Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAMP		ENSG00000127837	"Angio associated migratory cell protein"	Q13685	2	218264123-218270257	"Plasma proteins, Predicted intracellular proteins"	"Angiogenesis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017717, HPA031868"	Approved		Supported	Microtubules,Cytosol		NA	NA			Microtubules	Cytosol	"CAB017717: , HPA031868: AB_2674078"	"unprognostic (1.57e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.11e-3)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.39e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (8.94e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.92e-1)"	"unprognostic (9.09e-2)"	36.3	40.4	41.2	35.5	49.1	15.9	36.7	40.8	48.5	36.5	48.5	30.8	48.3	38.7	38.2	34.1	50.0	40.1	50.2	39.7	37.3	35.7	38.2	49.8	28.8	29.0	39.0	51.4	53.1	59.2	44.0	37.9	40.4	40.8	39.3	37.2	28.7	43.9	41.4	47.8	42.6	39.0	42.8	32.8	32.2	51.4	50.9	36.5	27.8	46.6	33.6	32.1	39.9	34.6	30.2	50.9	15.7	53.2	27.2	31.6	41.8	32.5	27.4	19.5	26.7	30.3	21.1	37.3	22.7	36.1	43.9	32.7	58.6	25.6	16.2	33.5	29.0	42.8	24.7	39.5	34.5	34.8	26.6	50.0	37.1	28.1	66.4	42.0	34.7	24.5	26.5	40.4	46.0	40.3	26.5	25.5	32.0	50.1	21.5	28.8	47.9	30.4	58.9	32.4	46.9	19.2	22.6	25.8	29.0	27.0	41.8	25.4	24.1	15.2	34.1	33.2	32.8	27.0	27.1	21.9	32.5	21.5	21.1	27.2	27.8	49.8	27.6	30.6	22.7	21.1	15.7	44.2	14.9	28.8	53.2	29.3	27.3	25.4	26.1	50.9	30.2	31.6	28.8	7.0	27.2	50.2	29.7	27.2	41.8	41.2	49.1	40.8	48.5	37.3	35.7	39.0	51.4	40.8	36.5	38.7	32.8	54.2	73.5	80.4	43.9	30.0	48.4	32.1	34.2	40.1	11.8	138.1	87.9	70.2	2.4	44.1	68.2	0.0	83.0	108.9	77.1	66.5	33.5	40.9	79.6	60.4	72.5	38.6	32.3	5.9	77.1	54.7	59.1	73.9	72.0	67.5	73.1	66.6	70.4	67.0	30.1	64.7	66.5	69.1	46.6	85.1	169.5	35.5	82.0	104.3
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44299654-44313326	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 11.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	8.6	10.7	15.9	16.2	11.8	11.4	9.9	23.5	19.8	11.4	14.5	11.4	13.0	15.3	14.1	10.4	17.2	13.4	15.9	10.4	13.2	8.9	10.3	12.6	10.9	13.4	12.4	14.3	17.1	13.8	16.2	14.2	10.1	11.1	13.2	9.8	11.2	14.4	14.6	10.2	16.8	18.3	12.1	8.8	14.1	12.3	12.9	14.1	14.7	12.3	10.4	13.4	10.2	13.9	7.1	3.2	3.7	3.4	3.7	5.5	2.8	9.7	7.3	9.6	17.6	5.7	5.2	12.7	8.0	4.1	8.5	8.2	7.9	5.3	10.7	12.8	3.5	9.0	7.3	10.6	11.5	3.3	7.5	16.9	12.4	7.1	9.3	3.7	11.5	11.1	4.4	7.3	6.8	7.3	5.2	7.2	15.0	14.6	10.5	4.5	10.9	9.6	9.9	7.1	28.1	7.1	11.5	5.8	7.3	4.4	8.8	22.8	8.2	6.9	7.8	10.7	6.7	7.2	15.0	6.1	9.2	9.3	5.7	10.0	6.2	5.7	11.0	5.2	10.2	15.9	3.7	2.4	0.0	3.4	3.3	5.5	3.6	4.8	4.4	2.6	7.1	4.7	4.3	0.7	3.7	3.4	3.2	3.0	2.8	15.9	11.8	23.5	19.8	13.2	8.9	12.4	14.3	11.1	14.1	6.0	3.5	2.4	1.9	0.6	6.3	2.8	7.6	4.0	3.4	0.0	11.8	4.4	0.0	2.1	2.2	2.9	4.4	0.0	0.3	4.4	1.4	1.2	0.0	2.4	2.7	0.0	0.0	3.7	2.8	0.4	4.4	1.6	0.0	5.4	1.4	1.5	1.1	0.0	4.2	0.8	6.7	0.0	1.4	3.3	7.0	0.4	4.5	2.2	3.3	1.4
AASS	"LKRSDH, LORSDH"	ENSG00000008311	"Aminoadipate-semialdehyde synthase"	Q9UDR5	7	122075647-122144280	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Multifunctional enzyme, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 98.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.0;granulocytes: 3.5;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 25.6;NTERA-2: 25.0;SuSa: 21.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020637, HPA020728, HPA020734"	Enhanced		Enhanced	Vesicles,Mitochondria		Yes	No		17000	Mitochondria	Vesicles	"HPA020637: AB_1844415, HPA020728: AB_1844416, HPA020734: AB_1844417"	"unprognostic (4.84e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.49e-2)"	"unprognostic (8.00e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (4.48e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.76e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.67e-1)"	13.9	9.5	7.4	4.8	11.8	1.6	11.2	2.7	9.8	16.0	8.1	12.5	8.2	2.2	16.8	11.6	6.4	14.9	6.7	12.6	8.8	3.7	14.4	35.8	9.1	3.3	15.2	5.0	36.7	10.7	14.9	10.4	7.1	9.9	9.2	3.8	9.2	5.4	10.4	11.3	4.4	5.5	9.3	12.1	5.2	9.0	5.1	13.2	0.8	7.8	8.3	3.1	11.0	9.0	1.0	0.4	3.5	0.1	0.3	1.2	0.1	0.1	0.0	15.8	25.6	13.3	8.5	6.2	4.3	4.6	4.5	6.5	7.3	0.2	0.0	0.2	3.0	5.1	2.7	18.3	8.2	6.2	0.0	6.7	5.5	3.5	4.7	10.8	0.0	1.8	7.5	0.2	5.4	5.7	12.6	10.8	7.3	1.4	10.1	3.1	0.0	0.5	0.0	25.0	0.0	1.0	8.3	8.4	0.3	2.1	1.7	1.6	0.5	1.4	0.0	2.6	21.7	0.4	0.0	4.9	8.8	2.7	4.1	4.1	2.2	1.6	0.0	3.2	0.5	3.4	3.5	0.1	0.0	0.7	0.0	0.1	0.5	0.8	0.0	0.4	1.0	1.2	0.5	0.0	0.3	0.0	0.0	0.7	0.1	7.4	11.8	2.7	7.3	8.8	3.7	15.2	5.0	9.9	13.2	8.9	28.6	1.5	8.9	5.6	6.3	8.1	7.6	0.0	7.9	14.0	15.7	9.1	0.0	1.8	9.2	9.2	1.0	0.0	1.5	2.5	9.3	5.2	3.5	98.3	1.2	11.1	2.9	19.6	1.8	5.4	17.5	1.5	11.8	0.0	2.4	8.7	2.6	2.9	23.0	7.8	2.2	19.4	21.6	6.4	1.5	4.1	4.2	2.2	1.5	3.7
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141888	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	31.4	4.3	1.4	2.0	6.6	0.4	12.1	0.7	1.9	12.3	9.9	4.7	2.9	1.8	7.9	6.9	10.5	4.9	7.2	13.2	1.5	0.9	3.0	53.9	9.3	3.6	10.9	0.2	22.0	1.9	1.1	6.0	1.8	11.2	8.0	3.4	4.2	7.1	1.9	6.6	5.0	3.9	9.8	21.0	1.8	4.4	5.0	9.3	0.0	6.7	6.6	2.5	16.6	11.7	0.0	1.2	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	20.7	30.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	13.1	0.0	1.6	0.4	0.8	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.3	1.4	6.6	0.7	1.9	1.5	0.9	10.9	0.2	11.2	9.3	0.0	0.0	2.7	0.9	2.7	13.9	4.8	0.0	0.0	1.2	3.5	5.9	0.0	0.0	0.2	2.9	2.2	0.5	0.0	0.2	0.0	27.1	0.1	0.0	95.4	1.2	0.0	2.4	2.5	1.8	2.2	47.5	2.8	5.0	1.0	0.1	3.9	0.5	0.0	11.3	0.6	13.8	0.0	1.7	0.9	1.0	2.5	0.0	0.0	0.0	0.3
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA			Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	28.2	13.3	13.7	13.1	10.6	11.7	20.4	14.8	11.5	17.0	19.0	41.4	8.9	17.5	19.2	18.7	18.3	20.8	15.8	19.1	24.0	14.0	13.6	19.9	19.6	35.9	10.3	17.6	6.2	9.8	10.8	19.8	7.6	11.1	10.4	16.7	8.8	10.5	17.6	3.9	29.6	9.3	15.8	21.7	18.9	16.7	28.6	6.8	16.9	43.3	10.4	17.1	25.6	27.2	19.2	10.9	10.0	14.7	10.3	12.7	18.4	22.2	19.6	6.0	5.6	17.1	9.9	9.0	5.9	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7	32.8	39.0	10.4	16.3	20.7	25.9	36.4	63.7	30.8	25.0	40.1	21.6	22.7	19.9	19.9	5.4	12.0	62.4	0.0	38.4	9.6	17.3	22.1	27.6	99.9	10.1	31.8	38.2	20.3	21.6	6.2	12.7	12.6	15.1	2.8	38.1	85.8	29.7	28.1	23.0	56.2	22.8	19.4	12.3	10.4	23.7	29.6	12.8	10.5	32.8	20.0
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145097932-145129179	"Predicted intracellular proteins"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No			Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	27.5	19.4	17.5	23.3	23.7	17.5	25.3	21.0	23.2	20.8	16.5	17.7	14.7	14.4	19.5	15.8	28.5	19.4	16.4	19.5	19.5	18.0	23.1	40.1	17.3	27.3	22.1	15.5	28.2	34.2	23.0	31.7	21.2	26.0	18.4	21.1	11.0	19.0	15.1	33.1	19.9	14.1	20.7	22.1	29.0	16.7	21.2	20.7	36.5	20.1	29.7	29.5	26.0	19.0	9.9	13.2	1.0	8.8	10.4	18.2	9.9	26.7	14.0	21.7	15.0	18.9	27.4	21.2	29.3	21.1	35.7	25.3	21.1	25.4	43.9	9.5	26.1	18.8	18.0	32.3	38.2	48.4	24.4	19.0	24.7	10.5	18.6	24.9	56.9	20.0	20.2	26.7	37.8	53.4	18.4	38.3	33.5	49.6	32.9	38.1	16.1	54.5	19.0	17.9	41.4	32.5	29.0	26.1	31.3	26.8	17.8	27.1	13.3	17.8	30.3	20.9	17.2	18.1	22.3	25.2	35.4	21.8	24.6	35.3	29.5	47.0	47.0	21.7	49.7	39.1	1.0	6.7	0.7	9.2	8.8	18.2	9.9	11.1	11.1	13.2	9.2	15.6	12.9	0.6	10.4	8.1	7.4	12.4	9.9	17.5	23.7	21.0	23.2	19.5	18.0	22.1	15.5	26.0	20.7	23.8	16.0	38.8	65.1	53.1	33.8	21.0	15.3	32.1	52.4	24.4	19.6	32.6	33.2	31.5	22.0	37.2	6.4	23.3	24.2	35.3	34.5	51.8	31.3	28.0	37.4	39.7	19.7	22.1	22.2	9.3	43.4	34.8	18.6	27.9	22.3	17.5	33.7	3.5	32.5	29.3	34.2	32.3	31.6	76.0	70.9	51.9	22.2	27.7	30.4	68.4
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571376-30597179	"Plasma proteins, Predicted intracellular proteins"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 70.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	16.1	12.5	12.1	11.8	13.9	31.9	12.4	12.1	15.7	11.4	13.7	9.8	9.5	7.1	17.0	9.6	14.6	10.9	10.6	13.1	12.0	7.3	15.5	18.3	13.5	9.4	10.6	10.5	12.5	14.0	23.1	16.6	21.6	13.7	12.4	13.6	9.2	14.1	15.3	70.6	21.3	17.6	15.2	12.7	13.9	19.6	22.0	13.2	14.7	13.8	14.9	13.0	14.2	13.5	10.1	9.3	4.1	7.9	11.9	14.3	6.5	12.1	5.4	7.1	9.7	8.0	5.2	3.2	10.3	5.3	7.1	9.9	18.0	3.0	10.2	11.2	6.4	9.8	8.8	10.5	6.0	13.9	7.2	9.1	12.4	7.6	5.6	2.5	12.6	4.1	4.7	6.2	11.1	2.8	1.9	2.3	2.9	22.6	3.7	7.9	2.7	6.6	2.8	4.9	4.2	3.3	20.8	7.0	10.7	5.5	11.0	6.5	13.4	5.6	15.6	3.1	3.5	3.9	3.4	7.1	13.9	4.2	3.3	5.6	13.6	22.0	17.7	1.5	14.7	10.1	4.1	7.9	3.4	14.3	6.7	12.2	10.1	10.4	12.8	7.1	9.1	9.5	9.7	3.7	11.9	7.3	9.3	5.9	6.5	12.1	13.9	12.1	15.7	12.0	7.3	10.6	10.5	13.7	13.2	47.6	84.6	56.7	79.8	76.5	41.7	75.9	38.2	49.5	78.5	55.8	62.8	83.9	51.4	84.1	80.0	46.5	74.6	46.7	75.7	116.4	50.0	62.6	85.4	115.0	44.1	52.4	48.7	34.4	39.0	122.9	35.9	46.8	33.7	67.7	40.5	42.0	84.8	38.6	48.8	58.5	108.2	71.1	55.1	135.4	94.1	74.2	138.9	55.4	45.7	74.3
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151212490-151227230	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	228	"Cardiomyocytes: 20.9;Cytotrophoblasts: 24.9;Extravillous trophoblasts: 22.8;Hofbauer cells: 18.5;Syncytiotrophoblasts: 27.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	18.3	15.4	14.9	15.9	18.8	9.7	12.6	19.0	29.6	10.9	14.2	16.3	12.9	9.5	14.9	17.7	16.1	13.7	13.6	22.2	14.5	17.4	14.2	10.6	12.4	16.1	16.4	23.3	13.6	17.7	25.1	14.9	15.2	17.1	13.9	17.7	13.7	12.5	16.8	46.6	17.4	10.7	21.7	12.7	15.5	13.9	20.7	16.7	15.8	14.8	16.5	22.4	14.5	11.2	13.0	14.2	6.8	15.0	15.7	22.4	14.5	17.9	29.2	10.2	36.4	20.9	17.5	13.9	21.8	18.8	28.4	24.2	24.8	12.6	29.5	18.9	24.4	23.9	14.2	32.1	26.7	27.7	14.7	26.7	12.3	14.5	15.0	24.6	29.0	19.6	23.1	22.6	31.6	18.6	12.3	23.9	17.7	35.1	12.4	25.3	45.6	32.2	34.6	24.7	21.9	31.7	20.7	16.4	27.2	19.5	13.1	17.8	17.3	20.8	21.9	14.6	11.3	9.3	15.0	21.4	18.2	7.3	21.7	32.9	24.1	25.7	21.8	25.1	29.2	34.3	6.8	12.1	4.0	15.9	14.3	22.4	12.7	16.2	15.9	14.2	13.0	15.3	15.8	1.7	15.7	15.0	10.2	16.9	14.5	14.9	18.8	19.0	29.6	14.5	17.4	16.4	23.3	17.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7"									"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.6	18.8	5.6	0.0	0.2	0.0	32.9	0.7	0.6	1.0	1.6	4.1	0.2	0.0	0.2	0.1	2.4	5.5	0.1	0.5	1.4	5.3	0.8	0.2	0.1	5.6	0.0	0.2	0.0	0.1	2.3	2.2	0.1	0.5	1.7	0.4	0.4	0.0	0.6	10.9	2.6	0.0	1.9	25.5	0.0	1.2	0.0	16.5	0.0	4.0	0.0	0.2	3.9	0.4	0.5	12.7	0.1	0.0	0.0	0.7	0.7	0.2	0.0	5.2	1.9	0.0	1.4	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5	3.0	1.4	0.5	0.2	3.4	0.0	1.1	0.0	1.4	0.0	0.0	0.0	14.3	1.7	0.0	2.6	9.0	135.7	0.0	0.2	47.1	2.1	0.2	5.7	25.0	105.8	0.0	2.9	13.5	1.0	0.4	1.1	1.1	5.0	0.0	2.9	0.9	0.1	35.1	0.4	4.5	0.2	0.0	1.4	0.9	3.4	0.4	31.5	0.8	0.8	0.1
ABHD14A	"DKFZP564O243, DORZ1"	ENSG00000248487	"Abhydrolase domain containing 14A"	Q9BUJ0	3	51971426-51981199	"Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038153, HPA056913"	Approved		Enhanced	Vesicles		NA	NA		260000	Vesicles		"HPA038153: AB_2675868, HPA056913: AB_2683275"	"unprognostic (4.15e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.92e-2)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.96e-1)"	"unprognostic (2.46e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.51e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.30e-2)"	11.8	28.0	23.3	6.0	25.8	9.0	9.2	39.6	45.0	18.3	7.3	12.2	8.5	8.0	6.9	23.2	5.4	19.6	9.3	16.4	22.3	27.8	26.2	13.0	9.7	8.9	16.6	23.4	14.8	20.6	15.6	21.3	7.0	18.7	11.6	5.6	26.1	17.7	12.5	23.8	3.9	6.6	8.8	14.5	7.7	11.0	6.2	7.0	6.6	24.1	8.4	8.8	9.2	7.4	15.4	13.9	4.5	6.0	12.0	30.9	15.3	2.8	5.4	3.5	10.6	35.3	17.8	1.9	3.8	6.3	4.6	6.2	6.2	11.5	3.2	2.6	9.4	5.2	2.4	3.8	4.2	1.5	10.3	4.3	9.4	16.2	20.5	9.9	12.8	12.6	16.7	2.9	3.9	2.0	10.3	5.9	6.2	3.8	10.9	7.1	3.2	5.9	13.1	2.0	13.5	13.0	4.2	1.8	30.3	8.8	4.4	7.3	11.3	9.5	2.0	5.6	0.8	3.0	14.1	3.4	4.2	4.5	10.0	4.3	15.9	14.8	2.6	7.8	20.6	6.0	2.1	6.0	4.5	30.2	3.5	30.9	15.4	26.7	26.8	10.4	12.4	24.6	26.2	0.6	12.0	2.2	13.9	25.7	15.3	23.3	25.8	39.6	45.0	22.3	27.8	16.6	23.4	18.7	7.0	6.0	17.1	20.4	20.4	8.7	89.3	21.0	15.3	24.1	19.4	31.4	23.6	9.0	28.2	13.8	3.6	14.2	8.5	0.0	10.8	11.5	41.8	21.4	15.0	11.6	25.9	55.6	38.7	17.2	11.8	18.4	81.4	13.0	11.8	4.6	11.8	36.2	13.3	2.9	31.1	69.3	86.1	19.4	11.3	16.9	59.2	4.8	4.1	34.6	14.0	13.2
ABHD16B	"C20orf135, dJ591C20.1"	ENSG00000183260	"Abhydrolase domain containing 16B"	Q9H3Z7	20	63861498-63862988	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	58	"Early spermatids: 120.3;Late spermatids: 172.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"eosinophil: 6.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 13.6;PC-3: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059272, HPA075886"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059272: AB_2683963, HPA075886: "																		4.3	3.6	3.0	5.3	3.8	2.0	1.1	0.6	3.0	1.3	1.9			4.1	2.3	0.0	2.9	2.2	0.9	2.2	1.9	2.0	2.6	2.0	2.2	3.4	1.5		2.3	4.8	0.0	3.2	1.3		2.9	0.0		3.6	0.0	3.1	2.4	3.4	0.0	1.2	7.4	5.0	9.0			2.0		0.0	1.4	1.5	1.8	1.6	6.3	1.8	0.4	2.0	1.6	4.1	2.7	0.5	1.1	0.0	0.0	6.3	4.9	0.0	0.0	0.0	13.6	5.4	3.8	4.0	0.0	1.2	10.6	0.0	0.0	0.0	2.6	3.3	2.4	4.7	9.8	0.0	1.4	6.9	0.0	0.0	0.0	0.0	0.2	0.0	2.9	4.6	4.5	0.0	7.1	2.2	4.0	1.2	0.5	16.3	4.8	0.6	1.4	0.0	2.8	2.0	1.6	4.6	2.7	0.6	0.2	5.4	0.6	1.7	2.9	5.1	1.5	2.0	3.7	2.1	2.5	2.1	1.5	2.1	0.3	1.8	6.3	1.9	1.2	1.2	0.8	0.7	1.5	1.5	1.8	1.5	1.1	0.8	0.4	0.8	1.6	2.0	1.6											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	172.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0
ABL1	"ABL, c-ABL, JTK7, p150"	ENSG00000097007	"ABL proto-oncogene 1, non-receptor tyrosine kinase"	P00519	9	130713946-130887675	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Apoptosis, Autophagy, Cell adhesion, DNA damage, DNA repair, Endocytosis"	"DNA-binding, Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002686, HPA027251, HPA027280, HPA028409"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	No			Nucleoplasm	"Nuclear bodies"	"CAB002686: , HPA027251: AB_1844453, HPA027280: AB_1844454, HPA028409: AB_10601011"	"unprognostic (4.82e-2)"	"unprognostic (3.99e-2)"	"unprognostic (5.55e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.89e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	20.1	11.6	12.4	15.0	18.1	10.7	22.0	6.7	16.0	28.9	34.3	29.1	12.1	11.9	26.6	16.9	21.4	20.8	30.9	14.2	10.3	8.4	9.9	6.7	13.8	8.7	24.1	9.4	24.2	12.2	27.7	14.5	13.6	17.1	27.3	15.8	19.4	14.6	18.0	10.8	14.2	17.0	66.6	14.3	10.8	21.9	9.8	21.2	5.8	19.5	11.4	9.1	35.8	31.9	3.1	3.1	1.1	5.0	2.4	2.6	1.6	7.2	16.1	17.2	20.8	25.3	30.9	6.3	12.7	19.9	14.9	12.6	12.6	9.4	11.9	7.3	16.8	15.3	14.0	8.7	11.7	11.0	7.4	5.4	7.8	27.4	10.7	17.3	11.9	10.9	22.5	12.9	26.6	16.5	20.8	20.6	15.4	43.5	9.5	18.1	13.7	15.1	9.8	19.1	11.3	11.9	17.5	22.3	12.8	15.1	8.5	16.1	20.1	21.3	8.3	10.2	10.5	16.2	11.0	23.6	57.2	14.8	21.8	19.9	2.9	6.8	15.9	23.5	9.9	18.1	0.2	2.1	1.1	2.0	1.2	2.6	3.1	2.0	1.9	2.0	1.4	1.9	1.7	0.2	2.4	5.0	3.1	0.9	1.6	12.4	18.1	6.7	16.0	10.3	8.4	24.1	9.4	17.1	21.2	8.9	9.9	4.2	6.4	8.1	6.2	5.8	12.7	5.3	5.7	14.0	11.8	11.3	1.7	12.6	3.1	14.3	15.4	0.0	9.5	3.5	27.8	8.1	2.3	13.4	13.7	9.5	21.2	20.3	13.7	7.4	25.9	6.5	5.0	3.6	15.7	15.7	14.3	20.3	24.1	8.4	9.7	19.4	21.0	11.9	13.6	5.9	12.7	7.9	19.1	6.4
AC118549.1		ENSG00000036549	"ZZ-type zinc finger-containing protein 3 "	Q8IYH5	1	77562416-77683419	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 19.0;Proximal tubular cells: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053663, HPA054913, HPA066197"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA053663: AB_2682222, HPA054913: AB_2682640, HPA066197: AB_2685635"	"unprognostic (1.30e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.13e-3)"	"unprognostic (5.38e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (6.96e-5)"	"unprognostic (2.91e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.43e-1)"	17.8	17.4	20.8	14.1	23.6	11.6	21.6	20.4	20.3	18.1	16.2	16.1	18.3	12.1	18.3	14.3	14.5	15.3	12.1	13.7	16.9	11.7	18.8	20.0	12.3	15.8	24.1	17.8	24.1	14.5	19.0	28.2	13.9	14.4	16.0	13.0	10.5	15.2	16.8	19.0	16.9	12.4	17.0	16.2	11.5	13.5	9.9	23.6	17.9	26.5	8.6	16.0	20.1	14.9	7.9	7.4	5.6	5.1	7.4	10.4	5.0	13.4	6.9	12.7	9.7	11.1	17.7	13.4	17.2	15.9	15.9	17.5	7.7	7.2	17.6	15.5	14.4	18.0	12.4	16.7	11.1	24.1	13.8	13.2	21.8	13.9	9.5	17.1	22.5	6.2	13.5	17.2	17.6	34.4	15.4	16.1	12.2	21.1	13.7	15.4	6.3	11.2	7.0	18.8	7.4	15.7	13.2	21.7	9.0	11.1	14.3	15.9	13.4	10.3	11.8	30.3	9.1	7.1	12.4	13.2	13.8	17.0	22.3	22.1	10.3	14.4	18.7	13.6	19.7	10.5	0.1	4.6	5.6	6.9	5.1	10.4	7.9	8.2	8.1	7.4	7.9	10.2	9.2	0.9	7.4	4.7	5.0	10.4	5.0	20.8	23.6	20.4	20.3	16.9	11.7	24.1	17.8	14.4	23.6	11.9	19.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	12.5	10.4	0.0	11.4	10.0	13.1	0.0	0.0	0.0	0.0	11.1	10.1	0.0	0.0	5.8	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	13.6	0.0	0.0	11.8	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
ACAD9	"MGC14452, NPD002"	ENSG00000177646	"Acyl-CoA dehydrogenase family member 9"	Q9H845	3	128879596-128916067	"Disease related genes, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037716, HPA046720"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA037716: AB_10673638, HPA046720: AB_2679773"	"unprognostic (1.04e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (3.61e-1)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.67e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.74e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.96e-3)"	"prognostic favorable (4.32e-8)"	"unprognostic (1.52e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.56e-2)"	"unprognostic (9.96e-2)"	18.1	20.6	14.0	13.1	15.4	8.0	15.4	14.7	17.9	13.6	13.4	15.9	21.1	11.3	16.9	13.1	21.6	15.6	16.4	21.6	10.7	13.2	15.8	24.0	11.6	10.4	13.6	17.8	13.1	21.1	30.6	14.2	13.8	13.6	13.0	12.4	16.0	19.0	16.0	30.8	45.0	10.1	13.8	10.2	12.1	14.6	19.5	10.8	13.9	14.8	18.2	14.9	12.6	14.0	7.2	14.0	4.1	18.1	5.0	7.5	8.9	25.1	13.2	10.6	7.9	16.4	11.6	11.3	12.5	13.8	24.1	20.7	18.5	15.3	18.7	11.7	15.7	16.3	21.1	18.5	24.5	16.0	12.3	12.6	17.0	26.7	13.1	12.0	13.3	7.9	12.6	9.6	14.0	15.8	13.9	19.4	14.9	8.0	9.1	16.0	25.4	19.6	11.1	6.4	26.0	18.9	15.2	10.0	19.0	16.9	16.1	12.3	7.9	19.5	18.3	12.1	10.0	24.2	28.8	11.5	10.1	8.8	10.2	11.9	9.1	4.4	16.3	16.1	12.4	12.7	3.1	12.0	4.1	7.5	14.7	7.2	7.2	6.8	6.4	14.0	4.9	5.7	7.3	1.0	5.0	18.1	7.9	6.5	8.9	14.0	15.4	14.7	17.9	10.7	13.2	13.6	17.8	13.6	10.8	14.9	23.7	9.7	10.0	5.6	14.5	26.4	7.6	10.7	11.4	14.0	9.8	22.7	18.3	18.4	14.9	9.8	8.1	0.0	15.5	15.2	10.1	7.5	16.1	23.3	26.7	9.5	5.2	17.8	9.5	12.6	9.5	8.4	15.1	16.2	6.3	15.8	13.0	7.6	13.8	18.0	10.9	12.9	13.3	15.6	10.0	12.4	25.6	7.5	14.1	6.0
ACADM	"ACAD1, MCAD, MCADH"	ENSG00000117054	"Acyl-CoA dehydrogenase medium chain"	P11310	1	75724347-75787575	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7;skeletal muscle: 82.8"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 330.8;Ciliated cells: 152.6;Distal tubular cells: 291.8;Hepatocytes: 232.4;Proximal tubular cells: 350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006198, HPA026542"	Enhanced		Enhanced	Mitochondria		NA	NA		1200000	Mitochondria		"HPA006198: AB_1078087, HPA026542: AB_1844469"	"unprognostic (9.04e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.09e-3)"	"unprognostic (1.61e-3)"	"unprognostic (5.68e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.40e-3)"	"unprognostic (3.35e-1)"	"prognostic favorable (3.83e-8)"	"unprognostic (1.27e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.24e-1)"	18.1	25.0	12.3	11.3	13.0	3.9	18.0	12.0	10.8	8.4	21.6	8.3	10.1	25.1	6.7	8.6	21.9	7.6	6.7	49.7	10.5	11.2	71.1	89.7	6.3	9.4	13.0	9.2	10.5	10.3	8.1	12.0	4.2	14.3	9.2	12.1	8.0	9.0	11.7	82.8	5.6	25.1	9.8	10.7	12.3	12.0	8.5	11.0	11.0	12.2	42.1	10.0	9.5	8.1	29.7	16.7	14.1	13.8	16.8	20.0	13.2	7.0	5.6	17.7	7.8	15.3	12.6	5.0	13.3	10.9	13.0	11.0	10.5	11.3	77.6	11.8	9.5	11.2	6.6	15.1	11.3	16.3	30.0	7.4	25.4	17.3	16.2	10.7	21.7	7.1	14.5	6.5	11.4	6.8	10.1	10.2	16.9	25.9	17.5	14.0	2.6	25.4	10.2	14.3	21.5	13.6	33.2	23.4	8.1	21.6	18.7	9.6	12.1	10.8	32.1	27.7	12.8	9.5	27.5	5.5	8.9	8.8	7.6	21.7	11.4	16.3	34.5	7.5	17.7	10.1	10.7	9.6	14.1	13.2	13.8	20.0	29.7	13.8	15.9	14.3	18.0	15.8	17.6	0.8	16.8	12.7	16.7	13.8	13.2	12.3	13.0	12.0	10.8	10.5	11.2	13.0	9.2	14.3	11.0	53.6	43.4	62.8	34.2	24.3	36.0	330.8	53.5	152.6	51.2	55.8	23.6	30.2	291.8	28.7	45.7	27.1	38.4	23.3	23.5	17.3	29.9	27.0	42.8	232.4	67.1	28.6	39.0	43.6	39.4	18.0	43.4	40.9	49.0	30.7	34.0	51.0	23.3	33.6	42.8	350.1	27.0	0.0	32.5	64.2	67.3	23.6	12.8	30.5	42.5	35.5
ACADS	"ACAD3, SCAD"	ENSG00000122971	"Acyl-CoA dehydrogenase short chain"	P16219	12	120725735-120740008	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.4;skeletal muscle: 50.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 312.7;Hepatocytes: 154.5;Paneth cells: 154.3;Undifferentiated cells: 144.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 23.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004799, CAB019284, HPA022271"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Mitochondria		NA	NA		15000	Mitochondria	"Nucleoplasm, Centrosome"	"CAB019284: , HPA004799: AB_1844471, HPA022271: AB_1844472"	"unprognostic (7.14e-2)"	"unprognostic (3.03e-3)"	"unprognostic (8.15e-2)"	"prognostic favorable (5.05e-4)"	"unprognostic (1.11e-3)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.04e-2)"	"prognostic favorable (3.33e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (6.34e-5)"	19.5	14.5	5.7	10.0	5.2	5.3	18.0	2.3	4.6	2.9	26.2	4.7	4.5	35.8	2.8	5.3	5.0	2.9	9.1	32.6	3.7	3.3	13.2	58.4	5.6	7.8	5.0	4.1	2.3	14.4	3.0	2.4	4.3	3.8	4.1	9.0	5.6	8.9	4.6	50.7	3.4	35.3	6.5	3.8	8.6	9.5	10.7	5.4	4.0	8.1	16.8	4.3	5.0	3.2	6.8	11.4	7.2	14.0	15.3	14.7	10.0	2.0	7.2	0.4	6.3	8.6	3.4	7.2	3.0	3.0	3.9	2.9	5.6	5.1	0.2	7.8	2.5	1.8	3.3	4.2	1.3	0.5	10.5	5.3	5.2	2.2	11.9	6.2	0.4	23.6	10.3	2.0	1.7	0.1	1.2	3.9	13.3	4.2	0.0	1.7	4.2	7.2	12.0	1.3	6.6	3.0	5.3	2.7	1.4	7.3	11.5	0.7	4.0	6.2	0.0	9.8	0.6	5.0	8.2	4.4	0.1	3.1	3.0	0.5	10.0	5.6	2.5	6.7	4.4	2.6	7.2	13.0	6.4	12.4	14.0	8.8	5.9	11.3	13.0	11.4	6.8	14.7	13.2	1.3	15.3	8.7	9.5	11.9	10.0	5.7	5.2	2.3	4.6	3.7	3.3	5.0	4.1	3.8	5.4	11.9	10.7	10.2	10.2	6.0	1.1	32.5	30.6	2.7	5.7	17.4	0.0	60.7	43.1	26.8	15.8	14.2	312.7	23.3	28.4	26.2	16.9	7.1	19.5	154.5	47.4	1.6	43.8	12.9	27.2	26.3	19.8	11.1	16.9	32.5	94.5	13.0	25.9	154.3	17.0	74.9	0.7	6.5	13.0	29.1	8.3	4.0	63.2	20.3	144.6	9.0
ACAT1	"ACAT, THIL"	ENSG00000075239	"Acetyl-CoA acetyltransferase 1"	P24752	11	108121516-108147776	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 267.1"	"Cell type enhanced"	"Detected in all"	10	"Distal tubular cells: 591.9;Hepatocytes: 643.6;Proximal tubular cells: 1104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 86.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004428, HPA007569"	Enhanced		Enhanced	Mitochondria		NA	NA		870000	Mitochondria		"HPA004428: AB_1078088, HPA007569: AB_1844482"	"unprognostic (3.70e-3)"	"unprognostic (2.23e-2)"	"unprognostic (7.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (3.59e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.20e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.06e-2)"	"unprognostic (6.62e-3)"	18.8	28.5	8.9	6.9	9.5	5.4	16.9	5.6	11.6	8.5	16.8	8.5	9.4	15.5	8.8	8.9	8.8	7.6	5.1	53.8	7.4	7.4	88.8	267.1	7.3	6.0	9.9	9.9	10.3	27.3	14.3	6.3	3.8	22.4	7.6	13.1	10.6	27.1	15.9	65.0	8.2	10.9	16.4	8.1	7.7	13.9	14.2	7.2	1.7	10.1	32.1	5.2	12.3	6.9	18.8	20.2	2.3	14.7	7.7	20.7	11.6	16.1	13.3	10.5	30.2	34.0	30.1	5.9	15.5	16.7	16.9	19.7	36.5	16.8	8.9	26.7	17.3	26.5	17.1	30.4	14.7	18.4	17.9	24.9	25.8	15.1	33.1	23.5	24.3	15.3	27.2	16.3	14.7	27.6	19.4	17.9	20.5	35.8	13.3	26.8	9.3	14.4	22.8	10.3	21.0	29.7	20.1	20.7	86.8	23.1	10.6	16.8	20.0	25.3	32.9	17.0	9.2	28.0	20.0	19.9	18.1	10.6	16.5	18.6	4.5	13.2	16.8	8.1	48.9	12.8	0.8	9.8	2.3	15.6	14.7	17.7	18.8	17.6	17.5	20.2	10.2	15.5	14.3	1.0	7.7	14.4	7.0	20.7	11.6	8.9	9.5	5.6	11.6	7.4	7.4	9.9	9.9	22.4	7.2	50.6	77.4	72.9	45.6	38.2	28.8	404.6	79.0	85.6	26.1	99.5	25.5	38.2	591.9	37.4	319.5	68.1	61.5	93.5	53.3	35.3	44.8	27.3	26.6	643.6	86.3	36.5	28.8	95.8	65.2	38.7	61.5	42.1	55.6	58.7	33.3	35.0	46.6	90.8	77.4	1104.9	23.8	64.7	64.3	159.1	28.1	42.3	21.1	42.4	83.1	20.7
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27195214-27242130	"Predicted intracellular proteins, Predicted membrane proteins"	"Autophagy, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	9.2	15.7	25.7	7.1	21.5	7.7	7.4	13.7	21.3	8.4	15.5	17.7	9.1	23.0	5.6	6.1	7.2	7.4	9.0	23.0	23.0	21.1	22.8	44.7	8.5	7.6	27.4	14.0	6.3	6.5	18.9	6.0	7.8	21.3	9.2	12.6	12.9	7.2	10.2	15.8	9.3	24.6	5.3	31.0	8.4	12.2	10.8	20.9	5.7	16.6	7.6	7.6	9.7	5.8	7.0	12.9	11.5	14.0	9.0	16.6	7.4	12.5	38.2	8.2	9.2	10.0	9.2	10.4	15.7	6.3	14.4	17.4	9.5	19.7	5.6	13.8	11.1	11.9	10.2	12.2	8.3	12.3	12.7	12.0	7.7	11.4	7.2	11.6	5.0	10.5	8.9	9.2	12.0	6.9	12.6	10.5	8.8	6.4	8.5	18.6	9.5	10.3	4.2	6.5	17.6	4.9	8.9	21.7	9.7	23.1	11.2	11.7	23.2	17.8	19.4	9.2	10.0	9.5	5.7	14.7	14.0	7.7	21.9	12.6	10.0	13.6	10.0	14.2	12.3	6.0	9.4	13.1	10.5	16.6	12.9	16.4	7.0	8.3	13.0	12.9	7.0	5.7	12.0	11.5	9.0	14.0	9.3	7.3	7.4	25.7	21.5	13.7	19.2	23.0	21.1	27.4	14.0	21.3	20.9	23.8	25.1	11.0	4.6	8.7	30.3	79.5	12.7	45.5	30.7	29.6	23.6	8.2	28.2	18.4	34.5	13.7	22.7	0.0	14.1	10.2	9.7	11.6	11.6	44.5	17.0	22.3	9.8	11.1	23.9	11.7	15.3	19.9	20.3	19.0	32.4	46.4	15.5	24.9	15.6	36.0	38.2	19.4	9.2	39.6	7.5	13.6	8.7	19.5	24.7	7.1
ACD	"Pip1, Ptop, Tint1, Tpp1"	ENSG00000102977	"ACD, shelterin complex subunit and telomerase recruitment factor"	Q96AP0	16	67657512-67660815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA049411, HPA057660"	Approved		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA049411: AB_2680752, HPA057660: AB_2683493"	"unprognostic (1.47e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (2.42e-6)"	"unprognostic (1.50e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.88e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.30e-1)"	9.8	9.7	10.8	12.0	13.4	15.9	9.6	20.5	21.7	12.5	10.4	10.3	9.5	7.6	13.3	8.4	7.9	16.0	9.7	8.6	9.6	9.5	9.1	5.3	9.4	16.7	10.1	9.5	23.2	9.2	10.8	11.9	8.8	11.3	11.2	4.8	11.2	9.5	12.6	11.9	9.6	8.3	12.2	8.3	12.2	8.9	21.1	7.4	16.8	11.8	4.8	13.3	12.4	9.0	27.7	14.2	17.1	14.4	25.3	26.1	14.9	19.2	15.3	8.9	8.7	4.4	3.0	18.7	7.9	5.7	12.7	15.3	20.0	9.5	5.3	9.4	4.6	10.8	15.6	5.5	15.3	4.2	5.4	17.9	11.3	6.7	20.0	2.8	14.7	18.4	4.3	5.1	16.7	8.6	4.6	8.1	15.7	6.9	3.7	6.2	21.0	14.4	14.5	11.0	7.8	10.4	20.1	9.7	22.4	5.1	8.0	13.0	11.0	30.1	3.2	6.9	2.8	7.1	8.4	6.3	13.3	11.0	15.6	11.9	10.1	12.8	16.8	12.2	9.6	11.1	17.1	11.5	13.5	26.1	13.3	22.5	27.7	24.6	22.7	13.0	23.1	19.1	20.6	16.2	25.3	14.4	14.2	23.4	14.9	10.8	13.4	20.5	21.7	9.6	9.5	10.1	9.5	11.3	7.4	6.0	11.0	12.7	12.1	12.8	13.6	2.2	7.6	17.4	10.3	10.4	3.9	19.3	8.3	17.0	40.8	14.3	5.4	0.0	17.1	20.0	14.4	7.4	27.6	4.0	13.7	12.7	12.0	11.6	9.2	57.0	14.1	12.7	21.9	23.4	6.8	12.9	14.5	7.0	11.0	10.0	9.5	6.5	13.3	57.5	23.0	8.4	9.5	26.2	8.3	8.0
ACTL6A	"Actl6, Arp4, BAF53A, INO80K"	ENSG00000136518	"Actin like 6A"	O96019	3	179562880-179588408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Growth regulation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 197.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012188, HPA018671, HPA063149"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB012188: AB_304125, HPA018671: AB_2669914, HPA063149: "	"unprognostic (2.13e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.24e-3)"	"unprognostic (7.79e-3)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.89e-5)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.80e-5)"	"unprognostic (4.21e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.21e-3)"	"unprognostic (5.20e-2)"	18.8	17.9	9.9	23.4	16.8	8.7	21.3	8.7	9.6	16.8	21.3	15.3	15.6	14.5	24.8	16.4	23.2	16.3	14.9	24.2	8.7	7.4	19.6	18.6	14.6	17.4	16.7	5.4	24.8	20.9	13.7	23.4	20.1	13.7	17.7	23.5	10.4	19.0	17.4	12.8	19.4	19.8	16.1	14.8	19.3	16.7	47.5	17.0	46.1	21.9	20.4	23.8	18.7	22.7	17.5	19.8	8.0	16.1	14.5	22.4	13.8	46.2	14.0	34.9	18.4	13.4	14.7	27.4	18.7	14.6	34.9	29.6	31.6	22.8	36.2	33.6	17.5	40.6	21.4	30.5	23.0	43.5	35.8	25.4	29.6	15.5	23.9	15.3	36.7	18.6	10.2	23.6	22.5	19.0	11.0	19.8	21.9	23.0	20.7	25.1	31.6	32.1	22.7	31.0	42.0	31.4	30.2	29.2	66.9	27.6	18.7	28.7	20.5	28.8	28.8	28.8	18.2	56.2	30.3	14.9	24.9	21.5	25.5	56.3	13.5	20.1	55.5	13.8	39.1	27.4	3.3	11.3	8.0	15.1	14.3	20.0	17.5	17.5	17.4	19.8	13.7	19.2	19.4	1.5	14.5	16.1	11.2	22.4	13.8	9.9	16.8	8.7	9.6	8.7	7.4	16.7	5.4	13.7	17.0	20.8	23.9	24.3	37.3	41.9	4.8	6.0	28.1	30.8	23.9	26.2	7.9	42.0	29.9	42.1	15.5	20.7	13.0	0.0	39.2	57.0	28.9	28.3	13.9	14.0	30.6	0.0	29.2	12.3	18.6	11.4	30.0	16.7	28.7	33.3	24.6	16.3	32.2	17.5	28.3	17.9	12.3	25.8	23.6	197.2	97.8	40.1	25.6	19.2	36.2	35.1
ADAR	"ADAR1, G1P1, IFI4"	ENSG00000160710	"Adenosine deaminase, RNA specific"	P55265	1	154582062-154627999	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, mRNA processing, RNA-mediated gene silencing"	"DNA-binding, Hydrolase, RNA-binding"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003890, HPA051519, CAB056157"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"CAB056157: AB_2665578, HPA003890: AB_1078103, HPA051519: AB_2681520"	"unprognostic (3.46e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.37e-2)"	"unprognostic (2.07e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.13e-2)"	"unprognostic (7.16e-2)"	"prognostic unfavorable (7.30e-5)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.00e-2)"	"unprognostic (3.94e-2)"	36.1	33.1	30.3	36.6	44.4	43.1	29.7	41.4	50.8	30.7	28.2	33.3	19.9	31.4	38.0	26.5	27.7	32.9	28.9	24.0	25.7	38.1	31.5	36.0	34.7	41.3	27.3	32.6	39.2	29.5	46.2	38.4	33.9	39.8	28.8	31.1	32.2	36.7	30.2	14.0	27.0	40.6	36.3	24.4	47.7	29.1	21.9	26.9	57.6	32.8	16.7	41.9	29.7	27.6	7.8	6.1	25.1	8.6	6.4	9.7	5.6	26.6	30.9	26.5	32.6	26.8	27.8	31.5	18.4	36.9	61.6	53.5	26.6	26.2	48.0	29.7	29.3	34.2	25.9	33.8	34.9	31.4	46.6	16.9	25.0	21.9	15.0	29.2	35.3	27.8	27.0	25.5	31.5	32.3	25.2	31.5	34.7	23.6	37.0	21.5	32.5	42.6	18.2	43.7	35.7	23.3	40.8	21.8	38.6	21.1	29.7	26.4	31.5	31.7	51.3	37.6	41.3	34.5	43.5	28.7	22.1	21.8	18.2	21.2	43.8	48.0	51.6	21.5	23.3	24.9	6.9	6.6	12.0	9.4	8.3	8.8	7.8	9.4	9.7	6.1	6.2	8.8	8.6	25.1	6.4	8.6	5.5	7.1	5.6	30.3	44.4	41.4	50.8	25.7	38.1	27.3	32.6	39.8	26.9	77.4	46.4	72.2	33.2	29.7	90.3	15.5	33.1	41.5	43.3	45.4	90.3	33.7	8.3	43.8	3.6	83.1	68.1	23.3	58.0	42.0	39.5	47.9	61.1	78.8	46.9	158.9	60.6	78.0	80.2	9.5	68.1	57.4	18.6	68.5	54.5	46.8	58.0	53.7	55.5	36.0	81.7	51.8	36.9	11.7	23.2	35.3	26.3	58.3	48.2	41.3
ADCY5	AC5	ENSG00000173175	"Adenylate cyclase 5"	O95622	3	123282296-123449758	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"cAMP biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 69.9"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 56.0;Paneth cells: 59.6;Peritubular cells: 69.3;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 18.0;RPMI-8226: 3.1;RPTEC TERT1: 6.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 347.3"	"Region enriched"	"Detected in all"	6	"basal ganglia: 205.1"	"HPA017730, HPA077682"	Uncertain		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA017730: AB_1844595, HPA077682: AB_2686851"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-3)"	"unprognostic (7.61e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.49e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.64e-2)"	"prognostic favorable (7.46e-6)"	"unprognostic (1.81e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.97e-4)"	13.3	3.0	12.5	3.7	32.0	0.6	9.3	2.6	14.4	4.5	11.7	10.4	3.1	4.2	6.2	4.4	13.8	5.3	7.3	69.9	10.4	8.3	5.3	2.4	2.6	2.0	15.0	8.6	10.1	5.7	1.1	7.7	4.8	9.7	13.8	4.6	4.6	3.1	16.3	2.2	1.1	4.8	13.5	8.8	4.7	9.6	5.9	16.0	0.0	1.0	0.2	2.6	9.5	8.5	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.7	1.6	0.1	0.1	0.1	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.4	0.2	2.7	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	18.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	3.1	6.5	0.6	2.2	2.0	0.0	0.6	0.1	2.2	0.0	0.1	0.0	0.1	1.5	0.1	0.3	0.2	0.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	12.5	32.0	2.6	14.4	10.4	8.3	15.0	8.6	9.7	16.0	0.0	0.0	0.0	0.1	0.2	16.5	56.0	2.5	0.0	0.0	7.0	0.0	1.1	0.0	11.5	0.7	0.4	0.5	0.0	6.3	3.1	2.3	0.1	0.0	0.0	0.2	0.0	0.0	2.5	0.0	1.1	19.0	0.0	0.0	1.8	0.3	0.8	0.6	59.6	69.3	0.7	1.5	64.7	12.2	0.7	5.6	0.6	10.4	0.0	1.2	0.0
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052461-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.2;fallopian tube: 25.1"	"Group enriched"	"Detected in some"	5	"Leydig cells: 10.6;Peritubular cells: 5.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	5.4	10.6	23.6	2.7	24.2	0.9	2.9	13.7	71.2	12.8	2.7	13.4	0.0	1.6	5.4	2.3	3.3	25.1	2.0	2.8	22.1	21.6	1.0	1.1	1.6	1.0	19.0	20.2	1.9	2.2	2.9	4.4	1.0	18.7	2.1	2.0	0.0	2.6	3.7	1.9	1.8	2.0	3.9	6.5	1.3	1.6	2.2	13.3	0.0	2.3	0.9	1.6	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	11.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.9	1.3	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.6	24.2	13.7	17.3	22.1	21.6	19.0	20.2	18.7	13.3	0.0	0.0	0.0	0.0	0.5	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	1.4	0.0	1.5	0.3	0.0	0.0	0.0	0.0
ADD1		ENSG00000087274	"Adducin 1"	P35611	4	2843857-2930076	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009794, HPA035873, HPA035874"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		1400000	"Plasma membrane"	Nucleoplasm	"CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.50e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (5.22e-2)"	"prognostic favorable (1.29e-7)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.03e-3)"	44.0	31.7	43.1	27.9	52.1	26.7	35.6	46.3	66.6	37.5	43.3	47.2	27.3	30.8	47.9	29.2	35.1	43.0	33.1	41.1	39.5	34.1	36.8	23.4	38.0	27.9	40.5	46.7	65.3	25.0	31.3	28.4	31.2	44.7	43.1	30.7	36.3	26.2	54.9	69.5	25.5	33.6	58.1	33.8	34.9	32.6	25.2	37.0	25.5	27.9	19.6	28.5	45.3	34.9	21.3	16.2	21.5	6.5	16.4	12.9	9.1	18.5	15.6	37.1	19.1	55.0	41.2	13.9	31.5	37.9	32.9	27.9	22.9	23.6	9.7	16.6	54.0	38.6	11.9	27.7	26.5	27.6	12.4	12.7	27.5	13.5	22.0	26.9	16.3	19.6	40.6	24.9	28.9	11.6	34.3	40.9	18.5	28.5	23.6	37.5	10.9	50.2	22.8	20.8	17.1	22.2	22.3	20.6	11.4	24.1	41.3	22.2	28.9	22.8	9.3	19.5	29.4	21.8	15.5	49.4	27.0	13.9	22.1	26.0	19.0	15.4	12.4	26.0	20.3	26.0	11.0	4.8	21.5	12.9	4.5	11.8	16.1	7.2	10.8	7.5	21.3	6.8	8.1	6.7	16.4	6.5	16.2	9.2	9.1	43.1	52.1	46.3	66.6	39.5	34.1	40.5	46.7	44.7	37.0	65.5	42.1	48.2	25.8	23.9	91.0	71.2	40.8	34.8	51.2	57.6	379.0	29.9	13.3	33.6	44.3	61.8	38.1	0.0	39.8	26.5	52.3	36.5	35.9	41.0	35.3	104.9	55.5	59.5	43.4	29.2	71.9	38.1	33.7	57.7	42.6	228.9	44.9	31.6	114.5	36.3	557.2	97.0	52.0	40.7	36.8	32.0	30.6	55.8	35.2	27.7
ADI1	"APL1, ARD, FLJ10913, HMFT1638, MTCBP-1, mtnD, SIPL"	ENSG00000182551	"Acireductone dioxygenase 1"	Q9BV57	2	3497361-3519736	"Enzymes, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 127.7"	"Cell type enhanced"	"Detected in all"	7	"Distal tubular cells: 752.7;Hepatocytes: 1079.9;Proximal tubular cells: 1041.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035403, HPA035404"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA035403: AB_10603576, HPA035404: AB_2674611"	"unprognostic (2.19e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-3)"	"unprognostic (4.23e-3)"	"unprognostic (2.36e-3)"	"unprognostic (4.00e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.56e-1)"	"unprognostic (9.94e-2)"	"unprognostic (6.76e-2)"	"unprognostic (8.74e-2)"	13.5	19.1	10.8	9.0	11.5	6.4	15.1	5.2	9.2	12.5	60.6	9.3	29.9	27.3	11.7	17.8	16.3	11.4	35.5	49.5	9.0	7.9	42.6	127.7	10.8	12.4	11.3	9.4	12.8	14.7	9.2	8.4	18.7	9.6	24.5	11.8	10.7	22.7	27.0	43.1	7.9	38.9	17.3	11.7	16.6	18.3	8.0	7.9	4.9	12.9	18.9	10.4	14.7	17.9	14.2	37.8	64.7	26.5	10.1	17.7	32.2	12.0	14.7	13.3	10.6	46.7	22.8	24.9	25.2	32.6	27.4	19.9	20.9	13.8	5.7	39.9	26.7	4.6	11.0	15.7	11.8	14.1	10.2	35.1	17.6	9.5	33.8	39.1	18.2	39.5	25.2	15.7	12.8	16.0	9.7	17.2	8.4	13.1	10.0	21.5	27.1	6.1	32.1	11.6	27.4	23.0	6.5	8.5	32.4	19.0	18.0	14.9	15.0	13.9	14.7	9.6	8.2	15.6	19.3	14.3	18.9	7.7	9.2	14.1	9.9	23.9	23.4	13.9	28.3	9.9	14.2	26.5	64.7	6.3	25.2	6.8	14.2	14.9	5.9	25.6	11.2	17.7	5.9	12.3	10.1	22.0	37.8	13.8	32.2	10.8	11.5	5.2	9.2	9.0	7.9	11.3	9.4	9.6	7.9	62.5	87.9	109.0	118.8	67.5	8.0	255.0	285.3	33.5	56.9	144.8	13.7	343.4	752.7	121.5	6.7	56.4	182.2	46.7	76.6	194.2	104.6	159.8	40.5	1079.9	211.6	7.9	54.8	164.5	143.1	16.8	126.8	60.1	194.0	117.2	123.2	123.6	76.7	181.4	197.7	1041.1	13.1	161.7	119.7	4.6	8.9	67.1	319.0	55.1	135.6	117.6
ADPRHL2	"ARH3, FLJ20446"	ENSG00000116863	"ADP-ribosylhydrolase like 2"	Q9NX46	1	36088875-36093932	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	Hydrolase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026641, HPA027104, HPA027141"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA026641: , HPA027104: AB_10601330, HPA027141: AB_1844619"	"unprognostic (3.22e-3)"	"unprognostic (5.10e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (3.71e-2)"	"unprognostic (2.63e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (4.37e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.74e-2)"	15.5	27.6	17.4	15.2	17.4	16.9	20.0	16.5	22.7	15.9	17.3	30.3	17.7	15.6	14.3	17.8	26.3	28.4	13.5	15.1	19.1	18.9	19.8	16.5	20.7	19.1	25.8	18.5	19.7	27.6	15.1	14.0	20.9	19.7	16.6	12.9	12.2	21.9	20.2	26.4	24.4	17.7	22.2	23.5	18.0	14.1	25.1	20.0	21.2	21.2	22.3	19.7	16.1	15.9	27.7	38.9	34.1	38.8	23.5	29.3	29.2	25.7	10.9	13.0	18.3	12.0	8.8	18.6	19.2	16.2	31.1	30.7	12.9	23.4	18.4	18.8	19.1	16.1	16.1	16.4	29.5	18.7	13.1	20.6	16.7	13.2	17.3	22.7	19.0	9.9	10.3	22.6	28.1	12.3	23.7	19.6	17.8	14.4	15.3	14.5	12.4	19.2	28.8	28.0	15.3	22.7	15.7	13.7	18.5	27.8	21.2	16.0	25.4	14.1	14.8	31.3	18.0	15.2	16.5	13.4	18.0	18.6	24.9	25.4	19.9	19.0	16.3	26.0	18.9	11.0	18.2	32.4	34.1	25.5	38.7	24.0	23.6	27.9	29.3	38.9	27.7	28.3	24.0	31.4	23.5	38.8	24.6	22.8	29.2	17.4	17.4	16.5	22.7	19.1	18.9	25.8	18.5	19.7	20.0	29.8	10.0	22.9	24.4	34.9	17.7	7.3	15.3	30.8	14.8	21.0	5.9	67.9	29.9	47.4	6.6	17.1	20.1	0.0	30.7	33.5	19.7	18.0	14.9	6.0	46.0	9.5	16.7	11.1	11.2	7.9	15.3	22.0	25.3	45.1	12.5	24.3	38.3	15.0	17.0	36.1	15.8	25.8	17.9	24.4	46.2	35.8	59.0	19.2	19.8	22.7
ADSL		ENSG00000239900	"Adenylosuccinate lyase"	P30566	22	40346500-40390463	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Purine biosynthesis"	Lyase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 79.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000525, CAB019285"	Enhanced		Enhanced	Cytosol		NA	NA		180000	Cytosol		"CAB019285: , HPA000525: AB_1078106"	"unprognostic (2.80e-1)"	"unprognostic (2.12e-1)"	"prognostic favorable (2.38e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"prognostic unfavorable (5.81e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.44e-2)"	9.3	11.6	5.0	13.7	8.5	11.2	9.0	6.8	10.1	7.9	9.5	7.3	4.4	6.0	10.8	9.4	9.7	9.0	6.9	14.6	4.5	4.7	12.0	17.3	6.8	17.6	4.9	4.9	10.5	21.8	5.4	9.1	9.5	5.1	7.1	9.7	9.2	14.7	6.4	79.0	6.2	9.4	10.7	4.9	14.5	9.6	10.9	4.4	18.8	8.4	23.6	15.5	9.5	7.4	15.3	28.8	11.0	22.7	19.8	34.0	24.6	21.4	25.3	21.8	31.1	14.7	20.8	25.3	19.6	19.4	42.6	32.5	41.8	12.6	62.4	16.7	22.7	19.4	16.2	48.6	31.6	43.8	16.6	45.7	28.3	28.6	38.5	30.9	92.1	23.8	22.3	17.9	37.4	39.7	21.1	31.4	28.2	33.4	27.4	31.8	24.0	28.4	32.9	35.5	25.9	27.0	43.3	45.8	44.3	27.4	17.0	14.1	13.9	23.4	13.0	37.2	20.0	17.9	29.1	20.8	22.8	42.2	20.1	37.5	26.0	45.4	47.8	19.0	34.2	22.2	11.0	19.3	7.8	16.2	22.7	22.8	15.3	34.0	21.7	28.8	14.9	27.0	20.8	1.9	19.8	20.2	14.9	34.0	24.6	5.0	8.5	6.8	10.1	4.5	4.7	4.9	4.9	5.1	4.4	11.9	9.6	11.9	15.4	16.1	15.9	25.7	20.4	5.3	7.9	3.5	35.3	78.9	6.6	48.2	34.1	17.1	14.2	0.0	38.1	60.7	23.3	13.9	36.8	21.3	54.2	6.4	13.3	33.2	40.2	16.1	23.0	24.7	11.8	41.5	20.7	43.1	33.8	7.0	13.4	13.5	17.0	25.8	17.6	39.7	73.9	13.2	27.7	27.4	37.6	9.3
AEBP2	MGC17922	ENSG00000139154	"AE binding protein 2"	Q6ZN18	12	19404045-19720801	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020893, HPA022282"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020893: AB_2670528, HPA022282: AB_2670931"	"unprognostic (3.28e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (9.15e-2)"	"unprognostic (4.56e-2)"	"unprognostic (5.19e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.47e-1)"	20.9	27.6	26.8	23.6	24.0	13.8	19.1	31.9	32.4	28.2	19.6	13.3	14.6	11.8	25.7	16.2	27.0	20.4	20.2	16.9	21.4	13.5	21.1	14.8	16.3	19.0	14.1	25.0	26.5	14.2	30.5	19.0	40.2	15.6	25.1	15.9	18.2	21.8	24.5	15.8	28.7	15.8	25.2	16.6	16.4	15.3	15.8	19.2	19.6	23.7	11.5	22.5	28.9	28.7	5.2	4.0	6.0	4.4	9.6	9.9	1.9	9.3	12.3	12.7	6.6	9.7	12.3	33.8	8.8	10.8	13.6	14.5	14.1	17.0	15.4	7.3	11.9	8.9	11.7	27.7	10.6	21.5	43.5	10.5	13.9	18.1	9.4	11.9	17.3	9.6	10.8	11.6	11.2	16.7	16.3	11.0	10.9	7.7	0.7	12.8	10.9	19.0	25.3	26.6	7.9	5.8	15.2	27.2	10.5	10.0	19.9	3.3	7.6	18.5	7.3	9.2	30.5	10.2	11.1	12.0	12.8	9.8	3.9	13.2	4.2	7.7	33.0	9.6	7.9	9.4	6.0	4.4	4.0	7.3	4.3	7.3	3.7	7.3	6.3	3.1	5.2	6.4	9.9	5.0	9.6	3.3	4.0	7.0	1.9	26.8	24.0	31.9	32.4	21.4	13.5	14.1	25.0	15.6	19.2	23.8	11.0	14.3	21.7	66.7	28.8	19.8	10.2	25.4	28.4	12.2	41.2	51.8	14.9	10.5	1.1	20.4	7.9	0.0	10.4	21.2	32.2	20.9	26.6	11.4	13.3	49.3	21.8	13.5	19.0	1.4	22.7	10.5	27.0	15.4	10.2	17.4	9.7	8.6	27.3	14.6	15.6	19.4	61.4	11.7	23.0	66.5	69.5	17.9	10.8	23.7
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 157.8;Alveolar cells type 2: 72.9;Ciliated cells: 85.6;Club cells: 75.1;Collecting duct cells: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	17.0	7.4	14.9	13.0	17.2	1.8	23.5	17.8	19.3	19.6	26.3	16.1	25.5	22.2	15.8	17.7	59.5	27.9	18.2	13.9	15.6	7.2	20.6	29.3	26.3	5.1	17.1	12.5	16.2	29.7	16.4	27.4	18.7	16.1	20.9	27.2	15.3	38.6	18.6	12.7	24.8	42.3	17.4	13.0	13.5	21.1	16.3	15.2	2.1	25.7	13.7	24.5	16.3	27.9	3.5	0.6	2.9	0.5	0.0	1.2	0.0	18.9	5.9	41.5	14.8	4.0	3.4	30.9	7.7	4.0	6.7	8.3	25.3	11.9	3.4	14.3	4.6	10.5	9.1	17.2	15.8	12.0	21.4	17.8	0.1	2.5	19.1	6.1	2.1	9.1	2.4	10.7	11.2	26.5	10.7	12.3	7.4	38.0	13.3	4.3	8.1	0.2	0.1	10.1	27.1	2.7	12.3	10.9	14.4	12.2	9.3	19.2	11.7	7.8	29.8	11.8	40.5	3.5	0.8	18.0	3.1	15.1	13.4	12.7	0.2	16.1	6.9	9.3	4.4	27.2	0.0	0.5	0.0	1.0	0.5	0.6	3.5	1.2	0.4	0.6	2.7	0.0	0.5	2.9	0.0	0.3	0.0	0.6	0.0	14.9	17.2	17.8	19.3	15.6	7.2	17.1	12.5	16.1	15.2	157.8	72.9	0.0	0.0	0.0	0.0	0.0	0.0	85.6	75.1	90.7	0.0	27.0	18.3	58.2	0.0	0.0	0.0	0.0	34.2	28.5	0.0	0.0	8.1	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.0	0.0	0.0	52.1	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	35.2	0.0	0.0	0.0
AHDC1	"DJ159A19.3, RP1-159A19.1"	ENSG00000126705	"AT-hook DNA binding motif containing 1"	Q5TGY3	1	27534035-27604431	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 59.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028648, HPA028685, HPA028691"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028648: AB_10599276, HPA028685: , HPA028691: AB_10601781"	"unprognostic (1.96e-1)"	"unprognostic (1.73e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (4.43e-1)"	"prognostic favorable (2.68e-4)"	"unprognostic (9.20e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (5.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	10.2	17.6	16.9	6.7	12.9	4.6	7.7	40.3	21.7	15.3	8.7	5.8	6.7	5.2	16.8	6.6	20.4	13.5	7.5	9.9	15.2	7.4	7.2	5.6	6.6	5.7	8.2	12.7	19.0	7.5	4.3	16.0	8.4	13.7	8.0	3.0	8.8	15.4	13.1	41.5	21.3	5.6	11.0	14.6	18.2	9.3	8.9	12.9	9.1	12.8	10.9	10.6	9.8	14.0	0.6	1.6	0.9	0.7	2.0	1.4	0.7	7.6	7.0	9.9	5.3	3.2	5.3	10.1	7.2	5.2	5.0	4.2	2.7	7.2	1.1	5.3	4.8	3.0	7.7	1.0	9.4	1.4	2.8	3.8	6.0	6.3	3.6	3.0	1.6	3.1	5.0	3.9	3.5	2.2	5.1	2.6	3.6	7.2	0.9	8.3	3.7	5.1	8.6	7.3	1.9	8.7	22.9	11.9	0.6	3.3	1.0	17.1	6.5	5.0	8.3	2.0	3.5	4.1	1.3	4.8	8.7	7.2	6.4	2.2	2.5	1.7	1.2	7.4	4.8	4.9	0.9	0.4	0.5	1.2	0.6	0.7	0.5	1.0	1.2	0.4	0.6	1.4	1.0	0.7	2.0	0.7	1.6	1.1	0.7	16.9	12.9	40.3	21.7	15.2	7.4	8.2	12.7	13.7	12.9	6.0	6.9	8.2	7.7	44.0	32.7	14.2	2.5	5.3	9.1	17.4	0.0	9.1	3.3	9.3	0.6	11.9	5.6	0.0	11.8	4.0	19.6	9.7	0.0	9.7	11.2	33.4	9.4	14.7	2.1	1.9	48.1	4.1	15.1	2.8	6.1	11.7	12.9	5.8	59.8	4.4	1.8	38.8	15.6	2.6	4.3	49.1	4.7	4.5	6.3	11.3
AHNAK	MGC5395	ENSG00000124942	"AHNAK nucleoprotein"	Q09666	11	62433542-62556235	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 86.5;fHDF/TERT166: 80.4;TIME: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019010, HPA019070, HPA026643"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA		950000	"Plasma membrane, Cytosol"		"HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426"	"unprognostic (1.39e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.63e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.98e-3)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (4.30e-1)"	"unprognostic (4.49e-3)"	"unprognostic (5.42e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (3.47e-6)"	85.2	8.2	15.3	35.3	9.3	10.0	91.1	9.3	10.8	69.7	66.3	16.8	36.4	13.0	52.2	47.4	96.9	39.4	59.2	55.8	20.9	6.0	18.4	16.0	54.9	16.6	16.2	13.4	40.2	8.9	8.0	5.3	39.8	15.9	42.6	26.8	29.6	35.5	36.8	64.8	88.4	38.2	101.5	16.1	16.9	38.3	16.9	16.2	5.8	18.4	72.9	44.0	54.3	86.1	8.2	28.9	15.3	30.1	11.1	16.7	12.2	26.5	15.7	1.4	6.5	64.4	86.5	10.4	24.1	29.6	15.4	8.6	13.5	9.5	0.0	9.2	80.4	11.9	35.4	6.0	29.7	19.7	21.5	1.0	3.2	23.3	4.0	12.3	4.4	21.2	31.2	34.9	30.2	27.7	19.7	31.7	0.4	3.0	20.5	31.2	10.3	0.0	8.6	0.4	8.5	23.8	0.0	6.6	15.9	34.2	17.4	0.0	1.3	24.3	10.3	10.3	31.1	19.7	4.1	84.1	27.5	17.9	34.1	10.6	3.6	0.7	0.0	20.9	1.4	8.9	15.3	30.1	0.1	16.7	17.5	11.0	8.2	10.7	13.1	28.9	5.2	1.4	7.6	0.4	11.1	14.0	7.9	7.9	12.2	15.3	9.3	9.3	10.8	20.9	6.0	16.2	13.4	15.9	16.2	408.0	109.1	70.5	114.1	425.8	1.3	166.6	206.4	97.7	178.6	183.2	0.0	83.1	11.6	83.1	9.2	245.0	291.2	0.0	57.2	123.8	177.9	136.3	226.0	73.3	79.4	1.6	45.8	165.7	304.6	18.1	418.0	252.7	301.9	91.0	140.5	27.9	164.5	142.7	438.1	5.4	1.0	174.6	271.5	1.7	7.6	533.5	85.5	86.3	79.4	166.3
AHNAK2	C14orf78	ENSG00000185567	"AHNAK nucleoprotein 2"	Q8IVF2	14	104937244-104978357	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skin 1: 131.1"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 101.5;Horizontal cells: 57.2;Suprabasal keratinocytes: 143.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"plasmacytoid DC: 1.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.6;ASC TERT1: 32.5;HBEC3-KT: 28.6;hTCEpi: 72.0;hTERT-HME1: 30.7;TIME: 32.3"									"HPA000878, HPA002940, HPA004145, HPA020111"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No			Cytosol	"Plasma membrane"	"HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.31e-3)"	"unprognostic (9.55e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (3.43e-1)"	"unprognostic (3.06e-3)"	"prognostic unfavorable (4.05e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.23e-5)"	6.9	1.8	2.9	2.0	5.6	1.0	8.5	3.0	13.7	17.2	23.0	2.9	5.7	1.7	16.3	2.9	25.8	7.1	3.2	1.5	2.4	3.1	1.1	10.8	2.3	1.0	2.7	11.6	1.8	1.2	1.2	0.7	1.8	23.3	5.7	5.1	10.1	6.0	14.6	1.6	131.1	4.8	19.9	4.8	1.1	7.1	3.2	0.8	0.0	1.2	14.4	3.0	10.0	19.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.6	20.0	0.0	1.4	28.6	32.5	0.0	2.4	5.1	0.9	0.4	0.0	8.9	0.0	3.4	18.8	20.0	14.5	0.0	28.6	0.4	0.0	0.1	0.0	13.3	0.1	2.6	0.0	0.9	4.1	72.0	2.8	30.7	12.3	12.5	0.0	0.0	0.0	14.4	1.6	0.0	0.0	0.0	2.1	9.9	0.0	1.3	0.0	19.6	0.0	0.1	0.1	10.6	0.0	0.5	0.6	1.3	0.0	32.3	6.9	4.3	7.9	2.2	0.0	0.0	0.0	21.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.9	5.6	3.0	13.7	2.4	3.1	2.7	11.6	23.3	0.8	11.9	1.4	0.0	4.0	101.5	4.7	1.0	0.0	25.4	18.2	1.8	2.0	0.0	0.0	10.2	20.6	16.7	0.0	0.0	7.7	0.2	11.4	1.9	16.2	0.5	1.0	57.2	0.0	1.8	0.3	1.6	0.6	0.7	30.4	0.0	0.0	3.0	41.0	0.0	0.4	0.3	10.5	0.0	7.2	0.4	3.8	143.9	0.1	0.7	0.0	4.9
AHSG	"A2HS, FETUA, HSGA"	ENSG00000145192	"Alpha 2-HS glycoprotein"	P02765	3	186612923-186621318	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Mineral balance"		"Cancer-related genes, Disease mutation, Hypotrichosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	269	"liver: 402.0"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 986.2"	"Cancer enriched"	"Detected in some"	284	"liver cancer: 1231.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"NK-cells: 1.4"	"Cell line enriched"	"Detected in some"	77	"Hep G2: 215.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001524, HPA001525, CAB026209"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	864000000000	140000000000	"Golgi apparatus"		"CAB026209: , HPA001524: AB_1078851, HPA001525: AB_1078849"		"unprognostic (6.40e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.47e-3)"	"unprognostic (3.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.64e-2)"		"unprognostic (3.99e-7)"	"unprognostic (5.21e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.04e-1)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	402.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	215.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.2	10.2	0.0	0.0	0.0	0.0	0.1	3.3	0.1	4.6	0.0	0.0	46.7	0.5	0.6	0.0	0.0	0.0	986.2	1.2	0.0	0.0	29.4	29.9	16.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1
AIMP1	"EMAP-2, EMAPII, p43, SCYE1"	ENSG00000164022	"Aminoacyl tRNA synthetase complex interacting multifunctional protein 1"	Q12904	4	106315544-106349226	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Angiogenesis, Apoptosis, Inflammatory response, Protein biosynthesis"	"Cytokine, RNA-binding, tRNA-binding"	Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017618, HPA018476"	Supported		Enhanced	Cytosol	"Secreted to blood"	NA	NA	6500000		Cytosol		"CAB017618: AB_2285445, HPA018476: AB_1848137"	"unprognostic (1.17e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.29e-3)"	"unprognostic (8.10e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.27e-2)"	30.7	26.6	20.2	25.7	24.5	42.2	30.3	22.5	22.9	29.9	33.7	17.0	33.6	27.7	29.3	28.4	35.0	25.6	23.7	23.6	21.2	18.4	40.4	35.3	23.4	24.6	29.8	21.8	35.9	27.2	24.1	44.0	27.3	26.5	29.8	28.4	14.1	25.6	32.1	67.8	22.6	39.1	32.8	30.1	26.9	25.2	15.9	29.4	31.3	35.9	40.6	25.8	41.2	25.9	28.2	35.9	24.6	32.7	23.7	33.4	16.6	22.9	14.7	15.5	21.9	18.6	27.9	26.0	30.7	23.6	24.0	28.8	25.3	33.9	40.7	23.2	25.5	18.9	23.0	23.6	29.1	34.4	22.6	14.8	24.0	19.0	40.2	35.7	47.5	27.8	21.5	33.6	25.5	41.4	17.9	20.8	22.4	41.0	22.0	26.5	16.6	32.0	22.6	17.6	31.7	14.7	26.3	31.4	36.6	29.7	20.0	24.9	18.5	19.6	54.2	27.6	22.8	25.9	33.4	17.7	31.7	29.0	23.5	35.7	25.0	35.0	41.6	26.4	37.2	34.0	22.4	26.9	24.6	21.8	29.0	26.0	27.7	27.3	21.8	27.6	28.2	28.5	25.9	3.7	23.7	32.7	35.9	33.4	16.6	20.2	24.5	22.5	22.9	21.2	18.4	29.8	21.8	26.5	29.4	65.5	48.1	80.4	112.4	44.6	44.9	91.2	84.1	77.6	91.0	62.8	33.4	105.8	132.6	104.1	59.3	50.6	74.9	23.3	110.5	122.1	61.9	108.3	78.4	110.0	97.3	23.8	70.9	63.3	84.2	9.9	91.7	82.1	30.4	91.0	106.7	52.5	101.3	87.7	80.2	119.0	35.9	58.2	70.0	117.4	69.1	43.8	126.2	64.5	109.4	153.1
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 165.9;Spermatocytes: 116.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"							"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	4.6	4.7	7.7	5.6	8.4	4.7	8.3	13.5	8.7	5.0	6.5	8.5	4.1	5.0	6.3	11.1	6.2	11.3	5.2	6.9	9.1	10.3	7.6	4.5	6.7	5.5	9.4	4.9	6.7	4.6	15.4	33.3	4.4	11.5	5.9	6.7	3.7	7.0	6.3	6.1	5.5	6.2	5.7	11.7	6.5	6.1	22.0	7.7	20.5	11.4	4.1	5.0	5.9	4.4	11.2	2.9	15.1	4.1	4.9	6.4	1.6	2.5	1.8	7.6	13.5	7.1	4.5	5.7	4.0	5.0	4.2	5.7	2.9	5.3	5.5	2.1	3.7	9.2	4.5	2.2	4.3	8.9	11.7	4.7	4.2	4.4	2.9	5.8	5.3	2.6	3.6	8.4	7.7	10.1	10.3	5.5	8.4	3.9	4.6	3.1	5.2	4.6	3.5	1.7	5.8	2.9	6.1	4.2	5.1	6.1	5.0	9.2	7.9	4.8	4.6	6.6	4.5	6.0	6.4	5.8	4.0	2.7	5.8	2.6	2.4	2.1	3.2	8.1	6.7	2.2	15.1	2.8	6.5	5.1	1.5	4.4	10.5	5.1	6.1	2.0	11.2	6.4	5.5	5.4	4.9	4.1	2.9	3.6	1.6	7.7	8.4	13.5	8.7	9.1	10.3	9.4	4.9	11.5	7.7	26.8	18.8	6.6	7.7	2.4	14.6	16.1	2.5	165.9	18.2	8.7	13.7	3.3	0.0	7.0	55.8	11.3	10.5	0.0	3.9	1.2	3.5	4.8	20.9	1.8	3.0	19.1	19.0	5.5	4.6	32.1	6.9	5.3	5.0	1.8	14.3	15.2	6.1	7.8	6.0	5.6	48.9	25.8	5.2	116.9	28.5	2.3	4.7	12.8	9.9	7.5
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239999-151358557	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Ito cells: 255.3;Muller glia cells: 521.2;Spermatocytes: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	184	"basophil: 20.4"	"Lineage enriched"	"Detected in single"	184	"granulocytes: 20.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 37.5;REH: 42.9;TIME: 42.7;U-251 MG: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		6400000	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	52.5	11.2	11.5	11.0	18.1	2.0	38.5	31.3	21.2	11.5	23.4	1.9	5.9	6.1	20.5	13.6	12.8	15.6	32.3	22.8	9.8	17.4	14.9	20.6	18.2	6.9	11.4	9.9	49.0	7.6	2.0	11.1	24.1	28.7	13.5	9.4	26.6	3.3	14.7	11.3	4.1	10.6	27.9	14.1	8.1	12.4	62.0	6.6	0.3	11.4	6.6	2.8	34.5	24.7	0.0	0.0	20.4	0.0	0.0	0.1	0.0	1.7	8.5	12.3	0.0	23.3	35.0	4.3	10.0	5.4	4.5	4.5	0.2	32.4	0.0	4.0	7.5	37.5	0.2	23.4	7.4	4.0	11.1	8.6	0.1	9.5	7.9	2.6	0.0	2.2	24.7	0.0	19.0	1.0	5.9	29.3	0.1	2.1	0.2	16.2	0.1	0.0	0.0	7.7	0.0	10.1	42.9	0.5	0.0	26.0	1.4	8.8	5.1	3.2	0.1	5.6	18.2	0.6	0.1	42.7	0.6	8.0	25.5	45.7	0.0	0.0	0.0	14.8	0.0	8.5	20.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	18.1	31.3	19.1	9.8	17.4	11.4	9.9	28.7	6.6	11.9	21.0	12.7	21.4	17.4	9.5	7.8	7.6	8.1	23.9	48.8	2.0	1.6	1.7	120.3	57.8	105.1	0.0	0.0	5.7	5.5	80.8	45.7	64.5	3.9	20.4	0.0	1.7	255.3	23.1	93.7	36.8	11.7	55.6	1.0	0.0	521.2	193.7	0.0	104.0	64.3	24.1	97.0	171.6	222.6	34.3	9.9	8.4	7.2	0.0	129.4
AKAP9	"AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, LQT11, MU-RMS-40.16A, PPP1R45, PRKA9, YOTIAO"	ENSG00000127914	"A-kinase anchoring protein 9"	Q99996	7	91940867-92110673	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Cone photoreceptor cells: 2100.9;Rod photoreceptor cells: 1161.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008548, CAB012909, HPA026109"	Supported		Enhanced	"Golgi apparatus,Vesicles,Centrosome"		NA	NA			"Golgi apparatus"	"Vesicles, Centrosome"	"CAB012909: AB_2533235, HPA008548: AB_1078121, HPA026109: AB_1844688"	"unprognostic (9.57e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.97e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.59e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (2.10e-6)"	"unprognostic (8.89e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.96e-2)"	13.7	15.9	18.0	22.6	17.1	14.9	15.6	35.8	17.5	14.4	24.5	4.7	17.2	25.5	13.0	17.1	15.3	12.4	15.0	14.8	13.3	7.0	19.5	25.1	19.9	13.2	12.4	12.3	22.3	21.3	22.1	40.5	12.9	14.0	11.9	25.3	11.1	20.1	25.9	29.6	16.1	29.1	12.0	11.1	10.4	15.0	6.9	14.4	10.3	14.9	15.7	8.6	14.0	14.2	34.4	39.5	31.9	16.6	10.6	20.3	3.4	11.4	7.1	10.6	6.7	15.2	11.2	7.5	8.5	5.9	4.4	5.6	12.1	10.0	10.4	12.5	7.5	9.3	10.6	10.2	5.6	8.2	9.4	8.7	11.4	12.5	7.9	6.2	18.9	12.2	7.0	8.9	9.1	10.4	9.3	9.5	12.0	16.9	17.1	7.5	16.6	12.8	7.5	8.1	9.4	8.9	7.8	17.7	8.4	6.1	12.6	17.3	12.1	18.2	20.4	8.8	13.1	5.3	9.2	17.4	8.9	11.5	15.5	11.6	12.2	13.5	14.0	7.9	9.6	10.0	31.9	16.6	21.4	18.4	9.3	15.4	31.4	18.7	16.7	7.2	34.4	20.3	19.3	23.2	10.6	16.3	39.5	14.9	3.4	18.0	17.1	35.8	17.5	13.3	7.0	12.4	12.3	14.0	14.4	488.4	309.8	122.9	114.8	91.9	252.0	215.2	267.5	697.3	270.7	167.5	2100.9	111.3	86.2	108.2	8.6	85.9	257.2	163.5	80.8	65.2	74.7	91.4	129.8	127.1	50.9	340.1	177.6	92.7	65.9	8.5	160.5	90.0	55.6	92.8	259.7	147.7	95.5	204.4	127.6	36.7	1161.3	135.8	61.8	76.2	133.4	97.7	279.2	105.4	127.3	84.0
AKR1C1	"DD1, DDH, DDH1, HAKRC, MBAB"	ENSG00000187134	"Aldo-keto reductase family 1 member C1"	Q04828	10	4963253-4983283	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 145.9;tongue: 74.5"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 239.5;Exocrine glandular cells: 290.3;Hepatocytes: 511.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 64.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"ASC diff: 185.8;Hep G2: 315.1;OE19: 134.5"									"CAB047303, HPA068265"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"CAB047303: , HPA068265: AB_2685966"	"unprognostic (1.54e-2)"	"prognostic favorable (3.05e-4)"	"unprognostic (4.04e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.05e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.65e-1)"	"unprognostic (1.82e-2)"	"prognostic favorable (8.03e-9)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.72e-2)"	"unprognostic (6.30e-2)"	52.0	3.8	2.1	3.4	4.1	1.4	36.0	2.6	2.7	2.2	3.2	2.6	1.2	6.2	1.4	4.0	19.2	1.7	16.1	22.1	2.6	2.6	32.0	145.9	11.2	2.5	5.4	1.4	3.8	4.9	0.6	4.1	0.7	6.6	5.1	3.2	3.8	13.1	3.4	17.1	4.7	4.6	4.8	6.8	0.9	21.9	5.2	3.2	0.0	11.5	74.5	5.0	17.4	10.8	0.0	0.9	4.2	0.1	0.3	1.7	0.8	0.0	25.5	0.1	25.7	185.8	22.4	0.0	0.8	5.7	0.3	0.2	0.4	0.0	0.0	0.3	5.7	4.4	0.2	0.0	1.3	0.1	0.0	0.0	0.7	4.1	315.1	1.8	0.1	0.0	11.4	1.6	2.6	1.6	0.0	0.6	0.1	5.4	0.0	4.4	0.1	0.0	0.0	0.0	134.5	0.0	0.0	0.0	0.2	1.4	4.8	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.4	5.0	2.2	0.1	5.9	0.2	0.1	0.0	0.0	7.9	0.7	0.0	4.2	0.1	1.1	1.7	0.0	0.1	0.0	0.7	0.4	0.2	0.0	0.3	1.5	0.9	0.3	0.0	0.9	0.4	0.8	2.1	4.1	2.6	2.7	2.6	2.6	5.4	1.4	6.6	3.2	62.5	27.2	1.5	11.8	18.8	2.5	2.4	239.5	96.4	128.5	59.3	0.0	0.0	11.6	33.9	14.9	17.8	9.3	70.0	290.3	0.0	13.4	11.4	4.6	511.8	0.3	0.0	1.7	26.4	14.5	8.0	140.4	3.8	101.3	8.2	1.7	47.9	184.6	0.9	138.6	40.8	4.3	0.0	14.4	1.7	0.7	17.9	0.1	0.9	2.6	140.8
ALB		ENSG00000163631	Albumin	P02768	4	73397114-73421412	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 3075.8"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 49859.9"	"Cancer enriched"	"Detected in many"	384	"liver cancer: 14213.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"naive CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enriched"	"Detected in some"	39	"Hep G2: 315.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB006262, HPA031024, HPA031025"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus"	"Secreted to blood"	NA	NA	40000000000000		"Golgi apparatus"	"Endoplasmic reticulum"	"CAB006262: AB_425297, HPA031024: AB_2673703, HPA031025: AB_2673704"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.44e-1)"	"unprognostic (2.46e-1)"	"unprognostic (9.53e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.37e-2)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.87e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.02e-2)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	4.9	3075.8	0.1	0.1	0.1	0.1	0.1	38.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.0	0.0	0.3	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	315.9	0.0	8.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	7.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	0.0	2.6	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	683.8	0.0	0.0	0.0	0.1	12066.1	0.0	0.0	36.6	0.0	0.8	61.3	4.3	2.0	0.0	0.0	1612.0	237.4	2.3	0.2	0.1	0.0	49859.9	8.2	0.0	1.7	1417.3	1529.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	261.7	0.0	0.0	442.7	0.0	0.0	0.4	0.2	0.2	0.1	17.7	22.3	0.0	0.0
ALDH18A1	"GSAS, P5CS, PYCS, SPG9"	ENSG00000059573	"Aldehyde dehydrogenase 18 family member A1"	P54886	10	95605929-95656706	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Proline biosynthesis"	"Kinase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 68.8"	"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 58.2;Paneth cells: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008333, HPA012604"	Approved		Enhanced	Mitochondria		NA	NA		23000	Mitochondria		"HPA008333: AB_1078125, HPA012604: AB_1844721"	"unprognostic (5.97e-3)"	"unprognostic (2.08e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (4.20e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.30e-3)"	"unprognostic (7.08e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.60e-9)"	"unprognostic (1.02e-3)"	"unprognostic (6.57e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.43e-2)"	6.3	10.4	7.1	10.4	7.9	5.2	7.7	7.3	9.3	13.7	20.1	7.2	20.5	33.8	9.3	12.3	12.8	8.5	15.2	7.2	6.2	7.1	13.0	28.9	6.6	7.4	6.7	5.3	14.5	40.7	12.7	17.4	14.3	7.7	9.6	19.4	7.9	68.8	20.5	3.5	9.6	45.4	10.0	5.4	8.6	15.2	8.4	5.4	12.7	25.9	9.7	15.9	8.6	8.2	13.1	5.2	0.3	4.0	13.0	16.3	8.0	18.3	17.4	16.8	44.0	22.6	21.8	18.1	21.5	32.3	21.9	27.6	34.9	14.7	62.6	20.1	33.8	10.6	24.4	33.6	22.1	24.9	17.7	26.4	19.8	12.4	49.5	14.8	34.6	22.2	22.9	13.6	17.8	34.9	36.4	22.9	23.6	18.5	13.2	16.3	26.4	31.2	22.3	19.8	30.5	17.4	29.4	19.2	21.4	25.5	14.0	16.8	16.6	17.1	13.6	15.8	20.1	20.3	16.2	18.9	9.1	14.5	23.4	24.6	15.3	11.3	38.3	17.7	40.1	11.6	0.0	1.4	0.1	15.5	2.7	16.3	13.1	14.2	16.0	5.2	9.0	12.1	13.4	0.3	13.0	4.0	3.1	13.3	8.0	7.1	7.9	7.3	9.3	6.2	7.1	6.7	5.3	7.7	5.4	6.0	8.6	11.5	6.6	10.0	5.7	4.3	10.2	16.0	14.8	19.2	0.0	36.1	1.7	12.5	0.7	5.4	58.2	0.0	18.4	25.8	17.5	15.6	8.1	23.1	10.1	9.5	19.0	4.9	3.2	0.4	8.6	3.1	15.1	2.8	37.5	5.2	12.4	54.7	11.3	7.9	2.8	0.0	5.6	5.1	9.0	7.0	25.3	8.7	30.7	8.1
ALDH1A1	"ALDH1, PUMB1, RALDH1"	ENSG00000165092	"Aldehyde dehydrogenase 1 family member A1"	P00352	9	72900662-73080442	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 207.2"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 583.5;Hepatocytes: 620.8;Leydig cells: 376.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 399.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"classical monocyte: 34.2"	"Lineage enriched"	"Detected in many"	30	"monocytes: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 294.7;Hep G2: 90.7;RPTEC TERT1: 52.5"					"Region enriched"	"Detected in all"	6	"midbrain: 171.1"	"HPA002123, CAB020690"	Enhanced	Approved	Enhanced	Cytosol		NA	NA		62000000	Cytosol		"CAB020690: , HPA002123: AB_1844722"	"unprognostic (8.46e-3)"	"prognostic favorable (7.77e-5)"	"unprognostic (5.59e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-2)"	"unprognostic (8.71e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.53e-2)"	"unprognostic (6.83e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.90e-3)"	20.0	26.9	8.8	12.3	21.4	3.9	10.8	44.8	11.7	33.6	53.6	14.5	65.3	77.1	25.5	87.1	14.5	27.8	38.3	8.9	12.5	5.9	86.7	207.2	31.4	9.4	56.4	3.6	35.8	69.7	0.7	57.5	7.9	14.0	20.0	13.1	30.2	31.8	40.3	12.1	2.7	76.5	17.1	29.1	16.3	75.5	43.0	14.9	2.0	45.8	21.0	16.8	14.1	16.0	0.3	0.5	1.1	34.2	0.0	0.1	10.5	0.0	294.7	0.0	0.0	1.7	0.0	0.1	10.2	0.0	0.0	0.0	9.9	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.7	0.0	90.7	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	10.5	0.0	1.1	0.0	11.3	0.5	0.0	0.1	0.0	0.5	0.0	0.0	3.3	0.1	52.5	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	34.2	0.5	0.0	5.8	0.0	0.0	0.1	0.0	0.5	0.3	0.0	0.0	1.1	0.0	0.4	0.3	0.0	10.5	8.8	21.4	44.8	11.7	12.5	5.9	56.4	3.6	14.0	14.9	89.3	82.8	17.6	12.3	2.4	0.0	2.8	211.5	583.5	271.8	109.9	0.0	1.1	330.0	52.4	8.7	10.5	29.0	23.3	296.8	1.1	30.2	1.8	152.7	620.8	115.7	0.0	52.7	105.0	82.2	16.5	376.3	13.6	6.8	5.4	141.2	0.0	193.4	16.9	194.8	295.4	0.3	25.8	9.2	3.6	3.8	2.8	2.1	20.0	42.1	18.3
ALDH1L1	"10-fTHF, FTHFD"	ENSG00000144908	"Aldehyde dehydrogenase 1 family member L1"	O75891	3	126103562-126197994	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 48.1;liver: 148.7"	"Group enriched"	"Detected in many"	6	"Hepatocytes: 554.3;Proximal tubular cells: 175.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 40.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.9;Hep G2: 23.9;Karpas-707: 24.7;RPMI-8226: 12.9;RT4: 66.0;U-266/70: 13.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036900, HPA050139"	Enhanced	Supported	Supported	Cytosol		No	No		640000	Cytosol		"HPA036900: AB_10672273, HPA050139: AB_2681031"	"unprognostic (5.93e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.42e-8)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.03e-3)"	"unprognostic (7.93e-2)"	28.9	12.1	13.7	1.8	17.1	1.2	6.0	8.6	10.9	7.8	4.9	5.7	2.3	1.1	1.9	2.2	3.6	3.4	1.9	8.1	8.9	5.3	48.1	148.7	1.3	1.2	9.2	10.1	11.3	10.2	1.4	0.9	1.1	10.8	3.3	3.3	5.1	34.1	4.1	30.7	1.5	1.3	2.4	7.7	1.1	1.9	4.9	6.2	0.0	1.7	6.2	2.8	11.0	3.1	0.1	0.8	0.8	0.2	0.2	0.4	0.0	0.4	0.0	0.0	0.0	10.9	0.0	0.1	0.1	0.4	0.1	0.2	0.0	0.9	0.7	3.2	0.0	0.6	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	23.9	3.2	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	24.7	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	12.9	0.3	66.0	0.1	0.1	0.3	3.2	0.0	0.2	0.0	0.0	0.1	0.4	1.9	0.0	0.0	13.6	4.2	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.4	0.2	0.2	0.2	0.0	0.8	0.1	0.0	13.7	17.1	8.6	10.9	8.9	5.3	9.2	10.1	10.8	6.2	0.0	5.9	4.5	44.7	0.1	0.2	14.9	22.9	10.7	64.8	12.2	0.0	0.0	61.3	2.2	18.0	2.7	2.3	0.0	4.8	0.1	0.8	8.1	25.6	554.3	0.1	0.0	1.2	12.3	15.3	25.4	24.5	2.6	3.3	0.0	9.1	35.7	1.9	0.0	21.2	175.8	1.0	6.5	1.0	1.1	1.2	0.0	0.1	7.0	2.2	48.0
ALDH1L2	"FLJ38508, mtFDH"	ENSG00000136010	"Aldehyde dehydrogenase 1 family member L2"	Q3SY69	12	105019784-105084577	"Enzymes, Predicted intracellular proteins"	"One-carbon metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"pancreas: 48.9;salivary gland: 31.6"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 8.3;monocytes: 6.4;Pancreatic endocrine cells: 5.6;Peritubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.3"	"Lineage enriched"	"Detected in single"	6	"dendritic cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 23.0;ASC TERT1: 31.5;fHDF/TERT166: 35.7;HHSteC: 20.3;HSkMC: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039481, HPA059282"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA039481: AB_10795465, HPA059282: AB_2732633"	"unprognostic (5.99e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.76e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.19e-8)"	"unprognostic (3.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.52e-5)"	4.2	1.2	3.2	2.7	1.9	0.7	2.7	5.3	2.7	5.5	2.2	0.9	3.3	2.4	2.9	3.2	1.5	2.6	2.7	2.9	1.6	2.0	0.7	0.4	2.7	2.0	2.0	2.1	1.0	48.9	0.7	2.8	1.1	2.5	3.6	2.3	4.8	31.6	4.5	1.0	1.5	1.3	5.4	5.3	1.2	3.7	0.8	1.3	0.0	2.2	1.4	3.0	3.9	2.2	0.2	1.3	0.0	0.1	0.0	0.1	0.1	4.4	0.4	0.2	9.6	23.0	31.5	0.5	14.2	9.2	1.8	4.9	0.5	0.0	0.0	0.6	35.7	0.0	0.0	0.0	0.3	2.3	0.0	0.1	0.2	0.0	1.1	20.3	1.8	0.0	25.5	1.1	4.8	9.1	0.0	1.0	0.0	0.7	12.9	3.7	0.0	0.0	0.1	0.6	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.3	1.6	0.0	2.9	7.2	0.1	2.1	15.2	0.1	1.4	1.4	0.0	0.7	16.0	4.2	0.0	5.8	6.6	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.1	3.2	1.9	5.3	2.4	1.6	2.0	2.0	2.1	2.5	1.3	0.0	1.1	0.0	0.1	0.5	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	3.7	0.1	0.0	0.0	8.3	0.3	4.3	0.3	0.0	0.0	0.4	4.8	0.0	1.8	0.3	4.5	3.4	1.1	5.0	6.4	0.0	1.2	5.6	0.0	6.3	0.0	0.5	0.0	3.1	0.4	0.0	0.5	0.2	0.0	0.0	0.1
ALDH3A1	ALDH3	ENSG00000108602	"Aldehyde dehydrogenase 3 family member A1"	P30838	17	19737984-19748943	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.2;lymphoid tissue: 70.3;stomach 1: 49.9;tongue: 106.6"	"Cell type enhanced"	"Detected in many"	15	"Basal keratinocytes: 39.2;Ciliated cells: 100.4;Club cells: 55.7;Suprabasal keratinocytes: 28.0;Urothelial cells: 32.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"pons and medulla: 1.8"	"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	22	"A549: 261.5;OE19: 326.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB045957, HPA051150, HPA063783"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"	"Nucleoplasm, Vesicles"	"CAB045957: AB_11127164, HPA051150: AB_2681364, HPA063783: AB_2685122"	"unprognostic (3.11e-5)"	"unprognostic (1.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.04e-3)"	"unprognostic (4.36e-3)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.84e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.23e-2)"	0.7	0.1	0.2	0.8	0.4	0.0	0.5	0.2	0.3	1.3	0.9	0.8	0.3	1.3	0.2	0.4	88.2	1.2	3.8	0.2	0.4	0.0	0.4	0.4	26.0	0.2	0.2	0.3	0.6	0.2	0.0	0.3	0.2	1.8	0.5	0.6	0.5	26.7	0.3	0.4	16.2	0.6	0.3	0.3	0.3	49.9	0.3	0.2	0.2	0.2	106.6	70.3	1.6	3.9	1.1	0.3	0.0	0.0	2.4	0.7	0.1	0.0	261.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	13.1	0.0	0.1	0.0	0.1	1.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	326.9	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.3	1.1	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.1	0.2	0.4	0.2	0.3	0.4	0.0	0.2	0.3	1.8	0.2	3.0	5.6	0.0	23.3	39.2	0.0	0.4	2.5	100.4	55.7	0.0	0.0	0.0	0.0	0.8	1.3	0.4	3.3	0.0	0.4	0.0	0.6	2.6	2.3	0.0	0.2	0.0	1.7	0.6	0.8	1.9	0.9	1.1	0.0	0.0	4.2	1.9	5.8	5.9	1.8	4.4	0.1	0.0	0.3	0.7	7.3	28.0	0.0	0.0	7.5	32.1
ALDH6A1	MMSDH	ENSG00000119711	"Aldehyde dehydrogenase 6 family member A1"	Q02252	14	74056850-74084493	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"kidney: 140.0;liver: 134.5"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 453.8;Proximal tubular cells: 730.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 25.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029072, HPA029073, HPA029074, HPA029075"	Enhanced		Enhanced	Mitochondria		No	No		9100	Mitochondria		"HPA029072: AB_10599176, HPA029073: AB_10601877, HPA029074: AB_10601000, HPA029075: AB_10602005"	"unprognostic (1.45e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (7.93e-2)"	"unprognostic (1.11e-3)"	"prognostic favorable (4.22e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.10e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.13e-1)"	"prognostic favorable (2.00e-15)"	"unprognostic (4.59e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.12e-1)"	14.1	6.9	31.3	2.8	30.9	2.3	6.7	11.6	26.4	8.0	11.0	20.1	4.6	11.0	5.5	5.5	5.0	6.2	4.8	15.6	21.1	14.2	140.0	134.5	4.7	3.0	19.4	18.5	12.3	11.8	16.4	3.2	4.0	14.8	11.0	7.2	7.1	7.8	7.8	10.5	3.4	9.3	5.6	13.1	3.1	9.6	7.4	18.7	2.0	12.1	4.0	3.1	6.3	3.3	4.5	5.6	25.5	3.8	5.5	6.7	2.8	4.6	4.0	5.7	12.1	20.9	10.2	9.2	3.2	6.1	3.5	6.0	9.1	5.2	5.4	7.2	6.9	2.9	2.7	13.0	3.6	7.7	4.8	1.8	2.5	4.2	9.9	23.8	1.3	1.2	15.0	6.6	4.5	11.4	9.2	6.2	12.2	4.0	7.5	2.4	17.8	3.7	2.0	4.5	17.2	2.7	7.6	5.9	7.1	5.6	3.5	2.3	3.6	10.7	11.6	2.8	10.1	29.7	4.8	1.9	4.0	4.9	6.2	1.2	5.1	9.2	5.5	5.2	1.6	3.8	13.3	3.8	25.5	4.5	2.9	6.7	4.5	5.1	5.3	5.6	3.6	6.5	4.6	1.5	5.5	2.4	3.2	3.6	2.8	31.3	30.9	11.6	26.4	21.1	14.2	19.4	18.5	14.8	18.7	35.7	48.4	23.6	21.0	8.1	17.6	73.0	48.4	25.4	29.6	62.8	3.9	22.5	170.8	8.1	19.8	13.5	22.3	0.0	2.7	12.8	13.1	38.6	7.0	453.8	14.9	11.1	16.3	58.3	22.2	15.8	26.7	9.0	23.6	20.8	37.9	90.4	5.6	10.5	45.3	730.1	15.1	12.9	21.7	10.5	3.9	6.5	25.6	6.9	37.0	15.2
ALG2	"CDG1I, CDGIi, FLJ14511, hALPG2, NET38"	ENSG00000119523	"ALG2, alpha-1,3/1,6-mannosyltransferase"	Q9H553	9	99216426-99221956	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation, Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041512, HPA041601"	Approved		Enhanced	"Actin filaments,Cytosol"		No	No			"Actin filaments, Cytosol"		"HPA041512: AB_10794380, HPA041601: AB_10794302"	"unprognostic (8.86e-3)"	"unprognostic (4.39e-1)"	"unprognostic (2.37e-1)"	"prognostic favorable (8.44e-5)"	"unprognostic (9.21e-3)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.06e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.28e-7)"	"unprognostic (4.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.81e-1)"	12.5	28.0	9.2	9.4	9.7	10.5	16.4	13.1	12.5	18.8	12.9	11.6	31.1	11.0	15.2	39.2	12.3	15.8	13.9	12.1	8.3	9.5	24.8	45.5	16.0	12.8	10.8	6.5	18.4	43.4	14.7	22.4	22.5	12.0	16.7	14.9	14.7	24.1	32.6	13.3	8.7	15.5	12.6	11.3	15.9	15.0	12.6	9.7	14.8	26.0	9.9	15.8	12.9	11.8	16.8	41.0	18.2	18.5	17.5	26.4	17.8	8.1	11.0	8.1	11.6	30.1	19.6	16.7	16.7	26.6	17.1	14.9	13.1	11.8	8.8	7.8	19.2	23.2	32.3	13.7	17.9	17.2	13.3	6.3	5.2	8.7	19.4	36.2	9.1	9.9	21.4	23.4	14.5	26.4	16.5	19.1	5.7	9.1	19.9	15.8	17.1	4.6	10.9	10.5	26.9	15.5	5.3	16.5	13.7	22.9	10.4	8.7	7.1	12.3	22.7	21.5	12.9	9.2	7.8	13.5	11.7	11.6	14.9	10.4	18.7	10.1	3.8	22.0	7.3	5.7	18.2	18.5	11.2	18.6	14.6	26.4	16.8	17.7	18.4	23.0	13.3	15.4	15.0	5.0	17.5	12.9	41.0	18.8	17.8	9.2	9.7	13.1	12.5	8.3	9.5	10.8	6.5	12.0	9.7	11.9	22.2	18.6	17.3	20.7	11.4	6.0	20.4	14.7	14.8	22.7	2.0	44.0	18.3	32.0	22.1	17.7	16.9	0.0	30.7	28.2	25.8	31.0	7.0	52.1	25.7	9.5	12.0	24.5	25.6	16.5	24.7	22.6	20.3	93.8	19.7	13.4	30.1	14.0	23.7	31.7	7.0	6.5	18.9	20.2	23.7	20.7	74.6	15.9	16.8	28.9
ALKBH2	"ABH2, MGC90512"	ENSG00000189046	"AlkB homolog 2, alpha-ketoglutarate dependent dioxygenase"	Q6NS38	12	109088188-109093631	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011198, HPA045392, HPA051976"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011198: AB_261971, HPA045392: AB_2679309, HPA051976: AB_2681680"	"prognostic favorable (6.67e-5)"	"unprognostic (3.66e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (9.60e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.39e-2)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (1.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (8.67e-4)"	16.1	12.3	13.6	16.9	13.4	8.2	22.3	12.7	20.5	12.9	11.7	15.2	14.6	9.0	18.0	14.2	14.1	18.3	12.2	12.3	13.5	12.3	12.0	25.6	9.8	17.0	14.3	8.9	23.1	18.5	7.1	7.8	8.1	15.7	15.0	10.7	10.8	18.9	18.5	20.0	25.0	10.7	15.9	15.4	12.3	12.6	14.3	13.5	11.3	13.9	19.7	16.5	15.5	13.8	16.9	13.1	1.1	6.7	9.0	18.2	6.9	13.0	22.4	12.8	28.6	9.0	12.3	20.4	8.7	5.8	9.2	10.3	23.5	9.4	20.1	8.7	5.0	4.3	9.5	21.5	8.7	5.4	17.9	19.2	10.0	12.7	21.4	12.0	13.8	9.4	12.6	19.0	8.7	22.4	11.4	3.5	19.4	14.8	12.0	6.1	23.0	12.7	27.8	17.7	13.8	22.8	11.3	12.5	21.6	12.2	18.2	13.2	22.8	9.2	30.0	18.2	5.0	18.4	8.5	3.6	10.3	11.2	9.7	12.8	16.9	19.6	43.8	8.8	12.0	16.4	1.1	5.1	0.7	8.0	6.7	14.1	16.2	12.1	11.2	5.1	16.9	18.2	10.7	0.9	9.0	4.3	13.1	9.0	6.9	13.6	13.4	12.7	20.5	13.5	12.3	14.3	8.9	15.7	13.5	8.9	4.6	11.9	40.0	45.2	4.3	5.9	10.2	13.4	18.2	8.7	2.0	14.2	13.3	16.1	10.1	14.7	2.6	0.0	20.7	22.0	18.8	11.8	5.8	19.2	9.1	4.8	8.1	4.9	7.1	4.9	24.7	7.4	25.3	3.6	10.2	10.0	18.9	2.9	16.3	14.6	6.4	0.0	27.8	8.8	28.1	52.4	4.2	11.5	14.5	23.5
ALKBH3	DEPC-1	ENSG00000166199	"AlkB homolog 3, alpha-ketoglutaratedependent dioxygenase"	Q96Q83	11	43880811-43920266	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 78.8;Late spermatids: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009674, HPA046489"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA009674: AB_1850460, HPA046489: AB_2679671"	"unprognostic (3.53e-1)"	"unprognostic (2.41e-1)"	"unprognostic (7.43e-3)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.71e-2)"	"unprognostic (5.42e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.35e-2)"	17.6	14.2	14.3	13.2	16.7	8.6	26.5	21.2	22.7	19.1	15.7	19.5	12.8	13.2	22.6	31.2	16.2	20.0	16.4	12.5	14.3	13.4	15.6	25.8	15.1	17.3	15.0	14.4	21.8	23.5	22.1	16.6	9.1	15.6	19.1	16.6	19.5	25.5	19.1	29.1	20.2	15.0	18.3	14.8	17.8	17.0	17.3	12.1	14.5	16.4	21.4	22.2	15.2	17.4	14.9	18.5	21.2	21.0	17.1	21.3	13.8	7.4	13.0	5.2	0.0	10.1	13.0	0.0	9.1	20.2	18.3	18.0	6.1	5.8	1.1	5.8	13.7	9.9	10.2	7.1	15.7	17.0	0.0	24.9	10.9	8.8	12.8	25.1	20.0	14.6	13.7	27.3	8.1	39.4	7.6	13.1	21.5	15.4	11.9	9.0	8.9	17.9	10.3	9.5	7.9	19.1	5.2	11.2	14.0	11.0	11.7	9.7	7.8	7.0	11.1	16.7	4.8	16.1	12.3	9.2	10.4	5.8	17.0	13.0	10.8	11.3	12.1	15.5	8.5	8.5	21.2	12.9	7.1	17.0	14.1	16.2	14.4	17.4	15.1	18.5	14.9	21.3	18.9	2.3	17.1	21.0	16.3	16.2	13.8	14.3	16.7	21.2	22.7	14.3	13.4	15.0	14.4	15.6	12.1	14.9	10.4	11.1	9.1	9.2	10.0	5.6	12.7	16.0	10.3	15.7	3.9	3.1	26.6	17.0	78.8	13.7	9.2	0.0	28.4	4.0	9.7	6.6	7.0	11.3	16.7	9.5	9.1	14.7	10.7	69.5	15.0	13.1	16.9	15.4	12.7	17.2	23.0	7.0	9.9	14.1	10.5	6.5	19.6	18.7	9.5	6.1	1.8	14.9	13.1	5.0
ALYREF	"ALY, ALY/REF, BEF, REF, THOC4"	ENSG00000183684	"Aly/REF export factor"		17	81887844-81891586	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"CAB016281, HPA019799, HPA061282"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB016281: AB_626667, HPA019799: AB_1844788, HPA061282: AB_2684464"	"unprognostic (1.41e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.89e-3)"	"unprognostic (5.35e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.13e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.55e-3)"	"unprognostic (6.58e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.74e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.09e-2)"	17.5	15.7	15.7	29.4	15.4	76.6	17.4	13.4	23.8	17.8	20.1	17.7	14.3	20.2	16.3	15.8	30.4	18.2	17.8	27.2	13.4	13.0	16.7	21.9	19.0	34.7	14.8	13.9	19.7	22.9	10.7	17.0	23.0	12.7	16.1	15.1	15.9	18.2	13.2	27.2	22.2	19.3	16.0	15.8	25.3	16.9	50.5	10.2	61.8	19.8	33.7	36.4	15.5	18.3	3.6	5.5	0.5	2.8	2.1	3.9	1.1	37.9	35.9	25.0	24.5	5.1	7.0	32.0	19.2	10.4	40.0	25.2	40.3	25.2	42.0	15.4	15.3	23.9	22.1	36.2	20.3	17.2	16.0	63.9	30.5	22.7	43.1	10.5	48.7	27.7	6.9	9.3	23.4	9.4	5.7	23.7	31.1	38.6	25.7	14.7	41.2	102.7	82.8	34.2	22.2	38.4	68.8	31.0	21.6	8.3	22.8	34.3	44.8	18.4	43.8	15.5	14.0	33.6	49.6	15.5	41.0	41.2	19.1	64.2	30.9	15.1	53.9	21.7	31.1	34.8	0.3	2.8	0.2	3.9	2.8	2.5	2.7	2.7	2.6	3.0	3.6	0.7	2.0	0.5	2.1	2.5	5.5	1.4	1.1	15.7	15.4	13.4	23.8	13.4	13.0	14.8	13.9	12.7	10.2	0.0	20.2	21.2	16.3	31.0	11.8	11.7	7.6	8.1	10.3	19.2	0.0	8.4	1.7	4.8	1.3	11.9	7.5	0.0	7.2	19.1	13.4	14.7	15.0	14.4	15.7	4.8	12.1	7.4	11.1	3.2	3.1	14.5	13.5	4.6	17.0	20.6	8.1	9.1	3.9	3.4	5.9	0.0	11.3	10.9	8.5	37.6	13.8	8.7	18.3	25.5
AMPD2	SPG63	ENSG00000116337	"Adenosine monophosphate deaminase 2"	Q01433	1	109616104-109632051	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Nucleotide metabolism"	Hydrolase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 64.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 58.9;Horizontal cells: 49.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"dendritic cells: 8.8;granulocytes: 29.7;monocytes: 24.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027137, HPA045760, HPA050590"	Approved		Enhanced	Cytosol		NA	NA		380000	Cytosol		"HPA027137: AB_2672129, HPA045760: AB_2679443, HPA050590: AB_2681184"	"unprognostic (2.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.43e-3)"	"unprognostic (9.01e-2)"	"unprognostic (5.25e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.78e-10)"	"unprognostic (9.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	8.1	22.7	20.2	21.7	41.3	64.4	4.9	16.3	26.8	9.5	10.1	9.5	6.3	17.1	9.0	6.0	5.9	11.8	13.2	5.2	21.7	19.4	7.8	13.0	8.2	10.7	14.2	14.2	16.3	9.4	13.0	37.1	10.8	18.3	9.7	5.7	15.7	9.1	12.2	2.1	10.0	11.6	9.1	8.5	15.9	8.3	5.3	12.2	10.3	6.4	3.0	7.5	8.2	8.1	2.8	8.8	29.7	24.5	3.0	4.3	5.4	10.9	12.7	18.7	15.8	16.3	16.3	7.1	15.6	31.9	16.0	15.8	9.7	4.7	5.4	12.0	29.2	10.5	8.6	9.8	14.5	9.9	8.7	13.2	28.5	16.7	10.8	15.3	12.1	30.7	18.3	7.7	21.1	16.4	28.9	13.8	11.9	8.8	14.7	11.4	16.9	17.9	29.0	12.1	10.2	13.6	12.7	7.2	8.4	14.7	6.7	14.5	15.3	10.6	13.0	12.6	7.0	7.3	11.3	13.1	19.8	23.0	24.1	16.0	29.5	14.3	7.8	29.5	18.8	20.6	0.5	9.2	11.2	3.4	19.6	4.3	2.8	3.3	3.4	8.8	1.7	3.8	2.8	29.7	3.0	24.5	1.4	2.6	5.4	20.2	41.3	16.3	26.8	21.7	19.4	14.2	14.2	18.3	12.2	3.0	8.5	8.3	4.7	7.9	35.7	2.5	17.8	4.0	5.7	0.0	58.9	4.0	6.6	9.7	2.9	6.2	3.9	0.0	9.6	7.4	11.8	4.5	3.5	17.8	10.5	49.3	16.8	6.2	37.8	1.3	12.0	28.6	5.0	1.0	8.6	9.1	8.3	0.0	20.1	3.9	5.8	12.9	11.7	4.5	2.6	7.0	2.2	10.1	9.7	3.4
ANAPC11	"APC11, Apc11p, HSPC214, MGC882"	ENSG00000141552	"Anaphase promoting complex subunit 11"	Q9NYG5	17	81890790-81900991	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 944.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA021989, HPA027838"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA021989: AB_1844915, HPA027838: AB_10600978"	"unprognostic (9.00e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.76e-1)"	"unprognostic (4.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.13e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.17e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.07e-2)"	"unprognostic (9.08e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.16e-1)"	29.3	26.1	44.9	21.9	34.1	39.6	27.2	19.5	31.8	19.4	26.3	14.8	30.3	26.1	19.2	27.5	31.7	24.6	26.0	63.6	32.9	26.7	25.9	38.4	18.5	26.7	35.2	31.8	17.2	40.3	12.6	20.6	25.7	29.8	25.4	12.2	18.1	48.8	24.0	94.2	21.6	24.8	25.4	27.6	18.9	25.9	42.2	27.3	18.5	32.5	45.7	17.0	23.5	25.5	54.9	107.5	74.0	80.1	43.1	52.8	80.4	41.4	97.5	23.2	34.3	18.5	21.1	26.6	20.1	15.8	18.3	20.9	40.0	36.6	13.1	22.5	17.7	20.2	24.2	9.3	25.7	6.6	19.2	70.6	19.6	43.3	60.3	20.8	14.6	17.4	23.4	23.5	18.7	15.3	11.9	29.3	17.9	26.7	38.2	18.9	74.7	35.5	24.2	21.9	40.3	72.8	14.8	22.1	26.3	16.7	37.3	29.2	47.4	21.7	34.3	39.4	16.7	41.9	35.6	17.4	35.6	28.5	38.1	37.7	18.7	7.8	16.5	37.4	22.3	28.4	70.1	80.1	74.0	45.3	63.7	42.8	54.9	46.4	49.5	64.6	51.6	45.2	43.5	40.5	43.1	59.3	107.5	52.8	80.4	44.9	34.1	19.5	31.8	32.9	26.7	35.2	31.8	29.8	27.3	119.1	121.6	108.7	168.5	132.0	55.6	277.3	203.8	155.2	153.6	188.5	19.6	436.4	442.7	236.1	329.1	152.3	247.2	186.9	293.4	435.1	217.2	291.4	105.2	427.2	386.6	31.8	182.7	139.3	155.4	944.1	168.2	179.2	248.0	315.6	205.6	112.3	274.1	235.0	154.9	400.2	53.7	103.5	220.7	379.1	245.5	163.2	425.4	121.6	237.2	254.5
ANAPC2	"APC2, KIAA1406"	ENSG00000176248	"Anaphase promoting complex subunit 2"	Q9UJX6	9	137174784-137188549	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018692, HPA066539"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB018692: AB_2258285, HPA066539: AB_2685688"	"unprognostic (5.20e-2)"	"unprognostic (8.86e-3)"	"unprognostic (1.43e-2)"	"prognostic favorable (8.91e-5)"	"unprognostic (2.29e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.41e-2)"	"prognostic favorable (3.67e-4)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.46e-2)"	"unprognostic (9.88e-2)"	14.6	15.5	13.3	15.3	17.9	19.0	14.1	21.8	26.9	12.2	11.8	28.5	17.7	17.1	15.1	12.3	13.6	13.8	16.4	14.1	12.5	10.2	12.3	19.1	13.1	19.1	22.4	14.5	15.4	23.7	10.6	12.6	11.0	16.2	15.2	5.0	15.5	25.7	14.5	20.0	25.0	16.2	9.4	13.3	19.3	16.2	31.6	13.4	14.0	14.4	11.7	15.2	13.2	11.7	1.4	2.3	0.6	3.2	1.1	2.4	3.3	10.2	22.8	5.5	9.1	6.7	4.0	17.4	9.2	5.9	8.8	6.8	13.7	10.7	11.1	10.9	6.1	8.2	21.2	6.6	7.1	1.3	14.1	11.3	6.6	26.6	12.4	7.9	10.1	11.6	8.0	5.7	5.9	3.2	4.4	10.7	10.3	9.7	13.7	4.1	28.9	12.1	14.3	11.2	13.7	17.4	14.5	13.6	20.6	6.8	9.1	7.3	11.0	14.0	19.1	5.8	2.8	20.3	13.9	11.2	13.1	10.4	15.5	8.3	6.7	9.8	12.0	10.5	7.0	9.4	0.3	2.3	0.4	2.4	2.4	1.4	1.4	1.2	1.9	1.9	1.4	1.4	1.5	0.6	1.1	3.2	2.3	1.2	3.3	13.3	17.9	21.8	26.9	12.5	10.2	22.4	14.5	16.2	13.4	0.0	0.3	6.5	7.4	8.2	4.7	3.1	7.6	0.0	1.2	10.4	3.9	22.6	11.6	9.4	31.6	5.7	18.6	0.0	9.4	9.5	8.5	6.4	11.5	10.4	13.6	1.6	9.8	12.3	9.5	40.9	10.3	6.6	13.5	16.2	14.6	3.5	6.9	7.0	8.9	13.4	4.3	0.0	9.9	30.0	24.3	8.3	20.5	10.2	11.3	6.3
ANKFY1	"ANKHZN, BTBD23, KIAA1255, RANK-5, ZFYVE14"	ENSG00000185722	"Ankyrin repeat and FYVE domain containing 1"	Q9P2R3	17	4163907-4263977	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024513, HPA024522, HPA065849"	Approved		Enhanced	Endosomes		NA	NA		5600	Endosomes		"HPA024513: AB_1844830, HPA024522: AB_10601453, HPA065849: AB_2685567"	"unprognostic (4.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.26e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.42e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.05e-1)"	14.7	19.3	16.5	15.6	21.9	15.8	14.1	20.1	25.6	15.9	25.2	33.7	9.4	12.4	27.0	12.3	15.3	17.5	13.3	11.3	19.6	14.2	13.0	15.3	16.7	13.9	21.3	17.2	23.3	13.7	27.1	16.4	15.4	23.2	14.1	15.8	16.0	16.2	14.5	15.3	21.6	15.0	16.6	20.7	16.1	14.7	12.2	26.6	15.4	16.1	8.4	16.5	17.6	15.4	1.6	3.8	2.3	9.7	1.3	4.0	2.6	11.3	26.2	18.1	12.2	24.6	18.8	11.7	12.7	13.3	20.7	20.5	11.6	7.7	9.9	10.4	19.1	11.0	17.9	16.5	13.5	18.2	5.2	16.9	9.6	18.8	10.8	13.7	5.7	11.8	19.6	14.3	14.7	10.9	11.0	12.0	9.7	9.3	9.6	13.9	8.8	8.6	6.2	7.6	8.9	9.3	13.1	12.1	5.4	10.8	15.4	6.1	9.5	18.3	8.6	11.2	14.7	9.9	7.6	15.3	13.0	6.9	17.7	16.8	3.1	2.4	3.3	15.9	11.8	15.5	1.6	5.0	2.2	4.0	9.7	3.8	1.3	2.6	2.9	3.8	1.6	2.7	2.6	2.3	1.3	9.3	1.5	2.6	2.6	16.5	21.9	20.1	24.7	19.6	14.2	21.3	17.2	23.2	26.6	26.8	18.2	0.8	8.4	11.0	22.0	3.6	7.6	18.7	11.4	17.4	27.5	9.3	1.7	9.2	3.6	13.5	10.1	0.0	8.3	8.1	9.8	13.8	3.5	17.8	16.7	25.4	11.6	22.1	21.9	3.0	13.6	14.0	16.9	2.8	11.1	13.5	11.0	3.5	18.0	6.8	31.5	6.5	10.3	11.2	12.3	10.2	5.1	10.1	13.5	13.3
ANKRA2		ENSG00000164331	"Ankyrin repeat family A member 2"	Q9H9E1	5	73552335-73565686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003968, HPA065263"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA003968: , HPA065263: AB_2685449"	"unprognostic (1.75e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.89e-2)"	"unprognostic (5.68e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.80e-3)"	"unprognostic (3.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.13e-3)"	13.0	19.4	11.9	9.2	17.1	18.7	20.9	22.8	18.3	15.7	13.5	16.6	13.1	15.0	20.0	21.0	13.3	18.5	15.0	12.2	18.1	15.8	9.6	15.9	20.7	13.9	20.6	12.3	23.3	19.7	11.4	30.2	15.4	23.1	19.8	16.4	17.5	19.0	14.3	14.5	13.4	15.3	17.8	30.7	13.0	16.2	10.3	15.8	18.1	22.2	4.5	14.7	14.9	13.3	10.7	5.9	16.9	7.4	7.0	15.5	7.3	5.1	3.9	5.8	6.1	10.6	16.2	17.7	7.1	10.6	6.2	9.3	1.2	8.0	4.8	5.7	7.0	7.0	3.7	2.7	12.6	8.9	10.1	4.8	4.2	3.0	5.5	8.3	2.5	8.3	16.7	17.1	7.4	7.7	11.6	6.9	6.4	4.1	8.1	7.1	3.1	4.3	6.5	3.1	1.9	2.9	2.6	6.2	6.6	4.8	6.4	7.8	6.1	5.4	4.3	8.4	9.3	6.5	4.2	8.6	2.5	3.0	4.0	5.1	16.0	11.5	4.1	6.2	4.1	7.2	16.9	5.7	11.3	8.7	4.6	10.5	10.7	10.2	12.1	4.9	8.4	15.5	14.2	9.0	7.0	7.4	5.9	11.7	7.3	11.9	17.1	22.8	18.3	18.1	15.8	20.6	12.3	23.1	15.8	3.0	8.6	26.7	25.9	14.1	25.6	7.7	35.7	16.0	12.5	17.4	9.8	22.6	23.2	10.6	0.9	12.1	16.1	23.3	14.6	18.8	13.1	25.9	18.5	19.5	9.2	22.3	23.2	16.0	16.2	1.7	30.2	11.1	11.8	12.6	19.4	15.6	14.7	18.4	27.3	14.0	21.5	25.8	14.4	23.0	15.1	10.8	40.8	18.1	16.2	31.3
ANKRD11	"LZ16, T13"	ENSG00000167522	"Ankyrin repeat domain 11"	Q6UB99	16	89267619-89490561	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019288, HPA041593, HPA049470"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB019288: , HPA041593: AB_2677567, HPA049470: AB_2680780"	"unprognostic (7.31e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (6.39e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.67e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.79e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.16e-1)"	24.2	23.3	22.8	25.6	23.1	48.7	41.4	32.3	31.7	22.0	24.1	22.9	22.0	22.4	26.9	18.9	25.0	23.4	23.4	22.2	24.6	20.0	17.8	15.1	32.3	33.8	20.8	21.0	32.6	27.9	33.7	31.5	18.8	19.3	20.5	14.9	23.3	21.4	25.8	27.0	35.8	24.1	26.7	20.3	26.1	22.6	21.3	22.1	26.1	21.6	19.3	19.6	23.4	34.4	4.2	7.2	11.7	5.9	9.8	4.5	1.8	21.9	27.5	27.7	21.2	17.1	17.7	26.8	25.1	16.9	15.2	10.8	32.0	23.6	20.4	17.4	18.2	17.1	22.3	18.9	23.1	17.2	10.1	22.6	16.1	19.1	25.6	25.9	11.8	18.3	19.6	23.5	19.9	25.8	22.1	18.2	34.3	34.5	16.3	19.0	20.8	19.5	29.8	24.3	11.4	25.4	40.4	32.0	17.0	15.8	18.5	16.3	20.0	36.2	7.6	26.0	14.7	17.8	18.6	33.6	32.1	30.0	17.7	27.5	29.8	10.4	25.4	25.8	19.6	17.3	7.5	3.9	3.7	3.8	4.0	4.3	3.1	4.3	4.5	2.1	4.2	3.8	3.5	11.7	9.8	5.9	7.2	4.2	1.8	22.8	23.1	32.3	31.7	24.6	20.0	20.8	21.0	19.3	22.1	122.1	96.0	57.0	118.7	103.5	174.0	224.2	89.2	33.5	56.9	68.0	149.2	36.4	26.6	65.7	85.7	83.9	67.5	46.7	62.6	29.3	87.3	94.1	53.2	57.8	42.6	147.8	102.5	75.5	58.0	27.9	96.1	74.6	45.5	95.6	51.2	90.0	94.9	50.7	99.7	28.0	102.5	38.8	89.3	78.8	102.6	106.9	32.4	71.0	51.7	144.5
ANKRD2	ARPP	ENSG00000165887	"Ankyrin repeat domain 2"	Q9GZV1	10	97572499-97583884	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"skeletal muscle: 472.2"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 151.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	18	"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in some"		"A-431: 14.8;A549: 5.1;BJ hTERT+ SV40 Large T+: 5.5;HaCaT: 11.7;RPTEC TERT1: 13.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040842, HPA040884"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"HPA040842: AB_10963794, HPA040884: AB_10969453"	"unprognostic (1.27e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.69e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	2.3	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	1.2	2.7	0.0	0.1	47.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.3	472.2	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	3.0	1.2	1.1	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	14.8	5.1	0.0	0.0	0.2	0.0	0.4	0.7	0.0	5.5	3.6	0.2	4.6	0.0	0.6	0.1	0.3	11.7	0.0	4.0	3.7	0.1	0.2	0.0	0.2	0.0	0.4	0.0	0.0	0.6	1.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	13.1	0.7	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.3	0.0	0.1	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	151.7	0.0	0.0	0.0	3.5	0.0	0.2	26.6	1.2	0.4	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.6	0.0	1.8	2.2	0.0	0.0	0.0	2.2	3.2	0.3	0.2	0.0	0.0	0.1
ANKRD34A	ANKRD34	ENSG00000272031	"Ankyrin repeat domain 34A"	Q69YU3	1	145959442-145964582	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 18.1"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 8.1;Cardiomyocytes: 2.9;Muller glia cells: 1.9"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 1.5;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029642, HPA029643"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA029642: AB_10599277, HPA029643: AB_10601878"	"unprognostic (1.98e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.68e-3)"	"unprognostic (9.66e-8)"	"unprognostic (6.36e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.76e-1)"	"unprognostic (9.23e-2)"	0.8	1.3	6.4	2.0	10.5	0.3	0.6	7.8	18.1	0.9	0.7	1.2	0.0	1.6	1.5	1.2	0.9	0.7	1.1	1.7	4.2		0.5	0.2	0.7	1.4	0.4	6.7	1.6	0.5	2.0	1.2	0.5	5.7	1.7	0.4	1.3	0.8	2.2	2.3	0.8	1.6	1.6	0.0	1.4	1.1	0.5	1.0	0.0	0.6	0.0	1.5	0.9	0.0	1.5	0.4	0.6	0.3	0.3	3.5	1.0	1.4	0.8	0.7	2.5	3.6	2.8	0.3	2.7	5.2	0.6	1.7	0.2	0.8	2.8	0.3	3.5	1.4	0.6	1.1	0.8	0.4	5.9	1.7	0.2	2.1	0.0	0.5	0.3	2.3	2.5	0.3	2.3	2.6	3.7	0.9	2.3	1.3	6.4	4.0	2.5	1.1	0.8	0.3	0.2	3.1	0.3	0.7	12.6	1.1	0.1	3.5	2.5	0.5	0.1	1.6	0.3	3.6	0.4	0.8	6.3	4.3	5.3	1.4	4.5	8.6	0.4	6.2	2.2	0.5	0.0	0.1	0.6	3.5	0.3	2.6	1.5	1.7	1.9	0.4	1.4	2.3	3.4	0.3	0.3	0.0	0.1	1.7	1.0											0.0	0.0	0.0	0.4	0.2	8.1	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.5	0.3	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.4	0.3	1.4	0.0	0.7	0.4	0.4	0.1	0.1	0.0	0.0	0.1
ANKRD45	"CT117, FLJ45235"	ENSG00000183831	"Ankyrin repeat domain 45"	Q5TZF3	1	173609561-173669862	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;fallopian tube: 24.8;parathyroid gland: 16.8;pituitary gland: 7.9;testis: 20.8"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 33.5;Cone photoreceptor cells: 35.3;Early spermatids: 19.6;Late spermatids: 9.9;Spermatocytes: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BJ hTERT+: 4.2;BJ hTERT+ SV40 Large T+: 3.8;BJ hTERT+ SV40 Large T+ RasG12V: 6.5;GAMG: 4.1;HBF TERT88: 4.3;SH-SY5Y: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031655, HPA031656, HPA031657"	Enhanced		Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA			Cytosol	"Plasma membrane, Centrosome"	"HPA031655: AB_10610975, HPA031656: AB_10600331, HPA031657: AB_10602196"	"unprognostic (1.93e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.80e-3)"	"unprognostic (2.91e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.61e-1)"	0.5	1.3	5.9	0.4	14.6	0.5	0.6	1.1	7.0	2.8	0.7	9.0	1.3	0.4	3.3	2.5	0.5	24.8	1.0	0.9	7.7	4.7	2.7	0.5	2.8	0.4	2.4	5.3	2.4	1.0	16.8	7.9	0.4	9.2	1.9	0.5	1.8	0.4	1.2	0.4	0.4	0.5	2.4	2.7	1.3	0.5	20.8	4.2	0.0	1.3	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.5	12.0	0.0	0.0	1.0	2.1	0.1	4.2	3.8	6.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	4.3	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.5	0.0	2.3	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.3	0.4	0.0	1.6	10.8	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.1	0.9	0.0	2.2	0.1	1.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.9	14.6	1.1	7.0	7.7	4.7	2.4	5.3	9.2	4.2	0.0	1.7	0.0	0.2	0.2	0.5	0.7	0.0	33.5	1.2	5.2	35.3	0.2	1.7	0.6	19.6	1.5	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	9.9	1.7	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.4	0.5	1.8	0.0	0.3	28.6	4.9	0.0	0.1	0.0	0.0	0.1
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433170-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 47.8"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;intermediate monocyte: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 10.2;BEWO: 31.2;HAP1: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310"	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.9	2.2	11.7	3.0	7.8	1.6	3.9	47.8	17.8	5.7	2.9	2.8	1.1	1.0	6.1	4.4	4.9	11.7	5.7	8.9	7.8	9.1	5.4	4.5	5.7	2.5	4.2	12.0	15.6	4.3	9.3	4.2	4.3	7.3	3.6	1.1	6.6	7.7	2.3	4.0	1.9	1.8	5.4	5.0	2.0	2.6	6.1	3.7	2.0	5.6	3.3	2.5	4.4	4.0	0.3	0.1	3.0	2.9	0.6	1.0	0.3	0.0	1.3	10.2	4.3	0.1	0.4	31.2	0.1	0.1	0.0	0.6	0.3	0.8	0.0	1.0	0.0	4.7	0.0	9.3	5.2	0.4	0.0	6.9	3.7	0.0	0.3	0.1	0.0	1.4	0.6	1.4	0.0	0.0	0.0	1.0	0.9	0.3	2.3	0.0	1.1	0.1	0.3	2.9	0.4	1.0	3.6	0.0	0.0	1.5	5.2	6.7	2.4	0.8	6.9	3.4	6.5	2.0	2.2	0.0	1.7	0.6	0.1	0.8	0.3	0.0	0.0	0.1	0.0	1.2	0.0	0.4	3.0	1.0	2.9	0.0	0.0	0.7	0.0	0.1	0.3	0.3	0.4	0.7	0.6	0.0	0.0	0.2	0.3	11.7	7.8	47.8	11.6	7.8	9.1	4.2	12.0	7.3	3.7	14.9	14.2	0.0	4.6	0.8	0.6	3.9	10.2	10.7	7.9	1.8	11.8	2.5	10.0	4.8	2.5	4.1	0.0	0.0	10.0	6.5	4.7	1.8	10.4	2.5	2.3	0.0	1.7	4.9	2.7	4.3	8.9	1.1	3.3	3.6	0.0	5.7	4.2	0.0	26.2	3.4	1.6	6.5	3.3	5.4	4.9	1.0	1.6	1.3	0.0	4.3
ANKRD61		ENSG00000157999	"Ankyrin repeat domain 61"	A6NGH8	7	6031376-6036386	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"bone marrow: 8.7;testis: 9.1"	"Group enriched"	"Detected in some"	19	"Early spermatids: 44.1;Late spermatids: 19.5"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 12.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029511, HPA050732"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029511: AB_10602430, HPA050732: "	"unprognostic (1.40e-1)"	"unprognostic (1.03e-3)"	"unprognostic (9.32e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.98e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.63e-1)"	0.5	0.5	0.0	0.7	0.2	8.7	0.7	0.5	0.9	0.4	0.3			0.6	0.6	0.0	0.4	0.5	0.2	0.6	0.1	0.1	0.3	0.5	0.5	1.1	0.0		0.8	1.0	0.1	0.5	0.4		0.4	0.0		0.9	0.0	0.6	2.1	0.8	0.0	0.2	0.9	0.9	9.1			0.9		0.0	0.5	0.5	0.6	1.5	0.9	1.1	0.0	0.8	0.3	2.2	6.0	1.8	2.8	0.3	0.3	2.6	1.4	0.4	0.6	0.6	3.0	5.6	1.1	0.6	0.2	2.6	2.2	1.0	0.0	0.7	0.3	0.8	1.5	12.7	0.4	0.2	1.7	2.6	0.4	1.2	0.5	1.1	1.3	0.5	1.7	2.0	1.8	0.7	3.8	0.3	1.8	0.9	0.4	0.7	1.6	0.5	0.3	0.5	2.9	1.4	2.5	1.4	1.6	0.2	2.9	3.0	1.1	1.2	2.4	4.9	2.9	1.8	1.6	1.8	0.9	0.7	1.4	1.5	0.9	1.1	0.0	0.1	1.1	0.0	0.0	0.0	0.8	1.5	0.6	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.3											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	44.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0
ANKRD7	TSA806	ENSG00000106013	"Ankyrin repeat domain 7"	Q92527	7	118214669-118496171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"testis: 184.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 2368.8;Spermatocytes: 2786.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;JURKAT: 5.8;SCLC-21H: 9.8;U-266/70: 12.7;WM-115: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA043489, HPA052941"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043489: AB_10959304, HPA052941: "	"unprognostic (1.29e-1)"	"unprognostic (7.22e-4)"		"unprognostic (3.13e-3)"	"unprognostic (6.16e-2)"	"unprognostic (8.49e-2)"		"unprognostic (1.69e-1)"	"unprognostic (5.51e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.57e-4)"	"unprognostic (3.32e-2)"	0.1	0.1	0.5	0.0	0.8	0.0	0.1	0.1	1.0	0.1	0.1	0.0	0.0	0.1	0.1	1.3	0.1	0.1	0.0	0.1	0.4	0.1	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.9	0.0	1.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	184.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.1	0.4	1.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.2	1.6	0.0	3.1	0.0	0.1	0.3	0.1	1.4	1.0	0.0	0.0	0.0	1.9	0.0	0.0	2.3	0.4	0.7	0.0	0.4	0.0	5.8	0.0	2.2	1.4	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	2.4	0.0	0.0	1.9	0.0	0.0	1.2	0.4	0.0	1.1	0.3	0.0	12.7	0.6	0.5	1.8	0.0	4.0	0.0	0.0	1.0	0.4	0.0	0.3	3.1	0.2	0.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.4	0.0	0.1	0.5	0.8	0.1	1.0	0.4	0.1	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	2.5	0.0	0.0	0.0	0.0	0.1	5.0	0.1	2368.8	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.1	3.2	0.0	0.0	0.0	635.0	36.5	0.0	1.7	0.0	0.0	1.2	0.1	0.0	27.6	1.4	0.0	25.8	0.1	2786.2	17.7	0.1	0.0	0.0	0.0	0.0
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 106.8;Late spermatids: 41.2;Spermatocytes: 20.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 100.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: AB_2665622, CAB068175: AB_2665623, HPA005680: AB_2667388, HPA050556: AB_2681175"	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavorable (5.97e-7)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	68.4	14.4	12.0	9.1	1.6	4.2	12.9	43.2	25.3	52.2	39.2	9.8	21.2	3.4	12.5	21.8	27.8	35.3	9.4	25.2	100.3	2.3	6.8	4.7	16.2	8.1	0.2	6.7	5.5	0.9	1.1	34.0	22.4	6.2	16.2	4.6	9.8	7.3	42.5	10.3	5.7	7.8	13.3	10.5	15.2	4.2	36.0	2.3	11.5	11.2	5.1	6.0	22.7	26.4	3.9	17.4	17.8	7.7	15.3	32.7	36.8	19.2	50.4	3.0	4.8	6.4	11.1	10.9	68.6	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5	0.0	0.6	0.0	1.0	12.6	0.0	0.6	0.0	2.7	1.2	0.0	0.0	2.5	0.0	0.5	106.8	0.1	0.9	0.0	0.2	20.2	3.5	1.3	0.0	0.0	8.0	0.0	0.0	1.8	1.5	41.2	1.1	2.6	0.0	0.0	2.2	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.4	20.9	14.9	8.2	2.4	1.5	1.6	1.4
ANP32A	"C15orf1, I1PP2A, LANP, MAPM, mapmodulin, PHAPI, PP32"	ENSG00000140350	"Acidic nuclear phosphoprotein 32 family member A"	P39687	15	68778535-68820897	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005231, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		740000	"Nucleoplasm, Centrosome"	Cytosol	"CAB005231: AB_2289588, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.03e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.83e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.17e-1)"	25.8	20.4	32.7	32.0	40.1	46.0	28.2	50.7	33.7	24.5	30.7	40.5	16.0	27.0	26.8	21.7	28.8	30.0	23.4	47.8	32.3	23.6	30.0	29.6	27.2	55.0	33.9	30.0	26.7	25.6	24.2	18.3	38.6	26.6	30.4	35.4	27.2	23.6	27.8	41.7	18.9	28.9	30.5	42.7	40.1	29.8	9.4	36.7	75.0	29.0	18.5	52.4	35.7	27.6	12.7	19.8	27.7	19.9	18.1	12.3	9.6	26.4	32.5	42.8	36.9	15.0	13.2	28.4	14.0	18.7	27.4	23.2	26.8	49.9	85.9	26.2	15.7	16.2	38.9	98.9	28.6	33.0	38.7	33.7	65.0	27.5	33.5	9.3	51.1	35.2	10.5	20.2	15.0	30.0	18.0	39.8	41.7	47.2	33.6	23.5	18.5	51.3	42.0	37.9	26.2	16.5	72.0	39.7	51.0	24.1	41.9	56.8	35.2	21.3	24.0	39.3	44.7	31.9	67.1	17.8	28.5	45.3	19.6	37.3	20.4	56.6	99.5	18.9	86.1	26.0	8.1	17.6	27.7	11.9	19.9	10.0	12.7	9.8	12.3	19.8	12.7	12.1	10.6	18.1	18.1	16.8	17.6	11.2	9.6	32.7	40.1	50.7	33.7	32.3	23.6	33.9	30.0	26.6	36.7	101.3	93.6	54.3	58.8	57.6	85.2	68.1	48.4	129.8	100.1	66.3	33.4	225.4	91.2	95.6	3.6	76.3	57.2	70.0	83.9	137.0	53.5	48.8	89.1	75.9	163.6	62.0	75.3	58.3	145.4	4.0	32.2	112.8	74.2	132.6	83.9	86.2	70.3	56.1	28.0	115.7	65.9	25.8	68.0	7.7	13.8	30.6	194.4	102.2	82.6	46.3
ANP32B	"APRIL, PHAPI2, SSP29"	ENSG00000136938	"Acidic nuclear phosphoprotein 32 family member B"	Q92688	9	97983361-98015943	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA063133, HPA067561, HPA069657"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		290000	Nucleoplasm	"Centrosome, Cytosol"	"HPA063133: AB_2684947, HPA067561: AB_2685861, HPA069657: "	"unprognostic (2.82e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (1.98e-7)"	"unprognostic (6.76e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.16e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.22e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.78e-2)"	43.0	24.6	37.9	46.5	55.5	105.7	37.7	15.6	30.1	43.2	38.9	81.0	24.6	32.7	46.3	38.4	40.4	28.4	39.2	27.0	41.8	32.0	26.0	35.9	35.0	70.4	55.7	21.7	51.1	46.0	29.3	20.7	37.5	41.8	38.9	42.3	26.2	32.5	29.7	29.4	38.6	34.9	45.3	88.3	38.6	36.7	19.0	47.6	85.9	37.0	31.9	81.8	64.5	58.6	34.8	32.6	36.8	44.6	22.7	51.3	25.1	71.5	38.7	43.2	36.0	24.3	43.0	39.4	37.2	33.0	40.0	33.7	48.5	35.2	87.8	22.3	24.9	30.5	47.4	58.1	42.0	45.9	56.9	32.8	76.0	33.2	52.3	31.3	130.1	44.3	32.5	30.7	32.1	66.3	32.6	34.7	78.8	146.1	62.2	30.8	95.5	98.2	115.7	16.8	70.3	38.5	58.7	67.3	41.7	26.1	30.0	34.9	30.5	43.6	42.7	38.1	22.2	24.1	48.7	42.0	26.1	42.3	32.8	39.0	56.5	63.8	53.0	24.2	52.3	48.6	23.1	27.2	36.8	22.7	30.9	31.3	34.8	42.7	31.9	32.6	29.6	51.3	38.7	11.3	22.7	44.6	31.8	50.8	25.1	37.9	55.5	15.6	30.1	41.8	32.0	55.7	21.7	41.8	47.6	80.4	91.7	174.3	178.4	160.5	57.6	74.9	101.9	53.5	93.3	71.5	23.6	273.1	82.9	105.6	102.1	109.0	128.4	327.1	148.0	437.2	99.8	129.7	116.6	84.4	250.6	112.8	144.0	112.3	244.5	70.6	135.4	174.1	121.4	164.1	222.6	53.5	126.7	126.7	136.5	75.6	33.5	148.8	133.5	138.6	318.8	134.8	278.6	173.4	278.8	183.9
ANP32D	PP32R2	ENSG00000139223	"Acidic nuclear phosphoprotein 32 family member D"	O95626	12	48472665-48473624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.3;REH: 1.2"									"HPA063133, HPA067561"	Uncertain		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Nucleoplasm, Centrosome"	Cytosol	"HPA063133: AB_2684947, HPA067561: AB_2685861"		"unprognostic (2.20e-1)"	"unprognostic (3.75e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.23e-2)"	"unprognostic (5.11e-2)"		"unprognostic (1.72e-3)"		"unprognostic (2.30e-2)"		"unprognostic (3.62e-3)"		"unprognostic (2.76e-2)"		"unprognostic (3.48e-1)"		0.1	0.9	0.3	0.0	0.2	0.1	0.2	0.2	0.6	0.0	0.5			0.0	0.6	0.8	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.7	0.0	0.2		1.1	0.1	0.0	0.2	0.5		0.3	0.2		0.4	0.3	0.2	0.0	0.1	0.2	0.2	0.5	0.2	0.9			0.8		0.0	0.4	0.1	0.1	0.1	0.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.2	0.2	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.4	0.4	0.0	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ANP32E	"LANP-L, LANPL, MGC5350"	ENSG00000143401	"Acidic nuclear phosphoprotein 32 family member E"	Q9BTT0	1	150218417-150236156	"Predicted intracellular proteins"		"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB021114, HPA063133, HPA067561"	Supported		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA		18000	"Nucleoplasm, Centrosome"	Cytosol	"CAB021114: AB_10057407, HPA063133: AB_2684947, HPA067561: AB_2685861"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (4.50e-5)"	"unprognostic (1.64e-1)"	"unprognostic (6.58e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.73e-3)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (3.82e-8)"	"unprognostic (1.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.52e-1)"	11.5	18.3	31.2	21.0	30.9	38.4	10.6	50.3	20.6	14.3	11.3	18.3	13.5	12.9	16.5	21.0	12.8	12.8	11.9	19.8	22.9	25.9	18.6	16.8	13.3	38.4	26.5	19.5	19.1	6.9	20.1	14.7	12.3	21.2	14.2	10.9	20.1	9.2	20.9	25.5	12.5	14.5	25.2	32.7	20.3	9.9	6.0	17.8	52.2	18.1	13.6	34.7	20.6	12.1	24.5	8.2	20.7	10.5	14.6	27.0	15.7	34.3	22.2	46.4	23.0	3.6	5.4	17.7	18.5	10.5	17.9	17.2	16.4	24.4	62.6	16.5	10.6	10.6	12.0	26.1	11.5	25.7	71.6	15.8	43.3	27.6	23.6	3.4	87.0	22.0	4.4	1.8	16.7	15.4	8.8	13.2	30.5	41.4	37.1	16.3	35.6	35.5	22.7	46.8	11.2	10.2	37.8	25.8	32.9	12.7	13.8	15.2	26.2	38.6	6.2	10.8	21.5	16.8	44.5	13.6	9.2	25.9	9.4	36.9	47.9	48.1	61.3	10.4	62.8	16.7	20.7	10.5	16.3	18.0	7.3	27.0	24.5	24.2	19.7	8.2	17.0	17.4	21.6	7.2	14.6	8.8	5.7	25.7	15.7	31.2	30.9	50.3	20.6	22.9	25.9	26.5	19.5	21.2	17.8	11.9	78.4	61.4	38.4	86.4	117.9	90.4	22.9	60.2	30.7	69.8	31.4	37.5	72.9	27.5	1.1	45.4	12.3	140.2	23.2	113.7	65.8	16.5	60.2	48.9	46.0	60.4	13.8	39.9	41.9	1.4	28.1	57.2	64.1	62.3	11.5	131.8	20.8	17.5	31.5	44.8	110.8	25.8	85.5	9.3	21.8	86.1	34.0	89.3	28.0	19.3
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	66.2	104.7	4.7	4.9	66.8	63.6	0.3	114.8	71.8	47.5	32.2	3.0	59.9	0.1	38.0	100.1	105.0	81.6	10.1	69.5	37.7	37.5	0.7	5.1	31.1	0.1	53.3	11.0	2.5	36.6	57.6	48.0	94.4	44.0	67.3	6.0	21.0	2.8	58.5	0.2	19.5	6.0	5.9	26.5	42.6	0.0	26.7	0.2	106.8	14.0	0.0	0.0	39.5	1.0	26.5	65.5	0.2	1.7	83.1	55.7	35.1	76.5	58.9	0.4	0.1	0.2	128.7	10.3	83.8	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1	541.9	512.9	7.3	2232.0	752.1	0.0	11.9	17.8	1060.0	889.5	59.3	0.0	1215.0	0.0	156.6	6.3	398.1	0.8	0.0	20.0	1352.9	735.1	1709.3	2387.0	2.5	570.9	0.0	5.1	113.5	449.6	2.3	206.0	1058.5	291.8	475.3	1.8	0.2	431.7	0.0	8.9	3.1	0.0	64.7	275.6	0.7	2.9	522.6	5914.0	282.4	0.5	4139.3
ANXA3	ANX3	ENSG00000138772	"Annexin A3"	P12429	4	78551519-78610451	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Phospholipase A2 inhibitor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 83.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 547.9;Ductal cells: 468.5;Exocrine glandular cells: 274.5;Pancreatic endocrine cells: 473.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	319	"neutrophil: 51.3"	"Lineage enriched"	"Detected in single"	319	"granulocytes: 51.3"	"Cell line enhanced"	"Detected in many"		"A-431: 51.5;CACO-2: 52.8;CAPAN-2: 71.5;EFO-21: 43.8;hTERT-HME1: 72.9;OE19: 61.8;RPTEC TERT1: 61.4"	"Low region specificity"	"Detected in all"							"HPA013398, HPA013431"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		7400000	"Plasma membrane"		"HPA013398: AB_1844861, HPA013431: AB_1844862"	"unprognostic (2.66e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.92e-3)"	"unprognostic (8.67e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-3)"	"prognostic unfavorable (1.28e-4)"	"unprognostic (4.82e-2)"	"prognostic favorable (8.48e-6)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.30e-2)"	20.3	1.1	4.0	7.1	7.4	83.0	16.2	2.4	6.8	7.0	8.5	2.3	0.9	4.2	3.4	4.2	25.0	4.6	11.7	20.5	5.2	5.2	19.8	1.6	46.0	5.7	6.6	5.6	2.8	14.7	6.5	5.8	33.7	10.4	18.8	7.4	2.6	50.8	3.6	14.2	4.1	9.3	5.3	4.0	11.0	23.4	1.8	5.0	2.0	45.3	13.6	7.4	2.8	5.9	0.1	0.0	51.3	0.1	0.0	0.0	0.5	51.5	9.8	0.1	0.1	0.1	0.2	0.0	0.6	0.0	1.5	1.4	52.8	71.5	0.0	43.8	1.8	0.0	20.4	0.0	37.7	2.3	0.2	0.4	4.6	21.1	3.1	6.1	0.6	0.0	0.3	33.4	0.5	72.9	7.6	14.9	1.2	0.1	0.0	0.2	2.0	0.2	0.0	1.6	61.8	7.2	0.0	0.1	0.0	61.4	5.9	0.0	0.0	30.4	7.5	2.1	25.3	1.3	0.6	18.9	0.1	6.8	0.0	11.6	0.4	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	51.3	0.0	0.1	0.0	0.0	0.5	4.0	7.4	2.4	6.8	5.2	5.2	6.6	5.6	10.4	5.0	547.9	38.9	0.0	51.1	22.0	0.0	6.4	58.6	36.1	144.5	36.6	0.0	172.1	14.9	468.5	0.9	32.1	19.7	0.0	274.5	87.0	24.3	117.9	4.7	0.4	16.1	0.0	5.2	20.3	0.0	0.0	2.8	1.7	5.0	36.1	30.9	0.8	473.1	58.5	0.4	1.1	0.3	0.0	9.5	1.2	0.7	5.8	52.5	0.5	28.7	32.0
AP002495.1		ENSG00000254469	"Putative short transient receptor potential channel 2-like protein "	Q6ZNB5	11	71865509-71928654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Ciliated cells: 2.7;Cytotrophoblasts: 4.7;Extravillous trophoblasts: 2.1;Hofbauer cells: 1.8;Syncytiotrophoblasts: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA051121, HPA051124"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		NA	NA			Nucleoli	"Mitotic chromosome"	"HPA051121: AB_2681349, HPA051124: "	"unprognostic (1.66e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.32e-3)"	"unprognostic (9.79e-4)"	"unprognostic (5.91e-3)"	"unprognostic (5.04e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.60e-1)"	"unprognostic (3.12e-3)"	5.8	6.9	8.2	7.7	7.3	9.1	7.3	7.4	8.7	7.5	6.3	11.6	21.7	6.1	9.2	13.2	6.2	7.2	5.0	4.8	6.4	4.9	7.6	5.1	5.4	8.9	6.8	5.4	12.1	7.2	7.4	12.7	4.8	6.6	7.2	8.5	10.4	7.9	15.7	5.9	8.8	7.5	6.4	6.5	7.9	6.9	9.7	11.9	11.6	8.7	3.6	12.2	7.1	6.8	6.0	7.5	3.4	4.5	1.8	8.5	3.2	2.8	6.4	5.1	4.8	1.9	2.0	3.2	3.3	2.5	3.5	3.3	7.6	7.3	6.2	3.0	2.1	4.2	9.2	5.4	3.4	3.9	9.0	4.7	10.0	7.2	4.5	1.4	4.8	3.4	2.6	1.6	5.7	4.6	2.8	5.2	8.8	6.7	9.2	3.5	5.8	4.8	3.5	5.6	9.8	4.7	4.0	18.7	4.3	3.7	3.6	7.6	7.8	4.8	4.5	10.1	3.9	6.5	2.4	4.9	2.7	4.8	5.2	2.0	5.7	9.1	7.7	4.7	5.1	4.4	3.4	3.0	2.5	4.6	4.5	2.9	4.2	8.5	6.3	3.5	6.0	8.2	6.8	2.6	1.8	2.7	7.5	7.1	3.2	8.2	7.3	7.4	8.7	6.4	4.9	6.8	5.4	6.6	11.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 gamma 1 subunit"	O43747	16	71729000-71809201	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		150000	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	23.2	29.8	20.4	19.2	26.3	59.1	22.4	31.8	29.2	19.7	20.4	29.2	19.8	19.2	19.6	23.9	30.1	17.9	18.7	14.5	18.5	17.4	32.8	29.5	23.8	20.0	24.2	20.1	18.3	25.6	53.5	27.4	25.1	27.9	20.8	23.4	20.8	28.2	20.2	30.0	27.7	24.4	16.0	20.3	24.3	24.8	26.5	26.7	30.0	23.1	21.8	28.3	18.1	20.1	7.5	8.5	17.6	8.8	7.6	9.0	4.2	16.5	24.3	18.7	19.0	20.0	19.1	16.2	17.2	16.5	23.1	22.3	23.4	18.4	20.6	16.6	23.4	16.8	21.2	25.2	18.9	31.1	8.3	13.0	13.4	12.7	17.7	11.8	16.1	44.7	15.9	13.5	30.8	19.1	14.6	19.5	14.1	17.8	8.7	22.6	29.5	14.9	13.6	17.0	13.1	10.6	24.0	15.0	22.0	21.6	19.0	17.2	10.3	21.3	13.5	9.5	20.1	23.5	12.8	23.0	19.9	15.5	10.6	12.6	13.8	17.9	42.6	16.0	13.1	16.9	5.8	7.9	10.9	8.3	8.8	8.3	6.3	7.3	9.0	8.5	7.5	5.9	7.2	17.6	7.6	6.8	6.0	7.3	4.2	20.4	26.3	31.8	29.2	18.5	17.4	24.2	20.1	27.9	26.7	29.8	33.2	26.0	27.0	25.5	25.6	10.9	48.4	20.1	19.4	34.9	68.7	10.8	16.6	16.6	197.4	21.8	29.4	0.0	18.7	11.5	18.8	36.6	20.7	51.9	14.6	28.6	22.4	25.2	31.0	105.9	16.4	23.4	21.9	10.8	21.7	16.7	25.1	24.1	18.7	36.0	62.0	19.4	22.8	25.0	34.2	33.8	20.5	22.3	17.8	42.6
AP5S1	"C20orf29, FLJ11168"	ENSG00000125843	"Adaptor related protein complex 5 sigma 1 subunit"	Q9NUS5	20	3820524-3828837	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034200, HPA043533, HPA048244"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	No			"Nucleoplasm, Cytosol"		"CAB034200: AB_1564201, HPA043533: AB_2732507, HPA048244: AB_2680328"	"unprognostic (1.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.49e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.91e-2)"	"unprognostic (5.15e-3)"	"unprognostic (8.17e-2)"	"prognostic favorable (5.53e-5)"	"unprognostic (2.92e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.09e-3)"	"unprognostic (5.08e-2)"	9.4	14.9	10.1	8.6	13.4	10.7	6.8	7.9	15.3	6.7	10.6	12.0	13.9	10.4	7.1	11.8	8.5	8.2	10.6	13.2	10.2	9.3	12.4	18.9	7.9	19.3	8.9	10.7	8.1	16.9	12.1	9.4	13.0	7.1	8.2	7.5	13.4	13.8	7.0	27.2	7.3	9.9	6.7	8.2	10.2	9.9	19.9	6.3	11.2	13.2	11.2	8.3	7.0	5.8	7.8	10.8	4.7	12.9	6.5	11.9	6.6	11.0	21.2	3.0	2.0	4.1	5.3	3.6	6.7	5.5	6.7	5.3	17.9	11.9	6.4	7.3	7.1	12.7	9.9	2.5	10.9	2.3	3.5	7.0	10.6	6.2	15.4	7.0	7.3	6.5	9.0	6.2	8.3	6.6	4.5	7.8	7.8	7.5	12.6	8.8	18.1	16.9	6.4	2.6	8.0	17.3	7.2	5.0	6.6	7.5	9.0	9.1	3.6	6.7	20.5	11.1	2.1	10.1	3.7	10.6	14.1	6.7	7.2	12.7	6.8	7.5	3.5	4.9	6.6	12.0	1.7	8.3	4.7	11.9	12.9	9.2	6.1	10.1	9.9	10.8	7.8	9.4	8.7	2.1	6.5	7.0	8.7	10.3	6.6	10.1	13.4	7.9	15.3	10.2	9.3	8.9	10.7	7.1	6.3	0.0	8.8	3.7	4.0	1.4	14.4	10.1	10.2	5.3	4.5	3.5	9.8	17.2	10.0	8.7	2.6	6.7	8.5	0.0	11.0	12.0	4.2	4.0	13.9	7.4	13.6	23.8	12.1	6.7	5.1	2.5	5.5	6.2	5.0	13.6	5.9	12.3	9.1	7.4	3.9	6.2	19.6	12.9	3.9	14.9	8.5	0.9	15.4	4.9	5.2	2.7
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.4"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 22.5;Horizontal cells: 84.2;T-cells: 21.8"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.8;naive CD8 T-cell: 7.5"	"Lineage enriched"	"Detected in many"	4	"T-cells: 7.8"	"Cell line enhanced"	"Detected in some"		"HEL: 7.6;SH-SY5Y: 18.7;U-937: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.8	3.3	17.6	3.0	12.1	3.0	1.7	33.4	28.9	1.2	2.0	3.6	0.0	2.5	2.1	2.5	6.7	1.4	2.1	1.6	24.2	14.9	1.4	1.8	2.1	3.6	15.1	14.9	1.8	2.6	1.2	2.3	1.6	7.5	3.0	2.1	1.6	1.8	1.7	1.6	1.8	2.7	1.4	16.2	7.9	1.8	5.6	2.7	1.9	1.9	0.0	3.4	2.9	0.4	0.0	0.0	0.1	0.0	1.8	7.8	2.5	0.0	1.4	0.6	3.5	0.0	0.0	0.0	0.8	1.3	0.1	0.5	0.0	0.0	0.0	3.3	0.0	2.2	0.0	0.5	0.0	0.0	0.0	2.9	7.6	0.0	0.1	2.9	0.0	0.2	0.4	2.3	0.4	0.0	0.3	4.0	1.7	4.4	0.1	0.0	0.4	0.2	2.1	1.0	0.0	3.1	0.0	0.3	0.1	0.0	0.0	5.0	18.7	0.0	0.0	0.1	0.1	0.0	0.9	4.0	0.0	4.1	0.0	0.8	0.0	0.1	0.0	0.1	13.4	1.6	0.0	0.0	0.0	1.4	0.0	0.2	0.0	2.1	4.7	0.0	0.0	7.8	7.5	0.1	1.8	0.0	0.0	0.0	2.5	17.6	12.1	33.4	28.9	24.2	14.9	15.1	14.9	7.5	2.7	0.0	1.1	0.0	0.2	0.3	22.5	1.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	1.6	10.3	0.5	0.0	0.0	5.1	0.1	1.0	0.1	0.0	0.2	0.9	84.2	0.0	3.7	2.4	7.9	1.7	0.0	3.3	0.0	0.0	1.2	5.3	0.0	3.5	0.1	3.1	0.0	3.1	0.6	7.0	0.3	0.1	21.8	0.0	0.1
APBB1IP	"INAG1, RIAM"	ENSG00000077420	"Amyloid beta precursor protein binding family B member 1 interacting protein"	Q7Z5R6	10	26438203-26567803	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 54.2;lymphoid tissue: 100.5"	"Cell type enhanced"	"Detected in many"	12	"B-cells: 48.4;Hofbauer cells: 56.0;Kupffer cells: 108.6;Macrophages: 52.4;T-cells: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 25.7;MOLT-4: 22.0;REH: 49.7;U-698: 52.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017009, HPA063903"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	NA			"Plasma membrane, Cytosol"		"HPA017009: AB_2669505, HPA063903: AB_2685147"	"unprognostic (1.31e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.79e-3)"	"prognostic favorable (7.48e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.74e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.38e-2)"	18.3	3.9	7.9	27.7	14.2	25.8	10.1	1.2	7.3	2.6	3.9	16.6	0.0	4.5	2.0	1.5	2.9	4.9	7.5	4.8	7.3	4.9	4.8	25.4	11.1	28.2	14.5	3.2	1.5	3.0	1.3	2.7	5.5	11.1	2.5	4.5	1.6	4.0	1.6	1.5	2.8	12.0	4.7	21.9	41.5	5.4	1.3	12.1	100.5	3.0	0.7	26.2	8.0	3.9	11.0	14.8	54.2	10.3	5.3	9.5	3.5	0.0	0.4	0.0	0.0	3.4	5.7	3.0	9.6	1.8	5.5	5.3	0.0	0.0	25.7	0.1	6.4	5.9	0.0	0.0	0.0	7.6	0.0	0.0	18.6	0.0	0.0	0.0	3.5	0.0	8.2	0.0	0.2	0.0	0.6	0.0	10.6	0.0	16.4	0.0	0.0	22.0	4.9	0.0	2.0	0.0	49.7	0.0	18.2	1.5	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.1	1.8	0.0	4.5	0.0	52.9	4.5	18.2	0.0	19.0	7.1	16.1	9.5	6.9	7.7	9.5	8.1	7.9	4.4	11.0	9.3	9.0	54.2	5.3	10.3	14.8	7.6	3.5	7.9	14.2	1.2	7.3	7.3	4.9	14.5	3.2	11.1	12.1	0.0	25.9	48.4	0.0	1.0	0.0	0.9	5.1	6.7	4.5	3.5	0.0	2.0	0.0	4.1	0.3	1.7	0.0	0.0	0.0	14.9	4.1	0.1	22.0	21.5	56.0	0.0	0.0	8.6	108.6	0.0	0.0	52.4	3.3	8.2	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	1.0	0.0	0.9	0.1	1.1	69.3	0.0	0.0
APEH	"D3F15S2, D3S48E, DNF15S2"	ENSG00000164062	"Acylaminoacyl-peptide hydrolase"	P13798	3	49674002-49683963	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029700, HPA029701, HPA029702, HPA029703"	Enhanced		Enhanced	Cytosol		No	No		1600000	Cytosol		"HPA029700: AB_10599278, HPA029701: AB_10600333, HPA029702: AB_10602411, HPA029703: AB_10601348"	"unprognostic (4.93e-2)"	"unprognostic (5.42e-2)"	"unprognostic (6.04e-3)"	"unprognostic (2.71e-1)"	"unprognostic (9.32e-2)"	"unprognostic (8.20e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.03e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.30e-2)"	"prognostic favorable (3.32e-10)"	"unprognostic (2.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.34e-2)"	"unprognostic (7.67e-2)"	12.3	31.4	14.3	16.9	18.4	17.3	13.5	14.2	28.2	13.4	23.5	14.4	25.3	24.2	14.1	19.0	23.8	17.2	19.1	23.1	14.2	14.2	33.6	36.9	15.0	23.9	13.9	20.0	13.9	22.7	33.5	26.6	18.6	16.3	16.1	26.6	19.5	19.8	19.8	55.1	16.9	21.7	14.1	9.8	19.2	21.9	22.3	11.7	22.6	26.6	26.6	20.7	19.9	13.7	20.5	26.2	30.4	27.9	21.8	29.5	28.1	25.8	21.1	23.2	30.0	20.3	13.6	30.7	16.9	21.7	23.8	25.5	34.0	28.1	33.1	19.0	19.2	21.7	24.0	25.9	39.2	18.1	15.7	10.7	35.7	35.3	27.8	20.1	38.2	55.6	15.4	29.6	13.6	28.3	23.8	21.5	23.3	22.1	16.5	23.6	23.9	26.9	19.4	13.7	37.3	19.3	10.2	19.9	43.0	47.1	61.4	11.1	19.3	19.1	46.4	21.0	17.9	30.6	20.4	9.7	14.7	25.8	23.0	22.8	18.9	13.5	19.7	25.4	27.1	21.2	30.2	25.5	30.4	28.5	27.9	22.5	20.5	23.5	26.7	26.2	17.4	24.9	24.2	8.0	21.8	26.7	21.0	29.5	28.1	14.3	18.4	14.2	28.2	14.2	14.2	13.9	20.0	16.3	11.7	38.7	22.3	16.0	19.8	7.7	7.8	42.0	33.1	9.4	20.5	26.2	11.8	72.6	36.5	39.0	4.6	8.3	73.8	23.3	30.4	54.6	12.8	15.2	23.1	65.2	45.5	7.9	25.4	14.1	36.8	8.1	14.1	18.1	20.3	22.6	44.7	21.8	35.8	28.8	12.7	64.9	9.9	12.9	14.2	30.5	28.4	8.2	51.9	25.3	51.1	21.0
API5	"AAC-11, AAC11, API5L1"	ENSG00000166181	"Apoptosis inhibitor 5"	Q9BZZ5	11	43311963-43344529	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026598	Approved		Enhanced	"Nuclear speckles"		NA	NA		7900	"Nuclear speckles"		"HPA026598: AB_1844927"	"unprognostic (4.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.58e-3)"	"unprognostic (6.08e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.69e-3)"	"unprognostic (1.45e-3)"	"unprognostic (2.87e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.06e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.05e-2)"	33.4	31.3	31.8	31.1	39.8	21.9	35.4	54.5	45.0	33.3	33.0	32.3	26.7	32.1	39.0	26.1	36.9	30.2	25.4	21.5	33.0	30.1	38.4	51.4	26.4	37.3	31.5	37.4	31.7	35.4	41.9	31.6	32.0	40.3	32.1	36.8	19.9	32.8	33.2	38.3	31.9	39.0	37.3	40.0	38.0	31.1	24.5	31.5	52.3	40.9	26.8	42.1	32.4	29.5	24.8	24.2	19.4	25.2	45.4	31.7	30.8	26.7	29.3	38.6	23.1	26.9	26.7	25.7	26.8	29.2	38.3	36.7	20.6	11.8	32.5	20.9	28.6	27.5	33.2	46.3	31.1	52.6	37.3	42.5	29.5	17.2	17.8	23.6	48.8	27.7	21.6	32.1	19.0	33.9	23.1	31.7	20.1	47.9	28.5	25.6	16.5	40.5	19.8	66.7	33.2	27.6	43.2	39.4	24.9	27.6	31.6	29.9	19.6	32.1	27.7	24.7	29.6	33.9	22.4	27.5	32.5	24.3	43.6	43.5	23.5	33.8	51.1	27.6	28.7	19.4	19.4	18.4	19.4	27.7	25.2	31.7	24.8	27.7	28.7	24.2	23.0	28.5	29.6	4.0	45.4	24.3	15.5	23.5	30.8	31.8	39.8	54.5	45.0	33.0	30.1	31.5	37.4	40.3	31.5	14.9	23.5	17.8	14.2	38.9	22.5	13.7	28.1	18.7	31.8	19.2	9.8	25.7	26.6	19.6	6.8	24.8	19.3	23.3	16.9	25.3	25.1	20.5	31.2	42.2	23.0	27.0	23.1	21.5	34.8	4.5	17.3	23.9	30.4	32.5	28.0	20.3	21.8	14.4	19.1	29.1	16.2	6.5	24.7	25.5	23.0	45.4	32.5	28.7	28.8	15.5
AQR	"fSAP164, IBP160, KIAA0560"	ENSG00000021776	"Aquarius intron-binding spliceosomal factor"	O60306	15	34851782-34969839	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040624, HPA055647"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA040624: AB_2677050, HPA055647: AB_2682874"	"unprognostic (1.73e-1)"	"unprognostic (3.71e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.04e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (2.97e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.84e-1)"	"unprognostic (3.13e-2)"	15.5	15.8	8.0	14.0	12.4	9.7	16.1	11.2	14.3	16.6	11.2	11.8	8.7	9.2	18.5	11.8	18.3	12.3	8.7	9.9	8.4	7.5	14.4	11.2	10.7	12.6	8.7	6.9	15.5	13.6	16.8	13.2	15.3	13.2	12.0	11.8	12.4	15.1	11.3	8.7	14.2	13.0	14.3	8.3	16.8	12.9	15.8	9.2	27.9	14.8	8.5	16.5	15.7	14.9	5.9	5.5	7.1	5.1	4.5	6.5	2.9	5.0	13.1	8.7	9.1	11.8	11.0	4.5	6.2	7.9	8.3	7.5	5.9	3.1	4.1	4.0	10.5	5.5	8.0	14.6	8.9	9.2	5.8	5.9	13.2	11.6	5.4	6.7	10.7	6.2	8.5	5.9	6.5	6.9	7.8	7.0	3.3	9.3	4.1	8.2	3.4	6.2	7.2	8.6	11.7	5.4	8.5	15.0	4.1	8.4	8.9	9.5	7.4	10.1	9.7	2.2	8.0	6.8	8.4	9.1	6.2	3.4	4.2	5.5	5.0	6.1	8.4	7.7	9.3	6.2	7.1	4.7	2.7	6.5	5.1	5.7	4.0	5.7	6.2	3.8	5.9	5.8	6.4	2.3	4.5	3.0	5.5	4.6	2.9	8.0	12.4	11.2	13.4	8.4	7.5	8.7	6.9	13.2	9.2	11.9	27.0	11.9	11.9	8.5	25.3	14.6	20.4	29.4	36.4	14.0	108.0	13.3	3.3	11.5	36.0	17.9	15.5	0.0	12.3	12.0	10.6	12.5	23.1	17.1	13.1	23.8	12.7	31.9	17.0	6.9	19.2	12.7	15.1	13.6	17.7	17.4	15.9	14.0	17.3	10.3	38.7	6.5	9.8	19.3	20.1	8.4	11.1	20.8	19.1	11.2
ARFGEF1	"ARFGEP1, BIG1, DKFZP434L057, p200"	ENSG00000066777	"ADP ribosylation factor guanine nucleotide exchange factor 1"	Q9Y6D6	8	67173511-67343677	"Predicted intracellular proteins"	"Protein transport, Transport"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023399, HPA023822"	Supported	Supported	Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA023399: AB_1844981, HPA023822: AB_1844982"	"prognostic unfavorable (8.76e-4)"	"unprognostic (1.62e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.52e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.13e-3)"	"unprognostic (1.31e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.61e-2)"	17.0	17.1	14.5	24.3	15.6	24.9	14.0	20.4	16.3	17.7	24.7	9.5	24.7	16.8	15.4	20.3	23.8	13.1	16.0	12.0	11.3	11.7	23.9	15.3	18.6	22.7	11.4	9.5	15.1	21.4	38.6	21.8	17.4	16.7	15.8	17.7	13.2	20.7	29.4	20.9	18.4	26.9	13.8	12.0	20.1	19.5	27.1	12.6	36.7	22.9	15.7	16.8	22.9	17.7	2.1	3.7	8.4	3.7	3.7	6.1	1.3	15.8	10.3	10.1	3.7	11.7	16.0	11.9	11.2	12.5	11.4	11.6	6.3	15.5	12.0	4.9	14.0	13.9	11.4	12.1	15.7	14.0	15.4	8.5	20.2	6.3	6.8	10.1	10.3	20.2	9.8	11.3	10.2	17.5	11.8	16.2	12.7	12.4	13.1	13.1	3.5	24.2	4.9	22.1	17.4	9.5	11.9	7.2	2.4	18.9	29.5	4.0	7.8	7.2	17.5	9.8	16.1	30.2	9.2	19.7	7.9	10.5	10.3	8.3	11.5	12.5	9.0	12.4	10.6	7.3	8.0	2.6	6.6	4.8	3.7	6.1	2.1	3.2	3.9	2.6	2.1	5.3	4.5	8.4	3.7	1.5	3.7	5.9	1.3	14.5	15.6	20.4	16.3	11.3	11.7	11.4	9.5	16.7	12.6	41.7	17.2	18.8	23.7	21.1	35.4	28.2	20.4	30.8	26.1	36.6	131.6	16.1	10.0	24.5	19.5	24.8	32.5	0.0	22.1	13.2	15.8	30.7	15.0	17.8	14.2	41.3	28.3	22.1	29.5	23.4	37.2	23.8	16.9	27.9	29.9	21.4	31.5	23.0	28.3	21.0	94.9	6.5	17.5	49.4	48.5	25.7	20.8	23.0	22.7	61.6
ARGLU1	FLJ10154	ENSG00000134884	"Arginine and glutamate rich 1"	Q9NWB6	13	106541673-106568164	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 91.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034962, HPA056792"	Supported		Enhanced	Nucleoplasm,Mitochondria,Cytosol		No	No			Nucleoplasm	"Mitochondria, Cytosol"	"HPA034962: AB_10611676, HPA056792: AB_2683236"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.21e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (3.92e-5)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.91e-3)"	"unprognostic (2.65e-1)"	"unprognostic (2.87e-1)"	"prognostic favorable (7.34e-5)"	43.5	31.8	59.1	46.5	63.6	67.5	46.1	82.1	72.8	37.9	41.7	44.9	33.5	35.2	62.2	50.9	38.1	50.2	55.0	40.4	55.7	20.6	30.5	24.4	65.3	75.7	62.5	44.5	65.2	34.1	24.0	61.1	48.3	44.0	38.9	48.6	35.5	46.8	48.2	34.1	53.0	54.3	43.3	51.8	50.4	42.8	25.9	67.2	40.2	45.5	22.0	61.0	44.0	44.9	23.7	23.2	34.7	18.0	16.5	18.6	10.9	26.6	14.8	67.4	15.1	10.7	18.6	15.0	29.7	9.0	10.0	15.2	30.2	38.8	32.4	10.2	11.6	11.7	30.2	14.2	12.2	18.8	42.1	15.1	37.2	91.5	15.5	9.5	60.0	24.8	16.6	16.1	9.1	12.3	25.0	12.7	22.5	13.4	25.2	12.8	9.4	23.7	31.9	17.8	19.6	5.6	40.9	16.9	15.4	11.2	31.1	17.6	25.3	14.0	22.5	6.7	27.9	17.7	31.1	23.0	13.4	13.4	14.9	16.6	28.3	23.3	38.8	27.7	38.5	15.3	34.7	18.0	16.7	18.6	14.6	17.2	20.7	13.8	11.6	14.4	23.7	15.8	13.8	30.3	16.5	13.4	23.2	15.5	10.9	59.1	63.6	82.1	72.8	55.7	20.6	62.5	44.5	44.0	67.2	131.0	200.7	147.3	175.2	232.4	221.8	78.3	101.9	224.9	215.0	108.2	127.6	118.5	84.6	100.9	28.5	282.9	157.6	93.5	97.9	120.4	173.1	219.9	158.9	69.6	87.5	287.6	180.1	188.4	85.6	18.1	236.2	133.0	121.4	162.3	134.2	304.1	112.4	133.3	204.7	39.4	283.1	213.4	189.5	194.6	112.8	229.2	154.9	147.4	126.3	268.6
ARHGAP19	"FLJ00194, MGC14258"	ENSG00000213390	"Rho GTPase activating protein 19"	Q14CB8	10	97222173-97292673	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"	4	"Ito cells: 12.3;Spermatocytes: 11.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035777, HPA043231"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035777: AB_2674777, HPA043231: AB_10796791"	"unprognostic (5.88e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.00e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.47e-5)"	"unprognostic (1.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.29e-2)"	5.6	3.7	5.6	8.8	7.6	18.3	8.6	7.2	5.3	7.4	5.1	11.7	3.2	4.1	6.9	3.4	6.1	6.0	4.0	4.9	5.7	4.6	4.6	3.2	5.5	14.1	10.9	3.6	11.4	3.4	8.0	7.3	6.0	7.4	5.8	5.3	7.3	6.4	3.7	4.0	6.0	6.6	5.3	14.2	12.0	4.3	20.1	7.0	30.4	4.4	5.5	14.3	6.7	5.9	5.5	5.3	15.5	7.3	4.1	6.0	5.1	8.1	2.6	14.6	25.6	0.9	3.9	4.5	4.0	4.1	6.5	4.6	5.2	7.3	18.2	3.4	2.7	3.8	5.5	12.2	5.0	8.2	9.0	6.7	11.9	3.3	3.5	0.9	18.3	12.8	2.0	1.7	4.5	10.4	2.1	8.8	25.9	11.7	9.6	5.6	4.0	16.6	3.9	7.9	5.2	2.4	20.0	12.5	5.1	1.9	3.6	1.1	6.8	3.0	1.5	6.7	5.6	9.1	9.6	4.1	2.6	3.1	4.1	10.4	8.6	8.8	24.6	3.3	21.7	2.9	15.3	7.3	10.2	5.2	6.6	4.9	5.5	5.1	4.8	5.3	5.5	6.0	5.3	15.5	4.1	5.7	3.0	5.9	5.1	5.6	7.6	7.2	5.3	5.7	4.6	10.9	3.6	7.4	7.0	3.0	2.7	3.0	1.2	0.8	2.1	1.2	5.1	5.3	0.0	0.0	0.0	1.1	0.0	1.1	5.9	3.7	1.7	0.0	1.4	3.0	1.8	2.3	4.7	2.6	2.9	6.4	0.0	12.3	8.5	4.9	3.1	4.0	1.7	1.0	1.9	1.6	0.9	3.5	3.9	0.6	1.2	0.0	1.9	11.4	9.6	2.0	0.8	2.5	3.1	1.0
ARHGEF1	"LBCL2, P115-RHOGEF, SUB1.5"	ENSG00000076928	"Rho guanine nucleotide exchange factor 1"	Q92888	19	41883161-41930150	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 61.0"	"Cell type enhanced"	"Detected in many"	8	"T-cells: 145.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009502, HPA012924, HPA060784"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363"	"prognostic favorable (5.92e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.29e-3)"	"unprognostic (8.10e-3)"	"unprognostic (7.63e-2)"	"unprognostic (7.59e-3)"	"unprognostic (4.99e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.29e-3)"	"prognostic unfavorable (3.36e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.65e-2)"	15.5	8.4	10.7	40.1	16.5	50.0	13.8	8.7	13.8	11.7	14.1	23.3	9.7	13.7	12.7	9.6	12.2	13.0	14.1	9.3	10.6	6.2	12.4	10.4	23.7	57.8	18.1	8.5	12.5	10.8	7.0	11.8	9.6	11.8	11.4	5.8	12.1	13.1	9.2	5.2	12.9	29.3	9.0	12.2	61.0	17.0	3.7	15.6	43.6	13.4	8.6	40.8	12.4	11.7	11.1	10.8	13.7	26.9	15.4	26.3	14.3	20.0	24.4	5.6	7.0	8.0	8.4	6.6	10.6	16.3	13.5	11.9	7.4	17.3	26.9	19.6	9.7	7.1	11.8	7.2	16.4	4.3	25.2	8.3	21.7	10.5	9.7	11.7	23.1	35.9	10.2	10.9	13.0	8.5	7.2	12.8	24.0	8.5	16.6	7.7	13.8	16.2	18.0	6.4	16.0	19.0	24.5	10.5	15.9	8.3	11.1	3.7	15.7	14.8	6.6	12.1	3.0	7.8	39.6	17.3	17.9	12.1	9.5	16.4	22.6	14.3	23.2	14.6	36.9	28.3	5.1	9.4	13.7	25.1	19.8	20.3	10.8	19.1	26.3	10.8	11.1	20.0	20.4	13.7	15.4	26.9	5.8	19.4	14.3	10.7	16.5	8.7	13.8	10.6	6.2	18.1	8.5	11.8	15.6	6.0	19.5	51.4	11.9	12.9	17.4	2.8	7.6	1.4	2.3	7.0	25.5	11.4	3.3	21.3	1.1	20.3	9.5	0.0	21.5	19.5	14.6	12.3	31.1	9.5	33.0	11.1	20.8	18.4	49.7	0.0	17.8	29.5	18.6	25.2	27.7	10.8	38.4	20.1	15.6	5.8	20.1	25.8	9.8	4.8	8.6	12.9	8.5	145.4	26.3	10.1
ARHGEF18	"KIAA0521, MGC15913, P114-RhoGEF"	ENSG00000104880	"Rho/Rac guanine nucleotide exchange factor 18"	Q6ZSZ5	19	7395113-7472477	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	10	"Basal keratinocytes: 2.6;Cone photoreceptor cells: 3.9;Intestinal endocrine cells: 1.7;Melanocytes: 1.7;Smooth muscle cells: 1.7;Suprabasal keratinocytes: 3.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042689, HPA071867"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA042689: AB_10794385, HPA071867: AB_2686466"	"unprognostic (2.55e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.26e-2)"	"prognostic favorable (3.11e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.79e-3)"	8.7	13.3	12.3	16.7	15.0	18.3	7.1	13.2	22.2	9.9	19.3	19.9	10.4	19.0	16.1	7.4	15.6	10.6	12.7	5.4	10.9	8.8	15.8	10.9	12.2	20.6	14.6	12.9	9.3	23.0	16.2	13.3	11.5	11.8	11.3	8.1	12.5	13.1	12.2	7.7	11.8	27.8	8.7	10.4	31.2	17.4	10.6	14.0	4.6	10.7	8.5	13.0	12.6	12.9	8.9	3.3	8.6	4.2	1.7	5.9	3.5	22.0	12.6	6.4	9.4	5.3	5.7	21.1	10.1	7.6	13.6	14.1	17.2	10.8	22.0	20.9	6.5	10.1	16.3	6.3	19.3	3.6	28.7	11.3	10.7	9.1	10.2	14.6	11.9	13.1	6.7	14.0	13.4	8.7	6.6	6.4	8.8	9.6	9.7	11.0	7.8	12.8	13.8	10.5	10.6	20.8	17.2	11.1	7.7	5.6	22.7	6.3	9.7	11.1	10.4	12.6	5.0	11.6	11.6	15.2	11.6	12.9	17.5	12.3	23.8	17.6	13.5	10.7	10.0	9.9	8.6	1.9	8.3	4.1	3.4	5.9	4.2	5.5	5.9	2.1	8.9	5.0	5.1	4.2	1.7	4.2	3.3	4.0	3.5	12.3	15.0	13.2	22.2	10.9	8.8	14.6	12.9	11.8	14.0	0.0	0.6	0.0	0.0	2.6	0.0	0.2	0.0	0.0	1.2	0.0	3.9	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.6	1.7	1.0	0.0	0.0	0.4	0.2	0.0	0.0	0.4	0.0	1.7	0.0	0.0	3.3	0.0	0.0	0.0	0.3
ARID1A	"B120, BAF250, BAF250a, C10rf4, C1orf4, P270, SMARCF1"	ENSG00000117713	"AT-rich interaction domain 1A"	O14497	1	26693236-26782110	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005456, CAB016334"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB016334: AB_673396, HPA005456: AB_1078205"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.69e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.54e-2)"	18.6	18.4	17.4	24.9	17.0	33.8	27.8	23.6	19.1	20.3	23.7	21.7	23.9	15.8	24.1	17.3	23.2	20.6	21.9	15.5	14.8	12.8	13.7	15.9	18.8	35.6	20.3	19.2	24.1	23.9	27.5	15.8	19.3	17.2	16.5	16.4	18.9	21.4	23.1	22.6	20.6	20.7	18.4	15.4	25.9	19.5	16.5	19.8	57.3	24.8	14.2	24.5	24.4	20.4	4.3	5.3	7.4	3.3	4.7	5.1	3.5	19.2	18.3	25.9	27.0	7.5	7.2	12.2	9.0	7.9	12.4	8.8	13.3	13.0	27.2	7.9	11.7	7.8	11.7	22.5	10.0	14.5	33.6	8.8	23.1	11.9	8.9	6.2	34.2	7.4	8.3	7.1	14.6	10.5	6.9	10.6	19.7	27.6	30.5	8.0	9.1	28.8	13.3	27.4	12.5	8.5	30.1	17.1	15.4	7.7	13.0	24.3	20.0	15.8	13.4	10.9	15.0	3.9	19.4	18.7	13.3	12.9	12.4	14.6	14.5	19.1	12.5	8.1	21.9	11.7	0.4	3.3	2.9	4.0	2.9	5.1	4.3	3.2	4.9	3.1	4.3	4.0	4.4	7.4	4.7	2.8	5.3	1.5	3.5	17.4	17.0	23.6	19.1	14.8	12.8	20.3	19.2	17.2	19.8	56.6	36.8	33.6	18.1	65.3	60.2	31.1	28.1	25.4	28.4	36.6	49.1	31.8	1.7	31.8	14.2	37.2	28.4	0.0	32.5	32.1	42.6	39.3	56.9	53.9	43.0	69.9	45.7	51.0	93.5	7.5	35.6	45.4	38.8	34.3	56.1	31.2	40.3	31.6	39.3	14.5	37.1	51.8	27.2	46.0	55.3	82.4	30.7	41.2	46.0	27.7
ARID5A	"MRF-1, RP11-363D14"	ENSG00000196843	"AT-rich interaction domain 5A"	Q03989	2	96536743-96552638	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Smooth muscle cells: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"HDLM-2: 73.1;RPMI-8226: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA002860, HPA023879"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA002860: , HPA023879: AB_1845014"	"prognostic favorable (2.05e-6)"	"unprognostic (1.08e-3)"	"unprognostic (1.69e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.24e-8)"	"unprognostic (2.74e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.13e-2)"	20.1	4.1	6.8	24.5	8.7	14.6	26.2	3.1	8.8	10.5	14.6	4.9	4.1	7.2	17.5	16.1	9.1	11.5	16.8	17.8	7.0	5.5	5.4	7.2	26.0	29.0	10.7	3.1	11.4	9.8	3.8	6.6	13.0	17.4	14.7	3.7	11.4	8.2	5.1	26.1	7.3	12.3	33.1	13.6	14.9	10.1	5.4	6.2	12.4	8.2	7.7	15.7	19.5	12.0	5.2	12.8	21.4	5.3	17.7	11.5	8.8	0.8	0.3	0.4	1.5	0.8	0.9	2.2	1.4	4.9	1.7	1.5	0.8	0.2	0.2	1.0	0.8	2.6	1.3	0.4	0.0	0.5	73.1	1.1	1.8	0.3	1.7	1.0	1.2	1.4	0.6	1.6	1.4	0.2	1.5	1.5	2.2	1.5	11.1	0.6	0.8	2.4	4.3	0.9	0.4	0.0	3.3	3.0	32.2	0.2	0.7	0.6	0.3	0.1	0.1	1.1	0.4	0.0	2.7	1.4	1.5	1.9	1.7	1.2	6.8	5.3	0.9	0.8	3.0	1.4	7.2	5.3	21.4	11.5	4.8	11.1	4.4	9.7	10.7	7.1	5.2	10.8	10.5	15.3	17.7	3.3	12.8	11.0	8.8	6.8	8.7	3.1	8.8	7.0	5.5	10.7	3.1	17.4	6.2	3.0	28.9	11.8	34.4	46.5	17.4	12.2	5.1	10.7	11.4	3.5	29.5	3.6	3.3	29.9	14.9	43.6	3.2	0.0	27.0	7.0	17.5	22.9	58.0	22.2	62.8	0.0	0.0	22.1	29.8	23.3	3.4	64.4	55.6	95.6	5.4	6.2	24.8	5.3	6.0	5.0	24.7	45.3	294.5	2.7	17.6	28.4	3.3	91.4	2.6	17.8
ARIH2	TRIAD1	ENSG00000177479	"Ariadne RBR E3 ubiquitin protein ligase 2"	O95376	3	48918821-48986382	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067381, HPA069715, HPA070963"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067381: AB_2685827, HPA069715: AB_2686182, HPA070963: AB_2686329"	"unprognostic (7.24e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.01e-2)"	"unprognostic (5.01e-2)"	"prognostic favorable (7.31e-4)"	"unprognostic (5.01e-3)"	"prognostic favorable (6.60e-4)"	"unprognostic (1.15e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.39e-2)"	15.0	16.2	14.1	12.8	20.6	16.0	19.2	22.7	22.5	14.1	18.6	25.4	13.9	10.0	18.7	29.2	14.9	16.2	12.8	38.5	15.8	14.9	14.3	17.2	14.5	17.8	24.7	18.3	18.3	20.5	23.1	19.8	15.3	19.7	16.5	15.5	19.2	13.2	19.5	71.3	11.4	14.4	23.0	18.8	17.5	15.7	27.5	21.4	17.7	18.7	15.2	17.2	16.4	14.1	20.6	21.7	27.6	24.5	15.8	32.6	25.3	14.3	14.5	14.0	19.8	20.7	11.4	19.0	16.9	19.8	21.2	23.5	15.2	12.8	29.3	7.9	18.1	30.8	8.6	28.8	17.3	26.0	19.7	17.5	30.2	19.1	12.4	18.8	22.3	14.6	12.2	26.2	26.4	35.9	12.1	15.9	14.1	23.8	20.1	18.7	9.9	22.5	9.2	23.8	15.5	22.0	8.4	16.0	24.4	12.4	19.4	6.1	16.6	16.6	20.9	16.2	17.3	10.6	15.9	15.1	12.9	18.7	19.2	26.5	26.3	50.8	37.1	14.1	18.7	16.1	27.6	24.5	26.2	32.6	21.6	22.1	19.5	20.9	26.7	21.7	20.6	21.6	27.8	17.2	15.8	13.5	18.7	22.9	25.3	14.1	20.6	22.7	22.5	15.8	14.9	24.7	18.3	19.7	21.4	32.8	22.3	31.1	35.9	45.2	56.4	60.0	30.6	37.5	58.0	27.9	82.5	31.2	24.9	23.6	8.2	33.8	20.3	23.3	37.3	30.6	28.0	46.9	42.9	36.5	23.8	54.0	16.0	35.0	26.4	4.7	38.6	33.2	28.7	41.5	22.9	39.7	33.1	22.9	40.7	25.6	73.6	25.8	35.4	140.0	77.3	47.2	44.6	50.1	26.5	58.6
ARMC10	"MGC3195, SVH"	ENSG00000170632	"Armadillo repeat containing 10"	Q8N2F6	7	103074881-103099764	"Predicted intracellular proteins, Predicted membrane proteins"	"Growth regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011036, HPA011057"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011036: AB_1080139, HPA011057: AB_1080137"	"unprognostic (7.03e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.18e-2)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (8.90e-6)"	"unprognostic (3.85e-3)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (5.57e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.90e-2)"	"prognostic unfavorable (2.49e-6)"	"unprognostic (1.02e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.14e-2)"	"unprognostic (5.67e-2)"	21.6	21.7	28.0	12.6	25.0	9.1	24.5	11.4	28.0	24.4	18.6	24.7	20.8	14.0	20.4	24.2	22.2	23.2	20.0	16.7	26.2	26.2	27.4	30.2	15.0	15.7	26.3	24.2	26.5	28.7	26.0	12.0	15.4	19.7	22.2	18.8	17.6	15.7	23.4	15.8	21.6	12.8	20.3	25.5	14.4	19.8	14.1	19.6	21.5	30.7	15.6	15.7	22.3	20.5	5.1	6.8	6.6	5.4	3.9	4.7	2.2	12.6	10.8	6.4	12.4	13.4	12.8	6.4	8.9	9.7	6.4	7.8	5.8	15.0	22.8	19.3	7.8	18.4	11.4	9.0	9.9	9.2	8.5	10.3	8.0	4.6	2.8	13.5	22.0	9.6	8.3	17.5	8.1	13.3	19.6	14.6	12.9	19.6	14.1	11.4	23.4	16.1	17.1	14.3	21.7	11.7	9.8	6.7	29.6	16.3	8.9	7.2	9.9	12.1	18.3	13.4	11.6	7.4	11.0	9.7	10.0	9.5	23.4	13.3	21.7	33.9	18.3	11.3	20.5	12.4	0.0	4.4	6.6	2.6	5.4	4.5	4.0	4.1	4.4	6.8	5.1	4.6	4.7	0.9	3.9	2.8	5.3	4.2	2.2	28.0	25.0	11.4	28.0	26.2	26.2	26.3	24.2	19.7	19.6	23.8	17.0	26.1	49.5	69.9	22.6	15.4	22.9	6.7	15.9	26.2	13.7	38.2	56.3	15.6	10.1	27.0	15.3	0.0	13.3	39.5	28.9	60.5	17.3	34.7	41.8	7.9	14.5	25.2	32.4	6.3	31.4	31.1	43.9	2.8	33.1	24.5	20.4	10.5	32.2	71.6	26.5	32.3	47.6	11.6	30.8	91.1	37.6	30.5	39.3	65.2
ARMC6	MGC19595	ENSG00000105676	"Armadillo repeat containing 6"	Q6NXE6	19	19033575-19060311	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 54.4"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 51.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041420, HPA041681"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"HPA041420: AB_2677469, HPA041681: AB_10793928"	"unprognostic (2.01e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.43e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-1)"	9.8	10.1	10.3	9.6	11.3	12.9	10.6	13.0	20.1	8.5	10.2	10.2	5.7	8.9	9.5	10.0	10.9	9.2	9.5	11.4	10.7	12.0	10.4	54.4	8.0	12.6	10.1	11.4	10.1	6.7	9.2	11.2	10.3	12.6	10.9	8.2	11.0	12.2	8.1	14.8	9.4	7.9	8.4	8.7	11.1	8.3	17.1	7.2	21.4	16.1	12.3	10.7	8.4	7.5	10.3	19.8	6.3	13.9	20.7	16.4	11.8	21.5	14.7	10.8	13.3	5.2	9.0	14.0	14.0	8.2	23.0	17.1	20.6	19.6	32.9	22.8	11.7	8.4	11.0	25.8	16.6	12.7	6.9	36.3	16.5	13.9	16.5	11.6	29.6	19.3	11.3	15.9	15.6	11.0	5.1	14.5	19.6	28.8	12.7	12.5	26.4	31.1	23.8	25.2	24.6	30.4	25.9	9.8	23.5	11.2	14.6	25.0	10.8	11.2	14.4	11.4	7.7	12.3	18.5	9.4	11.8	10.3	16.7	28.6	9.8	17.3	31.6	9.8	40.0	15.3	6.3	13.3	3.5	16.4	13.9	12.3	10.2	9.2	14.2	19.8	10.3	12.0	13.5	2.8	20.7	10.8	12.7	15.9	11.8	10.3	11.3	13.0	20.1	10.7	12.0	10.1	11.4	12.6	7.2	0.0	5.1	8.2	6.4	6.0	13.4	5.3	10.2	2.7	6.8	12.2	11.8	18.4	6.6	16.1	19.0	6.7	8.4	0.0	9.1	16.5	6.6	9.4	1.1	51.6	18.2	4.8	14.5	8.6	16.1	32.0	9.5	8.6	5.0	18.0	9.8	15.6	9.2	12.7	7.8	10.2	16.2	12.9	5.0	15.6	30.0	8.8	10.9	7.9	14.7	4.2
ARSJ	FLJ23548	ENSG00000180801	"Arylsulfatase family member J"	Q5FYB0	4	113900284-113979727	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Basal glandular cells: 42.2;Glandular cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ: 20.4;HUVEC TERT2: 18.4;LHCN-M2: 18.6;TIME: 23.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 15.4"	"HPA036481, HPA036482"	Uncertain		Enhanced	"Actin filaments"	"Secreted in other tissues"	NA	NA			"Actin filaments"		"HPA036481: AB_2675146, HPA036482: AB_10672356"	"unprognostic (1.98e-1)"	"unprognostic (1.55e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (2.54e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.20e-1)"	"prognostic favorable (2.97e-6)"	"unprognostic (2.26e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-2)"	3.5	2.2	2.6	2.0	2.7	0.0	2.6	10.3	3.4	7.9	4.7	0.9	4.1	1.0	4.8	2.2	9.1	4.6	6.0	5.2	1.5	1.2	9.4	3.4	6.9	3.5	1.8	3.6	4.7	2.6	13.3	1.8	6.7	4.2	7.2	5.4	1.8	9.1	3.9	0.8	1.7	1.7	10.5	2.9	0.5	5.8	0.9	2.0	0.6	1.9	3.6	1.7	7.5	18.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	2.5	0.2	0.0	4.5	9.3	0.0	20.4	15.5	12.8	5.0	0.5	1.4	0.0	2.6	9.6	4.5	2.2	0.1	5.0	16.1	0.0	0.9	0.0	2.0	0.0	13.9	0.0	0.0	5.7	5.1	8.6	17.8	9.0	18.4	0.0	0.0	0.0	18.6	0.1	0.0	0.0	0.6	0.0	3.7	0.0	2.2	0.0	16.8	0.0	0.0	0.7	1.3	0.2	0.9	3.4	0.1	0.0	23.4	14.8	4.0	2.2	9.6	0.0	0.0	0.0	7.2	0.0	4.5	0.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	10.3	3.4	1.5	1.2	1.8	3.6	4.2	2.0	32.8	9.8	0.0	42.2	2.6	0.1	0.9	10.2	4.0	12.5	24.4	0.0	0.3	0.0	7.3	0.0	4.0	0.9	0.0	0.7	0.1	13.6	38.6	0.0	1.3	0.4	1.6	22.5	3.7	0.0	0.0	2.3	0.7	3.3	0.0	16.4	5.2	3.6	2.9	1.4	2.9	0.1	0.0	15.1	0.0	0.2	1.0	0.3	0.5	4.3	22.3
ARVCF		ENSG00000099889	"ARVCF, delta catenin family member"	O00192	22	19969896-20016808	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 30.8"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 21.6;Muller glia cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 15.7;SCLC-21H: 15.0;SH-SY5Y: 11.5;U-2 OS: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016162, HPA055264, HPA063675"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.09e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.00e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.76e-6)"	3.4	6.6	9.0	1.8	6.1	6.0	3.2	30.8	11.1	3.4	3.2	7.7	3.5	2.7	4.2	14.6	3.1	2.6	8.0	6.2	8.1	8.1	5.0	4.9	3.9	1.4	3.8	6.8	2.9	8.7	4.9	7.3	2.7	5.9	6.1	1.1	6.4	8.7	4.6	13.4	5.3	3.7	3.6	4.0	13.4	5.2	5.2	2.8	0.5	12.1	1.6	1.5	2.8	1.8	0.0	0.6	0.0	0.2	0.7	1.2	0.8	3.3	0.3	4.5	5.9	0.0	0.0	4.7	0.8	0.3	0.2	0.5	0.9	0.7	1.4	3.7	0.4	0.4	3.1	0.7	1.4	0.0	0.4	5.6	0.4	0.3	3.5	1.3	0.5	1.1	0.1	0.6	0.2	0.2	0.3	3.7	1.0	15.7	0.4	0.0	3.0	0.2	2.1	4.6	1.0	1.8	8.3	0.2	0.4	0.8	0.7	15.0	11.5	0.9	1.4	2.2	0.8	1.2	0.4	1.3	0.1	13.1	0.5	0.3	1.8	0.5	0.4	0.2	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	1.2	0.0	0.7	0.0	0.6	0.0	0.8	9.0	6.1	30.8	8.9	8.1	8.1	3.8	6.8	5.9	2.8	3.0	1.6	0.0	2.6	1.8	8.5	5.0	5.1	1.4	0.0	1.8	21.6	3.8	0.0	7.0	2.1	1.6	1.2	0.0	4.6	1.7	1.9	4.2	0.0	3.2	1.2	4.8	8.6	4.3	1.0	1.3	3.7	0.9	3.3	0.0	6.2	18.8	9.7	0.0	3.2	5.0	7.6	0.0	3.1	2.2	9.2	1.6	3.7	0.0	1.8	0.9
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894220-118909167	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Erythroid cells: 116.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.8	14.1	21.5	9.1	23.8	7.9	14.4	20.3	17.5	12.9	10.4	12.6	16.1	8.5	12.3	15.6	13.7	12.3	9.0	14.6	18.1	19.2	14.4	13.3	15.0	16.3	21.6	14.9	20.9	10.8	25.7	12.9	9.5	15.2	12.0	12.5	9.1	11.6	15.4	16.6	12.9	11.7	11.6	21.4	15.2	11.8	10.5	14.8	36.9	20.2	14.9	16.4	13.3	12.2	13.4	12.8	12.2	7.9	12.1	30.8	17.6	6.0	3.9	13.8	9.2	11.9	7.0	11.1	8.3	8.3	10.9	12.3	4.8	5.3	10.2	13.7	5.9	9.5	6.7	11.9	10.6	13.9	7.3	11.0	15.0	9.4	30.9	8.3	25.3	7.8	6.1	10.8	9.4	14.4	14.6	14.4	32.7	23.2	27.4	12.8	6.4	29.5	20.0	5.7	9.1	13.5	16.2	5.6	12.7	14.5	7.9	8.9	6.8	8.4	8.5	9.7	4.5	4.9	23.7	12.3	5.1	7.5	7.0	12.7	8.5	14.1	14.9	13.3	20.2	10.9	6.6	6.0	12.2	16.3	6.3	22.7	13.4	26.6	20.9	12.8	8.1	29.1	23.8	1.0	12.1	7.9	9.7	30.8	17.6	21.5	23.8	20.3	17.5	18.1	19.2	21.6	14.9	15.2	14.8	14.9	19.9	35.3	13.8	26.2	15.4	23.4	12.7	24.1	15.9	8.7	3.9	59.8	53.0	28.9	26.4	23.7	8.5	116.8	20.7	67.2	19.7	9.5	22.0	13.9	21.7	23.8	28.4	14.1	16.8	7.8	23.6	19.0	15.1	26.2	10.5	22.6	19.3	10.5	21.9	22.6	12.5	12.9	29.7	26.5	40.0	28.9	39.0	47.3	16.7	11.1
ASMTL		ENSG00000169093	"Acetylserotonin O-methyltransferase like"	O95671	X	1403139-1453762	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Horizontal cells: 87.4;monocytes: 172.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 52.7"					"Low region specificity"	"Detected in all"			"HPA003630, HPA021865"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"HPA003630: AB_1078230, HPA021865: AB_1845099"	"unprognostic (3.89e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-2)"	"unprognostic (7.99e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.17e-2)"	"unprognostic (5.23e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.91e-3)"	"unprognostic (7.24e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.70e-2)"	"unprognostic (8.38e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.20e-1)"	10.4	11.7	28.5	8.9	42.3	9.1	33.6	24.5	38.9	46.4	10.6	3.3	3.3	6.9	52.0	9.2	8.6	11.4	8.2	50.0	29.4	11.4	35.2	15.3	7.0	11.8	25.5	55.3	47.6	13.2	9.9	31.4	27.5	36.7	12.5	4.6	3.3	16.2	16.0	10.0	11.0	8.9	7.5	31.9	11.5	9.0	4.6	25.0	3.3	12.8	3.3	7.2	9.1	31.5	19.8	23.3	34.5	16.4	27.8	16.9	12.3	5.3	9.4	11.2	8.5	6.7	10.5	15.6	6.4	8.4	7.3	9.4	8.5	6.5	9.5	3.6	8.4	7.9	2.0	2.9	3.1	4.6	14.0	9.4	8.1	6.2	10.1	15.4	3.8	52.7	13.9	5.3	5.6	5.4	8.2	8.6	7.4	4.1	7.7	5.8	20.1	16.4	15.1	13.5	5.0	5.8	13.4	10.6	23.0	5.1	2.9	0.4	5.3	8.6	11.1	7.9	8.0	2.5	5.2	11.2	6.1	6.7	11.5	2.3	9.9	3.0	24.1	7.8	5.6	1.8	20.1	14.2	34.5	16.9	16.4	14.8	13.8	15.3	15.6	12.1	19.8	13.5	10.6	20.4	27.8	11.5	23.3	16.5	12.3	28.5	42.3	24.5	38.9	29.4	11.4	25.5	55.3	36.7	25.0	11.9	6.5	18.6	21.6	16.4	16.6	16.5	2.5	10.7	6.8	14.0	3.9	28.3	23.2	11.7	0.8	17.9	15.9	0.0	14.8	22.3	23.9	19.4	54.2	24.6	17.5	87.4	13.8	14.1	11.0	1.5	24.2	15.1	11.8	172.3	16.9	15.3	11.0	17.3	40.7	25.8	9.4	32.3	24.5	2.3	7.9	13.7	55.5	20.2	17.0	16.6
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		52000	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.6	27.8	14.9	32.1	29.7	18.3	18.4	17.5	24.2	34.0	26.8	21.7	16.8	15.5	27.4	22.7	39.0	18.1	20.6	23.4	16.3	23.8	32.3	13.4	21.0	24.6	31.8	19.8	26.1	21.1	20.6	27.4	16.3	22.0	24.0	18.4	16.6	21.1	26.5	75.3	26.1	15.9	37.7	21.7	52.4	19.4	23.2	30.3	31.7	28.8	27.7	23.5	23.7	31.9	28.0	13.3	26.3	19.1	20.4	48.1	16.3	53.2	40.6	38.0	63.9	14.3	33.7	32.4	26.4	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5	3.0	6.5	44.7	52.5	61.4	33.5	7.4	66.2	9.4	5.7	52.4	15.7	89.1	112.7	135.7	88.0	42.9	87.6	46.7	116.1	66.8	58.1	46.3	34.5	24.5	125.2	27.0	53.9	36.8	50.0	143.9	44.5	54.1	77.6	138.9	56.6	59.9	93.6	94.7	53.0	177.7	23.1	32.3	54.5	52.9	128.0	69.5	92.6	59.8	57.4	54.0
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97852118-97872542	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 68.0"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 197.3;Erythroid cells: 93.5;Late spermatids: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"B-cells: 8.6;T-cells: 13.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA004924: AB_2667295, HPA029318: AB_10602389, HPA064737: AB_2685341"	"unprognostic (3.93e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.79e-5)"	"prognostic unfavorable (9.42e-6)"	"unprognostic (2.28e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-3)"	"prognostic unfavorable (6.21e-7)"	"unprognostic (5.33e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.33e-1)"	6.5	7.5	15.9	10.9	21.4	7.6	9.9	31.7	32.3	5.7	10.1	9.4	5.6	6.5	10.0	19.9	10.2	6.9	6.8	9.2	24.5	20.4	6.5	5.9	9.6	16.0	16.3	13.4	19.2	68.0	16.7	16.7	3.2	35.9	9.2	12.7	4.4	49.9	9.3	3.5	13.6	7.8	11.3	20.6	11.0	20.8	16.9	9.2	3.6	16.7	8.2	15.0	9.6	6.6	8.6	1.4	1.5	1.2	2.2	13.2	3.2	19.0	7.3	7.4	60.1	5.9	8.3	18.1	14.1	9.0	6.7	20.2	9.4	7.6	15.0	7.1	28.7	14.0	8.7	19.1	22.3	16.1	18.7	14.1	4.8	3.7	7.0	54.3	30.6	13.5	16.3	75.0	8.8	54.5	3.6	5.5	14.1	26.8	53.3	10.6	40.3	0.9	8.1	10.1	45.6	20.0	2.3	1.4	39.3	4.3	3.7	32.3	24.3	3.6	19.6	76.0	9.9	8.3	21.5	1.4	3.3	22.1	8.8	6.6	63.1	31.5	57.1	41.8	13.9	32.1	1.5	0.3	0.5	3.8	1.2	4.9	8.6	7.4	3.4	1.4	6.2	10.2	5.5	1.5	2.2	0.8	0.1	13.2	3.2	15.9	21.4	31.7	32.3	24.5	20.4	16.3	13.4	35.9	9.2	8.9	4.5	3.7	18.8	11.0	20.1	5.9	12.7	1.4	3.4	8.7	23.6	2.0	6.6	34.4	197.3	3.1	1.7	93.5	52.9	7.7	6.6	17.6	8.1	1.6	1.0	23.8	23.4	2.5	0.6	147.0	8.9	1.8	8.5	11.8	12.9	8.5	38.4	11.9	8.9	3.1	25.4	6.5	12.3	2.3	7.0	9.5	4.7	13.3	7.9	15.2
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ASXL2	"ASXH2, FLJ10898, KIAA1685"	ENSG00000143970	"Additional sex combs like 2, transcriptional regulator"	Q76L83	2	25733753-25878516	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034646, HPA058040"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034646: AB_2674261, HPA058040: AB_2683586"	"unprognostic (4.78e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.88e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.68e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.75e-2)"	15.0	14.9	14.5	14.1	16.5	10.4	13.1	23.0	16.1	14.4	13.9	15.7	13.0	9.8	14.7	9.9	17.5	12.1	10.0	14.2	15.2	8.9	14.7	10.2	13.1	15.3	14.3	8.5	11.4	12.1	28.0	17.4	17.4	13.9	10.5	14.2	12.6	15.3	14.1	20.5	14.2	12.9	13.3	12.3	15.4	12.1	20.7	18.0	26.2	16.5	10.7	17.0	16.7	13.5	3.0	3.7	4.7	2.7	1.8	4.5	1.3	15.7	9.5	7.3	5.2	7.3	10.3	9.4	8.7	13.6	8.5	7.7	10.5	8.6	9.8	5.1	9.8	10.0	9.8	14.4	10.6	12.3	9.8	6.6	17.4	8.5	11.5	6.2	19.2	17.4	5.1	11.1	13.0	10.3	7.6	10.9	6.2	15.1	7.9	9.0	6.4	9.0	6.4	10.3	9.2	6.7	10.1	25.0	7.9	7.9	10.7	8.0	9.0	10.5	10.0	8.8	7.5	5.6	8.2	14.4	12.1	13.8	10.4	12.5	16.1	15.8	20.5	11.3	16.2	8.6	2.1	2.4	3.7	4.5	2.7	3.6	2.7	3.5	3.9	2.3	3.0	3.0	3.6	4.7	1.8	2.4	3.7	2.5	1.3	14.5	16.5	23.0	16.1	15.2	8.9	14.3	8.5	13.9	18.0	23.8	17.9	16.0	8.0	28.7	21.5	25.8	10.2	38.8	15.9	8.7	23.6	9.0	13.3	13.9	36.9	22.2	10.5	0.0	12.4	7.4	14.5	11.0	23.1	13.9	16.0	23.8	9.9	26.4	25.3	19.7	18.1	21.6	21.9	15.4	16.7	13.6	14.9	14.0	12.4	12.9	24.1	38.8	11.0	30.5	24.7	35.9	12.2	28.8	15.6	13.8
ATAD2	"ANCCA, CT137, DKFZp667N1320, MGC29843, MGC5254, PRO2000"	ENSG00000156802	"ATPase family, AAA domain containing 2"	Q6PL18	8	123319850-123416350	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 53.8"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 74.6;Spermatogonia: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 75.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029424, CAB056158"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB056158: AB_2665580, HPA029424: AB_10611680"	"unprognostic (1.56e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.08e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.02e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (8.33e-15)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-1)"	"unprognostic (4.84e-2)"	"unprognostic (6.17e-2)"	4.1	4.9	4.6	12.6	9.2	22.8	7.2	5.6	6.9	14.0	8.6	1.5	13.4	5.3	4.7	5.0	10.7	4.7	3.5	13.7	4.2	6.3	2.2	10.1	9.8	13.7	4.0	4.3	9.9	3.9	3.5	18.7	5.2	4.0	11.4	7.5	2.4	6.8	15.4	13.8	7.2	6.6	5.5	4.1	8.8	6.9	20.2	3.4	53.8	4.8	6.3	12.7	9.9	5.9	4.3	2.3	7.2	2.8	4.0	7.4	1.8	25.5	9.9	14.2	4.8	2.5	3.2	6.2	20.0	6.9	17.3	19.3	7.5	11.1	16.7	6.1	6.3	6.8	12.2	18.9	6.4	27.8	23.2	10.1	30.0	10.7	15.2	1.0	10.9	14.9	1.0	1.0	16.4	5.4	3.7	5.2	9.8	14.0	17.0	12.8	26.4	31.4	8.2	2.5	19.3	9.9	16.4	16.9	9.0	6.1	11.7	18.2	7.9	29.0	75.6	5.1	6.0	15.4	10.4	3.2	13.1	18.1	10.3	24.0	5.5	9.8	15.5	8.6	18.4	10.2	7.2	1.5	5.4	2.9	1.3	4.0	4.3	4.2	4.8	2.3	2.8	2.8	3.0	0.4	4.0	2.8	0.3	7.4	1.8	4.6	9.2	5.6	6.9	4.2	6.3	4.0	4.3	4.0	3.4	6.0	8.3	14.2	19.9	14.1	2.5	22.9	2.5	5.3	11.4	3.5	3.9	8.2	1.7	2.4	46.2	6.7	2.2	23.3	1.9	21.2	7.3	19.9	13.9	14.0	9.7	1.6	1.2	9.2	11.1	17.9	6.9	6.6	1.7	5.4	4.4	5.2	2.7	3.5	13.1	0.9	2.1	0.0	8.6	74.6	90.7	10.7	11.3	15.3	12.8	24.8
ATAD3A	FLJ10709	ENSG00000197785	"ATPase family, AAA domain containing 3A"	Q9NVI7	1	1512151-1534687	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (8.42e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (6.62e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.87e-3)"	10.8	13.9	11.2	16.3	11.3	25.0	9.3	9.3	14.8	9.2	11.0	11.1	12.5	16.4	10.4	7.6	16.8	9.3	11.9	15.9	9.2	8.2	12.9	26.7	9.7	13.9	10.5	13.3	8.5	20.4	8.1	16.6	11.3	8.3	10.7	6.2	9.6	19.5	9.5	31.1	13.3	12.2	8.9	8.5	12.4	13.0	12.7	9.1	14.0	12.4	21.1	14.3	9.3	9.4	3.3	4.7	1.3	6.2	5.1	4.0	2.1	21.1	11.9	5.3	13.5	2.7	3.2	12.6	17.5	5.2	15.5	9.4	30.5	14.6	11.7	12.1	6.9	5.7	18.1	7.4	10.3	2.6	11.2	32.0	20.4	29.3	20.4	5.1	29.3	13.1	3.7	3.4	12.5	5.2	2.0	6.7	12.9	31.8	9.0	5.5	14.9	22.0	26.8	10.8	7.1	25.6	24.0	10.0	24.2	4.2	8.9	26.7	10.5	10.8	16.5	13.7	1.9	7.2	14.5	9.1	15.8	12.3	24.1	21.3	13.5	13.2	47.1	15.4	44.0	7.0	0.2	4.0	1.3	3.3	2.9	2.5	3.3	3.8	4.0	4.7	3.0	3.4	1.5	0.1	5.1	6.2	4.4	2.8	2.1	11.2	11.3	9.3	14.8	9.2	8.2	10.5	13.3	8.3	9.1	3.0	7.0	11.9	8.0	18.1	10.3	9.5	7.6	1.4	4.5	7.0	5.9	16.8	6.6	21.0	7.6	11.1	10.0	0.0	18.2	36.3	8.9	11.6	9.2	13.1	19.8	22.3	13.2	4.3	5.0	8.2	5.2	7.7	15.1	5.4	13.0	10.2	20.6	5.8	7.4	9.7	9.0	0.0	10.3	5.4	25.6	21.2	16.5	5.3	20.7	12.2
ATAD3B	"KIAA1273, TOB3"	ENSG00000160072	"ATPase family, AAA domain containing 3B"	Q5T9A4	1	1471769-1497848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 3.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA058968, HPA064867, HPA065305"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058968: AB_2683864, HPA064867: AB_2685375, HPA065305: AB_2685459"	"unprognostic (6.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.68e-1)"	"prognostic unfavorable (1.81e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.48e-9)"	"unprognostic (2.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.68e-1)"	13.7	7.6	7.5	18.9	9.5	24.3	10.4	11.6	10.8	7.4	9.6	8.7	8.2	12.1	10.0	7.0	11.3	8.1	8.4	6.4	7.5	6.5	9.9	14.5	9.8	17.3	9.5	8.1	10.1	16.5	3.2	13.6	10.3	7.6	11.0	3.8	8.8	16.3	16.5	9.9	15.8	12.3	8.8	6.8	14.5	15.4	9.3	8.2	7.9	9.3	6.6	13.1	5.9	10.0	0.3	0.8	1.4	3.7	0.2	2.0	0.5	6.9	0.0	2.1	11.6	0.6	0.9	15.9	11.2	2.6	11.0	8.4	25.7	20.5	9.8	3.5	4.3	6.6	12.8	14.1	7.0	2.3	8.3	13.3	6.8	16.8	15.7	2.6	11.3	8.0	2.5	0.4	18.1	1.1	0.2	3.8	3.2	20.2	2.2	4.0	3.5	13.4	13.2	22.6	4.6	25.7	10.8	3.4	7.1	3.2	4.6	8.9	7.2	8.3	10.7	9.5	1.4	1.6	4.0	4.7	3.0	6.4	17.4	11.8	6.4	8.8	23.8	9.5	18.8	3.3	0.0	0.7	1.4	1.6	3.7	2.0	0.3	1.0	1.4	0.8	0.0	0.3	0.1	0.0	0.2	1.9	0.5	0.0	0.5	7.5	9.5	11.6	10.8	7.5	6.5	9.5	8.1	7.6	8.2	6.0	26.1	12.0	6.7	23.4	14.1	4.0	10.2	1.4	7.9	8.7	19.6	10.1	1.7	7.4	3.2	6.8	8.4	0.0	6.5	33.5	8.1	6.7	11.5	7.6	10.8	12.7	6.9	4.9	2.8	1.8	4.0	6.3	10.1	3.6	9.1	7.8	9.4	8.0	2.8	1.7	15.6	6.5	8.2	5.1	9.6	20.6	14.9	8.4	10.6	10.2
ATF1	TREB36	ENSG00000123268	"Activating transcription factor 1"	P18846	12	50763710-50821122	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016222, HPA055069, HPA055406"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016222: AB_2290030, HPA055069: AB_2682688, HPA055406: AB_2682807"	"unprognostic (1.71e-1)"	"unprognostic (1.50e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (3.65e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.94e-2)"	"unprognostic (4.31e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.27e-1)"	"unprognostic (8.75e-2)"	24.4	20.7	9.8	13.7	9.5	10.2	16.2	28.1	10.6	22.4	19.7	8.1	14.6	12.3	19.2	14.2	16.2	15.5	13.4	20.0	10.8	8.0	17.7	19.8	15.1	15.8	12.2	6.0	24.7	11.8	18.1	15.2	36.1	11.9	20.7	15.1	12.5	16.3	14.2	37.9	12.9	18.8	13.4	12.3	22.9	12.7	9.3	13.9	34.4	30.8	16.3	16.2	21.6	20.0	13.3	13.6	26.3	12.3	12.2	18.8	11.6	13.5	9.8	10.4	10.6	15.0	16.0	25.9	14.4	24.8	22.8	18.0	20.1	21.5	18.7	23.8	16.6	10.0	11.3	12.3	14.8	24.4	18.4	12.7	20.6	22.2	10.7	28.8	29.6	19.8	17.0	23.5	16.3	26.8	23.8	11.0	13.2	25.1	18.1	16.9	20.1	18.6	18.8	15.1	15.7	15.7	17.9	16.2	22.1	17.3	9.3	14.0	7.6	30.5	13.3	21.7	14.9	18.5	18.1	7.6	16.1	19.5	13.5	11.4	10.0	11.8	29.9	15.5	16.7	7.6	4.2	11.5	26.3	13.9	12.3	15.8	13.0	15.1	16.4	13.6	13.3	18.8	14.3	7.3	12.2	7.7	6.2	17.9	11.6	9.8	9.5	28.1	10.6	10.8	8.0	12.2	6.0	11.9	13.9	50.6	14.4	34.4	42.6	66.9	12.0	12.9	10.2	18.7	23.9	12.2	0.0	27.2	44.7	20.3	6.5	18.6	17.3	70.0	18.5	60.0	36.0	33.7	9.3	15.7	24.6	12.7	5.8	15.4	21.9	4.9	29.7	29.4	21.9	18.0	13.9	12.9	18.2	14.0	26.2	25.4	6.9	38.8	32.0	9.3	10.2	47.7	67.4	30.9	21.2	30.7
ATF2	"CRE-BP1, CREB2, HB16, TREB7"	ENSG00000115966	"Activating transcription factor 2"	P15336	2	175072250-175168382	"Enzymes, Predicted intracellular proteins, Transcription factors"	"DNA damage, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 100.8;Late spermatids: 111.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003769, HPA022134"	Supported	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003769: AB_562241, HPA022134: AB_1845138"	"unprognostic (1.11e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (7.08e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.70e-2)"	"unprognostic (6.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.02e-2)"	"unprognostic (4.40e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.21e-3)"	"unprognostic (6.70e-2)"	25.3	21.0	25.3	14.3	29.3	14.3	19.7	39.6	33.4	27.5	15.9	18.0	15.7	12.8	22.4	22.6	16.0	19.5	17.9	14.1	25.1	28.0	23.0	26.8	15.2	17.6	23.2	18.4	27.3	19.0	24.0	33.0	19.9	29.6	19.0	16.0	14.9	16.8	19.1	13.9	10.1	13.2	18.3	22.9	17.5	13.8	19.9	18.9	34.6	32.6	10.2	20.1	21.7	16.7	15.0	18.7	24.2	14.8	15.3	22.0	14.3	7.3	6.5	19.4	12.5	17.3	18.5	8.9	12.1	20.8	14.7	21.4	14.0	13.8	11.1	13.3	14.2	17.4	7.2	14.7	7.4	23.1	13.8	8.5	15.7	11.9	30.5	19.4	14.5	16.5	13.8	16.5	18.9	22.6	19.5	20.2	10.5	12.7	17.4	16.4	5.6	23.4	18.1	18.0	12.6	14.8	20.4	8.9	17.2	21.5	6.5	16.1	13.3	15.2	4.7	17.8	16.3	10.5	16.2	12.7	17.2	9.0	9.1	7.2	16.6	25.0	14.2	13.5	13.9	11.6	24.2	14.4	16.8	18.2	12.8	22.0	15.0	15.7	18.8	18.7	12.7	18.3	19.9	9.3	15.3	14.8	10.5	19.8	14.3	25.3	29.3	39.6	33.4	25.1	28.0	23.2	18.4	29.6	18.9	14.9	10.4	18.4	14.2	29.3	20.8	18.7	20.4	21.4	14.8	22.7	9.8	11.7	11.6	12.1	100.8	23.3	13.2	0.0	6.1	9.9	28.8	16.7	28.9	24.6	16.4	38.1	15.6	18.4	26.8	111.2	30.2	20.4	28.7	10.0	14.8	24.9	12.5	8.6	26.9	14.9	24.6	12.9	38.1	32.4	11.7	22.1	5.3	24.5	13.6	9.5
ATF7IP	"FLJ10688, p621"	ENSG00000171681	"Activating transcription factor 7 interacting protein"	Q6VMQ6	12	14365632-14502935	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016578, HPA023505"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA016578: AB_1845147, HPA023505: AB_1845148"	"unprognostic (2.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.48e-2)"	"unprognostic (5.84e-2)"	"unprognostic (8.56e-3)"	"unprognostic (7.36e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.88e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	17.5	15.0	11.1	36.4	15.3	25.2	16.6	29.4	12.7	18.0	12.9	14.1	16.0	7.3	16.1	14.5	20.2	13.0	15.2	18.3	11.7	8.3	11.3	14.0	16.2	25.2	13.8	10.7	19.5	13.0	23.3	23.3	22.4	11.9	15.7	12.3	14.4	21.7	18.0	25.4	15.6	16.6	15.4	12.3	23.9	12.5	30.1	13.6	38.8	20.2	12.6	24.5	17.2	27.3	25.0	9.9	15.9	9.7	8.6	13.4	6.6	10.9	6.5	27.1	15.7	14.3	18.3	5.9	11.5	6.7	9.3	14.4	15.0	11.8	18.3	8.1	8.1	17.1	11.1	16.8	10.9	21.2	13.1	9.8	12.3	11.2	3.2	8.4	8.3	7.3	9.8	9.1	11.5	12.0	14.8	20.3	6.7	7.2	10.0	14.7	10.4	11.9	7.3	17.3	5.7	6.2	24.9	29.9	9.9	8.1	21.6	8.7	7.2	13.5	7.9	7.6	23.0	8.0	9.8	9.3	13.2	8.5	7.5	9.8	6.5	6.3	26.0	8.4	7.9	14.1	15.9	8.1	13.6	12.9	6.3	13.4	16.9	11.0	12.5	7.2	25.0	8.9	12.2	13.5	8.6	9.7	9.9	13.4	6.6	11.1	15.3	29.4	12.7	11.7	8.3	13.8	10.7	11.9	13.6	62.5	34.4	42.4	10.8	6.0	51.5	58.1	15.3	32.1	38.7	33.2	64.8	13.8	6.6	13.0	53.7	33.7	9.3	23.3	10.6	7.7	14.3	12.4	24.4	25.9	17.2	60.4	27.0	27.6	42.9	13.3	27.0	26.9	5.0	26.2	21.6	26.7	13.6	10.5	27.6	14.0	38.8	12.9	11.3	42.6	23.5	5.8	12.9	45.7	19.5	9.1
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.4	1.3	4.1	3.2	4.9	4.0	2.6	3.2	3.2	1.6	2.5	1.6	3.5	9.6	2.1	4.1	2.9	2.9	0.5	10.8	2.8	7.6	1.6	7.5	6.9	2.7	3.6	9.8	31.3	3.9	1.5	3.6	4.5	17.9	4.9	17.6	1.0	13.2	1.8	4.7	11.3	16.9	0.6	6.4	1.5	5.6	2.9	4.2	5.3	4.9	3.1	2.4	1.3	7.2	3.0	3.4	3.6	13.5	6.8	4.4	1.6	7.9	2.5	6.0	1.5	4.2	1.9	8.8	2.4	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3	6.0	18.4	16.7	5.1	14.8	2.6	4.4	5.1	6.7	3.4	5.2	2.0	6.8	0.0	3.7	0.5	7.9	8.0	0.0	0.9	3.1	5.6	2.8	23.0	2.9	15.2	4.8	12.6	12.9	45.9	0.4	9.5	38.5	3.3	16.2	9.0	4.0	2.3	43.6	7.4	1.6	3.7	0.0	6.6	1.6	7.7	15.2	10.3	23.5	10.4	4.2
ATG2B	"C14orf103, FLJ10242"	ENSG00000066739	"Autophagy related 2B"	Q96BY7	14	96279202-96363870	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000880, HPA001427, HPA019665"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.45e-2)"	"unprognostic (7.60e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.49e-2)"	3.6	3.4	2.6	2.5	4.1	4.4	5.2	9.2	4.5	3.9	3.2			3.1	4.9	4.4	2.9	4.0	3.0	2.7	3.2	3.3	4.5	6.0	3.4	3.1	3.0		5.1	8.1	9.7	4.1	2.7		4.0	3.2		3.1	3.1	5.2	9.3	4.3	3.8	2.7	3.9	3.6	6.5			4.9		3.5	3.3	3.6	1.5	1.6	2.1	1.0	2.5	3.0	0.7	4.1	5.2	6.5	5.1	11.3	10.5	5.2	6.1	8.7	6.7	7.6	2.8	2.8	9.2	5.8	9.9	4.5	5.7	8.8	6.0	10.8	8.5	4.5	4.0	5.7	2.5	7.4	7.3	4.4	8.8	6.1	9.0	7.2	7.1	8.4	7.0	4.6	8.3	5.3	6.6	6.6	6.3	3.1	4.8	5.4	6.1	14.6	6.2	7.5	5.1	6.4	7.2	9.2	3.8	4.4	7.0	6.0	4.2	11.2	3.7	1.7	9.0	3.9	8.4	6.9	8.6	7.6	5.1	3.6	0.6	1.0	1.7	1.6	0.6	3.0	1.5	1.8	1.7	1.3	1.5	1.9	2.0	2.1	2.5	1.0	1.6	2.7	0.7											11.9	10.5	7.5	2.8	12.2	24.5	11.2	7.6	2.7	6.8	8.7	25.5	4.4	3.3	5.2	31.1	9.8	8.2	0.0	5.2	2.7	7.8	11.1	6.9	23.2	3.6	30.2	7.9	13.5	10.5	36.0	11.8	8.9	1.7	3.6	11.8	8.5	4.9	10.5	9.9	6.8	19.0	6.5	8.5	15.6	13.8	24.6	13.2	6.5	8.7	3.1
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 242.0;Late spermatids: 574.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		1600000	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	40.3	17.7	7.9	11.8	10.4	8.2	28.3	5.6	7.4	20.9	15.0	12.4	14.0	6.7	22.5	15.7	23.4	14.5	15.1	9.7	7.0	5.0	15.0	23.6	15.9	24.7	10.9	5.4	22.3	18.4	12.9	8.8	11.8	9.8	17.9	11.7	14.0	17.5	15.4	7.6	20.3	11.0	35.6	12.8	12.0	14.1	43.3	10.7	11.0	18.9	14.2	13.0	32.2	22.3	6.2	9.6	6.6	13.7	7.4	11.8	8.1	13.3	12.9	3.6	8.9	19.3	26.3	0.0	15.9	18.9	16.0	11.0	10.3	21.0	7.8	16.5	27.4	12.3	8.6	6.8	10.7	23.1	11.6	1.8	7.9	14.5	0.0	12.7	15.6	12.0	16.7	18.0	20.5	13.4	10.7	17.2	9.1	8.8	21.9	18.5	14.5	5.7	9.8	4.6	4.4	10.2	12.3	9.1	11.7	13.3	9.6	2.0	5.5	47.6	11.4	15.3	5.0	21.0	6.0	23.7	33.7	16.1	32.9	11.1	6.2	8.5	15.8	18.1	10.5	20.4	6.6	9.1	4.0	10.8	12.4	11.8	6.2	9.0	8.7	9.6	5.2	7.5	10.1	3.9	7.4	13.7	4.8	9.9	8.1	7.9	10.4	5.6	7.4	7.0	5.0	10.9	5.4	9.8	10.7	41.7	22.7	18.0	39.1	38.8	4.3	7.8	30.6	13.4	21.6	31.4	0.0	5.8	1.7	37.0	242.0	45.4	28.8	23.3	43.5	16.5	29.6	47.3	16.2	46.1	35.2	4.8	10.3	47.9	54.0	574.9	50.3	34.8	40.5	40.5	18.4	12.4	59.3	22.9	63.3	18.2	7.0	71.1	60.4	25.8	27.3	35.5	3.3	23.5	15.9	44.8
ATM	"ATA, ATC, ATD, ATDC, TEL1, TELO1"	ENSG00000149311	"ATM serine/threonine kinase"	Q13315	11	108222484-108369102	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, Neurodegeneration, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 196.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 48.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000102, HPA067142"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB000102: , HPA067142: AB_2685789"	"unprognostic (9.77e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.36e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.68e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-1)"	8.3	10.9	12.7	26.5	19.3	16.8	9.4	17.7	14.4	10.9	8.5	10.9	8.8	6.0	11.2	11.4	6.9	9.5	9.2	9.6	12.4	8.5	7.7	9.5	10.1	33.4	19.6	6.7	20.5	20.7	15.7	29.2	8.8	14.5	9.1	7.9	7.2	15.1	9.8	6.2	8.4	16.5	10.6	23.4	22.6	8.9	6.1	17.9	19.5	10.7	5.1	26.9	10.7	10.7	13.7	6.1	13.5	12.5	7.6	18.5	4.4	2.7	3.9	7.7	4.1	10.0	14.6	2.0	6.1	6.8	3.5	5.9	4.8	6.5	9.6	9.1	4.9	5.6	4.1	5.8	5.1	5.5	7.7	3.4	8.7	4.8	4.8	5.3	10.5	9.4	9.4	3.2	5.4	10.4	7.7	7.4	8.2	8.4	6.6	6.9	2.0	7.1	9.7	6.3	4.1	3.9	5.6	5.3	15.1	4.0	5.5	5.2	6.4	7.1	3.3	10.5	7.1	5.0	5.9	11.5	8.8	4.9	5.0	5.7	4.4	4.6	48.5	5.8	11.5	9.8	13.5	5.7	3.8	14.9	5.3	10.4	11.1	10.5	11.3	2.7	13.7	18.5	17.9	10.8	7.6	12.5	6.1	5.3	4.4	12.7	19.3	17.7	14.4	12.4	8.5	19.6	6.7	14.5	17.9	35.7	21.0	122.7	17.4	11.2	101.7	35.4	10.2	13.4	19.4	21.0	198.3	14.8	5.0	7.7	12.8	18.8	4.9	0.0	10.6	10.5	26.4	9.5	12.7	21.2	26.0	57.2	19.5	36.8	82.2	2.7	36.5	48.1	25.3	9.0	15.9	35.9	7.6	10.5	26.2	10.3	196.6	25.8	17.3	18.7	33.6	10.8	3.5	111.7	11.7	9.9
ATN1	"B37, D12S755E, DRPLA"	ENSG00000111676	"Atrophin 1"	P54259	12	6924463-6942321	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA031619	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031619: AB_10601667"	"unprognostic (3.86e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.80e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (1.44e-1)"	"unprognostic (6.90e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (7.35e-2)"	37.6	38.6	34.6	20.1	28.1	4.3	25.9	57.5	45.5	33.7	30.5	27.0	38.3	22.8	35.7	17.2	21.2	34.7	28.0	25.6	32.8	22.4	21.6	8.8	26.3	11.9	24.4	33.8	72.0	28.7	37.4	43.8	27.6	29.2	28.9	14.2	29.2	44.0	40.9	26.5	28.3	20.5	33.4	29.5	19.3	22.3	8.8	29.4	2.3	42.0	7.3	9.1	30.0	57.6	2.6	2.1	2.5	0.5	0.5	2.5	0.7	15.5	20.3	22.0	44.2	20.8	18.8	36.7	18.6	16.0	19.1	13.6	20.5	18.6	4.2	5.9	22.9	15.7	10.4	13.4	18.2	10.1	49.4	13.3	19.8	18.8	9.7	32.2	4.0	30.2	30.4	13.4	23.9	18.8	33.0	18.7	6.4	16.7	8.6	16.9	22.3	8.7	3.7	45.0	7.2	8.6	18.2	11.9	3.1	14.0	22.0	6.8	21.9	19.0	22.2	13.3	22.5	8.4	11.2	24.2	22.5	29.0	17.7	28.4	6.6	2.2	2.9	17.5	5.2	23.5	1.9	0.5	2.5	2.5	0.3	2.2	2.6	1.1	1.4	0.6	2.3	1.4	1.9	0.0	0.5	0.1	2.1	1.2	0.7	34.6	28.1	57.5	45.5	32.8	22.4	24.4	33.8	29.2	29.4	14.9	18.8	2.4	11.1	26.9	27.8	12.2	15.3	10.7	21.6	27.9	17.7	23.4	13.3	16.4	1.7	28.0	25.9	0.0	26.2	12.8	25.2	15.6	9.3	7.2	10.2	23.8	20.8	27.6	11.9	2.6	59.0	9.4	20.3	7.2	23.5	15.7	23.6	19.8	49.5	9.9	25.4	19.4	22.1	5.8	7.1	21.8	31.0	7.2	18.8	15.2
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	14.0	7.2	9.1	10.7	4.6	6.3	16.2	6.7	3.9	5.7	4.7	22.6	16.3	7.1	8.2	5.6	7.4	12.0	8.2	5.5	5.6	7.1	7.7	8.2	6.0	11.7	7.3	15.3	13.4	4.2	4.3	6.9	4.2	4.6	15.0	6.5	5.6	1.2	4.0	5.3	6.9	9.7	3.9	16.1	5.1	6.1	3.7	4.0	31.3	3.3	14.6	4.0	6.5	8.5	5.6	12.4	3.2	20.5	9.8	0.0	12.5	7.4	5.0	3.9	7.5	3.0	2.5	14.5	6.3	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2	202.5	171.3	5.6	2.8	9.6	29.4	38.0	35.7	16.0	45.5	15.7	221.9	0.6	5.0	31.2	0.7	19.8	4.2	0.0	10.0	26.5	10.6	5.3	11.5	13.2	17.6	12.7	11.5	24.5	33.5	1.4	10.3	21.3	10.1	7.2	3.3	10.4	18.9	5.8	4.6	15.8	44.2	0.0	5.1	3.9	9.0	8.4	7.2	5.7	5.2	3.7
ATP23	"KUB3, XRCC6BP1"	ENSG00000166896	"ATP23 metallopeptidase and ATP synthase assembly factor homolog"	Q9Y6H3	12	57941541-57957269	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 39.5"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 11.7;Distal tubular cells: 14.9;Extravillous trophoblasts: 11.6;granulocytes: 10.5;Hofbauer cells: 9.7;Proximal tubular cells: 18.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 15.2;RH-30: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035804, HPA043204"	Uncertain		Enhanced	"Vesicles,Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Cell Junctions, Cytosol"	"HPA035804: AB_10601026, HPA043204: AB_2678361"	"unprognostic (2.56e-1)"	"unprognostic (1.31e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.30e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.28e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-1)"	6.7	4.9	4.3	5.2	5.3	11.3	4.8	6.1	4.8	5.6	8.2	1.3	2.5	3.9	3.2	4.2	7.3	3.1	2.4	6.4	4.2	3.6	5.4	6.2	2.7	6.8	2.7	3.8	4.2	5.8	3.2	3.0	3.5	2.9	5.1	8.2	2.3	3.4	3.3	11.7	5.6	4.3	6.5	3.4	3.7	3.8	39.5	2.0	20.8	4.7	5.9	4.7	6.3	6.2	3.0	4.5	12.0	4.5	2.6	5.6	3.0	2.0	1.5	1.9	2.2	2.8	2.7	1.0	1.9	2.0	2.2	2.1	1.2	2.5	6.9	2.5	1.5	2.2	1.9	1.8	2.0	3.8	3.5	1.8	4.5	1.3	2.0	1.2	9.1	3.1	1.4	1.5	1.3	0.6	2.2	1.5	5.0	4.7	5.0	1.8	3.1	4.9	15.2	1.7	3.4	3.7	3.2	49.9	2.9	1.8	2.6	1.2	1.8	3.1	2.9	1.6	0.9	5.0	8.6	0.8	1.7	2.9	2.2	1.9	4.1	2.1	3.6	1.8	9.8	2.7	7.6	4.5	12.0	3.5	2.4	2.6	3.0	4.0	3.3	4.5	3.0	4.3	4.0	1.9	2.6	4.2	2.1	5.6	3.0	4.3	5.3	6.1	4.8	4.2	3.6	2.7	3.8	2.9	2.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	3.5	0.0	11.7	14.9	5.1	0.0	0.0	0.0	0.0	9.4	11.6	0.0	0.0	10.5	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.8	0.0	0.0	4.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
ATP5F1B	"ATP5B, ATPSB"	ENSG00000110955	"ATP synthase F1 subunit beta"	P06576	12	56638175-56646068	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"ATP synthesis, Hydrogen ion transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 693.2;Distal tubular cells: 1049.5;Proximal tubular cells: 698.1;Syncytiotrophoblasts: 952.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001520, HPA001528, CAB017527"	Enhanced		Enhanced	Mitochondria		NA	NA		100000000	Mitochondria		"CAB017527: AB_1121153, HPA001520: AB_1078243, HPA001528: AB_1078242"	"prognostic unfavorable (7.17e-6)"	"unprognostic (5.69e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.92e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.11e-2)"	"prognostic favorable (1.43e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.30e-2)"	41.3	66.2	32.4	34.1	53.4	39.3	33.1	55.4	92.6	26.1	73.0	34.4	36.1	68.1	27.9	28.5	58.6	28.5	36.9	225.0	33.2	34.9	95.2	85.7	28.3	39.2	40.5	35.5	25.1	42.7	85.2	30.1	31.3	69.6	29.0	78.5	42.8	64.7	38.1	236.2	42.3	74.6	35.5	24.9	33.5	51.0	31.4	18.3	47.5	38.4	123.6	45.8	36.6	32.8	41.2	91.7	40.2	90.1	36.3	46.6	105.6	66.5	81.0	64.4	99.3	58.1	62.1	113.8	67.7	63.2	117.1	66.8	131.5	74.3	118.4	73.4	83.4	49.0	89.2	135.6	82.1	106.1	55.5	93.9	129.9	75.6	80.6	72.0	145.2	92.0	76.1	82.9	91.5	118.2	89.2	96.2	88.4	116.9	136.5	98.2	61.7	107.5	85.4	108.4	88.2	156.0	103.7	72.1	150.9	127.5	118.6	73.7	65.5	103.5	148.2	115.1	70.7	139.1	109.8	65.2	46.1	51.4	67.3	73.1	65.9	81.9	122.5	69.4	97.2	70.6	40.2	64.6	34.6	40.2	80.6	44.9	41.2	38.0	42.7	91.7	31.7	31.1	36.7	17.8	36.3	90.1	46.3	46.6	105.6	32.4	53.4	55.4	92.6	33.2	34.9	40.5	35.5	69.6	18.3	125.0	160.8	0.0	0.0	0.0	0.0	0.0	0.0	188.7	149.0	263.5	0.0	693.2	1049.5	441.8	0.0	0.0	0.0	0.0	323.3	482.8	0.0	0.0	133.7	0.0	535.7	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	490.5	0.0	0.0	298.7	0.0	0.0	698.1	0.0	0.0	0.0	0.0	0.0	0.0	952.2	0.0	0.0	0.0
ATP5IF1	"ATPI, ATPIF1, ATPIP, IP, MGC1167, MGC8898"	ENSG00000130770	"ATP synthase inhibitory factor subunit 1"	Q9UII2	1	28236109-28246906	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 1141.6;Distal tubular cells: 877.0;Exocrine glandular cells: 585.4;Proximal tubular cells: 988.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027999	Supported		Enhanced	Mitochondria		NA	NA		1800000	Mitochondria		"HPA027999: AB_10600984"	"unprognostic (2.80e-2)"	"unprognostic (3.72e-2)"	"unprognostic (2.95e-1)"	"prognostic favorable (6.38e-8)"	"unprognostic (2.04e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (8.20e-4)"	"unprognostic (5.94e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.15e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.48e-3)"	17.1	35.1	65.9	32.1	64.0	58.5	20.9	41.8	71.7	24.6	54.5	15.7	33.8	78.2	18.6	24.1	26.4	31.9	38.4	135.2	51.8	60.7	60.2	55.4	20.1	28.7	46.8	58.7	20.5	33.8	20.7	37.6	19.4	53.0	30.4	30.5	24.8	34.5	34.4	135.2	26.3	58.7	15.4	31.0	25.9	45.0	72.4	26.2	24.3	25.0	44.6	23.5	17.9	18.6	56.5	64.2	35.7	35.2	39.1	64.8	55.2	45.6	23.7	13.9	13.2	10.5	11.5	16.6	20.5	10.2	17.6	17.3	22.8	33.5	32.3	30.9	12.4	6.6	27.9	15.9	20.4	13.9	24.1	53.6	27.6	102.7	30.7	11.4	21.0	28.0	13.3	33.9	15.6	12.6	17.2	16.8	38.6	48.8	29.5	12.5	30.3	31.2	38.9	46.3	17.2	29.3	29.9	15.4	45.6	34.2	30.4	28.2	20.3	25.4	26.5	26.1	14.2	39.3	23.3	17.3	5.7	15.7	22.2	24.1	76.4	46.0	44.6	27.0	57.7	6.6	30.3	35.2	35.7	46.5	31.7	46.2	56.5	49.6	49.1	42.3	43.7	46.7	45.0	30.9	39.1	28.3	64.2	64.8	55.2	65.9	64.0	41.8	71.7	51.8	60.7	46.8	58.7	53.0	26.2	190.6	249.0	0.0	0.0	0.0	0.0	0.0	0.0	1141.6	276.4	518.2	0.0	390.3	877.0	342.1	0.0	0.0	0.0	0.0	585.4	173.6	0.0	0.0	159.3	0.0	316.5	0.0	0.0	0.0	0.0	0.0	0.0	64.5	0.0	214.6	0.0	0.0	472.8	0.0	0.0	988.7	0.0	0.0	0.0	0.0	0.0	0.0	210.5	0.0	0.0	0.0
ATPAF2	"ATP12, Atp12p, LP3663, MGC29736"	ENSG00000171953	"ATP synthase mitochondrial F1 complex assembly factor 2"	Q8N5M1	17	17977409-18039209	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 50.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023329, HPA059422"	Supported		Enhanced	Cytosol		No	No			Cytosol		"HPA023329: AB_1845209, HPA059422: AB_2684011"	"unprognostic (3.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (4.40e-2)"	"prognostic favorable (4.95e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.70e-3)"	"unprognostic (1.67e-2)"	"prognostic favorable (6.00e-5)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.15e-1)"	"unprognostic (2.62e-2)"	9.8	23.1	14.2	11.0	12.5	18.0	11.4	18.1	20.9	10.3	14.3	17.1	12.7	11.5	9.9	12.1	16.1	11.1	8.9	25.3	12.4	12.6	19.1	21.6	9.8	12.5	12.7	11.6	9.8	14.5	20.0	14.2	11.5	13.0	11.3	14.1	15.4	19.5	10.7	28.3	16.4	13.8	11.2	10.9	13.6	12.9	17.3	12.5	12.9	14.2	13.5	19.1	13.0	10.4	13.0	24.2	6.9	20.6	3.9	6.0	9.7	5.7	10.7	7.1	6.7	7.1	7.7	7.1	5.1	7.4	10.9	9.3	14.1	8.8	11.5	11.4	8.7	6.0	8.9	6.7	10.8	9.6	9.2	5.3	2.5	6.9	8.1	12.0	3.6	8.0	9.1	7.8	9.8	5.5	7.7	12.4	9.6	4.0	4.0	5.9	11.6	8.4	5.5	4.7	21.4	6.1	8.7	12.4	13.2	8.7	5.1	4.6	6.2	6.7	3.5	6.2	50.3	11.2	7.3	5.2	2.7	5.8	10.2	4.8	2.8	3.5	4.2	5.0	5.3	14.2	3.5	20.6	6.9	4.8	14.0	5.3	13.0	3.7	4.6	24.2	9.4	5.7	4.4	1.4	3.9	10.1	20.5	6.0	9.7	14.2	12.5	18.1	20.9	12.4	12.6	12.7	11.6	13.0	12.5	6.0	8.5	16.9	12.6	13.6	9.0	25.4	17.8	21.4	6.8	12.2	31.4	27.6	56.3	18.3	40.0	10.9	11.3	0.0	10.6	25.5	10.8	12.5	12.7	18.3	40.8	9.5	13.9	8.0	20.6	31.1	6.1	17.9	16.9	28.9	15.7	9.6	13.2	21.0	6.3	41.3	16.8	0.0	12.2	15.2	11.9	16.6	24.0	10.9	19.4	8.2
ATXN1L	BOAT1	ENSG00000224470	"Ataxin 1 like"	P0C7T5	16	71845991-71885268	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 197.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062596, HPA062789"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062596: AB_2684802, HPA062789: AB_2684868"	"unprognostic (1.51e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.33e-8)"	"unprognostic (1.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (8.42e-4)"	19.2	12.0	17.1	14.2	15.9	41.3	16.2	11.9	20.9	15.0	15.4	22.7	9.1	10.2	19.4	9.8	14.7	14.2	14.5	11.9	13.5	10.9	23.4	10.0	14.9	11.4	14.7	13.1	16.7	16.3	29.3	10.3	14.6	14.7	14.4	11.9	14.2	14.4	14.0	15.9	18.6	14.9	16.3	14.5	13.8	16.0	25.3	16.9	10.9	15.1	8.2	12.9	16.2	18.5	1.8	1.3	3.2	2.1	2.0	3.0	1.4	8.5	11.6	11.8	8.6	13.9	6.9	13.9	7.2	8.1	13.2	10.1	16.5	9.6	9.6	11.4	11.3	6.0	15.1	10.0	11.0	14.4	2.6	8.8	7.0	12.1	11.5	10.4	8.5	14.4	9.9	14.1	14.9	10.8	8.7	11.9	12.7	7.9	7.7	7.7	24.3	14.3	8.4	10.8	6.7	5.5	15.4	12.0	11.4	9.1	12.0	6.3	10.8	14.4	7.7	8.8	13.0	11.9	9.1	14.3	14.5	15.3	9.1	9.7	17.4	14.6	22.9	9.0	5.8	12.2	3.2	1.5	1.7	2.3	2.1	1.6	1.8	1.7	2.0	1.3	1.5	3.0	2.7	2.2	2.0	0.9	0.8	3.0	1.4	17.1	15.9	11.9	20.9	13.5	10.9	14.7	13.1	14.7	16.9	0.0	8.8	10.7	13.3	20.3	11.2	11.0	7.6	5.3	5.7	14.0	13.7	7.2	14.9	10.6	37.1	15.7	13.6	0.0	10.3	6.3	10.5	13.0	12.7	10.6	7.5	14.3	7.5	13.5	8.8	197.6	13.8	11.3	11.8	15.4	7.5	8.0	12.2	16.4	12.0	14.0	15.5	12.9	14.4	20.4	17.9	21.8	9.6	23.5	8.5	23.8
ATXN2	"ATX2, SCA2, TNRC13"	ENSG00000204842	"Ataxin 2"	Q99700	12	111443485-111599676	"Disease related genes, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018295, HPA020339, HPA021146"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018295: AB_1845130, HPA020339: AB_1845131, HPA021146: AB_1845132"	"unprognostic (3.08e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (2.34e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.58e-1)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.40e-2)"	21.3	23.4	25.1	24.3	26.5	15.5	34.5	32.4	32.8	21.2	20.7	32.6	20.5	17.6	24.0	20.3	17.6	26.5	20.8	25.9	24.6	26.7	19.0	20.8	30.2	15.2	29.5	25.9	30.2	16.8	33.4	23.3	25.2	26.4	22.0	17.6	21.0	16.2	24.0	28.0	15.1	15.4	26.7	28.8	16.5	16.8	30.8	30.2	18.4	23.8	14.2	13.1	22.7	24.5	9.9	8.0	11.1	10.8	10.7	10.6	4.8	18.9	22.8	20.5	21.9	21.1	18.0	17.3	25.0	14.7	17.9	15.3	13.5	14.3	15.2	8.9	25.9	14.1	15.5	27.9	10.9	22.2	13.8	24.2	23.3	12.5	22.8	28.5	15.4	12.8	17.9	12.1	22.3	24.6	28.3	16.3	12.9	29.0	9.2	21.2	14.7	12.7	13.8	20.3	10.8	14.9	12.2	12.5	12.1	17.0	24.0	18.9	16.6	25.8	29.0	13.2	16.8	17.6	9.1	25.5	21.7	13.7	19.8	14.1	15.7	21.4	15.8	12.3	12.8	14.6	10.3	6.8	11.1	8.2	6.8	10.6	9.9	9.2	9.3	8.0	6.1	8.5	7.1	7.8	10.7	10.8	4.8	4.1	4.8	25.1	26.5	32.4	32.8	24.6	26.7	29.5	25.9	26.4	30.2	74.5	67.7	20.4	26.9	31.4	99.3	31.9	25.5	52.2	48.9	34.9	127.6	26.0	3.3	21.8	8.2	36.2	18.2	0.0	22.0	22.0	34.9	31.4	23.1	32.7	21.1	62.0	39.7	69.3	34.5	6.6	60.7	30.7	30.4	14.4	27.9	39.3	26.1	17.5	44.6	12.4	87.1	32.3	34.9	72.8	69.6	30.7	39.2	21.5	30.3	38.4
ATXN2L	"A2D, A2lp"	ENSG00000168488	"Ataxin 2 like"	Q8WWM7	16	28823035-28837237	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041506, HPA043391, HPA071955"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA041506: AB_2677521, HPA043391: AB_2678459, HPA071955: AB_2686478"	"unprognostic (1.64e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.33e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (5.59e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.83e-2)"	"prognostic unfavorable (7.99e-7)"	"unprognostic (1.79e-1)"	"unprognostic (1.61e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.98e-1)"	24.7	31.1	32.5	38.7	30.4	56.8	44.9	57.9	42.5	27.4	24.6	28.0	22.8	35.1	28.4	22.9	29.5	26.2	25.8	24.8	31.1	22.2	30.9	32.9	37.1	46.2	33.8	36.1	31.7	34.8	39.9	44.8	31.2	28.9	29.2	22.8	22.5	30.9	34.2	27.9	31.7	31.9	27.8	33.6	44.0	30.2	77.2	33.1	45.2	31.4	19.5	36.8	25.5	38.8	6.8	9.5	4.2	3.7	3.0	4.0	1.4	17.8	23.0	23.9	26.9	14.8	15.3	28.1	18.1	17.6	19.9	22.3	29.0	21.4	41.7	23.3	12.8	31.3	26.1	22.4	18.2	22.2	32.5	19.9	27.7	27.3	29.5	26.7	31.2	39.2	19.5	21.9	28.2	40.6	17.7	17.5	41.6	36.2	52.9	16.3	25.5	37.9	52.9	24.2	10.9	16.1	50.1	16.6	28.9	11.9	18.6	25.0	19.9	10.5	20.1	21.8	15.8	21.9	33.0	20.8	24.8	20.6	15.9	24.8	75.7	52.6	37.4	18.7	30.0	28.5	0.7	3.7	2.2	2.9	3.3	3.0	6.8	3.5	3.5	2.7	5.7	3.3	4.0	4.2	3.0	2.6	9.5	2.8	1.4	32.5	30.4	57.9	42.5	31.1	22.2	33.8	36.1	28.9	33.1	26.8	32.3	17.5	21.3	32.4	29.7	1.6	28.1	12.0	17.0	19.2	43.2	19.8	1.7	15.3	49.2	24.3	18.2	0.0	17.3	19.6	20.3	21.6	24.4	13.4	21.5	25.4	23.6	28.3	22.5	13.8	19.8	25.3	8.5	20.8	21.3	9.2	25.3	17.5	18.7	3.3	45.8	12.9	15.3	69.2	27.9	27.1	28.7	21.8	21.3	21.7
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Group enriched"	"Detected in many"	6	"Erythroid cells: 46.7;Extravillous trophoblasts: 76.2;Hofbauer cells: 23.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Enhanced	Nucleoplasm,Midbody		Yes	Yes			Nucleoplasm	Midbody	"CAB005862: AB_449204, HPA037708: AB_2675623"	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.6	28.6	42.7	20.5	0.9	1.4	16.4	20.0	10.8	41.5	38.3	37.0	12.6	41.6	10.4	7.9	17.3	30.7	30.9	13.7	34.3	18.2	50.8	24.8	16.4	31.2	0.1	13.0	24.4	0.7	0.6	24.3	15.2	4.1	19.0	27.4	15.4	16.1	18.1	19.8	47.5	18.6	26.5	13.7	12.7	32.2	39.3	17.2	9.0	8.2	9.3	13.2	17.8	8.0	13.6	13.3	14.0	8.8	7.4	16.6	17.1	14.9	52.0	11.8	7.8	31.3	8.0	19.9	33.6	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4	0.0	0.3	2.2	0.3	3.9	0.0	1.1	0.0	0.0	3.4	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.4	46.7	0.0	76.2	4.7	0.4	4.6	0.6	23.9	0.0	0.0	4.9	6.3	0.0	0.6	4.4	1.7	0.0	4.2	0.0	0.2	2.9	0.0	0.0	0.0	0.0	0.3	0.7	2.0	2.0	7.6	2.5	6.3	1.4
AZU1	"AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC"	ENSG00000172232	"Azurocidin 1"	P20160	19	825097-832018	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	Chemotaxis	"Antibiotic, Antimicrobial, Heparin-binding, Serine protease homolog"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"bone marrow: 238.2"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 3.3;Kupffer cells: 4.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.3;neutrophil: 7.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.6;monocytes: 3.3"	"Cell line enriched"	"Detected in some"	7	"THP-1: 154.5"					"Not detected"	"Not detected"			"HPA055851, HPA075964"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA		290000	Vesicles		"HPA055851: AB_2682943, HPA075964: "	"unprognostic (1.12e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.44e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.01e-6)"	"unprognostic (1.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.04e-2)"	0.3	0.2	0.4	0.2	0.5	238.2	0.6	0.0	0.6	0.2	0.2	1.0	0.0	0.2	0.2	0.2	0.2	0.8	0.2	34.6	0.4	0.5	0.2	1.5	15.3	0.2	0.2	0.0	0.5	0.1	0.1	0.9	3.8	0.2	0.2	0.2	0.2	0.6	0.2	1.0	0.4	0.2	0.2	0.1	18.6	0.2	1.2	0.0	20.6	1.3	0.0	0.2	0.1	0.4	0.0	0.8	7.6	3.3	0.0	0.3	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	154.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	3.3	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	7.6	0.0	0.5	0.0	0.0	4.1	0.4	0.5	0.0	0.6	0.4	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.2	3.3	0.0	0.0	0.0	4.6	0.4	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.8	0.0
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711477-44718877	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Immunity		"Amyloidosis, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"monocytes: 43079.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 178.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA	1790000000	3200000000	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	127.2	50.9	24.2	109.2	29.8	131.1	85.2	11.8	23.1	70.5	111.4	29.1	43.3	79.1	72.7	74.7	80.5	36.8	112.8	73.6	26.0	23.1	109.7	140.3	191.2	172.1	42.2	18.8	54.8	42.7	7.8	40.5	91.9	33.1	78.7	128.9	53.5	121.5	40.9	45.7	94.1	178.5	55.1	56.7	272.8	52.5	30.0	29.5	108.0	97.7	71.5	131.6	135.9	73.5	138.9	74.9	341.3	132.8	128.8	215.8	323.7	33.7	14.9	1.4	8.4	55.5	74.8	52.9	22.3	45.6	36.4	61.8	19.4	78.7	16.1	31.6	21.7	34.6	29.7	5.6	9.9	17.5	112.5	13.2	61.2	90.6	22.5	42.2	34.2	36.7	37.8	9.3	11.1	12.0	49.2	24.8	9.3	15.5	2.2	40.2	18.0	14.0	90.3	2.5	9.7	31.9	17.1	36.6	101.9	31.7	139.7	5.9	2.1	23.3	18.9	26.3	8.0	6.3	178.1	49.3	71.4	7.9	94.1	43.6	41.7	95.3	29.9	69.6	113.1	34.1	221.2	90.4	210.9	126.8	132.8	125.9	138.9	171.7	141.1	58.9	109.4	137.0	167.5	341.3	128.8	106.5	74.9	215.8	323.7	24.2	29.8	11.8	23.1	26.0	23.1	42.2	18.8	33.1	29.5	3147.5	4324.0	5959.3	2738.0	6967.5	30.8	1001.8	3658.6	2584.4	1819.9	1992.5	25.5	1178.5	880.3	10047.2	36.4	7847.2	5137.6	1074.6	7941.0	3388.9	4495.5	5043.9	2851.5	3441.9	11377.9	4.8	2180.6	6477.0	10376.7	71.4	2794.5	10340.1	6397.4	43079.4	4753.5	280.0	9393.5	5334.1	1587.5	2212.2	49.3	3951.7	5055.6	55.6	68.2	7534.8	673.0	11479.7	3001.5	5867.1
B3GAT1	"CD57, GlcAT-P, HNK-1, LEU7, NK-1"	ENSG00000109956	"Beta-1,3-glucuronyltransferase 1"	Q9P2W7	11	134378504-134411918	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 76.0"	"Cell type enhanced"	"Detected in some"	30	"Bipolar cells: 34.2;Horizontal cells: 22.3;Muller glia cells: 119.7"	"Group enriched"	"Detected in some"	11	"glioma: 10.8;prostate cancer: 3.5;thyroid cancer: 4.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 3.8;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	39	"T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"AF22: 17.4;HMC-1: 19.3;NTERA-2: 16.7;SH-SY5Y: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002500, CAB010893, HPA069468, HPA074314"	Enhanced		Enhanced	Vesicles	"Secreted in brain"	NA	NA			Vesicles		"CAB002500: AB_563601, CAB010893: AB_1078474, HPA069468: AB_2686138, HPA074314: "	"unprognostic (6.72e-2)"	"unprognostic (3.97e-4)"	"unprognostic (2.13e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.52e-2)"	"unprognostic (2.60e-3)"	"unprognostic (6.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.57e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.26e-2)"	1.5	5.8	38.9	1.7	23.7	2.1	5.6	9.2	76.0	1.7	1.5	25.8	0.0	1.8	1.6	1.7	1.4	1.6	1.7	1.5	43.4	14.9	2.1	6.0	1.8	3.3	30.3	19.5	1.5	1.7	1.4	0.9	1.4	19.7	4.2	1.5	2.1	2.2	1.8	1.4	1.8	1.6	1.5	45.1	2.1	6.0	1.8	25.2	0.0	7.7	0.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.0	0.0	17.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.0	0.0	0.7	0.9	1.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.1	16.7	0.8	0.0	0.3	0.0	1.2	0.0	0.1	2.3	6.4	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.8	1.9	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.4	38.9	23.7	9.2	33.7	43.4	14.9	30.3	19.5	19.7	25.2	0.0	0.0	0.0	0.0	0.0	34.2	1.0	2.5	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.9	0.1	22.3	1.7	0.0	0.3	2.5	0.0	0.0	0.0	0.0	0.0	119.7	0.0	0.0	0.4	2.3	6.3	0.0	0.0	0.2	0.1	0.0	0.1	3.2	0.0	0.1
B4GALT1	"beta4Gal-T1, GGTB2"	ENSG00000086062	"Beta-1,4-galactosyltransferase 1"	P15291	9	33104082-33167356	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 56.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 56.9;SiHa: 107.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA010806, HPA010807"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		98000000	"Golgi apparatus"		"HPA010806: AB_1078255, HPA010807: AB_1078254"	"unprognostic (7.57e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (6.85e-7)"	"unprognostic (1.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.07e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.68e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.93e-3)"	"unprognostic (4.98e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.07e-2)"	"unprognostic (3.46e-2)"	32.0	19.5	4.5	22.5	4.5	22.1	35.1	5.9	3.5	25.4	20.4	6.4	29.1	6.5	19.5	34.1	24.7	26.3	24.2	33.1	3.2	2.5	31.7	91.2	34.9	44.9	5.8	2.2	56.8	20.1	30.2	11.9	79.0	5.9	22.6	11.1	32.1	39.1	42.7	15.0	17.6	18.9	17.7	6.4	38.5	19.9	37.6	3.6	23.1	39.3	16.9	41.0	26.4	21.6	24.8	56.4	24.9	9.1	18.2	16.5	5.4	16.2	12.0	2.2	3.1	11.4	20.2	40.7	17.0	21.3	10.3	10.2	7.3	19.0	6.2	10.8	24.7	13.3	8.8	2.3	21.0	10.3	56.9	2.3	3.5	50.2	5.6	22.5	2.9	6.0	22.5	37.7	11.7	14.3	22.2	10.9	1.9	4.0	7.8	9.7	14.2	2.6	5.8	1.3	9.0	3.7	3.4	2.1	4.1	30.7	14.2	1.7	2.1	107.2	20.9	4.2	7.3	26.4	5.3	10.0	7.3	8.7	23.5	6.6	1.3	2.8	3.9	22.8	4.0	2.7	6.2	9.1	5.0	13.0	7.8	16.5	24.8	8.7	11.4	6.1	20.7	5.3	6.7	24.9	18.2	6.0	56.4	5.7	5.4	4.5	4.5	5.9	3.5	3.2	2.5	5.8	2.2	5.9	3.6	80.4	65.7	101.3	48.3	125.9	1.4	29.7	86.6	26.8	59.1	158.7	19.6	74.7	13.3	63.1	9.2	49.6	45.8	23.3	110.1	134.4	71.0	89.2	36.8	170.8	48.5	0.0	8.1	90.9	71.6	5.1	46.9	58.9	91.1	22.6	42.2	7.2	120.8	32.3	41.8	46.1	39.5	51.8	65.3	4.8	13.4	94.7	145.4	44.5	21.7	74.5
BABAM1	"C19orf62, FLJ20571, HSPC142, MERIT40, NBA1"	ENSG00000105393	"BRISC and BRCA1 A complex member 1"	Q9NWV8	19	17267350-17281249	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Mitosis, Ubl conjugation pathway"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA054386, HPA068786, HPA077609"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA054386: AB_2682471, HPA068786: AB_2686034, HPA077609: "	"unprognostic (5.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.18e-2)"	"unprognostic (9.45e-3)"	"unprognostic (2.05e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.12e-2)"	"unprognostic (7.21e-2)"	"unprognostic (3.31e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.79e-1)"	"unprognostic (5.74e-2)"	23.2	26.7	39.8	24.2	33.6	37.3	23.7	32.5	50.0	25.6	25.6	24.5	18.7	25.5	24.9	20.5	26.3	22.0	26.8	36.8	35.2	33.3	24.0	31.2	21.6	30.7	34.4	33.8	23.6	29.2	22.2	15.7	31.9	25.8	22.7	23.8	20.8	30.5	25.5	72.7	25.0	23.4	23.9	23.3	29.1	24.5	24.6	22.2	34.5	19.2	33.5	31.3	21.4	19.8	44.7	51.6	51.6	50.1	33.2	55.2	59.7	35.4	19.9	20.1	19.1	22.5	16.0	45.9	21.3	28.4	43.1	43.0	22.8	42.5	25.2	50.9	29.5	19.2	17.7	23.6	29.5	27.7	36.1	37.6	22.1	26.4	27.6	18.3	39.7	28.3	24.2	20.6	28.5	17.0	23.6	36.2	36.1	36.8	29.6	31.1	29.0	39.9	37.7	52.6	29.9	42.9	26.9	26.6	33.2	31.6	17.5	19.5	35.4	25.8	27.0	23.3	24.1	23.7	32.1	26.0	26.2	16.6	32.0	35.4	39.7	47.5	33.1	37.2	52.6	24.6	50.0	50.1	51.6	45.4	46.0	43.4	44.7	42.0	43.8	51.6	43.3	39.2	38.6	12.6	33.2	43.4	42.8	55.2	59.7	39.8	33.6	32.5	50.0	35.2	33.3	34.4	33.8	25.8	22.2	11.9	33.8	59.1	31.8	31.0	19.2	29.8	35.7	16.0	21.6	33.2	13.7	144.3	86.2	64.8	47.6	38.0	52.1	23.3	63.0	136.2	53.0	40.9	45.1	42.0	86.6	15.9	42.1	35.6	36.2	68.8	33.9	46.9	62.4	98.2	53.3	27.8	60.0	57.5	41.8	72.1	12.0	38.8	52.6	40.7	69.5	36.1	132.2	58.6	59.6	34.3
BAD	"BBC2, BCL2L8"	ENSG00000002330	"BCL2 associated agonist of cell death"	Q92934	11	64269830-64284704	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004205, HPA028185, HPA062105"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB004205: AB_626717, HPA028185: AB_10603445, HPA062105: AB_2684684"	"unprognostic (1.47e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.24e-3)"	"unprognostic (2.60e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.26e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.95e-2)"	23.1	23.2	35.3	12.6	30.7	17.7	20.6	15.9	43.9	21.2	25.7	22.7	20.1	24.0	18.3	19.7	18.8	23.2	22.5	30.3	32.7	23.8	21.4	22.3	17.7	14.3	29.6	20.2	18.8	26.9	19.4	15.2	24.9	18.4	22.9	13.6	23.1	39.9	27.0	23.9	20.4	21.1	17.2	22.9	14.9	37.8	18.6	14.8	19.3	29.2	15.8	14.1	18.2	14.4	26.5	42.0	43.5	32.3	24.0	30.7	23.1	32.3	30.4	8.9	13.4	10.8	13.2	13.1	13.8	16.1	21.2	16.9	18.5	18.6	6.9	24.8	12.8	16.6	17.2	5.8	21.7	4.2	27.0	21.3	8.6	27.6	8.8	16.7	7.5	16.2	12.7	18.7	16.3	10.0	16.2	13.4	15.3	3.3	15.0	9.2	32.1	16.7	16.9	3.5	9.3	38.9	15.9	5.2	19.5	12.9	15.3	18.4	24.7	13.9	16.5	16.8	3.5	24.7	11.2	11.0	26.0	17.6	40.3	15.1	28.6	21.2	7.1	21.3	5.4	14.2	32.5	32.3	43.5	25.3	24.0	25.8	26.0	26.9	24.6	22.5	26.5	19.4	20.0	41.7	24.0	22.6	42.0	30.7	23.1	35.3	30.7	15.9	43.9	32.7	23.8	29.6	20.2	18.4	14.8	29.8	43.4	37.4	59.5	91.7	63.3	42.1	63.7	49.5	20.5	50.6	17.7	138.0	116.0	88.3	29.3	45.0	146.4	23.3	96.2	163.4	112.5	51.0	24.2	45.0	63.9	44.5	99.9	51.0	25.6	67.7	68.7	35.1	104.6	69.5	94.0	52.4	95.9	140.3	80.2	115.9	36.1	58.2	78.3	87.6	27.7	104.1	213.3	43.6	85.3	55.6
BAG3		ENSG00000151929	"BCL2 associated athanogene 3"	O95817	10	119651370-119677819	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	Chaperone	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 115.2;vagina: 160.1"	"Group enriched"	"Detected in many"	5	"Basal glandular cells: 723.0;Cardiomyocytes: 186.4;Glandular cells: 269.5;Urothelial cells: 305.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 7.6"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018493, HPA020586"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		890000	"Plasma membrane, Cytosol"		"HPA018493: AB_1845257, HPA020586: AB_1845258"	"unprognostic (1.18e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.31e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.32e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.18e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.03e-2)"	17.8	14.1	18.8	7.7	25.7	2.7	38.3	18.4	20.7	11.7	14.1	7.3	6.5	6.3	10.1	10.6	23.3	8.7	17.0	38.2	20.6	14.3	16.8	10.1	14.3	5.9	20.9	4.5	7.3	9.3	27.6	8.8	16.5	27.4	14.4	6.7	5.5	14.6	12.9	115.2	18.5	5.6	20.4	35.8	4.4	15.1	8.1	20.6	1.3	11.1	32.7	12.8	14.0	160.1	0.3	0.8	0.4	1.1	0.2	7.6	1.0	26.5	30.2	8.5	10.9	21.9	15.4	15.8	24.3	20.6	18.6	16.0	12.8	13.0	1.0	11.6	20.8	24.2	39.6	8.6	42.8	12.9	13.0	14.2	1.4	8.1	15.9	18.6	0.0	6.1	15.5	24.8	13.5	21.4	19.8	20.7	4.7	11.3	6.6	18.4	38.0	1.4	5.9	3.3	8.9	34.6	0.1	12.0	4.6	14.0	6.0	1.5	1.4	9.6	17.1	12.5	9.6	10.7	3.5	25.8	9.8	8.5	13.2	34.6	6.1	3.6	0.6	18.3	0.4	7.4	0.0	1.0	0.0	1.2	1.1	2.0	0.3	4.4	1.5	0.8	0.0	7.6	2.7	0.4	0.2	0.5	0.2	3.0	1.0	18.8	25.7	18.4	20.7	20.6	14.3	20.9	4.5	27.4	20.6	20.8	36.3	0.9	723.0	70.5	2.3	186.4	10.2	29.4	46.6	7.0	17.7	35.8	23.2	16.0	20.3	50.1	18.0	0.0	22.4	39.6	80.3	269.5	24.1	13.7	29.0	1.6	36.8	27.6	7.2	25.2	20.8	15.4	52.3	5.4	12.1	30.3	26.4	8.2	22.6	33.1	1.0	19.4	68.0	17.1	15.1	66.6	61.4	5.7	10.6	305.7
BAG6	"BAT3, D6S52E, G3"	ENSG00000204463	"BCL2 associated athanogene 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 339.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		2000000	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	20.8	30.1	16.1	18.4	21.7	16.9	18.1	22.1	31.2	23.9	23.8	22.3	17.9	38.2	25.1	38.6	19.9	23.8	21.4	25.5	15.1	14.1	20.6	41.8	25.7	18.1	15.9	15.6	22.0	22.2	6.6	20.7	27.0	17.5	20.5	30.7	24.4	20.9	19.6	50.5	22.3	31.0	17.3	13.2	23.7	26.1	101.8	16.2	39.9	22.9	30.4	27.1	18.3	19.3	4.8	8.4	8.2	7.5	3.2	6.3	3.1	1.9	14.4	16.8	3.4	8.4	13.0	3.8	3.4	2.7	3.3	3.6	35.8	1.6	2.5	26.0	27.8	20.7	2.4	2.0	29.5	5.4	4.1	39.5	11.1	1.8	22.7	12.6	3.3	33.0	10.4	11.9	2.9	3.9	15.0	9.7	20.4	21.0	11.6	24.1	5.6	2.0	19.6	2.1	3.2	2.6	4.9	2.3	4.6	14.4	5.2	2.4	4.5	1.3	4.1	3.3	4.3	30.2	27.7	1.9	11.4	8.7	2.0	3.3	15.2	20.0	22.1	15.5	2.7	3.6	8.2	5.7	6.6	6.3	7.5	5.0	4.4	4.4	4.1	4.5	4.8	3.5	4.2	5.8	3.2	6.8	8.4	3.0	3.1	16.1	21.7	22.1	31.2	15.1	14.1	15.9	15.6	17.5	16.2	44.7	36.5	27.4	30.3	28.5	26.7	70.2	43.3	36.1	39.8	34.9	17.7	53.0	26.6	57.4	195.1	37.0	85.3	23.3	43.3	57.5	32.9	30.2	48.4	36.0	49.4	47.7	73.6	38.1	38.8	339.6	30.8	35.7	27.0	30.7	49.7	29.6	55.0	57.5	37.1	40.2	39.7	38.8	37.2	93.9	52.8	31.0	99.9	35.4	49.8	33.1
BAIAP2	"BAP2, IRSp53"	ENSG00000175866	"BAI1 associated protein 2"	Q9UQB8	17	81035122-81117432	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 172.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023310, HPA027421"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA023310: AB_1845264, HPA027421: AB_10602392"	"unprognostic (2.20e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.97e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (7.58e-6)"	10.1	10.9	29.0	4.1	37.4	1.7	11.5	19.6	45.3	14.6	11.8	11.4	18.0	4.3	10.1	26.0	45.9	20.6	17.6	8.7	22.1	10.6	20.6	26.3	20.0	3.6	7.3	24.3	5.1	7.6	8.4	19.2	17.0	9.8	25.7	7.1	11.8	17.0	17.1	3.9	52.6	4.9	10.8	5.4	6.2	20.1	9.2	12.3	2.1	10.2	20.1	20.2	11.1	20.5	0.1	15.4	4.8	7.8	1.3	2.7	2.3	30.1	13.9	8.9	11.6	7.1	9.6	10.4	12.4	8.2	11.3	5.0	18.9	15.3	0.1	9.0	11.0	23.4	29.4	8.1	14.3	4.3	0.1	10.2	6.1	12.3	14.0	6.7	0.0	9.0	4.0	16.9	9.3	4.9	10.5	6.0	0.3	7.9	0.2	6.5	16.0	1.2	6.8	3.7	20.0	12.3	1.8	2.2	24.8	34.6	10.6	11.7	12.8	19.9	28.9	33.6	7.7	25.4	7.0	7.3	26.4	25.1	4.3	13.1	0.4	0.1	0.4	23.0	1.0	5.7	0.0	5.9	0.4	2.7	7.8	0.9	0.1	1.0	0.9	8.3	0.1	1.2	1.5	4.8	1.3	7.2	15.4	0.4	2.3	29.0	37.4	19.6	45.3	22.1	10.6	7.3	24.3	9.8	12.3	71.5	36.6	4.8	115.9	56.6	35.5	15.3	17.8	83.0	31.8	21.0	74.6	60.3	6.6	9.5	8.4	26.9	4.7	0.0	4.5	5.5	34.7	89.9	13.8	62.5	35.9	11.1	47.1	47.3	18.5	20.9	6.4	27.1	38.8	25.2	20.7	17.7	9.1	6.2	3.5	23.1	18.0	0.0	19.4	7.4	20.0	65.7	84.4	7.2	12.4	172.9
BAIAP2L1	IRTKS	ENSG00000006453	"BAI1 associated protein 2 like 1"	Q9UHR4	7	98291651-98401068	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 91.6;Urothelial cells: 132.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 27.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA019484, HPA021257, HPA023874, HPA029503"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330"	"unprognostic (1.75e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.31e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	4.7	11.2	1.3	16.9	1.1	0.0	10.3	0.3	0.9	6.1	27.3	1.1	10.8	16.2	3.6	4.7	17.9	6.8	29.6	2.1	0.7	0.6	8.9	31.0	15.4	0.9	0.8	0.2	2.6	47.4	4.7	16.9	17.0	1.2	15.2	12.5	6.5	14.7	12.3	3.3	11.3	34.0	3.4	0.7	1.4	33.0	11.6	0.4	2.1	18.0	11.2	14.1	18.9	12.9	1.3	2.7	0.1	0.2	0.0	0.9	0.1	15.8	12.6	0.3	0.3	0.0	0.5	21.2	4.1	2.7	2.1	1.6	17.5	23.8	0.6	6.2	1.5	18.3	14.1	5.9	17.4	1.9	0.0	7.6	0.0	5.4	9.9	2.6	0.0	5.7	0.6	23.5	1.2	17.3	4.8	0.0	0.0	9.4	0.0	1.8	13.3	0.0	0.0	10.0	22.9	6.8	0.0	0.2	2.5	13.5	14.0	9.1	1.8	9.5	27.7	4.8	14.3	7.7	0.3	0.5	3.2	15.4	0.6	1.8	0.3	4.7	8.0	0.3	2.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	1.3	0.9	0.2	0.1	0.0	0.2	2.7	0.1	0.1	1.3	1.1	0.3	0.9	0.7	0.6	0.8	0.2	1.2	0.4	11.9	19.3	0.0	43.5	14.8	0.6	1.9	28.1	37.5	28.4	21.0	3.9	10.1	8.3	49.7	27.7	7.5	49.7	0.0	67.4	67.3	2.9	91.6	0.0	13.0	2.2	1.6	30.9	0.0	0.8	35.9	0.9	1.5	8.5	4.6	43.9	1.3	82.9	31.7	0.7	0.8	0.8	0.0	4.3	29.0	49.5	16.9	10.2	0.0	28.5	132.5
BAP1	"hucep-6, KIAA0272, UCHL2"	ENSG00000163930	"BRCA1 associated protein 1"	Q92560	3	52401013-52410350	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 81.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004322, HPA028814, HPA028815, HPA055560"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004322: AB_626723, HPA028814: AB_10602393, HPA028815: AB_2672785, HPA055560: AB_2682850"	"unprognostic (1.52e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.41e-3)"	"unprognostic (8.53e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.30e-3)"	"prognostic favorable (3.29e-7)"	"unprognostic (6.37e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.92e-1)"	13.8	17.6	35.6	14.7	33.3	37.3	13.5	21.8	50.4	12.5	17.0	16.3	11.5	12.4	14.7	14.6	21.2	12.1	15.7	16.4	41.5	15.5	16.6	19.0	14.9	15.2	19.4	27.6	16.9	16.3	30.0	11.1	14.8	19.6	14.4	14.9	15.6	17.9	14.6	24.8	40.5	13.9	14.5	10.0	16.1	13.3	37.3	14.7	18.6	15.3	12.9	16.0	14.1	11.7	5.5	8.4	11.3	5.0	3.0	8.5	3.9	14.8	16.9	20.6	17.4	19.9	12.8	23.2	14.7	19.1	24.0	18.6	20.5	13.9	21.4	7.4	20.5	27.1	12.1	21.6	23.8	15.3	21.1	20.5	26.4	35.8	21.2	18.5	24.8	23.5	19.1	31.9	26.5	14.2	13.2	19.1	41.2	22.6	18.9	18.0	12.9	29.4	34.0	23.2	11.8	20.6	12.7	16.7	21.1	14.8	24.1	7.8	25.3	18.1	5.3	21.5	12.1	14.8	34.3	20.4	21.7	20.0	26.0	27.3	28.7	37.7	30.6	23.7	26.2	25.6	3.4	5.0	7.4	8.5	3.9	4.0	5.0	6.8	6.9	3.3	5.5	4.9	6.4	11.3	3.0	3.1	8.4	6.0	3.9	35.6	33.3	21.8	50.4	41.5	15.5	19.4	27.6	19.6	14.7	0.0	13.6	15.0	8.8	28.0	15.3	19.3	10.2	5.3	9.1	24.4	0.0	12.2	10.0	12.0	81.1	12.4	17.6	0.0	14.3	13.1	11.8	9.7	20.7	25.8	11.0	9.5	10.4	15.4	19.3	32.6	9.5	10.2	11.8	11.8	12.9	9.9	12.6	15.3	11.0	14.6	11.3	19.4	13.2	30.9	12.4	20.6	10.1	11.3	16.4	8.5
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.3;epididymis: 126.9"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 416.6;Muller glia cells: 714.2;Syncytiotrophoblasts: 617.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 42.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 42.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 63.6;HeLa: 111.9;SiHa: 107.5"	"Low region specificity"	"Detected in many"							"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		85000000	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	9.2	6.7	64.3	28.4	37.4	31.1	4.8	37.2	107.3	16.2	5.2	4.0	15.1	3.8	15.5	126.9	4.0	3.6	12.7	4.4	65.0	55.8	4.2	7.7	9.1	30.2	30.1	56.6	11.7	2.5	3.6	6.4	36.4	21.9	32.2	5.5	7.9	3.8	11.5	1.6	6.0	5.7	14.2	11.0	21.9	9.2	2.2	4.3	3.7	3.6	1.3	35.4	17.6	13.0	2.5	1.6	42.4	1.1	0.6	0.1	0.2	0.0	16.7	20.9	0.0	10.0	10.7	29.9	20.9	6.9	17.6	18.7	0.8	0.0	6.5	2.9	14.9	63.6	1.3	13.3	14.6	22.9	2.6	7.5	0.0	111.9	0.0	22.4	12.9	0.1	18.4	18.2	19.9	16.8	22.6	19.0	0.0	0.0	0.0	18.7	24.0	0.0	11.8	15.4	0.0	5.1	0.0	0.0	3.6	6.3	4.1	13.4	2.8	107.5	9.9	0.0	48.5	0.0	13.4	24.2	23.3	0.0	1.9	3.3	0.2	0.0	3.5	23.5	16.0	3.0	6.2	1.1	7.8	0.0	0.4	0.0	1.8	0.0	0.0	1.6	2.5	0.0	0.0	42.4	0.6	0.6	0.1	0.1	0.2	64.3	37.4	37.2	107.3	65.0	55.8	30.1	56.6	21.9	4.3	8.9	7.4	119.4	82.9	191.9	32.5	1.2	0.0	54.9	18.2	8.7	11.8	112.9	0.0	0.6	0.4	8.9	0.0	23.3	3.0	281.6	123.4	116.0	26.5	0.9	53.1	230.4	0.0	41.7	176.3	0.0	0.6	106.8	27.0	416.6	0.3	714.2	1.2	0.0	0.0	0.0	54.1	0.0	24.5	0.0	1.5	51.4	617.6	1.0	0.6	11.2
BATF	"B-ATF, BATF1, SFA-2"	ENSG00000156127	"Basic leucine zipper ATF-like transcription factor"	Q16520	14	75522425-75547015	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 41.1;lymphoid tissue: 26.6"	"Cell type enhanced"	"Detected in many"	18	"granulocytes: 226.5;T-cells: 75.6;Urothelial cells: 57.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"T-cells: 41.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 82.7;MCF7: 31.1;RT4: 19.5;SK-BR-3: 15.9;U-937: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA059588, HPA064962"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059588: AB_2684074, HPA064962: AB_2685392"	"unprognostic (3.33e-3)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (8.30e-4)"	"prognostic favorable (5.35e-6)"	"unprognostic (3.02e-2)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.72e-2)"	"unprognostic (7.17e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (3.74e-9)"	"unprognostic (4.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (4.30e-4)"	4.9	1.3	0.9	15.8	4.7	13.8	7.6	0.2	1.9	2.8	2.8	0.2	1.0	2.0	1.3	1.4	2.6	1.9	7.0	3.1	1.0	0.7	1.9	3.0	7.9	20.2	2.1	0.2	1.6	1.6	0.5	1.2	3.7	1.9	5.2	1.1	1.0	6.0	8.3	0.9	2.8	8.0	2.6	2.7	26.6	5.7	0.7	1.9	6.2	2.7	3.4	23.1	10.4	7.3	7.1	9.0	5.0	8.9	6.4	41.1	8.4	1.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.7	0.0	1.8	0.0	0.3	2.7	2.2	8.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.4	2.4	0.0	31.1	1.0	6.7	0.0	13.0	0.0	0.2	0.0	1.4	0.0	19.5	0.0	0.0	0.0	15.9	0.6	0.0	1.4	4.3	0.0	0.0	0.0	1.0	0.0	7.7	8.2	0.0	0.0	23.0	0.0	1.2	8.9	2.7	19.6	4.9	15.4	7.1	21.4	25.1	9.0	5.2	8.6	18.1	5.0	6.4	4.2	1.0	41.1	8.4	0.9	4.7	0.2	1.9	1.0	0.7	2.1	0.2	1.9	1.9	8.9	43.8	23.6	46.3	4.7	0.0	0.2	2.5	9.4	13.6	3.5	0.0	0.3	0.0	0.3	0.5	0.7	0.0	0.0	2.3	0.2	3.3	20.8	226.5	0.8	49.2	0.0	0.0	3.1	16.0	0.2	0.0	19.3	5.0	9.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.9	75.6	0.0	57.9
BAZ2A	"KIAA0314, TIP5, WALp3"	ENSG00000076108	"Bromodomain adjacent to zinc finger domain 2A"	Q9UIF9	12	56595596-56636816	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005782, HPA063806"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA005782: AB_10601089, HPA063806: AB_2685128"	"unprognostic (1.70e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.72e-4)"	"unprognostic (3.72e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.64e-2)"	"unprognostic (3.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.43e-1)"	25.5	22.8	18.2	25.5	22.4	45.5	25.5	39.0	26.0	25.6	23.2	24.6	23.2	20.1	25.2	21.8	28.0	21.5	24.1	19.1	18.7	11.6	19.9	19.7	31.5	25.0	23.1	13.5	32.6	26.2	33.8	36.1	29.0	19.4	21.9	22.1	27.6	24.0	34.5	24.7	26.0	27.6	19.4	19.2	32.9	20.9	34.1	24.4	46.1	26.4	19.6	30.3	27.3	30.5	5.1	8.6	20.1	9.0	12.6	3.6	1.7	20.4	20.9	27.0	22.5	15.7	16.0	27.2	14.3	19.6	20.2	14.9	24.5	24.9	30.3	21.1	16.6	17.3	17.8	31.9	18.8	18.7	19.5	17.1	34.3	12.8	12.4	17.4	19.8	25.9	14.1	19.5	17.5	25.6	22.9	20.2	12.5	36.4	36.7	11.6	13.1	16.4	13.2	24.6	14.0	15.9	13.9	20.0	20.6	14.6	20.2	18.3	15.2	23.9	25.1	13.2	31.5	27.6	18.1	27.8	10.3	20.4	13.3	10.0	20.5	19.2	28.2	9.8	14.3	15.3	6.5	5.1	3.7	3.6	4.5	3.0	4.3	2.8	2.7	1.8	5.1	2.4	2.1	20.1	12.6	9.0	8.6	2.5	1.7	18.2	22.4	39.0	26.0	18.7	11.6	23.1	13.5	19.4	24.4	62.5	60.7	48.0	38.2	45.2	69.5	21.4	25.5	20.1	27.3	24.4	129.6	38.6	6.6	27.8	52.5	40.9	47.2	0.0	25.1	27.9	32.9	50.8	40.6	25.1	20.9	30.2	42.9	52.2	50.1	51.1	56.1	40.8	37.1	57.7	40.9	27.3	28.7	38.6	54.1	9.6	68.6	84.1	49.5	82.5	133.9	54.1	80.0	43.6	29.6	49.2
BBX	"HBP2, HSPC339, MDS001"	ENSG00000114439	"BBX, HMG-box containing"	Q8WY36	3	107522936-107811324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 761.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006049, HPA050646"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA006049: AB_2667504, HPA050646: AB_2681200"	"unprognostic (7.57e-3)"	"unprognostic (1.49e-2)"	"unprognostic (8.73e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	10.6	22.6	13.1	11.0	20.6	11.2	10.8	12.8	15.1	14.3	13.2	15.4	27.8	6.7	15.1	28.3	10.2	13.2	12.7	11.5	14.8	11.6	14.9	7.3	10.8	10.4	24.5	9.0	21.0	9.0	35.7	39.6	17.8	17.5	17.4	7.3	9.1	11.8	25.1	8.5	7.5	9.4	14.0	26.7	14.1	9.6	43.9	25.5	13.5	19.3	8.0	10.1	15.9	15.6	33.7	16.3	25.2	17.5	25.2	26.1	11.4	18.6	17.3	14.9	22.3	13.3	19.4	12.2	17.7	18.3	16.1	17.9	1.9	15.2	9.7	22.2	11.2	18.4	13.0	16.7	21.5	24.4	12.5	7.8	14.5	14.0	4.1	15.8	19.9	9.0	16.2	15.8	16.2	32.6	22.7	13.5	11.7	6.7	14.6	13.6	6.2	11.2	2.0	7.3	0.2	14.7	15.9	14.1	11.0	10.2	14.1	10.7	10.9	31.3	3.1	15.4	16.0	12.4	4.5	17.7	19.8	14.7	7.3	12.6	6.2	4.1	11.0	17.9	10.3	11.5	25.2	9.1	21.6	22.6	9.2	26.1	32.8	20.3	22.8	12.7	33.7	25.7	21.1	14.9	25.2	17.5	16.3	13.4	11.4	13.1	20.6	12.8	15.1	14.8	11.6	24.5	9.0	17.5	25.5	59.6	69.7	91.3	125.6	75.7	90.3	93.6	76.5	44.2	45.5	90.7	60.9	172.5	41.4	69.4	761.4	73.0	16.6	46.7	65.1	74.7	80.3	95.3	31.2	27.6	41.9	162.1	63.8	57.1	54.0	372.5	144.7	68.9	64.1	36.1	33.3	141.5	56.6	43.5	193.7	88.0	61.1	142.3	128.8	73.5	118.0	66.0	165.9	68.7	36.0	108.0
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	55.1	52.0	14.4	72.3	64.2	19.5	33.5	26.8	30.8	31.9	41.1	41.9	40.5	32.3	122.4	43.4	42.5	55.9	36.0	56.3	26.7	15.9	53.7	20.4	41.2	36.0	31.5	33.1	44.2	26.0	48.9	31.1	36.6	33.6	39.0	19.1	27.6	58.9	35.7	57.7	21.2	45.1	16.5	74.8	53.8	23.2	16.1	72.4	50.0	60.5	18.9	26.8	12.0	59.6	40.2	23.7	21.8	37.4	40.7	28.1	27.7	38.0	53.7	60.5	116.6	42.9	54.8	44.9	24.6	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1	104.2	111.8	94.7	188.6	125.9	40.7	56.9	135.0	112.4	95.5	122.1	43.2	414.9	31.5	221.9	4.3	139.7	190.7	23.3	182.9	352.4	105.7	160.9	92.5	177.7	341.5	30.2	99.2	204.4	127.2	16.4	97.5	153.8	151.8	150.5	117.5	122.3	207.2	171.9	93.0	136.1	33.7	155.2	85.4	143.9	179.9	114.0	450.0	97.8	147.8	228.6
BCL2L13	"BCL-RAMBO, MIL1"	ENSG00000099968	"BCL2 like 13"	Q9BXK5	22	17628855-17730855	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 182.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002052, HPA030994, HPA050377"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002052: AB_563431, HPA030994: AB_10795024, HPA050377: AB_2681107"	"unprognostic (1.59e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.86e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.04e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.45e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (3.20e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.27e-1)"	"unprognostic (2.81e-1)"	15.3	17.4	13.3	7.6	14.2	10.9	17.3	13.0	17.4	9.2	11.9	14.8	8.8	8.3	10.5	10.7	14.5	11.7	10.0	18.9	12.7	12.2	18.9	20.9	10.6	9.3	14.4	13.4	10.4	22.0	25.8	12.3	14.1	12.2	11.1	14.1	15.2	12.4	9.5	61.2	15.5	12.4	11.7	13.0	8.3	11.2	22.9	11.5	12.1	13.5	14.5	12.3	14.6	10.2	6.5	11.3	4.7	17.3	10.4	8.3	9.5	13.8	6.2	9.9	9.4	16.6	15.9	13.2	9.9	17.4	14.7	16.8	7.0	9.2	12.0	7.2	14.2	14.8	19.0	11.4	15.3	15.4	11.5	8.7	11.3	5.6	3.6	20.6	15.7	9.8	12.9	17.9	12.6	34.1	18.4	12.8	10.0	28.1	11.3	16.0	9.3	8.0	5.0	7.8	22.4	7.7	8.4	15.3	4.5	15.3	9.6	14.1	8.8	13.1	13.3	23.7	25.8	9.1	15.6	12.8	8.8	4.5	12.5	9.5	9.7	8.8	10.3	13.1	12.1	15.0	3.8	17.3	4.7	4.6	15.6	5.7	6.5	6.2	5.7	11.3	5.4	5.5	4.5	4.4	10.4	11.0	5.7	8.3	9.5	13.3	14.2	13.0	17.4	12.7	12.2	14.4	13.4	12.2	11.5	20.8	11.8	21.7	29.2	21.9	182.7	38.9	12.7	14.7	29.6	17.4	11.8	42.2	44.7	26.6	26.6	14.3	28.3	23.3	27.5	28.8	15.8	31.6	8.1	30.6	23.9	46.1	22.4	12.9	27.2	9.5	13.0	22.7	15.1	58.7	26.7	45.9	28.7	14.4	14.5	33.8	30.9	0.0	15.5	21.7	21.4	23.7	80.2	19.1	22.9	31.8
BCL9L	DLNB11	ENSG00000186174	"B cell CLL/lymphoma 9 like"	Q86UU0	11	118893875-118925608	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049370, HPA053421"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049370: AB_2680732, HPA053421: AB_2682145"	"unprognostic (1.67e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.61e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.83e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.90e-3)"	18.4	18.9	10.2	17.2	10.0	13.3	23.8	31.7	9.9	27.4	16.4	6.7	15.8	13.2	22.3	12.8	18.9	22.2	21.2	15.6	9.0	4.1	10.9	9.0	17.1	13.8	9.5	7.7	22.2	16.4	9.0	6.5	31.9	9.1	16.1	4.1	14.5	21.5	14.7	19.1	19.9	14.6	22.8	7.9	13.9	14.0	9.0	8.6	13.0	12.2	11.9	16.7	21.9	25.6	0.6	0.6	1.1	0.5	0.7	2.2	0.8	12.3	22.5	3.2	5.9	10.5	10.2	20.7	17.1	13.2	5.4	3.2	23.9	24.7	3.4	22.9	17.9	22.2	24.0	1.5	31.4	1.4	4.1	0.8	3.3	12.6	8.2	11.9	1.1	3.2	12.9	19.6	6.5	13.1	10.5	4.8	2.0	4.3	3.9	3.7	20.8	2.5	0.9	3.8	7.4	13.0	5.3	1.4	2.3	5.7	8.6	1.7	2.6	24.1	36.6	3.4	6.0	28.8	1.4	16.0	17.5	13.3	5.2	14.5	0.8	0.0	1.0	9.4	3.9	9.9	0.0	0.5	0.0	2.2	0.0	1.5	0.3	1.2	1.3	0.1	0.6	1.9	1.5	1.1	0.7	0.0	0.6	0.2	0.8	10.2	10.0	31.7	9.9	9.0	4.1	9.5	7.7	9.1	8.6	14.9	11.5	2.4	8.8	34.5	18.4	2.0	15.3	4.0	11.4	7.0	3.9	9.8	0.0	11.8	0.1	10.1	8.0	0.0	12.7	7.0	11.6	18.2	2.3	10.0	3.8	12.7	5.2	11.1	5.2	0.0	13.6	2.6	6.8	19.8	5.0	6.9	20.3	7.0	13.4	2.2	2.8	25.8	14.7	0.5	1.0	39.5	29.6	11.8	6.3	9.1
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		190000	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	22.6	20.9	19.3	20.6	33.6	93.9	26.8	56.9	31.0	27.6	23.2	13.3	18.1	15.2	25.8	21.3	22.7	22.9	12.4	17.0	20.4	19.0	19.3	22.0	19.9	22.7	24.4	19.5	33.5	20.5	34.8	50.2	25.5	27.8	21.4	23.7	14.2	23.5	18.2	26.8	22.2	20.8	23.1	22.4	22.7	22.2	16.7	27.2	38.6	24.7	21.5	25.4	24.0	23.2	22.2	25.2	35.7	20.4	29.1	24.9	13.4	18.4	16.0	38.1	31.7	12.1	10.2	19.3	35.2	21.9	23.7	25.3	22.8	12.5	38.8	21.9	26.9	26.4	17.9	42.5	23.2	29.9	21.3	26.4	48.3	23.1	24.7	14.0	80.7	30.8	14.0	11.6	33.5	21.0	8.7	21.0	17.9	42.8	19.2	24.8	22.0	32.2	9.2	28.0	12.4	16.7	29.3	47.8	17.2	17.8	35.4	32.4	22.4	34.5	16.6	13.5	14.9	15.6	16.4	28.8	18.8	27.7	22.5	34.3	16.3	29.4	53.5	11.2	26.0	21.8	15.4	16.4	24.2	21.1	20.4	21.0	22.2	19.4	17.6	25.2	19.8	24.9	22.3	35.7	29.1	19.7	14.9	14.7	13.4	19.3	33.6	56.9	31.0	20.4	19.0	24.4	19.5	27.8	27.2	190.6	153.2	83.6	108.7	60.7	127.0	77.9	45.9	167.3	142.1	54.1	198.3	96.6	28.2	81.2	9.9	101.1	66.6	23.3	56.7	91.0	71.4	104.6	151.4	53.9	65.0	96.9	114.1	63.8	71.0	10.5	113.1	102.2	65.8	111.0	71.1	93.3	66.1	77.5	102.9	34.9	131.3	109.9	75.2	98.4	119.5	62.2	107.3	105.5	70.0	102.3
BCOR	"FLJ20285, KIAA1575"	ENSG00000183337	"BCL6 corepressor"	Q6W2J9	X	40049815-40177329	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA056308, HPA073591"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056308: AB_2683095, HPA073591: AB_2732227"	"unprognostic (2.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.45e-1)"	"unprognostic (9.26e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (3.82e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.91e-3)"	"unprognostic (6.83e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.55e-1)"	9.1	12.8	8.7	8.7	10.5	20.6	13.3	11.5	12.0	10.0	12.6	22.7	11.9	7.8	11.1	13.9	13.6	10.4	8.6	13.0	7.1	5.4	11.2	13.3	11.4	15.2	12.9	8.4	19.8	13.6	19.7	11.9	12.5	10.7	13.2	8.2	13.7	11.1	16.5	28.8	13.6	10.3	12.9	8.6	11.4	11.5	9.8	15.8	18.4	16.0	11.4	13.5	13.8	25.5	6.5	7.3	7.6	7.1	8.2	6.8	11.8	13.1	8.7	17.8	21.7	2.0	1.6	3.1	4.5	7.1	5.7	4.7	3.7	5.3	12.0	5.3	8.3	3.7	12.4	29.0	3.8	5.1	20.9	26.4	13.4	13.4	14.4	3.4	10.8	7.7	2.6	5.6	6.3	3.6	8.4	7.7	7.9	34.3	29.0	7.0	8.4	24.4	22.6	17.5	6.2	13.6	11.9	18.4	13.5	10.5	8.3	12.8	23.1	9.4	8.3	7.0	9.1	8.9	23.8	6.4	6.2	7.8	9.1	5.0	17.2	13.3	12.5	5.4	9.9	9.5	7.6	5.0	4.5	6.8	6.1	4.3	6.5	4.7	3.9	7.3	5.5	4.7	4.8	1.1	8.2	7.1	3.1	5.5	11.8	8.7	10.5	11.5	12.0	7.1	5.4	12.9	8.4	10.7	15.8	20.8	23.2	12.3	3.2	13.1	34.2	7.6	10.2	6.7	5.7	10.4	11.8	3.7	1.7	4.5	2.1	17.4	4.9	0.0	9.1	5.5	13.6	7.9	23.2	9.5	6.4	14.3	15.6	19.0	11.0	2.1	9.8	8.6	5.0	7.2	11.7	7.7	6.6	0.0	7.4	4.0	22.0	0.0	26.4	1.1	13.5	12.2	1.7	7.5	7.6	2.6
BDP1	"HSA238520, KIAA1241, KIAA1689, TAF3B1, TFC5, TFIIIB150, TFIIIB90, TFNR"	ENSG00000145734	"B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB"	A6H8Y1	5	71455615-71567820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 7.3;TIME: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064166, HPA077984"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064166: , HPA077984: "	"unprognostic (4.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.65e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.50e-2)"	"unprognostic (5.86e-2)"	7.8	8.7	6.1	4.4	9.0	3.3	7.9	13.1	9.8	5.9	4.4	2.5	3.3	1.5	6.1	3.3	5.0	7.8	5.2	4.0	6.6	3.4	6.5	4.2	3.7	3.5	6.3	5.6	5.0	10.7	1.5	10.0	3.7	5.7	4.9	4.1	1.9	4.9	6.1	10.0	6.5	4.1	6.1	4.1	4.7	3.6	4.9	7.5	6.7	7.9	2.5	3.0	5.7	3.7	2.5	1.4	1.8	0.4	1.9	1.3	0.1	0.2	2.3	4.4	1.1	0.1	0.5	4.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.3	1.6	5.0	0.0	0.1	0.0	3.5	0.0	0.0	0.1	5.6	1.0	2.7	0.6	0.0	0.0	0.0	0.0	0.7	2.4	4.1	0.0	7.3	0.0	1.8	2.4	0.0	0.4	0.0	0.3	4.8	4.7	0.0	4.0	1.9	1.7	0.0	6.1	0.0	0.9	3.6	2.6	0.0	0.0	9.7	4.7	0.1	1.6	0.0	1.5	3.8	0.0	0.0	0.4	5.2	0.0	0.1	1.8	1.3	0.4	0.6	0.9	0.6	0.5	0.6	2.5	1.3	0.9	0.5	1.9	0.0	1.4	0.4	0.1	6.1	9.0	13.1	9.8	6.6	3.4	6.3	5.6	5.7	7.5	56.6	88.2	43.6	51.4	39.5	73.1	98.6	45.9	57.6	83.0	33.2	96.2	32.1	1.7	38.7	21.8	53.7	20.2	46.7	31.3	41.0	40.7	42.1	55.6	24.1	27.5	89.0	56.2	22.1	17.5	16.8	54.4	37.3	27.0	55.1	25.9	46.5	39.7	23.0	51.2	8.2	121.3	51.8	48.6	64.7	53.0	37.9	40.3	55.4	32.3	59.9
BHLHE41	"BHLHB3, bHLHe41, DEC2, SHARP-1, SHARP1"	ENSG00000123095	"Basic helix-loop-helix family member e41"	Q9C0J9	12	26120026-26125127	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.9"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 333.3;Cone photoreceptor cells: 172.8;Horizontal cells: 236.8;Muller glia cells: 283.4;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	35	"memory B-cell: 5.3;naive B-cell: 1.6"	"Lineage enriched"	"Detected in single"	54	"B-cells: 5.3"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 33.8;Karpas-707: 14.3;RT4: 44.7;U-266/70: 19.2;U-87 MG: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056035, HPA077617"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA056035: AB_2683017, HPA077617: "	"unprognostic (1.57e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.32e-2)"	"unprognostic (6.62e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.29e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (8.73e-5)"	"unprognostic (5.23e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.61e-3)"	"prognostic favorable (1.09e-4)"	7.0	11.7	23.8	5.8	32.3	1.2	10.7	22.9	26.9	30.6	7.6	33.3	3.0	2.8	6.9	15.6	3.2	34.5	14.1	14.7	25.9	19.6	3.8	1.4	9.1	6.0	38.9	14.0	10.9	6.4	6.2	11.2	8.3	28.3	8.2	9.1	19.0	13.4	11.7	58.9	3.8	4.3	4.3	49.6	6.2	4.4	4.0	44.0	0.9	43.6	6.4	13.3	16.5	6.7	5.3	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	7.6	3.5	1.7	0.8	1.3	0.1	0.5	0.0	4.8	0.0	0.7	1.5	11.4	4.0	0.1	0.6	0.4	0.0	0.6	0.3	0.0	0.0	0.3	1.9	0.1	0.5	0.4	2.8	5.5	33.8	0.0	0.0	0.0	14.3	0.8	0.4	0.0	1.3	3.7	1.3	2.8	0.0	0.6	10.9	1.8	44.7	0.0	0.0	0.5	0.2	10.1	0.2	0.0	0.0	2.3	2.6	3.1	0.3	2.0	19.2	11.0	0.0	16.5	1.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	32.3	22.9	26.9	25.9	19.6	38.9	14.0	28.3	44.0	0.0	0.6	22.9	50.0	5.4	333.3	33.5	33.1	42.8	10.3	27.9	172.8	22.2	0.0	35.8	0.2	4.8	10.8	0.0	19.8	2.4	18.8	38.9	5.7	0.0	71.2	236.8	12.6	3.1	2.7	0.4	27.9	35.2	13.5	47.7	3.0	283.4	13.9	5.7	25.1	2.1	289.4	6.5	6.6	0.5	0.4	2.9	5.9	0.0	3.3	52.5
BIN2	BRAP-1	ENSG00000110934	"Bridging integrator 2"		12	51281038-51324668	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	6	"blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 77.7;Extravillous trophoblasts: 144.3;Syncytiotrophoblasts: 132.6;T-cells: 174.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 23.8;HMC-1: 40.6;Karpas-707: 17.7;NB-4: 40.4;RPMI-8226: 15.8;THP-1: 34.2;U-937: 22.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA038666, HPA038667"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA038666: AB_2676139, HPA038667: AB_2676140"	"unprognostic (8.44e-3)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.48e-1)"	"prognostic favorable (6.34e-4)"	"unprognostic (4.63e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.65e-3)"	"unprognostic (4.03e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-1)"	4.6	1.8	3.5	12.3	4.7	38.0	1.7	1.8	2.0	2.3	3.3	3.6	0.7	2.2	1.4	2.8	2.2	1.4	3.6	2.2	3.1	2.1	2.5	3.1	7.7	23.9	4.4	0.9	1.8	2.3	0.0	1.7	8.4	3.2	1.8	3.6	1.5	4.7	0.6	1.9	2.0	3.3	2.3	4.1	18.3	2.6	3.5	3.9	24.8	1.9	0.7	17.5	4.4	1.9	10.5	17.1	85.3	59.9	35.8	47.7	61.4	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	23.8	0.0	0.0	0.0	9.9	40.6	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	17.7	0.0	0.1	6.9	40.4	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	34.2	0.0	0.0	0.0	0.0	0.0	9.5	0.0	2.3	0.0	22.4	0.0	85.3	30.9	37.4	47.7	49.0	38.5	8.1	32.4	39.8	17.1	10.5	25.3	33.5	61.0	35.8	59.9	6.3	40.9	61.4	3.5	4.7	1.8	2.0	3.1	2.1	4.4	0.9	3.2	3.9	3.0	27.8	26.9	0.1	0.6	0.0	0.6	2.5	6.7	4.5	1.8	0.0	77.7	14.9	0.0	19.8	1.0	1.2	0.0	0.0	144.3	1.9	0.1	53.3	0.9	50.9	0.0	1.2	8.6	57.8	18.7	0.6	49.5	1.7	10.0	9.1	0.0	0.0	3.5	0.4	0.7	0.0	0.0	0.7	32.5	7.7	0.5	132.6	174.0	6.9	0.0
BIRC7	"KIAP, ML-IAP, mliap, RNF50"	ENSG00000101197	"Baculoviral IAP repeat containing 7"	Q96CA5	20	63235883-63240507	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	"Protease inhibitor, Thiol protease inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 14.4;placenta: 13.6;retina: 21.1"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 56.9;Melanocytes: 25.3;Muller glia cells: 46.0"	"Cancer enriched"	"Detected in many"	10	"melanoma: 73.7"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.0"	"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 63.7"	"Not detected"	"Not detected"							"HPA047850, HPA061283"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA047850: AB_2680181, HPA061283: "	"unprognostic (3.60e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.11e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.24e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.82e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.84e-2)"	1.6	1.3	1.0	0.7	1.0	0.3	0.7	0.1	2.2	3.0	1.3	0.5	0.1	0.4	0.8	14.4	0.3	0.3	0.5	2.8	0.9	1.1	2.6	0.8	2.3	2.2	4.9	1.0	0.2	0.1	0.1	0.6	13.6	1.5	0.4	0.3	21.1	0.8	0.1	0.1	4.9	0.3	0.2	4.3	1.6	0.3	0.4	0.3	0.3	0.3	1.0	0.5	0.4	1.8	0.0	0.0	0.0	0.2	0.0	2.0	0.1	0.1	1.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	6.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	63.7	1.6	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.0	0.1	2.2	0.9	1.1	4.9	1.0	1.5	0.3	0.0	0.6	0.0	0.0	1.1	0.0	0.6	0.0	0.0	0.0	1.8	0.0	1.4	0.0	0.6	0.1	0.0	0.0	0.0	0.6	8.2	0.5	0.0	2.3	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	46.0	2.3	0.0	0.0	1.1	0.8	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"brain: 10.6"	"Group enriched"	"Detected in some"	28	"Alveolar cells type 2: 2.9;Ciliated cells: 1.4;Club cells: 4.5;granulocytes: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 2.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HaCaT: 3.0;HEK 293: 12.2;HeLa: 5.2;PC-3: 6.7;SCLC-21H: 3.4"									"HPA045845, HPA050126, HPA050374"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106"													"unprognostic (6.01e-2)"					1.0	1.0	2.7	3.7	4.5	1.1	1.4	10.6	5.7	1.0	2.9	1.3	2.6	1.0	2.1	1.1	1.0	2.6	1.0	1.9	2.7		3.2	2.4	2.3	1.5	2.2	2.7	1.0	1.9	1.0	2.7	1.3	2.6	2.0	1.0	1.1	1.0	2.7	1.0	1.0	1.0	2.6	0.6	1.8	2.6	1.2	2.3	0.3	1.7	1.5	1.0	1.0	1.0	0.0	2.8	0.0	1.4	1.3	2.9	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.7	0.0	0.1	0.6	0.0	3.0	0.3	0.0	0.0	0.0	12.2	0.0	5.2	0.0	0.5	2.5	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.4	0.1	3.4	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.1	0.6	2.9	0.0	0.7	1.0	2.8	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.3	1.0											0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BMP2	BMP2A	ENSG00000125845	"Bone morphogenetic protein 2"	P12643	20	6767664-6780280	"Cancer-related genes, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 147.9;Basal keratinocytes: 148.5;Suprabasal keratinocytes: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"NK-cell: 2.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 21.2;HeLa: 13.8;hTERT-HME1: 12.5;RT4: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA058610, CAB078457"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	24400		Vesicles		"CAB078457: AB_2532532, HPA058610: AB_2683777"	"unprognostic (2.22e-2)"	"unprognostic (9.32e-2)"	"unprognostic (6.12e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.70e-3)"	"unprognostic (3.12e-3)"	"unprognostic (8.51e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.53e-3)"	"unprognostic (5.39e-3)"	"unprognostic (7.81e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.01e-2)"	"unprognostic (7.49e-2)"	11.1	1.1	1.6	10.5	3.1	0.6	5.3	1.8	7.5	3.7	13.1	2.6	1.9	4.2	3.4	6.7	3.7	3.7	15.6	3.9	2.4	1.6	3.6	3.8	12.8	1.3	2.9	1.3	3.1	9.2	4.7	2.3	7.6	2.7	8.8	9.5	18.3	2.0	1.2	2.6	9.1	13.4	3.4	1.4	8.0	13.8	1.1	2.7	0.3	13.2	6.2	3.1	14.1	9.1	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.5	2.3	0.0	0.0	21.2	0.0	0.0	0.3	0.7	0.0	7.1	4.2	1.8	0.0	0.0	3.8	0.0	13.8	0.0	1.0	0.0	0.6	0.1	6.4	0.0	12.5	2.7	4.3	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.5	2.5	0.5	4.1	0.0	0.3	1.6	16.8	0.8	1.1	5.0	0.0	0.0	4.0	0.0	4.4	1.0	1.2	1.9	0.0	0.6	0.2	0.5	0.0	2.1	1.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.0	1.6	3.1	1.8	3.3	2.4	1.6	2.9	1.3	2.7	2.7	74.5	147.9	4.5	34.3	148.5	0.4	4.6	53.5	0.0	13.6	1.8	0.0	0.1	0.0	19.3	0.3	9.7	64.5	0.0	8.3	0.1	15.5	30.2	8.1	2.4	2.7	0.0	10.9	46.1	3.7	0.0	5.5	1.9	8.5	1.0	18.4	4.8	23.9	17.3	0.0	0.7	0.2	19.4	38.9	0.0	0.1	104.4	0.1	0.0	15.1	24.3
BMS1	"BMS1L, KIAA0187"	ENSG00000165733	"BMS1, ribosome biogenesis factor"	Q14692	10	42782801-42834937	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"		"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036589, HPA043081"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli, Mitotic chromosome"		"HPA036589: AB_10601460, HPA043081: AB_2678305"	"unprognostic (1.46e-2)"	"unprognostic (4.31e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (1.06e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.43e-1)"	"unprognostic (4.82e-2)"	17.8	15.3	10.4	15.8	19.7	17.4	16.2	22.5	20.6	15.5	12.9	13.7	11.2	11.8	23.1	13.4	17.8	14.0	10.0	14.4	10.8	13.3	17.8	16.8	14.1	17.2	12.6	15.4	17.5	16.2	24.7	28.0	15.3	22.8	14.1	15.4	12.3	18.8	14.0	29.9	18.1	13.8	14.7	15.0	18.3	13.5	14.8	13.4	20.7	14.0	17.2	19.2	14.4	15.9	9.8	8.4	3.4	9.1	6.2	11.6	5.6	16.8	14.4	14.0	15.9	10.6	8.8	13.6	14.2	15.0	16.8	14.5	19.8	13.3	9.0	10.1	12.2	9.4	14.8	22.8	18.3	22.1	13.1	16.0	12.0	11.2	16.8	9.2	32.4	11.4	7.9	9.4	18.1	17.6	9.4	12.7	10.5	21.0	9.7	11.9	14.2	18.0	10.7	17.7	11.7	15.3	16.6	14.7	9.6	9.3	14.9	10.7	11.4	12.3	13.8	11.7	15.3	16.7	9.4	15.3	7.9	28.3	15.7	23.0	7.8	9.6	26.3	11.5	24.0	6.0	3.4	5.1	2.9	8.6	9.1	10.2	9.8	10.6	9.3	8.4	7.4	11.6	10.0	0.7	6.2	7.4	4.4	7.5	5.6	10.4	19.7	22.5	20.6	10.8	13.3	12.6	15.4	22.8	13.4	29.8	24.9	24.6	24.5	20.4	21.0	41.4	22.9	68.3	44.3	22.7	9.8	24.5	18.3	25.0	12.0	26.4	7.9	0.0	30.5	25.1	21.9	17.4	20.9	17.1	17.5	20.6	16.1	23.9	18.6	8.1	21.9	21.0	32.1	41.5	10.4	11.4	29.2	7.0	15.6	23.2	25.6	19.4	20.3	35.2	53.5	22.2	20.8	20.0	16.8	36.0
BNC1	"BNC, HsT19447"	ENSG00000169594	"Basonuclin 1"	Q01954	15	83255903-83284714	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.4;testis: 27.5;tongue: 20.2"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 78.8;Early spermatids: 37.3;Late spermatids: 74.8;Suprabasal keratinocytes: 51.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 25.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 16.3;HBEC3-KT: 37.1;hTCEpi: 41.7;hTERT-HME1: 40.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063183, HPA066947, HPA077428"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063183: AB_2684957, HPA066947: AB_2685752, HPA077428: AB_2732345"	"unprognostic (1.86e-3)"	"unprognostic (1.08e-1)"		"unprognostic (7.89e-3)"	"unprognostic (5.55e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.45e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.89e-4)"	"unprognostic (6.94e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (8.46e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.95e-3)"	"unprognostic (1.01e-2)"	12.7	0.1	0.0	1.6	0.1	0.0	0.9	0.0	0.4	2.7	1.5	0.1	0.0	0.0	0.4	10.8	13.4	0.8	0.1	1.4	0.1	0.0	0.1	0.1	0.7	1.3	0.2	0.2	0.6	0.0	0.0	0.0	1.9	0.5	0.4	0.0	0.7	1.7	0.2	0.1	7.9	0.2	0.3	0.3	0.1	0.0	27.5	0.0	6.0	0.2	20.2	3.7	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	1.4	2.1	0.0	0.6	0.1	7.1	10.0	0.0	0.1	0.0	0.3	4.3	0.0	16.3	0.8	37.1	12.9	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	1.8	41.7	6.3	40.7	1.5	6.9	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	3.7	0.0	0.0	4.8	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.2	0.2	0.5	0.0	0.0	0.0	0.0	9.7	78.8	0.0	0.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	37.3	0.5	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.1	0.0	0.0	1.3	0.0	74.8	0.6	0.5	8.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.2	16.3	5.9	51.1	0.0	0.0	0.0	4.6
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 467.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	17.9	6.9	16.4	11.1	45.7	28.8	13.9	18.2	53.5	17.1	37.9	3.1	8.7	5.5	17.2	34.2	23.9	9.2	8.1	23.4	57.0	3.6	4.5	22.9	7.1	5.4	25.5	2.0	39.8	34.6	18.4	19.3	11.6	56.7	21.8	13.7	10.3	13.4	35.8	7.8	14.2	7.6	5.3	11.3	7.5	7.6	20.8	10.9	17.7	11.7	17.5	15.6	8.8	1.7	13.8	18.8	9.0	4.3	28.6	32.1	13.9	20.0	4.1	19.7	8.9	7.4	48.9	4.1	7.2	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9	80.4	113.7	54.1	47.2	87.7	108.8	31.1	30.6	89.7	69.4	97.7	31.4	24.2	41.4	101.3	153.2	88.4	28.4	467.2	33.9	141.0	136.5	90.8	116.8	23.2	118.2	77.9	115.7	155.9	197.5	155.5	296.6	132.1	101.3	70.3	45.5	412.0	125.0	28.8	326.7	215.8	62.1	142.3	150.4	113.3	98.5	110.7	135.9	55.4	28.1	62.0
BOD1L1	"BOD1L, FAM44A, FLJ33215, KIAA1327"	ENSG00000038219	"Biorientation of chromosomes in cell division 1 like 1"	Q8NFC6	4	13568738-13627723	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 12.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 12.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036943, HPA037362, HPA041290"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036943: AB_2675397, HPA037362: AB_10670380, HPA041290: AB_2677393"	"unprognostic (1.07e-1)"	"unprognostic (3.27e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.29e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.15e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.02e-2)"	"unprognostic (1.72e-1)"	"prognostic favorable (3.48e-6)"	"unprognostic (2.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.02e-2)"	"unprognostic (6.60e-2)"	17.5	12.6	18.9	23.8	24.3	40.2	18.3	30.4	34.9	21.5	16.8	10.4	18.2	12.1	20.5	19.8	15.2	16.9	14.1	13.6	18.4	12.4	14.2	12.6	22.8	22.0	20.1	21.7	26.8	16.0	28.6	16.0	18.3	21.1	15.4	14.5	7.1	17.1	27.3	13.2	19.5	20.9	18.2	21.1	26.9	16.1	18.0	21.6	23.4	16.4	11.7	22.3	16.5	16.2	2.2	2.5	12.2	1.4	0.7	1.6	0.5	10.2	13.8	13.8	9.9	16.8	17.8	10.6	11.9	12.6	9.9	11.2	10.3	11.2	13.8	5.4	13.0	18.5	7.0	11.2	11.8	19.2	9.5	6.5	19.4	17.4	12.6	10.4	29.1	16.1	14.2	13.5	20.5	15.9	13.7	10.2	9.8	13.6	16.6	12.4	6.1	15.0	19.5	17.7	6.6	12.0	11.5	20.5	5.5	18.5	10.4	8.2	15.1	13.1	4.6	10.6	15.5	5.4	11.3	23.1	15.4	8.1	9.5	15.6	19.7	11.5	17.5	15.2	13.8	12.2	2.5	1.4	2.8	1.6	1.4	1.3	1.7	1.0	1.1	0.9	2.2	1.5	1.1	12.2	0.7	0.9	2.5	0.9	0.5	18.9	24.3	30.4	34.9	18.4	12.4	20.1	21.7	21.1	21.6	77.4	85.8	51.3	16.8	23.4	156.0	80.3	53.5	52.2	75.1	34.9	84.4	13.6	3.3	26.0	15.3	42.2	24.0	23.3	21.8	14.9	25.9	20.4	60.2	30.4	18.6	152.6	33.4	33.7	36.5	13.5	46.6	34.3	23.6	21.6	26.0	103.2	26.0	21.0	54.5	4.5	187.0	45.3	24.0	75.4	15.2	25.2	15.6	37.3	21.0	22.8
BOP1	KIAA0124	ENSG00000261236	"Block of proliferation 1"	Q14137	8	144262102-144291370	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047869, HPA066764"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA047869: AB_2680193, HPA066764: AB_2685716"	"unprognostic (6.92e-2)"	"unprognostic (5.03e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.06e-3)"	"unprognostic (3.32e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (3.35e-5)"	"unprognostic (2.25e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.23e-7)"	"unprognostic (7.83e-2)"	"unprognostic (4.33e-1)"	"unprognostic (8.49e-2)"	"unprognostic (4.06e-3)"	4.8	4.3	5.7	7.7	5.9	7.8	6.4	6.3	6.9	2.0	3.9	1.6	2.0	5.1	2.7	1.5	6.8	2.6	4.8	5.1	5.5		2.8	6.2	2.3	6.6	4.1	6.7	2.7	17.5	5.1	2.2	3.2	4.3	2.9	1.5	1.5	5.8	3.0	19.0	7.4	4.5	4.9	2.0	4.8	4.4	8.3	3.3	6.3	3.9	6.7	4.5	3.5	6.9	5.2	6.4	2.5	4.7	3.5	5.7	2.5	12.5	24.6	3.4	14.5	2.0	2.3	12.6	8.7	1.8	8.8	5.5	18.6	7.3	15.3	14.9	3.3	3.3	10.1	6.2	10.3	2.0	13.4	24.8	19.2	14.9	14.1	4.6	8.5	10.6	4.5	5.1	7.4	6.7	1.7	5.5	14.2	19.3	5.1	3.4	32.0	22.8	10.9	8.3	12.9	67.8	17.5	5.1	23.3	3.6	8.4	19.1	7.6	9.3	12.1	5.9	1.7	8.9	8.1	10.3	8.1	25.0	10.9	24.9	4.9	3.1	12.8	6.0	13.8	10.6	0.0	4.7	2.5	4.4	4.7	4.8	5.2	4.9	5.7	6.4	4.5	4.4	4.1	0.2	3.5	4.0	4.1	4.2	2.5											8.9	6.1	13.4	13.8	0.5	10.2	6.7	10.2	2.7	6.8	10.4	0.0	21.5	5.0	24.4	8.9	8.7	7.0	0.0	18.7	35.1	9.3	10.0	10.3	13.1	19.1	14.3	25.8	3.7	6.4	15.5	9.8	7.5	0.0	11.8	9.2	13.7	20.3	8.6	9.2	13.6	4.2	12.9	4.3	10.4	60.5	0.1	14.9	8.7	21.6	11.6
BPTF	"FAC1, FALZ, NURF301"	ENSG00000171634	"Bromodomain PHD finger transcription factor"	Q12830	17	67825524-67984378	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029069, HPA048289"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029069: AB_10602597, HPA048289: AB_2680342"	"unprognostic (1.22e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.74e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.24e-2)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.56e-1)"	16.1	16.2	28.0	28.6	28.7	22.3	19.5	61.9	35.3	20.7	18.5	18.9	17.0	12.1	20.1	24.0	17.9	17.8	17.4	13.9	26.6	17.7	17.1	14.7	24.1	31.7	31.6	22.2	27.1	16.3	31.3	29.7	17.2	26.0	17.3	18.0	14.5	16.9	18.4	17.9	29.5	18.2	16.5	18.4	21.1	17.4	23.6	33.5	41.4	19.0	12.3	30.1	16.7	32.5	12.6	10.4	15.1	4.8	9.7	7.3	1.4	13.3	17.5	25.7	13.0	14.3	13.7	14.1	10.5	9.8	12.6	11.0	16.1	9.6	54.9	7.8	11.7	10.0	10.5	25.1	11.3	20.6	7.7	24.2	21.1	16.8	22.0	6.8	30.7	17.0	10.0	12.8	12.6	9.6	11.5	23.6	17.6	23.8	15.8	10.9	20.5	31.3	15.3	19.6	12.5	16.0	22.6	31.1	10.8	11.1	16.8	19.4	22.2	14.4	38.9	14.8	32.6	16.4	17.8	16.5	19.3	15.1	7.0	12.9	13.0	13.0	32.6	9.1	14.9	7.4	15.1	3.9	7.5	7.3	2.2	5.9	5.7	5.9	5.7	2.8	12.6	6.2	6.4	8.9	9.7	4.8	10.4	4.2	1.4	28.0	28.7	61.9	35.3	26.6	17.7	31.6	22.2	26.0	33.5	107.2	124.1	51.4	47.2	66.7	204.4	114.1	56.0	96.4	130.8	55.8	135.5	32.0	6.6	51.8	19.7	85.7	44.6	46.7	54.5	27.7	63.0	50.8	115.8	38.4	36.7	187.5	121.0	64.4	50.9	14.5	100.7	50.8	60.8	45.1	58.7	132.3	54.5	60.4	104.7	15.3	196.3	64.7	58.2	135.4	80.7	66.0	32.4	81.2	68.6	50.4
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968660-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	26.1	35.1	26.8	30.1	28.9	96.2	26.8	42.2	28.8	34.9	27.4	30.6	46.4	21.2	35.0	28.7	33.2	33.0	27.6	21.7	26.5	20.1	28.9	27.5	28.1	28.2	34.9	19.5	40.6	65.5	28.8	33.7	27.2	29.0	28.5	21.8	29.3	32.6	41.7	28.6	28.7	25.6	27.1	26.4	33.4	32.2	66.9	33.1	38.7	58.5	27.1	33.2	26.8	35.8	12.3	13.0	14.0	11.2	12.9	19.5	12.0	19.1	7.5	18.6	13.6	10.1	9.3	26.1	15.1	18.7	19.1	16.5	8.0	13.3	14.4	16.7	21.4	13.1	10.1	11.8	12.2	16.9	14.1	53.9	13.9	9.4	6.6	14.5	22.8	24.3	9.6	10.6	17.1	15.6	25.9	6.8	11.6	17.5	28.9	7.3	3.8	25.6	4.0	10.4	21.6	7.0	30.3	5.5	20.4	5.1	9.0	28.7	11.4	16.8	21.2	21.2	12.4	14.5	12.9	8.5	26.3	12.5	7.4	18.7	43.0	35.8	36.1	7.4	13.3	15.7	10.2	9.1	14.0	19.5	11.2	17.6	12.3	13.0	13.1	13.0	11.8	9.1	13.5	12.9	12.9	10.9	10.8	16.3	12.0	26.8	28.9	42.2	28.8	26.5	20.1	34.9	19.5	29.0	33.1	71.5	114.1	98.7	188.7	188.4	73.7	146.1	94.3	71.0	75.1	57.6	98.2	75.1	18.3	58.2	233.1	107.9	140.5	23.3	79.1	101.6	100.8	173.4	111.0	77.8	71.2	52.4	248.8	105.0	87.8	140.2	80.6	111.7	118.1	78.5	135.2	56.5	69.4	115.4	72.5	35.3	62.2	38.8	179.1	77.0	117.6	198.4	171.5	138.4	122.8	198.6
BRD4	"CAP, HUNK1, HUNKI, MCAP"	ENSG00000141867	"Bromodomain containing 4"	O60885	19	15235519-15332545	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015055, HPA061646, CAB068177, CAB068178"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB068177: AB_2665685, CAB068178: AB_2665686, HPA015055: AB_1845435, HPA061646: AB_2684575"	"unprognostic (2.83e-3)"	"unprognostic (2.39e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.53e-3)"	"unprognostic (3.03e-3)"	"unprognostic (6.13e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.98e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.22e-1)"	23.0	20.7	27.8	25.6	30.1	25.2	20.4	32.1	29.9	20.8	19.6	17.2	18.9	17.6	23.4	12.5	22.9	18.6	15.8	21.3	20.3	12.4	18.1	25.3	22.5	22.7	14.8	17.6	27.3	31.3	19.1	18.8	34.0	17.6	20.8	10.7	18.9	22.0	19.3	47.7	27.3	21.0	20.3	13.9	26.8	20.2	20.1	16.8	34.2	21.5	11.6	23.7	20.9	24.8	6.9	4.3	11.6	4.4	4.9	3.5	2.0	20.4	20.7	12.9	24.3	12.3	8.7	15.6	15.1	12.3	11.9	12.6	21.8	30.9	25.7	25.0	16.4	11.7	20.5	15.0	14.2	10.4	25.7	9.9	24.3	18.1	19.0	18.8	24.0	27.1	12.8	14.7	14.8	29.2	7.9	11.5	17.3	41.1	26.1	7.6	26.5	22.5	17.3	26.3	9.4	24.3	28.3	13.6	16.1	9.5	22.1	15.6	14.1	19.9	14.6	17.0	11.0	14.6	16.4	18.3	31.2	14.9	27.7	23.7	21.3	18.8	13.1	17.2	19.5	24.2	5.2	3.6	3.9	3.5	4.4	2.7	5.4	3.1	2.9	2.1	6.9	3.1	2.9	11.6	4.9	3.9	4.3	2.2	2.0	27.8	30.1	32.1	29.9	20.3	12.4	14.8	17.6	17.6	16.8	59.6	53.2	59.1	104.0	104.5	62.2	73.0	56.0	22.7	28.4	24.4	78.5	177.3	21.6	46.6	107.0	73.3	66.9	93.5	57.8	59.0	72.1	110.7	34.8	77.4	51.9	74.7	109.2	55.3	67.7	148.2	71.7	51.2	42.2	43.3	47.3	38.6	55.1	44.4	75.0	28.3	85.9	71.1	85.8	52.5	37.5	125.2	212.7	56.7	51.5	128.6
BRD7	"BP75, CELTIX1"	ENSG00000166164	"Bromodomain containing 7"	Q9NPI1	16	50313487-50368934	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Wnt signaling pathway"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042389, CAB046458, HPA060171"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB046458: AB_2066024, HPA042389: AB_2677974, HPA060171: AB_2684214"	"unprognostic (2.10e-2)"	"unprognostic (9.52e-3)"	"unprognostic (7.06e-2)"	"unprognostic (3.39e-2)"	"unprognostic (7.27e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.38e-4)"	"unprognostic (2.15e-1)"	"unprognostic (8.97e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (6.34e-2)"	23.5	26.9	38.8	33.7	39.0	42.2	39.1	34.5	35.9	24.5	30.7	32.4	26.4	23.4	29.0	38.1	37.3	27.1	24.4	41.2	35.3	31.9	29.9	22.9	27.9	32.1	38.4	26.9	26.8	36.5	53.3	35.1	37.9	42.6	29.5	30.3	22.2	26.9	30.7	37.9	31.2	31.1	27.2	48.1	32.1	29.0	41.5	36.4	46.1	31.2	26.5	36.4	24.5	40.0	8.8	11.2	9.6	6.8	12.3	12.1	3.7	22.3	19.7	34.7	20.6	14.7	14.6	22.9	18.4	18.2	29.1	13.2	33.1	22.8	33.4	19.3	16.3	18.1	20.7	31.7	18.5	33.6	15.1	26.3	22.6	15.8	45.7	17.3	31.1	25.0	10.6	27.9	14.9	25.8	17.7	19.3	33.2	32.6	10.7	17.7	14.5	35.2	42.0	27.2	23.6	18.8	43.4	32.6	24.2	25.4	15.8	27.0	21.9	22.3	21.7	15.0	31.0	13.0	28.3	19.4	18.5	22.5	15.2	17.8	5.1	1.9	57.1	14.5	22.7	18.3	8.2	6.8	9.6	8.8	5.7	6.8	8.0	8.9	8.1	5.4	8.8	10.1	12.1	4.0	12.3	5.1	11.2	8.5	3.7	38.8	39.0	34.5	35.9	35.3	31.9	38.4	26.9	42.6	36.4	35.7	59.7	42.5	27.5	45.1	90.5	31.9	48.4	50.9	36.4	47.1	62.8	63.5	91.2	20.0	32.8	31.4	37.2	46.7	19.9	40.7	28.7	42.0	15.0	35.5	26.0	85.8	34.5	23.9	27.0	15.6	30.2	35.5	25.3	14.4	38.2	74.8	20.8	37.0	26.5	46.0	113.1	51.8	22.1	155.1	163.9	55.3	60.5	24.9	35.5	64.3
BRD9	FLJ13441	ENSG00000028310	"Bromodomain containing 9"	Q9H8M2	5	850291-892824	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021465, HPA023197"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021465: AB_1845441, HPA023197: AB_2671106"	"unprognostic (3.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-3)"	"unprognostic (4.61e-2)"	"unprognostic (5.89e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (5.88e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.53e-3)"	"unprognostic (3.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.28e-2)"	"prognostic unfavorable (2.37e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.02e-2)"	13.7	12.3	14.5	15.2	23.8	12.7	12.9	31.8	22.0	13.0	13.0	16.1	10.9	11.7	17.9	10.0	12.8	14.9	9.1	15.3	16.2	10.9	9.1	8.5	11.9	14.3	15.1	15.0	16.3	14.6	13.2	18.2	10.9	14.4	11.2	11.1	11.1	14.7	14.7	25.8	13.1	12.5	12.7	13.9	12.5	13.6	18.5	21.1	16.8	13.3	12.0	15.9	15.6	14.4	6.5	3.1	6.2	4.7	2.7	4.8	1.1	6.2	3.8	12.0	11.9	4.3	8.8	13.7	12.5	7.3	12.5	9.2	7.9	8.5	8.0	19.3	11.8	13.3	5.8	8.1	11.3	10.5	43.9	5.5	10.4	13.8	3.9	9.4	15.0	8.9	6.6	3.3	8.8	7.7	8.8	12.2	14.3	12.7	5.7	9.4	6.4	17.3	8.6	7.2	5.7	6.5	11.0	7.3	6.8	6.3	8.2	7.1	12.6	23.9	8.4	4.4	6.6	7.5	13.2	12.1	11.2	7.5	5.8	12.1	9.2	4.2	14.2	9.4	14.4	13.6	6.2	4.7	5.4	3.5	2.4	4.6	6.5	4.2	4.8	3.1	4.9	4.8	3.0	4.1	2.7	3.1	1.8	4.5	1.1	14.5	23.8	31.8	22.0	16.2	10.9	15.1	15.0	14.4	21.1	17.9	15.6	25.2	12.1	22.6	66.5	21.2	25.5	2.7	14.8	22.7	43.2	15.1	19.9	21.0	76.4	21.8	20.0	0.0	17.1	26.0	16.9	10.8	18.5	18.4	18.2	95.3	15.6	33.7	23.0	43.5	21.0	16.9	13.5	24.4	24.0	25.2	23.6	21.6	18.4	12.6	85.2	25.8	16.5	33.9	61.3	17.8	16.5	29.9	21.8	11.5
BRIX1	"BRIX, BXDC2, FLJ11100"	ENSG00000113460	"BRX1, biogenesis of ribosomes"	Q8TDN6	5	34915376-34925996	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039614			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA039614: AB_10963698"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (1.82e-1)"	"unprognostic (5.85e-3)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (3.37e-2)"	"unprognostic (3.84e-3)"	"prognostic favorable (6.34e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (3.07e-9)"	"unprognostic (1.95e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.09e-2)"	18.9	18.4	20.4	15.6	24.0	30.6	23.7	24.9	24.1	16.4	14.4	10.7	18.9	11.9	18.1	18.2	23.4	17.6	11.9	16.4	15.8	15.2	17.0	18.6	14.0	22.2	21.1	15.6	19.4	13.4	15.6	19.1	24.5	20.9	15.9	16.5	7.7	15.7	14.5	19.7	15.9	13.3	22.9	18.6	17.0	14.7	13.4	21.9	17.0	16.6	14.2	23.1	21.6	21.7	22.9	14.0	4.1	10.4	15.0	22.1	16.2	14.8	14.7	15.0	20.7	6.5	9.3	29.6	18.4	13.0	24.9	15.9	20.0	19.7	32.8	9.5	10.9	27.7	12.4	26.2	18.9	28.3	17.6	25.9	21.9	35.2	17.8	17.9	34.8	15.2	11.2	12.3	22.9	20.7	7.6	11.4	17.2	38.3	10.0	16.2	16.1	24.1	38.1	24.2	17.6	21.6	21.6	27.2	14.1	14.3	17.3	18.2	16.3	38.0	26.7	17.1	12.4	16.7	21.5	6.8	19.1	20.9	13.7	35.1	9.1	19.4	41.6	16.5	40.1	23.7	4.1	8.5	4.0	14.4	7.9	20.4	22.9	17.7	18.1	10.7	18.0	22.1	19.6	0.5	15.0	10.4	14.0	16.4	16.2	20.4	24.0	24.9	24.1	15.8	15.2	21.1	15.6	20.9	21.9	26.8	30.7	36.9	76.5	96.6	20.2	18.6	15.3	46.8	48.9	22.7	11.8	108.4	41.4	38.0	10.5	32.1	8.4	23.3	37.3	80.2	49.4	31.2	18.6	11.5	37.1	20.6	20.2	16.5	12.9	6.8	36.5	20.6	30.4	33.3	17.8	15.1	37.9	10.5	27.3	26.6	34.1	6.5	35.4	54.6	70.7	83.7	105.5	31.6	29.0	66.5
BSDC1	"FLJ10276, RP4-811H24.7"	ENSG00000160058	"BSD domain containing 1"	Q9NW68	1	32365103-32394731	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031358, HPA031360"	Approved		Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus"	"Plasma membrane"	"HPA031358: AB_2673841, HPA031360: AB_10601120"	"unprognostic (1.42e-1)"	"unprognostic (8.97e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.82e-5)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.56e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.92e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.07e-1)"	21.9	34.7	30.5	16.8	33.9	45.6	22.8	44.0	41.2	20.7	20.5	34.4	30.8	20.7	25.9	36.8	19.9	22.5	23.4	19.6	27.7	27.1	20.1	41.4	19.6	16.6	27.8	27.2	32.0	37.1	44.5	26.4	28.1	32.5	24.8	24.3	22.2	30.4	21.2	19.0	25.1	23.9	22.8	28.9	20.1	21.4	40.4	27.3	16.2	23.9	16.1	20.3	19.5	19.8	8.4	6.8	36.4	5.8	5.2	6.8	5.4	17.5	9.5	19.6	18.2	28.0	23.5	15.9	20.1	27.4	25.6	25.8	13.9	16.2	12.7	23.1	29.1	18.7	16.2	15.4	15.1	20.5	24.2	19.5	10.2	17.9	15.8	26.1	12.8	17.6	23.7	33.8	23.3	16.2	31.3	22.0	17.4	27.4	21.9	18.4	9.2	14.9	11.5	17.2	13.2	15.4	12.3	14.8	17.1	18.7	13.6	28.7	15.8	18.8	19.6	19.2	30.9	15.8	11.3	21.9	16.1	13.6	22.3	16.9	24.8	29.4	9.3	20.7	14.0	12.0	36.4	4.9	17.2	6.5	5.8	6.8	5.9	5.8	5.4	4.6	8.4	6.8	5.9	8.1	5.2	5.1	6.8	6.1	5.4	30.5	33.9	44.0	41.2	27.7	27.1	27.8	27.2	32.5	27.3	29.8	15.2	36.9	49.2	25.2	48.7	17.1	35.7	14.7	10.3	24.4	78.5	42.9	16.6	31.5	87.7	26.6	52.4	70.0	38.4	26.0	26.1	51.5	20.7	49.0	18.0	81.0	38.5	52.8	18.7	78.5	50.6	15.3	30.4	26.2	43.0	35.7	38.9	31.6	44.6	22.6	66.5	38.8	25.9	28.6	41.1	22.6	80.7	37.0	35.7	42.7
BUD13	"Cwc26, fSAP71, MGC13125"	ENSG00000137656	"BUD13 homolog"	Q9BRD0	11	116748170-116772988	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038340, HPA038341"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038340: AB_2675967, HPA038341: AB_10671528"	"unprognostic (1.89e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (5.07e-5)"	"unprognostic (1.77e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.63e-1)"	15.1	10.0	9.7	20.4	12.4	12.9	16.1	19.0	15.5	21.2	20.6	16.1	11.6	12.8	19.4	13.8	16.3	16.8	13.7	13.2	9.5	9.4	12.4	11.3	14.4	17.5	10.8	7.8	20.4	13.8	15.7	13.3	18.0	11.0	17.1	16.3	13.5	14.7	13.4	18.5	15.1	20.8	15.5	12.4	18.1	14.7	29.8	11.9	37.9	18.1	14.0	21.2	16.6	22.6	10.8	8.5	20.1	8.7	7.1	11.9	5.7	11.0	6.1	17.2	10.3	5.5	6.6	8.6	10.9	12.2	12.6	12.3	14.3	16.8	23.5	13.9	9.0	13.2	15.6	13.8	8.5	13.9	13.7	5.6	27.4	4.4	10.8	6.7	23.0	16.4	6.0	10.0	10.6	10.9	8.1	12.2	23.4	17.5	11.7	10.3	8.7	28.0	20.4	10.3	15.8	9.7	21.2	14.8	18.1	8.9	12.8	10.2	13.6	12.8	9.4	5.0	11.4	12.9	15.3	6.9	14.5	9.2	7.3	14.5	4.8	6.0	19.4	4.7	21.3	12.8	14.3	7.8	20.1	10.9	7.8	11.9	10.8	9.4	8.6	8.5	8.8	10.8	8.8	9.5	7.1	8.7	7.5	8.0	5.7	9.7	12.4	19.0	15.5	9.5	9.4	10.8	7.8	11.0	11.9	8.9	3.5	6.9	10.0	6.8	6.6	3.7	2.5	12.0	5.7	8.7	11.8	7.2	6.6	6.8	7.7	6.6	10.2	23.3	7.2	9.4	5.1	5.1	10.5	5.4	7.0	3.2	9.2	6.7	7.9	3.2	8.3	8.1	6.8	4.6	6.4	6.9	5.1	6.8	10.3	3.9	6.5	6.5	3.6	33.2	21.3	4.3	8.2	10.0	9.7	5.8
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921188-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	11.5	13.4	6.0	11.5	7.2	6.0	17.5	5.0	8.9	7.8	7.9	4.6	5.3	4.0	11.0	5.4	11.7	9.3	10.0	17.6	5.9	6.8	8.0	18.6	7.1	7.4	5.8	6.5	11.8	15.9	10.6	5.4	11.3	7.4	8.0	6.8	4.8	9.6	7.9	31.7	9.2	5.0	12.6	6.3	9.9	7.3	8.9	4.6	20.1	7.1	11.9	12.9	7.3	10.1	4.0	9.3	0.9	3.4	4.5	5.5	2.2	11.9	14.8	8.2	11.6	6.1	6.9	16.8	12.2	6.4	19.3	14.1	20.4	3.1	22.0	11.1	9.1	13.2	7.9	24.9	17.8	15.2	7.9	27.1	20.5	10.4	22.9	10.6	14.6	9.0	8.9	11.6	18.0	16.4	4.2	13.2	12.9	26.0	4.9	12.7	20.4	15.3	14.7	6.4	37.3	15.6	18.3	11.2	14.0	10.7	10.2	16.5	10.0	8.1	7.4	14.2	6.6	8.6	12.9	10.2	11.2	13.3	7.6	17.7	5.7	7.4	47.6	3.8	14.8	11.7	0.0	3.4	0.9	3.9	3.4	5.5	3.8	2.5	3.1	5.4	4.0	1.3	3.0	0.3	4.5	3.1	9.3	3.1	2.2	6.0	7.2	5.0	8.9	5.9	6.8	5.8	6.5	7.4	4.6	0.0	3.8	8.9	21.5	27.5	2.5	2.5	5.1	4.0	5.7	1.8	3.9	19.5	3.3	20.9	6.2	7.1	1.4	0.0	14.8	19.5	10.6	9.6	2.3	6.6	10.6	0.0	5.2	4.3	1.0	3.4	7.5	5.3	8.5	7.2	5.5	3.4	18.6	0.0	6.7	8.4	2.8	6.5	17.3	6.5	26.9	22.1	24.4	5.0	9.9	23.5
C11orf1	FLJ23499	ENSG00000137720	"Chromosome 11 open reading frame 1"	Q9H5F2	11	111878935-111885975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	16	"Early spermatids: 375.8;Late spermatids: 825.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038410, HPA057519"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038410: AB_10672591, HPA057519: AB_2683454"	"unprognostic (1.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (9.32e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.26e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.86e-2)"	"prognostic favorable (1.39e-4)"	"unprognostic (3.76e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.08e-1)"	11.5	21.2	20.3	12.5	34.8	8.9	29.2	8.3	13.9	12.6	15.8	11.2	21.0	11.8	10.4	39.3	17.7	17.0	19.8	20.8	16.6	18.2	40.1	31.2	15.8	12.4	20.2	12.0	17.1	47.6	19.9	18.9	8.3	14.3	16.6	15.8	12.7	22.6	29.5	8.3	16.9	15.5	10.2	17.4	10.0	15.6	31.4	12.2	10.6	24.2	15.0	10.2	14.2	9.5	14.8	19.0	5.0	8.2	9.5	22.0	6.3	8.0	10.4	13.6	15.0	15.7	12.1	14.1	4.5	11.5	3.7	4.7	17.3	15.1	29.6	21.5	7.6	10.6	9.5	5.4	16.5	5.8	13.1	7.7	10.0	2.2	13.4	9.9	14.6	7.1	22.1	26.0	13.1	25.3	16.6	4.5	31.9	14.3	22.4	12.4	7.9	19.7	23.0	15.5	28.2	15.9	10.2	14.1	41.2	22.9	14.9	12.2	11.7	2.8	10.6	9.6	13.6	21.2	10.3	3.9	13.7	9.8	6.0	6.2	13.1	19.1	44.2	7.0	17.4	8.3	3.3	4.4	5.0	8.2	8.2	15.4	14.8	13.7	10.4	6.4	10.2	22.0	16.4	1.1	9.5	5.5	19.0	9.7	6.3	20.3	34.8	8.3	13.9	16.6	18.2	20.2	12.0	14.3	12.2	23.8	17.5	18.4	55.8	21.1	6.9	48.4	20.4	42.8	31.8	33.2	5.9	24.6	170.8	16.9	375.8	13.5	15.8	46.7	23.8	20.6	13.9	36.9	28.8	31.0	21.2	14.3	25.3	9.2	7.3	825.1	25.3	19.0	23.6	19.0	36.6	26.8	21.3	17.5	23.0	138.3	12.9	19.4	12.7	47.1	30.9	25.7	17.6	12.7	46.6	52.8
C11orf52	"FLJ25219, MGC14839"	ENSG00000149300	"Chromosome 11 open reading frame 52"	Q96A22	11	111918032-111926872	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 3.2;Ciliated cells: 10.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.5;CAPAN-2: 11.1;Hep G2: 9.4;MCF7: 8.4;RPTEC TERT1: 13.7;SK-BR-3: 11.7;T-47d: 38.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA038387, HPA038388"	Uncertain		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA038387: AB_10670167, HPA038388: AB_2675987"	"unprognostic (1.30e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.84e-4)"	"unprognostic (1.48e-4)"	"unprognostic (2.57e-1)"	"unprognostic (8.04e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.07e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.80e-1)"	"unprognostic (5.38e-4)"	"unprognostic (1.44e-1)"		"unprognostic (1.84e-1)"	"unprognostic (3.03e-1)"	1.8	0.5	0.7	1.0	1.9	0.0	13.8	3.2	0.8	1.7	7.6	0.9	25.9	4.9	2.1	12.8	3.9	8.9	11.3	2.0	1.0	0.6	38.7	12.9	12.7	0.3	2.9	0.3	2.2	38.0	12.6	12.8	25.8	2.2	9.1	2.9	1.6	23.8	33.9	5.3	5.5	12.4	1.0	2.5	0.6	10.9	0.8	1.0	0.8	22.9	2.1	3.0	4.6	3.6	0.0	0.0	0.0	0.1	0.0	0.7	0.0	2.1	0.0	0.0	0.0	1.4	0.2	8.5	0.5	0.4	0.1	0.0	3.2	11.1	0.0	5.2	1.2	0.0	2.6	0.0	0.7	0.0	0.0	0.3	0.0	0.2	9.4	0.0	0.0	0.0	0.3	2.6	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.7	8.4	0.0	0.0	0.0	5.8	0.9	0.0	0.7	0.0	13.7	7.5	0.5	0.0	0.0	11.7	0.0	1.2	38.4	0.7	0.9	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.9	3.2	0.8	1.0	0.6	2.9	0.3	2.2	1.0	6.0	3.2	0.0	0.7	0.1	0.0	0.4	0.0	10.7	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.5	0.0	0.1	0.3	1.1	0.0	0.0	0.5
C11orf71	FLJ20010	ENSG00000180425	"Chromosome 11 open reading frame 71"	Q6IPW1	11	114391443-114400511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in all"	5	"testis: 83.2"	"Group enriched"	"Detected in many"	15	"Early spermatids: 502.7;Late spermatids: 1567.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 19.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063943, HPA074787"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA063943: AB_2685157, HPA074787: AB_2686712"	"unprognostic (1.24e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (7.35e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.04e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (7.01e-9)"	"unprognostic (5.68e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	3.9	7.3	5.7	3.4	12.1	2.2	5.7	4.1	8.1	4.2	4.9	10.2	5.6	5.5	3.7	18.0	3.2	5.4	3.9	5.4	6.9	6.1	10.6	15.0	3.9	4.3	10.3	4.7	5.0	6.9	8.7	6.9	2.5	6.7	5.6	4.6	5.7	7.2	5.0	9.9	5.6	5.1	2.1	5.7	5.4	5.2	83.2	12.2	6.4	9.5	4.7	3.2	3.1	3.1	10.5	13.6	14.5	17.7	13.2	11.9	11.3	1.2	3.3	3.5	11.1	5.3	3.1	2.5	0.5	1.4	1.4	1.3	2.7	19.9	5.3	7.1	0.8	6.9	5.1	2.3	2.3	1.7	6.1	1.4	4.0	2.4	5.3	5.0	2.3	4.5	5.0	2.6	1.8	5.6	1.6	1.7	8.9	4.1	5.0	2.6	4.5	4.2	3.5	1.8	4.4	2.1	3.1	2.8	13.6	3.1	2.4	9.6	3.8	12.5	1.4	1.9	3.8	9.4	1.3	1.7	0.3	5.2	3.9	0.9	4.9	7.9	4.1	0.7	5.5	1.4	11.7	17.7	11.1	10.3	11.1	6.3	7.0	7.0	7.1	10.6	10.5	11.4	11.9	14.5	13.2	12.2	13.6	7.7	11.3	5.7	12.1	4.1	8.1	6.9	6.1	10.3	4.7	6.7	12.2	3.0	11.2	1.5	13.8	2.4	9.8	18.7	0.0	24.1	5.7	5.2	3.9	14.3	69.6	12.0	502.7	7.0	13.5	0.0	16.8	2.2	3.7	14.4	5.8	0.0	10.1	12.7	17.4	0.0	0.0	1567.4	12.0	9.1	5.0	10.0	19.0	23.4	11.0	17.5	8.5	59.7	12.5	6.5	4.1	23.4	8.8	2.3	12.2	1.7	15.1	9.5
C12orf43	FLJ12448	ENSG00000157895	"Chromosome 12 open reading frame 43"	Q96C57	12	121000486-121016502	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046148, HPA061739"	Uncertain		Supported	"Nucleoli,Golgi apparatus"		NA	NA			Nucleoli	"Golgi apparatus"	"HPA046148: AB_10965169, HPA061739: AB_2684597"	"unprognostic (1.51e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (3.53e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-3)"	"unprognostic (9.70e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.36e-1)"	10.0	8.6	12.1	7.5	12.9	7.5	8.7	15.2	19.6	7.4	10.2	8.5	3.1	5.7	11.4	5.3	7.2	11.2	5.8	8.7	8.4	8.5	7.2	12.0	7.8	9.2	8.3	11.1	14.3	8.8	9.3	6.8	8.3	13.1	7.3	6.4	8.0	10.0	8.0	7.2	6.4	5.8	10.0	7.1	7.3	7.2	7.1	6.7	7.5	7.6	4.0	8.4	9.6	6.9	16.2	10.7	5.8	13.7	11.0	19.9	13.4	9.8	22.3	11.7	9.1	10.4	8.2	12.9	12.2	12.6	20.6	13.0	16.0	9.3	18.3	12.6	11.8	10.9	11.2	13.7	18.7	12.4	21.9	15.3	14.6	9.5	11.8	12.3	19.3	11.8	9.6	9.9	18.9	12.0	13.1	11.8	19.3	17.3	4.9	10.8	16.2	21.1	15.2	20.8	7.7	16.7	19.0	13.8	13.8	12.6	14.8	16.0	10.2	16.4	7.2	13.2	10.2	19.4	9.1	11.2	11.4	13.7	9.2	12.8	8.9	12.8	14.3	15.0	11.6	16.8	3.7	10.3	5.8	16.9	13.7	15.4	16.2	16.7	16.4	10.7	13.0	19.9	16.9	1.6	11.0	11.4	8.6	15.1	13.4	12.1	12.9	15.2	19.6	8.4	8.5	8.3	11.1	13.1	6.7	23.8	17.8	18.3	14.4	7.8	17.3	5.9	7.6	22.7	7.9	17.4	19.6	19.3	19.9	13.9	4.8	14.4	4.9	0.0	15.9	18.1	10.8	10.6	13.9	10.2	14.6	15.9	2.4	11.1	11.0	8.2	12.7	8.1	13.5	25.2	7.7	15.4	13.1	8.6	12.0	12.9	13.6	19.4	14.4	12.6	12.8	6.8	11.4	16.6	9.5	10.6
C12orf57	"C10, GRCC10"	ENSG00000111678	"Chromosome 12 open reading frame 57"	Q99622	12	6942978-6946003	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046182, HPA059163, HPA066043"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA046182: AB_2679572, HPA059163: AB_2683937, HPA066043: AB_2685603"	"unprognostic (5.89e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.20e-3)"	"unprognostic (8.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (8.74e-4)"	"unprognostic (4.25e-2)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.47e-2)"	"unprognostic (3.26e-1)"	"unprognostic (6.81e-2)"	"unprognostic (8.39e-3)"	34.1	46.2	40.0	22.3	36.3	32.5	57.5	32.9	47.1	55.1	40.6	17.3	66.1	22.7	63.7	48.5	38.2	55.3	54.2	61.1	30.9	35.3	38.0	43.3	34.2	47.5	35.3	23.2	132.1	116.3	14.1	49.9	26.5	23.1	58.6	20.7	42.5	52.9	73.4	45.5	42.6	22.3	45.3	21.7	22.8	30.9	25.9	16.3	91.6	50.8	29.3	34.1	50.6	78.1	33.4	43.5	11.8	15.8	17.6	52.6	30.8	14.2	42.0	49.2	48.3	34.0	40.8	16.3	18.8	46.7	16.4	26.1	16.6	24.4	4.4	15.0	29.3	21.1	13.8	18.7	23.3	3.9	25.5	38.9	38.1	34.6	23.5	64.7	15.5	37.5	48.8	27.9	12.6	17.3	32.2	27.5	36.1	13.0	38.8	15.1	42.8	32.5	20.1	87.8	23.8	15.4	36.3	43.9	65.2	21.8	36.0	21.9	64.2	30.3	31.0	37.7	24.3	7.8	82.3	28.8	33.0	31.3	13.1	27.9	28.8	23.2	23.6	34.0	0.4	22.0	11.8	3.9	3.6	38.8	6.4	25.6	25.2	43.8	41.0	5.8	33.4	52.6	42.9	1.6	17.6	15.8	43.5	38.1	30.8	40.0	36.3	32.9	47.1	30.9	35.3	35.3	23.2	23.1	16.3	59.6	118.9	155.2	220.4	234.9	85.7	193.7	191.1	83.0	124.0	116.9	23.6	106.7	310.0	168.6	133.9	186.1	158.5	0.0	372.0	184.2	224.0	232.5	145.5	244.6	58.5	35.0	299.7	176.1	78.4	224.0	419.7	91.0	219.4	62.3	387.2	96.5	211.2	244.1	354.7	163.1	67.1	284.6	342.1	44.5	93.2	187.9	129.0	231.0	327.3	202.6
C15orf39	"DKFZP434H132, FLJ46337"	ENSG00000167173	"Chromosome 15 open reading frame 39"	Q6ZRI6	15	75195643-75212169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.7"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 16.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5.7;granulocytes: 16.9;monocytes: 10.4"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039961, HPA041907"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA039961: AB_10673024, HPA041907: AB_2677736"	"unprognostic (3.53e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.46e-2)"	"prognostic favorable (7.94e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.74e-1)"	"unprognostic (8.47e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.14e-1)"	14.7	10.2	3.5	9.6	5.3	36.1	9.0	2.5	4.1	11.8	8.5	3.1	3.8	7.9	16.5	5.8	13.1	11.5	13.9	7.7	3.5	3.3	5.6	5.3	11.7	11.6	3.3	2.2	23.3	11.4	5.2	7.5	24.4	3.9	10.0	3.9	7.7	12.5	5.3	4.4	9.9	7.6	10.0	3.3	21.1	6.6	71.7	3.2	11.1	7.8	9.0	17.0	10.5	13.7	0.8	5.7	16.9	10.4	2.2	1.3	2.2	7.7	15.9	3.4	4.0	4.7	3.1	10.5	2.2	4.6	2.6	2.8	19.6	10.8	17.5	7.6	3.3	9.6	10.5	14.8	6.8	0.7	17.1	16.7	34.7	7.7	13.4	5.4	9.9	35.9	4.0	5.4	5.6	2.6	3.3	6.7	6.7	14.8	26.2	0.8	4.6	9.5	12.2	10.8	5.2	6.4	8.7	2.6	18.6	1.6	6.1	10.1	3.2	5.2	12.1	8.2	3.6	4.1	12.7	5.7	4.6	7.0	8.3	6.5	19.0	11.9	10.1	4.6	19.3	4.5	4.8	4.2	12.2	1.3	8.2	1.0	0.8	0.7	0.9	2.7	0.5	0.6	0.8	16.9	2.2	10.4	5.7	0.9	2.2	3.5	5.3	2.5	4.1	3.5	3.3	3.3	2.2	3.9	3.2	23.8	5.6	6.0	5.7	13.3	0.2	1.6	7.6	6.7	9.1	3.5	0.0	9.9	0.0	13.8	38.4	10.0	5.4	0.0	12.4	13.9	12.0	4.3	17.3	1.5	10.6	0.0	7.5	9.8	20.8	54.3	10.9	11.3	6.8	12.6	5.9	0.7	14.8	23.2	10.3	1.4	1.9	12.9	10.5	11.2	5.3	12.4	17.5	6.4	7.4	12.7
C19orf47	FLJ36888	ENSG00000160392	"Chromosome 19 open reading frame 47"	Q8N9M1	19	40319536-40348527	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 35.4;skeletal muscle: 118.0"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 20.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 20.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041843, HPA046309"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA041843: AB_10959886, HPA046309: AB_10960266"	"prognostic favorable (6.50e-4)"	"unprognostic (1.35e-3)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (2.75e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (2.26e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.28e-2)"	3.2	2.9	4.5	4.2	5.7	4.7	4.4	5.8	9.1	3.5	3.3	9.2	3.6	3.8	3.8	3.1	7.4	2.8	3.5	35.4	4.2	3.8	2.9	4.4	3.4	4.5	6.2	5.0	3.6	3.8	3.7	3.7	4.8	5.6	4.5	2.5	3.6	4.9	4.6	118.0	5.2	3.6	3.7	4.8	3.7	3.0	10.0	5.3	5.0	3.8	6.4	4.7	4.1	5.0	2.1	1.6	20.2	1.6	1.7	2.3	1.3	12.9	19.9	8.4	9.1	5.0	4.5	11.6	13.4	6.2	12.7	15.4	16.5	5.4	15.1	7.5	6.3	6.7	6.5	10.2	12.3	5.3	18.5	12.5	12.3	12.4	12.5	3.7	12.4	8.0	4.5	7.3	17.1	6.1	3.4	7.7	14.1	15.0	8.9	10.7	12.6	18.5	7.0	5.4	10.4	7.6	18.4	13.8	7.6	4.1	11.4	10.8	8.8	14.4	13.6	5.2	5.2	8.1	10.3	10.1	16.0	11.2	10.8	18.3	10.7	14.7	15.0	6.8	11.9	11.0	20.2	1.6	4.7	1.3	1.4	1.6	1.6	2.3	2.1	1.6	2.1	1.6	1.2	5.7	1.7	1.6	1.6	1.6	1.3	4.5	5.7	5.8	9.1	4.2	3.8	6.2	5.0	5.6	5.3	3.0	3.2	0.0	2.4	4.2	2.9	39.1	2.5	1.4	2.3	0.0	2.0	9.1	0.0	3.2	8.0	3.7	2.9	0.0	3.9	11.7	4.7	1.6	4.6	3.8	5.8	3.2	3.5	5.5	5.6	17.1	1.7	2.6	5.0	2.8	2.8	2.9	3.3	0.0	6.3	2.4	1.8	6.5	2.1	14.9	5.5	6.0	13.3	2.2	2.3	1.4
C1orf116	"FLJ36507, MGC2742, MGC4309, SARG"	ENSG00000182795	"Chromosome 1 open reading frame 116"	Q9BW04	1	207018521-207032756	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA011888, HPA011889"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		7900	"Plasma membrane, Cytosol"		"HPA011888: AB_1853872, HPA011889: AB_1853873"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.35e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.19e-2)"	"unprognostic (8.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.87e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (1.01e-5)"	"unprognostic (5.17e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.57e-3)"	"unprognostic (1.19e-1)"	0.2	0.3	0.2	1.6	0.2	0.0	4.1	0.2	0.4	7.1	8.3	0.3	0.2	8.4	1.0	1.1	49.4	0.6	14.0	0.2	0.3	0.1	4.3	1.1	42.8	0.2	0.2	0.2	0.5	7.0	0.0	0.9	1.4	0.4	18.8	2.7	0.3	12.5	1.9	0.3	14.4	16.5	0.6	0.2	0.4	20.3	0.4	0.2	0.4	6.8	16.0	37.1	6.1	12.3	0.0	0.0	0.7	0.0	0.1	0.0	1.8	18.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	32.4	0.0	2.1	0.0	0.0	40.0	0.0	38.4	0.0	0.0	0.0	3.3	0.3	0.5	0.0	0.0	0.2	0.0	20.4	0.0	11.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	11.8	1.0	0.0	0.0	0.0	18.7	4.8	0.0	0.1	0.3	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.2	0.2	0.2	0.4	0.3	0.1	0.2	0.2	0.4	0.2	163.8	71.9	0.0	39.9	18.4	0.0	42.3	28.1	41.5	78.5	10.4	0.0	0.0	13.3	21.7	4.8	0.0	31.1	0.0	21.6	0.0	0.5	57.3	5.8	0.0	0.2	0.0	10.3	0.0	0.0	3.3	0.3	0.6	0.0	0.0	16.3	0.0	41.6	7.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	20.5	0.0	0.0	7.4	120.4
C1orf174	RP13-531C17.2	ENSG00000198912	"Chromosome 1 open reading frame 174"	Q8IYL3	1	3889125-3900293	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008270, HPA065778"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA008270: AB_1845633, HPA065778: AB_2685557"	"unprognostic (4.91e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (5.84e-4)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (7.24e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.02e-2)"	"prognostic unfavorable (2.73e-6)"	"unprognostic (3.71e-2)"	"unprognostic (3.95e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.46e-2)"	17.6	17.4	15.0	18.8	16.5	24.0	17.8	16.3	19.2	15.4	16.9	21.3	11.6	15.6	19.4	20.1	19.3	19.7	21.1	13.4	15.3	15.4	18.1	24.8	14.5	20.2	15.8	17.1	19.6	20.0	5.4	13.3	24.4	16.7	18.9	15.6	16.5	15.9	17.2	22.9	15.6	16.5	20.1	13.7	22.4	16.5	18.9	15.3	26.9	21.9	19.7	22.4	19.5	15.0	16.5	18.7	30.4	28.8	16.1	27.6	13.6	14.3	8.4	13.3	11.2	11.2	7.0	9.4	13.2	7.4	11.8	12.1	12.2	22.8	11.4	14.9	9.7	16.5	13.9	14.0	9.0	13.3	19.3	13.6	29.4	8.6	17.9	6.9	20.9	15.3	7.4	5.9	12.4	10.0	9.2	9.4	14.1	22.9	11.7	8.2	10.7	21.6	16.1	15.1	19.2	17.8	16.4	22.2	10.7	8.0	8.7	12.8	10.6	12.0	18.0	18.1	12.8	7.5	12.8	10.2	17.1	12.8	28.3	12.5	4.5	4.3	21.9	8.3	23.3	5.6	27.7	16.1	30.4	27.6	28.8	24.0	16.5	18.7	20.9	18.7	15.2	17.9	22.7	13.3	16.1	18.8	10.3	19.3	13.6	15.0	16.5	16.3	19.2	15.3	15.4	15.8	17.1	16.7	15.3	8.9	4.8	14.9	10.8	19.5	9.8	3.4	7.6	12.0	14.8	5.2	7.9	52.5	23.2	19.2	104.9	12.3	10.9	0.0	16.9	53.1	17.4	9.5	36.8	11.6	27.7	11.1	10.9	9.8	14.0	14.5	15.8	18.9	13.5	16.2	13.6	11.7	14.8	14.0	18.0	17.2	10.5	12.9	12.3	20.1	26.0	15.4	22.3	24.5	15.6	9.9
C1orf52	"FLJ44982, gm117"	ENSG00000162642	"Chromosome 1 open reading frame 52"	Q8N6N3	1	85249953-85259672	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036072, HPA061790"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036072: AB_10602696, HPA061790: AB_2684610"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (5.37e-5)"	"unprognostic (6.67e-3)"	"unprognostic (2.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (4.93e-4)"	"prognostic unfavorable (1.17e-7)"	"unprognostic (8.01e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.14e-1)"	"unprognostic (2.05e-2)"	14.4	13.5	22.4	13.4	30.1	42.9	17.4	13.8	25.8	11.8	12.3	19.1	9.4	11.3	14.2	16.9	12.0	11.3	12.2	13.0	25.4	19.3	9.9	13.3	14.6	20.3	20.6	19.9	13.9	14.2	11.0	15.6	21.0	17.9	13.1	11.9	8.8	11.5	11.8	18.0	19.8	10.7	12.0	18.7	14.1	12.0	17.0	20.3	12.4	11.4	8.8	14.3	11.2	12.3	27.3	20.8	25.6	21.4	15.5	23.6	16.7	13.4	6.1	11.9	9.9	13.0	9.9	20.7	13.7	8.3	15.1	14.8	8.7	7.2	12.4	12.9	12.0	13.5	9.0	24.0	7.8	15.2	12.8	15.0	16.7	10.7	10.9	11.5	17.2	7.8	7.9	11.1	13.2	10.1	10.6	9.5	18.7	19.7	13.7	8.8	3.7	13.1	14.0	36.7	6.5	8.8	14.5	13.8	5.3	15.0	8.4	7.3	11.4	3.8	10.7	20.2	15.7	6.1	28.0	9.1	8.3	12.4	15.2	16.8	13.0	21.7	18.9	4.9	13.2	9.3	25.6	15.1	22.8	16.4	21.4	17.6	27.3	15.6	14.2	19.4	16.7	23.6	22.9	23.6	15.5	17.6	20.8	12.9	16.7	22.4	30.1	13.8	25.8	25.4	19.3	20.6	19.9	17.9	20.3	41.7	26.4	35.3	50.1	129.1	22.6	21.3	7.6	30.8	33.0	15.7	21.6	54.0	16.6	32.5	28.7	43.0	21.5	23.3	24.1	49.7	56.0	31.9	49.7	14.7	32.0	14.3	37.2	25.8	27.0	8.0	33.9	37.1	30.4	16.2	18.9	25.6	27.3	23.5	23.0	17.3	25.6	38.8	54.2	91.6	55.3	112.7	56.8	36.3	22.0	60.4
C2orf42	FLJ20558	ENSG00000115998	"Chromosome 2 open reading frame 42"	Q9NWW7	2	70149880-70248615	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 41.2"	"Cell type enhanced"	"Detected in many"	20	"Early spermatids: 194.1;Late spermatids: 86.2;Spermatocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031840, HPA031841, HPA031842"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031840: AB_2674066, HPA031841: AB_10601124, HPA031842: AB_2674068"	"unprognostic (8.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.73e-1)"	"prognostic favorable (5.94e-5)"	"unprognostic (4.66e-2)"	"unprognostic (9.41e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.49e-3)"	6.2	5.9	6.2	4.3	8.7	3.1	6.8	10.7	11.8	6.4	4.5	11.5	6.6	3.2	6.6	8.5	5.0	8.7	5.7	4.2	7.2	6.4	6.3	11.2	4.5	8.2	7.3	6.2	8.3	5.0	8.6	8.2	5.9	6.7	5.0	4.0	7.4	4.6	5.8	4.8	4.9	4.6	5.8	6.1	6.7	4.4	41.2	8.2	9.7	6.2	2.1	8.3	6.2	7.5	12.8	6.6	8.0	6.6	17.9	14.2	9.0	4.9	8.4	8.0	7.2	15.9	9.8	9.0	12.0	8.0	10.1	8.4	6.4	4.6	6.2	7.0	7.5	16.1	7.0	8.1	6.8	10.7	11.0	7.2	7.5	5.9	6.4	14.2	6.2	7.6	11.6	13.0	9.2	11.9	10.5	9.3	8.2	6.3	24.8	12.7	4.7	8.0	8.8	5.6	8.4	9.0	7.7	10.7	11.5	8.2	6.0	6.6	6.6	6.4	11.0	12.1	5.7	4.7	7.5	7.2	8.8	6.1	8.1	9.6	13.3	13.2	6.4	7.2	10.0	7.7	1.9	6.6	8.0	11.2	6.1	14.2	12.8	11.4	13.4	6.6	11.5	13.2	13.7	7.0	17.9	6.1	6.0	12.6	9.0	6.2	8.7	10.7	11.8	7.2	6.4	7.3	6.2	6.7	8.2	0.0	2.1	11.8	2.6	2.3	6.6	2.4	0.0	5.3	1.2	5.2	0.0	7.4	6.6	3.1	194.1	2.6	2.9	0.0	2.1	3.0	4.0	2.7	2.3	5.8	3.8	0.0	1.2	5.5	3.5	86.2	6.9	2.7	3.3	1.0	2.2	7.0	1.7	2.9	7.4	5.4	3.9	0.0	3.1	42.3	11.7	3.8	8.0	6.4	2.1	1.8
C5orf51	LOC285636	ENSG00000205765	"Chromosome 5 open reading frame 51"	A6NDU8	5	41904188-41921636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043779, HPA063816"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043779: AB_2678666, HPA063816: AB_2685130"	"unprognostic (6.64e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.92e-3)"	"unprognostic (3.93e-2)"	"unprognostic (3.41e-2)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (4.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.67e-2)"	16.6	12.4	15.9	12.7	21.5	3.4	15.9	20.5	21.3	14.7	12.5	23.5	12.6	10.5	14.9	21.9	16.2	11.4	12.2	12.8	16.0	17.5	15.3	14.0	10.7	13.1	20.6	12.3	22.1	11.9	24.1	18.6	17.2	25.1	16.5	12.6	13.2	12.9	15.4	7.2	14.1	11.9	16.8	22.1	12.8	11.5	9.4	18.5	16.2	19.0	6.9	14.0	18.9	13.5	5.6	6.8	21.0	7.4	5.6	7.4	7.9	7.4	5.7	11.7	24.4	24.0	18.9	12.8	8.8	15.3	12.5	13.4	5.7	7.7	8.0	10.9	9.8	21.8	4.8	15.4	8.3	18.1	10.7	4.7	7.7	17.3	8.5	29.1	9.8	5.9	18.4	12.1	14.6	16.9	8.0	10.7	9.7	13.7	13.8	13.2	7.7	9.2	10.1	11.6	4.5	3.1	8.1	16.2	12.4	8.3	7.2	7.1	11.1	28.1	13.5	14.5	10.9	15.0	10.1	7.7	14.9	8.9	11.2	8.5	7.0	11.3	8.2	16.5	17.3	10.5	21.0	6.9	6.6	4.7	5.6	6.0	5.1	5.5	5.0	6.8	5.6	7.4	4.9	4.7	5.6	7.4	4.1	3.9	7.9	15.9	21.5	20.5	21.3	16.0	17.5	20.6	12.3	25.1	18.5	29.8	8.6	14.5	7.4	8.9	9.2	13.4	12.7	10.7	9.1	14.0	5.9	11.0	8.3	9.8	9.1	9.0	5.1	0.0	6.7	10.7	9.3	9.4	4.7	16.3	12.5	7.9	10.4	8.6	16.1	8.9	8.3	6.7	6.8	10.8	9.2	14.5	7.3	5.8	7.4	10.8	9.0	12.9	11.3	6.6	7.8	11.5	14.1	5.0	7.4	9.1
C7orf43	FLJ10925	ENSG00000146826	"Chromosome 7 open reading frame 43"	Q8WVR3	7	100154420-100158715	"Predicted intracellular proteins"			"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019359, HPA029463, HPA029464"	Approved		Enhanced	"Vesicles,Plasma membrane,Centriolar satellite"		NA	NA			Vesicles	"Plasma membrane, Centriolar satellite"	"HPA019359: AB_1848677, HPA029463: AB_10600001, HPA029464: AB_10600205"	"unprognostic (1.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.19e-3)"	"unprognostic (2.59e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.36e-3)"	"unprognostic (5.68e-3)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-1)"	"prognostic favorable (6.19e-5)"	"unprognostic (2.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.54e-3)"	7.0	10.4	10.6	23.0	11.3	12.2	12.2	24.8	23.2	6.7	14.0	9.4	13.6	16.2	9.6	10.8	12.1	8.4	10.5	6.4	12.8	13.9	12.3	12.9	19.0	21.4	10.8	10.6	5.7	11.6	18.7	14.5	21.6	14.6	10.2	13.5	8.8	13.5	10.8	10.1	28.1	16.4	6.9	6.0	25.8	14.9	26.8	6.9	17.6	12.2	7.4	14.0	8.5	7.8	2.1	0.7	5.2	1.7	0.5	2.6	1.0	4.8	6.3	7.5	12.6	4.7	2.5	8.4	9.1	7.2	6.4	4.6	4.9	5.8	6.2	8.4	6.9	9.9	9.5	3.5	7.3	2.5	11.6	6.8	4.6	7.9	4.3	5.6	5.8	21.8	5.1	5.0	6.2	4.8	4.6	5.5	6.4	10.1	11.3	8.3	15.2	13.1	12.4	8.3	9.1	9.2	7.9	3.4	6.9	5.5	5.6	9.5	10.1	8.2	24.0	4.8	5.2	4.8	7.0	7.6	12.7	10.8	16.8	7.0	16.9	15.9	6.3	7.1	8.0	13.4	1.7	1.0	3.5	2.0	1.6	1.4	0.9	2.6	1.8	0.7	2.1	1.5	2.2	5.2	0.5	1.7	0.6	0.2	1.0	10.6	11.3	24.8	23.2	12.8	13.9	10.8	10.6	14.6	6.9	0.0	3.2	2.9	4.0	4.9	7.5	1.4	0.0	4.0	1.2	7.0	0.0	4.8	0.0	4.6	3.5	3.1	8.8	0.0	7.3	5.9	2.3	5.6	0.0	1.5	7.0	11.1	4.1	5.5	5.6	2.5	2.0	5.4	0.0	9.0	5.1	5.0	9.1	10.1	1.1	2.1	5.1	6.5	2.3	14.0	5.9	9.5	16.2	4.4	5.3	4.8
C8orf44	FLJ11267	ENSG00000213865	"Chromosome 8 open reading frame 44"	Q96CB5	8	66667615-66685564	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043660, HPA054753"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043660: AB_10794889, HPA054753: AB_2682592"	"unprognostic (6.19e-2)"	"unprognostic (7.50e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.61e-3)"	"unprognostic (8.20e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.73e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (7.35e-2)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (4.01e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (2.68e-6)"	5.8	4.5	15.8	6.1	18.1	8.6	9.6	16.6	14.9	6.6	5.3	10.4	7.2	4.3	8.4	27.7	4.2	7.7	5.6	5.8	10.6	7.7	5.9	4.0	4.7	10.1	11.4	9.0	10.2	4.6	6.8	14.6	5.8	8.6	6.8	8.3	8.9	7.7	7.0	11.6	12.4	5.3	5.9	9.2	7.5	6.4	15.3	11.5	9.4	10.8	3.0	8.0	6.8	6.0	5.8	4.4	5.7	3.1	0.6	3.8	1.5	8.7	3.4	5.8	4.1	3.5	6.9	3.2	2.4	2.3	3.3	3.9	3.5	9.9	9.8	1.6	4.1	4.7	6.0	5.5	2.1	4.6	7.3	5.3	8.3	10.5	7.2	2.8	3.7	5.9	5.8	4.9	4.4	4.8	6.5	4.1	10.9	9.4	6.5	3.3	3.2	4.1	5.1	5.0	6.5	4.3	4.0	1.9	2.0	4.8	1.8	4.7	3.8	2.6	1.7	3.1	4.3	5.8	2.4	5.9	3.5	4.7	3.4	1.5	7.7	2.6	4.0	5.7	4.0	1.8	5.7	3.1	4.0	1.9	2.5	1.4	5.8	2.4	2.2	2.6	4.8	3.8	2.8	3.6	0.6	1.3	4.4	3.4	1.5	15.8	18.1	16.6	14.9	10.6	7.7	11.4	9.0	8.6	11.5	3.0	3.4	3.7	5.3	0.6	8.6	26.0	0.0	5.3	4.5	7.0	7.9	2.7	10.0	2.0	0.9	3.8	2.6	0.0	3.4	1.6	4.4	4.8	3.5	2.4	2.6	1.6	6.3	3.7	4.4	1.3	8.6	4.9	1.7	1.8	3.6	7.0	2.4	4.3	8.5	3.3	6.0	12.9	3.9	16.4	5.7	1.4	1.4	2.9	3.3	3.4
C8orf59		ENSG00000176731	"Chromosome 8 open reading frame 59"	Q8N0T1	8	85214076-85220421	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044805, HPA071903"			Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli"	Cytosol	"HPA044805: AB_2679095, HPA071903: AB_2686469"	"unprognostic (1.61e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.22e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.03e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.84e-3)"	28.1	28.2	25.3	25.3	21.9	33.0	46.1	18.9	26.5	33.0	38.4	12.6	36.3	28.1	32.0	45.5	44.8	28.7	25.8	41.5	20.6	24.1	32.3	47.1	20.8	30.7	26.3	27.2	45.1	35.1	19.5	36.0	27.7	24.4	35.5	27.7	14.7	37.8	36.2	43.9	24.8	37.1	33.7	27.0	32.2	36.9	16.7	25.7	39.1	43.5	53.6	32.0	39.1	35.2	33.3	42.7	21.3	25.3	36.5	38.0	23.9	38.9	19.9	29.6	19.2	18.4	35.7	23.2	26.0	25.0	30.4	30.0	23.2	33.8	9.7	21.5	17.2	28.5	27.2	20.5	28.5	34.3	27.4	22.4	57.6	18.8	34.2	21.8	21.6	26.1	30.2	33.9	19.6	24.8	33.1	25.8	35.0	25.8	24.0	25.2	30.7	47.7	40.6	8.5	88.2	34.8	20.4	24.8	44.2	29.5	25.0	10.0	21.5	19.7	32.4	35.7	37.3	37.3	32.3	19.7	19.4	40.7	21.5	24.6	27.9	32.7	45.8	38.7	27.7	21.5	21.3	20.5	13.4	24.7	25.3	29.5	33.3	32.7	30.1	34.8	29.9	38.0	36.3	5.1	36.5	21.5	42.7	32.1	23.9	25.3	21.9	18.9	26.5	20.6	24.1	26.3	27.2	24.4	25.7	80.4	65.2	124.2	47.1	48.2	25.9	26.3	86.6	147.2	103.5	34.9	9.8	86.5	56.3	152.0	93.6	67.1	76.6	46.7	240.4	102.1	84.3	40.2	75.1	136.0	90.6	22.3	36.9	108.6	132.2	20.6	173.2	92.3	54.0	180.3	112.7	58.4	213.9	84.2	122.0	90.6	33.5	155.2	88.6	128.1	91.8	40.0	64.3	104.7	101.8	39.3
C9orf78	"HCA59, HSPC220"	ENSG00000136819	"Chromosome 9 open reading frame 78"	Q9NZ63	9	129827290-129835863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021216, HPA021232, HPA021242"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA021216: AB_1845836, HPA021232: AB_1845837, HPA021242: AB_1845838"	"unprognostic (1.00e-1)"	"unprognostic (4.23e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.03e-2)"	"unprognostic (3.50e-2)"	"unprognostic (6.02e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (3.49e-7)"	"unprognostic (5.34e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.94e-1)"	23.9	29.0	42.7	24.5	44.0	73.8	28.0	37.0	34.5	24.0	24.7	27.6	25.5	21.8	24.1	28.9	26.2	21.5	24.8	28.7	40.3	39.6	44.8	41.7	21.8	35.7	39.5	30.8	31.1	26.3	20.9	26.6	24.5	29.3	27.5	27.6	18.0	26.7	26.4	45.8	27.8	25.9	28.9	38.7	28.1	22.5	32.3	32.8	42.0	33.6	23.5	34.0	32.4	31.3	28.5	22.9	57.6	43.6	37.8	52.8	34.4	9.3	9.3	10.0	15.6	17.9	12.1	12.4	13.6	11.0	12.2	8.9	9.7	9.9	14.6	11.0	15.5	19.2	20.1	13.7	11.6	10.2	14.3	9.8	23.3	16.6	10.2	11.9	33.8	24.1	11.0	20.6	14.9	12.7	12.3	11.1	62.7	58.3	17.9	14.8	22.4	43.3	43.5	14.8	38.1	22.3	12.5	15.4	30.9	12.2	6.4	8.3	15.8	20.5	19.1	16.3	9.9	16.7	23.9	12.5	18.2	13.8	17.8	17.1	8.0	23.2	23.8	15.1	27.5	14.9	36.4	23.3	57.6	44.4	35.3	43.9	28.5	46.4	48.0	19.2	28.1	52.8	48.2	18.0	37.8	43.6	22.9	48.9	34.4	42.7	44.0	37.0	34.5	40.3	39.6	39.5	30.8	29.3	32.8	83.4	75.8	65.1	59.9	69.4	38.3	50.4	61.1	103.1	105.8	54.1	35.3	62.3	106.1	56.0	34.8	56.1	58.8	186.9	78.2	64.8	51.4	57.1	128.5	71.9	59.9	30.2	81.0	35.6	56.4	11.6	54.7	75.9	69.2	90.2	53.5	48.4	55.0	38.6	57.3	121.7	34.8	77.6	67.6	82.1	101.3	74.3	56.5	139.4	52.1	49.2
CACYBP	"S100A6BP, SIP"	ENSG00000116161	"Calcyclin binding protein"	Q9HB71	1	174999163-175011715	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 117.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025753, HPA057038"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		360000	Cytosol	Nucleoplasm	"HPA025753: AB_1845878, HPA057038: AB_2683318"	"unprognostic (4.70e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.96e-3)"	"prognostic unfavorable (1.12e-6)"	"unprognostic (1.50e-2)"	"unprognostic (2.03e-2)"	"prognostic favorable (1.39e-5)"	"unprognostic (4.55e-2)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.97e-1)"	"unprognostic (6.79e-2)"	15.1	15.9	38.3	20.3	39.7	24.6	36.2	36.1	46.5	16.0	16.7	10.7	12.5	13.3	14.0	22.5	13.9	15.6	12.7	13.0	36.9	39.1	23.4	18.5	13.3	25.2	33.8	22.8	26.5	10.1	21.4	17.2	19.1	33.1	17.0	18.6	7.9	11.8	17.2	29.8	12.6	14.0	14.4	29.0	13.3	11.7	23.3	27.5	16.2	19.1	12.6	23.9	16.6	117.2	26.7	20.1	17.3	30.2	25.3	29.0	25.8	30.3	21.0	30.9	13.2	10.3	11.6	19.9	23.3	13.8	30.2	22.1	21.6	19.0	32.0	24.3	16.5	21.7	16.6	38.5	17.0	31.3	16.9	23.5	24.0	20.7	23.1	7.8	32.2	15.1	7.8	10.5	24.8	15.0	15.6	21.2	28.8	48.0	18.0	21.7	11.3	49.5	29.5	29.4	45.8	9.8	22.4	22.0	36.9	21.5	24.3	21.3	20.5	15.8	27.7	24.0	43.6	21.5	28.2	10.9	17.2	18.4	24.0	37.3	17.4	50.0	71.0	14.4	28.3	19.9	17.3	16.1	15.9	19.0	24.4	22.1	26.7	27.5	23.0	20.1	20.4	29.0	25.7	8.7	25.3	30.2	16.6	28.5	25.8	38.3	39.7	36.1	46.5	36.9	39.1	33.8	22.8	33.1	27.5	80.4	34.1	105.0	107.7	103.9	56.2	89.6	38.2	80.3	52.4	33.2	58.9	184.6	129.3	83.6	75.6	64.3	63.7	23.3	82.6	245.4	120.8	92.6	91.1	35.8	172.4	28.6	114.6	40.5	47.3	21.9	79.7	120.6	102.9	341.8	42.9	55.2	88.9	53.2	69.3	119.5	79.1	32.3	106.6	100.9	149.2	74.9	120.0	115.4	82.3	81.3
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 89.2;granulocytes: 237.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	6.6	0.0	0.2	0.0	1.3	0.2	0.1	0.2	0.0	0.0	8.2	0.0	0.1	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.2	0.0	0.0	52.2	0.0	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	14.9	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5	8.9	11.1	0.0	0.0	0.2	3.5	0.3	0.0	2.7	0.0	0.0	5.9	0.0	0.0	1.7	2.1	0.1	0.0	0.0	89.2	0.1	0.4	0.1	237.6	0.0	0.1	28.6	0.0	0.0	0.0	2.3	5.8	0.0	5.0	0.0	0.0	2.5	10.4	0.0	0.0	0.0	6.7	0.0	0.3	0.3	3.6	0.0	0.1	0.0	0.0	0.1
CALCOCO1	"calphoglin, Cocoa, KIAA1536"	ENSG00000012822	"Calcium binding and coiled-coil domain 1"	Q9P1Z2	12	53708517-53727745	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 42.9;HSkMC: 41.0;hTERT-RPE1: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038313, HPA038314"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		11000	Cytosol	Vesicles	"HPA038313: AB_10675794, HPA038314: AB_10672587"	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.11e-2)"	"unprognostic (8.42e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.66e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.85e-3)"	"unprognostic (8.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.63e-3)"	"unprognostic (9.88e-3)"	31.6	18.9	30.9	13.6	45.6	14.2	27.7	88.2	46.5	22.5	34.9	27.7	23.5	13.7	27.3	29.7	24.0	25.5	28.0	44.8	32.1	15.4	19.7	14.6	35.0	13.6	28.8	25.3	29.1	26.0	36.9	28.1	23.2	30.3	26.1	15.6	27.1	33.0	33.8	59.2	54.4	20.3	35.8	20.5	22.1	30.7	14.4	38.7	11.1	22.5	20.4	16.3	34.6	23.0	8.1	5.4	34.7	10.3	8.3	14.7	10.1	4.8	4.8	6.9	8.6	42.9	28.6	4.7	9.0	21.4	7.8	10.0	2.0	17.0	1.9	9.7	24.0	3.8	5.1	3.3	9.1	6.8	7.8	5.9	3.4	9.8	1.6	22.2	1.4	7.8	41.0	21.0	7.8	6.7	48.7	14.1	8.8	2.8	15.9	13.6	2.0	3.9	4.8	1.5	4.1	5.2	4.8	4.1	6.2	11.6	2.9	4.3	7.6	6.7	2.5	9.2	14.6	7.6	4.3	15.6	3.1	4.6	3.6	1.4	15.8	5.0	0.7	15.3	1.6	4.3	34.7	9.2	33.4	12.7	10.2	9.3	6.7	9.0	10.1	5.4	8.1	8.0	8.6	32.6	8.3	10.3	4.0	14.7	10.1	30.9	45.6	88.2	46.5	32.1	15.4	28.8	25.3	30.3	38.7	32.8	11.8	13.7	16.2	28.7	34.6	9.9	30.6	16.0	12.5	21.0	33.4	18.1	5.0	13.9	41.1	16.9	10.4	0.0	10.0	7.3	22.0	19.8	7.0	15.3	13.6	25.4	27.4	28.3	20.2	37.9	44.0	16.8	18.6	14.4	19.4	30.7	17.0	16.1	38.9	9.8	41.6	19.4	16.5	19.5	7.7	44.4	38.1	21.8	12.3	12.9
CALD1	"CDM, H-CAD, L-CAD"	ENSG00000122786	"Caldesmon 1"	Q05682	7	134744252-134970728	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 224.5"	"Cell type enhanced"	"Detected in many"	8	"Leydig cells: 1615.7;Peritubular cells: 1885.2;Sertoli cells: 2257.2;Smooth muscle cells: 2337.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"neutrophil: 4.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 79.3;fHDF/TERT166: 128.9;U-138 MG: 82.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000006, HPA008066, HPA017330"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		Yes	No		110000000	"Plasma membrane, Actin filaments"		"CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917"	"unprognostic (2.16e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.80e-3)"	"unprognostic (3.05e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.07e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (6.52e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.18e-3)"	38.6	17.4	6.7	33.4	11.1	0.0	26.6	11.9	9.1	83.1	141.0	6.0	111.4	12.6	82.3	59.8	122.8	45.8	46.3	20.1	7.7	5.0	33.5	39.6	26.1	12.9	8.7	8.5	76.3	6.9	4.1	17.8	57.4	8.9	87.8	25.1	10.9	12.4	133.3	15.3	12.9	39.2	224.5	8.5	35.9	64.5	29.7	9.7	2.1	20.3	14.1	5.3	205.3	70.4	0.1	0.2	4.3	0.2	0.4	0.2	5.9	12.1	8.0	18.1	15.9	62.7	50.9	17.9	71.6	79.3	24.6	27.3	14.5	0.3	0.0	17.1	128.9	16.4	2.9	11.5	21.3	33.5	0.1	3.9	0.4	9.5	9.8	41.3	0.0	0.0	39.0	15.9	27.5	15.6	37.8	20.7	0.0	0.0	0.1	36.7	0.0	0.0	0.2	21.6	0.0	2.8	0.1	16.1	0.0	5.0	3.3	3.1	7.9	25.1	3.3	9.6	57.0	0.7	0.1	55.2	82.7	14.5	15.7	24.3	0.0	0.0	0.0	28.7	0.0	61.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	4.3	0.4	0.0	0.0	0.0	5.9	6.7	11.1	11.9	9.1	7.7	5.0	8.7	8.5	8.9	9.7	20.8	21.2	22.4	285.3	373.4	156.1	350.6	211.5	9.4	25.0	41.8	5.9	146.5	19.9	303.7	58.2	355.4	0.0	23.3	20.1	802.8	618.3	367.0	4.7	529.8	38.7	87.4	3.5	505.2	24.5	42.4	1615.7	35.2	318.9	11.8	0.9	180.9	118.9	0.0	1885.2	249.0	13.7	2257.2	2337.7	6.8	10.3	150.2	231.4	15.0	0.2	28.3
CAMTA2	KIAA0909	ENSG00000108509	"Calmodulin binding transcription activator 2"	O94983	17	4967992-4987652	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 63.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027835, HPA051147"			Supported	"Nucleoplasm,Vesicles,Actin filaments,Mitochondria,Cytosol"		NA	NA			Nucleoplasm	"Vesicles, Actin filaments, Mitochondria, Cytosol"	"HPA027835: , HPA051147: AB_2681362"	"unprognostic (2.82e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (7.08e-2)"	"prognostic favorable (6.00e-8)"	"unprognostic (3.42e-2)"	"unprognostic (9.02e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.19e-1)"	9.8	6.4	27.0	9.2	25.2	6.4	5.4	63.6	44.9	6.2	8.0	6.4	3.8	7.3	6.2	3.1	8.4	6.8	6.1	8.0	33.8	17.4	5.5	4.2	8.8	6.2	11.7	19.1	6.7	11.7	14.8	21.3	5.1	18.5	6.8	8.0	5.5	8.7	9.1	20.1	8.6	9.0	10.5	6.5	8.7	8.0	9.0	8.8	2.7	6.5	2.9	6.5	6.5	4.7	1.3	2.2	5.7	8.1	1.1	2.7	2.1	8.0	14.4	2.7	3.8	18.1	12.6	5.6	7.8	8.7	7.4	6.6	3.6	2.2	9.5	7.6	12.2	6.3	8.2	10.2	12.2	4.2	13.3	13.2	6.0	7.8	4.0	10.4	3.5	25.8	8.7	15.3	7.0	11.0	9.0	12.3	7.4	9.7	8.7	6.9	5.3	6.2	2.2	0.4	9.6	6.0	5.4	3.0	3.7	8.4	8.5	3.7	3.2	4.9	9.0	2.4	4.8	7.9	3.5	16.3	5.9	3.5	6.2	12.7	4.4	4.7	3.4	14.4	7.0	5.7	1.0	2.2	1.8	2.7	3.0	2.1	1.3	1.2	2.5	1.4	0.9	1.8	2.0	5.7	1.1	8.1	2.2	1.1	2.1	27.0	25.2	63.6	44.9	33.8	17.4	11.7	19.1	18.5	8.8	3.0	13.7	8.3	3.5	6.2	12.1	5.9	15.3	5.3	3.4	10.4	9.8	5.2	1.7	6.8	29.0	6.9	16.3	0.0	9.8	6.8	6.8	5.5	12.7	11.9	7.7	33.4	10.9	14.1	9.2	39.5	9.5	8.0	3.3	8.2	13.1	4.3	9.1	12.4	8.9	10.5	9.6	12.9	12.3	5.2	7.6	9.2	10.4	10.2	9.5	3.4
CAND1	"DKFZp434M1414, KIAA0829, TIP120, TIP120A"	ENSG00000111530	"Cullin associated and neddylation dissociated 1"	Q86VP6	12	67269281-67319951	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055748, HPA062833, HPA069053"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No		4200000	"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA055748: AB_2682905, HPA062833: AB_2684876, HPA069053: AB_2686074"	"unprognostic (1.50e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	21.3	26.7	28.7	19.1	38.3	19.6	27.0	34.6	32.6	23.9	20.0	17.5	17.0	19.7	22.8	29.9	26.6	20.6	19.0	15.2	24.8	27.0	25.4	27.7	18.7	25.4	23.3	29.0	29.0	22.1	33.2	27.1	23.3	33.2	24.1	21.7	15.8	19.6	22.0	11.1	29.5	19.5	22.4	21.5	20.2	19.3	26.9	23.8	39.4	27.0	17.0	30.2	21.1	22.1	11.9	7.8	6.1	10.1	14.7	15.2	4.3	22.5	23.2	35.4	25.1	27.2	21.3	23.8	22.4	19.4	23.7	20.9	21.5	12.9	48.7	19.6	22.4	14.9	21.6	38.0	25.5	27.2	18.4	22.8	27.4	18.7	20.3	17.8	32.3	15.6	20.1	19.4	21.6	20.0	29.1	22.0	23.9	21.7	27.3	25.5	22.1	29.2	21.9	37.4	17.4	16.2	28.6	30.4	20.6	21.8	38.5	36.4	18.1	27.9	25.7	18.1	31.1	27.6	14.9	18.7	18.8	12.2	12.9	16.9	9.0	11.0	41.5	22.4	19.2	19.3	6.1	5.0	5.5	11.6	5.9	14.1	8.6	14.2	12.7	7.8	11.9	15.2	12.7	2.2	14.7	10.1	6.6	14.7	4.3	28.7	38.3	34.6	31.8	24.8	27.0	23.3	29.0	33.2	23.8	56.6	27.6	42.6	43.5	51.6	88.5	14.7	45.9	34.8	29.6	41.8	110.0	31.5	11.6	27.1	2.8	38.6	46.3	0.0	24.9	36.0	41.4	44.6	7.0	41.5	27.1	82.6	43.6	38.1	40.0	7.7	63.9	30.4	32.1	52.3	46.0	63.0	29.9	24.6	57.3	27.3	106.8	25.8	34.2	72.7	42.4	55.8	37.3	47.9	38.5	52.1
CANX	"CNX, IP90, P90"	ENSG00000127022	Calnexin	P27824	5	179678628-179730925	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004738, HPA009433, HPA009696"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		82000000	"Endoplasmic reticulum"		"CAB004738: AB_626784, HPA009433: AB_1078380, HPA009696: AB_1078379"	"unprognostic (6.56e-2)"	"unprognostic (9.34e-3)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.57e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.17e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.15e-1)"	49.3	35.4	40.0	35.8	40.9	57.6	37.8	27.3	49.1	93.0	33.6	37.1	48.3	44.0	42.7	115.4	31.6	31.7	30.0	51.3	36.9	50.9	61.6	120.8	34.7	30.1	47.5	27.9	41.0	78.2	13.7	33.0	70.5	44.9	33.5	55.1	32.2	121.5	48.5	28.5	23.4	68.5	60.5	48.8	38.2	31.7	34.3	30.0	31.0	113.4	25.9	29.9	41.4	47.6	10.1	26.3	25.9	28.9	18.7	22.6	30.0	8.4	23.8	20.2	12.3	43.5	32.3	10.2	43.5	47.8	50.3	42.7	20.7	19.5	63.9	61.1	34.8	25.6	5.8	31.7	23.7	57.5	16.4	9.6	10.3	59.3	13.4	59.3	19.6	9.7	6.3	43.6	27.0	78.5	15.4	20.8	4.9	8.1	24.9	5.5	7.8	9.9	0.3	4.1	3.6	1.4	10.3	14.7	7.0	37.0	24.9	10.2	2.4	12.2	5.2	109.0	25.3	41.2	8.7	38.6	11.5	19.2	13.0	33.7	7.6	26.2	16.1	17.4	12.8	11.2	25.9	28.9	8.8	17.7	21.2	22.6	10.1	13.9	16.3	26.3	7.7	9.5	10.6	6.1	18.7	18.0	25.3	10.1	30.0	40.0	40.9	27.3	33.3	36.9	50.9	47.5	27.9	44.9	30.0	184.6	236.5	93.5	89.0	131.9	112.0	432.6	180.9	323.9	284.4	172.7	149.2	138.7	41.4	148.7	197.6	180.1	166.6	46.7	132.3	187.5	146.3	221.3	188.7	393.6	206.3	151.0	170.9	163.9	186.1	659.2	147.3	192.4	167.0	120.8	179.5	201.8	157.0	97.9	179.6	160.8	108.3	90.5	152.7	141.2	80.8	141.4	204.7	88.6	178.9	131.5
CAPG	"AFCP, MCP"	ENSG00000042493	"Capping actin protein, gelsolin like"	P40121	2	85394748-85418432	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 121.1"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 535.8;Hofbauer cells: 1102.8;monocytes: 603.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;classical monocyte: 97.4;eosinophil: 58.2;intermediate monocyte: 36.4;memory B-cell: 50.1;myeloid DC: 121.1;naive B-cell: 37.1;NK-cell: 48.3;plasmacytoid DC: 84.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 81.3;HMC-1: 116.7;SK-MEL-30: 84.8;U-937: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018843, HPA019080, HPA019092"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No		6700000	Nucleoplasm		"HPA018843: AB_2669948, HPA019080: AB_1845979, HPA019092: AB_1845980"	"unprognostic (2.82e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.28e-2)"	"unprognostic (4.37e-2)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (8.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.96e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.68e-2)"	"unprognostic (5.30e-3)"	"unprognostic (7.89e-3)"	44.3	4.9	10.1	18.3	10.8	32.4	17.6	3.3	7.6	19.9	13.8	17.6	17.7	6.8	14.0	16.0	52.3	12.9	25.2	4.1	8.5	6.5	35.4	2.9	44.3	26.9	14.7	4.8	10.6	8.9	40.3	5.2	15.6	11.9	15.0	11.0	7.6	22.5	19.3	2.6	39.2	11.5	9.9	17.6	10.9	25.9	8.4	10.0	21.2	31.5	28.1	40.2	27.0	31.1	50.1	121.1	79.0	97.4	48.3	9.7	67.5	22.8	11.0	0.0	1.0	7.8	17.0	11.8	8.7	0.9	8.6	8.5	1.3	81.3	2.9	12.4	16.3	9.1	26.7	0.0	17.1	3.7	17.6	0.6	8.2	20.2	4.8	6.1	4.6	116.7	14.7	13.2	7.8	9.7	0.4	5.6	16.9	0.9	6.8	5.9	19.3	12.3	54.3	3.4	17.1	14.6	12.3	1.3	1.3	32.6	11.4	0.1	0.1	10.9	14.7	84.8	6.3	6.1	58.0	21.6	18.4	4.0	0.6	0.3	0.1	0.6	1.2	41.7	61.9	0.2	79.0	97.4	58.2	1.1	36.4	3.4	50.1	9.7	3.7	121.1	37.1	2.8	1.3	14.1	48.3	10.3	84.1	9.6	67.5	10.1	10.8	3.3	7.6	8.5	6.5	14.7	4.8	11.9	10.0	17.9	29.8	86.2	131.0	107.6	0.5	1.1	63.7	9.4	23.9	300.1	0.0	25.0	179.1	90.0	3.2	5.8	101.1	0.0	81.2	260.0	55.7	64.5	535.8	0.9	1102.8	1.6	27.6	3.1	175.5	12.5	43.4	306.0	140.0	603.3	55.7	37.8	257.6	119.4	21.2	88.5	1.1	12.9	23.5	6.3	40.4	148.2	29.9	59.9	86.5	209.1
CAPRIN1	"caprin-1, GPIAP1, M11S1, RNG105"	ENSG00000135387	"Cell cycle associated protein 1"	Q14444	11	34051683-34101156	"Predicted intracellular proteins"	Differentiation	"Protein synthesis inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 388.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018126, HPA063617"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018126: AB_1849929, HPA063617: AB_2685062"	"unprognostic (3.79e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.51e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (8.67e-8)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	36.7	34.5	32.7	32.0	37.5	38.4	41.5	45.8	48.7	40.4	32.0	34.0	31.2	30.2	42.6	31.6	36.1	40.8	28.7	34.4	32.1	30.5	35.8	27.8	30.8	36.0	27.5	35.7	41.0	30.6	61.2	33.4	36.8	29.7	32.4	40.4	26.2	35.3	37.7	43.8	29.8	31.3	42.6	38.3	35.5	28.3	80.0	30.3	64.3	35.1	32.9	38.8	41.5	32.9	14.3	26.0	15.8	28.2	21.6	20.7	17.7	33.3	40.3	60.3	34.8	46.5	47.7	31.3	43.1	43.4	50.5	47.3	36.7	20.5	53.8	25.9	52.5	42.9	45.1	76.7	50.3	61.5	32.2	41.2	42.0	40.5	32.1	28.5	66.6	32.0	41.9	28.0	31.9	59.6	44.6	50.3	37.6	53.6	25.5	53.5	26.8	57.8	13.0	30.8	39.4	38.1	45.2	82.2	23.8	32.1	63.6	40.0	39.1	48.5	26.6	23.8	38.8	46.8	28.7	48.0	42.6	30.4	43.3	48.6	27.9	40.2	58.2	30.5	29.5	48.4	15.8	21.2	8.8	14.1	27.4	20.7	14.3	16.6	17.3	26.0	12.8	17.5	16.5	9.4	21.6	28.2	14.2	19.4	17.7	32.7	37.5	45.8	48.7	32.1	30.5	27.5	35.7	29.7	30.3	32.8	37.9	34.4	36.0	69.0	37.6	50.0	22.9	29.4	25.0	61.1	17.7	40.7	26.6	49.7	388.5	43.6	38.1	0.0	51.9	49.7	45.8	44.7	16.2	39.2	50.8	23.8	69.0	39.3	61.9	214.2	44.3	47.7	37.1	45.9	46.6	33.8	61.1	43.8	68.2	37.4	30.5	38.8	45.4	146.7	72.4	63.7	38.3	31.9	57.5	69.7
CARM1	PRMT4	ENSG00000142453	"Coactivator associated arginine methyltransferase 1"	Q86X55	19	10871513-10923070	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 64.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032961, HPA043561, HPA048073, HPA069313"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB032961: AB_2068446, HPA043561: AB_2678554, HPA048073: AB_2680250, HPA069313: "	"unprognostic (9.46e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.76e-2)"	"unprognostic (7.81e-2)"	"unprognostic (6.18e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (7.88e-6)"	"unprognostic (1.71e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (8.37e-4)"	12.2	8.8	12.3	12.6	16.1	13.2	9.6	12.5	17.7	15.8	14.0	9.3	9.0	11.5	19.6	9.1	20.5	14.8	12.4	14.7	11.2	7.2	9.3	14.5	8.9	12.4	7.8	10.2	13.0	16.9	8.2	6.9	15.3	9.5	12.6	10.2	12.0	11.4	13.2	64.3	12.5	12.0	15.6	6.6	9.8	11.1	17.5	8.6	9.4	10.0	12.7	15.6	15.8	15.9	1.3	1.6	0.3	1.4	0.1	2.6	0.4	22.6	16.9	24.2	32.8	20.2	27.7	23.2	16.3	28.3	24.2	23.3	26.0	8.3	31.2	19.6	28.4	12.2	21.7	24.7	24.5	15.3	34.9	20.1	9.6	11.0	31.5	17.3	14.4	12.5	18.9	16.0	16.5	20.0	13.8	30.6	24.9	22.9	28.1	14.2	40.9	25.1	12.4	29.9	15.2	28.1	35.1	12.4	36.3	14.6	11.7	17.6	16.9	11.6	14.1	15.7	12.6	14.1	12.4	18.3	29.2	16.5	27.7	19.0	27.4	21.6	27.3	19.2	23.2	12.6	0.0	1.4	0.2	1.2	1.4	0.5	1.3	0.9	2.6	1.3	1.3	1.0	0.9	0.3	0.1	0.7	1.6	0.8	0.4	12.3	16.1	12.5	17.7	11.2	7.2	7.8	10.2	9.5	8.6	8.9	13.5	11.5	4.9	6.9	31.0	0.8	17.8	8.1	6.8	8.7	49.1	16.3	6.6	11.8	25.6	5.7	28.0	46.7	16.9	26.3	10.3	10.9	1.1	23.7	22.3	42.9	26.5	11.1	17.8	13.0	26.2	7.5	5.0	28.9	25.6	10.2	20.3	25.9	18.0	7.3	19.9	6.5	9.2	25.8	16.4	6.0	10.1	4.1	21.2	9.0
CARS	CARS1	ENSG00000110619	"Cysteinyl-tRNA synthetase"	P49589	11	3000922-3057613	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 92.3;Early spermatids: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002383, HPA002384, CAB075734, CAB075735, CAB075736, CAB075737"	Enhanced		Enhanced	Cytosol		NA	NA		110000	Cytosol		"CAB075734: AB_2665740, CAB075735: AB_2665741, CAB075736: AB_2665742, CAB075737: AB_2665743, HPA002383: AB_1078399, HPA002384: AB_1846033"	"unprognostic (9.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.46e-1)"	24.9	15.9	15.8	15.8	17.7	9.0	15.9	9.5	29.1	13.4	16.3	19.1	11.1	15.9	14.0	10.7	16.0	10.8	14.2	12.5	15.3	18.7	10.7	22.1	15.1	17.2	23.3	15.9	14.5	42.5	14.9	15.9	14.0	23.0	10.8	17.6	7.4	20.3	14.8	24.6	18.8	17.8	21.0	16.1	14.8	22.8	13.4	17.3	9.8	23.0	14.5	22.7	14.4	19.4	8.3	13.3	18.0	23.9	16.4	18.1	11.6	7.4	3.8	4.9	14.8	19.3	17.8	4.4	19.1	21.8	13.2	23.9	9.3	17.9	11.6	5.6	24.1	0.0	19.2	16.2	21.7	18.2	33.8	3.7	6.5	6.5	7.1	46.3	13.5	14.4	29.3	17.1	11.4	12.7	0.0	17.4	28.8	10.9	41.0	13.0	11.3	9.5	0.0	18.5	26.5	6.8	4.6	8.2	14.5	0.0	12.5	10.6	14.1	4.7	13.4	20.9	3.8	0.0	0.0	6.0	5.4	5.1	13.5	0.2	30.5	27.8	7.4	0.0	7.1	10.7	7.7	12.0	8.8	15.2	10.5	13.0	8.3	13.6	13.6	13.3	6.0	7.5	12.1	18.0	16.4	23.9	5.2	18.1	11.6	15.8	17.7	9.5	29.1	15.3	18.7	23.3	15.9	23.0	17.3	17.9	31.5	21.7	25.4	12.8	11.7	6.7	2.5	92.3	27.3	10.4	5.9	18.8	8.3	35.4	93.7	13.7	18.6	0.0	34.2	34.8	12.6	16.1	20.7	16.8	18.9	14.3	18.3	13.5	15.1	39.9	11.5	14.7	8.5	14.4	16.9	10.8	37.5	21.0	18.0	13.4	10.0	6.5	14.1	39.5	24.2	10.5	27.0	24.2	14.3	35.5
CASC4	"DKFZp459F1927, H63"	ENSG00000166734	"Cancer susceptibility 4"	Q6P4E1	15	44288729-44415758	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043015, HPA049488"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		400000	"Golgi apparatus"		"HPA043015: AB_2678271, HPA049488: AB_2680790"	"unprognostic (2.64e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.81e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.60e-2)"	"prognostic favorable (1.45e-5)"	"unprognostic (2.15e-1)"	"unprognostic (3.56e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.12e-1)"	21.0	48.4	40.2	17.4	40.2	7.8	24.1	29.9	35.6	34.5	24.8	29.6	37.5	15.6	28.8	30.3	13.4	30.7	27.8	23.6	39.5	34.2	30.5	32.6	22.3	15.2	32.4	22.8	32.3	21.2	40.9	42.8	18.7	33.8	38.8	24.4	25.6	24.8	34.0	14.1	9.1	16.2	24.8	40.6	18.5	27.3	18.7	33.2	17.0	46.7	12.1	15.5	21.8	20.8	9.8	9.1	28.2	12.6	8.0	13.5	8.9	13.3	11.5	15.7	27.2	42.5	37.1	9.7	24.5	36.8	13.3	17.1	5.5	23.3	3.9	33.8	34.4	14.9	16.0	10.0	7.3	14.2	20.4	5.6	6.2	13.5	10.0	19.7	12.2	21.4	21.9	8.3	14.8	11.4	38.2	15.4	10.5	9.4	30.2	16.4	6.5	10.3	9.4	4.3	17.6	7.9	8.8	9.0	12.3	17.0	15.6	7.0	16.3	18.6	17.1	7.7	8.7	18.8	14.4	23.0	23.7	12.7	34.9	20.7	24.6	41.9	8.2	27.7	17.1	15.2	10.7	10.6	15.0	12.1	7.7	13.5	9.8	10.1	12.0	9.1	9.5	7.9	8.0	28.2	8.0	12.6	8.2	9.9	8.9	40.2	40.2	29.9	34.0	39.5	34.2	32.4	22.8	33.8	33.2	59.6	49.7	24.4	29.9	21.1	37.1	17.3	38.2	87.0	54.6	61.1	27.5	13.7	8.3	35.5	9.3	39.0	28.8	0.0	49.2	16.2	58.6	84.9	22.0	59.9	23.7	41.3	58.2	39.9	48.5	12.7	61.5	37.7	33.7	88.4	65.4	35.9	36.2	20.1	75.3	28.3	20.7	45.3	38.9	32.5	7.0	16.2	10.6	30.5	46.0	43.0
CASP8	"Casp-8, FLICE, MACH, MCH5"	ENSG00000064012	"Caspase 8"	Q14790	2	201233443-201287711	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction"	"Hydrolase, Protease, Thiol protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 52.5"	"Cell type enhanced"	"Detected in many"	5	"T-cells: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001302, CAB002047, HPA005688, HPA006191"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"CAB002047: AB_563465, HPA001302: AB_1846057, HPA005688: AB_1846056, HPA006191: AB_2667535"	"unprognostic (5.21e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.60e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.10e-1)"	"unprognostic (4.79e-2)"	"prognostic favorable (1.25e-4)"	"unprognostic (7.75e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (7.67e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.53e-3)"	14.1	10.6	2.0	31.6	2.6	27.1	10.2	1.4	1.8	7.9	18.5	3.9	7.0	9.6	9.6	12.0	11.7	9.1	12.1	4.4	2.1	2.3	16.4	14.8	17.1	28.3	3.9	1.1	8.2	7.6	1.8	5.9	12.3	3.2	9.8	8.7	4.4	9.6	8.4	2.7	7.4	34.7	5.1	5.0	37.7	7.4	3.8	2.7	43.7	6.7	10.7	43.4	9.6	7.3	13.8	13.7	52.5	17.0	22.2	26.4	12.0	14.5	12.4	3.6	10.1	10.1	14.8	5.6	6.4	6.3	7.6	12.6	16.6	25.4	1.6	14.1	4.9	13.7	7.4	7.9	7.6	15.1	9.4	7.2	14.2	10.1	15.8	8.2	11.0	15.4	12.8	18.8	14.4	11.3	6.4	7.2	12.3	12.7	31.6	6.9	6.0	14.3	11.6	5.9	8.0	11.1	10.8	7.5	25.9	14.3	16.2	1.1	0.5	8.3	13.8	8.2	3.5	3.6	8.6	9.0	8.2	8.6	4.3	5.0	28.7	12.8	9.9	12.3	14.8	7.7	20.7	13.0	24.9	25.0	17.0	23.1	13.8	20.5	26.4	13.7	7.8	13.3	16.9	52.5	22.2	15.6	6.1	24.0	12.0	2.0	2.6	1.4	1.8	2.1	2.3	3.9	1.1	3.2	2.7	23.8	26.1	34.1	10.1	6.6	1.5	1.6	7.6	16.0	18.2	5.2	9.8	7.5	13.3	9.0	5.6	7.1	19.8	0.0	7.3	10.3	3.8	8.1	23.2	10.4	11.2	0.0	4.1	5.5	25.6	0.7	2.3	21.7	6.8	19.8	13.0	0.1	9.6	12.7	0.7	20.0	0.4	0.0	1.4	0.7	0.4	6.8	2.9	55.4	12.1	12.7
CAST		ENSG00000153113	Calpastatin	P20810	5	96525267-96779595	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 201.9"	"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 948.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009491, HPA036881, HPA036882, HPA075906"	Enhanced		Enhanced	"Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		18000000	"Endoplasmic reticulum, Cytosol"	"Plasma membrane"	"CAB009491: AB_2259755, HPA036881: AB_2675359, HPA036882: AB_2675360, HPA075906: "	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.53e-3)"	"unprognostic (1.94e-2)"	"unprognostic (6.11e-3)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.16e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (4.98e-4)"	38.3	20.7	10.4	25.0	16.3	22.1	32.0	8.7	21.7	38.0	44.6	10.5	18.6	25.6	24.8	25.9	87.4	19.5	25.5	98.5	11.9	10.6	27.2	38.2	29.5	21.1	14.3	12.5	26.9	14.8	22.3	25.3	52.6	24.8	30.0	34.5	12.7	38.7	23.2	201.9	40.7	56.3	36.2	18.7	21.7	22.2	21.2	15.6	10.1	25.6	51.2	34.1	42.2	57.0	24.5	32.7	12.4	48.0	18.3	26.6	27.2	48.5	40.0	6.8	17.7	41.1	76.6	24.0	34.6	49.0	27.7	36.1	9.9	29.6	7.0	32.7	46.9	41.3	82.6	12.9	47.1	33.5	45.1	12.2	9.0	42.4	11.7	31.6	5.9	15.7	34.6	43.6	39.7	64.9	38.7	30.9	5.4	7.5	22.7	33.7	15.3	2.9	0.2	5.3	13.2	14.9	2.7	23.0	12.0	55.0	20.5	28.7	6.9	35.3	19.4	22.6	16.2	11.8	6.4	41.1	37.8	16.1	25.2	34.9	7.6	20.2	3.3	42.9	3.2	10.4	2.5	48.0	7.0	26.6	29.0	25.2	24.5	23.9	26.5	32.7	22.7	12.2	16.3	12.4	18.3	32.2	9.0	24.2	27.2	10.4	16.3	8.7	21.7	11.9	10.6	14.3	12.5	24.8	15.6	375.2	182.6	82.4	358.6	212.9	34.7	740.0	140.1	410.9	277.5	102.9	17.7	150.3	112.7	215.3	948.1	166.8	282.7	280.4	218.0	79.9	187.6	259.7	169.0	148.0	103.8	12.7	136.3	108.6	206.2	312.7	159.3	211.5	124.9	235.4	207.6	36.8	240.8	170.9	137.6	98.2	16.9	90.5	162.6	20.9	10.1	220.1	117.7	139.5	143.0	490.4
CAT		ENSG00000121691	Catalase	P04040	11	34438925-34472062	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Hydrogen peroxide"	"Mitogen, Oxidoreductase, Peroxidase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 258.3;liver: 184.8"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 350.4;Hepatocytes: 400.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	13	"eosinophil: 258.3"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 258.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 76.4;THP-1: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001515, HPA051282, HPA055838"	Enhanced		Enhanced	Vesicles		NA	NA		960000000	Vesicles		"CAB001515: AB_384710, HPA051282: AB_2681419, HPA055838: AB_2682937"	"unprognostic (3.62e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.59e-3)"	"unprognostic (5.43e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.80e-3)"	"prognostic favorable (9.67e-4)"	"unprognostic (9.95e-3)"	"unprognostic (3.22e-1)"	"unprognostic (7.23e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.77e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.77e-2)"	"unprognostic (6.59e-3)"	70.0	33.0	9.4	10.1	9.6	54.2	36.1	3.1	7.7	15.3	26.6	18.6	15.7	22.2	13.5	9.5	14.8	14.2	19.0	22.4	10.7	5.2	50.4	184.8	26.1	21.3	14.5	6.0	11.0	24.7	7.1	5.0	16.4	10.2	23.2	11.3	11.4	14.5	13.2	27.8	19.7	29.2	11.6	11.3	17.9	15.9	6.2	11.6	23.4	41.7	14.9	11.5	20.4	24.9	7.6	19.9	258.3	17.5	5.5	5.0	17.8	6.2	6.9	5.1	8.0	49.2	21.4	10.8	8.0	10.1	8.9	9.8	3.9	6.3	15.4	7.7	15.7	13.2	14.9	8.5	8.6	9.9	13.5	7.8	13.0	7.4	22.2	5.8	76.4	6.5	11.5	6.0	2.7	1.1	12.6	10.8	9.4	26.9	6.4	11.2	5.9	15.6	13.6	0.0	29.4	16.8	11.1	24.2	12.6	24.5	23.7	2.6	4.1	8.9	14.4	11.8	0.0	20.7	63.8	7.6	5.4	5.2	13.4	4.7	5.2	2.9	3.3	10.6	52.6	3.9	12.5	17.5	258.3	3.2	14.7	3.8	7.6	3.8	3.6	19.9	6.8	3.8	4.0	17.1	5.5	15.5	13.4	5.0	17.8	9.4	9.6	3.1	7.7	10.7	5.2	14.5	6.0	10.2	11.6	211.4	229.6	40.9	69.6	25.6	11.8	38.0	73.9	89.7	77.3	69.8	25.5	60.5	190.6	26.7	2.1	31.6	91.9	350.4	23.0	26.6	50.3	53.0	22.1	400.0	121.0	0.0	46.1	49.7	114.9	3.8	72.5	85.2	25.3	295.8	48.0	21.2	16.4	52.6	72.9	233.4	17.7	77.6	65.1	4.1	9.6	23.7	33.9	35.5	72.9	69.8
CAVIN2	"cavin-2, PS-p68, SDPR, SDR"	ENSG00000168497	"Caveolae associated protein 2"	O95810	2	191834302-191847255	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 1: 384.1;Alveolar cells type 2: 70.0;Club cells: 150.2;granulocytes: 170.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"basophil: 9.9;neutrophil: 8.9"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 9.9"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 28.2;HEL: 20.6;HUVEC TERT2: 64.0;LHCN-M2: 99.1;TIME: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039325, HPA062122"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		Yes	No		160000000	"Plasma membrane"	Cytosol	"HPA039325: AB_10805473, HPA062122: AB_2684688"	"unprognostic (6.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.47e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.90e-1)"	"prognostic favorable (8.45e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.39e-3)"	60.3	8.9	4.9	10.1	8.3	1.8	37.8	2.8	6.1	26.1	32.6	2.8	14.5	3.9	23.9	17.4	18.2	19.5	45.3	46.5	7.1	5.3	15.9	10.4	57.9	20.1	8.9	5.6	20.4	7.6	3.2	4.3	11.6	5.8	19.3	8.9	9.8	6.9	11.2	35.7	3.8	10.6	39.3	7.1	52.9	8.8	7.2	4.4	0.3	34.5	20.1	2.8	33.2	34.5	0.1	1.0	9.9	0.8	0.4	0.1	39.0	0.0	3.5	1.2	0.0	0.1	0.6	0.0	0.7	0.6	0.1	0.2	0.0	0.0	0.0	4.5	28.2	0.0	0.6	0.0	5.5	0.4	0.0	0.0	20.6	0.2	7.8	8.0	0.0	0.0	1.5	3.6	0.6	1.7	0.4	64.0	0.0	7.4	0.0	99.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	26.0	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.8	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	8.9	0.4	0.4	1.0	0.1	39.0	4.9	8.3	2.8	6.1	7.1	5.3	8.9	5.6	5.8	4.4	384.1	70.0	0.0	0.0	0.0	0.0	0.0	0.0	53.5	150.2	0.0	0.0	0.1	5.0	1.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	170.9	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
CBFA2T3	"ETO2, MTG16, MTGR2, RUNX1T3, ZMYND4"	ENSG00000129993	"CBFA2/RUNX1 translocation partner 3"	O75081	16	88874858-88977204	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Repressor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 75.9"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 11.5;Mucus-secreting cells: 13.5;Sertoli cells: 19.4;Smooth muscle cells: 11.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 26.0"	"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 21.4;K-562: 37.4;MCF7: 17.3;MOLT-4: 19.0;NB-4: 23.1;REH: 37.6;T-47d: 17.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA059931, HPA062423, HPA065890"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059931: AB_2684168, HPA062423: AB_2684758, HPA065890: AB_2685575"	"unprognostic (2.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (9.24e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.98e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.30e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.04e-5)"	"unprognostic (2.18e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.62e-2)"	"unprognostic (9.35e-3)"	10.0	1.7	3.6	11.3	7.4	8.2	6.1	26.0	5.4	2.3	3.9	1.3	1.4	3.9	3.2	2.1	2.1	1.9	2.5	6.2	3.0	3.0	0.7	2.0	6.4	9.5	2.0	3.8	0.9	24.9	0.7	2.7	3.8	2.3	3.7	1.5	3.1	4.5	2.9	14.2	2.6	5.5	1.5	1.2	14.7	3.5	3.2	2.2	75.9	2.4	2.0	10.3	3.6	4.8	3.7	11.6	3.6	4.9	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	21.4	0.0	0.0	0.0	5.6	10.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	37.4	0.2	0.0	17.3	19.0	23.1	0.4	0.0	0.0	37.6	0.3	3.7	0.0	0.0	7.4	1.6	0.8	0.1	0.1	0.1	17.1	6.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	12.4	0.0	6.5	0.0	1.1	2.7	2.7	0.0	3.2	0.0	3.7	0.0	0.0	7.1	2.1	0.0	0.0	3.6	0.1	4.9	11.6	0.0	1.7	3.6	7.4	26.0	5.4	3.0	3.0	2.0	3.8	2.3	2.2	0.0	1.4	11.5	5.1	2.3	7.7	1.6	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.2	0.0	3.6	0.9	0.0	2.4	0.1	1.6	2.5	5.8	5.7	2.4	0.0	3.5	2.5	2.8	0.0	2.0	6.4	0.0	1.0	13.5	0.1	1.4	0.0	0.7	0.5	1.2	19.4	11.2	0.2	4.5	1.9	0.2	1.0	0.8	3.8
CBX4	"hPC2, NBP16, PC2"	ENSG00000141582	"Chromobox 4"	O00257	17	79833156-79839429	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 109.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 39.0;SK-MEL-30: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008228, HPA012021"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA008228: AB_1078413, HPA012021: AB_2668603"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.39e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (8.72e-8)"	"unprognostic (7.49e-2)"	"unprognostic (2.87e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.07e-1)"	7.1	9.9	11.6	11.3	14.8	109.1	7.0	9.0	22.5	5.9	6.2	20.4	6.3	8.3	5.9	6.3	14.8	6.7	10.3	12.0	12.9	12.9	6.5	15.3	9.0	13.9	15.4	10.8	9.3	16.8	16.2	14.8	17.0	13.9	8.9	4.8	14.5	12.9	6.9	3.8	20.6	8.5	5.2	12.6	16.3	10.8	5.5	13.1	29.2	8.3	6.7	19.2	8.6	7.1	3.6	4.2	5.2	1.7	1.0	3.8	1.3	10.8	9.7	3.0	12.7	1.9	1.7	8.3	4.9	2.9	1.8	1.9	7.0	6.1	4.2	7.0	1.9	4.0	5.6	3.2	3.2	1.3	4.5	6.2	2.3	9.3	13.0	9.2	12.4	18.6	2.3	19.3	1.6	3.0	3.0	1.5	12.4	7.2	23.7	1.9	7.8	17.0	12.7	1.6	11.3	9.8	17.7	3.0	18.8	2.5	5.2	3.1	5.9	7.4	39.0	43.4	1.3	9.2	19.9	3.8	10.6	9.4	6.5	6.3	20.5	10.4	11.8	6.7	10.8	14.0	3.9	1.4	4.1	2.4	1.5	1.8	3.3	3.1	3.3	0.9	3.6	3.8	3.5	5.2	1.0	1.7	4.2	0.5	1.3	11.6	14.8	9.0	22.5	12.9	12.9	15.4	10.8	13.9	13.1	3.0	14.9	15.9	2.2	20.7	30.6	37.0	12.7	9.4	9.1	1.8	21.6	27.3	0.0	7.5	0.1	13.5	11.5	23.3	6.4	3.3	11.4	6.6	6.9	13.5	11.7	19.1	50.6	20.3	20.6	0.6	4.0	10.2	16.9	4.6	38.4	26.1	7.5	15.9	5.3	2.6	40.4	6.5	11.0	0.0	2.5	26.8	7.2	16.0	26.7	4.8
CBX5	"HP1, HP1-ALPHA, HP1Hs-alpha"	ENSG00000094916	"Chromobox 5"	P45973	12	54230940-54280133	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016699, CAB017548"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017548: AB_2071368, HPA016699: AB_1850627"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.80e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.97e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.64e-2)"	9.7	18.2	26.3	16.3	28.4	17.3	16.0	22.3	32.3	13.8	12.0	25.3	10.4	8.7	11.7	18.0	11.2	18.9	10.6	22.0	22.1	28.4	20.8	10.1	11.6	19.8	22.4	18.8	22.2	12.2	42.5	26.8	13.9	20.4	13.9	13.0	19.5	10.5	16.0	14.1	19.5	10.4	12.6	25.3	11.7	11.8	26.8	20.3	37.0	27.4	9.0	23.4	10.0	11.6	11.3	18.4	3.7	6.1	6.2	8.2	3.6	8.8	26.4	41.4	19.1	5.5	12.0	9.6	13.7	9.9	11.6	12.1	10.2	28.4	24.5	18.5	13.5	13.9	7.5	29.3	8.5	19.9	38.8	6.4	21.6	30.0	3.6	4.3	11.4	9.2	5.9	5.8	19.9	17.6	13.2	12.8	22.8	24.5	24.3	19.1	15.3	36.2	11.9	33.1	3.7	3.2	35.9	23.2	13.6	12.1	8.1	20.8	32.1	25.7	5.8	3.0	17.0	22.4	19.3	16.8	19.7	17.0	7.4	16.2	6.1	6.8	47.1	12.5	11.7	20.5	0.8	4.7	3.7	6.2	4.9	5.0	9.4	6.7	5.7	7.8	11.3	6.6	6.1	0.7	6.2	6.1	18.4	8.2	3.6	26.3	28.4	22.3	27.2	22.1	28.4	22.4	18.8	20.4	20.3	35.7	44.5	47.7	38.8	41.1	105.7	135.1	56.0	92.3	52.4	78.5	43.2	45.4	89.5	54.0	84.3	46.6	14.0	70.0	51.5	49.9	48.3	35.9	29.0	27.7	32.9	173.2	25.9	32.5	22.5	38.8	59.8	30.8	33.7	55.1	34.8	65.1	38.7	7.0	75.7	47.7	56.4	32.3	42.9	202.7	89.2	28.5	21.9	35.2	33.3	23.0
CBX8	"HPC3, PC3, RC1"	ENSG00000141570	"Chromobox 8"	Q9HC52	17	79792132-79801683	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031462	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031462: AB_10601252"	"unprognostic (4.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.81e-2)"	"unprognostic (3.26e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.94e-6)"	"unprognostic (2.92e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.26e-2)"	"prognostic favorable (3.84e-5)"	"unprognostic (4.74e-1)"	"prognostic unfavorable (5.39e-7)"	"unprognostic (6.99e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.51e-1)"	"unprognostic (5.99e-2)"	5.0	4.6	6.3	7.5	4.3	3.6	4.6	4.4	7.2	3.8	4.3	5.1	3.9	5.4	3.6	20.5	3.9	13.9	7.3	4.8	5.6	2.7	6.9	7.8	6.2	5.0	4.5	5.0	3.2	7.9	10.0	11.0	4.7	4.7	3.6	1.6	5.9	4.8	6.9	3.9	4.2	4.1	2.2	3.3	4.3	5.5	13.6	5.5	12.8	4.4	1.7	4.0	2.6	2.5	4.9	5.7	14.6	6.8	3.0	3.4	2.1	7.8	16.1	4.3	15.5	2.4	1.5	5.2	4.0	2.9	3.5	2.4	8.8	4.0	5.8	11.4	2.2	3.1	7.4	5.5	1.2	1.5	4.4	7.7	2.1	8.5	9.3	2.8	8.6	18.2	1.3	2.5	2.2	0.7	3.4	0.7	6.9	5.1	2.6	1.0	9.6	9.8	12.8	1.7	5.7	8.8	9.2	3.8	10.6	2.6	5.4	6.3	12.7	5.8	18.5	9.2	1.5	9.7	11.3	1.8	7.3	10.1	2.9	6.3	7.5	2.9	3.7	4.5	8.6	4.0	1.0	5.2	14.6	3.4	6.5	1.2	4.9	1.9	2.0	5.7	2.1	1.9	1.8	6.5	3.0	6.8	4.6	1.9	2.1	6.3	4.3	4.4	7.2	5.6	2.7	4.5	5.0	4.7	5.5	0.0	0.3	1.3	0.7	1.5	5.2	2.1	10.2	1.4	0.0	3.5	7.9	6.1	0.0	4.1	2.7	1.2	3.2	0.0	4.8	2.4	1.5	0.8	5.7	2.6	4.2	7.9	8.7	0.6	2.8	0.0	0.9	1.1	1.7	1.0	6.3	6.8	3.7	4.0	2.1	1.9	10.8	0.0	2.8	0.5	11.4	1.0	2.1	3.8	3.7	0.3
CCAR2	"DBC-1, DBC1, KIAA1967, NET35"	ENSG00000158941	"Cell cycle and apoptosis regulator 2"	Q8N163	8	22604632-22621514	"Predicted intracellular proteins"	"Apoptosis, Biological rhythms, Cell cycle, DNA damage, mRNA processing, mRNA splicing, Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Metalloenzyme inhibitor, Repressor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019907, HPA019943, CAB072827, CAB072828"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA		5300	"Nucleoplasm, Nuclear bodies"		"CAB072827: , CAB072828: , HPA019907: AB_1852452, HPA019943: AB_1852454"	"unprognostic (3.42e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.23e-2)"	"unprognostic (5.13e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.54e-2)"	"prognostic favorable (5.60e-4)"	"unprognostic (1.71e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.77e-1)"	28.6	32.7	27.8	35.4	38.3	63.1	29.9	45.0	59.1	26.7	33.0	38.4	28.0	25.7	37.3	24.6	31.7	32.8	30.0	21.9	24.6	25.0	25.2	28.1	29.7	39.7	24.8	36.3	37.8	28.0	34.5	31.5	32.3	33.2	28.8	23.4	27.2	29.1	25.4	44.4	39.8	30.9	25.2	22.4	41.2	29.7	62.4	25.0	63.5	29.4	23.3	37.0	30.6	26.2	13.3	10.7	14.4	21.0	12.2	24.3	14.3	26.7	50.1	48.5	25.2	19.2	16.2	32.3	26.3	26.0	38.9	34.8	44.9	22.2	44.3	33.2	28.7	35.8	33.6	44.5	31.2	28.2	17.9	26.6	52.3	38.7	34.8	17.8	28.6	44.8	16.7	28.1	30.9	19.1	22.6	27.9	40.3	54.6	28.2	28.7	32.0	86.1	30.2	70.6	29.0	18.3	57.7	40.1	23.7	20.1	63.8	24.3	56.7	29.6	34.1	22.7	24.5	31.0	27.1	45.0	28.9	38.3	34.7	34.6	20.8	25.8	52.2	32.5	25.2	44.8	12.9	10.1	14.4	24.3	17.4	20.7	13.3	18.2	18.3	10.7	13.2	18.3	19.0	3.7	12.2	21.0	10.1	20.9	14.3	27.8	38.3	45.0	59.1	24.6	25.0	24.8	36.3	33.2	25.0	14.9	3.4	11.0	8.0	12.4	11.5	7.1	7.6	14.7	5.7	15.7	15.7	21.1	8.3	16.3	3.9	8.7	18.0	0.0	15.6	18.8	9.5	9.9	8.1	10.5	13.4	9.5	21.4	9.8	10.8	5.6	13.8	8.6	11.8	10.8	17.8	14.3	17.7	11.5	11.3	7.7	11.8	19.4	12.2	30.0	21.7	13.4	19.8	14.9	18.3	8.6
CCDC124		ENSG00000007080	"Coiled-coil domain containing 124"	Q96CT7	19	17933016-17943991	"Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041708, HPA046765"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041708: AB_2677628, HPA046765: AB_2679793"	"unprognostic (9.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.22e-1)"	32.2	21.8	28.8	23.1	25.7	28.1	16.3	16.8	34.4	15.0	22.3	16.8	16.5	20.0	29.0	17.8	22.0	13.6	20.0	34.8	26.5	22.3	18.1	24.4	15.5	16.2	26.4	23.8	15.5	29.4	14.0	12.3	16.3	18.5	17.6	7.6	16.1	34.7	19.9	96.8	20.6	21.2	20.5	20.2	20.7	26.7	14.0	13.3	13.6	19.1	29.0	14.1	17.0	33.2	30.2	39.1	31.9	42.4	32.4	42.2	28.7	48.4	34.5	11.8	23.3	7.9	6.1	38.8	24.3	8.0	13.0	11.0	25.9	20.3	37.1	35.3	10.2	8.5	18.6	13.0	23.3	3.8	38.9	71.4	30.7	27.0	30.0	15.4	34.4	21.2	9.7	15.5	13.2	12.6	7.4	13.6	24.7	39.3	15.7	6.7	47.8	33.7	43.8	26.7	16.7	59.2	33.3	21.5	40.5	10.6	17.6	23.6	33.9	17.0	19.7	24.2	5.0	18.0	12.9	28.8	22.1	27.5	42.3	37.6	22.2	23.4	35.7	27.4	41.8	27.7	27.4	39.0	31.9	42.2	42.4	33.5	28.2	32.8	38.8	39.1	30.2	26.1	31.6	9.5	32.4	30.2	34.5	36.9	28.7	28.8	25.7	16.8	30.4	26.5	22.3	26.4	23.8	18.5	13.3	17.9	4.5	43.2	45.5	80.4	21.8	12.6	28.1	6.7	9.1	69.8	2.0	86.3	116.0	142.5	25.0	54.0	90.6	0.0	172.9	115.7	72.5	52.7	27.6	49.5	97.5	9.5	58.6	41.1	56.9	74.0	30.2	52.2	91.1	104.6	46.2	32.1	165.3	48.0	38.9	105.4	17.4	19.4	59.2	31.6	40.5	96.0	69.2	45.4	56.2	62.5
CCDC137	MGC16597	ENSG00000185298	"Coiled-coil domain containing 137"	Q6PK04	17	81666364-81673904	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052637, HPA053914"	Uncertain		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA052637: AB_2681894, HPA053914: AB_2682306"	"unprognostic (3.04e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (1.35e-7)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (2.21e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (4.26e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.39e-1)"	11.3	10.9	10.9	16.0	14.1	20.2	10.2	11.3	17.0	10.3	11.5	8.0	8.9	16.2	9.1	6.4	25.2	9.2	9.1	9.1	12.1	9.0	10.6	12.1	8.7	18.8	12.4	11.9	8.4	12.0	9.4	8.4	11.2	11.8	13.1	6.4	5.7	13.0	9.9	12.7	29.8	11.8	10.3	9.1	17.7	11.4	13.4	12.4	9.8	9.2	13.1	16.6	10.6	14.7	12.8	12.6	10.2	9.2	11.9	11.2	5.9	12.4	24.7	6.7	12.0	4.9	4.9	13.5	14.3	6.8	20.6	11.4	21.8	7.5	12.9	7.6	8.5	11.6	16.4	13.9	16.1	7.7	6.6	21.4	20.0	11.0	17.3	7.5	15.3	13.1	7.2	8.7	18.9	8.5	4.5	14.5	14.0	19.0	6.9	9.6	13.6	15.2	16.6	16.1	9.5	25.0	18.2	12.7	8.3	6.5	11.4	16.5	21.3	13.1	27.0	11.7	7.9	19.5	12.7	9.9	29.8	17.4	11.9	19.7	18.2	10.5	13.0	10.7	15.0	16.9	1.9	7.8	10.2	11.2	8.4	7.0	10.3	9.7	9.6	7.4	12.8	10.7	9.6	3.5	11.9	9.2	12.6	9.5	5.9	10.9	14.1	11.3	17.0	12.1	9.0	12.4	11.9	11.8	12.4	20.8	13.4	25.0	19.6	28.2	5.7	6.2	10.2	26.8	25.0	12.2	2.0	19.0	16.6	24.5	1.0	19.6	12.7	23.3	18.6	32.2	11.4	18.3	18.5	10.9	21.5	17.5	6.9	14.1	11.0	0.9	12.7	18.2	15.1	33.3	13.4	12.9	26.4	13.6	12.7	10.2	7.1	6.5	15.6	31.2	46.5	30.1	17.4	29.9	17.0	18.6
CCDC14	"DKFZp434L1050, FLJ12892"	ENSG00000175455	"Coiled-coil domain containing 14"	Q49A88	3	123897305-123961408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035278, HPA035279"	Uncertain		Enhanced	Centrosome		NA	NA			Centrosome		"HPA035278: AB_2674548, HPA035279: AB_10601253"	"unprognostic (7.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.45e-2)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (6.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (4.76e-4)"	"prognostic unfavorable (3.50e-8)"	"unprognostic (2.14e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.37e-2)"	"prognostic favorable (2.72e-5)"	11.3	9.7	13.6	22.4	15.2	30.0	19.1	8.0	16.2	14.5	18.8	10.8	7.7	12.0	20.4	31.9	10.2	15.8	14.9	9.1	13.6	8.7	13.3	13.7	14.1	14.3	14.3	13.0	20.6	15.4	7.8	24.4	9.7	14.5	17.2	31.8	9.6	14.3	9.8	5.9	20.2	15.9	13.6	17.4	13.7	12.8	22.5	16.0	36.5	14.0	11.2	13.3	12.7	13.0	2.1	4.5	3.0	2.2	6.0	5.6	1.9	16.7	9.8	30.3	12.0	4.2	6.2	14.2	33.7	11.1	16.3	18.9	7.6	11.9	5.0	8.6	7.0	12.7	19.0	11.0	5.5	22.1	4.1	7.7	19.9	18.0	7.1	4.0	13.0	12.8	6.2	3.5	8.5	9.1	20.7	7.7	19.8	10.2	9.2	11.2	8.3	11.3	6.2	9.1	7.3	11.5	19.5	12.6	5.7	9.4	13.7	10.6	12.6	19.7	4.9	12.8	19.1	11.8	9.6	10.1	39.5	20.5	12.1	10.9	8.7	6.0	14.9	13.3	10.0	13.7	2.8	1.6	3.0	3.9	2.2	2.6	2.1	3.4	3.3	1.0	2.0	3.8	3.2	0.3	6.0	0.6	4.5	5.6	1.9	13.6	15.2	8.0	16.2	13.6	8.7	14.3	13.0	14.5	16.0	20.8	56.7	6.7	33.3	19.5	35.1	11.0	28.1	18.7	30.7	34.9	56.9	19.0	0.0	20.0	29.2	21.5	42.4	46.7	12.1	20.0	27.5	16.9	24.4	17.3	17.6	27.0	86.3	27.0	18.7	14.7	30.2	21.2	23.6	13.6	87.0	23.6	17.3	49.1	29.4	7.8	79.1	19.4	25.5	98.1	43.0	14.1	9.7	24.9	75.9	16.3
CCDC174	"C3orf19, FLJ33839"	ENSG00000154781	"Coiled-coil domain containing 174"	Q6PII3	3	14651746-14672659	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043468, HPA060129"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043468: AB_2678493, HPA060129: AB_2684208"	"unprognostic (6.10e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.58e-3)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.86e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.81e-5)"	16.8	12.9	15.7	13.4	17.5	27.1	17.1	22.3	18.2	19.2	18.5	17.8	15.2	16.8	24.0	14.5	16.1	15.5	12.9	14.4	13.1	10.9	17.9	15.3	13.0	15.7	17.9	14.8	28.0	18.6	15.7	29.9	15.6	16.9	17.7	13.7	12.6	16.1	15.7	26.9	17.4	20.6	14.9	18.7	20.2	18.2	15.3	19.2	23.1	17.5	9.8	18.4	19.0	17.6	14.7	9.5	21.0	9.9	15.4	16.7	8.4	5.1	5.7	8.8	9.3	12.2	10.1	22.3	7.0	10.0	8.8	6.9	6.4	6.1	10.8	5.1	6.1	6.0	4.6	6.3	5.8	6.9	8.1	7.7	11.0	6.8	6.8	17.7	10.7	12.8	11.6	15.0	11.8	14.6	12.4	7.5	11.6	10.9	9.9	6.5	9.1	11.2	9.5	11.8	8.6	9.4	8.4	8.2	8.8	9.0	9.2	4.3	11.6	8.1	6.4	11.2	10.7	9.7	15.3	6.9	7.1	6.9	6.5	8.0	13.2	11.7	12.6	7.1	8.3	9.6	21.0	9.5	18.4	12.1	9.7	14.1	14.7	15.1	13.9	8.4	13.3	16.7	13.3	18.4	15.4	9.9	9.5	10.3	8.4	15.7	17.5	22.3	18.2	13.1	10.9	17.9	14.8	16.9	19.2	8.9	34.6	52.9	25.1	14.3	31.2	32.7	28.1	36.1	34.2	12.2	19.6	26.1	48.0	29.4	124.0	26.9	26.2	70.0	30.5	21.0	25.8	23.3	50.8	26.6	23.1	14.3	17.7	27.6	22.9	39.8	31.1	28.8	13.5	55.1	21.6	23.3	32.0	31.7	37.8	29.8	23.3	32.3	21.7	47.7	31.1	11.8	54.9	42.1	21.1	27.8
CCDC43	FLJ31795	ENSG00000180329	"Coiled-coil domain containing 43"	Q96MW1	17	44673069-44689779	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 50.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA023078, HPA023391"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA023078: , HPA023391: AB_1846146"	"unprognostic (6.05e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.58e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (3.42e-5)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.13e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (2.08e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.11e-1)"	10.4	10.4	14.3	8.5	15.6	13.8	10.0	14.9	14.7	7.9	9.3	9.8	7.2	9.1	8.2	9.0	10.7	7.6	6.1	16.3	13.8	10.4	11.2	7.5	7.5	9.6	11.9	9.2	7.3	9.4	12.3	5.8	14.2	14.4	9.8	12.0	6.9	8.9	7.6	50.6	8.8	8.8	8.6	14.4	9.8	8.5	7.3	9.6	10.9	10.8	17.1	10.9	9.1	7.8	11.5	17.5	10.7	17.9	15.8	14.7	10.0	12.3	14.8	14.1	12.4	9.6	14.3	25.9	18.9	11.2	18.6	18.3	20.0	13.3	21.6	14.7	15.3	13.3	9.7	23.2	21.8	27.1	26.3	27.0	19.3	24.4	29.4	17.3	27.0	14.6	12.8	22.2	19.3	26.4	12.8	18.0	17.8	20.3	15.1	18.8	15.3	26.3	19.2	14.5	11.7	19.1	17.1	35.5	18.6	19.0	8.1	14.2	14.0	13.8	11.1	19.1	22.2	28.4	18.4	15.5	23.1	17.0	13.7	25.0	15.4	19.4	25.0	16.9	15.8	16.4	10.5	16.0	10.7	12.9	17.9	11.9	9.3	12.2	14.3	17.5	11.5	12.0	13.0	3.3	15.8	11.7	12.4	14.7	10.0	14.3	15.6	14.9	14.7	13.8	10.4	11.9	9.2	14.4	9.6	11.9	16.0	19.3	8.6	11.7	21.9	35.1	12.7	21.4	21.6	8.7	9.8	36.1	33.2	19.2	0.6	20.0	10.5	23.3	21.3	38.6	13.5	9.4	32.3	12.4	26.9	20.6	17.2	16.5	17.8	2.7	13.0	21.6	20.3	18.0	14.4	17.4	18.5	10.5	12.0	25.8	19.2	6.5	17.6	3.5	10.4	9.8	21.2	12.1	19.9	7.1
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745250-63776351	"Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	26.2	42.1	26.7	18.7	43.3	11.4	26.7	32.4	31.3	24.4	38.2	23.0	29.2	39.9	20.6	26.3	28.9	21.2	22.8	42.4	26.5	24.0	40.0	71.8	27.4	13.9	29.4	24.8	27.0	30.5	49.3	28.5	49.9	26.4	29.3	38.4	17.7	30.0	29.7	71.9	23.5	44.0	20.7	31.5	26.8	35.9	15.1	34.7	13.3	29.4	24.3	18.1	29.8	24.5	19.9	41.9	37.4	30.8	20.8	25.7	24.2	38.6	36.7	22.8	20.0	32.3	21.5	44.6	39.6	25.7	27.1	32.1	32.4	35.3	30.5	21.2	27.6	31.4	31.8	27.6	24.2	48.1	10.7	28.1	43.9	30.3	31.6	31.0	35.0	23.1	22.6	34.2	37.3	32.2	19.2	22.5	15.3	48.8	26.8	22.0	31.2	26.8	12.9	19.9	48.6	37.4	24.9	44.5	41.9	32.5	44.1	21.0	28.6	26.5	68.0	31.7	30.3	44.8	19.1	28.7	50.8	32.5	36.8	45.4	26.8	31.8	31.5	29.6	22.4	40.9	22.2	30.7	37.4	22.1	30.8	25.7	19.9	21.9	20.3	41.9	16.0	22.9	20.2	24.5	20.8	30.4	27.9	23.4	24.2	26.7	43.3	32.4	31.3	26.5	24.0	29.4	24.8	26.4	34.7	134.0	106.5	47.7	83.7	89.5	39.7	111.9	63.7	88.3	134.2	57.6	13.7	93.7	8.3	87.2	11.3	69.1	81.5	46.7	91.7	81.3	51.1	84.9	42.9	81.9	52.3	54.0	50.2	59.5	48.5	10.0	44.3	53.4	37.1	57.7	79.0	57.4	77.1	56.1	52.6	28.2	22.6	71.1	79.8	53.4	31.7	79.4	120.5	30.6	79.3	73.5
CCDC86	MGC2574	ENSG00000110104	"Coiled-coil domain containing 86"	Q9H6F5	11	60842071-60851081	"Predicted intracellular proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 200.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041117, HPA041540"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA041117: AB_10794984, HPA041540: AB_10794299"	"unprognostic (2.93e-1)"	"unprognostic (6.59e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.47e-3)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (7.36e-5)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.65e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.47e-1)"	"unprognostic (3.76e-2)"	"unprognostic (7.54e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.25e-2)"	13.5	12.4	7.3	8.6	11.0	6.1	11.2	3.3	11.2	5.8	6.7	7.9	3.4	7.4	8.4	5.0	9.3	7.4	8.3	9.3	6.7	6.4	8.1	11.4	5.4	8.2	10.0	6.0	11.3	13.6	200.8	12.7	7.3	8.5	11.9	4.7	6.7	6.4	6.2	20.2	10.4	6.2	7.3	6.7	9.3	7.7	47.8	8.7	10.2	7.9	12.6	6.5	8.6	6.5	6.9	20.0	5.0	19.5	4.2	8.5	6.7	21.0	28.7	7.1	20.5	5.8	9.6	9.7	14.2	11.1	26.1	14.0	24.4	14.2	25.8	27.2	7.7	18.6	19.8	24.0	17.1	12.0	9.1	26.6	13.1	12.7	34.0	19.2	20.5	22.5	10.9	13.0	24.1	15.3	3.8	19.3	14.2	41.9	13.3	12.7	24.9	30.8	31.3	28.7	12.5	41.3	21.0	10.7	64.9	9.1	9.0	16.1	10.4	9.1	21.1	16.6	4.7	21.3	8.2	12.6	26.0	16.0	35.3	30.7	11.2	16.5	27.9	21.3	22.2	31.4	2.6	9.1	5.0	6.5	19.5	6.9	6.9	6.9	6.0	20.0	6.5	8.5	7.4	0.7	4.2	6.3	11.2	6.2	6.7	7.3	11.0	3.3	11.2	6.7	6.4	10.0	6.0	8.5	8.7	0.0	2.1	3.0	15.4	32.7	9.3	0.4	2.5	0.0	4.5	1.8	7.9	15.9	6.6	20.4	19.7	6.8	2.6	0.0	10.4	14.1	9.5	18.2	4.7	2.4	16.0	3.2	6.9	3.7	2.8	10.6	10.6	7.9	15.1	4.6	4.9	3.6	13.7	3.5	5.6	5.4	7.9	19.4	20.2	37.1	19.1	27.0	6.9	6.1	9.7	15.5
CCDC90B	"MDS011, MDS025"	ENSG00000137500	"Coiled-coil domain containing 90B"	Q9GZT6	11	83259097-83286407	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 347.8;Spermatocytes: 279.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011130, HPA011931"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA011130: AB_1846170, HPA011931: AB_2072332"	"unprognostic (5.85e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.34e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.48e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.57e-3)"	"unprognostic (5.76e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.01e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.41e-1)"	15.8	32.0	25.0	11.1	23.3	11.6	18.0	14.3	17.9	15.4	14.5	14.6	17.2	12.1	12.6	29.3	14.3	13.5	15.2	18.2	22.3	25.6	16.4	31.3	11.0	15.0	29.9	14.9	19.4	16.6	15.2	29.5	18.3	24.5	16.3	14.9	8.4	14.5	14.8	12.2	11.6	18.2	14.9	43.9	17.1	13.6	42.2	28.3	15.5	21.6	12.3	13.5	14.8	13.0	18.5	12.7	32.6	19.0	22.5	21.1	12.4	7.2	10.8	18.4	5.9	25.0	18.9	11.3	14.8	12.7	9.4	10.0	12.6	25.3	17.7	19.5	21.9	19.4	9.3	8.1	19.0	12.5	12.4	6.4	10.9	7.3	10.4	21.1	11.0	9.5	21.0	25.7	12.0	34.7	18.5	21.3	19.6	16.1	15.2	34.1	12.9	11.0	14.1	15.2	31.7	13.5	12.8	16.6	15.2	19.4	10.8	9.0	20.8	10.4	8.4	9.6	25.9	21.7	10.3	20.4	18.4	11.6	34.5	10.0	14.8	19.3	18.0	7.4	8.9	18.1	30.8	8.9	32.6	12.3	19.0	15.6	18.5	17.9	17.0	12.7	16.9	15.5	15.5	4.5	22.5	19.0	9.3	21.1	12.4	25.0	23.3	14.3	17.9	22.3	25.6	29.9	14.9	24.5	28.3	11.9	12.5	34.2	43.7	20.9	33.7	49.1	15.3	24.1	15.9	34.9	13.7	62.9	58.0	53.7	347.8	38.6	19.2	0.0	42.7	46.4	36.0	35.2	47.4	39.9	56.5	39.7	32.2	26.4	28.8	188.9	39.4	41.6	20.3	61.3	31.8	23.0	58.7	35.1	24.1	57.7	44.3	25.8	30.1	279.8	83.5	25.3	43.3	28.8	30.4	38.0
CCDC93	FLJ10996	ENSG00000125633	"Coiled-coil domain containing 93"	Q567U6	2	117915478-118014133	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054183	Approved		Enhanced	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA054183: AB_2682408"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (2.51e-1)"	"unprognostic (8.12e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.40e-2)"	23.0	20.6	12.9	21.9	14.3	27.2	14.5	23.9	15.6	12.3	18.1	12.8	16.0	17.3	16.8	16.9	10.9	12.3	14.9	23.4	13.1	13.0	14.6	11.0	15.9	16.0	11.8	11.5	20.3	18.0	24.0	26.8	18.6	13.3	11.4	16.0	14.6	13.6	24.9	20.6	16.0	18.1	17.2	15.1	17.1	12.1	15.9	12.0	17.4	17.1	10.2	20.4	11.9	19.2	4.2	3.0	6.3	5.5	3.9	5.7	2.3	13.5	6.0	16.7	14.6	24.2	16.7	14.1	16.2	10.6	10.6	11.0	13.0	8.8	11.7	11.1	12.6	19.1	11.8	9.6	8.4	13.9	15.1	9.8	14.7	10.6	17.4	10.7	15.9	16.8	11.4	8.8	16.7	19.9	14.8	11.2	14.2	8.0	8.3	11.9	5.9	10.0	17.3	7.5	9.8	9.8	12.8	13.1	7.8	8.8	14.5	13.3	7.9	10.5	8.0	11.4	15.6	6.7	9.9	15.7	18.4	15.5	15.5	11.2	10.9	11.3	18.4	10.6	11.9	10.7	6.3	4.2	4.5	5.7	5.5	5.6	4.2	4.1	4.7	3.0	4.1	5.6	4.8	4.4	3.9	3.4	1.5	1.8	2.3	12.9	14.3	23.9	15.6	13.1	13.0	11.8	11.5	13.3	12.0	17.9	26.2	5.1	10.4	15.7	30.5	38.3	5.1	18.7	21.6	1.8	45.2	11.0	8.3	21.2	3.9	12.7	16.0	0.0	14.4	6.6	12.2	10.2	14.0	5.0	13.7	19.1	16.0	12.3	17.1	6.2	12.7	14.1	3.3	20.8	10.3	13.5	23.0	10.4	13.4	7.8	37.9	6.5	12.7	37.0	27.8	14.1	10.8	11.4	11.7	14.5
CCM2	"C7orf22, MGC4607, OSM"	ENSG00000136280	"CCM2 scaffolding protein"	Q9BSQ5	7	44999475-45076469	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"monocytes: 208.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020273, HPA021669, HPA065815"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020273: AB_1846185, HPA021669: AB_1846186, HPA065815: AB_2685562"	"unprognostic (4.30e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.37e-3)"	"unprognostic (3.92e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (5.06e-7)"	"unprognostic (2.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.48e-1)"	16.7	18.3	31.6	20.7	52.0	11.2	8.6	21.3	36.1	9.7	12.5	13.9	8.6	10.5	7.2	7.0	10.6	8.4	9.1	13.7	29.8	23.1	7.9	31.6	12.4	30.7	29.0	14.2	8.2	17.9	16.5	11.2	11.5	17.8	7.7	8.8	6.9	13.6	12.6	27.0	13.4	10.6	13.3	14.7	20.8	11.2	10.5	11.5	37.5	7.4	8.2	23.4	15.4	12.6	14.8	7.3	32.4	13.8	17.6	50.6	11.1	13.6	15.1	9.1	18.0	17.2	15.1	6.7	16.6	13.7	11.9	16.1	10.9	14.2	19.3	12.8	21.0	37.8	17.9	5.6	21.4	7.9	21.5	10.8	8.5	12.1	7.7	15.2	3.5	23.1	17.0	14.1	20.9	9.0	11.1	21.6	28.3	9.8	15.7	23.8	20.6	16.9	46.8	10.5	11.4	16.8	9.0	5.2	15.6	12.1	13.2	17.5	13.6	13.6	10.7	7.3	12.3	12.3	16.1	16.3	16.2	13.8	16.2	15.8	28.1	22.0	38.9	15.9	12.7	19.5	27.1	10.5	31.2	17.3	12.1	11.6	13.6	20.5	18.7	7.2	14.8	19.9	14.7	32.4	17.6	13.8	7.3	50.6	11.1	31.6	52.0	21.3	36.1	29.8	23.1	29.0	14.2	17.8	11.5	17.9	20.8	51.3	20.1	41.6	18.3	12.5	17.8	6.7	21.6	14.0	3.9	22.8	21.6	27.6	5.8	25.3	21.7	0.0	33.3	31.3	26.3	15.3	34.7	50.4	43.3	77.9	15.0	27.0	34.3	8.0	19.5	45.2	32.1	208.2	13.4	21.4	35.1	11.5	19.1	17.0	11.9	19.4	27.8	16.2	36.4	20.1	8.7	56.6	13.5	16.1
CCNA2	"CCN1, CCNA"	ENSG00000145386	"Cyclin A2"	P20248	4	121816444-121823933	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lymphoid tissue: 122.3"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 70.0;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 6.8"	"Group enriched"	"Detected in many"	5	"NK-cells: 1.7;T-cells: 6.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"CAB000114, HPA020626"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB000114: AB_563675, HPA020626: AB_1847376"	"unprognostic (4.02e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.66e-3)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.25e-1)"	"unprognostic (1.67e-2)"	"prognostic unfavorable (9.17e-5)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (3.92e-3)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (4.43e-6)"	"unprognostic (8.38e-3)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.59e-1)"	3.2	1.5	1.3	18.6	1.7	21.6	1.8	5.1	1.2	2.5	6.3	1.0	0.8	6.6	2.2	2.1	11.7	1.7	2.4	3.2	1.8	1.8	1.7	1.6	3.4	15.6	1.6	0.8	4.5	0.9	0.5	3.2	12.0	1.3	2.2	7.8	1.0	2.1	0.8	1.1	4.2	7.4	2.4	1.8	8.9	2.9	8.4	0.8	122.3	1.4	18.8	18.4	2.5	5.1	0.3	0.9	0.6	0.3	1.7	6.8	1.9	38.7	10.1	27.7	11.8	1.5	3.8	22.7	27.1	11.9	36.0	26.8	22.0	24.1	35.7	7.3	14.2	12.7	13.1	34.8	15.9	29.7	17.1	16.1	28.6	13.4	21.3	0.3	43.1	20.3	1.0	1.2	14.9	8.9	5.7	21.5	19.0	40.7	35.9	28.5	13.9	54.9	25.0	21.8	24.3	11.3	25.2	53.7	17.4	10.2	7.7	11.8	12.5	14.2	17.4	7.5	21.7	14.5	18.3	12.7	16.9	25.7	17.8	25.8	22.8	24.1	40.9	9.7	43.9	18.7	0.0	0.3	0.6	0.2	0.1	0.1	0.3	2.0	1.4	0.9	0.1	0.0	0.5	0.3	1.7	0.3	0.1	6.8	1.9	1.3	1.7	5.1	1.2	1.8	1.8	1.6	0.8	1.3	0.8	0.0	0.6	0.0	0.7	2.5	1.1	0.7	0.0	2.7	1.2	0.0	11.8	5.7	0.0	0.3	4.8	0.7	1.5	70.0	0.2	72.3	3.3	1.1	0.0	1.5	21.0	0.0	1.2	2.5	7.5	1.5	0.9	2.9	1.7	0.0	3.1	1.3	0.4	1.5	1.1	0.0	14.2	0.0	0.9	6.1	7.9	1.1	7.1	3.2	6.4	1.3
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 610.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.6	40.6	55.8	49.6	2.9	5.0	131.7	26.0	19.5	68.6	58.1	60.0	55.4	36.1	31.7	23.9	78.7	37.0	56.1	56.8	77.0	35.4	27.7	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.3	27.4	6.3	36.6	35.4	27.6	28.7	55.8	55.9	27.2	23.7	31.0	19.5	25.8	28.7	40.2	37.0	25.1	21.7	28.4	17.9	44.7	21.1	19.2	32.8	40.3	20.9	15.3	15.3	49.7	27.6	64.9	14.4	26.6	50.4	21.2	34.9	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3	0.0	0.3	5.2	4.8	10.2	4.2	1.5	2.5	13.4	4.5	5.2	2.0	53.5	1.7	5.3	63.8	1.8	2.9	46.7	1.2	610.8	11.3	3.6	2.3	3.0	50.4	0.0	1.2	6.2	6.0	9.4	2.8	4.4	3.3	3.6	4.6	2.8	2.5	0.0	2.5	4.3	2.9	6.5	3.1	28.8	70.2	6.4	34.7	4.4	11.5	2.7
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.7	25.3	41.6	10.3	1.9	3.8	22.1	23.8	15.3	36.9	30.4	40.9	17.7	26.7	17.3	15.4	21.6	35.5	39.3	20.2	34.9	27.7	21.1	34.6	29.6	23.2	0.5	25.7	22.3	1.4	2.7	15.9	20.3	7.2	25.0	33.0	34.9	42.9	27.8	20.9	29.3	37.5	30.7	12.4	15.0	34.3	58.9	27.1	11.6	20.3	25.9	17.5	32.6	17.7	21.5	34.0	30.7	25.7	13.0	18.4	31.2	20.2	45.3	19.1	28.7	47.5	12.0	58.9	25.9	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2	0.0	1.1	7.8	1.0	4.2	0.0	0.3	0.0	1.4	2.3	0.0	0.0	26.7	0.0	0.4	102.4	0.4	1.7	163.5	0.2	106.5	1.1	1.7	0.0	0.8	25.3	0.0	2.9	3.1	10.7	30.4	4.0	4.2	0.0	3.6	5.5	0.0	0.5	1.7	1.8	0.0	0.2	0.0	0.0	88.2	36.6	5.4	13.6	3.2	12.4	2.0
CCND2		ENSG00000118971	"Cyclin D2"	P30279	12	4273772-4305350	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 32.3;HBEC3-KT: 29.5;HDLM-2: 49.7;Karpas-707: 71.8;RH-30: 47.0;SuSa: 37.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049138, HPA054196"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA049138: AB_2680650, HPA054196: AB_2682412"	"unprognostic (2.98e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-2)"	"prognostic favorable (2.52e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.23e-2)"	"unprognostic (4.52e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (7.06e-2)"	13.7	39.3	20.8	12.0	15.9	23.6	10.4	6.1	22.3	14.4	28.3	8.1	24.3	18.5	21.9	41.9	12.2	16.5	9.1	36.9	17.5	7.3	6.0	5.7	12.8	24.5	7.9	17.0	11.6	18.4	8.3	19.2	23.5	9.3	16.4	24.2	14.1	8.3	22.4	2.0	9.2	19.6	45.5	14.0	16.5	11.1	5.2	8.6	6.2	18.5	6.9	13.6	22.3	16.3	3.9	2.1	4.6	1.0	9.1	14.8	5.4	0.0	0.0	32.3	0.0	5.6	0.8	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.2	0.0	0.0	4.1	0.9	29.5	0.0	49.7	0.8	0.3	0.0	0.2	0.1	12.6	2.7	10.8	4.9	0.0	22.3	0.2	0.0	0.9	3.4	71.8	6.3	0.0	0.0	16.6	13.3	0.2	0.0	0.0	47.0	23.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.1	2.3	0.0	9.4	0.0	0.0	1.2	12.2	0.0	0.1	9.1	0.0	4.1	1.0	4.6	9.1	0.2	13.7	3.9	13.0	11.0	2.1	1.5	8.2	9.8	1.5	9.1	0.1	1.0	14.8	5.4	20.8	15.9	6.1	22.3	17.5	7.3	7.9	17.0	9.3	8.6	56.6	49.3	25.1	24.4	94.8	6.8	305.9	0.0	9.4	43.3	12.2	0.0	2.6	0.0	2.5	0.7	38.4	26.9	46.7	59.7	1.7	135.6	5.7	54.3	0.8	12.0	3.2	62.3	17.8	13.3	0.9	48.6	38.9	37.1	6.4	146.6	155.3	32.6	35.1	116.7	1.0	3.7	25.8	50.5	0.7	3.6	34.6	5.3	61.2	109.0	7.0
CCNDBP1	"DIP1, GCIP, HHM"	ENSG00000166946	"Cyclin D1 binding protein 1"	O95273	15	43185118-43197176	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.4"	"Cell type enhanced"	"Detected in all"	12	"Cytotrophoblasts: 313.6;Syncytiotrophoblasts: 883.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	8	"HEL: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020664, HPA041065"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB020664: , HPA041065: AB_2677282"	"unprognostic (4.48e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.68e-2)"	15.6	10.9	3.4	12.6	5.3	55.4	17.5	10.8	9.5	8.8	9.4	5.6	11.5	7.6	11.3	10.7	18.3	10.4	9.6	14.1	3.9	6.9	8.2	8.4	11.6	23.6	6.1	5.6	5.6	13.4	5.2	9.6	24.1	9.3	8.8	9.0	7.7	11.3	12.8	21.1	12.0	12.9	8.2	6.0	12.8	11.8	5.9	5.4	8.3	15.6	5.9	11.0	15.9	11.7	5.4	2.9	16.9	8.0	4.6	7.6	1.6	0.3	0.4	0.6	0.3	1.6	1.1	0.6	0.4	2.0	0.4	0.4	0.5	0.4	0.6	0.5	1.4	0.2	0.6	1.4	0.6	0.3	0.9	1.4	16.9	0.8	0.6	1.2	0.8	1.0	2.0	1.6	0.2	0.6	1.7	1.3	0.3	1.0	0.6	0.6	0.0	0.5	1.9	1.2	0.7	0.5	0.5	0.6	1.5	2.2	0.7	0.8	1.3	0.6	0.5	0.4	0.7	0.1	1.6	1.6	0.5	0.2	1.3	0.3	2.0	0.7	0.3	1.7	1.8	0.5	16.9	1.9	4.9	5.2	3.3	5.4	4.4	5.6	5.1	1.6	5.4	5.9	6.1	6.1	4.6	8.0	2.9	7.6	1.6	3.4	5.3	10.8	9.5	3.9	6.9	6.1	5.6	9.3	5.4	44.7	55.2	77.3	44.9	30.8	27.2	52.0	35.7	92.3	50.0	27.9	19.6	313.6	76.3	59.3	11.5	45.0	55.7	140.2	52.3	67.6	49.5	41.5	54.4	28.2	77.3	42.9	44.4	47.9	82.6	10.0	43.7	59.8	60.8	151.5	49.4	52.2	58.5	56.1	27.6	38.5	63.1	45.3	48.9	65.4	36.8	35.3	883.1	83.0	45.2	73.2
CCNE1	CCNE	ENSG00000105173	"Cyclin E1"	P24864	19	29811898-29824308	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 23.3;placenta: 46.7"	"Cell type enriched"	"Detected in many"	14	"Extravillous trophoblasts: 1526.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 81.6"	"Low region specificity"	"Detected in all"							"CAB000308, CAB016682, HPA018169"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000308: , CAB016682: AB_1614564, HPA018169: AB_1847384"	"unprognostic (2.90e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.47e-3)"	"prognostic unfavorable (6.35e-6)"	"unprognostic (5.78e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (3.89e-5)"	"unprognostic (1.26e-3)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (2.97e-4)"	"unprognostic (3.29e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.11e-16)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.46e-1)"	1.6	6.8	2.4	4.5	2.9	23.3	0.6	6.3	3.3	0.8	3.0	1.7	1.1	2.3	1.2	0.6	4.7	0.7	2.2	4.4	2.3	2.8	1.2	0.7	1.1	4.6	1.9	1.9	0.9	1.4	1.7	1.0	46.7	2.8	1.1	3.8	1.5	3.2	1.2	2.2	4.4	2.5	3.0	1.7	4.6	2.0	12.3	1.6	4.1	1.6	2.1	5.9	2.7	2.5	2.7	1.6	1.6	1.9	0.0	1.4	0.5	4.1	8.6	6.6	9.4	1.4	1.6	81.6	6.6	1.4	2.9	3.6	8.7	8.4	3.5	15.7	2.9	3.8	1.3	7.8	3.4	4.2	11.1	4.8	2.9	8.4	9.1	1.1	11.5	7.9	1.7	1.9	4.0	0.5	0.9	3.5	3.5	11.8	1.6	4.4	6.2	6.3	3.3	11.0	9.4	2.0	9.5	7.7	2.6	2.2	6.6	5.6	4.7	9.5	11.7	1.0	10.1	2.6	8.6	2.0	6.9	25.9	4.1	4.4	6.6	4.6	23.9	3.9	1.4	3.7	0.0	0.1	0.0	0.6	1.9	1.1	2.7	0.5	0.4	1.6	0.2	0.1	0.9	1.6	0.0	1.9	0.0	1.4	0.5	2.4	2.9	6.3	3.3	2.3	2.8	1.9	1.9	2.8	1.6	0.0	1.1	0.8	1.0	4.2	2.4	2.8	0.0	0.0	2.3	0.0	0.0	112.5	0.0	0.4	7.1	1.1	1.7	0.0	0.6	1526.8	4.8	1.9	0.0	0.0	37.5	3.2	2.9	1.3	0.3	2.6	1.1	1.1	1.7	0.0	2.7	1.8	1.0	2.9	2.1	0.2	0.8	6.5	3.1	14.1	19.5	5.3	96.8	2.2	3.8	2.4
CCNI	CCNI1	ENSG00000118816	"Cyclin I"	Q14094	4	77047158-77076005	"Predicted intracellular proteins"		Cyclin		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 248.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010206, HPA039853, HPA061470"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Nuclear bodies"	"CAB010206: AB_2073599, HPA039853: AB_2676710, HPA061470: AB_2684533"	"unprognostic (3.68e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.10e-4)"	"unprognostic (3.81e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	49.0	26.6	48.1	47.1	45.8	50.3	121.1	101.3	248.9	66.3	56.8	21.6	36.9	25.6	56.7	69.0	56.2	50.7	45.2	87.7	44.8	34.1	48.2	34.5	64.7	70.1	55.8	33.5	94.9	65.4	36.5	33.1	35.4	46.7	61.4	34.9	32.7	45.5	62.9	64.3	38.5	45.8	61.6	58.1	41.3	42.4	53.0	20.3	55.4	81.2	28.2	60.0	82.7	62.6	49.2	42.9	70.5	39.8	33.6	56.2	24.3	24.6	14.8	48.4	42.2	72.8	66.6	18.5	19.1	46.7	30.2	29.2	18.2	37.6	45.6	29.3	47.8	18.9	12.9	33.0	66.7	48.2	32.3	13.0	27.3	17.3	17.3	71.5	46.8	55.2	52.0	79.9	27.8	68.4	86.9	42.3	24.1	23.3	49.7	42.9	28.4	60.8	44.3	21.2	17.3	9.2	38.2	45.7	19.2	45.0	28.2	61.4	33.6	25.3	38.9	30.8	35.4	22.1	20.0	28.6	37.0	22.1	39.3	25.9	27.6	12.5	48.2	31.3	32.4	23.9	43.1	32.9	70.5	31.7	33.4	44.9	46.6	52.4	47.2	37.3	49.2	56.2	47.4	47.0	33.6	39.8	42.9	44.8	24.3	48.1	45.8	101.3	248.9	44.8	34.1	55.8	33.5	46.7	20.3	160.8	205.6	381.1	554.3	375.7	387.2	381.6	262.4	87.0	102.4	186.7	64.8	225.4	673.1	338.9	56.4	305.8	254.0	186.9	291.0	357.2	371.0	733.0	274.5	108.3	295.2	171.6	395.9	297.7	542.3	122.9	559.2	420.6	381.3	312.8	295.3	254.5	414.7	272.5	929.9	450.1	187.1	543.3	450.1	159.5	349.2	345.0	317.4	433.7	302.4	523.8
CCNK	CPR4	ENSG00000090061	"Cyclin K"	O75909	14	99481169-99535044	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Transcription, Transcription regulation"	Cyclin	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000645, HPA077073"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000645: AB_1078606, HPA077073: AB_2732331"	"unprognostic (8.07e-2)"	"unprognostic (9.32e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.71e-2)"	"unprognostic (9.22e-4)"	"unprognostic (1.50e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.78e-3)"	"unprognostic (8.94e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.21e-2)"	21.9	18.4	16.1	20.3	20.6	70.4	16.9	25.0	17.6	20.4	21.0	26.2	15.3	20.4	20.2	16.6	25.2	18.6	15.8	18.4	17.0	13.2	18.7	16.5	21.5	21.4	18.9	11.0	26.0	16.9	12.6	28.7	21.0	16.7	16.2	23.2	20.6	21.6	16.2	36.3	20.6	22.5	16.9	19.0	23.1	20.1	50.5	22.4	35.9	19.1	21.0	29.7	21.0	18.5	6.8	6.0	15.6	7.0	6.0	9.3	3.9	16.3	18.4	19.0	15.9	15.5	16.2	34.9	21.8	19.6	22.8	26.6	26.7	21.9	25.9	15.3	23.5	17.0	18.8	20.2	28.1	32.1	25.3	10.6	23.9	12.5	22.9	20.4	33.6	27.4	17.5	21.8	22.7	26.2	10.9	17.1	26.0	21.6	23.1	19.8	35.2	25.8	13.6	18.7	20.4	16.4	23.3	25.6	13.6	12.7	31.4	15.7	11.7	19.6	10.1	9.0	19.3	27.6	15.3	20.7	8.2	13.2	71.9	19.5	19.7	25.6	31.7	21.1	15.7	16.8	5.8	6.5	13.9	9.3	7.0	8.1	6.8	7.2	8.0	5.6	6.6	8.4	7.6	15.6	6.0	6.8	6.0	7.3	3.9	16.1	20.6	25.0	17.6	17.0	13.2	18.9	11.0	16.7	22.4	11.9	35.2	21.7	34.4	32.6	15.9	8.7	17.8	45.5	42.1	21.0	19.6	20.8	11.6	16.6	34.3	20.7	27.5	23.3	21.3	23.6	19.9	39.1	19.7	17.0	21.5	17.5	18.9	27.6	29.1	13.7	20.8	24.0	16.9	27.1	32.0	14.6	24.2	28.5	17.0	13.7	29.9	0.0	15.1	70.7	62.3	39.5	22.8	28.7	29.2	60.7
CCNT1	"CCNT, CYCT1, HIVE1"	ENSG00000129315	"Cyclin T1"	O60563	12	48688458-48716998	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Transcription, Transcription regulation"	Cyclin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 95.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004892, CAB009016, HPA072012"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009016: AB_2073888, HPA004892: AB_1078607, HPA072012: "	"unprognostic (1.76e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.38e-1)"	"unprognostic (5.78e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.92e-1)"	16.6	14.9	13.1	12.9	17.4	38.1	15.7	20.9	17.7	13.4	12.6	16.5	10.9	9.9	19.9	13.0	13.8	15.8	10.5	11.8	13.5	8.5	13.0	14.1	15.6	14.9	14.3	13.2	21.5	15.9	18.4	19.6	18.5	14.5	12.8	12.4	12.8	12.6	11.2	18.8	16.4	14.6	13.3	12.1	16.8	13.8	22.6	15.7	22.4	16.5	10.9	15.9	15.3	13.2	5.5	4.4	14.8	2.8	3.7	4.9	0.9	7.6	10.6	10.5	10.4	8.4	9.8	12.8	10.3	8.1	7.8	6.4	13.1	9.4	20.8	13.5	6.6	5.6	9.6	16.7	7.3	11.6	11.6	10.7	21.6	17.1	5.9	9.9	23.8	11.0	7.8	10.9	9.8	13.5	11.3	6.4	12.3	20.7	9.0	9.4	4.9	11.1	11.1	11.4	4.6	8.7	10.8	16.8	8.9	7.8	14.0	11.2	12.7	15.8	8.6	12.6	8.7	11.4	13.7	6.5	9.0	9.2	6.4	9.0	13.9	18.7	18.6	10.2	33.9	5.2	6.8	2.8	7.9	3.6	1.8	4.9	4.3	3.1	3.5	1.7	5.5	4.5	4.0	14.8	3.7	2.0	4.4	1.8	0.9	13.1	17.4	20.9	17.7	13.5	8.5	14.3	13.2	14.5	15.7	14.9	17.6	17.9	16.5	34.2	20.2	11.3	15.3	24.1	14.8	12.2	21.6	11.3	3.3	7.0	95.2	23.3	11.2	0.0	6.0	11.3	13.4	16.0	28.9	12.9	8.8	36.5	11.5	22.7	18.0	21.0	15.5	16.2	20.3	5.4	14.3	16.7	6.5	10.5	13.8	7.9	13.0	6.5	23.7	16.1	13.2	39.3	14.5	24.5	10.9	27.8
CCR7	"BLR2, CD197, CDw197, CMKBR7, EBI1"	ENSG00000126353	"C-C motif chemokine receptor 7"	P32248	17	40553769-40565472	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"blood: 252.3;lymphoid tissue: 110.6"	"Cell type enriched"	"Detected in many"	6	"monocytes: 2758.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 252.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 252.3"	"Cell line enriched"	"Detected in some"	79	"HDLM-2: 175.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB003796, HPA031383, HPA074467"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB003796: AB_562261, HPA031383: AB_2673854, HPA074467: AB_2686693"	"prognostic favorable (3.84e-4)"	"prognostic favorable (8.03e-6)"	"unprognostic (2.26e-3)"	"unprognostic (1.32e-3)"	"unprognostic (2.35e-3)"	"prognostic favorable (7.61e-7)"	"unprognostic (2.71e-4)"	"unprognostic (2.58e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.68e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.12e-1)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.02e-1)"	"unprognostic (7.95e-2)"	2.8	0.4	0.2	26.0	0.2	5.2	1.7	0.2	0.3	2.2	1.2	0.3	0.8	0.3	1.2	0.5	1.4	2.3	2.0	1.9	0.2	0.2	1.5	1.7	3.4	110.6	0.3	0.2	1.5	0.3	0.0	1.0	1.0	0.4	1.3	2.1	0.7	8.4	0.2	0.2	1.1	16.2	0.2	0.4	20.3	1.8	1.2	0.3	57.1	2.0	1.2	53.8	4.2	1.3	58.8	2.9	2.3	0.3	44.1	252.3	109.3	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	175.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.0	0.1	1.1	0.2	0.0	0.0	1.1	0.3	0.2	3.1	0.1	3.6	37.2	53.3	15.3	0.2	58.8	252.3	133.9	2.3	44.1	0.2	2.9	30.3	109.3	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.3	0.0	5.9	116.5	1.4	4.4	0.0	0.3	0.0	0.0	2.3	1.8	0.0	111.5	0.0	0.4	0.1	0.1	0.0	0.0	6.9	6.3	3.3	0.0	2.3	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	12.9	15.1	2758.4	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	3.9	0.2	0.5	3.9	432.7	16.2	0.0	3.3
CCZ1	"C7orf28A, CCZ1A, CGI-43"	ENSG00000122674	"CCZ1 homolog, vacuolar protein trafficking and biogenesis associated"	P86791	7	5898725-5926550	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (1.91e-1)"	"unprognostic (2.97e-3)"	"unprognostic (3.15e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.82e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.10e-1)"	"unprognostic (9.25e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.27e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-1)"	17.2	33.0	19.0	16.5	22.6	25.7	27.9	19.5	28.2	15.5	15.7	15.4	10.5	16.5	18.9	15.8	23.2	15.2	16.7	23.3	19.1	17.0	15.9	21.2	17.1	32.3	17.8	23.5	13.5	39.1	25.7	17.2	15.7	19.4	15.6	19.9	13.7	28.9	13.9	33.3	19.3	18.5	16.7	18.6	18.4	16.0	36.1	12.6	19.4	17.7	23.9	20.3	19.7	15.8	3.7	7.1	10.2	10.4	9.2	16.6	2.8	46.1	18.1	24.9	31.9	25.8	23.8	17.4	18.5	22.1	18.4	19.6	8.7	23.7	28.4	10.6	27.5	51.9	25.0	17.1	19.6	20.1	12.7	26.3	14.2	22.3	15.9	26.1	28.7	16.7	24.2	24.3	13.7	13.3	25.7	33.3	27.6	33.1	21.9	26.5	27.7	18.9	37.8	46.6	22.5	24.5	27.2	24.8	23.1	14.8	27.8	23.7	42.5	17.9	35.7	18.6	39.7	26.3	36.6	25.0	18.6	48.5	21.9	29.1	16.7	28.3	33.9	12.6	38.6	40.5	10.2	4.9	8.6	5.5	7.6	5.5	3.7	7.2	7.1	7.1	2.7	4.6	5.4	4.7	9.2	10.4	4.3	16.6	2.8	19.0	22.6	19.5	28.2	19.1	17.0	17.8	23.5	19.4	12.6	3.0	19.7	29.9	21.3	40.2	53.8	9.8	17.8	32.1	14.8	29.6	58.9	32.6	26.6	54.9	4.1	35.3	31.1	0.0	62.4	30.8	31.5	20.9	15.1	16.3	31.7	22.3	28.7	78.0	32.1	1.1	35.1	38.3	43.9	83.8	30.6	36.4	60.1	32.0	33.9	19.2	52.4	77.6	50.9	36.5	31.8	47.3	29.2	43.6	30.3	26.8
CCZ1B	"C7orf28B, DKFZP586I1023, H_NH0577018.2, MGC19819"	ENSG00000146574	"CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated"	P86790	7	6794134-6826770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA045114, HPA050006"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA045114: AB_2679219, HPA050006: AB_2680989"	"unprognostic (8.06e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.74e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.96e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.24e-1)"	2.5	4.5	3.6	2.1	4.4	3.2	4.2	3.8	8.4	2.7	3.5	10.7	2.1	2.6	3.5	7.0	5.7	5.3	3.5	2.6	4.0	3.6	3.0	2.4	3.4	3.7	2.9	2.1	3.0	3.3	11.8	2.6	2.7	9.1	3.0	2.5	5.2	6.6	7.0	10.6	3.4	2.7	2.1	2.7	3.0	3.2	5.4	2.1	3.0	2.5	2.1	3.5	4.3	2.6	4.3	5.6	10.5	9.5	6.1	6.6	1.8	13.0	4.7	9.4	23.4	8.4	8.3	10.4	8.1	12.3	9.9	10.9	5.4	8.6	5.5	9.7	11.7	18.1	8.9	17.7	10.2	11.3	3.3	6.3	3.8	5.7	13.4	8.7	27.5	19.5	5.5	5.5	9.4	4.9	4.8	8.5	17.5	7.3	6.4	9.9	22.3	13.1	12.3	26.2	12.4	8.8	8.2	20.3	6.8	7.3	9.7	14.7	23.5	9.1	17.9	12.1	8.4	14.6	31.6	9.3	2.8	8.8	11.5	17.4	6.5	13.3	4.0	9.1	28.9	16.8	10.5	3.8	6.5	3.8	4.6	4.5	4.3	4.5	5.6	4.8	3.9	3.2	4.2	4.8	6.1	9.5	5.6	6.6	1.8	3.6	4.4	3.8	8.4	4.0	3.6	2.9	2.1	9.1	2.1	6.0	10.1	18.1	7.8	7.4	8.6	6.7	5.1	30.8	11.4	3.5	13.7	8.6	13.3	16.3	2.7	9.2	10.2	0.0	24.7	9.4	10.3	7.4	2.3	6.8	9.4	15.9	17.9	16.0	13.2	2.3	6.6	16.3	13.5	25.2	16.4	11.0	20.1	14.4	9.9	9.0	11.1	19.4	10.0	11.4	8.8	10.9	6.6	13.8	12.5	10.8
CD24	CD24A	ENSG00000272398	"CD24 molecule"		6	106969831-106975627	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in many"	6	"kidney: 383.7"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 1347.9;Exocrine glandular cells: 3019.5;Pancreatic endocrine cells: 1516.5"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in some"	26	"eosinophil: 30.4;memory B-cell: 23.4;naive B-cell: 15.0"	"Group enriched"	"Detected in many"	202	"B-cells: 23.4;granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 66.4;RPTEC TERT1: 313.7;SK-BR-3: 91.2"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	0.5	0.5	12.8	2.4	9.9	17.9	25.5	0.5	2.9	69.5	30.6	0.7	1.6	1.2	34.5	5.9	38.1	6.0	25.1	4.2	22.7		383.7	0.8	0.7	0.9	4.8	7.2	15.6	40.0	0.0	5.7	48.2	13.0	3.2	21.2	0.7	15.9	16.6	0.4	0.5	0.8	2.2	4.9	0.7	16.4	0.5	6.5	0.4	48.8	1.2	11.3	4.0	8.1	23.4	0.0	30.4	0.1	0.0	0.0	0.6	23.4	14.5	0.2	1.9	0.0	0.0	27.5	0.0	0.1	0.1	0.0	0.2	0.1	2.3	7.2	0.0	1.0	48.5	8.2	18.3	0.1	0.0	0.1	0.0	17.9	1.0	0.0	0.3	0.1	0.1	21.1	0.2	1.2	1.1	0.1	0.0	0.5	0.0	0.4	29.4	0.1	0.1	66.4	52.2	5.6	54.8	0.0	0.2	313.7	60.5	41.1	30.3	16.6	91.2	0.0	31.1	42.1	0.1	0.0	0.0	0.2	0.2	0.7	0.0	0.1	31.0	0.3	0.1	0.1	0.1	0.0	30.4	0.0	0.0	0.0	23.4	0.0	0.0	0.0	15.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.6											145.9	106.6	139.4	57.2	0.0	6.5	1.1	1003.8	691.9	180.9	1235.3	2.0	679.9	1347.9	1087.4	21.0	2.3	819.9	0.0	3019.5	709.4	9.3	444.2	10.4	3.8	61.3	0.0	552.5	53.4	8.9	32.3	9.5	11.8	0.0	55.9	391.5	1.1	1516.5	703.5	2.1	408.2	0.5	6.5	0.4	0.5	4.9	0.0	466.9	12.5	734.9	281.9
CD2BP2	"LIN1, PPP1R59, Snu40, U5-52K"	ENSG00000169217	"CD2 cytoplasmic tail binding protein 2"	O95400	16	30350766-30355361	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041508, HPA061309"	Enhanced		Enhanced	"Nuclear speckles,Cytosol"		Yes	No			"Nuclear speckles"	Cytosol	"HPA041508: AB_2677523, HPA061309: AB_2684476"	"unprognostic (5.66e-2)"	"unprognostic (7.50e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.71e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.76e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.66e-1)"	24.6	33.0	23.6	27.8	24.4	17.8	22.5	27.6	43.4	24.2	25.4	27.4	31.8	25.8	32.3	29.0	23.1	30.0	35.6	27.4	23.1	23.7	24.8	18.2	22.3	30.2	23.2	27.3	29.7	30.9	46.3	30.3	22.3	20.3	25.8	21.3	20.8	27.4	40.7	31.7	22.0	22.6	28.1	20.6	32.0	24.5	23.4	19.8	26.8	29.8	25.9	36.5	22.9	19.9	38.2	28.1	51.3	39.0	29.2	37.6	29.9	21.7	26.5	22.4	20.2	18.7	17.8	19.0	24.2	29.2	27.6	29.7	20.2	26.3	33.6	30.0	26.3	25.4	24.0	22.8	28.4	22.2	19.9	26.8	14.2	25.1	23.7	26.9	20.1	26.3	19.1	24.1	30.6	19.7	19.0	28.6	25.2	16.0	25.9	27.6	52.3	27.7	17.1	30.1	17.0	15.7	41.1	18.6	25.3	22.4	21.9	18.4	35.2	16.2	28.7	16.3	19.3	27.2	16.3	20.4	31.9	22.2	16.0	21.1	43.5	31.6	30.9	21.8	18.7	26.0	36.3	26.3	46.2	31.7	30.8	25.1	36.2	25.8	29.4	23.3	38.2	21.8	26.9	51.3	29.2	39.0	28.1	37.6	29.9	23.6	24.4	27.6	43.4	23.1	23.7	23.2	27.3	20.3	19.8	29.8	25.3	41.6	42.3	25.5	27.7	23.3	38.2	32.1	18.2	34.9	19.6	52.1	51.4	70.2	14.8	35.4	46.6	23.3	84.6	47.7	31.5	34.5	47.3	12.4	61.0	11.1	31.7	24.5	37.6	11.3	32.8	32.5	37.1	107.4	29.5	41.6	75.5	63.1	33.6	64.1	25.0	38.8	44.3	34.6	43.2	26.6	74.1	50.1	29.2	46.0
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Group enriched"	"Detected in some"	5	"ASC diff: 82.7;HEL: 39.3"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	82.7	0.8	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.1	39.3	0.1	6.3	0.0	0.0	0.0	8.0	3.1	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	0.7	2.7	4.5	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.5	10.4	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5	6.0	69.8	5.2	0.1	6.5	0.0	491.8	7.6	0.0	5.7	7.0	0.0	8.5	0.0	0.0	9.2	46.6	0.0	163.5	0.0	9.4	14.4	0.7	14.0	12.1	1111.0	0.0	0.0	465.9	196.7	2.3	0.6	68.0	15.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.3	685.6	31.5	4.7	0.7	4.1	15.3	1.3	0.0	0.1
CD3EAP	"ASE-1, CAST, PAF49"	ENSG00000117877	"CD3e molecule associated protein"	O15446	19	45406209-45410766	"Predicted intracellular proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 109.3;Suprabasal keratinocytes: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-251 MG: 65.8"					"Low region specificity"	"Detected in all"			"HPA041664, HPA041734"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Mitochondria"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"	Mitochondria	"HPA041664: AB_10795693, HPA041734: AB_10794489"	"unprognostic (1.03e-1)"	"unprognostic (8.98e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.46e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (4.79e-9)"	"unprognostic (1.62e-3)"	"unprognostic (3.21e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.99e-2)"	"unprognostic (7.26e-2)"	"unprognostic (6.29e-9)"	"unprognostic (1.02e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.53e-2)"	7.3	5.9	7.7	8.4	9.7	4.0	7.1	14.9	9.0	5.6	5.5	6.5	2.9	4.9	6.4	3.0	9.9	7.1	6.4	6.7	7.1	6.4	5.2	6.8	4.5	7.2	8.1	6.0	8.7	18.3	6.6	7.3	5.1	8.0	5.2	4.9	3.1	7.2	4.6	14.2	8.4	4.3	6.6	5.6	5.8	4.3	5.2	9.3	3.6	6.1	7.8	8.5	5.5	5.8	3.5	15.9	1.3	3.7	3.2	4.1	2.1	10.4	10.8	1.7	7.9	2.6	2.1	7.0	5.0	1.7	8.9	5.2	10.6	7.5	16.3	5.3	3.7	7.2	10.1	15.6	14.3	6.3	8.0	10.1	9.0	4.1	7.8	4.4	9.1	3.2	3.2	9.2	12.9	7.1	2.2	6.4	6.0	20.5	3.3	8.6	12.3	6.9	2.6	12.7	11.6	9.1	9.4	6.9	10.7	3.5	7.8	10.8	4.0	10.7	14.3	2.3	3.8	7.2	5.5	6.2	12.7	13.3	7.3	65.8	5.9	23.4	17.3	6.3	13.0	9.1	0.9	2.8	0.3	1.7	3.7	3.4	2.8	2.2	2.4	5.0	3.5	3.1	4.1	1.3	3.2	3.3	15.9	1.2	2.1	7.7	9.7	14.9	9.0	7.1	6.4	8.1	6.0	8.0	9.3	6.0	12.8	10.0	23.3	109.3	4.5	1.2	7.6	6.7	12.5	1.8	9.8	13.7	1.7	15.9	0.2	9.0	1.7	0.0	5.8	19.4	6.6	7.7	5.7	4.2	10.0	11.1	4.6	4.9	2.6	0.5	8.9	7.0	11.8	2.8	4.3	3.5	11.0	0.0	10.6	6.1	5.8	0.0	8.9	0.5	18.9	96.7	6.4	0.0	9.5	11.5
CD84	"hCD84, mCD84, SLAMF5"	ENSG00000066294	"CD84 molecule"	Q9UIB8	1	160541095-160579516	"CD markers, Predicted membrane proteins"	"Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.0"	"Cell type enhanced"	"Detected in many"	14	"granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063316, HPA068020, HPA070502"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	NA		36000000	"Plasma membrane"	Vesicles	"HPA063316: , HPA068020: , HPA070502: AB_2686274"	"unprognostic (4.38e-2)"	"unprognostic (6.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.00e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.54e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.08e-1)"	15.9	4.8	3.8	18.5	4.5	6.7	3.7	1.3	3.4	3.3	3.2	7.9	7.7	2.5	2.5	4.3	2.7	3.1	6.4	5.0	3.8	3.0	3.1	5.1	9.2	26.0	6.0	2.2	1.8	4.3	0.9	1.9	7.1	5.3	3.7	4.7	2.4	4.3	9.8	1.6	2.7	9.6	4.1	11.1	25.6	3.5	2.8	5.9	13.8	2.9	2.3	16.3	5.8	2.7	5.1	5.4	21.0	7.3	1.0	8.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	6.8	27.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.0	0.0	6.7	5.1	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	0.0	1.5	0.0	21.0	7.3	11.0	6.9	6.3	5.2	5.1	5.9	8.2	5.4	4.7	3.5	6.3	1.0	1.0	2.4	3.2	7.9	6.1	3.8	4.5	1.3	3.4	3.8	3.0	6.0	2.2	5.3	5.9	0.0	8.3	23.1	0.7	2.2	0.2	1.2	5.1	1.4	2.3	0.0	0.0	0.4	0.0	0.0	0.6	2.6	0.0	0.0	0.2	0.3	0.8	0.6	177.3	0.9	84.2	0.0	0.0	5.5	123.8	0.5	0.6	52.0	5.0	78.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	2.0	0.8	42.4	0.0	0.7
CDAN1	"CDA-I, CDAI"	ENSG00000140326	"Codanin 1"	Q8IWY9	15	42723544-42737128	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.7"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039404, HPA040787"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA039404: AB_10673530, HPA040787: AB_2677137"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.71e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.17e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.04e-1)"	6.5	9.0	8.4	9.8	8.1	14.4	9.8	16.2	9.7	11.8	6.8	8.7	9.4	6.0	11.0	9.6	7.1	9.1	7.2	5.2	6.4	4.4	6.3	6.7	6.6	8.0	8.3	7.4	21.7	9.6	9.1	9.5	6.7	5.8	11.4	5.5	9.3	10.6	10.1	6.6	10.1	6.9	9.3	5.1	8.1	8.0	14.7	8.6	14.7	9.0	3.3	8.2	10.2	12.2	0.3	0.8	3.7	0.3	0.0	0.6	0.1	6.9	4.7	6.5	9.3	5.8	5.0	7.8	9.2	3.9	9.0	6.5	11.8	3.7	3.3	10.2	5.1	8.8	13.7	6.9	4.1	2.6	8.5	6.4	12.6	8.5	4.6	4.3	9.2	11.9	6.8	4.7	5.6	4.1	5.5	6.8	11.5	16.0	5.1	7.3	3.8	7.1	12.2	3.2	6.7	7.6	10.3	8.1	2.9	2.8	6.9	5.3	6.1	7.2	10.1	1.5	4.3	7.7	13.8	4.9	9.5	8.5	7.7	10.5	10.1	10.6	7.5	4.9	13.8	7.7	3.7	0.3	1.7	0.5	0.1	0.6	0.1	0.4	0.5	0.0	0.3	0.4	0.3	0.4	0.0	0.0	0.8	0.1	0.1	8.4	8.1	16.2	9.7	6.4	4.4	8.3	7.4	5.8	8.6	0.0	3.0	0.8	1.7	1.6	3.1	2.2	5.1	1.4	1.2	7.0	3.9	2.6	0.0	1.4	0.3	2.2	1.6	0.0	1.5	1.2	1.9	1.8	1.1	2.4	1.8	1.6	4.6	4.9	4.4	0.9	4.0	1.3	0.0	1.0	2.0	4.8	1.5	0.0	4.6	1.1	4.1	19.4	1.0	4.2	1.9	1.1	1.8	2.5	2.7	1.4
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358955-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.0;testis: 73.2"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 97.6;Erythroid cells: 70.0;Extravillous trophoblasts: 127.9;Spermatocytes: 74.9;Spermatogonia: 48.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.5;memory CD4 T-cell: 3.3;memory CD8 T-cell: 3.6;NK-cell: 9.8;T-reg: 11.2"	"Group enriched"	"Detected in many"	9	"B-cells: 4.5;NK-cells: 9.8;T-cells: 11.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.3	1.2	0.6	16.6	1.1	20.2	1.8	0.8	1.3	2.1	6.2	2.8	0.4	5.8	1.1	1.6	17.8	0.4	1.9	1.2	0.9	0.5	2.2	1.2	1.8	13.4	1.1	0.7	0.9	0.5	0.0	0.4	3.9	1.2	0.8	7.0	0.4	2.9	0.4	0.6	4.6	6.4	2.8	1.2	7.8	4.4	73.2	0.7	42.0	1.2	11.7	21.7	1.9	4.2	4.5	0.9	0.8	0.1	9.8	11.2	2.7	52.6	25.7	35.9	23.4	1.2	3.2	34.4	24.4	21.9	71.2	38.0	40.3	43.8	30.5	14.3	22.4	25.1	37.1	39.2	46.6	59.5	23.9	29.0	44.6	25.4	24.9	0.3	31.1	16.3	1.0	2.2	49.4	44.8	6.2	30.1	29.3	20.1	21.0	32.2	20.4	29.9	19.1	45.4	25.1	34.6	43.5	49.3	19.3	17.3	14.0	21.2	10.4	43.1	29.2	13.5	28.8	20.5	39.4	15.6	21.3	50.0	23.6	75.6	16.1	14.3	31.6	15.3	38.8	31.7	0.0	0.1	0.0	0.4	0.0	0.0	4.5	3.3	3.6	0.9	0.9	0.1	0.3	0.8	9.8	0.0	0.2	11.2	2.7	0.6	1.1	0.8	1.3	0.9	0.5	1.1	0.7	1.2	0.7	0.0	0.6	16.2	2.0	9.3	0.0	0.7	0.0	2.7	1.2	0.0	0.0	13.4	0.0	2.1	97.6	0.7	3.2	70.0	0.3	127.9	4.1	2.0	0.0	1.0	30.9	0.0	0.0	8.0	5.0	7.0	2.6	5.2	0.0	2.8	2.9	0.2	0.7	0.0	1.8	2.1	2.6	0.0	1.4	74.9	48.1	7.3	8.9	1.3	15.5	2.6
CDC25C	"CDC25, PPP1R60"	ENSG00000158402	"Cell division cycle 25C"	P30307	5	138285265-138338355	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Hydrolase, Protein phosphatase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lymphoid tissue: 23.3;testis: 22.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 32.9;Late spermatids: 35.1;Spermatocytes: 36.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.1;T-reg: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB003800, HPA066991"	Approved		Enhanced	"Nuclear speckles"		No	Yes			"Nuclear speckles"		"CAB003800: AB_562081, HPA066991: AB_2685760"	"unprognostic (2.45e-3)"	"unprognostic (5.89e-3)"	"prognostic favorable (2.49e-4)"	"unprognostic (9.72e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.03e-6)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (5.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.00e-1)"	"unprognostic (0.00e+0)"	"unprognostic (5.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.59e-1)"	"unprognostic (3.06e-1)"	1.1	0.6	0.3	6.7	0.4	5.2	1.1	0.4	0.6	0.6	3.3	0.1	0.7	3.0	0.3	0.6	2.5	0.2	0.4	0.7	0.4	0.4	0.4	0.6	0.7	2.6	0.4	0.3	0.3	0.3	0.0	0.4	1.9	0.3	0.4	4.0	0.0	1.2	0.7	0.2	1.1	3.7	0.5	0.3	1.7	1.2	22.3	0.2	23.3	0.3	1.8	5.0	0.6	0.9	1.0	0.1	0.7	0.0	2.1	2.7	0.5	13.3	5.6	18.8	14.5	0.4	1.9	4.7	8.1	8.7	18.4	25.4	13.5	26.0	6.2	6.8	4.9	20.2	7.3	15.5	12.4	17.8	5.1	10.6	4.7	7.6	10.0	0.1	3.2	4.9	0.4	0.5	10.9	9.0	1.9	11.8	13.5	6.9	12.3	11.2	7.4	8.7	8.1	4.8	10.6	6.1	5.7	17.2	7.3	3.2	4.1	9.5	5.9	18.1	5.5	8.6	17.3	9.2	6.7	3.5	10.2	8.6	7.0	12.9	7.5	6.1	6.1	4.0	6.8	7.7	0.0	0.0	0.1	0.6	0.0	0.0	1.0	0.5	0.3	0.0	0.2	0.0	0.0	0.7	2.1	0.0	0.1	2.7	0.5	0.3	0.4	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	32.9	0.0	0.3	0.0	0.0	5.7	0.2	0.3	0.0	0.2	2.2	0.0	0.0	0.0	0.3	35.1	1.7	1.2	0.0	1.0	0.6	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	36.3	8.3	0.4	1.1	0.0	1.6	0.1
CDC27	"ANAPC3, APC3, D0S1430E, D17S978E, NUC2"	ENSG00000004897	"Cell division cycle 27"	P30260	17	47117703-47189422	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016315, HPA028129, HPA052399, HPA065835"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB016315: AB_627228, HPA028129: AB_10603559, HPA052399: AB_2681814, HPA065835: "	"unprognostic (2.34e-2)"	"unprognostic (8.83e-3)"	"prognostic favorable (1.77e-4)"	"unprognostic (4.26e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.93e-3)"	"prognostic unfavorable (4.38e-4)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.05e-3)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (2.64e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.95e-2)"	"unprognostic (3.66e-2)"	29.2	18.9	19.4	18.7	25.2	23.0	23.3	26.0	33.0	23.7	17.2	14.8	13.8	14.4	23.2	19.6	17.6	17.6	18.6	22.8	18.3	22.6	16.8	23.8	20.4	21.3	19.4	23.9	19.5	14.3	27.8	26.8	25.0	31.5	17.6	18.2	14.6	15.7	16.5	31.6	15.5	15.3	24.4	17.7	24.2	16.1	23.5	17.4	25.2	42.8	15.5	22.9	23.6	17.3	9.0	7.7	9.6	10.3	12.8	11.6	5.4	23.6	25.4	21.3	17.1	14.4	22.9	12.7	33.5	30.2	32.0	32.8	16.2	12.5	31.9	22.6	28.0	20.5	11.4	22.9	18.9	44.2	45.8	23.5	37.1	26.8	14.4	15.6	21.7	16.9	16.6	9.3	28.8	22.8	15.5	33.0	18.7	29.5	17.8	26.0	20.1	26.7	9.9	10.1	13.4	20.7	14.4	54.7	14.1	19.3	15.0	14.2	17.3	16.8	5.9	18.6	19.0	17.9	15.4	35.1	33.5	29.1	21.1	24.7	18.2	31.5	28.9	18.5	13.0	23.1	9.6	4.4	6.2	8.1	10.3	7.8	6.0	6.8	8.5	6.0	9.0	6.7	7.6	5.7	12.8	7.4	7.7	11.6	5.4	19.4	25.2	26.0	33.0	18.3	22.6	19.4	23.9	31.5	17.4	8.9	22.9	28.9	16.0	23.1	20.2	34.3	22.9	10.7	28.4	19.2	15.7	24.5	13.3	23.9	23.6	38.7	10.6	163.5	23.1	29.3	36.3	14.9	25.5	25.2	24.1	33.4	13.3	37.4	24.8	22.5	26.2	19.8	6.8	31.5	13.5	19.5	24.1	10.5	28.0	17.4	13.9	19.4	33.0	88.5	35.1	23.5	9.6	21.0	14.3	13.1
CDC42EP4	"BORG4, CEP4, KAIA1777, MGC17125, MGC3740"	ENSG00000179604	"CDC42 effector protein 4"	Q9H3Q1	17	73283624-73312175	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Horizontal cells: 711.9;Muller glia cells: 543.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 15.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023335, HPA024797"	Approved	Supported	Supported	"Plasma membrane,Actin filaments,Microtubules"		NA	NA			"Actin filaments, Microtubules"	"Plasma membrane"	"HPA023335: AB_10603783, HPA024797: AB_10600696"	"unprognostic (8.76e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.49e-2)"	"unprognostic (5.43e-3)"	"unprognostic (6.29e-2)"	"unprognostic (9.01e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.08e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	36.0	27.7	24.4	15.2	31.2	8.8	65.2	35.5	45.4	23.5	21.6	28.7	33.4	24.3	23.9	44.5	19.7	41.8	25.2	27.6	28.9	18.4	12.0	15.4	15.9	12.2	20.8	21.1	50.3	50.8	19.9	20.8	15.8	30.7	18.0	13.0	21.8	22.0	38.5	16.7	16.4	22.0	18.9	30.6	11.9	21.6	13.7	24.2	5.9	26.5	14.2	18.9	14.1	46.1	0.1	3.6	4.7	15.6	0.2	0.1	1.4	11.0	25.7	9.6	7.9	19.6	16.4	24.2	9.8	12.3	9.4	6.9	5.4	15.7	0.0	8.7	12.0	10.8	7.8	6.7	6.6	5.8	0.5	6.2	2.5	13.3	12.9	9.7	0.4	2.8	20.4	5.8	8.0	4.1	7.6	10.6	0.2	6.7	0.5	5.8	8.3	0.4	3.2	5.3	33.4	17.8	0.3	4.2	1.1	11.2	12.6	6.3	9.5	7.1	20.7	6.9	7.8	24.1	3.6	10.7	8.9	18.4	6.9	7.0	0.5	0.4	0.0	14.3	1.7	22.8	2.8	2.6	4.7	0.1	7.0	0.1	0.1	0.0	0.0	3.6	0.0	0.1	0.0	4.6	0.2	15.6	0.1	0.0	1.4	24.4	31.2	35.5	25.1	28.9	18.4	20.8	21.1	30.7	24.2	11.9	17.0	1.7	60.5	43.3	9.5	9.2	20.4	10.7	13.6	12.2	5.9	26.8	10.0	25.7	0.5	32.6	42.4	0.0	37.9	30.8	31.7	40.3	12.7	24.5	5.4	711.9	30.0	42.4	5.3	0.7	17.0	7.3	28.7	16.2	36.7	543.1	26.1	29.8	14.5	6.3	17.8	129.4	81.4	0.9	1.4	39.3	70.5	2.5	25.0	85.3
CDCA5		ENSG00000146670	"Cell division cycle associated 5"	Q96FF9	11	65066300-65084164	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 39.9;testis: 27.9"	"Group enriched"	"Detected in many"	5	"Early spermatids: 41.6;Extravillous trophoblasts: 30.6;Late spermatids: 84.2;Spermatocytes: 40.4;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"NK-cell: 5.8;T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"NK-cells: 5.8;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023691, HPA076007"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA023691: AB_1846392, HPA076007: "	"unprognostic (3.14e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.21e-6)"	"unprognostic (1.41e-3)"	"unprognostic (7.55e-3)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (8.72e-6)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (3.55e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (8.97e-2)"	1.3	1.3	1.1	12.3	1.1	27.4	4.3	1.0	2.8	1.6	3.8	0.6	0.0	3.3	0.9	1.4	7.9	0.7	1.4	1.3	1.1	0.9	1.3	1.3	1.9	9.5	1.1	0.5	0.8	0.7	0.2	0.7	5.5	1.3	0.9	4.7	0.1	1.5	0.1	0.7	2.4	3.6	1.7	0.7	5.7	2.1	27.9	0.2	39.9	0.7	6.6	9.9	1.5	2.3	1.2	0.8	0.3	0.5	5.8	4.2	1.4	30.7	17.6	16.9	14.3	1.1	1.8	14.1	22.0	9.2	25.8	20.6	18.0	18.7	28.0	12.7	7.1	30.4	21.3	27.3	12.1	25.2	28.0	11.9	25.2	12.8	15.1	0.1	26.8	20.4	0.6	1.1	24.1	11.2	2.7	7.8	33.6	28.5	51.8	15.7	25.5	37.8	27.7	26.6	15.2	21.4	33.2	18.7	26.7	5.3	11.8	22.0	16.5	14.1	20.2	14.9	11.0	26.0	13.2	4.9	23.4	24.2	24.6	24.4	26.2	41.5	45.6	9.4	16.6	24.1	0.0	0.2	0.3	0.8	0.0	0.1	0.7	1.1	0.6	0.8	1.2	0.1	0.8	0.1	5.8	0.5	0.7	4.2	1.4	1.1	1.1	1.0	2.8	1.1	0.9	1.1	0.5	1.3	0.2	0.0	0.3	0.8	0.8	3.4	0.8	0.8	0.0	0.0	1.2	0.0	2.0	3.7	1.7	0.9	41.6	0.9	0.9	0.0	0.7	30.6	1.8	0.4	3.5	0.0	9.5	1.6	0.0	1.3	2.8	84.2	2.6	1.9	0.0	3.6	2.3	0.8	0.5	0.0	1.4	0.3	0.2	0.0	0.3	40.4	22.0	0.9	3.1	1.9	2.8	1.0
CDH15	"CDH14, CDH3"	ENSG00000129910	"Cadherin 15"	P55291	16	89171767-89195492	"Disease related genes, Predicted membrane proteins"	"Cell adhesion"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 44.2;skeletal muscle: 60.3"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	24	"cerebellum: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RH-30: 57.9"	"Region enriched"	"Detected in some"	7	"cerebellum: 17.6"	"Region enriched"	"Detected in all"	6	"cerebellum: 17.9"	"HPA009139, HPA070961"	Enhanced	Supported	Enhanced	"Golgi apparatus,Plasma membrane"		NA	NA		390000	"Golgi apparatus, Plasma membrane"		"HPA009139: AB_1078372, HPA070961: AB_2686328"	"unprognostic (1.26e-1)"	"unprognostic (7.70e-3)"	"unprognostic (6.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (7.79e-3)"	"unprognostic (2.70e-3)"	"unprognostic (2.84e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.30e-3)"	"unprognostic (7.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.14e-7)"	"unprognostic (3.09e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.64e-2)"	0.8	0.2	0.0	0.1	0.0	0.1	0.1	44.2	0.2	0.7	0.1	0.0	0.0	0.2	0.1	2.8	0.6	0.1	0.1	0.1	0.0	0.0	0.2	0.8	0.2	0.1	0.0	0.0	0.1	0.9	0.1	0.0	0.8	1.8	0.5	0.1	0.0	0.3	0.2	60.3	0.1	0.1	0.1	0.3	0.6	0.1	0.3	0.0	0.0	0.1	6.5	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	57.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	44.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.2	0.2	0.0	0.6	0.3	0.0	0.0	1.3	0.0	0.4	0.0	0.0	1.7	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.3	1.6	4.3	0.0	0.1	0.0	0.0	0.0
CDK12	"CRK7, CRKR, CRKRS, KIAA0904"	ENSG00000167258	"Cyclin dependent kinase 12"	Q9NYV4	17	39461511-39564907	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 87.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008038, HPA073305"	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA008038: AB_1078570, HPA073305: "	"unprognostic (2.02e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-3)"	"unprognostic (6.87e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.32e-1)"	16.0	13.1	12.4	17.4	9.2	32.4	14.0	23.4	17.8	18.2	17.6	9.6	15.7	11.1	15.7	12.0	16.9	12.2	12.5	11.0	10.1	6.7	10.2	18.5	13.5	15.2	10.9	14.3	17.4	11.3	19.0	12.2	18.4	9.5	12.7	11.7	10.4	15.6	11.1	11.1	17.0	16.5	11.0	10.6	16.3	11.8	18.9	8.3	29.0	15.0	5.4	17.3	16.3	20.5	5.1	4.0	10.4	2.9	6.6	4.0	0.9	8.9	11.1	6.7	6.2	4.9	5.5	6.2	8.1	6.9	11.1	8.3	13.6	5.5	12.7	7.1	8.5	11.3	14.6	13.3	10.2	10.8	8.3	11.4	13.7	7.5	10.5	4.8	18.7	9.6	5.9	7.1	13.5	10.7	4.6	6.7	7.7	23.2	8.4	6.3	4.2	15.3	4.8	7.0	4.4	5.0	10.1	14.4	7.2	4.2	10.7	7.2	4.6	10.3	87.5	7.0	10.1	11.2	8.1	7.2	10.1	8.1	7.0	10.4	6.9	4.9	17.9	7.2	7.9	6.6	10.4	2.9	4.1	4.0	2.2	3.0	2.9	2.5	2.7	1.8	5.1	2.9	2.7	9.7	6.6	1.8	4.0	2.0	0.9	12.4	9.2	23.4	17.8	10.1	6.7	10.9	14.3	9.5	8.3	23.8	26.1	37.7	45.0	57.5	45.4	12.1	35.7	29.4	40.9	36.6	60.9	27.7	11.6	24.4	15.9	29.6	32.0	23.3	23.8	24.7	35.7	62.9	27.8	38.9	23.9	33.4	29.9	27.6	37.0	14.0	34.5	34.5	25.3	27.9	26.9	31.5	36.1	31.6	31.8	12.9	67.7	32.3	33.0	113.1	90.5	60.3	48.7	42.9	28.8	77.9
CDK2		ENSG00000123374	"Cyclin dependent kinase 2"	P24941	12	55966769-55972784	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 78.7;Extravillous trophoblasts: 67.5;Melanocytes: 82.7;Syncytiotrophoblasts: 142.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 88.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 107.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013115, HPA066915"	Enhanced		Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"CAB013115: AB_2536375, HPA066915: AB_2685748"	"unprognostic (2.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.38e-3)"	"unprognostic (4.69e-3)"	"prognostic unfavorable (1.46e-10)"	"unprognostic (1.05e-1)"	"unprognostic (1.76e-1)"	"unprognostic (6.16e-2)"	"unprognostic (6.75e-2)"	10.7	7.6	4.5	20.8	6.5	18.7	11.5	4.2	4.3	12.6	11.6	3.5	6.0	6.1	10.7	6.4	13.6	10.8	12.6	10.1	5.4	2.2	8.3	16.7	19.5	12.2	6.0	2.0	14.2	8.3	5.2	4.2	49.0	7.3	10.8	9.1	51.2	9.3	9.9	10.8	14.6	9.3	11.8	5.0	12.5	10.1	7.8	5.1	39.3	9.5	10.7	14.7	16.7	10.1	9.3	10.8	5.2	3.9	4.5	7.6	4.3	16.8	9.1	20.1	11.1	4.1	5.3	37.0	21.0	11.0	26.2	24.5	19.2	16.3	16.1	15.8	7.8	10.5	10.8	15.3	9.2	26.6	18.9	15.0	18.5	15.1	7.3	1.3	14.6	13.4	2.8	2.3	17.7	6.1	7.6	13.2	16.7	17.5	14.7	18.1	13.0	30.3	12.4	8.0	11.5	13.6	29.6	19.3	12.1	7.6	16.6	8.3	10.7	24.0	8.8	107.8	12.0	19.0	10.7	7.3	18.1	17.5	13.9	15.3	8.3	9.6	20.0	10.3	10.7	15.6	5.2	3.6	3.1	7.0	3.9	7.0	9.3	3.2	5.0	2.7	6.1	3.0	5.3	1.7	4.5	1.6	10.8	7.6	4.3	4.5	6.5	4.2	4.3	5.4	2.2	6.0	2.0	7.3	5.1	14.9	3.7	5.2	20.1	24.8	0.0	2.6	12.7	5.3	9.1	1.8	0.0	78.7	1.7	10.5	0.4	15.0	2.1	0.0	5.0	67.5	17.6	10.9	10.4	8.9	11.6	1.6	5.2	8.6	4.8	0.2	13.8	6.3	82.7	47.7	6.3	3.8	9.0	0.0	4.2	3.8	3.4	0.0	14.4	2.9	7.7	27.5	142.8	5.7	6.8	18.0
CDK5RAP2	"C48, CEP215, FLJ10867, MCPH3"	ENSG00000136861	"CDK5 regulatory subunit associated protein 2"	Q96SN8	9	120388869-120580170	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035820, HPA035821, HPA046529, CAB079753"	Approved		Enhanced	"Cell Junctions,Centrosome"		NA	NA			Centrosome	"Cell Junctions"	"CAB079753: AB_2665827, HPA035820: AB_10671939, HPA035821: , HPA046529: AB_2679688"	"unprognostic (7.72e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.84e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.63e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.41e-2)"	10.3	12.0	12.3	13.0	23.2	21.3	15.2	20.0	19.9	15.7	13.0	22.0	9.1	5.8	11.9	8.4	12.8	11.2	10.2	18.3	14.9	7.9	7.8	20.1	10.9	14.0	21.6	9.8	18.6	9.3	17.0	20.3	8.8	15.1	14.5	9.2	10.6	21.3	11.6	41.7	16.0	10.2	15.6	14.2	11.2	12.3	19.8	25.7	23.4	11.9	8.5	14.9	12.8	16.5	7.4	2.7	13.7	5.2	4.7	4.5	1.9	9.5	16.9	23.5	14.1	10.1	15.0	12.6	12.4	9.5	14.1	13.2	13.2	12.7	17.9	5.7	12.1	9.6	21.2	18.5	14.2	13.6	14.3	7.4	15.3	30.9	23.5	9.5	18.9	10.2	27.0	9.5	12.4	16.5	10.6	12.2	21.7	14.1	15.6	18.4	21.6	20.2	12.1	21.7	20.5	12.8	19.8	28.1	8.4	10.0	7.7	15.4	17.7	21.5	11.8	14.3	10.6	27.8	13.0	8.1	12.2	13.4	14.3	14.0	11.4	15.8	20.1	12.7	12.1	25.7	13.7	2.2	3.5	4.5	2.1	4.4	5.7	4.2	4.1	1.3	7.4	3.5	3.5	2.9	4.7	5.2	2.7	3.3	1.9	12.3	23.2	20.0	19.9	14.9	7.9	21.6	9.8	15.1	25.7	26.8	36.1	14.1	10.3	6.3	24.3	48.4	15.3	41.5	20.5	1.8	15.7	9.3	6.6	10.8	27.1	10.3	5.9	23.3	12.4	10.0	11.9	11.1	16.2	18.8	9.3	17.5	8.1	6.7	10.0	25.6	20.4	12.9	11.8	13.6	10.2	23.9	9.9	5.9	21.9	3.6	28.0	32.3	13.2	57.4	36.8	5.9	6.1	13.8	6.7	7.3
CDKL1	KKIALRE	ENSG00000100490	"Cyclin dependent kinase like 1"	Q00532	14	50329404-50416461	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 17.9;Ciliated cells: 34.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059605, HPA065919"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA059605: AB_2684080, HPA065919: AB_2685578"	"unprognostic (4.12e-3)"	"unprognostic (3.22e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.23e-3)"	"unprognostic (9.36e-3)"	"unprognostic (2.63e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.36e-2)"	"unprognostic (5.53e-8)"	"unprognostic (1.21e-1)"	"unprognostic (7.96e-2)"	"unprognostic (9.39e-3)"	"unprognostic (3.31e-3)"	7.1	2.1	7.5	1.8	5.1	0.9	3.0	2.7	20.2	14.1	5.9	1.6	2.5	8.4	12.1	2.3	2.6	16.4	2.6	2.9	7.1	2.4	18.8	1.1	4.3	3.0	2.0	12.3	10.5	2.0	1.4	1.4	4.9	2.9	4.0	5.7	1.6	2.5	8.4	1.7	3.0	3.0	7.7	3.1	3.7	2.0	1.9	1.4	1.3	5.0	6.1	2.1	7.0	5.6	5.7	1.3	6.0	2.5	3.8	6.7	2.6	6.1	4.9	0.6	2.4	6.5	7.9	0.3	2.1	3.9	2.2	2.6	2.0	5.8	0.4	2.6	4.6	2.2	4.2	0.9	0.6	2.5	6.7	2.4	6.5	2.1	1.7	7.4	5.9	3.5	1.7	3.6	4.6	10.1	1.8	8.5	6.2	2.7	2.6	1.0	0.3	1.9	3.1	0.7	1.6	2.3	0.7	2.8	1.9	6.9	2.3	1.1	1.3	2.5	16.7	0.6	0.1	0.2	5.0	2.7	5.7	2.9	5.7	4.7	0.9	0.4	0.4	1.0	6.2	7.0	6.0	2.5	4.4	6.3	2.3	6.2	4.6	4.4	6.7	1.3	5.7	3.4	3.7	1.4	3.8	0.3	1.2	4.1	2.6	7.5	5.1	2.7	20.2	7.1	2.4	2.0	12.3	2.9	1.4	17.9	6.9	1.3	3.2	2.7	0.4	0.4	0.0	34.8	4.5	10.4	0.0	0.1	5.0	0.9	0.3	2.1	4.7	0.0	1.6	0.1	4.7	1.2	1.1	0.2	0.3	0.0	1.7	6.7	1.9	0.9	8.3	1.1	0.0	0.0	2.3	0.8	1.2	3.7	3.2	5.5	0.7	0.0	1.3	0.0	0.2	2.4	0.2	2.5	3.4	1.4
CDKN2AIP	"CARF, FLJ20036"	ENSG00000168564	"CDKN2A interacting protein"	Q9NXV6	4	183444591-183448198	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 103.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 60.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041397, HPA062142"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041397: AB_10794297, HPA062142: AB_2684696"	"unprognostic (9.00e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (7.65e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (3.00e-5)"	"unprognostic (2.93e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.23e-2)"	14.2	14.3	13.9	13.6	15.6	32.3	15.9	20.8	13.8	18.1	18.1	15.0	10.1	18.7	17.1	13.2	27.7	13.0	13.3	15.0	13.0	12.9	18.1	17.2	17.8	17.8	15.4	10.7	24.0	18.4	15.9	21.9	16.4	14.0	21.5	14.2	13.0	15.9	15.2	11.1	14.2	18.0	14.8	13.7	16.0	17.2	20.1	12.2	24.7	23.4	20.6	27.3	16.6	24.1	8.3	4.6	28.5	5.9	8.1	14.7	8.4	5.1	2.9	8.7	6.2	7.3	5.3	6.5	8.7	7.3	9.0	6.0	4.3	5.0	17.3	1.8	5.9	3.7	4.1	7.9	6.4	9.5	7.0	4.7	17.9	14.0	5.5	5.8	13.1	7.2	6.3	6.0	5.3	7.0	4.8	7.1	6.6	8.9	18.7	6.2	2.7	14.8	10.7	6.3	1.9	6.0	12.8	4.2	6.9	60.3	4.9	8.9	7.6	6.3	26.6	10.4	5.9	3.9	11.4	4.0	3.2	4.5	2.9	7.0	9.1	3.7	8.9	5.0	11.3	5.1	28.5	4.8	10.4	9.0	5.6	9.4	7.4	11.1	9.7	4.6	8.3	14.7	13.3	5.7	8.1	5.9	3.1	10.9	8.4	13.9	15.6	20.8	13.8	13.0	12.9	15.4	10.7	14.0	12.2	14.9	30.7	18.2	22.6	31.9	21.9	15.7	22.9	33.5	27.3	15.7	9.8	20.1	14.9	11.0	103.2	21.8	25.7	0.0	13.7	12.2	23.7	35.9	61.1	12.8	13.7	20.6	29.1	17.8	8.8	51.4	19.5	18.9	20.3	11.8	19.1	18.8	13.2	20.1	16.3	10.5	19.8	12.9	21.1	32.3	36.3	34.8	15.7	34.1	17.5	48.5
CDKN3	"CDI1, KAP"	ENSG00000100526	"Cyclin dependent kinase inhibitor 3"	Q16667	14	54396849-54420218	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle"	"Hydrolase, Protein phosphatase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"testis: 80.3"	"Cell type enriched"	"Detected in many"	4	"Early spermatids: 2056.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 16.1"	"Group enriched"	"Detected in all"	5	"NK-cells: 5.8;T-cells: 16.1"	"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005285, HPA039311, HPA058874"			Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005285: AB_2078884, HPA039311: , HPA058874: AB_2683842"	"unprognostic (3.46e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.79e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.73e-1)"	"unprognostic (6.08e-2)"	"unprognostic (1.51e-3)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (2.50e-3)"	"unprognostic (2.85e-3)"	"prognostic unfavorable (7.46e-4)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.71e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.92e-2)"	"unprognostic (4.31e-2)"	2.4	1.0	1.6	6.5	1.7	12.8	1.5	1.5	2.5	1.0	4.5	0.2	0.2	3.8	0.9	1.1	4.4	0.7	0.9	3.0	1.4	1.9	1.0	1.1	1.1	8.8	1.7	1.9	0.9	0.7	0.0	1.0	2.3	2.8	0.9	5.8	0.9	1.7	0.1	3.9	1.8	4.0	2.2	1.0	2.3	1.8	80.3	0.3	18.3	1.1	6.4	9.5	2.1	1.8	2.0	1.6	1.1	1.4	5.8	16.1	2.9	55.2	21.2	16.3	16.3	2.7	3.3	9.4	13.2	19.5	28.2	31.2	16.0	27.6	27.2	9.7	20.6	29.7	40.7	24.7	16.0	52.7	32.6	11.9	13.8	15.3	26.4	2.0	17.2	9.8	1.2	1.0	17.6	30.7	9.9	17.9	26.4	6.9	34.8	33.8	39.3	23.8	14.0	5.7	54.1	46.0	14.8	14.4	5.9	14.9	12.1	6.7	8.5	24.2	14.3	10.5	12.8	29.6	14.7	6.5	12.5	42.9	19.7	31.2	8.4	9.7	18.7	20.9	24.9	22.8	0.0	1.3	1.1	1.2	1.4	0.6	2.0	5.2	4.3	1.6	0.9	2.7	2.2	0.9	5.8	0.9	1.2	16.1	2.9	1.6	1.7	1.5	2.5	1.4	1.9	1.7	1.9	2.8	0.3	0.0	0.0	0.8	3.1	8.2	1.4	9.3	0.0	0.0	1.2	1.8	2.0	9.8	0.0	2.8	2056.4	2.0	2.9	256.9	2.1	27.0	6.6	2.2	6.9	1.8	31.5	4.8	7.5	4.9	7.5	483.1	19.8	5.7	1.7	3.6	6.2	1.2	2.0	6.2	9.9	1.7	2.3	0.0	2.1	159.2	36.4	5.6	3.4	7.0	12.8	1.4
CDV3	H41	ENSG00000091527	"CDV3 homolog"	Q9UKY7	3	133573730-133590261	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 153.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029761, HPA029762, HPA029763"	Enhanced		Enhanced	"Nucleoli,Plasma membrane,Cytosol"		NA	NA		220000	Cytosol	"Nucleoli, Plasma membrane"	"HPA029761: AB_10600193, HPA029762: AB_10611247, HPA029763: AB_10601679"	"unprognostic (1.17e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.21e-6)"	"unprognostic (1.20e-1)"	"unprognostic (3.30e-1)"	"unprognostic (8.45e-3)"	"unprognostic (3.29e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.87e-2)"	"unprognostic (7.59e-3)"	46.4	26.5	20.7	45.7	22.4	44.9	38.1	13.2	22.3	25.6	29.5	20.2	16.2	18.5	27.0	26.1	34.1	22.0	25.4	50.5	19.0	18.3	26.2	40.2	34.3	47.6	22.5	20.6	32.8	34.4	25.6	22.5	34.8	24.4	24.6	23.9	18.7	24.6	16.7	106.6	23.1	27.7	33.1	25.4	56.6	31.4	38.2	21.5	61.1	33.9	32.5	52.1	43.8	37.2	10.6	14.2	14.7	11.1	5.3	20.8	4.5	50.8	11.8	20.9	13.8	24.2	29.9	24.8	28.1	36.6	28.2	28.0	29.3	20.5	65.0	42.7	31.4	32.6	22.0	29.9	28.1	52.8	41.5	11.3	38.4	13.0	17.9	37.7	42.7	24.7	28.3	29.5	25.1	67.9	20.0	35.5	19.3	27.6	43.7	40.7	14.6	34.9	24.7	21.1	22.1	15.2	21.3	27.8	52.1	29.6	20.7	16.6	12.5	26.7	19.9	33.4	31.3	64.3	26.2	43.9	30.1	28.4	23.8	27.8	63.8	47.8	153.1	16.8	25.9	17.4	11.5	9.6	14.7	12.2	10.7	12.8	10.6	11.7	12.4	8.5	6.5	9.4	14.4	8.7	5.3	11.1	14.2	20.8	4.5	20.7	22.4	13.2	22.3	19.0	18.3	22.5	20.6	24.4	21.5	53.6	71.1	101.7	142.6	129.7	20.9	78.7	53.5	28.1	42.1	80.3	9.8	43.1	31.5	38.9	281.1	76.6	64.9	0.0	75.3	62.7	68.5	184.4	43.9	86.4	99.8	22.3	45.3	81.0	95.3	485.8	31.7	84.0	52.3	32.5	44.7	88.5	74.6	39.3	33.6	39.1	27.1	25.8	54.6	20.4	24.7	112.0	29.4	62.3	47.8	220.3
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27962137-27971139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 21.2"	"Group enriched"	"Detected in some"	7	"Enterocytes: 190.4;Intestinal endocrine cells: 60.0;Mucus-secreting cells: 200.2;Paneth cells: 129.8;Undifferentiated cells: 183.4"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 14.7;CAPAN-2: 4.9;HEK 293: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: AB_2680823"		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	21.2			13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.1	14.3		0.0	0.0	0.0	0.0	16.3	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.7	4.9	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.1	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	20.8	0.0	0.0	190.4	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.4	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	200.2	0.0	1.1	129.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	183.4	0.1
CEBPB	"C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5"	ENSG00000172216	"CCAAT/enhancer binding protein beta"	P17676	20	50190734-50192689	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 121.9"	"Cell type enhanced"	"Detected in many"	7	"Smooth muscle cells: 658.6;Suprabasal keratinocytes: 699.3;Syncytiotrophoblasts: 1179.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 13.6;monocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 45.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB004213, HPA061355, HPA062267"	Supported		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB004213: AB_626772, HPA061355: AB_2684487, HPA062267: AB_2684731"	"unprognostic (2.30e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.79e-2)"	"unprognostic (9.85e-3)"	"unprognostic (9.26e-3)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (2.44e-12)"	"unprognostic (7.29e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.63e-2)"	56.9	54.7	7.0	35.9	9.9	21.1	34.4	1.8	6.2	22.8	25.2	6.4	8.0	8.0	19.4	11.2	19.2	21.7	20.2	33.6	8.4	4.4	15.3	92.5	51.3	20.4	9.5	3.0	33.6	18.6	4.1	7.4	75.1	7.7	21.1	5.0	14.0	14.6	11.7	121.9	23.9	19.4	12.6	9.5	40.3	15.3	14.3	8.1	1.5	46.1	25.3	10.7	30.8	30.6	0.4	1.2	13.6	6.1	0.4	0.5	0.5	7.4	3.4	0.3	4.1	19.3	7.6	33.5	10.1	16.0	7.0	6.2	3.4	6.9	4.9	19.4	4.1	34.4	10.2	1.0	9.9	4.7	3.5	2.5	1.5	4.4	5.0	23.8	2.4	9.8	8.1	26.3	8.9	15.8	14.6	0.9	5.1	7.1	9.1	4.3	2.8	1.1	5.3	2.1	7.1	9.9	3.5	1.0	5.5	2.3	1.8	2.0	1.3	8.4	20.9	45.0	2.3	5.5	13.8	1.3	14.6	11.1	12.4	9.7	19.4	8.0	4.3	26.6	5.6	6.3	5.9	3.0	9.1	0.4	5.3	0.1	0.4	0.4	0.5	1.2	0.3	0.3	0.2	13.6	0.4	6.1	0.0	0.2	0.5	7.0	9.9	1.8	6.2	8.4	4.4	9.5	3.0	7.7	8.1	32.8	78.5	51.8	281.2	643.3	2.2	40.0	84.1	21.4	31.8	43.6	0.0	157.2	26.6	27.6	4.6	30.6	66.5	0.0	11.5	550.7	468.0	220.5	50.7	350.5	326.4	3.2	64.1	81.0	362.0	5.0	120.0	403.2	205.8	1.8	77.9	46.2	16.6	52.6	90.5	50.0	3.3	155.2	658.6	0.7	9.1	699.3	1179.1	63.8	45.7	245.2
CELF1	"BRUNOL2, CUG-BP, CUGBP, CUGBP1, EDEN-BP, hNab50, NAB50, NAPOR"	ENSG00000149187	"CUGBP Elav-like family member 1"	Q92879	11	47465933-47565569	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016114, HPA044597, CAB069989"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016114: AB_627319, CAB069989: AB_2086153, HPA044597: AB_2679012"	"unprognostic (1.05e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.34e-2)"	18.4	22.8	28.3	19.9	30.8	25.8	22.7	49.5	29.8	17.8	20.7	16.6	22.9	14.7	22.9	20.1	21.5	19.0	16.5	19.3	18.7	14.1	18.5	36.5	21.0	24.0	12.8	20.2	18.9	19.2	54.3	19.6	18.2	14.6	16.3	17.7	18.4	18.0	19.7	45.4	20.1	20.1	31.4	11.9	22.3	17.9	20.4	17.7	15.8	19.5	17.0	24.6	20.6	23.8	15.4	12.4	20.6	15.5	7.0	16.1	8.0	17.9	32.0	26.6	27.3	20.9	22.4	22.7	19.3	20.1	24.4	25.6	27.1	21.4	47.5	13.5	20.8	29.5	26.9	41.1	27.4	41.2	19.8	17.9	14.6	42.0	19.4	20.4	22.8	16.2	17.1	16.9	26.5	32.3	17.3	22.2	20.6	27.3	19.4	15.6	24.0	23.5	18.3	37.2	22.4	18.9	24.3	21.3	18.6	21.0	32.2	25.0	21.1	25.7	23.9	15.7	28.5	33.7	15.1	25.5	28.0	27.6	26.7	26.1	16.7	15.1	37.9	22.6	10.9	22.7	10.9	10.8	20.6	12.8	9.6	16.1	14.6	13.5	14.5	12.4	15.4	14.7	12.1	14.6	7.0	15.5	7.7	9.2	8.0	28.3	30.8	49.5	29.8	18.7	14.1	12.8	20.2	14.6	17.7	50.6	34.1	56.8	64.7	95.7	73.0	45.8	86.6	37.5	29.6	75.0	90.3	45.7	18.3	52.0	15.0	60.9	41.1	46.7	48.3	42.8	47.4	90.8	20.8	179.6	61.2	120.8	82.1	87.2	102.7	7.0	48.9	83.5	40.5	34.3	52.3	66.2	69.1	45.6	51.9	31.8	44.1	51.8	57.1	53.7	63.4	95.4	30.1	57.3	64.3	86.4
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.1;HaCaT: 15.2;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.7	24.1	4.6	3.9	0.0	0.0	2.2	0.7	1.5	1.4	0.3	5.7	6.8	0.0	11.9	0.1	9.3	15.2	3.8	11.5	0.5	0.0	4.6	0.0	9.7	0.2	0.2	1.5	0.6	0.0	10.8	0.0	9.6	9.1	0.0	0.6	0.0	0.0	0.0	10.9	0.0	1.7	1.7	2.8	3.8	0.0	0.0	2.8	6.4	5.4	0.2	0.3	7.5	6.0	1.2	1.9	17.3	5.1	0.3	0.0	0.1	0.0	0.1	4.6	0.2	2.4	6.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0	38.7	16.8	1.3	3.3	15.1	0.0	10.2	0.0	33.5	27.3	5.2	0.0	1.0	0.0	1.4	1.2	5.5	0.0	0.0	0.6	1.7	1.7	3.6	0.0	1.6	2.4	0.0	1.2	1.3	0.0	5.0	0.0	1.3	5.0	1.8	2.0	1.3	2.6	0.0	0.0	11.0	0.3	0.0	1.0	0.2	0.2	13.7	0.7	0.0	1.5	4.7
CENPB		ENSG00000125817	"Centromere protein B"	P07199	20	3783851-3786690	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011626, HPA053507, HPA054405"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"CAB011626: AB_726801, HPA053507: AB_2682173, HPA054405: AB_2682477"	"unprognostic (2.01e-1)"	"unprognostic (8.47e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (2.40e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.93e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.46e-1)"	30.4	18.9	41.2	18.0	41.6	11.9	22.9	13.0	28.9	22.4	23.0	41.1	18.7	19.6	18.4	19.8	22.3	18.1	27.3	26.9	41.9	29.1	19.8	20.3	20.0	16.0	48.0	14.7	25.0	23.9	22.7	12.1	15.2	22.0	18.6	12.3	13.0	27.6	24.3	58.3	32.6	19.9	20.1	55.8	19.8	21.9	9.0	21.9	19.6	21.7	26.4	14.9	20.7	28.0	3.7	4.2	1.4	4.5	3.9	5.0	2.5	32.0	41.4	8.1	17.3	17.3	13.8	5.2	23.1	16.9	14.9	12.1	16.8	23.2	11.2	7.2	21.4	23.3	26.0	6.4	26.3	7.5	15.9	11.0	23.8	14.9	14.8	20.2	7.7	8.0	15.6	14.1	21.3	13.7	11.7	12.7	14.6	15.3	7.1	12.6	52.9	23.0	17.8	10.2	18.2	49.4	19.2	1.0	8.2	15.5	19.9	20.0	14.9	19.1	26.9	18.0	3.8	16.9	17.2	21.5	25.9	14.0	22.3	35.2	8.6	12.4	6.6	9.0	27.8	16.9	0.1	4.5	1.4	5.0	4.0	3.5	2.5	3.6	3.1	3.2	3.7	3.3	3.8	0.6	3.9	2.6	4.2	1.0	2.5	41.2	41.6	13.0	28.9	41.9	29.1	48.0	14.7	22.0	21.9	6.0	17.9	1.5	4.7	12.4	16.8	13.6	33.1	10.7	10.3	14.0	9.8	4.5	3.3	16.2	0.8	17.9	29.0	0.0	25.4	6.4	12.7	10.4	7.0	22.2	19.3	20.6	19.7	17.8	20.8	3.9	20.1	13.0	16.9	10.8	24.3	28.3	24.5	20.4	24.4	6.5	12.2	12.9	13.7	1.2	1.3	12.3	3.8	6.4	21.0	6.2
CENPM	"C22orf18, CENP-M, MGC861, Pane1"	ENSG00000100162	"Centromere protein M"	Q9NSP4	22	41938721-41947164	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.3;lymphoid tissue: 41.5"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 48.5;Ciliated cells: 109.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 19.5;T-reg: 23.3"	"Group enriched"	"Detected in many"	7	"B-cells: 19.5;T-cells: 23.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042404, HPA056500"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA042404: AB_2677981, HPA056500: AB_2683156"	"unprognostic (3.78e-2)"	"prognostic favorable (3.40e-5)"	"unprognostic (7.15e-3)"	"unprognostic (2.65e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.50e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (5.99e-7)"	"unprognostic (9.54e-3)"	"unprognostic (2.44e-1)"	"unprognostic (8.73e-2)"	"unprognostic (5.61e-2)"	1.6	1.4	1.1	31.9	0.9	18.2	3.8	1.9	1.2	1.7	6.9	1.1	0.4	6.0	1.4	2.2	8.9	9.6	4.3	3.2	1.0	0.8	2.1	1.4	4.2	17.0	1.0	0.4	1.4	0.6	0.0	0.4	3.4	0.8	1.2	3.7	1.1	3.3	0.9	0.5	6.3	7.2	1.1	0.9	9.7	4.5	13.5	0.4	41.5	0.9	5.5	18.8	3.2	3.3	19.5	0.3	0.8	0.1	2.9	23.3	4.0	22.2	22.9	12.8	8.4	1.0	0.9	5.5	11.0	5.7	19.3	19.7	26.5	11.9	28.9	8.3	5.7	12.5	8.6	9.6	11.2	4.8	8.3	40.1	13.5	24.5	18.4	1.0	25.6	15.4	0.8	0.8	12.4	5.8	2.0	7.2	26.8	10.2	28.0	11.2	34.4	25.5	26.8	6.9	13.5	17.0	24.6	12.8	30.1	7.8	13.3	14.7	2.8	16.9	10.1	5.8	2.2	9.6	16.7	3.6	18.8	28.1	12.4	18.2	15.0	10.4	26.7	6.5	21.4	20.5	0.8	0.1	0.0	3.2	0.0	4.3	13.1	9.4	4.1	0.3	19.5	1.8	2.4	0.5	2.9	0.0	0.2	23.3	4.0	1.1	0.9	1.9	1.2	1.0	0.8	1.0	0.4	0.8	0.4	0.0	4.3	48.5	2.2	1.8	2.1	0.4	0.0	109.7	1.2	0.0	0.0	14.1	14.9	1.9	2.9	0.3	4.9	23.3	0.6	28.0	3.1	1.8	2.3	0.8	35.5	3.2	7.5	4.3	3.1	4.0	1.1	6.5	6.8	2.8	35.1	0.1	1.4	8.6	0.4	0.2	0.5	0.0	0.0	37.0	36.7	0.9	7.3	17.3	19.2	3.8
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463378-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	7.2	7.6	10.4	11.2	15.4	6.4	8.7	10.9	11.4	6.6	5.8	6.4	5.8	4.2	7.5	7.1	12.1	6.4	5.4	10.0	11.5	9.3	7.6	6.8	5.8	10.0	19.8	7.7	10.4	4.8	4.6	8.9	9.1	15.3	7.4	7.5	2.7	5.5	5.4	6.9	6.1	5.1	7.0	18.7	8.8	5.6	8.8	18.3	15.1	6.0	9.1	12.7	9.5	6.4	7.8	5.0	7.2	3.1	4.4	5.6	2.3	16.4	4.6	14.7	9.1	4.0	6.3	13.0	21.4	12.3	20.6	29.0	5.6	6.7	11.2	10.7	6.0	16.1	6.0	7.6	7.7	30.5	12.1	10.7	8.2	7.4	9.0	1.7	17.4	10.4	2.8	4.3	25.2	8.8	5.3	7.5	9.8	12.6	11.2	15.2	4.7	12.2	8.2	9.1	14.4	4.2	8.8	17.4	12.1	6.0	6.8	7.9	7.9	10.0	6.0	11.2	15.2	7.7	16.0	4.4	16.0	12.4	12.5	19.0	5.1	13.2	10.0	10.8	13.1	15.4	4.1	2.2	7.2	4.0	2.7	4.2	7.6	4.3	4.6	2.5	7.8	4.7	4.5	1.6	4.4	3.1	5.0	5.6	2.3	10.4	15.4	10.9	11.4	11.5	9.3	19.8	7.7	15.3	18.3	0.0	2.4	6.7	8.9	7.7	5.4	5.1	7.6	10.7	3.4	7.0	2.0	12.0	6.6	7.0	1.0	6.3	1.6	0.0	6.9	23.5	8.4	4.8	4.6	2.8	8.8	6.4	2.4	13.5	10.8	1.9	8.1	5.5	3.3	7.2	2.7	12.4	6.0	3.6	10.3	3.1	5.0	6.5	5.1	16.8	28.6	6.0	10.4	6.4	4.5	5.4
CENPT	"C16orf56, CENP-T, FLJ13111"	ENSG00000102901	"Centromere protein T"	Q96BT3	16	67828157-67847811	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 86.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041220, HPA058036"	Approved		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA041220: AB_2677367, HPA058036: AB_2683585"	"unprognostic (9.84e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.04e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.18e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.04e-2)"	"unprognostic (3.15e-2)"	"prognostic favorable (2.96e-4)"	"unprognostic (6.64e-3)"	"prognostic unfavorable (1.57e-7)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (9.74e-3)"	10.1	7.3	14.1	11.8	11.8	11.5	9.6	28.2	17.4	13.3	11.5	7.6	7.7	6.8	10.9	12.0	9.9	10.5	6.3	11.9	11.5	12.2	7.6	8.5	6.7	8.5	10.2	10.8	13.5	18.6	9.9	8.5	17.2	10.5	8.8	5.8	8.4	11.4	13.3	11.5	31.9	8.9	12.0	7.9	7.8	9.3	22.5	10.9	8.1	8.6	7.1	8.0	9.9	8.7	7.1	8.2	8.3	10.0	6.6	11.9	7.6	4.9	4.9	6.9	6.9	5.6	5.5	10.1	19.7	9.2	20.7	16.7	5.2	3.7	2.1	4.8	13.1	3.6	8.2	5.0	8.8	7.1	3.4	6.4	0.8	2.1	7.3	3.7	0.4	4.7	6.0	5.3	14.1	3.0	3.0	8.3	5.4	12.4	2.4	9.7	7.7	6.3	6.9	9.2	3.9	4.8	8.7	3.1	11.4	7.7	2.0	2.7	4.6	14.8	3.1	3.9	4.4	4.1	6.6	6.4	2.9	5.1	4.5	4.6	4.8	3.7	12.2	2.2	3.9	5.0	2.0	10.0	8.3	9.4	9.0	10.1	7.0	8.8	11.9	8.2	7.1	8.0	10.4	4.4	6.6	5.6	8.1	11.1	7.6	14.1	11.8	28.2	17.4	11.5	12.2	10.2	10.8	10.5	10.9	14.9	9.9	19.7	18.4	18.7	24.8	7.3	12.7	8.1	10.3	19.2	7.9	26.4	5.0	17.7	36.3	19.5	15.8	23.3	12.5	20.2	23.7	10.4	8.1	8.6	13.1	23.8	12.6	12.9	8.5	34.7	22.5	14.6	16.9	7.2	11.0	14.6	15.7	14.0	20.8	7.8	10.2	25.8	27.8	86.3	33.6	16.9	25.2	26.3	11.5	12.2
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227635	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 72.3;Early spermatids: 103.7;Spermatocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	5.9	4.3	4.2	5.3	6.0	3.8	5.4	9.4	7.8	6.4	6.3	4.8	6.6	2.1	9.1	4.4	4.1	7.2	5.2	4.0	4.5	2.6	7.7	2.6	5.3	4.6	4.8	3.2	7.9	4.1	9.6	19.1	4.5	5.8	4.7	4.9	2.7	5.5	4.6	4.1	4.1	4.2	6.4	7.6	5.8	4.9	14.4	6.4	11.6	7.7	2.1	4.2	7.3	5.4	2.5	1.8	2.2	1.3	0.1	2.6	0.8	2.9	1.3	8.8	9.5	5.2	7.8	5.5	3.3	3.2	4.7	5.8	3.8	4.0	3.2	3.2	2.6	8.4	4.6	5.1	3.1	7.5	8.1	3.6	5.8	5.9	2.8	2.9	6.3	5.6	3.6	2.3	4.8	1.8	6.3	5.2	4.8	11.8	3.7	3.4	1.5	1.6	4.1	5.8	2.1	2.1	9.0	11.3	1.7	3.5	2.7	6.0	7.5	2.4	1.4	2.5	6.6	3.1	4.6	4.2	4.7	4.2	4.1	3.7	2.9	3.9	1.9	2.9	3.5	5.8	0.0	1.3	1.5	1.9	1.2	2.6	2.5	1.5	1.7	0.7	1.6	1.2	2.0	2.2	0.1	1.0	1.8	0.3	0.8	4.2	6.0	9.4	7.8	4.5	2.6	4.8	3.2	5.8	6.4	29.8	14.5	5.0	6.4	0.0	5.2	7.6	0.0	72.3	12.5	8.7	11.8	5.8	5.0	10.5	103.7	6.3	5.1	23.3	6.2	4.6	5.0	3.5	17.4	2.6	4.7	27.0	10.9	8.6	5.6	39.3	10.9	6.1	0.0	1.8	4.5	11.2	5.3	14.0	11.3	5.0	13.8	12.9	3.6	62.7	22.4	0.0	3.2	7.5	5.2	3.3
CEP170	"FAM68A, KAB, KIAA0470"	ENSG00000143702	"Centrosomal protein 170"	Q5SW79	1	243124428-243255348	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.7"	"Group enriched"	"Detected in many"	37	"Early spermatids: 1512.0;Late spermatids: 3749.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042151, HPA045597, HPA045787"	Uncertain		Enhanced	"Mitotic spindle,Centrosome,Cytosol"		Yes	No			Centrosome	"Mitotic spindle, Cytosol"	"HPA042151: AB_2677876, HPA045597: AB_2732522, HPA045787: AB_2679453"	"unprognostic (2.97e-1)"	"unprognostic (2.49e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.60e-2)"	"unprognostic (6.83e-5)"	"unprognostic (8.05e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (1.30e-9)"	"unprognostic (2.21e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.49e-3)"	"unprognostic (9.62e-3)"	9.5	6.1	13.7	10.8	13.2	36.5	6.8	27.7	23.2	7.4	5.4	11.4	3.1	3.1	9.1	5.2	5.5	6.4	11.1	8.6	12.8	11.2	3.8	6.7	8.4	7.3	19.3	13.7	13.3	2.8	2.8	10.8	9.8	20.2	5.0	4.2	3.3	4.2	5.5	9.3	4.2	4.7	7.4	25.8	7.8	4.2	53.7	18.0	11.6	14.4	3.3	8.9	8.6	6.6	9.4	8.4	12.3	10.1	2.8	4.7	2.1	6.0	5.1	13.2	11.1	8.2	15.9	2.9	16.1	9.6	12.1	11.5	3.2	5.9	4.5	9.9	13.7	4.1	3.0	11.3	6.9	17.3	10.0	6.5	4.7	4.8	2.2	7.1	8.2	8.8	10.0	1.9	38.6	16.9	27.7	28.2	2.7	11.3	4.7	15.3	1.3	5.0	4.4	16.6	1.2	14.5	9.0	9.4	1.5	2.5	1.0	19.1	25.7	8.2	0.7	7.7	10.8	2.8	11.2	31.1	22.6	6.7	12.1	18.5	4.6	5.9	9.0	12.0	7.5	51.9	3.5	8.3	7.6	1.9	10.0	2.7	3.6	3.8	1.6	8.4	9.4	4.7	2.7	12.3	2.8	10.1	5.5	2.9	2.1	13.7	13.2	27.7	15.8	12.8	11.2	19.3	13.7	20.2	18.0	17.9	16.6	13.7	4.2	13.5	41.1	19.0	7.6	25.4	11.4	12.2	5.9	3.1	0.0	18.9	1512.0	31.0	0.7	0.0	6.1	6.7	26.8	3.3	22.0	6.8	31.5	42.9	10.4	18.4	34.9	3749.4	40.9	70.8	21.9	31.5	1.9	11.4	19.1	0.0	33.2	2.1	18.3	25.8	15.7	71.0	23.8	10.0	1.6	7.0	1.6	3.1
CEP295	KIAA1731	ENSG00000166004	"Centrosomal protein 295"	Q9C0D2	11	93661639-93730358	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 78.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038595, HPA038596, HPA038597"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106"	"unprognostic (1.35e-2)"	"unprognostic (3.08e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.73e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.03e-3)"	"unprognostic (2.14e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.73e-2)"	"unprognostic (4.99e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.18e-2)"	8.4	7.4	15.8	12.1	15.4	19.6	11.7	30.6	20.5	10.0	10.0	6.1	9.4	8.6	10.5	11.2	8.4	7.7	7.6	6.5	12.1	8.1	7.6	6.3	8.6	14.1	10.7	14.7	12.2	8.1	8.5	24.5	8.5	12.1	10.6	9.8	5.1	7.9	9.4	13.4	12.5	9.2	7.8	13.8	11.7	8.0	15.5	15.0	11.6	12.3	5.2	9.9	10.7	8.9	6.3	3.0	9.1	3.1	2.7	3.0	0.6	7.2	6.7	17.2	14.8	8.1	7.9	8.5	9.4	6.9	9.0	10.5	12.3	14.0	2.2	14.0	5.9	12.4	13.6	8.7	6.9	9.1	10.4	6.8	13.2	19.4	6.1	4.9	11.9	13.0	5.7	4.1	8.4	7.5	8.5	7.4	12.2	14.9	14.0	11.3	6.2	6.1	19.6	5.8	13.7	6.9	12.3	16.4	8.9	7.3	12.8	10.3	9.7	14.8	10.0	2.7	11.7	16.4	6.5	7.5	8.4	11.0	15.1	7.2	5.2	11.3	14.7	5.0	14.0	11.5	4.1	3.1	5.7	2.8	1.5	2.2	5.0	2.5	1.9	1.3	6.3	3.0	2.5	9.1	2.7	2.0	3.0	1.7	0.6	15.8	15.4	30.6	20.5	12.1	8.1	10.7	14.7	12.1	15.0	8.9	14.7	0.0	2.0	0.0	27.0	7.8	2.5	9.4	10.3	5.2	25.5	9.3	3.3	6.5	78.2	6.3	2.6	23.3	6.8	9.1	4.6	3.6	15.1	3.2	6.9	17.5	3.5	5.5	8.6	15.5	11.8	4.8	0.0	4.6	7.0	7.8	5.0	4.3	13.4	3.0	37.3	6.5	1.4	39.0	17.0	0.0	5.5	6.4	6.4	2.2
CEP350	"CAP350, KIAA0480"	ENSG00000135837	"Centrosomal protein 350"	Q5VT06	1	179954738-180114880	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 741.2;Late spermatids: 585.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028355, HPA028357, HPA030845, CAB079754"	Enhanced		Enhanced	Centrosome		NA	NA			Centrosome		"CAB079754: AB_2665828, HPA028355: AB_10599491, HPA028357: AB_10599426, HPA030845: AB_2673633"	"unprognostic (9.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.78e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.17e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.65e-3)"	"unprognostic (3.84e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.25e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (4.22e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.13e-1)"	17.2	11.3	13.8	18.9	18.0	26.5	14.0	23.1	14.8	15.3	16.9	13.1	10.5	11.1	13.9	11.9	13.4	11.9	10.8	12.8	13.1	9.4	11.4	12.6	12.4	16.9	17.7	12.3	18.0	13.7	27.2	25.5	14.4	16.2	11.6	13.9	9.0	13.5	12.1	44.2	15.1	22.1	11.5	14.6	17.8	13.4	28.8	18.5	29.8	13.9	11.6	16.5	17.0	20.1	7.2	5.9	8.1	3.7	3.2	6.1	1.3	12.9	9.4	12.2	4.3	10.3	9.6	11.4	8.8	11.9	7.6	8.4	10.4	7.8	14.4	9.6	8.0	6.6	16.1	9.1	5.1	10.0	13.9	6.3	10.2	11.9	6.5	11.3	20.1	9.6	9.6	8.0	9.9	13.1	5.6	9.3	13.7	19.8	10.9	8.2	9.5	11.8	5.6	11.3	12.7	2.4	10.3	13.4	11.1	5.4	27.1	8.6	9.1	14.7	9.9	16.8	9.0	10.7	18.2	9.5	10.9	7.6	9.6	9.3	19.1	24.1	28.1	5.1	8.7	16.1	2.3	3.7	8.1	5.4	3.4	6.1	4.1	3.9	3.4	3.0	7.2	4.2	3.5	7.3	3.2	3.0	5.9	5.7	1.3	13.8	18.0	23.1	14.8	13.1	9.4	17.7	12.3	16.2	18.5	110.2	57.9	32.6	27.9	33.8	54.3	69.8	28.1	71.0	53.4	12.2	80.5	16.2	5.0	20.5	741.2	46.8	32.1	23.3	33.4	20.9	31.5	29.9	27.8	25.1	25.1	58.8	44.4	71.2	59.9	585.2	49.8	51.5	18.6	83.8	25.2	34.6	32.4	21.0	39.6	8.4	50.5	25.8	38.7	171.0	27.4	40.8	22.0	43.7	25.5	37.7
CFAP157	C9orf117	ENSG00000160401	"Cilia and flagella associated protein 157"	Q5JU67	9	127706989-127716002	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5"	"Cell type enriched"	"Detected in some"	6	"Ciliated cells: 348.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 19.8;pons and medulla: 30.2"	"Cell type enriched"	"Detected in single"	11	"MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA021474, HPA021786"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA021474: AB_1845801, HPA021786: AB_1845802"	"unprognostic (1.69e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (3.02e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.71e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.14e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.93e-4)"	"unprognostic (9.32e-3)"	"unprognostic (4.95e-3)"	"unprognostic (5.71e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.28e-1)"	0.4	0.4	3.1	0.3	19.8	0.3	0.3	0.1	0.4	5.3	0.3	7.0	1.6	0.2	1.0	24.0	0.8	44.8	0.6	0.4	4.6	5.8	0.4	0.3	6.1	0.4	0.0	0.0	4.4	0.9	0.2	4.4	0.3	30.2	0.4	0.2	0.0	0.5	1.3	0.4	0.6	0.3	0.2	0.5	0.4	0.4	11.5	3.5	0.0	0.4	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	9.3	0.9	1.2	0.0	0.0	1.2	1.2	0.0	0.0	0.0	0.9	1.3	1.4	1.4	0.0	2.3	4.6	0.0	0.0	0.0	3.4	1.1	0.9	7.6	2.3	0.0	0.7	2.1	0.0	0.0	0.0	0.0	0.5	0.0	2.8	3.1	0.7	0.0	6.6	1.3	0.5	0.9	1.7	4.9	2.0	0.9	1.5	0.0	0.4	6.4	1.1	1.9	3.6	0.7	0.2	3.2	0.3	1.7	1.9	1.5	5.0	0.8	1.0	2.6	1.2	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	19.8	0.1	0.3	4.6	5.8	0.0	0.0	30.2	3.5	8.9	10.9	0.0	0.2	0.0	0.6	0.0	0.0	348.0	51.2	0.0	0.0	0.0	1.7	0.3	44.7	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.2	0.0	0.0	0.0	0.3	61.4	0.3	0.4	0.0	0.0	0.6	0.8	0.0	0.0	0.7	0.3	0.2	0.0	0.0	11.4	1.1	0.0	0.0	0.0	0.2	0.1
CFAP45	"CCDC19, NESG1"	ENSG00000213085	"Cilia and flagella associated protein 45"	Q9UL16	1	159872364-159900163	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 35.5;testis: 29.7"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 306.5;Early spermatids: 187.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 10.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 6.0;neutrophil: 4.9"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 6.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 11.2;HEL: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042204, HPA043618"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042204: AB_10966555, HPA043618: AB_10959305"	"unprognostic (1.88e-1)"	"unprognostic (4.15e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.18e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.80e-4)"	"unprognostic (2.57e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-12)"	"unprognostic (2.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.83e-3)"	"unprognostic (1.65e-1)"	0.3	0.3	2.0	0.4	7.5	0.6	0.5	0.0	0.2	2.5	0.2	11.9	0.0	0.4	1.3	10.5	0.4	35.5	0.2	0.5	3.1	2.8	0.3	0.2	6.1	0.3	0.1	0.1	7.3	0.1	0.1	0.2	3.3	12.5	0.2	0.2	0.0	0.2	0.5	0.2	0.3	0.2	0.4	0.5	0.5	0.6	29.7	3.4	0.0	0.7	0.0	0.3	0.4	0.1	0.7	0.3	6.0	0.3	0.2	0.5	0.2	2.5	0.6	0.0	0.0	0.1	0.3	11.2	1.3	1.6	2.4	1.0	1.9	3.3	1.1	0.5	0.6	1.3	1.6	0.3	0.3	1.4	0.6	0.3	14.5	0.6	0.1	0.7	1.2	0.5	1.0	0.8	2.6	0.9	3.4	1.7	0.4	1.5	0.5	0.4	3.5	0.2	1.1	0.6	2.1	1.2	0.0	1.2	0.5	0.4	0.6	1.0	0.2	1.3	3.9	0.4	3.4	3.8	0.2	2.2	1.0	3.0	2.0	2.4	1.2	0.0	0.4	5.4	0.5	0.8	0.0	0.3	6.0	0.0	0.3	0.0	0.5	0.3	0.5	0.3	0.7	0.0	0.5	4.9	0.2	0.0	0.3	0.0	0.2	2.0	7.5	0.0	0.1	3.1	2.8	0.1	0.1	12.5	3.4	0.0	3.7	0.0	0.7	0.0	0.0	0.8	0.0	306.5	54.6	5.2	0.0	1.5	0.0	1.4	187.0	2.3	0.0	0.0	2.0	6.4	0.4	0.9	3.5	0.0	0.4	0.0	0.0	1.3	1.6	33.1	2.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	1.4	0.4	0.0	0.0	0.4	19.0	2.3	0.0	0.7	0.0	0.0	1.1
CGGBP1	"CGGBP, p20-CGGBP"	ENSG00000163320	"CGG triplet repeat binding protein 1"	Q9UFW8	3	88051944-88149885	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 111.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035568, HPA037017"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035568: AB_10670022, HPA037017: AB_2675433"	"unprognostic (2.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.96e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.00e-1)"	"prognostic favorable (7.79e-4)"	29.6	23.9	26.1	27.5	28.6	38.5	80.0	33.3	36.9	28.7	28.3	19.4	23.7	23.1	30.7	23.6	23.5	24.2	23.6	33.8	23.1	21.6	28.4	30.8	29.1	39.4	24.4	26.4	37.1	25.9	40.6	33.2	26.4	21.2	27.3	26.0	23.7	25.2	24.9	30.8	19.2	30.0	29.7	28.9	33.9	25.1	22.4	22.0	76.0	32.7	16.7	37.4	27.7	30.9	24.8	19.9	41.6	23.0	20.8	25.1	19.8	8.0	13.8	23.0	16.4	20.3	18.1	7.4	16.1	14.6	17.0	20.2	10.1	11.9	17.6	10.9	14.4	13.3	6.4	18.1	12.2	21.0	26.6	10.0	26.9	12.1	9.0	18.1	17.8	19.2	16.3	12.7	18.7	24.2	21.0	17.3	20.1	12.7	18.4	19.2	12.8	26.7	12.7	12.6	13.5	11.6	17.3	21.6	12.6	12.7	12.3	4.5	15.1	13.6	7.8	38.0	16.9	11.8	21.6	16.7	20.6	15.2	111.3	16.8	13.5	16.3	19.3	15.7	17.4	17.6	41.6	21.2	39.4	23.3	21.7	22.7	22.5	20.7	23.9	19.9	24.8	25.1	20.5	39.8	20.8	23.0	17.9	23.0	19.8	26.1	28.6	33.3	36.9	23.1	21.6	24.4	26.4	21.2	22.0	47.6	40.0	45.5	57.2	47.3	33.0	39.5	35.7	16.0	46.6	38.4	15.7	48.1	56.3	34.4	15.7	65.2	42.3	23.3	36.4	51.7	55.0	57.7	45.1	49.4	36.3	63.5	40.2	61.4	45.7	28.6	64.5	53.4	38.8	34.3	30.1	61.7	41.1	34.9	47.0	52.9	30.4	64.7	68.9	82.4	49.4	43.7	70.1	69.0	31.8	57.8
CHAMP1	"C13orf8, CAMP, CHAMP, ZNF828"	ENSG00000198824	"Chromosome alignment maintaining phosphoprotein 1"	Q96JM3	13	114314335-114337626	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA006623, HPA008900"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Midbody ring"		Yes	No			Nucleoplasm	"Nuclear bodies, Midbody ring"	"HPA006623: AB_1845548, HPA008900: AB_1845547"	"unprognostic (6.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.89e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.40e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.67e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-1)"	13.7	16.8	11.8	12.7	18.5	16.5	13.3	25.2	19.8	12.4	13.3	15.9	10.9	13.7	16.7	11.7	12.6	16.7	10.7	10.3	11.6	12.2	12.7	20.6	12.3	19.9	12.5	12.4	17.8	20.8	12.8	9.5	13.5	16.6	14.5	14.3	12.4	13.2	14.7	16.1	12.6	16.4	14.2	11.4	16.8	16.3	11.6	11.9	35.0	15.2	9.8	23.1	14.3	11.2	7.9	14.5	7.0	6.8	3.7	5.7	2.5	15.4	6.7	24.9	10.5	8.9	13.9	10.7	16.4	13.8	15.6	17.5	9.9	9.4	31.9	6.7	12.8	9.8	9.9	18.1	13.1	23.3	12.3	22.3	20.9	9.7	8.7	10.1	30.4	12.5	13.6	8.2	12.3	12.1	5.5	7.5	11.1	13.2	8.8	19.9	6.1	20.2	8.9	18.7	19.0	8.8	20.3	11.7	11.0	11.8	9.6	12.1	14.4	9.4	21.4	15.5	18.1	12.3	25.7	8.2	8.6	13.8	9.1	10.0	11.3	11.5	34.7	17.1	18.0	16.4	7.0	4.0	5.2	4.7	4.6	5.7	6.8	4.3	4.5	4.5	7.9	3.5	3.9	1.0	3.7	6.8	14.5	2.8	2.5	11.8	18.5	25.2	19.8	11.6	12.2	12.5	12.4	16.6	11.9	8.9	8.1	18.2	6.1	3.0	10.9	5.3	15.3	9.4	1.2	12.2	3.9	11.4	11.6	10.4	0.8	8.6	9.6	0.0	9.9	14.5	8.3	14.3	9.3	18.8	18.9	14.3	10.4	10.4	17.7	1.0	10.9	12.0	11.8	14.4	12.5	8.1	10.8	8.0	10.6	14.0	9.6	6.5	6.2	8.8	20.5	3.3	6.6	8.2	10.4	3.0
CHCHD2	C7orf17	ENSG00000106153	"Coiled-coil-helix-coiled-coil-helix domain containing 2"	Q9Y6H1	7	56101569-56106576	"Disease related genes, Predicted intracellular proteins"	Transcription	Activator	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A-431: 224.0"	"Low region specificity"	"Detected in all"							"HPA027407, HPA052510"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027407: AB_10959659, HPA052510: AB_2681856"	"unprognostic (8.68e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.90e-5)"	"prognostic unfavorable (9.41e-5)"	"unprognostic (4.38e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-2)"	41.5	112.8	57.2	33.0	59.5	73.0	46.0	39.3	56.9	38.0	46.6	33.2	45.5	51.9	34.2	53.8	50.1	39.2	44.3	75.3	46.8	50.2	56.2	66.9	34.2	62.6	58.3	49.0	43.8	77.8	28.4	42.8	38.4	42.3	41.3	40.1	45.3	56.5	70.0	147.2	33.0	49.3	45.7	42.6	34.1	44.2	27.1	28.1	48.9	62.1	65.9	38.8	38.5	30.9	63.2	107.7	52.6	69.1	51.5	72.8	121.3	224.0	39.2	25.9	53.4	20.5	28.3	19.2	33.0	31.3	42.5	41.2	35.9	37.5	65.7	43.7	20.2	55.1	38.2	32.7	36.1	34.3	42.7	59.6	38.8	33.1	51.1	38.1	52.2	62.7	25.2	41.4	31.9	39.1	23.1	31.7	58.1	81.3	40.0	34.6	31.1	70.3	161.7	56.0	61.6	62.6	47.4	25.2	107.9	38.1	29.3	49.4	61.5	26.0	64.1	41.4	18.5	73.2	74.7	25.3	26.3	61.6	108.7	48.5	37.0	52.6	117.2	41.4	56.4	32.5	40.5	69.1	52.6	53.1	61.0	54.8	63.2	57.2	56.3	79.5	57.8	51.6	52.8	37.0	51.5	59.5	107.7	72.8	121.3	57.2	59.5	39.3	56.9	46.8	50.2	58.3	49.0	42.3	28.1	238.2	265.3	489.1	766.8	637.3	337.7	148.9	461.1	385.4	275.3	392.6	58.9	829.8	1576.7	867.5	105.9	435.3	847.1	303.7	1153.3	1054.3	581.8	939.9	386.6	693.4	849.1	465.6	519.8	355.4	420.9	153.5	568.7	575.0	723.7	764.7	720.0	545.6	1044.9	757.6	475.6	1300.4	258.3	420.4	656.7	417.0	565.7	628.8	1027.6	495.9	809.6	1069.0
CHD2	"DKFZp547I1315, DKFZp686E01200, DKFZp781D1727, FLJ38614"	ENSG00000173575	"Chromodomain helicase DNA binding protein 2"	O14647	15	92900189-93028005	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060744, HPA060960"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060744: AB_2684353, HPA060960: AB_2684398"	"unprognostic (1.65e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (2.67e-2)"	"unprognostic (7.85e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.70e-2)"	23.7	16.6	18.7	23.6	21.1	66.7	21.8	35.1	22.8	24.1	19.9	19.7	17.6	15.7	26.1	31.9	20.3	18.4	16.8	15.3	18.5	15.7	17.7	17.6	30.4	25.2	22.1	13.9	26.3	20.9	27.5	41.9	33.1	19.1	22.4	16.1	22.1	21.2	19.9	24.3	25.2	24.3	20.3	30.8	26.9	20.8	20.4	22.4	39.5	28.8	11.3	37.4	34.7	19.0	25.5	17.2	34.5	6.3	8.0	17.5	4.6	10.7	5.9	16.0	7.0	10.0	24.6	12.3	10.1	10.4	6.8	8.5	7.5	14.2	2.6	8.5	8.8	11.7	16.1	9.3	10.0	9.6	0.0	5.5	12.8	11.8	6.4	13.4	13.5	10.1	15.5	12.3	8.1	16.6	14.2	11.6	19.1	13.3	30.4	10.3	6.6	7.0	7.0	10.1	5.3	6.6	10.1	14.6	14.5	7.1	14.5	8.9	9.5	17.6	6.5	13.2	16.8	7.3	11.4	18.4	5.6	7.4	4.8	6.4	29.0	11.6	11.1	8.6	8.1	4.9	14.9	6.3	15.0	12.9	3.3	11.8	25.5	12.6	10.1	3.3	23.4	17.5	12.5	34.5	8.0	5.8	17.2	12.3	4.6	18.7	21.1	35.1	22.8	18.5	15.7	22.1	13.9	19.1	22.4	65.5	165.7	52.5	97.7	146.0	66.2	34.7	25.5	105.7	153.6	43.6	86.4	24.4	3.3	30.1	45.6	46.5	39.7	23.3	32.9	20.4	79.4	107.2	94.9	29.8	22.2	54.0	56.9	23.4	43.8	28.3	32.2	70.9	91.1	47.7	34.3	34.1	46.6	37.7	35.3	8.7	80.7	32.3	55.9	14.4	10.0	158.0	50.6	94.7	35.1	111.1
CHD4	"Mi-2b, Mi2-BETA"	ENSG00000111642	"Chromodomain helicase DNA binding protein 4"	Q14839	12	6570082-6614524	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012008	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012008: AB_1846633"	"unprognostic (6.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.40e-3)"	"unprognostic (8.99e-2)"	"unprognostic (3.36e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.82e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.66e-1)"	23.5	34.9	21.9	50.0	33.5	27.2	25.9	29.4	25.1	28.1	29.5	29.3	38.5	18.6	37.2	35.4	29.1	28.0	40.3	52.8	23.5	19.2	29.5	25.0	25.5	30.9	33.6	19.4	34.6	27.4	58.4	25.3	29.5	27.2	21.5	26.0	26.5	24.8	46.2	33.7	31.1	24.4	36.6	30.3	29.4	27.2	29.7	28.9	75.7	38.4	33.7	38.4	34.7	24.3	12.6	16.8	12.8	9.1	13.5	16.7	5.8	20.4	18.7	46.4	17.4	19.0	21.4	27.3	22.7	22.2	25.1	23.2	31.2	15.9	44.1	9.0	25.7	16.4	18.3	43.5	25.0	33.9	33.0	22.4	61.6	29.1	19.4	16.5	48.3	29.6	20.7	12.4	24.3	17.0	31.7	29.3	24.7	48.4	22.0	23.8	25.6	45.8	15.8	44.4	19.0	17.7	39.3	28.5	24.1	15.9	24.2	22.0	28.3	29.2	32.6	22.6	53.2	14.9	27.5	27.2	25.7	54.7	18.8	26.5	35.7	21.2	56.3	17.0	29.5	18.7	9.0	7.7	9.2	12.2	9.1	12.0	10.5	10.3	11.1	7.9	12.6	13.0	12.3	12.8	13.5	8.1	16.8	16.7	5.8	21.9	33.5	29.4	25.1	23.5	19.2	33.6	19.4	27.2	28.9	56.6	102.0	59.1	45.6	60.9	103.2	110.8	66.2	96.4	79.6	83.7	66.8	38.6	11.6	71.4	71.8	70.5	43.4	23.3	62.1	41.7	66.9	40.2	81.1	60.6	61.2	131.9	93.2	49.7	44.2	45.3	60.9	57.6	45.5	56.9	59.2	71.6	76.6	24.6	70.0	30.3	60.2	51.8	73.5	97.0	107.1	59.1	56.9	61.8	61.8	37.3
CHD8	"DUPLIN, HELSNF1, KIAA1564"	ENSG00000100888	"Chromodomain helicase DNA binding protein 8"	Q9HCK8	14	21385194-21456126	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Repressor"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052186, HPA076133"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052186: AB_2681754, HPA076133: "	"unprognostic (3.45e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (7.31e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (8.35e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.88e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (8.07e-3)"	13.9	14.5	13.0	14.8	21.5	34.8	17.0	28.9	25.7	15.8	14.4	26.6	14.1	11.1	18.3	13.4	17.4	15.9	11.7	12.3	13.5	13.3	14.0	11.2	15.5	18.5	15.4	15.2	20.7	19.0	34.7	25.3	15.2	20.3	16.3	14.6	19.3	15.7	14.9	16.9	24.5	16.4	17.2	13.1	19.2	16.1	15.2	18.1	29.9	17.4	10.4	24.8	16.6	14.5	12.3	7.8	12.8	7.4	8.7	8.6	3.0	16.5	21.7	24.1	11.2	15.4	13.3	13.6	13.2	15.2	20.1	20.1	18.8	14.4	27.4	8.3	17.6	15.9	20.3	29.4	18.5	25.4	20.9	13.4	24.0	14.5	22.8	14.3	33.2	22.9	17.9	15.1	22.5	16.2	15.6	17.8	21.7	16.7	14.7	15.1	17.8	23.8	13.6	18.4	16.1	18.4	22.4	18.2	9.2	14.9	30.6	17.6	16.9	20.6	16.1	11.4	22.7	11.3	16.1	20.9	16.7	12.8	9.8	15.6	16.7	19.9	27.4	6.7	12.3	16.6	12.8	4.8	12.1	7.7	5.0	8.6	5.8	6.8	7.5	3.3	12.3	7.4	6.4	11.0	8.7	7.4	7.8	5.7	3.0	13.0	21.5	28.9	25.7	13.5	13.3	15.4	15.2	20.3	18.1	35.7	52.5	15.1	10.4	11.2	32.4	18.1	20.4	36.1	43.3	31.4	25.5	12.2	1.7	19.0	1.6	18.0	11.3	23.3	20.2	10.1	9.9	12.1	26.7	12.4	15.0	22.3	26.0	14.1	20.9	2.5	15.0	13.0	10.1	19.8	16.3	19.2	21.3	14.0	16.6	6.3	22.9	0.0	13.3	26.2	22.4	14.4	10.3	22.3	14.7	11.1
CHGB	"SCG1, SgI"	ENSG00000089199	"Chromogranin B"	P05060	20	5911430-5925361	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 424.9;pituitary gland: 177.5"	"Cell type enriched"	"Detected in many"	11	"Intestinal endocrine cells: 997.5"	"Cancer enriched"	"Detected in many"	6	"pancreatic cancer: 154.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.6;T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.6"	"Group enriched"	"Detected in some"	23	"SCLC-21H: 66.7;SH-SY5Y: 102.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008759, CAB009403, HPA012602"	Enhanced	Supported	Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		24000000	Vesicles		"CAB009403: AB_2081255, HPA008759: AB_1846704, HPA012602: AB_1846706"	"unprognostic (1.79e-3)"	"unprognostic (7.72e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (7.96e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.18e-3)"	"unprognostic (7.93e-2)"	"prognostic favorable (9.96e-4)"	"unprognostic (8.56e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.81e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	3.4	424.9	8.2	1.4	10.2	0.8	1.0	82.5	16.4	0.8	3.0	2.1	1.2	7.7	0.9	1.3	0.8	2.5	0.8	7.6	20.7	15.4	1.7	0.7	1.0	1.1	7.2	9.1	3.0	17.0	0.8	177.5	0.8	51.8	5.6	2.5	0.7	0.9	1.2	2.1	0.9	4.4	0.9	2.3	0.8	19.7	2.4	0.8	0.0	1.9	0.4	0.9	0.8	0.1	0.0	0.6	0.0	0.0	0.0	2.6	0.2	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	66.7	102.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	0.6	0.0	0.1	0.4	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.2	8.2	10.2	82.5	16.4	20.7	15.4	7.2	9.1	51.8	0.8	3.0	3.7	0.0	8.2	3.8	86.9	51.2	0.0	8.1	1.2	66.3	19.6	0.0	1.7	0.4	6.1	3.4	1.7	0.0	0.3	0.0	2.3	2.3	0.0	0.0	0.1	71.5	997.5	0.0	0.3	6.0	0.9	1.5	6.8	1.8	2.8	9.3	37.4	5.8	0.4	0.1	49.6	12.9	1.4	50.2	27.7	3.1	0.2	0.0	1.4	3.0
CHIC2	BTL	ENSG00000109220	"Cysteine rich hydrophobic domain 2"	Q9UKJ5	4	54009789-54064690	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Basal keratinocytes: 309.8;Suprabasal keratinocytes: 326.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026782, HPA026784, HPA076603"	Uncertain		Enhanced	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317"	"unprognostic (4.56e-2)"	"unprognostic (2.24e-3)"	"unprognostic (3.47e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.94e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.56e-2)"	"unprognostic (9.40e-2)"	17.0	17.5	9.5	14.6	9.7	23.7	17.1	17.9	12.0	12.8	14.2	7.1	11.9	13.0	16.8	14.9	25.3	11.0	22.1	14.3	7.3	7.9	12.3	20.2	17.7	13.5	6.6	10.0	13.2	9.9	5.5	16.7	18.5	9.9	12.3	9.6	15.9	15.3	9.9	10.9	24.7	20.6	10.8	8.1	18.5	12.9	50.1	8.3	32.3	11.8	11.6	20.5	12.9	16.3	8.4	10.9	63.8	15.9	13.6	15.6	13.6	11.6	2.1	6.5	5.7	10.8	8.3	6.3	16.2	17.2	9.7	9.7	8.3	10.4	9.9	14.5	10.4	8.8	3.5	8.7	11.8	10.5	5.4	4.4	5.4	2.0	6.3	32.4	8.7	11.2	11.2	9.7	14.6	22.4	19.6	14.2	10.8	5.8	7.5	19.3	3.2	10.2	14.1	4.3	5.4	8.0	6.7	3.5	3.8	11.1	3.9	9.4	8.9	3.8	5.7	11.8	9.7	3.0	13.1	24.1	12.5	9.7	17.8	10.4	8.9	4.2	8.1	9.2	8.8	8.9	56.0	15.9	32.2	12.6	12.4	12.1	8.4	12.8	14.2	10.9	8.2	11.8	12.7	63.8	13.6	12.5	9.1	15.6	13.6	9.5	9.7	17.9	12.0	7.3	7.9	6.6	10.0	9.9	8.3	6.0	8.2	16.1	80.5	309.8	7.1	4.0	12.7	29.4	7.9	7.0	7.9	24.6	14.9	37.6	40.4	37.2	22.7	23.3	24.6	33.5	50.4	75.8	36.8	21.5	22.8	12.7	24.8	38.6	38.9	11.4	15.8	40.6	64.1	23.4	21.3	8.2	45.8	24.6	23.0	22.8	7.0	19.4	37.6	152.1	82.4	326.7	39.9	39.9	18.0	124.8
CHTF8	"CTF8, DERPC, FLJ20400"	ENSG00000168802	"Chromosome transmission fidelity factor 8"	"P0CG12, P0CG13"	16	69118010-69132584	"Predicted intracellular proteins"	"Cell cycle, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051872, HPA065522"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051872: AB_2681647, HPA065522: AB_2685503"	"unprognostic (7.86e-3)"	"unprognostic (1.99e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.46e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.86e-3)"	"unprognostic (9.88e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (3.59e-9)"	"unprognostic (3.74e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.45e-1)"	27.8	29.9	20.5	25.1	26.8	12.7	34.3	18.5	24.4	29.3	27.8	18.8	36.3	18.4	33.5	40.5	33.1	38.5	26.0	25.7	18.5	15.5	42.0	46.8	27.2	32.2	24.8	23.0	30.9	60.8	37.0	27.6	38.0	17.6	31.4	26.7	31.4	38.7	30.2	22.9	30.4	30.3	30.0	18.7	37.9	30.9	32.1	20.6	51.5	56.9	23.2	37.1	27.8	32.4	35.7	32.5	46.9	35.7	26.3	32.9	32.2	34.2	31.7	42.7	27.3	35.0	34.0	33.4	30.7	29.5	49.2	41.0	34.9	48.9	35.7	40.0	28.3	27.9	41.7	45.4	52.7	41.6	24.4	24.3	36.6	23.2	20.4	29.3	36.0	37.4	29.5	36.2	38.6	28.2	34.9	50.0	28.3	40.3	15.0	41.3	30.0	41.4	35.4	41.1	45.5	24.8	59.1	22.6	46.9	40.1	26.5	36.3	29.4	43.9	19.4	35.9	37.6	34.6	45.1	31.6	30.5	28.8	17.9	27.4	29.2	37.9	53.6	27.6	25.2	34.1	46.9	32.5	28.6	27.1	35.7	30.8	30.5	27.8	31.5	32.5	35.7	28.6	27.2	18.1	26.3	34.9	29.3	32.9	32.2	20.5	26.8	18.5	24.4	18.5	15.5	24.8	23.0	17.6	20.6	14.9	13.9	29.5	17.9	12.8	11.5	12.2	25.5	13.4	7.9	22.7	3.9	56.7	51.4	34.5	5.0	19.0	27.1	0.0	41.8	56.3	18.4	24.1	6.9	34.5	37.5	6.4	27.1	29.4	28.0	14.3	19.8	22.2	11.8	45.9	27.7	18.0	36.9	23.0	25.5	53.5	7.9	6.5	14.7	22.1	41.9	15.1	55.7	20.1	28.1	16.0
CHTOP	"C1orf77, DKFZP547E1010, FOP, SRAG"	ENSG00000160679	"Chromatin target of PRMT1"	Q9Y3Y2	1	153633982-153646306	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028647, HPA030540"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA028647: AB_10602699, HPA030540: AB_2673516"	"unprognostic (2.72e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.41e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.80e-2)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (8.65e-2)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (9.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.30e-3)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (1.58e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic favorable (2.69e-4)"	22.1	26.5	34.6	33.0	41.1	42.5	32.8	40.6	51.0	25.1	22.7	29.1	29.7	23.4	29.9	30.0	28.5	30.0	22.1	35.3	32.3	24.9	26.0	29.9	32.3	33.6	42.6	32.8	34.6	37.9	31.9	29.2	31.0	32.3	27.0	26.5	20.8	25.0	30.5	83.6	31.5	25.4	29.1	47.1	37.7	25.9	35.0	39.8	34.5	32.8	30.6	33.3	21.6	33.1	29.2	34.8	43.0	28.2	20.5	31.9	27.4	26.4	23.4	39.8	24.1	17.3	12.7	31.6	18.7	17.4	26.8	23.2	26.0	26.9	30.0	28.5	17.5	17.6	24.5	38.2	27.4	17.8	35.0	35.2	23.6	35.7	21.5	21.6	36.1	29.7	14.8	31.8	25.8	36.9	22.4	21.4	33.0	28.9	23.2	20.0	33.6	38.7	36.6	46.2	38.7	29.3	24.1	24.3	33.1	26.0	36.7	24.2	28.1	20.0	29.1	31.3	27.6	31.1	50.1	18.3	18.1	26.8	22.7	30.2	32.5	27.1	34.8	19.0	29.6	21.0	43.0	28.0	25.2	31.7	28.2	31.5	29.2	31.2	30.7	34.8	27.4	31.9	28.4	19.8	20.5	25.5	26.8	31.8	27.4	34.6	41.1	40.6	51.0	32.3	24.9	42.6	32.8	32.3	39.8	29.8	31.2	60.7	103.3	55.9	38.3	63.7	43.3	24.1	34.2	50.6	31.4	78.2	43.1	53.9	18.8	54.0	43.4	46.7	56.5	101.7	51.2	66.2	45.1	36.6	60.9	41.3	57.8	47.3	40.7	12.7	41.4	41.9	33.7	72.1	44.9	42.0	50.7	48.0	39.6	37.8	49.7	19.4	59.0	110.0	97.7	54.0	107.6	44.9	46.5	107.5
CIITA	"C2TA, MHC2TA, NLRA"	ENSG00000179583	"Class II major histocompatibility complex transactivator"	P33076	16	10866222-10943021	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 17.9;Macrophages: 36.9;monocytes: 58.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.3;REH: 40.9;U-266/70: 8.6;U-698: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016084, HPA054757"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016084: AB_627261, HPA054757: "	"unprognostic (1.45e-3)"	"unprognostic (1.38e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.92e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.33e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-2)"	8.0	5.9	4.6	47.7	7.1	4.3	6.8	1.5	5.5	6.3	3.7	10.6	4.2	10.4	8.1	10.4	4.8	5.2	8.1	4.9	4.7	3.5	8.8	2.9	15.0	27.0	9.4	1.1	2.5	3.5	1.9	4.0	1.2	6.6	5.5	4.3	5.5	13.3	4.3	2.9	4.4	17.4	3.7	15.6	25.9	6.2	1.5	7.4	12.6	6.1	5.2	67.2	6.3	6.8	27.3	19.0	6.5	11.9	0.7	0.5	1.7	0.1	0.2	0.3	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	5.6	5.1	0.8	0.0	0.9	0.9	0.0	0.0	0.1	23.3	0.3	2.9	1.1	0.6	0.0	0.5	0.4	1.0	0.0	0.1	0.0	0.9	0.0	0.3	0.3	2.0	0.1	0.3	0.2	0.4	0.1	0.2	0.1	40.9	0.3	3.6	0.0	1.7	0.9	0.1	0.9	0.3	0.9	0.3	0.5	1.7	0.3	2.1	0.3	0.6	0.2	8.6	0.6	12.1	7.7	0.5	6.9	0.2	11.9	6.5	0.3	9.5	0.1	17.9	0.1	0.5	17.7	27.3	0.1	0.2	2.8	0.7	10.0	19.0	0.4	1.7	4.6	7.1	1.5	5.5	4.7	3.5	9.4	1.1	6.6	7.4	6.0	17.9	12.3	0.3	2.1	0.6	2.8	2.5	2.7	1.2	3.5	0.0	0.1	0.0	2.5	0.6	4.2	3.4	0.0	1.7	0.2	1.0	0.3	10.4	1.0	9.1	0.0	2.4	2.5	15.6	0.0	0.6	36.9	6.8	58.7	0.7	0.4	1.7	0.0	0.0	3.3	0.9	0.0	0.9	0.0	0.0	2.5	0.1	1.0	0.4	0.3
CIZ1	"LSFR1, ZNF356"	ENSG00000148337	"CDKN1A interacting zinc finger protein 1"	Q9ULV3	9	128166064-128204383	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020380, HPA020387"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020380: , HPA020387: AB_2670425"	"unprognostic (1.28e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.49e-3)"	"unprognostic (3.13e-3)"	"unprognostic (8.05e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.47e-3)"	31.9	24.3	33.6	23.8	36.0	36.7	36.7	39.4	40.4	31.5	35.7	28.0	21.3	26.8	33.6	20.9	30.3	33.5	26.7	25.5	30.5	19.9	19.7	12.1	22.2	24.8	29.4	27.5	56.3	41.7	23.1	21.1	21.9	23.4	30.1	21.8	23.3	31.3	28.8	51.4	49.6	26.1	40.0	27.3	22.5	28.9	35.4	37.0	30.3	22.8	24.2	27.0	35.2	39.3	6.7	4.6	4.9	5.8	8.1	8.3	3.2	23.0	27.9	23.9	22.5	24.7	29.9	23.4	18.2	27.4	33.5	19.0	25.5	20.3	27.1	15.5	30.7	27.9	33.6	18.4	19.6	18.3	24.6	21.0	25.9	35.0	16.4	28.5	24.0	30.9	28.9	35.1	36.7	31.3	24.4	22.6	17.4	62.6	23.5	20.1	53.9	31.4	24.4	20.7	31.2	28.7	26.7	25.2	27.9	15.1	15.9	29.8	23.1	40.5	28.7	24.0	11.1	29.9	31.3	23.9	35.8	25.5	40.6	34.1	27.3	30.8	26.2	25.3	16.1	38.3	4.6	4.3	4.9	5.0	5.8	4.5	5.7	6.1	6.4	4.6	6.7	6.1	5.5	0.7	8.1	4.3	4.6	8.3	3.2	33.6	36.0	39.4	40.4	30.5	19.9	29.4	27.5	23.4	37.0	3.0	11.7	14.1	19.6	20.6	21.1	8.7	12.7	5.3	9.1	17.4	27.5	19.0	11.6	22.6	63.0	13.4	23.6	0.0	38.7	23.5	21.6	14.9	9.2	4.7	19.4	15.9	21.9	14.7	16.7	60.3	32.2	14.9	18.6	20.8	17.7	17.7	26.4	14.0	29.4	14.6	23.8	12.9	20.8	24.4	24.7	21.8	17.4	17.9	25.5	13.3
CKAP2	"FLJ10749, LB1, se20-10, TMAP"	ENSG00000136108	"Cytoskeleton associated protein 2"	Q8WWK9	13	52455429-52476628	"Predicted intracellular proteins"	"Apoptosis, Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 42.3;lymphoid tissue: 49.2"	"Cell type enhanced"	"Detected in many"	9	"Erythroid cells: 140.2;Spermatocytes: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA008410, HPA027821"	Enhanced		Enhanced	Microtubules,Cytosol		No	Yes			Microtubules	Cytosol	"HPA008410: AB_1846832, HPA027821: AB_10602208"	"unprognostic (1.85e-1)"	"unprognostic (2.09e-3)"	"unprognostic (2.44e-2)"	"unprognostic (4.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.03e-2)"	"prognostic unfavorable (3.26e-5)"	"unprognostic (3.38e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.60e-3)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	4.6	9.2	7.1	12.1	12.2	42.3	4.4	16.4	9.9	4.3	6.7	1.9	2.3	9.0	4.2	5.2	14.7	3.0	4.1	5.3	5.8	7.8	5.0	3.2	5.0	13.5	5.9	5.8	3.5	2.4	3.4	10.9	10.2	16.1	4.6	7.4	1.4	6.7	3.6	5.8	10.4	7.0	6.5	5.5	12.4	4.2	22.1	5.2	49.2	5.0	10.3	14.8	8.1	6.6	15.2	16.1	30.4	12.8	2.5	15.7	4.2	19.5	10.6	42.5	21.0	5.5	5.5	10.7	32.3	19.1	37.7	24.3	15.2	24.8	37.6	5.2	24.0	17.6	23.0	29.2	16.4	52.6	25.4	24.1	33.9	11.9	10.8	2.3	33.6	13.8	4.0	6.8	17.6	23.2	11.2	22.8	16.1	14.2	15.6	41.5	9.2	23.1	16.6	25.1	30.5	11.2	22.2	24.4	16.4	11.5	10.7	13.0	16.9	18.2	13.4	9.9	22.5	14.7	16.2	15.0	10.9	16.8	17.0	32.3	9.2	13.5	46.3	7.6	17.6	28.7	30.4	7.2	10.4	5.4	10.4	4.8	12.2	8.2	6.4	7.5	15.2	6.5	5.5	2.2	2.5	12.8	16.1	15.7	4.2	7.1	12.2	16.4	9.9	5.8	7.8	5.9	5.8	16.1	5.2	6.0	3.2	36.9	3.9	13.4	9.9	7.3	0.0	2.7	9.1	1.8	5.9	24.3	8.3	5.2	32.6	9.8	4.5	140.2	5.2	34.8	11.3	2.6	16.1	4.3	26.4	1.6	6.9	16.5	20.7	39.9	6.9	16.4	0.0	14.4	7.9	12.3	2.8	3.5	15.9	6.7	5.8	6.5	6.2	150.2	65.4	13.4	8.4	11.7	11.3	2.4
CLASRP	"CLASP, SFRS16, SWAP2"	ENSG00000104859	"CLK4 associating serine/arginine rich protein"	Q8N2M8	19	45039040-45070956	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA060469, HPA062455"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060469: AB_2684289, HPA062455: AB_2684770"	"unprognostic (2.99e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.76e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.69e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.36e-1)"	"prognostic favorable (1.02e-5)"	14.5	12.2	14.1	16.5	24.6	40.4	13.6	19.0	25.7	12.0	14.5	27.4	13.0	17.6	14.4	14.5	14.7	13.8	13.4	9.6	16.2	12.2	11.6	11.6	13.9	17.7	26.8	16.2	18.3	28.6	13.7	19.8	12.0	18.4	14.7	9.4	10.7	16.8	17.2	21.5	17.0	20.6	14.6	22.1	18.5	18.3	14.3	22.4	7.8	14.7	9.9	14.1	11.7	15.3	7.1	5.1	9.2	3.6	2.7	4.1	2.0	11.0	15.9	6.5	4.8	2.1	3.4	14.5	9.6	3.6	7.4	7.4	7.3	10.6	17.4	7.3	3.8	2.9	12.2	9.9	7.3	3.3	8.6	14.7	10.3	8.5	9.2	4.9	6.9	14.2	4.2	4.0	5.0	8.9	3.5	5.0	11.8	16.3	9.9	2.5	11.1	18.4	23.0	9.0	7.3	9.3	14.7	7.3	13.2	4.9	11.1	7.5	11.7	7.7	7.4	7.0	3.7	9.5	15.1	7.5	7.3	9.1	6.1	14.5	14.4	11.6	15.6	5.1	11.2	5.9	0.7	3.6	5.5	3.8	2.6	3.5	7.1	2.3	4.1	3.2	6.4	3.3	2.9	9.2	2.7	3.0	5.1	1.9	2.0	14.1	24.6	19.0	25.7	16.2	12.2	26.8	16.2	18.4	22.4	3.0	2.7	25.1	23.5	20.7	25.6	3.6	20.4	2.7	3.4	15.7	15.7	20.7	5.0	9.7	15.9	13.5	27.2	0.0	13.0	24.6	15.0	15.3	12.7	13.9	15.2	19.1	9.2	14.7	17.4	4.6	20.1	18.1	3.3	19.8	22.5	22.0	12.7	21.0	16.6	6.5	28.8	32.3	16.5	61.4	27.7	18.9	30.3	20.0	17.9	18.2
CLIP4	"FLJ21069, RSNL2"	ENSG00000115295	"CAP-Gly domain containing linker protein family member 4"	Q8N3C7	2	29097705-29189643	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 177.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043366, HPA056246"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA043366: AB_10963051, HPA056246: AB_2683078"	"unprognostic (1.97e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.47e-3)"	"unprognostic (3.64e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.82e-3)"	"unprognostic (3.62e-1)"	"unprognostic (4.32e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (3.59e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.99e-2)"	16.8	9.7	12.1	8.6	19.5	2.0	18.8	12.7	19.7	8.3	13.4	17.3	7.2	4.8	13.1	8.8	22.1	12.5	12.7	26.6	13.7	12.1	7.7	4.6	17.2	8.7	19.8	12.8	22.3	6.2	12.1	22.9	39.2	15.8	16.5	7.1	15.7	10.4	15.2	46.0	28.0	7.3	23.5	18.4	9.1	8.1	15.2	14.4	7.1	31.1	16.8	9.8	19.6	13.0	1.1	1.8	1.3	17.5	3.9	9.8	3.7	28.1	7.9	1.2	4.3	11.5	17.4	0.0	11.2	19.3	6.3	7.2	0.2	18.6	3.5	5.7	19.2	25.3	11.6	1.2	8.7	9.0	6.5	1.9	0.0	9.9	0.4	29.4	0.0	5.8	12.2	22.2	8.3	30.5	22.8	4.4	2.6	0.1	11.2	9.5	0.2	2.7	1.2	0.3	1.6	1.7	0.0	7.2	0.5	11.6	5.0	1.9	4.9	9.7	4.0	10.1	1.2	0.0	1.7	13.8	1.5	11.5	4.9	4.8	5.8	0.0	0.0	6.9	0.0	4.5	1.3	4.6	0.1	6.3	10.7	9.8	1.1	4.8	6.5	1.8	0.4	5.5	5.4	0.9	3.9	17.5	0.0	1.7	3.7	12.1	19.5	12.7	19.7	13.7	12.1	19.8	12.8	15.8	14.4	59.6	16.7	2.9	19.3	15.1	29.8	57.7	0.0	5.3	11.4	12.2	27.5	5.7	3.3	9.1	177.9	2.9	0.0	0.0	7.9	1.6	24.8	16.7	4.7	1.0	10.0	19.1	0.0	2.5	28.6	66.0	25.3	11.8	8.5	1.8	0.0	20.9	16.8	0.0	22.6	5.0	19.4	12.9	9.5	10.4	0.5	23.8	18.0	17.9	0.0	21.3
CLK2	clk2	ENSG00000176444	"CDC like kinase 2"	P49760	1	155262868-155278491	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055366, HPA059507"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA055366: AB_2682795, HPA059507: AB_2684044"	"unprognostic (2.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.84e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (2.82e-4)"	"unprognostic (2.38e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.43e-4)"	15.3	16.6	14.6	15.0	19.0	12.9	17.1	33.1	20.2	22.3	18.0	18.7	18.1	14.5	22.6	19.9	15.5	18.2	13.9	11.8	17.1	7.3	17.3	18.2	14.7	22.2	16.9	16.9	24.7	15.9	29.2	21.6	19.2	13.5	22.1	13.5	16.1	16.4	18.2	10.4	21.4	15.6	17.0	13.5	27.0	13.7	13.7	20.3	18.1	22.9	8.0	22.2	16.7	20.1	2.8	1.9	4.8	1.7	0.7	4.1	1.1	5.9	5.1	18.7	5.7	9.4	5.1	16.0	5.3	6.5	4.1	4.2	5.4	4.3	13.0	7.4	3.6	2.2	8.6	9.3	6.9	3.9	9.4	7.3	10.3	5.4	6.9	8.1	12.8	10.4	4.1	6.4	6.0	12.2	11.9	7.2	11.1	14.5	9.0	6.2	10.3	8.7	7.6	12.2	15.0	7.3	9.7	11.3	13.9	10.5	13.4	8.9	12.7	2.0	6.4	4.9	14.7	9.8	15.7	4.7	2.5	6.8	4.6	4.4	17.2	14.7	11.8	5.1	9.2	2.9	4.8	1.7	3.4	2.0	0.8	2.9	2.8	3.4	1.8	1.8	2.4	3.4	4.1	2.1	0.7	0.8	1.9	1.7	1.1	14.6	19.0	33.1	20.2	17.1	7.3	16.9	16.9	13.5	20.3	14.9	22.4	4.8	4.8	4.0	5.8	13.3	12.7	4.0	18.2	7.0	3.9	6.8	0.0	5.2	6.3	8.3	4.3	0.0	3.8	7.3	7.2	3.9	9.3	5.8	6.0	4.8	6.4	8.0	10.5	5.4	7.2	5.8	3.3	7.2	7.9	5.4	4.4	3.5	2.8	2.8	5.7	6.5	3.3	8.3	3.8	4.0	10.4	4.4	6.3	4.3
CLOCK	"bHLHe8, KAT13D, KIAA0334"	ENSG00000134852	"Clock circadian regulator"	O15516	4	55427903-55547138	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, Transcription, Transcription regulation"	"Activator, Acyltransferase, DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001867, HPA027565"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA001867: AB_1078537, HPA027565: AB_1846975"	"unprognostic (1.30e-2)"	"unprognostic (9.02e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.48e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.01e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.07e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-2)"	9.3	9.2	7.8	5.8	11.7	1.7	8.4	16.2	14.3	12.5	9.5	5.2	9.2	7.1	10.5	8.4	13.9	8.1	6.7	10.5	7.9	7.9	12.4	9.1	8.2	9.4	7.0	9.8	11.7	8.6	18.7	21.9	8.5	8.4	9.7	8.4	5.6	8.2	9.2	16.1	9.4	12.6	13.8	8.3	9.1	9.6	18.5	5.0	4.0	14.7	5.9	5.2	8.4	17.1	2.5	3.6	0.6	3.0	2.9	4.7	1.4	13.6	5.9	5.4	8.4	8.1	8.2	2.7	14.1	11.6	9.9	9.1	3.7	10.9	3.7	7.3	16.4	7.4	11.4	6.9	10.9	16.7	4.5	2.5	2.9	6.3	4.6	7.2	4.7	3.4	4.8	10.9	13.6	13.4	7.4	9.2	3.1	6.7	7.5	14.8	7.5	2.6	2.7	3.9	11.2	6.9	1.7	6.2	2.4	7.6	7.4	5.3	4.7	10.2	12.6	6.4	4.7	4.2	2.6	12.7	13.4	14.4	4.4	18.9	6.8	4.9	2.3	11.9	4.2	10.6	0.0	3.0	0.6	2.8	3.0	4.7	1.4	3.2	2.5	3.6	2.5	1.9	2.4	0.6	2.9	2.7	2.1	3.1	1.4	7.8	11.7	16.2	14.3	7.9	7.9	7.0	9.8	8.4	5.0	38.7	23.0	9.8	18.1	27.6	61.3	50.4	12.7	12.0	13.6	14.0	41.2	9.5	1.7	11.5	25.0	28.9	20.3	0.0	14.4	5.7	30.8	25.1	3.5	25.9	10.1	31.8	38.2	28.8	12.7	12.1	22.2	14.3	10.1	8.2	19.3	29.6	19.8	15.3	33.9	17.0	39.4	12.9	30.8	56.9	73.3	32.9	4.3	10.2	14.9	46.9
CLSPN		ENSG00000092853	Claspin	Q9HAW4	1	35720218-35769967	"Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 12.6;lymphoid tissue: 30.4;testis: 10.0"	"Group enriched"	"Detected in many"	5	"Extravillous trophoblasts: 33.9;Rod photoreceptor cells: 96.1;Spermatocytes: 71.5;Spermatogonia: 133.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Region enriched"	"Detected in single"	12	"basal ganglia: 7.0"	"Low region specificity"	"Detected in all"			"HPA026305, HPA026312"			Enhanced	"Nucleoplasm,Golgi apparatus"		Yes	Yes			"Nucleoplasm, Golgi apparatus"		"HPA026305: AB_2671833, HPA026312: AB_2671837"	"unprognostic (4.75e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-3)"	"unprognostic (3.54e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.18e-6)"	"unprognostic (3.99e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.63e-2)"	"unprognostic (8.71e-6)"	"unprognostic (3.23e-2)"	"unprognostic (7.61e-6)"	"prognostic favorable (4.92e-4)"	"unprognostic (5.12e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.29e-1)"	1.5	0.8	0.9	11.5	1.0	12.6	1.7	0.3	3.6	0.9	2.1	0.1	0.0	1.0	0.5	0.9	2.9	0.5	2.8	0.6	1.1	0.6	1.0	0.7	1.9	6.0	0.6	0.1	0.5	0.5	0.3	0.4	4.3	0.7	0.5	2.7	1.9	1.0	0.0	0.4	1.2	3.4	1.0	0.8	4.4	1.1	10.0	0.5	30.4	0.5	4.2	6.6	0.9	1.2	0.9	0.9	3.4	1.1	1.3	1.6	1.1	8.7	7.3	15.9	8.4	1.1	2.1	5.9	18.0	5.0	13.2	17.7	11.5	8.2	18.7	5.8	4.8	9.6	8.8	15.5	6.2	20.7	12.8	7.0	26.3	15.9	5.1	0.0	21.5	15.5	0.4	0.2	22.7	1.6	1.5	7.1	11.2	17.7	13.0	12.6	5.7	22.6	4.9	15.0	6.0	5.2	14.4	24.1	5.6	2.7	14.5	5.9	6.9	15.6	4.8	3.1	11.2	4.1	8.5	5.1	19.0	14.4	11.6	20.0	4.7	11.4	19.7	6.0	15.4	15.3	1.6	1.1	1.1	1.6	0.5	0.5	0.4	1.0	0.8	0.9	0.9	0.4	0.8	3.4	1.3	0.7	0.8	1.3	1.1	0.9	1.0	0.3	3.6	1.1	0.6	0.6	0.1	0.7	0.5	0.0	0.3	1.5	4.6	4.9	7.9	1.1	2.5	0.0	3.4	0.0	11.8	5.5	0.0	1.3	6.2	1.9	0.4	0.0	0.6	33.9	3.9	1.4	1.1	0.0	14.0	1.6	1.2	3.7	3.2	4.9	2.3	6.5	3.3	15.4	1.6	6.6	0.9	1.9	0.4	0.0	96.1	6.5	2.5	71.5	133.3	1.8	8.7	5.1	4.1	2.6
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 1086.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA		2100000	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	60.0	64.8	65.0	46.9	60.8	35.4	55.5	68.6	86.3	58.1	71.4	55.5	35.8	65.6	58.1	64.5	63.8	65.2	56.4	31.4	62.6	62.0	72.2	60.0	48.7	53.1	67.1	67.0	78.1	52.8	42.8	47.0	78.2	67.9	53.3	67.6	48.1	58.8	47.6	33.2	47.5	58.3	52.4	71.5	59.6	56.3	48.3	41.9	58.2	77.1	49.4	54.5	46.2	60.5	31.3	57.3	29.1	59.5	22.6	40.5	45.9	59.2	47.6	35.9	27.3	52.4	52.8	57.9	61.5	46.9	49.5	58.3	35.6	26.7	44.8	34.1	40.9	88.0	25.3	45.0	42.7	45.6	30.3	36.3	34.4	48.4	36.3	70.6	36.4	31.8	58.1	47.5	56.8	45.1	46.4	61.1	24.3	29.8	23.7	74.6	20.6	32.6	46.4	57.3	39.3	68.1	31.6	23.8	25.4	66.9	42.5	27.9	46.9	25.7	30.2	50.5	43.8	27.3	45.0	78.1	40.0	45.0	45.7	63.9	15.9	37.3	47.6	49.3	51.2	35.3	29.1	56.6	28.0	26.5	59.5	27.8	31.3	28.9	27.2	57.3	30.6	26.4	22.8	22.2	22.6	45.6	49.5	40.5	45.9	65.0	60.8	68.6	86.3	62.6	62.0	67.1	67.0	67.9	41.9	119.1	126.5	113.2	237.0	175.3	139.0	42.8	198.7	195.4	110.3	171.0	56.9	788.4	393.0	429.4	38.8	221.8	317.2	93.5	293.9	375.3	205.3	232.4	71.6	147.2	759.2	87.4	176.4	320.4	351.1	69.8	243.4	230.3	185.5	340.9	269.6	211.2	383.1	322.6	202.6	507.5	105.0	174.6	193.6	246.1	233.4	168.9	1086.8	114.0	299.8	286.9
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		51000000	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	39.5	45.7	47.4	35.1	57.6	30.7	57.9	59.1	83.6	38.1	45.0	25.1	47.7	27.9	38.7	52.3	32.1	30.9	34.1	39.9	47.1	53.7	48.6	46.0	46.5	60.7	53.9	59.3	29.8	23.3	96.1	30.0	51.5	57.0	38.9	48.9	22.7	28.6	54.4	44.2	30.5	27.7	45.8	47.8	28.0	34.2	29.4	28.8	28.0	43.7	26.6	31.2	37.1	40.6	10.0	24.6	13.9	24.6	12.3	15.6	13.1	47.4	71.8	35.4	35.0	59.8	48.8	40.5	51.0	53.8	45.7	47.8	44.0	29.2	33.0	58.6	72.4	50.6	31.3	52.8	42.4	61.1	35.5	28.4	54.1	45.4	68.2	45.7	37.0	31.3	46.1	26.0	69.5	44.8	36.0	50.5	16.9	53.9	46.8	71.2	84.6	21.9	11.0	30.5	43.4	41.9	19.5	59.3	40.0	51.2	67.3	31.8	37.8	31.6	20.7	30.2	47.8	49.2	23.3	64.5	83.9	50.1	40.0	52.2	36.8	51.7	30.5	61.5	25.1	51.2	10.5	20.9	13.9	12.7	24.6	15.6	10.0	11.7	13.7	24.6	9.1	10.0	11.0	13.4	12.3	20.7	16.1	14.5	13.1	47.4	57.6	59.1	83.6	47.1	53.7	53.9	59.3	57.0	28.8	92.3	94.7	38.0	37.2	56.7	86.7	68.8	86.6	72.3	81.9	73.3	56.9	86.9	23.2	67.8	20.6	66.0	118.0	93.5	84.2	40.6	77.3	84.0	65.9	162.9	151.0	81.0	115.9	156.5	173.7	53.1	68.4	90.2	50.6	62.3	109.9	47.7	89.2	73.7	88.1	105.0	55.3	77.6	61.2	51.7	37.2	69.4	90.3	33.1	108.8	72.3
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	14.4	17.4	23.1	17.3	17.7	22.4	14.6	25.0	25.0	14.5	18.0	15.5	21.3	15.0	19.5	19.4	12.6	16.9	15.0	18.8	17.6	16.1	13.9	16.6	15.2	19.2	16.0	22.7	22.6	18.4	24.4	20.2	20.6	16.9	16.3	13.1	17.1	17.6	17.9	28.9	16.6	16.5	17.6	12.5	21.7	15.9	63.9	17.8	18.4	15.7	14.1	20.7	16.2	14.8	11.1	9.8	8.1	13.2	9.7	11.5	7.8	7.0	6.7	9.7	15.8	11.0	10.1	11.8	8.4	11.7	21.5	24.1	10.1	4.7	14.7	9.6	12.4	20.2	7.9	12.3	8.7	16.5	10.1	10.9	8.1	7.8	11.2	8.5	11.6	5.5	8.7	6.5	11.8	8.5	11.3	10.0	13.7	17.9	10.8	11.2	11.5	14.7	10.4	4.8	4.7	6.4	11.7	11.5	8.4	6.9	8.6	10.7	8.1	9.5	7.3	12.1	7.3	12.4	9.0	9.2	12.9	9.7	5.1	9.4	12.4	6.4	77.6	5.1	12.2	14.1	8.1	10.2	6.4	10.1	13.2	8.5	11.1	8.9	10.7	9.8	8.1	9.9	8.0	6.6	9.7	9.9	8.2	11.5	7.8	23.1	17.7	25.0	25.0	17.6	16.1	16.0	22.7	16.9	17.8	8.9	8.6	7.3	3.4	3.2	13.3	7.9	7.6	13.4	15.9	7.0	31.4	14.0	0.0	4.0	20.1	9.0	4.2	23.3	7.4	6.2	6.4	3.4	3.5	7.4	6.6	11.1	8.1	9.2	5.9	8.3	7.2	7.5	3.3	13.6	7.5	10.1	6.4	3.5	6.3	3.5	10.9	6.5	4.9	14.4	9.9	4.1	17.4	8.7	5.4	2.8
CNDP2	"CN2, CPGL, FLJ10830, HsT2298, PEPA"	ENSG00000133313	"Carnosine dipeptidase 2"	Q96KP4	18	74495816-74523454	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 76.6;RPMI-8226: 98.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026196, HPA036898, HPA036899"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		2400000	"Nucleoplasm, Cytosol"		"CAB026196: , HPA036898: AB_2675370, HPA036899: AB_2675371"	"unprognostic (2.81e-2)"	"unprognostic (9.96e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.57e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.31e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.15e-1)"	"prognostic favorable (3.50e-6)"	"unprognostic (2.37e-3)"	"unprognostic (4.65e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.34e-1)"	19.0	11.5	31.0	19.1	36.0	6.1	16.9	10.4	33.0	39.4	37.6	45.2	27.0	51.3	12.5	35.3	20.4	38.9	25.9	11.6	31.1	26.4	89.0	66.4	22.1	23.0	36.1	24.1	11.4	27.6	15.7	13.7	28.8	27.2	34.7	22.2	14.1	16.9	32.7	7.5	11.8	71.1	10.4	39.4	39.2	27.2	6.5	32.5	10.9	43.9	11.6	21.4	28.4	12.0	29.6	49.0	12.5	44.4	31.4	23.9	30.3	10.2	13.9	10.1	9.5	12.3	7.3	42.4	10.8	10.2	14.8	14.8	8.0	11.1	13.0	13.7	11.7	11.6	15.6	15.3	20.5	10.6	19.4	6.0	12.9	7.0	12.8	18.0	25.2	20.1	11.0	15.8	12.8	23.1	8.4	12.9	15.6	13.6	76.6	9.8	11.5	13.4	12.1	15.2	6.8	8.3	14.6	11.6	98.6	58.2	43.1	11.0	5.8	8.4	60.2	14.4	25.2	25.2	10.4	13.5	15.9	13.5	3.5	7.2	14.3	58.7	17.3	10.8	18.4	13.2	7.8	30.0	12.5	21.8	44.4	23.8	28.9	17.6	20.3	49.0	29.6	19.1	20.7	4.4	31.4	43.1	43.0	23.9	30.3	31.0	36.0	10.4	33.0	31.1	26.4	36.1	24.1	27.2	32.5	68.5	54.2	53.8	35.3	8.1	33.7	22.9	91.7	60.2	38.7	113.4	15.7	128.9	159.2	142.6	2.2	45.9	105.2	0.0	136.1	106.3	20.6	56.1	11.5	102.8	184.6	41.3	62.7	36.8	86.2	3.2	17.3	82.3	16.9	112.8	71.7	80.3	99.7	74.1	15.6	371.2	24.6	12.9	15.9	4.8	7.3	8.4	91.2	36.3	82.5	47.4
CNN3		ENSG00000117519	"Calponin 3"	Q15417	1	94896949-94927278	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 9.7;naive CD4 T-cell: 11.1"	"Group enriched"	"Detected in many"	14	"B-cells: 9.7;T-cells: 11.1"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 95.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009849, HPA051237"	Enhanced		Enhanced	"Actin filaments,Cytosol"		NA	NA		320000	"Actin filaments"	Cytosol	"CAB009849: AB_2276410, HPA051237: AB_2681399"	"unprognostic (8.47e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.22e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.85e-2)"	"unprognostic (8.87e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.77e-3)"	"unprognostic (2.33e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (1.99e-4)"	49.3	78.5	53.4	27.9	53.9	1.2	82.7	25.3	44.7	55.1	36.3	30.8	20.8	45.4	74.0	31.4	53.6	39.4	55.3	33.0	46.8	40.3	74.2	50.6	59.0	28.6	45.3	27.0	61.5	28.0	21.6	33.5	88.5	67.8	38.8	30.2	47.5	32.9	48.9	16.1	16.6	33.4	68.6	78.2	30.8	30.6	21.1	41.9	9.3	44.3	18.4	17.2	48.7	74.5	9.7	0.1	0.4	0.1	0.7	11.1	2.6	44.9	8.7	49.6	43.7	35.5	31.9	22.0	21.7	43.0	36.6	58.1	40.2	4.0	0.0	50.1	28.0	36.3	12.9	36.2	19.3	53.0	0.1	12.8	2.0	6.1	30.4	66.0	0.0	0.0	29.8	3.0	45.2	10.5	64.1	32.8	2.9	0.4	4.1	95.4	0.0	2.1	0.1	38.1	0.0	4.7	0.0	59.2	0.2	47.7	18.7	3.0	30.4	18.1	7.7	30.7	38.7	13.9	4.5	20.1	24.5	42.0	9.0	70.6	5.0	2.9	0.1	5.3	0.0	36.7	0.1	0.0	0.0	1.9	0.1	3.1	3.9	2.0	1.1	0.1	9.7	11.1	7.6	0.4	0.7	0.1	0.0	0.0	2.6	53.4	53.9	25.3	43.6	46.8	40.3	45.3	27.0	67.8	41.9	140.0	65.4	13.7	201.6	69.5	9.8	33.1	81.5	65.6	75.1	120.4	19.6	195.8	369.7	231.6	114.0	306.3	50.5	23.3	214.4	29.9	297.7	266.3	13.9	115.7	19.8	1.6	69.5	399.0	29.8	108.9	254.3	14.6	187.3	8.2	41.2	367.2	119.5	39.1	359.2	359.0	12.3	258.7	319.2	10.3	37.5	68.0	172.1	10.1	89.1	330.4
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918293-103090221	"Disease related genes, Predicted membrane proteins"	"Ion transport, Transport"		"Disease mutation, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 35.6"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 30.2;Syncytiotrophoblasts: 33.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	5.7	19.8	9.5	6.6	13.8	13.3	5.0	16.8	15.1	6.0	11.8	12.5	8.0	6.9	6.6	5.8	3.3	8.9	9.4	4.1	7.8	10.9	15.6	7.9	6.4	4.1	10.4	8.6	8.8	6.8	35.6	10.6	14.3	9.6	5.0	11.2	7.7	5.2	7.1	3.0	7.2	7.7	6.9	9.3	4.1	5.4	8.0	12.7	3.3	10.0	1.9	3.0	6.2	5.4	1.3	1.3	2.8	0.8	4.5	1.1	0.4	4.7	7.8	3.1	8.2	7.9	3.2	8.4	2.3	9.4	3.1	3.8	5.5	4.2	1.8	3.5	3.3	5.9	6.3	6.6	4.4	2.3	3.1	11.6	2.6	4.3	11.1	4.6	1.8	3.6	4.2	6.4	3.1	10.5	7.8	1.9	5.4	4.5	10.6	1.7	8.0	2.1	2.1	4.9	4.6	4.9	5.2	3.9	2.2	2.4	2.8	4.4	5.7	5.6	1.4	5.9	9.3	10.1	3.5	1.5	4.2	6.3	2.9	4.0	11.6	12.8	3.3	7.4	6.3	1.7	1.9	0.8	0.7	1.0	0.8	0.8	1.3	0.7	0.5	0.6	0.7	0.8	0.7	2.8	4.5	0.4	1.3	1.1	0.4	9.5	13.8	16.8	15.1	7.8	10.9	10.4	8.6	9.6	12.7	6.0	6.7	7.5	2.1	2.2	15.8	3.5	0.0	8.1	7.9	5.2	11.8	13.9	1.7	1.8	8.4	3.8	24.6	0.0	4.8	2.7	2.9	2.2	3.5	5.4	3.3	30.2	6.4	3.1	1.5	10.4	3.1	2.7	6.8	1.0	4.2	6.5	2.7	11.5	3.2	4.4	15.7	12.9	7.8	15.0	5.4	3.6	33.3	3.1	7.4	1.8
COA3	"CCDC56, COX25, HSPC009, MITRAC12"	ENSG00000183978	"Cytochrome c oxidase assembly factor 3"	Q9Y2R0	17	42795147-42798704	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 601.8;Proximal tubular cells: 547.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031966, HPA071122"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA031966: AB_10602115, HPA071122: "	"unprognostic (1.20e-1)"	"prognostic favorable (3.40e-4)"	"unprognostic (5.65e-2)"	"prognostic favorable (8.93e-4)"	"unprognostic (7.62e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.25e-2)"	"unprognostic (8.44e-3)"	"unprognostic (1.52e-1)"	"prognostic favorable (6.62e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.01e-2)"	13.4	17.8	34.5	11.1	26.7	4.6	20.6	19.5	31.8	18.7	33.7	18.0	18.2	35.9	14.0	62.6	30.2	26.2	20.0	26.3	29.3	26.0	57.2	44.1	13.7	14.1	31.2	22.2	17.0	97.0	16.2	15.0	17.8	26.1	22.0	31.6	14.9	30.3	25.1	28.7	12.6	33.5	14.5	21.6	12.2	27.1	9.5	17.1	13.1	22.8	28.6	19.8	14.1	18.1	56.1	49.2	46.0	59.1	46.2	50.5	59.7	16.2	55.2	25.4	13.9	23.5	20.0	15.6	12.8	19.6	30.7	27.8	21.7	20.6	0.9	36.4	15.5	28.9	15.9	19.5	31.3	29.1	15.9	51.3	11.0	26.0	68.6	16.6	14.8	13.3	20.3	23.6	28.9	16.6	15.7	24.3	7.9	17.5	14.1	27.1	26.7	4.8	32.4	11.6	33.5	19.9	19.4	37.1	27.9	31.1	22.5	19.0	15.9	13.1	13.9	22.2	22.9	43.2	19.4	14.8	33.5	17.5	14.1	16.9	16.7	18.0	8.7	25.1	14.8	22.6	46.0	59.1	36.8	39.8	54.9	41.6	56.1	41.4	40.2	49.2	51.2	38.4	38.2	6.3	46.2	45.5	32.9	50.5	59.7	34.5	26.7	19.5	31.8	29.3	26.0	31.2	22.2	26.1	17.1	26.8	53.5	65.9	51.4	32.6	33.1	216.0	178.3	105.7	47.8	253.0	19.6	126.9	601.8	110.3	8.4	56.1	184.6	0.0	208.4	149.1	56.0	56.9	34.6	366.5	106.3	42.9	76.7	73.6	73.2	15.0	51.8	46.4	84.4	81.2	165.8	62.7	139.6	178.9	42.5	547.1	26.6	38.8	61.8	48.1	47.3	48.6	85.5	37.4	224.0	60.3
COG3	SEC34	ENSG00000136152	"Component of oligomeric golgi complex 3"	Q96JB2	13	45464898-45536630	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040353, HPA054470"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA040353: AB_10794027, HPA054470: AB_2732585"	"unprognostic (1.75e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.75e-1)"	"unprognostic (4.04e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.18e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.51e-2)"	"prognostic unfavorable (9.53e-4)"	"unprognostic (5.82e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.71e-1)"	12.5	17.4	8.7	17.1	14.0	10.9	17.0	19.7	14.5	16.9	17.1	13.0	22.4	13.2	16.9	20.6	14.4	14.0	12.8	12.5	8.9	9.4	16.5	46.2	12.1	11.7	9.3	10.0	17.9	29.4	10.9	22.6	32.9	11.5	20.9	20.7	12.9	28.3	25.2	12.5	14.7	18.8	13.3	10.1	14.8	15.6	9.9	11.2	17.4	18.5	8.7	18.5	14.8	14.8	5.1	7.2	7.4	4.6	4.9	8.0	3.8	5.4	4.9	9.5	8.6	12.6	14.5	9.1	9.1	13.0	10.6	8.9	7.2	10.1	7.5	4.1	10.8	7.9	12.0	7.8	9.2	16.2	5.8	6.4	8.4	6.0	12.6	15.6	12.3	8.1	10.8	13.9	7.0	25.1	12.9	10.3	7.4	5.4	4.6	12.7	8.4	6.8	11.6	7.8	27.4	6.0	8.0	5.6	7.0	9.9	8.9	4.7	8.6	5.9	11.6	12.1	9.4	7.9	12.8	9.6	5.1	4.0	9.5	5.8	6.5	3.5	7.8	9.8	6.2	9.1	7.4	4.1	7.3	7.5	4.6	8.0	5.1	5.8	6.4	3.1	4.9	6.6	6.1	3.7	4.9	2.9	7.2	6.2	3.8	8.7	14.0	19.7	14.5	8.9	9.4	9.3	10.0	11.5	11.2	8.9	31.8	15.2	12.2	14.1	9.4	16.9	20.4	9.4	23.9	12.2	13.7	12.4	13.3	9.4	12.9	12.1	27.1	23.3	32.9	15.5	10.8	25.6	16.2	73.3	9.8	9.5	21.4	20.3	20.8	7.4	13.0	14.6	10.1	6.4	43.3	5.2	18.0	34.5	12.7	11.9	10.4	6.5	9.9	11.5	6.6	14.1	27.5	17.5	21.4	19.0
COG5	"GOLTC1, GTC90"	ENSG00000164597	"Component of oligomeric golgi complex 5"	Q9UP83	7	107201555-107564514	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020300, HPA041583"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA020300: AB_2081406, HPA041583: AB_2677564"	"unprognostic (3.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.41e-1)"	"unprognostic (3.11e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.40e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.91e-3)"	"unprognostic (8.73e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (1.15e-1)"	17.2	15.8	15.2	13.7	14.9	16.5	13.9	16.1	17.7	24.8	12.1	15.0	18.3	8.8	28.4	14.0	16.4	10.9	20.3	25.7	13.3	10.3	12.7	8.9	12.9	9.5	14.7	12.5	16.7	18.9	40.3	28.4	14.4	13.4	25.6	14.1	10.5	34.0	20.6	16.5	15.8	12.5	23.8	17.5	10.8	13.1	12.6	15.3	14.0	26.3	11.5	17.3	13.9	21.4	9.8	8.6	10.1	12.9	7.0	12.3	8.9	16.2	7.5	6.8	2.6	2.0	1.8	6.7	12.0	14.3	6.4	10.2	4.8	7.5	2.3	4.6	11.8	14.7	8.4	2.8	2.1	9.3	11.3	2.1	1.8	3.1	8.0	1.5	4.6	10.7	6.1	1.1	12.5	14.0	12.2	18.4	4.6	5.2	8.9	12.3	8.0	4.8	0.0	0.9	16.0	8.1	2.1	3.0	4.2	5.5	7.8	1.5	10.1	4.1	12.4	13.1	8.5	1.2	3.0	20.9	3.9	6.6	19.9	7.0	2.9	6.7	5.0	10.5	6.4	19.0	9.9	10.8	10.1	9.6	12.5	12.3	9.8	12.0	10.3	8.6	8.2	10.2	10.1	5.1	7.0	12.9	5.5	9.5	8.9	15.2	14.9	16.1	17.7	13.3	10.3	14.7	12.5	13.4	15.3	3.0	13.3	7.0	10.2	10.9	20.8	22.6	5.1	12.0	12.5	14.0	31.4	8.8	1.7	9.2	12.8	11.7	13.0	0.0	9.5	6.7	12.2	18.0	3.5	4.9	10.2	11.1	9.9	7.4	11.0	17.5	10.9	12.3	11.8	10.8	14.9	7.8	8.4	10.5	11.7	5.4	17.5	25.8	6.2	14.0	13.2	11.7	8.8	13.8	12.5	12.3
COL4A3BP	"CERT, GPBP, STARD11"	ENSG00000113163	"Collagen type IV alpha 3 binding protein"	Q9Y5P4	5	75356345-75512138	"Disease related genes, Predicted intracellular proteins"	"Lipid transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 52.0;WM-115: 45.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035645, HPA042608"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035645: AB_10600700, HPA042608: AB_2678075"	"unprognostic (2.45e-1)"	"unprognostic (7.16e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.29e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.24e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.91e-1)"	30.0	25.5	16.5	17.1	21.9	17.9	21.4	34.4	21.2	26.9	19.9	14.9	21.5	13.5	20.5	11.6	21.9	17.1	17.4	14.9	15.2	16.3	21.1	22.7	19.6	13.4	22.5	12.4	17.9	12.4	24.6	25.9	17.8	18.2	19.0	14.6	14.8	17.5	16.1	33.4	14.2	19.3	18.9	16.6	17.2	17.0	21.3	20.7	17.8	37.4	14.3	15.9	21.8	19.1	6.4	9.8	20.9	16.6	5.1	8.8	5.7	16.6	8.6	8.3	7.2	52.0	14.5	11.1	9.4	11.6	7.2	9.6	12.9	9.6	8.1	20.3	9.9	10.0	10.1	12.6	12.9	11.1	9.9	5.8	6.7	9.5	6.8	13.2	6.6	7.8	10.9	9.2	8.5	9.7	11.8	8.3	10.7	12.1	12.2	9.5	8.8	7.9	5.0	10.7	3.8	6.4	6.7	11.0	7.4	11.8	20.2	6.4	6.4	11.8	8.3	11.6	18.3	8.1	11.4	11.3	4.9	5.9	8.8	7.7	11.3	14.9	9.4	8.5	11.4	45.0	5.0	13.9	10.6	6.0	15.6	5.6	6.0	6.2	5.6	9.8	6.4	5.9	5.8	20.9	5.1	16.6	5.7	8.8	5.7	16.5	21.9	34.4	21.2	15.2	16.3	22.5	12.4	18.2	20.7	56.6	58.5	6.4	28.0	16.7	30.7	32.7	22.9	71.0	75.1	17.4	21.6	13.6	18.3	19.6	83.3	28.1	19.2	0.0	19.2	13.9	20.9	36.3	47.5	17.9	31.6	41.3	26.4	55.9	33.0	73.0	32.2	37.4	49.0	19.8	15.6	31.1	21.5	13.1	39.3	22.3	33.1	19.4	19.6	41.5	31.5	23.3	23.2	21.3	14.3	38.3
COMT		ENSG00000093010	Catechol-O-methyltransferase	P21964	22	19941607-19969975	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	"Methyltransferase, Transferase"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 139.3"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 779.9;Syncytiotrophoblasts: 542.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 118.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001169, CAB011233"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"		NA	NA		560000	Vesicles	"Endoplasmic reticulum"	"CAB011233: , HPA001169: AB_1078402"	"unprognostic (5.20e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.08e-2)"	"prognostic favorable (3.68e-4)"	"unprognostic (2.99e-2)"	"unprognostic (2.32e-3)"	"unprognostic (5.54e-3)"	"unprognostic (9.14e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.14e-3)"	"prognostic favorable (5.67e-4)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.27e-1)"	"unprognostic (7.09e-2)"	"unprognostic (3.97e-1)"	"unprognostic (1.07e-2)"	18.6	49.0	29.4	14.3	28.8	24.3	27.8	19.6	32.9	22.4	23.4	42.4	36.1	21.0	19.8	33.8	58.1	19.4	36.8	28.1	28.9	22.3	31.1	139.3	30.9	17.0	29.0	18.4	36.3	27.2	14.1	12.7	59.0	23.3	25.7	8.9	24.9	67.3	30.9	21.5	27.7	28.6	15.5	41.0	17.8	24.8	18.2	23.7	11.5	19.2	44.0	32.0	36.3	28.0	11.2	55.1	10.9	60.0	12.9	15.6	28.0	19.1	19.7	2.3	19.5	22.2	19.8	0.8	21.8	27.4	18.7	21.4	16.7	22.4	7.7	9.7	31.1	7.4	26.3	3.7	23.3	5.0	16.7	24.9	13.8	10.5	39.0	41.5	23.0	5.5	25.2	28.9	16.2	16.1	18.0	17.5	12.5	55.7	16.5	15.0	118.8	9.0	41.3	4.8	52.7	6.7	13.6	19.5	10.6	19.7	60.8	9.5	8.4	7.2	61.7	18.0	1.3	13.3	64.7	20.9	33.4	12.8	10.9	16.3	6.1	2.6	6.3	36.0	31.0	23.0	10.2	60.0	10.9	15.6	39.9	12.8	11.2	10.8	12.6	47.7	10.7	9.6	10.6	2.4	12.9	26.6	55.1	13.3	28.0	29.4	28.8	19.6	32.9	28.9	22.3	29.0	18.4	23.3	23.7	116.1	64.8	45.5	189.7	90.7	68.3	29.9	109.5	88.3	85.3	144.8	9.8	779.9	271.9	173.4	3.6	68.7	98.5	0.0	167.1	75.3	99.4	123.4	70.4	231.9	281.1	23.8	81.1	74.9	149.0	7.4	124.3	142.1	227.7	154.1	89.3	151.7	163.3	110.1	169.0	60.7	34.5	135.8	91.5	4.4	5.3	107.9	542.4	36.6	110.1	180.5
COPB1	COPB	ENSG00000129083	"Coatomer protein complex subunit beta 1"	P53618	11	14443440-14500027	"Plasma proteins, Predicted intracellular proteins"	"ER-Golgi transport, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012338, HPA043954, HPA064403"	Supported		Enhanced	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		400000	"Golgi apparatus, Vesicles, Cytosol"		"CAB012338: AB_726922, HPA043954: AB_2678746, HPA064403: AB_2685258"	"unprognostic (2.35e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (6.91e-4)"	"prognostic unfavorable (5.63e-7)"	"unprognostic (4.69e-3)"	"unprognostic (3.42e-2)"	"unprognostic (3.60e-1)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (8.94e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-2)"	30.9	33.0	18.4	23.5	20.8	31.2	55.4	23.7	23.6	32.5	26.6	15.5	42.0	25.9	32.2	33.0	32.2	28.3	25.1	34.8	18.9	16.8	37.6	56.6	38.4	53.9	22.6	15.5	31.3	52.2	40.1	43.5	52.3	22.2	31.9	31.3	17.2	43.4	41.7	21.9	24.7	33.1	39.7	26.1	29.8	30.2	21.7	20.6	46.0	37.7	26.7	28.0	28.2	27.3	26.7	33.9	27.9	30.4	28.0	39.6	24.8	31.6	27.2	29.1	21.8	48.6	56.4	23.5	48.0	50.4	42.8	50.4	21.0	49.3	30.8	21.6	60.6	40.7	34.9	32.7	32.2	53.0	28.8	27.2	32.7	19.5	31.9	43.2	30.0	33.3	39.3	42.5	28.6	54.3	39.4	44.7	17.3	24.2	25.3	53.9	23.8	27.2	18.5	15.1	38.7	29.5	22.3	40.1	20.9	38.6	29.3	18.7	20.0	37.2	30.1	24.6	35.1	27.3	26.2	45.4	41.2	21.3	44.4	26.1	13.6	22.9	33.9	31.1	18.8	38.4	27.3	24.9	27.9	32.2	30.4	39.6	26.7	27.5	32.9	33.9	22.6	27.6	28.6	20.5	28.0	30.3	20.4	29.3	24.8	18.4	20.8	23.7	23.6	18.9	16.8	22.6	15.5	22.2	20.6	101.3	47.9	37.9	48.3	34.6	27.2	25.8	35.7	141.8	100.1	41.8	25.5	57.0	34.9	66.2	10.9	46.0	51.5	46.7	71.3	60.9	51.3	55.0	62.5	55.0	54.4	17.5	42.1	54.6	45.5	9.5	47.2	47.5	20.3	64.9	78.6	33.3	79.8	38.6	51.9	43.9	26.9	51.8	41.8	89.3	61.5	31.2	97.8	51.7	43.2	51.2
COPE	epsilon-COP	ENSG00000105669	"Coatomer protein complex subunit epsilon"	O14579	19	18899514-18919397	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB034345, HPA041605, HPA043576"	Supported		Enhanced	"Golgi apparatus"		NA	NA		210000	"Golgi apparatus"		"CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563"	"unprognostic (1.48e-1)"	"prognostic favorable (2.41e-4)"	"unprognostic (1.15e-1)"	"unprognostic (5.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.75e-2)"	29.8	44.6	44.7	43.1	48.1	72.4	25.8	25.8	56.3	36.2	37.8	47.7	32.5	48.1	29.5	32.6	40.9	30.7	32.4	40.0	40.5	39.5	48.4	113.3	30.2	42.7	46.1	36.3	30.6	62.4	23.5	44.8	45.9	39.5	34.3	20.7	33.8	75.5	38.8	35.3	30.8	46.3	23.0	44.5	41.8	41.0	41.8	33.3	65.5	52.3	30.8	45.3	31.7	27.4	57.6	98.3	90.3	89.8	48.0	64.5	112.2	31.0	30.2	17.3	30.7	15.8	18.8	50.1	27.2	26.2	30.6	35.0	36.3	25.4	25.3	37.0	22.9	19.8	21.0	14.3	27.5	6.0	15.7	63.6	15.0	27.2	54.9	42.2	29.8	38.7	22.9	26.0	18.5	20.4	16.3	24.0	29.3	23.0	65.1	15.4	73.8	32.4	56.7	32.7	40.8	72.4	37.2	15.6	74.3	19.8	31.4	24.3	38.9	17.0	27.7	29.5	8.3	23.3	49.1	24.0	19.5	14.4	49.3	28.7	62.6	54.5	30.9	33.3	51.9	32.2	84.3	89.8	90.3	53.8	77.3	47.3	57.6	51.7	47.1	78.9	51.2	38.7	44.1	89.5	48.0	64.4	98.3	64.5	112.2	44.7	48.1	25.8	56.3	40.5	39.5	46.1	36.3	39.5	33.3	3.0	18.1	183.1	156.2	142.0	47.3	8.0	104.4	18.7	13.6	109.9	27.5	330.4	393.0	279.1	142.0	115.5	396.1	46.7	322.0	362.9	175.8	233.8	103.6	138.4	395.5	54.0	161.7	108.6	191.9	269.0	134.0	267.7	232.8	472.5	210.2	212.1	288.5	259.6	125.2	313.0	51.1	122.9	135.9	176.4	227.6	171.9	453.4	205.0	211.1	224.0
COPS5	"CSN5, JAB1, MOV-34, SGN5"	ENSG00000121022	"COP9 signalosome subunit 5"	Q92905	8	67043079-67083783	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 275.9;Late spermatids: 320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004242, HPA004845, HPA051531"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB004242: AB_627835, HPA004845: AB_1078557, HPA051531: AB_2681522"	"unprognostic (1.90e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.85e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.15e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.88e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-2)"	20.2	26.3	29.4	19.6	28.6	16.2	28.1	28.5	40.3	18.0	21.7	15.6	20.2	22.0	17.6	21.7	24.0	17.7	15.5	46.8	27.6	27.5	27.4	33.7	16.8	17.5	31.8	29.9	17.0	20.7	23.3	21.7	24.3	33.7	18.3	25.5	9.9	19.6	18.9	64.0	16.8	22.5	23.3	39.2	16.1	20.7	27.4	31.3	19.6	18.5	29.2	22.4	18.3	16.5	20.7	35.1	33.7	30.0	26.5	28.1	22.3	28.8	27.4	23.3	21.3	24.5	26.2	18.5	25.4	20.9	35.3	31.9	17.7	35.6	26.8	11.7	26.2	25.5	24.2	31.2	28.0	39.0	25.7	26.9	38.1	27.5	23.8	23.8	24.0	23.1	23.8	36.0	28.8	37.2	27.3	34.4	28.3	45.0	18.6	31.6	26.8	42.3	42.2	30.9	60.8	31.5	27.2	16.6	21.1	37.4	25.7	14.1	19.5	14.6	28.3	24.6	21.5	46.6	24.8	25.4	18.0	22.2	21.7	19.9	23.4	29.8	35.7	26.2	27.4	24.5	26.0	28.6	33.7	20.8	30.0	21.7	20.7	20.1	23.1	35.1	17.5	21.6	19.1	21.2	26.5	28.3	18.4	28.1	22.3	29.4	28.6	28.5	40.3	27.6	27.5	31.8	29.9	33.7	31.3	20.8	21.3	38.7	36.8	43.8	32.5	99.1	43.3	26.8	29.6	29.6	31.4	115.4	74.6	65.8	275.9	33.7	37.6	0.0	52.3	84.4	39.7	44.8	34.7	33.9	69.9	23.8	32.8	31.9	28.8	320.8	40.0	37.7	27.0	55.9	34.2	45.4	48.3	45.6	48.1	56.1	44.9	32.3	31.6	126.7	59.2	41.5	106.9	39.5	48.7	48.1
COQ8B	"ADCK4, COQ8, FLJ12229"	ENSG00000123815	"Coenzyme Q8B"	Q96D53	19	40691529-40718207	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 11.9;Ciliated cells: 16.0;Collecting duct cells: 12.2;Ductal cells: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027229, HPA027277, HPA027279, HPA028303"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA027229: AB_10600100, HPA027277: AB_10599857, HPA027279: AB_10601219, HPA028303: AB_2672551"	"unprognostic (7.57e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.65e-2)"	13.6	17.8	21.1	13.1	16.4	11.5	10.0	24.1	19.2	13.6	13.6	18.6	14.8	17.9	15.0	13.2	16.6	26.5	16.7	14.7	15.7	10.7	11.8	15.6	12.1	12.2	15.5	12.1	16.3	19.4	12.6	32.7	7.9	13.2	15.1	5.7	12.3	16.8	17.6	10.3	12.9	18.6	16.2	15.6	12.1	17.5	12.5	16.7	16.8	15.5	6.9	13.2	14.8	11.8	12.9	15.0	17.7	15.6	9.7	13.1	10.5	8.3	34.3	7.0	13.5	6.3	6.1	6.5	7.8	8.5	5.9	6.3	10.7	15.2	11.2	15.1	4.5	7.0	7.3	4.9	8.7	2.1	13.4	10.2	10.7	20.9	5.9	10.8	3.7	16.8	8.0	9.3	4.3	5.2	6.7	6.6	13.9	5.7	6.2	4.1	5.1	4.8	4.5	5.4	9.2	3.6	8.0	9.9	8.5	10.2	14.2	12.6	10.3	10.5	16.1	16.9	4.5	14.4	14.0	6.2	5.1	17.3	3.6	4.6	6.8	5.5	5.7	19.3	4.2	7.0	15.8	15.6	14.6	11.6	15.4	13.1	12.9	9.0	12.4	15.0	11.7	8.9	9.1	17.7	9.7	13.7	8.7	8.8	10.5	21.1	16.4	24.1	19.2	15.7	10.7	15.5	12.1	13.2	16.7	11.9	4.6	0.0	0.0	0.0	0.0	0.0	0.0	16.0	4.5	12.2	0.0	9.4	10.0	12.4	0.0	0.0	0.0	0.0	9.5	7.9	0.0	0.0	1.1	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	10.4	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0
COX20	"FAM36A, FLJ43269"	ENSG00000203667	"COX20, cytochrome c oxidase assembly factor"	Q5RI15	1	244835322-244845057	"Disease related genes, Predicted membrane proteins"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043617, HPA045490"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043617: AB_10965694, HPA045490: AB_10962869"	"unprognostic (5.84e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.03e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.02e-3)"	13.1	37.9	30.2	17.5	28.9	12.5	14.9	22.0	25.8	11.8	20.5	11.8	9.3	18.2	17.5	16.9	20.6	11.4	16.2	35.4	22.8	27.7	36.7	23.6	11.1	13.4	32.1	18.3	26.7	15.1	14.3	15.1	15.0	19.2	20.2	11.8	27.9	11.3	15.5	33.3	8.1	19.4	42.5	22.0	10.1	17.9	21.1	17.0	10.4	17.5	20.2	10.7	23.0	16.5	18.2	16.3	11.6	18.4	12.2	22.5	10.5	36.7	9.2	9.3	29.0	6.4	4.8	21.9	15.5	10.3	8.9	8.0	26.2	25.7	5.6	19.7	10.4	17.3	9.6	4.9	12.4	12.0	15.6	3.4	10.8	13.5	24.1	8.6	26.4	16.6	4.3	6.0	13.1	9.2	12.8	10.1	6.3	22.2	23.3	18.3	9.1	14.2	11.8	24.6	26.6	19.2	10.5	11.5	34.0	16.5	8.7	5.4	14.9	19.4	10.2	20.1	9.8	18.9	7.6	19.6	19.8	26.0	17.2	33.2	37.0	50.7	11.9	25.2	29.5	18.9	5.7	8.8	11.6	15.4	18.4	15.1	18.2	18.3	16.8	15.0	16.0	11.0	16.9	1.7	12.2	17.8	16.3	22.5	10.5	30.2	28.9	22.0	25.8	22.8	27.7	32.1	18.3	19.2	17.0	17.9	46.2	77.5	98.6	75.7	105.2	57.3	178.3	52.2	58.0	181.5	43.2	203.1	351.5	126.1	26.1	56.2	109.3	93.5	164.5	133.4	54.1	70.8	70.6	249.2	109.9	84.2	59.4	39.3	60.1	57.2	64.5	84.0	69.2	129.8	72.2	94.2	142.7	87.5	75.3	253.1	99.4	64.7	95.9	66.9	97.5	66.0	221.2	70.2	105.2	80.4
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.9	23.3	14.4	23.9	17.0	15.5	62.3	25.7	14.4	17.1	19.1	64.4	20.9	33.7	55.3	16.4	27.0	30.5	16.6	25.8	7.8	26.2	70.6	45.4	25.8	76.9	32.7	43.0	33.3	28.7	22.9	16.4	12.8	17.5	14.6	27.0	33.3	14.9	13.2	49.4	27.1	62.4	28.4	34.1	122.6	26.7	24.8	50.4	23.0	30.7	28.6	30.6	25.0	30.2	48.2	20.0	16.1	45.1	26.5	15.6	26.6	25.0	16.5	38.9	36.8	25.7	28.3	37.0	16.1	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0	205.4	224.6	375.1	495.2	343.3	204.5	3263.7	647.1	369.4	268.4	759.0	214.0	640.2	3068.8	479.5	156.4	370.1	2132.4	140.2	527.3	778.4	340.5	424.2	320.2	1125.6	767.8	133.5	711.5	338.8	489.5	270.1	325.7	488.5	865.4	798.1	1204.0	259.4	460.5	1508.0	286.4	1849.4	303.9	439.8	473.4	213.2	290.0	419.6	512.8	265.9	1320.1	744.1
COX7A2L	"COX7AR, COX7RP, EB1, SIG81"	ENSG00000115944	"Cytochrome c oxidase subunit 7A2 like"	O14548	2	42333546-42425088	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059124, CAB073545"			Enhanced	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB073545: , HPA059124: AB_2683912"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.27e-2)"	"prognostic unfavorable (4.13e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.43e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.02e-1)"	25.1	73.3	47.3	24.4	63.3	47.7	45.4	35.2	58.2	33.4	33.8	21.0	28.8	31.7	30.2	37.9	20.9	31.2	27.1	49.8	40.4	45.3	50.9	48.9	24.0	28.1	42.6	35.6	49.8	49.3	24.9	42.7	24.0	34.9	29.5	36.2	32.3	37.0	30.3	24.4	21.5	32.1	28.4	33.1	23.1	29.4	24.8	20.5	28.0	35.8	35.8	30.9	24.5	31.1	45.1	59.7	57.2	48.7	40.5	53.7	100.9	38.3	24.6	27.3	29.6	46.9	66.9	32.7	31.8	46.5	29.1	37.2	26.9	27.8	34.0	31.9	36.4	37.3	17.2	32.5	33.7	42.6	52.2	25.0	23.0	17.6	47.7	55.3	34.5	25.6	65.6	67.9	28.4	68.8	42.2	40.9	26.7	33.4	58.4	45.0	31.2	41.1	57.4	26.8	45.4	25.6	22.5	47.4	28.8	41.6	31.1	32.5	37.1	13.3	33.6	91.2	31.7	24.1	40.3	30.8	26.4	34.6	31.9	31.0	48.0	53.6	25.5	37.4	37.5	22.4	57.2	48.7	27.2	39.0	42.0	50.0	45.1	47.9	45.3	53.1	37.6	53.7	46.1	21.6	40.5	46.3	59.7	52.8	100.9	47.3	63.3	35.2	58.2	40.4	45.3	42.6	35.6	34.9	20.5	29.8	61.2	171.1	166.3	235.9	115.5	140.5	132.5	96.4	51.2	141.3	35.3	190.2	547.2	206.3	15.8	157.6	103.8	23.3	199.6	263.9	167.1	184.8	86.4	193.0	204.8	123.9	277.2	113.5	243.6	17.7	149.8	177.9	209.2	287.7	202.3	182.8	197.6	161.4	149.2	386.1	95.5	109.9	206.0	195.8	267.6	214.7	275.6	186.4	235.2	168.4
CPOX	"CPO, CPX, HCP"	ENSG00000080819	"Coproporphyrinogen oxidase"	P36551	3	98521132-98593723	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Heme biosynthesis, Porphyrin biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Cell type enhanced"	"Detected in many"	13	"Erythroid cells: 140.2;Extravillous trophoblasts: 67.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015736, HPA054448"			Enhanced	Mitochondria		No	No		140000	Mitochondria		"HPA015736: AB_1847194, HPA054448: AB_2682490"	"unprognostic (2.14e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.34e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.62e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.57e-1)"	6.6	8.9	12.6	9.0	29.9	30.2	6.6	10.1	21.1	7.5	8.2	29.6	5.7	17.7	8.8	6.4	14.1	6.4	7.2	6.9	17.5	11.7	5.6	29.3	6.3	9.1	42.9	16.2	9.5	6.9	9.9	5.5	14.8	23.7	7.4	10.3	3.4	7.2	7.2	8.5	10.8	12.3	7.7	32.8	9.1	7.7	3.9	36.0	7.7	6.2	7.0	9.8	8.5	10.4	1.7	1.7	0.0	2.1	2.1	3.0	0.7	16.6	8.1	7.2	12.7	13.5	10.0	20.7	10.8	7.8	11.1	12.7	13.4	5.2	1.7	12.1	5.7	12.3	12.1	8.9	11.6	19.0	5.3	7.8	58.1	4.6	17.3	6.9	12.2	13.8	7.8	9.8	10.5	4.4	13.1	10.6	7.2	11.1	7.5	10.4	5.1	12.3	10.5	8.5	9.3	14.8	8.8	16.4	7.7	9.4	6.9	4.8	4.7	11.4	3.9	32.3	8.4	6.1	7.9	8.8	16.6	16.3	9.5	7.8	11.6	9.1	9.4	16.5	13.5	12.1	0.0	2.1	0.0	1.4	1.0	2.5	1.7	2.4	2.9	1.7	1.5	0.8	3.0	0.0	2.1	0.7	1.1	1.1	0.7	12.6	29.9	10.1	21.1	17.5	11.7	42.9	16.2	23.7	36.0	3.0	8.3	6.9	4.0	6.5	3.4	7.1	2.5	1.4	0.0	3.5	7.9	21.7	1.7	3.0	0.0	5.8	6.4	140.2	1.6	67.8	9.9	4.4	1.1	30.1	11.2	0.0	8.1	11.6	10.8	0.0	6.9	8.9	11.8	10.8	8.6	6.0	2.8	0.0	7.4	5.1	5.3	12.9	9.0	0.0	3.2	8.9	8.9	10.7	9.7	3.7
CPSF1	CPSF160	ENSG00000071894	"Cleavage and polyadenylation specific factor 1"	Q10570	8	144393229-144409349	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065167, HPA068906"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA065167: AB_2685426, HPA068906: AB_2686055"	"unprognostic (6.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (1.05e-1)"	"unprognostic (2.00e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (6.54e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.90e-2)"	"unprognostic (9.66e-3)"	11.9	13.5	13.4	18.6	17.2	27.0	14.3	28.5	18.0	11.7	15.1	16.3	14.9	40.7	17.8	8.9	13.0	16.2	14.3	10.3	13.0	8.2	13.0	15.0	13.7	17.4	16.6	11.5	19.8	22.4	7.3	21.6	11.1	15.4	18.4	7.6	14.9	26.9	13.8	14.7	25.2	29.8	11.7	11.0	21.2	16.3	27.9	16.1	27.1	17.7	10.6	16.0	13.1	13.4	7.5	8.8	4.9	9.3	5.7	10.0	5.8	9.4	13.3	12.1	12.6	6.5	5.2	11.9	8.9	5.6	7.3	7.6	13.4	12.2	10.9	8.7	6.6	4.9	8.6	6.8	7.5	2.0	9.8	19.7	21.4	14.9	21.4	5.5	8.1	13.3	5.7	3.2	6.7	3.9	4.4	9.7	18.2	17.9	9.3	3.6	40.3	21.2	17.1	7.3	7.9	18.8	15.3	4.9	8.7	7.7	14.0	9.9	9.8	11.5	7.2	6.5	3.6	12.7	9.1	8.3	5.0	19.4	11.0	9.8	5.6	4.4	10.3	6.8	13.8	5.9	4.9	7.8	4.9	8.0	9.3	8.4	6.9	8.5	8.4	8.8	7.5	7.5	7.1	1.5	5.7	8.6	4.1	10.0	5.8	13.4	17.2	28.5	18.0	13.0	8.2	16.6	11.5	15.4	16.1	14.9	22.7	3.0	3.6	9.0	10.3	8.3	15.3	8.1	11.4	8.7	11.8	8.9	1.7	7.8	15.6	11.1	19.5	0.0	9.9	9.4	9.3	3.4	13.9	7.2	13.0	7.9	12.6	9.2	8.3	30.3	13.0	13.0	13.5	8.2	23.9	4.3	9.8	11.5	15.2	4.6	13.8	6.5	8.0	24.2	22.0	10.8	6.1	10.4	24.2	3.3
CPSF6	"CFIM, CFIM68, CFIM72, HPBRII-4, HPBRII-7"	ENSG00000111605	"Cleavage and polyadenylation specific factor 6"	Q16630	12	69239537-69274358	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039973	Supported		Enhanced	"Nucleoplasm,Nuclear speckles"		No	No		500000	"Nucleoplasm, Nuclear speckles"		"HPA039973: AB_10795242"	"unprognostic (1.50e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.37e-3)"	"unprognostic (5.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (6.82e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.57e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.20e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.41e-2)"	22.3	26.4	29.4	28.1	32.6	52.0	23.1	49.1	32.2	24.8	20.7	24.3	21.3	21.8	27.4	34.5	27.1	23.2	17.0	21.8	24.3	16.4	20.0	19.7	21.6	36.1	23.6	26.8	42.2	23.5	28.6	36.4	21.0	24.9	21.5	21.5	22.2	25.6	21.4	25.4	23.3	23.1	22.3	20.7	24.7	21.9	22.1	25.8	42.8	25.5	10.5	32.9	21.3	24.2	22.0	25.5	21.0	21.5	19.3	30.2	12.4	28.7	24.2	35.8	25.1	13.9	15.9	27.0	19.0	22.7	27.1	25.7	25.2	19.8	45.9	19.6	19.2	15.1	27.2	35.1	22.4	29.0	29.9	23.9	37.0	25.0	28.8	20.8	49.9	27.1	19.0	17.8	21.8	9.0	18.2	20.8	27.7	38.0	49.3	22.4	33.5	46.7	32.7	34.6	24.0	20.7	47.5	28.4	32.1	21.3	34.3	30.2	26.6	25.5	23.9	25.9	22.4	28.7	35.4	23.9	20.5	25.1	19.3	31.0	31.7	25.6	57.4	16.6	29.3	26.3	21.0	17.1	18.7	19.7	21.5	20.9	22.0	22.0	20.2	25.5	19.0	17.0	20.1	5.2	19.3	17.8	18.3	30.2	12.4	29.4	32.6	49.1	32.2	24.3	16.4	23.6	26.8	24.9	25.8	11.9	19.8	32.8	39.9	67.5	52.9	29.0	22.9	21.4	25.0	17.4	35.3	55.0	31.5	46.3	14.2	31.0	20.8	0.0	49.2	71.9	38.1	25.5	34.6	18.7	34.7	84.2	50.4	17.2	27.8	13.5	52.6	28.0	23.6	55.9	26.2	35.0	48.6	21.0	49.8	20.2	42.9	38.8	30.4	71.1	72.7	51.7	42.8	35.2	31.1	46.0
CREB1		ENSG00000118260	"CAMP responsive element binding protein 1"	P16220	2	207529737-207603431	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Early spermatids: 355.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003803, HPA019150"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003803: AB_562092, HPA019150: AB_1847220"	"unprognostic (1.20e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (8.41e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.74e-2)"	"unprognostic (4.82e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.45e-2)"	21.2	12.9	19.4	24.8	17.0	22.9	16.7	25.5	18.7	17.6	15.7	14.3	14.7	12.6	19.3	14.9	17.9	15.4	15.5	14.4	15.4	14.5	14.6	13.1	17.7	21.7	15.8	17.7	20.5	12.9	19.8	20.0	19.8	16.1	16.3	16.2	11.2	16.2	14.9	11.6	14.3	15.2	19.5	19.8	19.0	13.3	39.2	18.5	38.4	19.7	13.3	27.7	16.1	23.6	22.1	20.7	34.8	19.1	28.4	22.5	14.5	15.3	13.8	25.5	9.8	15.0	15.4	14.6	9.9	14.8	17.2	18.1	13.9	15.6	10.0	13.3	14.5	20.2	13.4	23.1	13.5	25.3	15.9	8.3	18.3	12.3	14.2	12.6	17.3	13.5	11.1	10.0	14.2	21.1	17.2	24.1	18.7	12.8	14.6	21.2	10.6	26.2	10.2	18.2	15.4	8.4	20.5	13.9	13.1	15.4	15.9	17.6	15.3	13.7	10.1	11.9	25.5	11.3	18.9	11.5	14.1	15.1	14.7	12.6	13.2	16.7	23.0	17.3	15.9	14.7	16.9	17.0	16.8	17.3	18.0	15.4	22.1	16.6	16.7	20.7	20.2	19.9	13.5	34.8	28.4	19.1	11.3	22.5	14.5	19.4	17.0	25.5	18.7	15.4	14.5	15.8	17.7	16.1	18.5	17.9	12.8	45.4	39.6	63.0	36.1	22.1	12.7	9.4	25.0	12.2	31.4	24.5	19.9	20.2	355.9	44.6	20.0	0.0	17.9	21.7	32.3	41.9	42.7	14.3	25.7	38.1	31.2	31.3	43.4	27.4	24.2	38.0	42.2	36.9	24.2	40.0	21.9	23.5	27.6	15.6	36.9	38.8	34.1	24.7	27.5	50.6	15.6	31.9	23.0	54.8
CREBBP	"CBP, KAT3A, RSTS, RTS"	ENSG00000005339	"CREB binding protein"	Q92793	16	3725054-3880726	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004212, HPA055861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"CAB004212: AB_626817, HPA055861: AB_2682948"	"unprognostic (1.17e-1)"	"unprognostic (8.51e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.09e-2)"	"unprognostic (9.59e-3)"	"unprognostic (6.98e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.24e-5)"	"unprognostic (1.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.97e-2)"	"unprognostic (8.23e-2)"	18.5	10.9	17.2	22.8	17.5	37.0	17.4	42.6	18.8	20.1	17.2	16.8	17.1	9.9	25.1	15.2	14.1	18.9	21.3	14.5	17.1	8.7	11.1	12.3	16.9	14.4	20.5	12.0	31.6	23.4	24.3	13.0	13.3	15.8	18.4	11.6	14.6	14.9	16.7	28.2	20.4	16.4	17.0	13.6	17.4	14.7	29.1	20.2	29.6	19.5	13.8	16.1	19.0	29.9	4.7	2.3	10.6	3.8	2.0	2.7	1.1	5.6	14.5	18.8	8.3	11.5	11.4	9.8	8.1	13.7	14.0	13.7	13.1	10.6	15.6	9.7	15.5	9.0	10.9	21.6	6.7	16.0	26.3	8.7	12.2	13.4	8.3	12.8	12.2	17.6	10.1	6.8	15.6	18.9	8.7	10.5	8.0	13.9	21.4	7.6	19.3	8.1	5.9	15.4	5.4	6.0	38.3	14.9	11.9	5.4	7.6	15.7	10.3	13.9	13.7	8.2	12.7	12.2	12.0	16.3	17.2	17.2	8.8	7.4	10.0	10.8	30.3	3.5	7.3	12.1	2.9	1.7	1.3	2.7	2.2	1.4	4.7	1.3	2.0	1.0	3.3	1.4	1.7	10.6	2.0	3.8	2.3	1.3	1.1	17.2	17.5	42.6	18.8	17.1	8.7	20.5	12.0	15.8	20.2	41.7	45.9	13.8	25.5	49.9	31.9	37.0	43.3	32.1	33.0	10.4	23.6	14.6	5.0	17.4	38.0	35.3	24.0	0.0	17.7	9.4	24.3	32.2	30.0	25.1	17.8	27.0	14.5	32.5	38.7	57.1	52.3	33.5	16.9	27.9	22.4	31.4	22.7	17.3	48.1	10.7	15.8	45.3	36.0	33.1	46.0	51.4	25.7	35.9	23.8	31.6
CRKL		ENSG00000099942	"CRK like proto-oncogene, adaptor protein"	P46109	22	20917426-20953749	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 89.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000532, HPA001100"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		1500000	Nucleoplasm	Cytosol	"HPA000532: AB_2666019, HPA001100: AB_1078569"	"unprognostic (5.54e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.92e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.60e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (8.82e-6)"	"unprognostic (8.40e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.61e-2)"	16.4	15.2	25.0	18.1	24.1	41.9	18.4	34.0	31.7	17.8	19.9	26.4	12.3	20.2	18.9	12.8	25.2	19.9	13.6	22.6	22.6	23.8	16.4	24.9	19.0	21.3	24.6	26.1	26.9	21.7	22.2	17.9	25.1	20.7	18.8	18.7	16.7	14.5	19.1	48.1	22.7	19.1	18.6	23.6	19.6	14.3	12.6	19.8	35.7	16.6	17.8	24.7	17.7	24.6	11.7	14.8	19.2	21.5	11.0	19.7	16.8	11.5	6.9	15.6	12.2	10.5	6.8	16.8	7.8	9.6	12.1	13.7	11.4	5.2	14.8	6.3	8.2	8.3	14.8	18.2	12.5	14.4	12.5	17.8	20.5	7.5	12.5	10.5	21.8	10.5	6.8	16.6	10.5	18.0	9.9	10.6	12.0	89.5	12.2	9.7	10.8	12.7	10.2	12.2	12.0	7.5	16.5	24.7	3.5	8.0	10.1	10.1	12.9	13.1	11.6	9.5	19.5	9.9	12.2	8.5	19.2	21.9	7.2	9.8	11.8	11.3	17.3	14.2	9.3	11.7	13.4	13.0	19.2	17.5	12.5	18.9	11.6	15.8	17.5	14.8	11.7	19.7	18.4	14.1	11.0	21.5	7.4	12.8	16.8	25.0	24.1	34.0	31.7	22.6	23.8	24.6	26.1	20.7	19.8	8.9	16.2	15.6	11.6	48.1	16.8	20.3	10.2	10.7	10.3	5.2	13.7	17.3	1.7	6.8	20.7	14.3	12.4	23.3	7.3	32.0	16.2	13.4	1.1	21.2	15.0	17.5	19.5	18.4	13.7	43.2	14.1	11.1	23.6	10.8	21.5	16.0	9.1	8.6	14.5	8.4	12.7	12.9	11.1	11.6	11.3	52.8	22.8	10.0	14.5	17.4
CRTC2	TORC2	ENSG00000160741	"CREB regulated transcription coactivator 2"	Q53ET0	1	153947669-153958625	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028454, HPA028465"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028454: AB_10599617, HPA028465: AB_10601991"	"unprognostic (4.91e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (5.75e-4)"	"unprognostic (4.32e-3)"	"unprognostic (2.86e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.54e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (7.90e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.35e-1)"	"prognostic favorable (6.12e-5)"	22.4	19.7	21.0	23.1	26.6	28.7	21.1	31.8	22.8	21.5	18.9	29.5	15.6	13.3	24.3	20.2	17.7	22.7	18.4	17.4	20.4	11.3	21.4	22.9	26.0	31.1	25.7	16.3	32.3	20.6	22.7	19.7	24.2	18.6	20.1	15.9	21.9	20.1	22.1	24.6	24.0	23.5	21.5	19.2	39.4	18.9	18.1	28.1	22.1	23.6	10.9	29.7	23.4	21.0	6.1	4.6	10.1	5.9	4.6	5.0	1.8	14.8	11.2	10.9	12.3	18.0	13.1	16.7	8.4	17.4	16.1	13.3	11.5	15.0	14.3	13.4	14.5	10.9	17.0	13.0	16.9	9.0	18.7	17.0	7.3	11.4	8.8	18.2	11.8	12.2	17.2	16.5	17.7	14.5	12.8	14.9	8.2	11.7	17.3	11.5	23.6	12.8	19.8	8.5	16.2	13.9	9.5	7.5	12.0	17.0	12.1	9.2	15.1	13.5	27.6	20.9	11.2	13.3	23.2	11.0	13.0	11.8	13.9	14.2	28.3	18.3	9.8	12.0	10.1	9.6	5.2	3.9	8.4	4.6	5.9	3.8	4.5	4.7	5.0	3.4	6.1	3.2	3.8	10.1	4.6	4.7	4.6	3.1	1.8	21.0	26.6	31.8	22.8	20.4	11.3	25.7	16.3	18.6	28.1	6.0	10.6	4.8	7.1	21.9	5.2	5.6	10.2	2.7	4.5	12.2	3.9	8.3	1.7	8.1	1.1	11.7	10.9	0.0	8.9	8.2	11.2	9.1	8.1	10.6	9.5	1.6	15.4	10.4	10.5	1.1	11.2	12.0	3.3	11.8	12.1	4.5	11.7	2.9	14.2	2.8	6.9	6.5	11.7	11.5	11.5	19.7	10.2	12.9	7.6	9.6
CRTC3	FLJ21868	ENSG00000140577	"CREB regulated transcription coactivator 3"	Q6UUV7	15	90529925-90645345	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 16.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 40.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043735, HPA063691"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA043735: AB_10794286, HPA063691: AB_2685092"	"unprognostic (7.60e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.48e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.22e-3)"	"unprognostic (4.67e-2)"	"unprognostic (9.32e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.30e-1)"	22.3	14.0	13.7	17.0	20.9	11.4	26.6	15.0	16.2	21.2	22.2	27.5	15.3	8.9	23.9	14.5	15.1	19.4	21.5	17.2	14.0	9.7	10.7	11.7	19.2	21.7	24.1	10.9	45.9	13.9	17.1	9.6	20.2	15.7	18.2	11.7	17.4	19.9	22.0	16.1	15.8	13.7	31.8	20.3	13.1	14.2	15.3	23.6	12.8	22.7	9.2	18.1	24.0	29.6	5.3	2.1	16.0	2.5	3.3	6.6	3.0	4.8	8.0	5.5	8.9	11.9	8.8	25.1	6.2	9.0	9.8	9.3	6.6	4.9	0.1	4.5	12.8	8.1	8.2	8.8	5.4	7.7	8.4	10.2	12.3	40.0	3.0	13.5	3.2	21.1	9.9	8.7	8.1	10.9	7.2	7.0	5.5	6.5	2.8	7.2	5.6	1.3	4.6	2.0	1.4	3.7	4.2	8.8	0.2	3.5	10.3	10.1	8.9	18.1	6.0	10.1	6.0	6.0	6.0	8.6	10.9	8.0	10.0	7.1	3.8	5.1	3.7	4.5	6.4	5.2	16.0	2.5	1.4	3.7	0.8	4.2	3.1	4.5	4.0	1.6	5.3	6.6	4.1	0.5	3.3	0.3	2.1	4.2	3.0	13.7	20.9	15.0	16.2	14.0	9.7	24.1	10.9	15.7	23.6	6.0	8.6	37.4	23.2	20.9	21.6	13.4	17.8	0.0	4.5	12.2	25.5	12.1	1.7	12.0	22.9	18.0	6.4	0.0	9.4	36.5	23.1	23.5	23.1	13.5	13.5	54.0	15.0	20.9	19.7	14.7	24.7	21.3	16.9	8.2	10.0	20.4	9.0	10.5	41.1	8.4	55.7	45.3	38.4	7.7	16.5	21.0	14.9	30.5	11.3	31.1
CRYAB	"CRYA2, HSPB5"	ENSG00000109846	"Crystallin alpha B"	P02511	11	111908565-111923722	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Chaperone, Eye lens protein"	"Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 743.1;skeletal muscle: 581.1"	"Cell type enhanced"	"Detected in many"	16	"Basal glandular cells: 1730.9;Cardiomyocytes: 6792.5;Proximal tubular cells: 5845.1"	"Group enriched"	"Detected in all"	6	"glioma: 426.4;renal cancer: 575.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC diff: 235.7;fHDF/TERT166: 76.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002053, CAB040560, HPA057100"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		12000	"Plasma membrane, Cytosol"		"CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337"	"unprognostic (1.06e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.02e-2)"	"unprognostic (8.41e-3)"	"unprognostic (9.29e-3)"	"unprognostic (7.35e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.68e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.92e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.70e-5)"	107.4	11.5	47.8	16.7	82.3	2.1	69.5	24.8	153.7	22.4	23.6	132.9	7.2	5.5	14.8	25.9	41.9	13.5	14.0	743.1	65.9	44.0	151.8	3.8	8.4	3.9	139.2	29.7	8.8	6.6	3.3	8.6	16.1	80.7	30.3	12.9	23.3	30.6	75.1	581.1	18.1	6.2	45.2	168.0	5.5	11.6	3.9	101.8	0.0	40.7	94.1	9.2	16.2	53.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.4	235.7	10.3	1.6	6.5	0.2	0.1	0.2	0.1	0.0	0.0	3.9	76.9	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	1.2	0.6	2.0	0.0	0.0	8.2	1.0	0.0	0.5	5.1	0.0	0.0	0.5	0.2	18.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.4	0.8	3.5	5.8	0.5	0.0	0.1	30.5	10.9	0.8	0.3	0.1	0.0	0.0	0.6	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	82.3	24.8	48.5	65.9	44.0	139.2	29.7	80.7	101.8	77.4	5.5	0.9	1730.9	155.3	11.4	6792.5	86.6	2.7	1.2	1270.1	17.7	2.9	573.6	165.7	20.3	23.3	0.0	0.0	10.0	5.8	309.0	1331.1	0.0	0.8	5.4	9.5	6.8	56.4	0.3	11.1	211.7	26.8	458.9	6.4	0.0	1097.1	19.7	0.0	176.4	5845.1	41.9	135.8	899.5	10.0	0.7	135.6	27.9	0.5	0.0	203.0
CS		ENSG00000062485	"Citrate synthase"	O75390	12	56271699-56300392	"Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Tricarboxylic acid cycle"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 125.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 207.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA038460, HPA038461, CAB075750, CAB075751, CAB075752, CAB075753, CAB075754"	Enhanced		Enhanced	Mitochondria		NA	NA		4400000	Mitochondria		"CAB075750: AB_2665756, CAB075751: AB_2665757, CAB075752: AB_2665758, CAB075753: AB_2665759, CAB075754: AB_2665760, HPA038460: AB_2676023, HPA038461: AB_2676024"	"unprognostic (7.67e-3)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.97e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.20e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.02e-1)"	37.1	35.5	11.9	16.3	20.4	19.3	55.6	28.5	43.8	17.2	27.4	14.1	11.3	25.3	19.9	10.8	31.7	16.5	14.0	79.2	11.2	14.5	26.7	12.3	17.3	30.8	12.3	14.2	16.9	20.7	28.1	14.3	11.9	24.8	16.2	32.7	19.8	23.1	17.5	125.9	22.8	27.0	21.2	15.0	18.4	21.4	7.9	11.1	20.7	17.9	48.2	26.1	22.9	19.1	19.5	37.1	59.6	27.8	15.9	19.7	18.2	35.8	38.8	31.7	41.1	42.1	39.2	20.6	29.9	29.4	52.7	36.8	54.7	35.2	70.1	29.4	37.7	22.6	38.9	87.5	45.0	50.4	24.3	44.5	48.1	28.2	39.4	23.6	58.8	34.6	43.1	43.0	41.3	50.1	43.4	59.1	36.6	49.8	42.1	45.9	28.8	48.7	18.1	25.2	27.2	56.1	47.5	37.2	52.9	32.6	36.4	41.6	27.3	38.7	46.1	30.3	30.8	64.1	34.3	39.2	26.6	37.3	37.5	31.5	27.8	42.3	45.6	24.5	43.4	24.9	14.5	22.0	59.6	15.2	27.8	19.7	19.5	18.3	14.3	37.1	16.7	19.4	15.4	9.8	15.9	27.0	20.5	19.3	18.2	11.9	20.4	28.5	43.8	11.2	14.5	12.3	14.2	24.8	11.1	14.9	33.2	16.0	18.6	34.7	21.7	207.5	22.9	10.7	19.4	12.2	58.9	15.6	29.9	31.3	5.1	27.0	51.5	0.0	38.6	26.0	18.2	26.3	27.6	26.2	31.0	9.5	16.3	17.2	29.2	3.6	18.7	33.5	10.1	27.1	43.6	15.1	37.2	23.0	18.7	17.3	36.0	12.9	25.9	18.4	24.7	45.7	14.1	18.1	64.8	26.5
CSDE1	"D1S155E, UNR"	ENSG00000009307	"Cold shock domain containing E1"	O75534	1	114716913-114758676	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 266.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 226.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018846, HPA052221"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		13000	"Plasma membrane, Cytosol"		"HPA018846: AB_1847266, HPA052221: AB_2681767"	"unprognostic (2.84e-1)"	"unprognostic (9.18e-3)"	"unprognostic (4.86e-3)"	"unprognostic (3.30e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.32e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.17e-3)"	"unprognostic (2.54e-2)"	71.2	31.4	33.5	25.8	33.2	37.9	42.1	29.6	35.4	39.0	64.7	29.6	35.9	29.5	46.4	38.9	58.8	30.3	29.4	64.2	33.2	31.7	37.4	39.5	34.2	31.4	41.6	31.4	43.9	37.2	50.3	38.4	38.8	44.4	52.6	32.9	32.0	43.2	42.0	266.5	33.8	46.5	88.3	42.4	32.2	39.9	41.5	35.1	39.6	55.7	73.9	31.9	75.4	45.5	43.9	59.0	57.9	65.2	48.1	62.3	80.5	61.7	21.8	38.8	38.7	44.3	57.6	54.3	54.6	40.8	36.8	29.9	31.9	18.7	48.7	46.1	52.0	21.5	26.3	43.0	42.4	53.7	59.5	29.4	47.8	39.7	28.2	39.2	35.5	28.5	41.8	46.2	44.0	58.1	50.0	42.0	41.2	48.4	32.0	44.9	226.5	47.5	22.7	73.9	26.0	29.4	35.6	120.2	22.9	29.2	48.7	48.0	31.8	53.4	44.6	41.3	42.8	22.9	56.7	50.6	43.5	60.0	57.0	59.9	48.9	53.2	54.6	56.2	40.3	132.6	46.4	57.7	57.9	40.9	60.8	55.5	43.9	52.2	49.7	59.0	34.7	62.3	52.3	40.9	48.1	65.2	23.0	56.7	80.5	33.5	33.2	29.6	35.4	33.2	31.7	41.6	31.4	44.4	35.1	184.6	166.5	131.5	180.2	192.1	123.0	534.2	132.5	139.2	159.3	122.1	55.0	150.1	192.3	174.5	301.0	172.2	163.0	93.5	175.1	175.9	149.1	211.7	211.6	144.5	141.9	93.8	210.9	124.6	242.4	459.7	149.8	180.0	209.2	170.5	206.0	141.9	193.9	122.8	212.2	179.3	91.0	161.7	255.2	219.6	163.8	204.6	228.3	138.0	172.8	220.6
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 153.6;Spermatogonia: 127.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	No		64000	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	36.2	25.2	30.9	23.7	12.0	15.5	33.4	28.6	15.2	90.0	38.2	82.4	29.3	37.1	38.4	18.1	36.5	42.0	45.3	53.7	86.0	6.0	22.0	25.7	29.7	39.9	7.3	28.3	14.2	8.6	20.2	44.0	25.5	12.4	29.7	20.7	36.3	14.7	33.7	12.4	34.1	14.6	25.9	30.3	37.6	21.7	50.8	28.9	19.8	25.3	27.2	15.8	45.7	49.5	16.2	24.5	41.3	18.5	19.1	48.0	40.3	28.2	40.5	8.6	20.8	34.8	28.6	22.9	25.5	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0	6.0	23.2	18.2	20.7	26.9	14.3	23.5	35.7	21.4	18.2	26.2	9.8	56.3	11.6	28.2	61.2	21.5	7.8	0.0	23.0	50.5	21.6	15.7	4.6	23.2	26.0	14.3	5.2	20.9	15.1	39.7	23.6	19.3	25.3	29.7	9.1	21.8	23.6	10.5	29.7	17.0	11.9	38.8	19.1	153.6	127.3	30.2	60.8	16.6	18.2	20.0
CSF2	"GM-CSF, GMCSF"	ENSG00000164400	"Colony stimulating factor 2"	P04141	5	132073790-132076170	"Cancer-related genes, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 9.5;lung: 6.8;pancreas: 4.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 10.7;Ductal cells: 12.3;granulocytes: 5.7;Pancreatic endocrine cells: 14.6;T-cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 9.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 9.5"	"Cell line enriched"	"Detected in some"	4	"BJ hTERT+: 45.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA057404, HPA062006"			Enhanced	Vesicles	"Secreted to blood"	NA	NA	23900		Vesicles		"HPA057404: AB_2683428, HPA062006: AB_2684654"	"unprognostic (7.29e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.77e-2)"	"unprognostic (2.09e-2)"		"unprognostic (1.05e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.68e-3)"		"unprognostic (1.87e-8)"	"unprognostic (4.81e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.06e-2)"	0.2	0.1	0.1	3.9	0.1	1.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.7	0.0	1.5	0.1	1.1	0.2	0.1	0.1	0.3	0.9	6.8	0.3	0.1	0.0	0.1	4.5	0.0	0.1	0.5	0.0	0.2	0.7	0.0	1.9	0.0	0.1	0.4	1.0	0.6	0.1	1.0	0.2	0.2	0.0	0.4	0.2	0.0	1.8	2.3	0.1	0.0	0.0	0.0	0.0	9.5	0.8	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	2.6	0.0	3.6	0.0	0.7	0.0	2.7	0.1	0.0	3.3	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	10.4	7.0	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.1	1.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	10.7	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.5	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	0.0	4.9	0.0	1.3
CSK		ENSG00000103653	"C-terminal Src kinase"	P41240	15	74782057-74803198	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 67.2"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 91.8;Kupffer cells: 77.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011203, HPA026488, HPA028425"	Approved	Approved	Enhanced	Vesicles,Cytosol		No	No		1500000	"Vesicles, Cytosol"		"CAB011203: AB_259070, HPA026488: AB_1847273, HPA028425: AB_10600899"	"unprognostic (1.05e-1)"	"prognostic favorable (5.14e-5)"	"unprognostic (2.59e-3)"	"prognostic favorable (8.22e-4)"	"unprognostic (4.15e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (1.74e-4)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.29e-2)"	9.3	8.0	9.5	39.3	11.0	19.9	12.6	18.7	13.4	12.1	13.5	11.8	7.3	16.1	13.9	6.4	33.3	10.6	11.2	14.0	9.8	8.5	8.0	20.9	15.6	67.2	11.1	7.4	10.5	6.7	6.6	10.4	8.8	12.2	9.8	8.9	9.8	13.2	7.0	8.7	14.9	26.2	8.5	10.9	62.7	13.1	8.1	10.6	62.7	8.1	9.5	47.4	17.4	13.2	35.6	22.8	49.6	46.8	16.3	30.7	19.9	12.9	18.3	9.0	14.7	8.6	6.6	7.7	8.7	8.4	16.6	11.8	16.7	12.0	58.0	11.5	7.8	15.4	13.5	18.8	17.5	4.7	28.1	23.2	49.1	6.7	16.7	11.9	25.6	62.6	9.3	8.7	11.8	10.6	8.3	12.5	27.4	14.1	20.2	9.8	21.9	18.4	15.1	11.1	11.7	13.1	20.5	7.7	42.3	7.6	28.8	14.9	10.3	11.3	23.7	15.1	6.0	16.3	37.8	10.8	20.1	10.6	15.7	15.0	10.8	21.8	59.2	10.4	49.0	13.6	20.7	19.7	49.6	23.4	42.4	20.0	29.4	20.3	23.1	22.8	35.6	15.7	18.4	39.1	16.3	46.8	13.2	30.7	19.9	9.5	11.0	18.7	13.4	9.8	8.5	11.1	7.4	12.2	10.6	3.0	11.6	91.8	7.2	8.2	16.5	8.1	12.7	5.3	6.8	8.7	5.9	6.3	1.7	8.5	10.0	11.5	27.7	0.0	12.0	11.0	7.6	9.3	25.5	25.0	46.4	27.0	9.1	12.3	77.9	2.1	8.3	44.5	8.5	36.9	25.3	6.5	15.2	17.3	7.8	6.8	4.1	6.5	8.5	3.8	11.3	8.0	4.7	60.9	22.8	10.5
CSPG4	"HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2"	ENSG00000173546	"Chondroitin sulfate proteoglycan 4"	Q6UVK1	15	75674322-75712848	"Predicted membrane proteins"	"Angiogenesis, Differentiation, Tissue remodeling"	"Developmental protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Sertoli cells: 116.4;Smooth muscle cells: 29.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 74.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 1.9"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001933, HPA002951, CAB016189, HPA042785, HPA050008"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA		28000000	"Plasma membrane"	Nucleoplasm	"CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991"	"unprognostic (5.21e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.56e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (7.60e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.04e-2)"	"unprognostic (3.21e-2)"	"prognostic unfavorable (4.93e-5)"	36.1	3.1	8.3	10.0	7.9	1.0	19.5	1.6	7.8	15.3	29.2	7.2	6.9	4.6	21.3	14.9	19.9	9.4	18.2	9.2	6.5	5.2	3.5	1.5	10.9	1.4	6.6	5.2	7.0	3.8	3.0	1.6	20.9	6.6	11.4	3.9	10.0	3.4	16.7	25.7	8.0	9.1	37.9	5.4	3.8	14.0	2.5	6.3	0.0	4.7	6.0	1.3	30.3	10.9	0.0	0.1	0.0	0.0	1.9	0.0	0.0	3.6	0.0	0.3	2.2	0.5	3.2	0.0	20.1	9.0	14.1	9.2	0.0	14.0	0.0	0.5	14.0	1.9	0.2	0.0	0.1	4.3	0.1	0.0	0.0	5.9	0.0	3.2	0.0	0.0	1.5	0.0	4.2	0.5	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	45.8	0.4	0.3	0.3	0.0	29.6	5.8	1.1	0.2	0.0	0.0	0.0	6.5	0.1	43.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	8.3	7.9	1.6	5.9	6.5	5.2	6.6	5.2	6.6	6.3	0.0	0.0	0.0	0.6	2.5	0.0	9.8	0.0	1.4	1.2	1.8	0.0	0.1	0.0	0.0	0.6	2.8	0.0	0.0	0.0	0.2	6.5	0.6	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.3	0.8	11.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	116.4	29.5	0.0	1.3	1.6	0.2	0.0	0.0	0.3
CSRNP1	"AXUD1, DKFZp566F164, FAM130B, TAIP-3, URAX1"	ENSG00000144655	"Cysteine and serine rich nuclear protein 1"	Q96S65	3	39141855-39154562	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 150.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045207, HPA058463"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045207: AB_10967202, HPA058463: AB_2683726"	"unprognostic (2.90e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (1.07e-4)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.51e-1)"	33.5	24.9	5.9	16.4	11.5	70.1	20.4	4.9	8.6	16.2	14.4	11.4	13.9	5.1	12.9	9.6	25.9	35.8	28.7	19.7	5.4	5.3	9.6	33.3	35.7	7.9	8.8	3.3	24.9	16.3	11.7	17.6	30.9	15.3	15.8	6.8	9.7	10.9	50.1	22.4	19.9	21.0	26.9	11.9	9.2	20.3	11.4	7.5	8.9	14.5	14.6	7.8	21.4	16.9	3.6	3.9	15.9	9.2	2.2	2.5	1.9	2.3	5.3	1.4	2.7	2.7	2.8	4.4	8.7	12.3	7.3	6.0	7.5	2.2	7.8	1.9	6.6	5.3	2.7	1.6	11.6	3.6	11.6	2.2	8.9	4.3	5.6	3.3	2.2	8.9	1.3	6.3	11.5	1.8	6.6	9.9	2.1	6.7	13.9	6.0	7.5	0.4	3.6	6.4	4.0	4.5	3.6	5.8	12.7	5.8	8.7	3.9	0.6	4.8	36.2	2.9	8.6	4.0	4.1	4.9	3.7	16.0	3.1	6.4	3.6	3.0	3.6	8.2	2.8	4.6	0.1	2.7	3.2	1.7	5.6	2.1	3.6	1.6	1.9	3.0	3.6	2.0	1.3	15.9	2.2	9.2	3.9	2.5	1.9	5.9	11.5	4.9	8.6	5.4	5.3	8.8	3.3	15.3	7.5	44.7	66.0	21.2	65.0	91.8	1.4	12.9	17.8	9.4	17.0	10.4	0.0	13.0	8.3	30.2	47.7	63.8	51.3	23.3	34.0	40.3	70.9	58.0	96.7	34.8	35.2	0.0	56.9	49.7	35.1	34.1	1.4	49.4	65.8	20.8	34.8	4.3	37.1	28.1	3.9	4.8	1.6	12.9	150.2	0.2	3.2	69.5	75.9	27.7	25.5	32.3
CSTF1		ENSG00000101138	"Cleavage stimulation factor subunit 1"	Q05048	20	56392371-56406369	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019270, HPA047275, HPA065000"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019270: , HPA047275: AB_2680008, HPA065000: AB_2685400"	"unprognostic (2.51e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.57e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.60e-1)"	14.3	16.6	9.7	15.0	15.9	6.8	17.1	14.8	14.9	13.2	11.9	14.5	9.1	8.1	17.5	12.6	16.4	15.2	12.0	11.9	10.2	9.6	18.1	27.5	12.8	17.2	12.9	9.4	20.1	18.4	20.1	19.0	14.1	12.2	14.1	12.7	14.6	22.8	11.7	18.7	16.9	13.6	13.6	10.5	17.1	14.1	28.2	11.4	32.5	15.8	15.8	21.9	14.9	12.1	15.1	15.7	9.4	11.6	21.0	22.6	12.9	8.6	8.2	10.4	7.2	10.8	9.8	11.4	11.8	13.1	23.6	17.7	17.8	12.6	17.8	12.8	8.6	15.1	14.6	16.7	20.1	27.8	5.6	5.9	17.4	14.7	10.7	6.5	14.5	11.3	9.4	11.7	13.2	11.4	9.0	14.1	11.3	14.7	8.7	14.2	20.2	16.1	7.5	9.6	17.0	10.8	12.0	22.4	15.7	11.4	8.9	11.6	8.0	15.9	43.8	11.7	12.6	17.5	10.1	7.7	19.2	12.3	7.9	11.3	6.1	9.5	19.4	15.1	9.6	9.1	7.5	11.6	9.0	14.9	10.1	19.0	14.8	19.1	16.8	14.9	15.1	21.1	18.4	9.4	21.0	8.2	15.7	22.6	12.9	9.7	15.9	14.8	14.9	10.2	9.6	12.9	9.4	12.2	11.4	8.9	13.3	9.3	10.1	8.1	8.5	8.1	15.3	12.0	7.9	17.4	13.7	26.5	16.6	14.9	11.5	10.5	6.9	0.0	12.9	17.1	7.4	9.9	17.3	19.1	13.4	4.8	4.7	13.5	20.3	4.2	12.7	6.6	5.0	17.2	9.3	12.0	10.7	12.7	12.0	15.9	11.1	19.4	6.2	17.7	36.6	7.8	17.6	15.4	10.7	8.0
CSTF2	CstF-64	ENSG00000101811	"Cleavage stimulation factor subunit 2"	P33240	X	100820359-100840932	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 23.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000427, CAB004680"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB004680: AB_425385, HPA000427: AB_1078580"	"unprognostic (2.02e-2)"	"unprognostic (8.70e-3)"	"unprognostic (3.50e-1)"	"unprognostic (3.43e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.09e-2)"	"prognostic unfavorable (8.23e-6)"	"unprognostic (2.02e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.98e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (1.75e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.89e-1)"	8.6	11.1	10.1	14.1	14.6	12.2	10.5	18.8	14.5	10.0	14.9	9.1	15.8	11.4	11.9	11.8	30.1	11.3	8.8	7.8	12.7	10.5	10.3	7.9	9.1	14.7	11.2	11.6	9.8	8.1	11.9	12.7	9.5	10.8	10.3	16.5	9.7	13.0	16.8	7.2	11.8	12.7	10.7	12.5	11.8	9.1	18.9	11.2	20.6	9.0	9.4	24.2	11.3	12.8	15.8	19.6	14.6	20.9	19.1	21.2	12.7	16.8	19.9	12.6	12.4	7.3	6.2	18.5	13.5	12.0	22.4	33.7	21.8	15.0	16.6	16.6	8.7	30.7	17.4	31.1	17.0	25.5	15.5	20.0	15.0	18.8	14.9	10.3	19.8	16.9	5.9	8.4	24.2	15.2	6.3	13.5	15.2	24.0	16.6	13.2	20.4	16.5	15.2	36.6	26.3	19.6	17.3	21.9	19.8	8.8	15.5	11.5	14.7	21.5	10.0	9.4	12.8	10.1	11.1	11.1	13.3	21.6	17.1	17.3	10.7	21.9	20.4	11.4	24.0	16.0	14.6	14.6	10.1	21.2	16.5	16.6	15.8	18.7	20.0	19.6	13.4	16.4	16.2	2.4	19.1	20.9	13.5	20.3	12.7	10.1	14.6	18.8	14.5	12.7	10.5	11.2	11.6	10.8	11.2	3.0	0.6	6.0	3.4	3.8	2.0	3.2	0.0	4.0	2.3	0.0	2.0	15.4	5.0	10.9	5.8	3.6	5.1	0.0	7.4	15.4	3.3	1.8	3.5	1.5	9.2	3.2	4.1	2.5	2.1	1.9	4.4	3.2	1.7	7.2	3.5	3.7	10.4	5.7	3.9	3.1	2.4	6.5	3.1	7.6	23.4	3.6	6.4	5.3	6.0	4.8
CSTF2T	"CstF-64T, DKFZp434C1013, KIAA0689, tauCstF-64"	ENSG00000177613	"Cleavage stimulation factor subunit 2 tau variant"	Q9H0L4	10	51695487-51699591	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039216, HPA062021"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA039216: AB_10795462, HPA062021: AB_2684662"	"unprognostic (2.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.06e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.42e-1)"	"unprognostic (5.92e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.96e-1)"	20.2	23.5	16.5	20.0	21.6	14.0	15.2	16.2	24.0	14.8	13.5	29.6	9.9	14.3	16.8	13.4	13.1	19.0	12.7	17.4	18.4	16.6	15.5	15.4	11.9	21.7	21.3	16.5	23.3	16.3	30.2	14.1	14.6	23.5	15.8	13.5	12.6	13.4	12.5	25.0	13.3	16.8	16.8	28.0	24.6	17.7	11.6	20.1	31.9	17.0	12.6	22.9	17.0	13.2	4.6	5.5	5.5	5.1	13.9	6.8	3.2	8.5	10.1	15.3	16.0	21.7	14.9	1.0	12.1	11.3	14.0	13.7	13.5	12.5	24.6	7.0	10.5	8.5	13.4	11.5	12.7	12.8	14.2	13.0	14.2	10.8	2.5	10.5	5.4	13.0	21.4	9.9	12.3	14.4	8.9	10.5	14.5	15.2	14.0	12.1	7.3	22.2	8.8	5.6	10.4	21.9	17.7	30.9	5.2	10.7	7.1	12.9	16.6	10.1	10.6	10.8	16.7	19.7	10.1	11.1	9.0	12.3	8.3	15.0	17.9	6.6	17.7	18.7	12.8	7.7	3.7	5.0	5.5	4.9	5.1	6.8	2.3	3.6	3.8	5.5	4.6	6.2	5.3	1.5	13.9	3.4	3.5	5.7	3.2	16.5	21.6	16.2	24.0	18.4	16.6	21.3	16.5	23.5	20.1	8.9	6.9	15.9	6.1	8.0	14.6	11.4	10.2	17.4	6.8	8.7	7.9	20.3	19.9	13.7	0.7	16.5	6.4	0.0	13.3	13.9	9.3	3.3	19.7	13.7	13.1	19.1	5.8	17.2	15.6	2.1	22.2	12.0	0.0	22.6	6.6	11.8	11.2	6.5	18.7	10.7	12.8	6.5	11.4	36.7	13.8	5.6	5.1	21.5	10.0	4.8
CSTF3	CstF-77	ENSG00000176102	"Cleavage stimulation factor subunit 3"	Q12996	11	33077188-33162371	"Predicted intracellular proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039743, HPA040168"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039743: AB_10795682, HPA040168: AB_10794025"	"unprognostic (2.38e-1)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.63e-4)"	"unprognostic (3.77e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.35e-2)"	"prognostic unfavorable (8.20e-6)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-2)"	"unprognostic (6.42e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.01e-3)"	9.6	16.0	27.4	16.4	38.2	11.2	16.0	30.7	35.5	12.1	13.2	11.2	14.4	16.0	16.2	50.9	16.2	13.0	13.2	11.9	24.9	23.4	15.0	19.5	12.7	20.0	17.7	22.2	17.0	12.8	21.3	45.2	15.6	17.4	18.7	16.9	12.7	13.5	13.3	12.3	21.7	14.6	12.8	20.4	15.9	15.7	21.8	19.1	20.9	19.4	15.1	16.8	13.3	15.2	9.2	11.3	9.4	11.8	9.3	13.3	5.3	18.3	18.3	34.0	22.6	8.9	15.8	25.5	18.7	11.6	20.2	27.2	14.0	15.0	19.9	12.8	11.3	13.6	24.0	29.8	17.1	32.1	20.3	50.5	20.5	39.7	22.9	10.4	26.6	12.7	11.8	12.2	15.2	15.2	16.4	25.9	15.8	27.0	14.6	26.4	13.9	25.0	13.9	16.6	13.4	22.4	20.3	33.7	15.3	21.6	26.1	26.0	14.9	21.2	12.4	14.2	22.5	22.2	17.1	16.0	16.5	21.1	27.4	23.9	13.6	19.1	17.4	20.5	26.4	16.1	5.4	7.9	9.4	9.6	9.9	11.0	9.2	11.4	9.2	11.3	8.3	12.3	12.2	4.3	9.3	11.8	8.6	13.3	5.3	27.4	38.2	30.7	35.5	24.9	23.4	17.7	22.2	17.4	19.1	17.9	16.0	27.9	37.5	16.8	33.5	18.5	25.5	72.3	43.3	55.8	5.9	56.0	53.0	20.9	31.0	22.9	14.4	23.3	14.5	25.8	32.3	29.2	13.9	51.6	24.7	12.7	30.6	12.3	21.3	9.8	27.6	20.7	27.0	28.9	26.0	29.9	17.7	14.4	28.0	36.5	25.0	25.8	21.7	72.7	51.5	16.9	28.3	20.8	31.1	52.5
CTAG2	"CAMEL, CT6.2a, CT6.2b, ESO2, LAGE-1, LAGE-1a, LAGE-1b, LAGE1, MGC138724, MGC3803"	ENSG00000126890	"Cancer/testis antigen 2"	O75638	X	154651972-154653579	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5;skeletal muscle: 5.7;testis: 11.9"	"Cell type enriched"	"Detected in some"	4	"Spermatogonia: 72.0"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 22.0;K-562: 27.8;OE19: 41.0;RPMI-8226: 61.9;SK-BR-3: 40.5;U-266/84: 70.1"									"HPA071467, HPA076586"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA071467: AB_2686402, HPA076586: "							"prognostic unfavorable (2.35e-4)"		"unprognostic (3.87e-1)"						"unprognostic (1.00e-1)"		"unprognostic (1.25e-2)"	0.2	1.0	0.4	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.2			0.0	0.0	0.0	1.0	2.9	0.0	8.5	0.0	0.0	0.1	0.8	0.2	0.0	0.2		0.8	3.6	0.0	0.4	4.4		0.2	0.0		0.1	0.0	5.7	0.2	0.0	0.0	0.0	0.3	0.6	11.9			0.0		0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.6	0.0	0.0	0.0	0.0	0.0	41.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	40.5	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.5	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	3.3	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	16.8	72.0	0.0	0.9	0.0	0.0	0.0
CTBP1	BARS	ENSG00000159692	"C-terminal binding protein 1"	Q13363	4	1211448-1249953	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Transcription, Transcription regulation"	"Oxidoreductase, Repressor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004217, HPA018987, HPA044971"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004217: AB_627312, HPA018987: AB_1847307, HPA044971: AB_2679161"	"unprognostic (6.19e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (3.81e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.65e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.35e-3)"	"unprognostic (3.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.22e-2)"	"prognostic favorable (8.94e-4)"	32.3	35.8	42.4	39.8	44.4	31.3	54.6	70.7	56.1	27.6	29.4	29.2	29.0	44.9	35.8	30.8	31.9	38.2	37.6	41.2	41.5	45.7	29.3	36.0	28.5	48.4	38.0	41.2	35.4	62.2	28.4	48.1	27.2	30.2	32.6	21.6	28.2	44.9	27.9	74.2	33.9	43.6	29.7	29.3	47.0	33.5	16.7	27.2	44.9	29.4	30.5	30.2	32.2	38.6	15.6	25.0	11.6	16.2	16.1	24.5	10.3	22.8	33.9	26.2	32.1	18.4	13.3	22.5	18.1	16.9	22.5	23.0	29.0	55.6	28.1	21.0	21.0	34.9	18.4	15.8	23.8	6.8	21.3	19.1	25.4	38.3	37.0	30.7	22.8	36.3	22.9	18.3	19.1	11.1	21.9	16.8	32.1	28.8	48.3	12.4	37.8	73.3	71.9	31.0	18.7	32.8	51.9	15.8	36.6	14.4	29.2	49.3	30.9	17.3	18.7	23.9	16.5	40.9	35.2	21.4	37.7	21.3	21.6	38.7	35.2	33.5	32.5	29.8	35.6	29.5	8.6	11.9	11.6	24.5	16.2	18.4	15.3	17.2	20.8	14.7	15.6	13.5	19.5	9.3	16.1	15.8	25.0	14.6	10.3	42.4	44.4	70.7	56.1	41.5	45.7	38.0	41.2	30.2	27.2	38.7	35.8	50.6	18.9	30.3	28.2	46.2	45.9	24.1	19.4	34.9	3.9	21.5	10.0	27.3	2.7	34.3	46.6	46.7	35.0	26.5	27.8	33.2	23.1	79.0	37.1	38.1	44.3	48.5	64.1	3.6	41.7	35.1	43.9	24.4	42.4	41.9	38.2	31.6	33.6	29.3	15.7	6.5	27.0	6.0	15.1	33.1	16.6	39.6	51.0	23.8
CTNNA1	CAP102	ENSG00000044115	"Catenin alpha 1"	P35221	5	138610967-138935034	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021089, HPA046119, HPA063535"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		5400	"Plasma membrane, Cell Junctions"		"CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033"	"unprognostic (2.25e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.80e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (6.18e-2)"	"prognostic favorable (7.34e-7)"	"unprognostic (1.54e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.04e-1)"	55.9	54.0	39.6	24.4	50.2	10.9	55.1	16.5	39.5	43.4	58.9	68.5	33.9	44.2	53.0	47.5	76.9	45.8	41.1	68.6	38.8	32.3	62.2	37.7	49.8	27.0	57.3	29.3	42.7	38.1	55.5	25.6	54.0	45.5	39.4	49.0	35.6	48.8	43.5	30.5	49.8	53.9	59.6	49.7	30.9	48.2	18.7	56.6	8.1	51.2	46.4	44.1	48.4	45.1	3.8	15.2	9.8	21.8	0.3	5.0	7.1	32.2	23.5	35.7	52.8	31.1	34.2	54.4	32.7	41.2	31.3	39.7	49.0	43.9	0.1	27.7	48.8	34.4	24.7	24.5	53.8	36.5	18.5	21.3	13.6	38.8	29.7	37.5	0.2	13.3	21.5	43.1	37.4	41.1	34.9	59.0	9.8	7.4	14.0	33.7	28.5	0.3	4.1	14.3	34.4	0.5	12.7	20.8	19.4	66.1	43.2	14.3	18.8	60.4	84.9	49.4	79.5	30.0	9.3	50.0	33.0	17.9	20.4	22.6	5.1	9.5	1.9	31.4	5.9	42.5	2.2	17.1	1.5	2.9	21.8	1.9	3.8	2.1	2.1	15.2	3.2	0.1	1.1	9.8	0.3	20.2	3.7	5.0	7.1	39.6	50.2	16.5	39.5	38.8	32.3	57.3	29.3	45.5	56.6	241.2	121.7	23.1	99.7	69.7	8.7	202.9	84.1	172.6	201.3	115.1	19.6	101.5	58.0	167.3	13.9	111.5	204.4	23.3	152.7	117.7	74.1	118.0	39.3	51.3	79.8	3.2	49.0	92.7	73.9	18.8	72.2	73.0	74.2	212.8	129.6	45.5	232.1	131.5	79.5	116.5	23.0	97.0	108.1	17.0	21.1	67.5	158.8	17.0	92.7	143.6
CTNNB1	"armadillo, beta-catenin, CTNNB"	ENSG00000168036	"Catenin beta 1"	P35222	3	41194741-41260096	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway"	Activator	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 451.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000108, CAB001950, HPA029159, HPA029160"	Supported		Enhanced	"Plasma membrane"		NA	NA		1000000	"Plasma membrane"		"CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996"	"unprognostic (2.47e-1)"	"unprognostic (3.48e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (1.61e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.20e-3)"	"unprognostic (2.79e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.88e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.61e-1)"	"unprognostic (9.79e-2)"	52.9	54.5	38.8	33.5	45.9	46.3	70.5	78.8	59.3	71.7	49.6	57.3	34.2	48.7	79.2	42.5	46.3	49.8	45.0	42.1	38.6	41.5	46.9	53.2	53.6	31.6	37.0	47.0	84.2	38.6	59.2	44.0	82.6	41.5	50.8	50.1	75.9	53.9	49.7	31.2	44.7	70.4	66.5	39.4	41.0	37.3	29.0	39.3	40.1	62.3	44.5	36.6	46.9	54.2	10.1	13.5	7.5	14.5	11.1	13.5	4.8	22.5	30.0	63.3	35.4	34.1	28.0	48.6	25.4	36.1	42.5	42.3	20.7	32.2	18.5	23.2	44.9	19.1	16.9	45.8	73.4	45.6	17.1	31.2	29.8	39.9	73.8	25.5	16.9	14.4	40.8	33.3	50.8	30.9	34.8	37.3	8.9	21.1	11.5	47.1	22.8	11.8	9.1	57.6	30.1	23.3	8.9	41.2	12.3	26.3	70.4	15.1	25.6	42.1	21.5	113.0	78.5	35.2	35.2	48.1	32.0	24.5	20.5	37.2	7.2	11.1	19.7	32.8	21.3	53.4	4.3	8.1	6.9	11.2	14.5	13.5	9.6	10.5	12.1	13.5	10.1	10.7	10.8	7.5	11.1	13.7	11.7	12.6	4.8	38.8	45.9	78.8	59.3	38.6	41.5	37.0	47.0	41.5	39.3	128.1	177.9	34.4	112.8	189.7	38.8	66.6	99.3	119.1	161.5	59.3	31.4	274.7	29.9	114.0	5.5	164.1	147.7	46.7	68.4	90.6	121.0	101.1	113.2	146.9	108.7	12.7	90.0	114.2	130.0	5.0	55.3	139.8	192.3	115.4	132.0	103.7	102.3	182.4	81.7	57.4	56.6	45.3	106.2	71.5	40.7	152.9	451.2	62.8	118.4	109.3
CTNNBL1	"C20orf33, FLJ21108, NAP, NYD-SP19, P14, P14L"	ENSG00000132792	"Catenin beta like 1"	Q8WYA6	20	37693955-37872129	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 296.8;granulocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 76.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004742, HPA027906, HPA027907"	Approved		Enhanced	Nucleoplasm,Centrosome,Cytosol		No	No			Nucleoplasm	"Centrosome, Cytosol"	"HPA004742: AB_1847323, HPA027906: , HPA027907: AB_10601362"	"unprognostic (2.81e-1)"	"unprognostic (3.42e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.44e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.81e-1)"	"unprognostic (5.31e-2)"	21.0	14.7	19.6	25.8	21.4	27.3	18.9	20.9	21.3	20.3	23.5	18.4	31.7	16.1	25.4	25.2	18.9	21.0	17.7	25.6	17.5	15.8	19.3	35.3	19.3	26.9	17.9	14.7	21.7	14.6	14.5	22.6	22.4	17.5	19.4	18.1	16.1	15.5	34.3	27.3	20.1	19.7	23.8	16.6	49.5	25.9	35.5	20.6	31.0	15.9	15.5	29.7	22.2	29.3	24.9	31.4	60.3	29.1	21.7	18.2	18.4	15.6	14.4	13.8	10.8	10.0	8.3	21.9	10.0	10.5	24.1	21.3	53.9	12.7	17.4	14.7	10.1	23.3	16.8	18.6	23.7	26.0	8.4	9.2	57.1	7.9	26.3	10.4	18.0	76.0	8.7	14.1	13.6	13.6	8.4	14.3	25.0	15.4	7.2	12.8	12.9	29.2	24.0	12.5	17.6	21.0	20.6	26.8	13.1	10.5	13.1	11.1	13.3	17.4	24.9	17.6	13.4	12.3	14.5	10.6	24.1	14.4	15.8	16.2	8.4	10.6	20.3	17.0	11.3	12.7	60.3	22.3	27.9	15.8	29.1	15.0	24.9	15.4	16.2	31.4	23.4	15.5	16.6	4.9	21.7	28.7	24.7	18.2	18.4	19.6	21.4	20.9	21.3	17.5	15.8	17.9	14.7	17.5	20.6	26.8	26.6	37.0	27.7	20.3	25.3	35.5	20.4	21.4	31.8	17.4	17.7	122.6	31.5	25.9	296.8	26.1	24.4	0.0	30.3	56.0	26.8	18.9	250.2	39.2	44.0	17.5	20.1	31.3	29.7	86.0	31.7	43.3	25.3	129.0	23.0	28.3	25.6	19.8	31.5	32.3	21.0	19.4	40.1	76.5	43.0	19.6	44.3	32.4	19.5	18.6
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 12.5;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 10.2;monocytes: 12.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		15000	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	39.7	19.9	15.1	20.4	17.0	3.2	31.4	15.0	20.5	28.8	41.9	25.7	49.2	37.5	32.7	32.7	76.3	22.9	28.8	18.2	15.6	10.3	30.6	31.2	34.0	11.6	14.4	12.8	23.3	50.4	41.9	34.5	49.8	16.4	29.7	39.8	34.4	46.4	39.1	11.8	48.7	82.0	22.8	17.2	25.9	39.4	27.8	14.7	7.1	38.4	34.9	45.6	32.3	38.9	1.4	10.2	0.4	12.5	0.4	0.5	2.3	37.3	28.1	25.1	16.7	13.5	18.6	35.6	17.1	19.4	15.5	14.9	21.7	41.5	0.7	30.3	21.3	14.8	49.1	20.2	26.0	20.0	0.4	6.6	9.3	11.0	24.6	14.1	1.9	14.7	20.4	31.5	19.7	20.2	25.3	47.3	0.6	13.9	0.4	17.2	12.1	0.7	3.5	17.8	25.4	15.1	0.7	21.1	0.8	23.3	39.9	2.3	11.2	24.3	33.3	25.3	43.9	34.9	2.5	40.0	15.0	12.9	14.7	9.7	1.3	0.8	1.1	14.0	1.2	26.4	0.0	6.9	0.2	0.2	12.5	0.5	1.0	0.1	0.4	10.2	1.4	0.2	0.3	0.4	0.4	11.9	3.1	0.2	2.3	15.1	17.0	15.0	20.5	15.6	10.3	14.4	12.8	16.4	14.7	137.0	81.3	9.5	80.1	104.1	22.4	14.9	145.2	44.2	68.2	134.3	37.3	80.9	11.6	90.0	11.2	89.8	213.8	0.0	84.6	65.9	33.0	98.5	32.3	112.4	38.4	14.3	82.8	94.5	50.5	7.8	26.2	39.5	45.5	20.8	134.3	40.4	110.3	157.3	36.0	43.0	26.8	25.8	28.8	32.2	19.2	175.3	76.0	8.7	98.8	174.5
CTR9	"KIAA0155, p150TSP, SH2BP1, TSBP"	ENSG00000198730	"CTR9 homolog, Paf1/RNA polymerase II complex component"	Q6PD62	11	10750987-10801625	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061027, HPA068122"	Supported		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA061027: AB_2684418, HPA068122: AB_2685959"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (3.65e-6)"	"unprognostic (6.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.40e-1)"	16.7	26.7	15.9	19.9	17.4	18.4	26.1	17.5	17.1	21.5	15.8	13.0	20.3	14.2	21.4	44.1	23.7	17.7	13.7	24.2	18.8	14.8	20.5	35.0	15.6	23.8	14.3	14.0	25.4	18.8	36.5	31.4	26.7	16.0	17.5	16.4	14.0	19.1	20.2	24.0	18.3	19.2	16.6	15.7	26.6	17.6	24.4	15.8	39.1	20.9	13.1	21.9	19.6	21.1	11.9	11.9	27.2	12.1	17.5	18.5	9.5	13.0	10.2	14.7	13.9	32.2	12.9	7.2	14.6	9.7	11.8	12.5	16.8	28.1	11.9	8.0	12.0	14.4	13.6	18.0	11.9	19.3	18.3	21.6	60.8	10.8	9.5	10.3	23.8	33.8	11.9	9.8	7.5	10.3	10.9	13.5	11.6	24.5	14.6	14.2	5.9	15.2	9.3	12.2	15.8	12.8	14.1	17.9	8.2	10.2	18.0	6.7	16.1	13.2	13.1	10.2	14.7	11.6	10.5	13.2	10.0	10.3	17.5	7.8	8.0	18.8	13.1	10.7	16.1	10.2	27.2	10.0	19.8	14.1	12.1	18.5	11.6	14.9	13.6	11.9	11.9	14.7	13.8	7.5	17.5	11.2	6.0	12.4	9.5	15.9	17.4	17.5	17.1	18.8	14.8	14.3	14.0	16.0	15.8	53.6	45.6	25.3	36.7	77.4	33.6	39.1	22.9	36.1	45.5	24.4	53.0	31.1	16.6	23.4	13.7	23.9	23.8	0.0	21.3	20.2	22.3	24.0	80.1	34.2	25.0	60.4	25.8	26.4	28.9	6.8	31.1	22.9	11.8	22.6	34.5	29.0	21.5	20.3	29.4	15.6	45.5	25.8	23.6	72.8	63.9	70.9	38.2	33.1	21.5	27.6
CTSA	"GSL, PPGB"	ENSG00000064601	"Cathepsin A"	P10619	20	45890144-45898820	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 125.7"	"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 279.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 113.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB024930, HPA031068, HPA072487"	Enhanced		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		18000000	Vesicles		"CAB024930: , HPA031068: AB_10601205, HPA072487: "	"unprognostic (8.61e-2)"	"unprognostic (3.37e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (6.33e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.40e-2)"	29.0	125.7	12.0	22.8	19.5	22.1	35.3	11.4	30.0	14.1	50.6	17.4	16.2	29.4	18.2	19.3	20.7	12.7	28.0	32.6	11.5	11.6	88.2	43.8	28.4	38.9	12.3	16.1	23.9	19.2	28.3	16.5	47.7	15.7	18.2	50.5	30.1	20.5	15.1	19.3	28.2	40.6	19.6	11.9	38.8	19.7	14.3	11.2	8.0	18.1	24.9	22.4	23.3	18.7	7.0	16.6	81.1	46.1	12.0	31.2	50.0	14.1	14.5	2.7	12.4	113.6	58.9	6.3	20.3	54.2	22.3	29.1	27.3	38.1	3.0	23.6	38.1	84.2	22.6	7.3	13.7	14.0	5.9	6.8	8.0	10.2	47.5	25.3	12.7	33.2	46.7	16.5	14.4	3.2	55.8	24.2	3.9	7.9	46.7	24.1	29.1	3.2	11.8	2.8	21.6	34.6	5.1	14.1	16.8	17.8	12.5	5.5	5.2	33.9	59.3	56.7	7.3	14.5	18.3	22.3	44.8	10.5	25.3	15.9	23.1	29.1	2.1	80.6	16.9	18.4	60.6	46.1	81.1	7.5	26.6	31.2	7.0	12.9	13.2	16.6	3.6	4.7	6.9	24.7	12.0	17.7	6.6	23.9	50.0	12.0	19.5	11.4	30.0	11.5	11.6	12.3	16.1	15.7	11.2	32.8	24.6	40.4	31.0	21.5	54.2	10.9	58.6	22.7	26.1	68.0	56.9	86.8	33.2	172.8	2.3	41.6	257.8	0.0	146.8	91.1	44.1	21.0	9.2	53.3	279.4	44.5	51.9	105.0	166.6	3.6	30.5	81.3	106.3	136.1	70.2	92.8	127.7	92.2	25.8	168.1	30.9	25.8	46.4	6.2	32.4	19.9	120.5	54.2	85.6	31.9
CUEDC2	"C10orf66, MGC2491"	ENSG00000107874	"CUE domain containing 2"	Q9H467	10	102423245-102432661	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036544, HPA041829"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA036544: AB_10670111, HPA041829: AB_2677694"	"unprognostic (2.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.24e-2)"	"unprognostic (9.78e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.48e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.58e-2)"	18.8	26.2	29.9	14.9	28.5	13.0	16.2	22.0	49.7	19.8	20.3	19.0	18.5	10.8	19.6	20.8	17.1	25.1	22.7	38.7	25.5	22.3	20.1	18.2	14.9	15.3	27.5	29.5	27.9	23.3	24.4	16.7	14.6	25.4	20.7	12.6	17.5	21.5	22.4	61.6	13.2	11.2	23.6	23.6	15.1	16.3	13.5	18.2	16.5	20.0	25.5	15.8	17.1	14.9	37.4	50.1	35.5	50.5	38.2	36.1	36.0	15.1	17.4	27.2	32.0	22.7	29.2	10.2	12.8	41.3	27.5	21.1	5.4	15.3	25.3	27.3	21.4	12.5	15.0	17.6	27.7	13.6	22.5	17.9	15.6	14.8	5.4	38.4	11.9	10.6	34.4	25.8	26.8	26.7	53.0	28.3	31.6	12.1	25.3	30.8	16.3	27.8	26.6	9.3	11.7	10.9	32.3	33.3	13.0	27.9	7.0	13.5	32.3	8.6	8.5	26.1	11.7	25.9	19.0	16.2	13.7	13.0	17.4	17.1	31.3	25.3	16.8	24.8	41.7	10.9	34.1	50.5	35.5	32.3	39.7	36.1	34.8	32.1	33.7	50.1	37.4	32.0	30.7	19.2	38.2	24.6	43.3	35.7	36.0	29.9	28.5	22.0	49.7	25.5	22.3	27.5	29.5	25.4	18.2	29.8	21.6	30.6	36.9	28.2	50.1	49.7	40.8	20.1	20.5	43.6	23.6	56.6	68.0	58.9	15.1	40.5	20.8	23.3	40.9	25.8	56.9	34.1	50.7	37.6	66.4	63.5	53.5	53.4	50.0	29.8	52.9	44.6	49.0	116.4	32.4	74.4	42.9	31.6	56.6	125.1	35.9	38.8	58.4	59.4	29.7	29.5	38.1	34.6	33.3	28.6
CUL2		ENSG00000108094	"Cullin 2"	Q13617	10	35008551-35090642	"Cancer-related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 245.9;Late spermatids: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002677, HPA024578"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002677: , HPA024578: AB_1847338"	"unprognostic (8.11e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (8.24e-6)"	"unprognostic (2.18e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.70e-2)"	"unprognostic (6.94e-2)"	"prognostic unfavorable (9.32e-5)"	"unprognostic (2.26e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.29e-1)"	16.2	14.9	17.2	12.6	22.6	14.3	13.6	16.8	20.9	11.6	14.3	9.0	18.1	11.9	13.6	9.5	14.3	12.1	10.1	15.7	15.4	15.1	12.2	17.2	11.9	15.4	14.3	20.8	12.9	17.7	21.4	19.3	21.9	17.3	13.3	13.0	7.0	12.8	14.1	33.7	14.2	12.4	16.1	14.0	15.1	14.5	27.9	15.4	20.3	13.7	14.4	16.6	15.6	12.3	11.4	11.9	10.0	13.7	11.3	17.4	7.7	20.0	11.9	15.7	13.5	18.0	19.9	16.7	23.8	13.3	23.6	23.8	15.9	19.3	16.0	13.2	25.1	17.3	18.6	22.8	21.9	27.1	18.8	14.9	20.9	12.9	14.0	19.8	11.3	13.8	19.1	18.3	25.8	9.0	18.2	26.2	17.1	23.9	14.6	25.7	13.7	18.8	6.3	5.7	13.9	48.8	15.9	25.5	10.0	21.6	15.8	7.7	10.3	13.3	16.8	18.7	18.3	12.7	13.0	24.0	14.6	16.3	24.9	15.5	6.1	8.3	19.3	28.1	25.7	10.2	9.6	9.3	10.0	12.3	13.7	17.4	10.8	14.0	14.7	11.9	11.4	16.7	15.5	4.4	11.3	13.3	5.4	16.6	7.7	17.2	22.6	16.8	20.9	15.4	15.1	14.3	20.8	17.3	15.4	20.8	9.3	10.7	8.3	10.6	12.2	23.2	7.6	22.7	22.7	8.7	9.8	21.0	13.3	16.2	245.9	19.5	10.6	0.0	15.5	16.7	11.8	7.8	19.7	17.9	17.5	22.3	10.3	12.9	19.7	133.1	13.0	19.8	10.1	24.4	9.5	15.3	15.9	7.0	11.0	11.5	13.0	0.0	14.1	33.9	31.3	11.4	31.0	18.1	11.5	8.1
CUL4B		ENSG00000158290	"Cullin 4B"	Q13620	X	120524609-120575794	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.2;Late spermatids: 113.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"fHDF/TERT166: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003046, HPA011880, CAB017786, HPA058979"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017786: , HPA003046: , HPA011880: AB_1847340, HPA058979: AB_2683868"	"unprognostic (2.34e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.91e-1)"	"unprognostic (3.88e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.12e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.87e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	20.9	24.0	19.0	19.2	28.1	12.2	25.3	28.9	25.7	32.6	20.5	12.1	25.7	14.0	24.2	47.2	29.3	19.6	18.5	19.4	18.5	20.2	19.1	20.4	23.8	23.5	17.3	20.4	30.1	18.8	34.4	48.3	17.0	18.4	30.8	17.2	15.7	17.3	27.3	10.8	17.7	16.3	36.0	20.5	19.9	17.0	34.0	17.3	29.8	18.8	13.9	24.1	40.4	22.5	7.6	12.5	15.4	4.3	5.5	8.3	4.9	11.8	10.0	8.4	8.9	36.9	18.8	6.7	26.9	32.3	22.3	23.3	9.0	33.7	11.9	9.2	61.9	39.5	8.8	17.1	7.9	25.4	6.9	8.9	5.8	14.6	6.4	16.0	6.2	8.3	20.9	6.0	12.8	11.1	40.3	39.8	6.4	8.9	9.3	21.5	6.3	8.1	6.5	12.7	13.4	10.2	6.9	8.3	12.1	7.4	5.9	9.5	8.0	19.9	9.8	9.8	10.9	8.3	5.7	52.4	16.0	8.9	21.4	24.1	5.9	10.3	14.8	17.4	8.5	14.4	5.8	4.3	9.0	7.2	3.8	7.7	7.6	7.0	6.6	5.1	5.7	7.9	8.3	15.4	5.5	2.7	12.5	8.2	4.9	19.0	28.1	28.9	25.7	18.5	20.2	17.3	20.4	18.4	17.3	20.8	11.8	6.0	8.4	13.5	15.6	14.3	7.6	17.4	9.1	14.0	13.7	8.8	11.6	8.5	78.2	15.7	9.9	0.0	7.7	19.0	13.1	10.1	13.9	13.5	14.7	23.8	23.6	43.0	28.3	113.1	19.8	13.7	11.8	8.2	16.6	13.0	13.8	3.5	20.1	9.8	12.9	12.9	13.4	11.3	12.1	12.0	8.4	12.9	13.0	8.3
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.5	20.5	7.2	21.9	26.8	12.3	3.9	7.8	10.1	7.9	8.9	9.4	7.3	34.7	7.0	13.3	3.9	8.2	14.7	13.0	8.8	10.2	14.0	11.5	9.2	14.8	12.4	21.3	5.6	12.7	8.1	12.6	26.2	9.8	13.5	20.2	10.1	7.7	5.9	6.6	19.1	22.0	7.2	9.7	7.7	13.0	8.5	13.3	8.3	3.9	2.4	5.4	3.6	5.7	9.8	10.4	9.1	12.2	7.5	3.3	4.4	3.6	10.3	12.7	16.5	24.3	10.8	45.8	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3	8.9	12.2	21.9	13.0	10.8	16.5	35.8	10.2	20.1	10.3	5.2	7.9	15.9	18.3	14.6	8.1	21.5	4.9	0.0	15.0	10.7	15.3	11.4	30.0	20.2	18.3	11.1	11.6	22.7	17.8	6.8	12.0	15.9	28.7	27.9	7.8	17.8	10.1	10.1	15.2	24.5	27.1	19.4	15.6	105.8	35.1	9.5	11.3	20.1	9.7	10.7
CWC25	"CCDC49, FLJ20291"	ENSG00000273559	"CWC25 spliceosome associated protein homolog"	Q9NXE8	17	38800434-38825481	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 29.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014874, HPA062997"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB014874: , HPA062997: AB_2684917"	"unprognostic (2.21e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.79e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.68e-3)"	6.0	4.4	5.1	5.5	5.8	29.7	4.6	6.6	6.2	5.5	4.8	4.4	5.4	5.4	6.0	3.6	3.9	3.1	4.5	3.0	4.3		4.6	4.8	4.6	6.5	5.0	3.7	5.0	4.3	4.0	7.8	7.5	4.4	5.1	4.1	4.4	4.5	6.3	7.6	8.6	5.6	4.3	6.5	5.2	4.0	10.4	5.8	7.8	4.6	4.4	6.4	5.4	5.6	4.5	4.8	18.0	5.2	3.4	4.4	2.5	5.9	7.4	5.3	7.4	6.5	5.3	4.6	6.2	4.8	8.8	6.7	6.2	6.2	8.0	4.5	5.9	5.9	13.6	5.9	4.7	9.5	7.0	8.3	5.6	7.5	6.5	6.4	13.8	9.1	5.5	7.5	7.1	6.2	7.6	5.4	8.6	8.7	8.1	5.7	3.9	14.3	14.5	4.7	5.0	4.5	10.5	7.2	6.3	7.7	6.0	5.1	4.7	6.1	4.1	7.4	7.6	6.3	11.0	5.8	6.1	5.3	7.9	10.0	7.3	5.8	10.3	6.6	7.4	6.0	7.6	5.2	5.8	3.9	3.0	3.3	4.2	3.6	3.7	3.6	4.5	4.4	3.3	18.0	3.4	4.1	4.8	3.1	2.5											53.6	65.8	41.0	55.5	56.7	36.2	16.5	20.4	42.8	40.9	22.7	78.5	31.2	24.9	23.9	91.6	38.3	59.9	0.0	20.6	29.6	30.9	43.3	57.7	21.2	25.2	25.4	40.1	33.7	24.5	18.9	34.5	34.1	25.3	34.3	24.6	32.1	24.1	42.1	32.5	21.6	45.5	38.8	31.1	88.3	31.3	67.0	66.1	52.2	22.8	57.6
CWC27	"NY-CO-10, SDCCAG-10, SDCCAG10"	ENSG00000153015	"CWC27 spliceosome associated protein homolog"	Q6UX04	5	64768930-65018763	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Dwarfism, Mental retardation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020344, HPA024149, HPA065809"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020344: AB_1856644, HPA024149: AB_1856645, HPA065809: AB_2685561"	"unprognostic (1.71e-1)"	"unprognostic (6.47e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.80e-1)"	"unprognostic (8.91e-2)"	"unprognostic (4.00e-3)"	"prognostic unfavorable (5.27e-6)"	"unprognostic (1.58e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.45e-3)"	15.6	16.4	22.0	14.9	30.4	21.7	16.4	30.1	25.6	16.5	17.5	13.8	14.0	11.8	19.4	15.7	17.3	14.9	13.8	22.1	20.6	19.9	17.5	12.1	12.8	17.0	22.3	20.7	23.3	10.9	21.4	28.8	17.5	26.2	18.6	18.7	11.4	13.3	16.0	24.0	13.8	15.9	24.7	23.3	15.0	13.9	19.6	23.6	22.5	17.2	18.2	18.6	18.6	20.0	15.1	14.6	8.6	11.5	17.0	15.9	9.0	15.2	10.2	18.4	34.0	15.8	19.3	20.5	16.1	13.4	18.0	19.0	17.0	19.4	22.7	28.2	16.7	20.3	9.7	19.2	29.1	32.9	18.9	15.7	17.0	17.2	14.1	24.2	17.8	11.6	12.8	22.4	22.7	28.9	16.0	19.0	26.0	16.5	15.0	17.8	15.2	24.7	16.1	14.9	8.0	12.4	23.0	24.7	23.6	17.1	13.3	21.9	9.7	19.6	8.0	18.1	18.3	17.4	26.2	15.8	10.6	18.7	16.9	25.6	11.7	15.2	22.3	19.9	31.3	18.8	8.6	11.5	7.9	12.8	11.3	15.5	15.1	14.2	15.9	14.6	11.9	15.4	15.9	2.5	17.0	8.5	12.0	15.1	9.0	22.0	30.4	30.1	25.6	20.6	19.9	22.3	20.7	26.2	23.6	8.9	25.8	20.1	22.0	14.5	30.0	55.8	20.4	33.5	14.8	14.0	13.7	36.6	18.3	35.9	197.3	26.9	10.5	23.3	28.8	45.9	24.6	20.8	18.5	10.5	28.6	19.1	28.7	14.1	17.2	37.1	35.6	23.8	13.5	29.7	16.0	31.3	33.5	10.5	33.9	21.9	53.9	32.3	28.4	43.0	28.9	17.6	25.7	23.6	26.6	17.4
CXADR	CAR	ENSG00000154639	"CXADR, Ig-like cell adhesion molecule"	P78310	21	17512382-17593579	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0"									"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		11000	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	4.0	3.1	6.4	3.2	9.4	1.3	5.8	2.0	15.4	6.3	27.1	12.5	9.0	24.9	3.3	9.3	15.0	6.5	17.2	10.8	7.9	5.5	5.1	28.6	9.9	4.2	9.2	5.6	1.1	12.0	5.2	11.1	0.3	11.6	9.2	15.4	3.7	16.3	15.8	0.6	30.0	41.4	2.1	13.0	1.4	17.6	8.5	6.9	0.9	13.1	4.9	3.8	14.7	10.0	0.8	0.4	2.6	0.5	0.9	2.7	0.9	5.6	3.1	15.4	0.0	0.0	0.0	9.3	0.0	0.0	0.2	0.9	32.2	4.9	2.0	6.9	0.0	4.6	9.8	7.8	2.0	0.3	3.1	6.6	0.0	9.2	20.8	1.0	0.6	0.0	0.0	8.5	0.4	0.1	3.7	3.0	1.9	0.1	0.1	0.0	0.3	1.2	0.0	37.3	5.0	0.0	0.0	5.2	4.0	12.9	36.0	6.2	4.2	3.6	4.1	2.1	16.5	8.6	0.1	0.1	0.0	9.3	0.1	2.2	1.5	2.5	0.1	1.2	0.0	0.2	2.6	0.5	0.4	0.5	0.2	1.0	0.3	2.6	0.6	0.1	0.8	2.7	0.8	1.4	0.9	0.2	0.4	0.5	0.9	6.4	9.4	2.0	15.4	7.9	5.5	9.2	5.6	11.6	6.9	131.0	63.6	1.5	156.7	287.2	15.2	27.4	137.6	50.9	55.7	97.7	25.5	1.0	5.0	109.2	4.3	2.0	199.0	0.0	81.3	0.2	6.8	133.1	5.7	114.1	0.6	0.0	77.6	70.6	23.6	4.0	2.0	5.3	21.9	1.0	96.0	11.6	81.7	112.0	0.0	4.4	10.0	6.5	3.8	4.2	22.3	300.5	0.6	3.8	81.0	165.3
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Cell type enhanced"	"Detected in some"	21	"Alveolar cells type 2: 17.5;Club cells: 3.4;granulocytes: 5.8;Kupffer cells: 5.0;Macrophages: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.4;HL-60: 6.9;HMC-1: 14.4;THP-1: 13.1;U-937: 12.9"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"		NA	NA			"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.9	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.1	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.5	0.0	13.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.9	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7	0.0	17.5	0.0	0.9	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.2	5.8	0.0	1.6	0.0	0.0	0.0	5.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.0	1.8
CXorf67		ENSG00000187690	"Chromosome X open reading frame 67"	Q86X51	X	51406915-51408843	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"placenta: 14.3;testis: 21.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 6.5;Spermatocytes: 4.9;Spermatogonia: 15.6"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 11.4"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.8"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	11	"B-cells: 1.1;T-cells: 1.2"	"Cell line enriched"	"Detected in single"	46	"U-2 OS: 27.7"									"HPA004003, HPA006128"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004003: AB_2667113, HPA006128: AB_2667517"					"unprognostic (4.21e-2)"			"unprognostic (6.36e-2)"		"unprognostic (3.37e-2)"	"unprognostic (8.58e-3)"	"unprognostic (3.57e-4)"	"unprognostic (1.47e-6)"	"unprognostic (4.55e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.26e-1)"		0.1	0.2	0.3	0.2	0.6	0.1	0.1	2.8	0.4	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	0.1	0.1	0.1	0.3	0.5	0.1	0.1	0.2	0.2	0.2	0.1	0.7	0.1	0.0	1.5	14.3	0.1	0.4	0.1	0.1	0.9	0.2	0.1	0.2	0.2	0.1	0.4	0.7	0.1	21.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.0	0.1	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.7	1.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.6	2.8	0.4	0.3	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	6.5	0.0	4.9	15.6	0.0	1.6	0.0	0.0	0.0
CXXC1	"CFP1, CGBP, hCGBP, HsT2645, PCCX1, PHF18, SPP1, ZCGPC1"	ENSG00000154832	"CXXC finger protein 1"	Q9P0U4	18	50282343-50288304	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044511	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044511: AB_10963081"	"unprognostic (4.47e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (3.82e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.08e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.41e-2)"	12.1	16.9	17.5	20.0	20.3	40.3	12.4	42.4	23.1	15.7	15.2	15.7	18.7	18.3	16.8	10.2	15.5	19.8	17.5	13.6	18.2	12.2	16.5	14.9	13.9	23.6	22.6	13.1	23.6	32.8	13.7	14.3	22.4	18.7	15.6	9.1	14.1	24.7	19.4	12.1	17.2	15.1	17.7	11.7	19.3	17.3	15.5	20.3	25.8	15.5	14.0	18.6	17.5	20.1	22.0	16.6	24.5	16.9	16.0	21.1	15.0	8.3	11.3	8.6	16.2	7.0	4.9	17.8	11.0	7.6	11.0	9.7	8.3	6.3	23.7	5.7	5.0	6.5	13.7	14.3	10.4	3.1	19.4	12.7	19.1	12.4	13.1	5.0	44.7	20.8	4.8	8.1	12.0	6.2	4.0	7.4	18.7	11.8	20.3	5.5	11.8	26.5	22.0	18.9	4.2	7.6	26.7	8.9	19.1	5.9	5.0	18.1	17.4	8.6	5.6	6.9	5.1	7.1	18.9	11.2	15.4	9.8	6.8	9.3	35.0	24.6	19.5	9.7	16.6	13.1	17.7	14.1	24.5	19.2	16.9	21.1	22.0	17.7	19.3	16.6	21.7	19.6	16.2	6.2	16.0	13.1	12.1	19.6	15.0	17.5	20.3	42.4	23.1	18.2	12.2	22.6	13.1	18.7	20.3	17.9	27.2	14.9	11.2	23.8	13.6	6.3	12.7	13.4	20.5	17.4	13.7	32.2	11.6	16.2	12.1	17.9	26.6	0.0	19.0	32.2	14.6	10.7	8.1	12.8	19.3	7.9	33.9	16.0	17.5	7.0	18.4	21.2	8.5	16.2	22.0	17.1	18.2	22.4	18.4	10.6	11.7	6.5	16.4	48.7	18.1	26.3	31.0	27.4	23.1	9.4
CYB5A	CYB5	ENSG00000166347	"Cytochrome b5 type A"	P00167	18	74250847-74292016	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 266.8"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 1827.0;Hepatocytes: 3445.7;Proximal tubular cells: 3021.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 154.8;RT4: 67.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006333, HPA047548, HPA058547"	Enhanced		Enhanced	Vesicles,Cytosol		No	No		780000	"Vesicles, Cytosol"		"CAB006333: , HPA047548: AB_2680084, HPA058547: AB_2683750"	"unprognostic (1.88e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (4.15e-4)"	"unprognostic (7.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (8.54e-2)"	25.0	13.2	4.3	11.0	5.8	1.5	39.4	6.9	5.9	7.5	68.2	4.3	38.5	37.7	4.9	16.0	8.3	7.0	34.8	14.5	4.1	3.7	76.2	266.8	67.0	9.2	6.5	3.4	25.1	75.3	10.1	6.5	7.2	5.2	13.5	9.0	6.2	7.6	54.9	4.3	11.4	70.7	21.2	11.5	10.3	18.0	12.2	5.5	4.6	4.6	7.9	4.3	21.6	18.8	34.9	16.9	2.1	12.9	10.2	38.0	13.5	10.0	17.2	9.0	0.0	154.8	27.5	12.0	6.9	15.1	14.8	22.3	20.3	11.0	12.3	4.9	12.7	7.3	22.5	0.0	9.5	11.8	22.9	11.9	4.5	9.4	53.8	24.0	8.6	5.9	46.1	7.6	8.4	4.3	8.9	8.1	11.0	7.3	4.6	12.4	18.1	4.8	10.3	4.0	14.2	11.2	12.0	2.9	0.2	14.8	67.5	25.7	10.7	6.7	18.4	8.2	8.0	36.4	8.2	7.6	0.0	11.6	3.5	8.8	3.2	13.3	3.8	9.1	2.4	8.5	1.1	9.6	2.1	16.7	10.8	38.0	28.5	18.7	19.6	16.9	34.9	18.4	23.1	1.1	10.2	12.9	14.8	14.4	13.5	4.3	5.8	6.9	5.9	4.1	3.7	6.5	3.4	5.2	5.5	592.6	899.4	80.0	70.0	87.0	10.0	73.8	919.7	746.8	1341.0	799.1	3.9	200.0	1827.0	177.8	6.0	109.5	224.5	0.0	443.4	144.1	156.3	120.6	38.2	3445.7	88.8	7.9	157.7	172.5	116.8	12.6	146.4	67.3	86.0	370.7	201.7	22.6	370.4	256.3	140.7	3021.0	12.1	51.8	70.7	13.6	36.0	195.7	37.2	60.9	256.7	159.2
CYB5RL	LOC606495	ENSG00000215883	"Cytochrome b5 reductase like"	Q6IPT4	1	54169651-54200036	"Enzymes, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 9.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA042671, HPA060463"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042671: AB_2678107, HPA060463: AB_2684286"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.90e-4)"	"unprognostic (6.45e-3)"	"unprognostic (9.75e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.80e-2)"	"unprognostic (5.08e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.86e-1)"	1.7	4.9	1.9	0.8	1.9	1.6	2.4	1.3	1.7	2.5	2.2			2.6	2.5	2.3	2.1	2.9	2.0	3.5	2.1	1.7	2.7	2.6	1.5	2.1	2.3		5.0	4.1	1.8	4.2	1.1		2.1	2.7		3.2	1.4	3.7	3.9	1.5	2.4	1.8	2.5	2.8	1.2			3.1		2.2	2.8	1.8	1.4	1.8	2.6	3.5	3.1	1.5	1.2	3.9	5.3	7.3	7.5	5.9	5.7	2.5	3.1	4.5	6.1	6.6	4.9	4.3	6.6	3.7	2.1	13.9	3.6	11.3	3.3	6.9	7.4	4.6	7.5	8.5	5.0	4.4	6.3	3.8	3.0	4.4	7.2	3.3	4.3	5.3	6.0	8.0	3.1	4.4	4.8	6.3	3.5	7.2	4.5	4.2	10.2	8.9	6.0	2.7	4.5	10.7	5.3	2.1	7.2	6.3	6.1	5.0	4.9	2.4	4.7	3.8	6.9	5.5	4.7	7.5	9.7	5.2	13.6	7.1	2.2	1.8	1.6	1.0	3.5	0.8	1.1	1.5	0.6	1.6	1.4	1.2	1.2	2.6	3.1	0.8	1.8	0.5	1.2											0.0	7.4	0.9	1.0	0.1	3.7	4.2	0.0	9.4	4.5	3.5	3.9	1.5	6.6	2.4	0.0	3.6	0.9	0.0	3.6	1.7	1.5	1.1	2.3	2.1	4.6	0.0	2.4	3.1	1.0	0.6	1.4	1.4	0.0	1.0	0.7	2.0	1.3	0.0	1.8	2.2	3.1	0.0	1.4	0.9	5.3	0.6	0.2	0.5	2.4	0.8
CYCS	"CYC, HCS"	ENSG00000172115	"Cytochrome c, somatic"	P99999	7	25120091-25125361	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Electron transport, Respiratory chain, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 109.6;skeletal muscle: 103.7"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1409.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004222, CAB005126, CAB018597"	Enhanced		Supported	Mitochondria		NA	NA		190000000	Mitochondria		"CAB004222: AB_627385, CAB005126: AB_2090472, CAB018597: AB_627383"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (2.81e-4)"	"unprognostic (4.44e-2)"	"unprognostic (7.04e-3)"	"unprognostic (5.67e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (1.30e-5)"	"unprognostic (1.18e-1)"	"unprognostic (4.94e-2)"	"unprognostic (8.75e-3)"	"unprognostic (7.04e-2)"	20.3	29.3	29.8	20.0	44.8	17.1	14.7	25.1	41.1	12.1	62.1	13.3	9.6	35.4	11.4	10.7	26.6	11.0	13.1	109.6	30.2	26.4	39.8	37.0	13.4	13.8	30.7	34.7	12.2	9.3	24.8	18.6	10.3	29.9	13.7	58.5	13.5	14.9	15.7	103.7	11.3	30.2	21.8	28.0	15.6	24.3	23.5	18.1	17.3	18.3	41.2	20.0	15.9	14.3	35.5	38.0	17.1	38.3	25.2	31.0	25.2	41.7	23.4	25.3	35.2	14.6	11.2	26.1	40.3	16.6	30.2	35.1	38.7	28.6	48.1	19.8	17.6	89.2	49.7	51.4	37.9	53.3	14.2	23.0	40.0	27.8	27.4	22.9	91.5	35.7	14.9	34.0	30.1	65.4	13.1	27.0	29.5	73.3	51.0	32.0	19.3	49.9	35.6	47.4	94.1	44.3	35.2	30.4	46.0	47.0	41.0	51.4	24.4	21.0	89.6	32.4	46.5	46.4	54.8	19.4	27.8	50.5	42.8	74.3	52.8	61.1	107.5	37.0	66.7	76.8	17.1	20.0	14.0	25.3	38.3	31.0	35.5	23.4	26.8	38.0	26.0	22.4	26.8	3.0	25.2	33.6	27.8	29.5	25.2	29.8	44.8	25.1	41.1	30.2	26.4	30.7	34.7	29.9	18.1	77.4	123.3	298.1	610.6	612.7	158.0	675.3	165.6	120.5	170.6	174.5	72.6	180.3	1409.2	260.2	374.4	142.6	539.3	116.8	187.6	286.9	225.4	312.0	210.9	174.2	320.2	125.5	369.3	82.3	121.9	99.1	83.4	292.4	560.1	339.0	300.1	181.9	228.9	349.1	88.1	469.8	154.2	135.8	467.2	297.7	184.8	625.2	292.1	228.4	388.1	691.0
CYHR1	"CHRP, KIAA0496, MGC13010"	ENSG00000187954	"Cysteine and histidine rich 1"	Q6ZMK1	8	144449582-144465677	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053653, HPA059543"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053653: AB_2682219, HPA059543: AB_2684056"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (1.58e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.54e-2)"	18.7	26.9	30.3	10.9	30.2	10.3	15.8	49.5	29.5	19.4	16.6	21.4	40.6	14.7	17.1	25.3	15.3	24.3	17.2	33.4	26.4	20.3	16.4	17.2	14.1	13.9	22.0	21.5	19.3	40.2	29.1	28.2	11.2	22.3	28.3	9.5	16.9	40.4	41.6	35.3	22.9	14.5	17.2	16.1	14.7	16.3	26.9	25.6	10.1	19.5	13.8	11.7	19.6	15.8	10.1	19.1	4.8	8.7	3.3	17.4	7.0	11.4	14.8	9.5	12.1	17.0	11.9	12.3	8.4	8.5	7.9	10.6	6.5	16.3	5.3	17.1	12.5	10.3	17.6	7.8	12.7	3.2	12.7	13.1	11.8	17.3	11.3	24.7	3.1	6.5	20.9	16.3	10.2	12.7	17.2	9.3	14.8	17.9	14.6	7.8	27.4	14.9	8.6	6.4	17.9	30.2	14.4	4.0	13.9	12.1	10.6	14.3	8.6	17.8	14.2	18.7	7.8	19.5	12.8	10.8	10.4	11.4	11.3	8.5	7.4	4.9	4.2	14.8	10.8	7.8	2.1	8.7	4.8	7.2	5.6	11.6	9.7	8.9	5.9	9.0	10.1	17.4	9.6	4.4	3.3	6.2	19.1	3.5	7.0	30.3	30.2	49.5	29.5	26.4	20.3	22.0	21.5	22.3	25.6	32.8	21.6	16.6	38.3	27.1	79.2	16.5	38.2	34.8	27.3	55.8	23.6	26.6	36.5	23.2	7.8	28.7	37.7	0.0	24.8	16.3	32.4	46.0	4.7	42.0	22.3	85.8	32.4	36.8	20.6	29.7	46.9	19.0	25.3	32.5	43.9	110.9	24.4	42.1	37.4	30.5	50.8	38.8	24.7	39.5	25.6	33.9	14.0	19.5	43.5	27.8
CYP27C1	FLJ16008	ENSG00000186684	"Cytochrome P450 family 27 subfamily C member 1"	Q4G0S4	2	127184120-127220078	"Enzymes, Predicted intracellular proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.6"	"Cell type enhanced"	"Detected in some"	10	"Club cells: 7.9;Collecting duct cells: 3.5;Leydig cells: 6.9;Pancreatic endocrine cells: 4.4;Suprabasal keratinocytes: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 8.4;HDLM-2: 12.1;hTERT-RPE1: 12.8;TIME: 12.1;U-138 MG: 12.4;U-251 MG: 8.1"					"Low region specificity"	"Detected in many"			"HPA062460, HPA068731"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA062460: AB_2732683, HPA068731: AB_2686023"	"unprognostic (1.90e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.03e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.31e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (6.29e-4)"	"unprognostic (3.49e-4)"	"unprognostic (1.83e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.64e-2)"	2.7	1.0	0.6	2.4	2.4	0.8	0.6	0.4	1.8	5.2	1.9	1.5	0.4	0.5	1.3	0.8	4.4	1.0	1.5	2.0	0.4	0.9	0.4	0.4	0.4	0.6	2.9	0.4	0.4	0.4	0.0	0.4	0.4	0.7	2.2	0.7	4.2	0.4	1.5	0.8	10.6	1.0	0.4	0.4	0.4	0.5	0.7	3.6	0.4	0.4	2.2	1.6	2.7	4.5	1.5	1.3	3.6	1.0	1.8	1.4	0.2	1.3	3.8	1.9	0.1	0.1	0.0	0.2	0.5	3.6	2.0	0.8	0.1	3.0	0.2	0.1	2.2	1.4	8.4	3.1	1.8	0.6	12.1	1.4	0.0	2.1	0.1	0.0	0.1	0.1	0.1	0.1	0.5	1.2	12.8	0.5	0.3	0.1	0.5	2.3	0.1	0.3	0.1	4.3	0.0	1.0	0.1	0.2	0.0	6.3	1.1	0.1	0.7	5.3	0.0	0.0	1.5	0.2	0.1	12.1	12.4	2.2	6.0	8.1	0.2	0.1	0.1	0.1	0.1	0.9	2.4	1.0	0.7	1.2	0.7	1.0	0.9	1.0	0.8	0.3	1.5	1.1	1.4	3.6	1.8	0.7	1.3	0.8	0.2	0.6	2.4	0.4	1.3	0.4	0.9	2.9	0.4	0.7	3.6	0.0	1.1	0.0	1.2	1.5	0.0	0.3	0.0	0.0	7.9	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.4	0.0	0.0	0.0	0.9	0.1	0.1	6.4	0.0	0.0	0.0	3.0
CYP51A1	"CP51, CYP51, CYPL1, LDM, P450-14DM, P450L1"	ENSG00000001630	"Cytochrome P450 family 51 subfamily A member 1"	Q16850	7	92112151-92142952	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"Monooxygenase, Oxidoreductase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 80.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 133.7;Club cells: 77.3;Early spermatids: 70.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 96.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041325, HPA043508"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA041325: AB_2677411, HPA043508: AB_2678520"	"unprognostic (6.68e-2)"	"prognostic unfavorable (6.12e-4)"	"unprognostic (3.48e-2)"	"unprognostic (1.18e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.59e-9)"	"unprognostic (1.82e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.09e-3)"	10.3	27.0	16.7	8.1	22.1	10.5	15.5	13.3	32.0	11.8	21.1	32.9	6.3	33.1	9.1	15.3	23.4	7.1	10.3	9.9	18.6	20.8	18.6	80.9	22.2	5.0	17.2	13.7	21.0	20.2	32.4	11.9	8.8	47.1	18.2	16.9	17.1	11.0	7.7	4.3	12.8	28.8	8.3	43.7	7.3	18.1	35.7	19.5	2.3	14.1	18.7	10.0	9.0	13.2	14.2	14.1	3.5	13.9	6.7	10.7	7.1	21.4	10.5	26.6	17.0	18.7	30.7	3.8	7.3	22.1	9.5	26.0	25.3	39.3	18.7	11.6	12.6	96.2	18.8	23.1	46.1	11.1	7.8	16.4	5.4	11.2	19.0	25.6	11.0	8.1	22.2	21.0	37.1	39.0	8.4	9.7	3.8	20.2	43.2	11.1	22.0	2.3	10.2	19.8	8.8	10.5	7.6	5.5	42.2	43.0	36.4	18.7	12.5	15.5	30.9	22.6	12.6	11.2	13.2	11.5	13.0	14.6	18.8	9.5	14.7	13.1	17.1	10.0	14.6	16.6	1.8	9.7	3.5	10.7	13.9	7.1	14.2	7.6	8.4	14.1	10.7	7.2	9.2	1.5	6.7	8.3	12.4	5.8	7.1	16.7	22.1	13.3	32.0	18.6	20.8	17.2	13.7	47.1	19.5	62.5	133.7	7.5	1.0	2.3	2.1	1.2	7.6	28.1	77.3	1.8	2.0	1.3	1.7	9.2	70.7	2.1	14.4	23.3	17.0	0.8	1.8	1.3	27.7	4.2	1.3	0.0	10.4	8.6	6.6	27.7	3.4	2.1	0.0	1.0	12.0	1.9	12.3	10.4	1.4	1.7	1.8	0.0	2.8	3.2	1.5	4.6	3.7	1.0	11.5	2.1
DAB1		ENSG00000173406	"DAB1, reelin adaptor protein"	O75553	1	56994778-58546734	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4;intestine: 20.8"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 20.8;Early spermatids: 6.5;Horizontal cells: 20.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 31.4"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.5"	"Group enriched"	"Detected in many"	16	"granulocytes: 1.4;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 6.0;fHDF/TERT166: 30.0;HeLa: 10.8;NTERA-2: 13.3;RT4: 17.7;WM-115: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB032329: AB_638973, HPA052033: AB_2681703, HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	1.8	1.7	5.8	0.3	3.8	0.0	0.7	31.4	6.2	1.7	1.0	1.8	0.5	15.0	1.0	1.0	0.6	1.6	0.8	1.8	5.3	1.4	0.7	7.5	0.8	0.2	1.1	4.2	1.2	0.7	0.0	0.7	0.0	2.0	4.0	0.3	2.9	5.2	10.2	0.6	0.6	20.8	0.3	1.1	0.6	1.0	0.9	0.7	0.0	0.8	0.0	0.1	1.9	1.0	0.0	0.0	1.4	0.0	0.2	5.5	0.1	0.0	0.0	6.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	0.0	0.0	1.1	0.0	13.3	0.0	0.0	3.2	0.0	0.1	0.0	17.7	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	1.4	0.5	0.0	5.5	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	5.8	3.8	31.4	6.2	5.3	1.4	1.1	4.2	2.0	0.7	0.0	0.0	0.0	0.0	0.0	20.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.1	20.6	0.0	1.3	0.0	4.3	3.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.5	0.1	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.7	0.0	0.0
DAB2	DOC-2	ENSG00000153071	"DAB2, clathrin adaptor protein"	P98082	5	39371675-39462300	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Differentiation, Endocytosis, Protein transport, Transport, Wnt signaling pathway"	"Developmental protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 194.4"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 1338.9;Proximal tubular cells: 964.6;Syncytiotrophoblasts: 1107.7"	"Cancer enhanced"	"Detected in all"		"renal cancer: 52.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"plasmacytoid DC: 26.6"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 26.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 43.0;ASC TERT1: 46.3;fHDF/TERT166: 67.0;TIME: 40.3;U-138 MG: 46.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009314, HPA028888"	Enhanced		Enhanced	"Nucleoli fibrillar center,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoli fibrillar center"	"CAB009314: AB_638976, HPA028888: AB_2672814"	"unprognostic (1.24e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (5.37e-3)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (7.38e-6)"	"unprognostic (3.11e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (9.67e-4)"	"unprognostic (1.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	51.6	44.2	2.6	12.2	3.5	0.6	21.8	6.1	2.6	16.6	14.0	4.1	4.5	3.3	16.6	34.8	10.8	9.6	13.3	25.1	2.9	3.0	75.2	6.9	22.4	31.8	4.0	2.1	12.7	11.3	3.2	3.9	194.4	4.7	11.6	14.6	14.6	12.9	5.3	12.7	9.3	10.4	16.0	5.2	21.1	7.2	8.7	2.5	7.3	10.9	8.4	7.4	17.8	14.7	0.1	26.6	2.2	2.5	0.9	1.3	7.0	0.0	1.6	2.5	5.4	43.0	46.3	3.1	27.8	28.4	11.0	18.1	20.3	0.1	0.0	1.7	67.0	10.8	0.0	0.3	1.0	15.4	0.0	0.8	3.7	36.9	6.6	10.4	0.0	4.8	28.8	0.0	17.8	3.2	17.0	32.9	1.9	0.0	0.9	18.1	0.1	0.3	0.0	1.7	0.7	3.0	1.0	6.3	0.0	7.3	0.6	0.0	0.0	3.3	1.8	15.5	4.1	0.1	0.9	40.3	46.9	5.2	5.4	2.2	0.0	0.0	0.0	16.3	3.4	6.1	2.2	1.2	0.2	1.3	2.5	0.0	0.1	0.2	0.7	3.4	0.1	0.1	1.0	1.8	0.9	0.6	26.6	0.2	7.0	2.6	3.5	6.1	2.6	2.9	3.0	4.0	2.1	4.7	2.5	35.7	35.6	25.8	1.3	12.9	0.7	50.4	61.1	9.4	7.9	90.7	66.8	112.4	167.5	58.4	0.6	97.7	30.4	23.3	1.6	14.9	120.5	7.2	24.3	2.1	1338.9	7.9	9.4	214.9	131.6	1.1	113.4	176.8	11.8	7.2	5.6	72.3	7.0	12.7	60.5	964.6	2.1	6.5	26.7	0.5	4.7	11.7	1107.7	10.8	19.2	0.7
DAP3	"bMRP-10, DAP-3, DKFZp686G12159, MGC126058, MGC126059, MRP-S29, MRPS29"	ENSG00000132676	"Death associated protein 3"	P51398	1	155687960-155739010	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Apoptosis	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023687	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA023687: AB_1847472"	"unprognostic (2.60e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (1.80e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.14e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	27.8	36.5	22.9	26.3	25.9	28.9	34.2	19.5	23.6	23.5	33.4	19.5	22.8	29.4	28.7	28.1	31.3	21.8	23.2	56.3	27.0	26.4	32.8	52.2	23.9	49.0	24.9	23.0	23.3	38.5	20.7	27.1	20.5	23.0	27.9	32.1	24.5	28.0	27.1	64.0	30.9	26.5	36.0	23.2	30.8	30.3	31.6	21.1	44.4	27.6	28.4	38.0	38.0	24.1	39.0	41.1	15.9	35.2	34.0	56.5	39.6	32.4	21.1	17.2	27.3	25.5	32.3	42.5	27.4	29.0	28.2	24.7	38.9	40.0	46.3	55.9	22.3	18.1	33.2	25.6	23.9	30.8	29.0	18.7	28.2	18.8	35.2	34.9	38.6	25.2	27.0	34.3	35.9	47.6	22.1	27.7	43.0	60.9	33.0	29.3	43.2	33.9	45.2	30.5	51.1	34.5	28.0	21.6	49.2	33.5	31.2	20.1	35.6	26.3	77.6	47.2	33.4	48.2	63.5	23.6	24.0	25.3	29.6	45.9	36.1	53.9	53.4	23.9	34.6	30.8	13.9	30.1	15.9	31.3	35.2	51.4	39.0	45.1	38.0	41.1	32.2	56.5	48.4	13.0	34.0	31.9	26.8	45.0	39.6	22.9	25.9	19.5	23.6	27.0	26.4	24.9	23.0	23.0	21.1	41.7	35.8	49.1	58.4	48.8	26.0	99.7	45.9	68.3	58.0	15.7	19.6	67.1	56.3	62.2	13.1	35.0	35.4	93.5	68.2	87.5	44.8	51.6	61.1	48.1	67.9	12.7	24.6	34.4	47.0	10.6	30.0	61.0	33.7	88.4	35.3	13.3	67.0	31.6	23.7	57.4	46.0	12.9	47.2	38.7	26.6	55.2	118.4	64.7	54.9	62.6
DARS		ENSG00000115866	"Aspartyl-tRNA synthetase"	P14868	2	135906677-135986100	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020451, HPA029804, HPA029805"	Enhanced		Enhanced	Cytosol		NA	NA		160000	Cytosol		"HPA020451: AB_1847479, HPA029804: AB_10599178, HPA029805: AB_10601994"	"unprognostic (6.13e-2)"	"unprognostic (8.16e-3)"	"unprognostic (5.54e-2)"	"unprognostic (5.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-2)"	"prognostic unfavorable (2.39e-6)"	"unprognostic (2.98e-3)"	"prognostic unfavorable (7.57e-4)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (6.54e-4)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (1.04e-1)"	"unprognostic (9.12e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.00e-1)"	30.3	29.7	35.0	27.6	35.5	19.7	34.9	18.0	28.3	27.6	25.4	25.6	26.9	14.8	30.1	26.7	44.4	26.9	19.6	29.8	29.0	28.8	34.6	35.5	19.7	32.3	32.1	25.6	34.0	27.0	26.4	24.5	31.7	23.8	31.0	20.3	20.6	26.6	28.3	45.1	30.6	21.4	42.4	33.8	29.8	23.6	12.8	25.0	42.0	33.0	33.1	36.7	45.3	30.2	48.6	30.5	11.2	18.8	36.6	42.7	30.6	47.9	19.7	16.8	17.8	18.8	23.6	38.6	24.0	26.9	26.3	25.8	42.5	20.9	56.0	37.6	19.7	19.2	27.7	25.8	31.0	47.8	25.6	23.1	34.1	19.5	44.1	24.3	45.5	22.7	22.7	25.1	29.3	26.5	33.6	14.5	26.3	36.5	17.9	21.8	22.5	34.9	39.2	19.8	19.5	18.8	42.6	36.6	39.1	31.6	18.7	12.0	22.8	18.4	16.7	18.7	18.0	18.3	32.5	10.8	23.0	23.0	16.9	23.8	49.3	26.8	60.2	36.2	34.7	14.2	6.0	18.8	11.2	27.5	18.3	41.2	48.6	41.3	36.0	30.5	43.8	42.7	37.0	7.3	36.6	14.0	29.2	36.9	30.6	35.0	35.5	18.0	23.8	29.0	28.8	32.1	25.6	23.8	25.0	56.6	49.0	70.0	90.1	67.0	59.0	74.7	38.2	48.2	51.2	43.6	31.4	98.6	77.9	93.1	1.7	54.2	20.6	23.3	71.9	123.6	68.6	66.4	31.2	58.6	82.4	50.9	37.0	53.4	79.2	4.0	64.2	52.3	59.1	111.0	39.3	83.6	78.4	23.0	72.2	75.2	23.7	51.8	71.3	25.1	45.4	63.2	114.1	63.3	53.4	76.3
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	10.4	14.3	10.7	13.5	11.9	8.8	10.8	11.3	14.8	11.8	12.2	9.4	7.3	11.2	13.2	43.7	13.5	12.6	12.1	9.1	9.7	7.3	9.2	12.0	10.3	18.3	10.2	8.5	13.8	18.6	24.4	10.4	11.6	11.6	13.0	14.1	7.3	10.7	15.2	14.8	11.6	12.7	15.5	8.1	20.4	10.5	20.2	11.5	25.0	16.1	6.8	30.9	11.5	10.9	17.0	5.9	12.6	11.2	15.3	18.2	21.8	2.1	0.0	7.1	2.8	1.2	2.3	4.7	7.0	22.9	17.9	13.2	0.8	2.4	6.9	2.5	5.4	20.5	1.3	0.1	5.7	16.6	8.2	15.6	9.0	12.4	11.1	3.9	9.6	2.6	6.0	8.5	2.0	5.3	5.3	0.5	4.5	5.0	4.5	5.5	5.2	3.8	21.3	0.4	0.1	3.3	5.9	0.1	7.7	1.4	0.7	8.5	2.2	0.0	0.4	3.7	3.5	2.2	0.2	5.9	4.4	5.6	0.2	0.1	7.8	16.2	14.9	3.3	4.4	4.7	7.8	7.5	12.6	16.3	8.0	18.2	16.6	15.4	15.8	5.9	17.0	13.9	14.1	7.4	15.3	11.2	5.9	17.1	21.8	10.7	11.9	11.3	14.8	9.7	7.3	10.2	8.5	11.6	11.5	6.0	21.4	27.0	17.6	52.0	17.3	7.5	15.3	14.7	25.0	12.2	17.7	21.7	19.9	29.4	9.8	20.6	18.0	0.0	33.3	29.5	26.3	21.9	35.9	13.5	21.9	14.3	20.2	11.6	13.7	4.7	16.4	20.8	23.6	60.5	19.5	17.7	46.9	21.0	21.9	11.9	73.3	12.9	23.7	48.8	34.9	53.2	20.7	51.7	20.9	30.2
DAZAP1	MGC19907	ENSG00000071626	"DAZ associated protein 1"	Q96EP5	19	1407569-1435687	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004201, HPA004631"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		1700000	Nucleoplasm	Cytosol	"HPA004201: AB_1078627, HPA004631: AB_1078626"	"unprognostic (1.50e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.31e-3)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.83e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-3)"	22.1	15.0	11.4	33.1	14.2	37.1	32.9	16.1	19.4	15.2	21.4	22.2	17.2	28.3	17.8	11.0	30.9	16.0	13.5	26.7	11.5	9.2	17.1	38.1	18.7	29.2	16.8	12.4	20.7	28.3	11.9	11.4	22.2	13.3	15.9	15.6	16.8	17.0	12.0	31.4	20.2	28.7	17.7	10.9	28.5	22.0	46.8	15.0	43.8	15.9	22.6	21.0	21.4	27.7	7.1	6.1	4.3	7.5	6.5	7.1	3.1	53.2	19.4	13.0	23.7	5.8	7.1	37.4	24.0	12.0	19.7	16.2	19.3	26.4	62.8	14.8	11.7	9.6	30.1	17.2	22.9	16.7	43.9	27.2	32.3	18.6	19.6	13.5	39.1	27.8	7.0	15.1	13.4	24.6	8.4	17.2	26.7	48.1	33.2	12.3	21.8	68.5	34.8	40.2	19.6	19.6	49.4	20.8	38.7	14.8	18.1	25.9	23.3	15.9	25.0	28.9	17.7	22.7	52.2	18.6	16.2	22.0	28.3	52.5	39.3	40.3	49.8	19.6	38.1	24.8	3.2	5.5	4.3	6.5	7.5	7.1	7.1	6.0	6.9	4.9	5.5	6.0	6.4	2.4	6.5	5.2	6.1	6.1	3.1	11.4	14.2	16.1	19.4	11.5	9.2	16.8	12.4	13.3	15.0	8.9	25.1	51.6	76.4	61.6	49.4	34.3	33.1	10.7	18.2	24.4	33.4	33.1	19.9	45.8	41.0	31.5	47.0	23.3	47.1	91.4	34.5	63.8	26.5	38.1	42.1	25.4	31.8	30.7	39.5	45.6	25.9	40.6	38.8	24.4	62.3	27.0	52.0	42.1	22.3	37.7	38.4	25.8	48.4	128.2	37.5	65.5	57.7	39.8	68.9	92.5
DBH	DBM	ENSG00000123454	"Dopamine beta-hydroxylase"	P09172	9	133636360-133659344	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Catecholamine biosynthesis"	"Monooxygenase, Oxidoreductase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"adrenal gland: 86.6;brain: 36.2;liver: 35.6"	"Cell type enriched"	"Detected in single"	43	"Ito cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	45	"pons and medulla: 36.2"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 2.0"	"Lineage enriched"	"Detected in single"	21	"T-cells: 2.0"	"Cell line enriched"	"Detected in single"	340	"SH-SY5Y: 206.1"	"Region enriched"	"Detected in some"	6	"pons and medulla: 23.2"	"Region enriched"	"Detected in single"	38	"pons and medulla: 25.1"	"HPA002130, HPA005960, HPA070789"	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	NA	NA		2000000000	Vesicles	"Endoplasmic reticulum"	"HPA002130: AB_2666554, HPA005960: AB_1078628, HPA070789: AB_2686312"	"unprognostic (1.93e-3)"	"unprognostic (7.52e-3)"	"unprognostic (8.53e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.18e-3)"	"unprognostic (3.38e-3)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.80e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.81e-7)"	"unprognostic (9.31e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.06e-3)"	0.7	86.6	0.1	0.3	0.1	0.0	0.0	0.1	0.8	0.3	0.0	1.9	0.7	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.5	35.6	0.3	0.6	0.0	0.0	0.1	1.3	0.0	0.6	0.4	36.2	0.8	0.0	1.0	0.2	5.9	0.0	0.0	0.2	0.0	1.4	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.2	206.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.0	0.1	0.0	0.0	36.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DBR1		ENSG00000138231	"Debranching RNA lariats 1"	Q9UK59	3	138161012-138174949	"Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035365	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035365: AB_10611956"	"unprognostic (1.20e-1)"	"unprognostic (3.72e-2)"	"unprognostic (8.48e-3)"	"unprognostic (2.04e-2)"	"unprognostic (2.83e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.24e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.33e-2)"	"prognostic favorable (1.36e-4)"	"unprognostic (5.37e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.79e-2)"	11.8	13.5	9.3	10.0	10.5	20.7	12.2	12.5	10.5	13.3	10.1	14.4	12.8	8.3	15.8	13.6	12.3	11.8	12.4	9.3	9.3	8.9	13.4	12.2	15.3	12.6	11.0	10.5	13.7	15.5	13.1	16.1	9.1	10.0	12.3	10.1	12.7	12.8	10.7	10.8	11.9	12.4	11.6	10.9	17.0	18.3	5.8	12.0	22.3	13.2	7.7	13.6	11.0	12.7	8.3	9.8	14.3	11.2	9.2	13.3	7.0	14.9	6.2	11.3	12.5	6.3	5.9	11.7	8.9	6.5	9.6	11.8	10.4	6.7	13.7	17.0	8.0	14.6	11.1	13.0	4.4	12.7	11.7	10.7	14.8	8.1	8.6	7.7	19.1	13.1	8.1	7.4	8.9	8.4	5.7	7.9	12.0	9.6	3.0	9.7	11.5	18.7	11.3	13.0	11.6	7.3	11.8	12.8	12.5	8.3	14.6	10.9	14.1	23.7	8.3	12.7	9.6	15.6	15.7	7.4	8.2	5.7	15.0	10.2	4.5	6.2	28.7	5.3	13.8	10.5	4.8	8.1	14.3	10.4	11.2	13.3	8.3	11.8	9.9	9.8	8.0	12.1	13.1	3.5	9.2	9.0	6.0	9.5	7.0	9.3	10.5	12.5	10.5	9.3	8.9	11.0	10.5	10.0	12.0	6.0	11.7	7.5	3.0	4.6	5.4	4.3	10.2	5.3	5.7	8.7	0.0	9.2	8.3	9.5	0.0	5.3	3.8	0.0	7.7	8.3	6.9	3.6	5.7	6.4	9.2	6.4	5.8	6.7	16.1	0.0	8.1	5.6	3.3	8.2	5.6	8.9	6.1	5.5	7.8	5.1	4.8	0.0	4.2	4.4	2.1	3.6	3.8	10.1	6.6	2.6
DCAF11	"GL014, PRO2389, WDR23"	ENSG00000100897	"DDB1 and CUL4 associated factor 11"	Q8TEB1	14	24114195-24125242	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003583, HPA031157"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003583: AB_2667001, HPA031157: AB_10603002"	"unprognostic (1.50e-1)"	"unprognostic (4.72e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.91e-3)"	"unprognostic (1.48e-3)"	"unprognostic (3.23e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.01e-1)"	"prognostic favorable (3.50e-13)"	"unprognostic (2.58e-1)"	"unprognostic (3.48e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.68e-1)"	7.6	20.8	14.4	12.1	15.4	21.7	10.3	14.2	23.0	8.1	14.0	11.5	18.7	23.7	8.8	14.1	13.5	10.5	13.6	13.9	14.1	10.9	15.3	56.2	9.8	13.1	12.3	15.5	11.8	42.5	21.1	12.6	8.6	10.4	11.6	11.3	12.3	18.3	19.4	26.8	8.9	25.2	9.5	9.7	14.2	14.4	13.4	9.4	13.1	17.1	13.2	10.5	10.6	7.3	12.8	18.0	20.9	16.5	23.9	17.2	14.8	6.2	10.5	5.1	4.8	5.9	4.7	9.3	5.1	7.8	9.5	8.9	6.6	10.5	11.0	4.9	6.6	6.3	9.1	8.7	7.4	6.4	11.2	5.2	10.5	11.2	33.5	8.0	13.0	14.6	5.2	8.6	4.9	9.6	6.3	6.9	14.5	6.9	11.2	5.5	19.7	12.9	11.3	3.1	17.1	9.5	12.1	9.5	13.0	6.9	16.0	10.9	7.3	4.4	15.2	7.7	5.8	8.9	11.1	3.9	7.1	5.9	5.7	6.1	17.2	16.2	13.4	5.4	10.5	7.9	15.1	15.3	20.9	15.8	16.5	13.7	12.8	14.2	14.4	18.0	12.5	14.7	13.7	13.2	23.9	13.1	9.3	17.2	14.8	14.4	15.4	14.2	23.0	14.1	10.9	12.3	15.5	10.4	9.4	26.8	50.8	26.1	16.7	7.8	34.9	33.5	33.1	20.1	22.7	36.6	45.2	27.4	39.7	34.6	15.9	12.7	79.6	93.5	40.4	26.6	14.9	21.0	11.6	112.5	32.6	15.9	27.7	18.4	19.3	20.4	8.3	16.1	16.9	40.5	34.2	28.5	29.3	33.2	13.8	39.6	26.0	25.8	13.3	12.6	10.2	9.9	42.2	37.0	39.4	17.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171756-24358052	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease mutation, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 37.0;kidney: 46.4;pancreas: 22.7"	"Cell type enhanced"	"Detected in many"	10	"Cholangiocytes: 61.1;Ciliated cells: 60.2;Collecting duct cells: 75.0;Distal tubular cells: 48.0;Ductal cells: 106.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 20.2;EFO-21: 14.1;Hep G2: 22.9;RPTEC TERT1: 74.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Enhanced	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		NA	NA			"Mitotic spindle, Cytosol"	"Microtubules, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.1	0.9	1.1	0.2	1.5	0.0	3.5	0.3	0.9	1.6	0.3	0.2	1.0	0.3	3.4	37.0	0.2	5.8	7.7	0.2	1.3	1.7	46.4	1.8	3.9	0.0	0.6	0.5	2.1	22.7	7.6	4.3	1.7	1.8	1.5	0.3	2.8	0.9	3.7	0.5	0.2	0.2	0.4	0.5	0.1	1.1	3.7	0.2	0.2	8.4	0.0	0.2	1.0	0.1	1.2	0.5	1.3	0.4	1.0	0.5	0.2	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	22.9	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.2	0.0	1.5	0.1	0.0	0.4	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.4	0.3	0.5	0.2	0.2	0.5	0.5	0.3	0.3	1.2	0.4	0.4	1.3	1.0	0.2	0.5	0.2	0.2	1.1	1.5	0.3	0.9	1.3	1.7	0.6	0.5	1.8	0.2	17.9	11.8	0.0	0.6	0.1	0.0	0.3	61.1	60.2	10.3	75.0	0.0	0.3	48.0	106.8	23.9	0.0	0.0	0.0	7.2	0.0	0.3	1.1	0.0	1.0	0.5	0.0	3.5	0.0	0.0	11.0	0.3	0.0	0.0	3.6	3.4	1.9	20.8	2.9	0.4	39.0	0.0	0.0	0.3	7.7	2.2	0.1	0.1	0.0	1.2	0.5
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 331.8;Rod photoreceptor cells: 442.7;Syncytiotrophoblasts: 325.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	Nucleoplasm		NA	NA		170000	Nucleoplasm		"CAB032821: AB_639050, HPA045174: AB_2679242, HPA068456: AB_2685992"	"unprognostic (3.45e-1)"	"unprognostic (8.38e-2)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.11e-2)"	"unprognostic (9.33e-2)"	"unprognostic (9.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (1.51e-8)"	"unprognostic (3.44e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.25e-3)"	19.3	83.3	19.9	14.1	24.9	16.1	19.7	22.9	33.8	21.3	16.2	24.9	33.3	18.4	23.9	30.6	19.8	26.2	17.4	21.1	18.1	20.8	21.7	26.8	16.0	21.7	18.3	23.4	31.1	23.5	107.3	22.0	80.3	27.3	19.4	17.8	33.0	23.9	27.2	57.1	24.1	19.7	20.7	16.7	17.5	19.7	36.1	14.4	33.3	22.1	20.4	21.0	22.6	17.9	19.6	30.5	17.8	23.5	22.0	32.5	23.8	39.3	42.5	41.2	36.1	39.3	37.1	62.0	37.0	47.9	45.0	34.1	45.9	33.3	59.6	33.0	50.6	26.9	36.8	60.5	44.1	48.6	30.1	32.8	34.2	40.7	47.4	27.6	48.8	29.7	43.7	30.3	44.4	38.4	31.4	48.3	25.5	68.7	32.6	39.5	47.8	60.2	23.0	54.7	24.8	36.7	49.7	52.3	62.3	31.4	43.7	36.8	37.5	40.0	46.8	36.8	38.4	58.0	20.7	39.8	32.0	30.2	36.5	26.2	37.6	39.7	52.9	35.3	26.1	30.9	17.8	20.9	17.7	24.8	23.5	32.5	19.6	22.4	24.8	30.5	17.9	20.7	23.1	2.5	22.0	21.0	16.8	24.4	23.8	19.9	24.9	22.9	33.8	18.1	20.8	18.3	23.4	27.3	14.4	26.8	65.3	45.5	43.2	46.8	67.6	79.5	38.2	42.8	48.9	50.6	331.8	218.9	14.9	38.9	12.5	47.4	47.5	0.0	36.5	109.7	39.2	49.2	29.0	61.1	65.3	82.6	71.2	47.3	39.9	13.6	78.9	30.6	40.5	42.3	50.3	62.6	44.2	28.1	58.4	41.7	442.7	32.3	39.2	87.4	115.3	52.2	325.6	38.3	51.6	46.7
DDI2	MGC14844	ENSG00000197312	"DNA damage inducible 1 homolog 2"	Q5TDH0	1	15617500-15669044	"Plasma proteins, Predicted intracellular proteins"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 54.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043119, HPA043225"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		170000	"Nucleoplasm, Cytosol"		"HPA043119: AB_2678326, HPA043225: AB_2678369"	"unprognostic (1.93e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.38e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.04e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.02e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.63e-2)"	"unprognostic (3.77e-2)"	14.8	8.1	5.1	10.5	7.1	10.5	15.0	8.7	8.4	8.7	10.8	8.2	9.8	9.0	12.3	9.6	19.4	7.7	8.3	12.5	5.8	4.7	10.4	24.9	10.2	9.1	6.7	5.2	8.3	9.4	14.8	8.0	11.5	7.5	12.1	7.9	11.5	13.5	13.8	54.8	13.3	9.2	8.0	6.5	9.9	6.9	4.3	6.0	11.1	7.6	11.7	16.4	12.1	12.3	3.8	5.4	0.8	2.3	2.0	3.5	1.4	7.5	4.4	8.0	8.3	11.0	8.7	7.8	4.7	3.6	4.2	3.6	10.7	6.9	19.0	5.6	5.2	3.1	8.0	17.4	7.6	7.1	8.7	11.6	14.8	7.4	10.5	4.7	19.6	7.5	8.6	9.1	7.8	8.4	5.2	8.5	12.4	23.8	7.0	5.1	5.1	11.3	6.5	7.6	11.2	3.6	10.7	11.3	11.2	5.9	6.3	9.8	5.4	8.8	14.4	13.1	9.4	7.5	5.1	7.4	6.0	5.2	6.8	5.8	6.6	8.0	15.4	4.7	14.3	4.7	0.7	2.3	0.4	3.3	2.1	2.9	2.6	2.5	2.6	2.3	3.8	2.8	3.5	0.8	2.0	1.6	5.4	2.3	1.4	5.1	7.1	8.7	8.4	5.8	4.7	6.7	5.2	7.5	6.0	8.9	15.2	11.9	12.2	13.6	23.7	23.0	12.7	29.4	22.7	3.5	13.7	17.5	1.7	6.8	1.5	12.1	15.1	46.7	6.6	16.1	13.9	22.6	1.1	54.8	13.2	33.4	14.5	16.0	21.2	0.4	11.8	12.5	15.1	6.4	22.4	8.0	12.5	3.5	6.3	16.5	36.7	6.5	12.3	10.0	7.8	17.7	33.6	12.7	20.1	12.7
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415562	"Enzymes, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 14.1;Muller glia cells: 9.1;Proximal tubular cells: 9.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.9;myeloid DC: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 10.9;RPMI-8226: 14.2;U-937: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	3.7	11.0	5.2	1.1	12.1	1.6	3.3	1.9	5.5	2.7	3.6	10.8	4.9	8.6	2.7	5.4	1.2	6.1	3.9	21.0	6.9	3.4	12.3	12.8	3.9	1.3	8.0	6.1	1.2	5.5	18.6	1.9	2.1	8.0	2.9	3.9	2.3	4.9	3.2	11.3	0.8	7.9	5.6	7.7	2.6	1.9	0.4	8.2	0.0	3.3	5.7	0.5	3.6	1.6	0.0	7.3	0.1	4.9	1.7	0.0	1.5	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.1	5.0	1.2	0.8	0.0	0.0	0.0	0.7	0.7	10.9	0.0	0.0	0.0	2.2	4.5	0.0	4.6	0.0	3.9	1.6	0.0	0.0	0.1	0.0	2.5	0.1	2.2	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	2.8	14.2	0.0	4.5	0.1	0.1	0.0	0.4	0.6	0.0	0.7	1.0	0.8	1.0	0.1	0.0	2.3	0.1	0.3	0.0	1.9	15.8	0.0	0.1	4.6	0.0	0.0	4.9	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	1.7	1.6	0.0	0.0	1.5	5.2	12.1	1.9	5.5	6.9	3.4	8.0	6.1	8.0	8.2	0.0	0.0	0.0	0.8	0.0	0.0	14.1	0.0	1.4	0.0	0.0	2.0	0.1	3.3	2.8	0.0	0.3	2.7	0.0	1.9	0.1	0.3	0.3	0.0	4.4	1.8	0.0	4.1	2.5	4.0	0.0	0.3	1.1	0.0	1.0	5.9	9.1	1.2	6.0	0.0	9.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.3
DDX18	"Has1, MrDb"	ENSG00000088205	"DEAD-box helicase 18"	Q9NVP1	2	117814650-117832379	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 90.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035400, HPA041056"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA035400: AB_10672091, HPA041056: AB_2677277"	"unprognostic (1.44e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.64e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.77e-3)"	"prognostic unfavorable (3.07e-4)"	"unprognostic (8.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.94e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.65e-2)"	35.3	21.3	20.5	28.7	26.0	17.4	31.2	27.1	25.6	31.2	27.9	16.7	21.6	20.9	32.0	22.9	27.8	28.5	21.3	22.9	19.6	19.1	32.0	40.3	24.1	35.0	25.5	22.9	36.3	29.5	21.0	25.9	25.0	25.0	25.0	30.3	11.5	24.2	26.6	37.0	24.9	26.3	28.3	30.8	46.5	26.2	22.9	31.1	40.7	31.3	23.9	37.6	37.6	23.7	22.2	20.5	9.4	18.5	17.2	23.6	16.3	22.0	10.0	15.0	13.5	8.9	8.0	24.8	13.1	10.4	18.1	16.0	24.6	14.6	32.5	21.5	10.8	16.8	17.1	29.0	16.9	26.8	16.5	20.3	31.0	9.4	24.7	12.4	41.4	16.2	8.3	15.7	23.0	23.3	9.2	10.8	16.9	33.8	14.1	13.8	13.7	22.6	21.6	37.6	18.7	15.2	19.7	23.4	28.4	12.0	13.1	14.4	24.5	15.2	16.8	17.0	15.9	10.6	22.9	8.3	16.2	23.9	11.4	23.5	16.3	20.2	90.0	11.9	19.6	7.2	6.2	13.8	9.4	16.2	17.3	20.6	22.2	19.3	18.5	12.5	19.1	23.6	20.7	3.6	17.2	18.5	20.5	15.0	16.3	20.5	26.0	27.1	25.6	19.6	19.1	25.5	22.9	25.0	31.1	89.3	53.4	123.6	65.7	171.3	131.1	44.8	122.3	89.7	94.4	115.1	78.5	95.4	99.5	87.4	10.8	105.7	49.3	23.3	99.4	101.8	89.3	52.4	108.5	162.0	78.1	77.9	54.6	103.7	79.2	10.1	98.7	99.7	87.7	93.8	85.3	76.8	106.8	59.6	97.6	93.5	118.7	64.7	108.2	111.4	127.7	140.4	74.3	107.1	93.0	50.8
DDX21	"GURDB, RH-II/GU"	ENSG00000165732	"DExD-box helicase 21"	Q9NR30	10	68956128-68985073	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity, rRNA processing, Transcription"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 515.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036592, HPA036593"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	No		14000	"Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA036592: AB_10673625, HPA036593: AB_2675208"	"unprognostic (3.04e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.12e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.39e-2)"	"unprognostic (9.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.74e-3)"	37.5	16.0	10.0	26.6	13.3	46.8	24.4	8.0	11.8	18.5	20.1	7.2	16.2	13.3	18.7	13.7	28.3	20.1	17.6	19.1	11.4	8.0	25.1	48.0	25.9	24.4	14.9	7.2	30.2	27.9	15.6	20.7	22.8	18.3	14.0	17.6	5.9	18.0	17.8	61.2	22.5	18.5	19.0	20.4	43.5	19.0	12.9	13.3	27.1	18.1	24.1	25.8	33.2	22.4	12.6	11.5	17.1	17.3	7.7	15.0	6.2	33.1	19.7	11.5	35.6	10.4	13.8	24.4	22.8	18.4	29.5	25.1	63.7	22.8	50.0	14.1	18.9	13.9	29.6	44.3	28.4	39.6	15.5	31.2	35.0	14.0	26.4	22.3	83.2	33.3	14.1	37.0	35.2	59.0	13.7	21.4	18.8	66.6	25.0	20.7	15.1	32.6	18.1	31.5	15.8	42.1	29.2	18.9	24.6	19.6	17.9	23.9	25.6	20.5	45.5	26.6	14.5	25.8	17.5	22.0	17.3	24.6	23.2	40.0	28.9	38.2	73.9	14.4	63.2	11.7	5.0	9.7	17.1	8.4	15.0	15.0	12.6	10.9	11.0	11.5	10.4	10.3	11.3	4.5	7.7	17.3	10.8	7.9	6.2	10.0	13.3	8.0	11.8	11.4	8.0	14.9	7.2	18.3	13.3	95.3	139.8	208.1	223.1	488.7	27.0	59.4	112.1	83.0	195.7	68.0	39.3	72.5	61.3	111.8	41.5	139.6	52.0	23.3	160.6	118.9	142.8	222.8	164.0	182.5	102.7	23.8	83.2	113.5	149.3	13.6	82.8	170.5	118.1	66.7	97.0	22.8	171.9	92.1	72.5	73.0	27.4	25.8	155.6	101.9	142.2	515.4	115.0	93.8	113.1	301.9
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.3	13.5	6.6	13.7	11.8	7.8	3.5	3.9	10.1	9.1	4.1	4.0	3.1	11.8	16.9	14.1	5.6	15.3	26.0	9.6	2.7	40.9	5.5	4.8	9.7	4.5	7.5	6.1	18.2	15.6	10.2	32.1	18.0	6.3	18.0	24.1	2.5	8.4	2.1	6.6	27.4	5.7	6.0	2.9	5.6	6.0	3.7	20.4	4.0	6.2	17.2	6.9	3.1	4.0	13.2	2.3	6.5	3.5	1.3	4.9	1.3	9.0	10.3	12.8	25.3	0.8	10.5	5.4	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8	20.8	37.5	38.9	22.5	12.8	19.8	3.5	7.6	48.2	27.3	3.5	21.6	11.5	5.0	7.9	0.9	17.1	14.7	0.0	7.0	10.1	12.1	18.4	34.8	5.8	8.7	14.3	16.6	10.4	8.9	2.2	15.0	21.5	8.5	8.2	7.4	10.4	7.8	9.3	11.0	4.1	27.3	25.8	12.7	6.0	5.9	11.8	14.2	27.4	8.6	20.7
DDX42	"RHELP, RNAHP, SF3b125, SF3B8"	ENSG00000198231	"DEAD-box helicase 42"	Q86XP3	17	63773603-63819317	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023447, HPA023571, HPA025941"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023447: AB_1847560, HPA023571: AB_1847561, HPA025941: AB_1847562"	"unprognostic (3.46e-1)"	"unprognostic (7.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.34e-2)"	"prognostic unfavorable (9.26e-4)"	"unprognostic (3.02e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.55e-2)"	32.4	28.2	27.1	26.3	39.4	24.2	32.5	34.1	40.7	39.1	31.2	33.7	20.9	23.0	39.2	30.7	26.1	34.4	35.1	25.6	25.6	26.7	23.0	25.7	26.4	27.5	29.6	35.8	43.5	41.8	36.8	26.2	30.7	34.1	39.0	28.0	28.8	34.0	35.6	44.7	29.2	26.7	37.7	27.3	26.9	30.5	28.6	21.5	33.2	26.1	21.8	33.7	42.6	25.4	7.6	5.0	8.4	4.4	6.7	6.6	2.8	30.9	32.6	29.3	30.1	29.8	24.1	31.7	30.5	27.5	28.0	27.5	30.6	20.5	43.4	12.0	34.1	23.2	24.9	33.1	27.1	37.1	12.7	21.7	32.6	31.6	37.1	29.4	37.7	22.4	30.7	25.9	25.3	30.8	23.8	27.7	22.5	36.2	18.4	28.3	25.3	36.0	21.1	28.0	24.9	17.5	31.5	50.5	22.2	25.5	36.6	18.5	35.1	23.0	41.6	26.0	43.3	28.5	31.2	29.4	41.4	25.3	16.7	35.8	20.6	16.5	40.0	21.3	20.9	21.7	2.6	3.9	8.4	6.2	3.2	6.6	4.1	5.2	6.1	5.0	7.6	6.6	6.4	2.9	6.7	4.4	3.0	3.1	2.8	27.1	39.4	34.1	40.7	25.6	26.7	29.6	35.8	34.1	21.5	74.5	54.3	18.8	21.3	27.7	38.2	41.5	22.9	75.0	64.8	34.9	35.3	28.4	11.6	24.6	7.1	33.8	21.4	0.0	23.3	19.4	28.9	33.4	29.0	26.8	20.2	47.7	39.1	29.4	29.5	9.8	45.1	26.6	13.5	54.1	34.3	42.7	31.2	24.6	47.4	18.9	43.5	38.8	36.0	46.6	53.5	26.0	22.9	19.5	33.8	26.7
DDX50	"GU2, GUB, MGC3199, RH-II/GuB"	ENSG00000107625	"DExD-box helicase 50"	Q9BQ39	10	68901278-68946847	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037388, HPA037389, HPA058196"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA037388: AB_10671752, HPA037389: AB_2675450, HPA058196: AB_2683635"	"unprognostic (2.05e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.90e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.02e-1)"	25.0	17.8	16.7	25.5	19.2	14.7	24.8	20.8	17.0	26.5	25.3	13.1	24.0	12.9	30.0	22.6	24.0	23.0	17.5	20.3	15.7	15.0	18.6	16.1	16.4	24.5	17.6	15.0	35.3	24.1	24.9	35.2	23.0	16.1	30.0	18.1	12.6	19.5	25.0	26.6	18.3	17.4	31.9	18.3	22.0	19.9	25.6	17.3	33.0	26.1	21.5	25.7	35.4	27.2	14.2	10.3	10.7	12.2	13.8	20.2	10.9	19.3	12.5	22.2	27.5	18.9	24.8	14.2	20.7	22.8	18.7	17.7	28.0	16.9	25.2	12.5	18.2	11.7	17.4	21.5	15.2	23.5	22.1	16.3	13.5	12.4	12.2	19.1	28.1	16.9	19.0	15.9	17.8	49.8	33.6	15.0	22.0	24.1	15.4	23.0	15.5	26.9	27.0	12.9	18.6	28.1	23.3	25.3	4.6	14.7	11.6	15.5	21.4	15.2	17.8	22.8	21.6	20.7	18.3	13.0	14.6	17.1	16.5	28.1	20.9	18.8	21.4	15.7	29.4	8.5	5.5	7.8	10.7	15.0	12.2	18.3	13.6	18.5	15.4	10.3	14.2	20.2	17.7	2.7	13.8	9.6	10.2	16.1	10.9	16.7	19.2	20.8	17.0	15.7	15.0	17.6	15.0	16.1	17.3	17.9	17.1	30.4	30.5	10.5	42.7	23.6	20.4	29.4	34.2	19.2	37.3	35.2	48.0	24.1	57.6	24.3	8.9	0.0	21.8	33.0	25.7	18.5	40.6	13.5	20.5	35.0	15.5	22.1	18.1	12.1	33.6	21.7	11.8	39.7	18.2	20.9	20.8	18.4	36.7	25.1	51.1	19.4	28.1	54.0	56.0	12.5	34.4	41.5	21.3	16.8
DDX55	KIAA1595	ENSG00000111364	"DEAD-box helicase 55"	Q8NHQ9	12	123602077-123620941	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039962, HPA044101"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039962: AB_2676774, HPA044101: AB_2678810"	"unprognostic (1.14e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.11e-9)"	"unprognostic (1.60e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (8.97e-12)"	"unprognostic (9.15e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.23e-3)"	15.0	13.5	12.3	16.4	14.0	27.7	16.3	21.4	13.9	13.0	13.2	15.7	16.2	12.0	14.7	13.2	14.2	15.0	11.8	8.8	11.4	10.9	10.2	17.8	11.2	19.9	15.6	10.3	17.5	25.9	13.8	20.3	12.3	14.4	14.4	14.5	11.9	15.2	12.6	12.6	21.4	12.9	11.9	10.5	18.8	11.6	11.2	14.8	16.9	12.2	12.5	16.5	11.9	23.1	13.4	12.8	7.3	10.0	12.2	15.7	8.5	10.1	14.5	11.1	11.2	9.6	7.6	16.8	12.6	4.6	11.3	7.8	16.4	7.5	15.1	10.1	5.5	10.2	12.6	16.9	9.4	13.2	11.3	15.3	20.4	16.0	12.1	7.3	25.0	16.1	6.4	10.0	13.4	15.5	8.8	8.1	12.3	20.8	8.0	7.9	10.5	24.5	34.1	17.2	11.8	14.4	18.5	11.9	9.8	7.9	17.7	13.2	11.0	10.3	13.4	17.2	9.7	23.8	16.2	8.3	9.8	12.9	15.9	15.6	14.8	18.3	27.4	9.3	18.0	16.6	2.8	9.2	7.3	12.0	10.0	12.7	13.4	11.6	12.5	7.5	11.3	15.7	14.7	5.6	12.2	5.9	12.8	9.1	8.5	12.3	14.0	21.4	13.9	11.4	10.9	15.6	10.3	14.4	14.8	20.8	11.5	9.0	8.3	9.7	18.5	2.2	7.6	13.4	10.3	7.0	21.6	11.2	6.6	9.6	42.5	10.5	5.1	46.7	10.4	13.9	10.1	8.4	24.3	8.5	12.6	14.3	6.9	6.2	6.6	50.7	15.8	7.9	6.8	4.6	10.5	15.6	11.6	7.0	13.8	5.4	25.4	6.5	8.5	17.9	19.6	14.8	6.4	10.2	8.3	7.8
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6, guanine nucleotide exchange factor"	Q9H4E7	6	35297852-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 43.5;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"	10	"Hofbauer cells: 76.8;Late spermatids: 127.4;T-cells: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 27.3;MOLT-4: 23.7;NB-4: 31.6;REH: 21.9;THP-1: 25.3;U-937: 37.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	2.9	2.0	4.5	34.8	4.6	30.3	3.4	0.9	3.1	4.3	4.7	6.9	4.7	5.3	3.1	11.1	15.3	2.7	6.8	2.6	3.8	2.7	3.1	2.5	7.5	42.7	5.3	1.0	2.0	16.5	0.7	5.1	4.2	4.8	10.6	4.0	2.9	14.1	6.7	0.9	14.4	15.2	2.4	7.1	32.6	8.3	6.7	5.0	42.6	4.7	9.3	51.7	6.7	8.6	13.9	21.0	43.5	13.8	25.9	31.5	20.7	7.5	0.0	0.2	0.2	0.0	0.1	9.6	0.8	1.2	0.2	0.2	0.4	3.2	9.0	2.7	0.4	0.0	5.0	0.0	6.4	0.1	0.3	0.3	10.1	0.1	4.0	0.2	18.2	13.3	1.5	8.2	0.1	7.4	0.0	0.0	27.3	4.5	21.7	0.0	3.9	23.7	31.6	0.4	0.9	0.9	21.9	0.2	12.1	0.8	5.7	0.1	0.0	0.6	1.9	1.7	0.4	5.2	25.3	1.2	0.1	0.2	0.0	0.1	12.4	11.4	7.5	0.0	37.9	0.0	16.3	13.8	43.5	31.5	11.0	25.8	13.9	25.7	31.0	21.0	12.5	27.1	26.1	26.7	25.9	9.9	13.9	26.9	20.7	4.5	4.6	0.9	3.1	3.8	2.7	5.3	1.0	4.8	5.0	6.0	10.1	30.6	16.6	10.5	2.3	0.5	5.1	2.7	6.8	5.2	0.0	20.5	0.0	0.7	44.9	1.7	2.9	0.0	8.6	14.6	1.5	5.8	17.3	0.5	76.8	3.2	4.1	3.7	28.3	127.4	2.6	28.4	6.8	7.2	8.5	0.8	5.8	10.5	1.8	0.2	1.6	0.0	1.2	4.2	0.7	10.3	10.5	75.9	7.2	12.7
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223868-18264823	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB015226, HPA054505, HPA057799"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	30.9	20.0	22.9	41.8	29.5	50.8	28.9	41.5	30.2	31.0	35.8	11.4	24.0	28.2	32.9	19.7	31.0	23.8	19.2	33.5	26.8	14.1	19.3	23.8	29.2	42.7	30.7	17.6	28.3	19.3	20.5	27.8	24.3	27.7	33.9	29.9	11.0	26.8	21.4	40.2	23.2	35.9	51.3	28.1	29.8	24.2	12.6	32.9	58.8	44.9	33.9	38.4	45.1	43.3	40.0	40.2	57.7	49.3	34.0	46.3	35.0	60.9	18.0	47.6	39.7	9.6	16.7	27.7	56.2	31.0	50.7	68.8	29.4	22.9	69.4	59.6	25.3	40.8	36.6	35.2	27.9	85.4	46.7	33.6	42.9	32.3	34.2	9.3	65.3	34.9	8.2	13.9	35.0	27.7	24.0	24.2	25.6	52.1	0.0	32.3	21.9	47.1	29.3	29.2	24.3	20.1	62.8	63.2	40.7	24.4	35.3	29.2	26.8	50.7	44.1	30.6	32.6	39.6	26.9	24.6	59.5	33.0	33.1	69.9	4.2	10.2	73.2	14.2	33.3	55.1	51.1	49.3	21.9	41.4	39.3	46.3	40.0	42.1	42.5	40.2	33.2	33.5	32.0	57.7	34.0	43.9	31.0	40.6	35.0	22.9	29.5	41.5	30.2	26.8	14.1	30.7	17.6	27.7	32.9	113.2	133.1	112.0	157.1	241.0	64.8	174.2	152.8	109.7	146.7	75.0	76.6	208.5	69.6	136.5	15.9	140.0	115.1	443.9	150.2	201.0	139.1	206.8	105.4	107.1	166.8	25.4	84.9	75.5	163.3	15.6	175.4	212.2	96.2	259.7	117.1	119.5	110.8	110.4	180.0	82.7	127.2	207.0	187.2	63.1	177.2	204.1	90.8	150.3	203.5	166.1
DENND2C	"dJ1156J9.1, DKFZp686G0351, DKFZp779P1149, FLJ37099, RP5-1156J9.1"	ENSG00000175984	"DENN domain containing 2C"	Q68D51	1	114582848-114670422	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.7;skeletal muscle: 31.1"	"Cell type enhanced"	"Detected in many"	14	"Basal glandular cells: 99.0;Basal keratinocytes: 97.0;Suprabasal keratinocytes: 150.2;Urothelial cells: 270.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 6.1;eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.1"	"Cell line enhanced"	"Detected in many"		"U-2197: 10.3;U-266/70: 22.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA029935, HPA054955"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029935: AB_10601208, HPA054955: AB_2682648"	"unprognostic (2.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.89e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.57e-2)"	1.9	0.7	1.5	0.7	1.5	0.8	1.7	1.4	1.1	8.6	1.1	0.5	0.8	0.6	4.2	1.7	28.7	1.0	1.1	1.5	1.3	0.5	0.8	2.1	1.7	1.7	0.6	0.3	1.1	4.0	2.4	3.6	0.3	1.9	2.5	0.6	1.6	3.0	1.4	31.1	10.6	0.6	2.4	0.6	0.5	0.8	4.5	0.2	0.0	1.3	16.0	10.4	6.2	6.6	0.6	0.1	6.1	0.2	0.3	0.5	0.3	1.7	0.0	0.1	1.2	1.5	1.7	0.3	0.5	0.9	0.6	0.9	0.2	0.0	0.0	0.8	3.5	1.2	6.5	1.2	4.0	0.6	0.0	1.6	1.0	0.4	0.1	0.5	0.0	1.6	1.7	3.9	2.4	2.0	0.1	0.2	0.4	0.1	0.3	2.1	5.1	0.2	0.1	0.8	0.0	0.9	0.0	5.5	0.1	0.1	4.9	0.0	0.0	3.9	0.1	0.4	1.1	0.8	0.3	0.2	0.9	1.3	10.3	0.1	22.5	4.0	0.0	0.9	0.0	0.7	6.1	0.2	2.1	0.5	0.0	0.5	0.6	0.1	0.4	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.1	0.2	0.3	1.5	1.5	1.4	1.1	1.3	0.5	0.6	0.3	1.9	0.2	26.8	2.1	0.0	99.0	97.0	21.6	6.9	12.7	20.1	4.5	7.0	19.6	0.1	0.0	5.6	23.7	8.7	0.0	0.0	6.4	0.0	5.3	46.7	2.3	11.0	0.2	0.0	0.0	13.5	3.4	9.1	4.6	1.6	6.8	1.0	0.8	2.0	20.3	0.0	2.1	0.6	8.7	0.0	8.5	23.4	49.0	150.2	0.0	0.7	0.5	270.3
DEPTOR	"DEP.6, DEPDC6, FLJ12428"	ENSG00000155792	"DEP domain containing MTOR interacting protein"	Q8TB45	8	119873717-120050913	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 67.6;skeletal muscle: 65.0"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 17.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 17.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 30.3;RPMI-8226: 54.0;RPTEC TERT1: 44.7;U-698: 15.9"	"Low region specificity"	"Detected in all"							"CAB020841, HPA023938, HPA023945, HPA024011"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"CAB020841: , HPA023938: AB_1847606, HPA023945: AB_1847607, HPA024011: AB_1847608"	"unprognostic (3.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.02e-2)"	"unprognostic (7.29e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.84e-2)"	8.1	30.2	6.4	5.2	11.0	1.1	9.7	5.1	9.2	18.9	12.7	17.8	5.7	7.8	16.0	5.7	7.2	12.7	6.1	4.3	7.3	6.3	22.7	7.5	2.7	8.5	9.5	6.1	12.5	5.6	13.3	13.6	4.4	7.5	6.4	4.8	0.7	67.6	7.9	65.0	4.3	7.4	7.7	8.2	5.3	20.0	2.1	11.5	0.7	45.0	20.7	2.7	4.8	5.7	0.1	17.1	0.3	1.5	0.3	0.8	0.8	0.0	1.0	0.1	0.3	6.4	1.9	0.1	0.0	0.1	0.1	0.1	0.7	0.1	30.3	0.7	0.3	0.0	0.1	1.6	0.0	0.1	0.6	0.8	4.1	0.2	0.1	3.9	0.8	7.1	1.7	2.9	0.2	0.1	0.0	0.0	0.5	0.0	5.0	0.1	2.0	0.0	0.7	0.4	13.2	1.0	0.1	1.4	54.0	44.7	1.2	0.9	0.2	0.5	3.3	0.9	0.9	2.9	0.1	0.0	0.1	0.2	6.4	0.1	13.4	3.1	15.9	1.9	1.1	0.2	0.0	0.8	0.0	0.2	1.5	0.7	0.1	0.3	0.6	17.1	0.1	0.8	0.5	0.3	0.3	0.1	0.8	0.3	0.8	6.4	11.0	5.1	9.2	7.3	6.3	9.5	6.1	7.5	11.5	6.0	9.4	4.5	12.1	4.6	2.2	2.2	15.3	0.0	5.7	24.4	0.0	0.5	72.9	3.3	1.3	3.6	3.9	0.0	10.6	1.5	8.2	11.1	11.5	10.5	2.8	0.0	16.0	4.3	11.8	1.1	10.9	7.6	13.5	1.8	2.9	0.9	1.3	20.9	3.2	24.6	0.4	0.0	1.7	3.2	3.2	4.8	0.3	0.0	14.7	16.9
DHODH		ENSG00000102967	"Dihydroorotate dehydrogenase (quinone)"	Q02127	16	72008588-72027664	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Pyrimidine biosynthesis"	Oxidoreductase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 72.4"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA010123, HPA011942"	Approved		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Cytosol"	"HPA010123: AB_1847648, HPA011942: AB_1847649"	"unprognostic (4.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.81e-1)"	5.9	4.2	4.7	8.8	5.1	2.9	5.0	2.7	5.0	5.9	4.4	6.1	1.4	3.4	6.6	2.3	5.1	5.2	2.3	11.5	4.3	3.0	6.6	72.4	3.4	5.5	4.8	2.7	6.2	9.9	7.1	4.0	2.6	5.2	3.9	4.8	5.9	6.0	4.4	11.7	4.0	3.0	7.5	4.0	3.5	3.4	4.3	5.4	4.0	3.6	7.1	5.1	3.5	3.3	11.2	13.4	3.9	8.1	9.3	12.9	6.8	7.4	15.5	4.5	7.5	2.4	3.2	8.6	6.4	2.6	9.7	7.5	12.2	6.8	16.8	8.7	3.5	5.4	7.9	8.9	6.9	11.5	3.8	8.4	9.2	7.5	12.0	6.8	12.7	6.8	3.1	7.1	11.7	12.3	3.1	7.0	11.4	14.0	3.1	5.9	19.8	12.0	12.2	10.2	12.7	6.1	15.2	5.9	17.7	5.8	4.9	5.4	6.3	8.6	9.2	4.2	5.8	8.2	6.4	3.0	8.9	5.5	8.4	9.3	5.9	10.9	28.4	4.6	14.0	8.1	3.9	8.1	0.9	9.3	7.7	12.7	11.2	8.9	9.0	13.3	10.6	12.4	12.9	2.1	9.3	5.6	13.4	7.1	6.8	4.7	5.1	2.7	5.0	4.3	3.0	4.8	2.7	5.2	5.4	3.0	9.6	9.5	6.4	4.9	5.7	12.1	7.6	9.4	1.2	7.0	3.9	12.0	5.0	6.6	2.1	6.7	0.7	0.0	4.4	9.6	6.0	5.0	8.1	106.1	6.9	3.2	1.2	2.5	5.3	2.3	2.6	3.4	11.8	3.6	4.4	4.8	5.2	2.9	2.1	20.1	4.2	0.0	9.9	7.9	8.0	3.3	2.4	5.0	6.2	4.1
DHX15	"DBP1, DDX15, HRH2, PRP43, PRPF43, PrPp43p"	ENSG00000109606	"DEAH-box helicase 15"	O43143	4	24517441-24584550	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047047	Approved		Enhanced	"Nuclear speckles"		NA	NA		30000	"Nuclear speckles"		"HPA047047: AB_2679916"	"unprognostic (4.46e-3)"	"unprognostic (2.47e-2)"	"prognostic favorable (5.74e-4)"	"unprognostic (3.35e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.53e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.60e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.77e-3)"	"unprognostic (2.51e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.59e-1)"	"unprognostic (5.41e-3)"	34.3	29.6	23.2	32.1	27.5	42.5	33.0	38.0	27.6	31.1	31.9	29.5	24.1	22.8	37.5	23.4	40.8	30.6	22.9	32.6	22.8	18.8	30.0	29.5	31.2	34.7	29.4	17.7	36.5	35.9	42.5	32.8	39.2	27.4	28.2	37.7	22.4	34.1	24.9	36.5	36.0	30.7	30.7	22.8	32.4	32.4	21.0	27.9	58.3	33.5	31.6	43.0	35.4	35.7	20.3	26.7	31.4	24.1	24.5	28.8	17.7	30.1	29.6	49.1	24.3	24.2	23.6	29.3	35.2	31.0	37.2	37.0	30.0	36.7	55.5	21.7	28.8	43.4	25.3	63.1	42.4	58.0	20.3	29.9	48.1	32.4	24.2	14.2	49.5	33.2	19.7	25.5	36.2	24.5	23.9	31.0	26.2	45.0	22.4	42.1	22.8	64.9	33.2	53.4	30.2	26.9	42.8	57.6	25.9	44.3	43.5	42.2	26.4	27.3	26.3	24.7	36.8	28.8	25.7	28.3	31.6	20.8	23.8	41.0	17.0	28.6	66.4	21.1	40.5	37.5	31.4	20.2	18.8	21.1	20.6	28.8	19.9	23.6	24.5	26.7	20.3	24.9	23.7	9.7	24.5	24.1	17.8	25.8	17.7	23.2	27.5	38.0	27.6	22.8	18.8	29.4	17.7	27.4	27.9	71.5	53.1	27.6	56.7	87.6	28.3	26.0	28.1	49.5	71.7	26.2	21.6	64.7	31.5	51.9	23.9	49.1	52.6	0.0	36.1	61.0	55.6	53.7	55.4	42.4	39.4	25.4	58.2	47.3	49.9	11.8	36.5	48.1	45.5	36.1	59.4	22.6	47.7	37.4	37.8	26.9	28.3	25.8	58.7	54.9	45.5	87.4	73.8	35.5	57.5	79.7
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000184047	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207663-122226568	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 9.3;Extravillous trophoblasts: 9.1;Hofbauer cells: 5.7;Syncytiotrophoblasts: 11.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001825, CAB003857, CAB016688"	Supported		Enhanced	Mitochondria		NA	Yes		21000	Mitochondria		"CAB003857: AB_365498, CAB016688: AB_1615783, HPA001825: AB_1857247"	"unprognostic (3.67e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.40e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.40e-1)"	17.2	29.7	21.9	15.5	24.0	26.7	24.8	21.9	30.1	20.4	25.9	29.0	14.3	20.6	22.2	36.6	23.5	21.8	19.2	20.3	21.2	26.8	31.7	37.2	15.8	20.9	28.3	23.6	22.4	32.6	22.9	30.6	28.5	27.0	21.1	24.2	22.4	22.2	20.2	25.8	18.2	21.3	21.8	29.2	18.5	19.8	62.7	21.8	23.2	26.9	23.0	22.8	20.5	17.9	32.8	35.0	27.5	29.1	29.9	32.1	26.8	19.2	38.3	27.1	18.4	19.5	19.1	20.8	20.1	19.8	23.7	21.3	33.1	10.1	23.6	18.9	18.1	17.6	19.2	29.5	24.0	28.1	20.4	23.0	25.9	15.8	30.3	27.7	27.8	10.8	26.3	17.1	27.9	41.9	26.9	27.3	23.6	29.6	10.0	23.0	28.8	22.7	40.9	21.8	27.7	36.0	20.7	27.0	25.9	26.7	30.1	25.7	26.2	26.8	10.8	21.8	31.9	36.3	19.6	18.6	18.3	22.5	20.7	18.1	21.9	36.6	33.8	23.3	21.5	24.0	23.6	28.9	27.5	30.4	29.1	29.1	32.8	28.4	28.4	35.0	26.0	27.9	28.2	12.7	29.9	26.5	26.8	32.1	26.8	21.9	24.0	21.9	30.1	21.2	26.8	28.3	23.6	27.0	21.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0
DIS3	"dis3p, EXOSC11, KIAA1008, RRP44"	ENSG00000083520	"DIS3 homolog, exosome endoribonuclease and 3'-5' exoribonuclease"	Q9Y2L1	13	72752169-72782096	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"rRNA processing"	"Endonuclease, Exonuclease, Hydrolase, Nuclease, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 123.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039281, HPA058762"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039281: AB_10795583, HPA058762: AB_2683810"	"unprognostic (1.61e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.97e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.35e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.03e-1)"	25.5	14.7	11.7	17.6	24.8	23.8	22.4	23.4	19.4	20.3	18.8	11.6	17.0	11.8	18.0	19.3	23.1	17.8	16.0	21.6	12.4	13.6	20.2	25.6	19.3	22.2	13.9	17.0	23.4	15.3	15.8	22.8	26.3	18.7	18.0	15.6	9.8	17.4	19.3	19.9	17.3	17.9	17.5	12.9	22.8	16.2	27.7	14.6	23.7	21.3	19.1	23.0	26.7	19.3	6.9	6.8	11.1	9.7	10.3	10.0	5.0	15.7	7.4	14.5	12.2	15.5	18.5	9.6	14.1	17.2	14.4	17.7	11.2	13.2	19.2	12.3	14.4	9.1	13.1	19.8	16.2	23.4	15.7	14.6	22.5	15.8	10.1	19.3	38.0	13.1	19.3	11.4	16.3	21.6	14.4	15.4	14.7	15.0	8.1	17.5	5.5	16.1	18.7	13.6	24.1	8.7	13.0	11.1	8.7	14.4	12.7	13.1	17.3	11.5	9.7	13.6	15.8	9.3	17.4	14.3	8.7	7.1	9.8	14.8	15.6	17.5	15.4	24.4	18.1	12.6	11.1	5.5	7.8	6.5	9.7	9.4	6.9	8.5	7.3	6.8	6.0	8.1	7.6	3.4	10.3	7.6	4.3	10.0	5.0	11.7	24.8	23.4	19.4	12.4	13.6	13.9	17.0	18.7	14.6	32.8	30.4	16.8	29.7	22.7	38.6	24.2	25.5	37.5	45.5	8.7	27.5	20.7	19.9	16.8	123.4	38.3	15.1	0.0	17.3	19.4	13.5	23.6	32.4	21.2	12.8	30.2	29.2	25.2	16.2	100.0	26.7	13.6	11.8	31.5	15.2	20.6	18.9	2.9	26.5	13.6	39.7	6.5	19.6	23.7	35.3	27.4	18.9	21.0	18.6	45.4
DNAJB2	"CMT2T, HSJ1, HSPF3"	ENSG00000135924	"DnaJ heat shock protein family (Hsp40) member B2"	P25686	2	219279267-219286900	"Disease related genes, Predicted intracellular proteins"		Chaperone	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036268	Approved		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA036268: AB_10670793"	"unprognostic (2.02e-2)"	"unprognostic (3.69e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.45e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.03e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.98e-2)"	"unprognostic (5.62e-3)"	19.9	34.1	48.9	10.1	51.3	14.0	20.9	43.1	62.6	18.4	14.9	51.6	19.8	13.9	13.7	29.0	15.7	25.6	16.3	26.9	52.6	46.8	23.2	16.6	19.4	13.8	65.7	43.4	26.2	41.3	27.8	28.7	16.4	50.0	24.3	10.2	17.2	36.1	23.7	57.5	37.7	14.3	10.3	71.3	14.6	20.7	24.1	54.0	5.2	27.4	10.9	12.1	13.4	41.2	3.8	1.8	5.2	2.9	3.5	2.6	1.1	13.1	5.4	8.7	8.1	18.5	8.9	11.6	12.7	10.7	11.5	9.7	25.3	8.2	8.1	15.5	12.1	26.1	19.0	11.0	14.1	6.5	17.1	4.6	15.9	9.6	12.0	12.3	2.6	14.5	8.6	40.9	12.4	15.3	20.5	5.0	9.1	2.7	9.3	8.4	6.8	4.3	3.2	5.1	11.5	10.2	5.1	7.1	4.8	12.5	9.4	8.0	9.3	14.7	15.1	24.2	24.0	11.2	5.3	6.5	16.6	32.5	4.7	10.9	10.4	3.0	13.3	16.6	2.5	12.1	0.0	1.1	5.2	2.2	1.0	1.7	1.7	2.1	1.9	0.7	3.8	2.6	2.6	1.2	3.5	2.9	1.8	2.2	1.1	48.9	51.3	43.1	51.0	52.6	46.8	65.7	43.4	50.0	54.0	17.9	32.7	22.5	39.8	25.3	96.5	55.2	25.5	32.1	17.0	36.6	53.0	32.3	66.3	51.1	34.5	19.9	30.4	93.5	29.1	27.6	27.7	53.0	25.3	16.3	24.5	76.3	51.5	19.6	16.2	53.9	33.6	17.5	30.4	30.7	37.8	72.2	54.1	23.0	36.7	38.4	79.6	19.4	26.9	45.0	19.3	44.2	57.7	26.6	18.3	19.2
DNAJB4	HLJ1	ENSG00000162616	"DnaJ heat shock protein family (Hsp40) member B4"	Q9UDY4	1	77979175-78017964	"Plasma proteins, Predicted intracellular proteins"	"Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 89.8"	"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 151.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.6;HUVEC TERT2: 43.5;LHCN-M2: 73.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004995, HPA028383, HPA028385"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB004995: AB_425882, HPA028383: AB_10599601, HPA028385: AB_10599944"	"unprognostic (1.21e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.40e-2)"	"unprognostic (4.76e-3)"	"unprognostic (4.32e-3)"	"unprognostic (3.93e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.22e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.01e-2)"	23.3	39.0	19.2	8.4	20.7	4.9	16.6	22.7	24.1	21.3	12.7	7.2	9.3	5.4	20.8	10.1	25.0	11.7	25.2	42.0	18.0	16.8	16.0	15.5	21.7	7.0	25.7	9.1	15.3	18.5	16.4	19.1	19.5	23.8	19.4	9.4	5.1	7.0	12.2	33.3	7.6	8.8	23.0	29.5	30.3	11.9	7.8	22.5	2.8	35.1	29.4	5.1	22.1	89.8	3.6	5.0	4.5	1.9	3.1	7.2	2.6	1.4	2.8	3.5	2.1	15.3	28.6	1.6	27.8	7.1	12.4	14.0	0.9	1.8	2.1	4.7	13.2	5.1	2.1	4.5	2.4	21.2	2.3	1.2	1.0	8.3	6.7	20.8	0.5	0.5	11.8	6.7	16.0	4.6	6.9	43.5	0.7	4.5	1.5	73.8	0.1	0.6	1.5	2.2	0.4	1.3	1.1	6.2	1.3	2.9	0.7	2.5	0.8	3.2	2.3	2.6	3.8	0.9	0.9	20.7	17.5	4.3	12.4	3.6	1.3	0.4	1.8	2.3	1.2	3.0	4.5	1.7	2.7	2.6	1.7	4.4	3.6	3.2	3.1	1.7	3.0	7.2	5.1	0.4	3.1	1.9	5.0	4.2	2.6	19.2	20.7	22.7	24.1	18.0	16.8	25.7	9.1	23.8	22.5	56.6	4.6	13.3	77.1	37.1	28.0	82.6	10.2	30.8	20.5	17.4	64.8	46.9	31.5	10.5	126.4	66.1	19.8	23.3	12.8	18.9	83.6	23.4	57.5	18.1	15.9	28.6	20.5	33.2	21.3	48.4	22.7	19.0	62.4	6.4	4.0	35.7	14.8	17.5	32.9	22.8	56.8	25.8	119.1	21.1	13.2	34.4	151.4	15.2	6.5	27.1
DNAJB6	"LGMD1D, MRJ"	ENSG00000105993	"DnaJ heat shock protein family (Hsp40) member B6"	O75190	7	157335381-157417439	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Suprabasal keratinocytes: 839.6;Urothelial cells: 816.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004670, HPA024258, HPA058593"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004670: AB_425825, HPA024258: AB_1847795, HPA058593: AB_2683767"	"unprognostic (4.37e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.26e-3)"	"unprognostic (6.66e-3)"	"unprognostic (4.68e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.71e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.41e-2)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.52e-1)"	24.0	23.1	38.0	17.9	35.0	51.3	40.5	42.2	41.3	17.1	25.5	21.7	19.1	14.5	23.3	38.8	33.2	20.9	17.3	37.0	31.7	32.2	24.5	16.7	19.4	16.4	37.6	32.2	22.8	18.8	17.2	20.2	24.4	37.7	19.5	17.2	15.3	20.1	25.6	96.9	34.2	15.6	31.7	33.9	17.2	16.8	38.3	35.2	12.2	17.9	23.5	21.9	23.4	51.9	32.7	30.4	74.3	48.1	35.5	42.1	55.0	37.8	23.0	28.0	28.3	28.4	25.8	25.9	42.6	34.9	39.7	43.6	31.3	38.3	14.6	80.3	31.5	36.1	24.3	19.0	29.8	61.6	29.2	26.0	26.1	13.9	22.1	26.2	19.3	22.0	22.6	28.9	30.0	14.3	39.9	29.5	15.7	42.3	14.6	50.8	25.7	48.2	38.1	56.0	26.8	30.7	26.0	20.2	20.3	32.7	23.2	16.9	44.7	33.3	26.1	31.1	60.4	19.0	27.4	36.7	25.1	19.1	59.7	36.6	28.0	39.9	17.1	35.7	44.5	31.7	70.6	41.5	48.8	36.2	41.6	36.1	32.7	33.2	37.2	30.4	28.1	42.1	39.3	74.3	35.5	48.1	27.6	38.9	55.0	38.0	35.0	42.2	41.3	31.7	32.2	37.6	32.2	37.7	35.2	44.7	57.9	61.6	535.0	672.2	87.1	103.2	40.8	135.1	83.0	92.5	76.6	239.3	164.2	120.8	82.9	125.4	92.1	46.7	61.0	198.1	160.4	315.0	212.0	42.7	149.9	89.0	185.4	94.5	124.0	94.1	139.8	162.9	268.2	444.6	63.2	102.0	105.0	73.7	190.2	165.4	87.6	97.0	208.1	297.0	373.7	839.6	425.0	152.3	79.1	816.5
DNAJC8	SPF31	ENSG00000126698	"DnaJ heat shock protein family (Hsp40) member C8"	O75937	1	28199456-28233025	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026275, HPA026283"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026275: AB_2671823, HPA026283: AB_10600907"	"unprognostic (1.42e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.71e-2)"	"prognostic favorable (6.95e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.07e-3)"	"unprognostic (9.57e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.50e-2)"	"prognostic favorable (2.39e-4)"	"unprognostic (4.84e-2)"	27.3	26.9	35.9	27.8	40.1	27.5	27.7	33.6	40.7	26.3	27.2	33.6	15.8	22.6	33.1	25.9	24.5	23.6	22.5	30.5	31.2	31.7	29.0	29.1	23.4	38.5	34.2	32.5	32.0	15.0	20.0	23.8	32.4	38.2	30.0	25.4	21.4	20.7	26.1	26.4	21.8	21.8	36.0	33.0	30.3	22.3	15.7	36.0	30.8	35.1	19.9	42.8	29.6	27.7	31.9	34.8	29.6	30.8	29.6	37.0	44.0	24.9	12.9	20.4	23.4	24.7	20.3	18.2	20.8	26.0	42.0	38.6	13.5	20.4	28.7	21.6	23.1	20.8	15.5	29.9	20.4	44.6	22.5	22.2	36.8	19.8	23.9	22.3	36.2	30.4	15.5	18.3	26.5	14.0	19.8	27.8	23.9	34.3	20.2	30.6	14.5	27.5	25.4	36.9	15.6	15.0	31.3	30.2	27.5	26.7	20.6	7.4	19.1	27.3	11.7	24.6	15.8	16.8	29.6	21.3	18.8	20.4	41.9	30.9	19.2	25.1	45.1	25.2	44.3	25.4	29.6	30.5	27.8	37.0	29.3	37.0	31.9	33.5	36.1	33.1	30.7	33.6	34.1	16.2	29.6	30.8	34.8	35.1	44.0	35.9	40.1	33.6	40.7	31.2	31.7	34.2	32.5	38.2	36.0	71.5	77.9	119.9	114.0	115.2	95.1	130.7	76.5	89.7	100.1	101.2	23.6	164.5	228.8	122.3	29.6	126.6	51.6	70.0	85.7	129.7	132.6	93.6	134.3	64.5	156.1	65.2	44.2	86.5	68.5	31.5	111.7	136.1	97.8	171.3	45.8	156.0	94.7	57.5	135.4	133.6	90.4	84.1	106.1	126.5	83.5	96.4	187.4	117.7	62.3	94.7
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		10000000	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	15.4	16.2	24.9	14.8	34.4	22.3	14.3	40.5	37.8	13.0	14.5	12.4	14.9	12.3	16.5	16.5	19.8	13.3	11.9	25.4	26.1	28.1	19.4	12.8	11.2	13.8	23.4	23.2	14.1	9.8	28.7	18.8	16.0	27.9	19.3	16.0	12.1	11.1	21.1	25.6	11.8	11.0	21.7	21.7	11.6	12.2	23.1	14.9	13.4	15.2	17.4	15.8	16.9	12.2	5.9	17.0	5.0	14.6	7.2	7.9	7.1	21.3	21.4	22.4	23.0	18.2	18.6	43.4	24.1	18.5	22.8	21.1	29.9	16.4	28.8	16.9	21.7	23.3	19.3	23.6	27.7	27.4	15.2	19.2	32.8	20.6	16.5	15.0	23.2	17.3	16.8	14.1	24.0	24.8	21.9	27.5	15.0	23.6	12.5	26.0	8.3	9.2	19.5	47.3	13.6	10.5	15.7	42.2	19.7	19.2	29.5	19.6	20.1	25.6	17.6	18.7	52.0	20.2	15.9	24.8	19.4	19.6	45.5	22.3	8.8	23.7	30.0	18.9	15.6	14.7	5.0	9.7	3.1	5.6	14.6	6.8	5.9	6.0	5.9	17.0	5.2	7.3	7.9	1.7	7.2	13.6	5.4	6.1	7.1	24.9	34.4	40.5	37.8	26.1	28.1	23.4	23.2	27.9	14.9	35.7	38.5	29.4	27.6	26.7	71.7	69.9	20.4	26.8	40.9	24.4	123.7	25.6	26.6	27.7	51.2	34.9	15.4	0.0	21.8	50.9	25.9	26.7	49.7	14.8	27.0	119.2	29.3	25.2	33.3	58.7	24.7	32.4	13.5	44.1	18.9	66.0	35.1	14.0	28.7	19.5	150.0	19.4	37.0	66.2	50.8	24.1	30.1	27.7	23.8	31.5
DNTTIP2	"ERBP, HSU15552, TdIF2"	ENSG00000067334	"Deoxynucleotidyltransferase terminal interacting protein 2"	Q5QJE6	1	93866283-93879918	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044502, HPA053707"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044502: AB_10960277, HPA053707: AB_2682236"	"unprognostic (2.95e-3)"	"unprognostic (3.84e-2)"	"unprognostic (6.21e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.41e-1)"	"unprognostic (8.92e-2)"	"prognostic unfavorable (1.90e-6)"	"unprognostic (7.94e-2)"	"unprognostic (5.57e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.80e-5)"	"unprognostic (2.59e-1)"	"unprognostic (8.41e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.06e-2)"	14.0	8.5	10.7	7.3	11.4	27.6	10.9	12.0	12.5	12.4	9.4	5.8	7.9	6.1	9.4	14.1	15.1	9.7	9.7	11.4	9.4	10.3	14.5	15.1	12.1	10.7	10.4	10.5	15.9	8.3	9.9	12.1	15.5	17.7	13.0	8.1	4.6	9.0	7.3	24.6	11.7	11.7	11.0	13.2	16.2	9.0	12.0	10.9	15.9	16.2	12.6	10.7	17.3	15.5	11.1	7.2	15.8	11.6	11.9	11.6	8.0	12.4	6.0	6.8	7.1	6.5	5.8	10.3	8.4	6.0	10.1	8.7	6.6	5.6	16.7	11.3	8.8	12.7	7.1	10.8	10.1	14.4	10.1	6.1	13.7	9.9	9.6	6.8	15.3	4.9	6.4	11.0	10.8	9.1	5.1	7.2	5.5	16.1	5.8	13.7	5.4	10.7	10.0	13.0	5.6	9.7	6.2	14.4	6.4	10.3	9.7	8.1	7.3	8.8	13.2	9.2	9.0	5.7	11.1	6.8	8.2	8.6	9.4	14.1	6.1	8.1	13.7	4.8	12.1	5.4	10.9	7.9	15.8	9.6	11.6	11.6	11.1	8.9	8.7	7.2	10.5	8.2	10.4	12.1	11.9	10.7	5.0	8.8	8.0	10.7	11.4	12.0	12.5	9.4	10.3	10.4	10.5	17.7	10.9	53.6	74.1	43.3	98.3	48.3	31.6	69.0	10.2	117.8	117.2	12.2	55.0	44.4	18.3	60.2	28.9	60.6	13.1	23.3	52.7	36.6	31.7	61.4	112.5	16.6	33.8	19.1	8.1	20.9	24.1	7.4	23.9	59.5	21.9	64.1	12.1	30.7	68.6	15.3	24.4	14.7	29.6	19.4	106.0	54.0	70.5	44.3	46.7	46.5	19.7	80.3
DOCK1	"ced5, DOCK180"	ENSG00000150760	"Dedicator of cytokinesis 1"	Q14185	10	126905409-127452517	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Phagocytosis"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.5;plasmacytoid DC: 2.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004378, HPA048692, HPA053277"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004378: AB_2094604, HPA048692: AB_2680495, HPA053277: AB_2682097"	"unprognostic (4.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.49e-3)"	"unprognostic (8.98e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.12e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.61e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.83e-2)"	17.1	7.7	27.4	8.1	36.8	1.0	17.4	6.9	25.4	23.5	12.5	27.4	14.3	12.2	18.3	18.0	13.8	17.6	16.2	12.9	24.4	17.8	18.9	9.0	12.8	8.0	34.5	11.4	24.2	12.1	38.6	5.3	17.9	25.0	16.1	13.0	9.4	15.4	18.3	9.7	30.0	13.6	21.2	25.4	8.7	11.0	6.6	32.3	2.2	25.1	9.1	5.5	14.5	18.5	0.0	2.3	0.0	0.7	0.8	0.0	0.0	6.4	12.3	24.0	17.0	12.3	16.6	5.3	12.9	27.3	9.2	9.8	7.6	7.4	0.0	4.3	19.0	8.4	7.3	7.6	9.6	10.8	0.1	7.3	4.0	8.1	8.9	12.1	0.0	6.0	13.4	2.9	9.5	20.7	22.0	21.1	0.0	0.0	0.0	13.8	6.4	0.0	0.0	5.9	4.9	5.5	0.0	15.7	0.1	9.1	7.1	1.4	10.2	13.5	7.6	12.0	17.7	1.9	0.0	22.0	16.6	6.6	4.2	12.3	0.0	0.0	0.0	13.3	0.0	10.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	2.3	0.0	0.0	27.4	36.8	6.9	25.4	24.4	17.8	34.5	11.4	25.0	32.3	29.8	16.9	0.0	12.4	15.2	0.0	10.1	7.6	25.4	23.9	21.0	0.0	12.0	0.0	11.0	9.3	21.5	15.7	0.0	6.2	10.1	12.7	11.5	0.0	7.3	4.9	0.0	5.2	27.0	4.5	18.9	30.2	4.9	6.8	3.6	14.8	7.1	11.6	7.0	34.3	7.8	1.3	12.9	13.4	1.8	7.9	14.2	10.5	0.5	11.7	8.8
DOCK3	"KIAA0299, MOCA, PBP"	ENSG00000088538	"Dedicator of cytokinesis 3"	Q8IZD9	3	50675241-51384198	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 20.8;Early spermatids: 10.4;Horizontal cells: 31.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 7.6;GAMG: 7.5;HMC-1: 6.1;JURKAT: 7.2;U-87 MG: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037543, HPA037544"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			Cytosol		"HPA037543: AB_10672495, HPA037544: AB_10670383"	"unprognostic (1.02e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-3)"	"unprognostic (6.35e-8)"	"unprognostic (2.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.34e-2)"	"unprognostic (1.45e-2)"	"unprognostic (5.83e-5)"	"unprognostic (7.96e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.24e-1)"	1.6	5.5	15.3	1.7	19.8	1.6	1.7	24.2	38.9	1.7	2.3	11.6	1.9	1.7	2.1	2.7	4.2	2.2	1.9	4.6	11.5	9.8	1.9	1.3	1.8	1.8	9.1	17.6	1.7	2.0	15.8	9.2	1.5	13.1	3.8	1.9	1.8	3.2	5.0	4.3	4.0	1.7	3.1	8.5	1.8	1.7	9.0	10.7	0.0	17.4	0.0	1.9	2.0	0.7	0.7	0.7	0.2	2.0	0.6	1.3	0.0	0.1	0.2	0.2	7.6	0.0	0.0	3.3	0.1	0.2	0.4	0.3	0.2	0.5	0.0	0.6	2.4	7.5	0.5	5.1	0.0	0.1	4.3	5.3	0.1	1.3	0.1	0.1	0.2	6.1	0.1	0.1	0.2	0.0	0.4	0.0	7.2	0.0	0.1	0.6	0.2	0.0	0.0	2.5	0.3	2.4	0.0	0.7	0.0	0.4	0.7	4.7	0.0	0.3	4.3	0.1	5.5	0.1	0.0	0.5	0.2	2.1	0.2	2.7	0.3	0.0	0.0	10.1	1.0	0.1	0.0	0.1	0.2	0.5	0.4	0.5	0.4	0.4	0.2	0.1	0.7	1.3	0.5	0.2	0.6	2.0	0.7	0.1	0.0	15.3	19.8	24.2	25.3	11.5	9.8	9.1	17.6	13.1	10.7	0.0	1.1	0.0	0.1	0.0	20.8	6.7	0.0	0.0	1.2	0.0	2.0	0.0	1.7	0.0	10.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	31.8	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	4.9	0.0	1.4	3.5	2.9	0.1	0.0	0.0	0.0	0.0
DOCK5	FLJ21034	ENSG00000147459	"Dedicator of cytokinesis 5"	Q9H7D0	8	25184723-25418082	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 87.6;Melanocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA017719, HPA056837"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA017719: AB_1847820, HPA056837: AB_2683253"	"unprognostic (2.16e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.25e-2)"	"prognostic favorable (1.91e-4)"	"unprognostic (8.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.61e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.69e-2)"	"unprognostic (4.21e-2)"	"unprognostic (4.18e-3)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (1.18e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-1)"	5.5	4.3	12.1	10.4	30.3	26.2	7.2	3.3	18.2	6.3	11.5	38.8	12.1	14.9	6.3	7.8	4.3	7.6	9.6	8.0	15.1	7.6	4.8	16.2	10.7	4.7	35.0	9.4	10.4	5.7	6.3	10.8	15.6	18.8	9.4	13.4	10.8	7.9	14.3	3.3	7.1	17.0	5.3	17.0	21.9	9.2	7.8	33.8	0.6	18.5	2.3	2.7	5.6	5.8	0.0	1.6	22.0	4.6	0.3	0.3	0.2	10.4	21.8	2.1	0.2	5.1	5.5	7.9	25.3	12.9	6.2	4.9	3.1	7.5	0.3	2.3	19.6	6.9	18.2	2.4	16.0	9.9	3.4	3.2	10.5	18.8	7.7	5.9	2.4	11.6	3.7	6.5	6.9	10.2	6.8	5.3	0.5	0.1	0.5	6.0	6.0	0.3	4.7	2.2	11.6	6.9	0.1	4.9	0.2	4.5	6.1	1.6	0.7	13.3	7.3	2.4	1.9	2.3	2.3	15.9	10.7	7.5	13.2	9.1	0.5	0.1	0.2	13.8	5.5	13.4	7.6	1.9	2.6	0.3	3.8	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.2	22.0	0.3	4.6	0.2	0.0	0.2	12.1	30.3	3.3	18.2	15.1	7.6	35.0	9.4	18.8	33.8	41.7	40.4	5.2	9.8	16.5	8.1	12.0	30.6	24.1	28.4	14.0	2.0	22.6	0.0	10.3	0.8	6.8	50.5	0.0	10.5	87.6	24.9	31.8	30.1	25.8	13.1	1.6	16.8	10.4	55.4	2.6	26.7	42.6	81.0	2.8	23.5	26.2	31.4	24.6	45.3	2.7	1.6	12.9	7.6	0.7	5.5	6.4	17.2	6.4	19.8	11.1
DOK7	"C4orf25, Dok-7, FLJ33718, FLJ39137"	ENSG00000175920	"Docking protein 7"	Q18PE1	4	3463311-3501473	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 19.1;skeletal muscle: 17.0"	"Cell type enhanced"	"Detected in some"	11	"Cardiomyocytes: 11.9;Collecting duct cells: 5.2;Early spermatids: 5.5;Intestinal endocrine cells: 5.8;Late spermatids: 4.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.0"	"Group enriched"	"Detected in some"	8	"cerebellum: 8.7;pons and medulla: 2.5"	"Group enriched"	"Detected in some"	14	"memory B-cell: 6.3;naive B-cell: 3.8;NK-cell: 3.2"	"Group enriched"	"Detected in many"	15	"B-cells: 6.3;NK-cells: 3.2"	"Cell line enriched"	"Detected in some"	4	"MCF7: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059449, HPA062780"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA059449: AB_2684023, HPA062780: AB_2732688"	"prognostic favorable (8.45e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-2)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.96e-2)"	"unprognostic (6.80e-3)"	"unprognostic (1.05e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.61e-3)"	"unprognostic (5.09e-1)"	"unprognostic (3.16e-2)"	"prognostic favorable (1.28e-4)"	1.2	0.5	0.1	0.2	0.2	0.2	0.5	8.7	0.7	1.5	0.3	1.4	0.1	0.1	1.3	4.7	1.1	5.0	3.7	19.1	0.4	0.6	1.4	0.4	1.7	0.7	0.1	0.1	1.3	4.3	0.0	9.7	0.1	2.5	0.7	0.1	2.4	2.0	6.4	17.0	0.3	0.1	0.7	0.1	0.6	2.2	5.3	0.4	0.1	0.6	1.8	0.6	0.6	0.1	6.3	0.0	0.0	0.0	3.2	0.3	0.2	2.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.9	0.0	0.1	1.0	0.0	3.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	27.8	0.0	1.1	0.2	1.2	0.1	0.0	5.4	0.2	1.8	2.4	0.5	0.1	2.3	0.0	0.0	0.0	6.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.3	0.0	3.8	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.2	0.1	0.2	8.7	0.7	0.4	0.6	0.1	0.1	2.5	0.4	0.0	1.0	0.0	3.2	0.0	0.2	11.9	0.0	1.4	4.5	5.2	0.0	0.0	0.0	1.9	5.5	0.0	0.0	0.0	3.8	0.0	0.3	1.8	0.0	0.0	0.1	0.0	5.8	0.0	0.0	4.8	0.9	0.0	0.0	0.0	2.1	0.0	1.3	0.0	0.0	0.4	0.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.7
DOT1L	"DOT1, KIAA1814, KMT4"	ENSG00000104885	"DOT1 like histone lysine methyltransferase"	Q8TEK3	19	2164149-2232578	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 62.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011875, HPA071217, HPA074977"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011875: AB_2668552, HPA071217: AB_2686364, HPA074977: "	"unprognostic (1.41e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.26e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.00e-4)"	"unprognostic (2.53e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.25e-3)"	"unprognostic (8.18e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.73e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	7.3	8.8	7.0	10.7	11.7	20.1	5.1	20.6	11.7	4.5	7.9	9.8	6.0	13.5	6.4	4.9	8.3	5.4	6.9	5.7	7.0	3.6	9.5	8.5	10.0	8.4	11.9	5.3	6.5	10.8	3.6	8.3	11.6	7.1	5.7	4.9	9.5	6.1	7.4	9.8	9.9	13.0	4.2	6.7	10.4	13.3	64.7	9.7	10.5	9.2	7.0	9.1	4.8	5.3	0.7	1.0	3.0	0.9	2.8	1.4	0.6	12.2	6.6	22.4	12.2	1.7	2.5	29.5	7.0	1.5	3.8	3.1	8.4	4.6	14.4	3.4	4.5	3.3	11.0	7.4	3.9	1.8	7.3	9.3	13.2	10.8	8.2	2.7	18.9	24.4	2.4	2.9	7.4	3.8	3.1	3.1	8.2	16.0	15.1	3.0	7.0	15.1	20.9	17.3	7.8	11.8	15.6	6.3	9.9	2.1	5.8	15.0	11.6	4.9	14.6	9.2	6.2	6.7	14.5	4.4	10.7	9.8	15.8	13.4	14.0	18.3	10.0	10.6	13.1	6.2	0.5	0.7	3.0	0.9	0.3	1.4	0.7	0.8	0.2	0.9	0.7	0.5	0.3	0.3	2.8	0.9	1.0	0.1	0.6	7.0	11.7	20.6	11.7	7.0	3.6	11.9	5.3	7.1	9.7	29.8	18.9	9.9	9.3	15.8	25.0	5.2	20.4	6.7	6.8	8.7	62.8	5.3	3.3	10.1	25.8	7.1	25.4	0.0	10.4	11.3	11.0	12.4	5.8	13.1	9.3	12.7	20.0	6.7	11.9	11.9	2.8	14.6	11.8	5.4	10.8	7.3	14.1	14.0	3.2	2.2	26.6	0.0	8.1	28.3	23.5	17.3	13.6	4.9	11.7	14.2
DPF3	"BAF45c, cer-d4, Cerd4, FLJ14079"	ENSG00000205683	"Double PHD fingers 3"	Q92784	14	72619296-72894116	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.3;skeletal muscle: 28.4"	"Cell type enhanced"	"Detected in many"	14	"Cardiomyocytes: 33.3;Cone photoreceptor cells: 102.1;Early spermatids: 36.1;Rod photoreceptor cells: 86.0"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Region enriched"	"Detected in all"	5	"cerebellum: 56.3"	"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.7;BJ hTERT+ SV40 Large T+: 9.4;HEL: 23.3;Karpas-707: 9.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA066790, HPA070601"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066790: AB_2685724, HPA070601: AB_2686284"	"unprognostic (2.38e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.98e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.54e-2)"	"unprognostic (9.71e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.85e-3)"	"unprognostic (4.08e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.96e-1)"	0.7	2.2	6.2	1.1	10.3	3.2	0.8	56.3	7.6	0.9	2.7	8.4	0.0	0.8	0.8	0.5	1.2	0.7	1.0	16.8	6.4	2.5	2.2	4.3	0.8	1.5	8.9	4.5	17.8	0.7	8.4	0.9	0.9	10.4	0.7	2.4	3.4	0.8	0.7	28.4	1.1	1.7	1.2	10.1	1.4	1.1	6.6	10.7	0.0	0.8	6.3	1.8	0.8	0.7	1.9	0.0	0.0	0.3	0.4	0.8	0.2	1.5	0.0	1.2	0.1	0.2	2.3	13.7	4.1	3.9	9.4	3.6	0.0	0.1	0.2	0.2	1.2	0.2	0.1	1.3	0.6	5.8	0.2	0.5	23.3	0.1	0.0	0.3	0.1	0.4	0.6	0.2	2.2	1.6	1.6	3.0	2.5	2.0	9.5	3.0	0.1	1.9	0.2	0.0	0.0	1.3	5.1	0.6	0.3	1.6	0.0	0.9	0.5	0.0	0.1	0.0	0.4	0.0	0.0	6.5	4.6	0.0	1.7	0.5	3.4	0.9	0.3	0.4	0.9	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.2	6.2	10.3	56.3	7.6	6.4	2.5	8.9	4.5	10.4	10.7	0.0	0.0	0.9	0.0	0.6	4.7	33.3	0.0	0.0	0.0	0.0	102.1	2.2	1.7	0.0	36.1	1.8	3.9	23.3	0.3	1.2	0.8	0.1	4.6	4.2	0.4	6.4	0.0	0.6	1.5	22.2	0.3	0.9	0.0	0.0	3.3	8.1	0.5	4.0	4.6	9.9	86.0	0.0	0.8	1.7	0.7	0.3	0.1	2.5	6.3	0.0
DPH6	"ATPBD4, MGC14798"	ENSG00000134146	"Diphthamine biosynthesis 6"	Q7L8W6	15	35217345-35546193	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042976, HPA055496"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042976: AB_10964890, HPA055496: AB_2682835"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.49e-3)"	"unprognostic (7.92e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.65e-6)"	"unprognostic (9.70e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.18e-2)"	"unprognostic (7.44e-2)"	13.3	12.7	8.0	6.8	16.1	6.4	15.3	11.6	15.8	14.7	9.2	15.5	10.8	8.5	23.9	17.1	14.7	11.5	10.5	14.4	7.8	7.2	14.7	11.2	8.7	9.3	9.7	12.0	16.7	19.5	15.8	31.7	11.1	13.4	8.5	10.2	14.6	11.5	14.7	24.9	15.2	8.7	16.8	11.1	8.3	9.6	11.3	10.6	7.1	15.3	16.5	10.0	11.0	11.3	8.4	6.3	0.3	6.5	13.2	10.8	4.4	10.5	5.7	9.6	8.1	1.7	7.9	9.4	4.0	7.0	9.7	5.1	7.6	9.9	3.3	9.8	3.7	11.8	12.2	11.1	11.5	11.6	2.6	7.0	12.3	6.5	12.0	10.3	6.5	8.0	6.6	14.6	3.9	18.9	6.0	9.3	7.1	13.5	13.4	8.9	4.1	8.0	6.1	8.5	16.1	5.3	10.0	9.0	4.5	8.4	13.5	7.0	6.9	7.5	8.4	6.4	5.9	29.0	9.1	2.8	9.5	9.2	9.4	6.3	12.0	19.0	8.3	8.2	11.3	9.0	0.0	6.5	0.3	6.2	6.0	7.7	8.4	8.3	8.6	6.3	6.5	10.8	9.5	0.3	13.2	5.6	5.4	5.4	4.4	8.0	16.1	11.6	15.8	7.8	7.2	9.7	12.0	13.4	10.6	14.9	6.9	12.6	16.6	27.5	31.5	11.0	17.8	5.3	17.0	8.7	37.3	22.9	11.6	12.0	2.1	9.5	10.1	23.3	21.1	18.8	11.6	7.6	3.5	7.3	15.0	17.5	5.2	6.7	10.0	1.6	13.0	10.9	15.1	15.4	6.0	16.6	15.1	7.0	6.3	16.4	22.2	0.0	11.3	8.3	15.1	20.3	18.9	5.0	9.2	11.1
DPP7	"DPP2, DPPII"	ENSG00000176978	"Dipeptidyl peptidase 7"	Q9UHL4	9	137110542-137115177	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 751.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.2;THP-1: 54.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021282, CAB025541, HPA059381"	Enhanced		Supported	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		1300000	"Golgi apparatus, Vesicles"		"CAB025541: , HPA021282: AB_1847673, HPA059381: AB_2683999"	"unprognostic (1.15e-1)"	"unprognostic (5.54e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (6.78e-3)"	"unprognostic (1.25e-1)"	"unprognostic (8.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.28e-2)"	"unprognostic (5.71e-3)"	"prognostic favorable (8.31e-5)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-1)"	28.1	45.2	23.7	23.4	35.3	31.8	20.8	23.5	27.5	21.5	22.0	24.9	40.7	23.2	17.5	35.8	19.1	27.0	30.2	44.7	24.6	29.2	21.0	29.9	25.6	34.8	29.7	25.9	14.3	55.4	23.3	42.5	21.9	24.2	28.8	6.9	32.8	73.1	41.6	25.3	26.9	17.8	22.8	21.7	29.1	24.4	30.9	26.8	18.9	41.2	17.5	24.7	21.3	16.6	20.0	60.8	12.2	43.1	19.2	36.8	38.2	6.9	11.0	0.9	0.9	13.6	10.9	1.4	10.5	17.2	7.0	4.6	10.4	5.7	13.7	11.5	6.9	0.3	15.0	8.0	2.1	0.3	13.4	0.5	6.3	15.2	0.3	30.5	16.9	35.2	13.4	8.3	3.0	6.3	10.2	9.1	17.0	13.8	10.7	4.6	19.2	8.5	16.2	3.7	25.2	10.8	12.5	0.1	57.2	11.1	7.7	17.6	12.2	12.1	31.9	29.7	0.2	11.4	54.9	11.0	17.9	6.1	11.3	7.2	13.2	7.5	3.7	21.4	10.3	8.0	6.8	43.1	12.2	34.4	37.6	35.5	19.7	31.1	29.6	41.7	20.0	28.1	25.1	2.6	19.2	22.6	60.8	36.8	38.2	23.7	35.3	23.5	27.5	24.6	29.2	29.7	25.9	24.2	26.8	50.6	79.4	78.5	85.1	59.5	68.6	52.7	58.6	42.8	46.6	50.6	33.4	44.8	31.5	93.8	230.4	57.3	44.4	23.3	59.4	85.7	82.6	106.0	74.8	62.7	275.2	114.4	84.6	55.3	148.6	751.7	143.8	125.9	158.6	165.1	27.0	123.1	65.3	48.9	159.1	69.0	73.5	51.8	56.5	57.7	46.0	56.8	43.0	127.1	37.4	74.0
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117333-111140216	"Predicted membrane proteins"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 18.0;THP-1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	21.8	10.1	5.9	14.4	6.6	7.9	18.4	13.5	6.9	8.4	12.0	7.5	5.7	10.6	8.6	11.1	10.0	12.7	9.1	11.7	5.3	6.0	13.0	9.2	11.5	19.9	9.3	4.2	12.3	8.2	5.7	9.9	14.1	8.4	10.1	8.7	8.8	10.7	7.1	10.6	7.0	15.2	10.1	15.1	24.9	9.5	6.1	8.3	15.0	10.6	6.7	14.7	16.8	7.7	16.1	11.2	3.0	10.9	6.2	10.4	11.4	2.1	0.1	3.4	2.1	8.7	7.4	6.2	8.3	3.2	2.0	4.7	2.5	1.1	7.5	5.5	4.1	2.9	2.4	4.9	1.3	4.0	9.0	3.5	4.2	2.6	1.2	6.6	0.7	1.9	5.2	6.2	3.4	1.3	3.4	1.0	4.8	2.3	3.3	2.4	1.4	4.0	5.4	6.6	3.7	4.2	3.8	3.9	3.2	7.5	2.2	6.6	2.5	0.9	2.8	18.0	2.4	4.8	19.8	3.6	0.6	0.8	4.2	5.5	4.3	1.2	12.7	1.5	8.3	1.3	2.7	10.3	3.0	6.5	10.9	10.4	13.6	9.0	8.1	11.2	16.1	9.5	7.9	2.1	6.2	7.6	11.2	5.4	11.4	5.9	6.6	13.5	5.4	5.3	6.0	9.3	4.2	8.4	8.3	11.9	11.8	165.2	43.6	41.8	11.3	21.7	28.1	46.8	10.3	41.8	2.0	75.5	36.5	45.2	6.8	30.1	51.2	23.3	40.9	73.1	42.1	53.3	24.1	20.8	163.1	19.1	12.7	38.6	143.2	5.9	31.1	92.1	77.6	53.3	43.0	19.9	40.7	48.4	23.3	58.6	7.4	38.8	31.9	4.2	7.4	46.3	61.3	39.9	38.8	55.3
DSC3	"CDHF3, DSC, DSC1, DSC2, DSC4"	ENSG00000134762	"Desmocollin 3"	Q14574	18	30990008-31042815	"Disease related genes, Plasma proteins, Predicted membrane proteins"	"Cell adhesion"		Hypotrichosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 78.6;head and neck cancer: 107.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9"	"Group enriched"	"Detected in some"	4	"basal ganglia: 1.3;hippocampal formation: 3.6"	"Low region specificity"	"Detected in some"			"CAB037328, HPA049265, HPA073937"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		2700000	"Plasma membrane, Cell Junctions"		"CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645"	"unprognostic (4.44e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.02e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.32e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.92e-3)"	"unprognostic (3.13e-1)"	"unprognostic (4.13e-4)"	"unprognostic (1.22e-2)"	"unprognostic (7.85e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.04e-5)"	1.5	0.0	0.0	0.6	0.0	0.0	10.4	0.0	0.0	11.9	1.0	0.0	0.4	0.1	2.1	1.4	73.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.4	0.0	2.4	0.1	16.0	0.1	4.5	0.0	0.0	7.2	0.3	0.2	99.1	0.2	0.1	0.0	0.0	0.0	0.5	0.0	2.2	0.0	92.4	28.4	1.0	14.4	0.7	0.2	1.0	0.5	0.4	0.4	0.1	4.5	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	71.0	0.0	16.3	0.0	0.0	3.9	0.2	1.4	0.1	2.7	0.0	0.0	2.8	42.0	0.0	30.9	5.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	5.8	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.3	0.2	0.2	0.4	0.3	0.2	0.0	0.7	0.3	0.4	1.0	0.4	0.5	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.0	1.4	0.0	43.5	444.8	0.0	1.2	0.0	2.7	19.4	0.0	0.0	62.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.1	7.5	19.6	0.0	0.0	4.6	0.0	2.4	0.0	0.0	0.0	0.0	0.6	37.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	602.1	20.9	0.0	0.0	96.7
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522801-15663058	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.0"	"Cell type enhanced"	"Detected in many"	6	"Rod photoreceptor cells: 136.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	7.2	5.0	22.8	10.5	91.0	9.3	7.7	6.7	18.4	6.8	10.5	7.8	4.5	7.2	8.0	12.5	7.2	6.9	7.9	12.0	15.0	18.0	11.3	5.0	8.4	16.9	18.5	10.3	7.3	6.7	13.1	8.5	9.3	13.7	8.1	10.9	13.4	6.7	10.1	15.4	7.1	7.6	11.9	9.4	10.2	7.6	5.5	17.2	9.3	7.8	2.7	19.4	8.6	8.1	17.8	17.9	8.1	7.1	26.9	12.1	6.6	15.8	6.9	5.9	12.7	8.7	9.9	9.1	8.2	10.7	19.7	17.9	9.1	7.4	22.5	22.1	11.6	16.3	5.5	11.6	8.7	18.0	14.4	15.5	15.8	9.0	13.5	15.2	15.9	13.5	9.4	13.4	10.0	14.9	9.0	17.3	15.5	14.9	5.6	11.8	18.6	16.5	25.3	4.1	13.5	10.0	19.6	11.6	17.5	18.4	16.6	12.1	5.1	6.4	15.4	19.3	14.3	11.1	10.2	7.9	11.2	7.3	11.5	15.0	15.1	28.9	15.8	5.2	14.1	21.1	5.9	5.9	8.1	12.1	7.1	8.0	13.7	10.3	10.4	6.4	17.8	9.8	7.9	6.8	26.9	4.9	17.9	6.9	6.6	22.8	91.0	6.7	18.4	15.0	18.0	18.5	10.3	13.7	17.2	11.9	9.9	44.3	12.8	25.8	42.2	26.6	17.8	9.4	6.8	14.0	55.0	37.3	31.5	32.0	38.0	30.8	18.0	0.0	31.0	15.5	19.0	10.2	54.2	4.5	46.0	23.8	13.3	16.0	15.1	14.5	9.5	25.1	35.4	33.3	15.2	31.7	24.9	8.6	14.5	53.8	136.7	6.5	24.2	17.4	12.7	19.3	14.0	27.9	17.5	9.3
DUS2	"DUS2L, FLJ20399, SMM1"	ENSG00000167264	"Dihydrouridine synthase 2"	Q9NX74	16	67987746-68079320	"Predicted intracellular proteins"	"tRNA processing"	"Oxidoreductase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 82.3;Late spermatids: 66.4;Spermatocytes: 44.7;Syncytiotrophoblasts: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042560, HPA043528"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA042560: AB_10965170, HPA043528: AB_10959753"	"unprognostic (2.21e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.23e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.18e-1)"	"prognostic favorable (3.50e-5)"	"unprognostic (1.44e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.81e-1)"	6.9	8.2	7.0	12.5	11.3	8.6	6.7	7.6	15.0	6.4	9.2	12.8	5.1	6.1	10.1	5.4	13.6	6.1	5.8	5.9	7.0	6.2	7.0	10.3	7.6	18.3	9.2	10.5	6.0	5.1	11.1	6.6	10.3	9.5	6.2	9.1	9.9	7.2	5.7	10.3	11.6	11.2	8.5	7.9	18.4	7.1	32.2	10.8	6.9	6.3	8.8	21.0	8.5	8.1	23.9	8.7	34.2	13.7	7.9	5.1	6.1	9.6	15.4	6.4	10.2	5.3	10.3	11.8	9.4	9.1	20.1	13.7	16.0	17.6	23.3	8.8	10.0	6.3	14.0	16.2	16.6	16.3	3.5	9.8	8.1	9.3	12.5	9.0	8.5	10.4	9.3	12.2	17.0	16.4	8.7	13.2	18.2	9.1	4.1	9.8	15.1	9.4	12.1	7.0	9.8	8.6	15.8	8.0	15.8	10.4	6.8	7.9	7.2	18.8	6.5	4.1	9.1	15.1	4.2	8.2	9.2	8.6	7.9	7.8	10.9	14.4	21.6	6.3	12.0	5.2	4.9	11.8	34.2	4.0	10.3	3.9	23.9	2.7	4.3	8.7	17.3	4.0	3.6	11.1	7.9	13.7	3.3	5.1	6.1	7.0	11.3	7.6	15.0	7.0	6.2	9.2	10.5	9.5	10.8	8.9	2.9	6.7	1.9	2.4	3.7	1.8	2.5	2.7	0.0	7.0	7.9	25.0	5.0	8.8	82.3	4.2	4.0	0.0	4.8	14.7	4.1	1.5	6.9	8.5	12.4	14.3	4.1	8.0	11.8	66.4	3.4	5.6	3.3	10.8	5.1	4.5	7.9	3.5	7.4	7.9	2.7	6.5	4.0	44.7	11.1	2.3	51.4	5.0	6.3	1.7
DUSP6	"MKP-3, PYST1"	ENSG00000139318	"Dual specificity phosphatase 6"	Q16828	12	89347232-89353271	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"	"Disease mutation, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 125.0"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 270.1;granulocytes: 438.5;Kupffer cells: 216.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 125.0"	"Group enriched"	"Detected in many"	11	"granulocytes: 125.0;monocytes: 79.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 82.0;NB-4: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017566, HPA053188, HPA064692"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB017566: AB_647991, HPA053188: , HPA064692: "	"unprognostic (7.35e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.77e-2)"	"prognostic favorable (7.21e-4)"	"unprognostic (2.35e-3)"	"unprognostic (2.10e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.84e-1)"	37.7	7.5	7.2	15.9	11.7	41.3	24.1	3.4	14.7	11.6	12.4	6.2	5.8	6.1	9.8	8.7	12.0	15.4	25.1	16.2	10.5	6.5	17.1	38.4	28.2	13.3	6.9	7.4	7.5	12.2	15.0	13.7	19.7	7.9	17.4	15.3	44.4	64.3	6.3	12.0	8.5	14.6	11.3	7.1	28.4	10.3	4.8	6.4	6.1	21.0	13.3	17.8	15.2	6.9	1.2	9.2	125.0	79.7	1.2	0.9	32.4	1.1	1.1	24.4	82.0	21.1	18.0	0.0	8.8	11.2	1.8	1.3	7.2	1.3	0.0	2.1	3.7	3.4	9.4	0.1	22.0	2.5	0.1	0.1	3.6	0.2	11.4	15.0	15.7	40.2	3.5	7.7	15.5	14.5	18.4	40.7	0.4	0.0	3.8	5.6	0.5	0.5	58.8	14.8	28.0	20.0	40.0	3.0	1.5	25.2	23.7	0.4	17.4	0.2	0.1	46.7	8.7	1.2	8.8	10.9	6.0	0.1	1.1	4.2	0.6	3.2	0.1	24.9	11.1	38.0	125.0	49.5	22.4	0.9	79.7	0.4	0.2	0.2	0.3	9.2	1.2	0.1	0.3	22.5	1.2	74.4	1.2	0.6	32.4	7.2	11.7	3.4	14.7	10.5	6.5	6.9	7.4	7.9	6.4	95.3	270.1	20.5	66.1	80.7	1.2	8.1	53.5	22.7	111.5	171.0	31.4	63.9	14.9	10.9	1.1	97.2	31.9	0.0	11.9	2.9	29.6	20.6	438.5	128.2	43.3	1.6	18.4	173.1	216.2	1.4	1.4	140.4	11.8	1.8	11.0	9.0	12.3	7.4	3.2	23.5	2.0	25.8	8.5	1.2	1.1	21.7	41.2	18.5	12.8	23.4
DVL2		ENSG00000004975	"Dishevelled segment polarity protein 2"	O14641	17	7225341-7234545	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009312, HPA021611, HPA022914, HPA064732"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB009312: AB_639776, HPA021611: AB_2670776, HPA022914: AB_1847683, HPA064732: AB_2685338"	"unprognostic (7.63e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (4.34e-6)"	"unprognostic (5.66e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.97e-2)"	"prognostic favorable (3.85e-4)"	"unprognostic (8.90e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.80e-1)"	"unprognostic (5.45e-2)"	14.6	16.7	16.9	11.0	24.6	12.5	14.2	22.3	16.2	20.2	15.7	20.0	12.3	12.6	24.3	12.3	22.6	18.0	15.3	12.8	14.5	8.2	13.2	7.8	12.2	14.8	16.7	12.3	30.6	12.7	15.7	26.3	14.9	12.5	18.9	8.6	18.9	14.4	19.3	11.9	21.2	12.9	18.2	10.9	12.7	11.4	14.5	17.0	24.6	16.1	9.5	16.3	16.7	19.7	11.7	7.8	11.6	5.4	7.2	12.1	6.9	13.1	19.2	23.1	23.0	17.7	16.0	10.0	9.2	16.8	22.3	28.6	16.3	11.2	18.8	14.0	10.2	17.4	19.0	19.1	12.4	8.5	18.5	22.0	12.2	20.4	17.1	31.1	6.8	10.6	24.0	21.4	21.1	11.5	15.6	9.2	22.0	10.3	8.9	13.3	12.3	25.9	6.8	7.9	8.8	7.4	38.2	15.0	11.4	12.2	11.7	10.2	20.8	16.7	8.4	20.1	11.0	12.1	9.5	7.6	12.6	11.4	23.5	17.0	13.9	11.6	8.6	14.7	10.3	19.5	11.6	4.7	10.7	12.1	5.4	10.1	10.4	8.3	10.7	5.6	11.7	9.9	10.1	2.1	7.2	5.1	7.8	5.0	6.9	16.9	24.6	22.3	16.2	14.5	8.2	16.7	12.3	12.5	17.0	8.9	8.9	5.7	20.2	15.5	14.9	5.6	7.6	5.3	9.1	17.4	23.6	17.9	5.0	9.3	0.7	9.0	9.3	0.0	9.0	13.9	17.8	13.7	14.9	4.3	12.2	9.5	12.7	7.4	8.2	1.5	24.2	7.4	10.1	12.6	13.0	12.8	6.9	10.5	20.8	4.2	30.2	12.9	11.3	18.9	30.6	16.8	30.6	10.0	20.8	12.0
DYRK4		ENSG00000010219	"Dual specificity tyrosine phosphorylation regulated kinase 4"	Q9NR20	12	4562204-4615302	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	9	"testis: 85.9"	"Group enriched"	"Detected in many"	7	"Early spermatids: 369.7;Late spermatids: 289.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA028065, HPA056073"	Enhanced		Enhanced	Vesicles		No	No			Vesicles		"HPA028065: AB_10601212, HPA056073: AB_2683028"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.07e-3)"	"unprognostic (2.03e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.46e-1)"	"prognostic unfavorable (6.52e-6)"	"unprognostic (1.86e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.98e-2)"	1.6	2.1	2.3	2.1	1.8	1.6	2.8	1.9	2.3	2.6	2.1	2.2	2.3	1.7	2.5	9.1	1.6	2.0	1.7	1.7	1.8	1.8	1.9	2.0	2.2	2.5	1.9	2.5	2.2	2.3	2.9	2.7	2.9	2.3	2.3	2.7	2.4	2.3	3.4	1.6	1.9	2.4	2.1	2.7	4.3	1.7	85.9	2.1	1.6	4.3	1.6	2.0	2.4	1.6	7.6	2.7	1.3	5.2	1.1	1.6	1.6	1.9	3.0	3.8	4.1	5.8	7.2	4.6	2.3	4.6	5.3	5.8	0.6	3.1	5.7	0.3	6.5	3.6	4.0	2.9	4.3	4.2	4.3	6.6	4.0	0.8	3.3	16.4	3.4	3.2	4.9	9.2	3.7	12.2	9.9	7.4	6.3	1.6	6.5	4.7	4.0	3.2	8.5	5.2	1.0	1.7	0.7	2.7	2.4	6.4	1.8	0.0	1.5	0.4	2.3	3.3	8.7	1.8	3.1	0.5	6.2	4.9	0.6	2.9	1.9	2.3	3.4	3.3	5.4	3.2	0.6	2.8	1.3	1.0	2.2	1.1	7.6	1.5	1.6	2.7	5.8	1.6	1.6	0.1	1.1	5.2	1.4	1.1	1.6	2.3	1.8	1.9	2.3	1.8	1.8	1.9	2.5	2.3	2.1	11.9	14.4	11.1	13.1	7.9	20.7	19.4	5.1	12.0	13.6	15.7	9.8	12.9	26.6	22.0	369.7	9.3	4.0	0.0	23.8	10.1	17.5	12.6	17.3	9.2	41.7	12.7	5.2	9.2	15.7	289.4	14.1	15.9	15.1	18.0	47.3	16.6	22.1	15.8	29.7	28.1	17.0	6.5	15.6	20.0	31.5	6.6	8.2	17.3	15.6	9.8
E4F1	E4F	ENSG00000167967	"E4F transcription factor 1"	Q66K89	16	2223566-2235742	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division, Growth regulation, Host-virus interaction, Mitosis, Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052042, HPA069007, HPA071325, HPA072309"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052042: AB_2681705, HPA069007: , HPA071325: AB_2686390, HPA072309: "	"unprognostic (3.05e-1)"	"prognostic favorable (9.13e-4)"	"unprognostic (7.31e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.89e-1)"	"prognostic favorable (1.10e-4)"	"unprognostic (9.16e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-2)"	"unprognostic (8.49e-3)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.85e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.12e-1)"	"unprognostic (8.93e-3)"	12.4	12.8	18.1	13.8	15.4	21.0	21.0	26.1	18.9	10.8	10.7	11.9	9.3	13.4	14.8	10.4	11.4	10.9	13.5	9.8	14.3	10.7	11.7	12.9	10.0	13.4	16.7	16.4	13.8	17.0	11.6	14.8	12.0	12.8	15.5	5.0	8.7	20.7	13.7	26.7	23.2	14.7	10.3	9.8	18.8	15.9	14.6	17.2	13.3	17.3	9.3	10.6	10.5	13.4	11.5	11.6	15.2	14.2	8.5	14.7	9.3	6.1	11.8	5.0	9.7	2.9	2.7	11.9	8.6	4.0	6.0	4.0	18.9	9.5	9.0	9.3	3.3	3.3	8.4	4.1	4.4	1.1	9.7	14.6	6.4	19.0	10.2	5.7	8.1	11.3	4.0	5.1	5.4	2.5	3.4	4.0	7.9	14.9	6.3	2.2	17.1	10.6	17.3	11.1	3.8	11.0	19.7	5.4	15.5	3.7	4.4	12.6	9.2	10.5	13.1	6.0	1.9	11.4	11.6	7.1	7.1	9.4	7.1	7.2	12.3	5.9	18.2	3.0	5.8	7.2	7.5	10.7	14.6	14.7	13.1	12.5	11.5	12.0	13.6	11.6	11.5	13.2	11.9	15.2	8.5	14.2	7.0	14.1	9.3	18.1	15.4	26.1	18.9	14.3	10.7	16.7	16.4	12.8	17.2	14.9	8.0	14.5	6.7	6.4	13.9	3.5	5.1	4.0	12.5	10.4	35.3	16.5	10.0	9.5	11.4	7.8	14.4	0.0	9.1	14.7	8.0	8.1	2.3	8.9	11.0	28.6	24.8	6.7	6.1	3.3	10.6	7.6	6.8	9.0	15.3	9.1	9.7	10.5	15.2	6.8	14.0	12.9	9.2	14.8	15.2	7.9	11.2	8.7	11.8	6.0
EAF1		ENSG00000144597	"ELL associated factor 1"	Q96JC9	3	15427355-15450635	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 55.7"	"Group enriched"	"Detected in many"	6	"Early spermatids: 229.6;Late spermatids: 321.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 56.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059516, HPA060569, HPA069538"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		Yes	No			"Nucleoplasm, Nuclear bodies"	Vesicles	"HPA059516: AB_2684048, HPA060569: AB_2684322, HPA069538: AB_2686147"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	15.6	11.5	13.9	12.2	20.0	55.7	11.4	18.1	19.1	9.8	11.7	13.3	11.5	12.7	10.1	9.9	13.1	9.4	12.9	7.6	14.3	18.1	13.7	22.2	12.0	12.4	14.7	13.0	8.0	11.8	13.0	17.6	18.9	18.6	12.7	12.4	9.6	9.5	15.4	8.6	15.9	12.5	10.4	13.7	15.1	13.7	9.7	10.1	14.0	13.0	9.1	12.9	11.9	9.0	5.1	9.9	7.1	7.4	8.1	15.4	4.3	4.0	6.6	7.0	7.1	4.1	3.5	56.2	5.9	4.2	6.8	6.7	9.0	4.5	11.3	3.8	4.3	4.5	3.4	9.0	5.2	7.9	9.2	6.5	9.7	6.0	8.1	9.2	9.1	7.9	4.6	9.3	9.9	6.7	5.2	6.8	9.3	10.3	8.3	5.6	8.3	9.0	5.1	12.4	7.6	6.8	8.3	5.8	6.2	5.9	7.1	7.2	12.6	7.2	6.8	6.9	9.4	10.1	7.3	6.6	7.2	5.3	6.3	8.5	11.0	22.1	11.9	7.0	10.9	8.5	7.1	7.4	4.5	12.0	5.4	15.4	5.1	10.1	9.3	4.3	3.8	6.0	9.8	6.7	8.1	6.5	9.9	10.5	4.3	13.9	20.0	18.1	19.1	14.3	18.1	14.7	13.0	18.6	10.1	8.9	12.9	2.9	7.7	41.7	6.8	4.5	7.6	6.7	10.3	12.2	5.9	7.2	8.3	7.8	229.6	11.7	13.6	0.0	7.0	11.7	16.0	15.1	10.3	27.0	14.1	20.6	33.0	11.6	21.8	321.2	10.6	14.6	21.9	5.4	11.2	4.8	11.8	10.5	11.3	18.9	6.0	25.8	11.3	18.6	11.5	47.4	30.0	20.4	10.9	14.5
EBAG9	"EB9, RCAS1"	ENSG00000147654	"Estrogen receptor binding site associated, antigen, 9"	O00559	8	109539711-109565996	"Cancer-related genes, Predicted intracellular proteins"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA021153, HPA021154, CAB072810, CAB072811, CAB072812"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"CAB072810: , CAB072811: , CAB072812: , HPA021153: AB_1856151, HPA021154: AB_1856152"	"unprognostic (3.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.06e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.72e-1)"	"unprognostic (9.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (5.16e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.71e-2)"	17.1	23.7	24.4	19.8	23.4	10.7	24.1	24.2	25.6	28.1	20.3	13.3	24.9	16.9	17.0	34.2	15.6	20.7	16.0	23.9	21.4	21.5	27.1	31.9	22.7	19.2	20.2	21.9	18.2	32.1	24.1	27.4	19.2	18.2	21.2	23.2	15.1	29.0	36.3	34.1	12.9	21.0	16.1	20.8	20.7	19.0	17.4	15.5	17.0	42.4	20.1	18.7	22.5	15.0	21.8	13.0	7.8	10.3	15.4	20.2	7.9	16.0	11.3	11.5	7.8	7.1	11.7	9.0	8.7	6.6	12.3	11.7	11.4	17.1	22.8	15.2	6.1	10.0	11.3	11.0	14.0	13.1	25.1	12.1	25.0	7.3	17.3	16.1	8.6	7.4	9.3	27.7	10.7	21.8	10.1	11.6	20.6	25.7	16.8	10.8	24.4	25.1	13.8	7.2	30.9	11.4	13.5	9.2	19.1	14.2	10.5	12.7	10.2	9.5	10.2	11.9	8.8	20.2	11.3	7.8	9.6	6.9	8.7	6.3	25.2	16.3	21.4	9.8	23.3	8.8	2.7	7.4	7.8	11.3	10.3	19.8	21.8	15.9	15.6	12.2	20.2	20.2	17.8	1.5	15.4	8.9	13.0	17.1	7.9	24.4	23.4	24.2	25.6	21.4	21.5	20.2	21.9	18.2	15.5	113.2	72.9	32.0	26.7	19.3	31.4	30.3	30.6	85.6	73.9	27.9	5.9	42.2	54.7	42.3	104.1	29.6	30.7	46.7	57.6	27.3	25.8	27.3	45.1	41.9	30.0	47.7	30.6	19.6	18.8	105.7	27.0	33.1	18.6	13.6	36.1	31.5	35.9	45.6	21.5	45.8	28.6	32.3	24.5	101.2	40.1	17.3	18.5	20.6	44.6	24.0
EBNA1BP2	"EBP2, NOBP, P40"	ENSG00000117395	"EBNA1 binding protein 2"	Q99848	1	43164175-43270936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026512, HPA028277"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA026512: AB_1847954, HPA028277: AB_10603664"	"unprognostic (9.30e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (7.64e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.10e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.33e-2)"	18.9	24.8	30.2	22.8	41.1	19.3	27.6	17.7	35.7	18.1	23.6	19.0	15.6	15.4	22.4	40.6	27.8	30.4	15.6	24.9	26.3	25.2	34.0	66.0	18.5	21.9	25.1	29.8	21.8	30.7	24.5	30.0	26.0	29.2	20.3	26.0	16.6	22.3	22.3	28.4	22.8	16.9	24.3	21.6	18.4	19.7	24.8	27.4	18.2	28.8	31.3	25.8	21.5	19.8	26.9	29.6	10.2	22.8	24.1	25.1	17.8	61.7	36.1	13.5	39.1	10.9	12.3	28.0	43.1	21.6	68.9	43.4	40.3	38.6	41.1	34.2	31.3	32.5	44.0	29.2	39.9	75.4	19.4	28.8	28.0	32.5	35.4	19.8	48.5	21.6	9.8	40.4	50.6	41.0	13.2	37.7	28.3	42.3	13.9	33.5	34.0	36.8	29.0	58.7	41.5	33.5	27.0	30.7	46.3	25.3	27.0	26.9	28.9	24.9	46.6	43.2	22.9	19.1	26.5	29.0	26.7	50.3	42.6	70.0	20.6	40.6	50.8	22.1	50.3	53.6	7.5	20.1	10.2	24.0	22.8	25.1	26.9	24.5	24.9	29.6	26.7	22.8	22.8	1.8	24.1	21.6	28.3	24.6	17.8	30.2	41.1	17.7	35.7	26.3	25.2	25.1	29.8	29.2	27.4	32.8	33.2	26.8	68.9	109.3	25.1	28.5	56.0	87.0	48.9	29.6	5.9	95.0	76.3	100.0	109.6	36.8	23.0	70.0	107.4	112.0	52.9	58.1	49.7	127.1	57.6	14.3	23.2	32.5	23.4	70.9	30.8	30.6	52.3	54.1	37.8	44.2	101.2	11.5	36.0	100.9	22.3	38.8	54.7	79.6	103.6	86.9	70.5	23.5	59.7	77.3
ECHS1	SCEH	ENSG00000127884	"Enoyl-CoA hydratase, short chain 1"	P30084	10	133362480-133373689	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Lyase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.2"	"Cell type enhanced"	"Detected in all"	11	"Hepatocytes: 1338.6;Proximal tubular cells: 2021.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003783, HPA021995, HPA022476"	Enhanced		Enhanced	Mitochondria		NA	NA		1500000	Mitochondria		"CAB003783: , HPA021995: AB_1847974, HPA022476: AB_1847975"	"unprognostic (3.68e-1)"	"unprognostic (2.46e-3)"	"unprognostic (9.57e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.51e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (8.57e-5)"	"unprognostic (2.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.50e-2)"	36.5	18.7	16.6	9.1	16.6	5.0	15.2	8.2	18.3	8.8	21.8	13.0	34.7	22.8	9.5	14.1	16.5	12.2	17.4	29.8	14.6	11.5	62.1	148.2	6.3	7.8	14.8	10.3	11.6	16.3	9.2	11.0	12.8	11.1	13.9	14.0	11.0	40.2	38.4	35.7	8.8	32.1	9.9	11.9	7.3	11.0	10.2	10.2	3.9	16.2	17.5	13.0	11.2	7.8	39.4	53.7	18.3	45.7	33.5	32.1	44.5	28.9	36.3	19.8	49.3	28.7	18.6	18.1	21.3	28.2	29.8	25.2	79.7	28.1	21.8	18.5	23.9	15.6	27.2	25.7	21.6	21.6	16.7	45.0	21.8	22.0	56.6	24.2	28.1	15.5	20.7	18.7	19.7	25.2	26.5	26.3	15.9	19.6	19.2	28.9	68.6	14.0	55.0	13.8	45.9	43.6	24.2	24.0	11.6	36.8	37.1	12.8	20.3	22.0	36.6	27.7	11.9	28.5	27.2	21.1	13.4	19.5	27.9	28.0	14.4	8.8	24.8	31.9	15.4	11.1	17.0	41.7	18.3	24.9	45.7	32.1	39.4	28.1	27.1	53.7	32.2	28.9	27.9	4.4	33.5	34.3	23.2	26.0	44.5	16.6	16.6	8.2	18.3	14.6	11.5	14.8	10.3	11.1	10.2	41.7	72.4	78.2	79.8	60.7	58.8	224.4	180.9	62.9	56.9	165.7	5.9	406.8	479.1	144.4	24.0	65.0	374.4	46.7	88.5	126.6	74.8	83.9	89.0	1338.6	193.8	42.9	126.4	78.5	88.6	29.7	71.9	72.7	128.2	149.7	152.5	112.9	99.9	252.6	86.3	2021.6	42.1	84.1	76.9	50.6	40.1	66.7	250.1	49.0	276.7	103.8
ECI1	DCI	ENSG00000167969	"Enoyl-CoA delta isomerase 1"	P42126	16	2239395-2252300	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 90.3"	"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041746, HPA043227"	Enhanced		Enhanced	Mitochondria		NA	NA		11000000	Mitochondria		"HPA041746: AB_10960693, HPA043227: AB_10960273"	"unprognostic (4.99e-2)"	"prognostic favorable (3.04e-5)"	"unprognostic (3.75e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-1)"	"unprognostic (5.14e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-2)"	"prognostic favorable (8.99e-8)"	"unprognostic (2.61e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.97e-1)"	"unprognostic (6.08e-3)"	15.7	12.5	12.5	9.8	10.8	9.1	16.8	12.8	11.3	10.9	27.6	9.7	20.3	30.9	10.6	16.7	15.5	13.4	17.3	56.4	10.1	10.3	36.5	57.4	10.3	10.7	12.4	8.8	10.8	30.4	11.1	11.9	10.6	13.0	13.4	8.4	16.3	40.9	19.1	90.3	10.4	31.2	14.1	10.1	8.0	17.2	8.4	9.6	10.4	38.7	25.4	10.5	14.4	11.5	7.6	6.5	3.9	7.1	5.8	6.7	1.7	7.3	17.7	6.8	27.8	2.6	3.7	25.5	7.4	5.2	6.2	9.1	31.1	22.7	10.7	18.7	4.6	4.4	18.3	7.9	7.1	0.8	18.5	40.7	3.3	16.5	38.4	23.8	9.6	1.5	6.8	16.8	5.1	11.1	4.4	6.1	0.2	17.7	22.7	2.1	30.4	0.9	14.4	15.7	11.9	17.9	33.6	7.3	51.4	11.7	8.4	23.4	14.8	18.1	34.1	22.5	3.5	22.0	17.1	5.0	4.8	18.1	5.2	8.3	25.2	14.8	17.4	6.3	8.9	6.8	3.2	6.8	2.7	3.8	7.1	6.0	7.6	5.5	2.9	5.5	7.4	6.7	5.6	3.9	5.8	4.2	6.5	6.7	1.7	12.5	10.8	12.8	11.3	10.1	10.3	12.4	8.8	13.0	9.6	3.0	23.3	31.8	94.0	18.9	51.2	90.1	94.3	9.4	14.8	73.3	41.2	151.4	255.4	28.6	6.2	23.5	150.2	0.0	31.7	67.6	25.6	72.7	5.7	199.4	41.4	20.6	43.7	26.4	26.7	4.2	22.7	23.7	37.1	14.4	73.5	52.4	28.1	70.2	22.6	187.7	57.7	0.0	30.2	2.5	15.8	19.4	91.9	17.5	89.4	98.4
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115689-4135597	"Enzymes, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 102.3"	"Cell type enhanced"	"Detected in all"	8	"Distal tubular cells: 363.1;Proximal tubular cells: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	17.9	29.2	13.2	7.3	17.4	4.5	17.0	8.9	9.5	15.7	18.0	10.7	14.9	16.2	15.2	26.2	10.6	12.7	12.4	32.1	10.3	11.1	56.8	102.3	7.4	8.9	13.3	7.2	19.0	59.2	8.9	17.2	11.1	10.3	14.6	14.0	13.3	9.0	10.5	45.7	5.6	22.7	10.3	11.9	10.1	23.2	11.9	9.3	13.3	17.7	26.6	7.5	12.6	8.9	20.6	25.1	7.0	16.2	25.5	27.7	16.7	17.8	9.7	16.3	35.3	20.5	30.5	2.0	25.3	25.9	27.6	24.7	7.3	2.7	0.7	31.9	27.5	25.1	9.4	18.4	14.7	40.2	6.7	21.1	9.4	13.7	39.3	11.9	8.5	4.7	20.9	9.0	23.5	13.2	37.6	57.5	30.4	30.8	6.9	26.1	7.1	24.0	21.2	11.0	1.7	34.8	23.3	20.2	0.3	14.9	3.6	0.3	7.6	1.5	10.6	22.3	30.8	24.5	4.0	58.0	20.8	11.4	18.4	15.0	10.5	18.8	1.8	10.7	7.5	16.1	6.9	15.5	7.0	18.9	11.5	25.9	19.9	22.3	26.4	25.1	20.6	27.7	27.1	0.4	25.5	16.2	19.2	23.6	16.7	13.2	17.4	8.9	9.5	10.3	11.1	13.3	7.2	10.3	9.3	26.8	25.1	23.1	44.0	16.3	13.3	158.2	86.6	121.8	59.1	34.9	11.8	242.5	363.1	46.4	49.2	44.3	33.7	46.7	154.5	15.1	57.4	23.5	22.0	167.8	55.4	17.5	50.1	41.7	22.4	39.8	58.7	24.7	33.7	36.1	38.2	54.7	71.1	41.2	47.7	504.9	43.8	25.8	23.7	25.7	33.2	11.2	85.2	49.0	60.0	20.4
ECT2	ARHGEF31	ENSG00000114346	"Epithelial cell transforming 2"	Q9H8V3	3	172750682-172821474	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Neurogenesis, Protein transport, Transport"	"Guanine-nucleotide releasing factor"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 50.8"	"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 60.9;Erythroid cells: 70.0;Spermatogonia: 37.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036363, HPA053261"			Enhanced	Nucleoplasm,Cytosol		No	Yes			Nucleoplasm	Cytosol	"HPA036363: AB_2732472, HPA053261: AB_2682094"	"unprognostic (3.83e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.22e-3)"	"unprognostic (4.49e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (6.82e-6)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.24e-5)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (1.19e-5)"	"unprognostic (1.08e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.33e-1)"	6.4	6.0	5.4	9.9	7.2	16.3	7.4	11.1	7.6	9.0	11.0	2.6	2.1	9.1	4.6	2.8	14.9	3.2	6.6	4.2	5.4	5.0	10.1	4.3	8.9	9.6	6.7	5.8	3.2	4.1	4.0	6.1	11.1	10.2	4.1	16.1	2.4	9.0	2.7	2.9	7.0	7.6	7.2	8.4	8.7	9.2	14.7	6.8	50.8	5.7	9.3	10.8	8.0	6.5	2.8	2.6	10.4	3.2	1.3	3.6	1.0	46.2	33.0	26.1	13.5	2.7	5.6	13.0	20.5	16.8	30.8	30.0	18.3	49.1	11.5	31.2	12.0	29.5	20.4	21.0	13.1	42.1	16.4	11.6	7.2	18.1	9.3	1.2	11.1	8.3	1.8	2.2	18.3	18.7	8.7	13.2	17.1	7.4	16.9	24.3	16.3	11.3	8.3	21.2	38.3	18.0	8.1	25.6	14.8	23.4	10.8	17.4	11.2	25.9	29.5	10.4	13.7	49.1	8.3	11.4	15.0	14.4	20.1	42.6	8.3	11.1	21.7	13.2	9.7	19.5	6.8	3.2	1.3	1.8	2.8	1.9	2.2	2.4	1.6	2.4	2.8	1.2	1.8	10.4	1.3	1.2	2.6	3.6	1.0	5.4	7.2	11.1	7.6	5.4	5.0	6.7	5.8	10.2	6.8	6.0	2.7	9.0	4.3	17.3	3.4	3.1	7.6	10.7	4.5	3.5	60.9	4.9	0.0	9.0	2.7	6.4	3.2	70.0	7.9	13.0	7.0	8.8	0.0	1.5	6.1	0.0	4.6	5.5	3.1	2.3	0.9	5.1	6.8	1.8	10.8	2.9	14.3	3.5	1.4	1.9	13.4	0.0	3.3	33.1	37.4	11.2	3.2	1.5	6.2	7.8
EDA	"ED1, ED1-A1, ED1-A2, EDA-A1, EDA-A2, EDA1, EDA2, HED, ODT1, XHED, XLHED"	ENSG00000158813	"Ectodysplasin A"	Q92838	X	69616067-70039469	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	Differentiation	"Developmental protein"	"Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 11.2;Early spermatids: 15.7;Ito cells: 14.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 4.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"EFO-21: 5.7;Hep G2: 18.4;OE19: 5.3;RPMI-8226: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA037972, HPA037973"			Supported	"Vesicles,Lipid droplets"	"Intracellular and membrane"	NA	NA			Vesicles	"Lipid droplets"	"HPA037972: AB_2675761, HPA037973: AB_2675762"	"unprognostic (3.76e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.25e-4)"	"unprognostic (4.33e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.01e-1)"	"prognostic favorable (1.04e-9)"	"unprognostic (8.63e-4)"	"unprognostic (7.64e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.79e-1)"	6.8	11.7	2.2	3.1	3.0	0.3	3.9	0.9	2.4	10.3	3.4	3.9	7.4	0.9	6.3	5.7	5.0	4.4	7.0	13.3	2.6	2.1	6.9	3.1	4.3	5.8	4.3	2.0	7.9	6.3	18.4	1.9	2.7	2.9	8.3	1.7	5.0	5.4	10.4	3.3	5.4	1.6	5.4	4.6	2.0	4.7	2.7	2.3	0.8	8.9	5.0	1.2	4.4	8.1	0.0	0.0	0.0	3.0	0.6	4.0	0.3	0.0	0.6	0.3	3.0	0.6	0.1	0.2	0.0	0.1	0.0	0.0	1.4	0.1	0.3	5.7	0.2	0.2	0.4	4.1	1.5	0.0	0.0	4.7	0.0	0.1	18.4	1.1	0.0	1.2	2.4	1.5	0.0	1.0	0.0	0.5	3.7	0.0	5.2	0.0	1.2	0.0	0.0	3.0	5.3	0.4	0.0	1.3	6.2	0.1	0.0	1.6	0.0	0.1	0.4	0.1	2.3	0.3	0.1	0.5	1.9	2.5	2.5	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	3.0	4.0	0.0	1.8	0.9	0.0	0.0	1.1	0.2	0.0	0.6	2.0	0.0	0.0	0.3	2.2	3.0	0.9	2.4	2.6	2.1	4.3	2.0	2.9	2.3	3.0	0.3	0.0	2.3	3.4	0.2	11.2	0.0	1.4	0.0	5.2	0.0	0.1	0.0	1.2	15.7	1.4	0.4	0.0	1.2	0.1	2.0	2.2	0.0	0.9	3.1	0.0	1.7	14.7	5.4	5.3	4.4	1.5	1.7	0.0	0.3	1.5	1.0	0.0	2.1	2.7	0.0	6.5	3.8	0.7	2.7	3.6	0.0	0.0	0.2	1.0
EDC4	"Ge-1, HEDLS, RCD-8"	ENSG00000038358	"Enhancer of mRNA decapping 4"	Q6P2E9	16	67873023-67884503	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 28.5;Ciliated cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041164, HPA043038"	Supported		Enhanced	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"	Nucleoplasm	"HPA041164: AB_2677339, HPA043038: AB_2678281"	"unprognostic (1.97e-1)"	"unprognostic (1.48e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.17e-1)"	11.3	12.6	14.4	13.2	20.2	25.2	12.1	33.3	27.0	11.9	18.5	17.5	11.2	16.5	15.5	13.0	14.3	15.4	15.2	11.9	12.8	11.9	12.8	10.8	12.9	18.0	14.4	15.2	19.7	18.6	23.6	18.4	13.1	15.6	13.2	14.3	15.0	13.4	13.4	22.0	19.1	15.0	13.5	10.7	15.4	15.8	18.1	15.1	25.6	12.9	6.8	19.2	15.9	11.4	6.2	6.6	4.4	11.0	9.1	12.2	6.4	9.5	13.4	9.2	8.3	8.7	6.4	18.3	8.8	7.3	17.8	14.4	21.7	9.0	15.7	9.7	12.0	7.6	13.3	18.3	6.9	9.4	6.0	23.2	11.2	8.4	11.5	10.3	13.3	12.5	8.7	9.6	18.0	8.6	10.7	13.5	11.6	19.4	2.8	10.6	14.4	17.4	34.5	9.1	6.4	7.7	26.6	11.2	16.8	7.0	7.0	16.0	8.6	23.3	6.5	6.4	7.9	12.0	18.4	8.9	7.3	10.5	6.8	11.7	15.0	8.7	38.3	5.6	16.3	6.7	0.7	5.9	4.4	10.2	7.0	9.5	6.2	9.0	9.8	6.6	5.4	9.0	6.4	2.9	9.1	11.0	4.8	12.2	6.4	14.4	20.2	33.3	27.0	12.8	11.9	14.4	15.2	15.6	15.1	20.8	28.5	0.0	0.1	0.0	1.3	1.6	0.0	8.1	5.7	0.0	3.9	0.1	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.2	0.2	0.1	3.5	0.0	0.3	0.0	1.2	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.0	1.2	6.5	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.1
EDEM1	"EDEM, KIAA0212"	ENSG00000134109	"ER degradation enhancing alpha-mannosidase like protein 1"	Q92611	3	5187646-5219957	"Plasma proteins, Predicted intracellular proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 57.5;lymphoid tissue: 89.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 96.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029565	Uncertain		Enhanced	"Endoplasmic reticulum,Aggresome"		NA	NA			"Endoplasmic reticulum"	Aggresome	"HPA029565: AB_10602032"	"unprognostic (3.03e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.57e-3)"	"unprognostic (4.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-1)"	6.5	7.6	5.3	13.1	6.7	26.3	7.0	4.8	6.3	6.7	7.6	4.5	5.1	5.9	8.4	6.4	10.5	7.0	6.2	4.8	4.3	3.1	6.6	57.5	14.2	16.9	3.9	5.0	8.6	20.3	10.2	6.5	14.2	4.2	6.6	7.6	5.5	9.7	5.7	3.7	10.1	11.8	5.4	3.7	15.4	7.8	7.8	4.0	89.4	7.8	5.5	23.5	8.8	8.1	9.9	10.3	4.3	5.8	2.9	8.9	2.8	4.7	4.8	3.0	3.0	4.0	9.0	9.7	7.8	10.6	5.4	7.1	2.2	6.3	25.5	4.2	7.7	11.8	3.7	3.3	10.7	8.3	48.9	1.9	8.7	4.5	4.9	18.8	10.2	25.5	8.1	13.1	11.5	12.7	7.3	10.7	33.3	2.2	35.3	6.6	2.8	20.5	3.9	1.5	2.2	3.6	29.9	5.4	23.4	6.2	10.0	0.4	4.0	5.6	8.1	11.5	2.8	4.1	32.9	10.4	10.4	7.3	8.8	8.9	20.8	12.6	43.9	17.3	9.9	8.6	3.5	3.8	4.0	5.8	5.0	8.4	9.9	8.8	6.5	4.6	6.8	7.9	6.2	4.3	2.9	5.8	10.3	8.9	2.8	5.3	6.7	4.8	6.3	4.3	3.1	3.9	5.0	4.2	4.0	56.6	96.8	35.0	6.3	18.3	4.1	2.8	17.8	6.7	20.5	15.7	9.8	8.0	0.0	6.0	9.1	11.3	14.8	0.0	10.5	26.0	8.7	10.9	23.1	65.7	15.8	1.6	8.1	14.7	33.3	37.6	7.8	35.8	15.1	47.7	22.7	3.5	14.0	0.0	8.5	7.0	3.5	0.0	12.2	6.7	2.0	23.8	34.2	21.4	10.1	16.1
EEF2	"EEF-2, EF2"	ENSG00000167658	"Eukaryotic translation elongation factor 2"	P13639	19	3976056-3985469	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Elongation factor"	"Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007795, HPA040534, HPA057351"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		9700000	"Plasma membrane, Cytosol"		"CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417"	"unprognostic (5.47e-2)"	"unprognostic (9.59e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.81e-6)"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.25e-5)"	"unprognostic (4.46e-2)"	"unprognostic (5.60e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.86e-2)"	104.2	84.9	64.0	66.7	57.1	92.7	77.5	55.7	96.2	93.4	91.3	55.8	80.8	95.4	100.1	75.1	115.1	83.4	88.6	104.1	51.6	44.4	65.5	161.0	67.7	108.9	51.4	38.3	167.1	395.7	45.1	72.3	63.7	47.5	105.6	41.3	67.7	191.3	64.4	260.8	87.2	100.9	112.3	46.8	85.4	98.5	70.9	32.4	123.4	127.1	112.5	108.3	111.8	94.7	84.9	60.0	10.0	58.4	48.3	76.3	83.7	95.2	68.4	39.8	105.1	106.7	192.3	57.3	74.9	101.4	71.7	70.6	107.8	44.2	199.0	44.6	69.1	31.9	72.3	62.8	116.0	38.0	49.6	104.2	50.8	65.7	110.7	156.0	109.1	88.4	248.2	122.7	63.1	97.7	104.2	74.2	97.5	99.1	146.7	43.6	138.2	97.9	83.7	105.3	34.4	69.2	109.1	59.2	126.5	59.0	85.2	109.0	101.3	47.1	94.3	135.0	39.5	91.9	132.7	88.9	51.4	53.7	104.4	115.2	157.4	105.6	99.0	76.6	137.2	67.0	10.0	58.4	8.3	38.6	45.8	68.7	84.9	67.7	50.8	60.0	70.7	76.3	59.4	6.1	48.3	43.8	50.5	58.4	83.7	64.0	57.1	55.7	96.2	51.6	44.4	51.4	38.3	47.5	32.4	205.4	339.7	970.0	885.9	1173.5	200.3	547.0	484.1	158.0	288.9	242.5	72.6	782.8	835.6	627.1	628.8	571.1	713.7	186.9	1561.0	1076.2	818.7	720.7	366.9	607.5	546.3	192.3	715.0	498.4	743.9	1007.5	933.7	543.3	612.4	762.0	931.2	218.1	963.4	716.9	782.8	713.6	97.3	575.6	971.3	259.8	261.2	1177.5	1039.5	756.1	908.5	772.4
EFCAB13	"C17orf57, FLJ40342"	ENSG00000178852	"EF-hand calcium binding domain 13"	Q8IY85	17	47323290-47441312	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"vagina: 29.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 161.3;Late spermatids: 143.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"CAB002501, HPA021633, HPA023249, HPA026561"	Uncertain		Enhanced	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Nuclear speckles"	"CAB002501: AB_564092, HPA021633: AB_1845594, HPA023249: AB_1845595, HPA026561: AB_1845596"	"unprognostic (1.66e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.43e-2)"	"unprognostic (8.79e-3)"	"unprognostic (8.75e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.46e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.90e-3)"	4.1	2.8	2.9	12.2	3.4	3.4	6.5	2.8	3.8	6.5	4.7	2.3	3.5	4.8	8.9	4.4	2.4	4.2	4.1	3.5	2.3	1.5	7.5	4.0	3.1	4.3	3.6	0.4	5.5	2.8	8.4	7.6	5.4	3.2	9.3	3.4	2.6	5.4	2.0	1.3	2.2	6.3	9.9	3.5	4.6	3.5	20.0	2.7	2.4	14.9	0.7	4.3	5.5	29.9	5.6	1.0	5.3	2.1	0.8	2.6	0.8	0.9	4.0	1.7	0.2	2.1	7.3	3.1	2.2	0.5	0.7	1.2	1.7	5.6	0.3	6.6	0.8	0.0	1.1	0.0	0.4	4.0	0.2	0.6	5.2	3.3	0.5	2.1	4.0	0.6	1.3	1.9	2.7	0.0	5.0	4.5	4.1	1.5	9.9	2.4	0.1	1.7	2.3	0.9	2.8	3.2	4.7	1.3	1.8	9.2	3.2	1.2	0.6	1.2	0.1	2.6	1.3	6.6	4.7	1.6	0.3	1.3	0.4	1.1	10.2	7.0	0.9	6.3	7.8	4.3	5.3	2.1	0.6	1.1	1.2	0.9	4.3	0.9	0.6	1.0	5.6	2.6	1.2	0.0	0.8	0.7	0.4	0.1	0.8	2.9	3.4	2.8	3.8	2.3	1.5	3.6	0.4	3.2	2.7	8.9	2.1	2.0	1.7	0.7	2.3	3.8	0.0	5.3	1.2	0.0	0.0	0.2	0.0	0.7	161.3	6.3	0.5	0.0	0.7	0.2	1.3	1.0	5.8	0.8	1.7	3.2	2.9	3.7	2.1	143.2	1.7	1.3	0.0	1.8	0.2	1.1	1.2	0.0	3.5	0.8	2.6	0.0	2.3	34.1	7.9	0.5	0.0	0.0	0.6	1.0
EFEMP1	"DHRD, FBLN3, FBNL, MTLV, S1-5"	ENSG00000115380	"EGF containing fibulin extracellular matrix protein 1"	Q12805	2	55865967-55924139	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016368, HPA049806, HPA070841, HPA071588"	Supported		Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA		1800000000	Mitochondria		"CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: "	"unprognostic (8.21e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.01e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.46e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (3.89e-8)"	"unprognostic (3.15e-3)"	"unprognostic (4.94e-2)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (6.68e-5)"	63.1	14.1	13.6	14.1	35.1	0.1	45.5	8.0	12.8	14.8	20.4	22.0	16.6	6.2	20.1	31.9	22.0	38.6	37.1	55.4	8.2	9.7	16.3	3.5	38.5	24.5	12.5	15.5	52.9	10.9	3.3	6.6	84.5	25.8	47.5	22.9	116.9	26.8	40.5	15.6	13.8	12.0	29.9	8.6	10.1	12.6	9.3	13.5	0.9	57.4	18.1	7.3	45.5	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.2	0.4	0.0	20.0	13.0	0.0	12.5	13.4	1.5	1.1	0.0	1.2	0.0	8.1	15.1	1.3	20.9	0.0	15.0	0.5	0.0	0.0	0.0	5.3	0.0	55.0	0.0	0.0	64.6	6.9	1.5	17.2	129.3	263.2	0.0	0.0	0.0	5.6	1.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.1	0.0	17.3	6.5	0.0	0.4	20.2	0.0	233.1	0.1	7.0	25.8	8.0	0.7	0.0	0.0	4.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	35.1	8.0	8.8	8.2	9.7	12.5	15.5	25.8	13.5	232.3	83.7	0.0	78.5	70.5	1.6	12.3	10.2	99.0	89.9	26.2	0.0	1167.9	8.3	27.4	0.3	12.2	0.0	0.0	23.4	127.3	186.9	9.1	2.3	0.4	83.0	0.0	0.0	68.7	0.6	0.8	39.4	4.3	16.9	1.0	0.0	149.0	2.2	0.0	0.0	6.9	3.9	0.0	22.5	0.0	0.2	27.7	744.0	0.0	0.0	3.9
EFTUD2	"SNRNP116, Snrp116, Snu114, U5-116KD"	ENSG00000108883	"Elongation factor Tu GTP binding domain containing 2"	Q15029	17	44849943-44899662	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022021	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA022021: AB_1848032"	"unprognostic (4.28e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.71e-6)"	"unprognostic (6.94e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.11e-3)"	"unprognostic (5.19e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.62e-2)"	"unprognostic (5.30e-2)"	"unprognostic (3.60e-1)"	"unprognostic (1.53e-2)"	22.5	26.5	16.0	23.1	27.0	25.0	17.7	13.4	34.9	14.8	20.3	22.0	10.4	16.6	22.1	15.4	27.0	20.2	12.7	22.6	16.6	16.7	21.5	27.7	17.3	25.2	15.8	19.8	15.3	20.0	21.2	15.3	27.5	22.6	14.9	23.2	19.1	27.2	15.7	49.6	22.0	20.3	18.5	15.7	25.9	18.5	30.2	13.1	36.9	18.6	17.9	34.9	18.6	16.0	12.8	31.8	31.6	31.5	15.6	16.9	23.3	22.7	45.6	22.3	36.0	17.1	16.9	26.2	18.1	24.3	45.8	39.8	35.1	19.6	39.4	21.4	22.8	35.3	26.1	48.3	31.7	53.6	39.6	40.1	39.1	28.5	37.3	18.9	46.0	29.1	18.3	18.2	42.4	23.1	17.7	39.6	35.7	48.1	15.4	26.1	22.7	46.1	30.4	22.9	53.8	38.2	32.5	45.3	34.2	26.1	25.6	36.7	21.9	17.8	13.2	18.8	34.1	35.0	29.1	24.0	34.5	26.6	20.8	45.6	16.3	20.4	39.6	27.7	25.7	35.1	12.3	31.5	31.6	15.2	31.0	16.9	12.8	13.5	14.6	31.8	12.5	12.0	13.3	5.1	15.6	29.7	13.7	13.2	23.3	16.0	27.0	13.4	34.9	16.6	16.7	15.8	19.8	22.6	13.1	0.0	12.3	16.4	10.8	10.4	13.9	15.9	28.1	14.7	12.5	17.4	31.4	30.5	3.3	25.5	9.7	16.3	14.6	0.0	23.3	26.0	12.2	9.3	19.6	18.4	34.2	25.4	10.4	17.2	31.7	4.9	11.8	22.3	5.0	49.5	12.0	14.3	21.4	10.5	8.5	10.1	16.1	19.4	9.2	24.7	36.5	12.8	22.8	13.1	20.5	10.3
EGFR	"ERBB, ERBB1"	ENSG00000146648	"Epidermal growth factor receptor"	P00533	7	55019021-55211628	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Host-virus interaction"	"Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 102.3"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1"	"Cancer enhanced"	"Detected in all"		"glioma: 136.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	12	"A-431: 345.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000035, HPA001200, HPA018530, CAB068186, CAB073534"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted to blood"	NA	NA	4740000	93000000	"Plasma membrane, Cell Junctions"		"CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044"	"unprognostic (2.62e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.78e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.98e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.04e-5)"	16.2	8.4	4.9	7.5	6.8	0.1	39.8	5.1	8.5	13.8	7.8	3.3	10.7	3.6	8.2	11.7	15.6	8.8	8.5	4.8	6.8	2.7	7.6	23.5	14.2	2.3	4.1	3.9	10.4	10.1	1.8	2.1	102.3	5.6	10.9	6.7	9.2	15.4	12.9	10.7	32.5	6.3	15.5	3.5	3.3	7.8	5.5	5.9	3.2	12.8	15.5	8.0	10.2	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	4.4	1.1	1.5	7.1	4.4	1.2	3.4	4.6	2.1	1.6	0.8	3.7	0.2	0.8	2.9	9.0	13.9	0.0	15.3	2.5	0.1	0.2	0.0	1.9	0.2	1.8	0.0	0.0	2.1	14.0	5.3	28.6	3.1	0.2	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.3	1.3	2.2	0.0	0.6	0.0	2.6	3.7	0.0	1.3	2.9	3.5	0.7	1.2	0.3	0.8	1.0	1.9	0.5	14.9	3.2	0.0	0.3	0.2	2.6	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	6.8	5.1	6.6	6.8	2.7	4.1	3.9	5.6	5.9	89.3	37.5	4.2	67.7	76.2	1.5	7.3	53.5	16.0	59.1	21.0	5.9	207.2	0.0	30.6	4.6	10.9	15.9	23.3	21.0	36.6	45.3	37.8	0.0	77.4	24.2	0.0	4.1	6.7	7.0	2.2	118.8	1.3	16.9	2.8	25.3	106.1	41.7	17.3	125.5	14.0	2.3	77.6	23.1	1.6	2.7	78.5	315.1	0.0	20.0	46.4
EGR1	"AT225, G0S30, KROX-24, NGFI-A, TIS8, ZIF-268, ZNF225"	ENSG00000120738	"Early growth response 1"	P18146	5	138465490-138469315	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 923.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.5;intermediate monocyte: 5.1;neutrophil: 9.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 9.9;monocytes: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 39.7;hTCEpi: 57.8;U-266/84: 87.2"	"Group enriched"	"Detected in all"	6	"amygdala: 88.4;basal ganglia: 148.1;cerebral cortex: 237.4;hippocampal formation: 138.8;olfactory region: 126.1"	"Low region specificity"	"Detected in all"			"CAB019427, HPA029937, HPA029938"	Supported		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB019427: AB_2097038, HPA029937: AB_2673258, HPA029938: AB_2673259"	"unprognostic (5.47e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.57e-1)"	"unprognostic (7.74e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.96e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.97e-3)"	"unprognostic (1.75e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.51e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.98e-3)"	78.7	47.9	5.5	114.3	23.3	18.3	28.7	23.7	25.0	61.8	40.5	31.6	8.0	6.8	51.7	15.6	47.2	187.3	158.4	42.9	7.0	8.1	22.0	68.8	39.7	18.6	4.9	7.0	130.9	23.0	15.8	43.3	24.3	17.8	45.2	21.7	56.1	18.7	100.5	19.4	54.2	29.8	60.8	4.4	8.8	46.1	14.7	2.8	19.4	76.6	67.5	26.6	43.2	20.3	0.9	0.9	9.9	5.1	0.1	0.2	0.4	4.1	0.1	9.0	13.4	24.5	39.7	1.0	7.2	4.5	9.7	7.9	5.1	3.7	0.2	1.1	15.6	33.4	1.9	0.5	14.6	4.5	0.2	0.6	0.5	1.7	1.4	3.1	1.5	11.6	3.1	57.8	8.6	1.9	7.6	0.8	10.6	21.2	5.1	2.8	20.8	0.6	6.5	0.8	15.5	0.0	0.1	1.3	0.7	7.4	2.5	11.3	1.3	8.7	24.2	18.7	9.1	0.3	1.2	0.3	3.5	4.6	1.7	2.7	12.1	87.2	1.7	4.1	19.8	1.0	0.0	3.5	0.4	0.2	5.1	0.0	0.9	0.1	0.1	0.9	0.3	0.2	0.2	9.9	0.1	1.4	0.0	0.2	0.4	5.5	23.3	23.7	25.0	7.0	8.1	4.9	7.0	17.8	2.8	256.1	658.4	51.0	240.2	161.5	44.6	590.3	183.4	53.5	87.6	27.9	60.9	127.7	6.6	145.2	1.2	175.3	431.9	0.0	86.9	88.6	317.5	418.7	343.2	161.3	107.4	3.2	923.5	169.4	153.0	1.8	152.5	134.7	101.3	10.0	629.1	114.5	132.3	391.8	49.8	5.0	87.7	219.9	490.3	2.3	1.9	175.0	108.5	55.8	355.8	76.3
EHBP1	"KIAA0903, NACSIN"	ENSG00000115504	"EH domain binding protein 1"	Q8NDI1	2	62673851-63046487	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 215.6;Late spermatids: 370.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035468, HPA035469"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA035468: AB_10671513, HPA035469: AB_10601365"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (8.78e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.03e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.15e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (1.95e-8)"	19.6	12.6	19.8	10.2	15.4	4.0	12.0	27.5	22.5	22.5	22.3	8.0	7.5	6.8	22.3	6.0	20.9	12.7	18.2	7.8	16.0	15.9	12.3	36.9	8.1	5.7	17.1	13.0	35.1	10.9	9.7	14.5	8.2	12.8	12.6	10.4	8.6	10.2	14.0	5.4	7.4	8.5	21.4	9.3	5.4	11.1	24.1	9.8	5.4	10.4	7.5	7.0	12.3	12.7	8.4	5.4	3.5	3.6	4.7	6.8	2.8	18.7	25.9	10.7	6.3	18.6	35.9	10.7	16.7	16.4	12.3	10.2	30.9	14.1	13.0	6.2	30.7	18.9	11.5	13.7	11.9	20.5	13.8	6.4	11.2	9.2	36.4	12.8	6.5	8.6	16.5	21.4	12.5	24.6	12.5	7.9	10.4	7.6	7.4	19.9	7.3	7.5	4.1	10.3	15.6	10.1	6.7	13.2	5.5	8.2	6.1	11.6	9.4	13.8	10.2	16.6	11.8	4.9	6.4	5.8	13.3	13.8	21.9	8.7	8.6	5.9	12.4	13.3	10.1	26.6	0.2	3.4	3.5	6.3	3.6	6.3	8.4	6.8	6.0	5.4	7.3	6.7	5.7	1.3	4.7	1.9	3.5	3.7	2.8	19.8	15.4	27.5	22.5	16.0	15.9	17.1	13.0	12.8	9.8	35.7	13.1	9.0	11.0	13.9	30.3	13.3	25.5	14.7	22.7	14.0	3.9	8.5	13.3	18.7	215.6	17.4	5.8	0.0	35.1	26.0	18.6	8.4	2.3	57.0	4.3	17.5	15.5	26.4	9.8	370.2	54.1	8.3	10.1	3.6	5.8	22.2	35.4	5.8	37.8	12.2	17.8	6.5	18.6	46.0	20.9	12.4	2.4	8.4	8.7	11.3
EIF2AK2	"EIF2AK1, PKR, PPP1R83, PRKR"	ENSG00000055332	"Eukaryotic translation initiation factor 2 alpha kinase 2"	P19525	2	37099210-37157065	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Kinase, RNA-binding, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003845, HPA019795, HPA063893"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB003845: AB_562332, HPA019795: AB_1848060, HPA063893: AB_2685144"	"unprognostic (1.70e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.77e-3)"	"unprognostic (8.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.15e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.65e-2)"	"unprognostic (5.32e-2)"	25.5	14.2	15.9	16.3	15.5	36.4	13.9	16.4	19.0	14.7	13.7	9.9	9.3	14.5	17.2	21.5	12.1	12.8	15.4	10.7	13.7	19.2	12.2	11.5	13.7	10.7	14.3	15.0	18.7	11.7	19.2	21.1	18.2	17.3	15.0	12.8	10.2	23.0	17.8	7.1	6.7	15.2	16.2	14.0	15.5	14.3	5.1	12.8	14.1	13.6	8.1	10.6	14.8	15.5	8.8	6.9	27.6	10.8	8.6	9.9	3.3	23.3	12.0	7.4	9.3	8.1	11.2	14.6	12.3	17.7	39.0	37.6	13.7	13.9	12.5	16.1	13.5	46.4	13.9	12.7	12.5	17.5	27.4	6.7	13.7	9.1	8.9	8.0	13.0	0.1	9.1	4.9	15.6	11.3	6.8	9.7	5.5	9.5	12.6	8.8	10.4	16.7	6.7	7.7	3.9	8.6	16.9	18.1	6.2	7.3	9.0	8.3	8.8	15.1	11.0	23.7	6.5	5.6	3.7	12.5	15.8	16.8	6.8	19.8	9.3	15.3	0.2	7.6	8.9	13.8	17.1	8.2	11.1	8.9	10.6	9.0	8.8	7.5	8.1	6.9	7.0	6.1	7.5	27.6	8.6	10.8	4.7	9.9	3.3	15.9	15.5	16.4	19.0	13.7	19.2	14.3	15.0	17.3	12.8	62.5	27.7	15.7	36.6	17.3	37.2	25.3	33.1	53.5	58.0	21.0	13.7	40.9	18.3	31.1	1.7	56.2	26.2	0.0	42.4	72.4	35.3	31.0	39.4	15.8	34.3	44.5	14.5	29.4	21.6	2.1	52.9	24.7	20.3	23.4	22.2	48.9	41.0	24.6	79.2	28.5	24.1	38.8	34.2	2.6	3.4	8.8	34.1	30.2	26.2	36.3
EIF2B5	"EIF-2B, EIF2Bepsilon"	ENSG00000145191	"Eukaryotic translation initiation factor 2B subunit epsilon"	Q13144	3	184135038-184145311	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015412, HPA064370, HPA069303"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB015412: AB_831253, HPA064370: AB_2685249, HPA069303: AB_2686114"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (3.38e-8)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.32e-2)"	15.2	20.1	15.3	15.4	20.2	10.6	21.5	24.5	25.8	15.1	18.8	17.8	24.3	17.3	16.3	14.9	24.3	15.4	14.0	21.5	13.0	16.1	17.5	27.5	15.6	20.1	20.8	15.1	16.0	19.1	27.0	21.2	20.6	17.7	20.4	23.7	15.3	23.2	21.0	47.2	22.8	18.2	17.5	14.7	21.1	19.6	11.9	17.3	20.9	17.4	16.9	26.9	19.1	18.3	12.7	10.3	10.9	8.4	11.2	17.2	6.5	24.4	11.2	13.8	15.0	13.9	11.4	14.9	14.6	15.6	21.4	18.2	18.4	12.3	22.2	16.9	14.3	28.0	18.9	24.7	17.0	21.9	19.9	20.3	36.3	11.4	16.1	10.8	27.4	19.3	9.5	15.4	12.9	13.4	11.0	15.3	22.3	19.6	19.4	15.1	20.5	20.0	19.1	18.6	29.8	20.8	21.7	16.6	25.0	19.5	21.6	14.9	16.5	12.5	39.7	16.2	11.5	36.7	27.2	14.2	13.0	15.2	12.3	28.0	16.7	23.1	28.3	15.5	29.4	16.2	7.2	8.4	10.9	7.6	7.4	10.5	12.0	11.9	12.7	10.3	12.7	17.2	10.7	1.6	11.2	7.7	5.0	9.5	6.5	15.3	20.2	24.5	25.8	13.0	16.1	20.8	15.1	17.7	17.3	23.8	20.7	22.3	31.6	27.4	19.3	21.5	10.2	18.7	30.7	34.9	7.9	33.4	44.7	20.0	2.6	22.5	23.8	23.3	31.3	23.2	16.4	34.3	16.1	23.6	22.0	33.4	44.0	16.0	16.5	2.1	17.0	20.5	18.6	34.3	24.5	13.3	21.9	14.4	13.8	25.8	15.0	12.9	21.7	13.4	13.0	25.3	32.3	23.6	26.5	37.1
EIF2S1	"EIF-2alpha, EIF2, EIF2A"	ENSG00000134001	"Eukaryotic translation initiation factor 2 subunit alpha"	P05198	14	67359997-67386516	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 211.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011663, HPA064885"	Supported		Enhanced	Cytosol		NA	NA		52000	Cytosol		"CAB011663: AB_2096478, HPA064885: AB_2685382"	"unprognostic (1.86e-2)"	"unprognostic (8.33e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (4.73e-7)"	"unprognostic (4.14e-3)"	"unprognostic (4.49e-1)"	"unprognostic (1.68e-2)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (2.95e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.65e-1)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (7.11e-4)"	35.5	26.2	18.7	24.8	26.3	18.9	22.5	18.9	30.6	17.8	25.7	16.3	16.1	18.5	22.9	18.0	34.8	18.4	19.1	27.9	21.9	17.0	23.8	45.0	21.1	24.1	19.9	20.8	22.9	27.8	21.3	16.3	28.0	24.1	24.4	24.2	12.6	19.9	21.0	52.0	23.8	18.4	30.9	18.9	22.8	22.9	29.1	15.1	27.3	29.0	29.9	28.0	31.1	23.1	26.6	32.9	17.3	32.7	25.7	29.2	30.2	67.4	22.5	15.9	24.4	15.4	17.4	34.1	30.2	18.0	34.1	29.9	26.3	24.2	30.5	15.3	22.7	23.0	26.2	36.6	28.8	52.1	22.2	13.7	19.7	22.0	18.0	16.2	20.9	19.3	14.1	16.8	30.4	46.6	13.4	27.7	19.3	33.4	23.7	33.6	33.5	28.5	16.4	16.2	40.6	37.8	21.9	26.4	21.7	20.9	31.1	23.0	16.2	21.7	25.6	23.3	14.7	43.6	18.2	21.1	45.2	48.8	21.8	32.0	20.6	22.4	46.1	26.2	37.5	29.0	17.3	24.2	14.8	23.9	32.7	29.1	26.6	27.9	25.7	32.9	21.3	26.0	26.5	3.3	25.7	27.4	22.5	29.2	30.2	18.7	26.3	18.9	30.6	21.9	17.0	19.9	20.8	24.1	15.1	26.8	38.1	35.0	67.4	126.8	22.8	84.7	33.1	26.8	44.3	21.0	11.8	70.2	59.7	77.0	64.0	51.3	22.3	0.0	54.6	82.1	48.2	40.6	34.6	38.0	62.8	35.0	12.5	23.9	39.6	23.3	28.7	43.9	49.0	66.7	24.0	20.9	60.9	11.5	38.2	53.2	26.2	25.8	78.5	211.8	73.9	114.0	78.1	41.7	33.8	65.0
EIF3G	"eIF3-delta, eIF3-p44, eIF3g, EIF3S4"	ENSG00000130811	"Eukaryotic translation initiation factor 3 subunit G"	O75821	19	10115017-10119918	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 1028.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 177.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041997	Approved		Enhanced	Cytosol		NA	NA		12000	Cytosol		"HPA041997: AB_10804123"	"unprognostic (1.80e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (3.94e-4)"	"unprognostic (4.90e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.40e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.43e-1)"	41.6	29.0	20.2	34.2	21.5	34.1	36.1	18.1	28.4	41.1	41.2	27.0	30.3	29.8	40.2	34.6	37.7	34.1	47.0	52.3	19.0	18.4	30.5	45.0	28.2	40.1	22.6	18.5	63.6	88.6	30.9	24.8	34.9	19.3	41.9	17.6	25.6	57.1	35.5	141.1	40.2	30.1	39.1	24.3	36.7	38.9	51.0	23.4	46.4	42.3	49.7	40.3	46.2	48.7	47.1	58.4	31.4	60.6	80.3	70.8	74.7	25.5	21.7	16.7	22.0	22.2	28.5	21.4	21.9	30.7	34.5	32.1	35.5	13.8	26.3	31.4	26.1	15.7	19.7	20.2	32.9	14.3	23.7	61.5	46.6	21.9	35.5	37.0	36.6	24.6	34.1	24.3	24.3	23.4	22.3	24.6	33.1	41.8	31.3	20.7	34.3	39.8	177.9	40.8	16.3	46.8	32.2	16.4	34.7	21.9	22.4	21.6	42.0	14.5	19.1	34.3	9.9	16.8	32.4	24.2	29.9	16.9	32.4	41.5	92.6	67.3	29.3	22.5	40.2	28.5	31.4	60.6	25.3	54.6	44.4	70.8	46.7	59.0	59.1	58.4	47.1	60.3	54.1	11.7	80.3	35.6	45.9	64.9	74.7	20.2	21.5	18.1	28.4	19.0	18.4	22.6	18.5	19.3	23.4	41.7	79.8	229.1	225.9	202.7	38.3	40.8	122.3	78.9	77.3	102.9	17.7	402.8	159.2	159.9	356.5	161.9	178.9	23.3	266.1	265.8	177.6	154.0	126.9	95.5	198.8	20.6	124.7	129.5	241.3	1028.3	220.4	229.7	138.3	284.1	165.6	56.1	195.2	164.9	166.6	222.1	38.4	161.7	224.0	181.2	151.2	208.6	440.9	257.6	191.5	210.8
EIF4B		ENSG00000063046	"Eukaryotic translation initiation factor 4B"	P23588	12	53006158-53042209	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA039072, HPA046164"	Approved		Enhanced	Cytosol		NA	NA		50000	Cytosol		"HPA039072: AB_2676333, HPA046164: AB_2679567"	"unprognostic (1.91e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.50e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.44e-1)"	"unprognostic (3.57e-1)"	"unprognostic (4.69e-1)"	"unprognostic (8.20e-3)"	35.6	36.9	20.1	21.5	25.4	26.4	34.5	29.5	30.2	41.0	27.9	35.4	26.8	26.7	35.8	18.8	30.9	40.1	33.6	25.0	21.6	15.2	27.8	29.4	22.5	28.7	23.1	27.9	94.9	55.8	31.0	37.2	22.2	24.3	25.9	24.5	27.0	39.1	21.0	76.9	31.9	24.4	37.9	25.7	27.5	31.1	31.9	29.5	27.2	32.9	33.6	39.0	35.7	33.5	27.2	26.0	10.5	24.0	25.4	46.3	33.9	24.2	39.6	27.0	35.1	49.2	91.6	35.8	23.7	56.0	21.7	20.0	40.6	39.6	148.3	35.6	34.9	19.2	27.2	48.1	53.3	27.3	29.1	28.7	57.4	54.4	43.7	36.9	82.0	33.6	92.5	53.9	25.8	79.5	133.0	42.6	44.9	62.6	61.0	35.5	53.3	49.5	51.0	49.8	26.4	20.7	50.8	38.4	61.7	29.7	40.2	28.7	38.4	24.9	54.1	47.2	36.8	61.8	52.9	39.1	15.2	33.2	16.6	20.8	53.5	59.3	37.8	25.5	35.4	21.1	9.1	20.0	10.5	30.0	20.8	43.1	27.2	36.3	33.1	26.0	19.6	46.3	42.6	5.4	25.4	24.0	16.3	29.3	33.9	20.1	25.4	29.5	30.2	21.6	15.2	23.1	27.9	24.3	29.5	137.0	177.4	171.7	216.0	184.7	81.9	129.3	163.1	127.2	185.4	89.0	29.5	123.9	154.2	105.8	197.8	119.6	131.6	23.3	149.6	203.6	128.6	182.1	226.7	168.6	97.0	60.4	178.9	163.9	258.4	403.4	187.3	156.0	133.3	138.9	167.7	83.8	157.4	73.7	183.9	205.7	79.6	109.9	160.6	65.8	44.3	206.1	149.4	183.0	188.6	203.0
EIF4E2	"4EHP, EIF4EL3, IF4e"	ENSG00000135930	"Eukaryotic translation initiation factor 4E family member 2"	O60573	2	232550052-232583644	"Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019253, HPA077074"			Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA019253: AB_1848092, HPA077074: "	"unprognostic (3.44e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (1.42e-1)"	"unprognostic (5.62e-3)"	"unprognostic (1.42e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.74e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.38e-2)"	19.0	22.9	27.9	24.0	24.4	25.4	19.4	27.1	38.1	17.6	30.7	18.4	17.0	24.4	26.2	18.2	32.1	18.5	20.0	21.3	25.8	14.8	29.8	43.2	20.4	21.0	18.6	27.2	22.0	26.2	16.3	25.0	26.8	26.3	19.9	35.7	16.1	27.3	15.9	77.6	23.8	25.2	25.3	27.0	25.4	26.7	25.2	21.5	18.1	19.1	24.8	27.1	20.0	21.2	13.5	38.9	49.6	46.8	14.1	24.1	29.7	27.9	23.2	28.4	21.0	20.9	28.6	43.9	37.7	20.4	26.0	26.6	25.6	26.5	27.4	10.7	36.7	30.7	23.9	32.0	32.8	32.7	24.5	26.4	37.5	25.1	33.9	25.4	52.4	35.5	24.5	24.6	27.3	19.7	26.5	42.2	13.4	35.2	9.3	29.3	45.1	21.3	44.5	45.3	31.0	19.4	18.4	63.2	17.9	52.1	33.4	27.7	37.9	20.1	23.3	24.0	32.0	22.2	36.8	38.5	24.4	32.1	25.4	27.8	17.5	16.6	36.1	27.3	28.9	21.1	49.6	45.1	40.7	14.8	46.8	11.8	13.5	15.1	15.4	38.9	12.2	12.9	13.1	29.5	14.1	41.7	15.2	24.1	29.7	27.9	24.4	27.1	38.1	25.8	14.8	18.6	27.2	26.3	21.5	38.7	52.3	42.4	59.6	33.8	19.5	33.6	71.4	34.8	31.8	33.2	17.7	120.6	63.0	146.2	103.8	31.0	104.8	0.0	131.7	170.6	55.5	66.8	42.7	102.9	110.3	19.1	63.4	46.1	84.3	214.1	35.4	81.8	28.7	140.7	94.2	22.7	139.4	87.7	36.4	98.2	18.3	25.8	36.6	47.9	59.9	44.7	152.5	45.7	76.5	86.7
EIF4ENIF1	"2610509L04Rik, 4E-T, Clast4, FLJ21601"	ENSG00000184708	"Eukaryotic translation initiation factor 4E nuclear import factor 1"	Q9NRA8	22	31436977-31496108	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001619, HPA002078"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"HPA001619: AB_1078727, HPA002078: AB_1078728"	"unprognostic (1.16e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.30e-2)"	"unprognostic (4.95e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.57e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.45e-2)"	10.9	10.9	18.8	13.4	18.9	12.6	10.8	19.4	20.8	11.9	15.9	14.4	12.3	11.8	14.9	14.5	12.6	13.3	8.6	13.2	16.3	11.8	11.9	7.6	10.7	12.3	12.5	15.7	16.9	10.9	18.1	12.2	14.3	16.2	12.5	12.6	12.7	11.2	15.2	17.4	13.7	10.3	13.8	11.8	11.4	11.3	43.6	14.8	8.8	13.3	7.7	15.3	14.1	12.9	6.6	6.5	3.1	10.7	1.7	5.7	3.0	13.5	8.4	21.3	11.5	12.0	10.7	8.6	9.9	12.1	15.6	14.6	9.5	4.9	17.8	5.9	14.7	10.4	13.4	19.2	8.9	14.4	13.9	19.8	7.3	13.5	10.8	12.5	28.2	12.9	12.6	12.3	11.6	13.2	14.3	13.0	10.5	17.5	19.1	14.6	16.1	18.4	13.7	9.7	12.7	6.9	21.6	17.8	18.2	15.8	10.3	16.5	15.4	13.7	11.0	10.2	14.7	11.8	11.1	14.5	10.4	13.7	10.3	10.9	14.1	13.5	17.4	10.0	10.3	12.2	2.0	3.5	1.6	5.4	4.2	5.7	6.6	3.0	5.1	3.2	3.3	3.1	5.1	3.1	1.7	10.7	6.5	2.0	3.0	18.8	18.9	19.4	20.8	16.3	11.8	12.5	15.7	16.2	14.8	11.9	14.6	5.2	5.7	6.5	17.1	19.1	12.7	5.3	10.3	12.2	11.8	8.1	8.3	7.3	42.3	8.4	5.1	0.0	5.5	4.9	6.9	5.7	5.8	7.9	6.9	17.5	11.5	9.8	8.4	66.1	13.6	6.1	6.8	16.2	10.1	8.5	8.5	0.0	14.5	7.8	13.5	6.5	6.5	25.4	6.4	9.3	5.6	6.2	7.6	6.2
EIF4G1	"EIF4F, EIF4G, p220, PARK18"	ENSG00000114867	"Eukaryotic translation initiation factor 4 gamma 1"	Q04637	3	184314495-184335358	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis, Translation regulation"	"Initiation factor, RNA-binding, Translational shunt"	"Cancer-related genes, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014774, HPA028487, HPA043866"	Approved		Enhanced	Cytosol		NA	NA		17000	Cytosol		"CAB014774: , HPA028487: AB_10602219, HPA043866: AB_2678705"	"unprognostic (4.14e-3)"	"unprognostic (2.10e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (4.27e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.55e-3)"	"unprognostic (7.06e-3)"	"unprognostic (2.42e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.33e-3)"	30.2	33.1	18.3	26.4	18.9	26.3	30.3	18.0	23.2	24.1	25.2	19.6	33.6	21.9	24.5	30.5	45.2	20.9	31.1	33.0	16.9	16.9	40.6	108.0	26.0	21.0	19.4	15.9	29.3	46.4	47.5	21.9	34.6	18.3	24.0	21.8	19.9	31.4	34.1	103.7	39.0	31.6	26.8	15.7	33.1	27.1	30.8	18.0	25.8	30.0	46.2	34.3	28.6	27.6	8.8	15.9	5.5	17.0	8.1	11.4	9.1	90.3	37.9	31.9	36.2	35.6	35.1	55.1	49.9	35.3	55.5	42.3	80.4	29.5	57.8	66.5	61.8	66.5	48.9	54.9	61.2	43.2	61.1	57.8	52.2	38.8	35.6	30.9	52.3	36.6	35.4	35.6	50.5	48.2	28.9	48.4	22.1	37.9	45.8	36.6	67.1	35.4	18.8	62.7	44.3	30.7	36.5	31.4	46.4	29.4	55.1	33.4	29.7	42.5	70.5	33.9	28.5	75.1	37.4	60.4	39.4	39.9	51.6	93.4	35.7	43.1	107.0	44.3	45.9	43.0	4.8	13.6	5.5	11.4	13.9	11.0	7.6	7.7	9.2	12.2	8.8	7.1	7.0	5.1	8.1	17.0	15.9	5.4	9.1	18.3	18.9	18.0	23.2	16.9	16.9	19.4	15.9	18.3	18.0	71.5	58.2	39.7	51.5	52.5	25.1	95.4	50.9	40.2	67.1	59.3	13.7	53.1	11.6	92.9	153.5	57.6	100.2	23.3	116.3	63.6	52.3	82.5	45.2	130.2	58.2	20.6	53.5	43.6	38.3	140.5	67.6	40.6	32.1	49.5	68.5	21.9	122.3	58.5	52.6	40.9	22.0	77.6	66.8	27.0	39.1	80.3	66.6	33.8	68.7	78.7
EIF4G2	"DAP5, NAT1, p97"	ENSG00000110321	"Eukaryotic translation initiation factor 4 gamma 2"	P78344	11	10797050-10809110	"Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Initiation factor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005163, HPA006773, HPA016965"	Approved		Enhanced	Cytosol		NA	NA		25000	Cytosol		"CAB005163: AB_638994, HPA006773: AB_1848099, HPA016965: AB_1848100"	"unprognostic (1.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (6.18e-5)"	"unprognostic (1.25e-1)"	"unprognostic (7.84e-3)"	"unprognostic (5.42e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.67e-4)"	"unprognostic (1.02e-2)"	"unprognostic (2.08e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.74e-1)"	86.2	86.5	81.0	73.8	78.4	124.4	122.8	76.8	84.8	94.3	102.2	64.5	70.2	57.5	108.8	85.3	125.4	83.5	82.4	199.1	83.8	85.7	121.2	115.8	84.6	71.3	92.0	66.4	81.3	76.1	117.7	118.9	187.1	96.8	90.8	90.2	69.5	84.4	97.1	162.7	84.2	102.0	113.1	104.8	120.0	83.9	60.5	65.5	110.6	110.0	81.9	96.5	107.8	98.9	48.4	57.5	87.4	72.2	44.5	52.7	114.7	106.7	87.3	118.2	64.3	80.4	89.6	80.0	99.1	106.8	93.1	62.3	92.0	127.2	61.3	59.6	123.0	67.6	64.0	129.0	92.6	121.2	99.6	54.2	78.1	55.3	67.3	68.8	119.3	67.1	72.1	69.6	55.1	70.3	78.4	99.8	57.5	60.3	69.0	111.1	53.0	88.9	40.9	82.5	71.2	85.3	82.1	69.0	39.2	73.2	161.4	44.1	71.1	115.9	77.4	59.8	79.6	68.1	52.0	96.3	112.8	74.0	95.5	83.0	33.3	101.6	94.0	65.3	68.6	119.5	50.2	60.0	87.4	42.3	70.9	52.7	48.4	45.7	47.8	57.5	40.6	40.4	41.6	42.9	44.5	72.2	28.5	50.3	114.7	81.0	78.4	76.8	84.8	83.8	85.7	92.0	66.4	96.8	65.5	300.7	242.9	205.7	326.9	562.6	127.4	347.3	186.0	165.9	205.9	139.6	115.8	281.4	207.2	310.1	126.1	303.6	306.8	46.7	318.9	312.1	251.4	276.0	194.1	191.7	247.1	155.7	237.7	196.4	207.0	110.8	193.3	240.5	237.8	222.8	201.5	149.9	422.5	243.1	226.3	255.2	114.5	129.4	327.4	202.8	214.2	550.8	883.2	197.1	182.5	470.4
EIF5		ENSG00000100664	"Eukaryotic translation initiation factor 5"	P55010	14	103333544-103345025	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 125.8"	"Low region specificity"	"Detected in all"							"HPA000867, CAB004226"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		21000	Cytosol	"Plasma membrane"	"CAB004226: AB_627507, HPA000867: AB_1078731"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.47e-3)"	"unprognostic (6.33e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.59e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.70e-2)"	"prognostic favorable (5.67e-7)"	"unprognostic (2.76e-1)"	"unprognostic (8.41e-2)"	"unprognostic (5.43e-3)"	"unprognostic (3.14e-2)"	35.7	31.9	36.5	20.8	41.1	67.7	34.4	31.5	47.2	21.3	32.5	25.5	18.8	31.7	27.6	23.5	34.0	27.6	26.2	34.1	37.9	34.2	37.9	78.4	27.3	37.2	37.1	33.3	24.7	32.1	30.1	26.7	31.9	39.3	23.4	32.5	19.2	28.5	32.8	59.4	22.7	31.5	39.5	36.9	31.1	28.2	39.1	27.0	29.6	40.1	30.5	31.1	29.1	37.9	96.7	96.6	90.1	74.3	86.8	90.5	102.2	21.9	25.7	29.9	13.5	26.0	23.1	31.7	32.3	35.1	33.4	25.4	37.8	23.4	22.8	20.5	29.0	28.7	29.4	37.6	32.7	57.0	18.5	15.0	20.2	13.6	19.9	27.1	36.5	17.4	24.7	22.0	29.5	40.4	27.9	33.5	16.7	41.9	21.8	27.5	31.4	24.8	12.1	15.6	41.9	49.1	21.1	38.9	14.2	19.7	71.4	26.7	18.7	32.4	24.3	26.2	29.2	23.2	16.8	25.4	26.8	18.2	34.0	33.7	65.4	125.8	47.8	26.3	25.7	31.1	83.4	74.3	90.1	74.1	73.2	82.6	95.9	76.0	69.3	70.7	96.7	90.5	76.1	80.3	86.8	73.8	96.6	62.3	102.2	36.5	41.1	31.5	47.2	37.9	34.2	37.1	33.3	39.3	27.0	134.0	134.2	172.4	275.5	302.0	187.9	268.9	94.3	211.5	160.3	69.8	174.7	201.6	182.4	188.8	177.9	189.8	216.8	116.8	244.5	166.6	191.4	206.1	270.4	218.5	155.2	166.8	191.4	125.2	135.3	526.7	118.5	188.0	145.1	271.5	121.6	154.4	191.1	147.3	163.4	197.4	198.0	116.4	294.0	384.8	335.3	231.9	412.9	139.6	161.2	208.2
ELAC2	"FLJ10530, HPC2"	ENSG00000006744	"ElaC ribonuclease Z 2"	Q9BQ52	17	12992391-13018187	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"tRNA processing"	"Endonuclease, Hydrolase, Nuclease"	"Disease mutation, Primary mitochondrial disease, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SuSa: 96.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019535	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019535: AB_1848106"	"unprognostic (4.24e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.24e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.98e-1)"	"unprognostic (5.31e-3)"	"unprognostic (3.09e-1)"	"unprognostic (5.31e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.70e-2)"	20.3	35.9	15.2	17.2	23.5	13.8	18.6	16.9	30.0	17.5	21.2	24.6	17.9	15.8	22.1	13.1	25.9	19.5	19.6	28.1	14.2	14.3	23.5	34.8	14.2	19.4	18.2	19.5	20.3	24.5	27.5	14.0	21.2	20.5	20.7	25.1	19.4	19.1	26.2	49.2	20.7	18.7	26.6	15.6	25.5	22.8	29.5	17.1	28.1	20.7	20.1	25.9	23.0	16.3	19.9	23.5	9.4	20.4	24.0	25.1	20.9	14.7	23.6	16.3	18.2	13.1	12.8	9.9	16.2	13.0	26.5	17.9	18.9	7.9	26.8	17.7	15.4	10.0	20.0	29.6	18.8	26.6	13.9	29.9	15.7	18.4	12.4	9.7	13.4	21.7	11.4	16.0	20.6	19.2	11.9	18.5	15.9	21.4	8.2	20.1	13.1	23.6	13.4	13.5	28.3	15.8	16.6	28.0	16.8	15.0	13.3	8.4	12.3	20.6	13.4	8.3	96.8	13.3	5.8	18.0	32.8	10.9	13.0	23.8	5.1	9.5	10.8	13.0	14.3	11.9	9.4	14.7	9.3	21.4	20.1	23.0	19.9	20.7	21.3	23.5	17.4	21.5	19.2	2.2	24.0	20.4	13.3	25.1	20.9	15.2	23.5	16.9	30.0	14.2	14.3	18.2	19.5	20.5	17.1	6.0	13.3	13.7	8.6	9.2	10.1	22.9	15.3	10.7	5.7	15.7	2.0	52.4	16.6	22.1	5.2	12.0	10.9	0.0	22.4	24.6	15.4	8.8	9.2	21.8	24.4	11.1	8.1	12.3	14.6	4.2	9.8	10.2	13.5	18.0	10.0	13.8	23.0	16.1	20.1	15.6	10.9	51.8	13.3	25.0	27.4	12.7	28.0	13.8	16.6	7.1
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017188	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Inflammatory response, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.8"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 1511.9;Glandular cells: 1015.6;Paneth cells: 1043.9;Urothelial cells: 1629.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 40.5;CAPAN-2: 57.8;OE19: 37.3;RT4: 41.5;SK-BR-3: 80.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	0.3	0.1	0.1	16.0	0.2	0.0	34.0	0.2	0.2	13.2	80.7	0.2	12.5	34.4	3.8	8.9	59.3	8.6	67.7	1.1	0.1	0.1	38.1	33.3	24.6	0.1	0.1	0.1	5.8	38.4	1.1	1.7	16.7	0.3	39.9	31.3	0.7	37.9	11.3	0.7	3.5	100.8	9.5	0.3	0.2	29.9	1.9	0.1	0.6	5.7	25.5	43.5	44.7	22.7	0.3	0.8	2.0	0.3	0.2	0.3	0.0	10.6	40.5	0.0	0.0	0.0	0.0	12.6	0.0	1.5	0.0	0.0	9.0	57.8	0.0	4.8	0.0	0.3	10.5	0.0	0.0	0.0	1.2	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.6	37.3	3.4	0.0	0.0	0.5	15.4	41.5	0.0	0.0	0.4	80.2	0.0	1.9	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.8	0.3	0.2	0.1	2.0	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1	273.9	377.1	5.4	575.3	4.5	1.7	1.2	448.4	586.2	343.5	312.3	17.7	60.7	34.9	553.5	0.0	1.1	1511.9	0.0	565.5	107.5	4.2	1015.6	40.3	30.4	7.8	0.0	434.4	0.6	1.3	0.0	0.0	12.0	8.5	25.2	963.0	2.0	453.3	1043.9	0.0	114.1	63.9	0.0	0.4	0.0	0.2	7.3	215.1	2.2	773.6	1629.9
ELK1		ENSG00000126767	"ELK1, ETS transcription factor"	P19419	X	47635521-47650604	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003808, HPA036084, HPA064381"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB003808: AB_562282, HPA036084: AB_2674931, HPA064381: AB_2685250"	"unprognostic (2.25e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.59e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (1.02e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.67e-2)"	12.1	20.9	37.2	10.8	52.2	11.5	8.2	32.6	32.9	11.1	9.4	4.9	14.6	8.1	11.4	17.5	8.5	13.1	9.9	12.4	23.3	11.6	7.7	19.0	8.9	10.4	5.7	22.7	37.7	9.8	12.0	7.5	13.7	6.7	9.3	9.8	7.4	9.8	11.3	17.9	8.6	8.5	10.8	4.4	14.3	7.5	19.1	11.2	8.7	6.9	8.3	11.5	8.9	6.7	7.4	11.7	3.9	9.5	4.2	12.7	6.3	17.2	13.6	7.0	19.4	12.1	14.7	9.7	14.5	17.3	17.8	18.5	9.5	13.1	13.6	8.0	15.7	28.8	10.5	18.4	15.5	16.9	15.1	17.5	11.3	12.5	8.5	26.9	12.3	19.9	14.1	14.1	28.5	19.2	14.9	10.2	19.4	23.4	16.1	14.5	22.8	13.0	14.1	16.2	8.5	28.8	14.2	17.6	21.3	9.5	7.5	15.1	12.6	24.4	8.7	20.5	16.6	22.1	7.9	8.1	20.4	21.2	26.5	13.5	26.7	36.7	14.2	22.6	22.4	12.7	2.0	8.1	3.4	7.4	9.5	8.6	7.4	9.5	8.6	11.7	6.7	8.4	6.8	3.9	4.2	7.8	8.2	12.7	6.3	37.2	52.2	32.6	32.9	23.3	11.6	5.7	22.7	6.7	11.2	0.0	7.0	7.4	10.8	14.9	13.3	7.5	5.1	1.4	4.5	7.0	3.9	6.8	5.0	6.9	2.9	8.0	4.5	0.0	6.4	8.2	8.2	10.6	8.1	11.9	9.0	4.8	9.8	18.4	6.5	0.9	13.0	9.0	6.8	20.8	7.7	8.2	6.0	3.5	28.0	4.4	6.8	6.5	11.3	1.9	7.8	13.9	7.4	7.2	10.5	9.5
ELMSAN1	"C14orf117, C14orf43, LSR68"	ENSG00000156030	"ELM2 and Myb/SANT domain containing 1"	Q6PJG2	14	73715122-73790285	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003111	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003111: AB_1078329"	"unprognostic (1.54e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.69e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.36e-3)"	"unprognostic (7.35e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.96e-1)"	17.8	8.1	11.2	18.7	10.1	18.8	17.4	17.8	9.9	17.3	13.7	14.5	9.7	11.2	16.8	11.1	14.0	12.7	15.8	11.2	8.3	6.3	7.7	7.8	13.9	12.9	7.6	8.2	18.6	8.7	21.4	7.6	12.8	9.4	14.2	6.0	16.8	13.1	13.1	13.4	26.1	14.1	13.9	7.6	18.8	12.6	8.2	11.8	8.8	11.0	9.5	20.0	16.1	15.0	2.9	4.4	3.1	1.9	2.1	1.8	1.3	6.8	7.7	2.8	5.2	2.6	4.5	5.4	2.8	4.8	3.9	3.5	6.7	8.2	10.0	3.2	3.8	4.1	10.6	4.6	7.9	1.6	13.2	2.8	16.0	6.6	2.4	4.3	2.7	34.9	5.9	4.9	3.4	4.3	3.4	6.2	3.5	8.2	9.3	1.9	16.0	6.3	4.4	0.9	3.4	6.4	7.4	15.2	2.6	5.9	7.4	3.6	3.0	10.6	14.7	5.9	1.6	11.3	5.9	12.3	8.1	9.4	6.0	3.0	7.3	3.4	11.1	6.6	3.4	9.4	2.1	1.9	0.7	1.2	0.9	1.8	1.8	0.6	1.3	2.1	2.9	0.7	0.8	3.1	2.1	1.1	4.4	1.4	1.3	11.2	10.1	17.8	9.9	8.3	6.3	7.6	8.2	9.4	11.8	23.8	22.4	64.8	25.5	78.6	20.9	18.6	20.4	13.4	10.3	17.4	49.1	32.2	13.3	17.8	1.6	26.4	41.7	0.0	14.9	23.4	29.6	22.2	22.0	17.1	23.3	11.1	39.2	43.6	34.2	2.2	25.0	22.4	69.2	28.9	30.4	17.8	17.2	28.8	29.4	12.9	33.8	32.3	25.0	1.1	18.8	54.5	24.6	26.7	20.2	5.8
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Glandular cells: 250.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	75.7	48.7	17.9	24.2	22.0	33.9	78.8	13.3	22.1	18.2	13.9	38.3	91.2	9.7	15.7	18.0	10.8	16.5	18.0	14.6	18.3	17.5	13.5	36.8	24.4	33.6	41.1	12.3	13.1	5.7	8.1	11.6	13.6	26.4	45.2	6.7	16.1	9.4	88.4	3.6	11.4	17.3	18.0	46.4	18.5	9.5	34.8	29.1	28.7	17.6	5.6	33.6	16.6	19.4	23.8	18.1	60.7	11.3	8.4	25.3	10.4	25.3	18.5	32.5	59.3	86.2	50.1	13.8	29.6	33.3	23.9	33.6	16.4	29.4	28.8	21.5	30.7	37.6	15.0	32.0	27.1	35.9	24.2	22.5	28.4	17.3	22.8	47.4	22.4	20.8	46.2	21.3	23.9	30.1	24.2	26.5	57.5	35.4	16.8	17.2	2.7	66.5	19.9	17.5	0.9	14.2	26.0	22.3	10.0	45.0	15.2	30.3	20.8	24.5	12.8	24.8	22.1	29.2	21.0	25.1	26.3	23.4	46.8	38.9	14.1	13.0	21.9	13.7	32.6	18.6	9.0	11.3	40.7	8.8	8.1	14.2	21.6	14.7	10.6	18.1	23.8	7.2	6.7	60.7	8.4	9.6	4.8	25.3	10.4	17.9	22.0	13.3	20.2	18.3	17.5	41.1	12.3	26.4	29.1	74.5	46.1	107.2	78.7	46.5	7.7	20.2	22.9	49.5	31.8	12.2	2.0	21.5	13.3	32.0	79.1	51.7	5.1	0.0	31.8	46.1	52.2	250.9	98.0	83.9	32.1	7.9	24.0	41.1	61.4	135.1	19.2	53.0	45.5	16.2	0.6	75.7	19.7	0.6	30.1	34.2	5.2	64.7	88.4	20.7	10.4	53.2	26.1	87.3	4.3	62.0
ELP3	"FLJ10422, KAT9"	ENSG00000134014	"Elongator acetyltransferase complex subunit 3"	Q9H9T3	8	28089673-28191156	"Enzymes, Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation, tRNA processing"	"Acyltransferase, RNA-binding, Transferase, tRNA-binding"	"Amyotrophic lateral sclerosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025297, HPA025812"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA025297: , HPA025812: AB_10601369"	"unprognostic (1.29e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (9.25e-4)"	"unprognostic (3.49e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.07e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.46e-2)"	"prognostic favorable (1.31e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	14.8	15.3	18.7	11.5	23.4	6.7	19.4	20.0	27.4	33.4	14.8	21.8	35.2	10.8	27.3	14.4	12.8	18.6	17.5	16.0	17.7	19.0	19.1	22.8	13.6	15.4	17.6	13.6	18.9	12.6	14.3	17.4	12.7	23.3	15.9	18.0	13.9	11.1	36.1	28.8	13.4	12.3	16.0	15.8	16.1	12.1	15.0	15.5	16.0	19.9	13.8	20.3	14.7	12.0	16.2	12.2	11.6	18.2	15.8	20.8	11.0	14.5	15.2	11.6	11.1	17.2	15.1	8.3	7.5	13.6	17.7	15.8	12.6	6.2	27.4	11.8	14.4	15.7	9.9	12.8	17.8	20.9	4.9	5.3	18.4	10.1	20.9	15.4	9.9	13.7	15.9	27.6	12.1	18.7	12.8	16.5	21.3	20.7	17.0	18.0	9.0	21.1	16.9	13.1	14.0	5.3	16.0	11.3	10.5	17.6	12.0	7.0	12.2	8.5	7.3	14.3	11.1	13.9	11.5	11.6	12.1	15.9	12.6	10.8	7.2	11.5	21.0	12.0	11.2	12.3	11.6	10.1	8.2	19.4	14.4	20.8	12.5	16.6	18.3	11.8	16.2	15.0	17.0	2.8	15.8	18.2	12.2	15.6	11.0	18.7	23.4	20.0	27.4	17.7	19.0	17.6	13.6	23.3	15.5	3.0	10.1	10.4	6.7	2.4	6.7	14.6	7.6	13.4	12.5	7.0	21.6	12.5	6.6	10.5	5.9	8.7	7.7	0.0	8.6	12.1	6.4	6.2	8.1	14.7	13.2	14.3	1.2	9.8	11.5	2.7	7.8	7.2	1.7	7.2	8.1	8.7	8.4	8.6	9.6	11.1	11.1	0.0	6.6	11.4	16.1	2.0	8.7	11.5	9.9	5.1
EMD	"LEMD5, STA"	ENSG00000102119	Emerin	P50402	X	154379197-154381523	"Disease related genes, Predicted membrane proteins"		Actin-binding	"Cardiomyopathy, Disease mutation, Emery-Dreifuss muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000609, CAB001545, CAB002029, CAB058694, CAB062552"	Supported		Enhanced	"Nuclear membrane,Endoplasmic reticulum"		NA	NA		520000	"Nuclear membrane"	"Endoplasmic reticulum"	"CAB001545: AB_2100047, CAB002029: AB_442088, CAB058694: AB_2665587, CAB062552: AB_2665586, HPA000609: AB_1078736"	"unprognostic (2.92e-1)"	"unprognostic (6.59e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.12e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.06e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.99e-1)"	25.0	17.5	14.0	17.6	16.0	21.0	26.5	15.8	21.8	24.8	21.3	13.7	22.3	14.0	32.3	25.7	22.9	27.2	28.7	29.5	13.1	14.1	18.2	21.2	22.0	37.4	13.3	16.5	35.9	29.4	20.5	22.8	15.4	11.9	25.5	11.4	20.7	24.5	29.1	62.0	18.1	13.7	40.4	13.1	17.6	20.1	16.1	9.7	16.6	28.1	24.4	18.3	31.7	20.6	23.2	30.5	24.5	19.7	14.7	26.9	15.8	30.6	11.6	8.0	8.8	7.3	14.6	14.4	15.1	16.2	19.3	20.3	10.3	6.0	24.4	23.0	15.5	40.7	17.1	15.3	18.7	8.2	14.3	33.4	11.4	17.0	6.0	19.8	11.0	12.6	12.8	14.9	17.2	21.5	13.0	13.4	10.4	9.4	10.5	13.1	13.0	19.2	20.2	13.4	17.9	36.2	16.0	12.0	23.3	10.4	5.9	10.2	12.6	7.8	13.1	18.4	8.1	9.2	8.3	12.1	9.6	18.3	21.6	21.6	34.4	25.5	44.0	11.7	18.6	10.4	16.6	16.9	24.5	26.9	19.7	25.0	22.5	25.7	25.7	13.5	23.2	23.1	22.4	18.1	14.7	14.0	30.5	23.9	15.8	14.0	16.0	15.8	21.8	13.1	14.1	13.3	16.5	11.9	9.7	29.8	39.9	28.9	65.6	63.7	31.2	18.5	30.6	20.1	30.7	26.2	11.8	50.6	59.7	39.0	13.8	27.2	18.0	0.0	47.4	56.3	49.5	56.7	53.2	33.5	46.5	28.6	23.0	27.0	17.1	11.2	37.7	46.4	64.1	59.5	33.9	40.7	39.0	28.8	42.1	35.0	29.9	25.8	51.0	10.7	34.1	67.2	104.6	47.8	27.5	59.3
ENAH	"FLJ10773, MENA, NDPP1"	ENSG00000154380	"ENAH, actin regulator"	Q8N8S7	1	225486835-225653142	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 61.0"	"Low region specificity"	"Detected in all"							"HPA028448, HPA028696"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA		18000	"Plasma membrane, Focal adhesion sites, Cytosol"		"HPA028448: AB_10600766, HPA028696: AB_10611249"	"unprognostic (2.56e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.35e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.71e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.24e-3)"	"unprognostic (8.84e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.93e-2)"	19.2	17.4	15.8	11.9	17.0	0.6	11.1	7.6	17.6	17.8	24.4	15.3	39.9	9.3	21.9	19.9	16.7	11.8	29.0	18.2	16.7	15.3	5.8	5.9	13.8	3.5	13.7	11.3	24.3	16.7	22.5	10.3	13.5	12.7	26.4	8.0	3.3	14.5	44.9	20.2	8.2	8.0	61.4	13.4	17.3	21.0	18.5	17.2	5.3	6.8	11.4	3.5	35.3	21.9	2.1	0.4	1.0	0.3	0.5	0.4	0.0	20.5	16.5	20.5	18.5	8.0	10.6	26.4	22.9	11.0	13.8	10.5	10.6	7.6	8.7	61.0	35.3	12.4	18.2	23.9	8.6	13.2	0.1	14.8	9.1	14.7	14.2	24.0	1.0	0.3	16.3	10.4	17.9	22.9	11.3	10.9	2.5	0.6	0.4	13.6	4.0	4.1	1.0	34.5	5.4	15.0	6.2	28.9	0.2	6.3	15.9	20.2	16.3	44.9	17.2	15.1	16.3	20.4	1.3	21.2	35.9	26.4	29.8	45.3	1.0	2.5	5.9	19.7	1.1	18.3	1.0	0.3	0.2	0.4	0.1	0.3	0.6	0.4	0.3	0.0	2.1	0.4	0.4	1.0	0.5	0.2	0.4	0.2	0.0	15.8	17.0	7.6	13.7	16.7	15.3	13.7	11.3	12.7	17.2	11.9	31.2	2.2	136.9	114.6	7.8	109.0	56.0	123.1	56.9	21.0	58.9	50.3	3.3	71.8	67.2	59.1	5.1	0.0	86.5	13.1	84.6	122.2	4.7	9.6	9.4	15.9	39.7	22.1	1.8	19.9	53.8	7.0	79.2	5.4	28.6	30.0	72.6	14.4	158.7	10.5	19.1	90.5	115.4	8.0	40.0	117.2	50.6	0.0	23.0	87.2
ENO1	"ENO1L1, MBP-1, MPB1, PPH"	ENSG00000074800	"Enolase 1"	P06733	1	8861000-8879250	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Plasminogen activation, Transcription, Transcription regulation"	"DNA-binding, Lyase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"monocytes: 2408.5;Muller glia cells: 2654.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB018614, HPA068284, HPA068721, CAB069394"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA		490000000	"Plasma membrane, Cytosol"		"CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119"	"unprognostic (6.51e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.86e-1)"	"prognostic unfavorable (2.71e-4)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.30e-8)"	"unprognostic (2.37e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.36e-3)"	68.6	57.7	92.7	94.9	109.6	121.8	73.4	46.6	119.4	47.3	63.8	74.6	21.7	71.3	44.9	24.2	138.2	52.2	55.0	45.2	79.1	70.7	180.4	165.4	64.8	80.3	74.9	62.7	58.2	31.6	52.7	35.5	70.5	88.6	38.6	66.4	62.6	106.1	69.1	45.0	74.6	70.3	84.0	56.4	80.0	44.3	31.7	48.8	98.8	55.4	91.0	119.3	73.5	62.9	38.7	114.1	22.1	105.4	55.5	63.7	159.3	182.3	159.4	76.9	65.8	64.4	71.9	69.7	99.1	109.9	213.7	200.9	102.1	105.9	131.5	132.4	119.3	87.5	90.0	130.6	264.6	218.0	89.7	138.0	111.0	161.9	126.7	96.7	221.2	68.4	74.2	80.3	169.2	257.3	161.8	136.8	67.1	121.6	51.4	138.5	90.3	83.4	118.4	83.9	65.5	160.0	86.4	114.6	214.7	252.9	43.5	104.0	64.2	116.3	169.4	122.3	96.7	84.8	66.3	125.1	148.0	131.1	126.2	168.6	146.8	104.1	199.5	229.8	181.4	124.2	13.9	105.4	20.8	52.3	75.8	59.1	38.7	55.8	53.8	114.1	32.7	45.6	47.8	22.1	55.5	72.4	31.2	63.7	159.3	92.7	109.6	46.6	119.4	79.1	70.7	74.9	62.7	88.6	48.8	259.1	414.8	250.1	443.8	370.0	168.1	63.1	310.8	202.1	440.2	575.7	66.8	1020.4	784.2	1640.5	217.6	199.3	508.9	23.3	1210.7	1855.9	354.5	232.4	289.9	288.6	1045.8	456.1	181.6	141.8	389.1	532.9	158.8	475.7	425.1	2408.5	221.4	2654.1	1226.2	336.6	126.9	717.5	187.6	148.8	217.3	150.6	148.2	305.6	837.7	297.2	410.6	403.0
EP300	"KAT3B, p300"	ENSG00000100393	"E1A binding protein p300"	Q09472	22	41091786-41180079	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000146, HPA003128, HPA004112"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000146: AB_2533138, HPA003128: AB_1078745, HPA004112: AB_1078746"	"unprognostic (7.67e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.54e-2)"	"prognostic favorable (7.45e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.66e-2)"	16.8	14.8	19.1	13.9	15.5	45.3	14.5	33.0	20.6	14.8	16.8	15.6	18.9	11.1	18.1	11.6	16.8	15.7	16.5	10.7	16.6	8.3	11.5	12.2	14.1	12.9	16.9	12.7	20.2	15.7	26.4	14.5	27.7	13.8	13.2	12.2	12.3	15.3	17.9	19.5	18.2	17.4	13.8	12.7	15.9	14.7	20.6	18.6	29.3	16.9	10.9	14.1	18.7	22.5	4.3	4.4	9.8	3.9	5.7	3.9	2.3	15.7	11.3	19.2	11.9	12.2	13.2	17.2	7.6	11.0	11.4	11.0	14.4	5.8	16.4	6.7	15.0	10.5	12.7	27.7	10.4	12.7	15.9	18.4	12.3	13.0	11.2	13.9	29.2	13.9	12.9	10.9	16.5	13.8	10.0	12.6	9.5	13.0	22.6	9.0	5.8	8.4	9.1	13.8	19.8	7.9	17.3	9.0	10.2	10.8	20.9	6.1	6.5	26.9	13.7	13.1	16.7	9.7	17.0	16.3	11.4	13.8	8.1	10.8	15.5	7.3	25.6	8.4	9.0	10.8	5.0	3.2	3.0	3.7	3.9	3.2	4.3	3.6	3.9	4.4	2.9	3.1	2.6	9.8	5.7	2.1	3.0	2.6	2.3	19.1	15.5	33.0	20.6	16.6	8.3	16.9	12.7	13.8	18.6	62.5	45.1	44.7	19.0	21.9	43.6	25.4	53.5	29.4	18.2	24.4	33.4	15.3	3.3	13.2	12.6	27.2	22.2	46.7	16.0	15.4	23.4	24.1	24.3	24.1	15.9	23.8	23.7	34.4	59.8	3.4	26.7	31.6	8.5	20.8	23.1	31.8	20.2	26.6	28.7	9.2	31.1	25.8	15.6	20.6	29.9	22.6	25.3	26.6	20.3	30.6
EPAS1	"bHLHe73, HIF2A, HLF, MOP2, PASD2"	ENSG00000116016	"Endothelial PAS domain protein 1"	Q99814	2	46293667-46386703	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Congenital erythrocytosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 200.8"	"Cell type enhanced"	"Detected in many"	6	"Endothelial cells: 341.0;Ito cells: 438.9;Smooth muscle cells: 281.4;Syncytiotrophoblasts: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	16	"basophil: 14.9;eosinophil: 7.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 46.9;BJ hTERT+: 46.2;HHSteC: 58.7;RT4: 58.1;TIME: 58.0;U-138 MG: 50.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031200, HPA069697"			Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031200: AB_2673785, HPA069697: AB_2732139"	"unprognostic (1.74e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.67e-2)"	"unprognostic (6.00e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.29e-2)"	"prognostic favorable (2.63e-4)"	"unprognostic (6.66e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.36e-1)"	71.2	14.2	12.5	17.1	15.7	0.8	101.7	5.3	13.9	24.9	20.9	8.9	11.3	12.0	28.8	13.0	21.6	24.8	35.2	40.0	12.8	11.0	35.2	31.2	200.8	27.2	14.3	11.1	20.2	15.5	18.1	9.4	119.6	18.4	20.7	11.5	41.2	13.3	18.7	25.2	13.0	15.6	19.2	12.5	20.5	12.8	13.8	8.0	1.1	43.8	15.2	10.3	32.2	39.3	0.0	0.0	14.9	0.1	0.7	0.1	0.1	5.3	5.7	0.3	0.4	27.6	17.8	46.9	16.9	46.2	9.7	10.6	1.0	0.9	0.0	4.2	32.2	9.7	2.6	0.1	13.5	7.3	0.1	0.2	0.0	1.8	12.0	58.7	0.0	3.4	26.0	18.7	19.0	13.4	7.2	33.4	0.1	0.5	0.0	5.9	4.6	0.1	0.1	0.2	3.7	3.2	0.1	0.6	1.7	6.0	58.1	0.2	12.0	13.3	30.6	3.6	12.5	2.0	2.3	58.0	50.4	1.4	6.7	1.4	0.0	0.0	0.0	36.7	0.9	1.2	14.9	0.1	7.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.1	12.5	15.7	5.3	12.6	12.8	11.0	14.3	11.1	18.4	8.0	71.5	137.9	8.1	61.5	42.7	3.5	58.5	50.9	30.8	96.7	3.5	9.8	93.6	1.7	15.5	12.6	341.0	66.4	0.0	45.9	256.0	104.5	46.7	40.4	77.4	47.9	0.0	4.1	438.9	58.4	41.8	11.5	23.9	27.0	0.0	13.6	89.1	25.9	40.4	6.0	24.0	57.7	278.1	281.4	1.2	1.7	29.1	292.5	9.6	11.6	58.0
EPB41L2	4.1-G	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	18	"Muller glia cells: 499.6;Rod photoreceptor cells: 1331.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		170000	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	50.2	16.5	29.6	17.3	42.8	3.9	21.1	6.5	40.1	20.5	23.1	32.3	7.2	12.3	23.0	13.7	13.2	25.6	18.0	22.8	33.4	24.6	11.5	12.1	24.4	15.4	50.5	33.1	44.4	9.1	8.2	8.4	26.2	34.8	11.2	23.2	52.0	10.1	15.8	16.0	7.1	21.4	20.6	59.5	25.3	11.7	32.2	51.9	6.8	15.2	14.6	11.6	15.2	16.6	10.5	8.6	0.5	8.8	1.0	2.5	1.3	8.3	8.8	20.0	27.4	13.9	22.3	6.1	14.2	18.0	14.5	20.3	16.8	11.9	10.2	26.7	19.5	11.8	4.3	7.6	13.1	29.0	43.3	17.7	18.3	10.5	9.6	8.2	0.0	22.3	10.9	0.2	25.6	9.9	23.5	22.3	15.6	49.5	29.3	9.2	2.1	14.3	3.1	18.5	35.8	9.6	22.3	24.0	0.9	24.4	8.0	2.1	0.0	5.9	0.1	11.5	21.4	3.0	19.1	27.0	17.1	32.3	28.9	42.7	24.3	0.4	9.5	11.7	0.1	26.0	0.1	3.1	0.5	1.0	8.8	0.9	2.9	1.0	1.2	8.6	10.5	1.7	0.7	0.0	1.0	3.3	2.3	2.5	1.3	29.6	42.8	6.5	39.6	33.4	24.6	50.5	33.1	34.8	51.9	6.0	11.8	15.4	12.1	13.7	52.8	12.6	22.9	20.1	28.4	1.8	212.1	2.8	0.0	28.2	273.7	47.2	31.6	0.0	14.3	5.1	74.8	3.3	42.8	3.4	29.8	27.0	9.8	39.3	104.6	245.3	67.6	61.1	10.1	17.2	36.8	499.6	37.8	21.0	43.5	9.8	1331.8	116.4	56.7	54.3	79.8	8.9	2.1	5.0	21.6	6.8
EPB41L3	"4.1B, DAL1, KIAA0987"	ENSG00000082397	"Erythrocyte membrane protein band 4.1 like 3"	Q9Y2J2	18	5392381-5630700	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Apoptosis	Actin-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.8"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 163.9;Late spermatids: 207.6;Syncytiotrophoblasts: 179.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	4	"monocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.9;HUVEC TERT2: 18.9;SCLC-21H: 21.2;TIME: 51.8;U-2 OS: 18.9;U-2197: 18.4;U-251 MG: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028605	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA		140000	"Plasma membrane, Cell Junctions"		"HPA028605: AB_10611963"	"unprognostic (3.58e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.61e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.40e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.07e-3)"	"unprognostic (5.81e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.65e-3)"	"unprognostic (8.99e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	17.1	19.4	12.0	16.4	32.1	2.5	8.9	35.9	36.3	5.1	10.6	36.2	1.4	29.8	5.8	7.1	6.8	8.8	6.0	6.0	11.3	16.6	21.0	3.1	8.8	8.8	46.4	15.9	7.8	4.4	14.7	9.0	12.7	46.8	4.0	8.4	3.8	3.6	5.0	4.6	3.5	27.9	8.3	27.2	10.5	3.2	35.9	36.6	0.9	4.0	1.5	2.6	5.6	5.8	0.0	2.5	0.7	11.6	0.0	0.6	0.7	0.1	0.3	1.2	0.0	17.9	20.9	14.1	4.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.4	7.5	0.0	12.2	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	1.4	10.9	0.0	3.9	0.0	5.2	18.9	0.0	0.1	0.1	0.0	0.0	0.1	0.2	2.5	0.0	4.0	0.0	0.0	0.0	0.1	1.5	21.2	0.1	0.0	0.1	8.3	10.5	0.2	1.5	51.8	0.1	18.9	18.4	22.2	0.0	0.0	0.0	0.0	1.7	2.1	0.0	4.5	0.0	0.0	7.7	0.0	0.0	0.0	0.0	2.5	0.0	0.6	0.0	0.7	0.0	11.6	0.0	0.0	0.7	12.0	32.1	35.9	27.7	11.3	16.6	46.4	15.9	46.8	36.6	17.9	8.3	0.0	3.7	14.2	75.0	2.0	5.1	2.7	3.4	7.0	72.6	84.0	13.3	0.3	163.9	11.1	47.9	0.0	0.6	44.2	10.4	3.0	0.0	0.5	50.4	3.2	8.7	3.7	66.5	207.6	20.8	56.6	10.1	55.9	6.1	2.9	1.2	7.0	7.4	56.6	13.2	0.0	5.0	1.9	3.0	7.3	179.0	2.2	7.2	1.3
EPB41L5	"BE37, FLJ12957, KIAA1548, YMO1, YRT"	ENSG00000115109	"Erythrocyte membrane protein band 4.1 like 5"	Q9HCM4	2	120013005-120179119	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Alveolar cells type 1: 202.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 25.1;MCF7: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037563, HPA037564"	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA037563: AB_2675546, HPA037564: AB_2675547"	"unprognostic (1.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (5.93e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.20e-2)"	"unprognostic (9.51e-2)"	"prognostic favorable (2.28e-6)"	"unprognostic (1.99e-1)"	"unprognostic (3.88e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.61e-1)"	4.6	5.0	7.4	6.0	11.6	1.1	13.3	19.4	12.6	7.4	8.6	6.9	4.3	10.6	7.2	4.9	7.0	10.2	6.2	4.9	8.5	7.4	25.6	42.3	36.3	3.8	7.6	6.5	9.4	20.3	13.0	15.8	7.5	12.2	9.9	7.0	7.1	10.8	6.6	8.6	6.6	9.5	7.5	14.8	2.2	7.0	22.0	6.1	2.9	25.2	6.4	5.0	5.3	8.4	4.7	0.4	1.8	1.4	1.5	3.2	1.4	8.0	2.7	11.2	8.6	7.8	5.7	9.7	1.7	1.7	3.6	3.3	25.1	5.4	0.1	6.1	2.1	4.6	5.5	15.0	6.8	5.4	1.6	4.6	2.3	1.3	14.0	9.1	1.0	2.5	5.1	13.0	6.8	4.9	3.2	10.2	4.8	5.4	0.6	7.2	37.6	1.9	3.5	10.0	3.7	2.6	0.0	3.3	2.2	11.4	7.8	5.8	11.1	7.6	13.5	3.7	16.0	6.5	1.9	8.4	0.3	5.4	5.7	1.7	0.8	1.5	4.2	0.9	0.0	2.1	0.3	1.4	1.5	1.1	0.3	0.3	4.7	1.2	1.1	0.4	3.6	3.2	2.4	1.8	1.5	0.9	0.0	0.5	1.4	7.4	11.6	19.4	12.6	8.5	7.4	7.6	6.5	12.2	6.1	202.5	30.3	2.9	19.7	21.8	31.4	12.0	15.3	20.1	25.0	31.4	23.6	11.9	18.3	15.8	22.4	5.8	17.7	0.0	19.5	10.0	13.3	24.0	0.0	47.8	2.7	7.9	14.9	16.5	1.9	16.2	8.3	3.3	13.5	1.0	10.2	18.1	20.4	17.3	8.9	23.7	33.6	19.4	7.7	33.8	43.9	19.1	22.1	2.5	9.7	30.4
EPHA6	FLJ35246	ENSG00000080224	"EPH receptor A6"	Q9UF33	3	96814581-97752460	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.9;ovary: 13.2;testis: 15.5"	"Group enriched"	"Detected in some"	67	"Early spermatids: 305.1;Late spermatids: 156.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 8.2;U-266/70: 24.9"	"Low region specificity"	"Detected in many"							"HPA007397, HPA058047"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007397: AB_2667821, HPA058047: AB_2683588"	"unprognostic (9.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-4)"	"unprognostic (7.21e-5)"	"unprognostic (8.51e-2)"	"unprognostic (1.32e-1)"		"unprognostic (1.82e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-4)"	"unprognostic (1.93e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.14e-3)"	0.8	0.5	8.7	0.5	9.8	0.3	0.8	27.9	9.9	2.2	5.8	1.1	0.3	0.6	2.2	1.0	2.1	4.2	2.1	1.1	15.4	1.3	1.3	0.5	0.5	0.4	1.1	6.8	13.2	1.4	0.7	0.6	0.5	5.7	2.5	1.8	0.2	0.6	1.7	0.4	0.5	1.1	3.2	0.8	0.4	1.7	15.5	2.8	0.0	4.3	0.0	0.5	2.1	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	8.2	0.0	2.1	0.0	0.0	2.0	0.0	0.0	0.4	0.0	0.8	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	2.1	0.0	0.8	24.9	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	9.8	27.9	9.9	15.4	1.3	1.1	6.8	5.7	2.8	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	305.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	156.3	2.8	0.0	0.0	0.0	0.0	0.9	0.1	0.0	1.4	0.6	0.2	0.0	0.1	3.4	2.3	0.0	0.1	0.0	0.0	0.0
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Aromatic hydrocarbons catabolism, Detoxification, Lipid metabolism"	"Hydrolase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 152.5;Proximal tubular cells: 198.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Group enriched"	"Detected in many"	4	"JURKAT: 50.5;K-562: 17.8;OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Enhanced		Enhanced	Cytosol		NA	NA		720000	Cytosol		"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favorable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favorable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	5.3	3.6	2.3	2.9	0.1	0.0	1.7	0.4	0.3	0.2	0.0	2.8	3.6	0.0	2.1	1.3	1.2	3.8	0.4	0.9	0.1	0.0	1.7	7.9	0.4	8.7	1.3	0.0	1.6	3.2	3.9	0.0	0.4	0.9	0.1	50.5	17.8	0.0	0.0	1.6	5.1	0.2	3.7	36.3	6.2	0.0	0.0	0.1	3.2	0.8	1.9	5.9	4.3	5.2	5.2	1.8	7.9	1.5	0.0	0.0	1.4	0.6	0.0	4.6	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9	6.0	13.4	4.7	14.5	10.5	33.3	21.0	15.3	24.1	10.3	26.2	74.6	18.1	152.5	4.7	6.3	6.0	93.2	0.0	5.7	2.6	7.2	27.0	5.7	98.6	1.8	31.8	22.4	10.4	3.5	2.4	27.6	0.8	5.0	2.8	54.7	84.9	4.3	74.7	17.7	198.6	56.3	0.0	12.0	1.5	7.0	15.9	6.9	5.7	88.0	6.7
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A, laforin glucan phosphatase"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease mutation, Epilepsy, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 60.9"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 23.5;Early spermatids: 28.2;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 20.3"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.4	6.0	8.8	1.9	9.0	2.2	3.6	4.0	8.9	3.9	11.1	8.6	2.5	3.4	4.8	4.8	8.9	4.3	3.9	19.4	9.6	8.7	8.0	5.7	3.5	3.4	11.9	5.5	5.9	2.9	5.5	3.3	2.0	9.6	6.2	3.4	5.6	3.1	9.2	60.9	2.4	3.3	13.9	13.6	2.5	4.6	3.3	7.1	3.7	4.2	15.7	2.9	10.4	6.0	1.4	1.0	0.3	1.4	5.4	2.4	1.0	1.1	1.7	3.3	6.3	8.2	2.5	1.4	3.0	3.5	2.8	3.4	1.5	1.7	20.3	2.5	3.5	3.4	1.8	1.2	1.3	2.5	7.9	1.7	3.3	2.4	2.5	5.0	11.3	2.0	2.1	6.8	1.7	0.6	3.7	2.0	4.8	1.4	5.2	3.5	2.6	7.5	2.4	3.4	3.0	1.7	4.3	3.0	5.9	2.5	1.7	6.1	6.1	5.3	3.2	7.0	3.1	1.8	6.5	4.3	2.8	1.4	2.6	2.3	3.8	3.8	8.2	2.4	2.7	4.4	0.0	0.1	0.1	0.4	1.4	1.1	1.3	1.1	0.9	1.0	1.4	1.2	2.4	0.3	5.4	0.3	0.9	0.2	1.0	8.8	9.0	4.0	8.9	9.6	8.7	11.9	5.5	9.6	7.1	6.0	1.0	3.2	0.8	0.8	7.9	23.5	5.1	2.7	3.4	1.8	5.9	0.7	10.0	0.9	28.2	1.5	0.3	0.0	2.0	0.6	1.2	1.3	2.3	5.8	2.0	28.6	1.2	1.3	1.5	14.1	2.8	3.1	6.8	0.0	1.5	7.5	1.1	1.1	2.1	6.3	6.7	0.0	2.0	1.6	1.3	0.4	0.3	0.0	1.0	0.3
EPPK1	EPIPL1	ENSG00000261150	"Epiplakin 1"		8	143857324-143878464	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"salivary gland: 14.8;skin 1: 14.1;smooth muscle: 15.7"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 121.8;Suprabasal keratinocytes: 239.8"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.1;EFO-21: 10.4;HaCaT: 10.3;HeLa: 17.3;MCF7: 14.9;SK-BR-3: 7.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA066808, HPA067357, HPA069333"	Approved		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA066808: AB_2685726, HPA067357: AB_2685826, HPA069333: AB_2686123"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (5.52e-5)"	"unprognostic (2.85e-2)"	"unprognostic (5.86e-3)"	"unprognostic (4.90e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.97e-3)"	"unprognostic (5.94e-3)"	"unprognostic (4.35e-1)"	"unprognostic (3.68e-3)"	"unprognostic (5.08e-3)"	0.0	0.0	0.0	3.0	0.0	0.0	1.1	0.7	0.0	0.4	7.8	0.0	7.2	3.1	3.4	2.4	6.0	1.4	2.3	0.0	0.0		0.8	0.0	4.2	0.9	0.0	0.0	1.0	1.9	0.6	0.0	2.8	0.5	2.9	0.8	0.0	14.8	4.9	0.1	14.1	12.1	15.7	0.1	1.5	1.2	2.3	0.0	0.0	0.0	7.2	4.3	4.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.8	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	5.6	0.4	0.0	10.4	0.0	0.0	10.3	1.1	0.1	0.0	0.0	2.6	0.0	17.3	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.9	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	3.7	1.8	0.0	1.6	7.1	0.0	0.9	5.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.2	0.0	0.0	2.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0											17.9	8.6	0.0	14.7	121.8	0.8	15.4	17.8	9.4	2.3	14.0	0.0	1.6	0.0	10.2	0.3	1.1	29.4	0.0	12.8	0.1	1.9	5.7	0.0	3.0	0.3	0.0	5.8	0.6	0.0	0.0	0.0	0.6	15.1	0.0	11.2	0.5	21.7	23.0	0.0	3.5	0.1	0.0	4.1	1.6	0.4	239.8	5.1	0.0	21.5	36.3
EPRS	"EARS, GLUPRORS, PARS, QARS, QPRS"	ENSG00000136628	"Glutamyl-prolyl-tRNA synthetase"	P07814	1	219968601-220046658	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Translation regulation"	"Aminoacyl-tRNA synthetase, Ligase, Multifunctional enzyme, RNA-binding"	"Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026490, HPA030052"	Enhanced		Enhanced	Cytosol		NA	NA		29000	Cytosol		"HPA026490: AB_1855979, HPA030052: AB_10601466"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.19e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.98e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.13e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.62e-4)"	25.0	20.4	16.8	18.6	22.2	13.2	20.6	24.2	26.3	19.3	20.4	15.4	13.6	15.8	17.8	15.3	25.2	15.9	11.9	20.1	15.9	18.0	23.3	31.6	17.4	20.8	21.7	16.1	21.3	32.7	47.1	38.6	15.7	34.9	14.3	23.2	9.4	64.0	16.3	42.9	19.6	23.3	18.9	24.7	22.3	20.1	13.2	20.8	28.0	25.1	25.7	23.4	18.3	16.3	14.7	15.4	6.4	16.6	14.2	19.8	10.7	30.1	19.2	13.9	38.0	29.6	32.9	34.9	39.5	27.7	25.7	28.9	22.7	24.4	57.9	22.0	41.6	10.4	32.3	34.9	31.8	34.6	28.3	22.2	31.5	25.9	19.4	32.4	52.2	27.0	23.7	40.9	32.8	41.1	21.5	28.1	28.0	54.1	45.7	25.1	14.9	22.4	12.7	26.9	35.7	39.8	23.8	24.6	56.6	23.5	13.3	33.1	26.0	23.1	38.3	40.3	20.8	35.4	57.1	24.9	12.3	22.7	37.6	36.7	31.0	35.2	49.0	28.3	37.6	38.8	4.2	11.9	6.4	14.0	16.6	19.8	14.7	14.1	15.6	15.4	11.5	15.9	16.3	0.4	14.2	13.7	5.0	13.5	10.7	16.8	22.2	24.2	26.3	15.9	18.0	21.7	16.1	34.9	20.8	65.5	52.5	37.9	33.6	17.6	45.2	67.4	15.3	69.6	69.4	29.6	62.8	36.3	18.3	58.3	19.1	33.8	24.4	23.3	87.1	48.7	27.0	24.9	47.4	18.8	38.0	39.7	29.4	22.1	23.8	7.4	43.7	27.7	20.3	53.3	32.2	45.5	61.8	14.4	44.6	21.4	47.0	38.8	27.8	57.6	34.9	17.8	30.6	29.8	41.8	29.3
EPS15	"AF-1P, MLLT5"	ENSG00000085832	"Epidermal growth factor receptor pathway substrate 15"	P42566	1	51354263-51519328	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Host-virus interaction, Protein transport, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008451, CAB010164, HPA061431"	Approved		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		67000	"Vesicles, Cytosol"		"CAB010164: AB_631445, HPA008451: AB_1848221, HPA061431: AB_2732662"	"unprognostic (1.45e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (1.05e-2)"	"unprognostic (7.72e-3)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.13e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	39.0	26.9	35.5	25.3	27.8	13.2	19.3	22.2	41.0	25.7	16.7	35.7	16.2	11.4	21.8	21.3	19.6	14.1	19.3	18.9	40.7	26.0	21.0	19.1	24.4	30.7	36.2	11.2	22.4	10.9	17.0	14.6	22.8	20.3	22.5	15.5	25.7	24.3	16.4	30.9	18.1	19.3	18.2	36.8	33.8	15.2	32.4	33.1	25.0	20.3	23.4	32.1	25.3	17.0	16.1	10.8	14.9	12.2	10.7	18.7	8.0	14.8	4.4	9.6	9.0	22.3	22.3	24.0	10.4	16.4	8.5	12.6	6.1	8.3	30.3	10.7	16.2	17.4	14.1	12.4	9.9	12.9	34.2	7.8	26.9	7.6	7.2	21.0	15.3	24.9	18.1	9.2	14.9	20.3	14.8	15.8	10.8	16.7	13.8	12.9	7.3	12.3	8.3	13.2	10.4	7.2	10.1	14.6	6.6	11.2	18.4	6.6	9.2	12.3	22.0	17.9	27.7	8.9	10.9	21.9	7.9	8.6	15.9	8.6	16.5	16.7	20.4	11.8	17.4	7.0	14.9	10.1	11.6	10.1	10.7	15.3	16.1	12.2	15.6	10.8	10.0	7.3	10.5	7.8	10.7	12.2	7.1	18.7	8.0	35.5	27.8	22.2	41.0	40.7	26.0	36.2	11.2	20.3	33.1	32.8	43.7	52.2	25.1	38.1	16.1	53.7	20.4	26.8	21.6	41.8	29.5	17.7	16.6	12.4	21.7	42.7	20.1	0.0	16.4	15.6	33.6	48.2	23.2	33.7	65.6	27.0	27.6	74.9	76.1	45.1	60.9	39.3	97.8	33.3	31.1	41.6	19.4	24.1	45.3	22.7	26.0	38.8	31.5	70.5	36.4	44.5	23.8	47.5	19.5	42.3
ERAL1	HERA-B	ENSG00000132591	"Era like 12S mitochondrial rRNA chaperone 1"	O75616	17	28854938-28861067	"Disease related genes, Predicted intracellular proteins"	"Ribosome biogenesis"	"RNA-binding, rRNA-binding"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"monocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021425, HPA024423"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021425: AB_1848228, HPA024423: AB_1848229"	"unprognostic (1.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.77e-2)"	"unprognostic (3.55e-1)"	"unprognostic (8.37e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (8.20e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.57e-3)"	"unprognostic (5.76e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.79e-2)"	16.2	24.8	24.1	13.3	31.6	12.7	19.4	25.1	47.9	18.4	20.9	27.1	15.8	18.0	21.5	19.2	20.6	22.2	17.2	24.5	23.0	22.0	24.9	33.7	14.8	16.0	21.3	20.2	22.0	18.1	29.3	15.4	24.7	27.6	18.0	23.4	17.3	28.2	21.2	34.1	18.3	19.7	21.8	18.4	17.0	18.2	17.3	15.5	20.4	20.3	21.5	23.8	16.1	14.8	20.1	29.0	11.1	23.1	20.8	18.2	14.9	16.2	31.5	18.4	20.9	20.4	14.0	18.0	12.9	18.6	39.4	32.4	30.7	10.5	20.8	15.8	22.3	29.8	18.0	33.7	29.5	32.9	20.6	39.5	16.8	21.0	31.0	26.1	19.9	15.3	18.2	26.4	31.9	30.3	15.5	32.1	26.5	33.3	13.2	21.9	25.4	20.7	30.7	17.0	29.8	15.1	19.1	29.3	26.9	23.8	18.5	19.6	15.8	21.2	52.1	16.7	28.6	36.7	23.4	12.9	16.1	18.1	17.7	27.3	10.6	19.3	22.3	17.5	17.4	16.3	11.1	17.9	7.1	17.8	23.1	13.4	20.1	15.2	13.0	29.0	18.6	17.6	18.2	1.4	20.8	15.6	15.0	16.3	14.9	24.1	31.6	25.1	47.9	23.0	22.0	21.3	20.2	27.6	15.5	6.0	3.2	11.5	12.7	7.1	9.6	6.0	22.9	5.3	3.4	10.4	5.9	59.5	31.5	26.1	1.1	10.9	16.0	23.3	18.8	44.1	11.4	11.1	4.7	20.3	31.0	11.1	20.7	9.8	8.2	3.6	13.3	8.0	10.1	110.0	12.7	14.5	17.0	10.5	14.9	25.0	6.5	19.4	9.5	18.9	22.2	10.2	43.3	10.9	25.2	8.4
ERBB2	"CD340, HER-2, HER2, NEU, NGL"	ENSG00000141736	"Erb-b2 receptor tyrosine kinase 2"	P04626	17	39687914-39730426	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 129.1;Enterocytes: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.8"	"Lineage enriched"	"Detected in many"	4	"T-cells: 8.8"	"Group enriched"	"Detected in many"	41	"OE19: 366.2;SK-BR-3: 179.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		430000	"Plasma membrane"	Cytosol	"CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500"	"unprognostic (1.97e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.21e-2)"	"prognostic unfavorable (8.99e-8)"	"unprognostic (2.96e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (9.17e-4)"	"unprognostic (3.92e-1)"	"prognostic favorable (2.41e-14)"	"unprognostic (9.29e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.96e-1)"	5.8	2.4	5.2	10.4	7.0	0.1	20.1	4.2	7.0	19.1	46.5	9.1	55.2	21.6	14.9	18.7	40.9	22.7	26.6	24.8	6.3	3.1	37.5	21.5	17.6	3.7	5.1	5.6	19.3	16.2	27.7	8.1	60.8	7.5	23.6	16.6	15.9	28.7	58.1	8.9	35.3	47.2	10.9	4.5	4.0	17.1	6.5	3.7	2.8	35.7	20.8	22.9	19.7	20.3	1.3	0.3	2.1	0.4	0.9	8.8	2.2	2.1	2.5	2.9	1.8	3.5	2.4	3.9	1.5	2.5	3.3	2.8	1.9	5.8	0.1	3.1	3.5	1.8	6.7	0.1	3.4	1.5	0.2	2.2	0.1	2.0	3.1	2.0	0.0	0.0	2.4	3.2	2.0	1.2	3.2	1.3	0.1	0.3	0.1	2.4	3.3	0.3	0.1	5.2	366.2	0.6	0.2	1.1	0.3	3.4	6.7	0.5	0.1	2.9	179.8	0.9	3.7	5.0	0.1	0.1	1.7	2.2	2.1	0.9	0.3	0.1	0.1	0.1	0.0	5.6	1.6	0.4	0.8	8.8	0.3	0.7	0.9	0.5	2.5	0.3	1.3	1.0	2.5	2.1	0.9	0.2	0.2	0.4	2.2	5.2	7.0	4.2	7.0	6.3	3.1	5.1	5.6	7.5	3.7	38.7	34.4	1.3	21.0	12.5	4.3	13.5	30.6	10.7	15.9	129.1	11.8	9.7	6.6	27.1	0.3	4.6	93.2	0.0	22.3	75.4	11.0	33.4	0.0	10.4	3.5	6.4	15.0	12.3	2.4	0.7	17.0	1.8	10.1	1.0	56.6	30.9	26.2	42.1	21.5	20.7	5.9	0.0	10.3	7.1	5.3	16.6	19.0	2.2	63.0	28.1
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407333-45478828	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004390: AB_2278023, CAB072859: AB_2665703, CAB072860: AB_2665704, HPA029773: AB_10602129, HPA050182: AB_2681044"	"unprognostic (1.54e-3)"	"unprognostic (5.99e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (2.57e-1)"	"unprognostic (5.80e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (6.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-1)"	25.0	28.2	25.9	20.2	27.5	20.8	30.6	28.4	34.8	26.4	21.5	35.4	20.6	20.8	27.4	34.6	28.6	30.9	24.0	63.5	24.7	24.4	22.9	24.2	21.3	26.3	28.3	25.0	37.6	42.9	31.6	32.0	20.3	27.4	29.1	17.1	29.1	53.8	24.4	43.3	43.5	20.4	26.1	23.5	24.3	22.4	21.6	26.7	22.6	28.4	25.7	25.1	22.0	26.0	16.6	69.0	5.3	29.7	12.6	14.2	17.9	13.9	24.1	20.5	29.9	14.1	26.8	6.5	21.0	28.1	25.5	34.0	2.6	13.7	8.3	5.9	22.3	13.6	10.8	6.5	66.9	15.8	18.0	6.6	12.3	9.2	8.2	29.4	12.4	23.2	19.9	14.4	26.6	24.1	22.3	27.7	9.6	7.5	16.6	40.0	9.4	11.7	10.0	4.8	12.7	9.6	17.7	9.6	11.1	18.7	8.9	8.8	18.5	13.3	11.4	18.3	7.1	13.8	23.8	15.9	23.0	22.0	14.0	21.1	12.3	9.9	8.9	26.5	10.7	69.4	4.7	29.2	5.3	14.2	29.7	9.6	16.4	8.7	11.0	29.3	16.6	7.0	11.3	4.0	12.6	21.8	69.0	10.2	17.9	25.9	27.5	28.4	34.8	24.7	24.4	28.3	25.0	27.4	26.7	20.8	37.2	34.7	96.6	63.0	0.0	31.4	35.7	49.5	35.2	19.2	0.0	32.3	76.3	41.3	22.9	40.9	32.2	0.0	57.1	27.9	72.1	73.7	48.5	24.1	86.0	0.0	38.1	33.2	64.8	84.9	73.4	73.4	64.1	25.2	36.0	0.0	64.4	35.1	53.7	53.0	0.0	45.3	61.7	21.5	39.8	46.2	29.7	37.4	38.3	82.3
ERCC3	"BTF2, GTF2H, RAD25, TFIIH, XPB"	ENSG00000163161	"ERCC excision repair 3, TFIIH core complex helicase subunit"	P19447	2	127257290-127294176	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037153, HPA046077"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037153: AB_796181, HPA046077: AB_2679527"	"unprognostic (2.31e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.85e-2)"	"prognostic unfavorable (1.62e-7)"	"unprognostic (2.74e-1)"	"unprognostic (9.13e-3)"	"unprognostic (9.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.30e-6)"	"unprognostic (3.71e-1)"	"unprognostic (8.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.92e-2)"	17.4	20.0	26.1	23.8	28.9	20.5	21.0	35.9	32.0	22.1	19.4	19.7	17.1	11.5	21.6	15.7	19.1	23.6	20.4	20.4	23.2	18.8	17.5	17.4	19.4	23.1	19.7	25.8	23.3	22.4	32.0	26.4	16.3	21.5	20.1	17.1	18.3	18.0	21.8	30.1	19.7	17.3	26.1	16.0	24.5	17.4	39.5	20.1	24.1	19.3	15.8	25.9	22.4	20.8	11.8	13.9	7.2	9.7	18.8	16.2	11.7	22.2	15.3	19.0	20.1	21.1	14.5	23.5	20.5	26.6	33.2	32.2	23.4	16.3	16.9	17.0	18.7	21.5	20.0	28.9	21.6	28.9	26.4	25.9	21.2	18.7	24.6	15.7	18.4	23.1	15.0	20.3	38.3	16.4	21.2	21.3	22.2	20.6	11.1	20.9	22.0	26.2	19.8	27.6	14.5	23.9	21.6	21.8	14.0	18.5	20.8	23.0	24.8	17.5	26.7	26.8	22.7	14.4	21.1	16.9	20.0	22.9	18.1	24.3	19.9	38.8	26.5	17.7	8.9	21.3	6.6	9.5	7.2	16.0	9.7	16.2	11.5	11.8	13.5	13.9	11.8	15.8	10.9	3.1	18.8	7.9	11.3	16.1	11.7	26.1	28.9	35.9	32.0	23.2	18.8	19.7	25.8	21.5	20.1	20.8	13.4	8.2	8.1	6.8	0.0	10.5	5.1	32.1	22.7	7.0	0.0	15.9	1.7	12.0	3.5	14.3	4.9	0.0	13.1	10.3	12.0	6.2	9.3	7.8	12.5	0.0	5.8	12.3	12.6	3.1	15.3	9.2	8.5	12.6	8.2	0.0	12.9	5.8	12.0	7.0	0.0	12.9	8.5	34.7	27.5	8.3	12.2	13.8	9.9	5.6
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102807146-102876001	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease mutation, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045845, HPA050126, HPA050374"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045845: AB_2679471, HPA050126: AB_2681027, HPA050374: AB_2681106"	"unprognostic (1.28e-3)"	"unprognostic (1.32e-3)"	"unprognostic (1.86e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.19e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.77e-3)"	"unprognostic (5.76e-3)"	"prognostic unfavorable (2.96e-6)"	"unprognostic (3.56e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (6.82e-4)"	22.3	19.1	15.9	16.1	17.8	23.7	20.1	26.4	20.8	19.7	27.0	17.9	27.0	25.0	22.1	25.7	21.0	15.1	21.1	15.4	14.6	13.1	18.7	28.1	19.9	26.4	17.1	16.2	22.9	22.3	15.7	25.6	17.9	19.0	20.1	23.1	15.9	20.5	24.7	14.6	25.8	31.1	17.0	19.4	30.6	21.9	14.0	17.8	40.8	21.8	16.6	26.0	22.4	19.6	10.1	10.8	23.4	17.4	17.7	17.5	12.0	14.8	5.4	10.8	6.8	21.7	20.4	6.6	15.1	20.0	8.7	11.4	8.3	20.8	9.3	7.6	15.2	6.1	15.5	9.6	13.8	9.1	14.1	5.4	13.9	15.7	7.2	10.6	28.3	18.2	19.4	13.3	10.1	15.7	13.8	15.2	19.7	6.5	8.5	15.3	4.0	15.2	19.6	4.7	17.9	7.6	8.3	8.1	9.4	18.0	8.3	7.3	10.8	7.9	13.3	8.0	8.7	11.9	26.4	15.3	6.8	3.4	5.7	9.4	12.5	3.8	4.7	26.4	11.5	8.4	23.4	9.8	18.3	16.7	12.3	15.5	9.6	15.5	17.5	10.8	10.1	16.6	16.1	7.2	17.7	17.4	7.7	16.6	12.0	15.9	17.8	26.4	20.8	14.6	13.1	17.1	16.2	19.0	17.8	3.0	7.4	14.6	5.7	6.4	0.0	25.5	7.6	6.7	13.6	0.0	0.0	7.7	0.0	1.0	44.4	9.0	18.4	0.0	1.1	6.6	8.2	3.7	18.5	17.1	9.3	0.0	4.7	10.4	14.3	23.3	20.4	9.9	6.8	1.0	19.0	0.0	1.4	16.4	14.9	1.2	0.0	19.4	6.1	10.6	6.4	6.0	4.8	25.4	16.6	4.3
ERF	"PE-2, PE2"	ENSG00000105722	"ETS2 repressor factor"	P50548	19	42247572-42255157	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 139.4;Suprabasal keratinocytes: 95.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058532, HPA067952"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058532: AB_2683744, HPA067952: AB_2685932"	"prognostic favorable (8.07e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (7.27e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.54e-2)"	29.0	18.1	17.8	17.5	22.0	11.2	20.4	8.3	29.6	27.0	23.5	48.3	14.9	28.4	29.8	15.5	18.4	34.6	42.1	21.5	17.6	12.0	20.2	27.2	22.8	15.2	26.7	13.7	41.0	24.1	14.1	25.0	15.5	22.7	21.0	8.8	23.7	15.2	15.7	10.1	23.3	28.1	17.4	17.7	19.0	17.5	20.8	25.2	18.0	22.9	18.4	16.2	25.0	18.1	0.6	1.0	3.1	0.2	0.0	0.5	0.1	18.4	44.9	19.4	21.8	4.3	11.2	5.4	17.5	12.5	18.1	18.4	20.3	21.6	15.3	11.1	16.1	16.2	20.3	14.0	40.9	13.3	7.5	9.6	9.2	25.2	25.8	11.8	10.6	15.3	12.6	13.9	13.9	15.4	23.6	15.0	12.5	19.5	12.8	9.8	37.4	12.0	8.0	16.2	17.6	9.7	15.0	7.0	6.4	11.1	16.0	8.9	18.3	19.6	14.5	20.2	13.8	14.5	19.1	17.8	26.7	38.5	9.2	32.2	14.6	16.3	12.2	26.0	11.4	36.0	0.0	0.2	1.7	0.2	0.1	0.2	0.0	0.1	0.1	1.0	0.6	0.3	0.3	3.1	0.0	0.0	0.1	0.5	0.1	17.8	22.0	8.3	29.6	17.6	12.0	26.7	13.7	22.7	25.2	3.0	1.7	8.3	24.0	139.4	14.4	6.5	25.5	1.4	1.2	8.7	21.6	6.2	6.6	16.4	8.0	29.2	22.0	0.0	13.8	4.2	11.4	20.6	11.5	25.3	10.2	9.5	25.3	41.7	13.2	3.1	10.3	15.5	52.3	2.8	21.1	23.4	12.4	25.8	9.6	19.2	11.9	12.9	30.3	2.6	15.6	95.9	12.4	14.9	19.1	12.2
ERGIC1	"ERGIC-32, ERGIC32, KIAA1181, NET24"	ENSG00000113719	"Endoplasmic reticulum-golgi intermediate compartment 1"	Q969X5	5	172834275-172952685	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 213.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018666, HPA018900"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA018666: AB_1848241, HPA018900: AB_1848242"	"unprognostic (8.86e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.71e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.53e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.06e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.22e-2)"	30.2	56.5	14.2	20.6	13.8	12.0	44.6	25.5	18.1	42.9	30.5	12.3	35.6	24.6	26.4	24.9	22.6	23.7	30.3	20.7	14.2	11.4	36.4	120.8	28.6	29.3	14.5	11.4	22.5	55.5	15.6	18.9	25.5	13.5	48.1	32.9	19.2	51.5	29.3	27.1	16.7	32.6	22.0	10.8	30.8	36.5	15.8	13.2	29.1	41.5	20.9	25.8	21.3	45.8	6.6	4.2	20.8	9.2	8.5	3.8	3.0	20.6	19.8	17.0	37.8	65.2	48.8	9.4	42.2	32.0	19.0	17.8	28.1	21.3	19.9	30.2	71.1	32.8	7.6	12.4	56.0	22.4	15.8	12.3	12.3	29.1	15.0	47.8	5.7	3.9	41.3	23.4	28.0	26.3	31.5	30.5	20.9	7.3	28.0	31.5	25.9	16.3	9.8	10.1	49.3	18.3	56.3	11.3	61.2	44.5	12.0	9.6	17.3	14.7	42.0	21.1	17.2	17.5	6.5	23.2	31.1	12.7	29.8	17.1	44.5	49.7	8.3	43.3	13.7	13.6	2.1	4.9	12.1	2.3	7.1	3.8	6.6	1.2	1.5	4.2	4.9	1.0	1.6	20.8	8.5	9.2	2.1	0.7	3.0	14.2	13.8	25.5	18.1	14.2	11.4	14.5	11.4	13.5	13.2	53.6	29.3	64.1	27.9	20.3	36.1	28.5	68.8	20.1	17.0	47.1	15.7	17.7	18.3	91.9	9.5	25.1	68.5	0.0	52.8	71.8	28.5	108.1	23.1	213.3	39.2	20.6	25.0	42.4	73.2	21.3	60.1	52.3	6.8	111.0	176.8	39.2	69.9	52.6	54.8	35.9	11.1	38.8	23.7	1.4	8.9	23.5	7.6	26.1	58.7	42.7
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Group enriched"	"Detected in many"	9	"Erythroid cells: 70.0;Spermatocytes: 30.1;Spermatogonia: 77.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	Yes			"Nucleoplasm, Golgi apparatus"	"Cell Junctions"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	25.1	19.1	8.6	10.4	1.1	1.8	4.8	15.1	6.4	14.1	16.1	6.7	5.0	9.3	8.0	3.9	11.8	13.9	10.4	4.1	21.4	7.2	4.4	11.0	8.6	7.1	0.1	5.6	10.3	0.3	0.4	8.2	2.1	1.4	5.2	7.2	8.8	14.2	8.1	4.9	22.6	2.5	5.8	13.8	6.4	10.0	25.7	6.8	4.6	15.2	3.7	5.5	7.6	9.2	3.8	3.3	6.3	6.2	2.3	8.7	18.0	17.5	11.8	1.9	5.0	11.5	4.8	9.4	12.0	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2	0.0	6.6	2.2	0.7	2.1	1.5	1.1	0.0	2.7	5.7	0.0	3.9	1.0	0.0	0.3	3.9	0.1	5.3	70.0	0.0	5.5	0.9	0.2	1.1	1.1	4.5	0.0	1.2	0.6	4.1	0.4	1.7	3.5	0.0	0.0	2.3	0.0	0.1	0.8	0.0	0.0	1.8	6.5	0.3	30.1	77.3	0.5	0.8	2.9	4.0	0.9
ESD		ENSG00000139684	"Esterase D"	P10768	13	46771256-46797232	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039700	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		16000000	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039700: AB_10697553"	"unprognostic (3.05e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (7.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.73e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	58.5	30.9	32.0	28.6	29.8	24.2	44.5	23.7	32.0	54.4	37.3	29.0	34.2	31.8	53.2	50.4	54.1	40.6	30.3	45.6	30.7	29.3	58.8	82.2	28.2	31.4	31.7	32.1	61.3	24.9	27.5	47.5	26.4	28.6	55.2	41.7	32.5	31.5	45.2	47.4	29.7	38.4	50.8	37.4	31.1	32.1	32.4	26.7	65.5	78.9	50.9	31.7	62.5	36.9	30.1	48.7	15.1	37.1	29.8	35.7	26.4	22.1	12.9	39.1	26.9	45.9	75.9	10.5	31.9	46.3	44.5	34.7	21.8	27.2	25.2	9.6	38.2	33.3	22.7	43.0	37.7	57.0	28.8	44.7	32.6	13.0	33.5	37.6	63.6	14.0	51.8	35.0	28.7	38.7	53.7	41.7	43.5	31.8	6.8	73.6	21.7	56.4	42.3	10.1	28.7	24.5	44.9	23.0	17.0	63.1	9.0	19.4	22.0	14.2	12.1	25.6	28.1	23.2	36.5	27.8	16.4	19.4	31.5	29.4	4.6	9.9	21.8	35.4	36.5	21.9	7.7	37.1	15.1	15.0	31.5	24.6	30.1	30.0	23.0	40.8	25.3	35.7	27.9	4.3	29.8	28.0	48.7	24.9	26.4	32.0	29.8	23.7	32.0	30.7	29.3	31.7	32.1	28.6	26.7	50.6	42.5	68.7	203.4	119.1	47.0	89.2	124.9	77.6	61.4	146.5	39.3	134.7	305.1	153.5	36.2	95.8	72.1	46.7	90.4	115.2	195.1	96.4	94.6	148.9	197.0	20.6	104.5	112.3	138.2	18.5	247.9	128.5	156.9	100.0	108.9	147.8	82.8	115.8	198.7	400.9	62.5	148.8	210.1	67.4	44.1	113.0	62.2	82.2	173.0	130.7
ESRP1	"FLJ20171, RBM35A"	ENSG00000104413	"Epithelial splicing regulatory protein 1"	Q6NXG1	8	94641074-94707466	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 65.1"	"Cell type enhanced"	"Detected in many"	6	"Mucus-secreting cells: 101.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"MAIT T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"A-431: 33.3;BEWO: 25.6;CAPAN-2: 35.1;HaCaT: 20.4;hTCEpi: 57.4;OE19: 34.8;RT4: 24.4;T-47d: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA023719, HPA023720, HPA067104"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA023719: AB_1856124, HPA023720: AB_1856125, HPA067104: AB_2685779"	"prognostic unfavorable (9.28e-4)"	"unprognostic (7.12e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.12e-1)"	"unprognostic (6.99e-3)"	"unprognostic (2.70e-1)"	"unprognostic (2.61e-2)"	"unprognostic (5.19e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (4.48e-2)"	"prognostic favorable (1.96e-8)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.29e-1)"	0.6	0.5	0.5	15.1	0.5	0.0	7.6	0.5	0.6	9.7	18.1	0.2	18.7	7.7	3.3	21.3	43.1	6.6	14.5	0.6	0.5	0.5	6.4	0.7	15.5	0.8	0.5	0.2	1.8	65.1	11.8	10.1	18.5	0.3	8.9	20.8	0.2	38.2	15.1	0.5	24.8	12.7	1.9	0.5	0.5	12.1	1.0	0.2	1.4	20.2	30.4	28.9	9.0	16.8	0.0	0.0	0.0	0.0	0.0	1.9	0.0	33.3	0.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	10.9	35.1	0.0	0.9	0.0	0.0	20.4	0.9	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.4	0.0	0.3	0.0	0.0	2.6	0.0	0.0	0.0	16.2	0.4	0.1	3.1	34.8	0.8	0.0	0.0	4.4	4.4	24.4	8.9	0.0	0.0	5.2	3.3	5.6	27.1	0.2	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.6	0.5	0.5	0.5	0.2	0.3	0.2	35.7	23.4	0.5	19.5	39.6	0.0	0.7	20.4	30.8	22.7	26.2	0.0	45.8	11.6	18.7	5.9	0.0	53.4	0.0	24.0	54.1	2.0	25.5	1.1	0.0	5.1	0.0	31.9	0.0	0.0	6.8	0.0	0.6	23.6	1.0	101.9	0.0	21.5	42.1	0.7	0.3	0.0	0.0	0.9	0.2	0.7	69.3	51.9	0.0	68.9	33.0
ESRP2	"FLJ21918, RBM35B"	ENSG00000103067	"Epithelial splicing regulatory protein 2"	Q9H6T0	16	68229111-68238102	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.2;pancreas: 41.5"	"Cell type enhanced"	"Detected in many"	8	"Late spermatids: 63.6;Syncytiotrophoblasts: 48.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;MCF7: 36.1;RT4: 19.4;SK-BR-3: 19.4;T-47d: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040751, HPA048597, HPA048618"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040751: AB_2677115, HPA048597: AB_2680458, HPA048618: AB_2680463"	"unprognostic (3.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.30e-2)"	"unprognostic (8.80e-2)"	"prognostic favorable (1.30e-6)"	"unprognostic (1.24e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.04e-3)"	"unprognostic (8.75e-3)"	0.4	0.2	0.2	7.6	0.5	0.0	3.9	0.6	0.3	4.7	8.0	0.6	4.1	4.6	1.2	10.2	30.1	2.1	12.4	0.6	0.3	0.1	13.4	45.2	15.6	0.2	0.2	0.2	1.3	41.5	7.0	2.5	11.3	0.7	6.6	5.6	0.8	17.3	5.0	0.3	17.6	8.5	0.6	0.2	0.2	12.8	7.0	0.3	3.0	18.4	25.7	17.1	6.4	9.4	0.0	0.0	0.0	0.8	0.0	0.8	0.0	12.4	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.1	11.7	6.2	0.0	0.5	0.0	0.0	12.9	0.0	9.6	0.0	0.0	8.5	0.0	3.5	9.3	0.2	0.0	0.1	0.0	13.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	36.1	0.0	0.0	1.3	9.3	4.2	0.0	0.0	0.0	4.8	19.4	1.3	0.0	6.2	19.4	0.0	1.6	29.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.3	0.1	0.2	0.2	0.7	0.3	17.9	12.1	0.0	4.0	5.7	0.5	1.0	15.3	2.7	10.3	22.7	0.0	27.4	0.0	10.0	23.1	0.4	10.3	0.0	12.2	3.2	0.8	6.9	0.0	28.2	2.4	0.0	8.1	0.0	1.5	63.6	0.9	0.0	1.7	1.0	23.1	0.2	11.0	7.0	0.0	3.5	0.2	0.0	0.3	5.7	1.5	7.4	48.9	0.0	15.1	7.1
ETFA	"EMA, GA2, MADD"	ENSG00000140374	"Electron transfer flavoprotein alpha subunit"	P13804	15	76215355-76311472	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018990, HPA018993, HPA018996, HPA024089"	Enhanced		Enhanced	Mitochondria		NA	NA		6300000	Mitochondria		"HPA018990: AB_1848277, HPA018993: AB_1848275, HPA018996: AB_1848276, HPA024089: AB_1848278"	"unprognostic (3.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.71e-3)"	"unprognostic (5.99e-2)"	"unprognostic (6.81e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.01e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (5.04e-8)"	"unprognostic (2.87e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.90e-2)"	18.8	39.9	12.8	16.4	13.6	10.7	26.1	7.6	13.4	8.6	26.4	7.3	9.6	27.5	10.1	11.1	18.9	7.7	12.6	84.4	13.3	8.5	36.4	78.3	9.8	15.7	11.9	12.9	7.8	28.1	7.6	11.0	24.0	11.8	11.2	26.0	9.4	15.8	10.8	84.0	12.3	29.2	17.3	11.8	11.7	18.5	9.7	10.8	10.8	11.9	37.9	12.8	14.8	11.5	24.6	50.7	25.2	38.8	36.0	29.3	39.4	21.7	35.9	23.8	24.9	26.9	28.7	37.5	26.4	30.5	34.2	30.7	31.8	40.7	36.6	26.5	26.2	25.9	55.9	92.3	36.6	39.9	43.8	18.0	39.8	26.1	36.7	21.9	37.9	29.7	21.4	34.7	17.3	28.9	18.8	34.5	11.8	37.6	38.0	35.0	34.3	7.8	31.7	18.5	40.5	10.8	34.4	29.6	48.9	37.7	70.2	24.9	12.6	39.9	91.2	36.1	57.7	46.9	40.2	20.2	33.4	22.7	29.2	31.8	18.6	38.1	45.1	24.1	50.5	23.6	11.2	38.8	25.2	22.1	34.5	20.8	24.6	20.8	22.7	50.7	20.2	17.0	21.1	9.9	36.0	28.4	20.3	29.3	39.4	12.8	13.6	7.6	13.4	13.3	8.5	11.9	12.9	11.8	10.8	53.6	38.2	49.8	84.3	47.5	12.6	330.7	79.0	33.5	34.2	34.9	21.6	240.1	177.4	96.7	9.4	51.7	207.6	70.0	73.2	147.6	65.4	64.8	37.0	330.0	115.9	50.9	62.8	52.2	76.6	5.4	55.0	77.4	54.0	158.7	117.7	20.6	89.9	152.0	54.8	301.8	18.1	45.3	63.7	39.6	31.3	49.9	251.0	56.8	156.2	138.0
ETFB		ENSG00000105379	"Electron transfer flavoprotein beta subunit"	P38117	19	51345169-51366418	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"		"Disease mutation, Glutaricaciduria"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.6;liver: 106.6"	"Cell type enhanced"	"Detected in all"	6	"Hepatocytes: 1022.8;Proximal tubular cells: 1001.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 183.6;OE19: 84.6"					"Low region specificity"	"Detected in all"			"HPA018910, HPA018921, HPA018923"	Supported		Enhanced	Mitochondria		NA	NA		640000	Mitochondria		"HPA018910: AB_1848280, HPA018921: AB_1848281, HPA018923: AB_1848282"	"unprognostic (1.44e-1)"	"prognostic favorable (6.45e-4)"	"unprognostic (8.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.20e-1)"	"unprognostic (6.93e-3)"	"unprognostic (2.63e-2)"	"unprognostic (7.79e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.75e-1)"	"prognostic favorable (6.45e-5)"	"unprognostic (2.19e-1)"	"unprognostic (2.54e-1)"	"unprognostic (4.83e-1)"	"unprognostic (1.99e-1)"	35.8	28.7	26.1	12.0	30.7	14.3	16.7	9.4	19.5	9.1	27.2	17.7	11.3	33.2	9.8	10.1	24.2	13.2	31.5	108.6	22.2	19.2	32.1	106.6	10.2	12.3	27.9	17.1	11.1	23.0	12.8	11.7	10.5	18.1	12.9	10.1	18.4	46.7	10.2	72.9	13.6	30.6	16.6	22.2	10.6	19.1	7.7	15.9	17.7	14.2	47.7	14.6	11.4	9.9	66.0	62.5	27.0	49.3	46.2	50.7	31.9	13.0	33.8	4.7	12.9	15.0	17.6	7.5	8.9	6.9	7.2	7.2	28.4	21.5	13.1	9.1	14.3	3.8	11.6	9.3	19.0	2.2	19.5	36.2	10.3	20.7	183.6	16.5	9.8	7.7	27.3	5.7	9.8	10.1	9.1	6.1	12.9	15.4	14.7	9.3	26.5	10.2	9.3	3.0	84.6	41.9	11.4	12.6	24.5	9.9	15.0	10.5	5.1	19.7	5.6	10.1	3.5	14.7	9.5	8.6	7.6	7.9	8.1	8.1	22.6	13.7	11.6	38.5	14.6	19.4	26.7	46.9	27.0	26.4	49.3	34.4	63.9	39.6	33.7	53.5	66.0	42.2	35.0	23.6	46.2	36.6	62.5	50.7	31.9	26.1	30.7	9.4	19.5	22.2	19.2	27.9	17.1	18.1	15.9	74.5	84.5	90.8	84.9	57.8	71.3	216.3	254.8	84.3	67.1	115.1	29.5	201.1	484.1	142.6	109.5	67.1	494.9	140.2	122.3	163.1	89.1	73.5	87.6	1022.8	188.0	41.3	161.8	136.9	151.1	228.9	99.5	69.4	271.7	69.5	259.6	93.2	146.4	263.1	107.5	1001.5	53.3	97.0	80.2	54.2	48.9	55.7	133.9	91.6	302.4	92.8
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 485.2;Paneth cells: 571.2;Undifferentiated cells: 334.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.1;OE19: 77.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		No	No		13000	Mitochondria		"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	11.5	15.3	3.1	10.9	17.1	11.6	1.2	18.0	49.1	15.5	15.9	4.5	11.8	0.0	13.5	17.2	4.9	9.4	4.5	27.1	4.1	5.8	1.4	2.9	6.6	12.7	7.7	4.3	4.1	11.9	21.3	6.0	16.8	20.5	11.5	11.2	1.9	19.5	7.6	7.8	5.0	4.0	0.8	77.6	7.4	5.7	1.3	2.5	33.7	24.1	0.0	3.9	4.6	16.5	10.8	5.3	5.0	7.2	9.6	2.5	10.7	3.0	3.3	5.5	4.3	0.3	10.9	17.9	12.9	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7	20.8	18.9	42.5	70.4	30.7	9.5	8.3	53.5	14.7	17.0	52.4	0.0	162.0	46.4	62.5	0.4	49.6	485.2	0.0	56.4	70.8	54.7	70.7	36.9	78.8	100.9	4.8	61.2	36.8	100.2	1.6	16.4	79.3	75.9	58.7	224.1	9.4	73.6	571.2	15.2	90.3	4.6	19.4	61.2	1.8	5.5	20.3	77.3	53.3	334.8	123.3
ETS1	"ETS-1, EWSR2, FLJ10768"	ENSG00000134954	"ETS proto-oncogene 1, transcription factor"	P14921	11	128458761-128587558	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Immunity, Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 122.5"	"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 159.3;Ito cells: 228.3;T-cells: 181.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 59.4;JURKAT: 62.5;U-698: 79.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002575, HPA063230"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002575: AB_563721, HPA063230: AB_2684965"	"unprognostic (1.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.18e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (1.30e-5)"	"unprognostic (2.02e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.48e-3)"	33.2	6.3	4.1	45.9	4.7	6.4	24.0	1.6	3.3	13.3	15.0	3.1	4.9	5.3	18.0	9.3	12.6	8.1	13.6	19.1	4.2	3.7	12.4	9.9	36.7	53.9	4.7	2.9	14.1	6.2	6.7	4.1	11.6	4.2	11.7	6.6	12.7	11.7	5.7	12.9	7.5	19.1	7.9	4.3	68.0	8.8	6.0	2.3	122.5	16.7	9.2	51.4	17.5	18.8	6.0	3.0	20.5	0.4	12.5	17.3	4.7	14.5	2.6	12.7	0.0	5.5	8.9	0.0	11.3	24.2	14.2	13.7	0.8	15.8	52.7	11.6	18.6	32.6	5.1	1.2	32.6	30.0	11.1	0.2	59.4	1.1	0.0	14.8	6.1	0.7	17.4	2.6	12.2	44.7	8.1	11.7	62.5	0.1	11.0	17.0	0.0	30.6	4.5	4.7	1.3	9.5	8.4	20.8	4.1	11.2	16.3	0.1	0.8	5.9	0.1	12.5	8.9	0.0	3.0	21.5	32.0	10.0	6.2	18.5	8.2	1.4	79.5	5.7	11.5	28.0	20.5	0.0	3.0	10.4	0.1	14.6	6.0	14.0	12.6	0.1	4.9	17.3	13.5	0.5	12.5	0.4	3.0	15.5	4.7	4.1	4.7	1.6	3.3	4.2	3.7	4.7	2.9	4.2	2.3	23.8	31.1	40.2	29.1	102.1	0.0	6.2	2.5	2.7	35.2	10.4	0.0	0.2	0.0	33.5	2.0	159.3	6.7	0.0	19.5	0.3	45.7	17.2	18.5	3.8	5.6	0.0	14.9	228.3	20.9	0.9	13.0	5.0	65.8	10.0	13.3	0.1	65.1	5.8	14.5	2.9	0.0	103.5	62.6	0.9	1.5	55.3	0.3	181.5	4.0	30.3
ETS2		ENSG00000157557	"ETS proto-oncogene 2, transcription factor"	P15036	21	38805307-38824955	"Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 580.2;Suprabasal keratinocytes: 425.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 16.5;granulocytes: 18.5;monocytes: 14.9"	"Cell line enhanced"	"Detected in many"		"HEL: 60.5;hTCEpi: 55.4;hTERT-HME1: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003176			Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA003176: AB_2666824"	"unprognostic (2.06e-1)"	"unprognostic (5.91e-2)"	"unprognostic (9.16e-3)"	"unprognostic (5.33e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.88e-3)"	"unprognostic (7.36e-2)"	"unprognostic (8.99e-3)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.10e-2)"	33.6	10.4	25.8	29.6	12.8	44.7	28.5	5.5	36.5	28.4	38.1	7.3	13.7	39.7	27.0	20.3	30.1	21.8	42.6	42.9	16.2	10.8	21.2	75.5	58.3	56.9	13.8	18.2	23.6	11.7	20.0	19.7	23.2	14.2	31.4	50.6	12.9	17.6	17.4	64.2	72.4	59.0	43.3	13.6	68.7	25.8	8.3	11.0	7.2	21.5	28.4	13.7	40.8	35.5	0.2	16.5	18.5	14.9	0.1	2.5	3.6	23.4	5.0	3.5	1.1	4.0	13.6	9.4	5.5	32.0	7.3	9.7	4.4	6.7	5.1	2.7	4.9	10.7	7.0	5.9	14.7	14.0	4.7	2.3	60.5	30.4	11.0	41.2	3.7	5.9	8.0	55.4	10.3	45.2	4.7	5.8	3.4	6.2	0.0	3.2	3.4	11.2	4.0	11.3	7.8	3.3	36.8	2.2	4.7	10.3	15.2	2.7	3.6	15.6	6.4	1.2	1.3	0.3	6.9	6.2	17.6	2.5	11.2	12.0	0.1	0.0	5.1	4.2	12.5	14.6	10.1	9.2	3.3	1.7	12.3	2.0	0.2	1.6	2.5	16.5	0.2	1.6	1.6	18.5	0.1	14.9	4.0	0.1	3.6	25.8	12.8	5.5	36.5	16.2	10.8	13.8	18.2	14.2	11.0	47.6	133.7	24.2	580.2	379.6	2.1	25.0	45.9	141.8	183.1	48.8	0.0	42.0	10.0	60.7	3.0	196.3	148.0	23.3	94.2	94.1	55.2	133.5	49.7	211.1	50.3	0.0	88.0	256.6	144.5	1.7	16.7	174.6	64.1	29.7	182.6	1.0	94.1	98.2	23.3	27.9	1.1	51.8	93.5	0.6	2.9	425.2	148.5	18.1	194.6	292.4
EWSR1	EWS	ENSG00000182944	"EWS RNA binding protein 1"	Q01844	22	29268009-29300525	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Calmodulin-binding, Repressor, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004230, HPA051771, HPA062953"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim"		No	No			Nucleoplasm	"Nucleoli rim"	"CAB004230: AB_675526, HPA051771: AB_2681602, HPA062953: AB_2684910"	"unprognostic (1.96e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.15e-2)"	"prognostic unfavorable (1.27e-6)"	"unprognostic (1.33e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.71e-2)"	"unprognostic (7.04e-2)"	"unprognostic (9.30e-2)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (7.33e-3)"	"unprognostic (1.79e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.50e-3)"	35.3	43.2	45.3	41.3	51.3	67.5	32.1	58.2	48.6	32.4	39.8	43.2	31.3	41.0	45.1	38.5	40.8	37.6	25.9	40.7	40.1	32.8	33.0	48.5	33.4	50.5	32.7	49.9	38.4	32.0	47.2	44.3	34.0	41.7	35.0	39.9	41.5	32.3	38.2	52.8	34.8	36.6	40.5	33.8	44.1	34.5	85.6	32.5	39.9	32.5	30.9	55.4	36.4	34.5	52.0	65.8	50.6	81.1	58.4	67.8	76.1	57.2	44.6	61.4	47.7	31.3	26.0	42.2	34.9	55.8	57.9	49.7	50.8	29.8	78.3	22.1	53.5	44.0	45.0	87.4	71.4	59.7	53.3	62.3	59.1	39.5	48.6	46.9	90.9	42.3	39.7	30.1	48.3	78.4	27.8	44.8	37.5	44.2	35.4	42.8	57.5	91.2	34.8	43.1	47.4	34.0	64.1	59.1	47.3	53.2	60.9	50.3	48.1	43.4	50.9	37.6	42.2	32.7	49.5	45.7	35.4	39.3	22.2	50.6	46.0	36.9	72.6	33.7	40.5	43.0	48.4	57.9	50.6	60.2	81.1	60.7	50.4	56.6	59.6	65.8	52.0	55.8	53.6	43.3	58.4	78.6	35.3	67.8	76.1	45.3	51.3	58.2	48.6	40.1	32.8	32.7	49.9	41.7	32.5	95.3	103.6	96.6	120.0	61.7	71.3	60.0	89.2	124.5	102.4	61.1	70.7	120.3	56.3	106.1	87.5	78.6	71.5	70.0	93.8	108.0	78.0	80.7	117.8	64.2	85.5	77.9	77.7	82.3	69.0	21.4	57.0	89.6	77.6	112.8	73.3	66.1	95.4	94.7	58.4	59.1	77.8	51.8	86.8	180.0	109.0	51.2	127.5	88.0	89.6	101.6
EXO1	"HEX1, hExoI"	ENSG00000174371	"Exonuclease 1"	Q9UQ84	1	241847967-241895148	"Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, Immunity, Meiosis"	"DNA-binding, Endonuclease, Excision nuclease, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 15.6;lymphoid tissue: 31.3;testis: 14.8"	"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 4.7;Extravillous trophoblasts: 14.1;Spermatocytes: 9.8;Spermatogonia: 6.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053079, HPA069738"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA053079: AB_2682037, HPA069738: AB_2732140"	"unprognostic (6.33e-3)"	"unprognostic (8.54e-3)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (8.21e-4)"	"unprognostic (2.43e-1)"	"unprognostic (6.34e-2)"	"prognostic unfavorable (6.94e-7)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.40e-2)"	"unprognostic (4.81e-3)"	"unprognostic (9.40e-2)"	"unprognostic (0.00e+0)"	"unprognostic (6.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.57e-1)"	2.1	1.0	0.9	10.3	1.0	15.6	1.0	0.3	1.3	1.3	3.1	0.3	0.1	2.9	0.7	0.8	6.2	0.4	1.3	1.5	0.7	0.6	0.9	1.3	1.5	5.6	0.6	0.3	1.3	1.3	1.8	0.4	4.6	0.7	0.7	3.9	0.3	1.4	0.1	1.0	1.7	4.2	1.0	0.6	5.7	1.5	14.8	0.1	31.3	0.6	4.0	8.1	1.6	2.0	1.4	0.6	2.9	0.7	0.9	3.3	1.0	15.1	10.1	16.7	11.0	1.0	2.7	14.1	20.2	6.8	18.1	19.8	12.6	8.6	16.6	9.9	4.7	9.5	15.1	21.1	8.4	21.5	25.6	18.5	15.4	10.8	6.4	0.3	21.9	11.5	0.6	0.4	18.0	4.9	2.2	5.6	16.3	30.8	21.9	14.4	7.0	23.6	12.4	22.8	18.5	10.0	17.1	15.6	17.7	3.7	9.6	18.7	23.7	13.2	10.7	7.1	8.2	9.9	13.6	2.0	17.6	15.5	16.5	27.2	16.1	21.3	26.7	6.1	17.9	20.9	2.9	0.7	0.0	1.1	0.0	0.0	1.4	1.1	1.1	0.6	1.3	0.6	0.2	0.3	0.9	0.0	0.1	3.3	1.0	0.9	1.0	0.3	1.3	0.7	0.6	0.6	0.3	0.7	0.1	0.0	0.0	0.0	0.1	0.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	4.7	0.0	0.0	0.0	0.0	14.1	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	9.8	6.9	0.1	3.3	0.7	0.6	0.1
EXOSC5	"hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p"	ENSG00000077348	"Exosome component 5"	Q9NQT4	19	41386374-41397479	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 115.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053150, HPA055677"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA053150: AB_2682058, HPA055677: AB_2682882"	"unprognostic (1.24e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.53e-3)"	"unprognostic (7.50e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.83e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (3.45e-7)"	"unprognostic (6.84e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.79e-2)"	"unprognostic (7.82e-2)"	9.1	14.3	12.6	12.3	16.6	13.1	11.1	7.6	21.3	8.8	12.1	10.8	9.0	10.0	8.1	6.0	14.6	13.6	6.4	11.6	12.0	10.3	7.9	25.1	5.7	17.0	13.4	9.9	13.2	46.9	3.2	4.9	6.5	10.3	9.5	6.6	6.3	14.0	8.1	30.9	18.5	9.5	6.6	14.0	12.7	9.8	7.5	11.8	16.8	15.1	15.7	12.2	11.3	8.6	22.9	36.8	3.3	23.7	17.1	21.1	13.5	17.9	33.5	4.7	13.8	3.0	3.8	11.0	7.6	3.6	12.5	10.3	19.5	13.3	28.0	19.8	3.7	6.4	6.8	9.3	8.5	3.9	17.8	32.1	12.5	12.7	14.9	9.6	22.4	12.4	4.7	19.1	10.0	9.6	3.4	5.8	16.0	16.6	20.1	4.1	23.4	19.3	15.8	16.6	25.4	16.6	18.3	12.9	25.2	5.0	12.8	18.2	13.6	11.0	18.3	18.6	3.2	8.5	27.7	4.6	13.1	11.0	8.3	23.3	31.7	40.5	30.4	10.2	32.4	11.1	3.3	21.7	0.6	13.2	23.7	15.8	21.1	14.4	13.3	34.1	22.9	21.1	18.5	1.5	17.1	14.0	36.8	11.1	13.5	12.6	16.6	7.6	21.3	12.0	10.3	13.4	9.9	10.3	11.8	3.0	3.7	19.5	26.4	27.1	5.6	8.1	17.8	18.7	11.4	17.4	3.9	24.0	31.5	14.5	7.3	9.0	5.1	23.3	18.3	115.4	11.0	15.5	4.7	17.9	26.6	6.4	8.2	4.3	13.8	5.6	15.5	19.8	13.5	14.4	16.8	4.8	20.0	5.8	11.7	19.5	2.1	6.5	18.4	11.9	27.2	29.1	17.7	11.7	30.9	22.0
EXOSC9	"p5, p6, PM/Scl-75, PMSCL1, RRP45, Rrp45p"	ENSG00000123737	"Exosome component 9"	Q06265	4	121801317-121817021	"Predicted intracellular proteins"	"rRNA processing"	RNA-binding	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 108.4;Spermatocytes: 107.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041838, HPA048257, CAB070171"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"CAB070171: AB_11026964, HPA041838: AB_10794492, HPA048257: AB_2680331"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.85e-3)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (3.28e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.21e-2)"	12.5	12.7	10.1	18.9	14.7	29.7	13.9	16.8	18.6	11.2	9.7	8.1	12.5	7.5	12.5	12.4	13.3	11.8	7.8	13.1	13.5	11.3	11.3	14.0	11.9	19.8	11.3	12.2	12.6	10.4	14.2	15.5	12.1	12.9	10.3	12.0	9.6	10.9	8.9	17.6	12.1	10.3	10.6	11.7	14.2	10.4	36.7	10.0	33.7	9.2	15.4	18.9	12.2	10.5	19.9	15.9	20.1	17.7	11.6	23.6	14.0	19.5	9.2	24.9	14.8	3.9	8.0	12.1	25.4	14.7	36.4	28.2	9.9	16.4	34.3	6.3	15.8	11.0	7.0	26.9	11.8	32.5	15.2	12.3	17.2	14.2	12.8	8.2	29.1	16.0	6.0	6.1	25.4	7.3	7.5	17.9	22.1	29.4	13.6	34.0	11.4	44.6	22.5	13.1	7.6	10.8	24.9	41.7	15.4	12.4	6.4	15.9	16.7	9.3	13.9	15.4	13.2	11.8	18.8	10.8	16.3	24.1	13.7	24.4	19.8	15.0	41.2	16.9	20.3	10.7	12.0	13.3	20.1	18.7	17.7	18.4	19.9	20.5	23.6	15.9	19.9	23.3	20.7	3.3	11.6	17.0	15.7	21.6	14.0	10.1	14.7	16.8	18.6	13.5	11.3	11.3	12.2	12.9	10.0	41.7	15.5	16.4	12.6	11.3	10.7	11.1	7.6	18.7	26.1	3.5	9.8	24.1	1.7	17.1	108.4	14.2	4.5	0.0	26.6	25.0	13.6	7.6	30.1	4.9	21.1	15.9	5.8	12.3	10.3	9.2	12.0	18.0	8.5	20.8	7.9	13.8	16.5	8.7	10.3	7.1	16.3	6.5	11.3	107.2	58.5	12.9	9.2	19.2	10.5	12.9
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819412	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 1685.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		75000000	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	22.8	56.4	30.9	31.2	31.4	24.7	13.3	4.0	21.5	18.0	45.5	28.2	35.2	33.8	9.8	25.8	71.8	25.1	30.2	34.3	37.6	13.9	53.5	16.2	44.3	36.7	14.8	19.0	20.7	33.0	77.1	14.6	125.1	23.5	21.7	22.8	37.0	27.4	32.0	13.6	47.5	87.9	22.8	12.8	26.0	55.4	21.4	22.2	41.6	37.1	34.4	75.6	38.2	25.3	81.7	30.0	24.3	31.2	20.7	61.7	41.1	88.1	48.2	11.9	17.1	1.3	1.4	69.7	27.7	9.1	31.3	26.4	56.4	48.9	88.8	27.5	31.6	15.0	67.6	23.5	30.9	36.4	31.0	15.2	1.8	29.2	24.9	31.8	21.9	13.7	2.3	24.0	29.4	28.6	26.8	20.5	12.3	17.5	43.5	18.1	23.2	31.1	26.5	19.9	24.1	16.1	23.4	5.6	20.2	64.3	26.8	21.7	17.7	48.5	69.9	5.2	57.0	17.0	29.0	26.4	10.1	32.5	13.9	42.6	30.0	27.3	76.1	6.3	11.3	12.0	24.3	14.0	16.4	34.8	31.2	41.0	81.7	36.7	42.9	30.0	67.5	19.9	26.5	6.1	20.7	30.6	14.0	61.7	41.1	30.9	31.4	4.0	21.5	37.6	13.9	14.8	19.0	23.5	22.2	884.4	543.1	187.4	615.4	546.1	5.3	247.6	119.8	1685.0	977.1	148.3	0.0	366.9	82.9	222.1	7.9	84.3	679.2	46.7	221.5	488.7	135.0	354.7	114.5	30.6	98.9	0.0	153.2	31.3	77.1	21.1	125.4	213.0	305.4	115.4	206.3	31.3	408.3	238.4	276.5	168.7	4.0	245.8	120.5	46.2	56.6	635.1	1039.8	112.2	143.1	1039.6
FAF2	"ETEA, KIAA0887, UBXD8, UBXN3B"	ENSG00000113194	"Fas associated factor family member 2"	Q96CS3	5	176447628-176510074	"Predicted intracellular proteins, Predicted membrane proteins"	"Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065968, HPA071246, HPA073828"	Approved		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Lipid droplets"	"Endoplasmic reticulum"	"HPA065968: AB_2685589, HPA071246: AB_2732176, HPA073828: AB_2686636"	"unprognostic (6.25e-3)"	"unprognostic (9.61e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.02e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.47e-2)"	"prognostic unfavorable (1.79e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.74e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.48e-1)"	21.1	27.7	17.5	16.5	28.5	21.7	20.8	25.4	28.3	21.5	19.2	24.4	17.4	17.2	22.3	21.5	23.0	21.0	18.0	15.1	16.8	18.9	20.5	34.2	17.8	17.2	16.4	15.9	29.3	25.9	32.4	31.5	32.0	25.5	22.3	23.1	24.6	20.1	18.6	15.3	25.5	22.6	22.2	14.5	21.0	18.8	31.9	14.2	30.0	23.1	15.2	24.3	20.7	17.5	7.2	10.9	10.0	14.9	12.4	13.1	7.5	13.7	15.7	15.6	17.3	22.2	17.7	21.4	18.1	20.8	20.7	22.4	20.4	25.0	12.1	20.5	19.1	37.7	21.4	22.3	45.9	28.7	48.1	12.3	7.9	16.1	9.9	22.6	17.1	10.4	23.3	20.2	25.3	21.1	13.4	17.1	13.8	11.3	16.6	19.7	22.9	14.9	9.1	12.6	15.0	13.4	14.8	13.6	13.4	17.5	18.3	13.9	14.8	22.1	19.2	20.0	14.0	22.5	13.7	19.1	28.5	15.5	15.6	24.1	14.2	15.2	15.8	18.0	12.3	24.8	10.0	9.2	6.1	10.0	7.6	12.2	7.2	8.2	10.5	10.9	7.0	10.7	9.5	7.8	12.4	14.9	7.5	13.1	7.5	17.5	28.5	25.4	28.3	16.8	18.9	16.4	15.9	25.5	14.2	26.8	43.3	7.2	26.4	4.7	42.5	12.5	17.8	38.8	34.2	17.4	43.2	29.9	10.0	28.6	8.7	24.9	14.4	0.0	32.2	33.2	25.2	27.7	30.2	21.9	19.6	14.3	19.1	25.8	12.7	3.6	28.1	13.8	11.8	21.6	16.4	44.7	43.0	8.6	29.4	7.7	28.0	25.8	18.9	48.6	53.9	7.4	48.4	13.8	15.7	25.7
FAHD1	"C16orf36, DKFZP566J2046"	ENSG00000180185	"Fumarylacetoacetate hydrolase domain containing 1"	Q6P587	16	1826941-1840207	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Proximal tubular cells: 175.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025530, HPA043226, HPA043534"	Enhanced		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB025530: , HPA043226: AB_2678370, HPA043534: AB_2678535"	"unprognostic (3.71e-1)"	"unprognostic (1.25e-2)"	"prognostic favorable (8.27e-4)"	"unprognostic (1.99e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.80e-14)"	"unprognostic (1.02e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.31e-2)"	10.4	17.0	10.4	6.7	9.9	6.5	9.2	8.6	12.7	6.8	21.7	9.3	8.2	26.7	9.8	10.9	14.8	5.8	10.2	15.8	10.9	11.4	46.8	43.6	5.6	5.2	10.1	9.4	7.9	17.4	9.0	11.1	10.4	9.9	8.1	11.1	8.5	9.1	9.8	20.2	12.4	24.8	6.9	8.8	6.3	14.9	6.9	9.5	4.7	12.5	19.0	5.7	9.9	7.9	18.5	23.1	8.6	27.5	19.6	16.0	13.7	8.4	19.1	9.1	16.1	12.1	8.8	5.7	13.9	6.9	9.3	10.2	12.2	8.8	5.4	11.7	8.6	14.4	17.4	7.1	11.2	8.4	8.2	16.9	4.8	16.5	28.1	11.8	8.3	9.4	11.6	14.7	8.5	5.7	7.9	12.1	6.6	5.0	5.7	11.6	38.7	4.5	12.6	5.4	7.8	14.3	10.4	12.4	15.2	33.4	10.6	17.8	14.8	18.2	14.7	21.8	6.4	21.5	5.7	17.6	15.3	10.9	9.0	7.5	8.2	17.2	6.4	9.7	6.1	6.5	6.5	23.5	8.6	14.4	27.5	13.0	18.5	14.5	15.7	23.1	16.9	16.0	14.9	2.0	19.6	19.1	17.9	14.7	13.7	10.4	9.9	8.6	12.7	10.9	11.4	10.1	9.4	9.9	9.5	23.8	16.0	12.3	12.4	12.5	20.0	37.0	22.9	17.4	17.0	40.1	25.5	18.6	43.1	43.5	88.6	14.7	72.1	23.3	34.0	12.3	14.7	9.4	4.7	30.5	26.4	17.5	28.2	8.0	8.1	38.9	13.6	18.2	15.1	23.4	22.1	16.9	34.9	30.9	14.5	175.3	22.4	12.9	14.1	7.0	8.3	21.0	12.8	10.7	41.2	8.1
FAM114A1	Noxp20	ENSG00000197712	"Family with sequence similarity 114 member A1"	Q8IWE2	4	38867677-38945739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 102.6;Peritubular cells: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 5.1;intermediate monocyte: 6.3;myeloid DC: 4.3;neutrophil: 3.8;non-classical monocyte: 2.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.3;granulocytes: 3.8;monocytes: 6.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 42.5;ASC TERT1: 44.4;BJ hTERT+: 50.7;fHDF/TERT166: 56.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA067948, HPA069104, HPA069701"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA067948: AB_2685931, HPA069104: AB_2686087, HPA069701: AB_2686175"	"unprognostic (2.13e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.66e-2)"	"unprognostic (9.40e-3)"	"unprognostic (6.77e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (3.63e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.44e-3)"	15.8	27.3	4.4	11.8	7.3	0.3	17.9	2.5	5.1	23.3	18.9	8.0	17.1	9.0	34.1	23.5	19.9	11.4	24.1	14.1	7.0	4.2	9.6	31.8	14.5	6.1	5.8	5.0	21.7	33.4	8.8	18.7	19.1	6.5	22.0	14.0	13.0	59.9	12.6	9.3	10.1	15.8	36.7	6.2	6.3	13.9	10.8	5.8	1.5	11.5	16.7	15.1	29.1	17.8	0.7	4.3	3.8	6.3	0.1	0.2	1.3	8.7	6.3	3.8	4.5	42.5	44.4	1.2	34.6	50.7	14.7	22.5	1.6	6.8	0.0	4.8	56.0	25.1	2.4	0.0	11.0	17.0	0.0	0.9	0.6	6.7	8.1	15.2	0.0	1.2	26.2	3.5	21.3	4.9	33.4	21.0	0.0	0.6	0.0	21.4	2.2	0.0	0.4	0.8	3.7	3.2	0.1	19.1	0.6	4.9	1.7	0.1	1.9	6.9	0.1	7.1	9.4	4.3	0.7	32.0	16.0	7.5	20.0	8.0	0.1	0.0	0.0	26.2	0.6	13.0	0.8	5.1	0.1	0.2	6.3	0.1	0.7	0.2	0.1	4.3	0.3	0.2	0.2	3.8	0.1	2.2	0.5	0.1	1.3	4.4	7.3	2.5	5.1	7.0	4.2	5.8	5.0	6.5	5.8	14.9	10.4	0.0	39.8	10.9	0.1	14.4	10.2	40.2	23.9	7.0	0.0	1.5	8.3	41.1	0.9	28.7	35.9	0.0	54.0	35.9	79.4	79.1	1.1	66.9	14.7	0.0	15.1	30.1	6.7	2.2	102.6	9.9	20.3	5.4	70.8	10.6	41.7	35.1	109.3	8.4	1.0	19.4	25.7	0.5	1.1	8.9	2.9	2.5	27.3	53.6
FAM120A	"C9orf10, KIAA0183, OSSA"	ENSG00000048828	"Family with sequence similarity 120A"	Q9NZB2	9	93451722-93566107	"Plasma proteins, Predicted intracellular proteins"		RNA-binding	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019734, HPA055800"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA019734: AB_1848369, HPA055800: AB_2682925"	"unprognostic (5.92e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-2)"	"unprognostic (8.93e-2)"	"unprognostic (5.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.71e-3)"	"prognostic favorable (1.08e-7)"	"unprognostic (8.16e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.00e-2)"	25.7	35.1	23.3	28.6	19.1	15.7	23.0	22.1	21.8	26.1	27.0	14.9	32.2	21.3	33.2	17.2	26.0	24.2	24.1	22.1	20.5	11.0	21.2	33.2	25.7	26.4	18.4	12.6	25.5	34.4	40.6	16.8	24.6	20.0	17.4	26.0	15.9	27.7	22.4	71.5	17.6	23.6	23.3	17.7	21.7	25.3	7.5	17.7	19.5	19.8	23.8	17.6	46.5	33.1	4.7	6.6	15.2	9.2	4.2	7.5	3.5	47.1	38.7	8.8	25.2	26.4	33.2	27.6	33.2	29.3	25.5	18.8	12.5	29.3	30.8	19.0	41.8	20.3	51.0	23.4	38.8	19.9	30.6	17.0	16.8	34.6	19.8	29.6	28.5	23.0	32.2	24.2	28.9	46.4	25.3	36.4	21.9	19.2	25.9	27.6	52.8	27.9	16.2	11.3	56.6	36.3	16.3	23.5	25.8	31.0	28.5	23.6	14.5	37.5	45.7	22.7	9.1	24.8	18.7	37.6	27.8	20.0	34.0	36.1	20.4	20.0	11.9	30.0	25.8	24.6	3.0	7.1	5.0	5.4	8.1	5.1	4.7	5.2	5.6	6.6	4.1	3.6	5.1	15.2	4.2	9.2	4.6	7.5	3.5	23.3	19.1	22.1	21.8	20.5	11.0	18.4	12.6	20.0	17.7	41.7	72.9	25.7	37.7	90.8	28.8	107.4	79.0	48.2	76.2	71.5	47.1	61.6	18.3	44.8	23.5	54.4	108.9	23.3	65.0	83.1	53.6	103.2	47.4	158.9	64.4	38.1	88.2	64.4	144.2	6.4	61.9	69.8	50.6	35.1	160.3	34.0	71.4	70.2	61.5	66.1	29.6	38.8	67.9	13.1	13.5	99.9	86.5	44.8	129.3	93.7
FAM129B	"bA356B19.6, C9orf88, DKFZP434H0820, FLJ13518, FLJ22151, FLJ22298, MINERVA"	ENSG00000136830	"Family with sequence similarity 129 member B"	Q96TA1	9	127505339-127578989	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 95.6;placenta: 103.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 3.7;intermediate monocyte: 1.3;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.4;monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021284, HPA021417, HPA023261, HPA024312"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		1200000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA021284: AB_1848373, HPA021417: AB_1848374, HPA023261: AB_1848375, HPA024312: AB_1848376"	"unprognostic (3.05e-3)"	"unprognostic (9.47e-2)"	"unprognostic (1.14e-3)"	"unprognostic (4.07e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-3)"	"unprognostic (6.45e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.20e-3)"	7.8	17.9	4.5	8.4	5.6	5.1	6.7	6.5	4.2	19.1	13.9	4.2	12.3	11.9	9.6	7.3	95.6	8.9	22.9	8.2	4.8	4.1	9.9	5.5	24.0	5.1	6.9	3.1	9.3	24.8	6.8	5.7	103.7	9.1	12.8	7.2	9.4	23.6	11.7	4.1	17.3	17.1	10.5	7.0	6.8	13.8	5.4	4.2	1.3	39.8	44.6	48.8	11.8	28.3	0.0	2.4	0.5	3.7	0.0	0.5	1.7	22.1	25.3	5.1	6.7	15.6	30.4	24.0	44.1	41.0	24.4	15.1	8.0	24.5	0.0	17.5	49.8	30.1	37.0	4.4	32.6	8.1	4.2	4.7	3.8	37.5	8.3	30.8	0.1	10.8	33.2	20.5	40.1	14.1	44.9	36.6	1.4	7.1	0.2	46.1	26.1	0.2	6.2	5.3	38.1	33.3	2.6	17.3	11.6	20.9	17.8	8.2	3.8	36.0	25.7	15.6	7.6	16.9	1.2	47.3	25.1	10.9	31.5	36.4	0.4	0.8	0.0	70.6	3.6	46.3	0.5	3.7	0.0	0.2	1.3	0.0	0.0	0.5	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	1.7	4.5	5.6	6.5	4.2	4.8	4.1	6.9	3.1	9.1	4.2	65.5	43.5	0.0	30.8	28.7	0.4	4.2	38.2	10.7	36.4	36.6	0.0	59.0	3.3	72.5	1.0	28.6	94.2	0.0	92.9	33.5	19.8	56.7	28.9	1.0	21.5	0.0	21.4	28.8	11.8	1.8	29.7	23.3	21.9	2.8	41.6	12.6	107.3	42.4	47.4	1.5	1.5	12.9	32.0	0.3	1.1	32.6	101.1	2.2	37.3	104.7
FAM131B	KIAA0773	ENSG00000159784	"Family with sequence similarity 131 member B"	Q86XD5	7	143353400-143362770	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell type enhanced"	"Detected in some"	13	"Distal tubular cells: 1.7;Intestinal endocrine cells: 2.4;Late spermatids: 2.9"	"Cancer enriched"	"Detected in many"	11	"glioma: 14.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 10.3;hTERT-RPE1: 6.5;NTERA-2: 16.8;PC-3: 16.1;SCLC-21H: 16.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021371, HPA029992"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA021371: AB_1852341, HPA029992: "	"unprognostic (1.70e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.61e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.54e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.19e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.53e-2)"	1.5	2.1	10.0	2.0	12.4	0.9	1.2	37.2	47.1	2.7	2.0	15.1	0.0	1.7	4.4	1.0	1.7	1.6	1.4	1.1	9.1	6.8	1.1	0.9	1.5	1.3	14.6	12.3	1.0	0.9	6.4	0.4	0.9	13.8	1.0	2.2	0.0	0.9	1.0	7.7	0.8	2.1	5.6	18.6	1.1	1.4	1.2	11.3	0.0	0.9	0.0	1.1	1.2	0.5	0.0	0.2	0.0	0.5	0.1	2.1	0.2	0.0	0.1	5.0	0.0	4.1	5.2	0.0	0.2	1.2	0.8	0.2	10.3	0.0	0.0	0.0	0.3	0.0	0.2	2.0	0.4	0.7	2.5	0.0	0.3	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	6.5	0.9	0.1	0.0	0.0	0.7	0.0	0.0	0.3	16.8	0.0	16.1	0.0	0.0	0.0	0.0	0.0	16.4	0.5	0.2	1.2	0.0	1.1	0.0	0.0	0.7	0.3	1.6	0.1	0.0	0.0	0.0	0.0	0.1	3.3	0.1	0.0	0.3	0.0	2.1	0.5	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.8	0.0	0.1	0.2	0.0	0.0	0.2	10.0	12.4	37.2	25.0	9.1	6.8	14.6	12.3	13.8	11.3	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	2.4	0.6	0.3	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6
FAM133B	MGC40405	ENSG00000234545	"Family with sequence similarity 133 member B"	Q5BKY9	7	92560793-92590394	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA066175, HPA069513"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA066175: AB_2685629, HPA069513: AB_2686143"	"unprognostic (5.54e-2)"	"unprognostic (4.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.87e-3)"	"unprognostic (8.56e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.73e-3)"	"unprognostic (9.01e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.38e-2)"	10.5	11.7	18.5	11.1	23.6	32.1	15.1	25.7	23.3	13.6	10.4	8.2	12.0	11.9	13.0	22.5	11.4	10.4	9.2	9.2	13.8	9.1	11.2	14.3	11.2	14.1	15.3	13.2	15.1	13.6	13.4	21.3	12.9	18.0	12.0	11.7	7.5	11.4	10.5	17.1	12.8	10.8	15.7	18.5	12.1	10.6	7.3	17.3	15.9	12.5	7.5	12.8	10.6	12.0	22.5	23.2	9.8	11.7	10.7	17.0	5.9	13.1	6.8	19.2	29.4	11.3	12.0	11.5	14.9	16.1	14.6	17.8	10.9	14.6	21.5	14.5	10.1	12.7	10.6	15.1	9.4	22.4	12.1	19.7	17.4	10.0	21.8	11.8	19.1	15.1	8.0	9.9	11.2	14.0	11.5	8.6	16.8	22.9	27.3	15.6	16.0	30.0	29.9	26.2	12.0	8.8	21.8	19.3	17.8	14.5	14.1	18.6	18.0	12.8	16.3	17.3	18.8	15.1	14.1	9.9	16.8	26.7	19.5	16.7	7.1	7.5	38.5	10.1	25.2	21.6	9.5	11.7	9.8	10.7	10.5	13.9	22.5	13.6	13.2	9.6	18.8	17.0	14.4	4.9	10.7	7.8	23.2	14.3	5.9	18.5	23.6	25.7	23.3	13.8	9.1	15.3	13.2	18.0	17.3	53.6	65.5	102.1	185.5	101.5	81.2	25.7	180.9	38.8	62.6	83.7	70.7	55.8	84.6	78.1	31.4	87.5	92.6	163.5	75.9	52.0	92.4	103.6	86.4	97.3	62.9	52.4	131.6	108.1	107.2	13.2	95.0	114.5	72.6	69.5	83.4	83.5	72.6	112.3	83.4	48.4	75.1	51.8	103.0	97.0	117.4	91.7	59.0	97.2	97.8	127.1
FAM162A	"C3orf28, E2IG5"	ENSG00000114023	"Family with sequence similarity 162 member A"	Q96A26	3	122384176-122412334	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035856, HPA058113"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA		29000	"Mitochondria, Cytosol"		"HPA035856: AB_10611965, HPA058113: AB_2683609"	"unprognostic (1.17e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.99e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.91e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.10e-2)"	"prognostic favorable (3.93e-4)"	13.6	32.8	24.9	18.6	49.9	14.1	18.7	10.7	44.8	21.8	57.8	11.5	19.6	22.7	17.0	25.5	58.7	13.8	25.4	54.2	40.2	21.7	35.9	78.1	12.2	16.5	23.6	27.7	30.2	71.5	24.6	16.1	7.3	31.0	27.3	61.3	16.2	17.7	23.1	56.6	29.2	21.2	27.2	24.4	10.9	25.7	16.9	18.8	8.6	17.9	48.6	16.7	34.6	36.0	26.8	29.4	25.3	24.4	16.4	33.1	12.9	28.8	6.2	9.2	17.1	16.9	15.7	4.7	11.8	10.6	11.3	28.8	15.4	13.3	31.4	20.6	4.0	9.3	20.2	16.6	28.8	30.2	16.2	12.4	25.4	10.7	27.5	11.1	24.8	9.1	18.1	15.1	10.7	22.7	38.0	14.9	31.0	17.1	12.6	16.1	11.3	25.2	30.2	13.6	65.2	32.8	15.2	13.2	40.9	32.7	70.4	13.8	11.0	8.8	21.0	24.1	14.4	13.1	12.2	10.5	11.2	8.0	6.5	12.2	25.0	8.5	31.8	33.2	24.3	5.1	2.6	9.3	25.3	21.7	23.0	32.1	26.8	29.8	27.1	29.4	23.9	32.6	33.1	3.0	16.4	24.4	24.6	27.1	12.9	24.9	49.9	10.7	44.8	40.2	21.7	23.6	27.7	31.0	18.8	26.8	42.4	71.1	131.6	113.8	30.4	312.0	96.8	46.8	43.3	123.9	45.2	42.9	457.6	109.5	73.0	47.4	279.5	23.3	152.7	35.4	52.8	85.5	85.3	207.9	83.9	36.5	102.7	38.1	49.4	23.4	124.5	76.0	99.5	146.9	326.4	45.5	161.9	325.6	139.7	345.2	28.5	103.5	89.6	141.1	55.3	116.1	39.5	54.9	245.2	156.6
FAM169A	"KIAA0888, SLAP75"	ENSG00000198780	"Family with sequence similarity 169 member A"	Q9Y6X4	5	74777574-74866951	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.8;epididymis: 23.6"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 120.0;Collecting duct cells: 47.1;Cone photoreceptor cells: 133.5;Horizontal cells: 81.0;Muller glia cells: 163.2;Rod photoreceptor cells: 163.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 22.8;Hep G2: 15.5;SuSa: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041574	Enhanced		Supported	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA041574: AB_10794382"	"unprognostic (3.39e-1)"	"unprognostic (2.25e-2)"	"unprognostic (1.75e-4)"	"unprognostic (5.87e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.53e-1)"	"unprognostic (7.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.93e-2)"	0.7	4.2	9.9	1.4	13.5	1.5	1.1	11.0	21.8	1.7	1.9	5.2	2.9	0.7	3.8	23.6	0.9	3.8	3.0	2.2	9.4	14.2	6.7	3.1	0.8	2.5	9.6	10.3	3.4	2.0	10.7	8.3	1.2	10.4	6.4	3.0	11.3	1.9	7.0	0.8	0.7	1.0	1.0	11.1	2.5	2.1	15.5	4.6	3.7	9.6	0.0	2.5	4.1	1.1	1.4	0.5	0.0	0.0	0.8	4.0	1.2	5.1	4.6	3.3	4.4	0.0	0.0	22.8	0.7	1.7	3.5	3.5	2.1	3.4	0.0	2.3	0.0	9.4	3.7	6.8	10.3	3.6	3.8	7.8	1.4	0.8	15.5	0.1	0.0	0.0	0.1	10.9	0.8	5.1	0.5	0.0	5.0	0.0	0.0	2.0	1.5	4.9	0.0	8.2	1.4	2.5	7.1	2.1	0.3	3.2	8.2	2.0	2.7	8.6	3.9	0.6	15.6	3.7	1.0	0.0	0.2	3.3	0.0	3.7	12.6	11.7	0.0	0.4	0.0	0.4	0.0	0.0	0.0	2.7	0.0	4.0	0.8	1.6	2.5	0.0	1.4	3.5	3.4	0.0	0.8	0.0	0.5	0.9	1.2	9.9	13.5	11.0	17.1	9.4	14.2	9.6	10.3	10.4	4.6	0.0	0.0	0.9	4.9	0.2	120.0	1.2	0.0	2.7	3.4	47.1	133.5	4.4	3.3	1.6	12.3	0.6	1.3	0.0	0.0	0.4	0.4	6.7	1.1	2.9	0.4	81.0	3.4	0.0	0.6	22.2	4.6	0.0	1.7	1.0	1.2	163.2	2.0	0.0	3.9	2.0	163.5	0.0	0.3	18.9	10.7	0.1	0.2	5.1	0.6	3.4
FAM193B	"FLJ10404, IRIZIO, KIAA1931"	ENSG00000146067	"Family with sequence similarity 193 member B"	Q96PV7	5	177519788-177554541	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035847, HPA035848"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA035847: , HPA035848: AB_10601320"	"unprognostic (6.58e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.95e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.78e-2)"	"prognostic unfavorable (3.71e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.15e-1)"	"prognostic favorable (1.30e-5)"	13.5	9.5	18.5	16.5	17.2	35.6	15.8	37.9	20.4	18.1	13.5	13.6	17.2	15.4	19.8	11.6	13.8	13.3	12.3	9.1	18.4	8.0	16.3	18.5	17.0	20.5	17.3	18.3	22.1	22.1	10.3	15.2	15.2	17.0	19.0	11.6	17.1	14.3	14.6	11.6	34.9	18.7	12.7	10.9	27.8	14.9	14.0	16.2	11.7	16.9	9.5	15.3	13.7	23.1	1.3	1.6	2.9	1.8	2.0	2.8	0.9	5.3	7.1	15.8	13.8	7.8	7.6	34.3	4.9	5.2	8.1	7.7	19.1	10.4	10.2	7.5	4.7	10.2	9.3	7.2	10.2	6.0	22.4	7.5	7.2	11.2	9.1	4.6	7.0	14.8	7.5	11.4	6.8	7.5	14.5	8.1	16.2	6.9	10.1	5.7	17.9	12.7	20.4	11.0	4.7	5.7	20.8	3.5	8.6	7.7	15.3	14.7	9.4	5.6	16.3	4.8	12.5	15.9	9.7	10.0	9.0	7.4	5.8	5.7	11.1	4.6	8.2	7.2	11.4	7.4	0.0	1.8	0.7	2.8	0.2	1.8	0.7	1.4	2.0	1.1	1.3	0.7	1.0	2.9	2.0	1.1	1.6	0.9	0.9	18.5	17.2	37.9	20.4	18.4	8.0	17.3	18.3	17.0	16.2	17.9	29.0	6.0	5.1	7.7	10.9	6.4	22.9	8.1	13.6	10.4	17.7	4.3	0.0	5.4	5.1	9.2	9.1	0.0	7.6	6.8	7.8	7.9	4.7	10.4	4.2	11.1	8.1	14.1	7.6	7.4	9.2	7.8	8.5	3.6	13.9	9.1	5.5	5.8	4.9	2.2	12.4	6.5	9.9	10.6	12.9	11.3	3.8	7.9	10.3	5.4
FAM208A	"C3orf63, KIAA1105, RAP140, se89-1, TASOR"	ENSG00000163946	"Family with sequence similarity 208 member A"	Q9UK61	3	56620133-56683237	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006735, HPA017142"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006735: AB_1852384, HPA017142: AB_1852382"	"unprognostic (1.46e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-3)"	"unprognostic (9.31e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.74e-1)"	10.3	11.6	11.4	10.9	14.7	8.0	9.8	13.8	11.6	9.9	10.1	14.3	10.5	7.3	12.6	5.8	11.2	11.1	9.0	9.9	9.2	5.4	8.1	5.8	8.5	14.6	15.2	7.1	11.9	12.6	22.9	19.2	7.0	10.5	7.6	9.6	8.6	11.4	7.6	7.4	8.2	10.4	16.9	11.6	10.5	10.2	21.1	13.0	13.8	14.6	4.1	14.2	14.3	12.9	4.1	3.3	3.7	2.6	2.9	4.4	2.0	23.1	9.2	14.4	11.3	7.8	13.7	7.2	10.4	10.7	10.0	10.5	7.6	17.4	36.8	3.9	10.4	16.8	9.3	14.3	12.2	14.6	18.1	7.2	14.4	13.5	3.4	5.5	15.1	22.9	6.5	10.3	9.7	17.6	11.8	12.9	14.0	13.9	21.3	12.7	8.1	18.5	3.0	8.0	12.3	14.2	9.9	14.3	12.2	9.6	17.1	9.6	11.9	22.7	9.1	11.4	8.6	15.0	17.5	13.8	13.0	12.0	11.7	15.8	19.4	27.0	18.7	15.0	22.4	17.1	1.8	2.6	3.7	4.3	2.0	2.8	2.8	3.8	4.4	3.3	4.1	4.1	4.2	0.8	2.9	2.3	2.5	3.3	2.0	11.4	14.7	13.8	11.6	9.2	5.4	15.2	7.1	10.5	13.0	14.9	33.1	18.2	14.9	17.5	31.9	22.6	28.1	33.5	21.6	14.0	21.6	11.6	8.3	12.5	13.8	28.2	12.7	23.3	14.7	7.4	19.2	13.4	17.4	13.0	18.1	35.0	17.9	31.3	45.6	6.3	34.5	23.3	13.5	17.2	17.4	26.0	14.8	10.5	21.5	14.1	25.8	45.3	22.9	72.1	46.0	20.3	7.7	26.1	17.2	10.9
FAM208B	"bA318E3.2, C10orf18, FLJ20360, KIAA2006"	ENSG00000108021	"Family with sequence similarity 208 member B"	Q5VWN6	10	5684838-5763740	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038042, HPA038043, HPA061547"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038042: AB_10673038, HPA038043: AB_10672402, HPA061547: AB_2684558"	"unprognostic (3.69e-2)"	"unprognostic (3.13e-2)"	"unprognostic (9.25e-2)"	"unprognostic (8.83e-2)"	"unprognostic (8.12e-3)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.39e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.36e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.88e-3)"	"unprognostic (2.90e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.79e-3)"	"unprognostic (5.23e-2)"	15.4	15.5	10.1	22.9	13.6	16.1	16.4	18.9	13.4	18.7	15.0	11.8	13.6	8.6	21.2	20.7	14.6	19.6	13.4	16.9	12.0	9.3	13.6	15.9	15.1	20.5	15.0	10.6	23.8	19.4	26.2	24.3	16.0	12.6	15.9	15.8	12.9	15.6	17.0	26.9	12.7	16.4	17.4	12.8	16.7	15.7	29.7	14.0	19.5	22.6	14.1	21.1	17.4	22.0	4.3	2.2	1.8	2.4	8.6	3.2	0.8	17.5	14.9	9.6	16.3	12.4	14.8	13.5	15.0	9.6	12.9	16.4	15.7	10.4	35.9	9.6	14.7	8.2	13.9	27.4	15.4	21.0	7.0	18.4	16.7	11.6	10.5	12.4	12.3	10.0	11.3	17.3	21.0	17.9	8.7	14.9	14.0	26.9	8.4	14.4	11.8	15.9	4.4	11.7	11.4	9.7	11.9	13.4	12.5	7.8	16.0	11.8	13.3	14.9	13.6	10.7	11.3	17.8	9.7	14.9	16.4	17.7	31.5	20.4	10.3	9.8	32.1	8.1	12.2	8.6	1.4	2.4	0.5	2.4	2.3	2.2	2.1	1.8	2.3	1.4	4.3	1.8	3.2	1.8	8.6	0.9	2.2	2.4	0.8	10.1	13.6	18.9	13.4	12.0	9.3	15.0	10.6	12.6	14.0	23.8	20.2	21.5	15.6	30.7	32.0	24.6	20.4	12.0	38.7	10.4	35.3	9.2	1.7	13.8	20.4	26.3	9.8	0.0	9.8	8.6	27.3	25.1	3.5	14.3	8.9	20.6	13.2	21.5	13.5	6.2	25.0	14.4	20.3	16.2	15.4	14.3	13.9	11.5	26.9	8.1	36.0	25.8	25.9	60.2	44.9	36.6	6.1	20.8	19.4	27.5
FAM217B	"C20orf177, dJ551D2.5"	ENSG00000196227	"Family with sequence similarity 217 member B"	Q9NTX9	20	59933764-59948680	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041021, HPA056698"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041021: AB_10959734, HPA056698: AB_2683212"	"unprognostic (1.78e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.43e-2)"	"unprognostic (5.05e-2)"	"unprognostic (9.04e-8)"	"unprognostic (2.78e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.63e-2)"	5.5	5.2	17.7	7.2	18.2	14.7	6.2	18.7	29.6	6.4	5.4	10.7	5.0	6.2	8.6	7.3	5.9	7.2	5.1	11.7	15.5	14.3	6.8	2.8	6.5	10.3	14.4	19.1	13.7	4.0	5.9	14.3	7.7	14.1	9.6	4.6	4.7	5.8	11.8	16.5	4.3	7.1	5.8	10.7	7.4	5.6	10.8	11.6	8.5	8.5	4.9	10.4	7.0	6.8	7.2	8.0	13.8	7.0	9.3	13.5	6.9	5.3	3.7	8.6	5.9	4.1	6.2	6.9	7.7	6.6	8.5	6.2	19.1	11.8	11.9	13.0	3.2	6.8	13.3	9.3	6.4	8.4	6.5	5.8	11.1	9.2	10.9	2.7	17.6	15.1	3.6	7.9	6.2	2.0	3.5	2.5	14.4	7.9	5.1	5.5	9.8	30.7	9.7	8.4	5.0	7.6	7.5	8.5	11.6	3.3	8.4	8.8	10.5	10.3	13.4	11.3	8.4	12.9	12.6	3.5	7.1	8.3	7.3	4.0	8.6	14.6	14.1	9.9	11.6	4.6	9.6	7.0	9.5	11.0	4.6	13.5	6.6	10.6	10.0	8.0	7.2	11.0	11.6	13.8	9.3	4.3	6.4	9.1	6.9	17.7	18.2	18.7	29.6	15.5	14.3	14.4	19.1	14.1	11.6	14.9	14.2	20.3	4.0	4.7	30.9	27.4	10.2	16.0	10.3	10.4	21.6	18.9	14.9	4.7	19.0	13.4	14.2	0.0	7.0	8.9	11.7	8.1	27.8	4.9	15.8	57.2	8.1	13.5	31.8	16.0	16.1	16.4	11.8	10.0	6.2	23.6	7.1	5.8	9.6	11.8	29.6	32.3	16.5	51.9	14.7	4.6	5.7	22.4	9.2	4.3
FAM222B	"C17orf63, FLJ10700"	ENSG00000173065	"Family with sequence similarity 222 member B"	Q8WU58	17	28755978-28855232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051840, HPA062239"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051840: AB_2681633, HPA062239: AB_2684722"	"unprognostic (4.11e-2)"	"unprognostic (9.72e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.40e-3)"	"unprognostic (1.57e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.18e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.28e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.18e-2)"	9.6	7.6	12.0	11.5	13.4	7.9	9.4	25.4	15.3	10.6	14.0	12.3	9.2	15.3	9.7	10.5	13.9	9.4	11.1	10.6	11.6	9.5	11.6	8.7	9.3	7.6	11.5	10.3	11.4	9.2	15.0	15.2	12.4	13.9	10.5	13.0	16.4	16.8	12.2	42.4	8.5	13.4	9.7	9.5	7.8	10.5	39.4	10.9	10.1	11.1	4.4	9.2	13.3	12.5	7.8	5.7	13.6	8.5	4.1	10.2	4.2	7.7	15.4	13.1	15.2	11.4	8.0	14.4	5.6	5.3	7.9	8.0	19.7	7.7	7.9	11.2	6.2	9.8	10.0	11.0	12.6	6.6	11.0	14.5	8.9	7.7	14.9	13.1	5.6	14.5	8.3	12.5	11.2	10.0	7.9	15.6	9.3	16.7	5.7	16.7	9.9	9.9	4.7	15.0	10.4	5.8	4.7	12.5	8.0	14.0	10.0	14.5	10.1	7.7	15.0	19.6	29.0	11.7	5.5	17.4	5.2	10.8	5.7	8.7	11.6	14.1	5.1	7.2	4.0	9.4	13.6	4.2	11.1	8.2	5.9	10.2	7.8	6.8	8.3	5.6	6.4	9.6	7.9	6.1	4.1	8.5	5.7	5.9	4.2	12.0	13.4	25.4	15.3	11.6	9.5	11.5	10.3	13.9	10.9	3.0	8.2	7.3	7.0	8.4	13.6	11.4	25.5	4.0	5.7	7.0	25.5	6.9	3.3	16.7	45.8	13.1	17.3	46.7	11.5	8.3	7.2	11.3	9.3	11.0	7.6	23.8	24.9	32.5	6.9	35.2	11.5	6.6	6.8	8.2	21.2	5.6	17.4	10.5	7.4	7.8	7.2	0.0	5.6	40.0	32.9	5.8	5.0	5.1	18.4	8.7
FAM241A	"C4orf32, FLJ39370"	ENSG00000174749	"Family with sequence similarity 241 member A"	Q8N8J7	4	112145397-112195256	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 49.5"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 56.6;Alveolar cells type 2: 52.1;Ciliated cells: 77.6;Club cells: 67.1;Collecting duct cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 26.5;HUVEC TERT2: 18.3"	"Low region specificity"	"Detected in all"							"HPA062443, HPA069294"	Approved		Enhanced	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA062443: AB_2684765, HPA069294: AB_2686111"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.81e-2)"	"unprognostic (5.25e-2)"	"unprognostic (9.20e-3)"	"prognostic unfavorable (8.87e-4)"	"unprognostic (4.08e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.39e-2)"	43.2	4.8	3.3	11.9	3.0	7.0	49.5	3.6	3.1	6.9	9.5	4.6	10.7	3.1	8.9	6.0	7.6	5.2	6.2	18.5	4.3	3.0	6.4	6.9	10.2	7.2	5.6	1.8	5.2	3.8	7.1	6.3	12.6	3.4	9.7	3.2	2.8	22.3	17.2	11.6	7.2	4.7	9.0	4.3	9.7	8.3	7.7	3.6	6.3	8.5	7.3	6.0	9.3	24.7	2.7	2.8	5.7	1.7	1.7	1.7	0.7	4.0	1.6	1.6	1.3	8.6	4.9	2.5	3.4	0.8	0.6	1.1	1.2	5.1	26.5	3.2	1.8	2.3	1.9	2.6	3.6	1.2	12.4	4.3	2.9	3.9	2.1	5.1	6.5	1.7	5.3	5.8	1.0	6.2	1.3	18.3	3.8	5.3	12.8	2.1	4.1	2.4	4.7	2.1	6.6	3.8	5.4	2.7	5.4	2.7	3.9	3.0	2.5	3.2	5.9	1.6	2.5	4.2	2.8	11.5	2.1	6.3	1.4	1.2	5.4	7.0	12.2	4.9	3.2	2.7	5.7	1.7	1.6	1.5	1.3	1.3	1.5	1.6	1.1	0.9	2.7	1.5	1.7	4.2	1.7	1.6	2.8	1.7	0.7	3.3	3.0	3.6	2.4	4.3	3.0	5.6	1.8	3.4	3.6	56.6	52.1	0.0	0.0	0.0	0.0	0.0	0.0	77.6	67.1	31.4	0.0	1.4	6.6	11.8	0.0	0.0	0.0	0.0	14.9	2.2	0.0	0.0	30.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	8.2	0.0	0.0	21.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0
FAM3C	"GS3876, ILEI"	ENSG00000196937	"Family with sequence similarity 3 member C"	Q92520	7	121348851-121396364	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"	Oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 398.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"memory B-cell: 13.9;naive B-cell: 11.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 13.9"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 167.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043376, HPA050548"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted in other tissues"	NA	NA		59000000	"Golgi apparatus"		"HPA043376: AB_2678452, HPA050548: AB_2681169"	"unprognostic (9.44e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.09e-3)"	"unprognostic (3.38e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.06e-2)"	18.1	18.0	38.0	13.7	29.8	3.2	16.3	26.5	46.6	38.6	27.1	8.2	12.8	65.6	20.9	23.0	15.5	14.3	13.7	24.6	23.4	20.0	24.3	20.7	15.9	15.3	20.6	42.0	15.7	35.5	20.6	15.8	21.7	30.6	12.3	21.2	11.1	20.4	13.2	9.0	14.5	60.8	16.9	14.1	16.8	21.9	9.0	12.7	6.4	42.8	11.4	16.2	17.3	15.9	13.9	1.1	0.6	0.9	2.3	1.8	0.7	16.8	4.3	8.0	8.5	13.6	22.6	7.3	18.2	8.1	5.5	7.0	3.4	167.0	16.0	8.6	9.4	15.6	11.2	4.6	10.1	11.8	1.9	9.1	4.4	2.6	3.4	9.9	7.4	8.4	22.6	6.9	7.8	7.7	14.8	9.8	3.2	2.9	20.3	43.1	2.8	2.8	5.8	14.4	5.8	6.0	4.4	8.2	6.5	34.3	9.8	5.2	5.1	5.4	22.3	9.9	17.6	3.1	4.1	23.5	14.4	4.7	31.3	12.4	19.4	8.6	6.3	15.5	7.7	25.7	0.0	0.9	0.6	1.8	0.9	1.7	13.9	0.8	1.4	0.8	11.9	1.0	0.8	0.2	2.3	0.7	1.1	0.4	0.7	38.0	29.8	26.5	46.6	23.4	20.0	20.6	42.0	30.6	12.7	8.9	32.3	73.0	174.8	63.7	109.7	59.0	40.8	38.8	47.8	52.4	21.6	74.8	51.4	169.6	2.5	40.5	66.5	23.3	169.6	170.2	99.2	134.9	19.6	32.1	40.3	42.9	50.3	46.1	27.3	4.5	88.9	38.7	94.5	40.5	46.7	50.7	269.6	77.2	90.2	60.6	51.8	71.1	82.5	23.9	18.5	58.1	100.7	42.4	72.4	398.1
FAM50A	"9F, DXS9928E, HXC-26, XAP5"	ENSG00000071859	"Family with sequence similarity 50 member A"	Q14320	X	154444126-154450654	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003585	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003585: AB_1080603"	"unprognostic (1.95e-1)"	"prognostic favorable (2.05e-4)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.73e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (2.56e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.64e-3)"	"unprognostic (6.35e-2)"	"unprognostic (3.28e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.14e-1)"	33.0	29.9	31.4	23.3	46.1	21.7	22.6	42.7	45.3	23.0	27.0	25.6	22.2	24.8	22.2	38.1	18.9	16.4	17.4	31.9	32.6	23.5	24.7	23.2	23.1	16.6	43.5	29.5	20.3	25.1	32.1	41.3	30.5	35.6	23.1	20.2	24.3	27.9	26.6	54.7	16.1	22.9	26.5	31.4	24.1	23.1	7.0	42.9	11.7	25.6	12.4	16.9	24.8	39.9	16.5	24.5	19.4	35.1	19.6	30.3	14.6	26.0	32.5	10.8	15.5	40.6	29.3	21.5	33.9	30.8	33.2	50.8	29.6	12.3	1.3	35.3	35.8	48.5	10.3	25.6	23.7	25.8	19.0	16.3	8.3	39.0	18.6	59.4	7.5	24.9	33.5	17.1	51.1	26.3	24.0	27.2	10.0	10.8	21.3	32.2	17.8	8.9	10.0	7.3	23.1	20.4	13.1	27.3	18.8	21.0	26.4	19.6	13.9	12.3	20.0	40.6	19.5	17.4	14.8	33.0	22.9	18.8	37.5	41.5	49.5	28.4	9.3	31.0	26.5	25.5	14.2	26.6	19.4	22.5	33.9	30.3	16.5	23.4	21.5	24.5	14.0	13.2	18.0	14.4	19.6	35.1	18.8	24.9	14.6	31.4	46.1	42.7	45.3	32.6	23.5	43.5	29.5	35.6	42.9	32.8	52.0	32.9	35.3	23.1	61.4	79.5	50.9	10.7	15.9	27.9	25.5	56.8	48.0	42.2	0.8	43.0	99.3	93.5	58.5	92.1	57.0	45.1	47.2	37.6	125.0	44.5	60.7	39.9	53.7	2.6	72.2	73.5	30.4	61.3	64.6	70.3	63.3	77.2	75.0	89.7	62.4	32.3	59.0	7.2	15.7	22.6	101.7	53.3	49.8	41.4
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849386-3851317	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 42.6;MCF7: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	7.2	9.5	13.4	5.7	20.6	3.1	5.7	18.7	16.7	6.7	6.8	11.0	8.4	10.1	8.3	6.7	5.5	11.2	8.1	16.0	12.8	14.2	12.9	12.0	6.2	7.1	11.4	14.9	14.4	12.7	5.8	7.7	3.4	9.7	8.2	3.0	5.9	15.2	9.8	41.1	7.9	6.9	10.2	10.8	7.7	7.9	10.2	9.9	5.8	11.8	5.7	5.5	7.5	13.3	14.9	10.1	3.4	9.1	19.4	20.5	5.6	3.1	4.3	0.0	0.0	2.6	2.4	0.2	3.8	1.8	2.6	3.3	0.0	5.9	3.4	4.1	2.7	1.0	2.4	0.0	1.5	1.9	42.6	2.3	0.0	10.2	0.0	2.7	0.0	0.0	2.7	3.0	2.0	0.6	0.8	2.6	0.0	0.0	0.0	2.3	13.4	0.0	4.7	0.9	2.0	2.0	0.0	0.0	0.0	1.2	0.0	6.0	5.3	6.2	3.9	0.2	0.0	4.2	3.8	3.5	0.0	0.4	5.1	0.0	0.0	9.2	0.0	1.4	0.3	7.1	3.4	4.7	2.4	7.1	6.1	16.8	14.9	13.6	9.2	6.1	12.9	11.3	7.1	1.9	19.4	9.1	10.1	20.5	5.6	13.4	20.6	18.7	16.7	12.8	14.2	11.4	14.9	9.7	9.9	14.9	6.5	6.5	5.9	5.7	17.4	15.7	5.1	4.0	7.9	12.2	3.9	3.3	28.2	10.7	24.9	4.1	2.2	0.0	9.9	4.8	5.8	2.7	3.5	18.8	8.7	14.3	1.2	8.6	4.1	25.0	7.8	4.0	11.8	10.0	3.3	19.1	7.9	3.6	10.3	32.6	12.6	0.0	7.9	34.4	39.6	5.8	0.8	4.5	3.3	1.6
FAM96A	"CIA2A, FLJ22875"	ENSG00000166797	"Family with sequence similarity 96 member A"	Q9H5X1	15	64072559-64094018	"Predicted intracellular proteins"	"Chromosome partition"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040459, HPA063729"	Approved		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	No	No			"Nucleoplasm, Cytosol"		"HPA040459: AB_10796456, HPA063729: AB_2685105"	"unprognostic (1.15e-1)"	"unprognostic (8.49e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.07e-2)"	"unprognostic (4.06e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.48e-3)"	"unprognostic (8.06e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.50e-2)"	13.6	32.3	11.2	19.1	12.8	17.0	13.9	9.0	10.3	8.5	24.3	13.6	17.7	31.3	8.1	14.9	13.6	8.3	14.0	20.6	11.2	10.8	39.4	89.7	18.1	22.7	15.2	8.0	7.8	27.0	10.6	15.4	25.2	11.2	17.2	20.2	10.7	16.5	15.7	28.2	7.6	45.5	6.4	14.9	25.2	17.9	8.9	13.8	20.5	30.1	18.3	19.3	14.6	9.0	51.8	63.7	23.7	48.6	11.8	21.3	38.2	19.9	29.3	17.9	11.2	15.2	18.7	11.8	15.7	17.5	21.0	22.3	28.9	32.3	33.2	27.7	9.9	27.9	22.1	35.0	15.4	17.9	27.1	18.9	27.0	26.5	27.1	12.0	43.7	23.4	14.7	15.5	13.6	12.2	14.3	21.2	18.7	36.9	25.7	14.8	33.8	16.6	37.9	26.0	24.9	15.6	26.8	23.7	73.5	27.1	23.5	19.2	14.5	12.5	28.6	30.4	20.8	21.0	45.8	12.7	16.7	23.7	19.0	33.8	24.9	58.7	29.8	20.2	79.2	15.8	16.2	48.6	16.9	10.1	44.1	12.4	51.8	15.3	13.5	42.6	48.8	12.3	11.6	23.7	11.8	36.7	63.7	21.3	38.2	11.2	12.8	9.0	10.3	11.2	10.8	15.2	8.0	11.2	13.8	35.7	30.8	96.4	18.3	15.9	7.2	70.8	79.0	45.5	40.9	33.2	3.9	101.5	140.9	70.9	2.4	23.8	94.1	0.0	74.8	83.9	35.7	38.2	19.7	217.6	196.6	14.3	55.4	41.1	140.8	3.6	15.3	99.6	40.5	211.0	97.7	14.5	84.6	87.7	7.8	151.8	6.7	12.9	23.7	21.4	49.8	19.2	74.3	58.6	129.3	21.4
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"Fanconi anemia complementation group I"	Q9NVI1	15	89243949-89317261	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.4;testis: 28.3"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 46.7;Spermatocytes: 45.0;Spermatogonia: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039972: AB_10673265, HPA040379: AB_2676951"	"unprognostic (6.88e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (6.82e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.59e-3)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.71e-13)"	"unprognostic (2.40e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-1)"	3.7	3.2	1.7	11.1	3.3	16.5	3.3	1.8	5.6	3.8	5.9	3.0	2.7	3.3	3.3	3.3	10.7	2.1	1.8	2.8	2.5	1.5	2.4	2.0	3.5	13.4	5.0	2.6	3.1	2.3	1.8	1.5	7.1	2.9	2.8	7.6	2.3	4.0	1.7	1.3	5.4	4.9	3.8	2.8	6.7	4.6	28.3	3.2	44.4	1.7	9.2	15.4	3.9	4.6	3.8	3.9	17.7	3.8	4.6	10.6	3.0	24.5	28.2	30.2	20.3	2.7	3.9	18.7	23.6	13.6	29.6	36.2	22.3	22.4	45.5	12.8	7.8	18.9	33.7	46.1	16.0	27.9	29.0	28.8	45.1	41.5	10.4	0.4	32.5	23.0	2.1	1.6	20.8	10.6	4.3	12.0	28.1	31.1	33.6	19.7	14.0	33.9	11.2	23.7	16.1	10.4	29.5	44.0	19.5	6.8	45.4	22.5	19.3	24.4	17.3	11.0	21.3	19.1	14.8	8.2	24.6	25.1	22.5	35.8	22.3	46.3	35.1	9.2	29.0	24.6	17.7	2.4	2.8	5.2	3.0	2.9	3.5	5.0	6.8	2.1	3.8	4.1	6.0	3.7	4.6	3.8	3.9	10.6	3.0	1.7	3.3	1.8	5.6	2.5	1.5	5.0	2.6	2.9	3.2	3.0	1.0	3.7	1.8	3.8	2.1	2.7	0.0	8.1	4.5	1.8	0.0	8.3	0.0	1.7	5.9	1.6	1.3	46.7	2.5	15.5	2.7	1.4	2.3	0.8	6.8	1.6	1.2	9.2	3.1	5.3	3.1	4.3	1.7	3.6	4.5	9.5	2.2	0.0	1.4	1.0	1.7	6.5	1.9	45.0	68.0	2.0	10.4	5.2	4.4	1.7
FASN	"FAS, SDR27X1"	ENSG00000169710	"Fatty acid synthase"	P49327	17	82078333-82098332	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	"Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 147.6"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 103.0;Hepatocytes: 169.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 155.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005192, HPA006461, CAB015417, HPA056108"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		1600000	"Plasma membrane, Cytosol"		"CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039"	"unprognostic (3.35e-2)"	"prognostic unfavorable (1.42e-5)"	"unprognostic (9.69e-3)"	"unprognostic (4.09e-2)"	"unprognostic (3.46e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.09e-2)"	"unprognostic (4.74e-3)"	"unprognostic (3.15e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (4.50e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.03e-3)"	147.6	7.8	8.2	14.2	11.5	11.1	57.5	19.1	23.0	6.6	27.7	17.0	14.1	8.2	4.7	14.2	17.1	4.3	19.4	6.3	7.9	6.7	3.7	30.8	26.8	9.8	7.3	11.5	6.4	10.4	6.7	15.3	8.4	21.7	28.8	3.4	7.6	16.9	10.8	7.5	17.2	6.5	4.6	8.4	5.1	11.9	6.6	8.8	1.9	5.1	10.7	5.4	8.0	6.6	0.5	1.4	0.0	0.8	0.2	1.9	0.8	23.6	24.8	11.5	7.9	18.7	12.7	24.7	4.7	6.1	5.0	9.2	25.9	16.1	7.9	3.9	3.6	14.0	19.7	11.1	21.7	0.9	3.7	48.3	16.3	18.5	34.6	5.3	8.8	2.5	12.1	5.7	12.7	3.0	1.7	5.6	7.4	24.6	7.0	1.7	40.9	9.5	14.0	22.4	3.7	14.4	8.5	6.5	15.6	5.6	30.3	28.7	16.0	6.9	155.8	12.6	4.4	27.8	16.8	9.7	7.3	15.1	6.0	11.3	9.5	2.1	8.1	4.4	9.6	10.8	0.0	0.8	0.0	1.2	0.5	0.7	0.5	1.9	1.4	1.4	0.2	0.7	0.6	0.0	0.2	0.4	1.1	0.6	0.8	8.2	11.5	19.1	23.0	7.9	6.7	7.3	11.5	21.7	8.8	23.8	103.0	0.8	10.3	6.9	24.9	4.8	25.5	6.7	10.3	10.4	5.9	28.9	3.3	18.9	1.2	4.5	20.8	23.3	24.9	65.8	10.4	65.5	12.7	169.2	11.7	28.6	17.4	11.1	6.9	1.3	15.3	5.0	16.9	8.2	18.9	12.3	16.1	17.5	10.6	5.5	9.5	0.0	9.6	1.9	13.9	12.0	24.7	10.7	18.3	17.5
FAU	"asr1, FLJ22986, Fub1, Fubi, MNSFbeta, RPS30, S30"	ENSG00000149806	"FAU, ubiquitin like and ribosomal protein S30 fusion"	"P35544, P62861"	11	65120628-65122473	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA059015	Supported		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA059015: AB_2683881"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.97e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.06e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.45e-2)"	79.7	95.0	90.6	84.9	76.2	186.7	95.4	50.9	80.9	103.6	134.8	77.6	63.4	77.8	84.0	80.5	115.2	100.0	87.2	133.9	70.0	58.9	88.0	162.9	77.5	182.6	78.9	40.8	176.0	202.8	27.5	56.1	73.2	46.6	123.5	53.0	67.8	97.3	76.7	190.8	86.8	93.8	97.5	72.4	130.9	79.2	53.6	53.2	126.8	121.5	83.6	149.5	122.0	136.6	291.3	169.7	90.9	119.0	116.3	253.8	346.5	78.9	52.0	46.0	72.8	45.0	67.3	63.0	45.1	43.9	63.2	40.1	58.8	79.3	94.1	122.5	38.7	42.6	69.8	42.6	60.1	26.3	69.0	65.3	75.8	54.7	80.7	82.8	89.8	83.6	82.9	100.1	54.3	73.9	60.2	48.7	91.0	70.7	111.5	33.4	98.7	103.8	181.4	126.5	59.2	86.7	101.0	36.8	184.5	58.2	44.7	64.0	64.3	35.0	101.3	140.8	28.6	90.5	124.6	46.0	57.2	66.0	88.2	72.0	121.3	115.2	160.1	69.3	70.0	64.7	90.9	119.0	70.6	128.9	107.0	176.1	291.3	212.1	165.5	132.1	281.7	253.8	198.1	78.9	116.3	92.8	169.7	153.8	346.5	90.6	76.2	50.9	80.9	70.0	58.9	78.9	40.8	46.6	53.2	595.5	951.7	2941.4	2547.1	3351.7	327.7	460.8	1579.6	745.5	1039.6	909.0	184.6	1889.5	1737.5	1225.7	710.1	1573.3	1664.2	1027.9	2337.8	2188.3	1714.1	2189.0	1307.1	1658.9	1928.3	179.6	1179.1	1412.4	2371.4	1489.6	2116.5	2866.9	2014.3	2418.4	1788.3	428.5	1806.3	2457.4	1155.5	1844.9	362.4	1099.5	2206.1	745.0	649.0	3667.7	2335.8	2033.7	2040.2	2956.6
FBLIM1	"CAL, FBLP-1, migfilin"	ENSG00000162458	"Filamin binding LIM protein 1"	Q8WUP2	1	15756607-15786594	"Predicted intracellular proteins"	"Cell adhesion, Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 180.0;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 54.1;TIME: 84.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA025287, HPA072750"	Approved		Enhanced	"Nucleoli fibrillar center,Cell Junctions,Focal adhesion sites"		NA	NA			"Cell Junctions, Focal adhesion sites"	"Nucleoli fibrillar center"	"HPA025287: AB_1848443, HPA072750: AB_2686554"	"unprognostic (4.10e-2)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (2.26e-1)"	"unprognostic (5.33e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.33e-2)"	"unprognostic (8.77e-3)"	"prognostic unfavorable (6.15e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (8.33e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.21e-2)"	11.6	6.0	1.7	12.8	1.4	0.0	10.1	0.8	1.3	21.5	36.6	1.4	26.8	24.6	30.3	15.8	17.8	16.5	60.2	21.7	1.2	1.0	18.2	3.0	14.7	16.1	1.8	1.6	36.0	13.0	13.9	3.8	21.5	2.3	26.7	15.7	9.0	13.0	26.5	4.1	6.2	62.8	18.7	1.3	22.7	18.9	22.3	0.9	1.3	10.3	7.4	6.3	24.7	16.9	1.8	1.3	4.6	1.2	1.6	1.2	0.3	6.5	3.7	3.3	0.1	0.8	1.7	4.5	11.2	17.9	8.3	6.7	1.2	9.9	0.0	24.3	18.0	14.4	12.7	2.4	25.7	4.1	0.0	1.2	0.0	0.9	6.3	21.6	0.0	0.1	8.5	17.2	6.9	16.5	17.2	54.1	0.4	0.2	1.6	2.8	0.1	0.1	0.1	3.4	10.3	4.8	0.0	0.0	0.2	10.4	4.5	0.0	8.0	5.9	0.7	1.3	7.2	1.4	0.1	84.4	11.0	1.5	0.1	5.1	0.1	0.2	0.1	1.6	0.0	0.1	4.6	1.2	1.0	0.7	0.5	0.6	1.0	0.7	0.7	0.4	1.8	1.1	1.2	3.5	1.6	0.7	1.3	0.4	0.3	1.7	1.4	0.8	1.3	1.2	1.0	1.8	1.6	2.3	0.9	11.9	21.5	5.2	54.8	76.6	3.5	30.9	45.9	12.0	29.6	15.7	5.9	5.8	0.0	80.2	2.4	18.4	138.3	0.0	46.9	102.1	26.9	24.2	17.4	1.8	5.3	1.6	44.1	38.1	0.6	1.8	74.2	10.4	13.5	3.6	47.1	10.0	88.8	84.2	180.0	1.2	5.1	142.3	66.2	2.3	1.8	54.8	16.2	6.1	40.4	47.2
FBXL3	"FBL3, FBL3A, FBXL3A"	ENSG00000005812	"F-box and leucine rich repeat protein 3"	Q9UKT7	13	76992598-77027195	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"		"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053283, HPA065626"			Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA053283: AB_2682100, HPA065626: AB_2685523"	"unprognostic (3.98e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.24e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.12e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.10e-3)"	"unprognostic (8.52e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-1)"	41.8	19.9	29.5	19.4	28.3	44.7	35.1	36.7	29.0	30.4	20.7	17.7	27.4	18.1	31.8	22.2	22.7	27.1	18.6	23.7	23.2	18.9	29.6	23.3	22.5	23.8	31.3	24.0	35.9	15.9	18.1	16.5	30.4	23.2	26.0	19.5	11.8	22.5	28.3	28.8	23.2	21.9	25.8	26.4	22.6	17.9	26.2	28.5	28.7	37.3	19.8	23.0	24.8	28.8	4.1	2.9	11.9	4.4	2.8	7.2	2.3	20.8	5.3	10.7	7.3	25.8	25.7	8.5	23.9	19.5	14.2	18.2	7.7	14.7	13.4	16.0	20.9	8.6	15.7	10.5	12.7	20.3	26.8	28.2	17.6	16.6	6.9	17.2	22.1	13.7	21.6	17.0	11.2	15.5	16.7	18.5	7.6	6.6	10.4	16.7	7.5	15.8	11.8	4.1	17.8	10.0	13.0	12.1	8.0	15.1	10.9	12.7	10.4	15.3	14.8	13.4	7.5	8.2	24.4	22.6	13.7	9.0	9.3	11.5	13.4	15.4	12.5	23.6	16.0	14.8	11.9	2.8	6.4	3.3	4.1	4.3	4.1	5.9	3.3	2.7	4.0	7.1	4.7	7.4	2.8	4.4	2.9	7.2	2.3	29.5	28.3	36.7	29.0	23.2	18.9	31.3	24.0	23.2	28.5	41.7	20.3	20.3	40.5	59.8	23.9	18.3	5.1	18.7	13.6	21.0	9.8	27.3	34.9	16.6	35.7	32.3	32.2	0.0	16.3	36.9	35.3	40.3	27.7	25.0	20.6	35.0	23.0	19.6	32.6	17.3	69.0	29.6	40.5	22.6	22.0	41.9	16.2	24.6	70.4	23.0	23.1	58.2	61.2	42.6	58.1	49.1	23.8	27.7	18.8	28.3
FBXO32	"ATROGIN1, Fbx32, MAFbx"	ENSG00000156804	"F-box protein 32"	Q969P5	8	123497889-123541206	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 200.5"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 172.4;Cardiomyocytes: 242.3;Glandular cells: 165.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 2.9;gdT-cell: 3.7;MAIT T-cell: 3.6;memory CD4 T-cell: 5.1;memory CD8 T-cell: 5.4;naive CD4 T-cell: 6.0;naive CD8 T-cell: 7.6;NK-cell: 4.4;T-reg: 4.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.9;NK-cells: 4.4;T-cells: 7.6"	"Cell line enhanced"	"Detected in some"		"GAMG: 17.4;HDLM-2: 59.1;hTERT-RPE1: 20.6;U-251 MG: 17.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058955, HPA065209"			Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA058955: , HPA065209: AB_2685433"	"unprognostic (2.55e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (8.58e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-3)"	3.5	1.5	2.4	4.9	5.1	0.8	13.2	1.0	3.8	5.6	31.1	8.9	14.4	2.6	25.3	5.8	8.1	15.8	16.6	26.1	2.9	2.1	1.5	1.0	1.7	4.1	10.2	2.5	9.5	2.0	0.9	5.6	4.9	7.3	19.7	8.0	4.2	8.0	23.1	200.5	3.7	6.5	36.9	8.8	1.7	10.8	3.5	7.6	0.2	9.0	15.1	3.1	24.8	16.1	0.6	0.2	2.9	0.3	4.4	7.6	1.4	1.7	0.3	0.0	0.0	3.8	0.9	0.6	0.3	3.9	0.2	0.4	0.0	1.0	0.0	1.1	2.9	17.4	0.1	0.0	0.3	0.3	59.1	1.3	0.0	2.0	0.0	5.2	0.0	0.2	7.6	2.6	0.9	1.1	20.6	0.2	0.8	0.1	0.5	0.2	0.4	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.5	0.1	0.3	0.4	6.7	6.8	0.4	6.6	0.1	0.2	1.1	0.3	0.3	17.7	6.1	0.8	0.1	4.5	0.0	0.8	2.9	0.3	0.0	3.7	0.2	3.6	0.6	5.1	5.4	0.2	0.6	6.0	7.6	0.2	4.4	0.2	0.1	4.5	1.4	2.4	5.1	1.0	3.8	2.9	2.1	10.2	2.5	7.3	7.6	0.0	3.0	0.9	172.4	10.2	7.9	242.3	2.5	2.7	20.5	7.0	33.4	13.8	8.3	11.6	2.6	7.7	43.7	23.3	26.4	10.2	11.3	165.2	0.0	1.5	4.9	20.6	98.1	0.6	3.2	2.7	36.8	2.9	42.2	1.0	40.8	51.7	39.4	23.2	57.7	3.3	92.8	19.4	73.6	5.4	1.3	5.5	91.3	21.0	19.3	65.2
FCHO1	KIAA0290	ENSG00000130475	"FCH domain only 1"	O14526	19	17747718-17788568	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 25.7;bone marrow: 18.9;brain: 30.2;lymphoid tissue: 22.6;skin 1: 13.4"	"Cell type enhanced"	"Detected in many"	6	"B-cells: 10.4;granulocytes: 9.2;Kupffer cells: 12.6;Macrophages: 11.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 28.2;RPMI-8226: 19.4;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041653, HPA062981"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA041653: AB_10795641, HPA062981: AB_2684915"	"unprognostic (3.02e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-3)"	"unprognostic (3.62e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.93e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.72e-9)"	"unprognostic (3.76e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.21e-1)"	"unprognostic (9.77e-3)"	2.2	2.3	13.6	13.7	18.9	18.9	1.9	11.4	15.2	1.1	2.7	30.2	0.0	3.7	1.8	1.8	1.5	1.9	4.5	1.1	17.8	11.7	1.0	2.7	3.4	22.6	23.0	10.0	2.2	0.9	0.8	2.6	1.4	10.8	1.4	2.6	0.6	2.7	1.2	0.9	13.4	4.0	2.1	15.9	13.7	3.5	4.3	23.3	16.4	1.2	0.0	17.3	5.1	1.0	9.9	10.4	25.7	9.5	4.1	5.7	4.4	0.4	5.4	3.5	2.5	0.1	0.1	3.5	0.5	0.1	0.1	0.2	0.7	0.6	28.2	8.1	0.2	0.6	1.1	1.7	1.0	0.1	12.4	0.9	2.2	0.7	2.8	0.3	6.9	4.8	0.0	0.1	0.1	0.2	0.2	0.7	14.0	11.0	13.5	0.0	7.8	16.0	12.5	1.7	6.6	13.4	13.6	0.1	19.4	0.1	0.5	0.6	1.3	0.1	2.8	0.4	0.4	2.7	7.0	0.5	0.1	2.0	0.5	0.2	8.6	3.9	15.2	0.4	17.4	0.3	6.9	6.6	6.5	5.2	9.5	4.5	8.8	5.7	4.5	9.7	9.9	5.5	4.4	25.7	4.1	7.2	10.4	5.2	4.4	13.6	18.9	11.4	15.2	17.8	11.7	23.0	10.0	10.8	23.3	0.0	1.0	10.4	0.4	0.0	6.7	0.8	2.5	0.0	0.0	1.8	0.0	2.7	0.0	0.4	1.0	0.8	0.8	0.0	0.0	3.7	0.4	0.2	9.2	0.0	6.5	0.0	1.2	3.7	12.6	0.0	2.3	11.9	1.7	4.6	1.4	0.2	1.4	0.0	8.1	0.0	0.7	0.0	0.4	0.7	1.7	0.5	0.7	5.4	1.0	0.1
FDX1	"ADX, FDX"	ENSG00000137714	"Ferredoxin 1"	P10109	11	110429883-110464881	"Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Steroidogenesis, Sterol metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 113.9;seminal vesicle: 55.6"	"Cell type enhanced"	"Detected in all"	11	"Syncytiotrophoblasts: 953.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041630, HPA062087"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA041630: AB_10793970, HPA062087: AB_2630366"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.29e-3)"	"unprognostic (4.67e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.32e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.10e-2)"	"unprognostic (5.48e-2)"	"prognostic favorable (3.58e-7)"	"prognostic favorable (2.53e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.80e-1)"	5.5	113.9	3.9	4.7	4.5	3.9	5.6	2.7	4.0	3.2	7.5	5.2	33.7	7.9	3.2	3.9	5.1	3.0	5.6	9.6	3.6	4.3	10.7	22.8	7.8	4.7	4.5	2.5	3.5	8.6	3.5	3.7	48.4	3.1	4.8	4.2	4.2	4.1	55.6	7.3	3.3	12.3	3.6	3.4	3.9	5.0	5.3	2.6	5.2	8.7	5.0	3.5	5.6	5.4	10.7	6.9	3.4	5.8	4.4	8.7	2.9	5.4	3.8	5.8	6.4	5.7	10.2	13.1	5.0	6.1	4.4	7.5	12.9	9.1	12.7	14.8	6.4	7.9	6.4	6.8	7.5	6.1	12.1	8.6	6.4	6.7	7.9	10.1	6.7	10.5	17.7	6.3	4.0	9.6	7.7	9.0	8.8	6.4	18.9	9.4	6.0	9.5	14.9	5.2	10.3	7.2	14.0	5.6	11.7	9.6	9.8	8.0	4.1	9.5	10.9	6.3	7.1	6.4	4.6	5.3	4.5	5.5	5.4	5.3	4.3	3.3	38.1	3.4	13.7	5.7	1.8	5.7	3.4	5.3	4.2	5.8	10.7	7.3	7.4	6.9	7.5	8.6	6.1	0.7	4.4	5.8	5.3	8.7	2.9	3.9	4.5	2.7	4.0	3.6	4.3	4.5	2.5	3.1	2.6	17.9	39.7	88.0	75.8	60.8	27.9	46.0	104.4	6.7	9.1	76.8	7.9	144.7	207.2	62.6	22.7	33.8	131.1	46.7	128.1	138.7	46.5	71.9	46.0	160.8	108.7	39.7	46.0	33.7	54.7	7.0	43.4	60.1	65.8	51.3	45.4	26.2	79.9	67.0	42.8	255.2	15.0	25.8	42.6	41.2	70.7	85.2	953.0	57.5	77.9	120.2
FDXR	ADXR	ENSG00000161513	"Ferredoxin reductase"	P22570	17	74862497-74873031	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cholesterol metabolism, Electron transport, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Oxidoreductase	"Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 93.9"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 47.2;Syncytiotrophoblasts: 38.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 30.1;Hep G2: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008597, CAB009818, HPA044393, HPA053673"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB008597: AB_1615557, CAB009818: AB_2102601, HPA044393: AB_2678927, HPA053673: AB_2682225"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-3)"	"unprognostic (7.51e-2)"	"prognostic favorable (2.38e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.13e-1)"	1.7	93.9	2.6	2.1	3.1	1.3	1.8	8.4	2.7	2.1	4.6	3.2	6.4	2.6	2.6	23.8	8.7	6.6	6.1	1.9	3.4	1.7	2.7	4.1	4.4	1.7	2.9	3.5	7.1	3.9	2.3	1.5	2.6	3.6	3.3	2.1	0.9	5.3	4.2	7.9	5.6	2.5	2.0	4.4	9.7	2.2	32.1	3.0	3.9	2.0	7.7	3.7	3.0	3.0	5.4	7.4	4.8	6.4	10.0	15.2	5.6	4.0	21.6	3.2	3.6	2.3	3.1	30.1	4.8	5.3	2.9	5.8	6.0	3.5	9.6	0.8	2.0	1.6	8.3	2.3	6.0	0.8	9.1	5.0	7.3	3.5	55.1	6.5	1.6	25.5	10.1	6.8	3.0	1.0	2.3	14.7	3.6	11.5	1.6	4.4	17.1	6.2	3.3	1.8	3.8	4.7	3.4	5.4	5.1	2.4	6.8	1.7	4.0	3.3	7.2	3.5	3.8	15.7	1.5	6.8	2.0	17.9	3.1	2.4	4.4	0.7	2.1	5.4	2.5	6.7	1.8	6.4	4.8	6.2	4.3	5.3	5.4	5.6	7.3	7.4	2.8	4.9	6.1	2.1	10.0	3.2	1.4	15.2	5.6	2.6	3.1	8.4	2.7	3.4	1.7	2.9	3.5	3.6	3.0	3.0	4.6	3.7	12.8	8.7	4.9	3.4	5.1	21.4	5.7	8.7	3.9	47.2	5.0	9.7	5.2	2.8	14.8	0.0	6.8	14.1	6.1	4.3	5.7	12.5	18.6	3.2	6.8	12.3	4.6	12.2	5.5	3.6	5.0	3.6	10.8	10.9	8.3	21.0	4.2	16.3	4.9	0.0	6.4	7.1	7.6	15.8	38.6	8.5	17.6	13.1
FEM1C	"EUROIMAGE686608, EUROIMAGE783647, FEM1A, KIAA1785"	ENSG00000145780	"Fem-1 homolog C"	Q96JP0	5	115520908-115544894	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 58.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059919, HPA060977"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059919: AB_2684161, HPA060977: AB_2684402"	"unprognostic (1.14e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (1.83e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.31e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.67e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.05e-2)"	18.2	6.8	15.9	8.6	19.4	58.5	14.6	21.1	19.6	15.1	14.2	12.2	10.7	12.1	11.3	7.5	16.4	8.7	13.8	28.6	13.9	8.6	8.7	16.8	15.3	7.3	12.9	17.1	10.7	12.1	6.9	8.2	7.2	14.9	11.5	13.7	6.4	8.5	9.9	24.3	13.1	17.4	12.2	15.3	9.0	14.2	14.1	14.5	4.1	9.5	15.4	7.4	16.5	10.2	3.3	6.1	6.4	10.9	3.0	5.5	3.6	8.3	5.0	7.3	11.3	13.1	18.5	5.9	13.3	10.6	10.0	11.7	5.5	7.5	8.6	9.1	9.7	11.6	6.6	5.8	11.1	14.8	13.2	5.5	4.5	7.2	4.2	8.7	3.0	6.1	12.1	9.4	12.5	11.4	9.4	9.8	7.2	2.8	11.3	15.1	3.6	7.7	5.0	5.1	5.3	6.4	6.6	13.3	9.3	11.2	15.9	6.0	4.8	8.6	6.0	14.3	6.1	7.8	6.0	17.2	17.3	9.0	15.8	11.8	9.0	6.5	6.9	10.1	8.4	6.9	2.5	6.1	6.4	3.8	9.4	5.5	3.3	4.0	2.8	6.1	1.9	4.6	3.7	6.4	3.0	10.9	1.6	4.4	3.6	15.9	19.4	21.1	19.6	13.9	8.6	12.9	17.1	14.9	14.5	20.8	9.9	10.7	13.5	23.6	14.9	28.2	20.4	13.4	11.4	10.4	19.6	3.5	5.0	10.4	38.8	19.0	31.9	46.7	7.2	6.7	26.4	18.1	12.7	36.5	6.8	4.8	16.0	17.2	16.7	59.6	8.1	16.4	28.7	5.4	24.9	18.7	16.0	17.6	6.3	9.1	26.4	0.0	24.7	6.9	6.1	21.7	4.2	6.9	17.8	26.6
FEN1	"FEN-1, MF1, RAD2"	ENSG00000168496	"Flap structure-specific endonuclease 1"	P39748	11	61792637-61797244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 36.3"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 61.7;Spermatogonia: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002262, HPA006748"	Enhanced		Enhanced	Nucleoplasm,Nucleoli		NA	Yes		38000	Nucleoplasm	Nucleoli	"CAB002262: AB_563729, HPA006748: AB_1848494"	"unprognostic (1.82e-1)"	"unprognostic (2.71e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.45e-2)"	"prognostic unfavorable (3.39e-6)"	"unprognostic (1.50e-2)"	"unprognostic (9.82e-2)"	"prognostic favorable (7.85e-4)"	"unprognostic (2.82e-3)"	"unprognostic (5.86e-2)"	"prognostic unfavorable (5.73e-6)"	"prognostic favorable (9.46e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.49e-3)"	"unprognostic (4.04e-2)"	4.8	9.6	7.9	14.6	8.5	23.9	7.4	16.9	14.9	4.9	11.0	8.5	5.0	8.1	5.0	6.6	13.3	4.2	7.0	4.6	8.6	8.5	4.9	9.3	5.0	22.5	8.3	9.8	3.9	6.3	5.2	7.9	11.2	12.6	4.7	12.0	7.3	9.3	4.6	11.2	6.8	8.2	6.4	7.1	12.3	7.2	16.2	5.9	36.3	3.5	10.6	25.5	6.1	4.2	11.5	18.1	14.5	9.4	13.3	18.0	7.3	31.2	28.8	31.6	17.0	3.1	3.9	20.1	27.7	15.8	33.9	38.6	25.1	23.6	45.1	21.6	11.7	32.0	33.1	44.4	24.2	34.8	23.7	24.5	23.8	39.3	25.6	2.4	37.0	24.7	2.7	3.3	31.3	8.3	5.0	13.2	25.5	36.0	32.7	28.1	39.4	51.6	33.3	34.7	24.6	28.2	35.4	36.6	46.6	13.5	29.6	36.0	29.9	18.5	24.2	15.9	15.5	35.1	26.0	8.8	30.2	38.2	38.4	27.8	25.9	40.2	46.9	21.1	24.8	26.0	14.5	5.0	10.2	12.4	9.4	13.1	11.5	10.0	11.8	5.8	11.5	11.2	11.3	2.1	13.3	8.8	18.1	18.0	7.3	7.9	8.5	16.9	14.9	8.6	8.5	8.3	9.8	12.6	5.9	0.0	2.1	12.6	4.8	9.2	21.1	4.0	5.1	6.7	3.4	0.0	11.8	28.6	6.6	11.6	16.8	2.7	3.1	23.3	10.5	61.7	7.6	4.4	0.0	6.8	21.8	14.3	4.6	1.3	5.1	9.8	5.2	7.1	5.0	19.0	5.3	29.9	9.3	6.0	6.7	4.7	20.5	0.0	4.2	33.0	63.4	5.4	25.9	14.1	13.0	3.7
FGB		ENSG00000171564	"Fibrinogen beta chain"	P02675	4	154562956-154571086	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Blood coagulation, Hemostasis, Immunity, Innate immunity"		"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"liver: 1908.6"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 15347.2"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 2262.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 77.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001900, HPA001901, CAB008624"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA		120000000000	"Endoplasmic reticulum"		"CAB008624: AB_1615610, HPA001900: AB_1078865, HPA001901: AB_1078864"	"unprognostic (1.16e-1)"	"unprognostic (3.89e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.44e-1)"			"unprognostic (2.20e-3)"	"unprognostic (1.42e-2)"			"unprognostic (1.79e-1)"		"prognostic unfavorable (5.72e-5)"	"unprognostic (2.48e-2)"	"unprognostic (7.91e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.1	1908.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	77.7	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	153.8	0.0	0.0	0.0	0.4	257.4	0.0	0.0	3.5	0.0	0.0	1.7	3.0	0.4	0.0	0.0	467.2	3.2	0.1	0.0	0.0	0.0	15347.2	0.3	0.0	1.7	349.9	342.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0
FH	fumarase	ENSG00000091483	"Fumarate hydratase"	P07954	1	241497603-241519761	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Tricarboxylic acid cycle"	Lyase	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 93.4"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 161.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017785, HPA025770, HPA025948, HPA027341"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB017785: , HPA025770: AB_10599603, HPA025948: AB_10602177, HPA027341: AB_10601222"	"unprognostic (1.03e-2)"	"unprognostic (3.82e-2)"	"unprognostic (9.46e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.76e-7)"	"unprognostic (1.05e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.24e-2)"	14.3	28.1	15.7	10.4	20.2	9.3	13.3	15.7	24.4	10.5	22.7	9.9	16.7	23.2	13.7	10.7	17.7	10.3	9.5	59.0	22.9	13.9	35.0	93.4	9.9	13.3	15.2	19.4	9.4	13.9	25.2	11.4	14.3	18.4	12.3	24.4	10.2	18.4	20.6	65.1	13.4	21.4	14.7	14.4	11.1	17.5	14.0	11.7	13.8	12.3	45.2	13.4	13.4	11.2	16.0	26.4	4.5	18.8	10.4	13.9	8.9	29.3	24.6	23.3	21.0	22.9	27.1	37.0	36.4	28.5	41.1	25.8	35.1	18.3	18.6	24.1	27.8	18.0	41.8	35.6	27.0	35.8	21.3	11.5	17.5	26.0	30.0	20.6	40.8	15.9	19.6	16.9	23.0	26.0	14.4	25.2	41.2	53.1	24.1	29.9	14.6	35.1	27.3	24.8	42.8	52.8	29.1	25.5	83.6	39.6	24.9	30.0	26.0	30.6	36.3	23.2	16.8	27.7	27.7	24.8	18.5	23.8	32.6	60.5	21.6	23.1	22.6	20.6	46.9	26.5	4.5	12.8	2.7	9.7	18.8	12.6	16.0	11.4	9.0	26.4	14.1	13.9	12.7	0.7	10.4	15.7	13.2	13.2	8.9	15.7	20.2	15.7	24.4	22.9	13.9	15.2	19.4	18.4	11.7	35.7	27.5	27.0	18.6	17.7	23.0	151.3	33.1	30.8	22.7	22.7	13.7	91.1	66.3	49.6	161.2	17.9	46.4	23.3	39.2	43.6	21.6	16.1	18.5	73.1	45.3	33.4	17.2	11.6	12.6	20.1	22.2	26.8	23.6	29.7	35.6	28.0	29.4	35.1	25.1	58.8	32.6	38.8	21.7	82.8	44.5	16.3	138.9	12.9	60.7	16.3
FHL2	"DRAL, SLIM3"	ENSG00000115641	"Four and a half LIM domains 2"	Q14192	2	105357712-105438513	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 312.0;ovary: 80.7"	"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 732.1;Extravillous trophoblasts: 503.8;Leydig cells: 525.0;Peritubular cells: 986.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"granulocytes: 7.8;T-cells: 4.6"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 79.9;RPTEC TERT1: 73.7"	"Group enriched"	"Detected in many"	4	"amygdala: 34.7;basal ganglia: 20.4;cerebral cortex: 51.8;hippocampal formation: 36.9;olfactory region: 18.3"	"Low region specificity"	"Detected in many"			"HPA005922, HPA006028, CAB008368"	Enhanced		Enhanced	"Actin filaments,Focal adhesion sites"		NA	Yes			"Actin filaments, Focal adhesion sites"		"CAB008368: AB_591383, HPA005922: AB_1078860, HPA006028: AB_1078858"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.42e-2)"	"unprognostic (5.89e-2)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.11e-2)"	"prognostic unfavorable (6.42e-5)"	"unprognostic (2.06e-1)"	"unprognostic (3.49e-1)"	"unprognostic (9.92e-3)"	"unprognostic (4.73e-2)"	8.3	9.8	1.5	5.7	3.6	1.5	8.9	0.8	5.6	16.3	10.5	1.4	5.1	6.0	14.8	12.1	9.2	6.8	16.5	312.0	2.5	0.4	5.5	7.8	2.1	2.7	0.9	3.0	80.7	1.6	0.2	4.1	16.7	1.1	12.8	7.4	18.5	6.2	8.7	9.4	5.6	16.9	11.9	0.8	3.9	12.7	13.4	0.7	3.1	6.6	16.9	5.1	18.1	7.6	1.4	1.3	7.8	0.8	1.5	4.6	2.6	22.5	5.3	3.1	0.1	10.1	12.8	29.6	42.8	11.3	27.5	33.1	9.5	35.3	0.0	3.6	52.1	34.0	7.0	4.6	38.9	31.4	0.9	3.5	15.8	6.5	7.1	40.0	0.0	3.5	26.6	21.4	43.2	28.8	55.2	56.0	2.6	4.1	1.3	79.9	0.8	3.6	0.1	6.5	15.8	16.7	0.0	4.8	0.6	73.7	16.0	0.1	1.0	16.0	7.2	11.1	3.2	9.0	0.5	26.9	20.0	20.3	22.1	34.4	0.4	0.0	0.1	31.9	0.0	20.6	7.8	0.8	1.0	2.2	0.4	1.5	1.1	1.8	3.6	0.7	1.4	1.4	2.9	4.5	1.5	0.3	1.3	4.6	2.6	1.5	3.6	0.8	5.6	2.5	0.4	0.9	3.0	1.1	0.7	8.9	6.1	0.0	732.1	416.1	8.9	221.1	15.3	12.0	54.6	27.9	2.0	150.7	3.3	97.9	3.5	21.5	61.9	0.0	105.2	503.8	71.2	120.1	10.3	9.2	22.4	0.0	55.8	20.9	1.2	4.9	525.0	6.6	21.9	4.6	119.3	1.5	144.0	32.8	986.1	15.3	12.4	213.4	132.8	6.6	21.1	259.6	149.4	5.0	30.8	351.4
FIP1L1	"DKFZp586K0717, FIP1"	ENSG00000145216	"Factor interacting with PAPOLA and CPSF1"	Q6UN15	4	53377643-53460861	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA037475, HPA058202"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037475: AB_10696933, HPA058202: AB_2683636"	"unprognostic (3.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.40e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.87e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.14e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.39e-1)"	25.7	24.4	20.2	27.6	25.8	35.8	24.0	23.0	25.1	24.5	18.0	19.4	16.1	16.0	27.4	17.7	23.4	22.4	16.2	19.7	17.1	16.6	19.7	19.0	20.3	24.5	20.1	26.0	32.2	16.9	26.6	26.6	28.2	20.9	21.7	21.0	16.2	21.5	18.0	33.9	24.5	20.0	23.5	19.4	24.5	20.4	40.2	22.4	42.4	22.7	17.8	29.2	26.6	22.6	26.5	32.7	36.5	24.0	33.7	32.4	21.3	18.3	12.1	22.2	13.3	16.8	17.1	28.4	23.3	29.3	19.0	14.7	17.6	17.1	33.7	18.1	24.8	17.8	11.6	24.1	17.3	24.7	11.7	13.1	26.6	10.0	16.2	26.7	39.5	22.8	19.6	15.8	24.0	24.6	18.4	14.0	20.4	30.6	15.8	14.9	13.5	35.6	18.2	14.6	23.5	11.9	32.0	10.1	14.8	15.4	16.6	17.3	18.7	16.3	18.8	26.7	21.8	10.7	14.7	14.7	19.5	17.0	18.1	27.9	19.8	11.5	42.6	16.9	24.8	34.7	25.8	16.9	36.5	25.7	17.8	29.2	26.5	25.8	25.1	22.6	24.2	28.9	25.4	20.7	33.7	24.0	32.7	32.4	21.3	20.2	25.8	23.0	25.1	17.1	16.6	20.1	26.0	20.9	22.4	23.8	20.1	45.5	37.4	34.5	40.5	13.1	17.8	45.5	27.3	26.2	17.7	52.0	31.5	34.1	7.4	26.3	21.3	0.0	30.6	43.6	38.6	25.4	47.4	18.7	28.6	73.1	35.2	33.2	19.4	8.8	61.9	27.7	30.4	46.9	24.6	45.2	30.3	31.7	50.2	19.6	28.8	38.8	24.7	112.4	78.8	29.7	72.2	41.5	25.5	30.3
FKBP4	"FKBP52, FKBP59"	ENSG00000004478	"FK506 binding protein 4"	Q02790	12	2794953-2805423	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"vagina: 209.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006148, CAB017441, HPA062857"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"CAB017441: AB_10618759, HPA006148: AB_1078875, HPA062857: AB_2684883"	"unprognostic (1.46e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.12e-5)"	"prognostic unfavorable (1.44e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.22e-1)"	16.2	21.6	26.0	13.7	30.7	13.3	40.7	50.4	31.9	19.9	22.6	22.8	36.2	13.1	20.1	30.7	34.2	25.7	16.4	20.4	25.0	32.5	31.6	31.3	15.8	11.7	44.7	23.4	23.9	30.3	30.1	19.5	32.0	39.4	30.2	25.3	11.5	30.1	31.6	33.5	25.3	16.1	26.4	25.2	11.5	25.3	36.0	42.1	15.6	47.1	16.5	18.5	17.4	209.6	13.8	6.0	10.9	13.7	8.4	14.0	9.9	15.3	34.2	9.9	16.6	12.3	7.3	47.5	15.1	5.4	25.0	16.9	34.0	18.8	20.5	4.3	9.7	17.4	21.1	61.5	20.5	30.1	37.5	39.4	22.6	25.1	12.0	9.5	17.6	6.2	6.6	18.8	29.5	29.6	14.9	14.5	20.8	20.7	29.3	10.0	44.1	30.9	16.0	84.3	45.3	24.7	18.6	17.4	12.3	21.0	19.6	14.3	20.5	17.5	47.8	7.6	64.7	64.4	12.0	7.7	12.3	38.7	13.8	38.0	7.3	11.2	30.3	10.9	26.4	12.5	10.9	10.8	5.9	12.5	9.8	14.0	13.3	11.1	11.8	6.0	13.8	11.8	13.7	1.5	8.4	13.7	5.3	10.1	9.9	26.0	30.7	50.4	31.9	25.0	32.5	44.7	23.4	39.4	42.1	6.0	8.6	47.9	182.5	127.9	60.2	11.7	40.8	16.0	12.5	50.6	70.7	148.6	131.0	77.3	90.2	33.8	86.8	0.0	22.4	85.7	62.6	189.3	39.1	41.9	54.7	92.2	101.7	12.3	15.0	26.1	32.2	42.7	87.7	52.3	61.6	41.8	62.2	84.2	36.4	112.7	51.3	84.1	88.6	179.1	92.0	116.1	186.7	20.2	77.5	121.3
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FK506 binding protein 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 277.2"	"Cell type enhanced"	"Detected in many"	7	"Kupffer cells: 325.8;Peritubular cells: 205.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 103.4;ASC TERT1: 64.4;HHSteC: 81.0;HSkMC: 97.8;hTCEpi: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	78.8	20.7	9.5	14.2	15.6	4.9	36.7	2.4	10.9	16.5	29.0	5.1	29.8	2.2	18.6	16.9	29.2	19.4	17.9	26.3	10.6	4.2	44.9	30.7	19.7	55.9	15.7	3.6	27.2	43.7	8.6	33.8	6.0	13.1	18.3	8.2	11.8	30.4	25.1	277.2	20.2	36.7	18.6	18.2	32.3	25.0	14.3	12.4	20.1	24.2	9.8	16.8	22.5	18.4	4.0	30.6	24.9	31.2	11.8	42.3	39.9	5.0	2.2	9.7	14.4	103.4	64.4	0.1	2.7	0.1	1.8	4.1	3.8	0.9	25.0	2.6	0.5	1.5	0.0	5.7	12.1	4.3	9.8	5.5	10.7	1.9	5.3	81.0	6.7	1.1	97.8	49.2	3.1	29.7	1.9	10.5	5.0	11.4	10.2	19.0	3.2	27.9	12.6	2.5	1.1	1.6	12.4	2.5	12.2	8.0	3.0	3.7	2.2	2.2	2.6	0.5	2.2	14.3	7.9	23.2	2.6	2.3	0.3	3.8	4.6	5.3	31.7	0.8	13.2	1.0	13.7	31.2	19.4	20.0	27.0	23.8	3.0	28.2	20.8	30.6	4.0	42.3	30.2	24.9	11.8	12.0	9.2	10.3	39.9	9.5	15.6	2.4	10.9	10.6	4.2	15.7	3.6	13.1	12.4	11.9	9.9	41.7	52.1	15.7	1.7	110.1	79.0	21.4	13.6	5.2	0.0	0.6	19.9	0.5	8.8	66.1	19.7	163.5	6.9	0.9	22.2	38.7	36.0	165.7	28.8	0.0	20.1	130.8	325.8	11.8	149.0	56.5	6.8	91.0	17.5	3.7	3.3	9.3	205.4	16.3	18.2	142.3	28.8	11.6	19.2	18.6	0.3	117.1	19.5	19.5
FLG		ENSG00000143631	Filaggrin	P20930	1	152302175-152325203	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Developmental protein"	"Cancer-related genes, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 21.9;skin 1: 109.7;tongue: 38.6"	"Cell type enriched"	"Detected in some"	13	"Suprabasal keratinocytes: 38.5"	"Cancer enriched"	"Detected in some"	7	"melanoma: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 14.3;NTERA-2: 4.5;TIME: 3.0;U-2 OS: 3.5;U-2197: 3.7;WM-115: 2.8"									"CAB002210, HPA027505, HPA030188, HPA030189"	Enhanced		Enhanced	"Cytoplasmic bodies"		NA	NA		500000	"Cytoplasmic bodies"		"CAB002210: AB_563731, HPA027505: AB_10600107, HPA030188: AB_10601749, HPA030189: AB_10601999"	"unprognostic (3.37e-2)"	"unprognostic (3.76e-1)"	"unprognostic (8.83e-2)"	"unprognostic (2.96e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.98e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.41e-3)"	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.8	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.4	109.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	38.6	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	14.3	0.0	0.0	0.0	1.5	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.1	3.0	1.2	3.5	3.7	2.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.9	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	38.5	0.0	0.0	0.0	0.0
FLII	"FLI, Fli1, FLIL, MGC39265"	ENSG00000177731	"FLII, actin remodeling protein"	Q13045	17	18244836-18258916	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Actin-binding, Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007084, HPA008903, CAB016132"	Approved		Enhanced	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA		1800000	"Nucleoplasm, Centriolar satellite, Cytosol"		"CAB016132: AB_627613, HPA007084: AB_1848638, HPA008903: AB_1848640"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (4.22e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	21.2	16.8	8.6	16.9	12.4	16.6	21.7	11.7	11.4	17.5	18.5	12.8	14.3	14.6	17.3	16.3	25.9	13.7	15.6	28.3	9.3	7.4	19.0	18.8	17.3	13.4	15.0	6.1	15.3	20.0	15.4	13.5	15.8	13.6	17.2	10.7	11.0	21.3	17.0	78.4	14.4	18.9	19.1	11.1	20.0	15.4	15.6	11.9	21.2	15.1	25.4	17.5	21.5	16.3	5.3	16.0	12.9	24.9	5.2	7.2	10.3	58.1	21.0	6.0	9.1	13.8	12.5	9.0	16.2	19.6	18.3	11.4	26.8	13.3	11.4	17.0	18.5	10.6	26.0	8.0	26.9	10.7	9.5	12.5	6.2	15.5	10.6	15.6	6.9	13.2	11.3	16.4	14.9	22.5	11.7	17.6	10.6	5.0	4.6	10.7	17.3	10.2	5.8	6.2	25.7	11.0	10.0	26.8	14.1	13.6	16.5	2.1	3.1	18.8	16.1	8.7	39.0	27.4	5.4	21.7	16.3	16.8	31.3	19.0	4.8	3.5	3.4	15.4	6.7	8.8	4.8	13.6	12.9	7.0	21.4	7.2	5.3	5.8	7.2	16.0	3.6	4.3	4.6	12.0	5.2	24.9	4.7	6.6	10.3	8.6	12.4	11.7	11.4	9.3	7.4	15.0	6.1	13.6	11.9	56.6	34.6	18.1	20.3	20.1	16.0	33.1	25.5	45.5	44.3	24.4	17.7	22.0	13.3	53.5	34.8	28.6	52.0	0.0	48.6	24.9	20.8	27.1	45.1	16.9	44.4	25.4	23.0	27.0	42.1	5.3	30.0	48.8	15.1	55.1	23.3	10.6	95.0	43.3	32.9	17.6	11.3	32.3	21.1	39.6	18.8	17.1	21.3	28.0	32.6	31.1
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 470.6;Sertoli cells: 413.9;Smooth muscle cells: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.1	67.8	23.9	30.8	20.9	27.7	39.3	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.5	90.7	94.6	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.6	15.2	38.5	28.6	31.7	26.4	12.4	79.8	31.9	52.5	39.8	9.2	6.8	52.3	38.3	20.0	13.6	9.9	25.2	9.1	45.1	13.7	21.7	6.7	20.8	18.1	5.3	12.1	48.8	7.9	39.3	19.2	7.6	9.0	95.2	61.2	59.0	61.9	107.5	32.8	19.2	15.2	56.8	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9	53.6	43.8	55.7	72.4	110.4	2.7	24.1	43.3	4.0	20.5	33.2	0.0	18.9	1.7	255.8	1.7	80.7	1.4	0.0	117.7	74.6	126.9	16.4	25.4	2.1	124.7	11.1	1.7	85.3	148.7	6.8	113.4	134.1	84.4	135.3	1.3	35.9	247.2	0.8	470.6	0.9	2.8	413.9	354.2	2.3	8.3	64.4	16.7	76.7	3.1	31.4
FLYWCH1	DKFZp761A132	ENSG00000059122	"FLYWCH-type zinc finger 1"	Q4VC44	16	2911937-2951208	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040753, HPA041001"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA040753: AB_10794880, HPA041001: AB_10794259"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-3)"	"unprognostic (7.91e-2)"	15.6	16.6	13.1	12.6	17.2	12.5	10.2	24.4	27.4	13.6	12.2	17.7	9.5	14.7	14.3	13.4	11.8	11.9	15.0	16.7	12.1	15.9	10.1	5.9	10.7	11.6	15.8	18.5	21.4	12.2	22.6	12.2	9.5	18.8	13.9	4.7	25.3	14.4	15.6	28.1	22.8	14.4	14.1	16.2	19.9	11.0	5.1	10.9	8.5	11.5	8.4	10.3	17.1	15.7	4.6	1.6	2.3	1.6	0.9	5.5	2.1	5.1	18.1	4.1	12.3	6.7	6.9	12.6	9.5	7.5	4.8	4.9	3.0	16.7	12.5	25.4	7.2	7.9	10.7	3.4	6.4	1.0	20.8	10.3	4.2	15.2	10.0	15.1	5.5	14.6	6.1	20.2	10.1	7.4	8.9	6.8	8.4	9.3	13.3	3.7	12.2	12.6	6.7	6.7	3.8	12.4	22.2	6.2	22.4	5.6	3.5	8.9	8.3	10.0	10.9	12.7	2.4	8.5	10.1	12.7	8.1	7.4	15.6	6.3	19.7	16.9	11.2	8.8	9.1	9.4	2.3	1.6	0.6	3.0	0.7	4.9	2.0	4.5	5.5	1.6	4.6	3.9	3.4	0.2	0.9	0.8	1.0	2.2	2.1	13.1	17.2	24.4	27.4	12.1	15.9	15.8	18.5	18.8	10.9	0.0	3.4	2.2	9.5	11.0	41.7	10.2	10.2	4.0	2.3	21.0	33.4	15.4	1.7	6.0	0.4	11.3	5.9	0.0	5.7	6.9	10.4	4.2	0.0	5.5	7.4	31.8	2.4	11.1	13.3	0.9	10.3	5.3	8.5	9.0	4.4	16.6	5.4	3.5	13.4	4.8	36.2	0.0	15.1	0.7	3.2	12.2	7.3	7.2	6.2	5.9
FMR1	"FMRP, FRAXA, MGC87458, POF, POF1"	ENSG00000102081	"Fragile X mental retardation 1"	Q06787	X	147911951-147951125	"Disease related genes, Predicted intracellular proteins"	"DNA damage, Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Neurogenesis, RNA-mediated gene silencing, Translation regulation, Transport"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012444, HPA050118, HPA056084"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB012444: AB_732400, HPA050118: AB_2681023, HPA056084: AB_2683033"	"unprognostic (4.11e-1)"	"unprognostic (1.25e-3)"	"unprognostic (1.89e-3)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.15e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.98e-2)"	14.9	13.3	24.8	14.9	21.1	28.3	14.3	32.6	25.7	16.0	14.5	17.7	14.4	13.3	21.2	33.2	13.9	18.3	12.3	15.0	22.2	19.0	26.5	30.3	15.3	15.7	23.3	22.8	23.4	11.5	27.8	20.5	49.9	18.9	15.4	15.0	14.0	12.7	19.6	7.8	17.7	15.9	18.3	23.1	20.1	13.2	14.5	19.2	21.7	29.0	9.8	16.1	17.1	27.3	5.3	3.4	7.3	3.5	4.9	7.4	2.4	15.0	13.5	14.1	9.5	8.7	7.0	11.3	8.2	8.6	13.1	23.8	14.9	14.3	30.1	33.9	10.1	15.3	26.1	22.5	10.1	14.7	11.8	15.7	8.5	25.2	13.9	9.0	9.3	5.3	7.6	5.8	11.1	10.4	8.0	10.9	8.3	5.2	20.0	11.7	19.6	10.5	6.9	6.3	10.5	7.7	11.8	40.5	12.7	15.3	40.5	12.5	8.1	9.4	8.6	12.1	20.4	7.6	8.5	10.4	10.7	9.2	13.1	20.4	21.5	21.4	32.4	9.7	16.1	5.6	2.8	2.7	6.6	6.0	3.5	7.4	4.7	3.9	6.6	3.4	5.3	5.0	5.8	7.3	4.9	3.2	2.8	4.7	2.4	24.8	21.1	32.6	25.7	22.2	19.0	23.3	22.8	18.9	19.2	53.6	28.2	11.2	14.2	27.8	32.9	34.1	10.2	22.7	25.0	21.0	11.8	29.8	16.6	12.9	0.8	23.7	20.0	0.0	8.5	37.5	23.5	17.7	19.6	32.7	13.8	66.7	14.3	16.5	24.3	2.3	27.9	14.5	33.7	6.4	14.6	37.0	11.3	18.1	28.0	32.1	28.8	6.5	25.5	8.4	16.8	28.2	34.1	16.0	14.2	22.9
FNBP4	KIAA1014	ENSG00000109920	"Formin binding protein 4"	Q8N3X1	11	47716517-47767443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039485, HPA040029"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA039485: AB_2676536, HPA040029: AB_2676808"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.58e-3)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.60e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (6.35e-4)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (3.54e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (7.23e-5)"	21.7	19.0	14.0	33.0	16.7	31.9	25.3	33.8	18.4	29.6	21.1	19.7	21.5	17.2	32.2	23.8	20.2	21.5	19.3	15.7	12.6	9.8	16.1	17.7	22.5	26.8	18.0	14.6	31.1	23.4	21.8	25.9	20.2	18.3	21.8	17.4	20.7	21.9	28.2	29.4	28.0	24.5	21.8	19.6	30.7	18.3	10.9	18.4	29.6	26.6	16.7	31.5	26.0	23.2	9.0	9.1	5.4	3.7	2.8	6.6	1.4	7.8	6.2	13.2	9.3	7.7	9.1	9.3	9.3	9.4	8.4	9.8	6.1	10.3	17.1	4.7	10.2	7.0	16.5	11.7	7.4	12.4	14.5	22.1	13.4	18.8	10.3	10.8	13.9	12.7	10.9	12.3	7.3	16.7	12.2	9.7	10.9	14.3	14.5	8.0	6.9	22.2	16.6	12.4	6.7	6.8	15.9	13.0	9.9	8.2	9.4	5.9	10.3	13.8	11.5	7.3	10.4	9.3	6.6	11.6	9.9	11.0	14.2	12.8	14.8	10.4	19.4	7.4	9.0	6.8	5.1	3.7	5.4	6.6	2.5	5.1	7.6	4.6	4.6	2.2	9.0	4.8	5.1	3.5	2.8	3.5	9.1	6.2	1.4	14.0	16.7	33.8	18.4	12.6	9.8	18.0	14.6	18.3	18.4	47.6	67.9	57.0	102.1	63.0	93.6	30.8	25.5	48.2	70.5	24.4	102.1	39.8	5.0	31.6	4.3	46.6	34.9	0.0	32.9	33.2	52.1	94.9	55.5	24.1	25.2	63.5	35.1	49.7	27.9	3.9	82.8	50.8	37.1	45.9	30.4	40.9	40.0	32.5	58.4	7.8	107.9	45.3	38.2	37.4	27.7	61.1	69.3	66.6	34.2	123.1
FOSL2	"FLJ23306, FRA2"	ENSG00000075426	"FOS like 2, AP-1 transcription factor subunit"	P15408	2	28392448-28417312	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Smooth muscle cells: 255.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 23.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA004817, CAB013460, HPA061417"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013460: , HPA004817: AB_1849014, HPA061417: AB_2684509"	"unprognostic (1.21e-1)"	"unprognostic (3.60e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.41e-2)"	"unprognostic (7.24e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.73e-3)"	"unprognostic (1.40e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.79e-2)"	62.8	66.9	7.3	24.6	11.2	74.5	22.5	5.4	11.9	34.4	35.4	7.0	15.0	11.4	43.8	16.3	49.6	26.6	42.0	30.3	12.0	4.7	17.2	12.6	32.2	4.4	10.2	3.6	62.0	14.1	4.1	14.2	20.8	15.9	36.4	15.9	11.4	16.2	22.1	56.3	31.1	37.2	40.8	20.0	20.4	25.4	13.8	8.0	2.1	13.6	16.2	14.5	47.1	79.7	0.0	2.5	23.0	6.2	2.7	5.1	2.8	12.5	8.6	0.5	6.7	7.1	12.6	18.2	10.8	11.0	17.3	15.1	10.2	10.0	0.0	15.9	13.8	17.6	12.1	0.7	14.2	15.6	2.9	0.9	1.3	16.1	1.7	11.2	2.2	5.5	20.0	36.4	20.2	17.9	14.6	9.0	0.4	0.1	3.6	11.5	2.0	0.2	6.8	1.0	12.8	4.3	0.5	16.8	1.2	27.7	43.6	4.6	0.6	17.5	10.3	3.1	5.2	1.1	10.1	26.9	36.4	24.6	21.1	15.6	5.6	2.0	0.0	24.1	12.3	6.2	8.8	6.2	5.4	5.1	4.7	5.0	0.0	1.1	2.5	2.5	0.0	0.3	1.7	23.0	2.7	3.8	0.8	0.7	2.8	7.3	11.2	5.4	11.9	12.0	4.7	10.2	3.6	15.9	8.0	29.8	69.6	2.4	72.6	127.2	0.5	23.8	50.9	13.4	25.0	158.7	0.0	19.1	16.6	56.4	1.1	60.9	113.3	0.0	51.5	108.4	60.6	59.1	105.2	12.4	34.3	0.0	26.9	49.7	65.1	2.2	20.8	81.0	81.0	38.7	56.3	0.5	55.4	66.6	23.0	25.4	1.0	25.8	255.1	1.7	2.5	131.7	42.0	34.6	44.8	118.3
FOXL2NB	"C3orf72, FLJ43329"	ENSG00000206262	"FOXL2 neighbor"	Q6ZUU3	3	138947234-138953451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 51.6;parathyroid gland: 25.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;fHDF/TERT166: 10.7;HEL: 10.6;hTCEpi: 5.0;SiHa: 8.3"									"HPA061017, HPA071790"			Enhanced	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA061017: AB_2684415, HPA071790: AB_2686447"	"unprognostic (3.32e-1)"	"unprognostic (1.13e-1)"		"unprognostic (3.86e-2)"	"unprognostic (4.07e-2)"	"unprognostic (4.40e-5)"		"unprognostic (3.30e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-10)"	"unprognostic (2.07e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.22e-2)"	0.1	1.0	0.6	0.1	1.4	0.2	0.1	0.2	0.9	15.3	0.1	0.5	0.1	0.0	12.6	0.9	0.2	7.3	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.5	0.4	51.6	0.4	25.0	9.4	3.2	1.0	0.1	0.0	1.3	0.1	0.5	0.1	0.3	0.1	2.5	0.3	0.1	0.0	0.4	0.3	0.1	0.4	0.3	0.1	0.4	2.3	0.6	0.5	2.8	0.4	0.7	0.4	0.0	2.1	1.4	0.7	5.5	0.3	0.1	2.3	0.1	0.0	0.2	0.0	0.3	0.4	0.2	1.1	10.7	0.1	0.5	0.2	0.1	0.2	0.1	0.3	10.6	3.3	0.1	0.0	0.1	0.4	0.2	5.0	0.2	0.1	0.6	0.0	0.3	4.0	0.3	2.6	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.0	0.0	0.5	1.5	0.2	0.2	8.3	0.2	0.0	1.0	0.2	3.1	0.2	0.4	0.3	0.3	0.1	0.4	0.2	0.1	0.3	0.3	0.1	1.3	0.4	0.3	0.4	0.3	0.2	0.4	0.3	0.3	0.2	0.6	0.4	0.3	2.8	0.7	0.2	0.5	0.4	0.0	0.6	1.4	0.2	0.9	0.3	0.2	0.5	0.4	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 15.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	29.6	7.7	11.5	12.2	12.6	36.7	35.4	28.0	18.1	19.9	16.1	12.6	9.8	7.8	17.4	16.1	22.3	16.5	18.0	12.9	9.7	7.7	10.7	14.0	21.1	16.8	12.4	14.0	28.8	52.3	14.3	8.8	13.1	10.3	13.8	11.0	14.3	21.2	10.5	54.7	20.3	11.3	13.9	7.9	14.2	14.8	13.1	13.2	11.6	13.1	12.7	10.2	17.1	20.3	1.8	2.7	15.7	4.6	3.4	4.0	1.0	9.1	3.3	6.0	9.7	18.6	22.3	7.5	7.6	8.0	6.7	9.2	5.9	8.3	5.9	6.5	8.9	9.8	6.7	6.2	9.3	10.0	5.3	9.0	14.7	2.9	4.4	21.7	3.5	10.8	25.4	18.8	13.7	18.8	9.3	5.0	5.4	9.8	40.1	12.1	5.2	4.9	5.4	3.9	4.4	5.0	5.7	17.1	19.7	13.3	7.0	10.6	27.6	6.5	5.3	7.6	11.0	5.8	11.7	8.0	11.4	6.4	7.0	9.8	0.7	6.9	5.6	6.2	7.1	7.8	6.7	2.9	5.7	3.6	1.5	4.0	1.0	1.9	3.0	1.7	1.8	1.7	2.3	15.7	3.4	4.6	2.7	1.8	1.0	11.5	12.6	28.0	18.1	9.7	7.7	12.4	14.0	10.3	13.2	41.7	39.5	22.4	61.6	60.1	55.0	28.2	73.9	44.2	46.6	24.4	66.8	19.2	14.9	43.0	12.5	63.2	36.2	210.2	26.5	31.0	67.9	115.8	15.0	60.6	39.1	49.3	64.2	66.9	66.3	12.1	98.7	35.8	54.0	43.3	49.3	89.6	53.0	33.6	94.4	15.9	67.1	32.3	89.8	7.2	18.1	40.7	34.4	35.5	29.9	108.9
FOXP1	"12CC4, hFKH1B, HSPC215, QRF1"	ENSG00000114861	"Forkhead box P1"	Q9H334	3	70952817-71583993	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 40.2"									"HPA003876, CAB011501"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011501: AB_732428, HPA003876: AB_1078907"	"unprognostic (2.31e-1)"	"unprognostic (4.35e-3)"	"unprognostic (2.09e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.38e-3)"	"unprognostic (3.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.05e-2)"	24.6	5.1	7.0	30.2	19.2	32.7	21.9	7.2	13.1	16.3	29.3	8.7	10.3	10.1	19.8	9.9	19.6	13.1	19.3	15.5	8.4	5.9	7.6	12.9	26.1	34.0	7.6	10.2	30.3	14.7	7.2	25.7	11.4	7.4	21.6	21.6	11.3	24.6	11.2	12.7	12.2	16.7	34.3	7.9	18.6	20.4	11.7	10.1	38.1	19.8	13.1	27.0	28.5	31.8	29.9	8.4	14.4	9.9	9.2	29.6	11.2	3.8	2.9	7.1	4.8	3.3	9.6	3.4	11.4	13.1	10.0	7.3	21.3	4.5	10.3	1.7	5.1	7.2	2.6	13.1	9.8	16.9	3.1	5.4	5.3	7.1	20.0	8.3	9.9	13.1	9.8	4.0	40.2	17.8	7.0	14.9	6.1	5.3	15.1	4.5	16.8	4.9	3.9	8.7	2.7	18.6	14.9	12.3	1.8	8.2	12.1	6.0	10.9	11.9	3.3	0.7	7.1	2.3	7.3	18.8	13.9	6.0	19.3	15.7	3.8	2.8	14.6	8.8	12.7	2.9	14.4	5.7	6.0	8.3	5.7	9.3	25.8	18.3	10.3	5.3	29.9	29.6	18.9	8.3	9.2	9.9	8.4	15.9	11.2	7.0	19.2	7.2	13.1	8.4	5.9	7.6	10.2	7.4	10.1	68.5	106.7	181.2	154.9	162.6	27.9	38.3	114.7	87.0	93.3	31.4	17.7	37.3	26.6	65.8	141.2	159.5	75.9	70.0	81.8	13.6	54.0	219.0	213.7	53.9	43.0	6.4	260.7	120.9	97.8	57.5	38.9	86.3	35.4	111.0	226.3	20.3	98.8	101.7	23.3	15.6	38.0	90.5	74.6	10.8	6.4	88.7	43.8	126.3	146.7	116.8
FOXP2	"CAGH44, SPCH1, TNRC10"	ENSG00000128573	"Forkhead box P2"	O15409	7	114086327-114693772	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 48.4;urinary bladder: 31.5"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 27.2;Muller glia cells: 42.1;Suprabasal keratinocytes: 22.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 15.0;RH-30: 27.6;THP-1: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000382, HPA000383, HPA001679"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000382: AB_1078908, HPA000383: AB_1078909, HPA001679: AB_2666415"	"unprognostic (1.21e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.83e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.69e-4)"	"unprognostic (2.04e-2)"	"unprognostic (6.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.04e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.84e-1)"	"unprognostic (9.81e-2)"	"unprognostic (4.19e-2)"	1.7	1.5	0.9	9.4	2.9	0.0	2.0	0.6	2.8	9.4	20.4	0.7	3.6	2.7	18.1	2.1	12.4	3.5	7.7	1.2	0.7	2.9	1.5	2.9	1.4	0.6	2.0	1.0	11.1	4.5	0.0	0.9	0.7	1.8	13.3	5.7	1.4	2.8	1.5	4.6	3.3	4.2	48.4	0.9	0.6	4.6	0.9	0.9	0.6	5.3	3.2	1.2	31.5	5.4	9.4	16.5	11.1	7.2	6.3	10.3	16.3	0.2	2.2	15.0	0.0	3.5	4.7	0.9	2.4	2.6	0.5	0.3	1.0	0.2	0.2	0.6	0.8	0.1	0.3	0.6	0.0	0.1	0.1	5.1	5.6	3.4	4.6	0.0	0.3	0.3	1.2	0.6	0.0	0.0	0.9	0.6	0.0	1.2	2.1	0.5	1.1	1.2	0.8	0.8	0.2	0.7	0.4	27.6	5.3	0.3	6.0	3.9	1.6	0.0	0.9	0.7	1.0	0.7	8.2	1.1	1.0	0.4	1.4	0.4	5.4	0.4	0.6	1.1	0.5	0.4	7.5	5.2	11.1	6.2	7.2	6.3	9.4	7.0	6.8	6.8	7.3	7.2	8.1	5.6	6.3	5.9	16.5	10.3	16.3	0.9	2.9	0.6	2.7	0.7	2.9	2.0	1.0	1.8	0.9	0.0	5.1	0.0	1.7	27.2	0.0	1.4	7.6	12.0	7.9	3.5	2.0	0.1	0.0	0.0	8.1	2.2	4.3	0.0	4.8	0.0	7.2	3.1	0.0	10.6	0.2	12.7	4.1	9.8	1.9	4.5	4.9	0.7	3.3	0.0	11.9	42.1	2.0	16.1	0.7	2.2	1.0	0.0	1.0	0.1	0.2	22.3	0.2	0.0	12.1	2.4
FTSJ3	SPB1	ENSG00000108592	"FtsJ RNA methyltransferase homolog 3"	Q8IY81	17	63819433-63830012	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055544, HPA062628"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA055544: AB_2682843, HPA062628: AB_2684813"	"unprognostic (1.33e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.60e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (1.27e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-1)"	"unprognostic (3.43e-1)"	20.1	19.9	14.2	15.8	18.2	12.5	16.4	13.6	15.2	17.5	17.4	22.4	25.0	12.9	22.7	19.4	17.6	17.3	16.8	19.2	14.8	9.2	24.4	24.9	13.9	17.5	18.9	9.5	22.3	14.6	30.6	13.3	15.4	16.2	19.3	17.1	17.4	16.5	18.1	25.1	21.2	16.2	21.5	17.7	19.8	16.5	13.0	17.8	31.1	22.4	19.7	26.0	18.0	16.8	9.8	13.3	6.5	12.8	12.3	15.1	9.0	20.6	32.6	12.6	17.9	20.4	17.6	19.6	20.7	15.2	23.7	18.9	27.1	13.9	27.6	8.5	12.1	12.5	14.3	23.5	19.7	30.6	4.7	23.5	24.8	23.2	25.2	14.9	31.3	18.1	12.4	15.6	36.8	17.8	12.1	19.7	17.0	24.6	11.3	15.8	34.8	27.5	10.2	34.0	23.3	33.3	24.6	34.7	19.4	15.5	18.9	11.7	45.9	24.4	20.8	14.1	26.3	19.8	10.5	17.7	17.7	24.9	19.7	38.2	27.4	38.5	27.5	15.8	20.9	17.1	4.5	10.8	6.5	11.4	12.8	15.1	9.8	12.2	14.9	13.3	9.8	9.8	12.0	2.4	12.3	9.2	10.1	14.2	9.0	14.2	18.2	13.6	15.2	14.8	9.2	18.9	9.5	16.2	17.8	29.8	23.8	10.4	12.4	12.2	6.9	26.9	20.4	29.4	30.7	14.0	9.8	13.8	11.6	21.2	6.1	18.5	13.1	0.0	29.2	13.7	11.6	9.0	24.2	17.1	12.5	3.2	12.2	9.2	15.2	11.9	22.5	14.0	8.5	20.8	11.2	13.8	23.1	13.6	18.0	21.6	8.6	45.3	17.9	10.4	12.8	11.2	13.6	10.0	16.4	9.1
FUBP1	"FBP, FUBP"	ENSG00000162613	"Far upstream element binding protein 1"	Q96AE4	1	77944055-77979110	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006149	Supported		Enhanced	Nucleoplasm		NA	NA		200000	Nucleoplasm		"HPA006149: AB_1849172"	"unprognostic (4.17e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.65e-2)"	"prognostic unfavorable (9.83e-9)"	"unprognostic (2.32e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-3)"	"unprognostic (9.80e-3)"	"unprognostic (9.02e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.46e-2)"	23.9	35.5	21.8	42.4	26.9	56.8	27.0	34.0	31.8	24.3	19.6	18.1	23.0	21.8	29.4	35.0	23.5	25.2	18.4	27.5	22.0	22.3	26.6	16.3	27.2	37.6	17.5	28.8	44.4	31.6	36.0	41.5	27.3	26.3	22.4	28.3	22.0	28.2	35.6	27.4	21.3	24.0	22.7	31.3	28.6	22.6	17.6	19.9	64.9	35.0	26.2	40.3	24.0	29.1	16.1	11.3	10.8	16.1	23.5	22.2	12.8	22.3	19.7	46.6	18.5	7.2	9.1	38.2	23.1	13.8	22.2	16.2	19.9	25.0	40.0	10.8	17.1	26.3	22.3	31.2	25.4	29.7	44.0	15.9	25.6	32.7	29.2	15.7	43.8	10.8	11.9	21.0	23.7	18.9	18.2	17.7	27.0	29.3	17.8	17.5	22.5	34.7	21.2	36.4	22.0	14.1	42.7	36.9	15.3	23.0	22.0	24.6	23.2	21.5	20.4	18.2	26.0	24.8	15.9	22.7	21.5	31.3	6.1	27.6	17.1	18.4	51.9	9.3	19.3	21.9	3.8	9.6	10.8	18.7	15.7	22.2	16.1	18.3	19.4	8.7	13.1	17.9	20.9	4.0	23.5	16.1	11.3	21.3	12.8	21.8	26.9	34.0	31.8	22.0	22.3	17.5	28.8	26.3	19.9	68.5	47.3	43.1	67.8	75.3	41.1	65.5	30.6	96.4	89.9	31.4	39.3	42.2	36.5	50.0	27.8	42.8	20.6	0.0	62.7	54.9	40.0	39.3	75.2	20.7	29.1	17.5	52.9	33.7	27.2	15.1	44.5	34.8	37.1	55.9	32.7	36.4	54.2	30.6	28.3	19.7	37.0	32.3	42.4	33.8	40.6	55.2	29.9	54.8	35.4	54.0
FUS	"ALS6, FUS1, hnRNP-P2, HNRNPP2, TLS"	ENSG00000089280	"FUS RNA binding protein"	P35637	16	31180110-31194871	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008784, CAB033036, CAB058691"	Supported		Enhanced	Nucleoplasm		NA	NA		190000	Nucleoplasm		"CAB033036: AB_2105208, CAB058691: AB_2665583, HPA008784: AB_1849181"	"unprognostic (3.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.86e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.12e-3)"	"unprognostic (1.87e-1)"	"unprognostic (5.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	44.0	24.2	35.0	47.1	43.3	41.7	29.9	64.1	59.0	39.7	32.4	48.6	22.6	28.0	54.5	44.7	29.6	48.6	35.9	32.0	32.7	34.6	30.3	24.4	27.7	51.3	31.1	39.0	66.7	28.8	41.7	24.8	44.1	39.2	29.1	30.2	39.3	27.6	30.5	43.6	24.3	28.7	46.5	33.7	36.2	27.7	40.7	30.7	66.3	29.1	40.1	49.6	30.3	31.4	16.4	22.3	24.2	29.0	14.2	24.8	9.4	48.3	42.0	55.3	35.9	13.6	11.6	58.9	65.2	23.7	29.8	22.8	56.6	32.6	74.6	46.5	32.9	36.9	21.1	55.1	42.2	28.5	44.3	35.8	63.0	31.7	57.0	22.8	67.0	43.4	23.5	11.6	43.0	29.2	14.3	28.4	44.4	66.8	25.4	37.0	59.2	48.6	59.3	84.2	29.4	46.1	79.9	73.7	42.7	33.3	35.5	36.1	64.8	42.8	30.2	32.3	36.7	36.4	74.6	35.2	47.8	48.0	31.5	68.8	23.6	45.2	105.0	26.7	45.6	57.7	5.6	17.5	24.2	24.8	29.0	24.0	12.8	17.4	21.8	19.3	16.4	20.3	21.1	14.9	14.2	25.1	22.3	13.9	9.4	35.0	43.3	64.1	59.0	32.7	34.6	31.1	39.0	39.2	30.7	95.3	108.8	163.2	313.8	128.6	263.0	87.0	94.3	111.1	129.7	99.5	123.7	234.5	58.0	142.1	94.6	197.5	188.3	46.7	133.2	323.0	212.4	178.2	227.1	52.9	180.4	190.7	203.5	174.3	132.4	22.8	284.5	176.9	156.9	172.3	132.7	214.0	132.4	175.4	202.6	57.5	247.1	161.7	222.6	158.2	225.3	134.9	246.8	262.6	169.5	255.7
FXR1		ENSG00000114416	"FMR1 autosomal homolog 1"	P51114	3	180868141-180982753	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Myogenesis"	"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 215.4"	"Group enriched"	"Detected in all"	4	"Early spermatids: 827.9;Late spermatids: 1326.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018246, HPA055475"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018246: AB_1849204, HPA055475: AB_2682828"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (5.96e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.90e-3)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (7.77e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.84e-2)"	12.4	13.8	13.0	7.6	16.1	13.7	11.7	14.8	15.0	11.5	14.3	10.5	11.4	7.5	14.7	10.1	13.4	11.7	8.9	36.1	13.7	14.3	10.1	11.3	8.5	9.4	19.4	9.6	16.9	11.4	11.4	17.3	12.7	18.1	13.1	7.4	6.5	10.2	11.8	215.4	7.7	7.9	12.3	23.4	9.1	10.5	39.1	19.4	17.2	16.2	22.7	10.0	15.6	28.8	13.8	14.9	11.4	14.0	11.0	21.8	9.4	36.1	16.8	36.4	28.2	28.0	32.0	16.5	28.8	29.5	32.4	32.1	24.7	18.3	18.5	47.6	19.8	51.2	17.5	29.3	17.6	45.4	24.4	19.7	18.8	22.2	28.2	29.9	11.6	15.5	33.7	20.2	16.3	39.1	48.6	32.6	18.2	15.0	22.5	40.7	13.0	22.1	19.6	41.0	22.4	18.5	15.4	46.5	19.7	24.9	11.3	15.4	19.7	24.9	29.0	37.2	53.4	40.3	22.4	25.9	24.4	27.3	15.2	56.5	21.0	26.3	22.0	25.5	16.8	31.1	8.9	12.9	10.0	12.9	14.0	13.6	13.8	13.8	11.7	14.9	9.5	17.6	14.4	11.4	11.0	10.2	10.5	21.8	9.4	13.0	16.1	14.8	15.0	13.7	14.3	19.4	9.6	18.1	19.4	59.6	64.8	54.7	82.6	69.6	69.6	196.5	38.2	131.2	89.9	33.2	53.0	80.5	49.7	73.6	827.9	71.9	29.3	93.5	65.6	84.4	66.3	54.2	121.5	58.7	58.6	82.6	51.6	52.2	63.0	1326.2	77.9	61.8	47.2	139.7	33.0	89.6	70.5	35.1	71.5	67.7	82.8	32.3	61.4	245.3	103.5	61.7	51.1	57.5	38.5	60.3
FYCO1	"FLJ13335, ZFYVE7"	ENSG00000163820	"FYVE and coiled-coil domain containing 1"	Q9BQS8	3	45917899-45995824	"Disease related genes, Predicted intracellular proteins"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 105.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 78.1;Rod photoreceptor cells: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035526, HPA057966"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035526: AB_10672867, HPA057966: AB_2683567"	"unprognostic (2.45e-1)"	"unprognostic (6.62e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.14e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.85e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.98e-1)"	"prognostic favorable (3.33e-11)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.99e-2)"	11.6	7.8	4.1	11.4	4.7	3.1	11.6	1.4	3.5	13.5	20.2	7.3	11.4	4.2	19.8	11.1	12.6	7.9	22.0	29.1	4.2	2.7	5.7	6.2	7.9	5.0	4.7	3.5	14.8	15.9	11.4	4.9	4.3	6.1	14.5	5.6	16.2	9.5	11.6	105.8	9.9	7.7	39.9	6.4	6.4	11.6	5.0	5.3	8.5	10.4	25.5	9.5	23.3	27.0	0.6	2.8	1.1	1.1	3.0	6.0	1.3	6.4	6.3	1.8	8.1	17.9	14.1	3.1	6.2	14.7	8.4	9.3	3.4	5.7	4.8	3.6	8.8	8.0	4.9	5.3	10.5	9.9	2.0	5.6	6.8	5.2	3.8	12.2	5.2	5.0	15.6	10.5	13.2	13.1	12.8	16.5	8.3	4.4	7.0	5.9	4.0	5.3	3.2	2.8	5.3	6.0	1.8	5.2	2.6	10.0	22.8	1.4	2.1	3.9	12.4	10.9	2.9	6.0	3.5	12.7	3.1	3.7	10.7	3.4	4.0	2.5	1.6	10.9	6.7	5.9	1.1	1.0	0.6	4.4	1.1	6.0	0.6	2.6	4.6	0.4	0.6	1.1	1.8	0.9	3.0	0.7	2.8	2.6	1.3	4.1	4.7	1.4	3.5	4.2	2.7	4.7	3.5	6.1	5.3	26.8	10.7	3.0	4.1	3.7	10.8	78.1	7.6	14.7	11.4	15.7	33.4	3.6	3.3	6.9	0.0	7.5	6.3	0.0	7.1	2.0	6.1	11.8	2.3	9.5	3.6	0.0	9.2	12.3	5.9	0.4	11.8	3.2	10.1	0.0	7.9	16.2	9.8	0.0	16.6	4.4	38.5	6.5	9.8	2.6	0.7	3.6	2.4	6.9	5.7	5.2
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Proximal tubular cells: 145.7;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"NK-cells: 15.3;T-cells: 43.2"	"Cell line enhanced"	"Detected in many"		"U-2197: 105.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		2000000	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	29.1	7.2	49.2	29.0	38.4	16.3	18.1	33.9	62.1	25.7	12.1	33.7	4.1	10.1	21.8	21.4	10.2	32.0	19.4	21.2	39.4	34.0	9.5	12.2	25.2	57.2	35.7	23.1	18.6	4.4	15.0	12.5	17.7	25.6	9.6	10.0	11.0	6.4	8.4	7.0	16.5	19.0	24.2	30.9	39.8	15.4	10.1	31.3	34.8	27.5	5.6	38.5	22.6	19.3	1.6	1.7	0.7	1.5	15.3	43.2	10.7	1.9	0.3	34.9	5.8	26.7	16.4	0.6	5.5	17.5	4.7	8.5	0.2	0.3	3.9	3.6	10.7	4.1	0.2	4.9	7.6	9.2	0.1	12.8	10.7	2.6	0.5	15.8	3.6	3.7	15.8	11.6	17.7	15.2	12.4	19.2	19.2	0.9	27.3	16.8	0.2	17.1	3.3	5.0	0.6	3.5	5.4	4.7	0.2	0.0	1.7	24.5	9.9	1.0	0.4	23.3	8.1	0.2	10.8	12.2	14.3	2.6	105.3	3.5	3.9	3.5	6.0	26.9	8.4	24.8	0.2	1.5	0.0	34.1	1.2	43.2	1.1	21.2	37.5	1.7	1.6	7.0	18.7	0.7	15.3	0.9	1.0	17.6	10.7	49.2	38.4	33.9	35.3	39.4	34.0	35.7	23.1	25.6	31.3	0.0	11.7	18.8	1.9	15.1	53.9	9.2	12.7	5.3	3.4	7.0	0.0	2.2	14.9	8.1	2.8	56.2	3.5	0.0	0.9	2.1	36.8	1.4	51.8	59.3	2.8	44.5	12.7	71.8	42.5	0.9	24.5	33.6	35.4	3.6	2.4	88.8	6.3	0.0	6.7	145.7	7.8	12.9	23.1	2.6	4.3	11.7	43.5	208.1	1.2	0.9
FZD10	CD350	ENSG00000111432	"Frizzled class receptor 10"	Q9ULW2	12	130162459-130165740	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 26.9;lymphoid tissue: 18.6"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 3.9;Basal keratinocytes: 7.4;Smooth muscle cells: 14.4;Suprabasal keratinocytes: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 8.6;BEWO: 9.9;hTCEpi: 5.7;RPTEC TERT1: 3.0;RT4: 4.8"	"Region enhanced"	"Detected in some"		"thalamus: 7.6"	"Low region specificity"	"Detected in many"			"HPA014484, HPA014485"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA014484: AB_1849132, HPA014485: AB_1849134"	"unprognostic (2.41e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.74e-2)"	"prognostic favorable (5.05e-7)"	"unprognostic (2.81e-2)"	"unprognostic (4.63e-2)"	"unprognostic (8.62e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.66e-9)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.07e-1)"	1.1	0.4	1.0	0.5	1.9	0.2	1.5	5.4	2.1	11.6	0.6	2.1	1.6	0.4	5.1	3.4	26.9	2.2	7.1	0.5	1.0	1.0	0.4	0.2	2.0	0.9	1.6	1.2	3.4	1.1	0.2	1.4	9.2	1.9	3.7	0.6	3.0	5.4	3.1	1.2	10.2	0.7	0.9	1.2	0.3	1.0	0.7	2.0	0.6	1.7	9.0	18.6	5.1	7.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	8.6	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	1.5	0.7	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	3.0	4.8	0.1	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	1.9	5.4	2.1	1.0	1.0	1.6	1.2	1.9	2.0	0.0	0.3	0.0	3.9	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	1.1	0.0	0.0	0.2	0.3	2.5	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	14.4	0.0	0.4	7.4	0.7	0.0	0.0	1.1
G3BP2	KIAA0660	ENSG00000138757	"G3BP stress granule assembly factor 2"	Q9UN86	4	75642782-75724525	"Predicted intracellular proteins"	"Host-virus interaction, Immunity, Innate immunity, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018304, HPA018425"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA018304: AB_1849350, HPA018425: AB_1849352"	"unprognostic (2.42e-2)"	"unprognostic (5.79e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.23e-1)"	"unprognostic (6.98e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (6.83e-2)"	"unprognostic (3.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (6.65e-5)"	"unprognostic (3.10e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (6.99e-2)"	22.7	24.7	28.2	21.9	48.4	31.6	23.9	52.2	55.6	24.3	28.6	21.5	18.7	24.5	25.1	18.7	24.5	26.9	23.3	23.0	29.3	46.3	32.3	33.7	21.3	24.8	31.3	30.0	20.4	18.8	31.0	27.6	17.7	57.9	37.7	27.3	16.3	22.0	24.2	69.7	15.3	27.8	25.9	35.2	22.9	22.0	27.4	19.6	29.9	35.4	28.1	26.6	26.9	17.9	18.8	20.4	32.5	28.2	31.9	41.4	24.7	27.6	28.8	47.0	38.7	40.6	41.5	15.6	42.6	40.8	27.3	29.1	37.2	38.8	53.2	38.2	34.0	25.1	18.7	48.4	49.7	40.0	31.6	20.0	55.2	28.7	41.9	35.8	50.6	41.2	32.8	42.6	33.1	34.4	36.7	49.3	34.0	40.5	40.6	43.5	17.8	58.8	18.2	49.2	38.9	13.3	44.6	58.0	27.8	32.3	34.0	38.6	41.4	31.3	45.1	55.3	50.3	21.7	25.6	49.9	27.8	22.6	31.1	23.7	39.6	37.7	54.6	39.8	34.7	36.0	32.5	17.0	30.7	26.8	23.1	41.4	18.8	26.1	28.8	20.4	14.6	26.3	28.4	16.6	31.9	28.2	9.9	22.1	24.7	28.2	48.4	52.2	55.6	29.3	46.3	31.3	30.0	57.9	19.6	50.6	115.9	82.1	60.0	79.0	59.4	66.9	22.9	78.9	92.1	50.6	47.1	31.6	34.9	45.0	180.8	63.3	78.6	46.7	59.3	41.8	54.5	74.8	101.8	66.8	40.5	66.7	130.0	49.7	73.0	184.9	24.5	67.6	57.3	90.2	97.3	31.7	70.8	56.1	37.4	71.9	60.6	19.4	46.4	56.0	66.1	68.0	34.6	94.8	60.7	90.4
G6PD	G6PD1	ENSG00000160211	"Glucose-6-phosphate dehydrogenase"	P11413	X	154531391-154547572	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Glucose metabolism"	Oxidoreductase	"Cancer-related genes, Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 83.1"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 77.3"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 77.3"	"Cell line enhanced"	"Detected in all"		"A549: 229.1;MCF7: 86.9"					"Low region specificity"	"Detected in all"			"HPA000247, HPA000834"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		No	No		12000000	Cytosol	"Centriolar satellite"	"HPA000247: AB_1078978, HPA000834: AB_1078977"	"unprognostic (1.73e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (9.45e-13)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.89e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.25e-2)"	21.9	29.4	10.4	15.6	10.7	51.4	18.2	8.4	14.7	12.2	7.5	13.6	4.8	7.2	14.0	13.2	29.0	11.0	24.7	10.1	8.8	10.1	15.4	3.7	20.8	31.0	10.3	8.0	19.8	7.9	5.9	20.7	9.2	10.9	11.3	7.3	17.8	13.9	8.6	4.4	11.3	7.3	17.5	11.1	20.3	9.9	83.1	9.5	22.5	24.6	44.8	25.7	24.1	19.0	3.6	7.6	77.3	16.2	12.7	10.3	11.8	15.7	229.1	4.7	18.1	19.9	27.1	4.2	11.0	31.5	11.2	19.4	10.5	5.9	10.1	17.1	25.0	45.4	14.0	7.3	18.6	5.8	10.3	5.1	10.7	51.9	23.6	38.8	10.8	36.9	13.1	5.5	21.9	4.7	17.6	23.3	7.5	6.4	4.4	20.3	86.9	6.9	7.7	3.4	50.2	17.0	6.8	2.7	11.1	33.8	19.6	4.8	6.0	10.9	42.8	9.2	6.4	6.4	9.0	27.6	7.1	25.0	9.9	16.9	5.4	7.0	17.4	19.7	7.2	14.5	29.3	16.2	77.3	10.3	13.6	6.6	3.4	2.7	7.4	7.6	3.6	3.5	5.9	27.1	12.7	11.1	3.5	3.5	11.8	10.4	10.7	8.4	14.7	8.8	10.1	10.3	8.0	10.9	9.5	0.0	17.1	21.3	18.5	11.1	5.7	0.8	20.4	4.0	0.0	10.4	17.7	26.0	24.9	35.4	8.1	12.8	18.6	23.3	25.6	33.4	18.8	16.7	38.0	0.8	41.6	31.8	9.1	16.0	63.9	10.4	24.2	25.3	18.6	130.8	9.6	11.9	34.1	9.1	15.2	11.9	24.6	6.5	12.3	10.1	34.9	12.0	30.3	39.5	9.9	26.5
GABPA	"E4TF1-60, E4TF1A, NFT2, NRF2, NRF2A"	ENSG00000154727	"GA binding protein transcription factor alpha subunit"	Q06546	21	25734570-25772460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003258, CAB004411, HPA028791"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004411: AB_627648, HPA003258: AB_1078928, HPA028791: AB_10602598"	"unprognostic (5.50e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.07e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.70e-2)"	"unprognostic (2.73e-3)"	25.3	15.2	11.6	17.0	16.9	13.6	18.3	15.9	15.4	17.6	17.1	11.4	18.8	12.7	19.5	15.9	15.1	15.4	13.6	18.6	12.5	9.5	14.6	18.8	13.3	18.8	12.9	9.0	20.4	13.3	19.4	20.3	34.5	12.5	18.0	14.2	10.8	14.2	15.4	18.2	11.5	17.0	15.8	18.4	20.0	12.3	19.5	16.3	37.7	27.3	10.3	19.0	18.4	35.3	8.9	6.6	12.0	8.2	10.8	10.3	6.1	12.8	5.3	15.8	11.2	16.2	22.0	12.2	10.3	11.6	8.6	8.5	6.7	11.0	27.6	8.2	11.9	8.3	5.9	17.5	10.5	14.3	15.6	16.2	19.2	7.2	6.4	11.0	20.4	13.0	16.0	10.3	11.4	10.8	14.1	15.8	15.1	17.5	16.7	14.3	6.4	22.0	8.9	21.8	14.0	7.4	18.4	22.7	16.9	10.0	8.6	9.7	13.1	18.5	11.8	12.6	10.0	10.5	15.8	15.5	10.4	9.6	11.3	8.5	13.4	11.5	24.5	10.8	15.7	12.5	12.0	6.8	11.5	7.4	8.2	9.9	8.9	8.6	8.7	6.6	8.4	10.3	8.7	8.7	10.8	6.0	3.4	8.6	6.1	11.6	16.9	15.9	15.4	12.5	9.5	12.9	9.0	12.5	16.3	8.9	11.8	14.7	10.4	10.3	6.6	6.7	15.3	6.7	13.6	21.0	0.0	14.8	3.3	6.9	5.5	20.4	9.0	0.0	7.0	10.8	11.7	9.2	5.8	17.5	10.8	12.7	8.6	22.7	19.7	2.1	16.4	11.5	6.8	7.2	13.3	20.9	7.5	8.6	20.8	8.5	9.4	19.4	12.0	27.7	17.4	11.0	21.1	13.1	11.2	11.6
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Fibroblasts: 1.7;Melanocytes: 1.7;Rod photoreceptor cells: 3.1;Smooth muscle cells: 1.9"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.7;NTERA-2: 35.6;SCLC-21H: 22.9;SH-SY5Y: 17.2;U-87 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	17.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7	0.0	0.0	0.0	0.0	0.2	2.4	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	3.1	0.0	1.9	0.7	1.5	0.1	0.0	0.0	0.0	0.0
GAPVD1	"DKFZP434C212, KIAA1521"	ENSG00000165219	"GTPase activating protein and VPS9 domains 1"	Q14C86	9	125261794-125367207	"Predicted intracellular proteins"	Endocytosis	"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029386, HPA029387"	Uncertain		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA029386: AB_10599604, HPA029387: AB_10600311"	"unprognostic (8.43e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.97e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-3)"	"unprognostic (2.77e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.82e-2)"	17.6	16.2	16.0	14.9	18.6	26.6	16.9	25.7	21.3	17.5	16.1	20.9	18.0	10.8	19.1	14.0	24.3	16.0	13.7	15.4	15.5	14.1	17.6	14.5	20.5	15.1	21.1	15.6	18.9	14.1	30.3	20.2	23.3	20.1	14.7	13.2	16.4	15.9	17.2	31.6	23.5	14.6	17.4	15.3	17.3	14.6	32.1	20.2	18.6	24.8	12.2	19.9	16.2	17.7	10.4	14.8	19.2	17.8	13.6	14.8	10.0	11.6	12.2	11.5	10.7	14.0	15.3	16.8	13.1	15.0	15.2	12.8	19.3	8.4	15.6	7.1	16.4	15.2	23.8	23.9	13.7	16.2	14.3	14.3	17.7	29.9	9.5	16.5	21.0	30.0	10.9	13.4	18.0	14.6	9.9	18.0	12.6	34.4	8.7	12.6	17.1	15.7	9.2	11.7	21.1	13.9	13.8	25.2	15.1	8.7	12.0	15.4	10.3	19.1	17.7	10.4	12.1	21.7	11.0	18.9	10.8	7.9	19.1	13.9	11.1	21.0	16.1	13.2	12.0	13.8	18.6	15.0	18.0	13.7	15.6	13.4	10.2	14.2	14.8	14.8	10.4	14.2	14.7	19.2	13.6	17.8	5.6	10.9	10.0	16.0	18.6	25.7	21.3	15.5	14.1	21.1	15.6	20.1	20.2	101.3	47.6	9.5	14.1	28.3	29.0	55.7	15.3	50.9	35.2	26.2	49.1	33.2	8.3	14.4	33.5	20.2	12.1	23.3	16.7	19.4	21.6	17.0	15.1	13.9	23.4	33.4	12.1	23.4	25.4	10.0	21.3	27.3	16.9	16.2	16.0	21.3	17.3	14.0	22.6	13.4	38.0	19.4	22.1	63.7	35.1	32.2	56.1	19.1	16.1	22.1
GATAD1	"FLJ22489, ODAG, RG083M05.2"	ENSG00000157259	"GATA zinc finger domain containing 1"	Q8WUU5	7	92447448-92459432	"Disease related genes, Predicted intracellular proteins, Transcription factors"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006105, HPA072785"			Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA006105: AB_1078956, HPA072785: AB_2686556"	"unprognostic (8.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.31e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.65e-3)"	"unprognostic (6.43e-2)"	"unprognostic (5.16e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.98e-3)"	20.1	20.9	14.7	13.7	32.1	8.7	21.1	19.5	23.5	23.1	18.2	32.9	20.8	17.6	23.2	29.8	13.7	21.7	20.0	14.9	18.3	13.4	21.5	17.5	22.5	12.4	37.7	21.4	32.9	27.3	19.7	22.5	19.3	22.1	21.7	18.3	19.5	17.0	21.2	10.4	15.3	16.9	22.2	28.9	18.9	21.1	11.5	31.8	6.5	28.1	8.0	11.3	21.4	18.7	4.5	3.8	7.3	3.8	3.1	3.0	1.1	8.6	5.5	11.3	11.8	14.7	17.0	9.1	8.7	13.0	9.2	12.7	6.0	13.5	6.5	12.1	6.4	21.6	10.4	7.7	5.9	9.8	11.3	8.4	8.3	5.5	8.3	20.5	9.9	22.5	12.8	14.2	7.0	20.6	16.6	10.3	4.8	16.8	14.0	10.0	12.5	3.8	14.1	15.2	14.0	10.6	5.1	13.4	8.5	9.9	9.8	10.1	16.0	11.4	12.1	16.3	14.7	6.8	13.4	9.4	14.8	11.3	22.3	11.1	11.3	3.9	7.2	12.4	6.5	20.2	7.3	3.8	3.4	2.6	2.3	2.5	2.8	2.0	1.6	2.0	4.5	2.1	3.0	3.9	3.1	2.5	3.8	2.0	1.1	14.7	32.1	19.5	23.5	18.3	13.4	37.7	21.4	22.1	31.8	44.7	54.7	23.8	32.5	11.7	77.4	13.2	20.4	45.5	33.0	45.4	66.8	21.8	3.3	18.5	3.3	25.3	24.9	0.0	19.1	19.7	20.3	33.0	50.9	19.5	21.7	58.8	16.1	30.1	26.3	3.4	42.0	29.9	20.3	10.8	35.4	86.9	22.4	33.6	32.9	13.5	125.5	19.4	26.7	10.7	7.0	15.6	17.3	18.5	29.9	26.0
GATAD2A	p66alpha	ENSG00000167491	"GATA zinc finger domain containing 2A"	Q86YP4	19	19385826-19508931	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006759, HPA024373"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006759: AB_1079549, HPA024373: AB_1849522"	"unprognostic (1.07e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.86e-1)"	"unprognostic (9.04e-3)"	"unprognostic (9.53e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.58e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (9.84e-2)"	19.2	16.1	14.7	24.4	15.3	30.5	25.9	11.1	14.2	12.9	22.2	12.2	20.4	24.8	16.7	16.1	23.3	13.1	17.4	16.3	16.2	11.3	21.2	28.7	22.3	29.9	12.8	10.1	16.0	28.5	13.8	16.2	26.9	15.3	11.7	13.0	18.1	16.7	20.2	17.9	29.9	26.4	13.1	14.8	28.1	19.5	42.0	11.4	34.1	16.1	15.3	24.6	16.3	23.0	3.2	4.9	12.3	4.9	3.7	5.2	2.7	18.7	16.1	15.0	22.2	6.2	6.5	31.6	14.8	10.1	15.5	14.8	29.1	19.9	36.8	22.6	14.8	10.3	15.7	14.0	13.1	9.0	12.5	15.2	27.0	16.1	16.0	15.3	29.9	23.4	10.3	9.7	16.1	13.1	5.1	15.4	21.3	43.0	11.9	8.9	21.2	35.3	11.9	31.6	17.4	14.7	37.7	15.1	17.1	8.0	24.8	28.5	15.9	12.8	15.6	18.7	10.2	14.1	12.6	30.0	29.5	14.2	34.4	27.6	14.9	18.7	39.4	18.4	25.3	17.1	5.6	4.9	4.5	5.2	2.3	3.1	3.1	3.1	4.2	2.1	3.2	2.3	2.6	12.3	3.7	4.5	4.9	2.1	2.7	14.7	15.3	11.1	14.2	16.2	11.3	12.8	10.1	15.3	11.4	11.9	16.3	12.4	16.8	49.5	14.4	10.6	10.2	9.4	12.5	14.0	17.7	20.2	11.6	19.7	14.7	28.5	34.2	0.0	26.2	27.9	19.3	19.6	16.2	25.1	23.4	22.3	15.0	25.2	24.1	13.3	14.4	19.3	30.4	16.2	28.2	17.4	36.9	32.3	13.1	22.5	18.5	19.4	21.7	12.1	33.7	48.6	30.7	35.5	26.9	23.0
GATAD2B	P66beta	ENSG00000143614	"GATA zinc finger domain containing 2B"	Q8WXI9	1	153789030-153923360	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017015	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017015: AB_1854905"	"unprognostic (1.90e-1)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.43e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.53e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.17e-2)"	12.9	9.6	16.5	16.2	19.8	22.2	13.6	33.2	24.4	12.0	12.4	22.2	10.5	10.7	15.7	9.0	14.6	13.1	9.6	19.3	16.3	11.0	8.8	10.5	15.9	18.4	15.1	12.3	17.1	16.0	19.4	11.1	14.4	14.7	10.8	9.6	12.3	10.7	14.6	20.2	17.2	11.9	17.6	13.9	14.6	11.6	24.6	17.9	29.5	19.1	7.6	17.7	12.1	14.4	1.3	2.9	6.7	1.1	1.5	1.4	0.7	4.8	9.2	8.2	9.0	1.7	5.4	4.9	3.0	7.3	9.6	11.3	4.4	7.6	9.5	7.2	6.8	5.1	9.8	11.4	5.9	7.9	8.6	7.9	9.3	10.0	1.8	5.6	5.6	13.3	4.2	4.2	10.7	21.3	4.6	9.1	13.4	6.9	13.1	1.9	9.0	20.1	1.5	3.6	3.8	4.5	20.5	4.1	10.4	1.9	6.8	9.5	10.0	11.2	13.8	5.9	6.3	12.7	4.8	8.1	9.4	8.4	5.2	6.4	17.8	12.0	14.6	5.3	3.7	8.1	6.7	1.1	0.9	1.3	0.5	1.3	0.7	0.6	1.4	0.3	1.3	0.5	0.6	6.4	1.5	0.5	2.9	1.1	0.7	16.5	19.8	33.2	24.4	16.3	11.0	15.1	12.3	14.7	17.9	8.9	11.8	11.8	11.6	38.9	43.4	14.5	22.9	12.0	9.1	24.4	37.3	8.2	6.6	10.9	12.5	23.4	7.9	23.3	12.3	5.5	12.9	16.7	24.3	19.5	11.9	33.4	22.8	24.5	27.8	5.2	25.0	17.4	13.5	34.3	19.5	18.6	14.4	20.9	32.9	7.9	35.5	6.5	19.8	25.5	19.8	41.5	8.2	24.5	14.0	16.0
GCC1	"FLJ22035, GCC1P, GCC88, MGC20706"	ENSG00000179562	"GRIP and coiled-coil domain containing 1"	Q96CN9	7	127580618-127593611	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Early spermatids: 108.4;Late spermatids: 98.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019369, HPA021323"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus"	"Plasma membrane, Cytosol"	"HPA019369: AB_1849552, HPA021323: AB_1849554"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.81e-2)"	"unprognostic (4.50e-3)"	"unprognostic (1.17e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.22e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.96e-2)"	11.5	14.1	13.4	11.0	13.7	17.7	14.2	13.9	12.8	11.6	10.2	12.8	8.6	9.6	13.2	10.3	14.1	10.7	12.2	9.0	10.2	7.9	9.8	17.8	10.4	12.3	19.8	7.6	13.6	12.7	14.8	14.5	13.6	13.0	11.5	9.6	8.4	13.8	11.0	12.5	14.5	12.9	8.4	12.1	15.5	12.7	20.7	17.9	15.7	11.8	9.5	14.4	10.3	29.2	8.4	7.9	15.6	9.1	10.2	11.6	8.8	8.4	11.4	5.0	10.8	11.3	7.8	7.0	7.4	8.6	7.4	9.4	9.5	5.8	7.8	4.5	6.8	16.8	9.3	7.3	8.1	8.0	10.8	6.6	5.7	6.2	4.9	16.8	9.8	9.5	7.3	22.3	7.9	15.7	7.0	7.0	7.8	9.3	8.9	8.3	8.4	9.5	8.5	10.5	9.3	8.9	6.8	5.4	8.8	6.4	6.5	8.0	11.6	7.9	37.8	14.7	9.5	6.4	7.1	9.0	11.0	3.5	9.5	8.4	24.5	10.7	5.0	10.9	10.1	11.2	5.8	8.1	15.0	9.1	8.2	11.6	8.4	8.2	8.9	7.9	8.0	6.8	6.7	15.6	10.2	9.1	4.6	7.6	8.8	13.4	13.7	13.9	12.8	10.2	7.9	19.8	7.6	13.0	17.9	11.9	7.7	0.9	5.0	9.4	3.7	3.7	5.1	0.0	3.4	3.5	3.9	5.4	5.0	4.5	108.4	5.6	6.6	0.0	5.5	3.9	4.3	5.3	1.1	6.8	4.5	11.1	6.9	4.9	7.9	98.5	4.9	5.4	11.8	5.4	7.5	4.4	5.5	5.5	3.5	3.3	5.3	6.5	6.1	5.6	4.5	9.2	8.7	5.7	4.5	5.1
GCC2	"GCC185, KIAA0336"	ENSG00000135968	"GRIP and coiled-coil domain containing 2"	Q8IWJ2	2	108448561-108509415	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035849, HPA035850"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035849: AB_10671941, HPA035850: AB_2674821"	"unprognostic (1.35e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (1.59e-1)"	"unprognostic (3.11e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.53e-3)"	"unprognostic (3.99e-1)"	"unprognostic (4.71e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.64e-2)"	10.9	10.6	12.0	15.2	21.6	20.5	13.1	5.0	16.8	11.9	13.6	3.9	26.7	13.4	10.9	32.0	9.5	12.4	13.2	8.0	9.3	5.8	12.8	8.3	14.2	13.0	7.8	15.6	17.6	13.1	11.5	24.3	8.6	15.0	14.6	13.6	4.3	14.9	32.3	9.6	9.3	18.1	8.4	11.4	11.7	18.1	15.5	10.5	11.1	13.8	6.1	10.0	16.3	11.3	14.3	17.6	20.3	8.8	7.9	23.0	4.5	7.6	5.8	7.7	2.7	5.7	13.6	13.4	10.6	12.6	4.0	6.7	11.3	9.4	8.9	12.7	7.3	9.0	6.3	4.3	7.5	8.6	10.8	7.5	12.1	9.9	7.5	6.2	15.6	8.9	14.4	7.1	10.6	8.9	7.7	7.0	7.0	15.4	7.3	7.6	4.7	6.5	8.1	12.3	3.7	7.7	6.6	9.0	8.4	4.7	12.7	8.0	9.1	11.9	8.8	9.1	7.4	4.4	5.1	12.0	8.3	12.5	7.9	4.1	9.7	16.9	10.7	9.3	4.0	5.1	20.1	5.2	13.7	15.4	4.6	14.9	14.3	16.9	16.0	4.0	13.6	23.0	19.7	20.3	7.9	8.8	17.6	12.3	4.5	12.0	21.6	5.0	16.8	9.3	5.8	7.8	15.6	15.0	10.5	140.0	86.0	63.4	57.6	21.2	153.9	76.3	66.2	305.1	113.7	99.5	131.6	36.7	43.1	92.4	48.8	52.5	110.3	0.0	71.8	48.3	34.8	87.9	78.7	28.8	32.2	66.7	82.1	52.2	44.7	34.5	66.2	49.5	32.1	88.4	140.1	60.4	93.5	112.2	77.8	56.4	118.6	51.8	39.6	164.6	90.6	15.3	54.3	109.0	68.0	89.7
GCN1	"GCN1L, GCN1L1, KIAA0219"	ENSG00000089154	"GCN1, eIF2 alpha kinase activator homolog"	Q92616	12	120127203-120194710	"Plasma proteins, Predicted intracellular proteins"	"Stress response, Translation regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018799, HPA019648, HPA024367"	Enhanced		Enhanced	Cytosol		NA	NA		40000	Cytosol		"HPA018799: AB_1849565, HPA019648: AB_1849567, HPA024367: AB_1849569"	"unprognostic (7.36e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (1.87e-8)"	"unprognostic (5.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.09e-3)"	"unprognostic (1.43e-1)"	23.1	14.6	7.9	14.3	14.4	15.7	14.4	18.3	20.6	15.3	15.2	22.3	9.7	11.5	31.2	10.2	20.2	14.8	11.3	12.6	7.7	7.8	14.7	19.1	14.0	16.0	11.5	6.8	18.9	19.9	23.8	21.4	24.4	14.9	15.1	12.2	16.8	33.3	13.2	36.0	20.9	15.5	14.4	9.7	18.3	17.2	16.0	10.3	22.2	20.6	14.3	27.4	15.9	15.1	4.3	4.9	2.2	6.5	3.1	7.8	3.1	16.9	33.5	12.1	13.6	19.2	11.7	42.5	15.2	13.3	15.9	13.0	28.7	11.8	22.6	17.3	21.8	10.1	16.8	28.1	21.5	10.0	15.0	22.9	27.9	21.9	19.8	12.5	25.7	17.9	14.3	12.6	18.8	17.8	14.0	14.5	10.3	32.7	5.8	13.3	17.1	16.2	19.5	21.4	16.3	20.5	19.8	12.4	22.3	10.9	58.3	19.9	20.0	25.0	10.9	9.0	12.0	23.2	14.6	19.8	13.0	14.5	8.5	15.7	23.0	21.1	22.9	12.5	13.6	13.0	1.2	3.1	2.2	6.4	3.2	7.8	3.9	5.0	5.3	4.1	4.3	3.8	4.0	0.1	3.1	6.5	4.9	4.6	3.1	7.9	14.4	18.3	20.6	7.7	7.8	11.5	6.8	14.9	10.3	8.9	19.9	2.2	5.4	0.0	12.7	0.0	10.2	5.3	17.0	21.0	9.8	12.3	1.7	13.2	1.1	8.0	6.3	0.0	13.7	32.8	8.2	11.2	4.7	20.2	10.0	15.9	3.5	12.3	9.5	2.7	13.3	3.2	0.0	10.0	14.2	9.3	16.6	10.5	12.0	7.8	11.5	6.5	0.0	7.7	21.6	0.0	12.2	6.9	15.1	11.2
GDF15	"MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB"	ENSG00000130513	"Growth differentiation factor 15"	Q99988	19	18374731-18389176	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Cytokine, Growth factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"placenta: 463.0"	"Cell type enhanced"	"Detected in many"	18	"Glandular cells: 1046.1;Syncytiotrophoblasts: 3600.0;Urothelial cells: 2603.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"pons and medulla: 6.5"	"Cell type enhanced"	"Detected in some"		"neutrophil: 6.3"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 72.3;Hep G2: 37.2;HHSteC: 100.5;TIME: 36.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA011191, CAB062554, HPA070957"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1260000	890000	"Golgi apparatus"		"CAB062554: AB_2665632, HPA011191: AB_1078962, HPA070957: AB_2732168"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.55e-3)"	"unprognostic (3.81e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.04e-3)"	13.4	2.2	0.4	1.0	0.6	0.0	13.1	0.4	0.5	3.9	13.0	1.0	1.9	1.8	5.9	1.9	2.4	1.1	13.1	1.2	0.5	0.0	64.7	24.1	12.6	0.8	0.4	0.5	2.9	21.9	0.3	2.4	463.0	6.5	25.5	11.0	1.6	2.4	5.1	13.6	1.1	1.8	4.8	1.2	1.4	12.0	2.5	0.4	0.4	5.2	0.5	0.8	47.0	2.7	0.2	0.8	6.3	2.3	0.0	0.0	0.3	0.3	16.2	1.6	0.6	3.9	3.3	72.3	5.6	3.0	0.2	3.3	0.7	5.0	0.0	10.2	0.5	16.9	0.1	0.0	2.0	0.8	0.0	0.3	0.2	1.5	37.2	100.5	0.0	6.2	8.6	24.3	15.7	10.2	0.1	17.1	0.0	24.8	0.1	3.9	3.9	0.0	0.1	0.9	5.7	9.0	0.0	0.6	0.0	11.9	15.9	0.1	0.1	0.0	0.9	20.2	6.4	0.4	0.0	36.0	0.0	1.3	0.3	0.2	0.2	0.6	0.0	9.0	0.0	4.7	0.0	1.8	2.1	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	6.3	0.0	2.3	0.0	0.0	0.3	0.4	0.6	0.4	0.5	0.5	0.0	0.4	0.5	6.5	0.4	32.8	67.9	2.2	222.2	1.1	0.0	0.4	45.9	80.3	68.2	246.0	0.0	48.7	28.2	235.7	0.0	5.8	50.0	0.0	324.0	161.2	17.1	1046.1	28.8	5.0	31.5	0.0	81.4	3.7	1.8	0.0	0.9	5.9	3.3	17.2	220.9	0.2	679.3	95.1	1.4	74.0	0.5	0.0	14.6	0.0	0.6	1.5	3600.0	0.5	186.1	2603.9
GEMIN5		ENSG00000082516	"Gem nuclear organelle associated protein 5"	Q8TEQ6	5	154887416-154938209	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Protein biosynthesis, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037392, HPA037393"	Uncertain		Enhanced	"Nuclear bodies,Cytosol"		NA	NA			Cytosol	"Nuclear bodies"	"HPA037392: AB_2675453, HPA037393: AB_10672489"	"unprognostic (1.14e-2)"	"unprognostic (2.81e-3)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (6.23e-5)"	"unprognostic (5.44e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.11e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.40e-3)"	"unprognostic (5.01e-2)"	17.7	10.5	9.4	13.8	13.2	6.4	17.0	11.2	11.7	12.9	10.8	16.5	12.1	7.0	14.4	10.2	11.3	13.2	8.6	14.8	9.5	10.4	10.3	12.3	9.5	14.9	14.0	10.5	18.3	15.4	17.1	15.1	9.9	10.4	12.8	10.1	9.1	10.4	13.3	23.0	15.3	8.6	14.6	11.4	11.0	9.6	13.8	12.5	19.7	11.9	11.0	14.5	12.4	10.9	6.1	4.6	2.9	4.0	4.5	7.3	3.4	8.7	12.9	8.4	19.5	9.1	7.7	10.9	8.5	5.2	14.9	11.1	21.3	7.8	23.0	10.8	8.1	15.4	9.3	24.9	15.5	20.4	4.5	11.7	13.9	8.5	12.8	5.1	24.1	8.1	5.8	7.2	20.7	12.4	5.4	12.1	5.6	22.0	5.6	11.1	11.9	13.0	9.7	11.8	6.8	10.2	16.9	16.5	19.1	6.2	6.0	11.1	7.7	9.8	10.9	6.9	8.7	12.9	5.6	7.3	13.5	9.6	10.1	19.0	5.7	8.6	18.1	5.7	20.0	11.8	0.0	3.1	2.9	4.5	4.0	7.3	6.1	4.2	4.3	4.6	5.0	6.3	6.6	0.3	4.5	3.9	3.4	3.9	3.4	9.4	13.2	11.2	11.7	9.5	10.4	14.0	10.5	10.4	12.5	0.0	5.4	5.1	4.3	9.2	6.0	11.3	2.5	1.4	19.4	3.5	0.0	3.7	0.0	5.3	1.9	6.8	1.8	0.0	3.6	3.5	7.1	4.1	1.1	7.3	4.0	15.9	1.2	6.2	11.6	3.0	10.0	2.9	6.8	5.4	3.0	7.1	3.1	0.0	12.4	3.8	3.9	0.0	7.1	7.9	17.9	13.9	1.7	4.3	5.4	3.4
GET4	"C7orf20, CEE, CGI-20, H_NH1244M04.5, TRC35"	ENSG00000239857	"Golgi to ER traffic protein 4"	Q7L5D6	7	876552-896436	"Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Cone photoreceptor cells: 3.9;Horizontal cells: 7.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019765	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Mitotic chromosome,Cytosol"		Yes	No			"Nucleoplasm, Cytosol"	"Nucleoli, Mitotic chromosome"	"HPA019765: AB_1845750"	"unprognostic (2.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.66e-4)"	"unprognostic (9.86e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.65e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.47e-2)"	13.7	39.8	22.4	14.8	21.4	28.5	15.3	22.1	23.5	10.3	15.5	20.9	19.0	21.8	12.3	23.8	18.8	14.6	12.8	18.7	16.4	15.4	27.8	37.5	12.2	15.1	22.9	21.5	16.5	32.6	11.3	32.9	21.7	18.9	16.8	9.9	15.2	25.0	21.9	53.7	29.7	20.9	12.6	18.9	16.9	22.2	32.0	22.7	12.5	16.0	21.8	12.5	14.3	17.3	23.3	31.5	28.9	30.7	24.9	27.3	21.9	26.3	13.0	9.1	13.4	4.7	3.3	28.9	7.3	5.2	9.4	9.4	35.3	33.0	9.7	7.7	4.2	26.2	16.8	10.2	8.0	4.1	3.9	17.5	5.3	10.2	19.9	10.4	9.1	9.9	4.9	9.7	8.2	5.4	7.1	7.4	11.3	34.5	9.0	5.2	20.0	6.9	21.9	32.7	15.6	19.5	14.5	1.6	10.4	8.3	15.6	16.5	17.8	6.7	24.9	10.6	11.6	18.9	16.2	7.4	6.9	15.6	16.0	10.0	13.6	8.5	12.5	7.1	15.7	17.5	16.8	27.4	28.9	24.2	24.7	23.7	23.3	26.5	24.0	27.7	23.2	26.0	27.3	21.1	24.9	30.7	31.5	24.5	21.9	22.4	21.4	22.1	23.5	16.4	15.4	22.9	21.5	18.9	22.7	0.0	1.9	0.0	0.2	0.9	0.8	0.4	0.0	2.7	3.4	0.0	3.9	0.9	0.0	0.6	3.6	0.1	1.6	0.0	0.6	0.6	0.3	0.4	1.1	0.0	0.6	7.9	0.0	0.0	0.3	1.5	0.0	2.5	0.0	0.0	1.9	0.2	0.8	0.0	0.0	0.6	1.1	0.0	0.2	0.5	1.0	0.9	1.4	0.9	1.7	0.8
GFER	"ALR, ERV1, HERV1, HPO1, HPO2, HSS"	ENSG00000127554	"Growth factor, augmenter of liver regeneration"	P55789	16	1984207-1987749	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Growth factor, Oxidoreductase"	"Cataract, Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 165.5;Enterocytes: 236.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041227, HPA063553"	Approved		Enhanced	Mitochondria,Cytosol	"Intracellular and membrane"	NA	NA			"Mitochondria, Cytosol"		"HPA041227: AB_10795538, HPA063553: AB_2685038"	"unprognostic (5.35e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.93e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.56e-1)"	"unprognostic (1.09e-2)"	9.7	12.2	9.7	15.2	9.9	10.7	14.8	15.2	12.5	8.1	24.8	10.8	15.2	29.6	10.1	10.2	11.0	10.2	16.1	17.8	9.8	9.7	13.7	33.5	17.1	18.1	10.7	9.7	9.4	43.8	19.2	10.9	18.0	8.0	11.9	18.0	10.5	22.5	12.5	27.5	8.3	33.2	9.2	9.6	15.2	12.8	20.0	7.8	7.7	15.1	15.0	11.4	12.4	17.1	16.1	9.1	9.8	12.7	7.8	17.7	7.7	11.4	18.3	15.0	12.2	6.3	12.7	19.5	13.3	13.0	18.8	15.4	26.3	19.2	6.4	18.2	9.9	11.0	17.3	11.4	17.6	11.9	20.0	23.4	8.9	18.0	29.8	11.5	12.9	16.8	8.1	13.7	16.4	14.8	11.9	8.8	13.9	13.8	21.6	13.6	27.0	14.6	13.9	24.1	9.7	18.3	32.1	11.5	20.9	19.1	9.0	13.2	12.6	18.0	38.4	14.2	8.1	18.3	13.8	8.1	18.3	20.4	10.2	22.9	36.7	19.8	18.5	6.1	8.8	15.4	3.1	12.6	9.8	9.2	10.5	9.9	16.1	12.6	15.6	9.1	13.4	11.5	7.9	1.1	7.8	12.7	4.0	17.7	7.7	9.7	9.9	15.2	12.5	9.8	9.7	10.7	9.7	8.0	7.8	3.0	7.0	36.5	18.9	14.2	10.7	14.9	25.5	8.1	1.2	8.7	0.0	34.0	29.9	38.0	165.5	17.1	236.0	23.3	70.3	48.9	16.9	17.7	12.7	53.9	39.8	7.9	26.2	20.9	29.7	100.1	16.1	25.1	21.9	45.1	48.7	7.8	54.6	92.1	11.7	50.8	7.9	12.9	18.9	45.9	23.0	12.9	31.4	35.2	62.4	23.3
GGA2	"KIAA1080, VEAR"	ENSG00000103365	"Golgi associated, gamma adaptin ear containing, ARF binding protein 2"	Q9UJY4	16	23463542-23521995	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 118.2;Rod photoreceptor cells: 162.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 51.2;U-698: 53.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB034422, HPA043313, HPA063634"	Approved		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"CAB034422: AB_2110748, HPA043313: AB_2678421, HPA063634: AB_2685067"	"unprognostic (1.27e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (8.53e-2)"	"unprognostic (2.22e-2)"	"unprognostic (4.91e-2)"	"prognostic favorable (9.70e-5)"	"unprognostic (1.68e-1)"	"prognostic favorable (1.68e-4)"	"unprognostic (7.82e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.15e-3)"	"unprognostic (8.55e-2)"	"prognostic favorable (3.91e-5)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (3.89e-2)"	"unprognostic (2.08e-1)"	16.4	25.7	9.0	39.7	13.8	20.0	13.7	26.0	14.8	15.0	11.1	7.5	18.5	6.7	16.2	15.1	13.9	12.6	13.0	13.1	8.5	9.9	18.7	13.4	21.9	42.4	7.3	10.1	25.1	37.2	25.5	18.9	14.5	9.7	18.7	11.1	37.6	35.2	24.1	18.3	13.8	22.4	10.6	7.6	31.8	16.0	11.1	6.9	26.0	28.3	12.8	52.4	15.3	13.1	15.3	12.9	5.3	3.5	2.6	3.8	2.3	6.0	7.6	10.3	9.4	6.5	7.2	8.8	7.3	7.1	5.7	6.6	10.2	6.1	51.2	10.7	7.6	1.8	9.6	17.7	9.1	7.3	8.1	15.7	9.6	9.7	17.0	5.7	15.6	6.1	6.6	8.9	7.0	4.1	8.6	7.2	5.0	16.3	7.8	7.0	9.9	5.8	10.2	14.1	7.1	6.7	34.5	13.6	14.4	9.1	8.4	7.9	9.4	6.1	9.8	9.0	12.3	8.4	19.4	7.8	6.3	6.8	7.1	6.5	15.0	13.3	53.8	6.3	11.0	7.2	0.1	3.2	5.3	2.8	3.5	3.0	12.9	3.4	3.3	4.0	15.3	3.6	3.8	0.5	2.6	3.0	12.9	3.2	2.3	9.0	13.8	26.0	14.8	8.5	9.9	7.3	10.1	9.7	6.9	44.7	33.8	58.9	31.0	30.3	64.2	24.1	17.8	14.7	20.5	21.0	108.0	19.1	21.6	15.4	20.3	18.4	6.9	0.0	16.4	31.7	17.3	17.7	9.2	13.9	60.0	6.4	16.9	14.1	21.6	25.0	22.7	23.5	25.3	118.2	12.0	21.2	15.7	7.0	24.8	15.8	162.9	19.4	13.7	28.2	66.4	12.8	19.0	24.9	10.7	15.9
GIGYF2	"GYF2, KIAA0642, PARK11, PERQ2, PERQ3, TNRC15"	ENSG00000204120	"GRB10 interacting GYF protein 2"	Q6Y7W6	2	232697299-232860575	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 342.4;Late spermatids: 441.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050899, HPA054612, HPA059918, HPA065064"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA050899: AB_2681267, HPA054612: AB_2682542, HPA059918: AB_2684160, HPA065064: AB_2685417"	"unprognostic (7.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (8.61e-2)"	"unprognostic (8.39e-3)"	"unprognostic (2.99e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.40e-3)"	"unprognostic (8.01e-2)"	"prognostic favorable (6.97e-5)"	"unprognostic (7.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.66e-1)"	22.8	22.1	20.7	16.5	19.4	15.2	19.7	33.0	21.7	17.9	17.5	25.0	21.2	15.9	23.7	15.0	18.6	17.8	13.7	21.3	19.2	15.7	23.1	13.7	15.7	15.4	21.4	15.6	24.6	26.5	47.5	38.1	18.1	21.5	19.4	16.9	18.1	21.4	21.7	41.5	23.4	17.2	22.3	27.5	18.9	18.2	53.4	22.0	19.2	22.4	17.7	17.3	20.8	20.5	10.1	9.8	21.5	14.6	9.8	9.9	5.2	16.1	15.6	18.2	18.9	24.8	23.9	20.4	20.4	17.5	14.9	16.1	14.5	13.5	9.7	5.4	15.2	24.3	17.1	21.7	16.4	18.4	22.6	16.2	35.7	16.1	22.0	15.6	28.9	22.8	15.0	16.9	18.0	25.7	15.9	16.7	13.5	33.3	10.8	17.1	17.1	18.9	10.3	18.5	13.3	11.5	19.3	36.0	13.2	14.0	24.7	16.2	13.5	20.5	15.0	15.8	14.5	14.5	20.2	24.2	15.9	13.5	17.8	15.7	21.9	14.6	19.1	14.4	17.0	15.4	21.5	8.6	10.8	7.9	6.7	9.9	5.6	6.5	7.2	9.8	10.1	7.8	5.9	11.2	9.8	14.6	7.6	9.6	5.2	20.7	19.4	33.0	21.7	19.2	15.7	21.4	15.6	21.5	22.0	53.6	54.8	27.6	28.8	14.0	49.5	79.9	15.3	61.6	68.2	34.9	56.9	27.8	21.6	26.2	342.4	38.3	25.7	23.3	23.5	17.9	19.7	31.1	16.3	26.2	24.4	46.1	18.4	16.5	31.6	441.2	34.8	21.3	25.3	20.8	23.6	40.9	25.2	10.5	34.6	14.6	38.4	25.8	20.2	92.6	88.6	16.8	61.2	19.8	26.2	38.2
GINS3	"FLJ13912, PSF3"	ENSG00000181938	"GINS complex subunit 3"	Q9BRX5	16	58295080-58406144	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 53.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041216, HPA048209"	Uncertain		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA041216: AB_10794989, HPA048209: AB_2680314"	"unprognostic (3.12e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-3)"	"unprognostic (6.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.75e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.76e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.14e-7)"	"unprognostic (9.76e-3)"	"unprognostic (5.34e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.07e-2)"	5.5	10.6	3.3	5.6	11.4	9.9	4.4	20.4	4.7	5.9	6.6	3.2	13.2	4.3	5.6	5.5	11.5	3.4	3.3	8.2	3.5	3.6	5.3	4.2	6.1	10.0	5.8	1.5	2.8	2.3	6.0	4.2	6.3	4.5	3.5	6.0	3.3	4.8	10.0	3.9	5.4	5.0	5.1	4.1	11.9	3.4	8.0	4.9	17.5	4.9	14.3	13.1	3.8	7.9	4.7	10.9	0.5	2.4	5.0	4.1	2.1	7.3	8.3	10.0	5.4	1.1	1.4	5.0	8.4	3.7	13.4	10.2	6.1	7.4	12.8	6.7	2.8	10.1	7.0	9.2	7.0	15.2	7.1	11.3	7.5	4.7	7.4	0.6	9.5	12.9	1.6	1.3	6.9	2.4	3.0	9.1	10.7	11.9	5.5	5.6	7.5	17.3	8.7	9.4	6.3	17.1	30.1	11.1	16.3	4.9	4.7	11.6	7.7	13.9	9.2	4.6	4.2	4.8	7.8	3.8	9.1	10.6	5.4	10.4	5.5	7.1	53.9	6.3	9.6	11.0	0.2	2.4	0.2	2.9	2.2	2.1	3.5	2.4	4.1	5.5	4.7	2.3	3.6	0.5	5.0	1.2	10.9	3.2	2.1	3.3	11.4	20.4	4.3	3.5	3.6	5.8	1.5	4.5	4.9	0.0	1.6	5.2	3.9	1.5	1.3	3.0	0.0	1.4	1.2	0.0	2.0	4.9	0.0	3.1	15.8	2.8	0.5	0.0	1.8	6.7	1.0	1.5	1.1	0.8	2.4	4.8	0.0	2.5	2.1	7.1	1.4	1.1	1.7	2.8	0.6	1.5	1.5	0.0	1.1	0.4	1.8	6.5	1.5	4.2	8.1	2.0	2.6	2.5	2.2	5.4
GLI1	GLI	ENSG00000111087	"GLI family zinc finger 1"	P08151	12	57460135-57472262	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	21	"Leydig cells: 27.3;Peritubular cells: 40.3;Sertoli cells: 12.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 7.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 12.2;BJ hTERT+: 7.8;NTERA-2: 7.9;RH-30: 35.9;U-266/70: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB009460, HPA065172, HPA068903"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB009460: AB_2111764, HPA065172: AB_2685427, HPA068903: AB_2732122"	"unprognostic (4.97e-4)"	"unprognostic (5.53e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-8)"	"unprognostic (4.59e-3)"	"unprognostic (2.98e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-2)"	3.2	1.7	4.0	2.1	2.5	0.6	2.1	8.2	4.4	14.4	3.5	0.0	3.0	3.7	12.8	8.3	0.7	4.7	8.3	2.7	2.9	1.9	3.2	1.8	2.0	1.3	1.5	2.0	4.7	1.0	0.1	1.2	0.6	3.3	5.6	4.9	9.6	2.9	4.3	3.1	2.4	3.7	3.8	2.8	1.2	2.4	6.2	2.5	0.6	3.3	3.4	1.4	4.8	4.6	0.9	0.4	5.2	0.2	0.1	0.5	0.1	0.0	5.6	1.7	12.2	0.2	0.0	0.2	0.7	7.8	1.3	1.4	0.2	0.4	1.9	0.0	0.3	1.4	1.0	1.0	0.7	0.2	2.1	0.1	0.0	0.6	0.1	1.3	0.3	0.6	0.5	0.2	1.3	0.4	2.5	0.2	1.2	0.4	4.1	0.6	0.0	0.4	0.2	7.9	0.4	0.5	0.6	35.9	0.8	1.5	0.0	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.1	0.0	1.4	4.5	0.4	0.2	10.0	0.4	3.2	1.2	0.8	2.2	2.2	0.2	0.9	0.1	0.0	0.0	0.9	0.2	0.0	0.0	0.4	0.4	0.3	5.2	0.1	0.1	0.4	0.5	0.1	4.0	2.5	8.2	4.4	2.9	1.9	1.5	2.0	3.3	2.5	0.0	0.0	0.5	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	27.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	40.3	1.0	0.0	12.9	0.5	0.3	0.8	0.5	0.1	0.0	0.0	0.1
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 31.8;Smooth muscle cells: 30.9"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062755, HPA065406"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062755: , HPA065406: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	3.6	6.0	1.5	2.3	1.6	0.0	2.4	4.3	2.4	5.0	4.4			1.2	5.8	1.0	1.2	4.3	7.4	8.4	0.9	1.2	11.5	0.3	7.8	1.4	1.4		8.0	3.2	2.2	5.3	5.7		5.6	0.2		3.0	5.8	1.1	1.5	1.2	4.3	0.2	0.8	2.7	1.9			5.3		0.5	5.6	2.7	0.3	0.0	0.2	0.0	0.0	0.1	0.0	4.0	10.6	1.7	3.9	1.4	5.7	3.6	4.5	4.3	1.6	1.2	2.9	3.0	0.0	7.9	4.9	1.9	2.6	1.0	4.5	0.1	4.7	0.0	0.0	8.1	1.5	6.2	0.0	0.8	3.3	1.1	1.5	0.7	2.3	1.5	0.1	0.3	1.8	1.1	2.6	0.1	0.9	3.8	0.6	1.8	6.8	2.3	4.8	0.0	0.1	0.8	3.7	5.2	2.2	1.0	0.6	6.3	0.7	3.4	2.4	3.9	28.0	1.4	0.8	0.5	1.3	0.9	0.2	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0											14.9	9.8	0.0	6.2	4.9	10.4	4.9	20.4	2.7	4.5	12.2	3.9	0.1	16.6	10.0	0.1	6.0	0.0	0.0	7.4	0.9	20.7	2.6	0.0	0.6	0.3	6.4	0.0	5.5	0.0	0.4	20.4	1.2	3.3	1.8	0.0	9.4	7.6	0.0	31.8	19.5	6.5	0.0	30.9	0.0	3.4	2.5	0.9	0.0	0.0	1.7
GLRX2	"bA101E13.1, GRX2"	ENSG00000023572	"Glutaredoxin 2"	Q9NS18	1	193090866-193106114	"Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 789.5;Late spermatids: 1440.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 69.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023087, HPA057224"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA023087: AB_1849778, HPA057224: AB_2683373"	"unprognostic (4.80e-2)"	"unprognostic (3.77e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.40e-3)"	"unprognostic (5.11e-2)"	"unprognostic (3.21e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (3.30e-7)"	"unprognostic (6.23e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.21e-2)"	"unprognostic (4.48e-2)"	14.1	17.9	13.8	9.7	12.2	10.7	16.3	7.4	22.0	7.8	14.9	6.6	7.4	14.7	6.7	14.5	13.1	5.1	8.8	23.5	13.0	13.3	14.3	28.2	7.8	6.1	16.5	13.1	5.4	10.4	4.6	9.9	9.5	22.3	21.8	11.7	7.4	8.6	11.6	28.5	8.9	12.7	10.9	12.3	7.6	10.3	27.9	8.7	2.3	7.7	11.6	9.0	9.6	10.2	10.8	17.4	19.6	21.4	11.6	14.1	10.9	13.9	17.2	4.4	9.8	16.3	10.6	7.8	20.5	8.9	17.0	14.1	10.6	13.4	6.2	11.5	8.5	20.7	13.6	5.2	11.7	17.4	13.7	9.7	12.0	11.6	12.3	17.4	9.8	12.1	7.1	10.2	23.3	11.8	6.6	10.7	4.1	17.7	6.6	20.5	19.3	7.8	18.0	5.1	22.3	12.6	7.1	7.1	14.2	16.3	9.2	4.2	3.8	8.3	24.6	69.6	6.8	10.7	11.1	6.5	13.3	3.4	28.9	21.1	13.3	13.7	11.9	12.7	11.3	18.4	7.8	15.2	19.6	10.8	17.9	11.9	10.8	11.3	9.7	17.4	8.2	10.2	11.4	7.6	11.6	21.4	7.3	14.1	10.9	13.8	12.2	7.4	22.0	13.0	13.3	16.5	13.1	22.3	8.7	8.9	8.5	18.7	19.2	16.3	7.1	57.9	15.3	8.1	7.9	15.7	5.9	33.7	24.9	36.1	789.5	17.5	28.0	0.0	35.9	32.5	22.1	28.9	45.1	29.9	40.5	1.6	13.3	10.4	12.1	1440.5	16.1	26.5	25.3	24.4	19.0	6.6	33.9	28.1	17.0	53.0	11.2	6.5	24.5	10.8	26.4	17.3	20.7	13.8	20.9	15.9
GLT1D1	FLJ31978	ENSG00000151948	"Glycosyltransferase 1 domain containing 1"	Q96MS3	12	128853427-128984968	"Predicted intracellular proteins, Predicted secreted proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 23.1;bone marrow: 25.4;liver: 24.7"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 11.5;Hepatocytes: 7.9;Kupffer cells: 11.4;Late spermatids: 34.0;Muller glia cells: 9.8"	"Group enriched"	"Detected in some"	6	"liver cancer: 6.2;testis cancer: 2.6;thyroid cancer: 4.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 23.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 23.1"	"Group enriched"	"Detected in some"	6	"MOLT-4: 12.4;NTERA-2: 18.0;SCLC-21H: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039051, HPA039052"			Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA039051: AB_10673299, HPA039052: AB_10672839"	"unprognostic (1.49e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.93e-5)"	"unprognostic (2.39e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.41e-1)"	3.0	0.6	7.0	7.0	12.4	25.4	0.6	7.1	15.5	1.8	0.6	1.2	0.2	0.5	4.1	1.4	0.9	2.1	2.1	1.2	6.3	10.5	1.2	24.7	2.2	4.5	5.8	6.4	0.6	1.2	0.4	1.0	1.0	7.6	1.3	0.7	2.6	0.4	1.9	8.2	1.3	0.6	3.6	1.6	9.2	0.6	14.7	1.3	0.1	2.0	0.0	0.8	1.7	0.6	0.0	1.4	23.1	3.8	0.0	0.3	0.8	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.3	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	23.1	0.0	1.1	1.4	0.0	0.8	7.0	12.4	7.1	15.5	6.3	10.5	5.8	6.4	7.6	1.3	0.0	0.0	0.5	0.0	0.8	0.4	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.5	0.0	0.0	1.8	11.4	34.0	0.3	1.7	1.7	0.0	0.0	9.8	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.6	0.2	0.3	0.1	0.0	0.0	0.0
GLYR1	"BM045, HIBDL, N-PAC, NP60"	ENSG00000140632	"Glyoxylate reductase 1 homolog"	Q49A26	16	4803203-4847342	"Predicted intracellular proteins"		"DNA-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017022, HPA048226, HPA050136"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB017022: , HPA048226: AB_2680320, HPA050136: AB_2681028"	"unprognostic (4.72e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.19e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.47e-3)"	"prognostic favorable (8.74e-7)"	"unprognostic (3.34e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.86e-1)"	24.1	33.2	39.1	29.4	37.4	27.5	22.5	26.3	44.8	24.8	32.6	31.0	32.8	30.7	30.0	20.6	32.1	33.9	26.1	28.3	29.8	24.8	39.0	30.5	24.5	27.6	27.0	33.1	22.2	27.4	53.4	34.7	24.1	37.1	30.4	32.3	28.5	29.9	29.4	41.6	24.3	29.9	30.1	27.3	30.7	33.9	17.4	26.0	27.6	29.6	17.2	30.0	35.3	22.7	7.6	8.3	22.2	14.5	5.2	7.5	5.5	13.1	14.7	24.3	15.1	21.4	17.2	23.3	24.9	18.6	19.1	16.4	20.7	23.5	21.5	23.8	22.9	15.7	14.6	30.4	20.9	17.3	34.9	18.3	22.1	17.7	14.5	12.1	35.7	41.2	16.3	16.6	18.0	13.3	18.4	24.2	20.3	37.0	18.6	20.7	21.4	29.0	19.8	28.8	19.8	11.1	37.5	19.1	26.4	23.5	19.8	29.7	15.1	27.0	25.3	11.5	27.9	28.4	37.8	26.8	13.1	14.7	59.1	15.5	15.5	21.6	45.0	9.4	17.8	26.8	6.3	10.9	5.7	7.5	9.8	6.5	5.1	4.9	7.1	7.3	7.6	5.2	4.6	22.2	5.2	14.5	8.3	4.9	5.5	39.1	37.4	26.3	44.8	29.8	24.8	27.0	33.1	37.1	26.0	35.7	45.5	25.1	16.3	16.9	31.8	36.2	30.6	93.7	46.6	29.6	27.5	23.2	56.3	20.8	7.9	26.3	37.1	0.0	16.8	26.4	21.1	25.4	30.1	47.3	28.0	42.9	44.5	25.8	38.6	8.0	22.5	29.5	20.3	44.1	38.4	22.8	24.2	37.4	15.2	42.9	40.9	19.4	16.9	20.9	24.5	21.1	29.9	17.5	33.2	17.0
GMEB1	"P96PIF, PIF96"	ENSG00000162419	"Glucocorticoid modulatory element binding protein 1"	Q9Y692	1	28668732-28719353	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044811, HPA052975"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044811: AB_10959666, HPA052975: AB_2682003"	"unprognostic (1.52e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.49e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.91e-7)"	"unprognostic (1.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-2)"	"unprognostic (8.41e-2)"	"unprognostic (4.79e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.13e-2)"	8.3	6.6	8.0	14.0	6.5	21.1	8.7	13.5	9.0	8.8	8.0	8.4	6.4	5.4	10.9	8.0	10.4	8.5	8.0	6.8	7.8	4.9	6.6	7.3	8.7	11.3	5.8	7.0	12.1	7.5	8.6	8.8	16.4	5.8	7.2	8.4	8.0	7.4	6.8	10.3	9.3	8.6	9.1	6.3	11.5	7.4	11.4	6.4	25.3	7.5	7.0	14.1	7.9	12.4	10.8	9.7	14.4	12.7	10.6	12.8	6.3	9.3	6.8	11.6	10.4	3.8	7.1	8.2	10.0	7.3	6.5	9.7	2.1	7.6	17.3	5.3	9.3	3.9	3.7	10.3	7.8	8.5	19.7	6.3	16.1	7.1	4.1	5.8	13.3	8.3	5.7	5.6	15.7	10.2	5.7	8.9	8.7	9.6	13.9	7.8	8.2	8.3	4.4	15.4	6.3	4.6	5.6	7.9	8.0	4.9	7.7	8.5	7.0	9.5	6.5	6.5	8.1	4.9	6.9	9.0	4.5	10.8	7.6	13.5	6.2	10.5	9.7	5.4	12.5	7.0	10.0	8.2	14.4	11.1	10.2	8.4	6.6	10.6	12.8	9.7	10.8	8.8	9.3	11.8	10.6	12.7	7.2	8.9	6.3	8.0	6.5	13.5	9.0	7.8	4.9	5.8	7.0	5.8	6.4	6.0	24.8	13.5	13.9	15.0	22.8	4.2	5.1	5.3	12.5	14.0	11.8	11.6	5.0	9.2	8.0	10.6	9.6	23.3	9.5	13.6	7.3	9.8	27.7	5.6	9.4	23.8	7.5	17.8	12.9	2.2	8.9	11.7	1.7	8.2	11.1	17.5	9.5	10.4	7.4	4.9	23.9	19.4	7.6	14.4	27.4	14.6	27.0	15.9	9.2	15.6
GMEB2	"KIAA1269, P79PIF, PIF79"	ENSG00000101216	"Glucocorticoid modulatory element binding protein 2"	Q9UKD1	20	63587602-63627041	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009706, HPA067455"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA009706: AB_1078996, HPA067455: AB_2685845"	"unprognostic (4.55e-1)"	"unprognostic (5.65e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.04e-1)"	"unprognostic (5.47e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.86e-3)"	"unprognostic (2.82e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.29e-1)"	9.3	8.2	7.4	9.0	9.8	29.8	8.4	13.5	11.5	8.7	10.5	7.7	6.9	9.6	10.6	6.1	10.0	11.0	9.5	7.4	8.1	6.2	7.7	9.3	8.7	11.5	6.0	6.5	11.5	17.6	9.6	9.5	14.5	7.2	9.9	5.1	9.8	16.0	7.5	10.1	10.0	11.0	10.3	7.1	12.1	8.8	18.8	5.7	24.7	18.0	9.5	10.4	9.2	13.8	3.0	2.6	4.4	5.6	1.9	4.5	2.2	10.8	6.6	8.1	7.0	4.0	3.7	10.8	7.5	4.8	12.1	6.4	20.5	8.1	8.6	7.9	6.5	8.8	15.5	6.3	11.1	5.4	4.6	7.1	6.6	9.7	9.8	5.3	6.3	11.1	5.2	10.6	7.8	9.8	5.1	5.3	11.0	9.8	6.3	4.2	11.6	15.4	13.9	5.8	12.9	10.7	16.8	8.3	7.9	5.0	9.6	12.2	10.0	13.6	12.0	7.8	3.9	14.7	10.4	6.6	13.4	7.3	7.9	8.3	12.0	9.8	13.7	8.0	5.9	8.6	0.0	1.9	3.2	4.5	2.6	4.3	2.1	4.0	3.9	2.1	3.0	4.5	3.9	4.4	1.9	5.6	2.6	2.7	2.2	7.4	9.8	13.5	11.5	8.1	6.2	6.0	6.5	7.2	5.7	3.0	6.4	2.2	10.1	5.4	5.1	2.8	7.6	1.4	4.5	3.5	0.0	3.7	1.7	3.9	18.0	4.7	5.1	0.0	4.6	5.3	3.0	11.1	2.3	5.7	3.8	7.9	9.2	4.3	2.8	5.1	3.7	2.6	1.7	1.0	7.9	1.7	5.0	7.0	5.3	3.0	4.7	6.5	3.7	14.9	9.7	4.6	9.6	4.3	5.3	10.3
GMIP	ARHGAP46	ENSG00000089639	"GEM interacting protein"	Q9P107	19	19629476-19643667	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 32.7;bone marrow: 31.0;lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 20.7;Kupffer cells: 34.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042484, HPA045481"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA042484: AB_2678018, HPA045481: AB_2679343"	"unprognostic (7.54e-2)"	"unprognostic (5.35e-3)"	"unprognostic (3.10e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.23e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.75e-3)"	"prognostic unfavorable (3.97e-5)"	"prognostic favorable (3.03e-4)"	"unprognostic (4.92e-2)"	"unprognostic (2.54e-1)"	"prognostic favorable (5.15e-4)"	6.1	2.8	3.5	20.3	4.9	31.0	4.0	0.9	4.1	2.9	6.9	4.3	2.7	7.0	2.7	3.2	6.2	4.4	7.9	3.3	4.3	3.4	4.2	3.9	11.7	28.0	4.2	2.5	2.4	4.6	10.6	3.0	3.9	3.4	4.1	4.6	2.7	6.0	4.5	1.5	4.9	15.3	2.9	4.9	40.0	11.1	2.2	3.1	26.8	6.2	2.7	23.2	6.1	4.5	6.6	6.7	32.7	13.9	4.2	6.4	4.6	4.4	2.1	2.8	3.0	3.1	1.6	11.2	2.8	2.5	1.7	1.6	1.7	6.1	11.0	5.8	2.0	2.2	5.4	1.8	3.1	1.1	3.8	2.8	3.5	3.3	1.8	0.9	9.8	43.8	2.0	2.1	1.8	1.0	2.0	3.8	9.9	2.3	4.0	1.8	6.6	6.1	16.2	1.6	5.8	3.8	10.6	1.2	6.3	3.2	10.7	2.4	7.2	3.9	4.1	1.6	2.2	3.8	14.1	7.0	3.2	1.8	3.6	2.1	2.0	0.8	9.1	2.0	12.9	2.1	2.9	8.3	21.5	6.4	10.6	5.9	5.9	4.0	5.7	6.7	6.6	4.5	4.6	32.7	4.2	13.9	6.1	4.5	4.6	3.5	4.9	0.9	4.1	4.3	3.4	4.2	2.5	3.4	3.1	0.0	15.1	15.6	1.1	1.0	0.0	0.6	2.5	1.4	2.3	0.0	0.0	0.5	0.0	3.8	0.1	1.4	13.3	0.0	4.2	4.6	0.9	1.6	6.9	0.9	20.7	0.0	0.0	2.5	34.3	0.0	0.6	16.5	1.7	17.2	6.3	0.2	9.4	12.2	0.7	0.6	0.0	0.0	0.9	0.1	1.5	1.0	0.7	15.9	5.8	2.6
GMNN	Gem	ENSG00000112312	"Geminin, DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 95.0"	"Cell type enhanced"	"Detected in many"	8	"Paneth cells: 272.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	4.5	3.9	10.7	11.2	19.0	24.1	10.7	15.6	9.4	4.9	17.1	3.2	9.7	7.6	5.3	6.3	8.0	7.3	4.7	3.7	11.0	10.2	10.8	8.4	4.4	12.0	13.6	9.8	7.2	95.0	2.6	7.5	7.9	10.7	18.4	18.9	3.4	4.2	11.6	3.7	17.3	7.4	5.7	7.9	12.6	9.7	19.6	11.9	26.1	13.2	11.0	9.7	15.2	7.4	8.5	9.2	15.8	6.7	5.3	15.2	5.6	24.9	14.8	37.6	15.5	5.3	5.7	25.1	24.5	13.0	29.5	32.4	28.7	9.0	25.1	31.3	7.9	21.7	14.7	32.5	18.1	31.8	9.3	34.0	34.4	26.4	47.0	5.0	26.7	12.6	4.6	5.9	17.9	7.0	6.1	14.5	19.6	43.2	13.4	20.8	19.5	50.1	28.9	20.5	20.4	11.7	29.2	29.4	32.2	12.4	21.8	30.2	18.6	11.0	18.2	21.6	22.1	19.1	16.4	7.1	18.1	18.3	20.8	41.5	14.9	45.7	47.1	5.5	50.4	25.9	5.3	5.3	15.8	4.6	6.7	5.8	8.5	8.9	7.1	7.4	4.5	6.6	7.3	3.0	5.3	4.7	9.2	15.2	5.6	10.7	19.0	15.6	9.4	11.0	10.2	13.6	9.8	10.7	11.9	6.0	14.1	15.7	25.3	29.3	8.9	9.4	15.3	33.5	52.4	41.8	2.0	52.0	8.3	78.3	58.9	14.3	21.2	0.0	100.1	110.5	15.8	27.7	12.7	15.3	45.0	11.1	24.9	9.8	9.2	17.5	8.9	12.4	21.9	19.8	24.9	29.4	43.9	272.7	10.3	14.6	12.1	19.4	12.3	132.2	59.4	55.6	40.7	17.5	87.0	19.7
GNL2	"HUMAUANTIG, Ngp-1, Nog2, Nug2"	ENSG00000134697	"G protein nucleolar 2"	Q13823	1	37566816-37595935	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027163, HPA060026"	Approved		Enhanced	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA027163: AB_10601655, HPA060026: AB_2684191"	"unprognostic (1.38e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (5.86e-9)"	"unprognostic (2.28e-1)"	"unprognostic (7.80e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (1.01e-2)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (2.90e-11)"	"unprognostic (3.36e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.87e-1)"	24.1	17.4	13.8	24.1	15.0	30.7	21.9	11.2	14.2	15.9	15.7	11.7	16.8	12.4	20.2	18.3	21.8	16.4	14.8	17.9	12.5	11.3	18.0	26.9	18.7	19.6	21.2	11.5	19.6	17.4	15.2	21.6	24.5	15.8	16.4	18.7	10.1	19.4	18.9	40.3	22.2	16.3	17.4	15.0	21.8	17.8	21.4	15.2	24.3	17.1	27.5	22.2	20.5	19.8	18.4	25.2	14.4	22.7	20.7	17.4	12.2	19.3	10.0	19.4	20.3	15.6	18.0	31.6	29.5	20.5	27.3	27.9	27.3	22.9	31.8	19.3	21.7	15.4	18.3	31.7	24.0	37.7	18.0	24.8	31.9	20.1	21.9	20.9	41.8	22.9	11.3	22.1	37.2	44.6	13.0	19.6	13.9	42.3	22.9	26.4	17.1	22.5	25.3	50.9	14.0	19.6	24.1	35.3	36.1	22.8	21.2	23.8	21.9	22.3	22.5	21.9	30.2	16.1	24.4	15.7	18.5	26.1	39.1	40.9	21.5	19.3	55.3	21.3	33.7	23.5	10.3	17.1	14.4	15.3	22.7	17.4	18.4	14.3	16.5	25.2	13.5	15.1	14.5	1.8	20.7	20.7	18.5	16.9	12.2	13.8	15.0	11.2	14.2	12.5	11.3	21.2	11.5	15.8	15.2	14.9	47.4	26.7	52.5	56.2	7.6	18.2	5.1	73.6	79.6	7.0	9.8	32.5	23.2	37.6	45.3	20.2	13.4	0.0	54.2	43.6	26.3	29.5	46.2	16.2	28.9	6.4	16.6	11.6	17.1	7.8	22.2	29.8	8.5	36.1	16.0	19.1	39.6	17.8	18.0	12.9	8.6	0.0	33.0	50.5	54.9	46.2	38.6	26.7	19.7	42.6
GNL3	"C77032, E2IG3, MGC800, NS"	ENSG00000163938	"G protein nucleolar 3"	Q9BVP2	3	52681156-52694492	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020770, HPA036742, HPA036743"	Enhanced		Enhanced	"Nucleoli rim,Nuclear bodies,Mitotic chromosome"		Yes	No			"Nucleoli rim"	"Nuclear bodies, Mitotic chromosome"	"CAB020770: , HPA036742: AB_2675282, HPA036743: AB_2675283"	"unprognostic (4.40e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.46e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.67e-3)"	"prognostic unfavorable (6.11e-4)"	"prognostic unfavorable (5.69e-5)"	"unprognostic (1.33e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.06e-2)"	27.7	28.0	14.8	21.8	17.5	13.0	40.5	17.2	25.4	25.0	27.0	10.0	22.8	21.6	22.2	17.5	41.8	17.4	16.1	20.5	21.6	15.9	19.3	50.4	19.5	26.6	18.4	15.7	27.2	45.1	14.1	43.3	24.7	23.4	28.3	27.0	8.8	30.3	27.3	52.2	24.1	21.2	19.5	19.6	32.0	22.7	15.0	16.9	18.3	18.1	34.3	35.8	44.3	24.9	16.2	21.6	1.8	8.9	13.6	19.4	10.0	21.6	16.2	23.7	25.4	22.6	23.1	36.4	26.7	21.2	28.6	21.5	24.4	15.9	50.6	8.9	20.5	22.0	15.7	39.1	25.5	38.4	31.6	27.8	38.7	27.6	37.4	47.2	55.0	28.7	20.5	45.5	30.9	48.3	19.1	22.4	20.5	42.5	27.1	19.4	15.4	33.0	30.7	40.9	31.2	31.8	19.6	19.3	62.6	22.5	30.3	16.9	21.7	16.7	38.4	37.4	22.2	15.1	31.2	17.3	19.2	20.4	27.9	55.8	29.9	48.3	76.7	20.4	40.1	30.2	0.6	8.0	1.8	11.3	8.9	19.4	16.2	15.3	13.4	13.9	13.5	17.7	16.6	1.0	13.6	6.4	21.6	9.7	10.0	14.8	17.5	17.2	25.4	21.6	15.9	18.4	15.7	23.4	16.9	20.8	41.6	75.9	90.4	145.4	17.9	47.2	20.4	58.9	134.2	12.2	9.8	64.5	34.9	72.1	42.3	45.7	17.0	23.3	90.4	94.6	60.7	74.6	59.2	40.2	36.4	20.6	45.8	21.5	21.0	20.0	48.1	42.7	74.2	74.9	51.9	16.5	84.9	24.6	32.2	31.0	12.2	6.5	94.8	32.6	58.9	134.4	75.5	45.9	64.1	112.5
GOLGA1	"golgin-97, MGC33154"	ENSG00000136935	"Golgin A1"	Q92805	9	124878357-124948492	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9;Spermatocytes: 43.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013065, HPA044329, HPA050555"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB013065: AB_221447, HPA044329: AB_2678897, HPA050555: AB_2681174"	"unprognostic (5.44e-2)"	"unprognostic (9.35e-2)"	"unprognostic (6.92e-2)"	"prognostic favorable (2.21e-4)"	"unprognostic (9.34e-2)"	"unprognostic (4.43e-1)"	"unprognostic (4.40e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.03e-3)"	"unprognostic (3.06e-1)"	"unprognostic (6.28e-3)"	"unprognostic (4.05e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.52e-2)"	13.2	16.2	11.2	13.6	16.0	7.7	12.1	11.0	15.3	11.8	15.1	22.0	16.9	15.0	19.3	9.6	15.2	12.3	11.5	14.9	13.6	9.1	11.8	16.0	12.0	11.5	17.3	13.2	13.6	15.8	16.8	15.1	14.2	16.6	13.1	14.5	19.3	13.4	13.4	20.0	16.4	14.7	21.4	16.9	13.7	13.5	30.0	15.7	8.7	12.5	11.2	12.9	18.2	12.5	5.5	6.7	11.5	5.2	4.1	6.9	1.8	6.3	11.5	7.0	7.3	12.2	10.7	8.9	10.5	11.4	11.3	8.3	7.6	7.6	4.3	5.3	11.8	8.7	16.8	5.6	9.0	8.3	6.2	5.5	4.6	14.8	10.0	14.0	5.4	10.9	7.3	6.6	10.9	13.3	8.2	10.1	5.5	7.3	7.4	8.0	13.4	3.8	6.3	2.5	15.3	10.7	2.4	10.1	9.3	5.8	8.8	4.0	7.6	12.8	10.5	6.9	6.4	20.0	3.8	11.5	10.5	5.9	13.4	9.7	9.4	14.4	5.0	13.3	5.7	11.0	10.4	5.2	6.1	6.4	5.0	5.2	4.6	4.0	6.9	4.7	5.5	4.2	3.9	11.5	4.1	3.9	6.7	3.7	1.8	11.2	16.0	11.0	15.3	13.6	9.1	17.3	13.2	16.6	15.7	6.0	11.8	3.7	4.0	1.8	15.5	17.5	7.6	25.4	13.6	5.2	60.9	5.7	3.3	8.4	9.4	7.4	8.5	0.0	7.7	4.0	3.9	4.3	15.1	11.9	5.7	17.5	5.2	11.1	7.8	7.7	5.5	5.5	8.5	9.0	10.3	11.8	7.4	0.0	8.5	5.1	36.7	6.5	6.3	43.3	19.6	3.8	7.2	5.3	8.0	3.5
GOLGA2	"GM130, golgin-95"	ENSG00000167110	"Golgin A2"	Q08379	9	128255829-128275995	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB015421, HPA021178, HPA021230, HPA021799"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB015421: AB_831377, HPA021178: AB_1849837, HPA021230: AB_1849839, HPA021799: AB_1849841"	"unprognostic (2.88e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.64e-4)"	"unprognostic (3.70e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.50e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.21e-2)"	"prognostic favorable (9.77e-5)"	"unprognostic (3.92e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.84e-2)"	"unprognostic (4.27e-2)"	23.3	21.2	21.2	15.4	27.0	15.5	23.4	23.0	30.5	37.7	20.0	23.4	35.0	15.3	30.7	32.6	34.7	23.6	22.1	32.2	18.9	21.4	23.9	30.5	22.5	11.5	16.9	20.5	30.7	47.1	54.2	66.6	34.8	26.3	29.6	23.5	27.6	31.3	38.2	27.6	33.0	23.5	30.4	33.3	15.4	24.5	16.1	18.6	11.3	26.8	27.4	27.9	28.9	30.9	5.3	8.8	21.1	5.0	5.0	4.6	1.8	14.5	14.6	15.6	16.3	39.5	45.3	14.5	29.3	37.8	23.5	21.3	17.6	13.3	6.9	11.1	44.3	25.1	28.6	8.8	13.7	22.2	10.0	8.5	7.4	34.3	14.2	26.3	11.3	22.7	28.9	22.0	23.6	24.5	37.2	18.7	16.1	23.9	17.2	22.7	30.2	9.4	9.6	4.8	26.2	26.3	9.8	17.6	11.8	18.8	12.2	9.0	10.6	18.3	15.4	12.9	16.5	36.2	9.3	26.1	31.7	16.6	20.5	15.1	13.2	14.6	8.7	27.9	5.8	20.5	15.7	4.7	7.9	4.6	3.5	2.9	3.9	3.0	2.4	1.8	5.3	3.2	4.3	21.1	5.0	5.0	8.8	2.3	1.8	21.2	27.0	23.0	30.5	18.9	21.4	16.9	20.5	26.3	18.6	41.7	66.3	18.6	24.6	28.2	66.7	75.3	43.3	80.3	56.9	40.1	39.3	32.7	36.5	38.5	26.9	31.3	51.3	0.0	52.8	30.4	48.0	41.2	63.6	61.8	25.1	23.8	44.3	51.5	22.5	4.0	63.3	20.0	23.6	15.4	66.4	27.5	47.6	38.6	60.8	25.6	48.8	12.9	33.0	42.2	27.1	39.6	85.6	23.5	30.2	32.2
GOLGA3	"GCP170, golgin-160, MEA-2"	ENSG00000090615	"Golgin A3"	Q08378	12	132768909-132828858	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Rod photoreceptor cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039809, HPA040044"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA039809: AB_10962348, HPA040044: AB_10981600"	"unprognostic (1.93e-1)"	"unprognostic (7.91e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (2.73e-4)"	"unprognostic (1.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (6.47e-5)"	"unprognostic (1.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.20e-1)"	17.5	14.2	14.7	17.6	17.0	13.8	14.5	23.7	21.4	20.1	19.9	17.6	20.6	12.3	18.2	20.0	18.3	14.3	20.7	17.0	14.6	16.7	11.2	18.7	15.5	16.0	15.8	13.2	20.5	39.1	16.1	32.1	18.8	16.2	18.0	16.8	14.3	26.9	19.8	20.5	21.4	15.5	24.6	12.9	18.2	22.2	13.9	14.1	9.8	15.3	15.4	18.2	17.1	16.1	7.3	8.0	5.1	4.6	7.3	7.5	3.5	9.8	20.1	7.2	12.1	25.3	17.1	13.3	16.9	12.8	10.7	9.3	19.0	4.4	13.4	9.1	24.9	9.0	10.3	7.8	10.2	7.3	3.5	9.0	13.5	20.3	12.4	14.7	14.7	19.9	12.9	12.5	14.4	14.5	13.7	10.3	9.3	13.1	5.3	11.1	15.2	12.8	13.7	7.4	7.7	13.6	10.2	8.0	4.8	6.8	23.5	9.1	5.8	14.0	12.5	8.0	8.1	16.3	10.9	21.1	12.6	9.3	14.1	10.8	16.4	13.7	18.2	15.8	8.8	16.0	5.1	4.2	3.6	7.5	4.5	6.6	4.6	5.5	5.9	4.1	7.3	6.3	6.6	3.2	7.3	4.6	8.0	4.5	3.5	14.7	17.0	23.7	21.4	14.6	16.7	15.8	13.2	16.2	14.1	41.7	37.6	16.4	9.3	19.3	25.8	31.4	10.2	16.0	26.1	14.0	94.2	11.6	6.6	14.1	23.9	20.0	46.6	23.3	24.0	20.0	25.5	24.2	11.5	23.7	14.3	17.5	21.4	18.4	8.8	27.7	23.9	11.4	16.9	12.6	43.4	20.3	26.8	27.5	21.2	8.4	104.5	6.5	19.6	19.4	23.9	29.0	19.3	14.1	19.7	22.6
GOLGB1	"GCP, GCP372, giantin, GOLIM1"	ENSG00000173230	"Golgin B1"	Q14789	3	121663199-121749767	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011008, HPA011555"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		35000	"Golgi apparatus"		"HPA011008: AB_1079011, HPA011555: AB_1079010"	"unprognostic (2.56e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.57e-2)"	"unprognostic (5.34e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.58e-2)"	"unprognostic (7.49e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (9.90e-3)"	"unprognostic (9.05e-2)"	16.7	22.3	17.6	12.5	24.0	12.8	25.7	22.3	28.0	24.6	16.8	8.2	27.1	12.7	16.5	35.0	15.9	14.0	14.0	16.6	16.8	10.3	19.7	17.2	13.4	8.5	26.1	14.5	20.9	23.4	26.2	39.4	24.4	17.7	28.0	18.4	12.5	21.5	29.3	11.7	20.5	20.6	21.3	30.6	14.8	16.6	12.1	20.7	9.0	19.3	12.9	10.1	17.2	13.6	3.6	5.8	16.4	4.4	3.9	5.0	1.5	12.4	10.1	10.0	6.5	19.4	21.0	6.3	8.1	17.9	7.9	8.9	8.8	4.6	2.7	6.9	15.1	7.9	5.8	5.9	8.8	9.3	3.9	11.4	7.7	12.1	12.1	11.6	8.5	10.6	17.1	21.0	4.9	12.4	17.1	9.9	4.7	3.5	6.3	8.3	9.0	2.5	6.2	6.5	12.1	10.6	3.4	7.9	6.4	11.7	12.9	7.1	7.9	10.0	7.1	10.5	11.9	8.9	9.6	13.8	7.6	4.6	3.3	5.8	11.7	6.9	4.6	10.2	4.2	2.8	1.7	4.4	4.3	5.0	2.2	4.0	3.6	4.0	3.6	2.7	3.2	3.7	4.0	16.4	3.9	1.7	5.8	3.8	1.5	17.6	24.0	22.3	28.0	16.8	10.3	26.1	14.5	17.7	20.7	271.0	217.5	57.3	76.1	45.8	96.8	233.9	61.1	235.5	260.5	50.6	115.8	64.0	10.0	92.8	49.3	75.2	103.8	0.0	97.4	43.0	46.5	79.1	109.0	56.8	29.9	65.2	88.1	67.5	38.4	14.5	183.8	42.9	32.1	73.9	106.8	82.0	80.8	76.4	187.0	23.3	194.7	84.1	52.3	117.3	42.8	40.0	126.1	28.8	70.0	79.9
GOLIM4	"GIMPC, GOLPH4, GPP130, P138"	ENSG00000173905	"Golgi integral membrane protein 4"	O00461	3	168008677-168095975	"Predicted membrane proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 383.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001677, HPA002315"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		730000	"Golgi apparatus"		"HPA001677: AB_1079017, HPA002315: AB_1079018"	"unprognostic (6.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.84e-3)"	"unprognostic (9.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.62e-3)"	13.0	7.1	25.5	10.8	25.6	4.2	9.3	12.4	24.2	11.3	28.0	18.6	7.4	34.8	15.6	7.1	9.3	9.7	16.2	28.5	31.3	13.8	17.1	31.7	15.6	5.5	24.6	23.2	11.6	8.8	13.3	10.3	12.0	26.8	10.2	28.0	13.3	8.9	7.9	15.5	6.1	44.2	14.6	36.2	11.7	13.0	4.9	30.9	1.8	11.0	12.0	5.0	10.7	12.2	2.0	4.5	11.7	3.3	6.0	0.8	0.7	6.6	9.9	14.1	8.9	24.1	17.9	4.2	39.4	21.2	10.8	9.9	11.0	8.2	14.7	47.4	23.7	17.3	12.3	12.9	11.6	16.4	22.9	16.6	23.8	29.8	13.6	9.7	22.6	13.6	18.6	6.1	9.9	9.8	9.6	12.3	0.0	12.1	42.9	12.1	11.1	0.0	6.1	13.8	12.6	10.7	0.0	14.2	20.4	6.0	2.4	12.7	16.5	24.2	7.3	7.9	9.8	9.0	10.3	22.8	34.4	13.2	23.9	31.4	16.7	11.9	31.7	17.0	13.6	15.3	3.0	3.0	11.7	0.8	3.3	0.2	1.5	0.2	0.6	3.7	2.0	0.0	0.3	0.1	6.0	2.5	4.5	0.0	0.7	25.5	25.6	12.4	24.2	31.3	13.8	24.6	23.2	26.8	30.9	44.7	105.2	7.5	21.5	36.9	14.2	142.4	53.5	13.4	34.2	34.9	35.3	9.2	14.9	18.7	1.3	65.5	167.7	23.3	25.9	12.0	109.4	20.4	56.6	158.4	37.0	15.9	60.8	43.0	34.5	1.5	36.8	47.8	35.4	18.0	109.7	383.7	19.8	168.4	48.1	30.0	58.3	45.3	104.0	5.0	38.5	31.5	4.6	20.1	119.7	6.8
GOLM1	"bA379P1.3, C9orf155, FLJ23608, GOLPH2, GP73"	ENSG00000135052	"Golgi membrane protein 1"	Q8NBJ4	9	86026146-86100173	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"gallbladder: 83.7;stomach 1: 114.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 319.9;Paneth cells: 285.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 343.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010638, HPA011929, CAB015341"	Enhanced		Enhanced	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		70000000	"Golgi apparatus"		"CAB015341: AB_2113334, HPA010638: AB_1849886, HPA011929: AB_1849888"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (8.14e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.40e-3)"	"prognostic unfavorable (1.30e-4)"	"unprognostic (4.89e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.23e-1)"	6.1	53.6	23.3	15.6	18.2	1.9	11.6	23.1	27.7	21.0	53.1	16.5	6.0	62.8	11.9	9.3	4.2	11.1	83.7	4.0	24.7	26.3	22.0	6.6	4.4	2.8	17.4	20.4	11.1	19.5	7.8	15.1	5.3	22.3	39.9	45.5	10.9	43.0	3.5	2.6	4.6	16.5	8.4	25.5	11.3	114.2	5.0	16.4	5.0	19.5	7.9	36.6	11.6	11.0	1.2	2.2	7.2	5.9	1.2	5.7	2.5	29.5	29.0	21.8	24.6	28.1	16.3	23.0	13.5	9.8	21.3	17.3	14.2	59.3	0.6	13.4	26.1	20.6	22.9	13.3	13.3	15.5	1.0	21.2	9.2	19.3	0.7	16.7	13.6	7.4	24.7	7.2	20.0	7.3	26.8	36.3	4.4	5.7	0.9	12.0	13.9	1.6	10.2	34.3	38.7	21.0	8.7	24.9	4.5	35.5	12.7	24.6	15.4	18.4	40.0	15.1	14.7	22.5	14.0	23.1	5.6	15.7	16.8	16.0	79.6	7.5	0.2	24.1	6.1	12.1	2.1	5.5	0.8	5.7	3.9	0.7	1.1	0.5	0.8	0.7	1.2	0.7	1.3	7.2	1.2	5.9	2.2	0.3	2.5	23.3	18.2	23.1	20.8	24.7	26.3	17.4	20.4	22.3	16.4	8.9	11.7	0.0	9.8	2.1	16.9	4.3	71.4	69.6	61.4	33.2	7.9	5.4	21.6	148.1	319.9	21.5	193.3	0.0	197.4	30.2	20.6	130.5	1.1	12.5	9.8	63.5	70.2	9.8	7.5	196.5	17.0	3.3	21.9	1.0	76.8	15.7	203.7	285.1	12.4	11.5	6.1	0.0	10.3	8.9	34.3	0.9	5.4	4.3	129.2	17.6
GON4L	"FLJ20203, GON-4, GON4, YARP"	ENSG00000116580	"Gon-4 like"	Q3T8J9	1	155749662-155859400	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 123.7;Rod photoreceptor cells: 164.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006986, HPA057305, HPA074504"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006986: AB_1080620, HPA057305: AB_2683408, HPA074504: AB_2686696"	"unprognostic (3.16e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (4.19e-4)"	"unprognostic (9.85e-3)"	"unprognostic (5.21e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.49e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.12e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.26e-2)"	"unprognostic (5.83e-2)"	17.4	12.5	13.5	16.1	18.9	13.6	18.3	30.1	21.6	17.6	15.7	14.4	18.7	11.8	25.8	18.3	13.7	15.9	12.0	14.0	14.8	10.2	14.9	12.7	16.7	18.3	14.8	13.0	17.2	16.3	26.0	22.3	15.9	15.3	16.1	15.4	16.3	15.2	15.8	18.8	17.8	17.5	18.3	16.5	21.1	15.1	14.1	16.0	25.1	18.8	11.4	24.8	16.9	16.0	7.0	5.2	10.2	4.7	8.4	6.6	2.5	11.4	9.5	18.4	11.3	11.6	14.6	11.6	10.4	12.9	13.5	13.2	11.3	10.5	13.2	11.4	13.6	6.8	13.3	13.6	12.1	15.7	12.3	9.6	13.2	11.7	6.3	11.0	15.5	12.3	12.9	10.7	14.9	14.2	13.9	15.9	14.7	16.8	5.1	11.3	11.7	13.4	9.4	20.3	14.4	10.9	12.4	11.7	14.7	9.9	13.8	10.3	17.3	12.7	12.9	10.0	19.4	14.1	18.6	17.8	11.0	9.1	11.2	12.9	20.7	13.8	22.2	9.6	9.3	12.1	5.0	4.7	4.0	6.6	3.7	4.4	3.7	4.3	4.6	4.7	7.0	4.5	4.1	10.2	8.4	3.1	5.2	4.2	2.5	13.5	18.9	30.1	21.6	14.8	10.2	14.8	13.0	15.3	16.0	14.9	32.6	21.4	18.8	10.8	69.8	18.6	15.3	16.0	34.2	19.2	123.7	20.5	8.3	19.9	17.3	35.0	19.8	0.0	15.7	19.3	20.6	22.5	38.0	11.0	17.2	73.1	31.2	23.4	16.3	8.5	32.5	21.6	15.1	34.3	17.7	44.4	18.7	20.1	25.8	10.1	164.4	38.8	17.6	49.5	37.5	15.3	37.6	34.6	19.6	19.5
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	18.4	15.6	17.2	21.1	22.2	6.5	21.5	30.0	27.8	26.9	19.3	17.0	25.7	12.7	25.3	20.1	15.1	20.3	17.3	22.8	18.9	17.8	15.6	19.2	14.1	19.0	18.6	21.8	28.3	16.9	32.6	34.2	21.2	21.2	18.0	21.8	10.7	17.5	24.6	17.6	19.5	17.3	20.7	18.7	18.5	15.5	17.6	18.3	32.1	25.3	13.2	17.4	18.7	26.4	9.9	11.0	9.8	5.5	10.6	11.9	4.9	5.7	6.3	8.2	10.9	18.0	21.4	13.0	24.1	17.8	13.2	13.7	9.6	6.5	17.5	10.5	13.5	26.2	13.1	15.8	11.6	18.6	8.7	8.8	16.0	16.4	15.4	18.8	21.3	10.7	25.3	32.5	9.8	28.7	26.7	11.2	12.3	14.9	7.2	26.6	5.3	8.8	16.6	7.1	9.9	6.8	13.6	15.9	12.6	10.1	5.4	11.7	9.1	24.2	8.4	6.4	16.4	6.1	20.7	13.3	0.9	12.1	12.2	25.9	12.9	11.6	14.9	16.5	18.1	10.1	9.8	5.0	3.8	8.4	4.5	11.9	9.7	9.1	8.9	6.6	9.9	10.7	10.8	3.7	10.6	5.5	11.0	8.9	4.9	17.2	22.2	30.0	27.8	18.9	17.8	18.6	21.8	21.2	18.3	20.8	17.7	13.7	21.2	41.4	55.8	35.1	33.1	33.5	22.7	19.2	21.6	65.0	23.2	23.3	25.7	32.0	27.1	0.0	22.3	50.4	51.1	21.8	31.1	35.0	32.7	69.9	32.2	39.3	19.9	10.2	39.1	21.9	27.0	17.2	57.0	39.5	17.6	37.4	39.6	20.7	34.1	32.3	30.3	106.6	43.2	52.2	43.7	28.7	34.0	22.1
GORAB	"FLJ11752, GO, NTKL-BP1, SCYL1BP1"	ENSG00000120370	"Golgin, RAB6 interacting"	Q5T7V8	1	170532129-170553446	"Disease related genes, Predicted intracellular proteins"			Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027208, HPA027250, HPA027746"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA027208: AB_10599622, HPA027250: AB_10611253, HPA027746: "	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.75e-3)"	"prognostic favorable (1.39e-4)"	"prognostic unfavorable (5.26e-4)"	"unprognostic (8.48e-3)"	"unprognostic (2.94e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (7.83e-12)"	"unprognostic (2.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.70e-1)"	7.7	14.7	8.4	9.4	9.2	0.5	10.6	8.7	9.5	10.7	9.4	4.8	7.0	4.8	8.8	10.5	6.3	6.8	6.7	8.2	7.4	7.8	7.2	11.1	6.8	9.6	6.3	8.1	12.6	9.7	6.5	20.6	9.4	8.7	11.1	10.4	6.3	8.8	13.1	3.3	6.5	7.0	6.4	11.1	10.4	5.6	8.6	7.3	8.7	10.5	4.2	9.7	10.4	10.0	6.2	7.3	1.2	7.4	7.9	9.4	5.5	5.1	5.0	9.6	3.6	12.9	9.6	6.3	7.8	12.1	6.9	7.2	3.2	8.8	7.5	9.0	7.9	4.5	6.5	9.5	4.6	9.2	8.0	2.9	5.0	6.5	4.0	8.7	6.6	5.1	8.3	4.5	7.4	6.9	8.6	5.4	4.3	6.8	3.7	7.3	1.2	9.5	6.0	8.5	11.6	6.3	5.7	6.4	10.0	6.2	3.8	2.5	5.3	6.5	7.9	18.2	6.4	5.0	11.7	6.9	11.0	5.8	4.3	10.8	6.7	7.3	6.6	9.2	6.0	9.8	1.0	7.4	0.0	4.7	7.4	7.4	6.1	8.3	7.2	7.3	6.2	7.3	6.2	1.2	7.9	5.7	4.6	9.4	5.5	8.4	9.2	8.7	9.5	7.4	7.8	6.3	8.1	8.7	7.3	0.0	10.7	6.0	2.9	2.5	3.9	6.7	7.6	1.4	6.8	5.2	2.0	5.2	3.3	9.4	1.6	7.4	5.1	0.0	5.3	5.6	10.4	4.1	12.8	5.8	6.3	4.8	0.0	3.7	6.3	2.6	13.0	3.9	3.3	10.0	6.4	3.4	5.8	7.0	6.0	4.4	7.2	6.5	8.5	13.1	7.7	1.4	4.7	5.7	6.0	2.7
GORASP2	"GOLPH6, GRASP55, GRS2"	ENSG00000115806	"Golgi reassembly stacking protein 2"	Q9H8Y8	2	170928464-170967129	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 120.2"	"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 275.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035274, HPA035275, CAB075758"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB075758: AB_2665764, HPA035274: AB_2674546, HPA035275: AB_10602600"	"unprognostic (2.04e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.94e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (3.13e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.38e-8)"	"unprognostic (1.26e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.13e-1)"	6.6	9.4	6.6	6.6	6.9	4.0	7.3	6.6	6.6	12.1	6.9	6.6	9.6	7.2	9.1	15.5	9.0	6.5	6.6	10.1	6.6	7.1	6.6	10.3	6.6	6.6	6.6	6.6	6.7	13.6	6.6	13.1	10.4	6.6	7.4	7.1	6.6	12.8	9.8	7.1	7.5	6.6	7.2	7.0	6.6	7.5	120.2	6.6	6.6	8.7	6.6	6.6	7.5	6.9	12.3	16.9	11.7	10.7	16.0	23.7	14.2	11.8	9.8	14.0	11.4	27.4	20.7	17.1	19.8	21.9	17.5	22.2	25.8	16.2	17.8	11.2	27.4	11.9	15.0	15.8	18.3	20.8	10.4	21.6	20.2	9.1	40.4	27.8	16.8	13.1	15.7	20.6	17.5	29.4	19.0	19.1	12.4	17.5	13.6	15.9	19.7	15.5	27.0	14.8	21.5	12.2	13.1	12.8	22.1	25.5	17.1	12.7	11.5	11.1	19.7	19.7	12.6	12.5	16.0	17.3	16.9	11.2	16.1	10.8	14.9	9.5	21.4	17.4	12.0	19.0	11.7	10.0	6.4	15.2	10.6	23.7	12.3	17.2	18.1	12.6	10.2	17.4	14.5	2.4	16.0	10.7	16.9	14.5	14.2	6.6	6.9	6.6	6.6	6.6	7.1	6.6	6.6	6.6	6.6	38.7	30.1	27.4	29.3	33.1	32.2	35.0	22.9	14.7	40.9	19.2	29.5	97.0	48.0	54.4	187.2	27.0	30.6	0.0	68.7	90.0	49.3	42.4	19.7	42.9	42.1	39.7	30.1	46.6	19.8	275.6	54.4	28.0	45.5	58.7	49.9	31.0	60.3	38.6	46.7	34.9	30.2	58.2	34.0	31.9	40.3	31.6	192.1	36.3	42.5	66.5
GPATCH4	"DKFZP434F1735, FLJ20249, GPATC4"	ENSG00000160818	"G-patch domain containing 4"		1	156594487-156601496	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028323, HPA054319"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA028323: AB_10601017, HPA054319: AB_2682447"	"unprognostic (2.80e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.17e-5)"	"unprognostic (2.40e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.33e-3)"	"unprognostic (9.60e-2)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (3.70e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.80e-2)"	18.2	13.3	14.7	16.9	27.7	9.4	15.1	6.9	22.5	10.0	12.1	8.3	3.9	9.7	13.8	10.0	14.0	11.6	7.2	11.9	12.6	12.1	18.0	23.1	10.0	15.7	15.3	12.4	15.3	12.9	19.6	16.2	10.0	24.2	12.6	14.6	5.7	11.5	11.9	47.1	10.9	10.0	15.1	10.2	16.6	12.5	8.8	13.2	8.0	10.3	19.0	19.1	12.5	10.1	16.6	10.1	0.3	11.2	10.7	15.9	7.6	17.1	23.7	10.0	14.4	9.2	7.1	13.0	21.3	8.5	16.7	9.8	24.2	13.0	41.4	17.7	14.9	10.8	12.0	22.7	18.8	18.5	12.3	22.5	24.7	23.2	18.5	8.3	55.1	16.0	8.0	15.9	31.6	28.0	4.7	11.7	13.5	40.4	10.4	13.5	32.0	22.6	13.3	43.8	29.9	25.0	22.6	17.1	28.7	11.5	20.4	15.8	23.8	20.4	44.9	13.1	11.4	14.7	26.8	17.8	15.9	21.7	16.5	38.1	19.1	21.0	53.4	14.4	28.6	24.0	0.0	5.4	0.1	13.3	10.5	13.4	16.6	13.5	14.7	10.1	16.6	15.4	15.9	0.3	10.7	11.2	6.4	8.5	7.6	14.7	27.7	6.9	22.5	12.6	12.1	15.3	12.4	24.2	13.2	29.8	34.7	41.0	38.8	65.5	7.1	24.8	28.1	16.0	40.9	15.7	7.9	31.9	21.6	38.5	7.6	30.2	8.5	23.3	48.9	40.5	22.6	43.6	56.6	37.8	33.7	7.9	35.5	14.7	10.7	7.4	24.7	22.6	21.9	19.8	19.7	4.3	44.1	14.0	25.1	25.9	5.9	32.3	59.0	37.1	39.9	54.7	12.9	29.7	28.3	36.6
GPKOW	"GPATC5, GPATCH5, Spp2, T54"	ENSG00000068394	"G-patch domain and KOW motifs"	Q92917	X	49113389-49123801	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000287, HPA001894"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000287: AB_1079015, HPA001894: AB_1079014"	"unprognostic (3.34e-2)"	"unprognostic (9.54e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (9.29e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.89e-2)"	14.9	14.6	20.1	11.8	23.1	15.0	13.8	24.3	25.3	14.5	14.8	22.6	11.7	15.3	15.5	13.4	14.7	17.0	11.3	17.0	17.6	20.1	12.3	15.8	12.8	14.1	22.9	28.9	14.3	11.5	22.4	15.8	14.7	20.0	13.8	13.9	12.1	13.4	19.3	31.9	16.9	14.1	15.3	20.3	14.0	13.5	8.0	22.3	15.7	14.2	9.0	14.9	14.8	12.1	21.3	17.0	20.7	24.8	17.8	29.5	14.6	20.5	21.9	14.7	12.3	13.0	11.3	16.0	13.4	15.1	21.3	22.7	15.9	20.7	8.6	10.3	16.4	21.9	14.6	16.2	15.8	14.0	18.1	17.3	9.0	18.4	11.2	15.6	10.6	19.1	12.3	20.2	17.0	17.4	12.6	15.9	17.5	11.0	13.6	13.8	33.5	14.5	17.7	10.4	11.1	17.5	18.2	16.2	23.4	10.9	26.3	12.3	14.3	15.5	14.8	14.3	16.2	28.4	13.9	17.7	12.4	18.8	17.9	12.6	21.0	14.3	11.7	15.9	17.7	19.0	19.3	16.8	20.7	29.5	23.1	24.0	15.4	23.2	22.0	17.0	21.3	19.7	18.5	13.3	17.8	24.8	15.5	22.7	14.6	20.1	23.1	24.3	25.3	17.6	20.1	22.9	28.9	20.0	22.3	17.9	8.3	11.7	11.1	7.1	14.9	10.4	28.1	6.7	17.0	7.0	3.9	23.1	13.3	22.4	0.8	10.8	14.9	23.3	22.2	16.9	13.4	9.1	11.5	13.0	14.5	4.8	7.5	9.8	7.0	1.3	14.4	10.8	5.0	15.4	10.8	15.8	21.4	21.0	14.2	17.0	11.7	38.8	14.4	5.2	17.9	8.7	36.6	14.4	10.7	10.8
GPRC5A	"PEIG-1, RAI3, RAIG1, TIG1"	ENSG00000013588	"G protein-coupled receptor class C group 5 member A"	Q8NFJ5	12	12890782-12917937	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 155.0"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 3.1"	"Cell type enhanced"	"Detected in some"		"basophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007928, HPA046526"	Enhanced		Enhanced	"Vesicles,Plasma membrane"		NA	Yes			"Vesicles, Plasma membrane"		"HPA007928: AB_1849318, HPA046526: AB_2679685"	"unprognostic (4.79e-2)"	"unprognostic (8.35e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.69e-3)"	"prognostic unfavorable (4.63e-6)"	"unprognostic (3.81e-1)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (9.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.49e-1)"	9.8	1.4	0.2	6.0	0.6	0.4	5.4	0.1	0.3	12.1	19.8	0.5	2.0	6.2	4.3	1.9	9.1	3.0	15.5	7.1	0.1	0.2	5.1	0.6	155.0	0.1	0.5	0.1	18.5	1.1	0.0	0.9	20.1	3.1	10.4	16.9	4.8	9.6	1.5	1.1	2.0	36.9	14.2	1.1	0.1	11.4	4.8	0.3	0.1	54.2	14.9	11.5	32.1	14.0	0.6	0.6	3.1	0.3	0.5	0.4	0.0	42.7	34.2	0.0	0.1	0.4	0.2	2.2	12.9	4.9	8.4	6.4	6.0	164.8	0.0	1.1	10.3	8.9	43.2	0.1	6.2	12.9	0.0	0.5	0.0	14.1	0.2	3.1	0.0	0.0	0.2	8.4	3.5	0.8	10.4	5.1	0.0	0.0	0.0	0.3	30.0	0.0	0.0	0.1	15.6	5.4	0.0	0.9	0.0	16.6	8.5	0.0	0.0	60.6	4.6	1.9	6.9	1.3	0.1	0.5	0.3	10.9	19.6	0.5	0.0	0.0	0.0	4.4	0.0	0.2	3.1	0.3	0.4	0.3	0.2	0.3	0.3	0.2	0.3	0.1	0.6	0.4	0.4	1.3	0.5	0.2	0.6	0.3	0.0	0.2	0.6	0.1	0.3	0.1	0.2	0.5	0.1	3.1	0.3	872.5	165.8	0.0	282.3	11.1	0.0	1.0	5.1	69.6	257.0	43.6	0.0	0.7	0.0	49.3	0.0	7.5	159.2	0.0	63.3	8.9	57.8	325.5	9.3	0.0	1.5	0.0	7.9	4.9	0.0	0.0	12.4	10.7	49.0	1.0	28.8	1.3	368.5	52.7	9.6	0.0	0.2	0.0	24.7	0.0	0.2	8.0	0.9	1.3	79.7	1048.5
GPS1	"COPS1, CSN1"	ENSG00000169727	"G protein pathway suppressor 1"	Q13098	17	82050691-82057470	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047448, HPA052848"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA047448: , HPA052848: "	"unprognostic (1.96e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.65e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.75e-3)"	"unprognostic (2.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.07e-1)"	"unprognostic (8.90e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.15e-1)"	23.5	23.9	27.2	19.3	28.2	23.6	18.8	27.7	47.2	20.5	18.7	33.3	19.8	22.4	21.5	21.1	22.2	24.5	19.2	33.4	28.7	26.7	29.6	39.9	17.2	21.6	28.7	25.9	25.3	34.4	23.2	22.3	20.8	28.0	23.2	12.0	25.1	37.1	28.9	67.1	26.5	19.7	16.8	23.7	20.7	21.9	36.0	18.2	32.3	25.3	29.8	20.6	19.5	17.0	26.1	37.3	25.2	34.5	29.7	44.0	36.0	27.1	50.8	18.9	24.7	13.4	12.9	26.8	18.3	14.7	29.1	24.1	44.4	17.0	13.5	16.5	18.3	21.2	20.7	18.0	23.4	9.9	8.9	64.3	22.8	28.5	49.2	22.3	24.8	22.1	18.5	17.2	25.7	15.4	11.7	30.3	23.4	21.3	15.6	16.1	53.7	42.2	28.2	24.0	26.2	38.0	26.0	26.0	21.9	17.9	28.4	32.5	50.9	18.6	34.5	27.0	15.1	39.1	22.5	17.2	29.1	34.5	22.4	29.3	28.7	12.0	14.2	22.7	16.0	26.1	19.6	34.5	25.2	33.0	31.7	34.5	26.1	34.8	33.0	37.3	24.5	25.0	31.2	5.4	29.7	28.6	25.7	44.0	36.0	27.2	28.2	27.7	47.2	28.7	26.7	28.7	25.9	28.0	18.2	11.9	21.9	21.6	19.7	22.2	28.4	50.0	28.1	32.1	18.2	19.2	23.6	60.9	51.4	48.6	24.6	27.5	66.9	23.3	60.4	58.8	33.4	21.0	24.3	47.8	53.5	46.1	39.6	30.7	32.4	58.5	27.9	36.5	32.1	45.9	33.5	36.5	43.4	45.6	29.7	84.8	24.9	6.5	35.6	48.3	48.5	26.2	45.2	25.8	42.2	17.0
GRN	"CLN11, PCDGF, PGRN"	ENSG00000030582	"Granulin precursor"	P28799	17	44345086-44353102	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 1368.6;Kupffer cells: 737.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"classical monocyte: 138.4;intermediate monocyte: 80.4;myeloid DC: 109.8;neutrophil: 61.8;non-classical monocyte: 36.4;plasmacytoid DC: 95.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 109.8;granulocytes: 61.8;monocytes: 138.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008763, CAB019394, HPA028747"	Uncertain		Enhanced	Endosomes,Lysosomes	"Secreted to blood"	NA	NA		91000000	Lysosomes	Endosomes	"CAB019394: , HPA008763: AB_1850339, HPA028747: AB_10603767"	"unprognostic (1.84e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.38e-3)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (7.41e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.57e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.34e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	66.8	27.1	8.2	31.2	10.2	76.4	30.1	5.2	13.9	29.1	45.0	16.6	46.2	23.2	29.8	76.5	104.7	18.8	51.4	46.9	7.8	9.5	39.3	43.2	74.9	81.1	10.5	9.3	20.7	21.6	11.6	18.0	116.4	11.4	28.7	25.1	23.8	54.5	42.1	15.2	37.3	42.9	21.1	13.4	76.3	25.6	21.0	9.7	23.5	31.4	46.3	52.1	34.8	38.5	13.0	109.8	61.8	138.4	2.1	3.8	83.8	17.2	28.1	8.6	23.1	70.2	37.0	26.3	21.1	67.3	34.8	46.3	12.2	42.4	50.8	45.3	34.1	49.1	26.8	12.3	49.3	15.8	8.3	26.4	5.4	14.8	25.6	35.6	8.8	71.7	48.9	65.5	29.0	19.1	68.3	39.6	9.4	10.3	7.6	23.6	25.5	5.0	25.3	6.5	16.8	47.5	14.2	26.8	59.8	38.9	20.5	8.2	10.9	28.3	13.4	52.0	30.9	30.4	33.2	47.5	65.3	15.7	44.6	14.5	17.0	46.2	17.3	39.4	20.8	18.0	12.5	138.4	11.9	2.7	80.4	2.1	13.0	2.9	2.4	109.8	8.2	2.2	2.1	61.8	2.1	36.4	95.5	3.8	83.8	8.2	10.2	5.2	13.9	7.8	9.5	10.5	9.3	11.4	9.7	80.4	76.5	96.8	125.1	100.1	22.2	74.9	117.2	30.8	66.0	207.6	17.7	350.9	8.3	337.2	1.7	134.9	311.0	0.0	271.0	268.0	137.7	79.7	74.9	71.0	1368.6	44.5	119.5	213.0	737.0	3.4	56.4	553.1	197.4	402.2	200.3	69.2	249.3	496.5	53.7	96.2	10.8	84.1	74.3	9.6	45.1	84.3	535.3	32.4	196.1	159.2
GRPEL2	"DKFZp451C205, FLJ23713, Mt-GrpE#2"	ENSG00000164284	"GrpE like 2, mitochondrial"	Q8TAA5	5	149345430-149354583	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 43.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018173, HPA023211"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA018173: AB_1850358, HPA023211: AB_1850360"	"unprognostic (3.13e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.87e-5)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (3.22e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (6.16e-8)"	"unprognostic (1.34e-1)"	"unprognostic (8.16e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.26e-1)"	7.4	5.1	5.4	6.5	6.4	5.3	9.8	10.9	8.9	13.3	4.8	3.7	3.9	6.0	5.4	5.8	43.1	5.1	4.3	6.3	5.5	5.6	7.5	5.7	10.2	8.1	5.1	5.2	7.5	6.8	7.2	6.5	8.5	8.4	5.1	4.8	3.7	7.2	6.7	7.8	5.4	5.8	4.3	4.4	5.9	6.1	4.9	5.1	7.4	7.9	14.4	12.8	6.1	11.5	3.5	3.8	8.2	2.5	3.7	13.5	4.6	9.1	4.9	7.2	25.6	4.6	4.7	14.3	8.1	6.9	7.9	11.1	12.0	6.1	9.4	8.6	4.2	10.7	7.0	11.4	11.7	10.1	5.0	9.5	11.9	9.4	6.8	13.7	11.1	6.1	6.9	14.4	9.7	15.3	3.3	4.7	12.4	10.3	23.4	5.8	6.4	7.3	9.6	9.4	5.6	18.0	9.1	9.9	12.5	5.1	8.5	14.8	12.2	8.1	15.1	24.1	4.9	13.2	13.4	5.3	8.6	9.5	6.1	11.9	8.6	11.5	9.2	8.6	16.3	7.7	8.2	2.5	3.3	5.1	2.4	6.2	3.5	7.7	5.7	3.8	1.9	10.3	7.7	1.9	3.7	2.5	1.0	13.5	4.6	5.4	6.4	10.9	8.9	5.5	5.6	5.1	5.2	8.4	5.1	8.9	5.4	1.4	4.4	15.9	6.6	7.7	2.5	1.4	4.5	8.7	7.9	7.8	1.7	5.1	5.7	14.0	4.5	0.0	5.1	14.0	6.0	4.4	2.3	7.5	5.1	3.2	5.8	18.4	10.1	4.0	3.7	3.6	6.8	3.6	4.4	4.3	6.3	3.5	4.9	4.8	6.6	0.0	5.1	10.3	10.8	17.1	4.7	6.9	7.0	6.7
GRSF1		ENSG00000132463	"G-rich RNA sequence binding factor 1"	Q12849	4	70815782-70839945	"Predicted intracellular proteins"	"mRNA processing, tRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 101.8"	"Cell type enhanced"	"Detected in many"	9	"monocytes: 449.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036984, HPA036985"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA036984: AB_2675415, HPA036985: AB_10672785"	"unprognostic (1.45e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (1.47e-5)"	"unprognostic (8.63e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (8.29e-5)"	"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.66e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.05e-2)"	"prognostic favorable (2.72e-9)"	"unprognostic (6.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-3)"	17.9	33.4	21.3	22.3	19.9	8.8	29.0	19.1	42.5	16.8	22.7	19.7	15.0	18.1	17.2	18.2	21.7	18.9	22.9	33.3	22.9	22.6	23.9	23.6	23.7	24.6	24.8	20.2	17.3	26.9	19.6	13.7	18.3	23.6	17.7	27.1	12.0	32.1	20.9	101.8	18.7	17.2	18.1	24.1	17.3	22.5	13.6	19.1	37.0	19.7	31.1	21.7	21.1	15.4	5.7	20.0	7.6	11.6	14.3	11.7	5.6	32.3	22.1	26.0	27.0	27.6	32.3	37.4	39.3	24.9	29.7	24.4	22.5	33.3	46.8	30.1	40.4	15.4	12.4	46.0	30.7	39.8	25.4	15.1	24.6	22.7	31.1	34.1	35.9	14.2	27.1	29.6	29.9	20.9	35.9	30.5	26.1	28.1	27.2	41.2	34.6	59.1	25.3	27.7	35.4	23.4	24.4	40.5	19.9	36.6	40.5	27.2	24.5	18.5	52.8	64.8	31.8	22.9	17.7	27.8	27.8	29.3	22.9	24.7	22.7	18.0	30.1	23.0	23.4	27.0	7.6	11.6	5.2	7.6	8.8	9.5	5.7	11.2	11.7	20.0	4.9	11.2	9.5	1.6	14.3	10.5	19.3	9.3	5.6	21.3	19.9	19.1	42.5	22.9	22.6	24.8	20.2	23.6	19.1	29.8	29.3	32.1	42.4	44.4	17.5	125.4	40.8	21.4	26.1	26.2	23.6	87.9	63.0	61.2	5.7	32.2	41.3	0.0	53.0	115.0	34.8	51.4	17.3	45.7	56.0	27.0	66.2	28.8	58.2	5.3	32.2	42.5	59.1	449.1	69.7	23.1	55.3	42.1	36.7	56.1	17.4	19.4	40.1	21.9	55.1	44.2	64.5	37.9	79.0	54.6
GRWD1	"GRWD, RRB1, WDR28"	ENSG00000105447	"Glutamate rich WD repeat containing 1"	Q9BQ67	19	48445773-48457022	"Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042643, HPA055680"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA042643: AB_10795510, HPA055680: AB_2682884"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.71e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.70e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.07e-2)"	16.9	15.5	9.2	15.7	11.1	14.8	15.5	12.9	14.1	13.6	14.1	10.4	11.9	15.6	18.7	12.8	20.0	15.0	16.2	16.9	7.8	8.6	13.0	26.3	12.5	17.5	11.0	10.3	19.3	35.5	16.5	10.3	14.7	9.5	13.8	8.0	12.0	18.6	14.4	29.1	18.3	11.5	13.3	8.2	19.4	14.7	13.1	10.9	18.6	17.3	19.0	17.3	14.1	18.0	21.1	18.4	1.4	17.8	17.4	22.6	16.5	17.0	45.1	7.7	14.4	6.3	6.2	6.6	13.3	6.4	19.2	16.1	25.3	12.7	24.4	11.6	8.3	10.8	14.6	19.1	20.6	7.6	18.2	25.8	22.2	15.3	18.0	7.3	20.9	14.3	7.4	11.4	18.1	9.2	4.3	9.5	13.4	31.0	15.4	8.0	17.7	22.0	52.6	20.9	18.2	13.2	27.4	8.6	17.5	8.0	21.1	17.3	9.6	15.0	21.3	6.6	4.8	10.5	10.6	10.1	17.9	15.1	7.8	31.6	15.7	35.9	22.8	6.0	18.9	20.8	0.1	11.0	1.4	19.6	17.8	22.6	21.1	18.1	19.5	18.4	20.4	21.3	19.7	0.8	17.4	13.5	13.6	15.6	16.5	9.2	11.1	12.9	14.1	7.8	8.6	11.0	10.3	9.5	10.9	3.0	17.4	22.9	20.9	41.1	12.6	6.5	15.3	18.7	14.8	12.2	0.0	35.6	19.9	28.0	1.7	18.0	7.3	0.0	15.7	30.6	18.6	13.5	19.6	14.7	21.5	20.6	18.4	11.6	10.7	14.6	15.8	12.4	27.0	35.1	9.0	5.3	18.5	7.0	11.7	15.3	13.0	19.4	20.2	6.1	34.7	35.5	29.3	20.0	13.4	17.6
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 151.1;Distal tubular cells: 34.9;Hofbauer cells: 35.4;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.7	7.2	3.1	13.3	17.0	9.6	5.3	7.6	20.4	8.0	11.3	7.4	0.3	0.1	6.8	21.0	26.7	6.6	1.8	33.5	14.0	0.0	0.7	0.2	12.6	15.0	14.3	0.0	0.5	10.5	24.5	14.1	33.8	23.9	13.5	4.4	0.9	1.6	17.8	0.1	0.6	0.2	3.3	0.0	5.1	0.0	10.9	0.0	24.1	6.9	0.1	19.6	12.0	0.2	13.3	8.3	0.7	0.8	9.1	7.6	13.3	10.2	9.1	0.8	0.2	4.7	22.9	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	5.2	0.0	151.1	34.9	1.5	0.0	0.0	0.0	0.0	0.8	19.3	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.4	0.0	0.0	1.3	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0
GSPT2	"eRF3b, FLJ10441"	ENSG00000189369	"G1 to S phase transition 2"	Q8IYD1	X	51743431-51746232	"Predicted intracellular proteins"	"Cell cycle, Nonsense-mediated mRNA decay, Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 75.1;Late spermatids: 136.6;Muller glia cells: 56.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 24.4;PC-3: 27.4;SuSa: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044769, HPA074588"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA044769: AB_10963577, HPA074588: "	"unprognostic (8.55e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.39e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.07e-1)"	8.6	11.1	11.6	8.6	17.6	3.6	9.3	14.1	18.3	8.2	7.3	6.5	3.4	4.8	8.3	11.5	4.2	8.8	7.6	9.8	11.5	19.5	9.6	16.0	7.9	12.0	9.2	13.0	15.3	7.3	7.1	14.9	3.6	8.8	10.5	5.5	6.7	8.9	9.7	7.8	4.0	7.6	8.0	6.7	9.0	6.5	18.4	8.8	18.4	9.1	3.8	12.1	7.7	4.1	9.5	9.7	2.7	4.1	7.2	8.3	4.2	0.0	4.9	10.1	0.0	7.2	6.2	0.0	5.7	1.0	4.1	5.2	3.1	5.1	14.5	0.0	4.8	12.7	1.6	0.0	2.6	4.7	0.0	6.4	0.2	0.0	0.0	5.3	0.0	6.3	8.2	1.3	3.6	3.6	7.0	5.9	6.8	3.8	1.1	7.2	0.0	1.2	0.9	24.4	0.0	27.4	6.9	9.5	0.0	7.4	5.3	0.0	8.5	0.0	0.0	4.9	21.0	0.0	4.7	3.7	4.1	8.4	3.8	3.7	0.0	8.3	0.0	5.4	0.9	4.5	2.7	2.9	1.8	5.7	4.1	5.7	9.5	5.1	5.3	9.7	9.5	8.3	7.1	0.3	7.2	3.1	8.2	6.4	4.2	11.6	17.6	14.1	18.3	11.5	19.5	9.2	13.0	8.8	8.8	11.9	10.2	4.7	5.0	1.5	16.1	14.9	17.8	13.4	7.9	14.0	7.9	8.5	5.0	11.5	75.1	5.3	1.1	0.0	7.6	4.2	6.0	5.3	10.4	15.3	5.5	11.1	2.9	8.6	7.0	136.6	11.8	6.3	3.3	11.8	3.1	56.0	5.5	4.8	17.7	9.8	9.4	25.8	4.7	11.8	7.3	1.3	2.9	7.2	3.2	3.1
GTF2E1	"FE, TFIIE-A"	ENSG00000153767	"General transcription factor IIE subunit 1"	P29083	3	120742637-120783069	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 21.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009884, HPA056359, HPA066881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009884: AB_2279381, HPA056359: AB_2683106, HPA066881: AB_2685740"	"unprognostic (3.19e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.94e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.38e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.10e-2)"	"unprognostic (8.29e-3)"	"unprognostic (4.94e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.97e-1)"	11.1	18.0	8.6	10.7	9.9	6.6	10.0	9.1	9.9	9.2	8.5	11.6	7.3	7.8	13.3	8.1	9.4	7.6	6.4	8.5	8.8	8.3	12.9	12.7	8.4	14.0	9.3	7.6	10.5	14.5	8.4	12.9	11.9	9.1	8.2	10.4	7.9	18.7	10.2	12.8	7.8	9.8	10.0	11.9	14.0	7.8	16.3	8.9	25.6	9.6	10.0	14.9	9.2	9.5	10.9	10.5	16.8	12.9	11.9	12.0	8.7	9.2	13.0	16.3	9.9	12.3	5.7	14.2	6.2	5.7	9.8	10.6	15.5	6.7	15.2	11.0	4.6	7.6	11.2	15.0	8.2	13.8	10.5	3.5	19.6	9.5	12.9	9.6	17.6	11.9	7.5	8.9	7.3	10.4	6.7	15.0	13.1	13.6	8.0	10.3	10.6	14.5	8.9	15.5	9.0	12.1	12.0	19.2	11.3	9.7	6.0	3.5	10.8	9.4	8.2	8.4	15.4	10.4	13.6	13.1	9.2	10.1	2.9	7.0	7.1	7.7	21.8	9.7	17.9	8.8	16.8	8.5	13.0	8.5	12.9	11.1	10.9	10.1	12.0	10.5	9.1	11.1	10.7	6.2	11.9	11.7	4.9	11.4	8.7	8.6	9.9	9.1	9.9	8.8	8.3	9.3	7.6	9.1	8.9	3.0	4.1	11.0	2.7	1.6	4.5	4.5	10.2	2.7	6.8	7.0	0.0	7.7	5.0	4.5	5.6	3.6	2.6	0.0	3.9	7.0	3.1	2.6	12.7	3.8	8.1	15.9	1.2	6.2	6.5	2.0	2.0	6.3	3.3	12.6	3.2	5.2	4.3	0.0	4.6	4.8	4.1	0.0	1.9	12.6	21.5	2.3	7.3	5.0	3.5	2.8
GTF2E2	"FE, TF2E2, TFIIE-B"	ENSG00000197265	"General transcription factor IIE subunit 2"	P29084	8	30578318-30658251	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA004816, CAB009603, HPA025065"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009603: AB_2114537, HPA004816: AB_2667252, HPA025065: AB_10601658"	"unprognostic (4.84e-2)"	"unprognostic (7.38e-3)"	"unprognostic (6.20e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (4.38e-1)"	"unprognostic (6.05e-3)"	"unprognostic (8.69e-2)"	"unprognostic (2.29e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (5.82e-7)"	"unprognostic (8.25e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.24e-1)"	19.0	21.9	11.4	16.2	17.0	7.5	26.7	21.2	13.1	16.4	19.1	10.7	15.1	16.8	17.7	15.8	20.0	12.3	11.7	12.7	11.1	10.9	14.7	21.1	13.4	20.3	11.6	12.2	24.2	44.6	14.1	22.5	14.5	11.9	14.2	14.4	12.1	12.6	13.8	9.9	14.8	26.2	16.3	11.6	17.2	20.9	31.0	11.7	21.4	17.2	10.6	22.0	16.9	27.5	16.4	8.0	5.6	4.2	8.7	7.9	2.6	21.7	17.6	12.2	12.8	32.9	29.4	9.2	23.6	21.4	19.4	24.8	10.5	15.6	28.1	20.1	21.0	28.1	15.4	20.0	22.0	25.9	12.5	11.8	14.0	12.3	24.9	32.0	6.7	12.4	21.5	29.2	20.8	21.2	19.4	26.7	21.0	26.9	17.3	30.4	14.7	32.8	16.9	13.7	26.3	21.2	17.3	13.2	14.0	21.0	14.9	9.4	12.2	13.1	8.8	18.4	16.8	8.5	8.3	20.3	12.8	13.3	10.8	16.0	17.7	24.0	30.4	20.2	11.6	16.9	3.0	4.2	5.6	3.9	3.3	4.2	16.4	6.0	7.9	7.2	9.3	5.9	5.9	2.2	8.7	3.3	8.0	6.7	2.6	11.4	17.0	21.2	13.1	11.1	10.9	11.6	12.2	11.9	11.7	0.0	9.6	39.5	36.7	42.6	8.9	7.8	17.8	21.4	11.4	14.0	9.8	36.2	16.6	26.8	61.8	21.5	30.5	0.0	29.1	39.9	29.8	60.5	11.5	25.6	31.1	4.8	12.7	27.6	20.2	43.8	36.5	28.3	20.3	76.7	19.8	7.3	37.7	23.2	66.4	35.1	13.8	25.8	30.9	56.0	82.0	40.7	51.9	30.9	21.8	88.4
GTF2F1	"BTF4, RAP74, TF2F1, TFIIF"	ENSG00000125651	"General transcription factor IIF subunit 1"	P35269	19	6379569-6393981	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 199.3;Late spermatids: 301.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022793, HPA028707, HPA070752"	Supported		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA022793: AB_1857946, HPA028707: AB_2672745, HPA070752: AB_2732163"	"unprognostic (1.30e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.00e-1)"	"prognostic favorable (8.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.99e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.96e-2)"	"prognostic favorable (9.80e-4)"	"unprognostic (1.34e-2)"	"unprognostic (7.02e-2)"	"unprognostic (9.92e-2)"	"unprognostic (4.25e-1)"	24.9	26.0	32.5	26.6	33.1	41.1	22.6	60.7	47.3	25.5	24.7	18.8	26.1	35.2	31.7	22.6	30.8	29.9	26.5	22.9	28.9	25.9	24.4	21.7	19.8	34.9	23.9	36.3	59.8	40.7	31.8	33.4	19.9	26.6	24.6	16.3	22.3	33.9	24.4	25.6	21.8	31.9	27.6	26.4	26.7	26.4	39.4	23.1	23.6	36.4	19.7	22.2	26.0	39.8	24.4	21.5	28.4	21.4	19.0	23.8	14.1	38.3	28.3	20.6	32.7	13.9	22.6	16.3	27.0	25.3	33.7	32.2	29.6	15.2	23.4	38.0	17.7	24.2	35.0	19.3	17.1	16.6	35.7	24.6	32.5	21.1	26.3	24.2	37.6	26.4	23.7	22.9	24.0	18.4	28.6	19.8	23.2	39.6	31.8	18.6	26.7	37.3	21.4	37.3	17.8	36.1	34.6	22.8	29.9	18.8	22.0	25.3	34.8	27.9	21.4	29.8	13.0	27.2	30.0	28.0	26.5	22.3	45.7	38.0	56.5	63.4	25.3	33.0	39.5	29.6	7.0	21.4	14.0	20.5	20.6	23.8	24.4	18.4	19.5	16.9	23.3	21.7	18.8	28.4	19.0	19.1	21.5	17.6	14.1	32.5	33.1	60.7	47.3	28.9	25.9	23.9	36.3	26.6	23.1	44.7	44.6	45.7	42.2	21.6	25.9	26.2	20.4	115.1	78.5	24.4	7.9	38.5	18.3	42.3	199.3	33.5	64.5	23.3	44.2	36.6	30.1	27.3	60.3	23.7	51.8	23.8	29.2	52.8	50.9	301.8	41.1	31.9	32.1	62.3	38.4	32.6	42.6	35.9	46.7	29.3	28.8	32.3	43.2	51.5	36.8	18.3	45.2	56.5	40.9	36.7
GTF2H1	"BTF2, P62, TFIIH"	ENSG00000110768	"General transcription factor IIH subunit 1"	P32780	11	18322295-18367044	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004637, HPA046660"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004637: AB_425470, HPA046660: AB_2679743"	"unprognostic (2.25e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (5.98e-9)"	"unprognostic (7.71e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.42e-3)"	"unprognostic (8.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.90e-2)"	"unprognostic (2.94e-1)"	27.1	26.4	24.1	18.2	28.8	10.5	33.0	32.6	35.7	21.5	21.6	19.3	24.1	18.0	23.5	23.1	26.2	18.6	22.9	21.4	24.1	20.4	25.9	25.0	19.1	23.7	19.6	22.2	27.2	24.3	27.1	32.4	24.3	27.4	22.5	20.9	21.2	25.8	26.0	20.8	32.4	21.7	20.6	21.1	23.4	20.5	38.5	23.3	22.7	29.3	21.7	25.7	22.9	22.2	12.0	11.8	20.3	12.1	15.9	13.9	8.8	12.3	11.4	9.6	13.7	22.1	17.6	12.1	18.5	20.0	16.5	19.0	11.9	4.9	20.7	7.4	19.0	23.8	17.2	15.8	17.0	21.4	9.1	15.6	13.4	11.7	12.0	31.5	25.7	14.6	19.8	20.4	10.2	32.4	13.6	14.5	11.0	20.5	11.0	23.7	11.5	12.9	20.5	8.4	20.8	16.5	13.3	20.5	9.6	13.6	17.0	11.0	11.9	15.3	14.8	22.8	8.7	7.7	15.1	10.7	22.3	10.8	39.8	15.0	5.6	13.3	15.2	19.2	20.2	21.1	20.3	10.9	11.3	9.1	11.0	9.8	11.7	11.5	10.1	11.8	12.0	13.9	11.1	7.9	15.9	12.1	6.5	11.0	8.8	24.1	28.8	32.6	35.7	24.1	20.4	19.6	22.2	27.4	23.3	14.9	12.8	15.4	18.2	42.8	16.7	22.8	22.9	28.1	22.7	10.4	19.6	21.2	6.6	19.7	33.7	20.4	13.9	0.0	26.5	23.5	19.3	19.1	17.4	11.4	21.7	20.6	7.5	21.5	18.0	32.8	15.8	23.4	21.9	24.4	11.2	20.1	23.7	8.6	15.2	18.8	19.3	6.5	26.4	48.3	30.1	45.2	23.6	15.3	15.5	21.4
GTF2I	"BAP-135, BTKAP1, DIWS, IB291, SPIN, TFII-I, WBSCR6"	ENSG00000263001	"General transcription factor IIi"	P78347	7	74657667-74760692	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004595, HPA026638"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004595: AB_628345, HPA026638: AB_1857959"	"unprognostic (3.47e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.28e-1)"	"prognostic favorable (6.35e-6)"	"unprognostic (7.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.88e-2)"	10.2	14.3	12.6	10.2	14.3	4.0	11.5	13.1	15.2	11.3	8.6	15.4	6.0	9.1	10.5	9.6	9.9	12.5	10.8	8.6	12.8		13.5	10.2	10.2	8.8	18.1	9.7	12.1	8.5	29.0	12.4	9.8	12.9	12.1	6.9	12.1	11.7	10.3	13.4	10.9	7.9	11.1	8.8	7.5	12.0	4.3	16.0	21.2	22.3	6.3	11.6	10.3	7.1	16.8	14.8	10.9	6.9	14.2	13.2	5.8	29.6	24.5	50.8	49.8	28.1	25.0	10.6	18.8	17.3	20.8	20.7	17.0	36.2	35.8	7.6	23.0	27.7	26.1	49.7	22.6	26.9	26.9	26.3	18.2	29.1	23.6	16.9	34.5	27.3	23.1	19.5	15.7	16.2	30.5	27.8	12.1	35.5	17.1	25.0	27.6	28.7	30.9	54.4	63.3	15.3	31.6	17.6	29.3	27.3	51.7	42.6	54.4	34.2	51.5	17.2	44.6	26.3	22.9	24.8	28.6	15.4	14.3	23.9	20.2	17.8	56.9	16.3	20.9	28.5	5.1	6.9	10.9	8.3	5.1	13.2	14.6	11.3	12.9	10.5	16.8	13.1	12.9	2.8	14.2	4.2	14.8	5.7	5.8											74.5	52.9	73.0	73.2	53.3	262.6	25.7	193.6	52.2	54.6	113.4	267.0	84.7	48.0	123.3	33.9	79.4	49.7	0.0	72.6	51.4	66.4	111.8	12.7	84.7	68.3	236.8	108.4	117.2	104.4	29.3	141.5	49.6	52.3	67.7	67.6	192.8	108.5	76.4	181.4	83.8	173.7	84.1	49.5	22.3	38.3	80.4	60.4	45.7	63.2	92.7
GTF3C5	"TFiiiC2-63, TFIIIC63, TFIIICepsilon"	ENSG00000148308	"General transcription factor IIIC subunit 5"	Q9Y5Q8	9	133030675-133058503	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067063, HPA069805"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA067063: AB_2685773, HPA069805: AB_2686201"	"unprognostic (1.07e-2)"	"unprognostic (1.78e-3)"	"unprognostic (5.58e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.55e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.73e-2)"	21.2	24.6	20.1	18.2	30.4	33.3	21.8	38.7	30.6	21.9	25.0	39.6	20.6	24.7	23.1	21.9	28.0	25.7	16.2	24.5	20.8	17.3	20.9	25.1	18.8	23.1	31.9	19.9	41.3	24.6	24.4	26.0	24.9	22.7	24.0	18.5	21.3	26.4	20.1	36.7	31.2	23.6	20.6	23.0	23.9	20.4	24.2	30.8	43.5	22.1	29.3	29.2	19.5	22.5	11.2	12.0	28.4	13.2	13.8	17.0	11.5	11.7	22.0	19.2	17.9	10.5	9.1	25.6	11.5	13.0	22.2	15.7	23.1	19.6	19.8	10.9	12.7	17.9	28.8	22.9	20.8	12.6	20.1	19.0	22.6	25.2	21.3	16.1	18.4	48.7	12.8	13.9	23.3	16.2	10.9	19.5	65.7	29.2	19.5	11.5	39.3	29.4	25.6	24.9	27.4	22.1	31.2	19.2	25.0	14.6	13.8	23.0	17.0	19.0	21.1	12.1	12.2	27.0	26.3	11.9	26.7	20.7	16.4	19.0	7.5	15.2	21.5	13.3	13.6	18.0	28.4	11.0	14.9	11.8	13.2	17.0	11.2	12.2	15.3	12.0	10.8	14.0	12.4	6.6	13.8	10.7	11.6	13.4	11.5	20.1	30.4	38.7	30.6	20.8	17.3	31.9	19.9	22.7	30.8	8.9	14.7	20.4	14.8	11.0	14.4	27.1	7.6	10.7	13.6	15.7	7.9	34.8	24.9	20.8	3.0	14.3	26.2	23.3	26.2	32.0	16.6	10.9	16.1	15.3	19.8	14.3	13.8	20.9	15.5	3.6	16.1	10.8	15.1	16.2	14.6	20.6	22.9	23.0	20.1	10.2	17.1	45.3	15.6	17.2	28.4	14.4	34.8	19.1	21.2	15.3
GTPBP4	"CRFG, FLJ10686, FLJ10690, NGB, NOG1"	ENSG00000107937	"GTP binding protein 4"	Q9BZE4	10	988019-1019936	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039618, HPA056468"	Uncertain		Supported	"Nuclear membrane,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	"Nuclear membrane"	"HPA039618: AB_10795292, HPA056468: AB_2683141"	"unprognostic (2.11e-3)"	"unprognostic (3.10e-3)"	"unprognostic (7.77e-3)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (3.72e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (8.85e-12)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (2.38e-5)"	"unprognostic (7.90e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.67e-2)"	19.0	24.6	11.3	13.9	14.9	24.8	14.2	11.6	15.0	11.0	10.5	12.2	10.3	9.6	14.8	10.1	12.2	15.8	8.9	11.9	14.1	11.8	11.8	14.0	9.5	13.8	14.0	10.1	16.3	22.8	12.7	18.3	13.8	15.3	11.1	12.2	8.9	10.3	9.9	24.8	11.4	11.0	14.4	18.1	13.5	12.7	22.9	12.2	14.2	11.9	16.3	16.3	11.6	10.4	10.5	11.3	10.7	14.2	15.8	14.2	7.7	21.0	17.2	14.5	12.7	10.3	12.3	10.4	19.8	6.9	24.3	20.7	25.4	16.4	30.6	6.0	15.7	8.4	16.7	28.6	18.1	28.4	15.1	17.9	33.5	12.4	15.5	16.3	14.5	18.1	15.9	15.4	26.7	18.6	9.9	13.2	23.8	34.3	12.7	22.2	19.4	22.2	13.7	21.1	28.0	11.9	22.1	12.7	21.1	14.4	13.4	7.3	22.0	13.0	16.7	22.9	14.9	23.9	14.5	11.4	11.6	6.4	27.8	24.0	16.5	31.5	38.5	13.0	15.4	9.5	10.7	8.4	3.0	11.6	14.2	13.6	10.5	11.0	11.7	11.3	9.9	12.2	11.8	1.4	15.8	10.8	7.4	14.2	7.7	11.3	14.9	11.6	15.0	14.1	11.8	14.0	10.1	15.3	12.2	53.6	69.5	32.8	58.3	55.6	25.5	29.7	22.9	66.9	108.1	27.9	17.7	41.8	28.2	54.3	49.0	30.8	10.0	23.3	37.9	45.9	31.1	41.3	62.7	24.3	30.8	22.3	21.2	20.9	25.9	13.8	23.0	29.0	21.9	38.7	24.5	27.3	52.1	17.5	27.6	24.0	31.8	19.4	25.8	86.5	85.2	58.7	79.8	24.5	28.6	76.5
GTPBP8	HSPC135	ENSG00000163607	"GTP binding protein 8 (putative)"	Q8N3Z3	3	112990918-113015060	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034831, HPA058631"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA034831: AB_10671506, HPA058631: AB_2683783"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.18e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.07e-5)"	"unprognostic (7.10e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.57e-1)"	"unprognostic (2.69e-1)"	7.5	9.3	7.4	7.3	7.8	9.5	7.3	8.5	10.1	7.1	11.9	9.2	8.3	8.0	8.3	5.2	12.2	6.4	7.4	20.0	7.6	7.6	12.2	8.2	6.2	13.2	7.6	8.3	10.4	12.1	13.0	12.1	9.3	9.5	8.2	9.3	6.6	9.6	5.2	25.3	6.5	11.8	7.4	11.7	9.3	9.1	22.7	8.9	25.4	13.4	14.3	10.2	9.6	8.0	6.7	12.2	6.7	7.0	11.9	15.8	7.8	19.6	9.0	11.9	13.4	7.3	12.6	9.5	13.6	11.8	14.0	17.5	15.8	8.5	12.9	8.0	7.5	11.3	13.5	15.8	13.1	16.1	5.7	11.1	35.3	9.0	8.2	6.9	22.5	8.7	10.0	9.4	7.7	5.5	14.5	12.8	15.2	12.4	15.3	13.4	7.7	14.3	11.0	24.5	9.9	17.1	12.2	11.0	8.2	9.8	12.4	13.8	14.0	11.0	8.7	18.1	10.7	9.8	15.3	7.7	10.2	15.1	3.7	12.7	10.0	13.1	18.0	10.2	18.7	11.2	6.7	7.0	4.5	10.4	4.6	9.1	6.7	11.9	10.0	12.2	5.9	15.8	10.3	1.0	11.9	3.9	5.8	8.2	7.8	7.4	7.8	8.5	10.1	7.6	7.6	7.6	8.3	9.5	8.9	14.9	9.6	16.3	11.9	11.9	9.3	24.2	7.6	13.4	7.9	5.2	5.9	23.6	19.9	14.6	58.0	10.3	10.5	23.3	15.9	20.5	12.6	10.8	19.6	7.2	20.3	9.5	9.8	10.4	14.5	21.7	10.9	14.2	10.1	12.6	9.7	8.9	13.4	10.2	5.3	23.1	12.2	0.0	17.5	35.6	28.1	10.7	12.7	16.7	11.9	16.1
H1FX	"H1X, MGC15959, MGC8350"	ENSG00000184897	"H1 histone family member X"	Q92522	3	129314771-129316277	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"bone marrow: 381.6;lymphoid tissue: 238.6"	"Cell type enhanced"	"Detected in all"	6	"Basal glandular cells: 485.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 139.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB012235, HPA040099, HPA068431"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"CAB012235: , HPA040099: AB_2676846, HPA068431: "	"unprognostic (1.01e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.13e-2)"	"unprognostic (8.48e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.51e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.50e-2)"	23.1	13.1	11.9	19.0	14.5	381.6	33.7	29.0	22.9	30.9	21.0	9.6	13.4	21.1	26.0	19.6	34.5	25.1	24.0	27.5	11.3	11.2	12.9	24.9	30.9	44.2	6.7	16.3	39.0	22.4	18.4	20.5	15.0	6.9	26.2	7.8	18.4	32.3	16.3	30.8	40.5	26.0	19.1	9.6	29.9	29.0	14.2	6.3	238.6	21.9	18.1	20.5	35.6	25.0	5.7	10.8	15.9	5.3	4.8	8.3	2.2	19.9	10.6	20.1	8.7	2.0	2.4	19.1	8.8	6.4	10.5	11.1	6.3	11.0	2.5	9.7	3.1	7.0	20.1	8.4	5.6	1.6	18.3	16.3	7.6	8.2	8.6	8.7	8.8	2.0	4.9	7.7	4.2	9.7	4.7	6.0	35.4	11.7	45.5	1.4	20.9	40.7	17.5	18.8	3.6	12.0	29.4	8.6	23.7	3.2	4.2	32.1	37.2	9.3	4.6	26.6	4.0	18.2	17.8	5.9	8.1	42.6	7.9	7.3	139.5	53.3	21.5	6.6	8.4	8.9	0.4	5.3	15.9	4.3	3.7	4.0	4.4	6.7	5.1	7.4	5.7	8.3	4.3	1.2	4.8	3.3	10.8	5.1	2.2	11.9	14.5	29.0	22.9	11.3	11.2	6.7	16.3	6.9	6.3	14.9	12.8	95.3	485.3	89.5	119.1	25.5	63.7	2.7	3.4	89.0	29.5	60.0	94.5	42.6	7.4	89.9	34.4	70.0	71.0	93.0	97.3	173.5	5.7	38.5	77.7	138.2	153.1	85.3	93.5	8.0	92.0	75.7	118.1	25.2	86.3	209.9	59.2	48.9	48.8	25.1	84.3	122.9	82.1	13.2	36.5	96.0	57.2	72.6	52.5	312.3
H3F3B	H3.3B	ENSG00000132475	"H3 histone family member 3B"	P84243	17	75776434-75785893	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 570.8;bone marrow: 441.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 570.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 570.8"	"Low cell line specificity"	"Detected in all"											"CAB037166, CAB037187, CAB037221, HPA042570"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037166: AB_2115285, CAB037187: AB_477069, CAB037221: AB_477076, HPA042570: AB_2678056"	"unprognostic (1.66e-1)"	"unprognostic (8.42e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.26e-3)"	"unprognostic (9.20e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.99e-1)"	57.2	41.2	38.1	58.9	48.6	441.9	71.4	60.2	47.0	86.6	44.6	65.9	42.7	37.9	60.5	77.7	93.2	70.2	75.8	35.1	38.5	33.9	42.8	48.1	64.2	62.3	50.4	41.2	141.0	90.9	33.0	41.5	58.5	42.7	60.5	26.6	65.8	58.4	55.4	71.1	114.0	58.0	63.7	51.8	65.9	45.1	66.9	46.2	78.6	58.9	69.1	55.7	78.5	71.9	78.9	88.1	570.8	98.4	80.0	77.2	203.5	117.9	104.8	43.8	43.2	25.0	39.2	60.6	55.9	49.5	68.7	55.2	112.2	84.0	59.1	53.4	32.5	48.6	46.5	34.6	77.3	39.1	32.2	78.0	52.7	55.9	94.9	56.5	87.5	67.9	42.8	47.9	70.4	90.8	30.6	51.6	38.6	74.6	106.3	35.3	173.6	125.6	73.5	35.1	38.2	117.1	93.6	80.2	64.4	54.2	70.1	88.9	98.7	56.7	83.2	120.0	24.4	65.2	94.6	48.1	123.3	109.1	53.2	148.0	128.6	76.0	71.0	65.2	83.5	67.2	182.8	98.4	259.3	74.4	86.9	70.2	78.9	71.8	70.5	86.7	65.3	77.2	64.5	570.8	80.0	78.9	88.1	76.0	203.5	38.1	48.6	60.2	47.0	38.5	33.9	50.4	41.2	42.7	46.2	851.6	868.5	887.7	3350.2	2457.1	1722.8	361.5	690.4	1184.5	958.9	922.9	382.9	1428.6	1080.9	1926.0	2467.5	1156.8	1059.1	327.1	1563.3	1285.8	1898.2	1719.4	1592.3	352.8	1655.2	575.2	1610.5	672.8	901.1	452.7	934.0	1810.8	1808.5	1233.6	1221.5	2460.8	1745.6	1627.3	545.9	699.9	1161.2	983.1	2751.1	2035.3	943.0	3026.0	2929.8	1269.9	852.2	2611.9
HACD3	"B-ind1, HSPC121, PTPLAD1"	ENSG00000074696	"3-hydroxyacyl-CoA dehydratase 3"	Q9P035	15	65530418-65578352	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014837, HPA060347"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		27000	"Endoplasmic reticulum"		"HPA014837: AB_1855914, HPA060347: AB_2684260"	"unprognostic (1.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.57e-1)"	"prognostic favorable (3.09e-5)"	"unprognostic (3.44e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.04e-2)"	9.6	37.4	31.0	7.4	36.0	6.2	33.3	28.6	37.6	18.5	12.5	24.2	10.1	12.2	13.1	19.4	8.4	14.3	14.7	5.9	29.2	44.8	35.0	50.0	12.7	7.2	36.5	26.0	21.7	12.6	22.5	33.9	15.9	45.9	18.5	15.1	17.9	11.6	15.8	3.3	11.7	12.0	12.2	41.5	8.5	29.0	13.9	19.7	8.9	30.7	5.6	8.3	18.8	10.4	13.0	9.0	2.7	6.1	11.7	19.9	11.2	19.4	43.6	48.5	24.2	30.6	18.5	23.0	21.6	18.7	24.6	27.8	33.4	29.2	24.5	18.9	23.4	30.7	53.9	78.2	18.0	22.1	13.6	43.6	19.5	21.9	36.4	15.5	24.1	15.0	18.9	13.5	16.8	12.2	23.8	23.9	14.7	25.5	9.3	39.6	23.2	17.8	18.8	41.3	52.2	14.8	20.2	41.1	27.6	35.1	33.9	29.3	25.9	23.3	26.3	24.4	47.7	26.7	12.8	18.9	31.3	27.6	15.3	29.9	18.2	54.0	34.6	20.9	23.6	18.7	2.7	3.9	1.2	17.6	5.8	19.9	13.0	16.1	16.6	6.8	13.0	18.9	18.5	0.4	11.7	6.1	9.0	12.4	11.2	31.0	36.0	28.6	34.1	29.2	44.8	36.5	26.0	45.9	19.7	59.6	49.7	22.9	50.2	0.0	116.3	6.4	61.1	66.9	51.2	167.5	94.2	155.3	21.6	61.1	83.6	35.9	7.7	46.7	39.9	101.8	47.3	63.7	15.1	153.2	44.7	131.9	42.1	42.4	18.0	21.8	80.8	16.2	0.0	3.6	25.8	78.8	35.8	14.0	83.1	44.0	65.7	77.6	27.2	123.2	116.2	0.0	94.6	13.1	52.6	77.6
HADHA	"GBP, LCEH, LCHAD, MTPA"	ENSG00000084754	"Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha"	P40939	2	26190635-26244726	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Lyase, Multifunctional enzyme, Oxidoreductase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015536, HPA056070"	Approved		Enhanced	Mitochondria		NA	NA		2700000	Mitochondria		"HPA015536: AB_1850473, HPA056070: AB_2683026"	"unprognostic (2.02e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.55e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.67e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.16e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (7.97e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.64e-2)"	41.6	35.3	18.1	13.1	19.5	17.0	23.9	17.4	16.9	20.2	44.9	26.5	15.7	48.1	21.1	15.3	30.8	20.5	15.1	80.0	15.6	15.5	41.3	71.7	17.7	19.3	21.6	13.1	27.3	37.5	29.8	23.5	21.3	24.8	21.9	32.2	23.6	21.1	16.6	117.5	23.3	66.4	25.1	27.8	24.0	24.1	18.7	19.0	25.2	25.1	41.3	24.6	26.9	18.8	15.3	28.9	12.4	32.2	13.5	17.6	26.0	23.6	21.1	13.9	22.7	55.2	34.5	11.8	18.5	20.0	19.1	16.6	26.6	23.0	15.6	12.2	32.6	19.7	15.1	24.3	35.9	17.3	35.0	29.8	23.4	22.4	44.3	19.0	29.4	17.2	35.3	23.6	27.1	27.3	20.0	32.0	16.8	31.8	31.7	24.6	29.0	12.8	33.0	11.9	17.8	40.7	11.9	30.0	33.5	21.9	28.5	9.8	19.5	21.8	22.7	25.1	11.3	12.1	28.6	29.3	11.1	16.5	16.7	13.6	10.4	20.6	27.8	17.4	34.9	13.4	8.1	27.7	12.4	12.3	32.2	14.8	15.3	14.2	15.0	28.9	11.2	16.7	15.3	7.4	13.5	28.0	11.0	17.6	26.0	18.1	19.5	17.4	16.9	15.6	15.5	21.6	13.1	24.8	19.0	83.4	81.9	90.4	122.8	79.0	34.1	285.8	71.4	101.7	126.3	73.3	49.1	149.8	111.0	102.7	26.5	92.1	406.5	23.3	94.5	78.0	88.0	61.7	134.2	168.3	142.3	19.1	87.7	68.7	130.6	58.2	85.7	124.9	77.6	129.0	139.2	61.8	86.9	196.4	79.2	150.1	61.9	51.8	104.9	121.4	35.2	90.3	108.0	105.4	168.5	92.1
HARBI1	"C11orf77, FLJ32675"	ENSG00000180423	"Harbinger transposase derived 1"	Q96MB7	11	46602861-46617909	"Predicted intracellular proteins"		"Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 63.9;Late spermatids: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038671, HPA045457"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038671: AB_10675947, HPA045457: AB_2679332"	"unprognostic (1.29e-1)"	"unprognostic (6.82e-2)"	"unprognostic (7.76e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.23e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.96e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.13e-1)"	3.3	5.9	6.3	3.3	13.9	7.5	3.7	2.6	8.5	3.8	4.4	11.8	5.4	4.0	3.6	5.4	4.4	3.3	3.7	3.7	6.0	4.4	4.6	4.9	3.2	4.6	16.6	4.2	2.6	4.8	5.4	8.3	5.9	9.2	3.6	5.3	3.4	4.5	3.0	4.9	5.0	4.1	4.5	7.7	4.3	6.2	19.2	13.0	4.8	4.1	0.6	5.0	4.4	3.1	6.7	8.2	20.3	10.2	6.0	10.1	4.5	3.7	6.0	5.0	4.7	10.0	6.1	5.9	5.4	5.2	7.4	9.4	4.2	4.2	6.5	3.5	4.4	8.3	7.2	5.3	4.7	6.9	7.5	6.3	6.6	4.7	4.6	11.6	6.1	8.9	7.7	12.6	4.9	9.6	2.8	4.6	7.1	10.2	8.1	6.1	7.8	7.5	2.6	13.6	12.1	7.4	5.0	7.1	11.4	5.7	4.4	4.8	3.9	6.4	6.9	7.6	7.0	11.4	5.4	4.3	7.4	5.8	9.7	4.8	7.8	8.2	7.0	5.7	3.6	7.5	20.3	7.5	10.2	10.1	10.2	7.1	5.0	8.3	7.5	6.2	6.7	8.1	8.9	11.1	6.0	9.2	8.2	9.8	4.5	6.3	13.9	2.6	8.5	6.0	4.4	16.6	4.2	9.2	13.0	0.0	2.2	4.4	2.2	0.9	3.1	1.6	0.0	5.3	3.4	0.0	2.0	4.2	5.0	3.3	63.9	1.4	2.1	0.0	1.9	3.0	1.4	1.6	0.0	1.7	2.9	3.2	1.2	0.6	3.4	52.4	2.8	1.8	1.7	5.4	1.3	2.3	2.4	0.0	1.8	2.9	3.4	0.0	1.4	16.5	11.9	2.4	7.8	2.1	1.4	1.7
HARS	USH3B	ENSG00000170445	"Histidyl-tRNA synthetase"	P12081	5	140673904-140691862	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036539	Approved		Enhanced	Cytosol		NA	NA		52000	Cytosol		"HPA036539: AB_10669796"	"unprognostic (9.35e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.33e-1)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.50e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.25e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.36e-1)"	22.4	24.5	28.5	21.1	35.5	18.1	21.0	41.1	46.3	20.6	22.7	20.0	23.6	17.4	21.6	23.5	26.9	23.7	17.5	25.1	29.5	35.9	20.6	34.2	16.7	22.4	36.9	33.0	24.7	25.2	29.5	38.7	15.0	38.2	21.7	24.8	13.6	22.1	27.9	27.1	33.9	16.4	28.0	21.0	18.3	18.8	16.6	23.5	17.6	19.4	20.3	28.5	19.9	20.9	16.8	22.1	10.7	22.9	25.2	29.4	23.4	20.6	30.2	18.2	39.7	23.2	25.3	19.2	33.3	24.0	38.5	36.0	54.9	17.5	27.5	29.3	37.3	31.1	21.7	27.6	53.5	36.3	23.3	34.1	19.8	39.2	34.8	28.8	31.1	17.0	26.7	16.8	41.9	23.9	23.0	38.6	17.1	17.3	22.9	40.0	35.5	22.1	29.0	14.3	16.7	19.9	20.5	26.4	22.4	30.9	26.4	28.6	27.7	27.6	40.2	26.2	18.3	29.6	17.5	32.2	36.1	13.9	20.3	44.8	23.1	27.4	27.8	27.4	26.1	24.7	6.7	14.1	10.7	29.4	20.8	26.3	16.8	25.8	27.3	22.1	14.8	28.2	26.9	4.3	25.2	22.9	15.6	22.1	23.4	28.5	35.5	41.1	46.3	29.5	35.9	36.9	33.0	38.2	23.5	14.9	19.4	29.8	29.5	27.2	27.3	7.7	20.4	14.7	15.9	26.2	13.7	35.0	38.1	46.0	30.2	30.6	23.2	0.0	37.0	41.1	27.2	20.1	15.1	76.4	31.4	28.6	24.8	26.4	17.5	15.9	23.3	22.3	35.4	61.3	22.2	20.7	37.7	23.0	32.5	33.8	20.0	45.3	41.8	29.6	30.4	28.4	30.1	30.2	25.5	25.7
HBP1		ENSG00000105856	"HMG-box transcription factor 1"	O60381	7	107168961-107202529	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 228.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020225, CAB032824"	Approved		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032824: AB_2114615, HPA020225: "	"unprognostic (9.00e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.43e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.49e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.50e-1)"	"prognostic favorable (7.70e-5)"	"unprognostic (7.39e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.26e-2)"	28.7	26.2	17.5	14.2	19.2	33.7	27.9	33.6	20.7	27.0	21.1	17.3	23.9	13.1	36.5	16.9	28.8	18.8	16.7	23.8	16.3	8.9	21.0	27.4	25.8	13.8	29.4	12.3	27.8	18.0	18.5	14.4	37.1	19.8	26.4	14.6	14.5	23.7	19.4	40.8	34.3	17.6	21.5	23.5	17.9	18.5	25.9	27.5	24.5	33.5	19.0	17.8	30.9	32.5	11.6	12.9	47.2	19.5	16.6	17.2	24.7	5.1	5.8	10.4	6.6	21.5	20.2	5.2	8.4	18.8	6.1	10.8	2.3	12.4	4.6	11.1	11.5	13.2	6.1	4.1	5.1	7.6	3.8	3.9	3.1	9.7	4.2	12.3	2.4	9.3	23.5	15.4	5.9	7.3	21.4	19.7	4.9	5.8	11.7	7.7	8.4	3.9	7.9	6.5	6.8	6.4	3.5	7.5	11.4	10.8	6.2	4.0	12.5	9.7	14.3	13.1	15.1	4.6	6.9	19.0	8.3	6.4	12.1	2.7	13.4	15.8	4.5	7.9	5.3	7.6	41.3	19.1	24.7	13.0	19.5	12.2	11.6	13.7	12.4	12.9	11.2	16.0	13.4	47.2	16.6	18.9	6.6	17.2	24.7	17.5	19.2	33.6	20.7	16.3	8.9	29.4	12.3	19.8	27.5	20.8	32.0	48.0	76.4	96.2	28.2	19.3	15.3	29.4	26.1	31.4	7.9	37.4	38.1	37.9	140.0	39.8	44.5	23.3	28.2	22.1	49.4	82.2	49.7	31.6	26.0	39.7	51.9	31.3	49.0	228.9	50.0	34.0	70.9	32.5	34.8	29.1	32.4	35.1	54.5	32.3	27.8	45.3	56.7	41.7	31.1	116.2	176.0	45.3	22.0	82.3
HCCS	"CCHL, MLS"	ENSG00000004961	"Holocytochrome c synthase"	P53701	X	11111301-11123078	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Lyase	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002946	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA002946: AB_1079041"	"prognostic unfavorable (8.69e-5)"	"unprognostic (6.89e-3)"	"unprognostic (8.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.44e-2)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (9.18e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (6.17e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.93e-2)"	10.6	14.2	8.8	9.0	12.7	11.8	9.6	11.0	17.7	6.7	15.5	7.4	8.0	17.2	8.5	5.5	15.8	6.9	9.8	36.9	8.4	8.3	15.9	19.0	9.5	10.1	8.2	11.1	10.0	11.4	11.5	10.0	12.8	10.6	7.8	15.2	9.3	12.8	8.0	41.6	13.8	14.4	10.4	6.3	12.3	12.2	10.5	6.0	10.3	10.8	16.4	11.8	11.4	17.3	18.1	28.4	13.3	29.7	8.4	11.1	8.7	23.2	26.7	12.5	12.0	11.8	11.4	13.3	23.4	17.9	29.6	25.4	31.0	17.0	14.4	12.1	18.8	33.0	21.6	25.9	22.4	29.0	13.5	20.3	14.5	34.3	15.4	20.9	15.7	17.7	11.1	17.5	28.2	19.3	16.0	21.0	11.1	26.8	16.8	19.9	31.5	11.4	12.8	22.7	14.1	29.0	11.2	25.1	28.4	19.9	18.3	9.0	10.7	23.4	25.5	15.0	27.6	19.7	11.4	20.6	19.2	10.4	49.2	19.9	12.3	12.6	19.2	15.5	12.7	18.4	10.1	22.5	13.3	9.9	29.7	9.5	18.1	9.7	8.9	28.4	15.5	8.5	11.1	6.2	8.4	24.8	25.9	10.4	8.7	8.8	12.7	11.0	17.7	8.4	8.3	8.2	11.1	10.6	6.0	6.0	4.5	22.9	41.8	48.7	5.1	47.6	20.4	16.0	15.9	15.7	0.0	29.4	43.1	32.7	3.8	15.8	37.0	23.3	25.6	30.7	17.7	30.5	12.7	15.3	36.7	7.9	10.4	12.3	22.9	1.3	12.4	23.8	23.6	31.5	20.2	8.7	46.3	31.6	9.9	30.7	7.1	6.5	25.0	13.4	25.4	40.3	34.2	13.8	28.1	88.7
HDAC1	"GON-10, HD1, RPD3L1"	ENSG00000116478	"Histone deacetylase 1"	Q13547	1	32292086-32333635	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005017, HPA029693, CAB068191"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005017: AB_2248344, CAB068191: AB_2665664, HPA029693: AB_10601659"	"unprognostic (2.51e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (5.76e-7)"	"unprognostic (9.57e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.47e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (6.86e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.72e-1)"	13.8	22.8	12.8	33.5	14.8	15.0	21.1	5.1	13.0	21.9	35.7	16.0	34.8	22.2	24.6	17.5	40.6	21.0	43.8	12.4	12.5	8.5	21.1	21.5	17.2	33.3	14.7	8.6	27.7	20.5	17.2	27.1	24.4	12.2	25.2	33.9	18.0	27.8	31.3	6.6	16.9	32.7	22.1	13.3	32.6	27.8	20.0	16.7	59.4	36.8	21.2	51.1	26.0	25.1	47.7	32.1	59.8	44.6	42.4	49.2	54.7	29.4	18.0	11.6	23.0	6.8	8.1	24.1	20.9	23.4	28.0	25.9	32.9	53.1	45.4	38.8	23.0	28.5	34.4	35.5	28.4	31.1	42.4	35.3	31.3	21.6	25.2	16.0	55.4	45.4	14.6	15.6	21.7	14.4	22.0	21.2	59.5	41.0	18.1	12.3	22.4	63.1	31.2	26.8	35.2	46.1	43.6	27.5	20.2	30.3	42.6	9.1	11.5	34.8	23.5	43.8	47.7	27.7	43.1	24.5	18.7	21.9	5.7	50.8	11.0	23.7	62.3	15.4	46.0	24.2	37.0	27.7	59.8	43.2	35.5	35.4	47.7	42.4	46.1	32.1	44.3	49.2	45.7	19.9	42.4	44.6	20.1	42.5	54.7	12.8	14.8	5.1	13.0	12.5	8.5	14.7	8.6	12.2	16.7	23.8	38.4	50.1	48.1	22.0	15.5	18.2	56.0	80.3	48.9	64.6	15.7	81.3	81.2	57.2	10.0	40.9	97.1	0.0	65.1	93.0	21.5	29.1	29.0	28.2	38.0	11.1	82.9	63.8	40.8	5.9	38.0	31.0	27.0	42.3	101.3	32.1	65.7	108.7	41.8	25.9	13.9	58.2	37.7	45.1	76.2	22.2	78.1	50.7	115.8	49.8
HDGF	HMG1L2	ENSG00000143321	"Heparin binding growth factor"	P51858	1	156742107-156766925	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Growth factor, Heparin-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026035, HPA048728, HPA053422"	Enhanced		Enhanced	Nucleoplasm		NA	NA		300000	Nucleoplasm		"CAB026035: , HPA048728: AB_2680503, HPA053422: AB_2682146"	"unprognostic (2.80e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (9.06e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (2.43e-8)"	"unprognostic (9.80e-3)"	"unprognostic (2.34e-2)"	"prognostic favorable (9.84e-4)"	"unprognostic (2.45e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.40e-3)"	"unprognostic (8.66e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.86e-2)"	27.6	24.0	24.4	26.4	24.6	78.7	51.5	26.7	22.1	29.7	57.9	22.4	23.9	40.6	22.1	22.9	53.0	34.9	38.1	41.7	23.5	18.3	64.5	92.6	38.0	32.6	23.7	12.9	29.0	35.3	25.6	19.0	49.1	20.4	21.3	37.5	15.9	26.5	30.6	57.2	39.2	83.1	21.7	25.5	30.0	25.6	11.8	22.4	79.0	38.3	64.8	44.0	30.9	29.6	7.5	14.5	10.4	12.3	6.1	9.7	7.8	72.9	36.2	41.6	19.8	24.1	33.2	46.0	24.2	61.9	56.8	37.2	40.9	78.0	49.4	47.9	48.2	25.3	51.7	61.9	54.4	56.6	40.0	43.9	42.2	52.6	35.7	32.1	61.8	35.7	23.8	52.2	44.4	86.8	45.3	41.8	39.1	55.2	41.4	46.2	53.7	50.9	68.5	73.5	117.0	51.4	57.5	24.9	65.9	62.4	24.7	62.2	67.6	57.8	76.5	29.1	53.8	61.1	96.1	36.9	28.8	44.7	36.4	61.4	55.9	69.4	86.0	38.3	49.2	36.6	6.0	12.3	10.4	8.5	10.4	6.3	6.7	7.3	7.5	14.1	7.5	6.6	6.2	7.1	6.1	11.4	14.5	9.7	7.8	24.4	24.6	26.7	22.1	23.5	18.3	23.7	12.9	20.4	22.4	65.5	86.4	36.5	146.2	130.9	60.7	81.8	79.0	123.1	80.8	68.0	25.5	38.8	68.0	89.5	37.7	46.6	109.5	70.0	112.1	90.8	73.3	173.1	30.0	144.0	46.2	50.9	119.7	27.6	33.2	33.1	37.7	55.8	37.1	37.9	83.0	56.2	134.0	51.8	43.2	94.2	31.4	19.4	48.5	28.7	24.6	139.4	45.9	41.5	82.1	206.9
HDGFL2	"Hdgfrp2, HRP2"	ENSG00000167674	"HDGF like 2"	Q7Z4V5	19	4472287-4502211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.1"	"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 31.1;Ductal cells: 22.5;Extravillous trophoblasts: 24.9;Hofbauer cells: 21.7;monocytes: 26.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042559, HPA044208"	Enhanced		Supported	Nucleoplasm,Mitochondria		No	No			Nucleoplasm	Mitochondria	"HPA042559: AB_2678049, HPA044208: AB_2678858"	"unprognostic (1.33e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.47e-3)"	"unprognostic (6.57e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.73e-3)"	"unprognostic (4.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.05e-1)"	10.3	9.6	15.4	10.0	13.6	8.1	10.3	15.3	21.0	9.7	8.8	9.0	8.0	10.1	12.3	10.4	6.6	10.2	9.9	8.5	16.6	13.5	9.8	9.9	7.3	10.2	11.9	13.2	15.9	10.6	8.3	10.2	9.6	10.5	10.1	5.0	7.8	11.3	16.8	39.4	10.9	9.2	12.0	8.8	10.3	9.2	49.1	9.5	13.6	7.3	6.2	7.4	7.7	9.0	7.0	2.2	3.6	1.8	2.3	2.4	0.8	27.7	16.4	28.5	26.4	12.4	12.7	19.9	22.4	12.1	24.7	22.0	18.7	12.1	24.5	13.1	16.4	13.0	15.9	18.9	20.4	14.5	27.3	30.0	15.0	12.3	24.6	16.1	14.8	21.5	18.1	11.1	16.9	8.3	17.6	22.5	23.2	17.2	30.9	11.9	19.7	33.4	29.7	32.6	11.2	29.5	33.3	23.5	15.7	15.3	14.2	31.5	31.1	21.8	12.5	18.1	16.3	12.3	23.6	29.7	15.6	21.4	29.3	21.1	38.4	20.0	17.2	21.9	23.9	16.4	0.0	1.8	3.6	1.4	1.1	0.4	1.1	1.5	1.1	1.6	7.0	2.4	0.9	0.5	2.3	0.6	2.2	1.8	0.8	15.4	13.6	15.3	21.0	16.6	13.5	11.9	13.2	10.5	9.5	6.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	17.4	9.1	12.2	0.0	31.1	16.6	22.5	0.0	0.0	0.0	0.0	17.5	24.9	0.0	0.0	1.1	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	26.2	0.0	0.0	19.1	0.0	0.0	18.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0
HDHD3	"C9orf158, MGC12904"	ENSG00000119431	"Haloacid dehalogenase like hydrolase domain containing 3"	Q9BSH5	9	113373419-113376999	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 54.7"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 204.4;Paneth cells: 171.9;Proximal tubular cells: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020427, HPA024158, HPA024585"	Enhanced		Enhanced	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA020427: AB_1850561, HPA024158: AB_1850563, HPA024585: AB_1850565"	"unprognostic (1.30e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (3.01e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.66e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.92e-2)"	"unprognostic (5.87e-2)"	"prognostic favorable (3.54e-7)"	"unprognostic (2.16e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.19e-3)"	4.9	54.7	5.1	10.1	8.4	3.3	12.7	6.2	8.5	6.0	29.8	5.6	10.6	38.2	6.4	15.5	13.8	5.8	18.1	9.1	4.6	5.3	17.7	36.6	4.4	6.3	4.5	9.4	7.2	23.7	20.5	9.1	6.5	7.3	10.6	16.8	8.3	24.4	12.5	2.8	11.4	47.1	8.0	4.8	6.0	17.7	4.5	4.0	8.0	18.2	6.1	6.8	7.0	6.9	12.1	10.6	5.9	2.9	5.6	12.3	5.8	3.4	9.7	2.1	5.8	5.2	2.3	17.7	2.5	4.8	4.1	4.5	17.8	17.0	7.5	3.2	1.4	8.2	13.3	3.3	3.9	1.4	10.4	7.6	10.3	5.3	11.0	6.1	0.6	8.0	3.6	8.3	3.3	9.5	4.8	2.1	7.0	8.1	1.9	1.9	22.1	4.7	3.0	4.7	34.0	7.6	3.9	0.0	6.0	5.2	7.1	5.3	3.4	4.3	18.8	6.3	4.8	11.8	2.1	2.1	0.8	0.0	0.7	0.8	4.6	9.0	3.1	1.0	0.0	0.6	0.1	2.9	5.9	9.9	1.6	11.2	11.3	11.5	9.0	4.5	12.1	12.0	8.9	1.9	5.6	0.2	10.6	12.3	5.8	5.1	8.4	6.2	8.5	4.6	5.3	4.5	9.4	7.3	4.0	8.9	8.5	18.1	18.5	8.9	9.4	12.0	73.9	22.7	11.4	22.7	9.8	23.7	72.9	66.3	0.1	8.9	204.4	23.3	138.2	16.2	7.5	24.3	7.0	74.9	17.6	1.6	38.8	8.6	5.1	0.9	13.3	6.7	10.1	19.8	61.9	10.8	96.2	171.9	8.5	218.3	12.1	6.5	7.5	0.2	6.1	12.8	26.4	17.3	72.5	40.4
HEATR1	"BAP28, FLJ10359, UTP10"	ENSG00000119285	"HEAT repeat containing 1"	Q9H583	1	236549005-236604504	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing, Transcription, Transcription regulation"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046917, HPA062200"	Approved		Enhanced	"Nucleoli fibrillar center,Mitochondria"		NA	NA		120000	"Nucleoli fibrillar center"	Mitochondria	"HPA046917: AB_2679863, HPA062200: AB_2684709"	"unprognostic (2.61e-1)"	"unprognostic (1.44e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.34e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (2.05e-4)"	"unprognostic (5.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.80e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (8.08e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.00e-2)"	14.1	11.0	9.2	14.7	11.3	15.2	13.8	15.0	13.9	10.7	10.6	8.6	8.3	7.6	15.9	9.4	14.7	12.5	8.1	9.4	10.0	5.8	9.9	13.2	10.6	16.5	12.9	6.9	15.8	17.2	13.5	12.8	10.5	11.6	11.1	10.8	8.2	12.6	9.5	12.7	14.5	11.6	13.1	6.6	16.1	11.5	20.3	13.2	18.3	12.0	12.8	17.9	12.7	12.8	9.9	5.9	1.8	4.5	6.4	10.0	2.4	14.5	17.5	9.2	13.9	12.9	14.5	20.6	11.8	7.6	13.6	12.2	17.6	12.4	23.9	13.3	10.8	8.4	17.7	20.9	12.6	18.5	12.0	24.0	17.0	12.5	15.0	11.6	30.3	11.0	11.8	11.4	20.5	17.8	6.6	15.5	11.1	38.4	8.1	13.5	7.8	14.3	8.3	36.7	18.7	7.2	16.0	13.3	22.4	8.7	14.7	8.6	19.2	14.3	10.2	12.2	6.4	12.1	11.4	14.7	13.7	12.9	17.6	29.1	15.4	19.2	28.3	12.2	17.0	20.3	1.8	3.6	1.1	7.3	4.5	6.6	9.9	7.2	7.9	4.3	8.1	10.0	9.4	0.5	6.4	4.3	5.9	5.9	2.4	9.2	11.3	15.0	13.9	10.0	5.8	12.9	6.9	11.6	13.2	3.0	10.9	8.8	9.3	17.5	11.2	3.5	12.7	12.0	14.8	5.2	17.7	7.0	3.3	7.4	5.7	10.0	2.7	0.0	7.1	8.9	9.9	7.4	31.3	8.9	6.6	6.4	4.1	11.1	10.0	0.9	13.0	7.4	1.7	6.4	5.5	4.4	10.4	2.9	9.6	3.5	10.4	0.0	9.2	21.3	30.8	14.8	4.1	10.2	8.3	9.1
HEATR3	FLJ20718	ENSG00000155393	"HEAT repeat containing 3"	Q7Z4Q2	16	50065941-50106387	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 25.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041990, HPA058579"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA041990: AB_10793940, HPA058579: AB_2683762"	"unprognostic (7.36e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.80e-3)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (7.68e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.79e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (2.26e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.17e-2)"	14.7	13.6	8.8	17.8	16.1	10.1	9.3	19.5	14.0	10.2	11.5	12.4	11.1	10.1	9.2	10.3	13.0	8.5	9.4	9.9	9.4	9.6	10.7	20.7	10.5	14.6	10.9	8.1	7.1	19.2	14.8	13.3	12.1	8.7	8.4	13.8	7.8	12.4	7.8	19.6	13.3	10.9	11.3	10.5	21.6	11.4	15.6	11.1	14.5	6.4	10.7	12.9	9.2	8.0	2.4	4.2	2.2	7.0	2.0	2.9	2.2	10.8	11.1	10.3	16.3	6.4	8.6	11.1	13.2	8.8	13.3	5.3	13.6	8.3	20.5	9.6	12.6	5.0	13.0	12.4	9.9	15.5	5.2	13.3	10.1	7.8	17.2	9.2	17.5	20.6	6.7	6.8	9.4	5.7	5.8	10.7	10.9	12.8	3.6	13.0	6.7	13.4	22.0	12.1	13.2	11.6	14.9	14.0	16.6	7.4	8.9	13.4	7.1	12.8	16.6	8.3	8.3	7.5	12.8	13.9	10.7	7.2	8.2	10.1	8.7	6.9	18.4	10.6	17.7	10.5	1.3	6.2	1.4	2.6	7.0	2.8	1.6	1.6	2.9	4.2	2.4	2.3	2.4	2.2	2.0	6.1	3.7	2.6	2.2	8.8	16.1	19.5	14.0	9.4	9.6	10.9	8.1	8.7	11.1	3.0	4.3	2.7	0.7	2.9	7.2	5.2	5.1	2.7	1.2	1.8	15.7	3.0	6.6	2.2	9.3	3.6	3.8	0.0	2.6	2.9	2.6	1.9	1.1	6.7	8.3	1.6	3.4	2.5	25.3	13.3	3.1	7.0	1.7	3.6	3.3	1.9	2.6	2.9	2.1	3.4	7.3	0.0	2.1	4.8	4.5	1.5	0.8	4.4	4.9	1.4
HECTD1	KIAA1131	ENSG00000092148	"HECT domain E3 ubiquitin protein ligase 1"	Q9ULT8	14	31100112-31207804	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002929, HPA054461"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA002929: AB_1850574, HPA054461: AB_2682496"	"unprognostic (6.71e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.20e-6)"	"unprognostic (6.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.91e-3)"	22.0	22.3	14.2	21.0	16.8	22.0	18.5	22.3	18.9	19.4	17.9	15.2	20.2	11.5	17.6	15.7	30.4	16.1	15.2	26.2	13.5	14.3	18.0	35.2	15.0	14.1	14.5	14.5	18.2	15.1	34.8	20.5	27.0	18.8	16.8	15.5	16.8	18.9	16.4	88.5	24.3	16.3	15.6	13.7	16.4	18.8	18.9	14.4	16.7	24.8	23.0	18.6	18.6	22.3	10.6	9.3	12.6	8.6	8.9	8.1	3.3	28.8	18.1	15.9	9.9	50.4	26.4	15.2	17.7	17.9	15.8	13.7	13.5	15.7	22.7	18.8	32.3	11.3	19.6	21.2	16.0	24.1	13.9	8.7	23.2	14.9	54.0	23.5	24.1	17.0	23.2	22.1	17.8	28.0	22.0	29.1	13.5	16.6	10.5	24.6	23.7	9.3	10.3	12.1	25.3	16.5	17.3	18.4	9.9	24.7	30.0	11.8	13.9	25.9	18.0	15.7	20.2	18.9	15.6	29.1	18.4	14.4	13.2	15.0	11.5	16.4	25.6	8.7	12.2	15.5	12.6	8.6	11.3	7.1	7.1	8.1	7.2	8.0	6.3	9.3	10.6	6.7	6.6	4.4	8.9	5.3	7.8	8.0	3.3	14.2	16.8	22.3	18.9	13.5	14.3	14.5	14.5	18.8	14.4	44.7	63.3	37.1	68.0	76.9	78.2	103.0	22.9	155.2	84.2	68.0	92.3	53.4	10.0	37.6	2.9	56.2	38.8	23.3	31.4	36.2	49.1	82.9	31.3	79.7	25.8	62.0	46.8	39.9	39.7	6.7	63.9	34.4	32.1	29.7	30.4	36.8	41.9	28.1	70.0	20.0	175.8	45.3	41.2	53.4	107.2	100.5	117.1	37.4	37.3	267.3
HEMGN	"CT155, EDAG, NDR"	ENSG00000136929	Hemogen	Q9BXL5	9	97926791-97944856	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 71.1;placenta: 20.2;testis: 32.5"	"Group enriched"	"Detected in some"	149	"Early spermatids: 1388.7;Erythroid cells: 724.2;Late spermatids: 1114.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 8.2"	"Group enriched"	"Detected in many"	27	"granulocytes: 2.1;NK-cells: 2.9;T-cells: 8.2"	"Cell line enriched"	"Detected in some"	4	"K-562: 77.0"					"Region enriched"	"Detected in all"	5	"cerebellum: 55.9"	"HPA019572, HPA019604, HPA019606"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019572: AB_1850588, HPA019604: AB_1850590, HPA019606: AB_1850591"	"unprognostic (1.94e-1)"				"unprognostic (3.15e-3)"			"unprognostic (2.50e-2)"		"unprognostic (9.00e-3)"	"unprognostic (2.12e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.45e-4)"	"unprognostic (2.77e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.25e-1)"		0.3	0.2	0.2	0.4	0.2	71.1	0.2	0.2	0.3	0.2	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.3	1.0	0.2	0.2	0.3	0.9	5.4	0.5	0.2	0.0	0.6	0.2	0.0	0.3	20.2	1.1	0.2	0.0	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.3	2.8	0.2	32.5	0.0	17.1	0.3	0.2	0.5	1.4	4.8	0.0	0.1	2.1	0.1	2.9	8.2	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	77.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.4	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.1	0.8	0.0	2.3	1.1	0.1	0.0	8.2	3.3	1.0	2.9	0.0	0.0	1.2	4.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	1388.7	0.0	0.0	724.2	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.3	1114.5	5.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	6.5	0.0	7.2	3.3	0.0	0.5	0.0	0.0	0.0
HEXIM1	"CLP-1, EDG1, HIS1, MAQ1"	ENSG00000186834	"Hexamethylene bisacetamide inducible 1"	O94992	17	45148502-45152101	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 390.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008926, CAB011625"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB011625: AB_2233058, HPA008926: AB_1079048"	"unprognostic (2.82e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.26e-2)"	14.8	25.3	30.0	12.6	25.3	30.4	13.7	41.4	37.4	16.2	21.0	10.7	18.5	17.8	17.0	17.2	18.6	18.2	18.6	16.0	31.1	15.6	20.9	19.0	15.8	11.8	24.9	19.2	14.8	15.6	12.2	24.4	56.7	27.5	19.9	10.8	12.6	16.4	25.2	29.7	22.6	20.2	19.5	31.4	20.7	17.3	17.1	21.7	8.9	17.2	14.3	12.3	17.8	30.6	3.7	3.4	15.9	6.7	3.8	4.6	2.3	13.0	41.6	8.7	12.5	14.4	7.7	21.3	11.6	10.5	9.6	10.8	19.5	18.6	5.7	35.9	12.2	4.6	10.6	5.2	11.4	7.8	11.8	12.4	17.7	22.9	23.8	12.6	11.0	23.6	9.0	9.8	7.1	3.1	24.2	4.8	10.1	7.8	13.9	7.2	17.5	11.5	12.8	8.0	12.1	12.6	4.8	7.6	7.0	25.3	23.2	4.7	3.5	17.5	19.8	18.7	9.2	20.6	8.7	9.1	9.7	13.5	5.5	21.5	12.7	4.0	3.7	8.9	10.4	11.0	15.9	4.3	6.6	4.5	6.1	2.7	3.3	4.6	4.0	3.3	3.7	4.2	4.4	10.5	3.8	6.7	3.4	3.9	2.3	30.0	25.3	41.4	37.4	31.1	15.6	24.9	19.2	27.5	21.7	68.5	92.7	29.4	49.2	75.1	23.7	46.8	86.6	41.5	59.1	24.4	21.6	110.7	6.6	30.0	2.1	58.5	171.5	23.3	20.3	55.9	57.3	53.6	120.4	33.6	37.7	14.3	50.7	41.1	29.4	2.1	32.5	51.4	50.6	42.3	63.9	24.3	22.5	108.7	41.1	40.3	26.5	25.8	75.9	2.1	6.4	62.5	390.9	55.4	47.5	30.7
HGS	"Hrs, Vps27, ZFYVE8"	ENSG00000185359	"Hepatocyte growth factor-regulated tyrosine kinase substrate"	O14964	17	81683326-81703138	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA004872, HPA007728"	Uncertain		Enhanced	Endosomes,Lysosomes,Cytosol		NA	NA		250000	"Endosomes, Lysosomes"	Cytosol	"HPA004872: AB_1079053, HPA007728: AB_1850681"	"unprognostic (6.52e-2)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (4.29e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.61e-5)"	"unprognostic (5.54e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.31e-7)"	"unprognostic (3.69e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.45e-1)"	26.8	33.5	34.7	31.9	44.7	66.5	28.9	35.7	45.6	25.4	31.1	35.2	24.5	33.2	27.3	37.2	42.1	32.8	29.1	25.4	32.7	30.4	34.2	31.3	29.4	34.3	39.8	44.2	33.2	39.7	21.8	31.7	32.4	40.7	31.9	31.1	23.6	38.2	27.9	36.3	57.5	32.5	32.6	28.5	38.5	35.6	53.1	38.1	22.2	26.2	25.9	32.5	24.9	34.6	12.2	14.6	28.9	20.2	17.2	18.7	18.8	33.7	27.6	20.8	25.8	18.8	21.2	22.8	25.4	24.6	29.8	23.0	23.2	24.2	9.4	17.4	34.3	33.2	28.7	17.5	27.8	21.0	8.1	29.3	20.3	34.6	29.1	28.3	17.5	26.8	23.7	30.5	33.2	47.3	38.9	37.2	23.2	22.1	17.4	31.3	20.4	19.1	40.4	15.0	28.3	29.2	20.9	16.6	14.9	29.1	25.6	29.8	35.4	19.3	49.1	22.5	25.5	30.1	33.9	30.9	58.0	34.1	28.7	47.2	22.3	7.9	12.0	35.7	22.9	30.5	25.2	17.4	22.3	18.7	20.2	12.4	11.4	13.5	13.0	14.6	12.2	10.1	11.7	28.9	17.2	19.1	12.4	14.9	18.8	34.7	44.7	35.7	45.6	32.7	30.4	39.8	44.2	40.7	38.1	23.8	26.6	16.6	18.4	24.7	29.6	2.2	22.9	13.4	21.6	21.0	33.4	28.4	1.7	42.3	55.8	20.5	45.2	0.0	36.8	31.4	19.8	38.8	22.0	17.4	25.9	22.3	10.9	15.4	21.8	107.7	26.7	24.3	21.9	25.2	29.5	20.6	48.5	29.2	21.5	11.0	33.7	12.9	21.7	39.5	39.2	26.5	42.0	20.8	27.4	34.4
HIBCH		ENSG00000198130	"3-hydroxyisobutyryl-CoA hydrolase"	Q6NVY1	2	190189735-190344193	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Branched-chain amino acid catabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 262.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036540, HPA036541, HPA067080"	Enhanced		Enhanced	Mitochondria		NA	NA		90000	Mitochondria		"HPA036540: AB_10673355, HPA036541: AB_2675182, HPA067080: "	"unprognostic (3.60e-3)"	"unprognostic (3.88e-2)"	"unprognostic (6.81e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.88e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (1.04e-10)"	"unprognostic (1.34e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-3)"	13.7	38.6	18.1	10.1	19.5	5.0	15.8	16.4	18.7	16.3	15.8	14.5	13.0	24.7	17.0	13.0	20.2	10.2	10.0	13.7	18.5	12.7	65.7	56.8	7.6	8.2	20.1	10.8	9.5	29.5	35.8	24.7	7.8	21.0	11.7	18.7	15.0	10.6	12.2	17.5	23.7	16.5	11.3	18.2	9.0	10.4	10.6	22.2	10.5	17.4	15.4	9.3	12.5	49.2	24.2	15.1	14.6	7.6	17.3	20.0	7.3	9.8	7.6	16.3	10.3	15.4	13.6	9.0	10.7	5.7	10.1	11.0	23.5	8.7	15.0	15.3	9.2	7.2	18.9	17.2	14.7	15.3	21.5	13.4	20.0	15.9	20.5	5.2	14.2	7.4	11.0	7.9	11.8	2.1	14.8	16.3	14.3	24.2	13.1	11.0	9.1	14.5	16.4	5.1	13.4	15.5	18.0	11.7	38.0	22.8	29.9	12.4	11.7	9.2	13.2	30.2	24.8	14.9	11.1	11.5	10.7	10.0	7.2	7.5	8.4	17.8	12.5	9.7	12.4	8.4	12.9	6.7	14.6	11.9	7.6	12.8	24.2	13.3	12.5	11.1	18.7	14.2	18.2	3.5	17.3	5.7	15.1	20.0	7.3	18.1	19.5	16.4	18.7	18.5	12.7	20.1	10.8	21.0	22.2	20.8	19.6	31.1	98.9	49.7	35.7	23.4	40.8	28.1	28.4	34.9	96.2	40.5	97.8	21.8	145.2	29.2	35.8	0.0	25.6	16.9	26.6	30.4	10.3	97.2	29.6	23.8	36.2	76.7	17.4	44.8	32.2	15.7	43.9	14.4	25.9	37.9	16.2	17.3	42.8	262.7	51.0	38.8	26.4	17.5	27.2	35.5	16.7	21.3	53.3	81.2
HIF1A	"bHLHe78, HIF-1alpha, HIF1, MOP1, PASD8"	ENSG00000100644	"Hypoxia inducible factor 1 alpha subunit"	Q16665	14	61695513-61748259	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 47.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 47.8"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 119.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000907, HPA001275, CAB017442"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB017442: AB_10621732, HPA000907: AB_2666139, HPA001275: AB_1079057"	"unprognostic (1.07e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.94e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.58e-1)"	"unprognostic (7.35e-2)"	"unprognostic (3.88e-2)"	31.9	62.0	15.6	45.2	17.8	125.2	24.9	22.7	18.5	45.7	15.3	12.3	23.5	10.8	17.7	31.3	31.2	21.7	50.0	19.4	17.5	16.5	76.4	42.7	42.8	27.3	18.3	11.0	34.5	12.7	13.7	26.8	24.2	25.1	17.6	13.9	14.0	24.6	36.2	8.0	17.4	16.9	18.7	27.2	57.3	16.0	21.1	12.4	24.7	26.9	18.4	28.8	37.8	21.5	6.6	6.0	47.8	6.8	6.2	7.9	5.1	38.0	15.2	15.3	43.7	24.3	39.2	20.7	31.7	38.2	39.9	36.0	6.6	12.6	9.3	23.9	39.1	11.4	9.0	9.8	52.0	50.0	4.0	5.1	5.7	14.0	11.4	54.2	2.4	6.2	68.3	16.5	29.3	31.4	53.9	25.1	5.4	3.8	0.0	119.1	7.9	7.4	2.9	13.8	6.0	20.1	0.5	34.3	2.7	51.5	25.3	12.9	14.3	59.4	8.5	20.9	21.8	8.9	4.5	14.9	90.7	20.3	30.0	26.6	5.0	7.2	10.6	47.8	4.7	24.5	11.2	6.8	47.8	3.8	5.5	4.9	6.5	5.0	4.4	6.0	6.6	7.9	5.1	18.2	6.2	5.6	2.9	3.4	5.1	15.6	17.8	22.7	13.2	17.5	16.5	18.3	11.0	25.1	12.4	65.5	115.1	54.6	71.5	94.4	49.4	37.3	86.6	33.5	69.4	247.7	47.1	22.6	87.9	226.7	3.1	113.7	30.7	0.0	216.2	57.6	82.5	54.8	217.2	23.7	123.2	147.8	63.8	177.4	143.9	3.6	22.5	156.8	97.8	76.7	36.5	141.2	213.6	23.0	45.6	116.2	52.0	51.8	129.7	27.4	24.9	76.9	21.3	60.6	34.8	75.6
HINT2		ENSG00000137133	"Histidine triad nucleotide binding protein 2"	Q9BX68	9	35812960-35815354	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 537.2;Hepatocytes: 366.2;Proximal tubular cells: 463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA020961, HPA059109"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1100000	Mitochondria		"HPA020961: AB_1850715, HPA059109: AB_2683906"	"unprognostic (9.64e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.61e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (3.71e-3)"	"unprognostic (2.87e-2)"	"prognostic favorable (2.97e-9)"	"unprognostic (4.29e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.72e-1)"	18.4	27.2	16.0	14.5	15.5	10.3	15.6	9.5	16.5	10.0	16.4	11.0	26.1	15.3	8.9	24.1	12.6	14.4	21.7	33.7	13.3	13.3	34.8	68.7	15.2	14.2	15.3	13.6	6.8	30.8	21.0	14.1	12.8	12.5	10.8	16.4	12.2	20.2	31.0	30.9	10.3	15.8	17.0	12.3	11.3	16.7	10.3	8.2	16.8	14.9	29.8	11.8	10.4	7.5	24.6	62.0	7.8	20.3	15.1	25.5	18.5	9.7	26.8	16.7	16.1	10.7	9.0	10.9	9.2	13.8	15.1	16.7	17.5	10.8	12.7	10.6	8.8	21.6	9.8	7.6	14.3	16.0	27.6	13.8	13.8	23.3	15.7	24.8	7.7	14.0	10.0	13.2	14.3	23.4	6.0	11.7	31.3	8.1	41.4	12.0	20.8	19.5	9.8	7.4	24.0	46.1	19.6	11.1	17.5	21.5	7.6	13.3	15.9	12.0	14.9	16.0	10.4	16.1	15.1	5.3	8.1	12.8	10.5	11.6	36.0	40.0	18.3	17.9	10.8	12.7	7.8	20.3	1.1	18.5	14.3	16.7	24.6	19.9	18.5	28.6	23.8	15.4	15.9	1.9	15.1	13.0	62.0	25.5	18.5	16.0	15.5	9.5	16.5	13.3	13.3	15.3	13.6	12.5	8.2	20.8	10.8	63.0	60.5	40.3	34.2	96.4	124.9	53.5	13.6	76.8	19.6	143.0	537.2	101.9	54.3	49.6	142.5	46.7	149.8	55.2	58.2	44.3	18.4	366.2	96.3	19.1	92.3	63.3	58.2	111.5	37.4	47.7	114.7	71.3	106.7	69.3	83.1	158.4	42.1	463.5	36.6	45.3	71.8	32.1	82.2	40.1	47.5	67.1	120.6	54.5
HIRA	"DGCR1, TUP1, TUPLE1"	ENSG00000100084	"Histone cell cycle regulator"	P54198	22	19330698-19447450	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 50.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB039243, CAB039244, HPA050714, HPA052902"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB039243: , CAB039244: , HPA050714: AB_2681219, HPA052902: AB_2681984"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.45e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (8.11e-4)"	"prognostic favorable (3.97e-4)"	"unprognostic (9.05e-2)"	"prognostic favorable (5.18e-6)"	"unprognostic (4.84e-2)"	"unprognostic (8.57e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.32e-3)"	9.9	9.8	14.8	10.0	13.6	19.9	7.4	16.7	16.3	8.0	11.7	10.9	9.4	12.4	11.9	8.4	9.7	11.5	10.0	9.2	13.4	11.6	12.8	15.0	9.1	11.4	11.3	10.0	10.8	11.3	25.6	11.4	7.6	9.8	7.6	9.4	8.9	8.6	8.7	15.3	10.8	12.1	10.3	8.3	10.2	10.1	10.5	10.6	20.3	50.0	4.6	10.0	8.9	18.2	8.2	2.9	6.1	1.2	3.6	2.4	1.2	8.1	7.1	10.1	10.4	9.9	6.5	7.1	6.8	7.9	11.3	11.2	16.2	4.7	15.7	3.4	8.8	6.8	9.6	14.3	8.6	7.3	9.8	16.6	14.6	7.7	14.8	10.8	33.7	10.8	7.9	8.4	8.8	8.7	6.1	8.1	15.9	74.9	8.4	6.4	10.0	16.5	12.0	9.2	19.2	7.2	13.2	14.4	4.6	6.5	9.0	14.8	9.9	7.8	7.9	9.4	5.3	5.0	11.8	9.4	7.8	11.6	7.9	8.0	9.0	8.9	16.5	9.0	10.9	6.4	6.1	1.2	5.0	2.3	1.2	2.4	3.7	1.3	2.3	1.5	8.2	0.6	1.7	2.2	3.6	0.6	2.9	0.6	1.2	14.8	13.6	16.7	16.3	13.4	11.6	11.3	10.0	9.8	10.6	6.0	0.3	6.9	1.9	8.1	8.5	2.0	5.1	0.0	0.0	5.2	2.0	3.2	5.0	5.3	5.7	3.6	7.0	0.0	7.7	3.0	4.1	3.8	0.0	18.1	5.6	15.9	2.4	7.4	10.8	1.6	4.6	2.5	10.1	3.6	8.5	4.5	6.6	10.8	6.3	9.3	4.0	6.5	4.2	7.1	7.5	9.3	2.5	3.3	13.3	1.8
HIRIP3		ENSG00000149929	"HIRA interacting protein 3"	Q9BW71	16	29992321-29996436	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA051897, HPA063205"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA051897: AB_2681655, HPA063205: AB_2684963"	"unprognostic (6.99e-2)"	"prognostic favorable (2.74e-5)"	"unprognostic (4.75e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.55e-2)"	"unprognostic (1.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (8.53e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.26e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.35e-2)"	9.4	11.3	16.8	9.2	26.8	15.0	10.0	23.4	17.9	10.9	11.3	20.7	10.0	9.6	11.3	10.8	9.5	12.5	9.0	17.6	16.4	14.6	10.6	13.6	12.8	12.7	22.9	13.6	18.2	11.4	20.0	14.2	8.4	15.3	10.1	7.5	11.5	12.8	15.5	29.0	13.3	9.2	13.3	20.1	10.8	8.5	34.0	23.9	21.0	11.8	9.0	11.9	10.3	12.4	13.9	14.6	10.8	13.9	9.7	16.6	8.3	11.0	11.8	18.2	12.3	5.8	6.3	6.3	8.8	7.2	9.6	8.1	9.9	12.1	19.6	18.6	5.8	6.5	8.3	11.9	10.8	6.3	19.4	14.3	21.0	15.7	11.1	5.4	18.6	18.5	3.4	8.2	9.1	13.6	5.1	5.5	22.6	10.9	25.0	5.0	8.1	26.9	11.8	6.0	7.2	7.5	29.4	20.3	22.5	6.1	4.8	13.2	15.8	8.4	7.5	6.2	4.6	10.6	13.3	5.4	12.9	9.6	9.0	8.6	17.3	12.1	13.4	11.9	17.5	17.3	3.5	5.9	10.8	13.4	9.2	9.3	13.9	15.3	12.4	4.9	11.7	16.1	14.9	2.7	9.7	13.9	14.6	16.6	8.3	16.8	26.8	23.4	17.9	16.4	14.6	22.9	13.6	15.3	23.9	62.5	22.9	6.7	16.0	11.3	36.1	27.0	10.2	26.8	20.5	8.7	13.7	21.2	24.9	8.4	13.9	14.6	13.6	0.0	10.7	25.6	12.2	5.7	30.1	12.3	16.1	14.3	9.2	8.6	9.9	8.2	19.0	13.5	5.0	10.0	9.1	34.7	6.1	10.5	21.2	15.3	39.9	12.9	19.6	94.0	51.7	9.9	9.6	19.2	13.3	4.2
HJURP	"DKFZp762E1312, FAKTS, hFLEG1, URLC9"	ENSG00000123485	"Holliday junction recognition protein"	Q8NCD3	2	233833416-233854566	"Predicted intracellular proteins"	"Cell cycle"	"Chaperone, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 27.4;lymphoid tissue: 51.1;testis: 20.9"	"Cell type enhanced"	"Detected in many"	17	"Early spermatids: 12.4;Erythroid cells: 46.7;Extravillous trophoblasts: 13.7;Spermatocytes: 18.4;Spermatogonia: 12.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;monocytes: 1.3;T-cells: 4.2"	"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA008436, HPA027261"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitochondria"		Yes	Yes			"Nucleoplasm, Nucleoli, Nucleoli rim"	Mitochondria	"HPA008436: AB_1850757, HPA027261: AB_2672184"	"unprognostic (5.63e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.75e-1)"	"prognostic unfavorable (3.37e-5)"	"prognostic unfavorable (2.46e-4)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (7.60e-2)"	"unprognostic (0.00e+0)"	"unprognostic (7.42e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-2)"	1.4	0.9	0.1	12.2	0.4	27.4	2.2	0.1	0.7	1.1	3.7	0.3	0.1	2.6	0.6	1.8	8.0	0.3	0.7	1.1	0.1	0.2	1.0	1.2	2.0	8.1	0.2	0.1	0.6	0.4	0.0	0.2	3.1	0.2	0.7	3.6	0.3	1.5	1.0	0.2	2.6	4.8	1.1	0.4	5.8	2.4	20.9	0.1	51.1	0.4	3.0	11.6	1.0	2.8	0.5	0.3	1.2	1.3	0.5	4.2	1.7	17.0	23.1	22.6	10.6	0.8	1.8	14.1	25.6	12.3	18.3	20.0	16.2	18.7	5.3	2.9	10.1	32.6	20.0	18.0	13.3	24.4	12.5	6.8	20.6	18.6	15.7	0.1	16.9	14.2	0.6	0.5	14.9	10.3	5.2	11.4	16.5	17.4	13.3	33.6	17.2	23.7	18.7	19.3	13.4	16.0	18.4	33.9	9.5	9.4	10.3	13.0	8.1	14.8	11.2	10.5	10.8	8.4	13.1	8.3	19.8	21.6	14.5	27.7	12.7	10.0	21.4	11.9	12.5	49.3	0.6	0.2	0.2	0.3	0.2	0.2	0.4	0.7	0.6	0.3	0.5	0.3	0.5	1.2	0.5	1.3	0.2	4.2	1.7	0.1	0.4	0.1	0.7	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.3	0.8	0.4	1.1	0.0	0.8	0.0	0.0	3.4	0.0	0.0	1.1	0.0	0.0	12.4	0.1	0.9	46.7	0.0	13.7	0.3	0.4	0.0	0.0	5.7	0.0	0.0	2.5	2.4	7.4	0.6	2.1	0.0	0.0	0.7	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.3	18.4	12.9	0.6	1.3	1.3	1.2	0.6
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell type enhanced"	"Detected in many"	25	"Cholangiocytes: 30.6;Ductal cells: 30.8;Enterocytes: 44.0;Muller glia cells: 172.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Cell line enhanced"	"Detected in some"		"A549: 14.8;CACO-2: 21.1;CAPAN-2: 41.7;EFO-21: 12.9;GAMG: 17.4;Hep G2: 12.2;RPTEC TERT1: 31.2"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA064198, HPA064230"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA064198: AB_2685210, HPA064230: AB_2685219"	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.1	41.7	0.0	12.9	0.1	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.2	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.2	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.5	0.0	0.4	0.0	31.2	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2	3.0	3.7	0.8	0.0	0.0	1.0	0.8	30.6	0.0	0.0	15.7	0.0	0.0	1.7	30.8	0.4	0.0	44.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	172.8	19.9	7.0	0.0	9.5	4.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	1.2	0.1
HLF	MGC33822	ENSG00000108924	"HLF, PAR bZIP transcription factor"	Q16534	17	55265012-55325065	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"liver: 78.8"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 122.6;Hepatocytes: 152.5;Horizontal cells: 87.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 13.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 2.4;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enriched"	"Detected in some"	6	"Hep G2: 60.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068156, HPA071210"			Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA068156: AB_2685963, HPA071210: AB_2686361"	"unprognostic (1.24e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.30e-1)"	"prognostic favorable (1.88e-4)"	"unprognostic (5.30e-3)"	"prognostic favorable (2.71e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.24e-3)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.55e-6)"	"unprognostic (8.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.60e-2)"	9.5	15.2	13.3	2.0	26.2	1.0	10.8	15.2	38.0	10.5	10.6	6.4	2.4	1.7	10.3	8.5	18.1	9.3	6.1	15.9	12.6	6.9	9.2	78.8	9.5	2.1	6.6	24.5	34.6	2.7	2.8	8.0	1.5	12.3	9.9	3.1	23.7	15.9	9.5	5.3	11.6	3.0	14.3	5.5	5.7	4.7	3.4	6.3	0.0	23.4	7.1	5.6	9.2	5.2	0.0	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	10.0	0.2	0.0	0.0	60.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.9	0.0	0.1	0.1	5.0	0.0	4.2	0.2	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.1	1.9	1.7	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.1	13.3	26.2	15.2	38.0	12.6	6.9	6.6	24.5	12.3	6.3	3.0	36.8	0.0	4.7	19.8	122.6	31.9	15.3	1.4	11.4	7.0	9.8	0.1	10.0	1.5	0.9	8.6	0.0	0.0	0.8	0.0	6.0	1.2	0.0	152.5	0.1	87.4	2.9	4.9	4.1	2.7	26.2	1.0	10.1	0.0	0.1	54.5	0.3	0.0	36.7	18.9	13.0	12.9	6.2	0.3	2.7	24.1	1.0	2.2	0.0	0.5
HLTF	"HIP116A, HLTF1, RNF80, SMARCA3, SNF2L3"	ENSG00000071794	"Helicase like transcription factor"	Q14527	3	149030127-149086554	"Enzymes, Predicted intracellular proteins"	"Transcription, Ubl conjugation pathway"	"Activator, Chromatin regulator, DNA-binding, Helicase, Hydrolase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 88.3;Spermatocytes: 110.2;Spermatogonia: 89.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015284, HPA049001"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015284: AB_1857263, HPA049001: AB_2680594"	"unprognostic (3.21e-2)"	"unprognostic (3.46e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.95e-3)"	"unprognostic (4.29e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.27e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.07e-2)"	10.2	22.1	12.6	8.4	17.6	9.0	12.4	29.3	23.8	11.1	11.0	12.4	6.2	4.8	12.4	9.6	7.1	10.8	8.6	16.5	15.8	16.6	15.6	16.3	7.1	9.8	15.7	19.0	17.6	12.0	16.5	25.1	7.3	29.9	14.7	7.0	11.3	9.3	11.1	9.7	5.1	6.6	12.7	19.0	7.5	8.7	37.7	14.0	17.1	19.0	4.8	9.6	10.0	7.8	8.4	9.2	8.8	2.3	5.4	10.4	3.5	24.6	12.0	17.2	13.4	11.5	14.9	1.7	16.7	10.0	12.4	14.5	9.7	17.2	15.9	20.5	7.7	24.3	0.7	23.0	6.6	20.8	8.8	11.2	38.2	9.4	3.9	7.2	10.0	15.9	9.4	3.6	9.2	5.4	19.0	7.1	26.0	13.3	10.4	16.9	12.4	20.5	15.4	12.9	12.5	15.1	23.8	19.3	2.5	10.2	8.0	17.0	10.0	25.4	11.8	23.0	9.5	35.2	9.8	5.0	14.6	8.8	20.5	18.2	15.4	8.6	20.8	14.3	13.7	5.6	8.8	1.3	4.0	5.6	2.1	10.4	8.4	4.9	7.2	3.9	5.4	7.2	7.4	0.2	5.4	2.3	9.2	4.4	3.5	12.6	17.6	29.3	23.8	15.8	16.6	15.7	19.0	29.9	14.0	23.8	14.8	13.8	7.6	4.9	88.3	34.8	17.8	30.8	21.6	29.6	39.3	6.6	29.9	7.9	9.5	10.8	1.3	0.0	7.3	8.2	10.6	11.9	53.2	14.9	7.6	44.5	4.7	15.4	4.0	5.8	31.4	7.5	5.0	3.6	6.2	35.2	6.8	2.8	30.4	15.6	75.2	12.9	14.1	110.2	89.0	3.8	1.4	13.8	6.6	4.3
HMG20B	"BRAF25, BRAF35, HMGX2, HMGXB2, SMARCE1r, SOXL"	ENSG00000064961	"High mobility group 20B"	Q9P0W2	19	3572777-3579088	"Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 228.6;Melanocytes: 217.6;Syncytiotrophoblasts: 254.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 81.6;WM-115: 84.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050220, HPA053157, HPA069832"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050220: AB_2681056, HPA053157: AB_2682061, HPA069832: AB_2686210"	"unprognostic (2.97e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (1.72e-7)"	"unprognostic (2.18e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.91e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.89e-5)"	22.2	19.0	14.4	19.2	17.1	18.7	22.8	7.1	15.0	23.7	24.5	18.5	28.3	20.4	27.0	22.6	26.0	20.6	28.9	17.4	16.3	8.2	25.0	23.3	17.4	13.0	20.3	9.9	19.0	21.7	19.3	9.8	35.2	14.8	33.6	12.9	18.8	36.6	23.5	12.5	25.9	24.6	22.6	14.6	18.6	24.2	19.0	16.2	44.8	29.4	14.0	25.0	24.0	24.4	18.6	32.7	31.1	35.2	27.7	22.9	24.8	18.6	8.0	7.2	17.3	9.1	8.2	13.3	12.1	8.8	11.0	8.4	2.9	6.8	10.2	11.4	8.7	10.0	9.1	4.2	8.2	6.6	9.0	9.6	5.0	26.2	7.6	5.8	6.8	24.7	7.0	9.9	6.3	4.2	11.3	11.1	9.2	8.3	17.0	7.2	25.3	12.7	12.3	8.3	16.0	16.2	8.5	12.7	13.9	8.2	12.0	4.5	13.8	16.9	29.4	81.6	7.2	22.2	18.4	15.9	5.9	13.3	20.8	10.2	16.0	8.4	7.1	15.3	17.3	84.1	19.1	34.5	31.1	21.2	33.6	18.9	18.6	18.3	22.9	32.7	15.9	19.7	18.9	19.0	27.7	35.2	29.5	19.9	24.8	14.4	17.1	7.1	15.0	16.3	8.2	20.3	9.9	14.8	16.2	26.8	17.1	34.9	44.6	62.6	3.3	5.9	22.9	17.4	19.4	17.4	9.8	97.1	77.9	53.0	20.8	36.2	53.8	0.0	39.7	228.6	45.8	57.3	38.0	17.4	72.0	7.9	64.1	27.0	24.0	36.4	34.5	48.2	217.6	123.6	117.2	30.7	48.6	54.6	42.1	56.9	17.4	32.3	56.2	38.7	15.6	69.8	254.0	28.8	59.7	56.3
HMMR	"CD168, RHAMM"	ENSG00000072571	"Hyaluronan mediated motility receptor"	O75330	5	163460203-163491945	"CD markers, FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 54.5;testis: 16.7"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 60.3;Erythroid cells: 256.9;Extravillous trophoblasts: 50.4;Spermatocytes: 80.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB002433, HPA040025, HPA043926, HPA061524"	Enhanced		Enhanced	Microtubules,Centrosome,Cytosol		Yes	Yes			Microtubules	"Centrosome, Cytosol"	"CAB002433: AB_564080, HPA040025: AB_2676805, HPA043926: , HPA061524: AB_2684551"	"unprognostic (3.53e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.38e-3)"	"unprognostic (8.88e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (5.52e-4)"	"prognostic unfavorable (1.93e-7)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (5.68e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.02e-1)"	"unprognostic (0.00e+0)"	"unprognostic (1.65e-2)"	"unprognostic (4.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.77e-2)"	1.6	1.4	0.6	13.4	0.6	11.4	2.4	0.4	0.9	1.7	5.0	0.6	0.6	4.5	0.6	2.3	6.4	0.5	0.9	1.6	0.8	0.7	1.4	1.8	2.5	10.9	1.0	0.4	0.6	1.1	0.6	0.5	6.9	1.1	0.7	5.6	0.4	1.6	0.2	1.4	2.3	4.8	1.4	1.9	8.6	2.6	16.7	0.3	54.5	0.7	5.6	10.8	1.8	2.1	1.2	1.8	0.6	0.7	1.5	4.8	0.8	21.1	13.3	27.2	14.5	1.4	2.7	20.3	20.1	9.8	25.2	22.9	27.0	40.9	35.2	19.2	6.2	34.4	24.5	31.4	19.1	43.1	31.9	9.7	21.0	9.5	13.2	0.4	18.6	19.4	0.7	1.1	23.7	18.6	4.2	14.3	24.2	19.9	28.8	26.2	7.7	19.6	10.6	23.4	14.2	14.6	21.4	36.4	17.6	9.8	5.7	22.7	12.6	29.9	9.4	11.4	13.5	27.7	15.0	9.3	18.1	15.4	14.5	26.9	15.5	25.9	28.4	12.0	28.9	17.4	0.5	0.7	0.0	0.5	0.3	0.9	1.2	1.0	0.6	0.9	0.9	0.4	0.7	0.6	1.5	0.0	1.8	4.8	0.8	0.6	0.6	0.4	0.9	0.8	0.7	1.0	0.4	1.1	0.3	0.0	0.6	15.5	0.8	2.3	0.6	1.7	7.6	4.0	4.5	0.0	0.0	5.1	0.0	0.6	60.3	0.1	1.3	256.9	0.2	50.4	2.4	0.8	0.0	1.7	17.7	0.0	1.2	3.1	3.5	44.1	2.0	4.3	0.0	3.6	1.6	0.0	0.1	0.0	0.7	2.4	0.7	6.5	0.0	80.6	18.5	1.3	3.8	1.0	4.2	0.9
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 53.6;Mucus-secreting cells: 31.7;Paneth cells: 41.9;Undifferentiated cells: 25.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdT-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.5;CAPAN-2: 16.8;Karpas-707: 4.7;OE19: 10.3;PC-3: 5.1;THP-1: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Enhanced	"Nucleoplasm,Cytokinetic bridge,Mitotic spindle,Cytosol"		NA	NA			Nucleoplasm	"Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	16.8	0.0	2.4	0.0	2.0	0.0	2.1	0.0	0.0	0.0	1.9	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.3	0.3	10.3	5.1	0.0	0.0	0.3	2.9	0.1	0.3	1.7	0.3	0.1	0.0	0.2	0.3	5.6	0.0	0.3	0.1	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1	0.0	0.6	0.5	0.6	0.0	0.0	0.2	17.8	9.4	1.2	3.5	0.0	0.0	5.0	2.2	1.7	0.0	53.6	0.0	3.7	0.0	0.0	1.1	0.0	9.0	0.0	0.0	15.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	31.7	0.0	5.6	41.9	0.0	13.6	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	25.9	2.8
HNRNPA0	"hnRNPA0, HNRPA0"	ENSG00000177733	"Heterogeneous nuclear ribonucleoprotein A0"	Q13151	5	137745651-137754376	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036569, HPA059404"	Enhanced		Enhanced	Nucleoplasm		No	No		110000	Nucleoplasm		"HPA036569: AB_10670840, HPA059404: AB_2684004"	"unprognostic (5.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.78e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"prognostic favorable (3.74e-4)"	"unprognostic (6.86e-2)"	"prognostic favorable (1.99e-4)"	"unprognostic (2.34e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.39e-2)"	25.6	30.9	18.1	31.8	21.4	40.7	62.9	35.2	43.8	27.0	21.2	11.5	17.2	21.0	38.1	26.3	25.7	29.3	29.5	29.1	15.7	18.0	17.4	18.5	40.4	61.2	16.5	22.5	42.7	34.8	15.1	20.4	30.7	16.6	22.1	17.2	20.0	18.6	20.8	38.1	23.2	23.1	33.4	16.8	24.2	24.3	25.7	13.6	50.1	26.2	22.5	21.6	24.8	24.2	5.2	6.1	8.0	4.4	7.8	7.1	1.5	14.4	14.5	28.2	28.4	13.9	8.9	29.0	11.1	9.2	10.0	11.6	27.0	11.4	26.3	16.1	9.5	11.0	13.3	15.2	17.3	12.2	13.2	21.2	17.0	9.3	16.3	12.8	15.5	18.1	14.3	12.2	7.9	9.2	11.0	13.8	23.9	13.8	17.7	10.0	18.8	29.0	20.9	22.0	6.9	10.6	34.9	20.6	13.2	9.8	16.7	35.8	29.1	14.3	10.0	18.8	32.3	12.7	18.0	13.4	16.0	13.7	8.8	21.1	17.9	14.4	18.7	10.4	18.0	15.8	4.2	2.4	8.0	5.9	4.1	7.1	4.2	5.6	5.9	4.2	5.2	6.1	6.0	2.6	7.8	4.4	6.1	3.2	1.5	18.1	21.4	35.2	43.8	15.7	18.0	16.5	22.5	16.6	13.6	80.4	53.0	188.3	346.9	489.4	73.3	31.1	99.3	37.5	62.6	96.0	35.3	296.0	145.9	218.1	24.7	188.8	85.5	70.0	128.8	402.7	254.2	247.7	94.6	65.2	171.4	79.4	226.9	148.0	122.8	31.9	146.2	137.9	266.6	273.3	165.1	127.6	167.3	162.1	141.8	99.3	53.7	84.1	348.8	141.2	79.6	423.3	305.8	240.4	208.3	323.0
HNRNPA1	"ALS20, hnRNP-A1, hnRNPA1, HNRPA1"	ENSG00000135486	"Heterogeneous nuclear ribonucleoprotein A1"	P09651	12	54280193-54287088	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001609, HPA001666, HPA005812, HPA007185, CAB010894"	Supported		Enhanced	Nucleoplasm		NA	NA		10000000	Nucleoplasm		"CAB010894: AB_261962, HPA001609: AB_2666383, HPA001666: AB_1850836, HPA005812: AB_2667441, HPA007185: AB_2667768"	"unprognostic (1.38e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.98e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.51e-2)"	"unprognostic (6.88e-3)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.54e-3)"	36.4	33.3	31.7	55.6	37.4	99.5	45.1	48.3	43.0	52.2	38.9	38.4	33.9	35.2	54.1	41.6	41.3	39.5	20.4	31.9	29.7	28.5	40.5	76.2	29.7	51.7	33.1	23.1	123.6	46.1	34.4	36.7	49.9	42.6	35.3	38.7	28.1	33.4	31.5	40.5	37.3	35.6	34.9	40.1	59.5	34.1	69.6	33.3	88.7	42.1	62.0	62.7	37.5	45.8	61.6	72.5	17.9	51.1	86.6	98.1	105.8	84.3	77.7	166.2	131.5	51.4	82.2	90.4	77.8	89.3	86.3	73.2	116.3	93.1	222.9	76.5	53.9	27.9	76.2	111.0	111.6	104.9	87.1	84.5	123.7	111.5	200.3	27.3	175.9	81.5	73.2	43.2	57.0	85.0	82.0	94.4	100.5	136.9	94.0	71.9	109.4	191.5	190.3	175.1	58.7	55.2	186.9	132.7	108.5	93.5	127.5	93.3	128.0	57.7	118.8	86.2	92.3	74.2	110.4	79.7	64.4	86.5	64.9	99.6	84.4	85.3	149.4	42.2	111.0	56.3	12.0	39.5	17.9	61.9	51.1	96.1	61.6	82.7	72.3	72.5	55.2	98.1	89.4	4.2	86.6	41.3	55.9	70.9	105.8	31.7	37.4	48.3	43.0	29.7	28.5	33.1	23.1	42.6	33.3	282.9	416.9	979.2	866.3	1257.9	240.2	144.8	512.1	277.1	532.3	279.2	88.4	1846.9	626.6	1015.4	131.7	691.4	446.7	116.8	1834.6	2353.9	905.7	556.1	513.1	175.1	878.1	103.3	791.7	392.3	666.2	95.5	972.8	726.1	558.5	1333.7	1093.4	203.6	1143.2	522.5	697.3	587.0	150.2	446.3	924.5	196.6	318.3	1103.1	1822.1	976.0	1319.8	750.5
HNRNPA2B1	HNRPA2B1	ENSG00000122566	"Heterogeneous nuclear ribonucleoprotein A2/B1"	P22626	7	26189927-26201529	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, mRNA transport, Transport"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001666, HPA005812, CAB012403, HPA065537"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000000	Nucleoplasm		"CAB012403: , HPA001666: AB_1850836, HPA005812: AB_2667441, HPA065537: AB_2685507"	"unprognostic (1.19e-1)"	"unprognostic (4.45e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.04e-3)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.25e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.35e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (5.12e-4)"	"prognostic unfavorable (8.01e-5)"	"unprognostic (6.74e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.56e-2)"	82.2	97.4	85.1	105.3	106.3	90.9	74.4	123.3	87.4	77.1	85.7	89.4	68.7	87.5	92.6	71.9	90.4	75.1	51.7	87.9	82.4	71.8	113.4	103.7	76.2	127.7	118.6	57.0	121.0	75.7	107.2	121.2	100.7	96.3	75.5	98.6	64.4	71.4	66.5	167.2	58.7	94.8	73.7	139.7	116.5	74.1	73.1	135.4	180.3	81.9	104.4	140.7	74.2	128.8	33.7	46.5	35.1	52.4	32.1	42.5	36.0	124.0	105.9	154.2	115.6	39.7	36.3	71.4	79.6	62.1	88.0	79.7	97.8	90.4	226.9	76.1	73.8	105.0	86.6	164.9	104.0	124.0	70.5	100.5	137.5	127.8	116.9	33.3	148.0	94.2	34.3	54.5	83.7	76.4	46.4	90.8	104.9	161.7	74.2	88.8	100.4	158.3	173.1	136.6	95.1	81.7	147.2	125.3	95.0	101.6	108.6	90.1	110.5	95.7	94.3	58.1	98.3	105.7	128.9	78.4	49.5	102.5	67.0	135.8	98.6	195.4	215.9	63.8	168.7	93.2	17.4	38.7	35.1	42.5	52.4	38.6	33.7	35.5	36.6	46.5	29.2	35.6	35.6	13.0	32.1	48.4	43.6	36.1	36.0	85.1	106.3	123.3	87.4	82.4	71.8	118.6	57.0	96.3	135.4	452.6	512.0	456.4	620.8	656.0	459.5	635.5	267.5	721.4	702.9	326.2	280.8	790.3	391.3	484.7	96.5	561.1	396.4	280.4	392.8	789.3	528.7	417.7	617.9	353.4	530.6	295.6	471.8	332.7	355.7	124.0	380.5	569.8	372.8	501.4	392.2	570.4	369.1	357.7	366.7	366.6	518.1	433.4	564.3	596.8	448.9	524.9	905.5	489.7	465.4	566.2
HNRNPA3	HNRPA3	ENSG00000170144	"Heterogeneous nuclear ribonucleoprotein A3"	P51991	2	177212563-177223958	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA001666, HPA005812, HPA066381"	Supported		Enhanced	Nucleoplasm		NA	NA		1500000	Nucleoplasm		"HPA001666: AB_1850836, HPA005812: AB_2667441, HPA066381: AB_2685666"	"unprognostic (2.85e-2)"	"prognostic favorable (4.87e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.95e-5)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.65e-2)"	"unprognostic (4.56e-2)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (6.95e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.10e-2)"	22.9	17.6	24.7	29.5	28.0	29.8	19.5	22.3	29.3	24.3	24.8	16.1	13.7	18.0	26.5	26.9	33.8	20.8	20.9	16.7	20.8	14.2	23.9	20.3	23.7	29.9	40.4	17.7	35.6	19.3	20.6	20.1	27.0	26.5	19.0	28.7	14.9	20.0	28.4	28.0	23.2	23.5	23.4	35.0	24.8	19.7	22.2	27.3	23.0	30.7	18.4	40.6	20.5	28.2	15.2	26.4	7.4	15.8	15.6	18.7	9.3	63.7	43.0	94.5	48.2	25.0	22.3	72.5	48.9	23.0	38.5	36.7	85.5	33.0	128.6	37.3	37.7	51.6	36.8	93.3	61.1	72.5	59.0	56.9	95.8	65.2	169.2	26.9	102.9	59.7	24.8	27.4	57.3	42.7	21.4	52.5	57.2	68.4	44.3	48.8	85.9	71.7	41.5	51.6	73.5	40.5	91.9	80.2	40.2	53.7	126.1	55.4	49.9	72.7	22.7	29.5	71.3	32.8	64.7	58.1	49.4	55.1	34.3	70.4	40.3	71.5	110.0	29.4	68.4	31.9	4.9	15.3	7.4	18.7	15.8	15.0	13.9	15.0	16.5	16.4	15.2	13.8	13.9	6.6	15.6	14.9	26.4	17.3	9.3	24.7	28.0	22.3	29.3	20.8	14.2	40.4	17.7	26.5	27.3	154.9	215.2	221.2	361.3	312.4	188.7	56.1	86.6	283.7	291.2	151.8	92.3	425.0	102.8	195.6	26.3	270.9	149.7	46.7	236.9	457.8	255.4	219.8	270.4	155.4	295.4	139.8	263.9	182.3	180.4	26.3	189.6	227.7	182.2	276.9	212.7	161.7	237.6	169.9	197.0	126.2	152.7	148.8	302.8	280.0	218.2	288.8	414.8	248.4	249.1	343.8
HNRNPAB	"ABBP1, FLJ40338, HNRPAB"	ENSG00000197451	"Heterogeneous nuclear ribonucleoprotein A/B"	Q99729	5	178204507-178211163	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046688	Approved		Enhanced	Nucleoplasm		NA	NA		380000	Nucleoplasm		"HPA046688: AB_10964924"	"unprognostic (2.23e-1)"	"unprognostic (6.21e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.09e-2)"	"unprognostic (6.17e-3)"	"prognostic favorable (9.79e-4)"	"unprognostic (9.12e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (1.35e-7)"	"unprognostic (3.47e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.08e-1)"	34.9	41.7	16.5	47.8	18.4	44.6	32.5	17.9	19.1	30.0	54.0	20.4	24.9	37.0	33.9	23.0	50.9	27.3	38.6	44.4	15.4	17.8	50.0	72.4	29.8	36.5	20.6	12.4	39.1	39.1	25.5	20.5	36.7	16.8	26.8	47.1	19.4	31.3	26.7	53.3	43.4	55.0	38.7	18.9	53.5	31.9	26.5	15.9	75.6	34.6	46.3	41.3	38.7	36.8	5.9	11.4	15.1	7.2	5.7	6.6	2.2	46.1	38.5	59.4	57.4	22.0	19.4	85.9	52.0	24.1	41.6	44.9	70.9	34.7	74.8	48.0	27.8	50.8	30.6	51.4	70.6	51.7	115.6	60.6	47.0	31.0	43.3	22.0	59.4	40.1	19.1	33.4	37.3	37.6	17.2	37.2	30.0	38.3	34.2	41.7	124.3	71.6	57.4	54.4	47.6	55.5	58.5	35.8	44.3	35.1	49.5	54.7	42.6	40.5	56.6	36.6	38.8	33.9	36.4	33.3	50.9	43.0	35.8	71.0	40.1	46.8	88.0	20.6	65.8	41.2	2.8	4.8	15.1	5.5	7.2	6.2	5.9	4.6	6.6	4.6	5.0	4.5	5.3	0.9	5.7	7.1	11.4	4.8	2.2	16.5	18.4	17.9	19.1	15.4	17.8	20.6	12.4	16.8	15.9	29.8	43.7	80.2	123.5	250.0	24.2	39.9	48.4	25.4	44.3	47.1	17.7	71.8	43.1	103.9	4.5	77.1	177.1	93.5	130.6	169.9	80.3	113.7	44.9	96.2	90.6	15.9	114.3	57.1	60.6	7.9	68.4	88.9	64.1	41.5	155.2	31.3	147.7	149.7	82.7	85.7	26.4	77.6	138.6	57.6	139.0	297.1	95.7	42.1	166.2	201.2
HNRNPC	"hnRNPC, HNRPC"	ENSG00000092199	"Heterogeneous nuclear ribonucleoprotein C (C1/C2)"	P07910	14	21209136-21269494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005223, HPA051075, CAB075755, CAB075756"	Supported		Enhanced	Nucleoplasm		NA	NA		1400000	Nucleoplasm		"CAB005223: AB_2117508, CAB075755: AB_2665761, CAB075756: AB_2665762, HPA051075: AB_2681335"	"unprognostic (1.92e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.21e-3)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (8.66e-3)"	"unprognostic (5.96e-3)"	"prognostic favorable (1.19e-4)"	"unprognostic (3.31e-3)"	"unprognostic (5.30e-3)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (7.36e-2)"	"unprognostic (3.73e-3)"	"unprognostic (2.28e-3)"	"unprognostic (5.42e-2)"	41.1	53.9	51.8	51.1	64.0	71.6	55.1	72.1	65.5	49.6	41.9	45.3	47.3	35.3	51.0	51.1	53.4	54.3	38.0	41.1	47.9	45.1	50.0	51.9	43.0	76.7	54.8	42.1	72.8	57.8	38.3	63.3	54.7	43.7	45.2	47.8	43.9	36.0	44.5	44.5	39.8	39.5	57.6	54.8	55.8	37.4	62.4	52.4	49.3	53.0	37.9	75.6	45.3	45.9	78.3	104.6	119.0	73.3	64.8	89.1	142.9	94.7	79.3	119.5	68.1	79.4	73.5	84.2	60.5	73.6	102.2	87.3	74.7	72.0	168.5	38.5	76.1	66.5	71.7	164.3	102.5	139.5	109.7	87.7	84.5	62.6	111.4	90.3	129.2	70.6	76.1	83.8	75.4	180.2	89.4	107.3	95.6	129.7	72.0	80.8	91.1	154.1	122.9	124.3	95.0	73.9	123.6	95.3	83.0	109.0	86.1	66.3	61.6	73.5	71.0	67.0	110.2	66.7	116.1	69.4	36.8	66.4	43.6	86.9	65.3	97.8	164.4	34.3	105.3	72.0	57.8	73.3	71.2	65.9	63.5	86.1	78.3	78.0	70.2	104.6	68.7	89.1	75.0	119.0	64.8	59.7	67.5	80.3	142.9	51.8	64.0	72.1	65.5	47.9	45.1	54.8	42.1	43.7	52.4	142.9	216.7	293.4	537.0	476.4	166.6	113.3	191.1	426.9	343.5	261.7	186.5	541.0	240.4	270.5	104.5	231.5	115.2	93.5	187.7	622.0	348.5	363.8	401.3	193.0	344.7	109.7	214.8	160.2	259.6	47.1	249.9	333.4	197.4	316.6	194.2	147.6	213.3	119.3	217.1	276.6	280.5	148.8	296.7	355.3	259.1	471.9	731.7	329.0	278.1	447.5
HNRNPD	"AUF1, HNRPD"	ENSG00000138668	"Heterogeneous nuclear ribonucleoprotein D"	Q14103	4	82352498-82374503	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"DNA-binding, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004911	Supported		Enhanced	Nucleoplasm		NA	NA		550000	Nucleoplasm		"HPA004911: AB_1078250"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.31e-2)"	45.5	40.0	35.4	58.8	46.1	88.0	49.4	49.1	40.6	55.2	49.8	37.2	40.5	45.1	56.2	39.1	55.5	47.9	48.5	40.8	28.4	27.4	36.4	40.6	43.2	72.2	26.5	37.1	64.5	48.9	51.6	38.7	51.9	32.9	44.9	45.8	41.5	52.9	48.6	51.6	49.5	49.9	53.1	27.9	61.4	46.7	30.4	30.7	136.1	41.5	53.7	80.4	58.2	49.9	17.8	21.8	18.0	11.9	12.4	17.5	5.9	60.1	23.9	103.1	32.7	13.6	17.8	48.7	47.4	36.6	54.7	47.2	42.7	53.5	123.3	34.4	32.1	29.1	29.8	81.9	35.5	86.0	22.9	42.3	88.3	32.9	57.8	27.8	117.0	45.5	21.7	15.9	44.1	44.7	28.1	49.4	60.3	97.1	42.7	46.4	23.2	142.4	81.3	85.7	45.1	22.2	105.5	104.8	51.1	45.6	36.9	52.1	56.2	46.7	40.7	23.6	50.2	30.4	46.7	41.7	42.3	57.7	32.5	60.9	45.3	35.6	143.5	32.5	60.5	48.1	18.0	10.8	10.8	13.2	11.3	14.5	17.8	15.9	16.5	12.3	14.4	17.5	14.5	13.1	12.4	11.9	21.8	17.2	5.9	35.4	46.1	49.1	40.6	28.4	27.4	26.5	37.1	32.9	30.7	95.3	129.9	97.5	173.8	232.1	125.8	176.6	81.5	117.8	162.7	106.4	58.9	238.7	59.7	146.2	21.6	142.9	61.9	93.5	181.6	291.7	117.2	144.5	88.0	106.3	135.9	101.7	140.7	111.1	121.5	16.8	115.6	129.0	86.0	133.5	128.6	156.0	133.5	42.1	96.2	65.2	99.6	109.9	139.4	99.7	128.2	200.9	227.5	109.0	142.2	181.5
HNRNPDL	"HNRPDL, JKTBP, laAUF1"	ENSG00000152795	"Heterogeneous nuclear ribonucleoprotein D like"	O14979	4	82422564-82430408	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056820, HPA063147"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056820: AB_2683246, HPA063147: AB_2684950"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.30e-3)"	"unprognostic (7.19e-2)"	"unprognostic (4.05e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.03e-2)"	60.5	43.9	52.0	58.8	82.9	98.2	58.8	67.6	79.7	50.1	51.9	60.4	42.9	41.8	73.7	57.8	45.3	53.5	42.4	47.7	49.0	44.7	43.0	37.4	52.9	64.4	86.9	74.2	101.7	66.0	43.5	41.0	46.2	79.0	49.8	44.5	31.6	46.4	52.3	89.7	46.0	47.8	60.6	69.4	55.7	51.1	32.8	80.8	48.3	49.0	59.2	51.3	44.9	51.5	27.7	20.3	14.4	31.1	17.6	35.6	19.9	52.6	27.9	104.1	20.6	39.1	21.4	34.2	57.1	62.1	50.9	48.5	38.3	43.7	98.3	36.4	61.8	26.3	41.1	78.4	52.7	59.8	21.6	56.8	56.9	45.2	68.6	18.4	96.7	42.4	37.7	15.3	56.9	51.0	40.3	40.3	62.8	73.7	40.8	49.3	22.0	90.3	67.9	71.4	47.8	33.0	81.1	84.1	44.9	59.3	34.5	44.3	76.6	35.5	45.9	33.5	49.0	48.0	55.0	33.8	51.4	63.5	33.6	68.1	48.0	45.9	108.2	45.0	56.6	43.2	14.4	15.7	13.2	28.5	25.7	23.3	27.7	25.5	26.0	12.6	26.8	35.6	30.6	6.7	17.6	31.1	20.3	19.4	19.9	52.0	82.9	67.6	79.7	49.0	44.7	86.9	74.2	79.0	80.8	253.1	256.3	276.8	560.8	585.3	217.8	173.8	101.9	365.4	381.1	144.8	100.1	445.7	252.0	241.5	42.1	260.0	120.7	23.3	220.9	513.8	334.8	344.9	370.4	124.1	286.8	166.8	226.5	117.9	193.0	32.1	196.8	307.6	295.3	348.1	161.4	241.5	205.1	122.8	190.6	215.4	158.8	161.7	311.0	158.6	399.4	484.4	435.7	307.9	180.7	425.7
HNRNPF	HNRPF	ENSG00000169813	"Heterogeneous nuclear ribonucleoprotein F"	P52597	10	43385617-43409166	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016884, HPA069667"	Supported		Enhanced	Nucleoplasm		NA	NA		2500000	Nucleoplasm		"HPA016884: AB_1856444, HPA069667: AB_2686166"	"unprognostic (9.93e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.65e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.51e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.33e-3)"	"unprognostic (4.89e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.22e-1)"	48.1	34.0	19.9	41.2	34.9	43.3	56.1	23.2	22.3	31.1	44.5	31.6	26.9	41.1	34.9	32.6	50.4	39.2	35.7	26.2	21.7	18.3	42.3	68.3	40.4	55.9	33.7	13.9	54.2	39.7	22.5	28.1	37.5	32.5	35.4	37.8	26.2	36.9	25.0	40.0	40.6	57.5	41.6	27.5	58.7	39.2	66.4	31.2	77.5	40.6	42.3	56.9	46.2	57.4	58.3	59.7	52.0	62.5	63.2	75.8	89.4	46.3	49.3	30.7	46.4	37.6	41.3	45.0	36.4	61.2	51.2	60.6	46.1	64.9	93.5	23.4	39.3	30.1	65.8	81.9	59.4	42.2	39.1	49.0	59.5	30.7	59.2	46.5	87.2	60.5	50.1	47.2	39.7	73.3	29.8	43.9	46.2	60.1	42.5	38.6	72.4	85.2	47.8	23.1	70.6	41.7	71.7	28.8	44.3	52.3	71.9	37.9	38.1	37.0	68.1	55.1	34.9	75.8	42.7	32.7	23.6	44.9	38.6	57.4	38.3	64.5	56.7	38.3	83.9	23.0	38.5	54.4	52.0	62.3	62.5	75.8	58.3	65.5	68.6	59.7	48.1	55.7	52.5	36.5	63.2	55.5	33.4	72.6	89.4	19.9	34.9	23.2	22.3	21.7	18.3	33.7	13.9	32.5	31.2	125.0	101.0	151.2	286.6	298.4	46.3	53.4	129.9	188.7	104.6	106.4	45.2	238.4	149.2	179.9	260.2	132.4	146.6	93.5	123.9	343.0	154.8	203.1	114.2	201.4	197.1	46.1	121.7	118.4	187.9	81.6	135.2	151.7	94.5	200.2	160.4	105.7	142.1	149.4	110.7	162.5	134.4	97.0	151.4	223.4	171.5	288.8	176.0	209.8	206.2	283.8
HNRNPH1	"hnRNPH, HNRPH1"	ENSG00000169045	"Heterogeneous nuclear ribonucleoprotein H1"	P31943	5	179614178-179634784	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal keratinocytes: 688.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, HPA016884, CAB032820"	Supported		Enhanced	Nucleoplasm		NA	NA		2100000	Nucleoplasm		"CAB032820: AB_2248257, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (9.01e-2)"	"unprognostic (3.83e-1)"	"unprognostic (3.45e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (7.85e-4)"	"prognostic unfavorable (3.29e-7)"	"unprognostic (7.99e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.65e-3)"	"unprognostic (8.64e-3)"	"prognostic unfavorable (3.46e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.72e-3)"	40.1	36.2	26.8	86.3	31.0	90.5	45.4	73.4	33.2	55.6	38.2	26.6	54.7	30.2	52.4	44.3	41.7	37.7	45.3	30.3	25.6	23.3	36.5	42.3	37.0	59.8	33.0	30.3	60.1	41.3	24.4	46.1	43.6	28.9	40.8	34.7	34.4	53.5	60.3	51.3	44.3	43.0	61.6	31.3	65.2	34.4	42.5	34.3	113.2	47.5	61.5	62.0	57.3	54.4	26.3	34.7	18.4	27.7	24.3	36.8	13.8	51.6	39.4	62.4	40.8	22.4	12.3	50.5	30.8	16.0	40.3	26.6	53.4	34.4	86.0	27.9	22.4	34.2	33.1	58.1	36.3	36.2	72.0	41.7	46.8	65.0	67.0	26.3	61.1	45.1	12.9	26.4	39.3	24.8	25.1	21.9	36.5	58.7	45.5	23.9	35.4	93.0	56.9	72.3	28.9	29.0	82.9	71.0	51.0	20.7	61.6	59.6	50.7	59.8	40.9	53.8	34.7	38.9	79.3	35.9	59.1	42.0	26.9	69.6	37.4	80.9	90.1	32.0	58.5	69.0	18.4	18.0	17.5	26.0	27.7	34.3	26.3	27.8	27.9	26.6	22.7	35.5	36.8	3.5	24.3	20.8	34.7	31.7	13.8	26.8	31.0	73.4	33.2	25.6	23.3	33.0	30.3	28.9	34.3	107.2	244.9	156.8	156.9	688.7	112.1	115.5	160.5	113.8	153.6	148.3	123.7	142.0	66.3	86.3	122.9	189.6	133.1	303.7	106.4	163.6	207.4	153.7	235.1	192.4	96.7	66.7	245.0	179.2	181.7	67.9	103.3	177.8	317.2	101.0	168.3	82.9	89.4	147.3	110.3	55.5	160.3	181.1	190.5	157.9	116.9	627.7	161.0	200.5	170.7	155.5
HNRNPH2	"FTP3, hnRNPH', HNRPH', HNRPH2"	ENSG00000126945	"Heterogeneous nuclear ribonucleoprotein H2"	P55795	X	101408295-101414133	"Disease related genes, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 253.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000914, HPA001359, CAB004436, HPA016884"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004436: AB_627737, HPA000914: AB_2666143, HPA001359: AB_1079076, HPA016884: AB_1856444"	"unprognostic (1.00e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (7.37e-4)"	"unprognostic (8.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.68e-2)"	49.5	44.2	43.4	34.6	51.9	38.3	42.7	49.1	53.9	37.0	32.2	33.8	33.3	34.1	36.6	39.7	36.7	32.7	28.2	35.9	40.3	42.4	49.8	46.1	34.5	30.1	37.1	46.4	47.8	28.4	77.5	50.0	44.9	48.8	37.9	35.9	25.0	30.4	45.2	54.8	40.0	43.6	39.7	36.7	42.2	30.6	18.9	34.2	44.0	44.1	39.9	39.9	41.7	34.4	16.7	28.8	65.9	32.1	22.1	19.4	22.6	31.1	21.7	42.6	25.5	37.6	32.8	20.4	26.7	37.2	25.2	51.6	18.3	28.0	32.1	27.3	37.3	34.7	28.7	48.5	36.9	34.6	31.2	23.8	23.8	52.7	24.8	32.2	29.5	23.4	33.3	34.0	24.9	24.5	30.5	34.2	17.7	24.1	46.5	38.2	39.9	24.2	26.0	26.8	51.0	21.3	23.2	45.4	31.2	54.3	41.6	19.6	35.8	39.8	19.0	30.1	31.5	24.2	28.2	37.1	14.1	25.9	40.1	10.9	15.7	22.5	22.7	29.0	34.3	17.5	29.3	29.4	43.2	18.1	32.1	19.4	16.7	17.7	18.2	28.8	15.6	18.7	19.2	65.9	22.1	30.4	12.1	16.3	22.6	43.4	51.9	49.1	53.9	40.3	42.4	37.1	46.4	48.8	34.2	26.8	63.6	43.1	84.4	63.0	39.8	45.6	33.1	44.2	47.8	85.5	11.8	120.9	84.6	83.4	2.9	54.0	50.2	23.3	64.4	53.5	57.5	42.3	80.8	70.6	73.2	15.9	58.3	47.3	65.5	4.3	51.2	73.1	65.8	105.6	41.2	38.4	56.0	48.0	55.5	110.9	28.7	77.6	49.5	8.0	21.3	63.0	253.0	48.5	42.5	60.2
HNRNPK	"CSBP, HNRPK, TUNP"	ENSG00000165119	"Heterogeneous nuclear ribonucleoprotein K"	P61978	9	83968083-83980616	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004435, HPA007644, CAB016225, HPA044105"	Supported		Enhanced	Nucleoplasm		NA	NA		5000000	Nucleoplasm		"CAB004435: AB_627734, CAB016225: , HPA007644: AB_1079077, HPA044105: AB_2678812"	"unprognostic (4.84e-2)"	"unprognostic (4.69e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.83e-3)"	"prognostic unfavorable (6.68e-5)"	"unprognostic (3.46e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.85e-3)"	"unprognostic (2.81e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.59e-1)"	"unprognostic (2.82e-1)"	79.0	92.0	70.0	80.7	81.7	146.9	97.2	88.0	104.8	77.9	70.0	68.8	80.9	74.5	96.3	69.0	95.8	79.6	67.5	80.4	68.2	71.5	76.0	90.9	77.7	125.0	80.9	72.9	96.5	102.8	91.4	74.5	92.3	67.3	69.4	75.2	58.6	76.5	104.6	101.4	78.7	76.7	100.9	86.3	96.1	72.5	60.3	78.6	162.5	79.9	80.8	106.9	81.0	77.1	59.7	76.1	92.7	71.0	75.6	73.2	136.4	122.3	84.6	145.5	86.1	69.9	77.5	116.9	86.6	107.7	108.5	102.2	70.8	87.7	145.4	59.6	90.6	94.1	94.1	145.4	105.1	132.5	99.9	85.6	102.0	74.2	100.3	92.6	126.4	101.3	78.8	80.4	92.5	123.1	81.8	110.4	82.7	103.7	74.7	106.7	107.3	156.7	86.7	129.2	124.4	82.4	136.9	116.0	96.9	105.1	101.0	94.4	112.1	91.1	97.2	86.3	105.3	96.2	107.5	90.3	75.6	89.1	76.6	112.8	78.7	103.0	105.6	72.2	102.4	106.8	77.4	71.0	90.1	53.9	69.2	67.3	59.7	62.5	61.2	76.1	56.8	65.1	59.3	92.7	75.6	65.8	45.2	73.2	136.4	70.0	81.7	88.0	104.8	68.2	71.5	80.9	72.9	67.3	78.6	190.6	233.2	308.4	456.1	449.4	175.4	171.5	206.4	338.6	282.1	249.5	84.4	518.7	334.9	379.2	22.5	338.4	245.6	163.5	321.8	621.5	373.1	281.2	324.9	300.6	341.5	147.8	371.7	237.6	349.5	31.1	309.8	311.8	310.4	423.8	309.1	344.3	335.2	270.0	301.9	310.5	156.5	271.7	398.2	345.1	248.3	392.2	609.3	308.9	346.3	397.3
HNRNPL	HNRPL	ENSG00000104824	"Heterogeneous nuclear ribonucleoprotein L"	P14866	19	38836388-38852347	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB016326, HPA051748, HPA052661"	Supported		Enhanced	Nucleoplasm		NA	NA		130000	Nucleoplasm		"CAB016326: AB_627736, HPA051748: AB_2681588, HPA052661: AB_2681905"	"unprognostic (5.33e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.67e-3)"	"unprognostic (8.99e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (1.45e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (9.69e-4)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (1.96e-11)"	"unprognostic (2.17e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.39e-2)"	44.1	43.3	32.8	47.1	37.1	102.7	40.6	48.9	47.6	38.9	46.2	42.5	35.9	43.7	47.8	34.8	50.1	36.2	42.0	39.7	31.8	31.9	39.9	52.9	43.2	48.0	36.2	32.5	41.6	41.6	36.1	28.1	47.9	34.7	34.6	49.1	35.6	37.5	39.8	44.7	50.7	48.1	49.4	34.3	44.8	38.2	34.9	39.4	102.8	53.0	36.8	67.6	37.9	40.5	3.1	6.2	3.5	3.8	2.2	3.6	1.9	46.2	36.6	46.5	29.9	18.5	21.8	43.9	38.5	26.6	35.8	34.1	39.2	35.6	73.5	31.5	24.7	27.2	28.4	57.3	43.2	53.3	56.6	31.1	60.7	23.3	34.9	19.7	56.0	41.1	23.7	20.5	36.1	35.7	20.5	39.5	32.5	58.8	38.1	37.3	36.6	57.9	34.6	54.7	32.5	25.4	75.3	53.2	46.2	40.1	34.8	39.0	36.2	38.7	30.4	15.5	33.8	39.8	31.2	35.3	35.9	40.9	31.5	55.3	36.6	49.1	82.7	23.1	49.6	39.2	1.1	2.6	1.7	3.5	3.8	2.7	2.2	2.5	2.1	3.5	3.1	2.7	2.2	3.5	2.2	2.8	6.2	3.6	1.9	32.8	37.1	48.9	47.6	31.8	31.9	36.2	32.5	34.7	39.4	20.8	57.5	59.4	53.2	31.5	76.3	16.1	20.4	25.4	36.4	21.0	60.9	36.1	6.6	30.0	12.1	37.0	50.9	0.0	38.1	29.7	32.6	50.4	38.1	62.1	23.8	31.8	60.4	42.4	60.8	8.9	26.2	37.5	25.3	31.5	62.4	41.8	34.9	35.1	21.2	17.8	69.2	19.4	36.3	19.1	19.6	41.5	43.7	49.8	62.6	36.9
HNRNPM	"CEAR, HNRNPM4, HNRPM, HNRPM4, HTGR1, NAGR1"	ENSG00000099783	"Heterogeneous nuclear ribonucleoprotein M"	P52272	19	8444767-8489114	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016113, HPA024344"	Supported		Enhanced	Nucleoplasm		NA	NA		170000	Nucleoplasm		"CAB016113: AB_627739, HPA024344: AB_1850879"	"unprognostic (2.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.59e-2)"	"unprognostic (6.91e-3)"	"unprognostic (4.70e-3)"	"unprognostic (7.34e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	41.1	38.3	43.2	57.1	44.8	83.6	39.3	66.1	56.7	41.0	45.8	32.8	45.7	42.0	51.5	35.5	54.5	40.7	41.2	38.3	40.4	29.0	38.9	53.9	37.9	55.7	36.4	35.5	56.3	36.0	57.6	42.2	44.8	37.5	37.9	41.1	35.7	40.4	52.4	98.8	43.4	40.8	48.7	39.6	50.1	38.3	41.0	45.4	91.7	41.4	40.0	64.7	37.9	64.3	26.0	32.4	16.5	35.0	30.6	36.6	28.2	61.8	42.0	79.8	31.9	18.3	20.4	50.8	37.4	28.1	46.6	35.5	59.8	19.0	91.4	49.9	33.7	33.5	38.2	81.3	46.7	58.7	57.0	67.1	81.1	42.7	57.2	19.0	82.8	43.4	21.0	23.7	39.5	16.5	13.7	41.7	34.4	81.3	26.3	36.9	42.1	79.5	71.8	68.6	34.1	51.2	89.7	69.2	43.2	24.5	60.0	43.9	48.8	62.8	33.9	35.0	39.8	40.3	49.4	48.4	40.7	49.3	42.7	69.7	38.6	71.1	106.1	30.5	67.6	44.2	6.9	28.2	16.5	36.0	35.0	36.6	26.0	31.4	35.9	32.2	24.6	34.0	33.0	7.7	30.6	25.7	32.4	31.6	28.2	43.2	44.8	66.1	56.7	40.4	29.0	36.4	35.5	37.5	45.4	119.1	188.2	159.3	181.9	147.8	207.0	80.6	96.8	250.3	285.5	111.7	66.8	237.5	82.9	166.9	9.2	145.2	70.1	116.8	237.4	247.6	125.5	75.8	253.7	134.1	152.1	130.3	182.7	108.6	128.8	17.2	105.0	125.4	104.6	223.6	109.3	163.0	169.0	103.7	133.7	73.2	167.9	207.0	191.9	152.3	129.3	119.7	219.3	156.9	140.9	130.8
HNRNPR	"hnRNP-R, HNRPR"	ENSG00000125944	"Heterogeneous nuclear ribonucleoprotein R"	O43390	1	23303771-23344336	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011687, HPA026092"	Supported		Enhanced	Nucleoplasm		NA	NA		50000	Nucleoplasm		"CAB011687: AB_2295532, HPA026092: AB_1850885"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.92e-1)"	"unprognostic (5.70e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (2.29e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.28e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-2)"	"unprognostic (4.12e-1)"	27.1	30.4	31.2	36.1	34.7	33.8	31.2	41.0	32.2	32.4	27.4	34.3	29.5	26.5	42.2	23.7	33.2	32.7	20.3	25.6	29.1	27.9	25.1	25.1	28.1	39.6	35.0	27.9	44.3	32.8	40.5	40.9	40.9	27.5	27.3	31.3	26.5	28.1	27.7	31.1	27.8	26.8	41.0	34.1	28.8	24.9	20.3	40.0	68.3	29.9	29.7	40.9	29.0	29.4	21.9	23.6	20.8	23.2	26.1	28.5	19.8	36.7	22.9	47.0	27.8	16.8	16.8	22.2	25.0	25.5	35.3	25.5	15.7	25.5	45.0	12.3	30.3	21.3	21.2	48.5	32.4	46.3	31.2	32.9	43.0	30.3	28.3	17.0	53.2	29.0	18.7	20.0	33.1	26.8	18.0	26.2	34.8	38.6	31.4	27.1	21.1	60.7	15.5	26.5	25.4	21.1	43.5	45.9	31.7	23.8	18.0	30.0	31.3	32.8	27.8	20.2	27.0	22.3	23.8	26.5	23.7	32.4	29.0	29.6	19.9	29.6	60.7	17.9	45.5	25.8	8.7	18.5	20.8	25.4	22.5	27.7	21.9	24.3	25.2	23.6	20.1	26.3	24.4	6.6	26.1	23.2	13.9	28.5	19.8	31.2	34.7	41.0	32.2	29.1	27.9	35.0	27.9	27.5	40.0	110.2	90.3	90.8	156.4	113.3	122.1	64.1	76.5	147.2	144.5	83.7	41.2	198.0	77.9	84.8	12.3	105.1	51.1	23.3	109.3	227.4	125.2	131.2	163.3	64.4	93.4	119.2	111.7	58.3	74.5	13.1	111.9	91.5	79.2	159.7	84.5	155.0	99.5	59.6	109.6	54.2	110.8	84.1	129.6	143.8	153.0	113.4	172.9	111.0	103.7	158.3
HNRNPU	"C1orf199, FLJ30202, FLJ37978, hnRNPU, HNRNPU-AS1, HNRPU, NCRNA00201, SAF-A"	ENSG00000153187	"Heterogeneous nuclear ribonucleoprotein U"	Q00839	1	244840638-244864560	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Cell division, Differentiation, Host-virus interaction, Mitosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011532, HPA041057, HPA058707"	Supported		Enhanced	Nucleoplasm		NA	NA		840000	Nucleoplasm		"CAB011532: AB_732983, HPA041057: AB_2677278, HPA058707: AB_2683796"	"unprognostic (1.38e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.26e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.87e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.62e-1)"	55.6	57.5	55.3	55.3	68.1	87.3	60.9	80.2	61.7	53.4	47.9	57.7	49.6	38.9	61.4	74.9	53.3	55.9	48.0	47.4	53.3	51.5	68.5	61.2	45.1	52.2	60.5	51.8	76.0	51.7	85.9	48.6	55.4	47.2	56.5	51.1	43.9	49.0	54.3	69.7	43.9	50.3	58.0	55.4	62.3	49.4	47.8	64.5	121.5	61.7	41.5	64.3	57.5	97.9	17.3	25.1	17.0	11.7	15.1	21.7	7.3	47.9	38.6	51.3	40.2	26.9	23.3	50.4	34.4	22.2	31.6	28.2	36.9	32.0	75.9	32.3	29.0	30.3	37.8	68.6	39.0	50.3	31.9	46.0	65.4	34.2	56.3	28.3	74.8	39.8	26.2	23.6	34.4	36.6	28.4	32.3	47.9	85.1	28.2	42.6	34.3	79.6	77.8	89.0	36.0	35.2	79.9	64.0	41.2	50.9	35.4	42.9	42.3	54.2	35.9	41.6	39.1	49.4	84.4	38.9	31.7	46.7	33.7	60.7	46.6	50.8	74.0	26.0	64.2	45.3	14.1	11.7	15.5	15.3	10.1	16.2	17.3	18.6	18.4	12.4	17.0	21.7	18.3	17.0	15.1	11.0	25.1	15.8	7.3	55.3	68.1	80.2	50.4	53.3	51.5	60.5	51.8	47.2	64.5	303.7	307.6	169.4	272.6	241.0	145.0	162.6	101.9	311.8	396.9	183.2	172.8	181.9	82.9	177.3	334.5	193.4	127.0	0.0	156.7	227.3	175.2	162.2	346.3	111.1	161.8	133.5	190.1	114.8	193.9	392.9	142.4	255.5	116.4	215.6	139.7	150.4	156.6	124.3	134.0	103.9	204.8	142.3	205.0	166.3	161.8	209.2	211.3	200.3	159.5	244.9
HNRNPUL1	"E1B-AP5, E1BAP5, FLJ12944, HNRPUL1"	ENSG00000105323	"Heterogeneous nuclear ribonucleoprotein U like 1"	Q9BUJ2	19	41262496-41307598	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046290, CAB046477, HPA049475"	Enhanced		Enhanced	Nucleoplasm		NA	NA		20000	Nucleoplasm		"CAB046477: AB_2120664, HPA046290: AB_2679616, HPA049475: AB_2680783"	"unprognostic (5.52e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.39e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.94e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (2.39e-1)"	44.8	37.1	31.0	40.7	32.2	72.3	40.4	35.9	40.3	48.9	48.0	47.3	38.1	38.6	50.3	33.3	43.6	41.4	43.6	52.9	28.9	24.6	29.1	28.4	39.0	45.5	30.8	26.7	58.8	44.9	34.3	33.7	27.9	28.8	38.3	35.8	40.8	45.4	44.7	50.9	48.4	40.1	55.5	29.7	41.2	39.6	54.3	34.5	85.2	39.6	45.9	50.2	52.7	44.1	9.4	13.0	13.2	6.7	11.5	19.3	4.8	58.1	77.5	46.0	42.4	22.7	27.1	17.6	35.6	40.8	44.3	40.6	45.1	44.8	52.2	24.3	42.5	24.8	19.2	43.4	40.1	50.3	51.0	37.7	57.7	35.8	35.0	26.5	53.8	53.6	29.0	25.3	39.5	36.7	39.8	41.1	39.4	41.1	49.4	39.1	44.4	68.4	31.6	35.1	55.6	28.3	44.7	37.4	29.0	32.4	61.6	36.8	33.6	78.4	45.1	20.2	32.9	34.6	59.9	40.8	49.9	48.6	22.7	65.8	58.2	37.4	49.1	31.6	43.9	65.7	9.0	5.9	9.4	12.3	6.2	19.3	8.6	14.9	12.6	6.7	9.4	10.1	8.0	13.2	11.5	6.7	13.0	9.8	4.8	31.0	32.2	35.9	40.3	28.9	24.6	30.8	26.7	28.8	34.5	74.5	69.5	91.1	39.9	49.9	61.0	56.5	33.1	53.5	34.2	29.6	68.7	44.1	38.1	50.3	36.2	49.6	41.7	93.5	54.0	50.7	57.7	39.1	56.7	37.5	55.7	46.1	73.6	58.9	80.2	56.6	80.0	61.8	33.7	61.3	60.4	65.5	55.5	31.6	67.1	24.6	98.2	77.6	60.1	100.8	116.2	52.7	44.6	105.4	68.9	37.6
HNRNPUL2	"DKFZp762N1910, HNRPUL2"	ENSG00000214753	"Heterogeneous nuclear ribonucleoprotein U like 2"	Q1KMD3	11	62712630-62727349	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041632, HPA056696, HPA067699"	Supported		Enhanced	Nucleoplasm		NA	NA		23000	Nucleoplasm		"HPA041632: AB_10960896, HPA056696: AB_2683211, HPA067699: AB_2685891"	"unprognostic (3.06e-3)"	"unprognostic (2.31e-1)"	"unprognostic (7.48e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.33e-2)"	"unprognostic (6.45e-2)"	26.6	17.3	35.3	24.5	42.1	22.1	25.8	52.1	42.3	28.1	32.2	23.5	22.9	26.8	27.6	37.0	28.5	23.7	27.2	23.7	31.9	29.6	24.2	19.5	24.0	30.1	32.8	35.2	26.3	25.3	33.1	19.5	26.9	27.7	26.3	27.8	21.6	28.0	31.2	38.8	35.1	28.6	34.2	26.7	29.5	24.0	17.1	28.4	36.6	20.8	14.8	34.6	26.6	31.3	4.0	5.0	4.4	3.8	2.6	5.1	1.7	35.9	17.1	28.9	17.3	16.3	20.0	4.8	23.2	14.3	18.6	14.4	11.8	12.6	42.4	11.9	19.8	15.7	20.3	18.0	22.9	25.0	17.9	9.3	39.8	22.2	13.3	14.5	41.6	26.7	15.5	18.1	17.5	21.9	14.4	22.6	11.0	15.0	16.2	21.3	21.6	41.3	37.8	13.6	13.7	13.8	29.1	26.4	20.2	23.2	22.6	17.1	19.1	24.0	20.4	24.4	14.5	14.9	18.1	24.5	21.6	9.5	26.7	24.4	20.3	16.8	42.0	19.4	20.1	19.7	3.2	2.9	4.4	5.1	1.9	3.7	3.4	3.7	4.3	1.7	4.0	2.9	3.6	3.8	2.6	3.8	5.0	3.3	1.7	35.3	42.1	52.1	42.3	31.9	29.6	32.8	35.2	27.7	28.4	26.8	8.9	31.2	12.6	26.2	27.8	37.2	33.1	8.1	13.6	50.6	9.8	21.3	5.0	24.6	5.7	28.7	53.9	0.0	31.1	22.2	25.3	20.4	15.0	34.6	32.7	39.7	36.9	39.3	58.6	5.2	38.9	27.8	13.5	22.6	52.8	16.6	29.1	47.2	43.2	21.9	17.9	32.3	27.8	12.9	20.1	28.1	21.1	24.9	53.4	15.9
HOXA9	"HOX1, HOX1G"	ENSG00000078399	"Homeobox A9"	P31269	7	27162435-27175180	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 35.1"	"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 46.4;Intestinal endocrine cells: 37.7;Proximal tubular cells: 60.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basophil: 5.4;myeloid DC: 6.0;NK-cell: 11.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.0;granulocytes: 5.4;NK-cells: 11.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 43.6;PC-3: 15.2;RPTEC TERT1: 15.0;SCLC-21H: 40.5;U-937: 14.5"									"HPA061982, HPA076200"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061982: AB_2684651, HPA076200: "	"unprognostic (4.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.35e-2)"	"unprognostic (8.44e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.80e-3)"	"unprognostic (6.45e-2)"	"unprognostic (7.58e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	3.2	3.4	0.2	8.8	0.1	2.4	8.7	0.1	0.2	15.5	12.8	0.2	4.1	0.0	10.4	16.8	1.4	12.2	0.3	0.1	0.1	0.0	35.1	0.1	0.8	0.7	0.1	0.1	2.0	0.1	0.0	0.1	1.4	0.4	16.6	4.5	0.2	0.5	5.6	21.0	13.3	8.2	13.1	0.7	1.0	0.0	2.4	0.1	2.6	0.3	0.3	0.3	16.2	11.4	0.5	6.0	5.4	1.0	11.7	1.5	0.5	12.7	0.0	0.0	6.4	2.1	1.6	0.0	5.1	4.1	0.4	0.4	0.8	0.5	0.1	0.5	2.7	0.0	11.9	8.2	0.0	0.4	0.0	43.6	0.1	0.3	0.0	0.2	0.0	0.1	2.2	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	15.2	2.7	0.0	0.0	15.0	0.2	40.5	0.0	5.4	0.0	0.1	0.2	0.0	10.7	0.4	0.0	4.0	4.9	0.0	0.0	0.0	0.0	0.0	14.5	0.0	5.4	1.0	0.0	1.5	0.2	0.2	0.2	0.0	0.1	6.0	0.5	0.3	0.1	0.9	11.7	0.4	1.9	0.2	0.5	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.8	10.6	22.2	0.0	0.6	0.0	0.0	0.0	17.4	0.0	0.3	46.4	0.0	0.0	0.2	7.9	0.0	0.0	0.3	10.8	14.2	0.0	0.0	0.3	0.0	37.7	0.0	4.8	0.0	0.0	1.6	5.0	0.0	19.1	0.0	0.0	18.4	0.0	60.8	0.0	0.0	3.6	0.0	0.6	24.1	0.2	4.4	19.4	11.5
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48729178	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 18.6;prostate: 38.3"	"Cell type enhanced"	"Detected in some"	17	"Glandular cells: 62.7;Intestinal endocrine cells: 187.8;Mucus-secreting cells: 92.1;Paneth cells: 66.2;Undifferentiated cells: 64.4"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	13	"PC-3: 59.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.4	10.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.4	0.1	38.3	18.6	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	3.6	2.4	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.6	2.0	0.0	4.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.9	1.0	0.0	1.0	0.0	0.5	0.0	3.0	0.0	0.0	0.3	1.4	0.9	0.6	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.7	59.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.4	0.2	0.0	0.2	0.0	0.2	1.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	37.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	40.4	0.0	0.0	0.2	0.3	62.7	0.0	0.0	0.1	0.0	187.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	92.1	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	64.4	6.4
HOXC9	"HOX3, HOX3B"	ENSG00000180806	"Homeobox C9"	P31274	12	53994895-54003337	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 18.9;skeletal muscle: 28.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 34.9;Fibroblasts: 20.8;Melanocytes: 37.1;Proximal tubular cells: 16.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 14.7;HDLM-2: 18.7;HEK 293: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA063965, HPA072160"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063965: AB_2685162, HPA072160: AB_2686491"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.19e-5)"	"unprognostic (1.23e-1)"	"unprognostic (4.09e-3)"	"unprognostic (7.12e-2)"	"unprognostic (6.92e-3)"	"unprognostic (1.06e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.08e-2)"	"unprognostic (9.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.53e-1)"	18.9	2.5	0.0	1.2	0.0	0.1	12.8	0.0	0.1	0.5	0.2	0.0	0.4	0.1	1.7	7.8	0.3	6.3	0.1	0.1	0.0	0.0	12.2	0.1	0.1	4.3	0.0	0.0	5.6	1.0	0.1	0.0	2.0	0.0	0.9	0.1	0.0	0.5	0.2	28.3	5.7	4.4	1.2	0.5	0.1	0.1	4.3	0.0	0.1	0.2	0.2	0.3	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	2.2	0.0	14.7	5.9	4.9	1.0	1.5	1.4	1.9	1.3	0.6	2.2	0.0	1.1	5.8	0.3	2.6	0.3	1.5	1.7	18.7	22.8	0.4	3.3	0.5	0.6	0.0	3.4	5.5	2.5	2.8	1.3	0.0	1.8	0.1	4.6	0.0	3.9	1.6	0.0	1.3	0.0	1.1	0.2	0.2	2.8	0.0	4.4	1.4	0.0	4.3	5.3	2.8	5.8	0.4	4.4	0.2	0.0	3.5	6.3	1.0	1.8	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.3	34.9	0.0	3.4	0.1	0.0	0.0	0.3	10.4	20.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.6	4.4	0.3	37.1	0.0	0.0	0.0	0.3	0.0	7.4	16.7	0.0	6.5	2.5	7.6	8.9	8.3	0.3	0.0	0.0	0.0
HOXD1	"HOX4, HOX4G"	ENSG00000128645	"Homeobox D1"	Q9GZZ0	2	176188579-176190907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.9;epididymis: 14.1;seminal vesicle: 20.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 21.0;Distal tubular cells: 21.6;Enterocytes: 18.8;Mucus-secreting cells: 16.6;Undifferentiated cells: 20.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 6.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 5.9;Hep G2: 6.0;RPTEC TERT1: 18.8;RT4: 14.4;SCLC-21H: 5.0"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in many"			"HPA040062, HPA056900"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040062: AB_2676826, HPA056900: AB_2683270"	"unprognostic (8.78e-2)"	"unprognostic (9.97e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.70e-1)"	"unprognostic (3.19e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.64e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.54e-5)"	"unprognostic (4.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.32e-1)"	2.4	0.6	1.5	1.1	3.5	0.3	2.0	0.6	3.9	0.5	5.2	18.8	11.8	0.7	0.8	14.1	0.9	8.8	1.4	0.3	4.1	2.2	6.8	0.2	5.7	0.9	9.8	1.3	1.2	0.5	0.2	0.2	0.3	15.5	1.7	3.7	0.3	1.0	20.4	0.3	1.2	4.4	0.9	18.9	1.5	0.7	2.2	6.3	0.0	0.4	0.0	0.5	4.6	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	5.9	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	6.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	18.8	14.4	5.0	0.9	0.0	0.0	0.9	0.8	0.0	0.0	3.3	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.5	0.6	3.2	4.1	2.2	9.8	1.3	15.5	6.3	3.0	21.0	0.0	0.2	3.8	0.0	0.0	0.0	0.0	4.5	7.0	0.0	0.0	21.6	0.0	0.0	2.9	18.8	0.0	0.0	0.0	0.1	0.5	2.3	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	3.3	0.0	16.6	0.0	0.1	11.5	0.4	2.9	0.0	0.0	0.1	2.6	6.4	2.3	0.0	0.0	20.6	1.8
HSD17B4	"DBP, MFE-2, SDR8C1"	ENSG00000133835	"Hydroxysteroid 17-beta dehydrogenase 4"	P51659	5	119452443-119637199	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Fatty acid metabolism, Lipid metabolism"	"Isomerase, Lyase, Oxidoreductase"	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 203.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021302, HPA021311, HPA021479"	Enhanced		Enhanced	Peroxisomes		NA	NA		6900000	Peroxisomes		"HPA021302: AB_1844350, HPA021311: AB_1844351, HPA021479: AB_1844352"	"unprognostic (1.03e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-3)"	"unprognostic (5.47e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (6.31e-6)"	"unprognostic (1.60e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.65e-3)"	25.1	42.4	22.1	15.5	21.3	6.4	46.0	12.3	23.6	27.8	30.1	24.1	83.8	28.6	16.2	20.7	24.6	15.1	20.6	27.3	23.8	21.2	31.3	116.3	30.5	16.7	27.0	21.7	15.1	29.9	33.2	20.5	19.0	23.9	20.9	25.2	10.7	20.0	86.2	20.7	19.2	30.5	15.6	33.6	16.9	20.7	8.1	25.5	10.8	48.9	17.3	14.5	24.1	25.3	6.1	11.1	31.4	13.6	3.2	4.2	5.3	17.8	15.4	29.0	38.4	72.4	34.0	15.3	17.4	23.5	16.5	30.1	12.7	29.8	23.9	35.9	18.8	24.3	18.0	21.3	37.9	25.8	26.1	19.7	31.4	16.8	24.2	18.4	9.9	49.2	29.6	15.9	17.7	16.7	19.4	28.2	16.5	10.7	13.9	17.9	15.5	15.1	6.4	21.5	44.1	10.9	19.3	29.1	25.8	26.4	49.4	21.9	18.9	40.9	6.4	19.0	28.7	23.7	16.7	20.0	16.2	11.1	17.8	14.2	7.1	14.8	8.8	18.4	26.5	15.9	31.4	13.6	24.7	3.4	8.0	4.2	6.1	3.2	2.9	11.1	5.8	3.1	2.9	2.4	3.2	7.8	6.9	2.0	5.3	22.1	21.3	12.3	23.6	23.8	21.2	27.0	21.7	23.9	25.5	68.5	94.4	20.8	34.3	13.3	18.5	62.9	81.5	24.1	47.8	34.9	13.7	57.8	71.3	28.8	7.4	26.4	50.3	0.0	31.4	21.8	24.2	32.2	65.9	203.2	70.1	14.3	31.7	31.3	50.9	9.3	31.9	35.3	8.5	103.6	42.6	44.1	23.2	24.6	48.1	50.5	15.4	6.5	20.0	15.9	22.2	15.1	54.3	13.1	51.1	31.4
HSD3B7	"C(27)-3BETA-HSD, SDR11E3"	ENSG00000099377	"Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7"	Q9H2F3	16	30985207-30989152	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	Steroidogenesis	Oxidoreductase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.1"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 52.9;Hofbauer cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	22	"basophil: 24.5;eosinophil: 13.5"	"Lineage enriched"	"Detected in single"	29	"granulocytes: 24.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 31.6;Hep G2: 23.1;HMC-1: 35.9;U-2197: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015965, HPA050521, HPA060847"	Uncertain		Enhanced	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA015965: , HPA050521: AB_2681155, HPA060847: AB_2684379"	"unprognostic (5.41e-3)"	"unprognostic (4.14e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.62e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.47e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (1.60e-6)"	"unprognostic (2.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.79e-1)"	21.6	11.2	2.5	7.5	4.7	1.8	7.3	2.7	4.0	4.9	8.3	4.6	2.8	11.2	5.3	6.4	9.4	4.4	7.4	5.2	3.1	1.6	25.6	74.1	6.4	5.6	3.5	1.4	9.3	17.7	5.6	2.6	6.1	3.7	5.9	3.2	2.9	4.5	2.6	5.1	7.8	13.3	6.7	4.8	8.3	4.8	3.6	3.7	1.0	2.9	4.5	4.6	8.0	3.9	0.1	0.8	24.5	0.8	0.2	0.0	0.3	7.0	8.1	0.8	4.1	2.9	10.7	0.5	8.8	14.0	1.7	3.6	0.6	12.3	0.4	2.9	10.8	0.3	2.1	0.8	1.3	0.9	31.6	1.9	0.5	6.4	23.1	2.7	0.1	35.9	5.1	2.2	8.4	1.7	4.1	0.8	0.4	1.6	0.3	6.6	15.1	0.2	5.0	0.6	3.0	1.1	0.8	2.8	7.8	5.4	0.4	3.0	1.5	1.1	5.8	0.8	0.4	11.2	0.5	4.1	3.7	1.0	34.9	0.9	0.6	5.1	0.4	14.3	0.9	0.3	24.5	0.8	13.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.6	0.2	0.0	0.3	0.0	0.3	2.5	4.7	2.7	4.0	3.1	1.6	3.5	1.4	3.7	3.7	3.0	6.2	2.7	2.2	7.0	0.7	1.6	25.5	1.4	0.0	14.0	0.0	1.7	13.3	34.6	37.8	6.5	20.6	0.0	26.8	2.6	9.0	2.5	9.2	52.9	55.1	1.6	7.5	6.7	7.9	1.1	6.1	14.8	13.5	21.6	7.2	1.9	19.4	11.2	4.9	33.2	0.4	12.9	9.0	0.6	1.1	11.0	1.1	1.0	15.7	2.4
HSDL2	"C9orf99, SDR13C1"	ENSG00000119471	"Hydroxysteroid dehydrogenase like 2"	Q6YN16	9	112379937-112472410	"Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 70.5"	"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 160.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Lineage enriched"	"Detected in all"	5	"granulocytes: 23.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042890, HPA050453"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA042890: AB_2678216, HPA050453: AB_2681131"	"unprognostic (3.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.90e-3)"	"prognostic favorable (9.23e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.15e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (9.29e-7)"	"unprognostic (1.44e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.35e-2)"	31.0	26.3	18.3	5.8	17.7	4.1	13.8	5.7	12.1	10.1	14.1	11.9	6.2	15.2	11.0	5.0	14.4	8.8	7.6	52.1	16.1	13.7	29.3	70.5	11.4	7.8	17.9	10.8	21.3	11.4	7.9	7.7	9.9	12.4	12.2	11.0	10.2	7.3	6.9	54.1	12.5	18.3	13.3	12.9	10.1	9.9	5.9	14.5	5.7	13.2	27.7	6.9	14.2	10.7	3.6	4.6	23.3	5.0	2.6	4.1	2.4	15.0	13.5	10.2	5.1	17.7	17.5	11.7	10.3	6.4	7.4	6.2	25.9	17.0	9.7	5.7	15.1	9.5	17.3	10.9	14.5	9.1	40.5	7.2	10.0	21.8	25.3	11.0	5.6	6.5	18.6	10.5	11.0	8.0	10.8	8.5	11.9	13.9	6.5	20.1	9.9	13.9	5.3	6.0	36.1	17.5	9.1	30.7	14.2	15.6	13.7	7.3	5.2	25.9	17.2	8.7	8.7	24.3	6.9	9.7	10.7	10.0	29.7	10.0	7.7	18.9	4.6	13.2	8.4	6.2	21.9	4.0	15.2	2.3	3.9	3.5	3.3	2.5	2.6	4.5	3.6	3.0	3.1	23.3	2.6	5.0	4.6	4.1	2.4	18.3	17.7	5.7	12.1	16.1	13.7	17.9	10.8	12.4	14.5	92.3	61.8	13.9	14.4	11.7	9.4	160.9	12.7	48.2	43.3	14.0	5.9	21.7	54.7	13.9	135.8	13.9	29.7	0.0	16.4	25.3	13.4	15.9	30.0	98.6	31.2	6.4	14.3	19.6	18.9	127.6	25.3	23.6	8.5	56.9	28.3	22.3	14.4	24.6	44.2	86.7	14.6	45.3	30.3	11.8	16.2	14.2	26.5	7.5	34.3	26.2
HSP90AA1	"FLJ31884, Hsp89, Hsp90, HSP90N, HSPC1, HSPCA"	ENSG00000080824	"Heat shock protein 90 alpha family class A member 1"	P07900	14	102080738-102139699	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 519.3"	"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 6915.7;Urothelial cells: 5558.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002058	Approved		Supported	Cytosol		NA	NA		94000000	Cytosol		"CAB002058: "	"prognostic unfavorable (5.59e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (3.09e-5)"	"unprognostic (7.79e-3)"	"unprognostic (5.71e-2)"	"unprognostic (7.81e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.65e-2)"	"prognostic favorable (1.18e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-1)"	50.8	75.3	96.1	46.7	106.8	64.1	118.6	81.3	113.4	51.0	47.3	50.7	43.0	31.0	40.7	55.5	40.9	94.7	61.0	70.9	99.6	113.3	75.6	62.5	51.7	48.1	134.4	58.6	53.4	40.1	94.9	121.6	67.2	143.6	63.2	53.3	23.4	57.0	57.0	65.2	35.6	38.9	51.0	139.7	35.7	41.3	84.6	132.7	53.5	91.5	34.3	59.5	54.2	519.3	30.7	46.9	31.8	29.9	57.7	63.1	21.9	86.8	118.8	75.9	52.3	46.1	39.0	100.8	96.7	46.5	118.6	66.9	72.1	81.6	106.8	91.1	62.1	77.8	96.5	217.7	94.5	216.3	80.8	71.7	82.4	67.9	92.0	22.8	122.7	63.6	36.6	40.2	75.8	27.9	74.2	65.4	115.4	113.8	54.9	107.3	117.4	131.1	56.4	78.8	160.2	112.4	126.5	103.1	46.1	68.8	112.3	100.0	72.2	122.2	92.0	53.9	132.9	118.3	49.0	46.2	83.0	53.7	123.3	183.5	52.0	162.1	158.0	78.5	75.9	99.9	31.8	19.9	24.0	47.8	29.9	63.1	29.6	40.5	49.0	23.9	30.7	30.1	43.5	13.5	57.7	27.5	46.9	39.2	21.9	96.1	106.8	81.3	102.7	99.6	113.3	134.4	58.6	143.6	132.7	1057.1	642.7	718.4	6915.7	1191.0	1040.4	2043.0	677.7	2973.9	1019.1	486.8	1981.1	1152.8	290.1	998.3	319.6	818.5	645.6	934.5	749.7	1610.0	1217.1	2796.5	903.1	527.2	1188.6	683.3	908.6	338.8	568.8	289.5	677.7	1578.9	1233.2	998.3	507.2	1211.6	739.1	659.3	679.6	610.3	3287.9	608.0	1393.6	3574.3	1881.8	973.5	1714.6	761.4	693.9	5558.4
HSP90B1	"GP96, GRP94, TRA1"	ENSG00000166598	"Heat shock protein 90 beta family member 1"	P14625	12	103930107-103953645	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 325.1;thyroid gland: 338.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003901, CAB005224, HPA008424, CAB078151"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		410000000	"Endoplasmic reticulum"		"CAB005224: AB_2119181, CAB078151: AB_2665765, HPA003901: AB_1851181, HPA008424: AB_1851184"	"unprognostic (1.03e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.14e-3)"	"unprognostic (3.00e-2)"	"unprognostic (7.22e-2)"	"unprognostic (8.77e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.03e-10)"	"unprognostic (2.95e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-2)"	49.0	57.1	26.9	50.0	32.0	45.9	60.3	16.5	25.5	45.7	43.4	17.5	108.5	32.1	42.2	127.2	34.3	42.0	32.4	67.0	27.1	32.0	74.0	325.1	46.6	49.2	31.5	26.0	53.9	95.5	47.1	50.0	123.6	29.4	46.9	46.9	15.8	43.8	136.8	25.4	19.2	54.4	45.0	37.8	89.3	37.0	25.7	27.9	44.5	338.5	24.0	36.9	66.1	106.1	25.6	81.0	22.2	23.8	40.2	53.3	33.9	72.0	39.1	78.9	81.0	80.8	76.3	107.1	121.5	91.9	64.7	86.4	69.7	67.6	21.1	96.6	127.5	83.5	50.4	77.7	130.5	87.4	49.8	29.6	56.7	44.1	71.9	124.7	57.1	44.4	44.7	58.2	79.7	114.4	219.3	124.5	25.7	45.3	80.2	85.5	25.9	34.3	63.9	64.9	73.3	47.1	31.3	50.9	88.1	86.6	45.5	23.4	56.2	75.8	78.5	76.6	126.8	63.8	84.9	71.6	49.0	42.0	39.8	50.6	82.1	76.8	39.0	97.7	42.3	75.8	22.2	21.2	6.9	45.6	23.8	53.3	25.6	26.7	39.3	28.0	15.9	18.0	31.3	4.9	40.2	19.3	81.0	16.4	33.9	26.9	32.0	16.5	25.5	27.1	32.0	31.5	26.0	29.4	27.9	220.3	319.5	129.9	714.2	274.9	44.0	581.2	221.7	394.9	445.9	244.3	147.3	520.4	48.0	366.6	40.3	299.0	344.0	186.9	218.9	824.3	597.0	564.5	392.9	721.4	494.0	73.1	389.8	556.8	268.7	19.1	521.5	350.1	399.9	234.4	276.1	146.4	329.7	262.6	317.5	229.3	75.2	213.4	401.9	313.5	187.6	227.8	770.3	202.8	314.4	519.2
HSPB1	"CMT2F, Hs.76067, Hsp25, HSP27, HSP28"	ENSG00000106211	"Heat shock protein family B (small) member 1"	P04792	7	76302544-76304295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	Chaperone	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 565.5"	"Group enriched"	"Detected in many"	4	"Basal glandular cells: 13325.7;Exocrine glandular cells: 5786.9;Urothelial cells: 14386.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 165.4;MCF7: 232.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000497, CAB004439, CAB047330, CAB047331, CAB047332"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		57000000	"Plasma membrane, Cytosol"		"CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172"	"unprognostic (2.55e-1)"	"unprognostic (7.25e-3)"	"prognostic unfavorable (9.94e-5)"	"unprognostic (7.07e-3)"	"unprognostic (3.47e-3)"	"unprognostic (6.61e-3)"	"unprognostic (4.08e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.78e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.63e-1)"	67.6	41.7	23.0	42.9	22.8	7.3	186.2	10.1	21.3	127.6	84.9	10.8	89.2	27.1	126.5	65.9	410.5	57.7	52.2	164.8	21.4	22.5	85.4	26.3	43.3	25.1	25.7	14.3	63.4	34.7	16.6	15.5	106.9	32.8	99.6	12.0	31.1	50.5	101.3	439.2	164.4	24.6	139.7	27.3	17.8	37.6	22.0	23.4	31.9	72.9	207.3	126.8	146.2	565.5	27.8	17.8	4.1	27.9	23.2	36.8	14.4	74.1	55.2	6.0	44.0	35.9	31.7	0.3	31.5	16.7	17.1	21.5	4.9	43.5	0.6	24.4	40.9	35.3	68.1	25.8	18.4	5.6	41.4	8.7	3.4	42.6	23.3	19.2	5.0	31.1	39.4	165.4	25.8	3.8	32.5	56.6	12.7	27.0	75.8	19.6	232.3	8.4	34.3	30.2	15.0	48.3	26.2	12.1	60.3	25.5	28.3	0.4	33.8	22.2	90.4	28.2	17.6	106.6	35.5	30.5	51.5	76.9	16.0	79.5	5.3	8.7	0.7	37.7	15.5	37.5	4.1	4.5	2.8	18.6	21.1	9.6	27.5	30.6	20.2	11.1	27.8	36.8	31.5	1.7	23.2	27.9	17.8	19.7	14.4	23.0	22.8	10.1	21.3	21.4	22.5	25.7	14.3	32.8	23.4	253.1	212.2	115.1	13325.7	1643.2	181.1	724.5	257.4	163.3	246.9	1085.2	304.3	116.8	1271.6	1614.7	8.7	728.0	540.2	0.0	5786.9	328.3	1183.3	2785.1	218.6	220.1	1062.0	66.7	404.2	589.9	103.8	18.4	277.3	433.3	1950.2	307.4	101.7	223.5	2381.8	1422.3	502.4	1699.1	24.3	601.5	2360.7	6.2	90.5	1959.6	2034.5	83.1	148.1	14386.7
HSPD1	"GroEL, HSP60, SPG13"	ENSG00000144381	"Heat shock protein family D (Hsp60) member 1"	P10809	2	197486581-197516737	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, Isomerase"	"Cancer-related genes, Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 162.6"	"Cell type enhanced"	"Detected in all"	5	"Basal glandular cells: 1171.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA001523, CAB002775, HPA050025, CAB072816"	Supported		Enhanced	Mitochondria		NA	NA		53000000	Mitochondria		"CAB002775: , CAB072816: , HPA001523: AB_1079028, HPA050025: AB_2680995"	"unprognostic (2.79e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.21e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.91e-2)"	"unprognostic (8.63e-3)"	"unprognostic (3.47e-2)"	"unprognostic (7.83e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.10e-2)"	28.5	125.2	28.7	23.4	31.8	21.0	55.9	18.2	24.3	17.4	30.3	17.8	23.3	28.9	17.5	18.5	27.2	25.3	16.3	24.0	24.2	27.8	67.1	147.5	22.4	25.3	35.5	16.1	30.2	50.6	32.5	25.9	27.1	33.6	25.9	37.2	11.9	17.6	21.0	36.4	13.7	32.0	23.6	32.4	22.7	25.2	10.9	35.8	22.7	38.7	29.4	30.3	33.3	162.6	25.6	30.3	6.2	29.3	23.1	33.5	22.2	41.2	50.8	42.6	38.2	29.2	30.6	62.0	43.0	22.7	51.8	38.0	170.3	24.9	125.5	56.1	22.4	64.2	42.2	166.7	47.4	73.5	30.8	66.9	89.1	82.2	197.1	27.5	98.7	28.0	34.5	55.0	45.9	80.9	36.5	40.6	69.3	109.7	49.2	38.0	52.8	61.2	99.9	84.2	54.3	106.3	73.7	52.6	90.6	54.4	43.2	55.8	31.7	43.1	46.7	55.2	91.1	32.3	58.6	18.1	32.2	44.7	41.4	67.9	27.6	60.7	104.2	37.8	59.7	34.5	4.5	19.7	5.3	15.5	29.3	28.8	25.6	25.0	21.8	30.3	21.0	33.5	29.0	6.2	23.1	25.8	20.2	19.7	22.2	28.7	31.8	18.2	24.3	24.2	27.8	35.5	16.1	33.6	35.8	154.9	133.3	218.4	1171.9	219.0	70.0	213.1	150.3	448.3	361.7	75.0	241.5	780.7	318.3	195.2	4.9	145.2	151.1	70.0	125.9	299.2	219.4	456.8	297.3	264.5	289.1	90.6	262.9	61.4	70.1	9.9	120.8	249.2	155.3	160.5	166.4	117.0	164.4	153.9	106.8	589.7	103.4	84.1	310.2	68.2	82.2	181.0	837.2	136.4	347.8	853.1
HSPH1	"HSP105A, HSP105B, KIAA0201, NY-CO-25"	ENSG00000120694	"Heat shock protein family H (Hsp110) member 1"	Q92598	13	31134974-31162388	"Cancer-related genes, Predicted intracellular proteins"	"Stress response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"vagina: 286.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 738.6;Urothelial cells: 485.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002060, HPA028675, HPA031569"	Uncertain		Enhanced	Nucleoplasm,Cytosol		No	Yes		820000	Cytosol	Nucleoplasm	"CAB002060: AB_563775, HPA028675: AB_10601581, HPA031569: AB_2673938"	"unprognostic (1.10e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.90e-4)"	"prognostic unfavorable (1.41e-5)"	"unprognostic (5.03e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.45e-3)"	"unprognostic (9.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.89e-2)"	13.7	19.8	36.6	12.2	57.1	9.8	33.7	11.7	44.0	14.7	10.6	9.8	13.0	6.1	13.3	21.7	13.9	31.0	18.1	14.2	34.8	40.3	16.6	14.8	15.9	17.4	36.5	16.3	13.4	10.1	15.1	24.1	19.8	32.7	14.5	14.5	3.6	7.0	17.3	10.5	11.0	6.4	15.7	34.8	9.0	12.2	35.0	34.6	12.1	22.5	7.8	23.8	17.0	286.1	9.0	6.8	2.1	14.6	13.7	12.8	5.5	13.7	26.5	21.8	2.1	21.0	11.9	14.5	23.9	21.3	37.2	17.3	31.1	21.5	35.8	15.0	16.6	52.9	26.8	84.1	21.2	48.1	28.0	10.6	31.0	14.6	27.4	6.9	21.5	24.8	7.5	49.2	24.8	14.3	19.5	21.5	12.6	25.9	5.7	26.1	18.8	30.8	24.6	31.0	67.6	19.8	24.3	17.9	11.8	28.1	16.8	22.6	18.8	21.8	21.4	11.0	34.9	7.2	21.0	13.1	12.8	16.3	18.4	26.4	4.5	14.7	30.7	10.7	26.1	21.4	1.0	3.9	2.1	6.6	9.6	8.1	9.0	8.4	10.0	6.8	7.8	12.8	11.9	0.4	13.7	14.6	5.3	5.3	5.5	36.6	57.1	11.7	44.0	34.8	40.3	36.5	16.3	32.7	34.6	122.1	81.5	33.2	738.6	190.6	38.7	130.6	17.8	302.5	185.4	43.6	392.7	17.7	24.9	44.8	71.1	92.6	26.2	0.0	31.1	55.8	207.2	407.7	251.8	21.5	79.0	28.6	217.9	24.5	27.7	22.4	31.4	113.0	155.3	47.7	22.5	16.6	37.1	45.6	36.7	22.8	57.7	38.8	156.8	128.9	138.0	125.3	35.6	28.0	26.7	485.8
HTATSF1	TAT-SF1	ENSG00000102241	"HIV-1 Tat specific factor 1"	O43719	X	136497079-136512346	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000504	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000504: AB_10752094"	"unprognostic (3.56e-2)"	"prognostic favorable (3.78e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.72e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.27e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-2)"	"prognostic favorable (8.13e-8)"	"unprognostic (7.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.05e-1)"	14.5	40.9	26.2	11.8	24.7	18.3	19.6	29.5	22.2	15.2	13.4	19.4	12.9	9.6	15.9	24.7	12.3	14.5	11.5	25.2	23.8	29.9	17.5	12.7	10.4	12.1	26.9	17.6	25.5	10.9	25.6	71.7	21.2	21.4	15.1	14.2	11.9	10.6	16.6	72.2	13.6	9.8	14.4	28.1	10.2	12.4	15.8	19.0	14.5	19.4	22.6	13.3	12.7	12.9	17.1	14.1	19.2	16.1	23.6	24.9	13.1	42.0	22.5	28.5	20.2	21.3	16.1	25.2	19.5	17.4	16.7	16.3	13.3	18.9	31.6	47.5	18.9	19.4	18.2	34.5	14.6	21.7	24.1	29.3	19.7	28.5	16.3	11.8	37.0	16.0	14.2	19.1	18.3	11.3	11.7	16.9	47.6	18.1	23.4	21.4	31.3	36.8	31.9	16.4	37.9	33.5	29.1	35.5	28.8	17.9	29.8	20.2	31.4	18.5	15.5	15.3	25.2	11.5	26.7	16.3	20.4	15.4	23.1	34.9	13.7	18.8	26.3	13.0	52.9	14.3	19.2	10.1	16.4	21.9	10.5	24.4	17.1	24.1	22.2	14.1	15.9	24.9	22.2	3.4	23.6	16.1	10.3	24.0	13.1	26.2	24.7	29.5	22.2	23.8	29.9	26.9	17.6	21.4	19.0	47.6	40.5	17.9	31.9	26.3	49.7	142.2	15.3	58.9	68.2	47.1	9.8	79.5	41.4	30.5	4.9	27.0	20.7	0.0	29.6	57.8	33.4	28.5	33.5	20.4	33.5	39.7	77.9	10.4	19.3	9.9	41.7	26.7	30.4	26.2	34.6	55.0	26.0	14.0	50.5	24.8	43.9	45.3	33.5	21.8	87.9	23.2	97.7	40.6	29.3	30.6
HUWE1	"Ib772, KIAA0312, UREB1"	ENSG00000086758	"HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase"	Q7Z6Z7	X	53532096-53686729	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Biological rhythms, Differentiation, DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002548, CAB022718"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3400	"Nucleoplasm, Cytosol"		"CAB022718: , HPA002548: AB_1080489"	"unprognostic (4.73e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.59e-2)"	"unprognostic (6.64e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.89e-2)"	"unprognostic (8.10e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.45e-1)"	24.6	28.2	27.7	23.8	43.3	22.4	28.0	37.0	41.1	31.8	25.9	34.3	26.6	17.1	31.9	52.4	27.4	26.5	23.1	27.1	28.0	31.8	30.3	26.2	20.3	23.1	30.0	30.2	43.3	27.8	59.8	34.2	27.2	34.6	27.3	22.7	25.6	26.4	29.6	59.1	50.1	22.1	33.9	23.9	26.6	25.7	28.4	27.7	32.4	27.6	20.7	28.6	27.0	22.9	5.1	7.2	8.2	7.0	6.9	8.9	3.5	50.2	31.0	20.2	14.2	35.4	21.2	24.9	15.1	19.5	16.0	16.7	23.6	16.2	26.4	10.3	27.5	28.8	24.2	45.6	25.3	21.9	38.0	20.2	21.0	27.8	18.3	32.5	31.4	12.9	20.2	19.0	38.3	44.1	15.8	27.6	20.7	20.9	17.1	20.7	31.0	17.0	17.6	27.6	13.8	22.3	15.7	27.8	16.0	26.5	34.9	16.9	12.2	42.7	19.1	13.6	39.5	27.3	15.3	35.1	14.7	21.1	21.0	19.2	15.0	14.8	23.0	15.7	30.8	21.1	4.0	4.7	8.2	7.2	3.8	8.9	5.1	6.9	7.6	6.7	5.1	4.9	4.9	4.2	6.9	7.0	7.2	5.7	3.5	27.7	43.3	37.0	41.1	28.0	31.8	30.0	30.2	34.6	27.7	47.6	43.2	23.8	25.3	26.8	53.1	98.6	45.9	37.5	36.4	38.4	47.1	26.9	1.7	35.4	22.3	29.2	24.7	0.0	30.4	29.3	24.4	33.4	20.9	43.1	21.9	77.9	45.8	31.3	25.6	21.6	26.2	26.1	25.3	40.5	28.4	20.9	40.0	17.3	36.7	12.2	31.9	12.9	33.0	17.1	43.7	36.4	31.7	37.1	29.2	40.4
IARS2	FLJ10326	ENSG00000067704	"Isoleucyl-tRNA synthetase 2, mitochondrial"	Q9NSE4	1	220094102-220148041	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Cataract, Deafness, Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024212, HPA024594, HPA024596"	Enhanced		Enhanced	Mitochondria		NA	NA		26000	Mitochondria		"HPA024212: AB_1851363, HPA024594: AB_1851368, HPA024596: AB_1851370"	"unprognostic (2.15e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.42e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.24e-5)"	"unprognostic (9.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (6.27e-3)"	25.9	39.3	18.0	17.9	16.9	6.7	31.9	15.1	20.8	16.9	26.2	14.8	24.3	18.9	21.5	16.8	23.8	18.8	16.5	40.0	17.5	12.6	29.5	37.3	16.8	25.9	15.6	16.0	20.5	20.5	42.5	15.3	26.2	17.4	18.5	24.9	15.0	22.4	22.3	57.8	22.2	23.4	17.7	15.7	16.1	18.5	15.7	13.7	19.5	17.8	25.9	20.1	24.9	18.7	16.8	20.0	17.2	19.0	18.5	22.6	16.8	38.3	36.0	20.7	20.3	31.3	31.6	49.9	23.4	25.2	25.9	21.0	34.6	40.1	35.5	31.7	28.9	20.1	37.3	28.7	29.2	30.0	24.5	34.6	17.6	29.4	38.8	19.5	27.9	19.1	22.8	29.8	28.0	29.0	25.1	25.2	23.1	43.4	20.6	33.9	21.3	22.0	20.2	26.9	30.0	23.9	19.5	41.3	56.8	37.3	25.8	11.2	31.5	35.4	55.0	36.4	24.8	63.6	31.7	25.7	25.6	21.4	34.3	39.1	17.7	27.1	25.8	27.1	22.0	28.3	17.2	16.7	15.1	16.8	19.0	22.6	16.8	18.4	22.0	20.0	13.6	20.8	19.0	3.3	18.5	14.5	7.3	19.7	16.8	18.0	16.9	15.1	20.8	17.5	12.6	15.6	16.0	17.4	13.7	32.8	33.1	24.4	24.3	17.9	26.7	126.1	15.3	58.9	45.5	27.9	23.6	68.4	10.0	37.8	12.3	43.0	33.8	0.0	56.4	44.9	24.9	20.4	18.5	88.4	40.3	19.1	34.8	38.6	46.6	2.0	34.5	26.7	18.6	25.2	50.3	28.6	54.2	28.8	40.0	28.3	31.0	45.3	22.6	32.5	40.2	23.2	60.0	22.7	61.0	20.5
ID1	"bHLHb24, dJ857M17.1.2"	ENSG00000125968	"Inhibitor of DNA binding 1, HLH protein"	P41134	20	31605283-31606515	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"seminal vesicle: 163.1"	"Cell type enhanced"	"Detected in many"	8	"Ito cells: 1636.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 75.9;HaCaT: 72.3;PC-3: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025915, HPA051456, HPA058518"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	Yes	No			Nucleoplasm		"CAB025915: , HPA051456: AB_2681492, HPA058518: AB_2683740"	"unprognostic (3.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (2.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.14e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.41e-3)"	28.6	12.3	8.2	15.2	9.1	4.4	33.2	5.6	13.8	36.3	33.3	15.4	38.5	36.4	25.9	11.6	78.0	25.1	19.0	33.5	8.7	8.4	22.3	23.4	57.4	17.9	10.0	7.9	12.3	5.8	4.0	25.7	22.1	14.3	56.4	13.1	34.9	10.5	163.1	23.0	16.5	40.6	16.9	8.1	15.3	48.6	7.8	4.0	2.4	78.8	36.2	21.0	80.0	26.4	0.4	0.7	3.9	0.7	0.3	0.5	0.5	10.7	35.5	0.4	7.2	4.7	2.1	27.7	45.5	1.8	8.4	0.9	18.7	16.2	0.0	75.9	12.1	9.9	72.3	5.9	2.5	1.3	0.8	3.7	5.9	30.8	60.2	6.4	0.1	0.3	8.7	10.4	0.0	0.6	14.0	5.1	4.0	13.0	0.3	16.1	14.0	1.6	0.2	25.5	48.0	75.7	0.1	29.7	0.5	1.6	29.7	13.8	12.9	37.8	13.6	0.3	20.1	8.3	1.0	27.1	22.6	44.0	7.2	30.5	0.8	0.8	0.6	26.3	5.6	3.0	0.0	0.6	0.9	0.1	0.2	0.0	0.1	0.1	0.0	0.7	0.4	0.0	0.5	3.9	0.3	0.7	0.0	0.0	0.5	8.2	9.1	5.6	13.8	8.7	8.4	10.0	7.9	14.3	4.0	220.3	143.7	26.8	631.9	90.9	1.0	20.7	76.5	89.7	271.8	216.3	3.9	104.2	31.5	429.0	5.6	483.5	528.2	0.0	472.2	442.0	137.2	501.4	21.9	90.9	22.4	0.0	550.7	1636.4	76.9	5.9	26.4	25.7	86.0	13.6	450.7	80.6	190.0	770.0	0.4	2.7	4.0	12.9	193.3	1.9	2.2	76.9	74.5	24.9	241.9	477.9
IDH3A		ENSG00000166411	"Isocitrate dehydrogenase 3 (NAD(+)) alpha"	P50213	15	78131498-78171949	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 47.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041465, HPA062971"	Supported		Enhanced	Mitochondria		No	No		2000000	Mitochondria		"HPA041465: AB_10794377, HPA062971: AB_2684913"	"unprognostic (2.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.01e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (6.49e-8)"	"unprognostic (1.40e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.39e-2)"	14.6	18.1	18.0	13.0	25.3	6.5	7.7	16.1	29.5	9.9	17.6	11.9	6.1	24.5	11.2	5.9	12.0	8.4	6.5	41.5	16.6	16.8	15.2	10.4	8.8	11.0	20.6	18.1	8.0	9.2	18.5	12.4	8.4	29.0	10.1	18.8	10.4	11.2	11.9	47.7	11.1	23.8	11.9	18.1	10.1	8.9	11.5	13.8	16.2	8.1	26.5	16.4	11.1	10.3	10.1	47.2	6.1	17.0	5.5	6.0	7.4	16.0	22.0	4.0	14.0	10.0	10.3	8.7	19.1	9.3	15.7	11.9	15.7	9.8	34.2	14.2	11.2	23.2	24.3	37.2	14.8	14.5	15.0	12.3	13.2	23.9	7.1	8.6	25.6	18.9	7.8	9.1	15.2	16.0	7.5	9.8	12.2	16.9	14.1	9.9	15.3	18.7	6.8	4.9	9.3	8.3	10.9	17.2	10.6	13.0	21.9	16.0	6.2	21.9	31.4	17.8	7.7	12.5	13.9	10.0	18.5	17.1	24.3	30.8	16.1	35.8	18.2	13.0	24.5	14.4	4.2	9.4	2.7	5.3	17.0	5.7	9.2	5.2	4.8	14.2	10.1	5.6	6.0	6.1	5.5	16.6	47.2	5.6	7.4	18.0	25.3	16.1	29.5	16.6	16.8	20.6	18.1	29.0	13.8	8.9	13.9	26.8	49.8	49.7	32.4	15.3	10.2	40.2	11.4	24.4	35.3	35.1	69.6	20.4	40.5	16.4	42.3	0.0	15.5	32.0	20.6	24.1	26.5	21.2	23.7	25.4	18.5	11.1	22.8	17.5	19.2	26.5	25.3	6.4	36.6	24.2	18.9	28.8	22.3	37.6	27.3	12.9	34.3	41.4	22.6	36.0	57.2	20.3	49.2	35.8
IDH3B	RP46	ENSG00000101365	"Isocitrate dehydrogenase 3 (NAD(+)) beta"	O43837	20	2658395-2664219	"Citric acid cycle related proteins, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049387, HPA054180"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA049387: AB_2680740, HPA054180: AB_2682407"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.69e-2)"	"unprognostic (4.75e-3)"	"unprognostic (1.39e-2)"	"prognostic favorable (6.78e-8)"	"unprognostic (8.89e-2)"	"unprognostic (4.02e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.16e-1)"	19.5	20.0	19.4	15.5	31.7	20.6	18.5	32.1	30.5	16.4	23.9	16.9	14.5	30.5	19.2	16.7	20.7	17.9	19.2	57.3	19.8	20.0	29.7	25.2	15.1	17.6	24.0	29.4	20.2	15.2	27.6	12.2	17.0	31.2	15.4	25.6	16.2	19.3	19.5	75.5	20.9	24.9	21.5	17.1	19.2	19.9	19.6	16.0	19.7	19.1	37.7	22.5	16.7	17.4	34.7	49.4	25.8	44.7	29.5	38.6	33.9	26.5	36.0	16.5	14.4	18.2	14.4	19.0	14.3	18.3	33.8	27.0	46.4	28.0	30.0	13.1	19.6	31.2	37.5	30.4	46.4	31.1	8.3	23.8	36.4	14.0	48.0	17.9	39.6	8.0	19.0	17.9	31.5	16.6	14.9	19.9	26.0	46.0	16.8	20.5	14.6	34.4	45.4	32.0	27.4	34.2	28.2	30.1	33.7	19.4	24.9	29.8	21.5	17.6	58.5	30.1	13.3	29.3	17.6	17.7	26.4	16.6	8.9	32.8	22.9	52.4	31.7	12.4	41.0	25.0	22.2	41.7	25.8	33.9	44.7	25.6	34.7	29.4	30.7	49.4	30.6	34.4	29.8	11.9	29.5	38.3	22.9	38.6	33.9	19.4	31.7	32.1	30.5	19.8	20.0	24.0	29.4	31.2	16.0	35.7	26.2	48.5	51.6	50.5	32.7	162.9	58.6	28.1	22.7	22.7	31.4	112.2	132.6	64.7	47.2	52.0	101.0	23.3	88.6	72.5	49.7	37.2	48.4	51.2	85.2	12.7	48.7	37.4	56.7	72.9	41.7	53.5	65.8	90.2	63.3	41.3	56.4	67.7	44.6	135.3	32.3	77.6	67.4	39.5	53.0	52.4	90.7	57.9	90.9	44.0
IDO1	"IDO, INDO"	ENSG00000131203	"Indoleamine 2,3-dioxygenase 1"	P14902	8	39902275-39928444	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Immunity, Tryptophan catabolism"	"Dioxygenase, Oxidoreductase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 77.7;placenta: 33.2"	"Cell type enriched"	"Detected in some"	552	"monocytes: 4555.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	17	"eosinophil: 77.7"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 77.7"	"Cell line enriched"	"Detected in some"	7	"EFO-21: 36.6"	"Region enriched"	"Detected in single"	13	"basal ganglia: 30.5"	"Low region specificity"	"Detected in all"			"HPA023072, HPA023149, HPA027772, CAB072820"	Enhanced		Supported	Nucleoplasm,Vesicles,Mitochondria,Cytosol		NA	NA			Cytosol	"Nucleoplasm, Vesicles, Mitochondria"	"CAB072820: , HPA023072: AB_1846220, HPA023149: AB_1846221, HPA027772: AB_1846222"	"unprognostic (1.68e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.08e-3)"	"unprognostic (7.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.06e-2)"	"prognostic favorable (5.27e-4)"	"prognostic favorable (3.32e-4)"	"unprognostic (3.59e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (1.12e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.97e-2)"	8.7	0.2	0.9	11.2	0.9	0.0	1.4	0.9	0.9	4.0	1.5	0.9	0.9	2.6	2.6	0.9	1.2	0.6	1.3	1.0	0.9	0.0	0.9	0.9	16.8	14.1	0.9	0.9	0.9	0.9	0.0	0.9	33.2	0.9	1.6	2.1	1.9	0.9	0.9	2.5	0.3	5.9	0.9	2.0	6.2	2.2	0.9	0.9	0.9	7.2	0.9	8.9	2.3	0.9	0.0	4.6	77.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	2.6	0.1	0.3	0.0	36.6	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.1	0.0	4.5	0.1	77.7	0.0	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.9	0.9	0.9	0.9	0.9	0.0	0.9	0.9	0.9	0.9	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.0	2.5	2.6	0.9	0.0	0.0	6.7	0.0	0.2	0.4	0.0	0.0	0.8	0.0	0.0	0.0	8.2	1.3	0.0	6.0	0.0	4555.6	0.0	3.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.4
IER2	ETR101	ENSG00000160888	"Immediate early response 2"	Q9BTL4	19	13150415-13154908	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 120.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 57.5;U-266/84: 73.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055387, HPA060574"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055387: AB_2682802, HPA060574: AB_2684324"	"unprognostic (3.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.35e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.01e-1)"	34.1	24.4	11.5	13.4	16.1	68.2	19.1	13.3	16.8	16.4	20.3	10.1	28.7	12.6	20.3	13.0	22.3	66.8	16.4	16.2	14.1	5.9	16.8	19.9	25.4	14.0	19.2	13.7	33.9	21.6	15.1	17.0	19.9	14.9	26.4	10.0	11.6	34.4	27.1	4.2	45.6	13.7	24.1	15.3	17.1	25.3	7.0	14.2	6.7	29.0	6.7	11.9	18.3	26.4	23.8	14.3	120.1	27.5	28.4	38.4	30.3	14.0	8.4	6.6	10.0	4.4	5.9	14.6	10.9	5.9	7.5	4.4	7.1	8.5	8.3	11.1	7.9	12.7	9.5	3.0	6.3	3.8	4.9	5.7	10.9	14.3	5.9	5.4	13.7	12.2	3.0	15.7	8.1	5.1	9.2	8.8	8.7	27.5	11.2	2.9	23.0	8.2	57.5	12.6	15.2	36.4	16.0	6.7	9.9	6.8	8.3	8.2	11.8	12.2	37.7	24.7	5.4	4.4	8.3	15.8	16.0	10.9	13.2	31.4	33.1	73.6	8.6	8.6	27.4	12.3	40.5	23.4	37.6	38.4	27.5	33.1	21.3	27.0	30.7	14.3	23.8	18.1	22.7	120.1	28.4	24.7	6.5	25.3	30.3	11.5	16.1	13.3	16.8	14.1	5.9	19.2	13.7	14.9	14.2	163.8	583.5	268.0	446.3	283.3	80.9	53.2	336.3	91.0	145.6	90.7	33.4	412.8	44.7	562.1	8.3	433.3	636.2	23.3	334.1	457.3	546.3	696.8	470.7	72.3	507.9	14.3	939.8	260.9	263.5	8.1	127.8	482.9	224.4	162.3	744.6	230.0	421.9	589.0	36.4	32.7	128.3	633.8	468.1	4.5	8.9	386.1	765.7	449.7	550.7	402.2
IFIT1	"G10P1, GARG-16, IFI56, IFNAI1"	ENSG00000185745	"Interferon induced protein with tetratricopeptide repeats 1"	P09914	10	89392546-89406486	"Predicted intracellular proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 54.7;Muller glia cells: 73.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 47.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 47.8;monocytes: 13.5"	"Group enriched"	"Detected in many"	5	"BJ hTERT+ SV40 Large T+: 115.4;BJ hTERT+ SV40 Large T+ RasG12V: 113.9"									"CAB045980, HPA053890, HPA055380"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB045980: AB_11125836, HPA053890: , HPA055380: AB_2682800"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (7.96e-3)"	"unprognostic (1.35e-3)"	"unprognostic (2.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.65e-3)"	"unprognostic (1.82e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.95e-2)"	"unprognostic (9.75e-3)"	"unprognostic (6.40e-3)"	17.4	25.1	21.8	4.6	18.4	10.5	8.7	38.8	29.8	9.2	8.1	9.9	3.5	4.1	8.0	13.7	7.6	10.3	17.5	15.6	16.5	24.0	23.7	28.7	16.8	3.4	20.1	22.6	10.3	6.8	19.5	13.5	12.4	28.8	9.6	6.4	10.6	46.4	8.2	18.3	3.3	4.7	10.1	24.9	20.8	4.5	5.2	18.3	5.0	7.9	7.7	2.9	9.6	6.2	2.2	2.7	47.8	13.5	1.3	4.5	5.2	3.2	0.3	0.7	5.6	2.9	6.0	0.0	3.8	24.1	115.4	113.9	0.3	3.4	0.2	1.3	4.9	21.9	2.5	0.3	0.3	5.6	0.1	0.3	0.4	2.7	0.2	3.3	0.4	0.3	4.8	0.0	2.1	0.0	2.1	0.1	0.5	0.0	2.5	1.2	0.0	0.7	2.1	0.0	0.0	2.1	0.9	0.2	0.6	2.7	0.3	0.0	0.1	0.9	0.4	22.5	0.8	0.2	0.4	0.1	0.5	0.6	0.7	0.4	0.2	0.3	0.1	0.7	0.7	0.1	6.8	8.9	10.6	1.2	11.0	2.1	2.2	3.2	2.2	2.7	2.2	4.5	2.7	47.8	1.3	13.5	0.1	3.4	5.2	21.8	18.4	38.8	29.8	16.5	24.0	20.1	22.6	28.8	18.3	32.8	7.2	0.9	3.2	2.6	26.7	16.5	2.5	25.4	6.8	8.7	17.7	2.9	54.7	11.5	0.4	34.0	0.5	0.0	4.5	14.2	8.7	1.0	2.3	9.8	30.9	30.2	0.0	8.6	10.5	2.1	17.8	7.3	1.7	2.8	0.3	73.1	2.3	5.8	41.1	21.7	12.7	38.8	4.2	0.0	0.4	1.5	1.1	1.3	0.1	0.4
IGF2BP2	IMP-2	ENSG00000073792	"Insulin like growth factor 2 mRNA binding protein 2"	Q9Y6M1	3	185643739-185825056	"Plasma proteins, Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 43.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 118.2;Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017126, HPA035145"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB017126: , HPA035145: AB_2674491"	"unprognostic (7.49e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (2.46e-3)"	"unprognostic (8.25e-3)"	"unprognostic (4.17e-1)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (7.37e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.94e-3)"	7.9	8.9	1.0	6.4	1.9	7.6	4.9	8.6	1.6	6.5	16.4	1.6	1.5	11.3	7.6	4.8	3.7	8.3	8.1	9.9	1.7	1.4	8.0	2.6	14.0	4.0	2.8	0.7	6.7	11.3	7.6	2.9	43.0	4.5	4.9	11.6	16.9	9.0	1.6	3.2	4.3	21.4	3.3	3.7	5.8	9.9	5.1	1.5	2.4	8.6	3.2	3.3	6.2	12.5	0.0	5.5	0.9	3.3	1.3	0.0	1.2	28.3	2.4	27.8	5.2	15.2	24.0	17.0	15.0	21.2	23.3	28.0	20.4	8.0	0.0	22.3	12.6	29.9	12.9	13.0	21.8	37.9	0.0	13.4	8.1	0.1	14.1	32.5	0.2	0.0	17.5	11.6	15.5	60.3	12.2	21.4	2.1	7.9	0.0	17.0	0.2	0.0	6.8	20.3	4.8	10.3	2.9	11.0	8.5	15.1	0.1	1.7	0.2	1.1	0.0	26.7	28.8	2.2	18.9	32.4	8.1	17.7	10.1	17.2	0.1	0.0	0.0	8.0	0.0	11.3	0.9	3.0	0.5	0.0	2.8	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.2	1.3	3.3	1.0	0.0	1.2	1.0	1.9	8.6	1.6	1.7	1.4	2.8	0.7	4.5	1.5	11.9	12.3	0.0	21.8	17.5	3.2	13.6	28.1	48.2	35.2	24.4	15.7	1.7	3.3	33.9	118.2	12.2	59.3	23.3	22.6	14.2	28.3	47.6	2.3	0.0	13.3	1.6	34.2	44.2	10.5	64.7	4.9	7.4	13.5	4.6	42.1	30.6	38.8	84.6	0.4	7.6	160.2	0.0	8.6	2.8	7.0	12.8	5.3	0.0	34.5	53.7
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969099-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		150000000	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	28.0	22.2	6.8	13.5	8.1	16.7	39.4	6.4	8.2	14.9	17.3	9.5	13.0	9.4	19.6	16.0	16.7	13.1	17.9	27.9	6.7	6.2	20.6	26.6	32.6	44.7	12.3	3.6	18.0	19.6	23.5	13.6	15.5	10.0	14.1	13.3	13.9	18.2	13.5	62.0	15.9	15.4	16.5	7.6	30.2	14.4	13.8	9.0	37.9	18.5	17.3	14.1	16.3	26.9	0.4	2.9	13.3	2.0	1.0	3.6	0.9	7.7	7.0	12.4	17.4	45.2	25.0	16.8	12.2	26.3	10.1	17.4	10.6	12.2	3.2	13.7	13.4	40.7	10.4	9.3	59.5	17.0	16.8	6.6	1.4	12.2	19.1	26.7	7.4	12.1	19.8	19.1	21.0	60.6	24.4	6.5	13.9	13.8	17.4	15.8	5.7	3.4	7.4	5.5	7.1	7.5	8.0	8.5	16.3	14.2	7.8	4.1	9.1	16.5	14.8	16.5	17.8	6.2	21.0	9.8	9.8	10.3	21.0	22.3	10.3	14.4	3.3	18.9	10.1	15.1	0.1	2.0	1.1	3.6	0.8	1.4	0.3	1.2	1.7	0.3	0.4	1.0	2.4	13.3	1.0	1.4	2.9	0.7	0.9	6.8	8.1	6.4	8.2	6.7	6.2	12.3	3.6	10.0	9.0	44.7	38.9	12.8	8.9	19.7	14.1	33.2	33.1	6.7	19.4	15.7	19.6	6.2	0.0	29.2	5.3	22.4	21.3	0.0	16.6	11.0	16.7	15.0	3.5	54.4	22.3	14.3	21.5	30.7	48.2	3.6	44.0	26.4	11.8	8.2	20.6	13.6	37.4	14.4	36.0	21.7	13.9	64.7	17.0	6.5	9.6	17.2	7.8	21.8	20.1	15.6
IK	"RED, RER"	ENSG00000113141	"IK cytokine"	Q13123	5	140647058-140662479	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	9	"Ciliated cells: 931.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048798	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA048798: AB_2680525"	"unprognostic (9.90e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (2.32e-7)"	"unprognostic (1.19e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.53e-3)"	"unprognostic (3.76e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.83e-1)"	42.0	37.7	35.6	35.3	45.6	61.3	36.9	56.3	41.6	40.2	38.8	44.1	31.3	29.7	44.3	41.0	45.8	79.4	28.9	40.1	36.6	35.6	40.7	36.7	37.0	43.3	34.2	39.2	48.3	27.4	42.3	47.8	39.6	41.6	43.8	38.9	31.0	37.2	41.6	71.4	39.6	40.0	48.3	39.4	45.6	34.1	54.4	45.4	69.5	42.0	37.8	49.4	55.4	37.4	54.3	39.2	76.6	50.0	53.9	76.4	60.5	32.6	35.4	31.7	46.1	35.4	31.1	38.1	38.8	41.2	43.2	43.6	49.6	37.4	38.1	50.0	40.2	47.8	33.8	47.2	53.0	50.3	55.9	37.4	37.8	59.7	31.5	37.7	60.0	39.1	34.0	34.8	43.1	38.7	31.1	36.5	31.6	38.6	35.8	38.3	28.8	52.3	59.0	21.1	26.6	37.8	39.6	47.7	38.0	32.6	30.8	29.6	32.8	47.8	44.8	45.8	29.0	51.2	46.4	39.3	36.4	25.1	30.6	46.4	51.9	78.5	53.5	41.5	45.5	27.6	76.6	39.2	65.6	57.0	44.0	50.3	54.3	61.8	58.0	39.2	50.1	65.7	61.1	66.1	53.9	50.0	37.3	76.4	60.5	35.6	45.6	56.3	41.6	36.6	35.6	34.2	39.2	41.6	45.4	151.8	106.3	83.8	77.6	41.0	68.2	107.3	76.5	931.5	209.3	82.0	27.5	103.6	102.8	88.8	302.0	80.4	62.6	46.7	87.0	83.7	71.3	48.7	126.2	63.8	63.2	50.9	32.7	46.1	49.8	12.7	90.9	69.4	54.0	101.8	46.7	96.1	88.8	53.5	78.8	76.3	74.9	71.1	90.4	282.4	138.0	39.6	111.1	103.8	53.4	64.7
IKBIP	"FLJ31051, IKIP"	ENSG00000166130	"IKBKB interacting protein"	Q70UQ0	12	98613405-98645113	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 19.8"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 19.8"	"Cell line enhanced"	"Detected in all"		"BJ: 53.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038677, HPA038678, HPA061541"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA038677: AB_2676146, HPA038678: AB_10672723, HPA061541: AB_2684555"	"unprognostic (3.06e-1)"	"unprognostic (1.06e-3)"	"unprognostic (2.13e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (4.00e-5)"	"unprognostic (6.28e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (4.60e-9)"	"unprognostic (7.37e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.16e-2)"	21.0	8.9	3.7	12.2	4.6	3.6	13.6	1.1	4.0	17.0	12.3	1.7	6.0	3.3	9.5	10.2	8.5	7.3	11.0	23.6	4.0	3.7	17.0	25.3	16.1	14.0	4.2	1.7	12.8	5.8	4.1	12.6	22.1	6.3	12.2	6.1	3.6	7.6	6.7	10.0	3.2	6.2	13.3	5.2	30.6	5.3	5.8	3.8	15.2	19.8	6.2	7.8	15.1	26.2	3.3	3.7	19.8	4.3	3.7	2.4	1.1	3.2	10.1	11.6	7.2	27.9	29.5	10.1	53.6	32.9	14.2	18.1	2.2	3.2	10.8	9.2	32.9	9.9	7.0	4.5	20.5	24.1	3.2	6.9	4.1	6.5	15.2	10.7	7.6	8.2	22.1	4.4	16.3	14.7	26.0	19.9	2.0	6.2	4.3	34.9	3.0	3.4	17.6	4.4	2.6	8.8	3.0	16.7	5.4	23.4	3.7	1.7	5.6	15.3	1.1	8.5	20.3	3.3	9.5	18.6	30.3	10.8	13.3	13.7	4.6	4.9	8.1	9.0	7.0	21.8	6.0	4.3	12.6	2.1	3.3	2.4	3.3	1.3	2.1	3.7	2.2	1.4	1.5	19.8	3.7	3.7	2.6	1.6	1.1	3.7	4.6	1.1	4.0	4.0	3.7	4.2	1.7	6.3	3.8	11.9	17.8	22.0	12.9	6.8	3.2	2.6	0.0	5.3	21.6	3.5	3.9	28.7	10.0	9.6	1.6	38.4	1.1	0.0	5.0	49.4	34.3	6.4	19.7	8.9	40.4	3.2	0.0	32.5	25.0	2.5	28.4	36.1	13.5	21.6	3.8	2.3	5.8	2.9	15.9	8.5	2.5	38.8	19.1	30.8	14.0	6.4	8.5	20.8	1.7	4.6
IKBKG	"FIP-3, FIP3, Fip3p, IKK-gamma, IP1, IP2, NEMO, ZC2HC9"	ENSG00000269335	"Inhibitor of nuclear factor kappa B kinase subunit gamma"	Q9Y6K9	X	154541199-154565046	"Disease related genes, Predicted intracellular proteins, RAS pathway related proteins"	"DNA damage, Host-virus interaction, Transcription, Transcription regulation"		"Disease mutation, Ectodermal dysplasia, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 28.8"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 63.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000426, CAB010373"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB010373: AB_2124846, HPA000426: AB_1851572"	"unprognostic (7.53e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.09e-1)"	"unprognostic (3.37e-3)"	"unprognostic (9.77e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.18e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.57e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.78e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.36e-2)"	6.5	5.8	5.2	10.2	6.1	15.1	5.0	5.4	9.2	5.2	4.5	9.1	5.9	7.5	5.2	6.2	6.3	4.5	7.7	5.1	4.9		3.9	16.3	6.5	10.4	6.9	5.1	5.1	6.1	3.5	2.0	6.8	6.7	5.0	3.9	5.6	5.7	3.9	4.6	11.4	6.6	8.1	3.7	10.8	7.4	4.2	6.2	6.9	5.0	6.9	9.9	4.9	6.2	11.3	13.7	28.8	21.8	13.8	17.9	13.5	15.6	16.1	3.9	12.8	8.9	7.5	10.8	10.5	13.7	11.2	16.2	11.4	9.4	12.6	26.6	11.8	32.1	14.7	5.7	9.6	4.8	15.0	8.0	10.3	23.3	21.3	13.8	10.1	36.1	8.9	8.1	15.7	6.3	7.5	13.3	12.6	5.7	12.6	9.0	15.2	10.4	16.9	3.6	12.2	26.8	11.5	6.2	13.4	11.1	10.0	7.0	7.0	13.0	12.2	7.5	3.5	7.1	11.3	13.6	10.4	12.1	27.8	25.1	24.7	17.5	23.6	15.5	18.3	15.2	10.5	15.4	28.8	17.9	20.5	12.3	11.3	11.4	13.0	13.7	10.1	9.5	11.3	25.4	13.8	21.8	12.2	13.0	13.5											3.0	11.0	14.9	10.9	11.0	5.1	6.1	15.3	5.3	7.9	12.2	9.8	20.4	1.7	16.8	0.7	11.9	11.2	23.3	14.9	14.8	12.4	9.6	28.8	28.0	25.4	23.8	4.7	9.2	21.2	1.6	13.3	18.6	11.8	63.1	6.7	11.4	17.2	11.5	13.1	6.5	9.8	6.5	12.5	3.4	13.6	9.3	31.8	22.4	7.6	12.2
ILF3	"DRBP76, MPHOSPH4, MPP4, NF90, NFAR-1"	ENSG00000129351	"Interleukin enhancer binding factor 3"	Q12906	19	10654261-10692417	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001897	Supported		Enhanced	Nucleoplasm,Nucleoli,Mitochondria		No	No		1100000	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA001897: AB_1078703"	"unprognostic (2.39e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.53e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.96e-1)"	"prognostic unfavorable (1.57e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.38e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (7.57e-3)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.20e-2)"	31.0	39.0	29.6	45.5	26.8	88.2	34.5	48.3	35.2	34.2	30.2	30.8	35.2	30.3	45.4	31.7	40.5	41.9	32.5	34.0	25.5	20.0	28.1	25.6	34.1	44.9	24.7	27.8	52.8	36.8	34.9	34.9	31.8	32.3	34.9	27.3	35.5	35.1	46.2	50.1	37.7	37.2	33.2	33.3	44.5	32.6	54.3	28.0	58.6	43.4	32.4	41.1	38.5	32.1	18.7	18.7	11.5	14.3	15.4	19.4	8.0	45.7	37.3	60.4	55.2	13.1	18.0	35.2	29.3	24.9	49.2	38.6	42.7	26.6	57.2	29.1	26.3	30.1	41.0	65.2	39.6	44.4	36.5	58.0	74.2	32.9	39.8	18.8	53.4	37.1	17.0	17.7	39.0	43.8	18.8	42.0	33.4	63.3	45.0	28.6	37.7	88.5	85.8	72.5	24.2	41.0	65.2	57.5	39.5	19.6	48.6	66.7	48.5	37.7	30.0	21.8	28.6	25.4	34.3	33.7	40.4	38.4	41.8	57.7	38.6	52.8	69.4	22.6	57.1	43.5	11.5	13.4	7.1	19.4	10.4	16.1	14.7	15.9	17.3	16.8	18.7	15.7	16.0	2.1	15.4	14.3	18.7	15.0	8.0	29.6	26.8	48.3	35.2	25.5	20.0	24.7	27.8	32.3	28.0	92.3	128.4	63.8	84.3	76.5	92.4	59.0	50.9	96.4	131.9	40.1	80.5	65.6	23.2	66.6	12.8	60.9	40.0	46.7	69.0	90.4	57.8	80.9	92.6	46.1	63.0	89.0	109.3	33.7	53.5	14.4	70.8	66.0	37.1	46.9	68.0	70.5	72.3	56.1	58.7	38.2	92.6	32.3	67.0	108.6	117.8	67.2	59.3	68.2	82.6	87.0
IMMP1L	"FLJ25059, IMMP1"	ENSG00000148950	"Inner mitochondrial membrane peptidase subunit 1"	Q96LU5	11	31432401-31509645	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038372, HPA058308"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038372: AB_10669643, HPA058308: AB_2732620"	"unprognostic (2.39e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.17e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (7.97e-4)"	"unprognostic (7.59e-2)"	"unprognostic (4.66e-3)"	"unprognostic (5.15e-3)"	"prognostic favorable (6.72e-4)"	"unprognostic (1.97e-1)"	"unprognostic (1.07e-2)"	"unprognostic (4.66e-1)"	"unprognostic (4.52e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.04e-3)"	9.1	16.6	25.4	11.6	27.8	8.8	15.4	28.4	18.5	10.0	11.3	11.7	12.8	12.1	9.6	25.6	8.4	7.7	5.1	20.4	21.7	17.4	16.2	11.9	10.7	11.2	16.1	12.1	14.0	23.8	7.2	18.2	8.7	11.4	11.2	8.3	17.4	13.6	12.0	39.8	10.1	10.3	9.3	13.2	7.6	10.8	13.8	12.6	17.6	10.0	13.3	10.8	6.8	7.5	16.4	20.0	14.8	1.7	16.9	21.7	7.8	10.2	15.0	39.6	11.7	5.3	3.6	7.4	13.6	3.0	5.7	4.4	11.4	7.9	10.7	9.5	5.8	16.5	11.9	13.6	10.3	8.6	14.4	28.8	12.6	22.4	14.5	5.7	16.5	12.2	3.0	9.2	3.3	7.4	15.9	6.1	21.7	20.2	12.9	5.4	12.7	20.7	23.7	8.0	42.7	13.2	16.3	34.2	10.4	19.4	12.7	10.9	12.5	15.8	7.9	13.5	26.8	18.0	16.9	2.9	13.4	13.3	10.4	21.7	11.8	24.4	18.6	17.6	11.3	13.1	9.0	1.7	14.8	15.6	1.6	14.5	16.4	14.0	15.5	4.0	15.0	17.7	21.7	0.3	16.9	1.6	20.0	16.6	7.8	25.4	27.8	28.4	18.5	21.7	17.4	16.1	12.1	11.4	12.6	32.8	10.5	28.2	25.1	16.3	29.6	46.2	20.4	24.1	9.1	57.6	31.4	31.7	101.2	15.6	27.8	14.6	14.3	23.3	21.0	26.9	15.5	23.7	20.9	35.9	18.2	41.3	54.3	17.8	9.5	7.0	12.4	11.6	8.5	10.8	27.6	51.1	14.4	21.0	19.4	81.2	35.9	32.3	15.3	62.7	19.8	23.8	19.8	28.7	31.9	22.3
IMMT	"HMP, Mic60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195770	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		240000	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	20.0	36.9	15.6	17.0	23.5	15.3	15.4	17.5	27.1	13.6	24.8	16.0	15.4	25.1	16.5	13.6	19.1	13.9	12.3	67.3	15.1	18.0	37.5	35.1	14.3	17.7	18.4	18.8	13.3	23.1	31.4	17.6	21.6	32.2	12.8	26.3	17.3	16.7	21.2	78.6	15.4	25.6	17.9	12.1	20.0	22.0	28.3	15.0	29.1	16.2	38.3	19.9	18.0	14.1	10.9	21.5	7.6	21.6	13.2	16.1	14.4	33.9	33.5	30.4	13.9	29.6	27.3	31.1	24.4	25.6	33.0	30.1	48.1	27.0	52.0	24.5	25.8	27.2	25.3	38.9	35.2	40.5	21.0	31.7	41.1	21.2	56.9	30.1	39.6	28.2	31.2	25.7	31.1	37.2	20.8	37.2	30.1	40.0	29.6	31.9	29.2	39.4	41.4	36.2	52.1	26.7	26.3	65.1	46.8	37.7	38.5	37.0	27.5	25.0	38.1	37.2	25.1	21.6	28.1	27.9	23.7	26.2	34.3	30.2	23.6	29.8	35.7	27.0	47.3	28.7	7.5	18.6	7.6	16.1	21.6	14.6	10.9	14.4	13.3	21.5	8.8	13.1	15.5	2.5	13.2	19.9	11.1	14.9	14.4	15.6	23.5	17.5	27.1	15.1	18.0	18.4	18.8	32.2	15.0	50.6	42.2	33.5	27.5	20.7	39.1	201.3	17.8	52.2	63.7	38.4	31.4	84.0	112.7	49.3	128.3	35.3	53.1	23.3	46.0	62.7	35.8	15.4	45.2	57.1	62.8	22.3	53.9	35.6	49.3	95.4	25.6	41.4	16.9	81.2	42.6	25.5	37.2	31.7	34.6	68.6	39.4	6.5	37.2	87.7	51.5	21.8	82.4	36.6	63.4	30.8
IMP3	"BRMS2, C15orf12, FLJ10968, MRPS4"	ENSG00000177971	"IMP3, U3 small nucleolar ribonucleoprotein"	Q9NV31	15	75639085-75648706	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060955, HPA061177"			Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA060955: AB_2684397, HPA061177: AB_2684445"	"unprognostic (6.01e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.04e-2)"	"unprognostic (7.64e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.44e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.69e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.22e-2)"	21.2	28.4	21.9	23.0	24.0	18.9	34.3	20.1	28.8	19.4	31.0	15.4	17.5	27.5	14.7	24.5	35.6	20.1	25.2	21.7	21.1	19.7	28.2	49.7	21.1	28.5	17.6	19.6	23.0	29.1	12.6	17.3	16.9	16.7	23.3	19.2	17.5	28.3	25.4	37.6	29.3	31.5	11.0	15.5	28.5	25.9	12.4	13.3	33.7	30.0	37.5	27.9	19.6	21.8	40.7	34.0	23.0	31.1	33.3	47.2	48.1	20.4	23.2	11.3	19.5	20.1	11.5	16.7	17.3	13.8	14.2	16.4	17.8	18.1	24.5	18.9	9.0	15.7	34.0	37.1	28.0	12.6	18.4	44.5	25.7	19.1	30.8	14.8	26.0	17.9	10.5	23.2	11.4	14.1	10.6	9.3	20.1	33.1	20.0	12.8	24.6	20.6	63.7	30.3	20.9	24.5	22.5	13.8	26.9	19.2	27.9	19.3	19.9	14.6	25.6	31.4	17.1	22.3	24.3	10.5	18.5	14.9	13.2	23.3	27.4	50.4	27.5	20.4	42.3	12.1	18.5	31.1	23.0	42.0	23.9	45.1	40.7	40.5	40.4	33.4	38.7	47.2	44.5	4.0	33.3	23.0	34.0	38.7	48.1	21.9	24.0	20.1	28.8	21.1	19.7	17.6	19.6	16.7	13.3	35.7	34.5	89.1	67.5	203.1	22.0	11.4	66.2	52.2	52.4	38.4	13.7	88.6	122.7	81.1	1.3	74.4	52.6	23.3	93.2	83.2	66.4	58.7	46.3	101.8	81.8	20.6	42.2	68.2	45.6	4.1	56.4	60.5	92.8	116.4	61.3	53.7	92.0	59.6	41.4	158.4	20.3	25.8	71.8	14.0	43.8	207.5	45.9	74.0	84.6	70.1
IMP4	"BXDC4, MGC19606"	ENSG00000136718	"IMP4, U3 small nucleolar ribonucleoprotein"	Q96G21	2	130342225-130347810	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066222, HPA066673"			Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA066222: AB_2685638, HPA066673: AB_2685701"	"unprognostic (8.26e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.70e-3)"	"unprognostic (2.18e-3)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.10e-2)"	19.0	15.7	13.1	19.5	15.7	17.9	14.2	6.6	25.1	9.4	12.2	11.7	9.2	15.6	11.1	7.4	20.1	9.2	12.7	30.5	11.8	10.1	13.5	29.1	10.6	22.2	14.9	12.7	9.0	36.3	2.6	7.4	10.5	15.4	9.5	3.4	7.1	26.0	12.5	52.3	10.8	15.5	12.5	8.5	11.2	16.4	9.1	13.7	8.5	12.0	10.9	11.5	17.1	9.7	34.8	31.6	7.0	26.8	26.6	25.4	26.7	19.4	17.8	0.8	15.0	2.9	3.5	13.9	11.9	5.7	8.5	8.8	38.4	12.4	52.2	18.7	5.7	8.4	11.8	1.6	12.5	0.3	11.9	13.4	16.0	5.0	32.3	15.8	15.0	11.5	5.8	7.7	15.2	6.8	1.2	8.5	12.4	17.9	16.1	2.2	36.2	11.2	6.3	13.5	9.1	23.6	15.7	6.3	26.7	3.7	13.8	9.2	10.3	9.1	27.7	9.9	0.2	10.6	10.8	9.4	16.0	15.3	16.9	24.6	16.3	20.1	43.3	12.3	9.6	22.5	2.4	25.5	7.0	25.4	26.8	22.6	34.8	22.4	21.9	29.3	30.7	22.4	22.2	2.9	26.6	25.1	31.6	21.5	26.7	13.1	15.7	6.6	25.1	11.8	10.1	14.9	12.7	15.4	13.7	14.9	22.7	67.7	56.9	94.6	23.3	49.6	61.1	13.4	33.0	41.8	3.9	56.3	86.2	67.2	18.1	38.3	44.6	23.3	95.4	82.6	49.8	54.8	46.1	77.4	68.9	15.9	52.4	25.8	29.9	46.7	28.4	45.9	74.2	73.1	42.6	14.0	74.6	45.6	24.1	115.0	21.1	25.8	72.6	26.3	45.4	96.5	41.2	37.4	60.5	76.3
ING3	"Eaf4, FLJ20089, MEAF4, p47ING3"	ENSG00000071243	"Inhibitor of growth family member 3"	Q9NXR8	7	120950749-120977216	"Disease related genes, Predicted intracellular proteins"	"Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004762, HPA067388, HPA067575"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004762: , HPA067388: AB_2685831, HPA067575: AB_2685863"	"unprognostic (1.35e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.26e-2)"	"unprognostic (7.09e-3)"	"unprognostic (4.07e-2)"	"unprognostic (5.18e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.86e-1)"	"unprognostic (6.90e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.72e-1)"	"unprognostic (5.64e-2)"	9.6	9.1	7.4	8.8	9.9	57.7	9.6	21.5	13.8	9.0	9.6	5.5	11.1	7.3	11.1	9.7	8.0	9.7	7.7	7.6	7.3	7.3	8.8	8.4	12.3	11.9	7.6	12.2	11.9	12.1	7.9	17.7	13.0	11.1	9.5	10.6	6.7	10.0	11.5	7.7	6.1	12.9	11.4	8.8	16.4	10.4	8.6	9.6	19.0	12.6	10.4	11.2	8.3	8.4	15.8	15.0	32.7	19.5	18.5	16.9	9.8	9.3	2.8	12.7	7.1	4.8	3.8	4.3	6.4	5.1	9.3	10.9	3.6	10.9	15.2	2.9	5.6	9.8	4.6	12.2	5.0	10.7	10.6	21.4	11.0	10.6	2.1	6.6	21.2	13.1	2.8	2.6	8.2	5.8	4.5	14.5	9.6	24.6	24.7	8.9	3.2	17.4	12.7	15.3	5.3	5.2	8.6	9.1	12.6	9.4	9.7	11.5	12.5	6.6	13.7	6.9	8.2	3.1	8.3	5.1	9.5	3.5	20.4	11.6	11.3	7.2	22.9	4.8	14.3	7.9	22.3	19.1	16.5	13.9	19.5	13.4	14.4	14.1	12.6	15.0	15.8	14.4	13.1	32.7	18.5	19.1	11.2	16.9	9.8	7.4	9.9	21.5	13.8	7.3	7.3	7.6	12.2	11.1	9.6	17.9	13.6	22.2	20.2	6.8	20.4	12.6	7.6	13.4	7.9	7.0	3.9	33.3	18.3	10.3	4.0	18.5	17.3	23.3	15.7	21.2	19.3	14.2	33.4	11.1	15.3	25.4	11.5	19.6	26.6	3.9	12.7	19.0	15.1	15.4	14.0	17.3	12.9	14.8	9.2	9.7	17.2	19.4	22.6	15.0	13.9	9.8	38.2	21.8	12.4	13.9
INTS13	"ASUN, C12orf11, FLJ10637, Mat89Bb, NET48, SPATA30"	ENSG00000064102	"Integrator complex subunit 13"	Q9NVM9	12	26905181-26938326	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 20.8;Extravillous trophoblasts: 13.8;Hofbauer cells: 13.1;Pancreatic endocrine cells: 13.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039543, HPA040109, HPA073020"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			Nucleoplasm	"Nuclear bodies, Vesicles"	"HPA039543: AB_10795150, HPA040109: , HPA073020: "	"unprognostic (2.09e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.01e-2)"	"prognostic unfavorable (1.17e-10)"	"unprognostic (5.22e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.78e-3)"	"unprognostic (3.75e-3)"	"prognostic unfavorable (3.16e-6)"	"unprognostic (1.02e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.78e-2)"	10.0	20.9	10.5	11.5	14.7	15.3	11.5	11.4	11.4	10.5	10.0	22.3	4.6	9.0	10.6	10.4	14.1	8.1	7.5	10.2	12.3	9.8	12.6	14.3	8.0	14.1	18.8	7.4	9.2	11.9	9.3	17.6	9.2	22.4	10.1	10.4	8.9	9.4	6.6	16.9	11.4	8.5	11.6	30.2	17.9	14.1	10.9	14.1	26.6	10.7	11.6	15.1	16.9	9.6	7.4	6.8	5.1	5.4	16.4	18.7	7.1	9.4	10.5	6.4	13.6	9.2	14.8	9.1	13.2	8.0	12.5	14.2	15.7	12.6	24.0	13.9	7.3	12.4	13.6	15.6	12.4	21.3	11.0	9.6	18.7	13.0	12.9	16.5	31.7	11.6	8.1	9.6	20.4	43.4	16.6	16.2	10.6	19.8	9.5	13.7	10.9	16.6	58.3	27.8	13.0	18.9	11.7	18.7	32.1	10.7	8.7	5.1	4.9	11.6	9.2	13.3	23.2	12.5	6.9	10.6	14.9	11.0	24.9	16.0	4.9	5.6	35.1	9.9	22.0	10.4	4.2	5.4	5.1	10.5	3.7	15.5	6.8	13.1	12.9	6.8	7.4	9.4	11.5	1.8	16.4	3.2	4.6	18.7	7.1	10.5	14.7	11.4	11.4	12.3	9.8	18.8	7.4	22.4	14.1	20.8	8.5	0.0	0.0	0.0	0.0	0.0	0.0	5.3	4.5	5.2	0.0	10.1	3.3	12.3	0.0	0.0	0.0	0.0	10.4	13.8	0.0	0.0	7.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	10.0	0.0	0.0	13.3	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0
INTS6L	"DDX26B, FLJ41215"	ENSG00000165359	"Integrator complex subunit 6 like"	Q5JSJ4	X	135520643-135582510	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 11.9;Alveolar cells type 2: 7.2;Ciliated cells: 12.0;Club cells: 6.8;granulocytes: 23.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 16.5;U-937: 15.3"									"HPA001552, HPA013200, HPA013335, HPA030747"	Uncertain		Approved	"Nuclear bodies,Centrosome,Mitochondria"		NA	NA			Centrosome	"Nuclear bodies, Mitochondria"	"HPA001552: AB_1078659, HPA013200: AB_2668801, HPA013335: AB_1847553, HPA030747: AB_2673589"	"unprognostic (2.03e-1)"	"prognostic favorable (5.39e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.75e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (5.54e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.28e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.37e-2)"	"prognostic favorable (2.94e-4)"	4.2	9.8	5.5	10.6	6.7	15.4	5.4	22.6	6.1	8.4	7.8	7.4	3.8	3.6	7.8	4.6	6.4	8.6	6.6	5.9	4.8	3.2	4.4	1.7	5.6	15.6	6.8	6.2	11.5	2.9	3.7	11.5	4.5	6.5	6.5	10.0	5.3	18.2	7.9	1.5	8.3	9.3	5.4	4.9	13.3	4.5	9.7	10.4	17.8	4.6	2.8	15.0	8.6	7.5	5.5	3.6	2.2	2.7	2.7	9.0	4.0	0.1	0.0	6.2	7.2	1.8	2.1	0.0	1.5	3.2	1.8	5.6	0.6	2.6	6.2	5.3	1.3	4.5	4.6	7.0	2.0	1.4	4.6	2.5	5.2	0.5	0.0	1.6	5.3	0.4	2.8	2.0	2.1	2.1	3.2	2.3	4.1	3.3	9.8	1.3	4.5	5.2	16.5	2.9	6.4	2.6	4.3	2.2	5.0	1.5	2.5	1.0	2.3	2.1	2.1	0.2	2.8	2.2	10.0	1.3	4.8	2.7	0.0	1.7	11.3	8.9	9.2	1.6	15.3	0.9	0.0	2.5	2.2	5.1	2.2	6.1	5.5	5.8	5.9	3.6	4.9	9.0	5.8	1.6	2.7	2.7	3.5	3.1	4.0	5.5	6.7	22.6	6.1	4.8	3.2	6.8	6.2	6.5	10.4	11.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	12.0	6.8	3.5	0.0	1.5	0.0	1.1	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.0	23.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
INTS9	"CPSF2L, FLJ10871, RC-74"	ENSG00000104299	"Integrator complex subunit 9"	Q9NV88	8	28767661-28890242	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051615, HPA066822"			Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA051615: AB_2681552, HPA066822: AB_2685729"	"unprognostic (2.19e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.79e-2)"	"prognostic favorable (9.45e-4)"	"unprognostic (2.46e-1)"	"unprognostic (1.56e-3)"	"unprognostic (6.91e-3)"	"prognostic favorable (7.71e-4)"	"unprognostic (3.64e-2)"	"unprognostic (5.01e-2)"	"unprognostic (4.72e-2)"	"unprognostic (2.48e-3)"	"prognostic favorable (1.91e-5)"	"unprognostic (2.51e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-1)"	10.8	28.8	10.5	14.1	13.4	8.1	11.0	14.2	16.5	11.3	11.7	15.5	7.7	9.3	16.4	16.1	14.1	13.7	9.1	13.0	9.5	7.6	12.8	9.3	11.4	17.9	15.2	8.1	11.4	12.5	13.4	24.0	11.4	12.1	11.6	12.9	17.9	15.5	10.6	14.1	12.4	11.9	12.8	13.5	20.4	11.7	15.2	13.3	28.4	17.2	8.5	23.1	13.2	11.2	17.6	24.3	15.5	19.3	19.9	17.0	9.3	13.2	9.4	11.3	12.0	14.0	6.6	5.0	6.1	8.4	10.7	11.9	6.5	7.5	13.2	8.6	6.2	9.6	11.1	21.8	12.5	15.0	5.5	8.9	13.2	5.3	11.3	10.2	6.6	10.3	7.5	9.0	12.9	9.3	5.8	13.2	19.1	27.8	7.7	7.1	7.3	30.5	12.0	15.3	15.6	6.1	19.7	13.1	6.9	7.5	9.2	8.2	15.0	6.3	8.3	11.1	9.5	8.0	7.5	7.7	6.2	16.0	10.5	7.7	4.0	2.7	16.4	9.6	11.1	8.8	12.1	17.7	15.5	15.4	19.3	14.3	15.4	13.7	17.0	24.3	17.6	12.5	13.1	7.2	19.9	13.7	12.8	16.3	9.3	10.5	13.4	14.2	16.5	9.5	7.6	15.2	8.1	12.1	13.3	6.0	3.4	4.7	2.4	2.1	2.1	4.6	7.6	1.4	2.3	3.5	5.9	6.7	1.7	3.0	6.1	2.9	2.3	0.0	4.5	3.8	3.8	1.4	0.0	1.6	6.7	1.6	5.8	2.5	4.1	3.3	7.2	2.9	3.3	4.6	4.0	2.0	4.7	0.0	4.2	3.3	5.5	0.0	2.8	3.0	3.3	2.6	4.0	3.2	3.3	1.4
IPMK		ENSG00000151151	"Inositol polyphosphate multikinase"	Q8NFU5	10	58191517-58267934	"Enzymes, Predicted intracellular proteins"	"Lipid metabolism, Phospholipid metabolism"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 48.0;Suprabasal keratinocytes: 50.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.4"	"Group enriched"	"Detected in many"	4	"granulocytes: 6.4;monocytes: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037837, HPA057542"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037837: AB_10670166, HPA057542: AB_2683460"	"unprognostic (4.52e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.22e-3)"	"unprognostic (6.85e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.39e-3)"	"unprognostic (2.10e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (9.96e-7)"	"unprognostic (1.79e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.27e-3)"	"unprognostic (9.02e-3)"	12.2	4.1	5.4	6.8	5.6	2.8	6.7	8.7	5.6	5.9	19.4	3.5	2.1	9.5	3.2	5.6	10.8	3.8	8.6	7.4	5.2	5.5	5.3	21.3	11.0	13.8	4.9	3.3	4.8	6.0	22.5	6.1	13.8	4.3	4.4	7.5	4.8	6.4	4.4	9.8	9.0	28.1	4.9	6.0	14.1	4.4	2.9	3.8	11.7	5.9	4.9	5.9	10.4	12.3	0.7	1.0	6.4	2.1	0.4	0.9	0.4	14.7	3.8	5.6	5.4	5.5	6.5	4.9	3.9	8.4	3.4	6.8	7.6	9.5	11.8	8.0	4.6	3.2	4.6	4.7	5.2	10.8	5.4	3.6	2.9	3.8	7.2	3.3	4.6	6.7	7.1	4.7	5.7	11.5	3.8	7.2	3.5	1.9	6.1	5.9	3.7	6.2	8.9	3.5	6.0	3.6	0.4	12.1	5.5	6.2	3.8	3.9	6.8	5.1	13.6	3.9	9.6	11.3	5.6	6.2	3.7	7.1	7.7	4.9	13.1	7.7	9.4	6.9	4.9	1.4	2.3	1.5	3.3	0.4	1.6	0.4	0.7	0.4	0.2	1.0	0.4	0.9	0.3	6.4	0.4	2.1	0.4	0.1	0.4	5.4	5.6	8.7	5.6	5.2	5.5	4.9	3.3	4.3	3.8	6.0	3.4	9.7	9.1	48.0	9.1	2.4	5.1	17.4	7.9	1.8	5.9	8.5	3.3	3.2	1.9	3.2	22.2	0.0	4.2	17.8	16.0	7.8	6.9	11.4	9.0	12.7	8.1	8.6	27.1	1.0	2.6	17.3	25.3	1.0	11.7	3.7	6.2	16.4	1.8	7.3	5.4	6.5	12.2	9.8	4.3	50.7	7.9	4.3	9.0	14.3
IRF2		ENSG00000168310	"Interferon regulatory factor 2"	P14316	4	184387713-184474580	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 173.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 50.9;Karpas-707: 53.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030813, CAB032306, HPA057327"	Supported		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB032306: AB_2249157, HPA030813: AB_10600718, HPA057327: AB_2683410"	"prognostic favorable (6.95e-5)"	"unprognostic (1.69e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.48e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.90e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.87e-3)"	"unprognostic (8.55e-3)"	"unprognostic (5.25e-2)"	"prognostic favorable (8.34e-5)"	"unprognostic (1.31e-3)"	27.5	30.6	15.2	31.0	19.3	11.3	21.0	21.5	16.4	21.5	23.7	28.8	16.6	21.2	19.8	16.5	20.5	18.1	17.3	16.1	15.3	12.1	15.3	26.1	24.0	38.7	22.8	9.7	28.0	14.9	12.4	24.5	19.7	17.8	20.5	20.4	16.8	22.1	16.1	21.9	18.1	27.7	21.2	22.4	39.4	21.3	8.4	22.0	36.1	24.0	12.6	34.5	28.8	26.4	22.2	16.2	83.9	27.5	18.1	21.9	17.2	6.1	4.5	5.6	3.7	12.3	12.7	3.3	4.5	14.2	11.1	11.7	1.3	11.9	3.8	2.4	6.7	9.1	5.7	3.8	8.6	7.2	50.9	2.1	10.5	2.5	8.2	12.2	6.4	8.9	13.6	7.9	6.3	16.5	9.6	8.4	4.6	2.0	53.1	4.6	4.3	12.3	7.8	1.2	5.6	3.3	16.2	2.1	16.9	8.5	9.5	2.4	3.7	6.4	5.3	9.3	2.4	4.1	5.8	6.9	3.2	3.5	3.6	3.9	15.2	12.1	3.3	6.7	6.3	5.6	17.7	19.4	34.5	16.4	25.3	16.9	21.2	16.3	17.6	16.2	22.2	17.5	17.3	83.9	18.1	27.5	4.1	21.9	17.2	15.2	19.3	21.5	16.4	15.3	12.1	22.8	9.7	17.8	22.0	35.7	23.2	51.9	43.4	43.6	11.8	19.6	28.1	64.3	26.1	24.4	5.9	27.6	31.5	24.5	0.1	35.9	32.5	23.3	26.4	13.4	30.4	57.1	26.5	32.6	42.8	19.1	29.4	37.4	73.6	1.3	34.5	47.6	18.6	173.1	25.9	25.5	27.3	37.4	49.8	23.7	7.8	38.8	24.7	0.2	1.1	38.9	22.3	58.6	20.9	59.3
IRF2BP2	IRF-2BP2	ENSG00000168264	"Interferon regulatory factor 2 binding protein 2"	Q7Z5L9	1	234604269-234609525	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Urothelial cells: 396.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 75.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027815, HPA062269"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027815: AB_10609994, HPA062269: AB_2684732"	"unprognostic (1.15e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.90e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.97e-2)"	"unprognostic (8.77e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.14e-1)"	"unprognostic (3.77e-1)"	17.9	14.5	11.3	21.1	12.9	48.0	29.9	16.5	17.6	19.8	19.3	13.8	10.9	13.9	20.3	13.1	17.3	17.1	31.6	19.6	12.7	11.5	12.3	20.4	35.0	30.3	11.1	10.6	25.3	22.6	15.9	10.8	11.1	13.9	18.5	18.1	16.8	19.6	12.9	18.8	25.2	20.0	11.6	15.0	16.2	17.0	23.9	11.3	28.6	21.1	14.6	19.5	17.4	19.4	4.0	17.4	8.9	4.5	2.8	5.1	2.3	7.5	11.7	8.4	12.9	17.7	14.1	10.1	6.1	5.2	3.7	4.1	6.7	9.4	0.0	14.4	5.8	12.3	10.5	4.5	8.0	5.7	12.4	10.6	7.3	9.2	19.8	14.4	26.9	25.7	16.5	18.6	8.1	15.3	21.0	9.1	6.9	6.3	15.6	9.3	2.2	6.8	28.7	7.6	17.8	4.5	13.4	3.9	17.9	7.0	6.3	16.9	11.9	9.8	13.1	19.1	8.7	12.6	75.3	10.2	13.1	5.5	9.7	11.4	34.7	9.0	2.5	6.5	24.6	17.7	8.9	4.5	7.6	4.1	3.4	4.2	4.0	5.0	4.8	4.5	3.9	5.1	4.3	2.3	2.8	1.8	17.4	3.7	2.3	11.3	12.9	16.5	17.6	12.7	11.5	11.1	10.6	13.9	11.3	125.0	159.6	51.3	373.3	289.5	29.7	48.7	129.9	73.6	138.8	48.8	9.8	34.2	11.6	50.2	20.2	107.9	65.6	70.0	43.0	37.5	72.0	119.8	103.0	148.0	75.7	55.6	139.8	102.5	119.4	18.0	64.5	110.8	104.6	13.6	101.3	95.4	59.9	66.6	76.4	35.8	18.6	77.6	123.6	20.5	17.0	346.3	66.4	45.8	141.3	396.8
IRF2BPL	"C14orf4, EAP1, KIAA1865"	ENSG00000119669	"Interferon regulatory factor 2 binding protein like"	Q9H1B7	14	77024543-77028699	"Plasma proteins, Predicted intracellular proteins"		Transferase	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050862, HPA061333"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA050862: AB_2681258, HPA061333: AB_2684481"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (8.78e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.51e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	24.2	21.6	12.7	13.7	13.0	7.9	24.4	20.3	17.9	21.0	21.0	9.8	18.2	11.0	19.3	13.3	16.3	26.3	23.4	21.3	12.9	12.3	19.7	16.3	15.6	12.7	13.8	7.4	36.9	18.2	35.8	17.2	13.7	15.7	20.2	6.0	19.7	26.2	20.2	15.9	17.0	11.1	18.4	13.5	18.4	13.9	15.3	13.4	27.4	27.6	7.1	9.8	21.8	24.6	2.1	12.2	9.9	2.4	6.5	3.4	0.7	6.8	6.0	14.9	16.7	4.5	4.2	21.3	7.2	5.9	2.0	2.7	2.8	11.3	2.4	5.3	6.1	5.8	10.7	2.5	5.3	1.7	11.4	8.8	3.0	5.9	3.8	5.9	0.8	13.8	5.6	4.2	3.6	3.2	16.3	2.7	5.0	4.5	27.4	2.6	18.7	9.2	6.4	6.7	2.9	31.3	1.9	4.2	5.6	7.1	10.1	11.6	16.8	10.2	10.7	17.8	4.2	7.4	1.5	4.7	9.5	9.3	3.1	4.6	10.6	11.3	4.1	14.7	2.1	11.8	1.5	1.6	1.4	3.4	2.2	3.2	1.7	3.0	3.1	1.4	2.1	2.5	2.6	9.9	6.5	2.4	12.2	2.9	0.7	12.7	13.0	20.3	14.1	12.9	12.3	13.8	7.4	15.7	13.4	20.8	14.7	25.3	28.2	65.5	56.8	14.7	38.2	8.1	9.1	61.1	27.5	17.1	31.5	19.5	1.2	24.8	5.6	0.0	16.4	44.6	44.5	25.7	25.5	42.3	28.3	9.5	45.8	48.5	47.9	2.7	27.9	17.0	33.7	0.0	13.5	45.5	16.0	3.5	32.2	19.3	10.0	38.8	33.3	1.7	28.8	44.3	38.4	25.5	11.9	17.6
IRF6	"LPS, OFC6, VWS, VWS1"	ENSG00000117595	"Interferon regulatory factor 6"	O14896	1	209785623-209806175	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 344.0;Suprabasal keratinocytes: 482.8;Urothelial cells: 297.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebellum: 8.6;pons and medulla: 4.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 16.4;HaCaT: 59.6;HBEC3-KT: 21.8;hTCEpi: 48.0;hTERT-HME1: 24.0;RT4: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA063121, HPA076162"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA063121: AB_2684942, HPA076162: AB_2686780"	"unprognostic (2.59e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (2.70e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.42e-2)"	1.0	6.3	1.1	4.1	1.0	0.3	13.3	8.6	0.9	11.7	12.9	1.0	38.6	9.2	3.9	31.4	63.7	7.6	17.5	10.3	1.1	0.8	12.9	18.4	8.8	0.3	0.9	0.7	3.9	13.9	10.3	6.8	26.7	4.4	21.8	11.3	1.5	24.8	34.6	0.6	45.6	20.3	3.1	1.1	1.2	9.5	4.3	0.3	13.0	22.1	32.3	33.8	15.0	19.1	0.9	0.5	2.0	1.0	0.6	2.8	0.7	16.4	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.1	0.0	0.0	3.4	5.8	0.0	0.0	0.0	0.0	59.6	0.0	21.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	24.0	0.0	0.9	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.3	4.6	0.0	0.0	0.0	0.0	2.1	21.3	5.3	1.7	0.4	9.5	0.5	1.1	6.8	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.2	0.1	2.0	2.8	1.0	1.9	0.6	0.6	0.9	0.5	0.9	2.1	1.1	0.1	0.6	0.1	0.2	0.0	0.7	1.1	1.0	8.6	0.9	1.1	0.8	0.9	0.7	4.4	0.3	14.9	7.2	0.8	177.1	344.0	0.0	23.2	40.8	46.8	50.0	33.2	0.0	79.7	23.2	31.5	0.9	4.3	54.6	0.0	16.8	20.9	7.3	126.3	2.3	30.2	7.1	0.0	57.5	1.3	1.2	0.0	0.6	2.3	33.7	1.8	54.2	5.2	36.6	51.8	0.0	10.3	0.4	0.0	10.3	9.0	3.6	482.8	135.1	0.0	36.4	297.3
IRF8	"ICSBP, ICSBP1, IRF-8"	ENSG00000140968	"Interferon regulatory factor 8"	Q02556	16	85898803-85922609	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 197.4;lymphoid tissue: 64.4"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 159.1;Hofbauer cells: 61.3;Kupffer cells: 76.1;Macrophages: 82.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 197.4"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 197.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 35.6;THP-1: 60.1;U-698: 140.9;U-937: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002267, HPA002531, CAB013480"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013480: AB_2533439, HPA002267: AB_1079143, HPA002531: AB_1851904"	"unprognostic (2.09e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.19e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.31e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.97e-2)"	"unprognostic (9.66e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.10e-2)"	12.4	4.0	6.8	36.1	8.8	19.2	6.7	2.6	5.3	2.3	7.8	8.3	6.8	12.3	2.3	3.0	3.7	2.9	5.6	2.9	5.8	3.3	5.6	9.9	11.7	60.4	9.3	3.1	2.1	3.1	0.2	2.2	2.7	6.7	3.3	10.0	2.2	6.1	8.9	1.5	2.6	36.4	3.6	10.9	64.4	6.5	2.2	8.8	18.4	3.6	2.3	63.3	8.3	2.1	31.8	197.4	0.7	10.8	8.9	0.3	9.8	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	3.8	0.0	35.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	3.2	0.0	1.1	0.1	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	60.1	0.0	0.0	1.6	0.0	0.1	0.0	0.0	140.9	0.0	19.9	0.0	0.5	10.7	0.2	0.2	10.8	0.3	29.3	0.1	0.1	23.7	31.8	0.3	0.2	0.7	8.9	7.2	197.4	0.0	9.8	6.8	8.8	2.6	5.3	5.8	3.3	9.3	3.1	6.7	8.8	0.0	6.2	159.1	1.1	9.3	0.0	1.2	2.5	0.0	2.3	0.0	0.0	0.5	1.7	0.4	1.4	3.9	16.1	0.0	1.2	4.7	6.4	0.9	2.3	5.6	61.3	0.0	27.5	3.1	76.1	3.7	0.3	82.3	42.2	7.2	5.8	0.4	0.2	11.9	0.0	2.2	0.0	6.5	4.4	0.5	5.5	8.2	0.9	13.8	19.3	2.5
ISY1	"fSAP33, KIAA1160"	ENSG00000240682	"ISY1 splicing factor homolog"	Q9ULR0	3	129127415-129161293	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA006312, HPA016995"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (2.20e-2)"	"prognostic favorable (2.46e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (4.08e-1)"	"unprognostic (5.94e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.34e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.49e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.54e-2)"	20.7	17.1	16.4	21.8	18.1	43.4	22.2	21.8	19.5	18.8	22.5	13.9	15.9	15.2	25.0	20.0	25.2	16.9	17.7	20.9	16.0	13.2	15.6	13.6	16.8	28.3	14.8	15.9	22.5	24.1	12.3	15.3	21.6	12.6	15.6	17.4	14.4	17.4	18.1	31.6	22.8	17.6	22.1	13.7	21.8	17.5	15.4	16.7	25.5	17.0	20.4	28.2	20.7	31.3	28.7	32.3	46.9	30.0	41.6	36.1	26.7	18.9	7.3	10.9	15.2	13.3	13.9	12.7	14.2	12.9	17.2	16.6	14.5	14.3	23.9	15.4	11.7	14.9	16.3	20.5	11.5	24.3	22.9	9.4	27.7	12.5	11.6	12.3	42.4	19.8	8.7	8.1	15.0	23.3	10.7	13.6	15.7	19.8	12.3	9.2	19.1	25.7	23.7	11.9	20.0	11.4	22.8	24.8	16.8	6.4	12.1	17.4	13.1	26.2	5.8	14.9	6.2	11.1	35.3	16.3	12.5	12.5	18.4	14.8	15.0	8.9	47.3	11.5	24.6	14.2	35.7	30.0	46.8	30.3	28.5	33.7	28.7	30.9	32.0	32.3	26.8	34.3	30.8	46.9	41.6	24.3	28.1	36.1	26.7	16.4	18.1	21.8	19.5	16.0	13.2	14.8	15.9	12.6	16.7	23.8	16.0	20.8	15.0	24.4	17.9	16.6	15.3	14.7	22.7	8.7	21.6	38.3	19.9	22.1	1.5	22.6	14.7	0.0	24.6	33.6	22.0	14.5	43.9	11.1	30.7	19.1	8.6	22.7	21.5	1.1	15.0	25.9	10.1	56.9	15.9	19.9	19.9	14.0	15.2	18.3	17.0	19.4	16.8	24.6	30.6	31.2	38.3	35.2	18.4	14.9
ISY1-RAB43		ENSG00000261796	"ISY1-RAB43 readthrough"		3	129087575-129161036	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	17	"Ciliated cells: 1.4;Club cells: 1.2;granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA006312, HPA016995"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA006312: AB_1079734, HPA016995: AB_1852387"	"unprognostic (1.09e-1)"	"unprognostic (5.42e-2)"			"unprognostic (1.52e-1)"	"unprognostic (9.05e-3)"		"unprognostic (2.81e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-1)"		"unprognostic (5.67e-2)"	"unprognostic (1.87e-1)"	14.4	15.8	11.8	17.9	13.1	11.9	16.2	15.9	14.2	15.0	14.7	9.9	11.5	7.9	17.8	14.6	11.7	12.9	12.8	11.5	11.6	7.7	15.9	22.5	19.1	17.0	10.6	11.5	19.1	17.6	17.7	13.3	13.0	9.0	15.3	14.4	10.3	13.7	17.2	18.2	10.6	13.3	16.1	9.2	20.4	13.1	11.1	12.0	18.6	17.1	14.8	16.8	12.6	23.0	0.6	0.7	2.3	1.8	2.1	3.3	1.9	15.5	3.5	8.0	7.4	10.2	6.0	3.6	7.5	17.6	12.1	15.0	1.8	8.1	0.5	11.0	13.5	13.9	6.0	3.1	12.6	7.6	5.9	1.1	1.4	1.5	6.2	17.6	6.4	8.0	13.9	6.8	7.6	4.9	12.2	15.7	14.7	2.5	6.1	10.5	6.5	9.6	4.7	5.5	16.8	4.2	8.2	3.5	5.4	13.2	6.0	0.6	3.6	3.5	8.1	11.2	7.0	4.0	6.1	12.7	6.0	5.0	8.4	3.4	8.9	4.1	2.7	6.8	0.7	8.2	0.4	1.8	0.5	2.4	0.9	2.6	0.2	2.2	3.0	0.7	0.6	3.3	2.5	2.3	2.1	1.6	0.6	1.8	1.9	11.8	13.1	15.9	14.2	11.6	7.7	10.6	11.5	9.0	12.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ITCH	AIP4	ENSG00000078747	"Itchy E3 ubiquitin protein ligase"	Q96J02	20	34363235-34511393	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Host-virus interaction, Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021126, HPA049032, CAB072824, CAB072825"	Supported		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"CAB072824: , CAB072825: , HPA021126: AB_1851941, HPA049032: AB_2680607"	"unprognostic (2.51e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.89e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.21e-1)"	20.7	16.7	18.9	15.4	26.9	20.5	17.5	19.8	26.7	23.9	18.2	37.9	15.2	16.9	18.4	15.1	35.9	14.5	14.5	17.9	20.4	15.9	21.1	46.5	18.5	16.8	29.2	16.5	19.3	17.1	21.6	26.3	26.9	29.0	17.5	20.4	16.7	20.1	18.4	24.0	19.2	20.3	19.8	30.4	17.3	17.3	34.8	32.3	22.3	22.7	13.0	23.6	19.6	21.0	7.3	11.4	19.6	6.2	6.2	11.4	2.7	20.2	13.4	13.7	9.8	15.1	21.6	16.4	16.5	18.9	20.7	20.2	37.6	31.3	9.9	16.0	21.0	28.2	25.7	20.8	33.3	25.2	7.4	6.7	28.8	11.4	22.5	15.8	11.8	13.0	11.0	17.0	17.4	27.4	18.7	15.5	14.4	16.3	17.2	16.1	10.1	17.2	6.2	6.6	12.5	15.9	14.5	28.9	22.9	12.3	35.3	8.4	6.1	30.8	12.1	18.5	14.1	14.5	10.7	15.0	24.7	14.8	16.1	12.2	13.7	14.3	14.5	15.3	7.6	14.4	3.6	5.8	6.1	10.8	6.2	11.4	7.3	3.8	5.7	4.5	6.9	3.3	4.9	19.6	6.2	3.8	11.4	4.8	2.7	18.9	26.9	19.8	26.7	20.4	15.9	29.2	16.5	29.0	32.3	11.9	17.9	13.3	15.9	13.4	19.6	20.1	7.6	28.1	33.0	29.6	23.6	15.1	5.0	11.7	46.0	17.5	21.6	0.0	14.1	17.6	16.0	23.0	18.5	43.1	14.0	14.3	11.5	16.5	22.8	102.3	20.8	21.2	25.3	23.4	15.8	34.3	16.6	21.0	14.5	18.0	26.8	12.9	17.8	25.7	21.5	14.2	39.2	20.6	9.9	38.9
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48233158-48270357	"Disease related genes, Predicted membrane proteins"			"Amyloidosis, Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 346.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 236.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 236.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 109.5;RPTEC TERT1: 155.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		2600000	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	89.3	79.6	60.6	41.3	61.6	25.0	79.6	87.2	65.8	72.6	58.3	64.9	93.4	83.4	61.2	346.2	71.5	53.2	59.4	86.9	75.9	61.4	198.7	65.1	80.2	75.9	71.7	49.8	100.7	48.5	27.0	63.1	132.0	50.2	66.5	36.0	80.8	75.1	99.8	30.9	73.5	81.0	53.1	90.0	78.5	64.5	44.7	48.3	35.0	73.1	63.0	47.7	63.3	74.5	13.3	23.3	236.4	46.6	17.2	31.7	73.7	8.6	7.6	12.8	23.9	48.8	29.7	19.0	23.0	29.2	11.6	14.7	5.4	41.8	2.3	19.6	16.8	9.2	35.6	6.9	16.7	9.8	6.8	16.2	16.5	6.2	14.7	21.0	16.2	109.5	17.8	14.9	6.8	7.5	58.9	14.9	11.6	4.2	20.1	14.1	5.9	26.1	35.8	35.0	25.1	10.3	11.8	12.7	11.8	155.7	41.2	4.4	17.2	20.4	16.8	11.9	44.8	10.9	17.3	24.0	9.7	9.7	12.5	11.2	7.8	7.3	0.3	14.1	9.4	21.6	136.9	46.6	141.3	21.3	35.7	28.1	12.0	29.8	26.5	23.3	13.3	31.7	26.5	236.4	17.2	35.5	10.3	28.7	73.7	60.6	61.6	87.2	58.0	75.9	61.4	71.7	49.8	50.2	48.3	646.2	271.8	308.5	1451.5	766.1	652.6	328.8	715.9	234.2	337.8	1889.5	176.7	1011.0	462.6	652.8	18.2	997.4	807.3	186.9	609.1	1937.1	842.6	824.8	565.6	490.5	1723.2	333.7	272.1	1299.4	1392.0	32.7	1728.8	1023.4	646.2	1577.2	438.3	1662.7	462.4	719.8	1890.9	2151.3	195.5	1203.0	551.5	116.1	261.4	1004.9	1230.6	638.1	376.8	1464.7
IWS1	"DKFZp761G0123, FLJ10006, FLJ14655, FLJ32319"	ENSG00000163166	"IWS1, SUPT6H interacting protein"	Q96ST2	2	127436207-127526886	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035719, HPA061866"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035719: AB_10669527, HPA061866: AB_2684628"	"unprognostic (3.11e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.32e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.10e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.81e-2)"	18.6	16.5	21.7	24.5	30.8	25.4	22.9	32.7	25.3	19.6	18.6	23.6	19.1	21.2	21.7	23.1	19.6	18.3	17.8	30.8	24.3	21.4	18.9	27.0	19.1	24.2	32.4	21.8	16.7	18.8	26.8	30.6	35.6	24.9	21.1	22.6	13.4	19.9	19.1	40.5	17.2	20.1	21.0	27.9	23.4	18.4	20.3	32.3	31.4	18.8	24.8	25.2	19.1	23.0	15.7	13.6	18.3	16.4	15.0	13.2	9.2	21.9	15.0	30.3	19.7	23.3	19.4	31.7	32.1	22.0	29.9	25.2	35.0	16.9	20.7	17.0	25.6	22.8	18.1	29.0	25.1	35.7	21.4	19.7	29.0	21.7	38.8	27.4	32.6	24.1	19.0	19.3	31.6	28.6	15.9	25.4	26.1	30.5	16.4	28.3	20.4	32.2	26.7	40.5	18.3	20.2	29.2	23.8	19.0	30.0	26.8	23.7	15.4	23.0	28.9	25.3	34.2	12.9	22.8	28.9	29.7	22.5	17.9	18.8	12.7	13.9	28.2	16.5	23.2	19.6	3.8	13.8	18.3	11.2	14.9	13.2	12.0	12.5	13.0	13.6	15.7	11.8	12.3	14.5	15.0	16.4	12.2	11.1	9.2	21.7	30.8	32.7	25.3	24.3	21.4	32.4	21.8	24.9	32.3	104.2	66.6	34.3	45.4	14.0	26.6	62.9	25.5	52.2	72.8	15.7	25.5	33.4	16.6	32.9	6.5	24.3	27.5	0.0	22.1	44.1	25.5	45.0	39.5	22.2	23.7	20.6	27.0	20.3	16.5	6.2	36.2	28.8	10.1	35.1	19.7	28.4	33.6	21.5	29.7	17.7	43.7	32.3	38.3	56.6	54.1	14.9	77.6	32.4	22.5	80.0
JADE2	"JADE-2, KIAA0239, PHF15"	ENSG00000043143	"Jade family PHD finger 2"	Q9NQC1	5	134524312-134583230	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025959, HPA055789"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA025959: AB_1855289, HPA055789: AB_2682922"	"unprognostic (8.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.69e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (4.42e-4)"	"unprognostic (1.58e-2)"	"unprognostic (3.49e-2)"	"prognostic favorable (5.36e-6)"	"unprognostic (3.73e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.87e-2)"	15.6	19.8	16.7	16.1	22.0	9.7	13.9	22.8	21.7	16.0	13.4	15.3	9.2	12.7	13.9	8.4	11.8	20.6	13.2	13.4	17.8	14.5	14.8	4.7	15.0	25.8	30.8	16.0	28.4	14.0	30.9	14.4	8.5	20.1	12.8	8.2	16.4	15.0	16.9	12.0	11.5	17.8	13.0	16.8	22.9	12.9	8.1	30.8	13.0	20.6	6.0	19.2	20.0	22.7	7.3	2.0	6.8	3.0	3.1	6.2	2.4	28.7	20.5	0.6	0.8	7.2	8.7	9.4	5.2	13.7	9.6	11.3	15.6	22.4	31.7	11.6	6.7	9.7	6.1	3.6	27.5	4.8	19.1	1.4	7.4	14.3	4.2	7.2	8.1	1.1	5.8	13.3	11.7	14.8	7.6	7.2	9.5	4.6	11.9	5.8	10.3	14.0	7.3	6.8	8.8	10.7	12.6	0.6	12.4	9.0	8.0	4.4	2.9	12.8	0.4	18.4	5.8	5.6	10.1	10.1	6.8	6.1	19.1	12.9	5.5	23.0	29.3	10.5	14.6	9.5	6.8	1.2	4.4	6.2	1.1	6.0	7.3	5.7	5.6	2.0	5.5	5.6	5.6	1.3	3.1	3.0	1.2	5.8	2.4	16.7	22.0	22.8	21.7	17.8	14.5	30.8	16.0	20.1	30.8	8.9	9.1	20.8	6.1	3.8	21.4	10.1	10.2	6.7	4.5	7.0	33.4	6.4	6.6	4.6	0.2	9.2	8.4	0.0	14.6	8.4	8.1	4.3	2.3	3.0	4.0	9.5	11.1	15.4	30.1	0.0	19.0	8.0	1.7	22.6	9.7	6.0	8.8	3.5	18.0	9.1	21.8	0.0	10.8	0.2	1.5	3.1	6.1	20.2	11.9	3.4
JAM3	"JAM-C, JAMC"	ENSG00000166086	"Junctional adhesion molecule 3"	Q9BX67	11	134068925-134152001	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Angiogenesis, Cell adhesion, Differentiation, Spermatogenesis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 77.0"	"Cell type enhanced"	"Detected in many"	7	"Peritubular cells: 60.5;Rod photoreceptor cells: 71.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 8.2"	"Group enriched"	"Detected in many"	7	"B-cells: 8.2;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"RH-30: 38.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003417, HPA050434"	Approved		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA		570000	"Golgi apparatus"		"HPA003417: AB_1851981, HPA050434: AB_2681126"	"unprognostic (1.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.23e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.68e-4)"	14.0	14.9	17.6	7.9	34.1	2.2	9.9	7.0	28.7	15.5	23.4	77.0	6.9	5.9	25.0	12.9	16.3	11.9	17.8	21.4	26.1	16.9	6.7	3.0	13.7	6.2	40.3	17.4	32.0	4.4	14.5	19.5	68.8	29.6	26.2	9.7	17.5	9.4	32.5	4.1	9.1	11.7	29.7	34.8	8.7	12.0	24.8	34.1	5.1	7.6	4.6	5.6	22.7	22.6	8.2	0.2	0.8	0.1	0.1	4.0	2.9	0.2	0.4	28.4	14.6	26.5	19.7	23.8	12.1	14.3	4.5	4.5	0.4	0.2	0.3	12.5	15.7	18.3	0.4	20.4	0.2	8.6	0.2	10.2	0.8	0.1	1.8	7.9	0.5	12.6	13.4	0.0	3.2	2.9	11.4	29.5	13.2	0.3	0.2	19.5	0.3	8.7	1.0	6.7	0.3	1.2	0.2	38.8	0.2	0.2	0.1	19.1	10.7	0.2	0.3	0.4	12.6	0.3	0.3	0.2	8.5	6.2	13.3	8.2	0.1	0.1	0.2	9.4	1.2	16.2	0.4	0.1	0.3	2.2	0.0	2.6	8.2	2.8	1.6	0.2	4.8	4.0	2.6	0.8	0.1	0.0	0.2	0.1	2.9	17.6	34.1	7.0	28.7	26.1	16.9	40.3	17.4	29.6	34.1	0.0	8.9	6.9	5.7	4.5	16.1	14.9	0.0	2.7	1.2	5.2	7.9	4.8	1.7	0.4	1.9	26.3	0.0	0.0	0.2	40.4	29.1	1.6	1.1	0.0	6.8	7.9	0.0	16.0	0.8	3.6	39.7	0.9	16.9	0.0	0.0	18.1	0.3	0.0	60.5	0.0	71.5	25.8	29.8	12.5	19.0	3.3	5.1	0.7	0.0	0.7
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321328	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 97.2"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 35.7;Basal glandular cells: 27.1;Cardiomyocytes: 31.6;Glandular cells: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1;OE19: 12.1;SK-BR-3: 24.2;T-47d: 17.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	1.7	0.6	1.8	0.7	5.7	0.5	0.8	13.7	3.1	0.8	1.9	0.8	0.4	0.8	1.5	1.7	1.8	0.6	0.6	3.3	2.1	0.7	0.8	0.5	2.2	0.5	1.0	4.2	0.5	3.5	1.1	0.4	1.1	2.4	1.8	2.8	0.0	1.3	0.8	97.2	0.7	0.9	1.4	2.4	0.5	0.9	0.9	2.3	2.4	1.2	21.5	1.4	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.4	0.1	3.1	0.0	1.0	0.0	0.7	4.5	3.9	3.1	1.0	0.0	5.9	0.0	3.6	0.0	0.5	2.0	0.2	0.6	2.6	0.0	2.9	0.0	0.0	7.8	0.5	0.0	0.2	2.8	10.1	0.0	6.8	12.1	2.0	5.1	3.9	0.0	0.1	9.0	5.2	0.7	0.0	24.2	1.2	1.2	17.2	0.1	0.0	1.2	1.7	0.4	1.0	0.0	0.0	0.0	2.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	5.7	13.7	3.1	2.1	0.7	1.0	4.2	2.4	2.3	35.7	8.0	0.0	27.1	2.5	0.0	31.6	0.0	8.1	15.9	1.8	5.9	0.0	0.0	0.2	2.1	0.4	1.3	0.0	1.2	0.0	2.1	24.9	0.0	0.0	0.1	0.0	12.1	0.0	0.0	0.4	0.9	0.2	1.7	0.0	10.1	0.2	3.4	8.0	0.0	0.7	0.0	0.0	2.3	0.1	3.6	1.8	0.0	0.0	5.6	16.6
JPT2	"C16orf34, FLJ13092, HN1L, KIAA1426, L11"	ENSG00000206053	"Jupiter microtubule associated homolog 2"	Q9H910	16	1678256-1702280	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 82.6;Ductal cells: 81.9;Extravillous trophoblasts: 170.9;Syncytiotrophoblasts: 141.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"							"HPA041888, HPA041908"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA041888: AB_10793937, HPA041908: AB_10794160"	"unprognostic (1.49e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.30e-3)"	"prognostic favorable (7.85e-4)"	"unprognostic (3.60e-1)"	"unprognostic (2.37e-2)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.22e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.78e-2)"	10.6	11.3	6.7	10.4	24.3	4.9	19.9	11.1	12.3	22.5	16.7	24.1	12.6	11.3	11.5	11.1	28.6	34.4	12.4	10.1	10.5	8.7	18.5	37.3	12.0	11.7	33.8	6.2	12.3	31.0	13.2	10.1	33.6	37.7	26.3	16.5	6.8	15.7	12.7	12.8	16.2	12.8	12.4	72.4	8.7	14.8	14.1	17.3	20.3	16.1	15.7	16.8	16.9	16.8	9.7	8.2	4.7	4.6	7.5	10.0	5.4	31.6	32.6	37.8	21.0	5.5	9.2	34.3	31.6	10.0	26.7	22.8	42.4	41.7	20.6	24.4	15.6	26.3	31.3	49.8	42.9	30.7	16.5	30.0	16.9	18.7	24.1	8.4	19.9	10.1	6.4	27.2	26.2	34.1	14.8	16.8	18.8	39.7	8.3	15.4	36.7	24.8	9.9	41.5	35.7	24.8	45.7	35.8	29.7	41.6	18.0	35.3	19.5	47.5	46.1	14.4	38.0	55.8	12.8	19.4	26.0	45.7	12.3	30.7	7.1	28.3	42.9	8.1	15.5	37.8	2.6	4.6	4.7	7.1	4.1	10.0	6.3	7.8	5.6	3.6	9.7	8.5	7.1	0.4	7.5	2.0	8.2	7.0	5.4	6.7	24.3	11.1	12.3	10.5	8.7	33.8	6.2	37.7	17.3	23.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	49.5	22.7	8.7	0.0	82.6	36.5	81.9	0.0	0.0	0.0	0.0	22.2	170.9	0.0	0.0	2.3	0.0	35.7	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	49.5	0.0	0.0	59.7	0.0	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	141.1	0.0	0.0	0.0
JUN	"AP-1, c-Jun"	ENSG00000177606	"Jun proto-oncogene, AP-1 transcription factor subunit"	P05412	1	58780788-58784327	"Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 71.6"	"Low region specificity"	"Detected in all"							"CAB003801, CAB007780, HPA031174, HPA059474"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB003801: AB_365485, CAB007780: AB_562268, HPA031174: , HPA059474: AB_2684030"	"unprognostic (2.06e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.11e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.83e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.81e-3)"	64.5	29.4	26.7	33.7	17.2	68.4	61.7	19.5	20.6	60.0	32.7	30.8	28.4	13.3	40.5	21.8	34.1	72.6	48.5	31.3	20.2	12.4	21.2	39.3	55.1	14.3	15.3	12.0	49.8	48.7	15.0	16.7	21.6	24.1	48.6	16.7	40.5	59.4	39.3	32.2	51.3	28.6	40.7	17.6	22.9	47.0	18.2	18.1	9.0	61.0	35.2	23.3	41.5	33.1	7.4	1.3	4.0	5.1	3.2	2.5	1.2	16.1	2.3	5.2	1.0	8.3	9.5	0.1	20.6	7.5	14.6	8.9	4.2	1.2	0.6	9.9	12.8	31.6	5.6	0.4	6.7	9.3	12.8	37.5	0.2	0.9	4.7	6.9	1.1	3.7	10.2	17.3	18.8	7.9	6.6	10.9	0.7	5.7	9.4	5.6	3.0	1.0	9.0	4.2	7.8	14.7	0.4	71.6	3.2	13.7	1.5	14.5	4.2	14.3	15.0	6.0	5.9	5.3	0.6	19.1	33.3	15.1	12.0	25.8	20.9	3.3	1.2	34.8	2.1	9.5	1.2	5.1	2.0	2.4	1.1	1.3	4.1	1.2	2.5	1.3	7.4	0.3	1.7	4.0	3.2	0.4	0.2	0.9	1.2	26.7	17.2	19.5	20.6	20.2	12.4	15.3	12.0	24.1	18.1	500.2	627.8	505.0	717.3	1097.5	107.5	1349.5	494.3	76.3	282.1	99.5	247.4	529.1	43.1	569.2	40.2	960.8	1411.6	46.7	449.9	86.5	867.7	1920.0	529.9	118.4	560.4	82.6	1440.1	352.4	430.2	18.1	1136.5	481.3	718.7	237.2	1907.1	688.6	543.7	1520.1	243.3	25.0	400.6	1513.4	1714.3	15.6	13.8	843.0	347.6	518.9	938.7	449.9
JUP	"CTNNG, DP3, DPIII, PDGB, PKGB"	ENSG00000173801	"Junction plakoglobin"	P14923	17	41754604-41786931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cancer-related genes, Cardiomyopathy, Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 146.3;skin 1: 126.1;tongue: 122.8"	"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 335.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.6;eosinophil: 14.8;intermediate monocyte: 12.8;memory B-cell: 7.9;myeloid DC: 7.8;naive B-cell: 7.4;non-classical monocyte: 20.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 81.5;OE19: 288.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002139, HPA032047"	Supported		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		61000000	"Plasma membrane, Cell Junctions"	Vesicles	"CAB002139: AB_563468, HPA032047: AB_2674124"	"unprognostic (3.96e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.11e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.29e-3)"	"unprognostic (9.60e-2)"	"prognostic favorable (2.06e-10)"	"unprognostic (2.50e-1)"	"unprognostic (9.49e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.51e-2)"	12.5	2.6	2.8	9.5	4.5	3.3	13.0	6.5	3.7	34.5	17.9	8.7	12.3	15.6	12.2	9.6	146.3	13.0	19.0	34.5	3.3	1.6	31.6	11.7	13.2	4.0	5.3	2.2	12.5	12.8	3.6	5.8	42.4	4.0	14.0	8.8	8.3	34.3	14.3	17.6	126.1	36.1	4.3	3.2	4.5	15.4	3.6	4.6	10.8	27.9	122.8	84.8	12.5	55.4	7.9	7.8	14.8	20.6	0.3	0.1	2.9	19.5	16.2	1.6	1.4	0.0	0.0	25.4	1.1	6.7	0.4	0.4	24.6	21.7	0.3	12.1	0.7	0.5	81.5	2.3	18.1	0.0	0.0	5.8	0.8	12.9	5.4	2.7	0.5	8.7	0.0	41.2	0.0	3.3	4.9	7.2	0.5	7.2	7.1	0.0	25.1	0.1	7.0	3.2	288.5	2.7	22.9	0.0	14.6	12.6	50.1	4.0	2.9	2.5	49.5	0.1	7.9	41.3	0.5	11.4	0.0	1.1	0.5	0.3	0.6	2.2	0.3	0.1	0.9	0.1	1.7	7.6	14.8	0.0	12.8	0.0	7.9	0.0	0.1	7.8	7.4	0.1	0.1	0.3	0.3	20.6	2.5	0.0	2.9	2.8	4.5	6.5	3.7	3.3	1.6	5.3	2.2	4.0	4.6	56.6	33.7	8.4	158.6	174.9	1.1	80.3	53.5	18.7	43.3	125.6	3.9	81.5	23.2	189.4	28.7	23.2	158.5	0.0	119.3	141.0	19.6	196.2	10.5	29.3	12.8	0.0	64.1	28.3	5.6	6.4	4.6	9.8	11.8	6.4	91.0	16.2	237.1	128.7	0.0	33.8	4.3	6.5	14.0	2.1	4.2	335.0	155.3	5.1	94.4	236.4
KAT2B	"GCN5, GCN5L, P/CAF, PCAF"	ENSG00000114166	"Lysine acetyltransferase 2B"	Q92831	3	20040023-20154404	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cardiomyocytes: 56.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002470, CAB004526, HPA055839, HPA073897"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004526: AB_2128417, HPA002470: , HPA055839: AB_2682938, HPA073897: "	"unprognostic (2.91e-2)"	"unprognostic (6.85e-3)"	"unprognostic (9.05e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.83e-3)"	"unprognostic (2.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-3)"	"unprognostic (7.13e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.63e-2)"	10.6	6.6	30.1	9.4	27.5	24.9	6.8	22.0	20.1	10.2	9.4	27.6	7.9	10.9	7.8	5.4	17.3	7.7	8.0	21.9	24.7	18.0	10.8	24.0	10.1	12.7	26.8	15.9	18.2	11.6	38.1	8.7	8.5	24.2	9.5	8.1	10.7	20.9	9.2	33.4	8.9	13.0	8.7	21.4	11.7	9.0	1.8	31.1	8.7	10.0	7.4	12.0	8.7	11.0	2.1	2.7	5.5	1.5	1.1	4.8	0.8	1.5	4.0	2.2	3.6	9.1	8.6	5.2	5.1	7.6	5.4	7.9	1.2	2.6	13.7	2.1	9.6	6.8	1.1	5.5	1.6	4.5	12.4	5.2	12.0	6.3	0.4	4.3	1.8	15.6	3.7	3.0	4.7	3.0	9.5	5.1	3.4	7.7	19.4	7.6	1.9	3.9	3.6	0.9	3.8	3.9	5.1	4.2	2.9	7.3	8.1	1.1	2.4	2.8	4.6	17.3	3.6	4.8	8.1	4.9	9.1	3.7	3.4	5.8	7.4	15.4	3.3	8.3	7.9	19.2	1.3	1.1	2.8	3.6	1.5	3.4	1.0	3.1	2.5	0.9	2.1	1.1	2.1	5.5	1.1	1.1	2.7	4.8	0.8	30.1	27.5	22.0	20.1	24.7	18.0	26.8	15.9	24.2	31.1	29.8	17.3	4.7	10.0	7.6	11.9	56.5	2.5	17.4	14.8	5.2	3.9	5.4	10.0	2.8	2.3	10.5	13.6	23.3	3.8	1.1	9.3	10.0	10.4	26.1	6.5	14.3	11.1	18.4	21.9	1.3	6.1	15.7	16.9	5.4	5.7	12.6	3.7	0.0	4.9	5.3	11.2	6.5	9.9	0.9	0.9	11.3	8.2	13.8	3.1	7.1
KCMF1	"DEBT91, DKFZP434L1021, PCMF, ZZZ1"	ENSG00000176407	"Potassium channel modulatory factor 1"	Q9P0J7	2	84971093-85059472	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030383, HPA030384"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030383: AB_10599977, HPA030384: AB_10601230"	"unprognostic (8.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (9.95e-2)"	"unprognostic (7.42e-3)"	"unprognostic (1.24e-2)"	"unprognostic (8.54e-2)"	"prognostic unfavorable (2.33e-7)"	"unprognostic (5.68e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (6.10e-5)"	"unprognostic (4.98e-2)"	"prognostic unfavorable (4.18e-6)"	"unprognostic (6.11e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.01e-1)"	19.2	13.3	17.9	20.2	16.0	23.6	26.1	13.4	18.6	15.0	20.2	10.7	20.3	15.4	16.3	18.8	28.5	12.8	17.9	30.4	16.5	12.0	14.8	20.7	16.4	18.8	13.7	11.1	17.2	48.6	14.7	18.7	20.5	14.4	17.5	21.4	14.0	19.4	15.7	67.2	17.6	20.6	25.7	10.3	16.7	16.8	29.0	11.5	19.7	18.7	21.8	22.5	23.9	34.0	4.0	4.2	8.1	3.4	2.8	8.8	1.5	27.6	21.7	19.4	14.9	20.5	19.9	33.1	29.6	27.5	28.4	19.0	26.5	29.9	30.1	29.8	40.1	28.4	18.4	15.1	28.6	37.6	22.5	10.5	19.2	16.4	27.0	40.2	21.1	18.3	20.5	45.3	27.8	77.2	25.4	21.4	16.3	19.0	24.0	28.4	25.5	20.3	11.7	21.2	35.2	18.3	14.7	27.3	18.8	25.7	24.3	18.7	14.0	17.2	22.0	28.7	23.3	10.2	13.5	18.2	29.1	28.3	27.1	30.7	27.4	33.8	30.5	21.9	15.6	21.7	5.0	2.6	8.1	4.5	2.2	3.6	3.5	3.2	3.4	2.2	4.0	2.8	3.1	7.5	2.8	3.4	4.2	8.8	1.5	17.9	16.0	13.4	18.6	16.5	12.0	13.7	11.1	14.4	11.5	29.8	28.2	27.9	82.6	63.0	31.1	41.6	20.4	10.7	25.0	12.2	13.7	22.2	21.6	33.1	65.6	24.8	41.1	23.3	45.9	22.3	26.3	94.5	17.3	29.8	18.4	68.3	18.5	25.8	25.1	87.4	23.9	22.8	25.3	23.4	27.6	31.3	46.8	35.9	27.3	28.6	27.5	25.8	36.8	31.0	29.4	69.1	34.1	19.1	28.1	106.5
KDM3A	"JHMD2A, JMJD1, JMJD1A, KIAA0742, TSGA"	ENSG00000115548	"Lysine demethylase 3A"	Q9Y4C1	2	86440647-86492716	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055543, HPA065162"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055543: AB_2682842, HPA065162: AB_2685424"	"unprognostic (1.97e-2)"	"unprognostic (3.03e-3)"	"unprognostic (1.32e-2)"	"unprognostic (4.04e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.15e-6)"	"unprognostic (2.01e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.50e-3)"	"unprognostic (4.44e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.66e-2)"	21.5	12.5	21.5	14.6	27.2	52.9	18.5	17.2	18.7	18.9	25.9	19.6	17.3	17.0	21.2	24.8	20.3	16.8	14.7	21.3	22.7	11.4	13.2	11.9	17.2	14.8	17.8	15.2	20.6	15.7	16.3	20.3	19.5	17.8	19.7	14.9	14.6	19.2	19.1	20.7	34.7	19.1	21.0	22.1	15.7	14.5	42.9	23.6	30.1	18.6	12.8	17.3	29.0	22.1	4.8	4.9	14.4	3.4	4.9	9.1	4.1	18.4	7.4	17.6	4.6	9.1	9.3	16.5	9.0	8.9	8.5	10.5	9.4	7.9	10.8	17.1	7.5	17.5	11.8	13.1	9.0	16.6	14.5	10.9	17.4	6.8	13.3	6.8	13.8	11.1	10.2	13.7	7.6	14.1	29.3	10.4	10.2	11.1	17.8	8.9	4.7	19.2	19.4	15.8	11.1	11.3	13.1	23.8	23.3	7.6	10.5	13.7	14.5	11.9	8.6	16.4	16.2	5.0	9.1	11.6	17.3	7.2	17.8	10.2	18.6	17.5	16.1	21.9	14.4	21.1	11.9	3.2	5.9	7.6	3.4	8.0	4.8	8.4	7.3	4.9	4.1	9.1	7.8	14.4	4.9	2.3	4.4	8.6	4.1	21.5	27.2	17.2	18.7	22.7	11.4	17.8	15.2	17.8	23.6	32.8	13.4	6.9	20.9	27.1	22.7	22.6	10.2	36.1	23.9	5.2	49.1	3.7	0.0	12.1	58.0	19.8	15.9	23.3	8.6	5.9	16.9	16.0	37.0	6.8	9.0	52.4	15.0	14.7	11.3	20.1	16.1	15.1	20.3	5.4	11.4	35.1	10.0	9.7	16.3	4.2	33.6	6.5	14.4	32.1	10.2	35.0	9.7	17.0	9.3	11.7
KDM3B	"C5orf7, JMJD1B, KIAA1082, NET22"	ENSG00000120733	"Lysine demethylase 3B"	Q7LBC6	5	138352596-138437028	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016610, HPA057202"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA016610: AB_1852004, HPA057202: AB_2683367"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.60e-2)"	13.5	12.8	10.0	10.9	12.6	12.2	14.9	20.2	14.9	14.0	14.2	18.4	13.5	9.9	20.0	18.0	13.0	14.7	12.5	11.8	14.7	8.6	12.8	8.4	11.4	11.5	12.0	9.6	19.8	17.4	27.9	15.1	11.7	11.3	13.6	14.4	18.5	16.3	16.3	29.6	16.5	14.0	21.5	10.7	13.3	12.6	10.4	12.2	25.2	16.1	9.0	16.4	21.9	19.4	4.1	5.1	9.3	4.6	7.4	5.7	2.2	10.6	15.0	28.3	25.9	13.1	10.9	21.9	7.4	12.0	13.2	14.8	16.7	11.8	21.3	13.4	14.0	18.1	11.0	23.0	16.5	15.1	14.0	14.1	18.3	13.3	12.6	11.7	14.7	20.0	13.0	18.0	10.2	12.2	10.4	15.7	12.4	14.3	11.4	15.8	13.7	19.2	18.2	14.0	14.5	6.2	23.4	21.8	13.9	18.9	14.8	15.0	16.4	12.6	12.4	10.9	43.9	11.8	18.6	15.1	7.9	8.2	8.3	12.8	15.8	7.5	18.9	5.2	20.8	11.2	0.3	4.6	6.5	4.2	3.6	5.7	4.1	5.0	5.2	4.1	3.9	4.4	4.2	9.3	7.4	3.6	5.1	2.8	2.2	10.0	12.6	20.2	14.9	14.7	8.6	12.0	9.6	11.3	12.2	14.9	14.9	8.8	12.1	14.2	19.4	29.7	25.5	10.7	13.6	21.0	27.5	10.5	0.0	12.9	5.9	12.7	15.8	0.0	14.4	8.0	12.8	16.3	12.7	18.3	15.1	22.3	20.2	17.8	45.4	2.2	19.5	16.7	15.1	17.2	28.8	20.6	16.4	26.8	21.5	12.6	29.9	25.8	12.7	12.3	13.9	18.9	9.2	11.4	23.0	17.3
KDM5C	"DXS1272E, JARID1C, MRX13, SMCX, XE169"	ENSG00000126012	"Lysine demethylase 5C"	P41229	X	53191321-53225422	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Dioxygenase, Oxidoreductase, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038244, HPA046147"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA038244: AB_2675911, HPA046147: AB_2679555"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.10e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.05e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.00e-1)"	19.5	22.9	22.4	22.6	24.7	26.3	17.9	43.0	31.7	25.9	19.5	23.4	16.7	22.2	29.2	13.3	26.9	24.8	15.2	17.6	21.6	15.3	17.0	18.8	20.6	25.8	24.6	21.8	33.1	22.5	37.7	31.8	34.0	22.8	18.7	13.5	17.0	25.6	17.1	36.6	28.4	22.2	23.6	16.0	25.0	19.4	10.6	26.2	29.0	22.2	11.3	24.5	21.5	26.4	4.5	4.3	4.8	4.0	2.8	6.1	3.8	16.9	23.1	24.8	19.0	17.2	15.7	17.6	10.6	12.4	14.4	13.4	15.6	11.1	15.8	13.8	13.9	40.6	15.2	28.0	22.7	11.0	11.8	41.4	15.3	24.7	11.0	21.2	18.1	30.6	12.4	16.7	28.1	34.7	20.6	21.2	13.2	29.7	10.5	10.5	21.7	13.2	20.4	21.0	8.8	21.7	15.0	14.8	17.1	9.1	16.3	18.7	24.1	32.2	29.9	12.1	23.8	20.9	16.0	14.5	16.1	13.9	14.4	10.3	15.3	12.4	12.0	20.9	21.5	11.9	3.0	3.8	2.7	6.1	3.6	5.1	4.5	3.7	5.7	3.1	3.2	4.5	2.9	4.8	2.8	4.0	4.3	4.3	3.8	22.4	24.7	43.0	31.7	21.6	15.3	24.6	21.8	22.8	26.2	11.9	12.2	11.9	9.7	10.8	25.0	7.7	17.8	12.0	12.5	7.0	23.6	10.6	3.3	13.4	0.6	14.3	21.7	0.0	18.7	11.4	11.3	12.4	12.7	19.8	12.4	23.8	30.0	18.4	14.6	1.7	13.6	9.4	13.5	10.0	27.8	10.9	20.8	24.6	14.9	4.2	16.1	0.0	10.3	7.0	14.6	13.9	17.4	10.2	15.6	15.9
KHDRBS1	"FLJ34027, p62, Sam68"	ENSG00000121774	"KH RNA binding domain containing, signal transduction associated 1"	Q07666	1	32013829-32060850	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005355, HPA051280, HPA056813"	Supported		Enhanced	Nucleoplasm		NA	NA		20000	Nucleoplasm		"CAB005355: AB_631869, HPA051280: AB_2681417, HPA056813: AB_2683240"	"unprognostic (1.31e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.55e-2)"	"prognostic unfavorable (3.68e-5)"	"unprognostic (5.01e-2)"	"unprognostic (2.51e-3)"	"unprognostic (4.03e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.03e-2)"	34.5	31.7	31.1	49.7	34.2	42.0	35.9	56.6	41.5	42.0	38.8	35.1	30.1	33.3	51.5	37.8	37.0	39.5	51.2	34.9	29.7	30.1	30.0	30.9	38.3	52.5	27.3	35.9	63.2	31.3	40.4	29.5	33.9	25.9	36.5	31.7	32.2	31.1	35.5	39.0	30.6	32.4	44.2	31.4	36.0	31.0	42.7	23.7	69.9	35.1	41.0	50.0	40.2	34.4	11.4	10.2	6.4	10.2	8.2	14.4	3.5	44.4	27.1	62.1	45.6	21.6	27.2	36.5	27.0	34.4	50.8	42.9	30.1	40.0	66.7	30.3	34.1	29.5	31.2	50.0	37.0	52.1	39.7	42.7	42.0	26.7	41.0	28.5	55.6	28.3	29.8	21.2	38.6	30.7	33.4	47.9	41.1	54.1	30.6	38.9	29.0	81.8	47.6	63.0	28.1	32.6	65.7	52.6	56.3	35.4	45.2	42.5	55.6	39.3	33.7	33.9	46.2	40.1	40.5	35.9	33.1	35.9	35.3	45.1	32.2	34.8	65.6	34.4	44.5	25.2	4.6	6.7	6.4	9.6	10.2	14.4	11.4	11.5	9.9	9.0	9.3	12.5	11.8	5.9	8.2	8.2	10.2	10.3	3.5	31.1	34.2	56.6	41.5	29.7	30.1	27.3	35.9	25.9	23.7	35.7	61.9	121.1	181.3	131.1	88.3	92.4	79.0	108.4	116.0	66.3	47.1	161.4	71.3	89.2	18.7	98.3	69.3	23.3	88.7	198.7	113.7	105.9	126.8	57.1	105.8	60.4	113.1	87.8	125.1	11.5	102.9	123.6	102.9	84.8	92.4	126.7	86.6	57.5	116.7	98.2	71.0	90.5	113.7	152.3	117.7	114.2	145.1	101.2	124.2	156.2
KHSRP	"FBP2, FUBP2, KSRP"	ENSG00000088247	"KH-type splicing regulatory protein"	Q92945	19	6413348-6424794	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034739, HPA056518"	Supported		Enhanced	Nucleoplasm		NA	NA		740000	Nucleoplasm		"HPA034739: AB_10601582, HPA056518: AB_2683162"	"unprognostic (2.16e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.27e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.84e-2)"	40.3	34.3	31.4	34.5	37.2	49.9	27.6	53.8	54.2	38.9	35.6	51.4	23.9	49.5	48.0	27.5	41.5	39.2	33.3	27.4	31.3	27.7	31.0	49.2	27.0	39.3	31.7	29.8	51.0	45.3	18.4	31.4	43.4	28.1	35.0	25.6	39.2	44.4	35.9	43.7	41.8	44.8	30.3	30.3	37.9	36.1	56.3	29.2	73.9	37.8	35.0	33.4	37.7	33.7	8.9	11.5	4.9	7.6	3.1	6.3	3.5	72.0	36.3	34.7	33.7	15.1	16.5	60.4	29.7	19.6	35.2	36.3	73.6	19.7	71.5	46.5	17.2	21.1	39.0	39.5	28.0	28.1	0.3	74.1	46.1	22.5	50.9	26.4	51.6	44.5	21.3	12.7	28.9	23.7	14.6	27.3	33.0	85.6	30.3	21.2	46.0	63.3	51.0	67.5	17.9	51.3	66.9	34.0	45.8	16.3	37.1	41.1	45.5	36.5	25.4	32.2	24.2	30.3	48.2	29.7	28.9	36.2	61.1	58.2	60.6	47.1	54.6	25.4	73.5	33.9	3.2	6.9	4.5	5.7	7.6	6.0	5.9	6.0	6.3	6.4	8.9	4.2	4.5	4.9	3.1	6.3	11.5	4.1	3.5	31.4	37.2	53.8	54.2	31.3	27.7	31.7	29.8	28.1	29.2	8.9	20.3	40.4	19.2	52.2	42.6	12.6	40.8	12.0	25.0	29.6	47.1	31.6	5.0	24.6	57.0	30.1	34.2	23.3	26.5	36.8	31.4	26.2	18.4	39.5	33.0	47.7	55.3	38.1	29.9	19.6	46.9	22.9	25.3	16.2	44.5	35.1	29.9	24.6	43.5	20.3	58.4	25.8	22.3	68.6	52.6	63.2	33.4	16.0	55.7	28.8
KIAA0753	"MNR, OFIP"	ENSG00000198920	KIAA0753	Q2KHM9	17	6578148-6640927	"Disease related genes, Predicted intracellular proteins"			Ciliopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Ciliated cells: 41.5;Early spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023057, HPA023494"	Enhanced		Enhanced	Centrosome,Cytosol		NA	NA			"Centrosome, Cytosol"		"HPA023057: AB_1852338, HPA023494: AB_1852339"	"unprognostic (3.72e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.93e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.82e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.77e-3)"	6.5	7.0	7.5	11.7	12.8	4.5	9.9	7.4	9.4	10.1	7.7	7.3	20.1	4.4	17.8	15.6	8.5	13.4	10.7	5.0	8.3	7.7	8.7	4.3	8.3	6.6	4.9	7.9	15.4	10.5	26.4	26.0	7.4	8.0	9.6	9.2	9.6	7.0	13.6	5.4	7.4	6.4	11.5	7.2	9.0	7.9	20.1	5.1	13.7	12.1	4.1	6.8	8.4	7.7	2.3	1.8	5.5	2.2	1.1	2.0	0.7	15.9	12.3	16.1	11.2	6.1	10.5	6.1	8.6	8.1	12.3	10.8	9.1	3.7	5.7	5.8	7.9	8.3	14.9	15.1	7.8	19.7	5.7	12.1	3.3	10.7	6.4	9.1	5.6	7.3	6.9	11.0	12.3	10.1	12.6	9.0	7.7	8.0	0.8	9.5	5.6	6.1	4.9	9.8	7.7	6.5	8.9	5.4	1.9	10.9	10.3	6.0	10.8	11.4	3.0	6.6	11.0	5.1	3.6	8.3	11.6	5.3	6.1	12.7	1.4	1.9	2.4	8.1	3.2	7.8	0.0	2.0	1.7	1.8	2.2	2.0	2.3	1.5	1.6	1.3	1.4	1.2	1.1	5.5	1.1	1.1	1.8	1.1	0.7	7.5	12.8	7.4	9.4	8.3	7.7	4.9	7.9	8.0	5.1	6.0	10.5	1.4	2.6	2.9	3.8	3.0	5.1	41.5	11.4	0.0	15.7	1.8	0.0	3.8	63.1	3.6	2.1	0.0	3.4	0.9	2.8	3.6	1.1	1.8	2.2	9.5	6.9	4.3	3.7	9.9	4.0	2.2	0.0	1.0	4.8	2.4	3.4	4.0	3.2	2.9	10.8	0.0	3.3	14.1	7.5	2.0	1.0	0.0	4.0	2.6
KIAA1143		ENSG00000163807	KIAA1143	Q96AT1	3	44737661-44761662	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 149.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045018, HPA061799"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA045018: AB_10964578, HPA061799: AB_2684614"	"unprognostic (1.31e-1)"	"unprognostic (2.74e-1)"	"prognostic favorable (3.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (6.00e-2)"	"unprognostic (3.01e-3)"	"unprognostic (2.23e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.08e-2)"	"prognostic favorable (3.26e-6)"	"unprognostic (1.82e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.46e-2)"	21.7	14.6	19.8	13.2	16.9	9.0	18.8	17.2	21.7	18.9	15.7	13.6	11.9	10.4	19.9	13.3	17.9	16.5	12.8	22.0	19.9	17.9	16.2	11.4	13.6	13.8	21.4	12.7	26.0	16.2	22.2	15.2	14.5	18.8	20.9	12.2	9.1	13.3	15.3	28.9	16.0	14.2	17.9	21.7	16.7	12.7	9.4	16.7	25.0	19.4	16.5	15.8	23.3	17.8	6.6	5.5	9.5	8.7	7.6	7.4	4.5	6.6	4.3	12.4	8.6	8.4	13.2	6.2	7.7	10.8	9.9	10.1	4.4	5.9	16.4	5.9	8.0	4.7	4.7	14.5	8.1	13.1	9.0	4.9	11.9	8.1	5.3	5.8	14.9	8.4	9.4	9.9	10.1	9.6	11.0	8.2	10.2	16.8	9.0	9.6	3.8	16.5	10.5	11.6	7.1	5.6	6.8	11.8	9.2	6.3	5.7	6.2	10.6	8.9	7.0	6.1	8.6	11.6	12.8	9.4	5.5	5.0	14.4	8.7	5.8	16.5	10.0	10.2	14.5	8.0	5.3	5.7	9.5	7.4	6.3	6.5	6.6	6.4	5.9	5.5	6.3	6.8	6.2	5.7	7.6	8.7	3.7	5.3	4.5	19.8	16.9	17.2	21.7	19.9	17.9	21.4	12.7	18.8	16.7	35.7	29.6	39.6	25.1	30.7	17.4	23.8	30.6	32.1	45.5	22.7	7.9	37.2	58.0	37.7	149.2	31.5	17.6	0.0	53.7	48.7	27.7	35.1	37.0	22.9	30.8	14.3	15.0	30.7	39.1	61.4	34.8	35.6	13.5	26.2	22.9	41.7	40.6	23.5	46.3	29.3	12.2	0.0	25.5	46.8	40.9	24.3	47.8	34.8	24.1	36.6
KIF20A	RAB6KIFL	ENSG00000112984	"Kinesin family member 20A"	O95235	5	138178719-138187715	"Predicted intracellular proteins"	"Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.7;testis: 18.2"	"Cell type enhanced"	"Detected in some"	23	"Erythroid cells: 46.7;Extravillous trophoblasts: 10.5;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NK-cell: 10.0;T-reg: 3.2"	"Group enriched"	"Detected in many"	64	"NK-cells: 10.0;T-cells: 3.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA036909, HPA036910"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cleavage furrow"		Yes	Yes			"Nucleoplasm, Cleavage furrow"	"Cytokinetic bridge"	"HPA036909: AB_10670245, HPA036910: AB_10671716"	"unprognostic (7.50e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.21e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (2.14e-12)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (9.73e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (9.05e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.16e-1)"	2.3	1.7	0.3	3.6	0.4	10.4	0.7	0.3	0.7	1.7	2.7	0.4	0.3	2.7	1.6	2.2	10.7	0.3	0.3	0.8	0.3	0.3	1.2	1.2	2.3	6.7	0.6	0.4	0.8	0.5	0.0	0.3	6.6	0.5	1.0	4.2	0.4	2.0	0.3	0.5	3.5	2.7	4.4	0.5	3.8	2.1	18.2	0.3	47.7	0.5	6.1	11.7	1.8	3.0	0.1	0.0	0.0	0.0	10.0	3.2	0.4	22.2	15.0	33.2	22.0	1.7	3.3	14.3	19.3	17.7	42.1	31.8	28.2	20.8	9.6	10.4	24.3	15.8	22.1	31.1	36.1	42.2	14.0	14.7	14.2	26.8	17.9	0.1	6.9	6.6	1.2	0.6	22.4	12.9	7.1	27.2	13.7	5.9	18.4	29.1	20.4	11.6	6.8	21.0	13.1	16.4	12.8	33.3	9.9	11.5	11.0	9.9	9.8	36.5	12.4	8.5	44.5	15.8	7.2	12.9	11.0	16.4	9.9	32.2	9.5	9.1	10.7	7.1	20.5	21.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.2	0.4	0.3	0.4	0.3	0.7	0.3	0.3	0.6	0.4	0.5	0.3	0.0	1.7	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.6	0.0	0.4	46.7	0.0	10.5	0.4	0.1	4.6	0.0	4.9	0.0	0.0	3.7	1.0	1.0	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	17.9	4.6	0.4	0.8	0.0	1.6	0.0
KIF21A	"FEOM1, FLJ20052"	ENSG00000139116	"Kinesin family member 21A"	Q7Z4S6	12	39293228-39443390	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.5"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 235.9;Ciliated cells: 303.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3"	"Group enriched"	"Detected in many"	8	"NK-cells: 3.1;T-cells: 8.5"	"Cell line enriched"	"Detected in many"	4	"SH-SY5Y: 63.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022079, HPA058432"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"CAB022079: , HPA058432: AB_2683717"	"unprognostic (1.08e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.06e-2)"	"unprognostic (7.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (8.07e-8)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.34e-2)"	3.4	10.1	17.7	3.1	18.5	0.8	5.1	22.1	36.7	8.4	9.2	7.7	2.9	7.1	7.7	4.7	16.0	26.8	5.1	13.4	18.0	28.7	20.9	15.6	4.8	2.2	26.4	18.0	3.2	10.1	17.4	12.3	6.4	41.5	9.3	10.6	5.9	16.4	3.5	8.0	8.5	7.9	7.2	29.2	5.0	9.6	9.5	9.6	0.0	7.1	2.5	4.1	3.6	6.0	0.7	0.0	0.1	0.0	3.1	8.5	1.1	5.9	7.6	10.7	4.5	2.0	1.0	8.6	1.5	0.7	2.0	1.4	13.7	7.4	0.0	4.8	0.6	3.2	5.3	6.1	3.7	1.8	11.7	4.9	0.0	13.4	12.5	1.6	9.9	0.0	0.6	8.2	2.5	12.0	4.6	2.6	2.6	11.2	12.3	1.6	3.5	1.2	0.0	14.4	0.0	6.7	0.0	0.0	6.8	7.6	9.9	14.7	63.8	5.8	9.3	3.5	11.4	10.8	1.2	1.8	1.1	4.7	0.3	4.2	5.6	1.9	0.0	2.8	1.4	0.9	0.0	0.0	0.0	8.4	0.0	4.1	0.7	5.2	8.5	0.0	0.0	1.3	5.9	0.1	3.1	0.0	0.0	2.3	1.1	17.7	18.5	22.1	31.6	18.0	28.7	26.4	18.0	41.5	9.6	35.7	17.4	0.8	18.1	16.5	235.9	106.3	17.8	303.8	69.4	12.2	290.6	12.6	8.3	23.9	92.2	5.8	23.8	0.0	35.7	84.3	10.0	29.0	13.8	39.9	3.5	130.3	23.1	8.0	2.4	60.6	2.8	2.1	13.5	12.6	25.5	106.4	33.2	20.1	2.5	41.7	184.9	0.0	9.8	22.7	7.2	26.8	49.4	20.8	23.4	14.6
KIF23	"KNSL5, MKLP-1, MKLP1"	ENSG00000137807	"Kinesin family member 23"	Q02241	15	69414246-69448427	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.8;testis: 20.4"	"Cell type enhanced"	"Detected in many"	12	"Extravillous trophoblasts: 31.4;Spermatocytes: 47.9;Spermatogonia: 18.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 7.7"	"Group enriched"	"Detected in many"	12	"granulocytes: 7.7;monocytes: 2.2;T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010414, HPA045208, HPA068831"	Uncertain		Enhanced	"Nucleoplasm,Midbody ring,Mitotic spindle"		Yes	Yes			Nucleoplasm	"Midbody ring, Mitotic spindle"	"CAB010414: AB_631959, HPA045208: AB_2679254, HPA068831: AB_2686045"	"unprognostic (1.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.99e-3)"	"prognostic unfavorable (3.18e-5)"	"unprognostic (1.43e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.69e-5)"	"unprognostic (5.85e-3)"	"unprognostic (0.00e+0)"	"unprognostic (1.15e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.17e-2)"	1.8	2.6	1.8	12.7	1.3	16.3	3.2	0.3	0.9	2.2	3.3	0.3	1.4	3.5	3.3	1.2	8.8	1.8	2.4	2.2	0.7	0.5	4.9	0.8	2.5	6.7	0.9	0.5	1.6	0.9	0.0	0.3	10.8	1.3	1.9	4.3	0.6	2.1	0.9	0.3	3.0	3.9	3.4	1.4	4.5	3.1	20.4	0.2	41.8	0.6	6.3	8.8	1.8	3.3	0.3	0.1	7.7	2.2	0.1	2.1	0.6	25.2	22.0	16.3	15.6	1.0	1.9	9.9	27.7	15.0	40.2	31.3	13.3	19.8	14.8	8.4	14.3	21.4	29.2	33.6	10.3	40.9	13.7	15.7	13.9	20.6	8.2	0.6	14.3	12.9	0.9	1.1	19.2	16.2	5.1	13.6	12.0	9.2	18.5	25.2	11.1	8.0	7.7	20.2	9.4	8.8	9.1	36.3	8.2	10.6	13.1	8.3	6.9	32.2	14.2	12.1	21.4	13.5	6.5	8.8	24.3	32.4	16.8	40.7	7.2	19.5	13.3	8.6	19.3	21.4	0.0	2.2	7.7	0.0	1.0	0.0	0.3	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.1	1.0	0.1	2.1	0.6	1.8	1.3	0.3	0.9	0.7	0.5	0.9	0.5	1.3	0.2	0.0	0.3	0.0	2.6	1.6	0.2	0.8	7.6	1.4	6.8	7.0	2.0	5.9	3.3	1.8	6.3	0.1	1.1	0.0	0.0	31.4	3.1	0.5	2.3	0.0	6.8	0.0	1.7	6.2	3.2	3.2	0.9	2.9	0.0	10.0	2.2	0.1	0.4	0.0	1.8	0.5	0.0	6.5	2.3	47.9	18.3	0.9	2.1	0.8	2.3	1.0
KIF2A	"HK2, KIF2"	ENSG00000068796	"Kinesin family member 2A"	O00139	5	62306162-62537249	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis"	"Developmental protein, Motor protein"	"Cancer-related genes, Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004715, HPA004716"	Approved		Enhanced	Nucleoplasm,Nucleoli,Centrosome		Yes	No		2100000	"Nucleoplasm, Nucleoli, Centrosome"		"HPA004715: AB_2667215, HPA004716: AB_1079211"	"unprognostic (2.40e-2)"	"unprognostic (3.43e-1)"	"prognostic favorable (1.70e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (5.45e-4)"	"prognostic unfavorable (3.17e-6)"	"unprognostic (8.77e-3)"	"unprognostic (4.69e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (3.81e-5)"	"unprognostic (3.53e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.58e-1)"	11.3	9.3	25.4	21.9	26.4	12.4	15.5	15.4	40.1	19.7	13.5	19.4	8.0	10.3	12.9	7.6	14.3	17.5	13.7	7.2	26.2	24.1	8.2	5.8	10.6	29.4	24.9	24.6	13.0	12.3	15.2	14.3	27.8	37.0	10.2	14.5	6.8	10.7	11.9	7.4	7.9	15.8	13.5	34.3	17.4	9.6	39.2	26.4	28.7	13.0	5.6	26.7	17.4	14.8	9.0	8.4	7.1	3.0	15.8	25.4	9.7	17.3	17.4	29.1	25.8	11.0	15.5	23.8	18.6	15.4	20.3	25.8	18.7	19.1	43.1	20.6	16.4	24.0	11.0	22.0	14.9	27.1	43.2	15.4	43.2	16.3	10.2	13.0	23.5	16.5	12.8	9.9	19.7	17.9	11.9	18.5	24.9	30.6	26.3	16.9	13.1	39.4	11.7	16.9	4.2	11.0	29.0	23.0	23.8	9.1	21.1	26.1	21.7	25.3	10.6	13.1	22.5	13.9	13.3	16.0	12.1	20.0	14.0	18.5	24.9	35.9	45.5	14.0	28.4	14.8	7.1	3.0	3.4	20.2	2.6	22.8	9.0	20.3	20.6	4.0	7.8	17.9	18.4	5.3	15.8	1.8	8.4	25.4	9.7	25.4	26.4	15.4	31.2	26.2	24.1	24.9	24.6	37.0	26.4	14.9	13.1	22.3	22.3	14.9	41.8	7.0	7.6	71.0	25.0	19.2	98.2	16.2	11.6	30.0	88.3	17.5	11.4	0.0	27.0	18.7	10.4	29.9	16.3	3.4	13.1	49.3	20.2	14.7	10.2	90.3	12.0	18.7	11.8	152.3	5.1	22.4	23.3	7.4	12.4	13.5	88.2	25.8	13.3	80.2	42.1	8.3	36.7	39.6	9.5	40.0
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009010-32056431	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		260000	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	26.3	19.9	55.7	20.2	55.5	34.1	23.0	22.2	42.4	23.8	34.2	21.7	20.9	23.5	25.7	17.8	28.0	20.3	28.0	48.4	51.5	39.3	21.1	15.3	23.8	16.5	62.9	26.1	18.2	18.9	56.8	22.4	27.7	38.3	31.8	30.0	8.9	20.1	25.6	34.3	17.6	28.6	37.2	80.4	21.1	23.1	27.7	43.7	25.0	23.5	21.5	16.1	33.8	28.1	13.8	27.6	30.0	18.9	13.4	16.5	9.2	30.0	25.6	34.6	24.3	24.8	27.5	14.8	41.5	19.7	32.1	27.5	28.1	33.3	20.6	18.0	49.2	18.3	25.0	31.6	26.5	43.1	17.7	17.2	26.2	23.9	27.3	28.6	18.2	28.9	22.2	37.7	37.0	25.9	25.6	41.0	18.3	31.5	21.8	44.3	18.1	18.9	10.3	5.6	28.9	11.7	24.9	64.6	8.5	24.7	21.1	33.7	24.6	32.1	12.8	30.9	25.2	15.5	26.1	34.1	32.7	30.7	37.8	30.7	6.6	7.5	24.3	31.1	37.7	30.7	20.8	15.2	24.2	11.8	18.9	11.4	13.6	14.9	12.5	14.2	13.8	13.3	13.0	30.0	13.4	18.9	27.6	16.5	9.2	55.7	55.5	22.2	42.4	51.5	39.3	62.9	26.1	38.3	43.7	169.7	163.3	57.7	133.6	189.3	172.7	357.9	96.8	192.7	126.3	99.5	94.2	100.8	38.1	183.2	92.5	169.2	111.4	46.7	153.7	110.6	139.0	208.1	87.9	41.0	117.4	143.0	127.0	87.2	110.1	28.3	54.7	125.3	96.2	194.8	188.9	82.6	173.1	143.2	123.1	50.5	125.5	84.1	199.1	513.7	177.6	206.9	277.6	86.3	159.0	207.4
KIN	"KIN17, Rts2"	ENSG00000151657	"Kin17 DNA and RNA binding protein"	O60870	10	7750962-7787981	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication, Host-virus interaction, mRNA processing, Stress response"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016339, HPA038700"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016339: AB_627860, HPA038700: AB_2676159"	"unprognostic (4.33e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.17e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.40e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (3.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-1)"	"prognostic favorable (3.23e-5)"	8.5	8.6	9.0	8.2	9.7	9.4	9.0	19.8	11.9	9.5	7.0	10.2	9.1	7.8	11.3	9.9	6.5	8.1	7.2	8.6	7.5	7.8	10.1	12.9	7.4	10.4	9.7	8.2	10.8	10.2	7.7	15.5	10.0	10.6	10.0	7.7	8.4	8.4	8.6	9.1	11.5	10.0	9.1	9.0	10.8	8.1	6.9	9.7	13.6	11.1	7.7	9.7	8.8	8.3	7.0	6.9	13.8	5.1	5.9	5.0	1.8	6.9	4.4	6.8	4.3	5.6	6.8	5.5	6.2	2.8	7.5	8.1	8.5	7.0	5.4	3.3	3.8	2.3	6.7	5.7	3.8	8.7	6.1	6.6	8.5	4.5	8.1	8.0	3.0	6.9	5.6	4.3	5.7	3.8	6.3	5.6	6.9	8.4	5.2	5.8	6.2	6.0	4.7	6.6	7.2	2.7	7.7	4.9	4.9	6.3	3.9	3.0	6.4	4.9	5.0	9.9	6.8	9.1	6.1	4.0	4.9	5.5	8.6	5.0	6.8	7.3	6.7	6.2	4.7	3.3	13.8	4.8	8.0	4.7	5.1	4.7	6.5	4.2	3.9	3.6	7.0	4.8	5.0	10.8	5.9	4.6	6.9	3.4	1.8	9.0	9.7	19.8	11.9	7.5	7.8	9.7	8.2	10.6	9.7	32.8	25.6	13.0	13.7	15.3	52.4	11.1	22.9	30.8	18.2	17.4	37.3	31.0	11.6	26.4	4.2	24.1	15.8	23.3	18.7	21.8	20.6	11.9	15.1	12.4	27.3	60.4	22.3	24.5	18.0	4.3	25.6	22.4	15.1	19.0	17.1	29.5	18.4	20.1	29.0	14.6	53.1	12.9	17.6	28.6	16.7	12.5	32.2	25.4	13.3	13.3
KLC2	FLJ12387	ENSG00000174996	"Kinesin light chain 2"	Q9H0B6	11	66257294-66267860	"Disease related genes, Predicted intracellular proteins"		"Motor protein"	"Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 51.7"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 52.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"gdT-cell: 4.6;MAIT T-cell: 6.2;memory B-cell: 3.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 3.1;naive B-cell: 4.7;naive CD4 T-cell: 2.2;naive CD8 T-cell: 2.7;NK-cell: 2.3;plasmacytoid DC: 4.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040416, HPA040434"	Approved		Supported	"Nucleoplasm,Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Mitochondria"	"HPA040416: AB_10795524, HPA040434: AB_10795367"	"unprognostic (1.29e-1)"	"unprognostic (4.95e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (3.16e-4)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.27e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.57e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.08e-2)"	7.5	12.5	15.9	7.9	20.7	2.9	6.6	51.7	49.4	7.4	7.8	7.5	6.5	8.5	11.3	6.0	8.8	9.0	8.0	15.3	20.0	17.4	6.7	2.4	6.6	7.5	13.8	26.0	11.3	11.2	15.4	15.4	6.4	29.0	13.6	4.4	8.2	8.4	15.5	23.8	9.3	7.7	10.1	8.6	6.6	9.8	17.4	10.0	13.5	6.3	4.5	5.6	8.8	8.5	4.7	4.1	0.8	0.4	2.3	6.2	1.5	20.4	25.1	12.2	7.3	7.4	6.0	9.5	14.5	10.4	14.9	11.5	13.6	6.1	9.3	14.0	10.7	19.2	17.3	12.5	14.0	5.0	14.8	15.8	1.8	19.8	9.2	14.3	4.1	9.9	6.0	18.6	17.4	14.2	9.6	6.9	11.2	9.9	12.5	11.8	28.8	23.2	6.2	12.1	5.9	20.9	8.9	6.3	12.6	11.6	11.5	33.4	16.1	10.6	9.5	17.3	7.1	15.7	2.8	11.3	24.5	21.9	29.6	19.0	13.1	10.9	5.0	17.3	2.8	9.8	0.0	0.4	0.8	4.6	0.1	6.2	3.6	2.2	3.1	0.6	4.7	2.2	2.7	0.7	2.3	0.3	4.1	0.6	1.5	15.9	20.7	51.7	49.4	20.0	17.4	13.8	26.0	29.0	10.0	3.0	1.0	5.6	8.0	7.9	32.1	1.4	0.0	5.3	1.2	12.2	11.8	8.8	11.6	15.0	8.9	4.5	2.9	0.0	7.2	16.4	4.8	12.0	0.0	2.1	2.7	52.4	35.6	4.3	4.6	3.4	8.1	2.8	11.8	10.0	5.8	14.1	13.4	3.6	13.1	9.1	26.5	0.0	16.2	24.4	25.6	8.4	10.6	3.3	3.7	7.1
KLF3	BKLF	ENSG00000109787	"Kruppel like factor 3"	P57682	4	38664196-38701042	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049512, HPA065054"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049512: AB_2680799, HPA065054: AB_2685415"	"unprognostic (4.20e-1)"	"unprognostic (2.08e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	"prognostic favorable (4.36e-4)"	"unprognostic (9.01e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.10e-3)"	23.0	14.3	11.1	14.7	14.4	41.7	25.6	8.9	13.7	20.2	31.2	21.7	10.4	21.0	20.0	14.1	51.9	14.6	39.3	12.0	11.9	8.1	13.2	25.2	21.4	16.6	16.2	8.2	36.1	18.6	21.6	11.4	20.4	13.8	19.0	27.6	12.4	24.0	17.6	12.5	43.1	40.3	18.7	16.7	22.3	25.6	7.9	18.2	6.5	16.4	25.7	34.9	26.1	28.3	4.0	3.1	14.3	10.9	2.7	9.4	2.1	9.5	6.6	25.0	5.0	11.5	17.2	7.9	5.3	15.5	3.6	4.5	6.2	17.7	0.0	7.5	11.5	10.4	10.5	7.1	9.3	5.8	0.1	5.2	9.1	9.7	13.0	11.8	2.2	0.0	15.5	25.8	5.2	9.7	6.8	13.8	3.6	25.9	4.5	5.7	2.2	2.4	4.0	5.8	19.8	4.8	3.2	12.1	10.4	12.8	23.1	7.2	9.3	5.8	4.6	11.1	10.5	2.8	3.2	21.8	12.0	6.8	20.3	5.7	6.3	2.0	0.0	4.9	6.9	5.1	8.8	4.0	14.3	6.3	6.9	4.3	3.7	7.0	5.6	3.1	4.0	9.4	5.6	12.8	2.7	10.9	0.7	7.2	2.1	11.1	14.4	8.9	13.7	11.9	8.1	16.2	8.2	13.8	18.2	20.8	25.6	15.7	113.6	107.8	41.2	15.3	63.7	21.4	23.9	29.6	29.5	23.5	10.0	75.6	0.6	80.0	132.1	140.2	75.2	17.8	67.1	127.0	19.6	48.4	47.0	33.4	83.1	51.0	71.6	1.9	48.1	51.1	47.2	34.3	132.6	51.1	83.4	132.3	45.3	18.4	36.2	25.8	29.9	0.7	0.9	194.5	22.9	35.8	87.7	244.9
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.7"	"Group enriched"	"Detected in all"	9	"Early spermatids: 436.9;Late spermatids: 1305.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	16.1	19.0	37.2	11.6	41.6	14.7	17.6	38.0	68.2	15.2	16.7	14.6	15.4	14.4	12.8	21.2	16.1	19.9	13.6	34.0	34.2	25.7	14.8	20.2	14.4	14.4	26.7	41.6	20.3	15.2	15.6	17.6	20.9	29.6	16.3	15.0	13.5	21.3	18.5	122.7	15.1	14.7	15.9	14.6	14.1	15.4	47.0	15.3	17.4	19.3	17.6	15.6	13.7	11.2	19.5	39.4	41.6	36.3	21.6	31.5	29.8	26.4	8.2	27.3	45.6	18.8	14.2	19.6	12.0	15.5	23.5	25.8	23.5	13.9	26.3	13.7	17.5	8.8	14.1	29.0	15.5	16.1	14.0	39.5	32.7	23.6	24.4	18.5	19.2	23.4	22.8	15.6	18.1	10.6	18.3	22.7	30.1	39.7	18.8	8.8	32.9	31.4	33.1	35.5	66.8	8.8	30.6	20.0	31.5	14.4	15.4	50.6	39.5	12.7	14.6	20.4	18.5	25.4	55.7	13.4	10.7	20.0	11.8	11.8	20.6	25.8	38.2	4.7	27.6	9.0	14.9	36.3	41.6	28.5	33.8	24.0	19.2	23.8	25.8	39.4	19.5	31.5	24.5	17.7	21.6	25.8	21.8	25.1	29.8	37.2	41.6	38.0	68.2	34.2	25.7	26.7	41.6	29.6	15.3	11.9	17.1	31.9	30.7	16.7	29.1	32.5	30.6	5.3	6.8	17.4	13.7	84.7	72.9	52.9	436.9	20.2	33.8	23.3	48.1	97.9	40.2	39.5	13.8	24.5	56.1	30.2	50.3	24.5	35.6	1305.6	41.4	26.0	32.1	61.3	43.7	33.2	40.4	43.6	55.5	45.1	21.9	51.8	26.8	102.4	30.2	18.1	89.5	30.2	50.7	28.0
KLHDC8B	MGC35097	ENSG00000185909	"Kelch domain containing 8B"	Q8IXV7	3	49171611-49176486	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Sertoli cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 19.4"	"Group enriched"	"Detected in many"	9	"granulocytes: 19.4;monocytes: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008463, HPA014467"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA008463: AB_1852563, HPA014467: AB_1852565"	"unprognostic (1.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.31e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.66e-1)"	"unprognostic (5.03e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (1.47e-4)"	"unprognostic (6.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-3)"	"unprognostic (4.78e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-2)"	15.0	44.0	5.6	4.7	5.8	3.2	12.6	4.5	8.8	12.8	19.3	6.2	10.5	4.6	15.9	12.2	22.6	11.6	13.6	30.5	3.7	8.5	5.6	8.8	6.6	6.3	4.9	5.4	29.6	6.2	5.2	4.2	7.9	5.2	15.2	2.5	21.8	8.4	9.5	15.8	9.8	5.4	18.0	2.4	6.7	6.7	10.0	3.0	2.0	17.1	10.7	6.6	20.0	8.8	0.1	0.6	19.4	5.7	0.0	1.4	1.6	1.5	3.4	14.3	7.2	8.8	5.2	4.4	5.2	3.0	5.2	4.2	2.2	4.6	0.0	3.0	8.7	1.5	0.0	3.5	3.2	1.3	2.8	0.9	9.2	9.3	5.8	16.8	0.0	5.4	8.7	15.3	6.8	0.5	11.8	13.4	3.3	14.3	0.1	3.9	0.4	0.9	10.2	4.7	0.8	8.2	1.4	1.4	0.4	3.9	0.8	0.6	16.2	4.2	0.1	10.4	3.1	4.3	4.5	5.8	4.0	11.3	7.1	1.6	1.3	0.4	0.2	2.9	0.0	1.9	0.0	3.8	19.4	0.8	5.7	0.3	0.0	0.4	0.6	0.3	0.1	1.4	0.8	6.7	0.0	5.0	0.6	0.1	1.6	5.6	5.8	4.5	8.8	3.7	8.5	4.9	5.4	5.2	3.0	8.9	10.4	0.5	10.9	6.8	1.2	36.6	7.6	0.0	5.7	7.0	2.0	6.9	14.9	13.0	6.0	17.8	0.7	0.0	5.2	7.0	14.6	6.8	1.1	5.8	37.1	0.0	6.4	33.7	5.4	5.8	14.1	6.3	11.8	0.0	2.0	19.8	8.8	1.4	13.4	11.3	2.6	97.0	26.4	3.7	4.1	8.5	41.6	2.1	1.5	6.2
KLHL7	"KLHL6, RP42, SBBI26"	ENSG00000122550	"Kelch like family member 7"	Q8IXQ5	7	23105758-23177914	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 452.0;Late spermatids: 236.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029491, HPA029492"	Uncertain		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029491: AB_10599605, HPA029492: AB_10600881"	"unprognostic (1.24e-2)"	"unprognostic (4.45e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (3.78e-1)"	"unprognostic (6.10e-2)"	"unprognostic (6.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (8.98e-5)"	"unprognostic (2.46e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.23e-2)"	"unprognostic (2.27e-2)"	7.5	14.6	9.2	5.6	13.0	8.2	10.3	12.6	15.1	8.8	5.7	7.9	4.7	5.9	9.1	9.9	7.7	7.4	7.6	37.1	8.1	8.7	9.2	7.7	6.4	5.8	8.3	9.7	9.6	5.9	7.1	6.1	6.5	15.9	8.1	6.3	8.6	7.2	6.8	7.4	8.6	5.8	8.1	10.6	5.8	5.2	40.7	6.2	9.6	7.2	5.1	6.7	6.9	7.1	5.5	5.5	32.0	8.7	4.2	8.0	6.0	10.9	9.4	25.9	30.6	12.7	11.1	9.5	9.7	14.4	14.3	16.7	11.4	8.0	10.8	7.9	11.8	23.7	11.9	9.9	6.8	12.1	2.8	7.1	7.1	8.1	14.6	9.5	14.3	5.6	9.8	8.9	16.4	13.5	11.4	18.2	13.4	12.4	11.8	23.3	12.6	11.9	22.8	35.7	7.5	11.2	10.6	14.5	9.8	13.4	9.5	15.6	15.3	21.1	10.5	9.9	16.6	8.7	7.5	7.7	12.1	12.6	26.5	11.5	18.6	15.2	25.7	8.0	15.2	14.4	18.7	7.8	32.0	6.8	8.7	7.1	4.5	7.3	6.4	5.5	5.5	5.5	5.4	7.4	4.2	7.5	4.0	8.0	6.0	9.2	13.0	12.6	15.1	8.1	8.7	8.3	9.7	15.9	6.2	20.8	5.6	13.3	15.2	20.9	19.9	85.8	5.1	16.0	9.1	8.7	27.5	18.6	10.0	15.7	452.0	14.1	4.9	0.0	15.3	24.1	17.0	11.5	20.8	5.9	16.7	35.0	10.4	14.1	15.3	236.4	15.5	14.1	11.8	12.6	7.6	23.5	14.7	0.0	19.4	9.8	15.0	6.5	19.1	94.0	10.6	29.5	19.8	15.2	6.4	22.7
KLHL8	KIAA1378	ENSG00000145332	"Kelch like family member 8"	Q9P2G9	4	87160103-87240314	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 56.2"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 205.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013856, HPA017762"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013856: AB_1852594, HPA017762: AB_2669660"	"unprognostic (2.93e-2)"	"unprognostic (4.91e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.46e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.53e-5)"	"unprognostic (4.24e-3)"	"unprognostic (3.05e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.57e-3)"	6.8	7.3	6.9	5.6	8.1	3.0	12.0	10.0	10.7	9.2	7.5	5.3	3.8	7.3	8.3	56.2	5.3	5.4	5.0	7.4	7.7	7.2	11.4	10.3	9.0	8.1	6.3	5.6	6.1	6.3	7.1	14.2	6.6	7.3	5.7	8.5	4.6	6.5	7.7	23.4	4.8	8.2	6.6	8.0	6.9	5.5	4.2	6.5	7.0	17.3	2.9	4.7	6.8	10.9	3.8	10.3	8.6	12.1	8.7	4.9	5.0	6.5	5.8	10.5	4.7	9.6	7.0	5.6	8.4	4.5	5.6	6.6	9.2	5.0	9.5	6.8	6.2	4.6	2.8	11.1	8.3	12.2	9.1	7.0	11.6	4.4	5.4	8.2	19.0	7.3	8.8	6.0	8.6	8.7	5.5	6.7	7.3	14.9	8.7	5.8	7.2	22.7	9.6	2.6	14.8	2.3	8.6	9.0	5.8	9.5	6.8	22.0	7.7	5.5	13.5	6.2	4.1	4.7	14.1	6.2	7.2	8.8	7.6	7.0	13.1	8.5	16.9	5.4	9.1	7.8	1.9	12.1	7.3	3.0	9.2	4.9	3.3	2.4	2.5	10.3	3.8	4.4	4.3	8.6	8.7	9.0	2.7	0.9	5.0	6.9	8.1	10.0	10.7	7.7	7.2	6.3	5.6	7.3	6.5	3.0	18.5	11.3	9.5	12.2	18.4	11.7	5.1	6.7	10.3	41.8	39.3	3.2	10.0	4.5	2.8	9.5	12.2	0.0	3.9	4.6	8.6	10.5	7.0	17.1	8.6	22.3	8.6	5.5	30.8	2.4	8.9	13.4	10.1	2.8	12.0	205.6	5.0	8.6	7.8	16.5	44.7	12.9	9.2	11.2	19.4	12.9	19.9	7.7	13.3	9.8
KLRG1	"2F1, CLEC15A, MAFA, MAFA-L"	ENSG00000139187	"Killer cell lectin like receptor G1"	Q96E93	12	8950044-9010760	"Predicted intracellular proteins, Predicted membrane proteins"	"Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 83.1"	"Cell type enhanced"	"Detected in many"	20	"Erythroid cells: 23.3;granulocytes: 113.5;T-cells: 58.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 71.3;MAIT T-cell: 83.1"	"Lineage enriched"	"Detected in many"	28	"T-cells: 83.1"	"Group enriched"	"Detected in many"	5	"HEL: 23.6;HUVEC TERT2: 8.3;NTERA-2: 16.2;U-937: 14.8"	"Low region specificity"	"Detected in some"							"HPA051403, HPA076494"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA051403: , HPA076494: AB_2686800"	"unprognostic (1.54e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.53e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.45e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.86e-2)"	15.4	3.9	4.4	7.3	5.8	5.6	5.7	12.3	5.0	3.2	3.5	7.1	0.8	1.7	5.6	4.2	2.2	2.6	7.7	5.1	4.4	5.8	3.2	6.4	5.5	17.3	8.3	3.4	2.7	1.9	1.5	5.6	1.5	5.5	4.8	4.7	5.6	3.5	1.8	3.1	2.2	5.0	3.9	5.5	19.0	3.6	2.2	6.8	6.8	2.9	2.3	11.1	8.3	2.6	0.5	1.3	2.4	0.6	2.9	83.1	14.0	0.1	2.2	1.2	1.7	2.0	0.4	1.1	0.3	0.3	0.2	0.7	0.8	0.7	3.1	0.1	0.3	1.6	0.2	2.9	0.3	0.3	2.3	1.5	23.6	0.3	1.2	0.6	0.8	1.2	1.4	0.3	0.4	0.0	0.4	8.3	1.8	1.0	0.3	0.2	0.5	0.5	1.6	16.2	0.8	1.5	0.9	0.7	0.0	0.3	0.3	0.4	3.2	0.7	0.4	0.9	3.1	0.2	1.1	0.6	0.5	0.7	0.4	1.0	1.0	2.8	1.8	1.4	14.8	0.2	2.4	0.3	0.2	71.3	0.4	83.1	0.5	15.8	43.4	1.3	0.5	4.3	29.9	0.9	2.9	0.6	0.5	1.2	14.0	4.4	5.8	12.3	5.0	4.4	5.8	8.3	3.4	5.5	6.8	0.0	7.0	4.7	0.4	0.3	4.1	2.5	0.0	0.0	0.0	0.0	7.9	0.8	1.7	0.5	1.7	1.6	0.0	23.3	0.2	0.3	0.4	0.2	113.5	1.8	3.0	4.8	1.2	16.0	5.9	2.0	0.6	1.7	1.7	1.0	0.0	1.5	0.2	0.0	0.0	2.2	3.5	0.0	0.5	1.6	4.3	0.0	0.2	58.9	0.6	0.0
KNL1	"AF15Q14, CASC5, CT29, D40, hKNL-1, hSpc105, KIAA1570, MCPH4, PPP1R55, Spc7"	ENSG00000137812	"Kinetochore scaffold 1"	Q8NG31	15	40594020-40664342	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"lymphoid tissue: 54.7;testis: 35.6"	"Cell type enhanced"	"Detected in some"	12	"Club cells: 3.4;Extravillous trophoblasts: 9.3;Hofbauer cells: 5.6;Proximal tubular cells: 8.4;Syncytiotrophoblasts: 3.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA026624, HPA049647"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		Yes	Yes			Nucleoplasm	"Nuclear bodies"	"HPA026624: AB_10601696, HPA049647: AB_2680840"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.59e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (2.06e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.20e-4)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-12)"	"unprognostic (3.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (7.36e-2)"	0.7	0.5	0.3	7.1	0.4	5.4	0.7	0.3	0.3	0.6	4.0	0.1	0.0	1.5	0.4	0.8	3.9	0.4	0.9	0.5	0.4	0.4	0.9	1.0	1.3	4.7	0.3	0.0	0.5	0.5	0.0	0.4	2.8	0.1	0.5	1.5	0.0	0.8	0.0	0.4	0.8	3.9	0.5	0.4	3.3	0.8	35.6	0.0	54.7	0.5	4.1	3.7	0.7	0.9	2.9	1.2	0.7	0.5	0.7	2.5	0.0	10.9	5.6	11.5	8.3	0.3	1.7	5.1	12.8	5.2	10.0	8.5	6.9	4.4	7.3	4.1	5.5	7.6	13.7	10.8	6.0	10.6	12.6	3.0	21.4	9.6	2.0	0.0	16.3	10.8	0.3	0.2	6.7	4.2	1.3	8.5	13.0	13.7	12.2	11.7	3.7	13.9	3.3	5.6	6.6	6.0	12.7	16.5	3.6	1.5	9.7	9.9	4.6	11.1	6.3	1.3	3.8	6.8	5.0	7.9	11.7	10.4	13.4	7.1	4.7	15.9	14.2	4.7	11.1	11.1	0.4	0.2	0.1	0.1	0.1	0.0	2.9	1.1	0.1	1.2	2.2	0.0	0.7	0.7	0.7	0.5	0.1	2.5	0.0	0.3	0.4	0.3	0.3	0.4	0.4	0.3	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	3.4	1.8	0.0	2.4	1.7	0.2	0.0	0.0	0.0	0.0	0.5	9.3	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0
KNOP1	"101F10.1, C16orf88, FAM191A, TSG118"	ENSG00000103550	"Lysine rich nucleolar protein 1"	Q1ED39	16	19701934-19718235	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041079, HPA066169"	Uncertain		Enhanced	"Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	Cytosol	"HPA041079: AB_10962350, HPA066169: AB_2685628"	"unprognostic (6.55e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-2)"	"unprognostic (8.57e-3)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (3.75e-6)"	"unprognostic (2.50e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.18e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.34e-3)"	"unprognostic (1.08e-1)"	6.9	7.1	13.9	7.6	34.7	3.9	13.8	11.1	23.7	7.1	9.5	20.9	8.5	8.2	8.5	10.9	10.1	8.1	7.3	6.9	17.0	10.5	6.2	7.6	5.5	9.4	33.1	9.1	12.8	19.6	17.2	6.4	10.3	18.1	8.1	11.1	4.9	13.9	9.8	15.2	15.0	8.2	5.8	21.2	6.4	9.3	10.0	33.2	4.9	7.3	5.8	7.5	8.4	7.7	7.0	5.2	1.6	8.0	4.5	12.8	4.4	12.4	19.2	21.4	16.2	5.3	5.0	11.0	7.7	4.2	7.4	7.5	13.5	10.9	14.9	31.7	4.7	6.5	11.6	16.6	10.6	7.2	10.0	11.6	8.8	10.9	17.7	9.7	13.7	6.9	3.2	15.2	9.7	8.0	6.5	7.8	10.6	26.9	6.7	6.9	16.3	12.1	11.4	41.7	12.4	7.7	26.1	11.5	17.3	7.8	11.9	19.3	16.3	9.6	12.4	12.6	12.8	14.5	9.3	9.0	11.7	12.0	7.1	10.2	9.9	20.5	18.7	6.3	10.5	11.3	0.4	3.5	1.6	4.8	8.0	7.2	6.6	6.9	4.8	4.2	7.0	12.8	7.2	1.0	4.5	7.0	5.2	4.4	4.4	13.9	34.7	11.1	23.7	17.0	10.5	33.1	9.1	18.1	33.2	6.0	16.2	27.4	24.0	10.9	38.4	6.5	40.8	17.4	12.5	36.6	82.5	46.7	39.7	78.4	1.8	39.8	26.2	0.0	57.5	34.0	26.3	21.6	5.8	47.9	31.3	33.4	14.5	23.4	23.1	5.2	56.1	24.0	11.8	27.1	35.8	17.1	64.2	10.5	50.5	25.8	56.7	45.3	37.1	37.0	132.6	14.1	20.6	20.0	51.0	21.1
KNSTRN	"C15orf23, FLJ14502, kinastrin, SKAP, TRAF4AF1"	ENSG00000128944	"Kinetochore localized astrin/SPAG5 binding protein"	Q9Y448	15	40382721-40394246	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 26.2;lymphoid tissue: 18.4;testis: 40.1;thyroid gland: 59.8"	"Group enriched"	"Detected in many"	4	"Early spermatids: 321.9;Late spermatids: 423.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA042027	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		Yes	Yes			"Mitotic spindle, Centriolar satellite"	"Plasma membrane"	"HPA042027: AB_10797378"	"unprognostic (2.35e-3)"	"unprognostic (6.83e-2)"	"unprognostic (3.01e-1)"	"unprognostic (5.23e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (3.43e-5)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (7.88e-9)"	"unprognostic (1.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.52e-2)"	5.5	4.4	6.7	5.5	6.3	7.3	9.0	8.1	7.0	3.3	4.5	4.0	8.0	5.3	3.9	7.8	6.2	3.4	2.5	4.1	6.0	5.3	4.2	7.0	4.1	8.0	4.6	7.1	3.4	3.5	6.0	4.2	7.4	6.8	4.4	6.3	2.5	6.4	5.0	7.5	4.2	4.1	5.9	4.3	4.8	6.2	40.1	4.5	18.4	59.8	6.0	9.1	3.8	3.7	5.9	11.0	10.0	26.2	5.5	5.5	4.0	31.2	14.7	29.4	19.2	6.5	10.1	15.3	21.7	16.9	44.9	39.7	31.5	13.8	12.1	11.1	14.6	35.8	36.2	31.3	20.1	40.7	21.5	15.3	35.9	33.0	19.8	6.1	19.2	18.8	5.2	11.6	22.6	22.7	11.0	25.1	30.5	25.8	21.0	37.7	15.8	16.6	15.5	18.5	26.8	22.4	17.1	22.1	14.0	15.6	13.0	28.7	19.9	18.1	20.0	4.8	18.6	20.9	13.8	12.9	21.7	22.2	22.1	30.0	18.0	29.1	21.8	13.4	25.8	17.7	4.8	10.3	10.0	4.8	14.5	4.4	5.9	3.6	4.4	11.0	5.4	3.5	3.6	5.9	5.5	26.2	7.5	5.5	4.0	6.7	6.3	8.1	7.0	6.0	5.3	4.6	7.1	6.8	4.5	8.9	0.6	0.8	3.1	1.9	7.8	4.7	2.5	9.4	5.7	0.0	7.9	14.3	3.3	9.5	321.9	1.7	1.6	46.7	8.1	35.4	6.2	3.8	1.1	5.7	18.4	4.8	2.4	3.1	7.5	423.6	8.3	7.6	3.3	8.2	3.6	7.0	8.7	0.0	6.7	4.4	7.4	0.0	2.7	83.7	18.1	1.3	17.6	3.2	3.0	2.8
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.9	17.8	30.7	15.5	20.0	22.1	9.7	23.2	19.7	25.5	23.1	21.4	14.7	21.9	21.4	25.5	20.2	15.8	24.0	19.8	37.7	5.9	9.1	26.9	16.0	11.9	11.7	23.8	12.4	15.3	25.8	18.3	25.8	12.5	27.8	11.9	18.8	12.7	23.1	14.0	17.2	5.7	13.3	21.2	19.2	17.7	25.5	14.0	11.1	21.1	21.2	12.8	24.9	13.6	20.2	25.1	18.0	14.1	23.7	16.0	17.6	7.8	17.9	12.2	12.3	40.7	22.4	16.7	16.2	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5	14.9	28.5	15.2	21.0	36.9	27.4	26.5	25.5	46.8	42.1	14.0	29.5	18.8	11.6	21.1	89.9	29.2	15.5	46.7	28.8	20.9	21.6	27.0	38.1	43.9	20.5	19.1	15.6	26.4	29.7	145.2	20.8	25.2	16.9	25.2	17.0	23.9	27.4	17.5	23.3	16.7	47.9	12.9	33.5	30.1	16.6	39.6	20.8	27.3	10.7	24.2
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 663.6;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	62.2	81.9	78.2	31.3	11.6	11.3	49.7	55.0	42.7	88.9	69.4	56.3	29.2	58.5	17.4	31.7	44.3	34.5	86.4	42.9	102.4	23.5	50.9	51.8	39.6	53.7	12.2	44.5	35.7	7.0	8.1	51.1	31.5	12.5	85.5	25.0	41.1	42.3	78.8	58.1	55.5	28.7	52.8	50.8	42.5	30.7	71.4	32.0	35.0	29.2	31.1	34.6	30.9	99.8	32.3	74.7	58.1	22.4	33.3	49.3	61.0	34.7	73.9	35.1	50.2	58.4	24.0	38.3	52.9	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0	11.9	32.3	47.6	33.0	97.4	19.1	12.6	7.6	8.1	18.2	17.4	7.9	59.0	13.3	31.3	663.6	49.2	9.8	70.0	22.3	244.0	94.4	18.1	43.8	15.3	104.7	30.2	41.1	16.0	36.5	186.9	17.8	52.4	50.6	104.6	9.7	29.4	18.3	10.5	13.8	26.9	17.8	32.3	72.6	296.7	211.0	77.3	99.4	34.5	15.8	20.4
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		250000	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.8	12.0	12.4	16.7	14.3	13.2	16.3	21.1	15.1	15.5	13.2	15.3	17.8	18.0	25.3	21.6	23.2	15.8	13.9	13.6	23.4	22.3	7.8	15.2	10.7	9.1	18.6	21.2	13.7	13.5	14.4	15.0	30.6	12.5	20.4	8.9	11.4	14.6	22.0	9.5	19.1	8.8	25.2	15.3	11.2	12.8	18.5	18.2	12.5	13.0	10.1	9.8	20.4	20.5	29.3	14.4	17.8	11.6	22.7	17.8	15.3	17.7	33.9	26.8	17.7	41.3	16.2	22.2	15.7	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3	35.7	24.3	27.5	63.0	109.9	56.4	153.2	20.4	40.2	43.3	10.4	74.6	22.7	29.9	33.3	19.9	45.0	51.2	0.0	32.4	20.6	50.3	69.0	30.1	26.1	35.0	50.9	27.5	29.4	41.9	14.3	31.4	45.8	42.2	26.2	29.9	52.1	57.1	33.4	32.5	31.4	60.8	32.3	42.2	40.3	21.8	110.2	34.0	29.9	30.5	94.6
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.7	74.6	47.5	43.1	23.0	40.0	47.7	52.2	46.8	68.5	53.9	130.2	26.1	56.5	35.7	48.7	48.3	31.0	85.7	48.1	104.1	34.7	52.3	62.4	60.2	40.7	23.7	70.6	41.1	32.4	21.2	78.6	77.1	29.2	45.1	31.5	70.5	38.7	52.9	47.6	65.4	21.2	45.2	29.9	47.2	40.6	84.0	32.9	28.1	62.7	41.8	38.8	35.7	19.2	30.2	59.2	41.5	27.3	37.5	74.9	46.5	38.9	63.2	47.4	54.7	81.0	31.9	34.2	54.9	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8	119.1	66.6	108.8	81.6	111.6	93.4	119.7	66.2	52.2	73.9	41.8	64.8	98.4	34.9	106.8	32.0	100.4	53.1	46.7	102.8	118.0	87.0	86.2	75.0	80.5	109.7	76.3	118.8	122.8	99.2	31.1	89.8	89.3	57.3	151.5	71.7	76.6	115.8	60.4	114.2	42.9	82.7	97.0	78.3	276.1	166.5	125.5	132.3	92.4	98.1	114.9
KRI1	FLJ12949	ENSG00000129347	"KRI1 homolog"	Q8N9T8	19	10553078-10566037	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 57.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043110, HPA043574"	Approved		Enhanced	Nucleoli		Yes	No			Nucleoli		"HPA043110: AB_2678321, HPA043574: AB_2678561"	"unprognostic (6.38e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (9.37e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.35e-2)"	"unprognostic (5.10e-3)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.46e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (4.89e-10)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.02e-1)"	14.7	12.5	10.4	23.6	20.6	19.1	14.3	27.8	19.6	14.5	13.4	16.6	12.4	12.7	15.9	17.6	17.2	14.3	15.0	12.1	13.1	10.3	11.9	13.3	12.4	25.2	16.7	9.8	17.2	19.5	21.0	18.3	10.9	14.9	15.6	9.8	20.3	14.7	18.2	23.0	25.3	16.8	15.0	17.2	23.0	12.7	14.6	18.6	46.8	15.6	10.9	21.3	15.8	15.9	8.5	14.1	2.5	4.9	8.5	11.2	3.9	12.3	6.3	8.1	11.7	4.4	4.9	5.6	11.4	5.4	7.2	6.7	9.1	4.5	18.2	13.5	4.6	6.3	9.7	9.9	8.9	8.2	19.8	22.5	57.8	12.2	5.9	8.1	22.6	21.0	6.0	7.3	10.4	10.7	6.3	4.6	11.1	16.1	18.6	6.2	11.0	23.2	33.7	13.0	10.0	15.1	9.8	10.6	9.0	6.1	11.0	13.4	6.3	13.4	7.9	8.4	7.5	9.9	16.6	5.5	9.4	7.9	25.2	23.8	13.2	15.3	13.1	7.9	18.4	14.0	1.3	4.5	2.5	11.2	4.9	10.3	7.1	7.5	9.0	5.8	8.5	8.4	9.0	0.8	8.5	2.5	14.1	5.4	3.9	10.4	20.6	27.8	19.6	13.1	10.3	16.7	9.8	14.9	18.6	14.9	23.8	9.3	12.1	11.9	14.0	6.1	7.6	22.7	22.7	14.0	37.3	9.8	1.7	6.5	3.2	7.3	6.7	0.0	6.4	7.3	8.2	6.6	18.5	7.4	6.8	11.1	9.2	9.8	10.2	5.0	7.8	8.2	8.5	1.8	7.8	8.9	5.0	7.0	8.5	3.9	51.4	0.0	7.3	28.7	15.0	12.0	3.8	15.3	9.5	5.9
KRR1	"HRB2, RIP-1"	ENSG00000111615	"KRR1, small subunit processome component homolog"	Q13601	12	75490861-75511636	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043433, HPA051690"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA043433: AB_10960988, HPA051690: AB_2681574"	"unprognostic (2.77e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.71e-2)"	"unprognostic (6.01e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.12e-2)"	22.5	18.4	14.2	15.1	22.0	38.0	17.8	29.1	23.3	21.2	14.3	6.7	14.6	12.6	18.3	15.2	24.2	14.7	10.5	12.5	12.6	10.8	23.7	25.0	13.5	18.2	12.8	16.4	21.7	15.0	17.8	33.5	21.4	19.8	20.9	11.8	6.3	20.7	14.2	28.8	16.6	15.2	15.7	16.1	19.8	15.1	12.3	17.3	24.3	20.5	22.4	18.1	19.6	16.4	15.8	10.8	8.9	4.6	8.6	14.7	5.6	25.4	21.1	13.3	11.8	10.5	9.6	24.3	22.3	14.2	17.6	11.3	15.4	13.4	27.1	18.2	11.0	17.6	13.4	17.8	19.6	19.9	22.3	18.1	26.2	11.7	17.9	12.7	46.1	16.6	9.9	16.8	20.2	19.3	17.8	12.0	25.9	28.9	8.7	17.2	16.8	26.8	13.1	19.6	14.1	19.3	21.3	25.6	16.3	19.6	32.2	16.0	13.3	21.1	15.0	26.3	13.3	24.9	18.8	14.9	16.3	10.8	16.8	23.1	17.4	21.8	17.0	8.8	16.3	29.3	7.7	2.4	8.9	10.1	4.6	12.4	15.8	14.1	11.4	3.9	14.4	14.7	13.8	1.1	8.6	3.7	10.8	12.5	5.6	14.2	22.0	29.1	23.3	12.6	10.8	12.8	16.4	19.8	17.3	65.5	42.2	31.8	91.0	43.6	53.3	22.4	15.3	48.2	54.6	38.4	31.4	56.6	49.7	37.5	4.0	32.2	15.1	0.0	42.7	45.8	41.4	40.8	36.9	36.7	26.1	69.9	17.2	22.1	18.8	5.3	48.6	29.3	11.8	32.5	23.2	65.0	33.7	27.9	50.2	37.3	53.6	12.9	36.3	55.6	54.8	38.8	58.9	48.4	29.3	62.9
KRT13	"CK13, K13, MGC161462, MGC3781"	ENSG00000171401	"Keratin 13"	P13646	17	41500981-41505705	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 1075.6;lymphoid tissue: 404.8;tongue: 499.8"	"Cell type enriched"	"Detected in some"	11	"Urothelial cells: 2979.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 899.2;head and neck cancer: 758.7;urothelial cancer: 504.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	100	"A-431: 216.9;HaCaT: 144.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000133, HPA030877, HPA069771"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		1100000000	"Intermediate filaments"		"CAB000133: , HPA030877: AB_2673641, HPA069771: AB_2732141"	"unprognostic (1.45e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (9.30e-5)"	"unprognostic (7.30e-3)"		"unprognostic (1.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.81e-3)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (1.45e-6)"	"unprognostic (1.80e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.33e-1)"	0.3	0.3	0.0	0.3	0.0	0.5	0.3	0.0	0.3	250.9	0.3	0.0	0.0	0.3	13.7	0.3	1075.6	0.3	0.6	0.5	0.0	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.3	0.3	0.3	0.0	0.3	0.0	2.4	0.3	0.1	134.9	0.4	0.4	0.3	0.3	1.7	0.0	0.3	0.3	0.4	0.0	0.6	0.3	499.8	404.8	14.9	222.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	216.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	144.9	0.0	0.0	0.0	0.1	0.0	0.3	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.7	0.0	0.2	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.5	0.4	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.6	1.3	250.4	2.5	0.0	0.6	0.0	1.4	14.8	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	66.7	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.2	51.8	0.0	0.0	0.0	0.4	0.0	0.1	2.5	269.4	0.0	0.0	0.0	0.2	0.2	0.4	1.4	0.3	0.0	0.2	2979.9
KRT14	"EBS3, EBS4"	ENSG00000186847	"Keratin 14"	P02533	17	41582279-41586921	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skin 1: 439.2;tongue: 363.5"	"Group enriched"	"Detected in some"	11	"Basal keratinocytes: 31612.6;Suprabasal keratinocytes: 10207.3"	"Group enriched"	"Detected in many"	6	"cervical cancer: 1263.1;head and neck cancer: 5910.5;melanoma: 1277.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 265.9;HBEC3-KT: 131.1;hTCEpi: 164.0;hTERT-HME1: 53.6;U-2197: 46.3"					"Not detected"	"Not detected"			"CAB000134, HPA000452, HPA000539, HPA023040"	Enhanced		Enhanced	"Intermediate filaments"		NA	NA		2200000000	"Intermediate filaments"		"CAB000134: , HPA000452: AB_1079177, HPA000539: , HPA023040: AB_1852201"	"prognostic favorable (2.66e-4)"	"unprognostic (1.64e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.02e-2)"		"unprognostic (2.03e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.00e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.49e-8)"	"unprognostic (8.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.22e-2)"	0.2	0.1	0.2	0.2	0.2	0.2	23.1	0.2	0.2	27.0	0.2	0.2	0.2	0.1	0.3	0.2	69.3	0.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	7.6	0.2	2.1	0.1	0.2	30.8	0.3	1.0	439.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	4.6	0.2	363.5	47.6	0.2	37.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	265.9	0.0	131.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	164.0	0.2	53.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	46.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	999.3	31612.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	6.8	0.0	0.0	56.3	2.6	68.2	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1887.9	0.0	0.0	0.0	0.3	3.5	0.0	0.0	0.0	0.0	75.4	0.0	0.0	10207.3	2.1	0.0	0.2	106.7
KRT17	PCHC1	ENSG00000128422	"Keratin 17"	Q04695	17	41619437-41624842	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 109.0;tongue: 144.0"	"Group enriched"	"Detected in many"	8	"Basal glandular cells: 10709.5;Urothelial cells: 6883.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 3317.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 653.9;SiHa: 272.2"	"Not detected"	"Not detected"							"CAB000029, HPA000452, HPA000453, HPA000539, HPA045062"	Enhanced		Enhanced	"Intermediate filaments"		Yes	No		750000000	"Intermediate filaments"		"CAB000029: AB_2133155, HPA000452: AB_1079177, HPA000453: AB_1079176, HPA000539: , HPA045062: AB_2679204"	"prognostic favorable (4.44e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.65e-3)"	"unprognostic (4.46e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.86e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.74e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.89e-1)"	0.7	0.0	0.7	0.7	0.7	0.1	52.3	0.7	0.8	12.6	0.8	0.7	1.2	0.0	1.0	3.1	38.6	0.9	0.9	0.7	0.7	0.0	0.8	0.7	3.7	0.7	0.7	1.0	0.8	0.7	0.0	0.9	4.1	0.8	15.0	0.0	0.7	26.8	33.4	0.7	109.0	0.7	1.2	0.7	0.7	0.0	0.8	0.7	5.1	0.8	144.0	19.7	55.6	25.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	6.5	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	66.1	0.0	67.6	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	653.9	0.0	50.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	24.8	0.0	0.0	272.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.7	0.7	0.8	0.7	0.0	0.7	1.0	0.8	0.7	20.8	7.4	0.0	10709.5	124.0	0.0	0.0	0.0	112.4	563.0	34.9	0.0	2.0	0.0	285.1	0.3	2.9	0.0	0.0	180.6	118.1	9.3	924.1	3.5	0.0	3.5	19.1	1.7	0.0	0.0	1.3	2.0	7.9	10.1	11.8	0.1	0.0	1050.1	0.0	199.8	0.0	0.0	0.0	5.7	0.4	0.2	108.7	4.8	0.5	0.6	6883.0
KRT6A	"CK6C, CK6D, K6C, K6D, KRT6C, KRT6D"	ENSG00000205420	"Keratin 6A"	P02538	12	52487174-52493257	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Allergen, Disease mutation, Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix, uterine: 209.2;esophagus: 422.1;tongue: 620.2;vagina: 179.1"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 93.8;Suprabasal keratinocytes: 132.4;Urothelial cells: 329.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3892.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"hTCEpi: 470.1"									"HPA045697, HPA061168"	Supported		Enhanced	"Intermediate filaments"		NA	NA		7200000000	"Intermediate filaments"		"HPA045697: AB_2679422, HPA061168: AB_2684440"	"unprognostic (8.10e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.06e-1)"		"unprognostic (2.45e-1)"		"prognostic unfavorable (1.45e-4)"	"unprognostic (2.43e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.89e-9)"	"unprognostic (8.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.13e-2)"	0.2	0.2	0.0	0.4	0.0	0.2	0.8	0.0	0.3	209.2	0.2	0.0	0.0	0.2	6.8	0.2	422.1	0.3	0.3	0.3	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.1	0.2	0.2	0.2	0.0	19.8	0.0	0.3	0.2	0.0	37.6	0.2	0.2	19.0	0.2	0.3	0.0	0.2	0.2	0.2	0.0	2.7	0.2	620.2	86.8	0.5	179.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	53.9	0.0	113.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	470.1	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	32.7	93.8	0.0	0.0	0.0	2.7	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	132.4	0.0	0.0	0.0	329.0
KRT80	KB20	ENSG00000167767	"Keratin 80"	Q6KB66	12	52168996-52192000	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 43.9;skin 1: 64.0;tongue: 41.8"	"Cell type enhanced"	"Detected in some"	13	"Ductal cells: 70.7;Pancreatic endocrine cells: 32.8;Suprabasal keratinocytes: 32.6;Syncytiotrophoblasts: 48.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 44.6;MCF7: 63.7;SK-BR-3: 29.5;U-2 OS: 41.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 5.7"	"Low region specificity"	"Detected in all"			"HPA077836, HPA077918"			Enhanced	"Intermediate filaments"		No	No		290000000	"Intermediate filaments"		"HPA077836: AB_2686857, HPA077918: AB_2686871"	"prognostic unfavorable (1.05e-4)"	"unprognostic (5.45e-3)"	"unprognostic (5.35e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.85e-4)"	"unprognostic (6.68e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (8.79e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.98e-2)"	0.2	1.9	0.1	0.0	0.2	0.0	3.9	0.0	0.1	5.7	0.5	0.0	1.5	0.0	0.5	4.2	20.4	1.4	1.8	0.2	0.0	0.1	2.7	0.2	1.5	0.0	0.0	0.0	0.6	9.0	7.3	0.2	17.5	0.0	1.8	0.0	0.1	22.1	1.6	0.9	64.0	0.5	0.0	0.1	0.1	0.2	0.5	0.0	0.8	0.4	41.8	43.9	3.2	10.7	0.1	0.9	0.3	0.9	0.0	0.1	0.0	44.6	15.0	0.0	0.0	0.0	0.0	12.5	0.6	0.4	3.5	1.0	1.0	19.6	0.0	22.0	0.5	23.2	22.3	0.0	0.3	1.2	0.0	0.0	0.0	23.4	0.5	2.4	0.0	0.0	0.2	2.7	0.8	5.4	16.4	5.3	0.0	0.0	0.0	1.2	63.7	0.0	0.0	0.0	13.0	2.3	0.0	18.4	0.6	20.1	8.0	5.7	0.3	11.3	29.5	0.2	1.3	5.5	0.2	3.0	0.0	41.3	0.0	16.0	0.0	0.0	0.1	4.2	1.6	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.5	5.6	0.0	0.3	10.2	6.7	1.2	10.4	0.0	19.7	0.0	70.7	0.6	0.0	0.0	0.0	17.4	0.6	0.7	4.9	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	32.8	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	32.6	48.7	0.0	0.0	7.8
KTN1	"CG1, KIAA0004, KNT"	ENSG00000126777	"Kinectin 1"	Q86UP2	14	55559072-55701526	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003178, CAB015331, HPA017876"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB015331: , HPA003178: AB_1079218, HPA017876: AB_1852652"	"unprognostic (7.00e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.83e-5)"	"prognostic unfavorable (3.76e-4)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.08e-2)"	"unprognostic (8.72e-2)"	"prognostic favorable (1.01e-6)"	"unprognostic (1.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	26.5	27.5	30.8	18.9	37.3	9.5	44.2	30.8	35.2	22.7	28.8	15.8	23.4	13.0	18.8	30.8	26.1	16.8	18.1	36.1	32.2	25.3	33.1	31.8	21.2	16.9	39.3	24.5	23.1	22.8	48.3	54.7	21.3	49.5	26.9	28.7	13.1	21.4	24.0	101.9	41.4	20.1	40.5	51.9	22.1	18.9	40.9	42.0	14.5	33.3	37.9	17.9	32.7	39.7	35.6	58.3	27.0	15.5	19.6	24.0	4.8	40.7	28.2	21.1	23.0	29.2	28.0	30.6	33.3	26.8	20.9	18.6	18.8	50.7	31.4	47.7	34.2	22.3	76.3	25.8	29.0	35.4	52.8	14.1	22.2	46.7	35.6	27.6	32.5	18.0	26.0	26.6	25.8	44.8	45.0	34.3	25.1	21.6	18.4	40.1	31.8	27.9	19.3	16.2	18.9	42.1	22.3	55.5	14.9	52.5	64.1	26.0	21.7	52.7	24.2	29.2	45.0	25.1	20.9	48.3	42.8	54.8	21.9	31.2	8.3	11.2	23.4	50.1	19.1	23.7	27.0	14.8	14.6	19.6	13.1	18.7	28.3	23.2	22.1	14.2	35.6	24.0	20.6	9.4	19.6	15.5	58.3	14.8	4.8	30.8	37.3	30.8	35.2	32.2	25.3	39.3	24.5	49.5	42.0	285.9	218.9	134.1	191.3	581.3	188.0	751.3	254.8	254.3	215.0	406.5	339.7	116.7	26.6	214.2	480.1	300.8	208.9	46.7	262.9	169.7	168.2	247.6	130.6	360.3	102.3	308.3	215.0	264.6	155.1	281.2	230.1	161.1	163.6	161.5	208.3	454.2	307.7	252.8	415.1	100.9	370.8	329.8	235.9	615.9	350.9	632.0	137.8	123.1	224.4	298.6
L1TD1	"ECAT11, FLJ10884"	ENSG00000240563	"LINE1 type transposase domain containing 1"	Q5T7N2	1	62194831-62212328	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 18.2;placenta: 34.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 82.1;Syncytiotrophoblasts: 23.6"	"Cancer enriched"	"Detected in some"	14	"testis cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"non-classical monocyte: 8.1"	"Lineage enriched"	"Detected in single"	17	"monocytes: 8.1"	"Group enriched"	"Detected in some"	22	"NTERA-2: 68.4;SuSa: 53.8"									"HPA028501, HPA030064"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA028501: AB_10599287, HPA030064: AB_10600538"	"unprognostic (2.03e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-1)"	"unprognostic (4.03e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.52e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.95e-1)"	0.6	0.8	0.2	18.2	0.4	0.0	0.7	0.4	0.2	1.6	6.9	0.0	0.3	0.1	0.3	0.4	0.4	0.4	0.3	0.3	0.2	0.2	0.4	0.2	3.1	1.6	0.2	0.1	1.3	0.3	0.0	0.4	34.0	0.7	2.4	1.6	1.5	0.7	0.1	0.6	0.3	0.6	0.5	0.2	2.9	0.4	8.5	0.0	0.4	2.4	0.1	0.1	1.6	1.3	0.4	0.3	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.2	0.4	0.4	0.2	0.2	0.2	0.2	0.1	0.7	0.0	6.0	15.4	0.0	0.5	0.3	2.5	0.3	0.0	10.7	13.6	0.0	5.9	82.1	0.0	0.0	0.3	0.7	0.2	0.0	0.3	20.0	2.1	0.3	1.1	0.0	6.6	3.2	10.2	0.0	0.8	0.4	1.7	2.0	0.0	0.0	4.4	0.3	0.4	0.9	17.3	0.0	3.9	0.0	0.9	0.7	13.2	0.1	23.6	1.9	0.6	0.2
L2HGDH	"C14orf160, FLJ12618"	ENSG00000087299	"L-2-hydroxyglutarate dehydrogenase"	Q9H9P8	14	50237563-50312548	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 38.7;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 40.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 10.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065409, HPA069708"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA065409: AB_2685485, HPA069708: AB_2686179"	"unprognostic (1.74e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.04e-2)"	"unprognostic (4.33e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favorable (9.75e-10)"	"unprognostic (1.24e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.02e-2)"	5.4	5.1	6.9	3.6	8.4	3.5	5.1	12.7	10.9	3.5	5.6	4.9	4.8	6.2	3.4	4.3	9.0	4.4	3.2	7.7	6.1	4.7	25.5	16.0	2.5	3.3	7.7	4.7	4.2	5.4	7.1	5.8	2.6	5.7	4.6	6.8	7.7	5.0	5.6	17.7	7.0	5.0	4.7	5.3	2.3	5.6	6.0	6.0	3.7	6.5	6.2	5.2	4.6	4.4	1.4	1.5	10.5	0.6	2.4	3.3	0.8	14.0	9.9	4.1	3.9	2.0	1.3	11.5	4.7	2.6	7.4	8.8	15.8	6.5	11.0	5.5	1.9	5.9	10.3	12.3	4.9	8.3	8.8	7.0	23.9	6.8	2.2	1.9	8.4	8.3	1.2	3.1	4.9	4.3	1.8	3.2	11.5	8.3	7.0	1.9	16.9	9.5	3.8	5.9	12.0	10.5	9.0	13.3	8.6	6.9	16.5	8.4	6.0	13.8	10.5	6.0	5.7	13.8	2.3	2.9	4.7	13.2	5.4	6.2	6.4	14.5	15.6	2.6	4.3	5.2	10.5	0.6	1.4	1.5	0.3	3.3	1.4	1.7	1.6	0.9	1.2	2.1	2.6	0.9	2.4	0.3	1.5	2.4	0.8	6.9	8.4	12.7	10.9	6.1	4.7	7.7	4.7	5.7	6.0	38.7	16.3	4.4	2.3	3.3	15.6	12.6	0.0	32.1	35.2	12.2	53.0	4.7	13.3	3.5	21.5	2.1	4.7	0.0	3.8	5.8	2.1	2.4	17.4	13.9	1.9	11.1	7.5	3.1	1.5	5.6	2.3	1.4	1.7	2.8	5.3	6.1	2.4	2.9	4.2	18.5	40.7	0.0	2.1	11.6	10.6	5.5	4.1	3.3	6.8	1.8
LAD1		ENSG00000159166	"Ladinin 1"	O00515	1	201373244-201399915	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 83.9;tongue: 66.9"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 171.5;monocytes: 433.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	28	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	28	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 36.7;CAPAN-2: 32.6;HaCaT: 47.4;HBEC3-KT: 36.0;hTCEpi: 35.0;MCF7: 40.2;OE19: 50.5;RT4: 34.6;SK-BR-3: 56.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA007256, HPA028732"	Enhanced		Enhanced	"Actin filaments"	"Secreted to extracellular matrix"	NA	NA			"Actin filaments"		"HPA007256: AB_1852681, HPA028732: AB_10602916"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.55e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.73e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	0.3	0.2	0.3	10.7	0.3	0.0	3.0	0.3	0.3	15.9	17.5	0.3	22.1	17.4	2.9	4.4	83.9	2.8	56.9	2.0	0.3	0.2	17.2	5.4	3.6	1.5	0.3	0.3	1.5	29.5	0.0	0.4	16.0	0.4	6.9	12.1	0.5	17.1	25.0	1.3	49.7	39.1	1.5	0.3	0.4	13.8	0.6	0.3	3.0	1.6	66.9	42.5	8.9	29.4	0.0	2.8	0.0	0.0	0.0	0.0	0.0	36.7	0.3	0.0	0.1	0.0	0.0	11.8	0.0	0.0	0.0	0.0	23.8	32.6	0.0	2.1	0.0	0.0	47.4	0.0	36.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	35.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	40.2	0.0	0.1	0.9	50.5	0.4	0.0	1.6	0.4	24.4	34.6	1.9	0.0	0.0	56.7	0.6	1.5	8.5	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.3	0.4	0.3	3.0	27.8	1.5	72.1	78.6	0.0	1.8	89.2	4.0	28.4	29.6	0.0	2.9	38.1	140.9	1.0	0.2	171.5	0.0	107.2	4.6	4.1	25.8	0.0	8.5	0.4	0.0	17.4	0.0	0.3	2.4	0.0	2.5	10.1	433.8	49.1	0.0	149.1	89.0	0.4	54.9	0.0	0.0	5.2	0.0	0.0	133.5	8.7	0.0	93.8	117.6
LAMP3	"CD208, DC-LAMP, DCLAMP, LAMP, TSC403"	ENSG00000078081	"Lysosomal associated membrane protein 3"	Q9UQV4	3	183122213-183163839	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 123.9"	"Group enriched"	"Detected in many"	7	"Alveolar cells type 2: 374.8;monocytes: 592.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Group enriched"	"Detected in many"	8	"granulocytes: 7.6;T-cells: 6.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 57.7;HDLM-2: 14.6;HHSteC: 21.4;hTCEpi: 19.5;JURKAT: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025133, HPA051467"	Enhanced		Enhanced	Vesicles		NA	NA		47000	Vesicles		"CAB025133: , HPA051467: AB_2681495"	"unprognostic (1.43e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.64e-2)"	"unprognostic (4.95e-2)"	"prognostic favorable (9.90e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (1.89e-7)"	"unprognostic (3.12e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	0.5	0.7	0.4	14.1	0.4	0.0	0.5	0.3	0.4	1.0	0.6	0.1	0.6	0.4	0.4	1.0	2.5	0.5	0.8	0.4	0.4	0.4	0.8	0.6	123.9	11.2	0.4	0.1	0.4	8.3	0.0	0.6	1.0	0.6	1.0	1.7	0.2	6.8	1.9	0.4	1.9	1.4	0.8	0.5	2.0	0.8	8.4	0.0	21.3	8.3	3.1	11.3	3.3	0.9	0.4	0.0	7.6	0.1	0.8	6.6	1.1	3.5	0.1	0.0	0.5	0.0	0.0	2.8	0.0	0.9	0.6	0.1	0.8	1.8	0.0	57.7	0.3	6.5	0.5	1.2	2.2	0.1	14.6	1.7	0.0	0.1	0.1	21.4	0.0	0.5	0.3	19.5	0.0	2.6	0.0	2.6	17.7	0.1	3.4	0.1	0.0	0.8	0.1	0.1	0.3	0.8	0.0	0.0	0.2	0.0	1.1	0.2	0.1	0.2	0.1	1.5	0.7	1.1	0.1	2.7	0.0	1.0	0.1	0.0	1.2	4.3	0.1	0.0	0.0	0.0	0.4	0.1	7.6	0.4	0.0	3.2	0.1	2.7	1.7	0.0	0.4	3.5	2.0	1.9	0.8	0.1	0.0	6.6	1.1	0.4	0.4	0.3	0.4	0.4	0.4	0.4	0.1	0.6	0.0	59.6	374.8	0.5	3.2	5.4	0.0	1.2	2.5	9.4	15.9	1.8	0.0	1.9	0.0	0.6	26.0	0.5	0.0	0.0	5.3	0.2	0.2	1.2	17.4	0.0	1.3	0.0	0.0	0.0	0.0	69.6	0.6	3.1	1.7	592.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	5.0	1.0	0.5	0.3	2.0
LARP4	PP13296	ENSG00000161813	"La ribonucleoprotein domain family member 4"	Q71RC2	12	50392383-50480004	"Predicted intracellular proteins"	"Protein biosynthesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039306, HPA039673"	Approved		Enhanced	"Nucleoli fibrillar center,Cytosol"		NA	NA			Cytosol	"Nucleoli fibrillar center"	"HPA039306: AB_10805362, HPA039673: AB_10795110"	"unprognostic (4.41e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.50e-2)"	"unprognostic (3.13e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.40e-2)"	"unprognostic (9.93e-3)"	"unprognostic (9.08e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.51e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.06e-2)"	"unprognostic (3.99e-3)"	15.1	22.5	12.3	13.5	14.4	9.4	15.0	12.2	13.1	12.1	13.8	8.1	17.7	13.0	12.4	11.6	15.1	10.7	10.4	14.7	11.3	10.4	28.5	47.8	13.6	11.3	15.6	9.0	11.5	17.1	18.3	23.1	17.7	14.8	13.1	11.7	13.4	17.3	14.7	31.3	10.2	14.8	15.7	17.9	10.9	13.2	11.2	13.5	14.0	15.9	11.2	11.8	14.0	21.4	11.8	15.6	8.9	14.6	10.9	12.1	8.9	14.9	21.4	14.2	10.4	13.3	11.1	24.2	18.5	11.0	18.3	14.7	41.7	17.5	35.4	22.9	11.5	17.0	14.4	30.9	12.5	24.2	21.9	12.7	28.7	20.1	14.8	12.4	31.8	17.0	10.0	12.1	21.6	23.4	12.1	16.1	13.0	41.2	16.9	17.0	13.4	26.0	10.7	20.5	9.7	18.7	19.2	22.6	20.9	9.9	22.6	16.9	9.9	32.8	17.1	19.1	13.8	14.9	12.9	23.2	12.2	18.1	14.0	17.4	16.6	44.2	31.4	16.9	13.1	10.1	8.9	11.6	7.7	11.4	13.0	10.8	11.7	10.1	6.4	15.6	11.8	12.1	9.6	6.5	10.9	14.6	13.5	9.8	8.9	12.3	14.4	12.2	13.1	11.3	10.4	15.6	9.0	14.8	13.5	44.7	33.6	18.1	22.2	63.1	38.6	40.9	22.9	24.1	25.0	27.9	82.5	21.5	8.3	17.0	7.2	19.1	23.3	70.0	20.6	14.9	30.6	32.6	19.6	105.2	23.1	17.5	23.1	26.4	35.8	21.2	13.8	20.7	25.3	28.9	20.6	20.5	24.0	17.3	18.0	37.0	50.8	6.5	33.0	33.5	42.6	65.0	28.6	15.2	22.3	25.5
LARP4B	"KIAA0217, LARP5"	ENSG00000107929	"La ribonucleoprotein domain family member 4B"	Q92615	10	806914-931705	"Predicted intracellular proteins, Predicted membrane proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036566, HPA042738"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA036566: AB_10673624, HPA042738: AB_2678137"	"unprognostic (3.02e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.77e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.13e-3)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (8.95e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.10e-3)"	"unprognostic (1.62e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.54e-2)"	17.5	23.1	16.5	27.7	20.7	17.9	17.3	23.8	23.8	15.0	19.7	21.2	20.9	21.7	19.1	23.6	30.9	17.0	19.4	22.0	15.8	13.0	17.6	17.0	25.4	23.0	16.0	16.7	18.2	21.0	22.3	18.6	27.1	18.3	20.0	18.4	18.9	22.1	28.1	37.1	25.1	21.7	16.0	14.4	25.2	25.3	22.9	15.9	29.5	25.8	16.8	21.8	18.3	20.0	8.3	12.2	13.5	13.6	7.7	9.8	5.2	21.4	18.3	9.5	10.6	8.7	8.9	13.9	14.7	6.8	15.8	15.5	24.7	24.4	26.4	5.8	14.4	4.7	22.9	16.9	12.2	13.9	17.7	12.3	21.6	12.5	14.4	14.2	16.2	19.5	9.7	14.2	16.0	9.3	9.1	10.8	12.4	28.7	17.2	12.8	21.4	23.1	14.3	10.3	21.2	8.5	16.8	8.3	17.7	12.8	16.5	9.4	13.4	14.2	27.5	10.9	9.7	25.8	15.3	15.1	12.2	3.3	38.7	14.5	19.7	23.5	26.1	13.6	13.1	7.7	12.9	12.6	13.5	8.7	13.6	9.0	6.7	9.5	9.8	10.8	8.3	9.2	9.8	12.0	7.7	11.1	12.2	8.6	5.2	16.5	20.7	23.8	23.8	15.8	13.0	16.0	16.7	18.3	15.9	47.6	50.2	9.7	12.4	27.0	18.8	39.5	33.1	28.1	34.2	22.7	25.5	13.9	5.0	14.8	12.1	17.9	31.3	23.3	14.0	11.0	17.2	22.4	7.0	15.6	19.0	22.3	13.2	14.7	29.6	4.7	16.1	24.5	16.9	19.0	36.3	23.2	24.6	23.0	22.6	14.6	23.9	25.8	12.2	23.8	21.2	37.3	38.7	14.1	31.0	33.3
LAX1	"FLJ20340, LAX"	ENSG00000122188	"Lymphocyte transmembrane adaptor 1"	Q8IWV1	1	203765176-203776233	"Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 26.7"	"Group enriched"	"Detected in some"	5	"granulocytes: 78.7;T-cells: 27.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 9.9;MAIT T-cell: 7.4;memory B-cell: 6.5;memory CD4 T-cell: 5.7;memory CD8 T-cell: 7.3;naive CD4 T-cell: 4.5;naive CD8 T-cell: 5.9;NK-cell: 4.6;T-reg: 6.0"	"Group enriched"	"Detected in many"	19	"B-cells: 6.5;NK-cells: 4.6;T-cells: 9.9"	"Group enriched"	"Detected in some"	4	"Karpas-707: 11.7;U-266/70: 14.4;U-266/84: 32.4;U-698: 12.3"					"Low region specificity"	"Detected in all"			"HPA002461, HPA003887, CAB025358"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Golgi apparatus"	"CAB025358: , HPA002461: AB_1079239, HPA003887: AB_1079240"	"unprognostic (2.85e-3)"	"unprognostic (3.83e-3)"	"unprognostic (3.90e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-5)"	"unprognostic (2.99e-2)"	"unprognostic (4.91e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (4.77e-1)"	"unprognostic (4.36e-1)"	"unprognostic (4.23e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.51e-1)"	1.6	0.6	0.4	19.9	0.4	1.3	1.3	0.4	0.4	1.8	3.4	0.0	0.2	2.1	1.2	1.1	4.5	1.1	3.8	0.6	0.4	0.4	1.0	0.8	6.3	17.4	0.4	0.0	0.7	0.6	0.0	0.5	0.1	0.0	2.2	2.6	1.1	5.7	1.5	0.5	1.0	5.5	1.1	0.5	11.7	3.4	1.0	0.0	22.7	1.1	0.7	26.7	6.3	2.8	6.5	0.0	0.3	0.0	4.6	9.9	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	11.7	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	32.4	12.3	0.0	0.9	0.0	0.0	0.0	0.3	9.9	0.0	7.4	6.5	5.7	7.3	0.0	1.5	4.5	5.9	0.0	4.6	0.0	0.0	6.0	2.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	3.4	11.5	0.3	1.0	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	78.7	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	27.9	0.0	0.4
LBR	"DHCR14B, TDRD18"	ENSG00000143815	"Lamin B receptor"	Q14739	1	225401502-225428925	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	"DNA-binding, Oxidoreductase, Receptor"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.7"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 163.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049840, HPA062236"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"HPA049840: AB_2680908, HPA062236: AB_2684721"	"unprognostic (2.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavorable (7.30e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.45e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.78e-1)"	16.7	4.2	5.6	22.9	7.8	37.0	14.6	5.5	7.2	23.4	37.7	14.5	10.8	16.8	31.4	19.5	17.2	21.8	11.1	7.2	6.5	6.1	15.4	18.9	12.3	31.0	9.9	4.2	14.3	11.8	2.4	5.0	11.2	9.4	19.6	19.7	6.2	8.2	16.6	6.8	7.3	20.4	32.8	9.9	25.4	21.5	8.0	8.9	88.7	8.7	6.9	28.1	28.8	16.2	14.1	13.1	70.9	15.0	12.2	19.9	20.2	25.1	9.9	33.5	14.9	14.1	8.8	16.9	6.6	8.4	13.9	14.9	19.8	43.4	51.9	14.8	6.9	8.3	19.2	23.9	7.0	21.0	30.2	24.8	12.9	9.6	16.9	8.7	56.1	22.9	7.6	4.5	12.6	11.2	7.2	17.6	25.7	39.1	35.3	9.3	3.5	51.4	31.7	30.2	24.7	3.4	34.7	30.5	48.3	15.9	11.8	9.0	11.9	11.3	8.4	5.5	15.2	11.5	37.0	11.5	3.8	20.0	10.7	23.8	12.7	17.3	58.0	5.2	25.4	13.0	22.2	15.0	21.1	15.3	10.1	17.1	13.8	14.6	16.2	13.1	14.1	14.7	17.4	70.9	12.2	7.8	6.6	19.9	20.2	5.6	7.8	5.5	7.2	6.5	6.1	9.9	4.2	9.4	8.9	26.8	31.3	74.4	22.1	24.0	4.2	5.1	50.9	28.1	45.5	29.6	5.9	27.8	5.0	20.9	0.7	42.7	17.2	163.5	17.2	18.7	25.9	27.1	9.3	64.4	38.4	11.1	25.9	44.2	84.0	2.3	31.4	51.1	25.3	15.4	30.9	12.0	18.1	21.0	30.4	22.5	9.8	38.8	33.0	14.0	27.7	31.0	9.3	46.3	62.8	28.9
LCOR	"C10orf12, DKFZP564P1916, FLJ13022, FLJ38026, KIAA1795, MLR2"	ENSG00000196233	"Ligand dependent nuclear receptor corepressor"	Q96JN0	10	96832282-96995959	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031429, HPA057621, HPA077000"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031429: AB_2673879, HPA057621: AB_2732616, HPA077000: AB_2686824"	"unprognostic (5.61e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.16e-4)"	7.5	6.4	9.9	9.2	11.6	35.5	8.6	25.7	10.5	7.8	13.8	12.6	9.4	17.4	8.9	8.1	12.9	8.3	8.3	7.8	7.3	6.9	9.1	10.0	9.4	9.7	13.6	7.5	13.1	16.9	10.3	20.3	25.9	10.8	8.7	14.1	9.5	12.1	7.4	11.9	7.1	24.2	9.4	11.4	9.9	10.9	7.6	11.7	13.2	10.5	6.6	13.2	12.5	9.7	6.8	4.8	12.2	4.2	3.4	5.4	1.9	11.2	7.4	13.0	6.0	3.7	4.2	6.7	5.7	5.0	6.5	7.1	10.0	7.8	11.9	6.0	5.5	5.5	6.5	12.6	6.9	11.5	5.6	6.5	12.2	4.3	11.8	7.3	11.5	7.1	3.8	5.9	9.6	16.7	6.5	7.0	6.4	10.2	6.2	9.5	5.4	6.7	6.1	4.3	5.8	3.4	9.1	10.3	3.5	6.5	25.1	6.0	5.2	5.5	3.4	7.3	6.2	7.4	5.1	9.7	5.3	10.7	4.2	9.3	5.9	5.1	13.9	5.1	11.9	2.4	2.1	3.8	6.4	4.8	4.2	4.6	3.8	4.0	5.4	3.1	6.8	4.7	4.7	12.2	3.4	2.5	4.8	2.4	1.9	9.9	11.6	25.7	10.5	7.3	6.9	13.6	7.5	10.8	11.7	17.9	23.2	11.8	15.3	13.7	43.1	12.4	48.4	50.9	29.6	29.6	72.6	11.6	10.0	25.1	0.8	17.3	59.9	0.0	29.4	6.5	12.3	29.5	25.5	19.5	12.0	38.1	45.1	24.5	25.9	1.1	9.5	27.5	20.3	19.0	30.3	10.3	34.4	42.1	13.1	21.3	55.5	19.4	20.8	19.2	25.0	11.3	32.3	23.0	29.6	29.7
LEO1		ENSG00000166477	"LEO1 homolog, Paf1/RNA polymerase II complex component"	Q8WVC0	15	51938025-51971806	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"granulocytes: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040741, HPA040941"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Centrosome"		No	No			"Nucleoplasm, Nucleoli fibrillar center"	Centrosome	"HPA040741: AB_10794859, HPA040941: AB_10805832"	"unprognostic (2.76e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.08e-1)"	10.7	15.2	15.0	15.3	27.9	8.3	17.0	42.6	24.4	13.4	17.8	14.1	9.7	13.9	12.6	11.2	24.4	9.7	14.2	10.6	14.0	14.0	21.4	27.8	10.2	17.2	14.8	14.9	10.6	10.3	25.2	22.4	12.7	22.7	13.8	21.0	9.1	21.2	12.5	13.5	21.8	19.8	12.6	15.3	14.3	13.9	9.8	18.5	23.4	12.0	9.4	18.2	16.9	15.7	12.3	15.3	9.6	15.3	18.9	19.7	10.0	9.6	22.6	14.6	11.7	15.1	13.1	10.5	15.8	13.1	13.6	12.4	15.6	6.4	19.6	9.3	16.2	15.1	19.0	19.4	14.1	13.1	13.0	8.8	30.9	18.4	27.3	11.9	27.8	43.2	14.0	11.1	10.6	13.8	12.9	13.2	16.6	18.7	10.8	16.1	41.2	14.7	21.1	6.3	28.9	9.7	16.5	25.3	20.5	11.9	27.2	10.4	15.9	12.0	18.5	12.3	16.7	15.4	25.4	15.7	13.5	9.3	12.4	18.8	8.5	26.5	18.1	11.8	39.9	14.3	5.4	9.4	9.6	18.7	14.6	17.5	12.3	18.7	15.2	15.3	10.1	19.5	17.5	2.3	18.9	15.3	11.5	19.7	10.0	15.0	27.9	42.6	24.4	14.0	14.0	14.8	14.9	22.7	18.5	32.8	27.7	10.4	12.9	23.2	35.2	17.1	20.4	45.5	39.8	7.0	9.8	21.3	13.3	21.4	1.6	15.0	19.3	0.0	21.0	22.3	16.2	9.1	262.5	12.3	16.9	25.4	7.5	8.6	12.3	2.1	7.5	7.8	3.3	14.4	16.3	20.9	17.2	14.0	12.7	17.9	20.8	6.5	9.2	15.6	9.0	21.7	14.8	15.4	13.9	20.1
LIMA1	EPLIN	ENSG00000050405	"LIM domain and actin binding 1"	Q9UHB6	12	50175788-50283546	"Predicted intracellular proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 458.2;Basal keratinocytes: 492.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 73.6"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023871, HPA052645"	Enhanced		Enhanced	"Plasma membrane,Actin filaments,Focal adhesion sites,Cytosol"		NA	NA		160000	"Plasma membrane, Actin filaments"	"Focal adhesion sites, Cytosol"	"HPA023871: AB_1852875, HPA052645: AB_2681898"	"unprognostic (6.22e-2)"	"unprognostic (9.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.08e-2)"	"prognostic unfavorable (1.76e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.27e-2)"	"prognostic favorable (2.79e-4)"	"unprognostic (7.12e-2)"	"unprognostic (9.26e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.43e-1)"	50.3	19.8	6.6	22.3	6.8	0.9	34.1	73.6	6.6	30.9	49.2	10.4	21.3	35.2	31.1	22.1	25.0	18.0	31.1	12.6	6.6	5.1	29.3	11.1	23.3	11.8	7.2	4.1	21.1	12.4	12.4	18.6	42.0	15.4	28.2	42.8	20.7	27.0	22.1	10.5	16.3	90.5	33.8	10.4	23.6	30.3	11.8	6.0	12.1	17.0	20.7	18.0	41.8	21.4	0.6	4.4	1.3	2.1	5.8	13.6	2.7	24.5	0.7	7.8	11.5	36.2	36.3	29.7	61.7	43.5	49.7	39.8	9.3	36.2	1.1	5.7	85.0	16.7	28.0	7.0	57.0	43.6	15.6	7.4	10.3	2.8	3.2	23.2	3.6	14.6	24.3	16.8	17.4	50.3	15.0	17.4	4.6	7.1	5.0	16.0	4.2	4.5	1.1	4.0	13.0	3.3	4.5	19.2	0.3	11.5	29.3	5.9	12.6	8.4	17.1	26.4	8.7	8.1	2.2	27.1	21.3	16.4	19.7	10.0	2.7	0.3	4.5	23.2	4.1	9.1	0.1	0.2	1.3	6.4	1.0	2.5	0.1	8.1	7.8	4.4	0.6	3.3	5.9	0.1	5.8	2.1	1.1	13.6	2.7	6.6	6.8	73.6	5.6	6.6	5.1	7.2	4.1	15.4	6.0	41.7	69.6	5.7	458.2	492.0	15.2	4.8	91.7	64.3	190.0	113.4	151.2	92.0	13.3	118.0	57.4	79.0	270.8	0.0	268.0	306.1	86.4	160.9	24.3	17.8	31.1	6.4	118.0	121.5	12.4	9.6	69.9	18.4	86.0	15.4	122.6	21.8	175.8	221.0	72.9	21.7	85.9	64.7	111.9	28.1	7.0	254.8	53.5	31.6	178.0	293.9
LLPH	"C12orf31, hLLP, MGC14817"	ENSG00000139233	"LLP homolog, long-term synaptic facilitation"	Q9BRT6	12	66116555-66130768	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA048920, HPA058786"			Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA048920: AB_2680556, HPA058786: AB_2683820"	"unprognostic (3.60e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.31e-2)"	"prognostic unfavorable (6.44e-7)"	"unprognostic (7.15e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.65e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.94e-2)"	20.4	38.1	16.4	20.4	16.9	40.9	17.9	10.9	20.0	16.4	20.2	11.2	19.7	16.4	17.2	17.1	21.3	14.4	13.4	19.9	15.7	13.9	27.8	31.3	14.5	21.4	20.6	16.7	18.2	16.2	11.1	18.0	24.3	17.3	18.1	18.6	9.9	15.9	14.5	47.3	13.9	27.9	21.0	26.7	29.7	18.6	20.0	17.6	23.8	22.9	23.5	21.6	23.6	22.4	23.6	24.6	34.9	34.7	20.0	29.4	21.1	27.2	22.1	13.6	16.8	15.9	15.7	16.8	32.0	20.7	23.8	20.2	19.1	11.6	31.7	26.4	21.2	18.8	23.4	21.2	19.4	32.3	27.7	18.2	33.5	16.0	17.0	19.2	58.2	23.6	15.8	20.1	20.2	21.8	18.7	20.5	16.1	28.9	22.8	27.8	29.3	26.0	39.2	29.2	22.3	23.5	22.1	25.1	22.8	23.3	33.0	13.7	16.9	20.7	22.1	33.7	15.0	28.4	31.8	22.1	18.7	26.8	22.7	29.0	17.7	27.4	46.9	24.4	27.4	28.3	22.2	25.6	26.4	23.7	29.0	27.0	23.6	27.6	25.5	24.6	21.7	23.9	25.2	34.9	20.0	34.7	21.2	29.4	21.1	16.4	16.9	10.9	20.0	15.7	13.9	20.6	16.7	17.3	17.6	11.9	36.4	61.0	44.6	24.2	16.2	20.7	50.9	30.8	53.4	29.6	3.9	54.4	56.3	64.5	29.5	27.6	32.9	0.0	61.6	55.9	32.7	30.8	87.7	53.9	56.6	20.6	13.3	33.2	50.4	10.0	40.6	51.5	33.7	79.4	24.4	25.7	76.7	34.5	28.3	61.5	14.5	25.8	23.6	77.7	46.2	26.7	60.8	41.5	28.5	46.2
LMO2	"RBTN2, RBTNL1, RHOM2, TTG2"	ENSG00000135363	"LIM domain only 2"	P25791	11	33858576-33892289	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Endothelial cells: 121.0;Erythroid cells: 46.7;Ito cells: 110.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 1.5;classical monocyte: 1.1;eosinophil: 3.0;intermediate monocyte: 3.1;myeloid DC: 4.3;neutrophil: 1.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 4.3;granulocytes: 3.0;monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"HEL: 23.3;HL-60: 23.2;K-562: 23.6;NB-4: 9.9;THP-1: 30.8;U-937: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016258, HPA029285, HPA070901, HPA070910"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016258: AB_2136572, HPA029285: AB_2672978, HPA070901: , HPA070910: "	"unprognostic (1.60e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.12e-4)"	"unprognostic (1.73e-3)"	"unprognostic (8.95e-2)"	"unprognostic (5.76e-2)"	"unprognostic (7.86e-3)"	"unprognostic (3.69e-1)"	"unprognostic (7.10e-2)"	"unprognostic (9.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.46e-2)"	18.2	6.1	13.8	13.6	15.6	28.8	14.5	5.2	18.4	9.4	5.5	10.3	6.4	6.2	9.7	9.9	6.9	8.6	9.1	6.4	15.8	12.2	12.9	5.5	15.9	22.2	14.2	7.2	5.1	3.9	4.2	8.3	8.5	11.9	8.3	2.7	14.6	4.5	4.0	25.0	4.2	5.5	6.6	13.9	22.0	4.4	3.6	11.1	1.0	10.7	8.1	13.3	11.1	14.8	0.5	4.3	3.0	3.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.5	5.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	23.3	0.0	0.0	0.1	23.2	8.1	0.0	0.0	0.0	0.0	0.0	4.5	0.0	23.6	0.0	0.0	0.1	2.1	9.9	0.4	0.0	0.0	6.6	0.3	0.0	0.0	0.3	1.9	0.0	0.1	0.2	0.0	0.1	0.0	30.8	0.3	0.0	0.1	0.7	0.0	0.0	0.1	0.2	2.1	10.9	0.1	1.5	1.1	3.0	0.0	3.1	0.1	0.5	0.0	0.0	4.3	0.0	0.0	0.0	1.6	0.0	3.6	0.3	0.0	0.5	13.8	15.6	5.2	9.5	15.8	12.2	14.2	7.2	11.9	11.1	3.0	10.3	7.6	7.8	7.4	1.4	1.7	7.6	5.3	0.0	5.2	2.0	0.3	0.0	2.9	0.2	121.0	0.0	46.7	1.7	1.7	8.4	4.1	7.0	1.0	33.2	0.0	0.0	110.5	41.7	0.7	3.7	42.5	10.1	0.0	0.0	1.0	0.9	0.0	0.0	5.6	1.9	0.0	2.8	0.2	2.7	5.3	18.0	0.5	0.4	19.5
LONP1	"hLON, LonHS, PIM1, PRSS15"	ENSG00000196365	"Lon peptidase 1, mitochondrial"	P36776	19	5691834-5720572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Hydrolase, Protease, Serine protease"	"Cataract, Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002034, HPA002192"	Supported		Enhanced	Nucleoplasm,Mitochondria		No	No			Mitochondria	Nucleoplasm	"HPA002034: AB_2756304, HPA002192: AB_1079695"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.66e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.11e-1)"	15.8	78.3	16.4	12.8	19.8	12.5	13.9	16.1	22.8	11.3	13.6	15.8	13.3	13.7	10.5	13.8	12.7	12.7	15.7	27.3	15.4	15.3	19.9	49.6	10.3	14.5	17.7	14.9	15.5	17.7	17.6	16.8	16.6	16.2	11.7	8.5	12.7	18.5	14.7	38.0	14.7	13.9	11.5	12.7	15.5	13.5	9.8	13.3	13.8	21.2	15.3	11.8	14.7	12.5	6.7	6.5	6.0	6.2	4.0	7.2	3.0	23.0	23.9	7.9	25.3	9.4	6.7	24.7	14.7	11.7	15.9	19.5	20.4	8.3	28.9	20.6	15.4	15.3	9.8	20.4	17.8	7.7	17.1	16.8	16.0	20.9	26.7	43.7	36.4	16.8	12.6	25.6	15.1	29.9	7.7	12.7	40.6	42.3	57.8	7.3	15.3	18.0	21.7	28.3	9.4	31.6	19.0	11.4	31.2	8.8	13.7	21.1	21.1	12.9	18.9	51.6	5.8	11.1	45.7	8.9	8.1	8.9	22.5	21.4	60.9	37.5	25.7	36.5	39.9	14.6	6.0	4.1	0.8	6.4	6.2	4.1	6.0	5.6	6.1	4.3	6.7	7.2	4.8	0.5	4.0	2.4	6.5	4.0	3.0	16.4	19.8	16.1	22.8	15.4	15.3	17.7	14.9	16.2	13.3	6.0	13.3	13.7	8.7	7.3	24.7	17.9	15.3	9.4	10.3	26.2	5.9	24.8	39.7	28.3	5.3	9.8	24.8	0.0	23.9	27.0	10.5	12.9	5.7	44.0	28.2	20.6	10.9	14.1	11.3	4.0	11.8	15.2	13.5	24.4	21.6	20.9	25.6	14.4	16.3	36.0	22.0	19.4	10.3	9.1	13.4	9.4	29.3	9.2	22.2	9.4
LOXL2	"LOR, WS9-14"	ENSG00000134013	"Lysyl oxidase like 2"	Q9Y4K0	8	23297189-23425328	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 15.5;Extravillous trophoblasts: 20.1;Fibroblasts: 16.6;Ito cells: 23.4;Sertoli cells: 25.8;Smooth muscle cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"pons and medulla: 22.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 109.9;BJ hTERT+ SV40 Large T+ RasG12V: 63.6;fHDF/TERT166: 71.2;TIME: 59.3;U-87 MG: 110.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025848, HPA036257, HPA056542"	Approved		Enhanced	Nucleoplasm	"Secreted to extracellular matrix"	NA	NA			Nucleoplasm		"CAB025848: , HPA036257: AB_2675025, HPA056542: AB_2683168"	"unprognostic (9.48e-2)"	"prognostic unfavorable (9.83e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (5.55e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (2.91e-2)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (9.05e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.91e-7)"	"unprognostic (1.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.68e-3)"	37.8	2.7	1.2	14.5	1.6	0.6	22.4	2.9	1.6	16.9	18.4	1.0	12.2	5.8	11.8	9.1	11.5	4.1	5.4	7.2	1.2	1.3	4.3	4.1	6.2	7.5	1.9	0.7	15.6	4.4	1.3	2.2	38.0	22.7	8.4	3.8	1.6	5.6	9.7	6.2	4.3	10.7	27.3	10.9	8.3	7.7	4.1	0.7	1.6	4.3	8.0	8.6	19.1	6.4	1.9	1.3	3.0	0.7	2.1	2.8	0.7	6.3	17.0	5.1	4.1	14.0	23.1	2.2	109.9	35.6	50.4	63.6	0.1	0.4	1.2	0.8	71.2	23.4	5.3	0.2	9.4	26.7	0.2	0.9	0.0	2.3	0.1	28.3	0.0	0.4	20.4	0.4	18.8	2.5	33.6	42.1	0.2	0.0	0.2	16.6	3.4	0.0	0.1	3.3	0.0	2.6	0.2	4.2	0.0	14.6	0.0	0.1	1.4	13.7	0.7	1.0	16.8	0.1	0.1	59.3	46.9	12.4	19.1	14.4	0.4	0.0	3.3	110.2	0.1	48.8	1.9	0.7	3.0	1.6	0.3	0.8	1.9	0.6	1.3	0.5	0.9	0.8	2.8	1.6	2.1	0.6	1.3	0.2	0.7	1.2	1.6	2.9	1.0	1.2	1.3	1.9	0.7	22.7	0.7	0.0	4.0	0.5	0.4	2.3	1.7	1.7	0.0	1.4	0.0	0.0	0.0	2.0	0.0	1.5	0.5	15.5	0.0	0.0	1.3	20.1	16.6	0.5	0.0	0.0	1.1	1.6	0.0	23.4	0.3	0.0	0.9	0.5	3.3	0.0	0.0	0.8	3.4	0.0	0.4	0.0	3.1	25.8	22.6	0.9	0.9	2.8	0.8	0.0	0.0	0.1
LPP		ENSG00000145012	"LIM domain containing preferred translocation partner in lipoma"	Q93052	3	188153284-188890671	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Activator	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 127.8;urinary bladder: 105.1"	"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 514.4;Late spermatids: 1329.9;Smooth muscle cells: 529.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 29.5;EFO-21: 36.6;U-698: 61.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011133, HPA017342"	Enhanced		Enhanced	"Focal adhesion sites,Cytosol"		NA	NA		520000	"Focal adhesion sites, Cytosol"		"HPA011133: AB_1853247, HPA017342: AB_1853249"	"unprognostic (1.50e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.05e-1)"	"unprognostic (2.43e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.56e-2)"	"unprognostic (3.44e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.48e-1)"	19.6	4.2	2.7	29.5	2.8	3.1	12.5	3.0	2.7	42.2	29.9	2.1	19.6	5.0	68.6	14.9	59.7	10.0	37.9	9.3	2.6	2.8	10.9	5.3	11.4	6.0	2.8	1.6	26.1	4.4	4.7	3.2	5.2	3.0	37.7	12.8	8.5	7.0	28.4	11.6	5.9	17.2	127.8	3.2	9.5	12.1	30.7	1.5	5.1	5.4	4.2	7.8	105.1	38.3	5.9	4.9	18.0	4.5	4.3	5.0	1.4	7.7	7.1	5.2	3.5	11.3	11.7	5.6	5.1	6.5	3.7	2.5	12.9	3.7	29.5	36.6	11.4	4.6	3.3	1.5	3.4	9.4	3.2	1.7	1.4	5.5	3.4	4.8	0.6	1.7	8.3	4.8	8.3	7.2	5.4	6.2	1.6	0.0	0.6	6.5	2.4	1.5	0.6	2.1	4.9	2.3	1.9	3.9	0.1	4.1	8.2	0.3	0.0	10.9	3.6	6.1	9.0	2.8	2.4	13.4	8.6	6.6	6.1	12.5	0.0	1.1	61.0	4.3	1.3	7.7	0.8	4.5	1.9	5.0	4.2	3.2	2.9	4.3	3.6	2.4	5.9	2.3	2.9	18.0	4.3	4.0	4.9	1.6	1.4	2.7	2.8	3.0	2.7	2.6	2.8	2.8	1.6	3.0	1.5	83.4	55.0	41.3	72.1	69.3	7.7	101.6	99.3	40.2	83.0	66.3	13.7	35.7	24.9	114.3	514.4	83.0	142.7	23.3	78.6	20.6	102.9	124.2	17.4	84.7	36.8	4.8	74.4	114.2	61.5	1329.9	208.5	76.2	75.9	36.1	86.3	27.1	104.6	158.4	448.3	61.0	7.4	329.8	529.6	8.1	6.6	59.6	15.6	39.5	123.5	109.3
LRCH3	MGC4126	ENSG00000186001	"Leucine rich repeats and calponin homology domain containing 3"	Q96II8	3	197791226-197888436	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012380, HPA017299"	Uncertain		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA012380: AB_1853260, HPA017299: AB_2669576"	"unprognostic (1.25e-1)"	"unprognostic (4.92e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.05e-1)"	"unprognostic (8.26e-2)"	"prognostic unfavorable (2.95e-4)"	"unprognostic (3.29e-1)"	"unprognostic (4.13e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.32e-1)"	16.4	14.0	19.3	23.4	19.1	11.0	18.0	37.5	19.1	21.9	19.0	28.2	15.6	11.0	24.7	14.8	15.6	18.3	16.7	18.2	15.9	14.5	12.6	14.2	14.8	23.4	19.7	13.1	27.5	12.9	23.7	26.0	15.2	15.4	20.4	16.7	23.6	15.6	22.4	23.0	15.7	15.9	28.3	15.9	18.7	15.0	20.2	20.4	27.0	13.5	9.5	26.0	20.3	18.0	6.9	2.8	22.6	4.8	4.9	6.0	3.3	18.1	6.5	17.5	10.8	21.2	24.1	6.8	13.2	16.0	16.1	18.9	15.3	9.6	9.9	20.7	16.2	22.9	11.9	14.6	12.8	21.7	7.9	9.1	16.5	9.7	13.0	14.5	12.6	13.0	16.5	7.8	15.3	19.6	15.6	19.0	8.8	10.4	16.5	15.2	15.4	9.5	5.5	12.0	9.3	13.6	10.0	10.9	7.1	8.5	10.7	8.7	9.4	16.0	12.1	12.7	16.8	21.2	11.1	18.5	13.4	7.7	16.2	13.2	15.3	13.7	9.0	12.7	18.0	12.6	22.6	3.4	7.0	5.9	4.8	4.5	6.9	4.6	5.0	2.8	5.7	4.3	6.0	2.3	4.9	4.6	2.6	4.4	3.3	19.3	19.1	37.5	19.1	15.9	14.5	19.7	13.1	15.4	20.4	29.8	24.8	15.9	14.0	9.4	55.4	14.2	17.8	16.0	19.4	8.7	53.0	7.0	1.7	10.1	9.5	20.2	6.8	0.0	8.4	5.5	19.9	12.7	10.5	13.0	7.6	36.5	5.8	41.7	13.0	7.1	23.3	15.3	16.9	28.9	8.2	26.6	11.3	7.0	26.9	4.2	44.4	19.4	17.0	16.3	16.6	9.3	5.0	14.0	9.2	13.1
LRPPRC	"GP130, LRP130, LSFC"	ENSG00000138095	"Leucine rich pentatricopeptide repeat containing"	P42704	2	43886508-43996005	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"	"Disease mutation, Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033786, HPA036408, HPA036409"	Enhanced		Enhanced	Mitochondria		No	No		16000	Mitochondria		"CAB033786: AB_2137450, HPA036408: AB_10670438, HPA036409: AB_2675108"	"unprognostic (1.49e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.72e-5)"	"unprognostic (1.68e-1)"	"unprognostic (8.34e-3)"	"prognostic unfavorable (2.31e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.68e-2)"	"prognostic favorable (6.65e-6)"	"unprognostic (9.07e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.00e-2)"	20.6	25.5	20.2	27.7	24.8	26.7	37.2	34.3	51.8	16.4	31.7	15.1	15.9	21.8	21.5	19.2	22.5	18.6	15.2	36.6	24.3	21.9	41.7	31.6	26.3	38.0	21.9	22.9	23.6	28.0	33.3	19.7	17.6	29.2	18.9	32.5	13.6	17.8	22.8	63.2	22.4	19.1	32.6	17.9	18.0	20.7	20.7	16.0	25.4	20.5	30.5	19.9	20.4	17.8	15.8	15.5	5.5	11.7	13.2	18.1	12.4	30.3	25.0	15.7	20.0	15.5	20.7	27.0	20.3	14.7	22.2	17.1	39.9	16.1	43.7	19.6	12.5	14.8	25.8	29.4	21.7	29.6	26.3	18.5	39.5	19.7	52.9	22.9	56.8	18.0	20.5	19.0	20.4	33.2	12.9	17.8	13.2	58.2	17.7	19.4	16.8	29.8	65.8	26.2	31.0	17.7	33.4	35.2	35.5	24.3	28.0	27.9	27.0	22.9	30.8	36.9	21.5	22.6	34.5	15.3	16.0	21.9	16.8	21.6	18.1	20.3	38.1	15.3	35.3	13.8	5.5	10.7	1.8	9.5	10.8	18.0	15.2	12.8	12.6	15.5	15.8	18.1	15.4	0.8	13.2	11.7	6.2	10.5	12.4	20.2	24.8	34.3	51.8	24.3	21.9	21.9	22.9	29.2	16.0	20.8	25.6	25.1	22.2	41.1	62.9	81.9	33.1	20.1	33.0	43.6	29.5	31.3	18.3	23.0	4.4	27.5	30.2	0.0	15.2	17.8	26.0	19.8	28.8	45.9	22.1	62.0	26.4	20.9	34.3	4.2	23.3	24.7	20.3	26.2	41.4	27.0	20.3	28.1	22.3	48.9	54.5	12.9	37.3	27.9	28.6	38.8	27.8	19.2	70.4	27.0
LRRC32	"D11S833E, GARP"	ENSG00000137507	"Leucine rich repeat containing 32"	Q14392	11	76657524-76670747	"Predicted intracellular proteins, Predicted membrane proteins"		"Growth factor binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endothelial cells: 91.0;Extravillous trophoblasts: 149.6;Fibroblasts: 48.9;Ito cells: 70.6;Sertoli cells: 38.8;Smooth muscle cells: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"neutrophil: 1.0;T-reg: 3.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.0;T-cells: 3.1"	"Group enriched"	"Detected in some"	6	"ASC diff: 42.0;ASC TERT1: 25.9;HSkMC: 16.1;HUVEC TERT2: 18.2;U-2197: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA055775, HPA058434"			Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		19000	Nucleoplasm		"HPA055775: AB_2732600, HPA058434: AB_2732622"	"unprognostic (3.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.84e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (3.93e-5)"	"unprognostic (7.99e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (2.64e-4)"	50.5	16.5	5.4	8.0	11.3	1.9	35.1	4.6	9.1	19.8	12.4	4.4	3.5	7.0	15.2	10.4	11.1	10.8	22.6	18.0	7.6	3.5	19.5	8.5	51.8	4.7	10.2	4.3	19.9	8.7	7.9	7.0	40.5	10.1	12.6	5.1	16.6	5.2	9.4	29.0	9.9	7.7	13.0	5.7	21.2	8.1	8.6	8.7	0.6	16.6	9.7	2.1	19.8	25.1	0.2	0.0	1.0	0.0	0.0	3.1	9.6	0.0	0.0	0.4	0.0	42.0	25.9	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.8	0.0	0.0	16.1	0.0	1.4	0.0	0.3	18.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	4.8	2.7	0.3	38.6	0.0	0.0	0.0	0.6	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	3.1	9.6	5.4	11.3	4.6	9.1	7.6	3.5	10.2	4.3	10.1	8.7	0.0	7.0	3.4	0.2	12.9	0.0	3.4	0.0	1.4	2.3	0.0	0.0	1.3	0.0	0.1	1.3	91.0	0.0	0.0	0.0	149.6	48.9	1.2	2.3	0.8	3.3	0.0	0.0	70.6	4.4	1.1	8.3	5.2	16.9	0.0	0.2	0.4	0.0	2.9	8.5	0.1	0.0	38.8	74.8	0.5	2.7	10.9	7.0	1.3	0.0	1.1
LRRC42	MGC8974	ENSG00000116212	"Leucine rich repeat containing 42"	Q9Y546	1	53946077-53968168	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047458, HPA050537, HPA064581"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047458: , HPA050537: AB_2681161, HPA064581: AB_2685292"	"unprognostic (3.13e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.88e-2)"	"unprognostic (9.97e-3)"	"unprognostic (4.01e-2)"	"unprognostic (7.95e-3)"	"prognostic unfavorable (3.88e-5)"	"prognostic unfavorable (6.02e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.67e-2)"	12.0	27.1	11.8	9.8	14.7	8.7	20.3	8.8	10.5	15.1	13.1	7.9	18.5	10.7	17.5	19.4	18.8	15.1	16.6	14.0	9.1	8.3	16.1	23.1	13.1	12.9	7.7	10.0	17.9	11.5	12.4	23.1	32.3	10.5	15.8	11.9	17.9	15.0	21.2	14.9	18.0	10.2	16.1	13.6	10.2	14.4	24.0	9.9	16.6	21.8	14.9	13.1	18.3	17.8	6.5	10.5	7.6	4.5	6.4	8.9	4.1	25.3	9.5	24.0	14.1	12.6	17.2	16.3	20.1	28.2	26.9	36.8	31.2	17.2	14.2	16.2	24.7	32.0	22.5	20.3	28.8	31.5	11.3	12.2	13.2	15.2	20.2	23.0	8.2	12.7	15.5	40.1	23.2	25.7	19.9	17.1	13.4	16.5	3.9	26.1	8.8	15.1	11.5	20.4	18.8	14.8	26.2	25.4	10.0	19.4	19.2	14.4	15.4	26.9	15.4	22.1	39.6	22.7	9.9	13.8	20.6	26.3	18.2	12.5	10.7	12.3	21.4	20.0	8.6	10.9	0.1	4.5	7.6	7.6	4.4	6.4	6.5	6.5	8.9	5.6	4.1	6.9	5.0	6.8	6.4	3.3	10.5	7.0	4.1	11.8	14.7	8.8	10.5	9.1	8.3	7.7	10.0	10.5	9.9	11.9	4.3	5.6	28.2	45.8	3.6	8.3	20.4	12.0	11.4	10.4	3.9	38.1	16.6	32.6	2.2	8.7	8.5	0.0	14.7	26.4	20.6	35.2	0.0	11.9	15.2	9.5	65.5	8.6	5.6	2.7	22.2	8.6	10.1	10.8	8.5	20.7	26.6	13.5	16.6	12.2	3.2	12.9	14.1	24.6	45.1	34.3	48.1	6.5	13.6	35.8
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397553	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		5400000	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	20.7	40.5	10.6	21.8	14.5	28.4	16.3	11.5	21.6	28.2	30.0	11.4	28.8	19.6	17.2	24.9	23.5	15.8	22.8	17.4	10.2	8.8	22.1	74.7	23.0	15.9	12.7	11.5	15.8	87.9	15.4	11.6	35.3	10.8	17.7	31.5	10.0	48.6	26.2	16.0	11.2	27.3	22.0	8.9	19.0	30.7	18.2	10.4	18.0	22.8	22.4	20.8	13.7	17.0	8.6	14.9	14.4	19.6	5.9	9.1	9.0	62.1	47.4	13.6	20.5	23.2	27.4	24.5	51.0	28.5	47.8	42.3	108.3	18.0	27.2	35.0	58.0	29.4	22.7	33.9	43.5	57.1	14.4	49.4	47.6	26.9	57.9	48.7	46.7	22.6	24.1	35.4	51.1	59.6	13.9	35.2	15.8	44.0	25.9	31.3	42.3	32.9	22.2	15.4	58.8	69.5	28.2	43.9	52.0	26.0	31.7	33.5	27.8	17.6	19.8	25.9	21.2	33.4	25.4	37.5	55.5	23.0	51.1	66.3	39.0	31.9	35.2	37.6	31.8	34.8	14.4	15.7	13.4	7.4	19.6	9.1	8.6	7.5	8.9	14.9	6.4	5.0	6.3	8.0	5.9	18.6	12.1	7.5	9.0	10.6	14.5	11.5	21.6	10.2	8.8	12.7	11.5	10.8	10.4	20.8	21.3	38.0	75.9	123.9	20.8	4.0	38.2	14.7	35.2	19.2	2.0	78.1	24.9	166.2	37.0	22.6	79.6	23.3	164.5	210.3	84.3	117.1	30.0	58.2	94.9	20.6	36.8	25.8	26.9	12.2	32.8	46.2	62.4	46.9	93.0	24.6	158.0	71.6	27.3	38.3	11.1	12.9	67.0	41.7	28.5	115.9	197.4	27.7	82.6	133.9
LSAMP	"IGLON3, LAMP"	ENSG00000185565	"Limbic system-associated membrane protein"	Q13449	3	115802363-117139389	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.4"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 208.2;Leydig cells: 116.8;Muller glia cells: 166.8;Peritubular cells: 86.3"	"Cancer enhanced"	"Detected in many"		"glioma: 13.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 7.0;SH-SY5Y: 14.2;WM-115: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054051, HPA076122"			Enhanced	Cytosol		NA	NA		200000000	Cytosol		"HPA054051: AB_2682358, HPA076122: AB_2686779"	"unprognostic (4.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.97e-3)"	"unprognostic (6.03e-2)"	"unprognostic (9.63e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.70e-2)"	"unprognostic (5.71e-2)"	"unprognostic (6.82e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.31e-2)"	2.3	12.7	21.9	4.3	23.7	1.1	1.6	43.4	48.4	17.8	5.5	16.6	0.0	1.9	4.4	2.8	3.4	2.9	11.3	2.1	23.7	18.8	2.5	1.0	8.5	4.0	17.6	21.5	4.8	11.1	0.6	3.1	1.2	18.3	21.1	3.5	1.2	1.7	6.2	0.7	4.6	1.9	3.3	13.1	1.7	3.2	3.9	21.3	0.0	4.2	0.0	5.2	7.3	3.4	1.6	0.4	3.0	0.8	0.3	1.0	0.3	0.2	2.2	7.0	0.2	0.7	2.2	0.7	0.6	0.3	0.2	0.7	0.2	0.4	0.5	0.2	3.6	0.2	0.1	0.1	0.1	0.3	0.5	0.1	0.2	0.8	0.3	0.1	0.5	0.4	1.7	0.0	0.8	0.1	0.2	0.0	0.9	0.3	2.3	0.0	0.2	0.8	0.6	2.7	0.3	0.8	0.2	0.1	0.1	1.7	1.6	1.6	14.2	0.0	0.1	2.2	3.2	0.2	0.8	0.1	1.5	1.3	1.7	0.4	1.5	1.9	0.2	0.5	0.2	34.6	3.0	0.8	1.4	0.9	0.5	1.0	0.7	0.6	0.5	0.2	1.6	1.0	0.7	2.8	0.3	0.6	0.4	0.5	0.3	21.9	23.7	43.4	23.7	23.7	18.8	17.6	21.5	18.3	21.3	0.0	0.6	0.5	0.2	6.8	47.9	18.9	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.0	15.9	2.5	0.0	0.0	3.0	0.0	16.0	17.5	0.0	0.0	0.3	208.2	0.0	1.8	0.0	18.1	116.8	1.8	54.0	0.0	0.0	166.8	0.6	0.0	86.3	0.0	9.7	0.0	1.3	0.9	0.2	4.4	0.0	0.0	0.0	0.5
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806984	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		26000	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	20.3	17.4	15.7	21.7	19.4	21.0	18.7	14.4	17.7	21.1	19.5	14.0	11.8	17.9	23.6	15.2	21.8	21.5	20.7	17.5	14.4	12.8	17.5	15.1	18.0	33.5	20.7	17.5	19.4	20.3	9.6	15.1	17.9	20.3	19.7	21.3	10.8	12.8	14.0	19.5	17.1	15.3	21.5	26.7	22.1	16.7	16.5	19.4	51.8	23.4	19.5	26.9	21.8	20.9	18.2	10.8	8.7	5.7	12.3	15.3	10.1	10.2	5.0	8.8	11.3	5.0	6.9	9.3	6.4	4.1	9.2	8.2	5.7	3.9	10.9	9.0	5.3	8.5	4.1	11.6	10.9	8.3	11.5	14.9	12.5	3.1	5.8	6.1	12.4	4.5	5.2	5.0	8.5	8.8	4.3	9.6	11.2	16.3	7.1	6.5	7.4	14.9	28.4	8.1	7.7	10.9	9.2	7.0	16.0	7.6	3.0	8.9	7.7	6.9	6.2	12.5	4.8	6.8	9.9	5.0	5.5	9.6	6.3	10.3	7.4	12.6	13.9	2.8	14.8	8.5	8.7	5.7	3.6	9.4	5.2	12.4	18.2	10.1	10.6	9.5	16.1	9.7	11.9	1.2	12.3	4.4	10.8	15.3	10.1	15.7	19.4	14.4	17.7	14.4	12.8	20.7	17.5	20.3	19.4	20.8	23.4	106.9	62.3	51.7	30.5	12.2	40.8	18.7	22.7	52.4	5.9	114.2	96.2	89.8	18.3	82.4	26.4	70.0	118.6	172.4	68.7	55.0	82.9	52.9	122.6	28.6	51.9	62.0	59.2	20.0	46.1	69.2	87.7	110.0	89.7	34.6	82.0	49.1	46.3	86.4	26.4	45.3	57.7	49.6	178.0	56.1	57.7	108.4	103.8	39.9
LTN1	"C21orf10, C21orf98, FLJ11053, KIAA0714, LISTERIN, RNF160, ZNF294"	ENSG00000198862	"Listerin E3 ubiquitin protein ligase 1"	O94822	21	28928144-28992956	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 218.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029143, CAB034164, HPA055604"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB034164: AB_2180094, HPA029143: AB_10671360, HPA055604: AB_2682859"	"unprognostic (3.67e-2)"	"unprognostic (7.07e-2)"	"unprognostic (7.78e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.42e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.38e-2)"	"unprognostic (5.40e-2)"	"unprognostic (9.98e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.52e-1)"	17.9	15.1	10.3	12.4	19.8	21.2	17.9	19.9	23.2	16.6	14.7	17.8	12.1	12.4	16.5	15.4	15.2	14.5	10.8	13.1	12.0	10.6	14.1	19.3	12.0	15.7	19.6	14.2	16.4	23.7	18.4	22.6	29.0	28.7	19.0	15.6	9.7	16.1	12.6	22.5	14.8	17.1	13.4	17.4	16.7	15.4	20.7	15.8	23.0	17.6	14.6	14.9	16.6	14.7	7.8	6.2	12.2	11.9	8.6	8.4	3.3	12.8	5.5	11.5	5.2	9.9	13.6	11.7	10.9	8.9	9.4	13.0	7.7	10.7	8.5	5.3	9.7	8.1	6.6	12.2	8.9	17.1	9.9	8.5	25.3	7.6	6.1	7.4	8.4	9.9	9.4	8.1	13.3	11.1	9.3	9.9	6.2	20.6	20.4	10.7	4.0	5.3	8.1	16.5	10.7	6.6	7.2	23.1	17.7	10.6	11.1	6.3	13.1	12.5	9.6	10.9	11.3	9.7	11.8	13.0	8.3	15.4	11.1	9.1	16.6	15.6	12.0	12.9	18.2	9.8	12.2	6.4	9.5	8.4	9.8	7.0	7.8	5.8	5.6	6.2	7.1	6.2	4.7	11.3	8.6	11.9	3.9	6.1	3.3	10.3	19.8	19.9	23.2	12.0	10.6	19.6	14.2	28.7	15.8	14.9	19.9	19.0	22.3	26.9	24.3	23.8	7.6	21.4	19.4	10.4	31.4	15.4	1.7	12.5	218.4	21.5	16.6	0.0	12.2	16.4	19.2	28.0	26.6	18.4	11.3	39.7	21.8	15.4	24.1	45.8	24.7	18.9	11.8	19.0	17.8	44.4	16.5	17.3	19.8	15.7	29.4	12.9	19.5	36.9	19.0	28.0	24.9	27.3	17.8	29.8
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843344-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	20.0	20.6	15.6	19.5	26.2	39.3	26.7	19.4	26.0	14.6	16.5	11.1	17.9	13.8	21.2	14.7	21.2	18.0	11.3	15.7	25.1	10.9	14.4	29.0	18.9	21.2	21.0	17.1	20.6	20.9	13.3	19.7	17.3	17.4	16.3	18.9	8.0	16.6	18.5	52.0	23.5	17.2	20.7	18.5	20.8	18.3	17.5	18.1	15.0	16.1	26.4	21.8	16.6	25.5	17.3	18.4	4.1	12.9	21.2	16.1	8.3	11.7	11.0	13.1	29.1	9.7	11.9	15.2	18.3	13.5	20.3	16.2	17.8	6.1	24.8	14.8	16.5	22.3	13.3	21.8	17.9	28.4	14.2	21.3	49.0	12.6	27.3	17.2	60.2	28.5	13.3	13.2	22.5	24.8	8.4	14.0	14.5	46.5	16.5	15.6	19.8	20.5	25.7	15.5	13.5	12.2	17.8	24.8	11.1	15.0	16.4	11.6	14.0	18.7	15.5	17.0	12.5	8.7	38.6	12.6	13.0	15.0	28.9	33.5	20.6	25.3	33.7	13.0	31.6	18.2	1.2	10.1	4.1	12.1	12.9	13.1	17.3	12.7	13.0	15.2	14.3	14.1	16.1	0.3	21.2	11.0	18.4	10.9	8.3	15.6	26.2	19.4	26.0	25.1	10.9	21.0	17.1	17.4	18.1	6.0	28.5	25.1	16.5	22.8	9.2	21.2	10.2	29.4	30.7	7.0	2.0	22.4	11.6	22.5	19.1	16.8	7.4	0.0	24.9	25.7	22.1	9.1	24.3	17.3	24.9	11.1	18.9	11.1	11.1	6.2	23.9	21.1	5.0	37.9	11.7	9.9	24.3	8.6	25.8	12.4	8.7	6.5	15.6	50.2	65.1	28.1	13.6	16.6	16.4	15.6
LUC7L3	"CRA, CREAP-1, CROP, FLJ11063, hLuc7A, LUC7A, OA48-18"	ENSG00000108848	"LUC7 like 3 pre-mRNA splicing factor"	O95232	17	50719544-50756213	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA018475, HPA018484, HPA020017"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA018475: AB_1847247, HPA018484: AB_1847248, HPA020017: AB_1847249"	"unprognostic (3.90e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.47e-2)"	"unprognostic (2.99e-3)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (7.23e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (5.35e-5)"	24.1	42.2	57.2	39.6	66.9	24.0	28.7	137.4	62.6	37.6	36.7	22.3	36.4	37.0	55.0	35.0	23.7	31.5	24.3	27.5	54.5	31.3	25.4	20.4	27.8	45.9	72.2	51.8	60.1	27.3	34.1	71.9	29.3	51.3	34.7	29.1	21.6	32.8	35.2	50.6	39.1	35.9	38.2	78.4	41.8	30.5	20.7	70.9	29.1	37.2	27.5	32.1	30.2	39.2	28.8	30.6	22.7	15.9	10.3	18.8	5.2	36.3	23.6	48.1	30.8	20.3	19.6	22.8	34.2	13.3	16.6	20.0	45.1	28.2	44.4	37.1	13.7	18.9	31.7	31.7	14.3	29.0	45.9	50.1	52.6	82.4	35.9	11.1	45.9	29.4	18.5	20.3	18.0	10.6	42.4	17.0	34.5	40.7	40.6	21.2	20.2	45.1	44.8	31.4	26.1	17.9	49.0	45.2	46.1	22.8	23.2	34.1	35.7	20.4	26.2	35.4	43.8	42.2	34.1	24.0	37.5	31.8	15.7	35.1	35.8	38.3	54.5	23.3	31.7	26.1	18.3	15.9	14.5	16.3	11.3	14.3	27.5	17.6	13.5	9.9	28.8	18.8	15.4	22.7	10.3	8.8	30.6	13.3	5.2	57.2	66.9	137.4	62.6	54.5	31.3	72.2	51.8	51.3	70.9	140.0	185.5	122.4	190.4	192.1	526.4	100.3	56.0	161.9	194.5	89.0	216.0	91.5	63.0	86.8	13.9	136.5	125.0	70.0	73.3	92.9	119.5	130.2	141.2	71.6	66.6	359.1	199.5	83.4	88.5	25.8	365.3	114.4	91.1	95.6	120.6	279.8	78.4	140.3	333.8	46.4	433.6	232.8	173.3	126.5	149.4	154.7	83.5	132.1	115.8	167.3
LYAR	"ZC2HC2, ZLYAR"	ENSG00000145220	"Ly1 antibody reactive"	Q9NX58	4	4267701-4290169	"Predicted intracellular proteins, Transcription factors"	"Immunity, Innate immunity, rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	12	"Spermatocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035880, HPA035881"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA035880: , HPA035881: AB_10669980"	"unprognostic (2.81e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.64e-2)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (1.08e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (8.82e-4)"	"unprognostic (5.05e-2)"	"unprognostic (1.59e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.94e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.72e-1)"	11.1	5.7	6.8	11.9	10.1	10.9	8.2	7.3	8.0	6.6	6.9	4.3	4.1	5.7	6.9	5.5	11.2	7.1	5.4	10.1	7.0	4.6	5.0	9.9	7.7	13.8	10.9	4.5	11.1	6.3	4.4	15.6	7.1	8.4	7.8	6.8	3.7	5.4	6.4	15.1	5.9	6.2	9.1	7.9	18.2	5.8	60.2	12.0	10.0	6.3	11.9	10.9	10.1	10.4	7.3	7.1	8.9	12.9	10.7	32.8	10.3	13.3	7.0	6.3	9.2	5.5	6.3	10.8	12.2	4.2	12.7	8.8	22.0	17.6	35.9	8.8	5.2	20.5	8.5	23.5	12.7	16.7	6.4	17.3	36.0	6.7	24.6	9.4	41.5	9.8	4.9	8.1	14.6	24.9	3.3	10.9	20.5	48.1	12.0	8.8	13.5	14.1	53.5	31.3	14.2	23.0	21.7	11.5	17.3	5.7	9.3	15.0	6.4	6.6	7.3	12.4	8.4	7.5	12.4	10.2	12.7	10.1	16.5	38.4	8.5	12.8	57.4	8.6	35.1	10.2	8.9	9.7	8.5	28.6	9.6	32.8	7.3	18.9	30.8	7.1	5.7	8.9	19.0	2.8	10.7	12.9	5.3	8.8	10.3	6.8	10.1	7.3	8.0	7.0	4.6	10.9	4.5	8.4	12.0	14.9	30.0	19.7	34.4	106.7	9.4	21.6	12.7	26.8	36.4	1.8	7.9	43.0	8.3	15.1	74.2	29.5	2.8	0.0	17.0	43.6	29.4	25.4	20.8	10.6	32.5	14.3	10.3	8.6	30.8	61.9	31.7	32.1	20.3	19.0	16.0	9.6	22.6	13.9	25.1	5.1	28.7	38.8	35.0	435.9	39.2	101.3	16.9	130.7	24.0	62.3
LYSMD1	"MGC35223, RP11-68I18.5, SB145"	ENSG00000163155	"LysM domain containing 1"	Q96S90	1	151159748-151165948	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028055, HPA064537"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028055: AB_10601912, HPA064537: AB_2685281"	"unprognostic (1.71e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.60e-3)"	"unprognostic (2.59e-3)"	"unprognostic (8.26e-2)"	"unprognostic (7.24e-3)"	"unprognostic (7.31e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.47e-3)"	"unprognostic (6.33e-2)"	8.2	11.2	9.0	4.7	11.2	2.1	10.0	20.8	13.4	11.0	9.3	13.0	10.7	10.6	12.1	7.9	8.6	11.4	8.7	13.2	8.8	9.1	9.4	9.3	5.9	5.2	8.5	9.9	19.8	10.9	13.8	14.8	13.2	11.0	10.6	9.8	11.1	9.0	15.4	20.6	9.2	8.7	12.4	9.3	6.3	8.2	7.3	10.6	8.2	11.1	6.4	5.7	10.0	8.8	3.6	3.3	7.2	2.1	3.1	3.5	0.7	4.1	4.5	9.7	7.6	5.7	6.4	7.6	6.1	5.3	7.2	6.5	2.8	5.0	5.5	7.4	3.9	3.7	7.3	7.6	4.2	5.3	10.5	8.4	3.1	7.4	3.0	9.0	3.2	5.1	8.9	9.4	6.7	9.7	9.8	3.0	12.6	6.2	5.3	5.0	6.6	8.3	4.1	6.2	4.2	5.8	6.0	7.1	3.2	5.3	1.9	11.8	14.4	4.5	13.9	7.8	12.9	8.5	11.2	3.0	5.6	3.1	3.5	7.8	16.9	12.9	2.6	4.8	1.3	5.2	3.8	2.1	3.0	2.1	1.3	2.4	1.7	2.5	1.4	1.6	3.6	3.3	3.5	7.2	3.1	1.7	3.3	3.3	0.7	9.0	11.2	20.8	13.2	8.8	9.1	8.5	9.9	11.0	10.6	0.0	0.3	0.0	0.8	0.8	4.1	7.5	0.0	4.0	4.5	5.2	5.9	3.4	3.3	1.8	0.3	0.9	3.4	0.0	0.5	2.3	2.7	1.0	0.0	3.2	0.5	1.6	4.1	2.5	0.0	0.0	4.0	0.0	1.7	0.0	1.9	3.4	1.9	0.0	5.6	4.3	7.9	0.0	3.0	1.6	2.5	1.0	2.4	0.0	2.7	0.9
LYST	"CHS, CHS1"	ENSG00000143669	"Lysosomal trafficking regulator"	Q99698	1	235661041-235883640	"Disease related genes, Predicted intracellular proteins"	"Phagocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 38.8"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 236.3;Rod photoreceptor cells: 167.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 13.0;monocytes: 5.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.7;SK-MEL-30: 12.7;THP-1: 44.9;U-937: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053366, HPA055725"			Supported	"Nucleoplasm,Plasma membrane,Centriolar satellite"		Yes	No			Nucleoplasm	"Plasma membrane, Centriolar satellite"	"HPA053366: AB_2682129, HPA055725: AB_2682898"	"unprognostic (1.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.11e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (5.27e-5)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.29e-2)"	"unprognostic (1.99e-1)"	10.3	5.2	6.4	9.0	8.8	31.3	10.6	10.5	7.1	8.8	5.3	3.8	3.4	3.4	6.8	4.3	6.6	5.6	5.8	4.7	4.3	2.4	5.0	6.1	10.9	7.8	4.2	6.0	6.2	5.0	9.1	12.6	5.5	5.3	6.0	5.0	9.6	8.2	4.8	3.9	11.7	6.3	9.8	9.2	11.3	8.4	6.4	6.3	38.8	8.5	4.0	7.6	9.3	10.6	1.6	1.7	13.0	5.9	1.7	1.0	0.7	3.8	0.9	0.4	0.9	6.0	6.9	0.6	1.4	5.7	1.5	1.4	0.0	1.0	0.5	0.6	3.1	3.6	1.8	0.5	0.7	1.3	13.7	1.2	1.2	0.8	0.3	1.1	1.8	1.7	2.3	3.6	1.9	4.7	2.2	1.2	0.6	0.1	0.8	1.2	0.2	2.3	3.9	0.1	0.7	0.4	0.1	0.5	0.0	4.4	4.2	2.5	0.5	1.5	0.0	12.7	0.5	0.5	44.9	2.6	1.1	0.5	1.3	1.2	0.9	0.0	0.0	1.9	17.2	3.2	0.4	3.1	5.7	0.6	3.5	1.0	1.1	0.3	0.7	1.7	1.6	0.2	0.5	13.0	1.7	5.9	0.2	0.2	0.7	6.4	8.8	10.5	7.1	4.3	2.4	4.2	6.0	5.3	6.3	17.9	50.4	48.0	71.9	63.1	61.8	9.2	10.2	24.1	39.8	10.4	88.4	5.4	10.0	5.6	9.9	41.7	11.5	0.0	10.7	4.0	23.9	49.0	106.6	14.5	28.2	49.3	9.2	15.4	73.1	13.4	25.9	70.4	114.7	236.3	11.3	23.7	24.4	14.2	20.5	9.0	167.4	12.9	28.6	79.6	22.6	57.0	7.3	65.4	6.3	82.9
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"		"Developmental protein"	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Cell type enhanced"	"Detected in some"	24	"Cholangiocytes: 12.7;Horizontal cells: 23.8;Muller glia cells: 5.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTERT-RPE1: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.1	3.3	0.8	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MAEA	"EMP, GID9"	ENSG00000090316	"Macrophage erythroblast attacher"	Q7L5Y9	4	1289851-1340147	"Predicted intracellular proteins"	"Cell cycle, Cell division, Erythrocyte maturation, Ubl conjugation pathway"	"Actin-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036886, HPA058185"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA036886: , HPA058185: AB_2683633"	"unprognostic (2.70e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (5.34e-4)"	"unprognostic (3.10e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.94e-3)"	"unprognostic (4.65e-3)"	"prognostic favorable (1.90e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.51e-2)"	23.6	35.4	25.5	26.3	28.4	19.5	20.9	34.0	35.8	24.4	33.3	21.7	26.8	39.9	27.3	23.8	34.7	26.0	29.2	36.6	23.7	33.1	33.2	27.9	19.1	26.1	23.3	32.0	33.4	32.0	21.9	30.3	27.6	34.0	23.6	17.2	22.3	36.7	28.0	27.3	29.0	38.2	20.9	17.7	31.0	30.3	23.3	26.7	26.5	26.1	28.5	26.5	26.3	25.4	19.7	18.9	48.2	28.0	17.0	35.8	21.9	22.7	27.0	19.2	19.0	12.8	12.8	25.0	23.3	12.2	18.8	17.3	28.0	29.3	20.7	18.2	16.7	34.9	16.9	18.4	28.5	7.8	16.6	20.5	19.5	29.8	26.7	15.3	21.9	21.0	15.9	15.6	15.2	9.6	13.1	15.2	20.0	27.1	16.6	16.5	24.1	32.5	33.6	25.3	24.7	29.1	31.7	15.4	18.7	20.1	27.5	34.5	24.1	20.8	15.7	15.8	11.2	29.0	19.1	21.3	35.1	15.1	16.0	38.5	20.9	32.0	22.8	24.5	20.2	19.3	23.9	20.2	27.2	25.5	20.7	35.8	19.7	20.5	24.1	18.9	16.5	18.3	18.8	48.2	17.0	28.0	13.3	23.1	21.9	25.5	28.4	34.0	35.8	23.7	33.1	23.3	32.0	34.0	26.7	17.9	23.5	19.1	12.9	16.7	25.9	30.8	12.7	14.7	21.6	15.7	19.6	42.4	39.7	39.2	5.8	20.4	33.8	0.0	26.5	43.0	21.1	18.9	10.4	15.3	34.2	20.6	19.5	18.4	22.3	8.2	32.8	16.9	27.0	55.9	30.8	20.6	33.1	32.0	35.0	28.1	18.6	12.9	16.5	25.9	41.2	17.3	79.6	27.4	32.9	18.6
MAFK	"NFE2U, P18"	ENSG00000198517	"MAF bZIP transcription factor K"	O60675	7	1530714-1543043	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 62.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2 OS: 34.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026820, HPA060841"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB026820: , HPA060841: AB_2684377"	"unprognostic (6.82e-2)"	"unprognostic (3.71e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.44e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.14e-1)"	15.7	14.3	12.6	12.4	20.1	16.3	13.0	4.2	12.5	9.3	18.0	13.5	6.7	18.2	14.7	5.0	10.1	10.2	12.7	30.9	13.2	11.8	10.5	10.9	18.7	8.7	19.7	11.0	7.2	34.9	6.0	8.7	62.4	14.5	16.1	5.1	6.7	11.0	12.0	26.8	12.8	16.8	26.1	12.1	11.3	13.2	4.1	13.1	22.8	9.1	9.7	7.5	13.7	19.0	1.9	5.1	3.6	1.7	1.5	2.6	1.4	20.0	14.4	0.5	2.1	1.6	2.0	11.0	13.3	7.6	3.2	2.3	10.3	5.5	4.7	4.9	3.3	21.9	15.6	1.2	3.8	1.4	7.2	10.5	2.7	18.4	7.5	3.7	6.4	8.7	2.0	5.0	5.4	4.1	4.0	2.9	14.8	7.0	2.6	1.5	13.2	7.2	23.1	4.6	4.9	14.6	10.9	0.5	7.9	3.0	8.3	6.2	2.3	8.0	23.8	5.8	3.3	9.2	8.6	6.9	5.0	34.8	25.0	7.2	5.0	1.5	7.8	6.6	8.9	7.0	1.7	1.6	3.6	2.1	0.8	2.3	1.4	1.2	2.5	0.7	1.9	2.6	2.0	2.2	1.5	1.7	5.1	2.2	1.4	12.6	20.1	4.2	12.5	13.2	11.8	19.7	11.0	14.5	13.1	38.7	21.2	5.1	38.8	56.7	1.8	2.4	12.7	9.4	15.9	29.6	2.0	7.9	1.7	12.6	2.8	17.5	32.5	0.0	12.9	7.1	20.6	51.3	9.2	11.6	9.5	11.1	22.2	10.4	16.3	3.8	4.4	14.9	18.6	5.4	21.7	7.5	30.7	26.8	2.8	2.1	0.6	12.9	22.7	0.5	4.7	50.4	65.2	8.6	13.4	64.3
MAGED2	"11B6, BCG1, HCA10, JCL-1, MAGE-D2, MAGED, MGC8386"	ENSG00000102316	"MAGE family member D2"	Q9UNF1	X	54807599-54816012	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Tumor antigen"	"Bartter syndrome, Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Peritubular cells: 301.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031572, HPA031573"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Nucleoli, Cytosol"		"HPA031572: AB_10599819, HPA031573: AB_10602181"	"unprognostic (1.33e-1)"	"unprognostic (8.60e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.69e-3)"	"unprognostic (4.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.97e-1)"	"prognostic favorable (2.88e-4)"	"prognostic favorable (2.82e-4)"	"unprognostic (6.34e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (9.43e-4)"	"unprognostic (1.58e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.58e-1)"	22.1	38.4	26.9	14.8	26.5	8.2	50.2	24.4	43.0	55.7	27.3	27.8	21.4	16.2	41.1	31.8	21.9	45.9	28.5	40.7	23.8	38.2	42.7	17.3	24.0	13.5	30.3	36.0	79.7	23.5	34.5	57.6	58.6	57.1	63.9	16.4	43.1	32.0	53.7	25.6	16.5	17.6	41.6	24.7	17.5	22.5	21.8	18.3	23.4	45.1	17.3	22.0	31.9	29.2	17.1	11.7	43.1	37.0	28.5	35.5	32.5	5.4	10.0	60.2	18.3	28.7	39.1	11.1	22.5	40.2	17.9	31.8	10.0	13.9	7.6	59.1	45.3	14.7	7.4	17.1	17.0	12.9	13.5	14.2	15.7	11.9	19.5	24.6	4.0	12.1	51.1	7.1	18.1	9.2	36.9	33.9	8.9	3.8	9.3	34.1	15.0	8.9	6.7	22.2	9.5	12.0	5.9	21.6	10.8	24.5	4.1	9.5	24.5	8.9	10.4	52.0	73.5	42.9	6.8	29.2	15.3	23.8	22.7	6.3	6.0	5.0	5.4	22.3	10.6	77.7	43.1	9.1	35.5	35.5	22.4	27.3	16.3	29.4	33.1	11.7	17.1	29.7	34.1	3.4	28.5	37.0	7.2	29.2	32.5	26.9	26.5	24.4	43.0	23.8	38.2	30.3	36.0	57.1	18.3	41.7	33.9	29.8	80.0	37.7	72.3	51.6	53.5	66.9	30.7	73.3	27.5	185.2	208.9	88.2	2.4	76.6	14.7	0.0	47.8	117.1	94.0	95.1	100.4	13.2	60.7	130.3	56.0	66.9	12.9	8.5	216.0	36.3	150.1	64.9	42.6	178.6	48.5	32.3	301.2	111.7	49.9	155.2	150.8	13.5	12.4	30.6	141.5	45.4	24.9	55.9
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048771-19790401	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 60.5"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 2.6;Early spermatids: 6.8;Spermatocytes: 6.3"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 3.6"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 31.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.8	2.0	0.3	2.0	0.4	0.6	0.3	0.9	0.8	19.4	0.6	0.1	25.2	1.3	2.3	0.3	0.3	0.4	1.3	1.6	0.8	1.3	0.3	0.9	0.2	0.8	0.0	1.1	0.3	0.1	4.7	0.4	0.8	0.9	0.2	1.4	0.5	0.4	0.5	0.4	60.5	1.3	0.7	0.3	0.5	1.7	0.7	2.6	0.6	0.3	0.1	0.5	0.5	0.0	3.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	31.9	0.0	3.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	3.6	0.0	0.0	2.0	2.0	0.3	0.9	1.6	0.8	0.8	0.0	0.8	0.7	0.0	2.6	0.0	0.2	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	6.8	0.0	0.0	0.0	0.0	0.4	0.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.7	0.0	0.0	0.0	0.4	6.3	2.1	0.1	0.2	0.0	0.0	0.0
MALSU1	"C7orf30, mtRsfA"	ENSG00000156928	"Mitochondrial assembly of ribosomal large subunit 1"	Q96EH3	7	23298739-23311729	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AN3-CA: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020487, HPA052210"	Approved		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA020487: AB_1845757, HPA052210: AB_2681762"	"unprognostic (3.62e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (9.71e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.68e-1)"	7.9	11.3	9.5	6.9	9.4	7.6	11.0	8.6	11.1	7.9	8.4	8.3	5.8	5.1	9.2	10.2	12.3	10.1	7.6	29.8	8.8	9.1	12.5	21.2	8.2	10.2	8.9	7.2	10.3	10.1	8.0	7.8	12.6	12.7	7.9	7.8	17.2	10.6	10.3	20.1	6.7	7.0	8.9	8.1	6.9	7.5	13.7	5.6	8.5	14.8	14.9	8.0	9.2	7.5	6.1	4.8	3.5	5.4	4.2	7.3	5.1	4.8	6.1	4.5	26.3	4.4	3.1	4.5	3.7	2.7	3.5	3.2	10.2	4.1	4.9	4.1	2.4	14.3	5.0	4.4	2.3	4.3	2.4	7.9	2.9	8.3	15.7	2.9	6.4	1.8	2.6	3.6	2.9	3.2	20.9	3.1	4.5	8.7	1.3	4.4	3.4	4.4	20.0	8.2	9.1	16.4	3.8	3.7	6.5	3.4	4.4	4.1	4.9	3.1	5.0	7.7	9.1	2.5	3.8	5.5	2.8	2.5	5.3	6.6	2.0	4.8	8.5	10.6	7.9	8.7	3.4	5.4	3.5	4.4	4.0	5.0	6.1	6.1	4.9	4.7	5.7	7.3	4.9	3.4	4.2	3.3	4.8	5.7	5.1	9.5	9.4	8.6	11.1	8.8	9.1	8.9	7.2	12.7	5.6	35.7	32.4	26.7	44.7	38.8	30.2	85.9	30.6	44.2	29.6	41.8	15.7	68.8	97.8	85.3	113.0	32.3	23.8	23.3	83.4	55.2	42.4	35.4	13.9	91.2	47.7	17.5	18.5	37.4	30.7	19.1	45.8	21.4	33.7	38.7	30.2	34.9	64.5	28.1	46.3	93.2	28.6	32.3	41.9	55.6	72.8	38.6	41.6	20.8	44.3	42.7
MAN1A2	MAN1B	ENSG00000198162	"Mannosidase alpha class 1A member 2"	O60476	1	117367449-117528872	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 122.4"	"Cell type enhanced"	"Detected in all"	7	"Extravillous trophoblasts: 201.3;Syncytiotrophoblasts: 318.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034559, HPA057364"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		1100000	"Golgi apparatus"		"HPA034559: AB_10671229, HPA057364: AB_2683419"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.92e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.11e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.95e-2)"	"unprognostic (8.01e-2)"	"unprognostic (8.19e-3)"	"prognostic favorable (4.08e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.38e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.08e-2)"	11.1	9.7	13.9	9.1	15.8	3.8	9.7	11.9	15.2	14.4	10.7	8.5	9.4	8.1	15.8	10.7	11.5	12.2	9.2	11.0	11.2	9.2	11.8	16.4	8.1	9.9	12.0	13.9	11.2	27.4	21.7	9.6	122.4	11.3	11.2	9.5	8.3	11.1	10.5	10.5	7.5	9.0	13.7	10.4	10.4	10.3	10.1	14.4	16.1	19.4	6.9	9.8	13.6	9.8	3.7	4.4	4.0	2.7	6.0	9.8	2.4	14.4	6.3	10.8	9.3	14.2	17.1	34.6	12.0	18.8	5.4	5.1	4.8	8.3	10.8	22.3	15.4	5.1	8.6	5.0	10.2	12.2	13.5	7.6	6.4	8.9	5.3	8.6	10.0	14.8	11.5	11.0	8.3	7.3	10.0	16.1	7.6	10.3	16.7	11.3	28.1	6.1	3.2	5.5	7.3	6.6	5.5	23.5	7.4	7.5	19.7	5.9	8.6	11.9	12.8	9.4	14.7	6.3	6.4	15.3	12.2	10.1	8.6	12.2	11.4	7.7	7.3	16.2	8.0	29.0	1.3	2.7	4.0	5.2	2.1	6.2	3.3	4.3	4.3	2.3	3.7	3.6	5.2	2.1	6.0	1.7	4.4	9.8	2.4	13.9	15.8	11.9	15.2	11.2	9.2	12.0	13.9	11.3	14.4	35.7	30.2	42.7	29.6	27.5	59.3	85.6	35.7	42.8	40.9	41.8	21.6	40.9	14.9	26.4	27.9	33.3	25.6	23.3	52.0	201.3	31.7	37.6	15.1	78.0	25.6	41.3	20.8	34.4	30.7	15.9	49.8	22.8	38.8	12.6	32.4	40.2	36.9	21.0	61.5	21.5	39.0	38.8	29.1	63.9	52.5	30.2	318.2	30.5	26.4	37.2
MAN2C1	"MANA, MANA1"	ENSG00000140400	"Mannosidase alpha class 2C member 1"	Q9NTJ4	15	75355207-75368630	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040627, HPA067407"	Uncertain		Enhanced	Nucleoplasm		NA	NA		9000	Nucleoplasm		"HPA040627: AB_10795490, HPA067407: AB_2685834"	"unprognostic (4.68e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.84e-3)"	"unprognostic (3.48e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.26e-2)"	"unprognostic (6.26e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.40e-2)"	"unprognostic (4.87e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.39e-3)"	29.9	28.8	22.6	20.4	26.0	30.0	24.6	27.5	25.5	25.1	25.1	26.8	23.8	22.9	27.8	27.5	20.2	24.2	23.3	28.2	18.3	12.9	22.9	21.4	25.2	17.0	23.0	28.3	32.8	22.3	28.2	30.6	22.4	18.3	24.9	14.2	30.8	25.6	20.2	37.9	30.9	27.7	20.0	15.0	28.1	23.0	28.8	19.9	21.0	34.7	15.3	19.5	21.1	21.3	2.3	15.7	2.6	16.2	3.9	7.3	8.5	5.5	13.3	11.1	8.0	12.7	11.0	13.8	12.9	12.2	6.8	5.7	9.2	19.1	2.7	7.6	9.4	6.2	17.2	6.1	8.7	4.4	15.2	13.4	17.5	25.2	9.1	18.8	11.2	2.8	13.1	8.8	6.4	8.1	14.4	15.8	8.0	10.0	14.4	5.5	10.8	5.5	12.7	4.7	6.6	5.6	7.8	5.6	16.6	8.9	25.9	6.6	12.0	8.2	12.5	5.8	8.3	12.4	13.1	30.9	14.3	10.0	9.9	12.7	14.4	3.5	4.4	9.2	12.9	14.2	2.6	13.3	2.0	7.2	16.2	6.8	2.3	5.3	5.2	15.7	2.0	7.3	5.1	1.4	3.9	12.4	6.4	7.0	8.5	22.6	26.0	27.5	25.5	18.3	12.9	23.0	28.3	18.3	19.9	20.8	52.5	12.9	13.4	11.9	32.1	2.0	5.1	16.0	18.2	8.7	51.1	14.5	3.3	9.4	8.2	17.2	21.3	0.0	7.7	8.8	15.0	13.8	31.1	21.5	17.5	27.0	32.8	33.2	37.8	10.6	21.6	24.1	15.1	19.8	21.0	18.6	9.2	14.4	11.7	12.3	52.0	25.8	10.4	18.6	10.9	7.4	17.7	12.7	20.7	11.9
MAOA		ENSG00000189221	"Monoamine oxidase A"	P21397	X	43654907-43746824	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Catecholamine metabolism, Neurotransmitter degradation"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Enterocytes: 358.2;Proximal tubular cells: 497.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;MAIT T-cell: 1.3"	"Group enriched"	"Detected in many"	10	"monocytes: 1.0;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 40.4;HHSteC: 75.9;HSkMC: 19.1;hTCEpi: 21.4;RT4: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009437, HPA054807, HPA059299"	Enhanced		Enhanced	Mitochondria,Cytosol		No	No			Mitochondria	Cytosol	"CAB009437: AB_2137260, HPA054807: AB_2682607, HPA059299: AB_2683970"	"unprognostic (9.54e-3)"	"unprognostic (1.63e-1)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.51e-2)"	"unprognostic (6.89e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.29e-2)"	"unprognostic (3.94e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.16e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.98e-3)"	72.3	11.0	8.2	10.2	7.8	0.3	35.2	3.3	6.1	12.4	85.7	2.8	10.7	53.6	12.5	6.2	36.6	12.0	14.7	37.8	6.7	8.3	77.8	45.9	34.4	5.2	11.1	6.1	14.2	24.4	9.6	1.5	79.8	8.7	26.2	39.9	6.2	49.1	12.9	12.5	11.2	90.1	23.6	3.4	2.1	19.3	5.5	4.7	0.0	68.6	9.7	3.9	35.3	35.1	0.0	0.0	0.1	1.0	0.0	1.3	0.1	0.0	0.8	0.1	2.4	40.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	4.1	1.5	5.4	0.0	0.0	0.6	1.6	0.1	4.3	75.9	0.0	4.1	19.1	21.4	0.0	11.2	0.0	4.8	0.0	0.0	0.1	1.4	0.6	0.0	0.1	0.4	4.9	1.2	0.0	0.0	0.1	5.5	31.3	0.7	1.9	0.0	0.0	0.0	0.1	0.1	0.0	2.1	0.0	2.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.0	0.1	0.3	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.1	8.2	7.8	3.3	6.1	6.7	8.3	11.1	6.1	8.7	4.7	65.5	115.2	10.9	141.7	9.7	4.4	90.1	91.7	34.8	50.0	57.6	21.6	9.7	102.8	29.5	19.6	35.3	358.2	0.0	12.0	17.7	14.2	55.4	5.7	169.3	6.2	3.2	36.6	36.8	14.9	22.5	5.2	4.0	10.1	29.7	119.4	23.2	31.4	140.8	0.0	497.3	21.7	6.5	15.1	1.1	0.4	12.5	173.1	3.1	215.1	89.9
MAP1B	"MAP5, PPP1R102"	ENSG00000131711	"Microtubule associated protein 1B"	P46821	5	72107234-72209570	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 102.5"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 675.4;Horizontal cells: 611.8;Muller glia cells: 420.2;Rod photoreceptor cells: 440.1;Sertoli cells: 756.7;Smooth muscle cells: 465.8"	"Cancer enriched"	"Detected in all"	5	"glioma: 48.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 64.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009792, HPA022275"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		140000	Cytosol		"CAB009792: AB_2137420, HPA022275: AB_1853944"	"unprognostic (9.96e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.57e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.67e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.75e-2)"	"prognostic unfavorable (8.22e-5)"	20.3	18.1	27.5	10.2	39.6	1.6	9.3	52.3	101.9	15.3	6.1	21.6	3.5	3.2	9.2	9.8	12.8	7.7	10.7	17.1	37.6	40.7	4.4	3.3	3.7	3.2	42.4	42.5	7.8	4.5	3.0	7.0	9.5	102.5	19.0	6.2	9.4	7.6	24.0	3.6	10.2	3.9	22.9	45.7	2.4	7.2	11.0	11.3	0.0	5.7	0.1	2.6	13.4	5.9	0.2	0.4	0.6	0.0	0.0	0.3	2.1	0.3	12.2	30.7	11.1	19.1	33.5	0.0	6.6	5.1	6.7	8.0	0.1	0.4	0.0	15.8	24.3	20.2	0.1	16.7	0.6	10.1	0.0	2.4	1.3	4.3	4.0	10.2	0.0	1.0	33.6	2.1	26.8	9.9	6.0	20.7	0.0	1.9	0.0	11.3	0.1	0.0	0.0	8.3	0.0	3.9	0.1	3.6	0.0	0.6	0.0	19.9	13.8	6.5	0.0	3.4	26.6	0.0	1.3	64.6	21.2	10.0	15.4	29.6	1.4	0.0	0.0	22.9	0.0	16.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.6	0.0	0.0	0.4	0.2	2.1	27.5	39.6	52.3	59.1	37.6	40.7	42.4	42.5	102.5	11.3	0.0	1.3	1.7	41.3	28.0	193.6	258.0	2.5	68.3	19.4	8.7	675.4	1.8	0.0	9.0	10.7	79.8	0.0	0.0	2.9	1.2	236.1	19.8	1.1	0.8	5.2	611.8	74.5	53.4	2.2	10.5	286.8	2.8	75.9	0.0	0.2	420.2	9.6	0.0	361.7	0.8	440.1	756.7	465.8	7.7	4.4	44.3	3.3	0.0	0.0	9.8
MAP2K1	"MAPKK1, MEK1, PRKMK1"	ENSG00000169032	"Mitogen-activated protein kinase kinase 1"	Q02750	15	66386817-66492312	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003834, HPA026430"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		62000	"Plasma membrane, Cytosol"		"CAB003834: AB_562310, HPA026430: AB_1853742"	"unprognostic (4.05e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (1.95e-4)"	"unprognostic (1.81e-3)"	"unprognostic (5.78e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.40e-3)"	28.6	16.9	33.9	19.1	54.1	29.0	23.6	32.5	48.4	12.5	12.1	8.4	10.2	10.0	11.8	16.5	22.0	10.6	14.4	19.1	49.2	26.4	15.3	53.1	16.4	23.3	17.6	31.2	13.5	11.7	23.4	12.0	15.4	17.2	14.4	12.9	9.1	13.2	12.4	39.5	12.3	10.9	16.9	17.4	14.5	10.8	7.8	12.6	12.6	12.3	9.7	27.9	13.6	18.7	4.6	16.2	5.5	8.2	8.4	7.9	2.7	33.6	15.9	31.9	13.3	19.3	14.5	18.5	24.4	20.9	26.5	23.7	23.8	27.7	30.9	30.3	20.1	20.2	30.0	29.8	35.7	31.3	24.9	17.8	9.9	16.6	12.9	15.6	13.0	14.8	11.2	22.1	19.2	28.5	28.3	20.7	15.8	17.5	39.6	38.7	13.0	10.5	17.1	16.3	31.2	13.9	11.9	19.7	27.5	25.7	14.5	19.7	11.0	19.8	15.5	20.5	26.9	14.0	11.2	28.5	34.6	21.2	24.4	36.2	24.5	43.6	19.7	36.5	23.1	16.1	3.2	8.2	5.5	7.4	8.2	6.7	3.0	6.6	6.9	8.3	4.6	7.9	4.9	3.9	8.4	7.3	16.2	4.9	2.7	33.9	54.1	32.5	46.9	49.2	26.4	17.6	31.2	17.2	12.6	26.8	21.9	30.2	40.5	73.6	8.5	16.9	38.2	6.7	13.6	24.4	13.7	40.9	39.7	65.3	10.2	19.0	20.0	46.7	20.4	39.4	31.3	59.4	9.2	116.5	44.9	9.5	20.8	17.2	91.3	18.3	20.8	67.7	50.6	88.4	17.0	33.9	70.1	21.0	20.5	28.5	5.6	6.5	53.6	16.3	44.5	58.8	43.3	40.5	16.8	65.5
MAP4		ENSG00000047849	"Microtubule associated protein 4"	P27816	3	47850690-48089272	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 131.5;skeletal muscle: 197.9"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 398.9;Cardiomyocytes: 855.4;Cone photoreceptor cells: 589.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038149, HPA038150"	Enhanced		Enhanced	"Plasma membrane,Microtubules,Cytosol"		NA	NA		120000	"Plasma membrane, Microtubules, Cytosol"		"HPA038149: AB_10672471, HPA038150: AB_10672505"	"unprognostic (2.51e-1)"	"unprognostic (4.48e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.36e-1)"	"unprognostic (4.57e-1)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (6.82e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-3)"	39.3	14.8	60.5	18.2	50.9	6.3	16.4	29.3	56.0	26.9	26.4	80.8	15.8	13.6	25.8	27.4	27.0	24.6	20.1	110.2	63.7	57.5	20.8	13.8	22.7	12.4	86.8	26.1	26.8	18.9	14.6	9.3	24.0	59.5	21.8	18.8	25.2	14.0	34.9	197.9	25.1	15.2	35.0	131.5	18.3	16.2	21.2	41.8	7.3	15.4	31.3	14.2	24.3	18.1	9.9	8.9	6.3	19.7	10.7	13.4	6.7	22.2	17.9	22.4	17.0	33.1	59.1	9.5	41.8	45.7	35.4	39.8	15.0	14.0	18.9	9.8	63.0	33.3	14.9	28.6	37.9	39.8	27.2	12.1	12.7	20.0	19.4	45.0	8.8	10.4	49.4	47.4	43.0	52.7	32.3	46.4	13.3	16.4	22.0	27.8	12.6	12.5	10.8	13.5	11.0	37.0	6.7	21.1	23.4	22.7	18.7	8.9	13.9	32.1	13.0	22.1	32.8	9.5	8.2	62.6	33.5	25.9	35.0	26.7	15.4	11.9	8.9	43.1	10.9	31.6	6.3	5.3	2.8	13.4	9.0	6.5	9.9	9.0	10.9	5.7	9.4	4.3	6.7	2.2	10.7	19.7	8.9	10.2	6.7	60.5	50.9	29.3	51.8	63.7	57.5	86.8	26.1	59.5	41.8	65.5	44.5	28.6	38.3	66.4	398.9	855.4	48.4	45.5	70.5	76.8	589.0	27.7	23.2	85.7	90.1	78.7	34.2	0.0	56.1	64.5	84.5	58.1	26.6	49.9	34.2	44.5	27.6	41.1	23.5	28.8	71.4	40.8	74.2	101.8	29.5	77.6	76.7	23.0	96.9	27.0	86.7	71.1	108.8	53.1	49.0	60.9	18.8	48.4	33.0	40.0
MAP7D3	FLJ12649	ENSG00000129680	"MAP7 domain containing 3"	Q8IWC1	X	136213220-136256482	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 212.2;Late spermatids: 231.1;Spermatogonia: 128.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA035598, HPA058101"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA035598: AB_10671108, HPA058101: AB_2683604"	"unprognostic (2.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (9.00e-5)"	"unprognostic (8.83e-3)"	"unprognostic (3.77e-3)"	"unprognostic (4.16e-5)"	"unprognostic (5.35e-2)"	"unprognostic (6.57e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (7.91e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.38e-5)"	26.1	4.8	2.9	9.3	3.8	4.5	21.2	0.9	2.2	14.3	9.0	1.7	6.8	2.2	11.4	12.3	10.6	13.7	6.7	17.7	2.7	1.9	9.9	6.5	6.9	6.4	4.1	1.1	23.6	2.8	8.3	14.1	32.6	5.5	9.4	3.5	4.6	3.8	8.6	27.9	5.3	6.2	15.3	6.5	11.8	6.5	16.0	3.1	9.5	9.6	10.2	4.9	13.9	14.6	9.8	6.2	5.9	9.2	8.4	9.3	3.9	15.7	5.6	4.3	7.3	9.7	10.2	5.9	15.2	8.4	12.5	17.2	5.6	7.9	8.2	24.7	13.3	13.3	7.6	12.4	8.1	17.2	7.4	12.4	4.9	9.0	0.0	10.6	11.9	5.1	20.6	4.7	12.8	16.0	7.1	9.7	13.6	4.1	12.9	9.2	9.9	14.1	4.5	6.0	3.9	0.1	14.0	11.6	4.0	0.4	2.4	3.0	6.4	8.8	3.3	5.5	7.7	0.0	5.5	29.0	13.4	7.7	17.0	19.3	8.8	10.5	9.4	9.1	20.1	6.3	5.9	4.8	1.4	7.5	5.5	9.3	9.8	7.1	8.2	5.8	8.5	7.6	6.0	1.0	8.4	9.2	6.2	5.0	3.9	2.9	3.8	0.9	2.2	2.7	1.9	4.1	1.1	5.5	3.1	14.9	7.0	15.9	5.2	6.4	0.7	34.1	17.8	6.7	11.4	17.4	0.0	9.6	1.7	8.2	212.2	18.4	1.6	0.0	12.2	78.9	27.3	1.4	34.6	25.0	13.2	19.1	5.2	60.8	18.1	231.1	58.7	17.4	6.8	25.2	2.3	12.0	11.4	14.0	44.9	26.1	2.6	38.8	44.3	41.7	128.3	4.3	11.2	17.5	3.0	2.6
MAPK7	"BMK1, ERK5, PRKM7"	ENSG00000166484	"Mitogen-activated protein kinase 7"	Q13164	17	19377721-19383544	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Differentiation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Sertoli cells: 25.8;Spermatocytes: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.1;SuSa: 29.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018561, HPA031031"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB018561: AB_2140544, HPA031031: AB_2673706"	"unprognostic (1.63e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (5.67e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.71e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.78e-2)"	11.5	15.0	6.4	7.3	7.6	9.2	11.8	12.5	7.9	13.4	15.3	7.2	6.0	9.2	13.1	14.1	17.3	9.4	11.8	8.2	5.9	4.7	10.8	4.8	9.9	9.2	8.2	5.2	25.4	5.7	7.3	7.5	12.5	6.7	14.0	6.9	10.5	7.8	12.3	7.5	13.1	11.2	13.8	7.1	13.2	8.0	13.3	7.5	4.5	8.6	11.3	10.6	12.7	15.9	2.2	2.6	11.5	7.4	5.5	4.7	3.0	3.6	5.8	4.8	3.7	24.1	10.1	5.6	5.0	4.6	6.9	6.4	6.7	0.6	2.2	4.0	8.6	5.1	4.1	5.6	4.6	4.3	3.8	4.3	1.0	4.1	2.9	10.4	0.9	3.7	10.6	3.2	10.5	3.7	6.0	5.1	4.3	1.9	0.8	6.9	2.4	7.4	3.9	5.5	3.7	3.8	4.0	7.0	1.5	2.3	2.0	2.2	6.4	5.1	0.5	2.5	29.6	3.1	1.2	2.8	7.4	5.5	8.2	3.4	1.4	2.1	0.6	8.6	0.9	4.5	1.0	3.6	11.5	4.7	7.4	2.5	2.2	2.2	4.1	2.6	1.4	2.1	2.6	1.3	5.5	6.5	1.7	1.0	3.0	6.4	7.6	12.5	7.9	5.9	4.7	8.2	5.2	6.7	7.5	6.0	3.5	6.2	5.5	4.8	2.0	1.7	0.0	1.4	2.3	5.2	2.0	4.8	5.0	7.1	6.3	7.1	9.0	0.0	5.3	6.9	8.3	5.5	2.3	1.3	6.7	0.0	10.3	6.7	6.7	5.9	10.6	6.3	3.3	2.8	5.7	14.5	6.2	13.5	11.0	3.0	2.0	25.8	8.6	31.4	10.6	3.8	4.2	4.4	6.1	5.2
MAPK8IP1	"IB1, JIP-1, JIP1, PRKM8IP"	ENSG00000121653	"Mitogen-activated protein kinase 8 interacting protein 1"	Q9UQF2	11	45885651-45906465	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 73.5"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 38.7;Horizontal cells: 63.5;Intestinal endocrine cells: 38.7"	"Cancer enhanced"	"Detected in all"		"glioma: 51.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058921, HPA070332, HPA079657"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA058921: AB_2683854, HPA070332: AB_2686254, HPA079657: "	"unprognostic (3.96e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.82e-1)"	"unprognostic (8.25e-3)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.20e-2)"	"prognostic favorable (1.23e-11)"	"unprognostic (7.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.80e-3)"	3.0	12.8	33.3	2.1	29.6	1.4	2.7	24.9	73.5	3.1	1.9	4.6	0.1	1.6	4.9	3.1	2.1	6.6	3.0	2.9	38.1	22.3	5.1	2.7	2.6	1.0	28.0	18.9	4.4	26.4	14.7	24.8	1.6	23.5	4.9	1.5	4.5	4.8	5.0	1.7	1.7	2.0	4.4	44.4	1.7	3.8	10.8	4.8	0.0	3.9	0.5	0.9	2.0	0.4	0.4	0.4	2.1	0.9	2.6	0.2	0.0	0.0	3.6	4.8	13.3	1.8	0.9	0.1	2.6	2.3	5.1	3.7	3.1	0.5	0.2	1.3	2.9	8.7	2.9	5.1	2.4	2.3	1.9	6.6	0.0	4.5	2.0	1.6	0.3	2.3	1.3	0.5	3.3	0.7	3.4	1.1	0.5	5.5	0.8	1.4	1.9	0.2	0.3	12.7	1.6	5.3	0.3	7.9	0.1	2.3	0.1	39.4	14.7	4.2	3.5	4.8	1.9	5.6	0.2	1.0	6.5	10.0	9.7	4.6	0.5	0.6	0.2	4.1	0.1	1.9	2.1	0.9	0.0	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.4	0.1	0.2	1.8	2.6	0.0	0.4	0.1	0.0	33.3	29.6	24.9	41.7	38.1	22.3	28.0	18.9	23.5	4.8	6.0	2.6	0.0	5.9	2.2	33.1	1.1	5.1	2.7	3.4	10.4	21.6	1.2	11.6	5.6	38.7	2.2	1.3	0.0	24.7	0.4	3.9	7.7	0.0	4.0	0.4	63.5	38.7	0.0	0.6	29.6	5.8	1.7	3.3	2.8	1.1	30.4	17.1	0.0	6.0	7.0	15.7	0.0	5.8	12.5	5.5	0.9	4.8	1.0	0.9	5.4
MAPRE1	EB1	ENSG00000101367	"Microtubule associated protein RP/EB family member 1"	Q15691	20	32819893-32850405	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003600, CAB009337, CAB019391"	Supported		Enhanced	"Centriolar satellite,Cytosol"		NA	NA		17000000	"Centriolar satellite, Cytosol"		"CAB009337: AB_2141629, CAB019391: , HPA003600: AB_1079309"	"unprognostic (3.74e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.48e-3)"	"unprognostic (2.98e-3)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.99e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.76e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.59e-3)"	35.4	23.4	30.9	30.9	28.7	77.5	27.2	12.3	25.3	26.1	39.3	34.0	25.9	18.3	40.0	29.8	30.0	28.4	27.4	31.7	26.9	25.0	33.6	14.2	30.3	31.9	36.6	17.5	29.5	22.1	19.7	20.0	35.2	27.9	29.1	28.1	24.7	22.0	35.3	20.4	19.3	25.8	42.5	37.1	38.5	29.1	31.7	24.1	48.4	35.2	26.1	31.0	39.1	30.0	19.7	25.7	66.8	41.4	27.3	30.3	42.1	31.0	28.6	32.0	18.3	17.3	15.8	45.6	30.5	19.0	47.5	35.1	82.5	28.9	47.4	30.6	27.3	48.5	28.5	38.1	34.0	52.1	16.0	14.9	91.3	19.9	44.0	18.4	32.8	40.6	17.0	17.1	38.8	26.0	16.3	29.5	27.0	41.0	27.1	41.7	19.2	44.9	28.7	23.0	31.9	26.5	30.3	56.8	25.4	25.9	21.5	20.0	21.0	54.6	24.2	31.3	30.6	35.0	24.5	26.1	53.6	28.9	26.7	39.2	23.9	32.9	51.0	28.4	75.2	29.7	55.1	33.6	66.8	28.1	39.3	29.1	19.7	26.9	25.9	25.7	18.9	27.3	30.3	36.8	27.3	41.4	23.6	27.0	42.1	30.9	28.7	12.3	25.3	26.9	25.0	36.6	17.5	27.9	24.1	17.9	34.2	60.4	129.6	117.9	10.3	33.9	28.1	30.8	33.0	52.4	7.9	94.3	71.3	67.9	73.1	54.9	44.5	23.3	67.9	106.9	60.2	92.7	113.1	12.3	96.7	9.5	68.5	33.7	89.3	54.6	33.1	84.1	67.4	151.5	35.2	27.8	62.8	37.1	60.5	57.4	11.1	64.7	114.0	59.6	50.9	96.9	141.5	79.8	37.3	118.6
MARS	"CMT2U, MetRS, SPG70"	ENSG00000166986	"Methionyl-tRNA synthetase"	P56192	12	57475445-57517569	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 118.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004125, CAB017097"	Supported	Approved	Enhanced	Cytosol		NA	NA		21000	Cytosol		"CAB017097: , HPA004125: AB_1079312"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (4.55e-7)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.85e-2)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.06e-2)"	23.8	26.7	35.1	27.3	29.1	23.0	19.8	25.1	36.0	17.4	23.9	23.1	23.9	17.3	23.3	36.3	29.5	17.9	16.1	25.0	28.0	29.5	20.5	45.9	24.3	25.1	40.1	25.5	25.8	48.3	35.7	34.0	22.2	30.9	25.6	24.7	19.8	26.0	30.0	24.5	18.4	20.1	33.7	30.7	30.7	31.3	29.6	30.9	21.4	26.9	22.3	34.3	24.3	27.9	12.9	29.3	19.0	27.0	14.1	18.9	15.5	16.8	23.4	15.7	27.1	17.6	10.7	28.9	24.1	28.2	25.5	27.3	25.1	18.7	29.6	16.0	29.2	15.9	19.2	35.7	31.1	26.8	25.6	15.5	20.9	8.7	14.1	39.2	31.4	24.0	15.5	48.4	29.2	75.7	12.2	18.2	37.8	32.3	63.4	17.7	23.3	28.1	23.7	29.6	27.0	25.8	24.4	118.3	30.6	19.2	13.2	20.9	21.3	12.5	19.3	33.4	18.4	25.4	41.2	13.5	9.2	27.3	13.3	14.3	58.2	58.8	35.7	22.7	23.9	31.5	12.1	14.6	19.0	18.9	27.0	17.2	12.9	12.9	17.1	29.3	7.7	11.1	15.2	7.2	14.1	21.8	28.4	13.1	15.5	35.1	29.1	25.1	36.0	28.0	29.5	40.1	25.5	30.9	30.9	35.7	22.7	29.8	15.6	16.6	14.8	10.1	12.7	28.1	29.6	17.4	31.4	24.6	5.0	32.2	19.0	13.7	11.1	0.0	39.9	18.6	15.5	18.1	26.7	11.3	17.0	6.4	14.5	8.0	12.0	6.6	12.0	22.6	3.3	32.5	10.3	11.5	33.5	14.0	14.2	9.8	28.8	12.9	17.9	33.4	34.1	14.1	31.8	20.3	9.7	23.1
MASP1	"CRARF, MASP, PRSS5"	ENSG00000127241	"Mannan binding lectin serine peptidase 1"	P48740	3	187217285-187292022	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 43.4;liver: 80.1"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 32.5;Cholangiocytes: 28.1;Hepatocytes: 57.1;Ito cells: 30.7"	"Group enriched"	"Detected in some"	9	"glioma: 6.8;liver cancer: 7.7;prostate cancer: 3.0;renal cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"BJ: 27.1;BJ hTERT+: 103.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	No	NA	8670000000	1800000000	"Nucleoplasm, Cytosol"		"HPA001617: AB_1079314, HPA009641: AB_1079313"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.99e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.25e-6)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.56e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.85e-2)"	"unprognostic (4.29e-1)"	2.1	1.4	3.6	1.2	3.8	0.1	1.2	1.9	10.2	43.4	19.1	14.8	2.4	0.8	34.9	7.1	4.1	6.7	3.3	39.6	6.1	2.5	1.6	80.1	2.2	0.4	6.4	3.0	1.7	0.2	0.2	0.5	3.2	13.0	17.4	2.1	0.1	0.9	19.4	12.2	2.5	2.6	17.1	21.8	0.4	0.6	1.5	6.7	0.0	1.3	6.3	3.5	4.4	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.7	0.0	27.1	103.4	0.4	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.8	1.9	3.5	6.1	2.5	6.4	3.0	13.0	6.7	0.0	2.6	0.0	0.1	2.6	0.0	32.5	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.0	0.2	11.0	0.0	0.0	57.1	0.4	0.0	0.0	30.7	2.4	3.8	2.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.7	2.2	0.0	0.0	5.9	0.0	0.0	1.5	0.1	0.5	0.0	0.1
MASTL	"FLJ14813, Gwl, THC2"	ENSG00000120539	"Microtubule associated serine/threonine kinase like"	Q96GX5	10	27154824-27186924	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 20.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027175, HPA054273"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA027175: AB_1853591, HPA054273: AB_2682433"	"unprognostic (4.10e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (2.19e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.05e-2)"	"prognostic unfavorable (4.81e-5)"	"unprognostic (3.78e-2)"	"prognostic unfavorable (1.71e-6)"	"unprognostic (1.55e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.79e-1)"	9.1	7.0	3.6	8.9	6.1	21.1	8.3	4.0	7.5	7.4	7.6	3.8	5.7	5.7	6.0	6.7	12.3	5.4	5.3	5.6	6.8	4.5	6.5	7.1	10.2	14.8	5.4	5.7	7.0	12.7	6.7	6.3	14.2	6.7	5.5	7.1	5.6	8.0	4.7	4.0	10.1	10.0	6.1	5.6	8.7	6.2	11.3	2.3	21.1	6.5	4.3	12.3	8.7	7.5	3.9	2.6	5.6	4.9	2.3	4.0	1.8	11.9	9.6	18.4	6.8	2.8	4.2	10.9	17.9	7.5	29.7	36.6	11.6	12.0	9.6	6.8	7.5	14.4	11.6	11.7	7.1	21.1	8.1	11.3	11.3	6.7	6.7	1.6	4.3	8.5	2.5	3.2	17.9	3.5	3.9	6.4	7.8	8.6	21.6	18.0	7.9	14.0	4.7	13.7	6.7	3.9	9.0	30.7	7.9	7.3	4.5	8.2	11.8	11.3	7.6	7.9	12.7	7.6	9.1	5.5	7.4	15.6	18.9	15.7	2.6	4.2	14.1	8.1	13.1	6.1	0.1	4.4	3.8	2.0	4.3	3.0	2.6	2.5	1.8	2.5	3.9	2.5	2.3	5.6	2.3	4.9	2.6	4.0	1.8	3.6	6.1	4.0	7.5	6.8	4.5	5.4	5.7	6.7	2.3	6.0	8.5	7.2	4.0	9.7	1.9	1.6	0.0	4.0	9.1	1.8	0.0	3.3	0.0	3.2	1.7	3.6	3.0	0.0	2.2	20.7	5.8	3.3	12.7	1.7	5.1	3.2	4.1	2.5	12.0	1.5	2.8	5.6	0.0	1.8	3.4	1.5	3.6	1.9	2.5	1.4	0.9	0.0	5.9	11.2	16.4	8.7	5.1	8.7	3.5	5.9
MAVS	"Cardif, IPS-1, KIAA1271, VISA"	ENSG00000088888	"Mitochondrial antiviral signaling protein"	Q7Z434	20	3846799-3876123	"Predicted membrane proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB009187, HPA049850, HPA053524"	Enhanced		Enhanced	Mitochondria		NA	NA		230000	Mitochondria		"CAB009187: , HPA049850: AB_2680912, HPA053524: AB_2682177"	"unprognostic (1.30e-2)"	"unprognostic (4.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.30e-2)"	"unprognostic (5.95e-2)"	"prognostic favorable (3.81e-4)"	"unprognostic (1.92e-1)"	"prognostic favorable (4.13e-5)"	"unprognostic (4.97e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (7.39e-2)"	15.9	13.9	13.0	15.5	17.7	10.8	25.5	17.7	15.7	12.3	18.5	17.2	15.1	17.2	14.9	10.6	17.3	13.8	12.2	15.4	12.3	8.0	13.3	13.9	18.1	17.4	19.9	9.0	18.9	22.5	23.4	13.7	12.0	13.8	13.1	18.6	13.6	15.3	22.4	39.4	22.1	17.0	17.1	13.7	12.7	15.8	5.9	17.1	15.1	14.6	14.0	14.3	18.2	21.6	5.1	5.6	6.4	6.9	5.9	4.8	4.6	16.6	19.4	7.9	9.8	21.8	14.9	6.2	10.1	13.0	10.8	7.9	15.1	10.8	7.2	6.2	14.1	30.8	21.0	9.4	15.1	11.1	4.4	4.6	13.9	7.2	24.0	12.1	8.7	5.9	15.0	12.9	18.3	10.9	10.8	10.9	9.5	15.6	5.6	10.5	15.0	13.1	7.4	5.0	8.3	10.7	9.9	11.0	7.2	11.4	16.7	5.9	6.2	11.5	22.5	9.7	11.7	12.0	8.1	16.4	14.8	5.5	17.4	11.7	11.4	13.7	5.1	5.8	10.7	7.5	4.4	6.9	6.1	4.8	5.1	3.6	3.8	3.8	3.7	4.4	5.1	4.4	4.4	6.4	5.9	5.5	5.6	3.0	4.6	13.0	17.7	17.7	15.7	12.3	8.0	19.9	9.0	13.8	17.1	53.6	40.3	27.3	12.5	1.9	31.8	52.6	66.2	25.4	35.2	27.9	15.7	28.8	11.6	21.9	0.9	25.1	79.6	23.3	26.2	23.2	18.1	15.7	8.1	39.0	21.3	42.9	33.4	41.1	29.1	1.5	28.4	13.1	1.7	17.2	28.4	23.6	28.0	21.0	26.5	18.3	34.3	32.3	8.1	4.2	3.8	1.8	15.1	19.2	45.8	14.3
MAZ	"Pur-1, ZF87, Zif87, ZNF801"	ENSG00000103495	"MYC associated zinc finger protein"	P56270	16	29806106-29811164	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Intestinal endocrine cells: 128.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048315, HPA059495, HPA065930"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA048315: AB_2680353, HPA059495: AB_2684039, HPA065930: AB_2685579"	"unprognostic (1.05e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.83e-1)"	"unprognostic (3.25e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.39e-3)"	"prognostic unfavorable (5.15e-4)"	"unprognostic (1.20e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (7.08e-2)"	23.9	32.2	49.3	34.0	37.9	86.3	62.2	57.3	49.0	31.7	51.5	25.5	30.8	34.8	33.1	26.5	31.1	34.9	31.4	21.3	43.3	30.1	22.8	33.0	31.3	52.5	30.5	32.4	38.4	39.8	44.5	30.2	24.2	22.1	48.1	38.8	29.0	32.3	31.2	41.0	35.8	34.6	29.1	22.9	34.5	28.7	28.4	25.4	141.5	30.2	26.7	40.8	30.6	39.4	5.7	8.4	9.5	9.9	16.4	28.6	8.7	28.1	37.6	38.9	42.3	21.1	20.1	35.1	20.6	16.9	32.2	23.4	48.0	40.7	50.6	26.9	40.2	15.9	25.7	63.8	26.9	11.5	41.2	102.1	33.5	81.7	65.4	29.7	82.8	41.8	21.4	38.1	27.0	30.6	30.1	32.1	71.6	49.0	44.6	15.2	116.4	79.3	70.6	39.4	30.9	29.4	78.5	36.7	58.9	26.2	30.7	59.8	46.6	19.7	42.8	25.8	26.1	36.8	80.0	22.0	35.5	28.6	13.5	32.0	32.6	41.0	55.9	17.4	54.8	29.3	6.8	6.3	9.5	26.1	9.9	28.6	5.7	17.5	24.8	8.0	4.2	14.6	21.4	5.0	16.4	6.2	8.4	18.4	8.7	49.3	37.9	57.3	49.0	43.3	30.1	30.5	32.4	22.1	25.4	6.0	4.8	31.8	14.3	29.2	60.4	0.3	33.1	9.4	6.8	10.4	11.8	21.0	24.9	29.7	2.1	30.0	41.1	0.0	35.5	46.9	42.8	30.2	33.4	34.2	49.7	44.5	128.1	28.8	32.4	3.4	25.9	25.0	43.9	13.6	101.5	21.1	32.8	59.6	34.6	17.0	30.3	32.3	47.4	17.7	20.5	31.0	14.0	40.1	104.1	11.3
MBD1	"CXXC3, PCM1"	ENSG00000141644	"Methyl-CpG binding domain protein 1"	Q9UIS9	18	50266882-50281774	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009017, CAB036003, HPA068850"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB009017: AB_2095559, CAB036003: , HPA068850: AB_2732121"	"unprognostic (2.12e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.88e-2)"	"unprognostic (5.01e-3)"	"unprognostic (9.20e-2)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (5.08e-6)"	"unprognostic (5.91e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (7.06e-3)"	"unprognostic (7.70e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.31e-1)"	14.7	21.7	18.0	18.8	20.8	29.4	15.7	27.1	29.4	15.3	17.2	18.8	16.2	18.7	18.4	16.6	21.1	16.4	16.8	19.7	19.2	14.0	17.4	18.9	16.0	20.9	21.8	23.1	20.7	19.7	28.2	24.2	19.4	18.2	18.0	13.9	15.0	19.6	19.5	25.9	24.2	18.3	18.3	15.2	22.6	18.0	72.3	21.5	19.1	19.9	20.0	18.2	19.1	20.0	13.1	11.7	22.2	11.6	14.3	17.4	12.1	10.4	9.9	11.1	12.6	12.0	9.8	12.0	12.6	14.5	17.5	13.5	7.4	8.3	16.6	9.2	12.2	10.2	18.9	12.7	22.0	10.2	18.5	8.1	10.4	14.0	7.8	23.2	25.2	22.1	11.4	35.6	19.9	45.7	11.1	14.3	16.6	13.1	26.0	13.4	9.7	21.1	13.2	10.5	5.5	7.9	19.6	8.2	18.0	8.6	4.7	14.8	14.0	9.3	9.0	11.5	9.4	11.4	23.1	15.5	19.0	8.7	6.1	12.7	48.3	20.4	17.4	12.3	19.4	17.1	15.2	11.6	22.2	17.4	10.1	16.4	13.0	15.2	14.4	11.7	13.1	15.9	12.8	15.6	14.3	7.9	10.7	13.9	12.1	18.0	20.8	27.1	29.4	19.2	14.0	21.8	23.1	18.2	21.5	8.9	24.0	8.2	12.0	20.1	15.2	24.2	12.7	13.4	19.4	15.7	17.7	24.4	11.6	13.0	58.6	18.8	17.5	0.0	11.9	19.1	14.4	10.8	8.1	16.3	16.1	14.3	12.5	14.7	14.3	75.6	14.4	15.2	15.1	12.6	19.9	16.3	16.7	17.0	18.0	8.4	19.0	12.9	17.6	96.5	17.9	25.6	43.0	14.6	17.1	15.6
MBD2		ENSG00000134046	"Methyl-CpG binding domain protein 2"	Q9UBB5	18	54151601-54224788	"Cancer-related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Kupffer cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 8.2"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037282, HPA067582, HPA067615"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB037282: AB_477234, HPA067582: AB_2685866, HPA067615: AB_2685872"	"unprognostic (4.86e-2)"	"unprognostic (7.21e-2)"	"prognostic favorable (6.49e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.71e-2)"	"unprognostic (2.36e-3)"	"unprognostic (8.04e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.19e-2)"	29.8	11.9	8.5	27.9	9.8	15.3	24.0	9.9	9.0	17.5	22.5	7.4	20.1	10.5	12.5	14.8	33.1	11.3	18.7	17.9	7.9	8.1	23.3	23.2	21.3	33.7	10.0	5.3	15.3	19.3	13.1	12.5	38.1	8.6	18.3	15.0	12.1	23.3	17.3	13.9	24.1	26.7	15.7	11.7	36.9	12.5	26.1	9.4	31.0	31.0	25.4	32.2	22.8	27.1	2.0	1.5	2.2	8.2	0.4	2.6	0.8	12.7	5.8	10.8	5.3	12.7	10.8	10.6	12.1	15.2	14.0	12.3	3.7	7.1	30.2	6.2	18.6	6.2	20.5	9.1	16.3	15.4	22.5	5.0	4.4	9.1	8.0	13.2	14.1	8.2	9.4	18.4	10.7	15.7	9.3	16.1	9.3	3.4	28.1	12.6	6.1	14.2	7.9	11.3	5.0	7.8	9.6	6.3	12.2	20.1	13.2	11.8	5.0	9.4	9.5	6.3	14.9	4.9	7.2	13.9	14.3	6.6	4.9	10.7	30.5	16.6	23.3	12.6	12.0	8.5	0.1	2.6	1.2	1.2	4.6	1.6	1.4	1.3	1.9	1.5	2.0	0.7	1.2	2.2	0.4	8.2	1.2	2.6	0.8	8.5	9.8	9.9	9.0	7.9	8.1	10.0	5.3	8.6	9.4	26.8	16.0	24.2	25.1	43.8	17.7	28.8	20.4	24.1	20.5	31.4	15.7	11.3	6.6	23.6	1.7	25.3	29.7	23.3	49.8	45.1	20.5	42.9	8.1	17.9	28.1	20.6	15.6	24.5	111.1	3.3	23.3	44.3	25.3	33.3	38.0	36.6	44.0	20.1	24.8	19.0	23.2	25.8	18.1	5.2	4.3	54.6	15.3	17.5	33.1	78.0
MBD6	KIAA1887	ENSG00000166987	"Methyl-CpG binding domain protein 6"	Q96DN6	12	57520710-57530148	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Rod photoreceptor cells: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 14.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.7"	"Cell line enhanced"	"Detected in all"		"RH-30: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038948, HPA038949"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038948: AB_2676285, HPA038949: AB_10671868"	"unprognostic (2.56e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.83e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.01e-2)"	16.0	21.1	15.2	22.1	18.4	35.0	18.7	20.2	15.2	22.3	22.1	19.6	35.2	27.9	24.9	22.6	18.0	21.7	25.2	13.1	15.2	7.6	21.0	21.6	17.6	16.3	18.0	11.1	24.3	22.4	24.2	60.6	35.1	14.0	19.9	14.3	34.8	23.7	37.0	22.5	25.1	22.8	14.6	16.1	34.4	28.6	31.1	18.7	16.1	48.2	14.0	21.9	19.0	20.3	1.4	0.5	14.7	1.1	0.7	1.3	0.6	8.7	12.5	9.7	10.3	6.7	4.8	13.6	10.1	6.1	6.5	4.9	12.9	13.9	8.8	7.8	5.4	6.5	12.3	8.8	7.6	4.6	17.4	8.9	15.5	12.1	8.7	8.2	9.2	40.2	8.4	13.4	7.0	10.0	10.2	8.7	7.5	9.8	23.4	5.2	9.0	9.5	9.2	9.3	6.4	9.2	9.5	46.8	6.7	5.6	17.3	13.4	8.1	8.1	16.2	9.9	6.1	18.2	14.9	8.6	7.2	11.9	7.3	6.8	24.4	8.2	6.1	9.4	5.8	12.1	0.0	1.1	0.4	1.3	0.9	0.6	1.4	0.2	0.4	0.5	1.0	0.6	0.6	14.7	0.7	0.4	0.4	0.2	0.6	15.2	18.4	20.2	15.2	15.2	7.6	18.0	11.1	14.0	18.7	6.0	16.2	6.7	12.6	9.7	56.0	5.2	33.1	12.0	10.3	8.7	25.5	9.5	5.0	7.2	6.7	12.7	14.9	0.0	10.4	6.7	8.2	11.5	18.5	24.3	12.2	23.8	15.0	15.4	20.2	7.8	13.6	15.0	11.8	1.0	19.5	28.3	8.8	17.5	12.0	3.7	67.0	19.4	7.6	39.1	29.6	10.8	18.9	13.1	15.7	14.9
MBNL1	"EXP, EXP35, EXP40, EXP42, KIAA0428, MBNL"	ENSG00000152601	"Muscleblind like splicing regulator 1"	Q9NR56	3	152243828-152465780	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Corneal dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016398, HPA035098"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB016398: AB_784435, HPA035098: AB_2674461"	"unprognostic (5.46e-3)"	"unprognostic (6.01e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.44e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.75e-2)"	"unprognostic (9.49e-3)"	"unprognostic (5.18e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.78e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.90e-7)"	"unprognostic (7.53e-3)"	"unprognostic (6.15e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.98e-1)"	55.9	17.5	14.5	50.8	17.0	28.5	43.8	11.8	14.5	46.4	44.0	10.8	18.0	15.2	41.1	23.6	33.3	22.3	27.5	29.9	14.3	12.9	18.6	16.5	39.6	45.6	18.0	9.1	30.5	12.5	12.5	16.0	10.4	12.6	30.5	26.0	12.7	18.3	25.1	87.6	22.8	29.5	59.8	22.1	39.6	23.1	14.6	17.4	71.9	18.5	34.5	46.0	64.4	29.3	25.0	30.7	38.2	27.4	33.6	39.9	40.2	27.8	23.0	3.7	8.4	29.6	30.6	2.8	35.0	28.4	23.1	19.4	10.1	16.4	28.7	17.9	49.0	7.2	12.8	6.9	20.2	34.3	22.3	9.4	31.3	11.7	4.7	16.5	37.4	22.9	14.2	11.0	26.6	20.8	17.8	47.4	11.6	15.9	39.2	22.4	9.6	34.8	13.7	1.5	8.2	18.4	35.7	11.6	35.9	11.7	14.1	3.0	3.4	15.2	8.3	14.8	1.4	11.5	57.1	39.8	31.7	12.2	21.0	30.1	41.0	23.4	33.0	18.5	46.8	17.0	32.6	22.7	38.2	37.2	27.4	39.9	25.0	30.5	30.9	30.7	24.1	38.9	33.3	35.4	33.6	22.8	11.1	27.0	40.2	14.5	17.0	11.8	14.5	14.3	12.9	18.0	9.1	12.6	17.4	140.0	156.6	98.0	41.0	189.8	25.7	160.6	45.9	78.9	139.9	36.6	60.9	20.0	18.3	32.5	2.1	146.2	138.0	70.0	54.4	8.3	91.5	50.3	155.2	83.5	55.2	30.2	45.4	75.5	193.7	5.9	82.8	171.1	97.8	129.0	61.7	16.0	47.0	71.9	67.1	29.9	84.3	97.0	113.3	4.9	10.9	213.0	12.4	228.4	54.7	46.0
MCCC2	MCCB	ENSG00000131844	"Methylcrotonoyl-CoA carboxylase 2"	Q9HCC0	5	71587288-71658704	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Ligase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 74.3"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 79.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038300, HPA038301, HPA061546"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA038300: AB_2675941, HPA038301: AB_10670661, HPA061546: AB_2684557"	"unprognostic (2.39e-1)"	"unprognostic (6.89e-3)"	"prognostic favorable (3.62e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.07e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.37e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.43e-8)"	"unprognostic (1.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.15e-2)"	"unprognostic (3.47e-2)"	12.4	29.4	9.2	11.8	13.6	2.7	30.5	7.9	10.0	11.2	15.3	12.2	15.1	13.0	9.7	20.0	14.5	9.1	12.3	74.3	7.6	8.1	35.6	61.9	8.4	11.6	7.8	8.0	9.6	18.9	14.1	10.3	15.1	13.4	24.6	18.1	12.8	20.6	29.4	17.6	10.8	14.1	7.8	17.0	11.0	13.6	6.9	6.9	9.4	22.2	13.3	14.3	15.7	8.5	8.8	16.7	1.7	11.5	12.9	10.2	6.7	11.9	16.5	7.1	27.1	7.6	7.8	12.1	5.7	9.6	11.8	8.5	28.9	15.2	27.7	21.0	8.3	9.2	9.9	12.3	19.0	14.8	14.7	15.7	15.0	8.5	31.7	13.3	7.4	14.3	10.0	10.0	10.8	8.6	5.3	10.3	8.0	18.9	10.4	8.1	32.6	0.1	13.6	9.3	10.5	9.3	14.5	20.4	40.7	30.6	21.6	11.2	12.4	24.9	36.9	12.1	3.5	30.6	18.9	7.5	4.8	7.5	8.7	15.3	7.5	13.8	17.2	7.9	20.7	11.9	1.7	7.4	1.6	6.1	11.5	7.9	8.8	7.9	6.9	16.7	8.6	8.0	8.7	1.2	12.9	6.8	7.4	10.2	6.7	9.2	13.6	7.9	10.0	7.6	8.1	7.8	8.0	13.4	6.9	14.9	23.4	22.9	14.2	11.7	12.8	60.9	17.8	16.0	18.2	15.7	5.9	40.3	18.3	18.3	3.1	14.2	19.6	0.0	16.1	19.0	8.9	25.3	12.7	79.8	15.6	3.2	28.4	8.0	10.8	7.4	12.7	12.2	11.8	19.0	22.7	19.0	14.2	17.5	19.1	48.4	11.4	6.5	9.1	3.9	13.3	12.0	53.2	12.9	28.8	18.5
MCL1	"BCL2L3, Mcl-1"	ENSG00000143384	"MCL1, BCL2 family apoptosis regulator"	Q07820	1	150574551-150579738	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 42.1"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	12	"U-698: 335.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002781, HPA008455, HPA031125, CAB068195"	Approved		Enhanced	Mitochondria		Yes	No			Mitochondria		"CAB002781: , CAB068195: AB_2665695, HPA008455: AB_1079334, HPA031125: AB_10602026"	"unprognostic (3.82e-2)"	"unprognostic (8.79e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (7.16e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.87e-2)"	"unprognostic (4.46e-2)"	67.7	37.1	19.0	59.3	21.6	134.5	46.3	15.3	18.9	35.9	38.5	19.0	23.9	21.2	36.1	27.6	56.5	57.2	73.3	32.5	20.4	14.9	30.5	76.7	61.8	52.4	28.2	11.4	32.1	41.9	20.3	27.7	59.4	26.7	34.0	30.7	31.0	36.0	24.5	39.8	45.7	50.2	38.9	26.4	51.1	44.3	19.8	23.0	32.3	45.4	53.3	57.4	40.6	59.4	5.0	6.2	42.1	8.0	3.8	11.1	3.9	10.0	5.2	9.7	5.8	19.6	20.6	13.2	12.3	12.7	13.0	10.5	6.4	8.3	12.8	7.3	8.8	7.0	13.5	7.3	14.8	13.1	10.5	5.0	5.2	8.3	7.4	15.4	8.8	11.9	11.3	17.0	12.7	24.8	12.1	14.3	3.9	11.7	18.6	17.0	11.1	4.3	6.7	17.8	8.6	9.1	6.6	7.8	6.7	14.3	7.3	7.5	10.1	8.8	12.0	15.9	15.3	7.6	13.6	17.5	8.3	8.7	5.2	15.5	23.8	27.9	335.8	14.2	7.0	10.8	7.6	8.0	18.8	6.1	6.5	7.2	5.0	8.0	6.7	6.2	4.6	9.6	7.2	42.1	3.8	5.8	3.7	11.1	3.9	19.0	21.6	15.3	18.9	20.4	14.9	28.2	11.4	26.7	23.0	184.6	337.7	161.5	413.1	434.6	37.7	75.0	170.7	65.6	141.0	31.4	56.9	80.9	34.9	139.8	191.3	189.6	281.5	23.3	149.6	178.6	195.3	286.6	340.1	210.0	235.2	11.1	249.0	192.8	356.1	271.6	67.3	381.9	259.8	113.6	185.2	58.8	165.7	122.2	57.3	57.2	70.9	77.6	218.3	33.9	33.0	500.0	226.1	179.7	132.6	219.4
MCM2	"BM28, CCNL1, cdc19, CDCL1, D3S3194, DFNA70, KIAA0030"	ENSG00000073111	"Minichromosome maintenance complex component 2"	P49736	3	127598223-127622436	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 69.9"	"Cell type enhanced"	"Detected in many"	9	"Cytotrophoblasts: 45.7;Extravillous trophoblasts: 22.4;Spermatogonia: 27.1;Syncytiotrophoblasts: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000303, HPA031450, HPA031495, HPA031496"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes		8600	Nucleoplasm		"CAB000303: AB_322519, HPA031450: , HPA031495: AB_2673904, HPA031496: AB_2673905"	"unprognostic (2.43e-1)"	"prognostic favorable (4.66e-4)"	"unprognostic (4.44e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (8.43e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.82e-1)"	2.9	3.7	2.1	24.3	4.0	32.5	3.5	6.7	3.2	4.7	7.1	3.3	2.2	4.7	4.7	5.9	11.2	4.8	5.4	3.6	2.0	2.3	3.9	3.4	3.4	14.6	2.2	3.5	5.1	3.0	2.4	2.4	26.4	3.0	3.2	6.0	2.5	4.7	1.9	7.0	6.0	7.1	2.9	2.9	13.3	3.8	20.3	3.9	69.9	4.1	16.6	20.7	3.4	5.1	10.4	3.6	0.9	1.4	5.8	10.6	3.4	25.1	21.4	23.5	20.5	1.4	3.0	23.0	13.2	8.5	26.6	29.0	35.5	16.7	27.1	12.9	6.5	22.8	20.3	41.9	15.2	16.6	22.4	26.2	44.9	28.7	25.8	0.9	41.9	19.6	1.6	1.7	18.0	2.7	3.2	8.3	29.6	22.3	24.9	9.8	33.3	38.8	30.7	34.4	21.6	18.9	43.6	33.7	38.8	5.5	19.5	29.3	22.2	33.9	10.1	3.5	9.9	21.7	32.9	4.2	20.7	17.7	25.5	17.8	25.8	29.2	67.4	14.3	31.7	7.9	0.0	0.6	0.2	4.7	1.4	5.9	10.4	4.1	5.5	2.8	9.2	3.9	5.0	0.9	5.8	0.3	3.6	10.6	3.4	2.1	4.0	6.7	3.2	2.0	2.3	2.2	3.5	3.0	3.9	3.0	1.3	6.7	1.7	4.0	2.2	7.6	0.0	10.7	5.7	0.0	0.0	45.7	0.0	4.1	0.7	1.7	1.0	0.0	1.6	22.4	3.3	0.7	1.1	1.7	15.2	0.0	3.5	1.3	1.6	0.7	1.7	1.6	1.7	15.4	5.1	1.5	1.7	0.0	1.4	0.5	1.7	0.0	2.8	6.2	27.1	2.6	28.0	3.2	12.0	0.6
MCM4	"CDC21, CDC54, hCdc21, MGC33310, P1-Cdc21"	ENSG00000104738	"Minichromosome maintenance complex component 4"	P33991	8	47960185-47978160	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 117.9;Late spermatids: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004497, HPA004873, HPA031052"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004497: AB_627916, HPA004873: AB_1079337, HPA031052: AB_2673712"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-3)"	"prognostic favorable (2.19e-4)"	"prognostic unfavorable (2.84e-5)"	"unprognostic (7.71e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.12e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (2.38e-4)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (3.53e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.40e-1)"	4.9	8.7	6.7	18.4	12.6	33.1	9.3	13.9	14.8	6.7	11.9	6.9	3.6	8.3	4.7	7.8	21.6	5.9	6.8	8.3	6.6	7.1	8.0	6.6	4.4	20.3	5.9	7.7	5.3	5.5	4.3	4.1	29.2	7.7	4.2	13.2	5.3	9.0	3.1	8.7	16.2	10.3	5.9	6.4	10.1	6.3	39.0	4.1	56.6	4.0	21.8	23.7	8.0	9.5	5.1	4.9	3.4	4.3	4.9	12.9	4.5	34.5	21.5	39.9	14.6	3.9	6.9	17.6	26.4	17.3	33.3	37.7	22.8	31.5	37.5	14.8	13.1	25.0	25.5	50.3	21.4	37.6	11.8	33.2	64.3	25.8	25.3	1.1	34.3	14.1	4.1	4.3	26.5	9.5	5.1	11.7	25.3	35.4	31.2	22.9	21.4	75.8	25.0	43.3	41.1	9.3	48.2	31.3	24.4	12.0	31.0	38.4	18.4	53.4	22.3	7.9	23.8	26.6	18.1	7.8	25.4	24.7	28.5	24.2	10.3	24.6	76.5	20.4	31.9	22.7	3.4	2.1	1.5	5.5	3.7	2.7	5.1	5.0	6.8	4.9	2.1	4.6	3.4	0.1	4.9	4.3	1.7	12.9	4.5	6.7	12.6	13.9	14.8	6.6	7.1	5.9	7.7	7.7	4.1	0.0	4.6	3.0	9.5	19.3	11.6	22.4	0.0	17.4	10.3	5.2	9.8	26.7	3.3	6.0	117.9	5.2	5.0	46.7	5.2	33.9	7.4	4.3	1.1	3.4	10.4	15.9	6.4	1.3	3.5	57.7	4.9	9.9	3.3	2.8	9.6	6.5	4.1	3.5	2.8	2.2	15.3	0.0	8.0	45.2	31.3	16.7	24.9	3.8	20.2	8.2
MCM5	CDC46	ENSG00000100297	"Minichromosome maintenance complex component 5"	P33992	22	35400063-35425430	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.0;lymphoid tissue: 60.6"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 115.2;monocytes: 225.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000101, HPA000845, HPA052880"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB000101: AB_2235163, HPA000845: AB_1079338, HPA052880: AB_2681979"	"unprognostic (6.71e-2)"	"prognostic favorable (2.81e-6)"	"unprognostic (5.29e-3)"	"unprognostic (7.94e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (1.78e-4)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.53e-1)"	12.1	4.9	6.1	27.5	9.0	57.0	9.1	6.7	5.7	10.4	11.5	12.3	5.0	9.5	10.8	10.8	15.8	8.7	9.4	5.2	4.4	3.4	6.8	8.0	9.3	31.1	8.8	3.7	17.9	10.8	6.2	3.6	19.3	5.8	7.2	8.3	6.5	8.9	5.1	8.8	10.3	16.7	6.0	7.8	31.2	8.4	16.4	8.8	60.6	9.0	17.7	33.0	8.7	9.6	46.8	30.9	19.0	26.0	21.3	32.9	24.0	39.3	28.6	22.6	23.0	2.2	4.5	19.9	26.3	14.0	39.4	37.5	19.0	19.7	26.1	15.3	13.4	16.3	19.7	22.6	20.9	12.6	21.0	41.5	37.2	28.7	38.0	0.8	76.8	33.7	2.4	1.9	23.5	6.4	3.6	17.4	23.9	23.0	39.0	14.9	32.5	62.5	25.6	30.1	26.9	17.0	70.8	32.1	32.8	7.7	22.9	17.5	18.6	36.2	14.5	8.1	12.4	15.2	29.4	10.3	39.8	30.2	24.7	27.1	21.7	26.8	49.1	25.8	29.1	30.3	19.0	20.7	14.5	18.4	24.1	13.1	46.8	16.1	19.4	27.1	37.0	13.1	14.8	9.9	21.3	26.0	30.9	32.9	24.0	6.1	9.0	6.7	5.7	4.4	3.4	8.8	3.7	5.8	8.8	6.0	8.2	53.6	8.0	9.4	1.5	3.4	12.7	5.3	4.5	7.0	0.0	115.2	5.0	14.8	1.9	7.5	3.8	70.0	11.1	61.5	6.2	3.3	15.0	5.1	47.1	1.6	3.4	13.5	21.1	3.6	10.0	25.5	6.8	225.4	9.2	4.5	9.4	7.0	5.6	3.7	3.2	19.4	6.4	11.2	52.2	5.5	68.8	20.8	32.2	4.7
MCM6	Mis5	ENSG00000076003	"Minichromosome maintenance complex component 6"	Q14566	2	135839626-135876426	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 66.3"	"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 46.7;Spermatogonia: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004818, CAB009577"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB009577: AB_2266309, HPA004818: AB_1079339"	"unprognostic (6.73e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.22e-3)"	"unprognostic (3.60e-3)"	"unprognostic (8.98e-2)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (5.70e-7)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-2)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (8.29e-12)"	"unprognostic (2.84e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.68e-1)"	11.3	6.3	7.2	17.7	8.4	23.1	9.5	12.3	9.4	9.1	11.9	5.1	2.9	8.7	10.4	8.8	12.6	8.7	7.6	6.0	5.0	5.5	6.8	7.0	8.5	23.9	4.9	8.0	10.9	4.3	6.2	3.4	10.9	5.9	8.6	12.2	6.2	6.9	6.7	8.2	8.9	16.7	10.4	7.2	14.1	8.0	13.2	3.7	66.3	5.1	11.4	27.5	10.8	9.8	5.5	9.4	5.3	4.0	7.0	13.9	5.6	23.3	14.3	31.3	19.9	6.7	8.8	12.3	17.0	12.9	19.8	22.1	29.3	17.9	40.8	12.5	12.3	8.7	13.9	31.6	15.5	21.2	20.9	21.8	40.5	21.3	9.2	3.1	48.5	18.1	5.2	2.0	14.4	4.4	4.0	13.4	32.2	28.9	34.5	14.5	23.8	59.2	35.7	28.2	20.6	14.4	29.4	37.5	37.3	9.9	20.6	19.7	16.8	22.4	10.7	10.7	23.4	12.3	30.6	6.6	13.8	11.5	14.8	12.8	20.7	33.7	53.7	19.3	37.2	16.4	5.3	1.4	0.9	7.6	4.0	7.1	5.5	10.5	9.2	4.6	3.2	9.6	11.8	0.8	7.0	3.6	9.4	13.9	5.6	7.2	8.4	12.3	9.4	5.0	5.5	4.9	8.0	5.9	3.7	0.0	2.4	2.2	3.8	6.0	2.2	3.2	2.5	4.0	6.8	3.5	0.0	26.1	0.0	4.4	2.1	7.1	1.3	46.7	5.8	20.9	11.3	1.5	9.2	3.0	20.4	3.2	2.4	9.8	4.0	1.6	8.6	5.8	5.0	3.6	9.2	2.3	2.8	3.5	15.9	1.0	0.5	0.0	4.2	15.6	41.4	3.6	8.9	17.5	9.7	1.0
MCM7	"CDC47, MCM2, PPP1R104"	ENSG00000166508	"Minichromosome maintenance complex component 7"	P33993	7	100092728-100101940	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002163, HPA003898, CAB016312"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB002163: AB_564113, CAB016312: AB_627235, HPA003898: AB_1853632"	"unprognostic (1.87e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.36e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (2.18e-4)"	"unprognostic (2.08e-2)"	"unprognostic (5.79e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.34e-3)"	"unprognostic (3.83e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.38e-1)"	8.6	5.2	17.5	13.6	21.7	37.3	11.2	20.0	20.6	8.2	14.2	19.2	15.0	10.4	16.0	6.3	10.7	8.6	9.9	5.1	18.1	12.4	5.5	8.5	7.4	22.4	23.7	9.5	12.6	13.1	7.5	10.3	10.7	15.5	10.0	15.7	7.2	9.2	9.2	11.5	10.1	10.3	11.7	23.5	10.7	7.8	14.9	22.3	7.5	9.4	4.1	28.2	10.3	10.0	7.3	5.7	1.9	5.7	7.6	9.0	6.0	24.9	28.8	31.8	24.0	3.1	4.1	16.3	15.2	18.4	42.5	45.3	22.0	26.4	42.3	14.5	10.8	27.1	19.8	46.7	22.1	35.9	21.6	39.9	26.9	16.2	15.2	1.7	45.7	17.5	2.8	4.2	31.1	18.7	5.4	16.1	24.4	51.5	34.7	21.5	53.3	77.6	18.7	27.9	23.2	20.9	41.8	46.7	51.6	8.2	15.1	20.8	31.7	24.0	22.3	7.5	18.6	10.2	19.2	6.8	16.0	29.1	31.4	30.1	14.5	24.8	76.1	11.1	36.7	28.6	1.8	2.5	1.9	8.1	4.1	6.2	5.3	5.7	7.9	5.5	7.3	5.9	5.7	1.6	7.6	5.7	5.7	9.0	6.0	17.5	21.7	20.0	20.6	18.1	12.4	23.7	9.5	15.5	22.3	8.9	17.0	23.7	20.7	41.4	8.7	7.9	15.3	24.1	9.1	3.5	13.7	90.8	8.3	17.6	40.0	14.5	15.8	70.0	22.4	78.1	17.3	11.3	24.2	10.4	34.4	6.4	16.7	8.0	10.8	22.7	19.5	16.5	18.6	17.2	34.7	10.1	16.0	20.1	14.5	9.1	11.9	12.9	22.7	83.2	67.3	30.9	60.2	28.7	60.9	12.3
MCMBP	"C10orf119, FLJ13081, MCM-BP"	ENSG00000197771	"Minichromosome maintenance complex binding protein"	Q9BTE3	10	119829404-119892556	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013792, HPA038481"	Uncertain		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			Nucleoplasm	"Cell Junctions, Cytosol"	"CAB013792: , HPA038481: AB_10794620"	"unprognostic (1.26e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.31e-3)"	"unprognostic (5.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (6.18e-4)"	"unprognostic (2.23e-2)"	"unprognostic (8.24e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.87e-2)"	33.6	15.3	11.7	23.2	13.8	14.6	35.5	17.2	13.8	27.0	26.3	16.9	11.4	15.5	28.0	14.9	26.4	23.0	18.7	26.3	12.0	10.2	18.7	23.7	28.5	38.6	17.4	8.5	29.2	18.2	23.2	17.6	35.4	14.2	22.5	21.4	15.7	21.0	17.4	30.1	23.8	20.7	26.0	16.8	26.0	20.7	15.4	15.5	38.0	24.5	28.2	24.7	32.5	28.6	4.5	6.9	12.1	9.7	4.1	5.1	2.4	31.0	22.1	31.0	21.4	15.7	19.3	18.2	28.8	31.6	36.7	38.0	28.8	25.5	36.2	13.3	23.0	16.7	29.0	37.0	29.0	43.0	26.5	27.3	18.6	17.6	22.0	24.4	34.3	45.0	15.8	16.4	33.2	43.8	20.2	25.1	23.7	17.1	27.3	24.0	23.0	43.0	20.7	15.6	23.1	16.0	27.2	60.0	18.4	15.7	21.4	13.4	17.2	21.0	17.5	24.0	24.3	11.9	24.5	19.4	18.1	17.8	18.3	34.3	19.7	21.9	40.1	21.6	23.1	11.1	12.1	5.3	3.6	4.2	9.7	5.1	4.5	3.9	4.4	6.9	1.8	4.2	3.8	6.4	4.1	6.1	3.5	3.9	2.4	11.7	13.8	17.2	13.8	12.0	10.2	17.4	8.5	14.2	15.5	14.9	13.9	20.1	27.2	38.0	10.0	16.2	12.7	10.7	18.2	19.2	3.9	30.7	11.6	9.6	3.3	32.4	15.1	0.0	11.5	42.5	26.3	18.7	17.4	23.1	33.4	30.2	10.4	30.1	35.7	4.9	27.9	31.3	21.9	8.2	18.5	16.9	12.8	7.0	21.2	17.5	17.1	19.4	29.9	27.6	61.5	37.4	33.2	27.4	26.9	24.5
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 41.6"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 35.7;Mucus-secreting cells: 42.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 14.5;HMC-1: 12.0;U-698: 15.9;U-87 MG: 18.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	5.3	4.1	0.8	19.7	1.7	12.6	2.7	0.7	1.5	5.4	12.3	0.0	6.9	5.6	4.0	9.5	5.7	4.5	10.3	4.6	1.0	2.2	3.6	2.3	12.4	18.4	2.5	0.8	3.8	10.0	5.3	24.4	17.1	0.6	6.8	10.2	2.5	16.8	9.6	0.8	4.0	10.9	4.0	0.9	41.6	3.7	1.7	0.4	3.0	8.7	4.1	12.9	6.2	14.8	2.7	0.1	21.2	0.5	6.8	4.4	1.1	2.5	0.0	0.0	0.0	0.0	0.0	1.8	1.3	0.8	0.2	0.1	1.7	3.1	7.3	0.3	0.0	0.0	5.7	0.1	4.7	0.0	1.4	0.5	14.5	2.0	0.8	1.0	3.0	12.0	0.8	5.8	0.1	6.0	0.0	0.0	2.5	0.5	4.1	0.0	0.0	1.4	8.0	0.6	2.4	2.6	3.3	0.1	2.7	0.3	7.6	1.4	0.3	0.1	2.4	0.9	0.5	0.0	0.2	0.0	0.0	1.2	0.0	0.0	8.7	0.1	15.9	18.0	7.9	0.9	3.2	0.5	7.7	4.4	0.1	2.1	2.2	1.2	1.9	0.0	2.7	0.5	1.9	21.2	6.8	0.5	0.1	0.0	1.1	0.8	1.7	0.7	1.5	1.0	2.2	2.5	0.8	0.6	0.4	3.0	24.7	20.4	10.8	3.8	0.8	0.8	5.1	5.3	15.9	3.5	0.0	13.2	0.0	2.7	3.2	2.1	18.6	0.0	4.1	5.9	7.2	13.7	35.7	1.3	7.5	0.0	15.0	1.3	12.7	3.9	0.3	2.1	1.7	0.0	42.4	0.2	4.0	21.0	0.0	1.7	0.5	0.0	0.8	0.1	2.0	1.9	20.5	19.7	18.7	14.9
MDH2		ENSG00000146701	"Malate dehydrogenase 2"	P40926	7	76048051-76067508	"Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Oxidoreductase	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 175.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019714, HPA019716, HPA019848, HPA026720"	Enhanced		Enhanced	Mitochondria		No	No		47000000	Mitochondria		"HPA019714: AB_1853678, HPA019716: AB_1853680, HPA019848: AB_1853683, HPA026720: AB_1853685"	"unprognostic (3.20e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (5.55e-3)"	"unprognostic (8.94e-2)"	"unprognostic (6.45e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.70e-2)"	"prognostic favorable (1.49e-5)"	"unprognostic (8.57e-2)"	"unprognostic (9.64e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.66e-1)"	18.1	39.1	17.4	15.4	20.6	18.3	22.2	15.3	34.4	14.9	27.0	13.5	16.9	32.5	16.6	13.5	31.8	19.4	17.6	103.1	17.1	18.8	29.1	101.9	13.8	26.6	17.4	21.9	17.3	35.5	16.8	16.9	17.5	20.5	17.9	24.3	15.0	26.8	21.5	175.8	24.6	26.7	21.9	12.8	21.1	22.3	17.6	9.5	22.4	20.1	76.2	23.8	19.9	17.8	37.1	52.8	22.1	45.3	30.1	45.6	44.7	29.0	47.7	17.3	43.2	19.7	21.7	29.7	19.5	25.2	28.0	25.4	41.9	35.0	44.0	8.8	25.7	30.3	29.7	44.3	29.2	20.0	31.3	64.1	24.4	25.6	38.6	24.3	38.0	25.3	27.4	26.1	27.2	40.6	22.0	26.0	27.4	76.9	25.7	25.9	65.8	32.9	67.0	38.5	51.5	60.2	26.9	21.3	63.2	26.2	38.4	43.3	39.4	19.6	98.1	40.3	23.0	55.7	42.9	20.1	28.1	26.6	30.5	38.8	28.9	23.8	48.7	24.4	48.7	42.7	22.1	38.9	18.2	32.7	43.5	34.2	37.1	36.9	35.3	52.8	32.1	36.0	33.1	10.2	30.1	45.3	47.1	45.6	44.7	17.4	20.6	15.3	34.4	17.1	18.8	17.4	21.9	20.5	9.5	47.6	54.0	113.9	144.7	120.7	61.8	448.3	122.3	80.3	48.9	109.9	17.7	283.1	379.7	210.0	208.8	86.2	316.5	0.0	291.5	257.6	93.5	138.9	53.1	240.8	220.1	68.3	162.9	73.1	117.9	127.9	92.0	117.1	172.1	171.3	226.5	63.6	223.7	228.0	93.3	301.0	48.8	84.1	129.5	71.9	69.5	145.2	246.6	109.1	306.4	194.4
MED10	"L6, MGC5309, NUT2, TRG20"	ENSG00000133398	"Mediator complex subunit 10"	Q9BTT4	5	6371881-6378594	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042795, HPA054188"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042795: AB_10796679, HPA054188: AB_2682410"	"unprognostic (2.33e-3)"	"unprognostic (3.31e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.14e-1)"	19.8	15.8	28.8	16.9	23.2	37.2	16.2	20.6	31.4	13.9	22.7	19.3	17.1	15.8	15.1	20.3	22.2	16.7	16.6	24.6	29.9	31.2	14.7	17.2	16.2	25.1	27.7	21.1	17.7	31.4	10.6	13.8	16.5	23.9	15.9	10.4	13.7	17.1	19.6	21.5	21.3	18.7	24.0	26.6	17.4	16.9	21.1	17.5	15.1	16.4	12.3	21.6	19.6	22.9	34.4	24.4	37.4	17.2	24.9	40.0	35.2	17.5	19.5	7.8	14.4	12.4	13.7	22.2	22.2	20.0	23.6	17.3	29.5	14.1	22.7	18.0	18.5	34.2	13.1	13.4	16.4	21.2	37.6	15.6	15.0	30.5	14.7	38.3	18.0	13.3	15.6	21.6	22.4	32.1	14.5	18.7	13.1	22.0	13.5	18.0	22.0	26.2	27.2	13.3	12.2	51.3	15.1	13.8	9.5	16.0	18.5	14.9	22.2	42.3	17.5	33.6	10.1	12.2	16.2	20.6	23.6	26.1	21.6	23.4	22.0	21.7	32.6	21.2	28.5	17.5	37.4	15.8	33.1	28.7	16.4	35.2	34.4	36.2	30.9	13.3	31.5	40.0	33.6	11.4	24.9	17.2	24.4	31.8	35.2	28.8	23.2	20.6	31.4	29.9	31.2	27.7	21.1	23.9	17.5	20.8	20.0	57.8	71.8	81.7	63.0	37.5	28.1	26.8	20.5	43.6	27.5	70.4	49.7	97.6	4.0	72.4	44.3	23.3	79.7	67.2	66.6	65.2	50.7	21.5	57.0	69.9	42.4	66.9	26.4	8.0	65.0	44.9	59.1	114.6	40.5	50.4	108.8	43.2	42.5	39.7	47.1	32.3	76.8	57.9	89.6	61.6	66.4	95.9	40.4	66.0
MED19	LCMR1	ENSG00000156603	"Mediator complex subunit 19"	A0JLT2	11	57703714-57712323	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039912, HPA040860"	Uncertain		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA039912: AB_10795262, HPA040860: AB_10794153"	"unprognostic (2.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (1.40e-1)"	"unprognostic (4.87e-3)"	"prognostic favorable (1.76e-6)"	"unprognostic (3.08e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.38e-2)"	12.7	19.6	18.2	12.1	26.5	9.3	15.2	15.5	22.8	13.8	13.1	11.4	19.0	15.0	13.3	22.2	16.0	13.7	10.4	10.8	16.8	15.6	15.0	17.7	11.5	10.6	12.9	22.9	11.7	12.4	13.4	17.9	22.3	12.2	14.1	12.8	14.4	14.6	15.9	12.8	17.6	10.3	13.1	9.9	11.9	11.8	23.1	12.5	10.5	21.2	9.7	16.3	11.8	15.5	31.1	25.8	20.8	24.8	15.3	25.9	17.7	16.6	10.8	13.1	12.1	14.0	12.6	15.6	14.4	11.3	13.9	14.1	7.6	13.1	9.3	22.5	13.7	12.2	12.8	9.7	9.1	12.4	12.1	10.6	7.9	6.8	7.0	21.1	8.6	9.5	10.3	16.8	13.8	27.3	9.7	17.8	7.6	8.6	9.2	16.6	8.0	12.1	16.1	11.4	11.9	21.7	11.7	18.6	11.2	9.2	7.1	10.2	14.3	11.6	11.9	25.3	11.6	25.1	8.9	14.5	12.1	14.5	28.4	12.6	11.5	11.0	8.7	16.5	6.4	12.6	16.9	18.8	20.8	21.7	24.6	23.3	31.1	24.4	23.1	17.8	26.7	25.9	24.2	11.7	15.3	24.8	25.8	22.6	17.7	18.2	26.5	15.5	22.8	16.8	15.6	12.9	22.9	12.2	12.5	8.9	21.9	25.5	55.2	77.8	32.7	14.6	30.6	33.5	17.0	48.8	33.4	51.2	33.2	41.6	8.2	35.1	30.4	23.3	39.5	39.8	40.9	37.0	21.9	22.9	25.9	35.0	22.3	30.7	19.0	13.4	26.2	18.0	35.4	29.7	23.5	33.2	33.5	24.6	28.0	32.0	55.2	19.4	28.8	97.7	85.4	72.0	61.1	32.6	27.1	49.9
MED6	NY-REN-28	ENSG00000133997	"Mediator complex subunit 6"	O75586	14	70581257-70600690	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030764, HPA069039"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030764: AB_2673601, HPA069039: AB_2686070"	"unprognostic (1.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.93e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-2)"	16.7	19.7	20.3	16.5	30.7	22.7	21.9	42.0	30.4	17.6	15.7	19.3	16.6	14.2	23.6	22.9	24.5	19.7	14.8	17.1	20.1	19.5	14.7	20.2	15.5	26.9	17.4	23.0	25.7	15.6	13.5	30.0	22.9	21.9	15.2	16.5	20.5	17.4	17.4	29.9	24.1	16.2	18.9	19.6	21.6	16.4	16.6	20.5	21.0	19.4	18.9	30.2	18.5	18.8	19.9	18.5	23.5	21.1	21.3	24.8	14.2	36.9	20.7	26.8	11.6	14.7	15.5	21.4	18.8	19.9	28.9	28.3	20.3	23.0	28.4	11.1	15.9	17.3	17.9	31.3	18.9	31.2	19.8	16.6	20.6	16.0	27.4	18.0	18.0	16.6	17.6	22.2	20.7	19.2	12.8	22.1	21.7	18.9	18.0	20.9	27.6	25.7	24.4	19.9	26.3	25.2	21.5	25.0	14.7	18.0	19.8	18.3	19.8	19.6	21.0	21.8	16.3	32.8	22.7	17.5	23.8	34.6	12.0	17.2	19.1	28.4	39.8	20.8	15.7	16.5	17.4	16.2	23.5	18.7	18.2	22.2	18.9	24.8	21.3	18.5	19.9	23.1	23.3	15.8	21.3	21.1	13.9	23.1	14.2	20.3	30.7	42.0	30.4	20.1	19.5	17.4	23.0	21.9	20.5	17.9	21.7	37.3	31.2	17.2	71.1	5.6	10.2	25.4	18.2	17.4	74.6	34.1	5.0	27.0	5.8	22.4	13.9	23.3	20.3	35.6	20.0	28.9	45.1	12.5	22.6	25.4	21.2	26.4	19.2	4.4	25.0	20.6	16.9	27.1	10.5	47.4	22.6	17.6	27.6	12.5	92.2	25.8	18.6	20.6	39.9	17.6	41.0	40.8	14.6	27.6
MEF2D		ENSG00000116604	"Myocyte enhancer factor 2D"	Q14814	1	156463727-156500828	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.8"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 163.0;Sertoli cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 55.0;U-266/70: 48.3;U-266/84: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004807, HPA007114"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA004807: AB_1079354, HPA007114: AB_1079353"	"unprognostic (3.17e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.53e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.45e-1)"	18.1	19.6	14.9	15.7	27.5	47.6	15.5	27.0	40.3	23.8	21.1	12.1	10.5	11.0	28.6	12.9	13.8	19.5	16.6	26.3	11.8	9.6	10.4	10.6	20.0	13.9	8.6	21.1	26.7	22.4	21.4	15.0	16.2	11.6	17.2	10.6	22.3	11.3	18.8	97.8	17.5	14.8	22.0	8.4	17.2	16.1	9.9	9.9	17.2	14.7	19.4	15.6	21.9	19.3	1.7	8.5	8.1	2.0	1.5	2.3	0.8	4.6	8.6	1.8	2.8	4.4	6.1	2.8	6.1	8.0	3.2	3.5	2.7	6.3	10.8	7.1	8.2	3.2	4.6	2.1	3.5	1.9	14.7	2.8	2.6	10.7	1.5	5.4	6.3	8.6	6.8	5.9	5.6	7.7	6.8	6.1	3.4	1.9	19.1	5.1	4.4	4.2	14.6	2.6	2.6	4.4	20.8	3.9	12.4	2.8	2.3	3.0	4.7	5.9	12.9	10.2	3.7	3.5	55.0	10.2	7.7	7.2	5.6	4.5	48.3	49.9	20.7	6.5	5.0	4.1	1.3	2.0	2.3	1.9	1.1	2.3	1.7	1.4	1.7	1.4	1.7	0.7	1.3	8.1	1.5	1.9	8.5	1.6	0.8	14.9	27.5	27.0	40.3	11.8	9.6	8.6	21.1	11.6	9.9	6.0	18.1	14.4	10.3	33.1	78.1	35.2	20.4	2.7	15.9	1.8	163.0	3.9	0.0	7.0	1.3	21.1	33.9	0.0	9.7	4.3	21.3	16.3	3.5	11.3	15.8	66.7	20.6	18.4	22.5	4.6	29.1	18.3	13.5	10.0	29.7	16.8	18.5	28.1	30.4	2.6	80.6	97.0	38.1	5.1	9.8	33.2	12.8	12.9	11.0	14.9
METTL1	"C12orf1, TRM8, TRMT8"	ENSG00000037897	"Methyltransferase like 1"	Q9UBP6	12	57768471-57772793	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in all"	6	"RH-30: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020914, HPA050450"	Uncertain		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA020914: AB_1853830, HPA050450: AB_2681130"	"unprognostic (5.24e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (4.25e-6)"	"unprognostic (5.67e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavorable (3.55e-6)"	"unprognostic (7.75e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.22e-1)"	12.2	16.6	6.7	13.8	8.8	8.4	12.3	2.2	6.9	7.6	7.6	4.5	10.8	3.3	9.4	21.2	10.3	9.0	10.7	8.1	5.8	5.0	20.9	15.3	7.7	8.8	7.4	4.6	17.6	34.9	10.9	10.6	8.3	6.5	11.0	10.3	5.3	17.9	17.2	20.4	8.5	5.7	10.5	5.0	8.2	7.3	11.4	5.4	4.5	15.1	15.6	9.8	8.8	7.8	6.1	12.6	0.7	6.7	7.3	18.6	5.1	6.1	11.2	4.7	4.3	6.4	4.4	6.4	6.6	6.0	11.1	6.0	7.8	8.6	7.4	12.3	8.0	6.3	7.3	7.2	10.2	10.8	4.4	8.4	8.6	4.3	9.5	4.5	9.3	4.5	3.9	9.3	12.4	8.7	5.4	5.9	4.8	7.9	7.4	5.6	11.9	6.5	11.1	11.1	8.2	11.3	5.8	78.7	10.9	9.7	7.7	5.0	4.5	6.9	7.6	6.1	4.9	10.0	8.8	4.4	4.5	5.0	7.9	8.7	3.4	2.5	9.0	6.4	6.7	9.3	0.0	4.7	0.0	5.3	6.7	18.6	4.7	6.9	6.5	10.3	6.1	9.5	9.2	0.7	7.3	1.1	12.6	3.3	5.1	6.7	8.8	2.2	6.9	5.8	5.0	7.4	4.6	6.5	5.4	8.9	3.5	8.9	11.4	9.3	2.9	3.6	2.5	1.4	17.0	5.2	0.0	15.0	21.6	15.2	11.3	7.1	1.3	0.0	20.6	19.6	12.0	7.7	12.7	9.0	22.2	3.2	6.3	4.3	1.0	8.6	10.3	9.0	6.8	27.1	5.6	1.6	12.8	0.0	4.6	53.6	5.5	0.0	14.7	4.8	14.7	9.2	8.1	4.3	9.1	10.5
METTL17	"FLJ20859, METT11D1"	ENSG00000165792	"Methyltransferase like 17"	Q9H7H0	14	20989770-20997035	"Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002955, HPA059802"	Uncertain		Enhanced	Nucleoplasm	"Intracellular and membrane"	No	No			Nucleoplasm		"HPA002955: AB_2144183, HPA059802: AB_2684129"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.00e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.29e-2)"	11.4	35.7	15.8	15.8	18.4	25.4	14.4	24.9	16.6	16.4	22.1	14.2	25.6	19.7	14.9	15.8	23.4	15.2	12.2	20.6	17.3	10.0	20.7	20.4	17.5	18.5	21.1	11.8	15.6	19.8	11.6	18.9	16.0	16.1	13.4	25.0	14.2	23.1	26.1	20.2	16.0	21.6	21.0	16.3	25.0	17.6	21.9	20.2	17.9	15.1	22.1	22.3	12.7	15.2	7.9	10.3	17.6	5.3	6.2	9.2	4.3	14.4	17.9	18.8	7.1	11.6	5.2	14.5	9.6	13.5	29.3	24.2	14.1	18.9	31.0	9.8	12.5	18.1	24.2	23.8	18.8	21.2	10.9	19.7	16.2	13.2	18.4	10.9	27.1	18.8	10.8	16.6	15.0	11.2	10.4	11.7	27.8	14.9	14.9	13.9	10.7	18.0	28.2	18.7	23.1	22.7	23.1	16.5	20.4	15.6	14.2	13.5	15.9	12.7	16.7	9.6	14.4	11.6	23.9	6.5	10.2	29.9	9.9	13.1	12.9	20.9	22.1	5.9	19.5	12.3	17.6	5.3	5.0	8.6	4.9	4.8	7.3	9.1	8.4	10.3	7.9	8.9	9.2	0.0	6.2	3.2	6.2	7.1	4.3	15.8	18.4	24.9	16.6	17.3	10.0	21.1	11.8	16.1	20.2	8.9	12.4	26.4	18.4	16.8	36.1	4.8	17.8	24.1	12.5	10.4	41.2	27.0	5.0	17.2	37.8	9.0	22.4	0.0	13.4	14.1	13.0	10.5	27.8	22.7	16.0	20.6	11.7	12.3	9.9	5.6	31.1	17.5	3.3	19.8	20.1	26.1	13.4	30.0	20.1	13.6	49.5	12.9	13.9	18.2	14.0	15.6	10.6	18.7	30.4	24.6
MGLL	"HU-K5, MGL"	ENSG00000074416	"Monoglyceride lipase"	Q99685	3	127689062-127823250	"Enzymes, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid degradation, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 404.8;Pancreatic endocrine cells: 322.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;intermediate monocyte: 28.5;non-classical monocyte: 18.3;plasmacytoid DC: 30.4"	"Group enriched"	"Detected in many"	13	"dendritic cells: 30.4;granulocytes: 11.6;monocytes: 28.5"	"Cell line enhanced"	"Detected in many"		"BJ: 46.5;BJ hTERT+: 53.6;LHCN-M2: 42.8;RPTEC TERT1: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011348, HPA011993, HPA011994"	Enhanced		Enhanced	Nucleoplasm		NA	NA		4300000	Nucleoplasm		"HPA011348: AB_2668490, HPA011993: AB_1853914, HPA011994: AB_1853916"	"unprognostic (1.84e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.83e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.83e-2)"	"prognostic unfavorable (6.41e-4)"	"unprognostic (7.63e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.11e-3)"	72.2	6.7	29.4	22.6	29.7	7.5	39.0	32.8	36.9	13.3	36.3	8.3	8.4	16.5	8.7	10.8	63.8	16.3	24.1	35.5	23.6	10.2	22.6	32.1	32.4	6.0	15.4	17.8	3.9	3.6	1.7	5.0	18.9	10.2	10.6	27.6	10.0	31.4	13.6	40.9	11.9	22.3	13.6	12.2	19.2	17.5	3.2	15.5	2.4	6.4	33.4	19.7	14.4	14.5	1.8	30.4	11.6	28.5	0.6	0.9	6.0	11.2	10.1	0.0	0.0	17.8	21.0	1.3	46.5	53.6	10.3	16.6	0.3	4.6	2.9	12.9	15.7	3.1	0.4	0.0	6.1	5.7	5.0	0.1	0.3	7.2	0.0	6.4	0.0	0.3	7.8	3.6	19.3	21.1	5.8	21.8	0.1	0.0	0.5	42.8	1.1	0.0	0.1	0.0	7.3	16.0	0.0	5.5	23.8	38.6	1.2	6.0	0.4	8.0	15.8	2.7	0.4	0.7	0.4	27.9	11.3	3.3	27.2	6.3	0.0	0.0	9.5	23.4	0.6	35.0	4.2	2.8	11.6	0.2	28.5	0.9	1.8	0.2	0.3	3.1	0.2	0.0	0.0	0.5	0.6	18.3	30.4	0.0	6.0	29.4	29.7	32.8	36.9	23.6	10.2	15.4	17.8	10.2	15.5	181.7	90.0	5.2	8.0	20.3	16.7	42.0	119.8	56.2	34.2	40.1	0.0	68.4	142.6	90.3	3.6	101.2	167.0	23.3	144.8	129.8	47.2	9.2	8.1	126.2	122.7	0.0	85.0	14.7	24.4	4.0	30.2	33.6	20.3	404.8	177.1	46.3	322.3	129.8	65.4	60.0	6.1	84.1	176.1	0.2	1.1	19.4	60.8	10.2	49.8	4.2
MGMT		ENSG00000170430	"O-6-methylguanine-DNA methyltransferase"	P16455	10	129467184-129768007	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 419.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002786, HPA032135, HPA032136, HPA069497, CAB069881"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002786: , CAB069881: AB_10002128, HPA032135: AB_2674171, HPA032136: AB_2674172, HPA069497: AB_2732134"	"unprognostic (1.10e-1)"	"prognostic favorable (9.42e-4)"	"unprognostic (1.48e-1)"	"unprognostic (5.81e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.67e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.32e-1)"	"unprognostic (4.89e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	11.7	11.3	7.4	15.5	7.6	7.1	11.3	3.5	9.1	8.3	12.2	10.0	19.6	10.8	15.3	17.1	9.9	15.2	14.1	10.5	7.1	7.1	12.6	45.6	7.5	11.6	8.6	6.6	12.3	16.5	5.7	5.8	4.5	9.2	11.2	3.4	11.8	14.9	24.5	14.4	9.2	9.6	10.9	8.1	8.6	9.9	11.7	3.9	16.0	10.2	14.9	14.7	12.6	13.0	20.3	17.7	6.5	15.3	18.2	21.2	16.6	0.0	2.5	2.7	13.0	5.7	11.8	10.2	5.7	6.4	4.2	4.1	15.8	16.9	11.8	9.2	7.4	0.0	7.7	1.7	6.1	1.9	0.0	1.0	2.3	5.8	10.1	8.8	0.2	6.8	7.5	0.0	2.4	0.0	0.0	0.0	20.0	0.0	8.3	5.1	21.3	9.3	12.1	0.6	10.9	10.2	10.8	0.0	4.6	7.8	5.8	2.7	6.8	6.9	2.8	0.0	2.2	11.2	9.2	0.0	5.5	2.8	0.0	0.0	0.0	0.0	6.0	0.0	3.8	0.0	2.6	15.3	6.5	19.1	14.8	18.6	20.3	17.5	17.8	15.8	19.9	17.6	18.9	1.8	18.2	13.7	17.7	21.2	16.6	7.4	7.6	3.5	9.1	7.1	7.1	8.6	6.6	9.2	3.9	11.9	14.7	57.0	56.4	45.4	15.7	37.8	86.6	57.6	15.9	97.7	7.9	41.1	107.8	40.8	70.9	48.0	68.8	23.3	51.1	53.2	48.9	49.8	64.5	419.1	76.3	14.3	52.4	98.2	75.3	90.6	62.5	39.9	62.4	45.9	56.4	33.9	74.4	47.0	51.9	227.8	39.0	45.3	55.7	43.1	97.3	37.3	22.4	67.1	59.6	48.8
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		750000	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.7	8.9	13.9	21.1	44.1	22.2	23.3	16.9	25.3	18.7	22.3	9.2	12.2	9.7	16.1	19.1	11.3	20.1	14.8	15.6	19.2	16.6	9.2	13.3	9.2	14.4	40.5	22.8	16.1	20.3	15.0	17.9	31.7	21.9	19.6	14.6	17.0	23.7	14.1	7.1	17.8	14.7	15.3	36.8	12.8	12.1	37.7	23.3	9.6	11.7	15.0	15.8	17.4	15.8	14.0	20.4	16.9	15.0	14.2	12.7	9.8	21.4	17.9	27.1	17.2	12.1	15.9	11.0	16.6	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6	65.5	44.7	27.0	22.7	16.7	55.5	55.8	28.1	60.2	58.0	5.2	29.5	23.4	0.0	21.4	25.4	21.9	30.2	23.3	30.0	14.2	25.4	40.1	16.3	52.3	18.5	42.9	58.0	17.8	17.4	18.1	34.2	23.7	18.6	13.6	83.2	42.1	26.6	22.0	46.0	21.6	37.6	19.4	25.6	49.2	40.6	14.1	30.0	34.1	22.9	26.0
MICAL3	KIAA0819	ENSG00000243156	"Microtubule associated monooxygenase, calponin and LIM domain containing 3"	Q7RTP6	22	17787649-18024559	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Exocytosis"	"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 10.0;memory B-cell: 3.3;naive B-cell: 5.2"	"Group enriched"	"Detected in many"	6	"B-cells: 5.2;granulocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"WM-115: 51.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000639, HPA003421, HPA034882"	Approved		Supported	"Nucleoplasm,Plasma membrane,Midbody ring,Cytosol"		Yes	No			"Nucleoplasm, Midbody ring"	"Plasma membrane, Cytosol"	"HPA000639: AB_10301319, HPA003421: AB_10601134, HPA034882: AB_2674371"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.68e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.07e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.58e-1)"	"unprognostic (3.82e-1)"	"unprognostic (8.86e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.64e-2)"	10.1	9.0	15.4	20.7	19.2	10.2	9.6	62.2	25.0	12.8	22.4	30.0	8.8	8.3	30.3	14.0	13.8	28.6	9.5	23.7	15.4	13.8	8.7	16.8	6.1	15.2	21.6	15.6	20.2	10.2	30.4	11.0	11.9	19.4	11.8	16.5	14.2	8.0	14.8	28.0	14.7	13.2	26.1	20.9	12.2	11.1	15.7	22.6	3.0	10.4	7.8	20.8	14.7	15.1	5.2	0.3	10.0	0.1	1.3	1.1	0.2	13.9	15.4	8.2	13.2	6.1	7.9	9.8	12.3	13.4	17.5	13.8	14.6	2.0	15.6	6.3	16.8	20.1	16.2	12.0	14.2	17.0	15.1	11.4	16.2	16.3	6.1	4.1	7.2	8.7	6.3	11.4	18.3	19.5	11.1	10.1	4.5	17.8	10.1	6.4	12.5	6.8	4.5	5.5	10.3	10.0	9.5	12.2	0.7	14.0	9.9	21.5	8.4	17.4	11.0	26.2	13.0	4.4	3.1	17.8	18.0	11.6	12.3	25.6	6.6	11.7	20.9	15.6	3.2	51.4	10.0	0.0	0.1	0.5	0.1	0.8	3.3	0.6	0.5	0.1	5.2	0.3	0.2	0.2	1.3	0.0	0.3	1.1	0.2	15.4	19.2	62.2	25.0	15.4	13.8	21.6	15.6	19.4	22.6	3.0	15.1	14.3	10.9	10.0	13.4	13.4	12.7	20.1	15.9	12.2	49.1	11.8	0.0	19.8	9.4	14.0	21.9	23.3	8.4	29.4	9.6	10.5	18.5	33.0	2.7	1.6	9.8	6.2	2.7	10.5	3.7	3.7	8.5	8.2	18.5	59.7	22.3	20.1	6.0	3.9	11.6	0.0	9.2	19.3	12.6	10.3	9.4	7.7	15.7	6.7
MIER1	"hMI-ER1, KIAA1610, MI-ER1"	ENSG00000198160	"MIER1 transcriptional regulator"	Q8N108	1	66924895-66988619	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019589, HPA050306"	Enhanced		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA019589: AB_1853953, HPA050306: AB_2681080"	"unprognostic (3.38e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (4.96e-4)"	"unprognostic (1.63e-1)"	"prognostic favorable (3.44e-8)"	"unprognostic (1.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (4.48e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.45e-2)"	23.5	20.0	13.9	23.2	14.8	70.3	19.9	15.9	14.9	22.2	22.9	10.8	18.8	13.2	19.3	17.9	16.0	15.0	19.0	12.5	13.3	12.9	16.0	20.7	19.4	22.2	14.8	10.9	22.9	11.8	11.2	20.2	18.5	13.3	19.9	20.7	10.8	12.6	22.5	14.0	14.1	22.3	25.6	15.0	23.0	16.1	15.9	13.9	30.4	17.4	13.9	16.3	23.9	34.3	8.5	7.6	24.3	12.2	9.6	14.9	5.3	14.1	8.4	10.3	18.4	21.2	14.6	11.5	15.0	17.0	15.4	16.7	6.8	8.9	14.3	5.7	16.9	13.7	9.5	12.7	16.2	22.0	16.8	9.8	31.4	22.5	10.5	17.2	24.7	18.7	14.5	12.3	17.1	17.8	17.6	16.5	17.9	16.5	13.0	17.6	4.4	35.8	9.0	14.4	6.5	5.4	15.7	24.8	9.9	12.8	16.3	6.2	11.9	22.4	13.8	14.6	10.4	7.4	16.4	19.3	17.6	12.5	17.2	13.8	16.1	14.9	20.9	14.3	10.9	10.6	21.6	7.4	16.6	12.8	8.0	14.9	7.5	11.6	11.3	5.5	8.5	12.0	11.7	24.3	9.6	12.2	7.6	9.5	5.3	13.9	14.8	15.9	14.9	13.3	12.9	14.8	10.9	13.3	13.9	14.9	43.7	34.7	30.9	42.8	36.6	29.9	20.4	36.1	34.2	26.2	23.6	32.0	38.1	31.5	37.6	46.8	73.5	0.0	35.1	21.8	47.2	42.0	89.1	45.1	20.1	38.1	40.5	35.0	36.9	40.6	75.4	43.8	13.5	51.3	46.9	62.0	40.3	63.2	87.7	24.9	46.9	77.6	49.2	49.7	56.8	30.4	28.7	56.8	35.4	56.7
MIER3	"DKFZp686L09111, DKFZp781I1119, FLJ35954"	ENSG00000155545	"MIER family member 3"	Q7Z3K6	5	56919602-56971675	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058349, HPA065946"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA058349: AB_2683688, HPA065946: AB_2685583"	"unprognostic (1.01e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.66e-2)"	"unprognostic (9.31e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.63e-2)"	"unprognostic (4.84e-3)"	7.5	7.3	5.6	8.0	7.7	8.0	10.9	23.0	10.7	10.9	25.9	7.7	5.4	19.4	15.3	8.0	7.1	8.4	5.5	6.5	5.9	5.4	6.7	9.5	6.1	6.6	9.2	7.4	13.5	14.7	12.1	12.5	8.7	9.2	8.2	19.5	9.6	7.9	8.7	8.2	6.2	14.1	8.0	8.5	6.4	6.9	15.0	8.1	12.4	8.6	7.7	6.6	7.4	12.2	4.1	4.4	4.4	4.1	3.8	6.0	3.4	6.4	9.4	13.2	24.8	8.8	7.0	18.3	6.1	7.9	11.6	13.0	14.9	5.5	7.0	7.4	7.1	10.5	8.2	16.5	6.5	12.5	3.6	7.6	6.0	11.3	7.1	6.6	8.1	12.4	8.1	8.2	8.6	7.2	7.2	7.5	8.6	7.7	12.1	6.7	7.1	12.2	9.3	10.4	2.9	5.5	20.6	12.4	7.2	5.5	12.9	11.0	17.6	18.5	6.9	9.1	11.0	10.0	7.7	7.2	3.3	10.4	5.9	10.9	7.5	10.1	17.6	6.3	6.3	7.2	0.6	2.4	4.4	3.3	4.1	4.9	4.1	2.6	6.0	3.8	4.0	4.8	3.3	2.3	3.8	3.3	4.4	2.5	3.4	5.6	7.7	23.0	10.7	5.9	5.4	9.2	7.4	9.2	8.1	14.9	4.8	1.9	4.4	11.9	7.1	7.1	10.2	4.0	6.8	3.5	13.7	3.2	5.0	3.5	11.5	5.8	44.2	0.0	5.0	2.9	8.2	7.4	4.6	8.5	3.5	9.5	11.5	8.0	5.1	5.6	5.5	4.8	1.7	7.2	14.2	6.6	6.3	12.7	8.1	4.2	13.2	12.9	6.6	11.7	4.1	8.5	5.7	4.9	8.9	5.4
MINDY1	"FAM63A, FLJ11280, MINDY-1"	ENSG00000143409	"MINDY lysine 48 deubiquitinase 1"	Q8N5J2	1	150996086-151008375	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	15	"Distal tubular cells: 33.2;Ductal cells: 11.3;Proximal tubular cells: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 26.3;eosinophil: 19.1;neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028351, HPA028358, HPA061086"	Approved		Enhanced	Nucleoplasm		NA	NA		240000	Nucleoplasm		"HPA028351: AB_10611110, HPA028358: AB_10601102, HPA061086: AB_2684425"	"unprognostic (5.73e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.88e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.06e-1)"	"prognostic favorable (3.43e-8)"	"unprognostic (2.30e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.50e-2)"	"unprognostic (6.06e-2)"	9.2	9.7	14.0	6.7	31.1	5.6	13.0	18.4	21.2	13.1	13.5	53.8	14.8	14.0	14.7	6.5	24.1	14.4	11.8	24.5	17.6	10.1	26.6	12.2	10.9	5.2	37.5	13.5	19.3	37.3	26.2	12.3	5.9	25.0	11.7	14.8	16.9	25.3	21.0	11.9	17.1	12.1	13.7	34.1	10.7	15.9	14.7	35.7	0.9	39.9	7.9	10.3	12.3	13.0	0.6	4.0	30.4	3.2	1.5	2.2	3.4	6.1	4.0	4.3	6.1	7.8	6.5	3.6	2.0	5.1	2.8	4.5	8.6	14.7	0.4	4.8	2.6	0.9	3.1	3.4	3.7	1.3	4.6	5.1	6.0	7.4	7.3	1.7	1.8	2.4	5.3	3.4	5.1	1.4	9.6	7.2	2.1	3.7	15.5	2.9	9.5	0.3	4.0	2.0	1.9	1.4	4.5	0.8	18.9	13.4	12.2	7.5	5.5	3.8	7.0	4.2	2.1	27.9	6.1	6.7	2.4	3.2	1.2	1.7	5.7	5.2	20.6	5.8	4.0	11.4	26.3	3.2	19.1	0.1	1.5	0.1	0.3	1.3	0.3	4.0	0.6	2.2	0.7	30.4	1.5	0.9	0.6	1.6	3.4	14.0	31.1	18.4	21.2	17.6	10.1	37.5	13.5	25.0	35.7	8.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	6.8	3.5	0.0	3.4	33.2	11.3	0.0	0.0	0.0	0.0	6.1	0.6	0.0	0.0	3.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	7.3	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0
MINDY2	"FAM63B, KIAA1164"	ENSG00000128923	"MINDY lysine 48 deubiquitinase 2"	Q8NBR6	15	58771192-58861900	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 137.0;Collecting duct cells: 78.5;Extravillous trophoblasts: 84.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 40.6"	"Low region specificity"	"Detected in all"							"HPA051103, HPA063669"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA051103: AB_2681345, HPA063669: AB_2685082"	"unprognostic (4.71e-2)"	"unprognostic (8.92e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.23e-2)"	"unprognostic (7.09e-2)"	"unprognostic (2.36e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (3.00e-8)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.77e-2)"	14.0	9.2	15.5	8.8	14.7	5.6	11.1	41.0	15.4	12.4	8.8	12.4	11.8	5.8	13.0	8.0	11.8	11.7	10.4	16.7	14.6	12.6	16.9	5.8	12.5	6.1	16.2	15.5	11.7	6.4	15.5	12.5	21.9	14.9	15.0	6.6	11.7	7.7	11.8	6.1	11.4	6.5	13.6	16.9	9.4	7.8	6.2	15.8	8.6	15.8	5.4	6.0	13.1	9.1	4.6	2.9	5.5	3.1	1.9	5.5	1.4	5.8	2.9	4.1	2.5	6.2	11.4	6.5	5.4	11.5	1.7	2.4	4.6	2.9	3.0	5.9	6.5	3.0	5.7	7.5	4.3	2.6	3.0	2.7	4.2	3.2	4.1	3.8	3.1	3.9	5.0	7.3	2.0	4.5	6.4	4.1	3.2	7.2	3.4	3.9	0.7	3.9	2.4	8.7	0.8	1.5	1.7	11.8	3.2	5.0	6.6	3.7	2.8	3.9	5.5	9.8	9.1	1.7	6.7	4.8	2.4	2.1	40.6	2.3	3.0	4.3	3.0	5.3	5.2	5.7	5.5	1.8	3.3	3.2	1.6	5.5	2.7	2.8	3.5	0.6	4.6	2.4	3.3	3.9	1.9	3.1	2.9	2.2	1.4	15.5	14.7	41.0	15.4	14.6	12.6	16.2	15.5	14.9	15.8	137.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	52.2	33.0	78.5	0.0	54.4	39.7	36.7	0.0	0.0	0.0	0.0	18.8	84.1	0.0	0.0	10.5	0.0	28.7	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	16.2	0.0	0.0	23.8	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	44.5	0.0	0.0	0.0
MIOS	"FLJ20323, MIO, Sea4"	ENSG00000164654	"Meiosis regulator for oocyte development"	Q9NXC5	7	7566872-7608929	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042928, HPA052223"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA042928: AB_10795610, HPA052223: AB_2681768"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (6.51e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.28e-6)"	"unprognostic (1.03e-1)"	"unprognostic (1.10e-2)"	"unprognostic (7.67e-3)"	"unprognostic (2.72e-1)"	9.9	7.8	6.7	14.4	9.5	10.3	9.6	11.7	10.3	9.9	7.0	7.3	10.3	5.5	8.8	8.7	17.1	8.1	6.4	8.0	7.3	5.6	12.0	11.2	7.4	13.9	5.7	7.2	9.0	16.2	24.6	14.9	11.0	16.8	14.7	8.7	10.9	12.3	14.3	67.7	15.3	8.9	8.0	8.8	15.2	10.6	11.9	7.8	14.0	6.8	14.6	19.0	9.3	12.2	10.5	8.3	8.9	11.0	6.4	7.5	4.2	18.9	8.5	10.3	12.3	8.1	17.5	8.6	14.9	11.9	9.5	9.6	10.5	7.5	16.8	4.7	8.8	25.6	17.2	10.4	10.9	12.7	6.8	9.1	4.1	10.2	7.0	11.4	18.0	4.7	14.5	13.7	8.5	21.4	9.4	8.5	5.7	20.9	13.8	40.2	13.2	4.0	8.2	20.8	9.6	9.1	12.5	15.7	16.1	8.6	9.7	10.8	17.5	7.9	22.7	8.8	19.8	12.3	16.2	7.4	14.9	16.0	8.2	12.6	12.3	13.5	15.0	13.0	10.5	17.3	0.0	5.9	8.9	5.1	11.0	4.3	10.5	5.5	4.7	8.3	9.5	7.5	5.8	0.6	6.4	5.3	5.0	5.4	4.2	6.7	9.5	11.7	10.3	7.3	5.6	5.7	7.2	16.8	7.8	8.9	11.0	15.3	12.4	10.8	7.9	16.5	10.2	12.0	9.1	7.0	11.8	14.7	14.9	11.0	29.5	6.4	6.3	0.0	15.2	7.3	5.7	25.8	9.2	15.1	13.8	11.1	4.1	6.7	20.9	40.8	5.5	13.5	6.8	5.4	8.1	7.8	11.3	9.0	7.1	8.4	15.6	12.9	6.6	24.4	28.0	16.6	17.7	12.5	9.3	16.5
MIPEP	MIP	ENSG00000027001	"Mitochondrial intermediate peptidase"	Q99797	13	23730189-23889419	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 80.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030676, HPA031669, HPA031670"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA030676: AB_10598907, HPA031669: AB_10600986, HPA031670: AB_10602198"	"unprognostic (2.05e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.75e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.76e-1)"	"prognostic favorable (7.66e-12)"	"unprognostic (1.62e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.90e-3)"	7.3	14.9	6.2	7.1	12.2	4.4	11.0	4.7	10.3	8.1	12.2	12.9	12.1	8.4	9.6	20.4	14.4	17.1	11.7	16.9	8.8	5.3	24.7	12.0	8.2	8.4	5.1	8.0	8.5	14.7	8.1	15.4	5.3	9.1	10.9	13.1	9.1	12.9	10.1	16.2	22.0	8.9	11.5	4.4	6.5	9.8	13.9	4.9	8.9	10.9	15.7	11.1	11.2	8.6	9.2	6.5	1.2	10.6	9.7	10.0	3.9	7.8	8.9	4.4	10.3	10.1	13.7	9.4	5.7	8.9	8.6	7.3	11.8	15.7	9.3	5.8	4.6	7.6	19.9	10.1	12.0	10.7	5.4	6.4	4.0	4.2	10.1	8.3	9.4	2.2	6.7	15.0	8.9	7.9	7.3	10.7	7.1	7.7	1.5	13.4	5.8	6.7	5.3	6.1	35.4	9.0	7.5	11.9	8.0	19.2	5.2	10.3	3.4	6.1	10.0	12.0	5.8	10.3	5.3	5.9	5.2	4.4	8.6	6.1	1.5	2.1	5.0	9.1	4.8	6.5	0.0	3.0	1.2	7.9	3.7	10.0	9.2	7.7	7.1	6.5	7.7	7.4	7.3	0.0	9.7	10.6	5.6	5.1	3.9	6.2	12.2	4.7	10.3	8.8	5.3	5.1	8.0	9.1	4.9	14.9	7.5	0.8	5.9	35.4	3.2	80.7	15.3	36.1	10.3	8.7	5.9	8.4	24.9	20.8	6.6	3.7	5.5	0.0	9.4	7.7	4.5	5.6	2.3	5.6	8.7	14.3	5.8	2.5	2.7	5.9	6.4	4.1	5.0	3.6	6.4	5.2	8.0	8.6	8.1	18.1	10.7	0.0	5.2	9.5	19.0	36.9	4.2	2.9	12.4	3.8
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751126-764318	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"gallbladder: 24.6;intestine: 63.8"	"Group enriched"	"Detected in many"	5	"Enterocytes: 892.4;Paneth cells: 434.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 37.2;HaCaT: 27.6;hTCEpi: 25.9;MCF7: 19.0;OE19: 23.2;SK-BR-3: 42.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"		No	No			"Plasma membrane, Focal adhesion sites"		"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	0.5	0.1	0.3	7.9	0.3	0.0	0.7	0.2	0.2	1.5	42.8	0.2	0.2	45.9	0.7	0.8	0.4	2.4	24.6	0.2	0.5	0.2	6.9	0.4	6.8	0.2	0.3	0.3	2.2	2.0	0.0	4.2	2.1	0.2	2.2	13.0	0.2	0.5	0.5	0.2	0.3	63.8	0.7	0.2	0.2	5.8	0.2	0.2	0.3	0.2	0.8	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	37.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.8	13.7	3.2	3.6	0.0	0.0	27.6	0.0	11.6	0.0	0.0	0.0	0.0	14.6	3.9	0.0	0.0	0.5	0.0	25.9	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	19.0	0.0	0.2	0.0	23.2	7.6	0.0	0.1	0.3	9.3	10.3	0.4	0.1	13.2	42.0	0.0	0.0	9.1	0.0	0.0	0.0	4.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2	35.7	10.1	2.2	4.0	0.1	0.0	0.4	2.5	26.8	15.9	10.4	0.0	0.3	1.7	48.8	0.4	0.0	892.4	0.0	41.8	2.6	0.3	34.5	9.2	0.0	0.1	0.0	55.7	0.0	0.0	0.7	0.0	0.8	0.0	1.0	139.5	0.0	94.0	434.9	0.0	21.7	0.0	0.0	0.0	0.0	1.5	0.3	1.7	0.0	93.0	40.9
MITD1	LOC129531	ENSG00000158411	"Microtubule interacting and trafficking domain containing 1"	Q8WV92	2	99161427-99181058	"Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036162, HPA036163"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036162: AB_10672236, HPA036163: AB_2674978"	"prognostic favorable (5.96e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.02e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (1.47e-6)"	"unprognostic (1.39e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (1.32e-11)"	"unprognostic (2.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.91e-2)"	"prognostic favorable (5.46e-8)"	18.8	19.1	19.6	26.3	34.2	11.7	18.8	20.6	30.2	16.6	17.6	13.5	14.4	15.6	17.7	15.5	20.0	16.6	14.2	13.6	21.1	12.5	17.9	17.1	15.2	33.6	29.0	12.5	18.4	13.8	6.6	28.9	16.8	21.6	14.9	21.0	12.7	15.5	13.4	12.8	15.9	18.9	17.8	30.2	25.9	17.4	7.0	33.1	20.2	17.7	14.0	28.4	16.5	26.7	25.0	24.0	22.9	20.8	19.2	21.5	10.3	23.8	6.4	13.1	5.0	15.5	20.2	18.1	11.4	16.1	16.1	22.0	7.9	20.2	16.7	13.3	9.3	36.9	18.2	12.8	12.7	27.0	23.7	8.8	14.7	9.6	16.6	23.1	24.6	8.7	15.9	10.9	14.1	13.6	14.9	18.1	16.0	12.0	10.3	14.5	5.7	23.5	36.6	11.0	15.5	12.8	13.3	18.9	14.3	20.2	13.5	4.3	6.4	11.2	10.4	14.2	24.0	5.4	19.7	13.5	10.0	13.1	10.4	14.1	12.2	9.5	22.7	18.2	20.9	9.9	12.9	20.8	14.3	15.2	18.1	17.0	25.0	21.5	18.0	17.6	24.9	20.9	16.7	22.9	19.2	16.2	24.0	18.2	10.3	19.6	34.2	20.6	30.2	21.1	12.5	29.0	12.5	21.6	33.1	23.8	14.5	44.4	24.8	16.8	11.8	9.5	20.4	24.1	26.1	33.2	13.7	40.8	38.1	40.3	15.6	29.2	22.3	0.0	53.0	27.8	25.8	17.8	30.0	29.7	44.5	11.1	15.1	28.3	17.2	4.0	47.2	30.9	21.9	47.7	23.5	18.0	46.0	32.6	37.1	41.5	51.2	38.8	18.9	14.9	12.8	15.3	18.9	41.5	24.7	16.3
MKI67	"MIB-, PPP1R105"	ENSG00000148773	"Marker of proliferation Ki-67"	P46013	10	128096659-128126385	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2;lymphoid tissue: 81.5"	"Cell type enhanced"	"Detected in many"	19	"Erythroid cells: 163.5;Extravillous trophoblasts: 71.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.4;T-reg: 1.3"	"Group enriched"	"Detected in many"	13	"NK-cells: 1.1;T-cells: 1.4"	"Low cell line specificity"	"Detected in many"											"CAB000058, HPA000451, HPA001164, CAB068198"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoplasm, Nucleoli rim"	"Mitotic chromosome"	"CAB000058: AB_2142367, CAB068198: AB_2665702, HPA000451: AB_1079186, HPA001164: AB_1079187"	"unprognostic (2.54e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.92e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (7.16e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (9.47e-5)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.61e-1)"	1.8	1.2	0.2	9.9	0.5	25.2	1.8	0.3	0.5	1.5	5.0	0.6	0.2	3.6	0.7	1.4	13.4	0.3	1.2	1.3	0.2	0.2	1.2	1.0	1.9	8.8	0.2	0.2	0.5	0.4	0.0	0.4	2.9	0.5	0.7	5.8	0.5	2.2	0.6	0.5	3.9	6.2	1.3	0.8	6.5	3.5	2.5	0.2	81.5	0.4	5.2	10.0	1.3	3.5	0.0	0.0	0.0	0.0	1.1	1.4	0.4	48.1	24.5	25.5	18.0	1.0	2.2	7.9	18.3	13.5	17.4	15.6	20.0	20.0	36.3	5.3	12.5	11.5	29.4	26.7	13.7	26.2	38.2	12.9	31.1	18.1	12.5	0.0	43.6	16.9	0.5	0.6	17.8	18.3	4.3	17.0	16.9	14.2	34.9	17.2	19.1	26.0	13.3	10.1	12.5	11.2	19.4	33.4	4.8	6.3	13.5	8.9	9.6	25.9	9.3	4.4	8.8	7.7	9.3	15.7	9.2	18.5	13.0	49.4	15.9	12.6	44.0	7.7	20.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.4	1.0	0.0	1.1	0.0	0.0	1.3	0.4	0.2	0.5	0.3	0.5	0.2	0.2	0.2	0.2	0.5	0.2	0.0	4.8	10.7	0.5	5.7	0.0	1.2	2.5	2.7	7.9	0.0	0.0	2.7	0.0	0.4	2.5	0.0	2.7	163.5	0.0	71.7	3.4	1.4	1.1	1.0	34.1	0.0	6.4	3.7	8.0	0.5	0.3	12.7	3.3	0.0	4.8	0.0	0.1	2.9	0.4	0.0	0.0	0.0	0.4	8.8	14.6	2.6	6.5	13.4	20.7	4.1
MLH1	"COCA2, FCC2, HNPCC, HNPCC2"	ENSG00000076242	"MutL homolog 1"	P40692	3	36993332-37050918	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013294, HPA052707, HPA060714, CAB070868"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013294: AB_2533406, CAB070868: , HPA052707: AB_2681923, HPA060714: AB_2684348"	"unprognostic (1.26e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (8.24e-5)"	"unprognostic (3.36e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.63e-3)"	"unprognostic (2.10e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (8.86e-2)"	16.3	20.7	18.2	19.4	21.4	24.4	18.7	19.7	19.6	15.3	17.3	28.8	19.6	12.4	18.7	23.6	15.1	16.2	14.4	32.0	17.3	17.7	18.8	20.5	17.8	22.8	19.9	16.0	17.6	18.1	26.0	29.4	17.3	19.2	18.5	17.7	16.7	15.6	18.1	46.4	14.2	14.1	21.1	21.6	20.7	16.5	27.6	21.5	29.0	22.2	19.5	24.5	16.9	21.4	12.0	12.9	13.2	23.2	6.7	13.4	9.0	14.2	22.5	28.1	0.0	12.5	15.7	12.6	21.3	17.0	24.8	26.4	17.0	15.9	35.3	10.6	17.3	14.0	9.8	24.2	18.0	26.6	16.0	12.5	24.7	20.8	23.8	13.9	30.3	17.2	11.7	12.7	23.1	28.8	9.8	15.3	23.9	31.6	16.9	25.1	11.5	31.6	12.4	20.6	14.5	12.4	3.1	34.4	14.9	15.7	15.5	6.0	14.2	21.6	23.0	14.2	16.4	33.2	21.6	12.1	19.5	21.0	19.1	25.0	13.4	36.6	33.1	15.1	28.7	17.5	10.9	11.7	13.2	13.4	19.5	9.7	12.0	8.4	10.7	12.9	10.3	9.6	9.7	3.4	6.7	23.2	6.1	12.5	9.0	18.2	21.4	19.7	19.6	17.3	17.7	19.9	16.0	19.2	21.5	23.8	12.0	16.0	10.7	6.4	19.2	37.1	15.3	16.0	13.6	10.4	9.8	27.1	16.6	12.5	20.3	11.2	5.3	0.0	13.0	23.0	13.4	8.0	7.0	14.5	17.5	3.2	5.2	12.3	14.3	9.5	10.3	11.4	8.5	19.8	7.2	14.3	8.6	7.0	13.1	9.2	17.9	12.9	9.5	37.0	25.4	4.8	16.7	13.1	7.6	3.4
MMS19	"hMMS19, MET18, MMS19L"	ENSG00000155229	"MMS19 homolog, cytosolic iron-sulfur assembly component"	Q96T76	10	97458324-97498794	"Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA051936, HPA056299"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051936: AB_2681668, HPA056299: AB_2683091"	"unprognostic (8.57e-2)"	"unprognostic (2.38e-3)"	"unprognostic (9.34e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (6.88e-4)"	"unprognostic (4.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.06e-3)"	"unprognostic (6.79e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.06e-1)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (3.39e-4)"	17.5	16.4	26.5	16.6	25.5	17.1	23.0	38.0	35.7	18.9	18.2	26.2	17.1	16.8	20.8	23.4	23.1	23.7	15.9	25.6	24.8	18.4	22.8	16.2	20.2	24.2	21.0	24.8	28.3	20.6	19.3	31.4	24.5	22.3	17.3	21.8	23.1	19.5	20.6	26.7	38.2	18.4	22.0	18.6	23.7	17.8	33.7	24.7	27.6	19.2	19.4	26.4	18.0	21.9	8.1	11.0	9.8	8.5	6.7	12.7	7.7	15.2	14.7	17.8	24.8	17.5	21.1	10.7	12.4	25.0	18.9	22.3	19.5	20.1	23.7	13.6	16.8	12.6	17.5	29.1	33.5	17.9	10.2	22.1	12.4	12.2	20.3	13.2	16.4	12.2	17.4	14.6	16.7	35.7	36.8	31.8	17.9	17.7	13.3	18.3	13.9	15.6	30.2	10.0	15.6	12.1	12.6	13.6	10.6	22.4	11.1	7.2	11.9	7.1	9.6	18.4	23.2	19.4	15.0	18.0	8.6	11.0	5.9	13.9	12.0	13.4	13.7	13.0	24.8	7.0	9.8	7.2	5.8	7.5	8.5	12.7	8.1	10.1	9.4	11.0	7.0	12.2	9.5	1.6	6.7	6.5	8.3	10.0	7.7	26.5	25.5	38.0	35.7	24.8	18.4	21.0	24.8	22.3	24.7	20.8	16.5	8.0	5.3	9.3	10.5	15.3	7.6	4.0	5.7	5.2	17.7	11.8	10.0	9.9	7.2	10.8	8.7	0.0	6.9	15.6	8.7	5.0	3.5	12.8	11.1	9.5	9.8	14.7	13.8	6.4	14.4	7.8	13.5	17.2	13.1	5.6	8.4	2.9	10.6	5.5	22.4	12.9	9.2	20.9	29.6	10.0	7.3	7.0	12.0	4.1
MNAT1	"MAT1, RNF66"	ENSG00000020426	"MNAT1, CDK activating kinase assembly factor"	P51948	14	60734742-60969953	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000701, HPA001154, CAB004495"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004495: AB_670057, HPA000701: AB_1079400, HPA001154: AB_2666212"	"unprognostic (4.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.52e-2)"	"unprognostic (3.48e-2)"	"unprognostic (6.34e-2)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.14e-3)"	15.3	14.9	14.6	10.1	18.9	9.4	19.6	29.2	20.2	16.9	11.4	11.8	12.2	6.8	17.3	15.0	13.7	18.9	10.8	15.2	14.0	14.2	19.8	17.0	10.7	9.4	13.8	15.4	16.2	10.3	42.8	33.2	13.7	18.7	16.3	9.9	11.6	18.4	12.8	53.0	8.4	7.1	14.6	15.0	9.2	11.5	8.8	11.8	11.8	14.0	15.9	12.5	13.6	12.3	14.7	25.7	11.6	5.1	18.9	10.8	3.9	60.9	11.8	14.7	10.4	17.2	19.0	16.1	22.5	24.3	27.5	22.3	9.4	21.5	14.7	17.1	16.4	14.9	19.5	16.4	25.8	39.6	18.3	17.1	9.9	11.5	13.8	21.4	22.9	5.3	11.5	19.0	17.7	19.7	26.6	26.2	21.5	14.6	14.1	30.6	20.9	14.2	14.4	8.0	11.6	26.4	14.8	40.2	9.2	32.3	28.8	13.2	9.0	17.2	14.5	20.8	17.8	22.5	11.2	19.9	21.2	22.4	9.9	16.8	6.2	5.2	21.1	17.1	3.9	15.3	4.7	3.6	11.6	8.5	4.6	8.8	14.7	9.1	8.9	6.6	11.3	10.8	10.7	0.3	18.9	5.1	25.7	7.5	3.9	14.6	18.9	29.2	20.2	14.0	14.2	13.8	15.4	18.7	11.8	29.8	18.0	15.9	49.9	22.0	39.8	44.5	28.1	66.9	35.2	27.9	29.5	43.5	68.0	30.1	2.7	27.0	2.9	0.0	38.3	30.0	22.1	39.3	31.3	19.1	17.5	22.3	16.7	15.4	4.5	4.9	27.9	11.3	13.5	13.6	13.8	46.7	45.6	11.8	28.7	46.9	58.0	51.8	35.9	54.6	50.7	15.8	30.1	25.5	14.2	38.2
MNT	"bHLHd3, MAD6, MXD6, ROX"	ENSG00000070444	"MAX network transcriptional repressor"	Q99583	17	2384060-2401118	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059532, HPA067578"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059532: AB_2684053, HPA067578: AB_2685864"	"unprognostic (3.72e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.31e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.97e-2)"	"unprognostic (3.47e-3)"	"unprognostic (2.27e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.09e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.98e-2)"	18.0	14.7	12.6	15.2	15.2	29.8	11.8	13.3	22.8	17.3	16.8	12.1	9.9	14.9	16.9	11.3	19.5	15.9	14.4	9.0	12.1	11.6	11.2	9.1	11.9	13.2	8.6	13.6	17.9	15.8	14.2	18.9	15.1	12.0	13.8	8.4	15.8	12.4	17.2	10.7	15.3	13.6	13.4	11.4	14.5	13.1	16.2	9.3	14.2	13.3	11.5	14.4	25.5	13.8	1.0	1.1	4.1	1.7	0.6	1.2	0.6	7.2	9.0	7.8	9.9	9.8	11.1	7.1	4.8	6.4	2.7	3.1	5.9	7.1	10.0	5.1	7.4	6.0	11.5	5.6	10.6	2.1	5.4	8.1	7.1	14.8	5.0	6.4	3.0	13.2	17.6	10.0	5.8	7.8	8.8	4.7	8.0	6.0	9.2	3.1	5.2	7.0	5.2	3.7	5.3	5.9	8.1	3.7	6.6	5.1	10.3	8.3	12.0	5.6	5.5	12.9	4.2	4.5	5.8	8.5	6.7	4.6	10.5	3.9	7.9	3.9	4.0	13.6	6.1	4.3	1.5	1.2	2.9	0.6	1.7	1.2	1.0	0.8	1.0	0.5	0.7	1.0	1.0	4.1	0.6	1.3	1.1	0.1	0.6	12.6	15.2	13.3	21.6	12.1	11.6	8.6	13.6	12.0	9.3	6.0	25.0	11.3	14.7	16.6	15.7	5.6	5.1	8.1	15.9	14.0	21.6	5.6	1.7	8.7	6.8	10.5	16.7	0.0	8.9	7.9	12.4	16.5	12.8	8.9	12.2	25.4	19.0	12.9	24.0	12.2	10.3	15.4	10.1	1.8	20.9	10.6	10.9	20.1	12.4	2.4	10.6	6.5	12.2	10.4	19.6	22.5	7.8	12.8	22.3	51.0
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 23.5;Hepatocytes: 33.6;Sertoli cells: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.9;naive CD8 T-cell: 2.5"	"Group enriched"	"Detected in many"	9	"NK-cells: 1.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 23.6;JURKAT: 30.1"	"Low region specificity"	"Detected in all"							"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	26.6	9.6	4.6	5.3	7.9	0.2	27.1	5.9	8.7	6.4	17.5	10.5	5.0	15.4	10.1	8.7	6.9	7.9	8.0	18.0	6.2	2.3	17.5	34.9	19.6	9.2	9.5	6.2	9.0	10.9	4.5	6.3	30.2	7.0	6.7	5.2	11.2	5.9	7.6	19.9	7.1	13.1	8.9	7.1	3.5	6.5	4.0	7.6	0.2	15.4	5.9	3.1	9.7	7.7	0.0	0.1	0.0	0.2	1.5	2.9	0.8	0.0	1.2	4.4	7.1	12.1	4.6	9.0	4.9	8.9	7.0	6.4	23.6	0.1	0.0	5.1	4.8	4.5	0.3	5.3	5.9	5.4	0.0	4.9	0.0	0.0	7.5	7.7	0.0	1.9	8.1	2.2	4.9	2.6	4.3	6.0	30.1	4.8	0.4	7.1	3.0	9.2	0.0	4.1	0.0	2.6	0.0	3.4	0.7	4.3	4.6	3.6	4.7	0.0	2.9	4.1	3.7	3.1	0.8	9.3	7.0	6.1	4.6	2.5	0.0	0.9	0.0	0.8	0.0	2.5	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.5	0.1	0.0	2.9	2.5	0.0	1.5	0.2	0.0	0.0	0.8	4.6	7.9	5.9	8.7	6.2	2.3	9.5	6.2	7.0	7.6	6.0	1.0	0.0	0.5	0.6	0.8	10.1	7.6	0.0	0.0	8.7	11.8	23.5	5.0	3.4	0.6	2.8	6.4	0.0	3.7	1.2	2.9	0.2	1.1	33.6	2.5	3.2	0.0	2.5	2.8	0.6	3.4	0.0	1.7	0.0	2.9	4.2	1.1	4.8	2.8	12.2	2.2	77.6	15.6	1.4	1.5	1.0	5.1	0.0	4.1	0.3
MORC3	"KIAA0136, NXP2, ZCW5, ZCWCC3"	ENSG00000159256	"MORC family CW-type zinc finger 3"	Q14149	21	36320189-36386148	"Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018406, HPA034848"	Approved		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA018406: AB_1858988, HPA034848: AB_2674359"	"unprognostic (4.01e-3)"	"unprognostic (4.86e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.29e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (6.40e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.38e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	18.0	11.2	15.6	15.4	16.4	28.0	17.5	30.9	16.3	20.3	15.3	10.1	14.1	10.6	22.5	10.6	23.0	17.9	13.5	12.5	14.6	7.9	11.6	13.0	17.0	20.6	17.5	12.1	29.3	11.3	14.8	25.1	20.6	16.6	16.1	12.1	7.3	20.6	14.2	28.1	20.1	14.8	21.4	21.0	19.1	14.0	10.8	18.2	25.5	15.0	17.6	20.0	22.9	23.5	11.2	7.6	21.9	10.7	8.2	11.9	6.6	12.2	4.7	11.4	7.5	11.8	12.8	16.1	11.6	20.3	13.4	11.1	7.6	8.0	5.9	4.5	13.3	13.3	6.2	8.9	11.6	14.1	11.1	7.0	24.4	5.1	5.6	7.7	12.5	21.8	8.0	14.5	12.8	17.7	14.0	10.7	9.3	19.5	15.1	10.8	4.0	8.0	6.8	9.4	15.0	5.7	9.9	5.7	10.6	5.9	12.8	4.7	12.3	13.5	8.8	13.8	9.2	9.9	10.5	14.3	13.0	3.2	8.7	10.0	6.7	5.9	5.7	8.4	19.9	9.3	21.9	7.5	16.1	8.4	9.4	8.3	10.0	9.2	7.9	7.6	11.2	11.9	8.5	11.7	8.2	10.7	4.9	11.3	6.6	15.6	16.4	30.9	16.3	14.6	7.9	17.5	12.1	16.6	18.2	26.8	20.8	20.5	44.0	60.8	20.0	17.6	12.7	32.1	25.0	21.0	7.9	13.4	3.3	14.1	38.2	20.4	10.1	23.3	10.9	15.8	35.2	39.4	46.2	13.6	15.7	15.9	10.9	12.9	25.7	13.5	17.3	33.9	23.6	21.6	14.7	15.5	17.4	14.4	25.1	5.3	11.9	12.9	20.2	24.7	32.9	71.4	21.1	24.5	9.0	52.9
MORC4	"FLJ11565, ZCW4, ZCWCC2"	ENSG00000133131	"MORC family CW-type zinc finger 4"	Q8TE76	X	106813871-107000244	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"placenta: 94.5"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 122.1;Alveolar cells type 2: 98.4;Ciliated cells: 111.1;Club cells: 109.2;Cytotrophoblasts: 213.9;granulocytes: 61.5;Syncytiotrophoblasts: 215.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"A549: 44.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000395, HPA015547, HPA050250"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000395: AB_1079405, HPA015547: AB_2669216, HPA050250: AB_2681063"	"prognostic unfavorable (3.56e-5)"	"unprognostic (3.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.29e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.56e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.69e-2)"	8.7	20.0	3.2	6.0	4.8	5.1	6.2	4.9	3.6	8.0	5.3	4.6	12.7	4.6	8.8	8.5	6.8	7.3	6.7	5.3	4.3	2.8	4.9	9.7	6.0	2.2	4.9	2.2	12.3	9.1	6.0	4.9	94.5	5.8	7.7	4.9	4.2	8.7	8.8	9.4	8.6	4.9	7.4	5.4	2.6	5.6	12.5	5.0	2.3	7.6	7.5	5.2	6.3	15.1	6.0	4.6	10.5	3.8	2.8	4.0	0.7	11.0	44.0	4.4	10.1	13.4	15.5	22.9	10.7	11.4	5.4	7.0	23.3	5.0	1.7	5.6	11.0	9.3	8.7	14.7	9.4	6.5	2.5	8.5	2.7	14.9	9.8	9.9	1.9	5.6	8.2	9.1	7.4	10.8	32.3	4.8	1.7	1.5	16.7	12.1	9.7	4.0	2.7	3.9	29.5	16.7	1.9	8.8	1.9	17.5	8.8	3.8	4.8	13.0	12.8	8.4	6.5	7.6	1.9	5.0	8.7	8.8	17.2	5.9	4.7	6.1	4.3	9.3	1.7	6.3	10.5	3.8	3.1	3.7	3.0	3.2	3.3	3.6	2.8	1.6	6.0	4.0	3.4	8.2	2.8	3.6	4.6	2.6	0.7	3.2	4.8	4.9	3.6	4.3	2.8	4.9	2.2	5.8	5.0	122.1	98.4	2.2	12.9	15.5	4.5	2.2	7.6	111.1	109.2	5.2	3.9	213.9	18.3	8.8	0.8	5.0	3.9	0.0	6.4	21.9	23.8	19.4	61.5	16.2	20.2	1.6	1.7	8.6	1.3	0.9	10.3	4.8	11.8	0.0	8.8	5.8	6.7	4.9	11.0	9.0	7.5	25.8	8.6	5.4	24.3	14.1	215.6	6.4	8.4	11.7
MORF4L2	"KIAA0026, MRGX"	ENSG00000123562	"Mortality factor 4 like 2"	Q15014	X	103675496-103688158	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Growth regulation, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 931.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031872, HPA054102"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031872: AB_2674081, HPA054102: AB_2682379"	"prognostic unfavorable (9.83e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.14e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (4.29e-5)"	"unprognostic (5.27e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.10e-2)"	"prognostic unfavorable (7.86e-7)"	"unprognostic (8.54e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.05e-1)"	33.3	51.4	50.4	26.6	53.5	23.9	51.6	52.8	66.8	76.2	32.9	29.7	62.9	25.8	74.0	63.4	40.2	55.2	39.5	38.5	50.0	71.2	44.0	76.5	34.3	19.3	45.5	48.8	99.8	36.2	38.6	81.8	77.4	63.5	47.4	40.3	23.4	35.2	57.8	44.9	27.4	27.8	93.7	46.1	25.9	31.5	33.5	34.7	21.5	46.8	35.6	29.9	55.5	45.3	21.6	40.7	24.7	24.7	25.4	29.1	21.9	61.5	41.8	56.2	24.8	83.8	63.0	75.5	82.5	72.2	68.6	70.7	42.8	55.5	42.1	67.7	78.4	84.4	41.9	70.3	61.1	86.0	19.3	31.9	22.4	71.9	48.4	91.9	30.6	21.3	68.4	54.5	58.4	77.1	58.7	75.2	21.9	36.7	58.2	83.9	62.3	27.3	30.2	53.4	74.4	47.6	27.7	52.8	44.5	68.5	37.5	53.7	41.8	62.2	46.2	61.5	62.5	30.6	29.8	62.7	40.1	26.9	69.4	44.0	29.0	35.4	37.4	71.7	62.2	60.0	24.7	23.3	18.4	25.4	24.7	29.1	21.6	24.3	23.9	24.3	19.1	26.9	23.1	9.5	25.4	24.6	40.7	19.7	21.9	50.4	53.5	52.8	66.8	50.0	71.2	45.5	48.8	63.5	34.7	116.1	147.5	88.8	414.6	322.8	43.3	119.2	122.3	420.3	177.5	104.7	9.8	369.7	208.9	242.9	24.0	127.8	101.6	93.5	114.3	931.5	289.9	258.5	150.3	162.2	144.9	55.6	171.3	128.3	54.0	17.4	306.3	110.7	178.8	79.4	116.9	105.8	160.2	115.2	540.3	206.2	33.5	142.3	300.8	27.0	40.2	277.8	488.0	71.4	94.4	332.6
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
MPHOSPH10	"CT90, MPP10, MPP10P, PPP1R106"	ENSG00000124383	"M-phase phosphoprotein 10"	O00566	2	71130314-71150101	"Predicted intracellular proteins, Predicted membrane proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035059, HPA035060, HPA049907"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA035059: AB_2674436, HPA035060: AB_10601875, HPA049907: AB_2680947"	"unprognostic (3.20e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-3)"	"unprognostic (6.13e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (3.89e-7)"	"unprognostic (1.24e-1)"	"unprognostic (2.91e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.23e-2)"	20.5	17.6	21.8	20.2	28.0	21.2	23.7	26.7	25.7	23.5	17.6	12.6	22.0	16.5	22.3	26.7	30.6	19.4	17.1	20.4	21.6	20.3	22.2	27.5	15.5	21.9	30.4	22.7	25.4	20.7	20.0	36.7	18.5	26.3	24.0	18.4	8.1	21.8	28.8	48.4	24.4	16.8	25.0	25.0	22.0	17.6	13.7	29.8	22.3	20.4	26.3	24.4	22.2	22.2	13.5	12.8	8.7	17.3	12.4	17.4	8.4	15.0	11.4	14.7	17.5	13.7	13.0	20.1	16.8	13.4	13.9	10.3	20.4	11.1	21.2	10.6	11.7	10.8	14.1	18.4	11.9	18.6	14.6	14.7	25.4	9.0	46.4	12.0	32.8	20.4	11.1	15.3	11.4	15.3	9.5	11.7	13.3	36.7	16.9	13.8	16.1	26.4	33.3	24.4	21.0	13.0	22.0	23.0	25.0	11.2	16.4	17.9	13.8	11.2	26.1	16.1	13.0	13.2	14.6	12.2	16.5	17.7	15.7	21.2	14.4	16.2	34.7	14.2	27.5	16.5	8.7	9.9	7.2	12.4	13.6	16.0	13.5	15.7	14.8	11.7	12.3	17.4	15.3	1.4	12.4	17.3	12.8	13.2	8.4	21.8	28.0	26.7	25.7	21.6	20.3	30.4	22.7	26.3	29.8	32.8	49.8	36.5	30.0	29.8	35.6	38.2	17.8	38.8	66.0	17.4	3.9	41.6	21.6	35.8	4.3	33.7	11.5	23.3	36.1	40.3	37.1	24.7	46.2	28.1	23.8	17.5	17.2	20.3	16.4	5.3	45.1	24.7	11.8	28.9	19.6	22.1	29.5	10.5	41.1	21.9	47.2	38.8	34.8	57.9	88.6	29.4	27.1	34.8	22.9	28.6
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415578-94493908	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 26.8;Ciliated cells: 21.4;Cytotrophoblasts: 31.8;Syncytiotrophoblasts: 23.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004081: AB_2145100, HPA002691: AB_1079409"	"unprognostic (5.59e-3)"	"unprognostic (4.35e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (7.14e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.66e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.06e-3)"	14.7	11.0	10.7	15.2	12.5	24.0	16.6	21.2	12.0	17.5	11.0	10.8	13.9	8.0	17.4	11.2	13.9	13.2	8.9	9.4	8.7	6.5	8.8	8.9	11.4	13.8	13.3	7.9	16.7	15.5	8.2	12.8	14.2	9.8	12.7	14.1	10.4	14.1	10.8	9.3	18.3	12.8	12.8	13.5	17.2	11.8	9.9	13.0	25.3	12.7	7.4	18.4	14.3	13.3	8.7	14.8	7.9	13.1	10.3	11.8	7.9	10.0	10.3	19.3	2.4	6.6	9.2	11.1	14.2	9.2	12.8	15.2	18.7	20.7	26.4	23.1	7.4	16.0	19.4	16.4	10.6	17.0	17.4	9.7	23.0	14.7	10.7	3.0	15.0	16.6	6.4	6.6	16.6	10.4	5.8	11.2	12.9	16.0	17.1	10.2	7.3	15.2	14.3	6.2	23.4	11.3	13.6	17.3	13.2	8.4	14.1	6.8	9.8	19.6	12.3	3.8	17.1	21.1	9.1	8.1	19.2	14.1	16.6	10.1	4.3	15.2	25.9	5.1	24.0	15.3	5.4	11.1	7.9	11.2	13.1	11.0	8.5	8.4	11.8	14.8	8.7	7.1	11.5	4.8	10.3	9.8	10.5	10.9	7.9	10.7	12.5	21.2	12.0	8.7	6.5	13.3	7.9	9.8	13.0	26.8	14.7	0.0	0.0	0.0	0.0	0.0	0.0	21.4	17.0	8.7	0.0	31.8	3.3	10.1	0.0	0.0	0.0	0.0	6.9	13.1	0.0	0.0	16.3	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	16.2	0.0	0.0	8.6	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0
MRPL10	"L10MT, MGC17973, MRP-L10, MRP-L8, MRPL8, RPML8"	ENSG00000159111	"Mitochondrial ribosomal protein L10"	Q7Z7H8	17	47823272-47831534	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021234, HPA029885"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021234: AB_1854098, HPA029885: AB_2673233"	"unprognostic (6.84e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.87e-2)"	20.8	23.2	18.3	23.8	25.2	17.7	34.3	22.2	25.9	19.2	24.7	11.5	24.4	21.2	22.8	26.5	20.3	25.6	28.7	44.0	18.9	18.1	21.6	26.0	29.6	39.6	18.0	19.4	42.9	34.7	17.8	12.3	19.3	16.9	17.6	19.6	16.5	18.2	27.5	43.2	15.5	17.6	37.9	21.4	19.6	23.8	18.6	13.2	19.2	20.4	26.6	21.2	26.0	19.6	17.7	20.4	11.2	18.3	11.6	31.6	17.7	12.8	28.5	12.0	12.2	28.8	26.5	22.4	11.3	19.1	19.5	16.8	54.8	17.7	20.9	26.5	14.6	12.9	12.3	17.1	22.1	17.4	20.1	27.1	16.8	15.3	38.3	24.9	15.0	9.4	29.8	19.2	23.2	32.9	23.1	18.7	20.1	22.4	21.0	15.0	25.3	15.3	18.9	19.8	22.1	27.4	12.3	23.5	23.2	21.3	12.7	14.5	23.3	8.6	9.9	24.2	23.7	29.6	15.9	11.5	17.6	14.6	11.8	15.9	36.9	28.5	16.8	15.5	11.4	11.8	11.2	17.6	8.2	31.6	18.3	29.8	15.9	21.8	27.9	20.4	17.7	18.6	21.9	7.1	11.6	14.7	12.4	24.3	17.7	18.3	25.2	22.2	25.9	18.9	18.1	18.0	19.4	16.9	13.2	6.0	9.9	19.7	19.4	11.1	14.0	30.8	12.7	4.0	12.5	14.0	5.9	74.6	39.7	34.5	17.5	17.7	16.1	23.3	47.8	49.4	18.8	14.3	8.1	12.3	36.0	30.2	8.2	18.4	26.5	24.9	22.7	16.2	15.1	35.1	19.1	17.0	35.4	10.5	22.6	32.9	10.6	6.5	35.8	15.6	29.8	10.9	64.6	59.9	28.1	15.7
MRPL45	MGC11321	ENSG00000278845	"Mitochondrial ribosomal protein L45"		17	38297023-38323218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"AF22: 12.6;Daudi: 30.3;K-562: 18.4;REH: 14.8;RT4: 11.3;U-266/84: 17.5;U-698: 22.4"	"Low region specificity"	"Detected in all"							"HPA023373, HPA023385"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA023373: AB_1854114, HPA023385: AB_1854115"	"unprognostic (8.56e-3)"	"unprognostic (4.09e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (7.21e-2)"	"unprognostic (1.37e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.01e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.13e-2)"	3.1	0.6	1.4	2.6	2.4	1.8	4.9	1.8	6.3	9.6	3.6	1.4	0.7	0.3	10.3	1.1	2.1	0.4	5.8	3.7	1.2		5.9	7.0	2.6	9.6	1.7	1.7	3.9	9.1	0.3	2.4	2.5	2.7	7.7	6.9	1.8	3.8	1.1	11.1	2.4	13.2	1.4	1.8	1.2	1.4	1.7	1.3	1.2	2.6	2.8	10.5	0.9	1.5	6.1	9.3	1.6	5.9	6.9	8.7	4.3	0.0	0.1	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.7	30.3	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	14.8	0.0	11.2	0.0	11.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	6.2	0.0	0.0	0.0	8.8	17.5	22.4	0.0	0.0	0.1	0.4	5.7	1.6	4.7	5.9	5.5	6.1	7.0	3.7	9.3	5.2	8.7	5.3	0.1	6.9	1.2	3.3	5.2	4.3											11.9	8.9	24.2	33.1	26.9	10.5	39.2	33.1	21.4	12.5	24.4	7.9	57.8	51.4	33.7	13.9	22.5	11.9	0.0	32.6	54.7	20.5	25.4	23.1	26.1	37.2	15.9	15.6	16.5	31.0	11.5	19.2	19.8	18.6	45.9	24.4	10.9	32.1	10.5	15.6	50.2	9.8	6.5	28.8	16.4	16.6	28.2	59.5	18.3	41.0	29.2
MRPS36	"DC47, MRP-S36"	ENSG00000134056	"Mitochondrial ribosomal protein S36"	P82909	5	69217760-69230129	"Predicted intracellular proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035802, HPA056795"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA035802: AB_10600933, HPA056795: AB_2683237"	"unprognostic (1.19e-1)"	"unprognostic (6.78e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.99e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.90e-1)"	"prognostic favorable (5.02e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.84e-3)"	13.6	13.7	16.7	9.1	21.4	12.8	13.8	10.4	24.8	8.0	16.8	4.7	12.6	17.1	9.1	11.7	14.4	8.2	10.9	42.8	17.6	13.5	34.8	26.5	17.0	12.2	16.3	14.3	8.8	21.7	11.7	10.4	9.3	17.7	10.8	17.8	6.4	9.6	9.5	29.8	8.1	20.9	13.9	11.4	8.0	13.9	6.8	10.0	10.8	12.7	22.3	11.5	9.9	9.0	27.9	24.4	24.7	27.5	21.5	34.7	14.9	15.0	14.5	10.3	14.1	18.1	18.4	27.1	13.5	13.0	17.4	21.5	20.1	16.9	16.2	28.2	11.4	39.0	15.5	17.1	20.5	17.3	19.0	17.9	11.1	17.2	22.3	21.4	11.7	15.1	19.1	14.7	16.6	7.9	18.2	12.8	16.9	13.0	12.2	15.3	16.3	17.9	18.0	7.6	13.9	17.0	10.6	17.9	24.8	29.9	17.1	14.4	14.0	13.9	20.3	23.4	17.6	15.5	17.1	9.2	7.8	13.3	17.2	23.1	12.9	21.1	21.6	13.6	22.0	10.1	24.4	20.4	24.7	21.4	27.5	23.6	27.9	24.5	23.9	24.4	22.4	22.2	23.4	22.0	21.5	24.7	24.1	34.7	14.9	16.7	21.4	10.4	24.8	17.6	13.5	16.3	14.3	17.7	10.0	107.2	66.5	83.4	83.7	72.4	23.1	309.5	66.2	80.3	67.1	83.7	13.7	104.2	339.8	101.8	99.7	60.0	188.1	70.0	121.7	153.6	58.7	76.5	55.4	177.7	110.9	27.0	89.1	47.3	85.0	30.9	59.8	70.3	101.3	140.7	126.9	34.5	120.5	134.0	65.0	323.7	35.2	71.1	78.8	34.6	32.8	67.1	103.1	62.3	150.9	95.7
MSL1	"DKFZp686P24239, hMSL1, MSL-1"	ENSG00000188895	"Male specific lethal 1 homolog"	Q68DK7	17	40122298-40136916	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 11.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.7"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 95.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022800, HPA023567"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022800: AB_1853057, HPA023567: AB_1853059"	"unprognostic (1.94e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.71e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.46e-1)"	"unprognostic (7.48e-3)"	"prognostic unfavorable (3.06e-6)"	"unprognostic (2.92e-2)"	"unprognostic (7.91e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.61e-2)"	27.2	26.0	31.4	26.6	31.6	29.9	56.5	36.0	45.1	44.6	31.7	25.8	42.7	30.2	39.3	35.1	29.6	38.7	31.9	22.2	31.6	20.3	27.5	21.7	29.3	27.2	31.4	36.7	32.0	28.6	40.5	39.9	28.4	27.2	32.6	28.7	20.3	27.2	32.9	29.2	35.4	28.7	32.5	24.5	43.6	27.0	32.8	33.8	22.1	39.3	23.9	29.4	34.0	52.7	1.7	1.9	11.7	1.3	0.9	2.3	0.8	9.1	10.9	23.5	15.3	21.4	18.6	12.1	16.1	17.2	20.4	18.5	10.9	9.9	20.3	12.4	16.9	13.0	17.1	19.7	10.6	21.1	17.3	15.9	11.2	15.0	12.9	11.2	15.1	21.9	15.5	17.0	15.0	12.5	20.8	18.7	12.4	17.6	16.6	16.2	5.7	24.0	16.8	10.0	10.1	7.2	19.8	13.0	18.3	14.8	10.1	21.8	12.9	15.1	95.0	12.0	22.4	22.2	21.0	15.3	13.8	15.4	10.0	13.5	26.5	14.8	20.3	14.0	11.3	16.0	0.0	1.3	1.0	2.3	0.7	1.2	1.7	1.3	1.8	0.9	1.1	1.3	1.2	11.7	0.9	1.0	1.9	0.8	0.8	31.4	31.6	36.0	45.1	31.6	20.3	31.4	36.7	27.2	33.8	26.8	38.4	15.6	33.7	44.4	55.0	22.6	22.9	26.8	22.7	10.4	11.8	12.6	3.3	16.7	12.4	38.4	28.0	0.0	18.0	11.4	35.5	45.8	3.5	31.4	21.1	49.3	30.0	38.6	33.5	19.8	54.1	27.8	30.4	5.4	31.8	34.6	19.9	23.0	37.4	6.0	28.4	38.8	36.3	69.6	48.1	57.5	14.2	15.2	28.5	42.5
MSN		ENSG00000147065	Moesin	P26038	X	65588377-65741931	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		340000000	"Plasma membrane"		"CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054"	"unprognostic (1.03e-1)"	"unprognostic (7.89e-2)"	"unprognostic (7.64e-2)"	"unprognostic (5.38e-2)"	"unprognostic (4.08e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.60e-5)"	"unprognostic (5.68e-3)"	"unprognostic (7.75e-2)"	"unprognostic (7.21e-2)"	"unprognostic (6.81e-2)"	36.3	17.6	10.2	40.7	14.4	38.5	98.2	8.6	18.6	25.1	21.3	19.2	7.6	6.5	33.4	14.2	15.7	21.8	20.2	53.8	11.5	10.4	25.6	29.5	102.8	85.0	17.5	5.4	28.8	19.4	5.7	10.2	24.2	30.0	23.1	13.0	16.6	16.3	21.9	13.6	19.5	18.3	41.4	21.8	31.6	17.3	9.0	12.9	18.7	26.2	17.6	38.1	22.7	28.9	16.0	36.4	54.1	69.0	28.0	37.1	81.8	28.3	21.7	21.3	17.6	25.6	33.9	0.1	71.8	46.5	39.8	30.9	0.0	5.0	23.7	64.2	63.5	21.1	19.5	22.5	51.2	52.0	44.0	6.2	65.9	37.7	0.0	24.2	80.0	106.7	25.3	11.0	73.2	64.8	38.6	87.9	33.2	31.9	74.1	63.0	0.0	47.3	60.0	26.4	0.0	41.4	24.8	38.3	18.1	42.6	0.0	0.1	0.0	57.7	0.4	22.8	25.1	0.2	43.6	139.1	45.4	28.8	61.0	47.5	26.9	40.7	25.8	33.2	101.6	50.5	30.8	44.4	30.0	37.1	58.9	27.9	16.0	20.4	29.1	36.4	13.9	14.0	21.3	54.1	28.0	69.0	5.2	15.5	81.8	10.2	14.4	8.6	18.6	11.5	10.4	17.5	5.4	30.0	12.9	166.7	148.6	101.2	51.9	182.5	0.5	23.6	10.2	32.1	70.5	64.6	3.9	5.0	24.9	169.4	1.1	154.5	2.6	23.3	146.5	11.7	88.8	25.9	158.4	46.9	150.1	4.8	0.0	91.4	236.8	3.0	68.1	215.1	65.8	158.7	2.3	38.6	229.7	3.1	102.9	81.2	1.8	71.1	127.7	1.9	3.6	130.7	3.5	174.0	1.8	47.2
MSRB1	"SelR, SelX, SepR, SEPX1"	ENSG00000198736	"Methionine sulfoxide reductase B1"	Q9NZV6	16	1938210-1943326	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 195.6;liver: 94.8;pancreas: 107.2"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 236.4;monocytes: 165.9;Proximal tubular cells: 237.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 85.8;neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 195.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008650, HPA043463, HPA069557"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB008650: AB_1619225, HPA043463: AB_2678489, HPA069557: AB_2686153"	"unprognostic (3.93e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.90e-2)"	"unprognostic (5.29e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.46e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.31e-2)"	"unprognostic (4.59e-3)"	7.9	4.0	5.2	9.0	6.3	27.3	5.1	3.2	6.1	5.2	13.1	5.6	7.5	8.7	7.9	13.5	16.9	9.6	13.5	13.7	4.7	4.1	24.9	94.8	9.6	15.6	5.5	4.1	7.3	107.2	2.9	3.9	11.6	4.1	11.0	5.1	6.2	4.7	9.4	20.5	8.0	17.0	14.3	4.3	18.2	9.6	8.1	3.6	3.7	5.5	19.8	4.5	14.8	4.8	1.7	10.9	195.6	26.2	2.4	2.8	12.2	6.8	17.3	6.4	15.2	12.0	5.3	11.0	8.4	10.6	12.3	10.7	27.7	7.5	6.6	27.5	9.7	10.8	11.2	10.7	7.4	3.8	37.0	12.2	5.1	6.4	44.1	11.0	14.4	12.2	9.8	6.5	8.9	1.7	3.9	12.3	8.6	8.0	3.7	6.5	37.5	8.1	23.6	8.8	12.3	9.9	11.8	8.9	31.0	19.2	11.4	6.2	8.2	9.5	10.6	5.1	4.3	11.5	25.5	7.3	3.7	10.4	7.4	4.9	9.8	15.5	12.6	3.9	13.6	6.5	26.0	26.2	85.8	2.2	12.0	2.1	1.7	1.8	1.8	10.9	1.7	1.4	1.6	195.6	2.4	10.7	4.6	2.8	12.2	5.2	6.3	3.2	6.1	4.7	4.1	5.5	4.1	4.1	3.6	8.9	14.9	11.5	10.5	5.8	6.0	32.4	38.2	20.1	3.4	31.4	3.9	30.0	79.6	56.2	3.3	12.0	75.5	23.3	97.0	102.6	13.1	12.7	4.6	236.4	55.0	7.9	57.8	19.0	79.6	10.4	8.6	26.2	15.1	165.9	31.9	17.1	66.7	63.3	21.5	237.9	3.0	0.0	19.8	35.7	9.1	8.3	32.3	20.3	27.8	18.7
MTA1		ENSG00000182979	"Metastasis associated 1"	Q13330	14	105419820-105470729	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004508, HPA005544"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB004508: AB_627969, HPA005544: AB_1079420"	"unprognostic (6.79e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.36e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.72e-3)"	"prognostic favorable (9.48e-5)"	"unprognostic (4.57e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.18e-1)"	23.4	20.1	22.4	24.7	24.3	22.0	22.9	33.8	23.4	17.9	18.9	21.9	22.5	22.3	22.1	21.3	14.9	22.5	20.0	27.7	22.1	17.3	14.8	15.1	20.1	22.3	22.8	18.4	31.4	31.1	15.7	26.5	16.1	19.4	21.9	10.6	22.2	28.7	24.8	29.1	20.0	19.8	27.1	15.0	23.6	18.9	31.4	24.1	27.3	21.1	16.1	16.3	19.3	20.5	1.8	3.7	2.8	0.9	1.8	1.8	0.6	13.3	10.7	19.9	19.8	7.6	13.0	17.6	10.7	8.1	10.6	10.2	13.8	18.1	26.2	11.1	7.8	7.5	18.4	14.4	10.2	7.2	17.1	24.2	13.6	9.7	14.1	16.9	17.1	10.5	14.6	12.9	7.5	17.3	14.8	15.0	19.6	15.4	11.4	5.5	24.0	30.8	33.9	28.7	19.1	22.7	29.1	12.1	8.5	8.4	10.5	32.2	33.5	14.4	16.7	15.3	10.6	15.1	16.3	10.8	8.6	9.1	14.1	11.1	23.4	11.2	16.6	10.7	11.6	14.9	0.5	0.9	2.8	1.4	0.9	1.2	1.5	1.2	1.1	1.1	1.8	1.5	1.8	0.2	1.8	0.5	3.7	0.9	0.6	22.4	24.3	33.8	23.4	22.1	17.3	22.8	18.4	19.4	24.1	3.0	13.6	15.6	26.8	13.9	0.0	8.1	15.3	2.7	7.9	33.2	0.0	10.1	14.9	11.4	24.8	18.0	14.8	23.3	17.3	6.9	18.4	25.2	5.7	11.5	9.4	0.0	17.9	12.9	12.5	9.1	33.4	11.0	11.8	8.2	18.6	0.0	14.9	7.0	30.1	7.7	0.0	19.4	23.4	21.9	11.6	16.7	7.8	15.7	21.8	39.4
MTA2	"MTA1-L1, MTA1L1"	ENSG00000149480	"Metastasis associated 1 family member 2"	O94776	11	62593214-62601840	"Plasma proteins, Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005315, HPA006214, CAB017522, HPA072727"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005315: AB_2146965, CAB017522: AB_831564, HPA006214: AB_1079421, HPA072727: "	"unprognostic (5.97e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.66e-2)"	"prognostic unfavorable (4.82e-5)"	"unprognostic (3.32e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.38e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.16e-3)"	"unprognostic (3.16e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.50e-2)"	26.3	20.4	16.6	28.0	17.9	28.7	20.5	21.6	24.8	23.9	22.0	31.5	15.6	17.1	23.8	16.9	45.1	19.9	23.7	18.8	15.8	12.4	19.0	23.6	21.8	35.5	19.7	12.7	35.0	13.7	22.5	19.8	22.3	20.9	21.9	27.3	21.2	22.3	22.1	12.7	41.1	23.5	25.0	23.8	39.4	19.9	25.7	18.9	64.6	19.3	20.3	49.1	21.7	27.8	12.9	12.0	8.4	13.2	10.4	17.3	4.4	24.8	21.8	34.8	45.5	15.6	14.7	24.0	21.1	29.7	42.4	31.1	20.6	21.8	35.5	22.8	27.7	22.7	33.6	46.9	58.4	36.1	35.1	23.5	37.8	23.6	20.7	24.3	42.6	48.7	16.4	32.9	29.8	44.6	20.2	39.2	37.1	41.7	28.3	30.3	48.3	54.0	54.4	30.0	23.7	25.5	51.9	24.8	41.5	30.0	37.4	27.8	25.5	22.0	31.5	17.8	28.8	36.9	29.3	27.4	23.9	22.0	26.9	24.3	21.2	27.4	50.2	17.4	31.2	23.0	5.6	6.4	8.4	17.3	11.0	14.6	12.9	14.4	12.5	10.2	9.8	13.7	13.5	2.9	10.4	13.2	12.0	11.6	4.4	16.6	17.9	21.6	24.8	15.8	12.4	19.7	12.7	20.9	18.9	3.0	3.8	13.4	3.6	11.8	0.0	3.4	2.5	0.0	5.7	1.8	0.0	11.3	5.0	4.9	0.4	6.2	7.9	23.3	8.1	8.8	6.6	3.3	10.4	8.2	7.3	0.0	11.5	14.1	16.4	0.4	4.6	5.3	1.7	7.2	10.5	0.0	6.9	5.8	3.9	2.1	0.0	0.0	5.7	5.1	5.3	9.8	15.8	7.5	11.5	3.9
MTDH	"3D3, AEG-1, LYRIC"	ENSG00000147649	Metadherin	Q86UE4	8	97644179-97728770	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010932, HPA015104, CAB068204, CAB068205"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB068204: AB_2665655, CAB068205: AB_2665654, HPA010932: AB_1079422, HPA015104: AB_1854173"	"unprognostic (1.01e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.05e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.25e-1)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.84e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.40e-1)"	26.5	28.5	17.2	28.3	21.9	44.5	29.0	21.8	20.2	27.5	24.9	20.7	24.7	23.2	31.6	28.6	27.6	23.6	23.5	23.6	18.7	16.6	24.3	97.8	21.9	31.4	26.5	19.6	26.7	22.7	27.1	18.0	13.4	23.0	24.0	22.8	16.4	22.3	21.2	49.8	19.5	32.7	29.5	34.6	35.8	21.8	19.0	24.8	40.0	30.5	22.7	27.5	27.5	35.7	26.2	42.4	17.4	26.6	19.2	20.9	10.1	38.8	20.2	13.2	18.1	22.0	23.3	6.5	35.0	29.8	22.4	17.4	11.9	29.1	36.0	39.5	34.3	24.8	25.9	32.0	24.3	31.4	38.3	16.8	66.1	21.9	14.1	26.7	34.6	30.8	17.8	24.5	27.1	61.8	21.2	25.7	26.6	43.1	64.0	23.7	16.1	58.3	9.6	8.1	34.0	24.6	38.2	15.7	52.3	14.6	22.4	20.0	15.0	24.8	21.9	27.4	13.3	33.4	22.2	26.7	31.8	11.4	29.2	25.8	35.7	38.9	36.5	29.2	40.7	27.7	17.4	26.6	13.4	14.2	17.8	20.1	26.2	20.4	20.9	32.6	18.6	20.8	18.4	3.8	19.2	19.5	42.4	11.7	10.1	17.2	21.9	21.8	20.2	18.7	16.6	26.5	19.6	23.0	24.8	119.1	103.5	196.6	171.8	232.4	0.0	87.6	201.2	52.2	100.1	134.3	0.0	9.1	21.6	197.1	211.2	149.0	122.0	46.7	201.2	89.0	152.1	236.8	136.0	389.3	243.9	0.0	116.8	148.0	225.6	132.2	180.9	250.7	175.5	149.7	148.0	0.0	214.1	126.3	203.3	76.1	0.0	219.9	203.9	116.5	108.0	275.1	11.4	146.0	177.0	291.2
MTF2	"M96, PCL2, TDRD19A"	ENSG00000143033	"Metal response element binding transcription factor 2"	Q9Y483	1	93079235-93139081	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 43.4"	"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 122.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069047, HPA069066"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA069047: AB_2686073, HPA069066: AB_2686078"	"unprognostic (1.84e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.56e-2)"	"unprognostic (7.88e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.26e-3)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (1.26e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (1.05e-4)"	"prognostic unfavorable (2.47e-7)"	"unprognostic (7.19e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.26e-2)"	6.8	8.0	8.5	19.7	18.4	21.9	10.3	24.3	12.2	9.8	8.0	8.6	4.9	8.0	9.0	8.5	7.2	7.6	7.4	5.3	9.0	8.2	7.6	7.3	8.6	19.9	8.1	9.8	12.0	7.0	6.7	13.9	13.0	9.2	7.0	8.4	6.7	6.7	6.8	7.1	8.1	9.5	6.8	8.5	12.7	7.2	17.3	9.2	43.4	9.6	7.1	19.4	7.9	8.3	11.7	12.0	14.7	10.6	13.0	14.3	6.2	7.4	3.6	12.5	8.2	2.2	2.1	14.5	4.8	3.8	8.3	10.4	6.1	4.1	24.1	8.8	3.0	7.1	4.0	11.5	5.0	12.3	9.3	8.4	16.6	5.5	8.2	3.3	21.6	7.1	2.6	2.7	7.8	4.7	3.8	7.9	18.8	18.7	7.6	5.1	3.1	31.0	18.0	21.3	3.3	4.8	25.2	15.4	6.5	7.7	8.1	7.8	9.5	7.9	9.4	9.6	13.8	5.6	15.3	4.5	5.5	8.2	5.2	7.1	5.9	6.7	42.8	1.1	12.9	3.5	9.4	9.4	14.7	11.3	10.6	12.9	10.0	11.7	14.3	12.0	11.7	13.9	12.4	7.2	13.0	6.3	11.4	12.9	6.2	8.5	18.4	24.3	12.2	9.0	8.2	8.1	9.8	9.2	9.2	26.8	27.2	56.4	25.5	41.3	0.0	11.7	7.6	17.4	28.4	36.6	0.0	60.2	6.6	29.9	3.7	39.3	25.4	23.3	16.9	56.8	29.0	28.2	57.8	13.4	30.0	0.0	30.9	35.0	26.7	5.0	30.2	40.6	16.9	42.3	29.2	0.0	27.2	31.6	22.3	12.9	0.0	38.8	23.6	122.6	74.3	37.8	50.8	48.4	30.8	32.0
MTFR1	"CHPPR, FAM54A2, KIAA0009"	ENSG00000066855	"Mitochondrial fission regulator 1"	Q15390	8	65644734-65771261	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 350.9;Late spermatids: 606.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 47.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA023152, HPA056120"	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA023152: AB_1854176, HPA056120: AB_2683043"	"prognostic unfavorable (4.06e-4)"	"unprognostic (4.58e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.56e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.53e-1)"	"unprognostic (5.69e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (8.25e-2)"	10.7	17.7	6.6	5.5	11.7	3.9	9.5	10.1	8.8	9.7	10.7	10.8	14.2	11.1	9.9	11.9	12.3	7.2	6.2	8.7	6.8	5.5	28.4	37.7	7.1	3.9	10.3	5.4	7.9	19.1	8.0	15.0	16.2	9.7	8.1	11.2	14.8	11.0	11.5	11.7	8.3	16.2	8.8	11.3	6.5	13.2	16.8	11.7	5.4	13.0	11.2	9.3	10.5	9.7	1.7	3.1	4.3	2.8	0.8	2.9	1.7	14.1	10.6	8.4	9.8	11.7	11.5	6.8	9.3	8.6	11.6	12.3	9.0	14.8	7.9	3.0	9.0	11.3	9.3	19.1	12.7	15.7	2.8	10.3	9.8	7.8	18.1	14.6	2.5	4.8	7.8	13.7	14.9	47.7	6.6	14.1	5.8	13.3	8.2	13.4	12.7	8.6	6.0	8.9	31.3	9.5	4.4	11.6	6.6	14.3	12.8	3.8	5.6	9.3	15.9	12.4	9.0	17.6	5.6	10.6	7.1	9.8	16.7	8.1	8.0	5.2	5.8	8.6	10.4	9.3	4.3	2.8	1.2	2.0	2.5	2.9	1.7	2.6	2.2	3.1	1.4	2.6	2.9	0.7	0.8	1.2	1.9	2.5	1.7	6.6	11.7	10.1	8.8	6.8	5.5	10.3	5.4	9.7	11.7	17.9	6.0	12.0	9.6	14.9	0.0	6.4	12.7	10.7	3.4	10.4	0.0	20.7	48.0	16.4	350.9	6.4	10.7	23.3	21.3	22.9	9.7	11.6	4.7	33.1	8.6	0.0	4.6	8.6	5.4	606.6	15.5	6.1	13.5	2.8	11.8	0.0	17.5	7.0	11.3	91.0	0.0	6.5	16.5	66.0	16.8	16.9	32.7	5.0	14.1	15.2
MTHFD1	"MTHFC, MTHFD"	ENSG00000100714	"Methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1"	P11586	14	64388031-64463457	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid biosynthesis, Histidine biosynthesis, Methionine biosynthesis, One-carbon metabolism, Purine biosynthesis"	"Hydrolase, Ligase, Multifunctional enzyme, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 121.6"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 125.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000704, HPA001290, HPA015006, HPA050052"	Approved		Enhanced	Cytosol		NA	Yes		250000	Cytosol		"HPA000704: AB_1079424, HPA001290: AB_1854177, HPA015006: AB_1854178, HPA050052: AB_2680998"	"unprognostic (3.58e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.85e-3)"	"unprognostic (7.62e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.29e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.84e-1)"	"prognostic favorable (5.93e-5)"	"unprognostic (2.45e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.29e-2)"	18.9	9.0	8.1	8.4	18.1	9.7	12.2	5.7	15.9	7.1	9.3	9.0	4.0	7.5	8.5	6.9	12.0	6.7	6.4	10.6	8.4	6.5	20.5	121.6	6.8	9.2	8.0	10.4	10.1	13.4	13.1	5.6	5.6	10.0	5.5	11.4	9.3	11.6	5.6	26.5	7.6	7.3	8.8	6.9	8.3	7.9	2.3	7.4	15.6	8.6	14.0	12.5	8.7	7.3	21.1	12.8	0.5	13.2	12.8	14.9	8.4	72.5	41.3	15.7	34.2	16.9	13.8	25.5	28.5	19.6	37.0	36.7	40.1	33.4	30.5	13.5	16.9	18.6	35.7	48.4	28.3	43.3	30.3	31.9	37.8	41.4	30.4	12.5	29.0	20.6	10.7	9.2	33.0	17.9	15.3	23.0	30.9	28.1	25.1	28.0	60.2	46.7	17.0	28.7	46.2	43.8	37.3	54.6	27.6	27.8	42.5	34.0	13.2	47.6	25.9	14.3	15.3	40.3	14.7	14.1	27.9	48.4	25.7	34.1	16.8	20.6	53.8	25.6	33.5	31.6	0.2	8.2	0.1	8.1	13.2	10.9	21.1	9.0	9.9	12.8	11.6	7.6	10.1	0.5	12.8	10.3	3.2	14.9	8.4	8.1	18.1	5.7	15.9	8.4	6.5	8.0	10.4	10.0	7.4	17.9	26.3	11.5	9.9	12.2	0.0	38.1	17.8	12.0	20.5	15.7	0.0	20.0	34.9	15.4	0.9	9.9	5.2	0.0	9.0	24.2	10.6	8.3	49.7	125.3	21.6	0.0	2.9	7.4	11.3	0.9	12.0	10.9	13.5	14.4	11.9	0.0	10.8	2.9	12.4	49.9	0.0	19.4	18.6	0.9	7.5	9.4	8.2	20.0	21.3	9.9
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865549-151101887	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 107.1;Syncytiotrophoblasts: 61.6;Urothelial cells: 39.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	10.4	10.6	8.0	12.1	8.1	12.2	7.1	32.4	10.5	6.5	6.2	7.8	10.2	3.4	8.5	7.2	6.4	8.0	7.3	10.7	7.5	7.9	9.5	6.9	17.1	11.0	12.3	7.6	22.2	13.7	7.1	9.1	15.5	8.5	5.0	9.1	12.7	3.4	10.5	2.5	5.7	4.7	10.9	10.2	8.7	5.6	13.6	6.6	6.7	12.2	5.0	11.4	8.7	5.1	1.1	3.0	0.2	0.8	1.0	5.0	0.6	12.0	10.5	13.7	33.7	3.6	12.6	33.5	19.0	20.8	19.1	23.6	21.1	11.3	44.5	12.7	29.0	11.3	12.9	21.9	18.5	23.8	18.3	19.9	18.5	18.7	19.3	22.6	33.8	3.0	14.9	23.7	18.5	33.8	17.2	31.9	24.9	43.9	23.3	19.6	25.4	16.5	7.0	14.0	12.1	9.7	19.8	10.2	19.8	12.9	5.9	13.7	10.2	25.1	11.1	15.5	13.0	3.5	23.7	24.2	12.8	28.1	28.4	26.9	19.4	18.0	46.4	21.3	31.6	16.5	0.2	0.7	0.0	0.8	0.8	1.3	0.8	1.9	2.1	3.0	1.1	1.8	1.9	0.0	1.0	0.8	1.5	5.0	0.6	8.0	8.1	32.4	9.5	7.5	7.9	12.3	7.6	8.5	6.6	0.0	1.7	10.7	5.1	5.8	0.0	2.4	2.5	4.0	2.3	14.0	0.0	18.7	6.6	10.4	19.2	7.1	0.9	0.0	15.4	107.1	15.4	4.1	0.0	1.0	21.7	0.0	1.2	3.7	2.4	3.4	0.6	10.1	33.7	1.0	2.5	0.0	15.0	0.8	7.4	12.2	0.0	0.0	6.1	0.5	6.4	3.0	61.6	3.2	3.5	39.1
MTIF2	IF-2mt	ENSG00000085760	"Mitochondrial translational initiation factor 2"	P46199	2	55236595-55269347	"Predicted intracellular proteins"	"Protein biosynthesis"	"Initiation factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006021, HPA061422"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA006021: AB_2147687, HPA061422: AB_2684514"	"unprognostic (2.91e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.87e-3)"	"unprognostic (8.86e-2)"	"unprognostic (5.57e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.85e-3)"	"unprognostic (3.01e-2)"	"unprognostic (6.58e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-3)"	"unprognostic (1.33e-1)"	13.8	17.8	13.6	12.0	15.8	9.6	15.5	9.4	17.7	12.0	21.1	11.2	17.7	21.0	10.0	15.9	17.5	10.6	11.2	24.5	13.5	12.1	27.4	32.2	10.6	17.5	15.5	11.8	10.4	24.6	20.2	20.2	12.5	22.6	12.2	25.1	9.7	16.3	14.3	31.5	12.3	26.9	15.0	16.9	16.3	16.3	9.0	14.6	16.1	20.6	27.1	15.2	14.5	11.6	9.6	13.9	9.4	12.8	17.2	12.7	6.9	15.5	15.1	8.9	15.3	11.1	15.2	20.5	14.3	11.5	13.8	12.1	17.9	15.1	25.6	27.2	13.1	15.5	13.9	21.2	20.6	22.9	28.4	16.3	23.6	11.8	33.0	21.2	37.1	14.0	16.7	21.4	19.1	40.0	12.3	11.0	14.4	41.7	14.7	14.3	12.9	11.4	25.0	19.0	19.5	18.6	12.1	28.7	24.7	13.4	13.8	16.1	10.2	12.7	21.1	25.8	11.4	11.2	12.4	10.9	14.5	16.6	17.2	23.4	27.6	24.6	7.0	15.3	27.8	11.4	5.4	11.0	9.4	10.1	12.8	12.6	8.3	10.3	9.4	13.9	9.6	12.5	12.7	4.2	17.2	10.7	6.8	11.7	6.9	13.6	15.8	9.4	17.7	13.5	12.1	15.5	11.8	22.6	14.6	20.8	20.5	13.7	15.4	6.8	0.0	72.4	30.6	30.8	15.9	7.0	0.0	25.4	24.9	27.1	13.6	7.9	20.9	0.0	29.3	25.7	10.8	11.5	20.8	25.5	21.3	0.0	18.5	9.2	18.0	14.8	8.3	15.7	8.5	36.1	15.7	0.0	26.3	17.5	9.9	20.7	0.0	6.5	11.7	27.4	16.2	6.5	13.6	8.3	32.1	12.4
MTUS1	"ATBP, ATIP1, ATIP3, DKFZp586D1519, FLJ14295, ICIS, KIAA1288, MP44, MTSG1"	ENSG00000129422	"Microtubule associated scaffold protein 1"	Q9ULD2	8	17643795-17800917	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 229.1;Endothelial cells: 164.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.2;naive CD4 T-cell: 4.8;naive CD8 T-cell: 3.6"	"Lineage enriched"	"Detected in single"	21	"T-cells: 4.8"	"Cell line enhanced"	"Detected in many"		"A549: 29.7;AN3-CA: 26.1;HUVEC TERT2: 77.2;SK-MEL-30: 21.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067903, HPA069795"			Enhanced	Nucleoli,Microtubules		No	No			"Nucleoli, Microtubules"		"HPA067903: AB_2685921, HPA069795: AB_2686198"	"unprognostic (3.20e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (1.05e-4)"	"unprognostic (2.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.73e-2)"	"unprognostic (7.93e-3)"	"unprognostic (3.33e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (2.04e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.53e-3)"	"unprognostic (2.43e-1)"	45.0	20.8	20.9	6.8	38.2	0.4	21.8	51.0	27.7	19.8	19.0	56.5	9.9	16.9	16.9	12.6	20.3	12.8	20.0	44.3	27.4	17.3	14.4	29.3	20.9	4.4	34.7	18.0	28.2	47.1	43.8	15.0	36.1	33.7	17.5	21.1	10.3	24.3	14.0	49.7	12.2	17.4	20.5	48.3	8.2	21.4	6.5	49.3	0.7	15.7	10.9	7.5	21.4	26.7	0.2	0.0	0.0	0.0	0.0	4.8	1.0	5.5	29.7	4.8	26.1	0.0	0.1	8.8	0.2	2.0	0.1	0.6	2.2	2.0	0.7	2.2	0.0	1.2	5.7	8.0	2.8	0.2	3.9	3.4	0.0	5.1	14.1	1.7	0.0	0.1	2.4	4.3	0.6	8.8	0.0	77.2	2.0	0.0	11.3	0.0	1.4	1.0	1.4	6.9	11.2	0.7	0.0	4.4	2.9	1.5	11.4	2.4	0.6	3.8	6.9	21.9	3.0	5.0	0.0	15.7	0.0	6.5	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.0	0.2	4.8	3.6	0.0	0.0	0.0	0.0	0.0	1.0	20.9	38.2	51.0	27.7	27.4	17.3	34.7	18.0	33.7	49.3	65.5	229.1	0.8	50.7	18.7	0.0	122.8	56.0	50.9	106.9	19.2	0.0	16.2	10.0	33.7	16.9	164.1	52.5	0.0	150.0	30.8	30.4	68.9	9.2	60.6	44.7	0.0	14.5	20.9	3.7	19.2	70.8	10.5	27.0	4.6	40.5	0.0	66.3	14.0	53.7	8.9	0.0	19.4	41.9	1.7	5.1	17.8	45.2	4.4	32.2	49.8
MXRA7	"FLJ46603, PS1TP1, TMAP1"	ENSG00000182534	"Matrix remodeling associated 7"	P84157	17	76672551-76711016	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 140.1;Muller glia cells: 291.2;Peritubular cells: 134.7;Rod photoreceptor cells: 125.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 93.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044819, HPA075316"	Uncertain		Enhanced	"Endoplasmic reticulum"	"Secreted - unknown location"	NA	NA			"Endoplasmic reticulum"		"HPA044819: AB_10964134, HPA075316: "	"unprognostic (1.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.07e-2)"	"unprognostic (8.33e-2)"	"unprognostic (5.39e-3)"	"unprognostic (4.67e-3)"	"unprognostic (6.21e-2)"	"unprognostic (4.63e-3)"	"prognostic unfavorable (1.80e-5)"	28.4	46.7	14.7	18.2	43.2	1.8	32.4	15.6	30.5	31.0	44.0	14.6	16.9	6.6	44.5	40.4	33.2	28.0	28.1	93.3	15.1	13.1	14.1	5.1	24.7	13.3	16.2	16.3	36.1	16.4	40.1	7.8	21.1	20.6	32.8	14.5	41.9	15.0	61.7	13.9	10.8	13.3	59.9	15.8	31.4	21.9	20.7	10.0	6.4	51.0	9.3	6.6	44.7	31.4	2.9	3.6	1.9	3.9	7.8	7.0	4.0	2.5	7.6	11.4	21.5	60.5	55.4	5.7	36.1	29.3	26.4	25.8	10.2	0.4	0.0	16.4	49.9	27.6	10.3	12.7	20.0	43.2	0.1	12.6	6.5	5.7	16.9	37.0	3.0	0.8	34.4	23.9	30.6	25.2	59.4	38.8	1.6	4.6	0.1	60.8	0.7	0.3	2.1	3.6	4.0	21.6	5.7	44.9	2.1	21.2	0.6	4.0	29.1	10.7	0.1	20.6	34.0	7.1	3.9	47.5	59.7	12.7	24.3	37.9	3.4	0.6	0.1	93.7	1.3	8.6	1.5	3.9	0.8	6.3	1.2	4.8	2.9	3.5	7.0	3.1	0.7	2.3	4.9	1.9	7.8	0.4	3.6	0.8	4.0	14.7	43.2	15.6	30.5	15.1	13.1	16.2	16.3	20.6	10.0	14.9	10.5	2.9	23.3	9.2	140.1	103.5	2.5	9.4	11.4	29.6	90.3	1.0	1.7	20.9	3.3	36.2	0.9	0.0	3.6	4.2	41.8	16.2	2.3	3.2	2.8	104.9	6.4	54.0	5.6	6.6	93.7	2.2	13.5	1.8	5.6	291.2	7.9	0.0	134.7	5.8	125.1	12.9	36.0	1.2	12.1	7.8	0.7	9.6	1.2	18.1
MYC	"bHLHe39, c-Myc, MYCC"	ENSG00000136997	"MYC proto-oncogene, bHLH transcription factor"	P01106	8	127735434-127741434	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 812.6;Basal keratinocytes: 900.0;Smooth muscle cells: 529.5;Suprabasal keratinocytes: 935.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 132.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000084, CAB010307, HPA055893, HPA066556"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000084: , CAB010307: AB_631274, HPA055893: AB_2682960, HPA066556: AB_2685691"	"unprognostic (1.45e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.94e-3)"	"unprognostic (2.41e-3)"	"unprognostic (8.14e-2)"	"unprognostic (3.36e-3)"	"unprognostic (5.80e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.19e-3)"	"unprognostic (9.86e-3)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (7.85e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (4.96e-5)"	67.4	20.8	3.2	46.6	7.1	16.3	36.0	1.2	5.0	23.9	23.3	3.8	11.8	11.1	23.8	14.4	47.6	59.5	32.4	23.7	5.8	2.2	11.2	36.6	16.0	40.5	5.8	1.2	38.7	64.6	2.1	7.4	14.9	9.8	20.6	11.3	6.1	14.4	21.8	69.6	78.5	17.2	21.3	12.0	38.3	24.7	16.3	3.8	40.2	9.0	48.4	27.1	28.9	37.3	25.5	8.8	1.0	10.3	20.9	55.2	22.0	7.2	14.0	1.2	12.5	20.4	24.1	3.7	8.7	3.8	10.9	9.1	19.2	19.1	74.3	12.3	5.2	10.7	15.8	65.1	28.3	7.2	17.5	22.7	44.7	23.8	25.0	18.8	31.2	7.2	16.8	62.6	7.3	58.0	8.8	12.5	26.2	66.0	39.3	5.4	20.8	51.0	68.1	3.5	31.3	28.1	28.4	5.3	132.1	9.1	7.5	86.4	8.2	4.0	34.1	22.6	2.1	13.9	20.5	15.2	8.2	9.8	6.3	10.9	0.7	1.2	35.9	7.2	35.0	4.1	0.7	10.3	0.1	8.6	9.1	43.4	25.5	31.1	18.6	8.8	20.6	55.2	34.8	1.0	20.9	6.1	0.3	24.8	22.0	3.2	7.1	1.2	3.6	5.8	2.2	5.8	1.2	9.8	3.8	53.6	68.5	50.1	812.6	900.0	0.0	10.2	28.1	18.7	83.0	12.2	0.0	20.0	1.7	71.3	0.9	89.5	6.3	0.0	37.0	51.5	149.4	176.0	54.4	27.1	25.9	0.0	12.0	96.3	42.9	1.1	91.5	19.1	160.3	3.6	66.1	1.0	60.5	11.5	63.3	5.3	0.2	45.3	529.5	0.5	0.7	935.3	4.9	39.5	82.4	301.8
MYCL	"bHLHe38, LMYC, MYCL1"	ENSG00000116990	"MYCL proto-oncogene, bHLH transcription factor"	P12524	1	39895426-39902256	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 46.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 21.7;Hepatocytes: 21.9;Mucus-secreting cells: 22.7;Urothelial cells: 22.1"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 28.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"classical monocyte: 11.5;intermediate monocyte: 5.5;myeloid DC: 12.9;plasmacytoid DC: 15.4"	"Group enriched"	"Detected in many"	75	"dendritic cells: 15.4;monocytes: 11.5"	"Group enriched"	"Detected in some"	7	"U-266/70: 96.4;U-266/84: 70.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA063132, HPA074515"			Enhanced	"Nucleoplasm,Mitotic chromosome"		NA	NA			Nucleoplasm	"Mitotic chromosome"	"HPA063132: AB_2684946, HPA074515: "	"unprognostic (7.45e-2)"	"unprognostic (6.91e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.83e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.92e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.01e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.53e-2)"	"unprognostic (5.80e-2)"	0.3	0.3	1.2	4.4	2.1	0.1	1.7	0.8	1.7	3.6	7.5	1.8	8.5	2.6	1.0	4.0	17.8	1.6	2.3	0.7	1.1	0.9	0.8	6.4	1.9	2.9	0.6	1.4	0.5	46.4	0.0	2.1	11.2	1.8	5.3	3.6	1.8	4.6	16.6	0.6	26.0	7.3	1.2	1.1	4.0	3.3	1.5	0.6	6.4	4.2	3.1	6.0	18.4	7.3	0.0	15.4	0.1	11.5	0.0	0.1	3.8	0.2	0.0	2.9	0.7	0.0	0.0	7.1	0.1	0.0	0.2	0.1	0.1	0.1	0.4	0.3	0.0	0.0	0.7	2.0	0.5	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	1.7	0.2	2.4	0.0	0.2	0.0	0.2	1.1	0.7	0.0	0.1	0.2	0.0	0.0	2.8	0.4	0.1	0.2	3.4	0.6	0.2	11.6	0.5	0.7	0.2	0.4	0.1	1.1	0.7	3.7	0.0	0.0	1.1	1.3	0.1	96.4	70.7	0.2	0.0	0.4	0.0	0.0	11.5	0.0	0.0	5.5	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.0	0.1	0.0	2.3	15.4	0.0	3.8	1.2	2.1	0.8	1.7	1.1	0.9	0.6	1.4	1.8	0.6	0.0	0.6	0.0	9.0	6.0	0.2	3.3	0.0	1.4	4.5	8.7	0.0	21.7	0.0	1.1	0.1	0.5	9.5	0.0	5.1	11.3	0.7	4.8	0.0	21.9	4.9	0.0	16.6	2.5	6.9	0.2	0.0	9.6	1.7	0.0	22.7	1.1	2.4	8.5	0.0	0.0	0.0	0.0	0.3	0.0	0.7	10.3	14.6	0.0	10.5	22.1
MYH10	NMMHCB	ENSG00000133026	"Myosin heavy chain 10"	P35580	17	8474205-8630761	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell shape"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 96.0;Cytotrophoblasts: 123.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 56.0"	"Low region specificity"	"Detected in all"							"CAB017180, HPA047541, HPA057198"	Enhanced		Supported	"Actin filaments,Mitochondria,Cytosol"		NA	NA		130000000	"Actin filaments"	"Mitochondria, Cytosol"	"CAB017180: , HPA047541: AB_2680081, HPA057198: AB_2683364"	"unprognostic (4.67e-2)"	"unprognostic (9.64e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.45e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.39e-3)"	"unprognostic (1.69e-2)"	"prognostic favorable (1.38e-4)"	"unprognostic (2.02e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.58e-2)"	"prognostic unfavorable (6.42e-4)"	18.3	12.3	12.6	5.4	24.7	7.9	9.6	15.6	30.8	16.9	7.3	5.4	5.3	1.9	19.9	12.4	5.0	18.0	18.2	25.7	15.1	12.9	23.7	13.0	40.0	4.2	9.5	16.7	21.8	6.9	14.7	18.4	35.9	19.2	12.9	3.1	8.6	4.7	19.6	3.3	5.1	3.9	15.7	4.9	3.3	7.1	5.3	5.9	2.7	9.7	2.6	3.0	9.8	7.4	0.5	0.2	2.8	0.1	0.0	1.1	0.2	13.3	8.8	56.0	18.7	7.3	8.8	25.2	11.2	10.1	13.6	14.6	23.7	2.0	0.1	7.4	11.0	7.4	1.3	27.8	13.4	15.2	0.3	22.6	15.5	5.7	20.6	17.2	1.3	1.0	12.5	4.9	17.5	6.8	8.4	21.8	18.1	21.5	0.0	8.4	5.3	16.4	0.4	26.3	0.9	1.9	26.3	16.6	0.0	15.4	5.6	4.6	25.2	17.5	0.8	17.9	44.9	4.7	0.9	0.7	12.8	9.4	0.0	9.6	2.1	2.6	3.4	0.0	1.2	28.6	0.0	0.1	0.1	0.3	0.0	0.3	0.5	0.3	0.6	0.0	0.2	1.1	0.5	2.8	0.0	0.0	0.2	0.3	0.2	12.6	24.7	15.6	30.8	15.1	12.9	9.5	16.7	19.2	5.9	20.8	13.1	0.5	8.0	4.1	35.4	26.9	7.6	26.8	14.8	96.0	47.1	123.2	14.9	10.8	44.7	37.5	0.0	23.3	1.6	73.0	63.0	8.6	1.1	13.1	13.8	33.4	2.4	60.2	3.8	18.2	3.4	1.4	1.7	1.0	1.4	23.8	2.7	0.0	37.4	12.9	34.3	0.0	10.8	8.2	29.6	3.4	64.0	2.2	1.7	3.1
MYH11	"SMHC, SMMHC"	ENSG00000133392	"Myosin heavy chain 11"	P35749	16	15703172-15857033	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin"	"Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 507.4;urinary bladder: 394.5"	"Group enriched"	"Detected in many"	29	"Peritubular cells: 1569.5;Sertoli cells: 614.4;Smooth muscle cells: 1327.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 173.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;NB-4: 3.9;U-698: 9.9"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 54.5"	"CAB002302, HPA014539, HPA015310"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		130000000	"Plasma membrane, Cytosol"		"CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.21e-3)"	"unprognostic (6.70e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (1.10e-5)"	"unprognostic (1.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-3)"	"unprognostic (4.06e-2)"	"unprognostic (9.53e-2)"	"unprognostic (5.00e-2)"	"unprognostic (5.45e-3)"	13.2	3.0	0.6	31.5	1.2	0.0	5.9	0.5	1.7	90.3	227.5	1.3	100.0	11.6	102.0	38.4	233.0	43.8	94.3	6.2	0.6	0.7	4.7	0.7	8.5	1.5	1.4	2.6	45.5	1.3	0.0	1.0	5.3	3.6	164.7	22.2	37.0	8.8	127.2	6.4	5.0	50.6	507.4	1.4	3.7	77.7	22.3	0.2	0.1	3.7	6.2	3.0	394.5	57.5	1.5	0.9	6.0	0.9	1.1	1.5	0.4	0.1	0.4	0.2	0.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.2	0.6	0.0	0.0	0.0	0.4	0.4	0.2	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	1.5	0.0	0.3	0.3	3.9	0.4	0.1	0.1	0.4	0.2	1.9	0.0	0.2	0.7	1.4	0.2	0.5	1.2	0.2	0.5	0.0	0.3	0.1	0.3	2.0	0.1	0.5	0.4	9.9	0.4	0.4	0.4	3.1	0.9	2.7	1.2	0.6	1.2	1.5	1.5	1.4	0.5	1.2	1.4	1.4	6.0	1.1	0.6	0.9	1.4	0.4	0.6	1.2	0.5	1.7	0.6	0.7	1.4	2.6	3.6	0.2	0.0	2.6	4.5	1.6	11.7	1.5	38.7	0.0	1.4	2.3	0.0	7.9	0.2	0.0	0.0	36.6	5.7	0.0	0.0	0.3	0.2	8.0	5.1	0.0	0.0	1.1	0.0	1.2	4.3	0.0	30.8	39.7	3.8	11.8	2.8	0.3	0.3	0.2	0.0	1569.5	0.0	1.6	614.4	1327.8	3.2	7.5	16.3	0.0	4.9	0.4	2.5
MYLK	"MLCK, MLCK1, MYLK1, smMLCK"	ENSG00000065534	"Myosin light chain kinase"	Q15746	3	123610049-123884331	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Aortic aneurysm, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 191.1"	"Cell type enhanced"	"Detected in many"	16	"Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7"	"Group enriched"	"Detected in many"	13	"dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3"	"Cell line enhanced"	"Detected in many"		"BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB020789, HPA031677, HPA048055"	Enhanced		Enhanced	"Plasma membrane,Actin filaments"		NA	NA		3000000	"Actin filaments"	"Plasma membrane"	"CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543"	"unprognostic (2.80e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.86e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.40e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (5.26e-3)"	"unprognostic (9.60e-2)"	"unprognostic (3.00e-1)"	"prognostic unfavorable (4.46e-4)"	14.9	4.9	4.5	19.8	10.9	0.0	14.4	0.8	5.8	77.1	107.3	22.0	93.2	9.4	111.2	48.3	96.0	56.3	40.6	6.6	4.7	3.2	8.3	5.4	13.2	6.5	25.8	2.8	50.2	1.6	0.5	1.1	8.0	16.0	85.1	27.6	6.0	17.6	158.6	1.6	4.8	33.3	191.1	28.8	7.4	38.7	17.4	13.0	0.2	4.1	2.5	3.4	137.1	21.3	0.2	2.8	4.5	1.3	0.0	0.2	17.3	2.5	7.7	2.0	1.3	2.1	0.4	0.9	36.4	55.1	23.6	16.9	1.6	1.4	0.1	8.2	45.0	11.2	0.9	0.9	0.3	29.0	0.0	0.1	20.3	0.2	5.0	10.9	0.1	1.9	6.8	0.7	4.6	6.9	38.5	1.8	0.2	0.2	0.1	17.4	0.3	0.0	0.5	2.2	0.1	1.0	2.3	1.2	6.6	59.6	1.4	0.3	1.1	3.7	0.4	0.6	5.0	0.2	0.0	6.7	7.2	2.6	1.7	5.9	0.6	0.7	0.0	18.5	0.2	1.8	3.6	1.3	0.3	0.1	0.2	0.0	0.2	0.0	0.0	2.8	0.1	0.2	0.1	4.5	0.0	0.0	2.7	0.1	17.3	4.5	10.9	0.8	5.8	4.7	3.2	25.8	2.8	16.0	13.0	14.9	34.7	2.9	24.1	18.2	2.5	16.5	33.1	5.3	6.8	26.2	117.8	0.6	3.3	4.5	38.5	34.3	13.8	0.0	3.6	0.6	23.4	4.9	2.3	169.4	4.0	3.2	10.9	66.9	9.2	26.0	97.0	8.0	18.6	0.0	3.0	4.8	2.7	24.0	649.2	9.6	18.7	271.7	829.4	3.0	3.3	17.7	2.1	0.5	3.7	1.6
MYO19	"FLJ22865, MYOHD1"	ENSG00000278259	"Myosin XIX"	Q96H55	17	36495633-36543435	"Predicted intracellular proteins"		"Actin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 50.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021415, HPA059715"	Approved		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA021415: AB_2266815, HPA059715: AB_2684111"	"unprognostic (3.12e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (8.33e-6)"	"unprognostic (1.07e-3)"	"unprognostic (1.39e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.17e-2)"	5.2	1.9	3.1	5.4	6.2	7.8	4.7	2.7	6.5	4.7	7.7	7.0	6.8	7.5	4.3	4.1	9.8	3.4	4.1	1.4	4.7		5.7	7.0	3.8	5.2	6.1	3.1	2.9	5.8	9.8	7.2	8.1	5.0	2.8	11.2	4.8	9.5	9.3	6.3	13.1	7.9	5.2	5.4	3.0	8.3	8.0	5.7	5.8	4.2	5.6	7.2	3.3	2.8	2.2	3.4	1.7	1.7	3.7	3.9	1.4	14.0	17.2	8.2	9.4	4.5	4.5	10.0	14.0	11.2	22.3	22.8	17.0	14.7	8.8	5.5	9.5	7.6	21.2	19.4	14.6	15.9	6.3	13.2	14.1	18.8	10.7	3.0	13.6	15.3	4.3	7.3	15.9	17.4	5.3	9.9	10.7	16.5	9.3	11.3	10.6	9.5	11.1	9.1	15.2	10.2	11.1	13.2	10.5	10.4	11.4	14.1	8.8	18.6	11.4	5.9	12.4	18.7	5.6	6.4	12.5	14.2	17.0	24.6	7.2	14.1	8.1	7.8	8.4	14.6	1.7	1.7	1.7	3.8	1.2	2.8	2.2	2.4	2.6	3.4	1.7	1.7	3.9	0.1	3.7	0.5	1.9	2.0	1.4											8.9	8.1	14.1	10.0	26.3	17.4	3.6	15.3	2.7	5.7	5.2	33.4	7.0	1.7	8.7	50.4	9.5	18.8	0.0	11.4	18.5	7.3	9.0	2.3	7.8	9.6	3.2	10.4	6.2	3.9	17.2	11.5	7.5	3.3	10.0	20.3	5.6	12.4	10.5	9.2	3.6	25.6	0.0	8.2	19.0	17.7	20.6	6.1	12.7	27.7	11.1
MYO1B	myr1	ENSG00000128641	"Myosin IB"	O43795	2	191245185-191425389	"Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 92.7"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 306.7;Hepatocytes: 373.0;Sertoli cells: 200.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2"	"Group enriched"	"Detected in many"	4	"B-cells: 2.7;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 75.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013607, HPA060144"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA013607: AB_1854251, HPA060144: AB_2684211"	"unprognostic (4.11e-3)"	"unprognostic (7.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.83e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.59e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.85e-2)"	"unprognostic (4.55e-1)"	"unprognostic (9.31e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (2.22e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	18.8	2.5	3.3	5.9	4.3	0.2	21.8	1.4	4.7	8.2	8.0	2.1	21.6	4.2	11.8	8.2	9.0	4.9	8.9	11.6	3.6	3.1	12.2	92.7	34.5	6.6	3.6	2.3	7.8	34.3	15.0	3.1	15.7	4.4	8.5	7.4	5.8	7.5	18.6	9.3	7.5	5.4	6.7	2.7	6.6	5.0	3.6	2.0	3.6	9.3	10.4	4.8	10.3	9.9	2.7	0.4	0.0	0.0	0.0	1.2	0.0	20.3	10.5	17.2	5.1	4.7	20.4	15.5	38.9	19.3	27.0	26.9	12.9	1.8	0.0	6.5	44.7	10.9	45.2	5.6	33.5	34.0	0.0	4.9	0.0	4.9	16.4	11.1	0.4	0.1	8.2	23.2	28.1	75.9	10.0	4.9	8.7	0.0	0.0	24.8	8.6	7.7	2.4	11.2	1.3	16.7	10.0	10.9	1.5	10.6	8.6	8.7	22.8	13.1	2.3	11.7	15.3	2.1	0.6	5.9	25.9	12.9	15.6	4.5	0.2	0.0	0.2	15.7	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.3	4.3	1.4	4.7	3.6	3.1	3.6	2.3	4.4	2.0	306.7	93.9	10.0	37.0	68.2	1.1	4.8	48.4	32.1	87.6	66.3	0.0	4.5	0.0	92.7	2.8	24.0	13.9	0.0	38.3	21.2	34.0	35.8	3.5	373.0	3.5	0.0	56.1	3.7	8.6	3.2	4.6	4.7	25.3	1.8	23.5	69.7	41.1	49.5	8.5	1.3	1.5	200.5	74.6	1.4	18.9	24.6	2.9	4.3	30.4	41.7
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492812	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		30000	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	61.5	8.6	3.3	20.1	4.1	0.9	45.7	4.4	4.3	33.8	35.5	5.3	17.2	14.0	36.0	20.5	34.3	20.3	38.2	29.3	3.3	2.5	24.8	24.8	30.3	13.4	3.3	3.8	23.7	44.8	8.6	7.6	32.2	6.1	27.4	12.7	20.0	44.5	19.0	20.0	17.1	29.9	40.8	3.6	12.3	24.2	12.6	2.9	9.4	23.0	21.3	18.6	32.0	32.4	7.9	1.7	0.8	3.1	0.0	3.5	2.2	36.1	39.7	4.3	17.6	20.3	20.2	16.6	36.9	30.7	24.4	20.6	26.4	19.9	3.6	26.7	56.8	16.3	30.7	6.4	25.7	12.8	16.0	16.2	3.4	21.6	9.7	30.1	0.3	18.3	15.7	12.8	22.4	12.9	22.4	31.3	2.3	2.7	3.0	20.6	27.6	0.4	0.2	2.7	22.7	7.4	1.4	5.9	6.5	22.4	18.9	1.7	9.6	23.2	33.9	14.8	11.1	27.8	1.8	41.0	35.4	27.2	17.3	31.8	2.4	1.9	1.5	28.2	0.8	30.6	0.2	1.3	0.0	1.5	3.1	0.8	7.9	3.5	1.6	1.7	6.7	1.3	0.7	0.8	0.0	2.6	1.6	3.0	2.2	3.3	4.1	4.4	4.3	3.3	2.5	3.3	3.8	6.1	2.9	116.1	28.1	21.6	34.2	35.3	2.0	63.8	53.5	6.7	40.9	82.0	0.0	49.1	18.3	52.4	13.7	49.6	118.0	23.3	44.8	23.7	45.2	47.9	11.5	36.3	17.3	4.8	37.9	89.0	11.3	8.0	39.1	20.0	60.8	33.3	90.6	4.0	74.6	84.6	45.6	11.3	2.2	116.4	76.0	2.1	8.1	37.3	39.8	6.4	57.2	33.6
MYO1F		ENSG00000142347	"Myosin IF"	O00160	19	8520790-8577577	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.9;bone marrow: 50.6;lung: 17.1;lymphoid tissue: 56.1"	"Cell type enhanced"	"Detected in many"	12	"Hofbauer cells: 69.4;Kupffer cells: 191.9;Macrophages: 117.9;T-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 15.5;HL-60: 15.3;HMC-1: 27.2;NB-4: 60.4;THP-1: 45.0;U-937: 24.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055242, HPA056036"	Enhanced		Enhanced	Cytosol		NA	NA		8800	Cytosol		"HPA055242: AB_2682754, HPA056036: "	"unprognostic (4.86e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.47e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.35e-2)"	7.6	3.7	4.8	22.9	9.1	50.6	3.6	1.0	4.6	2.2	4.3	7.5	0.4	4.6	2.1	4.7	2.7	5.4	6.5	4.0	5.2	3.1	3.7	6.2	17.1	24.8	9.0	1.7	2.5	2.3	0.6	2.3	4.8	6.9	3.3	2.3	3.5	3.3	1.3	1.2	1.8	8.5	3.9	9.9	56.1	3.9	1.3	7.0	4.2	2.7	1.8	11.1	6.8	2.5	1.5	15.4	64.9	23.7	7.5	14.9	18.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.1	0.0	0.0	0.0	15.5	0.0	11.2	0.0	0.0	0.0	15.3	27.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	0.0	0.0	0.0	60.4	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	45.0	3.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	24.8	0.0	14.4	23.7	24.5	14.9	19.6	11.6	1.5	5.9	10.2	15.4	0.7	0.4	4.6	64.9	7.5	22.4	1.9	8.1	18.6	4.8	9.1	1.0	4.6	5.2	3.1	9.0	1.7	6.9	7.0	3.0	20.1	25.2	1.9	3.0	0.7	2.1	7.6	0.0	4.5	1.8	2.0	4.1	1.7	1.2	5.2	2.7	2.1	23.3	0.8	6.0	3.1	1.2	30.1	5.6	69.4	6.4	1.2	14.1	191.9	3.6	2.3	117.9	6.8	53.3	1.7	1.4	1.7	1.9	1.1	2.1	0.3	0.0	2.8	2.7	2.1	4.6	4.2	142.2	2.4	1.4
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 333.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 8.6;MAIT T-cell: 4.0;memory CD4 T-cell: 2.7;memory CD8 T-cell: 4.9;naive CD8 T-cell: 4.8;NK-cell: 3.3"	"Group enriched"	"Detected in many"	20	"NK-cells: 3.3;T-cells: 8.6"	"Cell line enhanced"	"Detected in many"		"RT4: 43.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	8.4	9.1	18.2	9.0	27.0	0.9	26.9	17.1	24.1	16.2	18.9	26.8	28.7	30.0	7.5	25.9	28.1	10.0	23.1	4.9	19.1	12.2	44.0	13.8	20.5	4.5	24.0	17.9	4.6	18.5	42.2	24.2	7.1	19.0	16.0	17.3	11.9	23.3	33.7	4.2	14.1	27.7	8.0	21.2	6.7	23.9	14.3	28.2	0.9	13.4	9.1	10.9	16.1	13.1	0.2	0.0	0.1	0.1	3.3	8.6	1.2	22.7	6.1	4.9	3.5	11.9	9.6	19.6	8.1	8.6	6.0	7.8	9.2	20.5	0.0	7.9	9.1	6.9	18.0	5.8	11.6	6.9	9.6	11.9	6.5	2.0	5.6	10.2	0.0	9.5	6.8	8.4	8.1	6.4	10.0	16.6	3.3	8.5	3.3	6.1	21.9	0.0	0.2	3.3	17.1	1.6	0.4	11.8	0.4	22.3	43.4	10.2	6.7	2.0	20.4	3.5	11.6	8.7	13.3	24.3	6.6	5.7	0.3	7.3	6.9	7.0	0.0	4.1	0.0	2.3	0.1	0.0	0.0	8.6	0.0	4.0	0.2	2.7	4.9	0.0	0.0	0.6	4.8	0.1	3.3	0.1	0.0	0.1	1.2	18.2	27.0	17.1	24.1	19.1	12.2	24.0	17.9	19.0	28.2	131.0	218.3	7.6	88.9	26.8	74.9	7.3	35.7	75.0	79.6	143.1	113.9	27.1	46.4	104.1	3.9	45.8	95.7	0.0	104.0	18.4	24.2	142.1	25.4	28.2	5.5	90.6	81.6	42.4	3.8	5.6	27.9	6.0	28.7	4.6	66.2	333.7	145.6	80.7	40.7	83.4	184.9	12.9	16.9	10.9	13.8	29.7	65.6	12.1	54.2	164.0
MYOD1	"bHLHc1, MYF3, MYOD, PUM"	ENSG00000129152	"Myogenic differentiation 1"	P15172	11	17719568-17722131	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"skeletal muscle: 31.8"	"Cell type enriched"	"Detected in single"	7	"Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	15	"RH-30: 103.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055436, HPA078647"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055436: , HPA078647: "						"unprognostic (1.07e-3)"				"unprognostic (2.10e-1)"					"unprognostic (1.01e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.5	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	4.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.0	0.0	0.0	0.0	0.0	0.0
NAA16	"FLJ22054, MGC40612, NARG1L, PRO2435"	ENSG00000172766	"N(alpha)-acetyltransferase 16, NatA auxiliary subunit"	Q6N069	13	41311205-41377030	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039761, HPA040157"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA039761: AB_10795112, HPA040157: AB_10793917"	"unprognostic (2.09e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.09e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.36e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-2)"	7.2	6.3	8.4	6.1	9.6	25.5	6.7	20.0	13.2	7.7	6.0	5.1	5.3	5.6	10.0	4.3	7.9	9.0	5.0	5.3	7.5	3.7	4.4	4.0	6.3	9.0	8.5	5.8	8.0	25.7	5.1	9.6	5.0	6.6	6.5	4.4	4.5	7.0	8.3	8.3	7.9	6.5	10.0	7.9	5.5	6.7	9.2	9.7	8.3	5.7	4.0	5.1	8.7	21.1	3.0	2.7	4.8	2.4	5.4	8.2	2.2	6.5	5.4	13.6	10.0	4.8	6.2	5.3	8.1	6.8	8.1	7.1	6.5	5.2	11.0	3.9	6.4	3.3	9.2	7.0	5.2	9.9	6.7	14.3	13.4	5.3	6.4	5.2	15.0	9.1	4.3	3.8	3.3	6.3	5.3	7.9	10.8	6.0	6.1	5.1	5.3	15.5	4.2	11.7	9.1	7.5	11.5	5.7	9.0	6.3	6.0	4.7	10.8	7.3	7.2	2.8	8.3	4.4	8.2	5.8	5.6	4.6	8.8	6.2	4.3	4.8	12.8	7.1	6.4	6.5	4.3	2.4	4.8	3.9	1.3	3.8	1.6	4.5	4.1	1.3	3.0	8.2	8.2	1.3	5.4	1.8	2.7	3.3	2.2	8.4	9.6	20.0	13.2	7.5	3.7	8.5	5.8	6.6	9.7	8.9	11.8	13.7	18.6	15.8	26.3	8.9	7.6	21.4	14.8	8.7	13.7	7.0	1.7	10.1	15.7	15.9	5.1	0.0	17.9	6.4	12.5	16.7	3.5	8.3	15.8	36.5	7.5	13.5	8.7	15.8	27.9	12.3	13.5	5.4	4.4	14.0	13.0	5.8	18.7	6.3	35.1	19.4	13.2	29.7	27.4	12.8	2.4	20.3	8.7	16.6
NAALADL2		ENSG00000177694	"N-acetylated alpha-linked acidic dipeptidase like 2"	Q58DX5	3	174438573-175810552	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"seminal vesicle: 29.3"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 60.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 11.7;BJ hTERT+: 4.2;fHDF/TERT166: 4.9;WM-115: 4.5"	"Low region specificity"	"Detected in many"							"HPA012413, HPA017425, CAB025586"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025586: , HPA012413: AB_1854274, HPA017425: AB_1854275"	"unprognostic (7.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.29e-4)"	"unprognostic (3.44e-3)"	"unprognostic (5.70e-2)"	"unprognostic (7.42e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.49e-2)"	"unprognostic (3.66e-6)"	"unprognostic (7.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.22e-2)"	4.9	2.3	2.2	4.6	3.7	0.8	7.0	1.9	2.7	8.3	8.3	5.4	23.8	2.4	9.7	10.5	2.3	5.0	8.9	5.4	2.5	1.8	7.0	3.7	3.3	1.3	2.3	2.0	5.4	3.9	20.6	3.0	6.4	4.0	9.6	3.3	4.4	17.0	29.3	1.8	3.2	6.6	6.0	3.6	2.6	4.5	1.9	2.9	4.9	3.5	2.6	1.7	8.7	5.0	0.1	1.7	0.2	0.1	0.1	0.8	0.0	0.0	0.0	0.2	0.0	3.5	11.7	0.1	2.3	4.2	0.6	0.7	0.2	1.3	0.0	0.5	4.9	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	3.2	0.6	0.1	0.0	3.0	0.4	0.0	0.0	0.1	2.3	0.4	0.2	0.0	0.0	1.6	0.0	0.0	0.2	0.1	1.7	0.2	0.0	0.0	0.2	0.2	0.9	0.3	3.1	0.1	0.5	2.3	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.0	4.5	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.1	0.0	1.7	0.0	0.0	2.2	3.7	1.9	2.7	2.5	1.8	2.3	2.0	4.0	2.9	0.0	11.5	0.0	7.2	2.1	7.6	2.8	10.2	18.7	6.8	12.2	11.8	16.3	6.6	6.8	60.1	2.1	11.1	0.0	2.3	1.5	7.8	18.3	4.6	2.4	1.6	0.0	8.6	3.1	0.3	28.0	14.1	0.7	3.3	0.0	1.1	7.7	2.5	3.5	11.3	1.7	6.6	0.0	2.3	3.2	1.9	1.6	10.3	0.0	14.9	13.7
NABP1	"DKFZp667M1322, FLJ13624, FLJ22833, hSSB2, MGC111163, OBFC2A, SOSS-B2, SSB2"	ENSG00000173559	"Nucleic acid binding protein 1"	Q96AH0	2	191678068-191696659	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 40.0"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 620.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054978, HPA067802"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA054978: AB_2682660, HPA067802: AB_2685899"	"unprognostic (5.43e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.80e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.89e-2)"	"unprognostic (8.07e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (8.20e-7)"	"unprognostic (5.64e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.02e-2)"	20.8	4.9	2.4	26.0	2.3	4.2	22.2	1.1	2.1	4.4	14.1	1.9	1.6	13.3	6.7	9.2	12.1	4.9	8.1	6.9	4.7	2.0	8.8	8.7	18.6	39.6	3.9	1.3	4.9	6.3	0.8	4.4	28.0	6.1	4.7	5.2	2.6	6.2	3.9	3.1	4.3	30.6	4.7	5.3	40.0	4.6	18.4	1.5	7.4	3.6	12.1	23.0	8.7	8.8	3.8	2.2	18.6	7.7	1.6	14.2	1.9	14.8	2.3	0.3	0.4	11.3	13.7	3.9	23.2	19.0	14.4	8.7	12.3	8.4	0.8	18.4	14.0	11.7	4.2	2.1	9.9	16.0	7.7	1.9	7.4	4.7	3.1	8.2	3.4	8.4	18.0	12.5	20.7	14.9	17.2	5.4	2.2	10.4	32.9	22.5	1.2	1.1	4.0	1.3	3.1	11.7	2.5	2.6	7.0	21.6	11.0	0.5	0.1	8.0	2.8	6.5	14.1	0.7	2.2	13.8	12.1	10.2	6.3	14.5	10.9	4.5	3.1	10.0	4.1	2.1	2.5	4.0	1.9	6.4	6.7	8.7	3.8	8.6	6.6	2.2	0.6	2.2	3.8	18.6	1.6	7.7	1.4	14.2	1.9	2.4	2.3	1.1	1.9	4.7	2.0	3.9	1.3	6.1	1.5	199.5	620.7	29.6	104.4	47.2	3.0	6.7	12.7	85.6	168.4	10.4	2.0	20.0	3.3	17.5	161.5	9.3	94.3	0.0	4.6	34.8	18.6	41.1	131.1	6.7	49.8	3.2	4.1	11.6	96.8	54.0	9.5	125.6	38.8	147.9	15.3	1.1	20.2	31.6	3.5	17.7	3.8	6.5	28.6	21.1	18.0	39.5	122.3	52.2	21.7	106.4
NABP2	"hSSB1, MGC2731, OBFC2B, SOSS-B1, SSB1"	ENSG00000139579	"Nucleic acid binding protein 2"	Q9BQ15	12	56222015-56229854	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 187.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044615, HPA057213"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044615: AB_10795884, HPA057213: AB_2683371"	"unprognostic (1.45e-1)"	"prognostic favorable (8.35e-6)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (7.44e-6)"	"unprognostic (4.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.96e-3)"	"unprognostic (6.52e-2)"	"unprognostic (4.72e-2)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.01e-2)"	14.0	26.7	27.7	16.7	33.3	16.2	15.7	23.6	32.6	16.2	19.5	17.6	14.9	22.8	16.3	19.4	15.0	16.0	23.0	16.2	25.8	25.2	21.0	17.7	11.7	18.0	26.4	24.4	23.1	25.8	17.2	17.0	8.6	24.0	15.8	19.9	17.6	15.9	19.6	51.8	14.0	22.4	16.7	20.2	14.9	17.0	18.6	20.5	10.6	20.6	21.7	18.7	15.9	14.7	17.1	13.5	15.3	14.9	25.9	21.0	10.2	25.4	26.4	25.1	27.9	10.9	11.9	4.8	15.4	12.9	22.4	13.4	15.8	23.0	19.6	31.4	14.1	16.0	20.4	23.3	19.4	17.1	36.9	21.9	32.7	18.5	12.1	11.8	23.3	31.9	10.1	15.5	26.7	21.7	19.2	14.3	24.3	16.8	33.8	16.1	23.1	31.5	26.1	18.4	15.2	25.3	28.6	23.5	29.2	10.6	10.6	32.0	23.7	24.7	30.6	20.9	4.1	35.0	20.8	10.1	15.8	15.0	33.1	28.2	22.9	34.9	12.5	29.4	21.8	29.2	15.3	9.9	8.6	17.5	13.8	19.4	17.1	14.7	15.8	13.4	12.6	9.2	15.3	1.9	25.9	14.9	13.5	21.0	10.2	27.7	33.3	23.6	32.6	25.8	25.2	26.4	24.4	24.0	20.5	14.9	17.6	19.2	18.9	16.6	15.5	8.1	12.7	12.0	3.4	22.7	2.0	25.5	41.4	27.1	73.7	17.5	25.1	0.0	61.7	33.3	19.1	11.3	17.3	18.5	27.5	14.3	17.3	16.5	16.1	187.0	21.9	20.4	30.4	36.9	24.4	24.4	31.4	24.6	32.2	28.4	11.8	19.4	19.4	9.9	24.7	14.9	12.7	27.7	34.4	9.3
NACC1	"BEND8, BTBD14B, BTBD30, NAC-1, NAC1"	ENSG00000160877	"Nucleus accumbens associated 1"	Q96RE7	19	13118103-13141141	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021238, HPA062245, CAB069927"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB069927: AB_1082966, HPA021238: AB_1845475, HPA062245: AB_2684724"	"unprognostic (2.19e-1)"	"unprognostic (9.20e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.75e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.04e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.97e-1)"	"unprognostic (9.74e-2)"	12.5	13.7	27.2	18.2	22.3	10.0	6.7	19.8	38.7	10.8	16.6	20.1	11.7	16.6	12.8	10.0	17.9	10.5	9.4	13.2	23.6	14.2	10.8	15.6	11.3	14.9	17.1	14.2	7.8	16.8	10.5	10.6	15.4	16.0	11.9	8.4	7.8	15.3	15.6	17.6	10.9	18.3	9.2	17.2	15.2	16.1	18.8	15.4	10.7	9.8	9.6	9.9	13.2	7.9	0.7	0.9	1.8	0.8	0.6	1.3	0.5	28.3	34.5	8.0	17.8	4.5	5.7	21.8	13.9	10.5	13.5	10.5	34.7	12.1	14.2	31.2	11.6	10.6	14.1	10.3	25.3	5.0	25.1	16.4	9.1	28.2	24.3	10.8	14.2	25.5	8.6	8.4	13.2	7.2	10.6	15.3	12.8	19.7	5.7	6.6	58.5	22.8	11.3	35.7	8.0	31.9	14.0	9.2	14.2	8.2	31.1	17.5	11.0	13.5	19.8	12.3	8.7	17.6	13.1	21.7	28.7	17.9	21.1	24.4	15.7	24.5	11.8	30.7	14.3	17.8	0.1	0.5	0.0	0.8	0.8	0.6	0.7	1.3	0.8	0.9	0.4	0.4	0.7	1.8	0.6	0.6	0.8	0.2	0.5	27.2	22.3	19.8	38.7	23.6	14.2	17.1	14.2	16.0	15.4	0.0	1.7	11.2	5.7	10.8	15.6	2.0	15.3	0.0	2.3	15.7	2.0	16.1	6.6	11.8	1.6	6.8	16.0	0.0	7.5	16.9	5.4	11.3	10.3	14.5	18.9	25.4	4.7	9.8	8.8	1.6	4.0	8.0	5.0	7.2	14.5	8.3	16.0	10.5	8.9	13.6	7.8	6.5	4.2	10.6	14.0	12.2	22.7	12.1	14.3	16.0
NAF1		ENSG00000145414	"Nuclear assembly factor 1 ribonucleoprotein"	Q96HR8	4	163110073-163166921	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036241, HPA036242, HPA066090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA036241: AB_2675017, HPA036242: AB_10673616, HPA066090: AB_2685614"	"unprognostic (6.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.45e-1)"	"unprognostic (8.73e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.05e-1)"	13.3	12.3	8.6	9.6	19.8	8.7	11.9	10.7	18.9	12.9	10.6	14.7	6.4	6.2	18.8	8.6	11.0	17.3	10.9	11.7	10.5	7.8	9.5	10.5	10.9	10.7	7.2	9.1	20.1	11.1	15.7	18.7	8.8	10.1	12.0	11.4	13.4	10.4	12.5	36.4	14.3	8.3	12.7	7.4	10.0	11.3	17.2	7.5	12.3	14.0	12.2	12.2	12.5	10.4	2.5	2.4	0.1	1.6	1.2	3.5	1.4	9.1	7.7	10.0	10.2	5.9	9.4	11.7	10.8	7.2	9.5	9.5	8.7	10.9	23.7	3.1	6.6	7.6	7.7	20.2	11.6	12.5	10.4	12.5	25.1	6.9	7.4	10.3	16.2	9.0	8.9	10.4	11.5	9.4	9.9	8.4	7.7	28.1	12.6	12.6	8.9	18.7	9.2	13.0	6.9	7.7	15.6	7.4	12.4	9.4	4.2	10.9	8.2	7.1	13.0	7.7	9.2	7.0	7.1	8.8	11.4	9.8	8.8	12.1	7.9	11.0	18.3	10.8	9.4	11.2	0.0	1.5	0.1	2.2	1.6	0.9	1.9	2.5	3.3	2.4	2.5	3.5	2.3	0.0	1.2	1.5	2.4	0.7	1.4	8.6	19.8	10.7	18.9	10.5	7.8	7.2	9.1	10.1	7.5	6.0	14.7	11.5	15.4	28.7	11.4	3.1	10.2	36.1	7.9	8.7	17.7	12.3	3.3	7.0	37.3	8.5	2.7	0.0	5.9	13.9	10.6	10.3	10.4	4.4	10.8	7.9	18.4	14.1	15.7	16.6	6.4	9.3	8.5	6.4	5.3	9.3	6.7	3.5	4.9	6.9	13.7	32.3	14.4	17.6	14.3	35.9	17.8	10.0	8.4	10.5
NANS	SAS	ENSG00000095380	"N-acetylneuraminate synthase"	Q9NR45	9	98056739-98083075	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019223	Approved		Enhanced	Nucleoplasm		No	No		200000	Nucleoplasm		"HPA019223: AB_1854298"	"unprognostic (2.95e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.24e-2)"	"prognostic favorable (1.71e-4)"	"unprognostic (7.31e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (2.08e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.79e-1)"	17.2	10.1	8.8	20.2	11.4	22.2	16.4	7.0	11.7	20.2	47.6	6.4	17.0	19.4	11.0	15.1	18.6	10.4	25.0	20.9	14.4	12.4	15.0	49.6	17.1	20.1	11.5	10.6	14.1	59.2	6.1	16.3	15.8	12.1	37.2	49.6	9.4	80.0	18.3	11.9	10.3	18.9	11.0	9.0	22.2	28.3	11.5	9.8	10.6	19.7	15.2	25.0	15.7	14.8	12.3	41.9	16.4	49.8	7.4	12.1	18.3	73.9	21.9	6.5	18.7	13.1	14.2	14.1	23.7	18.6	19.4	15.9	26.1	10.6	22.8	11.5	26.0	20.5	26.3	12.0	20.3	16.2	18.3	18.0	13.5	24.5	52.1	36.3	15.2	11.1	11.9	13.9	20.6	23.6	22.6	20.6	11.4	24.5	23.8	14.1	50.8	10.2	22.0	11.2	53.6	28.4	19.8	17.8	23.2	15.4	22.7	13.2	6.9	15.2	82.5	20.1	7.5	27.3	16.5	53.6	15.1	14.7	38.7	24.2	22.2	18.4	8.7	17.9	18.5	11.7	5.3	42.1	6.0	8.0	49.8	12.1	12.3	10.5	8.3	41.9	10.1	11.5	7.8	16.4	7.4	43.0	38.4	11.9	18.3	8.8	11.4	7.0	11.7	14.4	12.4	11.5	10.6	12.1	9.8	26.8	52.4	47.0	107.6	62.3	8.1	21.5	53.5	151.3	77.3	21.0	17.7	73.6	59.7	41.8	35.3	57.3	177.1	0.0	89.0	121.2	62.1	166.7	43.8	28.6	139.8	9.5	62.4	25.2	52.6	53.6	30.0	94.4	123.2	58.7	195.9	13.3	63.2	189.8	24.8	47.7	7.0	12.9	96.2	7.2	16.9	54.0	126.1	27.7	245.2	195.9
NAP1L2	"BPX, MGC26243"	ENSG00000186462	"Nucleosome assembly protein 1 like 2"	Q9ULW6	X	73212299-73214848	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 49.8"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 24.8;Horizontal cells: 17.5;Muller glia cells: 12.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"EFO-21: 12.1;Karpas-707: 10.2;NTERA-2: 13.0;U-2197: 10.5;U-266/84: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054050, HPA057065"			Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA054050: AB_2682357, HPA057065: AB_2797258"	"unprognostic (1.12e-1)"	"unprognostic (6.64e-5)"	"unprognostic (4.22e-2)"	"unprognostic (9.64e-4)"	"unprognostic (1.78e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.66e-1)"	"prognostic favorable (5.41e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.95e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.45e-2)"	2.3	5.8	15.7	2.2	20.0	0.9	3.2	37.5	49.8	4.5	2.8	2.0	0.2	1.3	4.9	8.0	2.8	4.2	2.5	7.2	21.0	22.8	8.0	1.3	2.5	2.9	15.7	28.7	8.6	2.6	10.5	10.2	0.5	20.5	10.4	3.1	2.6	3.1	5.9	1.1	4.9	1.7	4.6	8.3	3.9	2.0	2.2	4.9	0.0	8.0	0.0	1.8	2.6	2.5	0.9	0.0	0.0	0.0	1.2	3.6	1.4	0.0	3.4	0.1	6.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.0	12.1	0.0	6.5	0.7	2.4	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.6	0.3	0.9	0.1	1.8	0.0	0.2	4.7	0.2	10.2	0.0	1.2	4.0	0.0	13.0	0.0	6.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.8	0.0	2.7	1.2	0.0	0.1	0.0	7.6	10.5	0.8	4.8	21.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.7	0.0	1.4	0.9	3.4	2.3	0.0	0.1	1.6	3.6	0.0	1.2	0.0	0.0	2.6	1.4	15.7	20.0	37.5	42.1	21.0	22.8	15.7	28.7	20.5	4.9	0.0	4.0	0.0	4.6	5.7	24.8	10.9	5.1	0.0	1.2	12.2	0.0	0.0	11.6	0.8	0.0	2.2	0.0	0.0	0.2	0.0	0.5	2.4	4.6	0.8	0.1	17.5	6.9	2.5	0.8	0.0	0.3	0.0	0.0	0.0	0.2	12.4	1.1	0.0	0.4	3.1	8.7	0.0	3.3	0.2	0.0	2.6	0.0	3.2	0.2	0.8
NASP	"DKFZp547F162, FLB7527, FLJ31599, FLJ35510, MGC19722, MGC20372, MGC2297, PRO1999"	ENSG00000132780	"Nuclear autoantigenic sperm protein"	P49321	1	45583846-45618904	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 344.6;Spermatogonia: 575.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028136, HPA030518, HPA030520"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028136: AB_2672497, HPA030518: AB_2673509, HPA030520: AB_2673510"	"unprognostic (5.59e-2)"	"unprognostic (1.34e-3)"	"unprognostic (5.02e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.36e-3)"	"prognostic unfavorable (4.96e-6)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (1.91e-8)"	"unprognostic (1.62e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	"unprognostic (5.32e-2)"	20.7	15.2	19.3	33.4	32.0	64.0	21.2	20.1	24.0	22.8	21.9	30.2	26.4	15.9	22.3	19.8	20.1	23.0	12.5	18.1	22.4	17.3	17.5	21.0	17.6	39.0	40.2	17.8	28.3	17.4	21.9	22.9	28.5	24.2	18.9	24.7	12.6	17.8	21.8	14.3	16.1	20.5	21.3	30.3	31.7	17.5	35.8	40.2	49.1	17.7	28.2	43.0	18.5	19.6	16.9	11.8	8.1	9.7	7.3	17.5	6.9	24.6	14.6	70.1	24.8	11.8	6.2	33.0	20.0	14.9	31.1	39.1	26.9	17.9	46.5	14.1	8.6	34.2	23.9	46.7	21.3	39.9	21.2	29.6	60.1	26.3	42.1	4.1	62.7	25.3	7.2	5.2	34.3	11.9	8.1	21.2	39.2	50.5	27.5	21.0	16.8	71.4	57.5	101.9	24.6	12.4	90.3	61.5	44.7	15.4	24.9	26.9	32.6	32.9	18.8	20.3	55.3	13.5	49.1	11.4	14.4	44.2	27.6	32.5	16.9	31.8	80.7	14.7	40.1	14.3	4.9	7.3	8.1	12.3	9.7	14.2	13.5	13.9	14.0	11.5	16.9	12.3	11.8	3.1	7.3	5.7	11.8	17.5	6.9	19.3	32.0	20.1	24.0	22.4	17.3	40.2	17.8	24.2	40.2	53.6	89.6	88.0	115.5	69.4	46.4	46.2	35.7	160.6	146.7	34.9	35.3	265.5	26.6	48.1	12.2	85.7	26.9	23.3	32.6	179.3	75.1	49.2	111.0	32.6	90.0	41.3	49.2	76.1	37.0	19.1	87.8	52.1	38.8	54.1	39.4	64.0	29.7	41.2	73.6	27.1	77.6	84.1	71.5	344.6	575.6	49.8	224.3	87.3	90.3	75.0
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody		Yes	No			Nucleoli	Midbody	"CAB035546: , HPA057576: AB_2683475, HPA071628: AB_2686426"	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (1.07e-4)"	"prognostic unfavorable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.4	17.6	9.4	20.0	11.4	10.1	10.9	12.4	9.1	15.8	12.6	19.7	7.2	40.0	9.2	10.4	13.6	18.9	35.4	18.9	20.2	11.1	22.7	18.1	14.4	18.4	10.3	45.3	13.2	10.3	13.0	10.3	29.0	7.4	12.0	19.3	39.5	14.0	13.1	23.6	36.9	20.6	13.5	21.6	21.2	27.8	31.9	16.7	9.1	21.8	14.0	10.6	16.7	17.7	7.4	9.5	17.7	12.5	9.6	14.1	11.2	20.6	22.9	15.3	18.3	38.1	14.2	18.8	13.9	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9	6.0	16.5	12.0	9.6	10.9	11.2	9.8	10.2	14.7	22.7	14.0	11.8	15.4	5.0	6.8	3.8	7.8	3.5	23.3	8.3	9.9	7.4	6.4	4.7	7.2	10.5	11.1	6.9	6.7	4.0	2.1	8.6	6.0	1.7	11.8	8.5	7.7	6.9	2.9	12.4	5.0	10.1	12.9	8.1	17.9	25.4	12.0	12.0	10.2	12.4	6.3
NCAM1	"CD56, NCAM"	ENSG00000149294	"Neural cell adhesion molecule 1"	P13591	11	112961247-113278436	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 110.6;heart muscle: 67.7"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4"	"Cancer enriched"	"Detected in many"	8	"glioma: 31.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	14	"NK-cell: 27.2"	"Lineage enriched"	"Detected in many"	14	"NK-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000142, CAB018071, HPA039835"	Enhanced		Enhanced	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA	1200000	2800000000	"Plasma membrane"	Cytosol	"CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705"	"unprognostic (7.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.82e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.63e-2)"	"prognostic favorable (9.11e-6)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (8.20e-4)"	"unprognostic (2.97e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.82e-5)"	3.5	36.4	22.7	3.0	35.7	1.8	2.1	20.2	110.6	13.3	9.0	55.8	0.3	3.4	24.7	3.0	4.8	8.3	3.6	67.7	22.5	19.2	2.3	2.6	2.0	1.7	45.0	27.1	21.9	2.3	1.1	9.1	1.4	38.8	8.4	4.6	5.5	2.5	10.9	14.6	1.8	5.3	25.6	27.6	3.4	6.7	2.9	39.2	0.0	16.9	0.7	1.7	7.0	6.5	0.0	0.0	0.4	0.1	27.2	2.0	0.9	0.0	0.0	6.9	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.4	0.1	0.1	1.0	6.1	6.5	0.2	0.1	0.0	0.0	0.0	0.1	3.9	19.5	0.0	0.0	0.7	0.0	3.1	4.2	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.3	6.8	0.0	0.0	1.6	0.6	0.0	0.1	0.0	44.0	3.1	0.0	0.0	35.8	17.6	0.0	0.1	0.0	0.7	0.0	0.2	0.0	24.5	11.4	0.1	10.2	0.0	0.1	0.0	2.7	9.2	25.9	0.0	0.1	0.0	2.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.4	27.2	0.0	0.0	0.1	0.9	22.7	35.7	20.2	41.6	22.5	19.2	45.0	27.1	38.8	39.2	0.0	0.0	0.0	0.4	1.4	108.7	109.4	0.0	1.4	0.0	0.0	35.3	0.5	1.7	14.4	4.5	0.3	0.0	0.0	0.0	0.2	7.6	0.3	1.1	0.5	0.4	165.3	5.2	6.7	5.1	3.9	14.1	1.7	0.0	0.0	0.0	263.9	1.7	0.0	9.6	0.0	95.4	0.0	3.8	0.5	2.3	1.5	0.1	11.4	0.0	0.1
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942597	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	27.6	34.5	39.4	26.8	42.1	11.4	35.6	33.4	37.8	28.0	25.4	17.9	25.2	21.8	26.6	32.1	23.1	24.9	22.5	22.6	37.5	33.3	31.9	21.6	20.3	37.6	33.5	28.9	30.8	27.8	28.3	30.4	25.4	31.4	28.3	26.1	18.7	19.8	27.8	41.8	20.1	19.9	33.7	39.0	24.3	21.3	20.4	31.3	24.9	29.8	19.3	30.5	27.5	23.7	26.1	19.1	9.7	20.8	19.6	28.9	17.6	35.7	11.6	26.9	34.0	30.8	27.0	19.3	27.0	20.1	17.1	17.8	25.4	13.0	23.9	60.4	18.8	22.1	21.8	34.5	29.3	26.7	12.6	22.7	31.2	13.5	21.1	27.3	36.4	21.8	21.6	25.3	12.4	35.0	25.6	26.2	26.3	17.6	25.5	28.6	41.6	27.0	22.4	34.3	33.9	37.6	21.3	20.6	22.6	24.8	25.0	15.2	40.3	16.9	32.5	47.1	22.4	72.1	29.0	24.8	17.7	18.8	21.8	48.5	39.3	36.3	41.1	24.1	41.2	26.9	3.8	18.1	9.7	19.2	20.8	28.9	26.1	23.5	22.5	19.1	20.5	27.3	24.4	2.3	19.6	20.1	15.5	20.8	17.6	39.4	42.1	33.4	35.7	37.5	33.3	33.5	28.9	31.4	31.3	23.8	35.0	86.4	59.4	46.6	55.7	35.2	20.4	37.5	50.0	40.1	55.0	50.6	82.9	57.9	91.7	48.0	33.3	0.0	43.2	65.3	43.0	45.0	51.9	29.2	58.3	42.9	43.3	31.9	50.5	46.4	34.8	49.6	30.4	71.3	40.2	72.8	56.6	43.0	48.4	59.3	55.3	25.8	53.0	32.3	58.0	39.1	44.5	49.8	42.2	83.5
NCF4	"p40phox, SH3PXD4"	ENSG00000100365	"Neutrophil cytosolic factor 4"	Q15080	22	36860988-36878015	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 130.3;bone marrow: 69.0;lymphoid tissue: 66.0"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 49.2;granulocytes: 71.7;Hofbauer cells: 162.7;Kupffer cells: 83.9;Macrophages: 82.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 58.0;eosinophil: 76.4;neutrophil: 130.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 130.3"	"Cell line enhanced"	"Detected in some"		"HEL: 18.6;HMC-1: 88.9;NB-4: 31.5;REH: 16.2;RPMI-8226: 31.3;THP-1: 29.6;U-937: 16.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB010146, HPA036156, HPA057975"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB010146: AB_627989, HPA036156: AB_2674974, HPA057975: AB_2683568"	"unprognostic (3.27e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.78e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.69e-2)"	"unprognostic (4.03e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (7.06e-8)"	"unprognostic (3.60e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-1)"	10.4	5.8	4.4	24.8	5.6	69.0	5.6	0.7	2.8	3.4	7.4	2.5	1.2	5.0	2.2	8.1	4.4	5.9	7.2	8.0	3.9	2.2	4.4	4.2	17.5	21.2	8.0	1.0	3.3	2.1	0.6	2.6	10.3	4.6	5.1	5.3	4.2	6.5	2.2	2.6	2.3	16.0	4.3	7.7	66.0	3.9	3.0	5.4	5.0	3.5	2.8	22.2	9.0	7.1	12.6	10.0	130.3	19.5	0.4	10.8	10.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	18.6	0.0	0.0	0.0	2.7	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.0	31.5	0.0	0.0	0.0	16.2	0.0	31.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	16.5	0.0	58.0	19.5	76.4	0.2	9.6	1.1	12.6	3.9	0.8	9.1	8.9	0.2	0.2	130.3	0.4	6.4	10.0	10.8	10.2	4.4	5.6	0.7	2.8	3.9	2.2	8.0	1.0	4.6	5.4	3.0	28.4	49.2	2.2	2.5	0.0	0.8	0.0	1.4	9.1	1.8	0.0	2.5	0.0	0.6	0.3	1.4	0.4	0.0	2.7	14.2	2.5	0.3	71.7	0.6	162.7	0.0	0.0	0.6	83.9	1.0	0.6	82.4	13.5	17.2	0.3	0.0	1.2	17.3	0.0	0.2	0.2	0.0	0.4	0.0	0.2	1.9	10.9	17.0	1.2	3.8
NCK1	"NCK, NCKalpha"	ENSG00000158092	"NCK adaptor protein 1"	P16333	3	136862208-136949823	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005063, HPA030766"	Supported		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB005063: AB_562169, HPA030766: AB_2673602"	"unprognostic (7.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-2)"	"unprognostic (8.77e-3)"	"unprognostic (4.24e-3)"	"unprognostic (8.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (9.14e-5)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.17e-2)"	44.5	15.7	11.5	24.5	13.4	19.3	38.9	22.6	11.6	23.7	18.3	8.4	16.5	10.2	20.8	19.2	35.9	14.6	13.9	16.8	11.8	11.1	14.0	20.9	22.4	33.0	13.9	12.1	19.6	14.3	17.9	17.7	22.7	13.5	26.3	19.5	10.8	24.0	15.8	29.0	27.3	14.3	24.0	13.5	18.7	12.8	14.7	12.7	41.1	23.8	23.5	29.0	27.3	43.3	8.5	13.3	26.8	27.1	11.2	20.2	11.9	20.0	8.9	11.8	9.7	27.4	26.6	13.2	14.9	26.8	17.3	18.1	12.9	20.0	19.7	30.9	17.4	22.4	15.5	16.6	15.1	23.1	14.2	6.8	17.1	12.6	10.1	44.6	12.3	11.8	24.1	19.9	16.8	33.5	17.7	26.5	18.7	10.2	17.6	18.1	10.9	27.9	10.0	11.2	18.1	11.3	15.3	11.0	18.9	16.1	13.8	8.4	8.1	26.8	12.0	23.9	15.0	17.3	13.6	13.1	11.3	7.3	16.0	8.4	17.7	13.8	24.4	11.9	11.1	12.0	26.8	12.4	13.2	19.7	27.1	20.2	8.1	15.6	19.8	13.3	8.5	12.6	15.0	7.2	11.2	13.4	5.2	15.0	11.9	11.5	13.4	22.6	11.6	11.8	11.1	13.9	12.1	13.5	12.7	8.9	15.7	26.5	64.7	66.4	18.9	9.4	15.3	10.7	23.9	8.7	5.9	42.1	13.3	38.5	9.2	68.0	17.2	0.0	24.2	41.6	41.4	45.8	9.2	33.7	45.3	23.8	13.3	25.2	28.8	7.3	40.9	45.6	40.5	48.7	17.1	19.3	29.4	23.0	25.1	18.7	12.7	12.9	33.0	44.9	32.9	72.8	51.0	68.2	15.6	120.8
NCKIPSD	"AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH"	ENSG00000213672	"NCK interacting protein with SH3 domain"	Q9NZQ3	3	48673844-48686364	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"brain: 39.6;parathyroid gland: 123.9"	"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 44.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019267, HPA050005"			Enhanced	"Plasma membrane"		NA	NA		42000	"Plasma membrane"		"CAB019267: , HPA050005: AB_2680988"	"unprognostic (1.55e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.64e-3)"	"unprognostic (5.50e-3)"	"prognostic unfavorable (8.57e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (1.60e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.09e-2)"	11.7	11.9	14.4	4.9	18.5	4.4	7.8	17.9	39.6	7.0	7.9	10.3	3.5	7.3	7.8	8.6	7.8	9.6	9.3	17.8	12.9	16.0	8.7	6.8	7.4	5.9	11.1	17.8	17.7	8.5	123.9	10.0	8.0	16.9	8.1	7.4	9.6	8.9	11.7	6.4	9.8	7.3	8.7	9.2	5.7	6.2	8.4	10.9	2.9	7.7	1.9	5.4	7.7	6.5	4.9	8.5	1.0	5.3	4.8	6.4	4.7	11.8	10.5	10.7	11.0	14.6	8.9	14.9	11.9	13.4	13.3	17.0	15.4	7.3	8.8	6.5	7.0	15.2	8.0	13.6	15.8	7.7	9.8	16.6	15.7	38.9	12.2	12.8	10.6	17.7	8.5	13.8	18.4	11.6	15.1	7.5	11.2	5.3	11.8	10.6	8.7	9.6	9.0	12.4	11.8	18.6	4.9	4.9	14.6	7.2	12.3	11.2	9.1	12.5	11.8	10.0	10.2	10.5	13.0	4.1	11.5	12.9	13.6	15.7	10.6	7.7	9.8	13.1	14.2	17.5	1.0	4.6	0.2	3.5	5.3	2.6	4.9	4.2	4.1	5.8	2.6	6.4	4.1	0.3	4.8	2.8	8.5	4.6	4.7	14.4	18.5	17.9	39.6	12.9	16.0	11.1	17.8	16.9	10.9	0.0	8.6	0.0	3.2	2.3	8.9	7.5	7.6	1.4	1.2	1.8	11.8	8.9	5.0	5.5	1.9	4.0	10.6	0.0	4.0	8.8	5.1	2.4	5.7	5.5	7.7	11.1	8.1	24.5	6.3	1.7	17.0	6.9	1.7	4.6	6.4	3.6	7.3	8.0	44.6	5.7	5.9	12.9	5.6	4.1	17.4	1.5	6.9	2.2	9.0	1.8
NCL	"C23, Nsr1"	ENSG00000115053	Nucleolin	P19338	2	231453531-231483641	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004210, HPA023981, HPA071110"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes		600000	"Nucleoplasm, Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB004210: AB_670270, HPA023981: AB_1854688, HPA071110: "	"unprognostic (1.91e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (2.28e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.72e-3)"	"prognostic unfavorable (1.41e-6)"	"unprognostic (3.74e-2)"	"unprognostic (4.31e-3)"	"unprognostic (9.78e-2)"	"unprognostic (6.70e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.42e-2)"	71.2	68.2	59.6	67.7	77.0	96.6	71.0	72.8	69.2	72.1	63.0	79.2	46.0	48.1	80.3	63.7	85.2	65.7	45.9	55.9	57.7	53.3	66.7	94.7	55.6	78.4	67.4	51.8	93.9	77.5	94.8	83.4	69.5	79.8	64.6	75.4	47.1	58.1	51.8	120.6	70.3	56.9	70.9	88.4	80.2	59.4	41.7	76.4	118.9	67.8	82.6	105.5	79.9	60.6	40.8	41.3	20.4	36.4	52.6	53.9	40.8	63.3	59.3	71.9	52.7	42.5	46.2	74.0	71.7	48.7	67.7	60.0	97.9	45.6	84.2	61.8	55.3	90.9	62.2	143.9	96.3	116.1	49.2	60.3	140.5	56.3	131.9	46.6	160.1	53.3	43.8	55.9	84.5	89.0	38.9	71.0	76.8	125.1	28.9	59.5	86.2	140.1	99.4	107.1	66.9	42.6	104.6	129.7	73.9	49.7	84.2	62.3	44.4	48.0	55.1	63.3	61.3	41.4	81.1	60.3	54.3	56.2	63.4	94.2	54.8	53.8	181.3	39.5	104.5	56.2	9.5	27.9	20.4	47.4	33.2	53.9	40.8	41.7	42.6	41.3	38.9	46.6	42.1	6.0	52.6	36.4	35.5	34.4	40.8	59.6	77.0	72.8	69.2	57.7	53.3	67.4	51.8	79.8	76.4	271.0	357.6	280.1	370.4	408.5	137.1	290.7	137.6	385.4	589.2	184.9	45.2	333.3	195.6	173.5	15.4	228.8	106.1	210.2	218.7	336.0	249.6	218.4	431.8	217.9	213.5	76.3	191.8	122.8	135.8	18.9	201.0	194.7	156.9	238.1	192.5	194.0	213.8	138.2	150.3	209.2	125.5	148.8	282.2	390.1	563.8	385.9	316.9	226.1	268.8	321.5
NCOA1	"bHLHe74, F-SRC-1, KAT13A, NCoA-1, RIP160, SRC1"	ENSG00000084676	"Nuclear receptor coactivator 1"	Q15788	2	24491914-24770702	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Acyltransferase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 41.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019402, HPA070213, HPA070520"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB019402: AB_2196189, HPA070213: AB_2686235, HPA070520: AB_2686276"	"unprognostic (2.73e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.46e-2)"	"unprognostic (9.89e-3)"	"unprognostic (7.60e-2)"	"unprognostic (2.36e-2)"	"unprognostic (7.06e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.93e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.15e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.92e-2)"	9.8	10.0	15.3	7.3	18.0	8.9	10.5	15.9	17.1	13.7	8.9	13.5	4.9	12.5	13.0	11.5	10.8	10.0	8.3	8.8	20.8	12.2	11.9	8.8	9.4	8.2	10.8	9.9	17.2	10.3	23.9	16.0	10.1	14.2	9.6	10.1	19.9	10.6	13.0	42.5	9.3	10.9	11.6	9.7	9.6	7.6	11.4	10.7	8.5	7.0	12.2	9.3	9.7	10.8	2.5	5.5	14.2	3.5	3.4	4.1	1.8	6.7	5.0	8.9	4.6	9.8	9.0	13.6	3.6	7.3	4.6	4.1	4.7	2.9	4.9	1.5	6.6	8.8	1.6	5.3	3.1	5.0	23.3	7.7	17.6	2.0	1.9	6.2	8.0	14.7	14.3	4.7	4.4	3.6	5.7	4.6	6.4	10.7	8.2	6.9	4.5	7.1	2.9	4.2	4.0	3.4	5.7	41.0	2.5	5.0	9.2	8.1	6.4	8.4	5.1	3.7	4.9	6.1	4.1	5.0	7.7	6.1	5.2	3.6	9.5	8.2	8.6	4.4	5.1	3.8	11.0	3.5	6.9	3.8	2.7	4.1	1.8	3.4	4.1	2.6	2.5	3.3	4.0	14.2	3.4	2.8	5.5	3.7	1.8	15.3	18.0	15.9	17.1	20.8	12.2	10.8	9.9	14.2	10.7	35.7	29.8	13.6	10.7	27.1	97.2	33.1	15.3	20.1	31.8	14.0	49.1	11.2	6.6	12.0	13.1	29.2	24.6	23.3	23.0	14.9	31.2	14.1	18.6	20.3	15.3	58.8	24.2	33.2	25.2	3.8	43.7	26.2	18.6	10.0	22.7	63.8	17.7	35.1	40.7	11.4	67.4	38.8	35.4	32.1	36.8	27.0	4.5	25.4	23.0	14.6
NCOR1	"hCIT529I10, hN-CoR, KIAA1047, MGC104216, N-CoR, PPP1R109, TRAC1"	ENSG00000141027	"Nuclear receptor corepressor 1"	O75376	17	16029157-16218185	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043246, HPA050288, HPA051168, CAB072830"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB072830: , HPA043246: AB_2678386, HPA050288: AB_2681073, HPA051168: AB_2681370"	"unprognostic (1.83e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.06e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.52e-2)"	"prognostic favorable (7.92e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.42e-2)"	19.6	21.2	25.4	24.0	30.8	27.0	25.0	41.8	31.5	24.0	30.6	19.6	18.6	33.2	29.0	19.5	25.0	20.5	21.9	17.8	22.4	17.8	25.6	33.8	20.1	19.5	25.1	19.1	25.9	24.3	39.9	39.8	19.8	21.6	20.8	29.7	17.1	20.9	29.1	43.0	23.8	36.9	29.7	26.4	23.7	29.8	22.1	26.4	38.8	25.3	15.7	23.8	29.6	27.0	43.4	29.9	78.2	24.8	30.4	35.5	19.7	20.4	34.2	24.4	20.3	20.1	15.3	12.2	15.1	17.1	16.6	15.1	18.3	9.4	21.5	10.7	26.3	12.4	15.6	30.0	18.3	24.7	28.6	22.2	21.4	29.6	21.4	19.7	13.4	25.6	15.7	19.2	25.7	30.1	14.2	23.0	30.4	18.6	8.9	16.3	13.3	23.6	8.6	12.1	36.0	9.3	23.6	24.8	10.0	17.2	23.2	8.3	13.9	24.9	10.9	11.8	65.5	10.5	15.3	20.0	17.1	10.1	12.5	20.8	6.1	7.1	12.5	16.3	16.0	14.6	78.2	24.8	52.2	31.3	19.5	25.9	40.7	35.5	34.1	17.5	43.4	34.7	34.8	48.5	30.4	24.0	29.9	31.7	19.7	25.4	30.8	41.8	31.5	22.4	17.8	25.1	19.1	21.6	26.4	74.5	98.7	86.4	91.4	60.2	144.1	78.9	66.2	61.6	72.8	50.6	149.2	79.2	29.9	80.2	53.7	68.9	164.0	93.5	85.1	85.7	74.0	70.9	83.3	105.0	67.5	122.3	84.4	59.5	70.8	35.4	94.0	84.8	35.4	184.0	101.0	81.4	89.5	133.5	114.2	37.3	152.7	90.5	89.5	82.3	75.1	59.6	73.2	110.7	125.6	110.0
NCS1	"FREQ, NCS-1"	ENSG00000107130	"Neuronal calcium sensor 1"	P62166	9	130172578-130237304	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.8"	"Cell type enriched"	"Detected in many"	5	"Horizontal cells: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 1.2;MAIT T-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018587, HPA019713"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB018587: AB_649907, HPA019713: AB_1854404"	"prognostic unfavorable (5.40e-4)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-3)"	"prognostic unfavorable (8.69e-4)"	"unprognostic (1.29e-1)"	"unprognostic (9.23e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (1.61e-3)"	"unprognostic (4.27e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.71e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (1.65e-1)"	5.8	12.6	76.8	7.9	56.6	4.6	2.8	18.6	66.2	7.7	20.1	6.4	5.0	3.6	12.6	4.1	24.9	13.5	8.7	4.6	74.3	25.7	8.7	1.6	2.5	1.6	20.6	28.1	4.6	3.5	1.5	2.7	1.6	17.7	14.9	6.8	4.2	5.3	41.6	0.9	10.0	4.3	34.3	6.8	1.1	5.1	2.2	7.1	0.0	20.1	0.7	2.7	16.4	4.6	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.8	16.0	8.3	16.6	5.2	11.7	4.0	20.3	9.4	15.6	10.4	7.6	4.0	0.0	7.4	25.6	18.3	14.2	13.5	17.8	7.0	23.2	4.1	0.0	10.6	8.1	8.0	0.7	9.8	13.6	9.1	17.6	11.2	13.9	14.7	3.1	5.7	0.1	22.5	22.6	1.4	7.8	12.7	4.2	6.7	0.0	26.3	5.4	15.2	5.0	22.0	20.7	12.5	6.0	12.0	6.6	11.1	5.0	11.5	30.3	24.7	24.3	26.0	0.0	0.0	0.0	35.4	2.2	32.6	0.0	0.0	0.0	1.2	0.0	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	76.8	56.6	18.6	59.9	74.3	25.7	20.6	28.1	17.7	7.1	0.0	0.0	0.0	8.5	8.7	2.7	3.6	0.0	5.3	7.9	10.4	3.9	0.0	5.0	6.6	0.3	0.0	0.0	0.0	2.5	1.5	7.1	4.5	3.5	0.0	3.6	106.5	1.2	1.3	0.0	0.0	1.1	2.3	5.0	17.2	0.5	18.7	4.9	0.0	1.4	12.4	3.1	0.0	20.2	0.0	0.9	6.0	0.5	0.0	0.0	2.6
NDUFAF2	"B17.2L, mimitin, MMTN, NDUFA12L"	ENSG00000164182	"NADH:ubiquinone oxidoreductase complex assembly factor 2"	Q8N183	5	60945129-61153037	"Disease related genes, Predicted intracellular proteins"		Chaperone	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048082, HPA054776"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA048082: AB_2680254, HPA054776: AB_2682598"	"unprognostic (7.28e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (2.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.76e-2)"	"unprognostic (8.40e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.10e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.66e-2)"	25.5	25.9	22.5	16.7	24.9	11.4	27.1	13.6	24.4	16.9	20.5	11.7	8.2	16.0	16.3	12.2	19.3	12.6	15.0	33.6	19.9	21.2	19.1	27.2	11.9	13.4	20.5	14.2	23.5	41.2	14.2	25.3	9.8	18.5	19.0	18.2	13.2	16.0	16.8	56.3	12.9	13.3	23.9	18.3	10.0	17.2	20.1	12.6	4.9	17.7	16.0	12.3	26.9	19.5	15.9	20.9	1.5	13.1	17.3	20.3	9.1	30.8	16.3	11.3	36.2	21.9	31.1	21.3	36.1	19.3	22.9	28.2	27.1	22.3	38.8	37.3	24.5	44.1	12.8	19.2	31.6	28.4	20.5	27.6	13.3	29.1	25.3	33.1	19.3	7.9	16.7	34.1	20.8	63.4	15.3	20.4	17.3	22.0	20.7	23.9	24.4	17.1	28.5	9.3	11.9	38.7	19.0	31.0	52.6	21.8	13.3	23.7	10.6	22.5	19.5	35.0	10.5	23.3	13.7	18.9	16.5	25.2	35.5	39.9	15.2	21.9	42.6	21.9	34.8	19.2	0.0	13.1	1.5	12.5	11.9	14.3	15.9	15.9	14.6	20.9	11.0	13.9	14.3	0.6	17.3	9.1	7.5	20.3	9.1	22.5	24.9	13.6	24.4	19.9	21.2	20.5	14.2	18.5	12.6	11.9	21.7	43.3	50.0	53.8	27.8	79.5	45.9	24.1	34.2	36.6	11.8	19.0	79.6	47.4	137.5	33.3	26.9	0.0	48.4	45.3	50.0	52.9	19.7	80.5	44.4	39.7	23.7	33.7	26.7	9.8	71.1	42.3	42.2	10.8	49.7	19.5	60.3	45.8	58.4	88.8	22.6	25.8	60.6	82.5	68.2	55.7	11.9	24.5	59.0	51.4
NDUFB6	"B17, CI"	ENSG00000165264	"NADH:ubiquinone oxidoreductase subunit B6"	O95139	9	32552999-32573184	"Predicted intracellular proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 591.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044001, HPA053334"	Supported		Enhanced	Mitochondria		No	No			Mitochondria		"HPA044001: AB_10959448, HPA053334: AB_2682116"	"unprognostic (4.09e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.14e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.49e-1)"	"prognostic favorable (7.47e-10)"	"unprognostic (2.70e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.83e-1)"	21.9	26.8	33.9	17.7	31.8	16.0	18.7	22.6	28.3	13.7	21.9	15.5	17.3	26.5	16.8	17.4	18.6	15.4	15.9	58.6	27.6	27.9	32.8	36.6	13.9	15.4	28.4	27.2	14.1	19.5	15.4	17.8	15.5	22.9	15.1	18.2	14.6	22.7	16.1	87.2	14.6	25.5	16.4	25.9	13.5	20.0	28.9	17.1	19.2	22.2	34.4	14.5	14.1	13.5	26.0	38.8	77.4	27.3	22.2	27.5	26.5	30.2	18.6	20.7	23.7	14.1	13.2	13.3	20.3	16.6	18.8	20.8	18.2	13.7	22.6	21.2	13.9	19.5	17.2	19.5	22.4	14.1	31.0	31.3	53.7	28.6	18.8	13.8	26.7	13.9	13.6	10.9	16.9	12.9	14.2	16.9	34.7	17.1	25.5	20.9	17.5	36.0	63.1	21.9	26.0	41.4	24.8	17.4	20.9	21.0	11.4	20.9	23.6	23.5	27.0	13.6	16.2	25.5	20.8	15.0	20.5	31.1	22.6	29.7	11.4	21.2	36.6	34.3	18.9	9.6	25.0	25.8	33.3	21.0	23.1	20.2	26.0	22.4	21.6	27.6	21.8	23.0	24.3	77.4	22.2	27.3	38.8	27.5	26.5	33.9	31.8	22.6	28.3	27.6	27.9	28.4	27.2	22.9	17.1	116.1	94.0	77.4	80.5	83.7	39.2	514.3	107.0	155.2	108.1	102.9	5.9	175.9	452.6	143.9	591.4	96.3	138.7	93.5	145.0	113.2	93.0	79.2	86.8	170.4	141.7	17.5	62.0	71.8	59.8	88.6	84.8	89.6	151.8	111.8	116.6	72.0	133.2	118.5	84.5	440.9	40.8	103.5	124.6	143.8	114.3	84.6	87.1	65.4	146.3	88.4
NDUFB8	"ASHI, CI-ASHI"	ENSG00000166136	"NADH:ubiquinone oxidoreductase subunit B8"	O95169	10	100523740-100530000	"Plasma proteins, Predicted membrane proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 742.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003886, HPA065549"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003886: AB_1079463, HPA065549: "	"unprognostic (4.07e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.33e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.78e-2)"	"unprognostic (3.02e-1)"	"unprognostic (6.46e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (8.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.10e-2)"	35.2	39.8	86.7	27.0	67.4	35.6	26.1	39.3	81.5	25.4	37.7	23.8	23.1	38.8	24.7	42.3	36.8	28.8	28.2	110.0	70.6	62.8	50.4	50.6	19.8	28.1	63.9	54.1	27.7	36.3	31.5	31.4	19.9	49.9	26.6	36.2	25.7	39.7	34.5	88.5	24.3	33.8	41.5	38.9	22.1	31.5	12.0	41.4	18.3	28.3	49.2	27.8	25.2	21.5	76.6	88.6	62.2	74.4	60.5	105.9	129.7	42.2	71.3	38.5	68.3	29.2	28.4	42.6	28.9	62.8	44.4	48.1	96.6	49.3	44.8	26.1	32.3	32.8	50.7	28.8	46.9	35.4	29.4	73.6	31.5	60.5	78.2	39.6	64.3	54.3	34.9	42.4	44.3	59.8	32.2	48.5	59.6	32.7	28.5	38.2	51.3	62.0	81.0	25.8	54.4	66.6	43.3	42.1	59.1	52.0	48.4	26.7	37.4	21.3	40.5	41.9	27.6	60.3	57.6	32.5	25.4	28.8	27.1	50.5	51.7	46.9	55.6	50.5	68.2	28.3	35.1	74.4	62.2	59.0	72.9	69.5	76.6	73.6	67.8	80.4	64.1	79.8	76.7	17.1	60.5	61.4	88.6	105.9	129.7	86.7	67.4	39.3	81.5	70.6	62.8	63.9	54.1	49.9	41.4	71.5	126.9	126.6	146.5	0.0	174.3	341.7	234.4	156.6	88.7	188.5	55.0	285.1	742.8	226.5	20.4	131.5	123.8	116.8	230.9	258.4	136.0	175.3	101.1	286.9	348.6	144.6	101.8	146.7	171.1	43.8	202.0	160.0	0.0	261.5	229.2	129.5	225.4	259.6	204.4	592.8	122.1	168.1	220.6	53.7	79.5	0.0	257.3	174.0	305.7	185.2
NDUFV3	CI-10k	ENSG00000160194	"NADH:ubiquinone oxidoreductase subunit V3"	P56181	21	42879644-42913304	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 129.5"	"Cell type enhanced"	"Detected in all"	9	"Cardiomyocytes: 701.2;Late spermatids: 1042.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019791, HPA020463, HPA030427, CAB034142"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB034142: AB_2298212, HPA019791: AB_1854357, HPA020463: AB_1854358, HPA030427: AB_10603024"	"unprognostic (1.62e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.56e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-1)"	18.1	14.1	16.9	11.1	17.2	15.8	14.6	11.8	23.2	12.0	15.9	11.9	14.6	15.2	15.1	15.7	15.6	12.7	15.4	54.9	14.2	11.0	15.1	24.3	10.8	12.5	14.0	18.6	16.0	17.7	13.2	13.1	11.6	19.2	13.6	11.4	12.2	19.4	21.8	129.5	15.4	13.5	16.9	16.0	13.3	14.3	20.3	13.3	6.6	11.6	18.5	10.6	13.3	11.8	9.9	22.9	16.0	22.8	10.5	8.8	10.3	9.6	11.4	11.0	18.0	13.6	11.9	13.6	19.2	11.0	11.5	9.6	20.7	11.9	10.7	15.2	7.2	15.6	10.5	12.8	16.9	7.5	6.1	15.5	35.3	13.3	16.2	21.4	12.0	18.5	13.3	14.7	11.6	18.4	10.4	14.4	7.4	27.9	14.0	13.1	18.9	8.0	18.2	14.4	21.5	22.4	13.9	8.0	33.4	15.4	12.8	8.1	8.4	19.3	22.8	12.7	6.2	19.6	15.9	16.9	10.8	7.5	13.8	13.6	20.8	13.7	12.2	14.1	21.6	16.2	3.7	21.4	16.0	8.0	22.8	8.1	8.1	7.6	6.7	22.9	9.9	8.8	7.7	3.8	10.5	19.6	11.3	8.8	10.3	16.9	17.2	11.8	23.2	14.2	11.0	14.0	18.6	19.2	13.3	50.6	37.7	43.0	46.0	17.6	69.1	701.2	89.2	92.3	27.3	85.5	64.8	46.1	195.6	69.0	416.9	34.9	128.4	140.2	87.3	49.8	41.1	75.6	30.1	285.4	97.8	54.0	75.1	62.0	81.5	1042.9	61.5	68.7	35.4	67.7	73.4	56.3	83.6	77.2	58.7	265.4	102.6	71.1	47.2	216.7	86.2	20.6	75.2	34.6	82.9	49.3
NECAB1	EFCBP1	ENSG00000123119	"N-terminal EF-hand calcium binding protein 1"	Q8N987	8	90791550-90959408	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 56.4"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 17.9;Alveolar cells type 2: 54.2;Cardiomyocytes: 55.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 6.1;hTERT-RPE1: 6.4;MOLT-4: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210"	Enhanced	Supported	Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB068208: AB_2665671, CAB068209: AB_2665672, CAB068210: AB_2665673, HPA023252: AB_1848013, HPA023629: AB_1848014, HPA025963: AB_1848015, HPA031262: AB_2673815"	"unprognostic (8.09e-3)"	"unprognostic (3.78e-1)"	"unprognostic (8.17e-3)"	"unprognostic (5.96e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.83e-3)"	"unprognostic (8.38e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.45e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (5.39e-3)"	2.7	4.9	19.7	2.0	27.3	3.2	1.5	0.5	56.4	1.4	3.7	12.1	0.3	1.7	4.1	4.4	3.6	1.6	3.1	10.9	19.5	9.8	3.4	1.1	6.8	1.4	16.0	30.7	3.8	1.3	1.9	1.9	2.8	10.8	2.6	1.1	4.1	2.5	2.0	1.3	1.9	1.8	1.3	18.7	2.4	2.1	5.2	17.4	0.0	2.9	0.0	1.0	4.2	1.2	0.5	1.8	0.3	0.0	0.7	0.9	0.2	0.1	0.1	2.3	0.4	0.0	0.1	0.1	2.5	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.0	2.3	0.0	1.0	0.0	0.1	0.0	4.6	6.1	2.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	6.4	0.0	1.7	4.0	4.4	0.0	4.9	6.3	3.1	0.8	0.0	0.1	0.0	3.9	0.0	0.0	0.0	4.1	4.3	0.1	0.0	2.1	2.9	0.0	0.2	1.5	3.8	3.8	0.0	1.6	6.0	3.6	3.1	3.8	0.0	1.8	0.0	0.0	0.1	0.6	0.0	0.4	0.2	0.4	0.6	0.1	0.5	0.6	0.9	0.3	0.7	0.0	1.8	0.9	0.2	19.7	27.3	0.5	37.1	19.5	9.8	16.0	30.7	10.8	17.4	17.9	54.2	0.0	0.2	0.5	3.9	55.7	0.0	0.0	4.5	12.2	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.2	0.0	1.3	0.1	1.1	0.0	0.1	0.0	0.0	0.6	0.0	1.0	2.3	0.7	3.3	0.0	0.0	0.3	0.1	0.0	2.1	5.6	0.5	6.5	2.7	4.3	1.7	0.6	0.0	0.0	0.0	0.0
NEDD8	Nedd-8	ENSG00000129559	"Neural precursor cell expressed, developmentally down-regulated 8"	Q15843	14	24216852-24232454	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004082, HPA027583, HPA060254"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA		5700000	Nucleoplasm	Cytosol	"CAB004082: AB_10695300, HPA027583: AB_2732439, HPA060254: AB_2732644"	"unprognostic (1.26e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.66e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.25e-3)"	38.2	48.1	55.5	30.7	58.1	34.6	42.2	34.1	62.4	41.0	36.3	26.8	32.6	25.0	32.2	59.9	40.3	34.3	31.3	50.7	47.1	49.5	46.5	48.4	30.5	31.5	49.4	54.6	34.3	33.4	101.1	31.3	39.7	45.5	31.6	40.0	27.4	37.2	40.7	70.7	36.5	28.4	43.0	36.0	34.9	29.9	25.7	34.3	26.9	37.5	44.7	46.8	30.7	32.0	60.2	76.1	90.2	60.1	43.2	64.1	89.9	26.0	45.7	37.1	26.2	42.2	36.9	27.0	35.6	37.8	42.0	38.8	31.5	31.9	22.5	20.9	50.1	35.4	27.5	37.0	55.6	59.1	31.7	22.4	24.0	42.1	107.3	36.6	39.7	25.2	39.2	37.0	35.3	27.8	39.6	50.1	26.4	21.4	26.4	64.7	57.9	31.6	37.7	27.4	48.1	53.5	22.5	29.4	22.9	48.4	49.6	15.7	36.6	30.8	31.4	25.6	39.6	19.0	31.6	37.5	23.9	24.0	30.5	31.5	31.4	47.3	32.6	17.2	22.9	22.6	73.5	57.9	90.2	46.8	60.1	50.7	60.2	54.4	51.9	56.9	51.1	51.2	52.0	62.2	43.2	59.0	76.1	64.1	89.9	55.5	58.1	34.1	62.4	47.1	49.5	49.4	54.6	45.5	34.3	134.0	147.7	239.7	188.0	246.8	91.4	436.0	229.3	136.5	126.3	294.8	45.2	457.7	504.0	309.5	46.7	283.5	261.3	163.5	353.5	526.2	324.5	205.0	213.6	344.7	501.8	100.1	204.1	216.7	303.8	60.6	252.0	280.5	254.8	432.0	208.2	154.8	360.0	256.1	259.2	606.3	68.0	207.0	308.8	113.9	219.0	337.9	350.8	243.7	228.6	222.9
NEFM	"NEF3, NF-M, NFM"	ENSG00000104722	"Neurofilament medium"	P07197	8	24913012-24919098	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 144.7"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 26.9;Early spermatids: 68.8;Late spermatids: 86.3;Rod photoreceptor cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"MAIT T-cell: 1.0;memory CD4 T-cell: 1.0;naive CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Cell line enriched"	"Detected in some"	23	"HEK 293: 292.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010900, CAB012976, HPA022845, HPA023138"	Enhanced		Enhanced	"Intermediate filaments"		Yes	NA			"Intermediate filaments"		"CAB010900: AB_477261, CAB012976: AB_2533154, HPA022845: AB_1854399, HPA023138: AB_1854398"	"unprognostic (1.41e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.38e-2)"	"unprognostic (5.17e-2)"	"unprognostic (6.32e-3)"		"unprognostic (6.10e-3)"	"unprognostic (2.57e-1)"	"unprognostic (8.55e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.61e-2)"	1.5	18.9	20.3	2.0	24.2	1.3	1.3	10.9	87.6	9.7	2.0	5.6	0.0	1.3	3.8	1.3	4.7	1.3	1.4	1.3	36.1	25.0	2.2	1.2	1.3	1.3	52.2	22.4	2.0	2.5	1.2	3.3	1.4	144.7	2.5	1.9	3.4	1.3	26.9	1.9	1.3	1.5	3.3	26.7	1.3	1.5	12.4	4.9	0.0	1.3	0.0	1.6	1.3	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	292.9	0.0	0.0	0.0	6.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.3	24.2	10.9	71.9	36.1	25.0	52.2	22.4	144.7	4.9	0.0	0.0	0.0	0.1	1.1	26.9	2.0	0.0	0.0	1.2	0.0	5.9	0.0	0.0	0.0	68.8	0.6	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	19.1	3.4	0.0	0.0	86.3	0.9	0.0	1.7	0.0	0.0	20.8	0.0	0.0	4.2	0.4	46.9	0.0	1.3	2.2	1.3	0.3	0.0	0.0	0.0	0.3
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787346	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA073029: AB_2732216, HPA073916: AB_2732245"	"unprognostic (1.52e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.05e-1)"	10.2	21.8	18.7	6.8	17.7	2.7	10.3	11.8	20.9	11.3	5.6	9.0	7.0	3.6	9.9	15.4	6.5	17.9	6.9	14.2	15.4	20.0	9.3	11.0	7.7	8.4	18.4	16.1	12.6	10.9	7.8	13.2	7.6	20.3	10.5	6.1	9.7	11.5	10.3	24.7	18.1	4.6	10.2	12.3	9.5	5.1	26.8	13.3	1.8	15.5	7.1	7.9	7.4	15.8	14.7	5.5	0.8	2.5	9.1	13.6	4.7	4.9	14.0	8.8	17.2	4.2	7.9	3.9	7.9	6.6	7.7	5.3	4.3	5.5	1.9	3.1	9.5	16.6	4.4	8.4	8.7	10.6	5.8	4.2	6.8	3.3	8.4	3.4	2.9	5.1	6.9	12.9	6.7	6.2	7.5	7.2	2.3	9.6	6.7	9.1	5.2	0.5	3.1	7.9	20.5	7.5	8.7	11.3	5.3	9.0	7.5	13.6	10.7	6.2	3.3	11.3	7.4	5.2	0.5	8.8	8.8	12.7	2.3	11.1	6.3	13.1	3.5	23.2	10.2	17.8	0.4	1.5	0.1	9.1	2.5	12.1	14.7	9.3	10.8	3.0	11.4	13.6	12.0	0.8	9.1	1.1	5.5	5.8	4.7	18.7	17.7	11.8	19.8	15.4	20.0	18.4	16.1	20.3	13.3	0.0	4.3	12.6	14.3	7.6	25.6	17.8	17.8	5.3	6.8	7.0	15.7	15.6	28.2	17.4	0.8	9.3	0.9	0.0	20.5	13.6	10.8	15.1	2.3	21.2	12.1	7.9	9.7	7.4	4.7	2.1	13.0	6.6	13.5	10.0	4.5	27.9	14.2	0.0	23.0	24.7	13.2	6.5	13.2	14.2	45.1	11.2	4.5	7.2	5.0	9.1
NEIL3	"FLJ10858, FPG2, hFPG2, hNEI3, ZGRF3"	ENSG00000109674	"Nei like DNA glycosylase 3"	Q8TAT5	4	177309836-177362943	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"lymphoid tissue: 70.8"	"Cell type enhanced"	"Detected in some"	8	"Club cells: 2.3;Extravillous trophoblasts: 2.9;Kupffer cells: 2.2;Spermatocytes: 1.9;Spermatogonia: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 26.6;HL-60: 29.0;Karpas-707: 38.1;MOLT-4: 29.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065761			Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA065761: AB_2685555"	"unprognostic (6.03e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.64e-7)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (6.09e-3)"	"unprognostic (7.67e-2)"	"unprognostic (6.51e-4)"	"unprognostic (2.82e-3)"	"unprognostic (0.00e+0)"	"unprognostic (3.25e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.04e-2)"	0.5	0.4	0.2	7.4	0.2	9.3	0.7	0.1	0.2	0.8	1.5	0.1	0.1	1.5	0.5	0.1	5.6	0.2	0.3	0.5	0.2	0.2	0.4	0.4	0.9	5.1	0.2	0.1	0.3	0.2	0.0	0.2	1.6	0.2	0.2	2.1	0.2	0.8	0.1	0.2	3.4	1.7	0.5	0.7	1.5	0.8	3.5	0.3	70.8	0.2	1.1	5.0	0.7	1.3	0.2	0.3	0.8	0.0	1.6	1.6	0.2	7.1	5.9	6.3	3.1	0.7	1.3	3.1	8.8	3.3	9.8	5.8	2.1	6.3	7.9	1.3	2.3	9.7	3.3	6.6	3.5	14.3	26.6	4.3	5.4	4.7	5.6	0.2	29.0	3.7	0.1	0.2	10.1	2.2	2.0	3.7	20.5	5.6	38.1	6.3	3.1	29.3	11.1	2.9	2.1	4.4	6.0	4.3	2.5	2.5	0.9	5.0	3.4	4.4	5.1	2.4	2.9	4.2	7.6	1.7	5.9	4.6	3.0	8.9	2.6	1.7	12.5	3.9	10.3	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	0.2	0.0	1.1	0.8	1.6	0.0	0.3	1.6	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.6	2.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.9	3.0	1.1	0.2	0.5	0.4	0.1
NELFA	"NELF-A, WHSC2"	ENSG00000185049	"Negative elongation factor complex member A"	Q9H3P2	4	1982714-2041903	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009960, HPA039858, HPA043931"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB009960: AB_2288566, HPA039858: AB_2676711, HPA043931: AB_2678737"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.32e-1)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.35e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.05e-2)"	14.8	13.7	18.3	17.2	19.0	20.0	16.5	36.4	23.2	17.0	15.1	22.5	15.7	21.6	19.5	15.1	26.1	21.0	11.4	10.8	16.8	12.2	14.7	10.9	11.4	15.8	14.1	12.0	26.9	27.0	12.5	19.1	16.8	13.6	15.7	8.3	16.2	28.6	28.4	17.4	23.4	21.2	13.3	11.9	18.4	20.6	26.5	18.3	18.0	16.8	10.9	21.6	18.1	19.5	20.5	14.9	12.0	14.0	13.1	18.5	10.3	10.8	10.0	8.7	16.0	3.6	3.8	17.4	5.8	4.1	7.0	5.6	16.6	18.7	19.2	8.4	3.7	8.8	10.3	8.8	7.3	3.4	9.8	13.7	12.6	7.4	15.6	5.3	13.0	12.9	3.2	6.5	4.7	5.0	5.2	5.3	10.9	23.8	9.2	3.0	12.6	25.2	37.5	25.3	9.3	15.2	23.0	7.6	12.0	5.0	9.1	23.9	14.9	6.7	8.0	9.9	5.7	15.4	9.9	6.0	7.1	8.1	8.2	12.8	19.7	20.3	21.3	8.2	13.7	8.8	6.0	12.3	12.0	14.2	14.0	17.1	14.6	16.3	12.6	11.9	20.5	14.2	11.0	4.7	13.1	11.2	14.9	18.5	10.3	18.3	19.0	36.4	23.2	16.8	12.2	14.1	12.0	13.6	18.3	11.9	14.1	15.2	15.5	29.0	18.7	4.6	10.2	16.0	18.2	12.2	37.3	23.7	8.3	17.3	20.5	9.3	14.7	0.0	12.1	24.1	15.8	15.0	9.2	6.7	14.0	35.0	15.5	10.4	10.3	6.0	14.4	10.4	13.5	19.8	16.5	20.3	13.5	17.8	12.4	6.5	19.5	0.0	10.3	28.3	36.5	33.4	23.8	13.8	18.7	23.7
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959110	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 512.1;Late spermatids: 1326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	19.4	21.1	18.5	17.6	20.4	18.4	26.8	10.2	18.2	22.8	20.4	19.0	23.5	15.8	20.7	30.2	21.7	30.4	20.4	22.6	18.5	17.0	19.2	13.5	17.0	20.9	18.5	18.7	21.2	46.1	12.4	18.0	23.7	27.5	14.4	17.9	12.7	24.9	22.4	40.4	19.6	18.1	19.5	28.0	16.3	18.1	58.1	18.2	28.3	20.8	16.9	14.7	15.3	18.8	23.6	25.2	28.8	33.4	20.7	22.5	23.4	17.3	12.4	17.4	13.5	6.2	10.2	13.9	12.9	14.0	11.8	6.5	18.7	9.9	13.4	14.5	13.5	29.3	12.7	6.1	6.4	6.9	11.3	13.6	8.0	13.4	23.5	10.2	15.6	9.1	9.1	17.3	10.4	19.5	21.9	10.9	12.1	12.9	16.0	13.4	28.8	22.9	10.2	6.7	21.3	4.3	20.4	13.8	21.0	14.8	16.2	11.1	18.3	10.1	11.2	24.3	12.6	16.8	29.8	10.0	10.8	22.0	11.4	24.0	26.2	27.1	14.9	7.0	9.9	21.0	20.0	25.4	28.8	21.6	30.5	21.8	23.6	22.2	22.5	25.2	23.6	20.1	20.4	14.5	20.7	33.4	18.5	20.5	23.4	18.5	20.4	10.2	18.2	18.5	17.0	18.5	18.7	27.5	18.2	14.9	27.5	38.2	55.6	41.9	14.9	41.2	76.5	119.1	33.0	31.4	11.8	84.5	112.7	75.5	512.1	48.4	82.2	0.0	118.3	93.8	44.0	50.5	43.9	30.6	74.9	11.1	32.8	41.1	50.2	1326.0	65.9	48.4	47.2	80.2	58.5	50.2	89.2	84.2	42.5	78.5	22.9	32.3	48.1	183.6	96.5	36.5	95.7	52.9	62.6	48.2
NES	FLJ21841	ENSG00000132688	Nestin	P48681	1	156668763-156677397	"Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 77.9"	"Cell type enhanced"	"Detected in many"	19	"Cardiomyocytes: 191.0;Endothelial cells: 67.1;Sertoli cells: 103.5;Smooth muscle cells: 44.2"	"Group enriched"	"Detected in all"	6	"glioma: 147.0;melanoma: 101.4;testis cancer: 34.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 92.5;HUVEC TERT2: 46.8;LHCN-M2: 74.7;RH-30: 76.5;SuSa: 52.8;WM-115: 36.1"					"Low region specificity"	"Detected in all"			"CAB005889, HPA006286, HPA007007, HPA026111, CAB058692"	Enhanced		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"CAB005889: AB_2251301, CAB058692: AB_2665584, HPA006286: AB_2667550, HPA007007: AB_1854381, HPA026111: AB_1854382"	"unprognostic (7.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.56e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (8.02e-7)"	"unprognostic (2.87e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.67e-2)"	"unprognostic (8.11e-3)"	22.1	4.2	6.2	7.1	7.6	0.4	13.8	6.0	13.3	16.9	5.9	13.0	7.5	3.1	23.4	12.3	10.0	12.5	8.9	77.9	6.5	5.1	15.7	4.5	16.0	4.2	8.2	5.1	13.2	2.2	7.5	5.6	8.9	12.8	14.6	4.0	12.2	3.8	20.0	25.3	3.2	4.9	16.1	12.0	26.8	4.2	5.3	6.2	0.4	8.0	16.8	3.5	12.7	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	92.5	19.7	0.2	5.1	0.0	22.3	17.6	0.3	0.5	14.6	0.2	0.0	5.3	2.1	0.0	0.4	9.3	0.0	0.2	0.0	0.1	0.1	1.3	6.6	0.8	0.0	5.5	4.3	0.0	0.8	0.0	0.7	46.8	0.0	0.6	0.0	74.7	0.6	0.0	0.0	15.0	0.8	12.8	0.1	76.5	0.0	0.0	0.0	0.2	14.9	0.5	0.6	17.2	52.8	0.2	0.1	33.8	0.1	5.2	0.6	1.2	0.0	3.3	0.0	2.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	7.6	6.0	6.3	6.5	5.1	8.2	5.1	12.8	6.2	0.0	7.9	0.0	0.4	2.2	0.3	191.0	0.0	0.0	1.2	17.4	0.0	0.2	0.0	1.4	0.4	67.1	0.0	0.0	0.0	1.9	14.4	0.4	0.0	0.0	1.5	0.0	0.0	23.4	0.6	0.0	7.5	1.1	1.7	1.8	0.0	13.2	0.4	0.0	3.9	0.0	1.1	103.5	44.2	0.5	3.1	2.0	0.1	0.0	0.0	0.3
NF2	"ACN, BANF, merlin, SCH"	ENSG00000186575	"Neurofibromin 2"	P35240	22	29603556-29698598	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Deafness, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 61.9;Late spermatids: 86.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003097, CAB005385"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"CAB005385: AB_2298548, HPA003097: AB_1079473"	"unprognostic (3.27e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.76e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.01e-3)"	"unprognostic (4.66e-1)"	"prognostic favorable (2.89e-5)"	"unprognostic (7.73e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.62e-2)"	11.8	12.4	23.6	11.1	20.1	10.0	15.4	20.8	28.1	10.8	9.7	9.0	11.8	7.8	10.5	11.3	14.2	11.3	8.0	19.7	26.6	16.4	13.5	11.1	11.9	24.1	18.0	13.5	11.0	12.9	46.8	8.6	6.9	11.4	10.2	8.7	9.5	9.3	15.4	25.7	12.1	8.5	11.9	10.7	10.4	8.8	21.6	10.1	14.9	15.6	11.5	9.9	10.6	10.2	8.5	13.6	6.6	17.3	11.6	15.0	9.8	26.6	10.8	3.8	24.6	7.4	7.4	3.6	21.7	12.2	23.8	20.6	10.6	6.6	7.1	18.0	22.3	16.5	9.5	7.8	12.6	21.3	10.3	6.1	8.4	8.1	7.6	7.9	12.0	10.0	6.8	5.7	16.9	20.6	8.1	16.7	4.6	4.1	6.6	23.1	11.2	7.3	4.8	2.8	6.3	10.2	7.6	20.3	6.8	24.2	12.5	5.8	4.0	12.4	8.4	4.9	4.0	5.4	4.8	31.0	35.5	40.5	15.4	36.6	10.3	8.2	8.5	9.4	4.7	22.6	6.6	9.5	3.6	15.0	13.5	12.8	8.2	11.3	10.1	13.6	8.5	9.8	9.2	2.3	11.6	17.3	9.3	9.4	9.8	23.6	20.1	20.8	28.1	26.6	16.4	18.0	13.5	11.4	10.1	6.0	16.1	9.0	9.6	12.6	16.5	19.9	17.8	6.7	7.9	14.0	9.8	9.9	18.3	42.9	61.9	9.8	8.4	0.0	21.5	6.3	12.6	9.5	23.0	12.5	12.4	28.6	12.6	10.4	10.0	86.8	6.6	7.2	8.5	6.4	7.5	17.3	28.7	15.6	11.7	16.2	8.5	6.5	14.9	21.4	7.2	12.5	3.2	10.9	9.8	8.6
NFIA	"KIAA1439, NFI-L"	ENSG00000162599	"Nuclear factor I A"	Q12857	1	60865259-61462793	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Leydig cells: 378.6;Peritubular cells: 412.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 37.8;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006111, HPA008884"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006111: AB_1854422, HPA008884: AB_1854421"	"unprognostic (1.50e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.44e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.22e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.20e-2)"	"prognostic favorable (7.01e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (2.03e-4)"	29.1	17.7	21.9	17.0	19.1	15.9	28.5	42.1	16.9	23.1	20.1	17.1	19.2	9.1	17.1	16.3	27.9	20.4	18.7	25.7	18.2	13.7	13.7	48.4	11.3	8.7	16.9	13.0	22.1	17.2	24.5	14.1	6.5	21.9	26.0	12.8	16.4	25.3	26.5	30.8	11.6	12.3	44.0	25.8	11.7	14.9	11.1	15.9	2.9	36.6	14.9	8.8	35.6	30.9	1.3	2.4	5.2	5.0	0.7	5.6	2.8	3.4	3.3	0.4	37.8	15.9	10.5	0.1	0.8	2.6	0.8	1.6	0.2	2.6	5.8	2.7	1.6	0.8	4.5	1.4	9.3	0.4	13.4	3.0	0.3	8.5	2.7	3.6	0.7	1.2	13.2	7.6	3.7	15.4	2.8	9.9	1.8	3.6	10.9	0.7	1.7	0.1	0.1	1.7	3.5	3.3	0.5	3.9	9.6	2.0	6.9	3.7	2.8	2.0	15.9	5.2	0.5	20.1	0.2	9.4	0.6	5.4	8.7	1.6	0.9	1.6	0.0	0.9	0.0	0.8	5.2	5.0	2.3	3.7	3.4	5.5	1.3	4.5	5.6	2.4	0.5	4.4	5.3	0.2	0.7	4.3	1.7	0.1	2.8	21.9	19.1	42.1	16.9	18.2	13.7	16.9	13.0	21.9	15.9	32.8	33.6	5.4	59.0	75.6	33.8	159.5	142.7	66.9	62.6	45.4	2.0	4.7	23.2	26.4	20.8	92.6	15.2	140.2	42.1	1.3	154.1	78.8	26.5	273.8	12.6	39.7	24.2	171.2	52.2	9.9	378.6	13.7	43.9	16.2	43.1	155.3	21.3	31.6	412.3	88.5	5.8	142.3	149.4	6.0	8.1	66.7	1.4	11.4	64.6	44.8
NFKBIA	"IkappaBalpha, IKBA, MAD-3, NFKBI"	ENSG00000100906	"NFKB inhibitor alpha"	P25963	14	35401511-35404749	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction"		"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.1"	"Cell type enhanced"	"Detected in all"	8	"Basal keratinocytes: 3603.5;Suprabasal keratinocytes: 2990.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 84.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003815, HPA029207"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB003815: AB_344886, HPA029207: AB_10603122"	"prognostic favorable (1.33e-5)"	"unprognostic (3.39e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.24e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.32e-2)"	"unprognostic (3.69e-1)"	"unprognostic (4.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (3.80e-2)"	49.0	38.5	14.9	63.7	25.7	209.1	60.8	16.1	27.8	33.8	32.8	10.3	36.7	13.5	21.3	15.6	50.4	30.5	34.3	30.9	18.8	10.5	30.6	45.1	73.0	47.7	29.7	7.8	57.4	22.1	6.5	25.3	25.5	21.8	28.7	18.6	19.5	44.2	64.6	33.1	48.2	42.3	24.9	23.0	47.4	26.1	19.6	23.9	35.0	27.8	46.2	38.1	41.8	45.2	45.3	55.0	118.2	58.3	33.2	37.3	51.7	13.1	11.7	4.4	4.0	26.1	17.4	15.8	5.5	52.8	11.9	10.6	3.6	8.0	8.0	14.7	8.7	28.0	17.4	8.4	22.8	17.1	48.5	3.2	3.9	8.4	21.5	15.6	6.2	3.3	18.9	23.0	8.1	20.7	7.9	10.7	4.0	3.3	12.9	8.4	15.5	8.2	15.0	4.1	12.8	7.2	18.6	5.1	6.6	20.4	84.8	4.0	6.9	14.6	25.7	6.1	9.6	14.6	13.3	19.9	16.4	5.9	4.7	8.8	15.8	16.0	13.6	13.7	4.7	3.3	35.8	58.3	36.6	24.2	33.4	37.3	34.0	29.3	25.4	55.0	45.3	25.6	21.7	118.2	33.2	22.1	29.7	19.5	51.7	14.9	25.7	16.1	27.8	18.8	10.5	29.7	7.8	21.8	23.9	497.3	711.4	171.6	1047.5	3603.5	25.1	132.1	298.1	131.2	346.9	59.3	11.8	146.4	165.8	692.3	3.4	543.9	448.5	23.3	344.2	134.5	404.0	1015.6	876.2	131.0	760.7	46.1	195.3	279.9	370.8	7.2	141.8	871.3	1029.1	602.3	143.8	87.6	391.8	259.6	109.3	89.7	34.8	200.5	1642.1	2.8	10.7	2990.0	552.0	370.7	198.2	907.4
NFRKB	"DKFZp547B2013, INO80G"	ENSG00000170322	"Nuclear factor related to kappaB binding protein"	Q6P4R8	11	129863636-129895590	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007082, HPA007128"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA007082: AB_1079481, HPA007128: AB_1079482"	"unprognostic (1.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (6.56e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.68e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.31e-2)"	"unprognostic (9.22e-2)"	"unprognostic (4.15e-2)"	"unprognostic (6.57e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.93e-2)"	5.8	7.8	10.1	7.8	13.7	13.4	7.3	17.0	11.2	7.8	9.2	7.6	7.0	8.5	12.7	12.4	8.7	12.5	6.3	4.5	8.4	5.2	7.4	6.6	7.1	8.8	7.5	9.1	14.6	11.4	10.3	10.2	8.4	7.4	9.6	6.7	9.2	9.9	9.6	10.4	14.6	9.0	11.8	5.5	7.0	8.3	27.0	7.0	13.6	18.8	6.6	10.6	10.5	9.5	7.8	8.5	11.1	9.8	3.7	11.5	6.9	7.8	7.5	17.1	9.2	7.3	7.3	10.8	5.4	5.0	6.5	6.4	23.4	13.6	18.8	15.0	4.2	9.6	20.2	16.5	10.7	6.1	7.4	14.4	37.1	13.6	9.7	5.3	9.4	12.6	4.6	11.9	10.7	11.3	7.5	11.2	12.7	21.6	14.4	6.5	7.1	8.0	16.3	8.7	11.6	17.8	11.9	7.4	8.6	8.2	24.8	8.8	9.2	12.3	12.2	3.4	13.3	28.4	8.8	8.8	9.8	9.7	7.2	6.8	4.6	5.6	17.3	4.1	18.7	8.4	11.1	8.4	10.0	10.9	9.8	11.5	5.9	11.1	9.1	8.5	7.8	9.3	7.5	10.0	3.7	8.5	7.7	7.4	6.9	10.1	13.7	17.0	11.2	8.4	5.2	7.5	9.1	7.4	7.0	8.9	15.9	5.2	15.5	26.1	9.3	7.3	7.6	12.0	13.6	7.0	9.8	16.8	6.6	9.6	8.2	7.0	9.7	0.0	8.8	13.2	10.4	9.4	10.4	10.4	9.0	7.9	8.2	8.6	8.1	5.8	13.6	7.3	13.5	10.0	8.8	9.7	8.9	7.0	9.9	6.9	10.6	32.3	8.4	39.3	45.3	30.7	19.5	10.0	10.6	15.4
NFX1	"MGC20369, NFX2, TEG-42, Tex42"	ENSG00000086102	"Nuclear transcription factor, X-box binding 1"	Q12986	9	33290511-33371157	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Activator, DNA-binding, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056310, HPA061382, HPA073519"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA056310: AB_2683097, HPA061382: AB_2684496, HPA073519: AB_2686614"	"unprognostic (3.90e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.02e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.81e-2)"	"unprognostic (8.71e-2)"	"prognostic favorable (3.75e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.13e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.14e-2)"	"unprognostic (9.62e-2)"	"unprognostic (3.20e-2)"	23.7	19.8	17.6	17.8	26.3	22.5	24.1	33.0	26.7	19.2	24.4	24.7	18.0	19.2	26.3	19.2	22.3	18.6	14.4	26.4	16.2	16.0	17.4	31.3	19.6	23.1	17.8	19.5	26.5	20.9	28.3	30.9	17.7	25.2	20.4	22.4	19.3	22.9	23.6	44.8	31.2	23.0	21.5	18.1	21.0	19.3	14.4	22.0	35.1	26.7	19.1	32.8	24.7	19.8	10.7	12.3	22.9	7.1	6.8	10.1	5.0	15.3	12.5	11.5	10.9	17.2	19.4	11.6	14.5	14.5	16.5	16.5	11.4	6.3	23.8	9.3	16.7	11.1	8.7	20.5	15.7	15.5	17.4	10.3	12.5	30.6	12.7	21.0	22.2	13.9	18.1	26.3	14.0	35.5	14.8	10.0	13.6	19.0	20.8	17.2	10.8	14.3	20.9	18.7	11.3	14.2	15.4	12.6	13.0	11.1	14.7	16.0	11.2	14.5	15.7	8.3	14.2	9.1	22.2	12.5	13.5	11.3	9.7	15.7	11.2	10.1	23.7	14.8	11.3	7.7	22.9	4.2	7.9	8.4	7.1	8.9	10.7	9.0	9.0	7.1	9.1	10.1	9.9	3.0	6.8	5.5	12.3	6.1	5.0	17.6	26.3	33.0	26.7	16.2	16.0	17.8	19.5	25.2	22.0	56.6	43.9	35.8	19.9	7.4	27.8	34.3	28.1	53.5	48.9	26.2	51.1	10.2	6.6	13.9	65.8	11.3	19.0	23.3	11.5	10.2	12.0	21.1	17.4	26.0	12.8	20.6	8.7	16.5	16.7	13.3	17.0	11.5	3.3	13.6	22.8	15.1	11.3	17.6	21.5	6.4	32.6	12.9	11.2	12.1	13.1	9.8	15.1	13.1	16.7	16.1
NGRN	DSC92	ENSG00000182768	"Neugrin, neurite outgrowth associated"	Q9NPE2	15	90265659-90278141	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 103.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041367, HPA076267"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge,Mitochondria"	"Intracellular and membrane"	Yes	No			Mitochondria	"Nucleoplasm, Cytokinetic bridge"	"HPA041367: AB_10796668, HPA076267: "	"unprognostic (2.82e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.22e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.68e-3)"	"unprognostic (3.21e-1)"	13.3	21.3	49.2	11.0	43.2	19.4	18.7	27.6	61.5	18.5	15.6	13.8	8.4	9.3	18.9	21.0	13.1	15.2	14.1	19.1	38.9	42.2	11.2	13.3	15.3	11.9	38.9	37.7	19.4	18.9	21.1	17.1	12.3	30.9	15.5	12.1	11.4	14.4	14.5	47.6	17.7	11.3	12.4	25.7	14.0	13.9	13.8	14.0	3.8	23.3	15.4	11.4	12.7	15.4	5.2	2.4	6.0	3.1	4.2	4.8	2.5	2.9	7.4	9.8	15.4	8.6	3.7	1.2	4.2	3.3	4.0	2.9	3.5	1.7	4.7	2.8	5.0	3.4	4.9	9.5	2.4	5.8	1.9	8.8	4.5	4.5	5.4	5.5	5.2	3.4	5.1	8.7	3.7	4.8	3.8	3.6	4.8	5.6	5.8	2.4	3.5	4.9	2.2	4.6	3.6	4.4	7.5	5.5	2.3	4.2	13.1	9.8	12.3	8.1	6.5	3.5	7.0	2.6	7.4	5.8	9.6	4.1	6.2	7.5	3.8	20.0	5.0	4.2	5.4	7.8	6.0	2.3	3.6	3.2	3.1	4.0	3.5	3.1	2.7	1.2	5.2	3.7	4.4	5.0	4.2	1.9	2.4	4.8	2.5	49.2	43.2	27.6	61.5	38.9	42.2	38.9	37.7	30.9	14.0	17.9	20.6	6.7	10.6	6.4	10.7	7.8	2.5	103.1	36.4	5.2	9.8	5.1	5.0	27.1	1.5	8.4	7.3	0.0	20.6	3.7	5.0	7.7	19.7	3.4	3.7	15.9	25.4	5.5	4.0	2.2	8.3	5.9	8.5	17.2	15.6	13.3	25.7	17.5	8.1	6.7	10.4	12.9	8.6	4.8	3.6	4.4	5.6	8.5	15.7	6.4
NID2		ENSG00000087303	"Nidogen 2"	Q14112	14	52004803-52069228	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 10.5;Fibroblasts: 9.3;Ito cells: 9.2;Peritubular cells: 8.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 53.2;ASC TERT1: 21.2;BJ: 27.8;BJ hTERT+: 23.7;HHSteC: 29.5;HSkMC: 110.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA052460, HPA058772"	Enhanced		Enhanced	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2500000	"Plasma membrane"		"HPA052460: AB_2681840, HPA058772: AB_2683815"	"unprognostic (6.51e-2)"	"unprognostic (3.55e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.05e-3)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-3)"	"prognostic unfavorable (7.34e-4)"	"unprognostic (4.58e-2)"	"unprognostic (2.87e-2)"	"prognostic unfavorable (2.78e-4)"	15.0	5.1	0.9	5.3	1.8	0.1	7.6	0.9	1.7	12.9	8.5	5.1	9.0	1.0	9.5	7.6	9.8	6.0	10.2	17.5	1.2	0.9	6.4	2.9	5.1	3.0	1.3	1.2	16.8	13.9	10.2	2.4	32.5	2.5	13.4	3.6	17.4	4.3	8.9	3.9	1.8	3.0	11.4	1.5	1.1	6.6	4.4	0.8	0.7	18.8	3.6	2.2	10.7	5.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.6	13.9	0.0	53.2	21.2	0.0	27.8	23.7	2.6	2.7	0.0	0.0	0.0	4.1	3.0	0.0	1.9	1.7	0.0	0.7	0.0	0.3	0.0	0.4	0.0	29.5	0.0	0.0	110.2	0.0	10.8	0.0	15.1	1.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.0	0.9	4.1	0.0	0.0	3.6	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.1	10.1	0.1	6.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	1.8	0.9	1.7	1.2	0.9	1.3	1.2	2.5	0.8	0.0	0.0	0.0	0.2	0.6	1.2	1.7	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.1	10.5	3.7	1.1	0.0	0.0	1.0	9.3	0.1	1.1	0.0	1.3	0.0	0.0	9.2	0.0	2.5	5.8	0.0	3.3	1.8	2.8	0.0	0.3	0.0	8.1	0.0	0.8	6.5	5.7	0.0	0.0	0.9	0.7	0.0	3.3	0.1
NIFK	"hNIFK, MKI67IP, Nopp34"	ENSG00000155438	"Nucleolar protein interacting with the FHA domain of MKI67"	Q9BYG3	2	121726945-121736923	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015382, HPA035735, HPA035736, CAB075728, CAB075729"	Supported		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"CAB015382: AB_2142390, CAB075728: AB_2665734, CAB075729: AB_2665735, HPA035735: AB_2674758, HPA035736: AB_2674759"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.49e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.15e-3)"	"prognostic unfavorable (2.92e-6)"	"unprognostic (7.74e-3)"	"unprognostic (4.63e-2)"	"unprognostic (3.21e-2)"	"unprognostic (6.02e-3)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (5.01e-11)"	"unprognostic (1.72e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	25.1	18.7	18.4	22.1	19.0	19.9	28.1	14.3	20.8	24.0	17.3	14.8	9.8	16.5	21.4	17.4	28.2	20.3	16.6	15.4	16.1	15.1	24.2	40.1	14.7	30.8	15.8	15.2	32.8	33.7	12.9	28.9	19.8	18.5	21.2	19.7	10.2	16.5	14.2	35.5	22.8	17.9	20.9	18.3	28.1	19.2	18.7	18.0	31.3	23.6	21.3	29.5	26.1	21.0	28.1	25.9	12.5	23.5	27.1	32.9	24.6	28.8	8.7	18.9	18.5	16.6	23.0	22.7	22.7	20.4	28.6	31.3	25.5	14.7	39.7	28.4	17.7	24.8	18.7	40.6	30.7	42.9	24.1	21.5	39.0	12.3	23.8	23.3	35.9	21.6	23.1	35.4	37.8	50.7	13.3	20.5	15.8	43.8	19.8	24.7	14.2	27.5	35.7	46.3	34.5	31.5	26.4	21.2	48.6	25.4	18.1	23.6	24.4	14.3	28.6	49.6	17.9	13.7	30.9	11.8	19.7	32.2	22.2	32.3	23.2	34.9	44.1	15.3	35.5	27.4	12.5	19.8	9.3	22.9	23.5	32.1	27.0	28.2	26.2	25.9	28.1	32.9	30.8	1.3	27.1	20.9	22.6	23.5	24.6	18.4	19.0	14.3	20.8	16.1	15.1	15.8	15.2	18.5	18.0	41.7	23.4	49.1	90.7	87.3	25.6	18.3	15.3	44.2	64.8	14.0	11.8	63.5	39.7	65.3	10.4	41.8	15.2	23.3	39.1	70.0	52.4	39.8	53.1	31.1	49.2	12.7	27.0	22.7	32.3	3.8	53.2	41.0	21.9	45.1	37.8	44.7	45.9	21.0	42.5	40.0	38.4	38.8	44.3	54.8	72.2	88.7	40.8	39.4	44.3	93.5
NIN		ENSG00000100503	Ninein	Q8N4C6	14	50719763-50831121	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 87.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA005939, HPA070691"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Centrosome"		NA	NA			Centrosome	"Nucleoplasm, Nucleoli, Nucleoli rim"	"HPA005939: AB_2667474, HPA070691: AB_2686296"	"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.41e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.81e-3)"	"unprognostic (1.78e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (7.66e-3)"	13.0	6.1	15.1	24.9	10.3	34.8	9.7	12.6	14.0	8.0	9.2	7.6	4.5	5.0	11.8	6.1	11.8	8.2	7.6	16.4	11.7	4.9	6.7	5.2	10.7	30.2	7.6	10.0	11.0	5.4	9.1	12.3	20.2	7.1	6.5	7.7	6.2	8.2	5.1	16.9	10.9	8.3	12.0	7.1	18.2	9.3	4.6	9.0	16.4	7.8	5.1	25.8	11.7	10.3	6.8	6.3	18.4	2.3	1.5	6.0	1.3	12.3	8.7	18.3	15.5	7.0	11.4	7.6	10.6	9.1	8.9	7.5	5.6	6.6	29.1	7.3	14.3	8.5	13.0	14.7	6.7	18.9	14.0	4.5	10.7	5.4	5.3	4.1	18.6	30.9	7.8	5.4	15.7	6.4	5.3	14.2	15.1	2.6	11.9	13.5	13.5	14.1	7.5	2.5	3.9	9.7	16.0	33.8	2.1	8.0	14.0	8.5	9.6	13.3	4.0	11.4	4.2	7.6	16.6	20.7	22.8	31.7	8.7	11.7	9.6	4.8	20.1	5.9	15.2	12.3	12.6	2.3	18.4	3.3	1.7	3.5	6.8	2.2	6.0	1.5	5.5	4.4	3.8	8.3	1.5	1.5	6.3	1.9	1.3	15.1	10.3	12.6	14.0	11.7	4.9	7.6	10.0	7.1	9.0	6.0	7.7	41.0	7.0	16.4	7.5	37.9	12.7	26.8	36.4	10.4	58.9	9.2	3.3	6.9	22.3	24.1	4.1	0.0	3.5	8.9	27.9	13.0	30.1	3.9	20.1	6.4	12.1	27.0	40.6	7.8	7.8	47.2	21.9	12.6	3.9	87.7	4.7	5.8	8.9	5.1	18.0	32.3	20.8	0.0	0.4	18.3	8.1	37.4	4.6	14.5
NKTR	p104	ENSG00000114857	"Natural killer cell triggering receptor"	P30414	3	42600614-42648741	"Enzymes, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022120, HPA051576"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA022120: AB_1854513, HPA051576: AB_2681540"	"unprognostic (2.73e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.27e-3)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.62e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.33e-2)"	"prognostic unfavorable (6.01e-4)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.82e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.05e-5)"	12.9	14.4	9.8	18.8	22.2	16.3	15.9	42.0	12.3	18.8	10.4	18.5	15.4	11.8	27.2	17.4	11.0	12.0	13.1	11.2	10.9	10.5	9.5	9.7	14.6	15.5	14.5	11.3	22.7	18.4	19.2	26.9	11.1	14.1	12.9	11.1	20.4	13.2	19.5	12.0	20.0	13.3	19.4	15.0	18.5	10.1	17.8	13.8	20.6	14.9	10.9	19.4	12.9	13.9	9.3	8.5	11.7	10.0	11.1	10.2	3.6	8.9	5.2	17.2	7.0	10.3	12.6	9.7	14.6	3.7	6.1	8.3	9.0	7.2	14.2	7.0	4.4	6.0	7.9	10.1	3.7	12.5	7.1	8.5	18.2	16.3	14.6	4.4	14.0	12.0	5.1	7.2	12.0	4.6	11.1	10.7	3.4	18.3	11.0	11.5	3.7	9.5	13.7	14.8	4.8	7.6	10.1	7.7	5.8	8.5	6.9	6.1	3.6	15.7	6.5	2.4	8.0	9.6	10.2	17.1	10.9	8.0	11.9	14.0	9.5	13.3	9.9	5.8	17.2	6.7	9.2	6.2	11.7	10.2	7.7	9.4	8.9	9.8	8.5	4.7	9.3	10.0	8.7	9.1	11.1	10.0	8.5	8.3	3.6	9.8	22.2	42.0	12.3	10.9	10.5	14.5	11.3	14.1	13.8	101.3	122.0	67.1	53.1	52.4	190.3	63.1	50.9	45.5	75.1	83.7	231.7	56.8	14.9	39.7	13.6	120.9	75.7	23.3	34.0	42.2	62.5	58.7	92.6	44.7	39.4	125.5	69.0	103.2	49.9	13.7	155.3	72.2	49.0	62.3	51.5	160.2	38.7	44.6	126.2	9.7	283.7	90.5	58.5	210.1	183.7	50.1	26.2	126.8	54.0	42.1
NME1	"NDPKA, NM23, NM23-H1"	ENSG00000239672	"NME/NM23 nucleoside diphosphate kinase 1"	P15531	17	51153536-51162428	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Endocytosis, Neurogenesis, Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008467, CAB040571, HPA041113"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB040571: , HPA008467: AB_1079492, HPA041113: AB_2677305"	"unprognostic (2.24e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.96e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.33e-3)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (4.54e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.90e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.07e-9)"	"unprognostic (9.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.46e-2)"	25.0	29.5	38.0	28.1	30.1	27.9	29.0	19.6	41.9	16.4	25.4	13.1	10.1	15.1	17.3	22.5	30.1	22.2	13.4	14.1	41.7	39.4	19.6	56.0	14.2	28.5	34.2	34.2	15.6	43.6	13.7	17.3	16.9	38.9	14.5	36.8	14.9	34.3	14.7	14.8	22.4	12.4	29.6	20.5	22.4	13.4	11.6	11.3	19.0	18.8	32.7	41.4	22.8	15.2	24.9	36.2	0.6	19.5	17.2	20.3	18.4	46.6	93.2	32.2	44.9	13.5	21.6	54.1	36.4	25.3	75.5	57.3	73.3	28.3	82.1	38.0	33.6	30.0	25.1	61.5	61.9	64.6	39.8	82.8	53.8	72.4	101.8	27.4	59.0	24.7	20.5	39.0	56.8	53.2	13.3	45.5	26.4	79.4	27.3	44.7	79.0	70.1	67.8	38.6	103.3	85.0	43.0	63.6	75.6	57.9	32.6	44.7	51.5	19.1	52.3	33.9	28.8	54.4	39.9	28.6	48.7	44.2	30.3	74.7	35.2	81.2	96.7	29.5	50.1	37.0	0.2	15.2	0.6	13.4	19.5	20.3	24.9	14.4	14.6	36.2	17.3	16.4	17.8	0.4	17.2	11.5	20.7	12.1	18.4	38.0	30.1	19.6	41.9	41.7	39.4	34.2	34.2	38.9	11.3	29.8	22.5	33.5	67.6	117.7	287.4	27.7	63.7	36.1	59.1	68.0	269.0	166.3	127.6	180.3	23.8	58.6	14.6	46.7	172.7	210.0	82.7	60.4	46.0	102.6	183.6	38.1	86.1	27.0	26.9	65.0	56.7	62.9	123.2	55.9	70.8	61.6	165.1	38.6	55.2	140.8	268.7	12.9	66.0	19.8	83.3	116.3	74.0	40.6	110.8	81.0
NMRAL1	"FLJ25918, HSCARG, SDR48A1"	ENSG00000153406	"NmrA like redox sensor 1"	Q9HBL8	16	4461680-4495763	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041353, HPA062287"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA041353: AB_10796343, HPA062287: AB_2684738"	"unprognostic (2.56e-1)"	"prognostic favorable (3.33e-7)"	"unprognostic (4.16e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.21e-1)"	10.0	20.6	19.2	8.4	23.3	11.0	17.8	7.0	31.5	16.9	14.1	23.5	19.2	17.1	12.9	18.1	17.0	20.7	17.3	17.0	19.6	16.1	18.1	26.2	12.8	14.8	20.2	23.8	20.1	30.7	14.5	14.2	16.7	17.7	18.9	10.0	14.6	28.7	17.6	3.2	25.3	13.6	12.4	20.1	13.6	19.9	7.0	14.2	14.6	18.1	10.0	12.9	12.4	11.7	13.3	19.5	11.6	19.2	8.9	23.5	17.3	10.2	14.8	2.3	8.2	4.9	4.7	12.4	7.5	2.5	8.5	6.7	15.9	17.4	0.3	15.1	8.2	2.3	11.9	6.6	9.6	3.7	9.2	3.8	9.0	10.9	7.6	11.0	10.7	7.0	7.3	11.5	9.3	3.5	6.7	8.4	32.8	11.5	0.2	3.9	32.7	21.7	10.4	10.3	12.3	13.9	23.7	0.1	12.7	8.9	5.9	3.5	9.6	12.8	21.7	8.2	1.8	20.1	9.7	5.0	5.1	0.3	3.8	0.1	0.3	0.1	18.0	2.3	9.6	9.9	4.7	19.2	2.0	23.5	11.3	18.3	13.3	15.9	22.4	18.2	11.2	17.0	17.7	11.6	8.9	8.7	19.5	14.0	17.3	19.2	23.3	7.0	31.5	19.6	16.1	20.2	23.8	17.7	14.2	23.8	27.0	25.1	32.1	24.3	10.5	20.4	35.7	28.1	29.6	40.1	0.0	90.4	44.7	30.4	11.9	19.4	26.6	0.0	43.3	84.8	27.7	25.0	19.7	67.4	56.7	4.8	19.5	29.4	28.9	21.1	27.0	24.5	33.7	22.6	34.7	36.1	32.0	33.6	28.7	68.0	9.4	25.8	22.8	4.1	40.1	26.7	53.7	27.4	39.1	17.1
NMRK2	"ITGB1BP3, MIBP, NRK2"	ENSG00000077009	"Nicotinamide riboside kinase 2"	Q9NPI5	19	3933103-3942416	"Enzymes, Predicted intracellular proteins"	"Pyridine nucleotide biosynthesis"	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"heart muscle: 271.6;skeletal muscle: 103.2"	"Cell type enriched"	"Detected in single"	1346	"Cardiomyocytes: 751.9"	"Cancer enhanced"	"Detected in some"		"renal cancer: 32.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"BEWO: 22.8;NTERA-2: 18.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049909, HPA054792, HPA072450"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA049909: , HPA054792: AB_2682601, HPA072450: AB_2686522"				"unprognostic (3.61e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.18e-2)"		"unprognostic (2.54e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.61e-2)"		"unprognostic (3.30e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.38e-1)"		0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	1.0	0.0	0.0	271.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	1.0	1.9	0.1	103.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	18.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	751.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
NOC2L	"DKFZP564C186, NET15, NET7, NIR, PPP1R112"	ENSG00000188976	"NOC2 like nucleolar associated transcriptional repressor"	Q9Y3T9	1	944204-959309	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044258, HPA062195"	Approved		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No		420000	"Nucleoli, Nucleoli rim, Mitotic chromosome"		"HPA044258: AB_10961284, HPA062195: AB_2684707"	"unprognostic (3.18e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.54e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.94e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.52e-1)"	17.7	15.6	13.4	20.5	17.8	23.8	18.2	23.7	27.4	15.0	15.3	15.6	13.5	16.8	19.0	13.5	27.7	18.3	21.8	23.0	15.3	15.3	15.2	36.6	14.0	19.3	18.7	19.0	16.9	26.8	20.8	15.3	15.9	16.7	16.6	11.1	14.0	22.0	16.5	40.0	32.4	14.6	14.7	13.6	17.5	16.4	21.1	18.0	22.7	19.8	29.5	21.8	17.5	18.0	14.3	20.2	11.3	29.0	18.8	18.4	16.0	27.6	27.6	4.9	32.1	9.0	8.0	18.1	20.7	9.7	29.0	15.9	36.6	27.2	31.2	29.4	13.7	24.1	25.4	36.7	30.9	12.3	19.6	41.8	16.5	35.7	31.7	20.3	36.3	16.3	13.1	8.8	31.8	21.3	9.0	14.0	11.1	46.6	14.4	12.8	43.8	23.3	22.0	28.3	20.0	32.8	29.3	20.6	37.8	13.3	11.7	34.7	34.1	27.4	41.5	25.3	7.8	18.5	19.9	16.0	17.3	24.7	18.9	35.3	24.8	26.7	56.4	21.5	51.6	14.4	7.2	17.0	11.3	14.2	25.7	18.4	14.3	13.8	13.6	20.2	11.9	14.3	11.1	1.6	18.8	29.0	13.0	10.9	16.0	13.4	17.8	23.7	27.4	15.3	15.3	18.7	19.0	16.7	18.0	14.9	23.9	46.0	71.4	61.6	53.0	2.8	20.4	20.1	13.6	34.9	58.9	54.4	14.9	44.4	5.6	27.4	17.0	0.0	39.8	56.2	34.7	37.8	12.8	19.8	34.6	42.9	28.8	17.8	23.1	8.1	27.3	24.1	23.6	30.7	23.4	21.7	31.2	17.5	20.1	15.2	68.2	32.3	49.2	36.7	73.9	71.6	49.2	39.9	41.2	60.5
NOC3L	"AD24, C10orf117, FAD24, FLJ12820"	ENSG00000173145	"NOC3 like DNA replication regulator"	Q8WTT2	10	94333226-94362959	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 70.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063958, HPA067638, HPA070981"			Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA063958: AB_2685160, HPA067638: AB_2685876, HPA070981: AB_2686331"	"unprognostic (1.29e-1)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.58e-2)"	"unprognostic (6.49e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.93e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.47e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.30e-1)"	16.7	13.2	9.2	11.2	14.5	3.7	14.4	10.8	12.7	13.5	8.9	6.0	8.4	6.7	14.1	8.5	14.3	12.1	7.3	8.8	9.3	6.6	11.0	15.0	9.7	14.9	16.4	7.7	15.4	7.8	12.5	18.2	11.0	14.5	12.5	8.2	6.3	9.7	8.9	18.8	11.6	8.4	9.8	16.6	19.8	8.1	14.1	13.1	12.8	15.7	13.6	16.0	16.1	10.6	13.7	4.3	0.5	4.1	7.5	5.8	3.1	17.9	9.8	6.7	21.5	7.0	11.4	7.9	14.4	11.4	19.8	23.0	16.7	12.7	19.5	10.6	7.2	10.2	13.0	19.0	8.6	32.1	13.3	14.2	13.2	8.2	10.7	14.0	20.9	6.0	6.5	8.5	20.8	21.0	12.9	8.8	7.3	20.5	9.9	19.4	6.0	13.1	15.6	14.1	10.5	10.9	5.9	15.3	10.7	11.7	5.6	4.8	11.9	10.3	5.2	15.9	7.8	13.4	8.1	8.5	12.7	12.8	11.5	24.1	9.4	18.8	27.1	11.6	20.3	9.4	0.0	2.4	0.5	4.3	3.9	5.4	13.7	4.4	5.4	4.3	12.6	5.8	5.1	0.1	7.5	4.1	3.8	4.0	3.1	9.2	14.5	10.8	12.7	9.3	6.6	16.4	7.7	14.5	13.1	17.9	10.7	18.7	20.6	21.1	20.3	20.0	10.2	28.1	47.8	21.0	7.9	18.3	21.6	16.6	2.2	24.1	2.0	0.0	11.8	11.5	13.4	12.0	28.8	9.2	11.3	12.7	5.2	13.5	14.5	3.6	17.0	13.1	11.8	25.2	6.0	21.0	12.3	2.9	23.3	18.0	20.6	12.9	21.8	59.0	70.2	19.1	12.7	13.8	8.6	13.5
NOL4L	"C20orf112, C20orf113, dJ1184F4.2, dJ1184F4.4, DKFZP566G1424"	ENSG00000197183	"Nucleolar protein 4 like"	Q96MY1	20	32443059-32585074	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 78.2;Late spermatids: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 32.2;HEL: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041768, HPA043600"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA041768: AB_10964172, HPA043600: AB_10961001"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.03e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.10e-1)"	"unprognostic (7.88e-2)"	"unprognostic (2.75e-3)"	"unprognostic (1.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.88e-2)"	"unprognostic (9.32e-2)"	"unprognostic (3.42e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (2.63e-4)"	7.7	8.0	13.1	9.0	14.9	18.9	8.7	19.4	14.8	6.5	16.3	35.6	8.7	19.9	6.5	13.8	2.8	9.9	11.0	5.0	13.9	11.7	9.8	5.7	10.6	8.0	20.5	8.7	3.7	12.1	5.0	19.9	12.1	16.3	7.5	15.0	12.5	11.0	9.8	1.9	3.8	20.7	7.4	17.9	11.3	14.3	33.2	20.1	16.7	8.5	2.6	6.5	10.0	8.7	1.9	2.2	7.2	11.7	8.9	8.7	4.7	3.9	12.1	7.6	5.2	1.6	2.5	1.0	2.5	2.1	3.2	2.2	32.2	9.2	0.2	7.5	3.3	5.0	1.1	2.4	7.0	1.4	0.9	1.9	25.3	5.9	23.0	4.3	0.3	1.5	6.3	1.0	2.3	1.5	7.3	19.2	5.5	7.5	3.4	1.5	2.2	8.2	7.7	4.4	12.0	11.3	3.5	0.9	1.3	5.3	0.7	10.1	8.2	7.9	0.2	4.3	8.2	1.6	7.7	20.1	3.0	10.5	2.7	2.6	2.5	0.8	1.7	3.3	13.7	9.0	3.0	2.2	1.1	6.6	4.9	5.8	1.9	4.4	3.8	2.2	1.4	8.7	7.1	7.2	8.9	11.7	0.3	7.0	4.7	13.1	14.9	19.4	14.8	13.9	11.7	20.5	8.7	16.3	20.1	6.0	3.5	1.7	9.0	0.0	34.0	7.4	5.1	4.0	2.3	12.2	62.8	0.2	8.3	6.4	78.2	21.3	50.9	0.0	6.9	1.6	5.0	14.5	11.5	3.9	8.2	7.9	16.8	26.4	3.0	112.0	5.2	4.7	0.0	5.4	33.1	14.8	10.1	34.5	4.6	17.7	55.8	19.4	6.3	53.6	3.9	0.0	0.3	12.8	28.2	20.1
NOL6	"bA311H10.1, FLJ21959, MGC14896, MGC14921, MGC20838, Nrap, UTP22"	ENSG00000165271	"Nucleolar protein 6"	Q9H6R4	9	33461441-33473930	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055891, HPA061002"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA055891: AB_2682959, HPA061002: AB_2684410"	"unprognostic (2.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (7.37e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (9.49e-4)"	"unprognostic (4.09e-1)"	15.3	14.9	13.3	17.7	19.7	21.0	14.9	16.8	30.8	16.0	11.4	14.6	9.0	10.3	15.3	11.9	21.1	12.8	18.2	13.1	12.4	10.6	13.8	41.6	13.5	15.8	10.1	11.4	20.5	20.5	22.7	18.2	15.4	19.2	17.5	14.8	12.5	15.5	15.5	23.4	23.5	11.3	17.0	7.3	17.6	13.0	19.0	7.8	13.8	13.2	19.7	20.9	12.4	14.5	4.2	7.1	0.3	8.4	3.9	6.0	3.4	15.6	22.6	8.6	19.5	13.5	9.3	14.8	17.5	13.1	20.5	17.2	24.9	5.8	27.3	8.0	19.6	9.0	11.0	25.0	25.1	21.7	17.3	10.4	14.0	26.3	13.8	13.3	31.9	20.6	10.3	20.8	27.1	26.2	8.5	13.4	10.1	22.8	10.5	16.2	13.8	17.8	32.1	31.2	17.5	20.6	15.4	8.5	14.2	15.8	18.8	10.2	14.1	14.6	18.9	6.2	9.6	7.6	18.6	14.9	12.6	17.0	15.8	30.4	10.0	14.0	23.1	11.2	16.9	14.4	0.0	4.0	0.3	5.4	8.4	6.0	4.2	4.1	5.2	7.1	3.6	5.1	4.8	0.2	3.9	7.9	3.8	4.0	3.4	13.3	19.7	16.8	30.8	12.4	10.6	10.1	11.4	19.2	7.8	3.0	14.6	4.5	5.1	17.7	4.5	5.5	7.6	4.0	11.4	3.5	5.9	3.4	3.3	6.7	17.3	6.0	2.3	0.0	3.4	4.8	4.1	6.5	3.5	6.7	4.4	3.2	9.8	3.7	1.2	17.9	5.5	2.7	5.0	1.8	4.1	4.2	4.9	0.0	5.6	2.1	3.5	0.0	5.1	2.3	6.1	22.6	2.5	5.0	6.8	7.4
NOLC1	"KIAA0035, NOPP130, NOPP140, P130"	ENSG00000166197	"Nucleolar and coiled-body phosphoprotein 1"	Q14978	10	102152176-102163871	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032654, HPA037366, HPA050388"	Supported		Enhanced	"Nucleoli fibrillar center"		No	Yes		10000	"Nucleoli fibrillar center"		"CAB032654: AB_2152006, HPA037366: AB_10670930, HPA050388: AB_2681109"	"unprognostic (3.23e-1)"	"unprognostic (5.58e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.03e-3)"	"unprognostic (2.36e-3)"	"unprognostic (7.34e-3)"	"unprognostic (3.43e-1)"	"unprognostic (3.74e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (9.19e-5)"	"unprognostic (3.15e-2)"	"unprognostic (3.73e-1)"	"prognostic unfavorable (8.25e-5)"	"unprognostic (7.68e-2)"	29.5	17.1	18.8	27.8	35.0	23.2	21.3	37.9	39.2	19.1	20.4	23.5	13.8	14.2	25.1	12.4	30.4	25.1	20.7	20.0	18.5	19.2	16.1	38.1	23.6	27.7	20.2	21.4	28.0	25.5	33.9	34.3	25.4	28.0	20.7	27.0	14.8	21.0	18.0	46.6	20.3	17.3	23.4	20.2	26.2	21.0	13.8	19.9	32.9	26.1	19.8	35.1	24.3	20.9	12.7	11.6	7.8	11.2	11.8	19.3	11.2	32.7	30.2	17.1	36.0	14.2	11.3	29.1	18.7	15.0	26.4	22.6	51.9	23.0	68.6	20.9	11.9	13.2	38.1	49.2	40.9	28.3	21.5	32.2	45.9	25.1	30.2	19.1	66.5	21.5	14.5	26.8	28.0	58.7	15.1	16.1	32.9	48.1	30.4	15.8	28.8	62.1	14.0	32.7	22.8	23.7	46.6	46.9	38.2	15.3	21.1	25.6	24.1	18.1	20.8	22.9	16.3	36.1	14.4	13.8	11.9	16.5	13.9	42.0	28.5	42.1	77.3	19.2	68.5	10.2	1.4	8.4	7.8	15.5	10.3	19.3	12.7	12.4	14.5	11.6	10.0	14.5	17.1	0.9	11.8	11.2	9.0	8.8	11.2	18.8	35.0	37.9	39.2	18.5	19.2	20.2	21.4	28.0	19.9	56.6	59.5	35.0	80.3	107.0	19.9	27.3	7.6	83.0	97.8	15.7	13.7	42.4	21.6	30.1	23.7	36.5	9.7	23.3	20.0	49.5	43.1	49.9	41.7	18.7	24.1	9.5	26.5	17.2	13.2	7.7	21.3	28.5	25.3	20.8	27.7	13.7	35.8	20.1	19.8	13.4	17.1	6.5	49.5	23.2	47.2	102.8	40.6	26.6	35.2	75.0
NOM1	"C7orf3, PPP1R113, SGD1"	ENSG00000146909	"Nucleolar protein with MIF4G domain 1"	Q5C9Z4	7	156949723-156973182	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019866, HPA051624"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA019866: AB_2670300, HPA051624: AB_2681556"	"unprognostic (1.24e-1)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.30e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.35e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.49e-1)"	12.3	10.9	10.8	16.9	14.2	15.3	11.1	13.0	15.9	9.7	11.4	9.9	11.1	8.9	12.8	9.0	12.9	11.4	8.1	8.3	11.2	6.4	8.4	12.2	9.9	13.4	11.9	11.7	13.9	14.5	11.1	8.4	10.3	11.4	9.6	10.0	9.3	10.5	12.5	21.0	15.5	10.5	12.0	10.0	12.1	10.6	13.9	11.9	9.9	9.9	9.8	12.4	11.4	17.0	5.0	2.8	2.5	2.8	2.6	3.4	0.9	9.1	7.9	5.8	8.7	5.9	6.2	8.0	9.2	4.5	7.5	6.1	8.5	7.8	16.1	9.3	7.4	7.6	7.5	10.5	11.1	9.2	7.3	9.2	13.5	6.6	7.9	4.8	23.5	8.3	4.4	5.5	6.7	8.7	4.3	6.3	9.1	20.3	8.7	6.7	12.0	14.8	19.7	14.1	8.2	8.6	10.6	8.9	12.4	4.8	11.0	7.2	8.8	8.4	6.7	6.3	6.9	3.2	12.7	10.1	8.1	2.6	15.0	11.8	11.2	8.0	14.9	10.4	17.0	7.6	2.5	2.8	1.5	2.1	1.9	1.2	3.8	2.7	2.9	2.8	5.0	3.4	1.8	1.3	2.6	2.1	2.8	1.0	0.9	10.8	14.2	13.0	15.9	11.2	6.4	11.9	11.7	11.4	11.9	8.9	16.5	13.4	26.4	34.9	15.8	9.2	12.7	17.4	18.2	5.2	19.6	12.5	3.3	16.5	7.2	14.4	6.4	0.0	11.8	17.3	12.0	18.5	19.8	13.1	12.8	11.1	7.5	6.7	10.5	1.8	16.1	18.2	23.6	14.4	10.4	9.8	12.4	10.5	12.4	4.9	30.5	0.0	14.6	28.2	35.7	37.1	6.1	12.8	14.6	26.9
NONO	"NMT55, NRB54, P54, P54NRB, PPP1R114"	ENSG00000147140	"Non-POU domain containing octamer binding"	Q15233	X	71283192-71301168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022069, HPA054094, HPA054559"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Nuclear speckles"		NA	NA		150000	Nucleoplasm	"Nucleoli fibrillar center, Nuclear speckles"	"CAB022069: , HPA054094: AB_2682376, HPA054559: AB_2682522"	"unprognostic (2.39e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (8.87e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.02e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.29e-3)"	"unprognostic (6.79e-2)"	"unprognostic (5.73e-3)"	"unprognostic (2.76e-2)"	"unprognostic (3.04e-2)"	37.2	55.9	30.2	37.7	30.8	51.2	37.2	54.8	38.6	45.4	33.4	36.0	38.4	29.9	52.4	40.5	41.0	40.5	37.2	30.5	27.5	29.0	40.1	43.3	37.3	45.7	28.8	31.7	69.2	61.0	39.4	48.2	42.4	27.5	40.8	37.5	42.5	39.8	41.4	37.2	38.4	35.2	40.5	38.3	45.9	40.3	34.4	29.0	98.4	51.0	39.1	57.4	43.6	36.8	44.1	47.3	35.3	51.8	45.4	51.8	58.9	59.7	66.1	91.5	50.2	37.3	38.6	50.1	49.0	45.6	66.3	58.6	52.4	44.4	68.0	54.6	45.1	45.8	44.7	136.6	42.6	73.1	51.7	91.2	55.8	69.4	52.2	31.7	78.1	49.0	40.8	30.4	67.1	45.0	55.0	54.5	49.3	71.1	71.3	61.2	53.0	101.1	71.2	114.0	60.3	53.7	90.9	96.0	58.3	50.9	52.9	63.5	78.9	63.5	41.5	56.3	55.5	39.0	50.6	50.0	42.9	64.5	60.0	56.7	41.2	77.9	77.4	32.1	90.9	61.4	35.3	44.8	34.9	45.8	47.6	51.8	43.7	46.6	44.9	47.3	44.1	50.8	50.2	20.8	45.4	51.8	41.2	50.1	58.9	30.2	30.8	54.8	38.6	27.5	29.0	28.8	31.7	27.5	29.0	71.5	74.4	79.8	78.6	112.2	63.2	53.3	94.3	53.5	84.2	41.8	39.3	104.8	48.0	113.5	9.9	89.5	55.4	70.0	96.7	148.6	89.4	78.5	84.5	108.5	99.0	50.9	134.1	70.0	136.1	12.1	98.7	83.7	54.0	104.6	95.9	77.6	111.2	84.2	120.2	93.8	45.1	64.7	107.2	22.8	62.3	107.0	108.8	84.7	122.4	84.4
NOP14	"C4orf9, NOL14, RES4-25, UTP2"	ENSG00000087269	"NOP14 nucleolar protein"	P78316	4	2937933-2963385	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039596, HPA055652"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA039596: AB_2676590, HPA055652: AB_2682876"	"unprognostic (4.70e-2)"	"unprognostic (6.47e-2)"	"prognostic favorable (3.93e-5)"	"unprognostic (7.32e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (2.41e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.44e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.77e-2)"	17.3	16.8	9.8	22.4	13.2	19.0	16.2	21.1	15.2	12.0	12.6	9.0	12.6	12.0	14.3	11.7	19.0	12.1	14.7	14.8	8.9	7.1	13.6	34.0	12.9	20.8	10.0	8.7	20.7	26.8	13.9	15.5	12.8	10.6	12.3	12.8	11.1	14.7	14.6	38.6	21.4	13.1	12.4	9.8	18.0	15.1	9.8	11.4	17.9	15.4	16.3	20.9	18.1	18.9	5.2	4.9	1.3	3.8	4.4	8.4	3.0	16.3	13.9	8.3	17.1	11.2	12.7	14.5	15.1	10.8	15.8	13.0	18.1	17.3	46.3	10.7	12.2	11.5	11.3	22.8	19.6	17.0	8.8	21.8	36.8	13.2	16.4	14.8	39.9	16.1	12.8	17.7	17.8	16.3	7.8	13.2	14.3	33.3	16.5	11.8	11.7	42.1	30.1	21.6	15.1	22.8	27.3	12.6	15.4	7.9	26.4	17.2	10.1	12.5	9.3	11.8	7.9	17.8	15.8	16.4	13.2	7.7	16.1	27.7	12.4	19.9	40.0	13.8	29.6	13.7	1.3	3.2	0.6	4.8	3.8	8.4	3.4	5.8	7.0	4.0	5.2	7.0	5.2	0.5	4.4	2.5	4.9	3.8	3.0	9.8	13.2	21.1	15.2	8.9	7.1	10.0	8.7	10.6	11.4	17.9	22.5	10.4	13.9	23.0	9.0	18.2	15.3	17.4	35.2	1.8	13.7	12.7	10.0	12.9	1.7	14.3	3.6	0.0	20.6	13.2	7.6	9.5	19.7	23.1	9.9	19.1	8.6	9.2	3.2	2.1	11.5	11.3	0.0	15.4	9.7	6.0	16.8	8.6	9.2	10.1	7.1	12.9	13.3	9.2	20.6	28.4	9.6	12.5	13.4	14.8
NOP16	"HSPC111, HSPC185, LOC51491"	ENSG00000048162	"NOP16 nucleolar protein"	Q9Y3C1	5	176383938-176388975	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 179.6;Suprabasal keratinocytes: 179.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036506, HPA058147"	Approved		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA036506: AB_10672223, HPA058147: AB_2683620"	"unprognostic (4.55e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.19e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.75e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.76e-1)"	17.1	12.8	11.0	15.3	12.7	13.2	13.5	6.1	10.4	8.5	13.3	4.9	8.4	12.0	9.5	8.1	23.2	9.6	9.9	18.2	8.0	8.2	18.2	34.3	8.7	15.0	11.0	8.8	10.9	16.2	5.8	7.2	9.5	14.8	9.1	11.8	3.2	8.8	7.7	50.2	15.6	9.5	8.7	6.8	14.7	11.2	12.2	9.5	9.4	11.3	29.3	17.1	11.1	12.2	26.8	30.3	2.7	26.6	24.1	22.6	13.7	17.6	27.0	6.7	28.6	9.9	10.4	26.1	14.7	8.7	21.3	18.5	37.0	17.8	29.5	20.1	10.9	21.6	16.7	31.5	48.6	14.9	37.5	25.7	15.2	19.9	31.3	20.0	31.1	18.0	10.8	21.9	19.5	24.2	7.0	15.5	14.5	29.7	15.1	15.3	51.4	23.7	42.9	23.7	27.0	34.3	19.9	9.5	31.3	19.8	15.1	20.2	17.0	8.6	35.0	19.5	6.8	15.6	22.8	14.0	16.3	16.7	15.2	36.6	19.4	23.0	32.7	12.7	42.6	14.0	2.1	16.8	2.7	17.4	26.6	22.6	25.1	19.6	18.7	24.9	26.8	21.5	22.5	1.7	24.1	13.0	30.3	13.6	13.7	11.0	12.7	6.1	10.4	8.0	8.2	11.0	8.8	14.8	9.5	6.0	18.7	26.1	87.2	179.6	3.6	28.3	30.6	17.4	51.2	1.8	3.9	42.2	31.5	52.0	5.5	36.6	15.8	0.0	45.6	43.9	34.5	39.0	25.5	35.6	34.5	0.0	20.1	9.2	8.5	3.1	18.1	22.4	54.0	27.1	25.0	3.4	46.9	8.6	13.8	56.7	2.9	6.5	76.9	28.6	31.6	179.5	32.0	17.3	40.3	81.4
NOP2	"NOL1, NOP120, NSUN1, p120"	ENSG00000111641	"NOP2 nucleolar protein"	P46087	12	6556863-6568691	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040119	Supported		Enhanced	Nucleoli		No	No			Nucleoli		"HPA040119: AB_10965321"	"unprognostic (2.88e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.15e-2)"	"unprognostic (8.74e-2)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.53e-1)"	"prognostic unfavorable (2.35e-10)"	"unprognostic (1.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.96e-3)"	16.5	12.7	14.8	21.7	17.1	30.9	15.3	14.8	14.9	10.8	12.8	6.9	7.3	14.0	15.2	11.4	19.5	15.0	11.2	12.8	11.9	8.7	12.8	31.2	14.0	25.9	14.7	8.9	14.5	21.5	12.1	15.1	12.3	13.8	17.4	14.7	9.0	21.3	9.4	32.6	19.1	15.7	14.7	8.9	23.1	13.4	19.4	13.2	24.7	16.8	18.5	27.2	11.5	17.1	12.6	16.5	3.3	11.5	11.9	20.3	10.9	16.3	26.4	7.2	24.7	9.2	7.9	39.2	14.9	9.6	17.7	15.3	32.2	16.7	35.1	4.1	7.3	18.6	20.3	27.6	16.5	17.2	41.4	25.9	34.4	25.2	18.6	12.4	33.8	19.8	8.0	16.3	21.4	33.3	7.8	11.9	18.8	24.1	5.6	14.0	20.3	18.1	29.4	60.3	21.9	14.8	25.9	21.1	17.2	12.9	22.7	5.5	11.0	23.4	25.5	12.3	29.8	4.2	16.2	11.2	12.2	16.3	15.8	34.3	7.8	11.4	52.4	11.2	19.4	21.1	1.4	8.2	0.9	14.8	11.5	20.3	12.6	14.1	16.6	16.5	10.1	17.3	17.6	3.3	11.9	10.0	14.5	9.7	10.9	14.8	17.1	14.8	14.9	11.9	8.7	14.7	8.9	13.8	13.2	11.9	5.0	12.3	13.4	21.2	5.5	5.6	5.1	2.7	1.2	3.5	2.0	10.0	1.7	10.0	16.0	8.0	2.9	0.0	10.3	10.4	8.5	9.5	7.0	6.6	10.6	6.4	6.9	9.8	9.2	6.6	8.6	8.1	8.5	9.0	7.6	2.5	10.6	5.8	4.6	1.0	2.8	12.9	12.0	10.7	19.5	18.6	6.1	7.2	11.2	11.5
NOP56	"NOL5A, SCA36"	ENSG00000101361	"NOP56 ribonucleoprotein"	O00567	20	2652145-2658393	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA049918, CAB075757"	Supported		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"CAB075757: AB_2665763, HPA049918: AB_2680952"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.18e-1)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.59e-7)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.04e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.42e-1)"	23.5	18.5	20.1	30.5	23.8	30.6	33.8	36.1	31.3	19.2	19.1	22.4	15.3	16.3	29.9	19.9	25.5	31.4	20.3	18.0	19.9	23.3	16.3	20.1	17.4	30.5	27.9	23.9	29.6	49.8	17.8	23.3	22.4	20.9	22.9	23.4	13.5	23.4	23.5	31.7	21.8	19.2	30.9	17.7	26.5	18.5	20.1	22.5	39.4	20.7	20.0	32.2	20.8	34.9	18.0	19.7	9.5	13.5	13.5	21.2	12.2	20.2	27.8	15.9	19.2	24.4	16.7	34.9	21.1	16.9	32.4	22.3	40.3	21.6	56.5	14.7	18.0	18.8	45.4	48.4	37.0	29.2	16.7	34.1	34.0	17.7	40.2	26.2	28.6	15.0	23.9	26.8	43.8	50.4	12.3	20.7	25.8	36.4	27.7	23.3	18.6	45.7	28.7	37.7	40.8	31.4	42.1	27.0	30.9	20.8	29.5	18.4	17.5	29.0	31.5	49.7	17.5	32.9	25.9	15.6	34.1	19.8	21.3	34.7	16.4	30.4	40.6	8.4	33.7	21.3	3.3	12.0	9.5	16.9	13.5	21.2	18.0	18.5	17.6	12.0	16.6	18.5	16.6	0.9	13.5	10.7	19.7	15.7	12.2	20.1	23.8	36.1	31.3	19.9	23.3	27.9	23.9	20.9	22.5	41.7	56.8	69.3	86.8	85.6	37.7	36.7	38.2	101.7	133.1	22.7	58.9	93.2	21.6	64.0	5.6	64.3	33.2	23.3	74.1	96.9	62.2	45.2	76.3	35.8	75.8	47.7	69.4	44.8	37.4	10.0	52.9	53.1	28.7	67.7	51.0	30.9	67.3	24.6	51.6	43.1	32.5	25.8	93.7	42.0	199.2	71.4	47.3	76.2	75.8	49.5
NOP58	"HSPC120, NOP5"	ENSG00000055044	"NOP58 ribonucleoprotein"	Q9Y2X3	2	202265716-202303666	"Plasma proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018472, HPA021062"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	Yes			"Nucleoli fibrillar center"	Nucleoplasm	"HPA018472: AB_1854564, HPA021062: AB_1854565"	"unprognostic (1.56e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.15e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.97e-6)"	"unprognostic (6.64e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (9.86e-4)"	"unprognostic (4.52e-3)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (3.38e-9)"	"unprognostic (1.79e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.60e-1)"	25.1	26.5	16.7	41.6	24.6	47.1	32.2	30.2	24.2	28.8	21.6	13.7	19.5	20.3	31.0	25.9	31.9	26.4	17.7	21.7	21.4	20.3	23.4	36.2	21.7	40.4	16.9	19.1	32.9	31.5	22.3	47.8	24.0	21.9	26.7	27.0	17.1	25.5	29.5	36.9	22.7	25.2	24.1	19.3	33.0	23.5	17.5	17.8	40.0	24.6	32.8	41.4	31.1	41.3	23.5	22.2	4.3	15.2	21.2	26.7	13.5	26.9	19.2	19.0	23.6	14.2	12.8	45.0	26.0	14.0	20.1	18.8	42.3	24.4	41.8	21.7	15.7	25.1	25.1	37.6	32.0	35.5	16.3	34.5	50.4	28.8	41.6	21.1	49.8	24.3	16.5	19.1	28.0	64.3	10.9	18.0	24.9	55.0	31.9	25.1	28.7	45.4	55.1	47.4	30.1	33.3	38.4	28.7	55.1	23.7	32.7	29.3	21.7	24.1	34.7	29.9	31.8	23.7	39.4	15.5	25.7	30.2	22.9	44.4	26.0	47.4	59.8	19.0	35.5	30.5	4.3	10.2	3.1	16.8	15.2	24.5	23.5	24.0	22.7	15.9	18.7	26.4	26.7	1.0	21.2	10.9	22.2	23.7	13.5	16.7	24.6	30.2	24.2	21.4	20.3	16.9	19.1	21.9	17.8	101.3	103.5	73.0	102.7	76.2	27.1	68.8	38.2	96.4	150.2	38.4	39.3	67.7	24.9	45.7	11.5	57.0	15.0	23.3	58.3	76.0	49.7	70.7	131.9	44.1	43.1	23.8	33.8	29.4	17.4	7.9	40.0	46.4	23.6	73.1	32.3	17.7	45.7	10.5	28.0	32.1	43.5	25.8	81.9	59.1	54.7	65.4	56.9	61.8	56.1	83.8
NOSIP	CGI-25	ENSG00000142546	"Nitric oxide synthase interacting protein"	Q9Y314	19	49555711-49590262	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 119.4"	"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 645.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043464, HPA062132"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043464: AB_10794284, HPA062132: AB_2684693"	"unprognostic (2.27e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.59e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.42e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.27e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.95e-3)"	13.4	13.9	14.2	14.0	14.0	14.3	11.5	12.1	14.2	11.3	15.9	12.3	13.1	17.3	12.5	8.1	12.7	11.1	11.7	14.9	12.3	11.4	13.2	14.5	12.6	24.6	18.3	10.8	12.9	39.7	7.1	13.6	15.6	14.3	11.6	7.9	11.3	19.2	11.4	66.9	11.9	16.5	11.0	13.1	18.0	13.9	40.2	16.3	20.6	15.5	17.6	16.3	11.7	15.0	20.4	21.5	31.8	16.8	29.7	119.4	69.2	66.5	36.1	14.1	31.0	12.6	9.2	13.5	15.7	13.9	26.5	24.4	25.2	11.8	17.9	27.6	13.2	11.1	14.9	13.8	27.6	11.6	20.4	39.9	22.6	20.8	28.0	19.9	18.3	19.1	12.0	19.2	20.1	10.9	10.8	15.9	28.8	25.0	14.3	13.8	17.8	18.6	39.4	19.1	25.0	31.4	24.4	23.4	15.9	12.3	20.1	17.6	22.9	21.2	18.1	15.8	6.7	14.7	19.4	23.5	23.0	19.5	8.0	30.0	26.9	50.8	24.2	8.7	25.2	17.7	28.0	16.8	23.5	35.1	15.7	45.4	20.4	71.4	40.2	16.6	19.8	119.4	65.8	31.8	29.7	14.3	21.5	37.5	69.2	14.2	14.0	12.1	14.2	12.3	11.4	18.3	10.8	14.3	16.3	17.9	37.0	70.7	51.2	64.7	22.7	33.5	58.6	30.8	14.8	48.8	21.6	81.7	72.9	76.5	286.4	75.9	124.9	46.7	245.7	72.4	65.6	38.9	66.9	45.0	63.5	11.1	56.3	82.3	64.5	645.6	66.4	58.6	59.1	85.6	76.3	39.5	185.4	94.7	67.8	92.9	31.4	58.2	62.7	203.6	46.2	66.7	114.0	101.0	98.9	47.7
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	4.0	1.0	0.0	5.8	43.7	5.3	3.0	0.0	0.1	0.0	4.6	7.3	4.1	3.6	0.2	0.0	1.8	0.0	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	13.6	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	5.6	0.0	1.3	0.0	2.1	0.0	8.1	0.0	0.0	0.0	0.0	3.8	5.8	45.2	1.2	0.0	0.0	0.0	6.0	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0	0.0	1.1	0.0	0.6	16.7	0.0	1.2	0.0	2.7	2.3	36.6	0.0	0.0	0.0	7.2	0.0	12.6	0.3	0.0	1.0	0.0	15.4	14.0	23.1	0.0	1.4	3.2	9.2	0.6	1.2	0.0	2.8	0.4	74.2	0.0	1.3	0.0	0.6	2.9	0.7	0.0	0.2	0.0	20.8	0.0	0.0	14.8	0.1	0.0	9.8	0.9
NPAT	"E14, p220"	ENSG00000149308	"Nuclear protein, coactivator of histone transcription"	Q14207	11	108157215-108222642	"Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045908, HPA066370"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA045908: AB_2679493, HPA066370: AB_2685665"	"unprognostic (6.93e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.82e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.60e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.38e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.93e-1)"	15.7	9.8	8.5	18.6	11.5	7.1	12.0	24.6	12.8	13.1	9.3	7.5	8.9	7.1	12.0	10.7	10.3	10.7	8.2	9.4	7.8	8.7	10.1	9.5	11.5	23.1	10.7	8.9	15.2	9.1	14.6	21.5	18.3	13.1	10.7	11.0	7.9	11.6	8.4	8.8	12.2	12.2	9.0	13.7	17.1	10.0	11.3	11.1	26.7	14.4	7.5	21.6	15.4	10.7	5.2	2.2	7.4	3.1	5.8	11.6	3.6	5.0	4.1	6.4	8.0	8.0	5.9	5.2	7.5	9.6	6.7	10.1	8.4	11.0	8.7	10.2	4.7	7.5	9.5	8.8	7.7	12.1	7.7	3.5	14.4	4.5	4.3	3.4	10.8	9.6	5.5	4.5	11.8	7.6	5.2	9.4	10.2	13.3	4.3	9.3	2.5	13.2	5.8	5.3	8.1	5.7	9.1	9.1	11.9	4.4	7.4	6.9	6.3	9.7	5.8	7.5	7.1	6.6	5.3	7.7	11.7	6.2	6.9	6.8	3.0	3.7	34.0	2.9	8.0	9.0	7.4	1.7	3.2	6.2	3.1	6.9	4.9	7.2	7.8	2.2	5.2	11.6	9.2	2.2	5.8	3.0	1.7	5.2	3.6	8.5	11.5	24.6	12.8	7.8	8.7	10.7	8.9	13.1	11.1	17.9	10.4	14.6	16.1	14.4	16.6	12.5	2.5	10.7	14.8	12.2	27.5	8.3	1.7	7.3	2.6	17.4	5.4	0.0	5.9	7.4	13.6	12.2	18.5	8.5	6.2	9.5	9.9	20.9	11.2	2.6	14.7	12.4	8.5	8.2	8.2	11.4	5.5	7.0	15.9	4.1	17.4	6.5	8.5	24.1	30.6	11.5	11.8	25.3	8.6	11.9
NPM1	"B23, NPM"	ENSG00000181163	"Nucleophosmin 1"	P06748	5	171387116-171411137	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011384, CAB012983"	Supported		Enhanced	"Nucleoplasm,Nucleoli rim"		Yes	No		810000	"Nucleoli rim"	Nucleoplasm	"CAB012983: AB_2533084, HPA011384: AB_1854692"	"unprognostic (1.84e-3)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (7.48e-4)"	"prognostic unfavorable (4.82e-6)"	"unprognostic (1.86e-2)"	"unprognostic (5.25e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (2.89e-6)"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.24e-2)"	56.8	44.7	29.9	61.1	33.6	76.0	67.0	37.7	34.6	113.5	57.8	24.8	39.3	36.7	78.2	50.5	81.6	65.0	44.0	48.5	28.8	31.6	64.9	78.8	59.5	128.1	36.1	27.9	177.4	102.0	27.1	57.9	65.2	36.1	87.2	49.3	29.5	47.3	48.2	67.9	42.7	52.8	92.4	43.2	85.9	54.0	56.7	31.3	111.3	112.6	66.5	82.1	116.8	65.7	85.3	54.1	12.3	29.1	59.0	126.6	91.4	119.9	81.3	98.8	139.9	60.4	110.3	147.3	109.2	99.8	148.0	133.3	193.9	84.8	321.2	86.8	63.1	99.7	70.4	137.0	248.2	192.8	100.0	108.7	113.3	79.7	142.8	89.5	228.2	94.0	97.3	87.5	100.4	198.1	116.7	110.3	74.8	137.8	73.9	107.4	149.0	148.9	162.3	123.6	64.0	99.9	133.7	109.0	164.6	126.2	84.6	77.9	62.6	65.2	106.8	197.6	72.0	131.0	101.3	68.9	49.5	109.2	56.9	183.8	59.2	107.6	193.2	74.9	185.8	98.7	12.3	26.9	8.4	45.7	29.1	84.6	85.3	85.1	66.2	54.1	62.8	126.6	99.0	4.0	59.0	23.1	48.7	73.2	91.4	29.9	33.6	37.7	34.6	28.8	31.6	36.1	27.9	36.1	31.3	321.6	347.3	775.5	994.0	1243.7	166.1	228.8	387.3	346.6	597.1	307.1	41.2	1400.5	630.0	839.1	64.3	646.8	150.8	116.8	796.2	1641.6	855.4	473.8	427.8	235.7	952.5	120.8	347.6	298.3	500.7	53.0	902.7	605.7	578.6	960.4	654.2	214.7	840.7	333.1	610.9	657.5	112.2	426.9	861.0	695.1	635.2	890.7	1286.9	674.9	783.2	797.7
NPY	PYY4	ENSG00000122585	"Neuropeptide Y"	P01303	7	24284163-24291865	"Plasma proteins, Predicted secreted proteins"		Neuropeptide		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 50.5;brain: 63.6;prostate: 131.2"	"Cell type enriched"	"Detected in some"	5	"Glandular cells: 55.9"	"Cancer enriched"	"Detected in many"	187	"prostate cancer: 1214.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	36	"SH-SY5Y: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016733, CAB034368, HPA036636, HPA044572, HPA056798"	Supported	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	30700000		"Golgi apparatus"		"CAB016733: , CAB034368: AB_2298657, HPA036636: , HPA044572: AB_2678996, HPA056798: AB_2630371"			"unprognostic (2.00e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (4.15e-1)"					"unprognostic (3.76e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.52e-1)"		1.6	50.5	27.2	5.5	63.6	2.8	1.0	0.1	55.9	1.0	1.8	2.8	1.4	4.7	1.1	1.1	2.5	1.0	1.4	1.0	11.9	20.6	1.1	1.0	1.1	1.0	2.6	18.3	1.0	4.0	1.0	0.5	1.0	1.9	131.2	1.7	0.0	1.0	14.7	1.0	1.0	5.0	1.4	1.4	1.0	1.7	1.3	13.9	0.0	1.1	0.0	1.0	3.9	4.5	0.5	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.1	124.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	27.2	63.6	0.1	31.2	11.9	20.6	2.6	18.3	1.9	13.9	0.0	0.0	0.0	1.3	0.1	1.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.2	0.2	55.9	0.0	0.0	2.2	0.0	0.0	0.0	0.0	8.5	0.3	0.0	1.7	0.0	0.0	0.4	0.5	0.0	0.4	0.0	0.5	0.0	0.0	2.3	2.1	0.0	4.2	0.0	0.0	0.7
NR0B1	"AHC, AHCH, DAX1, DSS"	ENSG00000169297	"Nuclear receptor subfamily 0 group B member 1"	P51843	X	30304206-30309598	"Cancer-related genes, Disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Receptor, Repressor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 23.9;testis: 36.0"	"Cell type enhanced"	"Detected in some"	15	"Intestinal endocrine cells: 5.2;Melanocytes: 1.7;monocytes: 4.6;Pancreatic endocrine cells: 2.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 35.1;RT4: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA061948, HPA067207"			Supported	"Nuclear speckles,Vesicles,Centriolar satellite"		NA	NA			"Nuclear speckles"	"Vesicles, Centriolar satellite"	"HPA061948: AB_2732673, HPA067207: AB_2732761"		"unprognostic (1.50e-2)"			"unprognostic (9.68e-2)"			"unprognostic (9.47e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.45e-3)"		"unprognostic (4.83e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.33e-3)"			0.4	23.9	1.0	0.0	0.8	0.0	0.2	0.4	1.1	1.3	0.1	1.7	0.0	0.0	0.4	0.9	0.1	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.1	0.0	0.5	0.6	3.5	2.1	0.0	1.6	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.7	0.6	0.1	0.7	36.0	0.7	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.1	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	5.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.4	1.1	0.9	0.9	0.5	0.6	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.7	1.1	0.0	1.7	4.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0
NR1H2	"LXR-b, NER, NER-I, RIP15, UNR"	ENSG00000131408	"Nuclear receptor subfamily 1 group H member 2"	P55055	19	50329653-50382982	"Cancer-related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005446, HPA056838, HPA070212"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA005446: , HPA056838: AB_2683254, HPA070212: AB_2686234"	"unprognostic (1.31e-1)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.86e-4)"	"unprognostic (1.34e-3)"	"unprognostic (1.68e-1)"	"unprognostic (5.24e-3)"	"unprognostic (2.26e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.45e-2)"	"unprognostic (5.23e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.69e-3)"	30.1	27.5	24.5	24.7	27.5	98.0	24.4	20.6	33.5	25.1	30.9	23.1	25.2	30.9	31.2	23.1	27.9	26.9	28.7	36.8	23.8	19.4	27.1	31.4	28.3	23.3	31.7	25.9	26.5	37.6	22.0	18.6	30.5	28.1	27.9	10.5	23.2	33.8	33.8	76.2	25.3	30.3	29.9	22.9	29.9	26.7	21.2	29.1	20.4	27.1	24.4	21.7	33.2	27.6	34.1	34.2	63.0	37.7	22.3	28.6	32.5	16.1	42.5	4.1	10.4	12.2	12.9	13.3	22.3	19.0	13.2	15.2	8.8	15.7	10.4	20.0	13.4	10.6	15.1	2.6	12.2	3.2	25.8	22.9	9.9	14.3	9.1	23.4	16.4	27.3	13.5	16.7	13.6	9.2	13.4	12.0	8.3	16.2	21.6	7.4	17.9	11.7	13.5	8.3	10.3	36.5	7.0	10.8	18.0	11.4	18.1	4.6	16.2	14.5	18.0	14.0	2.4	12.4	13.7	15.2	17.8	14.5	18.2	19.8	27.1	22.3	7.6	35.5	10.8	17.9	39.1	35.9	63.0	27.7	35.0	27.0	34.1	27.4	25.9	34.2	34.1	28.6	24.9	55.4	22.3	37.7	29.5	24.4	32.5	24.5	27.5	20.6	33.5	23.8	19.4	31.7	25.9	28.1	29.1	26.8	27.8	34.4	74.6	38.1	39.5	23.4	25.5	9.4	7.9	29.6	13.7	57.0	54.7	54.4	5.2	46.6	78.1	0.0	63.6	44.7	33.4	68.0	50.6	17.4	46.9	35.0	20.0	20.9	26.7	6.8	42.0	44.5	57.3	84.8	39.8	39.5	60.4	87.7	50.2	46.2	21.7	38.8	58.5	32.5	30.0	40.0	117.1	47.8	32.6	81.4
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Group enriched"	"Detected in some"	4	"Enterocytes: 29.0;Hepatocytes: 28.7"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1											0.0	0.0	0.5	0.0	0.0	0.0	0.8	2.5	0.0	0.0	1.8	0.0	0.0	1.7	0.0	0.0	0.0	29.0	0.0	0.2	0.0	0.0	0.0	0.0	28.7	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0
NR2C2	"hTAK1, TAK1, TR2R1, TR4"	ENSG00000177463	"Nuclear receptor subfamily 2 group C member 2"	P49116	3	14947584-15053600	"Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006313	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006313: AB_1079503"	"unprognostic (1.32e-1)"	"unprognostic (3.87e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"prognostic favorable (1.51e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (5.82e-3)"	13.2	13.1	22.5	17.0	17.5	17.1	16.1	30.5	26.4	11.9	14.0	12.8	14.1	18.5	17.8	11.0	13.6	12.6	12.3	14.5	18.3	12.0	12.4	12.6	18.7	16.9	12.6	20.4	18.8	14.2	18.0	23.2	11.9	13.1	12.3	12.2	13.7	13.0	21.5	31.5	19.6	18.1	15.7	13.5	18.8	14.7	29.2	13.3	26.0	19.4	9.0	15.5	15.5	17.8	5.1	4.2	6.2	3.4	2.7	4.9	1.5	10.1	11.5	13.2	10.2	9.4	11.3	30.3	14.7	11.9	11.9	12.4	7.4	10.0	15.7	7.7	13.1	10.5	10.2	12.1	7.5	12.4	20.6	17.2	20.5	24.6	6.6	7.9	15.0	15.9	8.9	10.0	15.0	7.9	10.0	13.4	15.5	14.5	10.8	10.5	9.0	23.0	11.8	8.7	4.8	11.9	18.5	15.7	10.4	5.7	15.4	8.4	21.1	13.3	11.2	13.5	10.9	11.2	15.0	17.3	18.5	22.1	16.8	20.0	16.5	21.3	17.0	13.3	14.4	16.2	6.2	2.5	1.9	4.9	3.4	4.4	2.3	2.7	2.9	2.6	5.1	3.9	3.5	3.5	2.7	3.0	4.2	2.5	1.5	22.5	17.5	30.5	26.4	18.3	12.0	12.6	20.4	13.1	13.3	20.8	9.8	10.9	9.5	3.3	15.5	5.1	12.7	24.1	7.9	7.0	13.7	6.7	5.0	6.1	46.1	6.4	10.7	0.0	6.3	6.3	5.8	13.8	9.2	7.8	6.7	12.7	24.1	20.3	20.9	49.4	17.8	7.7	5.0	7.2	10.7	13.3	9.4	11.8	19.4	5.7	16.3	0.0	4.8	30.9	16.3	2.8	12.5	13.6	10.6	10.7
NR3C1	"GR, GRL"	ENSG00000113580	"Nuclear receptor subfamily 3 group C member 1"	P04150	5	143277931-143435512	"Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Receptor, RNA-binding"	"Disease mutation, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004248, CAB010435"	Supported		Supported	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"CAB010435: AB_2155784, HPA004248: AB_1078976"	"unprognostic (1.38e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (3.64e-5)"	"unprognostic (1.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.85e-2)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.06e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.45e-2)"	27.7	8.6	13.5	26.1	14.9	29.6	23.5	30.1	19.2	14.9	14.2	17.0	10.5	13.0	14.7	12.9	18.2	13.7	14.7	17.4	13.4	14.1	13.5	27.3	22.0	16.1	18.3	12.8	15.5	12.5	21.9	18.9	31.9	13.6	14.3	10.3	14.2	12.0	15.2	40.4	18.3	14.8	16.8	17.2	17.5	13.4	7.3	18.2	37.1	18.0	15.1	18.2	14.8	32.2	11.1	13.6	33.7	11.8	10.9	9.6	7.3	10.1	20.7	1.5	0.0	13.6	15.2	1.8	15.9	19.1	13.8	15.9	1.5	13.6	9.0	7.3	23.3	16.1	9.6	0.1	12.5	17.1	5.0	7.1	2.3	28.0	4.5	12.8	9.3	7.2	11.0	16.2	22.6	22.1	17.2	5.1	4.1	3.3	34.3	12.1	3.6	5.4	6.6	4.1	1.7	4.4	1.9	14.4	19.1	4.0	0.7	2.7	2.1	27.8	4.0	6.6	1.8	1.8	13.4	12.2	33.4	6.6	15.9	12.0	6.9	6.3	14.1	17.5	9.6	11.6	25.4	9.8	17.9	9.3	11.8	7.7	7.6	9.6	8.9	13.6	11.1	9.2	8.9	33.7	10.9	10.5	12.4	5.8	7.3	13.5	14.9	30.1	19.2	13.4	14.1	18.3	12.8	13.6	18.2	62.5	66.3	52.2	35.5	52.2	11.3	38.3	43.3	45.5	46.6	24.4	15.7	34.4	14.9	27.4	129.9	67.3	15.8	0.0	28.6	30.5	63.9	36.5	86.6	160.0	47.2	35.0	27.0	55.3	56.4	113.7	58.4	78.4	50.6	53.3	2.3	41.2	29.3	21.0	67.1	50.1	55.0	148.8	81.5	18.0	35.6	49.2	30.6	85.5	12.0	12.3
NR6A1	"CT150, GCNF, GCNF1, RTR"	ENSG00000148200	"Nuclear receptor subfamily 6 group A member 1"	Q15406	9	124517275-124771310	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 28.2"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 112.0;Spermatocytes: 68.9;Spermatogonia: 111.8"	"Cancer enriched"	"Detected in many"	16	"testis cancer: 27.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 8.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.8;CACO-2: 11.0;Hep G2: 10.7;K-562: 14.1;NTERA-2: 17.0;U-266/84: 10.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA031461, HPA045145"			Enhanced	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA031461: AB_2673894, HPA045145: AB_2679233"	"unprognostic (1.73e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.53e-1)"	"unprognostic (1.34e-6)"	"unprognostic (4.40e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.52e-5)"	"unprognostic (6.31e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.71e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.09e-1)"	0.6	1.0	2.9	1.4	3.4	5.5	1.8	5.8	3.5	0.8	7.9	1.2	1.3	2.5	0.9	1.4	2.2	1.0	0.9	1.0	3.3	1.3	1.9	2.8	1.8	0.7	2.1	2.4	0.6	3.3	1.5	2.2	4.2	2.2	1.7	2.3	1.7	1.5	1.4	1.9	2.6	5.3	0.8	2.3	1.1	0.7	28.2	2.8	0.0	7.3	0.8	1.1	1.3	1.4	0.3	1.0	8.6	1.2	0.1	0.0	0.1	0.5	1.2	6.3	0.8	0.1	0.1	47.8	0.1	0.4	0.3	0.5	11.0	1.2	2.1	0.4	0.0	1.6	1.1	0.6	0.5	0.7	0.5	2.0	1.7	1.8	10.7	0.0	1.0	3.1	0.0	0.6	0.5	0.7	0.1	0.1	0.5	14.1	0.3	0.2	0.2	0.0	1.3	17.0	0.5	0.5	0.5	0.6	0.9	0.2	0.8	0.9	0.3	0.0	0.3	0.4	9.8	1.1	0.5	0.0	0.6	1.3	0.4	0.3	1.4	10.3	1.9	0.3	1.0	0.3	0.1	1.2	2.0	0.0	0.9	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	8.6	0.1	0.6	0.2	0.0	0.1	2.9	3.4	5.8	3.5	3.3	1.3	2.1	2.4	2.2	2.8	0.0	7.7	0.0	15.1	33.2	2.8	1.4	10.2	4.0	4.5	5.2	27.5	30.8	1.7	7.9	43.0	2.7	13.2	0.0	3.1	112.0	3.0	14.2	1.1	5.5	7.1	1.6	4.6	1.3	1.8	22.4	1.1	4.6	8.5	5.4	6.7	8.0	2.3	7.0	1.8	1.9	10.5	0.0	2.1	68.9	111.8	34.8	25.6	0.0	13.0	11.9
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 44.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	14.2	5.6	1.4	6.5	2.4	10.0	11.4	2.2	2.5	16.2	6.6	2.9	5.8	2.6	15.3	5.3	11.4	7.7	7.4	7.5	1.5	1.4	7.3	3.0	8.1	15.7	2.1	1.5	13.7	5.7	3.6	1.7	11.3	2.4	10.4	4.2	5.4	4.2	7.0	4.5	9.0	6.0	7.4	2.4	9.6	4.2	9.7	2.2	23.3	5.0	14.4	11.9	9.9	9.2	4.2	3.7	1.6	3.8	0.8	1.6	1.0	3.8	3.7	6.9	4.8	1.1	3.8	0.8	1.9	3.9	6.2	5.7	3.9	2.7	6.5	1.4	4.0	2.8	6.0	3.8	6.5	1.8	9.0	2.0	4.0	5.3	5.1	1.4	3.1	6.1	2.3	2.4	6.0	2.3	2.1	4.8	5.4	3.5	6.0	4.2	3.4	4.8	3.3	1.4	4.3	2.2	11.7	4.6	7.9	2.7	2.0	2.6	2.2	2.2	2.8	1.2	2.2	4.5	3.0	1.9	5.7	3.1	3.2	3.5	2.2	4.0	2.3	0.9	8.3	7.3	0.9	3.8	0.2	1.0	1.1	0.8	4.2	1.1	1.6	3.3	4.1	0.5	0.6	1.6	0.8	0.4	3.7	0.8	1.0	1.4	2.4	2.2	2.5	1.5	1.4	2.1	1.5	2.4	2.2	3.0	1.3	16.4	5.8	8.8	0.2	1.6	10.2	0.0	6.8	1.8	2.0	15.7	3.3	9.9	8.4	11.7	0.2	0.0	5.0	23.5	13.6	1.2	12.7	0.8	15.3	3.2	1.2	1.8	21.2	44.7	5.2	14.9	3.3	27.9	1.9	1.1	5.2	0.0	5.6	0.6	1.5	6.5	9.2	4.5	1.7	5.5	4.2	8.6	3.0	2.6
NSA2	"FLJ94393, HCLG1, HUSSY-29, TINP1"	ENSG00000164346	"NSA2, ribosome biogenesis homolog"	O95478	5	74766991-74780113	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis, rRNA processing"	Ribonucleoprotein		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA043487	Approved		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA043487: AB_2678507"	"unprognostic (4.79e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.14e-3)"	"unprognostic (4.24e-1)"	"unprognostic (2.15e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.44e-1)"	25.4	32.6	17.4	26.8	29.3	28.3	24.0	14.0	29.4	31.8	25.8	8.0	18.0	26.2	26.5	22.6	27.9	22.9	13.5	27.7	20.8	13.6	27.4	35.4	27.0	42.5	16.7	19.1	54.2	31.2	13.5	35.4	25.4	20.3	27.8	20.6	10.4	33.8	17.9	51.1	17.3	22.2	23.1	28.5	28.5	24.3	44.5	15.7	26.4	27.2	21.7	26.1	36.7	26.1	17.0	11.1	4.4	11.9	13.1	19.3	6.1	20.6	11.3	14.0	18.8	8.7	16.1	21.4	14.8	7.7	9.5	7.5	18.7	20.3	16.7	31.6	8.2	23.3	12.8	11.0	16.3	13.4	11.4	17.0	8.7	22.0	21.4	8.1	15.2	20.5	10.6	15.4	12.7	9.4	15.5	7.9	15.2	8.6	14.1	10.1	15.7	25.5	38.2	9.3	8.8	9.9	18.3	16.4	31.5	11.9	22.8	15.0	19.6	8.9	17.3	39.9	11.0	16.3	43.3	9.1	7.3	22.1	13.7	42.5	14.1	18.8	27.3	18.3	27.0	10.8	4.4	7.2	4.2	10.5	11.9	15.1	17.0	16.0	15.8	11.1	12.4	19.3	19.1	1.3	13.1	8.8	10.4	15.8	6.1	17.4	29.3	14.0	29.4	20.8	13.6	16.7	19.1	20.3	15.7	74.5	77.0	155.5	140.9	83.6	31.6	79.5	137.6	66.9	104.6	59.3	13.7	119.1	127.6	113.6	331.3	86.4	114.1	116.8	204.5	170.1	84.0	110.5	116.6	184.7	121.5	47.7	134.0	113.5	170.4	102.0	257.7	109.4	79.2	149.7	219.3	47.0	172.0	119.3	161.2	158.4	31.4	135.8	91.0	120.5	95.0	75.2	113.3	107.1	207.0	165.4
NSDHL	"H105e3, SDR31E1, XAP104"	ENSG00000147383	"NAD(P) dependent steroid dehydrogenase-like"	Q15738	X	152830967-152869729	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"Disease mutation, Ichthyosis, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000248, HPA000571"	Enhanced		Enhanced	"Endoplasmic reticulum,Lipid droplets"		NA	NA			"Endoplasmic reticulum"	"Lipid droplets"	"HPA000248: AB_1079507, HPA000571: AB_1079506"	"unprognostic (1.84e-1)"	"prognostic favorable (5.65e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.03e-1)"	"unprognostic (5.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.63e-1)"	"prognostic favorable (6.09e-5)"	"unprognostic (3.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.79e-2)"	17.4	24.8	11.0	7.7	10.5	6.0	20.4	7.7	15.0	13.4	23.4	13.9	20.5	13.3	10.4	35.7	36.2	11.9	7.4	16.7	14.3	11.4	11.6	38.1	9.9	8.7	9.7	10.4	9.8	7.9	9.8	6.9	7.9	18.9	12.0	10.7	7.9	12.2	17.7	6.9	14.5	24.0	9.9	14.2	7.3	9.6	8.6	9.3	6.0	11.0	22.2	17.0	7.5	16.1	16.2	17.5	16.4	17.7	17.0	17.3	13.0	40.6	14.9	20.4	10.6	17.6	13.4	11.5	8.1	10.9	14.8	18.8	20.6	22.2	20.1	27.3	11.0	55.0	20.9	26.5	37.5	13.1	6.7	15.2	8.2	14.6	20.9	12.8	8.2	6.7	16.4	14.5	28.9	7.3	6.4	13.7	8.9	13.6	9.1	11.2	18.0	8.0	10.7	8.1	20.4	18.0	6.0	14.8	16.5	30.7	16.8	7.4	8.4	7.2	10.9	8.5	14.8	7.2	10.5	11.6	6.9	11.4	16.6	15.6	12.9	8.6	34.6	12.8	12.9	6.5	16.4	17.7	15.8	15.6	16.2	15.7	16.2	15.6	13.5	17.5	12.9	11.4	12.6	1.9	17.0	12.1	15.6	17.3	13.0	11.0	10.5	7.7	15.0	14.3	11.4	9.7	10.4	18.9	9.3	11.9	14.7	9.7	9.8	9.6	3.8	21.0	15.3	18.7	10.3	12.2	0.0	18.3	8.3	16.9	8.7	7.4	12.0	0.0	17.6	18.3	9.8	7.8	8.1	26.3	16.1	1.6	5.8	8.0	8.3	5.9	7.8	9.3	5.0	15.4	8.7	10.3	16.2	7.8	8.5	11.5	5.4	0.0	8.2	3.7	8.2	10.7	15.6	5.7	9.4	15.3
NSFL1C	"dJ776F14.1, p47, UBX1, UBXD10, UBXN2C"	ENSG00000088833	"NSFL1 cofactor"	Q9UNZ2	20	1442162-1473842	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047108, HPA050628"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		920000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA047108: AB_2679935, HPA050628: AB_2681194"	"unprognostic (7.55e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.59e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.97e-2)"	"unprognostic (6.90e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.44e-2)"	"unprognostic (7.50e-3)"	15.7	22.7	20.2	10.2	23.5	15.8	15.3	18.2	26.5	16.6	14.7	17.1	9.3	11.1	17.4	21.2	19.8	19.9	12.2	21.9	16.7	18.2	14.8	19.8	12.7	9.6	17.1	22.4	22.7	10.8	12.4	9.9	21.5	24.2	16.8	13.9	20.1	13.6	21.8	49.7	25.6	12.4	18.9	15.8	12.2	12.6	11.1	15.3	12.8	13.1	14.8	12.4	15.9	13.7	14.5	12.0	32.4	10.9	5.9	11.0	9.4	21.3	24.8	15.9	15.1	14.4	13.4	11.8	10.0	18.0	24.5	18.2	20.9	17.4	11.9	8.1	18.1	23.3	20.3	9.7	26.2	18.9	4.4	10.6	12.0	4.4	24.0	15.2	11.6	7.3	11.4	9.6	25.5	8.5	14.2	17.4	8.6	15.5	10.7	17.1	10.2	12.1	22.2	17.1	16.5	27.5	5.8	19.8	11.6	28.5	15.0	9.2	11.3	12.1	24.1	10.9	9.7	14.7	8.0	16.1	19.0	14.0	11.0	16.3	8.6	15.3	9.9	14.1	16.3	13.4	10.7	8.9	32.4	8.5	10.6	8.5	13.9	9.2	8.3	12.0	14.5	10.5	9.2	29.1	5.9	10.9	9.5	11.0	9.4	20.2	23.5	18.2	26.5	16.7	18.2	17.1	22.4	24.2	15.3	20.8	21.0	25.3	52.2	79.2	58.7	30.5	20.4	25.4	30.7	29.6	21.6	128.5	48.0	77.9	14.8	36.0	52.0	0.0	82.5	121.5	43.5	44.6	39.3	35.8	71.3	66.7	41.9	25.2	37.6	26.4	36.2	39.7	40.5	47.7	29.3	44.2	95.4	52.6	43.5	54.7	37.5	77.6	53.6	80.7	105.4	66.1	126.8	34.5	37.5	81.7
NSG2	"CALY3, HMP19, Nsg2"	ENSG00000170091	"Neuronal vesicle trafficking associated 2"	Q9Y328	5	174045604-174243501	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 120.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	8	"glioma: 12.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	58	"SCLC-21H: 21.9;SH-SY5Y: 35.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046531, HPA056191"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA046531: AB_2732528, HPA056191: AB_2683062"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.36e-5)"	"unprognostic (1.93e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.81e-2)"	"unprognostic (3.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.02e-2)"	"unprognostic (5.20e-2)"	"unprognostic (9.31e-4)"	"unprognostic (1.55e-1)"	1.7	23.1	31.6	3.0	92.4	1.4	1.4	19.7	120.8	1.4	3.6	5.0	0.0	2.8	1.4	1.7	1.5	1.4	1.6	1.6	27.3	40.2	1.6	1.4	1.6	1.4	20.2	27.6	1.4	2.0	1.4	0.9	1.4	22.5	1.4	4.1	0.8	1.4	1.5	1.4	1.4	3.8	2.5	4.6	1.4	3.3	5.0	11.7	0.0	1.8	0.0	1.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	92.4	19.7	49.8	27.3	40.2	20.2	27.6	22.5	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
NSMCE4A	"bA500G22.3, C10orf86, FLJ20003, NSE4A"	ENSG00000107672	"NSE4 homolog A, SMC5-SMC6 complex component"	Q9NXX6	10	121957088-121975217	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037459, HPA038412, HPA044872"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037459: AB_10696932, HPA038412: AB_2676005, HPA044872: AB_2679124"	"unprognostic (1.16e-3)"	"unprognostic (2.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.73e-2)"	"unprognostic (4.09e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (2.72e-5)"	"unprognostic (3.16e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (1.64e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.01e-3)"	21.8	17.7	11.1	27.1	17.6	16.2	26.0	14.0	12.5	23.7	26.6	14.0	14.3	22.8	20.8	17.1	22.3	18.0	16.7	17.8	11.0	8.2	15.4	23.0	22.3	22.2	18.5	12.6	20.0	24.3	13.3	10.5	15.5	12.2	21.1	20.3	15.2	24.5	23.0	15.9	14.6	26.1	26.9	12.2	20.0	23.7	6.5	16.8	23.3	21.8	15.8	20.6	26.7	16.8	24.0	24.9	8.8	17.6	18.7	22.4	17.2	16.8	20.8	22.3	19.9	7.9	10.4	16.5	9.5	17.1	16.4	22.9	16.0	13.2	22.5	7.4	7.5	9.0	14.7	13.1	10.4	13.0	27.0	30.9	14.8	7.1	29.9	6.7	16.6	10.4	7.0	8.0	9.6	15.7	9.2	17.3	20.7	13.5	16.3	9.1	13.7	30.2	24.5	11.7	12.1	16.4	26.1	17.4	24.2	11.2	14.1	6.1	12.0	10.8	7.4	14.7	9.4	8.1	15.9	14.0	6.5	11.7	10.9	19.6	21.8	23.1	34.7	8.1	22.7	6.9	0.1	15.4	8.8	15.3	17.6	17.7	24.0	20.6	19.8	15.9	21.7	21.8	17.7	1.4	18.7	17.1	24.9	22.4	17.2	11.1	17.6	14.0	12.5	11.0	8.2	18.5	12.6	12.2	16.8	20.8	27.8	29.6	39.9	15.0	20.2	17.1	25.5	17.4	20.5	12.2	31.4	41.8	29.9	24.3	0.3	29.5	27.6	46.7	53.2	31.1	22.0	38.1	11.5	31.4	31.1	25.4	20.7	17.2	18.3	0.4	32.8	19.0	20.3	55.1	31.7	29.1	29.2	37.6	31.5	30.2	36.0	25.8	24.5	6.1	11.7	18.9	55.4	25.8	40.3	43.9
NSUN5	"FLJ10267, NOL1R, NSUN5A, p120(NOL1), WBSCR20, WBSCR20A, Ynl022cL"	ENSG00000130305	"NOP2/Sun RNA methyltransferase family member 5"	Q96P11	7	73302517-73308867	"Disease related genes, Predicted intracellular proteins"	"rRNA processing"	"Methyltransferase, RNA-binding, Transferase"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020536, HPA045590, HPA046867"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA020536: AB_1858789, HPA045590: AB_2679376, HPA046867: AB_2679847"	"unprognostic (3.94e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (3.96e-4)"	"unprognostic (3.54e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-2)"	9.0	7.7	11.2	13.1	12.8	40.9	8.7	12.9	14.4	8.5	10.3	15.0	4.8	12.6	12.3	6.9	10.8	12.0	8.1	9.4	10.8	9.3	9.4	9.8	8.0	16.1	19.4	11.9	10.6	19.6	9.5	8.3	8.3	13.6	9.7	6.2	7.7	13.6	9.7	27.1	11.8	12.1	10.9	11.6	15.8	9.6	14.6	13.6	23.5	10.6	11.2	12.1	10.6	8.9	33.5	21.2	18.7	14.4	16.8	22.3	15.3	12.2	17.0	4.8	10.5	2.0	2.5	18.2	5.9	3.4	9.1	9.8	22.9	9.1	20.2	4.0	2.9	13.4	10.6	9.0	5.9	3.0	13.3	20.9	7.6	12.4	13.1	7.8	16.8	10.4	3.4	9.9	7.8	6.6	2.1	1.2	15.2	24.9	4.8	4.3	29.5	14.2	34.6	19.3	9.0	13.1	17.4	3.6	28.9	3.9	6.1	12.4	20.7	10.3	27.6	13.3	5.4	17.7	13.4	1.9	0.1	13.3	13.2	3.9	19.3	24.9	28.8	0.2	23.6	0.9	14.2	14.4	15.0	14.0	12.5	11.0	21.5	15.9	14.3	16.5	33.5	22.3	18.8	18.7	16.8	9.3	21.2	17.3	15.3	11.2	12.8	12.9	14.4	10.8	9.3	19.4	11.9	13.6	13.6	6.0	6.1	51.6	17.1	15.0	25.1	17.1	25.5	10.7	12.5	34.9	11.8	33.4	31.5	36.0	12.8	7.3	18.6	0.0	28.6	37.8	16.9	12.9	26.5	20.3	30.9	30.2	3.5	6.7	17.4	16.3	27.0	19.4	20.3	46.9	16.4	13.8	24.0	17.5	19.4	19.5	21.4	6.5	14.1	60.6	58.5	18.6	18.2	25.4	19.9	15.5
NTMT1	"AD-003, C9orf32, HOMT1A, METTL11A, NRMT, NRMT1"	ENSG00000148335	"N-terminal Xaa-Pro-Lys N-methyltransferase 1"	Q9BV86	9	129608884-129636131	"Enzymes, Predicted intracellular proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 302.3;Late spermatids: 570.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020092, HPA058420"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA020092: AB_1853831, HPA058420: AB_2683713"	"unprognostic (4.74e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.24e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.57e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.50e-3)"	10.2	25.7	11.9	11.5	13.1	13.8	10.0	13.2	15.3	8.9	10.7	9.0	14.4	11.7	8.8	13.6	10.2	7.8	16.6	31.8	11.5	11.5	11.7	16.8	8.9	11.5	15.7	11.3	8.8	19.5	9.4	10.8	12.1	13.8	10.2	7.4	9.4	13.0	11.4	54.6	10.7	10.2	13.6	10.3	13.1	10.5	56.2	10.7	10.8	12.3	22.1	9.8	12.3	14.5	27.1	28.4	20.3	34.2	14.8	26.6	19.4	16.7	34.8	14.4	24.4	9.2	13.7	15.5	31.9	18.9	32.3	28.0	28.5	22.0	21.6	16.4	22.7	23.3	32.7	30.2	28.1	20.4	16.6	16.2	9.0	31.3	28.7	29.5	18.1	13.7	14.6	14.3	33.8	16.9	10.4	17.6	19.3	33.0	16.2	16.8	55.4	20.4	24.5	18.8	31.2	30.4	19.4	17.0	43.2	13.0	9.6	29.3	15.3	15.7	29.5	21.8	9.6	24.5	9.5	11.9	38.9	19.7	36.0	33.4	12.8	15.2	32.8	17.7	18.8	22.2	15.1	27.3	20.3	25.2	28.7	24.8	23.4	25.5	26.6	26.4	27.1	26.4	22.0	7.6	14.8	34.2	28.4	23.4	19.4	11.9	13.1	13.2	15.3	11.5	11.5	15.7	11.3	13.8	10.7	3.0	11.5	55.2	60.7	88.7	16.0	2.8	20.4	10.7	18.2	21.0	21.6	61.3	82.9	57.5	302.3	31.5	59.1	0.0	48.7	71.0	52.7	55.2	30.0	42.9	59.3	39.7	19.4	20.3	27.3	570.1	32.5	46.3	52.3	28.9	25.6	18.8	57.3	24.6	23.3	72.8	22.1	25.8	84.4	60.3	47.2	86.8	113.4	40.1	37.2	65.8
NUB1	"BS4, NUB1L, NYREN18"	ENSG00000013374	"Negative regulator of ubiquitin like proteins 1"	Q9Y5A7	7	151341699-151378449	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"monocytes: 930.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021220, HPA050722, HPA053648"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA021220: AB_2670630, HPA050722: AB_2681220, HPA053648: AB_2682217"	"unprognostic (7.04e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (8.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (8.76e-2)"	"unprognostic (2.69e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.83e-3)"	20.1	17.3	17.1	22.1	15.5	13.2	20.5	20.5	20.0	22.2	25.0	17.6	17.3	30.9	24.4	17.6	18.1	19.8	17.0	16.5	14.8	12.9	17.1	18.9	21.2	28.7	14.3	15.4	25.4	21.7	28.0	26.4	23.7	18.5	21.6	15.3	16.2	19.8	15.7	30.3	16.9	38.3	20.8	19.8	26.5	17.7	56.0	16.0	32.3	26.5	15.9	19.8	25.3	22.3	21.1	18.9	28.9	24.0	24.5	24.7	17.1	27.0	12.3	16.6	9.8	17.3	21.2	13.8	21.8	20.1	16.6	19.2	12.0	24.0	29.2	28.9	13.6	21.3	13.7	9.9	14.2	10.7	25.8	16.7	10.6	11.7	7.6	24.3	24.6	13.8	13.5	16.7	11.9	11.3	20.6	10.9	14.9	27.7	0.8	13.3	14.5	43.5	18.7	26.0	27.7	16.2	24.2	17.2	4.4	12.3	13.4	15.6	26.0	40.9	17.6	20.8	12.1	12.0	14.2	22.0	14.1	5.0	18.7	20.6	28.5	21.7	25.7	28.5	21.2	23.0	10.4	15.7	20.7	20.9	20.3	24.7	21.1	18.3	21.1	13.6	19.9	20.4	19.0	28.9	24.5	24.0	18.9	14.3	17.1	17.1	15.5	20.5	20.0	14.8	12.9	14.3	15.4	18.5	16.0	68.5	57.3	44.2	28.5	22.0	35.4	51.7	30.6	72.3	71.7	24.4	11.8	39.1	51.4	43.6	181.4	36.0	42.1	0.0	60.6	37.7	28.4	41.4	69.4	33.4	27.3	46.1	28.2	30.7	34.8	15.4	40.9	42.6	15.1	930.6	41.4	52.7	51.5	17.5	38.5	30.5	40.1	25.8	38.7	96.0	12.7	25.3	41.9	48.0	21.9	30.6
NUCB2	NEFA	ENSG00000070081	"Nucleobindin 2"		11	17208153-17349980	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"salivary gland: 160.3"	"Cell type enhanced"	"Detected in all"	8	"Ciliated cells: 702.6;Early spermatids: 595.9;Syncytiotrophoblasts: 968.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 188.9"	"Low region specificity"	"Detected in many"							"HPA008395, CAB015931, CAB079781"	Enhanced	Supported	Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	1250000		"Golgi apparatus"		"CAB015931: , CAB079781: AB_2313672, HPA008395: AB_1854683"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.27e-6)"	"unprognostic (5.24e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.81e-1)"	"prognostic favorable (1.98e-4)"	"unprognostic (1.46e-2)"	"unprognostic (3.38e-2)"	"prognostic unfavorable (3.94e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.02e-3)"	10.2	13.9	9.5	7.5	13.1	66.4	17.9	13.5	7.5	18.3	7.8	3.8	79.5	6.6	11.4	59.6	29.7	13.7	7.3	25.0	7.5	10.9	10.8	51.1	12.5	13.5	8.5	7.6	15.4	92.8	58.9	69.7	35.8	10.3	13.4	8.3	5.8	160.3	104.9	7.2	4.2	6.8	11.3	9.4	9.8	11.4	18.7	6.1	86.1	22.7	17.7	10.4	12.1	11.0	3.7	71.7	28.8	7.6	45.2	49.5	20.1	12.2	5.1	5.7	17.2	12.9	17.8	6.9	27.4	40.0	12.3	21.8	5.0	2.8	18.9	6.9	26.0	11.5	5.3	3.6	6.9	19.3	13.0	8.0	13.9	6.4	8.7	37.3	188.9	25.6	7.7	9.2	8.8	21.6	30.7	15.0	71.0	12.0	38.3	12.1	10.8	66.5	68.3	1.3	20.0	5.4	24.6	13.9	1.5	5.5	3.9	6.8	3.8	12.0	12.1	6.1	8.7	9.9	51.4	13.4	13.1	12.1	39.5	11.5	7.5	4.1	10.4	15.1	66.8	11.1	28.8	7.6	27.6	17.1	5.0	22.3	3.7	16.3	31.5	6.9	2.4	46.0	49.5	7.0	45.2	4.0	71.7	7.0	20.1	9.5	13.1	13.5	7.5	7.5	10.9	8.5	7.6	10.3	6.1	41.7	59.0	14.1	53.1	24.5	64.5	145.2	50.9	702.6	152.4	40.1	51.1	105.9	23.2	65.4	595.9	97.2	5.4	23.3	116.0	281.9	179.4	156.8	63.8	119.0	65.3	33.4	40.7	105.0	27.2	377.7	138.7	39.7	65.8	11.8	82.2	101.2	103.6	8.6	107.5	16.5	80.2	45.3	51.5	125.6	53.1	26.3	968.6	104.6	35.5	54.9
NUDC	NudC	ENSG00000090273	"Nuclear distribution C, dynein complex regulator"	Q9Y266	1	26900238-26946862	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027183, HPA028105"	Enhanced		Enhanced	Cytosol		NA	NA		18000	Cytosol		"HPA027183: AB_10600086, HPA028105: AB_10601988"	"unprognostic (1.40e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.61e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.10e-2)"	30.7	57.9	49.9	25.8	44.9	31.8	30.9	40.1	59.0	30.5	35.7	32.0	31.7	25.8	30.0	53.0	26.6	69.2	28.2	41.8	39.3	41.0	28.2	46.8	26.4	27.3	39.6	49.7	34.5	44.7	36.7	32.3	29.2	38.6	34.2	23.7	25.0	35.0	43.9	65.6	30.8	22.9	39.0	32.9	29.2	36.6	41.4	35.9	30.0	36.8	24.8	29.5	37.6	84.4	73.7	69.0	63.1	62.8	57.9	71.8	64.8	42.6	44.7	23.5	32.6	18.8	16.9	26.7	34.3	21.2	46.3	34.2	41.0	29.9	35.9	30.4	23.4	34.1	33.6	49.9	45.2	35.8	27.8	51.7	44.6	45.5	70.1	33.2	47.0	33.0	18.1	29.6	55.6	36.0	20.2	33.9	42.2	63.5	20.2	31.1	37.1	47.2	60.9	61.7	56.1	58.1	49.5	29.8	36.6	39.4	16.9	39.2	29.4	37.3	23.8	30.2	23.1	23.2	29.0	33.4	33.1	39.5	41.3	43.9	40.7	63.9	43.3	35.7	66.5	37.1	63.1	60.3	57.5	69.1	62.8	69.7	72.0	70.4	65.3	59.8	73.7	70.0	71.8	41.0	57.9	60.0	69.0	66.5	64.8	49.9	44.9	40.1	59.0	39.3	41.0	39.6	49.7	38.6	35.9	125.0	96.1	101.3	254.2	136.9	88.8	139.6	127.4	592.9	157.0	104.7	49.1	182.7	222.2	232.6	46.2	119.1	64.9	0.0	274.8	170.3	125.0	214.5	143.3	551.3	129.0	104.9	125.9	76.1	61.3	97.3	125.7	95.2	143.4	146.1	65.8	130.4	273.1	71.9	143.9	157.8	81.0	109.9	158.4	185.6	247.7	129.7	136.0	118.6	82.6	183.4
NUDT22	MGC13045	ENSG00000149761	"Nudix hydrolase 22"	Q9BRQ3	11	64225941-64230686	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039334, HPA053464"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA039334: AB_10795174, HPA053464: AB_2682160"	"unprognostic (2.72e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.65e-2)"	"unprognostic (6.61e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.76e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-1)"	"unprognostic (8.54e-2)"	9.2	16.8	8.1	16.0	9.2	14.3	9.8	7.3	12.8	9.2	24.2	9.1	30.9	29.6	9.1	16.9	17.8	9.0	16.7	23.4	8.3	7.0	21.1	30.1	10.2	15.9	10.5	8.4	7.9	26.4	13.8	12.2	14.7	8.6	12.3	8.5	9.0	28.6	35.2	24.9	12.9	23.7	11.4	7.8	20.5	18.5	7.8	7.7	19.5	15.4	15.7	19.6	13.5	9.4	30.0	49.1	20.0	33.9	19.2	25.0	20.1	14.7	9.4	2.4	9.9	3.6	4.4	9.0	6.2	6.5	4.5	4.2	6.1	12.6	7.0	16.5	6.2	6.8	15.5	1.4	9.9	0.6	9.0	4.0	9.4	6.9	6.3	10.8	6.0	15.7	6.8	7.4	4.8	5.1	3.4	7.3	8.4	4.6	7.7	5.3	22.1	8.4	11.2	3.7	9.1	19.9	10.4	4.0	26.0	7.8	8.2	5.5	8.8	5.5	20.9	24.8	0.9	21.3	6.9	6.7	7.6	7.2	23.8	5.3	28.9	11.4	4.4	26.1	7.1	8.8	13.8	28.7	20.0	23.0	33.9	20.5	25.3	20.3	22.4	29.1	30.0	18.0	19.6	17.3	19.2	31.8	49.1	25.0	20.1	8.1	9.2	7.3	12.8	8.3	7.0	10.5	8.4	8.6	7.7	3.0	13.4	41.3	23.3	10.6	12.3	3.1	61.1	4.0	6.8	38.4	11.8	92.1	139.3	53.1	12.7	17.7	92.0	0.0	76.6	42.4	24.2	26.6	14.0	47.8	50.9	28.6	35.7	27.0	50.0	6.5	18.7	38.1	32.1	73.9	66.5	25.6	56.4	92.1	18.4	113.9	16.8	12.9	20.6	4.9	8.3	15.3	56.4	39.2	56.2	28.8
NUFIP1	NUFIP	ENSG00000083635	"NUFIP1, FMR1 interacting protein 1"	Q9UHK0	13	44939249-44989483	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029958, HPA029959"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA029958: AB_10598911, HPA029959: AB_10602308"	"unprognostic (2.01e-1)"	"unprognostic (5.32e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-2)"	"unprognostic (9.74e-3)"	"unprognostic (4.52e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.04e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.31e-1)"	"unprognostic (5.24e-2)"	8.9	9.8	10.4	10.7	16.4	17.4	11.6	11.0	17.2	9.8	7.8	10.8	4.8	7.1	11.7	14.4	9.2	9.2	6.3	6.4	12.7	9.6	10.2	13.7	11.2	8.5	8.9	12.6	13.7	11.5	9.3	9.6	7.7	7.9	9.1	7.9	6.3	8.6	8.8	17.0	10.1	6.4	10.3	10.0	8.4	8.6	14.1	8.8	11.4	10.1	6.8	9.3	8.9	8.3	6.6	6.3	1.1	3.7	8.3	6.9	2.5	5.4	4.3	7.3	6.1	5.0	5.3	8.8	6.5	5.6	12.1	7.8	11.6	8.8	16.0	5.5	6.0	7.3	8.6	13.6	9.2	15.8	4.9	10.7	12.2	2.9	10.4	8.4	15.7	5.0	5.5	8.6	8.1	12.4	4.7	6.0	8.3	9.7	2.7	8.5	6.2	12.9	9.9	17.3	14.6	7.1	12.8	7.0	9.8	7.3	4.7	4.0	9.0	5.6	7.6	7.0	7.2	5.8	8.8	4.5	6.2	5.3	7.9	8.9	3.7	5.7	20.2	7.0	11.1	8.7	0.0	3.7	1.1	3.9	3.7	6.9	5.9	4.3	4.1	4.7	6.6	6.8	5.1	0.2	8.3	2.3	6.3	2.4	2.5	10.4	16.4	11.0	17.2	12.7	9.6	8.9	12.6	7.9	8.8	6.0	9.8	6.7	10.1	13.7	7.2	4.0	5.1	5.3	18.2	5.2	11.8	13.3	14.9	11.0	34.3	7.7	2.4	23.3	14.4	12.0	9.3	4.8	17.3	8.1	9.3	7.9	5.2	8.0	4.3	47.9	10.0	7.9	8.5	6.4	4.7	8.2	8.9	0.0	10.6	12.2	6.6	6.5	8.5	26.7	28.3	14.4	7.3	6.2	8.1	7.1
NUMB	C14orf41	ENSG00000133961	"NUMB, endocytic adaptor protein"	P49757	14	73275107-73458617	"Cancer-related genes, Predicted intracellular proteins"	Neurogenesis	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 64.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002874, CAB011478"	Approved		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB011478: AB_443023, HPA002874: "	"unprognostic (5.28e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.14e-2)"	"prognostic favorable (2.32e-6)"	"unprognostic (9.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.87e-1)"	27.3	21.5	26.2	24.5	23.5	21.3	26.4	37.1	27.0	24.2	35.9	17.3	26.1	31.3	30.8	23.9	30.1	28.8	28.8	23.3	23.3	14.1	30.3	35.5	40.5	23.0	18.9	20.7	29.2	26.8	31.8	28.3	29.9	23.4	23.7	29.4	22.3	34.2	23.9	16.4	24.6	45.3	38.0	26.1	32.9	25.1	19.0	19.8	20.1	27.7	17.0	26.2	30.5	26.9	5.2	15.2	64.9	20.9	2.7	3.8	11.6	21.4	14.7	10.6	9.6	21.5	32.9	14.5	20.3	27.5	16.4	17.5	17.7	27.0	9.8	12.8	25.1	12.0	14.2	12.5	20.9	25.0	15.0	7.0	7.8	9.6	11.4	22.9	7.2	18.5	18.3	22.6	40.4	24.2	18.1	35.4	15.5	14.2	11.8	20.7	19.3	13.1	10.0	4.9	24.3	15.8	8.4	14.8	6.6	22.7	32.8	4.4	11.4	25.4	17.2	10.3	18.8	25.8	10.7	33.9	24.7	13.9	15.8	8.7	9.9	11.4	8.9	49.6	8.5	10.8	16.3	19.8	20.8	3.0	17.1	3.1	5.2	3.0	3.3	15.2	5.1	3.1	2.8	64.9	2.7	20.9	2.8	3.8	11.6	26.2	23.5	37.1	27.0	23.3	14.1	18.9	20.7	23.4	19.8	59.6	43.5	56.4	25.1	38.0	28.9	18.3	35.7	45.5	52.4	52.4	76.6	21.2	21.6	24.4	10.3	58.3	51.2	0.0	22.8	25.9	40.1	33.7	23.1	45.1	40.4	14.3	39.1	52.2	90.4	4.6	41.7	93.0	43.9	27.9	35.0	49.3	36.8	39.1	34.6	33.5	48.7	25.8	30.8	38.4	29.8	40.7	28.7	24.9	30.2	40.8
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.2	9.7	21.4	18.6	9.5	11.2	20.8	15.1	14.4	23.1	24.8	16.1	9.0	36.6	25.3	13.7	19.2	14.1	25.0	14.9	37.5	19.2	18.6	19.6	10.7	16.6	7.1	28.3	18.3	11.8	12.1	24.1	17.5	8.8	13.6	12.4	45.4	11.8	15.5	10.4	20.9	17.2	16.6	7.4	10.5	27.7	27.4	34.4	10.2	19.1	23.7	13.7	12.9	21.4	12.9	35.4	13.8	10.3	12.4	23.5	13.3	11.0	23.5	15.0	21.5	37.0	5.8	13.1	27.6	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8	17.9	21.0	16.6	35.4	67.9	13.1	10.9	10.2	17.4	11.4	15.7	15.7	17.8	1.7	7.7	20.7	23.4	10.7	0.0	5.2	18.0	24.9	29.7	3.5	24.5	15.1	15.9	20.1	12.9	17.1	16.4	16.1	16.8	20.3	6.4	12.1	8.0	12.4	3.5	13.8	9.1	12.5	12.9	23.6	29.1	20.3	69.4	20.0	20.2	14.6	28.0
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 50.6;Late spermatids: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.8	11.0	12.0	17.7	3.7	5.5	43.1	11.2	5.9	15.4	11.3	16.2	11.4	15.7	5.2	7.2	16.7	11.3	20.2	11.0	24.2	10.3	11.4	12.2	40.1	7.5	4.7	20.3	8.6	4.0	4.6	23.7	12.0	4.2	8.1	7.1	22.1	8.4	10.2	6.8	10.8	5.5	11.3	8.5	10.0	13.1	37.8	12.5	3.5	13.3	14.5	10.0	25.8	11.1	6.5	8.9	13.7	8.1	7.0	18.6	15.6	14.0	17.0	9.6	16.0	21.1	8.7	18.4	14.0	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5	3.0	5.0	11.5	5.6	9.3	6.5	7.3	2.5	12.0	11.4	3.5	5.9	11.9	0.0	5.9	50.6	7.4	3.8	0.0	5.2	17.5	5.8	6.6	4.7	7.9	6.8	4.8	1.2	13.5	8.8	71.9	10.3	7.4	0.0	4.6	9.7	3.5	5.5	3.5	9.6	3.1	13.1	0.0	6.1	27.7	19.6	10.2	6.3	8.7	10.3	4.4
NVL	NVL2	ENSG00000143748	"Nuclear VCP-like"	O15381	1	224227334-224330387	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028207, HPA028219, HPA028224, HPA028654"	Supported		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA028207: AB_10601382, HPA028219: AB_2672526, HPA028224: AB_2672529, HPA028654: AB_2672714"	"unprognostic (1.50e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (5.77e-5)"	"prognostic favorable (2.95e-4)"	"unprognostic (4.43e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (4.10e-11)"	"unprognostic (1.67e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.37e-1)"	11.3	12.6	13.3	14.3	12.6	12.5	16.2	24.4	15.7	14.2	13.8	16.9	11.4	9.0	17.1	12.2	11.6	13.5	8.5	9.8	10.4	9.9	13.6	9.4	11.8	16.9	10.5	10.8	16.9	19.3	16.8	20.7	25.8	13.4	14.2	16.0	16.5	11.6	12.6	9.8	22.7	12.5	17.5	13.3	16.4	11.1	9.4	12.0	23.8	15.5	8.5	19.1	14.4	13.7	14.0	9.9	12.5	15.2	12.3	13.5	7.9	14.6	8.3	17.4	13.9	6.5	9.4	17.5	12.5	8.7	16.5	15.2	12.7	12.6	20.4	13.5	7.9	6.6	13.9	18.9	11.7	18.0	15.9	26.1	9.8	14.2	6.5	11.2	19.3	15.6	7.6	9.3	14.7	16.6	7.9	10.8	12.4	25.6	12.6	10.8	11.4	14.9	9.6	26.8	11.0	14.9	18.8	21.7	13.1	10.0	10.3	15.4	13.5	18.9	28.9	17.1	15.5	13.8	17.6	10.4	13.2	8.6	15.3	23.1	8.3	18.1	21.7	8.4	15.7	13.7	12.5	8.2	8.2	13.1	13.0	13.0	14.0	13.5	9.6	9.9	10.1	11.3	11.5	0.8	12.3	15.2	9.6	9.5	7.9	13.3	12.6	24.4	15.7	10.4	9.9	10.5	10.8	13.4	12.0	20.8	23.9	8.8	3.8	4.6	13.9	8.8	5.1	21.4	13.6	1.8	9.8	16.6	11.6	8.1	5.6	6.0	8.6	0.0	7.2	11.3	8.7	4.4	15.1	2.9	9.1	9.5	4.1	5.5	5.7	2.2	8.9	6.6	5.0	5.4	11.5	9.4	6.7	17.5	10.3	5.6	21.0	0.0	8.3	14.6	12.6	4.0	15.3	7.5	14.5	3.8
OAZ3		ENSG00000143450	"Ornithine decarboxylase antizyme 3"	Q9UMX2	1	151762899-151771334	"Predicted intracellular proteins"	"Polyamine biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"testis: 102.2"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 9340.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030136, HPA045808"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030136: AB_2673331, HPA045808: "	"unprognostic (2.12e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.01e-4)"	"unprognostic (1.57e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.05e-6)"	"unprognostic (3.94e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.50e-2)"	"unprognostic (8.36e-2)"	0.4	0.3	0.5	0.7	0.5	0.0	0.6	0.6	0.6	0.3	0.4	0.4	0.7	0.1	0.3	2.0	0.4	0.2	0.3	0.6	0.5	0.5	0.5	0.8	0.6	0.8	0.5	0.5	0.3	0.6	1.4	0.6	0.3	0.4	4.0	0.5	0.3	3.1	0.7	1.0	0.3	0.3	0.5	0.6	0.6	0.2	102.2	0.2	0.3	0.8	0.7	0.4	0.4	0.6	1.4	3.2	2.2	5.0	2.6	2.4	1.6	1.2	2.3	1.4	3.3	1.1	3.3	2.9	2.3	0.6	2.2	1.0	1.3	3.1	1.0	2.0	0.7	1.6	1.2	1.3	2.3	0.7	7.3	6.9	1.1	4.4	1.8	1.3	0.6	1.3	5.1	1.4	2.6	3.5	1.4	3.4	3.0	1.4	3.7	2.3	9.7	0.9	1.6	3.3	4.6	2.5	0.4	1.1	1.7	0.4	2.9	1.5	3.6	1.0	5.2	4.6	3.2	10.4	2.7	3.0	1.3	0.7	2.6	1.3	5.1	9.5	2.6	1.7	1.6	3.5	2.2	3.0	0.6	1.4	1.5	1.3	1.4	1.3	2.4	3.2	1.2	1.5	2.2	2.1	2.6	5.0	1.3	2.2	1.6	0.5	0.5	0.6	0.4	0.5	0.5	0.5	0.5	0.4	0.2	0.0	1.7	0.0	2.1	0.7	0.6	1.2	0.0	2.7	1.2	0.0	2.0	1.4	1.7	1.8	2210.4	2.7	3.0	0.0	2.7	2.3	1.1	27.3	1.1	2.6	4.0	0.0	3.5	1.8	4.0	9340.9	42.6	1.1	1.7	2.8	7.2	1.6	2.5	4.2	40.0	2.8	1.6	0.0	0.8	57.9	27.9	0.5	1.3	0.0	1.8	3.1
OCIAD2	MGC45416	ENSG00000145247	"OCIA domain containing 2"	Q56VL3	4	48885019-48906937	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Pancreatic endocrine cells: 896.7;Proximal tubular cells: 1166.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 56.2;U-251 MG: 66.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040979, HPA041090"	Enhanced		Enhanced	Mitochondria		No	No			Mitochondria		"HPA040979: AB_10795497, HPA041090: AB_10796236"	"unprognostic (4.29e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.76e-2)"	"prognostic favorable (7.37e-4)"	"unprognostic (3.49e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (6.56e-4)"	"prognostic unfavorable (6.89e-4)"	"unprognostic (1.38e-1)"	"prognostic favorable (2.67e-5)"	"unprognostic (1.10e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.24e-3)"	"prognostic favorable (2.34e-4)"	4.0	10.7	24.5	15.7	18.3	4.7	8.1	3.7	14.0	7.2	23.0	1.9	14.0	41.6	8.9	19.5	12.4	7.7	22.3	7.2	19.9	11.7	51.6	43.6	6.6	10.7	9.7	9.9	3.7	13.2	9.4	18.7	2.9	8.8	8.8	17.3	6.6	18.3	12.9	1.8	9.0	37.5	5.2	4.1	5.2	27.9	4.1	5.7	24.9	14.9	5.8	13.3	9.3	8.5	29.7	22.9	32.7	0.6	27.1	60.8	26.1	34.4	18.4	0.2	0.0	0.0	0.0	0.5	9.0	4.1	4.8	4.6	0.0	42.8	6.0	40.1	5.1	43.2	11.1	5.1	56.2	5.0	14.0	3.8	0.0	13.5	0.0	4.5	16.9	0.0	2.6	25.7	0.0	11.0	14.2	20.1	24.2	0.0	3.0	5.1	13.0	28.3	11.4	17.7	39.1	24.9	6.4	0.0	9.9	49.9	22.7	39.8	12.1	12.9	4.4	0.9	0.1	4.5	4.2	33.4	0.0	37.2	0.2	66.8	8.5	9.7	19.0	28.7	0.0	0.0	32.7	0.6	12.4	20.4	0.2	27.0	29.7	38.4	29.2	3.4	27.0	50.2	33.6	2.1	27.1	0.2	22.9	60.8	26.1	24.5	18.3	3.7	14.0	19.9	11.7	9.7	9.9	8.8	5.7	26.8	63.5	79.5	119.3	96.9	7.4	32.5	201.2	73.6	62.6	167.5	27.5	30.6	184.1	416.6	0.8	82.3	395.2	46.7	497.9	9.4	14.8	156.3	35.8	172.0	35.7	1.6	294.2	16.5	3.7	1.2	4.6	15.3	62.4	17.2	244.9	20.9	896.7	160.4	20.1	1166.8	52.0	0.0	20.8	0.9	2.2	114.8	12.8	114.6	155.7	207.5
OGDH	E1k	ENSG00000105953	"Oxoglutarate dehydrogenase"	Q02218	7	44606572-44709066	"Citric acid cycle related proteins, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Glycolysis	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 99.3"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019514, HPA020347"	Supported		Enhanced	Mitochondria		No	No		53000	Mitochondria		"HPA019514: AB_1854772, HPA020347: AB_1854773"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.39e-1)"	"unprognostic (5.64e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.45e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (2.22e-14)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.88e-3)"	18.9	20.8	12.3	14.5	18.5	8.7	11.0	14.3	23.7	10.1	19.4	15.9	13.5	29.0	16.2	11.1	19.5	11.1	11.8	73.9	11.3	12.8	28.8	14.8	13.0	11.1	14.2	11.7	9.8	13.0	25.5	11.0	14.5	22.2	12.3	13.3	22.3	23.7	15.9	99.3	15.6	35.5	16.4	10.1	12.1	14.9	11.3	11.0	11.3	17.8	39.8	15.8	13.0	10.8	7.2	13.4	7.5	20.4	11.2	25.7	11.6	10.8	22.8	13.7	20.8	21.2	23.3	13.3	17.0	16.6	19.3	16.9	20.7	22.5	47.8	20.2	24.7	39.0	33.8	27.0	25.4	18.9	27.9	7.1	14.5	46.1	10.2	10.8	17.9	16.3	21.6	19.3	27.4	19.7	14.2	26.2	16.0	16.7	14.3	20.4	15.3	17.7	10.3	12.6	30.2	25.7	17.0	9.6	53.6	22.2	32.4	23.4	11.2	24.5	34.1	10.6	25.9	20.2	18.0	20.6	13.9	12.6	24.2	19.6	13.0	24.9	26.4	25.3	20.3	25.3	4.8	12.1	7.3	11.7	17.7	12.8	7.2	13.5	11.7	13.4	5.9	5.8	7.0	7.5	11.2	20.4	6.6	25.7	11.6	12.3	18.5	14.3	23.7	11.3	12.8	14.2	11.7	22.2	11.0	6.0	22.7	20.4	11.1	17.3	20.1	100.7	15.3	12.0	9.1	45.4	17.7	19.4	26.6	13.2	43.1	14.2	61.4	0.0	14.8	14.3	16.4	14.4	20.8	17.5	29.3	58.8	22.4	14.1	22.4	20.0	10.9	21.9	20.3	21.6	29.2	15.4	16.7	21.0	16.3	38.9	22.2	19.4	18.2	9.1	20.0	23.1	30.7	13.8	27.6	14.2
OGG1	"HMMH, HOGG1, MUTM, OGH1"	ENSG00000114026	"8-oxoguanine DNA glycosylase"	O15527	3	9749944-9788219	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Proximal tubular cells: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027514, CAB047301"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB047301: , HPA027514: AB_10602189"	"unprognostic (6.95e-2)"	"unprognostic (7.82e-3)"	"unprognostic (7.19e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (7.83e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.43e-3)"	"unprognostic (9.66e-3)"	"unprognostic (4.23e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (2.06e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.59e-1)"	10.4	12.9	15.4	28.5	16.2	12.7	11.5	22.0	17.7	16.7	18.8	16.2	10.5	22.0	16.2	13.1	10.0	14.7	12.1	10.7	14.7	10.8	30.1	17.8	9.9	28.5	12.3	14.1	22.5	12.0	5.8	10.2	10.3	15.3	14.4	10.2	14.6	14.3	13.2	7.4	11.5	28.2	12.1	13.6	14.1	10.8	7.3	15.6	19.8	12.2	6.3	25.5	12.2	13.3	12.2	11.9	15.4	8.5	19.4	15.4	8.3	5.7	10.8	10.9	6.8	10.7	12.3	20.2	7.5	7.8	11.6	13.9	10.3	5.7	35.2	5.0	9.5	18.5	5.6	6.4	8.2	4.9	12.5	9.2	17.5	17.4	14.8	11.3	6.8	11.2	12.2	10.6	20.0	8.5	9.4	14.3	5.0	5.5	5.7	11.0	10.8	5.4	6.7	5.8	5.2	15.5	4.0	7.4	11.4	6.5	2.9	4.9	8.6	9.7	7.9	5.8	5.9	12.4	11.6	9.2	11.8	12.4	9.2	12.3	5.7	8.2	18.1	9.5	19.6	7.2	11.3	8.5	15.4	15.1	6.6	14.6	10.4	13.0	12.3	7.6	12.2	10.2	9.6	2.1	19.4	5.3	11.9	15.4	8.3	15.4	16.2	22.0	17.7	14.7	10.8	12.3	14.1	15.3	15.6	0.0	4.3	24.5	8.6	4.8	19.3	2.0	7.6	4.0	2.3	8.7	33.4	5.4	10.0	7.2	0.6	8.3	10.4	23.3	5.9	8.2	9.7	5.0	2.3	8.5	15.7	7.9	17.2	6.7	6.7	0.9	13.3	8.2	6.8	12.6	7.6	10.3	7.1	10.1	12.7	65.4	29.4	25.8	9.0	8.3	15.3	4.0	3.3	13.8	12.2	4.3
OLA1	"GTPBP9, PTD004"	ENSG00000138430	"Obg like ATPase 1"	Q9NTK5	2	174072447-174248698	"Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035790, HPA041443"	Approved		Enhanced	Cytosol		NA	NA		3600000	Cytosol		"HPA035790: AB_10601977, HPA041443: AB_2677483"	"unprognostic (3.30e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"prognostic unfavorable (9.73e-8)"	"unprognostic (6.51e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.13e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.62e-2)"	"unprognostic (9.75e-2)"	28.5	23.1	39.3	18.0	40.6	23.0	29.1	39.4	52.4	18.5	23.5	14.7	12.2	24.9	17.9	20.6	29.9	19.8	20.0	27.9	35.4	34.3	28.4	33.3	14.7	26.1	28.8	27.9	17.1	31.1	19.7	23.8	20.7	45.3	21.5	27.3	15.1	18.9	18.2	50.1	25.9	24.0	18.8	27.0	18.7	19.2	23.1	16.5	36.1	31.9	27.2	25.6	21.9	18.4	12.7	24.5	9.6	16.3	16.7	16.6	13.9	40.4	19.2	31.6	52.5	16.8	37.0	57.0	32.7	33.1	45.8	35.0	45.5	24.1	55.8	32.9	26.2	34.0	32.3	38.3	37.8	54.1	25.4	32.7	52.1	18.6	47.2	32.6	58.8	21.3	32.4	47.3	48.5	51.7	42.1	40.4	20.3	56.7	19.2	39.6	26.1	53.2	61.1	37.1	43.9	63.1	40.5	51.1	38.4	57.2	43.9	51.4	29.4	22.2	33.1	46.2	35.1	23.5	50.0	29.2	30.2	38.3	30.0	47.5	17.9	44.8	42.5	29.6	40.7	26.7	9.6	16.3	4.6	11.5	16.0	16.6	12.7	13.4	14.6	24.5	11.1	15.8	15.1	1.4	16.7	12.4	15.0	16.6	13.9	39.3	40.6	39.4	52.4	35.4	34.3	28.8	27.9	45.3	16.5	32.8	27.0	45.5	62.9	55.6	45.7	65.7	33.1	36.1	45.5	29.6	33.4	127.3	87.9	131.0	196.0	41.5	47.7	0.0	92.2	85.5	49.4	49.5	40.4	23.6	86.6	31.8	67.9	20.3	55.3	68.3	37.4	50.8	30.4	66.7	72.7	43.8	98.5	38.6	48.1	106.1	29.4	25.8	61.3	77.1	35.2	56.0	88.6	58.0	102.0	66.2
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 170.7"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 620.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	19.3	21.4	16.1	8.4	15.4	9.6	17.9	17.1	20.4	9.5	11.8	9.4	5.8	14.3	9.4	6.9	14.5	7.3	10.1	32.5	11.9	13.6	16.6	16.7	12.0	9.5	16.2	18.0	22.1	8.2	8.9	9.9	13.0	21.0	9.9	13.4	5.8	10.2	10.2	170.7	17.6	16.0	10.3	16.9	12.4	12.7	16.0	12.5	4.9	6.4	24.5	8.4	11.0	19.8	6.0	1.8	11.9	1.1	16.0	34.5	9.2	18.4	5.3	3.0	4.1	40.9	42.2	3.5	22.2	25.4	16.9	28.0	9.2	24.8	0.1	8.8	30.4	26.5	17.3	3.9	21.3	12.9	42.9	2.1	3.8	7.4	4.9	41.9	0.1	14.0	22.6	16.9	16.1	16.9	41.8	14.3	5.4	4.7	28.7	22.7	3.9	1.8	0.5	1.2	5.0	2.3	0.3	5.9	1.9	20.6	13.2	0.8	3.1	19.3	5.9	14.4	12.2	12.6	2.6	39.0	13.9	6.9	18.8	6.2	14.8	5.1	0.1	20.9	3.2	2.6	11.9	0.8	0.1	19.7	0.5	15.0	6.0	24.9	22.6	0.1	3.4	10.1	12.3	0.7	16.0	1.1	1.8	34.5	9.2	16.1	15.4	17.1	20.4	11.9	13.6	16.2	18.0	21.0	12.5	62.5	31.4	21.6	40.4	66.1	34.5	210.2	58.6	71.0	84.2	29.6	17.7	73.8	28.2	124.6	229.9	71.6	159.4	93.5	100.1	33.9	80.3	54.6	67.2	28.0	27.2	85.8	40.9	41.7	11.3	620.2	88.6	13.1	86.0	59.5	91.3	27.5	138.2	161.4	97.2	125.5	92.1	109.9	116.4	72.2	7.5	68.1	63.0	86.3	38.1	54.0
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA016583: AB_1848720, HPA061823: AB_2684619"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	13.1	1.4	6.0	1.5	2.0	6.7	7.4	1.2	3.4	2.2	11.3	5.0	4.4	12.3	1.4	5.1	11.3	1.1	5.1	0.0	14.8	3.1	8.0	2.2	4.9	4.2	5.0	15.0	0.6	2.1	5.1	0.2	1.9	5.5	13.3	6.4	1.0	1.0	13.6	14.3	35.2	6.2	4.5	15.6	6.5	2.3	7.1	2.5	3.4	5.4	0.8	2.8	3.8	5.5	0.1	8.7	1.9	6.5	7.8	3.5	9.2	5.6	3.8	2.5	1.8	5.2	8.8	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1											26.8	16.0	20.4	7.7	20.0	1.9	3.7	22.9	8.1	15.9	1.8	3.9	2.0	1.7	10.9	2.7	38.3	8.6	23.3	17.0	12.5	10.4	5.4	6.9	14.3	32.8	0.0	2.4	32.5	19.7	9.7	12.4	33.8	20.3	19.8	7.1	4.5	23.1	7.0	8.9	9.0	6.5	0.0	8.2	1.2	3.2	32.6	6.5	41.5	16.4	7.5
OSBP	OSBP1	ENSG00000110048	"Oxysterol binding protein"	P22059	11	59574398-59616144	"Predicted intracellular proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039227, HPA043625"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA039227: AB_2676401, HPA043625: AB_2678587"	"unprognostic (3.09e-2)"	"unprognostic (3.76e-2)"	"prognostic favorable (2.08e-5)"	"unprognostic (7.80e-3)"	"unprognostic (7.32e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.22e-1)"	"prognostic favorable (3.08e-7)"	"unprognostic (1.25e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.67e-1)"	15.6	36.6	12.3	10.6	16.3	13.8	16.5	14.7	18.0	16.1	18.8	13.7	35.4	17.3	15.9	19.9	15.9	13.8	19.5	14.7	10.3	11.6	26.3	54.8	12.9	9.7	12.4	12.7	16.6	30.2	31.4	14.7	29.4	17.9	16.1	17.3	12.6	27.7	26.2	32.5	20.9	22.3	15.1	9.5	12.5	19.1	11.3	12.1	18.8	19.6	12.5	13.8	16.7	13.7	4.6	7.9	3.5	3.1	4.0	6.1	2.1	17.7	14.9	11.1	14.9	26.2	24.6	12.2	14.5	18.9	17.5	15.8	16.8	18.1	18.0	19.5	16.7	21.5	18.7	20.4	19.3	19.8	17.3	9.4	12.1	11.6	11.3	28.1	15.4	24.0	18.8	24.1	16.4	43.4	18.3	18.7	16.9	20.7	16.8	15.5	8.2	14.5	11.4	12.6	26.1	14.7	14.1	17.8	12.4	20.8	20.7	13.1	9.3	17.2	21.6	19.8	16.0	30.2	9.9	20.2	15.0	10.5	22.4	9.7	23.5	19.0	18.3	16.9	11.2	12.0	3.5	3.1	2.8	5.9	2.9	5.5	4.6	6.1	4.6	3.2	3.4	5.6	4.7	3.0	4.0	2.5	7.9	2.6	2.1	12.3	16.3	14.7	18.0	10.3	11.6	12.4	12.7	17.9	12.1	23.8	7.0	11.2	14.5	35.1	21.6	29.9	33.1	20.1	17.0	26.2	21.6	11.7	6.6	12.1	7.6	17.2	30.7	0.0	16.0	10.9	16.4	26.0	27.6	56.3	13.4	25.4	28.8	10.4	12.9	10.6	14.7	12.1	13.5	3.6	35.0	16.7	18.6	22.9	18.7	17.9	19.4	6.5	13.7	21.8	13.2	41.4	25.7	10.2	25.1	19.0
OSBPL5	"KIAA1534, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087116-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	17.6	7.0	4.2	10.3	6.2	17.8	20.7	4.4	8.8	24.7	15.6	7.5	24.0	9.0	17.1	15.9	8.1	12.6	13.8	10.0	4.6	6.5	8.1	2.7	12.9	10.5	6.9	6.4	9.6	8.4	2.4	6.5	7.8	9.8	15.9	5.2	9.0	17.1	17.5	28.0	17.8	9.6	20.1	11.9	20.3	10.2	4.4	6.3	36.5	9.3	9.6	3.8	14.3	17.7	0.0	2.7	1.0	10.1	10.0	9.3	3.9	1.7	2.7	3.3	3.8	9.9	4.6	0.0	8.9	4.3	3.6	2.5	0.0	5.1	0.0	2.7	5.0	2.5	6.6	0.6	2.5	0.5	1.7	2.5	7.4	8.8	0.0	8.0	6.6	1.1	7.1	2.9	1.3	1.3	2.7	2.4	13.4	2.6	0.0	1.8	4.9	14.4	36.7	2.4	1.1	5.8	7.5	4.5	1.0	1.4	1.6	5.5	0.6	3.6	13.1	3.4	2.0	5.4	17.5	8.1	4.5	6.2	10.7	1.5	1.8	0.0	0.2	4.8	12.4	5.7	0.2	3.1	1.0	9.3	4.4	1.2	0.0	1.0	3.4	2.7	0.0	0.6	3.6	0.4	10.0	10.1	1.2	0.1	3.9	4.2	6.2	4.4	8.8	4.6	6.5	6.9	6.4	9.8	6.3	0.0	5.6	0.5	2.3	4.2	12.7	2.8	2.5	5.3	3.4	3.5	7.9	0.3	1.7	2.9	0.0	7.5	7.7	0.0	1.7	0.4	7.8	2.9	1.1	0.0	1.7	58.8	0.0	3.7	5.9	1.0	8.3	2.5	3.3	0.0	5.4	3.5	2.4	7.0	15.9	1.7	0.6	12.9	8.5	0.0	0.6	5.9	0.0	7.7	6.8	2.2
OXCT1	"OXCT, SCOT"	ENSG00000083720	"3-oxoacid CoA-transferase 1"	P55809	5	41730065-41870519	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 108.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 212.2;Distal tubular cells: 159.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 56.9;SiHa: 74.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012047, HPA061425"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA		1000000	Mitochondria		"HPA012047: AB_1854857, HPA061425: AB_2684515"	"unprognostic (4.26e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.82e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (7.42e-3)"	"unprognostic (1.74e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.62e-1)"	"prognostic favorable (1.86e-8)"	"unprognostic (2.66e-2)"	"unprognostic (9.99e-2)"	"unprognostic (5.86e-3)"	"unprognostic (2.28e-3)"	21.9	8.0	17.3	7.5	30.3	5.8	9.5	26.6	36.8	6.7	9.2	8.3	10.7	4.4	8.6	8.7	13.1	6.9	7.5	108.8	19.3	15.2	25.3	1.2	4.2	9.5	13.1	25.7	7.2	3.0	20.9	8.4	2.8	21.2	12.5	10.4	6.6	8.5	14.7	13.4	10.7	6.5	17.0	8.9	5.2	14.6	6.2	5.3	22.8	13.0	10.7	11.8	8.0	7.5	8.0	4.6	3.3	1.6	7.5	15.6	5.1	7.9	0.3	6.6	7.9	20.5	11.0	0.0	14.3	9.1	11.9	7.2	1.2	5.4	20.7	3.5	10.9	6.1	4.7	18.0	12.9	14.0	17.7	2.1	14.5	56.9	2.7	8.9	28.2	4.9	10.3	3.5	11.6	19.6	5.8	10.8	18.9	2.9	26.7	13.6	1.0	23.5	1.3	1.4	0.0	5.7	18.7	18.5	15.6	9.7	0.6	6.6	6.8	74.0	0.0	8.7	0.6	0.1	6.1	6.5	9.5	12.4	16.2	11.5	4.4	3.6	0.8	14.3	20.7	7.2	1.0	1.0	3.3	9.1	1.1	10.9	8.0	9.2	9.8	4.6	6.1	10.8	8.9	0.3	7.5	1.6	1.8	15.6	5.1	17.3	30.3	26.6	36.8	19.3	15.2	13.1	25.7	21.2	5.3	6.0	8.6	7.5	12.0	13.2	13.1	212.2	7.6	5.3	18.2	10.4	2.0	5.2	159.2	4.7	14.3	5.6	2.3	0.0	0.6	9.8	8.4	11.2	9.2	0.0	29.1	12.7	12.7	4.9	1.0	5.6	5.8	4.4	15.1	3.6	13.4	11.3	3.9	3.5	7.1	11.3	19.5	12.9	15.6	36.7	14.9	18.9	5.7	17.3	15.5	5.2
OXSR1	"KIAA1101, OSR1"	ENSG00000172939	"Oxidative stress responsive 1"	O95747	3	38165089-38255488	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Urothelial cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008237, CAB017181"	Supported		Enhanced	Cytosol		NA	NA		21000000	Cytosol		"CAB017181: , HPA008237: AB_1079540"	"unprognostic (2.16e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-2)"	"unprognostic (3.53e-3)"	"unprognostic (4.05e-2)"	"unprognostic (4.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.95e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.99e-3)"	17.6	16.8	9.4	18.3	13.4	24.2	15.9	17.4	14.9	16.8	15.4	9.2	35.7	12.4	14.9	14.7	31.6	11.6	18.9	15.5	11.9	9.0	18.3	17.6	14.6	13.9	13.6	9.3	16.7	12.3	23.7	15.3	21.4	12.3	16.5	16.8	13.0	15.1	23.9	32.6	17.4	21.4	17.0	12.9	15.8	14.0	11.2	13.2	26.2	14.2	24.1	19.6	23.5	19.2	2.3	4.4	10.1	4.8	5.0	4.7	1.6	17.7	8.1	16.3	11.3	11.4	13.2	18.5	15.7	21.6	22.8	24.8	10.5	11.6	19.7	8.0	18.8	9.8	11.1	21.8	16.2	30.1	20.8	8.9	21.5	17.3	11.4	13.6	13.3	13.2	10.4	19.1	21.0	34.1	21.5	14.2	25.5	16.3	11.4	39.0	5.0	25.6	9.6	17.1	11.5	9.7	8.9	13.6	15.2	14.0	13.5	8.5	13.1	17.2	43.6	10.7	18.7	14.3	8.7	12.9	14.3	14.2	21.7	23.2	8.7	10.3	14.5	19.7	16.6	28.5	10.1	2.8	6.1	3.3	4.8	3.5	1.9	4.0	3.1	4.4	2.3	3.0	3.7	5.5	5.0	4.1	2.5	4.7	1.6	9.4	13.4	17.4	14.9	11.9	9.0	13.6	9.3	12.3	13.2	11.9	26.3	13.3	24.0	39.2	11.8	26.6	2.5	12.0	27.3	26.2	19.6	9.4	16.6	25.2	3.1	17.1	28.7	0.0	12.5	15.6	14.9	44.7	15.1	17.8	13.4	20.6	23.2	12.3	32.9	1.4	8.9	28.2	6.8	33.3	18.0	7.6	33.8	24.6	12.0	19.4	5.5	12.9	26.7	12.7	15.0	45.4	27.6	17.5	15.3	110.3
P4HA2	C-P4Halpha(II)	ENSG00000072682	"Prolyl 4-hydroxylase subunit alpha 2"	O15460	5	132191838-132295315	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Dioxygenase, Oxidoreductase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HHSteC: 62.2;U-87 MG: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA016997, HPA027824, CAB062557"	Enhanced		Enhanced	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	No	No			"Endoplasmic reticulum, Vesicles"		"CAB062557: AB_2665641, HPA016997: AB_2669501, HPA027824: AB_2672402"	"unprognostic (1.30e-3)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.56e-3)"	"unprognostic (1.28e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.62e-3)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-3)"	"unprognostic (2.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (2.77e-7)"	"unprognostic (2.50e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (3.12e-4)"	10.2	5.6	7.1	6.5	5.4	0.8	12.2	9.5	7.8	14.4	12.5	4.6	6.1	9.8	20.0	35.3	11.6	13.7	9.7	26.1	6.6	7.0	34.4	6.3	16.0	4.3	6.3	4.2	6.7	42.5	6.7	15.8	15.1	9.5	9.3	14.6	15.1	21.1	8.4	7.1	9.3	17.1	23.3	5.1	6.3	12.6	5.1	4.4	4.1	12.2	10.8	5.4	11.3	34.5	0.2	1.0	3.1	1.3	2.6	2.6	0.7	10.3	6.3	2.0	10.1	28.3	33.8	11.5	48.2	41.2	20.5	50.8	14.2	9.1	0.2	14.2	51.6	22.9	13.0	6.3	25.2	32.5	7.6	2.1	0.0	9.3	8.6	62.2	0.0	6.2	20.4	37.3	24.3	22.4	30.7	10.8	0.0	3.7	0.6	25.0	4.1	0.0	0.0	0.5	9.5	5.2	0.1	0.6	1.6	5.7	2.0	1.0	2.8	12.3	4.1	8.2	16.5	5.1	0.7	16.5	31.2	12.2	9.4	10.4	4.4	4.7	2.0	60.1	0.0	8.7	0.0	1.3	0.0	2.6	1.1	2.4	0.0	1.4	0.4	0.6	0.2	0.0	0.4	3.1	2.6	0.2	1.0	0.0	0.7	7.1	5.4	9.5	7.8	6.6	7.0	6.3	4.2	9.5	4.4	32.8	10.1	1.4	26.7	14.9	7.9	11.8	12.7	60.2	14.8	10.4	21.6	2.4	5.0	58.5	1.0	9.8	35.4	0.0	62.7	51.9	40.5	21.4	5.7	5.9	7.2	0.0	14.5	15.4	1.8	1.6	7.5	4.7	28.7	3.6	12.9	7.5	69.0	34.5	4.9	34.1	5.5	25.8	27.8	18.2	29.4	8.5	6.3	2.5	10.8	16.5
PABPC4	"APP-1, iPABP"	ENSG00000090621	"Poly(A) binding protein cytoplasmic 4"	Q13310	1	39560816-39576790	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 137.3;skeletal muscle: 117.8"	"Cell type enhanced"	"Detected in all"	6	"Kupffer cells: 414.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027301, HPA056496"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"HPA027301: AB_2672208, HPA056496: AB_2683153"	"unprognostic (6.81e-2)"	"unprognostic (7.01e-3)"	"unprognostic (2.93e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.22e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"prognostic unfavorable (3.00e-10)"	"unprognostic (1.87e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.08e-1)"	30.0	19.2	9.0	23.0	7.9	20.8	19.6	7.2	9.6	19.1	26.0	14.0	22.0	12.4	22.2	21.1	20.3	13.7	20.2	32.0	8.6	7.2	12.3	28.8	24.9	38.2	8.3	7.3	28.6	137.3	9.1	8.2	16.2	8.6	20.7	11.5	15.4	16.4	22.9	117.8	12.9	21.1	22.4	16.4	27.5	28.0	29.2	6.4	21.5	18.1	51.1	21.0	25.3	20.3	13.9	13.7	6.7	21.2	8.2	21.4	5.5	57.5	15.7	16.7	27.7	41.8	83.0	54.9	34.1	23.9	26.5	19.7	31.4	30.2	49.8	33.9	42.8	12.6	30.8	31.8	38.1	34.3	25.4	26.2	41.9	17.9	31.2	41.9	27.7	28.2	71.9	45.1	32.2	49.1	37.4	33.2	39.6	44.4	27.6	42.5	22.5	28.7	35.8	51.6	19.4	18.0	22.1	53.5	37.7	25.5	56.9	15.8	24.0	23.8	22.7	51.5	31.7	24.2	82.2	29.9	25.8	35.8	62.4	43.0	71.2	78.1	38.7	38.3	28.1	14.7	6.7	13.9	3.5	9.9	18.0	10.6	13.8	16.1	10.3	13.7	13.9	21.4	15.1	1.4	8.2	21.2	13.5	11.2	5.5	9.0	7.9	7.2	9.6	8.6	7.2	8.3	7.3	8.6	6.4	17.9	49.3	108.2	65.3	49.6	24.0	117.4	112.1	8.1	54.6	45.4	76.6	73.5	34.9	38.4	37.3	38.0	79.4	70.0	78.6	128.3	61.8	38.6	51.9	117.5	95.8	31.8	56.9	82.3	414.4	19.0	63.9	76.1	54.0	32.5	56.2	26.4	58.7	46.3	43.5	34.2	89.3	6.5	60.6	30.6	120.1	36.5	89.6	43.3	61.7	91.4
PAG1	"CBP, PAG"	ENSG00000076641	"Phosphoprotein membrane anchor with glycosphingolipid microdomains 1"	Q9NWQ8	8	80967810-81112068	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 124.4;Melanocytes: 133.3;Sertoli cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.6;HMC-1: 26.2;SK-MEL-30: 20.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001632, HPA066527"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"		"HPA001632: AB_1079557, HPA066527: AB_2685685"	"unprognostic (8.30e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.91e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.73e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.24e-6)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (6.82e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.94e-3)"	5.5	3.8	5.3	20.2	6.1	12.2	4.1	22.3	7.6	2.7	12.3	5.4	2.3	8.6	3.5	2.8	2.9	3.2	12.1	5.5	6.4	4.3	3.2	6.4	20.3	21.2	7.5	4.2	2.6	16.6	0.8	4.2	17.7	7.7	3.9	10.1	10.6	5.0	4.4	3.8	6.2	14.9	3.5	9.9	12.1	5.1	1.4	7.4	15.2	3.4	0.4	15.3	6.2	4.4	2.2	4.1	10.9	13.3	1.6	6.8	2.4	0.0	0.0	2.7	0.1	5.2	5.0	0.1	1.1	8.8	0.5	1.1	0.1	0.0	19.6	0.1	0.3	4.4	0.8	0.0	1.0	0.5	0.5	2.5	11.4	0.2	0.0	5.3	1.8	26.2	2.4	0.7	5.1	4.8	0.5	0.0	3.5	0.1	0.1	8.4	0.1	6.8	0.1	0.2	4.4	0.8	5.2	1.4	0.1	0.9	4.2	0.5	1.0	0.0	0.2	20.3	0.5	0.6	1.9	0.1	0.6	0.3	0.0	0.6	3.2	0.8	7.0	5.6	6.5	4.8	10.9	1.4	1.9	2.6	6.3	6.5	2.2	6.6	4.6	1.8	1.4	5.4	4.0	2.3	1.6	13.3	4.1	6.8	2.4	5.3	6.1	22.3	7.6	6.4	4.3	7.5	4.2	7.7	7.4	0.0	11.3	16.6	3.6	27.9	36.6	12.1	12.7	0.0	18.2	3.5	0.0	0.5	0.0	2.2	3.2	10.5	93.4	0.0	5.7	19.0	22.5	7.3	124.4	8.1	23.3	60.4	3.5	17.2	58.9	1.5	2.3	68.1	133.3	38.7	19.5	45.0	2.3	48.0	7.4	0.3	3.0	122.9	31.9	0.2	0.7	19.7	1.9	59.0	19.2	3.4
PAIP1		ENSG00000172239	"Poly(A) binding protein interacting protein 1"	Q9H074	5	43526267-43557758	"Predicted intracellular proteins"	"Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA073653, HPA076187"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No		18000	"Plasma membrane, Cytosol"		"HPA073653: AB_2732234, HPA076187: AB_2686784"	"unprognostic (4.70e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.62e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.13e-3)"	"unprognostic (2.98e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (3.54e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.30e-1)"	30.1	26.6	26.9	15.4	26.0	20.6	35.9	22.7	32.6	30.2	27.8	25.0	19.6	18.3	28.4	26.0	26.1	22.8	23.3	45.6	26.8	24.4	34.0	38.3	21.3	20.8	28.6	21.5	24.8	23.5	30.9	24.0	29.0	23.0	32.1	24.3	21.3	23.4	31.7	62.8	16.6	24.2	38.7	33.4	21.0	23.8	44.3	27.3	29.9	38.5	20.6	18.6	31.5	36.8	14.1	35.0	23.4	12.4	12.5	16.4	10.9	22.3	19.9	39.1	37.8	41.0	32.5	32.0	19.7	44.0	37.6	32.8	18.5	27.5	14.9	34.2	27.8	56.7	14.7	60.9	23.8	38.5	12.3	23.6	11.7	39.9	29.1	36.2	17.4	18.5	34.4	46.1	25.4	48.0	38.3	35.8	11.1	27.0	20.2	37.5	24.0	19.2	24.1	19.3	21.3	25.7	15.1	29.5	20.8	46.7	27.6	22.2	33.7	63.2	24.4	43.7	37.5	34.8	25.4	19.9	34.2	28.4	17.0	24.7	15.3	25.8	22.3	19.9	27.1	29.4	17.4	12.4	23.4	10.5	10.4	14.0	14.1	13.1	14.5	12.4	13.2	16.4	13.0	4.6	12.5	11.1	35.0	11.4	10.9	26.9	26.0	22.7	32.6	26.8	24.4	28.6	21.5	23.0	27.3	29.8	43.3	27.5	65.7	65.1	49.0	115.4	68.8	36.1	22.7	41.8	19.6	65.0	134.3	105.9	128.9	65.0	26.0	0.0	80.1	76.8	67.2	70.0	23.2	46.9	51.3	33.4	43.1	41.7	35.2	40.9	70.8	42.8	79.2	64.1	51.5	68.8	98.5	49.1	62.6	115.0	51.4	25.8	65.1	136.3	84.8	58.1	57.0	27.4	45.2	69.7
PALM	KIAA0270	ENSG00000099864	Paralemmin	O75781	19	708939-748329	"Predicted intracellular proteins"	"Cell shape"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 47.6;brain: 56.5"	"Cell type enhanced"	"Detected in many"	7	"Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"non-classical monocyte: 4.7"	"Lineage enriched"	"Detected in single"	35	"monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041713, HPA049578"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA041713: AB_10794305, HPA049578: AB_2680822"	"unprognostic (9.08e-3)"	"unprognostic (2.97e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.39e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.36e-2)"	"prognostic favorable (9.81e-4)"	"unprognostic (2.74e-2)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.00e-2)"	47.6	11.8	49.1	5.1	39.9	2.2	11.3	13.3	56.5	22.7	8.2	12.4	4.2	9.2	10.7	6.7	5.8	17.7	7.2	9.6	37.7	18.9	21.9	3.5	9.0	2.2	19.2	28.1	21.2	2.1	1.2	10.2	17.6	11.9	12.2	2.7	6.1	5.9	18.6	7.0	6.9	7.5	9.0	14.7	10.5	3.6	8.2	12.5	0.0	3.3	3.3	1.9	5.0	8.4	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.0	4.4	8.6	16.5	1.3	0.1	1.2	1.1	0.0	1.1	0.3	1.0	0.0	0.0	15.3	0.1	0.1	1.5	4.3	0.0	0.2	0.0	8.5	0.0	3.5	5.4	6.0	0.0	0.1	3.9	0.0	0.7	0.0	2.4	0.6	1.9	3.0	0.1	1.1	8.7	0.6	5.1	3.5	0.8	2.4	27.2	0.0	0.1	0.4	0.0	0.9	17.5	4.4	0.0	0.1	2.8	1.5	4.1	0.0	0.0	9.0	14.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	49.1	39.9	13.3	44.4	37.7	18.9	19.2	28.1	11.9	12.5	0.0	1.7	1.4	5.5	6.4	7.6	3.6	0.0	0.0	3.4	5.2	11.8	0.8	44.7	1.6	1.1	26.3	2.1	0.0	0.2	2.5	21.8	8.7	0.0	0.2	0.8	23.8	0.0	46.6	2.2	5.3	44.8	1.6	16.9	0.0	0.0	69.4	0.3	0.3	42.5	43.5	4.2	0.0	13.3	0.9	1.3	6.0	1.6	0.0	0.0	5.0
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128928-94181972	"Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 90.6;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	13.5	9.4	7.9	13.5	14.3	3.8	18.0	7.8	14.8	10.1	11.8	5.6	4.3	6.1	10.8	6.6	9.4	8.7	13.7	13.4	5.6	10.2	8.7	19.4	14.7	6.7	7.4	9.2	9.0	8.5	10.1	7.8	11.0	8.7	9.4	8.6	3.9	9.7	8.6	29.8	11.5	7.4	14.7	5.0	9.6	10.7	12.3	7.4	12.7	10.2	13.9	8.7	13.6	14.1	2.6	5.0	3.6	7.4	4.2	5.1	6.1	11.7	5.0	13.2	8.0	12.3	16.8	8.6	14.7	31.3	12.7	15.6	12.7	18.6	3.7	13.8	14.9	23.3	24.9	10.4	24.3	12.8	16.1	5.4	17.4	5.3	6.5	11.9	8.9	15.6	13.2	17.1	16.5	14.9	8.2	10.5	9.9	11.2	13.7	14.1	3.7	14.8	2.1	10.5	9.5	9.1	17.7	17.6	4.7	8.2	11.7	5.5	16.1	10.3	5.9	7.0	7.0	12.6	4.6	7.6	25.2	13.0	8.2	14.5	2.2	8.5	6.2	10.5	9.3	16.0	3.6	7.4	0.5	4.3	4.2	5.0	2.6	3.5	4.4	5.0	2.4	3.2	3.6	0.5	4.2	2.6	0.8	5.1	6.1	7.9	14.3	7.8	14.8	5.6	10.2	7.4	9.2	8.7	7.4	0.0	8.3	1.9	8.9	90.6	1.2	3.1	0.0	6.7	2.3	1.8	0.0	10.6	0.0	12.9	4.7	3.1	3.3	0.0	15.8	28.0	12.4	6.8	9.2	6.4	16.9	0.0	2.4	2.5	4.4	2.2	4.0	10.1	16.9	3.6	3.3	0.9	18.5	3.4	3.5	1.9	1.3	0.0	14.4	1.0	6.8	63.1	19.9	3.2	2.8	13.1
PAPOLG	FLJ12972	ENSG00000115421	"Poly(A) polymerase gamma"	Q9BWT3	2	60756230-60802085	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"	"RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017795, HPA035349, HPA035350"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB017795: , HPA035349: AB_2674583, HPA035350: AB_2674584"	"unprognostic (1.83e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.39e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.72e-4)"	"unprognostic (2.49e-1)"	"unprognostic (6.97e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.62e-2)"	12.3	9.5	11.6	11.6	11.9	5.8	9.9	19.4	15.3	10.2	8.2	9.8	7.8	6.8	12.1	6.2	10.1	9.0	10.2	8.5	15.1	10.1	8.6	6.9	9.4	14.8	10.9	11.3	17.1	9.9	13.3	18.9	11.8	12.5	9.6	9.2	7.7	11.1	8.7	13.1	11.7	9.7	9.9	21.0	15.0	9.1	14.2	11.0	23.1	27.5	6.6	14.3	10.9	11.1	6.1	3.7	13.2	6.9	9.4	9.7	4.1	5.2	4.9	9.2	7.4	11.8	8.9	8.8	5.8	5.7	5.0	5.3	8.3	4.5	7.5	6.1	4.4	6.6	8.9	13.0	5.5	9.4	13.0	6.9	9.6	4.7	5.8	7.1	10.0	6.6	6.7	6.5	6.0	12.7	7.6	8.0	7.8	9.4	7.2	5.6	4.2	11.5	6.9	14.5	7.7	4.5	9.4	16.3	6.8	5.4	5.0	5.4	7.5	9.3	5.8	5.2	10.7	3.8	6.1	7.5	6.4	7.7	4.8	5.4	7.1	4.2	18.3	5.2	11.4	4.6	13.2	4.1	8.7	6.7	4.3	8.3	5.9	7.2	6.0	3.7	6.1	7.9	7.3	10.6	9.4	6.9	3.3	9.7	4.1	11.6	11.9	19.4	15.3	15.1	10.1	10.9	11.3	12.5	11.0	11.9	9.8	4.5	13.0	11.1	5.7	6.3	5.1	8.1	10.3	8.7	23.6	5.3	3.3	3.9	4.3	9.2	4.3	0.0	3.7	3.5	8.2	12.6	12.7	4.0	6.5	4.8	2.4	10.4	11.6	3.3	6.9	12.4	11.8	7.2	5.1	5.1	3.6	5.8	8.1	2.4	10.1	25.8	8.2	23.3	14.7	13.9	7.3	15.8	3.2	12.0
PARP1	"ADPRT, PARP, PPOL"	ENSG00000143799	"Poly(ADP-ribose) polymerase 1"	P09874	1	226360691-226408079	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"DNA-binding, Glycosyltransferase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 400.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000147, CAB003839, CAB003840, HPA045168, CAB075726, CAB075727"	Supported	Supported	Enhanced	Nucleoplasm,Nucleoli		NA	NA		39000	Nucleoplasm	Nucleoli	"CAB000147: AB_430876, CAB003839: AB_365493, CAB003840: AB_562187, CAB075726: AB_2665732, CAB075727: AB_2665733, HPA045168: AB_2679240"	"unprognostic (2.02e-1)"	"unprognostic (9.40e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.29e-1)"	"unprognostic (9.22e-2)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (2.20e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (1.35e-5)"	"unprognostic (2.38e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.64e-1)"	17.3	16.6	31.2	35.7	31.2	14.3	15.3	21.1	29.2	14.3	21.8	37.4	10.3	15.0	18.2	13.0	18.1	15.0	10.8	24.2	27.8	21.9	13.4	24.8	14.1	56.3	40.7	21.8	14.6	28.1	62.6	22.9	28.7	30.4	22.0	19.2	16.3	17.0	24.7	47.3	11.7	19.6	25.5	49.1	32.7	15.9	22.5	34.8	29.5	14.5	16.5	70.2	19.9	13.7	53.0	16.5	9.0	17.5	11.1	21.8	11.5	28.9	15.5	43.2	30.6	11.3	9.4	24.6	19.2	17.1	26.1	21.5	24.7	14.2	84.4	28.7	11.6	11.5	21.8	59.4	18.8	23.1	35.4	82.9	32.6	20.7	16.1	6.8	54.2	15.8	9.2	7.5	21.0	14.9	7.3	20.3	19.6	51.9	43.1	13.5	13.8	17.3	19.6	79.5	40.9	30.8	52.5	74.0	78.0	12.2	20.7	43.5	38.1	25.0	28.0	15.7	31.8	23.5	34.0	15.4	13.9	23.0	18.7	35.9	17.6	29.4	72.5	11.6	18.3	31.1	9.0	6.7	6.9	18.3	11.3	21.6	46.8	19.4	18.0	14.3	53.0	15.2	16.4	1.0	11.1	17.5	16.5	21.8	11.5	31.2	31.2	21.1	28.4	27.8	21.9	40.7	21.8	30.4	34.8	50.6	68.3	130.2	75.6	64.2	94.4	106.4	43.3	75.0	97.8	54.1	133.5	400.4	61.3	77.0	28.3	54.0	16.8	23.3	91.9	75.6	55.5	70.8	116.9	65.7	117.1	85.8	72.1	31.9	42.2	16.3	37.2	45.7	59.1	93.8	46.5	78.6	54.3	24.6	32.9	36.1	102.8	45.3	47.4	92.8	211.4	42.0	115.1	74.0	57.9	42.9
PASD1	CT63	ENSG00000166049	"PAS domain containing repressor 1"	Q8IV76	X	151563622-151676739	"Predicted intracellular proteins"	"Biological rhythms"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	301	"testis: 30.0"	"Cell type enriched"	"Detected in some"	8	"Spermatogonia: 63.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"BEWO: 20.0;HMC-1: 31.8;U-266/84: 14.8"									"HPA011122, HPA011152"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA011122: AB_1854990, HPA011152: AB_1854991"										"unprognostic (3.34e-1)"					"unprognostic (1.02e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	8.0	63.0	0.0	0.0	0.0	0.0	0.0
PAX3	"HUP2, WS1"	ENSG00000135903	"Paired box 3"	P23760	2	222199888-222298996	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Myogenesis, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Deafness, Disease mutation, Proto-oncogene, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.1;retina: 39.6"	"Group enriched"	"Detected in some"	8	"Early spermatids: 10.9;Late spermatids: 19.5;Melanocytes: 32.1"	"Cancer enriched"	"Detected in some"	24	"melanoma: 20.3"	"Group enriched"	"Detected in some"	6	"cerebellum: 19.1;pons and medulla: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 7.6;BJ hTERT+ SV40 Large T+ RasG12V: 9.1;HBF TERT88: 6.7;RH-30: 13.1;SK-MEL-30: 23.1"	"Group enriched"	"Detected in some"	7	"cerebellum: 3.9;midbrain: 1.6;pons and medulla: 1.4"	"Group enriched"	"Detected in many"	5	"cerebellum: 10.0;midbrain: 11.7;pons and medulla: 3.5"	"HPA063659, HPA069000"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063659: AB_2685080, HPA069000: AB_2686067"	"unprognostic (2.57e-2)"				"unprognostic (1.48e-2)"	"unprognostic (1.27e-2)"		"unprognostic (1.65e-1)"	"unprognostic (2.61e-2)"	"unprognostic (3.70e-1)"		"unprognostic (6.18e-2)"		"unprognostic (1.41e-1)"	"unprognostic (2.26e-1)"		"unprognostic (9.70e-2)"	0.8	0.1	0.0	0.1	0.8	0.1	2.9	19.1	0.2	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.1	0.2	2.2	0.0	0.1	0.2	0.1	0.0	0.1	7.8	0.4	0.1	39.6	7.9	0.2	8.6	7.9	0.1	0.1	4.2	0.1	0.2	2.9	0.8	0.0	0.1	3.9	0.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	5.2	5.1	7.6	9.1	0.0	0.5	0.0	0.0	3.5	0.1	0.0	0.0	0.0	6.7	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	5.4	0.1	0.0	0.0	0.0	13.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	23.1	5.9	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.9	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.8	19.1	0.1	0.0	0.2	2.2	0.0	7.8	0.8	0.0	0.0	0.0	0.0	2.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.9	0.0	32.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.3	0.4	0.0	0.0	0.0	0.0
PAX6	"AN, AN2, D11S812E, WAGR"	ENSG00000007372	"Paired box 6"	P26367	11	31784779-31818062	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.3;retina: 29.4"	"Group enriched"	"Detected in some"	5	"Horizontal cells: 249.5;Muller glia cells: 410.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 78.3"	"Cell type enhanced"	"Detected in some"		"basophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9"	"Group enriched"	"Detected in many"	5	"cerebellum: 61.0;olfactory region: 41.2"	"Low region specificity"	"Detected in all"			"HPA030775, CAB034143"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034143: AB_1127044, HPA030775: AB_10601243"	"unprognostic (2.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (8.34e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.42e-3)"	0.8	2.0	12.6	0.8	10.4	1.1	1.0	78.3	23.5	0.8	1.1	9.3	0.0	3.5	0.8	1.8	0.8	0.8	0.8	0.8	16.0	3.7	0.9	0.9	0.7	0.9	3.9	9.1	0.8	15.8	0.8	4.6	0.8	10.8	0.8	1.4	29.4	0.8	0.9	1.9	1.6	2.0	0.8	16.1	0.8	19.4	2.8	9.8	0.0	0.8	0.0	1.0	1.1	0.3	0.2	0.2	1.6	0.4	0.4	0.5	0.1	0.0	0.1	9.4	12.1	2.9	4.0	3.6	0.0	0.0	0.1	0.0	0.7	2.2	0.0	3.8	1.2	5.5	0.2	1.0	0.0	0.2	0.0	11.3	5.3	8.8	5.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	32.3	0.0	3.3	4.2	0.0	0.1	0.0	2.2	0.3	0.2	0.0	6.1	0.0	4.4	0.0	0.5	0.3	0.4	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.0	3.2	0.2	0.0	9.9	0.0	0.1	0.0	5.0	0.0	0.0	1.6	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.2	0.2	0.2	0.3	1.0	0.4	0.4	0.2	0.1	0.1	12.6	10.4	78.3	12.2	16.0	3.7	3.9	9.1	10.8	9.8	0.0	0.0	0.0	0.0	0.5	15.4	4.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	249.5	71.5	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.1	410.0	4.1	0.6	0.0	0.0	27.5	0.0	0.3	3.7	2.9	0.0	0.0	0.0	0.0	0.0
PAX8		ENSG00000125618	"Paired box 8"	Q06710	2	113215997-113278950	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"kidney: 69.3;thyroid gland: 120.5"	"Group enriched"	"Detected in many"	4	"Collecting duct cells: 233.8;Proximal tubular cells: 100.4"	"Group enriched"	"Detected in many"	12	"endometrial cancer: 60.6;ovarian cancer: 63.5;renal cancer: 33.2;thyroid cancer: 122.2"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"EFO-21: 27.1;GAMG: 16.8;RPTEC TERT1: 63.8"	"Region enriched"	"Detected in some"	4	"pons and medulla: 5.8"					"HPA030062, CAB055097, CAB061888, HPA064554"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB055097: AB_2236705, CAB061888: AB_10895719, HPA030062: AB_10603982, HPA064554: AB_2685283"	"unprognostic (2.63e-3)"	"unprognostic (3.80e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (7.24e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.16e-1)"	"unprognostic (4.13e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.02e-1)"	0.9	1.4	1.1	0.5	0.4	0.0	0.6	0.2	0.8	3.8	0.4	0.2	11.7	0.1	2.2	15.2	0.6	9.6	0.8	0.6	0.5	0.5	69.3	0.4	0.5	0.7	0.4	0.3	3.8	0.6	0.1	0.7	0.8	1.5	1.1	0.1	0.5	0.5	10.0	0.3	0.5	0.6	0.4	0.8	0.3	0.4	1.9	0.2	0.4	120.5	0.0	0.2	0.8	1.9	4.4	2.8	1.5	3.4	1.9	2.5	1.1	2.9	0.2	0.1	0.0	0.1	0.0	1.0	0.8	2.7	0.2	0.4	1.8	0.5	0.5	27.1	0.2	16.8	0.0	0.5	0.8	0.2	1.2	0.0	0.4	0.2	1.0	0.3	0.0	0.0	0.7	0.1	0.2	0.6	3.3	0.0	0.0	0.4	2.0	0.8	0.6	0.3	1.2	0.1	0.7	1.8	0.0	0.2	0.6	63.8	4.7	0.5	0.0	3.4	0.0	1.8	0.0	0.0	1.1	0.9	4.6	0.1	0.8	2.3	0.4	1.4	0.1	4.0	0.6	0.0	1.5	3.4	0.0	0.6	1.8	1.5	4.4	1.5	1.1	2.8	1.9	2.5	1.5	0.5	1.9	1.3	1.1	0.8	1.1	1.1	0.4	0.2	0.8	0.5	0.5	0.4	0.3	1.5	0.2	3.0	1.3	0.8	1.7	0.6	0.6	0.8	2.5	0.0	4.5	233.8	0.0	2.1	39.7	9.6	1.5	0.5	5.8	0.0	2.6	2.0	1.9	1.0	0.0	0.0	4.5	0.0	4.6	1.3	1.3	3.1	4.6	2.6	0.0	2.8	2.3	3.3	17.3	7.0	0.4	100.4	0.7	6.5	0.1	4.2	5.8	0.6	0.7	1.0	3.7	1.7
PBRM1	"BAF180, PB1"	ENSG00000163939	"Polybromo 1"	Q86U86	3	52545352-52685917	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015629, HPA059373"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015629: AB_1855012, HPA059373: AB_2683994"	"unprognostic (1.87e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.32e-2)"	"unprognostic (2.89e-3)"	"unprognostic (3.06e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.06e-1)"	24.3	14.8	13.8	20.6	15.9	17.2	24.4	19.1	13.8	18.9	18.5	14.0	22.9	12.2	25.9	13.9	19.9	18.9	13.7	15.9	11.1	10.0	11.7	14.5	14.9	16.5	16.5	8.2	25.1	15.4	14.4	30.6	28.0	14.7	16.1	15.3	12.7	17.5	16.2	21.8	17.2	14.3	21.1	15.6	19.1	14.8	13.1	13.7	51.0	22.0	10.5	17.1	22.4	23.0	6.6	10.7	11.1	8.7	4.6	7.4	1.9	12.5	8.1	29.0	14.2	14.3	14.6	20.3	17.3	11.9	20.0	17.6	9.1	8.5	30.4	2.4	20.3	16.6	8.6	25.1	13.1	24.4	32.5	13.5	28.8	15.3	7.0	20.5	24.0	21.9	13.6	15.2	22.4	14.5	15.8	19.3	24.1	16.4	16.7	20.1	4.2	39.5	7.2	17.6	8.5	13.3	20.7	18.2	15.5	8.3	24.5	19.7	21.8	20.8	5.0	16.5	18.4	9.4	13.9	22.2	18.8	14.3	16.2	21.1	12.1	19.0	28.9	11.6	19.5	18.7	10.1	5.0	11.1	4.8	3.2	4.9	3.6	4.8	5.3	4.8	6.6	7.4	4.7	2.7	4.6	8.7	10.7	4.5	1.9	13.8	15.9	19.1	13.8	11.1	10.0	16.5	8.2	14.7	13.7	38.7	54.1	19.5	31.0	35.9	42.0	48.4	28.1	53.5	38.7	22.7	45.2	31.3	16.6	31.4	28.7	40.3	25.3	23.3	40.4	28.9	31.5	35.3	27.8	37.0	45.9	28.6	33.8	35.0	63.3	14.7	31.7	46.6	45.5	50.5	30.6	28.5	42.9	28.1	54.8	13.9	43.3	25.8	45.3	41.9	32.8	45.0	42.6	34.1	34.5	33.3
PBX1		ENSG00000185630	"PBX homeobox 1"	P40424	1	164555584-164899296	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Sexual differentiation, Steroidogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"HEL: 30.9;NTERA-2: 30.3;SK-BR-3: 62.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003505, HPA003881, CAB018768"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			Nucleoplasm	"Nuclear bodies, Cytosol"	"CAB018768: AB_675783, HPA003505: AB_1855019, HPA003881: AB_1855020"	"unprognostic (2.26e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.09e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.21e-3)"	"unprognostic (6.94e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.24e-3)"	"unprognostic (2.30e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.25e-1)"	13.2	17.3	14.9	8.3	15.0	1.4	16.4	14.1	17.4	73.4	26.3	11.2	15.9	13.6	67.2	15.3	20.8	35.1	25.8	12.6	10.9	9.7	15.4	4.2	10.4	2.3	11.6	14.6	35.2	29.4	21.3	12.4	9.6	8.1	27.6	9.3	10.2	19.6	25.1	16.8	6.0	14.6	56.8	8.0	5.1	13.9	9.7	8.7	2.7	17.4	8.5	6.6	32.2	24.7	0.0	0.1	2.9	0.0	0.3	0.2	2.5	1.1	22.6	22.3	6.0	15.1	7.3	1.3	9.5	6.1	2.6	1.8	4.3	4.0	0.0	2.0	12.9	1.4	7.9	8.8	2.5	1.0	1.1	9.4	30.9	18.2	0.0	10.0	0.0	7.9	7.2	0.0	1.6	0.7	5.6	0.1	0.0	0.0	0.0	0.7	14.9	0.0	0.1	30.3	1.3	1.1	0.0	7.4	9.0	1.8	13.5	0.8	13.2	10.9	62.4	0.0	21.3	23.7	0.0	0.1	1.3	3.1	8.8	2.7	2.8	21.3	0.0	0.1	0.0	0.1	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.0	0.1	0.0	2.5	14.9	15.0	14.1	17.4	10.9	9.7	11.6	14.6	8.1	8.7	20.8	15.2	0.9	91.3	20.3	27.6	44.2	91.7	25.4	21.6	31.4	104.1	89.0	28.2	41.5	72.1	39.2	28.0	0.0	58.9	4.5	75.2	44.0	71.4	17.3	8.6	4.8	87.2	60.8	1.6	78.2	59.0	6.8	15.1	1.8	35.4	34.9	31.8	59.6	97.6	49.4	28.8	38.8	62.7	0.9	11.5	24.6	87.5	3.2	39.4	82.1
PC	PCB	ENSG00000173599	"Pyruvate carboxylase"	P11498	11	66848233-66958376	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Gluconeogenesis, Lipid biosynthesis, Lipid metabolism"	"Ligase, Multifunctional enzyme"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 41.1;liver: 76.0"	"Cell type enriched"	"Detected in many"	5	"Hepatocytes: 192.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 3.8;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033742, HPA043922, HPA058765"	Enhanced		Enhanced	Mitochondria		Yes	No		96000	Mitochondria		"CAB033742: AB_2283532, HPA043922: AB_2678732, HPA058765: AB_2683812"	"unprognostic (2.10e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-1)"	"unprognostic (3.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.00e-1)"	"unprognostic (3.63e-1)"	"prognostic unfavorable (7.86e-5)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"prognostic favorable (8.22e-5)"	"unprognostic (8.58e-3)"	"unprognostic (5.67e-2)"	"unprognostic (9.15e-3)"	"unprognostic (1.05e-1)"	41.1	10.7	11.1	2.8	14.6	3.1	12.9	13.1	14.9	2.4	3.8	10.7	21.4	5.6	2.1	2.4	5.0	2.7	2.9	4.0	11.3	8.9	18.7	76.0	2.1	1.6	15.5	11.5	4.4	4.3	19.4	4.0	4.1	10.9	5.4	3.1	3.4	24.2	24.4	5.7	2.8	6.7	1.8	9.4	1.5	3.3	6.1	13.1	0.6	4.2	2.5	2.5	2.2	2.1	0.6	2.6	0.0	3.8	0.3	2.9	2.0	2.9	9.1	3.4	8.3	13.9	5.5	3.5	1.9	7.9	3.6	3.5	4.5	3.3	0.0	3.8	2.9	4.8	3.9	3.8	21.0	1.1	1.8	5.3	4.5	28.3	17.3	10.9	0.0	5.9	21.0	5.4	2.9	6.6	2.3	2.9	7.9	8.5	0.0	1.2	19.4	5.1	2.4	6.4	7.7	7.6	3.8	7.0	1.8	3.3	0.9	7.4	10.5	17.6	9.4	7.2	2.6	7.7	1.2	3.2	4.0	3.7	4.7	2.1	2.0	2.3	0.0	4.1	2.9	3.4	0.0	3.8	0.0	1.2	0.9	1.4	0.2	0.5	1.9	2.6	0.6	2.9	1.6	0.0	0.3	0.5	1.0	1.5	2.0	11.1	14.6	13.1	13.6	11.3	8.9	15.5	11.5	10.9	13.1	0.0	4.8	2.2	1.1	1.1	4.7	3.7	10.2	0.0	1.2	3.5	2.0	15.6	1.7	3.1	15.2	1.4	18.6	0.0	1.6	3.5	1.9	2.4	9.2	192.6	11.2	0.0	8.6	4.3	6.9	39.9	0.6	1.6	5.0	32.5	4.2	9.2	2.3	7.0	3.9	37.8	4.7	0.0	1.4	6.0	4.2	0.5	21.3	1.3	6.0	1.1
PCBD1	"DCOH, PCBD, PCD"	ENSG00000166228	"Pterin-4 alpha-carbinolamine dehydratase 1"	P61457	10	70882280-70888784	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Tetrahydrobiopterin biosynthesis, Transcription, Transcription regulation"	"Activator, Lyase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.0"	"Cell type enhanced"	"Detected in all"	7	"Hepatocytes: 577.2;Proximal tubular cells: 733.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 67.0;Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037575, HPA061723"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		210000	Nucleoplasm	Cytosol	"HPA037575: AB_10671761, HPA061723: AB_2684594"	"unprognostic (1.02e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.80e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.38e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.76e-2)"	"unprognostic (7.43e-3)"	18.3	25.5	18.1	9.6	15.6	4.3	19.7	13.2	14.8	13.9	18.4	7.8	24.3	12.6	13.9	21.4	26.5	25.6	22.9	32.5	10.8	23.7	38.7	99.0	14.0	7.8	16.7	12.3	18.5	73.0	15.8	15.5	11.7	16.4	26.9	20.3	16.3	16.2	20.7	23.1	5.8	17.2	18.1	14.5	10.2	19.2	7.0	8.7	4.3	36.8	16.2	12.3	22.4	31.8	11.8	20.9	3.5	19.4	8.0	16.9	7.5	20.2	48.2	2.9	29.9	10.9	10.2	3.9	6.6	10.9	10.2	8.2	67.0	36.0	4.1	19.1	7.2	7.9	13.5	18.2	10.5	7.0	10.9	32.8	3.6	7.7	65.8	11.5	3.6	13.5	10.0	11.5	10.1	4.8	15.5	27.4	2.6	7.1	0.3	7.1	33.9	0.4	12.1	4.0	54.9	45.1	1.9	4.0	13.3	42.9	21.0	12.6	21.4	5.4	37.3	14.2	8.4	10.8	7.0	11.3	1.7	14.3	2.5	16.0	0.1	0.8	0.1	9.3	11.8	2.6	0.0	10.7	3.5	8.8	19.4	6.9	11.8	11.6	12.6	20.9	4.1	3.8	7.9	0.6	8.0	13.3	15.3	16.9	7.5	18.1	15.6	13.2	14.8	10.8	23.7	16.7	12.3	16.4	8.7	38.7	59.6	41.0	140.4	44.3	32.7	140.4	142.7	72.3	73.9	177.9	5.9	105.7	384.7	161.2	1.3	33.8	116.6	23.3	147.5	63.7	71.1	169.6	31.1	577.2	160.3	33.4	169.3	32.5	54.4	5.8	62.5	71.4	74.2	90.2	228.3	70.5	157.8	147.3	89.8	733.2	28.5	84.1	57.7	4.9	7.9	40.0	64.9	33.8	199.7	158.3
PCBP1	"hnRNP-E1, hnRNP-X, HNRPE1, HNRPX"	ENSG00000169564	"Poly(rC) binding protein 1"	Q15365	2	70087454-70089203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Viral RNA replication"	"DNA-binding, Ribonucleoprotein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037113, HPA043803, HPA068497"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		No	No		12000000	"Nuclear speckles"	"Cytoplasmic bodies"	"CAB037113: AB_1840915, HPA043803: AB_2678676, HPA068497: AB_2685996"	"unprognostic (1.63e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.08e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.94e-3)"	"unprognostic (2.01e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.65e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (3.85e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.90e-2)"	52.7	57.6	34.4	49.7	36.7	79.5	149.6	33.3	39.9	38.8	47.2	32.4	45.7	41.1	54.1	39.3	55.6	39.3	45.4	55.1	34.0	31.2	41.6	69.5	46.3	77.8	43.5	29.8	42.3	88.3	42.8	30.5	52.7	37.5	36.3	31.2	29.6	47.9	42.0	149.0	41.5	39.6	59.7	39.1	52.0	43.2	31.6	42.1	91.0	43.8	59.9	48.4	49.6	148.0	15.1	29.2	49.6	32.1	31.6	30.3	28.9	61.0	63.1	54.6	42.6	58.9	45.2	88.0	45.9	42.5	45.6	38.3	73.1	41.2	84.2	23.7	52.1	49.3	54.8	64.0	66.8	46.8	60.0	49.4	67.2	38.7	111.6	66.5	55.6	64.8	39.3	43.7	37.5	52.4	34.2	57.8	22.8	68.8	62.4	57.1	76.0	71.6	83.6	55.1	58.1	41.8	58.0	59.8	84.3	61.9	63.3	51.9	41.8	37.7	77.4	54.2	40.3	46.0	50.6	53.0	42.8	53.8	36.2	57.8	83.1	85.3	85.4	45.3	77.3	52.6	12.6	30.8	45.5	30.3	32.1	27.8	15.1	23.7	26.0	29.2	14.4	24.2	26.9	49.6	31.6	26.7	21.0	27.7	28.9	34.4	36.7	33.3	39.9	34.0	31.2	43.5	29.8	37.5	42.1	142.9	126.1	207.0	259.8	429.9	61.2	0.3	191.1	77.6	87.6	186.7	21.6	344.0	230.5	178.2	24.5	194.4	308.0	280.4	172.1	388.1	237.1	214.9	113.0	353.2	342.4	55.6	171.4	230.2	473.7	20.0	172.3	379.2	285.1	245.3	179.1	119.4	191.5	189.4	175.3	361.9	37.4	168.1	288.4	83.0	70.6	477.1	588.2	233.9	170.9	314.6
PCDH7	"BH-Pcdh, PPP1R120"	ENSG00000169851	"Protocadherin 7"	O60245	4	30720415-31146805	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 16.7;RH-30: 47.0;RT4: 24.8"	"Low region specificity"	"Detected in all"							"HPA011866, HPA046521"	Uncertain		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"HPA011866: AB_1855047, HPA046521: AB_2679682"	"unprognostic (1.87e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.48e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (6.46e-5)"	"unprognostic (1.96e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.91e-2)"	"unprognostic (2.09e-4)"	"prognostic unfavorable (6.42e-4)"	"unprognostic (1.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.56e-2)"	2.0	3.2	11.9	4.9	11.5	0.4	3.0	1.2	25.3	23.2	18.4	1.7	34.3	3.1	15.3	22.9	13.0	8.9	7.4	16.7	13.4	11.9	2.2	1.2	2.8	1.4	8.0	11.0	4.5	1.1	0.5	0.8	0.5	11.7	9.9	7.3	6.2	1.6	32.2	0.9	10.1	5.3	23.7	5.3	15.3	14.2	1.2	4.4	0.0	3.9	1.3	1.4	20.1	7.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	5.6	7.8	11.7	11.5	0.0	1.4	0.0	0.7	0.3	0.7	10.2	0.0	0.0	0.0	0.0	5.8	0.5	14.7	1.3	0.0	16.7	0.0	10.6	0.0	12.1	0.2	0.0	6.8	3.4	0.3	4.2	6.9	2.8	0.0	0.0	0.0	3.4	0.0	0.0	0.0	3.4	3.5	1.5	0.0	47.0	0.0	0.3	24.8	0.3	0.1	0.1	0.4	0.5	3.3	0.7	2.6	0.0	9.5	2.4	2.6	0.0	0.0	0.0	0.0	7.4	0.0	6.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	11.5	1.2	24.9	13.4	11.9	8.0	11.0	11.7	4.4	0.0	0.0	0.0	66.6	75.6	29.7	73.6	0.0	13.4	3.4	61.1	0.0	0.1	0.0	0.1	12.1	4.8	0.0	0.0	0.6	0.1	7.7	12.5	1.1	0.0	0.3	9.5	0.0	12.9	0.6	7.9	0.3	0.8	20.3	0.0	0.0	1.3	15.4	0.0	26.9	0.0	2.9	0.0	12.2	1.1	2.4	33.8	0.1	0.0	0.0	51.1
PCGF1	"MGC10882, NSPC1, RNF68"	ENSG00000115289	"Polycomb group ring finger 1"	Q9BSM1	2	74505043-74508580	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA011356, HPA069156"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA011356: AB_1855063, HPA069156: AB_2686095"	"unprognostic (2.41e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.71e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.18e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.00e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.13e-1)"	3.8	3.1	2.5	2.5	6.1	4.8	4.5	5.6	7.4	4.2	4.6	4.1	2.5	4.0	5.2	2.5	3.0	4.4	2.5	2.9	2.5	2.3	3.4	3.3	3.5	4.0	2.5	6.2	5.4	4.1	4.4	4.2	3.1	5.4	3.1	3.4	2.5	3.6	2.5	2.5	4.3	3.2	3.0	5.7	3.1	3.4	5.1	2.5	2.5	5.1	2.5	4.1	2.6	3.4	7.5	8.5	2.9	7.7	4.1	8.1	3.9	4.0	2.9	2.4	3.5	2.2	3.5	4.3	4.5	4.9	4.2	2.5	7.5	2.0	6.0	2.1	4.3	7.5	2.2	4.3	5.8	2.9	5.2	8.4	2.5	3.5	5.5	3.8	7.8	4.2	6.4	4.2	2.5	12.9	5.9	2.4	6.4	7.2	4.3	2.6	6.1	5.7	8.1	3.9	5.8	2.8	4.4	6.1	2.9	5.3	5.4	3.2	10.7	3.7	4.5	6.4	3.1	1.7	7.3	3.1	4.8	4.3	7.8	4.1	3.5	3.1	5.0	4.2	3.9	5.4	1.7	7.7	2.9	5.4	5.5	6.0	7.2	7.0	6.8	8.5	7.5	5.7	5.6	2.7	4.1	6.1	4.8	8.1	3.9	2.5	6.1	5.6	7.4	2.5	2.3	2.5	6.2	5.4	2.5	3.0	2.6	4.2	8.8	11.1	5.1	2.8	12.7	1.4	3.4	3.5	3.9	9.9	26.6	9.7	14.5	5.8	10.3	0.0	9.0	14.2	11.1	8.8	10.3	5.4	12.1	4.8	1.2	6.2	8.7	2.3	7.2	11.0	6.8	13.6	11.7	6.0	10.0	17.3	4.6	13.2	8.7	6.5	8.3	13.5	7.4	16.6	15.3	8.5	8.1	6.4
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Gluconeogenesis	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 152.4;Hepatocytes: 291.7;Proximal tubular cells: 166.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 35.3;hTCEpi: 34.3;SK-MEL-30: 32.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		NA	NA		3300000	Mitochondria		"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.5	3.1	0.9	5.9	3.7	3.7	15.0	6.9	8.3	5.8	9.4	5.1	6.4	14.1	0.8	10.6	1.9	8.1	6.0	8.9	4.8	7.2	0.2	2.5	1.7	27.5	35.3	4.9	11.1	4.3	34.3	3.6	8.9	1.6	4.6	16.4	7.2	26.1	2.2	23.9	1.2	2.5	1.0	12.5	4.2	2.8	3.4	8.0	1.7	8.6	3.7	5.9	5.3	6.8	32.5	0.9	9.2	7.6	0.8	1.2	6.7	1.8	1.9	17.9	5.6	3.5	3.5	7.7	3.1	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3	11.9	22.0	24.4	8.8	3.0	4.1	1.2	20.4	2.7	3.4	17.4	0.0	3.4	29.9	17.2	49.9	3.5	152.4	0.0	67.0	11.6	5.3	6.8	1.1	291.7	56.2	0.0	8.7	10.4	15.0	15.5	3.1	14.5	6.8	29.7	43.0	5.6	27.0	63.4	2.8	166.4	5.4	0.0	5.1	8.6	0.9	4.3	2.5	9.6	63.5	11.9
PCM1	PTC4	ENSG00000078674	"Pericentriolar material 1"	Q15154	8	17922840-18029944	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 451.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023370, HPA023374, CAB058695"	Enhanced		Enhanced	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			Centrosome	"Nuclear membrane, Cytosol"	"CAB058695: AB_2665588, HPA023370: AB_1855072, HPA023374: AB_1855073"	"unprognostic (1.52e-2)"	"unprognostic (1.77e-2)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.45e-1)"	19.6	19.0	26.2	26.7	40.4	25.1	25.1	29.2	29.0	25.0	21.1	21.6	22.8	12.4	23.3	27.3	16.4	26.4	17.8	23.0	22.9	18.4	18.8	22.0	19.1	21.1	24.5	24.9	29.1	27.0	42.0	35.8	19.8	26.4	20.2	16.3	16.2	19.4	25.3	63.1	17.6	18.3	26.7	27.2	20.8	17.9	80.0	28.0	40.2	28.2	19.1	20.4	27.0	22.6	11.5	14.9	19.9	7.5	11.2	13.0	4.3	20.6	22.1	34.0	45.0	19.2	20.0	17.6	17.5	21.5	18.7	21.1	14.9	12.4	27.1	12.1	17.4	16.1	15.0	21.7	16.1	31.9	8.9	8.4	46.6	15.6	30.3	21.4	20.4	12.0	17.4	17.2	21.7	24.1	16.4	21.4	28.4	31.4	21.1	22.8	10.3	43.6	33.7	28.0	17.3	6.4	26.3	30.4	9.7	15.5	28.8	26.0	19.6	18.7	10.3	26.8	15.2	16.2	29.7	19.1	17.1	14.0	20.8	14.7	9.0	19.9	24.3	14.4	22.5	17.4	19.9	6.0	14.4	11.5	3.8	12.0	11.1	10.4	13.0	5.9	11.5	11.6	11.6	6.4	11.2	7.5	14.9	10.3	4.3	26.2	40.4	29.2	29.0	22.9	18.4	24.5	24.9	26.4	28.0	119.1	118.7	34.0	55.5	30.0	182.6	220.7	38.2	392.1	177.5	82.0	329.9	42.5	24.9	61.5	377.1	62.9	27.3	70.0	51.3	30.8	46.8	39.6	133.4	45.3	37.2	122.3	68.3	61.4	51.5	176.2	85.4	63.1	52.3	59.5	45.1	137.5	50.9	39.3	91.9	20.6	207.3	122.9	58.7	451.7	165.6	33.4	50.6	87.1	43.7	42.1
PCNA		ENSG00000132646	"Proliferating cell nuclear antigen"	P12004	20	5114953-5126626	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Host-virus interaction"	DNA-binding	"Cancer-related genes, Deafness, Disease mutation, Dwarfism, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 115.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB000148, HPA030521, HPA030522, HPA030523"	Enhanced		Enhanced	Nucleoplasm		No	Yes			Nucleoplasm		"CAB000148: AB_628110, HPA030521: AB_10600218, HPA030522: AB_10602096, HPA030523: AB_10602199"	"unprognostic (5.21e-2)"	"prognostic favorable (1.86e-5)"	"unprognostic (2.96e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.17e-1)"	"unprognostic (5.60e-3)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.78e-2)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.11e-3)"	"unprognostic (7.46e-2)"	13.9	21.4	11.1	31.8	15.8	87.2	13.7	17.2	14.6	13.7	23.1	15.6	13.7	18.9	15.7	13.7	36.0	12.7	17.5	13.6	11.6	9.8	21.7	14.9	17.8	41.6	18.8	10.8	14.4	14.3	14.0	13.9	24.0	14.3	10.8	26.1	18.7	17.7	15.6	11.0	16.5	20.5	12.8	16.1	24.5	15.7	40.5	17.4	115.8	18.1	40.7	38.7	17.3	17.2	16.9	16.0	8.7	11.6	19.6	24.4	16.9	74.2	58.5	59.3	25.5	14.1	13.2	41.6	48.9	28.8	46.1	65.6	45.6	59.4	75.5	15.9	17.4	40.4	55.8	35.0	58.9	42.3	22.4	38.7	53.0	22.5	106.2	6.0	72.5	23.8	9.6	14.0	39.2	9.3	9.7	26.3	50.4	47.2	63.8	44.9	26.8	138.7	80.3	44.4	58.0	32.4	76.6	52.2	60.9	20.8	43.4	51.0	34.6	34.3	53.0	33.6	22.8	37.4	37.0	17.5	33.3	38.3	46.8	55.8	32.4	92.5	127.9	15.0	69.1	42.6	2.4	11.6	8.7	19.2	10.9	23.8	16.9	24.4	19.3	16.0	13.6	22.4	20.1	3.8	19.6	11.4	14.7	23.3	16.9	11.1	15.8	17.2	14.6	11.6	9.8	18.8	10.8	14.3	17.4	41.7	27.0	42.4	43.7	60.1	36.0	11.2	17.8	34.8	43.3	55.8	25.5	92.8	51.4	37.7	137.5	25.2	25.5	46.7	34.8	161.2	34.6	21.0	20.9	24.7	83.0	30.2	19.1	35.6	27.3	83.6	33.4	41.7	35.4	67.7	35.2	57.6	24.8	21.0	37.8	36.6	74.2	51.8	33.9	133.4	89.3	43.4	55.5	43.6	63.4	25.0
PCNP		ENSG00000081154	"PEST proteolytic signal containing nuclear protein"	Q8WW12	3	101574095-101594437	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA035011, HPA063861"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035011: AB_10601386, HPA063861: "	"unprognostic (4.34e-2)"	"unprognostic (9.65e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.08e-3)"	"unprognostic (7.67e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.91e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.05e-1)"	27.9	30.4	40.0	25.8	48.5	30.7	34.0	48.6	40.2	33.8	32.2	25.0	25.0	24.1	34.1	34.4	30.5	28.3	25.5	35.6	35.1	36.9	32.0	29.7	29.0	32.2	41.1	35.7	45.9	25.2	34.6	32.9	30.7	39.8	36.9	28.6	26.8	25.4	32.8	37.2	24.1	22.8	48.6	32.3	24.3	24.8	17.8	38.0	25.1	38.7	22.4	34.6	40.1	44.3	19.8	15.8	31.0	22.1	23.6	22.9	25.6	39.0	21.5	30.6	24.4	28.8	41.5	34.4	27.0	36.0	27.6	31.3	25.7	21.5	41.5	20.0	28.8	27.4	21.2	41.0	34.3	58.1	30.0	23.3	44.6	26.7	30.7	21.5	40.9	21.7	24.4	33.7	23.3	31.2	39.3	38.1	18.4	41.6	24.4	33.9	16.5	35.1	34.6	49.6	31.9	34.6	20.6	28.8	31.5	36.5	23.1	41.2	32.5	25.1	24.7	36.0	36.3	22.6	31.1	24.4	25.4	35.3	13.2	28.5	18.5	28.6	50.9	25.4	43.7	31.3	31.0	15.1	24.7	15.6	17.7	20.3	19.8	20.5	18.9	15.8	16.0	21.1	19.4	13.7	23.6	22.1	12.5	22.9	25.6	40.0	48.5	48.6	40.2	35.1	36.9	41.1	35.7	39.8	38.0	56.6	85.6	123.1	198.8	206.6	88.0	104.4	40.8	76.3	75.1	61.1	37.3	103.3	225.5	110.5	19.7	119.3	36.9	93.5	83.2	165.8	133.0	159.9	99.4	48.4	81.1	92.2	78.6	69.3	77.9	9.6	121.1	124.6	237.8	140.7	62.5	68.0	98.5	63.1	126.6	113.9	66.7	129.4	228.9	90.0	72.4	208.4	197.3	140.2	67.4	167.6
PCNT	"KEN, KIAA0402, PCN, PCNT2, PCNTB, SCKL4"	ENSG00000160299	Pericentrin	O95613	21	46324122-46445769	"Disease related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	Dwarfism	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 82.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 10.7"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.3;granulocytes: 4.9;T-cells: 10.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016820, HPA019887, HPA032101"	Enhanced		Enhanced	Centrosome		NA	NA			Centrosome		"HPA016820: AB_1855079, HPA019887: AB_1855080, HPA032101: AB_2674151"	"unprognostic (9.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.35e-2)"	"unprognostic (3.40e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.59e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.86e-2)"	"unprognostic (1.95e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.86e-2)"	4.7	4.7	16.6	6.9	20.4	12.6	3.6	8.3	16.5	3.2	4.0	4.4	3.8	3.7	3.7	4.1	5.1	3.4	5.0	8.2	12.0	4.2	3.2	4.4	4.3	6.4	7.0	9.7	4.9	3.3	5.9	8.0	3.4	5.6	4.0	4.1	2.0	4.1	4.1	82.3	10.4	4.0	4.2	4.3	5.5	4.6	14.5	9.7	9.1	4.4	2.2	4.8	4.7	5.1	0.4	5.3	4.9	1.2	0.5	10.7	2.3	9.3	7.4	11.4	7.0	5.7	5.8	7.2	7.2	5.0	7.2	6.5	8.9	6.1	9.3	4.7	8.2	9.9	6.7	9.2	6.3	5.0	27.3	12.9	24.8	13.8	6.8	2.0	12.5	10.3	3.1	4.8	9.7	4.8	3.5	5.5	10.1	12.5	14.2	9.9	15.5	12.3	12.9	11.3	8.5	5.1	15.3	4.7	8.2	5.6	10.1	14.0	6.2	15.7	9.8	4.7	2.9	9.3	9.8	7.5	13.0	6.6	7.4	11.5	12.2	10.2	10.1	8.1	12.3	7.0	4.9	0.8	1.3	2.0	0.6	5.9	0.4	0.9	5.9	2.3	0.2	0.7	10.7	0.5	0.5	1.2	5.3	0.9	2.3	16.6	20.4	8.3	16.5	12.0	4.2	7.0	9.7	5.6	9.7	26.8	33.0	4.5	5.0	7.3	11.2	30.0	12.7	17.4	22.7	0.0	5.9	4.4	0.0	5.7	17.8	6.0	6.4	0.0	6.6	6.7	5.4	3.8	15.1	8.2	18.3	22.3	15.0	7.4	7.5	19.3	11.8	11.4	0.0	15.4	6.6	3.9	5.0	6.5	11.3	3.7	10.2	25.8	7.1	43.2	42.2	6.1	5.4	10.0	8.1	4.9
PDAP1	"HASPP28, PAP, PAP1"	ENSG00000106244	"PDGFA associated protein 1"	Q13442	7	99392048-99408829	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021103, HPA050294, HPA060836"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		40000	Cytosol	"Plasma membrane"	"CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374"	"unprognostic (2.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.67e-4)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.97e-2)"	26.7	25.7	25.5	25.0	23.9	23.0	22.4	23.4	28.5	22.8	25.9	18.3	21.6	21.1	25.8	21.6	32.2	20.5	23.4	30.2	23.4	20.4	25.2	31.8	20.5	20.2	23.2	23.5	23.4	28.2	23.3	18.0	28.8	24.2	23.0	22.0	19.0	27.8	26.4	103.5	24.8	19.6	26.9	22.2	20.5	22.6	19.7	24.3	20.1	22.4	37.2	25.2	24.1	28.2	11.3	15.8	24.2	11.9	20.4	14.2	4.6	31.3	27.4	18.6	23.6	14.4	15.0	12.0	26.0	15.1	21.1	17.9	27.7	15.7	13.8	23.1	24.5	26.8	17.0	22.3	26.1	20.6	19.7	24.8	14.0	26.5	24.1	21.1	26.2	13.9	15.7	19.7	23.1	38.0	19.1	21.0	22.9	33.0	25.3	20.6	65.4	36.3	35.8	23.7	32.0	29.8	16.8	18.6	23.9	21.3	24.2	19.0	38.2	19.5	31.1	13.2	21.8	13.7	13.8	19.0	28.4	31.5	33.7	40.7	24.3	27.8	30.7	22.8	23.5	29.6	7.6	9.4	8.6	12.4	11.9	11.1	11.3	11.5	8.9	7.4	11.1	8.3	10.3	24.2	20.4	10.6	15.8	14.2	4.6	25.5	23.9	23.4	28.5	23.4	20.4	23.2	23.5	24.2	24.3	80.4	78.5	58.8	93.4	55.3	99.3	58.0	66.2	127.2	88.7	40.1	31.4	195.3	142.6	147.5	43.9	96.1	85.9	0.0	148.5	178.1	80.5	110.4	69.4	70.3	101.3	73.1	113.2	60.8	32.4	62.9	77.3	76.3	97.8	137.1	82.1	110.3	138.1	86.8	86.7	87.8	76.8	51.8	85.5	104.4	108.0	57.3	154.2	80.4	92.4	105.8
PDCD6IP	"AIP1, Alix, Hp95"	ENSG00000170248	"Programmed cell death 6 interacting protein"	Q8WUM4	3	33798352-33869707	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011905, CAB016212, HPA051604"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		6200000	Vesicles		"CAB016212: AB_673819, HPA011905: AB_1855111, HPA051604: "	"unprognostic (1.53e-1)"	"unprognostic (2.63e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.12e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.23e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.88e-3)"	"unprognostic (4.49e-2)"	"prognostic favorable (3.90e-9)"	"unprognostic (9.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.11e-1)"	39.1	26.8	18.6	26.2	27.2	16.0	27.0	24.0	31.5	33.8	36.8	26.3	16.5	28.6	33.7	22.7	45.2	27.1	26.2	29.6	20.7	19.7	42.8	41.5	29.9	24.8	22.7	18.1	33.0	21.2	34.9	26.3	43.2	48.9	26.6	34.0	23.0	27.4	20.4	29.5	31.7	57.9	25.9	24.8	32.2	29.1	24.2	16.8	35.9	35.1	25.6	37.3	28.6	31.6	11.8	12.3	10.8	18.2	12.0	9.7	8.9	17.9	18.8	12.2	10.2	31.9	32.9	13.4	23.1	22.1	20.6	21.5	13.0	17.7	25.8	14.4	30.3	13.4	16.0	18.8	24.2	23.5	10.8	15.7	22.1	15.5	10.7	21.3	22.0	22.9	25.6	28.1	23.2	27.8	24.7	30.5	12.0	19.8	10.7	29.8	9.4	13.5	13.2	11.7	16.5	23.4	12.9	15.0	16.7	25.7	15.4	6.0	10.8	22.6	27.1	12.2	20.6	26.2	21.2	37.7	24.4	12.3	20.2	19.1	10.9	14.5	21.6	23.0	24.2	12.0	6.3	13.4	10.8	8.7	18.2	9.3	11.8	9.6	8.6	12.3	10.1	8.5	8.2	8.1	12.0	17.2	5.7	9.7	8.9	18.6	27.2	24.0	31.5	20.7	19.7	22.7	18.1	48.9	16.8	80.4	77.5	41.0	48.9	37.1	29.4	46.6	76.5	112.4	72.8	61.1	49.1	43.5	31.5	60.9	71.2	58.2	165.2	0.0	68.3	44.1	40.1	52.8	51.0	50.4	54.7	23.8	34.7	52.8	89.1	35.9	68.4	71.9	27.0	31.5	82.0	25.1	88.6	90.8	75.7	55.1	45.5	45.3	38.7	87.4	42.1	37.8	80.8	39.2	56.8	62.1
PDCL3	VIAF1	ENSG00000115539	"Phosducin like 3"	Q9H2J4	2	100562690-100576735	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 154.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018469, HPA027094"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Cytosol	Nucleoplasm	"HPA018469: AB_1855116, HPA027094: AB_10601387"	"unprognostic (1.34e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (6.07e-5)"	"unprognostic (1.44e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (2.55e-5)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.22e-2)"	"prognostic favorable (4.23e-4)"	12.9	15.9	14.7	16.4	16.2	12.0	18.0	10.7	16.5	12.7	18.8	14.3	15.3	10.5	20.1	23.5	22.5	14.9	13.1	17.6	14.6	15.8	20.9	12.2	13.5	14.0	24.4	15.9	15.4	10.4	10.8	11.4	17.1	17.4	19.6	17.9	10.2	12.0	15.4	35.7	22.0	12.1	49.6	18.3	14.5	13.3	14.0	14.5	13.4	13.0	18.8	19.6	29.9	16.8	26.5	33.4	22.2	43.6	25.6	31.4	23.3	12.8	18.0	19.0	16.4	6.1	8.6	21.1	16.0	9.9	29.0	18.1	22.6	8.0	20.7	24.4	18.7	39.1	10.8	23.4	15.4	23.0	33.3	20.2	21.9	9.7	26.4	16.2	23.1	23.4	9.5	28.3	25.6	16.4	7.6	17.8	16.6	18.1	14.1	21.5	21.9	23.1	35.5	24.8	13.8	26.5	22.6	20.3	14.5	17.7	29.8	17.8	15.7	12.6	17.2	17.6	16.0	13.5	16.0	13.9	18.2	19.4	14.1	22.0	8.5	15.8	21.8	11.3	27.0	14.3	18.6	19.3	22.2	19.4	34.9	22.1	26.5	29.7	21.5	33.4	20.8	31.0	23.8	2.1	25.6	43.6	18.4	31.4	23.3	14.7	16.2	10.7	16.5	14.6	15.8	24.4	15.9	17.4	14.5	17.9	28.0	24.3	30.3	58.3	10.6	33.9	20.4	22.7	33.0	14.0	5.9	56.6	51.4	45.5	25.5	21.8	14.2	0.0	33.9	42.2	26.3	23.8	88.1	14.7	52.5	11.1	19.0	15.4	12.4	11.4	13.6	57.2	33.7	154.1	22.6	13.5	29.8	17.5	31.5	63.2	11.2	51.8	50.5	5.2	45.8	50.3	43.8	40.8	28.7	30.1
PDIA3	"ERp57, ERp60, ERp61, GRP57, GRP58, HsT17083, P58, PI-PLC"	ENSG00000167004	"Protein disulfide isomerase family A member 3"	P30101	15	43746392-43773279	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 877.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002645, HPA003230, CAB011199, CAB015181, CAB075744"	Enhanced		Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		390000000	"Endoplasmic reticulum"		"CAB011199: AB_609902, CAB015181: AB_2160857, CAB075744: AB_2665750, HPA002645: AB_1079031, HPA003230: AB_1079030"	"unprognostic (9.20e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (8.95e-5)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.11e-8)"	"unprognostic (1.82e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.63e-2)"	16.9	21.2	10.0	20.5	13.5	20.8	31.1	12.7	9.2	24.7	19.4	12.3	33.9	22.2	19.7	42.4	21.7	18.4	25.1	20.6	10.2	12.7	27.3	112.5	20.0	34.6	12.4	10.3	22.4	46.8	21.1	21.7	44.0	13.3	24.6	21.2	13.7	43.4	36.9	8.7	17.9	28.8	15.8	11.4	25.2	20.5	17.1	14.3	15.6	74.0	16.4	19.8	14.7	28.3	7.7	18.3	13.5	10.8	11.7	14.1	14.5	12.3	4.6	9.8	21.9	19.9	21.4	30.1	24.7	24.5	18.4	22.9	12.9	12.7	14.1	16.1	28.2	12.3	19.7	12.4	24.0	16.1	10.2	18.4	19.1	7.4	11.9	32.8	10.7	13.9	13.7	19.9	13.9	23.5	21.7	32.0	4.5	11.0	6.9	17.9	4.2	3.6	12.2	9.9	19.0	18.7	7.1	15.4	10.6	15.7	10.1	9.9	11.0	20.6	19.8	7.8	10.4	13.8	11.0	21.6	15.3	8.1	12.3	12.0	3.2	3.6	14.8	19.6	17.0	11.5	10.0	10.3	13.5	13.4	10.5	14.1	6.5	8.5	10.8	9.6	7.7	7.2	8.4	2.9	11.7	10.8	18.3	6.7	14.5	10.0	13.5	12.7	9.2	10.2	12.7	12.4	10.3	13.3	14.3	178.6	134.5	154.1	249.6	170.7	50.3	49.5	142.7	231.6	287.8	158.7	39.3	559.5	59.7	337.0	18.9	151.7	227.1	23.3	345.2	636.6	296.9	292.3	254.2	280.2	396.2	66.7	178.5	269.5	152.1	20.5	234.7	267.6	231.2	285.9	259.4	139.7	260.6	167.0	260.3	106.7	46.2	122.9	160.2	185.1	135.1	129.7	877.1	174.3	233.4	256.5
PDLIM7	ENIGMA	ENSG00000196923	"PDZ and LIM domain 7"	Q9NR12	5	177483394-177497606	"Predicted intracellular proteins"	"Differentiation, Osteogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 159.6"	"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.8;Exocrine glandular cells: 213.2;Pancreatic endocrine cells: 210.7;Peritubular cells: 209.7;Sertoli cells: 161.7;Smooth muscle cells: 171.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 27.2;eosinophil: 20.5;neutrophil: 80.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 80.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018794, HPA048815"	Approved		Enhanced	"Actin filaments,Focal adhesion sites"		NA	NA		7600000	"Actin filaments, Focal adhesion sites"		"HPA018794: AB_1855155, HPA048815: AB_2680530"	"unprognostic (7.70e-3)"	"unprognostic (3.75e-2)"	"unprognostic (9.27e-3)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.18e-3)"	"prognostic unfavorable (4.07e-4)"	"unprognostic (5.01e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.19e-10)"	"unprognostic (6.72e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.68e-2)"	12.4	5.6	3.7	21.1	9.3	12.5	8.3	0.5	5.9	54.6	76.0	3.2	42.6	9.0	85.0	35.8	33.9	35.5	52.3	11.1	3.8	5.0	8.3	2.4	11.6	8.9	3.5	5.8	28.2	3.1	2.1	10.3	11.5	5.6	42.0	7.6	17.6	9.1	61.7	159.6	5.3	16.5	129.5	3.1	12.7	27.0	11.7	2.4	3.7	5.4	24.9	6.5	67.8	19.6	1.8	4.8	80.6	8.4	0.4	1.4	3.9	24.9	5.0	23.9	18.8	6.5	11.9	24.2	47.9	26.1	27.3	19.6	9.6	22.6	4.5	49.5	29.3	15.0	12.1	3.9	32.4	6.3	6.2	5.8	14.7	16.3	9.0	17.7	7.8	49.6	25.8	5.5	21.8	10.5	38.7	16.3	4.1	10.9	3.2	19.7	19.3	1.4	17.3	16.5	4.8	21.5	29.1	21.3	2.8	18.2	5.1	3.7	7.8	18.7	3.6	9.1	8.4	5.1	7.0	58.6	32.9	35.7	12.5	43.7	0.8	0.9	5.3	15.6	8.4	7.4	27.2	8.4	20.5	0.9	3.9	1.1	1.8	0.6	1.4	4.8	1.0	0.6	0.7	80.6	0.4	4.9	0.3	1.2	3.9	3.7	9.3	0.5	5.9	3.8	5.0	3.5	5.8	5.6	2.4	0.0	1.1	5.9	34.1	12.9	5.2	16.1	5.1	4.0	2.3	24.4	13.7	10.1	21.6	173.8	19.2	30.0	1.3	0.0	213.2	44.5	47.3	13.0	17.3	0.9	64.5	7.9	3.4	50.3	15.5	30.6	41.4	23.5	10.1	34.3	1.9	12.4	210.7	35.1	209.7	6.7	20.4	161.7	171.6	10.9	35.2	13.8	11.8	14.9	1.7	21.1
PDS5A	"KIAA0648, PIG54, SCC-112"	ENSG00000121892	"PDS5 cohesin associated factor A"	Q29RF7	4	39822863-39977956	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036661, HPA036662"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036661: AB_2675233, HPA036662: AB_10696783"	"unprognostic (4.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.62e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.97e-1)"	"unprognostic (6.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.81e-2)"	24.9	18.7	15.8	34.7	17.3	22.6	44.9	25.9	19.2	20.5	23.8	12.7	22.9	17.5	20.7	19.8	28.3	17.2	17.4	18.3	17.0	16.6	21.1	29.6	26.8	35.1	16.5	13.1	26.3	23.7	34.0	18.7	30.3	15.5	19.9	22.0	12.2	23.2	21.4	22.3	21.6	21.9	18.7	19.3	26.9	18.1	12.1	15.4	61.3	26.0	18.6	29.9	21.3	41.7	5.2	4.6	3.7	3.4	6.3	6.7	2.2	19.6	14.7	18.9	19.9	18.3	18.4	15.1	15.9	15.2	18.9	18.9	14.2	22.3	38.4	17.6	18.8	30.1	10.8	32.2	18.6	27.3	12.8	12.2	26.3	18.5	14.9	18.3	32.1	22.6	12.1	21.1	20.0	29.7	16.8	24.0	23.0	31.1	16.4	19.3	13.8	40.0	28.2	10.7	18.6	9.9	37.4	33.7	14.0	18.1	20.0	26.2	15.5	22.0	15.2	14.1	14.8	15.4	28.5	22.5	21.4	22.3	15.5	26.9	13.9	24.2	41.3	15.3	33.0	16.8	3.7	2.5	3.7	5.2	3.4	6.7	4.5	5.1	5.7	3.8	5.2	6.2	4.7	1.0	6.3	2.2	4.6	4.2	2.2	15.8	17.3	25.9	19.2	17.0	16.6	16.5	13.1	15.5	15.4	80.4	55.3	32.7	32.4	50.4	33.3	34.7	12.7	17.4	53.4	21.0	56.9	26.4	6.6	19.2	7.4	38.6	26.7	0.0	22.5	31.3	29.0	40.9	27.8	51.6	26.8	12.7	29.3	43.0	40.7	5.0	30.5	41.3	43.9	22.6	36.1	14.1	31.8	24.6	31.1	22.3	25.8	32.3	25.8	28.7	44.7	59.6	32.4	34.1	34.7	50.3
PDS5B	"APRIN, AS3, CG008, FLJ23236, KIAA0979"	ENSG00000083642	"PDS5 cohesin associated factor B"	Q9NTI5	13	32586427-32778019	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039513, HPA040015"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039513: AB_10671999, HPA040015: AB_10671047"	"unprognostic (3.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.91e-2)"	14.8	11.2	18.9	11.8	20.5	25.8	17.0	21.2	27.5	21.8	16.2	8.0	10.2	8.1	25.4	18.3	9.8	16.1	10.6	9.8	17.2	16.0	13.6	12.6	14.1	15.9	12.6	22.9	22.0	9.9	15.4	17.8	14.2	14.7	17.7	11.3	8.6	11.3	13.9	14.0	13.6	13.6	16.5	12.5	16.6	12.7	15.3	14.3	29.1	14.0	7.7	13.7	16.9	24.2	9.2	7.7	8.3	6.5	5.6	8.3	3.3	6.2	3.8	17.3	9.2	8.3	6.0	4.8	10.7	7.2	9.1	9.2	5.2	10.5	23.0	3.8	5.2	9.1	8.4	12.4	6.7	10.8	18.3	4.7	20.7	6.9	7.2	4.9	18.9	12.8	4.6	3.4	7.5	6.8	5.9	6.8	9.3	7.1	15.5	8.3	8.0	22.6	14.2	12.7	13.2	4.6	23.1	23.9	7.8	5.8	5.2	4.5	10.9	12.2	12.2	4.5	11.0	11.7	12.7	13.4	8.7	8.5	6.2	6.3	4.8	5.3	19.6	3.7	12.9	12.6	5.8	6.0	8.3	7.2	4.9	8.3	7.8	8.3	7.4	7.7	9.2	8.2	7.9	7.5	5.6	6.5	5.3	5.9	3.3	18.9	20.5	21.2	27.5	17.2	16.0	12.6	22.9	14.7	14.3	14.9	24.6	19.1	19.2	25.6	41.6	22.1	25.5	36.1	31.8	26.2	23.6	19.7	5.0	12.7	12.2	37.9	13.5	0.0	13.6	15.6	29.2	22.6	23.1	24.9	15.6	44.5	30.6	23.4	34.4	9.8	62.2	26.6	33.7	24.4	20.0	17.5	12.0	12.5	58.7	9.6	20.1	71.1	56.1	46.6	59.4	25.6	5.1	28.9	16.3	11.2
PDXDC1	KIAA0251	ENSG00000179889	"Pyridoxal dependent decarboxylase domain containing 1"	Q6P996	16	14974591-15139339	"Predicted intracellular proteins"		"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 91.1"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 401.3;Late spermatids: 547.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"T-47d: 47.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047369, HPA049121, HPA051484"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA047369: AB_2680015, HPA049121: AB_2680641, HPA051484: AB_2681502"	"unprognostic (3.67e-2)"	"unprognostic (4.99e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.47e-3)"	"unprognostic (4.97e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.32e-1)"	"prognostic favorable (3.13e-4)"	"unprognostic (4.58e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.88e-1)"	10.5	13.2	11.0	11.7	10.7	6.0	27.8	15.4	16.9	13.8	21.6	9.0	11.8	27.7	10.9	16.5	14.2	11.0	16.6	15.5	11.5	8.1	21.9	33.8	11.2	12.7	10.2	10.0	11.2	37.4	17.2	26.0	19.6	12.8	19.6	25.3	13.7	25.2	14.7	22.1	8.8	30.9	13.1	14.9	10.6	24.6	91.1	8.7	6.9	16.3	8.2	9.5	13.4	11.1	11.0	12.8	12.0	8.3	7.7	12.6	7.8	8.0	11.8	12.2	10.2	6.8	8.3	20.3	7.6	6.7	5.6	7.8	14.5	17.6	15.4	16.7	10.1	8.1	13.2	8.6	7.7	8.2	9.4	11.8	9.3	19.9	38.0	17.9	7.3	22.3	8.6	8.1	9.8	8.3	11.1	5.9	8.4	6.8	10.1	13.3	19.7	4.8	3.9	6.0	7.9	4.5	7.5	5.0	18.3	9.0	13.1	12.6	9.0	20.4	11.7	19.5	8.1	47.4	11.5	9.1	4.4	4.0	4.8	9.8	9.5	9.2	14.9	9.0	6.2	13.9	3.2	8.0	12.0	11.0	8.3	12.6	9.2	8.0	8.9	12.8	11.0	10.0	9.4	1.1	7.7	6.6	5.9	7.0	7.8	11.0	10.7	15.4	16.9	11.5	8.1	10.2	10.0	12.8	8.7	35.7	64.2	44.4	35.2	34.0	30.0	37.5	76.5	53.5	60.3	27.9	29.5	42.4	23.2	33.3	401.3	30.8	115.5	46.7	50.6	46.8	36.2	61.2	38.1	114.3	27.4	38.1	154.8	28.3	33.9	547.7	45.5	27.9	25.3	22.6	185.7	19.3	38.0	111.2	42.8	35.6	48.6	45.3	23.4	134.2	70.5	37.3	67.5	33.0	94.5	51.0
PDXK	"C21orf124, C21orf97, FLJ21324, FLJ31940, MGC15873, PKH, PNK, PRED79"	ENSG00000160209	"Pyridoxal kinase"	O00764	21	43719094-43762307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase"	"Charcot-Marie-Tooth disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 68.9"	"Group enriched"	"Detected in all"	7	"Early spermatids: 1421.5;Late spermatids: 3146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030196, HPA030197, HPA030198, CAB033918"	Enhanced		Enhanced	Nucleoplasm		NA	NA		870000	Nucleoplasm		"CAB033918: AB_2162502, HPA030196: AB_10599735, HPA030197: AB_10601792, HPA030198: AB_10603570"	"unprognostic (1.01e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.29e-2)"	"unprognostic (4.31e-3)"	"unprognostic (3.64e-3)"	"unprognostic (1.32e-1)"	"unprognostic (8.66e-2)"	"unprognostic (9.34e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.10e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.51e-3)"	28.1	13.2	37.4	8.7	36.6	13.3	13.3	21.9	38.5	9.7	13.8	11.0	15.7	16.7	9.0	13.2	11.0	12.9	8.8	11.4	26.1	30.4	22.8	17.4	20.4	9.5	24.1	22.7	16.4	17.6	25.7	20.7	12.6	20.3	10.6	11.8	7.8	18.3	13.9	5.8	14.3	22.1	8.8	10.1	7.8	15.2	68.9	10.7	3.9	13.6	7.0	11.0	9.7	8.6	2.7	2.5	1.3	7.7	1.9	3.3	2.4	17.4	21.4	3.4	6.5	8.4	11.9	4.2	6.3	9.9	6.1	5.2	17.4	27.3	5.9	6.7	9.0	8.5	13.2	6.6	17.9	4.1	6.6	5.7	6.0	23.4	12.8	16.5	5.6	8.7	16.8	17.2	6.4	7.2	10.0	2.9	2.6	10.4	13.6	5.8	11.8	0.8	10.1	9.3	17.0	8.2	6.7	2.0	16.3	26.6	21.4	3.3	3.9	26.1	24.2	9.3	1.5	8.0	7.9	5.1	4.5	8.8	6.0	5.8	8.3	3.9	3.4	18.4	16.2	4.3	1.3	4.8	0.2	1.7	4.4	3.3	1.4	1.7	1.9	2.5	2.7	2.0	1.4	1.3	1.9	7.7	1.2	1.5	2.4	37.4	36.6	21.9	38.5	26.1	30.4	24.1	22.7	20.3	10.7	74.5	71.3	17.5	132.2	25.2	41.8	39.3	25.5	21.4	31.8	96.0	21.6	37.3	152.5	146.7	1421.5	25.3	96.0	46.7	174.9	62.9	26.6	143.6	32.2	46.0	193.8	49.3	28.9	18.4	44.0	3146.3	46.3	89.3	40.5	27.1	42.8	10.9	164.5	30.9	50.9	69.5	40.4	6.5	25.8	332.6	27.9	24.8	103.8	22.4	42.8	203.8
PELP1	MNAR	ENSG00000141456	"Proline, glutamate and leucine rich protein 1"	Q8IZL8	17	4669774-4704337	"Predicted intracellular proteins"	Transcription	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053966, HPA056028, HPA060760"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA053966: AB_2682325, HPA056028: AB_2683013, HPA060760: AB_2684355"	"unprognostic (8.81e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.81e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.31e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (2.20e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.15e-2)"	14.0	12.3	19.8	13.8	22.0	10.5	10.9	22.9	28.0	12.6	11.8	25.5	8.4	12.9	14.3	9.8	17.4	17.3	11.4	18.2	19.9	18.8	9.6	10.6	11.2	17.2	20.2	18.6	21.0	18.9	18.2	17.0	12.4	18.3	13.8	8.6	13.8	16.5	14.7	38.2	17.2	11.6	12.2	18.7	13.6	12.4	21.3	18.1	17.0	14.5	12.3	13.3	11.2	10.6	3.8	3.5	5.8	3.4	3.8	4.5	1.9	15.9	35.0	13.9	21.9	10.8	8.0	31.2	11.6	8.1	16.1	17.3	34.1	11.8	38.5	17.9	9.1	11.4	24.6	25.8	18.1	9.2	19.9	36.8	17.1	17.6	27.5	14.0	13.8	23.1	9.8	11.3	19.8	16.7	8.3	11.9	20.8	20.6	16.9	8.8	21.9	26.0	16.3	22.8	15.5	11.8	27.5	12.3	18.9	11.2	12.1	14.0	18.7	19.9	14.7	14.9	13.9	17.7	9.4	12.0	12.5	17.7	18.9	22.3	9.1	15.6	16.0	14.1	14.3	16.0	0.9	2.4	5.8	3.1	3.1	3.1	2.6	3.0	2.4	2.4	3.8	3.3	4.5	1.4	3.8	3.4	3.5	2.0	1.9	19.8	22.0	22.9	28.0	19.9	18.8	20.2	18.6	18.3	18.1	20.8	29.6	16.3	12.9	13.2	23.9	19.8	5.1	20.1	19.4	8.7	15.7	24.8	1.7	13.2	47.9	13.2	6.2	0.0	12.6	23.5	14.1	12.3	29.0	9.0	14.7	33.4	12.1	4.9	4.5	17.5	8.6	13.8	10.1	107.4	16.1	12.5	11.1	12.4	18.0	4.1	16.6	6.5	9.9	21.4	71.6	14.3	17.7	13.1	18.8	10.6
PES1	"NOP7, PES"	ENSG00000100029	"Pescadillo ribosomal biogenesis factor 1"	O00541	22	30576625-30607083	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040210, HPA062439, HPA066670"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	Yes			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA040210: AB_2676885, HPA062439: AB_2684764, HPA066670: AB_2685700"	"unprognostic (1.82e-1)"	"unprognostic (5.88e-2)"	"unprognostic (5.59e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.23e-3)"	"prognostic unfavorable (1.84e-9)"	"unprognostic (3.29e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.65e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.42e-1)"	24.4	28.1	26.0	26.1	30.1	28.2	29.6	19.0	31.8	19.7	21.9	27.2	18.1	20.4	28.0	21.3	31.2	28.0	22.7	18.1	26.3	18.5	24.2	34.9	19.8	30.0	27.2	26.6	30.5	49.0	31.3	17.0	20.2	23.6	24.2	19.2	18.6	22.2	22.1	34.1	32.3	19.8	22.9	24.3	26.4	25.2	34.5	27.2	21.2	25.3	23.1	24.9	21.8	22.6	14.4	17.8	3.9	19.4	12.4	16.2	16.3	34.3	39.2	14.5	30.8	16.7	16.4	22.3	22.9	18.8	39.1	30.5	45.4	14.8	46.6	20.5	26.0	30.2	24.0	44.5	40.8	28.8	19.9	42.8	22.6	22.5	39.1	41.7	54.5	23.8	23.1	25.7	40.6	40.9	18.7	25.1	16.7	37.2	19.0	23.6	43.3	26.4	55.3	28.1	33.8	28.8	33.8	25.3	45.6	21.4	23.8	25.1	26.0	22.6	25.8	30.3	12.1	18.1	28.0	19.8	45.9	34.8	23.3	38.2	24.2	20.7	47.6	32.2	25.1	29.3	3.9	15.8	3.9	13.3	19.4	16.2	14.4	12.4	12.7	17.8	13.8	14.2	12.7	0.6	12.4	13.9	15.4	9.5	16.3	26.0	30.1	19.0	31.8	26.3	18.5	27.2	26.6	23.6	27.2	3.0	17.6	13.7	18.1	20.0	6.4	3.4	25.5	26.8	19.4	24.4	7.9	30.6	21.6	36.3	38.4	21.1	24.6	0.0	38.0	33.3	14.9	13.1	17.4	20.7	33.9	3.2	22.5	28.8	29.7	10.4	18.4	20.8	20.3	31.5	19.9	13.1	33.1	14.0	19.1	39.6	8.1	19.4	18.4	23.5	19.3	19.9	23.8	15.0	24.7	12.2
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.6;Syncytiotrophoblasts: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.6	14.8	12.6	13.8	9.3	8.8	8.2	18.1	15.3	20.2	19.3	15.6	29.1	11.4	18.1	13.8	12.0	18.7	13.1	17.4	9.7	16.0	21.4	14.0	16.1	21.3	14.0	15.8	20.2	10.6	14.1	15.3	14.1	12.1	12.9	15.1	21.9	11.8	9.1	12.9	15.1	20.8	12.9	12.3	17.4	16.4	10.5	16.3	15.9	10.4	15.0	17.2	17.5	14.7	16.3	10.2	13.5	11.4	12.4	14.8	15.6	14.3	15.3	17.0	13.8	22.3	16.2	21.9	15.7	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4	8.9	1.3	7.5	12.5	6.4	14.7	6.1	5.1	21.4	2.3	8.7	25.5	40.0	6.6	15.0	2.2	6.0	18.7	0.0	12.7	15.4	7.1	9.7	5.8	48.3	20.4	17.5	8.6	9.8	7.9	2.4	7.5	5.9	11.8	32.5	8.4	13.8	14.7	10.5	5.3	14.8	60.6	6.5	7.2	5.9	12.1	7.0	54.1	8.5	10.5	11.2
PFDN2		ENSG00000143256	"Prefoldin subunit 2"	Q9UHV9	1	161100556-161118111	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 570.2;Suprabasal keratinocytes: 561.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028700, HPA058304"	Approved		Enhanced	Cytosol		NA	NA		60000	Cytosol		"HPA028700: AB_10603983, HPA058304: AB_2683673"	"unprognostic (2.56e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (9.59e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.46e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavorable (4.39e-8)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.66e-2)"	36.5	30.4	47.2	22.7	41.7	40.9	20.9	25.1	38.8	19.6	19.9	27.8	15.1	19.1	20.8	29.1	19.7	18.5	16.0	38.2	41.4	48.6	25.9	41.1	18.5	23.5	52.2	32.9	18.5	20.8	13.6	29.3	25.1	42.7	20.1	17.9	12.9	21.2	20.8	62.2	15.0	18.4	19.4	48.6	21.2	17.8	22.1	31.8	14.7	18.3	20.9	24.3	22.7	26.2	34.4	61.7	33.4	37.3	18.2	28.5	21.0	43.4	29.2	22.7	29.4	20.7	19.8	24.8	32.4	29.4	28.0	22.2	38.4	33.1	29.5	38.1	21.0	27.7	32.3	34.4	39.7	33.8	32.1	35.5	32.6	41.5	54.2	61.0	44.7	32.7	22.2	52.3	45.0	128.2	21.3	31.4	30.8	47.8	20.8	25.1	44.1	33.4	53.1	44.5	51.2	73.2	28.7	23.0	35.2	30.3	26.1	30.0	50.0	24.9	32.9	51.6	30.9	27.1	56.4	27.6	29.0	42.6	36.4	67.6	32.0	30.4	56.6	35.3	30.6	39.8	24.7	32.7	33.4	19.2	31.4	21.8	34.1	23.5	23.1	39.1	34.4	24.8	24.1	16.2	18.2	37.3	61.7	28.5	21.0	47.2	41.7	25.1	38.8	41.4	48.6	52.2	32.9	42.7	31.8	29.8	37.8	97.5	214.7	570.2	76.9	106.9	73.9	81.7	40.9	109.9	15.7	156.1	290.1	151.8	21.8	101.2	75.9	0.0	130.4	209.7	150.8	165.7	97.0	123.5	154.2	20.6	97.3	81.6	57.7	15.7	117.1	160.7	175.5	129.8	71.4	55.8	186.7	64.2	103.6	225.6	50.4	77.6	263.3	153.5	288.9	561.7	150.2	74.8	76.8	356.8
PFKFB2		ENSG00000123836	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2"	O60825	1	207034366-207081024	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 70.2;Late spermatids: 128.8;Rod photoreceptor cells: 111.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 13.9;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 16.7;granulocytes: 13.9"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA049975, HPA063575"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049975: AB_2680977, HPA063575: AB_2685046"	"unprognostic (1.30e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.96e-3)"	"unprognostic (9.74e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.30e-1)"	"prognostic favorable (3.23e-7)"	"unprognostic (1.54e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (1.86e-2)"	3.3	6.1	9.8	5.8	16.6	15.7	5.1	2.1	14.6	7.3	16.0	19.5	5.3	23.2	4.0	9.1	7.7	4.5	9.1	22.8	14.1	7.7	22.0	3.6	10.9	5.3	13.4	15.1	4.3	11.9	6.2	27.5	3.0	25.3	3.9	18.1	22.4	6.3	3.5	34.9	6.4	18.7	4.0	17.4	12.5	10.7	6.1	15.1	6.5	38.4	8.8	5.0	3.4	3.6	1.6	16.7	13.9	1.9	1.1	0.4	0.4	9.7	4.3	2.8	4.9	5.9	2.9	4.7	1.4	1.7	2.4	1.3	10.5	14.1	1.7	2.2	2.2	7.4	13.9	2.1	5.2	1.4	0.3	2.1	13.8	10.8	3.9	4.9	0.0	9.7	4.1	8.0	2.3	13.2	2.9	0.5	5.8	9.4	0.1	1.3	2.9	2.3	0.4	3.9	4.7	6.5	0.0	0.0	0.2	3.3	10.1	4.5	2.7	9.1	15.4	11.4	3.2	10.6	1.1	0.2	0.0	5.3	7.5	1.3	4.5	4.4	0.9	6.1	0.0	2.6	1.0	0.9	13.9	0.2	1.9	0.3	1.3	0.1	0.3	0.8	1.6	0.3	0.4	2.6	1.1	1.3	16.7	0.0	0.4	9.8	16.6	2.1	14.6	14.1	7.7	13.4	15.1	25.3	15.1	6.0	42.0	4.5	3.4	13.5	7.3	70.2	5.1	14.7	5.7	15.7	0.0	0.5	21.6	4.0	47.4	2.7	43.0	0.0	6.7	0.4	2.5	6.5	9.2	4.9	4.9	3.2	5.8	1.3	11.3	128.8	2.6	6.0	20.3	1.8	18.9	8.1	10.5	27.7	2.8	30.6	111.9	0.0	3.2	3.1	3.3	10.2	1.3	1.0	27.6	11.2
PFKFB3		ENSG00000170525	"6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3"	Q16875	10	6144934-6254644	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Kinase, Multifunctional enzyme, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 105.6;skeletal muscle: 135.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 184.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 20.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 72.7;RPTEC TERT1: 45.9;T-47d: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008266, CAB020795, HPA043889"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020795: , HPA008266: AB_1855239, HPA043889: AB_2678717"	"unprognostic (1.61e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.89e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (1.87e-7)"	"unprognostic (1.89e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"	105.6	9.0	16.4	25.7	17.9	77.0	43.4	8.5	29.4	6.6	8.8	29.1	10.6	7.4	9.4	6.3	13.0	14.4	22.4	5.7	16.6	13.2	22.1	11.2	15.1	12.1	19.2	12.9	8.0	8.1	4.0	10.2	7.5	20.7	5.4	3.8	19.3	9.1	20.0	135.7	11.8	6.9	6.5	36.0	12.4	6.7	4.6	16.8	3.3	2.9	4.7	10.3	10.3	10.1	1.5	3.6	20.5	7.1	0.8	4.7	2.9	5.2	72.7	5.8	4.7	21.9	2.7	3.0	7.7	5.5	5.8	9.0	3.4	19.3	9.0	5.1	3.3	4.5	17.0	6.2	12.3	6.7	10.7	4.3	5.3	3.7	1.2	1.8	5.1	8.1	1.9	4.1	9.9	2.4	14.8	11.1	6.3	3.9	3.4	4.6	8.6	3.6	4.8	5.6	7.5	5.1	8.2	2.8	3.5	45.9	2.7	5.5	2.2	5.6	6.2	11.0	10.4	47.8	6.1	14.0	6.1	5.6	0.7	9.3	7.0	2.4	8.1	16.7	6.0	9.2	2.2	5.6	5.5	1.8	7.1	4.7	1.5	3.4	2.3	3.6	1.4	2.5	2.4	20.5	0.8	4.1	2.2	3.2	2.9	16.4	17.9	8.5	16.9	16.6	13.2	19.2	12.9	20.7	16.8	71.5	75.9	13.7	14.3	91.1	7.8	17.3	15.3	13.4	42.1	184.9	49.1	0.2	0.0	42.7	5.1	29.2	7.4	0.0	22.5	4.6	29.8	4.3	41.7	11.6	19.4	6.4	8.2	9.2	79.2	6.1	2.6	37.7	43.9	23.4	5.2	0.4	46.2	5.8	6.7	2.4	1.6	0.0	21.1	0.7	1.6	55.8	0.8	21.3	5.4	9.9
PGAM2	PGAM-M	ENSG00000164708	"Phosphoglycerate mutase 2"	P15259	7	44062727-44065587	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Glycolysis	"Hydrolase, Isomerase"	"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"heart muscle: 111.6;skeletal muscle: 379.1;tongue: 119.0"	"Group enriched"	"Detected in many"	13	"Early spermatids: 421.0;Late spermatids: 1332.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;neutrophil: 1.1;plasmacytoid DC: 1.3;T-reg: 1.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.3;granulocytes: 1.2;T-cells: 1.7"	"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 39.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA043801, HPA050314, HPA060173"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		60000000	Nucleoplasm	"Nucleoli, Cytosol"	"HPA043801: , HPA050314: AB_2732558, HPA060173: AB_2684215"																		1.4	0.8	2.0	0.4	2.2	0.4	0.5	6.9	2.1	0.5	0.5	3.6	0.0	0.6	0.5	9.1	6.1	0.6	0.7	111.6	2.1	3.2	0.8	0.4	0.4	0.4	4.2	1.6	0.5	0.6	0.6	1.3	0.4	2.0	1.9	0.4	2.3	7.6	0.5	379.1	0.4	0.4	0.4	3.2	0.5	0.5	16.7	1.1	4.8	1.5	119.0	4.8	0.4	0.0	0.3	1.3	1.2	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.0	4.3	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.3	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	1.3	1.7	0.2	2.0	2.2	6.9	2.1	2.1	3.2	4.2	1.6	2.0	1.1	0.0	0.0	0.5	0.2	1.0	4.3	0.0	0.0	0.0	0.0	0.0	9.8	0.0	68.0	0.0	421.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.0	0.0	0.3	1332.7	7.2	0.4	1.7	0.0	0.0	3.8	0.2	0.2	5.6	1.9	4.2	25.8	3.1	30.5	5.6	0.5	0.0	0.0	0.2	0.4
PGGHG	"ATHL1, FLJ22635"	ENSG00000142102	"Protein-glucosylgalactosylhydroxylysine glucosidase"	Q32M88	11	289135-296107	"Enzymes, Predicted intracellular proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 148.7"	"Cell type enhanced"	"Detected in some"	19	"Alveolar cells type 1: 148.9;Alveolar cells type 2: 104.9;Club cells: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 54.5;U-266/70: 14.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA039383, HPA058829"	Uncertain		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA039383: AB_10796225, HPA058829: AB_2683830"	"unprognostic (1.40e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.83e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.77e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.92e-3)"	"unprognostic (2.85e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.12e-4)"	5.6	1.8	6.0	16.7	9.3	6.3	10.5	2.9	7.7	12.7	5.6	3.3	10.4	21.1	6.9	14.9	5.6	8.4	8.3	4.4	6.3	1.7	14.8	17.0	15.7	24.6	7.6	2.5	3.5	148.7	2.6	3.6	3.4	8.0	8.5	3.0	7.1	8.9	21.8	5.6	2.4	23.2	5.2	10.1	24.2	4.7	2.3	7.5	6.3	18.0	6.4	15.4	7.3	8.7	2.3	2.5	4.9	4.2	6.9	8.5	2.7	2.1	2.3	4.4	4.8	1.8	1.6	3.3	1.7	1.4	1.0	0.8	2.0	6.1	0.0	2.2	2.0	2.1	1.3	0.3	0.7	0.1	5.2	1.6	1.0	1.5	2.6	2.2	0.1	9.4	5.9	0.6	0.3	0.3	3.7	3.3	54.5	4.0	6.5	0.5	3.1	8.9	4.7	3.4	0.7	0.3	8.5	0.8	3.0	2.3	0.7	0.0	1.0	0.6	3.2	2.9	2.0	2.3	1.1	3.0	2.1	2.9	0.6	0.2	14.3	0.4	2.3	0.3	1.7	2.4	1.5	0.9	1.2	8.5	4.2	7.2	2.1	1.3	4.7	0.6	2.3	3.1	6.1	4.9	6.9	3.2	2.5	0.2	2.7	6.0	9.3	2.9	7.7	6.3	1.7	7.6	2.5	8.0	7.5	148.9	104.9	0.0	0.0	0.0	0.0	0.0	0.0	18.7	58.0	31.4	0.0	0.3	0.0	4.9	0.0	0.0	0.0	0.0	7.1	2.9	0.0	0.0	5.8	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.0	14.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PHACTR3	"C20orf101, PPP1R123"	ENSG00000087495	"Phosphatase and actin regulator 3"	Q96KR7	20	59577509-59847711	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 56.1"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 11.9;Bipolar cells: 9.8;Cardiomyocytes: 7.3;Cholangiocytes: 10.2;Club cells: 6.8"	"Group enriched"	"Detected in some"	5	"glioma: 3.8;lung cancer: 1.6;pancreatic cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"THP-1: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051834, HPA054847"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051834: AB_2681629, HPA054847: "	"unprognostic (7.14e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.72e-2)"	"unprognostic (1.43e-7)"	"unprognostic (1.99e-1)"	"unprognostic (2.87e-2)"	"unprognostic (5.83e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (7.71e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.32e-1)"	1.6	2.7	31.3	1.8	29.2	2.0	1.4	15.9	56.1	1.5	1.9	20.0	0.0	2.1	1.3	2.0	2.8	1.4	3.3	3.0	27.3	14.6	2.0	2.1	5.3	1.4	28.3	19.4	6.9	1.5	1.4	0.5	1.9	21.3	1.4	1.8	0.0	1.3	1.3	1.4	2.6	2.1	1.5	25.4	8.0	1.8	1.8	29.8	0.0	1.4	0.0	1.4	1.6	0.0	0.0	2.5	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.8	0.0	0.0	0.0	10.4	0.0	0.7	2.7	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	31.3	29.2	15.9	34.1	27.3	14.6	28.3	19.4	21.3	29.8	11.9	0.3	0.0	1.0	0.6	9.8	7.3	10.2	1.4	6.8	3.5	0.0	0.0	1.7	0.1	0.9	0.1	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.2	4.8	1.2	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	1.8	0.0	0.0	0.0	1.6	0.0	0.7	0.0	0.7	0.4	0.0	0.0	0.8	3.0
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600268-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	3.9	4.9	7.9	3.2	7.6	1.5	4.2	8.9	8.2	3.7	3.2			2.1	4.9	3.9	4.8	4.2	3.6	5.0	7.2	6.5	3.8	4.0	3.1	5.2	6.9		6.6	3.5	4.6	3.0	3.5		4.5	3.0		3.5	3.2	5.7	5.7	2.3	4.3	6.6	3.2	2.9	2.5			4.6		5.3	3.8	3.0	10.4	8.2	8.8	7.2	13.1	11.2	6.6	9.6	9.7	8.6	16.9	12.6	12.5	12.3	13.8	10.2	11.3	10.7	13.7	9.8	9.7	12.6	17.5	13.9	7.9	12.2	18.9	16.6	15.8	13.3	8.1	11.4	5.5	7.5	6.6	9.0	12.3	10.6	11.2	10.1	10.6	9.6	5.5	6.5	11.4	17.3	8.3	9.3	8.4	11.0	6.5	8.1	7.6	12.2	8.0	10.5	11.4	11.5	13.1	12.2	10.9	14.1	8.8	14.3	9.4	15.0	19.2	10.8	10.6	20.8	8.9	8.4	11.0	13.7	11.2	13.8	8.8	6.3	8.1	9.6	7.2	10.9	10.4	9.5	9.9	6.2	9.5	10.8	11.2	5.3	13.1	7.2	8.2	8.0	6.6											23.8	31.5	43.5	29.2	25.3	57.1	47.0	15.3	76.3	38.7	33.2	37.3	44.7	63.0	45.9	31.1	34.6	15.3	0.0	29.2	41.6	31.9	25.6	45.1	25.4	26.2	71.5	26.4	21.5	16.8	8.7	38.9	26.7	20.3	55.1	22.5	88.5	34.5	22.8	38.9	39.8	65.9	45.3	24.7	51.1	80.1	22.6	43.0	27.7	23.4	25.1
PHB2	"Bap37, BCAP37, p22, REA"	ENSG00000215021	"Prohibitin 2"	Q99623	12	6965327-6970825	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014889, CAB026335, HPA039874"	Supported		Enhanced	Mitochondria		NA	NA		780000	Mitochondria		"CAB014889: , CAB026335: AB_2283865, HPA039874: AB_2616448"	"unprognostic (4.64e-3)"	"unprognostic (4.32e-2)"	"unprognostic (9.65e-2)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (3.07e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.17e-2)"	"unprognostic (5.61e-2)"	36.2	46.2	20.0	41.5	21.3	33.5	37.1	21.6	29.7	42.7	48.6	19.8	42.8	40.0	46.3	36.2	55.6	37.7	29.1	44.3	17.9	17.2	36.0	72.8	24.0	64.9	18.8	18.8	68.9	92.3	28.0	22.1	27.4	17.2	48.6	39.5	25.8	62.7	29.1	72.9	39.5	46.3	56.0	17.5	36.6	37.5	20.5	19.0	57.2	50.4	77.4	45.7	46.4	39.9	36.4	47.6	20.9	35.9	38.1	41.6	34.4	36.9	35.7	30.0	40.6	24.3	42.5	67.0	26.2	33.8	46.4	36.8	56.4	38.9	77.0	11.6	25.3	28.7	30.2	54.7	46.2	37.6	42.7	45.7	40.4	23.1	52.9	40.9	65.1	29.8	43.8	31.6	29.4	64.1	46.8	45.5	22.5	36.0	17.7	32.7	36.7	59.8	59.6	114.6	32.2	31.9	42.0	48.1	47.8	37.1	41.6	15.5	53.6	21.1	60.4	67.7	63.9	9.5	52.2	27.4	20.0	32.8	15.8	55.2	17.8	21.6	79.2	27.0	34.0	28.4	20.9	30.0	14.6	30.8	35.9	37.3	36.4	35.3	35.8	47.6	34.8	32.0	31.8	12.4	38.1	30.4	44.4	41.6	34.4	20.0	21.3	21.6	29.7	17.9	17.2	18.8	18.8	17.2	19.0	44.7	42.0	120.9	90.2	66.1	40.4	39.9	81.5	40.2	38.7	33.2	37.3	183.0	97.8	103.8	2.2	69.9	132.2	46.7	140.2	226.3	64.5	78.8	63.4	148.3	144.5	17.5	96.5	85.3	105.7	4.4	90.0	74.4	69.2	134.3	123.4	72.7	115.8	66.6	64.7	112.8	33.1	71.1	81.1	32.6	58.9	66.7	142.2	78.4	212.2	93.2
PHF12	"KIAA1523, PF1"	ENSG00000109118	"PHD finger protein 12"	Q96QT6	17	28905250-28951771	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 25.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021410, HPA021452"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021410: AB_1855287, HPA021452: AB_2670708"	"unprognostic (9.50e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.69e-2)"	"unprognostic (3.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.02e-3)"	"unprognostic (6.71e-2)"	"prognostic unfavorable (1.24e-5)"	"unprognostic (2.16e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-3)"	14.0	12.0	16.7	16.5	17.9	38.4	15.6	30.7	18.4	17.1	17.4	18.5	25.4	13.2	21.0	16.4	11.4	18.1	16.1	11.3	13.0	10.5	14.2	14.8	17.2	17.7	18.6	15.2	20.7	20.3	18.6	18.7	12.2	14.0	23.4	12.9	18.9	16.6	24.5	15.6	16.5	18.0	16.2	10.2	25.2	15.4	17.5	18.2	22.1	18.9	7.3	18.0	19.2	16.6	4.5	4.9	25.6	2.7	3.5	4.3	1.5	10.2	16.4	22.5	13.5	13.7	9.8	10.6	10.1	14.9	15.5	14.9	10.9	9.6	11.4	12.6	11.6	12.7	10.6	14.4	8.5	15.1	18.9	15.6	12.0	18.2	8.6	12.4	12.9	15.0	10.8	9.3	14.2	13.1	14.6	11.1	14.9	10.2	11.9	9.7	10.5	24.6	17.5	13.1	22.0	7.3	24.2	18.5	11.3	10.3	12.6	15.3	13.2	15.1	24.1	12.1	12.3	13.1	18.3	6.7	12.9	11.9	12.4	12.0	14.8	13.1	13.4	9.9	10.1	13.2	9.6	2.7	3.9	3.9	2.2	3.9	2.7	3.1	4.3	1.5	4.5	3.0	3.3	25.6	3.5	2.4	4.9	1.7	1.5	16.7	17.9	30.7	18.4	13.0	10.5	18.6	15.2	14.0	18.2	14.9	7.5	13.3	7.2	13.6	20.8	5.9	7.6	4.0	13.6	3.5	13.7	6.2	1.7	7.6	7.2	14.3	7.8	0.0	9.1	6.3	8.7	17.0	13.9	9.6	8.0	23.8	10.3	16.0	11.3	4.1	15.8	11.6	11.8	17.2	15.4	12.3	8.3	7.0	15.6	3.8	21.0	25.8	11.8	14.4	11.1	14.3	5.0	17.5	9.8	11.9
PHF20	"C20orf104, dJ1121G12.1, TDRD20A"	ENSG00000025293	"PHD finger protein 20"	Q9BVI0	20	35771974-35950381	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 349.5;Late spermatids: 510.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029619, HPA029620, HPA029621"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA029619: AB_10600090, HPA029620: AB_10601110, HPA029621: AB_10602201"	"unprognostic (1.21e-3)"	"unprognostic (7.30e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (2.49e-4)"	"unprognostic (2.76e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.01e-2)"	19.1	11.6	14.0	16.8	19.0	14.1	17.2	25.1	19.2	15.9	15.9	16.1	8.1	8.1	19.1	11.6	16.5	14.2	14.8	15.2	14.1	13.8	11.2	11.1	16.5	17.3	14.9	13.0	18.9	9.4	17.9	20.0	15.6	15.0	14.7	11.7	14.7	15.3	15.7	46.6	12.9	12.3	17.2	18.9	20.8	12.7	17.4	15.2	19.4	14.2	14.5	20.8	18.7	21.8	12.0	8.2	23.6	11.9	13.0	12.4	6.5	9.7	7.8	13.7	20.3	10.0	11.5	12.8	11.2	10.7	11.3	9.9	22.8	7.4	16.4	10.2	14.9	13.9	6.1	12.6	15.6	13.8	7.4	5.4	30.5	15.0	8.4	10.0	14.6	11.9	9.0	22.0	11.9	18.4	13.4	12.3	11.7	12.5	10.6	12.9	5.8	14.7	8.5	6.8	6.5	9.8	10.8	20.3	9.7	9.0	6.8	12.5	10.2	20.0	23.2	10.2	13.0	18.3	10.9	17.2	25.1	5.7	13.0	11.4	9.8	11.6	12.0	18.5	10.7	12.8	11.9	8.6	23.6	10.6	9.0	11.3	12.0	10.5	11.9	8.2	9.8	12.0	12.4	20.5	13.0	11.9	7.7	5.5	6.5	14.0	19.0	25.1	19.0	14.1	13.8	14.9	13.0	15.0	15.2	35.7	39.9	77.0	65.2	30.9	75.5	47.0	30.6	57.6	40.9	36.6	92.3	85.9	31.5	25.8	349.5	40.9	11.8	0.0	17.4	39.0	36.8	47.3	136.5	15.3	46.9	108.1	34.5	39.3	53.1	510.4	33.1	60.9	37.1	31.5	24.9	44.2	20.8	25.7	50.2	19.5	75.2	19.4	39.6	55.4	46.4	24.7	18.7	82.0	29.0	53.3
PHF23	"FLJ16355, MGC2941"	ENSG00000040633	"PHD finger protein 23"	Q9BUL5	17	7235028-7239722	"Disease related genes, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052410	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052410: AB_2681822"	"unprognostic (1.76e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.72e-2)"	"unprognostic (6.44e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	13.5	29.9	16.8	17.6	20.6	6.4	14.6	13.9	18.1	16.7	28.2	15.5	22.2	16.8	18.4	18.3	24.9	15.6	19.5	17.1	18.1	15.1	26.6	30.7	13.4	20.2	19.7	11.2	22.0	15.4	14.8	15.7	21.3	11.6	18.7	13.2	13.4	14.3	18.3	15.1	13.2	21.7	17.2	11.1	21.3	14.2	16.6	16.3	36.1	18.4	15.7	24.7	19.8	15.8	14.1	15.5	17.0	7.8	9.0	17.6	7.2	18.3	28.9	33.1	21.5	21.5	22.0	12.9	25.0	27.5	30.6	26.0	15.9	13.0	27.1	15.6	26.6	21.6	17.9	30.9	20.5	25.3	27.2	25.1	20.3	19.7	17.4	34.7	9.7	32.3	30.0	19.8	26.4	17.8	32.1	28.8	13.2	22.3	6.6	35.4	13.8	16.7	19.8	31.3	13.3	12.7	23.0	16.1	13.1	32.3	10.2	10.9	34.8	17.8	14.7	28.1	20.7	17.7	11.8	26.4	27.0	19.0	15.9	30.9	12.4	12.7	13.8	24.2	16.0	23.1	17.0	7.7	13.5	15.9	6.0	13.8	12.1	12.2	17.6	8.6	14.1	10.3	12.7	14.9	9.0	7.8	15.5	10.0	7.2	16.8	20.6	13.9	18.1	18.1	15.1	19.7	11.2	11.6	16.3	6.0	8.6	11.8	18.1	74.8	11.8	13.7	15.3	6.7	9.1	21.0	5.9	27.6	33.2	33.9	15.8	25.1	18.0	0.0	18.6	18.0	27.7	20.4	17.3	11.9	31.6	15.9	17.9	17.8	17.0	16.2	23.0	18.9	32.1	40.5	16.6	15.1	31.0	25.9	16.3	22.4	8.4	38.8	40.1	27.7	18.5	72.8	64.2	15.2	15.5	25.0
PHF5A	"bK223H9.2, INI, MGC1346, Rds3, SAP14b, SF3b14b, SF3B7"	ENSG00000100410	"PHD finger protein 5A"	Q7RTV0	22	41459717-41468725	"Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028885	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028885: AB_10602079"	"unprognostic (4.38e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (3.02e-8)"	"unprognostic (3.39e-3)"	"unprognostic (3.97e-3)"	"unprognostic (4.46e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.12e-1)"	"unprognostic (5.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.91e-2)"	24.5	20.8	21.4	21.4	24.9	47.6	27.8	21.3	27.3	20.7	24.0	27.6	18.2	22.0	24.4	26.8	28.8	22.2	21.9	18.3	22.0	20.8	26.1	28.9	20.0	30.9	32.4	23.8	21.9	25.9	18.1	24.5	29.7	23.0	20.1	29.0	21.5	22.4	20.0	32.4	25.3	26.9	22.3	29.5	27.1	24.8	27.3	28.8	38.0	23.4	30.4	38.4	21.3	22.8	33.8	34.2	39.5	33.5	30.4	35.0	40.0	21.8	15.9	27.2	17.9	20.1	15.3	18.9	22.5	18.3	29.4	24.9	21.6	13.1	31.7	13.1	16.6	20.7	17.0	36.8	26.6	33.4	19.5	38.3	19.7	24.0	25.0	21.0	51.5	15.7	14.6	20.8	23.2	29.0	12.3	20.7	22.8	26.2	20.4	21.1	29.3	41.6	34.3	27.2	60.8	23.4	31.6	24.2	22.2	19.4	17.4	13.4	11.3	24.6	16.3	24.2	20.0	13.1	26.8	14.1	15.8	27.5	12.5	26.9	16.9	29.6	53.3	15.1	22.6	16.6	21.4	33.5	38.9	27.0	30.8	35.0	33.8	31.2	33.6	34.2	30.4	30.9	30.1	39.5	30.4	28.4	28.8	32.5	40.0	21.4	24.9	21.3	27.3	22.0	20.8	32.4	23.8	23.0	28.8	20.8	11.5	67.5	63.0	68.6	23.0	9.7	35.7	20.1	7.9	10.4	3.9	79.5	39.7	49.1	6.3	40.0	29.3	46.7	48.8	96.5	39.8	40.0	33.4	19.2	51.8	12.7	14.5	31.9	30.2	8.9	39.1	48.0	32.1	76.7	29.2	30.1	53.9	31.6	39.3	31.5	20.3	97.0	45.3	54.3	80.0	80.0	91.3	58.6	39.3	89.1
PHGDH	"PDG, PGDH, SERA"	ENSG00000092621	"Phosphoglycerate dehydrogenase"	O43175	1	119648411-119744226	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD8 T-cell: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 99.3"	"Low region specificity"	"Detected in all"							"CAB003681, HPA021241, HPA024031, CAB068216"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		9000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB003681: AB_425928, CAB068216: AB_2665666, HPA021241: AB_1855299, HPA024031: AB_1855300"	"unprognostic (2.30e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (1.48e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (9.80e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.24e-2)"	"unprognostic (4.45e-3)"	"unprognostic (8.80e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.78e-3)"	18.8	1.9	33.3	4.4	32.1	4.4	13.8	7.8	27.2	11.9	5.8	49.7	9.4	4.2	6.1	41.0	16.7	24.5	3.9	5.3	26.7	20.5	14.0	53.2	4.3	5.7	42.0	20.7	17.3	58.2	67.5	5.7	6.4	23.3	24.5	4.7	8.7	62.9	16.4	1.7	35.9	3.0	8.1	28.3	1.9	9.0	8.6	38.1	9.9	15.8	7.3	7.3	7.9	14.1	6.7	3.2	2.9	0.7	1.2	16.5	3.2	13.6	5.6	14.6	35.0	8.4	11.0	27.2	12.3	22.3	17.7	29.3	28.8	2.4	0.0	5.4	33.0	1.9	18.4	27.0	25.7	12.5	0.1	24.6	4.3	19.6	19.9	17.3	27.5	0.1	15.8	43.0	16.9	20.0	9.9	12.7	48.8	7.9	32.6	7.8	53.5	18.4	8.4	36.4	10.6	42.5	16.2	25.3	2.3	1.2	16.2	15.7	14.4	9.0	6.1	99.3	13.9	12.3	47.0	0.1	2.9	15.3	17.9	13.8	26.9	6.7	27.5	35.8	38.5	22.7	2.9	0.7	0.2	2.9	0.2	0.2	6.7	1.8	4.9	3.2	2.7	9.1	16.5	2.0	1.2	0.2	1.8	2.4	3.2	33.3	32.1	7.8	27.2	26.7	20.5	42.0	20.7	23.3	38.1	3.0	9.3	9.7	92.1	46.0	0.8	2.0	84.1	21.4	7.9	19.2	2.0	32.1	114.4	48.9	40.9	3.3	0.2	0.0	120.7	43.3	25.5	86.4	5.7	90.0	8.0	0.0	1.7	2.5	1.3	81.6	62.7	4.8	54.0	19.0	1.1	79.1	39.9	2.5	120.2	80.4	2.9	12.9	16.0	5.2	3.4	67.4	21.2	5.0	1.5	39.9
PHOX2B	"NBPhox, Phox2b, PMX2B"	ENSG00000109132	"Paired like homeobox 2b"	Q99453	4	41744082-41748970	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.5;brain: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	99	"pons and medulla: 24.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	91	"SH-SY5Y: 53.6"	"Region enriched"	"Detected in single"	17	"pons and medulla: 5.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 2.0"	"HPA074325, HPA074941"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA074325: AB_2686678, HPA074941: AB_2732272"			"unprognostic (1.01e-1)"								"unprognostic (2.47e-1)"			"unprognostic (5.27e-2)"				0.0	14.5	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	24.8	0.2	1.4	0.8	0.0	0.0	0.0	0.0	3.2	0.5	0.4	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	53.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PICALM	"CALM, CLTH"	ENSG00000073921	"Phosphatidylinositol binding clathrin assembly protein"	Q13492	11	85957684-86069882	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 25.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019053, HPA019061"	Enhanced		Enhanced	Vesicles		NA	NA		28000	Vesicles		"HPA019053: AB_1855361, HPA019061: AB_1855362"	"unprognostic (9.27e-3)"	"unprognostic (7.29e-2)"	"unprognostic (3.51e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (5.36e-3)"	"unprognostic (9.02e-3)"	"unprognostic (9.80e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.31e-1)"	"prognostic favorable (2.02e-6)"	"unprognostic (1.26e-2)"	"unprognostic (5.21e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.02e-1)"	72.9	24.2	35.6	43.1	51.4	37.1	51.3	30.2	39.7	38.7	35.9	60.0	27.7	39.6	41.6	26.0	41.3	31.5	48.1	41.4	43.7	34.2	63.9	53.8	45.1	35.2	52.0	33.5	38.2	29.7	70.6	23.8	76.7	50.7	29.9	32.0	26.7	31.8	37.0	35.5	35.0	45.3	49.9	70.7	49.5	30.7	22.9	55.1	31.0	30.8	28.5	34.8	44.0	49.2	2.1	7.1	25.8	8.5	3.9	5.3	3.1	29.2	13.9	22.1	15.5	33.9	35.7	41.7	37.7	48.9	29.8	26.3	54.9	39.9	22.8	38.9	60.3	31.2	24.2	23.1	27.5	43.1	6.7	8.3	64.7	19.0	17.4	34.6	15.2	29.2	30.9	29.8	55.8	46.5	50.6	32.2	15.4	41.4	18.8	56.0	17.2	17.7	14.0	12.1	47.2	7.9	12.3	33.4	16.2	57.8	24.7	13.4	10.9	46.2	15.6	12.4	29.0	21.2	12.3	34.9	55.1	19.2	64.9	30.0	6.7	17.7	20.9	13.0	12.0	37.1	3.6	8.5	4.2	3.9	7.2	3.3	2.1	2.9	5.3	7.1	1.4	3.0	2.7	25.8	3.9	7.2	2.5	3.8	3.1	35.6	51.4	30.2	39.7	43.7	34.2	52.0	33.5	50.7	55.1	32.8	63.6	25.0	34.9	103.0	19.5	39.7	33.1	32.1	25.0	68.0	11.8	37.0	26.6	54.1	51.3	74.2	54.8	70.0	32.6	99.4	46.2	37.9	47.3	49.9	74.3	38.1	24.1	74.3	121.6	73.1	33.1	105.1	57.3	46.9	31.2	20.9	64.7	45.6	41.1	65.4	16.5	77.6	77.5	17.1	12.0	84.3	34.6	40.6	25.2	76.6
PIGN	"MDC4, PIG-N"	ENSG00000197563	"Phosphatidylinositol glycan anchor biosynthesis class N"	O95427	18	61905255-62187118	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"GPI-anchor biosynthesis"	Transferase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"Alveolar cells type 1: 300.7;Alveolar cells type 2: 289.2;Ciliated cells: 257.0;Club cells: 244.5;granulocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039922, HPA040374"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA039922: AB_10805597, HPA040374: AB_10794738"	"unprognostic (1.93e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (6.51e-4)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.71e-1)"	12.6	14.1	8.3	10.2	13.2	13.7	13.5	10.5	12.4	15.1	13.2	16.6	12.2	12.0	18.3	12.7	33.2	9.2	11.0	12.8	9.6	7.8	11.2	15.9	9.0	9.5	10.4	8.8	12.9	16.6	19.7	27.2	17.1	11.9	15.2	15.7	14.7	20.3	13.7	15.2	19.0	12.7	9.6	15.4	9.3	17.4	16.2	12.2	18.6	15.3	12.7	18.6	16.8	18.1	13.1	13.4	14.8	10.0	16.3	11.5	4.5	16.7	10.1	10.0	12.7	12.5	17.0	13.4	16.7	13.1	10.9	13.1	13.0	17.1	18.5	24.4	12.6	9.8	23.2	13.4	14.1	17.3	15.4	9.0	11.3	15.5	10.2	9.0	23.1	13.2	9.9	9.5	11.0	12.9	11.9	13.7	13.3	13.3	27.8	12.0	15.2	11.5	7.0	16.9	13.3	9.4	12.4	18.7	17.9	13.5	25.8	11.4	11.8	22.2	15.7	7.0	29.1	25.0	14.8	15.6	22.2	16.3	8.8	12.4	29.5	27.4	9.2	12.2	13.2	21.6	11.4	10.0	7.6	9.6	8.5	9.9	10.3	9.7	9.2	10.8	13.1	11.2	11.5	14.8	16.3	9.0	13.4	7.8	4.5	8.3	13.2	10.5	12.4	9.6	7.8	10.4	8.8	11.9	12.2	300.7	289.2	3.4	7.8	7.1	6.5	7.7	17.8	257.0	244.5	10.4	3.9	7.7	1.7	9.6	3.9	5.3	5.9	0.0	8.3	8.5	5.8	12.6	147.5	11.3	8.7	6.4	6.4	11.6	5.9	5.3	6.6	7.5	3.3	8.2	13.4	8.0	8.7	10.5	3.5	3.7	6.8	6.5	4.1	18.4	4.7	14.9	8.7	5.0	11.9	10.7
PIMREG	"CATS, FAM64A, FLJ10156, FLJ10491, RCS1"	ENSG00000129195	"PICALM interacting mitotic regulator"	Q9BSJ6	17	6444415-6451469	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 27.3"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 50.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA043783, HPA049934"	Uncertain		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA043783: AB_2678669, HPA049934: AB_2680959"	"unprognostic (5.32e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.37e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.23e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.50e-2)"	"unprognostic (0.00e+0)"	"unprognostic (8.65e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.11e-1)"	1.9	4.5	1.2	1.6	1.1	3.1	2.2	1.0	0.8	1.3	4.7	0.6	0.4	4.3	1.6	1.7	6.0	0.3	2.5	1.6	0.5	0.5	0.8	0.9	2.1	1.7	0.6	0.4	1.6	0.4	0.0	1.0	0.9	1.2	0.8	6.2	0.4	1.3	0.4	0.4	3.7	4.5	2.7	1.0	9.5	1.8	1.0	0.4	27.3	0.4	3.9	3.6	2.3	2.0	0.4	0.0	0.8	0.4	3.3	1.5	1.2	12.6	17.1	50.8	22.8	0.4	1.5	3.9	14.9	9.2	24.5	16.6	10.1	5.5	0.0	6.0	12.1	12.1	9.3	25.6	6.6	13.2	19.5	10.2	0.0	10.2	12.2	0.0	0.5	15.5	0.8	0.4	10.1	3.9	2.3	7.7	11.3	3.0	7.2	15.3	9.1	2.7	0.1	22.2	10.2	11.2	22.7	20.4	8.9	4.0	1.9	11.6	16.3	12.9	13.4	12.6	6.4	6.2	1.2	3.6	19.2	15.6	11.3	24.3	2.6	9.2	0.0	7.5	6.2	29.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.3	0.0	0.4	0.2	0.7	0.8	3.3	0.4	0.0	1.3	1.2	1.2	1.1	1.0	0.7	0.5	0.5	0.6	0.4	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PIN1	dod	ENSG00000127445	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 1"	Q13526	19	9835257-9849682	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Cell cycle"	"Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.2"	"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 571.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB004528, CAB009326, HPA068650, HPA070887"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		30000	Nucleoplasm	Cytosol	"CAB004528: AB_628132, CAB009326: AB_2237080, HPA068650: AB_2686014, HPA070887: "	"unprognostic (2.54e-1)"	"unprognostic (6.14e-3)"	"unprognostic (6.50e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.23e-3)"	"prognostic favorable (3.25e-4)"	"unprognostic (9.43e-2)"	"prognostic favorable (7.80e-5)"	"unprognostic (2.20e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.21e-2)"	24.5	36.3	40.0	18.7	38.8	25.6	9.3	27.4	66.0	9.2	15.8	18.1	8.5	22.9	14.0	8.3	11.3	16.4	10.1	25.9	38.0	35.2	17.4	14.5	13.2	14.8	38.7	37.2	13.9	21.1	9.5	13.6	13.3	57.3	23.2	6.5	14.1	21.3	15.7	50.2	10.2	21.7	11.1	19.6	15.4	19.6	24.8	15.0	19.7	9.9	8.1	9.3	11.1	9.7	36.4	72.8	88.2	44.9	40.7	53.8	46.2	26.2	24.1	18.0	16.7	6.3	5.6	10.6	19.7	8.5	14.7	14.2	22.3	8.4	16.3	31.4	7.3	15.3	13.5	12.4	11.9	4.7	34.7	52.6	42.4	29.6	19.2	10.3	19.7	24.9	7.7	8.0	9.5	4.5	11.0	11.9	29.3	19.1	24.8	8.8	18.4	29.9	77.2	17.2	11.0	37.1	27.4	18.7	27.3	10.5	12.9	22.7	26.7	19.0	9.5	22.0	7.7	12.2	23.7	20.1	20.4	16.3	31.5	31.5	32.1	30.1	21.9	21.7	25.3	25.0	52.2	43.4	88.2	42.0	44.9	39.2	35.6	41.5	42.1	39.7	36.4	33.1	37.2	26.8	40.7	41.7	72.8	53.8	46.2	40.0	38.8	27.4	66.0	38.0	35.2	38.7	37.2	57.3	15.0	26.8	21.5	49.1	53.7	42.8	68.5	65.3	43.3	56.2	14.8	59.3	11.8	107.3	139.3	95.7	197.0	54.9	69.5	46.7	95.4	80.4	81.4	55.2	63.4	41.4	123.0	57.2	95.8	47.3	50.0	571.0	83.4	67.4	118.1	174.1	57.9	60.8	85.6	73.7	122.0	109.4	50.6	64.7	97.1	136.8	72.0	57.6	46.0	94.4	62.6	47.8
PIN4	"EPVH, PAR14, PAR17"	ENSG00000102309	"Peptidylprolyl cis/trans isomerase, NIMA-interacting 4"	Q9Y237	X	72181353-72302926	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 68.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054483, HPA064504"	Approved		Supported	"Nucleoplasm,Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoplasm, Nucleoli"	"Mitotic chromosome"	"HPA054483: AB_2682503, HPA064504: AB_2685274"	"unprognostic (2.47e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.77e-2)"	"unprognostic (8.42e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.49e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.92e-1)"	"prognostic favorable (2.58e-4)"	"unprognostic (3.34e-3)"	"prognostic favorable (2.66e-4)"	14.4	11.3	15.0	8.0	14.7	6.1	18.8	10.7	16.2	9.7	9.7	8.4	6.7	9.5	11.6	19.3	8.9	8.7	30.7	11.2	15.2	12.2	15.6	23.2	7.9	7.9	12.9	11.0	12.7	8.1	8.0	9.2	9.8	10.0	10.4	11.1	6.6	30.7	37.1	68.7	7.3	9.6	9.2	12.4	16.7	9.3	4.7	6.9	9.7	12.9	40.1	9.1	7.8	9.2	28.9	26.8	23.4	23.6	22.4	33.4	22.7	15.4	18.1	19.0	12.9	13.0	10.9	10.1	10.6	12.2	13.0	13.4	9.1	11.5	4.6	31.0	10.9	17.6	11.0	16.8	18.6	16.1	11.7	37.8	7.9	21.6	23.9	7.2	12.5	6.7	7.3	10.3	14.2	4.9	14.7	13.2	14.2	13.3	20.6	9.7	18.7	10.9	21.1	13.5	17.6	16.4	10.9	15.1	13.7	16.5	10.8	12.2	21.7	12.4	5.8	10.9	14.6	9.0	11.5	13.2	5.9	9.1	16.2	7.7	7.1	7.6	7.7	17.0	12.6	6.4	21.9	23.3	23.4	26.8	23.6	26.4	28.9	28.3	25.5	22.8	26.4	29.3	29.4	9.7	22.4	21.8	26.8	33.4	22.7	15.0	14.7	10.7	16.2	15.2	12.2	12.9	11.0	10.0	6.9	62.5	35.0	52.8	54.1	38.4	26.9	74.7	81.5	84.3	51.2	113.4	7.9	137.4	154.2	102.6	10.6	70.5	117.6	23.3	102.2	92.0	70.9	50.1	55.5	238.7	95.4	27.0	88.9	80.4	73.2	6.2	69.0	61.7	57.3	68.5	76.9	55.6	124.5	101.7	76.4	218.0	33.7	84.1	78.3	14.4	39.1	40.9	100.9	62.3	82.1	54.0
PITX2	"ARP1, Brx1, IGDS, IHG2, IRID2, Otlx2, RGS, RIEG, RIEG1, RS"	ENSG00000164093	"Paired like homeodomain 2"	Q99697	4	110617423-110642123	"Disease related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Disease mutation, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.4;retina: 53.5;skeletal muscle: 28.8"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 12.7;Cytotrophoblasts: 5.5;Enterocytes: 6.5;Extravillous trophoblasts: 5.4;Hofbauer cells: 6.6;Spermatogonia: 5.6;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"hypothalamus: 2.1;midbrain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.1;HEK 293: 8.0;LHCN-M2: 18.6;RH-30: 15.7"	"Region enhanced"	"Detected in single"		"hypothalamus: 9.8"	"Region enhanced"	"Detected in single"		"hypothalamus: 5.1"	"HPA050074, HPA062728"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA050074: AB_2681005, HPA062728: AB_2684851"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (9.29e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.14e-2)"	"unprognostic (9.61e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.11e-15)"	"unprognostic (6.97e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.98e-2)"	"unprognostic (9.91e-2)"	0.6	0.1	0.0	18.6	0.0	0.1	0.3	0.0	0.1	1.1	3.0	0.0	0.3	0.1	0.1	1.3	2.7	0.2	1.1	3.5	0.0	2.1	0.3	0.1	0.1	0.1	1.1	0.0	0.1	0.5	0.1	12.5	30.4	0.0	8.3	0.3	53.5	9.3	0.2	28.8	0.9	3.4	15.9	0.0	0.1	0.5	0.3	0.0	0.0	0.1	16.8	0.4	19.4	5.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	1.9	0.0	0.7	1.9	1.6	3.0	0.6	0.3	2.0	1.5	18.1	0.0	0.0	3.9	3.7	2.4	0.3	0.1	0.0	1.1	0.0	8.0	0.0	1.4	0.0	6.7	0.0	3.8	2.1	0.1	0.3	0.0	0.6	0.0	2.0	0.5	0.0	18.6	0.5	2.0	0.0	0.3	0.0	0.3	0.0	15.7	0.0	0.3	2.5	0.0	0.0	1.4	2.5	0.2	0.3	0.1	0.0	0.0	2.5	5.9	0.0	2.9	0.0	0.1	0.8	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	12.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	6.5	0.0	0.3	5.4	4.5	0.2	0.0	0.0	6.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.9	0.0	1.3	0.0	0.0	1.7	1.2	5.6	0.1	8.8	0.0	1.2	0.0
PJA2	"KIAA0438, Neurodap1, RNF131"	ENSG00000198961	"Praja ring finger ubiquitin ligase 2"	O43164	5	109334709-109409994	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040347, HPA057636"	Supported		Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA040347: AB_10795631, HPA057636: AB_2683485"	"unprognostic (5.78e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.83e-2)"	"unprognostic (2.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (4.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (5.64e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.94e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.00e-2)"	21.6	27.0	40.1	15.9	49.9	29.0	22.1	41.6	63.0	29.0	23.8	19.7	16.8	12.5	29.2	25.0	20.7	20.3	18.6	24.4	44.3	46.2	24.1	29.2	19.4	14.3	36.8	44.0	35.4	14.8	42.8	30.3	21.8	53.2	31.7	20.6	12.5	17.3	37.7	17.1	13.6	15.9	39.2	37.6	19.5	15.8	17.0	27.4	16.7	35.9	9.7	16.3	35.5	21.4	10.3	11.7	29.9	15.5	10.7	12.2	10.6	11.8	8.2	33.3	25.6	33.1	36.3	18.1	19.6	29.6	15.5	25.5	7.6	16.2	15.3	27.2	37.6	25.0	6.9	19.4	24.1	28.5	13.0	7.3	17.7	16.9	10.3	23.5	13.2	26.3	25.0	20.2	20.7	29.9	27.9	24.7	13.8	12.1	28.9	25.0	7.2	15.8	12.2	6.6	7.3	5.5	10.3	29.3	25.5	24.1	10.7	6.4	16.4	20.2	7.4	23.6	23.3	16.7	19.6	28.4	22.1	10.8	20.3	9.1	19.5	16.6	18.2	23.4	18.4	14.5	17.3	11.6	17.3	9.5	12.2	9.4	10.3	9.4	8.7	11.7	7.4	12.1	8.9	29.9	10.7	15.5	4.9	12.2	10.6	40.1	49.9	41.6	63.0	44.3	46.2	36.8	44.0	53.2	27.4	62.5	47.1	47.1	45.8	56.3	93.5	116.8	50.9	41.5	45.5	54.1	58.9	19.9	41.4	32.7	16.4	64.5	53.5	0.0	28.7	23.4	57.5	66.5	46.2	90.1	46.6	73.1	64.9	65.1	78.4	15.1	78.9	53.7	57.3	31.5	47.8	99.2	29.4	20.1	87.0	45.1	78.2	77.6	80.4	73.2	30.2	50.8	22.0	50.7	29.6	32.0
PKM	"OIP3, PK3, PKM2, THBP1"	ENSG00000067225	"Pyruvate kinase M1/2"	P14618	15	72199029-72231822	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Glycolysis, Translation regulation"	"Allosteric enzyme, Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skeletal muscle: 541.2"	"Cell type enhanced"	"Detected in all"	5	"monocytes: 1878.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019421, HPA029501"	Uncertain		Enhanced	Cytosol		No	No		540000000	Cytosol		"CAB019421: AB_2252325, HPA029501: AB_10602118"	"unprognostic (8.73e-3)"	"unprognostic (4.63e-3)"	"unprognostic (1.68e-2)"	"unprognostic (3.09e-1)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (1.30e-4)"	"prognostic unfavorable (2.74e-6)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (5.17e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-2)"	23.2	76.8	53.8	49.8	70.4	57.5	41.6	56.6	85.9	65.7	31.2	32.1	31.5	26.4	24.7	41.8	76.4	37.9	32.9	94.8	50.1	57.1	60.9	6.1	33.3	39.4	62.5	63.6	26.2	15.6	33.3	28.3	27.1	80.5	34.8	31.9	54.4	47.1	47.5	541.2	51.8	25.1	44.7	34.9	30.7	26.7	29.0	29.4	23.5	23.8	114.4	60.6	53.1	40.9	25.1	79.6	14.9	90.6	11.6	37.4	114.9	81.9	210.9	42.5	50.3	51.2	57.5	35.1	88.9	207.7	142.9	144.6	59.3	101.0	62.4	90.0	166.4	106.4	119.5	134.4	181.0	112.0	109.5	63.5	38.2	106.1	49.1	35.6	49.5	82.5	52.2	84.3	110.0	45.2	185.5	84.1	32.1	9.5	50.1	225.2	50.9	18.5	21.3	52.6	125.8	80.5	55.0	136.1	118.9	189.6	105.5	44.2	48.3	116.0	71.6	90.9	74.7	50.2	36.1	65.4	162.8	89.0	159.0	161.3	64.4	90.9	55.0	200.4	82.0	159.4	12.6	90.6	14.9	23.5	52.6	22.8	25.1	31.3	23.2	79.6	16.1	27.3	20.2	11.8	11.6	40.2	16.2	37.4	114.9	53.8	70.4	56.6	85.9	50.1	57.1	62.5	63.6	80.5	29.4	110.2	78.1	134.8	464.1	502.3	450.3	279.7	94.3	129.8	157.0	786.9	347.5	523.8	679.8	1147.1	307.8	224.6	361.4	70.0	528.2	1096.0	273.6	329.6	203.1	2.0	698.2	1005.9	270.8	71.2	307.3	1333.1	145.6	439.7	337.4	1878.3	130.3	624.4	887.7	231.5	252.1	165.5	510.0	122.9	245.6	32.6	84.3	340.0	481.5	163.0	247.6	730.1
PKN2	"Pak-2, PRK2, PRKCL2, STK7"	ENSG00000065243	"Protein kinase N2"	Q16513	1	88684222-88836255	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Cell adhesion, Cell cycle, Cell division, Cilium biogenesis/degradation, Host-virus interaction, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 35.7"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 35.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034861, HPA057913"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Intermediate filaments,Centrosome,Cytosol"		Yes	No			"Nucleoplasm, Intermediate filaments"	"Nuclear bodies, Plasma membrane, Centrosome, Cytosol"	"HPA034861: AB_2674363, HPA057913: AB_2732617"	"unprognostic (7.52e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (5.95e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.99e-1)"	21.9	20.7	12.2	21.2	13.7	33.5	27.6	25.6	16.6	28.6	39.3	12.6	15.1	22.9	20.0	20.2	28.2	17.1	13.3	16.2	10.3	8.9	15.9	15.9	26.0	16.4	13.7	8.7	27.2	18.9	24.6	29.7	20.8	13.3	19.6	23.6	14.1	19.5	25.1	15.9	17.5	49.0	17.5	12.5	18.0	15.9	12.4	16.2	29.1	20.3	14.4	13.1	21.9	22.0	4.0	3.7	35.7	4.5	1.4	3.0	1.0	23.7	9.3	18.5	11.1	12.4	14.1	12.0	14.1	13.0	15.8	16.5	9.9	17.1	9.4	16.8	13.4	19.5	18.8	18.0	10.7	21.7	3.3	13.1	6.9	19.4	8.4	10.9	6.8	2.1	11.6	11.1	12.4	15.0	12.6	18.0	7.5	11.5	6.9	17.0	4.8	7.8	5.9	9.3	9.0	10.9	7.5	28.2	3.8	14.0	46.8	9.0	5.9	21.1	12.2	18.1	14.6	9.1	6.2	16.8	13.5	12.1	17.2	14.7	3.8	3.2	6.4	5.6	6.7	5.0	4.9	4.5	6.8	2.6	2.5	2.3	3.3	2.3	2.4	2.1	4.0	3.0	2.6	35.7	1.4	3.2	3.7	1.8	1.0	12.2	13.7	25.6	16.6	10.3	8.9	13.7	8.7	13.3	16.2	38.7	52.6	24.5	42.6	42.9	83.6	41.1	40.8	45.5	39.8	66.3	84.4	37.5	10.0	51.4	2.1	51.2	79.8	70.0	52.5	29.4	35.1	52.3	15.1	32.6	20.4	62.0	42.5	51.0	34.3	2.9	50.3	29.0	30.4	41.5	55.9	64.3	62.0	87.7	45.3	22.4	151.6	38.8	29.8	35.8	18.8	45.8	31.2	21.0	50.9	118.4
PKNOX2		ENSG00000165495	"PBX/knotted 1 homeobox 2"	Q96KN3	11	125164687-125433389	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	14	"Early spermatids: 28.7;Melanocytes: 8.5;Peritubular cells: 16.6"	"Cancer enhanced"	"Detected in many"		"melanoma: 8.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 27.2;AN3-CA: 6.8;hTEC/SVTERT24-B: 5.4;LHCN-M2: 8.0;SK-MEL-30: 5.4;WM-115: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028867, CAB034342, HPA055368, HPA066962"	Supported		Enhanced	"Nucleoplasm,Cytokinetic bridge"		NA	NA			Nucleoplasm	"Cytokinetic bridge"	"CAB034342: AB_2164138, HPA028867: AB_2672802, HPA055368: AB_2682796, HPA066962: AB_2685757"	"unprognostic (2.91e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.44e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.70e-1)"	"unprognostic (4.10e-6)"	"unprognostic (1.76e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.48e-3)"	5.8	4.1	10.0	3.3	12.4	0.7	1.7	16.3	25.7	5.1	2.8	3.6	0.2	2.0	5.6	4.7	2.7	9.8	3.4	7.9	7.3	6.9	2.9	1.1	9.6	2.4	5.2	12.3	23.6	6.3	0.9	7.3	12.8	6.9	10.2	2.8	24.3	2.5	8.7	19.5	4.0	2.4	4.6	4.6	3.4	2.5	7.2	3.1	0.0	18.3	8.4	2.2	3.3	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	27.2	6.8	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	1.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.2	0.0	0.0	2.7	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	4.4	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.4	16.3	25.7	7.3	6.9	5.2	12.3	6.9	3.1	0.0	0.0	0.0	0.0	0.8	0.9	4.3	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.7	28.7	0.5	0.0	0.0	0.2	0.0	1.4	1.8	0.0	0.0	0.2	7.9	0.0	1.3	0.0	7.4	4.6	0.0	8.5	0.0	0.0	3.3	0.2	0.0	16.6	0.0	0.2	6.5	3.1	0.7	0.1	0.4	0.1	0.0	0.0	0.0
PKP2		ENSG00000057294	"Plakophilin 2"	Q99959	12	32790745-32896840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"		"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 134.7"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 399.9;Extravillous trophoblasts: 148.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 10.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 56.3;OE19: 20.4;SuSa: 45.7"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 22.1"	"Low region specificity"	"Detected in all"			"HPA014314, CAB037336, HPA056908"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB037336: , HPA014314: AB_1855451, HPA056908: AB_2683272"	"unprognostic (1.89e-1)"	"unprognostic (1.70e-2)"	"prognostic favorable (8.55e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (6.79e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.94e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.76e-2)"	3.1	0.7	1.4	7.9	5.2	1.1	3.3	2.2	1.8	6.1	14.2	1.4	6.9	6.5	1.2	2.0	3.3	21.6	4.4	134.7	3.9	0.9	3.6	13.6	1.1	3.4	0.7	2.0	9.5	5.4	9.6	14.7	24.1	3.8	3.5	13.3	12.6	24.6	5.0	3.4	1.9	13.3	1.3	1.3	2.4	4.8	3.4	0.4	2.7	0.6	2.3	4.3	2.0	2.1	0.6	3.9	10.4	2.1	1.5	1.0	0.6	15.7	3.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	56.3	14.2	0.0	9.7	0.0	2.1	14.0	1.9	12.4	0.0	0.0	4.5	0.1	0.6	14.7	8.8	0.8	0.2	0.0	11.7	0.0	13.6	6.3	0.5	0.0	2.8	4.4	1.3	4.1	0.0	0.1	8.6	20.4	2.7	0.0	6.8	4.7	4.1	7.5	1.7	1.5	0.6	3.3	0.0	45.7	7.1	0.2	0.1	0.0	6.3	0.0	3.8	3.7	0.0	0.1	0.0	0.0	0.7	5.1	1.4	10.4	0.4	1.6	1.0	0.2	0.6	0.4	3.9	0.6	0.9	0.5	1.2	1.5	2.1	0.8	0.6	0.6	1.4	5.2	2.2	1.8	3.9	0.9	0.7	2.0	3.8	0.4	0.0	0.0	2.4	42.2	6.3	1.0	399.9	15.3	12.0	19.4	1.8	3.9	39.7	3.3	12.2	3.0	3.5	74.7	0.0	8.6	148.3	17.6	16.8	4.6	39.3	7.7	1.6	26.0	3.7	13.1	1.3	10.9	7.4	10.1	0.0	60.1	13.0	16.5	52.6	2.1	8.4	1.1	0.0	1.4	5.4	7.2	2.9	34.7	0.7	87.1	25.7
PKP3		ENSG00000184363	"Plakophilin 3"	Q9Y446	11	392614-404908	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 69.0;skin 1: 48.4;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 206.5;Extravillous trophoblasts: 144.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;NK-cell: 2.3"	"Group enriched"	"Detected in many"	5	"NK-cells: 2.3;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"A-431: 37.6;CAPAN-2: 26.4;HaCaT: 50.7;hTCEpi: 33.2;MCF7: 23.7;SK-BR-3: 38.5"	"Region enriched"	"Detected in single"	37	"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"CAB012993, HPA062937"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"CAB012993: AB_2533221, HPA062937: AB_2684908"	"unprognostic (4.74e-2)"	"unprognostic (5.28e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.25e-1)"	"unprognostic (6.73e-3)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (3.55e-2)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (2.16e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.15e-2)"	0.6	0.0	0.2	3.7	0.3	0.0	3.3	0.2	0.3	14.5	14.6	0.3	5.0	11.2	1.9	6.2	69.0	2.6	8.9	0.5	0.3	0.1	0.6	0.2	4.3	0.2	0.2	0.2	1.1	10.2	3.9	3.8	23.2	0.2	4.5	3.6	0.2	12.5	2.5	0.6	48.4	25.4	1.0	0.2	0.3	10.4	0.5	0.2	2.2	5.8	59.0	29.9	2.8	21.5	0.3	0.0	0.0	0.0	2.3	1.6	0.1	37.6	7.3	0.0	0.1	0.0	0.0	15.8	0.3	0.2	0.8	0.4	15.0	26.4	0.0	1.5	0.3	1.7	50.7	0.0	19.2	0.1	0.0	9.5	0.0	4.3	10.4	0.1	0.0	0.0	0.1	33.2	0.1	8.1	0.1	0.1	0.0	11.2	0.2	0.1	23.7	0.1	0.0	0.0	19.0	12.7	0.2	0.0	0.1	0.4	7.6	10.8	0.1	10.9	38.5	0.0	0.5	13.9	0.1	1.3	0.2	1.4	0.7	0.2	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.8	0.0	0.3	0.0	0.7	0.0	2.3	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.3	0.3	0.1	0.2	0.2	0.2	0.2	14.9	15.4	0.0	43.7	64.1	0.0	1.1	7.6	9.4	12.5	12.2	0.0	112.3	0.0	83.2	0.0	0.4	206.5	0.0	54.5	144.7	3.5	34.6	13.8	0.0	11.6	0.0	20.8	0.0	0.0	0.0	0.9	1.8	1.7	3.6	76.4	0.5	96.8	93.0	0.0	0.7	0.1	0.0	1.6	0.0	0.4	77.5	91.8	0.0	83.6	52.6
PKP4	p0071	ENSG00000144283	"Plakophilin 4"	Q99569	2	158456964-158682879	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 111.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 5.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037334, HPA066647, HPA070648"	Approved		Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cell Junctions"	"Plasma membrane"	"CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291"	"unprognostic (2.76e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.48e-2)"	"prognostic favorable (5.80e-4)"	"unprognostic (2.34e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.82e-2)"	"unprognostic (9.69e-2)"	"prognostic favorable (3.29e-7)"	"unprognostic (2.23e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-3)"	7.3	3.9	42.7	3.7	42.1	4.2	15.5	14.5	26.6	19.8	7.1	49.9	6.9	7.1	8.3	8.9	10.7	11.8	8.9	12.1	47.7	31.2	34.2	9.7	7.3	3.0	66.9	14.7	8.3	8.7	12.2	6.6	3.4	28.4	7.8	8.1	10.4	19.3	13.1	4.0	9.4	6.4	8.5	111.7	3.2	7.7	5.6	31.6	3.3	18.2	2.4	5.5	9.1	6.9	0.1	0.7	1.0	5.3	0.0	2.1	0.5	16.7	9.3	12.9	14.6	5.9	6.5	12.3	14.0	7.5	21.1	18.3	31.3	15.9	10.7	10.4	16.2	7.7	13.6	16.6	13.9	35.3	16.1	8.5	10.1	10.5	25.5	10.0	16.0	2.2	2.8	13.5	14.5	22.1	12.8	10.6	13.8	13.7	17.1	16.0	18.5	7.0	6.8	13.7	23.4	7.1	9.3	19.2	9.2	31.1	12.1	22.4	4.0	9.7	14.6	11.4	12.4	17.3	14.7	4.9	12.6	14.2	9.3	17.5	9.8	8.2	7.9	7.4	8.8	12.2	0.0	1.0	0.0	0.4	0.3	0.7	0.0	1.5	0.6	0.4	0.1	1.2	0.4	1.0	0.0	5.3	0.7	2.1	0.5	42.7	42.1	14.5	26.6	47.7	31.2	66.9	14.7	28.4	31.6	38.7	17.6	4.9	19.0	24.0	32.4	44.7	50.9	33.5	34.2	45.4	27.5	0.3	19.9	20.4	10.2	56.2	10.3	23.3	15.9	0.3	10.4	28.3	9.3	23.7	2.6	4.8	8.6	20.3	8.1	7.0	10.0	6.7	6.8	1.8	17.6	8.1	14.4	10.5	15.9	25.9	18.6	12.9	13.4	10.7	5.9	26.6	0.2	3.5	19.5	18.6
PLCG1	"NCKAP3, PLC-II, PLC1, PLC148, PLCgamma1"	ENSG00000124181	"Phospholipase C gamma 1"	P19174	20	41136960-41196801	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Host-virus interaction, Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"gdT-cell: 5.9;MAIT T-cell: 8.0;memory CD4 T-cell: 5.2;memory CD8 T-cell: 4.9;naive CD4 T-cell: 5.7;naive CD8 T-cell: 5.4;NK-cell: 4.0;T-reg: 4.4"	"Group enriched"	"Detected in many"	8	"NK-cells: 4.0;T-cells: 8.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004277, HPA036681, HPA036682"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004277: AB_628119, HPA036681: AB_2675245, HPA036682: AB_2675246"	"unprognostic (2.77e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.31e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.09e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (4.72e-4)"	"unprognostic (3.32e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (2.65e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.79e-2)"	20.2	15.1	25.1	20.9	22.1	8.3	34.9	52.6	26.8	19.9	13.9	23.4	12.5	16.5	27.6	13.9	13.5	17.0	18.7	20.9	25.4	13.6	15.3	6.8	19.3	30.7	18.5	20.5	28.7	9.1	16.9	14.2	22.2	18.7	18.4	13.2	20.0	13.2	20.6	13.4	22.3	17.1	22.2	15.4	20.1	12.4	19.9	23.9	48.1	28.5	11.9	21.9	17.1	21.1	0.7	0.0	0.0	0.0	4.0	8.0	3.3	5.4	6.9	33.2	24.3	13.3	9.3	10.6	8.9	11.5	18.0	15.3	16.6	1.8	12.1	11.0	9.7	18.9	10.1	14.4	16.0	10.5	3.4	7.7	0.8	11.5	19.5	10.1	4.7	3.3	11.9	9.0	13.3	10.4	16.3	20.0	26.0	9.0	8.0	16.2	40.4	29.2	3.7	12.3	7.0	12.7	23.3	24.2	5.9	9.9	10.0	11.8	22.5	16.0	7.5	16.0	19.4	8.7	5.6	21.6	43.1	14.0	13.7	10.8	8.9	3.9	10.0	10.2	5.2	17.8	0.0	0.0	0.0	5.9	0.0	8.0	0.3	5.2	4.9	0.0	0.7	5.7	5.4	0.0	4.0	0.0	0.0	4.4	3.3	25.1	22.1	52.6	26.8	25.4	13.6	18.5	20.5	18.7	23.9	14.9	6.5	0.8	1.8	4.9	3.7	9.2	0.0	1.4	3.4	3.5	9.8	1.3	0.0	2.7	5.1	15.8	6.4	0.0	1.4	1.6	6.1	1.9	1.1	2.5	3.2	3.2	1.7	13.5	2.2	5.3	14.1	1.7	3.3	1.0	9.8	7.2	2.8	3.7	17.3	2.4	4.6	12.9	5.1	11.6	11.5	6.0	0.7	6.9	5.1	0.9
PLCH1	"DKFZp434C1372, KIAA1069, MGC117152, PLCeta1, PLCL3"	ENSG00000114805	"Phospholipase C eta 1"	Q4KWH8	3	155375580-155745067	"Enzymes, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	"Hydrolase, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.7;testis: 15.8"	"Cell type enriched"	"Detected in many"	6	"Early spermatids: 148.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 8.4;AF22: 27.2;NTERA-2: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA036176, HPA057978"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036176: AB_10671837, HPA057978: AB_2683569"	"unprognostic (1.08e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.50e-4)"	"unprognostic (6.41e-2)"	"unprognostic (2.94e-5)"	"unprognostic (5.04e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.24e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-2)"	"prognostic favorable (3.03e-5)"	"unprognostic (3.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.37e-2)"	0.3	0.3	3.9	0.7	14.1	0.5	3.9	7.4	14.7	2.1	3.9	5.7	4.1	3.9	1.4	12.9	0.5	12.4	2.4	2.5	4.5	3.6	2.1	0.4	6.1	0.3	3.4	7.3	0.5	2.5	0.8	3.2	0.8	6.5	0.8	3.9	5.6	2.3	3.4	0.6	0.5	3.9	0.5	1.9	0.3	5.8	15.8	2.9	0.0	8.9	0.0	0.4	1.3	0.4	0.1	0.3	0.7	0.0	0.0	1.2	0.9	0.0	8.4	27.2	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	6.7	0.0	0.6	0.0	0.1	0.0	4.8	0.0	0.0	0.0	2.5	6.8	0.0	0.9	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	2.9	1.6	6.2	14.5	0.9	1.1	0.6	0.0	0.0	1.7	0.1	2.5	0.6	0.0	6.5	0.0	4.2	2.9	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.9	3.9	14.1	7.4	14.7	4.5	3.6	3.4	7.3	6.5	2.9	3.0	12.8	0.0	0.3	0.0	10.0	0.5	7.6	25.4	3.4	1.8	3.9	0.0	0.0	1.9	148.2	0.1	2.4	0.0	2.0	0.2	0.0	0.1	0.0	0.0	0.2	23.8	2.9	0.0	0.3	10.0	1.1	0.0	0.0	0.0	4.3	19.3	1.5	2.9	0.4	1.9	3.0	0.0	0.0	2.1	1.1	0.1	0.0	0.0	4.7	0.1
PLEKHA1	TAPP1	ENSG00000107679	"Pleckstrin homology domain containing A1"	Q9HB21	10	122374696-122442602	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 261.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 6.9;NK-cells: 11.6;T-cells: 16.5"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002043, HPA064795"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA002043: AB_1079632, HPA064795: AB_2685354"	"unprognostic (1.79e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.70e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.41e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.07e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.69e-1)"	"unprognostic (7.98e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.42e-2)"	"unprognostic (4.31e-2)"	"unprognostic (5.23e-2)"	11.7	7.4	18.2	8.7	30.2	2.6	13.6	15.8	37.9	13.6	14.9	25.4	11.4	17.1	17.9	14.5	26.7	8.8	16.3	19.4	19.8	16.6	27.1	25.4	24.4	9.0	15.6	24.4	13.9	18.1	18.8	22.9	30.6	20.7	12.7	13.9	9.5	16.0	13.6	22.5	43.9	17.2	16.0	19.6	8.7	14.0	25.5	15.0	3.4	18.7	13.9	11.7	16.1	16.1	6.9	1.8	1.3	1.6	11.6	16.5	6.2	7.8	7.3	7.4	5.1	10.8	12.3	8.9	8.8	15.4	5.3	5.8	6.1	10.0	4.9	4.3	7.9	5.4	17.4	7.0	26.9	4.9	3.5	6.8	0.0	7.2	7.2	7.1	0.9	2.3	6.7	22.3	4.4	18.8	8.8	17.9	10.4	7.3	0.0	4.9	3.0	4.4	0.7	5.7	12.1	4.9	1.2	10.6	0.9	64.9	8.8	10.1	4.9	11.4	8.5	8.9	10.9	4.7	0.1	17.0	4.5	3.7	4.9	4.4	0.0	0.0	1.6	7.0	0.0	2.8	0.1	1.5	1.3	16.5	1.4	10.8	2.9	10.0	13.2	1.8	6.9	15.9	13.5	0.5	11.6	1.6	0.9	6.6	6.2	18.2	30.2	15.8	37.9	19.8	16.6	15.6	24.4	20.7	15.0	134.0	37.7	19.5	46.6	64.7	41.5	49.8	43.3	33.5	60.3	54.1	70.7	47.5	34.9	55.8	165.5	60.9	41.2	0.0	73.6	39.9	30.4	51.3	4.7	42.4	29.9	25.4	21.5	27.6	18.2	261.8	40.9	15.7	23.6	28.9	21.1	25.4	58.5	28.1	33.9	98.4	50.3	25.8	30.1	90.5	82.0	74.2	33.2	33.3	24.5	60.8
PLEKHA3	FAPP1	ENSG00000116095	"Pleckstrin homology domain containing A3"	Q9HB20	2	178480468-178516462	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Late spermatids: 278.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034496, HPA034497"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA034496: AB_2674189, HPA034497: AB_10603126"	"unprognostic (1.24e-1)"	"unprognostic (2.33e-2)"	"unprognostic (5.93e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.83e-2)"	"unprognostic (4.02e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.96e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.51e-2)"	"unprognostic (8.52e-2)"	7.1	13.6	8.1	7.4	13.4	9.3	6.4	14.0	10.2	8.6	8.5	6.9	6.1	9.1	7.3	13.0	6.8	7.2	6.8	12.2	8.0	8.9	9.8	8.1	7.2	6.5	8.7	5.4	10.6	7.4	13.0	12.6	9.7	11.0	9.1	5.5	9.1	6.1	9.3	7.6	4.0	9.8	14.4	7.3	7.6	7.8	18.7	5.4	7.3	8.4	4.0	6.0	14.3	6.5	4.2	2.4	2.5	1.5	2.9	2.8	0.4	4.4	3.0	3.5	4.5	6.9	3.7	6.6	7.2	5.6	3.6	3.9	1.2	3.0	3.8	9.4	5.1	10.1	3.1	3.2	1.9	6.8	11.6	3.1	6.0	3.1	3.4	4.8	3.7	6.7	3.3	6.3	6.7	4.2	6.5	3.3	3.4	2.8	6.1	4.6	1.4	5.0	5.5	5.8	3.2	4.3	2.6	5.1	6.6	4.7	2.6	3.6	5.0	3.6	2.6	10.7	5.1	3.1	6.6	3.6	7.1	7.0	9.0	8.0	7.5	14.7	3.7	9.3	3.1	4.0	1.4	0.9	1.2	1.9	0.9	1.7	1.9	2.8	2.1	0.9	4.2	1.8	2.0	2.5	2.9	1.5	2.4	1.1	0.4	8.1	13.4	14.0	10.2	8.0	8.9	8.7	5.4	11.0	5.4	14.9	13.4	18.8	38.7	38.4	85.4	50.8	20.4	14.7	10.3	26.2	39.3	24.4	66.3	35.0	146.0	41.9	13.5	23.3	41.2	15.3	24.3	69.4	10.4	40.2	14.5	125.5	24.8	36.2	28.8	278.6	32.2	29.0	28.7	26.2	21.1	44.5	35.0	11.5	49.1	45.2	58.8	77.6	39.1	63.9	31.7	26.6	25.5	25.5	16.5	54.2
PLEKHA7	DKFZp686M22243	ENSG00000166689	"Pleckstrin homology domain containing A7"	Q6IQ23	11	16777317-17014443	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 23.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 6.8;MAIT T-cell: 4.5"	"Group enriched"	"Detected in many"	6	"granulocytes: 6.8;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 43.4;HaCaT: 28.7;OE19: 23.8;RT4: 39.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038610, HPA066103"	Approved		Enhanced	"Nucleoplasm,Cell Junctions,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	Cytosol	"HPA038610: AB_10671746, HPA066103: AB_2732738"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.81e-2)"	"unprognostic (4.30e-2)"	"unprognostic (2.51e-2)"	"unprognostic (6.95e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.13e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (9.74e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.81e-1)"	"unprognostic (2.65e-2)"	6.8	1.2	5.3	6.6	8.0	0.1	10.7	2.9	4.9	7.7	18.1	10.9	10.0	17.7	4.7	6.0	30.6	6.0	15.1	13.6	7.5	4.2	18.1	9.0	6.4	1.2	7.2	4.6	8.1	18.9	19.1	3.2	18.7	14.5	6.0	11.5	18.2	15.0	16.3	2.7	8.9	32.0	2.7	8.1	1.7	15.2	7.4	7.9	1.4	7.2	1.9	5.5	10.7	12.4	0.5	0.9	6.8	0.3	0.2	4.5	0.3	5.1	4.6	4.9	2.2	0.2	0.0	8.1	0.0	0.1	1.7	3.2	7.9	43.4	0.0	2.0	0.6	0.2	28.7	6.5	0.0	1.2	1.5	6.3	13.3	3.7	5.4	0.1	0.0	0.1	0.2	2.5	0.0	0.1	4.0	0.0	5.6	0.5	0.1	0.7	3.3	3.0	0.1	2.7	23.8	4.5	4.1	0.0	1.0	4.2	39.3	3.1	0.3	5.9	16.9	0.2	9.3	4.3	1.5	1.1	0.0	1.6	1.2	1.0	2.9	0.9	5.8	0.0	0.2	0.0	0.2	0.3	6.8	0.6	0.1	4.5	0.5	0.8	0.6	0.3	0.2	0.2	0.4	0.6	0.2	0.1	0.9	0.1	0.3	5.3	8.0	2.9	4.9	7.5	4.2	7.2	4.6	14.5	7.9	3.0	13.4	0.0	1.2	0.6	1.2	8.7	5.1	6.7	12.5	10.4	23.6	5.4	3.3	4.7	11.7	2.3	8.4	0.0	5.3	0.8	0.6	0.8	2.3	2.4	1.7	0.0	0.0	0.6	1.0	4.5	0.6	2.4	0.0	1.0	4.6	3.9	7.6	3.5	0.4	8.1	10.6	0.0	0.3	0.2	0.5	0.4	5.0	0.5	2.6	4.6
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 43.2;Ito cells: 39.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 14.7;naive B-cell: 15.9"	"Lineage enriched"	"Detected in single"	29	"B-cells: 15.9"	"Cell line enhanced"	"Detected in many"		"AF22: 12.5;HAP1: 18.4;Karpas-707: 16.4;U-698: 11.4"	"Region enriched"	"Detected in many"	5	"thalamus: 56.1"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	27.5	2.2	7.3	10.6	7.3	2.3	10.0	2.4	7.1	8.3	5.8	10.1	4.8	4.8	7.8	14.1	9.6	8.9	8.1	5.9	7.7	6.7	4.5	5.1	12.1	13.5	10.5	3.0	4.7	2.8	8.2	5.1	13.9	11.1	4.1	6.2	3.4	3.5	5.4	6.4	8.9	6.0	5.7	19.6	28.9	4.5	7.3	7.7	39.7	6.0	5.8	13.3	7.4	8.5	15.9	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	12.5	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	6.9	3.0	4.9	4.8	0.0	1.2	1.8	18.4	1.6	0.0	7.7	2.0	0.3	0.9	0.0	0.0	0.0	1.4	0.8	4.7	0.0	0.1	0.0	7.7	4.1	0.0	16.4	0.0	0.2	1.5	0.0	0.9	4.8	0.5	0.8	0.0	0.0	3.6	8.2	0.4	0.1	0.0	2.2	1.5	1.4	0.0	0.0	7.7	0.0	1.7	0.0	3.3	0.0	0.0	11.4	0.0	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.5	14.7	0.3	0.4	0.0	15.9	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.4	7.3	7.3	2.4	7.1	7.7	6.7	10.5	3.0	11.1	7.7	0.0	3.8	8.1	0.6	3.8	0.2	1.6	2.5	5.3	3.4	7.0	0.0	4.2	3.3	2.3	2.7	43.2	4.3	0.0	1.0	1.3	9.9	0.7	0.0	3.0	0.5	0.0	5.2	39.9	6.1	1.3	0.3	0.8	5.0	8.2	9.0	8.3	6.3	10.5	0.4	2.8	0.5	0.0	2.3	1.0	0.9	3.1	2.4	3.2	4.2	2.4
PLIN3	"M6PRBP1, PP17, TIP47"	ENSG00000105355	"Perilipin 3"	O60664	19	4838341-4867768	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	Transport		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006427, HPA066538"	Uncertain		Enhanced	"Lipid droplets"		NA	Yes		9300000	"Lipid droplets"		"HPA006427: AB_1079289, HPA066538: AB_2685687"	"unprognostic (1.18e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.55e-2)"	"prognostic favorable (2.62e-4)"	"unprognostic (2.94e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (3.27e-5)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (2.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.34e-2)"	"unprognostic (8.24e-2)"	"prognostic unfavorable (9.15e-7)"	"unprognostic (2.62e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.39e-2)"	13.2	28.9	7.4	16.9	16.3	25.5	12.7	2.8	10.8	17.8	17.5	37.9	4.2	29.1	9.3	12.6	46.9	9.5	14.8	12.4	9.2	7.0	10.4	19.6	9.9	13.6	32.4	8.3	23.4	8.1	3.1	3.9	28.3	17.8	11.0	8.9	6.7	18.1	9.7	40.0	31.8	38.6	11.1	26.7	13.1	11.1	13.6	25.1	20.0	13.1	35.8	29.1	14.1	19.7	12.5	28.9	45.9	37.5	9.4	8.4	19.0	28.2	16.7	11.7	10.6	12.9	42.1	5.1	41.2	38.4	33.3	30.8	10.9	25.8	14.6	9.4	51.7	17.6	13.0	5.3	23.2	19.6	16.7	7.6	15.9	9.5	19.9	9.3	11.3	24.2	32.9	9.7	23.5	5.1	19.0	17.3	4.7	24.1	6.5	40.2	11.6	16.1	15.3	8.8	12.9	27.1	27.7	15.7	8.2	28.3	6.5	0.5	5.5	12.8	11.6	10.1	9.9	14.9	25.7	25.7	17.7	17.5	70.7	21.2	9.2	11.7	10.1	53.3	16.1	20.4	28.3	37.5	16.1	3.8	26.2	3.8	12.5	6.7	4.3	28.9	9.3	5.4	3.4	45.9	9.4	18.0	21.4	8.4	19.0	7.4	16.3	2.8	10.8	9.2	7.0	32.4	8.3	17.8	25.1	17.9	24.6	17.5	48.4	126.4	0.2	2.5	10.2	64.3	42.1	10.4	2.0	124.8	31.5	90.9	8.1	25.3	190.9	0.0	74.9	62.3	89.7	37.6	54.3	14.4	92.9	0.0	39.0	29.4	63.2	9.8	33.1	85.3	52.3	65.9	60.5	22.6	161.7	98.2	49.8	32.3	0.6	51.8	50.5	46.1	15.6	200.5	162.9	17.5	40.8	62.6
PLIN4	"KIAA1881, S3-12"	ENSG00000167676	"Perilipin 4"	Q96Q06	19	4502180-4518465	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 155.0;breast: 80.6;skeletal muscle: 45.2"	"Cell type enhanced"	"Detected in some"	14	"Cardiomyocytes: 31.3;Cholangiocytes: 10.2;Hepatocytes: 25.9;Ito cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	9	"ASC diff: 77.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA044682, HPA054657"	Enhanced		Enhanced	"Lipid droplets,Plasma membrane,Cytosol"		NA	NA		11000	"Plasma membrane, Cytosol"	"Lipid droplets"	"HPA044682: AB_2679044, HPA054657: AB_2682559"	"unprognostic (2.97e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (8.31e-4)"	"prognostic unfavorable (2.31e-4)"	"unprognostic (6.65e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"	"unprognostic (4.94e-3)"	155.0	1.2	0.9	7.4	0.8	0.8	80.6	0.5	0.9	2.4	8.5	0.6	2.4	0.8	3.7	2.2	3.8	2.5	8.3	15.5	0.6	0.1	0.6	11.1	0.4	2.0	0.8	0.8	2.9	3.3	0.3	0.2	0.3	0.9	2.8	1.2	0.7	6.8	3.9	45.2	1.8	2.4	10.3	1.3	0.4	3.5	0.7	0.8	0.1	0.7	8.2	0.7	5.9	3.9	0.0	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	77.0	0.5	2.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.4	1.1	0.0	0.0	2.5	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.1	0.0	0.9	0.8	0.5	0.9	0.6	0.1	0.8	0.8	0.9	0.8	0.0	4.5	0.0	1.0	0.2	0.1	31.3	10.2	0.0	3.4	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.0	0.0	1.3	0.3	0.0	0.4	0.0	25.9	0.1	0.0	0.0	10.4	2.7	0.0	0.0	0.0	1.7	0.0	0.0	0.5	0.9	0.0	3.9	0.8	0.0	6.5	0.5	0.5	0.5	0.3	0.3	0.0	0.0	1.3
PLPBP	PROSC	ENSG00000147471	"Pyridoxal phosphate binding protein"	O94903	8	37762593-37779767	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Distal tubular cells: 86.2;Exocrine glandular cells: 43.8;Hofbauer cells: 41.9;Proximal tubular cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB017033, HPA023646, HPA023733"	Approved		Enhanced	Cytosol		NA	NA		20000	Cytosol		"CAB017033: , HPA023646: AB_1855741, HPA023733: AB_1855742"	"unprognostic (1.55e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.35e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.28e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.85e-2)"	23.3	18.2	22.0	14.6	23.3	8.4	20.6	19.7	23.2	15.7	29.1	16.1	18.3	21.3	17.2	16.2	14.0	18.9	16.4	30.1	19.7	21.4	37.0	48.2	16.5	14.7	20.7	20.3	17.8	38.4	26.2	17.9	13.2	15.3	19.5	25.5	15.2	18.6	19.2	32.6	11.0	24.7	19.4	18.5	15.1	20.0	7.2	15.4	16.6	30.6	15.7	18.3	20.1	28.8	27.4	40.0	46.1	46.5	24.1	39.2	34.2	17.4	17.1	14.2	12.8	10.7	13.1	11.1	20.0	18.1	13.9	15.8	20.3	9.1	21.0	23.9	15.9	22.4	16.0	26.4	21.0	23.3	17.4	11.1	29.1	6.8	19.4	21.1	13.2	19.8	9.6	19.6	13.4	21.8	15.5	20.9	30.1	15.3	16.8	11.6	12.9	42.6	12.3	16.8	36.1	14.0	28.0	17.4	12.3	22.7	22.9	8.4	9.2	16.5	8.0	20.8	10.9	17.4	17.4	18.5	7.7	23.5	25.8	13.0	16.5	32.4	15.6	10.8	19.4	13.7	46.1	38.4	45.6	31.8	43.8	33.3	27.4	32.6	30.5	40.0	22.9	29.2	27.8	16.2	24.1	46.5	23.7	39.2	34.2	22.0	23.3	19.7	23.2	19.7	21.4	20.7	20.3	15.3	15.4	8.9	24.5	0.0	0.0	0.0	0.0	0.0	0.0	25.4	14.8	29.6	0.0	17.4	86.2	32.4	0.0	0.0	0.0	0.0	43.8	26.8	0.0	0.0	11.6	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	20.8	0.0	0.0	30.6	0.0	0.0	63.4	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0
PLRG1	"Cwc1, PRL1, Prp46, PRPF46, TANGO4"	ENSG00000171566	"Pleiotropic regulator 1"	O43660	4	154535006-154550435	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035931, HPA035932, HPA061486"	Supported		Enhanced	"Nuclear membrane,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nuclear membrane"	"HPA035931: AB_2674868, HPA035932: AB_10673224, HPA061486: AB_2684536"	"unprognostic (6.51e-2)"	"unprognostic (5.66e-3)"	"unprognostic (6.10e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.20e-5)"	"unprognostic (2.92e-1)"	"unprognostic (9.84e-3)"	"unprognostic (1.64e-2)"	"unprognostic (1.97e-1)"	20.2	18.1	23.3	14.9	30.9	17.5	25.2	29.3	28.6	22.7	19.5	24.7	16.7	15.6	24.4	19.3	24.4	22.8	16.0	16.2	22.9	22.2	26.0	34.9	17.1	20.4	28.9	24.3	23.9	14.2	28.2	21.9	17.8	29.4	18.4	22.7	13.3	19.4	23.3	23.0	16.5	22.1	29.2	32.5	19.1	16.8	13.3	25.9	22.0	24.8	22.3	31.5	18.3	16.5	25.2	25.2	23.2	30.9	34.0	28.8	23.7	23.9	19.6	25.4	27.1	30.1	26.1	21.4	30.8	37.8	42.2	34.5	23.1	21.2	26.1	15.8	36.6	27.8	17.7	33.1	41.2	46.9	26.3	16.5	31.4	15.6	22.3	30.8	31.2	26.4	28.0	38.3	49.8	39.2	25.4	36.1	28.9	32.0	33.6	36.6	17.1	23.9	14.9	19.2	19.1	21.4	23.8	13.2	15.8	29.2	15.4	14.8	16.7	18.8	20.3	29.4	25.1	19.5	21.9	23.2	25.2	28.6	22.2	27.4	17.6	22.8	32.9	23.7	15.1	33.5	23.2	19.4	15.2	23.7	22.5	28.2	25.2	24.8	25.6	25.2	19.2	26.6	24.8	5.2	34.0	30.9	24.8	28.8	23.7	23.3	30.9	29.3	28.6	22.9	22.2	28.9	24.3	29.4	25.9	23.8	14.9	29.0	28.9	14.4	27.4	22.1	12.7	37.5	14.8	21.0	11.8	43.2	13.3	39.6	14.7	21.9	18.7	0.0	30.4	31.8	28.3	15.4	45.0	25.5	30.6	58.8	26.0	17.2	20.6	1.3	25.9	20.4	13.5	38.7	14.1	29.8	28.6	20.9	32.9	29.0	19.5	19.4	21.7	22.8	29.6	15.2	37.1	28.8	19.1	20.2
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146050-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	6.8	5.0	4.8	11.4	6.9	6.5	7.6	11.2	4.9	11.9	13.4	4.4	9.3	7.0	11.3	7.1	14.2	11.0	9.1	16.9	5.1	5.5	9.6	9.7	6.2	8.3	3.7	3.1	21.0	11.3	12.5	23.8	6.9	8.6	23.5	8.5	17.6	8.6	8.7	38.5	10.2	8.0	27.7	4.8	5.2	7.6	4.0	2.9	16.6	23.0	10.6	12.1	19.5	8.5	4.1	2.4	3.0	1.0	4.8	4.0	1.5	11.9	5.3	4.8	7.4	1.6	1.0	0.3	6.0	6.0	9.0	11.6	6.2	5.9	34.9	7.4	1.3	7.7	4.6	9.8	4.8	20.6	10.8	12.5	7.0	3.2	5.8	1.8	20.2	5.7	1.6	3.6	3.4	7.3	7.4	2.1	10.5	2.7	18.7	2.8	1.8	12.7	16.0	1.9	10.4	5.3	21.2	23.8	25.3	10.1	2.3	13.5	9.4	3.6	5.8	5.9	6.5	0.0	17.9	3.5	0.2	5.5	1.9	12.6	10.0	14.6	7.4	2.5	17.5	0.8	1.9	1.0	2.9	2.2	0.6	3.5	4.1	2.7	3.7	1.6	3.1	4.0	3.5	3.0	4.8	0.6	2.4	0.5	1.5	4.8	6.9	11.2	3.9	5.1	5.5	3.7	3.1	8.6	2.9	8.9	9.3	11.5	19.6	26.9	19.1	18.2	28.1	10.7	14.8	15.7	29.5	2.0	5.0	11.3	4.3	10.5	4.9	0.0	9.0	1.9	14.7	40.0	5.8	7.3	3.0	7.9	10.4	7.4	8.2	7.0	22.7	3.2	16.9	19.8	16.1	10.3	16.0	3.5	18.0	13.2	21.1	6.5	17.6	4.5	6.1	27.7	1.0	10.0	24.9	14.4
PML	"MYL, RNF71, TRIM19"	ENSG00000140464	"Promyelocytic leukemia"	P29590	15	73994673-74047812	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Apoptosis, Biological rhythms, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008312, CAB010194, CAB016304"	Supported		Enhanced	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"CAB010194: AB_2166848, CAB016304: AB_628162, HPA008312: AB_1079643"	"prognostic favorable (3.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.53e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.30e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (6.27e-8)"	"unprognostic (1.58e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.99e-2)"	46.2	15.4	13.5	29.9	13.0	30.0	50.0	11.4	17.2	24.7	21.9	8.3	22.1	16.9	29.4	22.1	19.3	23.0	25.6	17.6	10.7	7.5	20.5	12.9	37.2	27.3	11.9	12.4	21.2	11.0	9.6	15.0	22.4	16.1	21.2	8.7	14.6	38.0	27.7	18.7	24.2	19.6	20.1	14.3	25.9	21.4	8.7	13.1	25.3	25.9	23.3	23.0	20.7	35.6	11.8	12.9	19.1	18.2	12.7	13.2	7.8	13.8	5.3	4.6	4.5	13.3	18.8	16.0	7.2	12.9	22.4	26.0	5.5	25.2	6.2	25.5	12.9	21.5	25.7	6.3	14.5	3.2	21.8	9.7	13.5	8.3	6.0	15.4	12.8	12.4	35.3	10.5	15.1	7.9	16.6	15.6	10.3	11.3	11.2	13.2	6.5	10.4	20.0	5.0	2.9	9.6	8.1	5.6	11.6	25.1	23.2	4.0	4.4	11.5	6.4	17.2	4.3	5.0	10.7	25.9	22.7	6.2	11.3	14.4	11.7	7.3	3.0	15.7	16.3	7.3	5.4	12.7	19.1	12.4	18.0	9.6	11.8	9.9	13.2	12.9	9.8	8.1	8.2	11.0	12.7	18.2	8.3	12.9	7.8	13.5	13.0	11.4	17.2	10.7	7.5	11.9	12.4	16.1	13.1	14.9	13.5	14.1	13.0	20.4	7.6	8.9	7.6	8.1	5.7	5.2	2.0	7.9	6.6	21.2	3.3	33.9	11.5	0.0	16.4	12.5	16.8	16.3	11.5	8.9	25.8	7.9	13.7	28.3	18.0	3.6	25.6	16.2	6.8	25.2	12.1	10.3	42.2	9.3	22.6	11.4	5.2	38.8	18.4	1.1	3.6	17.1	4.1	15.7	10.8	22.2
PMPCA	"Alpha-MPP, INPP5E, KIAA0123"	ENSG00000165688	"Peptidase, mitochondrial processing alpha subunit"	Q10713	9	136410570-136423761	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021648, HPA063735"	Supported		Enhanced	Mitochondria		NA	NA		6500	Mitochondria		"HPA021648: AB_1855491, HPA063735: AB_2685108"	"unprognostic (9.80e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.01e-2)"	"unprognostic (8.19e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.32e-2)"	"prognostic favorable (8.00e-5)"	"unprognostic (9.47e-3)"	"prognostic favorable (2.14e-6)"	"unprognostic (4.27e-3)"	"unprognostic (1.57e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.54e-2)"	15.2	27.3	19.8	14.6	23.8	20.1	13.2	20.3	24.3	12.3	15.1	13.0	10.4	18.6	14.2	14.1	16.5	13.6	14.9	37.0	15.6	14.8	17.0	48.3	12.3	18.4	15.2	21.9	15.5	18.2	14.7	19.5	15.6	16.8	15.2	11.9	12.8	20.3	17.1	56.7	17.5	17.0	13.8	14.1	18.9	16.3	23.2	12.5	14.0	15.0	19.8	15.3	13.1	13.4	25.5	30.1	17.0	25.1	32.1	30.8	28.2	14.4	27.2	13.0	26.2	9.9	14.5	20.0	15.1	12.2	21.2	15.4	31.0	17.3	20.3	15.9	15.3	11.3	33.9	24.0	22.1	9.4	29.1	29.0	16.3	35.0	37.4	17.4	21.2	14.2	21.2	15.3	16.5	8.5	12.0	17.9	18.9	41.3	13.4	13.1	40.1	20.0	27.3	26.5	25.9	25.7	24.9	18.4	44.9	14.5	10.4	26.7	17.6	20.3	29.0	17.6	9.3	39.5	28.9	14.7	15.1	16.2	12.4	19.2	8.3	10.9	21.8	19.9	18.5	13.5	15.4	25.1	17.0	27.2	24.4	26.4	25.5	25.7	29.3	30.1	23.7	30.8	26.9	5.9	32.1	23.2	15.3	24.3	28.2	19.8	23.8	20.3	24.3	15.6	14.8	15.2	21.9	16.8	12.5	14.9	25.3	23.9	29.5	24.5	22.5	31.3	10.2	13.4	18.2	21.0	21.6	90.0	41.4	28.9	19.7	20.2	19.7	0.0	26.4	41.5	17.6	17.8	24.3	54.0	33.8	17.5	20.0	20.3	17.4	12.4	17.5	14.1	15.1	21.6	22.3	19.3	25.1	17.3	21.2	37.9	25.3	38.8	16.9	32.8	39.5	23.5	86.8	23.0	30.4	23.5
PMPCB	"MPPB, MPPP52"	ENSG00000105819	"Peptidase, mitochondrial processing beta subunit"	O75439	7	103297422-103329511	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040674, HPA074168"	Approved		Enhanced	Mitochondria		No	No		57000	Mitochondria		"HPA040674: AB_10961998, HPA074168: AB_2686671"	"prognostic favorable (2.79e-4)"	"unprognostic (3.11e-1)"	"unprognostic (7.18e-3)"	"unprognostic (3.03e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.67e-2)"	"unprognostic (7.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.42e-3)"	"prognostic favorable (2.95e-8)"	"unprognostic (2.59e-2)"	"unprognostic (9.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.39e-2)"	29.1	41.8	31.8	23.0	34.3	41.5	31.6	41.1	38.4	29.0	26.9	21.6	28.2	35.1	32.0	25.9	27.9	26.9	23.5	41.4	27.7	20.1	45.9	47.2	21.9	31.3	32.6	35.0	36.8	40.6	41.1	33.9	24.8	34.2	31.6	31.5	20.8	30.6	31.0	31.5	31.6	31.0	25.7	27.8	27.9	33.6	31.3	35.9	37.2	33.2	24.2	30.0	30.7	27.9	19.5	18.4	9.7	16.1	12.9	21.9	15.7	12.4	18.0	21.2	28.6	12.9	26.2	16.0	11.6	20.0	23.5	28.0	19.2	14.3	32.0	18.6	19.7	25.1	16.2	25.5	18.7	22.4	11.2	30.4	11.1	30.9	25.6	15.7	15.2	13.1	23.9	17.4	18.3	17.7	22.5	12.4	24.1	21.4	32.6	21.4	28.9	25.1	35.8	26.0	24.8	22.6	17.6	14.9	32.5	22.0	22.3	26.7	32.6	15.6	46.2	22.8	22.4	18.9	20.4	10.2	20.7	24.9	36.9	21.5	25.0	31.9	24.6	15.4	24.5	16.3	9.7	14.1	9.3	14.7	16.1	16.1	19.5	17.1	14.7	18.4	14.3	21.5	17.4	4.4	12.9	13.6	9.4	21.9	15.7	31.8	34.3	41.1	38.4	27.7	20.1	32.6	35.0	34.2	35.9	29.8	31.7	53.2	52.9	32.5	29.3	64.2	28.1	49.5	40.9	26.2	21.6	104.2	61.3	64.5	72.7	34.3	36.7	0.0	64.0	49.3	41.1	31.6	58.9	46.5	48.7	22.3	26.0	24.5	42.2	18.6	48.1	38.4	25.3	93.8	43.0	33.6	54.8	42.1	46.7	96.5	33.4	64.7	42.9	84.6	53.0	32.9	104.5	57.5	55.1	47.7
PMS2	"H_DJ0042M02.9, HNPCC4, MLH4, PMSL2"	ENSG00000122512	"PMS1 homolog 2, mismatch repair system component"	P54278	7	5973239-6009125	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010235, HPA066490, HPA070310"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB010235: AB_2167281, HPA066490: AB_2685677, HPA070310: AB_2686250"	"unprognostic (5.13e-2)"	"unprognostic (6.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.14e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (1.23e-5)"	"unprognostic (5.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.81e-2)"	6.3	7.4	8.7	6.0	19.8	3.6	8.1	15.5	21.2	6.2	6.0	11.5	6.9	6.4	6.4	6.3	7.5	7.5	5.0	5.3	9.0	10.3	14.2	5.8	5.5	9.1	8.4	9.5	7.5	7.1	16.6	7.1	5.9	16.2	7.0	6.2	8.0	7.1	7.8	5.7	14.8	6.8	7.1	7.5	6.9	6.1	4.8	5.8	7.5	12.4	5.7	10.7	7.7	6.5	6.2	5.8	7.2	7.9	4.0	9.3	6.3	9.7	10.6	8.5	21.2	6.7	9.9	7.3	5.2	4.0	5.1	4.1	9.2	7.0	18.3	6.2	7.5	11.5	13.4	12.7	3.4	5.5	7.2	5.2	8.0	8.6	6.6	11.4	9.8	5.5	10.4	9.7	4.0	15.2	7.3	9.4	8.7	14.9	8.9	8.4	9.0	2.9	7.0	8.6	4.4	6.5	10.0	10.3	9.3	10.7	7.3	7.8	16.8	10.2	14.9	11.2	13.2	18.5	6.9	8.0	6.5	14.5	9.5	9.4	12.0	20.0	18.5	4.5	9.7	14.8	7.2	5.4	3.1	8.4	7.9	9.3	6.2	6.6	7.2	5.8	5.6	8.8	6.2	2.4	4.0	3.2	5.3	6.4	6.3	8.7	19.8	15.5	21.2	9.0	10.3	8.4	9.5	16.2	5.8	11.9	5.1	17.2	8.2	4.4	12.6	2.8	5.1	6.7	7.9	10.4	21.6	7.8	29.9	4.7	6.9	7.4	2.0	0.0	2.9	5.4	5.5	8.4	4.7	9.6	4.5	28.6	5.2	7.4	7.3	5.6	11.8	4.9	6.8	5.4	2.3	5.2	3.5	2.9	9.6	32.0	14.2	25.8	6.6	24.2	10.2	7.0	10.6	8.5	2.6	10.2
PNKD	"BRP17, DKFZp564N1362, DYT8, FKSG19, FPD1, KIAA1184, KIPP1184, MGC31943, MR-1, PDC, PKND1, TAHCCP2"	ENSG00000127838	"Paroxysmal nonkinesigenic dyskinesia"	Q8N490	2	218270392-218346793	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Distal tubular cells: 431.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010134, HPA017068"	Approved		Enhanced	Mitochondria		NA	NA		31000	Mitochondria		"HPA010134: AB_1079645, HPA017068: AB_1855495"	"unprognostic (3.15e-3)"	"unprognostic (1.80e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.29e-1)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (5.13e-5)"	"unprognostic (7.98e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.44e-3)"	21.8	28.3	33.2	15.9	41.0	13.4	16.4	26.6	51.1	29.8	27.5	14.3	28.9	18.1	14.6	37.0	13.3	28.3	30.4	37.3	31.0	26.5	42.4	107.0	23.4	34.2	33.2	23.6	18.1	18.8	22.3	15.6	28.1	26.8	34.8	25.1	15.9	27.3	27.1	33.8	12.9	15.9	16.6	25.7	18.0	29.5	23.3	20.6	11.6	29.7	15.3	16.3	19.0	13.4	64.0	32.7	44.9	35.4	38.4	43.3	38.9	15.3	20.2	14.8	23.2	22.3	18.9	27.4	9.7	21.0	23.1	26.0	33.1	15.2	18.0	19.5	16.1	25.5	16.0	28.5	18.2	16.2	37.4	35.6	26.3	37.0	48.9	24.4	16.9	11.7	25.7	18.0	15.7	4.6	15.5	24.9	14.3	19.3	23.6	20.4	44.2	22.0	40.5	14.7	35.6	20.7	21.7	14.9	15.1	26.5	23.4	14.4	12.1	6.9	47.4	27.5	16.6	15.7	16.5	15.3	9.6	16.5	11.3	13.2	9.8	10.0	19.4	24.4	28.0	11.6	33.7	35.4	44.9	32.1	34.1	30.4	64.0	35.1	38.3	32.7	52.0	38.8	37.3	9.8	38.4	31.0	30.4	43.3	38.9	33.2	41.0	26.6	51.1	31.0	26.5	33.2	23.6	26.8	20.6	65.5	73.4	56.6	80.2	49.0	53.5	126.7	104.4	100.4	62.6	186.7	5.9	149.0	431.0	54.5	7.7	70.9	168.7	0.0	43.7	85.9	107.8	126.2	56.5	206.0	114.9	33.4	116.6	73.1	82.4	10.5	95.5	48.6	129.9	72.1	149.8	127.6	39.4	144.0	116.7	212.9	34.8	90.5	76.9	45.9	44.3	54.5	64.6	55.8	176.1	86.0
PNPLA2	"ATGL, desnutrin, FP17548, iPLA2zeta, TTS-2.2"	ENSG00000177666	"Patatin like phospholipase domain containing 2"	Q96AD5	11	818902-825573	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Lipid degradation, Lipid metabolism"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 158.1;breast: 155.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055173, HPA062602, HPA075175"	Approved		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA			"Lipid droplets"	Nucleoplasm	"HPA055173: AB_2682725, HPA062602: AB_2684804, HPA075175: "	"unprognostic (2.11e-2)"	"unprognostic (3.37e-2)"	"unprognostic (5.87e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.68e-2)"	"unprognostic (6.39e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.00e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.46e-1)"	"unprognostic (4.09e-1)"	"unprognostic (2.07e-2)"	158.1	7.2	1.6	9.4	1.8	11.2	155.2	2.7	2.3	4.1	35.9	1.5	3.8	5.6	4.5	7.8	8.6	4.3	7.2	12.6	1.7	1.1	15.6	7.4	11.3	4.5	1.6	1.6	4.9	11.8	2.5	4.2	11.6	1.8	5.2	1.5	1.9	8.1	8.1	25.0	6.1	23.1	3.0	2.1	4.9	8.2	4.0	1.5	1.5	11.3	4.8	5.1	13.0	18.6	4.2	6.5	18.7	8.5	3.6	5.3	3.6	10.5	8.3	1.7	4.5	65.2	5.8	11.2	11.3	9.1	7.1	6.3	7.1	10.7	6.3	6.7	8.5	4.4	9.5	2.6	4.7	2.2	8.1	23.1	8.7	3.7	11.3	21.4	6.0	11.0	11.4	6.1	4.7	5.5	7.3	5.8	4.7	7.4	6.4	6.3	6.2	8.0	13.1	5.0	10.8	17.9	7.7	3.8	14.1	7.0	2.4	6.4	8.5	21.0	17.9	6.5	1.1	7.7	6.9	10.4	6.4	5.0	4.1	5.1	24.7	15.2	5.3	16.1	8.5	4.4	9.3	8.5	18.7	3.6	5.5	3.5	4.2	4.6	5.2	5.7	3.6	5.3	4.3	7.7	3.6	6.0	6.5	3.9	3.6	1.6	1.8	2.7	1.9	1.7	1.1	1.6	1.6	1.8	1.5	6.0	16.9	27.0	63.2	39.3	8.8	42.3	63.7	5.3	13.6	48.8	7.9	56.2	28.2	55.9	14.2	38.0	114.0	23.3	57.3	27.0	25.2	72.1	11.5	41.9	27.6	11.1	49.4	84.1	28.5	4.2	44.8	24.9	40.5	27.9	80.0	34.7	98.9	112.2	36.7	37.9	7.5	64.7	32.2	42.2	28.2	36.0	141.7	36.2	41.4	167.2
POC5	"C5orf37, FLJ35779, hPOC5, MGC120442, MGC120443, MGC120444"	ENSG00000152359	"POC5 centriolar protein"	Q8NA72	5	75674124-75717481	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 63.9;Late spermatids: 39.9;Rod photoreceptor cells: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037509, HPA037510, HPA061521"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037509: AB_2797227, HPA037510: AB_10672349, HPA061521: AB_2797263"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.08e-2)"	"prognostic unfavorable (1.60e-7)"	"unprognostic (1.99e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.97e-1)"	"unprognostic (4.62e-2)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (1.09e-4)"	8.3	8.9	9.3	9.2	17.0	12.4	13.5	12.7	11.5	9.8	7.1	10.1	6.4	6.2	10.9	12.0	6.1	12.8	6.2	5.4	8.6	8.3	9.8	6.6	8.2	14.1	13.8	8.7	16.2	7.8	8.6	6.5	10.5	16.2	9.8	9.1	10.2	6.7	7.7	5.6	8.9	8.6	10.4	13.6	15.1	7.6	25.5	11.1	27.2	8.3	5.3	14.6	8.5	8.4	15.6	15.2	20.4	9.9	14.9	18.5	7.6	9.0	7.1	11.9	11.9	5.2	4.2	8.8	8.6	5.1	15.2	11.5	10.4	8.2	12.0	16.8	4.5	20.5	8.4	10.6	8.4	11.4	12.5	6.9	7.8	5.3	5.6	7.0	9.0	15.6	4.7	8.3	11.4	19.4	5.1	6.0	12.4	7.5	22.1	7.0	10.5	14.7	11.4	5.1	2.0	6.2	9.2	9.9	14.3	6.9	4.4	9.5	10.5	8.0	4.4	9.1	6.2	8.4	10.2	2.6	5.1	11.4	8.9	17.2	13.9	28.7	17.5	7.7	11.8	12.2	7.1	9.3	20.4	13.7	9.9	12.0	13.4	14.0	14.8	13.6	15.6	14.7	14.0	8.8	14.9	7.6	15.2	18.5	7.6	9.3	17.0	12.7	11.5	8.6	8.3	13.8	8.7	16.2	11.1	6.0	12.0	8.0	2.7	2.4	12.5	3.6	5.1	21.4	5.7	7.0	11.8	5.9	8.3	6.5	63.9	5.3	2.3	23.3	6.0	6.6	3.7	1.9	2.3	1.8	5.3	9.5	4.7	6.2	3.7	39.9	5.8	5.0	3.3	1.0	4.5	4.6	4.8	2.9	6.7	4.2	37.8	6.5	3.1	29.3	15.1	2.5	3.4	7.5	4.5	1.3
POGK	"BASS2, KIAA15131, KRBOX2, LST003"	ENSG00000143157	"Pogo transposable element derived with KRAB domain"	Q9P215	1	166839447-166856344	"Predicted intracellular proteins"		"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007838, HPA031630, HPA075919"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA007838: AB_1079651, HPA031630: AB_10601490, HPA075919: "	"unprognostic (3.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.31e-2)"	"unprognostic (3.18e-3)"	"unprognostic (4.20e-2)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (4.85e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.11e-2)"	12.1	10.3	24.3	15.1	27.3	10.4	24.2	18.4	23.6	17.6	13.1	27.6	8.4	10.2	17.6	12.6	16.1	13.5	12.4	11.1	24.4	18.4	15.7	12.0	20.9	13.5	27.7	17.7	19.9	14.8	30.0	10.0	15.1	21.1	12.0	15.4	12.2	12.9	15.2	6.6	20.2	12.1	16.8	30.5	14.5	14.9	6.8	25.6	9.2	13.0	5.2	17.7	16.9	24.2	9.4	10.0	6.3	10.8	9.9	7.3	5.6	15.8	13.5	14.8	18.2	15.7	13.1	8.4	11.0	11.3	14.2	10.8	10.2	13.6	17.9	16.6	11.4	12.1	15.9	18.4	14.7	13.0	21.7	12.6	7.0	12.3	7.2	13.4	25.1	19.8	9.9	23.2	15.9	22.9	12.6	12.6	16.8	24.1	12.1	13.5	7.6	15.5	6.3	24.2	18.6	15.6	17.8	8.1	15.8	14.8	38.9	19.4	23.4	15.7	21.8	20.3	23.0	20.7	23.4	11.6	15.1	15.0	11.8	19.9	17.2	22.1	23.4	8.4	12.6	14.2	2.8	7.7	6.3	6.7	9.9	7.3	9.4	6.5	7.1	10.0	5.8	6.1	6.3	1.1	9.9	10.8	5.0	5.6	5.6	24.3	27.3	18.4	23.6	24.4	18.4	27.7	17.7	21.1	25.6	50.6	15.0	10.2	22.1	19.5	30.6	7.9	15.3	12.0	23.9	12.2	9.8	9.2	1.7	15.3	2.2	16.8	7.4	0.0	13.9	10.1	12.1	19.9	23.1	12.1	14.0	46.1	8.6	12.3	18.1	0.7	10.0	16.1	8.5	10.0	12.1	14.5	12.4	14.0	17.0	7.4	27.0	12.9	13.4	0.9	2.1	21.0	7.6	7.5	15.2	25.1
POGZ	"KIAA0461, ZNF280E, ZNF635m"	ENSG00000143442	"Pogo transposable element derived with ZNF domain"	Q7Z3K3	1	151402724-151459465	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Cell division"	DNA-binding	"Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006800, HPA008781"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006800: AB_1855516, HPA008781: AB_1855517"	"unprognostic (2.87e-1)"	"unprognostic (7.16e-2)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.99e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.00e-2)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (3.92e-5)"	"unprognostic (2.32e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.29e-1)"	"prognostic favorable (4.40e-4)"	11.6	15.2	18.3	15.6	20.1	23.5	18.2	40.6	24.8	16.1	17.8	22.2	21.9	10.0	24.2	39.0	11.0	23.9	17.7	12.4	15.4	13.5	16.9	14.4	13.9	12.7	18.7	20.7	37.4	13.2	33.0	26.8	10.4	17.3	17.8	14.5	17.1	15.4	17.6	15.4	24.1	13.0	19.3	20.3	16.7	13.1	21.2	21.8	20.3	21.6	7.4	13.9	15.0	17.6	5.2	4.0	7.8	2.6	2.9	5.6	1.8	9.8	12.9	32.4	18.3	14.5	14.1	11.1	8.7	8.0	10.0	10.4	14.4	10.3	20.8	15.1	10.9	7.9	8.7	18.7	9.3	13.1	17.6	10.4	12.7	17.6	8.3	10.7	17.5	13.0	12.5	7.6	11.0	13.3	18.7	15.8	15.7	11.9	20.1	9.7	25.3	19.3	11.4	22.9	10.2	7.8	18.9	15.6	10.6	10.7	16.2	17.7	18.1	14.7	12.5	14.4	27.6	16.3	23.0	13.2	12.1	14.5	10.0	12.5	14.6	12.5	40.3	8.7	9.3	10.2	7.8	2.5	5.5	4.2	2.1	3.6	5.0	4.2	5.6	2.2	5.2	4.3	4.2	4.8	2.9	2.6	4.0	2.9	1.8	18.3	20.1	40.6	24.8	15.4	13.5	18.7	20.7	17.3	21.8	56.6	41.2	14.7	23.8	40.2	81.8	15.1	35.7	18.7	28.4	61.1	78.5	13.4	3.3	19.4	12.1	41.3	27.5	0.0	12.8	9.3	31.4	29.8	26.6	38.4	18.3	74.7	55.9	49.7	22.8	6.9	49.8	26.0	49.0	19.8	30.0	52.4	20.1	26.4	69.3	9.8	57.4	64.7	32.5	27.9	57.7	29.7	9.6	25.9	33.7	23.5
POLD2		ENSG00000106628	"DNA polymerase delta 2, accessory subunit"	P49005	7	44114681-44124358	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA excision, DNA repair, DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 217.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026745	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026745: AB_1855520"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.10e-3)"	"unprognostic (1.50e-3)"	"unprognostic (4.94e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.44e-3)"	17.2	19.1	17.5	14.3	16.7	16.3	33.9	14.3	25.9	15.8	15.4	17.1	12.6	13.9	16.1	9.7	27.5	34.5	14.5	35.9	16.3	13.8	15.9	43.6	15.3	16.2	15.2	14.7	24.4	49.0	18.9	17.9	12.9	15.0	15.9	12.9	17.4	19.9	14.3	42.6	19.3	11.5	15.7	13.7	11.9	16.0	14.4	14.8	27.7	20.3	25.1	15.8	13.4	16.7	28.1	37.0	3.2	13.7	13.3	29.3	21.3	26.5	35.1	19.6	41.0	17.4	18.7	19.4	16.4	16.5	22.5	16.9	29.6	25.6	61.5	21.0	23.5	45.1	36.8	32.0	44.7	14.7	17.4	37.6	13.5	37.7	25.0	19.9	41.3	16.6	17.0	27.4	34.8	33.9	23.7	18.8	41.6	49.5	29.6	24.8	43.3	50.3	78.1	30.8	38.3	34.5	33.9	26.3	87.2	19.5	17.2	38.9	30.4	20.4	73.7	14.0	13.2	42.6	53.3	14.7	29.9	37.7	36.6	51.2	46.5	68.7	58.9	26.8	41.9	42.2	0.5	13.7	3.2	17.9	12.4	26.8	28.1	21.6	18.2	23.2	27.3	29.3	21.4	1.1	13.3	11.8	37.0	17.0	21.3	17.5	16.7	14.3	25.9	16.3	13.8	15.2	14.7	15.0	14.8	6.0	35.1	22.3	62.4	43.8	38.9	57.0	38.2	60.2	37.5	27.9	29.5	61.7	87.9	57.0	88.9	29.0	11.8	0.0	52.0	69.9	44.0	51.0	25.5	84.6	40.8	50.9	40.3	20.3	12.3	217.8	38.6	15.8	47.2	10.0	53.1	37.9	39.5	14.0	50.2	78.7	48.2	19.4	68.0	59.4	64.6	52.9	29.6	23.3	71.7	63.1
POLDIP3	"KIAA1649, PDIP3, PDIP46, SKAR"	ENSG00000100227	"DNA polymerase delta interacting protein 3"	Q9BY77	22	42583721-42614962	"Predicted intracellular proteins"	"mRNA transport, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 116.8;Late spermatids: 271.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018419, HPA048790"	Approved		Enhanced	"Nuclear speckles,Cytoplasmic bodies"		NA	NA			"Nuclear speckles"	"Cytoplasmic bodies"	"HPA018419: AB_1856928, HPA048790: AB_2680522"	"unprognostic (2.00e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.05e-3)"	"prognostic favorable (7.79e-4)"	"unprognostic (2.82e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (5.96e-2)"	"prognostic favorable (3.36e-4)"	"unprognostic (3.73e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.19e-1)"	17.7	24.5	25.8	22.9	31.6	43.8	25.3	30.9	33.2	28.4	23.2	36.2	23.4	19.2	31.3	27.8	28.1	41.4	28.8	20.6	25.9	19.2	24.4	19.7	25.1	24.4	38.0	24.9	71.5	24.1	27.7	24.4	30.8	27.4	27.5	22.5	24.0	28.1	27.0	23.8	28.5	21.2	27.2	24.5	26.9	28.0	28.2	38.3	37.9	33.5	17.4	33.2	21.2	27.0	22.2	33.0	22.7	28.5	20.9	26.8	27.0	17.4	17.9	40.4	18.8	18.3	21.0	25.9	20.1	17.1	31.1	23.2	20.9	12.1	29.6	13.0	23.8	14.7	20.3	42.0	23.0	24.3	14.2	31.0	23.5	21.0	21.6	17.0	36.5	24.1	14.6	26.3	22.8	23.8	26.0	21.8	22.5	25.1	19.7	24.4	19.5	30.4	26.5	22.3	22.9	16.9	38.7	36.8	20.0	25.8	11.3	13.3	11.4	24.4	21.3	21.5	24.8	19.6	26.9	19.8	19.7	23.9	13.3	20.2	19.2	23.4	27.5	16.0	22.7	27.7	18.1	28.5	22.7	25.7	26.5	26.8	22.2	23.0	21.8	33.0	22.2	25.6	22.5	16.6	20.9	22.7	16.9	23.7	27.0	25.8	31.6	30.9	33.2	25.9	19.2	38.0	24.9	27.4	38.3	17.9	13.7	27.3	20.7	17.4	29.4	10.4	15.3	14.7	13.6	19.2	19.6	31.6	18.3	25.3	116.8	15.7	18.8	23.3	21.6	31.9	16.3	27.2	24.2	15.3	20.0	23.8	18.4	16.0	20.8	271.9	20.1	18.4	18.6	49.5	13.5	17.7	21.5	17.5	23.3	15.1	14.4	45.3	20.2	20.9	35.0	15.4	43.6	25.4	16.9	19.7
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576150-43615660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Erythroid cells: 23.3;Spermatocytes: 17.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 41.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	7.4	9.4	7.5	9.7	10.4	4.6	7.2	10.5	10.5	8.5	8.4	12.7	8.0	5.7	9.6	7.1	11.4	7.8	6.2	6.7	5.3	4.4	7.2	7.5	9.8	16.3	8.9	8.1	7.4	13.0	7.1	9.7	5.1	7.9	6.9	10.1	8.9	8.6	5.6	9.5	11.7	7.9	11.8	6.9	9.2	7.6	24.7	6.8	22.1	9.9	6.2	18.3	8.6	8.4	8.6	4.3	4.5	2.6	6.8	7.2	3.2	20.5	4.7	6.4	9.3	9.1	15.1	15.2	22.0	6.9	12.9	14.8	5.4	3.6	22.8	5.5	8.9	3.7	5.2	6.4	13.8	16.1	11.5	4.9	6.7	13.3	15.6	6.8	11.4	9.0	10.1	17.0	10.5	5.7	5.2	12.1	7.0	10.5	13.7	16.2	6.8	10.3	3.0	1.9	15.7	3.6	11.3	6.6	5.7	4.9	15.4	7.2	2.5	7.0	5.8	3.5	7.4	8.3	5.1	16.4	11.9	11.6	5.6	11.1	12.9	8.9	41.2	5.7	6.7	12.9	4.5	2.6	4.1	7.2	2.5	6.4	7.8	6.0	5.2	2.1	8.6	5.0	5.2	2.0	6.8	1.9	4.3	7.0	3.2	7.5	10.4	10.5	10.5	5.3	4.4	8.9	8.1	7.9	6.8	11.9	5.1	4.9	2.6	4.1	6.3	2.4	2.5	5.3	7.9	3.5	9.8	1.7	5.0	2.0	7.6	2.1	2.6	23.3	0.7	2.4	2.6	2.1	0.0	2.1	1.5	0.0	5.2	0.6	1.5	6.0	3.1	1.7	1.7	2.8	2.2	2.3	1.6	2.9	2.8	1.4	8.5	0.0	3.1	17.9	5.9	2.6	1.6	2.9	3.1	2.5
POLK	"DINB1, DINP, POLQ"	ENSG00000122008	"DNA polymerase kappa"	Q9UBT6	5	75511756-75601144	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 167.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012035, HPA057303, HPA068117, HPA069375"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012035: AB_2668606, HPA057303: AB_2683406, HPA068117: AB_2685957, HPA069375: AB_2686131"	"unprognostic (9.66e-2)"	"unprognostic (5.29e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.73e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.65e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.96e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.02e-1)"	14.7	12.7	10.1	8.6	12.9	6.3	13.4	17.0	13.4	18.1	10.7	8.8	13.6	6.3	21.3	12.1	11.7	10.5	9.5	11.4	14.1	10.5	12.6	12.3	12.2	9.2	14.1	12.9	15.5	11.1	18.5	23.9	15.2	17.2	13.9	8.1	6.5	10.2	10.5	15.2	10.3	9.2	15.4	16.9	13.1	9.0	9.8	12.4	12.1	18.8	9.3	8.9	12.7	10.2	7.0	7.5	6.0	13.3	4.6	4.5	2.5	6.4	6.6	4.1	5.3	5.5	10.9	3.5	12.3	8.8	9.6	10.0	4.2	5.2	6.6	10.2	8.1	6.3	2.5	3.8	4.2	11.6	7.3	4.5	6.0	5.8	2.0	10.4	3.9	5.0	5.1	5.3	7.7	5.3	7.7	8.0	4.4	5.3	3.9	9.1	0.5	7.5	3.1	1.5	0.7	3.9	3.2	10.6	4.6	5.8	2.2	4.2	4.6	9.3	2.5	3.3	2.9	3.6	3.7	10.1	7.1	3.6	3.3	7.0	4.6	4.1	6.0	4.7	6.1	12.1	5.7	7.1	3.4	3.3	7.9	2.9	7.0	3.7	4.0	6.1	5.4	4.5	3.0	6.0	4.6	13.3	7.5	4.1	2.5	10.1	12.9	17.0	13.4	14.1	10.5	14.1	12.9	17.2	12.4	29.8	39.4	38.7	18.4	13.1	33.6	17.1	30.6	18.7	29.6	27.9	19.6	14.0	19.9	16.1	167.0	32.1	9.2	23.3	13.7	11.0	21.7	14.6	49.8	20.9	18.7	62.0	14.3	49.7	37.8	38.8	34.8	32.2	21.9	27.9	12.4	23.5	16.5	11.5	36.0	17.0	40.7	6.5	16.5	43.4	16.6	11.3	5.6	18.5	10.6	10.5
POLN		ENSG00000130997	"DNA polymerase nu"	Q7Z5Q5	4	2071918-2242121	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 9.2;Spermatocytes: 17.6;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035939, HPA035940"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035939: AB_2674875, HPA035940: AB_2674876"	"unprognostic (8.52e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.83e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.02e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.49e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.82e-2)"	13.6	3.9	6.1	2.5	5.7	1.8	5.2	11.1	5.5	2.8	2.9	3.5	2.9	2.7	4.0	5.8	2.6	3.6	3.3	2.8	4.4	2.9	3.6	3.4	3.0	2.7	4.3	4.0	2.8	3.1	2.4	7.6	2.3	3.8	4.6	1.8	1.7	4.7	3.5	2.7	2.7	2.4	3.3	5.6	3.5	2.9	12.3	5.2	8.5	2.4	0.9	2.6	2.5	2.6	0.2	0.1	2.4	0.0	0.0	0.9	0.1	0.3	2.7	0.5	2.0	5.7	2.2	0.0	2.0	1.0	1.1	1.6	0.1	0.2	1.2	0.6	1.7	1.0	0.4	2.2	0.8	1.6	0.3	2.9	0.1	2.0	0.0	0.7	0.2	2.6	3.1	0.8	1.7	1.4	2.6	0.6	0.5	0.2	2.3	3.1	0.3	0.2	0.2	0.2	0.1	0.6	0.0	3.8	0.9	0.8	0.5	2.5	0.0	0.2	0.0	0.2	1.0	0.1	0.7	0.3	0.1	1.9	1.1	0.6	0.6	0.7	0.0	0.6	1.9	1.1	0.0	0.0	2.4	0.2	0.0	0.9	0.2	0.2	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.1	6.1	5.7	11.1	5.5	4.4	2.9	4.3	4.0	3.8	5.2	0.0	0.0	0.0	1.0	0.8	3.2	1.6	2.5	1.4	2.3	0.0	0.0	0.2	3.3	0.4	6.8	0.8	0.0	0.0	0.9	0.2	1.7	1.1	0.0	0.6	0.5	3.2	4.6	4.9	1.0	9.2	4.0	1.4	0.0	0.0	0.0	2.6	0.4	0.0	3.5	0.5	3.6	0.0	1.3	17.6	10.0	1.4	0.0	0.7	0.2	1.3
POLR1A	"DKFZP586M0122, FLJ21915, RPA1, RPO1-4"	ENSG00000068654	"RNA polymerase I subunit A"	O95602	2	86020216-86106155	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription	"Nucleotidyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010145, HPA031513, HPA049700"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Intermediate filaments"		No	No			"Nucleoli fibrillar center"	"Nucleoplasm, Intermediate filaments"	"CAB010145: AB_675814, HPA031513: AB_2673916, HPA049700: AB_2680856"	"unprognostic (1.22e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (3.70e-9)"	"unprognostic (1.06e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (4.31e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (7.20e-2)"	14.3	12.9	10.1	12.4	16.5	9.7	10.3	12.2	20.3	11.1	11.0	17.4	8.3	9.4	19.5	7.4	13.5	12.3	11.7	12.7	9.0	9.2	11.5	15.1	9.4	9.6	9.0	9.4	12.6	14.3	18.2	15.9	11.4	13.8	10.7	11.8	13.9	11.2	12.5	22.5	12.3	8.6	16.0	8.0	11.2	10.4	14.9	10.9	14.0	10.3	11.4	14.2	10.9	9.6	2.6	2.6	1.8	2.5	2.0	3.8	1.2	9.4	21.6	9.6	18.5	9.5	7.6	14.0	8.7	5.8	12.6	7.8	27.0	7.5	21.7	9.3	8.9	12.2	11.0	24.7	12.9	11.2	9.0	12.8	18.7	9.2	18.1	6.7	17.7	10.1	5.8	8.1	18.6	14.5	4.8	9.7	10.1	24.7	5.5	8.6	8.4	13.1	7.5	17.5	12.7	14.3	15.8	21.1	10.2	5.6	15.5	15.0	7.8	9.6	12.8	6.9	6.9	7.5	6.2	15.4	15.3	12.1	13.0	17.5	7.8	7.5	19.0	7.9	15.3	13.4	1.8	1.5	0.2	3.0	2.5	3.8	2.0	1.5	2.5	1.8	2.6	1.4	1.8	0.7	2.0	1.9	2.6	0.7	1.2	10.1	16.5	12.2	20.3	9.0	9.2	9.0	9.4	13.8	10.9	3.0	7.8	6.1	2.9	3.8	11.5	7.8	15.3	6.7	3.4	8.7	15.7	5.7	3.3	5.9	2.4	5.7	4.2	0.0	4.0	4.4	3.8	4.3	5.8	7.2	10.2	11.1	9.2	4.9	2.8	1.5	5.8	3.1	5.0	1.8	6.1	2.9	5.0	0.0	4.9	3.0	10.1	0.0	4.7	4.2	7.5	2.4	3.2	4.4	9.0	3.7
POLR2I	"hRPB14.5, RPB9"	ENSG00000105258	"RNA polymerase II subunit I"	P36954	19	36113710-36115346	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 926.9;Late spermatids: 1719.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035632, HPA045156"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035632: AB_2674711, HPA045156: AB_10964748"	"unprognostic (1.95e-2)"	"unprognostic (7.88e-3)"	"unprognostic (3.54e-1)"	"unprognostic (7.41e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.86e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	9.6	10.7	27.4	6.1	26.7	10.7	14.3	17.5	29.3	15.1	12.4	24.5	9.8	12.4	9.2	10.7	11.5	18.2	10.4	21.6	25.8	23.7	10.7	19.8	8.6	10.1	29.0	17.1	14.0	25.9	9.7	14.0	8.3	16.2	10.9	6.6	7.4	18.4	18.5	30.3	14.8	7.1	9.4	37.8	10.3	11.4	26.8	16.6	9.7	11.4	15.9	9.3	8.3	7.9	13.5	22.0	6.9	10.2	9.2	13.7	10.3	7.4	23.6	4.0	4.1	2.9	2.4	8.9	6.7	3.6	9.5	5.4	14.6	5.4	15.9	13.9	2.4	3.5	4.9	6.6	9.7	2.0	14.5	24.7	18.2	6.9	11.1	6.8	15.3	7.8	3.6	5.4	5.4	5.6	2.8	4.2	8.9	11.4	7.1	3.0	21.2	8.0	16.4	9.2	22.7	20.4	14.6	5.9	10.4	7.6	4.5	25.8	14.7	7.8	14.0	4.0	3.0	6.7	5.1	4.1	6.4	11.0	4.2	9.0	6.7	13.0	11.2	8.7	9.9	6.8	6.9	10.2	5.9	9.0	7.2	11.8	13.5	11.2	12.3	13.2	13.3	13.7	12.7	0.6	9.2	8.7	22.0	10.7	10.3	27.4	26.7	17.5	29.1	25.8	23.7	29.0	17.1	16.2	16.6	77.4	63.0	61.4	82.8	70.2	62.0	215.0	145.2	326.6	109.2	155.3	23.6	129.0	298.4	131.5	926.9	106.7	149.5	140.2	208.3	142.1	97.5	103.1	80.8	234.2	108.6	31.8	101.9	92.7	71.3	1719.1	128.9	73.2	160.3	125.4	134.4	86.3	165.9	201.5	144.9	353.5	48.4	109.9	114.1	313.9	161.1	95.2	86.8	65.0	140.6	77.0
POLR3C	"RPC3, RPC62"	ENSG00000186141	"RNA polymerase III subunit C"	Q9BUI4	1	145824088-145842505	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	15	"Early spermatids: 260.3;Late spermatids: 416.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027508, HPA027516"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027508: AB_10600091, HPA027516: AB_10600894"	"unprognostic (1.43e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (6.87e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.41e-2)"	"unprognostic (4.46e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.34e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.38e-1)"	21.1	11.9	13.5	21.2	13.4	16.9	21.7	28.3	16.4	18.0	14.2	12.2	11.1	9.4	19.2	16.2	15.1	16.9	14.6	12.7	12.1	9.9	15.7	15.3	13.3	25.4	14.7	15.8	21.9	23.1	16.7	10.9	13.9	12.6	15.7	15.9	11.9	16.9	13.0	18.3	20.3	14.9	17.5	11.0	20.5	14.9	29.3	15.0	26.5	15.9	11.4	21.3	17.5	15.8	21.1	23.6	29.5	23.9	20.6	20.7	15.9	16.1	13.4	11.2	9.2	14.7	18.0	11.9	15.3	18.8	21.8	20.9	19.3	8.7	27.9	15.5	20.9	11.9	16.0	18.1	16.3	22.7	11.4	14.2	14.9	15.7	11.5	26.6	30.6	19.3	17.1	12.0	24.4	43.5	12.5	13.5	13.4	18.7	16.5	23.0	22.4	15.8	13.9	16.0	16.9	18.0	14.9	14.0	18.3	14.2	11.6	10.4	15.7	13.7	20.2	20.7	18.5	15.5	28.6	14.1	19.2	15.3	10.4	21.3	25.8	25.0	32.4	7.0	15.9	14.8	29.5	20.9	21.1	15.9	23.9	20.7	20.1	17.6	16.4	22.0	21.1	18.0	16.4	1.7	20.6	17.3	23.6	14.9	15.9	13.5	13.4	28.3	16.4	12.1	9.9	14.7	15.8	12.6	15.0	6.0	9.6	9.0	6.7	4.4	3.1	15.7	5.1	8.1	10.3	3.5	3.9	9.9	10.0	9.4	260.3	6.8	4.7	23.3	18.5	10.2	9.0	4.8	8.1	4.5	12.4	1.6	4.1	7.4	9.7	416.7	9.5	9.1	1.7	11.8	6.5	3.6	14.3	7.0	13.8	10.2	3.7	19.4	11.3	18.9	17.0	3.8	8.0	8.7	7.3	8.1
POLR3D	"BN51T, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245104-22254600	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061331: AB_2684480, HPA067875: AB_2685912, HPA068461: AB_2685993, HPA069089: AB_2686081"	"unprognostic (2.33e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.38e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.02e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (9.15e-6)"	"unprognostic (1.15e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.93e-2)"	"prognostic unfavorable (2.12e-4)"	14.7	12.9	10.3	14.0	13.6	9.8	18.4	8.8	15.7	13.9	11.9	13.9	8.2	9.3	14.3	9.3	16.5	11.9	13.9	16.6	10.0	8.3	11.7	11.2	12.7	13.4	16.5	13.7	18.1	20.8	10.5	16.3	20.2	13.2	14.5	11.9	9.7	14.5	11.2	34.4	11.9	9.6	17.5	13.5	13.2	12.2	29.4	12.0	8.0	12.6	10.8	13.1	14.7	15.9	9.1	13.6	1.6	5.7	11.2	10.7	5.3	6.7	20.2	11.0	12.4	10.8	15.8	11.9	18.2	11.3	15.6	13.4	14.3	5.7	22.2	15.5	11.5	16.6	11.8	25.2	8.4	12.6	7.3	9.5	19.4	10.2	19.4	17.2	6.0	15.3	13.1	17.1	19.7	23.0	16.8	13.1	16.4	25.6	14.6	12.7	10.1	22.1	12.8	27.8	15.0	11.5	17.4	14.7	17.0	7.4	6.0	12.7	23.4	7.3	8.4	25.3	14.8	6.5	8.5	14.3	15.3	14.3	18.9	17.9	16.8	15.5	13.7	10.2	11.2	20.1	0.1	5.6	1.6	8.5	5.6	10.4	8.3	9.1	10.3	7.4	9.1	10.7	9.4	0.2	11.2	5.7	13.6	5.9	5.3	10.3	13.6	8.8	15.7	10.0	8.3	16.5	13.7	13.2	12.0	8.9	6.2	12.3	29.1	17.3	11.2	10.2	2.5	12.0	11.4	10.4	15.7	13.5	10.0	17.8	33.8	11.9	5.9	0.0	10.2	25.8	15.8	23.9	18.4	4.9	12.5	3.2	20.6	12.9	8.4	31.7	14.7	7.7	8.5	14.4	13.3	4.3	19.8	5.8	12.0	10.6	11.4	19.4	15.5	36.2	50.0	16.8	22.5	12.9	11.2	32.9
POLR3E	"FLJ10509, RPC5, SIN"	ENSG00000058600	"RNA polymerase III subunit E"	Q9NVU0	16	22297375-22335103	"Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041419, HPA041477"	Approved		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA041419: AB_2677468, HPA041477: AB_10796345"	"unprognostic (3.09e-2)"	"unprognostic (8.59e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.42e-2)"	"unprognostic (7.73e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (1.74e-4)"	"unprognostic (8.14e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.96e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.41e-2)"	10.8	15.8	8.9	10.4	11.1	9.8	15.5	11.7	12.9	11.7	10.7	12.0	13.0	9.7	12.4	9.3	13.1	11.1	8.5	13.9	10.9	7.0	9.5	14.0	9.5	12.7	11.1	9.8	11.0	21.2	15.7	15.8	8.9	10.7	12.7	6.6	11.8	15.0	15.2	50.7	12.7	8.9	9.2	10.0	9.5	12.4	9.6	10.7	10.4	12.3	9.1	14.0	11.4	10.4	5.9	5.7	1.9	3.8	5.3	7.2	4.8	6.6	9.3	2.7	6.7	5.3	4.0	9.2	5.4	2.8	3.6	2.5	11.7	4.7	13.8	7.1	3.8	2.5	6.4	13.3	7.5	2.9	9.1	19.0	7.0	10.1	22.3	6.5	10.9	7.8	3.9	8.3	7.7	9.4	1.7	9.1	5.8	19.9	5.6	4.1	10.8	10.9	4.5	13.7	7.4	7.9	14.3	6.0	17.7	3.7	4.0	9.9	7.4	5.1	9.5	5.2	2.3	5.5	6.3	5.7	3.6	4.1	3.1	5.9	7.6	13.5	12.7	4.1	8.4	6.7	0.0	3.3	1.9	6.5	3.8	7.2	5.9	7.2	6.8	5.7	5.1	7.0	5.8	0.3	5.3	3.1	3.3	7.2	4.8	8.9	11.1	11.7	12.9	10.9	7.0	11.1	9.8	10.7	10.7	3.0	14.3	16.6	20.1	28.8	22.8	16.2	7.6	16.0	11.4	17.4	29.5	19.3	5.0	10.9	31.0	13.1	10.9	0.0	11.0	16.4	14.4	22.7	27.6	11.1	11.5	19.1	14.5	5.5	12.3	13.9	11.5	9.4	13.5	7.2	16.4	10.6	13.0	11.5	8.5	9.1	38.3	12.9	16.5	18.4	16.2	34.6	23.7	19.2	15.0	23.8
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	17.1	12.6	15.7	35.3	8.5	7.0	13.1	12.3	10.5	12.3	10.7	22.2	10.9	23.7	4.0	10.6	13.7	13.2	15.6	11.9	13.8	20.5	31.1	17.7	12.6	14.7	8.7	36.6	22.6	9.2	8.5	16.3	15.0	8.0	9.1	13.8	48.4	17.8	12.0	13.2	21.8	23.3	16.5	9.6	15.3	20.0	12.3	20.0	6.2	15.1	22.5	19.8	10.8	20.8	11.0	11.0	17.3	19.3	12.8	22.1	13.6	17.4	24.6	21.4	19.8	34.4	12.9	23.5	21.8	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5	35.7	28.2	12.7	8.8	22.3	31.1	4.4	25.5	17.4	20.5	17.4	92.3	14.5	5.0	10.8	6.8	14.2	16.9	23.3	14.7	10.9	16.5	15.7	16.1	20.3	13.8	38.1	17.2	17.8	15.8	4.2	13.8	18.3	18.6	7.2	19.6	18.3	17.2	10.5	16.6	5.4	23.8	12.9	15.9	14.2	11.8	27.0	16.2	18.1	19.0	18.4
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell type enhanced"	"Detected in many"	13	"B-cells: 158.6;Bipolar cells: 50.4;Kupffer cells: 98.2;Macrophages: 80.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.5;Daudi: 39.0;hTEC/SVTERT24-B: 15.3;U-266/70: 27.1;U-266/84: 26.2;U-698: 30.9;U-87 MG: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404, HPA073998"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB002513: AB_442118, HPA049056: AB_2732550, HPA062096: AB_2684681, HPA064404: AB_2685259, HPA073998: "	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.2	2.8	18.5	1.8	3.6	0.1	0.5	39.0	1.0	1.0	0.3	0.3	0.2	3.0	8.3	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.8	0.8	0.6	15.3	1.0	0.1	1.1	0.8	0.4	9.0	0.4	0.3	0.1	2.0	0.1	0.0	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.3	0.2	0.0	4.9	1.5	7.9	0.8	0.0	0.3	27.1	26.2	30.9	15.0	1.0	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2	0.0	9.5	158.6	6.7	6.9	50.4	2.2	5.1	1.4	3.4	0.0	5.9	0.7	0.0	0.9	12.2	1.4	2.7	0.0	2.5	0.8	2.0	2.9	5.8	0.8	41.8	1.6	9.1	4.9	98.2	7.7	0.9	80.0	8.5	1.8	1.1	1.7	2.5	0.0	0.4	0.5	6.9	0.0	2.4	31.0	7.0	7.8	3.1	17.5	0.7	4.7
POU2F3	"Epoc-1, OCT11, PLA-1, Skn-1a"	ENSG00000137709	"POU class 2 homeobox 3"	Q9UKI9	11	120236640-120319944	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"ductus deferens: 36.5;seminal vesicle: 13.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 18.5;Pancreatic endocrine cells: 12.7;Suprabasal keratinocytes: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.2;EFO-21: 2.7;SK-BR-3: 5.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019652, HPA073468"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Nucleoli, Nuclear bodies, Plasma membrane, Cytosol"	"HPA019652: AB_1855585, HPA073468: "	"unprognostic (1.75e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.41e-4)"	"unprognostic (2.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (8.56e-3)"	"unprognostic (9.34e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.69e-3)"	"unprognostic (1.70e-1)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.45e-1)"	0.2	0.2	0.1	0.2	0.1	0.0	1.6	0.1	0.1	1.2	0.9	0.0	36.5	0.7	0.4	1.2	2.5	0.3	0.4	0.2	0.1	0.1	0.3	0.2	1.6	0.4	0.1	0.0	0.2	0.3	6.4	1.3	4.4	0.1	1.1	0.1	0.0	1.1	13.2	0.1	38.2	1.0	0.2	0.1	0.2	0.4	0.6	0.0	0.4	4.5	4.8	2.2	0.7	2.6	1.0	0.7	2.1	0.5	0.9	0.6	0.2	2.5	0.0	0.0	0.2	0.0	0.0	0.8	0.3	0.6	0.0	0.0	0.1	7.2	0.3	2.7	0.0	0.1	1.3	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.7	0.4	0.2	0.0	0.1	0.0	1.4	0.0	0.1	0.1	0.2	0.3	0.1	0.6	0.0	0.0	0.1	0.0	1.9	0.5	0.1	0.1	5.3	0.0	0.9	9.7	0.4	0.8	0.0	0.2	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.1	1.4	0.4	0.5	0.5	0.3	0.5	0.5	0.6	0.4	0.1	1.0	0.6	0.6	2.1	0.9	0.5	0.7	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	5.1	0.0	9.0	18.5	0.0	0.8	0.0	1.4	2.3	10.4	0.0	1.2	0.0	3.6	1.7	0.0	0.3	0.0	1.2	0.2	0.2	5.0	0.0	0.4	0.1	0.0	2.9	0.0	0.0	3.8	0.0	0.0	5.0	0.0	0.0	0.2	12.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	33.0	6.6	0.0	0.5	10.1
POU3F1	"OCT6, OTF6, SCIP"	ENSG00000185668	"POU class 3 homeobox 1"	Q03052	1	38044611-38046794	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.5;skin 1: 31.0"	"Cell type enhanced"	"Detected in some"	15	"Basal keratinocytes: 24.3;Cone photoreceptor cells: 21.6;Muller glia cells: 14.6;Rod photoreceptor cells: 19.3;Suprabasal keratinocytes: 48.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.1;HDLM-2: 19.2;NTERA-2: 5.3;SCLC-21H: 3.8;SK-MEL-30: 15.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 7.0;cerebral cortex: 3.5;hippocampal formation: 9.7"	"HPA055980, HPA073824"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055980: AB_2682995, HPA073824: AB_2686635"	"unprognostic (9.99e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.61e-4)"	"unprognostic (2.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.67e-3)"	0.8	2.1	4.0	0.9	10.5	0.7	0.8	1.2	6.8	0.6	0.7	1.1	0.0	0.6	0.7	0.8	3.4	0.7	0.7	0.7	7.7	0.9	0.7	0.6	0.6	1.7	3.9	2.9	0.7	0.8	0.6	0.0	0.6	1.4	3.6	0.6	1.6	0.6	0.7	1.3	31.0	0.7	2.5	0.6	0.7	0.7	1.5	2.6	0.0	0.7	1.3	1.7	1.5	0.4	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	11.1	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	19.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.1	0.0	0.0	0.1	0.0	0.7	3.8	0.0	0.0	0.0	15.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.0	10.5	1.2	6.8	7.7	0.9	3.9	2.9	1.4	2.6	0.0	0.0	0.0	1.7	24.3	7.4	4.3	0.0	0.0	0.0	0.0	21.6	0.1	0.0	0.0	0.2	0.7	0.4	0.0	0.0	0.1	0.9	0.8	0.0	0.0	0.2	1.6	1.7	0.0	0.0	0.0	0.3	0.0	6.8	0.0	0.6	14.6	0.0	0.0	0.0	0.0	19.3	0.0	2.0	0.2	1.7	48.8	0.1	0.0	0.4	2.1
POU3F3	"BRN1, OTF8"	ENSG00000198914	"POU class 3 homeobox 3"	P20264	2	104855511-104858574	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"brain: 18.9;epididymis: 27.2;kidney: 23.7;seminal vesicle: 12.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 55.8;Distal tubular cells: 23.2"	"Group enriched"	"Detected in some"	6	"glioma: 21.5;renal cancer: 24.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"AF22: 27.6;AN3-CA: 26.4;HEK 293: 10.2;RPTEC TERT1: 31.4;SH-SY5Y: 8.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052792, HPA056039, HPA067151"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052792: AB_2681951, HPA056039: AB_2683018, HPA067151: AB_2685790"	"unprognostic (3.05e-2)"		"unprognostic (1.07e-1)"	"prognostic unfavorable (4.26e-5)"	"unprognostic (9.66e-2)"	"unprognostic (1.97e-1)"			"unprognostic (4.69e-1)"	"unprognostic (1.16e-1)"			"unprognostic (7.28e-2)"	"unprognostic (1.15e-3)"	"unprognostic (7.15e-2)"			0.2	0.2	9.0	0.1	8.6	0.0	0.1	4.3	18.9	0.0	0.3			0.0	0.0	27.2	0.0	0.0	0.0	0.0	9.9	6.0	23.7	0.0	0.0	0.1	8.9		0.1	0.0	0.0	0.0	0.0		0.0	0.1		0.0	12.1	0.0	0.5	0.0	0.0	10.0	0.0	0.1	0.1			0.0		0.1	0.0	0.0	0.4	0.4	0.9	0.2	0.3	0.2	0.0	0.0	0.0	27.6	26.4	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	3.2	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.9	0.6	0.0	31.4	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.4	0.0	0.0											0.0	0.0	0.0	0.1	0.7	0.8	1.0	0.0	0.0	0.0	55.8	0.0	0.0	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.0	0.0	0.0	0.2	0.0	0.0	0.0	7.7	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PPARA	"hPPAR, NR1C1, PPAR"	ENSG00000186951	"Peroxisome proliferator activated receptor alpha"	Q07869	22	46150521-46243756	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Erythroid cells: 93.5;Hepatocytes: 134.7;Rod photoreceptor cells: 152.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 12.1;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.8;granulocytes: 12.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058901, HPA067049, CAB075701"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB075701: , HPA058901: AB_2683849, HPA067049: AB_2685770"	"unprognostic (1.96e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.94e-3)"	"unprognostic (4.30e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.94e-2)"	"unprognostic (2.95e-1)"	"unprognostic (5.52e-3)"	"unprognostic (4.50e-2)"	"unprognostic (1.01e-1)"	"prognostic favorable (4.39e-9)"	"unprognostic (4.84e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.18e-2)"	5.7	6.6	5.8	6.0	6.2	4.2	6.9	2.6	4.5	3.8	11.8	5.9	9.9	13.9	4.8	6.6	6.3	3.9	9.1	19.6	5.1	4.1	17.8	30.9	3.8	3.4	6.1	4.9	9.1	13.4	6.6	3.5	3.1	7.8	6.2	7.1	13.5	8.1	8.2	17.1	5.8	19.7	5.0	4.7	3.5	5.7	2.7	7.1	1.3	5.4	10.4	4.8	7.3	12.3	1.5	3.8	12.1	1.4	0.9	1.5	0.3	6.9	1.7	2.2	7.7	12.4	8.0	4.9	6.1	12.1	6.6	6.8	3.4	3.4	2.5	3.1	14.1	6.0	3.1	6.5	8.0	5.9	7.2	8.3	7.7	4.4	7.1	7.7	5.3	13.3	6.3	6.4	4.8	11.1	5.6	1.4	5.7	2.8	5.8	6.1	1.8	6.0	1.9	0.3	5.8	1.7	7.1	8.0	3.2	4.5	4.1	2.2	6.6	2.3	2.2	7.7	3.2	2.5	4.1	2.3	6.8	7.4	6.2	2.6	5.9	3.4	1.0	10.7	6.0	2.1	1.7	1.0	12.1	1.4	1.4	1.2	1.0	0.7	0.7	0.7	1.5	0.8	0.6	0.8	0.9	0.8	3.8	1.5	0.3	5.8	6.2	2.6	4.5	5.1	4.1	6.1	4.9	7.8	7.1	3.0	9.9	5.2	13.1	20.7	14.7	84.0	25.5	2.7	7.9	7.0	58.9	6.8	8.3	7.2	0.4	16.1	66.1	93.5	14.3	5.4	13.0	13.9	4.7	134.7	7.4	4.8	19.1	20.9	22.5	0.4	18.1	9.6	3.3	11.8	34.6	15.2	11.6	24.6	28.3	36.9	152.6	6.5	14.4	0.7	1.7	29.9	2.5	7.5	31.6	17.9
PPARG	"NR1C3, PPARG1, PPARG2, PPARgamma"	ENSG00000132170	"Peroxisome proliferator activated receptor gamma"	P37231	3	12287368-12434356	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Diabetes mellitus, Disease mutation, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 97.6;breast: 102.1"	"Cell type enhanced"	"Detected in many"	11	"Cytotrophoblasts: 90.9;Extravillous trophoblasts: 187.1;Urothelial cells: 210.8"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 33.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.8;intermediate monocyte: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 47.9;ASC TERT1: 27.3;BEWO: 56.5;CAPAN-2: 25.2;HSkMC: 28.1;RT4: 34.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB004282, HPA051239, HPA063663"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB004282: AB_628115, HPA051239: AB_2681400, HPA063663: AB_2685081"	"unprognostic (7.35e-3)"	"unprognostic (3.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.27e-3)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (9.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.77e-1)"	"prognostic favorable (1.59e-8)"	"unprognostic (1.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.68e-3)"	"prognostic favorable (5.52e-5)"	97.6	1.6	1.9	17.1	1.2	0.7	102.1	1.5	1.3	3.1	24.9	0.8	2.1	7.5	3.5	2.2	2.8	2.4	8.7	12.5	1.4	0.9	6.7	5.9	24.8	11.4	1.1	0.9	6.7	1.2	2.8	0.3	26.8	0.9	10.4	13.9	1.1	5.8	1.5	5.0	2.7	9.6	7.4	1.2	7.0	11.9	3.5	0.6	0.9	6.2	4.3	2.1	30.2	14.1	0.0	0.4	0.0	2.3	0.0	0.7	0.3	9.7	8.7	0.0	0.0	47.9	27.3	56.5	0.9	10.5	1.3	0.5	1.8	25.2	0.0	0.0	0.9	17.1	4.0	3.5	0.1	0.2	23.5	4.9	0.0	1.9	2.3	12.8	0.0	0.0	28.1	2.3	2.4	9.1	5.0	0.1	0.2	0.0	0.0	2.0	2.5	0.0	0.1	0.1	22.7	25.2	0.0	0.0	0.0	7.2	34.5	0.0	0.2	4.1	1.5	0.5	1.7	0.0	7.8	7.9	1.8	2.6	1.0	0.0	0.0	0.0	0.0	0.8	0.1	0.2	0.0	1.8	0.0	0.0	2.3	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.3	1.9	1.2	1.5	1.3	1.4	0.9	1.1	0.9	0.9	0.6	3.0	7.4	0.0	33.7	0.9	0.5	5.2	2.5	2.7	3.4	5.2	0.0	90.9	1.7	0.1	2.6	17.7	47.1	0.0	0.6	187.1	4.3	35.2	9.2	3.8	46.3	0.0	8.1	19.6	14.5	0.8	3.7	8.6	3.3	2.8	20.5	0.5	10.2	42.1	0.0	11.3	0.0	12.9	5.7	7.9	21.8	1.0	74.4	1.3	16.6	210.8
PPHLN1		ENSG00000134283	"Periphilin 1"	Q8NEY8	12	42238447-42459715	"Predicted intracellular proteins"	"Keratinization, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 85.8"					"Low region specificity"	"Detected in all"			"HPA038902, HPA038903"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA038902: AB_10674844, HPA038903: AB_2676263"	"unprognostic (4.06e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.28e-7)"	"unprognostic (2.85e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (5.06e-5)"	"unprognostic (3.16e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.04e-2)"	25.6	32.4	29.0	37.2	34.2	37.6	27.8	43.0	32.2	24.3	23.7	18.9	27.7	19.2	35.3	27.7	27.0	25.3	24.5	29.0	25.6	28.7	25.2	25.2	23.0	44.3	23.8	35.0	30.6	21.3	20.7	39.9	24.2	26.3	22.6	27.1	21.6	31.1	24.9	32.0	26.1	26.9	28.3	24.6	30.5	23.1	48.4	24.9	51.4	23.1	28.6	47.2	28.1	25.3	25.0	24.1	23.1	14.5	23.7	33.2	12.2	14.7	13.8	16.4	13.6	14.8	16.5	14.5	17.4	19.8	18.3	15.2	22.2	18.7	25.2	22.1	18.5	8.6	13.8	16.8	18.2	22.6	21.6	17.5	39.4	14.2	20.1	15.6	46.4	22.8	19.6	18.7	14.5	14.0	20.9	22.8	22.2	19.2	19.5	20.0	11.3	26.0	28.0	14.2	40.5	13.7	22.2	18.7	23.1	28.5	13.1	11.6	17.1	15.3	12.4	14.9	16.3	18.9	23.3	15.7	10.7	19.1	10.3	14.9	22.5	31.3	40.6	18.1	85.8	7.0	21.0	12.8	23.1	19.3	14.5	23.2	25.0	24.7	25.9	24.1	21.1	22.7	22.6	8.3	23.7	13.4	22.9	33.2	12.2	29.0	34.2	43.0	32.2	25.6	28.7	23.8	35.0	26.3	24.9	38.7	47.5	78.2	56.2	67.3	59.8	29.5	45.9	54.9	54.6	40.1	27.5	73.8	31.5	53.2	175.7	43.2	30.4	23.3	59.6	62.8	45.5	38.3	54.4	29.8	46.7	35.0	32.3	38.1	37.1	48.4	54.1	61.7	60.8	100.0	34.6	43.3	55.2	38.6	49.1	39.8	57.0	51.8	37.6	123.1	54.7	51.7	37.0	76.2	39.2	43.7
PPIL2	"CYC4, Cyp-60, UBOX7"	ENSG00000100023	"Peptidylprolyl isomerase like 2"	Q13356	22	21666009-21700015	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"K-562: 71.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035344, HPA055637"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035344: AB_10672863, HPA055637: AB_2682869"	"unprognostic (1.97e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.90e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.77e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.45e-3)"	"unprognostic (5.46e-2)"	"unprognostic (5.39e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.54e-3)"	15.0	21.5	19.4	20.9	24.6	16.6	13.5	24.1	30.9	17.7	17.4	25.3	19.1	18.6	21.8	17.0	22.3	15.7	16.5	20.0	17.2	17.1	21.2	20.3	14.6	23.7	15.6	20.9	16.6	31.4	23.6	30.2	31.4	19.0	19.5	17.6	23.6	22.0	16.5	25.5	17.5	19.1	15.2	15.0	21.3	19.5	18.4	17.6	32.8	27.0	13.6	33.5	17.4	16.2	8.7	11.7	4.8	17.3	12.8	13.2	9.1	6.6	6.9	8.1	8.5	8.3	7.1	7.3	8.7	6.2	10.7	9.2	7.0	4.4	11.5	5.3	9.7	5.4	9.8	10.8	7.5	6.4	7.1	11.1	10.7	6.9	8.3	6.0	16.9	10.1	7.7	6.8	7.6	5.8	6.5	9.2	7.3	71.2	8.3	7.6	10.4	7.6	4.6	7.8	12.4	4.3	9.8	12.0	2.3	5.4	6.7	12.7	6.9	7.9	12.7	2.9	5.0	9.1	5.7	11.1	6.7	11.0	7.9	5.5	9.6	7.0	8.7	7.6	6.4	8.1	1.0	8.6	4.7	9.5	13.9	11.4	7.0	11.1	12.0	11.7	8.7	9.8	8.9	4.8	12.8	17.3	11.1	13.2	9.1	19.4	24.6	24.1	30.9	17.2	17.1	15.6	20.9	19.0	17.6	8.9	25.6	20.6	7.3	2.9	22.7	4.0	30.6	6.7	17.0	14.0	31.4	13.2	11.6	10.6	57.9	5.4	16.9	0.0	14.6	12.4	5.7	12.9	16.2	16.6	13.2	17.5	10.9	11.1	24.4	67.5	11.2	14.4	1.7	10.0	20.5	12.3	15.0	17.3	12.7	7.0	29.8	0.0	4.4	18.6	16.3	5.0	18.5	15.9	18.4	10.3
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504733-149546038	"Enzymes, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	20.0	20.1	20.6	15.0	35.5	30.6	21.2	35.1	27.8	24.0	15.3	19.7	10.1	14.1	21.1	27.2	15.7	18.0	19.8	18.3	21.3	15.6	18.8	23.0	17.9	15.7	20.9	18.0	32.9	16.0	20.8	36.6	22.6	23.9	20.5	16.8	15.7	18.2	16.7	14.8	15.4	16.0	20.0	22.7	17.6	16.0	15.9	19.4	27.0	26.8	8.2	16.8	22.0	19.2	21.4	16.6	24.9	17.8	28.7	24.6	14.8	11.1	6.0	21.0	17.3	12.5	16.4	19.6	22.0	21.0	24.1	25.7	12.6	11.4	11.8	15.2	16.9	14.4	10.1	16.0	8.4	38.3	17.1	15.1	13.0	13.2	21.6	19.7	23.6	11.1	12.8	14.4	24.6	20.6	13.5	13.1	8.6	28.3	7.1	18.7	11.9	13.4	20.3	16.6	11.2	9.5	18.2	19.4	5.9	18.3	8.5	12.4	9.5	26.2	11.5	15.0	15.2	13.5	17.2	15.3	16.0	12.5	28.3	20.9	9.4	4.8	18.5	13.5	19.0	23.0	24.9	16.1	18.1	14.7	17.8	20.4	21.4	19.5	16.9	16.6	16.6	24.6	18.7	13.4	28.7	16.1	16.2	20.7	14.8	20.6	35.5	35.1	27.8	21.3	15.6	20.9	18.0	23.9	19.4	62.5	64.3	22.6	54.3	43.4	44.2	33.3	17.8	80.3	61.4	43.6	7.9	43.1	36.5	34.7	17.2	37.3	15.2	0.0	23.1	37.9	55.5	27.1	73.0	18.7	31.8	27.0	22.3	30.7	21.3	9.6	57.2	29.9	38.8	47.7	19.7	40.0	26.4	22.9	52.6	27.5	35.5	51.8	68.4	58.2	53.4	39.5	54.6	41.5	20.0	32.7
PPM1G	"PP2CG, PP2Cgamma"	ENSG00000115241	"Protein phosphatase, Mg2+/Mn2+ dependent 1G"	O15355	2	27381194-27409687	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 93.3"	"Cell type enhanced"	"Detected in all"	17	"Early spermatids: 1236.5;Late spermatids: 2467.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035530, HPA035531"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035530: AB_10670021, HPA035531: AB_10610283"	"unprognostic (7.50e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (3.14e-7)"	"unprognostic (9.36e-3)"	"unprognostic (7.73e-2)"	"prognostic favorable (6.08e-5)"	"unprognostic (3.74e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.78e-1)"	"unprognostic (7.83e-2)"	12.7	17.0	9.9	19.9	9.2	19.4	30.2	10.9	19.3	17.9	14.6	9.1	16.9	12.1	26.8	12.5	19.4	19.2	17.7	13.6	8.8	7.6	12.6	18.6	14.7	20.2	9.4	8.0	13.4	18.6	13.8	13.2	11.4	8.7	10.2	16.4	9.1	16.4	18.7	24.1	10.9	12.2	14.9	6.7	14.7	14.1	93.3	8.4	25.8	14.1	19.1	22.5	25.2	17.3	20.2	40.3	24.5	29.1	22.7	38.3	19.0	50.9	42.1	30.9	23.7	19.7	16.1	28.5	31.8	20.9	38.2	30.7	64.8	27.0	60.2	23.4	22.5	32.5	27.9	51.9	35.7	34.4	25.1	42.2	58.6	30.7	68.4	17.8	57.8	24.8	17.4	20.7	38.9	31.4	18.2	36.5	29.9	49.0	18.7	28.9	45.6	42.9	62.8	44.9	35.4	30.4	44.4	64.8	31.6	25.8	35.6	41.6	47.1	28.5	31.6	22.8	25.6	17.5	19.0	29.3	28.6	34.6	25.0	48.2	40.8	45.7	95.2	22.4	47.4	21.4	22.1	17.8	24.5	26.9	22.3	26.5	20.2	28.7	27.9	28.5	18.0	21.7	22.4	9.1	22.7	29.1	40.3	38.3	19.0	9.9	9.2	10.9	19.3	8.8	7.6	9.4	8.0	8.7	8.4	59.6	43.5	61.1	65.0	72.0	42.0	33.6	50.9	61.6	66.0	66.3	27.5	71.4	28.2	97.8	1236.5	66.3	54.6	23.3	120.2	139.9	42.7	66.0	58.8	37.8	76.1	46.1	77.4	35.6	49.4	2467.5	65.0	65.1	23.6	147.9	59.6	64.9	122.3	42.1	66.8	48.3	34.6	45.3	45.8	594.3	323.3	70.4	44.4	79.7	83.2	121.2
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600400-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	11.5	19.1	10.8	19.6	12.6	5.2	17.4	18.8	16.2	20.4	13.0	24.2	17.0	12.6	14.7	13.0	14.7	15.2	16.4	9.7	15.9	10.3	14.0	20.4	14.6	14.1	14.5	12.4	16.0	21.6	28.8	17.9	10.1	10.4	14.9	15.5	19.6	12.8	21.0	14.1	12.8	13.0	15.4	14.1	17.4	15.6	21.6	11.8	33.5	16.6	12.5	17.0	14.7	13.2	4.8	6.1	6.2	5.4	1.8	5.7	3.5	5.4	6.8	8.7	7.1	7.9	5.4	4.6	5.4	7.0	7.9	6.6	7.3	3.4	5.3	4.0	4.6	7.1	8.5	10.2	10.1	6.0	5.8	5.5	6.6	5.9	3.5	8.1	5.8	6.5	6.4	5.9	6.9	14.4	6.2	7.1	10.5	6.1	6.7	6.9	6.8	7.3	4.9	4.4	4.7	4.8	7.7	9.0	10.3	7.9	6.8	12.1	5.3	7.1	6.8	6.1	7.1	6.8	7.1	4.4	6.1	5.3	6.7	4.4	12.4	6.7	5.8	5.7	6.7	5.3	6.2	5.1	5.6	5.3	4.5	5.7	4.8	3.7	4.3	5.6	4.0	3.5	3.9	6.2	1.8	5.4	6.1	3.9	3.5	10.8	12.6	18.8	16.2	15.9	10.3	14.5	12.4	10.4	11.8	29.8	32.3	50.6	46.1	62.0	63.4	50.4	25.5	45.5	28.4	26.2	123.7	37.8	29.9	22.0	27.0	59.5	73.1	0.0	20.0	22.1	35.9	41.1	42.8	30.7	28.6	33.4	68.5	38.6	27.8	7.7	42.8	51.6	35.4	33.3	69.9	54.1	26.0	52.6	28.3	33.7	94.6	32.3	49.7	44.2	23.8	68.1	74.0	50.1	58.1	29.5
PPP1R13L	"IASPP, RAI"	ENSG00000104881	"Protein phosphatase 1 regulatory subunit 13 like"	Q8WUF5	19	45379634-45406349	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 78.3"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 77.1;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 35.6;hTCEpi: 52.2;hTERT-HME1: 36.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB005016, HPA041231, HPA059883"	Approved		Enhanced	Cytosol		NA	Yes			Cytosol		"CAB005016: AB_2168576, HPA041231: AB_2677376, HPA059883: AB_2684151"	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.74e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.31e-3)"	"prognostic unfavorable (3.39e-5)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (5.40e-4)"	"unprognostic (2.52e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.55e-3)"	"unprognostic (1.34e-1)"	"unprognostic (7.69e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	6.7	6.6	2.5	3.6	4.1	0.6	14.5	3.5	3.4	13.2	6.2	2.4	8.5	2.9	5.8	8.2	51.6	3.6	4.7	37.2	4.0	1.2	8.0	5.7	8.5	1.6	3.9	2.5	4.4	12.4	6.6	6.6	38.7	3.9	11.5	3.8	5.1	17.8	15.7	3.8	78.3	7.1	3.8	3.3	2.5	4.4	1.6	6.1	2.7	10.6	24.4	25.6	13.2	22.9	0.6	0.7	0.0	1.5	0.0	2.3	0.2	21.2	3.0	1.2	1.0	1.3	0.8	18.5	3.8	0.6	4.8	6.7	6.0	19.8	2.5	1.7	3.0	9.9	28.4	1.0	35.6	4.4	6.5	1.5	0.3	9.8	2.2	2.8	0.2	0.9	1.1	52.2	7.6	36.2	21.7	8.9	2.1	2.1	0.9	0.3	17.4	0.4	0.4	1.4	9.7	5.0	1.9	1.5	0.4	6.2	25.5	0.6	2.2	19.7	18.9	0.4	8.5	16.5	0.5	13.6	6.1	18.7	0.4	18.7	10.6	10.9	1.6	0.9	0.7	1.5	0.0	0.0	0.0	1.5	0.4	0.7	0.6	2.3	0.4	0.2	0.2	0.1	0.7	0.0	0.0	1.5	0.7	1.3	0.2	2.5	4.1	3.5	3.4	4.0	1.2	3.9	2.5	3.9	6.1	32.8	8.8	0.5	77.1	61.0	2.0	34.3	20.4	8.1	22.7	19.2	9.8	69.5	5.0	28.4	0.5	11.2	15.4	0.0	13.4	33.0	6.1	31.1	4.6	2.1	6.7	0.0	6.9	8.0	2.6	0.2	5.5	2.7	11.8	1.8	6.2	2.2	35.6	14.0	11.7	2.7	25.6	6.5	10.4	2.9	1.9	62.0	107.4	0.7	7.1	62.2
PPP1R26	KIAA0649	ENSG00000196422	"Protein phosphatase 1 regulatory subunit 26"	Q5T8A7	9	135479079-135488893	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 17.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044686, HPA063817"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044686: AB_10795987, HPA063817: "	"unprognostic (1.79e-1)"	"unprognostic (8.80e-3)"	"prognostic unfavorable (3.98e-4)"	"prognostic favorable (9.91e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (9.23e-2)"	"prognostic favorable (6.20e-13)"	"unprognostic (4.46e-3)"	"unprognostic (8.31e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.07e-3)"	5.2	6.2	13.8	3.0	10.1	1.0	8.4	3.0	18.2	6.0	6.4	6.9	12.4	7.9	5.0	6.4	5.1	9.0	8.1	11.3	13.2	10.2	8.1	6.6	8.9	2.1	8.3	9.6	7.5	12.5	22.9	11.9	5.4	9.1	7.4	4.4	8.9	13.3	10.8	6.9	4.0	8.0	8.1	5.7	4.7	11.4	6.1	7.3	1.1	8.2	2.8	4.5	7.4	3.7	0.6	1.7	3.0	1.3	2.6	0.6	0.4	6.7	10.2	5.5	5.6	2.3	2.0	0.0	3.7	5.1	5.1	3.4	9.9	11.8	0.0	7.1	3.6	13.0	25.3	5.0	4.8	1.7	0.3	5.6	0.1	15.4	7.3	5.5	3.3	12.6	1.4	9.0	2.5	6.3	5.6	3.2	0.0	6.7	0.0	2.9	15.4	0.1	1.0	8.0	13.9	14.1	0.0	9.6	11.2	4.9	9.1	8.4	12.4	6.6	9.3	6.9	4.5	7.1	3.0	3.8	1.9	8.6	9.1	4.2	5.2	12.3	0.2	4.0	0.6	4.8	0.0	1.3	3.0	0.4	0.4	0.0	0.6	0.2	0.0	1.7	0.4	0.0	0.0	0.3	2.6	0.6	0.3	0.6	0.4	13.8	10.1	3.0	18.2	13.2	10.2	8.3	9.6	9.1	7.3	3.0	4.8	0.0	2.0	1.9	10.1	7.3	17.8	2.7	2.3	7.0	7.9	0.4	5.0	5.2	0.2	2.3	5.2	0.0	2.9	0.7	2.3	4.1	2.3	4.9	4.8	1.6	6.3	4.3	2.4	0.0	1.1	1.1	3.3	0.0	9.7	7.2	6.1	7.0	1.8	3.9	7.7	0.0	1.7	0.3	3.6	1.5	0.2	0.0	6.5	2.3
PPP1R8	"ard-1, ARD1, NIPP-1, NIPP1, PRO2047"	ENSG00000117751	"Protein phosphatase 1 regulatory subunit 8"	Q12972	1	27830778-27851676	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Endonuclease, Hydrolase, Nuclease, Protein phosphatase inhibitor, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027406, HPA027417, HPA027452"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"HPA027406: AB_1854488, HPA027417: AB_1854489, HPA027452: AB_1854490"	"unprognostic (5.61e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.42e-3)"	"unprognostic (3.76e-2)"	"unprognostic (2.00e-2)"	"unprognostic (9.09e-3)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (4.82e-2)"	"unprognostic (2.14e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.16e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.26e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.58e-2)"	18.0	14.5	28.6	15.5	37.0	23.2	19.4	23.1	29.7	18.9	16.0	18.2	12.0	13.3	24.0	15.6	19.6	19.4	14.6	16.2	23.4	17.7	13.9	14.8	17.6	28.6	24.6	25.7	24.6	18.5	14.2	18.9	17.4	24.4	15.3	18.0	11.7	15.1	19.5	17.8	17.8	15.1	21.8	24.6	16.9	14.3	21.4	25.6	20.7	17.9	9.4	24.6	18.6	16.0	11.9	9.7	17.0	11.4	14.0	16.5	14.9	21.1	15.0	32.7	21.2	20.6	21.6	18.8	22.8	24.0	39.1	31.7	16.8	24.4	30.3	16.1	25.9	15.2	19.1	38.4	21.3	28.4	25.4	23.4	39.5	20.4	24.7	20.8	36.3	28.1	18.8	23.3	35.4	31.7	17.6	23.1	26.0	33.4	20.7	23.2	13.8	39.6	21.4	40.4	18.7	17.5	32.5	27.1	28.8	21.0	19.5	22.9	20.9	28.0	21.9	27.0	17.5	19.2	22.9	19.0	19.3	17.6	30.2	21.1	19.2	29.3	38.3	18.8	47.4	24.6	17.0	10.0	9.1	14.0	10.0	16.5	11.6	11.6	15.8	9.7	11.9	12.8	12.1	5.9	14.0	11.4	7.3	11.4	14.9	28.6	37.0	23.1	29.7	23.4	17.7	24.6	25.7	24.4	25.6	14.9	7.7	28.1	17.4	15.3	22.6	11.5	7.6	18.7	20.5	5.2	2.0	41.6	26.6	24.8	26.4	14.6	12.6	0.0	22.4	34.1	19.0	13.0	25.4	15.8	23.1	7.9	11.1	20.3	14.3	18.7	22.2	16.9	10.1	40.5	14.5	19.8	24.7	16.1	15.9	19.9	13.9	25.8	16.4	27.9	40.2	12.3	36.7	24.5	15.3	17.4
PPP3CA	"CALN, CALNA, CNA1, PPP2B"	ENSG00000138814	"Protein phosphatase 3 catalytic subunit alpha"	Q08209	4	101023409-101348278	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Calmodulin-binding, Hydrolase, Protein phosphatase"	"Craniosynostosis, Disease mutation, Dwarfism, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.8"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	7	"prostate cancer: 98.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA012778, CAB018581"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		35000	Nucleoplasm	Cytosol	"CAB018581: AB_2168324, HPA012778: AB_1855660"	"unprognostic (6.66e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.87e-2)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (3.38e-2)"	"unprognostic (2.51e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-2)"	"unprognostic (5.74e-2)"	12.2	9.2	22.7	7.4	71.8	7.7	10.6	42.1	52.4	9.4	9.5	4.8	9.8	5.8	6.2	6.9	7.4	7.2	6.8	4.3	36.0	13.5	5.8	8.4	10.0	6.7	10.1	22.1	9.6	4.7	7.0	4.2	6.6	11.9	34.6	8.4	2.6	10.4	21.1	23.7	11.4	6.4	7.9	7.5	6.9	11.0	5.3	13.0	3.8	6.8	6.8	8.9	8.4	6.8	27.7	18.3	44.3	14.9	22.3	15.5	6.6	19.4	13.8	3.8	7.5	21.6	16.4	7.4	21.5	19.8	8.7	9.2	8.0	24.4	9.3	9.0	19.4	10.8	9.8	13.9	28.6	14.8	22.7	6.4	14.7	19.8	10.2	15.9	23.6	7.5	17.0	15.0	19.0	21.8	16.6	16.3	6.0	5.7	25.6	13.9	23.4	4.9	17.7	6.4	22.5	9.0	9.0	35.0	10.7	8.4	15.4	30.4	11.5	17.7	15.2	10.3	5.5	13.6	13.5	19.0	20.6	23.5	18.8	14.2	12.0	12.2	16.4	11.4	13.4	5.5	24.6	11.8	24.8	13.6	11.4	15.5	27.7	12.9	13.1	9.9	23.4	6.2	12.3	44.3	22.3	14.9	18.3	8.6	6.6	22.7	71.8	42.1	51.5	36.0	13.5	10.1	22.1	11.9	13.0	71.5	48.8	59.1	33.3	149.9	74.7	24.1	33.1	32.1	20.5	29.6	37.3	28.9	28.2	18.2	1.8	105.6	33.9	0.0	27.3	76.5	53.9	157.6	33.6	37.0	32.1	17.5	122.2	43.6	52.2	4.7	60.1	49.5	87.7	44.1	39.6	19.3	41.1	107.8	57.3	31.7	81.9	12.9	39.4	7.2	22.1	150.4	23.0	55.4	39.9	32.0
PPP4R2		ENSG00000163605	"Protein phosphatase 4 regulatory subunit 2"	Q9NY27	3	72996785-73069199	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034695, HPA039837, HPA073758"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA034695: AB_10671231, HPA039837: AB_2676707, HPA073758: AB_2686632"	"unprognostic (4.60e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.98e-3)"	"unprognostic (5.62e-2)"	"unprognostic (8.86e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.87e-2)"	"unprognostic (2.86e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.35e-1)"	16.7	19.6	18.3	17.2	25.9	57.7	17.7	18.0	23.4	19.7	17.5	15.7	10.7	16.1	18.0	13.2	15.9	18.7	15.6	24.5	18.6	14.2	15.8	34.0	17.6	15.8	30.8	14.8	24.0	15.1	21.0	20.2	28.5	20.5	14.3	16.2	13.4	16.1	12.0	27.2	12.1	18.1	15.9	20.8	17.1	14.0	17.0	25.8	28.4	17.1	9.8	16.5	14.4	18.8	7.1	14.3	17.7	4.7	8.5	13.6	3.2	12.6	14.8	31.7	19.3	17.0	15.0	19.2	25.3	17.9	23.1	24.2	21.6	15.2	23.7	14.8	15.2	22.0	9.0	24.6	14.1	30.0	36.1	9.2	26.9	16.7	25.5	18.6	39.0	28.1	16.1	21.0	27.8	22.8	16.1	16.4	24.5	23.7	27.4	19.0	18.3	32.4	17.4	29.1	18.8	12.3	30.5	17.9	22.0	19.4	33.8	7.6	18.9	29.5	19.5	23.4	24.1	17.8	22.2	17.9	20.8	25.0	23.8	21.5	17.1	35.0	46.9	14.6	30.2	23.2	5.4	4.7	10.7	10.6	2.6	11.7	5.5	10.9	10.9	4.0	7.1	9.6	8.7	17.7	8.5	4.1	14.3	13.6	3.2	18.3	25.9	18.0	23.4	18.6	14.2	30.8	14.8	20.5	25.8	53.6	23.0	41.6	103.2	104.1	49.6	47.9	48.4	57.6	52.4	26.2	13.7	62.2	16.6	53.0	36.6	47.4	48.4	46.7	46.6	59.6	54.0	103.0	29.0	63.5	37.8	47.7	51.6	33.2	36.2	6.8	49.5	45.3	54.0	37.9	52.8	50.0	57.3	56.9	45.6	38.3	34.0	38.8	45.8	101.1	66.9	95.4	115.7	31.6	45.2	114.6
PPP6R1	"KIAA1115, SAP190, SAPS1"	ENSG00000105063	"Protein phosphatase 6 regulatory subunit 1"	Q9UPN7	19	55229780-55258995	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 195.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043989, HPA063681"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA043989: AB_10987309, HPA063681: AB_2685087"	"unprognostic (1.15e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.82e-6)"	"unprognostic (2.22e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.65e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.20e-1)"	13.2	18.4	27.8	30.8	26.2	49.7	9.8	12.5	28.0	11.2	20.7	14.0	9.0	22.9	13.5	11.3	17.5	16.8	17.7	12.8	27.3	12.4	12.5	25.1	14.6	45.2	13.0	14.0	11.9	12.5	13.9	15.3	15.8	9.8	11.7	7.8	11.5	13.7	14.4	18.4	13.3	22.9	11.3	9.2	31.6	25.1	39.9	13.4	57.3	14.0	13.4	31.0	17.7	12.6	2.6	21.2	4.4	3.0	6.1	9.2	4.2	20.3	29.6	6.0	9.6	7.2	6.7	15.5	13.1	11.5	13.8	11.8	19.5	14.1	53.2	7.2	11.6	10.2	10.0	2.1	13.6	5.4	19.8	50.5	40.3	14.2	14.3	12.5	59.5	39.9	9.8	7.9	13.6	9.3	7.4	8.8	37.3	21.0	23.6	8.8	13.0	43.5	21.4	8.2	16.7	24.4	26.7	11.9	44.0	9.7	26.1	17.4	9.6	12.1	14.7	12.8	5.4	8.0	44.9	11.4	21.7	10.7	8.3	19.6	11.8	21.3	37.7	19.7	49.2	16.5	0.0	2.0	4.4	9.2	3.0	5.3	2.6	3.8	7.2	3.0	2.3	4.0	5.9	2.3	6.1	2.4	21.2	2.7	4.2	27.8	26.2	12.5	28.0	27.3	12.4	13.0	14.0	9.8	13.4	11.9	23.2	31.3	6.8	2.5	16.6	2.2	17.8	20.1	10.3	17.4	9.8	9.6	0.0	20.1	195.4	11.7	24.0	0.0	24.5	7.5	9.9	16.6	7.0	18.1	27.5	28.6	14.6	16.0	29.7	28.2	17.3	25.3	0.0	13.6	17.4	13.7	32.0	21.2	18.4	9.8	14.2	19.4	2.1	31.4	32.1	3.0	9.5	27.3	13.0	36.9
PPP6R3	"C11orf23, DKFZp781E17107, DKFZp781E2374, DKFZp781O2362, FLJ11058, FLJ43065, KIAA1558, MGC125711, MGC125712, PP6R3, SAP190, SAPL, SAPLa, SAPS3"	ENSG00000110075	"Protein phosphatase 6 regulatory subunit 3"	Q5H9R7	11	68460731-68615334	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017183, HPA038467, HPA038468"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB017183: , HPA038467: AB_2676029, HPA038468: AB_2676030"	"unprognostic (9.46e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.20e-3)"	"unprognostic (3.29e-1)"	"prognostic unfavorable (8.23e-4)"	"unprognostic (1.54e-2)"	"unprognostic (6.43e-2)"	33.0	29.8	16.7	25.7	24.1	36.5	26.8	35.7	25.8	33.2	29.6	27.9	24.9	21.5	43.8	24.3	29.9	26.6	24.6	27.5	17.3	16.5	28.8	28.2	27.9	26.8	25.0	18.5	36.4	23.8	49.0	48.1	40.0	23.7	28.3	27.5	28.2	28.2	29.2	46.4	25.8	31.5	35.5	24.3	31.1	27.7	28.2	24.0	45.5	39.2	34.8	31.8	34.3	26.9	14.8	15.0	16.9	16.7	11.7	17.7	7.1	24.4	29.0	30.1	21.0	16.1	16.4	23.3	21.5	20.9	25.0	23.0	50.3	24.9	28.2	21.2	20.0	26.4	23.2	33.0	24.3	33.2	27.3	13.9	32.6	29.5	16.9	15.4	30.9	29.2	16.2	16.4	25.7	27.9	14.1	22.8	22.7	27.5	21.1	17.8	32.8	31.0	23.9	15.0	48.5	17.2	29.2	41.0	27.4	16.7	35.6	17.0	20.3	30.5	24.2	44.3	26.2	35.9	16.6	22.6	24.7	23.4	26.2	18.2	16.7	23.2	37.1	17.9	13.7	26.2	14.6	11.5	14.4	14.7	15.2	14.0	14.1	15.6	14.4	7.4	14.8	17.7	16.1	16.9	11.7	16.7	15.0	15.0	7.1	16.7	24.1	35.7	25.8	17.3	16.5	25.0	18.5	23.7	24.0	41.7	36.5	27.5	21.7	29.5	48.6	33.5	28.1	24.1	38.7	26.2	53.0	16.9	13.3	13.4	59.6	29.4	28.0	23.3	14.3	14.1	23.1	34.0	26.6	21.2	15.0	25.4	29.2	29.4	18.4	17.8	28.7	25.2	20.3	10.8	26.5	31.9	19.2	28.3	29.7	13.5	49.0	19.4	28.1	27.7	29.7	31.0	27.5	26.6	23.4	35.3
PPRC1	"KIAA0595, MGC74642, PRC"	ENSG00000148840	"Peroxisome proliferator-activated receptor gamma, coactivator-related 1"	Q5VV67	10	102132994-102150331	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 39.4;Suprabasal keratinocytes: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038511, HPA057571"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038511: AB_10672521, HPA057571: AB_2683472"	"unprognostic (2.27e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.35e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.96e-2)"	"unprognostic (4.29e-3)"	"unprognostic (6.31e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.86e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (8.65e-2)"	"unprognostic (4.22e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.93e-2)"	18.9	12.0	10.0	20.2	12.3	18.1	14.2	13.1	12.2	13.4	15.6	9.5	9.7	9.1	17.4	10.1	18.4	16.2	14.2	14.4	9.3	6.1	10.3	18.0	18.9	14.2	15.0	7.8	25.4	35.6	13.5	13.1	15.3	10.4	14.2	9.8	10.0	12.6	9.7	32.8	19.6	11.3	17.0	9.7	14.7	14.8	11.5	11.4	13.2	12.2	15.9	19.3	14.2	15.4	4.0	4.6	0.3	2.4	7.6	4.6	2.2	13.3	20.0	12.3	24.6	11.0	11.3	15.8	12.0	16.2	17.3	14.4	22.4	15.4	29.2	10.1	18.0	10.9	25.2	25.0	23.8	15.3	11.9	19.5	27.7	14.3	21.5	14.8	21.8	12.1	15.0	21.4	20.2	38.5	11.5	10.7	12.0	20.6	17.3	13.6	22.9	17.4	30.5	21.1	12.7	11.9	24.4	17.5	12.4	14.8	13.3	8.5	12.4	10.2	11.4	14.3	12.4	18.4	11.5	11.7	13.8	17.5	14.0	26.9	14.5	10.2	26.3	15.6	27.4	6.9	0.0	2.1	0.3	3.6	2.4	4.6	3.1	2.8	4.4	4.6	4.0	3.3	4.1	0.1	7.6	2.3	1.9	1.7	2.2	10.0	12.3	13.1	12.2	9.3	6.1	15.0	7.8	10.4	11.4	26.8	10.4	12.2	29.1	39.4	4.5	7.4	5.1	2.7	12.5	5.2	3.9	6.7	1.7	7.4	0.7	10.5	3.3	0.0	8.3	10.5	11.3	19.5	10.4	7.3	7.7	1.6	8.1	8.6	3.5	1.8	5.8	8.5	8.5	2.8	9.1	2.0	10.6	5.8	6.0	2.2	3.4	6.5	17.6	6.4	11.8	38.0	4.2	5.3	8.1	30.1
PQBP1	"MRX2, MRX55, MRXS3, MRXS8, RENS1, SHS"	ENSG00000102103	"Polyglutamine binding protein 1"	O60828	X	48897912-48903143	"Disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"		"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001880	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA001880: AB_1079671"	"unprognostic (7.25e-2)"	"prognostic favorable (1.48e-4)"	"unprognostic (5.98e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.48e-2)"	"unprognostic (4.33e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.68e-7)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.70e-3)"	24.8	35.3	29.2	22.4	28.5	34.8	28.3	30.3	35.0	27.4	31.9	25.9	23.9	35.6	34.9	22.6	26.9	29.0	25.3	23.5	25.8	30.8	24.8	34.7	20.5	24.7	27.9	25.6	38.8	37.1	21.3	30.2	19.5	26.5	26.0	18.9	27.2	33.6	27.3	43.3	31.9	31.7	29.6	25.3	25.6	27.4	13.6	25.8	31.7	33.8	23.1	27.7	26.6	32.5	32.3	36.7	20.5	30.6	27.7	41.3	27.6	28.7	35.4	19.0	18.4	16.7	11.8	14.4	16.9	19.8	34.1	21.3	42.3	12.8	26.4	14.2	11.3	26.0	22.5	32.0	12.6	13.2	23.1	27.6	22.9	27.7	30.3	16.7	26.9	20.6	15.4	23.6	28.1	28.5	13.8	18.7	10.2	21.5	50.1	14.7	46.7	11.5	27.0	17.7	19.7	38.8	19.2	19.1	59.9	21.1	19.0	28.4	15.2	22.1	24.6	18.6	14.9	30.4	20.7	17.2	15.5	27.3	19.2	22.3	29.5	29.9	19.8	8.8	25.4	16.0	14.5	30.6	20.5	23.2	29.6	30.3	32.3	32.1	23.1	36.7	26.3	32.5	30.1	8.4	27.7	26.3	31.6	41.3	27.6	29.2	28.5	30.3	35.0	25.8	30.8	27.9	25.6	26.5	25.8	38.7	63.6	71.5	66.1	99.4	35.7	35.0	40.8	44.2	46.6	29.6	11.8	49.7	41.4	56.1	4.9	56.2	114.2	46.7	82.8	48.6	67.9	49.5	70.3	38.4	61.3	17.5	67.3	31.3	75.5	3.4	64.7	71.8	84.4	117.2	55.4	32.9	62.7	136.8	41.1	89.1	22.4	38.8	85.5	2.3	13.8	102.6	45.7	50.4	57.2	58.3
PRCC	RCCP1	ENSG00000143294	"Papillary renal cell carcinoma (translocation-associated)"	Q92733	1	156750610-156800817	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017151, HPA019463, HPA019481"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB017151: , HPA019463: AB_1855672, HPA019481: AB_1855673"	"unprognostic (6.12e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.68e-3)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (8.63e-4)"	"unprognostic (3.03e-1)"	"unprognostic (9.16e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (8.99e-15)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (1.02e-2)"	31.3	24.9	28.5	25.8	29.7	33.7	23.7	33.2	43.5	29.8	30.0	35.9	21.8	24.6	35.1	22.8	30.3	25.6	28.7	23.8	28.0	24.5	26.1	33.1	22.0	30.1	22.1	25.2	30.1	23.7	31.0	22.7	38.8	22.6	25.6	21.5	25.6	37.2	24.0	47.4	33.6	30.1	25.7	20.4	29.7	24.1	26.2	19.2	51.9	27.5	29.8	30.7	25.4	23.8	21.4	27.1	36.9	23.1	19.3	22.1	16.9	20.1	17.4	13.8	15.8	11.6	9.2	24.0	14.1	13.8	15.7	13.6	27.3	17.0	20.7	24.4	11.1	9.1	21.0	19.6	14.8	12.3	25.8	25.6	15.1	12.9	17.6	14.3	20.8	17.9	13.0	17.2	13.7	12.5	12.3	14.4	13.7	24.9	19.3	11.0	35.9	23.7	24.4	33.3	28.1	21.7	20.8	12.2	27.8	16.5	19.4	24.5	43.8	14.9	37.6	23.3	23.7	27.0	33.5	13.2	16.0	16.8	17.6	23.1	49.7	74.3	32.0	15.8	13.5	14.8	26.9	20.0	36.9	20.5	20.6	19.6	18.0	18.5	22.1	22.4	21.4	18.4	18.9	19.3	19.3	23.1	27.1	18.5	16.9	28.5	29.7	33.2	43.5	28.0	24.5	22.1	25.2	22.6	19.2	8.9	16.0	27.9	32.9	46.5	17.3	10.6	20.4	12.0	15.9	19.2	21.6	54.4	18.3	35.7	5.8	27.0	25.1	0.0	28.1	52.6	29.2	25.0	16.2	15.3	37.9	27.0	33.0	23.4	18.7	7.1	28.1	25.4	20.3	51.3	23.1	16.5	29.8	27.4	26.9	23.7	16.8	32.3	32.5	33.6	48.1	44.8	84.6	34.1	27.7	31.8
PRKCA	PKCA	ENSG00000154229	"Protein kinase C alpha"	P17252	17	66302636-66810743	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Apoptosis, Cell adhesion"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 77.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 53.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003844, HPA006563, HPA006564, CAB016290"	Enhanced	Approved	Enhanced	"Plasma membrane,Cytosol"		NA	NA		1900000	Cytosol	"Plasma membrane"	"CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625"	"unprognostic (3.06e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.53e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.43e-2)"	"unprognostic (6.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.35e-3)"	"unprognostic (8.77e-2)"	4.0	19.6	26.5	9.0	22.8	2.5	3.0	10.8	33.9	7.0	13.8	19.0	3.5	14.6	14.8	6.7	4.7	6.1	10.8	5.8	31.6	15.6	16.7	6.5	6.0	8.4	18.7	15.6	20.4	5.5	1.7	6.0	6.5	17.6	17.2	11.2	7.0	3.1	22.3	6.6	3.8	12.7	13.7	15.0	7.9	7.9	3.7	14.4	0.4	4.5	1.3	5.9	9.5	9.5	0.0	1.4	0.1	2.7	0.1	4.0	1.0	2.3	12.5	2.6	2.6	6.3	16.1	0.3	13.4	8.8	9.7	8.3	1.4	1.5	3.1	3.6	21.7	16.3	0.3	1.3	1.6	21.2	5.2	3.0	0.0	7.4	6.5	8.6	3.9	21.1	7.0	0.6	12.1	10.4	14.2	8.3	15.1	8.1	0.0	15.0	0.7	7.8	2.4	1.0	6.1	6.7	1.4	19.1	0.0	3.4	2.1	1.5	8.6	4.4	2.6	0.1	2.8	0.3	5.5	24.8	16.9	9.8	10.5	8.4	0.0	0.0	0.3	53.7	0.0	8.3	0.1	0.6	0.0	0.5	0.8	1.5	0.0	2.5	1.2	1.1	0.0	4.0	2.3	0.0	0.1	2.7	1.4	0.5	1.0	26.5	22.8	10.8	28.2	31.6	15.6	18.7	15.6	17.6	14.4	0.0	9.6	3.9	15.4	9.4	33.9	7.9	40.8	5.3	4.5	38.4	2.0	3.3	6.6	11.3	2.5	3.0	24.2	0.0	5.9	2.8	11.0	12.4	20.7	11.9	19.7	9.5	8.1	36.8	8.2	1.3	49.5	7.7	10.1	1.8	32.8	43.1	7.2	20.1	45.6	16.8	77.1	25.8	17.0	1.1	1.7	9.2	12.7	24.1	21.3	12.3
PRKCD		ENSG00000163932	"Protein kinase C delta"	Q05655	3	53156009-53192717	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 17.7;classical monocyte: 22.9;eosinophil: 17.0;intermediate monocyte: 22.2;myeloid DC: 17.6;neutrophil: 20.7;non-classical monocyte: 15.3;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in all"	7	"dendritic cells: 17.6;granulocytes: 20.7;monocytes: 22.9"	"Cell line enhanced"	"Detected in all"		"SK-BR-3: 64.7;THP-1: 46.1"	"Group enriched"	"Detected in many"	5	"basal ganglia: 124.2;thalamus: 366.1"	"Low region specificity"	"Detected in all"			"HPA001863, HPA001890, CAB010469, CAB013225"	Enhanced		Enhanced	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA		300000	Cytosol	"Endoplasmic reticulum, Golgi apparatus"	"CAB010469: AB_632229, CAB013225: , HPA001863: AB_1079627, HPA001890: AB_1079628"	"unprognostic (3.59e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.97e-2)"	"prognostic unfavorable (2.24e-4)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.95e-3)"	27.8	33.4	9.4	29.7	11.5	30.3	17.6	5.7	10.7	10.3	27.8	10.1	43.7	21.4	5.5	21.3	18.3	16.1	33.7	11.9	8.3	3.7	16.5	4.5	29.2	24.5	10.2	5.6	8.1	13.4	6.1	5.1	7.5	7.1	17.9	16.1	10.3	14.1	40.7	3.9	17.1	42.9	17.4	10.2	32.1	24.8	9.6	8.0	10.5	26.9	13.4	26.3	22.9	12.7	3.1	17.6	20.7	22.9	2.4	1.5	6.4	7.9	3.0	1.2	2.1	9.2	5.3	11.4	4.8	6.1	5.9	5.8	7.4	7.8	20.4	2.1	10.4	10.3	3.6	8.1	11.8	4.9	17.8	6.1	11.3	4.2	7.9	5.9	14.9	25.7	4.1	8.6	6.1	5.6	5.3	5.1	2.2	2.2	2.9	8.5	19.5	1.6	25.5	3.2	11.9	5.6	1.7	3.1	4.9	6.4	17.0	2.0	1.4	3.6	64.7	9.9	6.3	5.4	46.1	7.4	2.9	3.6	3.8	4.5	4.5	6.9	10.5	6.8	25.8	5.5	17.7	22.9	17.0	1.5	22.2	1.0	3.1	1.1	1.2	17.6	2.9	0.8	0.7	20.7	2.4	15.3	8.5	1.1	6.4	9.4	11.5	5.7	10.7	8.3	3.7	10.2	5.6	7.1	8.0	3.0	19.7	17.6	21.2	26.0	0.0	4.5	12.7	16.0	17.0	14.0	0.0	2.5	3.3	7.6	26.7	1.8	56.8	0.0	9.6	13.5	8.7	14.8	5.7	1.7	38.4	1.6	25.5	3.7	43.0	59.4	8.3	35.2	10.1	21.6	29.0	1.8	10.3	49.1	6.3	10.9	0.0	6.5	9.4	5.2	1.9	24.3	7.3	7.5	20.6	28.8
PRKCQ		ENSG00000065675	"Protein kinase C theta"	Q04759	10	6427143-6580301	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Immunity, Inflammatory response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 19.7;lymphoid tissue: 32.1;skeletal muscle: 63.4"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 2: 6.5;Distal tubular cells: 6.6;T-cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"gdT-cell: 12.7;MAIT T-cell: 9.8;memory CD4 T-cell: 13.5;memory CD8 T-cell: 13.2;naive CD4 T-cell: 10.7;naive CD8 T-cell: 10.0;NK-cell: 6.5;T-reg: 19.7"	"Group enriched"	"Detected in many"	11	"NK-cells: 6.5;T-cells: 19.7"	"Cell line enhanced"	"Detected in some"		"HEL: 29.8;JURKAT: 21.2;MOLT-4: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065279, HPA073098"			Enhanced	"Centriolar satellite"		NA	NA		200000	"Centriolar satellite"		"HPA065279: AB_2685453, HPA073098: AB_2686571"	"unprognostic (6.61e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.69e-3)"	"unprognostic (2.46e-1)"	"unprognostic (8.40e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.22e-1)"	"unprognostic (5.26e-2)"	"unprognostic (7.74e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (3.51e-2)"	0.9	0.7	3.6	9.4	4.3	3.1	0.8	0.9	5.2	1.3	1.1	7.4	0.1	1.2	1.8	5.4	1.6	2.6	1.3	0.5	4.4	4.0	4.6	0.9	3.3	6.6	4.0	2.2	1.1	7.7	0.3	1.0	0.4	2.7	1.4	1.3	5.4	2.8	1.0	63.4	0.6	2.5	0.8	3.6	3.4	1.4	0.9	4.5	32.1	9.1	7.5	6.8	1.9	0.8	0.0	0.1	1.1	0.2	6.5	19.7	5.2	0.0	2.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.2	1.8	0.2	0.0	0.0	0.0	0.0	1.8	3.1	0.0	0.0	2.0	29.8	0.0	0.2	0.3	1.4	0.3	0.1	1.9	0.1	0.1	0.0	0.2	21.2	6.5	0.0	0.0	0.0	22.3	4.2	3.1	0.2	0.0	4.3	0.7	0.0	6.3	1.5	0.2	1.1	0.0	0.0	0.0	1.9	0.0	3.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	1.1	0.1	0.1	12.7	0.2	9.8	0.0	13.5	13.2	0.1	0.0	10.7	10.0	0.8	6.5	0.0	0.0	19.7	5.2	3.6	4.3	0.9	5.2	4.4	4.0	4.0	2.2	2.7	4.5	3.0	6.5	0.0	0.1	0.0	1.6	0.3	0.0	1.4	1.2	1.8	0.0	0.0	6.6	0.2	1.8	0.0	0.0	0.0	0.7	0.1	0.3	0.0	1.1	0.0	0.4	0.0	1.7	1.3	1.5	4.5	0.0	0.5	0.0	0.0	0.3	1.5	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.9	2.0	0.0	0.0	25.4	0.3	0.1
PRKDC	"DNA-PKcs, DNAPK, DNPK1, HYRC, HYRC1, p350, XRCC7"	ENSG00000253729	"Protein kinase, DNA-activated, catalytic polypeptide"	P78527	8	47773108-47960183	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, Ribosome biogenesis"	"DNA-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005167, HPA035174"	Supported		Enhanced	Nucleoplasm		NA	NA		1100000	Nucleoplasm		"CAB005167: AB_2172845, HPA035174: AB_2674504"	"unprognostic (3.14e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.70e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.60e-2)"	"unprognostic (7.76e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.76e-3)"	"unprognostic (2.15e-2)"	21.3	20.5	16.0	22.3	22.0	27.4	30.2	16.5	23.1	19.6	20.6	17.3	18.1	12.0	26.2	14.5	27.4	24.4	13.0	21.1	20.8	15.2	16.7	18.4	17.0	33.6	16.6	18.2	24.6	23.8	33.4	29.4	20.5	17.3	17.9	20.3	17.8	17.9	17.8	34.0	23.9	18.4	27.0	20.3	24.4	19.1	20.5	15.9	44.4	20.8	15.9	27.9	21.3	19.1	17.0	13.9	7.1	11.5	11.5	11.3	2.3	32.9	28.2	27.5	26.1	17.1	18.2	11.6	14.0	13.8	19.8	19.5	18.4	10.9	31.5	12.2	17.2	14.7	18.8	36.3	19.2	31.0	6.9	22.5	61.8	25.4	22.5	7.4	23.5	12.9	13.1	6.3	31.1	32.7	7.6	20.3	21.9	41.1	13.3	21.8	15.5	33.1	19.4	30.2	23.1	8.6	16.2	21.6	11.1	9.9	28.4	13.8	17.5	43.3	14.1	13.6	17.7	20.2	16.2	23.5	25.9	22.0	20.4	28.1	11.6	14.8	45.3	14.6	26.7	20.9	6.7	8.1	3.5	8.7	6.3	10.9	12.6	10.8	8.8	5.9	17.0	11.3	10.3	7.1	11.5	11.5	13.9	7.4	2.3	16.0	22.0	16.5	23.1	20.8	15.2	16.6	18.2	17.3	15.9	35.7	26.0	39.5	30.4	34.1	100.6	65.8	25.5	52.2	39.8	40.1	117.8	48.3	14.9	34.6	26.1	40.5	10.5	0.0	30.9	53.5	37.0	37.2	43.9	39.8	32.1	98.5	24.8	33.7	41.6	10.8	52.6	32.7	18.6	29.7	26.8	69.1	30.3	14.0	65.4	18.7	102.0	51.8	28.8	106.0	117.5	35.5	27.6	38.3	45.0	27.8
PRMT7	"FLJ10640, KIAA1933"	ENSG00000132600	"Protein arginine methyltransferase 7"	Q9NVM4	16	68310974-68358563	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044241	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA044241: AB_2678869"	"unprognostic (9.33e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.31e-5)"	"unprognostic (2.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.74e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.31e-1)"	14.8	14.4	15.6	12.7	22.0	11.1	12.9	29.4	20.5	11.4	11.7	20.2	13.9	7.0	18.9	11.9	12.7	18.1	9.3	23.1	14.4	13.1	9.5	12.2	9.7	17.0	11.2	18.7	21.9	14.8	12.0	14.0	11.4	13.3	12.8	7.6	20.8	17.3	16.2	34.0	16.9	9.9	18.5	11.6	12.4	9.9	17.0	13.1	24.4	11.1	12.0	14.9	13.3	10.4	10.8	26.2	9.9	8.5	18.6	18.1	11.5	10.2	16.7	8.0	20.0	7.6	7.2	26.7	10.3	5.6	13.1	10.9	42.3	10.3	21.9	17.4	8.7	4.8	13.4	11.3	10.4	7.3	7.8	16.9	6.5	18.8	19.1	5.5	11.9	10.2	8.0	4.5	10.8	10.2	8.1	7.8	11.4	15.4	1.2	7.1	17.2	14.7	18.5	13.1	10.3	11.4	19.8	11.7	14.8	6.1	9.4	10.9	8.5	34.5	8.7	7.0	6.8	14.5	11.9	9.3	9.3	8.3	11.1	9.2	6.7	12.4	22.5	11.8	12.8	9.6	9.9	7.0	5.9	15.8	8.5	18.1	10.1	10.6	13.9	10.2	10.8	16.1	14.1	0.8	18.6	7.7	26.2	11.7	11.5	15.6	22.0	29.4	20.5	14.4	13.1	11.2	18.7	13.3	13.1	17.9	11.7	10.4	7.4	6.2	20.5	11.8	15.3	14.7	9.1	8.7	51.1	21.8	5.0	11.0	3.4	6.8	24.9	0.0	14.4	6.5	8.0	6.2	6.9	7.5	10.2	28.6	12.7	6.7	5.9	3.2	10.9	8.3	8.5	4.6	27.0	9.4	15.1	26.9	12.4	6.8	16.4	12.9	5.7	6.3	20.0	5.3	9.7	15.2	23.3	9.3
PROB1	C5orf65	ENSG00000228672	"Proline rich basic protein 1"	E7EW31	5	139390592-139395713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 37.7"	"Cell type enhanced"	"Detected in some"	26	"Cardiomyocytes: 25.4;Ito cells: 4.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.1;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 48.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA053354, HPA060103"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053354: , HPA060103: AB_2684205"	"unprognostic (4.14e-2)"	"prognostic favorable (9.26e-4)"	"unprognostic (2.60e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.53e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.40e-1)"	"unprognostic (8.28e-3)"	"unprognostic (3.21e-2)"	"unprognostic (4.84e-4)"	"unprognostic (7.10e-2)"	"unprognostic (1.75e-2)"	"unprognostic (9.05e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.89e-2)"	"unprognostic (8.24e-2)"	0.6	1.6	0.7	0.3	0.8	0.0	0.3	0.0	0.3	0.3	0.3			0.6	0.5	0.1	0.3	0.7	0.1	6.6	0.7	0.6	0.7	0.0	0.0	0.4	0.5		0.0	0.0	1.8	0.8	0.2		1.3	0.0		0.7	0.6	37.7	0.0	0.8	0.1	0.2	0.3	0.6	0.0			0.1		0.1	0.3	0.1	0.5	1.1	0.0	0.1	0.0	1.1	0.0	0.6	0.4	0.1	0.1	0.0	0.2	0.2	0.5	0.1	0.5	0.5	2.0	1.3	3.0	0.5	1.6	0.0	0.3	0.2	0.0	0.1	48.1	0.6	0.7	1.2	0.2	1.3	0.0	1.6	0.4	0.4	1.2	0.3	0.4	0.1	2.0	0.2	3.0	1.7	0.5	2.5	1.2	0.6	0.3	1.2	7.7	0.2	5.8	0.1	0.0	0.6	0.3	2.8	3.0	0.1	0.7	1.1	1.6	0.2	0.1	0.1	0.1	0.2	0.4	0.8	4.3	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	0.1	0.5	0.0	0.0	0.0	0.0	0.1	1.1	1.1	0.0											0.0	0.0	0.0	0.2	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	2.2	0.0	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.0	1.1	1.4	0.0	6.5	1.7	0.1	0.3	0.0	2.2	0.0	0.2	0.3
PROX1		ENSG00000117707	"Prospero homeobox 1"	Q92786	1	213983181-214041502	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 72.4"	"Cell type enhanced"	"Detected in many"	17	"Bipolar cells: 195.1;Hepatocytes: 270.2;Horizontal cells: 494.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 15.4"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"memory B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 16.0;RH-30: 8.5;SH-SY5Y: 41.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA000842, HPA001030, HPA027298"			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA000842: AB_2666112, HPA001030: AB_2666177, HPA027298: "	"unprognostic (3.07e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (3.42e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.29e-3)"	"unprognostic (6.64e-2)"	"unprognostic (4.56e-6)"	"unprognostic (7.24e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.71e-4)"	"unprognostic (1.05e-1)"	2.3	9.6	3.7	2.1	8.1	1.0	2.9	14.0	5.8	1.8	3.0	13.1	0.3	2.7	1.9	2.0	1.5	3.0	2.6	13.1	6.2	4.1	5.4	72.4	2.0	13.5	8.4	4.3	7.3	13.9	1.0	11.4	1.3	5.5	1.4	3.2	2.4	1.1	1.3	4.1	1.5	3.1	1.7	9.6	14.9	2.8	5.9	9.2	0.0	7.5	0.6	1.5	1.6	2.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	0.1	1.2	0.0	0.0	0.0	0.5	0.3	0.0	16.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	1.2	2.8	0.0	0.2	0.0	0.2	0.0	0.8	1.0	0.7	0.0	8.5	1.2	0.1	0.2	1.2	41.2	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	8.1	14.0	5.8	6.2	4.1	8.4	4.3	5.5	9.2	0.0	2.9	0.0	1.0	5.3	195.1	97.2	84.1	1.4	2.3	8.7	2.0	0.0	13.3	17.3	37.5	17.8	2.6	0.0	2.4	0.1	6.7	2.3	0.0	270.2	0.7	494.2	64.2	4.9	4.5	5.9	1.1	1.1	10.1	0.0	15.2	38.7	5.2	79.3	1.1	0.3	8.6	0.0	2.7	0.2	0.1	4.0	0.0	0.0	8.0	0.6
PRPF19	"hPSO4, NMP200, PRP19, PSO4, SNEV, UBOX4"	ENSG00000110107	"Pre-mRNA processing factor 19"	Q9UMS4	11	60890730-60906588	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, mRNA processing, mRNA splicing, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012448, HPA038051, HPA059070"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB012448: AB_2170868, HPA038051: AB_2675807, HPA059070: AB_2683896"	"unprognostic (5.73e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (4.11e-8)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.37e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.70e-2)"	"unprognostic (9.62e-2)"	"unprognostic (7.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (3.41e-3)"	20.5	32.2	33.6	27.0	37.9	32.0	28.9	49.6	61.8	30.4	30.6	21.3	24.5	24.2	27.1	21.4	36.7	34.9	20.1	18.0	32.8	46.3	21.5	39.4	18.0	33.1	35.0	50.0	41.3	31.3	45.7	37.6	24.9	46.2	37.7	31.5	21.5	28.8	30.9	31.9	39.0	24.6	28.8	23.7	28.3	23.7	15.2	24.4	46.3	25.3	24.4	41.7	24.8	24.8	3.1	5.3	4.4	11.8	2.4	3.3	1.2	43.7	34.2	38.4	27.4	22.6	19.8	34.9	23.8	32.4	47.9	36.0	37.5	33.0	63.4	32.1	22.8	28.7	40.1	54.0	42.9	37.3	43.2	34.5	52.7	27.1	40.3	32.7	69.6	37.6	21.0	32.7	36.8	41.5	14.0	37.1	38.9	52.3	36.7	23.4	61.6	70.3	52.4	67.9	34.5	46.1	62.5	39.3	49.6	24.2	28.7	32.8	39.5	29.5	49.1	39.7	18.3	51.3	38.6	23.2	21.2	34.2	36.9	38.4	32.8	45.9	63.8	26.4	47.8	31.9	4.4	11.8	2.6	3.2	5.4	2.6	1.3	2.6	2.3	4.8	3.1	3.3	3.0	0.7	2.4	2.9	5.3	2.2	1.2	33.6	37.9	49.6	61.8	32.8	46.3	35.0	50.0	46.2	24.4	17.9	21.3	32.2	30.9	37.4	31.5	14.9	17.8	18.7	26.1	26.2	9.8	75.0	23.2	33.3	15.9	20.3	20.2	23.3	44.7	70.4	22.6	29.5	22.0	40.0	40.5	58.8	37.5	16.5	27.1	2.7	34.2	21.5	25.3	47.7	32.9	24.1	30.9	24.6	36.4	22.4	22.1	45.3	22.3	18.4	35.8	36.4	34.0	23.8	47.8	26.8
PRPF3	"hPrp3, Prp3, RP18, SNRNP90"	ENSG00000117360	"Pre-mRNA processing factor 3"	O43395	1	150321476-150353195	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027226, HPA067116"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027226: AB_1855770, HPA067116: AB_2685783"	"unprognostic (2.75e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.59e-5)"	"unprognostic (7.89e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (3.19e-5)"	"unprognostic (6.77e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.78e-3)"	21.9	18.6	22.1	28.6	24.0	38.4	23.3	37.8	27.5	21.2	20.0	25.6	27.8	16.7	35.7	27.9	18.6	21.5	17.4	17.3	18.9	12.3	17.6	19.7	20.9	26.2	19.6	19.5	32.7	17.4	22.5	41.9	23.5	17.0	22.0	20.3	27.7	18.9	23.2	19.2	21.6	20.1	22.5	23.6	26.8	16.2	18.9	24.0	27.6	27.7	18.1	27.3	20.7	20.9	13.2	9.3	12.4	19.1	9.9	15.6	7.7	16.0	17.4	17.7	11.3	11.9	13.0	24.1	16.8	11.8	26.1	18.1	13.3	15.1	21.3	11.3	13.7	24.4	19.0	32.0	11.8	23.5	10.6	14.8	18.4	25.3	12.6	11.9	22.6	11.9	9.4	16.4	22.2	19.2	12.4	15.8	14.4	21.8	12.9	18.5	23.9	18.5	19.7	25.4	41.4	15.8	27.0	14.4	14.0	10.7	9.7	15.3	13.5	14.1	16.6	12.7	25.0	19.7	54.5	12.5	16.4	12.7	13.8	27.6	12.4	22.2	23.9	10.9	20.5	17.0	6.9	8.6	12.4	15.6	11.4	15.0	13.2	11.3	10.1	9.3	10.2	11.7	12.1	5.2	9.9	19.1	7.5	8.5	7.7	22.1	24.0	37.8	27.5	18.9	12.3	19.6	19.5	17.0	24.0	32.8	22.6	8.6	11.5	10.4	29.6	10.9	5.1	22.7	21.6	10.4	17.7	13.9	11.6	12.9	7.7	17.9	12.4	0.0	10.1	13.5	9.9	9.7	22.0	8.9	10.6	30.2	2.4	12.9	9.1	3.2	18.7	11.2	10.1	11.8	13.3	29.6	11.0	8.6	17.3	4.4	42.9	12.9	14.1	41.1	14.0	8.8	16.7	14.9	10.1	8.8
PRPF38A	"FLJ14936, Prp38"	ENSG00000134748	"Pre-mRNA processing factor 38A"	Q8NAV1	1	52404564-52420839	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053099, HPA058407"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053099: AB_2682044, HPA058407: AB_2683709"	"unprognostic (1.29e-1)"	"unprognostic (6.12e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.34e-2)"	"unprognostic (8.40e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (3.83e-5)"	"unprognostic (3.83e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.69e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (6.54e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.82e-1)"	13.5	13.2	21.5	16.9	19.2	25.4	20.6	30.5	18.5	17.3	17.2	20.7	12.9	12.9	22.1	16.0	15.0	18.0	11.3	11.5	19.1	16.8	15.4	12.1	15.1	22.1	20.3	14.0	28.1	12.6	19.2	19.9	15.9	16.6	17.6	19.1	17.2	13.4	15.1	10.0	17.4	16.2	14.5	19.3	17.8	12.9	18.8	22.1	36.4	19.3	13.7	22.1	14.1	20.1	9.1	9.7	12.5	8.8	13.3	15.3	6.6	8.3	4.1	14.7	7.0	5.9	5.8	8.8	5.7	3.9	9.5	9.2	7.5	4.2	17.3	6.0	3.9	7.4	6.2	20.9	6.2	12.4	9.4	16.0	23.2	15.4	7.7	7.2	25.8	8.6	4.4	5.6	10.4	10.1	7.2	8.0	12.6	21.3	4.5	5.6	4.7	19.9	15.5	18.1	8.9	9.7	19.6	22.3	14.5	8.4	5.0	9.8	12.0	11.6	9.6	11.2	10.4	6.7	21.0	6.2	5.4	8.1	8.0	11.2	8.7	12.4	17.5	8.0	22.6	6.8	12.5	7.5	10.5	9.8	8.8	13.3	9.1	11.0	11.8	9.7	8.5	15.3	11.6	6.0	13.3	8.6	5.4	10.7	6.6	21.5	19.2	30.5	18.5	19.1	16.8	20.3	14.0	16.6	22.1	38.7	27.2	33.7	76.8	47.2	31.2	23.5	15.3	17.4	30.7	15.7	88.4	53.1	29.9	28.6	65.9	47.2	52.0	23.3	25.7	65.9	30.1	36.9	57.8	15.5	35.1	23.8	34.3	22.7	35.1	11.0	23.9	30.8	28.7	23.4	38.6	45.7	21.8	45.6	31.5	26.9	42.6	51.8	41.1	111.6	55.6	48.9	86.5	62.3	47.3	64.1
PRPF4	"HPRP4, HPRP4P, PRP4, Prp4p, SNRNP60"	ENSG00000136875	"Pre-mRNA processing factor 4"	O43172	9	113275343-113292905	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021794, HPA022248"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA021794: AB_1855772, HPA022248: AB_1855773"	"unprognostic (1.70e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (9.35e-4)"	"unprognostic (1.95e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.00e-2)"	"unprognostic (6.76e-3)"	"unprognostic (2.18e-3)"	"unprognostic (4.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.57e-2)"	16.4	20.9	13.8	23.8	17.4	18.4	21.7	19.4	23.2	15.2	15.7	14.4	20.0	13.4	18.9	28.6	22.9	17.8	17.6	16.8	15.3	13.9	21.5	24.3	15.2	19.6	12.4	19.2	24.3	22.7	19.1	19.6	17.2	19.0	20.6	17.6	13.9	16.8	19.7	26.1	21.8	14.7	21.1	14.4	18.7	15.9	16.6	12.6	21.8	16.5	18.2	23.1	18.0	24.6	16.5	19.9	18.1	21.7	17.0	17.9	13.7	12.8	22.0	14.7	16.1	10.4	10.7	14.9	20.1	10.1	22.2	16.4	21.4	12.0	26.7	11.9	10.9	22.9	29.6	30.7	17.7	25.1	18.9	11.5	13.6	19.2	15.7	9.5	23.8	12.5	7.7	12.1	23.2	22.5	8.3	10.6	15.0	23.2	14.9	18.9	20.0	22.3	17.1	23.3	33.6	24.3	20.8	35.2	18.4	9.7	10.5	19.3	13.1	29.5	16.0	9.3	12.4	24.9	12.4	10.4	18.1	13.7	23.3	25.6	19.1	51.7	26.3	14.0	15.4	23.2	18.1	15.8	15.1	15.2	19.3	17.9	16.5	15.2	13.8	19.9	16.4	15.5	15.3	5.3	17.0	21.7	13.1	13.6	13.7	13.8	17.4	19.4	23.2	15.3	13.9	12.4	19.2	19.0	12.6	8.9	17.3	24.5	12.9	14.0	20.0	12.5	7.6	18.7	18.2	17.4	17.7	21.3	21.6	13.9	13.3	9.0	4.7	0.0	14.7	27.7	14.9	9.8	18.5	8.1	16.2	27.0	16.8	6.2	10.2	10.2	10.6	17.5	5.0	31.5	12.7	22.1	12.2	10.5	10.3	13.2	22.1	0.0	15.6	28.3	21.0	16.4	18.0	11.4	12.0	12.5
PRPF8	"hPrp8, Prp8, PRPC8, RP13, SNRNP220"	ENSG00000174231	"Pre-mRNA processing factor 8"	Q6P2Q9	17	1650629-1684882	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"	"Cancer-related genes, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 237.6;Rod photoreceptor cells: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009941, CAB015457"	Supported		Enhanced	Nucleoplasm		NA	NA		240000	Nucleoplasm		"CAB009941: AB_2171185, CAB015457: AB_831685"	"unprognostic (1.23e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.45e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.23e-1)"	30.0	37.4	23.1	25.7	40.3	39.0	26.2	43.1	57.2	31.2	28.0	36.5	29.5	19.4	35.6	28.4	29.4	35.4	28.1	34.0	22.2	24.3	23.3	35.5	27.9	30.7	21.3	23.9	47.7	25.9	66.5	45.4	31.1	32.5	30.7	27.2	45.1	30.5	33.1	46.3	30.7	27.5	36.3	17.9	34.1	26.4	45.9	19.6	63.4	30.9	22.2	41.2	32.2	27.9	14.5	20.1	10.0	12.3	10.1	17.1	5.4	18.7	41.0	24.7	20.0	21.4	16.8	19.9	14.1	18.0	27.6	22.4	38.0	9.3	27.6	15.0	25.3	21.4	26.2	60.2	24.2	31.9	17.4	38.7	21.9	35.6	32.5	12.5	25.9	24.4	15.9	15.5	35.6	24.9	14.3	24.2	19.6	21.6	22.0	19.8	20.5	18.7	32.4	17.0	16.2	15.2	36.7	14.1	13.2	10.6	20.9	12.7	19.1	28.4	10.3	13.9	21.6	15.2	17.4	22.3	16.9	14.5	25.7	32.1	8.0	8.3	19.5	14.0	18.8	20.8	10.0	6.5	6.7	15.7	8.9	17.1	13.3	14.7	15.7	9.7	14.5	13.0	16.4	7.1	10.1	12.3	20.1	14.8	5.4	23.1	40.3	43.1	57.2	22.2	24.3	21.3	23.9	32.5	19.6	56.6	70.5	44.4	25.5	26.8	124.9	33.1	56.0	34.8	56.9	45.4	237.6	37.8	6.6	32.2	9.5	43.6	40.3	23.3	35.2	22.6	31.1	25.8	50.8	34.2	34.2	68.3	35.1	36.8	40.3	8.9	67.9	32.5	18.6	38.7	37.2	56.5	35.5	37.6	49.1	15.8	234.7	71.1	36.0	74.1	83.3	24.3	33.1	38.7	42.3	27.4
PRR14	MGC3121	ENSG00000156858	"Proline rich 14"	Q9BWN1	16	30650717-30656440	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052022, HPA060265, HPA075914"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052022: AB_2681698, HPA060265: AB_2684236, HPA075914: "	"unprognostic (1.57e-1)"	"prognostic favorable (8.19e-5)"	"unprognostic (3.74e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.42e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.61e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.54e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.31e-3)"	17.7	13.8	15.1	18.2	14.1	24.4	16.1	27.4	17.2	19.5	18.8	19.2	16.4	19.3	21.7	11.1	18.1	17.2	16.7	10.1	14.5	9.1	16.5	15.1	15.8	18.9	16.4	7.8	18.2	19.6	18.6	15.3	13.9	10.6	17.8	9.8	14.8	22.1	22.6	13.6	24.5	18.4	15.6	13.6	23.4	23.2	9.3	13.7	31.2	17.7	10.0	19.3	16.4	19.6	8.8	5.8	18.1	8.2	6.1	8.4	4.5	8.7	10.9	9.2	7.1	8.1	5.6	6.2	9.3	5.3	9.2	8.3	5.0	7.3	15.1	8.0	5.6	4.6	8.9	7.1	10.3	2.7	21.4	20.8	8.7	11.2	9.9	11.5	7.2	20.9	5.3	11.0	6.0	5.5	9.8	11.3	4.0	11.3	9.9	4.8	21.8	16.3	12.5	2.9	5.1	5.8	12.3	4.2	20.7	5.3	3.7	7.0	16.5	3.6	12.7	8.2	1.9	15.5	4.1	8.2	7.9	8.8	7.3	9.3	23.2	14.7	9.0	5.3	15.8	6.9	8.6	4.9	17.8	8.4	4.8	6.4	6.3	6.9	8.4	4.6	8.8	6.4	6.5	18.1	6.1	8.2	5.8	8.2	4.5	15.1	14.1	27.4	17.2	14.5	9.1	16.4	7.8	10.6	13.7	8.9	7.2	15.2	22.4	20.3	13.4	5.0	25.5	6.7	5.7	12.2	13.7	12.9	13.3	19.0	5.3	18.6	21.3	0.0	19.2	12.8	16.3	19.2	11.5	9.0	16.1	1.6	12.1	19.6	12.7	1.8	17.8	17.0	8.5	37.9	14.8	12.0	18.0	14.0	19.8	11.8	12.8	19.4	20.8	17.0	22.6	20.1	11.8	24.9	16.6	14.9
PRRC2C	"BAT2D1, BAT2L2, KIAA1096, XTP2"	ENSG00000117523	"Proline rich coiled-coil 2C"	Q9Y520	1	171485551-171593511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025766, HPA028659"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA025766: AB_1845277, HPA028659: AB_10600786"	"unprognostic (4.16e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.66e-3)"	"unprognostic (8.71e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.19e-3)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (7.76e-6)"	"unprognostic (7.03e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.34e-2)"	33.1	21.2	32.9	40.1	35.7	61.2	32.6	44.3	37.0	35.1	26.0	19.8	41.4	21.2	32.9	38.8	37.3	28.5	26.3	23.5	27.4	25.4	25.5	30.2	35.2	39.8	33.8	30.2	37.3	29.6	47.2	43.7	35.9	30.6	28.7	32.4	18.2	31.4	53.9	24.5	38.5	33.2	32.9	36.7	37.3	27.6	27.3	36.9	45.3	29.5	30.3	41.1	35.3	33.8	4.8	4.4	7.5	2.9	5.8	3.0	1.0	26.6	20.7	29.0	19.1	20.6	24.0	21.5	15.4	22.0	18.1	16.6	31.6	19.1	39.3	24.3	22.5	14.7	23.9	31.4	24.5	28.0	22.1	16.7	29.9	16.0	22.0	21.4	48.3	24.4	23.1	18.9	30.6	45.8	16.4	26.3	21.6	39.3	21.8	20.5	12.7	28.8	20.5	38.3	21.4	36.0	21.8	21.6	19.2	25.6	29.9	18.8	19.3	23.4	28.0	17.8	40.1	19.0	34.0	32.7	20.6	19.0	19.9	31.9	18.3	19.5	57.8	13.1	23.9	18.4	3.4	2.9	1.5	2.9	2.7	3.0	3.7	2.8	2.8	1.2	4.8	2.6	3.0	7.5	5.8	2.8	4.4	2.1	1.0	32.9	35.7	44.3	37.0	27.4	25.4	33.8	30.2	30.6	36.9	276.9	218.4	153.4	214.3	148.4	154.9	94.9	127.4	184.7	273.0	82.0	131.6	168.2	21.6	138.0	25.6	177.6	134.0	46.7	131.7	178.0	148.4	210.4	252.2	99.5	112.3	130.3	158.3	113.5	118.5	20.7	128.9	166.9	91.1	219.2	79.1	116.7	164.6	91.2	90.5	36.1	164.3	77.6	114.7	173.0	161.2	127.5	398.8	179.9	89.0	320.3
PSAPL1		ENSG00000178597	"Prosaposin like 1 (gene/pseudogene)"	Q6NUJ1	4	7430294-7434973	"Predicted secreted proteins"	"Lipid metabolism, Sphingolipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"skin 1: 42.2;stomach 1: 23.9;testis: 19.9"	"Cell type enriched"	"Detected in single"	14	"Suprabasal keratinocytes: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 11.9;OE19: 23.0;RPMI-8226: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA038013, HPA038482"	Approved		Enhanced	Cytosol	"Secreted - unknown location"	NA	NA			Cytosol		"HPA038013: AB_10673652, HPA038482: AB_2676037"		"unprognostic (2.64e-2)"				"unprognostic (2.40e-1)"		"unprognostic (9.33e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.90e-3)"	"unprognostic (2.52e-1)"		"unprognostic (2.08e-2)"	"unprognostic (2.75e-1)"		"unprognostic (2.63e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	3.2	0.1	0.1	0.1	0.5	0.1	0.1	0.0	0.1	1.4	0.6	0.0	1.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	42.2	0.1	0.1	0.1	0.1	23.9	19.9	0.1	2.5	0.1	0.1	2.1	0.1	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0
PSAT1	PSA	ENSG00000135069	"Phosphoserine aminotransferase 1"	Q9Y617	9	78297143-78330093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Serine biosynthesis"	"Aminotransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 56.0;liver: 112.2"	"Cell type enhanced"	"Detected in many"	15	"Hepatocytes: 129.9;Proximal tubular cells: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 13.3"	"Lineage enriched"	"Detected in many"	4	"T-cells: 13.3"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 147.9;SK-MEL-30: 90.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB014882, CAB040567, HPA042924"	Enhanced		Enhanced	Cytosol		NA	NA		1700000	Cytosol		"CAB014882: , CAB040567: , HPA042924: AB_2678223"	"unprognostic (8.26e-3)"	"unprognostic (4.69e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (5.62e-5)"	"unprognostic (4.05e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.86e-1)"	"unprognostic (9.85e-2)"	"unprognostic (2.25e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (6.00e-7)"	"unprognostic (3.87e-3)"	"unprognostic (1.21e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.71e-1)"	3.1	25.0	44.6	3.8	33.4	1.7	3.0	8.5	50.5	2.4	3.3	44.8	0.9	3.2	2.7	28.4	9.3	16.0	1.6	1.4	33.9	22.3	56.0	112.2	1.6	4.5	42.2	24.6	3.7	54.6	4.8	2.1	2.2	21.9	5.3	3.3	8.1	26.2	2.8	1.1	24.7	2.8	2.3	29.8	2.4	7.0	5.1	35.0	2.2	13.7	4.9	5.9	4.2	2.6	3.0	0.2	0.2	0.1	0.0	13.3	3.1	26.7	18.0	15.2	26.9	4.5	5.3	35.9	22.7	16.2	11.6	21.7	4.6	5.2	17.4	10.1	51.1	10.5	26.6	25.9	25.1	17.4	17.0	9.2	5.9	8.3	35.4	41.6	33.1	10.7	16.9	147.9	15.3	41.1	2.8	10.5	68.0	6.3	44.8	9.6	10.0	11.3	5.3	34.8	50.3	19.7	5.6	9.8	20.4	15.8	6.2	6.9	16.0	6.3	10.9	90.5	10.0	5.2	41.8	2.4	2.9	9.5	10.8	18.4	30.5	28.1	0.1	34.2	26.2	13.9	0.0	0.0	0.0	4.9	0.0	5.7	3.0	4.8	6.5	0.2	1.0	7.9	7.3	0.2	0.0	0.1	0.0	13.3	3.1	44.6	33.4	8.5	24.9	33.9	22.3	42.2	24.6	21.9	35.0	0.0	0.0	16.4	6.8	37.3	0.8	0.5	0.0	2.7	0.0	10.4	0.0	25.8	53.0	14.1	1.3	2.1	0.7	46.7	41.7	10.5	2.4	14.9	0.0	129.9	4.4	4.8	3.5	3.7	3.2	1.7	4.6	1.8	18.6	6.4	2.0	22.2	28.4	0.0	1.8	244.0	1.3	0.0	1.0	1.4	2.8	44.4	7.8	4.4	3.0	11.2
PSIP1	"DFS70, LEDGF, p52, p75, PSIP2"	ENSG00000164985	"PC4 and SFRS1 interacting protein 1"	O75475	9	15464066-15511019	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 273.8;Spermatogonia: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 132.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013718, HPA019697"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013718: , HPA019697: AB_1852779"	"unprognostic (8.54e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-3)"	"unprognostic (5.10e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.98e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.99e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.39e-1)"	15.1	20.3	42.7	20.8	48.8	24.9	12.2	65.3	49.4	22.6	16.1	19.0	11.5	10.8	27.9	18.2	12.9	20.0	14.9	16.0	38.7	42.7	16.1	10.5	15.6	35.4	34.1	30.2	43.6	8.1	18.8	24.9	18.7	32.4	18.3	15.3	12.3	9.0	21.1	16.3	12.3	14.2	21.3	37.7	24.6	12.5	37.2	29.3	70.4	18.1	6.5	31.9	17.0	16.1	11.4	2.6	8.5	4.3	8.0	16.4	1.9	17.9	11.9	40.7	29.8	8.8	10.7	9.1	21.7	15.5	19.5	23.3	5.0	9.3	38.3	5.0	11.4	10.9	5.0	25.3	11.7	28.3	25.1	15.3	132.4	31.3	9.3	10.7	15.4	14.7	8.9	3.4	16.3	12.0	19.5	17.0	18.1	21.8	21.3	12.6	6.5	31.9	38.4	63.1	0.4	18.6	29.8	22.2	7.7	10.9	6.3	25.9	28.5	19.4	8.6	10.1	26.5	8.6	20.8	12.0	14.2	14.4	10.6	20.5	9.1	12.8	34.5	11.4	15.6	8.1	8.5	2.1	4.2	5.5	1.6	6.7	8.4	11.0	7.6	2.4	11.4	16.4	10.1	7.2	8.0	4.3	2.6	9.8	1.9	42.7	48.8	65.3	46.6	38.7	42.7	34.1	30.2	32.4	29.3	50.6	32.2	51.9	42.9	28.3	223.7	37.1	20.4	58.9	36.4	45.4	62.8	99.5	53.0	8.4	62.0	69.9	10.7	46.7	7.5	66.4	50.7	20.2	15.0	16.3	26.7	130.3	36.5	55.3	27.7	44.5	116.5	31.1	38.8	43.3	27.2	149.7	3.6	23.2	126.2	41.8	252.4	122.9	61.2	273.8	282.5	18.4	34.6	73.4	41.7	15.4
PSMA1	"HC2, MGC14542, MGC14575, MGC14751, MGC1667, MGC21459, MGC22853, MGC23915, NU, PROS30"	ENSG00000129084	"Proteasome subunit alpha 1"	P25786	11	14504874-14643635	"Enzymes, Predicted intracellular proteins"	Immunity	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB033765, HPA037646, HPA043891"	Supported		Enhanced	Nucleoplasm		NA	NA		27000000	Nucleoplasm		"CAB033765: AB_2253026, HPA037646: AB_10670386, HPA043891: AB_2678718"	"unprognostic (1.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.66e-3)"	"prognostic unfavorable (3.79e-5)"	"unprognostic (3.28e-3)"	"unprognostic (7.44e-2)"	"unprognostic (3.43e-3)"	"unprognostic (8.27e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (4.03e-11)"	"unprognostic (1.93e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.23e-2)"	46.6	46.3	33.7	36.0	40.2	45.7	39.0	28.3	42.7	33.4	35.5	23.1	37.4	37.3	42.1	43.1	43.7	33.0	32.2	55.4	31.7	34.1	47.8	61.0	38.8	42.3	32.0	32.4	34.0	35.6	28.2	39.4	55.2	36.9	35.6	42.4	32.9	34.9	37.1	86.6	35.3	42.7	39.0	26.7	45.8	37.3	31.6	25.9	53.0	45.5	62.8	42.2	41.5	31.7	24.2	55.4	20.9	42.3	30.5	35.7	45.2	67.4	47.7	40.0	47.9	39.9	40.2	33.4	39.9	52.5	60.9	50.1	41.3	85.2	59.0	44.2	42.1	55.8	50.9	45.6	49.5	57.7	57.3	67.7	36.8	31.7	48.7	52.4	61.0	48.1	38.9	29.5	33.0	69.2	44.5	59.5	47.6	69.0	49.8	54.1	44.7	55.5	45.9	33.4	57.6	71.2	37.6	59.3	36.7	52.9	47.9	33.0	20.8	42.5	47.7	35.6	43.1	28.4	37.3	47.0	39.9	37.5	69.8	48.7	21.8	58.3	52.8	59.0	48.6	50.9	20.9	42.3	11.0	24.3	31.1	32.3	24.2	28.3	27.2	55.4	20.6	25.7	25.0	9.4	30.5	29.4	31.3	35.7	45.2	33.7	40.2	28.3	42.7	31.7	34.1	32.0	32.4	36.9	25.9	77.4	91.8	78.9	188.2	127.0	44.8	0.0	73.9	65.6	95.5	83.7	17.7	398.7	217.2	193.4	40.4	121.2	89.1	70.0	203.0	301.8	137.7	149.4	72.1	111.7	261.1	54.0	38.6	87.8	164.2	23.5	107.9	156.0	136.7	273.3	81.1	94.3	195.2	111.4	119.9	182.7	40.0	84.1	135.9	126.7	65.4	132.7	524.5	142.0	111.1	217.3
PSMB2	HC7-I	ENSG00000126067	"Proteasome subunit beta 2"	P49721	1	35599544-35641844	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026322, HPA026324"	Approved		Enhanced	Nucleoplasm		NA	NA		15000000	Nucleoplasm		"HPA026322: AB_1855821, HPA026324: AB_1855822"	"unprognostic (3.54e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.63e-3)"	"unprognostic (6.93e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (3.49e-7)"	"unprognostic (2.81e-2)"	"unprognostic (5.23e-2)"	"unprognostic (3.34e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.80e-6)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	26.5	30.5	29.4	28.0	35.1	37.2	25.3	20.1	50.9	23.2	26.1	35.9	15.4	27.5	27.8	25.0	30.4	26.5	20.7	23.8	30.6	33.4	27.9	63.8	24.6	30.4	30.6	24.8	22.7	24.6	22.0	21.8	37.5	32.6	23.1	27.8	22.8	23.0	24.9	54.7	28.2	27.0	28.7	32.5	29.3	22.8	23.5	21.5	42.8	22.7	29.1	34.0	23.9	22.4	24.6	30.2	19.4	35.3	25.1	28.1	25.4	40.9	25.7	28.1	19.1	14.9	17.9	35.5	19.4	22.9	40.1	32.7	30.4	49.3	40.9	45.7	22.9	24.5	25.5	36.1	32.2	33.8	33.3	33.5	37.1	28.1	29.7	26.9	38.9	21.9	19.5	20.4	47.9	23.2	16.4	31.5	33.9	44.2	23.4	25.8	18.8	50.6	29.1	37.5	18.2	27.4	31.4	28.6	28.8	27.8	22.2	24.9	18.3	22.3	21.1	30.1	33.5	15.5	17.7	21.6	20.1	23.7	18.9	45.9	20.2	32.4	41.5	29.7	41.0	34.8	17.4	27.0	19.4	23.1	33.0	23.4	24.6	23.1	24.2	29.7	19.3	16.7	20.9	9.7	25.1	35.3	30.2	28.1	25.4	29.4	35.1	20.1	50.9	30.6	33.4	30.6	24.8	32.6	21.5	59.6	61.8	70.7	120.5	98.8	48.7	51.8	71.4	68.3	47.8	62.8	15.7	342.2	122.7	240.6	77.0	88.7	69.5	23.3	197.3	290.1	75.1	97.6	33.6	136.0	195.7	55.6	94.4	84.7	99.4	12.8	93.2	93.1	72.6	231.8	76.2	58.8	222.8	74.6	85.9	183.0	36.4	90.5	72.1	168.5	124.8	97.5	369.7	82.8	96.1	159.8
PSMB7		ENSG00000136930	"Proteasome subunit beta 7"	Q99436	9	124353466-124415444	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Hydrolase, Protease, Threonine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052408, HPA054902"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	No		2700000	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA052408: AB_2681820, HPA054902: AB_2682635"	"unprognostic (7.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.64e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-3)"	"unprognostic (3.98e-2)"	36.9	56.9	51.0	32.8	55.1	53.4	41.9	33.7	52.7	26.6	33.3	34.0	27.9	32.5	33.6	52.1	41.9	32.6	29.2	59.6	44.5	41.3	53.7	87.1	27.0	33.6	43.6	46.9	32.7	67.1	38.5	24.1	53.2	47.3	28.8	37.1	31.1	48.2	26.9	76.7	48.7	32.2	31.4	39.9	28.6	33.1	50.3	36.5	48.2	32.7	67.7	39.5	32.3	30.8	53.4	67.9	45.2	62.7	53.6	66.2	69.0	52.6	64.4	44.1	53.3	31.2	37.2	63.6	51.3	70.8	74.4	51.4	84.6	51.6	60.1	41.5	48.0	73.5	75.4	54.9	54.3	68.4	57.8	47.4	37.7	102.4	70.2	70.5	74.7	37.6	44.5	48.0	77.5	77.7	57.5	62.4	54.6	76.8	42.8	57.4	91.7	53.5	50.2	65.2	80.2	92.2	47.4	65.8	70.2	52.6	34.5	52.1	42.3	48.8	62.5	76.0	45.2	72.1	32.9	49.4	48.2	38.9	61.4	76.8	46.5	130.1	60.7	80.6	46.1	67.6	40.4	61.7	45.2	41.8	62.7	45.0	53.4	48.1	46.1	67.9	47.5	46.3	44.9	27.3	53.6	58.4	57.8	66.2	69.0	51.0	55.1	33.7	52.7	44.5	41.3	43.6	46.9	47.3	36.5	71.5	73.0	111.6	140.8	172.4	37.7	121.6	112.1	101.7	62.6	66.3	21.6	382.0	280.2	281.6	279.3	121.5	147.6	46.7	340.4	299.5	140.7	127.9	102.7	222.4	205.6	31.8	135.5	87.8	123.1	322.3	128.9	128.4	189.0	172.3	121.7	86.0	308.8	129.0	117.8	341.8	43.4	84.1	126.0	246.2	184.2	191.3	408.7	106.6	146.6	177.4
PSMC1	"p56, S4"	ENSG00000100764	"Proteasome 26S subunit, ATPase 1"	P62191	14	90256495-90275429	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 178.0"	"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 478.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000872, HPA016885"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		46000	"Nucleoplasm, Cytosol"		"HPA000872: AB_1079705, HPA016885: "	"unprognostic (4.10e-1)"	"unprognostic (9.70e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (1.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.11e-2)"	23.7	21.6	28.2	16.7	26.6	26.9	24.6	17.1	39.1	18.4	21.0	11.8	14.3	12.7	23.7	27.9	23.4	18.0	13.7	34.5	37.8	19.1	22.8	29.7	17.9	16.2	19.8	29.3	16.1	20.4	21.8	15.9	25.3	37.2	19.0	23.0	12.1	18.9	22.8	178.0	22.9	17.2	23.2	31.3	19.3	20.0	42.1	15.6	14.4	18.0	29.2	25.4	23.3	17.2	21.4	37.7	57.0	38.1	28.7	36.4	37.8	32.4	30.9	35.5	37.0	31.2	28.7	37.4	31.5	44.2	69.7	52.6	28.5	36.7	27.7	48.2	38.1	32.0	33.8	43.4	36.8	81.7	33.1	19.0	21.7	20.7	24.4	27.0	32.9	29.1	25.7	29.2	45.3	33.4	29.2	41.9	30.9	30.6	16.7	47.8	61.7	24.4	42.9	31.3	42.0	38.3	29.4	46.0	22.6	39.2	33.9	37.4	25.0	25.7	67.0	26.3	30.8	42.1	29.1	31.7	26.9	24.0	28.8	45.5	29.0	45.7	41.1	38.9	30.0	40.9	30.9	37.6	57.0	26.6	34.1	26.2	21.4	27.5	27.2	37.7	20.7	25.3	24.8	41.7	28.7	38.1	26.4	36.4	37.8	28.2	26.6	17.1	39.1	37.8	19.1	19.8	29.3	37.2	15.6	95.3	66.7	41.0	73.5	57.8	47.2	33.6	99.3	137.9	116.0	52.4	49.1	265.6	101.2	136.5	478.8	81.7	77.7	46.7	171.7	144.5	72.1	66.8	95.8	167.6	133.3	74.7	54.8	77.3	91.6	350.7	70.8	81.8	64.1	188.4	56.4	79.4	161.0	64.3	77.1	126.3	54.1	84.1	75.2	77.1	45.5	43.8	392.6	74.6	66.8	81.4
PSMD3	"P58, Rpn3, S3, TSTA2"	ENSG00000108344	"Proteasome 26S subunit, non-ATPase 3"	O43242	17	39980797-39997960	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 141.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017038, HPA048972"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No		380000	Nucleoplasm	Cytosol	"CAB017038: , HPA048972: AB_2680579"	"unprognostic (3.44e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.87e-2)"	"unprognostic (8.36e-3)"	"unprognostic (5.75e-3)"	"unprognostic (7.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.89e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (4.47e-7)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.45e-2)"	25.1	27.7	20.0	25.0	26.1	22.0	21.3	30.0	40.3	22.5	28.1	22.4	16.8	23.2	26.8	21.2	27.7	22.7	23.7	36.1	20.6	21.4	23.8	54.4	20.8	22.3	19.2	23.7	24.0	23.6	28.1	20.8	33.8	24.5	23.2	25.4	21.4	22.5	21.9	93.2	33.2	23.5	24.7	17.6	26.9	21.1	19.9	17.5	35.7	24.3	39.2	26.3	20.7	21.2	15.6	24.3	14.4	17.0	13.1	17.7	12.0	32.7	40.9	22.5	32.3	18.4	11.9	26.8	24.2	25.2	43.7	34.0	33.8	28.3	39.5	61.0	25.9	29.3	51.5	39.9	31.6	29.6	39.7	44.5	22.8	21.0	33.4	16.7	30.7	25.6	15.8	27.0	46.2	20.3	14.7	24.6	27.7	46.5	24.7	20.2	23.9	47.5	21.1	31.2	21.3	24.3	35.0	31.3	37.0	21.8	22.2	29.7	22.5	23.1	141.9	19.9	28.6	31.9	26.6	21.9	18.9	33.5	27.9	43.2	26.9	34.1	44.0	29.0	23.2	30.5	6.6	16.8	14.4	15.1	17.0	15.1	14.4	14.6	17.7	24.3	15.6	13.7	16.5	5.5	13.1	14.3	16.7	12.6	12.0	20.0	26.1	30.0	40.3	20.6	21.4	19.2	23.7	24.5	17.5	41.7	37.3	61.7	49.4	41.4	70.1	17.3	15.3	16.0	29.6	15.7	19.6	147.2	39.7	91.3	204.0	32.3	72.1	23.3	91.5	109.0	44.2	48.0	24.3	44.4	86.1	57.2	25.3	27.0	23.7	35.1	58.1	39.1	62.4	73.1	44.9	81.4	81.7	58.8	50.9	43.1	47.4	25.8	47.6	47.1	57.9	39.0	227.2	36.2	61.2	47.1
PSMD4	"AF, AF-1, Rpn10, S5A"	ENSG00000159352	"Proteasome 26S subunit, non-ATPase 4"	P55036	1	151254703-151267479	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038807, HPA039252, CAB047300"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB047300: , HPA038807: AB_2676217, HPA039252: AB_10673418"	"unprognostic (3.83e-2)"	"unprognostic (7.89e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.61e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (6.66e-10)"	"unprognostic (9.80e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.03e-2)"	"unprognostic (3.91e-1)"	27.5	28.0	44.3	24.4	46.4	25.5	29.9	25.7	50.4	21.9	28.6	28.3	16.5	22.7	25.1	41.5	26.7	31.4	21.8	38.7	37.5	36.8	25.3	44.7	20.2	28.2	47.5	44.8	26.7	27.7	27.4	19.3	30.0	43.2	23.0	28.1	24.3	25.6	31.2	86.7	28.0	20.5	39.3	29.6	26.3	25.8	35.9	29.1	23.1	23.7	25.7	36.2	28.0	19.8	62.7	65.1	111.6	76.0	54.2	74.2	88.2	42.3	51.0	37.7	30.8	41.1	30.5	41.1	28.7	35.3	45.9	36.7	66.7	48.5	34.4	70.6	40.5	31.8	44.4	48.4	43.4	39.3	56.1	42.2	33.6	43.5	68.7	45.4	39.4	39.2	33.0	36.1	52.4	48.5	34.5	40.0	38.7	52.2	43.8	38.4	124.8	36.2	48.0	71.6	65.6	51.6	30.8	36.7	62.1	45.0	36.3	29.6	50.5	31.9	46.9	38.0	58.2	49.0	78.0	35.1	22.9	36.0	28.1	49.0	52.5	65.1	73.4	38.0	37.2	41.7	59.6	71.5	111.6	43.0	76.0	48.4	62.7	50.5	47.3	65.1	61.1	46.4	46.0	95.8	54.2	75.5	39.2	74.2	88.2	44.3	46.4	25.7	50.4	37.5	36.8	47.5	44.8	43.2	29.1	53.6	55.8	113.9	90.7	78.8	48.8	216.6	79.0	80.3	42.1	57.6	25.5	289.4	142.6	149.2	182.3	103.4	106.2	93.5	163.0	189.2	97.9	84.2	80.9	96.2	163.2	31.8	80.8	69.3	92.1	179.3	97.5	96.7	99.5	354.3	71.9	58.4	143.7	95.1	92.6	161.4	44.8	116.4	130.8	169.8	77.8	75.7	346.7	94.7	97.0	85.8
PSMD7	"MOV34, P40, Rpn8, S12"	ENSG00000103035	"Proteasome 26S subunit, non-ATPase 7"	P51665	16	74296775-74306288	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 498.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019379, HPA049824, HPA056069"	Enhanced		Enhanced	Nucleoplasm		NA	NA		340000	Nucleoplasm		"CAB019379: , HPA049824: AB_2680899, HPA056069: AB_2683025"	"unprognostic (4.75e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (6.95e-2)"	"unprognostic (7.62e-2)"	"prognostic unfavorable (6.64e-5)"	"prognostic unfavorable (7.71e-6)"	"unprognostic (1.97e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.91e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.06e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-2)"	26.5	30.3	23.6	20.8	32.8	45.7	21.7	21.7	34.4	17.7	26.6	22.4	17.0	19.8	24.3	26.1	31.5	16.9	17.6	59.0	22.0	21.7	25.0	47.8	20.3	23.5	24.9	22.9	17.1	18.8	23.2	17.4	44.1	36.1	30.3	28.3	16.7	22.8	27.1	88.8	30.6	22.3	26.4	25.1	27.1	21.8	20.3	22.4	30.7	18.2	34.4	28.4	34.6	22.3	50.3	71.0	64.7	60.8	44.6	56.5	58.1	27.2	45.4	33.7	17.2	24.4	25.3	42.6	38.4	32.4	47.3	43.9	60.1	38.0	37.4	42.7	31.1	20.9	35.4	26.9	34.8	42.3	22.1	29.6	28.9	35.3	45.8	32.2	46.7	49.3	23.2	35.1	42.6	42.8	21.1	41.4	23.7	42.7	16.6	30.1	67.6	26.8	44.2	36.6	27.9	22.8	38.8	21.8	49.7	25.0	41.2	21.5	24.3	37.3	14.0	22.0	26.9	29.7	32.2	37.5	28.4	23.8	30.9	28.7	35.6	45.7	109.0	38.7	34.2	29.3	45.6	58.4	64.7	49.8	60.8	48.5	50.3	49.7	52.0	71.0	36.1	48.7	49.9	34.8	44.6	60.2	59.6	56.5	58.1	23.6	32.8	21.7	34.4	22.0	21.7	24.9	22.9	36.1	22.4	62.5	54.4	81.1	136.0	92.7	50.9	45.6	63.7	85.6	83.0	43.6	7.9	286.0	68.0	118.6	92.9	69.2	93.5	70.0	165.2	180.6	80.2	157.1	101.6	127.1	167.8	54.0	82.1	71.8	72.2	15.2	52.3	110.5	94.5	141.5	71.9	64.7	136.6	87.7	61.5	80.1	48.3	90.5	77.3	113.4	94.9	113.0	498.5	82.8	82.9	180.5
PSME3	"Ki, PA28-gamma, PA28G, REG-GAMMA"	ENSG00000131467	"Proteasome activator subunit 3"	P61289	17	42824385-42843758	"Predicted intracellular proteins"	"Apoptosis, Cell cycle, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 225.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008388, HPA012510"	Supported		Enhanced	Nucleoplasm		NA	NA		260000	Nucleoplasm		"CAB008388: AB_592552, HPA012510: AB_1855752"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.30e-3)"	"prognostic unfavorable (5.41e-5)"	"unprognostic (6.02e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	29.8	32.4	31.7	27.8	37.6	28.2	25.9	22.7	52.7	25.3	28.6	25.3	16.7	26.3	28.4	18.8	44.9	24.8	22.1	32.1	24.8	25.9	47.9	48.5	24.8	32.5	28.7	28.3	27.1	31.0	38.1	21.3	31.3	34.9	23.9	32.0	26.8	29.2	27.5	49.7	32.3	30.1	28.9	21.0	32.8	30.5	32.7	20.4	34.5	29.7	20.4	39.5	31.1	24.8	26.2	38.0	50.4	43.3	32.4	32.3	38.4	39.0	64.8	29.8	31.7	27.3	27.9	40.6	44.9	34.2	62.0	43.8	54.0	29.7	60.0	35.2	38.7	33.8	35.3	48.2	47.4	72.9	30.7	48.3	32.0	33.8	38.6	30.9	70.3	37.1	27.3	32.6	46.8	46.9	17.6	37.9	32.5	62.6	21.4	41.9	22.7	66.0	24.5	44.1	56.4	35.4	43.5	54.3	47.8	32.8	55.4	37.4	38.3	27.4	23.0	34.7	46.2	53.2	30.3	36.5	48.7	34.1	40.2	65.2	33.5	51.6	75.8	34.3	40.6	49.6	22.9	38.2	35.0	30.1	43.3	32.3	26.2	24.8	28.9	38.0	24.1	23.1	26.1	50.4	32.4	35.2	21.3	28.9	38.4	31.7	37.6	22.7	52.7	24.8	25.9	28.7	28.3	34.9	20.4	17.9	22.9	26.1	27.0	26.9	12.0	31.9	25.5	17.4	18.2	27.9	13.7	38.0	23.2	57.0	225.1	19.7	27.4	0.0	45.8	61.2	19.5	29.4	21.9	24.5	43.4	12.7	23.7	17.2	29.8	99.0	14.4	20.8	15.1	42.3	22.2	16.0	52.4	20.9	18.7	37.0	18.5	19.4	21.9	30.2	45.8	41.3	63.7	17.0	27.9	49.5
PSMF1	PI31	ENSG00000125818	"Proteasome inhibitor subunit 1"	Q92530	20	1113263-1189415	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	19	"Early spermatids: 1123.3;Late spermatids: 3219.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041122, HPA041300"	Approved		Enhanced	Cytosol		NA	NA		270000	Cytosol		"HPA041122: AB_10805838, HPA041300: AB_10794370"	"unprognostic (1.79e-2)"	"unprognostic (8.96e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.43e-2)"	"unprognostic (9.14e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.03e-2)"	"unprognostic (4.71e-1)"	"unprognostic (2.45e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.18e-2)"	"unprognostic (8.32e-2)"	27.3	21.5	23.4	23.9	26.4	27.3	23.0	22.9	32.7	21.8	26.5	26.9	19.8	27.2	24.6	24.1	29.3	22.5	27.4	27.7	21.6	21.2	25.1	63.7	23.7	29.9	23.2	19.8	28.2	48.3	23.7	20.4	20.5	28.2	21.2	19.3	26.2	33.6	24.0	67.2	25.3	28.4	23.9	23.4	22.8	25.7	86.2	19.2	31.9	27.7	42.1	24.5	26.2	25.7	31.4	28.7	51.5	33.9	24.1	33.6	26.2	38.6	35.2	8.5	20.2	18.2	19.3	14.8	23.6	17.9	21.4	19.2	33.1	27.2	19.7	15.9	24.4	23.0	35.1	21.8	40.0	26.9	11.5	13.1	28.1	6.3	60.1	24.5	32.9	9.5	19.3	23.2	24.2	37.5	13.2	23.0	15.7	28.0	39.6	17.4	20.6	41.9	28.8	12.6	22.2	21.7	20.2	18.0	32.3	18.9	32.8	21.6	15.3	26.0	45.6	21.4	8.4	30.6	11.9	27.4	27.5	18.8	31.8	31.8	24.6	48.2	21.1	12.2	22.8	20.9	43.2	28.6	51.5	23.0	33.9	26.5	31.4	30.8	25.0	28.7	27.6	28.4	24.7	31.1	24.1	33.2	16.4	33.6	26.2	23.4	26.4	22.9	32.7	21.6	21.2	23.2	19.8	28.2	19.2	32.8	43.6	51.3	52.3	36.6	32.7	45.6	25.5	32.1	27.3	38.4	3.9	59.1	69.6	90.2	1123.3	44.7	57.7	46.7	90.0	73.1	49.0	49.8	49.5	57.6	88.7	20.6	64.8	52.8	47.0	3219.2	71.7	56.6	49.0	82.0	52.3	45.6	80.0	65.4	83.4	64.4	26.8	116.4	64.1	69.0	63.9	42.4	61.9	53.2	59.6	60.7
PSMG1	"c21-LRP, DSCR2, LRPC21, PAC1"	ENSG00000183527	"Proteasome assembly chaperone 1"	O95456	21	39174769-39183851	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 67.3"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 408.1;Spermatocytes: 226.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA057193, HPA070225"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		No	No			"Nucleoplasm, Golgi apparatus, Cytosol"		"HPA057193: AB_2683363, HPA070225: AB_2686236"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.10e-1)"	"unprognostic (9.38e-2)"	"unprognostic (5.06e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.66e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (2.84e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.17e-3)"	7.0	11.0	8.2	8.7	8.0	15.1	6.9	7.7	13.1	7.0	10.2	4.7	5.2	9.2	8.2	9.2	12.5	6.9	9.4	7.6	7.5	8.9	11.7	21.4	6.1	8.1	6.9	10.2	7.9	21.5	5.1	10.0	7.5	8.5	5.7	10.0	7.3	8.0	5.2	13.0	7.0	8.4	8.3	7.1	7.0	7.1	67.3	4.6	7.8	10.6	10.4	7.6	6.7	7.4	11.4	11.5	7.3	7.9	6.7	14.9	7.9	27.1	8.9	6.5	8.9	3.2	3.7	17.3	15.0	6.6	11.8	7.6	16.3	7.1	29.4	8.0	4.2	10.5	7.8	10.2	8.0	7.7	12.6	16.1	55.6	13.8	21.1	5.8	26.4	11.1	5.1	6.0	12.5	12.6	2.6	6.2	12.8	40.9	16.9	7.0	14.4	16.2	14.3	22.4	10.4	13.9	26.5	8.1	29.9	4.9	8.1	20.7	6.1	18.9	10.7	14.9	1.2	10.1	13.3	7.0	13.6	4.7	18.2	21.2	13.0	20.5	25.5	11.5	44.7	10.4	7.3	6.4	3.5	10.6	7.8	12.2	11.4	14.9	12.2	11.5	9.0	11.9	10.4	0.5	6.7	7.9	10.5	12.6	7.9	8.2	8.0	7.7	13.1	7.5	8.9	6.9	10.2	8.5	4.6	6.0	18.3	19.9	34.3	120.8	14.8	21.8	22.9	12.0	29.6	19.2	3.9	93.4	56.3	35.1	408.1	22.4	14.4	0.0	43.3	92.9	37.1	22.6	34.7	28.1	51.9	7.9	28.7	19.6	18.1	33.7	29.4	26.6	43.9	26.2	40.2	9.4	31.9	21.0	31.1	76.3	16.1	25.8	31.9	226.4	91.0	85.4	45.5	20.3	50.8	26.7
PSPC1	"FLJ10955, PSP1"	ENSG00000121390	"Paraspeckle component 1"	Q8WXF1	13	19674752-19783019	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038904	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"HPA038904: AB_10673291"	"unprognostic (2.13e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.14e-3)"	"unprognostic (2.14e-2)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.13e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.69e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.92e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.61e-2)"	"prognostic favorable (1.46e-4)"	"unprognostic (7.72e-2)"	10.6	14.6	17.8	14.1	18.7	45.0	16.8	24.6	24.7	13.9	15.0	15.3	11.7	12.6	16.0	23.3	15.6	17.1	12.8	11.4	18.9	19.8	13.1	9.2	10.2	19.0	14.6	18.4	16.3	11.2	8.4	23.6	25.7	15.9	11.9	16.4	17.6	11.4	9.4	20.3	14.7	13.1	15.0	12.2	13.8	12.3	23.9	13.6	27.5	12.9	10.7	21.2	12.3	10.9	18.2	17.8	14.8	18.7	9.6	18.2	12.1	18.4	7.7	18.1	9.0	7.5	8.0	23.5	9.9	13.1	18.8	17.1	25.4	10.7	24.7	10.7	10.5	9.8	9.4	20.9	12.0	19.7	10.6	10.2	28.2	5.5	30.9	14.7	20.3	18.1	12.2	2.5	11.4	12.8	7.4	16.0	24.5	15.3	10.1	16.4	20.0	23.7	19.8	25.3	10.2	10.2	16.3	18.1	12.8	19.3	28.0	16.7	8.6	13.5	22.9	8.6	18.1	13.3	21.4	9.4	11.4	10.9	10.8	9.4	8.8	5.2	42.6	5.2	12.2	13.5	10.6	18.1	11.0	10.2	18.7	11.1	18.2	13.7	9.4	16.6	18.0	13.8	10.4	14.8	9.6	13.5	17.8	18.2	12.1	17.8	18.7	24.6	24.7	18.9	19.8	14.6	18.4	15.9	13.6	17.9	25.6	35.9	21.3	29.7	39.8	24.2	20.4	24.1	15.9	15.7	55.0	59.0	18.3	25.3	13.9	22.2	14.0	0.0	29.7	85.2	25.3	15.0	9.2	9.4	23.6	28.6	24.2	25.2	29.3	17.3	29.1	21.8	18.6	46.9	18.6	25.3	21.5	20.1	25.1	19.5	66.0	32.3	30.3	143.2	73.9	29.7	67.3	30.5	23.2	22.7
PTCD3	"DKFZp666K071, FLJ20758"	ENSG00000132300	"Pentatricopeptide repeat domain 3"	Q96EY7	2	86106182-86142157	"Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041154, HPA041382"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA041154: AB_10795488, HPA041382: AB_10795695"	"unprognostic (1.16e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.30e-3)"	"unprognostic (2.40e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.92e-3)"	"unprognostic (2.06e-2)"	"unprognostic (4.78e-2)"	"unprognostic (3.78e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.26e-1)"	"prognostic favorable (6.77e-4)"	"unprognostic (3.69e-1)"	"unprognostic (7.79e-2)"	"prognostic favorable (6.86e-4)"	13.9	18.6	18.5	12.2	23.2	18.0	14.5	24.5	22.7	13.0	17.5	19.7	11.3	14.3	15.2	15.5	12.7	13.6	9.6	35.0	17.7	16.6	18.0	21.9	11.7	15.4	20.2	19.0	20.2	13.8	17.9	22.7	13.2	21.4	13.0	19.7	11.4	11.1	12.9	45.4	14.2	14.2	13.4	17.9	15.8	14.8	22.8	20.5	20.4	14.9	13.1	15.3	12.4	13.0	13.4	9.4	6.3	11.1	11.9	14.7	7.5	7.8	18.9	11.2	9.4	8.4	8.8	13.5	17.3	7.0	9.2	9.3	35.1	7.6	19.7	6.1	9.1	9.9	14.5	22.6	8.9	11.8	8.8	19.9	15.6	11.8	29.0	8.7	12.6	11.9	10.4	6.5	7.0	12.6	9.7	8.0	14.8	16.2	7.5	8.1	7.3	10.4	15.1	10.2	15.6	12.1	14.1	15.9	14.9	12.6	15.8	12.3	7.5	7.6	12.7	14.8	11.0	6.7	7.8	5.6	7.3	7.9	7.5	9.5	17.7	22.8	16.0	7.1	14.5	5.6	3.4	8.6	6.3	11.6	5.9	13.6	13.4	10.5	12.2	9.4	13.4	14.7	10.7	0.3	11.9	11.1	9.4	11.8	7.5	18.5	23.2	24.5	22.7	17.7	16.6	20.2	19.0	21.4	20.5	53.6	27.4	22.3	21.6	23.1	60.5	94.8	17.8	24.1	42.1	22.7	62.8	46.9	21.6	16.2	23.2	22.4	21.0	0.0	10.3	21.6	24.3	12.7	32.4	38.0	18.9	35.0	29.9	22.7	15.0	17.5	25.0	13.2	8.5	16.2	21.0	49.5	14.2	22.4	18.4	24.4	63.1	12.9	16.5	90.5	54.4	21.7	30.7	24.5	35.3	17.5
PTMA	TMSA	ENSG00000187514	"Prothymosin alpha"	P06454	2	231706895-231713541	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047183	Approved		Enhanced	Nucleoplasm,Cytosol		No	Yes		610000	Nucleoplasm	Cytosol	"HPA047183: AB_2679972"	"unprognostic (1.49e-3)"	"prognostic favorable (6.56e-4)"	"unprognostic (3.73e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.56e-2)"	"unprognostic (3.72e-3)"	"unprognostic (2.35e-3)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (1.99e-7)"	"unprognostic (5.54e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.81e-3)"	"unprognostic (8.64e-3)"	72.8	37.7	60.0	78.4	65.2	161.4	76.1	38.2	64.2	75.0	80.9	53.9	33.9	56.3	84.8	59.9	83.7	66.7	47.2	38.7	66.3	48.3	67.3	73.5	63.5	104.0	68.7	59.6	80.5	79.5	31.3	97.9	59.1	54.2	50.0	82.7	42.2	55.5	53.4	60.6	92.5	62.8	58.4	86.6	90.1	69.2	113.9	67.2	127.5	73.4	50.4	118.6	70.0	69.9	189.1	134.7	114.4	126.9	117.0	167.3	255.0	99.6	59.9	85.5	76.2	26.0	34.7	87.8	68.1	57.2	59.5	62.5	58.0	116.9	157.9	78.1	53.1	41.2	52.8	120.2	83.9	75.7	125.1	94.5	203.5	49.5	93.6	32.3	230.8	87.1	50.3	31.5	52.7	43.6	56.8	97.0	129.0	118.2	67.2	51.9	142.5	324.2	314.8	128.7	99.1	50.0	223.4	60.9	107.3	72.8	89.1	174.5	107.4	78.2	78.3	59.4	70.5	59.0	183.6	72.0	50.2	89.1	61.3	73.1	81.5	40.1	316.2	34.3	141.6	80.4	114.4	113.6	75.3	99.1	114.0	143.5	189.1	143.8	120.6	126.3	160.4	160.6	134.8	23.1	117.0	126.9	134.7	167.3	255.0	60.0	65.2	38.2	64.2	66.3	48.3	68.7	59.6	54.2	67.2	902.2	1420.8	3111.4	3331.5	6879.8	692.5	258.3	1666.3	1917.9	1803.9	2156.5	276.9	2179.3	3208.0	2815.5	89.5	3767.9	1421.2	1752.0	3609.4	4317.6	3273.0	2682.0	2759.5	1209.1	2876.6	767.5	1629.9	1539.5	3031.9	138.7	1209.6	4164.5	3499.0	2458.1	2866.2	2213.1	3219.9	1988.5	1320.3	2161.4	753.7	1895.0	6501.7	798.6	2809.8	6944.4	2286.6	2724.1	3072.9	3503.3
PTPA	"PPP2R4, PR53"	ENSG00000119383	"Protein phosphatase 2 phosphatase activator"	Q15257	9	129110950-129148946	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 50.6;Cytotrophoblasts: 42.8;Distal tubular cells: 46.4;Ductal cells: 58.5;Exocrine glandular cells: 54.1;Hofbauer cells: 45.3;Pancreatic endocrine cells: 49.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005695, CAB022068, CAB035999"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		4800000	Nucleoplasm	Cytosol	"CAB022068: , CAB035999: , HPA005695: AB_1855658"	"unprognostic (4.97e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.13e-2)"	"prognostic favorable (6.50e-5)"	"unprognostic (1.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.69e-1)"	16.5	35.1	41.6	19.8	41.2	18.1	23.9	32.0	74.2	27.5	27.4	27.2	30.1	18.3	26.7	26.0	31.8	30.1	28.7	42.1	38.0	32.4	32.6	41.0	22.1	19.8	30.8	35.5	23.2	22.4	55.0	22.5	21.4	37.0	33.4	21.7	20.8	36.0	41.5	110.7	27.2	18.8	35.3	21.9	24.4	23.8	62.4	17.6	23.7	27.2	37.0	21.3	22.1	23.9	12.6	19.2	7.8	15.5	17.7	18.4	14.9	24.3	43.2	26.6	49.3	18.0	22.1	26.6	25.5	28.9	35.0	24.5	23.1	30.1	25.4	19.3	43.2	39.8	39.7	27.8	31.4	30.2	45.0	15.2	15.7	45.7	21.9	53.6	27.0	34.1	26.5	31.0	25.6	24.4	53.1	35.6	26.6	23.2	28.2	29.4	63.2	24.6	16.7	41.9	66.2	43.0	24.6	24.6	46.6	36.7	30.6	28.9	20.4	51.6	53.3	31.9	26.4	56.5	11.8	26.1	29.1	26.3	30.0	35.9	25.8	65.9	22.9	35.8	17.7	40.1	5.8	15.5	7.8	18.4	15.5	17.6	9.6	14.0	16.4	19.2	12.6	13.1	13.1	5.4	17.7	14.4	13.8	14.0	14.9	41.6	41.2	32.0	74.2	38.0	32.4	30.8	35.5	37.0	17.6	3.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	50.6	0.0	42.8	46.4	58.5	0.0	0.0	0.0	0.0	54.1	37.3	0.0	0.0	8.1	0.0	45.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	37.9	0.0	0.0	49.9	0.0	0.0	32.9	0.0	0.0	0.0	0.0	0.0	0.0	31.7	0.0	0.0	0.0
PTPDC1	"FLJ37312, PTP9Q22"	ENSG00000158079	"Protein tyrosine phosphatase domain containing 1"	A2A3K4	9	94030794-94109856	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 32.3"	"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0"	"Group enriched"	"Detected in many"	5	"B-cells: 1.1;T-cells: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016747, HPA026832"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016747: AB_1855908, HPA026832: AB_10602917"	"unprognostic (3.99e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.90e-3)"	"unprognostic (4.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.61e-2)"	7.0	12.0	7.6	4.4	32.3	1.5	6.4	4.7	16.4	4.7	4.9	25.3	1.4	3.1	6.2	4.9	4.4	4.4	4.7	10.0	12.1	6.9	5.1	2.4	6.8	3.7	13.9	8.9	6.3	12.2	6.8	8.9	3.7	19.9	5.6	5.9	4.1	4.3	4.4	7.0	6.2	3.6	8.3	20.5	3.0	7.1	15.0	13.0	1.6	5.1	1.3	3.9	4.9	3.6	1.1	0.3	0.0	0.2	0.0	2.0	0.1	6.1	2.7	4.9	6.3	6.1	8.5	6.5	4.5	3.2	4.6	3.9	2.6	5.2	5.2	3.1	3.4	10.6	4.9	5.0	2.9	4.5	7.0	1.4	1.2	7.2	2.8	8.0	1.4	4.0	8.4	10.5	7.0	9.8	2.8	4.9	8.6	3.0	0.0	8.6	3.3	5.2	2.2	3.4	5.0	5.1	5.6	9.7	0.0	2.6	1.5	4.3	5.5	6.2	5.8	9.7	6.8	3.1	2.5	6.9	6.2	3.8	9.5	5.4	7.6	8.4	0.7	4.6	2.5	8.6	0.0	0.2	0.0	0.1	0.0	0.1	0.4	1.1	0.0	0.3	1.1	2.0	0.7	0.0	0.0	0.2	0.2	0.0	0.1	7.6	32.3	4.7	16.4	12.1	6.9	13.9	8.9	19.9	13.0	0.0	7.7	1.9	2.6	4.2	10.5	8.4	2.5	1.4	1.2	5.2	9.8	0.3	3.3	2.9	8.0	5.7	0.9	0.0	2.5	1.6	5.0	1.9	5.7	0.8	2.7	4.8	3.4	6.2	0.3	3.8	3.4	2.7	3.3	0.0	2.4	2.3	5.0	1.1	13.4	1.0	9.8	19.4	4.8	12.0	15.9	3.8	0.2	2.5	2.3	1.7
PTPMT1	"DUSP23, MOSP, PLIP"	ENSG00000110536	"Protein tyrosine phosphatase, mitochondrial 1"	Q8WUK0	11	47565430-47573461	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Late spermatids: 522.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA043932, HPA060060"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043932: AB_2678738, HPA060060: "	"unprognostic (6.61e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.37e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (3.04e-5)"	"unprognostic (3.29e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.93e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.68e-3)"	"unprognostic (1.21e-1)"	"unprognostic (5.39e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.75e-1)"	24.0	24.5	22.3	13.1	23.2	19.8	23.3	16.5	25.2	15.7	14.8	18.5	17.5	14.6	14.7	21.4	14.3	16.9	17.9	17.1	18.5	21.9	20.1	21.8	25.1	16.7	23.1	16.2	15.7	39.3	18.3	18.7	21.8	14.4	15.8	11.5	20.1	26.4	19.5	23.4	11.2	13.1	12.7	17.6	14.7	16.9	44.6	10.3	10.8	19.9	15.7	15.0	11.0	11.5	20.4	40.8	22.1	24.4	15.4	17.5	16.8	22.2	12.6	1.5	10.1	11.7	9.0	4.3	13.1	12.4	13.1	12.5	20.9	11.9	16.0	14.5	9.8	12.2	19.1	10.4	13.6	14.0	19.5	31.3	7.4	25.8	26.3	17.2	14.3	9.8	8.9	15.5	6.1	18.8	10.1	9.3	15.9	18.8	12.3	9.6	42.0	12.2	18.5	9.4	3.8	23.4	22.4	8.5	13.7	15.8	14.3	9.4	11.5	19.9	7.3	11.8	6.6	33.8	15.4	10.0	9.7	15.0	15.7	19.7	18.7	12.5	10.9	7.6	12.4	5.9	6.0	24.4	22.1	16.0	20.9	15.4	20.4	15.2	17.3	27.7	18.0	15.2	14.4	1.9	15.4	19.4	40.8	17.5	16.8	22.3	23.2	16.5	25.2	18.5	21.9	23.1	16.2	14.4	10.3	20.8	25.4	25.3	13.5	15.9	13.5	5.3	48.4	41.5	22.7	38.4	3.9	63.4	61.3	87.9	188.7	19.1	21.4	0.0	74.6	54.2	24.4	20.5	16.2	36.5	56.1	4.8	30.1	30.1	29.8	522.3	43.1	32.4	43.9	60.5	41.0	48.4	92.6	28.1	43.9	62.0	11.6	19.4	21.2	109.7	21.3	15.2	64.2	24.9	61.2	18.6
PTPN1	PTP1B	ENSG00000196396	"Protein tyrosine phosphatase, non-receptor type 1"	P18031	20	50510321-50585241	"Enzymes, Predicted membrane proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;monocytes: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009329, HPA012542, CAB015217"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		11000	"Endoplasmic reticulum"		"CAB009329: AB_2174944, CAB015217: , HPA012542: AB_1855915"	"unprognostic (1.67e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.95e-2)"	"unprognostic (2.40e-2)"	"unprognostic (6.47e-3)"	"unprognostic (5.87e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.58e-2)"	22.1	22.2	12.1	31.9	16.0	35.3	17.9	12.9	16.6	18.2	17.8	18.8	14.2	10.5	20.0	16.6	23.2	17.1	18.0	20.5	15.8	9.0	43.8	16.7	42.7	36.1	14.1	14.1	21.8	12.2	31.2	18.8	28.3	18.7	20.0	14.8	21.0	16.3	15.0	41.0	18.6	21.9	16.9	15.8	45.3	17.5	23.5	13.3	26.9	15.7	13.9	42.8	20.0	18.4	15.9	9.4	18.8	16.4	3.9	10.7	6.4	21.1	10.7	12.9	8.9	8.5	11.7	18.4	14.2	13.6	41.9	15.3	31.3	44.6	10.5	25.3	13.1	16.5	18.8	10.2	40.9	26.7	15.5	9.1	14.8	10.4	16.5	16.9	15.4	20.4	13.6	28.7	18.9	23.3	18.4	24.0	12.8	25.8	9.7	22.7	11.8	16.5	12.2	6.8	11.7	14.7	14.7	15.0	10.0	24.1	15.9	10.4	11.9	20.4	26.0	23.0	11.3	16.8	16.5	35.6	36.6	14.7	16.4	17.6	10.6	8.5	12.8	22.9	10.5	13.5	12.0	5.6	18.8	10.7	9.5	7.9	15.9	9.0	8.2	5.5	13.7	7.7	8.3	12.2	3.9	16.4	9.4	7.1	6.4	12.1	16.0	12.9	16.6	15.8	9.0	14.1	14.1	18.7	13.3	211.4	72.3	67.9	44.4	76.4	23.0	27.2	10.2	32.1	47.8	34.9	45.2	41.8	19.9	20.5	47.2	26.1	20.4	0.0	16.9	17.3	21.4	26.7	67.2	18.6	32.9	41.3	17.9	37.4	28.2	22.4	13.0	52.2	35.4	327.4	13.7	13.8	28.9	11.5	11.3	59.6	25.9	19.4	34.0	20.7	24.3	41.3	45.4	43.7	15.5	55.1
PUF60	"FIR, RoBPI, SIAHBP1"	ENSG00000179950	"Poly(U) binding splicing factor 60"	Q9UHX1	8	143816344-143829859	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 73.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045733, HPA052096, HPA059714"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045733: AB_10960503, HPA052096: AB_2681722, HPA059714: AB_2684110"	"unprognostic (3.49e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.34e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.64e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.42e-2)"	35.4	21.1	28.5	19.1	29.5	51.1	20.8	22.8	40.0	19.5	28.4	37.3	16.7	41.2	25.6	21.3	23.8	30.8	23.8	26.7	29.8	25.5	21.7	34.4	18.0	28.7	29.9	30.9	23.9	24.4	13.3	21.6	33.0	24.3	22.8	11.2	22.8	39.1	31.4	47.5	36.6	23.8	21.0	29.4	26.2	28.5	28.9	27.9	28.7	23.2	24.2	21.9	20.2	21.3	40.9	42.9	28.3	44.6	41.4	50.9	53.3	21.2	49.5	7.5	7.2	4.0	3.6	12.4	17.1	6.3	16.5	16.7	21.6	24.1	18.6	16.3	13.4	12.8	18.8	20.3	21.2	0.9	20.4	32.7	23.9	26.2	22.8	14.7	7.8	16.8	10.1	13.3	21.7	6.7	4.8	15.9	20.8	19.3	8.3	4.9	73.0	35.7	5.3	18.6	13.7	44.1	19.4	10.3	19.6	4.6	21.1	14.5	17.2	21.8	9.3	17.5	2.0	26.4	3.6	18.1	17.0	41.3	20.1	22.1	15.5	21.8	24.5	17.1	11.6	16.4	24.1	37.9	28.3	45.6	43.3	50.9	38.6	38.3	45.2	42.9	40.9	35.8	41.7	21.1	41.4	44.6	26.2	44.9	53.3	28.5	29.5	22.8	40.0	29.8	25.5	29.9	30.9	24.3	27.9	35.7	45.6	62.1	84.0	95.7	56.5	52.6	38.2	66.9	47.8	27.9	27.5	127.5	77.9	88.5	14.8	59.5	85.2	0.0	78.5	109.1	67.7	50.1	55.3	71.2	88.1	41.3	64.2	39.3	46.1	34.6	59.2	57.1	86.0	133.5	53.5	174.2	79.1	97.9	55.5	90.1	46.1	64.7	74.1	92.1	123.9	93.6	145.0	64.0	69.8	74.0
PUM1	"KIAA0099, PUMH1"	ENSG00000134644	"Pumilio RNA binding family member 1"	Q14671	1	30931506-31065991	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Translation regulation"	RNA-binding	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027424, HPA027449"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA027424: AB_10602918, HPA027449: AB_2672281"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.19e-3)"	"unprognostic (4.42e-2)"	"prognostic favorable (7.62e-8)"	"unprognostic (1.57e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.74e-1)"	25.1	26.3	30.1	17.1	35.0	36.3	27.0	38.1	35.9	24.0	20.8	28.1	16.5	17.6	27.6	24.5	22.6	29.1	18.3	22.0	24.2	29.7	23.6	20.3	20.4	18.8	22.8	25.5	33.9	21.8	38.1	31.7	31.4	33.1	22.8	24.0	25.8	25.4	23.9	40.7	29.7	22.8	25.9	20.1	19.1	20.6	15.9	22.1	27.9	28.3	15.6	27.1	23.4	24.1	18.9	25.2	27.6	24.8	28.5	27.1	22.0	16.4	22.1	36.0	22.8	28.4	24.6	24.7	19.8	24.2	20.6	23.5	23.2	28.6	19.5	20.9	26.7	12.9	24.3	29.5	21.8	26.7	16.1	25.7	21.0	25.9	27.5	19.9	25.6	20.2	26.2	27.7	27.3	29.0	27.3	28.1	18.6	28.9	18.4	23.5	13.8	25.0	18.5	36.8	20.6	15.5	26.0	24.6	20.7	30.1	25.1	29.8	22.7	27.3	21.2	23.4	41.7	21.4	19.5	29.2	17.2	15.6	22.8	19.6	14.8	13.6	21.5	15.4	19.0	21.7	27.6	24.8	18.5	25.7	23.8	26.3	18.9	23.2	25.0	25.2	18.8	26.6	26.9	14.8	28.5	24.6	14.6	27.1	22.0	30.1	35.0	38.1	35.9	24.2	29.7	22.8	25.5	33.1	22.1	68.5	50.4	39.5	44.5	80.1	52.6	70.4	76.5	18.7	44.3	34.9	74.6	42.5	19.9	36.8	23.3	48.8	36.7	70.0	31.4	36.3	46.0	63.4	17.4	50.5	29.7	31.8	100.5	44.2	71.5	13.3	66.7	39.7	16.9	15.4	66.5	44.7	48.2	31.6	75.7	38.8	56.7	32.3	42.2	36.3	19.1	81.9	65.2	34.6	58.4	78.2
PUM2	"KIAA0235, PUMH2"	ENSG00000055917	"Pumilio RNA binding family member 2"	Q8TB72	2	20248691-20352234	"Predicted intracellular proteins"	"Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030316, HPA049670"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA030316: AB_10610289, HPA049670: AB_2680845"	"unprognostic (2.41e-1)"	"unprognostic (8.77e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (3.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.87e-2)"	20.3	20.7	21.1	35.2	20.0	18.3	25.2	41.2	26.0	31.4	35.4	19.5	13.5	20.5	26.1	20.5	25.1	19.9	25.7	25.7	22.1	19.8	22.9	25.6	24.6	26.8	20.7	21.1	29.1	23.2	32.9	24.2	39.3	17.5	24.3	22.9	21.8	22.7	42.6	19.2	27.7	27.8	20.5	18.5	25.4	23.5	14.6	20.2	56.2	35.7	21.7	28.1	26.8	29.0	6.6	5.6	15.3	8.6	9.4	10.0	4.8	24.0	17.6	21.5	15.4	13.3	14.0	23.2	17.6	17.4	15.8	14.3	14.6	11.3	32.3	4.0	14.8	18.7	13.5	21.7	12.0	24.3	30.1	13.9	32.9	12.9	19.9	14.6	34.6	31.5	10.1	25.7	15.0	27.2	15.4	18.2	18.5	25.2	27.1	18.6	11.6	31.0	20.2	19.0	21.7	11.6	26.5	37.4	24.3	14.5	21.9	18.6	26.6	14.7	19.3	15.3	15.0	11.3	19.4	18.1	20.6	20.1	13.1	21.6	32.3	39.1	61.2	12.5	25.0	17.7	11.8	5.5	7.4	8.1	6.7	9.8	6.4	9.0	9.8	5.6	6.6	10.0	8.0	15.3	9.4	8.6	4.7	6.8	4.8	21.1	20.0	41.2	26.0	22.1	19.8	20.7	21.1	17.5	20.2	32.8	45.9	28.4	26.0	70.7	87.4	35.5	25.5	24.1	31.8	45.4	58.9	28.4	10.0	15.5	6.9	34.6	29.0	0.0	13.2	14.8	36.0	39.5	19.7	48.2	24.9	55.6	33.3	44.2	65.6	4.9	31.7	30.6	30.4	14.4	46.3	24.3	19.1	20.1	24.8	23.8	68.2	32.3	38.1	16.1	17.7	93.0	43.5	39.6	37.7	44.8
PUSL1	FLJ90811	ENSG00000169972	"Pseudouridylate synthase-like 1"	Q8N0Z8	1	1308567-1311677	"Predicted intracellular proteins"	"tRNA processing"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032057, HPA039999"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA032057: AB_10601251, HPA039999: AB_2676792"	"unprognostic (2.04e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.91e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (7.55e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (1.62e-5)"	"unprognostic (3.05e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.44e-1)"	7.6	11.7	8.0	8.8	6.8	8.8	9.1	9.4	9.2	13.6	9.2	9.8	15.4	9.9	11.2	14.4	17.1	9.1	10.3	9.2	7.9	6.0	9.5	16.2	7.1	7.8	12.2	6.8	11.4	19.5	6.2	13.2	8.0	6.6	12.4	5.0	9.5	23.3	13.7	11.0	17.0	9.6	7.5	6.5	8.8	11.4	8.3	7.7	9.0	10.6	16.7	11.9	10.9	9.8	9.0	11.3	5.8	16.6	8.1	13.4	7.8	10.1	4.6	4.6	7.9	2.2	3.6	6.3	9.2	5.1	9.1	6.1	15.8	6.7	6.2	7.5	4.5	3.8	8.4	5.1	8.4	1.6	6.9	33.9	8.6	8.3	9.4	8.6	10.2	8.3	3.5	4.4	5.0	3.8	2.5	4.1	8.7	11.0	2.9	4.2	8.3	9.6	13.3	6.3	8.6	20.3	8.9	3.5	14.7	7.0	3.9	21.5	7.9	7.2	21.6	7.3	2.2	6.0	6.8	4.8	5.9	6.1	9.6	8.7	11.4	3.6	26.4	7.3	9.3	3.5	3.6	12.3	5.8	10.6	16.6	10.6	8.9	11.6	8.7	11.3	9.0	7.7	7.7	4.9	8.1	14.0	7.1	13.4	7.8	8.0	6.8	9.4	9.2	7.9	6.0	12.2	6.8	6.6	7.7	0.0	4.0	8.2	8.8	19.6	7.5	1.6	10.2	6.7	6.8	7.0	5.9	21.2	10.0	20.2	7.7	6.7	10.5	0.0	20.2	34.1	10.4	13.7	6.9	8.9	18.2	3.2	5.1	3.1	9.7	11.8	8.1	8.9	6.8	5.4	10.0	3.4	20.9	8.6	10.6	14.0	7.5	0.0	9.5	17.4	16.4	16.8	28.8	12.8	11.3	16.9
PWWP2B	"bA432J24.1, FLJ46823, PWWP2"	ENSG00000171813	"PWWP domain containing 2B"	Q6NUJ5	10	132397168-132417863	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 53.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.8;MCF7: 22.5;SK-BR-3: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038056, HPA038502, HPA078118"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA038056: AB_10697093, HPA038502: AB_2676048, HPA078118: "	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.51e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.00e-1)"	"prognostic favorable (5.75e-4)"	"unprognostic (4.77e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.19e-2)"	7.3	14.1	5.1	4.2	14.7	3.0	6.6	1.8	13.4	5.1	10.0	2.0	9.0	6.4	4.3	3.3	8.9	5.1	8.4	3.8	6.4	4.3	4.1	2.3	5.5	3.7	4.1	6.9	4.7	23.4	8.9	6.3	12.6	4.3	5.5	3.3	5.1	14.0	5.9	19.5	6.2	5.7	5.4	1.1	14.9	14.7	6.5	7.1	2.1	5.7	4.8	6.9	5.8	4.5	4.9	2.1	3.7	7.2	7.2	2.0	1.0	10.9	6.7	0.8	4.3	0.6	0.5	29.8	1.3	1.3	0.8	0.7	2.9	6.5	0.0	4.6	0.8	1.7	11.8	1.2	1.6	0.1	8.1	3.3	1.3	5.9	2.8	3.2	3.6	4.9	0.4	4.2	0.4	1.2	0.7	0.6	1.5	2.1	0.9	0.5	22.5	0.1	13.6	1.3	4.3	4.9	2.6	0.0	2.5	0.3	8.3	5.5	6.8	0.8	17.4	3.4	0.9	5.3	8.9	2.2	0.4	2.4	2.1	0.9	0.2	0.1	2.3	2.7	3.3	0.8	0.0	2.4	3.7	2.0	5.0	1.6	1.5	1.1	1.3	2.1	4.9	0.9	0.8	0.4	7.2	7.2	1.3	0.0	1.0	5.1	14.7	1.8	13.4	6.4	4.3	4.1	6.9	4.3	7.1	20.8	11.2	11.2	12.6	15.7	5.9	4.9	12.7	22.7	5.7	8.7	7.9	27.4	11.6	13.6	28.6	8.5	17.3	0.0	18.8	44.1	7.2	13.6	2.3	1.1	11.5	14.3	24.3	12.3	10.5	53.6	3.4	7.7	13.5	3.6	29.5	1.9	10.0	23.0	2.1	1.3	11.8	0.0	2.4	0.9	0.9	17.8	44.3	2.5	18.4	25.5
PXN		ENSG00000089159	Paxillin	P49023	12	120210439-120265771	"Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 124.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 49.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003841, HPA051309"	Supported		Enhanced	"Focal adhesion sites,Centrosome,Cytosol"		NA	NA			"Focal adhesion sites"	"Centrosome, Cytosol"	"CAB003841: AB_562188, HPA051309: AB_2681436"	"unprognostic (4.00e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.51e-2)"	"unprognostic (3.55e-3)"	"prognostic unfavorable (1.09e-4)"	"prognostic unfavorable (3.72e-5)"	"prognostic unfavorable (7.12e-5)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (3.12e-2)"	"unprognostic (9.19e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.75e-2)"	35.4	26.2	17.9	26.7	16.5	31.6	45.9	15.5	18.6	25.0	29.0	12.4	31.7	25.6	27.6	30.9	16.0	29.8	31.8	26.2	18.0	7.6	27.6	13.1	35.8	42.9	15.7	8.1	14.8	16.3	17.6	13.9	34.0	15.8	24.9	23.5	24.7	22.1	40.1	98.5	19.7	34.7	44.4	20.3	34.0	20.6	19.8	14.4	9.9	26.7	22.8	11.6	30.1	45.7	0.5	7.6	49.5	12.3	14.4	26.3	14.5	33.2	16.5	5.9	5.9	11.9	31.0	40.1	28.2	24.6	23.0	12.1	19.2	21.0	2.3	18.5	28.6	22.3	23.8	4.1	51.4	18.4	1.8	3.7	0.4	12.2	6.9	17.2	0.5	0.7	15.1	33.6	24.0	27.4	26.0	40.8	6.2	5.9	3.8	44.9	22.1	2.0	0.7	8.4	14.5	57.5	4.9	9.8	2.0	23.6	32.0	9.7	2.9	25.3	7.8	15.2	14.5	19.2	2.7	53.7	16.0	17.5	19.9	33.5	4.0	2.2	0.8	46.0	5.0	31.2	9.8	12.3	13.4	26.3	4.4	14.2	0.5	12.1	17.2	7.6	0.4	9.6	12.8	49.5	14.4	0.2	1.2	9.1	14.5	17.9	16.5	15.5	18.6	18.0	7.6	15.7	8.1	15.8	14.4	53.6	30.4	3.0	29.8	37.5	7.1	11.5	25.5	28.1	35.2	40.1	31.4	31.3	16.6	30.3	1.2	56.8	59.3	0.0	34.6	124.5	18.0	29.6	17.4	15.3	29.4	11.1	52.5	57.1	49.0	1.6	22.5	13.7	25.3	10.0	49.9	6.9	56.8	50.3	17.7	11.6	30.4	6.5	10.5	3.8	8.0	16.9	20.9	28.7	28.4	33.9
QARS		ENSG00000172053	"Glutaminyl-tRNA synthetase"	P47897	3	49095932-49105135	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 438.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036986, HPA036987"	Enhanced		Enhanced	Cytosol		No	No		21000	Cytosol		"HPA036986: AB_10672344, HPA036987: AB_2675418"	"prognostic favorable (1.43e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.13e-3)"	"unprognostic (6.62e-3)"	"unprognostic (6.53e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.33e-1)"	"unprognostic (9.14e-2)"	"prognostic favorable (5.60e-6)"	"unprognostic (2.73e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.11e-1)"	20.9	16.3	9.7	19.3	10.2	18.4	22.7	15.8	13.2	17.6	27.3	13.1	27.7	17.2	12.3	19.8	35.1	16.4	20.0	22.0	9.8	9.6	27.1	26.0	15.0	33.9	12.4	7.2	21.6	33.8	20.3	13.7	25.7	9.6	16.2	29.9	15.2	31.7	28.7	33.3	26.7	31.8	16.7	11.2	21.1	16.9	30.1	11.3	36.8	16.5	34.8	33.3	19.4	18.5	20.4	40.0	8.9	32.3	21.8	24.0	19.6	18.8	19.2	32.1	45.9	41.3	44.9	33.1	21.0	48.1	41.7	41.0	24.3	24.5	58.4	13.5	34.8	23.4	24.0	45.5	34.6	30.0	16.6	36.3	46.0	30.8	42.3	21.8	37.4	28.4	47.3	30.3	32.1	27.3	44.8	45.5	34.2	20.5	26.0	30.5	10.1	26.9	33.6	27.5	38.6	30.0	17.8	27.0	43.0	28.0	28.1	11.8	32.8	18.6	47.3	28.9	33.0	39.2	43.7	26.2	19.0	27.0	31.3	23.4	22.4	38.1	32.8	19.5	33.7	12.0	8.9	23.1	8.7	13.5	32.3	18.1	20.4	16.8	14.9	40.0	15.2	15.5	15.4	2.6	21.8	26.1	16.9	24.0	19.6	9.7	10.2	15.8	13.2	9.8	9.6	12.4	7.2	9.6	11.3	20.8	57.3	55.9	52.1	59.8	10.1	50.4	40.8	22.7	35.2	38.4	9.8	160.6	58.0	67.5	150.2	50.3	110.2	23.3	94.9	127.6	48.0	47.5	38.1	41.8	85.6	19.1	62.3	50.3	98.5	438.0	54.4	55.2	45.5	120.0	127.2	20.6	67.1	71.9	34.3	63.0	13.0	45.3	43.4	18.4	46.6	75.3	156.4	69.2	176.8	57.2
QRICH1	FLJ20259	ENSG00000198218	"Glutamine rich 1"	Q2TAL8	3	49029707-49094363	"Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037677, HPA037678"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037677: AB_10671883, HPA037678: AB_2675603"	"unprognostic (2.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.77e-3)"	"unprognostic (6.94e-2)"	"unprognostic (2.82e-2)"	"prognostic favorable (7.46e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-1)"	28.9	27.6	20.4	23.6	26.8	43.1	27.8	38.9	35.0	26.2	23.3	27.0	21.2	21.0	30.7	22.0	28.4	26.7	23.7	21.5	20.9	16.7	20.3	22.1	26.0	30.3	17.8	22.1	30.5	23.3	30.7	27.3	32.1	23.6	22.6	21.4	28.4	26.4	26.0	32.3	34.1	30.0	24.6	15.9	35.2	25.8	53.9	21.8	40.3	25.9	20.2	37.1	28.1	23.6	15.5	16.0	15.9	26.0	15.8	20.1	11.1	18.6	17.9	35.6	16.4	23.4	22.5	22.2	21.1	27.7	35.4	32.3	19.5	23.7	29.9	13.6	27.5	28.6	14.9	32.6	29.5	30.8	25.6	19.6	29.3	24.8	16.1	21.1	25.5	33.8	25.5	22.5	35.4	22.7	21.6	27.4	27.6	19.8	27.4	24.0	13.8	37.1	17.5	29.1	19.6	22.5	18.6	18.6	24.7	22.1	29.1	13.6	27.4	24.0	22.4	17.4	29.4	20.0	28.9	23.8	23.2	26.4	20.5	30.1	24.7	28.7	36.2	21.2	24.6	26.5	14.0	13.2	15.9	16.8	16.5	19.9	15.4	16.2	18.6	16.0	15.5	17.5	20.1	9.9	15.8	26.0	11.4	16.6	11.1	20.4	26.8	38.9	35.0	20.9	16.7	17.8	22.1	23.6	21.8	8.9	13.9	26.2	11.9	19.7	13.5	17.6	17.8	12.0	17.0	19.2	21.6	22.0	1.7	13.7	8.6	15.8	13.1	0.0	11.9	22.9	14.2	14.3	16.1	18.7	17.0	11.1	24.9	18.4	24.3	7.9	20.8	21.5	11.8	17.2	21.2	10.6	16.0	7.0	29.0	9.7	17.1	6.5	17.0	40.7	25.1	19.7	30.8	18.4	16.9	13.5
QSOX2	"DKFZp762A2013, QSCN6L1, SOXN"	ENSG00000165661	"Quiescin sulfhydryl oxidase 2"	Q6ZRP7	9	136206333-136245841	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 26.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012716, HPA017280"	Uncertain		Enhanced	"Nucleoplasm,Golgi apparatus"	"Intracellular and membrane"	NA	NA		5700000	"Golgi apparatus"	Nucleoplasm	"HPA012716: AB_2173315, HPA017280: AB_2669565"	"unprognostic (7.29e-2)"	"unprognostic (7.35e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.06e-3)"	"unprognostic (5.96e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (9.64e-6)"	"unprognostic (1.23e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.10e-2)"	7.2	8.0	8.4	15.9	14.1	16.0	7.3	30.3	10.6	5.8	5.8	9.4	8.9	6.0	8.1	13.2	5.6	8.1	5.5	7.0	7.6	7.1	7.0	9.2	6.5	19.1	11.0	6.7	9.4	21.7	12.1	29.2	5.8	9.6	6.1	6.7	7.9	6.5	4.9	5.1	12.4	10.3	8.1	7.1	14.6	7.6	11.7	10.1	8.3	12.1	6.0	16.7	5.4	6.4	3.4	0.8	1.6	0.3	0.4	0.8	0.2	7.0	17.1	14.2	18.8	8.0	9.8	17.9	8.9	10.0	17.5	16.1	12.7	15.3	10.8	14.8	12.0	32.2	22.8	16.8	12.9	14.2	15.9	8.4	5.8	28.3	14.0	11.4	17.2	8.9	7.8	13.2	17.3	21.1	7.7	12.8	11.4	14.0	29.3	9.2	11.9	6.3	11.5	16.8	21.2	10.9	11.8	18.5	17.7	6.0	6.3	15.2	11.5	14.1	11.2	7.5	9.7	8.0	10.1	7.3	21.3	15.4	17.4	20.3	10.4	13.8	23.8	14.2	9.1	19.8	1.6	0.3	0.7	0.5	0.0	0.8	1.9	0.6	0.2	0.1	3.4	0.2	0.4	0.1	0.4	0.0	0.8	0.3	0.2	8.4	14.1	30.3	10.6	7.6	7.1	11.0	6.7	9.6	10.1	8.9	6.4	6.9	2.5	5.0	16.1	3.1	0.0	8.1	5.7	5.2	17.7	1.2	1.7	3.3	4.9	7.0	1.1	0.0	3.4	2.5	4.7	4.8	1.1	3.4	2.0	4.8	15.6	2.5	4.8	4.7	5.5	2.7	0.0	1.0	4.9	2.8	3.5	0.0	6.7	1.9	8.2	6.5	5.7	16.8	26.4	10.0	0.8	3.1	3.4	3.3
RAB11A	YL8	ENSG00000103769	"RAB11A, member RAS oncogene family"	P62491	15	65726054-65891991	"Predicted intracellular proteins"	"Cell cycle, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 810.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013097, HPA051697, HPA060686"	Approved		Enhanced	"Vesicles,Centriolar satellite"		No	No			"Vesicles, Centriolar satellite"		"CAB013097: AB_2533987, HPA051697: AB_2732569, HPA060686: AB_2684342"	"unprognostic (4.15e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.74e-3)"	"unprognostic (6.85e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.17e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.60e-2)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (4.37e-4)"	"unprognostic (4.29e-2)"	"prognostic favorable (1.46e-5)"	"unprognostic (9.93e-2)"	"unprognostic (1.83e-2)"	"unprognostic (5.23e-3)"	"unprognostic (1.21e-1)"	43.3	64.1	32.4	27.0	49.6	25.1	35.4	34.9	57.3	41.3	49.9	27.7	30.5	31.4	36.4	31.7	131.6	34.2	42.8	34.5	35.0	40.5	52.4	28.7	38.1	32.8	34.3	36.6	35.6	24.5	32.3	36.6	60.5	60.5	35.8	52.2	33.7	58.3	31.2	27.3	79.8	35.2	34.3	33.1	55.3	47.9	47.4	25.1	32.4	46.2	60.7	62.1	51.7	60.6	18.1	31.5	54.0	33.3	15.1	24.5	59.5	38.1	45.3	46.3	33.5	42.4	39.9	60.5	40.9	41.7	37.3	44.6	41.6	68.8	50.2	41.8	46.8	37.0	59.2	72.8	54.1	35.3	32.7	43.5	60.1	32.8	36.8	32.3	28.1	35.8	40.6	61.7	36.6	30.5	39.9	82.5	27.3	48.2	29.9	52.5	37.9	27.8	22.3	38.5	143.2	25.8	23.7	35.2	46.5	100.1	100.4	33.4	35.5	29.4	46.8	37.9	57.3	61.9	32.9	62.3	29.6	42.2	28.4	36.1	15.8	37.5	39.0	27.4	47.8	31.6	32.4	32.1	51.8	14.0	29.8	14.3	18.1	21.0	16.6	31.5	14.1	19.8	15.5	54.0	15.1	33.3	20.3	24.5	59.5	32.4	49.6	34.9	57.3	35.0	40.5	34.3	36.6	60.5	25.1	53.6	56.3	73.5	139.3	170.7	40.9	79.0	109.5	121.8	60.3	177.9	31.4	272.5	293.4	292.8	266.5	253.3	195.7	23.3	299.7	258.8	118.0	163.7	74.9	76.3	202.8	54.0	197.9	219.8	109.3	44.8	90.0	141.5	177.2	290.4	192.9	96.3	318.8	179.9	81.3	212.8	30.7	45.3	81.1	257.1	103.5	248.5	810.7	71.0	152.8	293.1
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899467	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 741.5;Urothelial cells: 458.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 39.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 39.0"	"Cell line enhanced"	"Detected in many"		"K-562: 29.7"	"Low region specificity"	"Detected in single"							"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles		No	No			Vesicles		"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favorable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	6.9	3.2	1.3	16.8	1.0	17.8	7.4	1.8	1.3	8.9	37.1	1.9	17.8	13.8	2.9	8.8	30.9	5.6	31.5	5.9	1.1	1.3	8.4	4.1	64.5	8.4	1.1	0.6	4.7	31.5	3.9	12.9	26.0	6.9	7.0	16.4	9.9	20.9	21.3	3.4	13.8	90.6	5.3	1.3	10.9	15.2	5.4	0.9	16.4	8.5	14.9	34.1	9.6	9.6	2.3	6.9	39.0	7.7	4.1	4.0	3.3	17.2	7.6	0.8	3.4	0.2	0.0	23.5	1.8	2.8	3.3	4.2	17.0	9.9	7.0	5.5	2.1	0.2	13.4	6.2	3.9	4.9	18.2	5.8	1.3	4.0	4.9	9.3	3.0	15.7	2.2	5.3	1.2	3.4	4.8	0.0	9.4	29.7	3.5	1.7	4.1	5.0	4.4	5.1	17.0	2.3	1.6	4.2	5.4	17.0	17.8	3.2	3.7	4.5	22.5	5.5	16.8	15.2	5.8	0.2	0.1	10.2	0.2	0.3	7.1	8.3	1.9	0.1	4.1	2.4	6.9	7.7	13.7	1.8	3.7	4.0	2.3	1.3	1.2	6.9	1.7	0.8	0.9	39.0	4.1	6.9	4.2	2.9	3.3	1.3	1.0	1.8	1.3	1.1	1.3	1.1	0.6	6.9	0.9	741.5	109.5	15.9	71.9	14.2	4.8	11.6	68.8	238.3	205.9	61.1	15.7	29.6	13.3	135.4	0.8	10.5	359.4	0.0	214.5	4.9	15.3	195.3	29.0	12.1	29.4	6.4	233.5	17.8	43.0	0.7	1.7	62.6	15.1	32.5	172.7	18.1	301.2	259.6	1.4	12.9	19.9	6.5	12.8	2.6	5.9	26.7	80.3	74.0	158.8	458.6
RAB11FIP3	"eferin, KIAA0665, Rab11-FIP3"	ENSG00000090565	"RAB11 family interacting protein 3"	O75154	16	425619-523011	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 70.5"	"Cell type enriched"	"Detected in many"	14	"Proximal tubular cells: 333.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028088, HPA028631, HPA030086"	Enhanced		Enhanced	"Nucleoplasm,Vesicles,Cytokinetic bridge,Centriolar satellite,Mitochondria"		Yes	No			"Vesicles, Centriolar satellite"	"Nucleoplasm, Cytokinetic bridge, Mitochondria"	"HPA028088: AB_10601672, HPA028631: AB_10601853, HPA030086: AB_10669596"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.22e-4)"	"unprognostic (2.87e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (9.87e-5)"	"unprognostic (6.71e-2)"	"unprognostic (4.74e-1)"	"unprognostic (9.66e-2)"	"prognostic favorable (3.16e-5)"	"unprognostic (1.12e-1)"	"prognostic favorable (7.99e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.44e-1)"	10.2	13.4	19.3	7.5	16.9	8.7	7.3	29.7	27.4	11.5	10.6	12.2	9.0	13.4	11.9	11.0	8.2	9.5	11.3	14.0	18.7	12.1	70.5	12.2	10.5	8.1	12.0	18.0	13.4	22.2	22.4	14.6	10.0	10.6	11.5	5.4	9.9	13.2	12.6	23.5	12.2	14.6	10.8	8.9	10.2	7.6	13.5	11.9	5.7	8.6	7.4	5.3	9.7	16.6	1.1	0.8	0.1	0.1	0.1	1.5	0.6	4.4	10.2	9.8	8.6	14.5	9.5	8.5	8.5	8.0	7.8	5.6	7.5	2.1	12.3	10.0	12.4	6.9	4.6	6.1	9.0	2.7	9.1	8.7	5.5	9.5	21.7	15.5	5.5	6.9	9.1	6.2	8.0	7.0	9.1	11.9	8.5	2.8	4.9	9.8	13.7	8.9	10.9	8.2	3.2	4.2	18.5	7.8	3.2	7.8	2.7	10.2	9.5	8.7	10.7	5.4	3.5	5.9	10.2	19.2	11.4	7.6	10.6	5.6	6.8	5.3	14.5	4.3	3.9	8.4	0.0	0.1	0.0	1.5	0.0	1.3	0.8	0.9	0.7	0.5	1.1	0.6	0.3	0.1	0.1	0.0	0.8	0.0	0.6	19.3	16.9	29.7	27.4	18.7	12.1	12.0	18.0	10.6	11.9	3.0	1.7	3.4	0.4	3.3	8.2	11.7	7.6	4.0	6.8	5.2	5.9	0.8	23.2	1.4	1.0	2.5	6.4	0.0	1.0	0.1	2.3	1.1	1.1	14.1	0.7	20.6	2.9	19.6	5.1	1.6	0.6	1.2	0.0	0.0	2.7	6.1	1.6	1.7	1.8	333.9	7.1	6.5	2.1	2.7	3.0	1.9	0.7	2.6	4.1	0.3
RAB11FIP5	"GAF1, KIAA0857, pp75, RIP11"	ENSG00000135631	"RAB11 family interacting protein 5"	Q9BXF6	2	73073382-73156721	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.4"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 64.5;Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.6"	"Lineage enriched"	"Detected in single"	18	"T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"TIME: 25.4"					"Low region specificity"	"Detected in all"			"HPA036406, HPA036407"	Enhanced		Enhanced	"Vesicles,Centriolar satellite"		NA	NA			"Vesicles, Centriolar satellite"		"HPA036406: AB_2675105, HPA036407: AB_10669778"	"unprognostic (1.49e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.58e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (3.87e-4)"	"unprognostic (3.23e-3)"	"unprognostic (1.45e-1)"	"prognostic favorable (2.26e-5)"	"unprognostic (1.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.66e-3)"	8.4	5.4	5.3	3.8	9.3	1.5	6.3	9.5	16.7	5.2	4.2	2.8	4.6	3.5	7.9	7.3	5.3	5.6	8.2	7.2	4.9	6.3	14.9	2.3	4.8	2.1	5.6	6.5	6.7	8.4	22.3	4.3	11.4	16.0	5.3	2.1	5.1	9.5	5.9	9.0	5.8	2.6	5.2	2.9	18.9	4.9	46.4	2.5	0.0	3.9	4.7	2.7	5.3	7.4	0.1	0.0	0.0	0.0	0.0	2.6	0.5	12.2	5.5	0.4	3.9	4.0	4.9	7.2	18.5	10.2	6.3	4.9	4.0	3.0	0.0	9.8	9.4	6.9	5.0	2.4	5.7	2.8	21.3	6.8	4.5	2.3	2.6	5.0	0.0	0.8	5.9	5.4	7.8	5.1	5.9	8.6	2.5	3.4	2.4	4.5	0.3	0.0	0.1	2.9	1.8	8.7	4.1	5.0	10.4	5.5	1.5	1.9	2.0	6.1	2.5	2.8	1.3	1.4	0.2	25.4	15.4	8.9	11.4	9.6	8.0	2.3	0.0	12.0	4.8	1.5	0.0	0.0	0.0	2.6	0.0	0.5	0.0	1.2	1.9	0.0	0.1	0.2	1.5	0.0	0.0	0.0	0.0	0.8	0.5	5.3	9.3	9.5	16.7	4.9	6.3	5.6	6.5	16.0	2.5	6.0	2.2	0.8	6.8	22.7	3.4	11.5	17.8	0.0	0.0	19.2	0.0	0.9	23.2	11.3	64.5	16.9	3.2	0.0	15.8	7.7	9.5	10.5	0.0	4.2	1.6	6.4	1.7	11.1	1.8	127.2	13.3	2.2	8.5	1.8	2.5	6.7	17.4	2.9	8.1	38.3	2.0	25.8	10.8	22.8	5.5	15.4	12.4	1.8	4.7	8.1
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222314	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 62.4;urinary bladder: 48.9"	"Cell type enhanced"	"Detected in many"	6	"Fibroblasts: 23.8;Leydig cells: 18.4;Peritubular cells: 28.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 32.6;U-2197: 57.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	6.0	3.0	6.7	5.7	5.1	0.2	4.0	7.3	4.8	23.1	32.9	5.1	9.6	3.0	34.1	8.0	9.7	8.1	12.4	7.0	7.4	4.5	3.3	1.8	4.9	1.7	6.4	5.4	8.2	1.6	2.9	3.5	12.3	6.7	24.9	7.5	3.6	2.8	26.9	4.7	3.1	7.0	62.4	6.6	1.1	8.7	4.3	7.2	1.4	15.1	3.9	1.7	48.9	11.2	0.3	1.5	1.3	0.6	0.9	2.0	0.3	4.8	1.9	7.0	4.9	10.7	32.6	6.4	14.3	24.8	12.6	13.1	4.2	2.3	0.9	4.4	22.9	6.3	1.7	7.2	5.2	15.0	3.6	3.4	3.5	3.2	3.3	6.6	1.8	0.5	12.1	6.0	15.6	14.7	6.1	6.5	2.1	5.4	3.0	13.9	4.0	1.6	1.9	2.6	3.2	2.6	1.7	10.3	1.4	8.7	3.4	3.6	2.5	7.1	3.4	3.6	9.1	3.1	2.1	8.7	19.6	6.1	57.6	8.3	2.6	2.8	2.4	11.0	3.9	9.6	0.3	0.4	1.3	0.3	0.4	0.0	0.3	1.1	0.5	0.3	0.3	2.0	0.8	0.0	0.9	0.6	1.5	0.0	0.3	6.7	5.1	7.3	4.8	7.4	4.5	6.4	5.4	6.7	7.2	11.9	5.3	0.0	1.6	3.7	2.9	3.1	2.5	6.7	1.2	0.0	2.0	10.0	0.0	2.8	2.1	1.4	1.3	0.0	2.5	8.4	23.8	3.6	0.0	3.0	3.7	1.6	1.2	4.9	0.6	1.3	18.4	1.3	5.0	12.6	1.2	3.2	2.8	0.0	28.7	4.4	0.7	0.0	9.0	6.7	7.1	4.4	11.4	0.0	1.2	1.4
RAB30		ENSG00000137502	"RAB30, member RAS oncogene family"	Q15771	11	82973133-83071923	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"B-cells: 41.7;Melanocytes: 40.5;monocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 23.2;naive B-cell: 25.1"	"Lineage enriched"	"Detected in many"	5	"B-cells: 25.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 22.1;HDLM-2: 19.7;U-698: 59.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054514, HPA060565"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA054514: AB_2682512, HPA060565: AB_2684320"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.21e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.14e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.85e-1)"	12.2	17.3	15.8	14.5	21.6	12.7	13.8	19.9	22.5	10.3	12.6	30.6	2.2	16.7	10.3	6.7	7.0	7.2	6.5	9.9	17.2	12.2	4.5	8.5	7.4	21.1	27.9	15.0	15.5	4.9	6.0	10.0	10.0	22.8	8.6	14.3	10.9	8.8	6.7	19.8	11.8	20.0	11.6	29.3	10.9	11.2	4.2	29.2	3.3	7.2	5.0	29.0	11.0	8.3	25.1	2.6	0.5	0.4	0.9	5.4	2.7	1.4	1.9	2.0	1.3	4.7	6.8	2.5	3.4	3.4	6.7	3.3	3.6	0.7	22.1	4.2	5.1	1.8	1.8	3.0	2.3	4.3	19.7	0.6	5.4	6.3	1.8	1.1	0.7	0.9	4.3	1.5	3.3	2.3	3.4	5.4	1.7	0.6	5.5	4.0	2.7	0.7	0.1	2.8	2.0	3.7	1.5	5.8	8.3	3.9	1.3	2.7	1.7	9.6	2.0	1.0	3.3	4.6	0.0	6.6	3.2	7.0	3.1	1.0	8.7	4.6	59.7	1.2	0.5	2.2	0.5	0.3	0.5	2.3	0.1	1.6	23.2	2.2	2.2	0.8	25.1	5.4	4.6	0.5	0.9	0.4	2.6	4.1	2.7	15.8	21.6	19.9	22.5	17.2	12.2	27.9	15.0	22.8	29.2	8.9	3.5	41.7	13.1	22.0	8.6	11.5	0.0	2.7	1.2	3.5	15.7	5.4	1.7	1.9	0.5	6.3	4.9	0.0	3.4	21.1	7.4	11.0	0.0	5.7	1.7	11.1	9.7	16.0	1.6	0.4	13.3	4.3	40.5	42.3	1.1	14.8	3.2	0.6	17.0	3.0	9.0	6.5	10.3	0.7	1.1	10.0	2.4	6.7	0.9	1.4
RAB5A	RAB5	ENSG00000144566	"RAB5A, member RAS oncogene family"	P20339	3	19947079-19985175	"Predicted intracellular proteins, RAS pathway related proteins"	"Endocytosis, Phagocytosis, Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004567, HPA049354"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		920000	"Nucleoplasm, Vesicles"		"CAB004567: AB_628191, HPA049354: AB_2680725"	"unprognostic (2.49e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.58e-2)"	"unprognostic (4.72e-1)"	"unprognostic (3.85e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.12e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.68e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.36e-2)"	25.8	21.2	42.5	19.3	34.7	26.5	25.5	25.2	36.6	24.8	21.9	26.0	18.1	21.6	17.5	33.4	32.4	16.3	24.7	28.3	38.4	38.0	25.5	31.3	22.5	16.3	43.5	33.8	16.2	21.9	39.2	23.8	36.1	35.1	24.0	23.4	16.2	25.4	23.3	35.8	27.2	21.6	21.2	49.1	17.0	23.6	15.7	30.3	22.7	31.4	22.2	20.8	23.7	23.7	5.0	11.2	22.7	14.8	12.5	7.0	6.8	11.6	10.7	15.7	10.8	27.6	24.6	16.0	20.6	24.2	19.7	22.8	12.6	18.6	8.6	12.5	22.6	11.5	7.4	11.7	15.3	23.1	14.8	9.7	12.5	10.4	12.2	34.6	17.4	15.8	22.5	29.1	23.0	33.9	24.8	24.8	11.5	14.3	13.9	23.5	18.0	13.5	12.5	19.7	16.2	17.3	10.1	11.1	12.5	40.2	15.5	4.9	16.3	14.7	18.5	23.7	24.5	14.4	14.2	24.6	14.4	12.5	18.2	17.4	17.2	28.2	11.4	22.9	16.0	23.3	15.1	11.4	18.7	5.3	12.1	7.0	5.0	6.3	6.4	11.2	3.5	5.9	5.4	22.7	12.5	14.8	7.4	6.6	6.8	42.5	34.7	25.2	36.6	38.4	38.0	43.5	33.8	35.1	30.3	56.6	39.7	36.6	109.3	151.1	33.1	53.1	22.9	46.8	40.9	40.1	29.5	67.4	87.9	48.7	14.5	60.9	53.0	23.3	40.0	57.3	76.1	98.0	84.2	36.4	48.3	14.3	59.4	39.3	42.9	12.4	33.9	55.8	79.2	41.5	43.4	64.7	48.5	38.6	33.2	49.4	31.1	51.8	76.2	19.5	25.5	164.4	137.4	44.9	37.0	131.9
RAB5C	"RAB5CL, RABL"	ENSG00000108774	"RAB5C, member RAS oncogene family"	P51148	17	42124976-42155044	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003426, HPA004167"	Approved		Enhanced	Endosomes		NA	NA		3600000	Endosomes		"HPA003426: AB_1079735, HPA004167: AB_2667156"	"unprognostic (1.41e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.75e-3)"	"unprognostic (3.69e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (1.56e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.06e-3)"	"unprognostic (4.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.12e-2)"	50.4	47.8	40.8	43.6	49.4	69.6	43.8	27.9	68.8	33.8	41.9	53.0	25.8	53.6	41.9	28.5	36.4	35.6	36.0	26.2	38.5	34.3	70.3	63.6	46.0	44.5	46.5	32.5	34.9	30.5	28.4	20.1	42.1	41.4	29.8	35.1	37.3	33.1	36.6	16.8	33.8	49.7	39.1	40.4	50.0	44.4	25.2	42.2	29.8	53.5	21.0	36.8	38.7	31.7	13.9	23.8	56.9	31.4	14.8	15.9	21.8	29.1	55.1	17.2	24.9	38.6	26.7	33.4	36.0	38.0	49.8	43.5	38.9	28.9	14.2	31.8	44.4	35.2	41.2	31.7	34.8	32.0	18.3	41.5	21.6	22.5	56.0	38.0	28.3	35.5	34.3	36.6	37.4	26.2	26.0	51.8	19.5	24.7	22.0	33.6	26.6	28.8	25.4	17.0	51.0	0.1	18.9	29.7	24.1	37.5	43.8	9.6	24.6	18.4	116.9	38.6	28.2	51.6	27.8	48.6	50.9	28.4	42.7	38.1	20.5	26.5	18.0	33.6	22.2	51.6	13.6	31.4	34.8	14.1	29.7	12.6	12.7	13.8	14.1	23.8	13.9	11.4	11.3	56.9	14.8	29.7	16.0	15.9	21.8	40.8	49.4	27.9	68.8	38.5	34.3	46.5	32.5	41.4	42.2	6.0	11.9	80.5	73.2	98.9	47.2	4.8	61.1	2.7	5.7	101.2	11.8	161.3	213.9	165.0	51.7	128.5	181.1	23.3	153.1	171.0	104.1	89.0	43.8	54.4	378.1	36.5	75.6	132.6	164.6	69.3	100.7	188.2	150.1	269.7	97.5	92.9	185.3	164.9	146.3	237.3	31.6	129.4	94.7	27.9	53.0	114.4	229.9	106.7	88.6	114.9
RABGAP1	"GAPCenA, TBC1D11"	ENSG00000011454	"RAB GTPase activating protein 1"	Q9Y3P9	9	122940833-123104866	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041651, HPA064860, HPA072273"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA041651: AB_10794673, HPA064860: AB_2685372, HPA072273: AB_2686504"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.45e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.90e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.19e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.76e-1)"	"prognostic favorable (6.06e-6)"	"unprognostic (1.39e-1)"	"unprognostic (2.75e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.05e-2)"	16.9	12.6	24.2	12.5	31.0	5.1	17.1	16.9	36.3	18.8	27.6	19.5	16.4	9.5	23.6	20.9	25.5	18.2	15.2	20.0	22.4	20.8	16.2	9.0	15.0	14.0	23.9	25.0	19.6	12.6	29.1	17.7	18.5	23.9	24.1	18.6	19.4	18.1	25.4	23.7	17.3	12.8	25.6	23.0	13.5	17.8	16.4	17.5	11.4	31.2	8.6	16.2	22.9	16.4	4.1	3.9	6.1	5.5	2.1	4.5	1.4	8.9	12.0	19.0	15.7	22.0	18.0	11.7	9.4	17.0	14.6	13.7	13.9	8.8	12.4	7.5	14.6	19.5	30.5	12.1	11.8	15.8	11.5	7.3	9.7	19.4	10.5	18.9	7.8	8.4	17.3	18.1	12.5	14.2	21.1	16.5	12.4	8.3	9.5	17.5	19.9	10.2	6.2	7.0	25.8	9.3	16.9	34.7	10.5	12.2	10.0	10.7	8.3	16.8	15.2	8.6	14.9	28.9	4.3	12.6	12.4	7.4	13.6	9.4	9.3	15.1	13.0	11.7	4.0	10.8	6.1	3.6	4.3	2.6	5.5	2.0	3.0	2.7	2.3	2.8	4.1	4.5	2.9	5.6	2.1	2.4	3.9	3.1	1.4	24.2	31.0	16.9	36.3	22.4	20.8	23.9	25.0	23.9	17.5	23.8	43.2	18.2	20.2	16.0	47.9	39.5	10.2	33.5	34.2	10.4	47.1	17.8	3.3	9.1	11.8	24.1	12.7	0.0	12.8	7.4	18.2	30.8	13.9	13.7	13.6	54.0	16.3	27.0	26.4	10.7	37.7	15.9	13.5	18.0	17.1	36.5	10.0	10.5	48.4	9.0	35.9	84.1	32.0	71.1	34.5	15.2	34.8	8.7	14.4	15.5
RABGGTA	PTAR3	ENSG00000100949	"Rab geranylgeranyltransferase alpha subunit"	Q92696	14	24265538-24271739	"Enzymes, Predicted intracellular proteins"		"Prenyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043488	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043488: AB_10794887"	"unprognostic (2.00e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.78e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.44e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.51e-4)"	"unprognostic (2.01e-1)"	6.9	9.9	8.6	7.1	9.4	8.7	7.5	9.4	16.2	8.2	9.8	8.4	13.6	7.2	6.4	11.6	37.2	12.3	8.1	10.9	6.9	8.0	12.5	15.0	10.6	10.7	7.7	8.5	8.0	16.4	15.7	10.2	14.1	10.6	8.0	8.0	7.2	12.8	9.2	11.1	13.3	12.1	6.9	6.1	11.5	9.4	11.3	7.0	7.3	9.4	20.3	18.2	8.4	11.4	6.5	12.7	6.7	16.8	6.9	6.3	6.3	3.5	6.0	2.3	3.2	3.8	7.0	12.8	5.4	5.2	8.8	7.6	6.1	5.3	5.5	4.0	6.6	3.5	7.1	2.9	12.5	3.5	7.0	7.3	3.2	5.1	21.0	7.2	6.7	12.2	7.4	14.3	4.3	5.8	5.0	7.3	6.1	2.8	4.3	6.8	15.6	3.6	5.0	1.4	5.2	8.8	3.1	2.2	3.8	8.0	6.9	6.3	3.7	4.1	8.4	4.4	3.6	4.2	4.8	5.3	4.1	3.1	1.9	2.9	5.8	4.4	3.5	2.9	4.3	6.4	3.1	10.0	6.7	5.9	16.8	5.1	6.5	5.7	5.1	12.7	4.2	5.0	4.4	2.6	6.9	12.4	4.0	6.3	6.3	8.6	9.4	9.4	16.2	6.9	8.0	7.7	8.5	10.6	7.0	8.9	12.3	17.9	17.1	15.8	6.9	10.1	25.5	12.0	9.1	5.2	5.9	32.5	13.3	22.0	2.6	7.4	21.7	0.0	23.8	25.8	10.7	12.8	35.7	5.9	24.6	11.1	12.6	7.4	15.6	5.6	8.3	17.3	15.1	18.0	13.1	8.2	28.8	21.0	6.7	18.0	4.1	6.5	12.8	3.0	24.9	10.8	47.9	18.7	15.8	17.4
RACGAP1	MgcRacGAP	ENSG00000161800	"Rac GTPase activating protein 1"	Q9H0H5	12	49976923-50033136	"Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein, GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 40.9"	"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 46.7;Extravillous trophoblasts: 40.9;Spermatocytes: 65.3;Spermatogonia: 40.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB025859, HPA039427, HPA043912"	Enhanced		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"CAB025859: , HPA039427: AB_2676503, HPA043912: AB_2678728"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.74e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.82e-2)"	"prognostic unfavorable (1.86e-6)"	"unprognostic (1.15e-3)"	"unprognostic (3.07e-3)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.12e-6)"	"unprognostic (5.56e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (3.13e-2)"	"unprognostic (4.94e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.15e-1)"	3.7	2.6	4.9	10.0	11.3	21.0	4.2	6.3	7.8	4.2	10.1	4.7	1.5	6.5	3.3	1.9	17.7	2.7	4.0	2.7	4.8	4.5	5.9	2.8	5.6	13.7	7.8	5.0	2.5	2.0	3.3	1.4	8.4	5.4	2.4	11.9	2.0	4.7	2.1	3.8	8.7	7.5	7.6	5.9	5.9	6.8	29.4	6.6	40.9	2.4	8.7	17.8	6.0	6.5	6.3	2.2	16.5	3.5	8.8	14.8	4.8	44.6	40.8	32.5	20.8	6.0	7.2	27.8	47.4	22.8	49.7	34.0	40.7	34.2	24.8	21.2	25.1	24.3	30.3	32.4	22.0	53.0	47.5	20.4	31.9	40.4	13.3	2.2	33.6	26.4	3.9	4.1	33.7	26.9	14.6	16.8	22.7	23.0	38.1	46.4	31.3	27.7	16.8	23.2	25.3	27.0	26.4	39.8	18.2	13.2	22.3	27.4	23.7	38.7	24.6	13.1	17.3	47.8	15.2	15.3	32.9	29.7	21.0	34.1	20.2	49.9	29.4	16.6	23.0	19.2	16.5	2.6	3.9	5.7	3.5	4.9	6.3	6.9	7.8	2.2	3.9	4.2	5.5	0.5	8.8	1.9	1.5	14.8	4.8	4.9	11.3	6.3	7.8	4.8	4.5	7.8	5.0	5.4	6.6	6.0	5.4	8.5	2.4	11.4	1.6	1.2	2.5	2.7	3.4	5.2	3.9	6.2	16.6	1.5	9.3	1.7	1.5	46.7	1.8	40.9	4.1	2.1	2.3	1.8	11.4	1.6	0.0	6.2	11.7	11.4	1.4	8.0	1.7	3.6	2.6	1.7	1.6	0.0	3.5	1.9	0.7	12.9	2.8	65.3	40.1	11.3	7.2	4.4	4.1	1.1
RAD17	"CCYC, RAD17Sp, Rad24"	ENSG00000152942	"RAD17 checkpoint clamp loader component"	O75943	5	69369293-69414801	"Predicted intracellular proteins"	"Cell cycle, DNA damage"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 97.3;Spermatocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004551, HPA005448"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004551: AB_628195, HPA005448: AB_1079738"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.28e-3)"	"unprognostic (2.21e-1)"	"unprognostic (2.30e-1)"	"unprognostic (6.04e-2)"	"unprognostic (7.75e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.59e-2)"	"unprognostic (5.74e-2)"	"prognostic favorable (5.79e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.24e-2)"	11.8	12.6	10.6	15.3	15.3	9.3	16.5	13.9	14.2	11.0	10.9	12.3	13.7	7.0	12.9	12.2	10.0	9.9	7.8	11.5	11.1	12.8	18.6	16.1	13.2	24.6	11.6	10.7	11.7	18.3	15.1	32.0	12.9	14.7	12.2	13.3	10.0	12.8	18.8	15.7	9.6	11.9	10.5	13.4	14.5	11.6	37.7	11.6	17.0	15.1	10.0	17.0	10.5	13.6	10.5	4.4	4.9	3.6	7.6	7.5	3.1	7.6	3.4	10.7	12.6	0.0	0.1	13.1	7.6	9.6	10.4	14.8	8.1	8.4	33.8	8.3	4.4	20.9	3.6	10.6	4.4	16.2	0.0	5.8	8.2	8.3	8.1	12.9	0.2	10.8	7.6	7.4	7.7	7.6	0.0	9.0	8.9	7.9	10.3	13.1	0.0	15.0	5.6	6.6	3.2	4.3	13.1	9.8	7.5	12.5	7.0	11.2	7.9	7.0	2.2	0.3	11.9	10.4	10.1	2.7	0.0	9.5	4.8	4.9	13.3	20.5	11.5	10.7	16.1	6.9	1.4	3.0	4.9	6.0	3.6	5.7	10.5	5.4	6.4	4.4	7.2	7.5	6.3	1.2	7.6	1.7	2.2	7.2	3.1	10.6	15.3	13.9	14.2	11.1	12.8	11.6	10.7	14.7	11.6	29.8	13.2	13.4	4.7	4.8	17.0	29.6	15.3	44.2	27.3	5.2	19.6	15.1	21.6	10.9	97.3	7.1	8.1	0.0	11.2	14.1	10.3	7.8	29.0	9.7	8.9	6.4	14.6	13.5	10.7	61.1	13.3	11.4	5.0	10.8	9.8	18.3	10.4	7.0	10.3	17.0	44.8	6.5	8.0	125.0	69.7	5.1	11.8	11.4	11.1	4.3
RAD18	RNF73	ENSG00000070950	"RAD18, E3 ubiquitin protein ligase"	Q9NS91	3	8775402-8963773	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006716, HPA006724, HPA008752"	Supported	Approved	Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA006716: AB_2667650, HPA006724: AB_2667655, HPA008752: AB_2668129"	"unprognostic (1.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.73e-2)"	"unprognostic (6.15e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.01e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (3.73e-4)"	"prognostic unfavorable (3.65e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.89e-2)"	6.2	5.7	7.4	5.6	12.7	7.9	9.5	16.4	11.4	5.5	6.6	3.9	5.4	17.7	6.5	3.7	7.6	4.9	5.6	4.4	4.7	3.3	4.3	5.7	5.9	7.6	8.4	6.9	7.1	4.2	3.4	6.9	6.9	5.7	7.4	9.0	3.5	7.5	3.5	3.7	8.5	10.5	6.0	7.8	8.5	5.1	9.5	9.8	16.6	6.7	4.7	7.5	6.1	6.8	3.7	6.3	8.7	3.0	4.3	5.5	1.5	9.9	9.4	7.9	4.7	2.0	4.2	9.7	15.8	5.4	15.2	10.5	8.6	6.4	12.3	3.0	8.9	8.9	3.5	8.3	8.2	15.6	7.6	10.5	10.4	9.5	5.1	1.2	13.7	9.0	1.6	3.0	15.0	10.2	4.1	4.9	10.5	11.1	12.2	13.3	11.5	13.9	9.8	11.0	7.9	17.4	11.1	8.8	9.7	4.4	7.7	3.3	7.5	7.0	6.8	5.1	6.5	7.0	6.1	4.0	12.7	6.9	10.7	13.5	6.2	9.4	26.7	9.3	15.3	9.3	7.4	2.7	8.7	3.0	3.0	5.5	3.7	4.0	5.2	3.4	3.7	4.3	3.2	1.2	4.3	1.8	6.3	5.0	1.5	7.4	12.7	16.4	11.4	4.7	3.3	8.4	6.9	5.7	9.8	14.9	9.8	8.2	5.8	9.8	5.1	2.0	5.1	4.0	9.1	3.5	2.0	6.6	1.7	6.5	3.3	4.2	3.8	0.0	7.1	10.7	4.3	7.0	12.8	2.9	5.9	3.2	1.7	4.9	3.7	2.1	3.7	4.6	3.3	7.2	5.0	2.8	7.9	5.8	2.5	2.4	2.2	6.5	4.7	15.5	13.6	10.3	5.6	4.6	5.2	2.7
RAD21	"hHR21, KIAA0078, SCC1"	ENSG00000164754	"RAD21 cohesin complex component"	O60216	8	116845935-116874866	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, DNA damage, DNA repair, Mitosis, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020044, CAB022065"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB022065: , HPA020044: AB_1856035"	"unprognostic (7.85e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.05e-1)"	"unprognostic (5.43e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (1.86e-3)"	"unprognostic (8.99e-2)"	"unprognostic (8.80e-2)"	"unprognostic (5.58e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-1)"	31.6	40.9	48.2	30.5	52.2	78.5	37.7	58.8	55.3	24.2	36.3	37.5	21.5	24.8	30.5	25.3	32.1	23.1	22.0	37.8	45.6	44.1	30.5	27.9	29.6	49.2	54.3	35.4	33.5	18.2	29.1	30.0	38.9	45.5	26.5	37.3	19.0	25.3	31.0	37.8	24.0	26.0	33.4	49.7	31.2	31.5	37.6	56.2	58.3	41.9	20.9	50.4	37.1	36.0	8.7	5.4	17.9	7.1	8.0	25.4	6.2	41.6	20.5	40.2	22.5	20.2	17.5	18.0	29.0	27.5	32.2	29.8	16.8	39.3	61.6	16.0	20.6	17.2	23.3	34.2	18.7	37.8	81.7	21.9	62.8	25.2	21.3	12.7	20.1	37.0	14.9	15.4	18.8	22.8	21.3	25.1	89.9	25.2	86.3	27.7	25.1	92.1	11.9	23.6	53.8	25.9	33.8	29.2	30.9	19.2	24.5	50.8	26.2	30.4	82.1	19.6	22.0	34.4	24.9	18.4	22.8	33.4	23.8	30.3	45.7	52.5	55.5	19.5	29.0	27.2	17.2	4.5	15.5	11.0	5.3	11.2	8.7	12.9	13.0	5.4	8.3	13.5	13.0	17.9	8.0	7.1	4.5	25.4	6.2	48.2	52.2	58.8	55.3	45.6	44.1	54.3	35.4	45.5	56.2	238.2	123.7	70.9	67.0	84.9	73.4	149.3	48.4	87.0	138.8	52.4	29.5	106.6	36.5	47.5	247.8	88.8	56.4	70.0	38.8	119.7	73.7	80.6	143.9	61.8	58.9	63.5	81.0	64.4	91.5	303.2	107.9	82.3	65.8	97.4	62.9	99.6	49.1	57.5	100.0	50.1	60.7	71.1	54.7	31.6	81.6	87.8	95.1	93.8	69.2	65.3
RAD23A	"HHR23A, MGC111083"	ENSG00000179262	"RAD23 homolog A, nucleotide excision repair protein"	P54725	19	12945855-12953642	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"skeletal muscle: 225.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026418, HPA053901, HPA057003, HPA065599"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		3100000	Nucleoplasm	Cytosol	"HPA026418: AB_2732430, HPA053901: AB_2682300, HPA057003: AB_2683309, HPA065599: AB_2685516"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.90e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.57e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.09e-3)"	"unprognostic (2.32e-3)"	"unprognostic (9.99e-2)"	"unprognostic (8.56e-2)"	"unprognostic (6.59e-3)"	19.6	15.2	19.1	13.4	17.7	19.9	16.0	15.1	25.3	12.9	18.0	14.6	10.7	13.6	15.3	14.3	19.9	17.7	13.6	34.3	16.6	16.0	13.2	24.5	14.2	14.1	15.4	15.6	17.1	21.1	14.0	12.3	17.3	15.5	15.1	10.7	12.6	18.6	15.8	225.3	19.8	11.9	16.5	15.4	15.7	14.9	19.1	12.5	14.6	17.2	37.7	13.8	20.7	17.0	29.5	30.0	22.7	35.6	26.5	32.1	22.5	31.6	11.7	13.6	14.0	22.6	26.0	22.8	15.5	31.2	36.9	33.6	13.1	22.9	27.0	35.8	23.3	24.9	24.6	18.6	32.2	14.0	38.1	23.6	10.9	15.2	12.6	44.1	23.5	32.0	26.5	48.4	26.6	51.0	22.0	25.3	42.9	27.9	24.9	33.2	31.0	29.2	29.1	18.6	28.7	29.1	15.5	14.1	43.9	28.7	12.7	25.2	19.8	17.2	31.3	34.3	10.4	24.4	40.8	19.8	53.1	14.2	63.0	47.3	36.0	30.2	19.7	43.7	44.5	43.6	10.4	27.9	22.7	29.7	35.6	32.1	29.2	25.3	25.1	23.4	29.5	24.6	27.8	3.9	26.5	34.9	30.0	27.0	22.5	19.1	17.7	15.1	25.3	16.6	16.0	15.4	15.6	15.5	12.5	80.4	45.1	117.4	151.7	107.0	47.8	58.9	99.3	85.6	69.4	52.4	19.6	181.0	140.9	124.8	141.7	106.7	99.7	397.1	165.8	204.0	114.4	158.2	108.6	79.1	154.6	49.3	83.8	66.9	72.2	22.4	109.6	119.4	135.0	233.6	105.8	52.4	156.1	119.3	107.1	115.4	44.7	109.9	155.2	223.5	168.2	128.1	204.7	114.9	143.0	156.7
RAD54L	"hHR54, hRAD54, RAD54A"	ENSG00000085999	"RAD54 like"	Q92698	1	46247688-46278473	"Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 41.9;testis: 56.6"	"Cell type enhanced"	"Detected in some"	11	"Extravillous trophoblasts: 7.8;granulocytes: 4.6;Spermatocytes: 8.0;Spermatogonia: 4.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA028954, HPA051537"	Approved		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA028954: AB_2672840, HPA051537: AB_2681525"	"unprognostic (2.12e-2)"	"prognostic favorable (6.67e-4)"	"unprognostic (5.12e-2)"	"unprognostic (5.36e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.75e-6)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.77e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.11e-16)"	"unprognostic (6.76e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.74e-1)"	1.9	0.6	1.5	12.9	4.7	9.4	1.3	3.0	1.9	1.1	4.8	0.7	0.5	2.8	1.2	2.1	5.2	0.3	1.2	1.5	1.8	1.5	1.4	0.5	1.5	6.0	1.9	0.7	0.8	1.4	0.6	0.5	4.2	0.9	1.1	5.8	0.6	1.4	1.0	1.4	3.0	3.6	1.8	3.2	4.1	1.7	56.6	0.6	41.9	1.7	3.8	9.6	1.0	1.7	0.5	0.3	0.0	0.1	0.9	4.1	0.7	9.0	6.8	20.5	12.5	1.5	1.0	19.1	10.7	4.7	18.1	18.6	14.5	6.0	17.8	8.2	4.5	16.5	9.4	18.9	6.0	16.0	9.7	19.1	21.8	18.2	14.4	0.0	21.8	12.8	0.6	0.5	18.0	5.3	3.0	5.6	20.7	15.6	18.2	9.9	8.6	27.1	24.2	18.3	8.0	11.2	21.7	11.4	7.8	4.4	7.8	9.8	7.0	7.8	10.8	2.6	17.4	3.8	15.9	2.4	19.5	11.6	10.0	18.0	7.7	4.4	19.2	5.2	14.5	7.8	0.0	0.1	0.0	1.2	0.1	0.2	0.5	0.2	0.3	0.3	0.2	0.0	0.1	0.0	0.9	0.1	0.0	4.1	0.7	1.5	4.7	3.0	1.9	1.8	1.5	1.9	0.7	0.9	0.6	0.0	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	1.8	0.1	0.2	0.0	0.0	7.8	0.4	0.3	4.6	0.0	2.2	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	4.2	0.3	1.4	0.0	1.2	0.4
RAI1	"DKFZP434A139, KIAA1820, MGC12824, SMCR, SMS"	ENSG00000108557	"Retinoic acid induced 1"	Q7Z5J4	17	17681473-17811453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023898, HPA054906"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA023898: AB_10971089, HPA054906: AB_2682637"	"unprognostic (7.57e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.28e-2)"	8.0	13.8	13.8	12.6	17.6	8.1	10.1	21.5	22.9	18.1	12.2	14.2	13.3	11.3	17.8	11.8	12.1	20.3	16.8	13.6	11.3	11.9	10.3	5.8	11.2	9.7	11.1	11.3	17.3	17.2	22.4	19.6	8.4	11.3	17.7	5.4	23.3	24.0	18.2	8.2	19.1	9.5	16.7	6.6	18.5	16.6	8.8	15.7	10.4	15.6	7.7	11.2	19.6	30.0	1.0	3.0	0.7	1.2	2.8	1.0	0.7	15.7	21.4	13.6	11.2	1.8	3.8	2.3	5.4	5.9	4.6	4.5	11.1	6.7	5.1	7.5	7.0	3.9	18.6	4.7	10.8	1.9	5.0	10.6	9.3	12.9	5.6	6.1	3.7	5.9	4.3	5.3	4.1	6.2	5.4	5.6	6.5	3.9	4.1	2.3	14.1	7.8	3.6	0.9	8.2	6.3	18.4	10.6	7.2	3.8	18.9	9.5	16.9	8.6	7.6	17.6	16.4	10.2	4.7	10.7	7.3	9.4	11.6	7.6	3.7	0.8	3.2	7.1	4.6	19.8	0.0	1.0	0.7	0.8	0.8	0.5	0.1	0.4	0.6	0.5	1.0	0.3	1.0	0.1	2.8	1.2	3.0	0.0	0.7	13.8	17.6	21.5	22.9	11.3	11.9	11.1	11.3	11.3	15.7	11.9	28.1	1.9	9.0	10.8	24.9	3.6	10.2	1.4	11.4	14.0	21.6	0.1	0.0	13.7	2.5	7.8	2.4	0.0	8.0	0.5	8.8	11.5	13.9	5.6	2.1	22.3	10.9	14.1	2.2	3.1	6.4	6.3	8.5	2.8	6.9	5.8	9.6	0.0	5.6	1.8	12.0	6.5	6.4	1.4	12.4	7.8	0.3	2.9	6.3	11.1
RALY	"HNRPCL2, P542"	ENSG00000125970	"RALY heterogeneous nuclear ribonucleoprotein"	Q9UKM9	20	33993646-34108308	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040971, HPA043614"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA		12000	Nucleoplasm	Vesicles	"HPA040971: AB_2677230, HPA043614: AB_2678581"	"unprognostic (2.06e-1)"	"unprognostic (9.54e-3)"	"unprognostic (3.72e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (3.60e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (8.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.80e-2)"	37.7	23.4	26.3	39.9	30.7	65.2	55.4	22.4	33.9	35.0	43.7	37.6	35.1	41.9	36.4	31.0	41.6	35.2	38.9	51.9	27.3	24.4	39.3	30.3	40.9	53.9	33.0	23.4	38.3	38.5	21.9	20.7	41.9	26.5	34.9	34.9	32.0	38.7	32.7	62.0	39.8	48.8	41.7	40.9	40.4	36.0	56.8	28.9	76.0	76.7	43.6	42.6	33.5	49.7	30.8	40.9	61.6	54.1	54.1	48.4	40.4	37.0	25.6	41.5	31.6	18.6	19.8	33.6	25.9	21.6	34.8	30.1	68.9	33.6	29.2	38.2	21.6	44.6	41.7	19.5	40.5	19.8	19.1	20.2	69.1	15.1	68.8	25.8	35.6	35.3	21.0	24.7	25.8	26.5	26.4	33.8	37.7	28.6	50.1	22.2	35.8	88.6	57.5	21.4	44.5	49.5	52.5	56.7	39.7	21.2	23.5	39.6	44.3	43.3	41.5	58.9	21.5	42.3	38.0	26.5	72.1	43.7	35.0	32.4	50.1	42.0	52.0	36.2	27.0	33.0	32.9	32.4	61.6	44.3	39.9	33.1	30.8	40.1	48.4	40.9	30.7	35.6	33.6	52.9	54.1	54.1	33.8	42.0	40.4	26.3	30.7	22.4	33.9	27.3	24.4	33.0	23.4	26.5	28.9	50.6	54.9	87.2	97.9	70.3	18.7	53.7	58.6	25.4	27.3	52.4	17.7	128.1	107.8	136.9	27.6	80.9	214.0	70.0	140.3	190.7	86.4	99.8	59.9	32.8	138.7	7.9	89.2	68.2	94.3	35.9	60.7	107.6	109.6	188.4	118.3	48.1	145.4	157.8	58.4	84.7	21.3	109.9	97.1	67.3	96.5	70.6	143.4	124.9	145.1	145.7
RALYL	HNRPCL3	ENSG00000184672	"RALY RNA binding protein like"	Q86SE5	8	84182787-84921844	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 25.6;brain: 54.9;kidney: 23.5"	"Cell type enhanced"	"Detected in some"	24	"Bipolar cells: 38.5;Distal tubular cells: 150.9;Horizontal cells: 31.8;Muller glia cells: 33.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 26.8"	"Low region specificity"	"Detected in all"							"HPA055868, HPA059112"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055868: AB_2682950, HPA059112: AB_2683908"				"unprognostic (1.13e-5)"	"unprognostic (1.62e-1)"		"unprognostic (7.48e-2)"		"unprognostic (1.36e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.82e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.52e-1)"			1.1	25.6	14.0	1.1	23.0	1.2	1.1	54.9	38.2	0.9	1.3	1.1	0.0	1.4	1.1	1.8	0.9	1.7	7.1	3.7	14.9	22.6	23.5	1.3	1.1	1.0	14.7	20.0	1.0	3.7	1.0	7.6	2.4	9.8	1.2	1.5	0.4	1.1	3.4	1.1	1.2	1.8	1.1	4.6	3.8	1.6	1.4	3.5	0.0	1.1	0.0	1.0	1.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	26.8	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.0	14.0	23.0	54.9	23.0	14.9	22.6	14.7	20.0	9.8	3.5	0.0	0.0	0.0	0.0	0.0	38.5	4.4	22.9	0.0	0.0	7.0	2.0	0.0	150.9	0.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	31.8	1.7	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	33.3	0.1	0.0	0.0	14.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130871879-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		2100000	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	52.3	68.3	46.9	75.7	62.7	80.6	53.4	42.1	62.6	38.1	61.9	32.5	41.4	41.7	47.9	59.9	96.4	44.0	36.1	55.2	53.9	59.7	52.6	65.9	50.1	90.3	48.9	61.0	46.9	51.3	31.8	43.8	57.0	50.8	37.0	65.6	28.6	43.7	40.2	84.2	45.5	45.1	59.6	42.1	60.1	47.8	87.2	31.0	84.8	51.7	89.6	108.3	44.7	49.5	94.1	69.3	34.3	62.3	60.5	96.5	110.2	97.8	134.7	116.7	67.5	53.7	66.3	90.1	129.3	67.8	126.1	87.2	144.7	104.3	161.8	87.4	92.9	79.3	63.5	169.6	134.3	137.0	54.2	133.5	95.0	102.8	146.3	65.7	164.3	81.9	62.1	84.0	108.7	158.0	84.2	121.8	116.3	140.0	48.2	123.7	120.3	160.2	198.5	136.9	101.7	215.5	125.3	100.2	90.7	117.6	171.0	107.1	65.5	74.8	67.6	90.7	100.9	133.2	119.1	84.2	72.9	111.4	73.9	120.3	67.4	109.7	227.3	74.9	101.7	101.2	29.6	51.5	34.3	69.6	62.3	84.7	94.1	95.5	79.9	69.3	78.5	87.0	82.5	10.7	60.5	58.0	65.7	96.5	110.2	46.9	62.7	42.1	62.6	53.9	59.7	48.9	61.0	50.8	31.0	169.7	129.5	266.6	518.3	564.3	160.2	103.4	160.5	183.4	197.9	160.5	35.3	577.4	328.3	654.2	67.6	212.9	137.7	233.6	391.9	1042.2	424.8	302.9	190.4	172.1	550.1	131.9	193.7	150.4	155.0	125.0	197.6	285.4	315.5	519.4	219.7	197.5	494.0	152.6	217.1	304.7	106.2	161.7	425.8	567.1	580.4	478.1	512.7	322.1	399.9	542.5
RANBP1	HTF9A	ENSG00000099901	"RAN binding protein 1"	P43487	22	20115938-20127357	"Plasma proteins, Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 603.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 217.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065868, HPA065931"	Supported		Enhanced	Cytosol		NA	NA		910000	Cytosol		"HPA065868: AB_2685572, HPA065931: AB_2685580"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.43e-3)"	"unprognostic (6.55e-3)"	"unprognostic (4.35e-2)"	"unprognostic (2.50e-2)"	"prognostic unfavorable (1.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (2.40e-2)"	"unprognostic (3.95e-1)"	"unprognostic (4.44e-2)"	"unprognostic (7.30e-2)"	26.4	28.6	27.9	34.7	28.0	57.1	26.0	32.4	46.0	23.3	33.3	25.7	17.2	30.5	29.6	15.7	38.7	26.4	23.1	18.2	25.1	28.3	22.5	41.1	21.8	50.4	28.4	34.9	26.8	37.0	16.0	22.0	26.8	28.4	20.5	25.7	18.1	24.1	21.9	22.8	23.0	27.8	30.7	24.4	30.4	24.9	58.3	26.7	58.2	22.0	27.6	40.7	22.2	25.9	37.6	37.7	24.2	33.7	29.7	37.1	31.4	39.2	20.2	45.5	24.7	7.6	9.2	38.4	36.2	15.9	47.2	34.3	36.9	14.1	61.3	16.2	14.5	21.4	36.6	42.2	31.6	25.9	26.3	100.4	51.4	20.7	38.7	11.7	82.4	28.0	10.1	15.1	37.3	13.3	10.9	21.3	28.0	217.8	24.7	21.2	30.7	59.6	56.3	51.8	50.7	35.8	60.7	64.1	15.7	16.2	21.6	45.6	33.8	33.2	18.5	20.7	21.0	12.9	34.5	16.3	32.8	63.8	24.5	40.0	24.9	33.7	97.3	17.8	37.2	27.4	6.6	32.8	24.2	25.8	33.7	28.3	37.6	37.0	32.7	37.7	33.8	37.1	28.3	3.3	29.7	29.6	35.0	36.9	31.4	27.9	28.0	32.4	46.0	25.1	28.3	28.4	34.9	28.4	26.7	32.8	33.3	117.6	133.4	243.8	42.1	38.6	86.6	38.8	30.7	85.5	5.9	311.0	235.4	167.8	320.8	110.1	58.6	93.5	98.1	603.6	164.4	101.1	64.5	166.2	238.0	35.0	113.0	81.0	79.6	149.2	134.3	122.3	168.7	160.5	134.9	84.0	127.5	115.8	128.7	162.5	29.7	97.0	178.2	431.1	339.5	257.8	162.8	117.1	220.6	182.0
RANBP3		ENSG00000031823	"RAN binding protein 3"	Q9H6Z4	19	5916139-5978142	"Cancer-related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043375, HPA043389"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043375: AB_10959889, HPA043389: AB_10963696"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.61e-1)"	"prognostic favorable (1.22e-5)"	"unprognostic (4.24e-2)"	"unprognostic (1.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.08e-1)"	"prognostic favorable (4.14e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.15e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (1.06e-2)"	19.5	30.2	24.8	25.2	31.5	20.9	18.6	38.2	40.9	21.2	29.8	31.6	18.3	24.7	28.2	16.5	23.4	23.9	20.3	30.8	25.0	26.5	19.3	24.6	21.9	26.7	24.3	21.2	29.2	33.1	22.4	26.1	22.3	28.8	25.6	14.2	30.1	27.9	28.0	33.9	21.2	25.1	27.9	25.0	24.9	24.9	36.7	28.0	33.5	21.9	14.7	27.7	28.0	20.9	20.7	21.3	25.0	21.4	14.9	28.7	20.1	30.2	21.3	18.1	20.2	13.7	13.9	12.9	19.4	18.3	22.7	24.7	26.9	10.7	28.6	21.8	15.0	14.3	18.9	16.1	18.9	14.0	29.2	26.3	15.3	16.7	31.9	14.9	22.4	22.6	13.6	13.1	14.2	16.2	10.6	16.5	15.7	27.7	27.1	12.8	12.7	37.2	10.9	33.2	13.2	27.0	27.6	17.4	26.0	14.7	23.5	20.0	22.5	17.2	18.2	17.1	11.1	13.9	17.0	17.1	19.2	14.1	33.5	28.4	28.1	28.3	24.6	24.3	28.2	23.6	13.2	20.8	25.0	22.7	21.4	23.3	17.0	22.0	22.7	21.3	20.7	19.6	25.1	24.0	14.9	20.6	20.2	28.7	20.1	24.8	31.5	38.2	40.9	25.0	26.5	24.3	21.2	28.8	28.0	23.8	18.7	17.9	17.1	10.9	15.9	13.3	17.8	20.1	13.6	7.0	23.6	23.8	36.5	25.9	39.7	15.2	15.8	23.3	18.2	26.3	16.4	14.7	17.3	9.5	21.6	22.3	12.7	6.7	14.3	57.9	15.5	17.0	20.3	44.1	14.6	18.9	18.6	10.5	23.3	14.7	16.8	19.4	13.7	51.1	37.9	10.3	29.6	21.7	13.3	20.9
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes			"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.2	30.6	20.0	20.9	10.8	8.9	24.3	50.5	27.6	51.0	26.7	37.1	19.2	31.4	40.8	37.0	24.6	54.3	36.3	39.8	30.8	25.4	56.3	26.6	29.9	28.9	13.5	42.9	20.0	8.6	19.0	36.3	32.2	16.8	26.7	11.8	34.1	22.4	29.0	49.9	25.0	34.9	21.8	53.1	36.4	30.7	19.7	33.1	19.9	33.4	18.2	12.1	35.9	31.8	18.5	19.2	18.7	17.3	41.2	39.1	37.5	21.5	41.5	16.7	22.2	29.9	27.3	30.5	22.5	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3	3.0	24.7	28.1	17.5	20.5	15.2	17.4	22.9	9.4	9.1	8.7	13.7	15.1	3.3	34.2	259.8	12.7	10.1	0.0	17.4	28.1	9.3	32.2	5.8	17.9	14.0	14.3	24.0	11.6	13.4	1320.8	13.8	17.1	11.8	10.0	13.9	7.8	29.0	6.5	11.3	11.2	24.4	0.0	9.0	18.0	19.2	27.0	19.8	23.8	10.9	19.2
RARB	"HAP, NR1B2, RRB2"	ENSG00000077092	"Retinoic acid receptor beta"	P10826	3	25174332-25597932	"Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"retina: 39.1"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 22.6"	"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1"	"Region enriched"	"Detected in many"	9	"basal ganglia: 97.9"	"Low region specificity"	"Detected in all"			"CAB002617, HPA004174"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002617: , HPA004174: AB_1079744"	"unprognostic (2.04e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.72e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (9.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.56e-3)"	3.9	7.1	2.4	2.3	22.6	0.0	6.8	1.5	9.1	13.4	6.0	2.2	6.8	1.7	14.4	7.5	8.1	6.2	5.3	13.6	2.6	2.2	17.5	6.2	5.6	5.6	2.0	3.7	12.2	1.5	12.8	18.9	13.9	3.2	13.0	2.3	39.1	13.7	11.8	2.5	1.4	2.4	14.7	4.6	7.7	4.8	1.7	4.8	0.0	10.0	2.9	4.6	12.1	10.2	1.0	0.4	0.1	0.6	0.1	0.8	0.0	0.0	0.9	0.6	3.1	7.0	1.8	0.0	0.8	0.4	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.5	0.1	0.1	0.0	3.7	0.0	0.0	0.0	41.7	6.6	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	4.2	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.5	0.0	1.1	3.4	0.1	0.0	0.0	2.8	0.1	18.1	0.0	0.6	0.0	0.8	0.1	0.3	0.3	0.5	0.5	0.4	1.0	0.6	0.8	0.1	0.1	0.1	0.4	0.0	0.0	2.4	22.6	1.5	9.1	2.6	2.2	2.0	3.7	3.2	4.8	0.0	0.3	0.0	17.9	0.1	4.2	9.3	7.6	6.7	12.5	10.4	23.6	0.1	0.0	1.4	1.3	3.8	0.0	0.0	0.8	0.1	3.1	5.5	0.0	2.0	0.3	4.8	0.0	20.3	4.1	0.4	0.0	0.0	0.0	0.0	0.0	27.5	1.1	0.0	0.0	0.5	6.1	0.0	9.2	0.2	1.1	0.1	0.2	0.0	0.0	7.1
RARS	DALRD1	ENSG00000113643	"Arginyl-tRNA synthetase"	P54136	5	168486445-168519299	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003979, HPA004130"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA003979: AB_1856083, HPA004130: AB_1856084"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (7.59e-5)"	"prognostic unfavorable (1.10e-8)"	"unprognostic (3.26e-3)"	"unprognostic (5.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.92e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.33e-2)"	21.8	26.3	16.0	18.3	15.3	6.2	22.6	17.1	18.4	21.2	29.4	9.1	20.4	33.3	22.9	21.4	34.7	19.5	14.4	21.7	19.8	12.3	29.8	33.5	18.7	18.6	13.9	15.2	21.3	33.0	19.9	34.5	30.3	15.8	18.9	27.4	15.5	34.0	15.4	27.8	27.9	48.7	21.5	14.5	22.1	24.4	17.2	11.8	20.5	21.5	32.3	23.7	22.4	22.6	11.1	21.8	5.2	17.7	16.8	16.3	11.7	27.2	32.4	24.0	26.6	33.2	38.1	41.3	40.2	34.6	41.9	49.0	55.0	29.8	29.0	33.0	38.2	43.1	26.5	31.4	54.1	54.7	30.1	21.6	19.5	29.5	34.5	28.8	46.0	20.8	29.2	28.9	45.6	21.9	25.8	33.5	15.9	29.1	14.7	44.8	25.2	19.1	18.3	39.4	24.0	22.1	8.4	35.0	27.6	37.3	31.1	22.9	28.2	30.7	35.5	41.5	30.5	32.3	19.3	33.2	30.4	27.9	23.4	46.8	14.7	26.9	29.8	33.1	32.9	28.8	3.4	14.4	5.2	12.5	17.7	14.3	11.1	12.6	13.3	21.8	6.6	15.6	16.3	4.0	16.8	16.4	10.3	12.8	11.7	16.0	15.3	17.1	18.4	19.8	12.3	13.9	15.2	15.8	11.8	53.6	32.3	25.1	37.6	26.3	25.0	43.6	35.7	46.8	39.8	24.4	25.5	88.8	14.9	80.1	16.6	27.5	40.6	23.3	83.1	79.2	34.8	24.5	26.6	31.4	51.1	12.7	12.6	33.2	24.6	11.6	23.0	35.0	27.0	72.1	36.7	22.7	61.2	38.7	23.0	36.0	22.7	19.4	28.9	27.7	42.2	31.1	70.5	20.1	44.8	35.2
RBBP4	"lin-53, NURF55, RbAp48"	ENSG00000162521	"RB binding protein 4, chromatin remodeling factor"	Q09028	1	32651142-32686211	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006264, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		27000	Nucleoplasm		"CAB006264: AB_425651, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (1.18e-3)"	"unprognostic (1.79e-3)"	"unprognostic (2.96e-3)"	"unprognostic (1.82e-2)"	"prognostic favorable (9.23e-4)"	"unprognostic (1.62e-2)"	"prognostic unfavorable (1.89e-6)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (1.57e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-2)"	23.8	33.6	28.2	34.3	27.8	23.4	29.1	30.5	35.1	32.2	24.1	32.0	42.3	20.5	36.0	29.2	26.0	35.4	21.3	24.0	27.9	24.8	25.2	25.4	23.0	43.9	30.6	29.0	37.6	31.3	27.0	32.9	26.2	26.9	24.2	35.5	31.2	30.1	43.1	31.8	24.9	26.8	32.6	26.9	27.6	28.8	53.4	31.4	73.3	35.8	20.5	65.2	32.5	26.6	33.7	45.4	26.7	39.4	33.1	32.4	48.4	15.6	13.7	39.2	28.6	12.1	11.5	15.9	11.9	10.4	24.4	23.8	19.6	32.2	47.5	13.2	14.1	14.1	10.1	42.9	12.4	26.3	18.5	20.6	44.3	27.7	25.7	17.5	41.8	19.2	12.6	15.8	18.4	12.0	19.0	18.0	32.9	31.1	34.1	20.8	10.9	53.5	13.1	43.6	15.5	16.0	52.0	41.3	41.2	17.1	33.5	37.5	22.3	28.2	10.1	19.3	40.4	17.3	19.3	14.9	14.8	15.1	18.7	16.0	27.0	28.3	53.3	17.7	33.8	22.7	26.4	38.8	26.7	31.1	39.4	32.4	33.7	29.7	31.4	45.4	26.6	26.7	28.8	10.2	33.1	35.3	38.3	30.3	48.4	28.2	27.8	30.5	35.1	27.9	24.8	30.6	29.0	26.9	31.4	38.7	41.4	104.6	60.7	63.4	104.9	19.4	79.0	50.9	46.6	69.8	135.5	102.1	71.3	72.0	18.9	58.2	40.2	23.3	50.7	69.8	69.6	53.3	47.4	69.1	71.5	100.1	93.2	70.6	73.4	13.7	73.6	63.2	47.2	72.1	69.7	74.5	62.2	28.8	83.1	53.7	104.1	97.0	47.5	120.2	77.3	67.8	71.5	85.3	75.6	47.1
RBBP6	"P2P-R, PACT, SNAMA"	ENSG00000122257	"RB binding protein 6, ubiquitin ligase"	Q7Z6E9	16	24537693-24572863	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA replication, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032866, HPA041725, HPA043544"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB032866: AB_2177791, HPA041725: AB_2677639, HPA043544: AB_2678543"	"unprognostic (1.04e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.83e-2)"	15.1	17.6	17.2	14.0	16.4	81.4	17.9	33.0	15.7	17.8	18.8	16.3	19.8	10.2	23.2	18.7	15.3	21.2	17.6	14.7	15.0	13.2	13.1	15.8	15.7	18.1	18.7	12.2	27.2	14.4	20.7	23.1	73.9	15.4	18.2	14.4	18.4	13.7	14.7	19.2	19.2	16.4	18.4	19.2	18.6	16.4	25.1	18.7	24.3	18.6	11.8	15.5	17.9	17.9	3.8	6.9	8.5	3.7	6.5	4.2	1.0	17.7	9.3	21.9	22.8	16.8	17.6	23.8	14.4	13.3	13.2	14.3	10.3	14.4	24.7	10.9	12.2	15.1	17.2	23.5	12.5	21.9	13.5	18.2	21.3	26.7	29.3	13.1	28.2	12.7	15.2	17.5	17.2	20.3	14.9	18.9	21.7	26.7	22.6	15.2	18.3	22.7	25.5	25.2	12.0	8.8	31.4	22.3	21.7	12.7	15.9	17.6	15.4	20.3	18.2	25.5	25.5	14.2	25.1	16.3	16.4	12.1	14.1	15.4	20.1	20.0	31.2	13.2	18.8	13.5	8.5	2.3	3.7	4.0	3.7	4.2	3.8	4.1	2.8	1.6	3.8	3.5	4.0	5.0	6.5	2.1	6.9	3.1	1.0	17.2	16.4	33.0	15.7	15.0	13.2	18.7	12.2	15.4	18.7	80.4	103.7	61.9	93.7	89.4	65.1	127.0	28.1	61.6	67.1	26.2	94.2	37.6	21.6	42.4	225.8	76.4	57.3	46.7	41.4	46.4	91.5	72.4	49.7	50.4	33.6	58.8	78.7	66.3	46.7	20.2	67.0	54.3	59.1	55.1	59.4	50.8	43.9	28.1	55.2	17.7	56.2	51.8	113.1	66.6	47.7	89.0	84.9	56.5	56.8	89.7
RBBP7	RbAp46	ENSG00000102054	"RB binding protein 7, chromatin remodeling factor"	Q16576	X	16839283-16870414	"Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 376.6;Syncytiotrophoblasts: 445.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037084, HPA060710, HPA060724"	Supported		Enhanced	Nucleoplasm		NA	NA		25000	Nucleoplasm		"CAB037084: AB_477448, HPA060710: AB_2684347, HPA060724: AB_2684350"	"unprognostic (5.18e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.68e-3)"	"unprognostic (1.09e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (3.64e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.00e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (5.65e-2)"	16.0	81.2	16.6	21.1	26.7	20.3	15.5	13.3	16.2	34.6	22.8	15.3	103.2	13.1	32.3	77.3	20.9	24.5	19.7	36.2	15.1	13.1	17.3	18.5	14.3	19.7	13.7	15.5	41.6	19.0	47.8	16.0	28.7	12.2	26.2	18.1	16.5	19.0	87.6	78.2	16.4	17.9	25.9	15.9	16.0	23.5	31.6	13.6	30.8	18.1	18.2	24.5	24.3	18.5	36.6	29.4	23.7	41.2	32.8	37.7	27.3	54.1	40.3	30.7	40.4	19.3	22.8	19.5	27.0	27.1	39.8	45.1	23.6	35.9	59.9	41.5	26.1	45.8	28.7	54.7	40.1	52.8	33.9	75.1	25.3	49.0	28.0	16.4	38.2	30.7	17.7	14.8	45.8	33.6	25.6	39.8	25.3	25.3	32.0	31.4	36.4	42.7	35.4	34.5	26.2	37.5	37.5	56.5	70.7	28.9	36.5	28.6	21.2	50.9	24.5	23.9	45.1	81.3	23.2	18.3	19.2	19.7	50.6	29.9	22.4	32.0	78.7	24.7	25.8	23.3	16.6	18.3	23.7	36.4	31.3	34.8	36.6	30.4	37.7	25.4	31.0	32.2	35.9	7.4	32.8	41.2	29.4	27.9	27.3	16.6	26.7	13.3	16.2	15.1	13.1	13.7	15.5	12.2	13.6	47.6	54.2	48.2	88.5	66.4	28.9	94.0	30.6	84.3	85.3	52.4	27.5	376.6	66.3	71.3	10.8	45.8	40.0	0.0	65.2	134.7	86.4	63.3	56.6	33.9	93.5	23.8	58.3	39.9	27.6	22.8	105.3	44.7	79.2	75.7	53.5	73.6	61.9	31.6	176.0	51.2	38.7	135.8	87.2	52.9	107.5	53.3	445.1	67.8	67.4	67.3
RBFOX1	"A2BP1, FOX-1, HRNBP1"	ENSG00000078328	"RNA binding fox-1 homolog 1"	Q9NWB1	16	5239802-7713338	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 57.2;heart muscle: 17.6;skeletal muscle: 67.6"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 81.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	15	"RH-30: 25.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040809, HPA066746, HPA075862"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus,Cytosol"		No	No			Nucleoplasm	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA040809: AB_10796228, HPA066746: , HPA075862: "	"unprognostic (3.75e-3)"		"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.19e-3)"		"unprognostic (8.82e-5)"	"unprognostic (5.02e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.00e-2)"	"unprognostic (2.28e-1)"		1.2	2.4	19.9	1.5	33.0	1.6	1.3	31.5	57.2	1.4	1.9	1.9	0.0	1.3	1.3	5.0	2.0	2.2	1.3	17.6	16.4	6.7	1.5	1.3	1.2	1.2	3.7	21.7	1.4	1.3	1.2	0.5	1.3	13.5	2.6	1.7	0.0	1.7	4.9	67.6	1.5	1.4	1.2	3.5	1.2	1.4	1.7	5.6	0.0	1.3	9.7	1.2	1.5	0.3	1.7	0.7	3.1	0.7	1.2	1.4	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	25.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.2	0.2	0.0	2.4	0.6	2.0	1.1	0.3	0.7	1.0	0.9	0.8	0.3	1.7	1.4	1.0	3.1	1.2	0.7	0.7	1.0	0.0	19.9	33.0	31.5	34.3	16.4	6.7	3.7	21.7	13.5	5.6	0.0	0.3	0.0	0.0	0.0	2.3	81.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	1.1	0.0	1.7	1.0	0.4	7.1	0.0	0.0	0.0	0.2	2.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.8	0.0
RBL1	"cp107, p107, PRB1"	ENSG00000080839	"RB transcriptional corepressor like 1"	P28749	20	36996349-37095995	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 2: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA054962, HPA056525"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054962: AB_2682652, HPA056525: AB_2683165"	"unprognostic (1.97e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.25e-5)"	"unprognostic (6.91e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.23e-2)"	"prognostic unfavorable (2.52e-6)"	"unprognostic (3.15e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.26e-1)"	5.0	4.3	4.9	12.3	7.1	20.4	4.8	16.6	7.8	5.1	5.6	5.5	5.9	4.0	8.1	3.0	7.7	4.4	3.6	4.0	4.0	3.6	3.3	3.0	4.5	11.1	6.5	2.2	7.8	6.0	5.9	5.9	8.3	5.7	4.4	6.1	5.3	4.8	2.7	10.2	5.3	5.9	5.9	7.1	6.9	4.6	8.2	5.5	19.6	5.3	6.1	11.4	4.7	7.1	5.0	5.1	2.2	1.9	3.6	7.4	1.6	12.2	7.9	10.0	6.7	2.5	3.4	6.4	14.3	6.4	12.4	12.9	8.4	6.9	13.7	4.1	5.9	7.3	12.1	8.9	9.2	20.7	4.7	4.8	13.5	9.5	7.1	1.5	17.3	9.4	1.6	1.3	16.3	5.8	2.1	6.9	9.1	9.8	13.3	7.0	5.2	16.1	5.7	2.9	6.2	7.8	10.5	29.8	10.4	2.8	6.1	2.4	6.0	15.6	9.0	4.1	3.3	5.8	12.5	4.5	21.9	8.4	20.0	12.4	4.4	7.8	13.9	15.7	12.2	10.8	1.4	1.2	2.2	5.0	1.4	4.2	5.0	5.6	4.5	2.2	3.9	6.0	4.8	0.6	3.6	1.9	5.1	7.4	1.6	4.9	7.1	16.6	7.8	4.0	3.6	6.5	2.2	5.7	5.5	6.0	14.1	9.2	1.4	2.2	5.2	2.4	0.0	1.4	10.3	0.0	2.0	4.7	0.0	1.3	1.3	2.1	0.8	0.0	1.0	4.2	2.5	0.6	8.1	1.0	4.0	3.2	1.2	1.8	2.8	0.2	2.0	3.2	1.7	4.6	1.1	4.0	1.1	2.8	2.8	0.6	12.8	6.5	1.2	8.7	6.6	1.1	3.2	5.4	2.3	0.7
RBM10	"DXS8237E, GPATC9, GPATCH9, KIAA0122, ZRANB5"	ENSG00000182872	"RNA binding motif protein 10"	P98175	X	47144869-47186813	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034972, HPA057372"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA034972: AB_10602919, HPA057372: AB_2683421"	"unprognostic (9.07e-2)"	"prognostic favorable (6.71e-4)"	"unprognostic (7.83e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.04e-2)"	"unprognostic (4.47e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (1.18e-1)"	"unprognostic (6.23e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.20e-3)"	18.1	22.2	19.8	38.0	21.9	34.0	17.1	41.2	22.9	19.9	20.5	25.7	22.7	21.8	22.1	17.3	23.7	26.2	29.1	21.7	19.8	18.3	18.4	21.6	17.1	27.2	20.1	19.2	36.4	27.4	20.1	28.3	24.9	17.9	23.5	14.2	18.5	25.1	28.8	20.6	23.8	23.7	18.9	17.2	24.7	20.5	8.7	21.4	32.9	26.8	18.0	22.7	17.6	20.9	15.9	14.6	14.4	19.2	12.3	18.3	11.5	20.9	22.7	21.8	25.8	11.7	9.6	25.3	16.0	9.4	16.5	16.1	19.8	17.2	25.6	9.8	11.0	21.1	20.5	28.4	20.1	9.1	26.0	25.7	19.1	27.6	20.7	17.1	19.3	23.1	12.6	9.7	27.3	22.2	11.9	17.7	24.8	15.9	20.6	10.0	32.0	35.4	32.8	35.9	15.8	25.5	31.3	18.2	26.4	12.2	18.6	25.9	19.7	24.1	18.1	15.3	13.5	22.2	19.3	15.4	19.5	24.8	21.0	16.7	21.7	17.5	21.1	17.3	14.0	27.2	14.0	10.8	14.4	18.3	14.5	17.0	15.9	14.7	15.3	12.3	15.6	14.8	14.1	10.1	12.3	19.2	14.6	16.6	11.5	19.8	21.9	41.2	21.9	19.8	18.3	20.1	19.2	17.9	21.4	38.7	44.1	14.3	20.3	9.8	26.5	30.9	25.5	30.8	36.4	8.7	13.7	27.7	10.0	17.2	0.6	18.8	24.8	0.0	15.2	23.9	18.1	14.5	23.1	19.8	16.9	20.6	34.3	14.7	12.9	1.6	16.7	11.8	15.1	18.0	24.9	14.0	16.8	18.6	24.1	11.5	25.3	0.0	16.9	5.7	6.1	9.3	38.6	17.5	23.4	16.5
RBM12	"HRIHFB2091, KIAA0765, SWAN"	ENSG00000244462	"RNA binding motif protein 12"	Q9NTZ6	20	35648925-35664956	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043258, HPA043621"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043258: AB_2678395, HPA043621: AB_2678584"	"unprognostic (8.94e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.04e-3)"	"unprognostic (7.57e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.19e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (7.96e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.67e-1)"	"unprognostic (3.29e-1)"	"unprognostic (4.44e-1)"	"unprognostic (3.92e-1)"	"unprognostic (6.87e-2)"	23.3	26.1	18.6	26.6	20.6	22.5	23.1	28.1	19.9	26.7	20.8	19.3	21.2	17.5	31.1	21.3	27.9	29.4	22.4	21.1	17.8	12.5	19.5	18.7	23.8	32.2	17.7	20.0	39.5	18.9	24.4	25.7	31.4	15.6	22.7	21.6	22.1	25.6	18.6	24.4	22.1	25.7	25.2	15.4	28.5	21.7	20.6	18.6	52.8	29.3	21.9	37.6	28.0	22.8	15.1	14.9	9.9	13.8	11.5	17.3	11.7	25.1	16.9	36.4	22.2	8.9	17.7	22.4	14.0	16.6	19.7	19.5	23.4	17.8	45.5	15.7	28.1	20.6	17.9	43.0	35.9	25.3	21.5	15.5	38.1	16.8	15.6	15.4	41.3	20.5	25.2	18.6	22.6	15.1	12.7	21.9	24.8	36.2	22.1	17.2	18.5	49.0	11.7	26.4	16.4	17.5	30.0	44.8	22.2	14.3	41.6	19.3	25.0	25.0	19.7	18.8	31.3	25.4	15.3	30.8	16.7	24.7	16.3	20.7	24.0	26.0	48.2	14.6	16.2	21.6	6.0	11.9	9.9	14.8	13.8	17.3	15.1	13.1	17.0	14.9	14.4	14.0	12.1	9.2	11.5	11.1	9.6	12.0	11.7	18.6	20.6	28.1	19.9	17.8	12.5	17.7	20.0	15.6	18.6	23.8	20.8	19.8	17.7	26.3	14.7	19.0	22.9	24.1	18.2	3.5	25.5	18.2	1.7	13.5	3.2	15.7	13.7	0.0	15.3	15.3	17.9	15.2	25.5	11.9	15.6	7.9	23.6	22.1	23.9	3.6	13.6	19.9	15.1	14.4	21.7	11.6	16.5	14.0	15.6	10.2	13.9	6.5	18.6	15.7	14.9	25.7	14.6	20.3	18.5	23.8
RBM15	"OTT, OTT1"	ENSG00000162775	"RNA binding motif protein 15"	Q96T37	1	110338506-110346681	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 48.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015201, HPA019824, HPA049642"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015201: , HPA019824: AB_1856113, HPA049642: AB_2680839"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.57e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (7.61e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.84e-2)"	"unprognostic (4.91e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.37e-4)"	"prognostic favorable (7.97e-4)"	"unprognostic (2.88e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.12e-1)"	8.5	7.6	6.3	12.2	7.6	48.7	7.9	18.6	8.3	6.6	8.8	7.6	8.3	7.3	8.5	7.2	8.0	7.3	6.6	8.8	5.2	4.3	6.3	11.0	10.5	13.7	8.3	6.0	8.6	7.5	7.1	8.1	7.1	5.9	5.7	5.7	8.1	7.4	6.4	17.2	7.2	11.3	5.5	5.0	12.5	8.3	14.0	7.9	21.8	7.0	5.3	13.4	6.5	8.6	10.5	4.8	9.8	6.9	5.0	9.9	5.5	7.1	7.8	7.0	7.2	4.5	4.7	11.1	3.8	5.0	6.0	7.9	9.5	6.5	13.5	6.1	4.3	4.9	10.1	11.0	9.5	8.9	14.0	10.1	10.9	11.8	6.9	6.2	11.8	11.6	4.3	6.6	8.3	7.8	3.1	6.3	10.3	15.4	23.7	6.0	7.3	10.6	9.3	15.0	6.3	4.4	12.6	10.6	9.2	4.9	7.2	8.5	4.3	8.3	10.5	8.0	7.9	7.2	14.3	4.4	5.7	10.4	6.2	6.9	18.3	9.2	29.3	8.6	12.0	7.1	8.2	6.9	9.4	7.0	6.0	9.9	10.5	7.7	6.0	4.8	10.0	6.8	8.2	9.8	5.0	6.4	4.7	7.5	5.5	6.3	7.6	18.6	8.3	5.2	4.3	8.3	6.0	5.9	7.9	6.0	3.0	15.3	8.2	29.5	5.4	10.8	7.6	9.4	2.3	3.5	13.7	7.6	0.0	3.4	6.2	9.8	7.5	0.0	3.1	6.2	8.9	8.6	28.8	13.5	5.6	0.0	9.2	10.4	5.7	4.1	3.7	5.5	8.5	1.8	8.4	5.6	4.2	2.9	4.9	3.3	7.1	0.0	13.3	24.4	14.5	29.5	3.9	12.5	7.6	6.7
RBM15B	"HUMAGCGB, OTT3"	ENSG00000259956	"RNA binding motif protein 15B"	Q8NDT2	3	51391268-51397908	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036645, HPA058136"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036645: AB_10671965, HPA058136: AB_2683618"	"unprognostic (2.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.29e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (3.01e-2)"	"prognostic favorable (1.84e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.84e-1)"	8.6	3.8	4.9	5.6	6.3	5.2	7.1	4.4	9.0	8.0	7.5	6.1	6.3	5.9	7.4	6.5	8.4	7.2	10.1	5.6	5.2		4.8	9.4	6.7	11.6	4.9	4.1	9.3	9.8	9.2	3.3	7.3	4.1	8.3	7.1	5.1	7.2	7.0	4.9	9.9	9.3	7.4	2.2	7.8	6.4	9.1	4.1	23.0	8.2	5.4	7.3	6.8	9.3	4.5	4.9	1.5	5.7	3.4	5.0	3.1	10.9	9.8	22.9	23.8	20.7	16.2	14.0	10.2	19.1	16.4	13.6	12.1	8.0	15.9	8.5	18.4	18.1	10.2	13.1	18.4	7.9	12.7	10.2	13.7	15.3	10.3	12.1	17.8	7.8	17.6	22.9	15.0	17.9	17.9	16.9	26.2	10.2	10.8	14.0	11.7	31.0	11.3	18.2	10.1	15.4	11.1	10.1	13.5	14.6	26.6	14.9	21.4	13.2	17.6	11.7	15.9	13.9	21.2	15.2	16.8	14.7	14.1	19.2	16.0	14.4	17.7	13.7	14.4	17.8	0.0	4.1	1.5	4.0	5.7	4.4	2.4	5.0	4.2	4.5	4.5	5.0	3.1	0.8	3.4	5.3	4.9	2.3	3.1											3.0	4.8	10.7	31.2	22.6	18.0	15.1	5.1	8.1	7.9	14.0	9.8	13.5	10.0	18.2	18.6	17.5	15.0	23.3	19.7	17.7	12.1	26.3	4.7	18.3	15.9	14.3	12.1	12.3	26.2	8.6	14.7	10.5	6.8	4.6	19.4	12.3	25.8	8.6	14.2	14.3	12.9	25.8	18.7	11.4	6.4	24.6	16.5	11.7	20.8	29.3
RBM18	MGC2734	ENSG00000119446	"RNA binding motif protein 18"	Q96H35	9	122237624-122264839	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057281, HPA077955"	Uncertain		Enhanced	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	No			Nucleoplasm	"Cytokinetic bridge, Cytosol"	"HPA057281: AB_2683394, HPA077955: "	"unprognostic (1.75e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (9.39e-3)"	"unprognostic (7.27e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.51e-2)"	"prognostic favorable (8.00e-7)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	12.8	14.8	16.5	9.1	16.5	15.1	24.6	18.1	20.3	14.4	13.4	10.5	13.7	10.4	13.6	16.2	11.8	11.6	11.7	27.2	16.7	18.6	17.3	12.2	10.7	10.9	17.8	13.2	15.1	13.7	16.0	18.2	16.2	16.3	17.2	12.6	8.2	12.6	13.9	29.4	10.1	10.8	13.2	16.0	12.4	12.3	7.6	15.0	11.9	15.3	13.5	11.1	13.0	14.4	8.7	9.5	16.0	13.0	7.7	10.0	8.2	5.8	6.1	8.4	9.2	12.4	15.4	7.3	13.3	10.9	9.1	8.5	7.0	5.8	10.2	5.8	8.6	10.1	13.7	13.1	13.8	11.5	10.4	5.9	7.6	10.2	5.9	14.0	15.1	10.5	13.1	15.7	9.6	19.6	9.2	13.1	8.3	10.4	8.0	13.6	6.3	7.8	9.3	6.5	19.8	10.2	7.0	17.4	13.8	12.7	6.6	17.6	9.3	10.0	14.1	15.0	6.9	8.2	8.6	7.2	8.6	4.9	13.7	13.0	11.7	21.5	8.5	14.1	9.4	10.2	6.8	9.2	16.0	10.0	10.5	9.6	8.7	8.9	9.7	9.5	6.0	9.3	9.7	9.7	7.7	13.0	6.9	9.1	8.2	16.5	16.5	18.1	20.3	16.7	18.6	17.8	13.2	16.3	15.0	29.8	10.9	16.7	9.8	19.3	11.8	46.6	7.6	17.4	13.6	24.4	2.0	28.1	23.2	20.9	61.1	24.8	12.3	0.0	14.0	35.6	16.0	18.9	17.3	13.7	24.5	3.2	18.9	13.5	21.4	54.6	12.4	16.2	18.6	10.0	16.7	15.8	18.5	13.9	15.9	18.9	11.6	19.4	23.1	10.1	19.4	22.6	47.6	17.3	13.6	14.1
RBM22	"Cwc2, FLJ10290, fSAP47, ZC3H16"	ENSG00000086589	"RNA binding motif protein 22"	Q9NW64	5	150690794-150701107	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001634	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA001634: AB_1079746"	"unprognostic (1.94e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.86e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.04e-2)"	"prognostic unfavorable (5.50e-6)"	"unprognostic (7.08e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (7.29e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (9.87e-3)"	26.2	17.5	20.3	16.3	26.3	50.1	21.2	29.4	29.5	20.6	20.1	37.4	16.7	17.4	28.0	18.5	18.8	23.8	20.5	18.5	19.7	19.1	20.0	18.8	20.5	23.5	25.7	16.9	29.2	19.6	21.5	18.0	37.8	23.5	20.9	21.5	19.1	18.3	19.2	30.4	21.5	19.1	19.7	28.0	23.0	17.8	13.5	24.6	38.6	23.8	16.3	27.6	20.3	19.2	25.8	24.9	36.3	28.8	28.4	26.7	20.8	14.9	16.3	25.1	29.2	17.0	16.0	35.5	15.3	17.6	31.0	35.1	26.4	22.2	22.2	24.5	15.0	29.4	15.8	32.5	28.2	32.4	24.6	25.7	17.6	16.2	11.1	16.4	31.1	20.8	13.3	22.5	25.7	16.9	13.6	21.8	18.3	18.6	22.4	19.3	17.4	28.7	20.7	15.0	18.4	17.2	29.4	20.7	19.7	15.3	15.4	23.6	17.9	17.2	28.6	28.2	15.7	29.7	27.9	14.4	25.0	19.8	10.9	27.9	20.8	23.4	32.0	19.7	28.4	18.7	17.6	20.8	33.5	24.4	24.9	26.7	25.8	22.6	22.7	24.9	25.3	24.6	22.9	36.3	28.4	28.8	13.3	24.2	20.8	20.3	26.3	29.4	29.5	19.7	19.1	25.7	16.9	23.5	24.6	26.8	26.2	37.5	47.4	23.1	34.3	26.9	28.1	28.1	39.8	15.7	23.6	46.8	21.6	29.7	5.0	41.2	27.1	0.0	29.8	38.5	28.7	21.3	62.3	15.1	38.1	28.6	24.9	27.0	25.1	2.6	40.0	33.7	21.9	45.9	27.2	34.4	23.2	35.1	42.8	16.5	16.9	32.3	29.3	21.3	28.8	19.1	60.8	45.7	30.2	34.3
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281346-17293875	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 41.0;skeletal muscle: 153.8;tongue: 37.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 165.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 29.0;RH-30: 29.8;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	3.4	0.2	1.4	0.9	2.2	0.1	1.1	0.3	1.9	7.0	2.7	0.1	3.0	0.5	9.7	7.3	3.4	7.8	1.7	41.0	1.5	1.7	0.3	0.4	0.4	0.2	0.5	1.1	2.1	0.2	0.1	1.8	0.2	0.3	3.6	2.4	1.6	2.5	2.2	153.8	0.4	1.2	9.3	0.5	0.4	0.8	1.3	0.1	0.1	1.4	37.3	1.9	5.1	2.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.7	4.5	6.0	0.0	0.0	0.0	0.0	9.1	3.3	6.2	6.6	0.0	0.5	0.0	2.9	6.5	9.8	0.0	5.6	0.2	11.3	0.0	0.2	0.0	0.5	3.1	0.2	0.0	0.5	3.3	0.0	1.2	0.2	8.0	0.7	0.0	0.0	0.0	29.0	1.3	0.0	0.0	2.0	0.0	0.7	0.0	29.8	0.0	0.0	0.0	3.9	0.4	0.0	0.0	0.1	4.9	13.9	0.2	0.0	2.1	5.0	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.3	1.9	1.5	1.7	0.5	1.1	0.3	0.1	0.0	0.0	0.0	0.2	1.0	1.6	165.8	0.0	20.1	2.3	0.0	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	9.2	0.8	0.2	1.1	0.0	0.2	1.6	4.6	0.0	0.0	1.0	0.0	0.0	1.7	0.0	3.9	0.6	0.2	0.0	0.7	0.1	0.0	6.5	16.2	0.3	7.7	0.9	0.7	0.0	1.5	0.1
RBM25	"fSAP94, NET52, RNPC7, S164, Snu71"	ENSG00000119707	"RNA binding motif protein 25"	P49756	14	73058436-73123898	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003025, HPA070713"	Supported		Enhanced	"Nuclear speckles"		NA	NA		250000	"Nuclear speckles"		"HPA003025: AB_1079748, HPA070713: AB_2686302"	"unprognostic (1.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.85e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (4.22e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.09e-4)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.73e-1)"	29.1	25.3	24.2	49.2	36.9	66.0	31.3	48.9	36.4	29.1	25.9	26.4	34.2	24.6	33.7	37.7	27.1	32.4	29.7	22.3	28.2	22.3	21.6	23.5	28.6	38.9	26.5	35.4	36.3	35.6	32.7	45.1	28.1	33.5	26.1	26.5	24.1	29.3	40.5	35.4	29.0	28.9	30.3	30.0	30.4	27.6	29.4	29.7	34.6	33.8	28.4	34.3	26.3	29.4	21.5	24.7	17.4	17.0	23.2	18.4	9.0	32.9	19.1	30.8	23.4	13.8	16.3	27.0	27.2	19.1	21.1	23.4	25.5	21.3	39.8	14.4	18.6	16.1	25.1	35.4	16.4	36.5	24.9	18.6	33.5	15.1	19.5	8.7	29.4	21.3	11.7	11.8	24.7	20.3	18.2	21.0	14.7	34.3	16.7	22.9	24.6	38.2	17.2	26.1	20.3	21.1	33.0	33.6	19.5	17.4	23.1	20.8	19.8	34.1	22.7	12.0	19.4	32.5	12.9	26.5	31.3	30.6	16.7	27.1	17.8	31.5	49.8	14.0	21.0	21.4	11.2	14.8	13.5	18.4	17.0	17.3	18.6	14.5	15.4	15.5	21.5	15.4	16.1	17.4	23.2	13.7	24.7	15.9	9.0	24.2	36.9	48.9	36.4	28.2	22.3	26.5	35.4	33.5	29.7	214.4	331.5	163.2	170.4	201.9	245.3	123.1	86.6	165.9	260.5	87.2	253.3	130.8	14.9	80.3	47.9	128.9	92.3	46.7	106.8	156.4	139.0	166.8	234.1	80.0	100.2	170.0	148.9	90.2	100.2	18.9	146.2	140.8	77.6	124.4	93.3	156.4	103.0	89.7	129.4	32.3	258.3	71.1	142.8	189.6	180.1	206.9	155.0	146.0	97.8	216.1
RBM28	FLJ10377	ENSG00000106344	"RNA binding motif protein 28"	Q9NW13	7	128297685-128343908	"Disease related genes, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019058, HPA026672, HPA031519"	Enhanced		Supported	Nucleoli		Yes	No			Nucleoli		"HPA019058: AB_1856118, HPA026672: AB_1856119, HPA031519: AB_2673920"	"unprognostic (2.34e-1)"	"unprognostic (1.87e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.72e-11)"	"unprognostic (6.83e-2)"	"prognostic unfavorable (6.44e-4)"	"unprognostic (7.20e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.45e-3)"	"unprognostic (7.15e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.04e-1)"	22.1	17.7	16.3	18.4	25.1	14.2	17.5	26.5	25.3	12.8	13.7	19.7	9.6	13.2	17.1	9.9	15.1	12.5	10.9	24.4	18.1	8.6	12.0	18.8	13.2	17.9	26.5	16.2	19.7	15.7	16.5	18.4	14.5	17.3	13.1	12.7	12.3	13.0	13.0	33.5	17.3	11.2	14.2	25.4	13.8	14.1	18.4	24.4	11.7	16.1	12.2	15.6	13.8	18.9	14.5	14.3	9.8	11.5	12.3	13.7	5.5	18.6	20.6	12.5	35.7	8.9	5.7	17.1	17.2	7.1	15.6	17.0	17.1	16.4	24.8	9.4	7.8	22.8	12.7	18.3	14.6	20.3	12.4	17.6	24.9	14.4	15.7	7.9	31.3	22.4	6.4	9.6	20.7	12.5	5.9	14.4	13.8	46.5	14.5	12.1	15.1	22.4	17.9	23.8	12.9	16.2	17.8	15.0	23.8	7.6	12.7	14.0	17.0	22.2	37.2	11.8	15.6	9.5	9.6	13.8	22.7	11.8	20.1	20.8	15.0	12.8	43.0	14.9	26.5	24.4	3.5	11.5	4.4	13.7	8.9	9.4	12.8	11.6	12.2	11.5	14.5	10.5	12.0	9.8	12.3	7.8	14.3	7.1	5.5	16.3	25.1	26.5	25.3	18.1	8.6	26.5	16.2	17.3	24.4	14.9	32.7	12.7	12.1	14.3	55.3	21.5	5.1	21.4	38.7	12.2	88.4	17.7	21.6	15.9	2.1	18.8	6.2	0.0	19.6	22.7	16.4	9.7	34.8	12.8	16.8	38.1	10.9	7.4	14.3	1.3	25.6	14.5	5.0	13.6	13.8	23.3	15.5	7.0	19.4	12.9	52.9	6.5	21.7	41.1	51.3	12.7	15.6	16.0	14.8	10.9
RBM3	IS1-RNPL	ENSG00000102317	"RNA binding motif protein 3"	P98179	X	48574449-48579066	"Predicted intracellular proteins"	"Stress response"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Exocrine glandular cells: 1250.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003624, CAB062559"	Enhanced		Enhanced	Nucleoplasm		NA	NA		24000	Nucleoplasm		"CAB062559: AB_2665621, HPA003624: AB_10602123"	"unprognostic (1.07e-2)"	"unprognostic (1.14e-3)"	"prognostic favorable (3.07e-7)"	"unprognostic (1.65e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	71.2	25.5	12.6	43.0	13.9	59.0	52.2	16.4	22.5	44.7	32.7	20.9	16.4	23.9	38.5	58.2	46.4	32.9	36.4	44.8	12.2	12.3	53.5	32.9	36.8	115.8	15.0	15.2	38.6	43.2	15.2	19.1	62.2	30.5	21.0	36.0	43.4	39.7	25.0	59.1	56.2	37.8	33.0	23.6	48.4	27.2	27.2	7.4	73.6	24.0	76.8	67.6	46.4	30.1	32.9	56.5	6.4	44.2	29.9	31.8	45.7	20.2	28.4	30.9	32.3	7.7	40.7	19.3	26.4	46.1	66.0	46.1	28.5	53.7	41.8	8.4	53.4	12.9	17.7	26.9	36.0	52.9	38.8	35.7	21.0	46.5	25.4	28.2	57.6	42.9	31.4	25.7	22.2	21.5	8.5	58.5	22.3	11.7	32.5	45.6	34.2	47.8	31.5	17.0	5.4	40.0	46.2	31.6	31.7	28.4	33.7	12.3	30.5	26.4	34.7	28.8	15.5	45.9	57.3	78.8	21.6	35.0	74.7	43.9	16.1	17.6	47.0	32.4	34.6	43.9	5.8	38.4	6.2	27.0	44.2	31.8	32.9	27.6	26.7	56.5	20.5	28.2	27.4	6.4	29.9	37.5	39.1	28.6	45.7	12.6	13.9	16.4	22.5	12.2	12.3	15.0	15.2	30.5	7.4	154.9	140.4	318.0	135.2	461.5	60.5	71.4	114.7	91.0	153.6	50.6	45.2	435.3	149.2	258.9	4.9	222.6	136.8	70.0	1250.6	594.7	406.0	86.3	255.6	72.3	381.7	39.7	237.4	173.7	454.7	10.5	227.6	401.8	496.0	551.0	243.6	125.2	635.6	224.5	138.6	113.6	76.3	129.4	465.6	25.6	174.8	443.8	409.2	335.1	293.7	176.9
RBM48	"C7orf64, DKFZp564O0523, HSPC304"	ENSG00000127993	"RNA binding motif protein 48"	Q5RL73	7	92528773-92538005	"Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021777, HPA025306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021777: AB_1845763, HPA025306: AB_1845764"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (3.17e-4)"	"unprognostic (2.86e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.43e-2)"	"unprognostic (8.04e-2)"	11.1	13.0	23.9	10.8	36.0	24.6	14.1	28.3	34.2	11.7	9.0	18.4	7.1	10.3	12.0	12.4	9.9	10.9	8.9	12.1	22.8	15.2	12.4	10.5	9.9	17.1	42.4	15.1	17.0	10.6	11.1	18.3	10.6	20.7	11.5	11.0	9.0	13.0	8.9	16.5	10.8	10.7	9.7	28.0	14.5	9.8	12.5	36.9	13.6	14.5	6.6	13.9	10.2	10.1	20.1	10.6	37.5	12.1	18.1	25.8	14.0	7.5	5.6	9.7	15.2	11.9	12.4	7.6	9.1	9.4	12.1	11.5	6.5	10.4	10.8	16.5	7.7	15.2	7.8	9.9	7.3	13.5	12.2	12.2	8.5	12.2	7.4	10.1	14.9	10.2	9.5	14.4	11.9	12.7	13.9	12.1	14.1	16.8	19.2	11.2	8.9	19.2	15.2	8.6	10.8	9.4	8.9	8.5	14.6	9.6	7.3	11.5	16.2	9.1	17.6	12.7	13.3	5.5	14.7	6.2	17.1	9.3	13.5	13.0	11.4	15.1	18.5	8.1	13.1	15.6	37.5	10.1	21.0	18.5	12.1	20.2	20.1	20.3	18.9	9.7	18.5	25.8	22.1	13.4	18.1	9.9	10.6	18.3	14.0	23.9	36.0	28.3	34.2	22.8	15.2	42.4	15.1	20.7	36.9	11.9	6.9	15.6	11.1	7.6	12.2	14.6	5.1	9.4	11.4	3.5	0.0	8.8	6.6	6.9	6.1	9.3	5.8	23.3	5.2	4.8	8.7	8.9	29.0	3.8	5.4	11.1	0.0	4.9	6.5	5.7	5.5	8.9	5.0	8.2	3.8	12.5	4.1	6.6	6.0	7.4	12.5	12.9	8.3	21.2	15.6	9.9	12.8	14.1	5.2	10.3
RBM5	"H37, LUCA15"	ENSG00000003756	"RNA binding motif protein 5"	P52756	3	50088908-50119021	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017335, HPA018011"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017335: AB_1856134, HPA018011: AB_1856135"	"unprognostic (4.11e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.61e-3)"	"prognostic unfavorable (9.77e-4)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.58e-4)"	"unprognostic (5.58e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.89e-3)"	33.8	25.9	34.1	43.7	37.8	37.7	37.0	51.2	38.9	38.5	33.1	47.7	41.3	25.1	53.2	45.9	28.9	40.5	27.6	28.5	31.1	25.0	30.4	26.9	30.3	41.2	38.1	38.4	63.5	36.3	37.7	58.6	40.3	30.3	41.5	33.5	40.4	35.7	37.9	45.9	54.5	34.7	37.9	41.1	47.0	30.9	36.4	39.5	41.4	42.0	28.5	45.5	31.8	36.6	14.3	12.2	29.6	14.4	14.0	20.1	10.3	9.7	12.1	43.8	19.0	18.3	26.7	10.3	29.8	18.0	22.2	15.7	12.1	11.3	23.0	10.3	19.4	21.9	8.6	29.6	14.4	23.9	21.4	10.8	28.9	41.2	10.8	22.7	26.4	23.4	23.7	16.4	24.1	23.8	38.3	23.5	23.7	19.7	15.5	20.8	8.7	26.8	17.9	15.7	16.7	13.8	14.6	19.2	11.8	16.1	49.1	6.3	14.6	24.5	10.7	14.8	31.2	9.9	25.4	26.6	14.8	15.5	20.4	17.2	21.5	31.4	24.4	11.0	16.2	17.0	29.6	14.0	18.5	17.5	14.4	16.6	13.7	15.8	18.1	12.2	14.3	20.1	15.8	26.1	14.0	14.0	9.3	18.4	10.3	34.1	37.8	51.2	38.9	31.1	25.0	38.1	38.4	30.3	39.5	65.5	105.1	31.8	36.7	28.4	88.7	39.5	17.8	100.4	86.4	36.6	172.8	40.3	10.0	22.5	120.2	50.7	39.5	0.0	18.1	21.2	40.9	41.1	64.9	37.6	27.8	89.0	70.6	55.3	39.9	150.2	59.5	45.4	42.2	37.9	45.1	49.6	24.7	36.8	54.5	7.6	131.6	32.3	43.2	48.9	34.1	29.6	68.3	55.8	33.6	34.9
RBM7		ENSG00000076053	"RNA binding motif protein 7"	Q9Y580	11	114400030-114414203	"Predicted intracellular proteins"	Meiosis	RNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 146.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA013993, HPA048003"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013993: AB_1856137, HPA048003: AB_2680231"	"unprognostic (2.90e-3)"	"unprognostic (8.21e-3)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.38e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.30e-2)"	21.6	13.0	11.4	12.9	14.9	39.9	20.2	15.1	13.0	19.9	17.2	11.9	8.4	11.0	20.2	13.9	19.2	18.2	15.4	13.9	12.1	7.3	14.7	28.6	18.2	18.7	15.5	8.7	26.3	14.9	14.4	17.7	23.8	11.9	20.9	16.8	8.4	18.1	12.1	17.2	13.9	17.7	18.7	15.8	20.0	16.6	16.7	16.1	22.0	21.5	12.5	15.8	24.3	20.5	13.4	15.4	36.2	16.5	17.5	18.6	12.7	12.8	8.6	11.3	10.7	14.8	20.1	12.4	21.1	28.6	24.8	28.7	18.7	29.1	15.5	29.5	19.6	22.8	11.7	13.7	15.4	32.6	14.3	7.5	18.5	9.8	15.4	25.1	12.1	12.9	19.9	20.6	20.7	29.2	22.3	22.0	12.9	18.0	2.9	19.1	3.7	14.1	12.4	14.1	12.1	14.3	11.1	20.6	14.8	20.7	14.3	9.2	8.8	18.3	8.6	9.6	22.4	8.4	8.3	19.7	7.5	17.7	9.5	22.1	7.6	7.8	13.7	5.3	21.5	12.7	36.2	16.2	18.2	13.0	16.5	18.6	13.4	14.0	12.3	15.4	11.9	17.5	15.0	15.6	17.5	16.0	14.8	14.9	12.7	11.4	14.9	15.1	13.0	12.1	7.3	15.5	8.7	11.9	16.1	14.9	18.8	43.6	71.5	59.9	11.2	12.8	10.2	24.1	19.4	27.9	11.8	43.4	56.3	42.2	146.5	38.3	29.0	0.0	30.7	67.9	54.3	61.6	39.3	23.2	27.3	7.9	45.5	34.4	25.7	16.1	29.1	22.4	40.5	31.5	26.8	21.6	37.8	33.2	15.9	28.4	11.6	0.0	60.8	29.2	15.2	60.0	77.2	40.5	34.3	73.7
RBMS1	"C2orf12, DKFZp564H0764, HCC-4, MSSP-1, MSSP-2, MSSP-3, SCR2, YC1"	ENSG00000153250	"RNA binding motif single stranded interacting protein 1"	P29558	2	160272151-160493794	"Predicted intracellular proteins"	"DNA replication"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 333.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HSkMC: 55.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047943, HPA061791"			Enhanced	Cytosol		NA	NA			Cytosol		"HPA047943: AB_2797235, HPA061791: AB_2684611"	"unprognostic (2.81e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.50e-1)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (6.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.16e-3)"	"unprognostic (6.70e-2)"	"prognostic unfavorable (1.33e-7)"	"unprognostic (1.84e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.32e-1)"	29.4	8.7	4.0	15.6	9.4	11.6	23.0	2.6	7.1	25.9	19.1	2.9	11.4	4.4	29.1	13.5	15.8	17.0	17.5	30.1	4.1	4.1	16.2	8.1	22.8	25.3	4.0	2.9	22.9	4.4	24.3	12.7	74.2	7.2	18.6	5.9	11.2	11.7	16.0	10.5	14.1	9.7	21.7	5.3	23.3	11.5	7.1	5.6	15.7	12.3	11.7	7.8	23.9	23.9	1.2	7.3	24.2	11.0	6.6	16.8	5.7	13.7	5.1	18.2	2.3	26.4	46.0	22.1	17.6	25.2	12.2	12.7	14.1	10.4	0.1	22.0	29.6	5.7	8.4	8.8	12.9	20.0	11.1	6.5	5.2	12.7	11.2	24.1	8.3	0.3	55.0	10.2	21.1	9.5	16.3	19.0	4.2	0.3	6.5	29.2	10.7	7.7	8.5	11.2	2.3	11.3	5.9	15.9	6.9	18.6	17.0	2.3	6.2	10.9	6.5	16.1	23.7	3.3	13.2	22.8	21.8	13.8	19.9	15.8	3.5	0.1	5.9	17.5	12.8	13.8	2.1	11.0	13.5	5.0	6.3	16.8	0.5	8.7	7.6	7.3	1.2	14.2	6.4	24.2	6.6	3.5	4.1	1.3	5.7	4.0	9.4	2.6	7.1	4.1	4.1	4.0	2.9	7.2	5.6	104.2	86.2	18.1	101.0	80.9	1.1	52.3	12.7	41.5	39.8	66.3	0.0	87.3	21.6	25.4	38.4	101.2	0.0	0.0	41.2	91.7	155.8	97.0	19.7	19.5	105.1	1.6	0.0	160.8	119.6	15.3	82.3	73.9	52.3	19.0	0.0	19.2	65.7	0.6	93.0	29.9	1.0	77.6	83.0	1.8	8.5	72.1	333.1	71.0	0.4	131.7
RC3H2	"FLJ20301, FLJ20713, MNAB, RNF164"	ENSG00000056586	"Ring finger and CCCH-type domains 2"	Q9HBD1	9	122844556-122905341	"Enzymes, Predicted intracellular proteins, Transcription factors"	"Ubl conjugation pathway"	"Repressor, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042863, HPA062144"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA042863: AB_2678204, HPA062144: AB_2732677"	"unprognostic (6.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.50e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.26e-1)"	16.4	10.7	25.4	14.1	28.8	30.6	14.1	18.7	27.6	17.1	13.0	10.5	14.4	11.0	14.6	9.7	16.5	12.2	12.6	15.7	18.1	11.2	15.0	14.8	16.2	19.2	12.3	25.3	14.7	9.7	19.0	16.2	16.3	12.6	11.5	13.1	9.4	13.2	13.9	16.1	13.8	13.0	16.3	14.4	15.2	12.8	12.8	13.2	18.9	15.0	11.5	18.8	14.1	13.7	8.6	9.6	12.4	10.4	4.9	8.9	3.7	10.0	14.7	19.5	10.5	10.4	12.4	10.9	12.8	14.1	15.2	13.3	17.7	10.7	16.8	10.5	17.1	17.8	23.6	20.9	15.1	16.7	7.7	8.3	9.6	26.4	11.7	13.7	11.4	15.4	11.9	14.7	14.8	21.0	12.6	20.8	14.6	13.5	12.4	19.2	13.5	11.1	8.0	9.7	13.6	13.6	11.2	32.3	10.8	14.8	8.0	23.0	16.0	22.8	14.1	11.6	14.1	16.9	9.6	20.6	11.7	9.9	15.9	22.9	8.7	14.1	18.4	13.4	10.1	13.2	12.4	6.6	8.5	8.9	10.4	7.3	6.5	7.3	8.9	5.8	8.6	7.0	6.8	11.8	4.9	9.3	9.6	7.1	3.7	25.4	28.8	18.7	27.6	18.1	11.2	12.3	25.3	12.6	13.2	38.7	32.8	12.8	10.7	9.7	18.4	31.3	12.7	12.0	11.4	8.7	35.3	12.6	3.3	10.7	4.0	26.6	12.3	0.0	10.0	12.7	13.4	18.1	16.2	12.4	8.5	27.0	22.3	31.9	20.4	6.4	12.4	15.0	13.5	15.4	22.4	15.8	18.0	3.5	17.0	11.0	17.8	19.4	15.6	25.0	12.6	12.9	19.2	30.2	13.2	22.7
RCCD1	MGC14386	ENSG00000166965	"RCC1 domain containing 1"	A6NED2	15	90954870-90963125	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039683, HPA040776"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	Yes			"Plasma membrane, Cytosol"		"HPA039683: AB_10794752, HPA040776: AB_10795478"	"unprognostic (1.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.63e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.10e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.49e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	5.2	9.9	6.1	12.5	8.1	6.1	17.3	14.3	7.0	5.3	9.2	3.3	5.8	8.0	6.4	5.9	9.2	6.2	8.7	6.2	5.5	6.7	8.5	11.3	6.6	5.7	8.4	1.5	8.2	12.1	9.3	3.2	9.4	6.0	5.6	7.4	3.1	8.2	6.2	5.2	11.8	9.7	8.6	5.6	10.1	6.5	18.9	7.2	21.9	11.0	8.3	14.5	6.4	5.7	3.1	2.3	0.1	2.0	1.7	2.9	0.8	4.9	7.3	1.7	3.6	4.3	5.1	12.9	5.7	1.0	1.6	1.7	3.5	9.4	17.3	9.2	3.5	0.1	10.6	5.6	1.5	2.8	14.5	11.5	12.5	12.3	5.0	3.6	5.9	4.9	3.8	5.1	1.7	2.3	6.6	2.7	10.2	9.4	11.4	4.9	1.6	7.1	6.2	6.6	5.9	3.0	8.5	8.7	18.4	7.7	2.3	5.6	6.4	9.9	6.3	6.7	9.5	7.3	11.5	4.3	1.0	7.2	4.2	0.2	20.5	8.4	10.3	1.9	13.2	4.8	0.1	0.7	0.1	0.8	2.0	2.1	3.1	1.7	2.7	1.6	2.1	2.9	1.0	0.1	1.7	1.1	2.3	2.1	0.8	6.1	8.1	14.3	7.0	5.5	6.7	8.4	1.5	6.0	7.2	0.0	2.1	13.7	10.1	6.5	6.0	8.1	0.0	1.4	1.2	7.0	3.9	12.3	3.3	7.2	1.8	4.5	11.8	70.0	4.2	16.3	7.1	7.3	0.0	7.4	10.2	0.0	21.2	3.1	7.5	3.9	8.1	5.4	5.0	4.6	16.7	10.6	4.9	14.0	7.4	10.4	2.7	25.8	6.4	20.6	18.3	7.9	7.6	3.2	21.5	7.4
RCN2	"E6BP, ERC-55, ERC55, TCBP49"	ENSG00000117906	"Reticulocalbin 2"	Q14257	15	76931619-76954392	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 147.5"	"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 314.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030694, HPA030695"	Enhanced	Supported	Enhanced	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		41000	"Endoplasmic reticulum"		"HPA030694: AB_2673573, HPA030695: AB_2673574"	"unprognostic (1.69e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (7.36e-5)"	"unprognostic (1.74e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.67e-2)"	13.8	14.7	29.9	12.1	32.6	9.9	16.8	25.1	37.5	16.8	15.0	17.3	28.1	10.4	20.6	147.5	14.9	25.0	15.3	17.3	29.5	41.5	22.6	9.3	13.5	12.5	27.2	29.5	18.8	11.0	28.4	17.8	27.7	24.6	19.6	17.2	15.5	12.0	21.9	22.7	10.6	11.0	18.2	18.5	12.4	13.8	48.2	14.8	14.8	22.1	17.0	14.3	17.8	13.3	15.9	12.0	9.8	7.2	14.1	19.0	11.5	20.2	14.4	64.4	30.3	27.9	31.8	40.3	24.2	33.1	31.6	26.5	17.8	17.5	12.7	35.2	26.3	34.1	31.2	48.6	20.9	40.5	9.7	38.0	6.3	21.1	29.4	33.3	22.6	9.7	28.7	28.9	15.5	20.0	33.5	33.3	21.9	15.8	12.7	32.9	13.0	22.4	15.6	49.0	21.4	16.1	23.7	42.4	8.1	20.8	27.4	36.8	36.8	39.6	22.2	46.1	59.9	21.6	25.2	17.8	37.4	30.2	23.7	49.7	18.3	56.3	15.1	21.3	19.1	33.8	4.5	4.8	9.8	14.8	4.4	17.2	14.8	15.7	19.0	10.2	15.9	17.8	17.2	2.6	14.1	7.2	12.0	10.9	11.5	29.9	32.6	25.1	37.5	29.5	41.5	27.2	29.5	24.6	14.8	23.8	40.4	56.2	99.4	72.9	83.3	92.8	50.9	25.4	19.4	94.2	35.3	163.6	41.4	99.8	42.5	52.4	14.8	23.3	39.4	255.8	92.7	76.9	28.8	26.7	49.5	120.8	70.6	55.9	24.2	59.2	57.2	29.6	87.7	34.3	51.1	85.4	53.2	35.1	88.1	44.0	51.5	58.2	72.1	314.9	144.1	61.9	136.8	66.0	76.6	95.7
RCOR1	"COREST, KIAA0071, RCOR"	ENSG00000089902	"REST corepressor 1"	Q9UKL0	14	102592661-102730576	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Suprabasal keratinocytes: 102.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001956, HPA049327, HPA054241"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB001956: , HPA049327: AB_2680715, HPA054241: AB_2682426"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.01e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.96e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.87e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.05e-3)"	"unprognostic (7.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (3.72e-4)"	8.0	5.9	4.2	15.2	4.5	25.2	6.2	8.8	4.4	9.8	14.6	3.8	9.7	7.0	9.7	9.7	16.4	5.8	10.4	6.0	4.4	4.4	5.3	6.0	15.1	8.1	4.1	2.6	7.3	5.3	8.9	6.0	12.5	3.6	7.1	6.7	6.3	8.5	7.6	11.2	9.5	16.1	6.5	4.5	8.6	7.9	18.4	3.8	21.2	5.4	10.4	12.9	8.7	10.3	0.8	2.8	7.0	3.1	1.3	1.1	0.9	10.5	9.9	8.9	9.8	7.2	10.0	18.9	10.9	7.8	10.3	9.8	9.0	12.9	11.9	9.0	9.5	5.2	16.7	13.4	7.8	15.5	5.0	4.9	22.1	9.0	8.8	9.8	21.9	20.0	7.0	12.3	9.0	14.0	11.1	11.2	11.3	17.5	9.1	10.3	17.2	13.6	14.8	4.4	11.7	17.1	35.1	9.0	5.3	12.5	13.1	11.6	7.2	24.5	11.3	7.0	11.7	15.5	17.4	12.1	7.2	5.4	22.7	7.1	6.7	8.1	12.8	8.6	16.1	7.5	4.9	2.7	3.7	0.4	2.9	0.6	0.7	0.7	1.1	2.8	0.8	0.6	0.7	7.0	1.3	3.1	1.1	1.0	0.9	4.2	4.5	8.8	4.4	4.4	4.4	4.1	2.6	3.6	3.8	44.7	30.7	22.9	21.2	51.2	7.5	15.9	5.1	12.0	23.9	3.5	2.0	24.5	5.0	5.7	4.2	11.8	21.2	0.0	6.4	16.3	18.3	23.4	24.2	10.9	13.2	9.5	20.2	12.3	35.2	4.0	22.5	28.9	23.6	1.8	16.0	10.0	12.7	13.3	19.8	6.9	5.1	0.0	20.6	22.4	18.5	102.9	36.0	13.8	18.0	56.9
RCOR3	FLJ10876	ENSG00000117625	"REST corepressor 3"	Q9P2K3	1	211258377-211316385	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007413, HPA007621, HPA071997"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA007413: AB_1079796, HPA007621: , HPA071997: AB_2732193"	"unprognostic (2.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (4.02e-3)"	"unprognostic (2.28e-2)"	"prognostic favorable (5.75e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.12e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.95e-1)"	"unprognostic (3.56e-3)"	15.1	15.0	17.2	14.9	19.6	25.8	18.9	33.7	21.7	17.3	16.2	17.3	26.8	11.8	19.1	21.9	13.5	16.0	17.1	20.8	16.3	14.4	15.7	13.5	15.8	15.3	18.8	20.8	27.5	18.2	21.4	23.8	14.1	18.6	23.7	13.4	17.3	18.0	35.5	55.3	17.7	16.5	23.6	18.1	17.5	14.4	31.4	21.3	20.6	30.0	16.4	13.4	17.9	16.3	10.0	9.5	27.3	8.5	11.8	10.7	5.4	9.9	7.8	15.9	8.9	13.8	12.9	17.7	11.3	11.3	12.8	13.3	7.6	13.0	14.6	7.9	14.5	9.0	15.0	12.7	11.2	10.0	14.9	7.5	13.3	14.0	10.1	15.5	20.1	12.9	14.3	10.6	13.9	17.2	14.1	7.9	14.5	13.8	18.3	18.5	6.6	10.3	11.6	17.4	6.8	9.6	11.3	30.8	16.7	10.6	17.2	10.2	22.2	29.0	15.1	21.1	15.7	18.9	14.4	10.8	11.4	13.0	14.7	12.7	16.2	10.6	18.3	9.5	12.0	10.0	15.3	8.1	27.3	6.0	7.5	7.9	10.0	6.5	6.2	8.5	8.0	10.7	7.6	13.7	11.8	8.5	9.5	7.6	5.4	17.2	19.6	33.7	21.7	16.3	14.4	18.8	20.8	18.6	21.3	35.7	41.5	10.2	9.5	12.9	43.2	61.3	28.1	25.4	29.6	14.0	33.4	21.6	18.3	8.4	51.5	15.5	17.7	0.0	13.4	12.4	17.2	13.2	18.5	18.7	17.5	22.3	32.8	20.9	20.2	93.2	20.8	21.1	21.9	17.2	17.5	25.7	9.1	16.7	25.5	19.9	49.5	0.0	20.2	56.9	31.5	14.8	21.3	17.5	16.9	7.6
RDH14	"PAN2, SDR7C4"	ENSG00000240857	"Retinol dehydrogenase 14"	Q9HBH5	2	18554723-18560680	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056686, HPA078577"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA056686: AB_2683209, HPA078577: "	"unprognostic (5.79e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.64e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.83e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.69e-2)"	13.8	16.2	10.7	8.7	14.3	5.1	14.0	14.2	15.4	11.3	14.1	11.0	9.6	12.7	16.2	14.3	16.0	12.7	11.0	29.0	12.2	10.4	23.0	22.1	12.5	14.6	11.7	9.0	11.7	21.0	23.5	13.5	14.2	13.2	20.7	12.0	10.6	13.8	13.1	27.8	9.9	16.3	22.9	10.3	15.4	15.9	11.1	8.8	17.4	18.1	13.6	10.7	18.1	17.9	9.9	7.6	7.2	2.0	3.7	7.6	1.6	18.6	5.9	5.0	4.1	15.1	16.1	16.8	11.4	11.7	10.3	10.3	4.6	9.7	18.4	6.8	6.8	13.4	10.2	7.2	13.3	12.1	10.2	19.8	7.2	6.5	13.8	12.9	8.7	9.8	12.2	13.6	10.0	15.7	14.5	9.5	7.5	12.8	6.3	16.9	6.0	7.5	15.4	13.5	14.3	16.9	11.0	13.6	7.9	20.2	12.2	7.7	13.4	6.2	13.7	16.2	10.9	6.8	5.0	9.5	14.7	9.1	11.6	13.5	17.9	14.7	13.7	10.5	6.0	11.5	1.7	1.8	7.2	4.4	2.0	7.6	7.4	5.1	6.3	2.3	9.9	7.3	6.0	0.8	3.7	1.9	7.6	5.8	1.6	10.7	14.3	14.2	15.4	12.2	10.4	11.7	9.0	13.2	8.8	14.9	10.9	21.4	26.0	21.8	22.4	43.0	22.9	2.7	6.8	15.7	5.9	40.0	26.6	32.8	16.1	17.9	14.0	0.0	30.8	42.8	33.7	31.0	12.7	26.8	21.0	14.3	12.7	17.2	15.1	9.4	61.9	14.8	21.9	22.6	27.1	25.0	23.9	32.3	42.1	30.5	18.0	32.3	30.7	71.9	28.2	16.3	38.2	17.5	29.8	23.7
RECQL	"RecQ1, RecQL1"	ENSG00000004700	"RecQ like helicase"	P46063	12	21468911-21501669	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009743, HPA030960, HPA064259"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009743: AB_655306, HPA030960: AB_10794912, HPA064259: AB_2685230"	"unprognostic (9.70e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.86e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.39e-1)"	"unprognostic (8.97e-3)"	"unprognostic (1.89e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (3.77e-3)"	"unprognostic (3.78e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.99e-1)"	"unprognostic (3.69e-2)"	32.7	15.8	10.0	22.0	12.7	10.8	18.2	10.9	11.2	18.0	16.3	9.4	11.0	7.5	19.8	14.4	18.7	14.6	14.1	17.9	11.2	7.2	19.6	18.0	19.5	25.7	15.3	7.6	16.0	11.9	8.0	14.8	17.1	12.0	14.0	12.7	6.7	13.1	12.4	15.0	12.4	15.5	20.5	19.5	34.0	12.9	10.8	13.0	27.4	17.4	14.3	25.0	22.6	13.0	19.3	15.2	11.3	20.7	23.1	28.0	13.8	17.2	17.5	13.3	9.8	26.9	33.8	15.4	33.3	28.2	21.5	25.2	19.1	14.4	20.7	12.9	22.7	27.3	12.6	14.2	16.6	30.7	34.6	9.4	25.3	19.4	8.1	10.4	17.5	19.1	18.8	8.6	30.5	22.4	19.8	24.1	14.6	8.8	10.1	28.3	8.4	19.1	20.4	22.1	5.3	11.9	15.8	53.9	16.0	8.3	11.9	3.6	10.6	24.9	6.7	17.5	48.0	17.0	11.2	32.5	30.3	19.7	26.5	30.9	4.1	12.2	45.4	25.6	10.3	22.2	9.3	11.8	11.3	21.9	20.7	21.3	19.3	20.5	21.0	15.2	16.0	13.6	18.8	5.5	23.1	18.8	11.6	28.0	13.8	10.0	12.7	10.9	11.2	11.2	7.2	15.3	7.6	12.0	13.0	20.8	19.7	38.7	12.7	20.9	10.9	7.3	12.7	30.8	25.0	14.0	13.7	9.7	8.3	16.8	0.5	36.0	3.2	0.0	21.6	23.8	30.7	7.0	50.8	11.9	25.0	14.3	9.4	28.3	30.7	2.0	20.4	35.9	28.7	49.5	6.0	17.7	24.4	5.5	35.3	9.5	10.9	12.9	25.8	6.0	8.1	37.5	3.0	41.7	6.9	8.2
RECQL4	RecQ4	ENSG00000160957	"RecQ like helicase 4"		8	144511288-144517845	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 21.0;lymphoid tissue: 18.9"	"Cell type enhanced"	"Detected in many"	13	"Extravillous trophoblasts: 7.1;Spermatocytes: 12.6;Spermatogonia: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	14	"B-cells: 1.9;monocytes: 1.0;T-cells: 1.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB017800, HPA025821"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB017800: , HPA025821: AB_1856168"	"unprognostic (5.92e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.17e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.12e-2)"	"unprognostic (4.12e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.12e-3)"	"unprognostic (8.82e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.34e-1)"	2.0	1.6	2.6	12.3	5.6	21.0	2.8	11.5	3.7	1.8	4.3	1.5	1.6	5.6	2.5	4.9	9.4	1.5	1.9	1.9	2.3	1.7	1.6	1.9	1.6	5.9	1.5	2.2	1.9	3.5	0.3	2.4	2.7	2.2	7.7	1.5	1.4	5.4	0.9	2.1	9.4	4.8	1.1	1.7	4.7	3.0	18.1	1.8	18.9	2.5	5.3	8.0	1.6	1.8	1.9	0.1	0.0	1.0	0.0	1.6	0.2	10.4	18.7	8.7	18.4	0.5	0.9	15.3	10.6	1.9	7.9	6.6	18.4	15.5	7.1	7.1	1.7	4.6	12.7	5.8	4.5	2.2	12.5	22.0	25.7	32.0	13.7	0.1	6.5	21.5	1.1	0.6	8.8	1.8	1.1	2.2	14.6	25.5	9.3	2.7	32.4	23.7	17.7	6.1	8.7	22.4	24.9	6.9	11.9	2.1	11.3	17.3	10.4	14.4	12.1	3.7	2.5	14.7	14.4	2.9	12.8	38.7	15.3	19.5	5.2	5.4	12.1	7.3	20.2	12.8	0.0	0.1	0.0	1.1	1.0	0.0	1.9	0.5	1.1	0.1	0.0	0.9	1.6	0.0	0.0	0.0	0.1	0.0	0.2	2.6	5.6	11.5	3.7	2.3	1.7	1.5	2.2	2.2	1.8	0.0	0.0	2.2	0.4	1.3	2.5	1.6	2.5	0.0	0.0	0.0	3.9	1.2	0.0	0.4	3.1	0.0	0.4	0.0	0.4	7.1	0.8	0.5	0.0	0.6	3.0	0.0	0.0	0.0	0.3	6.2	1.1	0.6	0.0	0.0	1.4	0.2	0.3	0.0	1.4	0.3	1.6	0.0	0.4	12.6	21.1	0.9	1.3	0.0	3.1	0.4
RELA	"NFKB3, p65"	ENSG00000173039	"RELA proto-oncogene, NF-kB subunit"	Q04206	11	65653596-65663094	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004264, CAB005030, HPA063461"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004264: AB_628017, CAB005030: AB_562171, HPA063461: AB_2685016"	"unprognostic (9.17e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.67e-2)"	"unprognostic (5.39e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.30e-3)"	"unprognostic (1.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.53e-1)"	36.2	23.1	21.4	27.6	32.0	50.2	37.8	21.5	28.2	35.6	32.3	22.9	23.6	23.6	36.9	26.8	36.4	32.8	33.6	28.9	21.1	12.9	28.4	38.5	37.7	30.8	35.6	13.3	51.9	29.0	27.3	19.3	27.1	22.6	31.1	19.7	23.9	32.8	39.2	46.5	35.2	26.7	33.5	29.5	38.1	31.8	20.6	30.1	34.3	26.3	30.6	36.4	54.7	38.8	15.2	13.2	18.3	14.4	21.3	23.3	12.4	26.2	27.0	12.1	16.8	19.3	18.8	12.2	20.2	24.5	23.3	18.9	12.3	26.7	19.9	33.9	28.3	27.4	23.5	13.8	24.5	16.5	23.4	19.9	21.8	20.2	17.8	21.2	16.2	31.0	21.6	24.2	25.9	30.7	22.7	28.2	15.9	21.9	23.1	18.7	35.0	29.3	13.6	7.9	16.0	23.8	24.5	11.8	29.7	19.5	23.8	9.9	22.9	17.2	27.1	26.9	9.6	31.5	10.6	38.4	25.2	21.6	38.5	19.1	35.2	32.3	21.2	28.5	11.1	24.0	10.5	11.3	15.1	20.5	14.4	23.3	15.2	18.2	20.4	13.2	13.7	17.3	18.2	18.3	21.3	12.5	13.1	17.8	12.4	21.4	32.0	21.5	28.2	21.1	12.9	35.6	13.3	22.6	30.1	29.8	26.7	18.2	42.0	42.0	8.6	20.2	15.3	14.7	21.6	10.4	7.9	20.6	24.9	37.4	3.6	38.3	20.1	0.0	39.0	20.1	24.9	50.9	42.8	17.9	21.7	14.3	18.9	33.2	23.4	5.6	26.7	20.1	30.4	41.5	22.3	13.7	49.8	20.1	24.8	13.7	9.0	12.9	37.1	9.9	17.9	37.8	36.5	29.6	19.6	63.8
RFC1	"A1, MHCBFB, PO-GA, RFC140"	ENSG00000035928	"Replication factor C subunit 1"	P35251	4	39287456-39366375	"Plasma proteins, Predicted intracellular proteins"	"DNA replication, Transcription, Transcription regulation"	"Activator, DNA-binding"	Neuropathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009520, HPA046116, HPA069306"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB009520: AB_2178317, HPA046116: AB_2679544, HPA069306: AB_2686115"	"unprognostic (8.23e-2)"	"unprognostic (2.30e-1)"	"prognostic favorable (4.43e-5)"	"unprognostic (4.15e-2)"	"unprognostic (4.08e-2)"	"unprognostic (3.38e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.47e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.62e-3)"	"unprognostic (4.48e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.47e-2)"	18.7	24.0	20.2	22.5	24.9	26.8	21.2	19.9	22.7	23.8	17.8	17.1	20.3	12.5	20.7	19.0	19.4	15.8	11.9	15.4	17.9	14.6	23.4	24.9	17.2	26.3	29.0	22.7	26.2	34.1	41.3	30.7	17.6	23.5	20.1	14.5	10.5	17.4	18.9	13.5	17.8	16.0	21.0	32.7	21.6	17.1	12.4	28.9	33.6	22.3	14.6	27.3	25.3	17.4	15.3	13.0	6.4	8.1	10.8	13.5	4.7	15.8	7.2	20.5	16.7	9.9	12.6	10.5	18.4	16.8	18.9	22.5	13.9	16.2	39.2	12.5	12.3	20.3	7.7	18.8	16.0	30.5	7.0	12.8	17.5	13.8	12.7	12.0	24.5	11.7	9.6	12.9	19.1	21.4	15.1	14.6	19.6	17.3	8.3	14.3	6.4	35.9	15.8	12.5	9.9	9.2	28.6	37.4	12.3	8.2	11.1	14.4	14.0	10.8	4.3	13.9	13.4	11.3	13.8	11.1	15.6	19.3	14.4	23.3	11.9	16.1	37.3	12.8	25.7	15.5	6.4	8.1	3.2	13.2	6.2	9.6	12.4	11.4	11.2	6.2	15.3	13.5	11.9	3.7	10.8	7.4	13.0	9.9	4.7	20.2	24.9	19.9	22.7	17.9	14.6	29.0	22.7	23.5	28.9	59.6	101.9	40.2	33.4	18.3	67.9	62.9	30.6	45.5	48.9	54.1	56.9	32.4	61.3	47.2	30.3	54.6	23.3	23.3	57.3	45.5	31.2	43.3	24.4	70.3	26.9	81.0	28.8	55.9	42.4	22.0	75.9	33.8	15.1	37.9	46.9	81.0	46.5	31.6	86.3	63.9	74.7	58.2	24.5	40.8	69.2	18.6	26.9	55.4	43.2	40.9
RFC4	"A1, RFC37"	ENSG00000163918	"Replication factor C subunit 4"	P35249	3	186789880-186807058	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 48.3;Spermatocytes: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004557, HPA049123, HPA058507"	Enhanced		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"CAB004557: AB_2178593, HPA049123: AB_2680642, HPA058507: AB_2683736"	"unprognostic (2.45e-1)"	"prognostic favorable (7.41e-5)"	"unprognostic (2.84e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.69e-3)"	"prognostic unfavorable (6.75e-7)"	"unprognostic (5.29e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.80e-2)"	"unprognostic (4.98e-1)"	"unprognostic (6.15e-2)"	"unprognostic (2.16e-1)"	7.1	6.9	11.5	14.1	16.0	26.8	10.5	28.0	13.9	8.8	11.6	5.3	5.8	8.2	11.8	7.3	13.0	10.2	7.6	8.0	8.6	6.2	8.2	9.3	6.6	22.1	14.5	9.8	12.7	11.9	6.5	9.0	11.0	12.5	7.3	16.1	5.9	8.1	5.8	8.1	8.7	11.8	13.6	8.4	15.6	9.8	20.3	12.8	28.6	6.4	11.0	25.2	8.3	8.5	11.2	7.7	7.4	10.3	7.0	16.5	6.2	34.8	12.0	28.5	18.2	4.1	4.5	22.5	16.9	10.7	27.0	29.9	17.9	16.7	25.2	39.3	8.1	25.9	18.4	25.1	16.5	33.3	38.0	22.1	25.9	18.4	18.2	3.2	27.3	17.4	3.8	6.0	18.5	14.5	6.0	9.0	39.5	20.1	35.9	18.4	16.6	34.3	25.6	25.2	31.2	16.4	27.2	24.5	34.6	9.7	13.0	27.9	13.9	21.1	23.3	19.1	22.4	39.6	26.2	4.1	16.4	20.7	27.4	50.4	20.1	44.4	83.9	14.4	30.1	21.5	0.0	2.2	7.4	9.8	3.3	9.4	10.6	9.7	10.1	3.9	11.2	9.8	8.9	0.4	7.0	10.3	7.7	16.5	6.2	11.5	16.0	28.0	13.9	8.6	6.2	14.5	9.8	12.5	12.8	0.0	2.1	20.1	13.1	5.4	17.0	6.9	10.2	9.4	7.9	10.4	0.0	26.7	5.0	9.4	18.6	4.5	2.0	23.3	14.4	48.3	5.1	4.1	8.1	2.9	20.0	7.9	1.2	6.7	2.1	7.9	9.8	5.2	1.7	15.4	4.2	12.4	7.9	3.5	7.4	6.7	14.0	6.5	10.3	67.9	38.7	2.6	9.4	8.6	11.5	3.1
RFWD3	"FANCW, FLJ10520, RNF201"	ENSG00000168411	"Ring finger and WD repeat domain 3"	Q6PCD5	16	74621394-74666881	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease mutation, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 46.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048258, HPA075649"	Approved		Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA048258: AB_2680332, HPA075649: AB_2686761"	"unprognostic (4.79e-2)"	"unprognostic (6.45e-3)"	"unprognostic (6.35e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.04e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.53e-3)"	"unprognostic (1.73e-3)"	"unprognostic (2.84e-1)"	"unprognostic (4.31e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	7.3	5.2	4.2	12.2	6.1	33.9	7.8	7.8	5.6	7.4	6.7	8.4	8.4	5.5	9.7	10.0	12.8	6.3	5.5	5.4	3.9	3.7	6.5	5.6	6.5	12.0	6.1	4.8	7.7	9.6	8.5	7.5	11.5	5.3	6.5	8.1	7.2	8.0	8.4	4.5	11.6	7.8	5.6	4.8	9.7	6.2	35.1	7.2	40.5	7.0	7.5	18.0	7.2	8.6	9.3	7.1	13.8	10.9	9.1	11.7	6.5	14.1	18.2	13.8	10.0	2.9	4.0	15.5	12.8	9.9	20.5	17.9	23.7	14.9	19.8	10.5	10.0	10.3	17.1	22.4	13.3	25.2	6.2	13.4	17.5	14.8	13.3	2.5	17.6	18.3	2.8	4.2	25.8	16.0	5.3	8.7	16.9	26.4	8.9	15.4	22.6	25.6	16.1	27.1	8.3	8.8	39.9	9.3	17.4	7.3	15.1	10.2	10.9	20.6	7.3	9.1	13.0	13.4	15.0	8.4	15.0	14.4	8.4	16.1	12.1	22.4	59.4	10.7	13.6	18.2	13.8	6.8	9.9	9.3	6.3	10.2	7.8	7.7	8.6	7.1	9.3	11.7	8.1	7.7	9.1	10.9	5.5	10.9	6.5	4.2	6.1	7.8	5.6	3.9	3.7	6.1	4.8	5.3	7.2	0.0	5.1	11.2	5.0	9.6	5.8	2.4	2.5	2.7	5.7	1.8	9.8	9.1	10.0	5.6	4.2	5.2	4.2	23.3	6.6	6.6	4.8	9.2	4.6	6.4	7.6	3.2	9.1	10.4	13.7	5.4	3.4	6.1	15.1	3.6	8.3	3.5	8.2	0.0	3.9	3.4	6.8	6.5	5.6	46.5	30.6	8.2	6.3	7.5	7.3	12.0
RFX1	EF-C	ENSG00000132005	"Regulatory factor X1"	P22670	19	13961538-14007039	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 122.1;Late spermatids: 79.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048722, HPA052966"	Approved		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA048722: AB_2680500, HPA052966: "	"unprognostic (6.40e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.63e-1)"	"unprognostic (5.45e-2)"	"prognostic favorable (2.42e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.61e-2)"	"prognostic favorable (4.92e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.56e-2)"	7.4	7.4	13.1	8.7	13.1	9.8	7.0	36.2	19.3	10.3	6.0	6.2	10.2	10.6	8.0	4.6	8.0	8.5	6.3	7.0	11.7	5.9	7.9	8.6	7.0	7.2	8.6	9.5	10.2	12.5	11.9	18.9	8.0	9.5	8.5	3.1	9.8	12.7	12.4	11.0	7.0	9.2	4.4	6.8	12.0	11.2	21.0	10.8	11.6	10.9	3.4	9.3	6.8	13.6	3.9	3.5	10.8	3.5	3.4	2.0	1.1	6.2	6.3	3.4	4.1	2.1	2.6	10.3	3.5	2.3	4.0	3.5	6.5	6.3	3.5	7.0	1.8	3.5	8.2	2.5	2.5	1.4	3.5	14.1	4.0	7.1	5.8	3.9	4.1	8.6	1.9	2.7	3.6	2.1	3.6	3.2	3.1	10.2	4.0	2.1	9.5	7.4	8.9	7.7	3.4	9.7	6.5	3.5	5.0	4.0	3.4	14.2	7.5	6.0	5.3	4.8	1.9	5.6	4.3	3.7	7.1	5.8	7.7	5.9	9.4	4.2	2.4	5.6	4.0	6.2	0.7	3.5	1.6	1.4	1.1	1.3	2.9	1.6	1.5	1.7	3.9	1.7	2.0	10.8	3.4	2.0	3.5	1.0	1.1	13.1	13.1	36.2	19.3	11.7	5.9	8.6	9.5	9.5	10.8	14.9	9.9	15.9	8.0	4.9	27.9	7.7	5.1	1.4	12.5	21.0	33.4	8.2	8.3	8.7	122.1	9.8	14.9	0.0	8.4	10.4	9.6	6.2	11.5	14.4	9.2	22.3	16.0	13.5	17.5	79.7	23.9	8.5	1.7	3.6	14.5	13.8	9.3	12.5	26.2	6.7	47.6	12.9	6.1	31.2	17.5	6.6	15.9	15.3	12.7	5.6
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049157: AB_2680658, HPA053330: AB_2682114"	"unprognostic (3.16e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.25e-3)"	"unprognostic (3.40e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.31e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.73e-2)"	"unprognostic (2.04e-3)"	16.2	11.0	15.8	19.5	17.8	28.4	15.6	7.6	15.3	19.5	20.1	14.9	17.4	16.9	16.6	20.3	21.8	25.3	12.8	17.7	14.3	12.7	19.0	11.3	14.3	22.5	16.0	10.1	18.8	17.9	12.2	14.0	21.9	13.6	17.7	9.0	16.1	27.0	22.4	32.0	18.7	15.3	11.9	13.0	26.5	16.7	8.5	9.3	49.6	36.6	21.8	23.4	15.1	13.8	25.1	31.7	28.4	18.2	18.3	23.3	15.7	18.6	11.7	8.3	16.6	2.9	8.2	20.9	9.3	9.8	16.0	15.9	9.7	39.1	18.4	23.9	9.6	6.8	13.9	7.1	18.4	7.1	12.6	11.1	14.6	11.9	14.1	30.5	20.8	31.1	15.6	10.9	14.0	10.3	9.8	15.9	18.3	29.1	21.0	8.7	37.4	27.1	27.7	10.0	19.7	26.6	23.0	8.5	32.0	13.2	13.1	6.9	14.4	9.7	12.4	22.8	5.8	17.9	42.6	15.5	8.8	9.3	20.7	14.9	24.3	26.3	27.3	12.7	26.0	16.7	20.5	17.7	28.4	15.1	18.2	12.6	23.6	16.9	16.3	20.0	25.1	17.1	16.5	7.6	18.3	13.3	31.7	23.3	15.7	15.8	17.8	7.6	15.3	14.3	12.7	16.0	10.1	13.6	9.3	29.8	34.6	34.2	28.5	19.6	7.8	3.3	25.5	41.5	14.8	29.6	2.0	50.0	64.6	40.6	4.0	26.3	43.3	23.3	49.9	50.7	21.3	23.9	32.2	13.6	54.2	14.3	35.7	31.3	48.3	7.6	28.1	33.6	20.3	68.5	37.0	24.1	47.4	36.8	18.0	53.8	10.1	38.8	25.9	5.2	17.2	21.5	38.1	28.0	39.4	21.3
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 233.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	12.3	50.9	44.3	9.2	64.6	12.1	12.1	14.4	68.3	17.9	11.9	18.5	43.8	18.2	8.5	31.8	14.2	22.6	12.5	14.1	48.5	69.1	18.5	21.7	22.1	8.9	33.6	29.9	12.3	23.6	81.3	56.5	10.6	37.1	15.8	9.1	23.0	22.8	57.3	6.0	14.4	12.5	7.0	16.2	9.5	15.3	15.5	10.7	9.5	34.3	4.2	7.6	10.0	9.6	11.1	13.5	76.4	14.0	13.2	27.4	12.2	7.5	25.0	11.2	22.7	6.6	4.3	4.7	4.6	18.1	10.5	8.9	13.5	20.9	2.9	4.1	8.7	22.9	12.3	7.4	5.4	3.2	8.6	14.7	2.5	15.8	12.9	18.2	4.3	23.6	9.4	13.3	11.7	5.3	16.2	6.7	19.4	5.8	18.6	8.9	50.4	8.1	24.1	11.0	14.9	14.3	6.0	7.8	21.7	17.2	13.6	14.9	29.7	17.1	36.3	17.4	9.0	23.7	8.2	6.2	16.4	13.7	10.8	9.4	15.4	5.3	4.5	16.4	6.8	20.0	76.4	14.0	17.6	18.9	13.9	16.6	11.1	21.3	16.7	13.5	10.8	18.0	15.3	24.0	13.2	7.9	11.1	27.4	12.2	44.3	64.6	14.4	68.3	48.5	69.1	33.6	29.9	37.1	10.7	38.7	29.3	20.0	41.3	20.6	34.2	7.7	53.5	46.8	39.8	82.0	31.4	45.1	16.6	79.5	128.0	23.5	40.6	0.0	89.9	35.2	36.2	52.9	189.3	34.5	39.0	17.5	86.2	65.7	29.1	233.4	39.4	32.1	57.3	21.6	32.4	62.9	61.3	31.6	49.5	44.0	27.9	6.5	24.7	38.5	29.7	20.7	43.5	43.7	23.9	42.0
RHOXF1	"OTEX, PEPP1"	ENSG00000101883	"Rhox homeobox family member 1"	Q8NHV9	X	120109053-120115937	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 8.1;brain: 9.2;testis: 27.8"	"Cell type enriched"	"Detected in some"	39	"Spermatogonia: 154.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 9.2"	"Cell type enriched"	"Detected in some"	6	"T-reg: 8.1"	"Lineage enriched"	"Detected in single"	30	"T-cells: 8.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HEK 293: 3.9;NB-4: 2.8"									"HPA052560, HPA056506"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA052560: , HPA056506: AB_2683157"	"unprognostic (5.03e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.31e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.89e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.50e-4)"	"unprognostic (1.97e-1)"	"unprognostic (5.85e-4)"	"unprognostic (3.00e-1)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.73e-3)"	2.8	0.5	0.9	0.5	1.1	0.3	0.9	9.2	1.7	0.5	0.7	0.5	0.5	0.2	0.5	0.5	0.5	1.5	0.5	0.5	0.8	2.4	0.8	0.5	0.5	0.6	0.8	0.5	2.2	0.5	0.8	0.9	1.1	0.5	0.5	0.1	0.5	0.8	0.6	0.5	2.4	0.5	0.5	0.5	0.5	0.2	27.8	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.7	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	3.2	3.9	0.4	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.0	0.3	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	8.1	0.0	0.9	1.1	9.2	1.7	0.8	2.4	0.8	0.5	0.5	0.5	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	0.0	3.9	0.1	1.7	0.1	1.0	0.1	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.6	0.0	0.0	0.0	0.1	0.8	0.0	0.0	1.4	0.0	1.3	0.0	0.0	2.9	154.2	0.3	0.0	0.0	0.1	0.0
RIPK2	"CARD3, CARDIAK, RICK, RIP2"	ENSG00000104312	"Receptor interacting serine/threonine kinase 2"	O43353	8	89757747-89791063	"Enzymes, Predicted intracellular proteins"	"Adaptive immunity, Apoptosis, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015273, HPA016499"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA015273: AB_1856299, HPA016499: AB_1856300"	"unprognostic (1.20e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.67e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.43e-3)"	"prognostic unfavorable (6.33e-5)"	"unprognostic (2.06e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (5.00e-6)"	"unprognostic (6.39e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.84e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.05e-4)"	12.0	5.5	9.3	11.2	7.9	13.6	10.0	3.0	9.3	9.7	7.9	10.6	5.2	3.5	10.9	7.8	8.3	7.0	17.3	11.6	9.2	8.6	7.7	10.4	18.7	10.9	11.8	5.8	8.9	13.2	14.7	7.3	20.8	9.1	10.7	5.6	4.6	10.2	5.8	3.1	10.4	6.9	10.4	16.5	14.2	8.3	5.6	11.5	5.1	8.5	4.9	11.8	15.0	7.6	7.5	6.9	19.4	11.2	3.8	5.5	4.3	10.3	3.6	1.8	2.6	4.5	6.3	3.4	11.5	19.6	6.1	7.9	3.1	5.4	8.0	17.9	6.4	4.9	2.5	4.9	3.8	11.3	5.7	4.9	6.7	1.7	3.1	12.7	2.4	3.3	5.0	3.1	8.7	28.1	6.5	6.4	0.0	3.2	2.6	5.6	2.1	0.0	5.1	1.0	4.7	8.5	1.7	2.6	3.9	14.3	4.6	0.3	2.0	2.7	7.2	5.4	2.5	7.0	3.0	5.7	3.7	3.5	6.3	5.3	5.3	2.4	4.8	9.1	0.2	2.4	8.8	5.7	19.4	3.6	10.6	4.1	7.5	5.5	4.7	6.9	4.3	5.2	5.5	4.5	3.8	11.2	2.3	1.2	4.3	9.3	7.9	3.0	7.4	9.2	8.6	11.8	5.8	9.1	11.5	32.8	17.8	13.4	31.1	51.2	2.4	2.8	5.1	10.7	22.7	3.5	0.0	10.6	5.0	66.4	5.0	9.5	2.3	0.0	53.1	35.2	38.5	46.3	42.7	2.6	39.0	3.2	0.0	5.5	25.3	1.6	7.2	48.6	18.6	50.5	5.2	10.0	41.2	0.0	5.6	6.7	0.1	12.9	22.7	8.1	10.9	42.2	70.0	12.7	6.6	40.4
RMDN3	"FAM82A2, FAM82C, FLJ10579, PTPIP51, RMD3"	ENSG00000137824	"Regulator of microtubule dynamics 3"	Q96TC7	15	40735884-40755851	"Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Differentiation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009975, HPA074840"	Supported		Enhanced	"Cytokinetic bridge,Mitochondria"		Yes	No			Mitochondria	"Cytokinetic bridge"	"HPA009975: AB_1078811, HPA074840: "	"unprognostic (2.54e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.35e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.50e-3)"	"unprognostic (2.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.94e-3)"	"prognostic favorable (6.70e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.79e-3)"	"unprognostic (2.04e-3)"	22.9	17.3	29.0	12.4	26.4	16.0	15.5	22.6	29.6	15.2	14.6	20.7	9.3	34.4	10.2	10.5	14.9	15.4	14.7	12.1	27.2	21.1	14.7	28.4	27.8	11.1	26.0	29.3	12.0	21.6	17.6	7.3	15.3	18.4	14.1	6.7	10.6	25.3	13.4	12.7	12.9	39.6	9.6	29.4	9.8	14.4	12.2	22.9	7.8	16.1	11.6	8.5	13.6	10.4	7.6	25.5	2.5	9.7	28.1	14.4	10.6	8.4	7.7	9.3	16.0	7.7	7.3	16.2	22.0	8.6	15.7	11.5	27.7	9.5	7.2	29.4	11.3	11.0	29.2	10.3	16.4	0.6	18.9	14.7	23.1	22.6	13.6	29.0	15.5	18.5	14.1	14.8	11.0	9.2	6.6	10.5	14.4	24.2	20.0	5.9	17.1	11.6	10.0	7.4	20.7	15.4	18.3	11.2	16.7	11.5	14.3	22.4	8.2	17.5	23.7	8.1	3.2	18.5	16.9	16.4	17.1	12.2	22.8	18.4	15.3	17.8	11.5	12.1	16.5	18.6	1.9	6.2	2.5	14.4	8.2	12.6	7.6	10.5	13.0	6.8	6.7	8.2	8.9	1.0	28.1	9.7	25.5	9.1	10.6	29.0	26.4	22.6	26.9	27.2	21.1	26.0	29.3	18.4	22.9	29.8	25.5	4.5	14.2	14.0	19.2	7.0	10.2	26.8	21.6	17.4	3.9	36.6	1.7	25.3	2.0	16.5	16.9	0.0	19.5	23.1	16.9	15.9	18.5	30.9	113.0	17.5	4.7	17.8	15.6	3.1	15.5	10.9	18.6	11.8	11.5	20.0	17.9	14.4	13.4	13.3	15.2	6.5	11.4	31.1	42.8	10.5	52.5	18.5	18.8	19.0
RNASEH2A	"AGS4, RNASEHI, RNHIA, RNHL"	ENSG00000104889	"Ribonuclease H2 subunit A"	O75792	19	12806556-12815201	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"	"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 44.8"	"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 97.8;Spermatocytes: 51.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042692			Enhanced	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"HPA042692: AB_10793981"	"unprognostic (6.74e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (6.18e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-2)"	"prognostic favorable (1.22e-4)"	"unprognostic (3.80e-3)"	"unprognostic (8.71e-2)"	"prognostic unfavorable (6.29e-6)"	"unprognostic (3.40e-3)"	"unprognostic (4.35e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.60e-2)"	6.5	5.5	6.4	11.4	10.6	21.9	6.6	11.0	7.5	6.8	6.6	9.2	1.6	8.6	6.8	4.4	14.1	6.0	5.7	5.1	6.7	4.8	8.7	5.9	5.5	9.2	10.6	5.8	7.3	7.0	6.2	4.1	11.8	6.1	5.3	5.7	5.5	8.8	4.3	7.1	13.4	7.1	4.4	7.8	12.0	7.4	14.1	8.4	44.8	8.6	13.4	17.4	6.0	8.0	11.3	7.8	7.1	6.8	12.9	8.6	5.0	14.9	11.3	6.8	6.8	1.0	1.9	8.4	7.0	2.9	10.5	12.1	8.9	5.7	16.0	10.5	1.6	5.9	8.9	5.6	6.9	5.8	8.7	15.1	7.7	12.0	6.8	0.8	7.0	7.1	1.0	1.7	8.8	3.2	2.0	4.0	13.1	10.6	4.8	5.0	25.7	12.9	7.0	6.8	5.6	19.7	13.9	9.9	11.5	2.6	5.9	14.2	8.3	7.5	2.8	3.2	3.1	7.4	4.4	3.8	12.5	6.3	17.7	11.5	11.6	12.8	12.7	7.4	11.3	10.0	7.1	6.8	6.4	8.6	6.6	7.0	9.8	7.0	6.1	4.2	11.3	6.6	6.5	6.8	12.9	5.9	7.8	5.5	5.0	6.4	10.6	11.0	7.5	6.7	4.8	10.6	5.8	6.1	8.4	0.0	1.6	10.4	15.3	12.5	15.9	2.4	10.2	4.0	1.2	0.0	3.9	40.3	0.0	3.9	12.7	4.9	4.6	0.0	5.4	97.8	9.3	6.6	3.5	3.4	41.5	7.9	8.1	10.4	10.3	15.1	7.8	11.9	11.8	6.4	7.7	10.1	1.9	7.0	4.6	0.8	11.2	6.5	11.3	51.9	45.0	11.5	19.0	12.5	19.0	7.3
RNASEH2B	"AGS2, DLEU8, FLJ11712"	ENSG00000136104	"Ribonuclease H2 subunit B"	Q5TBB1	13	50909678-51024120	"Disease related genes, Predicted intracellular proteins"			"Aicardi-Goutieres syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 120.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 68.3;REH: 57.1;THP-1: 51.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040084, HPA041469"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040084: AB_10697714, HPA041469: AB_2677496"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"prognostic unfavorable (2.54e-8)"	"unprognostic (1.05e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.34e-1)"	11.9	10.5	11.3	20.2	14.1	28.3	10.9	11.3	10.9	14.0	15.2	9.4	12.9	8.9	20.0	12.6	11.6	15.8	11.6	14.7	10.0	8.8	9.1	7.9	14.3	25.7	11.8	9.9	14.0	18.0	6.3	12.0	10.6	8.5	15.4	12.4	9.6	12.7	12.9	15.8	8.5	13.9	15.5	10.0	18.5	11.5	16.4	11.3	120.1	15.8	11.0	20.4	15.1	12.2	34.2	31.3	5.5	13.9	12.0	34.5	16.9	7.9	6.6	3.6	7.2	4.8	9.5	8.6	5.7	6.6	8.3	7.0	8.6	12.4	22.8	3.7	5.9	8.0	7.7	11.3	5.3	10.0	8.3	9.2	20.4	4.6	5.0	6.5	37.3	13.5	3.8	6.7	7.3	6.5	7.6	7.3	48.0	11.3	10.9	11.3	3.8	68.3	50.7	11.6	17.3	5.2	57.1	10.6	15.3	6.3	4.7	8.0	11.7	6.9	2.5	7.3	4.8	3.9	51.0	5.2	7.5	6.2	8.8	12.7	14.6	9.6	27.0	1.9	27.9	8.7	0.9	12.6	5.5	11.1	13.9	12.7	34.2	22.1	18.2	18.2	29.0	19.9	18.5	2.1	12.0	11.9	31.3	34.5	16.9	11.3	14.1	11.3	10.9	10.0	8.8	11.8	9.9	8.5	11.3	35.7	22.1	62.1	24.8	16.7	12.9	43.5	20.4	53.5	28.4	15.7	5.9	29.9	24.9	37.0	45.2	13.9	8.1	23.3	44.0	45.2	22.6	20.1	50.8	13.1	86.8	1.6	11.6	16.5	44.7	31.5	25.6	35.6	15.1	89.2	18.7	8.1	26.5	3.5	28.0	22.5	4.7	12.9	24.2	70.7	39.5	18.3	15.0	48.4	36.3	22.0
RNF168	FLJ35794	ENSG00000163961	"Ring finger protein 168"	Q8IYW5	3	196468783-196503768	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 199.9;Late spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046109			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046109: AB_2679540"	"unprognostic (6.15e-3)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.11e-1)"	"unprognostic (1.11e-2)"	"unprognostic (4.22e-1)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (6.81e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (4.83e-3)"	"unprognostic (2.80e-3)"	"unprognostic (5.98e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.65e-2)"	20.8	9.3	8.9	10.7	11.1	31.6	18.7	21.1	13.0	13.6	11.2	10.7	12.3	11.1	13.9	8.5	14.3	10.1	10.9	12.0	10.2	10.2	7.5	18.8	14.3	12.0	13.8	11.0	14.6	9.2	12.0	8.1	9.9	15.3	10.1	10.8	9.1	11.0	13.6	20.8	20.1	10.1	12.9	10.5	11.7	10.7	18.4	13.4	17.6	9.6	13.9	15.2	14.7	17.1	6.2	5.8	21.8	10.0	7.7	11.6	5.7	12.5	5.0	9.0	11.8	8.4	6.1	12.9	7.7	4.9	5.2	8.2	9.8	6.2	13.3	17.8	6.4	7.3	12.8	12.6	9.2	8.0	6.3	6.2	25.2	12.7	12.1	4.4	7.7	6.3	6.1	3.5	8.1	7.2	3.7	7.5	11.0	7.5	14.0	5.2	21.2	25.5	4.6	10.7	6.8	6.5	11.5	10.5	10.8	4.4	17.4	7.5	7.6	8.7	10.7	6.6	7.0	16.2	6.9	7.4	9.0	7.1	9.5	10.1	12.0	11.2	20.2	8.8	9.4	7.1	21.8	6.6	7.5	11.6	7.1	10.4	5.7	9.8	8.3	5.8	6.2	8.7	9.1	7.3	7.7	10.0	5.5	6.2	5.7	8.9	11.1	21.1	13.0	10.2	10.2	13.8	11.0	15.3	13.4	14.9	29.1	17.1	44.2	89.0	35.1	19.7	12.7	18.7	19.4	14.0	56.9	11.4	14.9	11.9	199.9	29.2	13.6	0.0	7.9	20.7	33.6	23.5	49.6	25.8	15.9	14.3	13.8	17.2	29.0	360.7	18.7	39.0	25.3	37.9	16.0	13.4	8.6	14.4	19.4	8.4	39.6	12.9	35.0	11.1	67.5	110.7	8.9	46.0	18.6	50.5
RNF169	KIAA1991	ENSG00000166439	"Ring finger protein 169"	Q8NCN4	11	74748868-74842413	"Enzymes, Predicted intracellular proteins"	"DNA damage, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038505, HPA046138, HPA047952"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	"Nucleoli, Nucleoli rim, Cytosol"	"HPA038505: , HPA046138: AB_2679553, HPA047952: "	"unprognostic (1.71e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.86e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.68e-1)"	"unprognostic (6.47e-2)"	"prognostic unfavorable (8.04e-4)"	"unprognostic (2.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.55e-3)"	"unprognostic (1.21e-1)"	12.3	7.0	12.0	11.6	14.0	23.1	12.0	22.6	15.6	13.1	11.2	12.2	6.3	7.4	14.2	8.2	20.6	10.7	10.8	9.2	12.6	5.9	8.9	9.3	16.9	11.3	15.4	9.1	14.6	10.7	17.5	10.4	8.6	13.9	10.5	10.0	8.4	12.4	8.8	15.0	14.1	10.3	14.2	10.1	12.6	10.3	7.2	14.9	12.6	11.5	7.4	12.5	13.1	15.8	0.6	0.8	5.0	1.9	1.2	1.6	0.6	8.3	6.4	7.8	7.6	5.0	6.8	3.1	6.5	6.2	7.3	6.4	10.7	6.3	14.9	6.7	7.8	5.0	8.1	10.4	7.8	9.6	7.4	6.7	10.3	11.8	4.2	5.8	5.4	8.6	6.2	6.2	8.3	19.0	8.2	11.8	10.2	9.1	12.0	7.3	7.0	9.3	9.8	3.0	10.6	4.2	8.7	18.5	8.1	4.7	8.7	3.5	6.3	8.8	6.7	14.2	6.5	8.4	7.0	7.8	12.2	10.3	7.6	5.8	8.7	4.5	17.7	2.4	6.0	7.0	2.8	1.9	1.5	1.6	1.1	1.2	0.3	1.5	0.9	0.8	0.6	1.1	0.9	5.0	1.2	1.0	0.8	1.2	0.6	12.0	14.0	22.6	15.6	12.6	5.9	15.4	9.1	13.9	14.9	8.9	10.7	13.0	26.3	17.6	51.9	2.8	2.5	5.3	7.9	3.5	49.1	5.0	5.0	8.8	2.2	11.7	6.7	0.0	9.5	5.0	9.3	37.6	6.9	11.0	7.6	35.0	11.5	8.6	10.7	2.2	6.9	9.2	10.1	1.8	7.8	33.2	9.1	5.8	9.9	9.1	32.5	25.8	15.1	10.4	10.9	16.3	6.8	16.6	9.7	39.6
RNF2	"BAP-1, BAP1, DING, HIPI3, RING1B, RING2"	ENSG00000121481	"Ring finger protein 2"	Q99496	1	185045364-185102608	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 78.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026803	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA026803: AB_10602086"	"unprognostic (1.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (5.85e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.01e-2)"	"unprognostic (5.51e-2)"	"prognostic unfavorable (1.94e-7)"	"unprognostic (2.08e-1)"	"unprognostic (5.51e-2)"	"unprognostic (9.89e-3)"	"unprognostic (2.52e-1)"	17.8	15.0	14.3	13.9	12.4	15.3	29.7	15.6	23.6	16.6	12.0	7.8	20.7	10.4	16.2	12.6	15.2	11.5	13.1	12.0	16.0	13.1	13.7	11.1	16.7	20.7	9.4	10.4	19.9	15.0	12.3	26.5	28.4	11.4	13.2	13.5	10.1	17.3	20.6	13.1	12.5	9.8	14.8	11.2	16.2	12.2	27.8	9.4	17.2	15.1	11.5	16.1	17.6	16.9	14.7	19.9	20.6	22.1	17.4	19.4	12.0	13.8	7.6	28.2	11.2	8.0	13.7	26.8	9.8	12.4	15.5	12.5	12.1	23.1	4.1	12.3	12.0	10.5	4.9	19.3	14.2	18.9	12.1	10.1	22.3	4.7	10.6	11.8	22.8	12.6	12.9	8.7	12.7	16.3	12.6	15.6	14.4	17.6	9.9	11.2	8.6	19.7	6.7	37.8	11.7	4.2	22.6	17.5	3.9	11.7	9.8	8.3	14.3	6.8	4.1	19.9	32.0	8.7	12.2	11.0	11.2	14.5	10.6	12.4	16.4	10.6	15.4	7.0	10.8	12.5	19.3	17.0	20.6	13.5	21.1	19.4	14.6	12.5	12.6	19.9	14.7	12.8	12.6	7.9	17.4	22.1	10.0	13.2	12.0	14.3	12.4	15.6	23.6	16.0	13.1	9.4	10.4	11.4	9.4	3.0	5.4	10.8	18.7	20.6	9.2	5.9	7.6	5.3	3.4	8.7	3.9	22.5	19.9	10.5	4.8	17.9	4.0	0.0	11.1	42.7	21.1	12.7	12.7	7.3	17.9	6.4	28.4	21.5	20.3	5.2	8.9	21.4	20.3	28.9	10.4	8.5	10.4	11.5	11.0	10.6	5.9	0.0	12.1	29.9	78.0	17.8	23.8	15.0	11.5	33.6
RNF20	"BRE1, BRE1A, FLJ11189, FLJ20382, hBRE1, KAIA2779"	ENSG00000155827	"Ring finger protein 20"	Q5VTR2	9	101533851-101563344	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012478, HPA051773"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012478: , HPA051773: AB_2681604"	"unprognostic (7.02e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.01e-1)"	"unprognostic (5.47e-2)"	"unprognostic (7.27e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (2.72e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.54e-3)"	16.4	17.1	24.6	17.0	24.9	12.1	17.7	24.4	26.3	18.6	16.4	27.7	15.9	10.1	18.3	18.7	20.4	19.1	13.2	24.1	22.3	22.1	20.5	14.4	14.9	15.5	25.2	20.7	21.1	19.5	31.5	23.1	15.1	30.0	21.6	16.1	16.8	16.2	17.7	32.0	16.3	12.5	23.6	28.8	17.0	13.9	28.2	25.8	21.2	22.0	15.3	18.6	21.1	19.0	13.0	12.5	21.0	23.5	13.8	18.6	10.4	9.7	24.8	14.3	15.7	17.7	14.0	12.2	17.0	13.7	17.1	15.0	15.0	10.4	21.6	9.2	13.1	14.3	24.8	16.6	14.5	17.6	22.5	7.7	11.5	22.7	15.0	13.0	19.8	13.9	13.7	15.6	15.1	19.6	12.9	10.0	8.0	10.9	12.8	18.5	12.7	15.4	5.3	31.6	22.0	12.6	14.9	49.6	10.7	7.0	9.4	15.3	19.3	24.1	12.9	14.0	15.0	11.6	9.4	14.1	15.9	16.0	11.3	14.3	13.9	42.7	11.8	14.0	7.5	19.2	21.0	12.7	19.1	18.6	17.5	14.0	13.0	15.4	13.9	12.5	11.2	16.2	14.9	13.9	13.8	23.5	7.9	11.9	10.4	24.6	24.9	24.4	26.3	22.3	22.1	25.2	20.7	30.0	25.8	23.8	24.5	7.5	8.1	5.7	29.1	42.4	10.2	33.5	26.1	21.0	5.9	13.6	5.0	14.3	26.2	11.3	12.2	0.0	12.1	9.6	11.5	7.2	20.9	16.8	14.4	41.3	23.6	7.4	23.8	15.2	16.7	20.0	10.1	27.9	10.7	27.6	10.2	15.3	22.3	9.1	23.0	32.3	14.4	24.7	15.8	5.1	6.4	16.0	12.0	5.4
RNF208	DKFZP761H1710	ENSG00000212864	"Ring finger protein 208"	Q9H0X6	9	137220247-137221581	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 27.4"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 21.6;Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 12.4;MCF7: 29.7;REH: 23.9;RPMI-8226: 13.2;T-47d: 10.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021256, HPA021429"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021256: AB_1844331, HPA021429: AB_2180654"	"unprognostic (2.97e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.33e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.10e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.50e-1)"	"unprognostic (9.51e-2)"	"unprognostic (2.95e-2)"	"unprognostic (8.42e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.12e-8)"	"unprognostic (3.41e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.40e-2)"	3.7	7.1	17.3	1.2	13.3	0.7	4.3	10.1	27.4	1.9	1.7	1.5	1.2	2.0	1.7	2.7	4.6	3.4	1.2	6.2	18.1	10.8	3.7	8.1	1.8	3.4	9.4	4.6	1.5	8.8	5.7	3.0	1.2	3.5	4.0	0.6	1.8	11.4	5.5	13.2	6.6	2.4	1.2	3.3	1.8	3.4	3.1	2.1	1.2	2.1	3.2	1.2	2.1	1.3	0.6	0.0	0.8	0.7	0.0	1.2	0.8	0.8	1.5	1.1	1.8	0.7	0.1	3.2	0.4	0.6	0.7	0.7	4.5	2.8	0.4	2.3	0.5	0.1	2.3	2.5	0.1	0.1	1.1	0.9	3.1	5.2	12.4	2.4	0.6	1.1	0.5	0.8	0.7	0.3	2.8	0.7	4.6	4.4	0.2	0.3	29.7	1.6	1.4	1.3	2.9	3.3	23.9	0.2	13.2	0.8	0.1	3.0	10.6	0.3	0.9	0.6	0.6	10.7	2.3	0.3	0.5	0.7	1.1	0.0	0.4	0.4	0.1	1.4	0.2	0.6	0.0	0.4	0.2	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.7	0.0	0.0	0.8	17.3	13.3	10.1	27.4	18.1	10.8	9.4	4.6	3.5	2.1	6.0	2.1	1.5	1.1	0.3	8.2	8.2	5.1	4.0	0.0	7.0	11.8	0.2	21.6	3.9	0.5	1.4	4.0	0.0	1.9	0.2	0.9	1.6	0.0	6.8	1.1	15.9	7.5	1.3	0.3	0.5	1.1	0.0	1.7	1.8	3.9	5.5	3.5	4.2	3.2	8.8	3.2	0.0	0.9	1.7	2.2	1.6	0.2	0.8	3.3	0.7
RNH1	"RAI, RNH"	ENSG00000023191	"Ribonuclease/angiogenin inhibitor 1"	P13489	11	494512-507300	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039223, HPA040781"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA		27000000	"Nucleoplasm, Cytosol"		"HPA039223: AB_10795581, HPA040781: AB_10796227"	"unprognostic (1.87e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.48e-3)"	"unprognostic (6.09e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (2.14e-5)"	"unprognostic (3.35e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.35e-2)"	39.8	35.7	18.5	27.6	25.7	40.8	57.9	14.7	33.1	34.9	27.8	43.0	25.9	27.3	36.6	34.2	51.4	30.5	32.8	49.5	20.4	16.5	32.6	46.2	36.1	36.6	37.1	25.3	36.2	32.4	25.7	21.1	35.1	24.3	30.7	8.7	25.6	37.5	33.2	41.6	60.7	26.0	37.7	31.7	29.8	25.3	37.9	29.6	17.1	41.4	41.9	25.8	35.5	38.6	12.9	47.8	10.3	53.3	9.8	12.1	35.3	21.3	30.3	3.3	11.3	18.5	26.3	12.5	20.0	13.9	18.3	15.9	17.0	26.1	11.8	15.5	38.1	11.7	20.0	5.8	20.1	2.9	15.0	27.6	7.9	8.4	15.6	62.3	10.4	25.6	22.4	29.8	10.6	13.2	8.1	12.4	7.6	10.3	20.1	10.4	21.3	8.1	19.8	5.5	12.2	30.9	10.3	7.3	15.1	11.2	7.8	9.7	6.6	12.0	17.5	19.9	2.1	12.5	33.0	22.2	31.3	9.2	11.3	13.4	12.8	13.6	8.7	34.2	23.8	20.5	5.7	44.4	10.3	10.4	53.3	12.1	12.9	11.2	10.4	47.8	9.5	10.5	9.3	3.2	9.8	48.7	13.9	10.7	35.3	18.5	25.7	14.7	33.1	20.4	16.5	37.1	25.3	24.3	29.6	104.2	68.6	78.2	202.3	179.6	102.0	71.4	86.6	58.9	50.0	75.0	104.1	190.2	190.6	176.0	77.4	124.7	114.8	23.3	144.3	181.6	179.4	129.6	138.4	60.6	342.3	158.9	55.0	87.8	170.9	28.6	195.9	258.9	183.9	413.0	69.3	139.4	142.6	119.3	169.0	169.2	137.1	174.6	167.4	144.3	173.7	227.2	255.5	84.8	86.0	194.1
ROBO1	"DUTT1, FLJ21882, SAX3"	ENSG00000169855	"Roundabout guidance receptor 1"	Q9Y6N7	3	78597240-79767815	"Predicted intracellular proteins, Predicted membrane proteins"	"Chemotaxis, Differentiation, Neurogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 46.4;Urothelial cells: 49.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB013524, HPA052968, HPA074461"	Uncertain		Enhanced	"Plasma membrane"		NA	NA		6500000	"Plasma membrane"		"CAB013524: , HPA052968: AB_2682001, HPA074461: AB_2732256"	"unprognostic (2.89e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (9.88e-4)"	"unprognostic (2.44e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.16e-2)"	12.5	10.1	15.5	10.7	30.2	0.4	7.3	12.5	22.0	15.9	9.4	14.7	1.6	3.5	10.5	8.2	13.7	5.6	8.6	9.0	12.3	12.4	3.7	4.0	8.3	9.3	14.7	8.9	18.4	2.3	2.1	29.6	8.4	12.2	14.5	6.9	8.5	5.5	13.8	4.5	21.8	5.4	11.4	8.1	9.2	5.0	10.8	15.7	14.0	5.5	8.8	18.8	13.2	14.1	1.0	0.7	0.0	0.4	0.1	3.1	0.1	0.1	11.0	10.5	16.8	14.8	9.7	0.5	8.4	11.3	6.7	5.7	0.2	4.6	0.0	0.0	10.4	5.3	4.4	12.8	8.7	8.5	0.1	16.3	6.4	22.0	17.3	3.5	0.1	1.7	16.1	12.0	25.4	12.1	12.7	6.7	0.0	0.8	20.0	6.9	5.2	0.0	0.0	13.4	3.1	4.0	0.3	11.1	0.1	0.0	3.5	8.2	5.6	18.2	4.1	6.7	10.6	12.9	0.1	0.1	22.5	9.8	13.3	14.3	0.7	0.0	0.0	20.4	0.0	18.6	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.7	0.3	0.0	3.1	0.0	0.1	0.4	0.0	0.0	0.1	15.5	30.2	12.5	13.6	12.3	12.4	14.7	8.9	12.2	15.7	3.0	11.2	0.0	17.6	29.5	10.2	3.6	0.0	1.4	7.9	7.0	3.9	8.4	0.0	0.5	21.1	4.7	0.3	0.0	0.2	7.3	26.7	15.0	1.1	0.0	1.2	1.6	1.2	15.4	2.5	46.4	18.4	1.3	13.5	2.8	0.1	6.7	0.3	0.3	23.0	0.2	1.0	12.9	11.2	1.6	5.1	29.5	4.7	0.0	0.2	49.2
RP9	PAP-1	ENSG00000164610	"RP9, pre-mRNA splicing factor"	Q8TA86	7	33094797-33109401	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031523, HPA050778"	Uncertain		Enhanced	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA031523: AB_10603235, HPA050778: AB_2681233"	"unprognostic (1.12e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (6.71e-2)"	"unprognostic (6.22e-2)"	"unprognostic (7.53e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.65e-5)"	"unprognostic (4.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.61e-1)"	10.1	13.8	11.7	9.4	16.0	20.7	14.9	17.1	16.0	10.9	12.2	13.0	7.0	10.3	14.6	18.8	8.1	10.0	10.7	19.2	11.1	10.1	11.4	11.5	9.7	19.4	17.4	8.6	14.2	16.9	10.4	14.2	11.7	11.0	14.0	11.8	12.8	15.0	14.4	34.7	10.7	12.5	15.7	11.8	17.2	10.5	15.2	12.6	13.6	15.6	9.0	18.2	13.4	16.0	34.1	11.7	8.1	5.0	5.9	8.4	3.3	9.9	14.3	15.1	17.2	9.6	9.0	7.2	12.7	10.9	14.7	11.8	12.7	7.3	12.6	8.4	10.5	18.1	10.0	18.3	10.9	19.0	5.7	11.4	9.2	11.3	11.8	16.9	12.3	6.5	9.0	10.3	16.7	33.1	12.0	12.0	13.5	16.5	11.6	14.7	20.6	13.2	33.8	12.7	13.3	10.3	13.3	13.1	8.4	10.6	9.6	14.6	20.0	8.9	20.0	21.7	18.7	10.5	17.1	9.6	14.6	20.5	12.9	20.6	18.9	17.1	25.1	10.3	17.6	28.2	6.4	5.0	8.1	6.6	3.6	6.1	22.0	7.0	7.4	5.3	34.1	8.4	7.8	0.9	5.9	4.6	11.7	5.9	3.3	11.7	16.0	17.1	16.0	11.1	10.1	17.4	8.6	11.0	12.6	11.9	8.5	17.4	13.8	18.7	16.3	32.5	12.7	10.7	11.4	14.0	13.7	16.9	18.3	14.1	3.5	21.7	10.5	0.0	13.7	16.3	19.4	11.5	3.5	15.1	16.0	7.9	9.8	14.7	7.6	2.7	16.7	9.9	21.9	9.0	16.4	15.8	13.4	5.8	15.2	13.5	12.9	25.8	20.2	33.0	48.0	15.7	8.7	11.8	18.0	10.7
RPA1	"HSSB, REPA1, RF-A, RP-A, RPA70"	ENSG00000132383	"Replication protein A1"	P27694	17	1829702-1900082	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004563, HPA006914, HPA046497"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004563: AB_628224, HPA006914: AB_1856410, HPA046497: AB_2679675"	"unprognostic (1.84e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (9.00e-9)"	"unprognostic (9.59e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.03e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.52e-2)"	19.8	18.9	17.5	22.2	18.6	15.7	19.6	21.0	19.2	20.1	21.2	17.0	26.7	15.9	23.7	20.1	23.8	23.2	20.6	27.6	15.0	15.6	13.3	15.2	19.2	27.6	19.6	19.8	28.8	17.8	18.8	15.7	15.2	15.0	20.2	16.5	20.9	22.9	23.3	46.1	23.6	18.6	21.7	15.0	18.7	17.0	13.9	17.5	36.7	21.1	24.4	33.1	23.6	19.1	24.6	14.5	23.9	19.7	34.2	27.1	25.2	27.7	28.6	26.0	23.9	13.1	13.3	29.1	22.9	14.3	30.5	31.9	40.4	12.9	39.2	21.6	14.5	11.9	25.9	32.2	19.6	34.4	25.6	37.9	23.7	35.4	16.8	8.7	17.4	21.1	10.8	12.9	30.0	13.2	10.8	22.0	25.3	22.4	22.6	21.3	16.0	37.5	11.2	19.9	19.7	16.7	52.2	13.9	21.3	13.5	19.3	11.2	17.5	32.5	11.5	20.2	19.6	23.4	13.7	17.0	20.7	18.1	24.0	34.6	6.3	16.4	22.6	14.8	27.5	25.8	16.7	11.3	23.9	25.9	16.2	26.3	24.6	27.1	25.7	13.8	15.4	26.8	24.3	5.5	34.2	19.7	14.5	25.0	25.2	17.5	18.6	21.0	19.2	15.0	15.6	19.6	19.8	15.0	17.5	8.9	14.3	22.9	13.7	26.3	17.6	18.2	28.1	18.7	11.4	38.4	3.9	55.5	5.0	16.5	15.8	20.1	15.1	46.7	17.4	61.3	22.4	11.7	33.4	20.3	39.8	35.0	15.0	26.4	37.7	27.5	30.0	18.4	27.0	41.5	20.4	34.7	13.6	3.5	32.5	8.5	17.6	0.0	22.7	13.1	21.4	25.5	36.4	25.5	18.1	8.5
RPA2		ENSG00000117748	"Replication protein A2"	P15927	1	27891524-27914746	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, DNA replication"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatogonia: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016538, HPA026306, HPA026309"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB016538: AB_670974, HPA026306: AB_10598913, HPA026309: AB_10601572"	"unprognostic (2.59e-1)"	"prognostic favorable (4.33e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.12e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.03e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.18e-3)"	"unprognostic (2.82e-2)"	18.6	17.1	33.6	24.3	38.8	20.5	26.6	23.6	30.5	20.0	15.4	17.2	17.6	9.9	19.5	26.3	18.7	28.8	19.2	22.5	31.4	22.1	19.5	18.4	19.3	37.1	22.0	26.7	32.6	15.3	16.4	27.0	17.2	25.4	17.2	19.0	18.0	16.2	19.8	45.0	22.6	16.8	18.6	22.1	28.4	15.3	34.6	27.7	25.4	30.7	17.2	37.9	20.3	17.1	46.2	31.5	48.4	18.1	49.3	55.9	65.9	13.2	12.6	21.2	16.0	14.4	13.4	12.9	24.6	16.7	31.5	27.4	17.9	16.4	33.7	15.8	9.7	11.3	12.3	30.0	13.9	30.8	25.0	27.8	39.2	17.1	15.4	7.3	52.0	27.6	5.7	7.8	30.4	15.7	9.8	13.6	30.6	40.9	29.4	18.2	13.4	37.0	22.7	41.6	26.0	27.1	24.7	31.5	15.7	11.3	14.4	18.1	17.6	27.2	11.0	21.5	17.6	11.3	15.4	8.7	7.8	16.9	42.1	16.1	23.9	53.2	29.3	19.3	46.1	14.0	42.8	18.1	48.4	51.6	14.0	55.9	46.2	48.8	47.3	20.4	39.0	55.8	53.9	18.1	49.3	18.1	31.5	42.5	65.9	33.6	38.8	23.6	30.5	31.4	22.1	22.0	26.7	25.4	27.7	20.8	14.9	53.6	28.2	18.7	26.4	26.0	28.1	30.8	25.0	21.0	2.0	71.3	29.9	26.8	35.0	27.8	9.3	23.3	18.1	52.7	29.0	16.7	60.0	13.5	44.9	7.9	13.3	26.4	35.6	17.1	38.3	36.5	35.4	118.2	13.1	96.8	21.4	7.0	43.5	17.7	30.1	32.3	27.8	118.9	183.5	19.6	46.6	91.4	17.8	15.7
RPAP3	"FLJ21908, hSpagh, spag"	ENSG00000005175	"RNA polymerase II associated protein 3"	Q9H6T3	12	47661249-47706061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038311, HPA038312"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA038311: AB_10671527, HPA038312: AB_10672512"	"unprognostic (5.76e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.21e-2)"	"unprognostic (7.28e-2)"	"unprognostic (4.47e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (9.89e-2)"	"unprognostic (9.87e-3)"	"unprognostic (6.34e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.11e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.35e-2)"	12.1	13.2	20.3	17.0	19.9	10.6	15.3	23.5	23.2	13.2	16.2	6.7	14.9	13.0	15.7	14.7	16.4	15.2	11.7	15.4	18.4	14.8	12.9	16.0	10.3	25.7	18.8	18.4	23.3	12.1	15.7	24.6	12.3	20.5	14.2	12.5	5.2	14.4	12.8	47.6	11.1	12.8	15.1	22.8	18.2	12.1	14.3	19.1	21.5	13.4	14.4	26.7	16.8	13.2	15.1	10.2	22.7	16.9	9.3	11.5	6.2	16.1	15.1	18.4	12.6	9.9	14.2	15.5	16.1	16.6	20.4	17.6	20.9	18.4	35.8	22.2	14.2	14.7	16.2	15.9	9.5	23.9	19.0	14.9	24.1	10.2	10.1	8.6	25.6	16.9	6.9	11.8	23.9	8.7	16.7	12.7	14.1	26.4	11.0	18.0	11.5	21.9	18.5	19.7	14.9	13.0	17.8	22.2	17.5	16.6	14.7	13.3	9.7	18.8	15.5	16.1	20.4	15.9	15.4	9.1	14.2	18.8	15.5	17.7	8.7	16.2	25.6	13.3	56.9	8.7	2.6	7.6	22.7	7.9	14.4	8.1	15.1	8.9	8.5	10.2	14.0	11.5	10.3	14.2	9.3	16.9	7.1	10.9	6.2	20.3	19.9	23.5	23.2	18.4	14.8	18.8	18.4	20.5	19.1	11.9	14.5	15.6	11.9	11.7	16.4	28.2	15.3	29.4	21.6	10.4	7.9	19.8	19.9	15.3	6.1	10.3	7.5	0.0	17.1	13.3	13.9	7.6	11.5	14.3	15.9	11.1	12.6	8.0	16.4	5.6	20.1	18.0	6.8	52.3	10.7	12.6	11.6	15.8	19.4	20.7	13.8	6.5	15.5	43.2	33.8	8.9	14.2	11.3	13.3	8.9
RPL10	"DXS648, DXS648E, FLJ23544, L10, NOV, QM"	ENSG00000147403	"Ribosomal protein L10"	P27635	X	154389955-154409168	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	"Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"	"Autism, Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB010339, HPA011311"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"		"CAB010339: AB_2181277, HPA011311: AB_1856431"	"unprognostic (2.46e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.37e-1)"	"prognostic unfavorable (7.67e-6)"	"unprognostic (6.84e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (5.68e-2)"	103.6	65.3	41.4	108.0	48.5	103.7	152.6	82.4	70.7	118.2	80.6	44.6	107.8	51.3	100.4	75.5	105.2	122.3	52.6	82.5	38.2	31.9	112.1	155.0	97.6	190.2	48.2	37.4	223.5	242.3	35.0	51.9	87.4	53.1	83.6	77.1	66.7	109.9	101.5	125.9	121.8	108.9	78.7	51.4	93.9	90.5	33.9	47.2	158.9	198.9	137.9	134.4	86.9	119.3	252.9	168.6	64.4	124.1	149.1	304.9	445.3	190.6	88.4	88.6	67.9	201.2	381.1	78.4	73.4	170.1	141.3	179.7	78.4	85.8	378.1	177.6	122.3	139.8	74.1	173.4	175.7	121.4	83.0	137.5	51.0	63.4	85.9	236.7	109.5	75.5	287.6	278.2	84.9	265.3	244.2	221.6	161.8	71.8	120.9	137.9	95.7	119.3	106.6	69.8	188.1	152.9	143.1	84.0	210.1	154.1	68.1	71.1	118.8	17.7	156.2	216.7	89.4	56.8	153.2	106.6	49.4	94.0	111.2	162.3	287.9	207.9	376.0	75.1	158.2	61.7	64.4	124.1	18.1	149.9	107.7	256.2	252.9	251.6	186.2	151.2	243.2	304.9	231.1	13.0	149.1	94.9	168.6	178.0	445.3	41.4	48.5	82.4	70.7	38.2	31.9	48.2	37.4	53.1	47.2	1664.5	2043.1	10322.4	11239.3	10721.6	451.7	309.0	3949.0	1271.5	2545.5	1934.9	233.7	5960.7	5721.4	3854.4	49.9	6113.6	2058.8	1915.6	11641.3	8484.3	6948.0	9869.1	2815.7	3204.1	6194.0	254.3	2785.1	5085.5	7653.2	131.8	7835.9	9465.3	7747.1	9437.5	6244.9	793.3	8332.0	5018.5	3353.3	5769.1	609.3	2942.7	9122.3	99.1	315.1	12724.6	6324.6	8194.7	7230.3	10693.0
RPL13	"BBC1, D16S444E, L13"	ENSG00000167526	"Ribosomal protein L13"	P26373	16	89560657-89566828	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051702	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		53000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA051702: AB_2681579"	"unprognostic (5.41e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.57e-2)"	"unprognostic (3.68e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.57e-2)"	"prognostic unfavorable (6.64e-4)"	"unprognostic (4.34e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.30e-2)"	82.5	56.0	46.7	105.0	38.4	112.7	150.9	37.7	44.0	114.5	114.9	31.3	76.9	65.5	118.4	85.4	144.0	98.4	101.6	85.2	38.6	32.1	60.8	118.3	90.4	385.1	38.8	37.4	231.3	255.8	36.5	57.5	66.0	27.0	136.2	44.4	43.0	267.3	87.6	197.4	137.7	66.7	90.2	44.8	104.7	71.1	106.5	24.6	135.0	102.4	129.6	98.6	109.3	156.8	277.8	163.1	26.9	96.9	120.7	299.0	355.4	67.5	75.1	53.4	86.5	96.1	160.2	111.9	42.7	92.6	89.3	36.3	113.4	104.8	95.0	88.2	72.4	35.5	94.0	63.4	112.3	44.6	26.6	176.0	32.3	41.9	150.3	205.8	39.2	39.5	194.0	239.4	57.2	144.3	145.7	93.0	120.4	98.7	54.2	68.5	211.6	107.4	308.2	109.2	133.6	79.9	160.2	56.6	133.5	108.4	56.8	75.3	110.2	59.1	77.3	128.1	35.2	152.0	233.4	54.2	57.7	62.3	50.8	58.5	82.2	77.2	96.9	75.3	138.7	60.5	26.9	96.9	15.3	129.1	74.9	239.2	252.5	234.3	176.5	116.8	277.8	299.0	230.2	10.7	120.7	56.7	163.1	163.7	355.4	46.7	38.4	37.7	44.0	38.6	32.1	38.8	37.4	27.0	24.6	1676.5	3076.1	8572.3	13242.6	11129.2	658.9	392.1	3263.7	1810.8	3433.9	1533.6	178.7	5497.3	3942.5	3304.0	3376.6	4985.3	2353.5	1588.5	9512.5	8594.0	5542.1	9230.0	2503.8	3991.9	4585.6	235.2	2827.6	3949.3	6200.5	9204.7	7634.3	6835.9	5176.0	5670.1	5289.2	713.9	6690.8	4380.2	3433.2	5399.2	577.3	2050.2	5882.2	1406.9	1082.9	14135.8	5156.1	7058.2	8155.8	12161.4
RPL19	"DKFZp779D216, FLJ27452, L19, MGC71997"	ENSG00000108298	"Ribosomal protein L19"	P84098	17	39200283-39204727	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"SK-BR-3: 959.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043014, HPA051987"	Approved		Enhanced	Nucleoli,Cytosol		NA	NA		100000	"Nucleoli, Cytosol"		"HPA043014: AB_10965840, HPA051987: AB_2681682"	"unprognostic (4.07e-3)"	"unprognostic (1.33e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.40e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.46e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (6.87e-5)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.60e-2)"	72.3	57.7	51.3	56.7	56.9	122.5	94.7	41.8	88.6	72.2	64.5	42.2	62.7	48.7	67.0	56.7	77.7	78.1	65.9	87.3	49.2	37.0	62.3	124.4	70.7	229.5	50.5	53.0	156.4	124.4	33.1	51.7	57.3	58.7	60.0	52.5	48.1	113.8	67.6	91.4	95.8	58.8	57.5	57.1	74.4	66.1	45.2	34.1	53.0	63.3	94.9	103.4	63.1	75.9	208.2	143.4	40.4	108.7	116.2	236.3	325.8	48.1	65.5	47.5	57.6	87.0	110.0	49.2	45.3	92.6	93.9	75.5	71.4	45.6	117.8	79.8	64.7	54.9	81.9	71.4	93.7	48.4	47.8	125.4	42.0	48.9	92.8	135.7	102.9	58.2	122.5	103.0	72.3	130.9	88.2	80.9	101.1	73.1	69.0	64.8	47.4	136.4	143.9	48.6	56.3	48.8	80.9	67.6	117.8	84.6	60.3	57.8	64.3	27.2	959.6	141.5	53.6	92.9	131.0	47.6	36.7	49.7	55.9	83.3	91.1	90.1	86.7	49.8	78.6	47.2	36.7	108.7	40.4	116.1	90.3	180.1	208.2	187.2	146.8	143.4	193.1	236.3	190.8	17.1	116.2	72.6	132.4	146.2	325.8	51.3	56.9	41.8	88.6	49.2	37.0	50.5	53.0	58.7	34.1	821.9	1155.8	5178.5	5153.7	4931.6	221.1	502.6	2265.0	995.7	1437.7	1080.0	88.4	3138.3	3070.4	2271.3	1107.8	2991.3	1604.9	1214.8	5434.8	4726.5	2858.0	4250.3	1510.1	1935.0	3620.1	125.5	1883.0	2240.5	3562.4	3346.4	3629.9	4014.1	3104.2	3202.1	2957.8	586.7	3801.6	2980.9	1917.8	3691.6	289.1	1506.9	3219.7	1098.4	764.8	5786.0	3261.3	3671.2	4220.8	5947.6
RPL24	L24	ENSG00000114391	"Ribosomal protein L24"	P83731	3	101681091-101686782	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA051653	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		19000	"Endoplasmic reticulum, Cytosol"		"HPA051653: AB_2681564"	"unprognostic (7.32e-2)"	"unprognostic (2.11e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.08e-1)"	"prognostic favorable (8.25e-4)"	"unprognostic (5.37e-2)"	61.3	58.9	60.6	99.3	68.8	87.9	135.5	73.0	90.1	94.7	64.0	15.8	84.3	49.6	74.2	98.0	75.5	65.4	82.9	110.0	45.6	43.8	58.3	70.3	122.0	256.0	50.7	46.3	174.7	211.4	25.9	65.5	68.2	53.4	69.0	54.7	30.4	133.9	109.9	175.9	66.2	46.2	98.7	80.7	51.4	60.5	30.2	44.1	61.3	84.7	134.3	71.7	105.1	175.4	128.2	107.7	29.6	65.6	85.5	173.8	214.1	165.3	55.0	84.4	93.1	92.6	165.8	127.7	95.3	106.6	129.0	94.5	109.4	73.3	182.5	118.4	72.9	51.6	88.1	97.7	118.2	129.2	97.8	98.0	108.2	47.8	81.8	91.0	121.6	57.3	160.9	151.6	81.1	145.0	127.7	109.1	88.3	99.0	91.1	118.6	110.6	129.7	186.4	151.8	150.8	119.5	114.4	83.3	174.3	131.6	73.9	180.7	84.0	49.7	89.3	211.5	75.5	109.1	223.9	79.7	56.3	104.4	30.7	115.9	80.1	102.2	319.2	75.4	128.8	94.2	29.6	65.6	16.3	86.1	57.1	125.2	128.2	136.4	104.2	90.5	127.0	173.8	132.3	10.9	85.5	56.9	107.7	121.1	214.1	60.6	68.8	73.0	90.1	45.6	43.8	50.7	46.3	53.4	44.1	881.4	1070.5	2163.1	2834.4	2028.6	247.2	305.0	1187.2	758.8	1325.1	579.3	80.5	1779.8	1921.5	1279.6	726.1	1676.7	912.8	607.3	2525.7	2622.3	1595.4	2203.5	1283.3	1194.7	1386.3	111.2	1311.9	1225.8	1564.2	477.7	2781.1	1768.0	1307.5	1765.6	1777.1	437.9	2399.6	1553.6	1411.5	2120.0	319.1	860.2	1451.3	472.4	280.9	2033.8	1958.3	1532.8	2167.1	2738.5
RPL27	L27	ENSG00000131469	"Ribosomal protein L27"	P61353	17	42998273-43002959	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Cancer-related genes, Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002649	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		30000	Nucleoli	Nucleoplasm	"HPA002649: AB_1079840"	"unprognostic (8.53e-3)"	"unprognostic (7.15e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.99e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-3)"	"unprognostic (7.32e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (3.86e-1)"	"prognostic unfavorable (7.80e-8)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.14e-1)"	78.4	66.9	61.7	82.2	45.7	150.0	148.7	63.1	82.7	75.1	76.8	27.2	65.4	48.8	74.8	80.1	91.9	64.9	80.8	120.6	46.2	38.5	76.2	121.7	109.5	222.2	49.2	49.0	123.7	185.0	17.2	44.1	81.0	48.3	65.3	55.0	43.8	119.1	78.5	127.5	113.8	61.9	82.4	43.6	84.4	69.7	40.3	28.8	72.6	70.5	153.8	78.5	86.1	80.9	178.5	152.7	44.2	99.0	111.4	184.7	216.0	114.1	144.8	88.7	128.4	157.1	233.0	143.3	133.0	109.3	143.0	102.6	205.0	89.9	216.5	113.2	104.6	77.6	100.2	101.6	169.8	137.6	100.2	241.7	85.0	121.4	216.7	193.9	244.1	89.5	219.6	145.5	96.5	123.8	146.7	118.5	114.9	158.0	134.0	132.0	111.6	203.2	206.9	134.3	132.4	92.7	142.6	249.8	244.5	120.8	154.3	99.8	110.2	52.2	103.0	211.8	125.8	173.2	258.0	133.7	106.6	105.6	130.2	195.6	117.1	188.5	211.9	95.8	151.7	108.6	44.2	99.0	29.5	106.6	87.9	150.2	178.5	159.0	124.5	118.6	168.3	184.7	159.1	20.4	111.4	67.3	152.7	112.5	216.0	61.7	45.7	63.1	82.7	46.2	38.5	49.2	49.0	48.3	28.8	681.9	960.2	2744.7	1731.4	2247.5	123.8	670.7	1245.8	627.7	1104.4	492.0	84.4	1811.7	1268.3	1382.3	339.9	1526.1	906.3	700.8	2626.7	2977.9	1476.5	1638.9	947.9	1517.2	1848.2	62.0	876.6	1298.9	2145.4	659.2	2254.1	2398.0	1353.0	2460.8	1687.2	280.7	2397.9	1157.3	1202.8	1660.9	156.7	853.7	1593.4	457.6	394.4	2946.9	1827.2	1797.0	2037.9	2132.8
RPL27A	L27A	ENSG00000166441	"Ribosomal protein L27a"	P46776	11	8682411-8714759	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 555.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA060776, HPA063379"	Supported		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA060776: AB_2684359, HPA063379: AB_2684997"	"prognostic favorable (7.84e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (2.83e-10)"	"unprognostic (2.28e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-2)"	65.9	58.8	49.6	116.1	81.5	146.4	149.4	47.8	80.5	69.7	69.9	25.1	64.2	60.1	73.2	74.9	98.4	76.4	88.5	103.5	59.9	33.9	57.0	71.3	111.1	316.9	44.5	49.3	132.2	278.5	10.4	54.6	64.8	64.0	70.1	75.7	42.1	115.8	70.1	124.6	97.9	69.2	109.2	47.1	92.0	72.4	56.8	28.5	74.6	89.3	127.5	120.5	71.0	128.7	341.9	188.5	71.3	122.3	161.9	351.8	555.6	169.7	118.2	75.5	90.6	104.1	199.1	114.2	110.4	139.5	126.6	97.4	149.4	158.7	240.8	87.3	96.5	54.0	124.3	99.6	154.0	95.5	87.9	214.1	106.0	115.4	184.3	172.7	192.0	124.8	217.5	275.3	19.9	211.4	174.9	125.4	144.2	109.1	76.0	106.9	127.9	143.0	289.5	122.7	126.4	123.8	125.3	79.3	146.3	118.9	170.2	86.5	155.5	40.9	157.2	171.4	83.3	69.5	220.1	113.9	41.3	111.3	106.0	139.4	86.6	189.8	197.0	94.8	131.6	74.8	71.3	122.3	37.8	208.1	119.1	266.8	341.9	295.7	244.4	188.5	301.2	351.8	290.3	29.7	161.9	108.1	180.0	198.2	555.6	49.6	81.5	47.8	80.5	59.9	33.9	44.5	49.3	64.0	28.5	1042.2	1639.1	5447.5	5197.7	4315.3	211.8	780.0	2010.1	1169.7	2127.0	936.9	108.0	4955.4	2420.5	2120.6	640.6	2975.9	1990.9	1378.3	4688.2	6270.1	2784.5	3963.3	2012.4	2288.9	3821.7	76.3	2038.1	2441.8	3815.0	1497.4	3355.1	4578.8	2687.5	3973.9	4593.3	390.8	4009.3	4780.0	1839.6	2272.7	251.4	1532.8	3189.9	395.7	439.9	5297.8	5030.9	4388.7	5800.0	5583.1
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619970-128681075	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		8200000	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	52.3	37.5	22.2	26.6	23.8	24.4	48.2	20.9	31.4	45.8	40.8	31.9	58.8	28.5	38.3	110.2	32.2	38.3	38.8	47.1	23.0	28.0	55.4	174.0	47.4	50.6	26.4	18.3	37.8	62.9	43.5	36.9	58.3	24.3	31.4	41.1	28.6	54.1	55.5	34.4	24.0	37.0	33.5	31.8	48.0	33.7	26.9	23.3	34.3	69.1	27.3	36.5	32.7	39.7	26.7	53.1	64.4	43.5	23.4	45.1	53.3	60.5	33.0	27.6	50.7	74.7	50.1	62.5	52.2	68.7	69.4	80.9	68.4	57.1	37.9	49.3	75.3	64.7	61.0	44.5	46.5	68.0	27.2	28.6	66.8	24.6	56.2	82.4	54.2	35.2	41.5	54.4	45.6	67.5	46.5	54.2	28.7	27.5	50.9	45.5	55.4	30.0	59.6	35.0	81.1	30.3	32.9	37.1	91.2	48.1	36.4	42.5	24.5	42.9	44.5	52.8	36.9	47.6	56.1	35.2	35.9	28.1	52.5	38.7	54.9	43.2	40.5	58.9	40.4	51.8	38.8	43.5	35.7	37.3	40.0	45.1	26.7	30.7	33.8	43.5	18.3	19.1	29.2	64.4	23.4	40.2	53.1	30.5	53.3	22.2	23.8	20.9	31.4	23.0	28.0	26.4	18.3	24.3	23.3	56.6	71.5	37.3	71.3	44.0	11.5	35.3	61.1	66.9	47.8	106.4	7.9	108.3	13.3	99.9	13.7	58.2	107.9	46.7	81.2	161.1	79.3	88.0	42.7	155.3	122.7	19.1	41.6	107.4	134.1	20.7	87.2	73.4	55.6	36.9	102.4	27.5	98.9	83.4	60.5	80.2	11.7	45.3	39.6	49.9	59.8	46.7	131.0	50.0	106.2	66.4
RPS16	S16	ENSG00000105193	"Ribosomal protein S16"	P62249	19	39433207-39435948	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA064222	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		No	No		36000	"Endoplasmic reticulum, Cytosol"		"HPA064222: AB_2685218"	"unprognostic (4.63e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.73e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.89e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.89e-3)"	"unprognostic (4.40e-2)"	"unprognostic (5.28e-2)"	"unprognostic (5.73e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.62e-2)"	89.8	60.8	49.0	123.2	46.1	127.3	126.9	39.8	46.8	124.8	120.7	48.6	80.0	67.2	97.9	80.8	150.1	108.1	105.9	118.7	41.7	35.7	81.5	147.6	103.7	243.2	49.2	29.9	248.1	457.6	19.9	48.8	97.0	35.5	129.5	52.8	73.8	130.5	87.6	205.5	113.4	110.9	126.3	52.2	136.7	92.1	57.4	37.7	153.9	125.1	183.6	151.0	143.8	159.8	153.7	106.4	17.6	71.8	71.7	179.1	225.5	138.9	297.8	80.0	90.7	120.5	148.7	74.3	64.1	75.0	83.8	77.2	189.4	77.2	117.8	83.2	79.9	31.8	46.4	93.6	155.9	53.0	137.6	221.5	93.0	101.4	195.7	123.1	135.7	63.1	173.4	243.1	73.8	117.9	114.0	107.3	152.3	118.7	133.3	87.3	214.7	185.4	136.9	98.8	176.8	109.0	124.3	82.7	142.4	91.9	156.9	81.5	117.2	48.1	216.7	164.7	56.2	62.1	263.7	64.5	69.9	91.6	74.0	139.4	185.8	192.2	149.3	72.3	129.9	67.4	17.6	71.8	11.0	84.5	57.9	120.9	153.7	140.8	105.6	91.9	143.2	179.1	143.0	13.2	71.7	48.2	106.4	94.7	225.5	49.0	46.1	39.8	46.8	41.7	35.7	49.2	29.9	35.5	37.7	1051.1	1483.9	3949.0	3037.8	3456.7	300.0	882.4	2025.5	1279.5	2023.5	772.9	182.6	3919.4	1871.8	1658.2	460.7	2103.8	1281.1	1471.8	3703.3	5212.0	2075.3	2629.1	1071.8	2095.9	2461.9	108.1	1421.1	1433.3	2612.0	1078.8	3908.0	3281.4	1931.7	3389.6	2360.5	436.5	2661.2	1690.0	1746.6	2505.6	404.4	1261.2	2305.1	506.0	777.6	3962.5	3964.9	2423.2	3346.2	3508.5
RPS23	S23	ENSG00000186468	"Ribosomal protein S23"	P62266	5	82273358-82278577	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Deafness, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054853	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		130000	"Endoplasmic reticulum, Cytosol"		"HPA054853: AB_2682625"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (6.61e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.29e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (3.87e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.67e-1)"	114.6	62.1	72.6	129.7	54.8	139.2	191.8	45.1	53.7	141.2	118.9	46.5	83.5	62.2	131.8	94.1	145.2	118.3	114.4	79.4	61.4	52.9	92.8	134.8	90.1	200.7	74.4	34.7	269.5	211.6	41.6	65.6	94.6	51.9	134.3	89.8	52.9	126.7	84.7	205.4	134.3	97.0	129.6	77.7	150.1	83.8	61.4	51.5	194.5	141.5	171.9	173.8	160.7	165.8	140.7	110.8	11.1	56.6	63.8	136.1	158.2	92.5	36.5	105.3	80.7	177.2	239.7	107.3	89.0	134.9	134.6	134.0	51.2	63.3	218.4	62.4	115.1	83.5	47.7	157.3	255.9	139.9	79.2	88.8	89.3	54.1	49.7	234.1	128.9	64.9	230.0	304.6	102.7	269.9	202.2	173.4	139.1	92.8	68.8	116.2	60.2	142.0	130.9	67.3	49.6	85.1	95.2	150.8	196.3	130.7	39.2	67.7	88.5	45.8	79.8	180.2	109.7	60.6	200.0	123.0	19.2	74.8	46.7	139.7	99.0	144.6	153.5	45.4	167.0	42.1	11.1	56.6	8.7	60.1	52.4	92.2	140.7	103.0	81.1	97.6	130.8	136.1	112.3	6.0	63.8	43.3	110.8	73.4	158.2	72.6	54.8	45.1	53.7	61.4	52.9	74.4	34.7	51.9	51.5	988.6	1141.9	5759.9	4914.2	5245.2	367.5	259.5	2438.2	829.8	1736.9	1080.0	163.0	4238.7	3231.3	2015.9	794.6	3082.6	1557.8	1238.1	4142.3	6097.5	3274.2	3882.5	1615.9	2361.6	3614.8	220.9	1831.3	2502.0	3505.0	1289.5	5717.9	4715.7	2717.9	3404.0	3317.6	563.2	3460.3	2745.9	2903.9	4001.7	470.7	1675.1	2898.4	786.8	872.2	6212.4	4350.9	3718.5	5163.2	5114.9
RPS24	S24	ENSG00000138326	"Ribosomal protein S24"	P62847	10	78033732-78056813	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA003364, HPA073508"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		70000	"Endoplasmic reticulum, Cytosol"		"HPA003364: AB_1079847, HPA073508: "	"prognostic favorable (1.50e-4)"	"unprognostic (1.58e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.01e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.25e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.10e-10)"	"unprognostic (3.18e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.65e-2)"	"unprognostic (8.22e-2)"	171.6	122.0	127.7	80.8	79.0	186.2	231.3	56.2	68.4	242.4	201.1	37.9	112.4	86.2	159.2	148.8	277.8	125.1	128.5	123.9	90.4	83.8	134.4	176.6	147.0	263.8	100.6	70.2	369.4	279.3	49.1	86.1	139.3	64.6	251.6	130.0	49.8	176.0	139.5	320.4	192.3	148.9	182.4	111.7	175.8	85.3	87.9	79.5	197.1	221.4	130.0	123.5	271.7	237.7	171.5	180.5	49.6	123.2	156.4	187.3	213.6	111.1	43.4	109.4	170.7	135.6	239.4	98.6	119.5	164.6	126.3	111.1	62.5	78.5	231.0	65.7	103.3	43.9	86.6	126.0	154.0	115.9	76.9	142.8	94.1	28.9	59.5	153.8	224.8	53.6	226.9	230.8	89.3	324.4	254.4	149.9	99.2	127.6	46.3	136.1	45.3	119.9	370.7	76.7	199.9	406.5	81.5	130.9	111.0	161.2	52.2	55.3	108.3	60.1	202.3	147.6	119.9	114.0	249.9	127.0	38.3	91.3	51.9	158.0	60.9	123.1	178.1	47.3	313.4	31.3	49.6	123.2	46.5	102.4	118.3	167.4	171.5	140.6	129.8	180.5	145.4	187.3	168.2	16.9	156.4	91.0	155.4	112.3	213.6	127.7	79.0	56.2	68.4	90.4	83.8	100.6	70.2	64.6	79.5	690.8	1269.5	3209.8	4202.0	3647.0	323.7	537.2	1994.9	927.5	1705.0	760.7	102.1	2994.5	2778.6	1946.3	1157.3	2319.7	1458.1	1097.9	3916.2	5172.5	2049.1	2966.1	1188.1	1848.0	2894.9	143.0	2011.7	1935.4	4187.3	3507.5	5250.7	4018.5	1926.6	2732.2	3111.1	529.6	2893.5	2823.1	2432.9	2781.3	330.7	1248.2	2260.6	575.1	551.3	4012.4	2962.0	2362.2	4939.3	4132.1
RPS26	S26	ENSG00000197728	"Ribosomal protein S26"	P62854	12	56041351-56044676	"Disease related genes, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043961, HPA055803"	Uncertain		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA043961: AB_10963579, HPA055803: AB_2682927"	"unprognostic (1.59e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.36e-1)"	"unprognostic (9.58e-2)"	"unprognostic (3.74e-1)"	"unprognostic (7.84e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.76e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.99e-2)"	36.5	66.6	33.3	29.0	48.8	39.2	49.7	23.8	73.7	44.5	45.6	34.9	20.5	20.0	35.9	50.4	49.9	43.5	28.4	39.8	25.8	24.8	61.8	154.3	29.5	56.0	31.4	26.2	75.8	80.4	25.6	29.7	28.7	45.1	35.4	49.1	28.5	38.0	41.1	62.2	50.9	57.5	36.9	30.0	51.6	40.3	47.0	32.5	47.3	58.4	60.0	78.4	46.7	41.2	93.0	69.8	29.8	42.8	63.6	107.4	108.8	53.4	65.8	75.0	27.8	103.9	154.2	75.2	54.5	81.0	90.9	53.2	101.0	24.2	119.3	34.5	57.5	30.0	25.2	84.2	46.9	62.3	47.2	135.1	63.0	43.9	60.2	96.0	40.9	34.6	93.3	150.3	47.9	54.6	35.9	69.0	85.6	42.9	39.8	73.5	82.9	30.6	74.3	73.6	65.4	149.1	41.7	22.5	73.4	75.9	54.2	28.2	48.8	21.3	47.2	30.9	23.3	41.7	45.8	22.3	22.6	46.3	28.8	43.7	34.3	65.6	64.4	25.1	81.7	28.9	29.8	41.4	27.1	74.6	42.8	83.8	93.0	97.8	81.8	55.3	79.8	107.4	99.3	17.0	63.6	38.2	69.8	101.7	108.8	33.3	48.8	23.8	73.7	25.8	24.8	31.4	26.2	45.1	32.5	208.4	201.5	1424.8	560.8	1563.9	119.2	23.8	1184.7	333.3	536.9	408.2	58.9	1212.8	824.0	801.2	63.2	800.7	1808.5	1004.5	2275.1	2554.3	1158.0	914.2	500.2	1753.2	1234.1	71.5	826.4	935.4	838.0	37.7	273.5	701.1	1386.7	874.7	1010.7	278.9	1348.0	1392.2	208.2	969.4	134.7	304.0	900.2	204.7	313.7	1585.9	1428.5	824.9	1127.8	1109.2
RPS3A	"MFTL, S3A"	ENSG00000145425	"Ribosomal protein S3A"	P61247	4	151099573-151104652	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"	Differentiation	"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 440.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047100, HPA053454"	Approved		Enhanced	"Nucleoli,Endoplasmic reticulum,Cytosol"		No	No		63000	"Nucleoli, Endoplasmic reticulum, Cytosol"		"HPA047100: AB_2679931, HPA053454: AB_2682156"	"unprognostic (6.24e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavorable (6.56e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.81e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.39e-1)"	71.7	46.9	48.4	69.2	47.7	124.7	160.3	40.4	43.5	114.1	98.4	30.4	61.9	45.0	75.3	84.4	142.8	73.3	53.9	51.1	36.8	33.3	72.8	94.2	79.4	102.5	42.6	43.5	179.5	143.8	18.1	49.3	70.5	38.0	113.3	62.4	39.0	113.8	48.5	116.8	97.1	73.5	62.0	43.1	94.2	64.2	61.9	30.7	120.4	126.8	111.6	90.6	111.4	86.3	211.6	187.7	44.3	92.8	142.9	282.7	440.7	80.5	59.3	113.1	111.1	145.6	285.0	115.5	85.9	132.7	121.8	75.4	114.6	117.8	365.6	43.0	93.6	43.0	53.5	114.6	143.5	115.8	80.5	110.9	78.9	73.3	132.3	168.6	187.3	81.9	211.3	296.1	74.9	199.3	172.0	144.4	137.0	126.9	191.5	144.6	120.4	202.3	222.6	106.1	129.0	45.9	148.2	110.4	122.3	141.0	97.9	108.8	107.7	38.6	141.4	189.2	83.4	94.6	227.8	87.6	59.6	78.9	65.7	94.5	148.9	239.5	223.9	76.5	136.8	70.6	44.3	92.8	27.2	120.6	74.5	203.9	211.6	203.1	157.9	156.5	185.7	282.7	226.9	15.1	142.9	62.1	187.7	145.5	440.7	48.4	47.7	40.4	43.5	36.8	33.3	42.6	43.5	38.0	30.7	902.2	1351.4	4981.2	6887.5	5470.3	389.5	334.4	1689.1	1088.1	1918.8	783.4	113.9	3954.4	3630.9	1946.8	1331.3	2405.0	1231.3	1425.0	3246.4	6519.9	2822.1	4092.8	1400.9	1318.9	2985.4	154.1	2072.9	2006.5	3842.5	3230.8	4100.5	4536.3	3092.4	3236.3	3439.0	634.6	3016.2	2304.0	2436.9	3691.6	432.9	1739.7	3595.7	655.4	688.2	5905.5	3840.1	4239.4	5672.4	6561.2
RPS6	S6	ENSG00000137154	"Ribosomal protein S6"	P62753	9	19375715-19380254	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 584.2"	"Low region specificity"	"Detected in all"							"CAB004027, HPA031153"	Approved		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		100000	"Endoplasmic reticulum, Cytosol"		"CAB004027: AB_2238583, HPA031153: AB_10602245"	"unprognostic (3.95e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.34e-2)"	"prognostic favorable (4.12e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.36e-2)"	"unprognostic (6.61e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.06e-3)"	90.0	65.3	64.1	110.2	70.2	166.3	152.8	37.0	50.4	125.4	149.9	38.8	57.4	73.0	91.6	97.7	166.8	87.7	81.5	70.0	51.5	44.4	88.5	91.3	104.0	243.5	66.0	36.2	206.6	441.2	26.1	64.0	67.9	64.7	152.5	83.9	53.3	109.1	72.1	129.5	139.9	96.3	157.8	84.5	137.8	87.5	67.2	53.2	127.9	147.0	119.7	125.8	207.4	143.4	237.2	135.7	30.1	75.5	129.7	274.9	399.9	108.2	71.2	72.4	84.8	122.8	189.6	87.0	73.2	95.6	88.0	73.7	59.2	50.2	249.0	72.5	69.9	31.2	53.3	81.1	112.7	95.7	129.7	77.6	164.1	92.2	107.3	150.0	86.9	82.0	157.2	206.1	58.6	172.9	126.7	105.8	112.5	68.9	101.6	94.9	65.2	184.0	584.2	135.8	86.0	48.5	144.1	73.3	118.4	121.8	93.2	72.4	97.4	27.7	118.0	151.3	60.7	76.8	317.7	77.5	50.7	54.3	52.4	114.4	48.1	93.1	169.0	34.3	130.7	29.6	30.1	75.5	23.3	111.6	67.1	193.2	237.2	205.0	150.5	135.7	196.8	274.9	215.8	12.8	129.7	60.6	126.1	152.7	399.9	64.1	70.2	37.0	50.4	51.5	44.4	66.0	36.2	64.7	53.2	1536.5	2830.0	6502.2	11967.4	8648.0	283.0	709.9	2662.4	2307.4	4835.2	1210.9	119.8	4727.3	4907.4	2480.2	2006.9	4335.8	1389.0	2149.2	5906.0	7578.1	3573.8	7361.0	3033.7	1998.6	3545.0	71.5	1975.3	3407.3	3797.3	4913.1	4288.0	4784.3	4367.8	4093.0	4198.5	516.9	4659.6	3594.7	2278.1	5890.0	305.7	1461.7	5142.7	1143.2	654.9	10561.7	4523.6	5315.7	7244.9	10415.6
RPS6KA4	"MSK2, RSK-B"	ENSG00000162302	"Ribosomal protein S6 kinase A4"	O75676	11	64359148-64372215	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 12.6"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 12.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008649, HPA023225"	Approved		Supported	Nucleoplasm,Cytosol		No	No			Nucleoplasm	Cytosol	"CAB008649: AB_1619460, HPA023225: AB_1854144"	"unprognostic (2.30e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.47e-2)"	"prognostic unfavorable (8.17e-4)"	"prognostic unfavorable (9.27e-4)"	"unprognostic (2.45e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.93e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.85e-1)"	14.9	9.1	13.3	15.7	17.1	13.2	7.6	37.6	22.7	7.7	12.4	13.1	5.8	14.0	11.0	6.9	18.5	8.1	10.5	7.8	10.9	10.1	8.7	9.6	10.9	15.0	16.7	9.9	6.5	9.2	5.7	4.7	16.6	9.8	8.3	8.4	10.0	10.9	8.9	16.3	17.3	15.4	9.8	11.5	22.2	18.3	3.3	13.5	7.6	6.7	16.7	16.4	9.7	8.8	0.5	12.6	1.4	3.0	0.3	1.0	2.1	28.1	15.8	2.3	5.7	5.1	4.8	32.6	15.0	7.9	11.8	5.8	15.6	14.8	2.9	17.5	8.6	15.0	26.1	2.7	12.2	5.8	8.9	5.3	6.6	13.5	7.9	5.1	6.7	12.4	4.7	11.5	10.0	8.2	4.2	7.1	5.4	2.7	4.1	5.9	25.8	6.0	10.5	2.5	10.9	33.3	11.8	9.4	9.4	8.1	13.0	3.4	2.7	15.5	9.5	13.0	3.4	11.1	8.3	14.1	16.1	20.2	29.0	13.3	4.9	3.8	2.9	10.6	7.7	8.1	1.1	3.0	1.4	0.9	2.4	1.0	0.5	0.7	0.7	2.7	0.4	0.4	0.4	0.2	0.3	1.4	12.6	0.6	2.1	13.3	17.1	37.6	22.7	10.9	10.1	16.7	9.9	9.8	13.5	3.0	4.0	5.7	4.6	10.8	6.3	11.8	5.1	0.0	1.2	3.5	3.9	60.8	5.0	13.7	0.2	7.4	17.0	0.0	21.8	31.5	9.1	7.1	19.5	6.4	26.9	7.9	8.1	11.6	29.2	0.7	10.3	15.3	8.5	12.6	11.6	3.1	40.7	10.7	6.3	7.3	2.0	0.0	9.2	0.7	7.2	9.4	39.0	8.7	13.9	8.5
RPS6KA5	"MSK1, RLPK"	ENSG00000100784	"Ribosomal protein S6 kinase A5"	O75582	14	90847862-91060636	"Enzymes, Predicted intracellular proteins"	"Inflammatory response, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"granulocytes: 86.9;Syncytiotrophoblasts: 93.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.1;SK-BR-3: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001274, HPA001780, CAB025458"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025458: , HPA001274: AB_1079417, HPA001780: AB_2666432"	"unprognostic (3.05e-2)"	"unprognostic (2.19e-3)"	"unprognostic (4.27e-4)"	"unprognostic (1.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (4.20e-4)"	"unprognostic (3.70e-2)"	"unprognostic (5.80e-4)"	"unprognostic (6.70e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.38e-4)"	"unprognostic (5.73e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.75e-1)"	4.9	2.4	8.3	13.0	21.6	5.8	16.3	32.9	12.2	7.0	11.0	12.0	4.2	9.3	11.8	2.6	11.9	8.9	6.7	6.1	9.0	7.9	4.5	4.1	6.1	7.3	12.8	9.7	10.2	4.9	12.0	6.9	14.9	11.0	8.0	11.7	2.8	8.7	9.9	14.3	6.6	9.8	19.4	17.1	7.4	9.8	5.2	13.7	4.8	8.6	7.8	7.7	11.6	7.3	5.8	2.5	20.0	3.2	8.4	7.1	2.2	1.2	1.7	2.0	1.3	0.0	0.4	8.7	0.7	1.1	2.3	3.4	0.9	2.3	5.9	2.5	2.2	1.6	3.8	1.7	1.7	4.8	0.9	3.1	5.9	1.7	0.2	0.0	5.8	30.1	0.5	3.6	1.4	1.1	0.5	2.5	4.1	0.6	6.7	2.3	2.5	1.8	2.9	0.6	3.7	2.7	3.2	9.6	3.0	2.5	2.2	10.1	3.2	2.5	15.1	8.5	1.8	2.9	1.9	0.5	0.7	1.3	0.6	2.9	2.9	2.8	5.1	1.4	4.3	9.5	10.5	2.7	7.8	3.6	2.1	5.9	4.4	4.8	3.5	2.5	5.8	5.6	3.0	20.0	8.4	3.2	1.0	7.1	2.2	8.3	21.6	32.9	12.2	9.0	7.9	12.8	9.7	11.0	13.7	17.9	27.4	40.7	37.9	35.8	29.4	14.1	12.7	37.5	29.6	7.0	15.7	31.0	0.0	8.9	5.5	19.6	27.6	0.0	4.6	4.7	13.2	25.2	86.9	6.8	6.4	25.4	15.6	14.1	16.1	2.1	13.0	16.9	18.6	2.8	17.9	12.9	3.0	11.5	11.0	2.8	29.2	12.9	27.6	13.1	23.7	40.5	93.5	39.5	18.8	42.3
RPS8	S8	ENSG00000142937	"Ribosomal protein S8"	P62241	1	44775251-44778779	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA029266			Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		52000	"Endoplasmic reticulum, Cytosol"		"HPA029266: AB_10601611"	"unprognostic (9.70e-3)"	"unprognostic (2.26e-1)"	"unprognostic (3.02e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.02e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.30e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (9.05e-9)"	"unprognostic (1.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (8.83e-2)"	"unprognostic (5.57e-2)"	55.7	60.7	44.8	44.4	46.3	100.1	82.0	50.1	65.5	69.6	47.8	33.8	37.0	40.7	61.9	48.4	78.0	66.7	43.9	36.8	34.6	23.7	41.6	74.1	36.5	77.7	34.8	34.6	195.0	98.3	13.1	37.2	45.4	36.8	53.5	42.5	32.3	61.0	72.7	53.7	91.2	45.6	39.4	35.6	57.0	47.4	71.9	29.0	64.8	40.9	97.3	72.0	52.7	71.2	146.1	98.0	15.3	50.2	61.2	128.4	168.5	102.3	51.3	82.4	108.5	143.3	225.6	134.8	75.3	119.5	106.5	85.7	87.9	112.1	194.1	83.1	91.2	68.6	70.3	105.6	131.1	78.8	70.2	184.5	72.3	73.0	116.8	203.7	143.7	71.0	179.4	217.6	70.9	190.6	153.6	127.2	117.8	107.4	136.5	99.0	81.0	157.9	153.8	180.0	86.4	88.8	127.3	100.9	216.6	119.5	88.1	88.2	101.8	40.7	228.4	298.5	83.3	79.8	289.3	86.7	53.0	92.9	81.2	127.8	107.8	105.6	146.7	64.8	172.7	63.4	10.3	50.2	15.3	55.1	49.1	94.1	146.1	101.4	76.7	79.2	124.5	128.4	106.7	5.0	61.2	38.1	98.0	84.2	168.5	44.8	46.3	50.1	65.5	34.6	23.7	34.8	34.6	36.8	29.0	1316.1	1723.1	6218.3	8263.7	7023.7	212.5	618.5	2667.5	1619.4	2842.4	1036.4	86.4	4856.6	3516.4	2080.0	402.3	3276.6	1407.7	2826.7	5263.3	6516.1	3553.3	5089.6	1744.1	1895.9	3113.3	57.2	2060.2	2974.6	3941.2	529.4	5688.8	4066.1	2795.5	3230.1	3644.2	416.1	4072.9	3794.5	2586.4	2671.8	154.0	1481.1	4301.1	393.8	413.6	9798.1	4485.5	3459.3	5777.2	7011.6
RPTOR	"KIAA1303, KOG1, Mip1, raptor"	ENSG00000141564	"Regulatory associated protein of MTOR complex 1"	Q8N122	17	80544819-80966371	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013514, HPA064306"	Approved		Enhanced	Vesicles,Lysosomes		NA	NA			"Vesicles, Lysosomes"		"CAB013514: AB_2533523, HPA064306: AB_2685240"	"unprognostic (5.09e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.75e-2)"	"unprognostic (3.34e-3)"	"unprognostic (1.17e-2)"	"unprognostic (9.63e-2)"	"unprognostic (8.80e-2)"	"unprognostic (4.40e-3)"	"unprognostic (8.46e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.77e-2)"	13.6	12.3	10.5	11.1	14.5	10.2	9.3	17.5	21.0	12.6	13.1	19.0	9.6	12.2	15.0	9.3	14.2	12.5	8.0	15.5	10.8	10.5	8.3	12.9	11.0	9.0	12.2	9.9	12.8	9.8	14.3	14.1	9.7	12.7	12.0	7.4	15.2	10.4	13.9	23.7	12.3	11.0	13.6	9.5	11.6	11.1	10.3	12.7	16.7	10.2	11.1	11.9	14.3	10.5	2.1	1.9	3.1	2.4	1.7	3.8	1.2	9.7	19.6	4.6	8.3	6.7	5.7	8.7	7.4	6.8	11.7	8.8	15.3	8.7	8.2	5.9	9.0	9.1	6.0	7.5	9.9	6.6	2.9	12.2	12.6	10.8	13.8	6.7	11.3	9.0	8.5	6.8	12.1	7.0	4.1	11.6	9.6	15.7	3.3	6.6	5.3	10.9	4.8	5.0	5.8	15.7	5.2	8.5	6.7	3.4	11.2	9.2	9.3	9.0	14.5	8.2	5.2	9.5	8.3	5.3	24.9	10.6	7.8	9.4	5.3	1.9	8.1	15.1	6.0	15.1	3.1	0.9	0.0	3.8	2.4	2.5	2.1	1.6	1.8	1.9	1.1	2.3	2.2	0.0	1.7	1.3	1.1	3.6	1.2	10.5	14.5	17.5	21.0	10.8	10.5	12.2	9.9	12.7	12.7	0.0	3.8	1.7	2.8	2.9	6.7	3.4	7.6	0.0	0.0	5.2	3.9	3.9	1.7	2.9	5.8	2.6	3.5	0.0	3.2	4.8	3.1	3.4	2.3	5.8	4.2	11.1	5.8	1.8	4.5	8.7	2.8	2.1	1.7	0.0	3.1	4.1	3.7	3.5	4.9	2.6	6.6	0.0	3.0	3.4	3.3	2.6	3.7	5.0	4.6	2.8
RRBP1	"ES/130, hES"	ENSG00000125844	"Ribosome binding protein 1"	Q9P2E9	20	17613678-17682295	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 136.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 18.8;plasmacytoid DC: 23.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009026, HPA011924"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		44000	"Endoplasmic reticulum"		"HPA009026: AB_1079852, HPA011924: AB_1856476"	"unprognostic (1.56e-3)"	"unprognostic (2.26e-3)"	"unprognostic (8.46e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (6.63e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.38e-4)"	19.9	18.3	6.7	16.1	11.2	5.9	13.8	4.9	7.4	22.1	23.6	17.8	49.5	18.5	16.3	24.4	17.1	12.3	37.3	15.8	7.8	6.3	27.1	88.9	20.5	10.6	13.0	5.6	23.4	136.1	24.7	18.4	51.4	10.4	19.4	16.7	14.8	84.2	56.0	7.7	11.0	32.2	13.0	13.3	20.4	30.0	12.1	12.2	5.0	32.8	11.6	19.2	18.7	18.9	0.9	23.5	18.8	4.7	5.7	2.5	1.5	30.4	21.7	6.5	14.6	30.1	32.7	34.4	47.8	40.2	20.2	27.5	48.3	28.8	11.8	16.1	45.1	20.9	30.7	7.0	38.8	16.6	5.4	5.4	13.6	6.3	49.8	43.3	5.0	17.2	43.1	11.7	32.7	19.4	30.0	19.9	4.2	5.6	11.5	30.3	13.8	1.9	11.5	7.6	67.9	21.0	3.5	17.3	40.5	17.1	10.4	3.3	2.5	27.2	64.6	19.6	14.5	11.3	7.7	35.7	43.3	16.1	22.4	15.7	21.1	16.0	3.9	16.4	5.4	22.0	5.4	4.7	18.8	2.5	2.9	1.7	0.5	0.8	1.4	2.4	0.9	0.8	0.9	4.2	5.7	4.0	23.5	0.7	1.5	6.7	11.2	4.9	7.4	7.8	6.3	13.0	5.6	10.4	12.2	89.3	202.0	34.3	70.6	52.5	17.0	30.9	147.7	131.2	145.6	90.7	29.5	233.8	38.1	171.5	35.2	132.5	313.0	0.0	359.4	194.5	183.3	135.6	113.5	227.0	102.0	23.8	93.1	135.1	51.8	28.3	117.6	73.6	67.4	86.6	259.3	193.4	291.3	208.5	78.1	62.7	35.4	32.3	138.2	74.8	93.6	48.8	445.7	36.3	168.2	180.5
RRM2B	p53R2	ENSG00000048392	"Ribonucleotide reductase regulatory TP53 inducible subunit M2B"	Q7LG56	8	102204502-102239118	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair, DNA replication"	Oxidoreductase	"Disease mutation, FDA approved drug targets, Neuropathy, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006854, HPA028812"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB006854: , HPA028812: AB_10602246"	"unprognostic (7.76e-3)"	"unprognostic (4.14e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.66e-1)"	"unprognostic (9.40e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.52e-1)"	"unprognostic (7.17e-2)"	11.8	18.6	11.7	11.5	11.4	4.3	9.3	8.5	13.5	9.5	10.1	9.8	9.5	10.2	8.2	10.8	8.0	9.7	8.2	11.3	17.5	12.8	17.5	15.1	15.8	12.6	14.9	10.6	9.7	9.5	34.7	24.8	11.6	23.1	11.2	11.1	7.7	9.7	10.9	34.6	7.4	7.6	8.2	26.1	10.6	7.1	6.6	9.4	6.3	37.1	8.1	13.1	10.7	7.0	7.4	6.2	18.3	8.4	3.0	3.3	2.8	5.6	10.0	11.9	7.0	16.8	16.2	9.4	13.0	15.8	7.0	8.2	3.5	4.5	35.8	12.3	14.3	7.1	2.1	5.7	13.2	9.9	5.8	6.2	9.0	4.2	7.5	13.6	2.7	19.2	20.5	24.9	7.7	11.8	16.7	19.6	6.2	6.6	5.5	22.4	5.5	4.7	5.2	6.6	6.1	7.4	3.0	4.8	7.2	16.3	6.4	3.0	5.9	6.8	3.6	7.7	31.0	9.7	6.2	14.9	10.9	21.1	7.5	3.5	5.8	5.3	32.6	16.0	4.2	11.5	10.0	5.1	5.3	2.2	4.5	3.3	5.6	2.0	2.8	6.2	7.4	2.3	2.5	18.3	3.0	8.4	1.8	1.4	2.8	11.7	11.4	8.5	13.5	17.5	12.8	14.9	10.6	23.1	9.4	53.6	24.0	7.2	8.1	17.2	13.1	17.9	20.4	38.8	25.0	38.4	13.7	11.2	21.6	6.2	1.6	16.4	6.4	0.0	7.0	4.9	10.4	10.8	10.5	20.3	11.1	9.5	28.3	18.4	21.8	1.1	13.3	17.8	16.9	7.2	10.3	23.6	5.5	7.0	13.8	18.1	14.7	6.5	10.8	8.2	10.0	16.2	4.0	12.8	11.7	5.4
RRP1	"D21S2056E, NNP-1, Nop52, RRP1A"	ENSG00000160214	"Ribosomal RNA processing 1"	P56182	21	43789513-43805293	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016818, HPA018166"	Approved		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			"Nucleoli, Mitotic chromosome"		"HPA016818: AB_1854561, HPA018166: AB_1854562"	"unprognostic (5.38e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.69e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.63e-3)"	"unprognostic (9.42e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (6.29e-5)"	"unprognostic (1.13e-1)"	"unprognostic (9.21e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.88e-1)"	12.0	10.6	12.1	12.8	15.6	9.7	9.4	11.4	20.0	8.6	8.9	18.0	6.0	10.6	10.0	9.1	19.8	10.9	9.3	8.5	14.3	11.3	8.3	16.6	7.3	15.1	16.3	14.4	14.8	16.6	9.4	7.6	10.3	14.9	9.4	6.7	9.9	14.7	9.8	15.6	20.1	9.7	7.4	11.5	11.1	11.9	13.8	15.6	10.5	9.6	11.4	14.7	8.9	9.8	10.9	8.8	1.5	4.3	10.4	12.3	6.0	16.3	8.8	6.0	10.1	3.3	3.8	11.7	8.4	4.9	11.7	8.3	23.1	9.7	15.8	7.0	4.5	10.8	8.4	11.2	8.1	5.3	7.8	22.0	22.5	8.1	14.0	6.9	14.2	8.1	5.0	7.7	11.7	9.2	3.0	6.2	14.9	29.4	11.9	5.4	19.3	12.3	19.5	20.3	11.3	13.2	22.8	4.9	29.1	6.0	9.1	14.4	8.6	8.7	9.4	11.0	1.7	9.8	9.8	7.0	7.8	8.9	8.2	14.4	14.9	12.8	16.4	11.9	23.8	10.1	0.1	4.3	1.5	9.7	4.0	12.3	9.6	10.1	9.9	8.8	10.9	11.2	7.4	0.9	10.4	1.9	7.5	5.8	6.0	12.1	15.6	11.4	20.0	14.3	11.3	16.3	14.4	14.9	15.6	14.9	20.8	16.0	24.4	64.2	17.6	4.5	7.6	20.1	39.8	7.0	19.6	27.0	6.6	26.5	3.5	19.1	9.1	23.3	28.6	31.6	22.6	15.8	20.7	13.5	29.5	7.9	20.1	12.9	6.7	2.4	17.8	19.7	40.5	19.8	15.3	9.9	31.9	5.8	19.4	17.0	17.4	32.3	24.7	22.6	29.6	61.4	25.4	13.1	25.2	35.2
RRP12	KIAA0690	ENSG00000052749	"Ribosomal RNA processing 12 homolog"	Q5JTH9	10	97356358-97426076	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 62.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 19.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049945, HPA074403"			Supported	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		No	No			Nucleoli	"Vesicles, Plasma membrane, Cytosol"	"HPA049945: AB_2680965, HPA074403: "	"unprognostic (2.79e-1)"	"unprognostic (7.65e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (3.12e-8)"	"unprognostic (2.64e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (2.54e-5)"	"unprognostic (2.58e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.81e-2)"	"unprognostic (6.99e-3)"	7.1	8.4	5.9	7.4	11.9	62.6	4.6	3.8	15.7	4.1	4.0	5.4	2.9	5.2	6.4	3.9	7.1	6.4	6.4	8.4	4.4	7.2	4.4	9.3	5.6	6.0	5.9	6.1	6.0	16.4	9.6	10.6	3.9	9.6	5.5	3.6	4.1	6.6	3.9	31.7	8.2	3.8	5.3	3.2	7.1	5.3	13.9	6.1	4.6	4.9	7.2	5.4	4.2	4.3	3.4	4.3	19.3	11.1	1.2	2.4	3.7	15.9	21.4	5.7	12.3	4.4	5.2	12.5	10.1	6.1	10.5	8.2	23.2	14.8	17.6	13.2	6.4	9.4	20.6	15.6	11.7	7.1	9.6	18.7	13.6	8.0	18.0	7.3	21.1	17.9	5.4	16.6	25.8	23.9	11.9	5.9	9.9	19.4	11.8	5.9	20.8	14.3	13.6	24.5	8.5	14.5	15.7	7.8	17.4	7.3	8.9	7.7	16.4	8.1	7.8	10.1	4.6	18.8	11.0	7.7	7.1	12.2	15.8	31.9	24.2	21.0	20.7	10.1	27.2	7.5	0.2	7.3	4.6	2.0	9.3	2.4	2.9	1.2	1.6	4.3	3.4	1.9	2.1	19.3	1.2	11.1	3.6	0.8	3.7	5.9	11.9	3.8	15.7	4.4	7.2	5.9	6.1	9.6	6.1	32.8	39.8	13.7	10.9	20.8	6.2	9.5	7.6	25.4	34.2	14.0	39.3	4.4	0.0	9.1	5.6	6.7	3.9	0.0	7.4	5.9	7.6	10.1	39.4	6.8	10.4	4.8	20.6	4.9	10.8	3.6	3.4	8.4	6.8	1.0	7.2	2.2	7.8	5.1	2.5	6.8	12.3	0.0	6.1	9.9	18.4	17.1	7.7	4.4	7.8	12.4
RRP1B	"KIAA0179, Nnp1, PPP1R136, RRP1"	ENSG00000160208	"Ribosomal RNA processing 1B"	Q14684	21	43659548-43696079	"Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 123.7;Early spermatids: 195.5;Late spermatids: 173.7;Rod photoreceptor cells: 138.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA017893, HPA020324"	Supported		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA017893: AB_1852274, HPA020324: AB_1852276"	"unprognostic (1.03e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.03e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.55e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (2.95e-9)"	"unprognostic (1.45e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.24e-2)"	12.7	10.3	10.7	20.0	13.7	7.6	14.5	13.9	12.5	13.1	11.1	11.5	9.4	9.5	16.1	9.2	15.7	14.0	12.2	8.4	9.5	8.6	7.5	17.7	10.4	22.8	13.1	7.5	20.0	20.6	11.8	11.4	8.4	10.3	11.3	10.9	15.0	13.9	12.8	21.6	14.1	11.1	12.9	9.9	16.9	11.8	32.5	12.6	25.6	9.6	12.6	20.5	13.5	14.1	6.0	3.2	2.1	2.7	5.8	9.8	5.3	16.9	10.0	10.7	16.1	7.0	7.5	8.8	8.9	6.4	9.9	8.2	22.7	7.4	33.2	5.9	7.0	11.5	7.6	26.4	15.4	11.8	11.1	21.0	19.6	11.6	14.2	9.7	30.5	7.8	7.7	9.9	11.9	13.8	6.1	11.0	14.4	30.6	9.8	8.7	8.8	24.2	9.3	36.5	11.0	11.2	32.0	10.8	23.2	7.2	8.1	21.3	11.4	16.8	12.4	12.4	4.1	8.1	9.6	9.8	3.1	9.7	8.1	16.2	13.3	16.9	39.7	9.7	33.0	10.0	2.1	2.6	0.7	7.2	2.7	8.5	6.0	9.1	8.6	3.2	5.3	8.6	9.8	0.1	5.8	2.3	2.6	7.0	5.3	10.7	13.7	13.9	12.5	9.5	8.6	13.1	7.5	10.3	12.6	29.8	16.0	22.1	12.1	20.3	28.9	10.4	12.7	21.4	28.4	5.2	123.7	6.5	1.7	12.9	195.5	15.9	4.7	0.0	13.7	13.6	13.6	12.0	33.7	16.6	16.5	23.8	5.2	11.1	11.9	173.7	20.8	11.6	8.5	11.8	8.5	14.7	16.6	0.0	25.1	9.5	138.2	0.0	16.0	24.0	34.2	27.7	3.7	27.3	13.8	12.2
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021645-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	25.0	29.7	21.0	24.9	27.2	23.3	57.7	18.0	42.1	21.3	22.4	16.0	24.9	19.4	23.8	24.7	31.9	20.6	20.1	31.3	22.7	21.4	25.2	32.7	24.1	46.5	21.1	28.0	17.3	37.4	37.0	28.8	23.4	27.3	24.6	23.8	19.5	23.5	36.4	61.9	28.4	21.4	28.3	28.5	29.4	25.7	23.9	15.8	25.0	22.6	30.9	31.8	23.7	28.2	6.5	9.7	4.0	4.6	3.1	7.7	1.2	39.4	22.3	22.2	32.4	24.0	22.5	18.7	31.3	28.4	40.2	39.5	40.5	17.3	18.3	25.6	32.6	29.5	21.2	37.1	38.0	44.5	23.1	37.8	29.4	24.8	43.2	27.9	24.4	22.9	22.7	23.3	48.0	20.6	14.4	32.6	16.6	35.5	20.0	37.2	41.6	29.3	26.7	24.6	70.7	23.2	27.7	21.9	21.1	24.6	37.4	28.5	25.0	23.1	21.2	35.8	21.8	29.2	30.1	26.2	37.2	28.3	24.4	49.1	18.8	28.2	48.9	16.2	30.9	34.5	3.9	3.6	3.1	5.9	4.6	4.7	6.5	4.2	7.0	3.7	2.6	3.9	7.7	4.0	3.1	3.6	9.7	2.1	1.2	21.0	27.2	18.0	42.1	22.7	21.4	21.1	28.0	27.3	15.8	0.0	14.1	20.6	9.5	11.8	15.3	13.7	28.1	8.1	12.5	19.2	15.7	25.9	11.6	31.6	8.6	11.3	10.5	0.0	38.9	36.9	13.2	13.1	5.8	34.3	25.3	17.5	13.4	22.1	14.3	18.5	10.9	13.4	13.5	28.9	11.3	25.1	32.5	7.0	17.7	16.1	17.2	6.5	12.0	7.6	10.2	16.3	28.1	10.0	12.8	12.1
RSF1	"HBXAP, p325, RSF-1, XAP8"	ENSG00000048649	"Remodeling and spacing factor 1"	Q96T23	11	77659996-77821017	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022626, HPA046129, HPA057547, HPA064567"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB022626: , HPA046129: AB_2679550, HPA057547: AB_2683462, HPA064567: AB_2685289"	"unprognostic (2.67e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.35e-3)"	"unprognostic (5.00e-3)"	"unprognostic (5.57e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.35e-2)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (6.19e-2)"	"prognostic favorable (5.94e-4)"	"unprognostic (1.71e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	15.9	20.1	20.4	19.5	23.5	21.1	14.4	32.3	20.0	19.0	14.2	11.0	15.2	8.7	19.3	14.6	13.4	14.1	15.7	13.1	18.7	17.2	14.0	10.9	15.6	13.2	16.2	15.3	26.0	15.6	25.3	27.3	16.9	18.7	16.3	12.0	8.1	13.4	21.3	15.7	13.5	12.7	16.7	15.8	16.2	12.5	21.1	21.8	22.4	21.1	8.4	12.3	21.3	25.8	21.7	18.5	27.7	15.7	13.6	17.1	4.0	10.5	7.1	24.8	13.2	8.4	10.7	9.3	12.5	12.3	10.3	12.7	18.7	14.8	18.0	13.4	8.7	15.9	11.1	14.5	9.3	19.3	12.8	6.5	16.9	10.1	5.0	8.1	16.0	12.1	8.9	7.1	14.0	22.6	12.0	12.9	6.0	27.5	17.1	11.8	7.2	11.2	9.0	14.4	12.7	9.8	18.8	43.1	11.7	5.4	13.8	15.0	15.2	19.2	7.6	7.5	13.5	13.6	8.0	16.1	18.2	15.8	28.4	8.9	10.3	13.2	41.5	4.8	10.9	13.6	21.3	10.7	17.8	17.1	9.9	11.7	18.2	10.3	10.7	8.1	21.7	14.3	14.2	27.7	13.6	15.7	18.5	9.6	4.0	20.4	23.5	32.3	20.0	18.7	17.2	16.2	15.3	18.7	21.8	110.2	97.4	50.0	60.3	80.4	120.3	86.5	48.4	78.9	81.9	69.8	70.7	51.8	39.7	63.9	69.5	87.9	40.1	70.0	48.5	44.1	80.8	77.0	91.4	37.7	39.8	138.2	82.1	72.4	47.5	29.1	117.3	58.4	54.0	85.6	57.6	115.2	62.7	57.7	111.0	31.1	94.9	103.5	72.1	96.0	109.4	73.4	56.4	77.8	54.2	72.5
RSL1D1	"CSIG, DKFZP564M182, L12, PBK1, UTP30"	ENSG00000171490	"Ribosomal L1 domain containing 1"	O76021	16	11833850-11851585	"Predicted intracellular proteins, Ribosomal proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043483	Supported		Enhanced	"Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli rim, Mitotic chromosome"		"HPA043483: AB_2678504"	"unprognostic (4.46e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.88e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (2.95e-4)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (6.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (3.24e-4)"	"unprognostic (4.72e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.68e-2)"	31.5	16.8	11.6	15.8	15.0	18.6	36.1	16.3	16.2	26.6	21.5	11.5	12.6	14.9	20.6	14.0	28.6	21.8	14.2	17.3	11.2	11.4	17.9	24.0	15.9	29.4	14.2	11.7	58.1	32.7	14.9	20.7	22.0	15.0	30.2	18.1	14.7	18.1	17.0	66.9	21.2	23.2	25.6	15.7	25.2	17.8	19.9	12.6	25.2	27.8	19.8	28.7	37.8	20.8	32.2	31.0	3.0	30.2	28.5	49.0	53.4	21.3	20.4	17.1	21.4	22.5	40.7	20.4	19.9	22.4	25.9	26.6	19.7	20.3	53.8	33.1	16.6	18.0	15.3	45.8	30.3	42.2	21.0	24.7	26.5	20.1	44.9	42.1	37.5	17.7	29.6	43.1	26.7	62.3	19.5	25.1	21.2	46.4	25.0	31.8	23.7	29.3	21.8	43.8	25.9	21.2	30.6	31.5	57.0	23.3	18.8	24.0	19.7	37.6	28.7	26.7	18.5	24.7	29.2	15.3	17.3	19.4	16.3	28.7	20.1	28.9	62.8	18.8	39.6	23.0	3.0	30.2	2.9	18.2	28.6	33.2	32.2	33.6	23.4	31.0	27.0	49.0	35.0	1.6	28.5	26.1	19.1	23.4	53.4	11.6	15.0	16.3	16.2	11.2	11.4	14.2	11.7	15.0	12.6	131.0	127.1	161.6	243.1	293.9	41.6	166.3	68.8	107.1	230.9	47.1	21.6	166.1	114.4	110.6	14.1	113.7	58.6	0.0	160.3	244.9	140.4	116.0	146.9	67.2	131.5	36.5	90.6	47.9	127.0	11.5	184.6	158.8	87.7	275.1	126.0	46.3	134.3	73.7	118.5	126.3	23.5	58.2	198.5	98.4	131.5	253.7	134.3	149.8	155.6	181.7
RSL24D1	"C15orf15, HRP-L30-iso, L30, RPL24, RPL24L"	ENSG00000137876	"Ribosomal L24 domain containing 1"	Q9UHA3	15	55180806-55197067	"Predicted intracellular proteins, Ribosomal proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA062724, HPA063392"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	NA			"Nucleoplasm, Nucleoli, Nucleoli rim"		"HPA062724: AB_2684850, HPA063392: AB_2685002"	"unprognostic (3.40e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.56e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.19e-3)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.44e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.41e-1)"	27.7	24.3	26.7	23.4	28.8	76.1	47.8	35.7	29.9	40.6	32.2	10.0	25.6	18.1	34.5	26.6	34.2	26.4	21.4	25.3	25.1	25.3	24.3	26.7	27.0	35.8	25.4	25.8	54.7	37.8	15.0	23.2	22.4	24.1	44.3	20.5	11.2	25.8	21.3	47.2	19.3	21.1	50.4	27.5	28.6	28.8	24.2	20.6	39.5	43.1	36.9	27.4	61.9	49.6	29.1	27.0	11.4	24.1	22.7	45.1	47.7	16.1	16.4	18.1	23.7	14.2	26.8	14.7	17.1	19.2	14.4	18.4	15.7	9.9	50.4	15.5	12.3	14.1	19.8	23.8	19.8	19.4	24.5	14.8	25.8	13.2	19.5	32.8	48.5	16.9	22.7	42.0	14.4	41.9	23.3	17.8	37.9	48.6	36.6	16.7	16.5	26.5	42.8	22.3	33.1	14.8	21.2	22.7	75.9	21.6	15.0	25.7	30.8	7.9	22.3	55.4	15.0	21.4	71.8	12.4	11.9	13.9	13.8	24.4	35.3	53.9	50.1	18.5	48.1	19.9	11.4	23.8	11.4	19.6	23.4	31.1	29.1	29.5	24.3	27.0	22.5	45.1	34.0	6.0	22.7	24.1	21.1	32.4	47.7	26.7	28.8	35.7	29.9	25.1	25.3	25.4	25.8	24.1	20.6	92.3	65.6	256.3	349.8	515.7	83.5	63.5	89.2	77.6	80.8	80.3	21.6	138.6	242.1	170.0	67.8	119.6	46.1	70.0	234.1	222.4	198.3	186.8	150.0	57.1	128.0	14.3	134.4	79.8	196.0	28.6	188.4	183.5	269.9	194.8	102.0	68.6	201.1	134.0	140.4	191.4	51.1	155.2	258.6	71.0	148.8	456.4	145.9	187.5	118.2	292.9
RTCA	"RPC, RTC1, RTCD1"	ENSG00000137996	"RNA 3'-terminal phosphate cyclase"	O00442	1	100266207-100292769	"Enzymes, Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027982, HPA027990, HPA028151, HPA028331"	Uncertain		Enhanced	Nucleoplasm		NA	NA		8700	Nucleoplasm		"HPA027982: AB_10601769, HPA027990: AB_2672452, HPA028151: AB_10602099, HPA028331: "	"unprognostic (4.79e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.82e-2)"	"unprognostic (6.76e-2)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (9.55e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.09e-3)"	"unprognostic (3.74e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.94e-2)"	20.9	25.0	19.4	17.8	24.9	25.5	20.0	22.6	31.7	14.7	22.9	20.3	19.9	31.7	14.2	26.0	27.0	13.4	19.9	25.5	20.0	21.0	31.7	23.0	16.1	21.8	21.5	20.7	13.3	27.7	21.1	17.2	21.2	33.1	20.9	22.2	14.1	18.5	17.4	35.4	14.6	37.8	15.4	20.5	24.2	21.8	12.2	12.4	25.0	18.3	20.2	20.8	18.7	17.5	9.6	8.0	8.2	19.6	11.0	20.1	7.7	22.0	11.4	11.3	15.2	14.3	23.3	30.9	26.2	12.8	17.1	14.8	18.6	11.1	22.6	19.9	16.6	21.1	11.2	13.8	12.4	20.7	22.6	11.5	14.9	13.0	23.4	22.1	27.1	23.6	18.9	19.6	22.3	29.9	17.0	21.2	16.5	25.6	34.5	25.8	7.3	13.9	21.1	17.3	15.7	22.1	10.0	20.2	9.9	21.0	18.1	9.1	11.4	16.9	24.5	35.8	18.5	5.3	34.8	18.4	16.2	11.3	25.2	31.4	20.0	20.1	18.1	34.0	23.6	9.6	8.2	9.1	7.5	10.8	11.3	13.8	9.6	10.0	12.8	8.0	7.1	9.3	10.5	4.4	11.0	19.6	7.6	20.1	7.7	19.4	24.9	22.6	31.7	20.0	21.0	21.5	20.7	33.1	12.4	6.0	14.4	26.1	13.0	12.0	22.2	49.6	7.6	13.4	10.3	17.4	11.8	48.9	21.6	37.0	11.5	17.5	35.4	0.0	30.2	65.3	13.9	14.2	12.7	15.3	69.5	20.6	18.5	22.7	41.9	6.4	17.8	28.9	15.1	50.5	26.6	20.6	46.7	37.1	12.0	49.6	26.8	6.5	12.3	27.2	14.7	12.8	38.8	32.0	29.7	15.7
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870966	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 144.6"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 227.2"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 4.5;intermediate monocyte: 4.6;myeloid DC: 7.9"	"Group enriched"	"Detected in many"	15	"dendritic cells: 7.9;monocytes: 4.6"	"Group enriched"	"Detected in some"	4	"HEL: 23.2;SCLC-21H: 28.7;SH-SY5Y: 46.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		140000	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	6.3	8.3	27.4	6.1	46.3	1.6	3.0	98.5	144.6	2.6	2.9	11.0	0.0	2.7	2.1	1.6	2.3	8.6	4.4	1.9	32.3	50.7	2.3	1.9	4.8	2.7	21.3	45.9	1.7	3.6	19.2	10.3	2.7	35.1	5.0	3.0	1.2	2.3	2.6	1.6	2.3	3.4	2.7	12.1	10.6	3.6	2.6	10.5	0.0	2.7	0.0	2.3	2.5	0.9	0.0	7.9	0.4	4.6	0.0	0.0	1.0	0.0	0.0	0.3	0.4	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.8	23.2	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	28.7	46.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.9	1.1	0.0	2.1	0.0	0.0	0.0	7.7	1.6	0.2	0.0	4.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	1.0	27.4	46.3	98.5	94.7	32.3	50.7	21.3	45.9	35.1	10.5	0.0	0.6	0.0	0.4	4.2	26.8	0.8	2.5	1.4	1.2	0.0	23.6	0.8	0.0	0.0	13.2	0.5	0.2	0.0	0.0	0.7	2.1	6.2	0.0	0.4	15.8	227.2	51.9	0.0	15.9	14.4	2.6	24.4	10.1	1.8	0.0	13.1	2.2	0.0	1.1	0.3	29.4	0.0	2.1	2.1	2.5	5.6	2.1	0.0	0.2	0.3
RTN4	"ASY, KIAA0886, NOGO, NSP-CL"	ENSG00000115310	"Reticulon 4"	Q9NQC3	2	54972187-55112621	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Muller glia cells: 3179.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 159.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005388, HPA023977"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		13000000	"Endoplasmic reticulum"		"CAB005388: AB_2285559, HPA023977: AB_2671391"	"unprognostic (1.31e-2)"	"unprognostic (1.71e-3)"	"unprognostic (6.76e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.00e-4)"	"unprognostic (5.79e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.91e-3)"	"unprognostic (4.38e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.91e-2)"	103.7	60.5	75.1	27.9	85.0	19.3	63.6	66.6	105.5	24.8	35.4	52.9	17.5	45.0	29.3	36.0	43.0	26.3	38.5	30.8	71.9	69.7	86.5	103.5	36.2	19.6	84.9	75.8	27.4	23.7	59.9	16.1	33.8	99.0	45.2	35.7	24.7	23.6	38.1	171.1	48.1	55.2	47.4	92.6	20.1	23.5	14.6	62.7	14.7	25.9	47.2	16.5	48.1	35.4	2.8	6.1	33.3	7.7	16.8	15.8	4.4	33.0	24.0	23.5	6.1	80.1	75.2	13.2	110.1	93.6	34.1	31.9	19.7	31.5	7.2	58.6	74.6	57.1	30.1	15.4	44.3	52.1	20.4	11.8	9.9	14.8	31.1	159.5	17.8	5.1	56.3	42.4	46.6	90.9	68.9	63.9	18.3	20.2	16.7	147.0	9.6	21.7	18.2	21.1	7.2	21.5	9.7	31.0	14.9	79.1	39.9	15.5	18.3	25.2	14.8	30.8	42.1	12.6	13.7	90.6	66.7	28.3	26.2	62.9	10.2	8.2	4.6	67.9	20.7	53.6	33.3	4.3	10.9	4.3	4.9	3.5	2.8	6.9	3.8	4.0	1.6	11.7	4.8	7.0	16.8	7.7	6.1	15.8	4.4	75.1	85.0	66.6	105.5	71.9	69.7	84.9	75.8	99.0	62.7	163.8	161.9	100.2	1062.9	943.4	647.1	108.1	226.7	159.3	127.4	642.0	357.4	421.2	247.1	487.4	360.7	341.8	464.3	70.0	283.5	513.5	379.7	775.3	148.7	573.6	570.9	402.0	213.0	178.0	338.1	193.3	155.1	405.6	323.9	461.7	231.2	3179.0	405.8	189.0	212.5	568.0	465.4	213.4	311.0	240.3	85.0	925.9	302.8	121.8	187.3	1082.8
RUNDC3A	"RAP2IP, RPIP8"	ENSG00000108309	"RUN domain containing 3A"	Q59EK9	17	44308413-44318671	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 92.6"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 54.0;Early spermatids: 20.0;Horizontal cells: 30.2;Intestinal endocrine cells: 37.5;Late spermatids: 59.4;Rod photoreceptor cells: 15.2"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	4	"T-cells: 1.3"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 35.0;SH-SY5Y: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023548, HPA070733"	Enhanced	Supported	Enhanced	Vesicles		NA	NA			Vesicles		"HPA023548: AB_1856069, HPA070733: AB_2732162"	"unprognostic (3.66e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.58e-3)"	"unprognostic (3.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.87e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.87e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.17e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.84e-1)"	1.4	12.9	40.5	1.6	28.5	2.8	1.5	33.0	92.6	1.3	1.8	4.8	0.0	2.2	1.6	1.5	1.5	1.5	1.6	1.8	40.9	20.6	1.7	1.3	1.5	1.4	22.0	23.2	1.7	4.3	2.4	16.1	2.5	15.6	1.5	1.8	1.6	1.4	1.6	1.3	4.1	2.2	1.8	8.0	1.5	3.3	5.2	4.4	0.0	2.4	0.0	1.4	1.5	0.0	0.3	0.1	0.0	0.2	0.1	1.3	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	2.4	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.1	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.1	0.0	35.0	22.3	0.2	0.0	0.2	0.0	0.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.3	1.3	0.3	0.1	0.1	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	40.5	28.5	33.0	49.2	40.9	20.6	22.0	23.2	15.6	4.4	0.0	1.1	0.0	0.2	0.2	54.0	1.1	0.0	0.0	0.0	0.0	5.9	0.0	3.3	0.9	20.0	0.0	0.0	0.0	2.8	0.0	0.2	0.4	0.0	0.0	0.2	30.2	37.5	0.0	0.0	59.4	1.4	0.5	0.0	0.0	0.0	5.0	1.4	0.3	3.2	0.5	15.2	0.0	0.5	0.9	1.3	0.4	0.1	0.0	0.0	0.3
RUNX1	"AML1, AMLCR1, CBFA2, PEBP2A2"	ENSG00000159216	"Runt related transcription factor 1"	Q01196	21	34787801-36004667	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"breast: 54.3;lymphoid tissue: 58.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 61.2;HMC-1: 36.9;JURKAT: 56.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA004176, HPA037912"	Enhanced		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA004176: AB_1078412, HPA037912: AB_2675733"	"unprognostic (4.06e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.62e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.47e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (1.48e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.47e-2)"	11.5	3.2	5.2	14.8	7.3	29.8	54.3	1.0	4.3	12.5	4.7	3.8	4.0	3.8	2.9	7.4	6.5	4.6	12.4	7.6	6.1	2.0	4.2	6.7	17.9	13.9	8.5	1.1	6.5	5.8	1.6	5.5	6.4	6.0	9.9	5.1	3.5	29.8	8.8	14.4	8.3	5.1	6.8	12.3	10.6	12.7	2.9	6.6	58.6	4.6	5.7	14.2	11.0	9.1	3.2	3.4	17.0	3.9	1.3	4.8	2.0	12.2	0.9	0.0	0.0	3.2	4.1	8.1	6.9	7.1	3.9	2.9	0.6	9.4	6.1	0.4	6.1	6.5	11.1	0.7	8.3	5.6	9.3	0.9	61.2	2.4	2.8	5.9	7.0	36.9	8.0	5.0	11.8	11.7	5.4	2.2	56.6	4.1	3.5	8.2	2.6	28.5	11.2	0.5	6.7	3.6	28.9	21.4	3.7	5.2	4.9	0.3	0.0	7.2	1.8	2.5	1.8	3.7	16.6	9.1	6.4	8.3	9.5	10.4	11.8	4.8	5.7	8.0	15.5	9.3	17.0	3.2	6.3	3.4	1.4	3.3	3.2	3.1	3.2	0.9	3.1	4.8	3.8	3.5	1.3	3.9	3.4	4.0	2.0	5.2	7.3	1.0	4.3	6.1	2.0	8.5	1.1	6.0	6.6	50.6	30.7	14.5	44.6	37.0	2.1	2.2	38.2	56.2	39.8	19.2	0.0	0.8	1.7	35.7	16.8	5.8	12.0	0.0	24.4	19.6	25.7	45.4	16.3	4.3	57.2	0.0	5.8	4.9	79.5	21.7	4.4	63.0	27.0	31.5	10.8	0.5	63.1	12.7	4.2	1.2	0.6	0.0	31.5	23.0	24.9	17.7	2.1	37.4	14.4	53.7
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"Runt related transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 67.7;monocytes: 20.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 16.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 18.6;Karpas-707: 29.1;RH-30: 24.3;U-698: 25.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	3.7	2.1	4.9	13.7	7.0	15.5	5.7	1.0	7.2	13.5	6.0	5.6	7.4	4.1	3.5	2.3	3.4	2.4	6.8	1.8	7.4	3.5	3.9	1.8	5.3	8.6	6.3	3.4	5.0	1.9	1.3	3.8	3.3	7.2	9.5	7.8	5.4	19.8	14.9	2.2	4.9	10.8	3.4	10.5	6.6	6.0	2.1	7.3	6.5	4.2	4.5	11.7	7.3	8.9	0.1	11.4	5.3	0.6	16.0	10.2	0.7	1.6	0.5	0.3	0.0	1.5	4.0	0.0	1.5	3.6	5.1	7.2	0.0	0.9	0.0	1.8	2.1	2.3	2.0	0.0	1.4	9.4	6.1	0.7	0.0	1.1	0.0	8.0	6.3	0.0	10.8	1.1	4.5	5.1	18.6	0.0	2.5	0.0	29.1	9.1	0.4	0.2	11.0	0.3	1.4	0.2	0.0	24.3	0.0	5.0	3.2	0.0	0.0	1.1	0.0	1.8	4.5	1.7	0.5	0.2	5.2	4.2	8.0	5.5	9.2	0.0	25.4	5.9	2.4	2.3	5.3	0.6	3.2	1.2	0.1	10.2	0.1	2.8	3.2	1.8	0.1	0.5	1.5	4.8	16.0	0.1	11.4	2.3	0.7	4.9	7.0	1.0	7.2	7.4	3.5	6.3	3.4	7.2	7.3	0.0	2.4	3.7	14.8	2.5	0.0	1.7	0.0	4.0	4.5	3.5	0.0	0.0	0.0	0.6	67.7	0.3	0.0	0.0	0.2	0.0	2.7	15.7	2.3	0.5	3.8	0.0	0.0	1.8	4.5	13.2	1.1	7.9	6.8	20.8	0.7	0.0	0.4	0.0	2.1	2.2	0.0	6.5	2.5	0.9	0.4	1.4	0.1	17.3	0.0	18.2
RUSC1	NESCA	ENSG00000160753	"RUN and SH3 domain containing 1"	Q9BVN2	1	155320896-155331114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028510, HPA029922, HPA029923"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA028510: AB_10599847, HPA029922: AB_10611390, HPA029923: AB_10602288"	"unprognostic (1.98e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.52e-1)"	"prognostic unfavorable (7.78e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.29e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (9.24e-6)"	"unprognostic (7.59e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.40e-1)"	10.9	15.9	24.8	8.7	24.1	8.9	12.2	46.1	45.4	16.6	20.2	5.6	9.2	17.5	13.0	7.4	21.8	12.4	13.6	12.2	18.5	22.3	12.9	4.9	11.0	7.4	14.4	26.4	13.3	12.5	11.5	21.5	14.7	26.1	16.3	19.0	8.7	18.1	18.1	8.7	22.7	19.5	15.3	8.9	7.6	14.2	3.1	6.2	12.6	8.4	11.4	8.8	12.1	16.1	3.4	7.5	5.1	18.9	2.6	6.4	4.2	22.7	14.4	8.3	12.2	10.3	11.3	16.1	10.9	7.0	14.4	16.2	16.5	15.1	4.5	8.3	11.0	8.2	31.8	12.8	15.8	6.2	6.1	16.4	6.4	14.3	8.6	8.5	6.4	11.2	11.5	10.0	14.4	5.0	7.0	14.8	9.9	9.7	3.1	12.4	43.4	8.0	8.2	16.3	42.0	23.0	10.9	5.8	7.9	13.5	17.4	8.6	14.0	9.2	25.9	5.5	14.1	38.6	11.0	6.7	18.6	15.4	17.4	21.5	2.5	5.6	2.7	13.0	8.6	5.0	5.1	6.8	3.2	5.8	8.1	6.4	3.4	4.7	5.8	7.5	1.5	2.6	5.5	0.9	2.6	18.9	7.1	4.7	4.2	24.8	24.1	46.1	45.4	18.5	22.3	14.4	26.4	26.1	6.2	8.9	10.1	10.9	16.6	24.8	14.6	9.0	10.2	6.7	18.2	17.4	5.9	25.0	19.9	19.9	0.3	23.5	60.7	0.0	15.6	61.6	23.7	24.2	8.1	6.4	18.6	35.0	15.0	12.9	10.4	0.0	17.0	11.5	18.6	10.0	42.2	12.8	20.4	37.4	17.0	22.0	6.6	19.4	21.7	1.8	7.2	30.6	31.8	13.8	33.3	22.1
S100A3	S100E	ENSG00000188015	"S100 calcium binding protein A3"	P33764	1	153547329-153549372	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 44.7"	"Cell type enhanced"	"Detected in many"	8	"Ductal cells: 19.6;Exocrine glandular cells: 21.7;Pancreatic endocrine cells: 15.4;Smooth muscle cells: 12.7"	"Cancer enhanced"	"Detected in all"		"urothelial cancer: 26.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"intermediate monocyte: 3.6;non-classical monocyte: 6.9;plasmacytoid DC: 8.9"	"Group enriched"	"Detected in many"	10	"dendritic cells: 8.9;monocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"A549: 33.9;HBEC3-KT: 18.1;HeLa: 22.1;U-2197: 19.8"					"Low region specificity"	"Detected in some"			"HPA042674, HPA056140"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		390000	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA042674: AB_10796581, HPA056140: AB_2683050"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.34e-3)"	"unprognostic (3.97e-3)"	"prognostic unfavorable (1.61e-6)"	"unprognostic (8.13e-2)"	"unprognostic (3.46e-1)"	"unprognostic (6.21e-2)"	"unprognostic (8.10e-2)"	4.7	0.6	0.6	3.3	3.1	1.5	2.2	0.6	1.7	3.7	1.2	1.3	0.1	0.4	2.4	1.6	7.4	1.6	1.6	7.9	0.5	0.7	10.2	0.1	14.2	4.6	1.7	0.1	1.2	5.3	0.0	0.3	5.6	3.5	3.6	1.0	0.3	2.0	1.6	2.5	44.7	1.0	1.8	1.5	2.1	0.7	1.4	0.4	0.5	1.7	2.1	4.9	3.7	4.0	0.7	8.9	0.0	6.9	0.0	0.3	0.4	2.9	33.9	0.0	0.0	3.3	2.1	0.0	2.3	12.4	2.9	4.9	1.0	1.1	0.0	7.6	5.9	4.3	9.0	0.0	18.1	1.6	0.1	0.0	0.1	22.1	6.1	0.8	0.0	0.1	1.6	9.3	7.2	8.2	1.8	0.6	0.0	0.0	0.0	16.0	0.2	0.0	0.0	0.2	0.0	4.1	0.0	2.4	1.8	9.9	7.3	0.5	0.0	2.1	2.5	0.7	10.1	0.1	0.2	3.0	1.2	1.9	19.8	2.5	0.6	0.6	0.0	15.9	0.2	7.5	0.0	0.2	0.0	0.0	3.6	0.3	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.9	8.9	0.1	0.4	0.6	3.1	0.6	1.7	0.5	0.7	1.7	0.1	3.5	0.4	3.0	0.3	0.0	1.2	9.2	0.0	0.1	2.5	0.0	4.5	0.0	0.0	0.2	1.7	19.6	0.0	7.0	0.0	0.0	21.7	1.6	8.1	0.6	0.0	0.0	0.3	0.0	0.0	3.7	0.0	0.0	3.7	0.9	1.7	6.4	0.0	0.0	15.4	0.0	0.4	0.0	0.0	0.0	12.7	0.0	0.0	5.6	1.3	0.0	0.0	1.7
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 419.2"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 1794.8;Kupffer cells: 3413.1;Macrophages: 4385.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 115.2;ASC diff: 149.4;BJ hTERT+: 287.5;fHDF/TERT166: 205.6;RPMI-8226: 108.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		13000000	"Plasma membrane"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	125.9	10.1	2.6	29.2	8.3	75.2	171.6	2.2	4.6	52.1	33.9	2.7	25.8	7.3	26.8	52.2	58.6	27.9	34.7	59.9	3.0	1.7	27.8	6.1	80.7	53.2	10.8	3.1	12.7	6.7	0.0	3.0	46.9	6.6	49.5	28.0	19.3	29.8	13.4	25.4	44.5	25.5	38.5	8.9	55.9	17.2	18.2	6.2	8.5	23.7	57.5	26.4	34.9	58.2	18.6	213.1	281.6	293.3	17.3	162.7	419.2	0.5	115.2	0.5	3.3	149.4	103.1	0.1	73.0	287.5	1.4	6.5	0.8	8.1	0.0	13.3	205.6	0.1	2.9	0.4	1.0	1.1	16.4	0.0	49.2	25.6	2.5	0.2	4.3	83.3	16.0	1.1	2.8	0.6	0.2	0.1	0.0	0.4	0.1	104.7	0.4	0.1	51.0	0.3	8.4	44.2	2.6	0.1	108.6	4.5	3.1	4.4	0.5	1.3	55.6	0.4	18.7	3.3	61.7	0.1	0.3	0.6	98.1	0.4	3.6	24.5	0.5	0.2	54.8	5.6	49.5	293.3	30.8	141.2	201.4	147.2	18.6	127.2	112.3	213.1	6.2	22.4	66.5	281.6	17.3	253.9	37.4	162.7	419.2	2.6	8.3	2.2	4.6	3.0	1.7	10.8	3.1	6.6	6.2	455.6	554.5	203.3	20.0	686.7	0.6	8.4	30.6	108.4	174.0	847.9	0.0	45.2	94.5	21.8	4.3	34.1	4.4	116.8	21.4	168.0	716.5	10.9	1330.4	13.0	1794.8	42.9	4.6	120.3	3413.1	10.7	218.3	4385.9	1132.0	911.7	7.1	3.9	22.9	14.4	43.2	14.3	2.7	148.8	785.1	1.6	3.6	606.6	44.6	1190.0	8.0	60.2
S100A6	"2A9, CABP, CACY, PRA"	ENSG00000197956	"S100 calcium binding protein A6"	P06703	1	153534599-153536244	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Pancreatic endocrine cells: 22500.8;Urothelial cells: 12910.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 325.2;RPTEC TERT1: 363.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002601, HPA007575, CAB040549, CAB047354"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA		5100000	"Plasma membrane, Cytosol"		"CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859"	"unprognostic (8.80e-3)"	"unprognostic (6.96e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.51e-1)"	"unprognostic (6.86e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.46e-2)"	"prognostic favorable (7.56e-4)"	126.4	32.6	14.8	104.9	29.9	73.8	223.6	13.3	14.6	95.4	176.8	10.1	51.2	70.2	65.0	135.5	126.5	42.2	264.5	112.3	13.0	22.5	103.4	6.0	151.9	61.5	45.6	7.9	38.1	13.5	0.5	17.7	100.1	27.3	85.1	85.5	28.5	58.7	55.2	59.1	45.1	98.1	88.9	35.5	27.5	69.9	29.6	17.8	4.9	76.9	183.0	36.2	150.9	145.0	30.7	130.1	303.7	180.7	9.1	69.2	201.7	75.2	84.2	0.0	6.9	141.8	184.0	0.2	92.3	230.5	46.8	61.5	5.8	157.5	0.1	29.3	137.0	43.4	32.7	1.5	132.6	22.1	31.0	0.0	15.8	56.4	5.1	53.7	0.7	10.8	85.8	110.2	50.1	86.8	64.3	103.8	0.0	0.0	0.1	116.7	11.3	0.2	6.4	0.1	325.2	138.6	0.0	10.4	27.2	363.5	69.9	21.7	3.8	125.5	127.9	94.9	0.0	17.6	24.4	151.6	45.2	11.8	92.4	149.8	0.2	0.2	0.2	175.8	16.8	96.6	139.8	180.7	74.1	62.0	96.8	67.3	30.7	58.5	60.3	130.1	17.2	37.3	49.5	303.7	9.1	86.9	68.3	69.2	201.7	14.8	29.9	13.3	14.6	13.0	22.5	45.6	7.9	27.3	17.8	4374.3	2209.1	330.5	4451.5	1322.1	4.2	292.3	1518.5	3121.1	4082.2	7746.6	0.0	1050.2	6310.0	5079.5	17.9	1309.7	5409.4	186.9	8886.8	1881.7	3759.3	5823.6	1721.8	17.4	2462.8	55.6	1958.6	890.1	3762.1	37.4	2790.2	5314.3	2911.9	5195.8	5391.4	88.0	22500.8	7016.5	1075.2	111.0	7.4	129.4	3153.8	7.1	13.9	872.0	1315.7	897.0	2304.5	12910.1
SAE1	"AOS1, FLJ3091, Sua1"	ENSG00000142230	"SUMO1 activating enzyme subunit 1"	Q9UBE0	19	47113274-47210636	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041906, HPA043552"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041906: AB_2677735, HPA043552: AB_2678548"	"unprognostic (9.69e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (5.49e-8)"	"unprognostic (9.86e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (2.76e-4)"	"unprognostic (1.27e-1)"	20.1	17.8	26.7	22.8	30.5	24.0	18.6	21.9	45.9	23.6	50.1	17.6	21.6	14.0	30.2	13.1	27.5	21.3	17.1	22.5	21.2	23.9	14.6	16.0	19.2	30.6	20.4	34.6	19.0	14.4	28.0	13.9	26.8	24.3	20.2	27.3	20.9	15.7	28.6	24.1	19.0	20.1	38.5	15.9	25.8	30.5	60.2	16.2	32.7	37.5	17.2	37.5	33.0	25.8	19.1	22.3	22.8	19.0	35.2	41.3	29.4	36.2	39.8	62.5	29.8	21.5	25.3	21.2	44.9	39.2	50.7	62.0	34.2	24.2	43.7	17.7	36.0	26.9	17.3	64.0	28.3	55.2	36.6	46.5	42.5	26.9	39.0	23.7	47.0	26.5	18.8	14.6	27.7	29.9	20.0	48.5	31.5	50.5	22.1	47.8	29.1	30.8	129.8	31.2	39.3	21.3	48.5	41.9	17.9	22.7	43.0	24.7	27.2	46.0	31.7	27.1	35.8	25.9	28.7	25.2	26.7	30.7	17.5	48.2	27.6	80.2	62.1	18.8	39.1	39.0	22.8	19.0	10.4	23.0	16.9	24.8	19.1	29.0	23.2	22.3	15.7	41.3	31.3	7.9	35.2	11.3	15.0	33.5	29.4	26.7	30.5	21.9	45.9	21.2	23.9	20.4	34.6	24.3	16.2	8.9	16.0	34.0	28.7	22.8	17.8	18.6	7.6	4.0	10.3	12.2	5.9	57.7	10.0	35.8	11.1	31.4	10.5	23.3	30.4	80.2	33.8	28.6	15.0	17.4	48.9	19.1	18.5	20.3	19.0	12.8	14.4	20.0	43.9	71.3	22.5	18.0	30.8	14.4	17.7	11.5	15.0	51.8	35.6	95.2	109.0	21.5	48.1	33.2	28.3	25.8
SAFB	"HET, SAFB1"	ENSG00000160633	"Scaffold attachment factor B"	Q15424	19	5623035-5668478	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001969, HPA016832, HPA020076"	Supported		Enhanced	Nucleoplasm,Midbody		NA	NA			Nucleoplasm	Midbody	"CAB001969: , HPA016832: AB_1850622, HPA020076: AB_1850624"	"unprognostic (2.41e-2)"	"unprognostic (8.18e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.81e-3)"	"unprognostic (6.50e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.62e-3)"	"unprognostic (9.31e-2)"	"unprognostic (5.76e-2)"	"unprognostic (4.85e-2)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.25e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (1.70e-4)"	28.7	27.6	26.4	34.8	32.5	50.7	26.2	50.8	36.0	28.9	29.7	34.3	18.6	31.0	32.1	17.3	26.6	25.8	22.6	26.9	28.2	25.8	23.8	29.0	27.1	38.0	31.5	26.2	35.0	29.2	31.2	35.0	35.5	28.1	27.5	20.5	21.4	31.1	28.8	53.6	35.5	31.0	27.8	31.4	39.1	28.4	30.3	32.1	61.4	26.3	19.5	31.3	30.7	45.6	32.8	31.6	48.4	42.3	31.2	37.5	30.5	27.5	24.4	29.8	19.1	13.2	11.9	34.1	20.7	13.5	17.7	15.0	36.6	15.9	44.8	16.5	10.3	14.9	26.0	28.6	17.0	18.7	30.2	28.0	32.9	22.5	34.2	12.5	40.4	29.1	10.6	15.8	15.8	16.9	12.7	14.0	19.7	45.6	23.0	13.5	24.5	42.5	32.0	39.6	19.0	24.4	42.8	32.6	31.0	13.8	23.2	27.4	23.6	23.3	18.8	21.2	17.9	17.4	21.9	21.5	18.1	22.3	22.1	31.8	37.4	31.9	41.0	17.4	33.6	23.9	35.0	28.4	48.4	36.2	28.4	36.7	32.8	36.0	35.2	31.6	32.2	37.5	36.0	30.6	31.2	42.3	26.6	34.5	30.5	26.4	32.5	50.8	36.0	28.2	25.8	31.5	26.2	28.1	32.1	29.8	16.0	30.4	40.5	58.3	38.8	35.0	10.2	85.6	50.0	15.7	33.4	43.6	21.6	36.0	5.2	35.2	30.0	0.0	30.2	47.2	40.1	31.6	48.6	24.5	32.8	47.7	28.6	23.4	21.9	4.5	33.1	39.9	28.7	50.5	36.7	29.9	28.1	28.8	24.4	22.4	44.2	19.4	47.0	78.8	82.8	57.1	52.3	44.7	34.5	34.2
SAGE1	"CT14, SAGE"	ENSG00000181433	"Sarcoma antigen 1"	Q9NXZ1	X	135889205-135913061	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	13	"testis: 10.9"	"Cell type enriched"	"Detected in single"	26	"Spermatogonia: 8.6"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 15.1;K-562: 10.9;Karpas-707: 18.8;U-2 OS: 5.3;U-266/70: 6.6;U-266/84: 16.4"									"HPA003033, HPA003208"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA003033: AB_1079865, HPA003208: AB_1079863"				"unprognostic (1.11e-1)"	"unprognostic (5.26e-2)"			"unprognostic (1.15e-1)"		"unprognostic (1.02e-2)"	"unprognostic (2.37e-1)"		"unprognostic (7.12e-4)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3		0.0	0.0	0.0	0.4	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	10.9			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	6.6	16.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0
SALL4	"dJ1112F19.1, ZNF797"	ENSG00000101115	"Spalt like transcription factor 4"	Q9UJQ4	20	51782331-51802520	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 8.8;testis: 11.7;thyroid gland: 8.6"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 25.4"	"Cancer enriched"	"Detected in many"	11	"testis cancer: 22.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	9	"NK-cell: 6.3"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 13.1;AN3-CA: 9.1;BEWO: 17.5;NTERA-2: 31.5;SiHa: 8.0;SuSa: 22.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015291, HPA015791"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015291: AB_1856548, HPA015791: AB_1856547"	"unprognostic (1.30e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-3)"	"unprognostic (3.55e-2)"	"unprognostic (7.43e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.42e-8)"	"unprognostic (5.90e-3)"	"unprognostic (1.82e-1)"	"unprognostic (5.00e-5)"	"unprognostic (7.41e-2)"	0.3	0.4	0.3	0.3	0.9	1.2	0.3	0.8	0.9	0.4	0.7	0.3	2.2	0.1	0.3	0.8	0.3	0.2	0.3	0.3	0.3	0.1	0.5	1.9	0.3	0.3	0.3	0.3	0.3	4.6	8.8	0.6	0.3	0.9	3.1	0.2	4.5	2.2	0.4	0.3	0.3	0.7	0.3	0.3	0.8	0.3	11.7	0.3	0.3	8.6	0.3	0.3	0.9	0.3	0.1	0.1	0.6	0.1	6.3	0.2	0.0	0.0	0.8	13.1	9.1	0.0	0.0	17.5	0.0	0.1	0.0	0.1	4.5	0.1	0.0	0.1	0.1	0.1	2.2	0.1	0.0	0.1	0.2	0.0	0.0	3.0	0.2	0.1	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	31.5	0.1	0.2	1.2	0.0	0.0	0.0	0.2	3.0	1.6	8.0	0.0	0.7	22.0	0.0	0.5	0.0	0.5	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.6	6.3	0.1	0.1	0.0	0.0	0.3	0.9	0.8	0.9	0.3	0.1	0.3	0.3	0.9	0.3	0.0	1.3	0.0	0.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.2	0.0	0.4	1.1	0.0	0.0	0.2	25.4	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	1.0
SAMD4B	"FLJ10211, hSmaug2, MGC99832, SMGB"	ENSG00000179134	"Sterile alpha motif domain containing 4B"	Q5PRF9	19	39342396-39385710	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 157.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016800, HPA059385"	Approved		Enhanced	Cytosol		No	No			Cytosol		"HPA016800: AB_1856552, HPA059385: AB_2684000"	"unprognostic (2.56e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-2)"	"prognostic unfavorable (2.17e-6)"	"unprognostic (3.41e-2)"	"unprognostic (8.66e-2)"	"unprognostic (6.24e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.91e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.89e-2)"	24.9	24.6	34.8	19.5	43.9	15.0	19.5	24.9	34.3	26.3	19.5	40.0	18.8	15.9	24.5	15.2	32.7	27.9	22.5	18.8	29.2	19.5	16.5	14.1	20.4	11.8	37.3	24.0	35.2	22.5	37.5	23.5	21.9	32.6	21.1	13.7	20.9	19.9	30.4	18.1	25.1	18.4	23.7	28.7	19.0	18.9	23.0	37.7	13.6	21.2	12.3	15.2	21.8	24.2	3.0	2.5	6.8	2.8	2.1	3.7	1.2	31.6	43.5	22.3	16.9	21.8	26.3	18.4	18.3	20.2	14.7	12.3	38.0	17.8	10.6	24.0	29.2	19.1	15.4	21.9	16.8	10.1	21.2	35.8	10.6	17.9	15.8	22.5	11.4	11.2	25.8	19.9	24.1	18.0	18.1	13.8	14.4	31.2	11.6	17.9	21.7	12.3	5.6	17.6	20.8	17.7	15.0	14.3	9.2	12.3	25.8	22.9	22.3	24.1	16.6	13.1	17.7	13.4	12.4	18.1	24.1	17.6	52.1	32.0	21.8	19.6	11.8	32.1	9.0	23.5	2.9	2.8	3.9	3.0	1.1	2.2	3.0	2.2	2.4	2.0	2.0	3.7	2.6	6.8	2.1	0.9	2.5	0.9	1.2	34.8	43.9	24.9	34.3	29.2	19.5	37.3	24.0	32.6	37.7	11.9	34.9	22.6	53.6	29.7	54.1	6.3	22.9	22.7	12.5	34.9	157.1	21.2	5.0	24.8	5.4	24.0	21.3	0.0	23.6	18.1	28.6	59.6	17.4	24.5	17.8	49.3	49.0	43.6	19.3	1.8	40.6	19.2	18.6	9.0	26.3	29.5	31.1	17.3	31.1	9.9	67.9	64.7	25.5	62.7	26.6	38.0	45.7	19.2	21.8	58.6
SAP30BP	"HCNGP, HTRG, HTRP"	ENSG00000161526	"SAP30 binding protein"	Q9UHR5	17	75667116-75708062	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042382, HPA052943"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042382: AB_10793881, HPA052943: AB_2681995"	"unprognostic (6.92e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.95e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (4.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.31e-3)"	"prognostic unfavorable (1.98e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.88e-1)"	"unprognostic (6.06e-2)"	"unprognostic (6.58e-2)"	19.2	18.4	28.7	21.7	27.6	28.6	22.1	25.2	31.2	25.3	22.6	39.0	15.4	17.2	25.7	26.5	22.0	22.8	22.0	22.3	29.5	24.9	19.3	23.1	19.6	24.3	29.6	23.9	23.9	21.0	29.2	21.1	25.4	24.7	22.3	22.4	22.6	31.8	26.6	31.2	19.3	19.2	24.5	31.7	24.3	20.1	21.6	25.0	26.1	20.4	15.6	31.0	25.4	21.0	21.3	29.9	21.6	21.4	22.6	25.8	20.1	13.0	15.7	13.2	12.3	13.1	13.8	14.6	13.9	15.4	26.1	27.3	14.4	11.0	14.2	7.5	13.3	24.1	10.2	15.7	15.6	26.9	5.0	17.9	11.1	11.4	15.4	12.9	11.7	9.8	12.9	14.3	20.0	21.3	14.8	36.0	15.1	13.2	11.3	20.6	13.7	19.0	9.8	10.9	19.1	18.6	12.4	19.7	10.7	22.1	11.2	8.9	15.2	12.8	12.7	14.5	21.0	20.4	10.0	13.4	22.8	14.0	10.0	18.4	8.2	3.2	16.8	15.4	8.7	18.2	13.6	21.4	21.2	23.7	17.5	25.8	20.9	21.9	24.2	18.1	21.3	21.7	22.5	21.6	22.6	20.0	29.9	23.0	20.1	28.7	27.6	25.2	31.2	29.5	24.9	29.6	23.9	24.7	25.0	50.6	60.8	45.5	99.7	44.0	18.7	43.6	22.9	76.3	79.6	21.0	11.8	51.1	58.0	63.1	43.1	62.4	47.7	23.3	63.6	54.6	56.3	38.2	74.1	31.8	50.3	9.5	34.4	45.4	38.7	69.2	41.1	51.7	54.0	68.5	33.6	59.7	77.0	45.6	32.5	35.4	14.4	64.7	61.4	29.6	29.0	39.6	80.3	65.0	24.9	96.7
SARS	SERS	ENSG00000031698	"Seryl-tRNA synthetase"	P49591	1	109213918-109238169	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Aminoacyl-tRNA synthetase, DNA-binding, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016939, HPA064668"	Uncertain		Enhanced	Cytosol		NA	NA		100000	Cytosol		"HPA016939: AB_1856585, HPA064668: AB_2685316"	"unprognostic (4.92e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.87e-2)"	"unprognostic (6.78e-2)"	"prognostic favorable (9.47e-4)"	"prognostic unfavorable (5.75e-4)"	"prognostic unfavorable (6.13e-5)"	"unprognostic (3.02e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.23e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.85e-2)"	"unprognostic (3.45e-3)"	35.8	42.6	46.1	28.2	45.9	16.3	38.3	42.6	60.6	40.1	37.6	31.2	30.9	33.5	39.4	36.0	42.0	39.6	28.7	43.9	55.9	47.3	37.6	58.6	44.5	28.8	46.4	56.0	44.4	68.7	55.3	40.1	44.9	64.1	34.3	41.0	22.0	54.2	42.3	72.3	46.1	31.1	42.9	41.0	29.4	46.0	20.9	35.0	25.3	75.0	32.9	38.7	41.8	60.4	54.3	45.9	48.6	48.3	41.0	66.1	88.9	33.3	13.1	25.2	37.9	37.9	34.4	43.4	35.1	36.4	30.5	38.1	25.3	10.3	36.0	18.2	49.4	17.0	18.3	39.2	49.6	35.5	25.4	23.9	13.9	16.2	18.3	76.2	17.5	15.7	42.3	86.8	35.9	78.3	26.0	36.3	45.5	31.8	45.1	29.6	31.9	19.4	8.9	10.5	20.0	31.0	16.1	32.2	16.1	23.2	17.7	35.0	18.6	16.8	27.1	95.1	20.0	15.3	20.9	28.6	18.2	22.9	25.8	24.5	34.4	13.9	29.5	57.4	19.3	61.8	35.6	44.5	48.6	56.0	48.2	58.4	54.3	59.3	55.4	45.9	52.5	61.8	57.7	21.3	41.0	48.3	29.6	66.1	88.9	46.1	45.9	42.6	60.6	55.9	47.3	46.4	56.0	64.1	35.0	47.6	92.0	61.1	90.9	109.9	51.2	87.9	81.5	66.9	81.9	68.0	21.6	157.2	112.7	120.1	15.1	64.7	75.8	70.0	195.0	122.6	80.4	56.7	96.0	112.9	78.0	55.6	66.7	63.8	59.4	21.0	73.1	68.8	60.8	110.0	61.3	56.1	142.9	49.1	65.4	85.4	34.4	129.4	118.7	46.1	22.4	95.2	157.6	64.0	84.6	77.6
SART1	"Ara1, HAF, SNRNP110, Snu66"	ENSG00000175467	"SART1, U4/U6.U5 tri-snRNP-associated protein 1"	O43290	11	65961689-65979828	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Allergen, Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031188, HPA031189, HPA031190"	Supported		Enhanced	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA031188: AB_10600092, HPA031189: AB_10601854, HPA031190: AB_10602289"	"unprognostic (2.93e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.52e-3)"	"unprognostic (8.15e-2)"	"unprognostic (8.97e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	22.3	17.5	26.4	25.0	27.8	50.7	21.7	28.5	27.2	21.4	19.6	17.7	20.9	22.7	26.3	17.4	19.0	20.3	20.7	19.5	23.8	16.8	15.8	18.2	19.0	26.2	23.0	25.7	26.8	28.4	22.5	19.2	22.4	25.2	18.1	12.0	15.9	27.1	27.2	34.6	26.2	19.9	27.9	29.2	29.2	20.3	20.4	25.6	24.0	20.5	19.1	19.0	20.6	41.3	5.9	5.8	12.1	5.3	4.1	8.1	2.7	22.2	27.0	12.4	16.6	12.2	9.7	19.0	17.4	12.3	20.1	13.2	19.5	15.6	25.4	20.0	15.0	24.3	22.0	15.6	15.9	10.2	20.4	15.4	29.4	19.2	18.0	18.3	25.3	24.7	12.2	12.1	18.6	16.7	8.0	12.4	19.1	18.5	18.1	11.5	40.3	32.6	36.5	21.1	12.0	25.9	35.8	18.0	26.7	8.3	14.9	14.0	19.9	16.4	16.9	20.1	6.0	18.9	20.7	18.5	25.2	24.9	24.7	24.2	27.7	21.6	22.3	20.9	12.9	21.2	2.0	4.5	12.1	7.1	5.3	6.0	5.9	8.0	7.4	5.8	5.4	5.9	6.6	6.3	4.1	3.1	4.9	8.1	2.7	26.4	27.8	28.5	27.2	23.8	16.8	23.0	25.7	25.2	25.6	6.0	7.8	27.2	18.9	20.1	17.6	7.5	17.8	10.7	9.1	15.7	9.8	28.9	5.0	19.2	6.3	17.4	27.1	23.3	25.3	26.5	18.4	15.6	32.3	13.0	26.1	15.9	12.0	15.4	22.1	5.9	34.2	27.3	16.9	38.7	18.6	20.4	22.2	20.1	31.1	13.4	20.5	32.3	25.8	24.4	26.6	19.1	37.9	24.6	20.2	15.3
SCAF11	"CASP11, SFRS2IP, SIP1, SRRP129, SRSF2IP"	ENSG00000139218	"SR-related CTD associated factor 11"	Q99590	12	45919131-45992120	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038862, HPA045456, HPA046345"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA038862: AB_10672830, HPA045456: AB_2679331, HPA046345: AB_2679630"	"unprognostic (2.83e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.67e-3)"	"unprognostic (9.00e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.15e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.30e-2)"	"unprognostic (4.13e-2)"	34.4	17.0	17.5	34.1	19.5	46.1	25.8	19.1	17.9	29.0	24.5	12.4	29.0	17.0	25.1	25.9	25.8	21.0	21.1	33.6	15.8	16.6	27.9	32.2	27.8	29.9	19.2	12.5	31.7	21.3	32.7	26.8	23.0	20.6	26.5	21.4	15.3	24.3	31.0	35.4	24.1	30.7	25.5	21.7	38.1	17.4	22.7	20.6	42.3	27.8	21.9	28.6	29.1	33.9	18.4	19.2	32.8	13.6	12.9	15.3	7.9	15.1	13.8	17.1	14.2	11.8	16.2	15.9	17.9	14.6	15.5	11.3	49.4	16.7	31.8	20.2	19.0	9.2	15.0	17.5	14.4	17.7	17.4	11.8	29.6	18.3	12.9	9.3	31.0	20.0	13.4	15.5	13.3	20.2	17.9	15.9	13.9	22.6	17.5	19.5	14.3	23.2	17.3	13.3	0.2	18.8	18.9	23.0	16.0	14.7	19.4	9.9	10.1	19.8	17.0	9.6	14.2	15.8	33.6	19.7	16.0	13.2	12.0	9.5	12.7	9.4	52.0	13.5	66.8	6.1	20.9	13.0	17.3	14.7	12.5	13.3	17.7	13.9	14.1	9.8	18.4	15.3	13.7	32.8	12.9	13.6	19.2	12.4	7.9	17.5	19.5	19.1	17.9	15.8	16.6	19.2	12.5	20.6	20.6	163.8	142.7	110.7	106.1	114.1	130.0	160.2	84.1	199.4	167.2	75.0	119.8	73.3	46.4	103.3	42.7	114.7	93.2	23.3	93.9	58.9	105.3	100.7	213.0	117.3	96.4	101.7	99.3	118.4	141.0	26.6	112.8	152.3	64.1	130.8	108.9	103.7	84.4	88.0	97.6	67.1	187.2	122.9	106.1	130.4	56.4	105.3	51.0	110.7	86.0	129.0
SCAF4	"DKFZp434E098, KIAA1172, SFRS15, SRA4"	ENSG00000156304	"SR-related CTD associated factor 4"	O95104	21	31671033-31732075	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018319, HPA018668, HPA021504, HPA028807"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018319: AB_1856784, HPA018668: AB_1856783, HPA021504: AB_1856785, HPA028807: AB_10602927"	"unprognostic (9.18e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.28e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.65e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.16e-3)"	18.8	14.9	15.1	32.7	16.3	19.0	18.4	24.0	21.4	19.9	23.2	20.3	12.9	19.4	21.6	17.6	22.3	16.8	22.3	15.4	13.2	11.5	14.0	22.5	19.0	27.1	15.3	11.9	23.9	18.5	23.7	18.1	20.3	14.3	17.6	16.8	17.1	18.4	19.3	23.3	24.2	21.9	16.1	13.3	23.7	17.9	25.6	14.6	44.2	16.5	12.8	26.4	18.9	20.4	14.1	12.0	12.7	13.2	9.6	12.8	8.4	14.0	9.4	18.9	13.7	10.2	7.9	12.9	10.5	11.1	11.1	10.4	17.9	10.2	28.9	6.4	10.2	12.2	8.8	20.5	10.2	12.3	12.9	12.2	23.0	7.3	14.9	11.8	24.5	9.7	8.7	11.6	14.9	12.8	7.1	9.7	11.6	30.4	15.1	9.2	18.9	26.0	17.9	24.3	13.8	8.1	25.8	21.1	9.5	7.7	11.1	13.0	14.1	16.1	12.5	9.1	10.9	9.6	16.5	11.2	11.6	11.2	11.1	10.6	9.8	9.0	33.4	8.3	19.8	10.8	8.2	9.4	12.7	12.8	13.2	12.8	14.1	7.5	12.1	12.0	14.0	8.8	9.5	5.0	9.6	11.4	8.4	6.6	8.4	15.1	16.3	24.0	21.4	13.2	11.5	15.3	11.9	14.3	14.6	6.0	9.7	35.8	31.3	41.4	22.2	7.9	15.3	20.1	12.5	10.4	23.6	14.1	3.3	14.7	7.8	15.8	31.5	23.3	12.1	13.5	20.6	25.6	11.5	19.8	13.5	20.6	19.0	18.4	19.1	2.0	20.4	14.9	32.1	16.2	16.7	15.3	14.7	18.4	13.4	5.0	22.8	12.9	17.5	20.9	22.2	35.9	15.8	20.0	19.6	28.7
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733325-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	27.9	19.1	17.4	32.0	19.1	36.1	27.5	28.1	22.2	30.0	23.4	18.2	20.8	14.2	28.3	21.6	18.5	25.1	21.9	19.3	16.9	13.4	19.8	17.6	19.6	23.5	16.2	15.1	32.6	20.0	33.6	24.1	23.8	14.8	24.4	20.7	17.9	21.9	30.1	28.5	26.9	21.2	23.8	14.3	21.7	19.9	25.4	20.2	42.6	24.7	20.1	22.8	26.1	32.9	5.4	3.3	3.8	6.7	6.1	7.5	2.6	8.5	8.4	24.9	15.0	16.8	17.3	15.3	14.1	19.9	18.7	19.0	13.1	8.7	26.9	11.5	16.2	16.6	11.7	21.9	18.6	25.1	11.7	11.0	24.1	9.1	16.0	19.5	22.2	16.2	18.6	19.8	16.3	25.6	14.5	15.8	11.9	27.9	16.4	17.1	15.6	23.7	15.1	17.3	13.2	6.3	22.8	13.6	14.5	15.8	15.8	15.4	18.0	14.7	19.4	10.7	18.7	12.7	25.9	14.4	10.7	13.0	13.8	14.2	15.4	11.3	29.8	13.3	13.9	16.5	1.2	2.8	3.5	6.0	3.9	5.8	4.8	6.2	5.9	3.3	5.4	6.3	5.6	3.8	6.1	6.7	3.2	7.5	2.6	17.4	19.1	28.1	22.2	16.9	13.4	16.2	15.1	14.8	20.2	23.8	18.6	14.1	10.3	11.2	17.7	31.1	7.6	13.4	9.1	12.2	23.6	9.2	1.7	9.3	2.7	13.5	12.2	0.0	10.2	7.4	13.5	10.4	33.5	10.4	11.2	12.7	12.5	19.6	25.1	4.2	15.3	11.4	10.1	6.4	13.9	14.8	11.9	8.6	11.7	5.3	18.6	25.8	8.2	21.4	22.4	9.4	8.9	10.0	13.6	12.8
SCD	"FADS5, SCDOS"	ENSG00000099194	"Stearoyl-CoA desaturase"	O00767	10	100347124-100364834	"Enzymes, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adipose tissue: 245.0;brain: 130.0;breast: 94.0;heart muscle: 109.2;liver: 130.8"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 300.1;Hepatocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 204.0;CAPAN-2: 141.3"					"Low region specificity"	"Detected in all"			"HPA012107, HPA063921"	Approved		Enhanced	"Endoplasmic reticulum"		No	Yes			"Endoplasmic reticulum"		"HPA012107: AB_1856610, HPA063921: AB_2685154"	"unprognostic (2.10e-1)"	"unprognostic (2.62e-3)"	"unprognostic (7.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.88e-2)"	"unprognostic (6.53e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (7.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (4.73e-2)"	"prognostic unfavorable (7.79e-5)"	245.0	21.3	59.8	11.4	32.7	5.5	94.0	12.7	83.9	5.3	10.8	63.6	0.1	21.4	3.7	7.0	13.4	1.7	18.3	109.2	61.5	43.4	5.0	130.8	32.2	23.1	65.1	23.6	12.7	6.1	7.7	1.5	5.3	34.5	24.4	10.1	4.5	24.9	3.7	2.4	3.4	6.1	4.6	130.0	4.2	5.9	12.2	35.4	1.4	2.0	6.9	5.4	3.7	5.0	2.0	5.3	0.2	3.3	2.9	5.1	2.1	31.0	28.6	61.1	41.9	204.0	117.7	12.5	3.3	73.7	8.0	42.8	24.6	141.3	13.1	2.6	7.8	36.6	55.6	33.6	119.4	7.0	4.4	13.9	7.3	18.2	49.2	39.4	10.2	8.0	64.0	36.2	31.1	54.8	21.6	15.2	29.1	20.4	40.1	3.2	48.6	11.6	12.2	21.2	9.1	8.2	5.4	22.6	41.1	34.9	34.9	3.8	14.7	6.6	31.2	64.1	18.5	35.0	22.0	6.0	0.8	9.5	0.7	6.8	11.2	6.0	20.2	14.6	32.0	5.1	0.0	1.5	0.0	3.0	3.3	5.1	1.3	1.2	1.6	5.3	2.0	1.0	2.9	0.2	2.9	0.0	3.0	0.0	2.1	59.8	32.7	12.7	27.9	61.5	43.4	65.1	23.6	34.5	35.4	50.6	300.1	34.7	3.9	3.3	4.0	2.9	35.7	9.4	23.9	0.0	5.9	2.0	0.0	12.5	52.9	9.3	13.7	0.0	59.1	53.1	9.3	26.0	5.8	153.5	29.3	25.4	24.8	41.7	97.6	68.6	3.4	8.2	55.6	17.2	15.7	11.8	21.6	2.9	1.4	3.8	4.7	0.0	4.4	0.9	1.1	1.9	14.5	5.2	16.8	3.5
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"		"Actin capping, Actin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 317.6;Early spermatids: 90.6;Enterocytes: 121.7;Paneth cells: 111.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 38.6;SK-BR-3: 41.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"		No	No			"Plasma membrane"		"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.3	0.1	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.1	8.5	0.2	0.2	0.1	0.6	0.1	2.2	1.3	0.1	0.2	0.0	38.6	1.4	1.7	0.0	0.4	41.8	0.0	0.3	4.4	0.3	0.0	0.1	0.3	0.8	0.1	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4	0.0	20.5	0.0	1.3	2.5	0.4	0.8	7.6	22.7	6.8	317.6	0.0	14.0	69.6	0.7	90.6	0.7	121.7	0.0	0.2	3.7	1.3	4.5	38.2	0.0	76.4	0.0	8.7	0.0	0.6	64.0	0.3	3.1	10.1	2.8	36.1	0.5	5.2	111.2	1.1	1.8	2.5	0.0	0.0	3.9	5.4	5.6	55.0	0.0	13.5	7.1
SCLY	SCL	ENSG00000132330	"Selenocysteine lyase"	Q96I15	2	238060889-238099413	"Enzymes, Predicted intracellular proteins"		"Lyase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"Early spermatids: 82.6;Late spermatids: 106.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020190, HPA055760"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA		110000	"Golgi apparatus"		"HPA020190: , HPA055760: AB_2682910"	"unprognostic (7.39e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.29e-2)"	"unprognostic (8.65e-5)"	"unprognostic (8.96e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.14e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.02e-3)"	"unprognostic (3.73e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.98e-1)"	4.1	3.8	6.0	6.3	7.4	5.3	3.6	10.2	7.4	4.3	6.3	11.1	5.7	9.8	8.4	8.3	4.5	4.6	5.4	6.5	7.3	6.8	9.9	24.1	4.0	6.5	9.6	4.7	6.3	22.7	5.2	5.1	2.6	6.6	5.0	4.3	6.4	4.5	5.6	5.1	2.8	9.6	5.1	9.4	5.6	3.9	15.3	6.1	8.9	8.1	6.3	5.3	4.6	4.0	5.0	5.7	6.9	5.6	4.2	8.1	4.3	5.7	9.7	6.2	16.6	5.0	3.4	12.6	5.8	2.9	6.2	7.6	6.4	4.7	9.6	1.7	3.3	19.9	8.4	24.3	12.4	5.9	10.9	21.8	11.1	13.0	22.0	9.4	9.2	9.6	3.8	6.1	11.6	13.3	2.6	11.5	13.3	19.3	2.7	6.3	8.6	9.1	16.9	20.1	8.0	8.1	10.7	12.0	9.5	5.9	2.0	7.1	15.1	6.4	10.3	10.4	4.8	3.2	13.6	4.9	9.4	6.1	12.4	12.4	6.8	6.2	4.8	5.8	18.7	7.4	2.0	5.3	6.9	4.7	4.3	3.7	5.0	5.7	8.1	5.7	3.5	4.3	4.2	0.9	4.2	5.6	1.2	5.3	4.3	6.0	7.4	10.2	7.4	7.3	6.8	9.6	4.7	6.6	6.1	0.0	0.0	3.7	1.9	1.4	5.3	2.4	0.0	1.4	0.0	0.0	7.9	1.1	3.3	4.4	82.6	2.7	2.1	0.0	3.2	1.4	1.9	1.0	0.0	2.4	3.4	6.4	2.4	1.3	0.0	106.4	2.8	2.0	1.7	2.8	2.6	2.3	2.7	5.8	0.0	1.7	6.1	0.0	1.7	6.0	4.8	1.4	0.6	2.2	2.8	1.4
SCRIB	"KIAA0147, SCRB1, Vartul"	ENSG00000180900	"Scribbled planar cell polarity protein"	Q14160	8	143790920-143815379	"Disease related genes, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Inhibition of host innate immune response by virus, Inhibition of host interferon signaling pathway by virus, Inhibition of host STAT1 by virus, Inhibition of host STAT2 by virus, Viral immunoevasion"	"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015463, CAB022081, HPA023557, HPA064312"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions,Rods & Rings"		NA	NA			"Plasma membrane, Cell Junctions"	"Nucleoplasm, Rods & Rings"	"CAB015463: AB_2238926, CAB022081: , HPA023557: AB_2671238, HPA064312: AB_2685242"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.78e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.77e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.16e-3)"	"unprognostic (3.46e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.83e-1)"	13.0	6.1	15.1	10.8	12.2	9.4	15.9	10.1	13.9	15.1	18.4	17.5	9.8	14.8	9.4	5.9	36.6	11.6	11.9	8.0	12.2	7.7	10.2	13.6	11.5	12.9	13.5	12.8	10.9	17.2	11.2	9.6	9.5	11.8	10.9	7.6	7.5	22.9	11.2	36.8	33.3	16.3	11.2	9.7	11.2	17.0	10.1	16.4	14.0	9.1	11.9	9.6	11.6	17.8	0.6	0.5	0.2	0.4	0.2	1.5	0.6	18.6	15.1	6.9	8.8	2.5	3.3	11.7	10.5	3.0	4.9	4.1	6.6	12.2	7.4	12.8	3.1	2.8	19.5	3.7	14.1	0.9	8.2	20.8	10.3	13.0	11.6	5.7	4.3	5.8	2.8	13.7	4.7	4.1	2.2	5.3	8.1	13.0	2.6	3.7	37.2	11.1	9.2	5.2	11.6	19.2	13.4	6.4	8.2	2.5	18.8	15.1	11.1	11.9	13.1	11.1	2.2	16.5	10.3	10.2	5.4	22.4	9.5	14.7	9.3	9.1	7.5	5.5	4.3	8.4	0.1	0.1	0.1	0.6	0.4	1.5	0.6	0.4	1.2	0.5	0.4	0.4	0.4	0.2	0.2	0.1	0.2	0.4	0.6	15.1	12.2	10.1	13.9	12.2	7.7	13.5	12.8	11.8	16.4	0.0	6.9	6.9	4.2	7.6	11.1	10.8	15.3	1.4	1.2	14.0	13.7	8.9	3.3	7.5	1.2	6.0	18.4	23.3	8.1	5.3	5.1	8.0	0.0	7.5	5.5	4.8	13.3	4.3	6.3	0.4	8.3	4.6	8.5	4.6	19.5	11.9	9.9	20.1	9.2	4.3	14.0	12.9	4.2	7.9	9.2	9.4	4.2	5.1	19.5	5.9
SDCCAG8	"BBS16, CCCAP, NPHP10, NY-CO-8, SLSN7"	ENSG00000054282	"Serologically defined colon cancer antigen 8"	Q86SQ7	1	243256034-243500092	"Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Obesity, Senior-Loken syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"WM-115: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025737, HPA044477, HPA072495"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA025737: AB_2671761, HPA044477: AB_2678955, HPA072495: AB_2686527"	"unprognostic (4.12e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (3.95e-2)"	"unprognostic (4.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.68e-3)"	"unprognostic (4.69e-2)"	13.5	12.6	17.2	10.0	17.7	7.9	13.0	12.3	17.6	11.4	10.5	22.5	10.4	7.5	13.3	17.7	11.6	17.9	17.6	12.8	16.8	13.5	15.2	7.9	14.8	10.4	17.4	12.0	19.9	17.3	18.0	32.4	11.4	14.2	15.5	8.3	10.7	16.8	13.1	15.1	10.2	9.3	11.3	18.9	15.0	11.0	8.0	20.9	17.4	32.7	7.2	10.4	11.8	10.7	9.8	9.9	9.3	10.7	12.5	8.6	5.2	5.5	4.7	0.7	3.5	5.2	3.0	5.7	3.5	3.0	0.6	1.3	4.5	9.9	2.1	5.8	3.0	0.5	1.9	0.6	4.2	1.4	3.6	5.6	1.8	3.5	2.0	3.3	1.8	4.6	6.1	4.0	3.1	6.6	5.8	4.3	3.8	2.6	3.3	2.5	1.5	0.7	4.3	0.6	6.2	7.9	2.9	0.8	1.8	6.2	3.6	4.8	4.8	4.1	2.1	7.9	0.8	3.7	2.8	4.2	6.0	1.4	1.8	1.9	4.5	2.2	1.0	2.8	3.8	26.3	9.3	10.7	9.0	6.0	10.5	3.8	7.5	6.4	7.8	9.9	9.8	8.6	6.5	6.9	12.5	5.7	7.9	5.0	5.2	17.2	17.7	12.3	17.6	16.8	13.5	17.4	12.0	14.2	20.9	38.7	84.7	13.8	32.4	33.1	69.9	24.6	38.2	72.3	44.3	38.4	82.5	40.2	64.6	55.3	13.0	36.0	15.4	0.0	26.3	74.3	34.9	29.8	47.5	24.3	104.6	62.0	30.7	43.6	40.6	25.5	48.9	49.4	33.7	31.5	16.5	60.3	40.6	23.4	41.8	25.3	72.7	38.8	19.5	47.6	11.3	43.0	22.0	14.9	22.0	20.9
SDE2	"C1orf55, FLJ35382"	ENSG00000143751	"SDE2 telomere maintenance homolog"	Q6IQ49	1	225982702-225999331	"Predicted intracellular proteins"	"Cell cycle, Cell division, DNA replication, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028467, HPA031255, HPA031256"	Approved		Supported	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles"	"Golgi apparatus, Plasma membrane, Cytosol"	"HPA028467: AB_10599192, HPA031255: AB_10601462, HPA031256: AB_10603568"	"unprognostic (9.69e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.68e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.34e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.98e-2)"	"unprognostic (3.84e-2)"	25.6	11.2	10.7	13.3	12.8	33.6	21.6	10.8	11.5	12.3	10.6	17.9	9.0	11.0	15.1	11.5	14.3	12.8	13.4	12.2	10.8	11.0	11.9	17.9	16.2	13.9	14.1	9.8	16.2	14.2	15.6	13.9	14.5	12.5	12.9	11.6	11.1	12.0	11.2	20.9	18.0	12.9	12.7	13.5	14.4	11.5	14.1	14.4	33.9	15.8	11.0	14.1	15.6	16.9	8.2	7.8	17.9	7.2	12.5	11.2	6.3	8.5	6.2	10.1	10.7	7.1	7.9	12.6	9.1	8.7	12.5	9.6	9.0	9.8	12.5	14.3	7.7	4.9	11.0	12.6	7.9	15.3	9.5	10.3	13.8	5.3	8.2	13.0	13.5	16.8	8.7	11.5	13.3	16.9	7.1	8.6	15.1	25.1	15.2	9.2	2.5	18.8	10.8	14.0	13.2	6.6	15.9	13.0	16.2	7.5	6.0	9.1	15.1	10.4	11.4	17.1	8.5	11.2	16.7	8.4	10.7	7.6	13.8	19.9	9.1	6.5	15.5	11.0	8.4	21.1	16.3	6.0	5.5	8.2	6.2	11.2	8.2	8.3	7.9	6.7	7.1	8.6	8.0	17.9	12.5	7.2	7.8	6.4	6.3	10.7	12.8	10.8	11.5	10.8	11.0	14.1	9.8	12.5	14.4	26.8	23.5	17.7	14.0	38.7	5.2	7.3	2.5	13.4	25.0	8.7	0.0	7.6	13.3	5.8	47.5	16.2	11.3	23.3	6.1	8.4	15.4	11.4	34.6	17.9	9.7	14.3	16.7	12.9	16.1	12.7	9.2	13.9	18.6	5.4	10.7	11.4	8.2	10.7	6.0	9.0	7.7	6.5	17.3	15.1	13.9	51.7	11.9	15.0	9.8	16.6
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-256700	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease mutation, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.1;skeletal muscle: 114.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		780000	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	17.6	31.4	15.3	11.5	20.3	10.6	12.8	18.8	29.0	10.2	29.4	17.3	10.0	44.3	11.3	12.1	15.3	12.6	14.8	100.1	15.8	14.5	36.5	55.4	10.7	11.7	19.6	19.3	14.5	14.7	23.2	9.5	9.2	29.7	10.7	24.6	14.5	17.3	12.0	114.0	11.5	39.9	16.5	13.2	13.9	21.2	14.6	14.8	15.7	12.5	39.6	12.5	13.2	11.1	28.3	31.9	29.1	29.2	27.1	48.9	32.4	18.7	30.4	12.5	20.4	21.6	16.2	34.0	14.5	18.4	25.0	25.5	32.9	25.6	23.2	45.8	16.5	18.9	24.3	22.1	29.6	14.8	49.4	20.2	11.8	84.1	42.8	13.4	14.7	15.4	16.1	19.0	18.6	9.9	19.9	27.0	16.6	19.0	19.3	11.7	28.7	19.4	39.7	4.3	20.5	38.6	25.1	18.2	45.0	53.1	24.9	13.8	7.9	68.2	44.1	17.9	8.1	26.7	18.6	19.5	18.5	18.2	11.0	11.9	20.6	8.8	17.1	17.9	21.2	11.7	17.8	24.4	29.1	36.4	29.2	32.1	28.3	34.8	35.1	31.9	24.5	34.5	31.7	5.9	27.1	24.1	20.5	48.9	32.4	15.3	20.3	18.8	29.0	15.8	14.5	19.6	19.3	29.7	14.8	32.8	63.8	52.9	58.0	54.4	45.7	238.2	76.5	58.9	40.9	71.5	96.2	94.1	121.0	78.8	32.8	37.6	207.8	0.0	39.4	87.2	53.2	29.4	42.7	135.6	60.4	95.3	45.6	43.0	39.1	20.2	63.3	43.9	86.0	78.5	75.8	40.3	44.9	92.8	52.3	129.8	77.8	77.6	45.0	66.5	55.1	31.5	129.4	59.9	128.8	78.3
SEC23IP	p125	ENSG00000107651	"SEC23 interacting protein"	Q9Y6Y8	10	119892711-119944658	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038403, HPA043305"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA038403: AB_10675796, HPA043305: AB_2678416"	"unprognostic (4.05e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.70e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.12e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.52e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-1)"	"unprognostic (6.81e-3)"	"unprognostic (3.43e-2)"	21.6	22.4	11.7	26.3	15.9	21.3	22.0	18.2	16.1	21.3	19.4	19.2	22.8	15.5	25.7	25.7	21.1	20.4	22.0	18.2	18.7	11.4	19.0	32.9	20.0	25.5	10.4	13.0	23.2	21.6	19.3	23.2	21.2	16.8	21.0	21.9	19.1	23.3	27.0	24.3	20.9	20.4	26.0	12.4	20.2	27.5	30.9	11.1	23.3	22.2	15.2	25.4	21.6	18.7	14.3	14.3	15.1	20.6	14.6	17.6	11.1	19.5	24.0	16.4	23.5	16.2	21.3	14.1	19.7	32.6	20.7	24.5	23.1	19.0	21.9	9.1	28.1	21.5	17.0	23.9	22.3	30.7	17.2	21.2	17.9	12.6	18.3	22.2	20.2	21.9	24.4	12.2	26.5	24.9	19.9	26.5	10.6	14.7	16.4	20.1	12.5	18.9	14.2	19.5	17.7	17.3	16.9	32.9	12.1	15.3	19.4	7.6	17.6	18.3	12.9	15.6	18.1	14.3	12.9	23.5	12.7	12.3	18.8	22.7	21.5	19.3	26.2	20.8	24.2	11.1	15.1	12.3	12.2	14.0	19.3	17.6	14.3	13.9	15.7	14.3	12.1	14.8	13.9	5.0	14.6	20.6	9.0	14.4	11.1	11.7	15.9	18.2	16.1	18.7	11.4	10.4	13.0	16.8	11.1	11.9	20.4	15.2	16.5	7.4	17.9	16.5	30.6	17.4	23.9	17.4	5.9	15.3	5.0	14.6	24.4	15.3	16.2	23.3	12.5	14.9	14.6	23.5	20.9	22.2	20.0	11.1	19.1	13.5	19.9	20.1	13.0	18.4	8.5	9.0	22.3	16.4	16.7	18.1	14.2	16.5	20.3	0.0	14.7	20.9	17.7	12.2	19.3	16.6	17.5	18.0
SEL1L3	KIAA0746	ENSG00000091490	"SEL1L family member 3"	Q68CR1	4	25747427-25863760	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 48.0"	"Cell type enhanced"	"Detected in many"	4	"Mucus-secreting cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 45.9"	"Group enriched"	"Detected in many"	5	"memory B-cell: 20.8;naive B-cell: 20.8;plasmacytoid DC: 17.9"	"Group enriched"	"Detected in many"	4	"B-cells: 20.8;dendritic cells: 17.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 65.9;OE19: 49.9;U-698: 43.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"cerebellum: 191.0"	"HPA040045, HPA058792"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA040045: AB_10796116, HPA058792: AB_2683822"	"unprognostic (1.01e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.11e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.21e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.28e-2)"	"prognostic favorable (4.33e-4)"	5.4	3.3	4.0	36.3	5.6	2.3	3.8	45.9	6.4	13.7	19.3	1.5	1.5	19.3	2.2	18.1	6.2	3.6	22.0	2.4	3.3	2.8	6.9	3.6	14.3	27.7	2.1	1.7	3.1	48.0	10.9	2.9	13.7	3.0	4.2	16.7	12.9	23.1	1.0	1.3	1.7	30.3	3.4	2.1	33.5	24.6	2.2	1.1	2.8	12.5	3.8	46.7	14.8	2.2	20.8	17.9	0.4	0.1	3.7	4.3	1.4	4.8	5.3	3.9	1.3	0.6	0.8	0.6	2.4	6.6	1.8	6.0	3.3	22.7	65.9	11.7	16.6	15.9	3.1	2.9	10.5	2.5	3.5	1.7	0.7	8.8	4.5	17.1	9.0	0.4	1.3	8.5	6.6	2.6	7.5	24.8	1.3	4.3	0.0	1.3	3.7	0.0	0.6	11.4	49.9	4.7	0.3	21.7	9.1	14.5	16.4	9.8	1.9	16.1	0.2	1.6	5.7	0.8	11.2	10.8	0.1	7.9	0.1	6.9	0.4	0.1	43.0	30.0	3.8	4.5	0.4	0.1	0.0	2.8	0.0	3.4	20.8	3.5	3.1	0.7	20.8	1.5	2.4	0.3	3.7	0.1	17.9	4.3	1.4	4.0	5.6	45.9	6.4	3.3	2.8	2.1	1.7	3.0	1.1	11.9	29.0	65.6	3.0	0.8	2.1	1.2	63.7	8.1	55.7	3.5	0.0	23.3	0.0	64.6	46.5	8.4	31.3	23.3	28.5	1.3	1.5	12.0	2.3	1.7	4.6	0.0	11.1	13.5	16.0	58.1	1.4	6.4	8.5	15.4	74.5	32.9	37.4	24.6	0.4	9.7	29.0	0.0	1.4	0.6	2.4	1.4	13.7	26.1	35.6	4.2
SELENOS	"AD-015, MGC2553, SBBI8, SELS, SEPS1, VIMP"	ENSG00000131871	"Selenoprotein S"	Q9BQE4	15	101270817-101277500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ductal cells: 173.0;Exocrine glandular cells: 166.1;Extravillous trophoblasts: 174.9;Pancreatic endocrine cells: 185.9;Syncytiotrophoblasts: 254.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 96.1"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 96.1"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010025	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010025: AB_1079900"	"unprognostic (1.90e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (1.33e-4)"	"unprognostic (2.42e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.83e-2)"	"prognostic favorable (5.19e-4)"	"unprognostic (2.42e-3)"	"unprognostic (4.42e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.66e-2)"	25.1	34.7	16.3	19.6	17.1	18.0	38.3	11.4	15.6	22.8	33.7	20.7	51.6	33.2	21.6	33.7	24.8	20.5	21.9	35.0	15.6	14.6	30.9	58.2	27.0	24.5	24.6	13.4	19.3	80.9	14.6	27.5	38.2	21.2	23.5	37.8	16.5	58.0	42.1	28.3	20.6	41.5	21.8	26.8	27.5	26.8	44.4	18.7	9.7	34.0	22.5	26.4	21.0	30.9	10.0	96.1	17.5	14.8	14.3	17.2	9.6	9.4	15.1	13.6	12.0	29.8	21.2	11.3	28.9	22.2	20.2	20.4	17.9	23.0	7.2	10.8	25.6	34.0	27.0	14.7	13.0	13.2	13.0	19.6	12.1	13.5	18.5	47.3	9.1	14.1	18.4	37.3	13.5	40.2	15.9	15.0	9.6	12.1	81.9	21.6	15.2	6.6	14.2	10.3	36.4	9.8	8.5	11.1	15.7	20.3	22.7	7.6	19.3	20.1	19.0	40.2	18.7	14.2	20.7	15.9	19.1	12.5	25.6	21.9	59.5	49.7	10.4	20.8	10.9	22.9	17.5	10.8	12.3	16.0	12.9	15.4	10.0	12.4	17.2	9.3	7.0	9.4	14.0	3.7	14.3	14.8	96.1	10.9	9.6	16.3	17.1	11.4	15.6	15.6	14.6	24.6	13.4	21.2	18.7	110.2	99.5	0.0	0.0	0.0	0.0	0.0	0.0	104.4	118.3	146.5	0.0	113.3	26.6	173.0	0.0	0.0	0.0	0.0	166.1	174.9	0.0	0.0	27.9	0.0	109.2	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	160.5	0.0	0.0	185.9	0.0	0.0	69.8	0.0	0.0	0.0	0.0	0.0	0.0	254.0	0.0	0.0	0.0
SENP1		ENSG00000079387	"SUMO1/sentrin specific peptidase 1"	Q9P0U3	12	48042898-48106308	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011765, HPA046491"			Supported	"Nucleoplasm,Focal adhesion sites"		NA	NA			Nucleoplasm	"Focal adhesion sites"	"HPA011765: AB_1079907, HPA046491: AB_2679672"	"unprognostic (2.66e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.14e-1)"	"unprognostic (5.69e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.72e-5)"	"unprognostic (6.48e-2)"	"unprognostic (2.44e-3)"	"unprognostic (8.20e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (7.61e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.28e-1)"	5.7	3.3	3.0	9.0	4.0	8.4	5.2	5.3	3.2	5.5	4.9	3.8	3.5	3.4	6.2	4.3	5.7	5.2	3.8	3.6	2.7	3.3	3.8	3.9	4.3	7.3	3.0	2.3	6.2	4.4	6.1	11.4	8.1	3.0	4.4	4.7	5.1	20.0	4.7	6.8	6.6	4.5	5.8	4.3	6.4	4.5	60.2	3.6	15.0	5.2	4.8	8.3	5.7	6.3	5.3	3.8	7.1	2.6	3.8	5.5	2.3	7.1	9.2	11.5	8.6	3.4	5.1	8.5	7.7	8.6	13.2	10.8	11.3	11.6	19.4	6.7	7.0	5.2	7.0	14.2	6.8	13.5	17.6	6.4	17.0	8.9	5.4	5.7	15.8	11.5	4.1	5.6	11.9	10.6	5.9	6.9	13.2	14.9	9.3	6.8	5.7	19.7	5.0	10.5	4.9	7.0	18.7	12.1	9.5	3.6	8.8	12.1	8.3	11.1	6.8	4.5	6.8	10.7	7.6	6.3	11.2	10.1	6.5	8.1	9.6	15.5	19.0	6.9	36.8	5.1	2.0	1.8	7.1	4.3	2.6	5.5	2.4	4.2	3.9	3.3	5.3	3.6	4.1	3.8	3.8	2.0	3.8	5.0	2.3	3.0	4.0	5.3	3.2	2.7	3.3	3.0	2.3	3.0	3.6	8.9	6.2	5.6	4.2	3.3	8.2	2.1	7.6	5.3	10.3	3.5	3.9	3.1	3.3	3.0	10.2	6.3	2.5	0.0	5.6	2.8	3.7	3.6	5.8	6.6	3.8	14.3	3.4	7.4	10.0	3.3	5.8	4.8	1.7	5.4	3.7	4.8	4.5	2.0	6.3	3.4	8.3	0.0	3.1	64.4	24.9	5.4	2.3	4.4	3.6	3.0
SEPT2	"DIFF6, hNedd5, KIAA0158, NEDD5, Pnutl3"	ENSG00000168385	"Septin 2"	Q15019	2	241315100-241354027	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB017190, HPA018481"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Actin filaments,Cytokinetic bridge"		Yes	No		8800000	"Actin filaments"	"Nucleoplasm, Plasma membrane, Cytokinetic bridge"	"CAB017190: , HPA018481: AB_1856684"	"unprognostic (6.31e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.03e-2)"	"prognostic favorable (8.21e-4)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (1.96e-3)"	"unprognostic (1.83e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.16e-1)"	"unprognostic (9.58e-3)"	"unprognostic (8.11e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.17e-2)"	64.2	46.4	76.5	42.9	69.9	29.1	58.7	34.9	61.8	69.3	48.4	85.2	57.4	37.8	59.5	59.8	46.8	48.2	54.0	56.2	65.8	55.4	64.6	31.4	51.2	51.3	76.5	52.7	63.4	73.0	56.6	56.3	58.9	60.7	53.7	53.3	48.8	43.6	64.7	39.5	32.0	42.2	81.8	100.8	51.5	45.6	67.7	57.2	36.2	64.2	39.0	47.5	56.5	42.6	25.5	51.2	38.5	50.5	51.3	36.9	59.4	32.3	29.2	79.5	52.0	74.1	80.8	41.2	71.7	70.7	46.1	58.7	16.4	35.2	13.2	17.1	82.0	25.0	28.8	51.9	48.5	75.9	33.2	36.9	52.9	29.2	60.1	45.3	50.3	32.4	71.9	31.8	38.4	37.1	52.9	80.2	33.8	47.2	19.3	67.8	23.3	29.8	30.8	57.9	29.2	21.4	29.5	100.0	27.8	68.4	49.6	57.1	38.4	49.7	34.3	47.3	59.1	20.6	45.5	75.8	56.5	24.0	54.5	42.4	38.2	33.2	46.4	48.6	30.8	78.1	38.5	46.0	26.3	30.3	50.5	36.9	25.5	29.6	31.2	51.2	21.6	26.2	27.4	16.3	51.3	37.2	38.6	29.5	59.4	76.5	69.9	34.9	52.3	65.8	55.4	76.5	52.7	60.7	57.2	142.9	106.2	90.8	0.0	77.2	51.5	114.7	71.4	117.8	135.4	89.0	70.7	118.8	114.4	0.0	157.8	127.2	51.6	46.7	0.0	159.0	147.1	0.0	333.1	52.1	119.3	54.0	85.8	135.1	100.6	140.6	121.7	111.3	82.7	0.0	73.4	155.1	0.0	79.8	174.6	96.3	58.2	109.9	144.2	131.8	84.2	80.8	116.3	82.9	87.9	0.0
SEPT7	"CDC10, CDC3, SEPT7A"	ENSG00000122545	"Septin 7"	Q16181	7	35800932-35907105	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Differentiation, Mitosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 1164.8;Sertoli cells: 802.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023309, HPA029524"	Enhanced		Enhanced	"Nucleoli,Actin filaments,Midbody,Cytosol"		Yes	No		16000000	"Actin filaments"	"Nucleoli, Midbody, Cytosol"	"HPA023309: AB_10600093, HPA029524: AB_10601573"	"unprognostic (7.91e-3)"	"unprognostic (6.89e-3)"	"unprognostic (9.49e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.22e-2)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (2.00e-2)"	"unprognostic (4.43e-2)"	"unprognostic (7.13e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.43e-3)"	35.5	28.5	89.0	26.8	77.8	31.9	29.5	41.9	81.5	35.1	28.7	54.3	11.5	15.7	37.8	36.2	31.7	25.4	34.2	47.5	86.4	58.1	24.3	21.5	28.3	38.8	79.6	66.2	42.8	11.2	22.9	31.9	41.0	72.0	28.4	28.2	9.6	14.9	29.9	21.7	29.1	20.1	42.6	76.8	29.5	18.1	19.3	98.2	33.0	22.6	17.3	41.4	36.9	24.0	40.4	24.0	47.3	24.8	69.1	56.8	48.6	36.1	17.4	44.5	29.2	50.2	51.9	22.8	46.7	43.1	39.9	34.4	27.0	28.1	34.3	31.7	47.5	53.6	27.5	31.4	31.1	57.0	23.4	16.5	27.6	24.4	14.6	29.3	33.2	30.5	33.6	24.4	31.3	30.9	41.8	41.5	27.1	21.6	27.1	64.7	16.9	33.5	55.8	47.7	33.9	24.7	34.6	42.4	19.7	38.6	27.0	23.9	42.0	32.6	42.0	27.9	76.2	31.0	36.8	35.0	40.3	47.8	24.7	51.4	32.0	29.1	86.5	25.7	55.6	85.0	47.3	20.7	34.9	55.4	24.0	56.8	40.4	39.6	50.5	24.0	37.4	35.6	44.9	39.3	69.1	24.8	17.2	34.2	48.6	89.0	77.8	41.9	81.5	86.4	58.1	79.6	66.2	72.0	98.2	142.9	97.9	186.4	0.0	141.0	199.4	207.8	40.8	222.1	184.2	129.1	43.2	148.6	127.6	0.0	342.3	214.2	64.6	23.3	0.0	161.3	239.6	0.0	368.3	69.5	168.4	1164.8	58.6	187.2	128.6	256.8	324.7	171.1	178.8	0.0	61.0	328.2	0.0	106.6	426.0	108.1	113.7	802.0	509.2	101.6	233.2	140.9	103.9	294.1	77.5	0.0
SEPT9	"AF17q25, KIAA0991, MSF, MSF1, PNUTL4, SeptD1"	ENSG00000184640	"Septin 9"	Q9UHD8	17	77280569-77500596	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042564, HPA050627"	Approved		Enhanced	"Actin filaments"		No	No		120000	"Actin filaments"		"HPA042564: AB_2678054, HPA050627: AB_2681193"	"unprognostic (7.65e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.34e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (1.61e-5)"	"unprognostic (4.23e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.80e-1)"	25.5	33.3	23.2	53.3	16.4	28.2	38.6	42.9	28.3	39.4	45.7	19.8	29.0	34.4	50.7	29.3	36.3	35.0	61.3	18.7	20.2	19.8	27.1	40.8	29.6	75.1	19.3	23.9	36.4	14.9	32.3	24.3	30.8	21.0	35.8	20.8	31.7	28.7	41.5	24.5	27.7	49.9	56.2	26.2	54.6	38.0	35.8	15.0	137.8	19.7	27.4	61.9	47.0	37.9	10.2	20.4	13.9	27.1	8.4	17.1	10.2	37.1	50.6	36.1	29.6	41.3	68.0	19.0	28.2	33.8	18.6	13.9	39.8	36.8	50.2	24.7	58.6	25.2	22.3	14.7	54.6	14.2	1.2	9.3	19.0	26.1	74.1	33.0	12.5	34.1	35.3	20.3	25.2	21.2	28.5	25.2	29.3	21.0	6.8	17.2	38.8	91.3	11.3	32.1	41.9	41.7	42.2	29.7	16.8	30.7	61.5	26.2	50.2	31.6	58.2	35.5	40.9	39.7	11.0	36.7	27.6	22.8	32.2	20.1	1.6	2.9	83.9	38.1	11.0	55.9	2.2	9.1	13.9	12.4	24.0	10.7	8.8	16.1	14.5	8.8	10.2	17.1	14.4	3.4	8.4	27.1	20.4	16.2	10.2	23.2	16.4	42.9	28.3	20.2	19.8	19.3	23.9	21.0	15.0	20.8	31.8	98.2	0.0	59.1	5.1	11.2	91.7	32.1	27.3	26.2	0.0	68.5	13.3	0.0	9.5	34.9	95.9	0.0	0.0	135.1	55.9	0.0	53.0	53.5	59.8	3.2	48.4	35.6	90.9	6.8	42.3	51.9	57.3	0.0	47.1	33.2	0.0	55.4	52.3	12.6	6.8	77.6	29.4	1.8	19.2	54.1	59.0	134.3	58.5	0.0
SERBP1	"CGI-55, CHD3IP, DKFZP564M2423, HABP4L, PAI-RBP1, PAIRBP1"	ENSG00000142864	"SERPINE1 mRNA binding protein 1"	Q8NC51	1	67407810-67430415	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020559, CAB026297"	Supported		Enhanced	Cytosol		NA	NA		430000	Cytosol		"CAB026297: AB_425924, HPA020559: AB_1856701"	"unprognostic (1.58e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.45e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.32e-3)"	"unprognostic (5.97e-2)"	"unprognostic (8.25e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.76e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.34e-3)"	38.3	30.4	22.5	35.7	30.0	33.8	36.9	25.4	27.7	35.4	32.8	25.5	28.6	30.9	36.4	35.2	68.4	25.9	39.4	32.6	22.3	19.1	30.6	48.4	27.5	47.9	29.7	18.6	33.5	56.1	52.2	21.8	28.7	25.0	34.8	27.1	23.2	41.8	28.5	87.5	50.5	29.9	42.0	26.8	31.9	31.5	35.8	28.7	48.9	42.6	54.1	41.3	36.0	40.7	34.3	35.4	16.8	30.2	46.7	44.4	33.9	59.2	36.2	38.9	38.7	34.7	31.9	57.7	62.6	24.6	43.5	36.9	69.8	26.5	114.7	46.9	33.7	40.4	45.7	61.0	58.6	47.2	51.2	73.4	105.6	68.0	61.8	30.4	85.5	40.5	32.5	39.5	55.8	51.0	28.8	47.1	37.5	117.6	40.5	34.7	41.3	64.3	51.9	135.3	39.5	47.9	74.3	85.4	57.3	33.7	49.4	65.7	46.1	48.6	52.9	56.6	33.9	28.9	52.3	49.1	40.0	48.6	57.6	84.1	37.7	48.2	102.9	32.9	81.2	44.6	9.8	27.4	16.8	35.0	30.2	44.4	34.3	35.2	35.3	35.4	33.4	41.4	37.4	9.0	46.7	27.4	32.3	41.7	33.9	22.5	30.0	25.4	27.7	22.3	19.1	29.7	18.6	25.0	28.7	232.3	185.1	214.5	341.9	609.6	146.7	119.8	186.0	238.3	320.8	111.7	86.4	217.4	205.6	253.5	407.2	294.6	134.6	186.9	310.6	429.9	231.1	212.2	213.7	301.4	265.1	135.1	220.8	148.0	205.2	164.8	204.8	212.7	182.2	266.1	277.0	146.7	292.1	133.3	262.0	212.1	123.4	135.8	315.9	477.7	288.9	629.1	191.8	235.2	341.4	442.1
SERGEF	"DelGEF, Gnefr"	ENSG00000129158	"Secretion regulating guanine nucleotide exchange factor"	Q9UGK8	11	17788048-18013162	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 115.8;Late spermatids: 197.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA037811, HPA037812, HPA074086"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037811: AB_10672726, HPA037812: AB_2675680, HPA074086: AB_2686658"	"unprognostic (2.67e-2)"	"unprognostic (7.15e-2)"	"unprognostic (7.00e-2)"	"unprognostic (9.04e-3)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (6.94e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.82e-2)"	8.2	14.2	30.1	7.5	22.3	4.7	15.2	24.4	31.4	13.1	10.7	9.5	4.3	6.1	11.8	17.7	9.6	13.9	10.3	9.9	28.6	24.1	15.6	12.3	10.0	8.0	27.9	18.1	26.1	17.4	17.7	19.3	4.8	23.0	13.6	11.5	10.1	12.3	17.1	11.8	11.1	6.2	14.4	10.4	7.6	10.1	3.9	10.7	7.8	25.3	8.8	11.8	9.5	15.6	15.4	14.4	8.9	11.8	11.3	22.0	14.1	6.4	7.4	7.1	13.3	12.3	12.7	4.3	5.1	11.6	6.0	7.9	5.3	2.1	5.8	6.7	6.5	17.4	8.4	25.1	16.5	5.2	12.7	20.4	8.9	6.8	21.9	13.8	7.8	10.3	11.4	18.1	2.9	12.9	18.7	6.5	13.2	5.4	11.2	9.2	10.0	7.6	17.1	5.4	21.9	8.9	11.0	7.8	6.4	14.6	9.7	16.6	3.9	9.6	9.6	9.7	15.0	4.5	7.4	3.3	6.3	7.3	8.2	6.1	7.7	9.3	7.5	9.7	9.1	6.0	7.2	11.8	8.9	21.1	9.3	17.4	15.4	21.3	16.0	14.4	11.1	21.7	19.2	1.2	11.3	9.4	5.9	22.0	14.1	30.1	22.3	24.4	31.4	28.6	24.1	27.9	18.1	23.0	10.7	6.0	5.0	11.3	18.7	23.6	13.1	10.4	10.2	5.3	7.9	10.4	2.0	6.2	33.2	14.7	115.8	11.3	7.9	0.0	21.5	10.6	11.8	15.5	13.9	12.3	12.5	11.1	46.6	7.4	15.5	197.3	18.1	11.9	20.3	10.8	13.0	15.2	13.8	7.0	20.1	30.0	8.2	6.5	20.0	6.2	5.6	17.7	2.6	20.6	12.4	17.2
SERPINA1	"A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1"	ENSG00000197249	"Serpin family A member 1"	P01009	14	94376747-94390693	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase, Blood coagulation, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"liver: 3314.2"	"Cell type enriched"	"Detected in many"	7	"Hepatocytes: 29973.4"	"Cancer enriched"	"Detected in all"	10	"liver cancer: 3850.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"classical monocyte: 110.2;intermediate monocyte: 165.9;neutrophil: 139.3;non-classical monocyte: 203.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 139.3;monocytes: 203.0"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 326.1"					"Region enriched"	"Detected in many"	6	"cerebellum: 334.2"	"HPA000927, HPA001292, CAB013211, CAB016648, CAB073396"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	2070000000000	210000000000	Vesicles		"CAB013211: , CAB016648: AB_1611888, CAB073396: , HPA000927: AB_1844761, HPA001292: AB_1844762"	"prognostic favorable (1.61e-5)"	"unprognostic (3.37e-1)"	"prognostic favorable (5.86e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.81e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.54e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.96e-1)"	0.9	0.4	0.7	4.9	1.4	3.0	2.4	0.2	0.7	2.6	7.5	0.5	3.1	6.3	0.8	8.6	0.4	0.7	14.2	1.0	0.4	0.5	74.1	3314.2	13.6	5.3	1.0	0.2	0.6	7.4	0.0	0.4	0.8	0.8	0.6	4.1	0.6	0.9	3.6	0.2	0.3	36.2	1.4	1.3	8.9	7.0	0.8	0.8	0.5	0.8	0.2	0.9	0.5	0.6	0.3	33.5	139.3	203.0	0.2	0.3	100.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	12.9	41.0	0.1	1.1	0.0	0.1	0.1	0.0	0.8	0.0	5.0	0.0	0.2	0.1	326.1	0.0	1.1	0.1	0.3	0.4	0.0	1.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.5	0.1	1.1	0.1	22.1	0.2	0.0	0.1	0.4	0.1	0.1	0.0	19.4	0.2	0.1	0.1	5.1	0.1	0.6	0.2	0.1	0.5	0.3	2.8	0.0	0.4	110.2	29.1	0.2	165.9	0.3	0.3	0.1	0.2	33.5	0.1	0.2	0.1	139.3	0.2	203.0	0.7	0.2	100.0	0.7	1.4	0.2	0.7	0.4	0.5	1.0	0.2	0.8	0.8	32.8	233.5	435.3	1.1	2.1	0.0	2.8	4603.8	45.5	60.3	143.1	0.0	1.4	58.0	1848.5	0.1	6.6	53.3	817.7	189.3	1.7	1.6	5.0	1.1	29973.4	171.4	0.0	11.6	922.6	1276.8	0.0	0.0	188.6	1.7	107.4	659.1	0.3	1376.2	37.4	0.0	447.0	0.2	0.0	5.1	0.0	0.1	1.5	5.4	46.5	24.7	7.1
SERTM1	C13orf36	ENSG00000180440	"Serine rich and transmembrane domain containing 1"	A2A2V5	13	36673912-36697839	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.2;endometrium 1: 30.9;fallopian tube: 25.3"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 8.9"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 3.7"	"Group enriched"	"Detected in many"	7	"amygdala: 13.9;basal ganglia: 10.1;cerebral cortex: 21.6;hippocampal formation: 26.5;olfactory region: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HAP1: 2.7;HEK 293: 3.2;NTERA-2: 8.0;SH-SY5Y: 4.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054814, HPA070485"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA054814: AB_2682611, HPA070485: AB_2686272"	"unprognostic (8.71e-2)"	"unprognostic (2.11e-1)"		"unprognostic (5.58e-3)"	"unprognostic (4.66e-3)"			"unprognostic (4.05e-3)"		"unprognostic (5.06e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.00e-8)"	"unprognostic (2.51e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.44e-2)"		5.0	1.8	13.9	0.5	10.1	0.5	1.2	0.3	30.2	16.4	0.7	1.3	1.8	0.6	30.9	13.5	0.5	25.3	0.5	0.6	26.5	2.0	0.6	0.5	5.6	0.5	1.5	11.6	14.5	0.8	1.0	11.2	0.5	2.4	0.9	0.5	8.2	0.5	1.2	0.5	0.6	0.6	17.4	0.9	0.5	0.9	1.5	0.0	0.0	9.3	0.0	0.5	1.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.0	3.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	4.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	10.1	0.3	21.6	26.5	2.0	1.5	11.6	2.4	0.0	8.9	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SESTD1	"DKFZp434O0515, Solo"	ENSG00000187231	"SEC14 and spectrin domain containing 1"	Q86VW0	2	179101692-179264790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	11	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 4.3"	"Group enriched"	"Detected in many"	4	"B-cells: 4.3;dendritic cells: 1.1;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058236, HPA077408"	Approved		Enhanced	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA058236: AB_2732619, HPA077408: AB_2732344"	"unprognostic (2.76e-1)"	"unprognostic (3.55e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (9.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.91e-3)"	"unprognostic (9.21e-2)"	"prognostic favorable (2.78e-11)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (3.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-2)"	23.6	5.0	11.2	6.5	11.3	8.1	32.1	10.3	17.0	12.7	10.0	15.8	9.1	4.3	11.1	7.9	8.8	6.4	12.0	9.6	13.5	9.9	12.7	6.5	16.9	6.2	14.4	9.4	9.0	6.2	8.9	7.2	12.5	12.7	9.4	7.6	7.6	16.6	9.2	5.7	7.0	8.7	22.5	21.0	6.5	9.1	15.9	11.5	3.7	6.1	6.2	9.1	19.9	23.7	4.3	1.1	0.2	3.7	0.6	0.1	0.6	0.0	1.2	15.5	2.8	28.2	12.3	8.2	5.4	2.2	2.3	3.9	2.7	3.6	2.6	7.2	5.1	2.8	2.5	6.5	3.0	4.1	1.9	1.8	3.2	7.0	7.2	2.2	1.7	1.4	9.1	1.3	3.5	8.8	5.4	9.1	2.7	0.5	1.4	3.8	1.8	4.1	0.2	4.0	2.7	1.6	6.0	10.2	1.7	6.2	13.7	3.4	5.8	4.7	2.1	1.5	12.0	0.3	2.0	15.9	7.6	3.9	3.8	2.7	0.8	0.0	6.4	3.8	0.7	2.2	0.0	2.1	0.0	0.0	1.8	0.0	2.7	0.1	0.0	1.1	4.3	0.1	0.0	0.2	0.6	3.7	0.0	0.1	0.6	11.2	11.3	10.3	16.1	13.5	9.9	14.4	9.4	12.7	11.5	101.3	25.1	16.2	20.3	8.8	27.5	13.3	12.7	24.1	21.6	12.2	17.7	7.6	14.9	23.4	6.1	21.5	17.0	0.0	23.7	53.0	41.0	56.1	0.0	8.1	11.3	284.4	24.0	19.0	24.6	6.0	11.2	24.9	13.5	1.0	5.8	32.4	30.0	14.0	28.7	30.6	10.6	19.4	24.5	31.7	61.3	8.8	15.1	4.3	6.4	58.7
SET	"2PP2A, IPP2A2, PHAPII"	ENSG00000119335	"SET nuclear proto-oncogene"	Q01105	9	128683424-128696400	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	"Chaperone, DNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005232, HPA063683"	Supported		Enhanced	"Nucleoplasm,Lipid droplets"		NA	NA		880000	Nucleoplasm	"Lipid droplets"	"CAB005232: AB_2185634, HPA063683: AB_2685088"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.15e-2)"	"unprognostic (4.37e-3)"	"prognostic unfavorable (9.41e-7)"	"unprognostic (2.00e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.54e-2)"	47.2	49.7	66.5	59.3	65.8	71.8	56.5	64.2	61.2	54.4	51.3	55.3	45.6	40.1	64.8	33.1	71.6	51.6	48.9	81.6	63.6	57.3	51.7	57.8	51.2	91.1	65.4	56.1	76.5	61.3	55.0	38.7	65.4	47.3	59.2	56.4	36.3	52.1	46.9	76.3	53.6	45.7	59.0	73.5	62.8	46.8	34.8	58.6	152.9	69.1	46.2	92.7	74.4	84.1	72.2	66.4	43.2	56.5	78.8	77.9	69.7	51.4	58.8	84.6	66.9	25.2	39.6	78.0	42.5	47.1	61.5	42.4	80.7	63.2	133.1	36.0	43.7	48.1	96.5	124.9	63.9	70.3	60.7	53.2	76.6	91.4	65.6	56.5	139.7	50.2	33.0	50.1	52.3	105.0	49.5	57.5	71.6	148.6	54.0	50.3	86.8	117.0	51.6	141.2	78.7	62.6	107.0	105.1	107.8	47.4	58.1	86.2	54.1	93.6	62.9	50.8	62.8	78.4	43.6	55.0	72.7	54.5	44.8	70.3	42.5	122.1	158.5	34.6	74.5	69.2	34.5	53.9	43.2	58.9	56.5	72.1	72.2	67.9	62.8	52.7	66.3	65.8	77.9	35.4	78.8	45.6	66.4	52.3	69.7	66.5	65.8	64.2	61.2	63.6	57.3	65.4	56.1	47.3	58.6	113.2	124.3	265.7	328.1	598.4	174.9	190.6	209.0	89.7	129.7	186.7	41.2	273.8	330.0	223.2	30.8	200.0	100.9	93.5	188.0	401.9	250.8	373.4	128.3	164.3	210.2	117.6	245.8	160.2	212.7	25.3	151.8	217.3	310.4	235.4	230.5	205.1	229.0	108.7	163.0	257.3	97.8	129.4	279.5	127.7	287.7	613.8	263.1	219.3	275.8	519.4
SETD1B	"KIAA1076, KMT2G, Set1B"	ENSG00000139718	"SET domain containing 1B"	Q9UPS6	12	121804180-121832584	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021667, HPA059412"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021667: AB_1856753, HPA059412: AB_2684006"	"unprognostic (1.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.13e-2)"	13.8	9.6	9.3	16.8	9.4	22.7	18.1	22.0	11.1	19.6	25.0	7.4	16.0	13.0	27.2	14.8	15.8	21.1	18.2	10.0	8.9	4.6	10.1	10.9	10.9	11.9	5.4	7.4	17.4	14.3	12.1	11.9	12.2	7.1	16.5	6.8	14.4	15.9	31.1	12.9	11.8	15.3	14.7	5.4	14.4	17.8	9.1	7.3	31.1	14.7	8.9	14.7	22.8	14.4	1.3	2.1	3.9	2.0	1.0	2.1	0.8	6.0	12.1	6.4	10.5	6.0	4.1	9.7	5.7	4.7	4.6	2.6	6.8	3.7	4.5	5.3	6.4	2.7	9.5	7.4	4.6	2.6	7.9	9.0	13.9	15.0	5.8	5.1	12.6	11.9	5.0	5.4	6.2	4.9	5.2	4.8	9.0	14.2	3.2	3.1	14.3	18.0	16.7	8.9	2.9	7.4	14.1	4.2	6.4	4.1	12.7	7.9	6.0	13.0	8.7	4.7	4.8	10.8	10.9	8.0	6.5	8.1	9.2	6.3	6.3	3.2	2.7	5.4	7.9	7.4	3.9	0.9	2.0	1.9	2.0	1.3	1.2	1.3	1.8	0.7	1.3	2.1	1.3	3.8	1.0	0.8	2.1	1.3	0.8	9.3	9.4	22.0	11.1	8.9	4.6	5.4	7.4	7.1	7.3	3.0	5.3	2.4	3.2	10.4	12.0	8.3	7.6	0.0	6.8	5.2	7.9	6.5	0.0	4.5	7.5	9.3	5.5	0.0	6.2	5.9	7.4	6.7	3.5	11.9	5.7	11.1	7.0	12.9	21.6	14.4	10.6	5.6	1.7	1.0	7.3	5.3	5.7	9.5	9.6	3.0	8.4	6.5	7.2	12.5	1.0	11.3	11.0	8.5	6.7	6.5
SETD5	FLJ10707	ENSG00000168137	"SET domain containing 5"	Q9C0A6	3	9397615-9479240	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Methyltransferase, Transferase"	"Autism, Autism spectrum disorder, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017093, HPA035574"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB017093: , HPA035574: AB_2674681"	"unprognostic (6.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.99e-2)"	"prognostic unfavorable (6.21e-4)"	"unprognostic (5.52e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (6.65e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.15e-3)"	18.9	21.9	33.1	18.2	29.1	13.2	40.9	58.0	38.9	21.7	20.7	15.4	22.1	14.0	24.0	27.0	20.7	22.0	18.4	18.3	29.6	13.8	15.4	22.1	26.5	29.8	23.0	30.1	29.7	22.7	25.6	31.4	23.0	25.1	20.6	20.4	16.7	22.3	22.7	16.6	29.0	19.8	24.1	22.8	22.5	18.7	21.3	26.6	21.0	25.9	14.8	24.2	20.4	37.5	3.7	4.0	4.7	2.0	4.3	4.1	1.0	9.9	12.0	24.7	11.2	14.6	15.2	59.0	9.8	13.3	14.3	16.5	11.9	12.4	21.7	5.9	14.3	12.6	8.3	23.0	13.0	15.8	15.3	11.4	21.2	20.2	11.0	14.9	16.2	14.1	14.7	21.2	21.6	25.7	14.8	15.1	15.4	20.8	14.3	12.2	14.6	14.3	13.5	18.7	7.6	9.7	16.6	19.5	9.6	11.2	16.1	9.9	15.4	14.3	11.8	8.9	23.0	15.8	11.9	17.9	15.1	17.3	8.1	11.7	10.4	13.0	36.2	10.8	11.7	14.1	2.3	2.0	1.7	3.8	1.2	2.5	3.4	2.5	4.1	1.3	3.7	2.4	2.2	4.7	4.3	1.4	4.0	1.0	1.0	33.1	29.1	58.0	38.9	29.6	13.8	23.0	30.1	25.1	26.6	38.7	45.3	34.4	46.5	83.5	109.6	20.7	48.4	56.2	59.1	40.1	108.0	31.2	3.3	31.7	6.2	57.1	35.1	0.0	29.5	33.8	55.5	67.5	46.2	41.4	21.1	52.4	60.0	57.1	28.8	7.5	61.9	31.1	42.2	30.7	47.0	38.4	36.6	45.6	50.5	9.8	62.8	12.9	58.0	37.5	39.3	79.9	47.9	50.7	42.2	63.9
SETD7	"KIAA1717, KMT7, SET7, SET7/9, Set9"	ENSG00000145391	"SET domain containing lysine methyltransferase 7"	Q8WTS6	4	139495941-139606699	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 64.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058111	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Mitotic chromosome"	"HPA058111: AB_2683607"	"prognostic unfavorable (8.28e-4)"	"unprognostic (7.07e-2)"	"unprognostic (4.04e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (9.10e-2)"	"unprognostic (6.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (6.56e-3)"	26.1	13.2	12.0	9.6	12.3	5.7	26.3	10.2	16.2	27.9	17.7	17.9	11.0	4.8	23.8	12.0	18.3	13.8	16.9	25.2	13.0	10.0	7.2	30.7	12.1	6.9	18.0	10.1	13.3	13.8	26.8	9.3	12.0	15.4	22.8	10.2	12.4	13.7	13.9	56.4	14.2	9.9	33.3	19.0	11.8	17.7	10.6	16.5	2.9	10.3	15.2	9.9	24.2	30.1	2.3	6.8	1.8	5.6	0.5	5.6	1.6	9.0	11.7	4.5	2.6	26.5	22.9	9.9	21.5	22.4	11.0	9.3	6.9	12.4	21.1	8.5	36.2	7.6	4.6	14.9	17.0	17.9	10.4	10.5	2.9	15.3	0.2	13.1	10.1	4.5	19.8	19.9	17.5	18.7	14.0	13.9	9.0	1.7	32.9	14.0	15.1	6.6	1.5	2.2	13.3	7.7	6.2	15.5	12.1	10.7	8.3	17.4	5.8	14.3	21.3	5.1	4.5	8.4	9.2	22.5	19.5	13.9	23.2	17.8	28.4	27.2	13.4	22.5	10.2	9.3	1.0	5.6	0.5	0.6	3.2	4.1	1.8	1.8	1.8	6.8	2.3	0.8	0.5	1.8	0.5	4.8	3.5	5.6	1.6	12.0	12.3	10.2	16.2	13.0	10.0	18.0	10.1	15.4	16.5	6.0	13.1	3.4	10.9	15.2	6.6	35.4	17.8	4.0	6.8	8.7	11.8	21.9	0.0	20.5	0.9	24.7	1.8	23.3	18.1	14.4	19.2	35.1	2.3	64.4	18.3	7.9	1.2	36.8	29.7	3.5	21.3	18.3	10.1	7.2	11.2	13.3	21.5	0.0	26.5	3.9	12.6	19.4	21.0	3.2	1.9	19.3	38.6	5.0	9.9	14.2
SF3A1	"Prp21, PRPF21, SAP114, SF3a120"	ENSG00000099995	"Splicing factor 3a subunit 1"	Q15459	22	30331988-30356947	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000690, HPA030083"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA		19000	"Nucleoplasm, Nuclear speckles"		"HPA000690: AB_1079933, HPA030083: AB_10602183"	"unprognostic (8.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.54e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.79e-1)"	"unprognostic (5.54e-3)"	"unprognostic (3.30e-1)"	"unprognostic (3.83e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.13e-1)"	32.6	30.2	23.3	37.3	25.6	44.6	35.0	33.6	37.3	29.2	26.4	24.8	27.7	26.1	36.3	23.0	32.2	29.4	30.7	26.2	21.5	16.6	24.9	29.7	28.5	48.2	23.5	26.1	45.7	31.4	44.4	27.2	25.9	19.6	27.2	24.5	29.7	31.8	33.1	45.5	36.3	29.5	27.6	18.7	34.6	29.1	78.4	25.7	50.9	32.9	26.6	34.9	32.7	42.6	13.2	10.6	16.2	13.7	12.1	16.6	8.3	26.4	18.6	25.6	24.8	15.2	13.7	30.6	21.0	13.4	22.9	17.1	24.6	17.7	33.1	14.5	14.8	18.1	25.5	32.4	22.3	25.2	30.0	28.4	30.9	23.1	20.1	13.8	61.9	34.4	13.7	15.8	28.9	23.6	13.0	16.4	18.0	34.1	34.7	16.6	15.2	30.1	14.1	42.3	20.4	15.6	43.0	32.1	26.8	13.1	29.4	26.6	24.3	26.7	16.3	24.2	17.8	19.9	20.4	22.9	29.4	26.2	20.9	38.7	26.9	32.4	33.5	22.6	23.0	30.2	7.6	9.8	15.0	13.5	11.3	13.7	12.8	13.5	14.4	10.6	13.2	15.3	13.7	16.2	12.1	13.7	6.4	16.6	8.3	23.3	25.6	33.6	37.3	21.5	16.6	23.5	26.1	19.6	25.7	53.6	60.9	28.0	23.1	23.2	17.9	26.6	35.7	48.2	37.5	29.6	15.7	28.2	14.9	22.6	85.6	29.2	25.3	46.7	25.3	33.8	23.4	23.0	50.8	23.6	34.7	25.4	24.1	28.3	35.7	91.2	32.5	26.1	16.9	63.1	29.8	24.6	24.5	31.6	35.3	14.6	17.4	45.3	23.9	54.7	41.0	23.8	28.9	30.5	28.2	22.2
SF3B1	"Hsh155, Prp10, PRPF10, SAP155, SF3b155"	ENSG00000115524	"Splicing factor 3b subunit 1"	O75533	2	197389784-197435091	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050275	Approved		Enhanced	"Nuclear speckles"		NA	NA		840000	"Nuclear speckles"		"HPA050275: AB_2681071"	"unprognostic (6.86e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.51e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.41e-2)"	53.9	49.9	36.5	54.5	44.9	88.0	57.9	60.8	47.3	72.3	54.2	44.3	45.6	36.8	64.6	72.0	50.5	53.3	43.1	39.6	34.7	26.0	49.7	50.7	53.1	65.3	56.5	27.7	73.6	60.5	66.2	81.4	64.6	46.7	50.0	51.0	37.0	54.4	45.4	49.3	48.5	67.8	41.2	50.2	88.1	48.8	33.3	53.5	113.0	53.3	38.0	65.7	62.4	56.0	32.7	41.9	41.1	37.8	39.6	45.9	29.4	30.2	27.8	62.7	34.2	48.6	49.7	52.6	42.4	43.4	37.0	45.5	53.0	32.7	57.9	28.6	43.1	38.4	29.4	62.6	34.4	58.0	44.3	38.9	61.2	68.0	62.3	36.7	65.0	44.7	51.9	33.7	38.6	47.5	63.1	43.1	38.6	43.8	40.0	41.0	26.6	59.7	62.6	49.3	34.3	44.0	52.7	53.6	38.4	51.5	77.0	35.2	43.6	40.5	24.8	29.0	81.0	24.5	49.8	43.4	29.1	25.0	29.3	30.1	36.4	59.2	83.1	27.9	39.3	32.1	27.7	33.1	39.1	37.5	37.8	40.6	32.7	32.5	35.3	41.9	30.8	33.9	33.9	41.1	39.6	36.1	23.8	45.9	29.4	36.5	44.9	60.8	47.3	34.7	26.0	56.5	27.7	46.7	53.5	166.7	222.4	88.0	131.1	105.8	96.4	104.9	73.9	257.0	221.8	87.2	68.7	93.6	48.0	91.8	6.7	106.2	77.2	46.7	82.1	86.2	104.2	87.4	231.0	63.5	87.0	89.0	106.0	112.3	145.9	14.9	111.4	119.2	72.6	130.8	98.8	119.0	91.7	60.4	98.3	63.2	88.9	116.4	99.9	81.4	93.6	103.8	119.3	119.3	74.2	125.4
SF3B2	"Cus1, SAP145, SF3b1, SF3b145"	ENSG00000087365	"Splicing factor 3b subunit 2"	Q13435	11	66050729-66069308	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045028	Supported		Enhanced	"Nuclear speckles"		NA	NA		57000	"Nuclear speckles"		"HPA045028: AB_10965174"	"unprognostic (1.48e-1)"	"unprognostic (1.51e-1)"	"unprognostic (6.45e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.10e-2)"	"prognostic unfavorable (6.43e-5)"	"unprognostic (8.43e-2)"	"unprognostic (4.69e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (3.51e-5)"	"unprognostic (4.03e-2)"	"unprognostic (3.56e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.60e-2)"	52.4	42.9	50.1	45.8	61.7	75.7	47.3	57.0	75.7	50.6	46.0	61.7	33.0	42.6	53.0	61.8	45.4	65.0	43.5	47.3	51.2	45.5	51.2	56.8	45.2	55.5	54.8	42.4	74.1	60.5	75.2	63.5	58.9	50.5	50.1	49.1	48.8	42.4	51.4	48.8	50.0	46.8	51.9	44.6	56.7	44.2	86.0	52.9	85.9	60.6	34.5	67.7	47.7	47.1	43.8	39.7	63.3	57.8	43.2	57.9	51.5	53.0	42.8	46.3	43.4	48.1	44.4	38.3	40.4	55.0	63.1	47.5	35.0	46.3	50.8	45.8	47.5	63.1	49.3	66.9	46.4	53.0	40.5	34.5	54.7	40.3	57.1	48.7	54.2	41.7	37.8	45.3	63.7	73.8	42.8	45.2	45.2	51.1	84.4	48.0	72.0	61.1	79.9	48.0	40.0	40.0	55.6	39.8	72.0	47.7	43.9	37.0	54.0	40.4	42.7	59.9	35.2	53.8	34.3	37.5	51.9	44.2	57.7	45.5	64.8	75.9	64.5	57.4	35.8	46.8	56.9	39.4	63.3	57.9	46.0	55.7	43.1	51.3	54.0	39.7	43.8	50.3	49.6	52.0	43.2	57.8	30.9	50.0	51.5	50.1	61.7	57.0	75.7	51.2	45.5	54.8	42.4	50.5	52.9	119.1	114.9	136.2	123.3	98.9	85.3	61.3	107.0	198.1	111.5	62.8	84.4	166.5	77.9	136.8	194.5	90.9	93.8	70.0	187.3	151.3	122.2	90.7	114.7	66.0	109.4	101.7	79.2	66.9	93.2	48.0	111.4	109.6	62.4	232.6	79.8	113.3	135.0	91.2	122.4	73.9	100.8	77.6	120.5	169.9	151.2	86.6	156.1	138.4	94.9	111.1
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094881-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	31.0	52.5	32.9	34.0	37.2	76.6	41.7	18.6	35.8	36.9	42.6	23.8	45.3	33.1	34.5	42.6	46.9	47.1	39.8	47.7	32.0	31.1	54.4	84.8	30.3	62.4	32.5	26.0	40.9	100.7	22.3	48.4	31.3	28.0	32.1	40.6	26.5	43.1	60.4	47.4	39.8	40.3	33.2	30.6	38.7	33.9	47.3	24.7	56.7	47.7	63.7	43.4	35.3	30.2	42.7	76.4	38.4	80.7	38.6	48.6	68.5	22.6	30.8	35.4	65.4	41.6	47.4	21.1	23.6	39.8	48.6	55.7	32.6	20.8	37.9	42.5	38.3	47.2	27.0	40.6	54.2	34.4	39.1	57.3	41.3	27.5	71.6	40.0	80.4	26.6	48.3	73.3	53.3	53.4	31.5	58.8	52.5	52.9	55.4	43.5	80.5	51.9	72.6	22.7	35.7	37.3	32.4	46.4	38.3	52.8	20.5	48.7	30.8	32.9	40.4	43.9	18.7	29.3	49.5	31.7	25.0	34.2	44.7	50.9	41.7	50.2	35.6	40.5	67.6	30.8	30.6	80.7	38.4	38.4	56.1	47.2	42.7	43.6	45.2	68.8	39.1	43.5	43.3	21.6	38.6	49.8	76.4	48.6	68.5	32.9	37.2	18.6	35.8	32.0	31.1	32.5	26.0	28.0	24.7	83.4	145.5	165.3	123.3	240.9	44.9	77.9	196.1	116.4	94.4	116.9	11.8	202.6	388.0	204.2	171.0	134.9	248.1	210.2	274.2	179.7	208.8	158.9	174.4	239.5	289.2	41.3	257.0	153.4	220.2	84.0	124.8	193.2	239.6	242.5	242.8	104.3	226.1	234.4	102.2	429.7	46.6	103.5	144.3	82.1	55.6	283.4	172.7	200.5	251.5	180.0
SFMBT1	"DKFZp434L243, RU1, SFMBT"	ENSG00000163935	"Scm like with four mbt domains 1"	Q9UHJ3	3	52903572-53046750	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 30.2"	"Cell type enhanced"	"Detected in many"	10	"Spermatocytes: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036152, HPA064564"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036152: AB_2674972, HPA064564: AB_2685288"	"unprognostic (2.78e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.39e-2)"	"unprognostic (6.79e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.57e-3)"	"unprognostic (7.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.55e-2)"	3.1	2.4	5.1	7.0	3.7	5.5	6.8	10.5	5.8	3.2	4.9	3.1	2.7	3.1	2.8	5.2	4.9	3.7	3.8	4.8	4.1	2.4	4.5	6.3	7.3	6.3	2.6	4.3	2.4	11.8	15.1	12.0	3.1	3.1	4.6	5.4	2.9	4.6	2.1	17.7	4.8	4.4	4.1	4.1	5.9	4.2	30.2	2.4	3.9	5.1	2.7	5.6	3.2	12.9	8.2	0.9	10.9	2.1	3.6	5.3	2.4	15.3	4.2	6.9	12.4	1.5	1.1	14.0	3.4	3.2	10.3	12.8	8.6	13.3	7.9	4.0	2.1	11.3	1.3	6.8	4.3	12.5	14.3	4.3	6.6	8.9	3.8	2.4	10.4	6.9	1.0	6.3	7.0	4.8	1.1	1.8	9.1	2.2	11.9	3.4	4.8	6.5	4.2	3.6	5.9	4.5	5.9	6.3	4.4	1.4	16.6	8.1	5.1	14.5	6.0	7.3	0.8	3.9	9.7	1.1	4.6	10.4	7.9	10.4	5.7	19.9	16.9	4.2	4.3	7.7	2.0	2.1	10.9	3.4	1.1	4.5	8.2	5.2	3.1	0.9	6.9	4.8	5.3	3.8	3.6	1.1	0.9	2.5	2.4	5.1	3.7	10.5	5.8	4.1	2.4	2.6	4.3	3.1	2.4	8.9	6.5	14.7	7.5	10.3	13.3	13.7	12.7	13.4	6.8	1.8	43.2	8.8	6.6	6.0	33.8	4.5	6.2	23.3	11.7	8.3	4.2	7.6	9.2	12.4	5.6	7.9	5.8	3.7	5.3	43.6	2.0	5.4	0.0	4.6	8.5	6.0	8.6	8.6	7.1	6.9	21.2	6.5	5.9	123.8	23.2	7.5	4.5	12.5	10.6	4.2
SFPQ	"PPP1R140, PSF"	ENSG00000116560	"Splicing factor proline and glutamine rich"	P23246	1	35176378-35193148	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, DNA damage, DNA recombination, DNA repair, Immunity, Innate immunity, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009886, HPA047513, HPA054689"	Enhanced		Enhanced	Nucleoplasm		NA	NA		280000	Nucleoplasm		"CAB009886: AB_2186937, HPA047513: AB_2680073, HPA054689: AB_2682574"	"prognostic favorable (9.56e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.99e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.91e-13)"	"unprognostic (3.10e-1)"	"unprognostic (4.00e-3)"	"unprognostic (3.85e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.03e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.16e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.07e-1)"	"unprognostic (3.77e-3)"	40.5	35.7	31.5	39.4	31.4	122.5	48.3	53.0	38.5	39.0	31.4	37.8	32.9	30.0	45.3	36.5	45.5	43.0	28.1	34.0	29.1	24.6	36.4	34.2	47.6	48.8	26.3	32.6	59.9	40.2	45.8	46.3	35.5	31.9	35.5	38.0	35.7	39.6	38.0	44.9	42.9	34.1	36.5	32.8	42.4	35.5	37.5	32.9	95.2	35.3	24.1	60.6	35.9	38.6	6.9	11.2	4.4	8.8	4.9	8.9	3.3	36.4	30.5	53.2	30.1	13.1	19.7	49.9	20.0	20.3	34.2	25.0	33.1	26.4	66.6	27.8	23.1	21.4	33.4	57.8	39.1	46.6	35.5	38.4	50.0	32.9	39.3	17.7	52.0	29.8	15.7	15.2	29.6	14.4	15.2	29.7	35.3	56.5	31.8	33.2	31.7	60.8	44.6	63.4	22.0	29.5	61.9	36.1	43.3	33.0	44.3	38.4	42.7	28.8	22.5	28.9	38.9	26.3	37.1	31.6	27.4	40.3	17.9	42.7	36.5	31.0	67.8	19.5	34.5	38.9	2.6	6.5	4.4	7.7	8.8	8.9	6.2	7.6	6.1	5.8	6.9	7.2	7.9	3.4	4.9	6.4	11.2	8.2	3.3	31.5	31.4	53.0	38.5	29.1	24.6	26.3	32.6	31.9	32.9	157.8	233.8	123.2	218.3	317.6	223.2	127.3	68.8	123.1	187.7	104.7	180.6	178.4	69.6	106.2	101.7	173.0	92.7	46.7	119.2	185.7	204.4	133.7	151.3	95.2	121.1	162.1	210.6	114.8	123.3	250.0	132.3	139.5	133.3	108.2	106.4	182.5	126.2	101.2	109.6	66.5	219.0	51.8	200.9	192.3	171.1	286.1	255.5	127.5	133.5	143.0
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Predicted intracellular proteins, Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 66.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in all"	5	"granulocytes: 34.2;T-cells: 16.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	5.6	14.0	15.2	12.0	20.9	12.9	8.1	20.7	24.5	6.5	18.8	7.9	5.3	13.2	6.5	6.0	12.6	6.6	7.1	9.4	14.5	18.3	28.3	66.8	5.3	17.0	15.3	17.0	13.6	9.7	7.4	11.8	10.4	15.1	7.6	12.5	5.7	7.7	8.0	11.7	6.3	13.4	8.1	15.0	8.2	10.1	5.0	11.0	13.9	7.7	7.3	17.8	11.3	9.1	4.5	3.0	34.2	2.6	4.8	16.0	5.6	10.2	32.6	16.7	18.1	5.7	12.4	26.9	26.3	11.1	22.2	21.5	40.8	20.8	21.5	20.5	13.7	27.4	13.2	31.9	45.8	24.1	52.5	26.7	15.8	29.4	17.8	8.4	30.8	20.0	10.1	9.0	24.6	10.8	13.2	17.0	20.0	22.6	17.1	16.1	36.0	35.9	2.4	13.1	17.4	10.7	30.2	17.1	23.0	8.4	40.4	28.5	18.2	25.3	24.0	12.8	14.4	11.6	10.2	16.5	17.6	27.9	12.9	34.2	21.8	25.6	49.1	28.9	27.8	18.3	34.2	2.1	10.4	11.3	2.6	9.4	4.5	16.0	12.6	3.0	3.8	12.7	12.9	0.6	4.8	1.7	1.4	12.7	5.6	15.2	20.9	20.7	24.5	14.5	18.3	15.3	17.0	15.1	11.0	3.0	15.7	26.8	27.4	17.3	52.5	14.8	12.7	13.4	11.4	17.4	45.2	35.0	21.6	24.5	0.9	12.0	58.5	23.3	16.4	61.7	22.4	20.3	9.2	86.9	14.8	73.1	30.0	7.4	9.4	2.0	43.7	8.0	10.1	7.2	18.2	24.5	26.6	17.5	32.9	46.2	47.8	25.8	27.4	3.0	3.0	18.9	25.9	42.7	18.0	23.5
SFXN3	"SFX3, SLC56A3"	ENSG00000107819	"Sideroflexin 3"	Q9BWM7	10	101031234-101041244	"Predicted membrane proteins"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008028, HPA048105"	Approved		Enhanced	Mitochondria		NA	NA		81000	Mitochondria		"HPA008028: AB_1079938, HPA048105: AB_2680265"	"unprognostic (2.55e-1)"	"unprognostic (3.32e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.82e-2)"	"unprognostic (4.94e-3)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (3.84e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (3.56e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	14.4	8.1	11.5	8.7	13.9	4.1	10.7	40.2	22.9	14.5	19.0	15.5	13.6	24.4	13.8	17.7	6.5	14.9	12.9	11.3	12.5	9.8	9.2	3.4	16.4	5.4	18.3	13.7	10.6	7.0	17.1	6.9	16.2	18.4	8.8	8.4	9.1	8.4	13.8	2.7	15.7	44.8	19.9	13.7	8.3	8.2	5.6	16.9	4.3	7.5	5.1	5.5	10.7	11.2	2.2	15.7	8.9	14.8	4.3	9.8	8.3	15.2	5.9	0.6	1.8	16.0	17.0	1.6	9.3	32.9	11.9	9.6	9.7	16.8	0.6	8.9	21.7	10.0	11.2	2.8	20.3	5.2	4.2	3.6	1.8	9.8	7.0	11.0	1.4	14.8	11.7	3.0	10.4	9.9	33.2	26.0	4.4	0.1	0.5	19.3	2.5	0.6	2.2	0.7	5.6	14.3	1.4	11.7	4.1	17.5	2.4	3.2	15.9	5.1	0.6	13.8	4.4	4.9	10.8	21.4	10.5	8.3	9.3	4.5	2.4	0.9	0.0	25.6	8.2	8.4	8.9	14.8	7.1	9.8	11.1	7.5	2.2	6.7	6.6	15.7	1.0	4.1	5.1	2.8	4.3	6.1	2.5	7.0	8.3	11.5	13.9	40.2	22.9	12.5	9.8	18.3	13.7	18.4	16.9	11.9	4.0	0.9	4.8	12.4	61.6	2.4	12.7	18.7	3.4	5.2	45.2	0.9	1.7	28.4	54.3	14.7	10.8	0.0	13.5	37.4	14.4	3.9	13.9	0.8	32.6	9.5	5.2	17.2	20.0	97.0	16.1	21.3	32.1	7.2	5.7	7.8	29.0	5.8	13.8	12.3	23.1	12.9	13.0	1.1	0.5	9.5	9.2	13.1	2.5	2.6
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 141.3"	"Cell type enhanced"	"Detected in many"	5	"Ito cells: 455.4;Syncytiotrophoblasts: 484.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 11.7;eosinophil: 45.9;neutrophil: 26.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 45.9;monocytes: 11.7"	"Cell line enhanced"	"Detected in many"		"HHSteC: 51.2;RPTEC TERT1: 78.5;SK-MEL-30: 50.9;TIME: 61.1;U-266/84: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	45.6	35.5	16.8	12.8	43.2	15.8	22.9	10.6	25.0	18.4	62.3	51.7	10.8	14.2	14.9	11.2	30.0	16.1	47.8	12.5	22.9	9.6	37.5	51.1	31.2	8.4	48.8	16.6	47.2	47.8	141.3	4.7	19.2	28.3	18.3	11.3	45.8	26.2	18.4	12.4	25.8	131.8	13.6	40.3	7.6	31.1	12.2	50.1	6.2	22.3	24.8	20.4	26.1	31.7	0.6	4.0	45.9	11.7	0.9	0.7	3.1	0.6	1.1	0.7	0.0	8.8	2.2	1.0	12.6	26.3	16.5	13.5	1.9	1.7	2.1	1.9	13.0	8.1	0.4	1.1	2.0	12.2	0.0	0.5	0.1	31.4	1.4	51.2	0.1	1.1	13.2	12.6	16.2	21.0	6.6	27.6	0.3	4.0	32.0	5.9	0.1	0.1	0.4	0.8	3.2	1.3	0.4	1.5	0.2	78.5	0.2	0.3	3.1	39.6	0.1	50.9	7.6	0.1	0.3	61.1	4.8	2.1	29.5	2.7	6.0	56.0	6.5	4.5	1.9	6.5	0.6	11.7	45.9	0.2	6.8	0.5	0.6	0.4	0.2	4.0	0.4	0.5	0.6	26.2	0.9	3.7	0.2	0.7	3.1	16.8	43.2	10.6	25.0	22.9	9.6	48.8	16.6	28.3	50.1	35.7	233.2	40.3	98.2	162.8	10.8	19.4	96.8	24.1	99.0	64.6	33.4	39.9	18.3	60.3	7.2	107.9	230.9	0.0	151.5	27.8	58.7	45.7	257.3	17.5	283.4	0.0	10.2	455.4	148.5	5.6	14.1	322.4	254.8	6.4	46.9	4.3	52.7	129.6	14.9	92.1	28.6	12.9	39.1	48.4	7.5	101.6	484.9	9.6	6.4	68.4
SGO1	"NY-BR-85, SGOL1"	ENSG00000129810	"Shugoshin 1"	Q5FBB7	3	20160593-20186292	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 40.1"	"Cell type enhanced"	"Detected in some"	27	"Cytotrophoblasts: 5.4;Extravillous trophoblasts: 33.5;Hofbauer cells: 8.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Not detected"	"Not detected"			"HPA035501, HPA069302, HPA069857"	Enhanced		Enhanced	Nucleoplasm,Kinetochore,Cytosol		Yes	Yes			Nucleoplasm	"Kinetochore, Cytosol"	"HPA035501: AB_2732469, HPA069302: , HPA069857: AB_2686214"	"unprognostic (6.87e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-2)"	"unprognostic (8.93e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.10e-2)"	"unprognostic (2.55e-6)"	"unprognostic (9.49e-3)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (1.52e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.64e-1)"	0.6	0.6	0.4	9.1	0.4	8.9	1.0	0.4	1.5	0.9	3.4	0.3	0.6	2.7	0.8	0.5	4.0	0.3	1.7	0.4	0.3	0.4	0.8	1.0	0.9	6.9	0.4	0.1	0.5	0.5	0.0	0.4	3.7	0.2	0.6	3.5	0.1	1.0	0.1	0.3	1.1	3.4	0.8	0.4	4.9	1.5	8.6	0.2	40.1	0.5	2.4	7.4	1.2	1.5	9.0	4.5	8.3	0.2	0.3	2.7	0.6	9.5	10.9	14.9	9.1	0.7	1.3	10.1	10.3	5.3	15.0	16.5	7.7	11.8	14.6	5.2	4.2	10.6	5.6	14.0	5.7	19.0	18.6	9.3	16.6	7.5	6.1	0.1	15.1	14.3	0.1	0.4	16.5	7.0	2.1	8.9	17.4	14.2	26.2	12.4	9.4	23.7	8.5	15.8	10.2	8.3	15.2	19.1	8.5	3.8	7.0	7.4	7.8	11.4	14.1	6.8	11.6	9.1	10.6	2.4	11.4	13.7	10.2	20.5	11.3	26.2	17.0	6.2	15.3	17.1	8.3	0.1	1.5	0.3	0.2	0.1	8.6	0.7	0.8	0.4	9.0	0.2	0.4	1.6	0.3	0.2	4.5	2.7	0.6	0.4	0.4	0.4	1.5	0.3	0.4	0.4	0.1	0.2	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	5.4	0.0	1.1	0.0	0.0	0.0	0.0	1.6	33.5	0.0	0.0	1.1	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
SGO2	"FLJ25211, SGOL2, TRIPIN"	ENSG00000163535	"Shugoshin 2"	Q562F6	2	200510008-200583782	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Meiosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.6;lymphoid tissue: 25.7;testis: 27.9"	"Group enriched"	"Detected in many"	4	"Ciliated cells: 14.7;Club cells: 11.4;Extravillous trophoblasts: 24.6;granulocytes: 10.5;Hofbauer cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA035163, HPA040817"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	Yes			Nucleoplasm	"Nuclear bodies"	"HPA035163: AB_10602397, HPA040817: AB_2677149"	"unprognostic (3.43e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.06e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.55e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.37e-4)"	"unprognostic (9.49e-2)"	"unprognostic (8.07e-9)"	"unprognostic (5.21e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.02e-1)"	5.3	1.7	1.5	8.6	2.3	5.3	3.5	4.0	3.1	1.6	2.7	0.7	0.3	2.1	1.6	1.0	3.7	1.6	1.3	1.4	1.9	1.5	1.8	1.0	1.9	6.5	2.7	3.7	2.2	1.2	1.1	0.9	2.2	3.2	1.4	2.9	0.1	1.7	1.5	1.0	2.0	2.8	1.7	3.5	3.9	1.7	27.9	2.3	25.7	1.5	4.1	7.0	2.0	1.8	3.8	2.1	12.6	1.9	2.4	4.2	1.4	15.7	7.4	17.9	8.0	2.4	3.9	11.1	18.1	7.6	15.6	15.7	11.4	10.7	10.3	8.5	8.6	16.5	11.8	15.7	9.4	26.7	20.6	7.8	19.4	10.7	8.1	0.7	20.2	15.7	1.5	1.1	15.7	8.1	3.8	13.8	14.7	14.9	15.2	29.5	7.0	16.2	8.3	12.7	11.2	18.5	12.8	23.6	9.4	6.5	6.2	10.5	7.2	13.3	6.5	7.9	15.1	6.9	11.9	8.3	16.4	16.3	15.0	15.8	6.9	14.4	22.4	10.3	13.6	23.4	12.6	1.8	5.1	2.8	1.7	1.9	3.0	3.2	2.8	1.0	3.8	2.4	3.0	1.3	2.4	1.9	2.1	4.2	1.4	1.5	2.3	4.0	3.1	1.9	1.5	2.7	3.7	3.2	2.3	3.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	14.7	11.4	0.0	0.0	3.2	3.3	3.1	0.0	0.0	0.0	0.0	2.3	24.6	0.0	0.0	10.5	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.0	0.0	2.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0
SH2D4A	"FLJ20967, PPP1R38, SH2A"	ENSG00000104611	"SH2 domain containing 4A"	Q9H788	8	19313617-19396218	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"myeloid DC: 1.4;neutrophil: 5.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.4;granulocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 50.7;U-2197: 37.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA001871, HPA001919"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA001871: AB_1079949, HPA001919: AB_1079947"	"unprognostic (9.08e-2)"	"unprognostic (8.40e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.72e-3)"	"unprognostic (3.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.70e-2)"	"unprognostic (8.84e-3)"	"unprognostic (2.81e-1)"	"prognostic favorable (6.02e-8)"	"unprognostic (1.67e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.51e-3)"	"unprognostic (4.11e-2)"	4.1	8.5	2.1	6.8	1.8	0.0	3.3	0.7	3.2	7.4	8.9	1.7	15.2	6.3	2.5	3.7	17.5	4.6	12.8	2.9	3.7	1.3	10.0	20.0	8.8	2.2	1.8	2.0	20.5	12.8	6.1	3.6	13.5	2.2	7.6	5.5	5.1	16.3	20.1	2.6	5.9	10.6	6.5	1.4	1.8	15.6	3.2	2.4	0.6	20.7	14.6	9.9	11.9	14.1	0.7	1.4	5.3	0.0	0.4	0.6	0.1	16.5	18.8	0.0	0.0	1.9	2.3	12.9	20.8	10.3	20.3	19.8	15.4	15.1	0.0	5.0	50.7	3.2	8.6	0.7	5.6	21.3	0.0	0.2	0.0	11.8	2.3	11.2	0.4	0.0	2.2	7.0	13.9	2.5	12.3	0.1	0.0	0.0	0.0	3.3	7.4	0.0	0.1	4.5	28.2	7.2	0.0	0.0	5.3	5.5	17.4	1.1	0.0	18.6	20.1	0.0	3.1	3.8	1.4	0.3	6.6	0.0	37.4	6.2	0.0	0.1	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.0	1.4	0.7	0.6	0.0	5.3	0.4	0.0	0.1	0.4	0.1	2.1	1.8	0.7	3.2	3.7	1.3	1.8	2.0	2.2	2.4	59.6	26.9	2.0	13.2	1.3	1.6	1.6	30.6	52.2	18.2	43.6	25.5	71.2	36.5	42.0	23.9	4.5	17.7	0.0	58.5	63.3	6.6	11.3	1.1	34.2	28.8	1.6	2.9	3.1	6.9	38.5	5.8	3.2	0.0	1.0	19.3	2.4	70.7	7.0	10.6	6.5	34.6	19.4	2.0	0.1	1.9	2.3	25.6	0.0	21.7	24.5
SH3BP5	Sab	ENSG00000131370	"SH3 domain binding protein 5"	O60239	3	15254853-15341368	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 199.4;Extravillous trophoblasts: 335.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036445, HPA057988"	Uncertain		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA036445: AB_10670106, HPA057988: AB_2683572"	"unprognostic (1.28e-3)"	"unprognostic (2.99e-2)"	"unprognostic (9.50e-2)"	"unprognostic (6.97e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.74e-2)"	"unprognostic (7.81e-3)"	"unprognostic (4.80e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.06e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.03e-1)"	38.6	72.5	12.7	20.0	13.4	29.9	35.7	34.8	22.3	30.5	12.7	20.7	42.0	7.5	33.9	20.4	11.9	32.2	29.0	9.6	17.2	11.2	19.6	9.9	38.8	25.1	13.0	18.9	49.6	7.1	30.0	14.7	19.5	15.1	13.5	4.9	12.4	22.4	45.1	61.7	10.1	10.3	21.0	19.0	14.8	7.2	17.0	10.8	9.3	20.8	7.7	18.9	25.3	44.3	13.3	4.8	8.0	3.9	13.0	28.9	9.5	7.4	3.7	1.7	3.5	16.1	13.6	94.1	4.1	2.7	2.2	2.8	2.4	3.4	6.2	1.7	10.8	4.7	0.9	0.8	3.5	1.9	4.8	3.4	4.2	16.9	0.4	6.1	1.1	2.1	10.9	2.6	10.2	2.2	10.6	31.4	8.1	4.6	2.1	3.0	26.6	14.8	6.9	3.7	0.9	5.6	0.2	8.4	28.1	2.7	12.4	4.2	2.2	5.6	5.1	5.9	7.2	4.6	3.1	24.1	6.0	8.4	5.7	3.1	0.8	1.7	4.3	11.5	4.1	8.1	3.5	3.9	4.5	28.9	1.3	9.1	10.9	13.7	19.9	4.8	13.3	7.5	9.8	8.0	13.0	2.1	2.2	5.7	9.5	12.7	13.4	34.8	19.2	17.2	11.2	13.0	18.9	15.1	10.8	0.0	18.9	87.1	5.5	15.0	40.9	0.5	7.6	6.7	17.0	64.6	13.7	9.5	3.3	2.9	199.4	71.8	1.4	0.0	7.7	335.6	62.1	6.6	2.3	5.1	28.9	62.0	2.4	138.1	68.8	76.3	45.5	65.1	32.1	17.2	1.8	4.7	3.6	0.0	111.4	22.1	45.9	6.5	7.7	2.1	3.0	10.7	144.9	40.5	0.9	8.1
SH3GL1	"CNSA1, EEN, MGC111371, SH3D2B, SH3P8"	ENSG00000141985	"SH3 domain containing GRB2 like 1, endophilin A2"	Q99961	19	4360370-4400547	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	Endocytosis		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 128.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021485	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA021485: AB_1856816"	"unprognostic (1.32e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (6.85e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.84e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.10e-4)"	"unprognostic (1.92e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (9.36e-8)"	"unprognostic (5.48e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.10e-2)"	20.5	22.4	12.8	17.7	14.5	28.9	17.5	19.1	25.9	21.6	18.7	13.3	11.9	25.4	16.9	12.1	66.0	15.0	16.1	13.2	13.0	8.0	13.8	19.7	14.8	13.0	11.4	13.0	23.5	20.5	5.6	17.3	33.9	9.4	17.1	6.2	14.9	22.1	16.8	8.6	40.4	29.8	18.8	9.0	19.5	16.4	13.7	11.3	10.1	14.2	19.1	33.0	22.2	30.0	6.1	6.5	9.7	5.1	3.8	7.4	3.4	31.7	14.4	15.0	19.8	17.6	27.5	27.7	27.7	24.0	24.8	24.7	22.5	16.8	7.2	11.8	27.5	12.0	26.3	10.6	30.5	6.6	9.5	17.7	8.6	19.9	29.4	25.5	7.7	9.8	23.0	21.3	20.8	12.9	12.3	29.1	7.0	22.3	16.4	19.8	26.6	7.5	8.1	37.6	11.6	16.1	5.9	20.9	12.5	19.5	28.2	14.8	22.8	24.5	24.5	17.4	7.4	16.8	12.3	43.8	23.9	17.4	49.9	28.1	10.5	6.4	7.6	34.3	20.2	32.7	1.0	3.8	4.8	5.0	1.9	4.8	6.1	7.4	6.9	5.0	4.5	4.2	4.5	9.7	3.8	5.1	6.5	6.6	3.4	12.8	14.5	19.1	25.9	13.0	8.0	11.4	13.0	9.4	11.3	8.9	22.1	14.3	32.2	54.0	16.6	3.3	7.6	6.7	9.1	8.7	5.9	32.6	11.6	31.4	5.6	21.5	32.5	23.3	25.4	128.0	43.2	30.1	9.2	18.8	42.1	9.5	9.8	33.7	15.9	4.9	30.2	14.3	21.9	16.2	16.3	12.4	36.0	15.0	22.6	17.9	8.0	12.9	23.1	13.3	12.4	75.0	37.0	13.8	16.4	59.9
SH3RF2	"FLJ23654, Hepp1, POSHER, PPP1R39, RNF158"	ENSG00000156463	"SH3 domain containing ring finger 2"	Q8TEC5	5	145936579-146081791	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 40.8"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 7204.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"basal ganglia: 11.5;cerebral cortex: 2.9"	"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"CACO-2: 34.6;GAMG: 15.3;hTERT-RPE1: 17.2"	"Region enriched"	"Detected in single"	14	"basal ganglia: 23.9"	"Region enhanced"	"Detected in some"		"basal ganglia: 14.5"	"HPA035903, HPA058119"	Uncertain		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA035903: AB_10696515, HPA058119: AB_2683611"	"unprognostic (8.90e-3)"	"unprognostic (2.00e-3)"	"unprognostic (5.11e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.47e-2)"	"unprognostic (9.96e-3)"	"unprognostic (8.22e-2)"	"unprognostic (3.92e-1)"	"unprognostic (7.37e-3)"	"unprognostic (2.44e-3)"	"unprognostic (1.66e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.13e-3)"	2.6	0.6	1.2	6.2	11.5	0.0	2.9	0.2	2.9	6.4	19.1	0.4	0.4	9.2	2.9	2.2	22.2	3.6	40.8	23.5	0.8	0.3	0.8	4.6	1.9	0.0	0.3	1.1	1.0	14.3	0.0	3.3	0.3	0.1	2.2	8.5	0.9	16.9	1.0	21.7	33.1	21.4	1.2	0.5	0.2	11.9	6.4	0.6	0.6	3.8	19.6	16.1	0.9	10.0	0.0	1.4	0.3	0.1	0.0	1.6	0.3	10.2	2.8	0.1	0.6	0.0	0.0	0.0	0.1	0.8	2.1	0.8	34.6	9.5	0.0	5.4	0.4	15.3	9.5	0.0	11.2	2.0	0.1	0.1	0.0	4.1	4.6	0.6	0.0	0.0	0.1	6.0	3.2	7.6	17.2	0.1	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.8	8.5	0.7	0.0	0.1	0.0	4.4	1.0	0.0	0.0	0.6	0.2	0.2	0.5	3.3	0.0	4.9	0.4	8.9	0.7	3.3	0.0	0.0	0.0	5.5	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	1.6	0.7	1.4	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.8	0.3	1.2	11.5	0.2	2.9	0.8	0.3	0.3	1.1	0.1	0.6	14.9	2.9	0.0	4.5	48.9	0.6	414.9	2.5	2.7	2.3	1.8	0.0	0.0	0.0	6.5	1412.5	1.5	27.7	0.0	7.6	0.0	0.5	1.3	1.1	8.3	0.2	0.0	1.2	0.6	0.0	7204.3	23.9	0.0	8.5	1.0	12.2	1.9	13.6	17.5	32.5	0.6	0.0	12.9	1.4	32.0	16.2	43.7	0.0	0.0	27.1	6.4
SHB		ENSG00000107338	"SH2 domain containing adaptor protein B"	Q15464	9	37919134-38069211	"Predicted intracellular proteins"	"Angiogenesis, Apoptosis, Differentiation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 74.8;Urothelial cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	71	"basophil: 8.1"	"Lineage enriched"	"Detected in single"	71	"granulocytes: 8.1"	"Cell line enhanced"	"Detected in many"		"OE19: 35.0"									"CAB010161, HPA049911, HPA052108"	Uncertain		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Nucleoplasm, Cytoplasmic bodies"	"CAB010161: AB_2187742, HPA049911: AB_2680949, HPA052108: AB_2681730"	"unprognostic (4.57e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.96e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.31e-3)"	"unprognostic (7.68e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.10e-1)"	8.6	5.6	7.5	5.3	15.9	7.2	8.0	1.4	12.5	8.2	8.4	16.1	3.2	10.1	6.1	5.6	19.6	5.9	29.4	20.2	8.9	5.0	13.6	34.2	11.6	3.1	17.9	5.3	5.6	17.8	13.7	13.1	7.7	12.6	12.9	7.0	7.6	18.9	11.3	6.4	13.0	9.5	11.9	7.6	6.7	14.1	3.5	16.3	2.7	7.7	10.3	11.1	10.7	11.9	0.0	0.0	8.1	0.0	0.0	0.1	0.0	8.1	12.9	1.4	0.2	1.5	3.6	2.3	9.0	11.0	6.3	4.9	3.0	5.7	0.0	10.9	7.7	14.6	7.8	5.1	13.3	4.4	6.9	10.3	0.0	4.5	9.5	10.0	0.4	0.4	3.2	4.2	9.9	7.6	14.7	6.4	1.3	3.2	2.7	7.3	5.5	1.0	0.4	3.4	35.0	12.3	0.4	3.8	0.4	13.1	2.9	13.9	11.1	1.2	9.8	2.2	11.5	6.2	0.5	7.9	2.9	10.6	1.5	14.3	0.8	0.3	0.1	17.4	0.8	2.8	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	15.9	1.4	12.5	8.9	5.0	17.9	5.3	12.6	16.3	6.0	6.4	0.5	74.8	18.1	0.3	8.1	35.7	2.7	6.8	21.0	7.9	8.6	13.3	14.6	1.8	9.8	10.5	0.0	17.2	1.0	5.7	35.8	0.0	19.8	5.2	0.0	7.5	5.5	1.3	3.4	0.6	2.1	6.8	0.0	10.6	2.0	17.9	8.6	0.4	18.2	1.4	0.0	4.7	0.5	6.8	29.6	3.3	0.0	7.4	45.7
SHC1	"p66, SHC, ShcA"	ENSG00000160691	"SHC adaptor protein 1"	P29353	1	154962298-154974395	"Predicted intracellular proteins, RAS pathway related proteins"	"Angiogenesis, Growth regulation, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001844, CAB005374, CAB016305"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB005374: AB_632395, CAB016305: AB_628249, HPA001844: AB_1856826"	"unprognostic (4.12e-2)"	"prognostic unfavorable (6.74e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.77e-2)"	"unprognostic (6.40e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (9.13e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (7.19e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.31e-1)"	45.1	36.4	14.6	27.8	15.9	20.4	43.6	11.8	12.6	33.9	30.5	11.1	32.9	23.1	34.8	28.1	31.4	32.5	30.5	23.4	11.7	8.5	30.1	54.7	37.5	36.5	13.9	8.7	36.1	21.5	23.0	44.7	47.3	18.9	31.9	23.7	31.5	22.4	24.9	22.1	20.3	39.5	35.4	16.0	38.6	25.8	16.2	11.1	19.9	37.7	21.1	29.8	40.4	31.2	13.9	21.8	31.9	27.0	12.7	23.7	19.8	13.8	28.7	22.1	35.5	24.2	48.6	11.6	50.5	46.0	29.4	22.4	10.2	33.4	7.4	41.4	60.7	8.4	11.9	5.8	50.0	26.5	9.1	3.2	19.1	23.6	18.0	63.4	6.1	21.7	72.2	59.4	36.6	45.6	80.2	64.3	3.2	8.4	60.2	61.4	11.3	7.0	3.7	19.3	11.3	12.2	6.4	7.3	15.4	14.1	10.5	2.8	76.9	30.2	16.9	16.5	40.4	24.7	13.0	76.3	46.4	29.0	9.8	26.4	27.2	17.4	12.6	45.3	8.3	60.0	17.0	20.8	31.9	23.7	27.0	23.5	13.9	19.0	20.9	21.8	13.3	15.6	14.1	17.0	12.7	25.7	10.0	14.1	19.8	14.6	15.9	11.8	12.6	11.7	8.5	13.9	8.7	18.9	11.1	26.8	24.2	12.3	42.7	31.7	4.8	2.0	20.4	6.7	15.9	5.2	5.9	21.8	6.6	27.1	0.6	78.8	30.8	0.0	24.3	49.6	36.6	37.1	17.3	38.1	20.4	23.8	12.1	79.2	21.7	1.5	21.3	17.3	16.9	10.8	23.3	10.0	25.1	25.1	32.5	7.7	6.8	19.4	41.2	2.8	5.0	31.9	50.9	14.1	20.4	37.3
SHOX	"GCFX, PHOG, SHOXY, SS"	ENSG00000185960	"Short stature homeobox"	O15266	X	624344-659411	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.3;breast: 13.9"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"pons and medulla: 6.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"BJ: 19.5;BJ hTERT+: 9.0"									"HPA035141, HPA060931"			Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA035141: AB_2674489, HPA060931: AB_2684388"	"unprognostic (7.51e-3)"	"unprognostic (1.99e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-1)"	"unprognostic (6.82e-2)"			"unprognostic (2.45e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.24e-2)"	"unprognostic (9.95e-2)"	"unprognostic (5.67e-6)"	"unprognostic (1.99e-1)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.38e-1)"	3.8	1.0	0.3	0.7	0.3	3.0	13.9	1.8	0.8	0.3	0.4	0.2	0.2	1.4	0.3	0.6	0.3	0.4	0.4	0.4	0.7	0.3	0.3	0.3	0.3	0.6	0.3	1.4	0.3	0.9	0.0	0.3	4.8	6.3	0.8	0.3	0.2	1.4	0.2	2.8	1.4	1.0	0.2	0.4	1.6	0.4	0.4	0.2	0.2	0.5	0.2	0.2	0.3	0.3	2.2	1.9	5.5	1.8	2.5	1.5	0.8	0.1	0.2	0.1	0.2	0.2	0.1	3.2	19.5	9.0	2.9	3.2	0.3	0.3	0.3	0.1	0.4	0.8	0.3	0.2	0.0	1.0	0.2	0.1	0.1	1.3	0.1	0.1	0.1	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.8	0.1	0.2	0.1	0.2	0.1	0.0	0.4	0.1	0.3	0.2	0.0	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.6	0.0	0.1	0.3	0.2	0.1	0.1	0.9	0.1	0.3	0.1	0.2	0.1	5.5	1.8	1.8	1.4	1.1	1.5	1.6	1.1	1.2	0.5	2.2	1.5	1.5	5.2	2.5	1.5	1.9	1.0	0.8	0.3	0.3	1.8	0.4	0.7	0.3	0.3	1.4	6.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1
SIK3	"FLJ12240, KIAA0999, L19, QSK"	ENSG00000160584	"SIK family kinase 3"		11	116843402-117098437	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 106.0;Late spermatids: 130.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045245, HPA048161"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045245: AB_2679270, HPA048161: AB_2680293"	"unprognostic (3.19e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.78e-2)"	"unprognostic (8.21e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (1.82e-1)"	"unprognostic (6.85e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-2)"	13.0	12.2	24.7	13.8	36.9	14.3	13.5	24.0	34.4	13.5	16.6	40.5	10.4	10.9	18.6	9.9	13.7	16.6	12.8	16.0	23.7	16.2	13.9	17.6	13.7	11.9	25.8	24.4	22.4	19.5	29.4	18.4	16.3	23.9	11.4	11.7	10.6	11.7	15.6	16.9	11.3	14.0	18.4	17.2	14.2	14.5	26.0	38.0	10.4	22.1	6.9	12.9	14.5	12.9	2.4	1.7	3.9	3.7	1.6	1.8	0.7	7.9	6.1	9.7	10.2	8.4	9.1	15.6	6.0	10.9	4.8	5.4	14.8	9.2	9.4	9.9	11.1	10.6	12.5	8.0	8.7	6.7	25.8	5.1	21.1	6.7	9.1	7.8	7.5	8.3	10.0	5.1	10.2	16.5	6.1	6.4	6.3	10.1	7.0	6.5	2.7	6.7	8.1	5.4	5.4	4.5	8.7	5.6	7.4	6.6	1.5	9.5	7.6	16.3	7.2	3.2	7.8	4.7	8.0	7.3	5.9	7.5	9.8	6.0	5.0	3.6	12.0	5.5	12.4	7.9	3.9	1.1	0.0	1.0	1.5	1.8	0.4	0.9	0.4	1.7	2.4	0.3	0.1	2.6	1.6	3.7	0.1	0.1	0.7	24.7	36.9	24.0	32.2	23.7	16.2	25.8	24.4	23.9	38.0	8.9	26.1	22.2	23.4	23.6	42.8	19.3	12.7	18.7	15.9	5.2	106.0	7.4	5.0	6.7	76.2	16.5	9.7	0.0	6.4	2.6	20.8	17.6	17.3	18.4	6.8	44.5	16.6	14.1	21.4	130.5	9.5	18.7	15.1	4.6	12.0	47.3	7.9	8.6	13.4	5.6	64.0	0.0	20.6	20.4	11.3	21.2	24.8	25.9	10.3	24.3
SIMC1	"C5orf25, FLJ44216, OOMA1, PLEIAD"	ENSG00000170085	"SUMO interacting motifs containing 1"	Q8NDZ2	5	176238367-176345991	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 29.3;testis: 41.5"	"Cell type enhanced"	"Detected in many"	8	"Spermatocytes: 64.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037889, HPA037890"	Uncertain		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			Nucleoplasm	"Nucleoli fibrillar center"	"HPA037889: AB_2675720, HPA037890: AB_2675721"	"unprognostic (1.15e-1)"	"unprognostic (9.97e-2)"	"unprognostic (3.81e-3)"	"prognostic unfavorable (2.32e-6)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.59e-2)"	"unprognostic (9.20e-2)"	3.1	15.1	5.4	5.0	3.9	2.0	3.3	10.2	5.4	7.5	4.5	2.0	2.9	3.9	8.0	6.8	3.1	9.3	5.3	2.0	6.2	4.4	1.8	5.1	3.1	3.5	2.5	3.0	29.3	3.4	4.2	7.6	3.3	3.4	6.1	4.9	4.0	3.8	4.7	5.5	2.3	5.1	6.2	3.0	5.5	5.1	41.5	3.7	4.5	2.1	2.7	3.4	4.4	5.4	7.1	8.1	10.5	5.3	10.8	6.3	3.5	1.8	5.0	16.3	13.0	8.5	8.4	8.2	6.9	6.8	7.2	9.0	17.5	5.4	0.0	8.6	8.0	14.8	1.7	17.6	12.3	9.0	3.1	13.1	8.8	3.3	2.2	19.1	9.6	6.8	5.6	5.1	4.8	8.7	5.3	6.7	3.2	22.0	8.5	8.5	8.6	9.4	7.6	5.9	2.3	5.5	14.0	10.8	12.1	4.8	3.7	10.7	11.6	7.6	1.1	6.6	5.9	4.4	18.4	4.7	8.8	4.7	8.0	5.9	2.1	2.4	13.8	3.5	6.4	5.0	7.0	5.3	10.5	5.2	5.2	6.3	7.1	6.3	4.0	8.1	6.9	5.3	4.1	0.7	10.8	4.0	3.9	4.1	3.5	5.4	3.9	10.2	5.4	6.2	4.4	2.5	3.0	3.4	3.7	8.9	3.5	2.7	4.8	2.6	15.3	3.1	2.5	2.7	3.4	1.8	3.9	0.2	1.7	3.2	27.6	2.1	5.3	0.0	3.2	2.1	4.3	3.7	0.0	7.5	2.0	17.5	12.7	4.9	4.1	9.8	27.6	2.8	5.0	4.6	9.3	5.8	4.1	7.0	32.5	2.1	4.5	32.3	5.3	64.2	24.7	2.3	0.7	5.0	8.9	2.6
SIN3A	"DKFZP434K2235, KIAA0700"	ENSG00000169375	"SIN3 transcription regulator family member A"	Q96ST3	15	75369379-75455842	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	Repressor	"Cancer-related genes, Disease mutation, Dwarfism, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004506, HPA047213, HPA062123"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004506: AB_2187766, HPA047213: AB_2679984, HPA062123: AB_2684689"	"unprognostic (1.94e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.15e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.52e-1)"	21.0	15.4	14.0	19.4	18.5	31.6	20.4	26.3	15.5	26.3	20.2	19.9	15.3	11.8	26.6	16.8	17.7	22.1	15.9	13.4	14.2	11.8	13.6	13.9	17.4	20.7	13.0	14.2	27.6	19.8	23.4	16.8	17.2	13.0	22.9	14.3	23.0	17.6	20.5	18.2	23.5	17.9	24.5	12.8	20.3	16.8	28.5	15.1	48.7	24.0	12.8	26.9	26.0	19.0	9.8	6.5	9.3	8.3	9.7	12.7	6.3	12.9	26.9	24.1	15.8	12.0	12.7	13.9	9.7	15.2	14.4	15.5	14.8	17.7	28.3	10.2	14.4	19.7	23.3	34.9	14.7	15.8	22.8	18.1	26.7	20.5	11.6	9.1	25.3	22.9	15.4	11.4	16.7	17.5	14.9	12.9	20.3	21.0	31.6	11.6	15.1	24.8	16.3	23.4	17.3	11.3	25.1	31.9	17.4	10.3	23.9	19.1	19.0	24.1	10.8	13.5	24.2	16.4	20.1	11.2	17.9	24.2	11.8	14.4	21.8	34.0	30.1	10.6	25.9	9.9	3.3	4.8	6.9	8.5	4.8	12.7	9.3	10.8	10.7	6.5	9.8	11.1	9.5	9.3	9.7	8.3	4.4	9.5	6.3	14.0	18.5	26.3	15.5	14.2	11.8	13.0	14.2	13.0	15.1	32.8	26.7	28.9	21.6	34.9	19.3	12.6	17.8	29.4	31.8	26.2	29.5	18.2	5.0	13.3	6.8	23.9	11.8	0.0	11.0	9.1	23.6	23.5	29.9	14.3	11.4	19.1	16.6	26.4	23.0	3.1	21.3	20.0	10.1	12.6	17.1	17.2	12.3	15.0	19.1	8.4	31.7	12.9	17.6	37.7	41.7	46.4	18.3	22.3	15.9	16.6
SIPA1L1	"E6TP1, KIAA0440"	ENSG00000197555	"Signal induced proliferation associated 1 like 1"	O43166	14	71320449-71741229	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 18.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002875, HPA077689"	Approved		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"HPA002875: AB_1079974, HPA077689: "	"unprognostic (1.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.34e-2)"	"unprognostic (5.64e-3)"	"unprognostic (4.19e-2)"	"unprognostic (4.14e-1)"	"unprognostic (7.89e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.09e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.27e-2)"	"prognostic favorable (6.80e-8)"	"unprognostic (1.02e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.03e-2)"	4.5	12.0	27.1	8.2	36.4	7.8	6.8	21.7	35.7	7.7	8.9	5.3	1.0	7.6	5.4	8.7	11.2	10.6	11.8	2.4	17.5	10.4	11.7	9.3	8.6	7.6	8.1	23.9	3.6	9.5	23.6	13.0	3.6	10.1	6.2	9.0	7.3	7.6	6.9	2.2	6.4	8.0	8.0	6.8	18.1	13.8	14.5	7.2	3.1	11.0	3.2	11.5	7.7	4.8	6.8	1.0	18.7	5.3	1.6	3.3	1.6	10.4	3.3	7.6	5.7	2.3	6.7	13.9	14.3	17.0	5.8	7.4	18.9	5.9	4.9	3.7	23.3	5.3	10.4	5.5	12.8	11.1	4.4	2.6	10.3	21.6	4.4	19.3	1.2	4.0	4.8	10.8	9.0	21.3	6.6	6.2	6.9	4.5	12.4	7.9	15.8	4.1	1.1	4.3	9.6	9.0	6.1	8.2	5.2	4.2	16.2	9.5	25.3	14.6	11.5	1.0	5.1	6.8	0.5	17.1	41.7	15.4	4.7	8.1	10.1	11.4	7.3	7.1	3.4	13.8	4.0	4.0	0.8	1.5	4.7	3.3	2.6	1.3	2.0	1.0	6.8	0.9	1.0	18.7	1.6	5.3	0.3	1.2	1.6	27.1	36.4	21.7	35.7	17.5	10.4	8.1	23.9	10.1	7.2	62.5	26.2	15.9	13.3	10.5	18.4	4.7	20.4	41.5	25.0	14.0	17.7	6.5	11.6	19.2	55.7	10.5	16.7	0.0	17.6	7.2	9.7	8.7	12.8	15.3	4.8	55.6	31.2	4.9	19.1	22.9	7.2	29.8	5.0	36.1	16.2	65.5	16.4	14.0	33.2	23.3	13.7	0.0	12.2	23.2	34.3	7.3	7.9	13.8	22.1	23.8
SKAP2	"RA70, SAPS, SCAP2, SKAP-HOM, SKAP55R"	ENSG00000005020	"Src kinase associated phosphoprotein 2"	O75563	7	26667062-26995239	"Predicted intracellular proteins"	"B-cell activation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 255.1;Kupffer cells: 178.5;Late spermatids: 271.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005560, HPA024045"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		3200000	Nucleoplasm	Cytosol	"HPA005560: AB_2667360, HPA024045: AB_2671416"	"unprognostic (8.52e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.76e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.91e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.51e-2)"	20.8	22.5	11.5	29.4	12.9	12.8	28.5	6.0	12.8	7.7	15.3	7.6	11.0	10.5	5.2	15.4	14.0	9.4	9.6	12.6	9.5	12.1	20.4	7.8	31.6	36.4	12.0	8.9	13.3	6.1	25.1	10.9	5.3	15.5	10.2	15.0	2.5	5.8	9.8	8.3	8.6	16.5	21.1	42.6	31.8	11.7	10.1	11.5	6.4	6.1	1.9	19.3	19.3	28.1	9.9	12.3	37.3	18.0	8.3	5.1	6.7	11.7	6.2	0.6	15.5	2.9	2.4	3.8	4.8	7.2	2.4	6.0	4.9	47.4	9.1	21.1	9.0	17.5	6.3	8.5	4.9	5.0	5.1	13.7	10.0	1.8	6.5	3.9	18.4	35.4	10.6	4.6	6.9	9.5	0.4	14.4	0.0	5.3	4.7	9.4	2.2	0.0	9.3	0.5	10.5	6.1	11.9	1.5	0.7	29.3	9.2	7.7	0.2	8.7	4.7	6.3	3.7	6.5	9.7	21.0	4.0	0.1	13.3	4.9	7.5	9.5	15.9	9.5	23.9	15.2	8.2	12.6	19.4	3.7	15.0	5.1	9.9	2.1	3.0	9.6	8.0	0.5	2.9	37.3	8.3	18.0	12.3	3.5	6.7	11.5	12.9	6.0	12.8	9.5	12.1	12.0	8.9	15.5	11.5	17.9	29.9	77.3	32.3	23.6	12.3	4.7	5.1	14.7	9.1	22.7	11.8	11.1	54.7	7.9	255.1	35.8	46.2	23.3	20.3	18.4	9.5	16.9	50.9	8.3	82.6	4.8	41.3	90.9	178.5	271.4	8.3	120.8	18.6	28.9	64.6	13.0	15.8	31.6	10.3	65.3	12.7	0.0	12.0	19.9	34.3	37.9	15.6	34.8	45.4	27.2
SLAIN2	"FLJ21611, KIAA1458"	ENSG00000109171	"SLAIN motif family member 2"	Q9P270	4	48341322-48426212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 234.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035824, HPA063599"	Approved		Enhanced	Centrosome,Cytosol		NA	NA		13000	Centrosome	Cytosol	"HPA035824: AB_10602399, HPA063599: AB_2685056"	"unprognostic (6.20e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (5.77e-4)"	"prognostic favorable (7.98e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (6.71e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.72e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.00e-2)"	14.8	9.3	6.8	11.7	8.6	7.0	12.6	9.2	10.7	18.4	20.7	6.1	11.7	6.9	18.1	12.2	24.0	14.3	12.3	21.3	7.3	5.6	12.8	16.1	14.0	10.6	7.6	7.2	16.4	10.4	17.2	9.4	29.7	8.0	19.0	13.1	14.1	15.2	17.3	49.2	20.1	15.5	30.6	6.2	11.4	13.2	23.6	5.8	23.8	12.1	22.2	16.9	24.9	23.7	7.7	8.5	10.9	8.6	10.7	13.5	4.2	12.5	4.9	9.0	8.8	13.9	17.2	6.3	19.4	24.8	17.4	18.1	4.9	10.6	7.6	12.0	22.2	31.3	8.3	36.7	18.2	30.7	6.2	3.7	13.3	7.3	5.6	15.0	12.1	13.6	14.6	27.0	20.1	23.5	13.1	10.2	6.8	8.4	8.5	17.4	6.4	13.9	10.0	3.8	9.9	7.1	7.9	17.5	4.8	15.2	13.9	6.0	7.6	7.9	5.9	8.3	8.6	7.4	8.7	12.9	19.1	18.1	12.0	19.7	11.6	12.0	6.5	15.0	13.8	13.7	10.9	8.0	9.6	8.8	5.8	9.9	6.1	11.0	13.5	8.5	7.7	9.1	9.8	7.5	10.7	8.6	2.9	7.1	4.2	6.8	8.6	9.2	10.7	7.3	5.6	7.6	7.2	8.0	5.8	50.6	34.2	23.6	40.6	74.9	14.4	68.6	15.3	75.0	27.3	26.2	13.7	24.2	18.3	26.4	122.5	23.3	27.7	0.0	30.2	23.9	23.6	48.5	21.8	28.9	19.9	33.4	24.2	22.1	17.5	234.7	25.3	24.3	18.6	29.7	30.2	19.7	25.2	28.8	34.6	20.7	38.1	32.3	32.3	69.6	47.8	79.9	63.2	29.8	19.0	50.2
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7;U-266/70: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.7	2.9	1.7	8.8	3.8	2.5	2.4	7.1	3.5	3.0	5.1	0.8	0.5	12.2	1.6	11.1	3.7	10.8	3.4	0.9	3.1	4.9	1.3	6.3	3.5	7.5	8.1	10.6	5.9	1.1	18.8	4.0	6.2	1.0	1.8	12.3	4.9	30.9	2.1	3.3	9.0	7.0	1.2	4.9	3.5	3.3	0.4	30.3	1.2	1.9	7.5	3.6	4.4	4.0	72.7	0.8	4.8	11.7	0.4	4.1	4.9	7.9	4.3	34.0	16.8	29.6	6.0	21.4	21.7	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5	0.0	2.4	14.5	2.0	17.7	5.4	4.4	2.5	4.0	1.2	1.8	31.4	0.9	0.0	1.4	23.4	4.5	0.7	0.0	8.1	1.1	5.6	2.5	6.9	10.9	17.4	6.4	8.1	9.2	4.5	34.0	10.3	9.5	81.0	5.4	6.2	14.7	8.6	0.0	28.0	1.2	16.5	0.0	9.0	1.1	0.6	5.4	2.1	2.5	4.4	0.9
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 34.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 34.6;monocytes: 22.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	39.3	5.7	3.4	16.0	5.4	16.2	45.0	0.9	3.0	20.7	15.8	5.0	50.4	4.9	14.3	33.7	33.9	18.1	31.2	10.0	4.5	2.2	23.7	4.1	23.4	17.7	8.2	0.9	33.3	24.6	0.2	9.1	25.8	4.9	35.2	13.8	5.2	99.0	55.7	6.9	18.6	12.1	23.1	5.3	19.8	17.9	21.7	6.1	14.9	6.5	28.4	25.9	48.3	44.9	7.0	34.6	0.9	22.4	6.9	5.6	7.4	23.8	44.1	10.6	16.0	27.7	23.6	25.1	34.1	39.0	25.6	37.2	40.0	27.0	26.2	16.7	84.6	14.7	38.5	30.9	40.5	19.1	17.3	28.0	43.4	16.9	37.5	71.7	30.2	25.6	38.3	101.3	30.0	76.2	8.6	13.6	35.0	45.8	69.4	13.6	40.6	13.8	81.3	18.5	85.5	19.4	15.7	12.0	37.2	14.3	52.2	16.4	12.0	16.8	46.0	36.5	8.6	26.5	39.9	10.1	15.4	24.7	12.0	27.7	43.1	41.6	21.8	29.0	37.7	37.7	0.0	11.5	0.9	5.3	19.9	4.4	7.0	3.1	3.7	17.8	2.5	0.7	2.3	0.3	6.9	22.4	34.6	5.6	7.4	3.4	5.4	0.9	3.0	4.5	2.2	8.2	0.9	4.9	6.1	0.0	15.9	11.9	134.3	51.3	0.1	19.9	20.4	4.0	7.9	0.0	0.0	80.4	3.3	26.8	14.6	17.1	22.0	93.5	55.3	97.4	44.3	44.4	28.8	0.5	33.9	0.0	10.3	26.4	16.8	10.3	17.5	27.3	18.6	10.8	88.4	0.6	35.9	74.6	18.4	23.9	0.8	6.5	22.6	4.4	4.3	24.7	20.4	20.8	50.3	96.8
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	24.2	5.4	16.6	5.1	11.4	15.1	8.3	8.5	10.0	15.1	16.7	6.6	8.1	0.0	7.8	15.6	6.7	9.5	4.9	13.7	20.5	6.0	2.5	1.5	8.1	3.2	9.5	3.9	3.2	11.2	9.7	8.8	11.3	9.8	11.5	3.5	4.1	8.2	19.1	15.9	2.2	0.8	9.8	10.0	6.2	4.1	21.7	7.2	10.2	12.5	3.2	5.5	12.0	8.6	11.2	16.4	8.3	6.9	7.8	8.6	4.4	15.3	9.1	2.3	1.3	0.0	2.9	7.1	5.1	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5	50.6	26.7	15.9	17.7	13.9	14.1	12.9	20.4	57.6	36.4	17.4	7.9	5.8	18.3	29.1	2.2	20.4	70.3	0.0	32.1	55.2	18.8	10.7	21.9	0.4	48.5	9.5	17.4	36.8	51.2	2.1	18.1	43.2	21.9	26.2	43.1	8.9	48.3	51.2	17.0	19.3	31.4	51.8	17.9	4.3	1.3	13.0	5.1	13.1	47.4	29.8
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 113.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	113.2	11.9	0.0	0.0	0.0	0.0	0.0
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319258-71381423	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 36.0;Extravillous trophoblasts: 36.5;Hofbauer cells: 32.2;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.8;Hep G2: 22.0;RT4: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	11.3	4.0	6.4	6.6	8.3	1.9	6.8	3.2	12.6	8.3	6.1	11.3	2.4	4.1	12.1	4.6	3.5	9.4	7.4	3.6	8.0	5.5	3.9	12.5	11.1	10.5	9.8	6.5	15.8	7.4	7.1	2.8	24.6	6.7	8.3	6.0	4.6	7.5	5.4	2.1	3.7	4.9	8.9	8.0	9.4	8.9	4.9	7.7	9.3	6.7	1.3	6.2	18.4	10.0	3.6	19.3	2.8	12.9	5.7	4.0	5.6	1.2	7.4	1.1	4.7	4.2	3.3	19.8	1.4	1.4	0.4	0.2	8.1	5.2	4.3	4.0	2.8	2.0	11.7	3.4	1.9	0.0	3.4	3.3	1.3	0.6	22.0	2.0	1.0	2.8	3.2	8.1	0.2	0.3	0.9	1.9	5.3	3.9	4.1	0.5	11.4	2.7	2.1	2.5	11.4	2.7	3.4	0.4	3.4	1.7	17.5	5.6	5.9	3.9	12.8	1.0	3.5	1.9	2.3	3.1	0.1	2.4	1.3	0.0	1.1	1.8	2.4	5.1	14.5	0.8	2.8	12.9	1.4	4.0	10.1	3.4	3.6	3.2	3.6	19.3	1.5	2.6	3.6	1.0	5.7	6.3	13.6	3.4	5.6	6.4	8.3	3.2	12.6	8.0	5.5	9.8	6.5	6.7	7.7	3.0	0.6	0.5	1.7	0.2	1.1	0.6	2.5	2.7	3.4	0.0	0.0	36.0	0.0	4.3	3.3	1.1	1.3	0.0	7.9	36.5	2.6	2.8	2.3	4.9	32.2	0.0	1.7	3.7	7.8	10.5	2.6	9.5	1.7	10.0	2.7	2.4	6.6	11.5	1.4	1.4	0.2	0.0	0.3	0.5	4.7	0.0	26.5	1.0	2.7	1.2
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		36000000	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.7	15.6	12.8	3.2	1.5	0.5	44.8	7.1	15.4	8.8	12.9	72.7	30.1	4.1	21.2	2.1	6.2	10.1	2.8	16.5	3.9	2.4	2.6	6.7	9.0	49.6	4.5	3.6	1.9	1.9	12.7	5.5	5.9	26.0	1.4	3.5	15.0	0.9	3.9	19.2	1.7	2.5	8.2	5.3	3.9	1.6	4.1	5.7	8.0	5.2	6.8	4.8	8.3	26.3	3.1	19.2	1.1	4.6	3.2	8.0	5.8	1.4	16.0	0.7	1.5	2.5	15.8	2.6	6.5	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5	0.0	2.6	23.8	35.5	254.3	8.1	23.0	25.5	28.1	9.1	26.2	62.8	686.5	5.0	47.8	4.0	9.9	16.8	303.7	10.3	412.9	42.1	25.5	5.8	1.3	74.8	4.8	17.6	0.6	1.3	0.0	7.2	3.2	20.3	61.3	13.7	394.9	72.4	18.7	13.8	1.6	31.1	0.0	20.2	0.0	1.7	208.3	2076.2	17.3	9.0	98.7
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	15.9	17.9	10.3	11.9	13.1	5.4	15.3	21.1	13.7	16.6	14.4	14.2	10.6	12.6	22.5	12.1	16.8	13.8	13.5	13.5	10.6	8.7	17.9	18.4	14.3	17.9	17.3	8.1	17.8	23.7	15.7	19.8	18.1	13.2	13.7	15.3	14.8	17.2	12.4	18.8	15.2	14.3	14.1	20.1	16.2	14.9	12.8	15.9	21.3	17.8	9.9	18.8	15.0	14.2	4.3	3.9	12.5	3.1	9.2	6.1	2.6	18.3	13.8	14.2	12.4	18.1	16.3	15.8	17.3	17.1	14.2	13.0	10.7	17.4	8.8	11.5	13.7	16.4	11.6	16.9	11.9	18.2	17.7	9.4	19.1	7.9	13.6	11.6	20.0	11.9	12.1	18.7	19.1	15.4	14.5	11.4	6.3	16.1	11.8	16.2	6.8	10.5	9.2	21.4	20.7	7.3	9.4	17.2	12.9	15.7	16.2	10.7	16.3	13.6	14.7	13.6	13.9	8.1	9.2	9.7	18.2	10.1	11.9	20.3	16.1	27.9	13.1	16.2	15.7	18.3	12.5	3.1	2.6	3.6	2.7	4.9	4.3	3.3	4.0	3.9	3.8	5.0	4.6	3.5	9.2	3.0	3.2	6.1	2.6	10.3	13.1	21.1	13.7	10.6	8.7	17.3	8.1	13.2	15.9	8.9	6.9	8.8	4.1	8.0	4.9	3.5	10.2	4.0	1.2	7.0	5.9	17.2	5.0	6.6	1.6	9.8	7.2	0.0	7.4	12.5	9.8	7.6	3.5	15.5	9.4	1.6	3.5	9.2	6.3	0.4	6.1	6.4	8.5	4.6	8.5	6.3	8.0	7.0	7.4	7.9	6.1	12.9	5.1	11.1	8.9	5.5	23.0	5.0	9.8	4.3
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572382	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	15.2	12.7	11.9	9.3	12.3	10.3	13.5	11.7	19.2	15.1	12.4	8.7	22.4	9.7	11.3	10.3	14.2	11.2	13.7	12.6	9.3	9.7	11.6	20.1	13.5	9.5	8.3	7.9	11.9	34.5	25.8	14.4	23.9	10.7	17.9	9.4	11.4	23.7	21.4	23.1	14.3	13.4	10.0	5.9	9.7	17.0	6.4	7.2	14.0	13.8	12.3	13.9	15.2	14.1	5.9	3.2	7.9	5.0	4.5	5.2	2.9	17.9	7.1	5.1	11.3	19.0	14.8	12.0	13.1	14.0	10.7	12.7	8.3	12.9	9.4	21.1	20.3	10.6	12.0	13.8	14.6	12.3	10.7	20.0	8.5	8.2	9.8	15.2	14.0	10.3	11.8	17.3	11.9	17.8	14.0	10.3	10.9	13.1	12.7	14.2	17.0	10.2	6.5	5.9	16.7	24.1	9.9	7.8	11.0	11.0	11.6	8.6	8.5	9.0	14.5	8.0	6.6	10.1	6.9	11.3	14.3	7.1	19.3	15.0	16.5	17.5	10.6	21.2	14.9	8.8	5.0	3.9	7.9	4.1	2.5	5.2	5.9	4.3	3.6	2.7	2.8	3.2	2.5	4.8	4.5	5.0	3.2	4.8	2.9	11.9	12.3	11.7	19.2	9.3	9.7	8.3	7.9	10.7	7.2	35.7	43.9	15.8	12.5	19.5	27.6	13.7	33.1	14.7	33.0	27.9	33.4	10.8	0.0	17.8	2.8	14.6	18.1	0.0	31.7	22.5	12.7	25.9	8.1	24.2	15.2	28.6	17.7	23.4	21.8	2.7	15.8	19.4	8.5	8.2	25.5	20.8	33.5	14.0	19.8	8.6	25.4	6.5	12.3	10.9	15.4	22.6	27.2	20.2	15.5	26.8
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81245000-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		44000000	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	22.8	18.6	8.1	17.0	11.3	18.5	43.0	9.9	10.2	15.8	23.8	13.8	22.0	21.8	17.4	30.7	13.2	15.2	28.4	17.3	7.4	9.2	18.0	59.2	24.6	23.7	11.6	6.7	23.7	55.1	6.8	30.2	23.2	10.0	16.0	6.5	15.1	33.3	26.1	8.7	11.2	26.2	10.9	10.4	21.0	19.1	25.0	12.3	20.2	25.9	10.3	15.8	18.4	13.0	6.6	10.0	17.2	15.4	4.6	9.8	7.9	17.3	30.5	5.3	28.1	20.6	9.7	31.9	21.4	19.3	13.1	15.5	14.1	29.2	13.3	24.5	14.7	14.5	21.0	5.4	10.7	4.9	13.3	16.0	13.4	10.9	23.9	18.4	13.1	32.1	16.8	8.0	11.8	7.7	10.7	25.1	9.7	9.9	20.6	9.8	22.1	8.0	22.5	5.3	16.1	15.1	13.0	11.2	13.4	9.2	16.4	10.3	26.7	17.2	10.8	23.3	7.8	15.4	27.5	24.6	21.2	12.4	15.8	11.4	18.1	7.9	7.6	12.6	20.4	21.7	11.0	10.2	17.2	8.1	12.0	9.8	6.6	7.8	9.8	6.3	6.6	5.4	5.8	8.2	4.6	15.4	10.0	5.5	7.9	8.1	11.3	9.9	10.2	7.4	9.2	11.6	6.7	10.0	12.3	23.8	35.2	11.2	10.8	7.3	11.5	14.7	40.8	6.7	18.2	10.4	17.7	47.8	5.0	33.0	17.9	21.0	56.4	0.0	23.2	52.2	22.1	16.5	15.0	66.3	42.5	23.8	43.3	27.6	39.2	46.8	30.5	26.6	13.5	19.0	55.6	28.3	24.6	42.1	25.8	20.3	9.1	32.3	15.3	16.7	21.5	6.4	52.3	17.5	40.8	10.0
SLTM	"FLJ13213, Met"	ENSG00000137776	"SAFB like transcription modulator"	Q9NWH9	15	58879045-58933653	"Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040256, HPA040381"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA040256: AB_10674990, HPA040381: AB_2676953"	"unprognostic (2.36e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.52e-3)"	"unprognostic (9.65e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.82e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.10e-3)"	"unprognostic (8.03e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.24e-3)"	32.1	20.2	26.1	37.1	27.6	46.9	35.9	38.0	28.8	32.6	28.2	25.9	27.6	27.4	27.4	25.2	35.3	25.0	25.6	24.6	27.2	24.2	29.5	32.1	25.9	35.9	34.1	29.3	29.0	22.4	40.0	40.9	38.2	32.4	26.6	30.5	20.6	38.1	45.6	39.4	32.0	29.2	29.0	34.3	38.2	34.9	24.4	34.6	50.5	32.9	30.5	38.8	31.3	32.8	31.2	32.4	32.6	21.1	27.2	29.8	12.5	27.5	30.3	26.7	13.5	18.3	13.9	22.6	20.1	23.4	18.5	18.1	20.9	16.7	52.0	18.8	18.3	20.3	24.8	26.4	22.8	25.9	33.3	17.2	37.7	31.7	15.8	16.0	29.6	29.2	12.9	22.9	19.6	16.5	11.4	17.1	24.2	33.4	30.3	21.4	19.8	29.4	22.9	29.9	16.5	14.8	22.7	24.4	25.0	22.5	36.0	22.0	19.0	20.8	20.4	20.3	31.0	16.3	32.4	17.7	22.7	33.2	24.7	26.7	21.4	42.2	37.8	18.0	36.6	22.6	32.6	18.9	25.6	29.2	18.0	29.8	31.2	23.4	24.8	18.6	27.6	25.7	23.0	26.9	27.2	21.1	32.4	20.9	12.5	26.1	27.6	38.0	28.8	27.2	24.2	34.1	29.3	32.4	34.6	142.9	158.5	113.0	87.4	86.1	111.1	98.2	50.9	128.5	149.0	101.2	92.3	60.3	66.3	78.9	82.2	77.3	62.6	23.3	101.1	133.7	70.3	79.3	113.5	93.5	57.0	112.8	70.4	49.1	81.2	88.7	80.0	95.3	74.2	90.2	65.9	83.4	100.5	58.8	83.1	61.8	133.5	71.1	74.5	165.4	68.0	91.5	94.1	94.8	69.0	108.9
SMARCA5	"hISWI, hSNF2H, ISWI"	ENSG00000153147	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5"	O60264	4	143513463-143557486	"Predicted intracellular proteins, Transcription factors"		"Chromatin regulator, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005227, HPA008751, HPA074181"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center"		No	No			Nucleoplasm	"Nucleoli fibrillar center"	"CAB005227: AB_2191863, HPA008751: AB_1857268, HPA074181: "	"unprognostic (9.21e-3)"	"unprognostic (7.99e-2)"	"unprognostic (4.99e-3)"	"unprognostic (8.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (3.85e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.82e-1)"	21.0	39.5	24.7	24.8	32.6	34.5	21.9	26.9	29.2	24.0	23.8	27.7	24.6	17.9	27.3	26.3	19.8	23.0	23.8	29.8	25.0	25.1	21.1	21.0	33.3	29.5	30.2	26.5	29.4	24.6	33.1	33.3	27.7	29.6	23.1	22.5	16.3	22.0	25.7	24.6	14.7	22.6	22.9	34.6	28.6	22.8	37.8	32.8	44.3	28.5	15.1	29.7	25.6	23.7	11.7	13.2	15.4	19.4	15.6	16.3	10.6	11.9	9.4	34.6	21.7	20.3	14.7	20.7	15.2	18.1	22.1	18.8	16.0	16.8	32.4	10.5	12.9	8.9	9.5	31.6	14.2	21.5	21.5	11.2	24.2	13.9	13.1	15.0	29.9	14.3	12.9	10.3	15.7	13.5	13.0	17.1	16.6	21.8	20.5	14.4	10.7	34.8	10.4	28.1	20.0	13.5	38.7	22.2	10.5	17.3	14.6	27.7	23.5	19.8	14.0	17.5	27.1	10.1	14.0	18.2	14.7	11.3	15.3	14.9	22.6	27.0	39.4	11.5	25.1	14.9	5.0	10.7	15.4	13.9	12.7	16.3	11.7	14.2	15.0	13.2	11.5	14.9	14.7	9.7	15.6	19.4	10.1	16.1	10.6	24.7	32.6	26.9	29.2	25.0	25.1	30.2	26.5	29.6	32.8	285.9	217.7	44.0	61.8	41.2	94.8	89.1	28.1	137.9	128.5	41.8	60.9	60.5	33.2	66.8	37.7	52.0	32.2	0.0	53.1	58.4	45.4	47.0	98.4	21.7	39.5	81.0	76.6	36.2	50.0	18.9	55.8	51.0	28.7	101.0	33.6	83.9	56.1	32.8	58.4	29.3	110.5	51.8	54.2	117.2	123.0	35.8	85.4	55.4	37.9	62.6
SMARCAD1	"DKFZP762K2015, ETL1, KIAA1122"	ENSG00000163104	"SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1"	Q9H4L7	4	94207611-94291292	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"Chromatin regulator, DNA-binding, Helicase, Hydrolase"	"Ectodermal dysplasia, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016737	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016737: AB_1857271"	"unprognostic (5.01e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.41e-3)"	"unprognostic (9.08e-3)"	"prognostic unfavorable (3.22e-5)"	"unprognostic (2.45e-1)"	"unprognostic (3.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (2.57e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.20e-3)"	12.8	15.4	15.4	22.2	14.6	8.6	20.1	26.7	25.1	15.4	13.6	9.4	14.4	12.6	19.6	17.5	17.2	16.5	13.9	12.9	13.6	14.7	16.6	14.9	21.6	22.8	17.6	11.1	20.8	15.0	17.2	33.0	18.3	14.9	15.4	16.5	10.2	14.9	20.9	11.8	26.5	13.9	15.6	17.9	17.6	13.9	15.3	16.2	42.0	20.2	11.4	17.8	16.0	15.9	5.5	4.3	3.5	3.0	7.5	6.2	2.7	7.4	9.7	30.1	19.7	8.7	14.3	15.6	13.3	12.5	11.1	10.7	8.7	12.2	19.2	9.2	11.4	10.1	6.5	21.2	11.2	16.1	14.7	9.6	13.8	10.5	13.3	12.6	20.1	14.8	14.6	9.3	13.8	17.8	13.8	17.3	16.8	22.8	8.0	16.8	5.9	34.2	10.7	20.9	9.4	4.8	19.9	17.2	9.8	13.0	9.1	17.7	26.2	10.2	17.2	14.6	19.3	8.8	13.6	16.3	14.5	15.5	8.9	10.1	11.3	16.9	23.0	13.6	10.8	17.9	3.5	2.5	0.3	4.6	3.0	4.8	5.5	5.1	4.9	4.3	4.2	5.5	6.2	0.0	7.5	2.9	3.7	4.1	2.7	15.4	14.6	26.7	25.1	13.6	14.7	17.6	11.1	14.9	16.2	11.9	9.9	6.0	5.4	10.4	19.7	12.3	5.1	37.5	34.2	8.7	15.7	11.2	1.7	10.8	1.7	14.3	5.0	0.0	8.7	9.4	10.1	5.8	22.1	11.0	9.3	17.5	8.6	11.1	14.0	1.8	13.3	12.3	3.3	7.2	12.6	9.4	12.3	8.2	17.3	12.7	18.1	6.5	7.2	26.5	34.0	8.4	8.0	16.2	10.9	3.8
SMARCC1	"BAF155, CRACC1, Rsc8, SRG3"	ENSG00000173473	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 1"	Q92922	3	47585272-47782106	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011576, CAB016336, HPA024352, HPA026853"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB011576: AB_2191988, CAB016336: AB_671095, HPA024352: AB_1857274, HPA026853: AB_10603030"	"unprognostic (3.47e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.83e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (3.37e-4)"	"unprognostic (1.33e-2)"	"unprognostic (4.28e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.66e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.45e-1)"	16.5	9.3	14.5	22.6	18.9	16.7	21.8	16.5	17.2	19.3	22.4	19.6	13.1	13.3	20.0	15.2	21.8	12.5	16.4	10.3	13.9	11.3	18.7	15.6	13.6	18.6	18.1	11.3	18.7	25.6	16.4	15.1	28.0	11.7	22.1	20.8	14.5	18.9	16.9	19.8	24.3	17.8	32.6	16.1	18.7	16.6	18.7	18.3	45.0	21.1	12.8	27.7	24.9	27.0	8.2	4.7	4.3	5.4	4.0	8.1	3.9	14.5	7.7	32.4	25.1	7.2	12.5	21.8	11.6	10.9	15.1	15.4	13.8	15.5	34.0	9.4	14.6	8.8	12.5	30.4	18.0	22.2	16.2	18.1	33.3	13.3	18.7	10.9	30.4	15.4	10.4	16.0	17.0	18.9	11.3	17.6	22.9	27.9	11.6	16.2	10.8	39.6	15.9	42.7	14.1	11.9	17.8	18.8	29.9	16.2	19.1	14.5	29.1	18.1	17.7	12.9	23.7	15.4	28.5	14.1	10.1	14.4	11.4	18.9	14.2	18.1	40.6	7.4	28.9	14.2	4.0	3.5	3.4	6.2	5.4	5.6	8.2	6.7	8.1	4.4	6.3	6.4	7.5	4.3	4.0	3.8	4.7	6.3	3.9	14.5	18.9	16.5	17.2	13.9	11.3	18.1	11.3	11.7	18.3	38.7	41.6	33.7	45.3	47.2	27.1	26.6	35.7	33.5	69.4	54.1	35.3	65.8	11.6	61.0	86.4	27.0	20.0	23.3	40.5	94.1	27.3	55.4	23.2	35.0	26.8	19.1	87.9	19.6	24.2	81.6	23.6	30.7	21.9	56.9	60.1	17.9	53.5	20.1	26.9	30.5	30.1	38.8	29.3	55.9	92.0	58.3	60.6	30.5	59.9	48.2
SMARCC2	"BAF170, CRACC2, Rsc8"	ENSG00000139613	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin subfamily c member 2"	Q8TAQ2	12	56162983-56189567	"Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004321, HPA021213, HPA061788"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004321: AB_2286337, HPA021213: AB_1857275, HPA061788: AB_2684608"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.31e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.74e-2)"	"unprognostic (8.79e-2)"	25.0	22.2	34.5	17.4	36.5	15.7	22.5	43.7	40.7	24.9	20.4	29.9	17.1	21.5	29.1	16.6	18.2	25.5	18.6	19.0	35.0	22.7	19.8	14.1	21.6	20.9	29.2	24.2	38.4	21.8	36.1	21.1	19.9	27.5	24.6	19.0	26.7	26.1	28.2	32.3	26.8	21.7	27.2	22.6	23.4	20.6	17.7	32.1	21.3	30.2	13.2	23.2	27.5	22.7	8.8	7.0	19.0	12.2	6.2	12.7	9.6	19.6	30.4	32.5	23.4	20.2	21.2	13.5	17.6	18.9	21.3	20.7	17.5	24.7	28.6	17.0	20.5	20.0	22.9	20.9	17.8	19.3	21.8	19.5	45.4	20.6	11.0	10.9	21.3	33.8	19.7	13.4	20.1	10.2	38.5	26.9	22.3	25.8	24.0	19.6	20.6	36.0	19.2	11.0	15.7	20.8	21.4	26.0	22.4	15.9	25.8	24.0	24.9	29.9	20.9	8.1	17.7	35.3	19.0	23.0	18.2	22.3	16.2	12.9	22.8	16.6	20.0	18.9	14.3	19.3	13.7	7.6	19.0	11.9	10.0	12.7	8.6	8.4	8.4	7.0	8.8	6.2	7.8	6.6	6.2	12.2	5.0	8.2	9.6	34.5	36.5	43.7	40.7	35.0	22.7	29.2	24.2	27.5	32.1	62.5	38.7	25.3	36.7	18.2	55.0	23.4	20.4	29.4	47.8	40.1	37.3	16.4	6.6	21.2	1.3	30.1	17.6	0.0	15.7	10.2	22.4	27.0	61.4	14.3	14.3	36.5	21.8	26.4	15.9	2.8	63.9	18.0	18.6	33.3	19.9	50.0	18.7	17.3	51.9	14.2	58.8	19.4	28.4	43.6	29.4	19.7	11.1	32.4	19.9	32.5
SMARCD2	"BAF60B, CRACD2, PRO2451, Rsc6p"	ENSG00000108604	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2"	Q92925	17	63832081-63843065	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059934, HPA061348"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059934: AB_2684170, HPA061348: AB_2684486"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.84e-2)"	"unprognostic (4.79e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (4.75e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (1.81e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.80e-2)"	22.0	25.0	6.9	23.1	11.5	21.2	25.6	29.0	12.5	21.7	24.6	14.3	36.5	17.8	17.2	25.8	30.7	22.7	25.9	13.4	8.6	5.3	16.0	21.3	20.1	26.5	15.8	8.9	18.0	42.5	17.3	16.1	33.2	10.1	24.2	18.0	15.0	42.9	30.2	11.1	36.3	25.6	22.1	8.9	26.1	26.4	17.7	13.6	40.6	23.3	23.7	28.0	23.7	22.5	11.0	14.5	13.0	11.6	9.1	13.6	6.7	26.2	17.2	4.6	20.8	29.1	47.6	26.0	9.8	14.7	21.7	14.2	20.1	15.2	30.4	5.7	17.7	8.9	18.0	14.9	22.6	13.7	8.1	35.7	20.7	7.0	29.5	23.9	24.3	23.1	37.0	28.3	11.6	10.3	12.9	17.8	22.4	16.3	18.5	12.9	63.6	38.5	26.1	10.7	42.2	19.7	39.4	16.1	35.1	15.7	20.0	17.4	30.9	12.3	50.9	21.1	15.2	47.0	24.3	11.7	13.8	8.3	12.6	16.9	21.7	16.1	20.6	10.8	24.2	10.0	5.4	11.6	10.6	11.5	10.0	7.6	8.8	12.9	12.3	14.5	11.0	8.6	11.6	13.0	9.1	11.5	12.9	13.6	6.7	6.9	11.5	29.0	12.5	8.6	5.3	15.8	8.9	10.1	13.6	26.8	46.8	21.8	16.6	20.4	10.3	5.0	25.5	22.7	27.3	15.7	5.9	43.2	3.3	14.5	0.8	14.6	27.6	0.0	17.0	34.6	23.0	18.1	13.9	72.9	19.3	11.1	31.8	22.1	34.0	2.4	45.8	19.0	13.5	16.2	38.9	16.7	17.7	31.5	29.0	10.0	11.6	32.3	15.0	13.4	17.9	27.1	44.3	13.8	36.8	16.2
SMARCD3	"BAF60C, CRACD3, Rsc6p"	ENSG00000082014	"SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3"	Q6STE5	7	151238764-151277896	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.2"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 59.6;Peritubular cells: 83.1;Sertoli cells: 64.7;Smooth muscle cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 8.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.6;granulocytes: 3.1;monocytes: 8.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 33.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063955, HPA065517"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063955: AB_2685159, HPA065517: AB_2685500"	"unprognostic (1.23e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.38e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.41e-3)"	"unprognostic (2.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.08e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.35e-3)"	"unprognostic (1.29e-1)"	9.7	16.0	34.2	4.0	40.3	4.9	9.8	25.4	36.8	12.9	5.6	7.8	7.9	2.9	8.6	11.4	6.7	14.5	10.7	38.5	22.2	24.7	4.9	2.0	8.3	4.0	18.7	18.8	19.2	7.5	6.8	14.7	4.6	13.3	10.8	3.6	7.6	6.6	18.1	75.2	5.7	3.4	10.0	14.1	4.3	4.8	9.0	11.6	0.0	7.4	9.5	2.5	10.1	4.8	0.2	2.6	3.1	8.8	0.0	0.8	2.1	0.3	2.8	9.4	33.3	15.0	6.7	0.7	6.1	6.2	3.6	2.1	2.1	1.9	3.6	2.2	9.6	1.4	0.6	7.5	0.6	1.4	1.1	4.6	0.0	1.9	0.6	12.9	0.1	6.1	15.9	0.8	1.2	0.1	15.7	0.7	9.3	7.2	1.2	19.0	3.8	0.6	4.7	2.9	0.9	1.2	0.2	14.8	0.1	3.2	0.0	5.4	11.0	5.8	1.0	4.4	1.5	0.8	9.3	1.1	2.3	3.7	7.1	2.0	7.9	0.0	3.0	6.6	8.2	10.3	0.6	8.8	0.0	0.2	1.9	0.1	0.2	0.8	0.0	2.6	0.0	0.5	0.8	3.1	0.0	0.4	0.0	0.7	2.1	34.2	40.3	25.4	27.9	22.2	24.7	18.7	18.8	13.3	11.6	6.0	20.8	0.0	31.9	9.5	12.7	59.6	17.8	6.7	5.7	10.4	3.9	0.4	26.6	14.9	1.8	4.7	0.0	0.0	2.1	0.2	19.3	7.3	2.3	0.4	3.4	11.1	3.4	2.5	17.1	8.9	46.9	6.4	6.8	1.0	0.0	23.4	4.3	0.0	83.1	1.7	4.6	64.7	51.5	1.7	9.5	4.1	0.9	0.9	0.0	8.1
SMC1A	"DXS423E, KIAA0178, SB1.8, SMC1L1, Smcb"	ENSG00000072501	"Structural maintenance of chromosomes 1A"	Q14683	X	53374149-53422728	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Meiosis, Mitosis"		"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005499, CAB025404"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB025404: , HPA005499: AB_1080028"	"unprognostic (2.00e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.89e-1)"	"unprognostic (9.80e-3)"	"unprognostic (9.49e-2)"	"unprognostic (4.48e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.18e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.89e-1)"	"unprognostic (9.39e-2)"	20.6	14.1	14.6	24.2	28.2	24.6	16.2	33.6	21.7	19.9	18.2	22.0	10.5	16.2	27.5	10.0	22.4	21.7	12.5	16.2	16.8	10.8	19.2	23.5	15.4	30.2	25.2	13.0	21.8	17.2	31.0	18.4	19.5	18.0	13.4	17.3	12.5	16.8	12.9	24.3	16.2	19.7	21.7	21.3	20.1	17.5	10.4	25.8	38.3	16.8	11.1	25.7	22.0	21.3	14.3	15.5	13.7	18.7	15.6	17.8	10.6	28.3	31.8	25.3	21.5	9.3	10.4	14.2	17.2	11.3	21.8	17.7	18.8	16.5	27.7	14.7	11.4	30.1	21.7	45.0	24.8	24.4	23.7	52.5	24.2	36.9	13.1	3.8	34.1	34.8	5.8	6.4	24.4	14.9	5.6	18.8	18.3	35.5	17.9	17.0	17.2	30.7	10.3	37.5	12.3	17.0	33.0	43.6	25.5	9.2	18.7	26.9	22.7	44.9	22.1	9.5	34.6	23.8	13.9	10.5	18.6	19.7	18.3	16.6	11.7	19.8	25.7	10.6	38.8	18.1	6.1	13.8	13.7	17.8	18.7	17.0	12.2	12.0	15.6	15.5	14.3	14.2	10.9	9.4	15.6	17.4	12.9	8.8	10.6	14.6	28.2	33.6	21.7	16.8	10.8	25.2	13.0	18.0	25.8	41.7	29.9	35.6	26.7	21.4	44.7	48.0	30.6	56.2	61.4	19.2	25.5	30.6	6.6	27.7	8.7	31.0	31.4	23.3	23.5	52.5	23.8	28.7	33.6	48.7	42.3	57.2	19.1	19.6	33.4	5.8	35.1	40.8	21.9	37.9	35.3	40.8	26.4	14.0	33.9	20.3	44.9	38.8	37.0	17.9	54.6	21.3	40.5	27.7	41.7	25.8
SMCR8	FLJ34716	ENSG00000176994	"Smith-Magenis syndrome chromosome region, candidate 8"	Q8TEV9	17	18315310-18328055	"Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation"	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021557, HPA024646"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021557: AB_1857283, HPA024646: AB_1857284"	"unprognostic (1.69e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.11e-3)"	"unprognostic (3.02e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.09e-3)"	"unprognostic (7.11e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.41e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.55e-2)"	"unprognostic (9.27e-2)"	10.4	10.0	6.1	11.1	11.4	25.0	10.5	13.9	15.8	8.7	8.5	11.2	10.6	8.0	12.2	6.9	10.4	9.1	7.8	7.3	7.2	6.3	9.6	7.9	10.7	12.4	6.7	5.7	10.8	9.6	14.0	17.1	11.6	9.3	9.7	9.3	12.0	13.6	7.9	13.3	10.4	13.0	7.9	7.1	16.1	10.9	8.8	8.8	15.8	9.5	4.7	15.8	12.5	10.9	1.1	1.2	5.2	2.2	1.1	1.2	0.9	5.8	8.1	4.1	4.7	5.8	3.9	7.5	4.2	5.6	7.4	7.2	12.4	2.5	3.4	3.2	5.1	8.4	7.8	8.0	4.9	6.9	7.0	6.8	6.4	8.1	3.5	6.2	2.5	15.9	4.9	6.4	8.5	5.4	4.9	5.3	5.0	5.3	3.3	4.4	3.5	4.2	3.7	3.9	7.5	3.4	4.7	10.5	5.4	3.4	6.7	2.2	5.0	4.7	6.1	9.0	22.6	12.4	5.1	5.2	4.3	5.2	11.1	5.5	5.0	5.6	1.8	5.9	4.0	4.3	5.2	1.7	1.5	1.0	1.2	0.9	1.1	0.8	1.1	1.2	0.8	1.2	1.1	2.1	1.1	2.2	1.0	0.7	0.9	6.1	11.4	13.9	15.8	7.2	6.3	6.7	5.7	9.3	8.8	6.0	11.2	3.2	2.9	0.3	7.2	2.8	5.1	4.0	10.3	10.4	2.0	3.2	0.0	4.4	2.9	4.5	4.3	0.0	4.7	2.5	3.0	4.9	8.1	4.9	7.5	6.4	3.5	11.1	15.5	1.5	3.7	8.3	0.0	7.2	8.7	2.7	5.5	3.5	3.9	5.7	6.0	0.0	2.8	6.7	7.0	0.5	5.0	5.0	6.3	5.7
SMNDC1	"SMNR, SPF30, TDRD16C"	ENSG00000119953	"Survival motor neuron domain containing 1"	O75940	10	110290730-110304951	"Predicted intracellular proteins"	"Apoptosis, mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061214, HPA070666"			Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA061214: AB_2684451, HPA070666: "	"unprognostic (4.65e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.63e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (3.16e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.68e-3)"	"unprognostic (6.88e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-1)"	21.3	18.0	16.7	20.0	17.5	38.3	26.6	24.0	20.1	19.0	18.1	17.5	13.5	13.9	23.6	13.1	24.1	18.4	16.7	19.4	15.0	15.4	19.3	20.8	23.5	32.7	15.0	14.4	23.4	15.3	18.0	24.3	25.2	16.5	18.0	16.1	19.6	18.0	17.4	34.3	19.0	16.6	21.3	22.7	21.8	17.0	19.8	16.9	30.0	18.9	14.9	24.7	25.4	22.4	6.2	9.2	17.4	9.7	6.3	8.7	4.5	15.6	11.9	17.5	20.1	13.6	16.3	13.0	18.1	19.0	24.2	24.9	15.3	19.4	22.2	11.8	11.3	13.9	17.0	25.7	12.5	27.3	12.5	13.8	22.2	10.2	17.8	16.3	24.3	21.4	12.6	13.4	19.2	32.4	18.0	13.3	12.9	19.9	20.8	18.6	7.4	25.9	23.7	19.5	12.1	8.3	22.5	35.1	11.6	13.5	11.3	8.8	11.8	11.8	10.0	20.7	15.8	12.3	14.0	14.5	14.2	16.2	13.0	23.0	17.2	17.8	33.7	14.2	34.2	10.9	5.7	9.6	14.7	6.1	9.7	7.5	6.2	7.9	7.6	9.2	5.5	7.1	6.8	17.4	6.3	9.7	5.5	8.7	4.5	16.7	17.5	24.0	20.1	15.0	15.4	15.0	14.4	16.5	16.9	26.8	29.6	33.5	33.3	61.8	25.5	19.0	10.2	34.8	29.6	10.4	19.6	28.1	28.2	21.0	5.4	32.3	18.8	23.3	15.6	27.2	32.9	39.7	57.7	21.2	28.0	31.8	17.9	21.5	34.0	3.8	27.0	39.8	33.7	40.5	14.8	22.3	19.3	17.3	20.8	26.9	30.6	19.4	28.8	44.1	36.1	72.9	38.6	30.5	17.4	60.1
SNAPC1	"PTFgamma, SNAP43"	ENSG00000023608	"Small nuclear RNA activating complex polypeptide 1"	Q16533	14	61762357-61796428	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 120.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 41.4;hTERT-HME1: 41.6;U-2 OS: 55.1;U-251 MG: 38.0"					"Low region specificity"	"Detected in all"			"HPA067076, HPA072276"			Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA067076: AB_2732757, HPA072276: AB_2732199"	"unprognostic (7.40e-2)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.94e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.68e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.01e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.47e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.26e-1)"	9.9	12.3	7.5	8.6	10.3	7.0	8.4	12.1	8.0	14.4	6.8	5.6	11.6	4.9	10.3	15.8	9.2	8.7	10.4	11.2	7.8	7.6	8.7	7.0	10.5	9.7	11.8	5.4	12.1	5.0	8.8	27.2	11.3	14.2	10.3	4.2	5.7	7.2	19.8	5.6	8.7	5.2	6.9	14.5	9.5	5.4	24.9	9.4	9.1	9.8	8.2	8.9	17.4	14.3	12.0	9.3	7.5	7.0	9.6	13.1	5.1	14.6	2.8	2.8	6.0	3.2	3.7	3.4	12.4	8.3	14.3	8.5	1.0	3.0	3.0	16.6	5.2	41.4	4.6	2.8	3.7	23.6	3.3	2.0	1.8	1.5	2.0	8.4	1.9	4.0	3.5	2.5	12.0	41.6	5.6	5.4	4.2	2.0	2.8	13.6	1.8	4.6	3.0	2.7	1.6	9.5	3.5	7.5	1.1	11.7	2.3	2.0	4.9	8.2	1.4	9.8	3.7	2.9	3.0	8.3	15.8	55.1	10.2	38.0	1.8	1.9	2.7	10.7	2.4	9.3	7.5	7.0	5.8	6.4	5.9	8.3	12.0	8.1	5.5	7.0	12.0	13.1	8.5	7.1	9.6	4.9	9.3	8.7	5.1	7.5	10.3	12.1	8.0	7.8	7.6	11.8	5.4	14.2	9.4	32.8	16.5	17.9	48.3	84.6	10.6	18.8	5.1	57.6	28.4	27.9	2.0	14.9	6.6	20.7	35.6	28.5	4.0	0.0	14.0	21.4	31.0	23.1	40.5	5.8	15.6	7.9	4.1	27.6	12.6	8.2	20.4	19.5	16.9	13.6	4.5	42.6	16.7	0.0	19.1	8.2	11.7	19.4	30.3	120.2	67.0	56.3	4.7	15.2	6.4	22.2
SND1	"p100, TDRD11"	ENSG00000197157	"Staphylococcal nuclease and tudor domain containing 1"	Q7KZF4	7	127652180-128092609	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 195.0;Syncytiotrophoblasts: 223.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002529, HPA002632, CAB019323"	Enhanced		Enhanced	Cytosol		NA	NA		1200000	Cytosol		"CAB019323: , HPA002529: AB_1857317, HPA002632: AB_1857316"	"unprognostic (2.06e-1)"	"unprognostic (8.27e-3)"	"unprognostic (2.21e-1)"	"prognostic favorable (1.95e-4)"	"unprognostic (5.10e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.26e-3)"	21.5	29.8	25.3	25.3	19.8	22.5	45.4	28.1	28.1	33.3	20.0	13.0	57.7	21.3	36.1	38.4	24.8	26.7	25.3	28.3	20.9	16.6	17.3	39.6	38.8	64.2	20.2	19.0	39.7	130.3	22.2	30.3	33.7	27.6	24.5	20.2	13.9	37.5	66.7	20.5	21.5	19.2	41.0	40.1	24.9	30.8	37.0	18.0	22.3	26.6	13.5	24.9	26.5	24.2	28.1	34.9	16.1	30.0	21.0	30.9	28.5	28.5	25.9	19.8	35.9	30.1	31.5	27.2	33.6	39.8	30.8	34.6	33.4	24.8	37.9	17.0	41.2	26.0	24.0	27.9	36.4	30.1	20.7	23.6	20.9	30.9	32.0	54.8	32.3	20.6	46.3	40.7	26.3	44.1	35.1	38.2	15.7	23.1	38.1	30.7	21.3	35.1	24.2	22.2	29.0	32.3	24.5	17.7	84.8	24.1	20.1	25.0	27.0	24.3	113.2	38.9	31.1	14.1	23.0	37.9	25.1	16.4	45.5	26.1	47.0	17.6	39.8	50.3	27.9	45.3	16.1	30.0	5.9	26.1	28.1	30.9	28.1	19.8	21.0	32.3	16.2	14.3	15.8	2.2	21.0	22.8	34.9	15.8	28.5	25.3	19.8	28.1	28.1	20.9	16.6	20.2	19.0	27.6	18.0	14.9	43.1	29.8	20.4	17.4	11.2	26.2	38.2	14.7	20.5	27.9	19.6	195.0	14.9	60.6	12.9	28.0	32.8	23.3	83.7	91.7	29.4	34.2	34.6	43.3	73.2	28.6	70.2	26.4	48.3	40.2	42.3	43.7	32.1	80.2	55.0	15.6	63.2	31.6	38.9	25.1	32.0	32.3	19.5	19.2	29.2	24.0	223.8	27.7	53.0	21.3
SNRNP70	"RNPU1Z, RPU1, Snp1, SNRP70, U1-70K"	ENSG00000104852	"Small nuclear ribonucleoprotein U1 subunit 70"	P08621	19	49085419-49108605	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB001718, HPA042050, HPA043516"	Supported		Enhanced	Nucleoplasm		NA	NA		30000	Nucleoplasm		"CAB001718: , HPA042050: AB_2677821, HPA043516: AB_2678523"	"unprognostic (2.22e-3)"	"unprognostic (5.27e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.58e-2)"	"unprognostic (4.01e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (4.59e-5)"	"unprognostic (3.63e-3)"	"prognostic unfavorable (6.12e-5)"	"unprognostic (5.18e-3)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (5.35e-5)"	46.9	46.5	50.1	65.8	57.0	51.9	29.8	89.6	73.1	36.7	36.2	40.5	46.5	45.8	44.0	38.8	38.9	34.0	35.4	33.3	46.5	34.6	30.6	35.0	29.3	47.6	53.8	49.0	43.3	36.1	37.8	41.8	34.3	43.4	43.0	27.3	26.6	42.7	52.7	73.5	48.1	44.6	28.5	41.5	45.6	45.2	30.5	58.1	34.9	39.8	25.6	37.3	26.9	35.0	5.3	3.2	3.2	3.7	7.9	3.9	1.2	34.5	40.0	28.1	20.1	11.5	7.1	34.5	26.8	16.5	28.1	24.2	24.3	20.4	42.3	25.9	17.3	23.4	30.9	34.8	25.3	20.8	27.7	92.8	38.6	20.1	27.6	6.0	41.7	26.0	9.9	7.0	20.0	13.6	12.7	20.9	20.2	39.5	13.1	16.7	29.9	43.0	66.6	35.6	18.6	34.6	50.0	27.9	24.7	17.1	21.6	24.2	28.7	33.6	18.9	17.8	19.3	20.0	25.1	31.1	20.6	38.7	18.0	42.9	34.9	29.4	51.5	17.4	27.2	19.3	1.5	3.7	3.2	3.6	2.5	2.1	5.3	2.3	1.5	3.2	3.5	3.9	2.3	1.7	7.9	1.9	2.8	2.4	1.2	50.1	57.0	89.6	73.1	46.5	34.6	53.8	49.0	43.4	58.1	17.9	62.4	92.3	143.3	123.9	97.6	25.0	56.0	36.1	47.8	71.5	84.4	155.8	39.7	97.0	14.1	68.1	71.8	23.3	90.8	176.6	99.6	110.3	53.2	72.3	109.6	108.1	113.3	63.3	61.9	12.5	120.6	80.2	65.8	77.5	97.3	96.3	92.5	74.8	104.0	62.4	104.8	122.9	97.6	108.5	89.7	114.3	147.5	77.8	98.4	135.5
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757406-34773794	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	20.9	24.6	28.3	25.5	29.5	56.2	23.5	19.0	26.7	20.3	28.2	19.0	26.9	26.6	28.5	33.7	28.1	32.1	31.6	56.8	24.4	22.4	26.7	34.9	25.3	36.3	27.4	28.3	26.3	62.5	18.5	19.5	27.1	23.8	22.9	24.3	19.7	30.6	26.5	54.9	20.7	27.3	25.0	29.3	28.6	25.5	66.6	26.3	39.8	36.9	47.2	33.7	24.1	21.0	58.6	53.4	32.6	56.7	38.4	58.3	55.5	47.4	29.4	38.7	50.4	21.0	20.5	29.8	27.2	30.0	54.6	46.2	50.6	18.8	53.4	36.5	33.8	38.2	22.9	58.2	40.7	44.5	35.6	61.4	41.2	25.1	69.7	36.5	52.3	26.3	25.3	39.7	55.4	39.5	21.7	34.5	52.2	66.1	31.2	39.3	39.8	62.6	86.6	42.2	70.8	35.9	43.4	32.7	51.3	35.2	20.3	48.0	34.4	24.4	25.2	59.6	26.2	38.7	79.3	22.9	33.6	39.4	27.3	66.2	34.7	90.1	75.1	15.2	91.7	56.9	26.8	43.8	32.6	35.3	50.1	40.4	58.6	43.5	40.4	50.3	51.0	47.4	43.0	7.9	38.4	56.7	53.4	58.3	55.5	28.3	29.5	19.0	26.7	24.4	22.4	27.4	28.3	23.8	26.3	113.2	104.2	62.5	63.3	39.0	23.7	207.1	84.1	131.2	119.4	64.6	23.6	209.0	160.8	134.3	96.2	66.7	54.9	23.3	135.8	171.0	97.6	66.3	77.5	85.5	197.4	27.0	87.2	63.8	66.9	49.1	51.2	87.8	60.8	201.0	86.3	68.5	129.0	73.7	39.3	158.4	33.1	64.7	62.8	146.4	108.6	39.1	94.7	91.6	100.0	62.6
SNW1	"Bx42, FUN20, NCoA-62, Prp45, PRPF45, SKIIP, SKIP, SKIP1"	ENSG00000100603	"SNW domain containing 1"	Q13573	14	77717599-77761207	"Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Spermatocytes: 252.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002457, CAB009931, HPA017370"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB009931: AB_2302187, HPA002457: AB_1080047, HPA017370: AB_1857339"	"unprognostic (1.24e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.40e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.27e-3)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (1.07e-1)"	"unprognostic (8.09e-3)"	"unprognostic (2.88e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.22e-2)"	30.5	23.4	20.3	24.0	24.8	59.5	28.3	32.1	26.2	26.1	27.6	29.6	21.5	24.6	32.5	24.3	29.1	25.4	20.5	26.3	20.6	18.3	23.5	25.3	24.8	31.5	23.9	26.7	32.1	26.5	19.8	31.6	32.3	26.8	29.8	24.9	22.3	23.4	17.6	41.8	33.3	30.7	30.8	23.7	32.3	24.2	36.3	24.3	37.5	34.1	24.2	30.4	33.0	25.0	32.5	38.2	47.8	44.1	47.6	47.1	35.5	39.3	29.1	30.0	31.8	24.7	27.9	34.9	27.1	23.9	29.8	27.6	28.9	36.2	38.5	24.8	20.1	22.7	38.8	35.9	25.7	40.7	30.6	28.4	31.1	26.3	28.9	35.5	21.7	36.9	21.4	34.5	27.0	37.4	32.5	28.9	37.0	44.4	28.9	22.8	40.3	38.6	36.9	33.5	44.5	39.3	41.8	38.8	26.4	27.7	36.5	32.3	34.9	37.3	33.0	37.3	32.2	47.3	41.8	30.6	32.8	37.5	29.5	32.3	28.7	40.6	42.8	29.7	35.0	36.1	42.0	38.0	47.8	32.1	40.6	36.0	30.9	36.2	36.3	38.2	32.5	38.3	36.0	36.1	47.6	44.1	22.7	47.1	35.5	20.3	24.8	32.1	26.2	20.6	18.3	23.9	26.7	26.8	24.3	86.4	43.0	62.2	66.5	50.3	55.1	46.0	43.3	109.7	79.6	50.6	33.4	68.5	64.6	65.3	25.3	65.0	31.6	46.7	61.0	83.4	54.9	37.6	88.0	26.6	66.2	36.5	41.9	45.4	48.4	16.5	72.2	71.0	37.1	92.0	37.1	67.4	58.2	45.0	69.6	39.6	63.7	64.7	69.5	252.6	138.5	47.4	91.2	73.9	40.5	62.2
SNX1	"HsT17379, MGC8664, SNX1A, Vps5"	ENSG00000028528	"Sorting nexin 1"	Q13596	15	64094123-64146090	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047373, HPA052761"	Approved		Enhanced	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA047373: AB_2680018, HPA052761: AB_2681939"	"unprognostic (3.99e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.50e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.15e-2)"	"unprognostic (6.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (9.88e-6)"	"unprognostic (2.27e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.95e-1)"	30.6	47.3	22.4	27.4	31.2	16.8	36.3	17.7	25.3	32.4	30.3	46.9	44.7	26.0	30.8	39.2	38.7	21.2	23.5	30.9	24.8	20.1	30.6	38.6	33.7	31.3	40.1	23.5	25.0	31.2	43.0	22.2	31.1	30.3	31.0	27.1	22.5	30.8	48.4	40.9	29.1	26.3	30.4	54.1	37.5	30.2	17.7	35.9	32.9	80.8	18.5	35.9	32.3	31.7	34.5	42.3	51.9	50.6	30.7	30.6	43.9	19.4	25.9	22.4	19.0	39.7	29.7	7.3	26.8	31.7	28.6	33.8	17.6	35.3	23.4	27.6	28.1	26.2	30.4	35.4	32.1	23.9	37.7	15.7	26.7	30.5	25.2	21.7	27.0	30.6	33.5	20.6	22.3	17.4	19.7	29.4	23.2	21.2	9.2	29.5	28.9	28.8	22.9	15.2	31.8	15.2	26.1	20.7	32.8	44.1	46.8	18.1	17.3	23.8	18.3	23.2	20.1	26.3	25.1	29.2	24.9	33.7	15.9	15.4	24.3	61.5	33.0	19.9	37.0	25.8	41.5	50.6	51.9	29.7	47.2	25.0	32.0	25.4	28.9	42.3	34.5	24.7	24.0	38.1	30.7	43.5	28.4	30.6	43.9	22.4	31.2	17.7	25.3	24.8	20.1	40.1	23.5	30.3	35.9	107.2	59.1	22.9	32.4	23.6	17.2	42.3	30.6	30.8	58.0	17.4	21.6	44.8	28.2	33.0	2.2	30.9	28.6	0.0	32.4	30.4	32.4	25.6	37.1	29.4	63.0	14.3	25.5	31.3	42.8	2.5	30.0	40.4	30.4	42.3	26.9	17.6	34.8	26.6	35.3	38.7	14.5	45.3	32.0	25.9	19.4	23.7	39.9	28.8	26.7	28.2
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377533	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	37.7	45.8	27.2	30.5	29.8	22.6	33.4	28.5	51.1	34.1	33.8	34.9	28.7	23.7	39.0	38.5	35.3	41.2	37.7	37.6	26.2	25.8	33.6	61.6	36.7	68.1	29.1	27.0	40.4	37.0	31.5	37.0	32.6	30.3	33.7	29.5	34.0	34.9	37.5	26.4	31.6	29.2	38.1	32.8	48.8	30.5	36.8	21.7	52.3	39.5	28.2	41.3	32.0	29.1	34.3	58.4	38.1	61.1	27.3	35.1	86.6	28.1	47.1	23.1	36.9	40.8	34.5	19.6	30.7	44.1	35.1	27.5	25.4	24.6	22.0	40.1	49.9	34.4	17.2	19.7	32.3	27.2	28.3	31.8	22.8	17.4	34.5	42.6	27.9	29.2	35.2	31.3	23.3	31.5	31.3	38.4	19.5	19.8	23.7	41.9	27.6	33.2	26.2	21.3	34.8	30.3	14.9	44.3	43.5	32.7	21.0	28.1	31.9	19.2	28.1	11.5	17.2	22.4	18.0	30.5	41.6	22.4	23.3	29.9	43.2	31.4	27.7	38.4	29.6	44.6	33.0	59.1	38.1	30.8	61.1	29.6	33.4	30.0	31.8	58.4	34.3	28.4	30.3	13.9	27.3	60.5	33.0	35.1	86.6	27.2	29.8	28.5	51.1	26.2	25.8	29.1	27.0	30.3	21.7	14.9	43.2	74.4	35.4	28.8	29.3	28.6	38.2	33.5	22.7	27.9	13.7	141.9	69.6	74.2	7.1	37.7	55.9	0.0	56.0	113.5	59.4	36.1	42.7	50.5	122.1	42.9	52.9	38.1	113.6	7.6	54.1	76.3	65.8	149.7	42.8	76.6	55.0	63.1	79.9	74.5	20.4	32.3	51.4	58.6	50.0	30.1	83.3	86.3	51.5	26.5
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.9;GAMG: 41.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Enhanced	"Plasma membrane,Cytosol"		No	No			"Plasma membrane, Cytosol"		"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	44.7	18.9	13.0	16.5	14.7	17.2	35.4	6.7	16.2	27.4	24.6	19.8	43.5	18.1	32.1	19.5	31.4	17.2	26.4	20.4	12.2	10.8	17.8	25.4	14.6	22.5	19.7	11.4	19.8	22.5	17.7	10.8	45.0	13.3	25.0	17.7	11.1	25.2	41.7	16.5	21.2	28.0	44.6	16.4	19.8	21.5	10.9	18.4	5.0	18.4	17.9	20.3	34.0	40.2	4.1	11.2	1.3	7.3	0.5	6.7	1.0	7.5	5.0	5.3	6.2	26.5	23.6	11.2	15.2	42.9	10.4	13.9	4.3	7.7	0.0	7.6	23.5	41.6	5.0	6.2	10.2	8.7	6.2	7.2	4.8	7.6	6.6	13.3	2.5	9.7	14.0	9.1	10.7	10.5	18.8	14.4	7.4	24.1	0.0	5.1	4.3	0.0	3.8	4.2	5.1	6.4	0.0	5.3	8.6	16.7	4.5	3.4	6.2	9.7	4.5	23.2	5.5	2.1	5.5	11.7	11.5	5.2	36.8	8.0	0.0	0.0	0.0	23.0	1.9	6.7	0.0	1.0	1.3	0.6	3.2	2.4	4.1	1.7	1.3	2.0	3.4	6.7	2.1	0.1	0.5	7.3	11.2	2.8	1.0	13.0	14.7	6.7	16.2	12.2	10.8	19.7	11.4	13.3	18.4	0.0	0.6	20.4	84.5	38.5	12.7	24.6	17.8	12.0	18.2	8.7	0.0	31.7	18.3	44.5	37.1	48.9	55.8	46.7	48.8	32.8	55.0	114.0	11.5	28.7	37.1	3.2	15.1	32.5	39.6	18.9	41.4	29.1	20.3	62.3	31.0	12.4	78.9	45.0	43.9	32.7	1.5	38.8	46.7	17.9	13.8	26.1	91.9	10.2	26.0	107.8
SOAT1	"ACAT, SOAT, STAT"	ENSG00000057252	"Sterol O-acyltransferase 1"	P35610	1	179293714-179358680	"Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 87.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009533, HPA047171"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB009533: AB_633499, HPA047171: AB_2679967"	"unprognostic (3.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.81e-3)"	"unprognostic (7.81e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.00e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.45e-3)"	"unprognostic (7.02e-3)"	"unprognostic (4.67e-3)"	"unprognostic (9.64e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.82e-1)"	23.9	87.4	4.1	8.3	5.7	7.0	9.6	2.9	4.0	6.8	7.2	5.6	7.8	5.5	8.2	6.0	3.4	8.3	9.8	5.7	5.5	4.1	12.1	8.8	18.6	13.0	6.2	2.3	10.8	15.5	8.1	14.6	11.6	4.9	13.1	6.9	9.6	51.1	8.9	4.1	5.8	7.0	7.5	10.5	13.6	8.1	6.8	4.9	4.0	6.2	2.9	7.2	9.4	8.7	6.6	24.3	19.8	26.8	18.5	16.0	14.8	20.4	9.6	7.9	11.7	30.9	16.9	42.5	9.9	17.5	22.0	25.7	9.8	23.4	11.6	15.7	18.0	26.8	7.5	25.1	5.9	23.8	13.2	5.2	5.4	8.1	10.2	12.7	9.2	2.1	13.3	3.8	25.7	22.1	9.3	9.4	14.3	11.6	6.0	34.2	4.3	9.8	3.0	3.8	3.3	3.2	12.2	10.3	6.8	19.4	12.8	2.4	6.2	15.3	6.5	5.7	9.8	6.8	6.3	8.9	26.2	12.6	28.6	21.8	8.5	31.0	9.9	10.4	5.0	48.5	19.6	26.8	0.7	14.0	17.0	13.5	6.6	13.1	13.1	24.3	5.5	12.7	12.6	19.8	18.5	11.1	4.4	16.0	14.8	4.1	5.7	2.9	4.0	5.5	4.1	6.2	2.3	4.9	4.9	20.8	33.1	10.4	8.5	8.9	7.2	5.6	22.9	48.2	14.8	19.2	13.7	14.8	1.7	33.4	19.5	13.0	7.9	0.0	21.9	46.9	18.6	33.8	13.9	21.9	69.5	6.4	57.5	21.5	66.9	10.8	30.2	63.1	21.9	44.1	27.7	6.8	20.1	10.5	24.4	12.8	13.0	25.8	13.0	5.6	8.2	4.5	7.3	27.9	16.8	6.5
SOD1	"ALS, ALS1, IPOA"	ENSG00000142168	"Superoxide dismutase 1"	P00441	21	31659622-31668931	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"Antioxidant, Oxidoreductase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 282.6"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 2529.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001401, CAB008670"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA	44900000	91000000	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB008670: AB_1623312, HPA001401: AB_1080132"	"unprognostic (1.73e-1)"	"unprognostic (1.18e-2)"	"unprognostic (4.43e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.59e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.47e-1)"	"unprognostic (5.28e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.26e-2)"	39.2	86.5	71.1	29.1	74.3	24.6	108.6	35.6	74.9	26.8	37.7	19.1	35.4	62.5	24.6	42.2	25.8	36.0	46.8	96.5	77.8	73.1	84.0	282.6	23.0	26.8	80.2	67.0	53.9	27.2	27.1	30.4	29.7	96.1	35.1	32.6	19.3	19.7	39.3	83.9	20.5	45.5	45.2	88.2	19.2	25.8	22.2	43.8	12.3	30.1	34.7	25.6	25.4	124.0	57.6	32.3	24.9	57.2	29.6	95.6	55.6	56.2	49.2	34.5	34.5	46.2	32.3	28.7	47.5	28.3	32.3	24.4	63.7	35.8	67.3	50.0	43.7	58.6	20.4	49.5	34.9	26.6	49.7	61.4	108.7	64.6	91.1	30.6	47.9	40.7	33.4	26.6	45.2	25.2	36.8	36.2	51.6	74.9	86.2	38.9	91.3	51.4	48.4	51.9	89.1	52.5	44.3	69.6	104.7	63.1	34.6	37.8	31.7	87.9	46.5	45.6	32.5	53.5	42.4	42.4	25.1	55.7	33.9	34.9	65.8	142.4	79.8	51.3	70.0	33.3	22.1	21.9	24.9	45.0	30.2	51.6	57.6	73.1	56.9	28.6	40.9	76.2	59.3	5.1	29.6	57.2	32.3	95.6	55.6	71.1	74.3	35.6	74.9	77.8	73.1	80.2	67.0	96.1	43.8	273.9	132.0	321.6	545.9	436.4	220.9	652.4	591.1	509.9	249.1	371.6	45.2	624.2	1382.7	369.6	242.1	264.2	846.2	327.1	713.9	544.4	341.5	540.9	215.8	2529.1	314.9	267.0	277.0	292.2	203.5	693.0	483.3	265.6	398.1	397.7	279.9	378.3	307.6	522.5	496.4	1894.8	157.7	433.4	418.2	79.3	538.3	305.8	607.1	266.4	526.4	451.3
SOD2		ENSG00000112096	"Superoxide dismutase 2"		6	159669057-159745186	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in all"		"blood: 254.9;skeletal muscle: 475.1"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 286.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	11	"neutrophil: 254.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 254.9"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 182.1;GAMG: 70.6;HSkMC: 80.3"									"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	77.8	28.6	6.2	82.8	13.8	147.9	32.5	3.6	12.5	13.1	25.6	5.7	3.6	9.1	13.3	16.6	20.3	12.6	19.9	42.4	5.8	6.4	157.4	197.5	33.9	52.7	14.3	2.6	31.8	24.9	6.9	7.0	10.0	16.1	27.1	6.1	6.4	39.9	7.4	475.1	9.0	8.1	27.9	25.5	18.4	13.8	13.6	7.3	3.0	36.8	20.8	11.8	43.4	52.8	2.3	5.8	254.9	22.7	0.9	4.5	15.0	3.6	4.6	4.1	9.4	26.6	44.5	2.1	5.3	182.1	6.5	15.1	9.5	2.1	7.5	16.0	5.9	70.6	6.3	4.3	4.6	4.9	7.3	8.9	7.9	7.8	16.2	19.8	7.5	3.4	80.3	7.7	20.6	15.4	4.6	3.3	4.8	10.8	9.0	6.2	3.9	6.2	4.8	6.9	4.4	5.8	8.4	5.6	6.9	12.1	6.0	7.8	3.0	11.2	5.7	2.3	1.6	3.5	3.6	3.1	19.2	6.9	10.1	9.2	3.8	9.8	9.0	21.1	5.8	2.4	6.2	19.2	9.4	2.2	14.9	2.4	2.3	3.1	2.2	5.8	1.8	2.6	2.1	254.9	0.9	22.7	0.8	4.5	15.0	6.2	13.8	3.6	12.5	5.8	6.4	14.3	2.6	16.1	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	286.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.8	0.0	0.0	0.0
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.8	14.0	36.4	20.5	32.2	29.1	26.2	19.5	26.1	20.7	19.6	23.3	20.2	45.3	11.4	32.5	23.9	20.7	42.2	32.6	33.0	18.7	20.7	58.7	19.2	30.9	23.9	55.2	27.0	30.8	38.0	24.5	37.6	26.5	31.4	24.7	44.2	45.7	29.7	28.1	29.5	31.1	39.7	30.5	16.3	29.0	38.8	33.4	32.0	24.9	20.9	20.6	32.7	28.0	22.6	31.5	25.5	32.5	31.2	22.2	20.7	16.6	21.2	42.9	35.1	54.1	23.8	47.4	21.6	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4	381.2	269.8	245.0	287.1	384.7	382.2	339.3	303.2	329.2	315.1	286.1	208.1	195.6	164.2	182.7	62.5	272.4	180.8	256.9	180.4	138.6	293.6	211.2	400.4	301.9	149.2	430.6	179.2	276.8	201.3	39.3	364.7	259.5	207.5	184.0	159.3	365.4	155.4	161.4	369.9	137.2	353.2	375.1	318.2	436.1	320.9	344.7	273.6	278.4	160.2	183.4
SOX12	SOX22	ENSG00000177732	"SRY-box 12"	O15370	20	325595-330224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 53.0;Cone photoreceptor cells: 39.3;Horizontal cells: 30.2;Rod photoreceptor cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.8;dendritic cells: 1.5;T-cells: 1.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055052, HPA061627"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA055052: AB_2682685, HPA061627: AB_2684571"	"unprognostic (1.02e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.81e-3)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.64e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.55e-1)"	"unprognostic (5.02e-3)"	"unprognostic (4.66e-1)"	"unprognostic (3.12e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.36e-2)"	"unprognostic (2.20e-2)"	5.2	7.4	11.0	4.9	10.2	5.4	10.3	27.5	14.1	8.2	7.8	10.1	11.0	4.1	10.9	11.3	5.8	10.2	5.2	6.8	10.9	8.8	8.3	4.7	5.3	5.1	11.3	5.7	14.6	12.6	7.7	7.0	5.0	8.4	8.7	3.0	7.8	8.8	13.8	2.3	9.0	4.8	8.5	6.9	7.6	5.0	8.2	10.9	12.1	8.2	2.0	3.8	7.8	9.0	1.8	1.5	0.3	0.2	0.2	1.3	0.2	3.7	13.2	12.9	8.7	6.3	4.6	3.9	5.2	4.5	4.7	4.7	2.6	3.9	8.4	4.0	6.0	9.9	4.4	9.4	1.7	2.7	4.2	6.5	5.4	5.1	26.3	8.1	7.4	1.4	6.3	5.4	4.0	1.6	7.8	6.2	5.8	12.7	4.4	3.0	9.1	2.5	18.3	21.1	2.1	17.4	13.2	3.3	6.8	6.7	0.4	15.9	18.5	3.5	15.3	19.2	5.6	14.5	10.4	7.0	18.4	18.3	0.5	4.5	12.8	13.4	8.7	3.4	7.4	3.5	0.3	0.2	0.3	0.5	0.1	0.2	1.7	0.6	0.8	0.2	1.8	1.3	1.1	0.1	0.2	0.0	1.5	0.8	0.2	11.0	10.2	27.5	10.7	10.9	8.8	11.3	5.7	8.4	10.9	0.0	2.7	0.8	2.1	3.1	53.0	11.0	5.1	1.4	1.2	7.0	39.3	1.2	13.3	1.1	0.6	3.8	1.1	0.0	0.3	0.4	4.3	2.6	0.0	4.7	1.8	30.2	8.7	8.6	1.9	1.7	9.5	0.7	5.0	0.0	4.0	8.3	0.4	0.0	11.7	4.8	37.2	0.0	5.7	0.9	7.0	1.0	0.6	2.1	3.7	0.3
SOX13	"ICA12, MGC117216, Sox-13"	ENSG00000143842	"SRY-box 13"	Q9UN79	1	204073115-204127743	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 4.1"	"Group enriched"	"Detected in many"	6	"NK-cells: 4.1;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.0;SK-BR-3: 50.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051790, HPA054843"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051790: AB_2681610, HPA054843: AB_2682622"	"unprognostic (4.88e-3)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (4.74e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.20e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.92e-1)"	22.2	10.7	11.0	6.9	8.6	0.8	18.4	9.2	9.9	37.0	17.2	14.4	16.1	13.5	30.3	12.4	10.9	22.3	16.4	9.7	11.0	6.9	19.0	12.3	20.5	4.3	13.7	7.0	13.5	12.8	34.2	5.6	27.3	14.3	23.5	8.3	13.7	13.1	18.7	14.2	9.9	16.8	18.2	12.1	8.4	8.2	8.7	13.3	0.1	10.4	7.5	7.0	19.5	19.2	0.0	0.0	0.5	0.0	4.1	2.6	0.3	8.5	5.5	11.9	0.8	11.4	3.4	24.0	3.3	2.0	5.3	3.3	4.6	6.4	0.0	11.0	2.1	1.4	13.9	4.5	4.3	2.5	3.9	2.2	0.0	3.7	5.1	2.6	0.0	5.0	3.5	2.2	3.3	2.9	2.6	7.6	0.1	0.0	0.0	1.1	10.5	0.0	0.0	15.7	13.9	6.7	0.1	4.0	5.2	4.0	19.8	1.8	0.9	3.4	50.1	15.0	11.1	22.3	1.0	4.4	1.2	3.2	5.1	2.3	0.0	0.0	0.0	1.9	0.1	3.1	0.2	0.0	0.5	2.5	0.0	2.6	0.0	1.2	1.4	0.0	0.0	0.0	1.0	0.3	4.1	0.0	0.0	0.0	0.3	11.0	8.6	9.2	9.9	11.0	6.9	13.7	7.0	14.3	13.3	6.0	11.4	0.8	7.9	1.9	0.5	24.3	10.2	1.4	4.5	8.7	0.0	4.3	1.7	2.7	8.5	12.7	12.6	0.0	1.3	5.0	5.0	6.6	16.2	5.9	1.2	0.0	7.5	8.0	0.0	20.2	19.2	0.7	1.7	0.0	5.5	6.3	2.9	7.6	18.4	3.5	0.9	38.8	15.5	0.2	0.7	1.4	1.6	1.9	5.4	5.7
SOX15	"SOX20, SOX26, SOX27"	ENSG00000129194	"SRY-box 15"	O60248	17	7588178-7590170	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 62.7;lymphoid tissue: 38.7;skin 1: 30.0;tongue: 59.0"	"Cell type enhanced"	"Detected in many"	13	"Basal keratinocytes: 185.8;Suprabasal keratinocytes: 148.4;Urothelial cells: 76.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 67.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 7.1;non-classical monocyte: 10.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.8"	"Group enriched"	"Detected in some"	7	"A-431: 41.8;HaCaT: 47.0;HBEC3-KT: 18.8;hTCEpi: 18.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA067196, HPA074049"	Enhanced		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Vesicles"		Yes	NA			Nucleoplasm	"Nucleoli, Golgi apparatus, Vesicles"	"HPA067196: AB_2685802, HPA074049: AB_2686656"	"unprognostic (5.79e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.81e-2)"	"unprognostic (5.00e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.61e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.97e-1)"	1.0	0.8	4.6	1.0	4.1	2.1	1.3	7.2	5.0	7.5	2.6	1.1	1.0	0.7	4.4	1.7	62.7	3.7	1.0	2.9	3.1	4.1	1.3	1.0	1.5	1.0	2.6	1.0	7.0	1.0	0.1	2.0	2.0	3.5	4.1	0.6	1.4	3.4	7.0	1.9	30.0	1.0	1.6	1.4	1.0	0.7	1.3	1.0	1.8	1.0	59.0	38.7	3.6	7.8	0.0	2.4	0.2	10.8	0.0	0.0	0.5	41.8	1.0	0.6	0.3	0.0	0.1	3.2	0.5	0.1	0.3	0.6	0.8	0.2	0.1	0.4	0.0	0.1	47.0	0.0	18.8	0.1	1.1	1.3	0.1	0.5	0.1	0.0	0.1	0.9	0.0	18.6	0.2	4.2	1.3	0.0	0.8	0.9	0.3	0.0	0.3	0.2	0.5	1.3	0.1	0.2	0.5	0.6	0.3	0.8	0.2	0.3	0.7	0.5	0.1	0.2	1.9	0.3	0.3	0.5	0.4	0.8	0.5	1.4	0.3	0.5	0.6	1.5	0.6	1.1	0.2	2.4	0.0	0.0	7.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	10.8	1.2	0.0	0.5	4.6	4.1	7.2	4.4	3.1	4.1	2.6	1.0	3.5	1.0	0.0	0.0	0.0	39.1	185.8	11.0	2.8	0.0	10.7	5.7	1.8	13.7	0.3	1.7	0.0	0.1	1.6	0.2	0.0	0.4	1.5	6.1	15.1	0.0	0.0	0.4	9.5	1.2	1.8	2.7	0.6	29.1	1.1	25.3	1.8	0.0	33.2	0.3	0.0	34.6	0.0	6.2	32.3	8.9	0.4	8.7	148.4	0.9	0.0	0.2	76.9
SOX2		ENSG00000181449	"SRY-box 2"	P48431	3	181711924-181714436	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 80.1"	"Cell type enriched"	"Detected in some"	9	"Muller glia cells: 455.6"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 68.9;HAP1: 29.3;NTERA-2: 56.2;U-251 MG: 12.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	1.8	2.5	30.3	2.0	25.8	1.5	1.6	13.9	80.1	1.8	2.3	24.3	0.0	2.0	1.5	1.8	15.9	5.0	1.8	1.7	36.0	19.2	1.5	1.5	3.4	1.5	19.4	18.5	1.7	1.6	1.5	5.8	1.5	18.6	3.9	2.0	1.0	6.3	1.9	1.6	1.8	2.3	1.7	18.4	1.6	9.7	3.0	22.4	0.0	1.5	2.1	6.9	2.3	1.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.2	68.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	29.3	0.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.2	2.9	0.1	0.0	0.1	0.0	7.6	0.1	0.1	0.3	0.0	0.0	0.0	11.9	0.4	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	25.8	13.9	20.0	36.0	19.2	19.4	18.5	18.6	22.4	0.0	5.9	0.0	41.2	0.2	3.5	0.4	0.0	52.2	38.7	3.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	4.9	1.1	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.6	0.2	3.3	0.0	0.0	455.6	0.0	0.0	0.0	0.0	8.2	0.0	0.1	1.5	0.2	0.4	0.2	0.0	0.0	7.0
SOX3	PHP	ENSG00000134595	"SRY-box 3"	P41225	X	140502985-140505116	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 18.2;testis: 12.4"	"Cell type enriched"	"Detected in single"	8	"Muller glia cells: 4.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.8;HEK 293: 8.3;NTERA-2: 18.6;SuSa: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054720, HPA075003"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054720: AB_2682584, HPA075003: AB_2686727"					"unprognostic (6.04e-2)"					"unprognostic (3.75e-1)"			"unprognostic (8.62e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.27e-3)"		0.3	0.5	2.6	0.3	2.7	0.3	0.3	0.6	2.6	1.5	0.3	5.0	0.0	0.3	0.6	0.3	0.3	18.2	0.3	0.3	2.2	5.0	0.3	0.3	0.3	0.3	2.0	1.8	4.7	0.3	0.4	3.2	0.3	3.6	0.3	0.3	0.5	0.3	0.3	0.4	0.3	0.3	0.3	2.3	0.3	0.3	12.4	0.6	0.0	0.5	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.7	0.6	2.6	2.2	5.0	2.0	1.8	3.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SOX8		ENSG00000005513	"SRY-box 8"	P57073	16	981808-986979	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 64.9"	"Cell type enriched"	"Detected in some"	22	"Muller glia cells: 120.0"	"Cancer enriched"	"Detected in many"	6	"glioma: 46.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.2;naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	5	"RH-30: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041640, HPA058665"			Enhanced	Nucleoplasm		No	NA			Nucleoplasm		"HPA041640: AB_10964357, HPA058665: AB_2683792"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.10e-2)"	"unprognostic (4.58e-2)"	"unprognostic (7.16e-3)"	"unprognostic (6.05e-3)"	"unprognostic (3.01e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.46e-2)"	"unprognostic (1.20e-3)"	"unprognostic (8.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.47e-1)"	"unprognostic (9.09e-2)"	1.6	1.5	18.4	1.8	25.1	1.0	2.5	3.2	64.9	1.2	1.4	20.9	0.0	1.1	1.1	1.1	1.2	1.1	1.5	1.8	22.6	14.5	1.0	1.0	1.0	2.7	26.5	5.4	1.0	1.5	1.0	0.1	1.4	12.0	1.3	1.5	0.9	8.6	1.4	1.3	1.3	1.2	1.2	27.1	1.8	1.7	1.9	30.4	0.0	1.1	0.0	3.1	1.1	0.3	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.3	1.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.5	0.7	0.1	0.0	51.7	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	2.2	1.1	0.0	0.0	0.0	0.0	0.0	0.2	18.4	25.1	3.2	11.8	22.6	14.5	26.5	5.4	12.0	30.4	0.0	0.0	0.0	0.4	0.3	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.1	0.0	0.0	0.2	0.1	2.1	1.4	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	3.1	0.0	1.7	1.0	0.0	120.0	0.1	0.0	1.8	0.0	5.3	0.0	0.8	0.0	4.3	0.9	0.0	0.0	0.0	0.1
SOX9	"CMD1, CMPD1, SRA1"	ENSG00000125398	"SRY-box 9"	P48436	17	72121020-72126420	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 63.4"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 178.3;Muller glia cells: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.5;Hep G2: 34.1;OE19: 26.3;U-251 MG: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001758, CAB022456, CAB068240"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB022456: , CAB068240: AB_2665670, HPA001758: AB_1080067"	"unprognostic (6.92e-2)"	"unprognostic (1.73e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.55e-2)"	"unprognostic (7.96e-3)"	"unprognostic (4.32e-3)"	"prognostic unfavorable (2.07e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.31e-1)"	"unprognostic (8.92e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.26e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.15e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.21e-2)"	3.1	2.6	32.2	4.3	31.6	1.1	23.4	20.3	32.4	7.4	14.6	28.4	8.1	16.6	3.5	1.9	7.7	7.4	11.7	9.5	35.5	15.7	11.7	3.9	3.4	1.9	14.6	13.7	1.2	31.9	1.2	7.0	1.4	21.3	21.7	15.7	12.9	63.4	14.4	3.0	13.1	12.9	2.1	15.6	1.3	35.2	25.2	20.2	0.0	17.8	5.3	5.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	6.9	14.3	28.5	1.4	0.4	0.0	1.7	1.5	3.0	1.6	9.6	14.8	0.0	1.1	0.4	16.2	11.2	0.0	6.7	2.8	0.0	0.9	0.0	1.5	34.1	0.1	0.0	0.0	0.2	0.6	3.5	3.3	17.4	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.5	26.3	10.6	0.0	11.6	0.1	12.9	0.7	0.7	0.7	1.4	1.7	0.0	8.1	6.1	0.1	0.0	5.9	15.9	3.1	23.5	0.0	0.0	0.0	4.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	31.6	20.3	26.7	35.5	15.7	14.6	13.7	21.3	20.2	11.9	3.5	2.2	77.1	49.2	1.4	13.8	178.3	26.8	20.5	34.9	0.0	0.2	6.6	53.5	3.4	1.4	28.2	0.0	41.0	0.0	3.8	85.0	4.6	3.9	0.2	0.0	57.4	0.0	0.0	7.1	4.0	2.6	11.8	1.8	90.5	170.2	39.9	21.0	0.4	46.9	6.5	6.5	6.2	12.5	1.5	15.6	0.1	0.5	78.3	71.8
SP1		ENSG00000185591	"Sp1 transcription factor"	P08047	12	53380176-53416446	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000330, HPA001853, HPA012292"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000330: AB_2171049, HPA001853: AB_1080069, HPA012292: AB_1857394"	"unprognostic (1.12e-1)"	"unprognostic (8.52e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.38e-2)"	"unprognostic (5.14e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.37e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.12e-2)"	20.7	18.1	8.8	13.9	14.2	17.0	20.1	30.0	14.7	20.9	21.9	17.5	19.3	19.6	25.4	21.2	35.0	20.4	18.7	12.1	14.1	6.8	31.3	14.1	17.6	14.2	18.3	9.7	22.5	17.9	19.0	11.3	19.5	14.4	16.2	20.1	21.5	25.8	19.5	22.0	25.8	30.0	18.4	21.0	19.0	18.8	22.4	15.2	25.8	16.6	17.3	26.6	25.1	21.6	2.7	3.0	11.2	4.2	1.7	2.8	1.4	17.7	19.5	22.4	16.3	18.0	20.8	17.8	12.9	16.6	15.8	14.6	16.2	35.6	24.1	17.1	14.7	10.2	25.8	25.7	17.4	17.7	18.4	14.9	21.2	24.7	8.8	12.6	19.3	18.0	22.0	18.2	16.2	31.6	28.7	16.2	19.3	20.3	35.0	11.6	25.4	28.8	14.8	12.4	13.7	14.7	20.5	21.6	14.3	12.5	32.2	11.8	15.8	26.1	21.9	13.2	18.4	27.5	20.8	15.7	18.6	17.4	13.9	13.7	12.1	13.8	24.1	14.3	16.1	14.9	4.5	4.2	2.5	2.2	2.7	2.8	2.3	2.2	2.1	2.4	2.7	2.4	2.6	11.2	1.7	3.1	3.0	1.6	1.4	8.8	14.2	30.0	14.7	14.1	6.8	18.3	9.7	14.4	15.2	20.8	12.9	13.5	18.3	21.2	11.0	6.7	35.7	12.0	21.6	29.6	7.9	13.5	5.0	15.2	44.6	19.7	33.8	23.3	11.9	13.5	16.5	21.7	5.8	25.9	16.0	15.9	12.1	28.8	37.1	35.5	25.3	17.2	8.5	9.0	29.3	20.6	15.6	17.3	24.4	18.4	9.7	12.9	17.0	27.9	22.6	27.4	17.8	13.1	23.4	40.6
SP2	KIAA0048	ENSG00000167182	"Sp2 transcription factor"	Q02086	17	47896150-47928957	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003357, CAB010245"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"CAB010245: AB_2121523, HPA003357: AB_1080070"	"unprognostic (1.23e-1)"	"unprognostic (1.66e-2)"	"unprognostic (6.30e-3)"	"unprognostic (5.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.39e-2)"	"prognostic favorable (1.82e-5)"	"unprognostic (5.34e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.66e-2)"	18.8	15.0	16.9	21.9	20.5	19.1	21.0	28.5	23.4	17.3	16.3	26.9	12.5	16.9	20.5	16.2	19.9	18.3	14.9	20.2	13.8	11.8	17.2	13.3	17.4	22.3	14.1	13.0	20.5	19.7	31.0	14.5	21.4	18.5	16.2	15.8	26.9	18.7	18.2	30.2	19.2	20.8	16.6	17.6	22.2	16.5	23.2	16.3	31.9	21.7	16.0	28.3	18.9	18.0	8.3	6.3	14.3	9.3	12.7	11.5	7.8	16.5	19.2	13.2	11.1	6.5	6.1	12.6	9.8	7.2	10.2	9.2	20.9	8.4	14.4	8.8	12.8	10.3	12.8	9.2	8.5	10.7	20.9	12.9	14.6	12.9	10.8	6.1	13.0	17.3	8.8	10.1	11.9	11.3	7.2	9.6	13.4	15.8	24.6	9.8	22.5	32.1	8.2	5.9	15.0	12.8	14.6	18.1	9.0	7.1	26.9	13.2	15.8	8.5	9.1	9.7	8.5	13.1	12.4	15.8	17.9	9.6	12.4	15.0	21.9	24.2	12.9	9.7	8.8	14.4	14.3	8.0	12.1	11.5	9.3	10.1	7.0	8.8	10.7	6.3	8.3	10.2	10.3	14.3	12.7	8.1	6.1	8.8	7.8	16.9	20.5	28.5	23.4	13.8	11.8	14.1	13.0	18.5	16.3	8.9	21.6	8.3	13.7	5.6	8.4	8.3	2.5	12.0	5.7	10.4	0.0	9.2	13.3	5.9	7.9	10.0	7.7	0.0	6.7	7.7	6.0	10.4	12.7	5.8	7.8	11.1	15.0	5.5	8.5	7.5	9.8	9.2	8.5	7.2	8.9	11.3	5.4	11.5	3.2	5.9	5.9	6.5	7.8	9.1	7.2	6.6	17.2	12.5	7.3	14.5
SP4	"HF1B, MGC130008, MGC130009, SPR-1"	ENSG00000105866	"Sp4 transcription factor"	Q02446	7	21428034-21514822	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010246, HPA040395"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB010246: AB_2194481, HPA040395: AB_2676959"	"unprognostic (1.57e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.28e-2)"	"unprognostic (9.14e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.09e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.26e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.18e-2)"	"unprognostic (7.80e-3)"	5.8	4.7	7.9	8.9	11.0	10.2	6.3	25.9	9.5	8.6	4.4	6.4	3.8	3.1	9.2	5.8	4.1	7.8	4.6	6.5	8.3	6.1	5.4	3.4	6.0	11.7	8.6	6.9	19.8	5.2	17.1	11.8	3.7	6.7	7.3	4.3	6.0	5.0	5.7	10.5	5.0	5.6	5.3	6.8	9.1	4.9	6.0	10.0	27.0	13.1	4.8	11.2	6.8	6.3	5.4	1.5	7.2	1.8	3.5	8.3	3.1	2.2	1.7	5.1	8.1	1.5	1.0	1.5	2.3	1.7	2.7	3.7	3.5	2.7	9.2	1.4	1.5	7.2	2.8	7.5	2.2	5.3	2.7	2.8	4.8	3.3	1.5	1.1	4.0	5.7	1.1	1.9	2.9	3.3	1.4	5.4	6.7	6.0	7.0	2.2	1.0	9.3	2.9	12.3	4.3	2.1	20.9	8.7	3.3	0.9	1.6	6.6	8.2	5.3	2.4	1.8	5.1	2.6	2.9	2.3	4.4	5.5	2.7	4.2	9.3	7.3	14.4	2.5	6.4	6.1	4.3	0.8	7.2	6.8	0.9	8.3	3.7	6.4	6.6	0.9	5.4	7.6	7.1	1.9	3.5	1.8	1.5	7.6	3.1	7.9	11.0	25.9	9.5	8.3	6.1	8.6	6.9	6.7	10.0	3.0	7.0	5.0	11.4	11.2	15.9	7.6	10.2	1.4	7.9	0.0	7.9	1.0	0.0	1.7	5.5	5.8	1.1	0.0	1.8	1.0	6.1	7.1	4.7	4.0	1.5	17.5	10.3	11.6	6.5	4.1	5.2	5.9	6.8	2.8	1.8	9.8	1.4	8.6	6.3	1.4	18.8	0.0	4.1	7.9	8.3	9.7	1.3	14.6	2.8	4.3
SPAG9	"CT89, FLJ13450, FLJ14006, FLJ26141, FLJ34602, HLC4, HSS, JIP-4, JIP4, JLP, KIAA0516, MGC117291, MGC14967, MGC74461, PHET, PIG6, SYD1"	ENSG00000008294	"Sperm associated antigen 9"	O60271	17	50962174-51120865	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 6.3;neutrophil: 13.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 13.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040446, HPA061458"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA040446: AB_10671691, HPA061458: AB_2684528"	"unprognostic (1.36e-1)"	"unprognostic (6.61e-2)"	"unprognostic (6.04e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.52e-2)"	"unprognostic (9.73e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-3)"	"unprognostic (2.27e-2)"	"unprognostic (9.53e-2)"	"unprognostic (7.67e-2)"	"prognostic unfavorable (8.10e-4)"	21.6	16.4	32.1	12.5	42.6	15.8	13.8	32.7	46.6	15.9	15.6	44.8	7.6	14.0	19.6	9.1	20.7	12.3	18.8	15.1	33.1	25.5	23.6	22.8	20.5	8.7	55.7	25.9	22.2	21.0	25.8	14.6	21.8	37.1	13.2	14.1	12.2	9.9	14.4	39.6	14.2	14.2	19.1	50.2	12.1	10.5	33.3	55.2	8.5	28.2	9.5	10.6	15.0	13.6	1.0	1.3	13.4	1.3	0.5	1.8	0.4	17.5	19.7	25.3	12.3	24.1	21.4	22.4	14.4	14.2	16.2	20.3	17.7	12.1	9.5	10.1	23.7	32.8	15.2	16.5	12.1	30.3	14.4	19.7	7.9	15.6	13.1	18.1	11.4	9.3	15.4	14.1	21.9	39.3	15.6	13.3	4.8	17.4	10.6	22.9	8.8	7.1	4.8	6.7	11.8	25.6	8.2	28.3	8.3	14.9	33.5	19.7	27.4	12.7	11.9	13.1	16.0	9.7	13.6	18.4	45.4	10.7	34.9	21.1	15.1	21.6	15.6	15.5	6.8	15.7	6.3	1.3	0.8	1.4	0.8	1.0	1.0	1.2	1.3	1.3	1.0	0.7	0.9	13.4	0.5	0.5	1.1	1.8	0.4	32.1	42.6	32.7	34.9	33.1	25.5	55.7	25.9	37.1	55.2	122.1	93.5	25.1	151.7	146.5	92.9	57.2	38.2	30.8	36.4	24.4	117.8	34.3	23.2	46.7	183.2	86.7	70.8	0.0	49.5	23.5	89.4	131.0	41.6	44.8	33.0	63.5	66.9	68.7	43.2	94.6	70.5	64.9	67.4	46.9	27.4	30.1	70.3	31.6	62.9	65.7	82.4	64.7	72.1	210.4	52.0	150.7	116.1	31.6	25.1	163.9
SPATA13	"ARHGEF29, FLJ31208"	ENSG00000182957	"Spermatogenesis associated 13"	Q96N96	13	23979805-24307074	"Plasma proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"granulocytes: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 19.6;HDLM-2: 26.4"									"HPA040185, HPA041208"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040185: AB_10795521, HPA041208: AB_10794193"	"unprognostic (8.80e-2)"	"unprognostic (9.32e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-3)"	"unprognostic (6.23e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.76e-3)"	"unprognostic (9.15e-3)"	"unprognostic (1.78e-1)"	"unprognostic (4.21e-1)"	"prognostic favorable (1.16e-4)"	5.5	11.8	14.7	13.9	23.7	21.4	11.8	5.5	15.2	9.2	8.8	33.7	10.9	9.4	7.8	11.9	3.2	8.2	9.8	6.4	15.3	10.5	13.1	17.8	15.3	16.8	27.9	7.4	12.1	29.7	6.1	8.3	13.7	17.7	12.1	10.2	7.5	6.8	9.8	2.4	6.3	11.5	6.2	25.7	47.8	13.8	5.2	27.2	11.9	10.7	3.1	12.8	6.5	4.5	1.2	2.5	19.3	4.7	9.6	17.7	5.8	1.8	2.9	15.3	1.9	0.5	1.3	0.6	4.5	19.6	2.3	2.0	3.7	7.7	11.7	2.4	4.1	1.2	3.4	4.3	1.3	5.9	26.4	5.2	2.8	2.2	4.3	0.7	4.5	2.2	1.7	0.2	2.5	1.4	2.0	3.8	6.3	0.0	9.9	2.4	6.4	8.2	1.5	5.0	12.4	3.8	7.2	5.9	6.2	10.4	5.8	5.6	4.3	0.9	9.7	8.7	3.5	1.4	2.6	4.4	3.0	2.4	0.2	3.2	2.3	0.0	0.0	2.6	4.3	14.4	2.4	3.1	0.0	17.3	4.0	13.5	1.2	14.7	17.7	2.2	1.0	15.6	16.0	19.3	9.6	4.7	2.5	13.8	5.8	14.7	23.7	5.5	15.2	15.3	10.5	27.9	7.4	17.7	27.2	3.0	25.8	4.5	1.9	4.7	0.7	3.6	0.0	45.5	27.3	14.0	0.0	1.0	3.3	16.3	8.1	18.2	21.2	0.0	13.6	11.9	11.0	26.3	66.1	0.0	10.1	0.0	31.0	0.0	0.0	5.1	6.9	13.4	5.0	1.0	24.3	20.0	17.3	31.7	7.1	4.7	0.5	0.0	7.1	1.9	1.9	5.4	18.7	13.1	22.8	7.8
SPATS2	"FLJ13117, SCR59, SPATA10"	ENSG00000123352	"Spermatogenesis associated serine rich 2"	Q86XZ4	12	49366584-49527424	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 114.2;Spermatogonia: 132.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA038642, HPA038643, HPA076823"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA038642: AB_2676128, HPA038643: AB_10672523, HPA076823: "	"unprognostic (2.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.56e-2)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (9.57e-8)"	"unprognostic (4.55e-2)"	"unprognostic (6.32e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (2.64e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (5.20e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.81e-1)"	7.7	8.2	10.6	19.9	12.4	5.6	9.4	25.7	18.0	13.5	12.1	4.0	7.7	11.2	19.0	8.3	9.1	6.7	11.0	7.5	11.7	8.9	9.1	5.1	8.0	14.2	9.0	11.0	9.0	12.1	30.6	24.8	8.6	15.6	10.1	11.5	9.8	19.2	9.2	9.7	15.8	10.5	11.6	6.1	11.1	12.2	24.2	4.5	8.8	13.6	5.4	19.1	13.7	13.8	7.8	10.2	1.9	1.8	1.6	2.3	1.5	7.0	15.7	13.5	15.9	7.9	12.5	4.4	8.2	11.6	14.1	11.5	14.5	15.9	17.4	19.2	7.3	9.1	8.4	11.6	15.6	18.3	13.1	6.7	15.6	12.0	11.3	14.4	4.1	9.4	10.6	7.8	22.2	21.0	46.2	32.9	7.8	8.3	16.1	14.5	12.2	8.4	6.2	14.1	11.3	16.0	12.9	22.7	20.8	13.1	8.9	15.3	13.8	17.3	11.7	19.8	8.8	20.2	4.8	29.8	6.2	15.2	5.6	5.2	21.4	24.1	14.2	8.2	7.2	8.9	1.9	1.8	0.6	2.3	0.5	2.3	7.8	1.9	1.5	5.0	4.9	1.7	1.5	1.3	1.6	0.3	10.2	1.4	1.5	10.6	12.4	25.7	18.0	11.7	8.9	9.0	11.0	15.6	4.5	17.9	20.3	22.0	45.5	51.5	37.0	8.1	20.4	6.7	14.8	34.9	21.6	8.5	5.0	23.2	64.2	40.9	8.4	23.3	24.4	9.8	35.6	26.6	10.4	4.2	7.0	39.7	35.2	25.2	7.5	27.6	29.4	17.9	18.6	19.0	17.3	21.1	32.7	7.0	31.5	9.3	4.7	51.8	25.5	114.2	132.8	52.8	4.5	14.9	27.3	22.4
SPATS2L	"DNAPTP6, SGNP"	ENSG00000196141	"Spermatogenesis associated serine rich 2 like"	Q9NUQ6	2	200305881-200482263	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 76.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055427, HPA066310"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA055427: AB_2682813, HPA066310: AB_2685655"	"unprognostic (1.13e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.39e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.17e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (3.95e-1)"	"unprognostic (7.84e-3)"	"unprognostic (3.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.99e-1)"	25.0	13.5	22.4	14.3	20.1	4.2	46.1	15.7	25.7	33.1	34.5	14.5	27.2	34.3	20.4	20.7	28.0	34.8	46.9	46.4	18.4	18.8	37.7	44.9	22.4	14.7	21.9	20.9	30.0	24.3	17.1	24.7	26.9	20.3	27.3	34.6	14.9	63.4	28.8	26.5	15.6	44.6	20.6	23.4	22.1	42.2	11.5	16.7	14.3	21.6	17.5	12.3	25.4	46.5	2.2	9.8	22.9	3.3	4.2	17.0	1.6	27.3	15.8	18.6	2.3	12.5	16.0	6.9	49.0	16.4	31.9	23.9	42.6	30.1	0.1	11.3	31.1	17.4	27.1	5.6	28.6	21.0	16.4	7.8	0.2	14.4	51.1	22.5	4.7	2.1	19.6	28.5	21.3	20.4	22.7	12.4	3.4	6.3	19.7	42.4	8.4	0.7	1.3	4.5	48.8	36.4	0.1	66.3	1.9	76.9	22.4	0.5	5.3	12.7	7.1	19.9	27.6	3.8	6.5	20.5	21.2	21.4	6.6	27.9	5.8	5.6	0.3	18.1	2.2	29.8	22.9	3.1	4.2	3.6	3.3	8.3	1.6	3.9	3.6	9.8	2.2	1.7	2.0	3.1	4.2	2.5	7.6	17.0	1.6	22.4	20.1	15.7	25.7	18.4	18.8	21.9	20.9	20.3	16.7	80.4	19.2	18.1	208.3	80.9	13.9	110.0	359.2	145.9	56.9	164.0	11.8	13.7	94.5	137.6	58.2	54.0	166.5	0.0	128.0	30.2	94.6	270.0	56.4	183.0	67.0	57.2	52.9	86.5	88.0	14.5	153.4	70.0	121.4	18.0	201.8	6.1	152.6	164.9	133.7	331.2	48.9	77.6	97.1	16.5	78.7	68.1	8.2	19.2	64.2	162.6
SPC25	"AD024, MGC22228, SPBC25"	ENSG00000152253	"SPC25, NDC80 kinetochore complex component"	Q9HBM1	2	168834132-168913371	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 38.0"	"Cell type enhanced"	"Detected in many"	11	"Extravillous trophoblasts: 31.3;Hofbauer cells: 12.6;Muller glia cells: 13.2;Spermatocytes: 21.2;Spermatogonia: 17.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	4	"B-cells: 1.1;T-cells: 2.5"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047144, HPA050544"	Enhanced		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA047144: AB_2679952, HPA050544: "	"unprognostic (3.52e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (8.61e-5)"	"unprognostic (3.15e-1)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (4.74e-6)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (1.84e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.11e-16)"	"unprognostic (9.91e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.57e-1)"	0.9	1.6	3.6	7.2	2.2	6.7	2.1	0.4	3.5	1.3	4.0	0.9	0.0	6.8	1.3	1.5	8.5	0.6	1.0	1.1	2.7	1.6	1.5	1.6	1.9	7.5	1.2	2.5	1.2	2.6	0.7	0.2	3.3	1.1	0.8	3.1	1.3	2.1	0.0	0.7	2.1	3.8	1.8	0.7	4.1	3.0	5.9	1.1	38.0	0.6	5.6	8.0	1.5	2.7	1.1	0.0	0.4	0.1	0.0	2.5	0.4	1.0	8.4	19.6	10.9	0.9	0.9	7.1	11.3	4.3	11.4	9.1	4.3	7.9	7.0	5.0	1.8	15.0	10.4	7.5	0.0	10.1	4.7	11.5	14.0	5.3	2.0	0.0	10.4	4.2	0.0	0.5	7.3	0.1	2.3	5.7	14.8	1.1	7.9	3.2	5.2	7.5	12.6	0.6	5.0	11.2	13.6	19.5	3.1	4.6	6.6	14.7	0.9	10.1	6.9	1.9	6.6	0.5	7.3	1.7	1.7	20.7	6.7	9.5	15.3	26.6	6.9	2.2	1.6	6.7	0.0	0.1	0.2	0.0	0.1	0.0	0.9	0.4	0.0	0.0	1.1	0.2	0.5	0.4	0.0	0.0	0.0	2.5	0.4	3.6	2.2	0.4	3.5	2.7	1.6	1.2	2.5	1.1	1.1	0.0	0.6	1.5	1.1	4.7	0.0	0.4	0.0	0.0	3.4	0.0	0.0	2.8	0.0	0.0	1.2	0.4	1.0	0.0	0.0	31.3	0.8	0.2	0.0	0.8	12.6	0.0	0.0	4.3	1.6	0.6	0.6	1.6	0.0	0.0	1.4	13.2	0.8	0.0	1.1	0.0	0.3	0.0	0.3	21.2	17.6	1.3	4.8	1.7	3.0	0.9
SPEN	"KIAA0929, MINT, RBM15C, SHARP"	ENSG00000065526	"Spen family transcriptional repressor"	Q96T58	1	15847864-15940460	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015825, HPA050257"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015825: AB_1856823, HPA050257: AB_2681065"	"unprognostic (3.91e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.06e-2)"	"unprognostic (6.93e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.83e-1)"	18.2	11.2	18.2	18.2	22.2	27.2	17.3	38.2	25.9	18.5	13.4	20.7	17.7	11.9	19.0	12.7	16.7	19.4	11.8	13.5	17.6	11.5	14.4	13.2	17.8	16.6	23.4	17.5	31.2	23.9	35.1	17.5	16.2	19.0	14.9	13.3	11.6	16.2	16.2	24.0	22.8	16.0	15.1	22.0	16.5	13.7	13.6	23.3	18.3	20.1	8.7	18.0	17.1	41.9	5.0	2.7	7.7	2.4	1.3	1.7	0.6	12.7	10.8	13.5	10.1	13.6	8.3	7.3	6.6	8.7	7.2	6.1	9.8	10.0	18.0	7.9	13.0	8.5	18.5	12.7	11.8	11.6	16.2	35.2	22.6	9.6	6.2	6.1	18.5	10.8	6.1	8.5	10.7	15.6	6.8	8.2	13.8	23.5	18.6	5.8	7.1	15.3	7.3	6.1	7.4	8.3	14.8	13.2	11.1	4.0	11.5	10.5	10.6	18.6	9.1	7.9	6.4	3.2	9.1	14.7	6.6	8.2	12.8	9.4	11.2	7.3	20.6	6.5	15.0	9.2	7.7	1.5	0.9	1.6	2.4	1.3	1.8	1.7	1.4	0.7	5.0	0.9	1.3	4.2	1.3	1.2	2.7	1.1	0.6	18.2	22.2	38.2	25.9	17.6	11.5	23.4	17.5	19.0	23.3	74.5	74.0	31.3	47.9	93.0	64.6	48.1	20.4	38.8	66.0	5.2	49.1	10.9	3.3	16.9	3.4	55.5	30.7	23.3	15.0	12.0	46.5	43.4	59.1	26.3	13.3	90.6	30.4	13.5	30.8	3.6	25.3	30.1	20.3	25.2	24.4	29.6	18.0	23.2	33.6	6.5	54.5	19.4	54.6	34.9	51.9	88.8	13.2	20.2	18.7	49.2
SPINK5	"DKFZp686K19184, FLJ21544, FLJ97536, FLJ97596, FLJ99794, LEKTI, LETKI, NETS, NS, VAKTI"	ENSG00000133710	"Serine peptidase inhibitor, Kazal type 5"	Q9NQ38	5	148025683-148137289	"Disease related genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 101.6;esophagus: 313.0;tongue: 97.4"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 45.0;Basal keratinocytes: 47.7;Cholangiocytes: 58.6;Mucus-secreting cells: 32.9;Paneth cells: 66.2;Suprabasal keratinocytes: 56.2"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 12.3;HeLa: 18.1;Karpas-707: 16.0;SuSa: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009067, HPA011351, CAB015347"	Enhanced		Enhanced	Vesicles	"Secreted in other tissues"	NA	NA		28000000	Vesicles		"CAB015347: AB_2196138, HPA009067: AB_1080084, HPA011351: AB_1857447"	"unprognostic (9.66e-3)"	"unprognostic (1.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.45e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.92e-3)"	"unprognostic (4.56e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.82e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.59e-1)"	0.1	0.0	0.2	0.1	0.1	0.0	2.8	0.1	0.2	101.6	0.7	0.2	0.1	0.0	3.2	0.2	313.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.3	0.1	0.2	1.7	0.2	18.1	0.1	0.2	48.6	0.1	0.1	0.1	0.1	0.7	0.2	0.1	3.6	0.3	97.4	65.3	0.3	64.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	1.5	0.0	0.0	12.3	0.0	1.1	0.0	0.0	0.0	0.0	18.1	0.0	0.0	0.2	0.0	0.0	3.4	0.0	0.0	0.0	0.2	0.0	0.7	16.0	0.0	1.7	0.0	0.0	2.2	1.6	0.2	0.0	0.0	0.0	0.0	4.7	2.4	0.0	0.5	0.0	0.0	5.9	3.8	0.0	0.0	0.0	0.1	0.0	0.0	4.2	1.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	8.9	45.0	0.0	1.4	47.7	0.0	0.8	58.6	6.7	9.1	0.0	0.0	1.7	0.0	0.0	9.3	6.4	13.4	0.0	1.1	1.6	1.0	0.6	1.1	0.0	0.1	0.0	4.1	1.3	0.6	2.7	0.6	0.6	3.3	0.0	32.9	0.0	4.6	66.2	0.0	0.0	0.0	0.0	0.9	0.6	1.9	56.2	1.3	0.0	20.3	2.3
SPP1	"BNSP, BSPI, ETA-1, OPN"	ENSG00000118785	"Secreted phosphoprotein 1"	P10451	4	87975650-87983426	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Biomineralization, Cell adhesion"	Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 303.9;kidney: 700.7;placenta: 331.0"	"Cell type enriched"	"Detected in many"	9	"Hofbauer cells: 50179.8"	"Cancer enhanced"	"Detected in all"		"glioma: 1690.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 19.2"	"Lineage enriched"	"Detected in single"	192	"granulocytes: 19.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 218.9;Hep G2: 107.8;RPTEC TERT1: 477.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 331.4"	"Low region specificity"	"Detected in all"			"HPA027540, HPA027541"	Enhanced		Enhanced	"Golgi apparatus"	"Secreted to blood"	NA	NA	114000000	54000000	"Golgi apparatus"		"HPA027540: AB_10600222, HPA027541: AB_10601446"	"unprognostic (4.74e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.13e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.96e-3)"	"prognostic unfavorable (2.84e-6)"	"unprognostic (2.46e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (4.31e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.63e-2)"	20.7	4.1	25.5	8.3	42.7	1.1	8.7	4.3	61.0	4.7	2.7	27.3	0.0	2.1	17.3	2.3	1.5	4.2	303.9	2.6	37.2	26.4	700.7	3.9	3.2	2.0	97.0	9.1	3.1	23.6	1.3	1.5	331.0	52.3	2.4	1.9	3.9	7.3	3.9	2.5	1.1	2.1	5.6	147.9	2.1	2.0	2.4	58.9	0.0	1.7	0.0	1.6	5.3	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	6.2	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	218.9	0.1	17.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	107.8	0.0	0.3	0.2	0.0	0.0	1.5	0.0	5.5	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.9	10.1	0.0	0.0	0.1	0.0	51.4	477.9	0.0	0.0	0.0	0.0	0.0	14.4	21.2	0.0	0.2	0.0	0.5	1.1	0.0	1.1	0.0	0.3	0.4	20.0	0.0	20.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	25.5	42.7	4.3	28.8	37.2	26.4	97.0	9.1	52.3	58.9	3.0	6.6	20.0	2.2	1.3	34.3	4.3	1834.4	2.7	0.0	2071.0	25.5	256.7	850.5	3124.6	0.0	17.5	0.0	0.0	59.8	221.1	15.4	0.3	0.0	2.9	50179.8	742.1	0.0	6.7	63.8	0.4	0.9	93.6	1.7	120.8	0.0	3889.3	343.9	0.0	0.0	5328.4	135.9	0.0	4.4	0.3	0.2	0.9	558.5	1.5	0.0	12.7
SPTY2D1	"DKFZp686I068, FLJ39441, Spt2"	ENSG00000179119	"SPT2 chromatin protein domain containing 1"	Q68D10	11	18606401-18634791	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039372, HPA040177, HPA047957"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA039372: AB_2676472, HPA040177: , HPA047957: AB_2680224"	"unprognostic (8.43e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (2.03e-1)"	"prognostic favorable (2.07e-4)"	"unprognostic (1.33e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.33e-1)"	14.0	12.7	6.2	9.7	9.2	33.6	11.9	10.9	10.9	13.7	10.9	6.9	9.9	8.3	11.9	8.6	15.5	12.5	12.2	9.9	5.8	6.5	14.9	25.1	9.7	8.7	6.0	6.8	16.7	16.9	13.6	14.0	15.3	8.5	12.5	9.7	7.9	13.3	13.9	16.3	12.5	13.7	9.3	7.6	15.0	11.0	7.1	5.5	17.7	12.8	8.0	13.3	12.5	11.8	2.7	3.4	7.8	5.7	7.3	8.7	3.3	8.2	8.1	6.5	9.1	10.9	11.4	10.0	12.2	13.4	10.2	12.3	7.2	3.6	18.5	6.9	11.5	8.0	8.6	10.8	9.6	14.7	9.7	10.1	7.4	4.9	6.6	10.5	15.6	14.8	9.4	10.0	6.5	13.3	7.4	11.2	11.1	10.3	29.5	11.3	8.9	10.4	6.2	5.9	16.2	9.1	9.6	18.1	7.9	10.7	11.9	6.3	8.9	10.9	12.7	8.5	8.9	7.9	6.7	9.8	10.0	8.5	19.4	7.4	10.3	12.7	14.5	11.9	8.7	8.4	7.8	4.1	5.8	5.7	5.7	8.7	2.6	5.6	5.7	3.4	2.7	5.2	5.6	6.0	7.3	5.4	2.9	6.0	3.3	6.2	9.2	10.9	10.9	5.8	6.5	6.0	6.8	8.5	5.5	23.8	45.0	23.8	18.6	49.6	12.8	23.6	12.7	61.6	34.2	26.2	9.8	12.3	14.9	21.5	1.6	21.9	22.7	0.0	21.7	19.7	31.0	20.1	56.6	25.6	14.3	11.1	42.5	21.5	27.0	1.7	17.5	31.7	15.1	13.6	24.2	13.8	21.6	22.1	13.1	12.6	11.2	32.3	23.0	10.7	14.2	58.1	23.0	35.5	18.6	29.3
SQSTM1	"A170, OSIL, p60, p62, p62B, PDB3"	ENSG00000161011	"Sequestosome 1"	Q13501	5	179806398-179838078	"Disease related genes, Predicted intracellular proteins"	"Apoptosis, Autophagy, Differentiation, Immunity"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Syncytiotrophoblasts: 1710.2;Urothelial cells: 1685.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 195.8;HHSteC: 135.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004587, HPA064165, HPA068843"	Supported		Enhanced	Vesicles,Cytosol		No	No			"Vesicles, Cytosol"		"CAB004587: AB_628279, HPA064165: AB_2685203, HPA068843: AB_2732120"	"unprognostic (1.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.31e-5)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.21e-1)"	"unprognostic (8.68e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.01e-1)"	47.8	74.5	12.4	21.6	16.0	19.5	60.4	26.2	23.4	25.2	31.7	20.9	39.8	22.9	29.4	27.7	30.8	23.1	45.2	51.9	13.9	12.8	38.6	88.3	33.3	33.4	23.2	16.3	32.3	51.8	22.7	33.6	72.7	15.6	36.2	15.2	28.9	39.0	36.2	102.8	15.3	22.0	36.3	15.5	25.6	40.0	18.9	17.9	18.8	60.4	45.3	17.5	47.9	64.0	27.8	34.2	100.4	58.3	28.2	38.7	52.4	13.8	79.6	3.8	11.4	56.4	38.9	57.2	20.4	60.8	16.1	20.7	15.6	57.5	2.2	56.6	31.2	107.5	17.3	7.5	17.2	7.6	195.8	11.7	6.6	28.9	24.3	135.0	6.7	36.2	32.6	21.8	30.2	46.8	44.7	16.5	1.9	6.9	46.8	34.5	10.9	2.5	6.5	9.4	41.1	24.8	5.2	8.4	21.8	23.9	61.0	8.4	7.3	30.1	29.4	72.6	8.2	14.7	11.5	36.8	28.3	12.6	26.8	26.1	70.0	73.3	7.3	64.6	11.4	31.4	90.0	58.3	59.9	32.7	39.6	38.7	27.8	28.9	29.2	34.2	27.1	24.0	24.0	100.4	28.2	36.6	14.8	38.7	52.4	12.4	16.0	26.2	23.4	13.9	12.8	23.2	16.3	15.6	17.9	172.7	223.0	86.1	1144.6	264.2	81.2	33.3	252.3	143.2	124.0	115.1	51.1	248.2	198.9	724.5	23.1	185.5	409.6	23.3	582.3	108.5	234.9	1101.4	374.4	241.5	260.7	85.8	326.4	132.0	116.5	47.7	301.2	245.4	219.4	921.6	190.4	130.1	730.8	241.9	243.6	251.6	67.2	161.7	335.8	31.2	49.4	226.5	1710.2	157.6	126.4	1685.2
SREK1	"DKFZp564B176, SFRS12, SRrp508, SRrp86"	ENSG00000153914	"Splicing regulatory glutamic acid and lysine rich protein 1"	Q8WXA9	5	66139971-66183615	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037673, HPA037674, HPA059332"	Enhanced		Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nucleoplasm, Nuclear speckles"		"HPA037673: AB_2675598, HPA037674: AB_10671376, HPA059332: AB_2683983"	"unprognostic (1.38e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (2.54e-4)"	"unprognostic (1.29e-2)"	"unprognostic (7.67e-2)"	"unprognostic (5.66e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.66e-2)"	"unprognostic (5.48e-2)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.08e-1)"	"unprognostic (6.76e-2)"	"unprognostic (6.69e-2)"	11.1	13.4	12.8	15.6	14.5	38.0	16.3	24.2	14.7	12.9	10.1	8.9	17.3	10.9	18.5	15.9	9.6	13.6	10.6	8.2	12.4	13.3	10.6	10.5	12.5	12.7	11.1	12.0	12.2	14.3	23.4	30.3	12.2	11.4	12.2	10.7	11.9	12.4	16.5	11.9	20.2	12.6	13.7	11.3	14.9	11.0	11.0	11.4	19.5	14.3	9.8	9.5	10.6	10.5	6.5	6.0	8.5	5.6	7.7	6.0	2.8	5.1	6.3	8.9	5.3	4.2	7.9	8.8	6.0	3.5	3.3	3.5	9.3	6.0	7.7	7.7	4.6	4.4	6.9	4.5	6.0	5.8	5.4	10.2	7.3	16.2	6.8	3.7	6.6	8.6	4.6	6.0	4.0	4.5	6.9	5.2	4.5	6.6	5.6	3.5	5.0	6.9	15.5	4.7	2.1	3.2	9.3	4.1	5.5	5.7	9.3	10.5	7.1	5.7	2.7	4.9	6.9	6.8	8.6	5.5	5.3	3.2	7.2	6.1	6.0	4.1	8.7	5.2	10.7	5.7	8.5	5.6	5.2	5.0	3.9	5.4	6.2	4.7	6.0	4.2	6.5	5.6	5.6	4.1	7.7	3.7	6.0	4.4	2.8	12.8	14.5	24.2	13.8	12.4	13.3	11.1	12.0	11.4	11.4	86.4	149.8	64.8	77.1	58.6	59.7	64.9	66.2	132.5	117.2	43.6	110.0	73.9	31.5	45.7	31.9	85.0	41.6	70.0	48.3	73.9	67.2	73.1	94.7	57.6	44.0	63.5	74.7	58.3	48.5	44.8	77.3	55.5	40.5	37.9	43.9	86.7	44.4	37.0	72.2	27.8	96.5	45.3	63.8	65.4	57.5	60.6	100.9	61.0	47.2	68.6
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		12000	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	17.2	13.9	27.6	24.7	15.6	16.1	27.1	20.2	13.4	20.3	23.3	15.3	29.0	38.6	12.8	17.1	13.5	21.7	27.5	19.8	26.7	13.2	19.1	29.6	27.0	18.1	10.9	34.1	19.7	10.9	12.5	16.4	24.2	23.2	17.5	19.0	28.7	21.2	20.8	14.9	30.9	22.9	45.4	14.1	9.5	27.6	22.1	18.8	17.7	18.0	16.8	15.2	21.8	17.7	15.0	21.7	15.9	16.7	19.4	17.8	18.5	24.1	20.2	19.0	14.5	47.7	19.2	40.1	19.7	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8	145.9	144.9	171.3	231.9	268.6	176.0	131.8	137.6	180.7	174.0	115.1	111.9	129.0	169.1	144.9	235.5	146.8	116.3	163.5	128.5	137.4	157.1	230.0	229.3	203.4	133.1	117.6	113.6	127.1	162.6	96.6	155.3	180.0	146.8	260.5	126.0	204.1	128.5	135.3	141.8	117.6	174.7	135.8	173.5	224.9	222.2	258.2	201.7	198.3	147.2	308.0
SRRM2	"Cwc21, KIAA0324, SRL300, SRm300"	ENSG00000167978	"Serine/arginine repetitive matrix 2"	Q9UQ35	16	2752329-2772538	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"basophil: 36.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041411, HPA066181"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA041411: AB_10796671, HPA066181: AB_2685630"	"unprognostic (8.48e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.23e-2)"	"prognostic favorable (6.77e-4)"	"prognostic unfavorable (5.08e-4)"	"unprognostic (7.39e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.72e-1)"	"unprognostic (3.50e-3)"	"prognostic unfavorable (4.82e-4)"	"unprognostic (1.05e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.84e-2)"	41.4	50.2	50.1	73.1	69.8	105.5	48.0	85.3	77.1	53.1	51.7	61.5	57.9	56.1	60.4	44.5	53.1	56.8	60.7	43.7	51.0	28.2	47.2	56.0	48.7	53.3	70.3	38.2	70.8	74.8	88.1	49.1	43.8	48.8	52.5	48.2	45.6	80.8	63.0	91.7	67.4	63.4	46.7	52.9	63.2	61.7	37.8	69.8	48.7	58.9	38.3	46.2	52.0	69.5	9.0	11.6	36.4	8.9	23.9	4.7	0.9	23.1	29.6	47.2	32.5	33.3	32.5	27.9	26.3	14.9	23.6	21.0	24.5	26.9	41.2	20.2	29.1	19.9	33.3	37.6	33.4	25.0	29.9	39.0	35.4	55.1	42.3	15.1	37.0	51.3	33.2	32.4	34.5	41.0	47.0	24.2	29.9	39.6	40.7	21.6	41.2	34.8	59.5	44.3	16.9	16.4	61.3	19.1	32.0	30.3	24.8	31.1	27.5	34.9	35.8	20.4	34.3	32.5	30.4	34.3	33.4	34.3	21.7	32.9	36.1	27.5	89.9	11.6	26.8	22.4	36.4	8.9	4.3	3.2	3.9	3.0	5.2	4.0	3.0	2.0	9.0	3.5	4.7	18.3	23.9	3.5	11.6	2.0	0.9	50.1	69.8	85.3	77.1	51.0	28.2	70.3	38.2	48.8	69.8	131.0	223.1	135.5	295.8	275.8	386.9	120.6	137.6	99.0	127.4	158.7	274.9	154.0	56.3	132.6	66.3	179.8	178.8	70.0	155.2	172.0	158.0	296.9	129.6	159.6	137.3	414.7	182.0	132.6	96.7	50.6	233.0	154.4	114.7	165.1	168.0	254.6	138.2	149.0	180.7	81.9	356.7	194.1	177.2	214.7	238.6	319.2	231.0	133.1	160.7	304.5
SRRT	"ARS2, Asr2, serrate"	ENSG00000087087	"Serrate, RNA effector molecule"	Q9BXP5	7	100875111-100888664	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 199.7;Late spermatids: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042858, HPA058379"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042858: AB_2678201, HPA058379: AB_2683697"	"unprognostic (5.83e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.90e-5)"	"unprognostic (4.36e-2)"	"unprognostic (4.99e-3)"	"unprognostic (2.35e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (1.01e-6)"	"unprognostic (6.30e-3)"	"unprognostic (2.77e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.10e-3)"	18.8	25.2	23.0	32.4	26.7	62.8	22.0	43.4	28.2	25.5	20.7	27.6	37.6	24.3	25.9	27.9	26.5	23.0	22.3	19.3	26.0	15.5	24.2	29.6	20.2	36.5	26.7	20.0	31.6	25.7	26.4	32.6	25.2	24.1	30.8	17.2	23.5	32.4	39.1	23.8	44.2	24.3	18.8	17.4	31.8	22.4	67.6	28.9	39.9	27.9	24.3	32.6	18.9	26.2	10.4	9.9	13.2	14.9	6.1	26.1	12.3	24.9	30.0	31.3	30.2	13.4	9.6	28.9	27.8	14.2	28.8	24.8	39.1	28.4	41.7	19.2	20.3	21.4	23.8	37.6	25.0	14.5	36.8	30.8	39.6	34.6	32.1	12.1	51.1	67.9	14.3	9.8	25.6	7.2	13.1	15.6	25.6	34.6	34.0	19.8	43.4	47.1	56.3	32.0	21.6	26.4	44.2	23.9	25.1	18.4	27.7	24.7	23.9	27.4	34.3	18.0	16.7	21.5	31.4	23.5	32.6	31.3	27.4	37.5	21.5	30.6	44.3	18.1	34.2	30.5	4.6	9.2	13.2	19.7	14.9	12.3	8.4	12.9	26.1	9.9	10.4	11.3	15.9	6.8	6.1	10.4	9.0	6.2	12.3	23.0	26.7	43.4	28.2	26.0	15.5	26.7	20.0	24.1	28.9	23.8	51.7	19.3	25.8	34.2	21.3	19.7	15.3	38.8	48.9	15.7	13.7	32.7	6.6	21.3	199.7	19.9	14.2	23.3	27.6	41.8	23.3	18.3	25.5	11.4	23.3	25.4	31.6	9.8	10.5	241.6	31.4	23.9	15.1	29.7	17.9	26.9	21.0	14.4	26.2	9.9	45.7	19.4	29.9	83.4	63.9	38.0	45.3	29.9	26.2	17.0
SRSF5	"HRS, SFRS5, SRP40"	ENSG00000100650	"Serine and arginine rich splicing factor 5"	Q13243	14	69726900-69772005	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043484, HPA056523"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA043484: AB_10797143, HPA056523: AB_2683164"	"unprognostic (2.08e-3)"	"prognostic favorable (7.91e-4)"	"unprognostic (1.89e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.07e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.00e-2)"	66.6	60.1	67.1	60.9	74.4	131.5	70.3	111.7	88.8	54.3	63.3	67.8	77.1	42.6	71.3	74.6	66.3	79.3	50.1	48.5	66.2	43.0	40.5	60.8	69.4	63.3	86.4	62.1	76.6	41.0	56.4	124.8	59.2	74.0	59.0	54.7	69.2	68.5	75.6	76.0	78.1	74.1	59.7	68.6	66.5	62.0	35.3	75.6	47.8	70.8	52.3	69.1	69.6	55.8	41.2	37.4	60.8	45.1	30.8	38.2	24.4	70.0	20.5	50.2	22.6	31.0	26.9	27.9	33.8	36.4	27.6	29.3	25.7	45.0	72.6	17.9	45.8	28.4	33.5	38.0	48.3	32.6	62.0	20.9	54.7	54.9	28.1	36.1	51.0	41.5	55.7	30.8	31.8	34.1	41.5	38.2	63.2	38.0	43.3	17.1	56.9	58.6	34.6	29.4	55.3	18.9	50.3	23.9	27.9	35.1	86.3	26.2	37.4	57.3	34.8	43.6	31.4	37.9	43.0	47.2	16.2	43.4	17.6	31.6	42.1	27.5	117.5	38.1	43.5	22.2	39.0	24.1	37.2	37.3	43.4	38.2	41.2	33.2	33.4	26.2	40.6	33.2	31.5	60.8	30.8	45.1	37.4	27.4	24.4	67.1	74.4	111.7	88.8	66.2	43.0	86.4	62.1	74.0	75.6	235.2	245.0	272.6	618.6	122.6	370.2	163.3	193.6	401.5	253.6	174.5	225.8	335.9	271.9	173.3	146.9	251.5	417.9	163.5	148.9	193.0	195.8	288.7	459.5	204.3	193.9	357.6	290.6	219.1	193.0	84.2	319.9	251.8	126.5	254.3	249.3	292.6	182.8	399.8	251.0	172.0	307.5	271.7	240.9	175.1	136.3	127.2	626.6	371.3	207.8	495.2
SRSF7	"9G8, AAG3, HSSG1, RBM37, SFRS7, ZCCHC20, ZCRB2"	ENSG00000115875	"Serine and arginine rich splicing factor 7"	Q16629	2	38743599-38751494	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043850, HPA056926"	Supported		Enhanced	Nucleoplasm		NA	NA		1400000	Nucleoplasm		"HPA043850: AB_10964495, HPA056926: AB_2683277"	"unprognostic (2.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (3.24e-2)"	"unprognostic (2.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.44e-3)"	"prognostic unfavorable (3.18e-8)"	"unprognostic (1.02e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.07e-3)"	42.2	32.2	32.8	51.1	37.3	76.7	39.2	34.7	38.9	26.8	37.2	21.4	34.8	20.4	34.1	27.3	50.2	36.9	25.9	29.8	26.9	24.6	25.1	34.9	34.3	45.5	37.5	23.8	31.7	38.2	20.4	50.4	34.3	32.8	27.4	37.2	25.0	32.8	32.4	31.7	26.2	37.7	36.6	33.4	34.8	38.8	35.9	33.0	44.1	26.1	38.6	59.2	28.2	40.7	20.9	47.6	8.8	33.4	20.8	22.9	22.3	44.4	38.7	52.0	33.5	16.0	12.7	36.8	38.1	16.4	38.4	31.0	45.6	34.3	72.7	26.1	24.7	35.7	25.1	65.4	46.6	46.3	45.2	40.9	43.8	27.7	46.5	13.6	53.7	31.9	7.5	15.9	26.4	51.1	16.1	31.8	30.4	63.2	29.1	32.5	49.5	68.0	47.6	56.8	51.9	35.5	60.4	43.6	41.2	28.5	43.2	35.7	34.7	36.4	32.2	25.5	34.2	29.4	49.1	27.4	23.3	36.5	19.9	53.0	32.1	48.1	108.6	27.7	56.4	32.0	6.4	23.1	8.8	21.3	33.4	22.9	20.9	16.4	21.0	47.6	14.1	18.6	21.1	2.3	20.8	19.6	28.6	17.4	22.3	32.8	37.3	34.7	38.9	26.9	24.6	37.5	23.8	32.8	33.0	74.5	215.1	214.9	400.1	230.6	113.1	58.5	71.4	103.1	134.2	61.1	111.9	262.6	132.6	156.5	100.6	205.2	175.7	93.5	114.8	395.5	179.8	170.8	309.8	83.0	212.6	114.4	170.8	124.0	110.1	27.4	128.3	171.7	145.1	221.8	114.8	196.9	126.7	138.2	103.3	87.8	205.4	116.4	213.8	249.3	306.4	212.9	209.3	335.6	161.8	319.7
SSBP2	HSPC116	ENSG00000145687	"Single stranded DNA binding protein 2"	P81877	5	81413021-81751797	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 89.9"	"Cell type enhanced"	"Detected in many"	6	"Muller glia cells: 139.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 38.3;MOLT-4: 35.5;REH: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020834, HPA068605, HPA071780"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB020834: , HPA068605: AB_2732116, HPA071780: "	"unprognostic (4.62e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.54e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.78e-3)"	"unprognostic (2.36e-3)"	"unprognostic (6.01e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.04e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.39e-3)"	18.9	11.5	16.3	11.1	24.3	11.0	20.0	49.8	21.3	26.5	18.8	13.6	11.1	5.2	27.0	27.2	21.3	26.4	14.2	26.3	16.1	22.8	10.3	3.2	11.3	15.4	19.9	16.2	33.1	8.7	42.4	31.0	11.7	20.9	16.1	11.7	20.0	14.6	19.5	16.3	19.6	10.3	26.1	20.6	8.9	13.6	6.9	21.5	89.9	12.8	11.7	19.9	19.0	18.5	16.2	8.1	26.2	12.2	25.6	15.2	7.9	1.0	1.9	24.2	13.7	14.0	21.3	1.5	5.0	4.6	4.7	4.9	0.0	2.0	16.7	0.3	5.9	2.3	0.1	6.6	2.7	4.6	7.1	2.8	3.5	4.1	0.0	7.9	1.7	9.3	21.8	23.5	0.8	4.5	10.2	2.0	38.3	2.2	8.2	5.0	2.3	35.5	2.8	3.3	0.0	1.0	53.5	5.5	12.7	2.4	0.9	12.6	11.4	5.3	5.9	1.8	10.2	8.7	4.9	1.3	1.8	3.0	3.5	1.3	8.7	6.7	28.0	6.2	3.1	1.2	20.7	8.6	26.2	2.4	7.6	3.8	9.9	7.7	4.3	8.1	16.2	15.2	5.3	12.5	25.6	12.2	2.6	3.4	7.9	16.3	24.3	49.8	21.3	16.1	22.8	19.9	16.2	20.9	21.5	8.9	18.1	15.4	39.3	31.0	60.9	38.4	7.6	29.4	33.0	27.9	25.5	5.9	14.9	10.5	5.4	19.6	2.3	0.0	8.8	2.8	30.8	11.9	24.3	1.6	16.4	39.7	14.5	18.4	15.4	3.4	35.1	18.7	33.7	5.4	4.7	139.7	6.3	10.2	45.6	4.1	43.9	51.8	68.0	6.3	20.3	31.7	6.2	14.4	3.5	26.4
ST13	"FAM10A1, HIP, HSPABP1, P48, SNC6"	ENSG00000100380	"ST13, Hsp70 interacting protein"	P50502	22	40824535-40857022	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043233, HPA046412, HPA047114, HPA047116"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"HPA043233: AB_2678377, HPA046412: AB_2679658, HPA047114: AB_2679937, HPA047116: AB_2679939"	"unprognostic (1.19e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.74e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.00e-1)"	"unprognostic (9.54e-2)"	"prognostic favorable (3.10e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.04e-1)"	"unprognostic (8.40e-2)"	43.0	46.0	36.8	26.2	32.0	20.9	39.9	32.2	35.3	45.0	36.4	41.3	33.0	23.9	57.1	37.9	32.9	46.5	32.7	44.0	33.8	33.6	63.2	72.0	23.7	25.0	40.8	28.8	141.6	31.8	38.6	38.1	35.9	36.6	45.1	27.6	30.4	34.8	37.8	75.3	28.3	25.9	42.4	52.0	25.6	31.9	29.3	40.5	38.7	50.3	38.5	30.2	49.4	76.7	41.3	29.4	23.3	36.6	28.2	62.1	39.0	45.8	37.0	56.0	48.8	52.1	80.9	51.0	43.5	55.7	54.0	47.3	66.5	27.5	66.2	37.7	43.5	49.0	33.6	73.6	42.6	64.3	42.2	47.0	47.5	74.3	75.3	47.5	68.6	38.5	71.9	45.2	48.7	33.1	68.2	55.6	41.5	56.7	29.0	51.5	34.4	60.1	32.7	31.8	55.9	24.5	69.4	47.8	52.1	54.8	69.6	18.6	18.9	50.3	40.5	62.2	67.4	39.2	43.4	41.8	45.2	44.1	37.9	35.2	33.5	65.9	62.1	61.9	32.2	43.5	23.3	21.4	22.5	24.9	29.3	37.8	41.3	39.1	29.6	29.4	36.6	62.1	46.7	7.4	28.2	36.6	20.7	32.7	39.0	36.8	32.0	32.2	33.8	33.8	33.6	40.8	28.8	36.6	40.5	131.0	179.9	243.5	322.7	276.8	89.2	128.6	326.1	322.5	245.7	162.3	15.7	330.2	477.5	243.9	414.3	227.7	216.0	163.5	179.4	326.2	254.0	270.9	201.1	499.1	287.6	36.5	251.4	181.1	216.6	710.5	472.6	248.9	200.8	355.3	224.0	239.1	201.5	178.5	388.6	803.1	51.8	219.9	251.3	314.7	140.1	239.9	418.9	181.1	280.9	275.1
ST6GALNAC3	SIAT7C	ENSG00000184005	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3"	Q8NDV1	1	76074719-76634601	"Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	23	"Endothelial cells: 21.6;Ito cells: 57.1;Kupffer cells: 11.7;Muller glia cells: 11.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 18.6;HUVEC TERT2: 23.6;SK-MEL-30: 32.2;TIME: 10.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054566, HPA055399"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054566: AB_2682526, HPA055399: AB_2682806"	"unprognostic (7.85e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.99e-2)"	"unprognostic (2.70e-4)"	"unprognostic (2.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.55e-3)"	"unprognostic (7.31e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.57e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.95e-2)"	"unprognostic (9.97e-4)"	"unprognostic (3.33e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.44e-4)"	20.7	2.9	7.0	3.6	13.0	5.3	13.9	3.8	9.7	4.3	4.0	13.4	2.0	1.8	10.7	2.1	3.8	4.2	4.7	7.8	8.8	6.0	14.9	3.9	7.5	5.1	16.3	3.6	4.7	2.2	12.6	4.3	5.7	12.9	2.5	4.7	2.8	2.3	3.5	3.3	1.9	2.7	8.3	19.0	3.0	3.0	1.2	12.5	0.0	23.2	1.5	1.7	5.5	5.2	5.9	3.0	5.2	8.3	0.4	1.9	2.6	0.1	0.0	18.6	0.0	0.3	0.0	0.0	0.0	2.2	0.3	0.2	6.0	0.0	0.3	1.2	0.1	1.2	0.0	0.0	0.2	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.5	23.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	1.4	0.0	0.9	0.8	0.0	0.0	0.0	1.4	4.6	0.0	0.0	32.2	4.5	0.0	0.1	10.4	0.1	1.5	0.0	1.7	0.0	0.0	0.0	0.0	4.2	2.8	0.0	8.3	3.7	0.0	2.9	0.0	3.3	0.5	0.8	3.0	5.9	1.9	1.9	5.2	0.4	5.3	0.0	0.0	2.6	7.0	13.0	3.8	9.7	8.8	6.0	16.3	3.6	12.9	12.5	3.0	1.0	1.3	0.1	0.2	3.0	1.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.4	0.8	0.0	0.0	57.1	11.7	0.4	0.0	1.5	5.0	0.0	0.3	11.0	0.2	3.2	0.0	0.0	0.5	0.0	0.3	0.2	0.4	0.4	0.1	0.0	0.0	0.1
STAC3	MGC2793	ENSG00000185482	"SH3 and cysteine rich domain 3"	Q96MF2	12	57243453-57251193	"Disease related genes, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"skeletal muscle: 222.7;tongue: 107.8"	"Cell type enhanced"	"Detected in many"	11	"Hofbauer cells: 36.5;Kupffer cells: 32.7;Macrophages: 17.2;monocytes: 16.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 8.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.9;monocytes: 8.0"	"Cell line enriched"	"Detected in some"	23	"RH-30: 230.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039285, HPA039527"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA039285: AB_2676427, HPA039527: AB_10673424"	"unprognostic (6.16e-2)"	"prognostic favorable (2.01e-4)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (7.11e-6)"	"unprognostic (4.58e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.14e-3)"	3.7	0.2	0.1	0.6	0.1	1.6	0.2	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.1	10.3	3.2	0.2	0.1	0.1	0.1	0.1	0.2	0.4	0.6	0.7	0.2	0.0	0.1	0.1	0.4	0.2	0.2	0.0	2.3	0.2	0.1	5.4	0.0	222.7	0.2	0.3	0.1	0.3	1.1	0.1	1.2	0.0	0.1	1.2	107.8	3.8	0.1	0.1	1.1	4.9	0.5	8.0	0.0	0.3	1.8	0.0	0.0	0.2	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.3	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	2.7	0.0	0.0	0.0	1.6	9.8	1.0	0.1	0.0	0.0	0.1	0.0	0.6	0.2	0.2	0.7	0.5	0.1	3.5	0.0	0.0	0.1	1.2	230.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.9	0.1	3.2	0.0	0.0	6.1	0.5	0.0	8.0	0.1	1.1	0.0	0.3	4.9	0.5	0.0	0.1	0.3	0.0	4.0	1.4	0.3	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	1.1	0.5	0.4	1.3	6.4	0.2	2.5	1.4	0.0	0.0	2.0	0.9	0.0	0.8	9.3	0.0	1.1	0.0	0.9	0.5	0.9	0.6	5.7	0.6	36.5	1.6	2.4	2.5	32.7	7.6	1.1	17.2	0.0	16.2	1.1	2.2	1.0	0.0	0.7	0.5	1.9	0.0	0.3	2.4	1.1	0.3	1.1	1.3	1.1	0.3
STAG1	"SA-1, SA1, SCC3A"	ENSG00000118007	"Stromal antigen 1"	Q8WVM7	3	136336233-136752403	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035015, HPA058653"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			Nucleoplasm	"Nuclear bodies"	"HPA035015: AB_10603117, HPA058653: AB_2683787"	"unprognostic (1.82e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.22e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.83e-2)"	26.0	10.9	13.3	12.9	15.6	12.9	17.9	46.5	14.3	24.8	14.9	11.2	12.0	9.1	21.3	10.8	12.8	16.8	10.5	12.3	12.9	7.4	12.0	10.2	13.3	12.9	14.0	7.2	22.6	13.8	17.3	20.4	20.5	14.3	16.3	14.3	13.0	14.5	14.0	20.8	17.2	12.7	16.8	9.5	14.5	12.2	9.5	18.9	29.7	15.6	11.7	18.6	17.0	29.0	8.9	6.7	13.2	4.8	8.0	7.4	2.9	17.6	9.2	15.5	13.3	11.7	20.4	8.3	19.9	25.5	18.7	17.8	15.6	7.8	13.8	12.6	20.6	15.1	12.3	16.7	9.0	25.6	16.9	7.8	14.7	13.4	8.6	8.9	25.6	14.9	12.8	10.3	13.7	15.4	10.9	14.5	15.1	9.4	28.0	11.8	15.1	16.8	8.3	10.1	12.2	7.3	15.1	16.9	18.4	10.2	12.7	7.6	12.2	21.3	8.5	8.9	8.4	12.1	10.9	12.1	21.6	15.8	19.2	17.5	20.9	14.3	31.4	13.3	8.8	13.8	4.8	4.4	6.5	7.0	4.6	7.4	8.9	5.9	6.3	4.1	7.3	6.7	5.2	13.2	8.0	4.8	6.7	6.9	2.9	13.3	15.6	46.5	14.3	12.9	7.4	14.0	7.2	14.3	18.9	23.8	21.6	31.2	28.0	35.5	41.8	8.9	12.7	16.0	29.6	15.7	37.3	24.5	10.0	17.5	1.9	25.1	29.0	23.3	19.2	22.1	23.6	19.6	21.9	17.8	15.8	27.0	18.0	32.5	14.6	2.3	45.8	19.5	15.1	24.4	23.3	29.1	21.6	17.3	30.4	8.4	65.9	25.8	27.2	32.7	43.2	32.0	26.5	27.7	21.2	21.7
STAT1	"ISGF-3, STAT91"	ENSG00000115415	"Signal transducer and activator of transcription 1"	P42224	2	190964358-191020960	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Antiviral defense, Host-virus interaction, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 90.5;BJ hTERT+ SV40 Large T+ RasG12V: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000931, HPA000982, CAB004049"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		22000	"Nucleoplasm, Cytosol"		"CAB004049: AB_2197984, HPA000931: AB_1080100, HPA000982: AB_1080099"	"unprognostic (6.90e-2)"	"unprognostic (6.47e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.35e-1)"	"prognostic favorable (1.75e-4)"	"prognostic unfavorable (4.23e-4)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (2.43e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.35e-3)"	"unprognostic (3.93e-2)"	27.9	27.2	17.4	47.8	17.8	19.5	20.4	15.0	21.7	21.0	19.8	14.9	17.5	22.7	17.1	27.4	23.3	14.5	29.0	25.5	15.6	22.2	34.9	35.7	29.4	57.9	16.9	18.8	24.3	18.7	20.0	24.0	24.3	23.6	23.6	20.3	17.9	47.5	18.0	20.1	17.4	24.6	24.8	21.8	49.0	24.2	13.5	10.4	58.7	36.2	18.5	30.2	29.3	16.5	10.8	16.2	55.0	47.1	22.7	54.1	44.6	8.9	9.6	4.5	7.5	19.9	26.9	14.6	13.7	41.9	90.5	101.9	15.2	10.4	3.7	8.7	29.3	30.1	7.6	5.1	10.9	18.0	30.7	4.2	16.6	7.6	8.9	13.8	8.5	10.4	17.8	7.0	16.7	5.9	9.9	10.8	6.5	9.0	22.0	16.6	7.3	6.4	10.8	6.3	5.8	15.8	5.4	12.4	4.5	11.9	11.2	6.3	6.1	16.1	6.2	41.9	6.7	6.4	10.6	9.5	18.0	10.6	15.5	8.8	37.4	54.8	3.5	13.7	7.3	8.3	13.0	36.9	27.0	14.7	47.1	19.9	10.8	35.1	21.0	16.2	8.6	35.8	26.0	55.0	22.7	27.6	7.4	54.1	44.6	17.4	17.8	15.0	21.7	15.6	22.2	16.9	18.8	23.6	10.4	68.5	26.4	26.1	13.6	19.7	12.8	39.2	48.4	49.5	50.0	50.6	23.6	11.6	6.6	40.3	8.8	23.9	22.2	0.0	32.6	47.9	29.1	25.0	50.7	45.1	91.4	3.2	20.2	25.8	63.7	2.6	20.1	70.4	16.9	25.2	23.9	14.3	30.0	22.8	28.0	36.2	16.5	38.8	21.7	18.5	24.5	27.4	7.0	25.4	27.4	24.1
STAT5A	"MGF, STAT5"	ENSG00000126561	"Signal transducer and activator of transcription 5A"	P42229	17	42287547-42311943	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Lactation, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 43.3;Peritubular cells: 38.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.8;HEL: 39.1;HMC-1: 22.8;K-562: 65.1;MOLT-4: 47.2;NB-4: 18.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB003860, HPA027873, HPA042128, HPA049883, HPA051156"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA		140000	"Nucleoplasm, Cytosol"		"CAB003860: AB_562347, HPA027873: AB_10603893, HPA042128: AB_2677864, HPA049883: AB_2680931, HPA051156: AB_2681366"	"prognostic favorable (5.87e-4)"	"unprognostic (3.09e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.15e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.49e-3)"	44.0	21.5	3.6	16.5	8.1	30.0	24.1	3.4	4.0	12.6	12.8	6.3	10.5	5.1	11.0	11.4	11.6	9.6	15.3	9.8	3.9	4.7	8.9	5.5	12.8	26.7	9.1	3.2	15.6	8.3	1.9	7.0	11.3	6.1	13.9	5.8	11.9	11.9	11.7	18.3	9.7	11.6	13.6	7.4	17.3	7.9	8.5	6.1	21.9	8.6	9.1	17.0	19.9	20.2	7.2	15.0	15.2	18.5	14.3	16.2	8.8	1.1	1.3	0.1	0.0	9.3	4.5	0.0	0.5	2.0	1.0	0.6	0.1	1.0	0.0	2.4	2.1	0.0	0.0	0.2	0.0	0.3	25.8	0.0	39.1	2.9	0.3	3.8	3.3	22.8	10.4	0.7	0.4	0.5	0.0	3.1	0.9	65.1	0.0	0.5	0.1	47.2	18.6	0.3	0.6	0.0	1.1	0.3	3.3	0.3	0.7	0.1	0.0	2.3	1.2	4.3	0.3	0.7	4.2	1.7	2.4	0.6	1.1	0.0	0.0	0.0	0.0	0.2	6.4	0.6	6.8	11.8	5.9	9.1	15.1	12.8	7.2	15.8	13.2	15.0	6.7	16.2	13.0	15.2	14.3	18.5	5.7	11.2	8.8	3.6	8.1	3.4	4.0	3.9	4.7	9.1	3.2	6.1	6.1	0.0	11.7	17.9	3.4	6.5	1.5	20.2	5.1	5.3	2.3	5.2	0.0	1.2	5.0	4.9	0.3	21.8	3.8	0.0	11.8	2.1	15.5	6.7	22.0	2.6	19.4	0.0	0.0	5.5	19.7	2.1	30.2	22.7	8.5	43.3	4.2	5.1	8.2	7.0	38.5	8.4	0.3	6.5	18.7	0.0	0.7	6.8	1.1	19.1	6.2	4.1
STAU1	"PPP1R150, STAU"	ENSG00000124214	"Staufen double-stranded RNA binding protein 1"	O95793	20	49113339-49188367	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020839, HPA049892, HPA072004"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB020839: , HPA049892: AB_2680938, HPA072004: "	"unprognostic (7.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.97e-2)"	"unprognostic (9.56e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (9.17e-3)"	"prognostic unfavorable (4.41e-4)"	"unprognostic (1.42e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-2)"	30.8	34.2	33.3	32.6	30.8	34.9	59.4	28.7	38.3	28.7	35.7	31.4	24.3	34.3	34.1	25.2	31.1	43.2	31.2	37.4	30.0	27.1	55.7	77.1	30.9	26.9	33.9	28.8	31.2	44.4	58.1	20.9	31.1	39.7	30.9	30.7	26.0	31.3	31.5	51.0	30.1	38.8	34.8	45.4	25.3	33.1	28.6	28.8	39.1	48.6	20.6	28.6	45.6	36.7	14.0	13.1	29.9	15.0	11.1	17.4	9.9	26.3	20.2	22.1	9.7	22.4	27.9	24.5	20.1	24.2	60.3	27.4	68.8	29.2	18.0	34.8	25.1	28.9	29.1	29.4	35.9	50.8	7.0	16.9	14.8	15.7	54.7	19.0	11.9	14.6	22.3	31.0	24.4	28.8	24.8	29.5	13.7	25.7	11.3	22.7	16.8	20.8	19.9	18.0	25.6	28.3	16.1	29.0	17.4	24.7	23.3	25.6	22.8	50.0	48.2	29.1	23.4	30.7	17.2	26.8	36.5	31.7	22.5	23.8	10.2	11.8	20.6	26.7	12.9	21.0	19.6	15.0	14.6	14.9	12.5	16.7	14.0	16.0	15.8	13.1	13.0	14.8	13.9	29.9	11.1	14.5	12.5	17.4	9.9	33.3	30.8	28.7	38.3	30.0	27.1	33.9	28.8	39.7	28.8	83.4	74.3	59.5	85.0	99.9	31.2	58.2	71.4	119.1	60.3	73.3	13.7	88.9	79.6	112.4	15.6	81.5	80.0	23.3	102.6	32.3	76.6	153.5	46.2	138.4	56.5	41.3	72.9	65.7	53.9	17.1	60.7	63.2	47.2	82.0	66.4	57.6	115.7	64.2	65.7	143.6	25.4	58.2	69.3	110.2	58.0	104.6	162.6	48.0	59.0	164.2
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.9	19.4	6.1	10.6	29.0	25.2	8.4	13.5	13.7	9.6	11.9	8.7	5.0	15.9	14.0	18.6	20.1	27.4	7.7	7.9	8.0	13.0	11.6	25.6	7.4	13.1	23.6	20.6	14.9	28.6	19.7	14.0	34.4	13.1	12.5	21.7	15.5	30.3	9.9	3.4	19.4	7.5	2.4	8.3	6.9	4.9	8.7	14.9	15.2	8.8	1.2	5.6	19.2	12.3	7.2	10.3	4.6	11.7	12.8	17.7	5.9	17.2	9.2	32.8	24.7	8.1	14.7	8.7	10.1	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0	14.9	8.0	10.3	6.0	14.5	4.9	3.9	12.7	9.4	5.7	5.2	13.7	20.7	1.7	12.2	3.6	14.7	8.6	0.0	12.5	11.0	12.4	10.5	28.9	28.0	13.7	15.9	8.7	20.3	19.4	4.9	25.3	12.4	16.9	5.4	12.9	16.9	10.2	3.5	10.6	3.5	3.6	25.8	18.1	20.9	8.1	19.4	14.5	22.0	7.5	10.3
STK11IP	"KIAA1898, LIP1, LKB1IP, STK11IP1"	ENSG00000144589	"Serine/threonine kinase 11 interacting protein"		2	219597860-219616451	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"				"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036837, HPA036838, HPA053192"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA036837: AB_10969754, HPA036838: AB_10672100, HPA053192: AB_2682075"	"unprognostic (3.37e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.22e-3)"	"unprognostic (8.36e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.63e-4)"	"unprognostic (9.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.80e-3)"	"unprognostic (9.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	5.7	8.4	10.1	11.9	10.7	15.2	6.4	15.0	9.5	5.8	8.2	6.7	6.7	8.1	9.2	14.3	8.2	9.1	9.5	6.2	7.0	6.5	7.2	5.6	7.4	11.4	5.1	7.5	17.0	9.9	7.0	21.2	12.1	7.0	8.2	7.2	6.2	5.8	6.3	5.1	16.3	7.9	7.5	5.9	10.6	6.4	27.7	6.4	26.5	8.9	7.1	9.6	5.9	6.3	1.7	14.8	5.0	6.1	3.4	2.7	2.1	7.0	11.0	11.8	8.0	4.2	7.5	12.1	6.3	5.5	10.2	8.7	10.1	12.0	4.1	6.4	6.0	9.3	17.5	5.6	13.4	7.6	6.0	8.5	10.6	11.2	8.1	5.5	11.0	28.1	7.2	12.0	8.6	4.3	10.5	6.2	7.0	7.9	6.2	5.7	13.8	6.4	13.7	11.8	3.3	6.1	12.2	4.3	3.2	10.2	11.1	7.8	12.3	4.0	10.0	8.2	9.9	6.4	10.8	4.7	11.1	9.5	10.6	6.0	6.9	3.0	7.3	8.4	6.1	6.9	1.5	3.9	5.0	2.7	5.7	2.4	1.7	1.3	2.2	7.6	1.5	1.1	1.1	1.3	3.4	6.1	14.8	2.1	2.1	10.1	10.7	15.0	9.5	7.0	6.5	5.1	7.5	7.0	6.4	6.0	7.0	0.5	1.9	2.1	7.8	3.2	2.5	10.7	6.8	7.0	17.7	8.6	1.7	4.8	11.5	3.7	8.4	0.0	5.6	4.7	4.1	2.4	12.7	3.0	7.6	11.1	12.6	5.5	8.4	24.5	23.6	6.0	3.3	1.8	8.5	6.0	3.5	3.5	13.8	2.2	11.7	12.9	4.0	17.2	11.5	2.4	13.5	4.1	5.6	2.5
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.5	9.8	0.8	4.5	105.9	30.4	0.0	26.3	26.2	7.4	11.7	1.3	1.9	12.0	6.5	32.8	4.4	2.6	5.5	24.4	13.2	7.3	2.3	27.9	21.7	3.8	57.5	10.3	5.9	50.4	86.5	11.6	15.4	2.1	26.5	3.7	6.0	16.1	16.1	7.9	0.3	7.9	12.0	0.6	3.1	1.4	0.0	26.1	5.8	0.3	1.0	0.1	22.0	19.5	11.3	8.2	6.7	8.5	33.6	17.2	5.4	17.1	2.4	6.8	7.5	0.7	6.6	10.4	9.2	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3	148.9	81.9	21.1	213.5	93.8	3.6	29.1	119.8	124.5	113.7	33.2	5.9	85.6	3.3	48.0	2.7	299.7	8.4	373.8	19.1	46.5	164.1	41.4	34.7	315.8	77.6	3.2	0.0	270.1	169.6	5.7	61.5	72.7	84.4	33.3	0.2	8.0	31.1	14.4	96.9	74.2	4.6	135.8	215.9	21.4	6.8	104.1	144.5	93.2	0.1	170.5
STRAP	"MAWD, pt-wd, UNRIP"	ENSG00000023734	"Serine/threonine kinase receptor associated protein"	Q9Y3F4	12	15882391-15903478	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027320, HPA055557, HPA073876"	Approved		Enhanced	Cytosol		NA	NA		290000	Cytosol		"HPA027320: AB_1857614, HPA055557: AB_2682849, HPA073876: AB_2686639"	"unprognostic (4.64e-3)"	"unprognostic (2.25e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.05e-3)"	"prognostic unfavorable (6.83e-6)"	"unprognostic (1.69e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (9.07e-4)"	"prognostic unfavorable (5.10e-4)"	36.7	39.8	43.5	28.1	43.2	24.1	46.4	38.1	55.3	30.5	29.4	19.3	29.2	24.7	31.8	29.1	33.7	24.7	25.8	54.0	55.7	44.9	46.4	42.9	27.7	30.4	35.8	48.3	25.5	38.7	40.4	36.7	34.4	47.1	27.8	29.5	20.5	26.0	32.2	109.2	25.3	23.6	37.4	51.5	20.7	28.9	32.9	27.5	27.9	42.6	36.6	29.4	28.6	29.8	36.9	44.6	30.8	41.8	29.2	43.4	38.5	32.4	38.2	36.5	31.1	32.4	32.4	48.8	39.0	27.2	35.2	32.9	54.7	28.7	36.2	19.4	39.6	34.4	23.6	43.6	42.8	52.0	48.3	35.4	36.6	30.4	23.9	53.2	42.4	17.8	31.2	36.5	38.8	43.7	38.9	40.9	23.8	28.0	11.1	45.7	22.6	35.2	20.3	129.0	20.9	25.1	27.2	50.3	20.8	40.7	33.5	23.6	40.1	31.4	21.7	42.5	76.0	40.6	22.8	34.2	26.4	31.3	27.9	47.8	12.7	17.2	59.4	32.4	23.6	33.2	26.8	36.7	30.8	34.6	41.8	38.9	36.9	36.0	33.3	44.6	30.8	35.4	37.3	17.0	29.2	35.9	27.4	43.4	38.5	43.5	43.2	38.1	55.3	55.7	44.9	35.8	48.3	47.1	27.5	35.7	36.8	74.9	140.3	216.3	84.6	96.8	40.8	44.2	42.1	62.8	33.4	132.9	233.8	149.7	27.7	77.1	37.6	46.7	119.4	167.9	122.0	110.6	46.1	73.0	98.2	57.2	101.9	64.4	87.9	61.5	64.7	73.5	121.4	105.6	50.2	130.3	114.5	67.4	95.8	178.6	74.9	77.6	196.1	150.4	65.6	199.2	246.8	82.2	78.1	179.1
STX12	"STX13, STX14"	ENSG00000117758	"Syntaxin 12"	Q86Y82	1	27773183-27824452	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041038, HPA055300"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		No	No			"Nucleoplasm, Golgi apparatus, Vesicles"		"HPA041038: AB_10794261, HPA055300: AB_2682778"	"unprognostic (3.47e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.78e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.24e-1)"	38.5	20.2	32.2	16.3	29.6	6.3	22.9	25.8	35.9	20.3	19.4	27.3	23.5	22.9	20.4	42.1	25.7	15.0	25.9	15.3	31.2	31.9	23.2	18.5	31.2	16.3	35.5	29.0	15.2	19.5	16.7	19.6	21.1	32.3	20.8	21.4	11.6	17.7	22.2	14.2	17.1	20.9	23.1	36.9	20.0	38.7	9.0	19.9	6.3	67.0	11.0	13.9	19.4	14.8	7.6	14.2	10.1	21.7	5.2	6.4	8.3	8.8	4.2	11.5	7.5	21.9	26.7	5.9	18.7	27.6	17.2	19.6	5.2	11.5	9.6	20.1	25.0	7.4	7.4	7.5	9.3	17.3	8.5	9.0	5.5	4.7	5.2	17.2	6.0	11.6	25.0	11.4	24.2	13.9	14.2	27.6	5.6	7.2	9.7	18.7	3.2	5.2	4.6	4.8	13.1	6.0	3.3	9.2	5.8	15.2	14.6	12.9	7.0	8.8	7.6	13.5	9.7	5.2	5.4	29.6	8.8	5.0	19.9	6.4	5.8	4.2	5.6	14.2	9.3	12.3	10.1	19.6	7.5	3.7	21.7	6.4	7.6	4.4	5.7	14.2	6.5	4.9	4.1	9.3	5.2	21.0	7.0	4.4	8.3	32.2	29.6	25.8	31.8	31.2	31.9	35.5	29.0	32.3	19.9	50.6	27.6	22.7	84.1	97.1	42.7	15.9	28.1	17.4	38.7	54.1	29.5	25.5	31.5	43.8	1.6	48.9	48.7	0.0	51.3	28.6	42.2	58.3	22.0	15.5	45.8	25.4	39.6	55.3	69.4	1.5	33.4	58.6	50.6	19.8	27.1	61.7	52.7	46.0	44.6	44.7	48.6	38.8	58.4	14.9	17.5	86.7	65.2	22.3	26.7	83.3
STX16	"hsyn16, SYN16"	ENSG00000124222	"Syntaxin 16"	O14662	20	58651253-58679526	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA041019, HPA042033"	Uncertain		Enhanced	Vesicles		NA	NA			Vesicles		"HPA041019: AB_10964273, HPA042033: AB_10963935"	"unprognostic (7.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (4.18e-4)"	"unprognostic (7.32e-2)"	"unprognostic (5.11e-2)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (3.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.89e-2)"	22.1	24.5	41.9	25.3	46.7	36.7	22.3	54.5	43.2	21.9	23.3	35.0	35.9	20.3	30.3	36.9	18.8	26.7	23.4	17.3	36.8	22.4	18.6	20.0	20.5	32.8	43.0	32.8	29.2	23.1	18.5	33.0	20.5	34.0	24.6	21.1	20.9	27.9	28.5	25.9	41.5	23.6	29.4	33.0	31.0	21.7	22.2	42.9	16.6	23.7	15.7	24.7	24.2	24.3	4.7	4.3	14.1	6.2	5.6	6.1	4.0	14.3	8.4	11.1	10.8	20.5	22.0	15.5	17.8	12.1	18.3	11.4	16.4	21.1	16.5	25.0	12.7	23.0	21.4	10.2	21.2	15.3	7.8	10.8	10.3	22.1	19.8	20.4	14.7	23.4	24.3	32.6	12.3	18.8	34.5	18.5	19.6	11.9	14.8	14.7	33.6	11.3	17.8	4.5	11.7	14.4	10.5	10.4	11.4	14.0	10.7	7.4	11.3	18.9	33.3	32.1	19.7	13.3	19.5	19.5	30.3	14.7	11.5	19.6	30.7	14.2	9.2	22.3	11.4	12.6	14.1	6.2	5.2	5.0	5.6	5.6	2.6	4.5	3.5	4.1	4.7	6.1	5.5	14.0	5.6	4.1	4.3	4.8	4.0	41.9	46.7	54.5	43.2	36.8	22.4	43.0	32.8	34.0	42.9	20.8	40.6	22.8	18.7	23.9	60.9	17.1	43.3	45.5	31.8	27.9	80.5	20.1	5.0	13.1	3.2	32.4	21.5	23.3	11.7	13.5	17.7	20.1	18.5	25.2	19.3	39.7	44.3	32.5	32.9	6.5	21.0	31.3	20.3	14.4	28.0	32.0	16.7	27.1	27.3	8.4	50.6	12.9	21.7	39.8	20.2	36.9	14.6	34.6	25.0	16.6
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	26.5	28.2	28.6	23.8	29.6	14.1	23.5	24.2	28.0	21.4	24.0	24.4	16.9	28.3	24.1	19.8	26.4	19.6	23.7	24.6	26.7	18.0	21.7	25.2	25.8	22.5	38.1	22.3	22.7	19.3	33.6	14.9	27.0	32.4	19.8	22.0	14.0	21.3	21.8	30.3	32.7	26.7	27.7	26.1	31.4	22.7	10.7	31.5	19.2	21.3	17.3	26.7	25.4	29.4	11.9	14.8	20.6	18.2	18.2	14.9	8.6	18.4	26.4	6.0	13.4	20.2	20.6	12.8	17.1	30.2	18.3	18.9	8.1	20.1	12.5	22.2	30.2	21.1	13.4	5.6	19.8	17.5	22.4	16.9	9.0	18.4	22.0	22.9	10.4	30.3	19.6	13.9	31.6	23.6	22.7	24.2	8.7	10.5	14.6	32.4	28.9	9.8	16.1	12.4	13.8	14.2	8.4	17.9	16.3	18.1	13.7	4.9	9.4	15.1	15.5	6.2	8.3	12.4	13.8	25.9	18.5	8.2	20.8	9.5	15.7	12.7	5.5	27.9	16.8	11.2	14.6	17.7	20.6	14.9	18.2	12.9	9.7	12.5	14.5	14.8	11.9	9.5	12.2	18.5	18.2	15.8	8.6	6.8	8.6	28.6	29.6	24.2	28.0	26.7	18.0	38.1	22.3	32.4	31.5	41.7	20.7	21.5	31.3	57.9	6.7	21.4	45.9	34.8	23.9	21.0	11.8	27.3	24.9	50.0	6.2	41.3	69.9	0.0	59.4	32.0	50.3	41.0	59.9	17.0	84.0	4.8	24.6	29.4	48.2	10.8	35.6	88.9	28.7	62.3	35.0	20.7	57.7	47.2	33.2	45.6	5.9	38.8	44.3	6.5	7.9	57.0	27.7	40.5	40.8	30.1
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	6.3	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	18.1	20.2	9.4	12.2	7.1	13.3	14.2	9.1	9.0	17.1	12.4	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	19.7	15.6	8.7	16.6	13.9	7.3	12.9	10.1	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0	14.9	15.2	3.7	16.3	43.5	11.7	5.6	0.0	13.4	11.4	17.4	5.9	22.0	10.0	9.1	6.4	22.4	7.8	0.0	8.5	21.8	11.5	17.4	11.5	4.3	24.6	7.9	22.4	11.1	21.9	8.0	7.8	30.2	6.8	19.0	12.7	6.0	11.1	14.0	12.4	6.7	10.1	6.5	13.3	4.7	14.5	33.0	17.2	13.3	9.8	18.7
STXBP2	"Hunc18b, UNC18B"	ENSG00000076944	"Syntaxin binding protein 2"	Q15833	19	7636881-7647873	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 101.5;lymphoid tissue: 101.5"	"Cell type enhanced"	"Detected in many"	6	"Kupffer cells: 332.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 25.5;classical monocyte: 58.1;eosinophil: 35.5;intermediate monocyte: 73.1;myeloid DC: 30.2;neutrophil: 45.6;non-classical monocyte: 101.5"	"Group enriched"	"Detected in all"	6	"dendritic cells: 30.2;granulocytes: 45.6;monocytes: 101.5"	"Cell line enhanced"	"Detected in many"		"HMC-1: 56.3;U-937: 49.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015564, HPA063868"	Approved		Enhanced	Cytosol		No	No		53000000	Cytosol		"HPA015564: AB_1857626, HPA063868: AB_2685136"	"unprognostic (1.20e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.75e-3)"	"prognostic unfavorable (4.65e-4)"	"unprognostic (4.22e-3)"	"unprognostic (2.35e-1)"	"unprognostic (6.25e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.85e-1)"	"prognostic favorable (7.68e-4)"	"prognostic favorable (5.13e-6)"	7.2	7.9	5.5	17.9	9.9	49.5	9.9	2.0	5.8	6.5	17.7	5.4	15.9	19.0	3.0	10.4	23.4	9.6	14.3	18.4	5.2	2.0	20.2	19.0	46.4	61.5	12.2	1.3	4.6	28.0	10.9	9.8	24.9	5.8	16.4	10.5	8.7	24.6	9.7	1.5	15.3	32.0	3.7	16.9	101.5	20.6	22.5	8.0	73.4	19.5	5.4	17.8	11.4	18.0	6.7	30.2	45.6	101.5	9.0	9.9	31.9	24.5	8.7	0.2	0.1	0.0	0.2	17.3	3.1	0.3	0.6	1.7	20.5	15.6	6.5	12.7	2.5	11.4	16.9	0.9	15.0	0.6	27.0	10.5	28.0	10.4	12.1	15.0	18.0	56.3	1.0	15.4	3.0	8.7	0.0	13.2	16.8	17.4	22.3	0.0	15.5	8.8	42.0	6.5	16.0	15.4	9.1	0.0	24.9	12.5	28.5	2.6	0.1	7.6	11.3	0.5	8.5	14.0	46.7	13.8	0.1	5.1	0.3	0.1	24.9	12.3	8.4	0.2	49.4	0.6	25.5	58.1	35.5	9.6	73.1	7.7	6.3	7.3	8.6	30.2	6.7	5.2	6.2	45.6	9.0	101.5	11.5	9.9	31.9	5.5	9.9	2.0	5.8	5.2	2.0	12.2	1.3	5.8	8.0	0.0	7.7	46.2	41.5	20.9	3.5	0.7	40.8	5.3	3.4	33.2	2.0	85.8	28.2	91.9	74.2	5.9	162.4	23.3	104.4	107.0	3.1	43.4	72.5	17.3	155.4	0.0	57.4	21.5	332.1	169.0	1.7	76.6	13.5	138.9	84.0	0.8	109.9	133.3	1.8	54.9	3.9	6.5	1.4	29.3	18.1	18.6	127.9	56.4	58.5	59.5
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 82.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 11.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.2"	"Cell line enhanced"	"Detected in many"		"HEL: 56.6;HMC-1: 61.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		11000	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	4.4	9.1	4.3	6.6	5.9	14.0	9.0	7.8	9.0	6.7	17.6	2.0	22.1	3.9	4.6	6.5	10.2	3.8	9.2	3.5	3.6	4.3	2.0	2.4	3.8	3.5	3.3	4.7	3.0	10.9	82.7	15.5	3.1	4.3	5.7	7.8	6.5	5.7	21.0	7.0	10.9	35.1	5.3	2.7	4.7	4.0	9.6	2.3	2.2	4.2	5.6	4.6	5.3	9.1	0.9	0.5	11.2	0.6	0.5	1.7	0.3	2.8	2.5	1.3	4.6	6.7	14.1	1.5	6.7	10.0	5.0	5.6	2.1	1.9	2.1	1.5	13.3	8.6	3.5	3.9	5.9	6.1	4.5	3.0	56.6	7.5	2.4	7.7	19.3	61.9	10.2	4.2	10.0	20.4	11.9	6.4	3.3	15.2	2.6	9.8	4.2	3.0	5.0	1.1	2.4	5.9	0.4	7.1	0.8	2.7	5.0	2.9	2.1	5.2	3.7	2.3	2.5	1.1	7.6	7.3	7.2	2.6	3.5	6.1	2.2	0.0	2.5	3.9	7.1	5.1	4.7	0.3	11.2	1.2	0.5	1.3	0.5	0.7	1.4	0.5	0.9	1.2	1.7	4.0	0.5	0.6	0.4	0.3	0.3	4.3	5.9	7.8	9.0	3.6	4.3	3.3	4.7	4.3	2.3	14.9	9.1	1.5	2.0	3.2	28.1	12.9	7.6	1.4	9.1	15.7	29.5	4.0	0.0	4.4	26.8	7.9	17.0	0.0	11.2	3.2	4.5	10.0	41.7	3.4	4.0	31.8	39.6	8.6	7.8	34.7	7.2	4.1	10.1	2.8	28.2	5.0	9.8	24.6	6.7	1.4	25.2	12.9	3.4	12.3	10.7	5.8	3.2	4.9	17.4	3.0
SUCLA2		ENSG00000136143	"Succinate-CoA ligase ADP-forming beta subunit"	Q9P2R7	13	47745736-48037968	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Tricarboxylic acid cycle"	Ligase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.0"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 204.8;Late spermatids: 235.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039435, HPA039536, HPA061528"	Enhanced	Supported	Enhanced	Mitochondria		NA	NA		6600	Mitochondria		"HPA039435: AB_10673144, HPA039536: AB_2676561, HPA061528: AB_2684553"	"unprognostic (5.66e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (7.59e-14)"	"unprognostic (3.53e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.29e-1)"	"prognostic unfavorable (1.22e-4)"	21.6	18.5	19.2	8.6	22.1	5.2	17.5	29.7	32.4	15.3	15.7	11.7	15.6	24.5	12.7	12.1	14.6	11.3	9.4	42.1	20.0	21.6	34.0	12.9	7.9	11.4	22.6	19.1	14.4	10.8	19.8	14.9	12.2	28.7	16.2	16.5	8.9	13.9	14.8	89.0	10.0	22.7	14.7	18.3	9.7	12.3	8.0	15.4	15.6	16.9	25.6	10.2	11.0	12.6	17.1	29.5	12.4	25.0	23.4	25.2	17.2	15.7	18.3	23.3	13.9	26.7	20.1	14.0	24.2	27.1	25.2	17.1	32.5	18.0	22.2	18.5	23.6	15.1	22.0	30.7	23.0	31.9	21.2	26.3	24.9	17.4	21.0	18.6	25.1	14.6	19.0	27.1	17.1	20.3	21.0	18.5	25.7	16.8	8.0	25.0	10.9	25.9	28.8	24.1	54.9	23.4	22.1	21.3	17.2	36.4	15.3	12.9	15.4	20.1	18.7	14.2	26.8	16.5	22.4	14.1	14.0	9.0	19.9	16.7	8.4	13.0	25.8	8.7	18.4	20.5	5.7	24.5	12.4	17.6	25.0	21.2	17.1	19.7	21.6	29.5	16.3	25.2	24.9	4.5	23.4	20.0	24.3	21.6	17.2	19.2	22.1	29.7	32.4	20.0	21.6	22.6	19.1	28.7	15.4	23.8	12.6	14.3	29.8	28.7	43.5	135.6	17.8	20.1	17.0	29.6	11.8	41.8	139.3	28.6	204.8	21.5	31.6	0.0	15.6	35.7	34.0	31.8	33.4	11.5	26.3	42.9	18.5	18.4	16.2	235.9	34.2	23.7	40.5	27.9	17.8	38.6	17.5	36.8	43.5	98.7	33.0	38.8	40.8	31.2	27.2	27.7	43.6	13.1	28.8	31.9
SUGP1	"DKFZp434E2216, F23858, RBP, SF4"	ENSG00000105705	"SURP and G-patch domain containing 1"	Q8IWZ8	19	19276018-19320844	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 83.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004890	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA004890: AB_1079935"	"unprognostic (1.08e-1)"	"unprognostic (4.51e-3)"	"unprognostic (5.21e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.14e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-3)"	"unprognostic (4.25e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.42e-3)"	6.8	8.2	14.8	9.2	13.4	5.6	7.0	16.4	17.0	7.3	8.6	9.1	7.8	9.7	9.0	6.9	9.2	8.3	7.1	11.2	12.1	8.7	8.6	8.6	8.3	7.9	11.0	9.1	7.1	10.5	9.0	8.1	6.4	10.3	8.4	6.6	8.2	11.2	8.7	19.7	7.4	8.5	8.5	10.8	8.1	8.7	20.2	10.9	9.8	6.5	6.8	8.8	8.6	6.2	12.9	14.1	14.1	21.9	15.8	17.0	14.4	12.0	2.5	5.9	7.2	5.9	5.7	15.4	8.6	11.4	12.3	8.9	5.6	9.0	11.8	11.8	11.3	7.7	8.3	6.6	10.0	6.0	8.3	5.5	9.8	3.1	4.0	6.9	6.8	10.6	10.9	4.8	10.7	4.5	6.2	8.8	9.0	12.6	6.3	10.1	9.6	17.1	10.4	12.6	12.1	7.8	14.3	8.8	13.5	9.0	5.1	10.1	13.1	8.4	7.1	14.1	6.6	8.1	12.6	14.1	8.8	9.1	11.3	10.5	11.2	11.1	13.6	11.0	9.1	10.9	7.8	14.1	14.1	16.2	16.8	12.6	12.9	12.7	17.0	14.1	11.9	11.9	12.6	12.8	15.8	21.9	13.0	12.4	14.4	14.8	13.4	16.4	17.0	12.1	8.7	11.0	9.1	10.3	10.9	14.9	16.0	8.8	6.7	4.1	11.0	18.7	12.7	6.7	14.8	14.0	3.9	15.8	14.9	12.9	33.1	9.0	13.3	0.0	12.4	11.5	6.1	3.0	9.2	7.3	12.4	1.6	9.2	6.7	6.3	83.0	10.3	10.8	10.1	22.6	9.1	13.8	11.3	11.2	11.7	13.6	7.6	6.5	9.2	27.8	16.4	5.0	14.1	12.8	9.4	3.1
SUGP2	"KIAA0365, SFRS14"	ENSG00000064607	"SURP and G-patch domain containing 2"	Q8IX01	19	18990888-19034023	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 170.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041557, HPA061111"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear bodies"	"HPA041557: AB_10794301, HPA061111: AB_2684432"	"unprognostic (1.35e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-3)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.94e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.41e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.60e-2)"	7.8	13.9	27.2	11.8	27.0	24.5	9.9	36.0	34.4	9.0	10.1	15.4	10.8	11.8	14.8	15.0	7.8	13.5	9.0	18.2	23.0	17.0	9.9	7.4	9.4	15.0	16.8	24.2	13.8	9.1	13.3	22.8	9.8	16.0	16.1	11.7	14.5	14.1	11.9	19.5	12.2	10.6	11.2	15.1	13.9	11.4	56.5	16.9	11.0	19.0	6.7	13.6	10.7	9.7	4.3	4.1	5.3	3.2	9.0	4.7	1.7	12.9	12.3	31.6	22.7	14.8	14.7	15.9	16.3	12.2	19.0	16.4	8.0	11.5	25.6	13.5	12.9	22.5	9.6	25.6	9.8	17.4	9.0	23.1	16.1	18.2	10.4	10.7	13.5	16.3	15.2	10.5	11.6	9.5	25.5	9.9	20.1	24.3	18.5	20.5	10.9	15.8	25.5	16.3	15.2	18.1	15.9	16.2	14.2	9.7	13.1	35.1	14.4	14.3	10.1	7.1	25.4	10.5	12.7	10.8	18.8	11.4	21.8	19.0	23.6	17.9	19.0	18.9	21.4	19.7	5.3	3.1	2.4	4.7	3.2	2.5	2.5	2.9	2.7	3.1	4.3	2.7	3.2	2.8	9.0	2.8	4.1	2.7	1.7	27.2	27.0	36.0	34.4	23.0	17.0	16.8	24.2	16.0	16.9	38.7	39.7	19.0	19.9	15.7	80.7	31.9	17.8	41.5	39.8	26.2	88.4	13.2	8.3	14.7	63.8	22.6	13.7	0.0	9.3	8.6	20.8	23.4	25.5	24.6	19.8	100.1	39.9	27.6	18.0	97.3	37.4	23.8	11.8	16.2	21.7	49.8	15.7	24.3	35.3	7.8	102.0	51.8	15.7	170.1	42.8	16.4	6.3	26.1	24.1	20.2
SUMO3	"SMT3A, SMT3H1"	ENSG00000184900	"Small ubiquitin-like modifier 3"	P55854	21	44805617-44818779	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"monocytes: 368.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012180, HPA042123, HPA048064"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB012180: AB_304041, HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (2.77e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.79e-2)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.81e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.80e-2)"	32.2	23.8	37.4	17.7	43.8	50.0	25.0	31.6	43.4	26.9	28.0	17.5	19.4	24.0	21.7	23.9	23.4	22.1	21.9	36.6	27.6	38.7	24.4	29.2	26.2	32.0	30.8	29.0	26.3	26.2	14.6	15.6	21.7	26.6	21.8	15.5	30.6	28.3	30.2	62.4	18.9	28.9	17.4	19.7	28.2	27.7	17.3	17.3	23.9	26.1	18.4	20.8	22.5	20.3	23.8	46.0	14.0	35.7	18.5	27.6	38.4	45.6	18.5	17.4	7.2	20.2	23.4	18.2	31.9	35.0	45.2	36.3	27.5	18.2	16.2	50.6	29.7	21.4	9.1	15.0	24.8	11.1	22.4	22.6	66.4	13.2	21.8	22.1	37.4	32.9	26.4	23.6	26.4	15.1	10.4	18.3	34.0	37.9	27.0	18.1	58.8	31.8	25.9	41.4	30.1	37.1	37.1	1.5	36.1	11.8	17.8	17.0	32.8	28.5	21.0	22.1	4.8	28.2	26.9	36.0	13.5	29.7	28.8	32.8	33.5	46.8	40.9	12.2	51.3	18.7	0.6	34.6	14.0	23.5	35.7	23.9	23.8	22.8	22.8	37.5	21.5	27.6	24.8	4.1	18.5	32.0	46.0	24.7	38.4	37.4	43.8	31.6	43.4	27.6	38.7	30.8	29.0	26.6	17.3	59.6	47.4	74.9	104.6	85.3	68.8	55.4	53.5	20.1	38.7	90.7	19.6	109.8	140.9	91.8	47.0	107.9	85.0	46.7	98.1	85.9	94.3	117.4	28.9	88.9	177.5	58.8	56.7	85.3	119.6	80.4	66.7	155.6	92.8	368.9	80.7	78.5	112.8	93.7	68.2	95.9	44.8	58.2	77.3	58.8	72.0	68.1	114.0	79.9	86.4	112.9
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 286.8;Late spermatids: 435.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	29.8	14.5	18.2	17.2	23.6	4.0	26.0	49.6	28.9	31.1	22.5	23.6	18.9	18.1	47.1	22.6	24.2	28.5	20.0	40.8	16.6	14.9	19.4	13.4	19.6	11.6	15.9	21.3	39.6	22.4	37.5	26.8	25.3	18.0	18.8	16.8	27.6	19.5	19.7	56.7	46.1	17.9	33.6	15.3	17.6	23.9	36.4	15.4	11.8	20.1	31.0	17.8	20.3	25.3	8.0	8.1	7.6	10.2	6.7	13.2	6.5	38.7	10.5	12.7	20.6	14.0	20.1	12.4	9.8	16.5	18.3	18.8	8.9	43.8	9.3	10.2	13.4	36.1	48.9	10.3	17.4	17.9	3.9	10.4	3.0	15.4	8.4	18.0	4.6	7.7	10.0	20.8	14.6	24.4	17.1	13.3	5.9	12.5	7.0	18.3	13.4	3.0	7.6	17.6	13.4	12.2	6.6	7.0	8.7	18.7	12.5	24.5	15.9	12.4	25.5	9.4	21.4	20.2	4.7	10.0	16.9	15.4	17.5	16.1	6.5	7.5	5.7	11.6	3.8	23.2	7.6	10.2	2.6	4.7	8.8	5.0	8.0	9.2	5.3	8.1	6.8	13.2	8.2	0.6	6.7	6.3	1.6	7.7	6.5	18.2	23.6	49.6	28.9	16.6	14.9	15.9	21.3	18.0	15.4	41.7	34.2	14.9	83.2	94.7	70.8	83.7	30.6	73.6	47.8	38.4	82.5	26.8	23.2	36.0	286.8	74.1	41.1	23.3	20.1	19.4	40.9	82.0	16.2	36.5	14.8	106.5	39.1	67.5	19.0	435.0	52.9	19.2	40.5	3.6	39.1	23.8	40.3	52.6	40.0	19.3	66.7	64.7	64.5	30.9	48.0	74.9	32.2	15.0	33.0	105.6
SUPT5H	"FLJ34157, SPT5, SPT5H"	ENSG00000196235	"SPT5 homolog, DSIF elongation factor subunit"	O00267	19	39436156-39476670	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029273, CAB034370"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034370: AB_2196394, HPA029273: AB_10603896"	"unprognostic (3.96e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (7.00e-5)"	"unprognostic (7.30e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.94e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.38e-1)"	27.7	26.2	39.4	28.9	41.0	64.2	23.5	46.8	50.7	26.2	29.2	34.2	21.0	27.7	33.0	22.3	24.2	26.9	26.7	27.8	34.9	28.6	22.6	28.4	25.5	32.9	28.7	42.3	39.8	34.2	39.3	42.9	26.3	31.3	27.8	21.7	25.7	37.6	27.5	55.9	27.7	29.7	24.4	34.4	30.1	27.9	77.8	37.2	22.2	30.1	17.5	27.9	30.3	31.1	10.8	23.4	25.9	12.2	8.2	8.0	6.9	33.5	54.4	20.1	20.1	19.2	13.5	17.1	29.3	18.6	17.7	19.7	35.5	21.0	40.9	27.7	27.2	14.7	13.2	26.9	19.2	13.9	40.0	26.4	45.8	26.0	21.6	17.5	37.2	31.3	21.5	14.5	22.5	23.2	19.5	16.8	36.2	34.4	21.2	17.4	34.1	27.3	11.3	25.1	28.2	13.8	27.8	29.6	20.8	18.3	55.8	19.1	26.0	34.5	27.6	18.8	17.9	16.8	20.3	35.8	18.0	21.0	22.4	37.3	35.0	56.8	50.4	22.1	21.5	22.1	18.5	12.2	9.6	8.0	6.5	8.0	10.8	5.6	6.5	5.8	8.7	6.4	5.1	25.9	8.2	8.2	23.4	6.0	6.9	39.4	41.0	46.8	50.7	34.9	28.6	28.7	42.3	31.3	37.2	41.7	79.1	45.9	20.1	45.8	45.3	52.6	30.6	68.3	56.9	41.8	80.5	32.5	11.6	31.8	50.0	42.9	54.2	23.3	30.4	37.8	29.7	29.1	44.0	52.8	32.5	46.1	85.6	32.5	25.7	57.1	41.7	36.3	38.8	35.1	48.8	26.7	41.7	38.2	38.9	18.8	55.7	19.4	32.0	67.0	46.5	43.3	45.2	48.4	40.2	24.7
SURF2		ENSG00000148291	"Surfeit 2"	Q15527	9	133356552-133361169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 50.1"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 358.5;Late spermatids: 675.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 43.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044340, HPA052213, HPA059710"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim"		No	No			"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044340: AB_2678900, HPA052213: AB_2681763, HPA059710: "	"unprognostic (1.53e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.24e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.46e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-1)"	8.3	9.2	15.8	9.0	13.2	8.2	10.7	13.1	14.5	5.7	8.8	7.4	10.8	13.2	6.4	12.0	11.0	10.7	11.2	8.9	13.4	11.0	14.3	12.0	6.5	12.1	13.1	8.7	9.0	17.5	7.1	11.3	5.9	10.3	7.7	5.7	7.7	14.2	8.8	11.5	14.8	11.4	6.9	9.4	8.6	9.3	50.1	6.6	10.6	10.1	14.9	9.8	6.5	8.3	17.5	15.6	13.1	16.2	13.2	26.9	14.1	7.2	12.5	5.3	6.5	3.8	3.0	11.1	3.7	3.3	5.9	3.1	17.1	6.0	7.2	5.4	2.4	5.1	19.9	8.3	9.0	2.7	6.9	11.5	5.7	14.3	6.3	7.7	9.3	4.3	3.6	10.7	8.4	12.4	2.1	2.7	8.9	9.0	5.0	4.0	43.6	9.6	6.2	16.6	17.4	24.2	10.7	7.9	16.9	5.0	8.3	19.7	9.9	8.2	13.8	11.0	3.4	14.7	4.4	5.1	9.0	9.1	9.2	13.1	6.2	12.3	7.8	5.7	5.6	9.0	13.1	16.2	12.0	17.8	16.2	23.1	15.6	21.9	20.2	13.8	17.5	20.8	19.7	7.1	13.2	11.6	15.6	26.9	14.1	15.8	13.2	13.1	14.5	13.4	11.0	13.1	8.7	10.3	6.6	11.9	7.8	21.6	25.7	74.8	17.9	12.4	45.9	48.2	17.0	21.0	2.0	33.0	89.5	56.4	358.5	19.4	48.7	0.0	70.1	21.0	22.4	21.1	9.2	21.5	25.8	12.7	35.1	20.3	25.9	675.3	24.2	22.4	40.5	27.9	17.1	13.2	50.2	28.1	23.0	64.0	18.9	64.7	32.0	140.5	86.5	77.0	21.4	26.1	23.8	17.8
SURF6	"FLJ30322, RRP14"	ENSG00000148296	"Surfeit 6"	O75683	9	133328774-133336398	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023608, HPA074622"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA023608: AB_1857671, HPA074622: AB_2686703"	"unprognostic (5.27e-3)"	"unprognostic (8.67e-3)"	"unprognostic (5.41e-3)"	"unprognostic (3.69e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.18e-3)"	"unprognostic (9.32e-3)"	"prognostic favorable (7.31e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.66e-1)"	14.8	16.8	19.9	15.0	22.7	16.2	15.7	16.4	25.8	13.9	16.2	14.0	11.9	21.7	18.6	10.9	17.4	18.5	15.9	13.9	19.1	17.9	14.5	16.2	12.6	17.6	19.6	22.9	27.4	23.1	16.5	11.8	12.5	24.6	15.8	13.1	11.6	18.3	19.5	47.3	17.8	22.3	18.0	23.6	18.8	13.6	16.5	19.8	8.6	14.4	11.1	13.5	15.3	19.1	7.7	8.9	3.9	4.7	4.6	8.5	3.6	4.1	6.4	5.0	7.4	3.1	2.9	8.3	6.5	3.9	5.8	3.7	10.1	7.1	11.9	5.1	3.6	4.3	12.5	6.4	6.9	2.2	7.9	7.2	8.2	7.4	6.0	5.6	13.8	7.1	4.1	6.1	6.1	5.7	5.3	3.0	11.7	17.8	6.5	5.2	10.7	11.2	11.4	14.5	16.8	11.7	11.8	6.9	12.1	5.1	4.0	10.5	8.9	6.4	10.5	5.7	3.2	9.2	7.8	6.2	13.4	7.1	6.7	8.9	4.8	6.8	15.5	5.0	9.5	7.8	3.9	4.7	1.9	6.8	4.4	7.0	7.1	6.2	6.1	4.9	7.7	8.5	7.0	1.3	4.6	3.7	8.9	5.0	3.6	19.9	22.7	16.4	25.8	19.1	17.9	19.6	22.9	24.6	19.8	41.7	23.5	25.1	10.6	21.1	24.6	26.3	30.6	17.4	35.2	21.0	5.9	26.9	18.3	29.0	1.1	20.3	37.7	0.0	16.8	19.1	14.3	11.8	24.3	29.2	18.5	20.6	32.3	12.9	11.1	2.4	25.6	14.2	6.8	21.6	37.2	16.4	23.6	28.1	26.2	11.9	20.1	0.0	17.0	18.9	21.0	24.1	15.9	16.6	47.0	10.5
SYAP1	"FLJ14495, PRO3113"	ENSG00000169895	"Synapse associated protein 1"	Q96A49	X	16719632-16765336	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000175, HPA000882, HPA048047"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA000175: AB_1080142, HPA000882: AB_2666128, HPA048047: AB_2680240"	"unprognostic (4.66e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.14e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.28e-3)"	17.6	31.3	13.1	12.9	12.3	26.2	16.5	10.2	14.0	17.1	23.8	12.2	16.1	20.6	17.0	13.7	18.5	14.4	20.7	25.7	13.5	13.7	28.7	51.4	17.6	11.4	15.8	11.0	19.9	14.3	22.8	15.9	18.9	18.4	16.2	16.1	10.7	15.9	21.3	22.5	12.6	33.0	12.3	17.3	13.7	16.9	10.1	11.2	15.3	16.2	13.3	15.1	17.9	13.5	12.6	11.1	17.8	15.0	13.8	15.2	9.1	15.9	13.5	9.8	18.3	13.3	15.2	4.5	12.8	9.2	10.7	10.7	12.6	13.3	12.5	18.8	12.5	21.9	9.6	11.9	16.7	14.4	8.1	23.8	5.0	14.6	12.0	9.5	8.5	7.8	10.3	7.9	18.5	15.8	12.5	14.7	3.9	10.7	7.1	14.4	18.8	4.5	9.2	11.4	8.9	14.9	5.0	12.4	12.6	15.9	10.6	10.0	12.3	23.8	17.0	12.6	13.3	22.6	7.7	11.6	13.8	7.3	28.0	10.3	7.7	6.6	14.6	13.6	4.3	11.2	9.2	10.5	12.7	15.2	11.3	12.3	12.6	13.0	13.9	11.1	10.8	13.1	13.6	17.8	13.8	15.0	9.2	14.4	9.1	13.1	12.3	10.2	14.0	13.5	13.7	15.8	11.0	18.4	11.2	59.6	59.3	59.9	76.6	56.9	18.5	68.5	81.5	190.1	93.3	75.0	21.6	57.3	94.5	102.2	188.0	47.2	124.9	23.3	115.1	64.1	49.1	85.9	200.3	200.6	44.7	22.3	101.7	67.5	63.9	250.6	39.1	90.0	64.1	53.3	93.6	45.0	138.4	150.8	51.2	108.8	19.3	58.2	83.4	13.3	21.5	45.9	125.9	62.3	95.4	91.2
SYCE1L	MRP2	ENSG00000205078	"Synaptonemal complex central element protein 1 like"	A8MT33	16	77199397-77213215	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 22.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 13.0;U-698: 10.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA062464, HPA066691"			Enhanced	"Intermediate filaments"		No	No			"Intermediate filaments"		"HPA062464: , HPA066691: AB_2685702"	"unprognostic (5.54e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (6.65e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-3)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.48e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (2.11e-5)"	"unprognostic (9.27e-2)"	"unprognostic (4.27e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.73e-2)"	3.5	3.4	2.8	4.1	2.7	2.9	3.7	5.2	2.4	8.7	5.0	0.4	11.5	2.1	7.8	7.6	4.4	2.8	1.8	7.0	2.8	3.0	4.3	1.4	1.9	4.5	2.1	1.4	8.5	2.7	2.3	2.3	1.6	1.5	6.6	1.6	5.4	11.1	8.7	1.7	4.3	4.6	2.0	2.5	4.2	2.3	22.4	0.4	6.4	8.0	2.0	2.4	2.3	4.4	3.5	12.2	12.0	2.2	2.7	10.5	3.4	2.8	1.1	2.8	1.3	0.3	0.0	0.5	0.8	0.3	0.5	0.9	0.6	5.7	1.9	3.8	0.6	0.2	4.1	0.2	0.0	0.3	1.7	13.0	0.4	1.0	0.0	1.9	0.9	1.2	0.1	0.4	0.1	0.3	0.5	2.0	2.6	0.7	0.2	0.3	4.2	0.7	1.3	1.9	0.4	4.5	6.7	0.7	0.6	2.5	0.8	2.9	3.4	0.4	0.3	0.0	0.3	0.1	1.2	6.5	0.4	6.5	0.9	0.2	5.5	2.1	10.1	2.8	0.7	0.2	4.0	1.3	12.0	6.1	2.2	7.3	3.5	7.9	8.4	1.6	2.6	8.7	8.0	1.3	2.7	1.6	12.2	10.5	3.4	2.8	2.7	5.2	2.2	2.8	3.0	2.1	1.4	1.5	0.4	3.0	3.0	6.0	9.6	15.3	3.7	2.0	30.6	1.4	5.7	26.2	9.8	5.2	13.3	23.2	19.5	7.5	6.9	0.0	24.3	3.8	9.0	15.6	1.1	10.6	2.1	1.6	21.6	16.5	13.5	35.7	12.7	3.1	18.6	2.8	30.3	14.0	19.1	22.4	6.3	17.9	35.5	6.5	4.2	34.7	8.1	14.9	2.4	13.4	29.9	5.7
SYNDIG1	"C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469199-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;heart muscle: 28.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 5.0;Cardiomyocytes: 12.1;Distal tubular cells: 5.0;Peritubular cells: 6.7;Proximal tubular cells: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.2;RH-30: 23.3;RPMI-8226: 22.1;SCLC-21H: 5.4;U-87 MG: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	2.6	1.7	12.5	2.1	12.0	0.7	0.8	21.3	22.7	4.5	1.5	23.3	0.3	1.9	2.6	1.5	0.9	5.1	10.0	28.2	12.8	8.8	6.2	0.7	1.1	2.5	14.5	12.9	1.3	1.4	0.9	0.6	0.9	11.5	3.2	1.6	0.5	0.8	14.8	0.6	0.8	2.8	3.1	22.4	1.4	2.2	1.3	16.6	0.1	5.1	0.0	3.1	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.2	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	23.3	22.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	12.0	21.3	19.7	12.8	8.8	14.5	12.9	11.5	16.6	0.0	0.0	0.0	0.0	0.0	5.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	6.7	5.4	0.4	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SYNPO2	MYOPODIN	ENSG00000172403	"Synaptopodin 2"	Q9UMS6	4	118850688-119061247	"Predicted intracellular proteins"		"Actin-binding, Muscle protein"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 185.8"	"Group enriched"	"Detected in many"	6	"Cardiomyocytes: 123.7;Peritubular cells: 95.5;Sertoli cells: 129.4;Smooth muscle cells: 291.5"	"Cancer enhanced"	"Detected in all"		"stomach cancer: 27.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.4;LHCN-M2: 9.4;SH-SY5Y: 40.3"	"Region enriched"	"Detected in many"	5	"thalamus: 64.1"	"Low region specificity"	"Detected in many"			"HPA030665, CAB037231, HPA049707, HPA068563"	Enhanced		Enhanced	"Vesicles,Actin filaments"		NA	NA			"Vesicles, Actin filaments"		"CAB037231: AB_262098, HPA030665: AB_10696210, HPA049707: AB_2680857, HPA068563: AB_2686006"	"unprognostic (1.50e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-1)"	"unprognostic (5.71e-4)"	"unprognostic (2.18e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (1.82e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.91e-4)"	11.4	2.3	1.8	9.6	3.9	0.0	7.3	1.0	5.6	26.5	56.0	4.4	20.5	6.5	37.5	23.9	37.0	14.2	19.4	29.0	2.6	1.5	2.4	1.7	3.7	5.7	1.9	5.2	27.9	1.4	0.9	2.6	3.8	3.8	35.9	11.1	21.2	4.1	58.8	185.8	3.7	14.5	88.7	4.0	6.1	29.5	9.6	3.1	3.0	3.7	12.8	2.1	50.7	15.5	1.8	0.2	2.0	0.4	1.2	2.3	0.4	0.1	1.9	0.1	0.0	5.6	1.9	0.3	5.9	6.4	0.2	0.2	0.0	0.3	0.6	0.0	26.4	0.4	0.1	0.2	0.1	0.3	2.5	0.0	0.3	0.4	0.0	1.3	0.0	0.1	6.8	0.1	1.8	0.1	2.0	0.0	0.1	0.0	0.3	9.4	0.1	0.3	3.6	0.6	0.0	0.0	0.2	0.7	0.2	0.1	0.1	0.2	40.3	0.2	0.1	0.0	1.7	0.0	3.4	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.3	0.0	1.9	0.3	2.0	1.2	0.1	1.9	1.3	2.0	1.2	0.1	1.8	2.1	1.3	0.9	1.2	0.4	0.2	2.3	0.4	1.8	3.9	1.0	5.6	2.6	1.5	1.9	5.2	3.8	3.1	3.0	1.4	0.8	19.5	11.9	0.3	123.7	0.0	4.0	0.0	1.8	0.0	1.0	0.0	0.0	1.5	7.7	0.0	0.0	1.7	0.7	19.8	3.2	0.0	0.5	1.3	0.0	0.0	15.4	0.8	3.9	25.0	1.9	5.0	22.6	0.0	0.0	0.2	0.0	95.5	0.3	0.3	129.4	291.5	0.5	0.4	7.0	0.7	0.0	0.0	2.7
SYNPO2L	FLJ12921	ENSG00000166317	"Synaptopodin 2 like"	Q9H987	10	73644881-73663803	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"heart muscle: 69.3;skeletal muscle: 72.8;tongue: 29.3"	"Cell type enriched"	"Detected in some"	220	"Cardiomyocytes: 650.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.5;head and neck cancer: 1.4;prostate cancer: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;HSkMC: 6.2;RH-30: 5.9;SK-BR-3: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA055192, HPA057142"	Enhanced		Supported	"Nuclear speckles,Cell Junctions,Cytosol"		NA	NA			"Nuclear speckles"	"Cell Junctions, Cytosol"	"HPA055192: AB_2682732, HPA057142: AB_2683348"	"unprognostic (2.75e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.20e-3)"	"unprognostic (3.65e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.54e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.44e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.34e-1)"	3.8	0.1	0.0	0.0	0.1	0.1	1.1	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	3.2	3.3	0.0	0.0	69.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.8	0.0	0.0	1.6	0.0	72.8	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	1.3	29.3	3.4	0.0	0.3	0.7	1.0	3.0	0.7	0.7	0.7	0.1	0.5	0.1	0.8	0.3	0.1	0.0	1.1	0.9	1.2	0.2	0.0	7.7	0.7	0.4	0.5	0.9	0.1	0.1	0.1	0.0	0.4	0.2	0.2	0.3	0.6	0.4	0.6	0.2	0.3	6.2	0.1	1.2	0.1	0.3	0.0	0.5	0.3	0.3	0.3	0.3	0.2	1.9	0.2	0.0	0.7	0.2	5.9	0.3	0.0	0.6	0.3	0.4	0.1	6.3	0.1	0.3	0.4	0.7	0.0	0.6	1.0	0.2	0.3	1.0	0.3	0.3	0.2	0.6	0.0	2.9	0.7	0.7	0.7	0.4	0.3	0.5	0.3	0.3	0.2	0.7	0.4	0.4	3.0	0.7	0.4	1.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	1.4	1.3	1.4	650.0	0.0	1.4	1.2	0.0	2.0	0.1	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.1	0.9	0.7	1.1	0.2	0.2	0.0	0.0	0.0	0.3	1.0	0.9	0.8	1.7	0.0	0.0	0.8	0.0	0.0	0.4	0.0	1.3	0.0	0.5	0.7	0.6	0.4	0.0	0.7	0.0	0.9
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134533	"Enzymes, Predicted membrane proteins"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hepatocytes: 60.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	13.8	20.8	11.0	33.0	15.3	13.8	14.9	13.3	19.3	15.1	14.2	21.0	20.2	13.2	16.0	21.1	14.4	16.1	15.3	12.9	11.3	10.0	16.4	78.0	14.2	28.9	18.2	8.7	17.1	68.1	24.4	21.0	20.9	14.4	15.0	15.4	13.3	48.9	22.6	16.7	14.4	19.6	13.6	12.8	27.1	18.3	14.4	14.9	10.3	23.5	8.0	42.2	13.3	12.6	17.5	13.0	11.6	5.4	2.2	5.5	3.8	8.6	11.1	6.7	9.0	17.1	9.8	6.7	9.0	9.3	11.5	8.2	6.0	15.2	49.0	12.3	11.5	15.2	13.5	7.3	9.1	9.5	7.6	5.5	7.7	12.9	13.4	20.8	11.5	14.0	12.4	16.5	10.1	23.0	10.3	7.4	5.2	9.6	25.1	6.7	12.9	5.0	8.3	7.2	9.1	7.7	8.5	5.7	19.7	7.2	8.6	4.4	9.0	8.3	20.7	14.5	6.2	15.4	7.6	7.1	8.0	5.3	14.3	6.0	50.2	34.7	56.6	10.8	5.9	8.9	11.6	5.4	9.3	5.5	3.3	5.0	15.4	3.9	5.1	3.1	17.5	2.9	3.0	5.2	2.2	3.2	13.0	3.6	3.8	11.0	15.3	13.3	19.3	11.3	10.0	18.2	8.7	14.4	14.9	14.9	21.3	22.2	6.0	15.7	10.2	3.4	33.1	9.4	20.5	10.4	31.4	11.5	1.7	10.5	4.3	8.3	15.8	23.3	16.3	12.6	12.1	13.4	1.1	60.4	13.6	12.7	8.1	14.1	14.8	3.5	19.0	11.6	11.8	6.4	25.0	10.8	17.1	12.4	12.4	7.2	17.1	12.9	7.5	21.0	10.9	14.1	35.8	10.2	14.5	11.6
TAB1	MAP3K7IP1	ENSG00000100324	"TGF-beta activated kinase 1 (MAP3K7) binding protein 1"	Q15750	22	39399741-39437060	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 52.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032328, HPA039988, HPA057104"	Approved		Enhanced	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"CAB032328: AB_2281637, HPA039988: AB_2676787, HPA057104: AB_2683338"	"unprognostic (1.76e-1)"	"unprognostic (1.79e-2)"	"unprognostic (7.88e-2)"	"unprognostic (6.73e-3)"	"unprognostic (9.23e-3)"	"unprognostic (4.30e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.93e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (7.35e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	12.2	14.9	18.3	13.6	20.8	13.6	12.5	24.7	28.1	16.9	16.2	32.0	10.9	16.9	18.8	10.7	13.6	17.9	19.2	18.9	17.9	15.7	12.4	14.8	13.7	15.8	22.7	18.8	26.7	19.5	16.3	12.5	13.8	15.9	16.9	9.1	19.6	21.6	19.1	27.8	17.3	15.7	14.3	17.2	17.2	14.4	11.9	20.6	13.0	13.3	10.9	13.0	16.8	14.3	5.9	8.2	6.1	8.7	5.2	7.6	6.3	12.0	12.5	12.7	14.5	13.5	11.5	11.3	10.1	12.6	15.5	14.7	11.5	8.7	18.2	8.0	9.8	8.6	14.7	12.9	14.8	6.2	14.1	20.6	8.0	15.3	11.3	11.8	15.0	15.4	11.5	13.2	11.7	12.8	11.8	11.3	11.1	14.5	12.5	7.7	7.8	11.5	12.5	8.9	19.0	12.8	20.8	18.2	18.1	11.9	12.9	11.3	8.4	14.3	17.8	12.5	8.3	14.5	16.5	9.6	10.8	17.3	8.3	8.2	19.8	12.7	13.2	12.8	10.6	10.5	1.4	8.7	6.1	7.6	7.2	6.2	5.9	4.6	6.1	8.2	5.9	7.5	6.7	1.3	5.2	6.7	3.8	4.6	6.3	18.3	20.8	24.7	28.1	17.9	15.7	22.7	18.8	15.9	20.6	3.0	4.1	4.9	2.8	1.8	52.3	6.5	5.1	2.7	3.4	3.5	17.7	10.3	0.0	5.2	1.3	4.5	4.2	0.0	3.4	7.1	4.7	2.4	4.7	4.2	6.1	27.0	10.9	3.1	5.6	2.4	7.2	3.9	5.0	8.2	4.5	11.8	4.8	4.3	8.5	4.2	18.2	6.5	4.7	7.1	8.9	2.9	4.7	8.2	5.6	1.3
TACC3	ERIC1	ENSG00000013810	"Transforming acidic coiled-coil containing protein 3"	Q9Y6A5	4	1721490-1745176	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 54.8;bone marrow: 26.0;lymphoid tissue: 64.3;testis: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 43.8;Late spermatids: 49.1;Spermatocytes: 69.6;Spermatogonia: 47.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"neutrophil: 54.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA005781, HPA006050, CAB010111, HPA022039"	Enhanced		Enhanced	"Vesicles,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	Yes			"Mitotic spindle, Centriolar satellite, Cytosol"	Vesicles	"CAB010111: AB_628323, HPA005781: AB_1857724, HPA006050: AB_2667505, HPA022039: AB_1857725"	"unprognostic (2.95e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.71e-2)"	"unprognostic (4.35e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.10e-3)"	"unprognostic (4.61e-2)"	"unprognostic (9.12e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (4.66e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.44e-3)"	"unprognostic (9.75e-2)"	3.8	2.7	1.1	39.1	1.1	26.0	3.4	2.1	1.4	1.9	4.4	1.1	0.8	4.5	1.8	2.7	8.8	1.6	3.5	2.0	1.4	1.3	2.5	2.4	4.3	20.1	1.3	0.7	1.6	1.0	0.5	1.8	5.7	1.1	1.6	4.9	1.6	3.0	1.2	2.0	2.6	7.7	2.5	1.8	15.6	3.4	58.1	0.9	64.3	1.6	7.3	27.9	3.2	3.0	4.0	10.4	54.8	19.9	3.8	17.9	16.1	25.4	21.2	32.5	18.6	1.7	3.6	18.3	28.9	15.5	33.2	22.0	23.5	30.8	32.5	12.3	15.7	38.6	17.2	34.3	21.0	33.8	14.3	18.6	27.5	17.6	21.6	1.6	37.2	23.4	1.5	1.4	20.9	12.1	7.3	25.2	26.8	24.8	25.7	31.4	20.8	49.0	53.3	35.1	21.8	27.9	34.8	23.0	13.0	18.8	38.6	25.3	15.9	17.4	11.0	8.1	25.5	21.6	21.6	14.7	19.4	23.2	17.5	43.5	18.0	23.9	52.1	11.2	36.0	27.4	24.7	19.9	17.9	5.5	9.0	6.0	4.0	12.3	7.6	10.4	3.8	17.9	9.8	54.8	3.8	5.5	3.1	17.5	16.1	1.1	1.1	2.1	1.4	1.4	1.3	1.3	0.7	1.1	0.9	0.0	7.9	16.0	0.5	1.9	1.0	2.2	0.0	0.0	4.5	8.7	7.9	3.3	0.0	2.1	43.8	2.5	2.0	23.3	0.6	16.5	2.6	1.0	4.7	4.3	35.7	4.8	1.2	4.9	20.5	49.1	2.6	21.9	0.0	12.6	3.1	1.4	1.9	3.5	2.5	1.8	3.2	6.5	1.0	69.6	47.8	1.3	3.3	15.3	5.7	1.3
TACO1	CCDC44	ENSG00000136463	"Translational activator of cytochrome c oxidase I"	Q9BSH4	17	63600872-63608365	"Disease related genes, Predicted intracellular proteins"	"Translation regulation"	Activator	"Leigh syndrome, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 76.5;Proximal tubular cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021626, HPA021643, HPA024294"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA021626: AB_1846148, HPA021643: AB_1846149, HPA024294: AB_1846150"	"unprognostic (1.26e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.55e-3)"	"unprognostic (9.82e-2)"	"unprognostic (1.30e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.83e-1)"	"unprognostic (8.09e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.38e-2)"	"prognostic favorable (3.73e-4)"	"unprognostic (1.35e-1)"	"unprognostic (4.12e-3)"	"unprognostic (5.21e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.60e-2)"	8.3	11.3	8.7	6.3	11.1	4.9	6.9	6.4	14.2	5.9	12.1	7.6	6.2	13.0	7.6	7.2	7.5	6.7	10.1	21.2	7.6	8.6	20.7	42.5	7.0	7.3	9.3	7.2	6.0	10.7	8.3	5.7	7.5	9.3	6.4	11.4	8.1	11.4	6.9	37.5	6.1	15.7	6.9	6.5	7.3	8.0	8.1	6.2	8.7	8.7	15.9	8.1	6.3	5.1	8.9	9.9	7.9	8.1	16.6	13.6	7.9	17.3	27.4	8.8	9.1	7.7	11.1	11.8	12.7	12.1	25.7	20.5	18.0	10.4	14.3	9.8	14.6	17.9	16.0	19.3	18.6	24.3	7.6	26.9	14.1	14.0	31.4	21.3	16.6	9.9	13.5	13.0	22.2	23.6	9.6	13.3	11.0	19.1	10.9	12.0	31.3	19.3	12.6	7.6	18.8	28.5	12.2	21.7	17.9	15.0	12.2	13.5	14.8	8.7	29.0	24.2	12.1	24.1	13.0	11.7	18.4	13.9	12.5	22.4	11.9	11.6	17.0	14.0	11.4	13.3	2.1	8.1	7.9	9.5	7.5	10.6	7.1	13.6	9.5	9.9	8.9	12.8	10.3	1.4	16.6	6.6	6.4	9.0	7.9	8.7	11.1	6.4	14.2	7.6	8.6	9.3	7.2	9.3	6.2	3.0	4.6	12.3	7.4	2.3	7.5	50.4	10.2	6.7	5.7	14.0	2.0	28.9	46.4	24.0	12.5	12.8	41.2	0.0	23.8	23.1	9.4	8.0	9.2	76.5	23.2	6.4	13.3	10.4	10.3	37.7	10.9	8.5	10.1	29.7	21.7	13.2	23.6	24.1	10.6	101.0	10.4	19.4	9.0	23.2	15.5	3.8	16.6	11.5	31.0	5.7
TAF13	"TAF2K, TAFII18"	ENSG00000197780	"TATA-box binding protein associated factor 13"	Q15543	1	109062486-109076002	"Disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044492	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA044492: AB_10962871"	"unprognostic (8.54e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (8.74e-6)"	"unprognostic (1.73e-2)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.42e-5)"	"unprognostic (1.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.61e-3)"	"unprognostic (7.22e-3)"	23.5	13.4	24.6	14.3	23.4	27.7	14.7	14.0	33.7	18.0	16.6	19.5	15.3	10.0	13.9	14.7	22.1	9.9	18.0	19.2	25.3	26.9	22.3	21.0	11.5	8.6	32.2	22.6	6.6	15.9	14.6	21.2	21.0	35.8	16.9	18.2	7.7	14.5	11.7	40.9	13.0	12.8	22.2	36.1	7.7	14.0	10.3	20.7	4.1	18.2	16.6	14.8	16.4	11.0	1.3	3.0	7.9	4.6	0.5	2.3	0.8	20.6	5.4	8.3	12.1	24.0	22.5	13.8	49.1	20.8	20.0	20.3	8.6	4.7	7.9	18.8	32.6	11.9	8.7	14.6	17.7	30.2	13.5	3.3	7.9	13.2	8.9	19.0	13.9	12.1	20.0	21.3	33.5	18.3	10.8	17.1	7.3	15.1	7.7	27.0	11.9	7.3	3.8	16.6	9.6	11.3	5.7	15.0	3.1	23.6	18.0	8.7	10.8	24.1	15.6	17.7	15.5	5.3	9.9	22.3	33.1	12.6	23.3	26.8	9.4	23.7	10.6	35.2	7.4	49.1	2.6	4.6	3.7	1.7	3.3	1.5	1.2	1.1	1.7	1.5	1.3	1.1	1.6	7.9	0.5	2.8	3.0	2.3	0.8	24.6	23.4	14.0	33.7	25.3	26.9	32.2	22.6	35.8	20.7	17.9	21.1	8.2	9.3	62.4	4.5	57.2	10.2	16.0	26.1	7.0	0.0	15.5	11.6	14.4	29.0	19.7	31.6	23.3	18.1	26.6	20.6	18.8	13.9	35.8	16.4	6.4	30.6	24.5	29.7	2.9	8.6	18.4	13.5	12.6	26.1	10.8	24.9	20.1	12.0	26.2	7.5	6.5	26.2	9.8	15.7	72.0	45.9	7.7	10.5	25.9
TAF15	"hTAFII68, Npl3, RBP56, TAF2N"	ENSG00000270647	"TATA-box binding protein associated factor 15"	Q92804	17	35713791-35864615	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"DNA-binding, RNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052059, HPA063647"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052059: AB_2681711, HPA063647: AB_2685072"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.48e-3)"	"unprognostic (4.75e-2)"	"unprognostic (8.06e-3)"	"unprognostic (2.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.99e-1)"	14.0	12.9	12.7	15.3	16.2	13.9	11.0	13.7	14.1	10.5	11.7	15.0	13.2	12.7	10.2	11.0	12.6	8.0	11.5	13.1	11.8		9.8	15.0	8.9	19.4	14.7	8.3	10.7	11.3	14.6	18.1	11.1	11.1	11.4	10.1	9.2	9.8	15.3	26.9	14.7	13.4	17.5	15.9	12.7	11.0	11.3	15.5	21.1	9.4	12.8	15.8	12.0	9.8	3.7	3.2	3.8	3.6	4.7	7.2	2.2	29.2	48.1	25.7	24.9	20.6	11.7	16.9	33.4	11.4	15.3	15.0	32.2	21.2	58.2	24.1	21.6	18.3	31.1	34.1	33.7	22.0	16.4	44.7	33.5	34.9	33.7	20.4	54.0	22.5	18.6	17.7	23.1	36.3	17.7	20.6	36.2	31.4	24.1	17.2	34.9	58.8	13.1	15.9	27.3	13.8	35.1	38.3	21.8	19.3	52.6	19.5	19.2	41.6	12.6	13.2	31.4	29.5	18.6	27.7	11.8	25.8	16.9	40.1	22.8	27.8	42.4	23.3	26.7	19.3	3.8	3.5	3.5	4.9	3.4	7.2	3.0	3.5	3.8	2.5	3.7	3.3	3.7	2.0	4.7	3.6	3.2	3.9	2.2											14.9	50.3	37.4	49.0	32.1	54.1	35.5	43.3	50.9	64.8	57.6	39.3	72.7	3.3	35.9	4.6	49.6	37.7	46.7	25.7	39.3	25.9	36.3	54.3	53.9	37.4	57.2	47.1	33.2	42.9	8.9	28.4	36.7	32.1	34.3	49.4	55.6	28.8	28.1	38.2	26.6	42.8	45.3	31.9	60.1	72.8	32.5	65.2	42.4	50.6	42.6
TAF4	"TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135"	ENSG00000130699	"TATA-box binding protein associated factor 4"	O00268	20	61953469-62065810	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008599, CAB031484"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB031484: AB_671207, HPA008599: AB_1080183"	"unprognostic (3.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.14e-1)"	"unprognostic (9.67e-2)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.00e-3)"	"unprognostic (4.39e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.99e-2)"	7.7	11.4	8.5	7.8	9.5	9.8	6.2	16.5	9.6	8.9	9.8	8.5	4.2	10.1	8.5	3.8	7.6	7.0	7.0	4.9	7.7	4.5	6.6	8.9	6.2	7.1	9.6	6.0	16.7	12.4	4.3	6.4	6.8	6.4	6.8	4.6	6.4	6.6	7.6	13.2	7.7	10.4	6.8	5.8	9.7	10.9	17.9	8.7	16.5	6.8	4.3	5.8	7.7	9.9	0.1	0.2	2.7	0.6	0.0	1.4	0.2	5.6	5.3	3.2	3.6	1.5	1.1	6.4	2.8	1.2	4.7	2.5	17.6	4.7	4.6	7.2	1.5	3.5	7.3	2.8	3.3	2.0	3.9	4.1	10.5	5.8	8.1	1.6	5.0	9.5	0.8	3.0	2.1	2.2	1.3	1.8	5.7	8.5	4.1	0.8	6.0	14.0	6.1	4.7	4.0	7.5	13.0	7.3	4.8	1.5	5.2	5.4	4.7	8.5	9.1	2.9	2.4	5.5	6.1	2.3	6.0	8.8	6.0	5.1	5.7	5.3	7.2	3.5	3.0	4.1	0.0	0.6	0.7	0.1	0.2	0.0	0.0	0.3	0.4	0.2	0.1	0.3	0.5	2.7	0.0	0.1	0.1	1.4	0.2	8.5	9.5	16.5	9.6	7.7	4.5	9.6	6.0	6.4	8.7	6.0	16.0	5.6	2.8	6.8	6.2	6.7	5.1	8.1	3.4	5.2	2.0	5.1	0.0	5.1	12.7	4.5	6.8	0.0	3.3	4.2	5.9	5.8	1.1	10.0	4.9	14.3	3.5	5.5	10.7	4.2	8.6	6.1	3.3	1.8	10.9	3.9	5.0	10.5	9.9	4.7	8.6	6.5	8.1	8.9	12.5	8.4	7.0	3.8	9.5	5.6
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	24.7	17.4	11.9	17.1	13.2	25.5	17.4	9.6	15.1	15.6	19.0	15.2	21.4	14.9	16.1	17.6	15.6	11.4	12.1	22.8	11.5	9.9	18.7	14.1	16.2	19.9	15.0	13.2	13.8	14.0	22.3	12.3	19.1	12.4	15.6	13.3	16.4	16.4	19.6	25.5	12.8	14.1	14.7	12.2	20.6	17.2	18.9	12.2	36.0	24.3	11.2	20.1	16.7	15.6	15.4	19.8	19.7	24.6	8.4	13.2	7.3	9.5	10.5	8.7	9.7	9.8	9.1	8.0	4.5	7.8	11.9	12.4	17.9	5.8	14.7	9.7	6.5	12.2	7.2	14.1	9.5	9.3	12.7	13.6	18.5	12.6	8.8	12.1	10.7	13.6	12.4	7.6	8.5	10.8	6.0	13.2	18.3	22.8	15.5	6.6	12.7	9.8	16.3	5.4	25.5	4.9	20.2	10.3	11.2	10.5	7.9	9.0	8.0	8.2	6.4	9.1	7.5	9.7	13.2	12.3	10.7	11.2	4.9	9.1	13.5	13.1	31.1	4.9	11.9	6.0	13.4	12.1	19.7	13.2	12.8	9.3	14.1	12.0	10.3	13.0	15.4	12.5	12.1	15.2	8.4	24.6	19.8	10.1	7.3	11.9	13.2	9.6	15.1	11.5	9.9	15.0	13.2	12.4	12.2	17.9	22.6	10.4	11.0	6.3	15.6	24.5	15.3	9.4	19.4	10.4	29.5	19.6	26.6	8.9	8.2	15.8	9.2	0.0	8.4	6.8	10.4	12.4	18.5	7.4	11.5	20.6	8.6	7.4	14.2	13.8	13.8	10.9	6.8	12.6	11.1	11.7	7.4	7.0	11.0	12.9	23.1	12.9	10.8	7.9	14.5	7.3	18.0	12.8	9.0	11.5
TAF9	"AD-004, CGI-137, MGC1603, MGC3647, MGC5067, TAF2G, TAFII31, TAFII32, TAFIID32"	ENSG00000273841	"TATA-box binding protein associated factor 9"	Q16594	5	69364743-69370013	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 444.4;Late spermatids: 626.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA028930, HPA053429, HPA058961, HPA072658"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA028930: AB_2672832, HPA053429: AB_2682148, HPA058961: AB_2683863, HPA072658: "	"unprognostic (1.25e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.76e-3)"	"unprognostic (8.38e-3)"	"unprognostic (5.40e-2)"	"unprognostic (1.77e-2)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.19e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.79e-1)"	11.3	7.2	6.8	5.5	8.4	16.6	8.8	6.5	9.5	6.7	8.0	4.0	6.3	6.3	5.9	10.0	10.9	5.1	5.7	9.2	5.6		11.5	18.0	6.5	8.2	6.8	6.2	7.3	7.4	4.4	10.8	8.6	9.4	7.1	9.1	4.4	5.2	5.2	11.0	5.3	9.7	6.9	5.7	8.7	6.1	30.1	6.8	10.2	9.8	9.8	9.8	7.8	5.0	24.9	21.8	29.8	28.8	14.9	25.0	31.2	16.9	17.8	11.4	19.1	18.2	23.9	29.8	16.9	25.4	28.4	38.0	18.9	20.8	23.0	12.7	24.2	53.7	12.5	15.2	33.9	37.3	10.4	18.8	18.8	29.7	23.8	44.5	18.5	27.3	28.2	22.5	19.6	44.0	19.9	22.9	21.0	18.8	18.4	26.7	23.3	20.9	29.0	13.6	6.4	14.0	13.6	18.9	26.0	24.1	18.6	18.9	13.5	16.0	9.8	29.2	19.8	15.5	27.3	16.0	11.0	16.8	11.7	27.8	17.1	20.5	28.9	16.1	22.5	12.6	28.4	28.8	29.8	14.9	26.1	22.4	24.9	22.2	18.3	21.8	19.7	25.0	21.4	4.5	14.9	20.6	13.5	23.2	31.2											17.9	30.6	51.1	138.1	154.5	21.2	61.3	43.3	33.5	31.8	22.7	13.7	101.8	76.3	62.8	444.4	55.3	36.5	23.3	69.7	133.9	64.7	69.2	37.0	41.2	94.4	19.1	29.6	34.4	40.6	626.5	60.4	60.8	94.5	53.3	53.5	24.2	76.7	31.6	32.2	66.6	33.1	32.3	93.7	328.5	65.8	142.7	87.4	36.2	61.0	135.9
TAL1	"bHLHa17, SCL, TCL5"	ENSG00000162367	"TAL bHLH transcription factor 1, erythroid differentiation factor"	P17542	1	47216290-47232220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 33.1"	"Cell type enhanced"	"Detected in some"	22	"Endothelial cells: 18.0;Erythroid cells: 93.5;granulocytes: 35.8;Ito cells: 30.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HEL: 52.8;HMC-1: 25.4;HUVEC TERT2: 11.0;JURKAT: 21.1;K-562: 16.5;TIME: 12.0"	"Region enriched"	"Detected in some"	5	"midbrain: 17.1"	"Low region specificity"	"Detected in many"			"CAB017805, HPA047866, HPA073983"	Approved		Enhanced	Nucleoplasm		Yes	NA			Nucleoplasm		"CAB017805: , HPA047866: AB_2680192, HPA073983: AB_2732246"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.95e-3)"	"unprognostic (1.33e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.18e-2)"	9.1	2.7	7.0	1.8	5.7	33.1	7.1	1.6	6.9	3.3	2.4	12.0	2.3	1.6	3.7	3.3	2.5	4.1	4.2	3.9	8.8	3.5	4.5	2.4	14.6	2.2	11.1	4.4	1.5	1.3	2.2	2.1	9.8	7.3	2.4	2.4	2.1	1.4	3.0	3.1	2.0	3.3	4.4	9.4	8.5	2.1	1.8	9.2	0.0	6.7	4.1	1.5	2.5	5.5	0.3	0.1	3.2	0.3	0.4	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	52.8	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	11.0	21.1	16.5	0.0	0.0	0.0	8.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.4	0.1	1.2	0.4	0.1	0.1	0.1	2.2	7.0	5.7	1.6	6.9	8.8	3.5	11.1	4.4	7.3	9.2	0.0	0.0	0.0	0.0	0.8	0.0	1.7	2.5	0.0	2.3	1.8	0.0	0.1	0.0	0.0	4.8	18.0	0.0	93.5	0.0	0.1	0.9	0.0	35.8	0.0	7.9	0.0	0.0	30.7	2.1	10.2	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.4	0.9	0.0	0.0	0.0	0.0
TARDBP	"ALS10, TDP-43"	ENSG00000120948	"TAR DNA binding protein"	Q13148	1	11012344-11026420	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB003703, HPA017284"	Supported		Enhanced	Nucleoplasm		NA	Yes		13000	Nucleoplasm		"CAB003703: AB_425904, HPA017284: AB_1857775"	"unprognostic (3.72e-3)"	"prognostic favorable (1.15e-5)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.52e-2)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.41e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.27e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.71e-2)"	36.1	38.1	52.3	43.3	62.9	31.7	42.8	86.2	61.8	38.7	39.8	47.6	37.5	39.8	45.8	47.2	47.8	37.9	32.4	40.8	49.5	36.7	39.3	48.3	40.2	52.8	59.0	45.2	53.0	39.1	60.2	68.1	44.2	46.5	43.3	52.9	38.4	41.7	45.3	57.1	43.0	43.4	50.5	44.7	46.1	38.1	34.5	62.6	52.2	46.7	38.0	63.5	38.1	47.9	29.4	31.7	16.5	24.8	33.6	31.1	17.0	52.6	36.2	62.1	31.8	33.7	28.4	36.7	36.2	32.0	59.6	44.6	42.7	38.9	70.2	26.6	40.2	35.0	37.8	75.2	42.1	78.6	37.6	36.3	53.2	60.1	56.7	27.6	63.7	35.4	23.1	47.9	41.8	34.3	33.5	42.2	27.7	68.3	39.6	50.4	42.5	46.6	51.7	49.5	50.5	32.4	55.3	49.8	44.6	42.9	39.0	42.4	35.0	49.3	39.1	27.9	47.4	39.1	45.0	38.5	40.0	47.0	32.9	52.0	29.6	36.5	74.3	26.2	64.1	42.4	16.3	19.6	16.5	25.4	24.8	31.1	29.4	26.0	24.6	31.7	21.2	25.9	27.7	7.9	33.6	23.6	22.2	26.8	17.0	52.3	62.9	86.2	61.8	49.5	36.7	59.0	45.2	46.5	62.6	29.8	67.3	58.2	67.5	101.8	36.2	65.0	33.1	64.3	60.3	27.9	27.5	55.0	28.2	39.9	5.6	56.1	37.9	46.7	47.0	69.3	45.5	61.8	39.5	45.1	43.8	35.0	63.7	35.6	47.5	7.8	43.7	40.0	33.7	38.7	45.1	35.8	42.4	31.6	48.4	33.2	37.8	32.3	50.6	50.2	31.1	100.1	61.4	41.7	47.8	60.0
TBC1D10A	"AC004997.C22.2, EPI64, TBC1D10"	ENSG00000099992	"TBC1 domain family member 10A"	Q9BXI6	22	30291990-30327046	"Predicted intracellular proteins"		"GTPase activation, Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"monocytes: 126.2;Syncytiotrophoblasts: 97.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA007725, HPA008142, HPA076041"	Approved		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA007725: AB_2667907, HPA008142: AB_1080209, HPA076041: AB_2686772"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.28e-1)"	"unprognostic (6.40e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.02e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.52e-2)"	13.5	10.7	8.4	14.5	13.4	7.8	14.8	10.5	13.6	16.5	12.0	4.6	17.6	9.3	9.7	16.0	31.5	11.6	13.8	6.4	8.4	6.6	16.0	10.8	14.3	15.6	6.0	6.5	16.2	12.7	8.9	13.0	35.7	8.1	13.6	6.1	17.3	15.0	19.4	4.3	27.1	10.4	10.5	7.0	15.8	10.6	17.5	6.1	19.8	14.6	10.2	22.7	12.7	23.2	13.3	22.3	21.0	23.9	12.9	26.1	17.1	11.1	4.5	1.9	5.9	5.6	7.1	14.6	6.6	9.8	7.7	12.4	5.2	4.4	5.6	6.4	11.5	10.7	11.1	2.8	6.2	4.1	4.2	7.5	1.6	3.8	3.7	14.4	2.2	8.0	9.4	10.2	15.4	2.6	8.2	3.5	12.7	2.9	5.5	5.8	13.6	16.1	4.8	1.1	21.6	5.8	7.2	7.9	5.1	7.7	11.2	3.1	2.5	6.6	10.3	15.2	5.4	8.8	1.4	6.4	14.7	6.6	8.0	3.5	5.4	2.3	5.1	10.2	3.4	8.4	17.0	8.9	21.0	16.5	17.1	18.2	8.4	19.3	16.9	12.8	13.3	26.1	21.3	6.0	12.9	23.9	22.3	16.2	17.1	8.4	13.4	10.5	10.5	8.4	6.6	6.0	6.5	8.1	6.1	6.0	4.3	9.8	37.3	43.7	7.4	2.2	10.2	1.4	7.9	5.2	17.7	49.7	19.9	17.7	5.4	13.2	18.4	0.0	9.1	68.0	28.7	20.3	9.2	6.8	22.9	1.6	10.3	11.6	7.2	4.2	20.1	15.4	25.3	126.2	14.0	26.6	14.6	14.8	8.5	18.7	35.6	38.8	20.6	20.0	12.5	32.4	97.3	27.7	10.0	28.5
TBC1D23	FLJ11046	ENSG00000036054	"TBC1 domain family member 23"	Q9NUY8	3	100261000-100325251	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038151, HPA038152"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038151: AB_10672405, HPA038152: AB_10672620"	"unprognostic (9.23e-3)"	"unprognostic (6.01e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.37e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.18e-2)"	"unprognostic (7.87e-3)"	"unprognostic (6.16e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.32e-1)"	26.2	28.3	13.4	13.2	14.3	20.4	17.8	28.2	18.9	18.0	17.9	13.6	18.2	18.3	19.1	14.3	20.5	13.3	14.4	16.2	12.8	10.6	20.8	23.2	15.8	11.6	17.6	13.8	19.6	18.5	18.3	25.6	33.5	16.8	16.5	16.0	12.2	20.6	10.6	30.9	20.5	29.6	15.5	19.3	18.2	15.2	17.0	18.1	19.1	16.8	15.7	15.1	21.0	16.9	11.5	17.5	22.5	20.1	20.8	15.5	14.8	33.6	6.9	8.1	4.4	15.7	21.3	7.9	20.4	20.5	21.3	25.6	13.8	5.8	8.0	10.0	21.3	12.5	11.4	29.0	12.9	33.4	4.8	7.4	22.0	8.5	8.9	16.0	9.8	17.9	17.2	10.7	11.7	17.2	18.3	11.3	6.4	18.1	12.0	13.6	6.9	7.8	4.8	9.2	11.5	13.3	6.6	17.6	9.5	12.7	7.3	11.6	6.6	10.7	8.2	13.6	10.7	8.9	9.6	11.2	15.1	14.9	7.1	13.0	11.7	12.4	14.5	20.3	9.5	12.8	22.5	16.6	20.6	12.0	19.3	12.6	11.5	11.8	11.1	17.5	10.8	10.9	11.6	11.2	20.8	20.1	7.5	15.5	14.8	13.4	14.3	28.2	18.9	12.8	10.6	17.6	13.8	16.8	18.1	38.7	9.3	9.3	16.1	27.9	16.9	25.0	10.2	20.1	19.4	12.2	13.7	16.8	26.6	23.0	40.2	21.5	17.1	23.3	25.5	16.4	27.8	23.7	28.9	15.3	12.5	33.4	6.9	9.2	15.9	34.7	19.0	16.5	23.6	4.6	15.5	15.1	27.7	11.8	13.4	16.1	29.3	12.9	23.7	18.2	14.7	33.9	55.0	15.9	12.3	20.7
TBC1D2B	KIAA1055	ENSG00000167202	"TBC1 domain family member 2B"	Q9UPU7	15	77984036-78077724	"Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 62.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041833, HPA048174, HPA052663"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA041833: AB_2732494, HPA048174: AB_2680297, HPA052663: AB_2681906"	"unprognostic (3.13e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-3)"	"unprognostic (6.68e-2)"	"unprognostic (3.07e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.19e-2)"	26.0	14.1	9.3	12.0	10.0	11.9	21.4	8.4	8.4	22.8	16.7	8.4	7.3	7.6	20.2	13.0	9.3	18.2	20.0	7.8	7.7	4.3	8.2	18.3	22.7	12.5	8.3	5.6	31.2	16.6	17.7	7.1	28.9	7.2	13.6	10.8	20.7	8.6	14.0	5.0	10.5	14.3	15.5	9.7	19.9	12.6	11.0	7.3	20.4	10.4	5.8	14.4	17.1	18.4	0.4	3.2	3.7	2.1	3.8	4.2	1.3	5.0	4.0	4.9	4.6	34.4	27.5	8.5	11.7	17.7	11.0	12.2	5.1	2.1	7.8	4.7	9.8	6.1	7.4	10.6	12.9	8.4	14.8	8.2	5.0	3.9	3.4	16.3	12.6	7.6	26.7	9.0	7.3	4.9	16.4	12.4	10.2	2.5	5.4	14.2	5.5	4.6	8.2	3.8	3.9	3.9	7.1	22.4	1.7	5.7	19.4	2.6	7.1	10.9	7.4	13.8	4.7	2.4	13.2	15.2	12.1	8.0	3.8	6.1	9.3	9.7	4.2	4.1	17.0	6.3	0.0	2.1	0.9	3.9	1.8	2.2	0.2	2.6	4.2	1.4	0.4	1.9	1.5	3.7	3.8	0.5	3.2	1.5	1.3	9.3	10.0	8.4	8.4	7.7	4.3	8.3	5.6	7.2	7.3	3.0	12.9	9.7	8.0	8.2	9.7	2.4	12.7	2.7	3.4	5.2	5.9	15.3	0.0	6.9	7.4	12.0	10.6	0.0	8.4	6.3	13.9	8.1	9.2	62.2	16.0	14.3	7.0	28.3	28.3	6.1	39.4	18.9	13.5	12.6	17.8	7.2	11.5	10.5	39.6	2.7	10.0	25.8	8.9	5.0	7.2	8.7	23.8	19.5	15.6	7.6
TBK1	NAK	ENSG00000183735	"TANK binding kinase 1"	Q9UHD2	12	64451880-64502108	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Disease mutation, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045797, HPA060211"	Uncertain		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA045797: AB_2679457, HPA060211: AB_2684222"	"unprognostic (4.73e-2)"	"unprognostic (8.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.48e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.54e-2)"	"unprognostic (1.24e-2)"	"prognostic unfavorable (4.20e-6)"	"unprognostic (4.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.26e-2)"	"unprognostic (9.56e-3)"	19.1	23.3	13.7	16.8	17.1	32.3	19.1	17.8	20.5	14.9	18.3	10.0	14.1	18.0	17.0	15.1	15.3	13.8	15.6	11.7	14.7	15.6	15.4	20.8	17.8	18.3	20.2	13.6	15.6	11.1	13.1	27.2	40.6	21.1	16.3	12.9	10.1	15.0	18.3	24.8	12.1	21.4	17.2	18.8	24.6	14.5	27.9	16.9	3.4	13.3	12.6	16.7	18.4	19.6	9.7	8.2	22.5	11.9	16.3	11.8	5.9	13.4	15.4	8.8	12.8	15.8	16.0	19.4	14.7	21.5	13.9	13.2	8.7	8.2	18.8	12.8	15.9	20.1	12.7	11.3	12.4	16.4	17.3	10.8	20.2	11.2	12.0	17.3	20.6	25.2	12.0	11.3	13.9	13.4	24.1	18.5	7.2	15.4	27.4	17.9	16.4	0.6	16.1	17.6	12.3	9.0	9.6	9.8	18.1	15.1	24.4	7.4	10.7	19.4	20.0	14.3	15.3	20.4	15.0	17.1	12.5	12.1	10.0	14.4	17.4	30.2	18.3	15.8	11.4	16.1	22.5	7.3	16.6	11.0	11.9	11.8	9.7	8.0	11.0	8.2	7.6	2.8	7.1	15.1	16.3	10.6	1.9	9.5	5.9	13.7	17.1	17.8	20.5	14.7	15.6	20.2	13.6	21.1	16.9	17.9	15.6	14.7	23.9	9.7	18.4	10.0	7.6	18.7	19.4	21.0	9.8	24.9	10.0	17.0	24.8	24.1	10.7	0.0	20.6	24.3	13.6	35.1	41.6	14.3	18.1	17.5	16.6	16.5	19.0	20.1	17.8	26.2	13.5	27.9	8.0	13.0	14.3	10.2	19.4	11.6	15.8	25.8	17.8	49.9	12.9	13.0	77.5	25.8	9.3	32.4
TBL3	"SAZD, UTP13"	ENSG00000183751	"Transducin beta like 3"	Q12788	16	1972037-1982933	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042562, HPA055695"	Enhanced	Supported	Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA042562: AB_10964911, HPA055695: AB_2682888"	"unprognostic (1.96e-1)"	"unprognostic (5.49e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.67e-1)"	"unprognostic (2.65e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.03e-2)"	"unprognostic (2.14e-2)"	"unprognostic (8.32e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (3.65e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.77e-1)"	8.9	7.9	6.0	9.5	8.3	6.0	5.8	16.3	9.6	6.2	6.8	8.8	6.8	7.7	7.1	6.3	9.4	5.4	6.0	7.5	6.6	6.1	7.2	8.7	6.9	7.2	7.0	7.3	7.7	8.9	10.5	5.5	7.3	5.7	5.7	3.6	5.6	10.5	6.0	18.2	9.5	7.8	5.9	4.8	6.7	9.5	20.5	6.5	9.5	7.2	11.5	9.3	5.1	5.4	8.5	11.2	5.8	12.0	14.8	12.1	8.5	5.6	10.9	3.0	5.9	3.0	2.4	9.8	5.2	3.4	4.5	3.7	13.9	10.8	7.5	12.2	3.9	4.1	15.2	4.8	6.0	2.4	5.5	6.9	4.7	5.5	5.2	3.4	8.1	4.5	2.4	4.6	5.6	3.3	3.6	5.6	4.6	9.5	5.5	2.6	9.0	10.3	4.5	7.1	5.0	4.4	18.1	5.5	12.5	2.2	2.1	7.0	5.4	4.7	12.1	4.4	3.1	9.1	5.5	8.7	6.2	7.4	5.5	10.0	10.1	4.4	11.8	3.6	5.2	7.1	4.8	10.2	5.8	12.1	12.0	10.7	7.5	8.9	11.8	11.2	8.5	11.4	8.6	2.5	14.8	11.7	5.7	9.6	8.5	6.0	8.3	16.3	9.6	6.6	6.1	7.0	7.3	5.7	6.5	3.0	9.8	7.5	13.4	11.6	12.1	14.3	7.6	4.0	10.3	17.4	7.9	22.6	6.6	21.3	84.6	9.2	22.2	0.0	19.4	20.7	8.2	12.3	14.9	12.4	17.7	9.5	13.3	8.6	9.7	53.2	13.8	9.8	6.8	29.7	13.7	16.1	19.6	20.1	10.3	13.0	8.7	25.8	9.9	14.4	17.7	15.9	18.8	10.9	15.4	12.4
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 71.2"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 221.6;Spermatocytes: 178.1;Syncytiotrophoblasts: 204.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	7.1	7.7	10.8	8.9	11.7	19.3	12.2	16.4	16.6	7.3	7.3	5.2	7.8	8.1	7.9	5.6	7.1	8.5	7.4	7.9	15.9	14.2	5.7	8.5	6.6	12.0	10.0	11.8	8.3	6.0	4.7	8.2	9.2	11.1	8.0	9.3	4.6	5.7	9.2	4.4	5.9	7.7	7.2	8.5	7.6	7.2	71.2	8.0	11.7	10.7	5.0	10.2	9.2	12.0	27.8	14.7	43.1	14.9	21.1	30.8	25.3	6.3	7.8	17.9	11.6	13.7	14.2	10.1	12.1	12.8	16.2	21.3	9.1	5.1	19.8	8.3	9.6	18.0	8.4	11.4	13.0	19.6	15.1	14.2	34.8	4.7	10.0	13.9	18.2	13.6	8.7	13.3	18.1	19.6	12.3	15.3	17.5	50.2	13.6	11.5	14.5	15.2	10.9	20.0	9.3	10.2	10.6	10.8	7.6	9.5	5.7	23.3	23.2	7.1	9.4	14.9	15.6	4.3	7.3	13.8	9.3	13.5	20.5	13.2	11.0	11.9	12.9	15.6	11.9	11.1	43.1	13.7	32.7	28.5	13.8	30.8	27.8	24.1	29.9	12.4	25.0	23.4	27.3	31.4	21.1	14.9	14.7	24.6	25.3	10.8	11.7	16.4	16.6	15.9	14.2	10.0	11.8	11.1	8.0	6.0	12.6	23.3	25.8	62.8	20.7	9.2	20.4	12.0	7.9	7.0	17.7	36.2	24.9	25.0	221.6	33.3	12.0	0.0	22.1	57.3	32.7	32.8	40.3	8.9	21.4	14.3	68.1	17.2	16.7	29.8	19.5	20.0	30.4	19.0	22.4	12.3	24.3	21.0	17.3	18.9	9.4	19.4	34.0	178.1	63.9	57.5	204.8	47.3	23.6	36.7
TBRG1	"FLJ14621, NIAM, TB-5"	ENSG00000154144	"Transforming growth factor beta regulator 1"	Q3YBR2	11	124622836-124635398	"Predicted intracellular proteins"	"Cell cycle"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055645, HPA068022"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA055645: AB_2682873, HPA068022: AB_2685942"	"unprognostic (1.64e-2)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.21e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.52e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.83e-1)"	"unprognostic (7.13e-3)"	13.3	16.0	13.8	15.9	24.8	7.9	9.8	10.3	33.1	9.2	10.9	13.6	8.0	18.7	10.2	14.4	11.0	8.8	11.8	8.7	12.8	9.3	12.9	17.5	14.0	17.1	15.3	18.0	9.4	17.2	11.4	12.7	12.2	15.8	12.9	15.3	8.3	12.1	10.7	18.9	16.0	17.3	9.5	12.2	19.0	15.2	7.4	16.5	7.6	13.4	6.6	16.3	10.8	9.3	24.2	17.7	25.5	19.5	11.1	22.6	9.3	4.9	4.1	4.7	4.2	8.6	6.4	4.4	9.6	5.9	3.2	3.4	7.0	4.1	6.2	5.9	6.6	7.7	8.5	5.5	7.1	5.5	4.3	5.1	24.1	2.1	5.6	7.7	11.5	23.1	6.5	12.7	4.4	6.4	4.9	5.3	6.6	9.2	6.2	7.8	2.5	4.9	9.5	5.8	12.2	6.4	3.2	5.7	3.6	5.6	5.3	3.2	4.9	4.3	6.0	5.7	4.7	9.1	6.8	10.0	8.4	2.7	5.3	5.6	4.7	5.4	6.8	4.4	11.0	5.4	20.5	19.5	25.5	20.4	17.6	15.6	22.5	20.9	17.3	11.5	24.2	22.6	18.0	24.9	11.1	15.5	17.7	19.5	9.3	13.8	24.8	10.3	33.1	12.8	9.3	15.3	18.0	15.8	16.5	41.7	50.4	29.8	40.9	41.0	19.1	20.6	35.7	34.8	46.6	22.7	11.8	28.8	44.7	33.4	41.8	42.9	45.1	23.3	41.6	24.3	42.1	68.1	68.3	58.7	32.8	28.6	27.2	28.3	39.1	4.3	35.1	58.3	32.1	33.3	38.1	26.2	46.7	42.1	31.5	48.0	18.7	25.8	39.2	28.1	22.3	42.0	40.4	49.6	30.4	63.5
TBRG4	"Cpr2, FASTKD4, H_TD2522F11.8, KIAA0948"	ENSG00000136270	"Transforming growth factor beta regulator 4"	Q969Z0	7	45100100-45112047	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020582, HPA050430"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA020582: AB_1857804, HPA050430: AB_2681125"	"unprognostic (2.22e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.46e-3)"	"unprognostic (1.41e-2)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (3.15e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.53e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.66e-3)"	"unprognostic (3.91e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.52e-1)"	13.7	16.8	10.8	16.0	15.6	14.9	13.0	12.9	22.1	10.5	20.8	15.6	14.1	21.8	14.2	8.2	20.1	12.8	12.4	26.2	9.8	10.0	20.9	27.7	10.5	17.0	10.6	8.9	15.6	16.9	11.3	10.1	16.2	14.7	13.6	14.1	10.8	14.2	12.4	42.6	16.9	17.8	13.9	9.9	16.2	14.0	22.5	9.5	15.0	13.8	23.7	20.3	14.5	13.3	15.8	20.1	10.9	24.2	9.7	21.0	17.5	13.0	30.4	9.7	21.3	8.8	8.2	19.6	10.6	9.8	20.6	17.1	32.9	18.4	25.0	16.4	10.8	28.5	34.2	22.6	24.2	10.5	12.9	21.1	17.1	19.9	22.4	14.7	19.5	17.7	10.8	22.5	19.6	14.1	7.3	12.6	21.5	47.4	12.6	12.6	22.0	19.8	44.7	30.8	29.3	24.3	17.6	12.5	36.4	12.1	13.4	19.3	18.3	10.8	60.2	20.9	13.2	26.8	32.5	9.8	15.3	18.5	9.3	17.2	22.7	22.6	36.5	14.1	28.1	34.4	7.4	13.3	10.9	18.4	24.2	17.6	15.8	15.4	17.8	20.1	12.3	21.0	19.9	1.0	9.7	20.4	7.5	14.6	17.5	10.8	15.6	12.9	22.1	9.8	10.0	10.6	8.9	14.7	9.5	3.0	18.9	26.9	23.8	31.1	14.5	24.1	15.3	5.3	9.1	19.2	0.0	53.3	36.5	29.7	12.3	11.7	28.7	0.0	16.1	61.7	16.9	15.1	13.9	27.7	30.7	11.1	21.4	10.4	12.6	14.5	15.3	17.8	16.9	45.9	30.0	14.0	25.4	21.0	11.0	36.6	12.9	12.9	19.4	46.1	32.2	25.6	40.0	17.0	44.5	25.9
TCEAL1	"p21, pp21, SIIR, WEX9"	ENSG00000172465	"Transcription elongation factor A like 1"	Q15170	X	103628704-103630953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Leydig cells: 262.6;Peritubular cells: 364.5;Sertoli cells: 148.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057345, HPA060384, HPA076762"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA057345: , HPA060384: AB_2732648, HPA076762: "	"unprognostic (1.98e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.60e-3)"	"unprognostic (6.09e-2)"	"unprognostic (2.03e-2)"	"unprognostic (9.85e-3)"	"unprognostic (6.54e-2)"	"unprognostic (4.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.56e-2)"	"unprognostic (8.76e-2)"	10.5	24.7	23.8	9.1	20.8	4.2	19.5	19.9	45.1	29.6	17.1	5.5	29.7	7.3	45.8	20.2	18.4	32.1	17.6	13.5	27.0	18.6	10.6	7.5	10.1	7.8	12.2	25.3	59.1	9.0	13.5	11.2	8.5	19.9	25.4	8.4	6.1	6.4	40.3	22.4	8.1	8.7	49.2	23.5	9.3	13.3	9.3	13.2	3.1	15.5	10.5	4.7	33.9	24.7	18.3	16.6	11.3	8.4	13.4	14.7	8.2	9.5	9.2	5.2	7.2	22.7	15.7	7.0	13.6	13.7	13.3	14.5	4.0	9.5	4.4	14.1	17.5	20.2	9.6	8.7	7.2	9.9	0.0	10.8	6.0	12.9	7.8	10.2	0.0	9.1	19.2	14.0	10.2	5.7	22.1	13.6	5.1	2.2	2.5	26.6	10.5	5.2	0.1	1.7	8.5	15.0	5.4	16.9	0.0	18.3	9.5	7.2	6.1	13.8	6.6	14.9	4.0	6.1	5.6	10.8	9.7	3.5	22.6	6.9	2.5	7.9	0.1	12.7	0.0	9.6	11.3	8.4	0.5	10.4	5.7	14.7	18.3	9.4	8.6	16.6	16.1	12.5	14.3	0.9	13.4	2.3	13.0	8.0	8.2	23.8	20.8	19.9	45.1	27.0	18.6	12.2	25.3	19.9	13.2	14.9	24.5	11.9	44.6	26.4	19.2	25.8	30.6	56.2	44.3	24.4	2.0	27.4	48.0	19.4	1.6	35.2	7.3	0.0	21.7	28.5	38.1	16.0	25.5	17.1	30.3	20.6	26.5	36.8	17.8	4.2	262.6	22.6	18.6	24.4	13.1	29.3	11.5	18.2	364.5	39.9	12.0	148.8	69.3	3.9	7.5	18.6	6.1	17.1	18.1	10.2
TCERG1	"CA150, TAF2S, Urn1"	ENSG00000113649	"Transcription elongation regulator 1"	O14776	5	146447311-146511961	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064854, HPA069752, HPA069808"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064854: AB_2685370, HPA069752: AB_2686190, HPA069808: AB_2686204"	"unprognostic (2.73e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (5.34e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.38e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.35e-3)"	"prognostic unfavorable (4.70e-11)"	"unprognostic (1.52e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.24e-3)"	15.7	12.1	16.8	20.9	28.1	34.2	16.7	36.3	22.7	14.2	15.3	13.7	10.1	15.3	19.6	13.9	18.6	17.5	14.8	14.5	16.3	12.7	10.7	10.0	14.7	23.8	12.4	19.1	20.5	12.6	14.4	18.5	17.8	17.2	15.0	16.4	13.0	16.1	19.0	34.9	19.0	15.2	17.5	12.7	16.6	16.8	19.5	14.9	21.9	14.7	14.9	23.9	18.7	16.5	6.5	10.5	2.6	11.6	10.5	8.3	5.8	19.4	14.5	22.5	15.3	6.2	9.8	28.3	14.8	12.0	16.5	19.6	23.3	20.8	33.6	11.1	12.0	11.9	17.5	27.1	18.6	25.3	19.8	21.8	22.2	16.3	14.1	6.6	32.7	17.4	6.8	11.0	15.9	17.5	9.2	14.6	28.7	25.8	12.4	12.6	13.9	28.5	18.5	22.2	11.2	16.5	28.0	26.4	22.4	10.4	15.4	14.6	18.0	16.4	17.6	10.8	14.2	18.6	16.5	16.1	14.4	17.0	12.2	22.8	12.9	14.3	45.3	13.5	28.0	16.1	1.0	6.4	2.6	6.7	9.6	7.9	6.5	7.8	8.3	10.5	6.0	8.2	8.1	0.5	10.5	11.6	5.4	6.9	5.8	16.8	28.1	36.3	22.7	16.3	12.7	12.4	19.1	17.2	14.9	50.6	36.7	36.9	37.7	40.0	54.0	32.3	17.8	40.2	43.3	22.7	58.9	41.0	1.7	22.8	2.2	28.7	13.8	23.3	28.9	50.1	36.0	30.8	35.9	16.6	26.8	33.4	27.1	23.9	27.2	4.1	26.4	26.8	23.6	23.4	32.9	21.2	32.4	24.6	23.0	5.5	36.8	19.4	33.0	77.9	60.0	40.0	36.7	24.9	41.3	51.5
TCF3	"bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, VDIR"	ENSG00000071564	"Transcription factor 3"	P15923	19	1609290-1652605	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Daudi: 76.6;REH: 76.2;U-698: 96.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018351, HPA049808, HPA062476"	Approved		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"CAB018351: AB_675504, HPA049808: AB_2680892, HPA062476: AB_2684775"	"unprognostic (8.82e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.91e-2)"	"unprognostic (8.25e-3)"	"prognostic unfavorable (2.46e-4)"	"unprognostic (2.07e-2)"	"unprognostic (7.99e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.29e-3)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (4.87e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.07e-1)"	"unprognostic (8.05e-2)"	13.0	8.8	12.8	31.6	9.8	33.2	17.4	8.3	11.9	15.5	16.2	11.9	9.4	18.1	16.6	11.3	16.7	12.1	19.0	9.4	11.2	6.2	11.9	8.9	13.2	42.0	10.7	6.0	18.2	13.5	6.3	13.9	10.8	11.0	17.1	9.7	12.4	13.6	6.9	11.2	16.7	23.0	8.8	10.4	33.1	14.9	36.0	11.2	63.2	15.9	11.6	38.0	15.2	13.9	11.3	12.1	2.9	2.8	2.3	4.2	1.6	15.9	8.2	22.6	20.3	3.2	8.6	10.1	9.9	7.8	11.4	10.1	16.2	12.6	76.6	11.3	8.1	2.1	16.6	13.8	10.8	6.7	46.4	9.2	7.2	10.3	17.6	7.4	17.6	10.1	5.5	12.5	8.9	6.9	10.2	13.7	28.5	29.6	26.6	7.2	28.2	48.6	17.1	31.4	9.7	8.6	76.2	10.4	17.3	7.7	14.1	21.6	30.3	9.4	9.3	11.5	8.8	11.8	31.4	16.4	15.0	17.8	18.5	16.9	64.8	31.6	96.6	9.8	22.5	13.4	2.9	1.3	0.9	3.5	1.4	3.7	10.8	2.2	3.2	2.7	11.3	3.2	4.2	0.4	2.3	2.8	12.1	2.1	1.6	12.8	9.8	8.3	11.9	11.2	6.2	10.7	6.0	11.0	11.2	6.0	7.8	26.7	4.5	12.4	10.7	8.9	2.5	0.0	10.3	1.8	25.5	3.4	1.7	9.4	6.7	9.5	13.5	0.0	5.9	7.4	11.5	8.0	6.9	3.9	6.7	4.8	15.5	8.6	7.2	3.9	12.7	6.5	10.1	5.4	13.0	9.0	14.7	14.0	9.6	4.5	13.6	19.4	10.5	3.7	15.8	11.5	2.4	8.6	18.4	6.7
TCF7	TCF-1	ENSG00000081059	"Transcription factor 7"	P36402	5	134114711-134151865	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"lymphoid tissue: 326.1"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 68.7;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 10.3;memory CD4 T-cell: 17.8;memory CD8 T-cell: 10.4;naive CD4 T-cell: 35.8;naive CD8 T-cell: 21.8;NK-cell: 14.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 14.2;T-cells: 35.8"	"Cell line enriched"	"Detected in many"	6	"MOLT-4: 170.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB019403, HPA058863, HPA070505"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB019403: AB_2199302, HPA058863: AB_2683837, HPA070505: AB_2686275"	"unprognostic (3.63e-3)"	"unprognostic (1.98e-3)"	"unprognostic (1.03e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.70e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.10e-2)"	1.8	3.6	1.3	21.8	1.5	5.2	3.1	0.9	1.2	2.1	3.3	2.5	2.2	5.6	1.4	16.3	2.7	16.1	2.6	1.6	1.5	1.2	2.7	3.7	4.0	41.8	1.3	1.0	2.5	7.2	0.2	6.1	1.4	4.7	2.9	2.3	3.6	7.9	1.8	0.9	2.9	15.1	0.9	3.3	14.4	3.7	2.4	1.1	326.1	4.4	2.2	32.5	3.3	1.5	1.2	0.1	1.0	0.1	14.2	35.8	6.9	0.0	1.0	1.1	3.9	0.5	2.1	1.5	0.3	0.5	0.1	0.1	8.0	2.5	0.0	1.9	1.7	4.3	0.1	1.7	0.4	0.0	0.3	1.7	0.0	1.1	6.0	0.0	0.0	0.2	0.1	0.0	1.6	0.0	0.7	0.2	29.0	1.0	0.0	0.1	0.0	170.0	0.1	1.2	2.5	1.4	0.2	0.0	0.1	0.4	0.1	0.4	3.4	0.8	0.2	0.2	0.9	0.2	0.9	0.2	11.0	0.0	5.0	0.3	0.1	0.0	0.0	5.8	0.0	0.5	0.7	0.1	1.0	4.4	0.0	10.3	1.2	17.8	10.4	0.0	0.4	35.8	21.8	0.7	14.2	0.0	0.1	2.1	6.9	1.3	1.5	0.9	1.2	1.5	1.2	1.3	1.0	4.7	1.1	3.0	3.4	22.9	24.6	14.0	27.8	2.7	10.2	1.4	0.0	3.5	68.7	20.0	0.0	5.8	2.4	4.7	21.4	0.0	8.9	23.4	10.8	11.6	20.7	3.2	6.4	9.5	12.1	6.7	5.2	1.7	5.8	4.9	10.1	9.0	12.7	8.3	15.8	17.3	4.2	0.8	53.0	0.0	16.9	3.9	9.4	9.9	25.1	47.5	14.4	12.3
TCL1A	TCL1	ENSG00000100721	"T cell leukemia/lymphoma 1A"	P56279	14	95709967-95714196	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"blood: 179.4;lymphoid tissue: 63.7"	"Group enriched"	"Detected in some"	5	"B-cells: 166.3;Spermatogonia: 48.5"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 64.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	381	"memory B-cell: 45.6;naive B-cell: 179.4;plasmacytoid DC: 79.8"	"Group enriched"	"Detected in many"	487	"B-cells: 179.4;dendritic cells: 79.8"	"Group enriched"	"Detected in some"	157	"Daudi: 71.1;REH: 92.4;U-698: 94.4"					"Not detected"	"Not detected"			"CAB004045, HPA016604"	Enhanced		Enhanced	"Nucleoplasm,Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	Nucleoplasm	"CAB004045: AB_2179419, HPA016604: AB_1857859"	"unprognostic (1.27e-3)"	"unprognostic (3.12e-4)"	"unprognostic (2.61e-4)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.75e-4)"	"unprognostic (7.70e-2)"	"unprognostic (9.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.06e-1)"	"unprognostic (4.55e-1)"	0.4	0.2	0.2	53.4	0.2	4.8	0.3	0.2	0.2	0.2	0.9	0.0	0.2	0.0	0.3	0.0	0.8	0.3	0.6	0.3	0.2	0.2	1.1	0.4	3.2	63.7	0.2	0.0	0.3	0.2	0.0	0.2	0.6	0.0	0.4	0.2	0.1	2.9	0.0	0.2	0.2	10.4	0.1	0.2	33.5	0.5	5.3	0.0	4.7	0.8	1.2	53.6	3.6	0.3	179.4	79.8	0.2	0.1	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.0	0.0	0.5	94.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	45.6	0.0	0.0	0.1	179.4	0.1	0.0	0.2	0.0	0.1	79.8	0.0	6.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	2.2	166.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	20.6	48.5	0.0	0.0	0.0	0.0	0.0
TCOF1	"TCS, treacle"	ENSG00000070814	"Treacle ribosome biogenesis factor 1"	Q13428	5	150357639-150400308	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033199, HPA038237, HPA038238"	Enhanced		Enhanced	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"CAB033199: AB_1130042, HPA038237: AB_10670660, HPA038238: AB_10671524"	"unprognostic (7.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.18e-3)"	"unprognostic (9.40e-3)"	"unprognostic (2.13e-1)"	"prognostic unfavorable (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.62e-5)"	"unprognostic (1.21e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-1)"	15.9	11.7	15.0	21.2	17.5	17.8	13.1	16.6	23.6	12.6	18.1	12.5	10.3	10.7	18.3	13.6	16.8	14.4	12.9	18.0	14.3	12.0	11.7	9.6	12.4	24.2	20.3	17.7	16.7	14.5	16.4	13.9	15.0	17.0	15.2	13.3	10.2	15.0	17.0	19.1	18.6	14.4	17.4	12.6	19.4	14.0	14.7	18.1	25.8	13.6	12.0	23.1	18.0	15.5	5.9	3.0	1.9	2.8	11.5	7.0	3.7	21.6	24.2	12.4	23.4	4.8	6.4	33.8	17.1	6.9	23.3	23.6	59.9	17.2	31.8	15.6	6.2	27.4	25.4	27.1	30.6	17.1	16.7	29.2	15.5	16.1	22.7	5.1	25.6	12.0	5.3	7.1	27.6	21.2	5.9	10.3	17.1	22.2	9.6	8.0	19.8	27.8	18.9	37.6	10.0	23.3	25.3	19.7	18.4	5.7	15.4	17.1	17.5	19.8	32.4	15.6	20.7	14.5	10.2	10.0	17.6	21.9	21.0	32.0	12.0	14.9	35.0	13.9	22.1	15.7	1.8	2.8	1.4	5.6	2.7	7.0	5.8	5.1	5.3	2.7	5.9	4.3	4.6	1.9	11.5	2.7	3.0	3.3	3.7	15.0	17.5	16.6	23.6	14.3	12.0	20.3	17.7	17.0	18.1	8.9	24.8	38.9	15.0	35.5	25.7	15.8	10.2	9.4	9.1	10.4	39.3	13.9	5.0	17.0	7.4	17.5	9.8	0.0	20.1	33.1	18.4	11.9	23.1	10.4	25.7	20.6	18.0	12.3	15.9	4.1	17.5	26.9	11.8	17.2	15.6	9.4	14.0	8.6	14.9	5.1	23.3	25.8	20.6	24.9	30.6	34.3	7.4	26.7	21.0	16.0
TDRD3	FLJ21007	ENSG00000083544	"Tudor domain containing 3"	Q9H7E2	13	60396457-60573878	"Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"granulocytes: 143.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034925, HPA067153"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034925: AB_2240523, HPA067153: AB_2732759"	"unprognostic (8.52e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (2.77e-4)"	"unprognostic (5.21e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.37e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.62e-2)"	"unprognostic (9.95e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.27e-3)"	13.7	12.0	13.0	10.3	14.7	6.9	16.9	13.8	14.2	16.7	17.2	11.7	14.2	12.9	15.2	14.2	16.5	14.4	12.7	16.7	12.9	10.6	16.2	13.5	16.9	11.3	13.5	14.8	20.6	21.3	15.3	15.4	12.4	17.7	15.5	15.5	11.1	12.5	14.8	42.4	15.2	16.7	19.0	16.8	12.9	14.8	15.9	15.0	18.7	16.9	18.6	12.1	19.0	15.4	3.8	7.2	2.3	3.5	3.0	6.9	2.1	4.4	4.9	10.9	25.4	4.4	9.5	6.5	5.1	5.8	6.0	3.9	3.2	7.4	10.9	2.1	7.5	5.1	6.3	8.9	7.5	6.5	8.2	6.8	20.3	9.4	6.2	8.5	14.2	10.6	6.4	10.7	3.5	10.6	12.5	8.1	9.0	4.5	6.7	6.5	4.8	12.7	7.4	8.3	16.1	3.8	6.8	5.3	7.2	8.2	5.9	9.7	11.6	7.4	9.0	18.5	7.8	4.6	6.2	6.8	3.8	3.9	4.3	5.6	13.3	11.5	9.4	3.6	7.4	11.7	0.5	2.3	2.3	5.5	3.5	3.8	3.8	6.2	6.2	3.3	2.7	5.2	6.4	0.1	3.0	2.5	7.2	6.9	2.1	13.0	14.7	13.8	14.2	12.9	10.6	13.5	14.8	17.7	15.0	20.8	28.8	13.4	9.0	7.0	29.0	40.4	5.1	33.5	25.0	10.4	51.1	7.3	18.3	11.5	16.8	12.8	9.3	0.0	15.4	8.8	8.3	6.1	143.8	7.2	6.3	19.1	16.7	8.0	9.4	17.0	17.5	11.6	18.6	8.2	13.8	13.4	9.6	15.3	17.3	9.9	28.8	6.5	7.5	33.9	15.5	5.8	5.6	13.8	13.8	6.3
TEAD1	"AA, TCF13, TEF-1"	ENSG00000187079	"TEA domain transcription factor 1"	P28347	11	12674591-12944483	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057339, HPA062471"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA057339: AB_2683413, HPA062471: AB_2684773"	"unprognostic (1.00e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.84e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.40e-3)"	"unprognostic (8.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.14e-1)"	"unprognostic (2.18e-2)"	16.3	6.6	8.2	6.7	6.6	0.0	23.5	7.8	7.7	13.6	12.6	7.3	9.5	4.1	14.1	7.9	16.4	11.4	10.9	16.5	10.6	4.2	13.1	8.4	8.2	1.9	8.0	4.9	12.1	8.6	25.2	18.5	17.5	7.9	13.9	6.7	11.9	8.8	10.4	41.4	7.5	7.3	21.4	7.2	4.1	9.1	5.9	8.2	0.2	9.6	12.8	5.0	22.2	20.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	22.0	21.9	16.7	19.4	18.4	19.2	28.7	30.4	23.3	23.5	21.9	20.4	19.4	0.1	8.3	36.0	10.4	12.7	19.2	11.4	36.9	0.0	7.5	0.0	36.9	6.3	17.3	0.0	1.7	16.5	5.8	17.1	21.4	18.3	4.7	1.4	9.7	0.0	33.0	4.2	0.0	0.1	6.2	4.5	8.7	0.1	22.6	10.8	15.4	14.1	9.2	10.9	32.1	14.9	18.7	23.6	7.3	1.4	10.4	34.2	27.3	28.1	20.6	3.2	6.6	4.0	13.4	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	6.6	7.8	7.7	10.6	4.2	8.0	4.9	7.9	8.2	83.4	14.2	0.8	28.4	88.3	12.7	55.4	33.1	56.2	40.9	47.1	11.8	18.1	1.7	14.0	5.7	23.3	7.0	0.0	10.9	45.4	42.9	45.8	0.0	35.5	3.2	1.6	44.9	20.9	2.4	5.6	21.9	2.5	23.6	0.0	10.4	29.8	25.0	7.0	22.6	24.5	18.8	6.5	34.0	3.2	26.9	47.9	10.3	0.0	8.7	49.8
TEAD2	"ETF, TEF-4, TEF4"	ENSG00000074219	"TEA domain transcription factor 2"	Q15562	19	49340595-49362457	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 45.7;Early spermatids: 59.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 4.1;naive B-cell: 5.2"	"Lineage enriched"	"Detected in single"	27	"B-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"AF22: 42.8;AN3-CA: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066292, HPA069963"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA066292: AB_2685651, HPA069963: AB_2686222"	"unprognostic (2.69e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.58e-3)"	"unprognostic (4.39e-1)"	"prognostic unfavorable (8.66e-4)"	"unprognostic (2.91e-1)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.78e-2)"	17.6	8.1	4.5	9.3	4.3	0.0	19.5	2.1	3.4	21.7	21.6	3.9	11.6	3.9	20.2	12.4	12.8	14.4	12.8	25.6	4.1	1.5	11.3	18.3	19.9	8.7	5.6	1.8	25.2	18.1	4.9	4.5	10.5	5.2	19.0	6.3	19.0	10.0	13.6	6.1	4.8	8.1	21.8	7.5	11.8	14.7	10.9	3.2	1.8	9.5	8.9	5.1	16.3	26.4	5.2	0.0	0.0	0.1	0.0	0.1	0.1	3.7	8.8	42.8	46.3	4.6	6.8	7.6	7.0	7.5	8.1	9.5	0.7	2.1	0.3	9.4	11.9	4.1	4.3	11.7	2.4	4.5	0.0	5.4	0.0	8.4	5.8	8.0	0.0	0.1	8.0	5.6	5.5	2.7	16.1	28.8	0.0	6.5	0.0	11.3	4.7	0.0	0.0	14.4	10.8	11.3	0.0	12.9	0.0	7.4	0.0	0.0	26.0	11.8	1.7	3.1	15.3	12.7	1.0	16.9	14.7	9.1	3.1	0.5	0.0	0.0	1.4	0.5	0.1	5.7	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.5	4.3	2.1	3.4	4.1	1.5	5.6	1.8	5.2	3.2	3.0	2.7	0.0	5.0	3.0	0.0	0.8	7.6	1.4	3.4	12.2	0.0	0.7	1.7	45.7	59.6	26.5	0.0	0.0	22.7	19.4	13.2	6.2	0.0	2.0	0.6	0.0	6.8	18.4	1.2	22.0	14.1	0.6	5.0	0.0	4.5	7.8	25.8	3.5	20.8	0.0	0.4	32.3	24.5	2.5	1.5	1.4	1.0	0.0	5.2	2.4
TEFM	"C17orf42, FLJ22729"	ENSG00000172171	"Transcription elongation factor, mitochondrial"	Q96QE5	17	30897336-30906820	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023788, HPA053044"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"HPA023788: AB_1848818, HPA053044: AB_2682023"	"unprognostic (1.22e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.11e-3)"	"unprognostic (3.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (9.20e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (8.64e-4)"	"unprognostic (2.11e-1)"	"unprognostic (6.18e-3)"	"unprognostic (9.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.37e-3)"	7.0	9.6	11.8	10.2	13.7	4.0	11.1	23.3	16.6	7.5	8.1	7.4	7.2	10.6	8.6	9.6	9.7	7.6	6.8	12.7	10.1	6.9	13.0	12.3	6.9	10.0	15.4	8.5	10.5	7.3	10.8	16.8	10.4	10.6	10.6	10.3	8.6	7.9	10.4	7.7	8.5	9.1	9.6	11.0	13.7	7.4	5.7	13.3	8.6	10.7	6.7	9.8	7.9	11.8	6.7	6.4	4.9	10.0	4.3	6.7	4.8	6.1	9.9	5.9	7.4	4.6	6.0	5.1	6.1	5.1	13.7	11.4	6.5	2.9	7.9	6.0	4.5	7.2	8.7	10.9	4.4	11.9	2.5	13.6	3.8	9.9	6.5	4.9	6.9	4.9	4.5	5.2	7.8	3.0	3.7	5.8	5.5	8.5	7.1	9.0	4.4	5.9	10.1	4.4	7.1	5.1	3.1	10.4	6.2	10.2	5.8	10.1	3.0	5.5	4.4	5.2	5.7	9.9	4.7	4.0	5.3	6.3	6.0	5.8	3.4	5.7	5.5	4.2	5.7	5.2	3.5	6.6	4.9	4.6	10.0	5.8	6.7	5.6	4.2	6.4	6.4	6.7	6.6	1.9	4.3	7.3	5.8	5.7	4.8	11.8	13.7	23.3	16.6	10.1	6.9	15.4	8.5	10.6	13.3	14.9	11.7	4.2	7.2	3.7	18.6	4.4	10.2	17.4	9.1	8.7	7.9	22.7	21.6	11.8	8.8	6.8	5.1	0.0	7.5	14.1	6.6	4.6	4.7	9.0	17.4	15.9	5.2	12.3	9.1	4.4	7.5	10.2	6.8	14.4	6.2	17.1	10.5	5.8	7.1	13.4	18.2	19.4	8.4	23.6	17.0	3.8	14.9	5.4	7.3	3.5
TERF2	"TRBF2, TRF2"	ENSG00000132604	"Telomeric repeat binding factor 2"	Q15554	16	69355561-69408571	"Predicted intracellular proteins"	"Cell cycle"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001907, HPA002735, CAB010451"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"CAB010451: AB_2201333, HPA001907: AB_1080246, HPA002735: AB_1857898"	"unprognostic (2.61e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.13e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.45e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (5.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	15.6	14.9	22.1	18.2	24.4	16.1	14.1	32.2	30.0	16.2	15.2	20.0	13.3	13.4	19.2	16.4	15.3	16.1	14.0	14.7	21.2	22.1	13.2	14.9	12.6	32.6	19.6	21.6	20.5	22.2	26.9	13.4	15.8	17.1	15.5	15.0	14.5	12.0	15.3	28.9	15.3	13.6	19.6	17.3	14.9	12.6	15.8	16.5	23.0	16.9	9.6	42.2	17.2	21.5	15.2	5.4	11.2	4.1	4.9	7.5	2.9	8.2	13.5	12.2	12.2	11.6	8.6	10.4	8.4	10.6	20.1	15.6	12.2	11.3	37.9	11.5	10.3	7.2	13.4	14.8	10.3	18.9	7.1	11.7	10.9	7.1	11.1	9.9	10.8	9.2	8.8	10.5	16.0	19.6	9.0	13.8	15.1	20.6	5.5	12.9	11.2	21.4	13.9	14.0	9.1	6.5	30.0	8.1	21.8	8.6	6.1	13.8	10.8	28.0	6.4	7.5	11.5	12.1	12.6	8.4	12.6	11.1	8.6	10.0	14.8	15.4	47.8	10.9	9.8	12.1	11.2	4.1	4.5	6.8	3.4	5.1	15.2	6.8	5.9	4.1	8.7	7.5	7.5	4.7	4.9	3.5	5.4	5.2	2.9	22.1	24.4	32.2	30.0	21.2	22.1	19.6	21.6	17.1	16.5	14.9	12.2	20.8	10.2	11.1	23.2	13.5	10.2	8.1	4.5	8.7	17.7	6.7	1.7	4.5	25.7	16.5	10.2	0.0	6.6	6.5	8.5	11.9	13.9	16.6	10.3	42.9	9.8	14.7	15.4	16.2	8.6	10.1	3.3	2.8	10.0	17.6	7.0	7.0	13.4	7.0	12.8	19.4	10.8	7.7	12.0	11.3	7.0	8.7	10.0	11.2
TES	"DKFZP586B2022, TESS-2, TESTIN"	ENSG00000135269	"Testin LIM domain protein"	Q9UGI8	7	116210493-116258783	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 226.3;Early spermatids: 327.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 51.4;hTCEpi: 58.1;SK-BR-3: 58.3"					"Low region specificity"	"Detected in single"			"HPA015269, HPA018123"	Approved		Supported	"Plasma membrane,Cell Junctions,Focal adhesion sites,Cytosol"		NA	NA			"Focal adhesion sites, Cytosol"	"Plasma membrane, Cell Junctions"	"HPA015269: AB_1857899, HPA018123: AB_1857900"	"unprognostic (9.81e-2)"	"unprognostic (5.53e-3)"	"unprognostic (4.79e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.01e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.84e-3)"	"unprognostic (4.81e-3)"	"unprognostic (8.81e-3)"	"unprognostic (6.19e-3)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.60e-2)"	"prognostic favorable (8.71e-5)"	"unprognostic (1.50e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.86e-1)"	12.1	2.9	1.2	36.4	1.5	8.6	22.1	0.8	1.2	42.4	53.1	1.5	43.9	9.3	47.6	21.2	22.6	19.5	15.3	7.9	1.6	1.4	14.3	4.6	16.8	20.3	1.9	0.7	17.1	12.3	3.1	4.2	21.2	3.3	26.1	16.8	5.0	19.0	50.9	5.2	9.1	27.4	84.5	3.0	19.1	25.2	18.4	0.7	17.1	26.3	11.2	18.4	71.6	33.9	26.8	21.9	56.8	39.6	49.0	40.5	34.7	24.4	5.2	5.9	0.0	2.6	6.7	13.8	12.8	6.2	2.4	2.3	12.9	27.3	0.0	51.4	8.9	0.3	25.2	3.1	18.8	5.9	12.1	10.1	2.4	12.1	6.3	15.7	11.1	0.0	14.9	58.1	8.3	21.1	16.6	6.7	0.0	2.5	8.6	0.6	5.0	0.0	0.1	3.9	28.4	14.9	0.0	0.0	9.6	24.2	9.4	2.7	25.5	18.7	58.3	14.1	17.9	0.0	4.5	11.3	0.1	0.3	18.9	0.1	20.5	9.9	0.2	1.6	5.7	19.4	56.8	20.2	53.4	40.5	32.6	39.0	26.8	31.0	36.6	21.9	23.8	31.0	35.0	10.5	49.0	39.6	5.4	31.5	34.7	1.2	1.5	0.8	1.2	1.6	1.4	1.9	0.7	3.3	0.7	226.3	36.4	52.3	147.2	177.9	2.3	14.5	38.2	84.3	97.8	34.9	11.8	16.7	18.3	104.8	327.4	24.0	101.5	0.0	97.9	69.1	27.0	83.0	17.4	9.9	14.9	1.6	48.4	15.4	52.9	82.2	1.7	62.3	27.0	36.1	57.8	23.0	142.2	58.6	0.4	10.3	12.6	6.5	20.6	18.2	9.7	107.3	24.4	57.4	44.4	125.3
TESK2		ENSG00000070759	"Testis-specific kinase 2"	Q96S53	1	45343883-45491166	"Enzymes, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 13.1;RT4: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027257, HPA063869"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027257: AB_10602477, HPA063869: AB_2685137"	"unprognostic (2.95e-1)"	"prognostic favorable (2.22e-4)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (1.87e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.01e-1)"	5.5	3.3	6.1	5.9	17.4	12.6	9.6	7.8	12.6	7.7	8.4	25.7	4.0	11.9	4.7	5.7	9.1	4.1	3.9	5.8	9.6	5.1	3.5	9.7	5.5	6.0	19.2	4.7	14.4	4.6	6.7	4.1	8.3	13.2	22.1	10.1	7.6	11.2	5.7	10.1	17.1	14.8	4.4	18.7	6.3	5.6	11.7	14.8	4.2	5.1	3.2	7.2	8.2	9.7	7.5	2.0	15.9	5.9	1.1	3.7	2.6	1.6	0.0	0.8	0.0	3.2	1.7	13.1	0.6	4.3	1.9	3.2	3.6	1.5	5.3	0.6	1.6	4.9	2.0	3.4	2.7	1.5	3.7	4.3	3.6	1.8	2.7	1.7	1.2	9.9	1.8	2.9	2.1	3.0	2.9	1.5	7.1	0.6	10.9	1.3	0.6	3.0	2.4	3.4	1.5	1.5	4.4	0.1	1.4	1.7	12.8	0.3	1.4	3.4	6.4	12.2	8.1	10.0	1.5	0.0	0.2	2.0	1.6	1.1	7.2	4.2	1.0	1.0	0.0	0.8	9.4	3.8	10.6	2.4	2.8	1.7	7.5	2.2	1.6	2.0	5.7	3.7	2.1	15.9	1.1	5.9	1.1	1.5	2.6	6.1	17.4	7.8	12.6	9.6	5.1	19.2	4.7	13.2	14.8	0.0	3.2	2.4	6.5	6.9	2.3	1.1	5.1	1.4	3.4	0.0	13.7	6.5	0.0	1.0	18.1	2.9	12.4	0.0	2.3	2.5	2.2	12.9	6.9	5.5	5.9	0.0	4.1	1.3	4.6	5.2	2.6	4.5	3.3	2.8	5.3	1.1	1.0	7.4	1.8	0.6	2.8	6.5	4.7	26.8	5.7	7.4	12.4	4.4	4.9	7.3
TFAM	"TCF6, TCF6L2"	ENSG00000108064	"Transcription factor A, mitochondrial"	Q00059	10	58385022-58399221	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 617.4;Late spermatids: 619.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA040648, HPA063684"	Supported		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA040648: AB_10795635, HPA063684: AB_2685089"	"unprognostic (5.30e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.34e-3)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.10e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.24e-2)"	"prognostic favorable (2.74e-4)"	"unprognostic (1.99e-2)"	"unprognostic (5.39e-2)"	"prognostic favorable (2.22e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.76e-2)"	19.3	21.2	11.1	21.0	12.1	28.5	15.3	15.4	13.9	16.8	21.0	7.7	12.5	17.6	20.7	12.1	17.4	15.3	11.0	15.9	10.2	11.2	22.4	31.4	11.5	21.5	12.5	10.7	18.4	14.3	12.3	23.9	22.2	12.9	17.2	14.7	9.2	16.3	10.6	21.7	10.2	18.7	16.1	10.8	21.0	14.5	40.2	11.6	35.4	22.2	14.8	18.4	16.6	11.8	13.1	14.1	7.2	9.5	14.3	13.1	6.8	21.5	12.3	13.9	14.4	4.1	5.1	15.9	9.8	9.8	12.3	13.8	43.3	23.2	43.0	14.4	4.5	9.3	16.9	25.4	13.8	19.6	18.3	22.6	16.3	9.4	16.1	6.4	41.2	13.4	5.1	6.4	15.0	13.8	5.9	10.6	12.9	38.4	19.9	8.6	11.8	32.6	16.2	26.3	9.9	12.9	26.0	30.0	19.3	7.6	14.6	18.6	12.8	19.6	27.4	24.1	11.9	29.7	12.3	8.1	9.2	29.4	10.5	26.3	20.2	30.8	54.2	11.8	31.8	6.9	1.0	9.5	3.7	8.5	9.0	11.0	12.2	10.3	8.9	11.5	13.1	13.1	10.4	7.2	14.3	7.2	14.1	8.5	6.8	11.1	12.1	15.4	13.9	10.2	11.2	12.5	10.7	12.9	11.6	50.6	24.7	36.3	36.6	44.5	22.3	31.1	43.3	37.5	61.4	19.2	15.7	83.2	74.6	32.4	617.4	32.7	10.6	23.3	38.6	59.4	34.2	33.1	27.8	54.6	37.5	36.5	14.9	23.9	17.8	619.6	38.3	33.8	21.9	26.2	34.1	37.2	30.5	21.0	29.0	61.4	19.4	25.8	30.9	42.9	56.9	47.8	43.8	30.2	47.6	24.4
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 130.5;retina: 48.1"	"Cell type enhanced"	"Detected in many"	17	"Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Cell type enriched"	"Detected in single"	10	"myeloid DC: 1.0"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6"	"Region enhanced"	"Detected in single"		"cerebellum: 4.3"	"Region enhanced"	"Detected in single"		"cerebellum: 8.6"	"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.4	0.3	0.3	0.0	0.3	0.0	19.0	2.2	0.5	4.4	0.8	0.0	18.7	0.2	0.5	17.8	18.3	0.4	1.7	0.7	0.3	0.2	6.4	0.2	0.5	0.1	0.2	0.2	0.3	0.3	0.0	0.4	130.5	0.6	5.8	0.2	48.1	19.4	26.7	0.2	36.0	0.4	0.1	0.4	0.2	0.7	1.6	0.0	0.1	0.4	16.6	9.9	2.4	9.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	16.3	6.3	0.0	28.0	0.1	0.0	6.0	12.1	9.3	9.9	9.8	0.6	6.1	0.9	1.6	3.5	5.7	17.5	1.5	20.7	9.5	31.3	15.8	0.1	14.8	0.0	0.0	0.4	0.4	0.0	30.2	0.0	22.0	5.6	0.0	0.3	0.9	0.0	0.1	3.6	0.0	5.1	0.1	1.0	7.8	1.7	1.5	0.6	5.6	6.6	4.1	0.1	14.9	26.2	23.8	31.6	17.3	0.5	0.0	3.0	0.8	2.1	7.6	0.0	1.4	0.2	1.6	0.5	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.3	0.3	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	37.5	116.1	3.1	2.2	0.0	8.1	15.9	29.6	2.0	245.7	6.6	2.0	4.6	0.8	0.0	0.0	0.3	224.5	5.3	38.8	0.0	0.0	17.7	76.3	1.2	0.0	0.0	2.1	0.6	0.2	118.1	0.0	0.5	2.4	2.2	0.0	0.0	0.2	4.2	0.0	2.1	3.9	11.8	120.9	585.5	0.0	0.4	39.3
TFB2M	"FLJ22661, FLJ23182, Hkp1"	ENSG00000162851	"Transcription factor B2, mitochondrial"	Q9H5Q4	1	246540560-246566324	"Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028482, HPA028554, HPA030265"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA028482: AB_2672633, HPA028554: AB_2732441, HPA030265: AB_10696209"	"unprognostic (4.38e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.79e-3)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.13e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.68e-2)"	"unprognostic (2.46e-1)"	"unprognostic (6.81e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.44e-2)"	"unprognostic (6.41e-2)"	"unprognostic (3.53e-2)"	10.6	23.1	4.2	7.2	8.4	15.5	9.0	8.4	9.9	7.0	8.9	6.5	9.4	8.2	9.5	7.2	9.5	6.9	8.5	11.3	4.3	5.5	15.5	42.3	5.9	8.7	4.8	5.7	6.5	19.7	5.6	7.8	10.5	7.6	8.9	9.6	5.9	13.6	8.9	21.4	8.7	10.3	6.8	6.5	9.0	9.6	8.7	5.7	13.0	15.6	7.3	12.0	9.1	6.5	10.6	11.0	1.2	7.5	12.6	10.4	4.5	12.6	12.2	4.7	8.4	5.9	8.5	16.6	9.3	9.6	10.6	9.8	14.8	12.3	22.7	14.6	9.4	6.9	11.0	11.4	9.9	14.7	8.8	4.4	11.5	7.5	13.0	9.8	20.2	10.4	8.4	11.9	9.1	10.3	5.8	8.2	8.1	33.1	7.8	9.1	5.9	10.2	9.1	21.1	22.2	12.5	10.2	9.4	27.5	9.6	14.0	10.5	21.3	9.0	16.4	30.8	5.5	11.9	19.5	6.0	7.4	9.0	10.4	24.3	22.6	37.7	17.9	9.1	20.0	9.3	0.2	4.7	1.2	8.4	4.8	10.4	10.6	7.5	8.8	11.0	10.4	9.6	8.2	1.0	12.6	7.5	9.5	10.3	4.5	4.2	8.4	8.4	9.9	4.3	5.5	4.8	5.7	7.6	5.7	6.0	6.5	9.3	11.9	47.4	3.0	15.1	2.5	8.1	17.0	15.7	9.8	20.8	24.9	11.2	1.0	11.7	6.8	0.0	13.3	23.0	10.8	10.8	13.9	32.0	10.9	0.0	10.9	6.2	9.7	1.9	6.1	7.6	5.0	5.4	12.1	4.5	9.1	8.6	4.2	28.3	3.6	12.9	16.0	7.2	22.3	39.3	17.6	8.7	19.0	9.2
TGIF2		ENSG00000118707	"TGFB induced factor homeobox 2"	Q9GZN2	20	36573488-36593950	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053786, HPA064522"			Enhanced	Nucleoplasm,Centrosome		NA	NA			Nucleoplasm	Centrosome	"HPA053786: AB_2682261, HPA064522: "	"unprognostic (1.42e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.10e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.19e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (3.75e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.14e-2)"	14.0	6.1	2.8	20.0	3.1	4.1	7.8	1.3	3.5	13.7	8.8	4.0	3.5	3.2	23.7	7.9	6.8	18.0	10.2	7.6	2.7	2.5	9.2	13.2	13.7	16.6	4.4	1.6	17.9	33.3	10.5	3.4	9.1	3.9	9.3	3.7	12.1	14.9	5.7	4.1	5.6	8.1	13.7	3.2	20.3	7.0	16.9	2.8	26.7	12.9	6.9	22.1	10.0	7.2	8.2	7.7	14.7	5.4	4.2	7.6	3.8	7.0	1.7	20.3	23.0	3.0	2.7	7.4	4.0	4.7	9.7	7.3	10.4	9.0	19.0	10.7	3.9	4.4	7.3	16.5	10.5	9.5	8.9	5.9	23.8	4.1	13.7	4.6	10.0	5.8	4.3	7.0	2.0	7.6	8.8	9.6	9.2	11.4	11.7	4.7	10.0	17.0	19.2	17.0	10.3	5.1	14.7	24.3	10.3	6.4	4.7	6.1	18.1	1.3	10.8	10.1	17.0	12.9	22.5	6.9	1.5	6.4	0.1	7.6	13.4	5.0	17.9	0.1	12.1	7.6	14.7	5.4	1.7	4.8	4.9	5.2	8.2	4.4	4.9	7.4	6.5	7.6	6.3	2.2	4.2	3.4	7.7	4.2	3.8	2.8	3.1	1.3	3.5	2.7	2.5	4.4	1.6	3.9	2.8	8.9	9.1	6.5	26.2	39.6	0.1	11.2	12.7	5.3	9.1	7.0	2.0	5.2	6.6	16.4	2.0	14.3	0.0	0.0	6.7	1.0	16.9	15.0	16.1	5.9	8.7	0.0	6.3	11.6	7.0	1.9	5.8	8.8	13.5	7.2	2.6	7.2	13.3	6.2	7.1	6.1	1.9	6.5	15.6	2.3	25.6	22.2	7.6	12.8	3.3	13.9
TGOLN2	"TGN38, TGN46, TGN48, TGN51, TTGN2"	ENSG00000152291	"Trans-golgi network protein 2"	O43493	2	85318020-85328425	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB011489, HPA012609, HPA012723"	Enhanced		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA		9800000	"Golgi apparatus"	Nucleoplasm	"CAB011489: AB_443302, HPA012609: AB_1857976, HPA012723: AB_1857975"	"unprognostic (3.03e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.50e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.52e-2)"	"unprognostic (5.19e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.37e-2)"	40.0	40.7	34.3	38.4	38.0	55.6	36.5	51.7	43.1	33.3	50.0	38.7	31.5	53.2	41.2	31.1	23.9	33.3	44.9	43.2	31.9	34.4	59.6	66.2	44.1	37.4	35.4	36.7	36.1	34.4	39.5	21.8	50.4	35.8	34.0	50.1	26.9	38.9	36.5	23.7	23.7	63.1	36.0	40.3	47.1	36.8	22.3	33.2	31.8	44.8	17.0	37.7	39.9	32.9	9.4	14.9	34.2	34.1	8.6	12.3	22.7	11.3	29.4	12.5	16.5	30.2	31.7	29.2	34.6	40.4	23.5	18.9	24.5	34.5	14.3	27.4	47.8	32.3	18.6	9.0	16.9	39.1	23.3	9.0	20.4	10.4	26.3	16.4	39.5	47.4	23.4	10.8	30.4	18.4	36.6	34.0	12.1	11.8	23.5	34.7	10.3	12.7	20.1	11.1	25.4	12.0	13.5	46.0	10.5	25.3	17.9	11.8	9.8	30.2	22.8	20.0	15.4	12.7	17.8	36.0	50.5	18.8	38.1	41.4	15.3	19.7	13.9	37.4	30.7	32.9	17.6	27.5	23.5	12.3	26.9	9.6	9.4	9.2	8.3	14.9	9.1	9.6	9.1	34.2	8.6	34.1	5.6	7.2	22.7	34.3	38.0	51.7	43.1	31.9	34.4	35.4	36.7	35.8	33.2	95.3	89.8	56.6	49.3	34.0	49.1	62.0	180.9	111.1	77.3	171.0	37.3	50.3	8.3	79.9	4.7	71.6	170.0	0.0	81.2	69.6	67.3	78.0	151.6	221.1	103.3	197.0	86.0	81.6	146.0	5.6	45.8	116.6	57.3	39.7	94.6	52.5	79.1	98.9	65.0	89.4	34.5	64.7	48.7	22.3	32.7	30.6	37.3	74.8	88.0	60.7
THAP8	FLJ32891	ENSG00000161277	"THAP domain containing 8"	Q8NA92	19	36034985-36054762	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 19.3;Spermatogonia: 19.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA064056, HPA070139"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064056: AB_2685184, HPA070139: AB_2686230"	"unprognostic (1.33e-3)"	"unprognostic (2.24e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (9.01e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.50e-1)"	"unprognostic (2.10e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.48e-1)"	4.6	5.3	9.1	3.9	10.3	1.3	3.3	6.0	8.7	5.7	11.2	10.1	3.9	4.9	6.4	6.3	5.2	6.8	6.5	4.8	6.5	6.6	5.4	5.6	4.6	4.3	8.5	8.1	6.3	3.4	5.6	6.1	6.4	9.9	5.6	4.1	3.6	5.7	7.5	12.7	8.5	5.0	7.5	9.0	5.0	4.8	15.8	13.3	10.1	5.2	2.6	3.5	7.8	5.0	5.9	6.2	10.4	9.3	7.0	8.4	5.3	2.5	7.9	3.9	3.3	10.5	6.6	2.8	2.3	4.1	4.6	7.6	3.5	2.0	3.8	8.1	3.6	4.7	1.3	2.3	2.9	1.7	2.9	1.9	2.4	2.0	4.0	12.0	1.1	2.3	5.5	4.5	3.1	1.8	5.5	2.3	7.4	2.2	4.7	4.7	4.9	3.1	3.1	3.6	4.8	2.9	3.0	1.3	3.6	3.9	2.4	6.9	5.2	4.0	3.3	2.4	5.5	3.5	1.7	1.5	6.5	4.2	3.4	1.8	3.9	3.3	2.7	6.9	2.3	3.9	10.4	8.6	9.5	7.2	9.3	8.1	5.9	7.5	7.2	6.2	4.9	6.1	8.4	4.0	7.0	8.0	6.2	7.0	5.3	9.1	10.3	6.0	8.7	6.5	6.6	8.5	8.1	9.9	13.3	3.0	3.0	2.7	1.0	1.0	2.1	3.1	5.1	0.0	2.3	7.0	2.0	9.3	1.7	4.0	1.8	1.6	2.6	0.0	0.5	4.0	3.3	0.9	5.7	2.9	13.5	3.2	6.3	2.5	5.1	3.9	1.7	1.8	1.7	5.4	1.3	4.3	3.7	1.5	3.9	7.4	2.2	0.0	2.5	19.3	19.8	1.9	8.8	3.2	2.3	1.0
THOC1	"HPR1, P84"	ENSG00000079134	"THO complex 1"	Q96FV9	18	214520-268050	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, mRNA processing, mRNA splicing, mRNA transport, Transcription, Transcription regulation, Transport"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 57.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019096, HPA019687"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA019096: AB_1857979, HPA019687: AB_1857980"	"prognostic favorable (8.43e-4)"	"unprognostic (2.06e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.83e-5)"	"unprognostic (6.74e-3)"	"unprognostic (2.49e-3)"	"prognostic favorable (2.89e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (1.80e-6)"	"unprognostic (2.03e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.42e-1)"	"prognostic favorable (9.62e-4)"	11.9	9.1	11.8	12.5	14.5	10.7	7.7	19.0	12.5	10.5	10.7	12.3	10.9	10.4	15.5	8.1	13.4	8.2	7.7	8.5	10.9	9.9	11.6	16.5	7.1	17.6	18.1	7.6	9.9	8.1	11.1	23.3	9.6	11.5	8.4	8.7	8.9	10.4	7.6	12.1	9.1	9.4	10.8	14.2	12.8	9.6	26.3	17.7	16.2	9.2	7.8	17.8	14.6	7.8	11.7	11.0	9.1	9.7	9.7	14.2	6.4	12.7	6.9	16.1	13.5	10.2	7.4	20.0	7.0	7.0	15.3	16.0	14.2	8.3	18.2	5.9	9.8	23.0	8.4	20.8	11.7	18.9	5.8	9.0	11.0	9.1	9.5	8.1	25.0	10.2	4.9	7.2	16.3	10.6	6.6	16.3	16.0	24.9	8.7	13.2	9.6	18.2	14.2	15.9	16.5	10.2	25.6	15.5	16.6	8.4	12.5	10.9	8.2	19.7	10.2	11.7	19.2	6.9	17.8	8.2	13.7	14.7	10.9	23.2	7.1	12.2	26.7	11.6	17.3	11.7	9.1	6.7	5.7	9.5	9.7	14.2	11.7	11.6	12.0	11.0	9.5	13.6	13.3	0.7	9.7	7.8	6.5	11.4	6.4	11.8	14.5	19.0	12.5	10.9	9.9	18.1	7.6	11.5	17.7	17.9	9.4	6.2	13.1	11.4	30.6	7.8	2.5	9.4	18.2	10.4	19.6	20.5	13.3	14.2	47.4	13.4	4.5	0.0	7.0	13.3	10.4	10.2	26.5	10.5	13.7	27.0	9.1	7.4	6.3	5.6	17.8	13.1	3.3	10.8	7.1	13.8	10.7	8.7	15.9	6.8	25.5	6.5	11.3	57.7	26.8	8.0	15.7	17.9	13.2	10.8
THOC3	"MGC5469, TEX1"	ENSG00000051596	"THO complex 3"	Q96J01	5	175917873-176034680	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 41.4"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 149.1;Spermatocytes: 102.0"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042764, HPA044009, HPA045071"	Approved		Enhanced	Nucleoplasm,Vesicles		No	No			Nucleoplasm	Vesicles	"HPA042764: AB_10965055, HPA044009: AB_10959603, HPA045071: AB_10959461"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.85e-3)"	"unprognostic (6.48e-3)"	"unprognostic (8.60e-2)"	"unprognostic (3.57e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.80e-3)"	"unprognostic (3.20e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.91e-1)"	2.3	3.5	8.5	2.3	5.8	8.3	6.0	12.5	6.4	4.7	7.3			3.0	3.4	20.0	21.5	4.0	1.6	1.7	8.5	3.2	4.4	6.0	2.8	7.3	2.6		5.3	3.4	0.4	3.7	4.5		3.8	5.9		5.5	4.1	2.6	7.2	4.1	3.0	2.0	4.3	4.5	11.9			5.1		12.5	5.1	7.6	24.0	13.9	4.7	10.5	12.6	41.4	19.2	22.3	12.5	13.3	29.1	12.8	11.5	48.6	13.5	12.6	29.9	34.8	17.7	18.3	29.2	19.6	7.7	32.3	19.3	20.2	57.5	31.6	20.0	29.5	15.7	12.4	19.2	4.2	25.7	14.2	9.7	24.5	25.7	13.0	6.7	16.4	27.5	23.8	13.2	18.8	26.9	17.3	15.8	11.4	22.3	45.8	30.2	16.9	30.4	21.3	16.8	25.8	14.9	28.0	13.7	13.8	20.2	15.6	23.6	12.5	10.3	11.8	15.9	24.1	6.6	11.6	17.5	7.7	25.0	8.0	4.4	9.0	4.7	13.7	10.5	16.5	16.5	28.3	16.8	13.9	24.0	34.9	21.9	1.3	12.6	9.4	12.9	41.4	19.2											11.9	7.5	18.0	23.9	39.5	12.1	3.1	7.6	8.1	5.7	24.4	9.8	43.8	34.9	21.6	149.1	14.1	7.8	46.7	16.8	69.7	17.4	13.6	11.5	19.0	21.6	6.4	16.1	16.5	9.9	84.4	13.6	13.4	8.5	15.4	15.9	7.8	19.7	7.0	18.0	35.5	10.9	19.4	18.4	102.0	45.3	35.8	16.7	23.5	28.5	21.7
THRAP3	"BCLAF2, TRAP150"	ENSG00000054118	"Thyroid hormone receptor associated protein 3"	Q9Y2W1	1	36224416-36305357	"Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012041, CAB017472, HPA063765"	Supported		Enhanced	"Nuclear speckles"		NA	NA		22000	"Nuclear speckles"		"CAB017472: AB_2271759, HPA012041: AB_1857983, HPA063765: AB_2685117"	"unprognostic (8.53e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (5.36e-4)"	"unprognostic (7.56e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.23e-1)"	33.9	30.5	19.8	27.2	28.5	26.8	27.0	30.7	33.7	25.5	26.6	28.4	24.8	20.2	30.2	23.6	29.7	25.1	21.5	28.1	19.7	20.2	25.2	37.1	24.6	32.4	21.2	20.1	29.6	24.8	38.6	32.6	35.6	28.5	32.1	24.1	26.3	27.4	23.7	79.1	27.0	29.3	27.6	20.7	32.6	26.5	23.8	22.2	57.4	29.0	28.6	38.8	27.4	26.1	36.2	23.1	49.3	24.0	25.2	29.8	22.2	31.3	20.3	35.0	29.8	28.0	22.8	29.3	33.8	34.1	34.1	35.2	23.8	28.9	58.5	12.8	34.8	24.1	29.1	39.0	32.8	42.7	30.1	21.9	48.5	31.4	25.1	30.5	49.2	32.7	34.9	20.7	34.6	29.4	23.5	37.4	35.5	40.1	30.4	24.4	17.8	52.9	27.3	41.4	19.5	16.0	50.7	41.5	31.2	24.4	44.5	22.2	26.5	38.6	25.0	28.0	35.4	23.1	21.1	39.4	28.4	33.0	26.4	35.4	18.2	32.0	53.2	26.7	33.7	29.5	36.6	20.1	36.7	29.8	24.0	25.2	32.2	25.3	26.0	22.7	36.2	26.8	23.3	49.3	25.2	23.8	23.1	21.3	22.2	19.8	28.5	30.7	33.7	19.7	20.2	21.2	20.1	28.5	22.2	107.2	81.4	114.8	82.1	50.5	89.2	98.7	56.0	99.0	85.3	45.4	29.5	126.9	82.9	123.3	5.3	83.5	50.1	46.7	91.4	130.0	82.0	97.4	88.1	63.2	88.9	82.6	69.5	65.1	67.8	7.8	74.2	78.2	69.2	174.1	63.3	132.3	90.9	52.6	78.5	58.7	85.1	90.5	82.4	132.9	116.0	59.8	120.5	106.5	79.1	64.3
THUMPD3	DKFZP434F091	ENSG00000134077	"THUMP domain containing 3"	Q9BV44	3	9362842-9386791	"Predicted intracellular proteins"		"Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 224.3;Spermatocytes: 126.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036170, HPA036171"	Approved		Enhanced	Nucleoli,Cytosol		No	No			Cytosol	Nucleoli	"HPA036170: AB_10671836, HPA036171: AB_2674985"	"unprognostic (2.13e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.25e-7)"	"unprognostic (6.54e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.19e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.59e-2)"	17.4	17.2	13.3	12.9	14.8	22.2	14.2	13.4	19.6	15.2	14.4	13.8	12.5	12.8	14.0	15.8	16.5	12.3	10.9	19.3	12.3	13.9	20.7	23.9	11.1	13.5	18.3	11.0	14.3	14.8	22.2	27.8	14.4	23.2	15.9	15.1	14.0	16.1	14.9	29.4	13.4	14.9	12.3	15.8	14.5	12.5	42.8	14.8	22.3	18.2	17.5	13.2	16.2	11.7	13.9	15.4	12.5	19.3	11.7	22.3	10.1	12.8	17.5	12.2	6.4	16.1	15.6	49.2	15.7	12.9	16.0	12.2	13.1	13.6	13.2	12.3	14.2	25.6	8.5	22.3	16.0	16.3	14.7	13.0	16.5	17.7	11.4	15.8	21.0	12.0	12.5	18.2	18.9	19.7	13.0	10.5	21.5	25.9	19.2	21.1	18.2	24.8	9.0	23.5	14.4	17.0	15.8	21.0	18.8	10.5	19.5	5.1	16.5	13.0	9.4	13.9	13.2	15.1	13.6	7.4	15.4	13.3	18.5	17.2	24.6	57.2	42.5	18.7	19.7	22.0	10.6	13.2	12.5	16.2	17.4	21.1	12.3	14.1	16.8	15.0	13.9	22.3	16.8	2.7	11.7	19.3	15.4	13.2	10.1	13.3	14.8	13.4	19.6	12.3	13.9	18.3	11.0	23.2	14.8	23.8	17.9	6.7	21.7	9.5	20.8	43.1	20.4	16.0	29.6	21.0	15.7	29.0	44.7	33.1	224.3	13.1	8.7	0.0	25.5	25.1	18.7	25.5	26.7	23.1	24.1	36.5	2.9	11.6	15.1	105.0	19.0	17.7	11.8	17.2	15.2	28.6	27.1	3.5	24.4	25.2	34.6	6.5	13.4	126.9	51.4	11.3	23.0	15.2	18.8	18.0
TIAM1		ENSG00000156299	"T cell lymphoma invasion and metastasis 1"	Q13009	21	31118416-31559977	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 110.1"	"Cell type enhanced"	"Detected in many"	7	"Basal keratinocytes: 74.4;Horizontal cells: 69.9;Suprabasal keratinocytes: 125.3;Urothelial cells: 72.7"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	8	"cerebellum: 110.1"	"Group enriched"	"Detected in many"	5	"classical monocyte: 10.7;intermediate monocyte: 9.6;memory CD4 T-cell: 8.3;myeloid DC: 5.9;naive CD4 T-cell: 10.9;NK-cell: 6.9;non-classical monocyte: 12.4;T-reg: 16.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.4;HEL: 18.7;HMC-1: 16.4;RT4: 19.4;SCLC-21H: 18.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 574.6"	"CAB010416, HPA034853"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cell Junctions,Cytokinetic bridge,Cytosol"		NA	NA			"Nucleoplasm, Cell Junctions"	"Nuclear membrane, Cytokinetic bridge, Cytosol"	"CAB010416: AB_2240410, HPA034853: "	"unprognostic (9.59e-2)"	"unprognostic (7.44e-3)"	"unprognostic (5.64e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.73e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.70e-3)"	"unprognostic (7.97e-3)"	"unprognostic (9.52e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	3.3	11.4	13.4	5.3	12.4	2.1	4.4	110.1	15.1	10.1	2.2	9.7	0.5	1.5	7.9	3.0	18.9	9.4	4.0	2.1	11.6	7.0	1.7	3.7	4.1	8.8	6.2	7.9	1.5	1.9	0.3	4.2	4.4	8.9	3.7	2.8	7.0	2.2	3.1	0.7	20.4	1.7	10.0	6.4	4.2	2.1	5.9	7.1	6.2	1.3	5.3	9.3	8.1	5.0	0.1	5.9	0.6	12.4	6.9	16.8	3.6	1.5	0.5	12.1	0.7	0.2	2.8	19.4	0.0	0.0	1.5	0.5	0.1	2.2	4.1	0.8	0.3	2.2	2.8	1.4	2.4	2.4	0.3	6.7	18.7	0.3	0.1	0.3	0.0	16.4	1.2	0.8	8.2	3.3	1.4	0.0	6.2	0.0	6.1	6.1	7.9	2.8	0.1	3.9	2.9	5.2	3.7	3.8	0.0	1.8	19.4	18.3	4.5	0.8	6.3	0.7	4.4	2.6	0.0	0.1	1.7	7.1	0.0	0.8	6.9	5.1	3.7	4.0	1.4	13.4	0.6	10.7	0.0	0.3	9.6	2.1	0.1	8.3	1.6	5.9	0.0	10.9	0.6	0.6	6.9	12.4	0.3	16.8	3.6	13.4	12.4	110.1	14.4	11.6	7.0	6.2	7.9	8.9	7.1	3.0	2.9	0.8	40.5	74.4	1.2	1.1	2.5	0.0	18.2	0.0	2.0	7.6	0.0	1.5	10.0	15.8	0.0	0.0	0.6	25.1	7.6	16.1	23.1	3.6	8.2	69.9	5.2	50.3	22.7	9.0	31.9	28.4	10.1	18.0	0.3	39.3	1.1	10.7	54.8	0.0	4.4	6.5	2.1	1.4	6.1	125.3	8.9	6.9	0.9	72.7
TIMM10	"TIM10, TIM10A, TIMM10A"	ENSG00000134809	"Translocase of inner mitochondrial membrane 10"	P62072	11	57528463-57530803	"Predicted intracellular proteins"	"Protein transport, Translocation, Transport"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039946	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA039946: AB_10673023"	"unprognostic (9.34e-3)"	"unprognostic (1.16e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.01e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.40e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.96e-2)"	"unprognostic (9.87e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.15e-2)"	22.2	19.5	29.1	16.7	28.5	18.3	27.4	14.8	34.3	16.6	21.6	17.1	25.9	16.8	13.7	29.1	20.2	16.0	15.4	25.2	25.1	22.7	26.7	41.3	13.1	25.1	27.2	24.6	13.0	25.8	18.3	14.3	13.8	19.9	14.4	23.1	15.8	23.8	20.2	32.3	15.3	12.4	17.2	21.0	20.1	15.9	20.5	16.1	18.4	18.5	25.9	29.8	13.6	12.1	45.1	38.8	5.9	22.6	16.5	33.4	32.4	27.1	41.5	19.5	18.7	17.0	14.5	24.7	23.3	18.8	37.3	21.3	30.5	23.9	51.8	26.9	20.7	32.6	20.9	27.7	27.1	33.8	17.6	20.5	32.8	15.9	39.3	18.0	43.0	37.1	13.6	22.0	36.1	25.2	9.9	23.0	34.6	36.3	23.7	27.3	57.9	23.1	57.6	20.5	23.7	44.7	38.9	41.2	45.2	18.9	18.9	15.9	20.4	24.6	49.1	29.8	20.1	36.7	16.5	14.4	21.5	40.3	36.9	44.7	33.2	43.4	41.7	19.9	21.7	35.8	5.9	22.6	5.0	19.9	21.4	22.8	45.1	24.5	21.9	38.7	41.9	33.4	29.1	1.3	16.5	19.8	38.8	21.3	32.4	29.1	28.5	14.8	34.3	25.1	22.7	27.2	24.6	19.9	16.1	11.9	8.3	59.6	36.7	109.2	16.9	112.2	84.1	14.7	31.8	41.8	3.9	61.1	179.1	67.1	101.9	57.3	85.0	70.0	108.7	85.9	56.1	50.4	51.9	191.0	112.4	7.9	25.9	41.1	52.6	211.2	42.8	77.1	77.6	106.4	36.8	30.6	73.4	48.9	48.1	130.8	11.8	12.9	87.7	92.4	50.6	113.3	33.1	41.5	65.1	45.8
TIMM17A	"TIM17, TIM17A"	ENSG00000134375	"Translocase of inner mitochondrial membrane 17A"	Q99595	1	201955491-201970661	"Cancer-related genes, Predicted membrane proteins"	"Protein transport, Translocation, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA010083	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA010083: AB_10602899"	"prognostic unfavorable (1.98e-5)"	"unprognostic (3.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.80e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.15e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.54e-3)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.45e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.81e-1)"	16.6	27.6	22.7	18.7	23.2	16.9	16.8	16.3	29.3	16.5	19.3	9.9	19.2	17.2	15.0	24.1	17.9	11.8	10.7	39.0	32.3	19.6	25.1	53.7	13.5	15.3	20.6	27.0	11.2	18.7	21.5	14.8	17.4	25.0	14.5	21.8	11.7	24.8	17.1	42.1	11.5	13.0	19.6	13.4	14.4	16.3	13.7	14.2	11.3	21.6	30.4	18.9	15.9	12.7	17.6	28.9	16.0	24.9	15.9	20.6	17.8	26.4	27.0	24.5	29.3	20.7	21.7	41.4	42.3	30.3	34.8	31.3	31.6	27.6	36.7	15.6	36.2	25.5	21.2	44.9	25.3	37.5	26.9	28.1	20.2	35.9	29.9	21.4	43.1	21.8	25.0	28.2	35.5	29.8	25.1	36.3	23.2	51.0	20.6	40.8	16.9	23.1	23.4	31.1	26.7	14.6	22.9	28.5	46.0	42.7	25.2	37.0	26.2	25.9	66.4	39.1	32.5	36.7	29.3	29.0	23.3	24.7	27.0	43.9	31.3	33.7	30.8	24.8	32.9	25.9	8.9	19.0	16.0	13.6	24.9	17.5	17.6	14.9	17.2	28.9	12.7	14.2	16.7	4.4	15.9	24.7	19.3	20.6	17.8	22.7	23.2	16.3	29.3	32.3	19.6	20.6	27.0	25.0	14.2	35.7	37.0	55.2	74.7	81.9	22.9	117.0	40.8	46.8	42.1	36.6	33.4	102.6	116.0	97.2	44.4	41.4	33.9	0.0	74.9	170.0	67.6	57.0	54.3	165.4	105.8	33.4	32.6	35.6	45.4	26.9	31.1	72.6	50.6	99.2	41.2	32.7	83.8	23.0	36.0	93.3	25.4	25.8	62.2	38.1	50.8	86.4	222.1	56.4	49.3	91.8
TIMM44	TIM44	ENSG00000104980	"Translocase of inner mitochondrial membrane 44"	O43615	19	7926718-7943920	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043052, HPA073108"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA043052: AB_10795713, HPA073108: "	"unprognostic (1.75e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (8.81e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.80e-2)"	"unprognostic (6.01e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.18e-2)"	12.8	15.3	11.8	13.0	12.4	7.5	12.7	16.2	17.2	10.8	15.3	8.5	14.1	16.1	12.1	11.8	19.4	10.8	12.6	39.2	12.9	10.3	13.5	19.7	9.0	9.2	11.7	7.7	13.8	20.2	7.4	10.3	8.9	12.3	10.8	6.3	8.5	17.3	21.4	48.8	12.6	10.5	17.7	9.0	12.2	12.2	9.4	11.6	5.8	12.5	26.6	8.8	13.0	9.4	9.0	16.2	10.1	12.2	9.6	12.1	8.4	18.5	10.8	5.8	10.2	10.1	9.4	8.5	11.2	9.1	15.5	14.1	23.8	4.0	27.2	12.9	9.3	12.4	13.0	23.8	12.5	3.9	12.7	36.2	13.6	9.2	20.0	24.8	16.3	5.7	11.0	16.1	13.2	16.4	5.3	9.8	17.5	25.0	9.7	6.7	18.8	14.2	10.7	16.8	17.9	46.0	15.0	8.3	12.7	6.8	12.0	13.9	7.2	9.9	13.5	31.7	5.2	8.3	15.9	5.2	7.4	11.6	18.7	21.1	19.1	24.0	26.4	5.2	23.7	12.5	10.1	11.7	3.7	12.1	12.2	10.7	8.7	11.1	11.2	16.2	9.0	10.7	10.4	0.6	9.6	7.2	13.2	9.4	8.4	11.8	12.4	16.2	17.2	12.9	10.3	11.7	7.7	12.3	11.6	32.8	13.1	36.5	29.5	24.7	51.6	31.9	30.6	10.7	12.5	27.9	39.3	33.9	56.3	37.7	8.0	22.3	35.7	0.0	36.8	32.1	23.8	24.1	32.3	52.9	31.0	49.3	38.5	21.5	16.7	9.9	33.9	18.0	20.3	11.8	35.3	22.0	38.9	24.6	27.6	29.0	55.4	32.3	29.2	35.1	33.3	17.3	27.2	20.3	48.5	25.1
TIMMDC1	"C3orf1, FLJ22597"	ENSG00000113845	"Translocase of inner mitochondrial membrane domain containing 1"	Q9NPL8	3	119498532-119525090	"Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053214, HPA055846"	Uncertain		Enhanced	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA053214: AB_2682081, HPA055846: AB_2682941"	"unprognostic (3.95e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (9.60e-2)"	"unprognostic (6.25e-2)"	"unprognostic (3.39e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.05e-1)"	"unprognostic (3.87e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.05e-1)"	13.6	17.2	18.1	10.4	16.7	5.9	13.8	8.6	16.2	16.4	12.2	20.4	21.5	9.2	13.3	19.4	18.5	13.6	14.9	43.9	15.9	15.4	22.8	20.5	13.0	15.9	20.9	11.9	11.8	12.5	20.4	17.4	21.4	16.4	15.2	14.5	14.0	14.3	21.6	37.2	16.0	15.3	12.7	21.9	14.3	12.3	13.3	15.6	9.9	19.9	20.3	14.5	16.7	11.1	12.4	13.8	16.3	15.5	8.5	15.8	15.5	14.3	13.5	6.7	5.8	26.2	17.7	15.2	4.2	14.1	12.2	14.0	9.1	8.8	10.5	7.3	14.8	8.4	6.8	16.9	13.7	20.0	8.8	6.1	7.7	6.3	10.2	13.8	6.0	5.1	15.5	21.1	9.8	12.8	7.8	17.2	9.9	10.5	10.1	22.4	17.8	6.3	12.7	9.0	12.1	16.8	5.3	4.7	13.8	18.3	7.2	8.9	16.6	4.3	6.6	16.1	9.5	10.8	16.5	8.6	6.9	5.2	6.3	7.3	6.5	6.1	14.3	11.7	15.3	10.8	6.8	13.8	16.3	8.4	13.0	10.1	12.2	8.3	10.3	13.8	12.4	10.4	9.0	3.4	8.5	15.5	11.9	15.8	15.5	18.1	16.7	8.6	16.2	15.9	15.4	20.9	11.9	16.4	15.6	23.8	35.3	16.0	40.6	33.3	24.2	144.4	40.8	61.6	37.5	38.4	13.7	129.0	127.6	61.0	5.3	55.2	40.2	23.3	54.8	92.7	41.0	35.4	40.4	45.5	75.0	20.6	27.6	31.3	30.4	5.2	43.7	39.7	42.2	83.0	41.1	57.9	47.3	40.1	51.2	112.8	25.9	71.1	52.6	99.3	50.0	36.8	148.4	31.6	44.9	43.4
TINF2	TIN2	ENSG00000092330	"TERF1 interacting nuclear factor 2"	Q9BSI4	14	24239643-24242674	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"parathyroid gland: 268.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059061, HPA069807"			Enhanced	"Nuclear bodies"	"Intracellular and membrane"	NA	NA			"Nuclear bodies"		"HPA059061: AB_2683895, HPA069807: AB_2686203"	"prognostic favorable (4.96e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.75e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.70e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.71e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.04e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.44e-2)"	15.8	27.8	10.4	17.0	11.3	13.3	18.2	10.1	16.7	14.5	13.1	17.9	12.9	9.5	16.8	16.1	22.4	12.6	13.7	12.4	9.3	8.9	14.8	11.4	18.8	27.0	13.7	9.8	15.4	17.1	268.9	11.9	15.3	10.9	13.5	12.5	11.3	14.8	15.5	14.9	13.9	12.9	15.1	11.7	21.0	14.5	7.7	12.4	26.1	16.6	12.6	19.5	14.9	14.2	27.3	17.7	46.9	21.4	25.4	27.4	28.8	11.8	10.8	15.7	8.2	17.4	13.0	8.0	12.2	15.5	17.9	16.8	4.7	13.4	17.4	7.0	17.2	12.9	11.6	8.8	10.8	11.3	22.1	4.5	10.9	10.0	18.6	15.0	11.5	15.7	14.2	17.6	14.4	13.7	16.8	19.3	16.7	4.2	22.3	14.4	13.0	17.2	5.7	3.6	12.6	13.5	14.2	10.0	12.6	15.9	17.0	9.7	9.0	12.7	12.1	10.9	10.9	8.6	7.4	15.4	8.4	10.3	14.2	9.5	17.2	12.2	9.9	10.1	6.5	12.4	41.6	20.6	46.9	27.4	21.4	21.8	25.7	21.6	25.5	17.7	27.3	22.8	22.8	26.0	25.4	19.6	15.0	25.2	28.8	10.4	11.3	10.1	16.7	9.3	8.9	13.7	9.8	10.9	12.4	14.9	26.0	52.5	56.3	14.9	21.3	12.1	5.1	4.0	25.0	17.4	7.9	26.9	29.9	28.2	6.3	25.4	18.8	0.0	41.1	22.6	22.4	33.0	39.3	16.3	32.0	14.3	12.6	20.3	21.3	7.8	21.9	28.3	20.3	43.3	15.6	37.8	31.0	23.0	28.0	18.7	15.9	25.8	31.1	21.2	20.9	22.0	35.4	55.8	15.2	48.8
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	15.9	21.1	24.1	17.9	42.4	18.0	16.6	17.4	32.4	17.4	18.4	59.9	14.1	22.3	23.1	12.4	13.2	18.7	14.9	18.5	22.4	11.2	14.8	16.3	15.9	20.8	45.2	18.3	31.4	22.6	17.4	17.0	16.4	25.2	21.2	10.6	17.6	21.1	19.9	28.4	15.5	19.3	17.2	25.3	22.2	17.0	18.7	46.7	14.4	21.2	9.0	16.0	18.0	15.8	10.2	7.6	15.2	10.7	6.6	12.9	8.7	21.1	8.4	14.8	22.1	12.0	11.3	16.4	13.5	14.5	14.4	15.7	12.6	9.3	11.8	10.3	12.4	13.8	18.8	12.3	16.1	9.3	20.2	19.1	15.0	14.7	13.7	14.5	15.2	21.8	12.9	21.8	17.9	15.8	11.4	9.4	15.4	12.8	22.4	12.7	11.8	14.8	25.3	12.9	36.4	12.9	17.9	9.7	12.6	8.8	11.7	9.8	13.6	11.5	7.1	17.7	9.6	12.6	30.0	8.2	19.4	15.0	16.0	19.9	16.5	13.5	21.1	8.4	17.5	16.3	15.2	9.6	7.2	10.4	10.7	12.9	9.1	8.4	8.8	7.2	10.2	9.6	10.3	5.3	6.6	9.1	7.6	4.8	8.7	24.1	42.4	17.4	32.4	22.4	11.2	45.2	18.3	25.2	46.7	11.9	10.1	7.5	13.4	6.6	9.5	6.7	10.2	5.3	4.5	12.2	27.5	17.0	3.3	7.2	0.9	9.0	6.7	0.0	7.1	14.3	9.9	11.3	14.9	6.7	8.6	7.9	10.9	4.9	5.3	1.1	9.8	8.2	5.0	8.2	7.4	8.2	8.0	6.8	12.0	4.5	14.4	6.5	9.2	11.7	11.9	3.1	15.7	7.1	6.2	7.4
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968865	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	22.1	11.7	27.5	9.2	32.8	2.2	18.0	12.0	36.3	24.8	16.9	37.5	10.7	10.9	29.5	27.6	45.7	22.9	18.2	26.0	28.3	19.1	20.4	20.8	31.1	7.8	29.3	21.3	23.6	19.4	30.1	17.7	38.3	23.4	17.8	15.5	15.2	18.5	15.4	16.4	17.8	14.4	29.4	31.7	10.1	16.7	25.9	32.6	1.2	23.1	17.9	13.2	18.5	27.3	0.7	0.2	0.3	0.4	1.0	0.2	0.1	26.1	19.3	10.6	8.7	9.4	13.1	12.0	8.1	7.2	6.8	7.7	26.6	10.5	0.1	11.0	10.8	9.0	19.7	6.5	9.1	8.7	0.2	7.2	0.1	10.4	11.2	25.3	0.0	0.3	7.2	6.6	8.4	16.3	10.4	15.1	0.0	9.7	5.4	5.2	14.5	0.1	0.2	9.7	11.9	6.1	0.0	15.0	0.0	13.6	16.1	5.2	7.4	16.7	7.3	6.9	21.9	5.0	0.3	23.6	7.0	10.7	4.8	11.1	1.9	1.8	0.1	7.9	0.1	3.9	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.2	0.3	1.0	0.4	0.2	0.2	0.1	27.5	32.8	12.0	26.1	28.3	19.1	29.3	21.3	23.4	32.6	157.8	42.2	2.2	89.8	31.8	36.2	95.8	38.2	29.4	43.3	55.8	9.8	24.8	21.6	107.0	12.1	131.3	49.5	0.0	72.9	11.2	45.0	132.7	5.7	41.4	3.3	119.2	44.1	93.3	8.4	9.4	31.4	5.7	60.8	2.8	31.6	34.9	126.3	31.5	60.1	20.9	49.7	77.6	86.8	53.9	47.9	52.6	28.1	4.4	19.1	142.6
TJP2	"DFNA51, X104, ZO-2, ZO2"	ENSG00000119139	"Tight junction protein 2"	Q9UDY2	9	69121264-69255208	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 241.2;Rod photoreceptor cells: 273.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.0"	"Lineage enriched"	"Detected in single"	8	"monocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"A-431: 53.3"									"HPA001813, CAB009228, HPA070714"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		790000	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB009228: AB_2203583, HPA001813: AB_1080764, HPA070714: AB_2732161"	"unprognostic (1.30e-1)"	"unprognostic (7.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.83e-3)"	"unprognostic (1.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.60e-1)"	"prognostic favorable (1.78e-14)"	"unprognostic (3.29e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.15e-3)"	"unprognostic (5.85e-2)"	25.2	9.5	23.7	8.0	29.7	5.7	20.7	35.6	24.9	9.0	20.0	50.3	20.6	27.2	11.9	7.3	28.9	12.6	13.2	19.8	35.1	12.7	23.3	34.5	23.9	5.8	39.7	20.5	20.9	13.2	43.2	3.6	18.0	32.0	13.5	16.7	19.1	18.0	23.1	8.3	18.6	25.7	15.3	39.7	3.5	30.4	17.8	41.1	11.1	22.5	9.0	10.8	26.5	26.6	0.0	0.2	0.4	4.0	0.0	0.5	0.5	53.3	1.7	4.3	4.8	20.1	19.7	23.3	8.1	6.0	13.0	7.1	6.5	19.5	7.7	8.1	4.5	7.0	32.9	6.9	17.1	14.8	27.3	5.0	7.4	4.6	32.9	5.7	3.0	14.1	15.3	12.3	10.1	6.1	3.7	27.2	2.1	4.5	5.2	6.8	7.5	1.1	0.4	10.4	33.4	11.7	3.9	6.1	0.8	33.4	35.6	1.9	3.3	2.9	20.8	0.6	9.9	6.7	1.6	39.0	9.7	10.5	7.5	8.3	5.4	1.1	0.1	11.2	4.3	3.6	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.4	0.0	4.0	0.1	0.5	0.5	23.7	29.7	35.6	17.5	35.1	12.7	39.7	20.5	32.0	41.1	41.7	21.4	1.4	65.1	57.9	241.2	34.6	50.9	9.4	5.7	3.5	33.4	24.0	0.0	27.8	2.7	42.7	67.5	0.0	20.8	23.1	14.7	83.3	5.7	92.7	4.9	17.5	11.1	25.2	17.0	3.6	27.0	2.8	27.0	4.6	41.5	123.0	32.6	42.5	13.1	1.4	273.3	0.0	10.3	21.3	11.1	56.0	36.2	3.1	36.2	146.9
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 259.3;Enterocytes: 138.3;Paneth cells: 101.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdT-cell: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.2;CAPAN-2: 22.3;MCF7: 9.8;OE19: 17.4;SK-BR-3: 13.0;T-47d: 27.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: AB_2682118"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favorable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	6.5	22.3	4.0	0.6	0.0	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	9.8	0.0	0.1	0.4	17.4	0.1	0.0	0.0	2.9	0.7	3.4	0.1	0.1	0.8	13.0	0.0	1.7	27.4	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2	8.9	10.7	0.0	6.7	0.0	0.0	0.8	30.6	34.8	12.5	29.6	0.0	26.9	16.6	16.8	259.3	0.0	138.3	0.0	21.0	3.5	0.2	4.8	4.6	4.9	2.4	0.0	12.0	0.0	0.0	10.7	1.7	0.1	3.3	0.0	40.6	0.0	16.7	101.7	1.1	5.1	0.0	0.0	0.2	2.1	3.3	0.1	33.6	1.5	46.1	23.1
TKT		ENSG00000163931	Transketolase	P29401	3	53224707-53256052	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Transferase	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 216.3"	"Cell type enhanced"	"Detected in all"	5	"Kupffer cells: 587.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"classical monocyte: 63.0;eosinophil: 41.5;intermediate monocyte: 31.0;myeloid DC: 32.5;neutrophil: 60.1;non-classical monocyte: 35.5"	"Group enriched"	"Detected in all"	8	"dendritic cells: 32.5;granulocytes: 60.1;monocytes: 63.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029480, HPA029481"	Enhanced		Enhanced	Nucleoplasm		NA	NA		190000000	Nucleoplasm		"HPA029480: AB_10599307, HPA029481: AB_10601895"	"unprognostic (5.05e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (7.21e-6)"	"unprognostic (6.78e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.06e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.90e-3)"	53.6	37.0	21.2	24.1	26.0	216.3	70.1	18.1	24.3	19.0	24.3	21.1	9.9	31.8	16.9	9.5	60.4	21.8	36.5	15.3	19.4	23.0	51.9	27.4	50.1	45.6	33.4	16.0	35.2	69.9	22.5	16.9	29.8	28.7	25.2	19.6	17.5	21.0	21.6	5.2	16.8	22.5	34.5	28.2	45.6	24.5	10.8	23.3	44.8	67.7	37.9	25.1	58.2	57.3	6.8	32.5	60.1	63.0	4.7	5.7	37.6	31.4	159.3	22.8	25.3	50.9	62.2	46.6	21.3	37.0	37.0	35.4	44.0	81.1	39.6	10.3	31.1	71.5	45.6	39.5	80.3	11.0	13.2	21.9	26.4	111.4	66.0	62.3	32.2	17.8	45.0	46.2	44.2	22.8	101.2	46.5	33.7	18.7	17.3	15.0	38.5	33.6	36.1	77.4	61.4	38.5	20.3	10.4	73.6	57.8	53.5	14.8	11.0	39.7	63.6	38.3	72.9	19.8	44.6	34.8	11.4	17.7	33.7	40.7	10.0	18.7	23.7	25.0	32.7	21.2	7.0	63.0	41.5	3.0	31.0	3.8	6.8	4.4	3.4	32.5	3.5	4.6	3.4	60.1	4.7	35.5	5.5	5.7	37.6	21.2	26.0	18.1	24.3	19.4	23.0	33.4	16.0	28.7	23.3	125.0	107.1	122.7	318.5	70.5	32.5	12.0	68.8	60.2	69.4	59.3	27.5	317.9	68.0	167.6	5.0	48.1	125.0	23.3	233.6	204.0	47.6	102.3	61.2	73.1	233.2	35.0	50.5	56.4	587.5	2.7	145.6	247.7	72.6	160.5	113.7	78.1	222.7	69.1	100.4	170.5	36.1	51.8	72.1	14.1	21.1	58.6	345.9	84.1	213.7	357.0
TKTL1	"TKR, TKT2"	ENSG00000007350	"Transketolase like 1"	P51854	X	154295671-154330350	"Enzymes, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	50	"blood: 28.6;testis: 103.6"	"Cell type enriched"	"Detected in some"	14	"Spermatogonia: 515.6"	"Cancer enriched"	"Detected in many"	8	"testis cancer: 44.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 28.6;gdT-cell: 12.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 28.6;T-cells: 12.0"	"Cell line enriched"	"Detected in single"	157	"THP-1: 102.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000505, HPA029155, CAB032191"	Enhanced		Enhanced	Cytosol		NA	NA			Cytosol		"CAB032191: , HPA000505: AB_1858022, HPA029155: AB_10603134"	"unprognostic (2.69e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (5.80e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.38e-1)"	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	103.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.6	0.1	3.3	12.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	102.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.0	28.6	12.0	0.1	1.8	0.0	1.4	1.1	0.0	0.0	3.1	2.7	0.4	3.3	0.1	0.1	1.5	2.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	23.8	0.0	0.0	0.0	16.9	3.7	1.3	0.0	0.0	0.0	5.3	0.0	0.0	1.8	0.0	1.1	25.8	1.4	35.6	515.6	0.1	0.0	0.5	0.0	0.0
TLX3	"HOX11L2, RNX"	ENSG00000164438	"T cell leukemia homeobox 3"	O43711	5	171309284-171312134	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"		"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	59	"brain: 46.6"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 5.2"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.7"	"Region enriched"	"Detected in some"	22	"cerebellum: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SH-SY5Y: 24.6"	"Region enriched"	"Detected in single"	7	"cerebellum: 2.5"	"Region enriched"	"Detected in some"	10	"cerebellum: 48.1"	"HPA030504, HPA060957, HPA069359"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA030504: AB_2732458, HPA060957: AB_2732655, HPA069359: AB_2732130"		"unprognostic (3.52e-2)"		"unprognostic (2.43e-2)"					"unprognostic (2.09e-1)"	"unprognostic (3.11e-1)"				"unprognostic (9.80e-2)"	"unprognostic (2.76e-2)"		"unprognostic (4.48e-2)"	0.4	0.5	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0
TMA16	"C4orf43, FLJ11184"	ENSG00000198498	"Translation machinery associated 16 homolog"	Q96EY4	4	163494442-163520539	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041571, HPA052688"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA041571: AB_10794381, HPA052688: AB_2681916"	"unprognostic (6.02e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (2.70e-5)"	"prognostic unfavorable (4.40e-4)"	"unprognostic (2.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (6.98e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-2)"	16.1	13.1	7.1	25.3	9.6	10.2	16.0	8.9	11.5	17.5	11.5	8.9	11.8	9.4	18.5	17.7	16.1	12.8	13.5	12.0	8.7	7.4	13.5	16.8	10.2	22.1	7.6	8.8	16.0	19.3	7.2	12.4	12.6	9.9	11.6	11.0	8.8	16.9	12.2	17.2	15.1	9.8	13.1	11.1	21.1	13.0	30.0	8.5	28.2	10.6	15.0	18.3	15.6	13.5	21.4	28.2	3.3	21.9	13.5	14.0	7.4	15.7	8.3	13.4	12.2	5.6	9.6	13.8	18.5	9.3	10.1	8.6	8.0	21.6	35.0	7.7	9.8	8.3	8.0	15.6	13.2	12.8	18.0	13.4	48.8	7.9	12.7	12.4	38.5	15.2	6.2	12.0	8.5	10.7	8.4	11.0	11.3	17.1	25.7	11.0	14.2	23.1	20.0	14.9	8.6	12.2	22.1	12.7	22.1	8.0	7.8	7.8	11.5	11.7	15.7	13.8	8.9	9.4	15.0	19.3	8.1	15.3	7.7	19.5	18.7	24.0	40.7	16.0	20.5	24.2	3.3	14.5	1.3	7.7	21.9	11.4	21.4	14.0	9.9	16.5	19.9	13.2	11.1	0.5	13.5	17.7	28.2	11.5	7.4	7.1	9.6	8.9	11.5	8.7	7.4	7.6	8.8	9.9	8.5	20.8	28.2	49.6	29.7	29.2	13.2	32.7	50.9	14.7	27.3	31.4	3.9	47.8	54.7	39.8	141.5	25.9	10.6	23.3	60.9	76.4	30.6	17.5	27.8	47.0	32.6	14.3	29.3	38.6	33.4	132.5	51.5	37.8	25.3	35.1	34.4	14.7	45.8	28.1	30.1	37.2	13.4	38.8	30.6	59.7	38.5	34.6	25.5	21.7	37.6	23.0
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 421.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	28.5	37.6	19.4	25.6	49.0	6.0	27.3	11.3	26.1	31.1	20.0	54.4	17.6	19.8	22.4	20.7	33.0	19.1	29.4	23.9	29.1	20.0	26.7	11.9	30.4	22.3	65.8	16.2	14.0	23.6	22.9	14.9	37.6	33.1	24.9	21.6	15.7	25.5	20.8	9.9	16.2	16.0	25.0	50.5	22.6	23.8	8.4	49.4	14.4	24.3	16.5	25.5	34.0	23.2	11.3	22.8	17.6	24.8	11.3	11.8	17.8	18.8	7.9	12.5	13.2	39.0	28.9	13.3	36.1	55.8	26.1	28.7	8.8	28.3	19.7	26.3	22.2	15.0	14.0	13.1	14.8	26.6	11.1	12.1	16.8	14.1	16.9	24.3	23.1	20.0	29.6	19.3	14.9	10.0	22.1	29.7	6.6	28.3	12.6	30.6	13.8	18.2	19.4	13.6	25.0	18.6	13.2	9.4	10.6	39.2	18.1	12.9	17.3	18.1	68.9	21.5	12.9	10.8	16.7	25.5	22.3	13.3	9.8	26.1	11.8	9.5	12.1	26.5	19.7	17.8	12.7	24.8	15.5	9.9	20.9	11.3	11.3	9.6	11.8	22.8	7.8	8.2	9.8	17.6	11.3	20.5	17.5	10.8	17.8	19.4	49.0	11.3	26.1	29.1	20.0	65.8	16.2	33.1	49.4	50.6	44.9	77.0	225.4	217.7	52.2	28.4	71.4	24.1	36.4	75.0	76.6	95.8	14.9	148.1	29.0	90.3	40.6	46.7	143.8	136.2	133.6	205.0	20.7	16.1	94.9	27.0	48.4	110.5	75.9	17.9	54.4	126.9	84.4	71.3	52.4	71.5	188.4	45.6	59.8	43.2	75.4	97.0	160.3	38.1	23.7	234.9	67.4	84.1	48.5	421.9
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787415-62790405	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	26.1	34.6	13.2	19.5	15.7	13.4	36.0	6.3	15.4	24.9	31.3	23.7	37.7	24.5	27.8	53.6	24.9	28.9	35.0	21.8	12.9	11.1	43.1	55.4	39.0	43.2	17.1	9.8	27.4	47.1	15.5	17.5	39.8	20.9	28.8	29.3	28.0	55.1	54.2	16.7	29.7	44.2	20.4	19.9	30.4	26.5	29.4	14.8	25.5	44.9	21.2	28.2	24.1	24.0	35.5	80.6	70.4	67.6	28.3	35.4	53.5	12.6	25.8	6.4	12.7	50.4	12.8	7.9	13.9	17.1	11.0	12.6	14.7	29.4	5.8	19.9	27.4	15.9	23.2	11.8	12.5	8.5	17.2	16.8	8.4	11.7	13.4	34.0	10.6	11.8	24.6	20.3	20.7	25.6	21.9	11.0	17.3	11.6	16.6	12.4	28.8	13.6	20.6	9.6	26.6	28.5	9.3	10.3	30.2	20.5	15.6	8.8	9.7	17.9	23.2	23.7	13.4	27.1	13.1	14.2	14.4	10.8	26.4	11.4	19.0	11.2	7.5	20.8	6.5	16.7	52.6	67.6	70.4	35.4	64.9	34.8	35.5	32.5	33.9	43.2	31.5	28.9	28.5	49.9	28.3	61.8	80.6	31.3	53.5	13.2	15.7	6.3	15.4	12.9	11.1	17.1	9.8	20.9	14.8	56.6	43.3	42.5	61.1	61.0	12.3	1.1	63.7	73.6	54.6	57.6	0.0	154.6	31.5	119.9	4.5	76.8	91.9	23.3	131.2	131.6	80.8	88.4	54.2	69.2	120.1	7.9	62.6	65.1	70.8	7.8	70.2	79.2	101.3	101.0	82.1	70.3	107.6	133.3	43.2	73.2	12.7	64.7	35.0	93.4	90.3	66.5	154.8	55.4	88.9	75.9
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	40.0	40.4	34.3	17.1	27.9	15.6	80.9	20.2	44.8	35.7	29.9	23.2	33.3	18.7	30.2	39.0	26.0	27.4	31.4	49.7	32.7	36.1	44.6	81.0	32.9	49.2	41.1	23.1	31.5	53.5	22.4	31.5	21.8	25.8	33.8	27.9	27.4	26.8	31.0	32.4	10.6	29.4	28.1	44.3	20.6	25.8	24.0	16.4	18.8	42.5	24.9	22.2	31.5	18.9	45.6	44.7	30.5	49.2	39.1	48.2	78.3	33.3	23.5	30.9	23.2	70.0	62.5	23.6	27.1	40.8	26.8	29.7	18.5	33.4	16.0	22.3	39.1	30.6	27.8	22.9	40.4	38.9	17.8	26.3	28.3	7.3	56.8	44.8	32.7	11.8	43.1	45.2	20.5	41.3	37.5	35.2	35.8	26.4	44.4	43.8	9.5	32.9	30.6	23.5	64.2	33.6	21.4	20.7	34.3	40.2	17.2	26.1	31.7	16.3	34.3	56.3	34.8	27.4	31.3	29.5	34.9	20.4	33.4	29.0	29.7	58.9	31.3	14.0	28.3	36.5	28.4	48.1	30.5	39.3	49.2	48.2	45.6	43.1	41.9	44.7	37.9	45.0	44.3	15.6	39.1	46.1	43.8	38.6	78.3	34.3	27.9	20.2	44.8	32.7	36.1	41.1	23.1	25.8	16.4	53.6	61.3	129.3	107.8	62.5	93.4	47.8	94.3	64.3	48.9	146.5	60.9	146.0	426.1	129.1	144.0	103.4	53.5	46.7	97.3	172.4	154.3	157.7	111.9	118.4	189.6	58.8	91.9	120.3	153.8	67.6	196.5	153.1	189.0	263.3	96.8	65.8	86.4	119.7	207.2	284.9	89.9	84.1	143.4	110.9	90.6	52.9	123.8	145.1	112.1	128.5
TMEM63A	KIAA0792	ENSG00000196187	"Transmembrane protein 63A"	O94886	1	225845536-225882369	"Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel"	"Disease mutation, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.4"	"Cell type enhanced"	"Detected in many"	4	"Glandular cells: 60.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.5;SK-BR-3: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066504, HPA066936, HPA068918"			Enhanced	"Vesicles,Centriolar satellite"		NA	NA		96000	"Vesicles, Centriolar satellite"		"HPA066504: AB_2685680, HPA066936: AB_2685751, HPA068918: AB_2686057"	"unprognostic (5.31e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.14e-2)"	"prognostic favorable (8.79e-4)"	"unprognostic (2.05e-1)"	"unprognostic (7.16e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.92e-2)"	10.5	7.4	14.7	11.6	38.8	18.6	12.2	4.1	23.2	14.3	14.0	91.4	17.3	12.2	12.2	11.2	6.6	13.9	12.9	8.5	30.2	15.1	14.3	15.1	12.6	15.4	59.3	16.4	13.1	22.4	11.6	5.3	11.3	34.9	22.3	17.8	5.7	55.8	19.1	6.9	9.9	13.3	8.8	71.0	14.0	22.9	3.0	49.6	11.2	8.0	4.5	12.4	13.3	9.6	5.4	10.0	5.5	4.1	8.7	16.6	5.7	9.2	2.8	2.4	7.0	19.4	6.7	16.8	7.1	7.7	7.9	8.0	10.1	6.9	2.6	13.1	8.6	4.7	14.3	2.6	4.3	3.7	8.6	4.6	11.3	6.5	6.0	4.5	4.2	29.7	7.0	2.7	4.7	2.8	11.0	5.1	5.9	9.3	2.2	6.2	5.8	3.7	4.2	13.2	29.7	4.6	3.7	7.5	37.5	12.1	24.6	0.2	1.3	5.2	41.7	5.1	5.9	9.6	4.0	6.1	4.6	3.2	4.2	6.4	0.9	3.4	0.6	4.2	2.3	8.4	5.5	3.2	3.0	9.4	2.7	10.6	5.2	12.1	8.9	2.5	5.4	10.9	6.3	5.1	8.7	4.1	10.0	16.6	5.7	14.7	38.8	4.1	23.0	30.2	15.1	59.3	16.4	34.9	49.6	6.0	8.6	16.0	22.4	3.0	0.8	3.6	28.1	14.7	11.4	19.2	2.0	32.4	1.7	29.4	9.1	4.6	17.3	0.0	22.5	4.5	7.8	60.8	17.3	16.0	15.3	0.0	18.5	11.1	9.1	8.0	17.0	10.3	3.3	5.4	32.5	18.8	18.4	20.1	12.4	11.1	1.3	25.8	8.2	0.6	4.9	3.6	18.8	17.0	46.1	29.3
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	9.7	13.2	24.4	8.7	21.4	14.0	9.4	33.2	34.3	9.1	19.7	14.8	7.5	17.1	8.2	11.7	21.1	8.6	13.2	16.6	21.6	15.2	10.7	28.6	35.0	5.2	13.1	18.2	8.0	10.6	19.6	10.2	12.8	22.8	12.9	18.4	18.6	13.9	8.8	29.4	29.6	17.0	9.7	13.8	6.3	24.5	22.7	16.0	4.7	11.4	14.8	8.9	14.4	13.4	1.3	1.3	1.7	2.1	0.3	2.6	1.2	15.4	8.2	7.8	13.2	12.3	7.3	13.2	6.3	8.6	7.8	7.4	5.8	5.7	2.6	10.5	9.4	11.6	15.3	9.1	23.6	4.5	7.2	7.9	7.6	6.0	17.0	8.7	1.5	8.0	10.0	20.5	10.0	6.3	14.1	7.1	6.0	24.6	4.6	7.8	15.3	1.6	3.7	4.0	58.7	4.1	2.0	4.8	4.9	19.1	14.7	8.5	6.9	5.9	13.6	14.1	9.9	16.0	4.0	8.4	9.3	11.1	7.1	7.7	5.5	4.0	3.0	14.5	2.6	11.5	1.1	2.1	1.3	1.4	1.1	2.5	1.3	0.7	0.7	0.9	0.8	1.0	1.1	1.7	0.3	1.4	1.3	2.6	1.2	24.4	21.4	33.2	34.3	21.6	15.2	13.1	18.2	22.8	16.0	14.9	29.0	1.4	12.3	12.0	16.3	2.8	10.2	0.0	7.9	10.4	15.7	12.5	1.7	13.4	56.9	6.8	47.1	0.0	13.3	14.8	10.8	15.8	0.0	31.6	21.1	15.9	17.9	12.9	8.3	71.4	10.9	7.0	6.8	7.2	26.3	11.1	25.1	40.4	8.5	10.2	26.6	6.5	9.2	1.6	5.8	15.9	16.7	4.3	18.0	22.6
TMEM71	FLJ33069	ENSG00000165071	"Transmembrane protein 71"	Q6P5X7	8	132685007-132760712	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 65.7;lymphoid tissue: 31.3"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 14.8;Kupffer cells: 23.3;Macrophages: 22.7;T-cells: 41.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 65.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 65.7"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.2;HDLM-2: 33.0;Karpas-707: 7.0;U-937: 19.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA058401, HPA070655"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA058401: AB_2683707, HPA070655: AB_2686292"	"unprognostic (1.39e-3)"	"unprognostic (7.27e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.91e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.62e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.29e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.73e-1)"	4.2	1.1	1.4	8.2	1.5	20.8	5.4	0.7	1.2	2.5	9.9	0.8	0.4	1.2	1.0	2.0	4.8	1.9	4.1	25.5	1.8	1.2	1.9	2.3	8.3	20.9	2.2	0.8	1.9	2.9	0.0	1.4	1.0	1.7	2.2	2.2	5.8	5.8	1.3	1.3	1.3	7.2	2.2	4.2	18.2	2.9	0.9	1.4	31.3	2.2	2.5	10.6	7.0	2.8	1.4	8.2	65.7	13.5	2.9	14.8	8.4	0.2	0.0	3.2	0.0	0.0	0.0	0.0	0.8	8.2	0.3	0.6	0.0	0.0	0.0	0.3	2.5	0.0	0.0	0.0	0.2	0.9	33.0	0.0	0.0	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	1.3	0.9	0.6	4.2	0.0	7.0	1.4	0.0	1.6	1.3	0.7	0.0	0.2	0.1	1.1	0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.2	0.4	0.5	0.7	3.4	0.0	1.6	0.0	5.8	19.5	2.4	12.5	13.5	23.9	8.0	3.9	14.8	1.4	5.9	5.6	8.2	1.3	9.0	6.5	65.7	2.9	3.2	0.2	0.7	8.4	1.4	1.5	0.7	1.2	1.8	1.2	2.2	0.8	1.7	1.4	0.0	4.8	4.2	1.0	0.8	0.0	14.8	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	1.3	0.1	1.1	0.0	3.1	0.0	0.0	1.3	23.3	3.6	0.0	22.7	5.0	0.0	0.0	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.2	0.3	0.2	41.5	0.0	5.1
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 74.7"	"Cell type enhanced"	"Detected in many"	15	"Pancreatic endocrine cells: 31.5;Urothelial cells: 92.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 9.1;CACO-2: 15.5;CAPAN-2: 14.8;EFO-21: 30.9;OE19: 17.9;SuSa: 20.9"					"Low region specificity"	"Detected in all"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.1	0.3	1.9	0.3	0.4	0.3	0.3	0.3	3.3	27.9	0.3	0.1	23.3	1.2	0.3	1.0	0.7	11.7	0.1	0.8	0.3	0.4	10.2	6.1	0.1	0.3	0.2	2.4	1.2	0.0	0.1	0.3	0.9	1.2	1.8	1.1	4.3	1.2	0.1	0.2	74.7	0.4	0.4	0.3	17.9	0.5	0.3	0.1	0.1	0.4	1.6	2.2	3.7	0.1	0.2	5.5	0.1	0.0	0.0	0.0	0.9	9.1	0.2	0.0	0.0	0.4	2.0	0.2	0.3	0.0	0.0	15.5	14.8	0.0	30.9	0.6	3.5	0.0	0.2	1.7	0.0	2.4	0.1	0.0	0.9	1.5	0.1	0.1	0.1	0.1	1.7	0.1	0.5	1.4	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.2	3.4	17.9	4.0	0.2	0.0	3.8	3.3	0.0	0.0	0.0	0.0	0.1	0.0	20.9	1.9	0.5	0.0	0.1	2.1	0.0	0.0	0.0	0.1	0.1	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.2	0.9	0.3	3.0	17.1	0.0	6.4	0.5	0.0	0.1	22.9	2.7	1.2	7.0	0.0	0.0	0.0	6.2	0.0	0.0	8.0	0.0	17.8	1.2	1.0	16.8	0.0	11.3	0.4	0.0	5.2	1.8	0.3	0.0	0.0	0.0	0.0	1.8	20.4	0.0	31.5	16.4	0.0	0.0	0.0	0.0	0.1	0.1	1.7	0.9	0.0	0.0	14.9	92.2
TMPO	"LAP2, LEMD4, TP"	ENSG00000120802	Thymopoietin	"P42166, P42167"	12	98515512-98550379	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding	Cardiomyopathy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 130.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008150, CAB009847, HPA070805"	Enhanced		Enhanced	"Nuclear membrane"		NA	Yes			"Nuclear membrane"		"CAB009847: AB_2205450, HPA008150: AB_1079235, HPA070805: "	"unprognostic (2.36e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.90e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.67e-3)"	"prognostic unfavorable (9.34e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.26e-2)"	10.8	9.5	8.1	25.0	9.5	36.8	12.7	19.1	11.0	16.9	22.9	10.7	8.7	15.9	18.4	17.1	23.0	15.4	10.3	9.6	8.5	8.3	15.8	20.5	13.8	34.0	9.0	11.2	34.7	21.6	9.9	9.9	13.6	7.6	15.6	17.6	12.5	14.0	9.7	9.4	11.7	22.6	10.7	9.4	29.1	16.8	11.4	10.3	130.9	13.2	12.2	35.4	13.0	17.9	14.1	10.9	18.1	33.1	9.7	15.6	13.3	30.8	20.4	50.3	25.5	4.2	5.6	29.8	25.4	13.5	34.5	25.1	22.2	15.5	53.9	15.6	14.7	12.6	19.8	42.1	19.1	31.7	37.7	26.1	46.1	18.6	14.6	3.8	53.2	30.8	3.1	6.3	20.3	10.9	12.0	19.6	33.6	38.9	20.9	21.4	19.4	86.8	42.0	30.2	28.6	19.1	72.9	33.3	37.3	12.2	28.8	39.8	23.8	43.5	27.3	13.7	20.6	30.8	25.6	10.5	20.0	17.5	13.6	25.9	22.8	38.8	60.3	5.7	30.9	26.5	18.1	14.4	6.1	9.5	25.0	10.2	10.9	11.1	10.8	10.9	14.1	15.6	11.7	1.1	9.7	33.1	6.1	13.3	13.3	8.1	9.5	19.1	11.0	8.5	8.3	9.0	11.2	7.6	10.3	29.8	18.0	45.4	21.4	24.6	20.8	7.1	25.5	36.1	48.9	29.6	11.8	16.5	26.6	16.3	26.8	36.0	27.6	70.0	27.6	75.5	19.0	17.7	27.8	45.0	32.2	9.5	27.5	32.5	64.7	21.9	26.4	40.1	16.9	34.3	51.4	24.2	21.6	31.5	38.2	27.8	47.9	19.4	15.6	38.6	53.5	20.5	9.8	33.1	42.9	16.3
TNFAIP8	"GG2-1, MDC-3.13, SCC-S2"	ENSG00000145779	"TNF alpha induced protein 8"	O95379	5	119268692-119399688	"Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 73.4;lymphoid tissue: 83.1"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 208.8;monocytes: 266.9;Syncytiotrophoblasts: 244.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054434, HPA057089"	Uncertain		Enhanced	Nucleoplasm		No	Yes		270000	Nucleoplasm		"HPA054434: AB_2682487, HPA057089: AB_2683331"	"prognostic favorable (2.45e-4)"	"unprognostic (6.06e-2)"	"unprognostic (9.81e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-3)"	"unprognostic (4.92e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.45e-2)"	"unprognostic (5.81e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.73e-2)"	21.1	2.1	1.6	49.9	3.0	17.8	18.9	1.5	1.7	11.3	8.0	1.6	4.7	4.3	9.7	9.2	15.0	4.6	9.7	8.5	1.8	1.7	8.7	8.4	22.0	71.3	2.9	1.8	4.2	12.5	5.2	1.7	36.1	12.2	11.8	5.5	4.2	13.7	5.8	2.2	14.4	21.4	6.9	3.6	37.5	13.1	4.7	2.2	83.1	9.3	8.6	41.1	12.7	12.8	50.3	25.2	73.4	19.7	19.7	54.4	36.5	7.5	5.3	2.8	4.6	6.1	5.1	26.0	4.2	11.4	3.2	6.6	2.9	8.8	14.2	1.3	4.7	5.1	10.8	2.3	12.8	4.5	15.5	4.9	22.5	11.9	4.9	2.9	27.1	25.0	5.7	12.1	9.6	4.6	6.2	4.3	28.3	8.7	44.5	4.4	2.9	23.0	35.4	4.3	4.4	2.5	7.0	12.6	20.6	12.8	15.2	1.5	2.2	15.8	3.1	1.5	9.7	2.7	31.0	2.1	5.8	2.2	4.0	4.9	21.9	24.0	28.6	6.7	29.0	3.4	73.4	18.6	55.3	22.6	19.7	43.9	50.3	45.5	33.2	25.2	44.2	54.4	34.9	10.6	19.7	14.8	12.1	34.8	36.5	1.6	3.0	1.5	1.7	1.8	1.7	2.9	1.8	12.2	2.2	8.9	16.0	115.2	57.1	142.5	0.1	8.9	15.3	48.2	25.0	17.4	0.0	133.6	14.9	46.4	1.9	18.9	1.3	0.0	87.0	135.2	42.9	45.5	208.8	0.5	45.7	0.0	1.2	6.2	52.3	1.1	2.0	76.8	35.4	266.9	7.6	3.9	105.8	2.9	1.8	11.0	0.5	45.3	34.0	0.4	14.9	104.3	244.7	119.6	3.8	58.5
TNIP2	"ABIN-2, FLIP1, KLIP, MGC4289"	ENSG00000168884	"TNFAIP3 interacting protein 2"	Q8NFZ5	4	2741648-2756376	"Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020818, HPA049886, HPA063197"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020818: , HPA049886: AB_2680934, HPA063197: AB_2684960"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.44e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (3.64e-1)"	"unprognostic (9.87e-2)"	"unprognostic (4.36e-2)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.47e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.94e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.97e-3)"	"unprognostic (4.02e-3)"	16.7	10.3	7.8	14.5	14.0	18.9	32.5	3.4	12.4	9.8	26.4	7.3	7.1	16.4	11.9	10.1	14.5	9.6	13.7	26.6	7.4	6.5	23.4	16.6	16.0	17.9	11.2	4.7	12.3	24.2	3.5	11.4	15.3	12.4	13.6	10.1	9.7	10.7	13.5	21.9	10.5	37.2	23.9	12.2	17.8	15.3	11.7	11.1	8.1	14.2	12.3	18.2	15.1	33.7	9.8	7.3	20.9	11.8	4.4	11.2	4.7	12.2	16.7	5.3	8.0	17.0	11.7	23.0	13.4	12.0	12.5	12.2	19.1	19.9	11.2	15.2	14.6	28.1	8.1	9.5	15.4	7.4	8.7	11.9	13.4	9.9	21.1	21.2	10.9	17.0	15.1	14.0	13.8	12.5	9.7	17.8	10.3	13.6	15.9	8.6	25.4	14.3	27.0	13.9	18.3	28.6	9.5	8.1	5.8	13.4	13.8	8.0	9.0	10.4	10.9	14.7	9.6	12.0	16.1	20.6	9.7	10.7	15.1	20.5	16.5	11.2	8.1	17.7	19.8	10.4	6.4	7.2	20.9	6.7	11.2	7.2	7.8	10.2	11.2	7.3	9.8	8.4	7.0	7.1	4.4	11.8	3.4	10.2	4.7	7.8	14.0	3.4	12.4	7.4	6.5	11.2	4.7	12.4	11.1	6.0	9.8	20.6	45.8	54.5	2.1	12.0	5.1	6.7	11.4	14.0	2.0	44.9	11.6	51.5	2.1	31.7	65.3	0.0	52.5	89.5	32.8	52.4	12.7	14.9	31.4	0.0	18.4	28.8	18.9	5.4	19.8	35.5	25.3	104.6	33.4	10.0	53.3	52.6	16.6	33.2	6.5	19.4	37.0	15.8	60.0	69.1	80.0	34.8	32.9	71.1
TNPO3	"IPO12, LGMD1F, MTR10A, TRN-SR, TRN-SR2"	ENSG00000064419	"Transportin 3"	Q9Y5L0	7	128954180-129055173	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039555, HPA041537"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA039555: AB_10672000, HPA041537: AB_2677539"	"unprognostic (5.76e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (3.29e-5)"	"unprognostic (1.86e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-2)"	17.8	24.0	22.6	23.8	20.5	28.9	16.2	29.6	21.4	15.2	18.4	15.8	30.1	15.5	19.7	17.9	26.3	16.1	12.9	16.1	16.6	17.7	19.1	21.6	15.4	20.5	17.7	15.5	20.7	19.8	21.7	19.2	13.9	18.4	16.7	19.7	15.6	19.0	20.4	41.4	19.2	17.8	18.9	16.2	17.2	21.9	36.3	15.1	29.5	22.3	15.9	26.4	22.6	18.1	16.6	15.9	20.9	21.7	14.4	17.4	10.5	20.3	23.1	18.0	30.3	17.5	15.1	15.3	18.4	16.1	17.2	20.4	18.8	18.9	25.6	8.6	19.6	32.7	15.1	36.3	17.7	24.8	21.2	16.1	18.8	19.2	14.7	16.7	34.3	16.1	14.1	18.1	21.0	18.8	15.1	21.4	21.2	42.6	18.4	21.9	15.1	29.6	25.4	51.4	22.5	21.4	21.2	16.7	20.8	17.4	19.2	22.4	17.7	19.6	9.2	20.6	27.2	10.4	21.4	16.0	21.9	10.9	25.7	25.0	23.7	18.4	35.5	31.6	35.3	37.9	20.6	13.6	20.9	17.4	17.2	15.5	16.6	14.2	15.4	15.9	15.5	14.1	16.1	15.9	14.4	21.7	7.7	14.5	10.5	22.6	20.5	29.6	21.4	16.6	17.7	17.7	15.5	18.4	15.1	14.9	14.7	29.0	13.4	6.1	22.0	17.3	17.8	12.0	13.6	17.4	21.6	21.1	6.6	20.5	30.3	15.5	17.6	23.3	21.6	30.1	13.4	15.7	10.4	23.2	24.5	35.0	11.1	15.4	23.5	19.0	15.5	20.1	8.5	44.1	20.5	14.0	25.4	17.5	16.6	15.2	20.6	12.9	12.7	72.0	30.2	7.2	29.3	15.3	22.6	23.5
TNRC18	"CAGL79, KIAA1856, TNRC18A"	ENSG00000182095	"Trinucleotide repeat containing 18"	O15417	7	5306790-5425414	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Bipolar cells: 56.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.6"	"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA020730, HPA024251"	Uncertain		Supported	"Nucleoplasm,Nuclear membrane,Mitochondria,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane, Mitochondria"	Cytosol	"HPA020730: AB_2670506, HPA024251: AB_2671498"	"unprognostic (1.66e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.67e-3)"	"unprognostic (4.44e-1)"	"unprognostic (1.81e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.29e-3)"	"unprognostic (2.14e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.34e-2)"	17.9	11.8	18.1	17.9	17.2	29.4	20.6	35.1	23.6	35.0	29.9	16.7	17.9	16.4	36.0	19.5	19.6	27.5	29.2	13.6	14.2	9.6	15.6	11.8	19.2	12.9	15.5	16.7	30.3	18.4	36.9	14.7	19.7	13.2	25.4	15.1	25.2	17.0	24.4	13.6	18.9	16.9	40.1	12.6	15.3	21.4	14.0	16.6	7.2	20.6	12.8	9.4	27.0	21.4	2.0	4.3	17.6	3.2	2.6	1.5	0.1	21.7	19.4	16.2	13.6	13.7	16.3	41.9	15.5	14.6	8.6	9.2	8.0	19.2	14.9	15.3	22.7	19.2	24.4	9.3	18.5	7.3	6.5	5.9	9.4	16.6	12.9	11.9	31.0	34.9	16.4	21.9	17.1	19.9	12.5	9.6	13.5	13.4	8.4	10.9	36.1	7.3	38.0	1.4	14.3	14.9	8.1	8.0	11.0	7.0	27.8	7.1	16.9	12.0	31.9	11.5	7.6	33.3	32.2	24.0	24.9	35.1	14.8	11.1	12.1	12.5	14.1	14.0	22.1	29.0	9.4	3.2	2.7	1.4	1.2	1.0	1.6	1.0	0.8	1.1	2.0	0.7	1.5	17.6	2.6	1.5	4.3	1.4	0.1	18.1	17.2	35.1	23.6	14.2	9.6	15.5	16.7	13.2	16.6	8.9	31.9	1.4	3.1	8.2	56.8	6.2	15.3	6.7	11.4	14.0	2.0	12.8	1.7	4.5	12.0	10.7	16.9	0.0	5.5	3.6	11.3	4.6	13.9	22.9	9.5	47.7	30.1	29.4	40.0	12.0	17.0	11.9	5.0	3.6	27.0	23.8	8.0	5.8	18.7	4.2	3.7	19.4	11.9	0.5	2.0	7.8	8.4	6.4	21.8	2.6
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 299.8;Peritubular cells: 473.8;Sertoli cells: 362.2;Smooth muscle cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.9;ASC TERT1: 25.6;fHDF/TERT166: 22.2;REH: 24.4;TIME: 21.7"	"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.9	25.6	0.3	7.9	2.6	0.4	0.3	3.4	0.0	0.0	4.6	22.2	0.5	0.5	0.3	0.4	0.2	3.1	0.2	6.7	2.0	0.9	3.5	0.0	0.8	12.1	0.0	8.5	0.0	15.3	11.1	0.0	0.2	0.8	6.6	0.9	0.0	0.4	0.3	0.0	0.1	24.4	5.9	0.3	1.6	0.0	0.7	3.5	1.3	3.4	0.8	2.2	1.1	2.4	21.7	5.7	10.4	5.8	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2	160.8	81.8	4.6	45.8	14.3	2.7	299.8	33.1	20.1	36.4	14.0	0.0	8.0	6.6	34.4	1.7	55.0	0.0	116.8	16.8	1.1	42.2	8.9	29.0	28.8	13.3	39.7	0.0	74.3	14.9	4.3	157.1	14.6	10.1	0.0	0.0	12.6	16.8	0.0	473.8	20.9	1.4	362.2	208.1	0.7	2.0	10.3	1.6	5.3	0.0	14.9
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 5.8;intermediate monocyte: 4.7;memory B-cell: 3.7;myeloid DC: 4.0;naive B-cell: 2.9;non-classical monocyte: 4.4;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 5.6;monocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"A549: 65.8;LHCN-M2: 42.4"	"Low region specificity"	"Detected in all"							"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	46.9	18.5	16.4	19.3	12.7	2.8	29.8	8.1	11.7	18.2	15.7	11.4	9.1	9.9	27.4	13.9	7.7	12.3	29.6	13.5	12.1	13.2	27.3	24.9	25.1	37.7	16.0	3.6	22.4	35.5	16.4	5.5	44.9	9.6	15.0	9.3	40.3	36.4	11.7	14.9	6.7	20.7	14.7	11.6	42.7	13.9	9.6	7.8	3.8	23.8	9.6	19.9	12.5	19.3	3.7	5.6	0.8	5.8	0.1	0.2	1.8	6.3	65.8	4.0	6.9	9.2	7.5	12.8	5.8	33.4	5.7	8.8	14.7	8.6	3.2	10.4	21.2	21.5	12.2	6.4	9.5	5.2	0.0	0.4	9.0	9.5	7.8	9.5	0.0	0.1	7.4	4.1	3.3	5.2	37.5	4.5	0.0	0.0	20.3	42.4	3.9	0.0	0.2	3.8	9.2	7.9	2.9	9.8	10.7	19.8	13.1	0.4	8.2	11.5	2.3	6.4	21.1	8.8	6.7	17.9	8.9	7.1	0.1	8.9	13.1	16.9	7.6	2.2	6.3	32.2	0.2	5.8	0.0	0.1	4.7	0.2	3.7	0.0	0.0	4.0	2.9	0.0	0.0	0.8	0.1	4.4	5.6	0.0	1.8	16.4	12.7	8.1	11.7	12.1	13.2	16.0	3.6	9.6	7.8	62.5	12.0	3.7	7.3	4.2	1.4	17.3	33.1	16.0	25.0	29.6	0.0	21.4	1.7	14.4	9.5	6.9	28.0	0.0	15.8	47.3	17.5	2.8	0.0	35.1	66.7	0.0	14.5	40.5	35.8	11.8	5.8	13.7	15.1	11.8	15.6	34.2	21.0	8.6	14.5	11.5	1.4	25.8	8.2	1.7	3.4	2.9	25.1	1.9	15.3	2.1
TOE1	hCaf1z	ENSG00000132773	"Target of EGR1, exonuclease"	Q96GM8	1	45339670-45343975	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053775, HPA069119"	Supported		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nuclear bodies"	Nucleoplasm	"HPA053775: AB_2682259, HPA069119: AB_2686090"	"unprognostic (7.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.90e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (9.05e-4)"	"prognostic unfavorable (6.12e-9)"	"unprognostic (4.67e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (2.71e-4)"	"prognostic favorable (9.98e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.08e-1)"	7.4	9.2	8.9	8.0	10.6	9.7	8.1	11.6	9.4	7.4	8.9	8.7	11.2	9.8	10.8	11.0	8.3	8.9	8.7	7.5	6.4	5.6	7.1	7.9	9.4	8.7	5.1	7.4	9.4	7.4	10.8	7.8	8.2	7.7	8.8	9.2	10.0	9.9	7.7	4.3	6.9	9.4	10.0	9.4	11.0	9.4	18.7	5.0	14.6	10.3	6.1	8.8	9.1	7.3	8.7	6.0	13.8	6.8	3.2	9.6	4.7	8.2	4.5	6.4	7.6	3.8	3.1	11.5	6.7	6.0	12.4	11.8	5.6	4.4	14.5	6.8	7.9	11.0	7.5	10.0	11.6	8.7	9.2	8.2	15.3	8.8	6.2	3.3	9.2	8.4	4.5	2.0	12.5	8.0	4.3	9.9	12.0	12.0	8.0	8.5	6.4	16.4	7.8	14.2	9.2	6.2	11.8	11.3	6.3	4.9	11.0	6.8	7.0	6.8	17.5	13.0	11.0	4.4	14.7	6.7	5.3	11.2	9.6	11.9	5.7	7.6	9.2	7.9	12.1	6.8	13.8	5.7	5.7	7.9	6.8	9.6	6.2	7.7	8.4	5.5	8.7	6.9	8.3	0.8	3.2	5.9	6.0	8.5	4.7	8.9	10.6	11.6	9.4	6.4	5.6	5.1	7.4	7.7	5.0	6.0	3.7	9.5	5.0	1.5	9.9	1.4	7.6	4.0	9.1	7.0	11.8	33.5	6.6	4.8	8.9	9.0	6.7	0.0	5.5	10.3	5.2	5.5	11.5	4.5	8.0	7.9	2.9	7.4	3.5	6.5	6.4	4.9	3.3	13.6	5.9	12.3	2.8	10.5	6.0	5.8	17.6	12.9	7.2	31.0	18.1	1.3	19.0	7.0	5.7	3.7
TOMM20	"KIAA0016, MAS20, MOM19, TOM20"	ENSG00000173726	"Translocase of outer mitochondrial membrane 20"	Q15388	1	235109336-235128936	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005585, HPA011562"	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"CAB005585: AB_628381, HPA011562: AB_1080326"	"unprognostic (1.30e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.49e-2)"	"unprognostic (8.65e-3)"	"unprognostic (1.17e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.16e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.97e-1)"	27.2	35.0	46.3	15.3	60.2	32.7	52.8	40.0	66.2	36.1	25.5	28.4	29.0	24.4	34.5	39.0	28.0	40.0	27.9	33.9	47.1	48.7	41.2	35.2	24.2	33.6	42.5	40.5	50.9	63.6	38.6	25.4	27.1	48.2	34.0	28.2	23.5	47.8	30.7	33.4	33.0	21.3	33.8	54.5	19.0	27.2	16.3	23.0	18.0	58.7	28.4	21.9	36.2	28.9	15.9	20.9	16.4	13.8	9.8	22.6	14.2	35.9	19.0	25.0	21.0	19.7	39.8	38.8	25.9	22.4	24.4	17.8	24.5	25.4	43.8	34.5	22.4	6.9	28.8	27.7	25.1	32.2	10.5	59.2	26.7	25.4	46.3	33.0	59.8	16.1	35.5	34.5	24.4	33.7	33.2	26.4	17.2	56.0	16.2	26.7	10.5	25.4	27.1	56.2	24.0	10.3	31.1	19.1	56.7	27.4	25.9	32.9	77.1	20.1	28.2	55.1	10.7	43.6	65.8	23.3	21.5	13.0	27.1	54.9	38.4	36.1	32.1	25.2	28.7	36.3	16.4	12.4	4.1	13.9	12.9	17.1	15.9	18.1	17.3	15.1	12.7	22.6	17.6	3.9	9.8	13.8	20.9	15.5	14.2	46.3	60.2	40.0	66.2	47.1	48.7	42.5	40.5	48.2	23.0	128.1	138.6	191.4	199.9	237.5	49.8	120.5	135.0	99.0	162.7	47.1	27.5	147.0	135.9	142.1	230.8	135.2	112.6	46.7	180.7	308.9	116.9	237.5	153.6	148.6	144.2	47.7	154.1	102.5	169.4	269.0	143.5	148.5	141.7	101.0	251.0	122.3	199.7	133.3	144.2	188.2	47.6	103.5	156.9	79.9	69.4	250.1	166.8	109.0	224.1	238.8
TOMM22	TOM22	ENSG00000100216	"Translocase of outer mitochondrial membrane 22"	Q9NS69	22	38681948-38685421	"Predicted membrane proteins"	"Protein transport, Translocation, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA003037	Supported		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA003037: AB_1080329"	"unprognostic (5.54e-2)"	"unprognostic (5.04e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (1.01e-1)"	"unprognostic (4.28e-1)"	"unprognostic (7.01e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.44e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.64e-1)"	27.6	26.2	25.6	30.1	24.3	29.5	29.4	17.6	28.2	22.2	26.8	14.7	22.4	28.0	20.1	25.6	34.1	24.4	23.8	31.6	23.2	21.0	29.4	46.0	18.1	32.1	24.0	19.8	27.8	47.5	10.9	12.6	27.6	18.5	21.0	32.8	15.8	31.4	26.7	38.2	24.6	29.7	22.8	20.0	27.7	23.3	24.7	11.3	44.2	27.4	40.4	33.5	24.1	30.2	22.5	29.7	6.9	22.9	18.0	21.3	28.6	19.9	11.8	18.1	19.2	13.4	12.5	19.6	16.6	11.5	24.3	18.3	21.4	12.0	20.3	13.7	16.2	16.7	16.6	27.5	25.1	19.6	17.5	30.2	27.3	9.3	20.5	17.5	72.2	19.4	17.1	17.9	21.8	14.3	12.7	17.8	19.9	20.6	16.3	16.1	15.5	21.6	33.6	27.8	26.5	24.1	24.1	23.5	19.2	16.1	14.7	21.3	14.1	19.3	24.6	18.8	12.9	17.0	23.9	18.0	14.9	28.0	13.6	24.9	22.5	27.2	31.4	18.7	25.1	20.3	4.7	22.9	6.9	16.9	22.0	21.3	22.5	18.3	17.8	29.7	18.0	18.7	20.0	2.2	18.0	18.1	25.8	21.1	28.6	25.6	24.3	17.6	28.2	23.2	21.0	24.0	19.8	18.5	11.3	23.8	38.6	136.2	98.0	148.4	29.1	63.5	89.2	22.7	36.4	68.0	15.7	155.1	189.0	110.6	102.3	74.4	68.7	23.3	115.2	191.6	75.3	74.7	74.8	86.3	145.2	27.0	100.8	54.6	102.5	107.7	51.2	105.1	108.0	150.5	120.6	48.5	110.8	66.6	51.2	199.7	22.3	71.1	82.1	92.7	139.6	183.8	113.4	104.6	157.8	129.1
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	23.9	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	7.9	14.5	22.0	48.2	15.9	16.4	38.5	42.3	28.7	33.4	44.1	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	11.1	16.7	39.6	11.9	29.2	29.6	20.3	57.8	17.2	35.6	44.7	21.6	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8	14.9	5.3	28.9	52.0	77.6	63.2	14.2	30.6	0.0	10.3	29.6	27.5	84.7	33.2	54.9	9.5	29.3	31.6	23.3	33.2	145.9	33.4	37.4	19.5	20.8	91.8	66.7	28.2	11.1	20.4	5.6	24.7	36.1	37.1	39.7	43.5	43.9	41.3	28.8	23.0	28.3	55.9	19.4	40.6	53.5	60.1	78.2	61.0	26.6	93.2	64.9
TOMM70	"KIAA0719, Tom70, TOMM70A"	ENSG00000154174	"Translocase of outer mitochondrial membrane 70"	O94826	3	100363431-100401398	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 22.5;Extravillous trophoblasts: 28.8;Proximal tubular cells: 36.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014589, CAB017156, HPA048020"	Enhanced		Enhanced	Mitochondria		NA	NA		120000	Mitochondria		"CAB017156: , HPA014589: AB_1858185, HPA048020: AB_2680234"	"unprognostic (2.74e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.69e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.01e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.62e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.53e-1)"	"unprognostic (3.34e-2)"	"unprognostic (6.98e-3)"	21.7	16.1	16.2	12.4	52.4	9.6	21.3	23.6	26.5	16.9	18.2	12.5	13.8	19.4	17.4	15.0	20.8	14.2	12.2	25.2	16.5	19.8	24.9	40.7	10.5	13.5	16.1	20.6	21.7	18.0	20.1	17.1	15.5	29.0	19.0	20.6	13.3	14.5	19.4	42.8	13.3	17.8	22.3	14.0	12.1	14.8	14.7	15.6	18.7	20.5	19.9	16.6	22.3	22.5	4.3	3.0	2.5	2.5	5.6	5.4	1.8	23.5	16.5	14.1	20.2	20.0	21.8	18.4	20.3	17.2	18.5	19.2	23.4	13.6	28.2	17.8	17.0	16.7	23.4	25.4	18.5	27.4	10.7	11.8	32.4	11.0	22.7	12.5	39.4	14.9	19.4	17.1	16.5	26.9	16.5	13.5	13.9	23.0	23.1	22.0	17.4	26.6	15.9	19.4	36.5	35.3	24.5	28.6	30.0	15.0	17.8	25.6	21.3	14.7	23.6	26.4	14.1	30.6	22.4	12.1	16.4	21.7	9.1	15.0	25.2	35.9	48.0	15.7	23.9	12.4	2.2	2.2	2.5	4.1	2.2	5.1	4.3	5.1	4.5	2.9	3.1	5.3	5.4	0.6	5.6	2.5	3.0	2.0	1.8	16.2	52.4	23.6	26.5	16.5	19.8	16.1	20.6	29.0	15.6	6.0	20.6	0.0	0.0	0.0	0.0	0.0	0.0	18.7	20.5	14.0	0.0	22.5	10.0	17.3	0.0	0.0	0.0	0.0	16.9	28.8	0.0	0.0	7.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	10.0	0.0	0.0	19.2	0.0	0.0	36.3	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0
TOP2B		ENSG00000077097	"DNA topoisomerase II beta"	Q02880	3	25597905-25664907	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Isomerase, Topoisomerase"	"Autism spectrum disorder, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004601, HPA024120, HPA050441"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004601: AB_628384, HPA024120: AB_1858191, HPA050441: AB_2681127"	"unprognostic (2.90e-2)"	"unprognostic (5.17e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (1.86e-7)"	"unprognostic (7.86e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.93e-2)"	19.3	18.8	23.4	23.1	29.7	26.5	21.1	48.4	33.5	24.1	22.4	21.1	18.9	17.1	29.6	25.6	21.1	20.6	20.7	22.7	22.0	19.9	20.3	18.4	17.7	28.2	21.0	28.5	26.8	17.2	43.0	21.6	22.3	26.4	24.7	20.8	17.6	21.3	22.3	31.3	20.9	19.3	24.4	23.4	24.6	20.1	11.3	22.7	60.2	28.3	20.7	27.3	34.8	21.5	5.5	5.6	5.3	4.6	7.8	7.2	2.2	10.7	11.1	24.6	30.1	8.2	10.4	9.8	10.4	13.4	9.7	10.6	5.7	8.5	33.3	7.3	15.0	6.0	9.1	20.3	11.6	16.3	15.9	10.9	50.4	13.8	9.5	5.8	39.4	27.0	7.4	5.8	10.8	9.5	9.8	15.7	22.8	16.9	16.4	12.4	11.9	25.5	9.7	18.6	7.2	8.5	106.6	13.8	15.4	8.7	37.9	12.4	21.5	15.5	11.1	9.5	14.8	11.5	35.3	15.0	13.5	10.5	10.7	11.1	25.4	14.4	35.3	8.8	29.5	8.9	4.2	2.9	5.3	6.3	3.3	6.9	4.3	6.1	6.4	4.3	5.5	7.2	6.4	2.0	7.8	4.6	5.6	4.4	2.2	23.4	29.7	48.4	33.5	22.0	19.9	21.0	28.5	26.4	22.7	59.6	57.9	25.1	36.1	34.8	53.5	109.0	43.3	34.8	40.9	24.4	53.0	41.2	11.6	29.3	2.9	32.2	17.7	23.3	28.8	20.8	35.0	47.5	31.4	33.5	23.1	57.2	57.0	21.5	40.9	4.8	36.2	38.8	21.9	21.6	32.6	46.4	32.0	17.5	31.5	21.9	89.3	32.3	36.7	66.2	27.0	33.0	39.0	45.0	37.9	57.7
TOPBP1	"KIAA0259, TOP2BP1"	ENSG00000163781	"DNA topoisomerase II binding protein 1"	Q92547	3	133598175-133662380	"Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 79.9;Spermatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022451, HPA036738, HPA036739"	Approved		Supported	Nucleoplasm		No	No			Nucleoplasm		"CAB022451: , HPA036738: AB_2675280, HPA036739: AB_2675281"	"unprognostic (7.72e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.76e-5)"	"unprognostic (2.05e-1)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (8.03e-2)"	"unprognostic (3.98e-2)"	"unprognostic (2.59e-2)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (2.74e-3)"	"unprognostic (8.65e-3)"	"unprognostic (7.97e-2)"	"unprognostic (2.52e-1)"	"unprognostic (7.64e-2)"	"unprognostic (1.60e-1)"	13.0	8.2	9.7	16.1	11.7	32.9	17.2	14.4	13.8	9.6	10.8	5.4	8.2	9.7	11.5	10.3	15.0	9.7	8.8	12.1	9.2	7.8	7.4	8.6	10.2	21.3	8.8	9.2	11.0	12.6	10.0	9.8	14.0	10.7	9.5	14.0	5.1	12.0	7.2	10.8	13.6	13.0	11.0	13.1	18.9	10.9	24.6	8.8	38.0	10.3	11.5	20.9	11.0	11.1	2.8	3.1	6.1	2.7	3.0	4.4	1.2	16.0	10.0	16.3	13.2	3.1	4.1	12.2	12.5	10.0	15.5	20.1	13.9	10.2	29.1	11.1	9.1	18.8	18.7	23.4	8.3	24.0	17.6	10.4	27.3	14.5	8.5	3.0	29.1	21.6	4.8	5.2	15.2	9.1	5.8	10.6	17.3	16.9	20.9	12.2	11.0	28.5	15.5	13.4	18.4	8.5	19.3	20.3	21.2	5.5	11.1	15.5	17.2	15.4	8.5	12.9	16.6	14.2	27.2	7.3	16.4	14.9	16.6	13.7	12.6	18.9	56.1	9.7	15.6	14.4	4.6	2.0	6.1	2.2	2.7	3.3	2.8	2.3	2.2	2.0	1.9	2.2	2.3	2.4	3.0	1.5	3.1	4.4	1.2	9.7	11.7	14.4	13.8	9.2	7.8	8.8	9.2	10.7	8.8	20.8	24.5	14.2	6.9	11.0	14.7	7.9	15.3	12.0	30.7	10.4	2.0	15.8	8.3	9.3	56.8	13.2	6.5	23.3	11.5	18.3	8.0	7.5	7.0	8.6	9.8	3.2	6.9	7.4	11.9	79.9	9.5	14.0	8.5	20.8	10.1	10.4	11.7	10.5	9.2	5.0	8.5	12.9	5.2	68.9	51.3	10.0	11.7	13.8	12.4	8.8
TOR1AIP1	"FLJ13142, LAP1B"	ENSG00000143337	"Torsin 1A interacting protein 1"	Q5JTV8	1	179882042-179925000	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 252.7;Late spermatids: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047151, HPA050546, HPA070991"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		17000	"Nuclear membrane"		"HPA047151: AB_2679956, HPA050546: AB_2681167, HPA070991: "	"unprognostic (1.41e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.00e-2)"	"unprognostic (6.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.10e-2)"	"unprognostic (4.40e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.02e-2)"	29.3	26.4	27.1	25.1	28.1	52.2	25.4	28.6	30.5	33.2	40.0	24.6	38.2	11.6	33.6	33.0	30.1	27.6	27.2	29.3	28.3	20.8	27.2	27.1	25.5	28.2	31.7	23.6	42.5	24.6	31.1	30.5	20.3	27.3	33.6	17.0	27.0	21.9	42.9	44.7	17.8	21.6	46.9	26.1	27.8	30.9	23.5	32.2	24.9	34.5	28.8	21.8	40.7	30.5	19.0	27.9	61.0	35.9	21.4	29.4	29.9	13.2	13.3	9.2	11.8	41.8	28.1	17.8	18.0	21.4	16.9	17.4	10.4	25.1	3.4	20.0	18.3	11.9	23.3	8.6	14.4	19.8	22.5	8.7	9.5	12.6	10.1	19.2	32.0	29.4	22.6	11.3	20.6	19.4	18.9	15.0	14.5	13.7	17.6	17.6	11.8	13.1	10.0	13.2	17.2	5.2	8.1	14.5	9.1	16.3	25.9	7.9	10.9	22.2	21.4	29.9	14.3	16.7	33.1	15.4	23.8	10.0	15.6	21.0	20.0	26.1	7.0	8.9	17.8	35.8	45.8	26.4	61.0	24.9	29.1	29.4	17.7	23.0	24.9	27.9	19.0	23.8	24.4	41.0	21.4	35.9	20.2	24.2	29.9	27.1	28.1	28.6	30.5	28.3	20.8	31.7	23.6	27.3	32.2	29.8	29.7	21.3	56.6	38.5	11.5	22.2	17.8	25.4	25.0	19.2	15.7	14.9	11.6	16.7	252.7	29.5	10.5	0.0	21.9	20.2	28.2	41.1	34.7	27.6	24.0	6.4	19.4	31.9	46.0	162.0	44.0	27.6	13.5	20.8	9.9	36.5	21.9	11.5	55.2	15.6	12.9	25.8	37.5	11.2	19.5	32.9	15.2	37.1	8.1	46.4
TOR1AIP2	"IFRG15, LULL1, NET9"	ENSG00000169905	"Torsin 1A interacting protein 2"	"Q8NFQ8, Q9H496"	1	179839967-179877803	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051849, HPA058348, HPA070542"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA051849: AB_2681637, HPA058348: AB_2683687, HPA070542: AB_2686278"	"unprognostic (1.22e-1)"	"unprognostic (8.49e-3)"	"unprognostic (2.61e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.92e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.17e-2)"	"unprognostic (7.64e-3)"	"unprognostic (3.06e-1)"	"unprognostic (3.45e-1)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (9.99e-2)"	"unprognostic (1.05e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.36e-1)"	13.3	16.4	11.2	7.3	13.1	30.4	17.5	12.1	11.6	9.1	19.8	10.0	26.9	15.2	11.4	18.7	15.9	8.5	10.1	11.2	11.1	10.0	11.7	37.9	13.2	9.5	9.7	10.4	13.5	16.4	17.4	19.3	41.3	11.0	9.3	8.3	10.0	9.9	16.9	23.0	12.0	30.7	11.6	12.0	9.0	12.2	8.8	11.2	6.7	17.4	10.5	9.5	10.4	13.4	6.9	9.2	17.7	8.7	4.9	7.4	2.5	12.8	12.9	10.3	21.1	25.4	14.2	40.5	17.0	20.9	13.9	14.2	19.1	22.4	10.4	21.7	18.5	7.7	19.4	17.7	17.7	18.8	11.7	9.6	12.7	21.1	15.8	18.6	13.4	14.7	22.3	13.8	18.7	20.4	12.3	19.5	10.0	24.4	11.2	16.7	7.5	9.6	9.3	24.4	14.4	3.2	10.7	14.4	14.8	10.7	22.3	8.6	21.8	19.3	21.6	16.6	20.8	21.5	9.8	25.1	20.2	18.6	11.2	13.4	17.8	25.3	20.9	11.1	9.8	19.0	17.7	6.6	7.7	7.1	8.7	6.8	6.9	6.8	6.1	4.4	6.9	7.4	7.2	13.4	4.9	7.9	9.2	5.7	2.5	11.2	13.1	12.1	11.2	11.1	10.0	9.7	10.4	11.0	11.2	142.9	48.3	19.0	58.0	222.7	27.1	30.5	122.3	32.1	64.8	73.3	35.3	86.6	21.6	52.0	23.9	50.1	79.9	46.7	55.0	166.0	51.6	49.3	18.5	210.0	37.5	30.2	21.1	42.4	43.5	15.3	54.1	35.3	45.5	47.7	44.5	44.6	76.2	32.8	80.2	38.5	31.3	51.8	41.2	27.2	29.1	218.2	150.8	44.9	38.5	99.9
TOX3	"CAGF9, TNRC9"	ENSG00000103460	"TOX high mobility group box family member 3"	O15405	16	52438005-52547802	"Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 18.7"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 40.8;Intestinal endocrine cells: 59.2;Muller glia cells: 158.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 20.0;HAP1: 9.8;Hep G2: 8.7;OE19: 10.4;RT4: 38.0;SCLC-21H: 13.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA040240, HPA040376"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040240: , HPA040376: AB_10795522"	"unprognostic (1.14e-2)"	"unprognostic (9.75e-3)"	"unprognostic (9.08e-3)"	"unprognostic (3.32e-2)"	"unprognostic (3.50e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.59e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (3.08e-12)"	"unprognostic (1.19e-1)"	"unprognostic (1.31e-1)"		"prognostic favorable (3.95e-4)"	0.7	3.1	7.1	5.0	4.7	0.0	3.9	0.6	6.0	7.0	13.5	6.0	0.2	9.4	1.3	9.2	0.9	3.0	14.8	0.2	3.2	5.3	9.5	5.8	2.7	0.1	5.4	3.6	1.0	7.8	0.0	5.8	0.3	5.1	1.8	15.1	2.7	11.0	0.7	0.3	1.1	13.5	0.9	7.0	0.2	18.7	0.7	4.7	0.0	0.2	0.3	2.1	7.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	1.7	0.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	10.4	0.0	0.0	3.4	0.1	4.7	38.0	13.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	4.7	0.6	4.3	3.2	5.3	5.4	3.6	5.1	4.7	6.0	5.1	0.0	0.2	0.9	2.6	0.6	40.8	17.4	6.8	33.2	0.0	0.0	3.3	1.4	2.5	0.0	22.3	0.0	4.4	0.0	0.3	13.0	0.0	4.9	0.1	38.1	59.2	1.3	0.0	0.8	0.6	0.1	0.0	0.0	31.7	158.0	9.8	8.6	0.0	8.6	1.5	0.0	0.3	0.0	0.7	0.3	0.0	0.0	28.7	1.1
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.4	36.0	19.7	14.2	9.2	11.0	20.8	7.0	15.8	19.4	24.6	1.0	10.0	45.8	31.9	13.8	18.9	43.0	28.5	19.3	18.2	10.2	19.1	18.5	20.2	17.1	27.7	0.4	9.6	13.9	22.5	9.4	26.1	11.2	19.0	6.2	0.9	1.8	9.9	34.6	31.1	22.7	19.8	2.5	0.7	60.4	13.9	15.9	14.5	21.6	11.7	20.3	23.1	15.6	5.9	10.2	27.0	1.7	24.6	23.3	7.7	0.3	11.8	12.1	8.8	19.7	6.0	2.4	19.6	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9	8.9	10.9	24.4	8.9	25.4	2.3	2.0	22.9	8.1	12.5	19.2	0.0	30.5	8.3	19.1	7.8	19.6	10.2	0.0	15.7	35.3	17.1	11.3	1.1	16.1	21.7	0.0	29.6	20.3	27.8	2.1	21.3	14.4	11.8	15.4	37.2	6.1	19.5	0.0	15.9	6.5	2.2	12.9	20.1	0.5	4.2	28.7	18.8	15.7	50.6	7.4
TP53BP2	"53BP2, ASPP2, PPP1R13A"	ENSG00000143514	"Tumor protein p53 binding protein 2"	Q13625	1	223779899-223845972	"Cancer-related genes, Predicted intracellular proteins"	"Apoptosis, Cell cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021603, HPA050429"	Supported		Enhanced	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA021603: AB_1844384, HPA050429: AB_2681124"	"unprognostic (1.29e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.83e-1)"	10.0	8.3	26.5	17.2	28.7	38.8	20.8	9.3	17.9	10.9	12.0	12.6	8.1	7.9	11.9	9.8	15.9	9.4	17.4	10.9	17.3	14.7	10.1	13.9	21.4	18.6	18.7	8.6	15.5	13.0	16.4	8.3	8.2	12.9	9.6	9.5	17.7	10.2	8.1	12.0	9.9	9.5	12.2	13.0	10.6	9.7	10.2	14.9	17.3	22.1	7.4	11.7	11.8	14.8	2.2	2.9	6.7	2.7	7.2	4.0	2.0	15.6	7.9	21.4	13.5	7.6	7.5	13.7	10.1	14.4	14.8	12.7	16.3	9.5	0.0	8.9	8.4	10.7	10.7	16.7	6.0	19.9	30.2	16.4	20.8	7.6	5.5	15.5	17.1	14.6	8.9	6.7	13.6	14.0	11.1	8.7	11.6	26.3	15.8	12.2	4.5	12.9	10.6	18.5	9.5	7.7	17.2	22.3	1.7	13.3	9.9	18.6	24.0	11.1	13.9	14.6	14.7	7.8	23.5	10.1	15.2	10.8	16.3	18.9	7.8	8.1	13.0	9.2	11.5	17.3	6.7	2.7	1.6	2.3	2.6	2.8	2.2	2.6	4.0	2.9	1.9	2.7	1.9	3.2	7.2	2.0	1.7	1.6	2.0	26.5	28.7	9.3	17.9	17.3	14.7	18.7	8.6	12.9	14.9	44.7	24.3	6.5	41.6	15.2	4.4	15.4	12.7	17.4	42.1	7.0	49.1	9.1	1.7	18.3	0.9	10.9	9.1	23.3	9.3	5.0	17.9	31.4	47.4	9.7	8.6	0.0	14.3	10.4	14.8	1.4	9.8	15.0	8.5	6.4	7.9	6.9	17.8	5.8	8.1	4.4	45.8	0.0	20.8	11.4	22.2	10.2	4.0	10.9	9.8	38.8
TP63	"EEC3, KET, NBP, OFC8, p51, p53CP, p63, p73H, p73L, SHFM4, TP53CP, TP53L, TP73L"	ENSG00000073282	"Tumor protein p63"	Q9H3D4	3	189631416-189897279	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease mutation, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 83.2;skin 1: 54.2"	"Group enriched"	"Detected in many"	12	"Basal keratinocytes: 244.6;Suprabasal keratinocytes: 247.4"	"Group enriched"	"Detected in many"	11	"cervical cancer: 37.9;head and neck cancer: 73.3;lung cancer: 37.3;urothelial cancer: 21.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HaCaT: 23.8;HBEC3-KT: 45.6;hTCEpi: 34.6;hTERT-HME1: 33.1;RT4: 50.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB000083, HPA006288, HPA006289, HPA007009, HPA007010"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000083: AB_2207187, HPA006288: AB_1080334, HPA006289: , HPA007009: , HPA007010: AB_1080336"	"prognostic favorable (1.07e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.38e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.87e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.74e-3)"	2.9	0.1	0.2	0.7	0.1	0.0	7.2	0.1	0.2	9.5	0.1	0.1	5.7	0.0	0.3	8.0	33.7	0.3	0.0	0.2	0.1	0.1	0.4	0.1	1.2	0.2	0.1	0.2	0.1	0.1	0.0	0.3	7.8	0.8	9.6	0.0	0.3	9.0	7.8	83.2	54.2	0.1	2.7	0.6	0.1	0.1	1.2	0.0	9.0	0.4	36.7	26.1	9.6	19.2	3.7	1.3	3.0	0.9	1.2	1.2	0.2	0.6	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	23.8	0.0	45.6	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.0	34.6	0.0	33.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.1	0.3	0.1	0.0	0.2	2.0	0.4	1.1	0.9	0.5	0.7	3.7	1.2	1.0	0.4	1.7	0.8	0.7	3.0	1.2	0.9	1.3	0.8	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.8	0.0	0.0	4.0	0.0	20.4	244.6	0.0	0.6	0.0	1.4	5.7	0.0	0.0	18.7	0.0	0.2	0.7	0.3	0.0	0.0	0.2	1.8	1.0	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	8.5	1.0	0.0	0.0	1.2	0.0	1.1	0.0	0.0	0.0	0.5	0.3	2.6	247.4	7.4	0.0	0.0	10.1
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 640.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	21.6	18.7	28.1	16.3	22.6	20.2	29.6	24.9	16.7	17.6	16.4	28.2	18.5	25.4	19.3	16.9	12.1	28.4	21.1	17.0	21.8	19.0	23.1	33.8	30.3	19.7	12.1	36.0	22.2	15.4	10.3	26.5	20.6	16.3	20.7	14.6	40.7	22.9	18.7	18.7	17.9	9.6	30.9	19.8	6.5	21.2	22.0	22.0	14.4	26.1	15.3	24.3	29.0	19.3	15.6	40.1	21.4	23.0	29.1	17.6	16.8	19.4	30.1	25.1	29.3	23.2	11.3	18.4	15.7	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8	202.5	98.3	78.9	89.1	89.9	87.4	160.6	35.7	133.8	120.6	55.8	74.6	117.3	19.9	88.2	106.7	100.9	41.3	23.3	65.3	89.1	87.0	62.9	77.5	34.3	63.0	93.8	65.1	57.1	60.2	23.6	116.2	74.5	52.3	147.9	49.2	93.4	74.7	52.6	110.3	23.7	104.0	129.4	82.9	640.0	239.5	86.7	126.1	97.0	64.6	75.6
TRA2B	"Htra2-beta, PPP1R156, SFRS10"	ENSG00000136527	"Transformer 2 beta homolog"	P62995	3	185915906-185938136	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Activator, Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011692, HPA063597, HPA064972"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		40000	Nucleoplasm	Cytosol	"CAB011692: AB_778565, HPA063597: AB_2685054, HPA064972: AB_2685396"	"unprognostic (9.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.58e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-3)"	"prognostic favorable (2.15e-4)"	"unprognostic (1.07e-1)"	"unprognostic (3.22e-3)"	"unprognostic (1.71e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.38e-1)"	"unprognostic (4.36e-2)"	36.2	38.0	34.9	52.5	32.4	34.5	34.1	29.8	29.1	30.5	39.5	20.3	31.7	22.4	37.8	32.3	36.5	27.1	31.0	26.4	29.9	30.1	33.0	37.1	27.1	36.9	29.8	21.9	28.9	31.0	28.6	31.3	38.0	20.9	31.6	27.5	26.1	26.6	32.3	50.8	22.7	24.9	35.7	27.1	31.9	28.7	38.4	25.1	57.2	29.6	47.3	42.8	34.0	50.3	34.5	37.0	30.7	21.0	20.6	25.0	10.7	31.8	13.1	33.0	16.8	9.6	7.6	18.2	25.8	16.7	28.5	22.6	21.1	16.8	30.8	31.1	13.2	19.7	20.8	36.1	25.1	33.6	25.9	22.9	28.8	11.9	28.0	12.8	30.5	23.3	7.3	12.5	16.8	16.3	9.2	21.8	15.4	27.5	19.7	21.8	16.7	75.5	44.3	49.2	31.1	20.5	45.9	26.6	35.9	27.7	13.9	24.5	24.4	17.0	24.0	30.4	17.7	24.2	33.9	12.4	19.3	25.3	16.1	38.8	36.3	88.4	57.5	19.9	35.5	30.4	30.7	21.0	16.1	20.2	17.1	18.1	31.7	19.8	18.7	18.3	34.5	25.0	22.7	22.1	20.6	18.6	37.0	18.5	10.7	34.9	32.4	29.8	29.1	29.9	30.1	29.8	21.9	20.9	25.1	59.6	114.4	168.3	155.0	229.4	101.5	57.6	104.4	62.9	102.4	66.3	184.6	157.7	61.3	105.4	125.7	154.8	106.8	233.6	94.8	196.4	163.4	151.8	191.8	78.1	151.9	68.3	218.4	179.9	244.9	31.1	118.2	213.7	128.2	216.4	142.0	89.2	85.0	121.0	110.3	42.8	196.4	103.5	173.1	132.6	147.0	227.8	179.8	202.0	165.8	133.4
TRAF2	"RNF117, TRAP3"	ENSG00000127191	"TNF receptor associated factor 2"	Q12933	9	136881912-136926607	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004603, HPA009972, HPA010634"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"CAB004603: AB_628389, HPA009972: AB_1080350, HPA010634: AB_1080347"	"unprognostic (7.77e-2)"	"unprognostic (4.54e-3)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (4.91e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.28e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.80e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-2)"	7.3	6.6	8.7	20.3	10.4	15.9	8.6	16.0	10.0	7.3	8.7	7.4	7.3	11.1	12.3	6.9	12.3	9.0	8.3	8.3	7.5	6.5	8.5	12.3	11.5	19.7	11.2	8.3	6.8	13.9	5.9	8.8	12.1	8.1	10.2	6.2	7.5	13.0	10.1	6.4	13.0	10.4	10.6	8.2	13.8	10.7	13.7	6.4	16.4	14.7	5.2	15.9	8.4	37.5	12.6	11.5	6.7	8.3	10.1	17.4	6.2	10.6	32.9	8.9	7.9	2.5	4.0	17.5	8.8	4.9	12.9	8.8	20.3	19.4	13.3	11.5	5.5	17.5	28.2	12.2	14.4	5.3	20.2	9.9	10.0	29.8	12.6	3.7	9.9	10.4	3.0	4.4	10.5	6.0	4.9	6.1	12.4	16.9	15.2	5.7	15.5	15.9	14.2	14.5	24.5	14.8	15.1	13.7	18.1	7.9	8.4	14.6	6.8	11.0	25.9	10.0	10.4	18.6	11.6	6.8	16.9	10.9	11.0	14.8	6.4	10.3	13.3	6.0	8.1	12.4	1.3	3.7	6.7	10.4	4.2	14.6	12.6	11.1	13.0	4.9	10.0	9.1	10.9	3.3	10.1	8.3	11.5	17.4	6.2	8.7	10.4	16.0	10.0	7.5	6.5	11.2	8.3	8.1	6.4	0.0	8.3	13.4	12.1	10.5	6.8	6.3	12.7	0.0	3.4	5.2	0.0	16.7	3.3	18.9	2.5	8.2	15.4	0.0	11.0	25.5	7.4	11.2	10.3	4.0	11.7	17.5	10.9	4.3	2.4	2.7	3.1	7.3	13.5	55.1	9.2	4.2	16.3	5.8	7.4	5.0	10.0	19.4	12.7	9.2	22.0	11.2	14.9	13.8	12.4	9.1
TRAP1	"HSP75, HSP90L"	ENSG00000126602	"TNF receptor associated protein 1"	Q12931	16	3651639-3717597	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041082, HPA044227"	Enhanced		Enhanced	Mitochondria		NA	NA		1100000	Mitochondria		"HPA041082: AB_2677291, HPA044227: AB_2678864"	"unprognostic (1.18e-1)"	"unprognostic (1.51e-1)"	"prognostic favorable (1.80e-4)"	"unprognostic (7.10e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.69e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.24e-2)"	"unprognostic (6.68e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.82e-2)"	19.1	20.3	19.1	15.9	29.7	14.2	17.5	21.1	38.5	16.8	23.0	18.1	13.1	18.6	17.1	14.2	34.4	28.5	20.8	40.0	22.1	20.4	24.6	62.6	12.3	20.6	17.1	30.7	23.5	54.7	18.3	13.6	15.5	23.2	15.4	17.8	16.4	19.7	13.7	80.3	31.2	14.1	20.9	12.3	15.2	19.7	20.0	15.1	16.4	16.0	39.8	21.2	17.2	18.2	20.0	24.6	1.3	17.0	12.7	22.3	13.8	19.1	48.1	10.0	26.4	11.1	11.4	29.7	11.6	10.6	27.0	17.0	59.8	27.4	61.7	22.1	11.2	7.3	36.1	39.0	29.1	11.9	23.6	42.6	18.0	41.3	41.8	19.1	32.2	12.4	13.4	20.3	21.4	33.6	9.8	18.5	21.0	56.4	22.5	8.8	62.6	23.1	23.9	18.5	22.8	24.5	53.2	21.0	85.1	20.0	14.3	47.7	18.2	12.1	44.8	23.3	8.4	32.4	23.4	10.4	11.4	20.3	19.9	16.9	24.1	26.5	48.5	7.1	26.0	15.5	0.0	10.8	0.3	11.7	17.0	22.3	20.0	17.1	14.8	24.6	13.9	20.3	17.1	1.3	12.7	12.3	3.6	14.2	13.8	19.1	29.7	21.1	38.5	22.1	20.4	17.1	30.7	23.2	15.1	20.8	17.4	12.6	35.8	22.6	26.7	1.7	43.3	20.1	14.8	29.6	9.8	94.7	74.6	58.6	17.5	15.5	13.6	0.0	47.2	42.8	18.6	22.2	16.1	41.4	41.2	44.5	34.1	14.1	14.2	10.0	15.3	15.9	11.8	36.1	32.9	17.6	32.3	3.5	20.1	84.4	17.9	19.4	30.1	35.4	77.7	24.6	56.2	10.2	65.0	31.9
TRAT1	"HSPC062, TCRIM, TRIM"	ENSG00000163519	"T cell receptor associated transmembrane adaptor 1"	Q6PIZ9	3	108822698-108855005	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"blood: 57.9;lymphoid tissue: 128.9"	"Cell type enriched"	"Detected in some"	10	"T-cells: 74.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 57.9"	"Group enriched"	"Detected in many"	160	"granulocytes: 53.1;T-cells: 57.9"	"Group enriched"	"Detected in some"	23	"JURKAT: 16.4;MOLT-4: 38.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002356, CAB026130, HPA072760"	Enhanced		Enhanced	"Plasma membrane,Mitotic spindle,Centriolar satellite"		NA	NA			"Plasma membrane"	"Mitotic spindle, Centriolar satellite"	"CAB026130: , HPA002356: AB_1080375, HPA072760: "	"unprognostic (1.54e-4)"	"unprognostic (1.41e-3)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.84e-2)"	"unprognostic (2.19e-3)"	"unprognostic (1.87e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.21e-3)"	"unprognostic (8.96e-3)"	"unprognostic (8.03e-2)"	"unprognostic (4.32e-1)"	"unprognostic (2.86e-5)"	"unprognostic (3.12e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.90e-4)"	"unprognostic (4.36e-2)"	2.6	0.3	0.2	8.2	0.2	1.8	1.3	0.2	0.3	0.8	1.0	0.1	0.1	0.9	0.7	0.3	0.9	0.8	1.9	0.7	0.2	0.2	1.1	1.0	4.0	17.8	0.2	0.2	0.5	0.5	0.0	0.4	0.3	0.3	1.1	1.0	0.1	1.9	0.3	0.4	1.0	5.5	0.2	0.3	9.0	1.6	0.5	0.1	128.9	1.1	1.0	9.8	2.8	1.1	0.1	0.1	53.1	0.1	0.3	57.9	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.4	0.0	1.1	0.0	0.0	38.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.1	0.0	10.5	0.0	21.2	0.1	42.1	21.6	0.0	0.0	57.9	14.2	0.6	0.3	0.1	0.1	17.9	22.9	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.3	0.1	0.0	5.6	0.9	0.1	7.4	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	2.3	0.6	0.2	0.0	0.0	1.8	0.0	1.4	0.0	0.2	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	6.9	0.1	74.0	0.0	0.0
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 20.8;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 55.1"					"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	4.9	8.7	9.3	7.7	8.7	16.7	4.0	18.1	10.8	12.0	5.1	2.9	9.7	4.2	10.0	4.0	12.6	7.2	6.9	2.8	4.5	3.9	5.2	1.4	4.0	9.2	2.5	4.7	10.2	2.5	7.5	9.3	3.4	3.5	8.8	4.7	7.3	3.7	5.2	1.3	8.4	6.6	8.6	4.9	9.0	5.6	11.2	4.8	23.4	3.3	3.6	12.7	13.3	11.0	0.4	1.4	8.1	1.1	2.7	3.0	1.1	5.2	3.6	4.1	5.2	1.9	4.3	5.8	4.0	6.4	4.6	3.8	0.0	2.8	4.9	0.8	6.0	6.3	6.3	5.2	4.9	3.7	55.1	0.4	5.2	3.0	0.0	1.3	9.6	16.9	1.7	6.9	4.1	1.6	4.1	0.0	3.3	0.0	1.6	2.0	1.1	2.4	16.4	4.5	3.8	3.8	4.5	0.3	1.8	2.7	6.5	3.3	1.7	2.4	0.0	0.4	2.3	2.3	13.1	1.7	2.6	3.0	4.2	1.1	0.6	3.5	5.3	1.7	8.8	0.0	2.1	1.1	8.1	3.0	0.4	2.9	0.4	2.2	2.7	1.4	0.0	1.9	2.0	3.8	2.7	0.2	1.2	2.1	1.1	9.3	8.7	18.1	10.8	4.5	3.9	2.5	4.7	3.5	4.8	3.0	2.2	0.8	2.6	7.3	10.8	1.6	2.5	4.0	5.7	5.2	0.0	2.7	0.0	1.3	2.3	3.8	2.3	0.0	0.9	0.7	7.0	1.7	11.5	0.0	2.7	7.9	2.9	8.0	4.4	2.0	13.0	5.8	3.3	1.8	1.9	4.9	0.9	2.9	20.8	0.2	0.5	25.8	4.4	2.4	6.1	6.5	1.0	7.0	2.8	3.4
TRIM11	"BIA1, RNF92"	ENSG00000154370	"Tripartite motif containing 11"	Q96F44	1	228393673-228406840	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028541, HPA043879"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA028541: AB_10600833, HPA043879: AB_2678711"	"unprognostic (1.73e-1)"	"unprognostic (9.73e-3)"	"unprognostic (5.48e-3)"	"unprognostic (7.73e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (7.42e-5)"	"unprognostic (1.08e-1)"	"unprognostic (9.74e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.40e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	8.8	9.2	8.9	13.8	16.5	33.2	23.8	45.2	11.5	8.7	11.2	6.4	15.1	10.1	8.7	10.6	13.3	9.4	13.9	6.9	9.2	8.5	7.7	7.1	27.5	18.6	9.0	8.0	9.0	11.9	8.5	7.2	9.4	7.1	10.5	9.7	6.0	14.4	18.2	5.0	12.5	11.8	8.6	6.0	16.5	12.6	9.5	7.8	20.0	9.0	9.7	13.1	9.5	24.3	6.4	6.9	10.0	11.4	9.4	11.8	5.4	13.9	13.2	7.1	9.7	5.4	4.4	33.6	9.1	6.1	10.6	8.5	16.1	12.2	10.5	10.2	6.1	7.0	22.7	8.6	8.8	4.5	11.6	20.6	8.7	12.2	8.6	14.6	10.9	13.2	6.0	14.0	11.0	5.5	5.4	5.2	17.2	19.7	13.5	5.4	9.0	13.2	17.2	18.1	11.8	11.7	13.0	6.4	12.6	6.9	17.1	11.9	21.8	7.6	21.6	12.0	3.0	15.3	18.3	5.8	6.8	9.5	15.7	18.8	13.9	9.2	9.2	8.4	8.8	10.6	6.1	6.9	8.3	9.6	8.2	10.2	5.8	10.7	11.8	6.9	6.4	6.3	8.4	10.0	9.4	11.4	5.5	9.8	5.4	8.9	16.5	45.2	11.5	9.2	8.5	9.0	8.0	7.1	7.8	3.0	7.2	3.9	12.3	14.1	12.6	2.8	7.6	4.0	7.9	1.8	2.0	13.8	14.9	13.0	105.9	8.3	22.7	0.0	9.7	12.0	7.0	15.1	5.7	4.9	10.0	4.8	13.8	6.7	10.0	12.4	8.9	9.7	5.0	25.2	16.1	8.1	14.3	17.3	7.1	6.3	1.7	6.5	9.7	5.5	11.8	16.9	47.9	24.9	13.4	22.9
TRIM24	"hTIF1, RNF82, TIF1, Tif1a"	ENSG00000122779	"Tripartite motif containing 24"	O15164	7	138460334-138589993	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 43.3;HMC-1: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043495, HPA061717"	Approved		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"HPA043495: AB_10962915, HPA061717: AB_2684592"	"unprognostic (2.40e-1)"	"unprognostic (9.52e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.96e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (9.94e-4)"	"prognostic favorable (6.57e-4)"	"unprognostic (4.01e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.25e-2)"	"unprognostic (5.54e-2)"	"unprognostic (6.34e-2)"	10.3	31.4	10.4	11.2	10.6	8.8	8.8	8.5	10.7	9.4	9.2	14.6	5.7	9.4	9.0	8.5	11.3	7.0	10.3	9.7	8.4	8.5	9.6	21.5	10.7	8.5	10.5	8.0	29.9	11.6	20.7	7.3	13.5	8.4	13.6	9.1	7.5	10.1	7.1	16.0	9.8	14.1	9.4	8.0	8.5	10.8	24.1	11.3	34.8	8.8	9.2	8.9	11.3	11.2	1.3	1.9	3.7	2.5	2.2	2.7	0.8	4.2	5.2	43.3	12.5	2.9	2.7	3.3	3.9	4.2	3.1	3.0	8.2	3.9	8.1	3.9	3.8	6.4	2.3	21.0	3.3	4.6	6.2	5.2	17.9	3.9	25.2	3.9	13.9	58.5	2.4	3.5	2.6	4.1	2.2	7.3	4.5	20.2	5.0	3.7	8.2	23.7	12.6	16.5	22.1	4.7	18.8	5.1	6.8	6.9	12.6	9.0	20.5	7.3	6.6	2.1	15.7	4.5	9.2	3.1	3.6	3.0	6.3	5.4	4.6	5.0	13.8	6.0	9.2	5.2	1.1	2.3	3.6	2.2	2.5	0.4	0.9	1.9	1.2	1.9	1.3	1.8	2.0	3.7	2.2	1.1	1.4	2.7	0.8	10.4	10.6	8.5	9.7	8.4	8.5	10.5	8.0	8.4	11.3	47.6	42.2	4.5	11.6	12.4	13.3	38.8	15.3	17.4	20.5	7.0	15.7	25.9	5.0	6.3	45.5	13.2	8.0	0.0	10.6	11.7	11.8	10.1	38.3	28.4	9.2	38.1	9.7	14.1	11.2	28.3	13.0	12.4	13.5	4.6	8.2	28.0	10.1	9.3	15.2	7.7	20.8	12.9	9.9	43.1	8.5	10.3	18.5	10.2	15.5	12.2
TRIM28	"KAP1, PPP1R157, RNF96, TF1B, TIF1B"	ENSG00000130726	"Tripartite motif containing 28"	Q13263	19	58544091-58550722	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010066, HPA064033"	Supported		Enhanced	Nucleoplasm	"Intracellular and membrane"	NA	NA		140000	Nucleoplasm		"CAB010066: AB_2209905, HPA064033: AB_2685179"	"unprognostic (2.76e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.99e-1)"	"prognostic unfavorable (1.85e-6)"	"unprognostic (1.20e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.92e-3)"	"unprognostic (9.28e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.67e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.22e-1)"	"unprognostic (3.28e-2)"	24.2	26.4	17.9	40.1	20.6	52.2	30.6	34.5	26.3	46.7	36.5	26.2	26.2	26.8	43.3	30.0	34.1	34.5	38.5	28.4	18.5	16.4	27.3	42.3	29.5	38.1	29.2	22.7	69.3	47.0	30.7	25.7	45.6	22.8	37.6	18.5	21.5	31.8	32.4	56.5	41.2	27.5	38.4	17.9	34.9	32.9	48.1	23.1	119.9	50.6	33.5	33.5	34.0	46.4	13.7	14.6	5.0	7.6	16.0	16.9	6.3	36.5	78.7	42.3	31.2	18.5	14.2	47.2	24.0	21.8	23.5	18.0	54.8	30.8	40.2	15.9	20.7	43.6	25.1	47.8	34.6	15.4	20.6	221.1	69.2	35.7	43.6	19.7	43.9	44.5	19.2	19.3	30.0	23.5	19.8	21.9	47.6	33.6	22.7	21.6	54.1	61.3	54.1	29.6	37.7	50.7	58.2	25.6	43.2	21.0	60.7	42.4	33.2	25.1	32.7	13.4	13.1	22.4	42.7	20.2	55.3	21.9	12.0	43.0	29.3	47.7	45.0	25.0	32.8	35.0	1.3	7.1	5.0	8.9	7.6	11.6	11.5	12.8	12.3	9.0	13.7	16.9	15.1	3.8	16.0	4.9	14.6	8.2	6.3	17.9	20.6	34.5	26.3	18.5	16.4	29.2	22.7	22.8	23.1	11.9	15.2	37.3	46.8	57.1	60.0	8.4	40.8	8.1	17.0	31.4	25.5	50.7	19.9	38.6	75.8	40.5	45.0	0.0	47.9	51.6	41.1	44.2	21.8	31.0	40.2	52.4	62.0	26.4	32.9	81.1	60.9	36.2	27.0	29.7	61.8	50.0	49.3	45.6	38.9	32.1	31.8	58.2	46.4	124.7	74.6	53.1	46.9	30.5	58.1	39.7
TRIM65		ENSG00000141569	"Tripartite motif containing 65"	Q6PJ69	17	75880335-75897003	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021575, HPA021578, HPA064820"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA021575: AB_1858314, HPA021578: AB_1858315, HPA064820: AB_2685359"	"unprognostic (1.82e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (4.74e-6)"	"unprognostic (5.36e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.78e-1)"	"unprognostic (5.82e-2)"	"unprognostic (6.00e-3)"	"prognostic unfavorable (1.82e-5)"	"unprognostic (2.86e-3)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-3)"	"unprognostic (7.50e-3)"	15.5	8.2	12.8	12.1	20.0	10.8	13.6	26.7	16.6	15.7	12.7	17.6	11.9	13.9	15.7	9.3	14.0	14.4	12.9	11.0	16.5	12.3	11.3	8.2	13.3	14.6	22.4	8.1	17.7	15.7	14.9	12.7	8.1	16.1	12.4	12.0	15.8	14.7	15.2	16.5	21.6	12.8	13.0	11.4	17.2	12.7	5.4	21.3	11.7	13.1	11.0	14.8	12.7	15.4	5.3	3.4	4.4	3.0	5.2	5.9	1.6	13.6	14.8	5.3	14.9	9.8	13.6	2.6	5.5	7.3	9.3	6.9	5.3	11.7	14.7	4.0	5.8	10.5	9.5	11.1	12.3	4.0	6.6	19.8	11.9	13.5	7.9	10.4	12.5	12.7	9.8	9.8	6.2	10.0	6.6	20.5	18.5	18.2	14.8	5.6	14.7	22.6	20.1	12.2	13.3	12.3	21.1	7.1	23.2	6.8	5.1	11.9	11.4	8.7	13.3	14.6	6.8	15.8	15.1	11.0	19.5	9.0	8.7	10.2	12.5	4.6	3.8	12.4	20.2	8.3	2.8	3.0	4.4	5.2	2.7	5.9	4.1	3.9	5.3	2.7	5.3	4.3	4.2	3.1	5.2	1.5	3.4	3.5	1.6	12.8	20.0	26.7	16.6	16.5	12.3	22.4	8.1	16.1	21.3	6.0	4.5	7.6	5.3	2.6	15.0	3.4	5.1	1.4	3.4	8.7	11.8	0.7	1.7	3.3	0.3	5.2	2.3	23.3	3.0	3.0	4.1	4.2	6.9	3.2	8.0	4.8	0.0	6.2	5.6	0.0	12.7	7.9	8.5	1.0	6.9	7.1	4.7	2.9	8.9	4.0	12.2	0.0	3.8	0.5	2.5	3.1	0.5	5.0	4.8	2.5
TRIM8	"GERP, RNF27"	ENSG00000171206	"Tripartite motif containing 8"	Q9BZR9	10	102642310-102660680	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023560, HPA023561"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			Nucleoplasm	"Vesicles, Cytosol"	"HPA023560: AB_10600414, HPA023561: AB_10601861"	"unprognostic (4.32e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.02e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.03e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.15e-3)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.36e-2)"	31.7	18.4	26.1	23.9	25.2	17.0	18.0	26.1	31.6	31.8	19.5	22.9	15.4	15.8	18.0	14.3	17.8	21.6	19.8	25.0	23.2	18.0	27.2	21.9	23.0	25.4	20.1	20.0	19.3	35.9	24.7	14.7	17.5	16.3	17.4	8.1	19.4	28.5	18.5	34.8	14.6	23.7	13.6	15.7	22.5	21.2	11.7	21.9	48.3	26.6	14.5	30.3	21.4	15.9	9.0	11.9	17.8	5.3	5.5	7.2	3.9	26.9	6.3	6.3	10.2	6.9	14.1	5.8	9.7	19.7	10.5	8.5	11.4	32.6	8.7	26.0	21.5	4.6	9.9	4.2	13.0	8.7	8.8	8.2	21.9	5.3	26.0	17.6	4.9	8.8	16.1	7.2	23.1	13.7	35.0	14.0	4.5	4.1	13.1	8.2	17.5	9.3	16.4	3.4	9.8	12.9	4.6	14.1	4.3	12.5	19.0	3.8	7.4	5.3	6.6	12.8	7.4	18.8	9.8	25.9	14.2	6.3	7.9	21.7	11.9	7.8	5.0	21.6	12.3	3.6	10.7	4.8	2.6	6.8	4.4	6.7	9.0	7.2	5.3	4.1	7.0	6.4	5.5	17.8	5.5	5.3	11.9	6.9	3.9	26.1	25.2	26.1	31.6	23.2	18.0	20.1	20.0	16.3	21.9	53.6	64.6	14.3	12.5	27.9	37.2	34.1	33.1	37.5	36.4	83.7	7.9	10.3	34.9	50.3	0.9	21.5	18.8	0.0	39.1	2.9	23.8	18.6	8.1	24.1	21.7	27.0	20.7	26.4	31.7	0.4	28.7	27.1	16.9	46.9	30.1	22.7	48.9	17.5	32.2	40.0	14.3	12.9	24.3	2.3	5.3	19.9	9.2	17.5	20.4	18.7
TRIP11	"CEV14, GMAP-210, GMAP210, Trip230"	ENSG00000100815	"Thyroid hormone receptor interactor 11"	Q15643	14	91965991-92040896	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002570, HPA070684"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA002570: AB_1078995, HPA070684: AB_2686295"	"unprognostic (1.65e-1)"	"unprognostic (2.81e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.89e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.78e-6)"	"unprognostic (1.78e-1)"	"unprognostic (5.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.55e-2)"	13.0	15.0	10.5	10.8	12.5	7.7	12.1	18.5	14.1	17.4	13.0	8.8	15.2	11.1	13.3	12.7	14.7	11.4	11.2	12.9	9.2	6.7	15.5	16.1	10.6	9.4	12.2	11.1	16.0	27.1	27.1	34.9	24.4	15.2	14.5	11.0	9.4	15.1	15.3	24.0	12.4	15.9	11.2	10.7	15.2	16.2	14.0	13.5	16.4	18.4	11.1	11.9	15.8	12.5	20.0	12.7	17.0	13.0	12.1	14.1	3.9	12.5	12.8	8.3	8.8	14.7	22.8	12.6	20.0	15.4	10.0	11.4	7.7	20.5	8.8	14.8	17.6	7.8	16.6	10.9	9.7	21.8	13.4	3.3	9.9	11.5	7.3	11.2	11.6	9.9	8.7	11.9	17.6	15.1	11.1	15.8	4.9	6.5	10.2	15.5	17.6	6.6	2.9	3.8	12.3	9.2	8.2	16.0	4.4	8.9	20.6	6.1	5.5	16.2	9.5	6.2	8.8	20.8	5.9	20.9	11.6	8.2	12.0	9.0	9.1	13.9	8.0	13.6	6.6	14.5	8.2	8.8	17.0	13.3	8.0	12.8	11.8	14.1	12.1	6.9	20.0	13.5	14.1	8.7	12.1	13.0	12.7	12.2	3.9	10.5	12.5	18.5	14.1	9.2	6.7	12.2	11.1	15.2	13.5	50.6	65.6	24.1	27.5	14.7	56.7	99.6	35.7	71.0	62.6	36.6	68.7	34.2	14.9	55.0	10.9	42.7	24.5	0.0	40.6	23.8	31.0	32.3	35.9	30.6	22.0	41.3	30.9	30.7	25.7	8.5	57.5	21.2	6.8	33.3	38.0	54.1	40.4	28.1	50.9	21.4	64.7	58.2	23.7	107.2	64.1	14.9	60.6	21.0	28.1	33.1
TRMT6	"CGI-09, GCD10, Gcd10p, MGC5029"	ENSG00000089195	"TRNA methyltransferase 6"	Q9UJA5	20	5937235-5950558	"Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047032, HPA050408"	Approved		Enhanced	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA047032: AB_2679911, HPA050408: AB_2681117"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.11e-1)"	"unprognostic (6.81e-2)"	"prognostic unfavorable (4.70e-12)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.65e-3)"	"unprognostic (2.52e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.87e-3)"	"unprognostic (4.96e-2)"	10.5	12.9	10.5	11.3	12.1	20.6	8.5	15.0	10.5	7.3	7.4	5.7	47.8	5.1	9.1	7.9	11.9	7.9	5.6	13.2	8.4	9.5	10.2	10.1	7.2	13.2	8.3	11.8	9.6	9.6	9.8	13.9	9.4	13.6	7.2	8.2	5.1	8.2	33.9	24.4	9.9	8.6	8.0	8.2	12.2	7.5	15.5	7.9	10.3	8.7	10.6	12.7	8.8	7.9	9.2	17.8	5.9	8.7	13.9	11.6	7.1	25.5	12.6	8.5	13.0	4.8	6.2	11.9	12.3	6.3	12.1	10.1	16.6	11.3	30.5	6.4	6.8	15.8	19.6	17.0	19.6	20.2	6.3	11.9	25.1	5.8	14.8	9.5	23.0	6.6	6.2	10.3	21.5	16.2	4.1	5.1	11.9	15.1	9.5	13.8	7.1	23.9	12.5	19.2	16.5	15.9	15.9	16.9	16.7	8.2	16.3	16.6	25.7	15.0	19.4	19.7	8.5	10.3	11.2	5.0	14.3	13.4	13.2	24.7	15.5	29.9	35.7	6.3	19.0	14.0	2.0	7.9	5.9	9.6	8.7	11.0	9.2	10.8	11.6	17.8	8.2	11.2	11.6	0.8	13.9	7.6	8.1	11.3	7.1	10.5	12.1	15.0	10.5	8.4	9.5	8.3	11.8	13.6	7.9	6.0	16.9	15.9	15.9	19.1	17.7	21.3	12.7	34.8	34.2	27.9	9.8	23.4	29.9	18.1	3.0	15.3	3.9	0.0	26.5	20.1	12.3	14.0	34.6	16.3	15.9	25.4	13.2	3.7	13.2	6.3	10.6	27.0	16.9	9.0	8.2	12.2	17.8	7.0	6.7	17.9	9.8	12.9	20.5	59.7	110.3	21.0	24.5	17.5	9.9	14.2
TSC1	"hamartin, KIAA0243, LAM, TSC"	ENSG00000165699	"TSC complex subunit 1"	Q92574	9	132891348-132946874	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Chaperone	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 99.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB011568, CAB012481, HPA074132"	Supported		Enhanced	Cytosol		NA	NA			Cytosol		"CAB011568: AB_732752, CAB012481: , HPA074132: AB_2686666"	"unprognostic (1.88e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.67e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.96e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.01e-4)"	"unprognostic (1.84e-2)"	"prognostic favorable (7.91e-4)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"	10.4	13.6	15.8	8.8	26.8	13.6	11.4	32.1	28.3	12.7	10.8	22.6	7.9	9.1	14.6	12.3	10.9	12.4	9.7	17.6	13.0	12.1	13.1	9.4	11.6	10.2	12.5	15.1	21.2	12.1	15.9	19.5	15.8	21.1	11.8	12.6	13.1	11.6	10.4	20.0	13.8	11.2	14.2	12.4	13.7	10.6	36.2	14.9	10.5	16.2	8.6	14.2	10.9	11.1	2.8	3.1	4.8	7.0	4.9	7.1	2.6	6.2	7.4	10.1	8.3	10.4	9.9	19.0	8.4	13.6	8.8	8.7	12.5	7.3	14.6	3.7	16.0	13.4	16.2	11.9	8.5	9.0	7.0	6.3	4.6	14.7	10.2	12.4	6.8	6.3	10.7	6.4	11.2	13.8	8.8	10.1	13.0	8.1	8.0	10.0	11.5	6.1	5.8	13.9	9.2	6.2	7.4	19.1	8.2	3.9	8.2	5.1	7.8	9.8	6.1	4.8	12.5	11.1	4.0	10.4	14.4	8.7	8.6	5.7	4.5	10.0	14.2	8.2	4.0	6.4	4.1	4.4	4.8	6.5	7.0	7.1	1.9	3.6	5.7	3.1	2.8	5.9	5.3	1.7	4.9	3.2	1.8	5.7	2.6	15.8	26.8	32.1	28.3	13.0	12.1	12.5	15.1	21.1	14.9	20.8	25.6	10.8	4.8	6.6	26.0	26.6	7.6	21.4	12.5	10.4	35.3	12.8	11.6	9.5	39.6	8.7	6.3	0.0	6.2	19.5	9.1	6.5	8.1	5.0	7.8	23.8	16.1	12.3	8.7	99.6	14.4	7.4	11.8	8.2	7.9	10.4	10.9	8.4	10.6	7.5	25.2	19.4	8.0	18.9	17.8	7.5	17.6	7.1	9.9	6.5
TSC2	"LAM, PPP1R160, TSC4, tuberin"	ENSG00000103197	"TSC complex subunit 2"	P49815	16	2047465-2089487	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"GTPase activation"	"Cancer-related genes, Disease mutation, Epilepsy, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002225, HPA030409, HPA049679"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB002225: AB_564043, HPA030409: AB_10602483, HPA049679: AB_2680848"	"unprognostic (2.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.05e-3)"	"unprognostic (3.43e-1)"	"unprognostic (8.94e-2)"	"prognostic favorable (5.06e-4)"	"unprognostic (4.32e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.96e-2)"	13.9	11.9	16.9	12.4	20.0	10.9	13.2	35.1	26.9	20.5	17.0	19.4	17.9	14.0	20.1	12.2	13.0	18.6	15.0	14.0	13.3	8.8	11.8	9.8	12.7	10.1	13.8	14.7	21.1	16.1	20.0	18.1	10.6	14.6	13.8	10.8	16.7	22.9	19.6	31.7	14.5	13.2	13.5	11.4	12.9	16.6	21.4	12.9	14.1	20.1	11.3	10.9	18.0	14.0	4.7	5.6	7.7	4.9	3.6	7.0	3.7	7.2	11.6	16.1	18.2	19.2	16.2	13.6	17.4	11.9	13.1	11.2	13.9	13.8	10.9	15.5	14.3	6.1	12.0	9.6	12.6	9.8	8.3	15.8	10.3	22.5	5.7	13.2	12.8	12.5	19.1	8.0	10.6	7.9	15.8	12.3	7.9	10.0	9.8	11.6	14.4	15.2	3.7	16.7	5.4	11.4	24.2	17.6	13.9	5.3	6.5	12.2	23.1	24.8	16.4	8.8	16.7	15.0	9.5	19.4	13.8	9.4	12.3	8.8	21.9	21.8	21.8	5.7	5.2	16.3	6.2	4.9	5.4	7.0	4.7	6.7	4.4	4.4	4.1	5.6	4.7	3.1	4.8	7.7	3.6	3.7	1.5	3.2	3.7	16.9	20.0	35.1	26.9	13.3	8.8	13.8	14.7	14.6	12.9	23.8	17.6	14.9	7.2	8.1	44.2	38.9	20.4	9.4	10.3	19.2	88.4	10.1	3.3	12.8	11.0	19.5	25.8	0.0	12.2	6.5	14.6	9.4	8.1	29.2	9.8	42.9	31.2	34.4	10.5	22.4	26.2	16.6	8.5	7.2	23.8	24.1	15.9	17.5	24.4	6.7	69.1	12.9	11.8	19.4	39.6	8.5	7.8	20.0	24.7	9.2
TSEN2	"MGC2776, SEN2, SEN2L"	ENSG00000154743	"TRNA splicing endonuclease subunit 2"	Q8NCE0	3	12484432-12539623	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, tRNA processing"	Lyase	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 41.2;Rod photoreceptor cells: 33.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027120, HPA027125, HPA027268"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			Nucleoplasm	"Centrosome, Cytosol"	"HPA027120: AB_10600197, HPA027125: AB_10601896, HPA027268: AB_10601347"	"unprognostic (5.58e-2)"	"unprognostic (4.49e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (1.42e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.71e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.99e-2)"	"unprognostic (4.90e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (3.49e-4)"	8.8	10.6	9.7	8.8	19.1	6.7	10.9	16.5	14.0	10.4	9.8	12.7	8.4	5.8	14.0	9.9	7.9	12.8	10.3	14.3	10.5	12.3	9.8	7.3	7.3	10.9	11.5	7.6	18.0	11.9	14.3	15.3	4.9	10.2	10.5	10.9	13.5	7.2	13.1	16.7	15.3	6.1	12.3	12.3	6.1	8.5	11.3	9.1	9.9	12.5	9.6	8.1	8.6	8.3	8.5	7.1	2.6	4.2	5.0	13.7	5.6	7.8	13.7	7.4	9.6	12.5	13.3	17.0	7.4	6.6	8.0	5.8	7.7	8.4	9.4	5.2	6.0	9.5	7.3	12.3	12.7	9.1	7.4	15.2	10.3	18.3	7.9	9.6	16.2	4.0	11.5	14.8	14.5	17.8	5.9	6.4	13.8	15.3	5.2	9.2	14.8	12.4	7.4	10.4	22.2	16.5	9.4	5.1	18.9	11.9	8.1	4.8	8.4	6.9	6.2	5.8	5.3	11.2	11.3	5.7	5.1	5.0	6.9	11.5	4.9	12.5	11.8	6.8	16.4	6.3	2.4	4.2	0.3	6.4	4.2	10.9	8.5	9.8	7.4	5.9	8.3	13.7	11.7	2.6	5.0	3.6	7.1	3.5	5.6	9.7	19.1	16.5	14.0	10.5	12.3	11.5	7.6	10.2	9.1	3.0	3.5	10.9	9.7	2.6	27.2	6.2	15.3	9.4	2.3	10.4	41.2	7.4	1.7	4.9	1.3	5.6	2.6	0.0	3.7	3.2	3.8	5.0	4.7	5.5	4.1	9.5	4.1	3.1	4.0	2.1	8.3	3.2	3.3	1.0	4.7	8.7	3.5	3.5	9.6	5.0	33.9	6.5	5.1	10.3	19.3	4.3	1.6	5.7	8.2	8.0
TSHZ3	"KIAA1474, TSH3, ZNF537"	ENSG00000121297	"Teashirt zinc finger homeobox 3"	Q63HK5	19	31274945-31349547	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.9"	"Group enriched"	"Detected in many"	35	"granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"cerebral cortex: 20.4;hippocampal formation: 16.8"	"HPA008834, HPA071010"	Approved		Enhanced	"Nucleoplasm,Plasma membrane"		No	No			Nucleoplasm	"Plasma membrane"	"HPA008834: AB_1080731, HPA071010: "	"unprognostic (2.56e-1)"	"unprognostic (3.88e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.66e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.91e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (8.76e-3)"	"unprognostic (8.22e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.73e-3)"	5.7	3.3	4.4	4.0	6.6	1.0	5.2	1.1	17.3	13.0	11.6	0.7	2.4	2.5	19.4	8.5	5.6	9.5	11.5	4.6	3.3	2.0	2.8	1.3	4.9	1.2	1.6	8.0	28.0	1.5	1.1	7.2	4.8	2.8	9.5	3.7	4.9	2.8	8.9	1.6	2.5	4.3	16.4	3.3	4.5	6.1	3.3	1.2	0.0	8.5	1.7	0.7	11.1	11.4	0.0	0.0	4.9	2.2	0.0	3.2	0.7	0.0	1.1	0.4	0.0	5.9	13.0	0.0	3.4	4.9	2.1	3.8	0.0	0.7	0.0	0.0	8.4	4.4	0.5	1.5	3.1	4.7	0.0	1.3	0.0	0.0	0.0	11.4	2.8	5.3	7.6	2.8	7.8	3.9	0.0	0.0	2.5	0.0	0.0	9.8	0.5	0.0	0.0	0.5	0.0	0.0	3.3	26.7	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.6	2.7	0.0	2.0	0.0	18.9	6.0	2.1	4.8	0.0	0.0	0.0	12.2	4.9	0.5	0.0	2.2	0.0	3.2	0.8	0.1	0.0	0.9	1.0	0.0	0.0	0.3	0.8	4.9	0.0	0.4	0.0	0.7	0.7	4.4	6.6	1.1	17.3	3.3	2.0	1.6	8.0	2.8	1.2	3.0	0.6	0.0	6.8	4.2	13.9	1.6	0.0	1.4	6.8	3.5	0.0	0.3	0.0	0.3	0.1	6.7	0.0	0.0	0.6	0.2	18.6	3.3	1.1	0.0	9.1	15.9	0.0	19.6	11.6	0.0	16.4	6.1	5.0	0.0	0.0	0.2	0.5	0.0	27.6	0.0	0.1	0.0	10.3	0.0	5.0	1.5	0.7	0.5	0.0	2.4
TSNAX	TRAX	ENSG00000116918	"Translin associated factor X"	Q99598	1	231528653-231566524	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024613, HPA031054, HPA031055, CAB034263"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		100000	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB034263: AB_2272293, HPA024613: , HPA031054: AB_10600415, HPA031055: AB_10602314"	"unprognostic (6.28e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-2)"	"unprognostic (6.52e-3)"	"unprognostic (2.70e-2)"	27.4	29.9	23.9	17.1	26.7	12.0	23.4	28.0	33.1	19.7	16.2	21.9	17.2	15.8	20.0	24.6	18.0	16.4	16.7	22.7	25.1	23.9	29.1	23.0	18.4	22.6	22.1	22.1	18.6	14.6	32.3	36.0	18.3	28.5	21.3	18.0	19.6	17.5	19.9	52.5	20.6	14.8	18.9	28.2	24.0	15.5	17.5	24.4	24.5	26.7	25.4	22.0	19.1	17.3	10.0	11.7	54.6	17.5	18.7	13.5	11.0	11.0	9.1	13.9	11.4	10.3	12.7	15.8	12.6	19.1	16.2	14.0	7.8	15.6	15.6	21.3	13.7	6.0	12.1	11.0	11.4	21.1	13.9	19.2	15.0	9.4	10.3	14.2	24.7	31.9	15.5	12.6	15.6	12.1	10.2	11.7	11.4	24.2	11.1	21.9	4.5	15.9	12.1	20.5	9.3	11.1	15.8	15.3	21.1	18.1	12.8	13.3	25.6	13.1	16.7	42.4	5.9	24.3	42.0	10.9	11.2	10.2	22.4	22.6	18.9	24.9	17.4	18.3	19.6	30.6	54.6	11.2	29.2	11.4	13.5	10.8	10.0	12.3	11.2	11.7	9.9	13.2	12.7	11.4	18.7	17.5	6.8	13.5	11.0	23.9	26.7	28.0	33.1	25.1	23.9	22.1	22.1	28.5	24.4	26.8	32.9	25.4	17.9	38.9	58.2	20.9	38.2	26.8	17.0	40.1	27.5	39.1	46.4	25.0	7.5	33.3	20.5	46.7	27.1	39.0	28.8	14.4	75.1	26.0	42.6	62.0	27.7	27.6	51.1	7.5	31.1	45.0	25.3	37.9	29.8	64.5	23.0	23.4	33.9	36.6	45.9	38.8	35.6	28.1	70.9	44.9	30.3	35.8	22.4	12.2
TSPAN2	"FLJ12082, TSN2, TSPAN-2"	ENSG00000134198	"Tetraspanin 2"	O60636	1	115048011-115089500	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 44.6"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 22.5;Intestinal endocrine cells: 37.7;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 11.9"	"Cell type enhanced"	"Detected in many"		"neutrophil: 35.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 35.0;NK-cells: 25.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 35.1;hTERT-RPE1: 9.8;U-937: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015640, HPA073306"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015640: AB_1858405, HPA073306: "	"unprognostic (4.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (8.89e-4)"	"unprognostic (1.57e-3)"	"unprognostic (1.64e-1)"	"unprognostic (9.73e-6)"	"unprognostic (6.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.48e-7)"	"unprognostic (5.40e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.80e-3)"	3.7	0.6	1.1	4.7	2.5	9.6	3.2	0.9	2.0	20.1	31.0	1.5	8.9	2.5	30.6	6.9	12.3	14.2	10.6	6.1	1.1	2.6	4.0	0.6	3.0	1.5	1.9	1.9	6.5	2.0	6.4	2.0	1.5	11.9	15.2	6.2	1.9	2.2	15.7	2.0	1.6	7.0	44.6	1.6	2.2	10.0	4.4	0.8	2.6	4.0	4.9	0.9	25.4	7.0	0.2	1.2	35.0	2.9	25.9	7.4	3.8	8.5	0.1	0.7	0.0	0.0	0.1	0.0	1.4	0.5	1.4	2.2	1.7	5.2	0.0	35.1	1.9	1.9	1.2	1.1	0.0	1.5	1.7	0.7	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	9.8	0.0	6.9	0.0	0.5	0.0	0.4	4.6	0.7	8.0	1.7	0.9	0.0	0.5	0.0	0.2	3.2	1.8	2.9	2.1	0.9	0.1	4.9	0.1	0.3	0.1	0.1	3.4	0.2	8.0	7.3	0.2	0.0	0.0	15.4	3.8	27.8	2.9	16.6	5.9	0.0	1.9	0.2	7.0	7.4	1.2	0.1	1.2	6.0	35.0	25.9	0.0	1.2	0.9	3.8	1.1	2.5	0.9	2.0	1.1	2.6	1.9	1.9	11.9	0.8	0.0	1.1	0.0	22.5	7.1	0.2	9.2	0.0	10.7	2.3	10.4	0.0	0.1	0.0	16.3	10.8	15.0	0.0	0.0	2.2	3.1	3.1	10.9	0.0	0.0	0.6	0.0	37.7	5.5	0.8	2.7	0.6	0.9	3.3	0.0	0.8	0.0	7.7	0.0	2.8	1.0	0.4	6.5	20.2	0.1	0.9	2.4	0.2	5.0	1.0	9.2
TTC1	TPR1	ENSG00000113312	"Tetratricopeptide repeat domain 1"	Q99614	5	160009113-160065543	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036557, HPA057502"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA036557: AB_10670112, HPA057502: AB_2683450"	"unprognostic (4.34e-3)"	"unprognostic (2.26e-2)"	"unprognostic (3.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (6.62e-2)"	"unprognostic (8.13e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (8.29e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (6.16e-2)"	25.3	28.0	44.4	21.0	36.0	14.3	25.4	31.4	44.9	21.7	25.2	25.4	16.8	16.9	21.3	38.4	24.8	21.0	16.6	33.9	41.7	42.9	31.3	27.7	20.5	26.9	48.9	33.9	23.7	16.0	25.7	23.9	22.0	56.7	22.0	29.4	15.9	23.7	25.1	50.5	21.6	20.6	26.7	37.4	25.2	19.7	20.3	26.6	27.4	26.8	20.0	33.5	25.9	18.0	46.0	38.4	54.2	41.3	43.2	45.3	52.8	24.6	25.8	19.4	32.3	23.0	16.6	22.0	27.8	24.7	30.6	36.4	36.2	28.9	25.4	54.4	23.7	41.7	19.6	25.6	38.0	49.4	47.0	27.2	22.7	20.5	26.0	32.6	37.6	19.1	15.5	25.3	27.0	22.6	22.6	36.6	22.7	21.6	25.4	34.7	19.3	27.2	29.6	21.9	20.2	26.5	26.4	27.1	28.0	38.6	23.3	16.0	18.0	19.2	23.0	51.2	19.0	36.4	36.6	25.7	20.4	17.6	18.1	42.7	18.3	33.3	24.7	28.2	43.0	26.4	47.0	39.1	52.4	32.4	41.3	40.4	46.0	38.4	37.6	38.4	40.6	35.6	39.4	54.2	43.2	39.0	34.1	45.3	52.8	44.4	36.0	31.4	44.9	41.7	42.9	48.9	33.9	56.7	26.6	62.5	43.2	61.0	31.3	41.8	35.3	213.0	38.2	119.1	63.7	43.6	19.6	89.8	137.6	100.6	91.3	58.7	48.5	70.0	92.5	63.6	46.1	30.3	78.8	57.2	77.4	33.4	33.9	48.5	45.7	22.8	43.4	66.2	27.0	80.2	40.1	73.1	84.8	45.2	60.1	114.2	37.9	58.2	62.8	148.9	94.5	41.4	83.5	54.3	45.5	19.2
TTC19	"FLJ20343, MGC19520"	ENSG00000011295	"Tetratricopeptide repeat domain 19"	Q6DKK2	17	15999380-16045015	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Electron transport, Respiratory chain, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023010, HPA052380"	Enhanced		Enhanced	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA023010: AB_1858429, HPA052380: AB_2681806"	"unprognostic (1.04e-2)"	"unprognostic (4.90e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.09e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.72e-2)"	"unprognostic (2.30e-3)"	"unprognostic (5.14e-2)"	"prognostic favorable (5.67e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.85e-2)"	"unprognostic (2.24e-1)"	8.5	13.6	10.3	10.1	16.6	16.4	11.2	16.5	22.6	10.1	13.8	10.3	10.5	18.7	11.1	8.9	9.3	9.9	11.8	13.4	17.0	10.4	15.4	13.2	10.8	7.9	9.2	15.3	12.7	24.8	11.5	15.5	10.1	15.7	12.0	9.6	13.1	14.0	12.7	8.6	13.9	16.1	7.2	8.9	8.3	13.3	6.3	6.8	6.0	18.7	8.0	8.4	10.0	10.9	3.5	2.8	9.0	2.0	1.7	3.3	1.0	6.9	5.9	6.0	10.1	5.1	5.0	4.5	5.9	4.1	2.8	3.0	5.8	12.4	9.9	13.1	3.3	3.8	8.9	8.2	6.8	3.4	16.1	13.9	8.1	7.3	4.9	7.9	8.1	12.5	5.1	5.6	2.3	9.7	7.4	5.9	11.2	4.8	7.1	5.8	6.6	8.7	5.0	9.9	9.3	4.1	13.1	6.7	7.0	8.9	8.3	6.3	4.7	7.6	8.1	14.9	19.1	6.9	3.5	10.9	3.8	1.6	5.4	7.4	5.8	2.5	4.6	9.1	9.1	8.7	9.0	2.0	3.8	2.0	2.0	3.3	2.8	2.5	3.3	2.5	3.5	2.8	3.1	1.7	1.7	1.6	2.8	2.6	1.0	10.3	16.6	16.5	22.6	17.0	10.4	9.2	15.3	15.7	6.8	38.7	30.5	47.9	58.4	93.5	137.2	30.7	33.1	18.7	28.4	43.6	135.5	60.2	59.7	46.3	34.1	65.0	53.6	46.7	35.9	32.8	37.1	61.4	31.1	29.4	22.9	122.3	43.8	28.8	19.2	4.8	38.0	31.9	52.3	30.7	45.4	81.2	37.0	52.6	31.5	37.9	170.0	45.3	31.9	17.6	28.1	102.0	54.8	55.3	51.6	61.7
TTC39A	"C1orf34, DEME-6, KIAA0452"	ENSG00000085831	"Tetratricopeptide repeat domain 39A"	Q5SRH9	1	51287258-51345116	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"Early spermatids: 357.0;Late spermatids: 452.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 23.4"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 23.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 21.9;MCF7: 17.2;SK-BR-3: 53.6;T-47d: 38.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA028098, HPA043440"	Uncertain		Enhanced	Centrosome		NA	NA			Centrosome		"HPA028098: AB_10601705, HPA043440: AB_2678483"	"unprognostic (5.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.35e-2)"	"unprognostic (7.60e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.86e-2)"	"prognostic unfavorable (5.05e-5)"	"unprognostic (1.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.73e-3)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.2	4.9	3.2	6.0	5.5	0.6	23.4	0.7	4.3	8.5	18.0	0.2	8.1	3.3	1.4	10.4	10.4	4.5	17.9	8.3	3.3	7.4	40.4	3.1	12.4	0.5	4.2	2.4	0.9	22.3	6.1	12.1	0.9	10.1	12.3	20.2	3.1	10.1	10.7	2.2	5.6	4.5	0.8	4.9	0.3	18.7	28.2	2.0	0.2	5.5	8.5	6.2	5.0	5.0	0.1	23.4	0.5	0.0	0.0	0.0	0.2	2.2	1.3	0.2	0.1	0.1	0.2	9.5	0.1	0.0	0.0	0.0	5.8	0.9	0.0	4.2	0.1	0.1	0.0	1.2	0.0	0.0	21.9	4.4	0.1	0.5	1.1	0.4	0.0	0.2	0.0	0.5	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	17.2	0.2	0.0	1.6	11.9	0.2	0.0	0.0	1.4	9.4	2.9	7.9	0.7	0.1	53.6	0.5	0.7	38.8	0.2	0.2	0.1	1.0	0.1	0.1	2.2	2.9	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	23.4	0.0	0.2	3.2	5.5	0.7	4.3	3.3	7.4	4.2	2.4	10.1	2.0	3.0	25.1	1.5	3.8	1.3	1.3	11.3	7.6	10.7	4.5	8.7	0.0	0.4	10.0	31.3	357.0	1.4	9.5	23.3	46.7	4.0	0.6	16.7	3.5	0.6	1.6	0.0	39.7	0.6	0.3	452.0	2.3	0.8	0.0	4.6	53.2	1.7	28.2	8.6	2.5	21.6	6.2	6.5	1.4	6.0	5.9	5.6	2.9	1.3	17.1	11.4
TTC4	"CNS1, FLJ41930, MGC5097"	ENSG00000243725	"Tetratricopeptide repeat domain 4"	O95801	1	54715822-54742657	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041608, HPA042459"	Approved		Enhanced	"Intermediate filaments,Cytoplasmic bodies"		NA	NA			"Intermediate filaments"	"Cytoplasmic bodies"	"HPA041608: AB_10794485, HPA042459: AB_10797496"	"unprognostic (4.89e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.62e-4)"	"unprognostic (8.91e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.21e-5)"	"unprognostic (1.39e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.42e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.79e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.76e-3)"	10.9	10.6	14.5	13.4	17.6	3.5	17.1	13.7	14.0	18.2	10.9	12.8	12.7	9.1	14.9	14.1	11.9	15.7	8.0	13.4	14.6	14.0	13.2	16.4	8.9	13.0	13.5	9.3	18.5	16.6	15.6	14.6	12.5	12.9	13.5	10.8	9.2	13.1	14.7	33.3	14.7	8.5	12.8	20.4	10.3	11.2	13.3	12.0	11.7	11.5	15.1	14.0	11.4	13.6	11.5	11.3	8.6	11.7	15.0	14.9	10.5	9.9	7.5	8.9	4.5	14.4	7.3	7.8	13.7	6.8	17.8	10.7	9.4	2.8	18.4	7.4	9.2	19.5	5.8	19.9	13.5	18.0	15.6	15.7	17.7	3.4	5.3	12.6	13.4	4.3	6.5	13.8	25.9	15.9	7.7	7.3	14.5	18.9	2.3	9.6	4.7	11.9	8.1	18.7	13.1	14.4	11.0	18.9	8.3	8.7	2.8	5.8	4.1	11.6	6.2	11.5	15.3	5.6	7.3	7.0	8.7	9.6	8.8	18.4	6.6	11.7	14.6	11.2	15.3	8.8	5.9	10.3	8.6	12.5	11.7	13.3	11.5	10.3	11.8	11.3	11.0	14.9	13.2	0.2	15.0	11.3	9.6	9.3	10.5	14.5	17.6	13.7	14.0	14.6	14.0	13.5	9.3	12.9	12.0	8.9	1.6	4.5	2.5	1.0	4.1	2.8	2.5	4.0	7.9	0.0	0.0	3.1	0.0	2.9	0.4	2.1	1.3	0.0	3.6	2.0	1.7	1.5	6.9	2.4	1.2	4.8	1.2	3.7	1.2	0.0	3.7	1.6	1.7	8.2	1.3	3.3	3.2	1.1	2.5	2.5	3.1	0.0	0.8	7.2	8.7	1.4	1.1	2.2	2.3	1.7
TTI2	"C8orf41, FLJ23263"	ENSG00000129696	"TELO2 interacting protein 2"	Q6NXR4	8	33473386-33513601	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023523, HPA029823"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA023523: AB_1845776, HPA029823: AB_10602337"	"unprognostic (6.30e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.34e-3)"	"unprognostic (5.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.27e-3)"	"unprognostic (1.07e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (9.35e-2)"	10.7	13.1	8.0	9.7	12.2	12.0	10.7	11.1	13.5	11.0	9.3	11.2	6.4	8.7	11.8	10.9	11.4	10.5	7.3	12.7	9.4	7.5	10.7	14.0	9.3	14.9	10.1	10.5	10.9	9.9	11.7	16.5	9.2	9.6	9.8	9.5	11.4	12.1	8.7	14.8	11.0	10.5	9.8	10.7	14.3	9.7	25.7	9.0	22.9	13.2	7.6	17.1	10.3	10.2	22.1	36.7	19.3	14.6	17.2	19.3	24.0	5.2	9.8	12.8	12.7	9.4	6.7	5.4	7.9	9.0	13.3	13.2	7.5	4.4	14.9	12.0	5.8	11.8	9.3	20.5	9.2	11.8	6.7	6.2	8.9	5.8	7.9	10.5	8.1	9.0	5.5	11.8	9.9	9.0	8.0	11.5	19.0	13.5	11.9	9.2	10.5	24.5	8.6	17.1	14.4	6.5	16.7	10.4	7.1	7.3	5.6	15.7	8.3	7.7	7.2	9.6	12.1	7.3	6.7	7.5	8.2	7.3	8.5	7.5	6.5	6.3	22.2	8.1	8.3	8.8	10.4	14.1	19.3	15.7	14.0	16.1	19.2	16.0	15.6	11.9	22.1	19.3	18.1	13.0	17.2	14.6	36.7	15.2	24.0	8.0	12.2	11.1	13.5	9.4	7.5	10.1	10.5	9.6	9.0	6.0	4.5	7.8	6.7	4.7	5.4	0.5	0.0	9.4	6.8	7.0	19.6	8.4	3.3	8.0	8.9	5.8	3.8	0.0	8.0	7.9	5.8	4.4	3.5	4.3	8.3	6.4	2.9	3.1	4.3	1.7	6.4	6.0	5.0	13.6	4.8	6.0	5.9	2.9	7.1	6.8	10.9	6.5	3.8	27.2	10.4	7.0	7.3	6.1	5.3	4.2
TUBA1A	"B-ALPHA-1, FLJ25113, TUBA3"	ENSG00000167552	"Tubulin alpha 1a"	Q71U36	12	49184796-49189324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted intracellular proteins"			"Cancer-related genes, Disease mutation, FDA approved drug targets, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 270.7;smooth muscle: 166.4"	"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 819.1;Ductal cells: 1030.6;monocytes: 926.1"	"Cancer enriched"	"Detected in all"	9	"glioma: 942.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 151.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 226.7;SCLC-21H: 152.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008686, HPA039247, HPA043684, HPA063394"	Enhanced		Enhanced	Microtubules		NA	NA			Microtubules		"CAB008686: AB_1624202, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (3.11e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.56e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.11e-3)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.07e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.27e-3)"	27.8	25.5	82.1	29.4	81.3	24.7	35.4	63.2	163.0	40.6	48.8	210.9	6.9	9.9	71.7	34.8	27.7	65.3	37.9	26.3	99.3	118.3	10.3	4.2	39.8	13.4	131.0	50.2	35.7	9.9	16.0	20.6	23.1	165.2	35.1	26.7	16.7	13.6	53.4	5.9	20.0	14.5	166.4	270.7	11.6	18.3	15.7	50.4	19.4	7.4	7.3	10.6	35.1	14.5	14.8	28.9	151.2	69.2	7.5	15.7	38.4	0.2	10.2	226.7	32.2	20.6	49.9	0.8	19.1	24.5	12.6	29.3	0.6	4.1	8.1	23.8	61.7	23.2	0.4	26.9	6.9	9.8	6.7	9.2	2.7	2.1	2.3	4.0	4.8	0.2	28.1	2.7	24.7	2.5	47.4	74.4	17.7	3.1	9.2	67.2	4.5	20.5	3.9	23.9	0.3	7.6	16.5	16.2	1.0	56.1	0.9	152.7	83.6	5.3	0.4	7.2	37.0	16.1	6.5	63.3	13.5	8.5	1.6	5.5	3.1	8.9	16.2	7.3	7.9	13.4	38.8	23.0	73.1	15.7	48.9	11.5	14.8	13.9	14.3	28.9	14.6	13.6	12.5	151.2	7.5	69.2	9.3	15.2	38.4	82.1	81.3	63.2	126.2	99.3	118.3	131.0	50.2	165.2	50.4	214.4	242.9	85.9	170.9	77.4	225.2	156.6	25.5	819.1	121.7	61.1	72.6	8.0	21.6	1030.6	8.3	170.4	2.2	0.0	13.8	13.6	257.4	39.2	532.6	1.0	383.6	235.2	754.8	152.9	63.0	14.2	179.2	227.9	173.7	926.1	14.3	698.4	320.1	4.2	134.0	28.1	331.3	161.7	313.6	10.0	11.3	86.8	13.3	132.0	9.6	82.6
TUBA4A	"FLJ30169, H2-ALPHA, TUBA1"	ENSG00000127824	"Tubulin alpha 4a"	P68366	2	219249711-219278170	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"			"Amyotrophic lateral sclerosis, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 416.2;Late spermatids: 672.1;Pancreatic endocrine cells: 390.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 79.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004621, CAB005887, HPA039247, HPA043684, HPA063394"	Approved		Enhanced	Microtubules		NA	NA		500000000	Microtubules		"CAB004621: AB_628411, CAB005887: AB_2288001, HPA039247: AB_2676410, HPA043684: AB_2678617, HPA063394: AB_2685003"	"unprognostic (8.08e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.03e-2)"	"unprognostic (2.56e-2)"	"unprognostic (5.18e-3)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (4.54e-6)"	"unprognostic (1.52e-3)"	"unprognostic (4.47e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.38e-3)"	"unprognostic (9.32e-2)"	5.0	9.4	22.4	13.4	30.5	37.7	7.5	23.2	63.3	7.4	13.8	4.5	5.2	8.1	3.4	5.2	27.1	6.1	6.1	23.5	24.9	23.6	13.2	10.5	7.2	20.9	20.4	21.9	6.1	8.0	18.1	6.5	2.9	43.1	7.9	12.4	5.7	15.6	10.7	124.1	63.5	9.5	6.2	6.2	15.7	10.1	8.2	3.3	6.2	3.7	34.8	25.0	9.1	13.9	25.8	4.2	66.8	13.0	14.8	32.0	49.2	19.2	16.1	0.0	0.0	1.7	1.3	0.0	2.9	9.4	0.5	0.3	3.6	20.2	25.4	33.0	2.0	31.9	48.8	9.0	79.7	0.7	14.7	0.1	31.8	30.0	2.6	1.4	10.6	11.5	1.2	29.6	4.3	9.4	5.1	3.3	0.4	3.6	17.4	19.1	0.7	0.0	19.1	6.2	15.1	19.2	1.1	26.2	15.5	24.5	1.4	16.3	0.2	37.9	3.3	0.1	0.3	1.4	9.0	2.2	9.6	5.1	11.1	10.3	7.1	8.6	30.6	35.2	20.2	0.4	22.1	12.5	32.4	22.5	8.6	23.2	25.8	32.0	30.2	4.2	17.7	30.4	29.5	66.8	14.8	13.0	0.7	27.5	49.2	22.4	30.5	23.2	63.3	24.9	23.6	20.4	21.9	43.1	3.3	41.7	43.9	91.6	169.1	161.5	104.5	57.4	17.8	0.0	31.8	47.1	72.6	0.4	119.3	200.8	416.2	26.3	83.1	93.5	178.3	0.4	11.2	32.6	15.1	28.8	6.2	63.5	103.5	29.4	16.6	672.1	15.5	24.6	74.2	4.6	89.4	31.3	390.1	46.0	7.1	67.0	61.4	0.0	21.7	4.5	4.5	213.7	2.1	167.5	43.8	126.3
TUBD1	"FLJ12709, TUBD"	ENSG00000108423	"Tubulin delta 1"	Q9UJT1	17	59859482-59892945	"FDA approved drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 42.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004609, HPA023980, HPA027090"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB004609: AB_628416, HPA023980: AB_1858456, HPA027090: AB_1858457"	"unprognostic (1.92e-1)"	"unprognostic (5.95e-2)"	"prognostic favorable (2.04e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (2.86e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.77e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (6.06e-4)"	"unprognostic (4.97e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.83e-2)"	8.7	8.0	9.3	8.1	13.8	6.8	12.4	19.9	12.2	12.3	11.2	13.5	16.6	6.7	13.6	16.4	18.2	10.0	8.3	8.4	8.9	7.2	8.5	9.3	8.8	10.2	16.1	8.5	16.3	13.2	10.4	18.7	7.2	12.3	12.3	8.2	11.7	11.4	12.2	9.9	11.6	7.5	9.3	13.4	9.3	9.6	9.2	16.4	16.2	15.5	10.3	13.8	14.1	13.0	10.1	8.8	14.1	7.6	8.1	17.6	6.9	6.0	8.3	6.5	6.8	3.7	2.6	5.5	4.7	2.8	6.3	5.2	9.0	3.9	5.5	8.1	1.1	4.3	5.1	9.1	2.8	6.0	3.2	11.1	6.4	7.0	10.6	2.0	3.8	3.5	1.4	4.5	5.4	2.0	2.2	4.9	5.5	13.8	3.8	2.1	42.9	7.8	4.4	5.7	6.7	3.7	8.4	9.6	8.6	2.4	2.8	6.1	3.7	3.4	2.7	3.2	8.2	6.4	3.7	1.5	4.5	10.1	3.1	5.1	4.5	6.8	8.4	2.1	4.3	4.0	5.6	7.6	14.1	10.9	5.0	12.4	10.1	13.5	11.5	5.2	8.6	17.6	14.2	8.2	8.1	5.3	8.8	14.1	6.9	9.3	13.8	19.9	12.2	8.9	7.2	16.1	8.5	12.3	16.4	11.9	45.1	5.4	12.7	14.0	7.1	4.8	7.6	12.0	20.5	3.5	5.9	5.1	10.0	4.6	1.3	7.7	2.6	0.0	4.2	6.5	8.2	11.1	10.5	3.2	3.5	3.2	9.9	6.7	4.8	0.4	5.2	6.2	6.8	3.6	5.5	7.7	3.3	4.9	7.8	3.1	7.7	6.5	10.3	11.4	28.1	14.8	3.3	13.6	5.4	5.7
TUFM	"EF-TuMT, EFTu"	ENSG00000178952	"Tu translation elongation factor, mitochondrial"	P49411	16	28842411-28846408	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Protein biosynthesis"	"Elongation factor"	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018991, HPA024087, CAB075730, CAB075731, CAB075732"	Enhanced		Enhanced	Mitochondria		NA	NA		2800000	Mitochondria		"CAB075730: AB_2665736, CAB075731: AB_2665737, CAB075732: AB_2665738, HPA018991: AB_1858458, HPA024087: AB_1858459"	"unprognostic (1.40e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.23e-3)"	"unprognostic (8.05e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (2.69e-6)"	"unprognostic (5.26e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.22e-2)"	"unprognostic (7.36e-2)"	27.3	47.8	28.8	32.3	31.3	27.2	40.4	22.3	41.4	25.3	41.7	27.1	34.4	44.0	26.6	22.3	40.0	32.7	37.6	69.2	25.6	25.8	45.6	68.4	28.6	46.2	33.1	24.4	25.9	75.0	48.3	22.7	23.0	27.3	23.4	37.6	25.4	40.9	33.1	77.3	28.1	36.1	26.2	25.8	28.4	36.9	47.0	21.5	32.5	37.0	55.4	33.9	26.8	23.3	30.6	57.3	21.7	44.2	25.5	38.8	45.4	29.3	55.9	17.9	37.4	26.0	23.9	36.8	21.5	25.1	34.4	32.6	60.2	32.5	66.1	39.8	21.5	19.7	57.6	42.4	41.7	20.6	26.3	64.9	25.2	45.2	72.8	30.9	45.1	23.5	30.5	33.0	37.1	37.0	22.4	40.9	36.7	56.5	26.1	24.9	59.8	43.2	44.1	40.1	36.1	34.7	59.9	32.5	96.1	29.7	28.8	31.4	38.4	18.8	67.2	29.4	15.4	40.0	36.8	26.0	20.6	24.0	25.4	32.8	39.9	41.3	28.8	26.3	56.7	26.9	21.7	44.2	19.5	31.3	42.3	34.8	30.6	29.7	32.7	57.3	27.5	28.5	29.5	9.1	25.5	31.6	34.9	38.8	45.4	28.8	31.3	22.3	41.4	25.6	25.8	33.1	24.4	27.3	21.5	65.5	70.3	105.7	207.8	149.3	93.5	117.0	178.3	137.9	64.8	167.5	82.5	299.6	283.5	183.0	309.9	94.4	289.0	23.3	252.4	240.7	112.6	188.4	103.9	224.8	230.1	69.9	142.6	95.8	162.5	472.6	101.2	129.8	131.6	183.1	194.4	129.6	169.5	172.7	105.0	374.4	91.2	84.1	142.8	184.3	182.3	136.4	240.1	147.2	348.8	236.5
TWISTNB		ENSG00000105849	"TWIST neighbor"	Q3B726	7	19695462-19709087	"Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019071, HPA022416"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"	Nucleoplasm	"HPA019071: AB_1858465, HPA022416: AB_1858466"	"unprognostic (5.66e-3)"	"unprognostic (3.43e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.85e-2)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (1.16e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.02e-2)"	"unprognostic (4.93e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.23e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.95e-3)"	"unprognostic (2.96e-1)"	16.4	13.9	11.5	13.6	17.6	21.5	15.8	13.2	20.8	16.1	14.0	9.9	12.3	8.5	20.4	9.4	14.8	14.3	9.7	14.6	13.5	12.5	13.3	15.9	9.9	16.6	13.1	11.7	17.5	12.6	15.4	12.0	16.4	13.5	15.3	11.0	6.4	11.4	14.5	25.5	13.8	11.4	22.7	13.4	17.7	12.4	10.8	11.3	20.8	13.6	14.1	18.8	20.2	14.4	10.8	7.7	3.5	5.0	14.6	11.6	5.0	11.7	9.0	6.6	9.9	7.8	9.6	5.2	6.8	5.1	8.0	9.3	7.3	10.4	13.2	19.9	8.4	10.1	10.7	13.5	12.7	14.9	4.1	10.4	12.2	7.2	5.6	11.9	24.9	8.9	8.7	9.0	8.7	10.5	5.4	13.0	9.3	18.8	11.9	11.4	4.3	13.7	23.3	17.3	12.3	10.2	11.2	11.5	13.9	13.1	6.1	4.8	7.3	6.2	16.9	8.4	11.4	6.8	22.4	10.8	16.6	8.9	15.3	16.4	15.3	9.4	33.6	11.2	37.5	24.2	3.5	3.9	1.1	7.2	5.0	10.8	10.8	8.6	9.5	6.0	10.4	10.0	11.6	0.3	14.6	4.7	7.7	7.8	5.0	11.5	17.6	13.2	20.8	13.5	12.5	13.1	11.7	13.5	11.3	14.9	23.5	21.4	59.8	110.2	25.7	20.1	10.2	24.1	37.5	8.7	11.8	32.6	36.5	21.9	4.1	30.8	6.3	23.3	23.7	26.9	40.3	29.1	118.6	27.1	30.4	31.8	23.4	29.4	15.2	2.5	29.7	41.4	59.1	25.2	16.5	19.0	19.5	14.0	32.9	24.5	12.1	19.4	57.7	25.0	44.7	125.0	13.8	37.3	21.5	43.6
TXN	TRX	ENSG00000136810	Thioredoxin	P10599	9	110243811-110256640	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transcription, Transcription regulation, Transport"	Activator	Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 447.3"	"Cell type enriched"	"Detected in all"	10	"monocytes: 27271.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 127.1;granulocytes: 104.5"	"Cell line enhanced"	"Detected in all"		"OE19: 265.0"	"Low region specificity"	"Detected in all"							"CAB008678, HPA047478, HPA055752"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		25000000	"Nucleoplasm, Cytosol"		"CAB008678: AB_1623676, HPA047478: AB_2680063, HPA055752: AB_2682907"	"unprognostic (2.12e-2)"	"unprognostic (1.27e-1)"	"unprognostic (9.77e-2)"	"prognostic favorable (3.40e-6)"	"unprognostic (1.80e-2)"	"unprognostic (2.13e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.93e-3)"	"unprognostic (1.66e-1)"	"unprognostic (4.96e-3)"	"unprognostic (7.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.51e-2)"	23.6	16.7	26.6	18.2	16.9	35.8	25.9	10.8	19.7	30.8	57.9	7.7	17.5	40.7	15.5	20.4	162.3	27.5	22.2	11.7	20.9	19.0	65.8	69.4	39.0	19.4	21.3	14.1	18.2	22.0	5.3	8.0	41.2	28.7	15.5	50.6	8.0	50.2	16.3	16.0	26.3	58.9	21.9	17.6	19.8	26.3	9.2	7.0	40.0	18.9	447.3	82.0	31.3	27.1	12.8	127.1	104.5	25.1	14.2	26.0	18.8	45.9	63.1	17.1	18.8	43.2	56.3	25.2	55.9	52.2	39.0	29.7	40.9	55.4	40.9	24.0	51.6	85.4	103.8	24.3	74.5	38.3	60.7	54.1	20.5	59.2	70.8	49.4	50.9	62.7	39.9	49.1	57.0	43.2	36.3	34.2	26.1	34.5	39.4	53.3	37.2	42.3	76.4	36.4	265.0	77.0	17.8	58.0	47.6	49.8	32.6	37.2	13.3	60.3	49.0	37.9	34.4	47.0	35.2	41.0	40.2	26.0	75.4	69.2	20.0	56.4	34.8	58.3	44.4	55.8	32.2	25.1	104.5	14.5	15.1	13.9	12.8	20.5	17.4	37.1	5.6	7.7	11.5	99.7	14.2	9.6	127.1	26.0	18.8	26.6	16.9	10.8	19.7	20.9	19.0	21.3	14.1	28.7	7.0	363.3	237.5	189.1	832.3	1158.8	34.8	96.1	504.4	436.3	374.2	249.5	19.6	560.0	824.0	1017.1	20.9	327.5	1162.8	233.6	1150.3	840.4	409.8	774.5	261.1	685.2	516.6	27.0	534.8	206.2	278.9	11.1	373.3	793.2	723.7	27271.2	934.3	40.9	1608.6	1292.8	268.3	2636.4	24.8	142.3	563.4	10.6	70.3	1303.3	391.5	213.2	1478.0	1356.2
TXN2	MT-TRX	ENSG00000100348	"Thioredoxin 2"	Q99757	22	36467036-36482030	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Transport"		"Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA000994, CAB008681"	Approved		Enhanced	Mitochondria		No	No			Mitochondria		"CAB008681: AB_1623682, HPA000994: AB_1080267"	"unprognostic (5.11e-2)"	"unprognostic (4.40e-3)"	"unprognostic (4.40e-3)"	"unprognostic (1.07e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.17e-2)"	"prognostic favorable (2.04e-4)"	"prognostic favorable (1.17e-6)"	"unprognostic (1.49e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.05e-1)"	22.1	69.9	33.4	24.7	33.2	23.5	41.9	23.2	51.1	23.0	25.9	20.8	24.5	36.9	19.8	22.7	28.7	26.9	27.6	60.1	28.0	28.6	33.4	51.7	27.9	35.5	30.3	31.7	35.0	51.1	30.8	17.3	19.6	30.4	21.6	26.2	24.6	25.0	27.5	72.3	21.0	28.1	26.3	35.6	25.2	26.7	19.1	21.2	16.2	29.2	37.3	23.0	23.0	19.8	31.7	51.3	14.4	43.3	32.0	30.0	45.1	14.4	19.7	21.6	36.9	32.5	35.4	24.8	19.9	31.1	33.5	38.1	23.9	15.3	36.5	18.4	30.9	14.6	22.0	41.4	34.0	19.5	25.0	36.0	41.6	26.9	35.2	27.4	50.0	39.8	47.3	27.0	28.0	21.9	28.1	30.3	20.4	43.5	30.2	29.9	21.3	22.7	38.8	17.5	44.7	26.0	20.8	22.8	25.3	33.9	23.5	30.1	30.4	20.0	43.9	35.7	18.0	30.9	48.5	23.8	37.4	29.2	20.5	19.4	24.6	17.4	35.5	33.7	31.2	21.2	5.2	40.8	7.1	25.7	43.3	26.8	31.7	25.6	27.0	51.3	29.0	30.0	27.9	14.4	32.0	35.2	39.1	24.8	45.1	33.4	33.2	23.2	51.1	28.0	28.6	30.3	31.7	30.4	21.2	56.6	49.0	65.6	79.6	74.1	107.9	96.0	79.0	53.5	53.4	66.3	37.3	190.8	257.0	78.1	16.6	64.6	168.3	0.0	93.1	240.7	63.4	47.2	68.1	102.9	150.9	109.7	86.0	69.3	73.9	27.8	52.3	81.0	74.2	82.0	111.4	131.5	75.1	94.7	47.7	140.1	54.1	19.4	58.7	50.5	41.1	78.4	173.2	69.9	151.3	64.8
TXNDC9	APACD	ENSG00000115514	"Thioredoxin domain containing 9"	O14530	2	99318982-99340702	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031844, HPA031845, HPA031846"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA031844: AB_10600838, HPA031845: AB_10670968, HPA031846: AB_10669916"	"unprognostic (3.63e-3)"	"unprognostic (4.26e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (4.31e-4)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (2.06e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.47e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.29e-1)"	29.2	20.7	16.8	17.8	19.4	13.0	25.9	20.1	25.3	23.4	21.1	13.8	14.9	15.2	19.0	23.9	28.8	15.8	15.7	23.9	18.1	20.8	42.9	33.3	17.0	22.3	19.0	13.9	20.4	15.1	13.3	27.6	33.9	27.3	19.5	23.3	9.3	19.4	15.3	22.8	16.2	21.6	21.4	22.1	32.3	16.7	14.9	17.5	39.6	21.2	28.1	27.8	20.4	18.3	32.6	28.9	45.2	36.7	35.2	41.8	40.2	25.6	8.3	21.3	10.4	20.6	20.9	22.9	29.6	27.4	31.3	30.5	22.8	19.8	19.4	23.8	26.0	28.7	18.6	19.3	30.7	37.1	14.1	16.4	21.0	11.8	26.0	19.8	25.1	15.6	19.1	27.6	26.3	19.6	16.6	35.7	11.9	24.0	18.2	36.6	13.0	14.7	22.0	15.6	16.1	22.8	11.0	19.4	18.7	44.3	19.9	13.2	10.8	14.1	19.8	31.3	26.4	22.7	20.3	24.5	23.1	22.5	14.3	20.7	7.5	11.5	23.4	18.9	26.1	20.8	45.2	27.6	28.2	29.1	28.5	36.3	32.6	34.7	32.9	28.9	26.0	32.9	32.8	26.8	35.2	36.7	28.8	41.8	40.2	16.8	19.4	20.1	25.3	18.1	20.8	19.0	13.9	27.3	17.5	8.9	11.2	34.3	26.2	31.3	9.8	26.2	20.4	34.8	25.0	34.9	7.9	67.9	71.3	76.6	55.0	37.9	22.2	46.7	60.7	67.0	32.9	22.6	17.3	22.4	50.5	12.7	20.1	34.4	28.6	13.8	25.6	31.6	25.3	60.5	22.3	19.7	68.9	20.1	21.9	96.4	16.6	25.8	20.6	25.2	41.2	34.0	68.0	35.0	23.0	21.2
TXNL1	"TRP32, Txl, TXNL"	ENSG00000091164	"Thioredoxin like 1"	O43396	18	56597208-56651600	"Plasma proteins, Predicted intracellular proteins"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002828, HPA002829, CAB016446"	Supported	Supported	Enhanced	Cytosol		NA	Yes		1500000	Cytosol		"CAB016446: , HPA002828: AB_1858358, HPA002829: AB_1858359"	"unprognostic (2.05e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.38e-3)"	"unprognostic (4.54e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (9.62e-6)"	"unprognostic (1.83e-1)"	"unprognostic (1.03e-2)"	"prognostic favorable (6.26e-5)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.51e-1)"	20.5	31.9	27.9	17.8	30.0	34.0	24.4	20.6	34.5	22.5	20.1	21.5	17.3	20.1	22.1	33.8	29.6	18.0	19.8	37.2	27.7	28.5	28.0	38.5	16.4	21.7	27.7	22.8	26.1	34.3	21.5	23.3	26.8	32.1	23.1	21.6	17.6	22.4	20.9	64.4	17.6	21.1	26.5	23.4	20.4	24.0	19.3	21.1	22.3	96.0	27.7	23.3	27.7	18.9	22.2	29.9	39.0	35.3	23.4	23.0	30.9	24.8	24.6	33.3	34.3	29.0	42.5	23.7	29.7	30.6	38.4	32.6	21.8	24.6	27.1	26.5	32.3	27.8	31.0	31.5	26.9	39.8	27.6	14.4	37.1	20.6	40.8	34.0	54.0	24.2	32.2	27.9	36.1	33.2	40.6	30.8	20.8	27.1	45.5	38.8	23.9	31.2	35.3	24.1	17.3	26.5	25.5	22.5	47.0	44.8	38.9	27.7	25.3	16.9	23.7	28.1	27.7	25.9	29.0	24.4	40.4	21.3	14.0	28.9	44.2	47.3	42.3	26.3	41.4	29.5	39.0	35.3	25.3	15.9	29.6	21.7	22.2	19.7	20.8	29.9	19.3	19.4	19.6	26.5	23.4	27.9	25.5	23.0	30.9	27.9	30.0	20.6	34.5	27.7	28.5	27.7	22.8	32.1	21.1	53.6	38.7	77.2	102.3	119.4	77.4	92.0	48.4	57.6	61.4	27.9	131.6	212.5	92.9	122.4	165.3	62.6	79.4	46.7	112.7	104.6	91.2	91.6	51.9	68.4	133.8	54.0	72.8	56.4	76.0	218.7	71.9	78.2	62.4	131.7	97.3	59.0	117.2	83.1	78.8	104.9	82.7	64.7	97.8	196.1	99.4	110.2	299.9	68.2	101.2	105.2
TXNRD3	"TGR, TR2, TRXR3"	ENSG00000197763	"Thioredoxin reductase 3"	Q86VQ6	3	126607052-126655155	"Enzymes, Predicted intracellular proteins"	"Differentiation, Electron transport, Spermatogenesis, Transport"	"Developmental protein, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.8"	"Cell type enhanced"	"Detected in many"	13	"Spermatocytes: 54.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.0"	"Lineage enriched"	"Detected in single"	4	"T-cells: 4.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020802, HPA036109"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB020802: , HPA036109: AB_2674945"	"unprognostic (1.41e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.92e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (3.90e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.72e-4)"	"unprognostic (5.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.51e-1)"	5.4	5.9	4.9	2.4	4.7	0.9	7.2	5.5	5.7	7.3	4.2	4.6	5.5	1.6	8.3	7.1	6.4	4.7	5.2	4.9	4.0	2.9	6.7	10.0	7.0	5.2	4.6	3.5	8.8	7.1	12.3	8.5	3.3	7.0	5.2	3.6	6.4	5.7	5.1	7.3	4.8	2.6	8.1	5.1	3.3	4.9	27.8	5.8	5.0	7.4	3.6	2.1	6.6	5.3	0.3	0.7	0.5	0.9	0.9	4.0	0.3	14.0	3.6	4.6	7.2	8.5	13.0	2.3	6.2	5.6	5.1	7.2	6.4	7.9	0.0	7.9	8.5	3.1	5.6	5.7	6.4	6.5	0.0	4.2	1.6	3.3	4.9	7.4	5.7	0.5	11.9	5.6	1.7	11.8	7.0	3.7	4.6	3.4	0.0	8.2	10.1	1.2	3.1	6.5	3.8	2.7	0.4	4.0	2.3	5.4	7.0	8.0	4.9	17.8	5.2	9.0	3.7	7.2	2.2	6.1	6.3	1.5	8.5	2.9	3.7	1.6	0.0	3.4	2.0	5.3	0.0	0.9	0.5	0.5	0.8	0.1	0.0	0.2	0.6	0.7	0.3	4.0	1.3	0.0	0.9	0.2	0.0	0.0	0.3	4.9	4.7	5.5	5.7	4.0	2.9	4.6	3.5	7.0	5.8	3.0	7.4	0.0	4.8	0.9	1.9	3.6	5.1	2.7	3.4	3.5	2.0	7.5	3.3	4.3	15.1	1.5	0.0	0.0	3.4	4.6	3.7	2.1	5.7	7.3	2.6	0.0	4.1	1.3	0.3	2.9	4.4	0.3	0.0	0.0	2.3	2.3	3.9	0.0	8.1	2.8	0.5	0.0	2.7	54.7	15.3	0.5	6.1	0.0	1.5	2.5
TYR	"OCA1, OCA1A, OCAIA"	ENSG00000077498	Tyrosinase	P14679	11	89177452-89295759	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins"	"Melanin biosynthesis"	"Monooxygenase, Oxidoreductase, Tumor antigen"	"Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	70	"retina: 82.0;skin 1: 25.2"	"Cell type enriched"	"Detected in some"	8	"Melanocytes: 175.5"	"Cancer enriched"	"Detected in single"	1755	"melanoma: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	864	"SK-MEL-30: 86.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000079, HPA043241, HPA050889, HPA064583"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: "	"unprognostic (1.16e-1)"								"unprognostic (1.01e-1)"		"unprognostic (1.85e-3)"		"unprognostic (9.75e-3)"					0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	82.0	0.7	0.0	0.0	25.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.3	0.0	175.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.8	0.0	0.0	0.0	0.0
U2AF1	"RN, RNU2AF1, U2AF35, U2AFBP"	ENSG00000160201	"U2 small nuclear RNA auxiliary factor 1"	Q01081	21	43092956-43107587	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Basal keratinocytes: 437.9;Melanocytes: 192.3;Suprabasal keratinocytes: 379.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA044833, HPA052083"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044833: AB_10960990, HPA052083: AB_2681720"	"unprognostic (1.10e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.06e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.29e-4)"	"unprognostic (4.81e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.31e-3)"	"unprognostic (8.85e-2)"	"unprognostic (2.14e-6)"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-2)"	20.0	15.1	20.8	19.2	21.1	48.5	61.0	25.6	20.8	16.1	21.5	9.7	12.3	17.6	28.8	26.5	19.3	27.6	17.1	19.5	19.7	15.8	14.6	17.1	35.2	33.5	25.7	2.9	22.1	48.3	15.3	27.8	21.2	20.8	23.9	13.7	9.6	44.5	19.8	33.0	16.6	20.4	38.7	23.9	21.0	17.5	33.9	22.7	20.6	27.3	26.5	20.0	22.9	31.7	58.4	82.8	81.2	54.1	33.1	55.5	53.8	25.3	27.8	15.1	11.4	8.9	6.4	35.5	22.0	15.3	18.0	16.1	64.6	9.3	43.4	12.0	14.3	24.7	12.4	31.6	23.4	9.3	34.0	71.5	70.2	14.2	24.3	21.7	30.2	17.3	8.8	14.4	29.1	18.6	6.5	14.8	26.6	38.5	19.6	12.5	47.7	24.9	33.5	32.1	21.7	32.1	41.2	14.6	21.8	12.0	10.7	23.0	17.6	23.6	14.3	11.7	4.3	17.4	17.6	18.5	15.0	20.4	13.5	23.0	26.3	30.9	35.9	14.4	55.6	23.1	48.4	52.6	50.9	42.2	52.5	41.4	55.9	46.4	42.1	54.1	58.4	46.4	44.8	81.2	33.1	54.1	82.8	55.5	53.8	20.8	21.1	25.6	20.8	19.7	15.8	25.7	2.9	20.8	22.7	17.9	17.8	8.9	29.0	437.9	21.8	2.8	7.6	21.4	27.3	1.8	41.2	16.3	1.7	4.5	1.9	22.2	22.9	0.0	5.1	15.6	26.8	31.7	26.7	17.8	19.6	17.5	17.5	28.8	21.4	2.0	17.0	27.1	192.3	2.8	16.7	13.0	4.0	17.5	21.2	2.8	59.6	6.5	29.2	14.4	17.7	379.0	19.9	20.0	22.2	30.1
U2AF2	U2AF65	ENSG00000063244	"U2 small nuclear RNA auxiliary factor 2"	P26368	19	55654146-55674715	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010910, HPA041943, HPA043562"	Supported	Supported	Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			"Nuclear speckles"	Nucleoplasm	"CAB010910: AB_262122, HPA041943: AB_2677760, HPA043562: AB_2678555"	"unprognostic (2.37e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.12e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.94e-2)"	"unprognostic (4.01e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (9.46e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.33e-2)"	"unprognostic (4.25e-3)"	"unprognostic (2.19e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.08e-2)"	32.1	39.3	40.0	51.9	40.0	68.2	34.1	53.4	44.1	39.6	43.7	41.2	37.0	46.2	45.0	32.5	47.9	43.6	35.4	33.8	35.0	29.4	36.5	39.1	35.6	59.6	41.1	33.7	51.4	38.3	37.7	48.1	42.9	31.5	36.8	29.7	35.9	36.4	39.5	33.3	42.7	43.0	34.7	32.4	58.1	37.4	104.4	41.4	68.4	42.0	34.0	50.4	36.3	42.9	3.0	4.1	5.5	4.0	1.4	3.0	1.7	44.2	72.7	44.5	36.5	21.1	21.4	48.0	35.9	33.8	61.8	60.2	42.2	42.2	53.6	29.2	30.4	30.6	36.3	55.2	50.0	27.5	40.3	92.3	44.9	32.5	38.7	34.3	51.0	51.5	29.1	30.3	46.1	30.5	23.2	35.5	36.3	53.5	34.6	31.2	41.6	70.8	44.9	49.0	38.3	57.9	77.3	28.7	42.8	33.9	51.9	52.9	41.1	39.4	37.3	22.7	26.0	36.4	54.0	30.3	54.4	39.5	25.0	75.8	31.5	42.6	63.6	24.2	50.6	46.2	0.2	2.6	2.2	3.0	4.0	2.6	2.1	2.7	2.4	2.4	3.0	2.2	2.0	5.5	1.4	2.6	4.1	2.9	1.7	40.0	40.0	53.4	44.1	35.0	29.4	41.1	33.7	31.5	41.4	3.0	7.8	30.2	34.6	40.3	39.4	2.0	28.1	2.7	10.3	26.2	29.5	50.4	16.6	27.1	3.6	25.3	37.1	0.0	20.6	50.3	29.4	26.5	34.5	24.6	32.5	33.4	43.7	25.2	23.2	5.2	41.1	28.1	18.6	39.7	38.5	23.8	24.5	21.0	32.2	19.6	49.8	0.0	31.7	23.3	28.8	34.4	60.1	33.7	38.2	39.4
UBA5	"FLJ23251, UBE1DC1"	ENSG00000081307	"Ubiquitin like modifier activating enzyme 5"	Q9GZZ9	3	132654446-132678097	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"		"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 126.0;Late spermatids: 301.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017235	Uncertain		Enhanced	Vesicles,Cytosol		NA	NA			Cytosol	Vesicles	"HPA017235: AB_1858507"	"unprognostic (4.34e-3)"	"unprognostic (6.44e-2)"	"unprognostic (7.70e-2)"	"unprognostic (3.49e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.40e-2)"	14.8	30.3	17.8	12.3	19.8	13.2	17.4	17.9	26.2	14.5	15.0	10.5	27.8	16.2	13.4	24.2	15.1	13.3	12.7	21.2	15.3	16.3	22.7	29.8	13.7	14.8	16.0	25.0	15.1	41.4	29.3	32.7	18.1	21.2	18.8	16.7	11.7	37.8	33.5	32.5	15.7	17.9	14.6	13.6	18.9	18.5	15.3	12.7	17.9	23.5	17.5	17.4	15.1	12.5	11.1	14.1	5.0	6.6	18.9	15.0	7.9	27.3	10.2	18.0	14.8	12.7	14.6	18.9	23.7	24.4	14.9	17.3	18.5	10.2	21.8	17.4	17.1	9.8	16.7	17.8	18.7	22.2	20.7	7.6	26.5	16.5	20.7	12.7	32.5	15.6	12.7	11.0	14.1	21.3	13.9	16.7	11.9	16.5	32.4	16.6	24.3	17.9	12.2	16.4	23.5	9.8	15.7	15.7	41.3	13.7	21.2	17.4	15.7	13.9	14.0	20.0	17.2	16.8	16.5	14.9	15.8	15.5	7.6	12.4	30.6	20.5	40.4	18.0	11.9	14.0	4.1	5.1	5.0	9.6	5.8	11.6	11.1	10.8	15.0	11.8	6.9	12.9	12.8	1.1	18.9	6.6	14.1	10.7	7.9	17.8	19.8	17.9	26.2	15.3	16.3	16.0	25.0	21.2	12.7	32.8	23.4	11.1	16.1	15.2	19.2	32.5	15.3	17.4	19.4	7.0	13.7	52.9	58.0	21.3	126.0	17.0	14.5	0.0	39.4	38.1	22.6	19.5	23.1	20.2	20.4	20.6	20.7	15.4	6.4	301.4	15.5	11.7	16.9	27.9	20.1	24.6	21.2	15.9	25.5	29.4	19.8	32.3	25.0	27.9	14.9	16.2	83.4	17.5	15.6	14.8
UBA6	"FLJ10808, UBE1L2"	ENSG00000033178	"Ubiquitin like modifier activating enzyme 6"	A0AVT1	4	67612652-67701179	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 126.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037001	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA037001: AB_10672787"	"unprognostic (2.52e-1)"	"unprognostic (4.89e-2)"	"unprognostic (3.97e-3)"	"unprognostic (2.81e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.38e-2)"	"unprognostic (5.30e-2)"	"prognostic unfavorable (7.01e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (4.05e-3)"	16.8	12.6	14.1	14.1	16.6	22.7	13.0	18.0	16.0	17.0	10.5	14.6	7.0	12.2	16.7	10.0	20.5	9.9	12.4	9.5	12.0	12.0	10.2	16.4	14.5	17.3	18.7	11.2	14.3	10.9	17.4	44.8	18.5	17.7	12.7	13.2	7.5	13.7	10.4	10.1	12.6	15.3	13.4	20.7	16.9	13.9	14.6	18.6	27.1	12.3	13.3	19.9	15.7	19.5	5.6	5.1	9.3	4.0	9.7	5.8	1.9	15.1	8.5	14.1	11.0	7.0	8.2	9.5	31.4	12.3	14.4	16.9	8.9	20.5	19.2	11.2	12.9	14.7	9.0	14.5	15.6	21.8	22.1	4.0	12.3	15.0	8.3	6.0	21.6	9.5	5.9	5.0	18.6	11.3	9.9	12.7	9.9	29.2	11.4	17.0	5.7	22.4	4.9	8.3	10.8	10.3	13.3	28.9	7.1	11.8	17.2	6.9	8.7	17.7	12.6	5.9	12.3	8.4	5.8	18.3	13.4	15.1	10.8	13.7	8.2	6.4	19.4	23.8	6.0	12.8	9.3	3.0	4.6	4.4	3.9	4.8	5.6	5.1	5.8	3.7	5.2	3.9	4.5	2.2	9.7	4.0	5.1	4.2	1.9	14.1	16.6	18.0	16.0	12.0	12.0	18.7	11.2	17.7	18.6	23.8	20.8	33.8	52.9	62.3	46.2	14.4	12.7	25.4	20.5	15.7	51.1	22.4	3.3	21.4	1.4	34.4	21.2	0.0	14.8	12.9	28.2	64.5	30.1	17.3	20.5	31.8	31.0	17.8	27.9	4.0	19.8	35.3	23.6	33.3	24.7	19.8	36.7	21.0	18.7	10.2	42.3	19.4	23.0	37.9	35.1	40.4	49.2	29.9	19.6	126.8
UBE2M	"hUbc12, UBC12"	ENSG00000130725	"Ubiquitin conjugating enzyme E2 M"	P61081	19	58555712-58558960	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004993, HPA054551, HPA057800"	Approved		Enhanced	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"		Yes	No			Nucleoplasm	"Nucleoli, Nuclear bodies, Cytosol"	"CAB004993: AB_436983, HPA054551: AB_2682520, HPA057800: AB_2683531"	"unprognostic (1.42e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.90e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.63e-3)"	"unprognostic (1.76e-1)"	"unprognostic (5.85e-2)"	"unprognostic (8.42e-3)"	18.1	26.0	51.8	16.3	38.9	32.1	13.6	28.4	52.4	15.2	20.4	17.0	20.5	17.8	17.3	19.6	24.9	19.3	17.4	43.2	35.1	33.9	19.6	19.1	16.5	18.1	32.1	30.5	19.4	20.2	25.9	22.8	32.0	26.4	18.4	16.7	15.0	20.9	22.6	61.9	19.2	15.9	19.2	19.8	18.5	17.9	31.8	16.1	32.7	22.2	21.2	19.9	18.2	23.5	3.8	7.6	10.9	4.3	1.8	3.8	2.1	21.5	39.3	19.9	18.9	10.6	12.7	14.5	22.5	19.8	16.3	14.1	23.7	16.8	22.7	17.0	15.9	32.7	14.1	22.1	22.2	12.3	25.8	134.3	33.0	25.3	15.4	26.0	29.8	26.2	13.6	17.4	24.8	29.5	17.9	19.6	21.5	16.0	28.7	21.6	22.1	23.8	27.1	12.6	25.2	34.4	22.2	16.6	29.2	18.8	27.2	35.1	28.7	19.5	23.9	21.0	7.6	14.3	27.4	14.6	51.1	10.4	16.0	39.8	34.8	52.5	24.3	32.5	26.5	33.3	6.8	4.3	4.1	3.5	2.8	2.7	3.4	3.8	3.7	3.1	3.8	3.7	2.5	10.9	1.8	2.7	7.6	3.1	2.1	51.8	38.9	28.4	52.4	35.1	33.9	32.1	30.5	26.4	16.1	6.0	15.4	10.4	28.7	35.8	101.5	34.7	17.8	12.0	6.8	17.4	19.6	18.8	6.6	15.3	18.8	19.0	45.1	23.3	26.0	17.2	20.9	42.6	19.6	28.7	30.5	103.3	39.5	20.3	27.6	27.8	16.1	18.1	33.7	11.8	28.6	85.9	31.9	25.4	13.1	25.9	58.3	25.8	25.5	26.4	7.9	49.7	43.8	15.2	31.9	47.5
UBE2V1	"CROC-1, CROC1, UBE2V, UEV-1, UEV1A"	ENSG00000244687	"Ubiquitin conjugating enzyme E2 V1"	Q13404	20	50081124-50115959	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 76.3;Club cells: 55.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA052535, HPA053186"			Enhanced	Nucleoplasm		NA	NA		4000000	Nucleoplasm		"HPA052535: AB_2681863, HPA053186: AB_2682073"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.35e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (4.58e-5)"	"unprognostic (2.58e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	35.2	35.3	44.9	31.7	52.4	25.6	29.7	36.9	61.7	27.4	37.7	33.8	19.3	34.2	29.1	32.7	43.6	27.4	28.7	38.1	37.5	39.3	39.2	61.8	34.1	36.8	36.4	33.3	37.2	60.8	36.7	23.2	45.9	44.7	30.3	37.3	38.7	38.6	35.0	46.0	37.8	40.1	43.7	29.0	40.2	33.3	23.2	23.2	35.0	30.2	32.0	50.7	49.0	31.7	37.4	40.1	33.9	39.1	54.2	57.4	70.2	29.8	18.7	35.3	21.1	29.0	50.0	19.6	34.0	33.6	72.4	34.9	93.2	22.5	29.1	31.5	44.0	31.5	26.5	25.8	46.6	63.1	20.3	16.3	28.4	14.0	41.2	26.2	34.6	23.1	39.8	28.1	35.6	23.7	40.9	48.8	24.1	35.4	17.7	40.4	20.1	31.1	27.5	24.6	40.0	33.1	17.2	40.3	26.5	49.9	21.5	20.7	25.0	34.6	60.5	25.6	36.9	23.2	31.4	42.3	40.2	37.2	34.0	27.3	17.6	22.6	23.6	43.8	18.1	27.8	25.5	39.1	33.9	56.6	38.5	57.4	37.4	47.0	53.9	40.1	31.0	48.3	52.4	13.8	54.2	33.0	31.6	44.4	70.2	44.9	52.4	36.9	61.7	37.5	39.3	36.4	33.3	44.7	23.2	47.6	19.1	17.1	2.6	5.3	4.5	6.9	12.7	76.3	55.7	10.4	5.9	5.2	19.9	9.5	14.5	6.3	7.4	0.0	9.7	4.6	4.1	2.1	33.7	11.0	6.1	0.0	9.8	16.5	20.0	15.2	7.2	7.7	8.5	19.8	4.2	3.0	15.6	7.0	4.6	12.6	4.9	6.5	5.0	10.3	6.4	7.4	5.9	10.2	4.3	3.5
UBN2	"FLJ25778, KIAA2030"	ENSG00000157741	"Ubinuclein 2"	Q6ZU65	7	139230356-139308236	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 109.8;Late spermatids: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 9.0;NK-cell: 3.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.0;NK-cells: 3.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019743, HPA020122, HPA020124"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA019743: AB_1848851, HPA020122: AB_1848847, HPA020124: AB_2212202"	"unprognostic (1.96e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (4.49e-4)"	"unprognostic (1.24e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-3)"	"unprognostic (9.88e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.54e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.05e-2)"	5.4	7.8	11.9	5.3	13.0	10.4	9.7	20.8	13.7	7.6	5.9	8.7	12.6	5.0	10.0	14.1	7.0	7.3	5.7	5.8	11.5	6.9	6.3	7.0	6.0	5.1	10.2	7.6	11.5	10.7	10.5	16.9	6.2	8.6	8.2	6.9	8.1	8.1	12.7	11.1	18.6	5.9	7.9	8.4	6.3	6.3	25.5	9.7	6.9	10.4	3.1	5.2	6.4	13.6	1.2	1.2	9.0	1.0	3.4	0.8	0.1	3.9	3.7	6.1	7.6	4.9	4.5	4.7	2.3	3.4	2.1	2.5	4.5	3.9	6.7	4.3	2.8	5.2	3.7	7.8	1.9	3.7	3.4	4.5	5.0	6.7	4.9	2.8	9.7	3.9	3.1	5.5	2.7	4.4	3.8	4.0	3.6	11.6	5.2	2.7	6.0	7.0	11.3	8.7	4.0	2.7	4.0	5.7	4.7	2.9	2.9	10.1	7.3	7.0	4.9	3.3	6.0	3.1	6.5	4.5	2.6	3.0	3.8	2.9	6.0	6.6	11.8	4.2	5.9	3.8	9.0	1.0	0.1	0.5	0.5	0.4	1.0	0.5	0.6	0.3	1.2	0.8	0.5	1.0	3.4	0.4	1.2	0.3	0.1	11.9	13.0	20.8	13.7	11.5	6.9	10.2	7.6	8.6	9.7	6.0	20.5	7.1	15.7	20.7	52.5	24.3	15.3	29.4	15.9	21.0	88.4	7.1	6.6	6.4	109.8	13.8	13.1	23.3	6.1	7.6	17.4	29.6	11.5	16.8	6.2	42.9	22.4	16.5	14.0	132.0	20.8	13.4	8.5	4.6	16.7	25.5	8.4	14.7	20.1	7.9	57.3	19.4	21.5	26.9	30.1	25.2	12.2	8.7	12.1	18.6
UBQLN2	"Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157"	ENSG00000188021	"Ubiquilin 2"	Q9UHD9	X	56563639-56567868	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	Autophagy		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006431, CAB013481"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	Yes		200000	Cytosol	"Plasma membrane"	"CAB013481: AB_2533341, HPA006431: AB_1078707"	"unprognostic (1.23e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"prognostic unfavorable (2.29e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.42e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.88e-2)"	"unprognostic (8.42e-3)"	13.4	20.8	27.0	13.9	40.7	9.4	16.2	34.9	35.3	17.3	13.6	17.8	15.0	11.1	17.0	16.7	18.1	18.2	14.5	20.8	26.2	28.6	13.9	18.9	14.0	16.4	21.2	26.6	27.0	10.6	25.5	18.3	15.6	20.8	21.1	12.5	13.3	13.7	21.5	24.6	13.5	11.6	18.7	18.8	13.9	12.9	5.4	16.7	18.0	20.9	10.9	17.7	16.4	14.1	5.5	10.9	25.0	19.4	12.1	20.4	10.9	18.6	13.9	14.0	16.3	32.2	20.6	8.8	15.1	18.0	11.4	12.6	7.8	8.8	14.3	16.6	17.8	17.8	11.0	26.6	16.9	13.8	22.1	16.0	5.8	19.2	8.2	16.9	11.3	12.8	19.1	21.4	15.3	13.4	16.5	9.9	9.3	6.7	15.8	17.9	8.7	14.5	9.9	11.6	6.0	16.6	13.0	18.1	13.5	23.0	14.6	17.3	16.2	21.8	9.7	8.8	25.6	16.2	8.4	11.1	12.1	12.4	17.4	9.1	6.0	7.4	9.9	13.6	12.0	10.2	25.0	14.1	14.1	9.9	19.3	11.1	5.1	15.1	11.5	10.9	5.5	20.4	12.2	12.4	12.1	19.4	3.9	14.1	10.9	27.0	40.7	34.9	35.3	26.2	28.6	21.2	26.6	20.8	16.7	20.8	12.1	13.7	34.3	27.7	41.9	31.1	12.7	13.4	9.1	17.4	17.7	23.0	14.9	17.9	0.0	17.1	14.4	0.0	14.5	22.2	23.5	24.0	12.7	19.2	21.1	39.7	32.8	18.4	34.3	0.4	23.0	18.9	16.9	27.9	18.1	22.1	15.8	14.0	34.3	10.9	31.2	12.9	32.5	0.3	0.2	26.6	33.4	17.5	18.8	32.1
UBTF	"NOR-90, UBF, UBF1, UBF2"	ENSG00000108312	"Upstream binding transcription factor, RNA polymerase I"	P17480	17	44205033-44221626	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004611, HPA006385"	Supported	Supported	Enhanced	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"CAB004611: AB_671403, HPA006385: AB_1080447"	"unprognostic (1.37e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-2)"	"unprognostic (3.15e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.96e-3)"	"unprognostic (5.44e-2)"	"unprognostic (9.01e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.00e-1)"	21.9	25.4	27.8	33.0	29.4	32.8	25.1	43.6	37.1	28.0	29.2	31.7	34.8	22.8	35.3	29.4	27.2	28.2	30.5	25.3	24.4	21.0	22.9	22.9	22.2	42.7	23.3	28.5	30.9	32.3	35.9	24.8	20.5	18.8	27.9	20.0	26.5	25.5	46.2	37.9	32.9	26.8	26.6	23.3	34.0	22.4	13.7	26.0	69.6	33.0	21.1	36.4	27.3	27.7	14.0	11.9	9.2	9.6	13.4	16.4	9.4	18.1	28.4	21.3	25.8	14.1	16.3	19.5	18.8	12.8	19.6	14.5	13.7	15.0	66.5	18.8	17.7	14.3	17.1	27.2	16.1	16.2	38.7	29.4	26.5	19.8	22.2	9.4	50.3	23.5	16.4	14.9	12.4	18.4	18.9	16.3	29.5	30.4	20.9	16.3	31.0	49.2	20.0	20.1	12.5	22.4	48.9	28.8	29.9	11.5	14.7	33.3	25.4	18.7	17.1	15.0	13.9	24.9	32.7	19.9	30.7	37.3	17.9	25.1	18.3	15.8	40.9	18.4	23.1	27.3	7.5	5.2	5.3	15.1	5.8	16.4	11.1	10.7	15.8	6.1	14.0	12.5	13.0	9.2	13.4	9.6	11.9	8.7	9.4	27.8	29.4	43.6	37.1	24.4	21.0	23.3	28.5	18.8	26.0	38.7	34.9	42.2	16.6	18.2	83.7	36.5	33.1	33.5	40.9	36.6	74.6	25.0	29.9	23.5	1.7	31.2	26.6	0.0	35.5	33.3	24.7	14.8	31.1	23.2	22.2	25.4	45.4	30.7	19.5	2.9	33.9	16.0	21.9	46.9	25.3	30.7	24.0	28.1	47.7	21.6	51.8	51.8	34.9	5.2	41.5	21.2	27.3	30.9	28.9	10.8
UBXN7	"KIAA0794, UBXD7"	ENSG00000163960	"UBX domain protein 7"	O94888	3	196347662-196432474	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048441, HPA049442"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA048441: AB_2680394, HPA049442: AB_2680769"	"unprognostic (8.36e-3)"	"unprognostic (4.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.05e-1)"	"unprognostic (6.64e-2)"	"unprognostic (5.12e-3)"	"unprognostic (1.49e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.45e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.40e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	13.8	12.7	14.0	11.2	17.6	29.9	13.3	30.4	16.3	14.5	13.1	19.2	13.5	9.0	17.3	14.3	13.4	14.4	9.9	9.6	15.6	12.1	11.4	10.4	13.3	13.3	16.3	12.9	21.4	12.9	23.1	23.4	14.9	16.2	12.4	11.5	11.4	12.8	13.3	10.3	17.5	12.9	13.4	14.0	13.5	10.8	17.9	19.0	24.7	13.2	6.7	13.6	13.9	17.2	9.6	6.3	10.4	6.5	7.6	9.5	2.8	15.1	4.4	18.9	10.0	9.9	17.5	7.9	12.7	8.4	7.3	6.7	12.4	6.6	14.1	26.1	8.5	9.7	12.3	14.1	7.6	13.6	5.8	8.7	22.7	10.3	6.7	7.6	11.2	7.3	10.4	8.6	10.2	12.8	13.1	11.7	10.4	10.7	9.9	8.5	6.6	11.7	6.1	11.0	6.3	6.1	13.6	14.2	9.6	6.0	6.4	12.9	9.7	19.7	5.7	10.1	15.8	15.3	9.6	14.7	8.5	7.5	7.5	13.5	13.5	18.5	20.7	7.7	13.3	6.1	10.2	5.9	8.9	6.1	4.9	5.8	9.6	5.4	4.0	6.3	7.5	9.5	8.3	10.4	7.6	6.5	2.9	8.7	2.8	14.0	17.6	30.4	16.3	15.6	12.1	16.3	12.9	16.2	19.0	41.7	16.8	11.7	12.6	42.0	34.6	16.1	15.3	25.4	23.9	19.2	66.8	14.0	5.0	9.9	30.5	22.2	11.2	0.0	8.7	8.8	21.7	21.2	8.1	10.5	11.1	30.2	44.6	21.5	20.6	19.6	27.6	19.9	21.9	15.4	16.7	21.5	10.8	8.6	26.5	9.4	45.6	32.3	20.8	29.8	21.3	47.8	15.8	27.3	15.5	14.1
UHRF2	"MGC33463, NIRF, RNF107, TDRD23, URF2"	ENSG00000147854	"Ubiquitin like with PHD and ring finger domains 2"	Q96PU4	9	6413151-6507054	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Ubl conjugation pathway"	"DNA-binding, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026633, HPA026697"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA026633: AB_2732431, HPA026697: AB_2732432"	"unprognostic (1.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.40e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.69e-3)"	"unprognostic (2.14e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.50e-1)"	14.1	12.9	10.6	25.4	12.2	49.1	19.0	24.8	11.8	18.6	15.6	12.7	17.6	7.9	17.5	15.1	13.3	12.0	11.9	11.3	10.2	10.6	10.1	9.8	13.5	19.3	12.3	10.5	18.9	14.5	12.7	12.7	14.6	11.4	19.3	12.0	10.7	13.0	16.4	15.7	11.0	12.0	17.1	12.2	14.1	11.6	10.6	14.8	40.3	15.2	10.2	19.8	18.7	18.2	5.1	2.5	7.5	1.4	1.2	3.6	1.2	6.7	7.7	11.1	4.7	9.1	13.2	8.1	15.6	9.6	9.8	17.2	4.9	4.9	10.3	3.4	7.7	9.1	4.4	10.2	9.1	15.0	18.7	4.7	18.0	15.0	7.8	7.5	8.4	6.1	5.9	5.9	7.6	18.8	18.8	38.2	10.6	1.7	10.1	23.1	2.3	14.1	32.7	4.3	9.9	5.7	16.0	5.1	3.6	7.3	4.6	10.0	3.9	6.7	4.5	9.7	14.1	5.6	16.9	32.2	10.5	3.8	4.3	13.0	2.7	8.0	12.1	5.1	7.4	4.1	7.5	1.1	4.3	2.3	0.9	1.7	3.5	3.6	1.8	0.7	5.1	2.3	3.0	1.3	1.2	1.4	2.5	3.5	1.2	10.6	12.2	24.8	11.8	10.2	10.6	12.3	10.5	11.4	14.8	6.0	11.8	25.0	9.7	19.2	22.6	42.0	5.1	5.3	9.1	12.2	29.5	10.8	1.7	5.1	16.0	20.4	8.1	23.3	3.4	8.5	12.4	13.9	17.3	11.3	9.2	27.0	6.8	15.4	11.7	5.9	17.8	11.0	20.3	6.4	12.4	6.7	6.0	12.9	13.8	5.1	34.9	12.9	13.7	37.2	17.2	16.7	4.9	13.8	11.3	7.1
UPF3B	"HUPF3B, MRX62, RENT3B, UPF3BP1, UPF3BP2, UPF3BP3, UPF3X"	ENSG00000125351	"UPF3B, regulator of nonsense mediated mRNA decay"	Q9BZI7	X	119805311-119852998	"Disease related genes, Predicted intracellular proteins"	"mRNA transport, Nonsense-mediated mRNA decay, Transport"	RNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001592, HPA001800, HPA001882"	Approved		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			Cytosol	"Nucleoplasm, Nucleoli"	"HPA001592: AB_2666373, HPA001800: AB_1080476, HPA001882: AB_1080474"	"unprognostic (1.79e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.64e-3)"	"unprognostic (8.58e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (1.52e-6)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (5.39e-4)"	"unprognostic (5.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (8.63e-3)"	"prognostic unfavorable (1.44e-7)"	"unprognostic (8.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.95e-2)"	9.7	10.3	19.4	11.5	21.9	14.5	10.8	34.1	24.0	10.2	13.0	9.3	12.8	14.2	14.6	13.5	13.0	8.8	8.4	7.8	16.9	17.5	10.0	12.4	9.0	17.2	16.5	21.7	14.8	8.7	14.3	26.7	10.5	17.2	12.4	13.2	9.1	9.7	14.4	14.5	18.6	11.1	14.2	21.7	12.9	9.9	15.0	21.0	9.9	12.5	11.5	18.3	12.6	12.9	17.5	10.0	7.1	5.9	7.9	8.1	2.7	11.9	7.2	15.1	12.2	6.9	4.5	9.7	11.5	6.5	9.0	8.0	13.5	8.6	21.5	9.8	4.8	12.9	11.4	19.5	6.9	11.5	12.2	14.3	19.9	24.0	7.1	7.9	21.5	9.9	3.9	5.3	15.4	18.8	8.2	8.3	12.9	19.2	18.0	7.5	14.5	15.1	27.0	29.1	15.3	19.8	14.8	17.3	15.8	7.3	6.0	20.1	13.9	23.5	9.5	17.2	16.4	5.0	12.6	7.2	9.4	7.2	15.0	24.3	9.9	11.0	29.1	7.5	31.7	10.9	7.1	5.3	6.8	7.5	5.1	5.7	13.8	7.0	5.9	3.8	17.5	7.6	8.1	5.9	7.9	5.9	10.0	7.8	2.7	19.4	21.9	34.1	24.0	16.9	17.5	16.5	21.7	17.2	21.0	29.8	25.5	28.9	28.2	33.5	47.9	17.1	15.3	42.8	47.8	24.4	53.0	33.2	5.0	27.3	107.2	24.5	27.1	0.0	22.8	39.7	29.2	18.5	57.7	19.2	25.4	27.0	26.6	20.3	15.4	17.6	28.1	32.2	23.6	49.5	21.8	39.5	18.6	31.7	30.8	12.4	94.7	12.9	36.2	32.2	32.4	33.2	53.8	34.8	32.2	21.3
UPP1	"UDRPASE, UP, UPASE, UPP"	ENSG00000183696	"Uridine phosphorylase 1"	Q16831	7	48088628-48108733	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 206.2;Macrophages: 205.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.4;hTERT-HME1: 103.9;SK-MEL-30: 24.1;WM-115: 23.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA054040, HPA055394"	Enhanced		Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA054040: AB_2682352, HPA055394: AB_2682805"	"unprognostic (1.16e-1)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.21e-3)"	"unprognostic (6.36e-2)"	"unprognostic (1.78e-3)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (3.81e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.39e-1)"	16.7	8.4	2.8	12.6	4.2	17.6	7.1	5.7	3.8	10.3	8.0	1.7	2.1	7.5	2.8	4.2	37.7	3.3	8.5	7.0	2.3	3.3	12.4	9.1	18.3	17.4	5.8	1.4	2.9	5.8	2.4	5.0	28.9	5.5	3.0	7.6	2.9	7.5	2.1	5.1	2.0	9.7	5.2	3.9	13.9	2.5	1.8	4.8	1.2	6.2	34.0	19.4	7.9	19.6	0.6	8.2	15.7	22.0	5.7	19.7	16.0	6.5	7.9	0.8	1.6	2.7	1.2	8.1	3.2	4.5	4.1	5.1	3.3	3.2	0.0	1.2	2.6	26.4	4.6	1.5	13.1	2.7	1.3	1.4	0.2	1.9	1.3	2.4	0.2	0.5	1.6	6.4	1.9	103.9	1.9	2.7	0.2	0.4	3.9	2.2	0.7	0.0	1.1	3.1	1.1	6.9	0.0	1.7	1.7	9.5	3.4	0.7	0.7	3.3	0.9	24.1	8.9	0.8	0.2	3.8	9.7	8.3	2.6	8.2	7.5	10.0	1.1	9.8	1.0	23.6	15.7	22.0	15.1	19.7	16.7	12.5	0.2	12.6	13.5	8.2	0.6	13.0	12.0	9.1	5.7	15.9	0.7	11.2	16.0	2.8	4.2	5.7	3.8	2.3	3.3	5.8	1.4	5.5	4.8	17.9	64.1	14.6	17.3	41.6	27.8	10.4	22.9	8.1	13.6	10.4	31.4	6.0	59.7	36.9	0.6	58.5	53.1	0.0	35.8	206.2	39.5	10.1	24.4	15.1	111.9	15.9	12.5	78.5	137.0	1.5	4.9	205.8	82.7	43.3	11.6	13.5	73.7	52.6	2.1	15.4	28.8	6.5	33.0	0.0	3.0	26.1	65.8	46.7	13.3	29.6
UQCRC2	"QCR2, UQCR2"	ENSG00000140740	"Ubiquinol-cytochrome c reductase core protein 2"	P22695	16	21952660-21983660	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007998, HPA019146"	Enhanced		Enhanced	Mitochondria		NA	NA		4000000	Mitochondria		"HPA007998: AB_1858648, HPA019146: AB_1858649"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.43e-2)"	"prognostic favorable (6.58e-9)"	"unprognostic (2.33e-1)"	"unprognostic (9.78e-3)"	"unprognostic (4.67e-3)"	"unprognostic (7.36e-2)"	22.7	26.8	20.6	17.1	32.7	20.5	21.3	29.2	33.7	17.7	38.4	17.4	19.5	45.0	20.8	18.6	28.7	20.0	19.1	94.9	19.8	19.3	35.1	35.8	15.9	23.6	20.9	28.5	21.9	20.8	36.6	20.2	17.8	29.6	17.7	40.5	18.5	22.1	20.2	103.9	22.2	42.0	30.4	16.5	16.5	29.3	10.3	19.2	25.2	21.4	70.0	22.9	27.9	20.0	20.0	30.6	14.3	29.3	18.7	25.7	27.4	19.3	21.2	13.1	8.7	14.7	20.6	18.6	18.8	15.3	17.2	17.5	34.3	19.1	38.3	16.9	16.1	12.8	35.3	21.3	18.8	19.9	17.5	19.7	21.7	18.7	48.4	15.5	27.5	54.9	24.0	23.6	13.4	18.5	17.6	22.5	21.3	23.4	20.1	18.6	25.6	28.6	17.9	14.4	24.5	16.4	33.5	30.5	41.9	25.8	22.8	18.2	13.3	26.6	33.6	20.2	16.6	38.4	29.3	19.9	12.2	11.5	11.9	16.7	14.5	10.5	34.0	20.0	29.3	13.9	14.3	24.7	12.8	16.9	29.3	21.9	20.0	20.5	18.6	30.6	15.8	22.8	20.8	9.1	18.7	27.6	13.2	25.7	27.4	20.6	32.7	29.2	33.7	19.8	19.3	20.9	28.5	29.6	19.2	59.6	42.0	98.3	164.9	80.5	95.9	481.5	84.1	72.3	54.6	68.0	82.5	196.5	386.3	104.6	67.7	84.2	282.6	23.3	96.2	128.0	82.0	92.1	91.1	104.1	172.2	65.2	109.2	63.3	130.3	64.8	63.3	104.5	124.9	144.3	181.4	81.7	88.0	175.6	91.2	254.0	122.1	77.6	118.3	52.3	51.5	77.2	232.7	106.2	298.0	149.1
UQCRQ	"QCR8, QP-C, UQCR7"	ENSG00000164405	"Ubiquinol-cytochrome c reductase complex III subunit VII"	O14949	5	132866560-132868031	"Disease related genes, Predicted intracellular proteins"	"Electron transport, Respiratory chain, Transport"		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 174.9"	"Cell type enhanced"	"Detected in all"	7	"Cardiomyocytes: 3256.1;Hepatocytes: 4283.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046693, HPA053323"	Approved		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA046693: AB_10968453, HPA053323: AB_2682112"	"unprognostic (3.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.92e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (1.09e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.72e-2)"	"unprognostic (7.31e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.81e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.37e-2)"	26.4	38.4	43.2	24.5	34.2	20.9	30.9	18.0	37.5	22.5	49.7	13.8	44.0	42.5	15.4	41.8	32.1	15.3	42.7	111.1	33.2	31.7	48.8	112.5	18.8	21.5	42.0	30.4	12.3	64.6	14.0	23.1	17.0	30.5	32.0	44.8	19.7	44.6	39.6	174.9	16.4	40.5	21.2	25.4	15.2	37.4	16.1	20.8	14.3	24.6	71.5	16.8	22.6	20.5	56.6	95.8	67.9	99.9	53.8	56.7	106.3	45.5	63.7	37.6	91.0	56.4	45.9	32.6	33.1	46.7	53.0	66.1	89.7	53.3	18.7	70.0	43.3	67.4	46.2	34.3	80.6	45.6	34.2	72.0	24.8	100.5	70.5	49.0	28.1	42.8	48.9	56.2	37.8	52.2	35.5	41.3	40.4	31.7	60.4	55.5	86.2	64.6	64.9	26.7	85.4	57.6	42.4	41.7	80.5	68.5	89.0	63.1	52.5	40.9	46.2	70.6	27.0	68.8	64.9	25.7	48.6	61.4	39.8	66.8	66.8	88.7	33.5	64.6	52.5	48.3	67.9	99.9	61.1	47.0	76.6	48.3	56.6	54.9	53.5	87.4	46.0	53.6	51.5	47.4	53.8	70.2	95.8	56.7	106.3	43.2	34.2	18.0	37.5	33.2	31.7	42.0	30.4	30.5	20.8	232.3	318.2	275.9	309.6	309.4	83.7	3256.1	1189.8	321.2	221.8	746.8	113.9	633.7	1536.9	621.2	357.1	305.7	1715.1	233.6	826.7	362.7	374.6	615.6	285.5	4283.6	668.1	68.3	527.7	324.1	428.0	786.4	261.5	374.1	678.2	396.8	861.3	232.4	704.3	1273.0	271.5	1804.0	170.0	181.1	456.8	296.8	123.0	449.3	470.6	222.6	1052.4	401.6
URB2	"KIAA0133, NET10, NPA2"	ENSG00000135763	"URB2 ribosome biogenesis 2 homolog (S. cerevisiae)"	Q14146	1	229626234-229660199	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 27.5;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008902, HPA046788"	Uncertain		Enhanced	Nucleoli		NA	NA			Nucleoli		"HPA008902: AB_2213805, HPA046788: AB_2679807"	"unprognostic (1.26e-1)"	"unprognostic (4.03e-3)"	"unprognostic (2.16e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	9.8	6.2	7.0	7.2	7.8	7.6	6.5	5.8	11.0	4.7	5.0	9.5	2.9	4.3	7.4	3.8	8.0	6.9	5.2	4.9	5.3	3.7	4.3	10.4	4.9	12.0	8.2	7.7	7.2	13.7	6.5	9.9	6.5	8.0	5.0	4.9	6.4	5.8	3.8	14.0	5.8	5.3	6.6	5.8	8.4	5.8	15.6	7.2	10.3	4.6	6.2	9.0	5.5	4.8	2.7	2.7	0.5	3.9	1.9	5.6	2.9	7.3	11.1	7.2	9.6	4.6	3.8	22.1	5.9	3.6	9.1	6.9	11.0	5.8	15.2	6.8	4.1	4.8	10.2	17.8	7.2	8.4	7.4	17.0	9.5	9.3	6.4	4.3	13.8	8.2	3.7	5.3	9.0	7.1	2.3	4.3	9.0	20.0	7.1	5.6	5.8	15.4	6.8	24.2	13.1	7.4	17.3	10.3	15.2	4.1	9.3	10.8	13.3	6.9	7.3	5.8	2.6	8.2	7.9	4.7	7.5	9.5	9.5	16.7	7.9	7.6	22.9	4.0	10.4	13.6	0.2	1.9	0.5	3.0	3.9	5.6	2.0	2.8	3.6	2.7	2.7	4.3	3.3	0.2	1.9	1.3	1.6	3.1	2.9	7.0	7.8	5.8	11.0	5.3	3.7	8.2	7.7	8.0	7.2	0.0	0.6	1.9	4.7	9.0	6.8	2.4	2.5	0.0	2.3	5.2	27.5	4.2	0.0	2.3	0.3	5.5	0.9	0.0	2.4	8.6	2.7	4.3	0.0	2.9	2.5	3.2	6.3	4.3	1.8	0.8	2.0	2.4	5.0	2.8	1.8	2.7	2.3	0.0	3.2	1.6	17.2	0.0	3.0	5.2	2.9	8.0	2.7	0.0	3.0	3.1
USF1	"bHLHb11, MLTFI, UEF"	ENSG00000158773	"Upstream transcription factor 1"	P22415	1	161039251-161045977	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001480, HPA036233, HPA036535"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB001480: AB_2213986, HPA036233: AB_2675012, HPA036535: AB_2675178"	"unprognostic (3.66e-2)"	"unprognostic (2.79e-2)"	"unprognostic (9.12e-3)"	"unprognostic (2.17e-1)"	"unprognostic (9.40e-2)"	"prognostic favorable (8.70e-4)"	"unprognostic (1.59e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"prognostic unfavorable (6.01e-12)"	"unprognostic (1.24e-3)"	"unprognostic (3.29e-1)"	"unprognostic (4.08e-1)"	"prognostic favorable (1.95e-5)"	15.4	17.0	21.6	16.9	24.4	14.3	13.8	31.0	27.6	15.2	17.6	15.6	15.6	17.7	15.1	15.5	12.6	17.1	16.2	17.4	21.6	22.1	15.2	19.1	16.7	23.8	19.7	19.4	17.2	9.8	19.0	12.3	17.3	17.1	14.4	18.0	14.7	13.8	19.0	27.4	14.6	17.8	18.0	18.3	26.7	13.7	8.5	18.7	21.9	16.1	13.5	30.3	18.5	13.8	3.9	5.7	8.6	4.7	2.0	4.0	2.0	8.2	12.6	15.1	17.5	20.4	11.7	20.3	7.0	15.1	21.8	17.0	8.8	10.5	10.7	14.8	11.5	9.5	10.4	17.8	11.0	12.3	9.9	10.5	9.2	10.5	9.2	11.9	12.8	12.9	9.5	11.1	15.7	12.8	13.9	20.3	18.4	15.1	11.6	13.6	9.7	19.7	14.0	31.1	18.1	16.5	17.2	11.8	13.0	10.8	13.3	8.5	16.4	12.7	16.5	8.8	22.8	13.7	41.8	11.9	10.9	6.9	6.6	11.2	9.8	12.4	17.0	9.4	12.5	8.3	4.7	4.7	2.7	4.0	4.5	2.4	3.4	2.5	2.9	5.4	3.9	2.7	2.6	8.6	2.0	4.2	5.7	2.7	2.0	21.6	24.4	31.0	27.6	21.6	22.1	19.7	19.4	17.1	18.7	6.0	8.6	3.2	0.6	2.1	3.6	0.7	0.0	8.1	2.3	3.5	2.0	1.9	1.7	1.6	0.3	1.9	6.3	0.0	1.2	3.3	1.8	1.0	10.5	0.4	2.8	4.8	2.9	0.0	1.9	0.0	0.3	3.2	5.0	2.8	2.7	2.0	2.1	7.0	0.0	2.5	3.4	6.5	1.4	0.5	0.4	1.6	2.9	4.6	3.2	1.3
USF2	"bHLHb12, FIP"	ENSG00000105698	"Upstream transcription factor 2, c-fos interacting"	Q15853	19	35268978-35279821	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029764, HPA046567"			Supported	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA029764: AB_2673190, HPA046567: AB_2679702"	"unprognostic (6.10e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.60e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.10e-1)"	"unprognostic (7.07e-2)"	"prognostic favorable (5.12e-5)"	"unprognostic (7.75e-2)"	"unprognostic (8.12e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-2)"	"prognostic favorable (3.28e-4)"	40.6	48.6	50.9	42.7	56.8	52.8	53.0	52.5	60.5	23.4	26.2	41.2	25.9	36.5	26.3	23.4	25.8	23.6	23.1	52.6	50.8	35.5	22.1	47.9	29.1	48.8	48.6	43.6	54.1	41.8	34.9	36.4	22.1	40.2	22.5	19.7	31.7	34.0	21.6	108.9	35.1	35.8	24.4	48.5	42.9	30.6	13.0	51.2	22.7	29.9	24.9	32.5	26.8	35.6	7.1	27.3	17.8	5.8	5.8	7.2	3.7	38.7	39.0	20.4	19.2	35.2	18.0	19.1	21.0	25.0	19.1	14.5	18.1	20.1	37.2	33.7	17.9	20.9	11.8	18.8	16.4	10.0	62.5	29.0	22.1	23.4	29.0	21.4	36.9	38.1	15.6	23.2	12.5	19.5	33.3	13.0	25.0	26.5	55.8	15.0	44.4	40.4	14.7	16.9	35.8	13.2	39.7	25.9	35.1	15.9	24.8	34.4	26.1	39.1	42.6	70.6	18.6	17.2	29.7	21.9	32.5	21.9	21.3	28.2	56.2	56.2	40.4	30.1	23.6	42.3	17.8	4.7	5.7	3.9	5.8	4.8	5.6	4.0	5.1	7.1	7.1	3.6	3.5	4.2	5.8	3.5	27.3	7.2	3.7	50.9	56.8	52.5	60.5	50.8	35.5	48.6	43.6	40.2	51.2	6.0	19.0	63.3	21.7	21.1	61.7	62.0	20.4	5.3	9.1	29.6	31.4	20.0	48.0	27.2	0.6	27.9	41.8	0.0	49.5	31.8	22.8	23.4	19.7	42.9	101.1	89.0	50.1	31.3	52.2	2.4	29.7	43.7	25.3	34.3	33.1	60.1	34.5	36.6	29.4	35.6	44.7	12.9	29.9	9.5	10.4	21.7	14.6	39.9	28.2	27.4
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Differentiation, Hearing"		"Cancer-related genes, Deafness, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.0;intestine: 57.0;kidney: 22.1"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 240.3;Muller glia cells: 140.5;Paneth cells: 192.9;Proximal tubular cells: 119.4;Undifferentiated cells: 94.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 31.4;HeLa: 11.2;OE19: 29.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol		No	NA			Cytosol		"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favorable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.1	0.1	1.6	4.3	7.1	0.0	0.0	0.8	3.3	0.1	23.8	6.2	0.0	40.5	0.0	6.3	0.0	1.3	26.0	0.3	5.0	2.3	22.1	0.4	0.0	0.0	4.8	1.9	0.3	2.1	0.0	5.2	0.0	3.5	0.1	20.7	1.8	0.0	0.1	0.0	0.0	57.0	0.9	10.2	0.0	11.5	0.2	3.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	31.4	4.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	7.1	0.8	2.3	5.0	2.3	4.8	1.9	3.5	3.6	0.0	0.0	0.8	0.0	0.0	0.7	0.6	48.4	0.0	1.2	5.2	2.0	0.0	18.3	18.8	1.0	0.0	240.3	0.0	25.0	0.0	0.0	0.0	4.6	0.0	0.0	1.6	61.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.4	140.5	34.3	192.9	0.0	119.4	3.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	94.1	0.0
USO1	"p115, TAP, VDP"	ENSG00000138768	"USO1 vesicle transport factor"	O60763	4	75724593-75814286	"Predicted intracellular proteins"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 94.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010108, HPA038282, HPA038283"	Supported		Supported	"Nucleoli fibrillar center,Golgi apparatus"		NA	NA		43000	"Golgi apparatus"	"Nucleoli fibrillar center"	"CAB010108: AB_628059, HPA038282: AB_2675928, HPA038283: AB_2675929"	"unprognostic (9.45e-3)"	"unprognostic (3.12e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.56e-3)"	"unprognostic (6.29e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.24e-2)"	"unprognostic (9.18e-2)"	"unprognostic (7.95e-3)"	"unprognostic (4.01e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.78e-2)"	18.1	22.1	9.9	14.9	11.5	4.1	14.6	13.8	13.2	18.1	16.5	9.1	24.9	13.0	18.6	25.3	20.1	15.8	12.1	35.4	10.9	10.4	18.7	38.8	13.6	10.8	11.5	11.7	23.2	23.6	16.8	32.1	23.1	16.1	19.4	14.0	11.4	20.8	22.2	94.4	13.2	17.3	19.1	14.7	13.5	14.8	15.3	10.6	15.0	20.7	27.0	14.1	23.8	18.8	10.1	14.6	16.8	21.2	19.1	20.7	11.2	14.2	11.3	16.0	21.3	39.2	52.0	14.6	33.6	41.3	18.5	22.6	11.2	22.2	18.8	20.8	30.8	16.0	16.6	23.8	20.9	28.0	20.7	9.3	13.0	10.1	23.6	30.8	17.1	15.0	29.4	25.8	19.3	37.9	36.0	27.7	13.2	22.4	21.7	27.4	9.4	16.8	9.0	21.8	30.3	6.8	11.2	15.2	15.1	27.7	16.6	12.8	12.4	12.3	26.2	21.2	24.9	19.2	14.0	21.2	17.0	10.6	30.8	12.6	20.5	11.0	9.2	25.3	10.3	20.1	16.8	11.4	10.1	15.2	16.5	20.7	9.3	12.9	14.5	14.6	10.1	13.6	13.1	7.0	19.1	21.2	11.8	12.9	11.2	9.9	11.5	13.8	13.2	10.9	10.4	11.5	11.7	16.1	10.6	56.6	72.1	28.3	45.2	33.8	31.7	119.3	33.1	77.6	72.8	24.4	41.2	41.6	29.9	33.3	7.0	31.7	32.6	0.0	42.1	41.2	49.4	55.7	47.4	50.5	38.8	25.4	38.5	33.2	29.4	7.8	72.8	35.6	27.0	52.3	62.2	30.7	47.4	31.6	64.3	39.6	50.3	38.8	44.0	44.7	71.1	35.3	75.7	29.2	38.5	52.8
USP36	"FLJ12851, KIAA1453"	ENSG00000055483	"Ubiquitin specific peptidase 36"	Q9P275	17	78787381-78841441	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012082, HPA012395, HPA052860"	Uncertain	Supported	Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nucleoli, Nucleoli rim"	"Nuclear speckles"	"HPA012082: AB_1858682, HPA012395: , HPA052860: AB_2681974"	"unprognostic (1.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.18e-5)"	"unprognostic (9.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.78e-1)"	26.3	23.4	12.9	21.3	16.0	36.5	28.1	28.3	17.4	17.2	16.4	25.4	19.2	12.3	25.1	22.2	14.6	18.0	21.9	17.4	10.4	11.2	15.9	16.4	20.0	17.2	17.5	16.0	41.3	33.6	19.6	30.0	23.4	14.6	21.0	15.1	20.4	21.8	45.5	19.5	29.3	15.1	25.2	14.5	18.2	17.3	20.8	13.7	12.8	19.3	11.2	22.2	24.6	18.1	6.7	12.4	8.9	5.3	5.6	8.8	2.5	16.0	19.4	5.7	10.6	12.3	13.7	11.0	13.2	13.4	12.7	8.6	18.8	8.1	20.5	6.7	11.7	13.8	11.8	13.4	9.8	22.8	4.9	20.3	18.7	28.3	19.6	12.7	20.5	10.3	11.9	16.3	18.1	40.6	9.8	11.0	9.3	14.9	21.7	10.4	12.3	18.6	20.8	8.8	12.0	15.6	14.4	12.6	13.8	8.0	17.0	16.9	10.3	9.5	44.3	24.0	13.0	11.4	13.1	9.3	30.1	14.0	17.5	23.3	16.1	6.3	25.3	11.8	16.0	9.4	8.9	3.9	3.1	7.6	5.3	8.8	6.4	7.2	6.4	2.3	6.7	8.0	7.7	5.7	5.6	3.3	12.4	4.8	2.5	12.9	16.0	28.3	17.4	10.4	11.2	17.5	16.0	14.6	13.7	11.9	41.5	16.3	21.0	45.9	31.4	13.5	15.3	12.0	26.1	14.0	31.4	6.9	5.0	8.7	12.1	20.4	6.8	0.0	8.3	8.9	25.9	22.8	19.7	12.4	34.2	25.4	17.7	12.3	20.6	6.1	10.9	34.8	28.7	10.8	13.6	17.3	10.7	8.6	11.7	4.1	32.5	6.5	22.7	14.2	10.6	37.9	10.8	30.5	14.0	20.4
UTP6	"C17orf40, HCA66"	ENSG00000108651	"UTP6, small subunit processome component"	Q9NYH9	17	31860899-31901765	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025936, HPA055806"	Supported		Enhanced	"Nucleoli,Mitotic chromosome"		Yes	No			Nucleoli	"Mitotic chromosome"	"HPA025936: AB_1845588, HPA055806: AB_2682930"	"unprognostic (1.55e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.54e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (1.86e-5)"	"unprognostic (5.68e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-2)"	"unprognostic (4.76e-2)"	19.3	17.9	18.7	16.9	19.3	19.0	26.4	28.7	19.3	17.7	19.5	18.0	12.5	10.8	23.4	30.4	15.7	13.3	10.7	13.0	19.5	17.0	16.7	20.7	15.4	23.3	16.2	16.1	19.5	17.0	14.1	26.0	21.4	16.2	19.9	15.9	15.0	15.9	15.0	17.0	25.3	15.2	17.0	18.8	23.1	16.4	18.5	19.1	23.2	17.1	18.5	28.1	16.0	15.5	15.4	19.7	13.1	10.9	5.7	8.0	7.0	8.5	5.6	7.9	4.5	8.2	5.4	9.6	7.4	4.2	11.3	8.7	20.1	4.5	12.9	9.3	6.8	10.9	11.2	11.1	9.2	10.4	3.3	16.8	8.0	12.6	18.2	9.0	12.3	8.3	8.3	9.2	11.0	8.1	10.2	7.2	8.5	14.1	7.4	9.0	7.0	11.4	32.8	10.4	10.6	8.8	12.0	11.3	12.6	11.6	7.9	5.2	7.9	7.8	5.6	12.4	12.8	13.6	23.0	7.5	17.0	12.8	8.9	14.8	8.3	14.8	18.7	11.6	8.5	9.1	10.6	10.8	6.7	7.6	10.9	7.3	12.7	8.0	8.0	13.6	15.4	7.1	8.0	13.1	5.7	9.7	19.7	7.7	7.0	18.7	19.3	28.7	19.3	19.5	17.0	16.2	16.1	16.2	19.1	17.9	22.4	27.9	22.9	22.9	16.2	12.5	7.6	30.8	30.7	5.2	7.9	36.3	8.3	22.3	20.6	18.0	9.1	0.0	20.7	41.1	23.1	22.0	35.7	14.4	32.5	11.1	5.2	12.9	20.5	3.6	17.3	29.1	8.5	44.1	14.6	17.8	22.2	7.0	15.9	15.0	16.0	6.5	23.1	62.6	62.6	22.7	32.0	13.3	15.3	27.6
VAC14	"ArPIKfyve, FLJ10305, TAX1BP2"	ENSG00000103043	"Vac14, PIKFYVE complex component"	Q08AM6	16	70687439-70801161	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027766, HPA075382"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA027766: AB_1848651, HPA075382: "	"unprognostic (9.25e-2)"	"prognostic favorable (8.33e-5)"	"unprognostic (2.83e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.94e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.21e-2)"	"unprognostic (8.93e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-2)"	"unprognostic (7.20e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.56e-6)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.80e-1)"	26.3	26.6	22.9	22.8	21.8	16.3	17.4	15.6	34.9	17.9	18.4	27.0	18.5	19.8	18.8	15.8	21.0	20.9	17.0	22.2	22.9	23.5	25.7	27.1	20.1	34.9	22.3	20.8	19.2	27.8	33.7	21.4	20.1	25.8	17.9	14.1	22.9	24.3	19.4	23.3	24.6	21.6	19.2	22.2	29.0	20.0	21.7	20.6	31.2	26.0	16.3	22.9	21.0	16.3	5.5	9.7	6.6	5.9	3.7	5.5	1.9	11.4	11.3	9.6	10.7	14.0	10.2	14.7	8.3	13.2	15.9	7.4	14.0	18.5	14.7	10.9	10.0	19.1	14.5	12.6	13.5	7.5	4.4	13.1	7.4	8.6	17.3	36.1	12.7	15.7	16.9	14.2	23.5	21.5	9.6	15.1	13.6	13.0	6.7	13.9	16.5	11.7	21.2	16.9	9.2	10.7	14.2	7.0	21.7	7.6	7.9	11.5	12.5	27.5	8.4	19.0	7.6	12.5	11.9	11.9	21.2	12.2	13.4	9.0	9.6	11.8	28.1	35.4	11.3	9.6	1.3	4.8	6.6	2.9	5.9	2.5	4.0	3.7	5.5	9.7	5.5	3.5	3.1	1.6	3.7	5.4	5.1	2.3	1.9	22.9	21.8	15.6	34.9	22.9	23.5	22.3	20.8	25.8	20.6	3.0	3.4	9.3	7.4	3.8	8.1	10.7	15.3	9.4	4.5	3.5	2.0	13.6	5.0	17.1	14.0	6.7	11.3	23.3	19.5	22.7	6.6	7.1	5.7	13.2	37.6	9.5	8.7	19.6	15.9	40.6	5.8	10.7	10.1	26.2	9.0	6.0	16.7	10.4	3.2	12.2	7.1	6.5	5.6	4.8	12.6	8.0	16.4	3.9	9.3	5.4
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914002-9960021	"Plasma proteins, Predicted membrane proteins"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		5300000	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	27.5	64.8	28.8	21.0	35.5	73.5	27.4	32.9	39.4	24.9	34.3	30.7	19.3	27.8	30.8	23.8	42.3	27.9	29.4	39.9	28.0	30.2	32.7	33.2	35.1	24.6	33.4	28.8	40.6	36.5	25.0	19.4	35.2	48.1	25.2	32.7	18.0	27.9	21.8	55.4	27.6	32.3	28.5	39.1	27.7	34.0	25.2	28.8	36.3	36.4	28.3	22.9	36.0	30.2	24.5	30.6	62.5	37.3	22.2	24.6	39.7	17.3	10.5	12.7	8.3	15.0	16.3	17.8	21.5	17.9	19.6	21.6	14.1	17.3	17.1	20.1	18.8	17.0	12.2	12.3	20.5	22.5	10.6	15.4	27.8	11.2	21.7	35.7	37.5	53.4	15.3	20.8	18.5	22.1	15.4	19.8	14.0	28.0	17.9	17.1	9.3	28.8	21.8	8.2	59.8	16.8	15.1	17.3	23.1	19.1	17.5	18.0	9.8	24.9	15.2	15.4	12.2	14.2	19.4	21.1	32.0	23.8	33.1	26.1	32.1	26.0	20.4	18.1	16.2	21.9	26.1	37.3	62.5	19.3	32.4	22.7	24.5	20.3	20.7	30.6	22.7	22.2	20.4	59.2	22.2	26.4	21.8	24.6	39.7	28.8	35.5	32.9	39.4	28.0	30.2	33.4	28.8	48.1	28.8	119.1	156.9	129.2	289.0	598.2	103.5	201.2	160.5	211.5	124.0	197.1	58.9	238.9	388.0	249.4	7.6	182.0	272.4	70.0	315.1	261.3	247.0	278.9	222.5	128.2	255.8	128.7	138.8	187.9	265.3	9.5	168.5	232.2	264.9	418.4	154.5	119.8	283.7	174.6	203.3	294.2	76.5	187.5	270.9	168.9	212.6	544.1	378.5	153.4	155.5	360.2
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.9	11.0	12.4	6.6	11.4	4.8	11.0	9.8	4.1	15.2	7.5	44.3	10.6	9.7	14.1	6.6	12.1	21.0	9.8	14.1	9.1	4.5	7.4	5.8	12.2	13.9	11.5	5.4	7.4	10.9	16.4	8.4	7.0	7.4	7.5	9.7	13.7	5.5	7.3	34.4	8.5	10.8	6.5	21.5	14.6	8.6	11.5	6.3	11.6	14.7	17.5	12.1	16.2	43.2	16.9	7.1	17.7	8.3	10.3	24.6	12.0	12.3	13.1	7.4	7.9	11.1	20.8	6.0	12.4	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8	41.7	23.2	11.7	12.1	10.4	26.4	43.1	25.5	18.7	13.6	29.6	27.5	28.5	29.9	29.7	4.2	20.4	30.7	0.0	26.6	42.2	18.8	15.2	9.2	32.1	14.0	33.4	20.8	14.7	14.0	5.1	17.3	13.9	13.5	24.4	22.3	34.0	29.0	19.2	23.7	31.6	29.2	12.9	20.5	20.4	28.3	9.3	37.2	18.7	24.2	13.6
VARS	VARS2	ENSG00000204394	"Valyl-tRNA synthetase"	P26640	6	31777518-31795953	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 205.7;Late spermatids: 188.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 25.2;U-266/84: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		23000	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	11.7	11.4	8.9	12.0	9.5	9.1	18.3	7.6	14.0	8.1	11.3	7.3	5.0	12.8	13.5	6.7	14.2	10.2	8.1	9.5	6.4	6.8	9.5	22.7	11.5	24.2	8.3	9.7	9.6	19.2	15.6	15.0	8.5	8.6	7.7	9.4	6.1	9.1	5.9	30.6	14.3	10.3	13.2	8.7	14.4	15.2	40.6	7.5	10.9	8.2	13.2	11.8	9.7	8.5	1.6	1.5	0.6	1.2	2.4	1.0	0.9	2.2	2.0	3.2	6.4	3.6	2.8	8.7	8.8	2.7	6.6	4.0	2.6	1.4	7.7	10.9	5.5	5.0	2.4	10.2	6.7	4.0	5.6	14.4	3.8	5.1	6.1	4.7	15.3	12.6	4.2	2.4	2.6	6.1	1.9	3.3	3.5	10.6	10.5	4.2	3.5	6.9	0.7	6.1	3.2	4.3	9.0	1.7	25.2	5.1	2.9	3.9	1.5	0.7	8.6	3.7	2.2	5.2	6.1	1.1	4.6	4.2	6.1	14.5	15.0	25.9	6.3	3.3	3.1	5.1	0.0	0.6	0.6	1.0	1.2	1.0	1.6	0.6	0.4	1.1	1.1	0.8	0.8	0.0	2.4	1.0	1.5	0.6	0.9	8.9	9.5	7.6	14.0	6.4	6.8	8.3	9.7	8.6	7.5	6.0	8.2	11.1	8.3	7.3	7.0	7.8	7.6	8.1	9.1	15.7	5.9	19.8	8.3	30.5	205.7	9.2	18.8	23.3	36.1	40.7	10.4	7.3	9.2	21.9	26.7	1.6	22.5	6.2	9.2	188.8	19.2	12.0	6.8	10.0	12.5	7.2	28.7	5.8	12.7	11.4	12.4	19.4	8.1	24.4	29.8	11.3	13.8	6.9	19.2	7.0
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 90.2;hTERT-RPE1: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	22.4	15.4	27.9	19.7	35.0	40.8	15.4	29.7	90.2	20.3	23.1	13.8	19.6	1.0	24.8	51.8	13.9	28.9	18.3	14.9	21.5	1.9	7.8	10.7	15.0	5.7	19.2	2.1	16.4	33.7	4.0	27.5	25.1	88.6	27.1	1.8	7.7	2.2	33.8	3.8	0.3	2.5	13.2	10.8	54.5	3.7	14.6	2.8	29.1	29.1	1.0	4.1	16.5	18.7	8.5	25.7	8.6	3.2	36.2	22.2	9.3	10.7	27.7	0.4	0.9	4.4	25.9	6.0	6.2	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3	92.3	37.8	11.5	94.3	102.0	13.5	304.7	50.9	28.1	77.3	40.1	80.5	44.5	3.3	59.0	2.3	54.3	61.0	0.0	53.1	67.5	69.7	88.5	33.6	30.6	21.4	15.9	36.8	73.1	36.2	4.7	46.3	28.0	25.3	9.0	29.5	12.2	85.6	31.9	72.2	12.4	35.2	103.5	102.7	14.2	10.9	81.3	33.2	19.8	37.5	76.0
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
VEZF1	"DB1, ZNF161"	ENSG00000136451	"Vascular endothelial zinc finger 1"	Q14119	17	57971547-57988259	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027520, HPA048315"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA027520: AB_10602680, HPA048315: AB_2680353"	"unprognostic (7.24e-2)"	"unprognostic (3.18e-1)"	"prognostic favorable (6.14e-5)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (6.46e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.28e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.03e-2)"	18.3	26.6	21.2	18.6	29.2	38.6	27.9	24.0	24.2	27.4	31.2	32.4	21.4	15.9	34.0	16.9	21.1	32.4	20.3	24.1	23.6	14.5	23.8	13.4	23.6	21.2	32.2	16.4	28.7	22.6	19.8	26.1	21.2	24.6	26.2	19.2	22.6	23.5	26.1	51.7	13.5	21.2	29.7	21.6	20.6	22.4	16.5	37.2	39.8	31.3	19.6	15.6	29.7	36.4	13.9	17.5	26.2	26.0	25.3	18.2	11.9	19.3	22.0	42.3	14.7	10.9	15.5	14.7	16.1	23.4	20.3	18.5	10.5	20.6	10.0	27.5	17.9	18.8	11.2	16.9	18.4	27.7	28.0	13.2	18.5	17.4	12.4	13.8	16.2	16.6	11.0	23.1	13.1	25.0	28.5	19.6	13.7	13.8	14.0	20.6	7.4	26.2	8.8	14.5	17.3	25.8	20.1	33.1	7.7	12.5	18.5	17.6	33.1	15.7	7.2	23.6	18.5	41.2	16.7	19.2	28.8	29.3	17.8	26.1	14.6	11.5	15.4	20.0	14.4	36.6	21.6	13.8	26.2	17.0	17.1	17.5	12.0	14.0	18.2	16.5	13.9	17.8	15.8	24.1	25.3	26.0	17.5	13.1	11.9	21.2	29.2	24.0	24.2	23.6	14.5	32.2	16.4	24.6	37.2	77.4	48.7	19.9	33.3	32.2	65.0	85.3	40.8	66.9	51.2	24.4	62.8	14.1	21.6	30.9	18.8	40.5	18.7	0.0	31.8	14.2	34.8	46.0	54.4	17.8	19.0	31.8	47.0	34.4	37.2	28.5	33.4	41.5	40.5	19.8	30.2	41.2	25.1	21.0	26.2	23.7	61.8	51.8	39.1	37.7	21.3	18.3	16.6	23.0	23.5	32.0
VGF	"SCG7, SgVII"	ENSG00000128564	"VGF nerve growth factor inducible"	O15240	7	101162509-101165593	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 59.4;pituitary gland: 30.4"	"Group enriched"	"Detected in many"	7	"Horizontal cells: 212.9;Intestinal endocrine cells: 123.0"	"Cancer enriched"	"Detected in many"	6	"melanoma: 236.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 36.7;SK-MEL-30: 99.1;U-2 OS: 18.0;WM-115: 29.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA055177, HPA072505"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1270000	2800000	"Golgi apparatus, Vesicles"		"HPA055177: AB_2682728, HPA072505: AB_2686528"	"unprognostic (3.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.19e-3)"	"prognostic unfavorable (4.25e-4)"	"prognostic unfavorable (3.31e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.25e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.84e-3)"	"unprognostic (3.70e-3)"	"unprognostic (9.82e-3)"	"unprognostic (3.79e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.36e-3)"	"unprognostic (2.21e-1)"	3.8	3.1	10.9	2.3	25.2	1.3	1.1	1.3	59.4	1.1	1.5	1.3	0.0	1.3	2.2	1.1	1.1	1.1	1.2	1.2	12.2	51.0	1.4	1.1	1.1	1.1	3.9	22.8	1.1	6.2	1.1	30.4	1.2	41.2	1.2	1.2	0.5	1.1	1.1	1.1	1.4	1.3	1.5	6.6	1.2	3.6	1.4	0.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	2.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.6	0.0	0.3	0.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.4	0.0	4.7	0.0	0.4	3.7	0.2	0.4	0.1	0.0	0.0	0.0	0.0	3.0	36.7	0.0	0.1	99.1	0.2	0.1	0.0	0.0	0.0	18.0	0.0	0.4	0.0	0.1	0.9	2.9	0.0	29.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	25.2	1.3	59.4	12.2	51.0	3.9	22.8	41.2	0.5	0.0	0.0	0.0	1.0	1.3	8.5	2.4	0.0	0.0	0.0	0.0	0.0	1.3	24.9	0.3	0.0	0.3	1.3	0.0	0.0	6.3	0.2	2.8	0.0	0.0	0.5	212.9	123.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.1	1.4	9.5	2.9	0.0	1.0	4.5	0.0	0.2	0.2	4.2	1.9	1.1	0.0	0.9	0.5
VHL	VHL1	ENSG00000134086	"Von Hippel-Lindau tumor suppressor"	P40337	3	10141008-10152220	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Cancer-related genes, Congenital erythrocytosis, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 54.7"									"CAB005430, HPA031631, HPA031632"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB005430: AB_2241850, HPA031631: AB_2673968, HPA031632: AB_2673969"	"prognostic unfavorable (9.02e-5)"	"unprognostic (1.10e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.55e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (7.84e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.28e-3)"	13.8	17.4	18.1	29.2	18.4	24.3	15.4	25.8	21.4	13.3	19.8	19.3	14.5	15.9	15.1	13.6	16.4	14.3	18.9	10.5	17.1	18.5	13.7	16.3	14.6	27.9	13.5	12.3	15.2	22.5	13.8	14.6	18.8	12.8	15.1	16.6	12.5	21.8	13.7	14.8	14.0	22.3	13.4	17.0	22.6	16.2	17.9	11.2	39.2	16.9	11.5	29.3	15.4	19.1	5.4	3.9	8.0	4.1	4.4	4.3	1.7	6.8	6.6	14.6	8.9	13.6	10.5	54.7	6.1	8.7	7.8	9.2	7.8	8.6	24.3	8.3	8.2	11.0	5.9	13.5	8.5	9.6	11.6	12.2	18.9	10.8	10.7	12.9	16.6	15.2	10.6	9.7	10.3	13.0	10.4	8.9	15.3	16.8	18.5	7.6	12.4	15.8	12.2	9.8	7.4	8.5	20.1	12.9	12.2	9.5	17.8	5.5	18.3	12.8	6.8	7.3	9.2	13.4	21.1	7.7	7.7	10.4	7.2	9.5	13.2	26.9	38.8	8.6	20.0	7.0	2.6	4.1	3.3	3.8	2.5	3.6	4.1	2.9	4.3	3.9	5.4	2.5	2.7	8.0	4.4	3.2	2.4	3.1	1.7	18.1	18.4	25.8	21.4	17.1	18.5	13.5	12.3	12.8	11.2	11.9	12.2	25.5	15.5	13.1	15.6	5.0	20.4	5.3	5.7	15.7	17.7	13.9	6.6	9.9	7.6	12.1	10.5	0.0	4.5	15.8	9.5	19.0	4.7	12.3	12.9	17.5	13.8	17.2	20.2	6.1	13.0	18.5	11.8	15.4	9.3	10.4	8.5	9.3	10.6	7.3	13.9	6.5	6.2	14.4	25.6	17.9	14.4	17.5	10.7	19.5
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419092-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	Apoptosis	"Actin capping, Actin-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 129.3"	"Group enriched"	"Detected in many"	5	"Enterocytes: 321.8;Intestinal endocrine cells: 109.0;Mucus-secreting cells: 120.3;Paneth cells: 175.6;Undifferentiated cells: 122.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	91	"CACO-2: 121.2;Hep G2: 56.9;OE19: 50.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		41000000	"Plasma membrane"		"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.3	0.2	0.6	5.7	0.8	0.0	0.3	0.7	0.4	0.3	36.6	0.3	0.3	68.9	0.3	1.2	0.3	0.2	22.6	0.3	0.5	0.5	4.6	6.1	0.3	0.3	0.5	0.3	0.3	7.2	0.0	0.4	0.3	0.3	0.3	32.6	0.3	0.5	0.3	0.3	0.3	129.3	1.2	0.5	0.4	0.9	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	2.5	0.1	0.1	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	121.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	50.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.1	0.0	0.4	0.0	7.8	0.6	0.8	0.7	0.4	0.5	0.5	0.5	0.3	0.3	0.3	0.0	0.0	0.0	0.2	0.7	2.2	0.4	17.8	0.0	0.0	0.0	2.0	0.2	3.3	6.7	1.5	0.0	321.8	0.0	37.7	0.1	0.6	0.3	9.2	28.8	0.1	1.6	109.0	1.3	2.6	0.0	0.0	1.0	0.0	0.0	120.3	0.8	15.1	175.6	0.0	26.6	1.2	0.0	0.8	0.7	0.9	0.6	0.2	1.0	122.8	0.4
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69172861	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		19000	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	30.7	25.8	31.8	18.8	37.1	25.2	29.6	42.6	37.2	23.3	27.5	14.5	15.1	21.4	24.5	20.7	37.1	20.7	20.9	40.7	33.3	21.1	34.3	26.5	23.9	17.7	26.5	25.4	24.1	19.3	31.4	24.5	36.4	29.9	23.9	28.8	15.3	25.7	20.3	29.3	33.8	28.0	22.9	35.4	24.7	22.7	34.2	29.1	21.8	27.8	23.6	22.8	30.8	27.3	16.9	28.1	28.2	29.4	34.7	28.1	25.3	33.4	12.8	15.8	28.3	27.9	25.4	14.0	20.5	33.4	25.1	28.7	30.1	32.9	10.5	16.7	22.4	23.9	23.3	23.7	20.5	35.0	9.4	12.9	15.6	11.9	16.8	36.1	23.6	12.6	23.0	32.2	25.1	55.9	34.0	26.3	12.5	30.0	14.8	40.0	10.7	10.6	26.8	10.6	17.1	32.6	13.2	26.2	12.5	29.3	19.9	9.7	14.5	27.9	38.6	37.3	14.9	15.2	20.3	30.3	17.1	21.9	27.7	26.7	8.9	21.5	17.1	23.4	38.6	8.9	28.2	25.4	22.9	27.9	29.4	25.3	16.9	21.6	28.1	28.1	13.7	19.2	26.6	23.0	34.7	24.2	11.5	24.1	25.3	31.8	37.1	42.6	37.2	33.3	21.1	26.5	25.4	29.9	29.1	68.5	47.5	29.0	70.8	107.3	21.8	36.4	35.7	50.9	63.7	38.4	13.7	103.0	68.0	58.4	46.4	48.6	35.8	23.3	46.6	75.5	56.3	52.1	42.9	27.6	75.3	19.1	15.5	31.9	46.6	23.9	39.1	86.2	59.1	73.1	33.8	53.3	51.3	41.0	42.1	58.0	26.2	12.9	72.1	78.0	63.2	93.5	203.8	67.5	35.4	66.3
VPS54	"HCC8, PPP1R164"	ENSG00000143952	"VPS54, GARP complex subunit"	Q9P1Q0	2	63892146-64019072	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055894, HPA067981, HPA070582"			Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA055894: AB_2682961, HPA067981: AB_2685938, HPA070582: AB_2686282"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.37e-1)"	"unprognostic (9.47e-3)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (3.20e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-1)"	"unprognostic (4.91e-2)"	15.5	14.2	10.1	11.1	13.2	12.6	14.3	22.1	12.9	18.6	17.1	11.4	17.3	12.9	16.3	14.4	13.3	14.4	13.7	12.5	11.3	8.5	15.8	15.5	15.2	9.6	14.3	10.6	18.0	21.0	34.2	32.1	13.0	12.1	17.3	13.5	14.3	31.9	19.4	12.2	13.1	16.9	17.5	10.4	13.3	13.7	12.2	12.5	18.3	17.5	11.3	11.3	13.5	26.2	3.1	2.8	4.1	3.2	3.0	4.3	1.0	16.7	9.3	17.0	13.3	12.5	13.2	12.5	10.9	16.4	11.6	11.5	16.9	10.9	11.7	8.2	14.3	17.2	7.8	16.7	9.8	20.6	16.6	11.1	11.1	7.1	28.5	11.7	7.5	4.7	12.2	14.8	8.2	17.8	13.9	17.4	8.4	12.1	9.9	14.6	7.4	7.7	7.4	10.3	17.0	6.7	7.8	16.7	6.6	12.7	9.8	9.8	14.7	9.4	12.1	12.4	14.0	8.7	14.8	12.4	14.9	11.9	9.0	17.7	22.8	6.2	15.0	10.9	15.1	12.6	4.1	3.2	1.3	2.1	3.2	2.6	2.4	2.1	2.5	1.8	3.1	2.8	2.2	3.0	3.0	2.5	2.8	4.3	1.0	10.1	13.2	22.1	12.9	11.3	8.5	14.3	10.6	12.1	12.5	14.9	18.2	4.6	7.4	9.8	17.8	11.7	7.6	8.1	18.2	1.8	11.8	5.3	1.7	6.5	41.8	11.3	9.5	0.0	11.3	5.4	11.3	16.0	2.3	14.3	7.0	22.3	12.7	8.6	8.6	28.3	17.3	8.8	5.0	0.0	17.7	8.9	10.1	11.5	11.7	8.4	16.4	19.4	8.9	13.2	6.0	9.2	4.6	6.4	11.0	12.2
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647075-67674831	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	37.5	21.4	49.3	14.9	39.3	14.3	32.1	12.6	32.9	11.3	22.8	16.8	16.1	21.3	12.5	42.5	34.1	14.6	22.0	49.6	36.9	30.4	39.0	30.5	14.8	16.3	38.1	20.5	12.7	27.9	20.3	11.3	21.0	24.2	16.2	27.4	15.4	25.7	18.8	31.0	21.8	20.2	22.9	37.1	15.6	20.7	15.4	20.2	8.2	25.9	18.8	19.5	19.4	24.2	18.7	22.4	52.1	29.6	20.1	21.7	18.9	38.5	19.5	11.4	6.6	22.7	13.5	16.4	17.1	10.6	8.3	8.5	9.7	13.9	11.6	14.6	19.0	10.1	10.9	13.0	12.9	13.5	11.8	8.2	11.7	11.8	12.3	9.7	7.2	8.4	13.1	14.1	9.2	9.5	22.0	9.5	8.1	7.6	9.1	12.0	45.8	9.0	26.8	7.4	26.7	31.5	11.0	12.9	4.2	12.3	23.2	6.4	13.1	12.1	16.4	24.2	9.1	15.3	20.4	13.7	23.0	34.4	18.5	15.8	8.5	9.1	17.8	19.4	13.6	10.5	28.6	23.4	52.1	19.8	29.6	16.9	18.7	17.5	20.2	22.4	16.4	16.7	20.4	10.6	20.1	24.7	14.7	21.7	18.9	49.3	39.3	12.6	32.9	36.9	30.4	38.1	20.5	24.2	20.2	23.8	34.1	49.1	46.9	37.5	22.4	26.0	53.5	48.2	38.7	62.8	21.6	89.3	184.1	93.0	115.6	46.6	134.6	116.8	115.1	143.6	54.1	81.6	62.4	79.1	116.8	14.3	44.7	56.4	74.2	380.3	38.6	65.2	67.4	137.1	84.4	35.2	113.0	108.7	37.4	203.8	35.3	19.4	41.0	101.0	65.5	46.2	105.3	34.1	80.0	77.1
VWA5A	"BCSC-1, LOH11CR2A"	ENSG00000110002	"Von Willebrand factor A domain containing 5A"	O00534	11	124115362-124147721	"Predicted intracellular proteins"			"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	15	"granulocytes: 538.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 25.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 28.2;HEL: 20.3;HHSteC: 15.8;HUVEC TERT2: 18.7;RPTEC TERT1: 20.6"					"Low region specificity"	"Detected in all"			"HPA037813, HPA037814, HPA061500"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA037813: AB_10672727, HPA037814: AB_10672287, HPA061500: AB_2684542"	"unprognostic (2.69e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.49e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.18e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.38e-2)"	"prognostic favorable (1.55e-5)"	"unprognostic (4.54e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.65e-1)"	14.8	20.2	13.8	7.5	13.4	1.6	16.0	2.3	9.3	15.5	23.9	7.5	10.0	16.7	16.6	17.0	12.6	9.9	19.9	6.5	14.1	24.6	16.0	4.3	19.4	6.8	12.5	6.6	9.6	15.3	5.5	34.2	25.9	15.2	22.5	28.4	10.3	31.2	13.2	3.0	17.9	24.0	13.6	15.0	6.0	17.8	6.3	7.6	3.9	13.7	7.1	9.8	14.9	11.8	4.5	4.8	25.6	5.3	4.3	7.5	3.6	0.0	0.2	3.6	0.2	3.9	3.6	1.3	0.5	0.2	0.3	0.1	0.2	28.2	0.0	3.5	0.6	4.9	0.1	0.7	6.4	0.0	9.6	0.0	20.3	5.1	0.6	15.8	0.2	9.5	10.7	0.7	0.6	2.1	1.4	18.7	2.7	1.1	3.5	1.1	0.1	0.4	0.3	5.7	0.0	0.7	0.0	12.6	0.1	20.6	0.2	3.2	0.3	0.5	0.2	1.0	8.7	2.5	0.9	0.5	0.1	2.7	0.1	0.0	1.3	1.1	0.0	11.7	0.4	0.2	25.6	4.8	0.5	2.9	3.3	0.7	4.5	3.2	1.7	4.8	2.3	4.1	2.6	0.3	4.3	5.3	2.6	7.5	3.6	13.8	13.4	2.3	9.3	14.1	24.6	12.5	6.6	15.2	7.6	8.9	36.5	0.8	11.6	15.2	2.9	2.4	7.6	25.4	14.8	31.4	2.0	7.8	8.3	19.7	32.8	3.6	25.8	0.0	25.0	2.1	7.8	8.4	538.2	2.4	29.2	30.2	14.5	1.8	5.6	3.6	2.6	6.0	5.0	2.8	22.5	12.0	20.8	17.3	0.4	11.5	1.1	0.0	3.8	0.2	2.3	10.9	1.6	4.9	22.5	14.0
WAC	"BM-016, FLJ31290, MGC10753, PRO1741, Wwp4"	ENSG00000095787	"WW domain containing adaptor with coiled-coil"	Q9BTA9	10	28532493-28623112	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036528, HPA042609, HPA074604"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA036528: AB_10670839, HPA042609: AB_2678076, HPA074604: "	"unprognostic (1.04e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.19e-2)"	"prognostic unfavorable (9.27e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.13e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.36e-1)"	30.6	25.2	36.5	29.8	40.9	59.3	30.4	83.3	46.0	30.4	36.5	27.8	26.9	24.9	33.3	30.6	29.0	28.3	25.9	40.8	37.4	31.6	32.2	28.7	29.4	32.9	36.4	35.5	39.6	33.8	41.8	44.2	34.8	35.4	32.3	28.8	21.2	27.0	31.7	31.8	28.9	27.5	36.4	38.1	33.5	27.3	28.1	41.0	30.1	36.5	18.3	36.6	40.3	78.9	15.0	14.9	19.9	20.6	23.0	17.6	9.7	31.3	20.1	41.3	25.2	34.1	32.9	29.1	30.5	24.2	35.8	41.1	28.5	35.1	41.8	22.1	28.1	28.2	30.6	33.5	23.0	39.6	42.9	27.7	44.3	22.5	22.3	39.8	21.5	34.8	28.3	44.3	39.2	34.7	35.4	31.5	33.7	39.0	39.0	29.8	24.2	47.7	18.9	23.9	24.4	10.4	34.6	57.0	28.0	25.6	18.3	41.5	31.2	25.3	33.6	45.9	34.6	25.5	34.5	26.1	22.8	28.3	24.6	26.9	21.1	18.7	45.4	24.1	41.0	20.0	14.6	12.1	12.4	14.6	20.6	17.6	15.0	13.2	16.8	14.9	13.6	15.0	13.6	19.9	23.0	15.9	11.3	14.2	9.7	36.5	40.9	83.3	46.0	37.4	31.6	36.4	35.5	35.4	41.0	86.4	62.7	75.1	84.6	156.4	108.3	98.2	58.6	34.8	55.7	38.4	90.3	50.1	26.6	39.8	80.4	72.4	67.2	0.0	40.9	51.4	74.3	94.2	54.3	51.3	46.5	101.7	66.7	68.2	99.9	76.5	76.8	83.5	72.6	38.7	70.0	65.8	47.1	63.3	77.8	50.0	84.7	58.2	80.8	79.1	54.1	160.8	82.8	82.8	62.6	118.0
WARS	"IFI53, IFP53"	ENSG00000140105	"Tryptophanyl-tRNA synthetase"	P23381	14	100333788-100376805	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Angiogenesis, Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 142.8;thyroid gland: 157.0"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 112.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"intermediate monocyte: 131.2;non-classical monocyte: 142.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 118.8;SK-MEL-30: 143.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005573, HPA018944"	Enhanced		Enhanced	Cytosol		No	No		53000000	Cytosol		"HPA005573: AB_2667366, HPA018944: AB_2669986"	"unprognostic (5.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.30e-1)"	"unprognostic (9.25e-2)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (5.14e-2)"	"unprognostic (4.26e-2)"	"prognostic favorable (1.94e-4)"	"unprognostic (4.84e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.53e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.92e-3)"	42.5	23.3	14.5	53.9	20.1	17.0	20.6	10.7	25.4	11.1	19.1	13.3	7.1	12.7	16.5	20.5	17.8	14.5	13.7	32.0	17.8	18.7	24.6	17.9	68.5	35.3	16.9	14.8	12.1	15.6	9.4	23.5	89.6	28.2	16.4	21.0	23.5	15.7	11.7	22.3	9.3	19.8	21.0	15.7	51.6	19.8	23.7	9.4	20.9	157.0	19.2	22.7	24.0	13.8	5.6	27.7	51.8	142.8	3.3	3.4	46.4	11.1	10.6	7.0	40.7	10.1	14.4	11.2	14.4	27.9	31.0	39.2	6.9	10.0	12.1	13.5	34.3	7.6	19.0	20.2	16.4	20.0	19.2	5.8	7.8	8.1	8.5	118.8	22.2	12.8	16.3	23.6	18.0	37.5	9.4	27.8	8.2	24.4	32.1	13.2	21.3	7.6	10.4	7.0	11.4	19.3	6.4	11.0	7.7	15.1	9.8	18.7	10.9	8.6	7.5	143.4	9.4	19.1	28.2	18.4	3.3	7.5	33.9	7.5	62.6	31.8	22.5	37.4	17.3	30.2	6.1	39.5	51.8	3.4	131.2	3.1	5.6	2.8	3.1	27.7	4.1	2.0	2.4	14.1	3.3	142.8	4.2	3.3	46.4	14.5	20.1	10.7	25.4	17.8	18.7	16.9	14.8	28.2	9.4	23.8	39.7	41.6	6.7	12.9	9.0	12.1	7.6	30.8	29.6	21.0	19.6	14.6	13.3	29.0	112.5	76.4	8.5	0.0	56.4	9.8	20.5	12.1	29.0	14.9	40.6	7.9	14.3	87.8	44.2	82.6	10.6	72.8	8.5	71.3	14.1	9.3	34.3	7.2	12.7	15.3	15.8	19.4	21.7	69.3	20.9	10.7	13.8	10.2	10.1	11.4
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169134	"Disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 41.8;Hofbauer cells: 44.7;monocytes: 46.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	26.2	22.1	14.4	22.8	18.1	16.0	20.2	14.8	16.8	20.8	16.2	16.4	21.1	11.5	22.3	18.0	15.9	15.3	18.2	13.3	14.3	11.9	25.6	28.5	19.4	31.5	18.7	11.9	21.7	19.6	20.7	30.1	23.8	24.0	18.5	14.8	14.6	17.5	18.0	18.0	24.3	21.9	18.2	22.1	36.5	14.3	9.9	17.4	21.3	17.9	12.2	29.8	16.7	18.9	11.4	7.9	11.0	20.9	5.3	3.6	4.3	10.0	12.2	10.9	7.9	25.6	25.5	13.0	15.6	18.1	18.4	17.0	8.6	5.8	22.7	8.7	26.2	11.8	9.4	9.2	9.6	14.8	8.2	7.0	4.6	11.3	7.1	17.2	12.9	9.0	20.4	11.3	16.6	13.4	19.7	29.7	8.1	9.2	8.1	19.9	5.1	7.2	13.4	13.1	7.1	10.2	13.7	14.8	7.1	24.4	11.8	7.0	8.8	16.2	11.5	16.0	14.4	8.5	13.9	36.1	22.3	6.1	14.1	10.2	10.6	10.0	18.4	15.7	11.4	22.3	9.9	10.2	5.9	2.1	12.4	3.1	11.4	3.4	2.8	7.9	9.0	3.6	3.4	11.0	5.3	20.9	4.0	2.3	4.3	14.4	18.1	14.8	16.8	14.3	11.9	18.7	11.9	24.0	17.4	32.8	18.7	0.0	0.0	0.0	0.0	0.0	0.0	32.1	21.6	41.8	0.0	19.1	16.6	22.0	0.0	0.0	0.0	0.0	19.0	23.9	0.0	0.0	24.4	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	46.9	0.0	0.0	22.7	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	26.8	0.0	0.0	0.0
WASHC5	"KIAA0196, SPG8"	ENSG00000164961	"WASH complex subunit 5"	Q12768	8	125024260-125091840	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 17.5;Exocrine glandular cells: 14.9;Hofbauer cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034216, CAB034219, HPA064649, HPA070916"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB034216: AB_2234159, CAB034219: AB_2130519, HPA064649: AB_2685312, HPA070916: AB_2686322"	"unprognostic (1.98e-3)"	"unprognostic (3.75e-2)"	"unprognostic (8.40e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.74e-5)"	"unprognostic (2.54e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.69e-2)"	"unprognostic (9.10e-3)"	"unprognostic (1.53e-1)"	"unprognostic (9.39e-3)"	"unprognostic (5.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.33e-2)"	21.7	28.1	16.7	17.3	25.1	18.5	20.1	17.1	23.7	18.7	18.2	38.0	13.0	17.9	22.2	16.5	19.6	15.8	18.0	17.1	16.9	15.2	23.2	18.2	16.8	23.0	22.8	16.4	16.5	17.1	25.9	26.4	22.0	28.7	18.3	20.7	17.9	22.6	17.3	23.1	18.6	16.8	20.7	24.5	19.6	18.3	9.3	22.5	25.0	23.9	17.8	20.6	20.4	16.0	8.4	16.0	9.7	21.5	13.5	13.5	9.6	15.7	18.6	10.2	12.5	23.3	25.0	6.7	16.9	26.1	18.0	19.2	6.9	17.1	14.1	12.1	22.1	10.5	12.4	16.6	15.5	23.7	18.6	9.3	19.0	11.5	9.0	22.7	5.8	19.3	24.8	10.3	14.8	13.0	13.8	20.6	12.5	10.9	14.6	21.8	34.4	17.2	4.6	9.7	26.5	18.9	11.7	9.2	14.4	13.7	19.8	5.4	10.8	19.8	44.8	15.7	11.1	19.3	10.1	17.9	9.8	21.8	16.2	15.0	13.1	12.0	12.7	26.0	11.0	13.6	7.7	13.7	9.7	11.8	16.8	12.5	8.4	11.3	11.9	16.0	8.1	9.1	12.5	4.8	13.5	21.5	5.8	13.5	9.6	16.7	25.1	17.1	23.7	16.9	15.2	22.8	16.4	28.7	22.5	3.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	8.1	9.1	10.4	0.0	11.0	5.0	10.4	0.0	0.0	0.0	0.0	14.9	8.8	0.0	0.0	8.1	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	10.0	0.0	0.0	12.8	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0
WBP11	"NPWBP, PPP1R165, SIPP1"	ENSG00000084463	"WW domain binding protein 11"	Q9Y2W2	12	14784579-14803540	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039710, HPA040037, HPA046403, HPA049126"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039710: AB_2676638, HPA040037: AB_10796115, HPA046403: AB_2679654, HPA049126: AB_2680644"	"unprognostic (4.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.15e-2)"	"prognostic unfavorable (9.40e-4)"	"unprognostic (5.67e-3)"	"unprognostic (3.30e-2)"	"unprognostic (2.68e-1)"	"unprognostic (9.69e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.96e-3)"	"unprognostic (6.11e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.09e-2)"	27.0	30.8	32.7	22.8	40.7	59.5	25.9	25.6	34.2	21.4	21.9	28.8	10.7	17.5	27.5	20.5	23.4	27.3	19.3	32.9	28.1	25.3	23.5	25.1	25.4	27.3	24.0	29.7	29.4	23.1	29.7	21.8	28.2	29.3	25.1	24.9	23.0	23.2	21.6	46.7	28.7	23.1	24.6	29.1	31.1	23.6	39.2	25.8	25.7	26.5	20.4	30.6	26.4	20.9	15.4	11.4	10.5	16.7	15.9	19.8	11.3	16.2	14.6	17.3	32.9	11.6	11.1	31.2	13.4	11.3	20.5	20.7	26.4	20.2	20.3	8.7	12.1	17.6	13.5	26.6	17.7	25.3	35.9	17.8	29.6	16.1	16.0	11.6	27.6	16.3	10.8	14.1	22.9	17.2	11.2	16.3	19.3	18.8	10.8	16.2	15.7	25.7	14.8	55.6	11.3	9.3	22.0	27.4	12.7	14.7	22.4	9.2	18.8	17.9	15.0	14.1	43.1	8.0	18.3	12.0	14.3	22.0	12.6	22.9	9.5	13.2	37.4	15.0	13.8	19.0	9.5	12.1	10.5	17.2	16.7	18.9	15.4	16.6	17.3	11.4	13.8	19.8	17.9	7.4	15.9	16.5	8.2	17.2	11.3	32.7	40.7	25.6	34.2	28.1	25.3	24.0	29.7	29.3	25.8	53.6	55.4	61.2	69.4	48.8	41.1	94.8	61.1	100.4	67.1	34.9	45.2	49.7	36.5	51.5	59.9	46.9	28.6	70.0	51.9	78.0	44.6	45.4	101.8	36.5	41.5	41.3	37.9	44.2	29.8	44.4	42.0	44.2	33.7	132.6	33.1	45.0	42.9	17.5	30.8	39.1	49.6	58.2	50.2	136.2	151.1	48.7	63.5	59.6	38.4	55.9
WDHD1	"AND-1, CHTF4, CTF4"	ENSG00000198554	"WD repeat and HMG-box DNA binding protein 1"	O75717	14	54938950-55027105	"Predicted intracellular proteins, Predicted membrane proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.1"	"Cell type enhanced"	"Detected in many"	9	"Spermatocytes: 10.6;Spermatogonia: 20.5"	"Cancer enhanced"	"Detected in all"		"testis cancer: 23.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000632, HPA001122"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000632: , HPA001122: AB_1080589"	"unprognostic (1.88e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.20e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.33e-4)"	"unprognostic (5.52e-3)"	"unprognostic (7.28e-3)"	"unprognostic (8.05e-3)"	"prognostic unfavorable (9.24e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.67e-4)"	"unprognostic (8.31e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	5.0	2.8	6.3	6.6	7.5	10.8	3.8	7.2	4.6	3.7	4.9	2.7	0.6	3.2	4.2	2.9	7.0	4.0	2.3	2.3	3.2	2.3	2.8	2.1	2.9	8.9	3.3	2.5	4.1	2.0	3.0	1.9	6.0	4.4	2.1	7.3	2.6	3.0	2.2	2.0	4.5	3.6	4.6	2.8	4.6	2.8	8.8	3.5	21.1	2.1	6.4	11.2	3.6	4.3	4.8	1.8	4.3	0.9	4.3	4.6	1.6	16.0	10.4	20.6	9.0	2.0	4.9	12.0	15.6	6.7	12.6	15.5	6.9	10.8	18.4	8.0	4.4	9.1	13.7	30.6	9.0	26.6	12.3	5.3	12.1	10.1	6.6	0.8	22.8	9.3	2.5	1.6	15.6	6.1	3.0	8.2	12.0	15.1	9.3	12.1	8.9	21.4	4.5	16.3	8.6	10.8	20.1	29.6	7.1	3.6	10.8	12.0	8.4	16.6	4.2	5.4	15.7	11.3	4.6	5.3	16.1	19.1	11.7	13.2	2.8	5.7	24.6	7.3	11.3	12.6	4.3	0.8	1.4	2.3	0.6	3.2	3.0	2.7	3.3	1.4	4.8	3.3	4.6	1.2	4.3	0.9	1.8	3.9	1.6	6.3	7.5	7.2	4.6	3.2	2.3	3.3	2.5	4.4	3.5	0.0	1.3	2.9	1.5	3.4	2.1	1.5	0.0	4.0	5.7	3.5	0.0	5.8	0.0	1.8	0.5	1.0	0.5	0.0	0.9	8.0	3.1	0.5	0.0	0.8	3.4	3.2	0.0	1.3	1.6	0.8	0.0	2.0	1.7	1.8	2.5	1.5	1.0	0.0	2.8	1.9	3.3	0.0	3.3	10.6	20.5	2.0	2.2	0.0	3.1	0.9
WDR26	"FLJ21016, GID7"	ENSG00000162923	"WD repeat domain 26"	Q9H7D7	1	224385143-224437033	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 63.9"	"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 178.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028538, HPA028539, HPA061094"	Enhanced		Enhanced	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Mitochondria	"HPA028538: , HPA028539: AB_10669752, HPA061094: AB_2684427"	"unprognostic (4.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.31e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.32e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.18e-1)"	"prognostic unfavorable (3.31e-6)"	"unprognostic (8.40e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.28e-1)"	8.2	7.2	6.7	6.7	6.7	18.5	7.2	8.2	7.3	7.8	7.0	6.7	6.7	4.0	6.8	9.3	13.0	5.9	7.0	7.5	6.7	5.0	6.7	9.3	9.0	7.2	6.7	6.7	7.0	6.9	9.2	6.7	8.7	6.7	7.0	6.7	6.7	7.2	6.7	15.2	9.9	6.7	7.1	6.7	10.2	6.3	63.9	6.7	6.7	7.0	6.7	7.4	6.7	8.3	1.5	2.1	8.3	3.9	2.7	2.7	1.3	11.9	6.2	19.3	8.9	25.8	29.4	13.9	17.6	28.8	16.1	15.2	9.8	13.6	14.2	17.7	28.3	6.2	10.9	11.3	15.1	26.5	11.1	12.9	9.8	8.1	9.2	28.1	10.2	17.2	27.3	21.9	17.0	16.1	26.7	26.8	8.7	12.9	14.7	21.1	6.6	10.5	9.9	18.6	12.4	7.2	9.7	20.2	11.2	19.6	12.1	7.0	17.9	20.0	27.1	21.5	21.1	31.1	16.8	28.1	13.8	6.3	12.9	21.1	15.7	7.5	9.7	15.7	7.3	17.0	4.1	1.9	3.3	2.7	2.4	1.5	1.5	1.9	2.1	1.8	1.4	1.4	2.1	8.3	2.7	3.9	2.1	1.6	1.3	6.7	6.7	8.2	6.7	6.7	5.0	6.7	6.7	6.7	6.7	98.3	43.8	19.4	25.3	99.0	23.8	42.4	45.9	41.5	50.0	33.2	29.5	23.4	5.0	19.2	178.7	37.6	21.6	0.0	20.3	11.8	51.5	39.3	46.2	31.0	44.5	36.5	34.0	44.2	119.9	79.7	34.2	49.8	43.9	12.6	40.3	16.9	26.6	25.9	26.5	17.0	22.9	19.4	41.9	36.4	24.6	107.0	57.1	31.6	23.8	59.3
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	6.7	8.0	8.6	11.8	9.2	7.0	9.3	10.1	10.9	9.9	7.9	10.3	7.1	8.1	17.2	10.2	8.9	13.4	8.1	5.0	6.1	4.1	7.2	6.3	6.6	8.2	5.9	5.1	18.2	8.5	8.4	9.9	5.9	7.2	9.2	6.3	8.4	11.2	5.9	5.9	7.5	8.6	9.1	4.7	7.8	7.7	21.5	8.6	7.6	12.7	4.2	9.0	10.2	10.8	4.7	2.1	1.5	1.1	0.7	6.0	1.2	4.4	6.3	15.8	8.9	4.7	6.2	7.9	6.1	1.5	2.9	4.5	8.4	6.6	4.5	4.7	1.9	6.3	9.1	5.0	4.3	4.5	6.0	8.9	8.5	11.3	5.4	3.4	4.7	1.3	6.1	3.8	3.9	4.6	7.5	5.8	9.2	19.8	9.3	4.8	6.7	3.0	11.7	7.4	4.8	5.5	7.9	5.5	6.6	3.7	4.0	9.0	10.8	5.0	3.6	3.8	5.6	4.4	8.0	5.6	4.3	5.4	6.3	7.1	8.8	3.5	10.0	5.3	9.3	7.4	0.2	1.1	1.5	1.9	0.7	3.2	2.1	2.0	2.5	1.1	4.7	6.0	1.7	0.5	0.7	0.5	2.1	1.2	1.2	8.6	9.2	10.1	10.9	6.1	4.1	5.9	5.1	7.2	8.6	8.9	3.8	5.6	5.1	1.9	12.7	3.2	7.6	14.7	3.4	12.2	5.9	4.2	0.0	2.2	21.5	5.8	3.3	0.0	1.3	2.3	4.5	3.7	3.5	3.9	1.9	20.6	4.1	11.1	1.3	6.8	7.5	2.5	3.3	1.0	4.2	7.0	1.7	5.1	9.2	1.3	13.8	0.0	2.7	14.9	9.4	1.0	1.6	4.4	6.0	4.7
WDR3	"DIP2, FLJ12796, UTP12"	ENSG00000065183	"WD repeat domain 3"	Q9UNX4	1	117929720-117966542	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027509, HPA054354, HPA072915"			Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoli	Nucleoplasm	"HPA027509: AB_10601808, HPA054354: AB_2682459, HPA072915: "	"unprognostic (6.77e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.91e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (1.29e-1)"	"unprognostic (9.52e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (8.90e-3)"	"unprognostic (7.47e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.93e-1)"	"unprognostic (8.65e-2)"	12.5	13.5	7.7	10.6	10.7	3.3	12.2	8.4	9.7	10.5	7.7	6.8	9.7	7.3	12.6	6.5	13.3	10.5	4.6	8.7	7.1	6.4	8.5	14.8	7.3	15.5	6.9	6.2	12.1	21.4	16.3	14.8	8.4	8.3	8.4	10.8	6.6	9.8	8.1	25.4	10.5	6.8	11.7	6.2	8.5	9.3	14.9	6.9	15.2	11.1	9.5	15.2	10.2	9.1	8.7	11.9	0.5	6.6	7.9	12.4	6.3	15.2	9.7	9.7	14.8	10.6	8.7	11.2	10.7	7.0	12.5	11.0	10.2	5.1	18.1	14.7	7.9	8.0	10.3	24.1	12.3	19.9	14.9	12.5	17.0	10.4	8.2	8.7	31.8	9.0	8.5	8.9	15.8	24.0	7.4	11.9	12.8	20.7	8.9	10.9	8.8	15.1	7.3	35.0	13.4	15.6	14.5	33.7	13.8	6.2	10.2	15.0	13.7	12.2	15.1	17.3	14.1	6.0	13.3	10.5	9.4	15.0	17.1	23.9	13.1	15.3	28.4	13.8	20.6	24.2	0.1	6.0	0.5	8.8	6.1	11.4	8.7	8.0	10.3	11.9	7.9	12.4	11.3	0.5	7.9	6.6	6.6	10.7	6.3	7.7	10.7	8.4	9.7	7.1	6.4	6.9	6.2	8.3	6.9	8.9	11.0	9.2	10.8	18.5	9.6	14.0	5.1	25.4	33.0	7.0	5.9	9.2	8.3	8.4	28.6	11.7	2.7	0.0	11.8	7.5	9.5	8.9	15.1	25.5	7.2	14.3	3.5	11.6	6.3	34.2	11.5	7.4	10.1	2.8	5.1	6.5	10.6	3.5	11.0	6.0	6.4	12.9	14.6	25.9	60.1	19.6	4.2	5.7	9.4	7.7
WDR33	"FLJ11294, NET14, WDC146"	ENSG00000136709	"WD repeat domain 33"	Q9C0J8	2	127701022-127811187	"Predicted intracellular proteins, Predicted membrane proteins"	"mRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026897, HPA046527"	Supported		Enhanced	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA026897: AB_1858803, HPA046527: AB_2679686"	"unprognostic (1.26e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.79e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.32e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (1.01e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.72e-3)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.04e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-2)"	19.8	19.2	18.1	22.5	22.5	18.8	21.7	51.4	24.3	20.9	19.8	22.0	22.8	18.2	32.2	19.0	20.6	18.6	17.9	16.8	17.7	16.5	22.3	32.3	18.5	25.0	19.4	14.5	29.2	21.8	26.4	41.8	20.9	22.0	21.9	19.5	24.4	25.3	17.4	22.0	27.8	21.3	21.0	22.2	28.1	18.0	24.5	20.8	39.5	25.2	16.6	30.5	21.5	22.4	24.4	21.6	26.7	18.3	25.9	26.3	14.4	18.5	10.5	18.4	14.9	10.9	11.4	19.1	17.0	13.6	18.0	17.1	24.4	14.3	23.6	18.9	11.2	16.6	15.2	20.7	14.4	23.7	21.6	12.4	22.7	13.4	26.0	12.3	27.3	17.0	11.1	15.3	17.2	14.7	12.9	15.3	21.4	18.8	21.2	12.6	11.7	28.3	20.0	22.3	12.1	12.0	19.9	18.6	18.7	10.3	24.2	17.2	13.4	15.2	14.1	12.0	18.1	10.9	16.0	14.2	14.2	20.8	15.8	14.5	20.7	31.6	45.0	11.6	10.9	13.2	21.2	16.7	26.7	21.5	18.3	21.9	24.4	21.9	20.6	21.6	23.0	23.3	22.1	11.4	25.9	18.2	15.8	26.3	14.4	18.1	22.5	51.4	24.3	17.7	16.5	19.4	14.5	22.0	20.8	32.8	38.9	53.6	65.1	97.7	50.6	43.7	50.9	26.8	25.0	34.9	60.9	70.6	39.7	41.7	25.0	53.7	27.8	46.7	39.3	76.0	51.5	42.9	63.5	58.0	43.8	57.2	37.8	42.4	42.9	17.6	46.6	47.4	72.6	84.8	34.6	30.4	34.6	31.7	47.4	42.1	55.4	45.3	50.9	89.8	72.4	101.3	92.5	69.8	38.3	50.3
WDR55	"FLJ20195, FLJ21702"	ENSG00000120314	"WD repeat domain 55"	Q9H6Y2	5	140664676-140674124	"Predicted intracellular proteins"	"rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043470, HPA048143, HPA075133"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoplasm	Nucleoli	"HPA043470: AB_2678495, HPA048143: AB_2680282, HPA075133: "	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.35e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (8.88e-6)"	"unprognostic (9.96e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.51e-2)"	17.9	12.4	7.6	17.8	8.8	18.1	12.9	13.0	12.7	9.5	16.6	11.4	16.9	14.9	12.0	11.0	18.8	10.9	20.2	9.6	7.7	9.1	15.3	29.9	12.7	15.0	12.6	8.5	12.0	16.2	11.4	13.2	13.9	10.6	12.8	17.5	8.9	16.7	14.8	18.2	15.8	20.8	11.1	8.9	18.8	14.9	8.0	8.5	12.5	12.0	14.0	21.4	13.5	11.0	10.4	11.3	10.4	18.9	11.3	14.3	10.2	7.9	10.9	5.3	21.3	8.3	6.7	14.9	7.9	9.8	8.5	9.7	18.7	10.9	7.5	10.7	10.3	15.3	9.9	7.2	13.9	6.6	6.9	5.9	8.5	9.0	7.6	8.0	8.9	16.1	7.9	8.1	11.6	6.2	5.8	9.0	8.4	5.9	5.9	9.3	11.3	8.2	8.0	5.6	11.4	9.6	7.0	7.7	7.0	10.1	12.0	5.2	7.0	10.9	31.9	12.1	6.8	22.6	9.6	8.0	11.1	5.8	12.7	10.7	9.8	7.6	5.9	14.3	11.9	6.5	6.9	11.7	8.6	13.9	18.9	14.3	10.4	12.9	11.8	11.3	8.8	10.5	10.7	10.4	11.3	15.4	8.4	14.1	10.2	7.6	8.8	13.0	12.7	7.7	9.1	12.6	8.5	10.6	8.5	8.9	18.4	22.6	8.8	12.9	12.9	4.5	5.1	17.4	18.2	17.4	11.8	19.4	18.3	17.5	20.3	9.5	24.1	0.0	24.4	36.3	12.9	11.7	19.6	13.5	18.9	22.3	14.3	8.6	12.4	6.8	8.9	18.9	8.5	26.2	17.8	5.6	23.0	28.1	7.1	15.6	7.8	12.9	12.3	7.1	9.6	11.7	19.5	20.0	19.8	12.9
WDR61	REC14	ENSG00000140395	"WD repeat domain 61"	Q9GZS3	15	78277835-78299794	"Predicted intracellular proteins"	"Transcription, Transcription regulation, Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039932, HPA040065"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA039932: AB_10796336, HPA040065: AB_10793926"	"unprognostic (1.08e-1)"	"unprognostic (1.85e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.74e-3)"	"unprognostic (4.21e-1)"	"unprognostic (5.72e-2)"	"prognostic favorable (2.03e-10)"	"unprognostic (1.04e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.18e-1)"	"unprognostic (1.09e-2)"	23.8	34.3	23.5	17.2	31.2	29.6	34.5	25.2	32.1	24.3	22.0	27.6	22.7	20.3	24.2	69.4	25.9	27.4	19.6	23.1	23.7	28.2	34.2	28.2	22.4	18.7	26.8	23.1	20.7	30.7	22.4	37.7	27.7	30.8	27.4	25.7	24.9	28.1	23.1	26.3	29.9	18.5	23.6	27.8	18.6	20.9	38.5	20.9	26.9	32.5	30.1	24.6	19.1	20.3	21.9	45.2	11.1	32.4	22.7	25.2	28.7	9.4	24.0	19.0	19.5	18.8	17.3	14.3	14.4	16.2	18.3	18.1	22.9	17.2	18.1	18.0	16.4	29.2	20.1	40.2	17.4	15.2	11.7	31.5	14.6	22.2	22.1	16.4	22.5	16.4	13.3	13.4	7.1	6.1	13.0	20.6	19.0	26.7	20.4	23.9	29.5	19.7	21.9	14.0	23.7	19.3	18.3	14.4	22.1	21.3	29.3	26.5	14.4	19.7	22.2	78.5	20.1	14.2	31.1	12.4	14.4	17.0	10.3	24.8	17.6	26.4	25.7	20.9	36.6	28.6	11.1	31.6	10.5	21.5	32.4	23.2	21.9	21.6	22.3	45.2	16.9	23.0	25.2	2.6	22.7	26.3	24.2	23.5	28.7	23.5	31.2	25.2	32.1	23.7	28.2	26.8	23.1	30.8	20.9	32.8	43.1	20.1	47.2	43.6	50.0	23.2	30.6	62.9	22.7	36.6	45.2	87.6	106.1	52.5	15.9	38.7	22.6	23.3	48.6	62.8	54.1	49.6	46.2	41.4	58.3	41.3	22.4	45.4	29.1	10.0	46.3	46.3	55.6	48.7	33.3	72.9	38.7	28.1	47.7	102.6	46.0	6.5	49.5	95.0	66.6	51.3	77.2	35.9	50.2	41.4
WDR62	"C19orf14, DKFZP434J046, FLJ33298, MCPH2"	ENSG00000075702	"WD repeat domain 62"	O43379	19	36054881-36105106	"Disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 25.6;testis: 88.4"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 42.0;Cone photoreceptor cells: 80.5;Late spermatids: 32.8;Rod photoreceptor cells: 46.1;Spermatocytes: 70.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 3.7"	"Lineage enriched"	"Detected in single"	9	"monocytes: 3.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA043255, HPA043639"	Enhanced		Enhanced	"Centriolar satellite,Cytosol"		NA	NA			Cytosol	"Centriolar satellite"	"HPA043255: AB_2678393, HPA043639: AB_2678593"	"unprognostic (1.77e-1)"	"unprognostic (2.79e-3)"	"unprognostic (3.16e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.78e-4)"	"unprognostic (2.00e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.82e-3)"	"unprognostic (4.72e-2)"	"unprognostic (4.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.73e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.67e-1)"	0.5	0.2	0.2	3.3	0.4	4.3	0.6	0.4	0.5	0.4	0.5	0.4	0.4	0.4	0.4	0.8	1.0	0.2	0.5	5.5	0.5	0.2	0.5	0.3	0.5	1.4	0.2	0.2	0.4	0.2	0.0	0.3	0.7	0.4	0.3	0.3	0.3	0.6	0.2	25.6	1.4	0.7	0.4	0.5	1.1	0.3	88.4	0.3	10.3	0.2	1.3	3.0	0.3	0.7	0.1	0.1	0.0	3.7	0.0	0.3	0.2	10.8	21.8	8.5	7.8	0.5	0.7	4.3	9.4	4.5	13.1	11.9	11.4	4.3	14.1	6.4	4.9	5.9	3.8	7.9	3.0	7.8	8.9	5.6	9.6	12.4	7.3	0.1	10.4	14.5	0.2	0.2	9.9	4.0	1.2	3.2	11.4	12.3	19.4	6.5	13.6	18.2	6.3	4.6	8.9	4.5	15.3	7.9	5.7	1.9	5.0	9.5	4.8	7.7	8.8	1.5	4.3	6.0	7.6	2.6	13.2	12.9	9.9	15.5	9.4	11.8	16.8	5.3	10.0	14.2	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.3	0.2	0.2	0.4	0.4	0.5	0.5	0.2	0.2	0.2	0.4	0.3	0.0	8.5	2.2	1.1	1.9	1.5	42.0	0.0	0.0	1.2	0.0	80.5	0.9	1.7	0.3	29.4	0.6	0.2	23.3	0.8	1.6	1.3	0.6	0.0	0.0	1.9	3.2	0.0	1.3	1.5	32.8	1.1	1.1	1.7	1.0	1.3	2.0	0.4	0.0	0.4	0.0	46.1	6.5	1.0	70.1	17.0	3.1	0.2	0.7	1.7	0.7
WEE2	FLJ16107	ENSG00000214102	"WEE1 homolog 2"	P0C1S8	7	141708353-141731271	"Enzymes, Predicted intracellular proteins"	Meiosis	"Kinase, Transferase, Tyrosine-protein kinase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Distal tubular cells: 1.7;Proximal tubular cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA027418, HPA054280"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA027418: AB_10603144, HPA054280: "	"unprognostic (6.35e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.88e-3)"	0.6	0.1	0.5	0.3	1.0	0.0	0.4	0.8	0.6	0.6	0.1			0.0	0.7	0.0	1.3	0.7	1.6	1.3	0.5	0.6	1.3	0.1	0.3	1.6	0.6		1.2	1.1	0.0	1.0	0.0		0.3	0.0		0.9	0.0	0.7	2.8	0.4	0.0	0.8	0.4	0.8	1.3			2.0		0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.4	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.2	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	1.4	0.1	0.1	0.0	0.3	1.0	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.3	0.5	1.6	1.2	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.0	0.2	0.1	1.7	1.1	0.5	0.0	0.4	0.7	0.0	0.0	0.0	0.4	0.0	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.0	0.5	0.0	0.0	0.2	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody		Yes	No			Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: AB_2671308"	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.3	13.4	17.0	19.3	7.9	10.9	14.2	7.0	11.9	8.2	8.2	25.5	11.3	23.5	12.9	7.2	11.6	7.3	10.0	2.9	8.8	12.5	8.2	7.2	6.4	12.3	9.4	12.3	14.0	13.2	8.6	9.4	7.4	10.7	8.9	12.8	9.7	8.0	27.6	17.1	8.7	18.1	13.3	22.2	16.0	6.1	11.4	7.7	10.6	18.3	23.3	12.5	11.4	9.2	4.8	12.5	8.9	17.2	27.3	10.8	21.4	18.1	14.4	8.6	12.2	11.4	11.4	18.4	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8	11.9	5.8	8.5	5.5	14.1	8.8	9.1	12.7	0.0	3.4	12.2	0.0	6.1	3.3	12.3	6.3	13.5	5.0	0.0	17.1	8.3	9.9	8.6	1.1	13.2	6.7	6.4	6.4	13.5	10.2	6.4	14.7	7.1	6.8	5.4	9.5	7.1	16.5	0.0	18.0	4.7	7.5	12.9	10.8	27.2	26.0	17.8	6.2	4.4	10.5	11.8
WRAP53	"FLJ10385, TCAB1, WDR79"	ENSG00000141499	"WD repeat containing antisense to TP53"	Q9BUR4	17	7686071-7703502	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Chaperone, RNA-binding"	"Disease mutation, Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Ciliated cells: 32.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA023026, HPA028130, HPA029928"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA023026: AB_10963931, HPA028130: AB_10961728, HPA029928: AB_2673257"	"unprognostic (1.45e-1)"	"unprognostic (3.50e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.53e-3)"	"unprognostic (3.86e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (4.70e-4)"	"unprognostic (8.69e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (8.26e-4)"	"unprognostic (2.68e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.93e-2)"	"unprognostic (4.04e-1)"	6.9	6.9	8.1	10.3	8.0	13.3	6.8	11.8	10.7	7.4	7.2	10.6	6.8	6.8	8.4	8.4	7.9	25.6	7.7	6.8	7.5	6.6	9.4	6.6	8.7	12.7	7.9	5.8	7.8	12.0	6.1	7.6	8.1	7.8	5.3	7.3	7.8	6.6	6.6	9.8	8.1	7.7	7.8	5.4	12.5	7.2	11.4	8.3	22.8	7.6	6.6	12.8	7.5	6.2	4.7	6.6	20.0	5.8	4.2	8.5	3.5	11.2	21.1	15.2	15.2	4.6	4.3	8.9	7.3	7.8	24.0	22.4	12.2	7.0	13.5	7.7	6.5	10.6	12.5	17.4	12.9	18.5	8.1	22.6	6.2	14.0	10.2	4.1	4.8	8.1	3.4	5.0	21.1	4.8	3.6	15.5	16.2	5.9	4.4	9.5	10.2	13.8	11.6	8.1	8.9	10.6	18.3	10.0	7.9	8.8	4.0	7.0	10.6	11.5	6.2	6.1	7.9	8.4	5.1	5.4	9.5	10.1	0.0	18.8	3.5	8.9	7.1	8.6	8.2	11.6	20.0	5.2	4.6	5.4	5.8	6.3	3.3	4.2	6.0	4.7	4.7	3.8	4.4	2.7	4.2	2.3	6.6	8.5	3.5	8.1	8.0	11.8	10.7	7.5	6.6	7.9	5.8	7.8	8.3	3.0	4.3	9.3	4.9	3.4	4.6	2.3	2.5	32.1	3.4	10.4	5.9	9.2	3.3	8.2	2.6	4.0	3.4	0.0	8.8	14.2	3.8	1.7	1.1	4.9	6.8	1.6	2.9	3.1	7.0	1.3	2.3	4.4	3.3	9.0	5.2	6.3	5.5	3.5	2.1	5.6	6.2	0.0	4.7	13.3	6.7	4.0	3.4	5.3	6.3	3.1
WT1	"AWT1, GUD, NPHS4, WAGR, WIT-2"	ENSG00000184937	"Wilms tumor 1"	P19544	11	32387775-32435630	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"	"Cancer-related genes, Disease mutation, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 69.0;fallopian tube: 34.5;ovary: 53.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 19.2;Late spermatids: 5.9;Leydig cells: 7.8;Sertoli cells: 6.5"	"Cancer enriched"	"Detected in many"	14	"ovarian cancer: 55.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.5;HMC-1: 17.4;K-562: 12.2;NB-4: 32.6;THP-1: 15.6"	"Region enhanced"	"Detected in single"		"pons and medulla: 0.5"	"Not detected"	"Not detected"			"CAB000327, HPA035717, HPA053848"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB000327: AB_2304486, HPA035717: AB_2674748, HPA053848: AB_2682279"	"unprognostic (3.09e-3)"	"unprognostic (9.97e-4)"	"unprognostic (3.32e-1)"	"unprognostic (8.24e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.98e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.23e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-10)"	"unprognostic (2.65e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.30e-2)"	10.3	0.0	0.2	1.8	0.6	0.0	0.2	0.2	0.5	20.3	1.5	0.2	3.7	0.0	69.0	9.3	0.4	34.5	0.8	2.1	0.9	0.0	5.3	0.2	0.8	0.5	0.2	0.2	53.4	0.2	0.0	0.2	6.9	0.3	0.9	0.0	0.2	0.2	4.2	0.2	0.0	0.4	23.7	0.2	14.6	0.0	24.5	0.2	0.2	0.3	0.2	0.2	1.3	4.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.1	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	4.7	13.5	0.0	1.2	3.8	9.0	17.4	0.0	0.0	2.8	0.0	0.0	0.0	2.8	12.2	0.1	2.7	0.0	7.9	32.6	0.7	0.0	3.8	1.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.8	15.6	0.1	0.0	2.4	0.0	0.3	0.0	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.6	0.2	0.5	0.9	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	19.2	0.0	0.9	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.3	0.0	0.0	2.5	0.0	5.9	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.2	0.0	6.5	0.0	1.9	0.9	0.0	0.7	0.0	0.0	0.1
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal keratinocytes: 372.2;Suprabasal keratinocytes: 398.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	37.6	31.0	21.5	38.7	24.7	106.0	37.5	30.1	22.3	29.7	28.2	19.4	25.1	19.1	33.8	34.6	30.3	28.8	27.3	28.9	22.0	22.1	28.5	28.8	29.7	36.1	20.9	21.2	37.1	30.1	23.1	31.2	35.0	22.1	33.0	28.7	23.7	30.3	27.2	81.2	29.3	28.6	30.9	22.6	36.5	27.1	20.4	21.6	53.2	36.3	26.2	39.3	33.4	34.6	26.6	22.3	33.4	27.1	23.9	30.5	14.7	13.8	13.3	30.0	27.4	35.2	39.0	19.6	21.7	73.7	27.8	37.2	25.7	13.2	34.4	13.1	23.8	61.2	18.9	29.1	25.4	36.2	17.9	19.5	34.3	14.5	36.2	29.5	31.0	20.8	46.3	24.7	31.0	41.1	21.3	21.1	33.8	36.8	32.3	29.3	13.9	42.7	41.7	25.4	21.6	11.2	28.5	19.4	24.6	29.9	17.1	28.7	20.9	40.8	23.2	10.7	21.2	10.7	38.5	18.8	19.7	21.4	28.5	31.5	23.4	26.0	53.0	18.1	31.1	19.6	27.2	19.2	22.6	23.4	24.3	26.4	26.6	28.3	27.8	22.3	23.8	25.6	25.8	33.4	23.9	27.1	18.9	30.5	14.7	21.5	24.7	30.1	22.3	22.0	22.1	20.9	21.2	22.1	21.6	32.8	59.0	84.2	176.7	372.2	29.5	46.6	84.1	36.1	35.2	57.6	33.4	93.4	72.9	99.7	34.1	64.1	45.2	46.7	70.5	105.3	82.6	229.3	39.3	81.8	67.3	35.0	59.1	50.3	77.6	39.5	60.4	106.3	231.2	127.2	57.7	39.0	73.8	54.5	47.7	75.7	31.8	71.1	169.7	61.3	74.5	398.0	124.8	111.7	56.9	130.8
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178783	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease mutation, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167"	"unprognostic (7.46e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.63e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.13e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.07e-1)"	"prognostic favorable (4.14e-7)"	"unprognostic (1.59e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.62e-2)"	"prognostic favorable (2.46e-4)"	20.2	17.1	14.2	24.0	30.2	8.4	21.4	16.1	19.3	22.3	18.9	20.8	27.5	18.0	24.6	18.3	16.9	24.9	25.1	12.4	16.2	14.4	24.6	23.4	19.9	21.1	33.4	15.2	35.0	20.9	35.4	26.7	28.0	22.1	20.9	15.9	16.7	17.6	30.3	22.4	30.5	23.6	17.7	22.6	23.3	15.9	12.9	30.6	18.5	25.7	12.4	20.8	22.4	22.3	10.9	7.0	34.6	8.8	8.8	12.2	6.1	4.5	11.6	13.1	8.4	19.7	13.6	44.5	11.3	32.3	10.9	8.5	4.2	5.4	15.1	5.0	13.7	5.1	5.7	8.6	18.0	9.0	6.1	7.4	8.0	12.3	7.8	17.5	6.0	15.3	19.3	21.4	14.5	29.1	12.8	12.9	6.9	11.0	8.2	12.1	9.5	4.9	5.7	7.8	7.4	7.9	6.3	5.9	12.1	13.8	13.5	2.8	10.2	12.3	10.2	8.1	21.5	10.7	4.9	20.2	4.2	11.5	6.4	5.2	18.9	13.7	8.9	10.1	7.0	15.2	12.0	8.2	9.4	9.8	6.3	9.6	10.7	11.2	9.6	7.0	10.9	12.2	8.7	34.6	8.8	8.8	6.7	9.2	6.1	14.2	30.2	16.1	19.3	16.2	14.4	33.4	15.2	22.1	30.6	56.6	54.6	22.2	18.7	12.2	33.8	11.2	33.1	84.3	73.9	15.7	37.3	34.0	29.9	16.3	1.9	24.9	12.3	46.7	16.9	17.1	16.4	15.5	44.1	30.4	16.2	25.4	15.6	22.1	24.3	1.8	28.4	28.4	8.5	38.7	12.2	29.9	15.2	14.8	26.5	34.1	50.6	25.8	18.0	22.7	57.3	9.7	26.8	34.6	13.3	8.7
XPNPEP1	"XPNPEP, XPNPEPL, XPNPEPL1"	ENSG00000108039	"X-prolyl aminopeptidase 1"	Q9NQW7	10	109864766-109923553	"Enzymes, Predicted intracellular proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025196, HPA030419, HPA030420, HPA030422"	Supported		Enhanced	Cytosol		NA	NA		760000	Cytosol		"CAB025196: , HPA030419: AB_10598917, HPA030420: AB_10611523, HPA030422: AB_10601783"	"unprognostic (3.17e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-3)"	"prognostic unfavorable (2.12e-5)"	"unprognostic (8.03e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.18e-2)"	16.6	14.7	13.4	16.1	18.9	12.8	13.6	14.8	22.2	15.7	20.6	19.5	14.1	33.2	17.5	16.1	17.8	15.8	20.3	17.8	13.7	11.4	18.3	21.0	14.8	14.9	13.8	14.0	17.8	46.0	14.9	15.9	19.0	17.2	16.0	26.9	15.6	19.6	11.3	18.5	20.4	38.6	18.6	11.9	18.0	16.8	15.1	12.0	9.9	15.7	15.2	24.2	14.1	13.8	5.5	24.0	10.0	21.0	14.7	10.6	13.4	25.5	11.2	18.0	24.5	29.4	27.6	13.8	14.2	29.1	21.4	23.2	21.8	22.0	36.5	12.3	21.9	10.9	13.6	14.2	17.6	21.0	10.8	13.7	24.3	7.3	9.0	20.5	18.9	20.3	27.2	10.9	23.5	20.9	32.9	35.1	23.7	7.9	11.7	27.1	8.6	13.5	11.8	7.0	19.4	12.2	15.1	36.3	6.5	27.2	8.0	5.5	20.9	12.4	7.9	23.8	20.5	9.6	17.7	18.0	8.7	11.4	13.8	12.5	19.9	9.7	31.2	20.6	26.5	6.9	10.0	13.7	5.6	10.6	21.0	7.3	5.5	7.0	9.5	24.0	4.8	5.0	6.6	1.1	14.7	17.5	18.8	7.5	13.4	13.4	18.9	14.8	22.2	13.7	11.4	13.8	14.0	17.2	12.0	6.0	15.6	11.9	11.4	7.9	19.1	15.7	20.4	12.0	10.3	3.5	5.9	33.7	14.9	29.4	4.5	12.1	36.7	0.0	63.7	24.7	19.7	19.6	10.5	9.6	27.2	25.4	16.1	16.5	16.1	4.1	17.0	17.4	8.5	39.7	34.2	24.9	47.2	35.3	28.0	18.8	18.4	12.9	8.8	8.4	37.1	7.5	21.1	20.8	34.1	19.3
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	39.4	35.3	47.9	35.9	21.7	29.2	35.3	43.7	28.2	46.0	39.4	46.9	29.7	57.9	30.6	29.9	46.8	33.5	73.0	30.3	67.7	35.3	26.9	57.0	36.3	29.3	15.7	57.4	39.0	16.4	22.7	36.3	39.6	34.9	37.5	29.2	65.7	33.8	42.3	20.8	47.7	25.2	55.7	47.2	27.1	42.8	54.7	35.2	20.9	30.0	38.3	20.4	42.5	35.9	21.3	50.4	29.4	28.4	25.0	43.2	49.1	35.1	42.9	27.5	45.3	84.0	26.8	49.3	38.9	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3	38.7	36.3	31.8	27.6	46.2	69.7	57.0	43.3	46.8	28.4	29.6	90.3	46.3	11.6	24.4	3.2	40.7	19.3	70.0	22.5	42.3	40.9	34.4	40.5	48.0	49.4	68.3	43.4	42.4	46.3	8.0	31.1	53.2	35.4	49.5	31.2	34.0	26.3	17.5	29.0	20.8	102.5	19.4	43.7	64.6	88.2	49.7	25.2	42.9	37.6	38.3
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522330-43576075	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.2;Spermatogonia: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	11.5	12.2	9.5	10.8	14.0	9.0	10.8	14.6	15.4	9.6	8.8	11.5	8.3	7.8	12.0	12.0	16.7	9.8	7.5	8.9	8.0	7.3	10.0	13.1	9.4	10.0	9.5	8.0	11.9	19.7	17.7	16.1	9.5	9.4	10.5	11.5	9.7	12.9	10.6	14.9	15.3	8.6	12.3	8.0	9.9	11.2	42.3	9.7	18.3	16.7	8.5	13.7	10.5	10.4	3.7	5.9	3.6	11.7	8.4	6.8	4.4	15.6	9.4	15.7	31.6	8.2	6.9	14.6	8.2	5.8	16.2	11.8	25.8	5.5	21.3	10.7	7.8	15.3	13.5	26.1	11.9	18.3	15.4	20.7	20.6	11.3	18.7	11.8	22.7	11.0	5.0	12.4	17.0	26.6	5.8	11.5	15.3	44.1	16.8	10.9	19.2	17.1	11.3	16.8	43.1	9.6	18.7	16.7	15.9	9.3	12.3	32.5	13.4	11.4	10.5	14.6	14.4	12.1	18.3	9.6	12.0	14.3	11.4	17.2	10.7	11.7	41.9	4.3	19.9	12.8	0.0	5.0	3.6	6.3	6.4	5.8	3.7	5.6	6.8	5.9	3.4	4.5	5.9	0.5	8.4	11.7	1.8	5.5	4.4	9.5	14.0	14.6	15.4	8.0	7.3	9.5	8.0	9.4	9.7	6.0	3.5	3.0	4.4	7.9	10.8	5.4	2.5	5.3	1.2	10.4	7.9	4.2	1.7	6.5	9.2	4.5	3.3	0.0	6.6	5.6	6.4	6.0	11.5	4.0	5.5	20.6	13.8	1.8	6.5	10.2	3.7	4.0	1.7	2.8	6.6	4.1	6.4	0.0	7.8	4.2	13.7	0.0	4.4	27.2	26.3	6.1	3.7	3.2	6.4	5.2
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404350-64451127	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.3	19.4	20.7	19.3	22.8	26.9	29.9	17.9	21.7	16.9	12.4	18.7	13.2	10.5	16.1	19.8	21.3	12.5	12.6	12.7	19.0	19.4	14.7	35.7	18.3	18.9	22.4	15.5	17.3	30.1	21.4	18.5	18.6	23.5	15.3	14.7	15.8	21.3	13.7	15.6	17.3	11.6	16.7	21.7	14.5	14.7	17.9	21.3	18.2	48.7	14.1	21.4	15.8	27.8	7.9	10.2	10.1	7.5	11.1	14.7	6.5	17.8	12.4	12.6	15.8	19.0	20.3	23.1	23.9	20.1	16.1	14.7	12.3	6.1	36.3	17.1	30.1	17.2	13.5	23.9	18.4	23.4	22.6	12.6	20.2	11.6	10.7	33.7	37.1	18.3	14.4	47.5	17.9	55.3	20.9	14.2	27.2	33.5	72.9	17.0	21.9	20.4	14.7	24.0	12.6	22.2	16.3	15.2	27.1	8.8	10.5	14.1	16.5	14.0	16.1	34.6	12.8	28.6	37.0	14.9	12.7	12.8	18.2	18.7	45.9	35.2	28.1	28.1	29.0	20.4	5.8	7.5	10.1	10.9	7.5	14.7	7.9	12.4	11.3	10.2	5.3	11.4	9.6	2.3	11.1	6.7	3.5	10.3	6.5	20.7	22.8	17.9	21.2	19.0	19.4	22.4	15.5	23.5	21.3	11.9	7.8	10.7	12.2	17.4	16.4	9.8	12.7	5.3	11.4	14.0	11.8	21.2	14.9	8.8	3.3	16.7	5.4	23.3	11.0	17.4	18.5	18.0	24.3	28.2	12.9	12.7	10.9	24.5	21.3	4.1	18.7	12.1	20.3	3.6	10.9	71.1	13.5	3.5	19.1	11.3	21.2	12.9	19.6	11.8	12.7	19.6	14.2	15.0	12.7	12.8
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543040-43580473	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Ciliated cells: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB005427: AB_2215661, HPA006717: AB_1858896"	"unprognostic (1.10e-2)"	"unprognostic (3.51e-3)"	"unprognostic (4.59e-1)"	"unprognostic (2.81e-2)"	"unprognostic (4.08e-1)"	"unprognostic (2.68e-2)"	"prognostic unfavorable (7.33e-5)"	"unprognostic (5.07e-2)"	"unprognostic (3.12e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.00e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.34e-3)"	"unprognostic (2.20e-2)"	"unprognostic (5.69e-2)"	16.6	17.5	20.8	18.7	22.4	22.4	16.9	23.6	22.7	20.3	17.4	19.2	18.0	13.6	23.8	18.9	20.2	24.9	16.9	15.7	16.5	16.3	16.3	10.4	16.3	22.8	15.8	21.1	34.2	22.1	19.4	32.0	19.7	15.7	16.7	12.6	21.8	16.4	19.2	18.8	20.4	14.2	18.8	15.3	19.5	17.2	25.0	17.9	38.9	21.5	12.0	21.6	18.1	17.2	14.2	13.6	20.3	14.2	10.6	17.7	12.9	25.6	21.1	25.0	22.3	12.2	11.5	13.3	14.4	16.3	19.0	20.8	13.2	18.7	19.3	18.3	12.7	18.8	13.3	14.9	16.5	11.3	21.3	15.4	24.7	20.6	15.3	12.3	13.9	21.5	13.3	11.4	24.0	12.1	23.2	17.1	22.9	15.5	19.7	16.8	21.2	28.7	25.1	7.8	20.0	9.3	24.2	15.6	11.1	16.2	20.5	20.7	13.1	17.9	17.5	8.6	13.5	16.5	34.1	9.6	25.2	19.7	7.5	17.9	21.7	20.9	14.2	20.4	12.6	27.3	20.3	14.2	16.8	12.9	13.4	14.6	14.2	16.1	17.7	13.6	12.6	14.0	12.8	16.3	10.6	8.3	10.5	16.2	12.9	20.8	22.4	23.6	22.7	16.5	16.3	15.8	21.1	15.7	17.9	14.9	9.8	9.7	6.8	5.5	11.0	7.4	2.5	48.2	11.4	7.0	5.9	25.8	16.6	12.7	22.1	9.0	7.3	0.0	10.1	16.2	11.7	4.1	19.6	4.9	18.6	4.8	13.1	9.2	19.5	13.6	9.5	11.8	13.5	14.4	13.0	7.3	11.2	8.6	12.0	11.8	11.3	6.5	8.3	19.0	12.9	6.1	16.7	17.5	13.3	2.4
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skin 1: 30.3"	"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 6.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA062422: AB_2684757, HPA068953: AB_2686062"	"unprognostic (2.52e-2)"	"unprognostic (1.81e-3)"	"unprognostic (6.75e-2)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.53e-4)"	"unprognostic (2.93e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.58e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.52e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.72e-2)"	5.4	3.3	8.1	15.1	7.3	22.0	5.4	11.3	8.0	5.5	5.8	6.5	4.6	5.4	6.4	5.1	8.5	6.1	5.3	4.4	6.9	2.6	4.1	3.8	6.0	11.1	7.3	5.4	7.0	7.8	2.1	4.4	5.6	6.8	7.7	6.2	5.3	11.1	2.9	8.9	30.3	7.0	2.3	5.3	13.5	6.8	10.1	5.0	17.6	5.6	6.7	14.2	5.3	9.0	4.5	2.0	3.0	3.3	2.5	3.9	3.6	12.7	23.3	12.8	15.9	1.1	3.3	23.3	14.1	4.7	20.0	21.6	12.9	20.5	20.3	12.2	2.9	15.9	20.4	14.0	21.0	12.3	12.5	14.5	19.8	11.4	11.9	2.0	17.7	12.9	2.5	2.1	17.6	11.2	4.2	8.1	20.7	12.2	12.5	10.3	27.8	30.7	14.0	11.0	18.7	16.6	25.0	18.5	8.0	4.4	17.6	12.7	10.5	16.6	9.0	5.8	7.4	14.2	13.9	7.0	10.4	12.2	33.0	15.4	10.7	9.7	25.2	6.5	14.7	15.9	2.6	1.6	3.0	3.8	3.3	3.9	4.5	3.3	3.2	2.0	4.0	3.3	2.2	1.2	2.5	2.5	1.4	2.5	3.6	8.1	7.3	11.3	8.0	6.9	2.6	7.3	5.4	6.8	5.0	0.0	0.0	1.9	2.1	1.3	1.5	0.2	2.5	1.4	3.4	0.0	2.0	6.8	1.7	1.4	0.4	0.9	2.0	0.0	1.6	4.5	0.4	1.4	0.0	0.4	3.8	3.2	1.2	0.0	0.0	1.5	0.3	1.5	0.0	1.8	5.0	1.3	1.4	3.5	1.1	0.0	2.1	0.0	0.9	3.4	5.7	1.1	2.6	0.0	5.0	0.7
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"		"Cancer-related genes, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Pancreatic endocrine cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RH-30: 37.1"	"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006801: AB_1858899, HPA051538: AB_2681526"	"prognostic unfavorable (1.80e-5)"	"unprognostic (3.05e-2)"	"unprognostic (5.12e-2)"	"unprognostic (3.91e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.38e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.91e-2)"	8.8	9.4	8.1	12.9	10.1	5.9	9.4	4.8	10.2	5.3	9.1	7.2	5.4	11.4	8.3	7.7	10.1	6.2	8.1	13.0	8.5	6.6	12.2	8.1	7.6	11.7	8.7	5.8	5.8	4.9	4.0	9.5	11.3	11.5	6.3	8.8	3.7	7.2	7.1	5.3	5.7	15.4	5.9	9.5	14.6	6.4	12.5	8.8	20.6	7.4	9.7	12.9	8.7	5.8	7.4	10.3	12.3	19.1	11.5	7.0	6.8	8.6	6.9	8.4	7.5	4.8	7.0	8.0	8.3	6.9	9.2	10.8	5.8	12.9	12.4	6.2	6.6	13.2	7.6	5.6	18.8	15.2	5.7	7.0	6.4	5.2	7.3	3.2	7.1	10.4	4.8	8.6	11.9	6.7	9.4	7.3	8.2	4.6	5.8	10.5	7.0	13.0	9.2	4.7	5.3	10.2	10.9	37.1	12.4	8.5	4.0	5.5	7.1	5.2	3.9	10.5	7.4	7.9	11.6	4.5	5.0	10.7	5.3	11.0	4.7	6.9	15.3	9.0	12.9	8.0	12.1	13.5	9.2	4.7	19.1	4.9	7.4	5.2	5.2	10.3	6.3	7.0	5.6	12.3	11.5	17.8	7.6	5.6	6.8	8.1	10.1	4.8	10.2	8.5	6.6	8.7	5.8	11.5	8.8	14.9	5.6	12.8	11.2	4.7	4.3	12.3	5.1	10.7	12.5	5.2	0.0	15.8	13.3	15.0	7.8	7.5	6.8	0.0	24.8	33.3	10.1	4.9	10.4	4.9	17.2	1.6	0.0	11.6	20.2	3.6	7.2	25.5	8.5	14.4	6.9	7.5	43.1	4.9	6.7	16.5	3.8	0.0	7.2	24.9	25.3	3.9	10.0	10.9	5.2	8.4
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Enhanced	Nucleoplasm		NA	NA		140000	Nucleoplasm		"CAB004468: AB_672929, HPA025813: AB_1858901, HPA064685: AB_2685322"	"unprognostic (4.23e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.07e-3)"	"unprognostic (3.44e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.00e-2)"	"prognostic unfavorable (2.10e-7)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.58e-2)"	"unprognostic (6.01e-2)"	53.7	47.6	35.2	47.0	56.8	47.0	56.6	47.0	59.7	51.2	44.3	45.2	39.5	39.5	62.9	43.8	61.1	51.7	41.2	43.7	38.6	36.4	62.4	67.1	43.8	56.2	41.8	45.2	58.7	46.7	63.0	56.1	54.3	58.3	46.0	53.5	36.1	49.4	47.9	65.0	54.7	46.5	49.7	44.2	60.5	47.9	36.9	38.0	112.4	64.2	55.6	65.5	56.5	47.7	38.6	51.5	60.9	61.3	50.4	54.0	82.3	38.8	33.0	74.1	39.6	32.9	37.8	44.8	46.3	47.9	53.5	57.7	70.8	38.7	37.6	37.8	40.4	46.9	34.8	72.8	56.1	82.6	35.8	50.1	81.6	52.2	66.1	40.9	72.6	40.0	34.4	30.0	62.8	27.5	38.3	63.1	46.5	51.5	34.4	69.7	37.4	81.1	36.7	86.1	39.4	29.5	71.4	65.5	31.1	57.6	44.3	65.0	54.8	37.2	27.6	33.3	78.1	33.9	54.5	45.4	50.4	42.4	32.9	52.3	41.7	50.5	84.0	39.2	57.0	49.4	60.9	51.5	51.8	50.2	54.0	54.0	38.6	49.1	50.9	51.5	37.5	49.9	49.8	59.4	50.4	61.3	31.4	49.3	82.3	35.2	56.8	47.0	59.7	38.6	36.4	41.8	45.2	58.3	38.0	98.3	108.3	82.7	152.6	101.0	129.3	138.8	101.9	165.9	152.4	96.0	43.2	176.4	82.9	239.3	65.8	131.5	70.4	70.0	206.2	196.4	122.7	101.3	140.1	177.3	138.8	84.2	128.0	77.3	91.0	17.1	94.0	132.7	65.8	380.5	79.8	130.6	194.7	63.1	121.6	110.9	102.9	109.9	137.9	221.2	164.2	105.1	138.4	124.6	99.6	138.1
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621119-41664048	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm		No	No		24000	Nucleoplasm		"CAB004254: AB_628453, HPA047549: AB_2680085, HPA062226: AB_2684716"	"unprognostic (5.55e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.82e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.47e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.77e-2)"	"unprognostic (7.95e-2)"	49.2	67.9	44.4	47.8	54.3	62.3	49.7	44.5	57.5	51.2	51.3	39.5	44.1	44.7	59.9	41.0	68.6	52.4	35.2	63.0	59.3	39.2	50.1	61.6	48.1	66.9	37.2	50.6	61.5	44.0	48.4	53.1	63.5	51.5	46.1	56.4	39.7	59.2	52.1	100.9	58.6	46.9	58.2	68.4	54.4	50.8	113.6	34.2	83.8	49.5	59.2	70.9	51.4	50.1	51.9	63.7	42.7	57.0	46.6	62.6	96.7	62.2	45.0	62.6	54.5	38.2	34.1	49.4	45.4	54.7	95.6	78.9	66.0	39.5	100.5	38.2	55.1	43.0	46.9	86.5	56.9	96.4	55.9	108.6	53.9	55.1	65.4	34.6	127.2	62.4	30.8	39.3	59.7	32.9	38.4	59.4	43.8	52.6	42.7	61.5	68.6	66.1	47.5	57.5	132.4	53.3	75.7	65.9	79.8	54.0	46.7	29.2	20.9	73.9	39.4	52.4	49.3	45.3	51.5	41.9	47.8	66.5	42.0	59.6	42.4	74.0	102.5	44.8	50.5	56.4	24.5	50.1	42.7	51.1	57.0	53.5	51.9	56.8	55.8	63.7	48.2	62.6	55.8	13.5	46.6	55.5	37.7	61.8	96.7	44.4	54.3	44.5	57.5	59.3	39.2	37.2	50.6	51.5	34.2	89.3	116.9	114.6	165.5	110.1	101.4	76.4	96.8	104.4	113.7	78.5	58.9	380.2	140.9	149.3	68.8	107.6	88.2	46.7	159.8	266.0	133.6	98.3	115.6	92.4	150.7	82.6	94.6	71.8	90.4	42.8	117.3	120.1	84.4	217.4	92.7	138.2	128.0	107.8	119.2	113.5	75.0	161.7	129.7	482.0	292.1	89.3	302.9	130.7	133.6	112.7
XRN2		ENSG00000088930	"5'-3' exoribonuclease 2"	Q9H0D6	20	21303304-21389827	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation, Transcription termination"	"DNA-binding, Exonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047118, HPA050485"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA047118: AB_2679941, HPA050485: AB_2681141"	"unprognostic (9.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (3.54e-5)"	"unprognostic (7.26e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.31e-1)"	42.9	35.1	12.5	24.5	17.7	38.3	30.4	18.0	16.4	26.8	22.8	18.6	23.3	14.4	38.6	25.2	22.1	30.6	21.8	19.3	13.7	10.3	31.4	35.3	27.5	33.4	17.4	12.1	32.1	26.4	30.0	35.3	26.5	15.9	25.7	20.1	19.1	27.6	25.0	36.8	23.0	21.6	24.1	18.6	40.9	23.2	27.4	18.3	41.1	31.3	20.4	30.6	33.1	21.7	16.0	30.6	35.0	33.9	21.7	24.6	23.8	27.4	32.7	36.1	27.6	27.0	33.3	35.8	25.3	33.1	33.8	39.5	21.8	31.6	27.1	15.1	26.5	46.1	32.7	40.6	42.6	43.5	12.2	20.5	35.0	12.3	41.1	23.8	31.4	30.5	31.5	21.6	37.2	32.7	30.2	29.0	26.1	28.0	23.3	31.3	21.5	46.2	20.8	28.1	26.8	22.1	34.0	61.4	23.1	28.8	29.2	28.0	36.4	29.5	36.4	27.1	29.2	20.4	37.5	26.7	34.0	25.5	7.7	31.9	20.6	26.4	29.1	13.1	14.7	25.6	15.1	33.9	23.8	18.6	27.2	24.6	16.0	20.4	20.2	30.6	15.1	21.8	21.0	35.0	21.7	32.7	13.2	24.0	23.8	12.5	17.7	18.0	16.4	13.7	10.3	17.4	12.1	15.9	18.3	56.6	105.5	63.6	78.1	56.4	39.0	48.7	53.5	108.4	109.2	38.4	39.3	93.9	23.2	104.4	113.2	77.5	32.5	0.0	104.1	85.7	61.2	59.6	79.9	61.8	93.6	47.7	57.1	43.0	136.4	16.3	53.5	87.6	57.3	76.7	45.4	69.3	88.3	45.9	52.3	62.6	44.7	58.2	72.1	99.1	113.5	58.7	88.0	62.3	54.7	73.2
YARS	"tyrRS, YRS, YTS"	ENSG00000134684	"Tyrosyl-tRNA synthetase"	P54577	1	32775237-32818153	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017936, HPA018950, HPA018954"	Enhanced		Enhanced	Cytosol		No	No		230000	Cytosol		"HPA017936: AB_1858916, HPA018950: AB_1858919, HPA018954: AB_1858915"	"unprognostic (4.05e-2)"	"unprognostic (2.52e-1)"	"unprognostic (4.21e-1)"	"unprognostic (4.78e-2)"	"unprognostic (9.54e-2)"	"unprognostic (3.38e-3)"	"prognostic unfavorable (6.97e-11)"	"unprognostic (5.05e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-3)"	"unprognostic (4.96e-2)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (3.57e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.94e-2)"	"prognostic unfavorable (6.57e-4)"	16.6	36.3	22.8	22.8	40.6	17.4	13.9	26.6	43.1	14.6	17.5	16.3	22.4	17.1	14.2	15.5	24.1	14.4	11.2	15.5	24.9	28.3	14.1	29.6	21.3	23.2	24.9	27.4	21.2	54.8	19.3	13.9	17.5	26.7	12.7	21.9	11.2	23.5	25.7	27.3	16.5	14.9	22.7	22.7	14.6	25.9	20.9	26.0	15.2	30.0	16.8	29.6	17.0	28.0	9.9	17.8	20.9	13.4	36.5	24.3	17.1	28.8	15.1	15.9	38.3	19.8	22.8	17.0	29.8	24.7	24.5	31.3	17.9	19.9	52.5	11.8	30.9	20.0	17.0	48.4	35.1	38.8	22.1	19.2	48.1	22.9	16.8	65.2	37.9	29.1	22.6	43.7	38.7	98.6	17.7	24.8	42.5	52.9	55.6	21.0	14.9	42.5	20.8	29.0	29.5	20.9	37.2	15.2	44.1	17.6	14.5	30.7	18.9	16.2	19.1	55.0	19.0	19.1	41.3	20.1	14.9	26.6	30.2	24.6	44.9	47.9	49.1	37.3	52.9	40.9	20.9	12.7	6.6	24.3	13.4	23.9	9.9	14.5	22.3	17.8	8.1	10.8	16.5	3.0	36.5	12.4	10.2	15.6	17.1	22.8	40.6	26.6	43.1	24.9	28.3	24.9	27.4	26.7	26.0	20.8	45.6	14.5	22.1	22.2	19.3	14.9	5.1	34.8	34.2	8.7	25.5	36.7	3.3	30.4	14.4	19.0	12.8	0.0	71.3	38.8	20.0	22.9	12.8	23.3	35.7	30.2	16.7	7.4	22.2	12.4	11.8	21.1	13.5	35.1	12.7	10.8	50.1	3.5	10.6	9.8	19.8	12.9	24.5	26.7	19.4	21.3	31.5	33.0	17.5	30.1
YBX1	"BP-8, CSDA2, CSDB, DBPB, MDR-NF1, NSEP-1, NSEP1, YB-1, YB1"	ENSG00000065978	"Y-box binding protein 1"	P67809	1	42682427-42702349	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, Mitogen, Repressor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"skeletal muscle: 128.1;testis: 426.5"	"Cell type enhanced"	"Detected in all"	8	"Early spermatids: 6931.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005875, HPA040304, HPA057159"	Supported		Enhanced	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		870000	Cytosol	Vesicles	"CAB005875: AB_2219278, HPA040304: AB_10795364, HPA057159: AB_2683355"	"unprognostic (8.59e-2)"	"unprognostic (5.16e-2)"	"unprognostic (9.27e-3)"	"unprognostic (2.68e-3)"	"unprognostic (7.76e-2)"	"unprognostic (8.03e-3)"	"prognostic unfavorable (9.87e-10)"	"unprognostic (2.80e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.51e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (3.59e-7)"	"unprognostic (3.66e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.25e-1)"	47.5	20.6	15.6	36.4	18.4	57.6	35.2	13.7	14.4	27.9	44.5	21.2	20.1	25.6	35.1	36.4	40.0	25.6	32.5	57.8	15.2	12.3	33.1	38.1	35.3	49.8	17.6	13.2	30.2	36.7	9.4	12.2	26.1	15.5	32.0	33.1	31.1	26.6	23.0	128.1	22.5	27.1	50.0	21.0	47.9	33.2	426.5	15.9	53.2	31.4	64.1	37.2	39.4	41.0	23.5	26.9	21.8	40.5	11.6	23.0	10.6	92.5	54.6	87.4	87.6	85.2	77.1	77.9	68.3	63.6	95.0	74.6	74.7	86.5	117.5	71.7	68.6	40.6	56.0	98.4	103.6	94.4	62.7	91.3	119.8	108.4	95.9	68.7	160.8	89.8	70.9	89.3	94.8	117.4	52.1	78.5	98.4	124.6	51.2	88.4	58.3	181.7	156.6	197.1	59.5	73.8	110.0	157.1	126.9	94.0	68.5	120.9	85.2	67.0	90.7	127.6	97.4	30.2	320.5	61.2	67.5	115.2	91.4	138.9	75.1	94.1	133.7	63.9	120.6	71.6	4.3	18.1	21.8	16.3	37.8	19.9	23.5	19.5	15.8	26.9	20.1	16.8	17.2	3.3	11.6	40.5	20.9	23.0	10.6	15.6	18.4	13.7	14.4	15.2	12.3	17.6	13.2	15.5	15.9	160.8	193.6	710.2	1008.1	1241.5	227.0	1010.1	351.6	187.4	286.6	308.8	141.4	639.1	1235.1	944.3	6931.7	600.7	713.3	817.7	771.6	1697.6	856.8	736.8	377.2	465.4	1556.8	114.4	564.5	393.5	1134.6	2234.4	695.5	1494.6	858.7	964.0	841.6	220.6	737.9	799.5	757.7	816.8	432.4	459.2	1265.4	2608.0	287.2	1138.5	402.6	588.8	1140.5	1354.3
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	19.0	13.4	19.8	38.3	44.6	36.1	11.9	23.0	35.7	19.1	24.2	16.0	13.9	7.8	18.4	42.2	16.5	19.2	14.5	22.4	12.1	14.3	20.8	12.2	19.8	30.4	34.6	12.9	18.4	36.0	29.3	16.2	16.1	32.5	28.7	13.3	13.2	18.1	22.7	29.2	9.8	16.5	10.2	99.8	14.9	8.7	9.1	20.6	34.0	20.3	16.0	22.9	10.4	13.9	24.3	15.7	22.9	27.2	27.3	21.7	11.4	11.9	15.8	21.3	17.1	15.5	15.4	11.2	14.6	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6	32.8	25.2	38.7	57.7	36.1	56.4	26.7	56.0	32.1	39.8	52.4	35.3	167.5	41.4	124.0	24.9	56.8	99.6	23.3	88.8	180.7	66.2	64.5	40.3	62.3	87.8	55.6	102.8	65.7	41.3	59.8	64.7	40.3	62.4	92.8	108.3	110.5	105.8	94.7	62.9	58.6	49.3	32.3	47.5	38.7	38.1	31.0	220.8	42.4	69.7	72.1
YTHDF2	"CAHL, HGRG8, NY-REN-2"	ENSG00000198492	"YTH N6-methyladenosine RNA binding protein 2"	Q9Y5A9	1	28736621-28769775	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity, Innate immunity, Oogenesis"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030063, HPA054080, HPA059621"	Approved		Enhanced	"Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Cytoplasmic bodies"	"HPA030063: AB_2732453, HPA054080: AB_2682371, HPA059621: AB_2684084"	"unprognostic (8.75e-2)"	"unprognostic (1.90e-2)"	"unprognostic (4.66e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (6.14e-9)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.18e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.29e-2)"	"unprognostic (6.97e-3)"	31.1	33.0	18.2	27.0	19.9	42.0	52.4	21.5	28.3	23.7	23.6	20.4	31.5	22.1	26.6	35.1	36.0	26.1	21.7	23.3	18.5	19.4	26.8	35.8	30.0	42.5	18.1	21.3	25.5	37.2	29.7	18.4	32.6	20.2	21.7	26.2	22.1	34.4	31.3	39.6	36.5	24.4	25.1	15.1	29.8	24.8	28.0	17.0	44.2	26.4	30.4	31.7	24.7	31.0	36.5	42.2	33.3	39.9	39.0	40.4	41.8	21.7	15.2	33.3	32.3	26.0	20.0	38.3	21.2	26.6	26.6	27.1	13.8	25.8	37.4	21.3	27.2	16.1	20.4	38.5	34.5	31.8	23.5	28.0	31.4	20.9	25.4	30.7	33.0	24.8	26.8	35.8	28.6	41.0	23.6	32.5	22.5	31.5	18.7	29.8	17.1	34.9	26.0	53.5	19.7	19.4	30.3	24.6	30.8	37.3	31.3	28.5	30.3	22.1	34.1	57.3	29.0	22.5	31.3	22.2	18.8	19.4	17.5	30.0	22.5	14.4	42.9	21.5	26.1	29.8	33.3	32.4	32.6	28.9	39.9	40.0	36.5	33.9	36.4	42.2	25.5	36.1	34.1	11.5	39.0	38.0	25.9	40.4	41.8	18.2	19.9	21.5	28.3	18.5	19.4	18.1	21.3	20.2	17.0	47.6	50.4	61.8	85.7	135.7	43.7	41.5	81.5	32.1	59.1	41.8	29.5	127.2	56.3	89.8	9.8	76.8	37.5	0.0	60.6	91.0	73.1	49.8	71.5	91.0	67.2	55.6	72.6	69.3	64.2	12.7	65.9	55.7	35.4	71.3	55.9	65.9	70.7	38.6	70.7	74.9	41.0	90.5	54.6	103.5	109.1	141.3	217.6	64.7	53.3	104.3
ZBED8	"Buster3, C5orf54"	ENSG00000221886	"Zinc finger BED-type containing 8"	Q8IZ13	5	160393148-160400097	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 9.4;Sertoli cells: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA045445, HPA055817"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045445: AB_10959608, HPA055817: AB_2682933"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.50e-2)"	"unprognostic (1.47e-5)"	"unprognostic (6.52e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.65e-2)"	"prognostic favorable (3.72e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.96e-3)"	3.6	8.1	10.4	1.9	12.4	0.6	6.7	20.1	8.8	11.1	6.3	9.9	5.2	2.9	10.5	13.5	3.8	9.4	4.4	6.8	7.9	6.6	6.7	2.5	4.2	2.5	14.2	6.4	18.8	4.4	6.3	21.7	7.6	9.7	8.3	3.5	5.6	7.9	10.3	4.1	4.8	2.8	8.2	9.5	3.6	4.6	7.0	12.5	2.1	9.5	1.5	3.1	5.5	9.0	0.8	2.9	1.1	3.1	3.3	2.4	1.6	5.5	4.4	10.9	9.5	8.7	6.4	4.5	4.8	4.5	5.9	8.9	3.9	4.4	4.6	9.2	1.6	13.9	6.0	6.2	2.8	7.9	4.7	6.2	2.9	6.4	5.0	3.3	1.9	3.7	2.5	5.9	4.3	2.9	5.4	3.0	3.9	2.0	4.4	6.2	2.2	1.7	3.1	2.6	2.3	4.7	2.3	12.6	3.0	2.7	1.6	11.2	3.8	6.3	1.8	5.2	4.5	4.2	1.9	2.1	8.8	5.9	2.7	3.9	4.0	6.8	1.1	6.3	2.8	8.6	0.0	2.4	1.1	2.4	1.9	1.4	0.8	2.2	1.7	2.9	0.6	1.7	1.3	0.3	3.3	3.1	2.6	0.0	1.6	10.4	12.4	20.1	8.8	7.9	6.6	14.2	6.4	9.7	12.5	0.0	0.3	0.0	0.7	0.0	4.6	2.4	0.0	9.4	1.2	1.8	2.0	3.5	1.7	1.1	0.8	1.5	0.0	0.0	0.4	1.2	0.9	0.8	0.0	0.0	1.2	3.2	0.0	0.6	1.2	0.0	6.1	0.0	0.0	1.8	0.6	5.8	0.7	0.0	5.3	1.0	3.9	12.9	0.5	1.6	4.9	0.0	1.1	0.0	0.6	0.3
ZBTB10	"FLJ12752, RINZF"	ENSG00000205189	"Zinc finger and BTB domain containing 10"	Q96DT7	8	80485619-80526265	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021554, HPA050569"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021554: AB_1858937, HPA050569: AB_2681179"	"unprognostic (7.97e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.26e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.28e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.86e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (4.65e-3)"	"unprognostic (2.40e-1)"	"unprognostic (7.15e-2)"	"unprognostic (2.63e-2)"	12.4	8.2	6.3	8.4	6.8	21.3	14.1	13.5	8.0	11.3	6.9	6.1	8.6	2.0	14.5	9.1	5.7	12.2	7.4	9.0	5.6	5.3	10.7	18.4	11.5	9.7	7.5	3.3	18.8	16.2	9.4	7.2	22.8	6.4	17.6	8.0	7.9	8.7	6.8	17.3	3.8	4.3	14.0	7.6	6.6	6.6	12.1	6.3	14.6	10.3	7.5	4.1	19.2	13.4	2.1	3.6	0.6	0.8	2.0	1.5	0.2	0.0	2.4	12.5	6.3	5.5	4.2	16.9	2.2	0.0	1.8	1.8	5.2	1.9	7.1	6.5	3.4	5.4	0.6	9.7	3.0	2.1	0.0	15.9	3.7	1.6	4.1	3.2	1.3	1.7	4.0	2.9	2.2	6.3	1.5	4.5	6.1	3.3	14.1	1.5	3.8	7.0	3.2	3.1	0.7	3.8	8.2	6.8	2.4	5.2	7.1	7.3	8.6	2.9	28.6	8.4	14.9	5.4	5.1	5.7	4.3	8.1	0.0	2.0	4.2	2.0	8.1	1.6	0.0	5.3	0.6	0.2	0.0	0.8	0.3	0.9	1.1	0.7	0.9	0.7	2.1	1.5	1.4	0.0	2.0	0.8	3.6	0.0	0.2	6.3	6.8	13.5	5.5	5.6	5.3	7.5	3.3	6.4	6.3	23.8	14.2	14.3	11.0	25.2	12.9	29.0	17.8	22.7	14.8	12.2	15.7	30.3	3.3	11.0	53.3	23.8	20.6	0.0	6.0	31.5	26.2	72.3	9.2	28.4	11.2	30.2	58.0	12.9	14.8	24.7	17.8	11.5	47.2	15.4	32.3	19.3	8.4	5.8	19.8	11.1	8.2	25.8	36.5	14.4	10.6	11.0	88.0	17.9	29.2	10.7
ZBTB11	"ZNF-U69274, ZNF913"	ENSG00000066422	"Zinc finger and BTB domain containing 11"	O95625	3	101648889-101677495	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015328, HPA024138"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015328: AB_1858938, HPA024138: AB_1858939"	"unprognostic (3.25e-3)"	"unprognostic (9.62e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (2.86e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.77e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.89e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.09e-1)"	11.6	11.0	14.8	14.8	16.5	44.0	13.7	21.9	16.0	14.1	11.9	8.5	8.4	11.4	13.6	10.4	14.1	10.9	10.5	9.1	12.3	12.4	10.5	12.9	14.2	16.6	11.2	12.9	15.0	16.4	19.1	14.3	14.2	14.3	13.0	10.8	7.1	15.2	13.2	16.2	16.6	12.7	12.3	13.5	16.6	11.7	13.7	13.6	28.7	13.6	10.2	16.4	14.4	22.3	6.8	8.0	9.6	11.6	5.2	9.0	4.6	9.8	11.0	7.3	9.7	11.4	11.2	12.8	9.7	9.4	8.8	9.7	9.9	6.8	11.9	7.9	7.2	8.1	12.2	10.8	10.8	15.8	12.4	7.7	26.5	10.2	9.1	8.8	18.6	9.7	9.0	14.0	8.1	18.9	8.0	8.6	13.8	15.1	14.6	9.4	12.0	16.3	8.3	6.9	10.4	16.3	13.4	11.4	14.4	8.2	11.7	21.4	7.9	12.5	10.3	12.8	4.8	13.1	10.2	9.8	13.6	10.1	5.6	9.6	16.8	13.9	22.3	8.5	12.3	9.6	9.6	6.3	7.0	6.8	8.2	9.0	5.4	5.8	7.5	8.0	6.8	6.8	5.6	4.3	5.2	11.6	4.8	6.3	4.6	14.8	16.5	21.9	16.0	12.3	12.4	11.2	12.9	14.3	13.6	29.8	14.4	13.7	18.0	41.2	12.0	10.8	12.7	24.1	26.1	1.8	31.4	8.2	0.0	5.5	2.6	16.7	9.1	0.0	4.8	6.6	21.6	14.6	8.1	8.9	6.8	20.6	19.4	15.4	25.9	2.3	7.8	20.4	18.6	8.2	10.2	11.7	6.7	3.5	13.4	4.8	22.8	6.5	16.2	16.1	19.3	42.9	14.1	22.4	9.5	20.4
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899607-31901992	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	20	"Cardiomyocytes: 3.9;Horizontal cells: 3.2;Rod photoreceptor cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	2.2	3.2	5.0	3.4	4.6	1.8	3.0	4.5	5.5	5.3	2.7	7.4	5.7	4.8	5.7	2.3	2.9	5.3	2.6	2.8	5.5	3.6	1.6	1.4	2.2	2.5	8.6	2.9	7.4	2.2	2.5	2.1	2.3	4.0	6.5	1.2	3.2	4.5	2.4	3.3	1.8	3.7	7.3	4.7	3.2	3.3	2.4	9.9	3.5	6.5	1.8	1.6	4.4	6.7	0.2	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.7	6.2	5.4	1.2	1.4	0.5	1.1	1.1	2.2	1.6	2.1	2.9	2.7	2.6	1.3	4.3	0.7	3.1	2.1	0.9	7.1	8.5	2.3	0.0	4.2	2.2	8.8	4.2	1.2	0.8	0.9	1.7	3.1	0.1	3.1	2.6	1.6	1.3	2.8	4.5	6.3	6.4	1.5	1.0	9.9	1.3	0.0	1.3	1.6	3.4	11.4	1.1	0.6	3.1	1.5	0.0	2.7	0.9	3.4	1.1	1.5	0.1	2.3	8.3	2.8	1.5	0.9	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	4.6	4.5	5.1	5.5	3.6	8.6	2.9	4.0	9.9	0.0	0.0	0.0	0.0	0.0	0.8	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
ZBTB20	"DKFZp566F123, DPZF, ODA-8S, ZNF288"	ENSG00000181722	"Zinc finger and BTB domain containing 20"	Q9HC78	3	114314501-115147271	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.6"	"Cell type enhanced"	"Detected in many"	5	"Collecting duct cells: 279.2;Early spermatids: 317.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 7.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015551, HPA016815"	Approved		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA015551: AB_2669217, HPA016815: AB_1858947"	"unprognostic (1.79e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.72e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.83e-3)"	"unprognostic (1.81e-1)"	10.7	7.3	6.3	2.9	12.3	4.0	6.2	17.3	9.3	7.2	4.2	10.8	5.3	1.7	6.6	17.4	3.5	4.9	4.3	6.1	9.7	5.2	9.8	9.8	4.4	3.3	14.9	3.7	12.7	5.9	5.3	26.1	2.2	11.5	10.0	2.7	7.9	5.4	9.2	12.1	4.4	4.0	7.5	19.2	4.4	3.9	44.6	14.2	2.1	9.1	8.1	3.3	5.2	5.0	18.2	4.3	7.8	3.6	4.1	7.7	2.7	2.3	4.4	1.7	4.2	6.3	2.8	0.0	1.8	3.9	1.1	0.9	2.5	0.8	0.6	6.1	4.6	1.5	0.1	6.1	1.0	1.1	0.5	0.1	0.6	2.1	1.9	1.5	0.3	0.0	2.7	0.3	2.5	0.8	3.9	1.3	0.5	0.1	1.0	6.4	0.0	0.3	0.2	0.4	0.0	0.2	0.2	5.1	0.0	4.3	0.0	0.4	1.0	0.8	0.0	1.3	0.2	0.0	0.5	7.2	1.6	5.5	0.3	2.7	1.6	0.0	0.3	2.6	0.4	2.0	7.8	1.4	5.1	6.1	2.0	4.2	18.2	6.0	5.6	1.6	10.7	7.7	6.6	3.1	4.1	3.6	4.3	2.8	2.7	6.3	12.3	17.3	9.3	9.7	5.2	14.9	3.7	11.5	14.2	148.9	92.8	51.6	33.4	22.9	70.0	42.8	101.9	45.5	35.2	279.2	56.9	0.2	41.4	165.4	317.2	68.7	13.9	0.0	71.6	0.5	90.0	35.5	79.6	95.2	3.8	76.3	30.5	49.7	16.5	71.3	97.8	22.0	30.4	34.3	15.3	183.7	101.7	11.4	113.5	147.9	113.2	84.1	55.2	6.6	4.3	16.2	0.5	36.3	16.6	21.7
ZBTB21	"KIAA1227, ZNF295"	ENSG00000173276	"Zinc finger and BTB domain containing 21"	Q9ULJ3	21	41986831-42010387	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Basal keratinocytes: 53.2;Suprabasal keratinocytes: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024655, HPA031757, HPA031758"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024655: AB_1859171, HPA031757: AB_2674031, HPA031758: AB_2674032"	"unprognostic (1.16e-2)"	"unprognostic (3.51e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.61e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.67e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.67e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.02e-1)"	13.1	41.0	11.0	6.8	12.9	39.2	11.8	11.5	14.4	10.3	7.5	8.3	7.4	4.9	15.4	9.2	8.0	11.4	13.8	9.4	9.6	7.3	8.0	19.6	10.3	5.8	8.3	6.2	19.6	10.7	20.9	11.7	18.3	8.8	9.6	6.2	6.8	8.5	8.6	5.3	13.8	7.6	9.9	8.9	8.7	8.9	13.1	10.4	10.1	12.1	6.4	7.1	10.7	14.5	4.9	5.0	5.0	6.2	1.3	5.9	2.4	6.5	5.2	5.1	5.8	7.3	5.7	5.0	6.1	8.8	5.9	9.0	6.2	3.3	11.7	2.8	6.1	10.6	5.0	7.5	4.3	9.6	6.1	7.4	1.3	5.3	3.7	5.6	4.5	2.8	3.2	9.3	8.2	10.8	2.6	3.3	6.4	7.6	20.4	4.1	9.6	12.2	2.2	5.1	4.8	6.5	5.2	5.8	13.6	2.6	5.3	7.3	4.3	8.5	12.8	5.9	2.7	4.5	2.1	3.7	8.7	4.9	6.0	6.0	32.6	28.5	11.0	11.4	7.6	5.6	0.2	4.9	2.4	3.7	6.0	4.2	4.9	4.0	2.9	5.0	4.5	5.9	4.3	5.0	1.3	6.2	4.3	2.6	2.4	11.0	12.9	11.5	14.4	9.6	7.3	8.3	6.2	8.8	10.4	6.0	37.9	18.5	32.4	53.2	12.5	3.7	2.5	16.0	15.9	7.0	2.0	5.7	10.0	4.7	11.1	17.4	4.9	0.0	4.3	4.2	27.2	23.1	16.1	17.8	5.5	30.2	4.1	9.2	7.6	4.1	3.7	12.2	33.7	5.4	8.7	9.4	3.7	6.0	9.9	4.4	13.6	6.5	19.6	15.2	11.1	55.3	8.1	10.7	5.1	16.2
ZBTB25	"C14orf51, KUP, ZNF46"	ENSG00000089775	"Zinc finger and BTB domain containing 25"	P24278	14	64449106-64505213	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054699	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA054699: AB_2682579"	"unprognostic (1.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-3)"	"unprognostic (5.32e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.26e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.56e-6)"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.04e-1)"	12.1	12.0	16.5	18.4	19.2	14.6	18.1	17.1	15.2	12.3	12.6	13.9	7.7	8.1	13.3	18.8	8.3	14.6	11.9	20.0	13.0	10.8	10.1	12.4	12.5	28.0	15.4	12.9	16.3	12.9	18.1	18.6	9.5	14.7	12.9	11.3	13.2	9.0	12.8	19.2	15.9	14.1	13.2	18.5	17.0	11.1	11.5	18.1	31.8	19.2	7.8	22.7	20.0	14.0	6.4	2.9	2.8	2.4	6.3	11.5	6.3	15.1	6.7	4.5	4.5	6.5	8.1	8.8	2.6	4.7	4.3	5.7	3.2	10.6	11.3	3.1	4.3	5.5	14.0	4.4	4.4	5.3	11.7	1.4	2.6	10.0	1.4	7.4	1.8	6.0	10.3	4.3	4.3	8.5	9.3	3.9	10.9	1.5	18.7	5.1	6.5	6.4	2.7	2.3	5.4	7.0	4.9	4.8	4.8	5.0	7.2	4.3	4.7	5.6	4.3	3.5	4.3	5.4	1.4	4.2	6.0	9.1	2.8	4.0	16.5	3.8	5.2	8.9	2.3	4.4	2.8	2.4	1.5	6.9	1.6	9.0	6.4	9.7	6.6	1.6	4.3	11.5	11.2	2.6	6.3	1.3	2.9	8.3	6.3	16.5	19.2	17.1	15.2	13.0	10.8	15.4	12.9	14.7	18.1	6.0	8.8	17.7	6.8	7.0	17.8	16.1	7.6	13.4	5.7	7.0	17.7	6.4	8.3	6.5	44.5	7.7	1.8	0.0	5.7	8.0	5.6	6.6	5.8	8.9	9.5	7.9	3.4	7.4	8.2	36.7	12.4	11.3	16.9	4.6	2.7	8.6	6.0	3.2	10.3	5.8	21.2	0.0	7.2	10.7	11.7	7.3	3.3	24.9	3.9	4.7
ZBTB33	"kaiso, WUGSC:H_DJ525N14.1, ZNF-kaiso, ZNF348"	ENSG00000177485	"Zinc finger and BTB domain containing 33"	Q86T24	X	120250752-120258398	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Wnt signaling pathway"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000755, CAB001980, HPA005732"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"CAB001980: , HPA000755: AB_1079167, HPA005732: AB_1079166"	"unprognostic (9.14e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.08e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.59e-2)"	15.4	10.4	12.8	9.3	15.5	20.2	18.0	16.3	13.9	9.6	8.5	11.6	9.1	9.1	7.7	11.5	14.9	10.0	9.0	6.0	12.6	15.0	8.0	22.5	10.7	14.0	13.4	11.6	12.2	11.6	17.7	15.5	10.2	16.7	10.5	7.9	6.2	15.0	10.0	9.5	21.6	10.2	6.0	18.6	12.7	9.9	6.9	14.8	29.3	17.4	5.3	14.6	10.3	9.7	3.4	8.9	14.2	8.9	5.1	7.2	5.2	9.3	10.4	14.2	12.9	11.2	12.8	16.7	7.2	9.7	8.5	10.5	6.3	8.2	13.7	13.8	7.3	11.3	14.4	22.4	11.4	10.8	15.1	16.1	14.3	15.8	8.5	8.5	14.2	16.3	9.1	13.9	8.6	12.8	12.1	14.4	13.8	9.2	16.0	10.4	11.2	13.3	9.3	17.3	14.0	11.3	15.1	10.8	21.8	8.6	16.7	26.0	11.0	15.3	15.1	17.0	11.1	8.1	20.1	14.1	6.8	5.0	10.1	12.8	9.0	9.1	17.4	9.5	20.4	8.4	14.2	6.1	7.7	4.4	8.9	7.2	3.4	5.6	5.5	8.9	3.3	7.1	4.8	1.2	5.1	5.6	8.5	4.9	5.2	12.8	15.5	16.3	13.9	12.6	15.0	13.4	11.6	16.7	14.8	14.9	6.5	4.2	6.8	11.3	4.3	4.5	10.2	12.0	15.9	1.8	0.0	6.6	1.7	4.9	0.1	6.9	4.6	23.3	5.8	6.9	5.4	6.9	0.0	16.6	6.8	3.2	8.1	8.0	9.9	0.0	4.0	9.8	3.3	10.0	7.8	6.5	6.4	5.7	2.5	2.8	1.4	6.5	3.1	2.9	11.7	11.4	7.8	9.6	6.5	10.1
ZBTB38	"CIBZ, FLJ35036, PPP1R171, ZNF921"	ENSG00000177311	"Zinc finger and BTB domain containing 38"	Q8NAP3	3	141324213-141449792	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 52.0;RPMI-8226: 75.3;U-266/70: 51.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014865, HPA059378"			Enhanced	Nucleoplasm		No	No			Nucleoplasm		"HPA014865: AB_2732412, HPA059378: AB_2683998"	"unprognostic (1.78e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.78e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.07e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.04e-1)"	18.4	27.6	19.6	16.3	26.5	5.4	20.2	50.9	30.1	28.0	23.2	11.6	15.5	14.9	36.1	11.1	14.4	20.1	25.4	21.7	16.3	12.5	18.8	13.2	20.1	16.7	17.6	21.0	21.3	17.3	43.5	21.8	19.9	18.3	19.7	21.9	13.4	22.8	21.3	56.7	11.1	20.4	30.1	18.7	11.8	17.1	17.4	20.1	2.6	20.3	9.4	19.5	25.7	24.5	11.4	5.1	13.6	5.3	14.8	17.8	6.7	10.7	16.0	1.9	3.8	17.2	16.3	2.5	17.4	21.0	16.9	24.7	8.3	6.3	0.3	7.2	15.1	13.2	3.1	2.1	14.7	38.7	10.4	3.0	3.0	15.3	4.8	19.3	0.2	4.5	12.2	8.7	17.9	36.4	27.7	12.9	0.3	3.2	52.0	19.1	1.1	0.2	0.6	1.9	3.0	2.0	0.2	5.5	75.3	10.9	6.7	0.7	2.7	25.5	2.5	9.2	3.4	5.2	2.7	31.0	13.8	3.5	26.8	8.1	51.9	30.2	3.8	23.7	0.3	7.6	13.6	3.4	9.4	17.8	5.3	13.3	11.4	11.7	17.7	5.1	5.1	9.1	14.7	4.0	14.8	4.2	2.5	15.3	6.7	19.6	26.5	50.9	30.1	16.3	12.5	17.6	21.0	18.3	20.1	71.5	54.7	23.8	31.7	18.1	86.6	104.9	66.2	48.2	69.4	55.8	70.7	27.6	24.9	35.6	201.9	74.9	41.3	0.0	27.8	12.6	45.6	45.5	64.9	27.0	27.6	133.5	34.5	48.5	19.7	97.7	65.3	39.9	37.1	95.6	43.1	55.0	48.7	28.8	96.9	39.2	66.4	116.4	91.0	7.2	10.0	16.3	104.5	67.8	69.1	34.1
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.0"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 141.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	9.4	11.1	3.0	8.8	4.7	11.6	11.1	4.0	4.9	9.5	33.7	11.3	22.3	27.3	5.4	4.5	29.1	5.9	13.2	6.4	4.3	2.1	9.3	19.1	10.5	6.3	8.0	4.3	6.2	18.2	5.1	6.4	11.3	5.9	9.9	8.1	9.6	19.1	18.6	11.8	33.3	54.0	5.4	5.6	10.3	11.2	3.8	7.3	1.8	14.3	11.2	16.0	8.6	12.4	2.0	2.3	5.7	3.4	1.5	2.5	4.3	7.5	13.5	1.2	4.1	6.2	3.5	16.6	5.2	6.2	5.5	6.4	9.0	11.0	3.3	9.4	5.8	4.3	11.5	3.8	7.3	1.1	18.0	4.3	5.5	22.5	6.0	9.1	4.2	15.2	4.6	26.2	7.5	9.3	7.4	4.3	0.5	7.8	15.3	3.1	14.3	0.1	9.4	4.1	12.1	11.2	3.1	0.9	20.7	8.2	7.9	7.7	7.9	10.0	26.8	4.2	5.3	16.7	14.1	3.6	3.6	6.3	7.0	4.3	18.2	11.1	3.5	8.3	14.0	4.0	0.9	3.2	2.9	1.5	3.4	0.5	1.6	2.0	0.9	2.3	2.0	1.7	0.5	5.7	1.5	2.9	0.2	2.5	4.3	3.0	4.7	4.0	4.9	4.3	2.1	8.0	4.3	5.9	7.3	8.9	0.0	4.7	8.4	31.3	14.0	1.4	20.4	0.0	1.2	5.2	2.0	9.2	10.0	11.9	2.2	4.1	141.0	0.0	13.0	12.8	5.6	21.8	5.7	23.7	12.7	15.9	6.4	4.9	30.8	5.6	8.3	16.2	15.1	6.4	27.3	5.1	14.5	48.0	6.7	8.9	9.8	0.0	6.3	0.4	1.2	46.9	23.0	7.4	33.0	16.9
ZC3H14	"FLJ11806, NY-REN-37, UKp68"	ENSG00000100722	"Zinc finger CCCH-type containing 14"	Q6PJT7	14	88562909-88627596	"Disease related genes, Predicted intracellular proteins"		RNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 73.1"	"Group enriched"	"Detected in many"	5	"Early spermatids: 961.1;Late spermatids: 410.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049798, HPA053510"	Enhanced		Enhanced	"Nucleoli,Nucleoli rim,Nuclear speckles"		NA	NA			"Nuclear speckles"	"Nucleoli, Nucleoli rim"	"HPA049798: AB_2680888, HPA053510: AB_2682174"	"unprognostic (5.80e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.47e-3)"	"unprognostic (9.57e-2)"	"unprognostic (7.21e-3)"	"unprognostic (2.77e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (2.09e-1)"	"unprognostic (8.23e-2)"	"unprognostic (3.71e-1)"	"unprognostic (4.25e-2)"	13.5	12.6	16.2	10.8	16.4	9.7	13.3	23.4	19.6	14.0	15.3	14.3	17.5	10.6	17.2	15.5	12.4	15.8	10.4	12.3	14.8	8.4	15.2	24.9	13.9	9.1	16.1	16.3	17.1	19.4	19.3	24.1	14.8	16.0	14.9	16.6	11.3	18.0	16.3	15.4	13.6	15.2	14.8	11.2	9.4	12.7	73.1	14.1	9.3	19.4	8.2	11.4	16.2	12.8	13.3	17.4	21.7	21.1	18.5	17.7	13.3	16.4	31.8	29.2	23.1	23.2	22.5	29.6	25.3	23.0	36.0	31.8	22.6	26.0	23.0	18.3	25.7	19.8	20.3	20.6	23.6	49.1	19.4	15.5	11.2	22.7	18.4	23.3	24.6	14.7	18.0	27.8	28.1	28.2	24.6	23.4	21.1	21.9	10.6	32.5	35.1	22.2	13.6	18.6	25.9	28.1	19.4	37.3	10.0	24.3	29.7	21.9	19.6	31.6	36.2	17.7	25.2	33.0	16.1	17.2	43.8	26.8	18.4	25.1	13.6	11.8	25.7	21.5	12.0	20.0	12.9	16.0	21.7	15.9	20.0	17.7	13.3	15.5	17.5	17.4	12.0	14.7	14.7	2.9	18.5	21.1	9.5	13.2	13.3	16.2	16.4	23.4	19.6	14.8	8.4	16.1	16.3	16.0	14.1	113.2	41.2	16.2	22.0	20.1	59.3	19.0	25.5	75.0	46.6	19.2	72.6	40.8	29.9	22.1	961.1	18.2	22.3	0.0	19.9	23.4	21.3	22.4	43.9	29.7	17.6	62.0	30.5	23.4	10.4	410.4	36.5	14.0	5.0	13.6	27.9	35.0	19.9	14.0	44.6	24.5	76.1	12.9	27.6	125.8	76.6	17.2	34.0	17.5	29.2	13.6
ZC3H15	LEREPO4	ENSG00000065548	"Zinc finger CCCH-type containing 15"	Q8WU90	2	186486156-186509363	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031099, HPA031100, HPA031101"	Enhanced		Enhanced	Cytosol		NA	Yes			Cytosol		"HPA031099: AB_10599418, HPA031100: AB_2257403, HPA031101: AB_10611669"	"unprognostic (1.51e-1)"	"prognostic unfavorable (6.45e-5)"	"unprognostic (2.24e-1)"	"unprognostic (3.11e-3)"	"unprognostic (5.92e-2)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (1.48e-7)"	"unprognostic (9.08e-3)"	"unprognostic (4.95e-2)"	"prognostic favorable (3.98e-4)"	"prognostic unfavorable (9.75e-4)"	"unprognostic (5.72e-3)"	"unprognostic (5.69e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.89e-2)"	"unprognostic (3.45e-2)"	25.2	31.1	35.7	25.2	40.1	67.3	38.0	32.9	52.6	24.7	24.7	10.5	30.2	29.0	25.1	30.7	28.2	19.8	22.6	25.2	60.0	35.4	32.8	40.3	20.3	29.5	32.3	33.5	24.5	32.7	26.9	35.3	29.4	51.6	24.3	28.9	10.7	25.8	26.2	58.0	27.0	29.9	27.4	43.4	28.5	23.3	23.7	21.7	28.3	30.5	19.0	30.1	30.0	38.8	32.8	31.1	28.3	39.1	32.5	36.9	22.4	27.2	18.5	22.9	29.4	26.1	26.5	34.4	30.4	20.8	28.2	25.5	53.9	22.1	37.2	27.9	21.5	36.2	19.9	42.1	37.1	40.0	33.8	32.2	53.4	28.6	59.6	35.3	54.3	32.8	21.6	41.2	30.6	43.6	24.9	30.2	23.2	51.0	29.2	29.4	24.5	34.6	38.8	43.2	36.0	46.9	27.7	31.0	34.6	35.7	33.3	27.7	20.4	19.2	26.3	43.9	36.0	18.5	39.6	25.9	31.9	27.6	19.5	36.2	25.5	42.7	53.2	28.3	38.6	27.8	28.3	27.5	26.9	27.2	34.0	33.7	32.8	33.8	34.5	31.1	24.7	31.5	33.2	16.8	32.5	39.1	27.5	36.9	22.4	35.7	40.1	32.9	52.6	60.0	35.4	32.3	33.5	51.6	21.7	68.5	78.9	141.2	127.1	188.5	73.2	87.6	66.2	78.9	102.4	109.9	56.9	114.7	217.2	91.2	123.7	87.8	121.8	46.7	90.4	141.8	94.0	129.7	109.7	114.6	109.7	54.0	97.5	65.7	86.1	224.0	72.8	100.6	60.8	118.2	99.1	80.5	96.4	97.7	82.0	189.8	120.6	32.3	103.2	184.4	186.8	182.8	148.5	83.7	117.5	153.1
ZC3H18	NHN1	ENSG00000158545	"Zinc finger CCCH-type containing 18"	Q86VM9	16	88570381-88631966	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040847, HPA041327"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA040847: AB_10794865, HPA041327: AB_10795005"	"unprognostic (3.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (4.06e-4)"	"unprognostic (1.10e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.07e-3)"	"prognostic favorable (3.68e-4)"	"unprognostic (5.83e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.29e-2)"	"unprognostic (4.01e-1)"	17.5	13.5	15.5	28.1	19.0	30.9	15.3	28.3	21.4	15.1	17.1	20.7	17.4	20.3	20.5	12.2	16.5	15.5	21.8	13.9	15.6	12.6	11.5	13.6	14.7	23.1	17.1	10.5	18.2	19.7	18.8	17.7	18.7	15.0	13.2	11.8	13.4	18.4	13.0	27.6	16.3	20.2	14.6	14.3	22.4	16.9	31.4	18.4	27.0	15.3	10.7	18.6	17.2	21.3	4.5	5.8	7.6	9.9	6.4	6.8	4.1	15.4	20.8	15.2	15.2	7.5	6.5	24.5	15.6	8.5	14.6	6.7	20.4	13.5	19.0	13.3	7.3	9.8	18.6	14.3	11.8	9.3	11.1	18.1	12.6	10.3	17.3	9.6	9.7	11.0	5.9	9.0	15.5	7.5	6.1	9.0	13.3	34.2	6.3	7.2	29.9	30.9	17.2	23.8	12.1	12.6	38.1	10.5	13.9	6.6	9.9	16.1	13.9	29.9	8.3	8.7	9.3	18.9	13.2	12.2	15.8	16.4	11.4	15.7	14.2	22.3	45.5	14.0	22.7	16.6	4.5	4.5	4.3	6.0	5.2	6.7	4.4	5.5	6.1	4.0	4.5	5.0	3.9	7.6	6.4	9.9	5.8	6.8	4.1	15.5	19.0	28.3	21.4	15.6	12.6	17.1	10.5	15.0	18.4	26.8	21.6	22.5	15.2	14.9	26.0	8.4	17.8	14.7	33.0	15.7	33.4	19.5	6.6	13.7	54.6	14.7	19.7	46.7	14.3	18.3	11.6	15.0	19.7	12.9	15.7	27.0	24.0	15.4	18.7	5.8	20.1	22.5	13.5	22.6	16.2	24.7	14.3	20.1	15.9	6.3	42.6	6.5	12.7	30.5	34.6	19.4	21.1	30.5	19.3	14.2
ZC3H4	"C19orf7, KIAA1064"	ENSG00000130749	"Zinc finger CCCH-type containing 4"	Q9UPT8	19	47064187-47113752	"Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040934, HPA041068"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA		8500	Nucleoplasm	Cytosol	"HPA040934: AB_10795495, HPA041068: AB_10796567"	"unprognostic (8.02e-3)"	"unprognostic (3.68e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.14e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.19e-1)"	"unprognostic (5.90e-2)"	"prognostic favorable (2.23e-4)"	12.0	8.2	8.6	14.5	16.9	8.5	18.2	25.6	13.9	8.9	9.6	14.7	9.8	11.5	12.8	6.0	11.8	10.4	6.5	8.2	9.3	7.6	9.2	10.9	19.9	14.1	16.5	5.2	14.6	12.5	10.4	45.4	15.4	13.9	9.7	7.2	10.8	11.8	10.4	14.1	13.5	11.5	8.5	26.0	16.0	11.5	14.5	12.4	17.5	10.5	9.3	11.5	10.3	24.0	5.2	6.8	6.2	3.7	5.2	5.6	1.2	8.8	13.8	8.6	12.2	4.8	3.0	8.8	7.1	4.0	6.7	4.5	9.8	9.9	18.7	5.3	4.8	4.1	15.4	3.8	10.1	4.3	11.5	6.1	13.3	8.4	7.4	4.2	12.6	14.2	5.1	2.8	6.2	4.9	3.6	5.4	11.6	12.8	7.1	4.3	15.4	14.2	21.3	12.8	6.0	4.7	22.4	7.4	8.4	5.0	14.5	10.5	14.9	10.8	9.1	5.3	4.4	9.5	10.2	9.5	9.1	8.9	5.8	9.9	9.3	7.5	16.7	7.1	10.3	12.9	4.6	2.2	3.2	5.5	3.7	5.6	5.2	4.9	5.5	2.9	5.1	4.3	4.8	6.2	5.2	3.5	6.8	3.1	1.2	8.6	16.9	25.6	13.9	9.3	7.6	16.5	5.2	13.9	12.4	3.0	13.3	13.6	5.5	19.8	24.1	11.2	25.5	12.0	12.5	19.2	13.7	5.7	8.3	9.9	11.9	13.0	15.8	23.3	10.1	5.8	13.5	7.5	11.6	11.9	10.9	15.9	18.4	17.2	27.8	5.4	15.5	14.8	6.8	13.6	20.6	17.4	10.3	16.7	9.2	7.0	23.0	6.5	10.2	13.0	9.2	19.6	7.2	14.4	14.9	6.7
ZC3HAV1	"FLB6421, FLJ13288, MGC48898, PARP13, ZAP, ZC3H2, ZC3HDC2"	ENSG00000105939	"Zinc finger CCCH-type containing, antiviral 1"	Q7Z2W4	7	139043520-139109719	"Plasma proteins, Predicted intracellular proteins"	"Antiviral defense, Immunity, Innate immunity"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"T-cells: 124.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047818, HPA059096"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA047818: AB_10962642, HPA059096: AB_2683903"	"unprognostic (1.68e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.61e-2)"	"prognostic unfavorable (8.77e-7)"	"unprognostic (5.40e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.72e-1)"	"unprognostic (5.41e-2)"	"unprognostic (3.31e-3)"	"prognostic favorable (6.86e-4)"	"unprognostic (6.47e-2)"	"unprognostic (1.99e-1)"	"unprognostic (7.84e-2)"	14.3	14.8	6.8	19.8	6.6	52.6	13.8	1.6	5.6	11.2	11.5	6.7	10.8	6.9	10.0	10.9	14.2	9.5	10.4	7.0	5.4	7.2	11.2	13.1	17.2	44.4	7.5	4.0	10.6	11.0	9.8	11.4	8.5	8.6	11.2	10.2	9.3	16.9	11.5	3.8	9.5	14.8	10.8	9.0	22.6	9.6	7.8	6.9	43.9	18.2	8.8	26.1	10.8	29.0	16.3	7.0	28.8	11.9	15.6	27.9	11.8	11.4	14.2	2.0	11.8	18.8	18.1	8.6	13.0	10.0	22.8	23.5	10.2	15.0	10.1	12.3	20.8	19.7	13.1	15.9	15.5	13.0	17.9	5.9	20.1	14.4	12.6	10.8	23.3	18.7	18.4	9.9	25.9	5.8	8.5	16.9	15.3	17.0	11.4	9.7	10.9	19.2	27.2	8.0	8.8	8.7	22.8	7.1	9.8	15.6	14.5	3.7	7.5	20.1	14.2	17.3	4.8	8.3	14.6	21.3	4.9	7.1	13.3	10.7	8.7	9.1	23.8	10.9	21.8	11.5	28.8	8.2	11.9	19.4	10.6	24.6	14.3	27.9	23.5	6.4	16.3	27.3	26.4	22.1	15.6	11.9	7.0	24.2	11.8	6.8	6.6	1.6	5.6	5.4	7.2	7.5	4.0	8.6	6.9	23.8	44.5	82.7	23.7	25.4	2.1	4.4	30.6	28.1	20.5	50.6	3.9	10.5	8.3	17.4	2.2	46.7	36.0	23.3	18.3	17.5	51.6	34.7	31.2	29.9	30.5	0.0	51.0	46.1	44.1	1.2	17.3	62.3	37.1	37.9	31.3	15.0	19.2	26.4	25.1	31.0	0.7	12.9	57.9	0.7	0.7	19.4	1.9	124.6	27.3	23.0
ZC3HAV1L	"C7orf39, MGC14289"	ENSG00000146858	"Zinc finger CCCH-type containing, antiviral 1 like"	Q96H79	7	139025706-139036029	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	11	"granulocytes: 4.6;Leydig cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 10.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 10.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA020386, HPA050741"	Uncertain		Enhanced	Cytosol		NA	NA			Cytosol		"HPA020386: AB_2257412, HPA050741: AB_2681224"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.35e-4)"	"unprognostic (3.07e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.34e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.49e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.84e-2)"	"unprognostic (3.08e-3)"	8.2	6.1	2.9	3.1	4.7	1.5	9.4	1.1	3.0	14.7	6.6	2.0	5.0	4.2	10.3	9.7	8.6	7.4	5.6	4.7	2.0	2.4	6.2	1.9	5.3	3.0	1.6	1.7	20.2	9.9	4.4	12.2	14.1	2.0	12.0	4.4	8.4	5.9	10.1	3.0	11.6	4.4	8.8	1.8	6.0	4.5	4.4	2.1	10.5	17.4	5.6	6.2	9.0	9.1	1.0	0.3	10.7	0.3	0.3	0.4	0.3	9.1	7.5	5.5	18.5	4.7	7.2	0.2	4.5	2.0	3.4	4.7	12.4	5.3	0.2	6.6	4.9	0.0	6.6	7.7	1.8	10.4	5.4	0.1	11.7	7.3	4.2	3.7	0.1	4.3	5.5	3.0	5.1	2.4	0.2	5.7	5.8	5.0	0.3	6.9	0.0	12.3	7.0	1.0	1.2	4.8	13.0	18.8	0.1	3.1	5.0	3.7	16.9	11.2	1.6	6.9	1.2	6.9	4.8	8.0	6.2	5.5	2.1	0.0	0.3	0.0	0.2	3.5	0.1	5.7	10.7	0.3	1.3	0.2	0.1	0.3	0.6	0.4	0.4	0.2	1.0	0.3	0.4	0.8	0.3	0.1	0.3	0.3	0.3	2.9	4.7	1.1	3.0	2.0	2.4	1.6	1.7	2.0	2.1	0.0	0.0	0.0	0.7	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	1.5	0.8	0.5	4.6	0.0	0.7	0.0	0.0	0.0	0.8	0.0	1.7	0.0	0.0	0.0	0.0	0.8	0.2	0.0	1.4	0.3	0.0	0.0	1.4	0.0	0.6	0.9	0.6	0.0	0.0	0.4
ZCCHC7	"AIR1, FLJ22611"	ENSG00000147905	"Zinc finger CCHC-type containing 7"	Q8N3Z6	9	37120539-37358149	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020600, HPA021088, HPA029522"	Uncertain		Enhanced	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA020600: AB_1858985, HPA021088: AB_1858986, HPA029522: AB_10601029"	"unprognostic (1.19e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.36e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.78e-1)"	"unprognostic (4.27e-3)"	"unprognostic (3.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.29e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.23e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.04e-2)"	"unprognostic (5.49e-2)"	15.2	12.7	9.9	28.4	11.3	16.2	16.8	16.5	12.1	16.1	13.4	10.2	20.0	11.3	19.2	14.9	11.5	13.1	12.4	10.2	10.1	10.3	10.0	11.1	10.9	27.5	11.8	8.4	21.9	19.8	8.6	30.7	10.2	11.2	13.5	14.2	9.8	14.3	19.2	9.9	12.7	13.9	14.0	11.8	18.4	11.8	14.3	12.4	19.9	16.1	12.3	29.3	19.2	12.9	29.7	7.5	10.9	8.5	10.1	11.4	5.2	7.4	5.0	7.0	7.5	7.3	11.4	6.5	7.3	8.5	5.7	7.8	5.0	3.6	26.4	4.0	5.7	6.7	3.1	6.7	6.9	8.2	12.1	4.7	7.5	8.2	4.3	11.4	12.9	7.5	7.8	10.8	5.9	23.3	10.9	6.5	9.8	20.6	9.2	5.1	3.5	9.9	7.2	7.4	8.1	7.5	48.0	4.7	6.7	7.1	2.9	7.9	5.7	5.2	6.3	6.7	7.2	4.5	8.4	5.8	4.2	5.3	6.0	4.4	3.1	5.8	31.5	6.8	8.4	7.7	4.7	4.4	10.9	7.8	5.0	7.7	18.1	8.9	8.8	4.0	29.7	11.4	10.4	8.8	10.1	8.5	7.5	7.4	5.2	9.9	11.3	16.5	12.1	10.1	10.3	11.8	8.4	11.2	12.4	32.8	14.4	78.3	25.6	25.1	15.3	9.3	5.1	24.1	20.5	5.2	9.8	13.5	23.2	14.0	40.8	19.1	9.7	0.0	13.7	21.8	25.2	22.7	23.1	10.6	14.4	11.1	18.3	15.4	13.0	15.6	25.0	16.4	15.1	9.0	19.9	18.5	12.5	14.4	18.4	15.4	23.6	6.5	21.7	45.1	42.1	28.5	15.6	27.7	19.5	19.2
ZCCHC8	DKFZp434E2220	ENSG00000033030	"Zinc finger CCHC-type containing 8"	Q6NZY4	12	122471600-122501073	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cone photoreceptor cells: 117.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037483, HPA037484"	Supported		Enhanced	Nucleoplasm		NA	NA		130000	Nucleoplasm		"HPA037483: AB_10671502, HPA037484: AB_10672485"	"unprognostic (1.96e-3)"	"unprognostic (8.48e-2)"	"unprognostic (5.55e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (7.40e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.36e-4)"	"unprognostic (8.86e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.48e-2)"	13.6	11.9	12.8	15.0	14.2	44.3	13.9	25.5	17.6	15.8	11.7	9.6	19.3	11.1	16.0	10.9	14.3	13.7	9.5	9.0	11.7	6.3	10.6	14.0	11.9	12.2	12.4	7.2	17.3	16.4	14.2	21.8	13.2	9.9	13.3	10.9	10.4	13.6	15.1	21.7	14.9	13.9	14.0	12.8	14.5	13.8	14.5	14.4	19.5	15.8	10.5	17.3	14.6	13.3	10.5	6.8	9.0	8.8	10.0	12.5	5.4	11.6	11.5	17.1	17.6	7.5	10.4	21.8	14.0	9.6	18.8	14.5	10.9	10.1	21.4	9.5	6.0	10.2	14.4	19.1	8.9	16.0	17.3	11.0	13.2	12.7	9.7	18.1	22.7	14.3	8.3	13.5	11.8	16.3	15.5	10.0	20.3	19.1	12.9	9.1	7.5	16.2	17.5	15.4	8.7	13.1	17.9	14.1	16.7	9.1	6.7	12.0	12.9	16.5	8.6	19.0	17.6	15.7	17.2	10.1	11.8	11.6	10.3	14.0	13.8	8.0	28.4	6.2	14.1	6.8	9.0	7.2	4.7	8.9	8.6	8.9	10.5	9.9	10.6	6.8	9.4	11.0	9.0	5.7	10.0	8.8	6.6	12.5	5.4	12.8	14.2	25.5	17.6	11.7	6.3	12.4	7.2	9.9	14.4	29.8	16.9	24.1	26.0	18.2	28.5	8.1	20.4	18.7	37.5	8.7	117.8	14.9	1.7	9.8	63.3	15.8	12.7	23.3	8.3	14.2	15.5	18.3	18.5	13.4	11.2	14.3	18.8	10.4	12.3	37.2	13.8	18.1	15.1	17.2	14.0	16.4	12.1	11.5	13.8	5.7	66.5	6.5	17.5	31.1	11.9	22.5	27.0	17.0	14.0	19.2
ZDHHC22	C14orf59	ENSG00000177108	"Zinc finger DHHC-type containing 22"	Q8N966	14	77131270-77142734	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 52.3"	"Cell type enhanced"	"Detected in some"	25	"Bipolar cells: 9.9;Cone photoreceptor cells: 3.9;Late spermatids: 3.3"	"Cancer enriched"	"Detected in single"	40	"glioma: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 5.3;NTERA-2: 5.6;RH-30: 9.4;SCLC-21H: 10.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA049471, HPA072213"			Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA049471: AB_2732553, HPA072213: AB_2686496"	"unprognostic (1.02e-1)"	"unprognostic (3.42e-1)"		"unprognostic (1.22e-4)"	"unprognostic (1.66e-1)"	"unprognostic (8.86e-2)"		"unprognostic (2.68e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.94e-4)"	"unprognostic (3.05e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.02e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.79e-1)"	1.1	1.5	11.2	1.1	12.6	1.1	1.1	8.4	52.3	1.1	1.2	6.7	0.0	1.1	1.1	1.4	1.3	1.2	1.1	1.2	14.5	18.4	1.1	1.1	1.1	1.1	10.7	19.5	1.1	1.1	1.1	3.1	1.1	9.2	1.1	1.3	0.5	1.1	1.1	1.3	1.1	1.1	1.2	3.6	1.1	1.3	1.4	5.1	0.0	1.3	0.0	1.1	1.4	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	5.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	5.6	0.0	0.7	0.0	9.4	0.0	0.0	0.0	10.4	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	11.2	12.6	8.4	29.5	14.5	18.4	10.7	19.5	9.2	5.1	0.0	0.0	0.0	0.0	0.0	9.9	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
ZFPL1	"D11S750, MCG4"	ENSG00000162300	"Zinc finger protein like 1"	O95159	11	65084223-65088400	"Predicted intracellular proteins, Predicted membrane proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014909, HPA017347"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA014909: AB_1859055, HPA017347: AB_1859056"	"unprognostic (2.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.12e-6)"	"unprognostic (1.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.63e-1)"	"unprognostic (7.34e-2)"	"prognostic favorable (2.73e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.34e-2)"	"unprognostic (6.94e-2)"	22.2	23.6	20.9	17.3	25.0	34.9	20.4	17.3	31.8	19.1	23.2	30.6	24.9	24.7	23.6	27.6	24.5	26.3	24.1	26.5	21.6	18.4	21.8	28.8	16.2	15.4	29.1	19.2	26.4	40.0	16.9	30.4	33.0	21.2	22.4	14.0	23.1	38.4	25.7	33.0	24.2	26.4	18.5	21.6	18.6	24.7	28.5	23.7	17.7	26.0	22.0	21.6	24.5	18.7	11.1	11.6	33.1	12.2	12.2	13.9	6.5	27.1	19.0	12.0	12.6	10.7	15.3	19.2	12.9	15.9	15.2	12.0	12.7	19.0	9.4	25.7	18.3	14.9	14.8	6.9	15.8	5.3	13.6	12.8	9.7	14.7	26.1	23.2	7.4	13.1	14.3	21.3	11.4	19.8	9.9	14.4	14.9	11.5	14.6	11.3	38.3	11.3	16.2	8.2	9.0	16.8	10.5	6.9	24.2	11.8	13.6	13.1	11.2	10.3	19.6	28.0	6.2	29.0	11.6	14.0	10.2	17.1	22.2	10.4	10.2	9.9	11.6	15.8	6.9	19.0	33.1	11.5	23.0	9.2	12.2	9.7	10.7	8.6	9.5	11.6	11.1	9.6	8.5	15.9	12.2	11.0	10.9	13.9	6.5	20.9	25.0	17.3	31.8	21.6	18.4	29.1	19.2	21.2	23.7	11.9	13.6	9.0	25.8	9.7	19.8	4.8	20.4	14.7	18.2	12.2	3.9	42.8	49.7	31.7	12.8	15.1	46.4	0.0	42.1	37.6	17.3	30.4	9.2	17.9	28.0	22.3	21.9	17.2	17.0	35.7	19.0	12.7	16.9	32.5	35.3	31.0	35.7	37.4	19.1	20.5	16.1	19.4	16.5	24.7	16.8	10.9	57.1	12.5	33.9	26.5
ZFYVE16	"KIAA0305, PPP1R69"	ENSG00000039319	"Zinc finger FYVE-type containing 16"	Q7Z3T8	5	80408013-80479350	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 17.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 17.3"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035935, HPA035936"	Supported		Enhanced	Vesicles,Cytosol		No	No			"Vesicles, Cytosol"		"HPA035935: AB_10672076, HPA035936: AB_10669662"	"unprognostic (1.11e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.00e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.91e-2)"	"unprognostic (4.23e-2)"	10.7	11.9	11.0	10.1	28.9	6.1	11.6	14.9	19.2	21.2	9.0	33.2	7.7	6.7	17.0	6.6	9.6	9.7	14.6	17.6	11.7	9.5	13.1	13.3	11.6	6.8	25.7	16.8	16.8	7.1	13.4	15.0	16.5	37.3	11.5	8.4	9.0	8.6	9.3	12.7	6.4	8.7	12.8	26.9	11.2	8.4	11.7	21.2	3.8	12.6	4.6	5.8	12.8	10.8	2.5	2.3	17.3	3.9	2.4	1.5	0.3	5.8	6.8	12.2	11.7	7.3	7.7	8.1	9.0	7.8	8.1	10.9	5.0	6.7	4.0	6.5	7.4	8.4	6.1	8.7	7.3	8.9	2.5	5.7	4.3	9.3	5.7	6.2	1.2	3.2	8.3	4.1	6.7	6.5	6.4	9.2	3.8	4.2	6.2	8.7	7.3	2.8	1.2	2.9	2.9	3.2	5.9	25.3	4.2	6.9	11.4	4.6	10.6	12.9	6.1	42.4	7.8	8.6	4.0	8.1	4.9	5.6	7.5	7.4	1.9	3.5	4.0	6.4	4.0	10.8	11.5	3.7	1.8	1.5	2.3	0.8	2.5	0.7	1.3	1.4	2.5	0.6	0.7	17.3	2.4	3.9	2.3	0.8	0.3	11.0	28.9	14.9	19.2	11.7	9.5	25.7	16.8	37.3	21.2	23.8	20.3	13.7	11.1	16.3	81.4	44.9	5.1	53.5	40.9	29.6	108.0	16.6	8.3	13.3	3.9	24.3	16.0	0.0	10.8	9.1	22.0	16.9	9.3	14.3	23.4	76.3	20.7	36.2	49.4	4.5	35.1	47.5	18.6	9.0	11.1	33.5	13.2	20.1	41.8	10.3	75.1	32.3	29.5	32.6	20.5	22.2	31.2	13.8	11.2	15.7
ZFYVE9	"MADHIP, PPP1R173, SARA, SMADIP"	ENSG00000157077	"Zinc finger FYVE-type containing 9"	O95405	1	52142094-52346686	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatogonia: 53.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017702, HPA065852, HPA065862"	Approved		Enhanced	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"CAB017702: AB_1128462, HPA065852: AB_2685568, HPA065862: AB_2685570"	"unprognostic (5.05e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.51e-1)"	"unprognostic (7.15e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.87e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.73e-2)"	10.2	10.0	13.6	3.8	18.4	1.0	13.0	28.4	27.7	15.5	8.0	9.5	10.1	6.8	14.1	9.1	10.8	12.2	8.1	10.4	13.8	15.7	15.2	10.7	11.3	4.1	13.8	15.8	19.5	16.9	32.3	14.6	7.4	18.7	13.6	9.9	9.6	9.8	13.8	25.5	12.3	7.4	13.3	11.6	4.2	8.6	14.9	8.0	1.5	19.5	8.8	4.2	10.9	13.8	0.4	0.0	0.0	0.0	0.2	2.1	0.4	9.8	4.7	6.8	8.7	16.7	15.0	11.1	8.1	11.1	9.7	11.1	5.5	0.8	0.0	5.0	11.5	13.4	3.6	12.0	13.0	14.9	0.0	8.2	2.8	5.4	6.5	11.1	2.5	1.7	10.1	14.8	8.4	19.2	12.0	14.0	6.7	4.3	1.8	12.9	2.2	3.5	1.8	8.8	2.7	8.3	3.1	11.6	0.9	5.5	22.2	5.7	5.9	9.0	7.8	10.4	14.3	3.6	3.3	12.9	9.8	3.9	7.4	4.8	2.5	1.5	1.2	6.9	3.1	3.9	0.0	0.0	0.0	0.3	0.0	2.1	0.3	1.6	0.4	0.0	0.4	1.3	0.7	0.0	0.2	0.0	0.0	0.0	0.4	13.6	18.4	28.4	27.7	13.8	15.7	13.8	15.8	18.7	8.0	8.9	5.1	0.0	9.7	4.5	19.7	10.9	5.1	2.7	14.8	1.8	3.9	3.5	6.6	5.2	12.6	7.9	5.6	0.0	6.4	4.8	5.2	6.5	1.1	6.8	0.4	22.3	16.8	3.7	1.2	10.3	14.1	0.5	6.8	0.0	8.1	12.2	4.3	8.2	15.6	8.2	14.1	12.9	5.8	27.1	53.7	6.5	2.4	2.1	5.2	5.7
ZHX2	KIAA0854	ENSG00000178764	"Zinc fingers and homeoboxes 2"	Q9Y6X8	8	122781394-122974512	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 24.1;REH: 25.8;U-698: 24.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006769, HPA006996"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006769: AB_10669919, HPA006996: AB_10670555"	"unprognostic (8.28e-2)"	"unprognostic (3.80e-3)"	"unprognostic (6.48e-2)"	"unprognostic (6.90e-2)"	"unprognostic (8.19e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.61e-3)"	"unprognostic (3.04e-1)"	11.3	12.4	14.6	26.2	14.8	7.1	12.7	11.1	16.2	15.1	8.2	22.2	9.8	6.0	15.8	10.6	10.8	17.7	13.9	16.3	16.0	9.8	9.7	15.9	13.2	26.8	19.3	10.3	31.5	20.3	10.1	13.5	7.1	12.4	16.9	7.7	12.7	13.4	15.2	31.1	9.3	11.7	13.6	14.3	15.9	8.3	5.2	20.0	17.9	15.3	10.9	24.7	17.7	11.3	12.2	5.4	9.6	1.9	6.9	7.5	3.2	2.6	1.3	7.7	1.5	3.8	1.2	0.0	1.6	5.1	1.8	2.4	0.3	8.9	24.1	6.7	5.3	1.4	2.2	5.1	3.1	2.0	10.8	3.4	11.2	1.7	8.5	4.1	2.7	3.5	3.3	3.7	1.7	9.1	8.7	2.0	4.4	0.4	8.5	2.1	7.6	2.5	2.4	4.2	1.4	1.8	25.8	4.2	1.9	8.5	6.8	3.3	1.9	6.5	19.2	3.2	5.4	3.3	6.0	3.5	1.4	3.7	1.7	3.4	2.2	0.0	24.7	1.4	2.1	2.3	9.6	1.0	5.2	6.9	1.3	7.2	12.2	5.0	6.7	1.2	11.0	7.5	5.9	5.1	6.9	1.9	5.4	5.1	3.2	14.6	14.8	11.1	12.8	16.0	9.8	19.3	10.3	12.4	20.0	6.0	2.9	16.4	4.3	4.8	2.4	8.9	12.7	2.7	1.2	8.7	0.0	0.4	3.3	9.4	7.5	6.7	3.1	0.0	5.5	0.2	7.8	11.8	8.1	9.9	1.7	4.8	4.1	7.4	5.4	1.9	9.8	2.5	10.1	5.4	4.8	12.8	7.0	3.5	18.4	3.7	0.7	0.0	18.1	0.5	0.1	7.8	1.1	15.2	3.4	7.8
ZMYM3	"DXS6673E, KIAA0385, MYM, ZNF198L2, ZNF261"	ENSG00000147130	"Zinc finger MYM-type containing 3"	Q14202	X	71239624-71255146	"Disease related genes, Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA003211, HPA075255"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA003211: AB_1080661, HPA075255: AB_2732287"	"unprognostic (2.17e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (5.18e-4)"	"unprognostic (5.03e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.93e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.30e-3)"	7.3	23.7	22.5	7.9	20.6	6.2	7.9	16.6	22.7	10.8	10.4	13.6	10.3	7.0	14.0	19.2	8.0	19.8	11.3	9.3	19.5	14.6	10.6	9.6	10.8	10.9	16.8	20.6	36.8	8.2	15.3	14.4	7.8	14.0	14.3	8.0	10.5	11.2	18.0	9.5	11.1	8.8	14.8	14.1	12.1	9.0	15.9	17.3	13.9	12.6	6.4	10.4	11.9	10.0	9.4	13.5	6.8	7.3	6.0	6.8	5.0	7.1	13.1	31.8	16.8	9.3	9.4	8.1	6.6	9.9	14.3	13.5	14.4	10.8	18.0	16.5	11.8	13.0	6.7	27.1	10.0	10.9	6.0	14.5	15.7	11.6	12.8	4.3	14.6	9.8	11.0	5.8	10.4	6.5	25.6	12.0	14.6	18.0	10.0	10.5	11.8	17.5	18.7	31.6	8.8	11.5	22.0	9.7	13.3	10.6	8.7	15.2	10.5	11.2	7.0	6.5	24.2	10.3	9.6	9.2	7.1	13.2	10.3	5.9	9.1	5.4	15.4	8.6	20.0	7.8	6.8	7.3	5.6	6.1	6.3	6.8	9.4	6.8	5.6	6.4	9.0	6.0	5.9	0.5	6.0	5.1	13.5	6.3	5.0	22.5	20.6	16.6	22.7	19.5	14.6	16.8	20.6	14.0	17.3	11.9	11.0	1.7	2.2	3.4	12.7	7.3	7.6	2.7	15.9	29.6	9.8	6.9	1.7	5.6	1.0	7.2	3.9	0.0	7.7	5.0	5.1	1.7	2.3	13.1	8.3	12.7	4.6	5.5	11.1	3.1	12.7	6.3	3.3	12.6	8.2	11.6	6.5	10.2	21.9	11.8	7.1	6.5	4.4	1.4	3.6	3.3	3.5	4.3	8.2	1.3
ZNF131	"pHZ-10, ZBTB35"	ENSG00000172262	"Zinc finger protein 131"	P52739	5	43065176-43192021	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007023, HPA027748, HPA074630"	Approved		Enhanced	"Nucleoplasm,Intermediate filaments"		No	No			Nucleoplasm	"Intermediate filaments"	"HPA007023: AB_2667726, HPA027748: AB_2672374, HPA074630: AB_2686705"	"unprognostic (1.23e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.84e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (2.52e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.94e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.76e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.46e-2)"	16.0	14.3	15.0	18.6	16.7	24.3	20.3	24.8	18.5	18.9	13.0	10.6	10.3	10.0	19.3	10.3	15.3	13.4	13.3	10.8	15.1	13.0	12.3	14.8	12.6	21.6	12.8	14.6	21.6	16.1	13.9	17.3	20.0	14.2	13.9	13.8	8.1	11.9	16.0	16.5	18.2	12.9	16.5	11.9	16.1	12.5	31.0	13.0	27.2	15.5	15.3	17.2	15.5	18.0	13.0	8.9	7.9	7.1	11.7	18.3	7.4	10.5	6.5	14.2	18.8	13.5	9.3	12.0	14.0	11.5	14.0	11.9	10.1	9.5	21.4	11.5	9.4	13.1	7.6	16.7	8.9	19.9	10.4	14.8	13.2	37.4	7.5	12.4	22.8	10.8	8.4	17.0	10.3	16.9	10.0	10.6	16.8	16.8	23.0	15.9	10.3	22.3	28.8	9.4	9.9	10.8	14.8	21.6	16.7	11.8	10.4	8.8	12.9	35.9	17.4	18.0	10.0	9.7	21.8	7.9	17.7	16.4	9.0	13.1	9.3	13.1	24.5	9.3	30.1	11.7	7.9	6.1	4.1	15.0	7.1	15.3	10.1	14.9	14.5	8.9	13.0	18.3	14.6	3.1	11.7	4.8	8.5	10.8	7.4	15.0	16.7	24.8	18.5	15.1	13.0	12.8	14.6	14.2	13.0	20.8	18.7	38.9	47.9	44.1	49.5	17.3	15.3	17.4	18.2	8.7	49.1	22.3	26.6	12.1	29.7	27.5	27.7	0.0	10.3	21.3	29.8	30.2	23.1	10.9	14.4	36.5	30.0	23.9	22.5	12.8	19.0	31.2	20.3	22.6	19.5	24.0	13.8	24.6	19.8	9.8	60.6	25.8	37.3	81.7	71.0	57.2	21.3	41.7	27.6	33.9
ZNF207		ENSG00000010244	"Zinc finger protein 207"	O43670	17	32350117-32381886	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Chromosome partition, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017013, HPA063908"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA017013: AB_1859124, HPA063908: AB_2685149"	"unprognostic (8.40e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (7.30e-8)"	"unprognostic (2.68e-1)"	"unprognostic (4.75e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (4.17e-8)"	"unprognostic (1.28e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.04e-1)"	41.0	36.7	29.7	42.6	29.9	101.0	37.1	51.0	35.2	40.1	33.2	39.1	31.0	26.9	44.3	37.5	61.0	35.4	29.5	32.5	25.8	24.4	33.3	33.7	40.3	45.6	35.4	25.5	43.9	31.3	38.4	53.1	52.5	28.4	32.5	41.3	37.7	42.1	31.4	42.4	39.7	34.9	39.0	41.4	41.8	34.7	32.7	33.8	74.9	35.6	46.5	60.4	42.0	43.1	28.3	45.7	39.6	39.1	36.9	38.8	35.6	37.8	46.6	50.5	28.4	27.1	29.3	40.5	38.0	53.6	54.1	48.7	44.3	36.3	52.2	29.4	46.6	42.0	39.2	65.1	46.0	61.2	26.8	43.6	53.5	42.7	45.5	28.4	67.7	49.2	33.8	27.7	37.9	21.2	30.5	49.9	26.6	54.2	40.3	51.8	34.6	54.1	31.8	43.5	36.3	26.6	48.7	45.3	48.7	44.6	74.1	35.4	39.5	35.7	26.3	33.5	45.2	47.5	40.3	35.2	30.6	36.4	31.0	51.3	34.5	51.1	83.4	26.1	32.2	47.3	39.6	34.2	34.3	33.0	38.4	34.1	28.3	30.4	30.3	45.7	22.1	25.7	29.3	17.7	36.9	39.1	21.6	38.8	35.6	29.7	29.9	51.0	35.2	25.8	24.4	35.4	25.5	28.4	33.8	74.5	102.5	74.9	153.6	132.7	131.5	29.5	58.6	99.0	149.0	61.1	212.1	105.3	46.4	78.7	38.1	90.4	96.3	46.7	92.1	139.6	97.2	143.7	71.8	51.6	86.8	95.3	111.3	88.4	95.4	18.3	99.2	106.7	52.3	121.8	73.1	61.6	105.4	86.5	91.9	39.8	151.1	122.9	93.9	117.2	108.3	129.7	149.4	101.5	89.7	220.0
ZNF217	ZABC1	ENSG00000171940	"Zinc finger protein 217"	O75362	20	53567065-53609907	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 65.5"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 114.7;Suprabasal keratinocytes: 93.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 50.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051857	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA051857: AB_2681641"	"unprognostic (4.17e-2)"	"unprognostic (4.05e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.17e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.87e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.52e-2)"	9.9	3.0	3.6	9.3	2.9	10.9	15.0	2.2	3.1	7.6	6.7	3.1	6.1	4.5	6.2	2.9	10.0	5.7	5.7	5.4	3.4	1.6	6.3	10.3	8.8	20.9	3.0	2.3	6.1	7.1	8.3	3.9	65.5	4.8	7.1	6.8	5.7	11.0	8.6	5.2	11.9	8.9	6.6	3.4	16.8	6.7	9.9	2.4	16.7	6.9	4.9	9.5	10.6	8.6	4.3	4.1	19.4	11.5	5.8	3.6	2.2	9.2	11.0	9.3	13.5	8.7	10.0	20.4	10.4	10.7	11.8	5.9	7.1	10.4	9.0	11.2	12.6	15.3	9.1	7.4	10.9	13.7	6.4	2.1	2.9	4.8	12.3	6.8	4.6	12.5	5.4	10.6	6.3	17.6	9.3	6.7	9.4	6.3	42.8	8.8	36.9	16.0	10.3	9.8	5.3	11.0	12.6	7.8	10.4	6.8	20.7	0.9	2.6	9.6	50.0	10.1	12.3	14.9	19.8	4.7	23.9	8.9	12.2	12.7	17.8	19.7	7.6	8.7	5.3	7.6	5.9	4.9	8.4	2.8	6.3	3.6	4.3	3.0	3.5	3.9	3.9	3.4	3.3	19.4	5.8	11.5	4.1	2.9	2.2	3.6	2.9	2.2	3.1	3.4	1.6	3.0	2.3	4.8	2.4	0.0	10.1	12.3	36.1	114.7	0.6	7.5	15.3	22.7	14.8	17.4	0.0	11.9	8.3	23.0	36.2	14.6	32.6	23.3	14.3	14.2	18.3	61.3	11.5	24.3	13.3	0.0	5.8	16.0	38.2	20.0	6.4	34.4	20.3	6.4	27.1	2.0	19.8	28.1	4.9	9.6	0.5	0.0	8.6	5.4	24.0	93.3	37.8	20.8	21.0	72.7
ZNF22	"HKR-T1, KOX15, Zfp422, ZNF422"	ENSG00000165512	"Zinc finger protein 22"	P17026	10	45000475-45005326	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA016736, HPA054893"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016736: AB_1859133, HPA054893: AB_2682632"	"unprognostic (2.87e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-3)"	"unprognostic (3.42e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.31e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (1.11e-5)"	"prognostic unfavorable (8.06e-4)"	"unprognostic (1.39e-1)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-2)"	28.5	7.9	15.3	14.5	14.0	12.4	38.6	13.5	13.7	15.7	12.1	9.9	14.7	10.8	18.0	14.0	11.4	15.1	10.5	14.7	14.2	13.0	17.0	22.8	14.1	19.9	14.9	10.2	21.6	29.2	5.5	11.1	22.6	13.6	18.1	12.5	10.2	12.9	11.9	14.0	6.2	13.1	13.9	15.6	17.8	12.4	9.0	14.5	40.1	25.4	11.7	19.1	12.2	12.1	19.8	24.7	13.4	10.9	25.2	25.2	13.6	11.5	1.8	16.2	10.0	8.6	6.2	0.1	5.4	11.1	13.9	15.1	6.4	9.7	11.9	8.9	8.0	3.1	1.9	15.5	5.7	19.8	7.4	0.2	12.4	3.0	0.0	18.0	24.0	4.3	11.0	8.4	5.7	0.2	0.1	21.9	32.6	16.2	21.6	10.9	0.3	44.6	36.3	9.7	6.6	3.2	32.9	22.5	16.8	10.8	9.7	15.7	13.5	4.9	9.9	8.0	15.5	2.1	24.1	12.1	10.2	18.8	7.1	18.1	12.4	12.1	11.4	6.5	0.9	10.8	8.0	10.9	13.4	21.0	10.3	25.2	16.0	13.7	21.6	14.3	19.8	18.9	23.1	1.1	25.2	6.5	24.7	7.7	13.6	15.3	14.0	13.5	13.7	14.2	13.0	14.9	10.2	13.6	14.5	26.8	20.6	39.5	55.7	17.1	32.7	8.9	53.5	41.5	30.7	31.4	9.8	60.0	48.0	50.3	2.7	58.3	4.5	46.7	37.4	50.1	50.3	45.8	31.3	47.9	42.0	36.5	38.4	77.3	24.7	2.4	41.1	26.9	18.6	74.9	34.1	47.6	36.1	10.5	48.1	37.2	30.4	32.3	36.2	37.5	34.5	11.5	44.5	30.5	34.2	25.9
ZNF266	HZF1	ENSG00000174652	"Zinc finger protein 266"	Q14584	19	9412598-9435578	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 46.5"									"HPA026836, HPA054110"	Uncertain		Supported	"Nucleoplasm,Vesicles,Rods & Rings"		NA	NA			Vesicles	"Nucleoplasm, Rods & Rings"	"HPA026836: AB_2672018, HPA054110: AB_2682383"	"unprognostic (2.50e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.60e-2)"	"prognostic favorable (3.94e-6)"	"unprognostic (1.72e-2)"	"prognostic favorable (4.47e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.00e-3)"	"prognostic favorable (3.03e-5)"	"unprognostic (2.92e-3)"	"prognostic unfavorable (1.82e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.56e-2)"	"prognostic favorable (9.15e-5)"	14.7	12.1	11.0	21.5	12.5	12.8	17.6	19.0	10.0	21.8	15.7	13.1	9.6	8.6	17.2	55.8	12.7	14.6	12.8	11.7	8.2	5.4	10.9	10.4	15.8	21.0	14.5	4.9	18.9	11.2	12.5	19.8	13.0	11.4	23.8	15.7	14.4	14.4	13.5	9.3	19.1	20.8	17.0	10.9	31.3	13.5	13.0	11.4	34.6	20.8	7.3	23.4	14.4	14.2	6.9	3.8	5.6	5.5	12.6	13.0	5.1	10.8	2.8	8.1	15.3	5.8	11.3	6.5	12.0	10.2	9.9	16.6	5.8	4.7	12.1	7.7	5.9	3.7	4.1	10.2	6.4	11.9	3.4	16.8	16.6	14.8	8.5	5.2	9.5	10.2	10.7	8.8	5.4	8.3	9.9	8.0	14.5	8.6	0.1	9.2	1.0	13.8	46.5	8.4	4.9	9.1	6.2	8.4	8.4	7.8	13.5	6.9	10.8	5.5	6.5	6.7	8.4	4.8	7.3	7.2	9.3	3.6	14.0	6.1	19.8	26.3	14.4	2.9	9.1	7.0	4.8	4.1	5.6	13.0	4.8	8.5	6.0	7.2	9.2	3.3	6.9	10.6	10.2	3.6	12.6	5.5	3.8	8.7	5.1	11.0	12.5	19.0	10.0	8.2	5.4	14.5	4.9	11.4	11.4	0.0	11.0	14.5	6.3	3.5	8.1	5.0	2.5	4.0	7.9	3.5	11.8	3.8	3.3	4.8	0.7	5.2	6.2	23.3	3.2	2.7	4.7	6.2	11.5	2.5	4.2	7.9	9.1	12.3	11.7	1.4	5.8	7.9	5.0	8.2	6.4	4.3	3.4	5.1	4.2	1.1	9.3	6.5	5.6	3.5	7.8	4.1	3.9	14.1	6.3	5.4
ZNF281	ZBP-99	ENSG00000162702	"Zinc finger protein 281"	Q9Y2X9	1	200404940-200410056	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051228	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051228: AB_2681396"	"unprognostic (3.13e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.23e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	"unprognostic (3.71e-3)"	"unprognostic (8.30e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.99e-2)"	"prognostic unfavorable (2.60e-5)"	"unprognostic (1.26e-2)"	"unprognostic (4.86e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.83e-1)"	8.4	5.7	8.8	11.4	18.3	31.2	8.8	22.4	13.1	8.5	7.9	9.1	4.0	6.2	8.8	4.6	4.6	6.8	11.3	5.2	10.5	9.2	8.1	22.9	9.1	11.4	17.3	8.1	6.7	7.6	7.0	8.7	10.3	12.0	6.1	5.0	4.1	6.4	5.1	7.8	3.1	7.3	9.8	11.2	11.4	7.5	10.0	19.9	19.9	5.9	4.8	12.3	8.8	10.2	7.1	5.3	24.5	5.4	4.7	9.3	2.2	11.0	10.8	15.1	7.0	6.0	8.3	13.2	11.6	18.3	11.7	11.1	10.6	8.7	15.9	6.9	13.2	13.7	7.5	16.2	10.8	14.0	17.1	9.9	12.7	8.2	10.9	6.6	11.6	7.3	8.0	12.1	12.6	13.8	14.9	10.5	8.7	18.3	2.6	11.8	5.2	11.9	7.3	35.1	3.4	9.8	11.3	10.5	9.5	12.0	5.6	5.3	14.1	11.5	7.7	10.1	24.8	15.4	8.5	14.2	21.9	16.4	5.0	12.3	9.9	9.6	20.4	11.6	9.2	11.6	8.4	5.1	18.4	6.6	5.4	6.7	7.1	5.7	6.9	5.1	6.5	9.3	8.1	24.5	4.7	4.9	5.3	6.7	2.2	8.8	18.3	22.4	13.1	10.5	9.2	17.3	8.1	12.0	19.9	59.6	29.3	27.2	21.7	42.7	47.6	12.9	30.6	17.4	23.9	26.2	27.5	11.5	11.6	18.9	2.1	26.6	10.7	23.3	9.2	25.2	20.8	19.3	5.8	62.2	18.0	17.5	25.7	28.3	42.5	0.9	9.2	21.8	21.9	16.2	10.4	17.4	14.8	13.1	7.4	15.8	32.4	12.9	20.8	46.8	38.7	19.8	10.3	27.4	10.6	13.6
ZNF300		ENSG00000145908	"Zinc finger protein 300"	Q96RE9	5	150894392-150904983	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 7.0;Spermatocytes: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 3.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.2;HeLa: 18.9"									"HPA028975, HPA051777"	Uncertain		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Nuclear bodies"		NA	NA			Nucleoplasm	"Nucleoli, Nucleoli rim, Nuclear bodies"	"HPA028975: AB_2672851, HPA051777: AB_2681606"	"unprognostic (5.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.21e-2)"	"unprognostic (3.23e-1)"	"unprognostic (8.62e-2)"	"unprognostic (6.85e-3)"	"prognostic unfavorable (3.21e-6)"	"unprognostic (3.62e-3)"	"unprognostic (2.99e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.50e-2)"	4.5	1.3	4.8	4.0	12.0	3.6	7.2	12.5	6.4	7.4	4.3	5.4	4.1	4.1	11.7	5.3	7.5	5.4	5.4	4.0	7.5	3.2	7.3	1.5	3.0	4.4	8.2	2.4	16.6	7.3	1.0	7.3	2.4	7.4	7.0	4.4	3.6	3.8	3.9	1.5	6.9	5.8	6.4	9.2	5.1	7.1	14.9	9.1	1.5	9.3	2.7	4.4	5.5	6.2	3.8	1.2	1.1	1.5	1.7	1.0	0.8	1.2	2.8	17.2	0.0	1.5	3.6	0.0	4.2	3.3	3.7	5.4	1.4	2.1	0.0	3.7	3.5	11.2	2.5	0.0	9.7	5.8	0.0	5.6	0.0	18.9	2.2	3.1	0.1	0.0	5.5	3.0	7.7	9.1	5.3	6.3	0.1	0.0	9.2	3.7	0.0	0.0	0.8	16.5	0.0	0.0	0.0	2.5	4.9	2.7	3.1	9.7	16.1	9.9	8.6	5.7	10.9	5.7	0.0	2.7	5.0	2.1	3.6	7.6	0.3	0.1	0.0	0.5	0.1	10.3	0.0	0.6	1.1	0.7	1.5	0.1	0.9	1.0	0.0	1.2	3.8	0.7	0.4	0.2	1.7	0.1	0.1	0.0	0.8	4.8	12.0	12.5	6.4	7.5	3.2	8.2	2.4	7.4	9.1	0.0	0.3	0.0	2.5	1.3	3.6	0.4	0.0	0.0	2.3	7.0	0.0	0.7	1.7	2.1	1.3	2.1	0.4	0.0	1.4	1.9	3.0	2.0	0.0	0.2	0.4	0.0	2.9	0.6	0.6	0.5	2.3	0.7	0.0	1.8	0.7	3.9	1.4	0.0	1.1	1.1	4.6	6.5	1.7	6.6	3.8	1.9	0.7	1.3	1.2	2.6
ZNF317		ENSG00000130803	"Zinc finger protein 317"	Q96PQ6	19	9140380-9163424	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042075, HPA048625"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042075: AB_10796471, HPA048625: AB_2680464"	"unprognostic (3.81e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.98e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.70e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.30e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.42e-3)"	14.6	17.2	18.4	22.8	19.4	36.1	30.3	22.0	24.1	15.6	17.2	22.1	12.4	17.9	19.4	19.5	17.8	17.2	16.9	13.1	18.3	16.1	17.5	20.5	17.1	22.2	19.7	15.2	18.8	21.5	22.0	19.9	14.5	14.6	18.2	17.1	17.9	15.3	18.5	14.3	22.0	17.8	16.9	17.0	25.7	18.0	8.7	19.4	27.0	17.0	11.2	23.4	16.2	15.5	19.0	14.4	14.5	15.0	21.7	20.9	12.9	8.6	7.4	8.1	10.8	8.1	7.9	7.0	7.3	11.4	10.0	12.2	8.3	4.6	14.7	9.4	7.5	11.9	8.8	13.2	12.3	13.1	12.1	17.8	12.8	6.7	9.2	11.1	13.5	13.4	9.4	16.8	11.4	19.9	8.7	8.7	13.2	12.0	17.1	10.0	7.2	17.0	43.6	15.1	9.2	15.9	12.1	10.2	11.8	8.7	14.7	14.0	9.6	10.1	9.0	11.3	7.3	6.7	14.4	7.7	7.1	6.5	16.1	9.6	21.6	20.6	16.7	6.9	12.0	9.1	13.9	14.1	14.5	13.6	15.0	20.9	19.0	17.9	15.4	14.4	16.0	17.1	18.5	8.8	21.7	11.9	13.2	20.8	12.9	18.4	19.4	22.0	24.1	18.3	16.1	19.7	15.2	14.6	19.4	8.9	12.0	9.8	6.8	6.5	6.5	5.9	12.7	12.0	12.5	5.2	5.9	4.4	3.3	4.6	0.6	7.1	5.7	0.0	5.5	4.3	5.2	7.0	12.8	9.8	7.0	7.9	6.9	5.5	12.7	1.3	3.4	9.5	5.0	3.6	7.2	4.0	6.8	3.5	3.5	7.7	4.8	0.0	5.2	2.1	1.1	5.6	9.2	13.8	9.2	8.9
ZNF326	"FLJ20403, ZAN75, Zfp326, ZIRD"	ENSG00000162664	"Zinc finger protein 326"	Q5BKZ1	1	89995112-90035531	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 134.9;Cone photoreceptor cells: 351.5;Rod photoreceptor cells: 448.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028450, HPA028461, HPA028466"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA028450: AB_2672616, HPA028461: AB_10601777, HPA028466: AB_10601677"	"prognostic favorable (9.46e-4)"	"unprognostic (2.45e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.67e-2)"	"unprognostic (8.61e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.62e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.84e-4)"	12.7	13.4	18.4	12.7	27.8	45.2	17.7	20.2	18.5	11.8	14.1	23.2	16.3	18.5	18.3	17.1	17.5	11.9	13.9	12.5	19.2	15.2	13.4	15.2	11.5	15.3	26.1	14.1	21.8	20.2	14.4	18.0	14.5	22.8	13.3	20.7	23.9	15.7	9.4	19.2	14.5	18.9	17.8	31.3	11.0	14.6	10.6	27.8	17.3	14.1	10.5	15.1	11.9	17.2	6.8	8.4	3.6	6.1	7.8	4.3	2.2	17.2	15.8	24.6	11.7	11.0	5.2	26.0	17.5	6.8	14.5	9.1	14.6	12.6	21.6	12.5	9.0	16.0	15.6	25.6	11.4	20.0	12.6	12.3	19.5	15.4	13.3	3.7	22.9	9.6	4.6	5.4	14.4	9.2	10.2	8.4	10.1	26.0	9.4	11.7	8.2	23.6	13.0	23.1	14.6	18.0	16.8	24.9	5.8	12.0	19.4	21.6	14.0	20.1	18.7	8.5	18.2	10.3	6.0	11.4	17.1	17.2	14.4	17.3	8.0	7.9	21.6	4.1	18.1	10.9	2.1	5.1	3.6	4.0	6.1	3.2	4.2	3.2	3.4	4.0	6.8	3.2	4.3	2.5	7.8	4.6	8.4	2.8	2.2	18.4	27.8	20.2	18.5	19.2	15.2	26.1	14.1	22.8	27.8	20.8	44.0	32.0	53.5	57.9	134.9	34.4	15.3	45.5	44.3	22.7	351.5	36.5	16.6	45.3	3.4	38.7	63.7	0.0	48.0	73.0	29.8	46.9	48.7	28.0	22.6	65.2	67.4	24.5	16.4	4.2	40.0	32.7	37.1	46.9	33.4	49.5	37.7	66.6	31.8	14.7	448.1	25.8	38.7	58.0	40.9	39.5	41.3	22.4	36.2	68.1
ZNF335	"bA465L10.2, NIF-1"	ENSG00000198026	"Zinc finger protein 335"	Q9H4Z2	20	45948653-45972172	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease mutation, Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063999, HPA071230"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063999: AB_2685170, HPA071230: AB_2686369"	"unprognostic (1.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.29e-3)"	"unprognostic (7.85e-2)"	"unprognostic (1.35e-2)"	"prognostic favorable (4.48e-4)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.74e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.30e-3)"	"prognostic unfavorable (7.04e-4)"	"prognostic unfavorable (2.77e-5)"	"unprognostic (4.10e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.44e-1)"	"unprognostic (2.88e-3)"	10.5	8.3	12.0	12.2	13.6	28.8	10.7	17.9	15.7	10.5	10.3	9.7	4.0	11.5	14.2	5.2	11.2	12.3	8.2	7.0	10.7	5.0	8.6	7.8	10.4	15.0	8.1	11.6	15.2	10.5	13.2	10.4	13.7	8.2	10.7	6.7	8.4	12.0	9.2	12.3	22.9	13.5	7.9	7.6	13.9	10.6	16.5	10.1	19.4	14.9	8.8	12.0	11.4	9.5	3.7	3.6	5.0	4.5	8.9	7.3	3.5	9.1	9.3	8.3	9.0	4.4	5.6	17.7	8.2	5.7	8.2	5.9	20.1	10.3	11.0	12.2	8.0	7.5	13.2	8.0	12.3	3.7	7.5	10.9	9.1	13.6	10.6	6.9	11.8	15.6	9.0	10.5	10.7	7.7	5.9	7.0	11.6	8.6	14.8	5.6	18.6	13.9	11.5	5.7	6.2	15.4	11.5	5.5	9.2	7.2	14.4	8.4	7.4	12.2	17.2	8.6	5.2	13.0	9.8	7.3	17.7	7.7	11.2	11.1	17.3	8.8	11.4	14.3	7.4	9.7	2.4	3.5	5.0	7.3	4.5	3.7	3.3	3.6	4.9	3.6	3.7	3.1	3.4	3.6	8.9	3.6	2.5	3.6	3.5	12.0	13.6	17.9	15.7	10.7	5.0	8.1	11.6	8.2	10.1	11.9	15.9	11.8	11.4	16.7	17.4	2.8	2.5	1.4	4.5	1.8	25.5	7.2	0.0	3.9	22.2	8.3	13.7	0.0	5.1	7.0	7.8	9.9	6.9	5.7	5.3	12.7	20.6	7.4	6.4	17.7	6.9	10.2	8.5	2.8	9.2	5.8	6.6	10.5	4.9	1.9	11.1	0.0	8.6	3.7	8.3	19.6	10.0	16.2	9.1	11.4
ZNF34	KOX32	ENSG00000196378	"Zinc finger protein 34"	Q8IZ26	8	144773114-144787345	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA053925, HPA060755, HPA066805"	Uncertain		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			Nucleoplasm	Cytosol	"HPA053925: AB_2682311, HPA060755: AB_2684354, HPA066805: AB_2685725"	"unprognostic (2.54e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.01e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.40e-2)"	"unprognostic (9.84e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.46e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	9.0	5.7	12.3	4.1	11.5	4.6	8.6	28.5	14.4	10.0	9.4	12.6	7.8	3.6	10.0	8.0	6.3	10.4	6.6	7.5	13.4	7.8	6.4	6.5	7.5	5.8	17.2	13.8	17.0	7.8	12.5	11.5	7.6	12.2	8.7	6.0	8.3	5.6	12.7	5.9	8.0	5.4	10.7	11.8	6.0	5.9	7.1	16.0	4.1	11.1	1.8	4.7	8.7	7.8	7.2	10.4	12.7	15.2	5.5	8.5	5.0	3.0	5.3	8.9	6.6	7.6	7.4	2.4	2.9	6.2	7.3	6.1	1.2	5.1	5.0	5.5	7.3	4.2	3.1	5.1	5.8	5.5	4.9	4.3	9.6	8.2	4.0	6.9	2.5	5.0	7.9	6.8	5.8	11.9	7.5	4.9	3.2	6.4	4.1	6.3	7.8	5.5	3.9	6.4	7.1	5.6	5.0	3.6	6.0	4.1	3.1	8.4	6.3	6.7	4.7	4.5	5.9	5.3	3.2	3.5	6.7	5.9	5.6	5.6	5.1	1.7	5.7	4.9	4.1	8.0	8.1	7.0	12.7	7.4	6.4	6.5	6.8	6.9	8.5	10.4	7.2	4.9	7.4	1.0	5.5	15.2	4.9	5.4	5.0	12.3	11.5	28.5	14.4	13.4	7.8	17.2	13.8	12.2	16.0	6.0	3.2	0.9	1.5	3.3	7.1	2.0	0.0	1.4	4.5	0.0	0.0	2.2	5.0	2.7	6.0	4.9	1.3	0.0	1.2	2.1	3.3	1.5	4.7	2.4	1.6	12.7	0.0	3.7	1.9	5.5	6.6	3.1	3.3	12.6	1.9	5.4	1.2	1.9	4.6	1.4	8.7	6.5	4.7	9.3	6.3	4.3	1.9	4.1	2.3	0.7
ZNF394	"FLJ12298, ZKSCAN14, ZSCAN46"	ENSG00000160908	"Zinc finger protein 394"	Q53GI3	7	99486519-99500324	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 77.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051421, HPA054639"	Uncertain		Enhanced	Nucleoplasm,Cytosol		Yes	No			Nucleoplasm	Cytosol	"HPA051421: AB_2681479, HPA054639: AB_2682553"	"prognostic favorable (3.56e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.83e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (2.11e-4)"	"unprognostic (3.62e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.70e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.42e-1)"	"prognostic favorable (1.09e-4)"	11.3	8.3	10.0	11.5	11.8	77.5	12.2	16.4	13.2	10.8	10.9	11.7	8.8	10.7	11.0	7.7	12.2	11.2	9.3	10.4	7.9	6.2	9.4	9.5	12.6	12.2	11.2	6.6	14.3	12.0	7.9	16.2	8.4	9.7	13.0	9.1	10.1	10.1	9.0	14.8	13.6	13.5	9.1	9.1	19.1	10.9	9.5	11.0	15.6	11.4	8.8	17.5	11.9	11.6	17.6	22.3	31.6	17.0	24.3	29.3	17.0	7.8	7.8	5.3	11.1	8.2	5.6	10.5	6.7	8.9	7.8	7.6	8.2	8.7	9.4	9.7	6.9	11.0	7.6	7.1	8.5	7.7	6.8	9.4	9.2	9.3	9.0	6.6	13.1	16.1	7.4	7.4	7.6	8.1	5.8	8.9	8.4	13.2	18.7	7.1	14.7	13.5	21.5	11.8	9.8	9.4	7.7	5.8	16.3	8.4	11.2	6.3	13.1	7.8	19.0	12.6	13.5	4.9	16.3	9.3	9.5	9.5	13.6	8.3	15.4	16.1	15.2	6.7	13.3	9.9	31.6	14.3	24.1	23.1	17.0	24.2	17.6	23.6	25.0	15.6	17.2	29.3	23.1	26.3	24.3	16.7	22.3	25.2	17.0	10.0	11.8	16.4	13.2	7.9	6.2	11.2	6.6	9.7	11.0	14.9	22.4	32.0	29.5	31.6	8.1	7.0	2.5	20.1	11.4	10.4	11.8	13.3	14.9	13.3	5.6	16.9	25.5	0.0	12.4	14.8	17.4	23.7	57.7	10.5	16.3	14.3	20.0	12.9	22.1	1.1	14.4	20.8	27.0	15.4	14.7	12.4	14.1	18.6	12.7	9.5	10.6	12.9	17.0	42.5	30.3	31.0	24.8	44.5	15.8	52.9
ZNF423	"Ebfaz, JBTS19, KIAA0760, NPHP14, OAZ, Roaz, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease mutation, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	12	"Late spermatids: 47.7;Leydig cells: 25.6;Peritubular cells: 51.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.6"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;NTERA-2: 12.6;REH: 10.7;SCLC-21H: 13.4;SH-SY5Y: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	10.8	4.1	10.3	3.0	8.8	0.9	7.3	9.1	9.0	14.3	4.8	7.7	6.8	2.2	10.0	9.4	6.7	14.0	9.3	9.1	8.8	9.5	1.9	1.5	6.7	3.7	8.6	7.2	13.6	4.2	5.3	4.7	5.8	7.5	12.2	4.0	14.5	4.0	13.8	28.7	2.4	3.3	9.3	5.6	2.2	2.6	7.1	7.7	0.0	4.9	11.0	2.2	5.3	7.1	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	24.7	1.3	2.0	0.3	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.0	1.6	0.0	0.1	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.8	0.2	12.6	0.0	0.0	10.7	0.0	0.0	0.0	0.7	13.4	40.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	10.3	8.8	9.1	8.8	8.8	9.5	8.6	7.2	7.5	7.7	0.0	0.0	0.0	0.2	2.4	8.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.2	14.5	9.1	0.4	0.0	0.2	0.6	10.8	0.1	0.0	0.8	0.6	0.0	0.0	12.9	0.3	47.7	25.6	0.2	1.7	0.0	1.3	7.5	0.2	0.0	51.2	0.0	1.0	0.0	6.4	0.5	0.6	1.5	0.2	0.0	0.4	0.0
ZNF432	KIAA0798	ENSG00000256087	"Zinc finger protein 432"	O94892	19	52031379-52095738	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 25.4;Rod photoreceptor cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA052082, HPA060274, HPA065606"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA052082: AB_2681719, HPA060274: AB_2684238, HPA065606: AB_2685518"	"unprognostic (1.62e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.04e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.41e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.49e-3)"	"prognostic unfavorable (6.47e-4)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (4.11e-5)"	8.6	9.8	8.4	5.9	12.5	9.4	9.6	11.0	9.1	14.3	5.9	4.5	6.4	6.4	8.3	12.8	7.2	7.9	5.2	7.0	9.8	5.9	10.1	4.3	6.0	5.6	7.8	7.3	10.8	19.0	8.5	15.5	6.3	8.8	17.4	6.2	7.3	7.5	6.9	4.2	9.7	8.6	6.4	10.8	8.3	6.9	9.3	11.2	8.9	14.0	4.2	5.6	8.2	7.2	5.6	3.0	4.1	4.1	2.5	5.7	2.9	4.3	3.6	9.0	13.2	5.5	6.8	3.0	4.9	4.2	3.8	6.3	2.9	2.6	3.2	1.7	5.6	4.2	3.2	4.5	5.1	6.5	3.1	11.3	8.8	8.2	5.4	2.6	0.0	8.2	7.4	3.6	5.3	7.6	7.2	5.1	3.6	2.6	13.2	7.0	2.3	8.8	5.1	3.3	2.2	5.7	4.4	8.9	4.8	5.4	19.5	5.2	4.9	7.7	4.2	2.6	6.2	4.0	3.9	6.5	3.6	5.1	3.6	5.0	6.6	9.0	6.9	6.8	0.8	6.0	2.7	3.6	4.1	5.1	4.1	3.6	5.6	3.1	3.4	3.0	4.9	5.7	4.0	3.8	2.5	2.1	2.3	3.7	2.9	8.4	12.5	11.0	9.1	9.8	5.9	7.8	7.3	8.8	11.2	14.9	10.6	2.4	2.9	1.8	9.5	5.2	2.5	13.4	18.2	8.7	15.7	2.1	3.3	2.7	12.2	4.1	2.1	0.0	1.4	5.1	3.7	3.8	11.6	0.8	2.0	25.4	9.8	4.3	4.6	9.0	3.4	2.5	3.3	2.8	4.6	6.2	1.4	5.1	4.2	2.2	29.8	6.5	3.3	8.0	7.5	1.9	4.1	3.2	3.0	2.1
ZNF444	"EZF2, FLJ11137, ZSCAN17"	ENSG00000167685	"Zinc finger protein 444"	Q8N0Y2	19	56132599-56160893	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 51.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056895, HPA065203"	Approved		Enhanced	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA056895: AB_2683267, HPA065203: AB_2685431"	"unprognostic (1.58e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.57e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.61e-4)"	"unprognostic (4.70e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (1.87e-4)"	9.4	13.4	15.0	7.1	21.0	3.7	8.3	14.9	20.1	9.0	14.8	12.8	14.3	13.6	10.5	9.9	6.6	11.9	11.2	10.5	13.5	13.3	9.9	37.4	10.9	6.1	12.3	11.0	12.5	25.3	8.5	12.2	12.5	8.0	14.3	5.3	10.4	14.1	25.6	17.2	11.5	11.3	7.5	10.3	8.6	17.2	9.2	10.4	28.1	16.6	2.8	8.2	10.4	6.8	4.3	3.5	3.5	1.7	3.7	7.1	1.8	4.7	9.1	8.4	7.3	3.6	3.7	5.5	6.1	4.0	5.2	5.7	10.0	5.4	8.4	5.4	3.5	2.6	4.4	5.2	4.1	2.2	7.3	51.5	8.2	6.1	18.0	5.9	3.6	7.7	4.3	3.8	4.2	3.3	7.9	4.6	10.5	10.6	3.7	3.6	6.2	11.8	10.3	9.1	9.5	16.7	13.8	5.4	4.4	5.7	4.4	9.0	12.4	3.1	10.3	4.5	4.8	10.2	6.7	6.0	9.4	8.1	2.0	6.6	9.1	7.7	6.3	5.9	5.0	6.1	3.1	1.7	3.5	4.1	1.4	4.5	2.0	6.9	6.9	2.1	4.3	7.1	4.6	0.2	3.7	1.0	3.5	4.2	1.8	15.0	21.0	14.9	20.1	13.5	13.3	12.3	11.0	8.0	10.4	3.0	14.9	10.2	14.2	2.7	16.7	11.4	33.1	13.4	9.1	10.4	7.9	16.2	8.3	23.1	26.9	15.8	12.8	0.0	19.3	7.9	9.2	13.8	10.3	34.7	9.4	19.1	28.2	19.6	5.3	28.6	11.2	3.9	15.1	19.8	24.4	16.6	21.0	10.5	11.3	18.8	13.6	25.8	13.2	10.4	19.8	4.5	10.4	13.1	19.3	8.9
ZNF500	"KIAA0557, ZKSCAN18, ZSCAN50"	ENSG00000103199	"Zinc finger protein 500"	O60304	16	4748239-4767624	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA035498, HPA057963"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA035498: AB_10602356, HPA057963: AB_2683565"	"unprognostic (3.83e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-1)"	"unprognostic (3.61e-3)"	"unprognostic (8.72e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.41e-4)"	"unprognostic (8.98e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.19e-2)"	8.1	6.4	10.2	9.4	7.5	5.9	8.1	13.8	11.4	10.3	8.0	11.7	11.5	8.4	12.2	10.9	6.2	8.9	10.4	6.0	6.2	5.1	6.0	5.2	7.2	12.5	6.6	9.4	13.9	8.5	9.1	8.0	6.7	6.6	9.3	5.3	10.6	11.3	14.9	7.5	8.5	7.5	7.5	5.4	11.4	7.7	7.2	8.4	9.9	9.2	7.1	8.3	9.2	8.4	5.3	6.5	3.4	2.5	3.0	4.9	2.1	2.0	8.4	2.8	7.3	3.3	3.0	12.8	6.1	6.8	7.6	5.2	3.7	4.0	4.4	5.3	3.3	2.8	4.7	5.8	3.2	5.6	3.2	8.8	3.6	10.6	5.0	4.7	2.5	4.0	3.5	7.8	3.4	6.5	7.5	4.3	5.6	5.3	7.0	3.0	4.6	5.2	4.4	3.6	1.6	3.0	9.3	6.7	8.7	2.5	2.4	10.4	6.8	5.2	7.9	2.3	2.0	5.1	4.1	4.8	7.2	5.5	8.0	2.9	6.7	4.5	3.9	2.2	2.1	4.5	2.3	2.5	3.4	3.9	2.4	3.3	4.9	2.5	3.0	1.4	5.3	4.2	4.9	2.9	3.0	1.7	6.5	3.9	2.1	10.2	7.5	13.8	11.4	6.2	5.1	6.6	9.4	6.6	8.4	11.9	2.4	8.9	2.6	2.2	16.8	4.8	2.5	5.3	2.3	7.0	23.6	4.9	1.7	3.8	6.8	4.9	4.9	0.0	2.7	3.8	3.6	4.3	6.9	4.0	2.7	17.5	8.1	9.2	3.3	1.3	10.6	3.1	1.7	9.0	4.9	12.1	2.9	0.0	10.6	2.2	20.5	0.0	4.1	12.6	8.3	1.9	3.8	5.7	5.2	1.6
ZNF512B	"GM632, MGC149845, MGC149846"	ENSG00000196700	"Zinc finger protein 512B"	Q96KM6	20	63956702-63969865	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 20.1;Cone photoreceptor cells: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006688, HPA008731"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA006688: AB_10963053, HPA008731: "	"unprognostic (7.00e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.40e-3)"	"unprognostic (7.19e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.99e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.12e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.95e-3)"	"unprognostic (3.72e-2)"	7.5	8.2	11.0	6.3	13.3	6.2	5.6	14.3	16.7	7.4	3.6	9.9	6.1	5.3	9.3	9.0	10.1	8.5	7.5	8.3	11.0	8.5	9.6	18.5	7.1	7.0	8.8	10.5	11.3	14.4	13.6	10.3	10.4	8.4	8.5	1.7	9.9	15.5	10.5	11.2	14.3	5.8	7.8	6.4	9.3	8.5	8.8	6.5	6.2	10.7	5.8	8.8	6.2	6.7	0.6	0.4	0.0	0.1	1.4	1.1	0.3	5.4	9.2	10.4	11.0	4.6	3.4	9.5	7.9	6.2	23.8	7.8	17.9	9.2	3.6	19.4	6.8	4.4	7.0	7.8	11.7	5.7	5.8	11.2	8.8	12.9	17.0	7.4	4.7	10.6	7.2	9.7	8.2	4.7	6.3	7.3	16.2	12.2	5.5	4.7	13.0	23.0	10.3	7.2	7.0	12.1	10.6	0.9	10.7	4.3	9.2	15.2	8.9	6.5	10.8	5.2	5.2	22.7	11.5	10.2	22.9	3.5	5.7	6.7	13.2	6.3	10.0	8.2	0.0	9.7	0.0	0.1	0.0	1.1	0.0	0.1	0.1	1.0	0.1	0.4	0.6	1.1	1.0	0.0	1.4	0.0	0.4	0.0	0.3	11.0	13.3	14.3	16.7	11.0	8.5	8.8	10.5	8.4	6.5	3.0	6.4	3.2	2.9	4.7	20.1	1.7	7.6	1.4	5.7	1.8	21.6	6.2	1.7	3.2	0.1	3.0	0.3	0.0	5.2	2.6	4.5	2.5	0.0	15.3	3.2	12.7	5.8	8.6	1.3	1.0	6.1	0.7	5.0	1.8	0.5	8.0	2.8	0.0	6.3	4.1	10.5	0.0	3.4	3.0	4.8	6.0	4.2	2.9	1.3	2.4
ZNF554	FLJ34817	ENSG00000172006	"Zinc finger protein 554"	Q86TJ5	19	2819874-2835773	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 15.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA060247, HPA063358"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			Nucleoplasm	Nucleoli	"HPA060247: AB_2684230, HPA063358: AB_2684995"	"unprognostic (3.81e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.84e-1)"	"unprognostic (3.58e-3)"	"unprognostic (5.05e-2)"	"unprognostic (7.36e-5)"	"unprognostic (1.65e-1)"	"prognostic favorable (9.31e-4)"	"unprognostic (1.82e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.57e-1)"	"prognostic favorable (1.99e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.79e-2)"	"prognostic favorable (5.00e-4)"	4.1	4.4	7.9	2.0	9.1	1.9	5.1	12.2	14.1	6.0	4.6	7.7	5.6	6.1	6.8	4.5	4.0	6.4	5.6	7.3	8.2	8.4	6.6	8.6	5.0	3.9	6.2	6.9	8.2	5.0	9.8	8.4	25.9	6.0	5.7	4.3	7.7	7.6	5.4	8.9	7.4	4.7	5.6	4.2	3.7	4.2	4.0	6.5	5.1	7.9	4.7	6.0	4.5	4.1	2.3	3.6	0.6	0.6	1.8	1.8	0.7	3.7	0.1	3.3	3.6	2.3	3.0	4.2	2.4	2.6	5.0	2.3	0.3	1.0	3.5	2.3	1.9	3.8	1.8	0.3	1.9	0.7	0.0	1.7	1.0	1.2	1.5	1.8	0.5	0.8	2.4	4.4	1.4	2.0	3.0	0.4	4.4	3.6	2.0	1.6	0.7	1.7	0.4	1.6	1.2	1.1	1.9	2.2	0.9	3.2	3.0	3.0	5.4	2.7	0.5	4.0	4.2	1.4	1.8	0.0	0.4	1.0	1.4	0.9	6.6	7.3	0.7	1.9	1.7	1.0	0.2	0.3	0.6	0.4	0.1	1.5	0.8	0.7	0.9	0.0	2.3	1.8	0.3	0.2	1.8	0.6	3.6	0.3	0.7	7.9	9.1	12.2	11.2	8.2	8.4	6.2	6.9	6.0	6.5	11.9	15.1	0.9	2.6	1.1	4.1	2.8	2.5	8.1	6.8	0.0	7.9	1.9	3.3	2.0	0.4	2.5	3.8	0.0	1.2	1.0	2.0	2.5	0.0	1.9	1.3	3.2	3.5	2.5	1.0	0.2	2.8	2.0	0.0	1.0	1.7	4.6	1.7	0.0	2.5	2.1	4.7	0.0	1.5	4.4	10.4	1.3	7.3	4.5	2.2	1.5
ZNF560	FLJ31986	ENSG00000198028	"Zinc finger protein 560"	Q96MR9	19	9466507-9498607	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 21.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 48.7"	"Cancer enriched"	"Detected in some"	7	"testis cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HEL: 17.9;HMC-1: 4.4;NTERA-2: 17.8;SuSa: 8.8"									"HPA045439, HPA074438"			Enhanced	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA045439: AB_2732520, HPA074438: "	"unprognostic (4.43e-3)"			"unprognostic (8.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.43e-2)"		"unprognostic (1.17e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.57e-3)"	"unprognostic (6.33e-5)"	"unprognostic (5.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (9.15e-3)"	"unprognostic (1.65e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.1	0.0	0.1	0.0	0.0	0.4	2.6	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	21.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.8	2.4	0.0	1.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	1.0	17.9	0.0	0.0	1.3	0.0	4.4	2.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	11.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	6.0	8.3	0.0	0.0	0.0	0.0	0.0
ZNF593	ZT86	ENSG00000142684	"Zinc finger protein 593"	O00488	1	26169871-26170873	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 59.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA054363, HPA059387"	Supported		Enhanced	Nucleoplasm,Nucleoli		NA	NA			Nucleoli	Nucleoplasm	"HPA054363: AB_2682462, HPA059387: AB_2684001"	"unprognostic (1.23e-2)"	"unprognostic (8.97e-2)"	"unprognostic (7.13e-2)"	"unprognostic (7.42e-2)"	"unprognostic (9.37e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.96e-2)"	"unprognostic (5.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-2)"	11.7	11.5	9.4	10.7	9.4	15.7	18.3	7.2	12.1	9.0	11.7	7.0	12.1	11.4	8.7	9.0	10.9	8.4	11.3	14.5	8.9	10.0	13.5	30.8	7.7	16.8	10.0	7.0	11.6	36.2	9.7	9.3	12.7	10.9	10.4	5.8	5.9	15.9	12.0	59.3	9.8	11.0	6.5	7.3	13.0	15.2	9.3	8.3	5.4	15.1	17.2	9.2	10.6	10.1	23.5	26.8	0.7	25.0	16.1	21.7	14.1	20.1	11.1	3.8	13.4	3.7	4.9	20.2	9.0	4.6	10.5	10.1	17.0	12.2	23.6	16.6	5.6	8.4	13.2	12.9	11.7	3.8	14.1	41.4	16.0	9.1	25.7	16.1	22.1	14.1	8.8	11.5	11.6	12.2	4.4	8.8	5.8	24.0	9.1	6.2	15.4	9.0	41.1	15.1	19.5	39.5	11.3	6.7	23.8	7.5	8.9	10.1	11.0	10.9	27.4	34.2	3.3	11.3	12.5	9.1	10.1	11.9	21.1	16.8	18.0	18.2	25.5	11.8	45.9	12.9	0.1	15.7	0.2	14.2	25.0	13.3	23.5	20.1	14.0	21.7	22.7	15.0	14.3	0.7	16.1	25.0	26.8	21.7	14.1	9.4	9.4	7.2	12.1	8.9	10.0	10.0	7.0	10.9	8.3	11.9	63.0	48.3	137.4	152.1	16.6	5.9	58.6	21.4	40.9	57.6	2.0	93.3	87.9	89.4	5.0	36.0	55.3	23.3	126.2	135.2	54.6	99.4	51.7	184.5	69.6	3.2	105.3	38.6	55.7	10.0	30.0	42.5	47.2	47.7	71.1	18.5	122.6	60.4	21.9	148.8	11.7	12.9	55.6	33.0	56.3	147.0	186.2	28.8	68.1	152.9
ZNF594	KIAA1871	ENSG00000180626	"Zinc finger protein 594"	Q96JF6	17	5179536-5191883	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 14.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA060283, HPA067178, HPA069360, HPA074493, HPA077596"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA060283: AB_2732645, HPA067178: AB_2685796, HPA069360: AB_2732131, HPA074493: , HPA077596: "	"unprognostic (6.67e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.24e-3)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.33e-5)"	"unprognostic (4.09e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (6.59e-2)"	4.0	6.2	11.8	8.4	11.2	1.3	8.8	13.8	13.4	7.5	6.3	8.0	5.3	3.1	9.3	8.4	4.2	8.3	4.2	4.9	8.9	5.9	6.7	3.8	4.1	10.1	13.6	6.6	19.8	6.0	15.3	15.9	5.8	9.2	9.6	5.1	6.0	6.5	10.2	6.7	3.8	6.8	6.0	8.3	8.4	5.2	7.8	11.1	11.9	10.2	2.1	10.2	6.6	5.6	5.9	4.5	1.1	1.0	2.4	5.2	1.0	5.5	2.5	10.7	8.3	1.7	1.9	8.9	3.8	1.9	6.8	6.5	7.0	2.0	12.6	6.0	3.0	5.0	6.2	6.8	0.2	8.7	6.7	6.9	4.1	8.8	3.5	2.4	0.0	4.1	1.4	1.1	4.0	0.0	1.8	0.7	7.5	1.6	3.2	2.3	5.3	3.4	1.7	4.8	0.9	3.4	7.3	9.0	1.7	1.9	1.5	6.3	8.4	2.9	1.5	5.7	4.9	3.4	3.0	0.1	0.1	3.8	3.4	2.7	2.1	4.1	3.0	0.6	0.0	4.1	0.4	0.8	1.1	3.2	1.0	2.3	3.5	3.3	2.9	1.0	5.9	5.2	3.4	0.4	2.4	0.9	4.5	4.4	1.0	11.8	11.2	13.8	13.4	8.9	5.9	13.6	6.6	9.2	11.1	6.0	3.8	1.4	1.2	1.0	9.4	4.2	7.6	6.7	4.5	5.2	5.9	1.0	6.6	1.3	0.6	1.0	0.0	0.0	1.0	0.6	0.9	0.8	3.5	0.8	0.8	14.3	1.2	3.7	2.2	2.6	3.1	0.0	0.0	1.8	0.9	8.2	0.7	1.1	2.5	0.6	9.8	0.0	1.0	2.3	3.8	0.3	0.2	0.8	1.2	0.4
ZNF609	KIAA0295	ENSG00000180357	"Zinc finger protein 609"	O15014	15	64460742-64686068	"Predicted intracellular proteins"	"Myogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040742, HPA040832"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA040742: AB_10963581, HPA040832: AB_10960400"	"unprognostic (2.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.11e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.28e-1)"	11.1	11.2	14.5	14.5	12.6	7.3	11.4	17.1	15.1	17.9	14.2	16.2	19.1	12.1	18.7	8.4	10.2	15.7	14.0	10.9	12.3	10.4	9.1	10.2	13.9	11.3	10.9	11.0	29.9	11.6	18.1	11.6	16.3	10.9	15.2	11.4	14.6	12.6	22.8	9.2	11.9	11.2	16.1	12.7	12.9	11.4	28.9	13.6	21.4	12.4	4.5	12.1	15.6	28.4	1.2	2.8	3.2	1.7	4.0	3.0	0.5	6.1	15.6	16.9	6.4	6.5	8.3	5.8	8.1	10.8	10.2	10.3	9.6	9.8	10.6	6.8	9.5	13.9	13.2	24.7	11.1	10.7	12.3	5.3	19.4	9.0	4.7	12.0	11.1	13.0	8.4	10.2	10.6	21.0	14.8	18.8	9.1	30.4	6.9	8.3	5.6	8.6	4.7	12.8	8.3	4.4	7.9	15.4	5.5	7.4	11.1	13.7	10.5	11.0	12.6	7.5	16.9	6.2	7.8	18.7	9.5	15.2	4.9	10.0	7.7	8.7	9.6	5.9	12.2	7.7	3.2	1.7	1.9	2.3	0.7	1.6	0.7	1.3	1.6	0.6	1.2	3.0	3.0	2.1	4.0	0.8	2.8	0.8	0.5	14.5	12.6	17.1	15.1	12.3	10.4	10.9	11.0	10.9	13.6	11.9	20.1	6.1	13.9	16.0	28.1	18.3	17.8	30.8	25.0	17.4	133.5	12.7	3.3	12.3	17.2	14.4	9.9	0.0	12.8	11.9	12.1	18.2	9.3	11.6	8.7	42.9	17.9	17.8	23.1	9.6	16.7	11.6	13.5	9.0	10.8	19.5	11.6	11.5	13.1	3.1	56.5	19.4	9.2	31.7	14.0	15.2	26.1	13.3	10.5	15.6
ZNF621	FLJ45246	ENSG00000172888	"Zinc finger protein 621"	Q6ZSS3	3	40524878-40574685	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA065518, HPA071440"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA065518: AB_2685501, HPA071440: AB_2686395"	"unprognostic (1.09e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.52e-3)"	"unprognostic (9.50e-3)"	"unprognostic (3.06e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.01e-3)"	12.3	11.3	14.6	10.6	27.1	11.6	16.6	20.4	17.3	14.2	11.1	26.2	15.5	9.6	16.4	18.3	9.1	10.9	11.3	9.3	17.3	14.1	11.8	10.0	12.5	11.1	26.7	12.1	14.1	15.0	18.4	15.6	10.6	17.6	13.3	11.4	12.1	12.6	14.8	10.5	16.2	10.4	15.9	22.7	11.6	11.2	8.6	24.7	4.8	13.9	8.1	11.5	10.4	10.6	7.4	4.3	5.5	3.4	4.9	4.8	1.8	9.2	4.9	13.0	12.8	9.5	14.1	7.0	9.6	11.8	12.7	12.2	10.4	5.0	3.7	7.2	12.9	8.6	3.1	12.4	7.1	14.9	13.0	13.7	12.4	18.4	9.6	15.1	11.7	12.1	11.2	16.3	12.8	20.7	14.1	9.9	4.5	12.7	10.9	10.5	5.0	2.9	13.7	7.6	3.3	10.1	1.3	8.4	3.9	6.7	11.2	4.3	11.4	9.0	7.2	11.4	13.5	10.9	9.7	12.2	21.4	10.6	10.1	13.8	16.5	15.4	7.9	10.1	8.7	13.2	5.5	3.0	2.5	3.9	3.4	2.7	6.1	3.8	4.8	2.4	7.4	4.4	3.9	4.4	4.9	1.9	4.3	3.1	1.8	14.6	27.1	20.4	17.3	17.3	14.1	26.7	12.1	17.6	24.7	8.9	10.5	7.5	4.2	1.3	12.5	10.1	10.2	4.0	11.4	10.4	11.8	4.5	5.0	6.0	6.0	8.7	5.0	0.0	4.9	2.9	5.1	4.9	3.5	4.0	3.3	14.3	9.8	5.5	6.7	5.7	6.9	4.4	3.3	10.0	5.6	9.4	5.5	3.5	11.3	2.9	15.0	0.0	4.9	9.4	7.0	1.6	4.6	5.7	5.8	4.2
ZNF622	"MGC17552, MGC2485, ZPR9"	ENSG00000173545	"Zinc finger protein 622"	Q969S3	5	16451519-16465792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036514, HPA036515"	Uncertain		Supported	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nucleoli"	"HPA036514: AB_2675167, HPA036515: AB_10672224"	"unprognostic (6.29e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-2)"	"unprognostic (6.53e-2)"	"unprognostic (8.24e-3)"	"unprognostic (4.71e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.19e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.78e-1)"	14.3	10.8	18.3	12.1	19.4	28.8	14.8	20.5	20.3	12.6	19.5	14.5	9.5	15.5	14.4	16.9	13.6	13.2	12.3	38.6	13.8	14.6	14.8	18.8	12.8	14.5	16.8	15.5	15.1	45.9	12.5	15.0	16.0	17.2	13.1	19.8	10.9	17.5	12.8	29.0	18.6	19.6	12.6	12.8	12.4	15.9	14.1	17.3	14.0	16.7	11.9	15.4	13.7	14.9	50.4	45.6	55.4	45.9	39.1	56.9	47.2	11.0	24.3	7.6	15.7	18.7	16.0	27.7	20.0	15.2	16.3	20.9	28.8	10.3	13.0	27.1	15.8	22.0	14.7	12.2	15.6	13.2	17.5	16.6	11.9	43.1	20.6	26.9	23.0	14.3	24.6	19.8	15.2	14.4	12.7	11.4	7.8	16.0	12.9	17.9	18.7	12.0	22.5	13.4	10.5	24.1	9.5	9.3	11.1	15.1	16.7	10.6	11.9	27.9	21.0	32.4	13.9	11.6	17.9	15.5	18.3	13.9	17.7	12.6	18.7	16.7	18.2	15.9	20.0	12.7	45.2	41.6	52.9	49.1	43.4	51.2	50.4	49.5	53.7	45.6	47.0	56.9	47.7	55.4	39.1	45.9	37.0	50.1	47.2	18.3	19.4	20.5	20.3	13.8	14.6	16.8	15.5	17.2	17.3	20.8	24.5	31.7	36.6	53.9	21.6	68.8	12.7	22.7	19.4	14.0	9.8	53.3	23.2	49.8	98.2	21.5	74.9	0.0	58.2	46.3	35.5	23.5	50.8	21.9	45.1	15.9	94.5	9.8	15.4	46.0	16.7	31.7	32.1	49.5	33.2	20.1	47.9	129.6	18.7	30.7	15.9	19.4	31.6	40.3	26.2	37.8	34.0	30.9	34.7	29.6
ZNF638	"MGC26130, NP220, ZFML, Zfp638"	ENSG00000075292	"Zinc finger protein 638"	Q14966	2	71276561-71435069	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036784, HPA057395"	Supported		Enhanced	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA036784: AB_10672478, HPA057395: AB_2683426"	"unprognostic (2.58e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.66e-3)"	"unprognostic (3.28e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.93e-2)"	"prognostic favorable (8.73e-5)"	20.7	19.1	22.4	14.9	26.0	18.7	19.8	51.3	25.5	19.8	19.7	23.4	13.0	11.3	26.0	14.8	17.3	20.1	14.3	16.0	20.1	11.9	18.7	22.9	16.4	16.9	25.4	19.9	31.1	15.4	28.9	46.7	16.9	23.9	17.2	14.7	14.1	20.6	15.5	33.2	16.9	15.8	18.4	22.7	16.0	17.3	21.0	29.7	26.0	22.5	11.2	16.1	26.6	17.8	14.8	10.2	32.4	12.8	11.8	14.1	6.0	14.8	21.5	33.1	15.4	19.5	21.4	25.5	17.0	19.8	14.5	13.1	20.5	14.6	24.5	15.9	15.5	22.7	12.6	30.7	17.5	21.2	24.9	17.1	32.2	23.5	18.6	16.9	29.4	21.9	13.6	17.1	15.6	29.1	20.8	22.3	16.6	32.2	14.5	21.1	14.9	20.7	21.7	28.6	22.4	13.8	17.7	50.1	17.1	15.5	22.8	25.5	16.8	21.0	14.8	21.5	34.5	13.8	18.2	22.8	18.0	26.3	13.3	17.1	11.9	18.3	24.3	15.1	19.3	19.5	32.4	10.1	18.7	11.4	9.5	10.6	14.5	10.6	10.4	7.9	14.8	14.1	10.3	17.1	11.8	12.8	10.2	8.9	6.0	22.4	26.0	51.3	25.5	20.1	11.9	25.4	19.9	23.9	29.7	62.5	96.8	21.9	49.0	28.2	107.5	95.4	33.1	95.0	67.1	38.4	115.8	33.4	16.6	33.6	9.1	50.4	34.1	0.0	35.4	23.2	45.8	52.3	76.3	39.4	28.2	63.5	36.9	35.0	35.3	11.0	69.6	45.7	21.9	49.5	31.9	69.1	35.4	26.0	60.1	17.0	107.8	32.3	40.0	110.7	64.1	26.5	42.0	42.7	33.6	45.0
ZNF672	FLJ22301	ENSG00000171161	"Zinc finger protein 672"	Q499Z4	1	248838210-248849517	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055779, HPA062506"	Approved		Enhanced	Nucleoplasm		Yes	Yes			Nucleoplasm		"HPA055779: AB_2682917, HPA062506: AB_2684786"	"unprognostic (1.64e-2)"	"unprognostic (3.45e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (7.42e-3)"	"unprognostic (1.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.51e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.35e-3)"	"prognostic favorable (1.79e-5)"	11.3	12.5	11.1	16.4	13.6	15.1	12.1	18.6	15.3	10.2	13.0	17.3	15.0	13.8	12.1	10.7	15.9	11.3	13.3	20.1	11.4	10.2	14.8	27.5	13.6	16.7	14.1	7.5	12.0	14.1	20.4	14.1	16.1	12.4	18.7	11.1	15.1	24.1	14.8	46.6	13.3	16.8	11.3	11.2	16.0	12.7	12.4	14.5	28.1	21.7	21.0	17.3	14.5	10.4	14.5	20.8	9.6	13.4	10.5	8.0	10.3	10.2	11.7	9.6	10.7	5.4	3.8	18.1	9.8	5.3	6.9	7.6	6.4	10.8	11.6	10.1	6.4	5.4	10.1	5.2	7.2	4.6	16.8	2.9	17.7	10.8	8.6	7.0	7.7	13.7	4.2	6.0	9.2	6.6	5.7	6.5	8.0	21.5	9.7	4.9	7.4	13.6	7.7	11.0	11.8	19.9	25.7	9.1	9.1	7.2	8.5	14.1	12.4	8.7	13.3	8.6	6.0	7.7	15.8	5.5	9.8	5.8	6.5	19.8	29.1	10.9	6.8	9.1	13.6	8.0	7.6	13.3	9.6	8.0	13.4	6.7	10.8	5.7	7.9	20.8	14.5	6.3	5.6	8.1	10.5	12.4	11.7	6.5	10.3	11.1	13.6	18.6	15.3	11.4	10.2	14.1	7.5	12.4	14.5	3.0	17.5	21.4	22.4	11.6	21.0	16.9	7.6	5.3	4.5	15.7	11.8	28.2	18.3	16.4	6.2	12.1	18.8	0.0	9.4	16.4	10.8	20.5	28.7	14.8	15.4	9.5	17.3	5.5	15.2	8.9	5.2	14.1	11.8	12.6	16.6	19.2	12.1	17.3	5.3	13.5	30.2	6.5	9.9	22.9	13.6	12.8	59.6	13.8	15.2	19.9
ZNF687	KIAA1441	ENSG00000143373	"Zinc finger protein 687"	Q8N1G0	1	151281618-151292180	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 13.1;neutrophil: 9.6"	"Group enriched"	"Detected in many"	6	"granulocytes: 13.1;monocytes: 4.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021193, HPA023948"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021193: AB_1859415, HPA023948: AB_2671380"	"unprognostic (2.23e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (9.64e-3)"	"unprognostic (2.44e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.39e-1)"	"unprognostic (9.91e-2)"	"unprognostic (8.69e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.54e-2)"	"unprognostic (7.99e-2)"	9.8	13.6	9.9	10.7	11.4	36.1	10.6	16.1	21.0	13.6	17.3	17.1	10.9	11.7	13.5	12.9	12.9	13.2	12.8	10.0	9.2	9.7	13.0	14.4	10.2	14.8	9.4	10.7	16.6	21.4	23.0	16.4	13.5	10.6	13.3	8.1	17.6	16.2	13.3	12.5	14.1	15.2	11.4	9.6	17.9	12.5	22.5	9.8	19.6	14.0	8.3	15.4	13.9	9.9	1.3	0.9	13.1	4.1	0.5	0.9	1.0	9.4	14.3	13.2	8.0	7.4	6.3	18.3	5.3	8.4	8.9	8.9	11.2	12.4	8.1	13.1	7.7	9.6	14.7	11.5	9.8	4.0	12.0	12.6	7.7	11.5	12.7	8.2	8.7	11.3	9.9	10.0	7.4	7.9	7.9	5.9	9.1	12.0	14.4	4.9	28.1	12.2	10.5	17.9	12.2	10.8	10.9	10.8	14.7	7.4	13.9	12.3	19.6	13.2	15.6	12.7	12.9	20.6	19.0	5.7	7.1	8.3	9.2	7.6	18.0	15.1	19.8	9.1	5.9	9.0	0.4	1.8	13.1	0.6	2.2	0.7	1.1	0.6	0.6	0.9	1.3	0.8	0.9	9.6	0.5	4.1	0.8	0.4	1.0	9.9	11.4	16.1	21.0	9.2	9.7	9.4	10.7	10.6	9.8	3.0	5.8	1.9	3.0	4.1	6.4	1.2	7.6	1.4	1.2	1.8	9.8	5.7	3.3	5.1	1.6	2.5	5.9	0.0	5.1	4.2	4.1	3.5	0.0	4.0	4.5	7.9	2.4	4.3	3.8	2.1	5.8	4.3	0.0	5.4	6.5	6.1	6.4	2.9	6.7	3.3	10.6	12.9	2.2	8.6	8.6	3.0	7.9	3.3	7.5	4.1
ZNF692	"AREBP, FLJ20531, Zfp692"	ENSG00000171163	"Zinc finger protein 692"	Q9BU19	1	248850006-248859144	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059337, HPA062792"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA059337: AB_2683984, HPA062792: AB_2684869"	"unprognostic (4.86e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.05e-2)"	"unprognostic (1.90e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-3)"	"unprognostic (5.66e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.50e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (5.65e-3)"	"prognostic unfavorable (7.72e-9)"	"unprognostic (5.32e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.59e-1)"	"prognostic favorable (8.35e-5)"	5.6	8.7	15.3	7.9	25.0	11.1	10.7	27.7	22.3	11.6	8.1	16.5	17.8	8.3	13.6	15.1	9.7	13.1	9.4	7.4	20.1	11.6	9.7	8.6	6.9	9.8	30.4	14.3	17.2	12.2	18.4	13.8	8.1	21.2	14.9	7.0	7.7	21.9	11.1	11.5	19.6	8.9	9.2	18.3	10.0	8.7	22.9	25.7	6.6	11.3	9.2	7.8	9.1	8.8	4.6	4.4	4.8	2.1	10.6	6.4	2.8	4.8	5.1	4.3	10.7	3.7	1.9	18.7	4.1	1.4	4.7	3.0	5.8	7.0	6.0	8.5	2.0	1.9	7.0	6.5	6.2	3.4	8.9	4.4	7.1	10.9	1.6	2.8	7.9	5.7	2.4	8.0	4.8	12.8	4.7	4.3	8.0	14.6	4.4	2.1	3.4	4.0	16.3	8.8	12.4	11.1	13.7	2.8	12.0	9.0	3.6	8.5	6.3	4.5	7.8	8.4	1.7	9.5	13.0	3.0	2.1	3.5	2.3	5.6	12.4	7.8	3.8	4.6	10.5	3.5	0.0	2.1	1.9	5.7	1.6	4.9	4.6	4.5	6.0	4.4	3.8	6.4	4.6	4.8	10.6	1.4	3.5	4.7	2.8	15.3	25.0	27.7	22.3	20.1	11.6	30.4	14.3	21.2	25.7	8.9	7.5	8.0	10.6	8.5	14.0	3.0	10.2	8.1	2.3	10.4	21.6	10.2	5.0	6.3	8.0	6.3	8.8	23.3	3.4	9.1	6.6	13.7	5.7	5.9	5.7	11.1	7.9	1.8	6.9	5.8	9.5	5.4	15.1	6.4	9.4	8.4	6.1	5.8	6.7	3.1	13.8	0.0	4.9	31.1	15.6	6.9	5.1	10.2	11.7	8.5
ZNF771	DSC43	ENSG00000179965	"Zinc finger protein 771"	Q7L3S4	16	30407297-30431108	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 27.0;REH: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030730, HPA046672, HPA059398"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		No	No			"Nucleoplasm, Nucleoli"		"HPA030730: AB_2673583, HPA046672: AB_2679745, HPA059398: AB_2684002"	"unprognostic (8.21e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.12e-5)"	"unprognostic (3.53e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.99e-3)"	6.6	6.7	15.3	5.0	14.5	4.0	5.3	10.7	18.3	6.6	6.1	4.9	6.6	4.5	10.4	7.2	4.6	7.5	6.1	4.6	13.4	10.6	9.2	8.6	4.1	3.3	8.8	16.9	10.8	7.3	8.1	6.2	2.4	8.8	10.1	5.4	4.0	4.9	12.3	18.2	6.1	4.3	9.6	5.1	3.6	4.8	3.7	8.1	1.9	5.4	3.5	4.2	6.8	5.6	6.6	3.7	1.9	2.5	1.8	6.2	2.7	3.1	3.6	5.0	4.1	7.2	3.0	3.8	4.7	2.3	3.0	3.1	1.6	1.6	3.8	8.0	2.3	3.7	2.4	5.2	2.1	3.1	1.3	27.0	3.2	2.4	4.8	3.7	1.6	3.8	4.6	1.6	3.7	2.3	3.1	3.0	4.0	7.7	2.3	2.5	5.7	3.8	5.2	4.0	1.9	2.9	17.3	3.7	2.4	1.7	1.3	7.9	5.0	2.5	2.2	3.0	2.7	2.9	1.8	2.7	5.0	6.0	2.9	3.3	3.5	3.7	1.9	3.3	3.5	3.2	1.0	1.1	0.7	3.6	2.5	4.9	2.7	4.3	4.2	2.8	6.6	6.2	3.7	1.9	1.8	0.5	3.7	4.4	2.7	15.3	14.5	10.7	18.3	13.4	10.6	8.8	16.9	8.8	8.1	3.0	0.3	2.2	10.4	4.5	11.2	6.3	15.3	0.0	1.2	5.2	9.8	4.8	28.2	6.4	1.3	5.8	5.3	0.0	3.7	2.6	9.4	8.8	1.1	16.3	2.9	11.1	4.1	14.7	0.6	1.5	23.3	2.8	5.0	1.0	8.1	15.1	3.6	4.2	28.0	23.6	7.1	12.9	8.9	1.1	1.6	5.8	3.0	3.9	9.8	3.4
ZNF789		ENSG00000198556	"Zinc finger protein 789"	Q5FWF6	7	99472841-99503650	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA029500, HPA050793"	Uncertain		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA029500: AB_10603009, HPA050793: AB_2681240"	"unprognostic (6.84e-3)"	"unprognostic (5.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.25e-3)"	"unprognostic (4.38e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (7.14e-4)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"prognostic favorable (5.31e-6)"	6.1	5.5	11.0	15.9	10.0	11.6	9.2	31.9	14.4	6.1	9.2	9.2	11.0	15.1	10.9	12.8	5.0	7.8	6.6	4.0	10.0	8.5	9.0	8.1	6.5	10.5	6.8	9.8	8.9	7.8	6.3	13.3	4.6	7.6	16.4	12.5	14.8	10.3	13.8	8.9	13.3	12.6	8.5	8.6	11.2	8.4	17.6	8.1	8.4	9.3	4.8	10.1	4.1	5.6	3.9	14.2	2.0	1.6	4.1	7.0	2.1	11.2	3.8	6.2	11.2	1.8	2.1	8.6	5.8	2.2	3.5	7.7	6.4	7.7	8.6	4.9	2.6	4.1	5.7	3.5	3.3	4.9	3.9	6.0	6.5	10.6	10.8	3.1	4.4	14.9	2.3	3.0	7.5	3.3	2.3	3.7	11.1	9.7	8.4	3.2	10.7	5.3	11.9	6.3	5.3	6.0	7.0	5.9	9.0	4.6	3.5	6.2	6.8	4.1	11.2	6.5	3.7	3.0	7.0	6.9	6.7	8.2	10.0	5.6	5.1	7.0	10.8	10.6	8.0	7.2	2.0	1.6	1.5	2.7	1.1	2.9	2.7	3.4	2.9	5.6	3.9	7.0	4.2	0.4	4.1	1.4	14.2	5.3	2.1	11.0	10.0	31.9	14.4	10.0	8.5	6.8	9.8	7.6	8.1	0.0	4.6	4.2	3.8	4.8	17.5	1.7	2.5	6.7	4.5	1.8	13.7	4.0	1.7	3.6	21.1	5.6	4.7	23.3	4.8	3.0	3.4	2.5	3.5	2.9	5.6	6.4	5.2	0.6	4.4	6.4	3.1	6.6	6.8	2.8	5.1	10.9	3.5	4.5	4.2	3.4	13.5	0.0	4.2	10.6	3.8	4.5	1.8	4.8	5.6	3.0
ZNF830	"CCDC16, MGC20398, OMCG1"	ENSG00000198783	"Zinc finger protein 830"	Q96NB3	17	34961530-34963775	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA024754, HPA027211"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA024754: AB_1859464, HPA027211: AB_1859465"	"unprognostic (2.87e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.39e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (2.01e-4)"	"unprognostic (2.01e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (8.63e-2)"	11.7	11.5	14.2	13.8	17.6	15.4	13.6	26.9	20.0	15.1	13.9	14.0	9.7	13.4	16.1	11.4	14.1	14.8	12.6	9.2	13.1	10.5	12.9	15.7	10.8	19.6	20.5	11.3	21.4	20.2	11.2	12.5	16.9	18.7	13.4	10.3	10.7	12.7	11.4	11.2	13.0	16.6	17.9	11.9	24.1	13.7	15.0	16.3	20.6	17.5	9.6	17.9	12.9	12.0	10.1	9.8	26.7	8.3	10.1	19.3	8.1	5.7	11.2	10.1	9.4	10.9	8.4	7.0	7.0	7.1	9.2	9.2	8.4	7.8	10.4	6.5	6.8	9.6	13.5	10.8	6.4	10.4	6.2	14.7	12.2	11.0	10.4	11.1	18.2	17.5	8.2	15.0	7.7	15.1	9.3	8.3	12.9	17.5	15.4	8.3	4.3	16.5	20.5	6.7	7.7	5.5	11.2	13.8	13.7	8.5	7.8	12.1	10.3	6.8	4.3	10.9	10.3	9.9	20.0	8.6	9.8	7.1	7.1	12.1	17.1	13.0	14.0	8.4	9.8	8.7	14.6	8.3	26.7	11.9	8.2	11.7	9.2	12.6	12.8	9.1	10.1	19.3	15.2	8.1	10.1	5.7	9.8	11.1	8.1	14.2	17.6	26.9	20.0	13.1	10.5	20.5	11.3	18.7	16.3	35.7	24.2	16.6	37.9	21.3	19.4	6.7	20.4	14.7	35.2	12.2	13.7	20.5	29.9	16.2	3.2	16.9	20.3	0.0	11.5	14.6	19.2	21.3	16.2	9.6	12.7	9.5	17.7	13.5	9.4	2.0	24.7	16.0	20.3	11.8	15.4	19.3	12.1	24.6	25.8	16.5	28.7	25.8	20.2	40.6	45.4	21.1	22.3	29.4	17.6	32.7
ZRANB2	"ZIS, ZIS1, ZIS2, ZNF265"	ENSG00000132485	"Zinc finger RANBP2-type containing 2"	O95218	1	71063291-71081297	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053960, HPA061949, HPA063298"	Supported		Enhanced	Nucleoplasm		NA	Yes			Nucleoplasm		"HPA053960: AB_2682323, HPA061949: AB_2684645, HPA063298: AB_2684979"	"unprognostic (2.10e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.15e-3)"	"unprognostic (8.11e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (7.29e-5)"	"unprognostic (4.25e-3)"	"unprognostic (1.24e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (1.57e-8)"	"unprognostic (3.96e-2)"	"unprognostic (8.51e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.84e-3)"	26.4	27.4	39.8	31.1	42.2	35.1	34.4	54.1	48.6	39.3	28.8	19.6	33.3	23.4	48.3	45.6	20.2	30.6	20.3	27.5	33.5	30.6	20.1	19.5	26.7	37.8	34.1	40.5	39.5	23.9	23.1	77.5	24.6	32.0	30.5	29.3	17.5	25.1	33.2	54.4	27.9	24.9	35.1	42.2	26.2	23.6	31.6	38.0	40.0	32.8	24.3	30.9	32.8	25.6	31.4	34.0	32.1	16.3	20.9	30.8	13.8	23.7	8.6	35.6	20.5	13.9	24.0	20.3	29.1	16.0	25.6	32.7	16.1	15.4	49.3	25.8	17.9	24.1	15.0	30.1	18.1	38.4	34.8	21.7	42.8	33.8	13.4	20.7	46.6	17.5	18.2	22.7	24.9	21.5	29.0	21.5	25.5	44.7	26.4	19.5	8.1	38.1	15.1	36.3	14.2	16.9	43.4	26.6	28.9	16.5	20.3	26.5	16.8	24.8	16.7	24.8	19.4	20.5	20.5	28.8	18.9	18.1	14.8	28.7	21.8	27.0	54.2	27.9	43.5	26.5	32.1	16.3	14.2	22.2	15.0	25.1	30.6	23.6	21.3	12.4	31.4	30.8	24.2	14.6	20.9	14.8	34.0	22.0	13.8	39.8	42.2	54.1	48.6	33.5	30.6	34.1	40.5	32.0	38.0	92.3	128.7	70.6	66.5	45.0	171.8	89.9	58.6	91.0	72.8	47.1	121.7	45.9	41.4	45.1	111.6	51.1	53.4	23.3	58.7	46.6	56.3	44.1	84.4	36.4	38.8	201.8	70.2	51.0	27.2	20.7	171.7	52.0	45.5	50.5	41.0	144.1	55.6	45.6	108.5	30.6	205.0	116.4	59.5	149.3	96.0	40.7	53.1	60.9	36.0	49.3
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267010-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Sertoli cells: 19.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	4.4	5.4	7.4	4.8	10.5	2.5	8.3	17.7	11.4	8.4	4.3	10.5	7.3	4.2	10.5	7.4	4.9	7.9	6.7	6.3	8.1		5.1	3.6	5.2	4.9	7.3	11.5	18.7	4.0	8.9	7.8	4.6	9.6	7.7	5.0	5.7	4.5	10.7	6.4	4.9	4.4	8.9	6.6	7.6	4.9	2.9	9.6	4.0	7.6	2.0	6.1	5.8	4.6	15.2	9.6	10.7	6.2	16.1	16.3	9.6	5.6	4.8	13.7	11.7	14.9	14.3	3.1	11.2	11.2	14.8	15.3	3.5	4.1	3.2	17.4	7.1	11.1	4.3	6.3	8.2	16.3	6.8	6.8	8.5	6.7	7.5	10.3	7.0	5.5	11.9	7.8	11.3	10.3	19.1	14.9	5.0	7.0	6.8	11.6	4.7	7.4	9.6	4.0	3.0	7.3	7.5	11.9	5.4	12.5	5.8	9.9	7.7	6.9	2.9	9.3	11.6	4.8	4.8	9.7	11.9	8.7	4.2	13.6	7.2	9.6	6.2	4.3	7.9	10.3	10.5	6.2	10.7	13.4	4.8	15.8	13.4	13.1	14.4	9.6	15.2	16.3	13.5	4.4	16.1	4.0	4.5	11.8	9.6											0.0	3.5	10.4	2.8	0.0	8.6	8.7	0.0	2.7	11.4	0.0	3.9	3.8	3.3	4.2	3.2	6.8	2.6	0.0	4.4	2.7	3.5	3.0	5.8	1.5	5.0	1.6	6.4	4.3	5.0	1.7	8.3	1.9	0.0	1.0	2.3	11.7	3.0	4.0	12.4	4.9	9.7	19.4	2.7	5.5	8.1	0.0	1.1	7.5	2.7	0.9
ZWINT	"KNTC2AP, SIP30, Zwint1"	ENSG00000122952	"ZW10 interacting kinetochore protein"	O95229	10	56357228-56361275	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 35.6;testis: 37.1"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 87.4;Late spermatids: 149.1;Spermatocytes: 124.1;Spermatogonia: 125.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"T-reg: 15.2"	"Lineage enriched"	"Detected in many"	5	"T-cells: 15.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA005757, HPA022264"			Enhanced	"Nucleoplasm,Nuclear bodies,Cytosol"		No	Yes			"Nucleoplasm, Nuclear bodies"	Cytosol	"HPA005757: AB_10600224, HPA022264: AB_10600995"	"unprognostic (5.59e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.38e-2)"	"unprognostic (6.58e-2)"	"prognostic unfavorable (1.77e-8)"	"unprognostic (6.36e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (3.72e-12)"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.46e-1)"	1.7	3.5	3.4	14.6	3.1	18.4	3.0	0.9	2.8	3.3	9.4	1.3	2.1	6.8	2.0	4.5	14.1	1.1	6.3	1.6	2.7	1.8	4.6	2.9	2.6	12.8	2.4	3.4	1.7	2.8	2.8	1.9	7.3	1.9	1.8	11.8	1.5	4.2	1.4	0.9	5.2	8.8	3.1	2.5	9.0	6.2	37.1	0.7	35.6	1.9	12.7	17.2	3.1	4.6	1.6	1.3	0.6	2.6	2.9	15.2	3.0	39.9	31.8	22.7	25.2	1.6	2.3	18.5	29.5	22.3	35.7	32.5	56.2	24.0	20.6	11.3	10.1	16.7	20.6	31.8	22.2	33.3	52.3	16.6	20.5	25.6	26.0	0.1	33.8	27.6	1.1	1.4	33.2	13.7	4.4	17.9	27.7	27.7	25.3	31.3	32.3	29.8	21.4	16.1	27.5	39.3	30.5	44.1	11.0	11.1	17.9	21.1	12.9	27.9	63.5	7.4	13.7	41.1	33.1	9.7	15.6	40.3	16.1	45.1	22.3	10.7	35.8	22.1	42.6	19.6	0.0	0.7	0.6	2.2	2.6	0.3	1.6	5.3	3.6	1.3	0.3	6.4	3.6	0.0	2.9	2.0	1.0	15.2	3.0	3.4	3.1	0.9	2.8	2.7	1.8	2.4	3.4	1.9	0.7	3.0	1.7	4.5	4.8	16.4	1.3	0.8	5.1	1.4	3.4	5.2	0.0	36.2	0.0	9.4	58.5	2.3	7.0	46.7	11.7	87.4	2.8	1.3	0.0	3.4	41.1	0.0	0.0	9.8	8.3	149.1	4.6	7.4	6.8	2.8	11.6	1.2	6.7	11.8	2.5	4.6	1.1	0.0	0.9	124.1	125.8	7.2	19.3	7.9	22.7	2.0